Gene	Gene synonym	Ensembl	Gene description	Uniprot	Chromosome	Position	Protein class	Biological process	Molecular function	Disease involvement	Evidence	HPA evidence	UniProt evidence	NeXtProt evidence	MS evidence	RNA tissue specificity	RNA tissue distribution	RNA tissue specificity score	RNA tissue specific NX	RNA single cell type specificity	RNA single cell type distribution	RNA single cell type specificity score	RNA single cell type specific NX	RNA cancer specificity	RNA cancer distribution	RNA cancer specificity score	RNA cancer specific FPKM	RNA brain regional specificity	RNA brain regional distribution	RNA brain regional specificity score	RNA brain regional specific NX	RNA blood cell specificity	RNA blood cell distribution	RNA blood cell specificity score	RNA blood cell specific NX	RNA blood lineage specificity	RNA blood lineage distribution	RNA blood lineage specificity score	RNA blood lineage specific NX	RNA cell line specificity	RNA cell line distribution	RNA cell line specificity score	RNA cell line specific NX	RNA mouse brain regional specificity	RNA mouse brain regional distribution	RNA mouse brain regional specificity score	RNA mouse brain regional specific pTPM	RNA pig brain regional specificity	RNA pig brain regional distribution	RNA pig brain regional specificity score	RNA pig brain regional specific pTPM	Antibody	Reliability (IH)	Reliability (Mouse Brain)	Reliability (IF)	Subcellular location	Secretome location	CCD Protein	CCD Transcript	Blood concentration - Conc. blood IM [pg/L]	Blood concentration - Conc. blood MS [pg/L]	Subcellular main location	Subcellular additional location	Antibody RRID	Pathology prognostics - Breast cancer	Pathology prognostics - Cervical cancer	Pathology prognostics - Colorectal cancer	Pathology prognostics - Endometrial cancer	Pathology prognostics - Glioma	Pathology prognostics - Head and neck cancer	Pathology prognostics - Liver cancer	Pathology prognostics - Lung cancer	Pathology prognostics - Melanoma	Pathology prognostics - Ovarian cancer	Pathology prognostics - Pancreatic cancer	Pathology prognostics - Prostate cancer	Pathology prognostics - Renal cancer	Pathology prognostics - Stomach cancer	Pathology prognostics - Testis cancer	Pathology prognostics - Thyroid cancer	Pathology prognostics - Urothelial cancer	Tissue RNA - adipose tissue [NX]	Tissue RNA - adrenal gland [NX]	Tissue RNA - amygdala [NX]	Tissue RNA - appendix [NX]	Tissue RNA - basal ganglia [NX]	Tissue RNA - bone marrow [NX]	Tissue RNA - breast [NX]	Tissue RNA - cerebellum [NX]	Tissue RNA - cerebral cortex [NX]	Tissue RNA - cervix, uterine [NX]	Tissue RNA - colon [NX]	Tissue RNA - corpus callosum [NX]	Tissue RNA - ductus deferens [NX]	Tissue RNA - duodenum [NX]	Tissue RNA - endometrium 1 [NX]	Tissue RNA - epididymis [NX]	Tissue RNA - esophagus [NX]	Tissue RNA - fallopian tube [NX]	Tissue RNA - gallbladder [NX]	Tissue RNA - heart muscle [NX]	Tissue RNA - hippocampal formation [NX]	Tissue RNA - hypothalamus [NX]	Tissue RNA - kidney [NX]	Tissue RNA - liver [NX]	Tissue RNA - lung [NX]	Tissue RNA - lymph node [NX]	Tissue RNA - midbrain [NX]	Tissue RNA - olfactory region [NX]	Tissue RNA - ovary [NX]	Tissue RNA - pancreas [NX]	Tissue RNA - parathyroid gland [NX]	Tissue RNA - pituitary gland [NX]	Tissue RNA - placenta [NX]	Tissue RNA - pons and medulla [NX]	Tissue RNA - prostate [NX]	Tissue RNA - rectum [NX]	Tissue RNA - retina [NX]	Tissue RNA - salivary gland [NX]	Tissue RNA - seminal vesicle [NX]	Tissue RNA - skeletal muscle [NX]	Tissue RNA - skin 1 [NX]	Tissue RNA - small intestine [NX]	Tissue RNA - smooth muscle [NX]	Tissue RNA - spinal cord [NX]	Tissue RNA - spleen [NX]	Tissue RNA - stomach 1 [NX]	Tissue RNA - testis [NX]	Tissue RNA - thalamus [NX]	Tissue RNA - thymus [NX]	Tissue RNA - thyroid gland [NX]	Tissue RNA - tongue [NX]	Tissue RNA - tonsil [NX]	Tissue RNA - urinary bladder [NX]	Tissue RNA - vagina [NX]	Tissue RNA - B-cells [NX]	Tissue RNA - dendritic cells [NX]	Tissue RNA - granulocytes [NX]	Tissue RNA - monocytes [NX]	Tissue RNA - NK-cells [NX]	Tissue RNA - T-cells [NX]	Tissue RNA - total PBMC [NX]	Cell RNA - A-431 [NX]	Cell RNA - A549 [NX]	Cell RNA - AF22 [NX]	Cell RNA - AN3-CA [NX]	Cell RNA - ASC diff [NX]	Cell RNA - ASC TERT1 [NX]	Cell RNA - BEWO [NX]	Cell RNA - BJ [NX]	Cell RNA - BJ hTERT+ [NX]	Cell RNA - BJ hTERT+ SV40 Large T+ [NX]	Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]	Cell RNA - CACO-2 [NX]	Cell RNA - CAPAN-2 [NX]	Cell RNA - Daudi [NX]	Cell RNA - EFO-21 [NX]	Cell RNA - fHDF/TERT166 [NX]	Cell RNA - GAMG [NX]	Cell RNA - HaCaT [NX]	Cell RNA - HAP1 [NX]	Cell RNA - HBEC3-KT [NX]	Cell RNA - HBF TERT88 [NX]	Cell RNA - HDLM-2 [NX]	Cell RNA - HEK 293 [NX]	Cell RNA - HEL [NX]	Cell RNA - HeLa [NX]	Cell RNA - Hep G2 [NX]	Cell RNA - HHSteC [NX]	Cell RNA - HL-60 [NX]	Cell RNA - HMC-1 [NX]	Cell RNA - HSkMC [NX]	Cell RNA - hTCEpi [NX]	Cell RNA - hTEC/SVTERT24-B [NX]	Cell RNA - hTERT-HME1 [NX]	Cell RNA - hTERT-RPE1 [NX]	Cell RNA - HUVEC TERT2 [NX]	Cell RNA - JURKAT [NX]	Cell RNA - K-562 [NX]	Cell RNA - Karpas-707 [NX]	Cell RNA - LHCN-M2 [NX]	Cell RNA - MCF7 [NX]	Cell RNA - MOLT-4 [NX]	Cell RNA - NB-4 [NX]	Cell RNA - NTERA-2 [NX]	Cell RNA - OE19 [NX]	Cell RNA - PC-3 [NX]	Cell RNA - REH [NX]	Cell RNA - RH-30 [NX]	Cell RNA - RPMI-8226 [NX]	Cell RNA - RPTEC TERT1 [NX]	Cell RNA - RT4 [NX]	Cell RNA - SCLC-21H [NX]	Cell RNA - SH-SY5Y [NX]	Cell RNA - SiHa [NX]	Cell RNA - SK-BR-3 [NX]	Cell RNA - SK-MEL-30 [NX]	Cell RNA - SuSa [NX]	Cell RNA - T-47d [NX]	Cell RNA - THP-1 [NX]	Cell RNA - TIME [NX]	Cell RNA - U-138 MG [NX]	Cell RNA - U-2 OS [NX]	Cell RNA - U-2197 [NX]	Cell RNA - U-251 MG [NX]	Cell RNA - U-266/70 [NX]	Cell RNA - U-266/84 [NX]	Cell RNA - U-698 [NX]	Cell RNA - U-87 MG [NX]	Cell RNA - U-937 [NX]	Cell RNA - WM-115 [NX]	Blood RNA - basophil [NX]	Blood RNA - classical monocyte [NX]	Blood RNA - eosinophil [NX]	Blood RNA - gdT-cell [NX]	Blood RNA - intermediate monocyte [NX]	Blood RNA - MAIT T-cell [NX]	Blood RNA - memory B-cell [NX]	Blood RNA - memory CD4 T-cell [NX]	Blood RNA - memory CD8 T-cell [NX]	Blood RNA - myeloid DC [NX]	Blood RNA - naive B-cell [NX]	Blood RNA - naive CD4 T-cell [NX]	Blood RNA - naive CD8 T-cell [NX]	Blood RNA - neutrophil [NX]	Blood RNA - NK-cell [NX]	Blood RNA - non-classical monocyte [NX]	Blood RNA - plasmacytoid DC [NX]	Blood RNA - T-reg [NX]	Blood RNA - total PBMC [NX]	Brain RNA - amygdala [NX]	Brain RNA - basal ganglia [NX]	Brain RNA - cerebellum [NX]	Brain RNA - cerebral cortex [NX]	Brain RNA - hippocampal formation [NX]	Brain RNA - hypothalamus [NX]	Brain RNA - midbrain [NX]	Brain RNA - olfactory region [NX]	Brain RNA - pons and medulla [NX]	Brain RNA - thalamus [NX]	Single Cell Type RNA - Alveolar cells type 1 [NX]	Single Cell Type RNA - Alveolar cells type 2 [NX]	Single Cell Type RNA - B-cells [NX]	Single Cell Type RNA - Basal glandular cells [NX]	Single Cell Type RNA - Basal keratinocytes [NX]	Single Cell Type RNA - Bipolar cells [NX]	Single Cell Type RNA - Cardiomyocytes [NX]	Single Cell Type RNA - Cholangiocytes [NX]	Single Cell Type RNA - Ciliated cells [NX]	Single Cell Type RNA - Club cells [NX]	Single Cell Type RNA - Collecting duct cells [NX]	Single Cell Type RNA - Cone photoreceptor cells [NX]	Single Cell Type RNA - Cytotrophoblasts [NX]	Single Cell Type RNA - Distal tubular cells [NX]	Single Cell Type RNA - Ductal cells [NX]	Single Cell Type RNA - Early spermatids [NX]	Single Cell Type RNA - Endothelial cells [NX]	Single Cell Type RNA - Enterocytes [NX]	Single Cell Type RNA - Erythroid cells [NX]	Single Cell Type RNA - Exocrine glandular cells [NX]	Single Cell Type RNA - Extravillous trophoblasts [NX]	Single Cell Type RNA - Fibroblasts [NX]	Single Cell Type RNA - Glandular cells [NX]	Single Cell Type RNA - granulocytes [NX]	Single Cell Type RNA - Hepatocytes [NX]	Single Cell Type RNA - Hofbauer cells [NX]	Single Cell Type RNA - Horizontal cells [NX]	Single Cell Type RNA - Intestinal endocrine cells [NX]	Single Cell Type RNA - Ito cells [NX]	Single Cell Type RNA - Kupffer cells [NX]	Single Cell Type RNA - Late spermatids [NX]	Single Cell Type RNA - Leydig cells [NX]	Single Cell Type RNA - Macrophages [NX]	Single Cell Type RNA - Melanocytes [NX]	Single Cell Type RNA - monocytes [NX]	Single Cell Type RNA - Mucus-secreting cells [NX]	Single Cell Type RNA - Muller glia cells [NX]	Single Cell Type RNA - Pancreatic endocrine cells [NX]	Single Cell Type RNA - Paneth cells [NX]	Single Cell Type RNA - Peritubular cells [NX]	Single Cell Type RNA - Proximal tubular cells [NX]	Single Cell Type RNA - Rod photoreceptor cells [NX]	Single Cell Type RNA - Sertoli cells [NX]	Single Cell Type RNA - Smooth muscle cells [NX]	Single Cell Type RNA - Spermatocytes [NX]	Single Cell Type RNA - Spermatogonia [NX]	Single Cell Type RNA - Suprabasal keratinocytes [NX]	Single Cell Type RNA - Syncytiotrophoblasts [NX]	Single Cell Type RNA - T-cells [NX]	Single Cell Type RNA - Undifferentiated cells [NX]	Single Cell Type RNA - Urothelial cells [NX]	RNAsingleCellTypeSpecific
CFH	ARMD4, ARMS1, FHL1, HF, HF1, HF2, HUS	ENSG00000000971	Complement factor H	P08603	1	196651878-196747504	Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins	Complement alternate pathway, Host-virus interaction, Immunity, Innate immunity		Age-related macular degeneration, Cancer-related genes, Disease mutation, Hemolytic uremic syndrome	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	6	liver: 295.2	Cell type enriched	Detected in many	4	Hepatocytes: 1052.9	Cancer enriched	Detected in all	9	liver cancer: 151.1	Low region specificity	Detected in all			Cell type enhanced	Detected in some		MAIT T-cell: 16.5	Lineage enriched	Detected in single	27	T-cells: 16.5	Cell line enhanced	Detected in many		HHSteC: 26.9;HSkMC: 26.3;hTERT-RPE1: 81.0;RT4: 47.7									CAB016385, CAB016769, HPA038922, HPA049176, HPA053326	Supported		Approved	Vesicles	Secreted to blood			396000000000	110000000000	Vesicles		CAB016385: AB_627572, CAB016769: , HPA038922: AB_2676271, HPA049176: AB_2680663, HPA053326: AB_2682113	unprognostic (2.40e-1)	unprognostic (9.86e-2)	unprognostic (1.22e-1)	unprognostic (8.39e-2)	unprognostic (5.40e-3)	unprognostic (1.80e-1)	unprognostic (3.75e-3)	unprognostic (7.40e-2)	unprognostic (1.06e-1)	unprognostic (1.04e-1)	unprognostic (9.08e-2)	unprognostic (2.08e-1)	prognostic unfavorable (1.92e-6)	unprognostic (6.50e-3)	unprognostic (4.49e-3)	unprognostic (1.73e-1)	unprognostic (1.37e-1)	28.6	5.5	1.6	3.7	3.8	0.1	8.8	2.6	2.7	10.4	9.1	1	3.9	3.7	2.5	8.7	15.2	3.4	17	47.3	2	1.2	7	295.2	11	10.3	5.3	1.7	40.9	1.9	1.7	4.3	5.1	5.3	10.3	10.4	6.3	19	3.3	10	11.5	8.1	12.6	4.2	3.3	5.8	6.4	2.9	0.7	22	22.8	5.8	17.2	16.8	0	0.1	0.6	0.1	0	16.5	1	0	13.6	0	0	21.4	12.1	0	5.5	13.5	0.7	2.9	0	2.5	0	2	0	0	0.4	0	5	0.5	0.2	0	4.1	16.2	0	26.9	0.1	0	26.3	0	4	1.7	81	16.8	0	15.3	0.5	19.1	0	0.1	0	0	0	0	0	19.6	4.3	0	47.7	0	0	0	0	0	0.1	0	0	1.2	16.2	0.2	0.1	0.1	0.1	0	0	2.9	0	1.2	0	0.1	0	1.8	0	16.5	0	6	3.5	0.1	0	0.4	1.4	0.6	0	0	0	0	1	1.6	3.8	2.6	2.7	2	1.2	5.3	1.7	5.3	2.9	8.9	14.5	21	47.7	39.3	0.4	6.2	30.6	119.1	131.9	5.2	0	0	0	1.9	1.5	55	0	0	0.7	0	200.9	8.6	3.5	1052.9	0.9	0	0	57.1	34.9	3.6	262.9	6	42.2	0	0	0.3	6.4	0	130.4	0	1.4	6.5	36.8	0.7	0.6	33.4	0.1	10.2	0	49.2	Hepatocytes
CFTR	ABC35, ABCC7, CF, CFTR/MRP, dJ760C5.1, MRP7, TNR-CFTR	ENSG00000001626	Cystic fibrosis transmembrane conductance regulator	P13569	7	117465784-117715971	Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters	Ion transport, Transport	Chloride channel, Ion channel, Isomerase	Cancer-related genes, Disease mutation, FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	4	pancreas: 103.0	Cell type enriched	Detected in many	5	Ductal cells: 325.5	Cancer enhanced	Detected in many		colorectal cancer: 23.9;pancreatic cancer: 28.0	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	22	CACO-2: 12.8;MOLT-4: 48.1;U-266/70: 26.3	Low region specificity	Detected in some			Region enriched	Detected in single	5	olfactory region: 6.3	CAB001951, HPA021939, HPA079652	Enhanced											CAB001951: , HPA021939: AB_1846578, HPA079652: 	unprognostic (6.38e-3)	unprognostic (9.55e-2)	unprognostic (1.77e-2)	unprognostic (1.44e-2)	unprognostic (8.74e-2)	unprognostic (8.57e-2)	prognostic unfavorable (9.44e-4)	unprognostic (3.20e-3)	unprognostic (1.13e-1)	unprognostic (8.89e-2)	unprognostic (1.55e-2)	unprognostic (2.14e-2)	unprognostic (4.78e-3)	unprognostic (1.24e-1)	unprognostic (2.58e-1)	unprognostic (9.08e-2)	unprognostic (6.64e-2)	0.4	0.2	0.4	10.5	0.4	0	0.3	0.3	0.3	2.5	19.8	0.1	0.8	10.5	0.6	2.1	0.4	0.4	15.8	0.3	0.4	0.3	1.1	1.4	5.7	0.1	0.5	0.1	0.3	103	0	0.3	0.1	0.1	1.5	12.5	0.1	22.4	0.1	0.3	1.1	24.2	0.3	0.7	0.3	0.6	0.9	0.1	0.1	0.3	0.2	0.3	0.4	0.3	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	12.8	0	0	1.3	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	48.1	0	0.8	0	0	0	0	0.2	0	0	0	0	0.2	0	0	1	0	0	0	0	0.1	0	0	26.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0.4	0.3	0.3	0.4	0.3	0.5	0.1	0.1	0.1	6	48.7	0	1.7	0	0.4	1.2	43.3	9.4	23.9	0	0	0	0	325.5	2.9	0	19.4	0	3.7	0	0.1	3.6	1.1	0.2	0	0	6.9	0	0	1.6	0.3	0	0	11.8	11.5	0.6	21.5	37.7	0	0	0	0	0.3	1.8	0.4	0	0	0	64.4	3.9	Ductal cells
SLC4A1	AE1, CD233, DI, EPB3, FR, RTA1A, SW, WD, WR	ENSG00000004939	Solute carrier family 4 member 1 (Diego blood group)	P02730	17	44248385-44268141	Blood group antigen proteins, CD markers, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters	Anion exchange, Ion transport, Transport	Blood group antigen	Disease mutation, Elliptocytosis, Hereditary hemolytic anemia	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		bone marrow: 95.7;placenta: 32.7	Cell type enriched	Detected in some	66	Erythroid cells: 1261.4	Cancer enriched	Detected in single	91	renal cancer: 16.3	Not detected	Not detected			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low cell line specificity	Detected in many			Region enhanced	Detected in single		cerebellum: 0.4	Low region specificity	Detected in all			HPA015584, CAB034438, HPA063911	Enhanced								160000000			CAB034438: AB_2123479, HPA015584: AB_1844824, HPA063911: AB_2685151	unprognostic (1.36e-1)	unprognostic (1.42e-1)	unprognostic (3.36e-1)	unprognostic (2.44e-2)	unprognostic (2.32e-2)	unprognostic (1.56e-2)	unprognostic (1.55e-1)	unprognostic (1.59e-1)	unprognostic (1.68e-1)	unprognostic (1.58e-1)	unprognostic (6.72e-3)	unprognostic (1.19e-1)	unprognostic (9.28e-3)	unprognostic (1.93e-2)	unprognostic (2.18e-1)	unprognostic (1.94e-1)	unprognostic (2.13e-1)	0.9	0.1	0.3	0.2	0.4	95.7	0.2	0.8	0.2	0.1	0.1	0.6	0	0.2	0.1	0.4	0.6	0.2	0.2	2.6	0.2	0.3	18.6	1.3	12.9	0.8	0.6	0.1	2.8	0.1	0	0.6	32.7	0.9	0.6	0.1	1.2	0.1	0.1	1.2	0.2	0.1	0	1	8.4	0.1	0.3	0	0.7	1.9	0	0.2	3.9	11.8	1.8	1.4	6.3	1.2	2.9	1.5	0.7	1.3	0.5	1.4	1.7	0.6	0.7	1	0.3	0.4	0.3	0.8	1.4	3.2	0.7	0.6	0.3	0.4	1.4	0.5	0.5	1.1	1.3	1.3	1.7	1.6	2.2	0	0.8	2.3	0.8	0.5	0.8	0.8	0.5	0.2	0.6	4.8	3.5	0.4	0.6	1	3.5	0.9	0.7	0.5	2.5	0.7	1.9	0.3	0.8	2.2	1	1.3	1.4	0.5	0.7	2.5	1.8	1	2.4	2.1	1.4	1.4	1	2.3	1.1	1.6	2.2	1.1	6.1	1	2	1.1	0.9	1	1.1	1	0.9	0.5	1.8	1.5	1.2	6.3	2.9	1.2	1.4	0.7	0.7	0.3	0.4	0.8	0.2	0.2	0.3	0.6	0.1	0.9	0	6	1.1	0	0.9	0	0.4	0.7	0	0	1.2	19.2	0	0.3	3.3	0	0.5	0	0	1261.4	0	0.9	0.3	0.4	0	0	1.3	0	0	0.6	0.3	0	0	0	0	0	0	0.2	0	0	0.4	0.2	0	0	0.2	0.9	0.4	0	0.7	0	0	0.5	Erythroid cells
PON1	ESA, PON	ENSG00000005421	Paraoxonase 1	P27169	7	95297676-95324707	Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters		Hydrolase	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	23	liver: 144.1	Cell type enriched	Detected in some	47	Hepatocytes: 399.2	Cancer enriched	Detected in some	78	liver cancer: 97.8	Not detected	Not detected			Cell type enhanced	Detected in single		NK-cell: 1.0	Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		A549: 1.5;HeLa: 1.0;RH-30: 1.0;U-266/70: 1.0	Not detected	Not detected			Low region specificity	Detected in some			HPA001610	Approved				Secreted to blood			96000000000	24000000000			HPA001610: AB_1079656	unprognostic (2.02e-2)	unprognostic (2.41e-2)	unprognostic (3.04e-1)	unprognostic (3.54e-2)	unprognostic (2.70e-1)		prognostic favorable (7.24e-7)	unprognostic (2.24e-1)	unprognostic (1.95e-1)	unprognostic (9.02e-3)	unprognostic (1.76e-3)	unprognostic (3.97e-2)	unprognostic (6.74e-9)	unprognostic (1.09e-3)	unprognostic (2.29e-2)	unprognostic (2.07e-1)	unprognostic (5.54e-3)	0	1.7	0.2	0.1	0.1	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0.2	0	0.1	0.1	0	144.1	0	0	0.1	0	0.2	0	0	0.3	0	0	0	0	1.6	0	0	0	0	0	0	0	0	0	0.1	0	6.1	0	0	0	0	0	0.1	0.5	0.6	0	1	0.1	0	0	1.5	0.1	0	0	0	0.1	0	0	0	0	0	0.6	0.3	0	0	0	0.1	0	0	0.1	0	0	0	1	0.6	0	0.4	0.1	0	0	0	0	0	0	0	0	0.4	0	0	0.1	0.4	0.4	0	0.2	0	1	0	0	0.3	0.6	0.1	0	0.3	0	0.2	0.4	0	0.5	0	0.1	0	0.2	1	0.3	0	0	0.2	0.3	0.6	0	0.2	0.1	0	0	0	0	0	0	0.1	0	0	0.3	1	0	0.5	0	0	0.2	0.1	0	0	0.1	0.1	0.1	0	0	0	0	1	0	0	0	0	0.4	7.6	0	0	0	0	0	0	0	0.1	0	0	0	0.2	0	0.1	0.6	0	399.2	0	0	2.9	8	8.6	0	0.6	0	0	0	0	0.3	0.1	0	0	0	0.3	0	0	0.4	0	0.1	0	0	0	0	Hepatocytes
ABCB4	GBD1, MDR2, MDR3, PFIC-3, PGY3	ENSG00000005471	ATP binding cassette subfamily B member 4	P21439	7	87401697-87480435	Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters	Lipid transport, Transport	Translocase	Disease mutation, Intrahepatic cholestasis	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	8	liver: 93.2	Cell type enriched	Detected in some	6	Hepatocytes: 235.3	Cancer enriched	Detected in some	11	liver cancer: 16.3	Low region specificity	Detected in single			Group enriched	Detected in some	6	memory B-cell: 4.9;naive B-cell: 11.4	Lineage enriched	Detected in many	8	B-cells: 11.4	Group enriched	Detected in some	5	SH-SY5Y: 12.0;WM-115: 22.9	Low region specificity	Detected in many			Not detected	Not detected			HPA049395, HPA053288	Enhanced		Approved	Nucleoplasm,Plasma membrane,Actin filaments,Focal adhesion sites						Nucleoplasm, Plasma membrane, Actin filaments	Focal adhesion sites	HPA049395: AB_2680745, HPA053288: AB_2682102	unprognostic (7.92e-2)	unprognostic (8.87e-2)	unprognostic (1.97e-1)	unprognostic (1.90e-1)	unprognostic (8.95e-2)	unprognostic (1.06e-2)	unprognostic (2.35e-3)	unprognostic (9.91e-2)	unprognostic (3.53e-1)	unprognostic (1.19e-1)	unprognostic (2.44e-3)	unprognostic (8.43e-2)	unprognostic (2.83e-2)	unprognostic (8.01e-3)	unprognostic (7.12e-2)	unprognostic (2.11e-2)	unprognostic (2.47e-1)	0.5	4.1	0.2	4.3	0.2	0.2	0.3	0.1	1.1	0.2	0.6	0.4	0	0	0.1	0.2	0.6	0.1	0.3	4	0.3	0.2	0.4	93.2	0.1	4.1	0.3	0.2	0.3	0.1	0	0.5	0	0.3	0.3	0.4	0.8	0.4	0.1	2.9	0.6	1.2	1.6	0.5	5.2	0.2	0.5	0.4	0.1	0.4	4.2	3.2	0.6	0.5	11.4	1.4	0	0	0	0.1	0.2	0	0	2.8	0	0	0	0	0.1	2	0	0	0	0	1.8	0	0	0.1	0.1	0	0	0	0	0.5	0.3	0	3.5	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0.1	0	0	0.3	0	0	0	0.3	0	0	0	0.1	12	0	0.6	2.2	0.5	0.2	0.5	0	0.2	1.6	0.1	0	0	0	2.8	0.2	0	22.9	0	0	0	0	0	0.1	4.9	0	0.1	1.4	11.4	0	0	0	0	0	0.4	0	0.2	0.2	0.2	0.1	1.1	0.3	0.2	0.3	0.2	0.3	0.4	0	0.3	23.1	0	0.9	0	9.3	0	0	0	1.8	0	0.9	0	0.1	0.6	0.8	0.1	0	0	0.2	1.5	0	0	235.3	0.5	36.5	0	5.5	5.4	0.2	0	0	10.1	0	0	0	0.1	0	0.4	0.5	0	0	0.9	0.5	0.1	0.4	0.1	0	0	0	Hepatocytes
SOX8		ENSG00000005513	SRY-box 8	P57073	16	981808-986979	Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	DNA-binding		Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	7	brain: 64.9	Cell type enriched	Detected in some	22	Muller glia cells: 120.0	Cancer enriched	Detected in many	6	glioma: 46.9	Low region specificity	Detected in all			Cell type enhanced	Detected in some		naive CD4 T-cell: 2.2;naive CD8 T-cell: 1.1	Lineage enriched	Detected in single	23	T-cells: 2.2	Cell line enriched	Detected in some	5	RH-30: 51.7	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA041640, HPA058665			Enhanced	Nucleoplasm		No				Nucleoplasm		HPA041640: AB_10964357, HPA058665: AB_2683792	unprognostic (1.40e-2)	unprognostic (2.56e-3)	unprognostic (1.59e-1)	unprognostic (3.10e-2)	unprognostic (4.58e-2)	unprognostic (7.16e-3)	unprognostic (6.05e-3)	unprognostic (3.01e-2)	unprognostic (2.53e-1)	unprognostic (1.16e-1)	unprognostic (4.53e-3)	unprognostic (4.46e-2)	unprognostic (1.20e-3)	unprognostic (8.50e-2)	unprognostic (6.18e-2)	unprognostic (5.47e-1)	unprognostic (9.09e-2)	1.6	1.5	18.4	1.8	25.1	1	2.5	3.2	64.9	1.2	1.4	20.9	0	1.1	1.1	1.1	1.2	1.1	1.5	1.8	22.6	14.5	1	1	1	2.7	26.5	5.4	1	1.5	1	0.1	1.4	12	1.3	1.5	0.9	8.6	1.4	1.3	1.3	1.2	1.2	27.1	1.8	1.7	1.9	30.4	0	1.1	0	3.1	1.1	0.3	0	0	0	0	0	2.2	0.2	0	0.3	1	9.7	0	0	0	0	0	0	0	0.5	0	0	0.6	0	0	0.1	2.2	0	0	0	0.6	0	0	0	0	0	0.1	0.3	0	0	0	0	0	0	0.1	0.1	0	0	0	0	1.5	0.7	0.1	0	51.7	1.9	0	0	0	0	0	0	1.7	0.1	0	0	0	0	0.3	0	0	0	0	0.4	0.1	0.1	3.8	0	0	0	0	0	0	0	0.5	0.1	0	0	2.2	1.1	0	0	0	0	0	0.2	18.4	25.1	3.2	11.8	22.6	14.5	26.5	5.4	12	30.4	0	0	0	0.4	0.3	1.4	1.1	0	0	0	0	0	0	0	0.4	0	1.1	0	0	0.2	0.1	2.1	1.4	0	0	0.1	0	0	1.3	0	0	3.1	0	1.7	1	0	120	0.1	0	1.8	0	5.3	0	0.8	0	4.3	0.9	0	0	0	0.1	Muller glia cells
CACNG3		ENSG00000006116	Calcium voltage-gated channel auxiliary subunit gamma 3	O60359	16	24255553-24362801	Predicted membrane proteins, Transporters	Calcium transport, Ion transport, Transport	Calcium channel, Ion channel, Voltage-gated channel		Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	18	brain: 32.2	Cell type enriched	Detected in some	46	Horizontal cells: 166.8	Cancer enriched	Detected in single	15	glioma: 0.7	Group enriched	Detected in many	6	amygdala: 12.8;basal ganglia: 13.1;cerebral cortex: 20.0;hippocampal formation: 12.7	Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HeLa: 1.3;Karpas-707: 1.0;U-266/70: 1.1	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA077238	Enhanced											HPA077238: 					unprognostic (5.61e-2)						unprognostic (3.09e-1)			unprognostic (2.12e-1)	unprognostic (1.17e-1)			0.4	1.8	12.8	0.4	13.1	0.5	0.3	0.2	32.2	0.3	0.4	0.1	0	0.3	0.3	0.4	0.3	0.4	0.3	0.3	12.7	2.2	0.3	0.4	0.3	0.4	1.8	2.3	0.4	0.3	0.3	0	0.4	0.3	0.4	0.4	0.1	0.3	0.4	0.3	0.4	0.3	0.4	0.3	0.4	0.4	0.6	0	0	0.3	0	0.4	0.3	0	0	0	0.3	0.1	0	0	0	0.1	0	0.3	0	0	0	0	0	0	0	0	0	0.2	0.2	0	0	0	0	0.1	0	0.1	0.1	0	0	1.3	0	0	0.5	0.1	0	0	0.1	0	0.2	0	0	0	1	0	0	0	0.2	0	0	0	0	0	0	0	0.1	0.2	0	0.2	0	0	0.1	0	0	0	0.2	0.1	0	0	1.1	0	0.2	0.9	0.2	0.1	0.1	0	0.2	0	0	0	0	0	0	0	0	0	0	0.3	0	0.1	0	0	0	12.8	13.1	0.2	20	12.7	2.2	1.8	2.3	0.3	0	0	0	0	0	0	3.1	0.4	0	0	0	0	0	0	0	0	3.6	0	0	0	0	0	0	0	0	0	0	166.8	0	0	0	2	0	0	0	0	0	0.3	0	0	0	0	1.1	0	0	0	0	0	0	0	0	0	Horizontal cells
CACNA1G	Cav3.1, NBR13	ENSG00000006283	Calcium voltage-gated channel subunit alpha1 G	O43497	17	50561068-50627474	Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels	Calcium transport, Ion transport, Transport	Calcium channel, Ion channel, Voltage-gated channel	Disease mutation, FDA approved drug targets, Neurodegeneration, Spinocerebellar ataxia	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 22.8;cervix, uterine: 13.6	Cell type enriched	Detected in some	26	Bipolar cells: 147.6	Low cancer specificity	Detected in some			Low region specificity	Detected in all			Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		A549: 13.4;GAMG: 5.0;HeLa: 4.6	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA004714	Uncertain											HPA004714: AB_1078368	unprognostic (1.90e-2)	unprognostic (5.83e-2)	unprognostic (2.85e-2)	unprognostic (1.08e-1)	unprognostic (4.00e-1)	unprognostic (9.89e-2)	unprognostic (1.47e-2)	unprognostic (2.73e-1)	unprognostic (1.02e-4)	unprognostic (1.47e-2)	unprognostic (2.16e-2)	unprognostic (9.76e-2)	unprognostic (4.87e-12)	unprognostic (3.34e-2)	unprognostic (1.62e-1)	unprognostic (1.56e-3)	unprognostic (6.63e-2)	1.7	1	3.5	0.9	5.2	1.3	2.1	22.8	17.1	13.6	1	2.7	0	0.9	7.4	1	1.6	5.7	1.2	3.8	2.4	8.8	0.7	1.1	0.9	1.2	5.3	7.9	7.1	0.6	0.6	0.4	1.4	6.1	2.5	0.8	4.3	1.1	1.6	0.8	3.9	0.8	2.1	5.9	0.9	0.9	1.7	2.3	0	1.2	0	1	1	3.9	1.3	1.3	2.7	0.8	0.7	1.4	0	0	13.4	3.1	3.5	0.9	0.1	0.2	0.1	0	0.1	0.2	2.8	0.5	0	1	0.1	5	0.5	1.6	0	0.3	1.8	0.6	0.9	4.6	0.7	0.1	0.2	0.3	0.1	0	0	0	0.8	0	0.1	0	0.2	0.1	0.7	0	0	1.2	1	0.8	1.4	1.1	0	0	0.2	4.1	1.8	2.8	0.1	0	2.4	0.2	0.1	0.3	1.4	3.9	0.5	0.1	1	0.1	0	0.6	0.1	0.5	0.5	0.8	0.6	1.4	0.4	0.7	0.8	0.7	0.8	0.2	1.3	0.9	1	2.7	0.7	0.4	1.3	0.5	0	3.5	5.2	22.8	17.1	2.4	8.8	5.3	7.9	6.1	2.3	0	0	0	0.1	1.6	147.6	4.1	0	0	0	0	0	0	0	0	1.4	0	0	0	0	0.3	3.6	0.4	0	0	0.4	4.8	0	0	0	0	0	0	3.3	0	0	1.8	0	0	0	0	5.7	0	3.6	0.3	0.2	2.5	0.1	0	0	0	Bipolar cells
TBXA2R		ENSG00000006638	Thromboxane A2 receptor	P21731	19	3594506-3606840	Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins		G-protein coupled receptor, Receptor, Transducer	Disease mutation, FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in some	7	Ito cells: 35.0	Low cancer specificity	Detected in all			Low region specificity	Detected in many			Cell type enhanced	Detected in many		naive B-cell: 12.6	Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		HeLa: 11.9;U-2197: 8.6;U-937: 7.4	Low region specificity	Detected in single			Low region specificity	Detected in many			HPA077366			Supported	Nuclear speckles,Plasma membrane						Plasma membrane	Nuclear speckles	HPA077366: AB_2686836	unprognostic (1.59e-1)	unprognostic (3.86e-2)	unprognostic (1.21e-2)	unprognostic (1.74e-1)	unprognostic (8.97e-2)	unprognostic (4.19e-2)	unprognostic (1.52e-2)	unprognostic (2.17e-3)	unprognostic (8.41e-2)	unprognostic (6.25e-2)	prognostic favorable (7.17e-4)	unprognostic (3.89e-2)	prognostic unfavorable (1.45e-4)	unprognostic (4.32e-2)	unprognostic (9.63e-2)	unprognostic (1.76e-1)	unprognostic (2.02e-1)	8.7	11.8	1.4	3.9	1.6	2.1	3.9	0.5	1.6	13.5	3.8	1.7	3.9	2.6	7.4	4.8	8	4.7	6	6.8	2.4	1.5	10.1	18.4	6.7	7.3	1.4	1.9	8.3	2.2	2.5	1.7	10.6	2.7	3.6	1.4	5	1.7	4.2	3.1	1.8	4.4	6.5	2.1	14.9	3.7	3.4	1.9	2.2	3.9	3.2	1.8	6.8	9.6	12.6	0.3	3.2	0.4	3.1	9.6	3.9	0.1	0.2	0.2	4.1	0.9	2.2	0.7	3	0.8	2.3	1.8	0.1	0.3	0.1	4.4	1.2	2.3	0.1	0.9	0	0.9	0.2	1	2.9	11.9	0.3	1.2	0	5.3	1.1	0	3	0	1.7	0.9	0	4.5	0.4	0.4	0.2	0.2	1.5	0.1	0.1	2.6	0.1	0	0.2	0	0.1	0.2	1.7	0.2	0.4	0.1	0.3	1.8	5.1	2.6	4.8	1.1	8.6	2.8	0.2	0.3	0.2	4	7.4	1.1	2.9	0.4	0.2	2.6	0.2	0.3	1.8	0.8	2.3	0	12.6	4.6	9.6	3.2	3.1	0.2	0.3	0.2	3.9	1.4	1.6	0.5	1.6	2.4	1.5	1.4	1.9	2.7	1.9	0	0	1.3	0.1	0.5	0.4	0.8	0	0	0	1.8	0	0.1	0	0	0	4.8	0	0	0	0.1	2.3	0.1	0	0	0.7	0	0	35	1.2	0	0.3	0	1.7	0	0	0.3	0.1	0	0.7	0	0.1	0	3.1	0.1	1.3	0.5	0.1	0	0	0	Ito cells
LGALS14	CLC2, PPL13	ENSG00000006659	Galectin 14	Q8TCE9	19	39704306-39709444	Predicted intracellular proteins	Apoptosis			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in some	34	placenta: 110.8	Cell type enriched	Detected in some	72	Syncytiotrophoblasts: 74.1	Cancer enriched	Detected in single	16	liver cancer: 5.3	Not detected	Not detected			Cell type enhanced	Detected in single		naive CD4 T-cell: 3.2	Lineage enriched	Detected in single	5	T-cells: 3.2	Group enriched	Detected in some	5	EFO-21: 5.5;U-266/70: 12.8									HPA065180			Supported	Nucleoplasm						Nucleoplasm		HPA065180: 										unprognostic (1.95e-1)								0	0.2	0.1	0.1	0.1	0.2	1.1	0.1	0.3	1.5	0.1	0	0	0.2	0.1	0.1	0	0.1	0	0	0.1	0.3	0	0	0.2	0.1	0.4	0	0	0.2	0	0.2	110.8	0	0	0	0	0.1	0	0.3	0.6	0.2	0	0.3	0.3	0.1	1.4	0	0.1	0	0	0.2	0	0	0.1	0.3	0.6	0	0	3.2	0.6	0.3	0	0.4	0.7	0	0	1.7	0	0	0.1	0	0.3	0.5	0	5.5	0.1	0.1	0.8	0.1	0	0.3	1.9	0.2	0.1	1	0.4	0	0.2	1.2	0	0.3	0.3	0.4	0.7	0	0.5	0.1	1.4	0	0.5	0.2	0.3	0.2	0	0.4	0	0	0.1	0	0.2	0.4	0.3	0.1	0.4	0.2	0.8	0.1	0.2	0	0.6	0.8	1	0.3	12.8	0.7	0.1	0.4	0.3	0.3	0.6	0	0.2	0.1	0	0.1	0	0.9	0	0	0.1	3.2	0.2	0.6	0	0	0.3	0	0.6	0.1	0.1	0.1	0.3	0.1	0.3	0.4	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0.6	0	0	0	0	0.9	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	74.1	0	0	0	Syncytiotrophoblasts
ARHGAP44	KIAA0672, RICH-2, RICH2	ENSG00000006740	Rho GTPase activating protein 44	Q17R89	17	12789539-12991643	Predicted intracellular proteins	Exocytosis	GTPase activation		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 24.7;parathyroid gland: 33.8	Cell type enriched	Detected in many	6	Horizontal cells: 168.5	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in many		HEK 293: 10.5;SK-BR-3: 8.0;SuSa: 14.6	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA038814	Approved											HPA038814: AB_10673295	unprognostic (4.30e-2)	unprognostic (3.48e-1)	unprognostic (5.18e-3)	unprognostic (2.69e-2)	unprognostic (1.42e-1)	unprognostic (1.80e-1)	unprognostic (1.83e-1)	unprognostic (1.68e-2)	unprognostic (5.35e-2)	unprognostic (2.17e-1)	unprognostic (1.45e-2)	unprognostic (4.02e-2)	unprognostic (3.95e-2)	unprognostic (6.31e-3)	unprognostic (7.53e-3)	unprognostic (3.98e-1)	unprognostic (9.58e-2)	3.6	2.5	13.5	4.3	17.2	0.5	2	23.6	24.7	2.5	15.4	2.7	3.8	7.5	3.3	3.7	1.6	10.6	5.7	4.5	16.8	11.5	3.2	1	12.3	2	7.1	11.1	5.1	4.5	33.8	11.3	9.8	15.5	3.7	12.5	4.6	5.6	4.8	2.6	1.5	7.6	3.6	3.4	1.2	3.7	2.5	2.8	0	7.3	0	2	2.3	3.6	0.6	0	0	0.4	0.3	0.6	0	0.4	1.6	1.3	1	0.1	0.7	4.4	1	5.2	0.3	0.5	0.8	0.2	4.1	0.5	1.7	2.7	0.7	2.8	0	0.1	0.3	10.5	0.1	1.6	1.7	0.2	0	0.3	0.2	0.4	0.3	0	0	0	6.5	0.3	0	0	5.1	0.5	0.4	4.4	2.4	0.4	3.8	0.4	0.9	0.1	1.5	4.3	0.3	0.1	8	0.1	14.6	1.1	1.5	0	4.2	2.4	1.6	0.1	0	0	0.5	0.9	0.1	0.6	0	0	0	0.1	0.4	0.3	0.6	0.2	0.4	0	0.4	0.1	0	0	0.3	0	0	0.6	0	13.5	17.2	23.6	24.7	16.8	11.5	7.1	11.1	15.5	2.8	11.9	10.9	2	5.1	2.4	14.1	6.8	15.3	6.7	2.3	8.7	2	1.8	0	3.5	15.3	1.9	13.4	0	3.9	0.9	2.3	4	0	0.5	0.6	168.5	11.5	3.7	0.8	2.6	4	0	1.7	0	12.8	7.2	4.1	7	10.3	0.6	14.4	19.4	8	0.7	5.3	1.4	0.7	0	29.9	2.8	Horizontal cells
MARK4	FLJ90097, KIAA1860, MARKL1, Nbla00650, PAR-1D	ENSG00000007047	Microtubule affinity regulating kinase 4	Q96L34	19	45079288-45305283	Enzymes, Predicted intracellular proteins, Predicted membrane proteins	Cell cycle, Cell division, Cilium biogenesis/degradation, Mitosis	Kinase, Serine/threonine-protein kinase, Transferase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	5	Horizontal cells: 112.8	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low cell line specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA039186	Approved		Supported	Cytosol						Cytosol		HPA039186: AB_10796223	unprognostic (1.64e-1)	unprognostic (1.95e-1)	unprognostic (1.57e-3)	prognostic unfavorable (8.31e-8)	unprognostic (2.02e-1)	prognostic unfavorable (3.05e-5)	unprognostic (1.90e-1)	unprognostic (2.16e-2)	unprognostic (6.26e-2)	unprognostic (5.64e-3)	unprognostic (1.24e-3)	unprognostic (7.50e-2)	unprognostic (3.80e-2)	unprognostic (6.89e-2)	unprognostic (7.23e-2)	unprognostic (4.65e-2)	unprognostic (3.02e-2)	11.8	13	19.4	10.3	26	8.4	15.2	21.9	28.6	11.4	10.2	9	12.9	6.6	14	17.5	13.5	12.9	13.4	14.7	22.2	15.7	8.7	13.5	11.7	10.5	14.3	21.6	21	16.8	13.7	12.9	12.1	15	12.2	6.3	14.1	12.1	14.2	40.7	20.6	7.5	14.1	10.8	12.4	10.3	32.1	12.3	11.2	10.5	11.5	9.4	13.7	17.9	1	2.8	3.5	2.9	1.8	4.3	1.2	8.9	3.8	15.1	11	10.8	17.2	4.2	6.6	10.4	9.9	9.3	2.3	5.1	4.3	5.7	12.1	8.2	6.1	10.7	9.7	5.6	7.9	8.8	8.6	4.7	8.2	19.9	2.1	7.5	21.4	13.8	8.3	9.6	17.5	13.2	9.6	10.9	10.8	10.7	7.5	7.6	6.7	6.5	7.4	3.3	29.6	4.9	2.8	9.3	7.2	28.4	12.5	9.8	8.7	5.1	15.3	4.1	12.5	10.7	8.9	6.8	6	4.3	12.1	9.6	4.9	9.5	4	7.1	3.5	2.9	0.7	3.4	2.2	0.7	0.9	1.2	4.3	0.8	1	2.3	2.6	2.9	1.8	2	2.8	2.4	1.2	19.4	26	21.9	22.7	22.2	15.7	14.3	21.6	15	12.3	11.9	1.9	3	9.5	22.1	20.9	7.3	10.2	0	2.3	8.7	23.6	3.3	10	7.8	2.1	10.5	3.3	0	5.3	1.1	7.5	8.5	2.3	10.9	5.8	112.8	5.8	18.4	8.4	4.1	15	6.1	3.3	2.8	6	13.2	7.3	3.2	13.1	5.6	14.6	0	7.3	0.5	6.1	21.1	9.6	6.9	3.4	14	Horizontal cells
TKTL1	TKR, TKT2	ENSG00000007350	Transketolase like 1	P51854	X	154295671-154330350	Enzymes, Predicted intracellular proteins		Transferase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	50	blood: 28.6;testis: 103.6	Cell type enriched	Detected in some	14	Spermatogonia: 515.6	Cancer enriched	Detected in many	8	testis cancer: 44.2	Not detected	Not detected			Group enriched	Detected in many	6	eosinophil: 28.6;gdT-cell: 12.0	Group enriched	Detected in many	6	granulocytes: 28.6;T-cells: 12.0	Cell line enriched	Detected in single	157	THP-1: 102.8	Not detected	Not detected			Not detected	Not detected			HPA000505, HPA029155, CAB032191	Enhanced		Enhanced	Cytosol						Cytosol		CAB032191: , HPA000505: AB_1858022, HPA029155: AB_10603134	unprognostic (2.69e-1)	unprognostic (1.92e-1)	unprognostic (1.98e-1)	unprognostic (5.80e-3)	unprognostic (2.43e-1)	unprognostic (1.83e-1)	unprognostic (1.36e-2)	unprognostic (1.00e-1)	unprognostic (2.10e-2)	unprognostic (1.61e-1)	unprognostic (1.98e-1)	unprognostic (2.01e-1)	unprognostic (1.63e-1)	unprognostic (1.34e-2)	unprognostic (3.90e-2)	unprognostic (5.04e-2)	unprognostic (2.38e-1)	0.1	0	0	0.1	0.1	0.3	0	0	0.1	0	0	0.1	0	0	0	0.3	0	0	0	1.3	0	0	0	0	0.4	0.1	0	0	0	0	0	0.3	0.1	0.2	0	0	0.1	0	0	0.1	0	0	0	0.1	0.2	0	103.6	0	0	0	0	0	0	0	0	0.1	28.6	0.1	3.3	12	2.7	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0.3	0	0	102.8	0	0	0	0	0	0	0.6	0.5	0	0	0	0.8	0	28.6	12	0.1	1.8	0	1.4	1.1	0	0	3.1	2.7	0.4	3.3	0.1	0.1	1.5	2.7	0	0.1	0	0.1	0	0	0	0	0.2	0	0	0	0	0	0.2	0.2	17.3	0	0	0	0	0	0	0	0	32.7	0.1	0	0	0	0	0.2	0	0	0	0.2	23.8	0	0	0	16.9	3.7	1.3	0	0	0	5.3	0	0	1.8	0	1.1	25.8	1.4	35.6	515.6	0.1	0	0.5	0	0	Spermatogonia
FMO3		ENSG00000007933	Flavin containing monooxygenase 3	P31513	1	171090877-171117819	Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins		Monooxygenase, Oxidoreductase	Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	18	liver: 170.2	Cell type enriched	Detected in some	12	Hepatocytes: 378.8	Cancer enriched	Detected in many	13	liver cancer: 94.9	Region enriched	Detected in single	5	pons and medulla: 1.4	Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	4	ASC diff: 25.4;ASC TERT1: 19.2	Not detected	Not detected			Not detected	Not detected			HPA013750	Enhanced											HPA013750: AB_1848968	unprognostic (1.87e-2)	unprognostic (6.30e-2)	unprognostic (1.00e-1)	unprognostic (6.81e-3)	unprognostic (2.64e-1)	unprognostic (1.31e-3)	prognostic favorable (3.46e-4)	prognostic favorable (5.60e-5)	unprognostic (2.95e-1)	unprognostic (9.34e-2)	unprognostic (3.02e-1)	unprognostic (7.21e-2)	prognostic unfavorable (1.13e-4)	unprognostic (1.84e-1)	unprognostic (2.59e-1)	unprognostic (3.45e-1)	unprognostic (7.27e-2)	9.5	2	0	0.8	0.2	0	1.3	0.1	0.1	0.2	0.8	0.1	0.1	0.3	0.6	1.2	1.7	2.3	0.3	0.8	0	0.1	6.4	170.2	3.7	1.5	0.2	0	0.9	0.7	0.3	2.7	0	1.4	0.2	0.1	3.6	0.9	0.1	1.9	0.8	0.4	0.2	0.1	0.1	0.6	0.5	0.1	0	0.8	1.2	2.6	0.2	0	0.7	0.2	0	0	0	0	0	0	0	0	0	25.4	19.2	0	0	1	0	0	0	0	0.1	0	0	0.1	0	0	0	0	0	0	0	0	0	1	0.3	0	5.3	0	0	0	0.4	0	0	0	0.8	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0.2	0.1	0	0	0.1	0	0	0	0	0	0	0.1	0	0.1	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0	0.2	0	0	0	0.2	0.1	0.1	0	0.1	0.2	0	1.4	0.1	11.9	0.3	0.9	0.3	0.3	0	0.3	5.1	32.1	27.3	0	0	0	0	0	0.1	1.3	0	0	0	0	0.9	0.1	0	378.8	0	0	0	4.9	6.9	0	0.3	0	1.7	0	0	0.2	0.1	0	0	0	0.1	6.5	3.8	0	0	0.4	0	0	0	0	Hepatocytes
NOX1	GP91-2, MOX1, NOH-1, NOH1	ENSG00000007952	NADPH oxidase 1	Q9Y5S8	X	100843324-100874345	Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters	Electron transport, Ion transport, Transport	Ion channel, Oxidoreductase, Voltage-gated channel		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		ductus deferens: 15.0;intestine: 36.3;seminal vesicle: 18.0	Cell type enriched	Detected in some	5	Undifferentiated cells: 70.7	Cancer enriched	Detected in many	18	colorectal cancer: 82.7	Not detected	Not detected			Low cell type specificity	Detected in some			Low lineage specificity	Detected in single			Group enriched	Detected in some	14	CACO-2: 25.8;OE19: 9.7	Low region specificity	Detected in single			Not detected	Not detected																unprognostic (8.31e-2)	unprognostic (2.07e-3)	prognostic favorable (9.71e-4)	unprognostic (1.67e-2)	unprognostic (3.37e-1)	unprognostic (6.55e-3)	unprognostic (5.48e-3)	unprognostic (8.68e-3)	unprognostic (1.32e-1)	unprognostic (5.23e-2)	unprognostic (1.18e-1)	unprognostic (3.86e-3)	unprognostic (2.56e-3)	unprognostic (1.64e-1)	unprognostic (1.78e-2)	unprognostic (5.28e-2)	unprognostic (1.81e-3)	0.1	0.1	0.2	8.8	0.2	0	0.1	0.2	0.2	0.2	28.3	0	15	0.1	0.3	0	0.1	0.1	0.2	0.1	0.2	0.2	0.1	0.1	0.2	0	0.1	0	0.1	0.1	0	0.3	0	0	0.3	36.3	0	0.1	18	0.1	0.8	1.7	0.7	0.1	0.1	0.1	0.4	0	0.4	0.1	0	0.1	0.6	0.1	0.2	0.7	0.9	0.6	0.8	1.5	0.2	0.3	0.9	0.4	0.3	0.2	0	0.3	0.3	0	0	0	25.8	0.3	0.3	0.6	0	0.2	0.6	0	0	0	0.3	1.2	0.4	0.6	0.7	0	0.5	0.3	0	0	0	0	0.3	0	0.5	0.3	0.2	0	0.2	1.1	1	0.7	9.7	0.9	0.6	0.6	0.4	0	0.9	0.4	0.5	0.6	0.3	0.6	0.2	0.2	0.8	0.2	0.3	0.2	0.5	0.6	0.3	0.6	0.3	0.7	1.1	0.2	0.9	0.3	0.3	0.5	0.3	0.3	0.2	1.1	0.2	0.1	0.1	1.5	0.6	0.1	0.8	0.6	0.7	1	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	8.6	0	0	0	0	0.1	0	0	0.4	0	4.7	0	0	0	0	0	0	0	14.9	0	0	11.5	0	0	0	0	0	0	0	0	0.1	0	70.7	0.5	Undifferentiated cells
TFAP2B	AP2-B	ENSG00000008196	Transcription factor AP-2 beta	Q92481	6	50818723-50847613	Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	Activator, DNA-binding	Cancer-related genes, Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	5	epididymis: 65.5	Cell type enriched	Detected in some	4	Horizontal cells: 413.2	Cancer enriched	Detected in some	8	breast cancer: 12.1	Group enriched	Detected in some	41	cerebellum: 4.7;pons and medulla: 6.3	Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	4	AF22: 32.4;SH-SY5Y: 60.4	Region enhanced	Detected in some		cerebellum: 11.2	Low region specificity	Detected in many			HPA034683, HPA062942	Enhanced		Approved	Nucleoplasm						Nucleoplasm		HPA034683: AB_10670966, HPA062942: AB_2684909	unprognostic (2.02e-1)	unprognostic (2.29e-2)		unprognostic (4.27e-2)	unprognostic (5.88e-4)	unprognostic (9.76e-2)		unprognostic (2.10e-1)	unprognostic (1.00e-1)			unprognostic (4.57e-1)	unprognostic (6.58e-6)	unprognostic (1.13e-2)	unprognostic (1.88e-1)		unprognostic (7.17e-3)	0.2	3	0	0	0	0	9.4	4.7	0	0.2	0.2	0	8.8	0	0	65.5	5.8	0	0	0.1	0	0.1	6.2	0	0	0	0.1	0	0	0	0	0.7	0.2	6.3	0.1	0	12.2	7	0.6	0	6.3	0	0	1.1	0	0	1.5	0	0	0	0.3	0	0.1	0.3	0	0	0	0	0	0	0	0	0	32.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.7	0	0	0	0	0	0	0	0	0	0	0	11.5	0	0	60.4	0	0.2	0	0.2	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4.7	0	0	0.1	0.1	0	6.3	0	0	0	0	0	10.4	6.9	0.6	0	0	0	48.8	7.9	10.5	46.4	0	11.5	0.3	0	0	0	3.7	0.3	0	0	0	1	413.2	0	0	0	0.5	0	0	101.3	0	0	2.3	0	0	0.4	0.7	9.7	0	0	0.5	0	3.8	4.1	0	0	0	Horizontal cells
MASP2	MASP1P1	ENSG00000009724	Mannan binding lectin serine peptidase 2	O00187	1	11026523-11047233	Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins	Complement pathway, Immunity, Innate immunity	Hydrolase, Protease, Serine protease	Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	98	liver: 185.1	Cell type enriched	Detected in some	68	Hepatocytes: 541.9	Cancer enriched	Detected in some	71	liver cancer: 41.9	Region enriched	Detected in single	4	cerebellum: 1.7	Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enriched	Detected in many	7	Hep G2: 20.5	Low region specificity	Detected in single			Low region specificity	Detected in all			HPA029313, HPA029314	Uncertain		Supported	Golgi apparatus	Secreted to blood			340000000	880000000	Golgi apparatus		HPA029313: AB_10669654, HPA029314: AB_10670029	unprognostic (7.00e-2)	unprognostic (8.37e-2)	unprognostic (2.75e-2)	unprognostic (2.89e-1)	unprognostic (1.86e-1)	unprognostic (3.26e-3)	prognostic favorable (1.60e-4)	unprognostic (2.92e-3)	unprognostic (3.13e-2)	unprognostic (4.04e-2)	unprognostic (6.90e-3)	unprognostic (8.30e-4)	unprognostic (7.14e-2)	unprognostic (3.91e-1)	unprognostic (2.62e-2)	unprognostic (1.05e-1)	unprognostic (1.09e-4)	0.3	0.2	0.3	0.4	0.3	1.8	0.3	1.7	0.5	0.3	0.3	0.3	0.3	0.3	0.4	0.3	0.3	0.4	0.3	0.3	0.3	0.1	0.3	185.1	0.3	0.6	0.3	0.3	0.5	0.4	0	0.3	0.3	0.3	0.3	0	0.3	0.7	0.3	1.4	1.4	0.5	0.3	0.3	0.6	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	1.4	1.2	1.2	0.2	0.8	1.3	0	0.5	0.3	2.9	1.6	0	0.1	0.5	0.8	0	0	0	1.3	1.1	2.4	0.7	0	0.6	0.7	0	0	0	0.6	2.3	1.4	2.6	20.5	0	2.2	1.7	0	0	0.1	0	2	0	1.9	0.8	0.5	0	0.6	0.6	1.2	0.4	0.2	0.6	1.8	1	0.5	0	1.4	1.8	0.7	0.9	0.5	0.5	1.8	0.6	1.3	1.2	0.9	0.6	1	0.6	0.8	1.1	1.7	0.6	1.9	0.4	1.2	0.2	1.1	0.7	0.1	1	0.7	0.9	0.8	0.5	1.4	1.3	1.3	0.2	0.8	0.2	1.2	0.1	0	0.3	0.3	1.7	0.3	0.3	0.1	0.3	0.3	0.3	0.3	0	0	3.4	0.2	0.8	0	0.4	2.5	1.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	1.1	541.9	0.1	0	0	8	7	0	0	0	1.7	0	0	0.1	0	0	0	0	0.2	0	0	0	0	0.5	0	0	0	0.1	Hepatocytes
STAB1	CLEVER-1, FEEL-1, FELE-1, FEX1, KIAA0246, SCARH2, STAB-1	ENSG00000010327	Stabilin 1	Q9NY15	3	52495338-52524495	Predicted membrane proteins	Inflammatory response	Receptor		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		lymphoid tissue: 90.8	Cell type enriched	Detected in many	5	Ito cells: 1114.7	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Group enriched	Detected in some	68	classical monocyte: 10.8;intermediate monocyte: 6.6;myeloid DC: 2.8	Group enriched	Detected in many	69	dendritic cells: 2.8;monocytes: 10.8	Group enriched	Detected in some	47	HUVEC TERT2: 33.9;NB-4: 46.8;TIME: 41.7	Low region specificity	Detected in all			Low region specificity	Detected in many			HPA005434	Approved		Approved	Nucleoplasm,Plasma membrane,Cytosol					60000000	Cytosol	Nucleoplasm, Plasma membrane	HPA005434: AB_1080097	unprognostic (1.18e-1)	unprognostic (2.89e-1)	prognostic unfavorable (7.59e-4)	unprognostic (3.63e-2)	unprognostic (1.21e-1)	unprognostic (1.49e-2)	unprognostic (1.08e-2)	unprognostic (2.23e-1)	unprognostic (2.38e-1)	unprognostic (4.00e-3)	unprognostic (2.66e-2)	unprognostic (3.19e-1)	prognostic unfavorable (3.88e-7)	unprognostic (3.16e-2)	unprognostic (9.40e-2)	unprognostic (4.70e-2)	unprognostic (1.08e-1)	39.5	37.6	8	26.7	12.8	6.5	41.3	3.2	6.8	13.1	23.4	6.9	4.2	16.1	13.6	26.4	9.7	15.5	16.8	19.7	5.4	4.2	19.2	35.8	21.7	80.7	9.1	2.7	9.9	7.1	4.9	11.9	32.1	10.2	13.5	18	23.7	10.4	9.7	8	5.1	18.7	18.3	7.2	90.8	11.6	9.7	8.7	2.6	11.9	11.4	11.1	15.9	15.4	0	2.8	0	10.8	0	0	2.1	0	0	0	0	0	0	0.4	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0.8	0	0	0.2	0	0	0.6	0	0	0	0	33.9	0	0.1	0	0	0	0	46.8	0	0	0	0	0	0	0	0	0.1	0.1	0	0.1	0	0	0	0	41.7	0	0	0	0	0	0	0	0	0	0	0	10.8	0	0	6.6	0	0	0	0	2.8	0	0	0	0	0	0	0	0	2.1	8	12.8	3.2	6.8	5.4	4.2	9.1	2.7	10.2	8.7	0	6.7	12.3	0.5	5.4	1	2	12.7	0	0	3.5	0	1.3	0	0	0.4	14.5	0	46.7	0	1.5	3.8	0	17.4	8.3	103.3	0	1.2	1114.7	238.9	1.9	4	46.3	11.8	0	0	0.5	0	0	19.1	0.3	0	19.4	1.5	0.7	1.1	4.3	1.8	4.3	0	0.2	Ito cells
SLC6A13	GAT2	ENSG00000010379	Solute carrier family 6 member 13	Q9NSD5	12	220621-262873	Predicted membrane proteins, Transporters	Neurotransmitter transport, Symport, Transport			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	7	kidney: 77.6;retina: 95.9	Cell type enriched	Detected in some	6	Proximal tubular cells: 261.2	Cancer enriched	Detected in some	18	renal cancer: 32.1	Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	5	RPTEC TERT1: 10.0;SuSa: 3.7	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA036449, HPA052726			Supported	Nucleoplasm,Nucleoli,Mitochondria,Cytosol						Mitochondria	Nucleoplasm, Nucleoli, Cytosol	HPA036449: AB_2675130, HPA052726: AB_2681927	unprognostic (8.45e-3)	unprognostic (4.20e-1)	unprognostic (5.44e-2)	unprognostic (1.64e-5)	unprognostic (1.13e-1)	unprognostic (8.02e-2)	unprognostic (1.32e-2)	unprognostic (1.30e-1)	unprognostic (1.75e-1)	unprognostic (2.15e-1)	unprognostic (7.21e-4)	unprognostic (2.93e-1)	unprognostic (1.25e-3)	unprognostic (3.79e-2)	unprognostic (2.62e-1)	unprognostic (6.23e-2)	unprognostic (1.91e-1)	0.6	0.5	3	0.4	5.8	0.5	0.5	2.1	5.8	0.5	0.5	2.5	0	1.8	0.5	0.9	0.4	4.2	0.5	1	3.1	2.4	77.6	13.2	0.9	0.5	3.4	4.1	0.5	0.4	0.4	1	0.5	4.8	0.5	0.5	95.9	0.5	0.5	0.6	0.6	0.8	0.4	5.7	0.5	0.5	1.1	2.1	0	4.9	0	0.5	0.5	0	0.4	0	0	0	0.6	0.9	0.3	0	0	0.1	0.3	0.1	0.2	0.2	0.2	0	0	0	0.5	0	0	0.5	0.1	0	0.1	0	0	0	0.4	0.1	0	0.6	0	0	0	1.3	0.2	0.1	0	0	0.3	0	0.5	0.4	0.4	0.5	0	0	0.2	0.1	0	0	0.2	0	0.1	10	0.1	0.1	0	0.1	0	0.9	3.7	0	0	0.3	0.2	1	0	0.4	1.4	0.9	0	0	0	0.2	0	0	0	0.3	0	0	0	0	0	0	0.4	0.9	0	0	0.6	0	0	0	0.3	3	5.8	2.1	5.8	3.1	2.4	3.4	4.1	4.8	2.1	0	1.1	0.5	0	0	0.2	1.3	0	1.4	0	17.4	2	0	41.4	0	1.1	0	0	0	0	0	0.2	0	0	19.7	0	0	0	0.6	0.6	0.4	0.3	0	0	0	0	0	0	0	0	261.2	0.8	0	0	0.5	0.5	0	0.2	0	0	0	Proximal tubular cells
FMO1		ENSG00000010932	Flavin containing monooxygenase 1	Q01740	1	171248471-171285978	Enzymes, Predicted membrane proteins		Monooxygenase, Oxidoreductase		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	5	kidney: 70.4	Cell type enriched	Detected in some	12	Proximal tubular cells: 142.2	Cancer enriched	Detected in many	8	renal cancer: 18.0	Not detected	Not detected			Cell type enriched	Detected in single	36	naive B-cell: 3.5	Lineage enriched	Detected in single	36	B-cells: 3.5	Cell line enriched	Detected in some	7	HSkMC: 22.0	Low region specificity	Detected in all			Low region specificity	Detected in single			HPA078132	Approved											HPA078132: 	unprognostic (1.04e-1)	unprognostic (1.05e-2)	unprognostic (5.87e-2)	unprognostic (1.34e-1)	unprognostic (5.32e-3)	unprognostic (1.89e-2)	unprognostic (1.04e-1)	unprognostic (4.04e-1)	unprognostic (9.16e-2)	unprognostic (9.03e-2)	unprognostic (1.36e-2)	unprognostic (2.23e-1)	prognostic favorable (2.81e-4)	unprognostic (6.49e-4)	unprognostic (1.40e-1)	unprognostic (3.58e-1)	unprognostic (1.37e-1)	3.4	3.6	0.1	0.1	0.3	0	5.6	0.1	0.4	5.6	0.8	0.3	0.8	0	2.5	3	5	3.3	1.8	0.9	0.1	0	70.4	1	0.8	0.1	0.1	0.1	5.9	2.4	0.1	1.1	0.8	0.2	1.1	0	4	4.2	1.5	0.1	4	14.4	1.5	0.1	0.1	0.5	1.6	0.1	1.8	1.7	5.3	10.3	1.4	1.1	3.5	0	0	0	0	0	0	0	0	0	0	2.9	1.1	0	0	1.2	0	0	0	0	1.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	22	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	3.5	0	0	0	0	0	0	0	0	0.1	0.3	0.1	0.4	0.1	0	0.1	0.1	0.2	0.1	0	0	0	0.4	2.9	0	8.7	5.1	0	0	3.5	0	0.2	11.6	0	0.6	0	0	0	0	0	8.8	0.1	0	0	0.3	0	0	0	0	1	10	0	1.7	0	0.3	0	0	0	2.5	142.2	0	6.5	1.4	0	0	1.9	0.7	0	0	0	Proximal tubular cells
ANOS1	ADMLX, KAL, KAL1, KALIG-1, WFDC19	ENSG00000011201	Anosmin 1	P23352	X	8528874-8732186	Disease related genes, Predicted secreted proteins	Cell adhesion, Chemotaxis	Heparin-binding, Protease inhibitor, Serine protease inhibitor	Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 25.5;lung: 37.1;parathyroid gland: 27.7	Cell type enriched	Detected in many	6	Alveolar cells type 1: 223.4	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	5	hTERT-RPE1: 25.9;NTERA-2: 23.4;U-2 OS: 11.3														Secreted in brain								unprognostic (2.93e-1)	unprognostic (5.33e-2)	unprognostic (9.54e-2)	unprognostic (4.16e-3)	unprognostic (7.77e-3)	unprognostic (1.58e-1)	unprognostic (1.55e-2)	unprognostic (1.17e-3)	unprognostic (4.53e-2)	unprognostic (6.43e-2)	unprognostic (2.09e-2)	unprognostic (6.24e-2)	unprognostic (1.71e-2)	unprognostic (9.38e-3)	unprognostic (6.77e-2)	unprognostic (1.63e-1)	unprognostic (3.56e-2)	5.4	4	13.8	1.3	14	0.6	3.6	1.3	18	4.5	1	7.3	1.3	0.7	0.9	3.2	1.6	1.4	1.9	4.6	11.1	7.9	1.1	1.1	37.1	1.8	5.7	6	0.9	0.8	27.7	1	1.4	19.3	4.1	1.3	6	2.8	4.5	10.9	3	0.9	1.1	25.5	1.1	1.1	5	8.5	1.3	8.5	1	1.2	1.6	1.9	0	0	0	0	0	0	0	0	0	1.2	0	0	0	1.4	0.5	0	0.7	0.1	0	0	0	0	0	0	2.5	0	0.4	2.6	0.1	3.5	0.3	3.8	0	0	0	1	0	1.9	0.2	0.1	25.9	0	0	0	0	0.3	0.2	0.1	0	23.4	0	0	0	0	0	1.3	0.4	1.3	0	1.1	0.3	0	3.2	0	0.6	0	0	11.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.8	14	1.3	7.6	11.1	7.9	5.7	6	19.3	8.5	223.4	9.3	0	4.2	0	6.4	6.2	0	6.7	36.4	0	3.9	0.1	0	0	0.2	0.5	0	0	0	0.2	1.5	2.9	1.1	0	5.2	0	0	2.5	2.2	0	0.6	1.4	0	0	0	21.4	0.8	0	1.1	0	1.5	0	0.3	0.3	0.7	0	0.1	0	0.1	0.8	Alveolar cells type 1
GABRA3		ENSG00000011677	Gamma-aminobutyric acid type A receptor alpha3 subunit	P34903	X	152166234-152451358	FDA approved drug targets, Predicted membrane proteins, Transporters	Ion transport, Transport	Chloride channel, Ion channel, Ligand-gated ion channel, Receptor	FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	6	brain: 30.1	Cell type enriched	Detected in some	4	Hofbauer cells: 12.1	Cancer enriched	Detected in many	7	testis cancer: 16.6	Low region specificity	Detected in all			Cell type enhanced	Detected in single		basophil: 1.5	Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		GAMG: 9.1;HMC-1: 7.7;Karpas-707: 13.0;PC-3: 7.6;U-266/70: 7.0;U-266/84: 11.6;U-87 MG: 7.7	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA000839, HPA029363	Approved	Supported	Uncertain	Nucleoplasm,Plasma membrane						Plasma membrane	Nucleoplasm	HPA000839: AB_1078929, HPA029363: 	unprognostic (9.63e-3)	unprognostic (2.04e-1)	unprognostic (2.02e-1)	unprognostic (1.18e-2)	unprognostic (7.07e-2)	unprognostic (5.42e-2)	unprognostic (2.34e-6)	unprognostic (1.24e-1)	unprognostic (2.70e-1)	unprognostic (2.39e-2)	unprognostic (2.63e-2)	unprognostic (1.73e-1)	unprognostic (7.29e-6)	unprognostic (7.42e-3)	unprognostic (6.20e-2)		unprognostic (8.13e-2)	0.7	0.7	7.7	0.6	15.2	0.7	0.7	1.3	30.1	2.2	0.8	3.3	0	0.8	1.2	0.8	1.3	0.7	0.7	0.7	10.9	15.9	0.7	0.7	0.7	0.7	4.7	10.5	0.6	0.7	0.6	0.9	5.2	6.2	0.8	0.8	0.4	0.7	1.8	0.8	1.1	0.9	0.8	2.1	0.7	0.7	1.8	1.1	0	0.7	0	0.9	1.8	0.4	0	0.1	1.5	0.3	0.3	0.2	0	0	0.8	0	0	0	0	3	0	0	0	0	0.2	0	0	0	0	9.1	0	0	0	0	0	0	0.1	4	0	0	0	7.7	0	0	0	0	0	0	0	1.3	13	0	0	0	0	2.4	5.5	7.6	0	0	0	0	0	0.2	4.7	0	4.8	0.4	0.3	0.1	1.2	0	4.9	6.5	0.3	1.4	7	11.6	0	7.7	0	4.9	1.5	0	0.2	0	0.1	0	0	0	0	0	0	0	0.1	0.2	0.3	0.3	0.1	0.2	0	7.7	15.2	1.3	28.4	10.9	15.9	4.7	10.5	6.2	1.1	0	0	0	0.1	0	0	0.2	0	0	0	0	2	3	0	0	0.1	0	0	0	0	0.3	0	0	0	0	12.1	1.6	0	0	0	0	0	0	0	0	0	2.5	0	0	0	0	0.2	0	0	0.1	0.9	0	1.6	0	0	0.3	Hofbauer cells
EHD3	PAST3	ENSG00000013016	EH domain containing 3	Q9NZN3	2	31234337-31269447	Plasma proteins, Predicted intracellular proteins	Cilium biogenesis/degradation, Protein transport, Transport			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 37.4;esophagus: 29.1	Cell type enriched	Detected in many	5	Ito cells: 172.5	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Group enriched	Detected in many	6	memory B-cell: 17.8;naive B-cell: 4.4	Lineage enriched	Detected in many	9	B-cells: 17.8	Cell line enhanced	Detected in many		BJ: 25.6;BJ hTERT+: 63.5;HEL: 24.6;U-266/70: 15.9	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA049890, HPA049986, HPA066751	Approved		Approved	Plasma membrane					41000000	Plasma membrane		HPA049890: AB_2680936, HPA049986: AB_2680983, HPA066751: AB_2685713	unprognostic (3.44e-1)	unprognostic (8.88e-2)	unprognostic (2.21e-1)	unprognostic (3.79e-2)	unprognostic (3.70e-2)	unprognostic (1.89e-1)	unprognostic (5.49e-2)	unprognostic (1.21e-1)	unprognostic (3.74e-2)	unprognostic (9.72e-2)	unprognostic (9.92e-3)	unprognostic (1.06e-1)	prognostic unfavorable (1.02e-4)	unprognostic (4.88e-3)	unprognostic (9.41e-2)	unprognostic (4.79e-3)	unprognostic (4.92e-3)	2.7	7.1	15	5.6	16.3	2	3.3	10.6	37.4	5.6	2.2	7.3	0	1.9	3.9	3.4	29.1	4.9	3.6	14.8	16.7	8.9	15	10.8	4.8	6.3	9.6	21.6	2.9	1.4	8.7	6	11.3	13.3	5.7	2.1	2.8	4.8	4.9	2.3	3	2.9	4.8	9.4	5.8	1.9	1.6	6.6	1.2	2.5	1.5	10.4	7.8	4.2	17.8	0.4	1	1.9	0.6	1.7	7.8	0.5	2.7	1.5	1.3	2.5	3.9	0.2	25.6	63.5	2.5	2.3	0	0.3	0.2	0.9	8.4	2.2	0.2	0	1.7	1.8	1	2.3	24.6	0.1	0	8.8	0	0	6.2	0.7	2.4	1	6.7	0	0	0	0.1	1.8	4	0.3	0	5.8	0	1.3	0.8	0.1	0.5	1.9	2.9	0.7	3.9	0.2	0.4	0	4.9	0.3	0	0	1.9	1.8	0.1	2	15.9	2	0	4.9	0	4	0.4	0.4	0.3	1.7	0.8	0.9	17.8	0.9	1.1	0.4	4.4	0.8	0.4	1	0.6	1.9	0	0.4	7.8	15	16.3	10.6	32.7	16.7	8.9	9.6	21.6	13.3	6.6	0	0	23.6	1.4	0.7	9.2	18.9	2.5	0	1.2	0	0	3.5	0	0.3	0	5.2	0	0	0.2	7.3	2.3	0.8	0	0.8	1.4	0	1.7	172.5	21.8	0	1.1	0.2	0	1	0	8.1	0.2	0	2.8	0.2	5.4	19.4	3.3	0.2	2.1	0.6	36.7	2.5	0	3.2	Ito cells
ACPP	ACP-3, ACP3, PAP	ENSG00000014257	Acid phosphatase, prostate	P15309	3	132317367-132368298	Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins		Hydrolase	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	8	prostate: 345.2	Cell type enriched	Detected in many	135	Glandular cells: 2098.0	Cancer enriched	Detected in many	275	prostate cancer: 1227.2	Low region specificity	Detected in single			Cell type enhanced	Detected in many		eosinophil: 43.1	Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		BJ hTERT+: 10.2;OE19: 12.7;RPMI-8226: 32.4;U-698: 9.4;U-87 MG: 9.0	Low region specificity	Detected in some							CAB000071, HPA004335, HPA063916	Enhanced				Secreted to blood			460000	9200			CAB000071: , HPA004335: AB_1079684, HPA063916: AB_2685152	unprognostic (6.67e-2)	unprognostic (4.70e-2)	unprognostic (1.76e-1)	unprognostic (7.77e-2)	unprognostic (1.74e-1)	unprognostic (2.58e-2)	unprognostic (2.46e-1)	unprognostic (7.41e-2)	unprognostic (1.81e-1)	unprognostic (3.78e-3)	unprognostic (2.14e-1)	unprognostic (5.95e-2)	unprognostic (9.38e-2)	unprognostic (1.35e-1)	unprognostic (1.18e-1)	unprognostic (3.91e-2)	unprognostic (1.71e-1)	0.4	0.6	0.4	0.7	1.6	1.4	0.8	0.3	0.7	3.9	0.4	0.2	0	0.4	0.3	2.5	14.7	0.6	0.2	0.9	0.3	0.3	6.2	0.3	2	2.7	0.6	0.8	0.4	0.8	0.5	0.3	5.3	0.7	345.2	0.7	0.8	9.1	0.2	0.3	2.5	0.4	0.4	2.2	1	0.5	1	0.6	0.2	1.3	6.6	6.8	0.5	1.5	0.2	11.2	43.1	9.7	0.9	0	2.9	0.2	0	0	0	0.1	0.6	7	0.1	10.2	0	0	0.2	0.2	5.7	0.4	0	0	2.9	0	0	0	0	0.3	1.2	0.2	0.1	0.1	4.1	0.1	0.6	0.8	0	0	0.1	0	0	0.1	1.6	0.1	0.1	0	7.8	0.4	12.7	1.2	0	0	32.4	3.1	3.8	0	2.5	0	1.2	0.3	1.1	0.2	3.7	0	0	0.1	1.5	0	0.4	0.2	9.4	9	7.3	0.1	0	9.7	43.1	0	8.6	0	0.2	0	0	11.2	0	0	0	8.5	0.9	7.7	0.8	0	2.9	0.4	1.6	0.3	0.7	0.3	0.3	0.6	0.8	0.7	0.6	0	10.7	0	13	0.8	0	0.5	0	0	4.5	7	0	9.6	0	1.1	0	0	1	0	1.6	1	0.8	2098	0	0	4.1	0	15.5	0	9.2	0	0	2.8	0	0	2.4	0.3	1.2	5.1	0	0	0	0	0	0	0.1	3	7.4	0	1	11.5	Glandular cells
YAF2		ENSG00000015153	YY1 associated factor 2	Q8IY57	12	42157104-42238349	Predicted intracellular proteins	Transcription, Transcription regulation			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in all	8	Cardiomyocytes: 1091.6	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Cell line enhanced	Detected in all		U-937: 45.4	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA026867	Supported		Supported	Nucleoplasm						Nucleoplasm		HPA026867: AB_1858911	unprognostic (1.41e-1)	unprognostic (2.24e-1)	unprognostic (9.30e-2)	unprognostic (3.06e-1)	unprognostic (2.06e-2)	unprognostic (4.12e-1)	unprognostic (7.10e-3)	unprognostic (2.70e-1)	unprognostic (2.86e-3)	unprognostic (2.44e-2)	unprognostic (3.58e-2)	unprognostic (5.57e-2)	unprognostic (4.57e-2)	unprognostic (3.42e-1)	unprognostic (2.33e-1)	unprognostic (5.76e-2)	unprognostic (1.20e-2)	11.2	11.4	15.6	7.6	14.2	9.7	10	16.3	19.7	11	7.9	8.4	6.9	7.2	10.9	11.1	8.5	7.8	10.1	39.4	12.9	13.3	10.5	19.2	8.4	12.4	13.2	11.3	11	7.6	7.4	14.6	10.2	14.5	9.3	8.3	8.1	7.1	10	43.9	6.5	8.9	11.6	10.8	11.3	7	7.8	9.1	12.7	11.9	8.3	10.5	11.2	9.1	13.6	10.8	32.6	9.8	14.2	14.1	5.2	7	5.3	8.2	6	10.4	9.5	4.7	9.1	9.3	8.7	8	7.4	5.5	4.5	7.6	8.3	3.4	5.5	8	5.9	11.9	10.6	8.8	9.7	2.9	3.8	6.2	9.1	6.1	6.7	8.6	6.7	13.7	8.6	8.6	4.7	9.5	10.2	10.8	3.4	9.8	12.1	1.8	8.2	5.8	6.8	9.5	6.4	10.8	4.7	5.9	8.3	7.6	9.3	7.9	3.9	6	7.4	8.1	7.8	6.1	8.9	4.7	9.4	11.9	14.8	8.2	45.4	2.9	17.9	9.3	15.1	10.9	9.8	11.1	11.2	10.3	12.4	6.9	13.6	8.3	8.6	32.6	14.2	8.9	10.8	14.1	5.2	15.6	14.2	16.3	16.7	12.9	13.3	13.2	11.3	14.5	9.1	20.8	12	51.1	37.6	51.6	71.2	1091.6	33.1	21.4	30.7	19.2	80.5	35.9	53	28.7	25.4	49	20.6	23.3	39.3	18.5	47.4	31.2	70.3	92.4	24.5	136.7	37.3	53.4	36.4	11.8	53.8	38.8	40.5	40.5	25.8	71.4	31.6	23	72.2	37.2	98.7	103.5	54.7	30.7	29.6	44.7	37.9	58.6	23	27.3	Cardiomyocytes
CLCA1	CaCC, CLCRG1	ENSG00000016490	Chloride channel accessory 1	A8K7I4	1	86468368-86500289	Predicted secreted proteins, Transporters	Calcium transport, Ion transport, Transport	Hydrolase, Metalloprotease, Protease		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	6	intestine: 242.9	Cell type enriched	Detected in some	56	Mucus-secreting cells: 1736.8	Group enriched	Detected in some	9	colorectal cancer: 86.8;pancreatic cancer: 27.7	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		BEWO: 4.6;K-562: 1.7;NB-4: 5.3;RPMI-8226: 5.7;SH-SY5Y: 4.1;U-2197: 3.3	Not detected	Not detected			Not detected	Not detected			HPA052787, HPA059301	Enhanced				Secreted to digestive system				70000			HPA052787: AB_2681947, HPA059301: AB_2683971			prognostic favorable (2.98e-4)								unprognostic (3.42e-1)			unprognostic (8.61e-2)	unprognostic (1.06e-1)			0.2	0.2	0.2	41.7	0.2	0	0.2	0.2	0.2	0.2	100	0.1	0.1	80.7	0.2	0.1	0.2	0.3	4.4	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.1	0.2	0.2	0	0.2	0.1	0.1	0.2	98	0.2	0.2	0.1	0.2	0.2	242.9	1.1	0.2	0.2	0.2	0.3	0.1	0.1	0.2	0.2	0.1	0.2	0.2	0	0	0.5	0	0	0	0	0	0	0	0	0	0	4.6	0	0	0	0	0.1	0	0	0.1	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0.2	1.7	0	0	0	0	5.3	0	0	0	0	0	5.7	0	0	0.6	4.1	0	0	0	0	0	0	0	0	0	3.3	0.1	0	0	0	0	0.1	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.1	0.1	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	30.3	0	0	0	0	0	4.6	0	0	0	6.4	0	0	0	0	0	0	0	1736.8	0	0	25.1	0	0	0	0	0	0	0.1	0	0	0	30.9	0	Mucus-secreting cells
CLCA4	CaCC2	ENSG00000016602	Chloride channel accessory 4	Q14CN2	1	86547078-86580754	Predicted membrane proteins	Transport	Hydrolase, Metalloprotease, Protease		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	6	esophagus: 182.1;intestine: 64.2	Cell type enriched	Detected in some	4	Urothelial cells: 115.2	Cancer enhanced	Detected in many		cervical cancer: 21.4	Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	988	RT4: 98.7									HPA017045, HPA064770	Uncertain		Approved	Nucleoplasm,Plasma membrane,Aggresome	Intracellular and membrane				210000	Plasma membrane	Nucleoplasm, Aggresome	HPA017045: AB_2291679, HPA064770: 	unprognostic (1.38e-4)	unprognostic (1.52e-1)	prognostic favorable (7.47e-4)	unprognostic (2.73e-2)	unprognostic (7.03e-2)	prognostic favorable (8.63e-4)		unprognostic (7.59e-2)	unprognostic (3.35e-1)	unprognostic (1.26e-1)	unprognostic (6.01e-2)	unprognostic (1.20e-1)		unprognostic (2.57e-2)	unprognostic (2.29e-1)	unprognostic (5.69e-2)	unprognostic (3.43e-2)	0.2	0.1	2.2	8.8	3	0.1	0.6	0	2	12.3	64.2	2	0	0.1	0.3	0.1	182.1	0.1	0.1	0.1	2.2	0.6	0.1	0.1	0.1	0.1	3.2	1.6	0.1	0	0.1	0	0.1	3	1.8	38.4	0	5.9	0.1	0.1	4.5	6.1	0.8	2.4	0.1	0.1	0.1	5	0	0.1	8.6	21.5	9	13	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	98.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.2	3	0	2	2.2	0.6	3.2	1.6	3	5	0	0	0	13.3	3	0	0.2	0	2.7	5.7	1.8	0	0	0	0	0.3	0	18.6	0	0	0	0	3.9	9.2	0	0	0	7.9	0	0	0	0	0	0	0	7.8	0	0	26.6	0	0	0	0	0.1	0	0	10.5	0	0	4.1	115.2	Urothelial cells
IGF1	IGF-I, IGF1A, IGFI	ENSG00000017427	Insulin like growth factor 1	P05019	12	102395874-102481744	Disease related genes, Plasma proteins, Predicted secreted proteins, RAS pathway related proteins		Growth factor	Deafness	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in many			Cell type enriched	Detected in many	5	Leydig cells: 1021.5	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Group enriched	Detected in some	7	memory B-cell: 2.4;naive B-cell: 4.5	Lineage enriched	Detected in single	9	B-cells: 4.5	Cell line enhanced	Detected in some		ASC diff: 21.8;HDLM-2: 28.4;K-562: 12.7;Karpas-707: 6.8;U-266/70: 8.1	Low region specificity	Detected in all			Low region specificity	Detected in many			HPA048946	Approved				Secreted to blood			103000000	410000000			HPA048946: AB_2680566	unprognostic (1.25e-1)	unprognostic (2.86e-3)	unprognostic (1.46e-1)	prognostic favorable (1.04e-4)	unprognostic (1.52e-1)	unprognostic (2.10e-1)	unprognostic (1.59e-3)	unprognostic (2.26e-1)	unprognostic (9.98e-2)	unprognostic (1.30e-1)	unprognostic (1.59e-1)	unprognostic (1.04e-2)	unprognostic (2.34e-1)	unprognostic (2.04e-2)	unprognostic (1.55e-1)	unprognostic (2.07e-1)	unprognostic (1.11e-3)	33.4	3.6	0.8	10.7	1.4	0.3	23	0.6	2.1	46.6	6.7	0.6	20.6	2.2	35	58.3	16.1	8.1	8.8	17.4	1.5	1	3.9	32.8	7.6	13.3	0.9	0.4	17.6	3.2	1.2	1.2	13.5	1.9	57.2	2.8	3.7	5.4	32	11.9	3.2	3.5	29.4	1	4.9	5.9	19	0.2	1.5	29.3	11.6	2.2	21.2	15.3	4.5	0.2	0.5	0.1	0.2	0.1	0.8	0.2	0	0	0	21.8	0	0.1	0.1	0	0	0	0.4	0	0	0	0	0	0	0	0	0	28.4	0	0	0.3	0	0.1	0	0	0.3	0	0	0	0	0	0	12.7	6.8	0	0	0	0.1	0	0	0	0	0	0.9	0	0	0.1	0.1	0.9	0	0.2	0.1	0	0	0	0	0	0	0	8.1	0.6	0	0	0	0	0.2	0.1	0.2	0.1	0	0.1	2.4	0.1	0.1	0	4.5	0.1	0.1	0.5	0.2	0.1	0.2	0	0.8	0.8	1.4	0.6	2.1	1.5	1	0.9	0.4	1.9	0.2	3	2.1	0	0.5	2.3	186.6	0.3	5.1	0	1.2	0	0	0.8	0	0	10.2	5.2	0	0	0.5	2.2	63.7	1.2	0	167.4	91.5	0	0	4.3	14.4	22.9	1021.5	9.8	13.5	6.4	0	2.1	0.1	0	181.8	1	7	0	3.3	1.6	1	2.4	1	2.9	0	0.1	Leydig cells
MARCO	SCARA2, SR-A6	ENSG00000019169	Macrophage receptor with collagenous structure	Q9UEW3	2	118942166-118994660	Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins	Immunity, Innate immunity	Receptor		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		liver: 66.3;lung: 65.6;lymphoid tissue: 58.7	Cell type enriched	Detected in some	6	Kupffer cells: 829.9	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Group enriched	Detected in some	4	classical monocyte: 15.8;intermediate monocyte: 26.7	Lineage enriched	Detected in many	5	monocytes: 26.7	Cell line enhanced	Detected in some		HaCaT: 4.0;THP-1: 5.7;U-2 OS: 6.2;U-266/70: 3.6	Not detected	Not detected			Low region specificity	Detected in all			HPA063793	Enhanced		Approved	Golgi apparatus,Vesicles					24000000	Golgi apparatus	Vesicles	HPA063793: AB_2685123	unprognostic (1.30e-1)	unprognostic (1.61e-1)	unprognostic (5.96e-3)	unprognostic (3.36e-2)	unprognostic (1.71e-2)	unprognostic (3.58e-2)	unprognostic (3.67e-1)	unprognostic (1.06e-1)	unprognostic (2.95e-1)	unprognostic (2.83e-1)	unprognostic (6.27e-3)	unprognostic (5.13e-2)	unprognostic (2.24e-3)	unprognostic (1.80e-1)	unprognostic (1.09e-1)	unprognostic (1.40e-1)	unprognostic (6.55e-2)	22.8	11.7	0.8	29.6	1.1	0.9	3.3	2.3	1.3	0.3	2.8	0.9	0	0.6	0.3	12.9	5.2	13.8	0.8	10.8	0.6	0.4	1.6	66.3	65.6	29.3	1.3	3.1	4.7	0.4	0.2	0.8	2.3	2.7	4.5	0.7	1	2.9	0.8	6.8	1.1	1.3	9.6	1.7	58.7	2.2	2.8	0.6	0	3	0.5	0.4	8.8	1.1	0	5	0.3	26.7	0	0	3.4	0.1	0	0	0	0	0.1	0	0	0	0	0	0	0.2	0	0.2	0.2	0.9	4	0	0.4	0	0	0	0	0.8	0	0	0	0	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0.8	0	0	0	0	0.2	0.1	0	0	0	5.7	0	0	6.2	0.9	0	3.6	0	0.2	0	1.3	0	0	15.8	0	0	26.7	0	0	0	0	5	0	0	0	0.3	0	3.2	0.4	0	3.4	0.8	1.1	2.3	1.3	0.6	0.4	1.3	3.1	2.7	0.6	23.8	42.6	0	0	1	0	0.4	0	24.1	30.7	3.5	0	0.6	0	1.4	0	0	0	0	0.2	0.7	1.5	0.1	11.6	0.8	145.4	0	0	13.5	829.9	0	0	63.5	0	0	0	0	0.3	0	0	0	0	0	0.1	0	0	0.6	1.6	1.3	0	0	Kupffer cells
SYT13	KIAA1427	ENSG00000019505	Synaptotagmin 13	Q7L8C5	11	45240301-45286319	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 38.1;gallbladder: 18.8	Cell type enriched	Detected in many	8	Intestinal endocrine cells: 323.7	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Cell type enhanced	Detected in single		basophil: 1.4	Lineage enriched	Detected in single	6	granulocytes: 1.4	Cell line enhanced	Detected in some		A549: 11.5;NTERA-2: 5.4;RPTEC TERT1: 35.1;SCLC-21H: 9.3	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA046224, HPA056602	Uncertain		Supported	Vesicles						Vesicles		HPA046224: AB_10961288, HPA056602: AB_2683185	unprognostic (4.96e-2)	unprognostic (1.06e-2)	unprognostic (9.92e-2)	prognostic unfavorable (7.79e-5)	unprognostic (1.00e-2)	unprognostic (4.17e-2)	unprognostic (3.75e-2)	unprognostic (9.83e-3)	unprognostic (2.19e-1)	unprognostic (7.58e-2)	unprognostic (1.21e-1)	unprognostic (2.47e-1)	unprognostic (5.66e-3)	unprognostic (2.94e-2)	unprognostic (1.76e-1)	unprognostic (8.70e-2)	unprognostic (5.13e-2)	0.4	4.5	15.8	1.5	15.1	0.4	0.5	19	38.1	0.3	10.6	1.2	0	10.9	0.6	0.3	0.4	0.5	18.8	4.5	11.8	19.5	8	0.6	0.8	0.4	10.6	15.1	0.4	6.4	0.4	9.4	0.4	27.9	2	11.2	0.9	1.4	0.4	0.5	0.5	11.1	1.1	2.2	0.5	9.2	1.8	0.3	0	1.8	0	0.3	0.4	0.2	0.2	0	1.4	0	0.2	0.2	0	0	11.5	0.1	0	0	0	0	0	0	0	0	1.7	0.1	0	0.7	0	0.1	0	0.1	0	0	0	0	0	0	0.1	0	0	0.4	0	0	0	0	0	0	0	0	0	0	1.5	0	0	5.4	0	0.1	0	0	0	35.1	0	9.3	0.4	0	0	0	0.4	0.6	0	0	0	0.1	0	0	0	0.4	0.1	1	0	0	1.4	0	0	0.1	0	0.1	0	0.1	0.1	0	0.2	0.1	0.2	0.4	0.2	0	0	0	0	15.8	15.1	19	31.1	11.8	19.5	10.6	15.1	27.9	0.3	0	0	0	0.2	0	1.1	8.1	15.3	0	0	3.5	23.6	0	5	1.2	3.1	0	10	0	0.5	0	0	4.2	0	0	0	1.6	323.7	0	0	8.2	0.3	0	0	0	30.8	0.5	5.3	17.5	0	0.3	1.5	0	0	1.9	0.2	0	0	0	38.3	0.1	Intestinal endocrine cells
SLC7A9	CSNU3	ENSG00000021488	Solute carrier family 7 member 9	P82251	19	32830509-32869766	Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters	Amino-acid transport, Transport		Cystinuria, Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Group enriched	Detected in some	4	intestine: 63.3;kidney: 26.4	Cell type enriched	Detected in some	5	Proximal tubular cells: 55.5	Group enriched	Detected in some	7	liver cancer: 6.6;renal cancer: 5.2;stomach cancer: 1.9	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	17	BEWO: 4.9;CACO-2: 11.3;Hep G2: 11.0	Not detected	Not detected			Low region specificity	Detected in all			HPA042591	Enhanced											HPA042591: AB_10962500	unprognostic (4.12e-2)	unprognostic (5.40e-2)	unprognostic (6.19e-2)	unprognostic (3.37e-3)	unprognostic (1.69e-1)	unprognostic (1.54e-1)	unprognostic (4.17e-2)	unprognostic (3.87e-2)	unprognostic (1.49e-1)	unprognostic (1.78e-1)	unprognostic (1.24e-1)	unprognostic (2.39e-1)	unprognostic (9.69e-2)	unprognostic (5.97e-2)	unprognostic (3.20e-1)	unprognostic (4.94e-3)	unprognostic (5.10e-5)	0.1	0	0.1	0.3	0.2	0	0.1	0.3	0.2	0.2	20.1	0.1	0.1	30.5	0.1	1.1	0.1	0.2	0.1	0.1	0.1	0.1	26.4	11	0.1	0.1	0.1	0.1	0.2	0.1	0	0.3	0.2	0.1	0.3	0	0.1	0.1	0.1	0.1	0.1	63.3	0.1	0.1	0.1	0	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.2	0	0	0	0	0	0	0	0	0.2	0	0	0.1	0.1	4.9	0	0	0	0	11.3	0	0	0	0	0	0	0	0	0	0.3	0	0	0	11	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0.3	0	0	0.1	0	0	0.5	0	0.1	0	0.1	0	0	0	0.1	0	0	0	0	0.1	0.2	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.2	0.3	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0.1	0	0.8	0.3	0	2.7	0	5.2	3.9	0.1	1.7	0	0.7	0	0	0	6.6	6.5	0	0	0	10.5	0.2	0	0	0	0	0	0.6	0	0	0	0	0.5	0.5	0	0	55.5	1.3	0	0	0	0.2	0	0	0	0	0	Proximal tubular cells
CPS1		ENSG00000021826	Carbamoyl-phosphate synthase 1	P31327	2	210477682-210679107	Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins	Urea cycle	Allosteric enzyme, Ligase	Disease mutation, FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	9	liver: 298.3	Cell type enriched	Detected in many	72	Hepatocytes: 1670.2	Cancer enriched	Detected in many	8	liver cancer: 136.1	Low region specificity	Detected in some			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in many		HeLa: 90.5;SK-BR-3: 27.3	Low region specificity	Detected in single			Not detected	Not detected			CAB003781, HPA021400	Enhanced		Supported	Nucleoli,Nucleoli rim					2100000	Nucleoli, Nucleoli rim		CAB003781: , HPA021400: AB_1847197	unprognostic (1.67e-2)	unprognostic (3.72e-2)	unprognostic (4.02e-2)	unprognostic (7.21e-7)	unprognostic (3.81e-2)	unprognostic (2.52e-1)	prognostic favorable (6.93e-5)	unprognostic (1.23e-2)	unprognostic (2.65e-1)	unprognostic (1.35e-2)	unprognostic (5.38e-2)	unprognostic (1.94e-3)	unprognostic (2.38e-4)	unprognostic (5.90e-2)	unprognostic (1.13e-1)	unprognostic (3.14e-2)	unprognostic (3.74e-2)	0.4	0.1	0.5	0.3	1.6	0	0.8	0.3	0.7	0.4	0.2	0.7	0.3	31.5	0.3	0.7	0.5	0.2	0.4	0.3	0.5	0.4	0.6	298.3	0.2	0.3	1.5	0.8	0.7	0.2	0	0.4	1.1	1.4	0.3	0	0.6	0.2	0.2	0.3	0.3	17.2	0.4	2.3	0.3	0.2	1.3	0.5	0	0.4	0.4	0.1	0.2	0.4	0.3	0	0	0	0	0.8	0	0.3	2.4	6.3	4.3	4.2	7.4	6.7	2.3	2.7	2.7	4.2	0.6	0	1	0.1	2.5	3.8	1.1	0.2	3.8	6.8	0	1.9	4	90.5	5.6	1.4	2.1	0	3.8	2.8	5.3	5.4	6.9	0.3	1.7	4	0.3	4.4	1.1	0.1	0.2	2.4	0	0.6	0.2	5.8	0.5	5.7	0	0.1	0.4	15.8	27.3	3	8.5	0	0.7	3	7	2.1	2.1	4.9	0	0.3	0	4.6	4.4	4	0	0	0	0.2	0	0	0	0.3	0	0	0.3	0	0.8	0	0	0	0	0	0	0.5	1.6	0.3	0.7	0.5	0.4	1.5	0.8	1.4	0.5	11.9	9.6	20.7	0.5	1.9	1.1	0.7	15.3	1.4	6.8	1.8	7.9	0.3	0	0.1	23.2	1.4	0.3	23.3	0.2	0.4	2.5	1.2	3.5	1670.2	0.2	0	0	16.5	22.7	3.6	2.3	1.8	1.7	0	0.1	1.4	0	0	1.1	0.7	2.2	0	2.5	0.3	1.1	1.6	17.4	5	0.1	0.4	Hepatocytes
C8B		ENSG00000021852	Complement C8 beta chain	P07358	1	56929210-56966140	Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Innate immunity			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	52	liver: 240.9	Cell type enriched	Detected in some	11	Hepatocytes: 251.9	Cancer enriched	Detected in some	181	liver cancer: 107.0	Not detected	Not detected			Cell type enriched	Detected in single	47	basophil: 4.6	Lineage enriched	Detected in single	47	granulocytes: 4.6	Cell line enriched	Detected in some	5	Hep G2: 5.8	Not detected	Not detected			Low region specificity	Detected in many			HPA023694	Supported				Secreted to blood				3600000000			HPA023694: AB_1847128				unprognostic (6.65e-2)			prognostic favorable (9.31e-5)	unprognostic (2.37e-1)			unprognostic (2.37e-1)			unprognostic (1.29e-2)	unprognostic (6.57e-2)	unprognostic (5.12e-3)		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	240.9	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0.1	0	0	0	0	0.1	0.1	0	0.7	0	5.8	0	1.2	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0.2	0	0	0.3	0.9	0	0	0	0	0	0.5	0	0	0	0	0	0.3	0	0.1	0	0	0.6	0	0.2	0	0.2	0	4.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.9	0	0	0	0.3	17.8	0	0	0	0	0	0	0	4.9	0	0	23.3	0.6	0	0	0	0	251.9	0.1	0	0	6.2	5.3	8.9	0.6	0	0	0	0	0	0.5	0	0	0	0	0	0	0.1	0	0	0	0	0	0	Hepatocytes
GABRA1	EJM5	ENSG00000022355	Gamma-aminobutyric acid type A receptor alpha1 subunit	P14867	5	161847063-161899981	Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters	Ion transport, Transport	Chloride channel, Ion channel, Ligand-gated ion channel, Receptor	Disease mutation, Epilepsy, FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	22	brain: 58.6	Cell type enriched	Detected in some	24	Bipolar cells: 209.5	Cancer enriched	Detected in single	5	glioma: 1.1	Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HEL: 3.7;SCLC-21H: 1.1;U-2 OS: 1.6;U-87 MG: 2.3;WM-115: 1.2	Low region specificity	Detected in all			Low region specificity	Detected in all			CAB022502, HPA029363, HPA055746	Enhanced	Supported	Approved	Nucleoplasm,Plasma membrane						Plasma membrane	Nucleoplasm	CAB022502: , HPA029363: , HPA055746: AB_2682904					unprognostic (2.58e-2)						unprognostic (4.78e-3)	unprognostic (1.84e-1)		unprognostic (3.31e-1)		unprognostic (2.43e-1)		1	2.6	8.5	1	21.9	1	1	35.2	58.6	1	1	1.8	0	1.1	1	1	1	1	1	1	10.5	8.8	1	1	1	1	6.7	22	1	1	1	0.1	1	7.4	1.2	1	0.2	1	1.1	1	1	1	1	1.3	1.1	1.5	1.1	0	0	1	0	1.3	1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.8	0	0	0	0	0	3.7	0.2	0.1	0	0	0.1	0	0	0	0	0	0	0	0	0.3	0	0	0	0.1	0.9	0	0	0	0	0	0	0	1.1	0	0	0	0	0	0	0	0	0	1.6	0.1	0	0.1	0	0	2.3	0	1.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	8.5	21.9	35.2	49.8	10.5	8.8	6.7	22	7.4	0	0	0	0	0	0	209.5	0.5	0	0	0	0	0	0	0	0	2.4	0	0	0	0	0	0	0.2	0	0	0	7.9	0	0	0	0	0	0	0	0	0	2.9	0	0	0	0	8.9	0	0	0	0	0	0	0	0	0	Bipolar cells
NDUFS1	CI-75k	ENSG00000023228	NADH:ubiquinone oxidoreductase core subunit S1	P28331	2	206114817-206159603	Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins	Electron transport, Respiratory chain, Transport	Oxidoreductase, Translocase	Disease mutation, Primary mitochondrial disease	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		skeletal muscle: 99.5	Cell type enriched	Detected in many	5	Cardiomyocytes: 534.9	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low cell line specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA064605, CAB070844	Enhanced		Supported	Mitochondria						Mitochondria		CAB070844: , HPA064605: AB_2685297	prognostic unfavorable (3.85e-4)	unprognostic (1.76e-1)	unprognostic (9.22e-3)	unprognostic (5.01e-2)	unprognostic (8.63e-3)	unprognostic (3.75e-1)	unprognostic (3.72e-2)	unprognostic (6.18e-2)	unprognostic (2.30e-2)	unprognostic (3.28e-1)	unprognostic (2.00e-2)	unprognostic (1.28e-1)	prognostic favorable (1.47e-12)	unprognostic (1.17e-1)	unprognostic (1.29e-1)	unprognostic (4.76e-2)	unprognostic (4.73e-2)	13.9	29	12.1	8.3	22.1	7.6	10.3	11.6	26.4	9.1	17.4	16.4	9.2	18.3	9.1	7.7	15.7	7.7	7.3	62.6	11.3	11.7	29.5	30.7	8.3	7.7	13.3	13.8	8.2	9.3	22.1	11.6	10.8	24.2	10.7	18.9	13.5	12.8	10.9	99.5	11	19.9	11.1	10.8	8.4	14.9	8.8	11.1	11.2	10.8	34.7	10.5	11.6	9.4	10.7	15.3	15.7	21.4	12.5	16.1	8.9	12.9	12.9	18.8	13.6	17.6	14.3	21.9	19.1	20.6	31.9	23.2	33.5	15.2	14.7	16.9	23.8	31.7	18.2	25.1	18.5	28.4	6.7	11.8	29.3	32.1	30	18.3	21.1	13.3	17.4	10.9	25	19.7	14.3	24.8	18.6	31.7	14.9	20.7	16.2	17.4	14	17.4	21.9	23.1	17.6	26.3	25.4	26.4	23.7	18.4	14.4	22	21.6	31.2	26.9	19	20.5	18.9	17.6	15.7	17.2	18.1	14.4	17.3	21.9	17.6	17.5	17.9	12	13.3	15.7	13.6	15.4	10.8	10.7	12.2	13	15.3	9.5	10.9	12.4	9.6	12.5	21.4	8.2	16.1	8.9	12.1	22.1	11.6	26.4	11.3	11.7	13.3	13.8	24.2	11.1	56.6	24.1	13.7	19.6	14.3	94.7	534.9	63.7	60.2	35.2	36.6	113.9	40.2	79.6	36.7	9.9	33.7	63.8	0	24.5	26.7	24.7	17.4	35.9	83.9	29.8	111.2	49	33.7	34.6	5.2	31.1	25.2	28.7	27.1	47.3	60.7	29.2	35.1	42.1	80.9	78.2	32.3	27.8	28.6	37.3	14.4	43.8	18.7	52.8	23.9	Cardiomyocytes
ABCC2	CMOAT, cMRP, DJS, MRP2	ENSG00000023839	ATP binding cassette subfamily C member 2	Q92887	10	99782732-99852192	Cancer-related genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters	Transport	Translocase	Cancer-related genes, Disease mutation, FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		intestine: 28.4;kidney: 25.6;liver: 74.3	Cell type enriched	Detected in some	6	Hepatocytes: 52.9	Cancer enhanced	Detected in many		liver cancer: 24.0	Not detected	Not detected			Cell type enhanced	Detected in some		basophil: 4.1	Lineage enriched	Detected in single	6	granulocytes: 4.1	Group enriched	Detected in some	5	A549: 60.2;Hep G2: 60.0	Not detected	Not detected			Not detected	Not detected			HPA071145	Enhanced											HPA071145: 	unprognostic (1.49e-3)	unprognostic (5.92e-2)	unprognostic (1.59e-1)	unprognostic (3.67e-1)	unprognostic (1.93e-2)	unprognostic (2.33e-1)	unprognostic (2.51e-1)	unprognostic (7.15e-3)	unprognostic (5.68e-2)	unprognostic (2.01e-1)	unprognostic (4.30e-1)	unprognostic (1.40e-3)	prognostic unfavorable (1.93e-5)	unprognostic (1.31e-1)	unprognostic (3.22e-2)	unprognostic (2.95e-1)	unprognostic (1.26e-2)	0.8	0.3	0.1	0.1	0.1	0.1	1.1	0.3	0.1	0.2	13.4	0.1	0.1	16.1	0.3	0.5	0.2	0.4	13.7	0.2	0.1	0.1	25.6	74.3	0.3	0.1	0.1	0.1	0.2	0.6	0	0.1	1.2	0.1	0.3	0	0.1	0.3	0.1	0.6	0.6	28.4	0.1	0.2	0.8	0.4	0.4	0.1	0.1	0.3	0.4	0.1	0.7	0.3	0.3	0.7	4.1	0.2	0.1	0.5	0	0	60.2	0.9	3	4.6	3.5	1	0.1	0.3	0.1	0.2	12.9	0.1	0.1	0.1	0.2	0.1	0.3	0.1	0.1	0.2	0.1	0.1	0	0.2	60	0.1	0	0.2	0.6	4.1	0.4	0.4	0.1	0.1	0.1	0	0.1	0	0.2	0	0.4	0.1	11.2	0	0.1	0	0.1	0.4	0	0	0	0.1	0.9	7.4	0.1	0	0.1	0.1	0.1	0.2	0.3	0.1	0.2	0	0	4.9	1	0.3	4.1	0.2	0.3	0.3	0	0.4	0.2	0.3	0.1	0.3	0.3	0.3	0.1	1.3	0.1	0.1	0.7	0.5	0	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0.8	0.1	0	0.2	0.4	2.5	4	0	0	0	0.2	0	0	1.6	0	0	0	0.3	0	0	0.2	1.1	52.9	0.2	0	0	0.6	1.3	0.2	0.3	0	5	0	0	0.2	0.1	0	0	9.1	1.4	0	0.4	0.7	0.3	0	1.4	0	0	0	Hepatocytes
HSD17B6	HSE, RODH, SDR9C6	ENSG00000025423	Hydroxysteroid 17-beta dehydrogenase 6	O14756	12	56752161-56787790	Enzymes, Predicted intracellular proteins	Lipid metabolism, Steroid metabolism	Oxidoreductase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	18	liver: 241.2	Cell type enriched	Detected in many	10	Hepatocytes: 1569.2	Cancer enriched	Detected in many	5	liver cancer: 170.3	Low region specificity	Detected in many			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		Karpas-707: 11.8;U-266/84: 14.6	Not detected	Not detected			Low region specificity	Detected in all			HPA059141	Enhanced		Approved	Nucleoplasm,Vesicles						Nucleoplasm, Vesicles		HPA059141: AB_2683922	unprognostic (7.70e-2)	unprognostic (8.76e-2)	unprognostic (5.08e-2)	unprognostic (1.92e-2)	unprognostic (2.01e-1)	unprognostic (3.79e-2)	prognostic favorable (6.32e-4)	unprognostic (1.06e-2)	unprognostic (3.21e-1)	unprognostic (1.44e-1)	unprognostic (1.35e-1)	unprognostic (6.74e-2)	unprognostic (2.50e-10)	unprognostic (1.26e-1)	unprognostic (1.79e-1)	unprognostic (1.08e-1)	unprognostic (1.05e-1)	1.1	0.5	3.6	1.4	5.2	0.2	0.3	1.2	2.4	9.4	3.3	0.5	2.6	0.6	4.1	0.7	1.6	0.9	2.6	0.4	1.6	1.4	0.5	241.2	8.7	0.3	2	2.6	1.1	0.3	0.2	0	0.9	0.6	7.9	1.3	1.4	0.2	10.2	0.2	0.2	0.7	11.3	1	6.2	0.8	3.2	0.8	0	13.3	0	0.3	9.9	2.3	2	2	0.1	1.3	0.1	3.4	0.8	0.3	0.7	1.7	0.3	1.7	1.2	2	3.6	3.1	1.7	1.7	0.4	0.4	10.2	1.5	0.4	0.5	0.3	5.3	0.9	1	6.5	2	3.2	1	0.5	1.1	1.6	5.3	0.9	0.3	1	0.5	0.5	0	9	0.9	11.8	0.8	2.1	4.6	1	6.6	0.6	0.6	6.3	0.7	2.5	0.2	1.2	9.7	2	1.7	3.1	0.8	0.6	0.5	1.3	0.3	0.8	0.8	3.6	0.9	10.3	14.6	6.7	1.2	5.9	0.6	0	0.2	0.1	3	0.6	3.4	2	2.5	2.4	0.6	1.1	3.3	2.2	0	0.1	1.3	2	2.8	0.8	3.6	5.2	1.2	2.4	1.6	1.4	2	2.6	0.6	0.8	160.8	89.7	28.7	2.3	1.1	0.2	0.2	35.7	2.7	17	0	0	1.3	0	0	2.5	0.4	0	23.3	0	2.4	4.8	9.9	0	1569.2	0.3	0	0	31.3	41.1	1.5	11.5	0.1	0	1.8	0.3	1	0.1	0	1.4	0	0.6	12.9	3.7	13.6	10.6	1.4	0.3	4.4	0.3	0.9	Hepatocytes
IBSP	BSP, BSP-II, SP-II	ENSG00000029559	Integrin binding sialoprotein	P21815	4	87799581-87812435	Cancer-related genes, Predicted secreted proteins	Biomineralization, Cell adhesion		Cancer-related genes	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in some		brain: 4.5;cervix, uterine: 4.0;pituitary gland: 6.2	Cell type enriched	Detected in single	46	Hofbauer cells: 6.1	Cancer enhanced	Detected in many		glioma: 12.2	Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	6	U-138 MG: 13.0	Region enhanced	Detected in single		basal ganglia: 0.9	Not detected	Not detected								Secreted in other tissues								unprognostic (2.53e-2)	unprognostic (3.55e-2)	unprognostic (1.49e-2)	unprognostic (3.93e-1)	unprognostic (3.75e-2)	unprognostic (9.48e-3)	unprognostic (1.03e-3)	unprognostic (4.07e-2)	unprognostic (1.12e-2)	unprognostic (2.39e-1)	unprognostic (2.02e-3)		unprognostic (5.81e-11)	unprognostic (6.20e-2)	unprognostic (1.96e-1)	unprognostic (1.30e-3)	unprognostic (2.11e-1)	0.2	0	1.9	0.6	0.4	1	0.1	2	4.5	4	0.1	0	0	0	0.7	0	0.1	0.1	0.8	1.3	1	0.1	0	0	0.2	0.1	0.9	0	0	0.2	0.8	6.2	1.1	2.6	0.4	0	0	0.3	0	0.6	0.1	0	0.3	0.2	0	0	0.3	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.7	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	1.3	0	0	0	0.1	0	0	0	0	0	2.3	0	0	0	0	0	0	0	0	0	0.6	0.1	0	0	0.2	0	0.1	0	0	0	13	0	0	0	1.8	0.3	0	0	0	2.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.9	0.4	2	1.5	1	0.1	0.9	0	2.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	6.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	Hofbauer cells
TFB1M	CGI-75, mtTFB	ENSG00000029639	Transcription factor B1, mitochondrial	Q8WVM0	6	155257509-155314493	Disease related genes, Predicted intracellular proteins	rRNA processing, Transcription, Transcription regulation	DNA-binding, Methyltransferase, RNA-binding, Transferase		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	7	Early spermatids: 196.9	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Cell line enhanced	Detected in all		Hep G2: 38.6	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA029428	Approved											HPA029428: AB_2673038	unprognostic (2.20e-2)	unprognostic (1.07e-1)	unprognostic (2.33e-3)	unprognostic (7.73e-2)	unprognostic (1.39e-1)	unprognostic (1.55e-1)	unprognostic (2.23e-2)	unprognostic (1.32e-1)	unprognostic (3.54e-2)	unprognostic (7.86e-2)	unprognostic (1.30e-1)	unprognostic (1.04e-1)	unprognostic (1.95e-3)	unprognostic (3.39e-2)	unprognostic (2.68e-1)	unprognostic (7.68e-3)	unprognostic (7.77e-2)	6.6	24.2	9.2	10.5	11.7	3.2	10.7	15.2	13.2	7	10.1	12.1	7.9	8.6	12	10.4	12.6	9.3	6.7	16.2	8.6	8	10.2	19.8	6.8	13.3	8.6	7.2	10.6	11.6	11.5	26.3	5.9	12.2	8.4	13.9	12.8	12.9	8.5	21.5	10.8	8.5	10.1	10.4	11.7	9.1	13.8	10.4	16.4	11.7	6.9	17.7	9.7	8.9	18.4	15.1	9.8	9.4	16.7	20	8.3	6.3	4.7	4.8	11.8	6	14.1	7.5	9.7	9	9.8	13.8	6.2	5.2	13.3	5.4	4.3	8.3	13.6	5.1	10.2	17.3	6.7	7.6	5.7	4.9	38.6	20.4	10.6	4.2	14.6	4.4	15.4	13.8	12.4	12.1	11.4	14.3	4.2	12.2	4.7	5.7	10.4	8.5	9	10.3	5.6	2.9	13.2	10.1	6	5.6	11.4	2.8	9.5	9.9	9.7	6	10.3	5.3	3.8	5.2	11.2	11.3	7.2	8.2	9.5	17.4	13.5	8.2	9.8	7	8.4	11.4	9.4	16.3	17.1	16.3	14.9	15.1	18.4	20	16.6	3	16.7	7.2	12.8	18.3	8.3	9.2	11.7	15.2	13.2	8.6	8	8.6	7.2	12.2	10.4	20.8	11.8	9	11.9	5.6	13.1	19.3	2.5	9.4	9.1	12.2	21.6	16.9	26.6	17.7	196.9	5	4.5	0	15.5	16	7.8	6.2	26.6	21.7	13.5	28.6	5.8	3.7	7.3	7.6	4.6	8.6	3.3	17.2	7.6	12.8	11.8	7	8.1	15.1	21.4	12.9	12.3	24.6	14.1	9.9	6.1	14.1	14.2	7.3	Early spermatids
MYOC	GLC1A, JOAG1, TIGR	ENSG00000034971	Myocilin	Q99972	1	171635417-171652683	Disease related genes, Plasma proteins, Predicted secreted proteins			Disease mutation, Glaucoma	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		retina: 100.8	Cell type enriched	Detected in some	4	Peritubular cells: 35.3	Cancer enriched	Detected in many	6	melanoma: 13.5	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Low region specificity	Detected in many			Low region specificity	Detected in many			HPA027364	Uncertain				Secreted to extracellular matrix				12000000			HPA027364: AB_10602036	unprognostic (2.02e-2)	unprognostic (4.65e-2)		unprognostic (4.44e-2)	unprognostic (6.29e-2)	unprognostic (1.43e-1)		unprognostic (2.33e-2)	unprognostic (3.42e-2)	unprognostic (3.02e-2)	unprognostic (2.82e-2)	unprognostic (2.54e-1)	unprognostic (1.94e-4)	unprognostic (5.35e-2)	unprognostic (1.87e-1)	unprognostic (3.87e-2)	unprognostic (1.24e-1)	26.9	0.8	0	0.5	0	0	8.4	0	0	5.4	6	0	5.3	2.4	8.1	7.6	40.7	7.4	8.3	12.6	0.1	0	0.2	0.1	3.7	0	0	0	3.9	2.1	0.2	0.1	0.1	0.2	9	2.5	100.8	10.5	4.8	21.7	2.4	2.6	39.4	0.3	0.1	29.9	2.8	0	0.6	14.9	28.2	5	26.1	6.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0.7	0.4	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0.7	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0.2	0	0	0	0	0	0.2	0	0.8	0	0	0	0	0	0	0	0	0.9	0.3	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0.5	8.1	0	0	0	0	0	0	0	35.3	0	0	0	1.4	0.1	0	0	0	0	0	0	Peritubular cells
MYOM2		ENSG00000036448	Myomesin 2	P54296	8	2045040-2165552	Predicted intracellular proteins		Muscle protein		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	14	heart muscle: 170.7;skeletal muscle: 75.9	Cell type enriched	Detected in many	15	Cardiomyocytes: 554.8	Low cancer specificity	Detected in many			Not detected	Not detected			Cell type enhanced	Detected in single		naive B-cell: 1.9	Low lineage specificity	Detected in single			Group enriched	Detected in some	8	HEK 293: 10.1;SCLC-21H: 4.3;U-266/84: 5.3	Not detected	Not detected							HPA001765, HPA005953	Enhanced		Approved	Mitochondria					120000	Mitochondria		HPA001765: AB_1079443, HPA005953: AB_1854258	unprognostic (2.81e-2)	unprognostic (1.11e-3)	unprognostic (8.19e-2)	unprognostic (1.35e-3)	unprognostic (2.11e-1)	unprognostic (1.86e-2)	unprognostic (2.30e-5)	unprognostic (1.10e-1)	unprognostic (5.17e-2)	unprognostic (1.34e-2)	unprognostic (9.56e-2)	unprognostic (2.54e-2)	unprognostic (3.89e-2)	unprognostic (2.71e-2)	unprognostic (9.01e-2)	unprognostic (3.22e-1)	unprognostic (1.14e-1)	2	0	0.3	0.1	0.4	0	1.7	0.9	0.9	0.2	0.2	0	0.2	0	0.5	2.7	1.2	0.1	0.1	170.7	0.3	0.1	0.7	0	0.1	0	0.2	0	0.2	0	0	0	0.1	0.1	0.9	0	0.2	1.2	1	75.9	0.2	0.1	0.3	0.1	0.4	0	0.2	0	0	0.6	8.9	1.2	0.3	0.1	1.9	0	0	0	0	0.8	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.8	10.1	0.3	0	0	0	0	0	0.4	0	0	0	0	0	0.3	0	0.6	0	0	0.6	0	0	0	0	0.4	0	0	0	0	4.3	0	0	0	0.1	0.2	0	0	0	0	0	0	0	0	5.3	0	0	0	0	0	0	0	0.3	0	0	0.5	0.4	0.2	0	1.9	0.8	0	0	0	0	0	0.5	0.5	0.3	0.4	0.9	0.9	0.3	0.1	0.2	0	0.1	0	6	4	0	2.3	3.2	2.8	554.8	17.8	6.7	0	3.5	0	0	11.6	3.4	5.4	2.3	1	0	1.5	0	1.4	1	5.7	6.4	1.4	6.4	0	5.5	2.8	6.2	0.6	2.3	3.3	3.6	2.5	7	2.5	0	1.4	21.4	4.1	0	17	36.9	22.7	2.5	0.1	8.7	1.1	1.4	Cardiomyocytes
SLC18A1	CGAT, VAT1, VMAT1	ENSG00000036565	Solute carrier family 18 member A1	P54219	8	20144855-20183206	FDA approved drug targets, Predicted membrane proteins, Transporters	Neurotransmitter transport, Transport		FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		adrenal gland: 25.4;intestine: 10.8	Cell type enriched	Detected in some	37	Intestinal endocrine cells: 133.5	Cancer enhanced	Detected in some		colorectal cancer: 0.8	Region enriched	Detected in single	4	midbrain: 2.0	Group enriched	Detected in some	12	intermediate monocyte: 2.3;non-classical monocyte: 6.0	Lineage enriched	Detected in single	18	monocytes: 6.0	Cell line enriched	Detected in some	8	SH-SY5Y: 39.2	Not detected	Not detected			Low region specificity	Detected in many			HPA006877, HPA063797	Enhanced											HPA006877: AB_2667690, HPA063797: AB_2685125	unprognostic (8.03e-4)	unprognostic (1.02e-1)	unprognostic (3.75e-3)	unprognostic (3.50e-1)	unprognostic (6.61e-2)	unprognostic (3.09e-3)	unprognostic (1.67e-1)	unprognostic (2.16e-2)	unprognostic (3.45e-2)	unprognostic (1.48e-1)	unprognostic (1.32e-3)	unprognostic (1.61e-1)	unprognostic (2.48e-2)	unprognostic (8.25e-2)	unprognostic (4.41e-2)	unprognostic (2.06e-1)	unprognostic (1.05e-1)	0	25.4	0.2	0.8	0.1	0	0	0	0.2	0.2	8.8	1.3	1.3	1.4	0.4	0	0	0	0.7	0.1	0.1	0.4	0	0	0	0	2	0	0.2	0	0	0	0	0.4	1	2.7	0	0	2.8	0	0	10.8	0	0.1	0.3	1.1	0.2	0	0.2	0.2	0	0.1	1.3	0.4	0	0.3	0.2	6	0	0	0.3	0	0	1.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	4.6	0	0	0	2.2	39.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	2.3	0	0	0	0	0.3	0	0	0	0.2	0	6	0	0	0.3	0.2	0.1	0	0.2	0.1	0.4	2	0	0.4	0	0	0	0	0	0	0	3.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	133.5	0	0	0	0	0	0	1	1.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	Intestinal endocrine cells
SOX30		ENSG00000039600	SRY-box 30	O94993	5	157625679-157671480	Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	Activator, DNA-binding, Repressor		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	18	testis: 42.5	Cell type enriched	Detected in some	7	Early spermatids: 287.1	Low cancer specificity	Detected in some			Not detected	Not detected			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		A-431: 4.2;CACO-2: 2.8;HDLM-2: 9.0	Not detected	Not detected			Not detected	Not detected			HPA006159, CAB009382	Enhanced											CAB009382: AB_2195963, HPA006159: AB_1080062	unprognostic (3.51e-2)	unprognostic (4.72e-2)	unprognostic (7.31e-2)	unprognostic (4.70e-4)	unprognostic (2.53e-2)	unprognostic (6.12e-2)	unprognostic (4.47e-2)	unprognostic (2.22e-2)	unprognostic (5.33e-2)	unprognostic (1.36e-1)	unprognostic (4.73e-2)	unprognostic (7.85e-2)	unprognostic (4.64e-4)	unprognostic (5.88e-2)	unprognostic (1.64e-1)	unprognostic (3.72e-2)	unprognostic (3.45e-1)	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0.3	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	42.5	0	0	0	0	0	0.2	0	1.6	2.3	1.7	0.4	0	1.7	0.4	4.2	0.1	0	0	0	0.3	0.3	0.3	0	0.4	0.3	2.8	1.8	0	0.1	0.1	0.2	0.5	0	0	0.2	9	0.4	0	0.1	0	0.1	0	0	0.1	1.2	0.5	0.3	0.3	0.3	0	0.3	0	0	0.4	0	0.1	0.9	0	0.9	0	0	0.4	0.3	0	0.2	0.1	0	0.5	0	0.3	0	0	0.2	0	0	0.1	0.1	0.4	0	0.9	0	0	0.3	1.7	0.4	1.6	0.7	0.3	0.3	1.1	1.4	1.1	0	1.6	1.4	1.1	0.1	0	0	2.3	1.7	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	1.2	0	0	0.1	0	0	287.1	0	0	0	0	0.1	0	0.1	0	0	0	0	0	0	0	38.8	1.7	0	0	0	0	0	0	0	1.4	0	0	0	0	27	8.5	0	0	0	0	0	Early spermatids
BEST2	FLJ20132, VMD2L1	ENSG00000039987	Bestrophin 2	Q8NFU1	19	12751702-12758458	Predicted intracellular proteins, Predicted membrane proteins, Transporters	Ion transport, Transport	Chloride channel, Ion channel		Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	4	intestine: 25.2;retina: 28.7;skin 1: 11.7	Cell type enriched	Detected in some	62	Mucus-secreting cells: 105.6	Cancer enhanced	Detected in some		colorectal cancer: 1.1	Not detected	Not detected			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Low cell line specificity	Detected in many			Not detected	Not detected			Region enhanced	Detected in some		cerebellum: 3.5	HPA046229	Approved											HPA046229: AB_10966140	unprognostic (3.19e-1)	unprognostic (7.58e-2)	unprognostic (1.54e-2)	unprognostic (1.02e-1)	unprognostic (5.74e-2)	unprognostic (4.02e-3)		unprognostic (2.77e-1)	unprognostic (1.87e-1)	unprognostic (2.18e-1)	unprognostic (2.43e-1)	unprognostic (3.46e-3)	unprognostic (9.18e-6)	unprognostic (3.45e-2)	unprognostic (6.95e-2)	unprognostic (2.90e-1)	unprognostic (1.64e-5)	0.2	0.1	0.2	4.1	0.2	1.8	0.3	0.2	1.3	0.4	25.2	0.2	0.2	0	0.2	0.7	0.2	0.2	0.3	0.2	0.2	0.1	0.2	0.2	0.2	2.2	0.2	0.2	0.4	0.2	0.4	0.2	0.2	0.2	0.2	12.8	28.7	0.6	0.2	0.2	11.7	11.5	0.5	0.2	0.2	0.1	0.3	0.2	0.2	0.4	1.5	5.2	0.2	1	3.1	2.7	2.2	0.8	1.7	2.1	1.2	0.9	0.7	2.3	3.5	0	0.4	1.6	1	0	0.5	0.7	2.6	3.6	2.9	0.9	1.2	0.7	1.8	0	0.5	0.6	3.3	1.6	2.4	3.3	0.9	0.4	1.2	5.2	0.5	0.3	0.4	0.3	1.4	0.3	0.6	0.6	1.5	0.5	3	0.8	1.9	3	0.2	2.6	0.4	1.3	0.5	1	1.2	1.9	1.9	1.5	0.7	0.6	2.7	1.8	0.9	2.6	0.9	1	1.6	2.1	0.9	1.3	1.1	1.3	2.7	1.9	1.7	0.5	0.4	1.4	0.8	1.1	2.2	1	0.8	0.2	3.1	2.1	2.1	2.2	1.7	0.5	2.7	0.7	1.2	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0	0	0	0.1	0.5	0	0.4	0	0	0	0	0	0.1	0	0	0	0	1.3	0	0	0.1	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	105.6	0	0	1.7	0	0	0	0	0	0	0.4	0.1	0.2	0	1.6	0.1	Mucus-secreting cells
DCUN1D1	DCUN1L1, RP42, SCCRO, SCRO, Tes3	ENSG00000043093	Defective in cullin neddylation 1 domain containing 1	Q96GG9	3	182938074-182985953	Predicted intracellular proteins	Ubl conjugation pathway		Proto-oncogene	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in all	5	testis: 95.0	Cell type enriched	Detected in all	4	Late spermatids: 9862.3	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low cell line specificity	Detected in all							Low region specificity	Detected in all			HPA035911	Uncertain		Approved	Nucleoplasm,Cytosol					70000	Nucleoplasm	Cytosol	HPA035911: AB_10673489	unprognostic (2.13e-1)	unprognostic (2.36e-1)	unprognostic (4.83e-3)	unprognostic (1.94e-3)	unprognostic (1.44e-3)	unprognostic (6.06e-2)	unprognostic (5.93e-2)	unprognostic (1.72e-2)	unprognostic (9.34e-2)	unprognostic (9.25e-3)	unprognostic (4.98e-3)	unprognostic (7.26e-2)	unprognostic (1.01e-3)	unprognostic (1.52e-1)	unprognostic (2.12e-1)	unprognostic (5.01e-2)	unprognostic (3.52e-1)	5	5.2	7.9	5	7.1	6.9	4.8	9.3	8.3	4.5	4.9	4.1	2.7	4.9	5.4	4.9	6.7	4.3	4.6	5.5	7.4	5	7.2	11.2	4.3	5	9.3	6.8	4.7	3.6	4.6	14.6	4.5	8	6.1	4.8	2.8	4.9	5.4	14.7	5.2	6.5	8.1	9.2	5.2	4.2	95	7.6	7.2	6.7	5.2	6	8.4	4.9	7.4	10.7	17.3	9.8	11.2	8	5.7	23.3	10.4	13.9	6	14.7	14.5	11.8	15	16.9	16.9	16.6	15.3	17.4	27.4	33	14	25.5	13.1	11.6	12	22.5	22.4	6.3	26.4	8.1	6.4	9.3	15.5	19.9	10.3	14.7	9.4	8.9	12.5	11.6	16.8	8.8	14.4	12.3	12.5	15.2	8.3	11.3	17.6	9.5	12	14.7	18.1	12.2	16.5	10.1	10.1	26.3	18.9	14.1	15.3	38.7	12.6	11.2	10.5	10.1	14.3	17.6	11.9	22	27.8	13.2	14.7	15.1	9.4	9.1	17.3	7.8	9.8	7.5	7.4	6.4	7.7	10.7	4.7	7.5	7.9	15	11.2	6.3	8.2	8	5.7	7.9	7.1	9.3	8.3	7.4	5	9.3	6.8	8	7.6	20.8	25.6	17.1	21.7	38.5	14.2	28.2	17.8	20.1	27.3	45.4	9.8	16.2	31.5	26.1	2225.5	18.8	26.6	46.7	26.5	15.7	27.7	32.3	28.9	42.3	24.9	17.5	25.8	17.8	32.1	9862.3	80.3	36.4	11.8	45.1	19.9	16.6	27.2	23.4	60.5	33.6	20.5	77.6	25.5	86.4	52	37.1	16.7	25.3	19.6	34.8	Late spermatids
GPM6B	M6B, MGC17150, MGC54284	ENSG00000046653	Glycoprotein M6B	Q13491	X	13771031-13938638	Predicted membrane proteins	Differentiation, Neurogenesis, Osteogenesis, Protein transport, Transport	Developmental protein		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	7	brain: 219.5	Cell type enriched	Detected in many	6	Muller glia cells: 1904.1	Group enriched	Detected in many	14	glioma: 192.5;melanoma: 41.0	Low region specificity	Detected in all			Cell type enriched	Detected in single	222	plasmacytoid DC: 33.4	Lineage enriched	Detected in single	240	dendritic cells: 33.4	Cell line enhanced	Detected in some		AF22: 42.8;AN3-CA: 42.4;ASC TERT1: 21.8;HSkMC: 32.1;SK-MEL-30: 42.1	Low region specificity	Detected in all							HPA002913	Approved											HPA002913: AB_2263553	unprognostic (1.56e-2)	unprognostic (3.42e-1)	unprognostic (1.83e-1)	unprognostic (3.70e-2)	unprognostic (8.55e-2)	unprognostic (2.75e-3)	unprognostic (2.12e-2)	unprognostic (1.92e-2)	unprognostic (4.27e-2)	prognostic favorable (2.67e-4)	unprognostic (1.79e-2)	unprognostic (4.78e-2)	unprognostic (2.38e-3)	unprognostic (8.34e-2)	unprognostic (2.12e-1)	unprognostic (1.04e-2)	unprognostic (2.00e-1)	4.6	5.5	68.4	3.9	55.1	2	12.4	24.1	219.5	10.2	5.7	68.7	1.1	3.6	4.3	6.7	6.4	4.2	3.9	5.9	62.6	33.1	4.5	2	6.7	2.6	68.9	47.3	3.1	2.9	1.9	2.6	2.1	44.1	9.9	4.9	3.2	7.4	16.9	2.1	7.1	4.3	3.8	109.4	7.2	3.3	3	64.8	0	3.5	0	2.3	3.3	2.7	0.1	33.4	0.1	0	0.1	0.1	0.2	0.1	0.1	42.8	42.4	12.1	21.8	0.1	0.2	1.9	0	0	0.1	0.1	0.2	0	0	0.1	0.3	2.1	0.2	0	0.1	7	0.1	2.8	0.1	0.4	0.1	0.2	32.1	0.2	0	0.5	0.1	0	0.8	0.1	1.9	0.4	0.1	0.9	0.1	13.4	0	0.7	0.5	3.8	6.5	0	0.1	2.1	1.2	0.2	1.2	42.1	12.3	0.2	0.9	0	0.2	0.3	0.1	0.5	0.1	0	0.1	0.4	0	3.5	0	0	0	0.1	0	0.1	0	0	0	0.1	0.1	0	0	0.1	0.1	0	33.4	0	0.2	68.4	55.1	24.1	43.1	62.6	33.1	68.9	47.3	44.1	64.8	0	3.2	20.4	22	29.3	74.8	1.1	0	13.4	5.7	21	82.5	3.8	0	3.2	0.4	6.3	3.8	0	3.3	2.8	24.2	20.1	4.6	0.4	1	25.4	1.2	16.5	1	1.5	22.5	1.8	339.1	2.8	2.6	1904.1	1.9	3.2	30.1	0.6	143.8	45.3	22.6	4.3	9.4	14.9	11.4	15.2	2.9	12.6	Muller glia cells
USP28	KIAA1515	ENSG00000048028	Ubiquitin specific peptidase 28	Q96RU2	11	113797874-113875570	Enzymes, Predicted intracellular proteins	DNA damage, DNA repair, Ubl conjugation pathway	Hydrolase, Protease, Thiol protease		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		heart muscle: 40.1;skeletal muscle: 50.2	Cell type enriched	Detected in many	5	Cardiomyocytes: 130.6	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Cell line enhanced	Detected in many		SuSa: 42.9	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA006778, HPA006779	Enhanced		Supported	Nucleoplasm,Nuclear bodies						Nucleoplasm	Nuclear bodies	HPA006778: AB_1080520, HPA006779: AB_1080517	unprognostic (2.54e-1)	unprognostic (2.72e-1)	unprognostic (2.99e-2)	unprognostic (3.72e-2)	unprognostic (5.51e-2)	unprognostic (2.30e-1)	unprognostic (9.73e-3)	unprognostic (3.00e-1)	unprognostic (2.04e-3)	unprognostic (1.82e-3)	unprognostic (3.17e-2)	unprognostic (1.19e-1)	unprognostic (5.11e-2)	unprognostic (2.06e-2)	unprognostic (9.03e-2)	unprognostic (1.35e-3)	unprognostic (5.03e-2)	3.9	3.4	4.8	8.6	5.7	2.4	5.7	26.4	8.6	11.6	5.1	4.9	14	4.7	6	6	5.7	5	4	40.1	5	4.8	5.1	5.6	5.1	7.2	6.8	4.5	7.5	4.1	10.6	9.7	3.9	4.8	8.9	6	5.7	5.7	12.2	50.2	3.5	5.1	11.6	6.4	6.9	4.4	5.5	3.8	3.6	5.1	10.1	7.7	7.1	4.6	10.3	4.1	2.1	3.7	17.9	16.2	6	8.6	9.7	13.1	17.3	10.8	10.7	9.3	6.4	8.8	8.6	14.8	14.4	12.5	11.5	14.6	8.6	19.9	17	18.5	12	12	12.8	8.4	6.1	6.8	7.7	6.6	7.8	6.1	6.4	9.1	10	11.9	12.6	15.5	5.7	10.5	7.5	9	4.4	5.9	12.8	15.7	16	7	14.7	18.3	13.9	9.5	8.5	5.7	6.2	15.2	5.2	4.9	42.9	12.6	2.7	8.2	9.6	14.4	8.7	6.5	5.1	7.3	9.7	0.9	15.3	6.2	0.1	3.2	2.1	16.2	2.4	8.4	10.3	4.1	11.4	4.1	8.4	2.7	9.4	0.9	17.9	3.7	1.2	5.6	6	4.8	5.7	26.4	8.6	5	4.8	6.8	4.5	4.8	3.8	8.9	9.1	10	6.9	1.4	16.1	130.6	5.1	14.7	10.3	5.2	17.7	3.5	5	5.7	1.4	4.3	5.1	0	3.4	3.7	4.7	6.2	1.1	6.7	3.9	4.8	4.7	6.2	4.1	1.4	6.4	6.5	1.7	5.4	10.3	10.1	4.4	3.5	13.1	6.3	20.2	6.5	5.2	10.8	10	1.8	0.9	24.5	9.2	4.9	Cardiomyocytes
COL9A2	EDM2, MED	ENSG00000049089	Collagen type IX alpha 2 chain	Q14055	1	40300487-40317813	Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins			Deafness, Disease mutation, Dwarfism, Stickler syndrome	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 35.3;pituitary gland: 32.1;retina: 40.8	Cell type enriched	Detected in many	9	Muller glia cells: 280.3	Cancer enhanced	Detected in all		prostate cancer: 68.2	Low region specificity	Detected in all			Group enriched	Detected in some	4	eosinophil: 6.4;myeloid DC: 2.7	Group enriched	Detected in many	6	dendritic cells: 2.7;granulocytes: 6.4	Cell line enhanced	Detected in some		HDLM-2: 35.4;HMC-1: 34.1;THP-1: 38.3	Low region specificity	Detected in all							HPA056316, HPA075286	Supported		Approved	Nucleoplasm,Vesicles	Secreted to extracellular matrix					Vesicles	Nucleoplasm	HPA056316: AB_2683099, HPA075286: AB_2732288	unprognostic (1.42e-2)	unprognostic (3.54e-2)	unprognostic (8.94e-2)	prognostic unfavorable (5.13e-4)	unprognostic (4.46e-2)	unprognostic (1.83e-3)	unprognostic (2.06e-2)	unprognostic (9.00e-3)	unprognostic (1.73e-1)	unprognostic (1.26e-1)	unprognostic (1.56e-3)	unprognostic (2.26e-1)	unprognostic (1.16e-3)	unprognostic (4.28e-2)	unprognostic (2.56e-1)	unprognostic (5.89e-2)	unprognostic (1.71e-2)	0.7	2.3	17.2	2.6	19.5	7.6	3.1	2.3	12.1	10	3.6	32	17.4	4.6	3.9	1.5	0.7	3.7	6.5	1	20.8	14.5	4.3	0.6	2.8	4.2	29.8	10.5	0.6	1.7	28.3	32.1	0.9	16.3	8.8	2.6	40.8	13.7	21.3	0.3	2	3.3	1.3	35.3	3.2	12.8	0.8	19.7	0.2	4.3	0.9	2.5	4	0.5	0.7	2.7	6.4	0.7	0.4	0.3	0.1	4.3	0.1	0.7	0.3	1	0.5	2.9	0	0	0.2	0.5	0.1	2.5	1.2	3.8	0.1	0	0.7	0	0	0.1	35.4	0.5	0.7	0.3	9.9	0.6	0.3	34.1	1.8	0	0	0	0.2	0	0.5	0	7.4	0	0.9	0.4	0.7	0.8	0	0.4	0.8	0	2.4	0	5.2	0.5	0.8	0	4.4	0.4	2.6	5.6	38.3	0	0	4.5	0	0.1	0.5	0	1.2	0.3	4.5	0.2	0	0.2	6.4	0	0.5	0	0.5	0.2	0	2.7	0.7	0.1	0	1.1	0.4	0.7	0.3	0.3	0.1	17.2	19.5	2.3	10.8	20.8	14.5	29.8	10.5	16.3	19.7	0	3.5	4.5	2.6	0.9	1.8	0.8	7.6	1.4	3.4	24.4	0	2.3	0	6.3	0	0	3.3	0	0.7	0.4	1.4	7.8	26.4	0	3.3	0	12.2	1.3	0.3	0.8	2	6.5	1.7	30.7	5.5	280.3	3.6	7	0	0.1	7.8	0	0.9	2.6	2.6	0.5	1.1	2.2	12.2	11.1	Muller glia cells
PTGER3	EP3	ENSG00000050628	Prostaglandin E receptor 3	P43115	1	70852353-71047808	FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins		G-protein coupled receptor, Receptor, Transducer	FDA approved drug targets	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in many		breast: 71.2;endometrium 1: 65.2	Cell type enriched	Detected in many	10	Distal tubular cells: 190.6	Group enriched	Detected in some	7	breast cancer: 4.1;renal cancer: 9.4	Low region specificity	Detected in many			Cell type enriched	Detected in single	49	basophil: 22.4	Lineage enriched	Detected in single	49	granulocytes: 22.4	Cell line enhanced	Detected in some		ASC diff: 15.2;HAP1: 10.8;HDLM-2: 16.3;HEL: 7.8;T-47d: 37.5	Low region specificity	Detected in many			Low region specificity	Detected in many			HPA010689	Uncertain											HPA010689: AB_1855883	unprognostic (1.53e-3)	unprognostic (3.48e-1)	unprognostic (1.11e-1)	unprognostic (3.86e-3)	unprognostic (1.47e-1)	unprognostic (3.37e-2)	unprognostic (4.80e-2)	unprognostic (2.01e-2)	unprognostic (1.24e-1)	unprognostic (4.64e-3)	unprognostic (1.54e-1)	unprognostic (1.97e-1)	prognostic unfavorable (3.50e-4)	unprognostic (8.83e-3)	unprognostic (1.86e-1)	unprognostic (1.92e-2)	unprognostic (1.41e-4)	32.5	3	3.9	6.8	0.7	0	71.2	0.2	1.7	7.8	6.3	0.1	3	0.5	65.2	16.6	1.7	4.8	11.3	2.6	0.6	2	41.5	0.3	0.6	2.2	0.4	1.4	2.4	10.7	0	0.4	0.5	1.6	3.3	1	0.1	15.5	3.7	0.5	6.2	1.8	31.9	0.5	0.3	9.1	4	0	0	0.7	3.2	0.7	4.4	5.7	0	0.4	22.4	0	0	0.2	0	0	0	0	0	15.2	0.3	0	0.3	0	0	0.4	0	0	0	0	1.7	0	0	10.8	0	0	16.3	0	7.8	0	0	0	0	0	0	0	0	0	0	0	0.1	2.4	0	0	0	0	0	0.2	0	0	0	0	0	0	0	1.4	0.5	0	0.1	0	0.1	37.5	0	0	0.1	0	0	0	0	0	0	0.1	3.6	0	22.4	0	0	0	0	0.2	0	0	0	0.4	0	0	0	0	0	0	0	0	0	3.9	0.7	0.2	1.7	0.6	2	0.4	1.4	1.6	0	0	0.3	0	0.2	4.4	1.1	0.8	0	0	0	19.2	0	0	190.6	2.3	0.8	0.9	0	0	0	2.2	2	1.5	9.2	0	0.1	3.2	2.4	1.3	0	0.4	1.1	2.8	8.5	1	0	0.2	0	0	0	3.3	0	6.5	5.1	0.1	0	6.6	0.1	0	0	0.1	Distal tubular cells
COL23A1	DKFZp434K0621	ENSG00000050767	Collagen type XXIII alpha 1 chain	Q86Y22	5	178237618-178590555	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		thyroid gland: 42.3	Cell type enriched	Detected in some	5	Muller glia cells: 56.2	Cancer enhanced	Detected in many		renal cancer: 41.3	Low region specificity	Detected in many			Cell type enriched	Detected in single	5	plasmacytoid DC: 3.1	Lineage enriched	Detected in single	5	dendritic cells: 3.1	Group enriched	Detected in some	4	K-562: 8.1;NB-4: 23.1;THP-1: 23.0	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA067824	Uncertain											HPA067824: AB_2685907	unprognostic (5.24e-2)	unprognostic (2.65e-1)	unprognostic (6.65e-2)	prognostic unfavorable (6.46e-5)	unprognostic (3.04e-1)	unprognostic (8.67e-3)	unprognostic (1.14e-1)	unprognostic (3.62e-1)	unprognostic (2.12e-1)	unprognostic (3.52e-2)	unprognostic (3.96e-2)	unprognostic (5.93e-3)	unprognostic (8.20e-2)	unprognostic (2.30e-1)	unprognostic (4.90e-2)	unprognostic (2.11e-3)	unprognostic (2.37e-1)	0.6	0.5	1.6	1.9	1.3	6.9	1.5	8.8	3.4	2.2	2.2	0.1	7.6	3.1	1.2	3.6	0.7	2	0.9	11.4	1.5	1	2.2	1.5	1.4	0.6	0.7	2.3	0.2	1.9	3	0.8	0.1	2.9	4.1	0.1	3.7	1.7	12.6	1.3	6.3	3.8	1.1	2.6	1.5	2.2	2.3	0.1	0.3	42.3	2.2	1.6	1	1.5	0	3.1	0	0.5	0.5	0	0.2	0	0	4	0.2	0.2	0	1.1	0	0	0	0	0	0	0.2	1	0	0	0	0	0	0	0	1.4	0	0	0	0	0	0	0.1	0.3	0	0	0	0	0	8.1	0.4	0	1	0	23.1	1.3	0	0	0	0	0.1	0	0	0.2	0.5	0	0	0	1.9	0	23	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0.5	0	0	0	0	0.2	0	0	0	0	0.5	0	3.1	0	0.2	1.6	1.3	8.8	3.4	1.5	1	0.7	2.3	2.9	0.1	0	0	0	2.5	1.9	0.7	10.9	0	0	0	0	0	0	0	0	0.3	2.1	0	0	0	0.2	1.3	0.4	0	0	0.5	0	0	1.8	1.6	0	0.3	0.9	0	0	0	56.2	0.1	0	2.5	0.5	2.5	6.5	4.7	1.1	2	4.1	0.1	0	0	0.1	Muller glia cells
SPO11	CT35, SPATA43, TOPVIA	ENSG00000054796	SPO11, initiator of meiotic double stranded breaks	Q9Y5K1	20	57329759-57343994	Enzymes, Plasma proteins, Predicted intracellular proteins	Meiosis	DNA-binding, Hydrolase, Isomerase		Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enriched	Detected in single	142	testis: 14.2	Cell type enriched	Detected in some	5	Spermatocytes: 58.6	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	19	Daudi: 1.7;SiHa: 1.3;U-698: 2.7	Not detected	Not detected			Low region specificity	Detected in many																																	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.7	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	1.3	0	0	0	0	0	0	0	0	0	0	0	0	2.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.5	0.3	0	0	0	0	0	0	0	0	0	0	0	0	58.6	11.7	0	0	0	0	0	Spermatocytes
CBLN4	CBLNL1, dJ885A10.1	ENSG00000054803	Cerebellin 4 precursor	Q9NTU7	20	55997440-56005472	Plasma proteins, Predicted secreted proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		adrenal gland: 23.5;brain: 16.8;epididymis: 11.8	Cell type enriched	Detected in some	4	Peritubular cells: 35.7	Low cancer specificity	Detected in some			Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	49	SH-SY5Y: 15.0	Low region specificity	Detected in many			Low region specificity	Detected in many			HPA074497		Supported			Secreted in brain				10000000			HPA074497: 	unprognostic (3.61e-1)	unprognostic (8.43e-3)	unprognostic (2.43e-1)	unprognostic (1.61e-2)	unprognostic (1.99e-1)	unprognostic (4.00e-1)	unprognostic (3.25e-1)	unprognostic (2.11e-1)	unprognostic (1.42e-1)	unprognostic (3.88e-1)	unprognostic (9.63e-2)	unprognostic (1.74e-1)	unprognostic (1.40e-3)	unprognostic (3.22e-4)	unprognostic (7.50e-2)	unprognostic (3.58e-2)	unprognostic (1.79e-3)	1.3	23.5	11.9	0.3	8.9	0.2	1.8	0.1	16.8	2.8	0.3	0.5	0.8	0.3	1.2	11.8	0.3	5.4	0.9	0.2	5.9	14.8	1	1.3	1.1	0.2	1.6	5	2.2	1.2	0.4	0.1	0.5	2.4	0.4	0.2	0.1	0.3	0.7	0.5	0.3	0.3	0.6	0.4	0.2	0.7	2.7	0	0	1.3	0	0.2	0.2	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	15	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	11.9	8.9	0.1	16.8	5.9	14.8	1.6	5	2.4	0	0	0	0	0.1	0	0.6	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0.1	1.6	8.5	0	0	0	2	0	0	0	0	0.2	0	0	35.7	0	0.1	0	0	0	0.1	0	0	0	0	0	Peritubular cells
ITIH1	H1P, IATIH, ITIH	ENSG00000055957	Inter-alpha-trypsin inhibitor heavy chain 1	P19827	3	52777592-52792068	Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins		Protease inhibitor, Serine protease inhibitor		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	95	liver: 321.2	Cell type enriched	Detected in some	23	Hepatocytes: 864.9	Cancer enriched	Detected in some	598	liver cancer: 329.1	Not detected	Not detected			Cell type enhanced	Detected in some		classical monocyte: 3.3	Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		ASC diff: 10.9;Hep G2: 3.3;HL-60: 2.5;RH-30: 1.4	Not detected	Not detected			Low region specificity	Detected in all			HPA041639, HPA042049	Approved		Approved	Vesicles	Secreted to blood			4490000	31000000000	Vesicles		HPA041639: AB_10796349, HPA042049: AB_10797379	unprognostic (1.87e-4)	unprognostic (1.31e-3)	unprognostic (2.38e-1)	unprognostic (8.55e-2)	unprognostic (1.03e-1)	unprognostic (2.64e-3)	prognostic favorable (1.89e-5)	unprognostic (2.27e-2)	unprognostic (1.70e-1)	unprognostic (1.30e-1)	unprognostic (2.91e-2)	unprognostic (8.45e-2)	unprognostic (4.53e-4)	unprognostic (4.02e-3)	unprognostic (5.70e-3)	unprognostic (2.08e-1)	unprognostic (2.24e-2)	0.1	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0.1	0	0	0.1	0.2	0	0	0	321.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0.2	0	0	0	0.1	0	0	0	0	0	0	1.1	0	3.3	0.8	0	0.9	0	0	0	0	10.9	0	0	0	0	0	0	0.2	0	0.1	0	0	0	0.1	0	0	0	0	0	0.3	0	3.3	0	2.5	0.5	0	0	0	0	0	0	0	0.2	0.5	0	0	0	0.1	0.1	0	0	0.1	1.4	0	0	0	0	0	0.7	0	0	0	0	0	0.2	0	0	0	0	0.3	0.1	0.3	0	0.7	0	0	3.3	0	0	0.9	0	0	0	0	1.1	0	0	0	0	0.8	0.2	0	0	0.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	38.2	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	864.9	0.1	0	0	18.4	14.8	1	0	0	0	3.6	0	0	0	0	0	0	0	0	1.4	0	0	0.1	0.1	0.5	0	0	Hepatocytes
MSH4		ENSG00000057468	MutS homolog 4	O15457	1	75796882-75913238	Predicted intracellular proteins	Meiosis	DNA-binding		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in some	7	testis: 33.0	Cell type enriched	Detected in some	4	Spermatocytes: 19.1	Not detected	Not detected			Region enriched	Detected in single	4	cerebellum: 2.6	Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		AN3-CA: 5.7;HDLM-2: 2.7;JURKAT: 3.0	Not detected	Not detected																				unprognostic (6.64e-2)	unprognostic (2.11e-1)	unprognostic (3.46e-2)	unprognostic (1.24e-1)	unprognostic (1.03e-1)	unprognostic (1.99e-2)	unprognostic (6.88e-3)	unprognostic (1.74e-2)	unprognostic (4.37e-2)	unprognostic (3.00e-1)	unprognostic (3.58e-3)	unprognostic (9.72e-2)	unprognostic (6.88e-8)	unprognostic (5.33e-2)	unprognostic (4.90e-2)	unprognostic (5.08e-2)	unprognostic (4.63e-2)	0.3	0.2	0.3	0.3	0.6	0.1	0.5	2.6	0.4	0.3	0.8	0.3	0.3	0.1	0.6	4.8	0.3	0.6	0.3	0.6	0.3	0	0.3	0.3	0.4	0.3	0.3	0.3	1	0.3	0	0.3	0.6	0.3	0.3	0.3	0.3	0.3	0.3	1.6	0.5	0.4	0.7	0.7	1.2	0.2	33	0.3	0.3	0.3	0.3	0.3	0.5	0.5	0.7	0.4	0	0.1	0	0.5	0	0.8	0.1	0	5.7	1.1	0.4	0.3	0.1	0	0	0.1	0	0	0.1	0.9	0.1	0	0.2	0	0.3	0	2.7	0.6	0.2	0.2	0	0	0.1	0.4	1.1	1.7	0.5	0	0.7	0.1	3	0	0.2	0	0	0.4	0	0.2	0.1	0	0.4	0	0	0.1	0.1	1.1	0	0	0	0.3	1.1	0	0	0.3	0.9	0.4	0.1	0.1	0.1	0.1	0.1	0	0.5	0.1	0	0	0	0.4	0.1	0.2	0.7	0.1	0	0	0	0.2	0.5	0	0	0	0.4	0	0	0.3	0.6	2.6	0.4	0.3	0	0.3	0.3	0.3	0.3	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	4.1	0	0	0	0	0	0	0	0	0	0.1	4.8	1.2	0.6	0	0.5	0	0	0	0	0	0	0.1	0.2	0.7	0	0.3	0	0	19.1	1.3	0	0	0	0	0	Spermatocytes
F7		ENSG00000057593	Coagulation factor VII	P08709	13	113105788-113120681	Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins	Blood coagulation, Hemostasis	Hydrolase, Protease, Serine protease	Disease mutation, FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	39	liver: 68.0	Cell type enriched	Detected in some	6	Hepatocytes: 131.2	Cancer enriched	Detected in some	17	liver cancer: 41.4	Not detected	Not detected			Group enriched	Detected in some	15	gdT-cell: 1.7;MAIT T-cell: 1.2;memory CD8 T-cell: 1.6	Lineage enriched	Detected in single	17	T-cells: 1.7	Group enriched	Detected in some	9	CACO-2: 16.6;Hep G2: 10.3	Not detected	Not detected			Not detected	Not detected			HPA004826			Approved	Mitochondria	Secreted to blood			351000000	1500000000	Mitochondria		HPA004826: AB_10602805	unprognostic (2.06e-1)	unprognostic (2.55e-1)	unprognostic (1.03e-1)	unprognostic (1.34e-1)	unprognostic (3.27e-1)	unprognostic (1.91e-1)	unprognostic (1.50e-3)	unprognostic (3.81e-1)	unprognostic (4.36e-3)	unprognostic (1.16e-1)	unprognostic (4.19e-3)	unprognostic (1.15e-1)	unprognostic (1.35e-3)	unprognostic (3.36e-3)	unprognostic (1.09e-1)	unprognostic (2.86e-1)	unprognostic (1.47e-1)	0.1	0	0.1	0.1	0.1	0	0.1	0.2	0.4	0.2	0.1	0.1	0.1	0.3	0.1	0.2	0.1	0.2	0.1	0.1	0.1	0.1	0.1	68	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.3	0.1	0.1	0.1	0	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0	1.7	0.1	0	0.2	0.1	0	0	0	0	0.2	0	0	0	16.6	0	0	0	0.2	0.1	0	0	0	0	0	0	0.1	0	10.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0.7	0	0	0.1	0	0	0	0.3	0	0	0.2	0	0	1.5	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	1.7	0	1.2	0	0	1.6	0	0	0	0	0	0	0	0	0	0.1	0.1	0.1	0.2	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0	0	2.4	0	0	0.6	0.4	2.5	0	0	0	0	0	0	0	0	0	0	23.3	0.2	0	0.5	0	0	131.2	0.1	0	0	3.7	3.1	0	0.9	0	0	0	0	0	0	0	1.8	0.1	0.1	0	0.1	0.1	0.9	0.1	0.1	0.5	0	0	Hepatocytes
USP13	IsoT-3	ENSG00000058056	Ubiquitin specific peptidase 13	Q92995	3	179652755-179789401	Enzymes, Plasma proteins, Predicted intracellular proteins	Autophagy, Ubl conjugation pathway	Hydrolase, Protease, Thiol protease		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		heart muscle: 34.8;skeletal muscle: 90.3	Cell type enriched	Detected in many	6	Cardiomyocytes: 182.3	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enriched	Detected in many	5	MAIT T-cell: 15.4	Lineage enriched	Detected in many	8	T-cells: 15.4	Cell line enhanced	Detected in many		HDLM-2: 36.6	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA004827	Enhanced		Approved	Nucleoplasm,Cytosol						Nucleoplasm, Cytosol		HPA004827: AB_1080497	unprognostic (1.00e-2)	unprognostic (2.09e-1)	unprognostic (5.82e-2)	unprognostic (7.14e-2)	unprognostic (9.94e-2)	unprognostic (3.96e-2)	prognostic unfavorable (2.40e-5)	unprognostic (1.76e-1)	unprognostic (4.55e-2)	unprognostic (7.79e-2)	unprognostic (1.69e-3)	unprognostic (2.22e-2)	prognostic unfavorable (3.46e-6)	unprognostic (4.93e-2)	unprognostic (9.79e-2)	unprognostic (3.38e-2)	prognostic unfavorable (3.06e-4)	6.4	7.5	2	2.3	2.8	0.8	3.5	2.9	4.1	2.7	2.1	4.6	1.5	0.7	3.2	3.8	2.6	2.5	2.5	34.8	2	2.3	2.3	3.4	6	2.5	2.1	2.1	7.2	3	3.3	9.8	1.9	3	3	1.8	3.1	3.3	2.1	90.3	1.8	1.7	3.7	2.5	1.6	1.6	5.6	1.3	1.7	5.5	17.1	3.2	2.6	1.9	2	1.9	0	0.4	0	15.4	0.7	12.5	5.4	10.2	7.8	4.6	6.4	4.9	7.4	8.5	10.9	9.2	7.9	4.4	15.5	8.3	8.9	12.3	0.9	11.4	4.5	13	36.6	4.9	4.1	8.1	7.4	3.3	11.4	0	6.9	1.6	8.5	10.8	5.3	8.7	6.1	2	20	9	8.2	6.9	2.1	7.9	1.1	4.9	11.9	10.1	12.7	7.4	3.5	5.8	7.5	7.1	9.5	4.3	3	16.4	8.2	9.4	13.2	10.5	11.3	28.4	9.7	8.1	31.7	6.1	7.7	12.2	0	0.2	0	1.3	0.4	15.4	2	1.3	2.9	1.5	0.6	1	1	0	0	0.4	1.9	0.6	0.7	2	2.8	2.9	4.1	2	2.3	2.1	2.1	3	1.3	8.9	31	4.3	1.7	2.3	12.7	182.3	5.1	2.7	9.1	1.8	5.9	8.7	13.3	1	2.1	9.7	0.3	0	3.7	1.6	7.1	3.4	2.3	6.8	3.7	15.9	9.2	27.6	3.1	2	8.6	4.7	13.5	0	1.6	6.3	1.6	5.8	8.9	2.7	9.7	12.9	5.3	5.1	2.1	1.4	4.2	3.2	3.8	1.6	Cardiomyocytes
LAMC2	BM600-100kDa, EBR2, EBR2A, kalinin-105kDa, LAMB2T, LAMNB2, nicein-100kDa	ENSG00000058085	Laminin subunit gamma 2	Q13753	1	183186238-183244900	Disease related genes, Plasma proteins, Predicted secreted proteins	Cell adhesion	Heparin-binding	Epidermolysis bullosa	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in many			Cell type enriched	Detected in many	4	Pancreatic endocrine cells: 902.6	Cancer enhanced	Detected in many		head and neck cancer: 231.3	Low region specificity	Detected in many			Low cell type specificity	Detected in some			Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		A-431: 49.4;CAPAN-2: 44.7;HBEC3-KT: 221.9;hTERT-HME1: 137.0;RPTEC TERT1: 53.2	Low region specificity	Detected in many			Low region specificity	Detected in all			CAB004257, HPA024638, CAB078165	Enhanced		Approved	Cytosol	Secreted to extracellular matrix	No	No			Cytosol		CAB004257: AB_627873, CAB078165: AB_2665800, HPA024638: AB_1852689	unprognostic (7.27e-3)	unprognostic (7.21e-3)	unprognostic (3.24e-1)	unprognostic (6.20e-3)	unprognostic (9.43e-2)	unprognostic (4.94e-3)	unprognostic (4.12e-2)	prognostic unfavorable (4.20e-6)	unprognostic (1.25e-1)	unprognostic (1.72e-1)	prognostic unfavorable (7.11e-5)	unprognostic (2.77e-1)	unprognostic (7.24e-2)	unprognostic (1.47e-1)	unprognostic (2.18e-1)	unprognostic (3.18e-1)	unprognostic (1.26e-1)	2.6	0	1	20.6	4.1	0	11.4	3.6	1.2	8.7	8.4	0.9	2.4	0.9	6.6	2.9	6.5	19	12.8	1.8	0.7	0.1	10.5	0.8	18.3	3.3	1.6	1.1	1.9	2.9	0	7	21.2	1.5	3.7	6.8	0.9	11.2	3.2	1.3	12.8	14.3	1.8	0.7	0.7	7.6	1.9	0.9	3.5	9.8	10	15.6	3.4	4.8	0.9	0.8	1.7	0.5	0.4	0.6	0.1	49.4	2.2	0	0	0.4	1.1	3.6	0.3	0.4	0.1	0	3.6	44.7	0	19	0.1	1.4	22.3	0	221.9	0.2	0	0	0	0	0	0.1	0	0	0.5	17.2	0.5	137	0.2	2.9	0	0	0	0.2	0.1	0	0	0.4	18.1	3.1	0	0.1	0	53.2	12.9	2.7	0	1.3	0	0	1.4	0.1	0.2	0.3	0.2	2.7	1.3	0.6	0	0	0	0.3	0	0	1.4	0.4	0.6	0.4	0.3	0.4	0.5	0.4	0.4	0.1	0.9	0.5	0.6	1.7	0.4	0.5	0.8	0.3	0.1	1	4.1	3.6	1.2	0.7	0.1	1.6	1.1	1.5	0.9	202.5	19.1	0	163.7	76.6	0	1.1	15.3	66.9	51.2	22.7	0	26.6	0	197.8	16.4	0.5	28.1	0	81.6	9.8	7.8	209.4	0	0	2.2	0	8.6	0	0	8.3	3.1	2.9	8.5	4.6	13	0	902.6	26	0.4	0	0	0	2.3	3.7	1	26	69.7	0.7	7.1	119.2	Pancreatic endocrine cells
CAMK2B	CAM2, CAMK2, CAMKB	ENSG00000058404	Calcium/calmodulin dependent protein kinase II beta	Q13554	7	44217150-44334577	Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins	Differentiation, Neurogenesis	Actin-binding, Calmodulin-binding, Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase	Mental retardation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 81.9;heart muscle: 39.2;skeletal muscle: 70.7	Cell type enriched	Detected in many	11	Bipolar cells: 838.1	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Cell line enriched	Detected in some	8	SCLC-21H: 42.0	Low region specificity	Detected in all			Low region specificity	Detected in all			CAB006849, HPA026307, HPA051783, HPA051785, HPA053973	Enhanced	Supported	Supported	Plasma membrane,Cell Junctions,Cytosol					680000	Plasma membrane	Cell Junctions, Cytosol	CAB006849: , HPA026307: AB_1845941, HPA051783: AB_2681608, HPA051785: AB_2681609, HPA053973: AB_2682328	unprognostic (1.88e-3)	unprognostic (4.49e-2)	unprognostic (3.55e-3)	unprognostic (1.36e-2)	unprognostic (5.25e-2)	unprognostic (2.90e-2)	unprognostic (8.78e-2)	unprognostic (1.09e-1)	unprognostic (1.44e-1)	unprognostic (2.71e-1)	unprognostic (1.17e-2)	unprognostic (1.60e-2)	unprognostic (5.23e-7)	unprognostic (7.04e-2)	unprognostic (2.34e-1)	unprognostic (3.15e-2)	unprognostic (3.95e-2)	1.4	8.1	20.6	1.4	46.7	1.2	2	60.1	81.9	1.2	1.4	4	0.7	1.7	1.3	18.8	2	1.8	1.2	39.2	36.5	18	1.7	3.5	1.2	1.8	10.3	21.3	1.1	3.3	5.6	9.9	1.1	13.4	3	1.4	2.7	1.8	2.2	70.7	1.8	1.6	1.2	4.1	1.3	2.4	2.3	4.8	0	7.7	2.4	2	1.1	0	1.3	1	3.2	1.2	3.2	1.2	0.8	0	0.3	0.2	0.3	0	0.2	0.2	0.1	0	0.1	0	0.1	0.1	0.1	0.9	0.2	0.1	0.1	0.2	0.8	0	1.1	2.4	0	0.1	0.1	0	0	0.5	0	0	0	0.3	0.1	0	0	0	0.4	0	5.3	0	0.2	0.1	0	2.4	0.1	0.9	0.1	0	0	42	2.2	0.2	0	0	0.1	1.9	0.2	0.2	0.2	0.4	0.2	0	0.5	0.4	0.1	0.2	0	0.2	3.2	0.7	1	0.8	0.9	1.2	1.1	1	0.5	0.5	1.3	1.2	1.1	2	3.2	1.2	1	0.9	0.8	20.6	46.7	60.1	42.4	36.5	18	10.3	21.3	13.4	4.8	0	0	0	27.8	1	838.1	74.9	2.5	0	0	0	43.2	0	8.3	0	0.8	0.6	0	0	0	0.1	0.4	2.6	4.6	4.4	0.2	57.2	39	0	1.2	2.1	1.7	0	1.7	0	0	14.1	0.1	0	0	0.8	46.7	0	0.9	0	1.7	0.4	0.2	0	0	0.7	Bipolar cells
CROCC	ROLT, rootletin	ENSG00000058453	Ciliary rootlet coiled-coil, rootletin	Q5TZA2	1	16740273-16972979	Predicted intracellular proteins	Cell cycle, Cilium biogenesis/degradation			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in all	4	salivary gland: 135.2	Cell type enriched	Detected in many	4	Rod photoreceptor cells: 111.2	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Low cell line specificity	Detected in many			Low region specificity	Detected in all							HPA021191, HPA021762	Enhanced		Supported	Plasma membrane,Centrosome						Plasma membrane, Centrosome		HPA021191: AB_1856395, HPA021762: AB_1856396	unprognostic (9.07e-3)	unprognostic (9.03e-2)	unprognostic (6.04e-2)	prognostic favorable (8.34e-5)	unprognostic (3.27e-1)	unprognostic (1.25e-3)	unprognostic (1.42e-3)	prognostic favorable (7.92e-4)	unprognostic (2.05e-1)	unprognostic (7.75e-2)	unprognostic (3.36e-3)	unprognostic (5.75e-2)	prognostic unfavorable (7.97e-4)	unprognostic (1.58e-1)	unprognostic (9.83e-2)	unprognostic (6.05e-2)	unprognostic (1.76e-3)	5	3.8	3.2	3.2	7	2.1	2.5	12.9	3	3.9	2.8	5.4	2.2	2.4	5.1	2.4	3.2	9.9	2.3	2.1	4.6	3.5	2.4	1.8	3.9	3.2	2.1	2.5	5	4.2	3	3.6	2.2	11.3	3.3	0.6	30.6	135.2	2.9	8.2	14.4	3.1	1.8	2.3	6.4	3.5	1.9	4.3	2.1	2.5	2.3	1.8	2.9	3.8	1.1	0.6	1.7	0.8	1.3	2.8	0.6	4.1	1.7	3.2	3.2	2.3	2.1	1.3	3	1	1	1.1	0.2	1.9	10.9	2.8	1.2	0.3	5	0.8	2.2	0.1	0.9	5.8	5	5.3	0.8	3.9	0.3	5.1	1.8	5.2	0.9	0.9	1.7	1.6	7.9	0.7	2.8	0.3	3.5	3.3	1.2	11.6	0.9	2.7	3.1	4.2	3.7	0.7	1.2	9.9	10.6	3.2	2.1	9.7	1	4.2	1.4	4.4	2.8	3.7	7	2.3	5	3.6	2.2	2.8	0.7	3.3	0	0.4	1.7	1.6	0.8	2.8	0.7	1.3	1.3	0.2	1.1	1.1	0.9	0.1	1.3	0.3	0.6	1.3	0.6	3.2	7	12.9	3	4.6	3.5	2.1	2.5	11.3	4.3	0	5.8	0.5	4.2	5.6	20.9	3.2	2.5	14.7	3.4	5.2	25.5	1.1	0	4.8	3.5	6.8	0.7	0	2	5.8	4.5	2.1	1.1	2.4	2	3.2	3.5	6.7	2.2	1.9	17.8	2.2	5	2.8	3.7	11.9	3.2	2.3	12	1.3	111.2	0	9.2	1.4	13.2	4.4	0.9	3.8	2.5	1.4	Rod photoreceptor cells
GATB	PET112, PET112L	ENSG00000059691	Glutamyl-tRNA amidotransferase subunit B	O75879	4	151670504-151761023	Predicted intracellular proteins	Protein biosynthesis	Ligase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	5	Muller glia cells: 317.1	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low cell line specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA042610	Uncertain		Supported	Mitochondria						Mitochondria		HPA042610: AB_10797502	unprognostic (2.52e-1)	unprognostic (3.33e-1)	unprognostic (1.01e-3)	unprognostic (5.08e-2)	unprognostic (2.31e-1)	unprognostic (6.91e-2)	unprognostic (2.24e-1)	unprognostic (5.77e-2)	unprognostic (2.06e-1)	unprognostic (6.76e-2)	unprognostic (1.37e-1)	unprognostic (8.17e-2)	prognostic favorable (1.20e-10)	unprognostic (1.91e-1)	unprognostic (8.39e-2)	unprognostic (3.09e-2)	unprognostic (2.46e-1)	11.2	17	12.3	10.5	13.6	8.2	9.2	10.7	19.8	7.3	9.7	11.2	6.4	5.8	5.9	8.9	10.1	9.1	7	31.3	10.7	10.8	21.4	21.8	5.3	6.8	15.8	11.1	12.1	6.8	14.6	8.4	9.9	10.6	5.9	9.9	7.8	7.7	7.1	22.7	8.5	6.3	8.1	22.6	6.9	7.4	7.8	10.4	10.5	7.7	18.9	9.3	8	5.8	9.1	17	1.5	13.2	6.8	6.8	8.3	8.8	6.9	9.9	9.5	14.5	14	8.6	11.7	15.3	20.8	16.3	11.6	14.5	12	3.1	12.1	12.7	8.3	21.2	22.4	22.3	6.7	13	5.5	9.6	23.9	14.2	11.3	5.5	14.4	14.4	20	7	12	15.4	17.1	21.4	10.5	15.9	9.7	14.1	12.2	10.1	7.4	13	12	9.5	9.5	18.8	7.4	10.3	11.4	9.4	13	13.7	10	11	8.2	8.4	10.5	5.7	7.2	8	12.6	16.3	10	14.7	10	7.6	0.7	9.4	1.5	4	13.2	6.3	9.1	5.3	5.6	17	8.2	6.8	6.4	0.9	6.8	9.4	6.7	5.4	8.3	12.3	13.6	10.7	19.8	10.7	10.8	15.8	11.1	10.6	10.4	8.9	3.7	2.2	5.5	0	8.7	58.8	0	2.7	6.8	10.4	7.9	19.7	23.2	8.8	5.7	2.9	2.6	0	6.4	13.2	7.4	2.9	1.1	13.6	15.4	9.5	2.4	2.5	6.5	6	4.9	5.8	0	13.6	5.9	317.1	6.9	6.5	4.2	14.9	13.6	6.5	3.6	12.2	12	0	11.2	1.5	8.8	2.6	Muller glia cells
CREB3L3	CREB-H	ENSG00000060566	CAMP responsive element binding protein 3 like 3	Q68CJ9	19	4153601-4173054	Predicted intracellular proteins, Predicted membrane proteins, Transcription factors	Transcription, Transcription regulation, Unfolded protein response	Activator, DNA-binding		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	95	intestine: 117.4;liver: 179.5	Cell type enriched	Detected in some	9	Hepatocytes: 100.8	Cancer enriched	Detected in many	18	liver cancer: 91.4	Not detected	Not detected			Group enriched	Detected in some	5	eosinophil: 1.0;T-reg: 1.5	Group enriched	Detected in many	13	granulocytes: 1.0;T-cells: 1.5	Cell line enhanced	Detected in some		CACO-2: 4.6;HDLM-2: 31.5;Hep G2: 10.0;HMC-1: 5.8;U-266/70: 6.9	Low region specificity	Detected in some			Not detected	Not detected			HPA040671, HPA056228	Enhanced											HPA040671: AB_2677072, HPA056228: AB_2683072	unprognostic (1.86e-2)	unprognostic (2.13e-1)	unprognostic (2.81e-1)	unprognostic (1.66e-2)	unprognostic (8.41e-4)	unprognostic (1.79e-4)	unprognostic (1.88e-1)	unprognostic (5.28e-4)	unprognostic (3.01e-1)	unprognostic (3.61e-2)	unprognostic (1.55e-2)	unprognostic (1.49e-1)	prognostic unfavorable (3.53e-6)	unprognostic (3.18e-3)	unprognostic (1.48e-1)	unprognostic (3.27e-2)	unprognostic (3.35e-2)	0.1	1.3	0.1	0	0.1	0	0	0	0.2	0	38.6	0	0	61	0	0	0	0	0.1	0	0.1	0.2	0.5	179.5	0	0	0.1	0.2	0.1	0.2	0	0	0	0.1	0	0	0	0	0	0	0	117.4	0	0.1	0.1	0.3	0.1	0	0.8	0	0	0	0	0	0	0	1	0	0	1.5	0	0	0.3	0	0	0	0	2.2	0	0	0	0	4.6	0.1	0	0	0	0.4	0	0	0	0	31.5	0	0	0	10	0	0	5.8	0	0	0	0	0	0	0.1	0	2.3	0	0	2.6	0.3	0	0	0	1.3	0	0.8	0	0	0.1	0.6	0	0	0	0	0	0.2	0	0	0	0.1	0	6.9	2.8	0	0	2.6	0	0	0	1	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	1.5	0	0.1	0.1	0	0.2	0.1	0.2	0.1	0.2	0.1	0	0	0	0.8	0	0	0	0.3	2.5	0	0	0	0	0	0	0	0	0	10.7	0	0	0.2	0	0	0	100.8	0	0	0	2.5	3.2	0	0	0	0	0	0.5	0	0.5	8.6	0	0.3	0	0	0	0	0	0	0	0	0.4	0	Hepatocytes
WISP2	CCN5, CT58, CTGF-L	ENSG00000064205	WNT1 inducible signaling pathway protein 2	O76076	20	44714844-44728509	Plasma proteins, Predicted secreted proteins	Cell adhesion			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		cervix, uterine: 109.7	Cell type enriched	Detected in many	12	Leydig cells: 367.7	Cancer enhanced	Detected in many		melanoma: 8.8	Low region specificity	Detected in some			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		ASC diff: 10.0;ASC TERT1: 26.9;HeLa: 15.0;HSkMC: 10.9;U-2197: 85.9	Not detected	Not detected			Low region specificity	Detected in all			CAB019273	Approved				Secreted to extracellular matrix				400000			CAB019273: 	unprognostic (1.87e-1)	unprognostic (2.64e-1)	unprognostic (3.01e-2)	unprognostic (1.12e-1)	unprognostic (1.70e-1)	unprognostic (2.83e-1)	unprognostic (1.83e-1)	unprognostic (1.85e-1)	unprognostic (2.53e-1)	unprognostic (9.42e-2)	unprognostic (2.81e-1)	unprognostic (7.95e-3)	unprognostic (1.76e-10)	unprognostic (1.55e-3)	unprognostic (7.21e-2)	unprognostic (4.84e-2)	unprognostic (1.28e-1)	57	6.5	0.2	2	2.2	0.4	32.7	0.1	0.5	109.7	4.7	0.6	8.6	0.6	7	12.4	47.1	5.5	8.4	29.7	0.3	0	0.5	0.9	25.6	0.9	0.1	1.4	48.4	1.8	0.7	0	0.9	0.2	20.1	0.9	0.5	4.3	8.9	18	30.6	1.4	22	0.2	0.5	1.4	37.7	0.4	0	2.5	3.7	0.6	18.2	18.7	0	0	0	0	0.1	0	0	0	0.9	0	0	10	26.9	0	0	0.3	0	0	0	0	0	0.1	0.1	0.8	0	0	0	0	0	0	0	15	0	0	0	0	10.9	0	0	0	0	0	0	0	0	0	1.2	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0.2	0	0	0.4	0	0	0	0	85.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0.2	2.2	0.1	0.5	0.3	0	0.1	1.4	0.2	0.4	0	2.2	0	1.3	28.4	0.2	7.5	0	0	0	0	0	0	0	0	1.6	1.9	0	0	0	0	14.4	1.3	0	0	0.1	0	0	25.8	0.8	4	367.7	1.5	23.6	0	0	2	0.2	0	30.1	0	0	12.9	24.7	1.7	0.8	19.6	0	0	0	2	Leydig cells
FAR2	FLJ10462, MLSTD1, SDR10E2	ENSG00000064763	Fatty acyl-CoA reductase 2	Q96K12	12	29149103-29340980	Enzymes, Predicted intracellular proteins, Predicted membrane proteins	Lipid biosynthesis, Lipid metabolism	Oxidoreductase		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	5	Syncytiotrophoblasts: 162.1	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enhanced	Detected in many		eosinophil: 23.7	Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		HEL: 26.3;HUVEC TERT2: 30.8;NB-4: 26.4;SK-BR-3: 32.5;TIME: 25.0	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA015884	Approved		Approved	Nucleoli,Golgi apparatus						Golgi apparatus	Nucleoli	HPA015884: AB_1853998	unprognostic (6.32e-2)	unprognostic (2.40e-2)	unprognostic (1.50e-3)	unprognostic (3.33e-3)	unprognostic (2.41e-1)	unprognostic (4.13e-3)	unprognostic (4.30e-2)	unprognostic (1.18e-1)	unprognostic (3.11e-2)	unprognostic (6.37e-2)	unprognostic (5.70e-3)	unprognostic (1.92e-1)	prognostic unfavorable (4.93e-4)	unprognostic (2.10e-1)	unprognostic (2.23e-1)	unprognostic (1.33e-1)	unprognostic (5.22e-3)	9.4	7.2	9.8	6.9	17.4	12	7.6	5.1	18.2	4.6	25.7	3.2	6.1	13.3	6.2	29.4	6	3.7	4.2	5.4	12.8	10.9	4	3.1	8.6	6.7	9.4	10.4	2.1	2.6	1	2.9	19.2	6.6	2.8	22.3	4.1	4.8	1.7	4.5	8.7	14	6	5.1	12.3	3.7	8.4	5.9	7.2	3.5	4.5	2.3	6.6	4.3	0.9	4	23.7	11.5	1.8	7.6	4.4	0.9	1.8	1.8	0.4	2.6	10.1	0.8	7.6	9	2.1	2	3	10.3	1.3	2	1	1.5	0.5	4.7	0	0.5	0.6	11.8	26.3	4.2	0.9	5.4	10.5	8.8	2.8	0	3.2	4.1	5.4	30.8	1	2.3	1	0.3	0.3	6.7	26.4	7.1	0.5	20.1	5.6	2.9	1.1	9.5	2.6	3.1	2.8	1.7	32.5	12.9	3.8	1.5	9.9	25	5.7	1.7	2	3.3	1.6	1.7	0.6	9.1	13.8	4.9	1.3	11.5	23.7	2.7	6.9	1.8	0.9	4.5	3.2	4	0.7	1.5	1.7	20.7	1.8	3.7	1.5	7.6	4.4	9.8	17.4	5.1	18.2	12.8	10.9	9.4	10.4	6.6	5.9	0	3.5	0	0.1	1.1	1.9	8.7	0	4	2.3	0	0	14	0	0	16.3	11.1	22.3	0	0.2	16.9	4.3	0.4	10.4	0	16.4	4.8	6.9	3.7	19.8	4.2	1.1	7.2	15.1	1	19.9	0.4	1.9	31.9	0.4	0.3	1.1	0	3.3	0.2	0.9	0.3	162.1	4.4	19.4	0.1	Syncytiotrophoblasts
NTHL1	NTH1, OCTS3	ENSG00000065057	Nth like DNA glycosylase 1	P78549	16	2039815-2047866	Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins	DNA damage, DNA repair	Glycosidase, Hydrolase, Lyase	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	12	Hepatocytes: 755.9	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low cell line specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			CAB025152	Supported											CAB025152: 	unprognostic (1.06e-1)	unprognostic (9.71e-2)	unprognostic (1.23e-1)	unprognostic (2.54e-1)	unprognostic (7.89e-2)	unprognostic (1.77e-1)	unprognostic (2.86e-1)	unprognostic (2.46e-2)	unprognostic (4.98e-2)	unprognostic (1.11e-1)	unprognostic (2.77e-2)	unprognostic (6.78e-2)	unprognostic (6.53e-2)	unprognostic (2.27e-1)	unprognostic (1.34e-1)	unprognostic (5.08e-2)	unprognostic (1.62e-2)	10.5	8.2	13.4	10.5	19.9	6	7.8	15.6	17.9	14.8	12.3	9	15.1	9.7	11.8	6.9	9.4	20.5	14.7	10.6	12.5	12.1	7.4	17.5	11.1	10.4	13.6	15.7	18.8	24.6	5.8	8.7	8.3	13.3	9.8	8.2	9.1	22.2	18.2	12.4	6.3	11.2	7.8	10.4	15.2	11.1	6.4	11.6	9.6	9.5	6.6	8.4	7.8	9.3	21.4	14.7	2.4	14.2	9.7	18.8	8.5	10.8	26.7	7.8	11.8	3.2	6.1	8.7	4.5	4.9	8.7	5.5	19	10.6	23.2	9.6	3.8	5.7	9.8	9.6	10.7	1.5	10.7	23.6	7.2	17	21.1	4.4	8.2	8.5	5.1	5.5	4.6	5	5.8	12.1	14.3	7.8	8.4	3.4	12.1	12.2	30.8	17.3	13.5	17.5	29.4	8.2	37.3	6.2	3.9	16.6	16.5	5	15.3	8.8	3	11	8.1	4.7	7.4	8.2	6.6	8.5	11.5	13.4	9.4	3.3	11.5	9.2	2.4	8.7	2	8.8	14.2	9.8	21.4	10.5	9.8	14.7	17.1	7.8	9.5	0.3	9.7	12.1	14.6	18.8	8.5	13.4	19.9	15.6	17.9	12.5	12.1	13.6	15.7	13.3	11.6	26.8	28	7.5	16.5	7.7	8.8	9.8	48.4	16	15.9	3.5	0	9	14.9	15.3	7.6	35.9	21.6	0	8	14.8	13.9	8.1	5.7	755.9	11.6	6.4	64.8	43	19.9	16.6	31.4	11.7	20.3	6.4	53.2	10.1	11.3	40.7	23.7	22.5	6	12.9	18.9	5.8	30.9	8.8	2.3	9.2	42.8	19.7	Hepatocytes
GLP2R		ENSG00000065325	Glucagon like peptide 2 receptor	O95838	17	9822206-9892102	FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins		G-protein coupled receptor, Receptor, Transducer	FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in many		gallbladder: 32.7	Cell type enriched	Detected in some	6	Rod photoreceptor cells: 24.5	Cancer enhanced	Detected in single		pancreatic cancer: 1.1	Group enriched	Detected in some	4	basal ganglia: 2.9;cerebral cortex: 4.1;olfactory region: 1.6	Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	5	HeLa: 42.8	Group enriched	Detected in some	6	cerebral cortex: 2.1;hippocampal formation: 2.6	Low region specificity	Detected in some			CAB022690, HPA049244	Supported		Supported	Plasma membrane						Plasma membrane		CAB022690: , HPA049244: AB_2680690	unprognostic (2.14e-1)	unprognostic (2.45e-3)	unprognostic (2.66e-3)	unprognostic (2.21e-2)	unprognostic (3.81e-3)	unprognostic (2.09e-1)	unprognostic (1.39e-2)	unprognostic (5.15e-2)	unprognostic (7.63e-2)	unprognostic (7.14e-2)	unprognostic (2.19e-1)	unprognostic (6.16e-3)	unprognostic (3.40e-8)	unprognostic (9.53e-5)	unprognostic (5.51e-2)	unprognostic (3.92e-1)	unprognostic (6.48e-3)	7.9	0.7	0.6	2	2.9	0	2.6	0.3	4.3	6.6	14.5	0	1.7	12.4	1.9	0.4	5.3	1.4	32.7	0.9	0.6	0.5	0.4	3.2	1.4	0.7	0.6	1.6	0.8	2.1	0	0.3	1.5	0.5	8.4	7.5	0.8	0.4	0.2	0.3	0.3	15.4	15.6	0.6	0.3	4.9	1.1	0.2	0	0.5	0.1	0.4	13.5	7	0	0	0	0	0	0	0	0	8.7	0	0	0.4	0	0.4	0	0.1	0	0	0	0.2	0	0	0	1.2	0.1	0	0	0	0	0	0	42.8	0.3	0.5	0	0	0	0.2	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0	0	0	4.3	0	0	0	0	0	0	0	3.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	2.9	0.3	4.1	0.6	0.5	0.6	1.6	0.5	0.2	0	0	0	0	0	0	0.4	0	0	0	0	3.9	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0.2	0	0	0.6	0	0	2.8	0	0	0	0	0.2	0	0	1.4	0	24.5	0	0	0	0	0	0	0	0	0	Rod photoreceptor cells
COL17A1	BP180, BPAG2	ENSG00000065618	Collagen type XVII alpha 1 chain	Q9UMD9	10	104031286-104086002	Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins			Cancer-related genes, Disease mutation, Epidermolysis bullosa	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		placenta: 85.8;skin 1: 123.2;tongue: 64.0	Cell type enriched	Detected in many	4	Basal keratinocytes: 520.3	Cancer enhanced	Detected in many		head and neck cancer: 227.4	Region enriched	Detected in single	4	basal ganglia: 1.2	Cell type enriched	Detected in single	15	neutrophil: 3.7	Lineage enriched	Detected in single	15	granulocytes: 3.7	Cell line enhanced	Detected in some		CAPAN-2: 24.8;HaCaT: 56.6;HBEC3-KT: 90.6;hTCEpi: 117.8;hTERT-HME1: 100.3	Region enriched	Detected in single	4	cerebellum: 1.1	Not detected	Not detected			HPA043673, HPA052963	Enhanced		Supported	Golgi apparatus,Plasma membrane	Secreted to extracellular matrix					Plasma membrane	Golgi apparatus	HPA043673: AB_10960893, HPA052963: AB_2681999	prognostic favorable (1.38e-4)	unprognostic (1.33e-1)	unprognostic (4.01e-1)	unprognostic (1.01e-1)	unprognostic (9.65e-2)	unprognostic (3.75e-1)	unprognostic (2.13e-1)	unprognostic (6.82e-3)	unprognostic (1.63e-1)	unprognostic (7.85e-3)	prognostic unfavorable (1.86e-4)	unprognostic (2.12e-1)	unprognostic (1.71e-1)	unprognostic (1.14e-1)	unprognostic (1.23e-1)	unprognostic (3.75e-2)	unprognostic (8.35e-2)	0.2	0	0.2	4.4	1.2	7.5	8.1	0.2	0.2	15.2	9.3	0.2	0.9	2	0.6	2.6	31.5	0.1	1.2	0.2	0.2	0.1	0.4	0.2	0.7	0.2	0.2	0.2	0.2	0.2	0	0.6	85.8	0.2	5	5.4	0.2	15.5	7.3	0.5	123.2	23.2	0.8	0.2	0.3	3.9	4	0.2	18.1	2	64	24.7	3	17.3	0	0	3.7	0.2	0	0	0.8	3.1	0	0.1	0	0	0	10	0	0	0	0	0	24.8	0	0.7	0	0.5	56.6	0.1	90.6	0.1	0	0	0	0	0	0	0	0	0	117.8	0	100.3	0	0.4	0	0	0.1	0	0	0	0	0.2	0.6	0.3	0	0	0	5.1	3.1	0	0	0	0	0.1	0.5	0	0	0.2	0	0.6	0	0.7	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.7	0	0.2	0	0	0.8	0.2	1.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0	0.6	0	12.4	520.3	0.6	0.8	0	2.7	20.5	0	0	3.5	0	0.7	8.5	1	105.8	0	0.8	8.3	2.1	0.6	0	0	1.2	0	2.4	0	0	2.6	0.3	1	32.1	0	5.9	0.4	45.8	16.1	0.7	0	0.4	0	1.7	8.3	1.1	121.8	4.7	0	14.5	8	Basal keratinocytes
CLDN18	SFTPJ	ENSG00000066405	Claudin 18	P56856	3	137998735-138033655	Predicted membrane proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	41	gallbladder: 37.4;lung: 91.9;stomach 1: 126.9	Cell type enriched	Detected in some	5	Alveolar cells type 1: 1488.8	Group enriched	Detected in some	11	pancreatic cancer: 113.7;stomach cancer: 186.8	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	20	OE19: 18.9	Not detected	Not detected			Not detected	Not detected			CAB013010, CAB013243, HPA018446	Enhanced		Approved	Cell Junctions						Cell Junctions		CAB013010: AB_2533382, CAB013243: AB_2533383, HPA018446: AB_2669866	unprognostic (1.03e-1)	unprognostic (1.49e-1)	unprognostic (2.93e-1)	unprognostic (1.04e-2)	unprognostic (1.41e-1)	unprognostic (8.51e-2)	unprognostic (5.14e-4)	unprognostic (2.00e-1)	unprognostic (1.29e-1)	unprognostic (2.60e-1)	unprognostic (9.54e-2)	unprognostic (1.38e-2)	unprognostic (4.42e-5)	unprognostic (1.66e-1)	unprognostic (2.26e-1)	unprognostic (8.26e-2)	unprognostic (2.95e-1)	0.1	0	0.1	0.2	0.1	0	0.1	0.1	0.1	0.1	0.7	0.8	0.1	0.1	0.1	0.1	0.3	0.1	37.4	2	0.1	0	0.1	0.1	91.9	0.1	0.1	0.1	0.1	0.2	0	0.1	0.1	0.5	0.1	0	0.1	0.1	0.1	0.1	0.1	0.5	0.2	0.1	0.1	126.9	0.3	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0	0.1	0.2	0	0.4	0.1	0	0.1	0.1	0.2	0.1	0.4	0.2	0.1	0	0	0	0	0.2	0.1	0	0	0.1	0	0.5	0	0.3	0.1	0	0.2	0	0.7	0	0	0	0.9	0.3	0.1	0.1	0.2	0.5	0	0	0	0.1	0	0.1	0.5	0.1	0.6	18.9	0.1	0.4	0	0	0	0.3	0.1	0.1	0.1	0	0	0.1	0.2	0.1	0.1	0.3	0.5	0.3	0.1	0.6	0	0	0.2	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0.2	0.4	0	0.1	0	0	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.5	0.1	1488.8	318.5	0	0	0	0.8	18.9	0	1.4	20.5	0	0	0	0	0.3	0.2	0	0	0	9.9	0	0	0.1	4.7	0	0	0	0	0	0	0.4	0	0.3	0	0	0	0	257.5	0	0	0	1.4	0	0	6.6	3.8	0	0	0	0	0	Alveolar cells type 1
ADAM7	EAPI, GP-83	ENSG00000069206	ADAM metallopeptidase domain 7	Q9H2U9	8	24440930-24526970	Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	14	epididymis: 309.9	Cell type enriched	Detected in some	15	Early spermatids: 89.5	Group enriched	Detected in some	16	prostate cancer: 1.0;renal cancer: 0.5	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	31	BEWO: 4.4;NB-4: 11.0;RPMI-8226: 2.8;SH-SY5Y: 3.3	Not detected	Not detected			Low region specificity	Detected in all			HPA008879	Enhanced				Intracellular and membrane							HPA008879: AB_10601789												unprognostic (1.03e-3)	unprognostic (3.96e-4)					0.1	0.1	0.1	0	0.1	0	0.1	0.1	0.1	0.1	0.1	0	21.7	0	0.1	309.9	0.1	0.1	0	0.1	0.1	0.1	0.5	0.1	0.1	0	0.1	0	0.1	0.8	0	0.1	0	0	0.2	0	0	0.1	1.3	0.1	0.3	0.1	0	0.1	0.1	0.1	6.8	0	0	0.1	0	0	0.1	0.1	0	0	0	0.1	0	0.1	0	0	0	0	0	0	0	4.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	11	0	0	0	0	0	2.8	0	0	0	3.3	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	89.5	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	5.9	0.3	0	0	0	0	0	0	0	0	1.1	0	0	0	0.9	0.5	0	0	0	0	0	Early spermatids
SCT		ENSG00000070031	Secretin	P09683	11	626431-627143	Predicted secreted proteins		Hormone		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Group enriched	Detected in some	4	blood: 39.8;intestine: 52.3	Cell type enriched	Detected in some	44	Intestinal endocrine cells: 257.8	Low cancer specificity	Detected in many			Not detected	Not detected			Cell type enriched	Detected in single	152	plasmacytoid DC: 39.8	Lineage enriched	Detected in single	152	dendritic cells: 39.8	Cell line enhanced	Detected in some		A549: 2.3;HSkMC: 5.5;U-266/70: 2.9					Low region specificity	Detected in many			HPA050961	Enhanced				Secreted to blood			571000				HPA050961: AB_2681291	unprognostic (5.28e-2)	unprognostic (6.18e-2)	prognostic unfavorable (3.70e-4)	unprognostic (2.72e-1)	unprognostic (7.91e-2)	unprognostic (1.73e-1)	unprognostic (2.43e-3)	unprognostic (4.19e-2)	unprognostic (1.07e-1)	unprognostic (3.54e-2)	unprognostic (1.88e-1)	unprognostic (1.33e-1)	unprognostic (4.01e-2)	unprognostic (8.37e-2)	unprognostic (5.45e-1)	unprognostic (6.09e-2)	unprognostic (1.13e-1)	0.2	0.1	0.2	0.4	0.3	0.5	0.2	0.5	0.4	0.2	52.3	0.3	0.2	30.4	0.3	0.5	0.2	0.1	0.2	2.3	0.3	0.4	0.4	0.4	3.1	1.1	0.3	0.2	0.3	0.2	0	2.6	0.5	0.4	1	0.1	3.6	1.4	0.2	11.5	0.1	10.5	0.2	0.5	3.9	0.7	3.5	0.2	0.2	0.6	1.6	0.7	0.4	0.2	0	39.8	0	0	0.2	0	0.1	0.4	2.3	0.2	0	0	0	1.4	0	0	0	0	0.9	0.6	0.6	0.2	0	0.1	0.7	0	0	0	0.3	0.7	0	0.5	0	0.7	0	0.3	5.5	0	0	0	0	0	0	0.3	0	0	0	0.2	1	0.2	0.1	0	0.3	0	0.6	0	0	0	0.3	0	0.7	0.6	0.2	0.2	0	0	0.6	1	0	0.4	2.9	1	0.3	1.6	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	39.8	0	0.1	0.2	0.3	0.5	0.4	0.3	0.4	0.3	0.2	0.4	0.2	0	0	0	0.1	0	0	0.4	2.5	0	0	0	0	0	1.7	0	1.2	0	3.5	0	0	0	1.1	0.2	0	0	0.2	0	257.8	0.6	0	0.6	1.4	0	0	0	3.5	0	0	5.8	0	0	0	0	0.2	0.4	1.6	0.1	0	0	1.2	0.1	Intestinal endocrine cells
FSTL3	FLRG, FSRP	ENSG00000070404	Follistatin like 3	O95633	19	676365-683399	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins	Osteogenesis, Transcription, Transcription regulation		Cancer-related genes, Proto-oncogene	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in all	6	placenta: 201.0	Cell type enriched	Detected in many	4	Extravillous trophoblasts: 2939.6	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		BEWO: 36.2;hTCEpi: 40.0;SiHa: 73.8;U-2197: 38.1	Not detected	Not detected			Low region specificity	Detected in all			CAB024899, HPA045378	Approved		Supported	Nucleoplasm	Secreted in other tissues		Yes		6800000	Nucleoplasm		CAB024899: , HPA045378: AB_2679300	unprognostic (9.86e-3)	unprognostic (1.32e-3)	prognostic unfavorable (3.01e-4)	prognostic unfavorable (3.03e-4)	unprognostic (2.19e-3)	unprognostic (1.51e-3)	unprognostic (8.64e-3)	prognostic unfavorable (4.61e-7)	unprognostic (9.50e-2)	prognostic unfavorable (1.65e-4)	unprognostic (3.50e-2)	unprognostic (5.91e-2)	unprognostic (1.03e-3)	unprognostic (7.22e-3)	unprognostic (3.07e-1)	unprognostic (3.75e-1)	unprognostic (5.89e-3)	19.9	29.1	4	10.7	6.2	5.6	24.7	1.3	4.2	13.1	14.9	3.8	8.1	3.8	12.8	15.6	12.7	14.1	13.1	27	5	2	13.7	5.1	26.9	8.7	7.3	4.5	16.8	11.7	1.4	5.3	201	6	14.3	3.1	12	4.5	11	4.1	6.2	6.5	20.6	10.4	3.9	9.1	34.5	4.9	0.7	7.2	5.5	1.4	16.7	18.3	0.9	2.2	0.1	4.4	0.6	2.6	2	1.9	15.9	1.1	0.8	5	12.8	36.2	27	4	6.8	2.5	5.8	3.1	0.8	10.9	18.2	3.9	13.9	0.9	23	2.2	1.6	1.9	0.7	22.2	4.7	21.6	1.4	2.6	16	40	7.5	31.3	17.6	1.2	0.8	1.7	1.1	10.2	7	0.5	0.8	1.3	13.1	5.5	1.5	0.7	1.8	9.4	0.3	0.7	1.2	73.8	1.5	0.8	1.4	1.3	0.7	16.2	6.8	23.5	38.1	9.9	1.8	0.8	0.4	1	4.2	3.1	0	4.4	0	1	4.4	0.2	0.3	1.4	1.1	2.2	0.9	2.6	1.6	0.1	0.6	3.2	0.9	0.2	2	4	6.2	1.3	4.2	5	2	7.3	4.5	6	4.9	17.9	3.4	2.2	19.6	12.9	1.6	12.8	30.6	2.7	1.2	8.7	0	22.7	6.6	69.7	5.6	4.5	0.9	0	56	2939.6	52.2	21.7	0	0.9	68.4	3.2	1.2	22.1	3.8	6.5	56.7	4	5	11.8	0.9	7.8	198.1	0	25.1	5.6	0.5	45.3	32.5	2.3	7.7	6.8	662.4	2.9	1.7	20.7	Extravillous trophoblasts
ST6GALNAC1	SIAT7A, ST6GalNAcI	ENSG00000070526	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 1	Q9NSC7	17	76624761-76643838	Enzymes, Predicted intracellular proteins, Predicted membrane proteins		Glycosyltransferase, Transferase		Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		intestine: 69.4	Cell type enriched	Detected in many	6	Mucus-secreting cells: 708.1	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Group enriched	Detected in some	5	memory CD4 T-cell: 11.2;naive CD4 T-cell: 4.2	Lineage enriched	Detected in single	25	T-cells: 11.2	Group enriched	Detected in some	4	K-562: 23.7;OE19: 44.4	Not detected	Not detected			Low region specificity	Detected in all			HPA014767, HPA014975	Enhanced		Approved	Nucleoplasm,Golgi apparatus					1200000	Golgi apparatus	Nucleoplasm	HPA014767: , HPA014975: AB_1857529	unprognostic (4.59e-2)	unprognostic (8.60e-3)	unprognostic (5.32e-3)	unprognostic (1.86e-3)	unprognostic (6.31e-3)	prognostic favorable (2.54e-5)	unprognostic (1.39e-2)	unprognostic (1.63e-2)	unprognostic (2.45e-1)	unprognostic (2.58e-2)	unprognostic (8.64e-3)	unprognostic (2.81e-1)	unprognostic (1.67e-1)	unprognostic (2.75e-1)	unprognostic (1.18e-1)	unprognostic (5.87e-3)	unprognostic (5.58e-2)	1.4	0.3	1.2	13.9	2.6	0.7	1.3	0.8	3.2	20.4	50.9	3.1	0.3	19.8	6.3	1.8	19.6	1.5	26.6	4.1	1.6	1.3	0.4	1.1	5.7	1.1	1.8	1.2	2	1.1	0.1	0.4	1.7	3.7	2.6	69.4	0.1	20.8	1.4	0.9	0.6	49	1.9	1.5	6	23.9	4	0.6	0	0.5	4.5	21.6	1.9	2.6	0	0	0.4	0	0	11.2	1.1	0	1.1	0	0	0	0	0.7	0	0	0	0	0	1.4	0	4.4	0	0	4.9	0	1.3	0	0	0	7.9	0.4	0	0	0	0	0	0	0	0	0	0.1	0.1	23.7	0	0	0	0.1	0	0	44.4	0.1	0	0	0.1	0	0.3	0	0.3	0	0	0	0.1	0	0.1	0.2	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0.3	0	0	0	11.2	0.2	0	0	4.2	0	0.4	0	0	0	1.4	1.1	1.2	2.6	0.8	3.2	1.6	1.3	1.8	1.2	3.7	0.6	14.9	6.9	0	5.2	0.1	0	1.5	30.6	112.4	76.2	0	0	0.1	0	1.6	0.2	14.2	50.8	0	16.6	0.1	0.6	3.2	0	0	0.2	0	31.7	4.3	0	0.5	1.4	0.3	0	0	708.1	0	27	66.2	0	0	1.1	0	0.1	0.3	0	0.1	0.1	0	108.2	20.7	Mucus-secreting cells
RPS6KA2	HU-2, RSK, RSK3	ENSG00000071242	Ribosomal protein S6 kinase A2	Q15349	6	166409364-166906451	Enzymes, Plasma proteins, Predicted intracellular proteins		Kinase, Serine/threonine-protein kinase, Transferase	Tumor suppressor	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	5	Horizontal cells: 271.7	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enriched	Detected in some	4	eosinophil: 17.5	Lineage enriched	Detected in many	4	granulocytes: 17.5	Cell line enhanced	Detected in many		ASC diff: 48.4;ASC TERT1: 35.5;HHSteC: 35.9;HSkMC: 31.9;hTERT-HME1: 38.6;hTERT-RPE1: 70.4	Low region specificity	Detected in all			Low region specificity	Detected in all			CAB026243, HPA045061, HPA054237, CAB069428	Approved		Supported	Nucleoplasm						Nucleoplasm		CAB026243: , CAB069428: AB_1622639, HPA045061: AB_2679203, HPA054237: AB_2682425	unprognostic (8.71e-2)	unprognostic (3.14e-3)	unprognostic (7.29e-2)	unprognostic (1.72e-1)	unprognostic (3.80e-1)	unprognostic (2.45e-1)	unprognostic (6.44e-3)	unprognostic (8.63e-2)	unprognostic (1.40e-1)	prognostic unfavorable (8.63e-5)	unprognostic (8.68e-2)	unprognostic (4.11e-2)	prognostic favorable (2.86e-5)	unprognostic (3.12e-3)	unprognostic (1.51e-1)	unprognostic (1.56e-2)	unprognostic (2.01e-1)	15.4	6.5	26.8	5.3	35.5	6.9	12.7	12.1	21.5	13.5	7.1	20.3	11.5	4.3	18.3	5.2	14	11.9	12.5	40.9	25	18.3	9.9	3.3	24.6	10.6	22.4	18.4	20.9	30.2	32.6	18	12.1	22.7	10.6	7.4	11.1	9	10.5	14.4	7.5	7.2	15.8	37.2	16.5	10.4	5.1	25.7	0.8	24.8	3.5	4.9	15.5	10.2	0.4	3.9	17.5	1.6	3.3	0.6	0.2	1.9	0	3.9	5.7	48.4	35.5	0	4.1	8.1	2.3	3.2	0	1.2	0.2	1.3	14.6	1.8	1.7	2	9	2.1	0.8	0.5	0	8.5	0.1	35.9	0.1	1.6	31.9	6.5	12.5	38.6	70.4	12.6	4.1	0	0	9.5	0.4	0.1	0.4	1	1.9	2.3	0.6	2	5.7	2.4	2.1	2.1	15.2	1.4	3.9	5.3	1	0.1	3	4.6	8.3	0.8	22.8	1.2	1.1	1.7	0.5	5.5	0.2	7.8	0.1	0.5	17.5	0.5	0.7	0.2	0.3	0.5	0.2	0.7	0.4	0.6	0.3	0.4	3.3	1.6	3.9	0.4	0.2	26.8	35.5	12.1	21.5	25	18.3	22.4	18.4	22.7	25.7	20.8	34.5	0	4.1	4.1	34.9	54.9	22.9	2.7	13.6	34.9	7.9	0.1	10	12.8	12	47.2	0.5	0	20.9	0.2	8	9.4	2.3	11.6	7.2	271.7	5.2	38.6	5	48.4	4.9	4.7	18.6	3.6	5.5	8.3	22.7	1.4	4.2	4.4	15.4	12.9	6.9	3.2	1.1	3	0.2	1.3	1.2	5.8	Horizontal cells
SPP2	SPP24	ENSG00000072080	Secreted phosphoprotein 2	Q13103	2	234050679-234077134	Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	879	liver: 113.0	Cell type enriched	Detected in some	22	Hepatocytes: 258.9	Cancer enriched	Detected in some	112	liver cancer: 65.3	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HEL: 1.1;RH-30: 3.5;RPTEC TERT1: 1.0;U-698: 1.4	Low region specificity	Detected in some			Not detected	Not detected								Secreted to blood				540000000										prognostic favorable (2.33e-6)	unprognostic (7.02e-3)		unprognostic (9.62e-3)								0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	113	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	1.1	0	0	0	0.6	0.6	0	0	0.9	0	0	0	0	0	0	0	0	0.5	0	0	0.3	0	0	3.5	0	1	0.8	0	0	0.4	0	0	0	0	0	0	0	0.2	0	0	0	0	1.4	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	11.9	3.5	0.9	0	0	0	0.3	7.6	2.7	3.4	0	0	0	0	0	0	0	0	0	0.6	0	0	0	4.7	258.9	0.1	0	0	5.5	3.2	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	Hepatocytes
ACAP1	CENTB1, KIAA0050	ENSG00000072818	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1	Q15027	17	7336529-7351478	Cancer-related genes, Plasma proteins, Predicted intracellular proteins	Protein transport, Transport	GTPase activation	Cancer-related genes	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		blood: 29.4;bone marrow: 30.3;lymphoid tissue: 51.5	Cell type enriched	Detected in many	5	Late spermatids: 2487.1	Low cancer specificity	Detected in all			Low region specificity	Detected in many			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Cell line enhanced	Detected in some		Daudi: 17.5;HDLM-2: 23.1;JURKAT: 32.7;Karpas-707: 22.9;NB-4: 28.3;U-937: 18.7	Not detected	Not detected			Low region specificity	Detected in many			HPA075570	Approved		Approved	Golgi apparatus						Golgi apparatus		HPA075570: AB_2732295	unprognostic (1.20e-2)	prognostic favorable (3.66e-4)	unprognostic (2.49e-1)	prognostic favorable (2.97e-5)	unprognostic (4.43e-4)	prognostic favorable (4.17e-5)	unprognostic (5.66e-3)	unprognostic (1.11e-2)	unprognostic (4.67e-2)	unprognostic (2.48e-2)	unprognostic (1.42e-2)	unprognostic (1.91e-1)	prognostic unfavorable (1.65e-10)	unprognostic (1.14e-1)	unprognostic (5.58e-2)	unprognostic (2.90e-1)	unprognostic (8.61e-3)	2.6	0.6	0.6	31.4	1.3	30.3	1.1	1	1.2	1.4	4.5	0.4	0.4	3.2	0.9	1.5	3.3	2	3.1	1.4	0.6	0.6	2.9	2.3	7.3	29.3	2.7	0.1	1	0.7	0	0.8	0.5	1.2	1.8	1.5	1.7	9.6	1.3	0.5	1.2	19.2	0.8	1.3	44.9	3.7	1.4	0.9	51.5	2.5	1	33.9	3.7	1.8	17.8	13.3	22.4	5.9	23.7	29.4	16.1	0	0	0	0	0	0	0	0.2	0	0.1	0.1	0	0	17.5	0.1	0	0	0	0	0	0	23.1	0	6.6	0.1	0	0	8.5	0.3	0	0	0	0	0	0	32.7	0	22.9	0	0	10.6	28.3	0.3	0	0	11.3	0.1	2.6	0	0	0	0	0	0	0	0.1	0	6.7	0	0	0.1	0	0	7.1	6	8	0.1	18.7	0	17	5.9	22.4	24.6	1.8	27.5	16.6	25.8	26.1	10.5	17.8	22.7	22.4	17.7	23.7	0.2	13.3	29.4	16.1	0.6	1.3	1	1.2	0.6	0.6	2.7	0.1	1.2	0.9	8.9	8.5	123.3	5.5	7.3	14.8	26.2	10.2	28.1	11.4	5.2	17.7	3.1	6.6	3.5	485	7.1	1.3	0	3	2.2	12.2	3.7	39.3	4.9	7.7	0	3.5	6.7	23.4	2487.1	18.7	24.9	23.6	19	2	9.6	4.6	0	14.5	3.6	19.3	19.4	8.5	14.2	10.7	6.5	3.7	282.4	1	3	Late spermatids
CYP2W1	FLJ20359, MGC34287	ENSG00000073067	Cytochrome P450 family 2 subfamily W member 1	Q8TAV3	7	983199-989640	Predicted intracellular proteins	Lipid metabolism	Monooxygenase, Oxidoreductase		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		adrenal gland: 18.0;intestine: 9.1;skin 1: 12.1	Cell type enriched	Detected in many	8	Intestinal endocrine cells: 94.6	Group enriched	Detected in many	5	colorectal cancer: 25.3;stomach cancer: 15.5	Not detected	Not detected			Cell type enhanced	Detected in some		neutrophil: 1.5	Low lineage specificity	Detected in single			Group enriched	Detected in some	7	CACO-2: 9.0;Hep G2: 32.8	Not detected	Not detected			Not detected	Not detected			HPA012753	Uncertain				Intracellular and membrane							HPA012753: AB_1847444	unprognostic (7.09e-3)	unprognostic (1.94e-2)	unprognostic (2.75e-2)	unprognostic (1.51e-3)	unprognostic (1.57e-1)	unprognostic (1.22e-1)	unprognostic (1.97e-1)	unprognostic (2.50e-2)	unprognostic (1.41e-1)	unprognostic (1.52e-1)	unprognostic (2.28e-1)	unprognostic (6.26e-2)	unprognostic (2.72e-5)	unprognostic (7.52e-2)	unprognostic (1.34e-1)	unprognostic (1.60e-1)	prognostic unfavorable (5.85e-4)	0.8	18	0	1.3	0	0	0.1	0	0.3	0.8	1.4	0	0	9.1	0	0	3.6	0.2	1.1	0	0	0	0.1	0.1	0	0	0.8	0	2.4	0.3	0	0.3	6.1	0.3	1.9	0.7	1.7	0.3	2.2	0	12.1	5	0	0.7	0.4	0.9	2.4	0	0	0	2.3	0.7	1.1	3.2	0.4	0.1	1.5	0.2	0.1	0.5	0.1	0	0.2	0	0.1	0	0	0	0	0	0	0	9	0.2	0	0	0	0	2.5	0	0	0	0	0.1	0	0.1	32.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0.8	0	1.4	0	0.3	0.1	0.1	0	0	0	0	0.7	0.2	0	0	0	0	0.4	2.8	0	0	0.1	0	0	0.2	0.1	0	0	0	0	1.5	0.1	0.2	0.5	0.2	0.3	0.1	0.2	0.2	0.1	0.4	0.2	0.3	1.5	0.1	0	0.1	0.2	0.1	0	0	0	0.3	0	0	0.8	0	0.3	0	3	0	0	1.8	3.5	0	0.3	0	2.7	2.3	0	0	0.6	0	0	0	0	1.1	0	0.8	0.4	1.4	0.7	0	0	1	0	94.6	0	0	0	1.7	0	0	0	5.7	12.1	0.1	2.9	0	0	0.6	0	0	0.1	0	3.9	1.6	0	4.2	3.1	Intestinal endocrine cells
SLC24A1	CSNB1D, HsT17412, KIAA0702, NCKX, NCKX1, RODX	ENSG00000074621	Solute carrier family 24 member 1	O60721	15	65611366-65660995	Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters	Antiport, Calcium transport, Ion transport, Sensory transduction, Symport, Transport, Vision		Congenital stationary night blindness	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in all	7	retina: 91.1	Cell type enriched	Detected in many	11	Rod photoreceptor cells: 301.7	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low cell line specificity	Detected in all			Not detected	Not detected			Low region specificity	Detected in single			HPA039370	Enhanced		Approved	Microtubules						Microtubules		HPA039370: AB_10960279	unprognostic (9.47e-2)	unprognostic (9.97e-2)	unprognostic (1.66e-1)	unprognostic (3.66e-3)	unprognostic (6.39e-3)	unprognostic (4.64e-1)	unprognostic (8.82e-2)	unprognostic (1.86e-1)	unprognostic (4.69e-2)	unprognostic (3.94e-1)	unprognostic (2.01e-1)	unprognostic (9.91e-2)	prognostic favorable (2.33e-6)	unprognostic (8.45e-2)	unprognostic (9.22e-2)	unprognostic (3.04e-2)	unprognostic (1.96e-2)	6.2	5.3	4.5	7.7	5	2.6	9.3	7	3.4	8.9	5	5.6	7.5	3.7	10.6	12.2	4.2	9	6.2	4.1	4.7	4.1	7.9	4.7	12	6	5.3	2.6	9.7	6.6	6.5	6.1	8.9	4	6	4.1	91.1	6.4	8.3	3.8	8.5	4.5	5	6.8	7.8	4.2	10.8	3.2	6.9	9	4.6	4.8	6	5.3	3.8	2.6	4.7	1.5	2.3	1.8	0.4	1.5	3.1	3.3	3	5	8.4	4.1	3.9	4.2	3.8	2.5	1.4	6.6	2.1	12.9	3.7	1.3	4.2	3.9	4.2	2.3	2.1	2.9	4.6	2.3	6.8	7.2	3	6.3	7.1	6.2	2.1	12.8	5.4	6.6	4.9	4.8	7.2	6.2	6.4	1.9	2.8	4.3	13.5	1.2	2	1	1.4	5.8	6	1.6	2.3	1	2.9	8	4.8	6.2	4.2	9.4	3.9	3.9	1.5	2.6	2.9	5.2	2.5	4.1	6.5	3.3	4.7	1.5	2.1	1.4	1.3	1.8	1.4	1.5	1.2	1.1	3.8	1.1	1.5	1.7	2.3	0.6	2.6	0.3	0.4	4.5	5	7	3.4	4.7	4.1	5.3	2.6	4	3.2	6	3.2	1.4	1.2	1.3	26.9	1.9	0	4	5.7	0	25.5	3.3	0	1.1	1.1	7	2.8	0	1.1	2	1.5	1.1	2.3	1.5	1.7	19.1	1.7	4.3	2.2	1.8	2.8	1.5	1.7	0	2.2	23.4	1.7	0	2.1	0.5	301.7	0	1.4	10.4	6.4	0.9	2.1	0.8	2.1	0.8	Rod photoreceptor cells
SLC12A1	NKCC2	ENSG00000074803	Solute carrier family 12 member 1	Q13621	15	48178438-48304078	Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters	Ion transport, Potassium transport, Sodium transport, Symport, Transport		Bartter syndrome, Disease mutation, FDA approved drug targets, Neurodegeneration	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	75	kidney: 143.2	Cell type enriched	Detected in some	5	Distal tubular cells: 177.4	Cancer enhanced	Detected in single		renal cancer: 1.0	Low region specificity	Detected in many			Group enriched	Detected in some	9	basophil: 1.9;neutrophil: 1.5	Lineage enriched	Detected in single	10	granulocytes: 1.9	Cell line enriched	Detected in single	26	RPTEC TERT1: 24.3	Not detected	Not detected			Low region specificity	Detected in some			HPA014967, HPA018107	Enhanced		Approved	Nucleoplasm,Vesicles						Vesicles	Nucleoplasm	HPA014967: AB_1854503, HPA018107: AB_1854504	unprognostic (3.52e-2)	unprognostic (1.30e-2)		unprognostic (9.65e-2)	unprognostic (1.74e-2)	unprognostic (7.77e-2)	unprognostic (1.04e-1)	unprognostic (8.72e-2)	unprognostic (2.06e-1)	unprognostic (9.85e-3)	unprognostic (2.81e-4)	unprognostic (9.75e-2)	unprognostic (2.61e-1)	unprognostic (5.47e-2)	unprognostic (2.03e-1)	unprognostic (5.20e-4)	unprognostic (8.52e-2)	0	0	0.3	0	1	0	0	1.4	1.5	0	0.1	0	0	0	0	0	0	0	0	0	0.1	0.3	143.2	0.1	0	0	0.3	0.4	0	0	0	0.1	0	1.4	0.1	0	0	0	0	0	0	0	0	0.1	0	0	0.2	0.1	0	0	0	0	0	0	0.1	0.1	1.9	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	24.3	0	0.9	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.9	0.1	0.1	0.1	0	0.1	0	0	0.1	0	0.1	0.1	0.1	1.5	0.1	0	0.1	0	0	0.3	1	1.4	1.5	0.1	0.3	0.3	0.4	1.4	0.1	0	0	0	0	0	0	0.8	0	0	0	36.6	0	0	177.4	0	11.3	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	9.6	0.3	0	0	0	0	0	0	0	0	0.7	0	0	0	0.1	0	0	0	0	0	0	Distal tubular cells
CACNG5		ENSG00000075429	Calcium voltage-gated channel auxiliary subunit gamma 5	Q9UF02	17	66835117-66885486	Predicted membrane proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Group enriched	Detected in some	6	brain: 6.5;lymphoid tissue: 3.3;retina: 8.8	Cell type enriched	Detected in single	17	Horizontal cells: 4.8	Cancer enhanced	Detected in single		glioma: 0.5	Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		NTERA-2: 1.7;RPMI-8226: 1.5;SH-SY5Y: 3.6;SuSa: 1.3;THP-1: 1.6	Region enhanced	Detected in all		olfactory region: 152.3	Low region specificity	Detected in all			HPA050115	Uncertain											HPA050115: AB_2681022					unprognostic (1.85e-3)					unprognostic (3.84e-2)	unprognostic (1.44e-1)		unprognostic (2.46e-6)	unprognostic (4.52e-2)	unprognostic (1.29e-1)			0.3	0.3	2.7	0.7	2.6	0.3	0.3	1.7	6.5	0.4	0.7	6.3	0	0.3	0.3	0.3	0.3	0.3	0.3	0.4	2.1	2	1	0.3	0.3	3.3	1.1	2.3	0.3	0.7	0.3	0.8	0.3	0.7	0.5	0.5	8.8	0.3	0.3	0.3	0.4	0.7	0.3	1.7	1.3	0.3	0.7	3.8	0	0.3	0	3.2	0.3	0.1	0	0	0	0	0	0	0	0	0.7	0.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	1.7	0	0	0	0	1.5	0	0	0.4	3.6	0	0	0	1.3	0	1.6	0	0	0.7	0	0	0	0	0.5	0	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.7	2.6	1.7	6.5	2.1	2	1.1	2.3	0.7	3.8	0	0	0	0	0	0.2	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Horizontal cells
PLXNA2	FLJ11751, FLJ30634, KIAA0463, OCT, PLXN2	ENSG00000076356	Plexin A2	O75051	1	208022242-208244320	Predicted membrane proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		pancreas: 39.9	Cell type enriched	Detected in many	6	Horizontal cells: 235.2	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in some			Low lineage specificity	Detected in single			Cell line enhanced	Detected in many		BEWO: 18.8;HaCaT: 19.3;HUVEC TERT2: 24.6;TIME: 56.5	Low region specificity	Detected in all			Low region specificity	Detected in all			CAB009763	Approved								580000			CAB009763: AB_2166388	unprognostic (8.25e-2)	unprognostic (3.91e-2)	unprognostic (8.85e-2)	unprognostic (2.77e-2)	unprognostic (8.66e-2)	unprognostic (2.07e-1)	unprognostic (1.97e-2)	unprognostic (4.84e-2)	unprognostic (6.88e-3)	unprognostic (7.06e-2)	unprognostic (2.61e-1)	unprognostic (8.41e-2)	unprognostic (4.49e-3)	unprognostic (1.26e-1)	unprognostic (5.40e-2)	unprognostic (1.27e-2)	unprognostic (2.40e-1)	7.2	2.4	8.3	2.9	11.8	1	3.9	27.5	14.7	4.7	10.5	2.5	2	8.2	5.4	3	13.2	4.6	7	6	9.7	4	4.3	2.7	12	1.6	3.7	10.9	16.9	39.9	2	2.8	10.2	6.7	4.2	8.8	5.7	3.7	4.5	7.6	10.8	9	12	2.9	1.7	11	1.2	3.9	0.4	7.2	4.7	4.4	8.3	9.1	0.2	0.7	1.1	0.7	0	0.4	0.2	2.1	1.3	2.4	0.3	2.7	5.4	18.8	1.7	1.1	1	0.1	0	0	0	3.5	1.3	0.4	19.3	0	10.9	0.3	0.6	0.3	0	2.3	1.2	1.1	0	0	1.4	3.5	0.8	5.1	0.7	24.6	0	0	0	10.7	0.2	0	0	0.3	3.8	3.3	0	2.5	1.6	2	1.3	0.7	4.4	2	1.6	2	4.9	0.1	0	56.5	0.4	0.6	2	3.5	0.1	0	0	2.3	0	0.9	0	0.7	1.1	0.2	0.2	0.3	0	0	0.2	0.7	0.2	0	0.4	1	0	0.3	0	0	0.2	8.3	11.8	27.5	14.7	9.7	4	3.7	10.9	6.7	3.9	26.8	25.8	2	10.2	4.2	1	3.9	10.2	12	39.8	0	2	5	1.7	3.6	0.6	31.8	40.9	0	13.3	2.1	9.8	4.5	5.8	4.9	2.5	235.2	8.7	29.4	3.5	0	9.2	2.2	5	1	27.3	0.3	17	37.7	6.3	1.1	2.5	6.5	5.9	0.6	0.6	9.3	1.6	1	24.2	22.6	Horizontal cells
NMRK2	ITGB1BP3, MIBP, NRK2	ENSG00000077009	Nicotinamide riboside kinase 2	Q9NPI5	19	3933103-3942416	Enzymes, Predicted intracellular proteins	Pyridine nucleotide biosynthesis	Kinase, Transferase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	10	heart muscle: 271.6;skeletal muscle: 103.2	Cell type enriched	Detected in single	1346	Cardiomyocytes: 751.9	Cancer enhanced	Detected in some		renal cancer: 32.8	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	4	BEWO: 22.8;NTERA-2: 18.9	Not detected	Not detected			Low region specificity	Detected in many			HPA049909, HPA054792, HPA072450	Approved		Enhanced	Nucleoplasm,Vesicles						Nucleoplasm	Vesicles	HPA049909: , HPA054792: AB_2682601, HPA072450: AB_2686522				unprognostic (3.61e-1)	unprognostic (5.92e-2)	unprognostic (1.18e-2)		unprognostic (2.54e-1)	unprognostic (1.03e-1)	unprognostic (7.61e-2)		unprognostic (3.30e-2)	prognostic favorable (1.19e-4)	unprognostic (1.72e-1)	unprognostic (3.29e-2)	unprognostic (5.38e-1)		0.2	0.1	0	0	0	0	0.1	0	0	0	0	0	0	0	0	5.5	1	0	0	271.6	0	0.1	0.2	0	0	0	0	0	0	0.1	0	0.2	0	0	0.4	0	1	1.9	0.1	103.2	0	0	0	0.1	0	0	0	0	0	1.4	18	0.8	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	22.8	0	0	0	0	0.6	0	0	0	0	0.1	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.9	0	0	0	0.2	0	0	0	0.1	0	0	0	2.8	5.1	0	0	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	751.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0.1	0	0.1	0	0	0	Cardiomyocytes
PPP1R12B	MGC131980, MGC87886, MYPT2, PP1bp55	ENSG00000077157	Protein phosphatase 1 regulatory subunit 12B	O60237	1	202348699-202592706	Plasma proteins, Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		endometrium 1: 105.2	Cell type enriched	Detected in many	7	Cardiomyocytes: 719.4	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enriched	Detected in many	7	neutrophil: 15.9	Lineage enriched	Detected in many	7	granulocytes: 15.9	Low cell line specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA024171, HPA024640	Enhanced		Approved	Plasma membrane,Actin filaments						Plasma membrane, Actin filaments		HPA024171: AB_1854266, HPA024640: AB_1854265	unprognostic (5.24e-2)	unprognostic (8.59e-2)	unprognostic (1.38e-1)	unprognostic (2.75e-2)	unprognostic (3.04e-1)	unprognostic (5.45e-3)	unprognostic (3.12e-2)	unprognostic (9.13e-3)	unprognostic (4.05e-2)	unprognostic (3.74e-2)	unprognostic (2.79e-2)	unprognostic (1.80e-1)	unprognostic (3.60e-3)	unprognostic (6.98e-3)	unprognostic (1.27e-1)	unprognostic (1.28e-1)	unprognostic (1.19e-1)	10.6	2.8	6.9	8.1	9	1.8	7.7	13.9	10.5	55.3	62	15	31	5.8	105.2	9.4	37.4	21.9	17.4	83.1	5.8	4.5	5	2.9	8.1	4.2	10.1	9.2	18.7	2.3	2	4.5	8.4	9.5	36.4	16.3	13.7	5.7	50.3	17.6	5.3	14.1	59.5	7.3	6.9	20.8	3.4	11.1	1.3	5	11.2	3.5	35.1	11.4	2.3	1.7	15.9	1.8	0.7	1.7	0.5	2.6	5.3	4.1	3.9	5.8	4.2	6.7	2.1	2.1	2.2	2.1	2.2	4.7	3	1	3.9	5.3	8.4	6	3.2	2.4	3.8	3.7	3	7.7	1.4	1.4	6.3	3.4	3.3	3.7	3.1	3.3	11.3	1.8	3.4	4.4	3.5	3.8	2	4.7	4	2.8	2.9	1.1	3.1	10.5	4.3	1.8	9.6	5	3.8	4	4.8	2.4	5.6	4.2	2.9	2.3	3.1	1.9	2.3	1.8	5.2	4.8	3.2	2.9	5.2	12.3	1.8	1.8	1.3	1.7	0.9	1.4	1.7	1.1	1	1.4	2.3	1.4	1	15.9	0.7	1.4	1.7	1.6	0.5	6.9	9	13.9	10.5	5.8	4.5	10.1	9.2	9.5	11.1	11.9	17.5	3.7	31.2	15.3	56.6	719.4	12.7	16	18.2	12.2	70.7	12.7	10	7.2	30.9	9.2	21.3	0	11.3	7.2	19	16.4	17.4	6.8	7.8	25.4	23.1	20.9	18.5	10.9	11.2	6	8.5	1.8	14	11.8	6.3	11.5	48.1	4.5	32.3	32.3	105.4	11.9	13.7	9.5	21.3	11.5	30.2	28.9	Cardiomyocytes
DCX	DBCN, DC, LISX, SCLH, XLIS	ENSG00000077279	Doublecortin	O43602	X	111293779-111412429	Disease related genes, Predicted intracellular proteins	Differentiation, Neurogenesis	Developmental protein	Disease mutation, Epilepsy, Lissencephaly	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		brain: 17.1;testis: 6.4	Cell type enriched	Detected in some	12	Rod photoreceptor cells: 22.7	Cancer enriched	Detected in some	5	glioma: 5.2	Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	8	SCLC-21H: 34.6;SH-SY5Y: 14.2	Region enriched	Detected in many	9	olfactory region: 90.9	Region enriched	Detected in all	5	olfactory region: 130.1	HPA036121	Enhanced	Supported	Approved	Cytosol						Cytosol		HPA036121: AB_2674950	unprognostic (1.36e-2)	unprognostic (1.99e-1)	unprognostic (7.36e-2)	unprognostic (4.00e-2)	unprognostic (1.50e-1)	unprognostic (2.24e-1)	unprognostic (2.00e-2)	unprognostic (7.18e-2)	unprognostic (3.24e-2)		unprognostic (2.33e-3)	unprognostic (3.67e-1)	unprognostic (4.90e-4)	unprognostic (5.02e-3)	unprognostic (1.27e-1)		unprognostic (1.85e-1)	0.8	1.1	7	0.7	9.2	0.7	3.2	0.7	17.1	0.7	0.6	0.9	0	0.7	4.1	3.6	0.6	0.6	0.8	0.7	4.2	5.4	0.5	0.5	0.6	0.7	2.5	6.7	0.6	0.8	0.5	1	0.6	3.7	0.5	0.8	0	2.2	0.6	0.5	0.7	0.7	0.6	3	0.6	1.2	6.4	2.3	0	0.6	0	0.5	0.6	0.3	0.3	0.4	0.6	0.2	0.7	0.4	0	0	0	3.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.1	0	0	0	0.5	0	0	0	34.6	14.2	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0.2	0.2	0.2	0.1	0.4	0.3	0.3	0.2	0.1	0.3	0.3	0.3	0.6	0.7	0	0.4	0.1	0	7	9.2	0.7	10.8	4.2	5.4	2.5	6.7	3.7	2.3	0	0	0	0	0	1.8	0.6	0	0	0	0	2	0	0	0.2	0.1	0	0	0	0	0.1	0	0	0	0	0.2	0	0	0	0	0	0	0	1.7	0	0	1.3	0.2	0	1.4	0	22.7	0	0.2	0	0	0	0.1	0	0	0	Rod photoreceptor cells
TYR	OCA1, OCA1A, OCAIA	ENSG00000077498	Tyrosinase	P14679	11	89177452-89295759	Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins	Melanin biosynthesis	Monooxygenase, Oxidoreductase, Tumor antigen	Albinism, Deafness, Disease mutation, FDA approved drug targets, Waardenburg syndrome	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	70	retina: 82.0;skin 1: 25.2	Cell type enriched	Detected in some	8	Melanocytes: 175.5	Cancer enriched	Detected in single	1755	melanoma: 351.3	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	864	SK-MEL-30: 86.4	Not detected	Not detected			Not detected	Not detected			CAB000079, HPA043241, HPA050889, HPA064583	Enhanced		Enhanced	Vesicles						Vesicles		CAB000079: AB_564045, HPA043241: AB_2678383, HPA050889: AB_2681264, HPA064583: 	unprognostic (1.16e-1)								unprognostic (1.01e-1)		unprognostic (1.85e-3)		unprognostic (9.75e-3)					0	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	82	0.7	0	0	25.2	0	0	0.2	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	86.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	7.1	0	0	0	0	0	0	0	0	0	0	23.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.6	0.3	0	175.5	0	0	0	0	0	0	0	0	0	0	0.2	0.2	1.8	0	0	0	0	Melanocytes
ACTN2		ENSG00000077522	Actinin alpha 2	P35609	1	236686454-236764631	Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters		Actin-binding	Cardiomyopathy, Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		heart muscle: 141.3;skeletal muscle: 320.9;tongue: 75.4	Cell type enriched	Detected in some	88	Cardiomyocytes: 1655.8	Cancer enhanced	Detected in many		head and neck cancer: 10.4	Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HEK 293: 3.1;HSkMC: 12.2;hTEC/SVTERT24-B: 7.6;WM-115: 2.4	Region enhanced	Detected in many		basal ganglia: 59.7	Low region specificity	Detected in many			HPA006035, HPA008315	Enhanced		Uncertain	Actin filaments					69000000	Actin filaments		HPA006035: AB_1078095, HPA008315: AB_1844543	unprognostic (1.75e-1)	unprognostic (1.50e-1)	unprognostic (2.41e-2)	unprognostic (1.69e-3)	unprognostic (2.91e-1)	unprognostic (4.32e-3)	unprognostic (7.85e-2)	unprognostic (2.97e-3)	unprognostic (2.17e-2)	unprognostic (2.80e-1)	unprognostic (2.97e-1)	unprognostic (2.66e-1)	unprognostic (2.71e-11)	unprognostic (1.30e-2)	unprognostic (1.10e-2)	unprognostic (4.98e-2)	unprognostic (1.22e-1)	3.5	0.6	1.6	0.6	10.7	0.6	0.7	0.3	2.5	0.6	0.6	5.1	0	0.6	0.7	4.4	3.7	0.7	0.7	141.3	2.5	1.4	0.6	0.6	0.9	0.6	4.7	1.4	0.7	0.7	0.6	0.1	0.6	2.7	2.8	0.6	0	4.9	0.6	320.9	0.6	0.7	1.5	3.9	0.6	0.7	0.9	4.3	0	3.5	75.4	4.8	0.9	0.1	0	0	0	0.4	0	0.1	0.1	0	0	0	0	0	0	0.4	0	0	0.7	1.9	0	0	0	0	0	0.4	0	1	0	0	0.1	3.1	0	0	0.1	0	0	0.7	12.2	0	7.6	0	0	0.3	0	0.6	0	0	0	0.1	0	1.3	0	0	0	1.6	0	0	0	0	2	0	0	0.7	0.5	0.5	0	0	0	0.2	0	0	0	0	0	0	0	2.4	0	0	0	0	0.4	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0.1	1.6	10.7	0.3	2.5	2.5	1.4	4.7	1.4	2.7	4.3	0	1.1	0	0.3	0.2	0.7	1655.8	0	0	0	0	0	0	0	0	6.7	0	0	0	0.6	0	0.7	0.3	0	0	0.1	0	0	1.3	0	18.7	0.6	0	0	0	0	0	0.3	0	0.4	0.6	1.1	0	1.4	1.9	2	0.1	0	0	0	0.1	Cardiomyocytes
NEBL	LASP2, LNEBL	ENSG00000078114	Nebulette	O76041	10	20779973-21174187	Predicted intracellular proteins		Actin-binding		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	4	heart muscle: 123.6	Cell type enriched	Detected in many	10	Cardiomyocytes: 2193.2	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Cell type enhanced	Detected in single		neutrophil: 1.4	Low lineage specificity	Detected in single			Cell line enhanced	Detected in many		HSkMC: 13.9;hTCEpi: 12.9;SCLC-21H: 28.1;SH-SY5Y: 17.0;SK-BR-3: 26.5					Low region specificity	Detected in all			HPA013994, HPA013995	Approved											HPA013994: AB_1854359, HPA013995: AB_1854360	unprognostic (3.79e-2)	unprognostic (1.92e-3)	unprognostic (3.44e-2)	unprognostic (3.57e-3)	unprognostic (1.50e-1)	unprognostic (2.43e-1)	unprognostic (1.20e-1)	unprognostic (6.25e-2)	unprognostic (1.05e-1)	unprognostic (6.20e-3)	unprognostic (2.36e-2)	unprognostic (8.42e-2)	prognostic favorable (2.77e-8)	unprognostic (3.51e-1)	unprognostic (8.11e-2)	unprognostic (4.46e-2)	prognostic unfavorable (5.56e-4)	1.3	6.9	16.4	1	17.2	0.7	13.2	21.1	16.1	2.6	2.9	9.8	0.1	1	1.3	1	10.8	1.1	1.7	123.6	16.5	12.7	12	1.7	14.1	0.9	12.7	13.3	1.5	6	6.6	16	5.1	12.6	7.3	4	2.2	18.8	8.1	0.8	16.2	1.3	1.4	10.6	0.8	4	2.8	12.5	0.5	30.8	3.9	3.8	2.1	4.4	0	0	1.4	0.8	0	0.5	0.2	0.6	5.2	8	0.3	0	0.1	11.1	0	0	0	0	0.6	0.7	1.6	8.2	0	0.4	4.8	0.5	0	0	0	3.3	0	2.5	0	12.5	0	0	13.9	12.9	0	1.3	0	0.3	0.2	0.3	2.2	0	12.2	0.1	0	5.8	5.3	3.1	0	0.1	0	2	1.1	28.1	17	1.5	26.5	0	2.8	8.9	0	11	0	1	0	0.3	0	0	0	0	0	0	0	0.5	0	0	0.7	0	0	0.2	0	0	0	0	0	1.4	0	0.8	0	0.5	0.2	16.4	17.2	21.1	14.1	16.5	12.7	12.7	13.3	12.6	12.5	202.5	60	0	11.7	16.4	72.9	2193.2	7.6	18.7	13.6	31.4	37.3	11	24.9	2.6	229.1	5.5	3.9	0	6.5	9.5	13.9	18.2	0	0	1.9	138.2	17.2	0	0.3	35.8	3.4	0.9	11.8	0	23.7	3.1	9.9	27.7	4.6	4.4	10.2	0	4.1	1.7	0.9	40.4	30.8	1.3	10.2	24.3	Cardiomyocytes
RBFOX1	A2BP1, FOX-1, HRNBP1	ENSG00000078328	RNA binding fox-1 homolog 1	Q9NWB1	16	5239802-7713338	Predicted intracellular proteins	mRNA processing, mRNA splicing	RNA-binding		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	5	brain: 57.2;heart muscle: 17.6;skeletal muscle: 67.6	Cell type enriched	Detected in some	11	Cardiomyocytes: 81.4	Cancer enhanced	Detected in single		glioma: 0.7	Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enriched	Detected in some	15	RH-30: 25.1	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA040809, HPA066746, HPA075862	Enhanced		Approved	Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus,Cytosol		No	No			Nucleoplasm	Nucleoli fibrillar center, Golgi apparatus, Cytosol	HPA040809: AB_10796228, HPA066746: , HPA075862: 	unprognostic (3.75e-3)		unprognostic (2.11e-1)	unprognostic (1.59e-1)	unprognostic (1.76e-2)	unprognostic (5.19e-3)		unprognostic (8.82e-5)	unprognostic (5.02e-1)	unprognostic (3.08e-1)	unprognostic (1.47e-1)	unprognostic (1.43e-2)	unprognostic (3.24e-2)	unprognostic (2.23e-1)	unprognostic (5.00e-2)	unprognostic (2.28e-1)		1.2	2.4	19.9	1.5	33	1.6	1.3	31.5	57.2	1.4	1.9	1.9	0	1.3	1.3	5	2	2.2	1.3	17.6	16.4	6.7	1.5	1.3	1.2	1.2	3.7	21.7	1.4	1.3	1.2	0.5	1.3	13.5	2.6	1.7	0	1.7	4.9	67.6	1.5	1.4	1.2	3.5	1.2	1.4	1.7	5.6	0	1.3	9.7	1.2	1.5	0.3	1.7	0.7	3.1	0.7	1.2	1.4	0	0.1	0.2	0.4	0.1	0	0	0.1	0	0	0	0	0.2	0.2	0.2	0	0	0	0	0	0	0	0	0	0.1	0.2	0	0	0	0.2	1.6	0	0	0	0	0	0.1	0	0.1	1.6	0	0	0	1.4	0	0	0	25.1	0.1	0	0.1	0.2	0	0.1	0.1	0	0.2	0.1	0.1	0	0.1	0.4	0.1	0	0.1	0	0.1	0.2	0.2	0	2.4	0.6	2	1.1	0.3	0.7	1	0.9	0.8	0.3	1.7	1.4	1	3.1	1.2	0.7	0.7	1	0	19.9	33	31.5	34.3	16.4	6.7	3.7	21.7	13.5	5.6	0	0.3	0	0	0	2.3	81.4	0	1.4	0	0	0	0	0	0	5.7	0	0	0	0.2	0	0.2	0	0	0	0.1	0	0	0	0	3.1	1.1	0	1.7	1	0.4	7.1	0	0	0	0.2	2.8	0	0	0.2	0.1	0	0	0	0.8	0	Cardiomyocytes
GNB1		ENSG00000078369	G protein subunit beta 1	P62873	1	1785285-1891117	Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins, Transporters		Transducer	Cancer-related genes, Disease mutation, Mental retardation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	6	Rod photoreceptor cells: 1104.1	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low cell line specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA040736	Supported		Approved	Golgi apparatus,Plasma membrane					60000000	Plasma membrane	Golgi apparatus	HPA040736: AB_2677106	unprognostic (9.49e-2)	unprognostic (4.91e-3)	unprognostic (1.24e-1)	unprognostic (1.56e-1)	unprognostic (3.34e-1)	unprognostic (9.07e-3)	prognostic unfavorable (3.61e-6)	unprognostic (1.99e-2)	unprognostic (3.60e-1)	unprognostic (7.27e-2)	unprognostic (8.47e-3)	unprognostic (1.95e-1)	unprognostic (9.76e-2)	unprognostic (1.08e-1)	unprognostic (4.62e-2)	unprognostic (1.14e-1)	unprognostic (7.90e-2)	55.2	42.1	84.7	55.1	82.3	41.7	37.8	78.8	112.5	44	52.1	46.4	26	55.4	44.3	31.2	41.7	38.8	36.6	39.6	74.7	65.7	43.9	38.7	47.1	47.1	68.5	52.1	45	33.9	48.9	36.9	45.3	56.6	40.1	41	70.7	37.6	41.7	19.7	35.5	65.3	51.2	61	51	40.8	31.4	39.2	44.5	37.6	19.5	45.6	42.2	54.1	7.7	18.8	18.4	13.2	10.6	9.9	6	54.7	51.8	61.6	42.9	35.2	38.8	23.8	77.8	51.9	70.7	55.6	42.3	54.9	57.2	57.4	78.5	40.1	28.9	61.7	56.4	64.7	87.8	30.3	55.5	49.2	48	44.4	33.3	61	34.3	39.8	67.5	62.9	47.8	57.3	45.4	34.3	51.8	67.3	34.1	73	26.3	35.4	28.2	42	71.3	47.6	45.2	48.4	34.1	75.8	86.4	72.1	47	63.1	44.3	32.9	45.8	87.3	62.3	41.8	48.4	56.4	35.1	61.2	131	53.3	70.4	35	7.4	11.1	17.1	8.7	13.2	8	7.4	8.7	9.7	10.9	7.7	5.9	6.5	18.4	10.6	13.2	18.8	9.9	6	84.7	82.3	78.8	112.5	74.7	65.7	68.5	52.1	56.6	39.2	65.5	41.8	61.1	42.7	76.6	128.2	51.2	58.6	30.8	35.2	71.5	164.9	36.8	39.7	78.1	24.7	107.9	139.4	0	86.3	77.4	70.2	78.2	52	51.3	89.1	170	118.1	93.9	126.8	25.1	70.5	95.3	50.6	74.9	88.7	159	130.7	84.2	82.7	56.2	1104.1	77.6	76.5	56.5	67.9	89	30.4	48	64.7	70.1	Rod photoreceptor cells
CLUL1		ENSG00000079101	Clusterin like 1	Q15846	18	596988-650334	Predicted intracellular proteins, Predicted secreted proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		retina: 45.2	Cell type enriched	Detected in many	7	Rod photoreceptor cells: 335.8	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		Hep G2: 24.6					Not detected	Not detected			CAB025264, HPA075240	Enhanced		Approved	Endoplasmic reticulum,Plasma membrane	Secreted in other tissues					Endoplasmic reticulum	Plasma membrane	CAB025264: , HPA075240: AB_2732286	unprognostic (1.75e-2)	unprognostic (9.15e-2)	unprognostic (1.50e-1)	unprognostic (1.51e-1)	unprognostic (7.81e-3)	unprognostic (3.00e-3)	unprognostic (1.96e-1)	unprognostic (2.97e-3)	unprognostic (8.38e-3)	unprognostic (3.76e-2)	unprognostic (4.85e-3)	unprognostic (4.96e-3)	unprognostic (6.36e-4)	unprognostic (1.32e-1)	unprognostic (7.89e-2)	unprognostic (1.29e-3)	unprognostic (2.37e-2)	0.5	1.4	5	0.5	3.8	4.3	3.1	4.5	6.6	2.1	1	1.4	1	0.6	1.9	0.7	1.6	2.4	2.5	0.4	5.9	6.4	7.5	0.7	1.8	0.8	4.9	2	7.4	1.6	2.5	6.1	0.7	5.1	12	0	45.2	3.1	1.6	0.1	0.8	1.7	0.4	5.3	0.1	3.9	3.4	2.8	0.3	9.4	0.1	0.4	2.1	0.3	1	1.3	2.1	0.3	0.1	2	0.5	2.6	3.9	7.5	5.1	0	0	4.5	2.9	0.2	0	0	3.1	1.5	3.1	0.7	0	2.7	1.1	0	0.4	0	2.5	7	5.2	2.1	24.6	0	1.7	1	0.2	0	0	0	1.3	0.3	7.7	7.3	9.1	0	0.8	3.1	5.6	0.5	3.2	1.8	6.3	3.5	11	0.8	0.8	6.6	4.6	2.9	1.8	2.2	6.3	2.4	0.8	0.6	3	4.4	2.1	1.4	5.2	9.1	6.5	2.4	3.4	2.6	0.9	0.3	0.2	0.2	0	0.1	1	0.4	0.2	0.5	0.1	0.1	0.8	2.1	0.1	0	1.3	2	0.5	5	3.8	4.5	5.7	5.9	6.4	4.9	2	5.1	2.8	0	1.6	0	3.4	0	23.9	0.1	0	4	2.3	0	19.6	0.4	1.7	0.2	0.4	0.2	0	0	0.2	0.1	0.1	8.5	0	0	0.2	15.9	0	0	0	0	0.9	0	0	0	0	46.9	0	0	1.1	0.3	335.8	6.5	0	8.4	4.5	0.1	0.3	0	0	1.4	Rod photoreceptor cells
SLC1A3	EA6, EAAT1, GLAST	ENSG00000079215	Solute carrier family 1 member 3	P43003	5	36606355-36688334	Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters	Amino-acid transport, Symport, Transport		Cancer-related genes, Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	11	brain: 188.6	Cell type enriched	Detected in many	9	Muller glia cells: 579.8	Cancer enriched	Detected in all	21	glioma: 168.1	Low region specificity	Detected in all			Group enriched	Detected in some	12	classical monocyte: 4.3;intermediate monocyte: 2.1;myeloid DC: 3.4	Group enriched	Detected in many	39	dendritic cells: 3.4;monocytes: 4.3	Cell line enhanced	Detected in many		AF22: 21.5;CACO-2: 34.7;HaCaT: 26.3	Low region specificity	Detected in all			Low region specificity	Detected in all			CAB002573, HPA037467, HPA037468	Enhanced	Supported	Approved	Nucleoli,Mitochondria						Mitochondria	Nucleoli	CAB002573: AB_564088, HPA037467: AB_10795027, HPA037468: AB_10671371	unprognostic (1.23e-1)	unprognostic (2.15e-2)	unprognostic (2.58e-3)	unprognostic (1.74e-2)	unprognostic (1.02e-1)	unprognostic (7.70e-2)	unprognostic (3.89e-3)	unprognostic (2.36e-1)	unprognostic (1.24e-1)	unprognostic (2.84e-2)	unprognostic (4.17e-3)	unprognostic (3.28e-1)	unprognostic (2.46e-1)	unprognostic (1.06e-1)	unprognostic (4.17e-2)	unprognostic (1.03e-1)	unprognostic (1.31e-2)	17.3	10.3	76.1	5.9	70.6	3.1	6.3	45.8	188.6	6.9	3.2	26.3	0	2.1	2.8	2.3	7.2	5.4	5.9	12	57.9	27.3	3.1	3.6	4.7	8.6	32.7	39.6	8.6	4	2.6	3.7	12.7	28.5	3.3	2.6	1.9	3	4.4	7.6	5.5	2.3	4.1	29.4	5.8	2.9	2.7	33.6	0	2.6	0.7	4.5	4.8	1.2	0	3.4	0	4.3	0	0	0.8	0.4	0.1	21.5	1.9	2.2	6	13.8	0	0	0.8	1.9	34.7	1.7	0	10.5	0.3	0.3	26.3	6.3	2.8	0.9	0.3	12.9	0	0.1	0	0.4	0.4	0.1	11.1	13	5.3	2.2	0.4	0	0.4	0	0.1	3.6	0	0	0.1	2.5	0	2.2	0	0.1	0	0	1.4	1.8	0	2.1	6.3	0.3	10.5	0	1	0	1.9	3.2	0	7.6	0	0	0	8.8	14.5	4.9	0	4.3	0	0	2.1	0	0	0	0	3.4	0	0	0	0	0	0.1	0.2	0	0.8	76.1	70.6	45.8	57.8	57.9	27.3	32.7	39.6	28.5	33.6	3	0.3	0.5	10.4	9.5	7.7	33.9	0	5.3	1.2	0	2	25.3	0	0.4	0.6	1.1	0	0	0	13.5	11.8	3.2	0	0.2	38.2	3.2	0	1.3	63.4	1.9	4	11	6.8	3.6	0	579.8	0.3	0	0	0	11.3	6.5	4.7	0.2	0.1	6.1	7.7	0	0	3.3	Muller glia cells
DUSP13	BEDP, DUSP13A, DUSP13B, FLJ32450, TMDP	ENSG00000079393	Dual specificity phosphatase 13	Q6B8I1, Q9UII6	10	75094432-75109221	Enzymes, Predicted intracellular proteins, Predicted membrane proteins		Hydrolase, Protein phosphatase		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		skeletal muscle: 75.2;testis: 18.6;tongue: 26.0	Cell type enriched	Detected in some	6	Early spermatids: 345.5	Low cancer specificity	Detected in some			Not detected	Not detected			Cell type enriched	Detected in single	39	neutrophil: 3.9	Lineage enriched	Detected in single	39	granulocytes: 3.9	Cell line enhanced	Detected in some		BEWO: 5.0;EFO-21: 5.9;Hep G2: 12.2;K-562: 4.7;LHCN-M2: 10.9;RH-30: 9.3	Low region specificity	Detected in some			Not detected	Not detected																unprognostic (1.79e-1)	unprognostic (2.39e-2)		unprognostic (2.39e-1)	unprognostic (7.07e-2)	unprognostic (1.66e-3)	unprognostic (2.47e-3)	unprognostic (8.63e-2)	unprognostic (1.97e-1)	unprognostic (2.63e-2)	unprognostic (1.27e-1)	unprognostic (3.92e-1)	unprognostic (2.22e-7)	unprognostic (1.93e-2)	unprognostic (1.54e-1)	unprognostic (4.81e-1)	unprognostic (2.09e-2)	0.8	0	0	0	0	1.8	0	0	0.1	0.1	0	0	0	0	0	3.3	1.2	0	0	5.6	0	0.1	0	0	0.2	0	0	0	0	0	0	0	0	0.4	0.3	0	0	2.3	0	75.2	0.1	0	0	0	0.1	0	18.6	0	0	1	26	1.9	0	0.1	0	0	3.9	0	0	0	0	0	0	0.1	0	0	0	5	0	0	0	0	1.1	0.1	0	5.9	0	0	0	0	0.1	0	0	0	0.1	0.1	12.2	0	0	0	1	1.1	0	0	0	0	0	4.7	0	10.9	0.6	0	0	0.7	0.1	0	0	9.3	0	0	0	0	0	0	2.4	0	0.4	0	0	0	0	0	0	0	0.4	0.2	0	0.2	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.9	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0.4	0	0	0	0	0.2	1.4	0	10.6	0	0	0	0	0	1.3	0	0	345.5	0	0	0	0.2	0.7	0	0	0	0	0.2	0	0	0	0	54.1	0.9	0	0	0	0	0	0.3	0	1.8	0	0	0	0	2.6	2.7	1.8	2.5	0	0	0.1	Early spermatids
AFM	ALB2, ALBA	ENSG00000079557	Afamin	P43652	4	73481683-73504001	Plasma proteins, Predicted secreted proteins	Protein transport, Transport			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	13	liver: 169.0	Cell type enriched	Detected in some	8	Hepatocytes: 272.5	Cancer enriched	Detected in single	167	liver cancer: 62.0	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	5	CACO-2: 5.9	Not detected	Not detected			Not detected	Not detected			HPA017006, HPA052437	Enhanced				Secreted to blood			54900000000	5000000000			HPA017006: AB_1844635, HPA052437: AB_2732575							prognostic favorable (1.80e-4)				unprognostic (5.73e-2)		unprognostic (4.24e-2)					0	0	0	0.2	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	12.5	169	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5.9	0	0.1	0	0	0	0	0	0	0	0	0	0.4	0	1.1	0	0.9	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0.9	0	0	0.5	0.6	0	0.6	0	0	0	0	0	0	0	0	0	0	0.4	0	0.3	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0.1	0	0	0	0	0.1	0.7	0	0.2	2.5	0	0	1.8	0	0.7	0	0	0	0	0	0	0.8	0	0	0	0	272.5	0.1	0	0	4.3	1.6	0	0	0	0	0	0	0	0.1	0	0	36.3	0	0	0	0	0	0.1	0.1	0	0	0	Hepatocytes
SCGN	CALBL, DJ501N12.8, SECRET, SEGN	ENSG00000079689	Secretagogin, EF-hand calcium binding protein	O76038	6	25652201-25701783	Plasma proteins, Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 22.3;pancreas: 39.7;pituitary gland: 47.9	Cell type enriched	Detected in some	6	Intestinal endocrine cells: 576.5	Cancer enhanced	Detected in many		pancreatic cancer: 38.2	Group enriched	Detected in many	11	cerebellum: 22.3;hippocampal formation: 6.2;hypothalamus: 22.0	Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	4	SCLC-21H: 23.6	Region enriched	Detected in single	16	olfactory region: 100.5	Region enriched	Detected in some	9	olfactory region: 282.4	CAB004005, HPA006641, CAB044060, CAB062563, CAB068232	Enhanced	Supported	Supported	Cytosol	Intracellular and membrane					Cytosol		CAB004005: , CAB044060: , CAB062563: AB_2665612, CAB068232: AB_2665613, HPA006641: AB_1079874	unprognostic (8.15e-2)		unprognostic (4.31e-3)		unprognostic (1.46e-1)		unprognostic (1.25e-2)	unprognostic (4.70e-1)			unprognostic (1.78e-2)	unprognostic (2.01e-1)	unprognostic (5.14e-2)	unprognostic (5.41e-2)	unprognostic (9.45e-2)	unprognostic (1.19e-1)		1.5	2.1	0.7	6	0.8	0.1	2	22.3	1.5	0.4	10.5	0.5	0.9	7.2	0.1	0.3	0.3	0	0.5	5	6.2	22	3.8	2.5	0.4	0.1	0.5	1.2	0.2	39.7	0	47.9	1.8	1.4	1.1	11.7	1.8	3.7	3	0.1	0.3	8	0.7	1	0.1	12.5	0.6	0.1	0.5	1.1	0.3	0.1	0.2	0.1	0	0	0	0	0	0.5	0	0	0	0	0	3.3	0	0	0	0	0	0	5.9	0	0	0.8	0	0	0	0	0	0	0.2	0	4.2	0	3.2	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0.1	0	0	0	0	0.3	0	0	0	23.6	0.5	0	0	0	0	0	0	0	0	1.1	0	0.1	0	0.2	0	0	0.1	0.1	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.7	0.8	22.3	1.5	6.2	22	0.5	1.2	1.4	0.1	0	0	0	0.1	0	0	0.3	99.3	0	0	0	0	0	0	0.2	0.1	0	1	0	0.3	0.1	0	4.7	0	0	0.1	0	576.5	1.8	0	0	0.6	0	0	1.8	2.8	0	7.8	2.9	0	2.2	0	12.9	0	0	0.1	0	0	0	1.1	0	Intestinal endocrine cells
RABL2B		ENSG00000079974	RAB, member of RAS oncogene family like 2B	Q9UNT1	22	50767501-50783663	Predicted intracellular proteins	Cilium biogenesis/degradation			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		epididymis: 59.0	Cell type enriched	Detected in many	4	Ciliated cells: 167.3	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low cell line specificity	Detected in all											HPA042642, HPA042700, HPA044007	Approved		Approved	Vesicles,Centrosome						Centrosome	Vesicles	HPA042642: , HPA042700: AB_2678120, HPA044007: AB_2678770	unprognostic (2.09e-1)	unprognostic (1.47e-2)	unprognostic (1.86e-3)	prognostic favorable (5.58e-4)	unprognostic (7.85e-2)	unprognostic (9.98e-2)	prognostic unfavorable (4.58e-5)	unprognostic (3.14e-1)	unprognostic (6.97e-2)	unprognostic (7.33e-2)	unprognostic (1.19e-2)	unprognostic (7.51e-2)	unprognostic (3.71e-3)	unprognostic (7.43e-3)	unprognostic (1.37e-1)	unprognostic (1.25e-1)	unprognostic (8.37e-3)	8.2	8.2	12.4	11.1	22.1	8.1	12.9	19.7	21.2	13	8.4	12.7	12.6	7.9	13.9	59	8.1	41.9	9.4	5.8	13.1	15.3	10.6	7	14.4	13.3	9.9	16.5	17.8	9.6	10.9	16.7	7.4	14.3	10	11	9.5	9.5	11.6	5.1	13.8	8.6	10.2	9.5	11.5	9.1	12.2	14.5	12.6	17.9	3.5	12.3	9.4	9.2	13.6	13.2	9.2	19.4	10.8	16.8	10.3	13.3	12.1	20.8	16.2	23.3	18.6	15.2	10	11.1	8.1	11.1	3.4	11.8	8.6	8.9	14.3	13.2	17.5	9.4	11.7	8.8	7.4	13.4	7.4	20.9	8.8	9.7	20.9	8	15.8	16	10.6	13.4	24.1	9	15.5	5.6	10.9	16.1	16.8	10.4	9.2	7.9	8.2	9.1	17.6	12	9	15.7	13.3	8.9	16.2	12.2	10.8	7.5	15	10.7	6.5	13.8	7.8	15.6	6.6	6.7	9.2	4.2	4.2	14.7	5.2	10.9	1	10.9	9.2	16.8	17.4	12.2	11.2	13	13.7	11.6	13.6	15.2	14.7	4.3	10.8	19.4	13.2	13	10.3	12.4	22.1	19.7	21.2	13.1	15.3	9.9	16.5	14.3	14.5	11.9	11.2	10.4	10.3	4.7	14.6	3.6	12.7	167.3	29.6	21	29.5	10.4	11.6	17.3	17	7.3	7.8	0	9.5	9.3	8.5	7.5	3.5	6.4	10.7	15.9	5.2	5.5	10.1	16.3	13	8.5	16.9	15.4	7.2	12.9	9	3.5	10.3	12.2	37.4	6.5	10.3	27.4	27	5	5.6	15.8	10.1	6.3	Ciliated cells
DCT	TYRP2	ENSG00000080166	Dopachrome tautomerase	P40126	13	94436808-94479682	Enzymes, Predicted membrane proteins	Melanin biosynthesis	Isomerase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	58	retina: 151.5;skin 1: 54.2	Cell type enriched	Detected in some	25	Melanocytes: 3369.1	Cancer enriched	Detected in some	215	melanoma: 155.5	Low region specificity	Detected in single			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	259	SK-MEL-30: 76.8	Not detected	Not detected			Low region specificity	Detected in all			HPA010742, HPA010743, HPA010800, CAB017634	Enhanced		Supported	Vesicles,Plasma membrane						Plasma membrane	Vesicles	CAB017634: AB_1130818, HPA010742: , HPA010743: AB_1847519, HPA010800: AB_1847520	unprognostic (5.99e-2)	unprognostic (1.67e-2)	unprognostic (1.54e-2)	unprognostic (3.17e-2)	unprognostic (2.45e-2)	unprognostic (3.35e-2)	unprognostic (2.15e-2)	unprognostic (2.81e-2)	unprognostic (6.07e-2)	unprognostic (1.81e-1)	unprognostic (3.64e-3)	unprognostic (1.06e-2)	unprognostic (6.18e-5)	unprognostic (6.97e-2)	unprognostic (9.87e-2)	unprognostic (1.22e-3)	unprognostic (2.42e-1)	0.2	0.2	0.5	0.1	1.5	0.1	1.7	0.2	0.6	0.2	0.1	0.3	0.1	0	0.2	0.5	0.1	0.8	0.1	0.1	0.4	0.5	0.1	0.1	0.1	0.1	0.3	0.1	0.2	0.1	0.1	1.4	0.1	0.3	0.2	0	151.5	1.4	0.2	0.2	54.2	0.2	0.1	0.8	0.1	0	0.3	0.4	0.1	0.1	0.3	0.2	0.1	0.1	0	0.2	0	0	0	0.8	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	76.8	0	0	0	0	0	0	0	0	0.1	0	0.1	0	0	0.1	0	0	0	0	0	0.3	0	0	0	0.2	0	0.8	0	0	0	0	0	0	0.1	0.5	1.5	0.2	0.6	0.4	0.5	0.3	0.1	0.3	0.4	0	0	0	0.1	135.3	0.7	0.8	0	0	0	1.8	0	0	0	0	12.6	0.1	0	0	0.2	0	0.2	0	0	0	0	0	0	0	0	16	0.9	0	3369.1	0	0	2.4	0	0	0.7	0	0.2	0	0.9	0.5	0.2	29.2	0	0	0	0	Melanocytes
CPB2	CPU, PCPB, TAFI	ENSG00000080618	Carboxypeptidase B2	Q96IY4	13	46053195-46105033	Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins	Blood coagulation, Fibrinolysis, Hemostasis	Carboxypeptidase, Hydrolase, Metalloprotease, Protease	FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	82	liver: 246.8	Cell type enriched	Detected in some	8	Hepatocytes: 1070.7	Cancer enriched	Detected in some	112	liver cancer: 268.4	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	76	Hep G2: 62.5	Not detected	Not detected			Not detected	Not detected			HPA004146	Approved				Secreted to blood				14000000000			HPA004146: AB_1078397	unprognostic (3.44e-2)	unprognostic (1.25e-1)	unprognostic (2.94e-2)	unprognostic (1.89e-2)	unprognostic (7.69e-2)	unprognostic (1.17e-2)	prognostic favorable (2.06e-4)	unprognostic (1.89e-1)	unprognostic (2.74e-1)	unprognostic (2.48e-1)	unprognostic (3.17e-2)	unprognostic (4.83e-2)	unprognostic (3.20e-3)	unprognostic (1.34e-1)	unprognostic (7.10e-2)	unprognostic (3.34e-2)	unprognostic (9.61e-2)	0.1	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0.7	0	0	0.7	0	0	0	0	246.8	3	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0.4	0.2	0.5	0.5	0.4	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0.1	0	62.5	0	0.2	0	0	0	0	0	0	0	0.1	0	0	0	0	0.1	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0.8	0	0	0	0	0	0	0	0	0	0.1	0.1	0	0.1	0	0	0.3	0	0.6	0	0	0.4	0.2	0.1	0	0	0.4	0.2	0.5	0.4	0.5	0.2	0.6	0	0	0	0	0.1	0	0	0	0	0	0	3	24.8	0	0	0	0	0	127.4	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0.1	0	1070.7	0.1	0	0	16	15.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.9	0	0	Hepatocytes
CHRNA3		ENSG00000080644	Cholinergic receptor nicotinic alpha 3 subunit	P32297	15	78593052-78621295	FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins	Ion transport, Transport	Ion channel, Ligand-gated ion channel, Receptor	Disease mutation, FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	7	adrenal gland: 33.6;lymphoid tissue: 57.2;retina: 74.1	Cell type enriched	Detected in some	18	Cone photoreceptor cells: 155.1	Low cancer specificity	Detected in some			Region enhanced	Detected in some		cerebellum: 6.0	Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	5	SH-SY5Y: 86.4	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA029430	Enhanced											HPA029430: AB_10603785	unprognostic (2.28e-1)	unprognostic (3.45e-1)	unprognostic (2.58e-2)	unprognostic (2.36e-1)	unprognostic (1.32e-1)	unprognostic (1.12e-1)	unprognostic (9.16e-3)	unprognostic (1.97e-1)	unprognostic (4.28e-2)	unprognostic (7.20e-2)	unprognostic (3.12e-1)	unprognostic (1.01e-1)	unprognostic (1.86e-4)	unprognostic (2.65e-3)	unprognostic (2.76e-1)	unprognostic (1.53e-1)	unprognostic (4.48e-1)	0.4	33.6	0.8	4	2.4	0.1	0.3	6	0.4	0.5	8.2	0.7	0.2	1.2	0.5	0.1	0.5	0.1	0.8	0.4	0.2	0.8	0.1	0.1	0.3	2.8	0.4	0	0.1	0.2	0.1	1.5	0.2	1.2	0.6	3.4	74.1	0.2	0.6	0.1	0.6	2.9	2.8	0.2	0.2	3.6	0.9	0.5	57.2	0.2	0.2	0.7	0.8	0.6	0.2	0	0	0	0	0.4	0	0	0	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	2.1	0	0	0	0.3	0.1	0.1	0	0	0	0.9	0	0	0	0	0	0	5.3	0	0	0	0	1.5	0	0.3	0	0	0.1	0	0	0	0.1	16.4	86.4	0	0	0	0.1	0.1	0	0	0	0.4	0	0.1	0	0.1	0	0	0.1	0	0	0	0	0	0	0	0.2	0	0	0	0	0.4	0	0	0	0	0	0	0	0.8	2.4	6	0.4	0.2	0.8	0.4	0	1.2	0.5	0	0	0	0	0	4.2	0.6	0	0	0	0	155.1	0	1.7	0	3.2	0	0	0	0	0	0	0	0	0	0.2	1.6	0	0	0	2.2	0	0	0	0	2.7	2.5	0.1	0	0	0	8.5	0	0	0.2	1.9	0	0	0	0	0.1	Cone photoreceptor cells
CDH7		ENSG00000081138	Cadherin 7	Q9ULB5	18	65750252-65890341	Predicted membrane proteins	Cell adhesion			Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	5	brain: 16.7	Cell type enriched	Detected in some	7	Muller glia cells: 44.1	Cancer enhanced	Detected in single		prostate cancer: 0.5	Low region specificity	Detected in many			Low cell type specificity	Detected in some			Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		AF22: 17.3;HEK 293: 3.2;Karpas-707: 6.3;RH-30: 8.3;U-87 MG: 3.9	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA061419	Supported											HPA061419: AB_2684511	unprognostic (2.81e-3)		unprognostic (6.95e-2)		unprognostic (2.26e-1)			unprognostic (2.24e-2)	unprognostic (3.45e-2)	unprognostic (2.41e-1)	unprognostic (3.95e-3)	unprognostic (2.88e-1)	unprognostic (4.28e-4)	unprognostic (2.70e-2)	unprognostic (1.49e-1)		unprognostic (1.72e-1)	0.4	0.6	2.6	0.3	4.3	0.6	0.4	15.3	7.5	0.3	0.3	0	0	0.4	0.3	0.6	0.3	0.3	0.4	0.4	0.5	2.5	0.3	0.6	0.4	0.3	1.5	2.1	1.6	0.3	0.3	1.2	0.3	16.7	3.6	0.5	1.3	0.4	1.9	1	0.5	0.3	0.2	1.3	0.4	0.3	1.8	0.1	0.7	0.5	0	0.4	0.3	0.2	0.8	0.5	1.9	0.4	0.6	0.4	0.1	0	0.2	17.3	0	0	0	0	0	0	0	0	0.6	0	0	0	0	0.1	0	0	0	0	0	3.2	0.1	0.3	0	0	0	0	0	0	0	0	0	0	0	0	6.3	0	0	0	0.1	0.7	0	0.3	0.1	8.3	0	0	0	0.1	0.4	0	0	1.8	0.3	1.3	0	0	0	0.1	0	0	1.1	0	0	3.9	0	0	1.2	0.4	0.4	0.3	0.2	0.3	0.3	0.3	0.3	0	0.8	0.4	0.4	1.9	0.6	0.3	0.5	0.2	0.1	2.6	4.3	15.3	5.2	0.5	2.5	1.5	2.1	16.7	0.1	0	0	0	0.5	0	2	0.8	0	0	0	0	0	0	0	0	3.6	0	0	0	0	0	0.8	0.8	0	0	0	0	3.4	0	0	1.7	0.6	0	0	0	0	44.1	0	0	0	0	4.1	6.5	0	0.7	0.7	0	0	0	0	0.1	Muller glia cells
SLC13A1	NAS1, NaSi-1	ENSG00000081800	Solute carrier family 13 member 1	Q9BZW2	7	123113531-123199986	Predicted membrane proteins, Transporters	Ion transport, Sodium transport, Sulfate transport, Symport, Transport			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in some	6	kidney: 67.5	Cell type enriched	Detected in some	17	Proximal tubular cells: 400.4	Cancer enriched	Detected in single	219	renal cancer: 10.9	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in single		BEWO: 1.0	Region enriched	Detected in single	5	cerebellum: 0.9	Low region specificity	Detected in all			HPA053615, HPA062714	Enhanced											HPA053615: AB_2682207, HPA062714: AB_2684846											unprognostic (1.86e-1)		prognostic favorable (8.95e-5)	unprognostic (1.71e-1)	unprognostic (3.76e-1)			0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	4.2	0	0	0	67.5	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	10.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.7	0.1	0	0	0	0	0.2	0	0.2	0	0	1	0.9	0	0.1	0	0	0.1	0.6	0	0	0	0	0	0	0	0.5	0	0.5	0.1	0.3	0	0	0	0	0.1	0	0	0.1	0	0	0	0	0	0	0.2	0.7	0.1	0	0	0	0.2	0.3	0	0.4	0.6	0	0	0	0	0	0	0	0.4	0.5	0	0.1	0	0.8	0.1	0.6	0.2	0	0	0.4	0.1	0	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	7	0	0	23.2	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	400.4	0	0	0	0	0	0	0	0	0	0	Proximal tubular cells
FAM135A	FLJ20176, KIAA1411	ENSG00000082269	Family with sequence similarity 135 member A	Q9P2D6	6	70412941-70561174	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	7	Horizontal cells: 225.6	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Cell line enhanced	Detected in many		RH-30: 24.2	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA031743, HPA031744	Approved		Approved	Nucleoplasm,Cytosol						Nucleoplasm	Cytosol	HPA031743: AB_10600767, HPA031744: AB_10601101	unprognostic (5.79e-2)	unprognostic (1.64e-1)	prognostic favorable (8.00e-4)	unprognostic (1.59e-1)	unprognostic (1.66e-2)	unprognostic (1.08e-1)	unprognostic (6.69e-4)	unprognostic (4.08e-2)	unprognostic (3.87e-2)	unprognostic (1.58e-1)	unprognostic (1.02e-1)	unprognostic (1.41e-1)	prognostic favorable (3.46e-4)	unprognostic (3.99e-1)	unprognostic (2.75e-1)	unprognostic (6.26e-2)	unprognostic (2.65e-2)	5.8	4.3	6.4	9.2	6.8	1.7	5.3	14	10.7	9.6	13.3	4	5.3	14.9	7.7	4.9	33.8	5.4	8.8	5.2	5.4	5.2	9.6	5.5	5.5	4.1	6.1	7.1	8	6.9	16.4	13.8	22.7	8.5	18.9	13	4.2	10.4	6.7	5.7	14.2	27.9	4.8	8.9	4.5	12.3	11	6	4.1	4.8	13.1	10.6	7.6	14.4	3.9	6.3	3.3	5.3	5.4	2.2	1.5	5.9	3.4	7.7	4.8	3.6	2.6	6.9	1.9	3.8	2.1	3.5	6.7	4.8	10.6	13.9	1.4	10.1	5.8	7.6	4.8	3.6	5.1	6.3	4.8	3.7	5.9	4.4	8.9	5	2.3	11.1	4	11.1	2.6	5.5	3.4	7.6	5.5	2.4	0.7	1.6	4.2	5	7.1	2.8	5.2	24.2	5	7.9	3.2	8.1	2.4	2.3	2.1	2.3	5.1	1.4	4	2.7	1.8	4.6	1.7	4.4	6.6	7.5	4.3	1.3	8.1	3.2	3.3	4.3	0.2	1.5	3.5	1.9	3	1.4	0.6	6.3	3.9	2.2	1.3	1.2	5.4	5.3	1	1.7	1.5	6.4	6.8	14	10.7	5.4	5.2	6.1	7.1	8.5	6	26.8	12.2	1.4	9.5	14.2	18.2	9.4	15.3	8.1	5.7	19.2	27.5	2.2	5	5.8	24.9	10	28.4	0	10.7	1.2	5.9	32.9	8.1	5.7	5.1	225.6	22.4	9.2	14.2	17.3	14.4	13.1	5	9	26.1	12.8	13.3	30	12.4	6.8	27.5	6.5	6.6	25.1	8.2	29.4	6.9	3.9	19.4	11.2	Horizontal cells
TRPM3	GON-2, KIAA1616, LTRPC3	ENSG00000083067	Transient receptor potential cation channel subfamily M member 3	Q9HCF6	9	70529063-71446904	Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels	Calcium transport, Ion transport, Transport	Calcium channel, Ion channel		Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	8	brain: 36.6;kidney: 28.0;retina: 105.2	Cell type enriched	Detected in many	4	Muller glia cells: 278.6	Cancer enhanced	Detected in single		renal cancer: 0.9	Low region specificity	Detected in all			Cell type enriched	Detected in single	16	NK-cell: 2.1	Lineage enriched	Detected in single	16	NK-cells: 2.1	Cell line enriched	Detected in some	4	HAP1: 19.4	Low region specificity	Detected in all							HPA072650, HPA074393	Enhanced		Approved	Vesicles						Vesicles		HPA072650: , HPA074393: 	unprognostic (3.74e-1)	unprognostic (6.30e-2)	unprognostic (4.79e-2)	unprognostic (4.81e-2)	unprognostic (1.38e-2)	unprognostic (8.88e-2)	unprognostic (1.49e-2)	unprognostic (2.19e-2)	unprognostic (1.11e-1)	unprognostic (1.89e-2)	unprognostic (6.10e-2)	unprognostic (1.15e-2)	unprognostic (1.82e-7)	unprognostic (3.51e-2)	unprognostic (5.64e-2)	unprognostic (1.74e-2)	unprognostic (1.50e-2)	0.9	1.7	6	0.7	4.5	1.1	0.8	36.6	5.1	0.8	0.7	9.6	2.1	1.8	2.4	3	0.7	1.3	1.3	1.4	9.4	6	28	0.9	0.8	0.7	8.3	3.5	5.3	1.5	0.7	6.8	0.8	34.8	1.4	0.7	105.2	0.8	5	1.1	0.8	0.7	1	8.1	1.1	1.6	5.3	5.9	0	2.1	0	0.6	0.8	0.5	0	0	0	0	2.1	0.1	0	0	0	1.1	0.1	1.3	3	0	0.1	0	0	0.1	0.1	0	0	0.1	0.1	0	0	19.4	0	0.1	0	0.1	0.1	1.5	0	0.3	0	0	0	0	0	0.3	2.7	0.2	0	0	1.2	4.5	0	0	0	1.4	0	0.1	0	0.2	0	1	0	1.3	0	0.2	0	0.4	0.2	0	0	3.6	0	0.1	3.5	0	0	0	0	0.5	0	1.3	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	2.1	0	0	0	0	6	4.5	36.6	3.8	9.4	6	8.3	3.5	34.8	5.9	3	4	0	0.9	0.3	9.5	4.8	2.5	1.4	4.5	15.7	62.8	0	5	0	3.9	1.3	0	0	0.2	0	1.5	0.4	0	0	0.2	1.6	14.8	0.6	0	1.7	5.2	1.1	0	0	0	278.6	0.1	0	8.5	25.8	4.7	0	1	1.5	0.4	0.6	0.2	0.8	0	0.3	Muller glia cells
SLCO1A2	OATP, OATP-A, OATP1A2, SLC21A3	ENSG00000084453	Solute carrier organic anion transporter family member 1A2	P46721	12	21264600-21419594	Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters	Ion transport, Transport			Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		brain: 17.9;liver: 11.2;retina: 14.2;salivary gland: 14.5	Cell type enriched	Detected in some	9	Alveolar cells type 1: 32.8	Cancer enhanced	Detected in some		testis cancer: 2.5	Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		NTERA-2: 13.3;RPMI-8226: 9.2;SuSa: 14.2;U-266/70: 19.8;U-266/84: 8.0					Low region specificity	Detected in all			HPA071152			Supported	Plasma membrane		No	No			Plasma membrane		HPA071152: AB_2686350	unprognostic (5.43e-3)	unprognostic (2.33e-1)	unprognostic (1.28e-1)	unprognostic (8.59e-2)	unprognostic (1.08e-1)	unprognostic (6.36e-2)	unprognostic (7.63e-2)	unprognostic (1.53e-1)	unprognostic (3.82e-2)	unprognostic (1.54e-2)	unprognostic (1.51e-1)	unprognostic (8.82e-2)	unprognostic (1.66e-4)	unprognostic (2.52e-2)	unprognostic (3.20e-1)		unprognostic (1.24e-1)	0.2	0.1	3.3	0	3.4	0	3.6	3.4	17.9	0.1	0.1	1.9	0	0	0.1	0.1	0.2	0.3	0.1	0.9	4.1	2.5	1.1	11.2	2.7	0.6	3	4	0.2	2.3	0.5	0.5	1.2	9.7	0.7	0	14.2	14.5	0	0.4	0.4	0.2	0	2.9	0.4	0.4	1.6	1.4	0	0.3	0	0.3	0.4	0.1	1.3	0.7	4.3	0.4	1.1	2.3	0.2	2	0.5	0.8	0.2	0	0	2.7	0	0	0	0	2.9	1.7	0.1	2.1	0.1	0	0.2	0.2	0.1	0.4	0.5	0.7	0	0.4	1.1	0	0.3	0.2	0	1.3	0.1	0.1	1.2	0.1	0.4	3.4	1.4	0	2	0.3	0.1	13.3	1.5	0.1	0.1	0.2	9.2	0	2	1.8	2.3	0	0.2	0.2	14.2	2.6	0.7	0	0	1.4	0.6	0.3	19.8	8	0.1	0.2	0.2	0.1	0.6	0.4	0.3	1.4	0.3	2.3	1.3	2.2	1.5	0.1	1	2.1	1.6	4.3	1.1	0.1	0.7	1.8	0.2	3.3	3.4	3.4	5	4.1	2.5	3	4	9.7	1.4	32.8	1.9	0	0	0	0	0.4	0	2.7	0	1.8	0	0.1	0	0	3.5	0	0	0	0	0.4	0.3	0	0	0.4	0.1	0	0	0	0	2.9	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0.3	0.9	0	0.1	0	0	0	Alveolar cells type 1
APOB		ENSG00000084674	Apolipoprotein B	P04114	2	21001429-21044073	Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins	Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport	Heparin-binding	Atherosclerosis, Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	145	intestine: 224.8;liver: 442.2	Cell type enriched	Detected in some	10	Hepatocytes: 2874.2	Cancer enriched	Detected in some	99	liver cancer: 295.0	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	30	Hep G2: 155.4	Not detected	Not detected			Not detected	Not detected			CAB016070, HPA049793	Supported		Supported	Vesicles,Cytosol	Secreted to blood			1490000000000	89000000000	Vesicles, Cytosol		CAB016070: AB_626690, HPA049793: AB_2680885	unprognostic (1.63e-2)	unprognostic (2.71e-2)	unprognostic (1.75e-1)	unprognostic (1.06e-1)	unprognostic (1.04e-2)	unprognostic (7.31e-2)	unprognostic (1.46e-2)	unprognostic (6.53e-3)	unprognostic (4.43e-2)	unprognostic (8.89e-3)	unprognostic (3.01e-1)	unprognostic (4.59e-3)	unprognostic (3.60e-3)	unprognostic (2.89e-2)	unprognostic (2.38e-1)	unprognostic (2.99e-1)	unprognostic (6.23e-2)	0.3	0.1	0.1	0	0.1	0	2.3	0.1	0.1	0.1	68.9	0	0	24.9	0.1	0	0.1	0.1	0	1.2	0.1	0.1	0.1	442.2	0.1	0	0.1	0	0.1	0.1	0	0.1	0	0	0.1	0	0	0.1	0	0.1	0.2	224.8	0	0.1	0.2	0.1	0.1	0	0	0.1	0	0	0.1	0.1	0.4	0.3	0.9	0.2	0.3	0.3	0	0	0	0	0	0.1	0	0	0	0	0	0	5.1	0	0	0	0	0	0	0	0	0	0	0	0	0	155.4	0	0	0	0.1	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0.2	0	0.2	0.2	0	0.2	0.2	0.1	0	0.4	0.2	0.1	0.9	0.3	0	0.3	0.3	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0	7	0	0	0	14.6	293	0	0	0	0	0	0	0	1	0	0	46.7	0	0	0	0	0	2874.2	0.1	0	0	51.5	53.3	0.7	0	0	0	0	0	0	0	0	1.4	0	0	0	0	0.5	0.2	0	0	0	0	0	Hepatocytes
GCKR		ENSG00000084734	Glucokinase regulator		2	27496842-27523684	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level				Tissue enriched	Detected in some	16	liver: 60.9	Cell type enriched	Detected in some	7	Hepatocytes: 76.9	Cancer enriched	Detected in some	8	liver cancer: 14.9	Not detected	Not detected			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		HEL: 12.7;Hep G2: 19.4;HUVEC TERT2: 6.2;TIME: 3.8	Not detected	Not detected			Low region specificity	Detected in all			CAB034098, HPA052227	Enhanced		Approved	Nucleoplasm,Cytosol						Nucleoplasm, Cytosol		CAB034098: AB_2247323, HPA052227: 	unprognostic (3.31e-1)	unprognostic (2.11e-3)	unprognostic (2.27e-1)	unprognostic (6.97e-2)	unprognostic (1.68e-2)	unprognostic (5.70e-2)	unprognostic (2.31e-1)	unprognostic (1.70e-1)	unprognostic (1.52e-1)	unprognostic (4.12e-1)	unprognostic (2.25e-3)	unprognostic (1.65e-1)	unprognostic (1.02e-7)	unprognostic (6.51e-2)	unprognostic (1.18e-1)	unprognostic (9.27e-3)	unprognostic (1.50e-2)	0.2	2	0.1	0.1	0.3	0.2	0.1	0.2	0.2	0.1	0.4	0.1	0.1	0.2	0.1	0.3	0.4	0	3.9	0.5	0.1	0	0.2	60.9	0.1	0.1	0.1	0.1	2	0.9	0.1	0.1	0.1	0.2	0.1	0	0.1	0.1	0.1	0.1	0.2	1.3	0.1	0.1	0.5	3.1	0.9	0.2	0.1	0.1	0.1	0.2	0.1	0.1	2.4	0.8	2.6	1.2	1.7	0.9	0.7	0.2	0.4	0.4	0.2	0.3	0.2	0.1	0	0.1	0.3	0	0.4	0.1	0.2	0.5	0.7	0.2	0.2	0.2	0	0	0.1	0	12.7	0.5	19.4	0.8	0.1	0.4	0.3	1	0.5	0.1	2.2	6.2	0	0	0.2	0.2	0.1	0.1	0.7	0.1	0	0	0.3	0	0.1	0.2	0.2	0	0.1	0.1	0.2	0.1	0.1	0.5	0.1	3.8	0.1	0.3	0.6	0.2	0.4	0.1	0.2	1.2	0.1	0.2	2.6	1.2	0.3	0.6	1	0.6	0.8	0.4	0.4	0.1	2.4	0.9	0.8	2.1	1.7	0.3	0.8	0.1	0.7	0.1	0.3	0.2	0.1	0.1	0	0.1	0.1	0.2	0.2	0	0	0	0	0.1	0	0.3	5.1	0	0	0	0	0	0	7.6	6.3	0.4	0	0	9	0	0	0.3	0	76.9	0.1	0	0	1.3	1.9	2.8	0.3	0	0	0	0	0	10.7	0	0	0	0	0	0.2	0.1	0.1	0	0	0	0	0	Hepatocytes
BCORL1	CXorf10, FLJ11362	ENSG00000085185	BCL6 corepressor like 1	Q5H9F3	X	129981107-130058083	Cancer-related genes, Predicted intracellular proteins	Transcription, Transcription regulation	Chromatin regulator, Repressor	Autism spectrum disorder, Cancer-related genes, Disease mutation, Mental retardation	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	7	Syncytiotrophoblasts: 78.1	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		AN3-CA: 20.4;HAP1: 30.8	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA031775, HPA031777, HPA068568	Uncertain		Approved	Nucleoplasm,Plasma membrane						Nucleoplasm	Plasma membrane	HPA031775: AB_10602332, HPA031777: AB_10671578, HPA068568: AB_2686007	unprognostic (8.07e-2)	unprognostic (2.78e-2)	unprognostic (7.09e-2)	prognostic unfavorable (2.20e-5)	unprognostic (4.58e-1)	unprognostic (1.68e-3)	unprognostic (1.96e-3)	unprognostic (5.56e-3)	unprognostic (2.39e-1)	unprognostic (8.02e-2)	unprognostic (4.46e-2)	unprognostic (2.04e-1)	prognostic unfavorable (5.00e-4)	unprognostic (9.18e-2)	unprognostic (2.60e-2)	unprognostic (3.09e-1)	unprognostic (1.41e-2)	7.5	7.9	7.7	5.2	9.1	9.8	9.1	19.8	10.5	8.7	8.3	10.7	8.1	5.4	9.2	5.4	5.8	9.3	4.2	6.9	8.4	4.5	7.5	4.7	6.7	5.3	7.6	5.9	11.4	8.9	13.4	15	28.9	7.5	8.1	4.5	6	6.5	8.4	6	6.5	6	8.8	5.3	7.7	6.6	26.1	8.1	6.8	10.3	2.2	5.1	6.7	8.5	1.2	1.6	3.5	1.3	0.8	1.3	0.7	2.2	5.5	12.9	20.4	7.6	5.5	3.6	3	3.5	3.9	4.5	6.6	1.4	1	6.7	6	3.7	1.3	30.8	1.2	3.7	2.2	4.5	10.6	2.7	2.2	3.8	2.6	3.1	3.4	2.5	7.7	0.4	5.8	4.7	3.5	5.1	10.8	2.5	1.3	3.9	8	3.5	1.8	3.9	8.3	5.2	1.4	2.2	0.3	2.1	7.3	1.6	0.4	2	7.2	4.5	4	3.9	3.2	4.1	3.8	2.9	3.5	6.3	1.6	2.1	5.4	1.5	0.1	1.3	2.8	1.3	0.2	1	1.2	0.9	0.8	1.6	1	0.6	0.7	3.5	0.8	0.5	0.7	0.2	0.7	7.7	9.1	19.8	10.5	8.4	4.5	7.6	5.9	7.5	8.1	0	3.2	0	2.3	10.5	1.8	6.4	5.1	2.7	1.2	7	0	10.7	0	3.2	0.4	7.1	2.7	0	0.9	4.2	5.8	2.9	6.9	3	2.8	7.9	11.5	3.1	2.6	1	4.4	1.8	6.8	1	1.7	3.1	2.3	0	3.5	2.2	1	6.5	4.5	3.5	5.3	10	78.1	1.5	2.8	2.5	Syncytiotrophoblasts
FCN1	FCNM	ENSG00000085265	Ficolin 1	O00602	9	134905890-134917963	Plasma proteins, Predicted membrane proteins, Predicted secreted proteins	Immunity, Innate immunity			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	5	blood: 318.5;bone marrow: 135.4	Cell type enriched	Detected in many	9	Kupffer cells: 627.5	Low cancer specificity	Detected in many			Low region specificity	Detected in some			Cell type enhanced	Detected in many		classical monocyte: 318.5;intermediate monocyte: 218.1	Lineage enhanced	Detected in many		monocytes: 318.5	Group enriched	Detected in some	7	NB-4: 15.7;U-937: 23.4									HPA000685, HPA001295, CAB016760	Enhanced				Secreted to blood			1060000000	63000000			CAB016760: , HPA000685: AB_1078840, HPA001295: AB_1078842	unprognostic (1.57e-2)	unprognostic (2.23e-1)	unprognostic (1.14e-3)	unprognostic (1.34e-1)	unprognostic (9.91e-2)	unprognostic (1.62e-3)	unprognostic (3.66e-3)	unprognostic (2.21e-1)	unprognostic (1.14e-1)	unprognostic (5.59e-2)	unprognostic (2.49e-1)	unprognostic (2.31e-1)	prognostic unfavorable (3.98e-4)	unprognostic (1.73e-2)	unprognostic (5.58e-2)	unprognostic (3.27e-2)	unprognostic (2.28e-1)	6.6	0.9	0.6	35.2	0.7	135.4	2.2	0.4	1	1.8	2	0.4	0	0.1	1.6	7.8	1	3.6	2.9	7.6	0.5	0.6	2.3	4.6	24.9	23.5	2.3	0.1	3.5	1.6	0	0.7	9.2	0.9	1.6	1	3	1.7	0.3	2.7	0.7	1.3	8.1	1.2	47.3	2.2	1	0.5	6.8	1.6	1.1	3.6	8.5	1.6	0.8	93.9	53.7	318.5	0.4	0.6	273	0	0.1	0.1	0	0.1	0	0.1	0	0	0	0	0.2	0.1	2.6	0	0	0	0	0	0	0	0.1	0	0	0.1	0.2	0	0.2	0.1	0	0	0	0	0	0	0	0.1	0.1	0	0	0	15.7	0.1	0	0	0.1	0.1	0.1	0	0	0	0	0	0.1	0.1	0	0	0	0.1	0.2	0.1	1	0	0.1	0	0.2	0	23.4	0	1.2	318.5	3	0.5	218.1	0.6	0.8	0.2	0.3	93.9	0.2	0.3	0.3	53.7	0.4	99	2.5	0.3	273	0.6	0.7	0.4	1	0.5	0.6	2.3	0.1	0.9	0.5	6	27.5	10.5	0.2	1.6	0	2.4	0	1.4	9.1	1.8	0	0.6	0	0	0	0.1	0	0	0	1.5	1.1	0.2	11.6	1.3	71.4	0	0	3.1	627.5	0	0	63	0	0	0	0	0	0	0	1.8	0	0	0	0	0	0.4	0.9	0.5	0	0.1	Kupffer cells
HBQ1	HBQ	ENSG00000086506	Hemoglobin subunit theta 1	P09105	16	180453-181181	Predicted intracellular proteins	Oxygen transport, Transport			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	5	blood: 8.0;bone marrow: 29.4;brain: 12.2;vagina: 10.7	Cell type enriched	Detected in some	8	Erythroid cells: 303.7	Low cancer specificity	Detected in some			Low region specificity	Detected in many			Low cell type specificity	Detected in some			Group enriched	Detected in many	6	granulocytes: 2.5;T-cells: 2.3	Group enriched	Detected in some	7	HEL: 13.4;Hep G2: 9.4;K-562: 33.1					Low region specificity	Detected in all			HPA062473	Enhanced		Approved	Lipid droplets					47000	Lipid droplets		HPA062473: AB_2684774		unprognostic (4.24e-1)	unprognostic (3.38e-1)	unprognostic (2.11e-2)	unprognostic (2.20e-2)	unprognostic (1.30e-1)		unprognostic (1.28e-1)	unprognostic (1.48e-1)	unprognostic (1.75e-2)	unprognostic (2.33e-1)	unprognostic (8.92e-2)	unprognostic (2.02e-3)	unprognostic (8.24e-2)	unprognostic (1.68e-1)	unprognostic (1.02e-1)	unprognostic (5.55e-1)	0.5	0.6	12.2	0.5	10	29.4	0.5	0.6	6.3	0.5	0.5	0.2	0	0.6	0.5	0.5	0.5	0.5	0.5	0.9	5.6	4	0.5	0.5	2.1	0.5	2.2	3.7	0.6	0.5	0.5	0.5	2.6	2.4	0.6	0.5	0	0.8	0.5	0.9	0.5	0.5	0.5	0.7	2.8	0.5	1.3	0.3	0	0.5	0	0.5	0.6	10.7	0.4	0.2	2.5	0	0	2.3	8	0	0.8	0.2	2.5	0	0	0.4	0.1	0	0	0.1	2.3	0	0	0.3	0	0	0.1	0.9	0	0	0	0	13.4	0.5	9.4	0	0.1	0	0.3	0	0	0	0	0.1	0.8	33.1	0	0	0.1	1.4	0	1.8	0	0.1	0.1	0	0.2	0.5	0	0.3	1.8	0	0	0.3	0	0	0.5	0.2	0	0	0	0	0.1	0	0.3	0	0	0	0	0	0	2.1	0	2.3	0.4	0.7	1.6	0.1	0	0.5	1.2	2.5	0	0	0.2	0	8	12.2	10	0.6	6.3	5.6	4	2.2	3.7	2.4	0.3	0	0	0	0	0.1	0	0.3	0	0	0	0	0	0	0	0	0.9	0	0	303.7	0	1.7	0	0	0	0	0.4	0	0	0	0.3	2.5	0.3	0	3.3	0	0	0	0	0	0	0.2	0	0	0.1	3.8	40.3	0.1	0.2	0	0	0	Erythroid cells
NOX4	KOX, KOX-1	ENSG00000086991	NADPH oxidase 4	Q9NPH5	11	89324356-89498187	Predicted membrane proteins, Transporters		Oxidoreductase		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in many	9	kidney: 65.2	Cell type enriched	Detected in some	6	Proximal tubular cells: 119.8	Low cancer specificity	Detected in many			Low region specificity	Detected in single			Low cell type specificity	Detected in some			Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		hTERT-RPE1: 8.5;HUVEC TERT2: 15.6;TIME: 34.8	Not detected	Not detected			Low region specificity	Detected in many			HPA015475			Approved	Nucleoplasm						Nucleoplasm		HPA015475: AB_1854574	unprognostic (2.91e-2)	unprognostic (1.08e-1)	unprognostic (1.74e-3)	unprognostic (6.58e-3)	unprognostic (1.92e-1)	unprognostic (2.33e-1)	unprognostic (8.83e-3)	unprognostic (8.95e-3)	unprognostic (3.80e-1)	unprognostic (6.88e-2)	unprognostic (1.56e-2)	unprognostic (1.73e-1)	prognostic favorable (6.14e-4)	unprognostic (1.99e-4)	unprognostic (9.71e-2)	unprognostic (5.69e-2)	unprognostic (3.03e-3)	7.5	0.6	0.2	0.6	0.6	0.3	6.5	0.3	0.5	1.2	0.9	1.1	0.4	0.3	7.3	2.5	1.5	0.8	1.3	6.9	0.6	0.2	65.2	0.3	1.2	0.3	0.3	0.2	0.7	1.1	3.8	0.8	1.7	1	2.6	0.4	0.8	2.6	0.9	5.1	1.1	0.5	3.5	1.2	0.4	0.4	1	0	0	1.7	1.7	0.4	2.1	1.1	0.4	0.3	1.7	0.3	0.8	0.3	0	0	0	1.1	0	0	0	0	1.8	0.1	0.3	0.1	0	0	0	0	0	0	0	0	0.1	0.1	0	0	0	0.2	0	0.1	0	0	0.4	0	0	0	8.5	15.6	0	0	0.1	0	0	0	0	3.7	0	0	0	0	0	1.1	0	0	3.1	0	0	0.2	4.3	0.3	0	34.8	0.1	2.7	0	2.4	0	0	0	0	0	0	1.6	0.3	0.4	0.3	0.2	0.3	0.2	0.3	0.2	0	0.4	0.3	0.3	1.7	0.8	0.2	0.3	0.2	0	0.2	0.6	0.3	0.5	0.6	0.2	0.3	0.2	1	0	0	0	0	0	0.6	4.1	1.1	0	0	0	10.4	5.9	1.2	13.3	0	0.8	1.1	0	0	0	0.6	1.1	0.1	0	0	0.2	0	0	3.7	0	0.4	0.3	0	0	0	0	3.7	0.1	0	1.1	119.8	19.3	0	0.3	0.5	0.1	0.3	2.1	0	0	0	Proximal tubular cells
SLC4A11	BTR1, CDPD1, CHED2, dJ794I6.2, FECD4, NaBC1	ENSG00000088836	Solute carrier family 4 member 11	Q8NBS3	20	3227417-3239559	Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters	Anion exchange, Ion transport, Symport, Transport		Corneal dystrophy, Deafness, Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		salivary gland: 34.4;thyroid gland: 42.7	Cell type enriched	Detected in some	4	Collecting duct cells: 106.4	Low cancer specificity	Detected in all			Low region specificity	Detected in many			Cell type enhanced	Detected in some		non-classical monocyte: 1.4;T-reg: 1.1	Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		HaCaT: 36.0;Hep G2: 21.0	Low region specificity	Detected in single			Low region specificity	Detected in single			HPA018120, HPA058377	Uncertain		Uncertain	Nucleoplasm,Vesicles						Nucleoplasm	Vesicles	HPA018120: AB_1857186, HPA058377: 	unprognostic (2.33e-1)	prognostic favorable (9.03e-4)	unprognostic (1.18e-2)	unprognostic (3.05e-2)	unprognostic (1.00e-1)	unprognostic (6.52e-2)	unprognostic (9.66e-3)	unprognostic (3.73e-2)	unprognostic (3.10e-3)	unprognostic (1.52e-3)	unprognostic (2.94e-1)	unprognostic (2.64e-1)	prognostic favorable (6.21e-6)	unprognostic (7.37e-2)	unprognostic (4.30e-1)	unprognostic (2.33e-1)	unprognostic (6.89e-3)	0.8	3.1	3.3	0.8	4.9	0.3	2.4	2.1	2.8	8.6	0.2	1.3	0.8	0.1	0.9	2	7.5	1.1	2.2	0.5	3	0.6	11.4	0.1	1.3	0.9	1.4	1.1	0.6	0.1	0.4	2.4	0.3	1.8	2.2	0.3	1.1	34.4	5.8	3.5	5.3	0.3	0.2	1.4	0.3	1.9	3.2	1.2	0.2	42.7	3.3	5.1	2.6	2.1	0	0.7	0	1.4	0	1.1	0.4	5.4	7.8	0.9	4.1	2.7	0.7	11.1	2.7	1.7	1.4	0.8	0.5	7.2	0	3.2	0.9	3.4	36	4.2	8.5	0.2	0	1.7	0.3	3.4	21	1.7	1.9	7	0.3	3.5	1.7	1.6	1.2	3.6	5	0.7	5	1.4	3.5	0.2	0.2	6.2	6.7	10.6	1.2	5.3	1.7	8.7	15.3	0.4	2.5	1.4	9	0.2	2.9	3.4	3.4	6.1	1.1	3.7	0.2	1.3	0.2	0.3	0	0	1.3	0.5	0	0	0	0	0	0.1	0	0	0.5	0.7	0	0.3	0	0	0	1.4	0	1.1	0.4	3.3	4.9	2.1	2.8	3	0.6	1.4	1.1	1.8	1.2	0	0	0	1.7	0.7	0.1	1.2	0	5.3	2.3	106.4	0	0	0	0.7	3.5	0.3	0	0	0.4	0.1	0.3	2	0	0	0.3	0	0	1.8	0.3	1.5	0	0	0	1	0.1	0	2.2	0.6	0.4	0.3	0	25.8	0.5	0.6	5.2	0.4	0	0	0	2.6	Collecting duct cells
C20orf194	DKFZp434N061	ENSG00000088854	Chromosome 20 open reading frame 194	Q5TEA3	20	3249305-3407625	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	6	Cone photoreceptor cells: 190.5	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Low cell line specificity	Detected in many			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA052103, HPA067418	Approved		Approved	Nucleoli fibrillar center,Cytosol		No	No			Nucleoli fibrillar center, Cytosol		HPA052103: AB_2681727, HPA067418: AB_2685835	unprognostic (9.77e-2)	unprognostic (8.39e-2)	unprognostic (5.03e-3)	unprognostic (1.83e-1)	unprognostic (1.18e-1)	unprognostic (4.26e-2)	unprognostic (1.66e-2)	unprognostic (7.64e-2)	unprognostic (6.41e-2)	unprognostic (1.68e-1)	prognostic favorable (1.68e-4)	unprognostic (2.97e-1)	prognostic favorable (7.68e-4)	unprognostic (9.58e-3)	unprognostic (3.70e-1)	unprognostic (2.00e-1)	unprognostic (7.52e-2)	15.2	13.4	18.5	6.9	20.1	4.6	11.9	20.3	21.9	12.6	11.8	25.3	7.3	5.8	12.5	9.7	11.7	12.8	11.3	19.4	16.3	17.2	14.2	3.7	13.3	5.7	16.5	20.3	17.2	7.5	8.5	10.4	12.2	17.4	12.2	6.4	10.9	6	16.5	36.8	7.5	6	17.2	23	9.5	9.1	13.5	16.9	4.6	13.2	4	4.3	12.2	11	1.6	3.5	1	3	0	1.7	0.7	2.9	2.7	7.4	3.6	15.5	17.2	0.8	7	7.8	4.6	5.9	0	3.2	0	1.9	9.2	5.9	3.5	2.8	6.8	6.4	0.6	1.4	0.8	1	7.3	7.3	0.9	0.4	13.9	5.3	6.1	5.3	6.6	9.2	2.6	1.4	0	6.7	1.3	1.8	4.8	2.2	1.6	1.8	2.1	6.8	0	6	6.1	1.5	4.4	3.1	5.5	9	6.7	5.2	8.4	10.2	5.8	2.6	3.6	3.3	0	0	0	1.8	0.8	4.4	1	3	0	1.7	1.5	1	1	1.3	1.7	3.1	1.6	0.5	1.3	0	0	1.4	3.5	1.4	0.7	18.5	20.1	20.3	21.9	16.3	17.2	16.5	20.3	17.4	16.9	26.8	8.6	2.2	6	6.2	33	22.9	7.6	17.4	9.1	12.2	190.5	1.3	1.7	6.4	22.4	15.5	0.3	0	4	4.9	11.6	4.8	13.9	2.1	16.8	28.6	0	26.4	28.8	5.8	18.4	17.8	8.5	7.2	0	11.7	8	2.6	12.7	5.7	14.2	12.9	14.7	18.2	20	5	1.5	4.5	0	4.3	Cone photoreceptor cells
CHGB	SCG1, SgI	ENSG00000089199	Chromogranin B	P05060	20	5911430-5925361	Plasma proteins, Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		adrenal gland: 424.9;pituitary gland: 177.5	Cell type enriched	Detected in many	11	Intestinal endocrine cells: 997.5	Cancer enriched	Detected in many	6	pancreatic cancer: 154.2	Low region specificity	Detected in many			Cell type enhanced	Detected in some		memory CD4 T-cell: 2.6;T-reg: 1.1	Lineage enhanced	Detected in single		T-cells: 2.6	Group enriched	Detected in some	23	SCLC-21H: 66.7;SH-SY5Y: 102.1	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA008759, CAB009403, HPA012602	Enhanced	Supported	Enhanced	Vesicles	Intracellular and membrane				24000000	Vesicles		CAB009403: AB_2081255, HPA008759: AB_1846704, HPA012602: AB_1846706	unprognostic (1.79e-3)	unprognostic (7.72e-2)	unprognostic (3.48e-1)	unprognostic (2.90e-2)	unprognostic (1.68e-2)	prognostic unfavorable (1.89e-4)	unprognostic (7.96e-3)	unprognostic (2.86e-1)	unprognostic (6.18e-3)	unprognostic (7.93e-2)	prognostic favorable (9.96e-4)	unprognostic (8.56e-2)	unprognostic (8.21e-2)	unprognostic (1.56e-1)	unprognostic (2.81e-2)	unprognostic (2.73e-1)	unprognostic (1.01e-2)	3.4	424.9	8.2	1.4	10.2	0.8	1	82.5	16.4	0.8	3	2.1	1.2	7.7	0.9	1.3	0.8	2.5	0.8	7.6	20.7	15.4	1.7	0.7	1	1.1	7.2	9.1	3	17	0.8	177.5	0.8	51.8	5.6	2.5	0.7	0.9	1.2	2.1	0.9	4.4	0.9	2.3	0.8	19.7	2.4	0.8	0	1.9	0.4	0.9	0.8	0.1	0	0.6	0	0	0	2.6	0.2	0	1.4	0.1	0	0	0	0	0	0	0	0	0.3	0	0	0.8	0	0.9	0	0	0	0	0.1	0	0.4	0	0.2	0	0.7	0	0.3	0	0	0.4	0	0	0	0	0	0.1	0	0	0.1	3.6	0.2	0	0	0	0	0.1	0	66.7	102.1	0	0.1	0	0.4	0	0	0	0	1.1	0	0.6	0	0.1	0.4	0.1	0.5	0.1	0	0	0	0	0	0	0	2.6	0	0.6	0	0.2	0	0	0	0	0	1.1	0.2	8.2	10.2	82.5	16.4	20.7	15.4	7.2	9.1	51.8	0.8	3	3.7	0	8.2	3.8	86.9	51.2	0	8.1	1.2	66.3	19.6	0	1.7	0.4	6.1	3.4	1.7	0	0.3	0	2.3	2.3	0	0	0.1	71.5	997.5	0	0.3	6	0.9	1.5	6.8	1.8	2.8	9.3	37.4	5.8	0.4	0.1	49.6	12.9	1.4	50.2	27.7	3.1	0.2	0	1.4	3	Intestinal endocrine cells
TBX5	HOS	ENSG00000089225	T-box 5	Q99593	12	114353931-114408442	Disease related genes, Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	Developmental protein, DNA-binding	Atrial fibrillation, Cardiomyopathy, Disease mutation	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		heart muscle: 44.5;lung: 14.0;placenta: 19.7	Cell type enriched	Detected in some	11	Cardiomyocytes: 62.0	Low cancer specificity	Detected in some			Region enhanced	Detected in single		hippocampal formation: 2.2	Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		BJ: 13.1;BJ hTERT+: 29.2;BJ hTERT+ SV40 Large T+: 6.8;BJ hTERT+ SV40 Large T+ RasG12V: 8.3;HAP1: 11.5	Not detected	Not detected			Not detected	Not detected			HPA008786, HPA064683	Uncertain		Approved	Nucleoplasm						Nucleoplasm		HPA008786: AB_10601720, HPA064683: AB_2685320	unprognostic (3.09e-2)	unprognostic (1.53e-1)			unprognostic (3.79e-2)	unprognostic (2.75e-1)		unprognostic (1.62e-1)	unprognostic (1.42e-1)	unprognostic (1.66e-1)	unprognostic (1.09e-1)	unprognostic (8.67e-2)	unprognostic (3.36e-7)	unprognostic (2.29e-2)	unprognostic (1.68e-2)	unprognostic (7.34e-2)	unprognostic (4.38e-3)	2.2	0.1	0.1	0	0.1	0	3.8	0.8	0.2	0.2	0.1	0.1	0	0	0.1	0.1	6.4	0.1	0	44.5	2.2	0.1	0.1	0.1	14	1.6	0.1	0.1	0.1	0.1	0	0.1	19.7	0.5	5.4	0	1.4	0.1	0	0.1	0.5	0.1	6.6	0.2	0.1	0.1	0.1	0	0	1	0	0	6.5	1.3	0	0	0	0	0.1	0.1	0	0	0	0	0	0	0.1	0	13.1	29.2	6.8	8.3	0	0	0	0	0.7	0	0	11.5	0	3.9	0	0	0	0	0	0.2	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0.1	0	0	0	0	0.1	0.1	0.8	0.2	2.2	0.1	0.1	0.1	0.5	0	0	1.1	0	0	0.1	3.6	62	0	0	0	0	0	0.1	0	0	1.3	0	0	0	0	0	4.7	0	0	0	0.2	1.6	0	0	0	0	0	0	0	0	0	5.8	0	0	0	0	0.3	0	0.1	0	0	0.1	0.1	0	0	0	Cardiomyocytes
ANKRD24	KIAA1981	ENSG00000089847	Ankyrin repeat domain 24	Q8TF21	19	4183354-4224814	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 22.1	Cell type enriched	Detected in some	4	Extravillous trophoblasts: 17.7	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Cell type enriched	Detected in single	9	memory B-cell: 1.3	Lineage enriched	Detected in single	9	B-cells: 1.3	Cell line enhanced	Detected in some		Karpas-707: 5.6;U-266/70: 18.9	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA041534, HPA048498	Uncertain		Uncertain	Microtubules,Cytosol						Microtubules, Cytosol		HPA041534: AB_2677537, HPA048498: AB_2680420	unprognostic (3.70e-2)	unprognostic (3.96e-3)	unprognostic (5.23e-9)	unprognostic (7.03e-2)	unprognostic (5.01e-2)	unprognostic (2.31e-1)	prognostic favorable (9.13e-5)	unprognostic (1.53e-1)	unprognostic (3.52e-2)	unprognostic (3.41e-2)	unprognostic (1.19e-3)	unprognostic (2.63e-2)	unprognostic (1.27e-2)	unprognostic (7.63e-2)	unprognostic (1.61e-1)	unprognostic (2.43e-2)	unprognostic (1.73e-4)	1.4	2.1	6	0.8	8.5	1.1	1.2	1.4	22.1	1	1.1	0.8	0.1	1.9	1	2.1	0.5	1.4	1.3	0.6	5.1	4.4	1.8	5.5	1.1	1	4.1	9.4	1.4	3.3	2.4	3.8	1.9	2.3	4.3	0.9	1	1.7	1.7	2.5	1.1	1.5	0.7	2.3	1.5	1.6	7.3	1.8	0.1	1.9	0.1	0.6	0.6	0.1	1.3	0	0	0	0	0.1	0	0.1	0.2	0	0.1	3.2	0.3	3.4	0.2	0.1	0	0	0.1	0.1	0.1	2	0.4	0.2	0.2	0.1	0.5	0	2.4	0.3	0.1	0.1	0.1	1.8	0.1	0.3	1.8	0.1	0.3	0.8	0.5	0.1	2	0.1	5.6	0	0.7	0	0.1	2.5	0.7	0.7	0.4	0	0.4	0	0.2	0.9	0.2	0.1	0.1	0.3	0.6	0.7	0.4	0	0.1	1.2	0.9	0	18.9	1.6	0.1	0.8	0.7	0.1	0	0	0	0	0	0	1.3	0	0	0	0	0	0	0	0	0	0	0.1	0	6	8.5	1.4	22.1	5.1	4.4	4.1	9.4	2.3	1.8	0	3.4	0	0.2	0	0.8	0.8	2.5	0	2.3	0	3.9	0.2	0	0.1	0.5	0	0.3	0	0	17.7	0	0.2	0	1	0.3	0	3.5	0	0.6	0.9	0	0	0	0	0.3	0.8	0	0	0	0.8	1.1	0	0	0.7	1.1	0	0.9	0	0.2	0	Extravillous trophoblasts
FETUB		ENSG00000090512	Fetuin B	Q9UGM5	3	186635969-186653141	Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Fertilization	Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	7	liver: 76.1	Cell type enriched	Detected in some	7	Hepatocytes: 37.1	Cancer enriched	Detected in some	12	liver cancer: 44.0	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HBEC3-KT: 1.5;Hep G2: 4.5;HSkMC: 1.0;NTERA-2: 1.7	Not detected	Not detected			Not detected	Not detected			HPA035132, HPA035133	Supported		Approved	Vesicles	Secreted to blood			47500000000	4500000000	Vesicles		HPA035132: AB_10601650, HPA035133: 		unprognostic (9.01e-2)		unprognostic (1.95e-1)	unprognostic (4.62e-1)	unprognostic (8.74e-2)	unprognostic (6.28e-3)	unprognostic (1.24e-2)	unprognostic (7.55e-2)	unprognostic (9.78e-2)	unprognostic (1.73e-2)			unprognostic (9.18e-2)	unprognostic (1.79e-1)	unprognostic (8.39e-2)		0	0	0	0	0	0	0	0	0.1	0.5	0	0.1	0	0	0.1	0.1	2.2	0	0	0	0	0	0	76.1	0	0	0.2	0	0	2.8	0	0	0	0	0	0	0	0.5	0	0	0.6	0	0	0	0	0	0.2	0.1	0.3	0	2.6	11.5	0	0.6	0	0	0	0	0	0.8	0	0	0.5	0	0	0	0	0	0.3	0	0	0	0	0	0.1	0.2	0	0	0	0	1.5	0.2	0	0	0	0	4.5	0	0.5	0	1	0.1	0	0.2	0	0	0.1	0.2	0	0.1	0	0	0	1.7	0	0	0.2	0.7	0.4	0.2	0	0.4	0.1	0.3	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0.2	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	3.3	0	5.5	0	0	0	0.2	0	0	0	0	37.1	0	0	0	1.3	2.4	4.2	0.3	0	0	0	0	0	0.1	1.5	0.4	0	0	0	0	0	0.1	0	0.1	0	0	0	Hepatocytes
RAB11FIP3	eferin, KIAA0665, Rab11-FIP3	ENSG00000090565	RAB11 family interacting protein 3	O75154	16	425619-523011	Cancer-related genes, Predicted intracellular proteins	Cell cycle, Cell division, Transport		Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		kidney: 70.5	Cell type enriched	Detected in many	14	Proximal tubular cells: 333.9	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Low cell line specificity	Detected in all							Low region specificity	Detected in all			HPA028088, HPA028631, HPA030086	Enhanced		Enhanced	Nucleoplasm,Vesicles,Cytokinetic bridge,Centriolar satellite,Mitochondria		Yes	No			Vesicles, Centriolar satellite	Nucleoplasm, Cytokinetic bridge, Mitochondria	HPA028088: AB_10601672, HPA028631: AB_10601853, HPA030086: AB_10669596	unprognostic (6.65e-2)	unprognostic (1.84e-2)	unprognostic (1.51e-1)	prognostic favorable (1.22e-4)	unprognostic (2.87e-2)	unprognostic (1.85e-1)	prognostic unfavorable (9.87e-5)	unprognostic (6.71e-2)	unprognostic (4.74e-1)	unprognostic (9.66e-2)	prognostic favorable (3.16e-5)	unprognostic (1.12e-1)	prognostic favorable (7.99e-4)	unprognostic (1.39e-1)	unprognostic (1.77e-1)	unprognostic (1.58e-1)	unprognostic (1.44e-1)	10.2	13.4	19.3	7.5	16.9	8.7	7.3	29.7	27.4	11.5	10.6	12.2	9	13.4	11.9	11	8.2	9.5	11.3	14	18.7	12.1	70.5	12.2	10.5	8.1	12	18	13.4	22.2	22.4	14.6	10	10.6	11.5	5.4	9.9	13.2	12.6	23.5	12.2	14.6	10.8	8.9	10.2	7.6	13.5	11.9	5.7	8.6	7.4	5.3	9.7	16.6	1.1	0.8	0.1	0.1	0.1	1.5	0.6	4.4	10.2	9.8	8.6	14.5	9.5	8.5	8.5	8	7.8	5.6	7.5	2.1	12.3	10	12.4	6.9	4.6	6.1	9	2.7	9.1	8.7	5.5	9.5	21.7	15.5	5.5	6.9	9.1	6.2	8	7	9.1	11.9	8.5	2.8	4.9	9.8	13.7	8.9	10.9	8.2	3.2	4.2	18.5	7.8	3.2	7.8	2.7	10.2	9.5	8.7	10.7	5.4	3.5	5.9	10.2	19.2	11.4	7.6	10.6	5.6	6.8	5.3	14.5	4.3	3.9	8.4	0	0.1	0	1.5	0	1.3	0.8	0.9	0.7	0.5	1.1	0.6	0.3	0.1	0.1	0	0.8	0	0.6	19.3	16.9	29.7	27.4	18.7	12.1	12	18	10.6	11.9	3	1.7	3.4	0.4	3.3	8.2	11.7	7.6	4	6.8	5.2	5.9	0.8	23.2	1.4	1	2.5	6.4	0	1	0.1	2.3	1.1	1.1	14.1	0.7	20.6	2.9	19.6	5.1	1.6	0.6	1.2	0	0	2.7	6.1	1.6	1.7	1.8	333.9	7.1	6.5	2.1	2.7	3	1.9	0.7	2.6	4.1	0.3	Proximal tubular cells
KIF4A	FLJ12530, FLJ12655, FLJ14204, FLJ20631, HSA271784, KIF4, KIF4-G1, MRX100	ENSG00000090889	Kinesin family member 4A	O95239	X	70290090-70420832	Predicted intracellular proteins		DNA-binding, Motor protein	Mental retardation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		bone marrow: 11.1;lymphoid tissue: 19.3	Cell type enriched	Detected in some	5	Erythroid cells: 46.7	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Cell type enhanced	Detected in some		T-reg: 3.2	Lineage enriched	Detected in single	5	T-cells: 3.2	Low cell line specificity	Detected in many											HPA034745, HPA034746, HPA061583	Approved		Supported	Nucleoplasm,Midbody		Yes	Yes			Nucleoplasm, Midbody		HPA034745: AB_10670978, HPA034746: AB_10670173, HPA061583: AB_2684564	unprognostic (8.17e-3)	unprognostic (2.78e-2)	unprognostic (1.02e-2)	unprognostic (3.46e-3)	unprognostic (3.20e-1)	unprognostic (1.64e-1)	prognostic unfavorable (7.37e-6)	unprognostic (2.18e-3)	unprognostic (5.06e-3)	unprognostic (1.34e-1)	prognostic unfavorable (9.44e-6)	unprognostic (3.79e-2)	unprognostic (0.00e+0)	unprognostic (3.09e-2)	unprognostic (1.10e-1)	unprognostic (1.09e-1)	unprognostic (1.47e-1)	0.9	0.6	0.8	3.3	1	11.1	0.5	0.4	3.4	1.2	4.1	0.4	0.4	3.4	0.8	0.4	7.4	1.5	2.5	2	0.8	1.3	0.7	0.7	1.5	5.8	0.5	0.9	0.4	0.4	0	1.3	2.4	0.8	0.7	5.2	0.4	1.2	0.4	0.8	2.3	3.6	1.2	0.5	4.9	2.1	7.5	1.1	19.3	0.4	0.4	7.2	1.1	2	0.7	0	0	0.2	0.2	3.2	0.3	22.5	15.8	23.9	11.7	1.1	2	9.4	17.2	9.2	23.5	20.5	17.7	13.3	13.9	10.8	8.4	18.2	13.6	25.8	9.3	26.6	15.9	13	15.7	19.3	12.5	0.2	17.4	10.9	0.7	0.5	19.5	11.2	2.8	14.3	10.7	19.9	30.9	22.1	14.5	15.9	8.6	24.1	24.1	16.8	17.7	32.3	13	5.6	8.9	15.8	13.2	28	11.9	7.3	12.6	9.5	6.8	9.9	15.6	20.3	16.7	20.4	8.9	15.3	20.1	8.2	19.1	23.4	0	0	0	0	0	0.1	0.7	0.4	1.3	0	0	0.1	0	0	0.2	0.2	0	3.2	0.3	0.8	1	0.4	3.4	0.8	1.3	0.5	0.9	0.8	1.1	0	0.3	0	0.2	1.5	0	0.4	2.5	0	0	0	0	1.1	0	0	0.3	0.1	0.1	46.7	0	10.3	1	0.1	0	0	4.3	0	1.2	1.8	0.6	0.5	0	0.9	0	0	1.2	2.4	0.1	0	0	0	0	0	0.2	7.2	5.8	0.3	1.5	0.5	2.1	0.3	Erythroid cells
DLL3	SCDO1	ENSG00000090932	Delta like canonical Notch ligand 3	Q9NYJ7	19	39498895-39508481	Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins	Differentiation, Notch signaling pathway	Developmental protein	Disease mutation, Dwarfism	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	7	brain: 38.5	Cell type enriched	Detected in some	6	Spermatogonia: 37.2	Group enriched	Detected in many	11	glioma: 29.2;melanoma: 15.5;testis cancer: 8.0	Low region specificity	Detected in all			Cell type enhanced	Detected in some		memory B-cell: 5.4;naive CD8 T-cell: 3.3	Group enriched	Detected in many	13	B-cells: 5.4;T-cells: 3.3	Cell line enriched	Detected in some	5	SK-MEL-30: 42.1	Low region specificity	Detected in single			Not detected	Not detected			HPA056533			Approved	Nucleoplasm,Plasma membrane						Nucleoplasm, Plasma membrane		HPA056533: 	unprognostic (2.52e-1)	unprognostic (3.81e-1)	unprognostic (3.13e-2)	prognostic unfavorable (2.94e-4)	unprognostic (9.85e-2)	unprognostic (1.41e-2)	unprognostic (1.65e-3)	unprognostic (1.85e-1)	unprognostic (4.82e-2)	unprognostic (6.58e-2)	unprognostic (1.06e-2)	unprognostic (4.20e-2)	unprognostic (3.82e-4)	unprognostic (4.94e-2)	unprognostic (5.13e-2)	unprognostic (4.15e-2)	unprognostic (2.97e-1)	0.6	0.6	8.9	0.7	10.1	0.6	0.6	1.4	38.5	0.5	0.6	10.3	0	0.5	0.6	0.5	0.5	0.5	0.5	0.6	6.5	6.8	0.5	0.6	0.6	0.7	4.5	1.9	0.6	0.5	0.6	3.2	0.5	4.3	0.6	0.5	0	0.6	0.5	0.5	0.6	0.6	0.5	3.6	0.6	0.6	1.2	2.3	0	0.7	0	0.6	0.6	0	5.4	0.3	0	0	0	3.3	0.4	0	2	0.4	1	0	0	0.3	0.5	0	0.3	0.1	0.3	0.4	0	2	0	0.8	0	1.2	0.5	0.1	0.6	3.1	0.1	0	0.2	0.1	0.5	2.4	0	0	0	0	0.1	0	2.3	0.5	0	0.2	0	0.1	0	0.4	0	3.2	0.3	0.1	0.1	0.1	0.1	7.4	7.6	1.5	0	42.1	0.1	0	0.1	0	0	1.4	0.1	0.5	0.7	0	0.4	0	0.2	1.2	0	0	0	0.9	0	0.4	5.4	0.2	1.3	0.3	1.2	0.2	3.3	0	0	0	0	0	0.4	8.9	10.1	1.4	4.8	6.5	6.8	4.5	1.9	4.3	2.3	0	0	0	0.2	0.2	0.2	0.5	0	0	0	0	0	0.2	0	0.5	0.5	0	0	0	0.5	0.4	0	0.2	0	0	0.2	0	2.9	0	0	1.6	1.1	0	1.7	0	0	0.5	0.2	0	1.4	0	0.6	6.5	0	5.4	37.2	0.1	0.2	0	0	0	Spermatogonia
SLC26A3	CLD, DRA	ENSG00000091138	Solute carrier family 26 member 3	P40879	7	107765467-107803225	Cancer-related genes, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters	Antiport, Transport		Cancer-related genes, Disease mutation	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	5	gallbladder: 53.5;intestine: 110.1;lymphoid tissue: 42.8	Cell type enriched	Detected in some	11	Enterocytes: 543.6	Cancer enriched	Detected in many	14	colorectal cancer: 52.5	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		BEWO: 2.3;CACO-2: 1.9;NB-4: 1.5;RPMI-8226: 7.6	Low region specificity	Detected in single			Not detected	Not detected			HPA036055	Approved											HPA036055: AB_10602401	unprognostic (1.26e-2)	unprognostic (1.28e-1)	unprognostic (1.12e-2)	unprognostic (2.69e-1)	unprognostic (4.02e-1)	unprognostic (4.09e-2)	unprognostic (3.05e-3)	unprognostic (6.31e-2)	unprognostic (1.68e-2)	unprognostic (1.20e-1)	unprognostic (1.14e-1)	unprognostic (2.05e-2)	unprognostic (8.85e-2)	unprognostic (8.01e-2)	unprognostic (5.52e-2)	unprognostic (2.54e-2)	unprognostic (3.58e-3)	0.3	0.3	0.3	42.8	0.3	0	6.1	0.3	0.3	0.4	110.1	0.2	0.3	58.4	0.3	1.2	0.3	0.6	53.5	0.3	0.3	0.3	0.3	0.4	0.3	0.2	0.3	0.2	0.3	0.3	0	0.3	0.2	0.2	0.5	92.7	0.2	0.3	14.4	0.3	0.3	106.5	1.2	0.3	0.3	0.4	0.3	0.2	0.2	0.3	0.2	0.2	0.4	0.3	0	0	0	0	0	0.6	0	0	0	0	0	0	0	2.3	0	0	0	0	1.9	0	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.5	0.1	0	0	0	0	7.6	0	0	0.7	0.5	0	0	0	0	0	0	0	0	0.2	0.2	0.3	0.1	0.1	0.1	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0	0	0.2	0	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.2	0.2	0.2	0	0	0	0	0	0	0.2	48.4	0	0	0	0	0	0	0	1.1	0	543.6	0	0	0	0	0.2	27.5	0	0	0	13.7	0	0	0	0.3	0	0	0	26.7	0	0	40.8	0	0	0	0	0	0.1	0	0	0	0	20.4	0	Enterocytes
SMPX	DFN6, DFNX4	ENSG00000091482	Small muscle protein, X-linked	Q9UHP9	X	21705972-21758163	Disease related genes, Predicted intracellular proteins			Deafness, Non-syndromic deafness	Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	23	heart muscle: 108.8;skeletal muscle: 155.8;tongue: 74.5	Cell type enriched	Detected in single	2069	Cardiomyocytes: 810.3	Cancer enhanced	Detected in many		head and neck cancer: 7.2	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	5	GAMG: 22.6	Low region specificity	Detected in some			Low region specificity	Detected in some			HPA077360			Approved	Plasma membrane					45000	Plasma membrane		HPA077360: AB_2732342	unprognostic (7.29e-2)	unprognostic (1.78e-1)	unprognostic (2.63e-1)	unprognostic (1.28e-1)	unprognostic (1.45e-1)	prognostic unfavorable (3.04e-5)	unprognostic (1.39e-2)	unprognostic (7.46e-2)	unprognostic (5.27e-1)	unprognostic (1.96e-2)	unprognostic (3.97e-2)	unprognostic (3.58e-2)		unprognostic (2.67e-2)	unprognostic (2.82e-1)		unprognostic (8.38e-2)	1.4	0	0.1	0.6	0.1	0	0.2	0.6	0.9	0.1	4	0	0	0.1	0.1	4.7	4	0.1	0.1	108.8	0.1	0.2	0	0.2	0	0.1	0.7	0.3	0.2	0.1	0	0	0	0	1.6	0.5	0	3.6	0.1	155.8	0	0.9	1.8	0.1	0	1.5	0.1	0	0	1	74.5	4.9	1.1	0	0	0	0	0	0	0.1	0	0	0	0.1	0	0	0	0	0	0	0	0	1.5	0	0	0	0	22.6	0	0	0	0	0	0	0	0.1	4	0	0	0	4.3	0	0	0	0	0	0	0	2.9	0.2	0	0	0	0.4	3	0	0	0.7	0	0	0	0	0	0	0	0	1.1	0	0	0	0	0.2	0	0	4.4	1.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0.1	0.1	0.6	0.9	0.1	0.2	0.7	0.3	0	0	0	0	0	0	0	0	810.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0.2	0	0.2	0	0	0	Cardiomyocytes
APOH	B2G1, BG	ENSG00000091583	Apolipoprotein H	P02749	17	66212033-66256525	Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins		Heparin-binding		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	550	liver: 823.7	Cell type enriched	Detected in some	37	Hepatocytes: 7635.3	Cancer enriched	Detected in many	232	liver cancer: 2878.9	Not detected	Not detected			Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Cell line enriched	Detected in some	20	Hep G2: 166.9	Low region specificity	Detected in many			Not detected	Not detected			HPA001654, HPA003732, CAB022214	Enhanced		Supported	Golgi apparatus	Secreted to blood			247000000000	44000000000	Golgi apparatus		CAB022214: , HPA001654: AB_1078181, HPA003732: AB_1078183			unprognostic (2.11e-2)	unprognostic (1.87e-1)	unprognostic (1.28e-1)		prognostic favorable (2.39e-7)	unprognostic (1.26e-1)		unprognostic (5.99e-2)	unprognostic (2.88e-3)		prognostic unfavorable (1.10e-6)	unprognostic (1.26e-2)	unprognostic (5.76e-2)			0	0	0	0.1	0	0	0	0	0.1	0	0.1	0.1	0	0	0	0.2	0	0	0.1	0	0	0	1.1	823.7	0.3	0	0	0	0	0.7	0	0	0	0.1	0	0	0	0.1	0	0.1	0	0.1	0	0	0.3	0.1	0.1	0	0	0.1	0	0	0.1	0.1	1.4	0.7	0.9	1.3	1	1.3	0.2	0	4.5	0	0	0	0	0	0	0	0	0	8.2	0	0.1	0	0	0.2	0.1	0	0	0	0	0	0.3	0.1	166.9	0	0.8	0.1	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	4.2	0	0.1	0.9	0	0	0.1	0	0	0.4	0	0	0	0	0	0.2	0	0	0	0	0.1	0	0.5	2.1	0.3	0	0	1.3	0.4	1.3	0.5	1.3	0.8	0.8	0.6	0.7	1.4	0.9	0.8	0.9	1	0.4	0.5	0.7	0.2	0	0	0	0.1	0	0	0	0	0.1	0	0	10.5	46.2	0	0	0	0	206.4	1.4	1.2	0	0	0	3.3	0.3	0.1	0	0	163.5	2	0	0	0	0	7635.3	0.5	0	0	134.4	149.8	0	0	0	0	0	0	0	0.3	0	0	12.9	0	0	0	0	0	0	0.6	0.7	0.8	0	Hepatocytes
CPA1	CPA	ENSG00000091704	Carboxypeptidase A1	P15085	7	130380339-130388114	Enzymes, Predicted intracellular proteins, Predicted secreted proteins		Carboxypeptidase, Hydrolase, Metalloprotease, Protease		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	3231	pancreas: 3541.6	Cell type enriched	Detected in some	10	Exocrine glandular cells: 8426.3	Cancer enriched	Detected in some	639	pancreatic cancer: 1377.7	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	5	AN3-CA: 16.2	Not detected	Not detected			Not detected	Not detected			HPA021836, CAB025197, HPA052215	Enhanced				Secreted to digestive system				17000000			CAB025197: , HPA021836: AB_1846005, HPA052215: AB_2681764	unprognostic (8.41e-2)			unprognostic (9.24e-4)	unprognostic (5.22e-2)	unprognostic (1.76e-1)	unprognostic (3.97e-1)	unprognostic (1.76e-1)		unprognostic (2.27e-1)	unprognostic (1.15e-2)	unprognostic (1.35e-1)	unprognostic (1.34e-6)	unprognostic (4.99e-1)	unprognostic (1.67e-1)	unprognostic (2.16e-1)	unprognostic (4.37e-2)	0.3	0	0.1	0.1	0.1	0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0	0.1	0.3	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	1	3541.6	0	0.1	0.1	0.1	0.1	0	0.1	0.3	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0	0.3	0	0	0	0	16.2	0	0	0.1	0	0	0	0	0.1	0	0	2	0	0	0	0	0	0	1.3	0	0	0	0.6	1.2	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0	3	0.6	0	0	0	0.1	0	0	0	0.2	2.3	0	0.3	0	1.9	0.3	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0.1	0.1	0.1	0.2	0.1	0	0.1	0.1	0.1	0.1	3	0	0	0.5	0	0	0.3	0	0	0	0	0	0.3	5	13.2	1.2	0	0	0	8426.3	0	0	0	0	0	0.3	0	0	0	0	5.9	0.9	0	0	77.5	0	2.3	847.8	0	0.7	0	0	0	0	0.5	2.4	0	1.4	0	0	0	Exocrine glandular cells
MYH7	CMD1S, CMH1, MPD1	ENSG00000092054	Myosin heavy chain 7	P12883	14	23412738-23435718	Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins		Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin	Cardiomyopathy, Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	6	heart muscle: 644.7;skeletal muscle: 596.4	Cell type enriched	Detected in some	2697	Cardiomyocytes: 8327.1	Group enriched	Detected in some	9	head and neck cancer: 12.2;prostate cancer: 15.4	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	32	HSkMC: 16.4	Low region specificity	Detected in many							HPA001239, HPA001349, CAB015384	Enhanced								31000000			CAB015384: AB_2147279, HPA001239: AB_1079438, HPA001349: AB_1079437	unprognostic (6.49e-2)	unprognostic (8.27e-5)	unprognostic (1.56e-1)	unprognostic (3.04e-3)	unprognostic (4.30e-1)	unprognostic (7.33e-3)		unprognostic (8.60e-2)	unprognostic (1.55e-1)	unprognostic (1.31e-1)	unprognostic (1.22e-1)	unprognostic (3.79e-1)	unprognostic (5.38e-3)	unprognostic (2.32e-1)	unprognostic (1.20e-1)	unprognostic (1.41e-1)	unprognostic (2.28e-2)	5.4	0.1	0.2	0	0.2	0	0.2	0.1	0.1	0	0.1	0	0	0	0	11.7	7.2	0	0.1	644.7	0.2	0.3	0.1	0.1	0.1	0.1	0.2	0	0.1	0.4	0	0.1	0	0	3.3	0	0	11.8	0	596.4	0.1	0.1	0	0.2	0	0.1	0.1	0	0	2.9	109.6	16.9	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	16.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0.2	0.1	0.1	0.2	0.3	0.2	0	0	0	0	0	0	0	0	0	8327.1	0	0	0	0	0	0	0	0	0.5	0	0	0	2.7	0	0	0	0	0	0	0	0	3.1	0.3	0.4	0.3	0	0	0	0	0	0.7	0	2.8	0	0	0	0	0	0	0	0	0	0	0	Cardiomyocytes
CEBPE	CRP1	ENSG00000092067	CCAAT/enhancer binding protein epsilon	Q15744	14	23117304-23119616	Disease related genes, Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	Activator, DNA-binding	Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	7	blood: 87.1;bone marrow: 29.4	Cell type enriched	Detected in some	4	Hofbauer cells: 6.4	Not detected	Not detected			Region enhanced	Detected in single		cerebral cortex: 1.3	Cell type enriched	Detected in single	201	eosinophil: 87.1	Lineage enriched	Detected in single	237	granulocytes: 87.1	Group enriched	Detected in some	4	HL-60: 59.4;NB-4: 30.7	Not detected	Not detected			Not detected	Not detected			HPA002928, CAB005113	Enhanced		Supported	Nucleoplasm,Cytosol						Nucleoplasm	Cytosol	CAB005113: AB_631240, HPA002928: AB_1078494	unprognostic (1.33e-2)	unprognostic (4.76e-2)	unprognostic (4.19e-2)	unprognostic (2.04e-1)	unprognostic (5.01e-2)	unprognostic (1.66e-3)	unprognostic (2.84e-1)	unprognostic (1.49e-2)	unprognostic (3.33e-2)	unprognostic (5.69e-2)	unprognostic (9.03e-2)	unprognostic (2.22e-1)	unprognostic (3.80e-3)	unprognostic (1.42e-1)	unprognostic (1.12e-2)	unprognostic (2.57e-2)	unprognostic (8.19e-2)	0.3	0	0.1	0.8	0.2	29.4	0.1	0.1	1.3	0.1	0.1	0.1	0.1	1.4	0.1	0.1	0.1	0.3	0.1	2.2	0.1	0.1	0.1	0.2	2.7	0.2	0.3	0.1	0.1	0.1	0	0.1	2.2	0.1	0.1	0	0.1	0.1	0.1	0.4	0	1.9	0.1	0.3	7.7	0.4	0.1	0.1	2.6	0.1	0.1	0.8	0.2	0.1	0	0.1	87.1	0.3	0	0.2	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	59.4	10.6	0	0	0	0	0	0	2.5	0	0	0	0	0.2	30.7	0	0	0	2.6	0	0	0	0	0	0	0.4	0	0	0	0	4.6	0	0	0	0.1	0	0	0	0	0	6.4	0	0	0.3	87.1	0	0	0	0	0.1	0	0.1	0	0.2	0.2	0.4	0	0	0.1	0	0.2	0.1	0.2	0.1	1.3	0.1	0.1	0.3	0.1	0.1	0.1	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	6.4	0	0	0.6	1.6	0	0	1.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	Hofbauer cells
KRT31	Ha-1, KRTHA1	ENSG00000094796	Keratin 31	Q15323	17	41393724-41397592	Plasma proteins, Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	4	brain: 21.2;skin 1: 72.1	Cell type enriched	Detected in some	5	Basal keratinocytes: 34.8	Low cancer specificity	Detected in many			Region enriched	Detected in single	22	cerebellum: 21.2	Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in single		HBEC3-KT: 1.7									HPA049550, HPA055194	Enhanced								560000000			HPA049550: AB_2680813, HPA055194: AB_2682733	unprognostic (3.92e-2)	unprognostic (3.50e-1)		unprognostic (3.30e-1)	unprognostic (5.51e-2)	unprognostic (7.71e-2)		unprognostic (4.60e-1)	unprognostic (6.98e-2)	unprognostic (1.84e-1)			unprognostic (4.07e-1)			unprognostic (4.26e-2)	unprognostic (1.65e-1)	1.5	0	0	0	0.2	0	1	21.2	1.2	0.6	0	0.6	0	0	0	0	11.3	0	0	0	0	0	0	0	0	0	0	0.7	0	0.1	0	0	0	0.8	0.2	0	0	0.5	0	5.5	72.1	0	0	0.5	0	0	0.1	0	1	0	0	0.8	0	0.2	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0.2	0	0	0	1.7	0	0	0	0	0	0.2	0	0	0	0	0	0	0.2	0.2	0	0	0	0	0	0	0	0	0.1	0.1	0	0	0	0.8	0	0	0	0	0	0.5	0	0	0.2	0.1	0	0	0	0.4	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	21.2	0.9	0	0	0	0.7	0.8	0	0	0	0	0.2	34.8	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0.1	0	0	0	0	0.8	0	0	1.7	0	0	0	0	0	0	0	0	0	0.1	0	0	6.8	0	0	0	0	Basal keratinocytes
WHRN	CIP98, DFNB31, PDZD7B, USH2D	ENSG00000095397	Whirlin	Q9P202	9	114402080-114505450	Disease related genes, Predicted intracellular proteins, Predicted membrane proteins	Hearing		Deafness, Non-syndromic deafness, Retinitis pigmentosa, Usher syndrome	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		adrenal gland: 58.2	Cell type enriched	Detected in some	4	Ciliated cells: 14.7	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enhanced	Detected in some		MAIT T-cell: 2.0;memory CD8 T-cell: 2.0	Low lineage specificity	Detected in single			Cell line enhanced	Detected in many		HDLM-2: 16.3;Karpas-707: 47.6;U-266/70: 29.9;U-266/84: 30.7	Low region specificity	Detected in all			Low region specificity	Detected in all																unprognostic (6.06e-3)	unprognostic (1.02e-1)	unprognostic (9.96e-2)	unprognostic (4.27e-3)	unprognostic (4.59e-1)	unprognostic (7.07e-2)	unprognostic (3.66e-2)	unprognostic (7.25e-2)	unprognostic (6.13e-3)	unprognostic (3.43e-2)	prognostic favorable (2.28e-4)	unprognostic (1.03e-1)	unprognostic (1.71e-3)	unprognostic (3.21e-2)	unprognostic (1.92e-1)	unprognostic (1.25e-2)	unprognostic (3.44e-1)	3.3	58.2	11.7	4.1	24.5	3.2	4.9	7.6	18.1	8.3	5.4	31.7	2.9	8.3	17.8	8.4	4.7	9.5	4.1	3.6	12	9.1	4	2.2	3.7	4.5	26	7.6	12.6	9.8	10.2	19.3	3.2	20	7.8	2.9	13	10.9	6.9	1.3	7.3	8	9.5	14.4	17.8	6.5	23.6	29.8	11	5.7	1.5	2.4	4	7.2	0.3	0	0.2	0	0.7	2	0.1	0.6	1	1.6	6	0.6	0.2	3.2	0.4	0.9	0.6	0.4	0.1	0.3	0	1.2	0.4	7.9	3.6	0.3	0.6	0.1	16.3	2.7	0	11.5	1.3	0.2	0	0.4	0.5	1.9	2.2	0.2	4.4	0	0.8	3.3	47.6	0.6	6	0	0.2	2.1	0	9.9	0.8	0	12.5	1.6	0.3	7.4	0.5	3.5	4.2	12.5	1.9	4	0.1	1	2.1	1.2	2.3	2.9	29.9	30.7	0.2	0.8	0	1.2	0	0	0	0.3	0	2	0.1	0.5	2	0	0.3	0	0.6	0.2	0.7	0	0	1	0.1	11.7	24.5	7.6	18.1	12	9.1	26	7.6	20	29.8	0	1.1	0	0	0	0	0	0	14.7	2.3	0	0	2.5	0	1.6	0	0	0	0	1.8	1.9	0	0	2.3	0	2.9	0	0	0	0	0	0	0	0	1.8	0	0	1.5	0	0	0.8	0	0	0	0	0	0	3.5	0	0	0	Ciliated cells
PDE6C	ACHM5, COD4, PDEA2	ENSG00000095464	Phosphodiesterase 6C	P51160	10	93612588-93666010	Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins	Sensory transduction, Vision	Hydrolase	Disease mutation, FDA approved drug targets	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	4	retina: 12.8	Cell type enriched	Detected in some	18	Cone photoreceptor cells: 53.0	Not detected	Not detected			Region enriched	Detected in single	7	cerebellum: 3.0	Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		Hep G2: 2.4	Not detected	Not detected			Not detected	Not detected																unprognostic (1.39e-3)	unprognostic (7.41e-3)	unprognostic (2.61e-2)	unprognostic (2.24e-1)	unprognostic (3.17e-2)	unprognostic (5.23e-3)	unprognostic (2.46e-3)	unprognostic (2.81e-3)	unprognostic (9.68e-2)	unprognostic (2.64e-1)	unprognostic (1.51e-2)	unprognostic (2.96e-3)	unprognostic (2.19e-7)	unprognostic (1.19e-1)	unprognostic (6.61e-2)	unprognostic (1.81e-1)	unprognostic (1.80e-3)	0.4	0.6	0.3	0.4	0.4	1.3	0.4	3	0.7	0.8	0.3	0.3	0.3	0.4	0.5	0.3	0.3	0.5	0.3	0.3	0.3	0.2	0.3	0.5	0.5	1	0.3	0.3	1	0.3	0	0.8	0.3	0.3	0.7	0	12.8	0.8	0.3	3.1	3.1	0.7	0.3	0.3	0.9	0.6	0.7	0.3	0.3	0.6	0.3	0.3	0.4	0.7	0.2	0.1	0.2	0.2	0.3	0.6	0	0.2	0.7	0.4	1.4	0	0.1	1	0.8	0	0	0	0.8	1	0.6	0.2	0	0.1	0.4	0	0	0	0.1	0.6	0.5	1.4	2.4	0.1	0.5	0.3	0	0	0	0	0.3	0	0.7	0.3	0.8	0	0.2	1	1.6	0.8	0.1	0.4	0.6	0	0.1	0	0.2	1.2	0.1	0.2	0	0.1	0.5	0.5	0.3	0.2	0	0.4	0	0.2	0.7	0.6	0.6	0.6	0.4	0.2	0	0.2	0	0.5	0	0	0.1	0.2	0.1	0.1	0.2	0.6	0.5	0.2	0.3	0.2	0.1	0	0	0.3	0.4	3	0.3	0.3	0.2	0.3	0.3	0.3	0.3	0	0	0	0	0	0.7	0.3	0	0	0	0	53	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.8	0	0	0	0	3	0	0	0	0	0	0	0	0	0	Cone photoreceptor cells
CYP26A1	CP26, CYP26, P450RAI, P450RAI1	ENSG00000095596	Cytochrome P450 family 26 subfamily A member 1	O43174	10	93073475-93077890	Predicted intracellular proteins		Monooxygenase, Oxidoreductase		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	8	liver: 23.2;retina: 7.3	Cell type enriched	Detected in some	9	Muller glia cells: 70.3	Cancer enhanced	Detected in many		testis cancer: 5.0	Low region specificity	Detected in some			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	7	AF22: 37.6	Not detected	Not detected			Region enhanced	Detected in many		cerebral cortex: 6.8														unprognostic (2.80e-1)	unprognostic (4.21e-3)	unprognostic (5.65e-2)	unprognostic (2.94e-1)	unprognostic (2.16e-1)	unprognostic (4.90e-1)	unprognostic (4.17e-2)	unprognostic (6.22e-2)	unprognostic (3.35e-1)	unprognostic (4.89e-1)	unprognostic (1.11e-2)	unprognostic (6.24e-2)	unprognostic (2.04e-11)	unprognostic (1.84e-2)	unprognostic (2.04e-1)	unprognostic (1.22e-1)	unprognostic (4.11e-1)	0.1	0.3	0.3	0	0.6	0.1	0.3	0.4	1.8	0.3	0.1	0	0	0	0.6	0.4	0	0	0	0	0.6	0.3	0	23.2	0.1	0	0.2	1.4	0.1	0	0	0.2	0.8	0.3	0.1	0	7.3	0.1	0	0	0.1	0	0.1	0.1	0.2	0.1	0.2	0.2	1.2	0	0	0.1	0.9	0	0	0	0	0	0	0	0	0	0.4	37.6	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0.8	0.1	0	0	0	5.2	0	0	0	0	0	0.1	0	0	0	0	0	0	0.9	0.3	0	0	0	0	0	3	0	0	0.2	0	0	0	0	0.2	0	0.1	0	0	0.4	0	0	0	0	0	0	0	0.4	0.1	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0.6	0.4	1.8	0.6	0.3	0.2	1.4	0.3	0.2	0	0	0	0	0	1.2	0.3	0	0	0	0	2	0	0	0.1	0.1	0	0	0	0	0.5	0	0.1	0	8.1	0.1	0	0	0	0	0	0	0	0	0	0	70.3	0	0	0	0	2.1	0	0	0.5	1.1	0	6.4	0	0	0	Muller glia cells
SORBS1	CAP, FLJ12406, KIAA1296, ponsin, SH3D5, sh3p12	ENSG00000095637	Sorbin and SH3 domain containing 1	Q9BX66	10	95311771-95561414	Predicted intracellular proteins	Transport			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		smooth muscle: 126.5	Cell type enriched	Detected in many	7	Cardiomyocytes: 479.0	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Group enriched	Detected in some	4	basophil: 7.6;eosinophil: 2.2	Lineage enriched	Detected in many	6	granulocytes: 7.6	Cell line enhanced	Detected in many		CACO-2: 15.2;HMC-1: 26.6;SK-MEL-30: 22.8	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA027559, CAB032850, HPA043084	Enhanced		Supported	Plasma membrane,Focal adhesion sites,Centrosome						Focal adhesion sites	Plasma membrane, Centrosome	CAB032850: AB_2286335, HPA027559: AB_10600812, HPA043084: AB_2678307	prognostic favorable (2.84e-4)	unprognostic (3.53e-1)	unprognostic (1.89e-1)	unprognostic (7.85e-2)	unprognostic (3.43e-1)	unprognostic (1.41e-1)	unprognostic (2.98e-2)	unprognostic (5.30e-2)	unprognostic (1.95e-2)	unprognostic (1.65e-2)	unprognostic (3.17e-2)	unprognostic (1.27e-1)	unprognostic (3.40e-2)	unprognostic (3.13e-2)	unprognostic (1.80e-1)	unprognostic (2.55e-2)	unprognostic (5.01e-3)	95	6.4	23	16.4	21.6	1.8	23.5	16.8	22.5	14.9	70.2	18.7	22.1	8.1	41.8	12.5	45	25.1	28.9	83.7	20.9	8.3	5.9	14.7	8.7	1.4	13.4	14.1	9.8	7.3	17.5	3.5	9.9	19.2	42	20	6.4	7.2	65.7	46.4	6.3	15.5	126.5	20.6	2.9	40	5.5	19.3	0	4	12.7	1.2	63.9	31.4	0.1	0	7.6	1.2	0.6	1	0.2	0.7	0.7	6.4	1.6	2.4	0.1	0.9	0.2	0.1	0.2	0	15.2	5.7	0	1.2	0.1	2.4	0.3	1.2	0.3	0.1	1.8	2.3	3.7	0.2	9.1	0.8	0	26.6	0.4	0.2	0.3	0.1	0.1	2.6	0.9	6	1.2	0.6	0.4	0	0.3	3	2.8	1.4	0.5	2.2	0.2	7.2	10	2.8	2	0.9	0.3	22.8	4.6	1.2	0.2	0.2	0	2.3	0.1	1.2	0.8	0.2	0.1	2.8	0.2	6.4	7.6	0.2	2.2	0.7	1.2	1	0.1	0.3	0.4	0	0.1	0.3	0.1	0.2	0.6	0.2	0	0.5	0.2	23	21.6	16.8	20.7	20.9	8.3	13.4	14.1	19.2	19.3	20.8	18.1	0.5	5.1	10.3	5.9	479	12.7	0	2.3	1.8	2	17.9	3.3	4.4	61.7	19	1	0	2.6	1.9	15.3	5.3	15.1	42.9	2.7	6.4	5.8	38.6	4.9	26.4	6.9	1.1	13.5	1	14	18.2	2.8	3.5	72.2	4.3	5.4	0	64.3	2.8	4.7	10.9	24.7	0	5.2	3.3	Cardiomyocytes
SMIM24	C19orf77, HSPC323	ENSG00000095932	Small integral membrane protein 24	O75264	19	3473986-3480542	Predicted intracellular proteins, Predicted membrane proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		epididymis: 160.8;intestine: 204.2;kidney: 76.9	Cell type enriched	Detected in many	6	Proximal tubular cells: 1384.0	Cancer enhanced	Detected in many		renal cancer: 78.4	Low region specificity	Detected in single			Cell type enhanced	Detected in many		NK-cell: 8.6	Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		CACO-2: 42.4;HEL: 20.0;Hep G2: 31.7;MOLT-4: 30.2;OE19: 50.3;REH: 16.6;U-937: 23.7	Low region specificity	Detected in many							HPA045046, HPA056027	Enhanced		Approved	Nucleoplasm,Cytosol						Nucleoplasm	Cytosol	HPA045046: AB_10964444, HPA056027: AB_2683012	unprognostic (2.18e-4)	unprognostic (4.63e-1)	unprognostic (5.68e-2)	unprognostic (9.60e-2)	unprognostic (1.93e-1)	unprognostic (6.23e-2)	unprognostic (1.03e-1)	unprognostic (1.61e-1)	unprognostic (1.64e-1)	unprognostic (2.85e-1)	unprognostic (2.84e-1)	unprognostic (1.07e-1)	prognostic favorable (4.13e-10)	unprognostic (1.68e-2)	unprognostic (2.14e-1)	unprognostic (8.36e-2)	unprognostic (3.11e-2)	0.2	0.1	0.7	0.6	0.9	7	0.3	0.2	2.2	0.2	137	0.4	2.4	71.4	0.2	160.8	0.3	0.3	46.7	0.3	0.4	0.5	76.9	7.2	0.3	0.3	0.4	0.6	0.3	1.6	0	0.9	0.2	0.3	0.3	2	0.2	0.3	0.4	0.2	0.3	204.2	0.2	0.6	0.4	24.8	1.2	0.3	8.8	0.2	0.2	0.2	0.2	0.2	3.2	2.4	3	0	8.6	2.1	1.1	0	0	0	0	0	0	0.7	0	0	0.1	0	42.4	0.1	0	2.2	0	0.1	0	0	0	0	0	0	20	0.2	31.7	0	1.7	0.5	0	0	0	0	0	0	2.9	0.3	0	0	0	30.2	4.2	0	50.3	0	16.6	0	1.1	0.4	0	0.4	0.6	0	0	0.4	0.1	0	0.5	0	0	0.1	0.3	0	0	0	1.7	0	23.7	0	3	0	0	0.1	0	0	3.2	0	0	0.1	0.6	0.7	1.7	0	8.6	0	2.4	2.1	1.1	0.7	0.9	0.2	2.2	0.4	0.5	0.4	0.6	0.3	0.3	0	0	1.7	0.1	0	12.1	0.2	229.3	0	0	55.8	25.5	0	202.2	3.9	5	0	64.6	23.3	11.3	0.1	0	0.3	1.1	8.5	0.1	0	133.5	0.6	0.8	11.2	0.3	0	0	1	34.7	2.7	11.1	51.8	0	1384	32.6	0	0	0.7	0.4	0	0	1	35.7	0.2	Proximal tubular cells
TREM2	TREM-2, Trem2a, Trem2b, Trem2c	ENSG00000095970	Triggering receptor expressed on myeloid cells 2	Q9NZC2	6	41158506-41163186	Disease related genes, Predicted intracellular proteins, Predicted membrane proteins		Receptor	Disease mutation, Neurodegeneration	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		adipose tissue: 35.6;brain: 34.8;lung: 24.6	Cell type enriched	Detected in some	12	Hofbauer cells: 939.0	Cancer enhanced	Detected in all		glioma: 93.5	Low region specificity	Detected in all			Cell type enhanced	Detected in some		plasmacytoid DC: 4.9	Group enriched	Detected in many	6	dendritic cells: 4.9;monocytes: 1.3	Group enriched	Detected in some	4	hTCEpi: 37.4;THP-1: 20.7	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA010917, HPA012571	Approved				Intracellular and membrane				19000			HPA010917: AB_1080365, HPA012571: AB_1858260	unprognostic (3.89e-1)	unprognostic (4.44e-3)	unprognostic (2.77e-2)	unprognostic (1.80e-2)	unprognostic (1.29e-1)	unprognostic (1.53e-1)	prognostic unfavorable (4.24e-4)	unprognostic (4.83e-2)	unprognostic (1.07e-1)	unprognostic (8.57e-3)	unprognostic (1.33e-1)	unprognostic (2.09e-1)	unprognostic (3.58e-3)	unprognostic (8.04e-2)	unprognostic (1.04e-2)	unprognostic (3.16e-3)	unprognostic (1.85e-2)	35.6	11.8	10.1	3	13.4	0.3	8.6	1.6	21.7	5.9	2.9	24.1	0	0.9	1.5	2.1	0.6	6.5	8.4	1.7	10.4	9.5	1	2.1	24.6	1.7	21.7	5.2	2.7	2.5	2.7	2.9	8.8	13.4	1.8	3.9	2.1	4.4	3	0.8	0.4	1.2	3.8	34.8	0.5	2.2	0.8	12.9	0	1.6	0.8	0.5	4.2	0.5	0.5	4.9	0	1.3	0	0	0.1	0	0.1	0	0	0	0.1	0.3	0	0	0	0.2	0	0	0	0	0	0	0	0	6.7	0	0	0	0.2	0	0.4	0	0	0	0.6	37.4	0.1	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.8	0	20.7	0	0	0	0	0	0	0	0	0	0	0	0	1.3	0	0	0.6	0	0.4	0	0	0.8	0.5	0	0	0	0	0	4.9	0	0.1	10.1	13.4	1.6	8.3	10.4	9.5	21.7	5.2	13.4	12.9	6	9.8	0	0	0.7	0.1	0.2	2.5	2.7	12.5	0	0	4	0	0	0.3	0	0	0	0	3.8	0.4	0	2.3	0	939	0	0	3.1	28.7	0.4	0.6	78.3	0	13.6	0	0.4	0	0	0	0	0.6	6.5	0	0	0	0.1	6.1	0	0	0	Hofbauer cells
MLN		ENSG00000096395	Motilin	P12872	6	33794673-33804011	Predicted secreted proteins		Hormone		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in single	175	intestine: 76.0	Cell type enriched	Detected in single	34	Intestinal endocrine cells: 3.4	Cancer enriched	Detected in some	6	testis cancer: 5.3	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		AN3-CA: 1.6;BEWO: 1.8;CACO-2: 7.3;RPMI-8226: 1.7;SuSa: 3.1;TIME: 3.4					Not detected	Not detected			HPA069392	Enhanced				Secreted to blood			450000				HPA069392: AB_2686136					unprognostic (7.70e-2)					unprognostic (6.70e-2)				unprognostic (4.44e-2)	unprognostic (3.14e-1)			0.1	0.1	0.1	0	0.1	0	0.1	0.1	0.1	0.1	58.4	0	0	76	0.1	0	0.3	0.1	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0	0.1	0	0.1	0.1	0	0.4	0	0	0.1	0	0	0.1	0	0.1	0.1	30.6	0	0.2	0.1	0.1	0.2	0	0.1	0.1	0	0	0.1	0.1	0	0	0	0	0	0	0	0	0	1.5	1.6	0	0	1.8	0	0	0	0	7.3	0	0	0	0	1	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.4	0	0	0	1	1.2	0	0	0	0	1.7	0	0	0.6	0.8	0	0	0	3.1	0	0	3.4	0.6	0	0	0	0	0	0.3	0	0.1	0.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Intestinal endocrine cells
SIRT1	SIR2L1	ENSG00000096717	Sirtuin 1	Q96EB6	10	67884669-67918390	Predicted intracellular proteins	Apoptosis, Biological rhythms, Differentiation, Host-virus interaction, Myogenesis, Transcription, Transcription regulation	Developmental protein, Transferase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	4	Early spermatids: 171.4	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low cell line specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			CAB003855, HPA006295, HPA052351	Approved		Supported	Nucleoplasm,Nucleoli fibrillar center,Mitochondria,Cytosol						Nucleoplasm	Nucleoli fibrillar center, Mitochondria, Cytosol	CAB003855: AB_365497, HPA006295: AB_1079975, HPA052351: AB_2681796	unprognostic (1.55e-1)	unprognostic (2.78e-1)	unprognostic (9.13e-2)	unprognostic (1.05e-1)	unprognostic (1.91e-1)	unprognostic (2.05e-2)	unprognostic (2.48e-1)	unprognostic (4.95e-2)	unprognostic (1.41e-1)	unprognostic (4.64e-2)	unprognostic (1.72e-1)	unprognostic (9.61e-2)	unprognostic (2.18e-2)	unprognostic (2.83e-2)	unprognostic (9.67e-2)	unprognostic (1.12e-1)	unprognostic (1.39e-1)	17.2	32.3	12.6	21.1	17.8	17	18.1	22.6	14.5	24.2	20.5	15.7	14	9.2	19	12.7	12.7	15.1	15.2	14.7	14.1	10.4	13.9	17.3	12.6	16.1	17	10.1	26.6	14.4	16.4	13.3	14.7	12.1	21.7	12.5	12.1	12.3	16.1	19.9	12.9	15	21	17.7	13.5	13.2	25.4	16.3	28.1	15.2	9.3	14.7	21.6	37.5	4.9	3.9	3.8	3.5	3.6	7.1	1.8	8.3	9.6	15.2	16.9	14.5	11.2	9.5	11.6	12	16	14.3	10.5	7.2	17.6	6.3	7.7	10	6.7	18.8	3.9	17.2	9.4	10.9	9.3	7.2	8.2	13.3	10	7.2	10.3	9.4	9.6	16.6	17.2	6.4	10.1	11.8	9.6	11.6	6.7	9.3	13.9	18.8	5.4	15.3	16.9	12	6.9	7.5	5.2	9.8	13.5	21.3	14.1	14.7	13.7	10.2	9.3	5.3	12.5	11.6	11	11.2	8.1	9.6	34.9	6.4	15.2	5.1	3.8	2.4	3.2	3.4	3	4.9	4.9	3.7	4.7	3.9	3.3	7.1	4.2	3.1	3.6	3.5	3.5	2.9	1.8	12.6	17.8	22.6	14.5	14.1	10.4	17	10.1	12.1	16.3	17.9	6.1	10.4	16.4	34.8	11.7	27	15.3	1.4	9.1	5.2	25.5	5.7	5	3.9	171.4	12.8	17.4	23.3	4.7	4.3	17.6	23.9	11.5	14.8	7.8	11.1	41.1	14.1	20.9	29	16.4	13.5	15.1	1.8	16.9	7	6.4	10.5	18.4	6.3	13.4	0	38.2	20.6	15.4	41.5	10.4	13.8	12.4	14.9	Early spermatids
SERPIND1	D22S673, HC-II, HC2, HCF2, HLS2	ENSG00000099937	Serpin family D member 1	P05546	22	20773879-20787720	Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins	Blood coagulation, Chemotaxis, Hemostasis	Heparin-binding, Protease inhibitor, Serine protease inhibitor	Disease mutation, FDA approved drug targets, Thrombophilia	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	47	liver: 170.8	Cell type enriched	Detected in some	10	Hepatocytes: 223.1	Cancer enriched	Detected in many	80	liver cancer: 334.4	Low region specificity	Detected in some			Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Cell line enriched	Detected in some	10	Hep G2: 64.2	Low region specificity	Detected in all			Not detected	Not detected			CAB008639, HPA055767	Supported		Approved	Vesicles	Secreted to blood				94000000000	Vesicles		CAB008639: AB_1618010, HPA055767: AB_2682912	unprognostic (1.68e-1)	unprognostic (8.27e-2)	unprognostic (4.40e-2)	prognostic favorable (4.09e-4)	unprognostic (5.42e-2)	unprognostic (1.23e-1)	unprognostic (1.12e-3)	unprognostic (1.56e-1)	unprognostic (1.13e-1)	unprognostic (1.74e-1)	unprognostic (1.21e-2)	unprognostic (2.88e-1)	unprognostic (3.94e-9)	unprognostic (2.01e-1)	unprognostic (4.66e-2)	unprognostic (8.36e-3)	unprognostic (1.46e-1)	0	0	0	0	2.3	0	0.2	0.6	0.9	0.3	0	1.4	0	0	0.3	0	0	0.1	0	0.3	0	0	0	170.8	0.3	0	0	0.7	0.3	0	3.6	0.1	0.2	2.6	0	0	0.1	0	0	0	0	0	0.5	0.4	0	0.1	0.1	0.5	0	0.1	0	0	0	0.1	1.9	2.7	0.7	0.4	1.3	1.7	0.1	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	64.2	0	0.2	0.1	0	0	0.5	0	0	6.4	0	0	0	0.1	0	0	0	0	0.7	5.2	0	0.2	0	0	1	0	0	0.1	0	0	0	0	0	0.5	0.1	0	0	0	0	0	0	2.3	0	4.4	0	0.4	0	1	0.2	1.7	0.4	0.5	0.6	0.1	1.9	0.9	0.7	0.7	1.3	0.2	2.7	0.7	0.1	0	2.3	0.6	0.9	0	0	0	0.7	2.6	0.5	0	13.7	0	0	0	0	0.8	5.1	0	0	0	0	0	0	0	0	0	0	23.3	0	0	0.7	0	1.1	223.1	0.1	0	0	4.9	2.9	0	1.1	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0.1	0	0	0	Hepatocytes
DDT	DDCT	ENSG00000099977	D-dopachrome tautomerase	P30046	22	23971365-23980469	Enzymes, Plasma proteins, Predicted intracellular proteins	Melanin biosynthesis	Lyase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		blood: 52.8;liver: 58.4	Cell type enriched	Detected in all	5	Hepatocytes: 4710.9	Low cancer specificity	Detected in all							Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Cell line enhanced	Detected in all		HEK 293: 68.5									HPA049871, HPA074115	Enhanced		Approved	Mitochondria						Mitochondria		HPA049871: AB_2680926, HPA074115: 	unprognostic (1.77e-2)	unprognostic (1.13e-1)	unprognostic (1.40e-1)	unprognostic (1.22e-2)	unprognostic (8.09e-2)	unprognostic (4.00e-3)	unprognostic (2.02e-3)	unprognostic (6.58e-2)	unprognostic (4.66e-2)	unprognostic (2.23e-2)	unprognostic (1.96e-1)	unprognostic (6.06e-3)	unprognostic (1.12e-1)	unprognostic (7.34e-2)	unprognostic (3.30e-1)	unprognostic (3.81e-1)	unprognostic (2.61e-3)	9.7	6.6	5.4	3.4	4.8	8.8	4.5	2.1	4.4	3	9.8			11.8	2.7	4.3	5.8	2.8	1.4	7.7	4.2	4	11.3	58.4	3.2	2.9	5.4		4.1	14.4	1.3	1.8	2.5		5.8	6.4		7.1	4.4	10.4	3.7	11.6	2	4.6	3.2	8.2	1.2			3.7		2.7	4.3	3.2	30.4	52.8	27.8	38	23.8	29	28.6	27.1	11.6	4	9.4	7.7	6.8	24.5	7.9	5.3	6.9	7.2	10.2	7.9	26	7.4	4.1	10.2	22.5	10	9.8	4.5	11	68.5	15.6	15.8	22.2	7.8	34.2	15.7	6.8	7.5	6.9	6.1	8	7.4	4.1	14.1	10.5	6.9	13.3	7.5	31	12.1	24	35	16.5	7.5	37.1	12.3	10	13.7	13.2	16.3	30.9	23.2	5.7	7.8	10.8	8.5	7.2	16	7.3	8.2	32.4	10.7	16.3	14.1	12.7	13.8	20.7	38	27.8	19.9	32.4	20.3	30.4	24.1	21.1	35.7	28.4	21.9	21.3	24.2	23.8	29.6	52.8	29	28.6											77.4	62.3	170.5	177.4	123.4	46.7	20.4	580.9	78.9	76.2	230.3	84.4	209.3	608.5	198.5	156.1	122	650.8	116.8	322.3	247	92.9	222.4	128	4710.9	242.3	41.3	249.4	161.4	217.6	261.8	108.4	147.1	150.1	220	322.2	63.3	238.6	309.5	104	969.7	70.4	77.6	140	72.1	40.3	164.4	250.7	154.1	488.9	247.4	Hepatocytes
PLA2G3	GIII-SPLA2	ENSG00000100078	Phospholipase A2 group III	Q9NZ20	22	31134809-31140607	Enzymes, Predicted secreted proteins, RAS pathway related proteins	Cilium biogenesis/degradation, Lipid metabolism, Mast cell degranulation, Phospholipid metabolism	Hydrolase		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		esophagus: 13.1;skin 1: 14.1;tongue: 17.4	Cell type enriched	Detected in some	7	Suprabasal keratinocytes: 15.6	Low cancer specificity	Detected in many			Region enhanced	Detected in single		pons and medulla: 3.1	Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	5	AF22: 14.2;AN3-CA: 14.3;NTERA-2: 7.3;SCLC-21H: 11.1	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA021016	Uncertain				Secreted to blood							HPA021016: AB_1855443	unprognostic (1.80e-1)	unprognostic (4.63e-3)	unprognostic (1.07e-1)	unprognostic (1.49e-2)	unprognostic (9.72e-2)	prognostic favorable (4.47e-4)		unprognostic (1.74e-2)	unprognostic (2.30e-1)	unprognostic (4.25e-2)	unprognostic (9.55e-3)	unprognostic (4.41e-1)		unprognostic (3.67e-1)	unprognostic (3.29e-1)	unprognostic (9.49e-3)	unprognostic (3.72e-2)	0.1	0	0.1	0.1	0.2	0	2	0.4	0.9	5.3	0.1	0.1	1.9	0.5	0.3	0.1	13.1	0	0.1	0.1	0.6	0	0.3	0.1	4.2	0.1	0.1	0.4	0.1	0.1	1.7	0.1	0.1	3.1	0.4	0	0.8	1.8	0.5	0.3	14.1	0.1	0.1	0.1	0.1	0.9	0.3	0.1	0.4	0.8	17.4	3.5	0.1	6	0	0	0	0	0	0	0	0	0	14.2	14.3	0	0	0.1	0	0.1	0	0	0	0	0	2.2	0	0	0	0.1	0	0	0	0	0	0.7	0.2	0.5	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	7.3	0	0	0	0	0.9	0	0	11.1	0	0	0	0	0.2	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.2	0.4	0.9	0.6	0	0.1	0.4	3.1	0.1	0	2.2	0	0.1	1.1	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	1.1	0	0	0.2	0	0	0	0	0	0	0	0	0	0	1.7	0	0	0	0	0	0	0	0	0	0	0.1	0.1	15.6	0	0	0	0.4	Suprabasal keratinocytes
SEZ6L		ENSG00000100095	Seizure related 6 homolog like	Q9BYH1	22	26169474-26383597	Predicted membrane proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	5	brain: 60.8	Cell type enriched	Detected in some	6	Horizontal cells: 20.6	Group enriched	Detected in some	6	glioma: 14.6;pancreatic cancer: 3.7	Low region specificity	Detected in all			Group enriched	Detected in some	6	intermediate monocyte: 7.4;myeloid DC: 7.2;non-classical monocyte: 6.3	Group enriched	Detected in many	73	dendritic cells: 7.2;monocytes: 7.4	Group enriched	Detected in some	7	SCLC-21H: 30.8;SH-SY5Y: 8.2	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA045135			Approved	Vesicles					2400000	Vesicles		HPA045135: AB_2732518	unprognostic (1.01e-2)	unprognostic (1.03e-1)	unprognostic (1.37e-1)	unprognostic (4.95e-2)	unprognostic (4.49e-2)	unprognostic (6.47e-2)	unprognostic (4.19e-1)	unprognostic (1.09e-2)	unprognostic (5.02e-2)	unprognostic (7.22e-2)	unprognostic (1.39e-3)	unprognostic (7.80e-2)	unprognostic (2.40e-6)	unprognostic (4.52e-2)	unprognostic (3.89e-1)	unprognostic (2.39e-4)	unprognostic (3.18e-1)	1.2	12.5	26.4	1.6	11.3	1.3	1.1	20.1	60.8	2.4	1.3	4.3	0	1.5	1.1	1.1	1.1	1.1	1.2	2.5	39.1	23.6	1.1	1.1	1.3	1.1	11.2	25.5	1.1	2.7	1	3.8	1.1	15	1.3	1.4	0	1.3	1.2	1.1	1.2	1.6	1.4	5.3	1.3	2.9	1.4	5.4	0	1.2	0	1.1	1.2	0.2	0	7.2	0	7.4	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.9	0	0	0	0	0	0	0	30.8	8.2	0	0	0	0.2	0	0.2	0	0	0.1	0	0	0	0	0	0	0	0	0	1.1	0	0	7.4	0	0	0	0	7.2	0	0	0	0	0	6.3	0	0	0.5	26.4	11.3	20.1	29.3	39.1	23.6	11.2	25.5	15	5.4	0	0	0	0	0.1	0.7	0.8	0	0	0	0	0	0	0	0	1.2	0	0	0	0	0	0	0.1	0	0	0.3	20.6	0	0	0	0.7	0.6	0.7	0	3.6	0	0.5	1	0	0.4	0	0.7	0	0	0.2	0	0.1	0	0	0	0	Horizontal cells
CRYBB1		ENSG00000100122	Crystallin beta B1	P53674	22	26599278-26618088	Disease related genes, Plasma proteins, Predicted intracellular proteins		Eye lens protein	Cataract, Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		blood: 10.6;epididymis: 17.4	Cell type enriched	Detected in some	36	Hofbauer cells: 64.7	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Group enriched	Detected in some	5	intermediate monocyte: 10.6;non-classical monocyte: 7.5	Lineage enriched	Detected in many	6	monocytes: 10.6	Group enriched	Detected in some	5	Karpas-707: 21.5;RPMI-8226: 38.7	Not detected	Not detected			Not detected	Not detected			HPA003448, CAB010058	Supported								93000			CAB010058: AB_668166, HPA003448: AB_2732396	unprognostic (1.31e-1)	unprognostic (5.56e-3)	unprognostic (1.39e-2)	unprognostic (1.44e-2)	unprognostic (2.29e-1)	unprognostic (2.18e-1)	unprognostic (7.89e-3)	unprognostic (1.51e-1)	unprognostic (9.51e-2)	unprognostic (1.05e-1)	unprognostic (1.10e-1)	unprognostic (1.33e-1)	unprognostic (3.88e-4)	unprognostic (2.62e-2)	unprognostic (1.23e-2)	unprognostic (3.22e-1)	unprognostic (1.76e-2)	3	3	2.5	2.1	2.2	1.1	2	0.3	4.4	1.2	1.1	5.6	0	1.1	1.1	17.4	1.4	1.5	2.3	2.8	2.4	1.9	1.1	1	2.9	3.1	3.8	0.3	1.2	2.6	0.7	1.7	8.3	1.9	2.7	0.8	1.7	1.3	1.1	1.1	0.4	0.9	1.6	3.6	5.7	1	1	1	0.8	0.6	0	1	2.3	0.7	0.3	1.7	0.5	10.6	0.4	0	0.6	0	0	0.1	0	0	0	0	0	0.1	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	2.7	0	0	0	0.7	5.9	0	0	0	0	0	0	0	0	21.5	0	0	0	0.1	0.9	0	0	0.4	0	38.7	0	0	0	0.1	0	0	0	0.1	0	2.2	0	0.1	0.2	0	0	0.8	0.1	0.8	0	1.1	0	0	1	0	0	10.6	0	0.3	0	0	1.7	0	0	0	0.5	0.4	7.5	0	0	0.6	2.5	2.2	0.3	4.4	2.4	1.9	3.8	0.3	1.9	1	0	0	0	0	0.2	0	0	0	0	0	0	0	0.4	0	0	0.2	0.1	0	0	0	0.4	0.4	0	1.1	0	64.7	0	0	0	1.3	0	0	1.8	1.7	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.6	0	0	0	Hofbauer cells
SOX10	DOM, WS2E, WS4	ENSG00000100146	SRY-box 10	P56693	22	37970686-37987422	Disease related genes, Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	Activator, DNA-binding	Deafness, Disease mutation, Hirschsprung disease, Kallmann syndrome, Waardenburg syndrome	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 64.4;salivary gland: 98.4	Cell type enriched	Detected in some	12	Melanocytes: 33.7	Not detected	Not detected			Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	704	SK-MEL-30: 62.9;WM-115: 90.5	Low region specificity	Detected in all			Low region specificity	Detected in all			CAB003171, HPA068898	Enhanced		Supported	Nucleoplasm		Yes				Nucleoplasm		CAB003171: AB_2195374, HPA068898: AB_2686054																		3.3	4	21	3.7	33.1	1.6	18.7	3.2	32.8	3.2	8.1	64.4	0.5	2.9	1.8	2.8	2.8	1.9	3.4	3.9	26.9	15.2	1.7	1.7	1.6	1.6	41.3	13.7	2.4	2.2	1.7	0.7	1.6	24.7	2.3	3.9	22.8	98.4	7.1	1.8	15.8	3.8	3.2	46.6	1.8	2.4	3.1	42.5	0	1.7	0	1.6	2.5	3.2	0	0.2	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	62.9	0	0	0	0	0	0	0	0	0	0	0	0.1	0	90.5	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	21	33.1	3.2	24.6	26.9	15.2	41.3	13.7	24.7	42.5	0	0	0	0	2.9	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0.9	0	33.7	0	0	0	0	0	0	0	0	0	0	0.6	0.5	0.6	0	0	0	0	Melanocytes
CYP2D6	CPD6, CYP2D, CYP2D7AP, CYP2D7BP, CYP2D7P2, CYP2D8P2, CYP2DL1, P450-DB1, P450C2D	ENSG00000100197	Cytochrome P450 family 2 subfamily D member 6	P10635	22	42126499-42130906	Enzymes, Predicted intracellular proteins, Predicted membrane proteins	Cholesterol metabolism, Fatty acid metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism	Monooxygenase, Oxidoreductase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	7	liver: 78.0	Cell type enriched	Detected in many	38	Hepatocytes: 435.9	Cancer enriched	Detected in many	35	liver cancer: 90.8	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		Hep G2: 4.4;HMC-1: 6.2;Karpas-707: 1.9;REH: 3.6;T-47d: 2.3;U-266/70: 4.3									HPA045223	Enhanced		Approved	Golgi apparatus		No	No			Golgi apparatus		HPA045223: AB_10962927	unprognostic (4.40e-3)	unprognostic (7.68e-3)	unprognostic (5.45e-2)	unprognostic (1.22e-3)	unprognostic (1.24e-1)	unprognostic (1.29e-4)	unprognostic (3.83e-2)	unprognostic (7.27e-3)	unprognostic (1.13e-1)	unprognostic (1.71e-1)	unprognostic (4.03e-4)	unprognostic (2.11e-2)	unprognostic (5.61e-5)	unprognostic (3.01e-1)	unprognostic (2.23e-1)	unprognostic (4.08e-1)	unprognostic (4.82e-5)	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	2.2	0.1	0.1	3.5	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	78	0.1	0.1	0.1	0.1	0.5	0.3	0	0.1	0.1	0.1	0.1	0	0.1	0.2	0.1	0.1	0	11.2	0.1	0.1	0.1	0.1	0.7	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0.8	0.1	0.5	0	0	0	0	0	1	0	0	0	0	0.1	0.2	0	0	0	0	0.2	0	0.2	0	0	0	0	0.1	4.4	0	0.1	6.2	0	0	0	0	0	0	0.3	0	1.9	0	0.3	0.2	0	0.6	0	0.2	3.6	0	1.1	0	0	0.1	0.3	1.2	0.1	0	0	2.3	0	0	0	1.7	0	0.3	4.3	0	0	0	0.7	0.5	0	0	0	0	0	0.8	0.1	0	0	0	0	0.1	0	0	0	0	0	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0.6	0	0.5	0.5	6.5	0.3	2.5	1.4	0	1.8	2	0.1	1.7	0.6	2.9	0.3	3.9	0	0.5	0.1	0.2	0.5	0	435.9	0.1	11.1	1.2	6.7	6.2	11.4	0	0	0	0	1	0.9	0.5	2.9	1.4	0.5	2	0	0.2	0.7	0.3	1	0.3	0.5	0.8	0.2	Hepatocytes
TCF20	AR1, SPBP	ENSG00000100207	Transcription factor 20	Q9UGU0	22	42160013-42343616	Plasma proteins, Predicted intracellular proteins	Transcription, Transcription regulation	Activator, DNA-binding	Disease mutation, Mental retardation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in many			Cell type enriched	Detected in many	5	Early spermatids: 125.1	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Low cell line specificity	Detected in all							Low region specificity	Detected in all			CAB017849, HPA036786	Approved		Supported	Nucleoplasm,Nuclear bodies						Nucleoplasm	Nuclear bodies	CAB017849: , HPA036786: AB_2675313	unprognostic (2.17e-1)	unprognostic (2.12e-2)	prognostic favorable (1.88e-4)	unprognostic (2.19e-2)	unprognostic (1.19e-1)	unprognostic (2.69e-2)	prognostic unfavorable (4.89e-4)	unprognostic (1.77e-1)	unprognostic (2.36e-1)	unprognostic (1.40e-2)	unprognostic (2.16e-3)	unprognostic (7.30e-2)	unprognostic (1.17e-3)	unprognostic (3.07e-3)	unprognostic (4.94e-1)	unprognostic (2.52e-1)	unprognostic (1.92e-1)	4.1	4.3	10.2	5.5	16.4	5.4	4.6	6.6	17.1	5.4	5.6	22.6	4.4	5.7	6.1	4.3	10.9	5.6	4.2	2.7	7.3	5.4	4.9	4.6	4.7	6.5	14.7	14.6	5.7	6.7	6.9	10.2	4.3	10.5	4.4	6.1	9.9	6.5	4.2	3.1	8.5	6.4	4.6	5.8	5.5	6	9.3	12.2	3.5	9.2	2.3	7.5	5.5	6.8	0.3	0.3	0.9	0.3	0	0.5	0	6.4	3.7	5.5	5	2.9	2.7	5.7	3	3.5	3.5	4.6	5.4	2.7	10.8	2.7	2.6	5	6.5	5.4	6	4.4	7.7	4.3	3.1	3.9	3.6	3.1	7.1	4.2	2.4	6	3.9	7.7	2.6	2.6	4.2	4.6	5.7	1.9	5.8	7.2	3.9	4.1	5.7	3	4.1	3.1	5.7	3.5	6	5.5	2.3	5.1	4.9	5	5.4	2.6	4.4	3.2	4.4	7.1	2.6	3.3	4.6	5.6	5.5	2.7	4.4	3	0	0.1	0	0.4	0	0.4	0.2	0.5	0.1	0	0.3	0.5	0.4	0.9	0	0.3	0.3	0.3	0	10.2	16.4	6.6	17.1	7.3	5.4	14.7	14.6	10.5	12.2	0	8.1	6.5	9.2	20	23.2	5.2	12.7	9.4	5.7	8.7	17.7	5.9	0	9.9	125.1	8.3	11.7	0	6.6	4.6	8.2	12.2	1.1	11.9	5.4	9.5	16.1	8	6.6	27.6	11.5	6.9	6.8	10	13.1	5.1	11.5	14	6	5.6	11.9	6.5	5.1	17.2	13.4	19.9	3.8	11.4	17.9	14.1	Early spermatids
MIOX	ALDRL6	ENSG00000100253	Myo-inositol oxygenase	Q9UGB7	22	50486784-50490648	Enzymes, Predicted intracellular proteins		Oxidoreductase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	43	kidney: 136.7	Cell type enriched	Detected in some	5	Proximal tubular cells: 1814.0	Cancer enriched	Detected in many	16	renal cancer: 56.0	Not detected	Not detected			Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		HDLM-2: 21.8;Hep G2: 4.9;Karpas-707: 11.6;U-266/70: 7.0	Not detected	Not detected			Not detected	Not detected			HPA039451, HPA039562	Enhanced											HPA039451: AB_2676513, HPA039562: AB_2676574	unprognostic (2.11e-1)	unprognostic (4.32e-2)	unprognostic (2.22e-2)	unprognostic (1.30e-2)	unprognostic (9.83e-2)	unprognostic (5.25e-2)	unprognostic (1.61e-2)	unprognostic (3.84e-3)	unprognostic (2.84e-1)	unprognostic (4.72e-2)	unprognostic (1.85e-2)	unprognostic (9.83e-2)	prognostic favorable (2.60e-6)	unprognostic (1.77e-1)	unprognostic (1.50e-1)	unprognostic (1.36e-2)	unprognostic (2.23e-2)	0.1	0	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0	0.8	0.1	0.1	0	136.7	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.4	2.7	0.1	0.1	0.1	0.1	1.3	0.6	3.1	0.7	0.4	1.4	0.4	0	0	0.1	0.3	0.2	0.1	1.8	0.2	0	0	0.1	0.1	0.3	0.1	0.6	0.4	0	0.1	0.1	0	0	21.8	0	0.1	0.3	4.9	2.9	0	0.2	0	0	0.1	0.4	0	0	1	0.1	11.6	0	1.1	0	0.1	0.2	0.5	0.4	0.1	0.1	0.1	2.3	0.1	0.1	0.3	0	0	0.4	0.4	0	1.2	0	0	0.5	0.1	0	7	0.6	0.3	0.1	0	0.2	3.1	0.4	0.6	0.5	0.3	0.2	1.3	0.5	1.4	0.1	0.9	0.5	0.6	1.8	0.4	0.7	0.6	0.4	0.4	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	1.7	2.4	0.8	0.7	0.5	0	0	0	0	94.2	0	0	359.8	0	0	0.1	0	0	0.8	0.1	0.2	0.4	0	0.2	0.1	0	1.2	0.6	0	0	0	0.8	0	0	0.4	0.2	0	0	0	1814	0.2	0	0.2	0.1	0.4	0.1	0.2	0.9	0	0.6	Proximal tubular cells
RASD2	MGC:4834, Rhes, TEM2	ENSG00000100302	RASD family member 2	Q96D21	22	35540868-35554001	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 71.0;seminal vesicle: 25.2	Cell type enriched	Detected in some	4	Sertoli cells: 45.3	Low cancer specificity	Detected in many			Region enhanced	Detected in all		basal ganglia: 71.0	Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		GAMG: 4.3;hTERT-RPE1: 13.4;SK-BR-3: 7.6;U-2 OS: 4.4;U-87 MG: 5.5	Region enriched	Detected in many	8	basal ganglia: 527.8	Region enriched	Detected in all	8	basal ganglia: 265.8	HPA005839	Enhanced		Approved	Plasma membrane,Cytosol						Plasma membrane, Cytosol		HPA005839: AB_1079745	unprognostic (1.76e-2)	unprognostic (1.98e-1)	unprognostic (3.33e-2)	unprognostic (7.00e-2)	unprognostic (1.43e-1)	unprognostic (7.07e-3)	unprognostic (9.76e-2)	unprognostic (5.49e-2)	unprognostic (2.06e-1)	unprognostic (1.12e-1)	unprognostic (1.04e-1)	unprognostic (9.00e-3)	prognostic unfavorable (2.22e-5)	unprognostic (3.75e-2)	unprognostic (1.61e-1)	unprognostic (8.42e-3)	unprognostic (6.22e-2)	1.6	7.9	8.6	2.5	71	3.4	1.3	1.8	23.5	1.1	8.3	2.2	3.2	2.5	3.5	16.4	5.2	6.2	2.5	2.8	4.1	5	0.8	0.5	1.5	0.6	3.4	8	0.8	1	0.9	1	0.4	2.1	9.6	4.4	3.5	4	25.2	13.6	0.8	3.4	7.5	2.2	0.4	1.8	0.6	15.3	0	1.4	0.1	1.4	3.8	1.2	0	0	0	0	0	0.3	0	0.2	2.8	0	0.5	0	0	0.1	0.7	0.2	1.1	0.9	0.1	0.5	0	0.2	2.4	4.3	0.1	0.2	0	1	0	0.7	0	0.1	0	1.4	0	0	0.2	3.3	2.2	0.3	13.4	0	0	0	0	0.2	0.2	0	0.2	0.2	0.2	0.3	1.3	0	0.9	0	0	2	0.3	2.2	7.6	0	0.2	0.6	0.2	0.1	1.8	4.4	0.2	0.8	1.9	0.6	0	5.5	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	8.6	71	1.8	23.5	4.1	5	3.4	8	2.1	15.3	0	0	0	0.2	0	0.6	1.7	0	0	0	0	0	0	0	0.2	0	0.5	0.4	0	0.2	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	10.9	0	0	0.2	0.7	0	0.1	45.3	4.1	0	0.1	0.1	0	0	0.2	0.1	Sertoli cells
ACR		ENSG00000100312	Acrosin	P10323	22	50738196-50745334	Enzymes, Predicted secreted proteins		Hydrolase, Protease, Serine protease		Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	87	testis: 106.3	Cell type enriched	Detected in some	4	Early spermatids: 388.8	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		CAPAN-2: 1.0;Hep G2: 1.8;HUVEC TERT2: 1.1;NTERA-2: 1.7;TIME: 1.5	Low region specificity	Detected in many			Not detected	Not detected			HPA048687	Enhanced				Secreted in male reproductive system							HPA048687: AB_2680494	unprognostic (1.71e-1)	unprognostic (1.26e-1)	unprognostic (1.04e-1)	unprognostic (6.27e-3)	unprognostic (3.58e-2)	unprognostic (8.04e-2)	unprognostic (3.30e-3)	unprognostic (5.41e-2)	unprognostic (1.51e-1)	unprognostic (2.28e-1)	unprognostic (1.34e-2)	unprognostic (2.12e-1)	unprognostic (1.48e-1)	unprognostic (1.23e-2)	unprognostic (1.71e-1)	unprognostic (2.27e-1)	unprognostic (1.25e-1)	0.9	0	0.2	0.2	0.3	0	0.6	0.2	0.3	0.2	0.2	0.2	0.2	0.1	0.3	0.7	0.2	0.4	0.2	0.2	0.2	0	0.2	0.3	0.6	0.2	0.2	0.2	0.2	0.2	0	0.2	0.2	0.2	0.2	0	0.2	0.4	0.2	0.2	0.2	0.2	0.2	0.2	1.2	0	106.3	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0	0	0	0	0	0	0	0	0	0.6	0.5	0	0.6	0.2	0	0	0	0.3	0	1	0	0.2	0	0.2	0	0	0	0	0	0.8	0	0	1.8	0	0	0.1	0	0.3	0	0	0	1.1	0.7	0	0	0	0.4	0	0	1.7	0	0	0.1	0	0	0	0	0.1	0.2	0.1	0	0.1	0.2	0	0	1.5	0	0.7	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0.3	0.2	0.3	0.2	0	0.2	0.2	0.2	0.2	0	0	0	0	0.1	0	0.4	0	0	0	0	0	0	0	0	388.8	1.3	1.1	0	0	0	0	0	0	0	0.1	0	2.9	8.6	0	86.9	3.1	0	0	0	1.3	0	0	0	2.5	0	0	6.5	0	28.8	1.7	0	0	0	1.5	0.1	Early spermatids
CABP7	MGC57793	ENSG00000100314	Calcium binding protein 7	Q86V35	22	29720084-29731839	Predicted membrane proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in some		brain: 30.3;pancreas: 9.6	Cell type enriched	Detected in some	24	Cardiomyocytes: 24.3	Cancer enhanced	Detected in some		pancreatic cancer: 3.9	Region enhanced	Detected in all		hippocampal formation: 30.3	Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Group enriched	Detected in some	12	HEL: 12.7;SCLC-21H: 12.6;SH-SY5Y: 4.0;U-2 OS: 4.2	Group enriched	Detected in many	5	cerebellum: 83.4;hippocampal formation: 224.8;midbrain: 72.1;pons and medulla: 115.1	Region enhanced	Detected in all		hippocampal formation: 65.6	HPA016439	Uncertain											HPA016439: AB_2669357	unprognostic (1.88e-1)	unprognostic (4.75e-2)	unprognostic (1.18e-1)	unprognostic (5.37e-2)	unprognostic (4.55e-1)	unprognostic (2.29e-4)	unprognostic (2.05e-3)	unprognostic (7.96e-2)	unprognostic (8.69e-3)	unprognostic (3.32e-2)	unprognostic (2.61e-1)	unprognostic (1.22e-1)	unprognostic (7.44e-7)	unprognostic (1.25e-4)	unprognostic (3.60e-2)	unprognostic (2.71e-1)	unprognostic (4.72e-3)	0.4	6	2.7	0.5	2.6	0.8	0.3	7.2	6.5	0.3	0.5	1.2	0	1.5	0.3	1.8	0.7	0.4	0.5	0.3	30.3	2	0.3	0.3	0.4	0.5	3.9	1.2	0.4	9.6	0.3	0.1	0.3	16.9	0.4	0.5	2.4	0.8	0.4	0.6	1	3.8	0.4	4.1	0.5	0.4	1.2	2.8	0	0.7	0	0.3	0.4	0	0.6	0.6	1.8	1.6	0.5	1.4	0.6	0.1	0.6	0.2	0.1	0	0	0	0.1	0	0	0	0.1	0.2	0.1	0.2	0	0.4	0.1	0	0	0	0	0.7	12.7	0.4	0.2	0	0.1	0.2	0	0	0	0	0	0	0	0	0.1	0	0.1	0.1	0.1	0.1	0.1	0.3	0.2	0.2	0.4	0	0	12.6	4	0.1	0.2	0.1	0.1	0.5	0	0.1	0.2	4.2	0.1	0.2	0.3	0.2	0.1	0.1	0	0	0	0.8	1.8	0.8	1.3	0.5	0.6	1.1	0.5	0.6	0.4	1	1.4	1.3	0.5	1.6	0.6	0.5	0.6	2.7	2.6	7.2	3	30.3	2	3.9	1.2	16.9	2.8	0	0	0	0	0	0.2	24.3	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0.1	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0.8	0.1	0	0	0	1	0	0	0	0	0	0.2	0	0	0	Cardiomyocytes
CACNA1I	Cav3.3	ENSG00000100346	Calcium voltage-gated channel subunit alpha1 I	Q9P0X4	22	39570753-39689737	FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels	Calcium transport, Ion transport, Transport	Calcium channel, Ion channel, Voltage-gated channel	FDA approved drug targets	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in some		adrenal gland: 4.6;brain: 8.1;lymphoid tissue: 4.3;thyroid gland: 4.1	Cell type enriched	Detected in some	6	Bipolar cells: 18.4	Cancer enhanced	Detected in single		thyroid cancer: 2.1					Cell type enhanced	Detected in some		naive CD4 T-cell: 1.9	Lineage enriched	Detected in single	20	T-cells: 1.9	Cell line enhanced	Detected in some		JURKAT: 1.2;SK-BR-3: 6.1;T-47d: 3.6	Low region specificity	Detected in all			Low region specificity	Detected in all																unprognostic (3.97e-2)	unprognostic (1.42e-1)	unprognostic (1.02e-1)	unprognostic (4.60e-2)	unprognostic (3.52e-2)	unprognostic (1.58e-1)	unprognostic (1.19e-1)	unprognostic (2.63e-1)	unprognostic (7.21e-2)	unprognostic (5.20e-3)	unprognostic (1.64e-2)	unprognostic (8.64e-2)	unprognostic (1.62e-2)	unprognostic (6.14e-3)	unprognostic (1.57e-1)	unprognostic (3.78e-2)	unprognostic (8.27e-4)	0	4.6	3.4	1.9	5.8	1.3	0.2	8.1	7.5	0	0.2			0.2	0	0	0.1	0	0.4	0	5	3.6	0	0	0.2	4.3	0.7		0	0	0	0	0		0	0.1		0	0	0	0.1	0.9	0	0.4	1.3	0.5	1.1			4.1		1.2	0.6	0	0	0	0	0	0	1.9	0.1	0	0.1	0	0	0	0	0.5	0	0	0.1	0.1	0	0	0	0	0	0.8	0	0.1	0	0	0.4	0	0.1	0	0	0	0	1	0	0	0	0	0.2	0	1.2	0	0	0	0.8	0	0	0.1	0.3	0	0	0	0.3	0	0.1	0.2	0	0	6.1	0	0.4	3.6	0	0	0	0.8	0	0	0.2	0	0	0	0.5	0	0	0	0	0	0	0.3	0	1.2	0.5	0	0	1.9	0.7	0	0	0	0	0.8	0.1											0	0	0	0	0	18.4	2.5	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	3.2	0	0	0.3	0	0	0	0	0	0	2.1	0	0	0	0	0.2	0	0	0	0.1	0	0	0	0	0	Bipolar cells
RANGAP1	Fug1, KIAA1835, SD	ENSG00000100401	Ran GTPase activating protein 1	P46060	22	41245611-41286251	Plasma proteins, Predicted intracellular proteins, Transporters		GTPase activation		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	5	Late spermatids: 1320.8	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low cell line specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			CAB004293, HPA050110, HPA062034	Supported		Enhanced	Nuclear membrane,Vesicles,Cytosol		Yes	Yes			Nuclear membrane	Vesicles, Cytosol	CAB004293: AB_2176987, HPA050110: AB_2681018, HPA062034: AB_2684667	unprognostic (1.30e-2)	unprognostic (3.16e-2)	unprognostic (1.66e-1)	unprognostic (7.97e-2)	unprognostic (2.57e-1)	unprognostic (2.54e-1)	prognostic unfavorable (1.08e-4)	unprognostic (8.28e-3)	unprognostic (8.09e-2)	unprognostic (9.87e-2)	unprognostic (5.84e-2)	unprognostic (7.56e-2)	unprognostic (7.07e-3)	prognostic favorable (5.39e-4)	unprognostic (2.06e-1)	unprognostic (2.74e-1)	unprognostic (2.68e-1)	12.2	30.7	23.5	16.9	28.4	28.5	16.1	17.6	41.1	8.5	11.8	23.1	7.3	12.7	9.5	9.4	26.1	11.5	13.7	11.5	26.9	30.4	12	25.1	11.5	19.5	31.7	28.6	10.6	20.2	11	17.7	16.1	28.1	11.4	9.6	7.1	16.3	13.3	12.5	51.6	12.8	12.3	22	14.2	16	64.3	28.3	22.1	12.7	14.4	21.7	13.3	29.2	8.7	7.6	8.2	14.8	7.1	13.1	9.7	58.2	30.6	20	20.9	10.8	8.9	24.3	50.5	27.6	51	26.7	37.1	19.2	31.4	40.8	37	24.6	54.3	36.3	39.8	30.8	25.4	56.3	26.6	29.9	28.9	13.5	42.9	20	8.6	19	36.3	32.2	16.8	26.7	11.8	34.1	22.4	29	49.9	25	34.9	21.8	53.1	36.4	30.7	19.7	33.1	19.9	33.4	18.2	12.1	35.9	31.8	18.5	19.2	18.7	17.3	41.2	39.1	37.5	21.5	41.5	16.7	22.2	29.9	27.3	30.5	22.5	2.8	9.5	8.2	11.2	11.2	13.1	7.9	11.3	10.3	7.1	8.7	10.5	8	2.7	7.1	14.8	7.6	11.6	9.7	23.5	28.4	17.6	41.1	26.9	30.4	31.7	28.6	28.1	28.3	3	24.7	28.1	17.5	20.5	15.2	17.4	22.9	9.4	9.1	8.7	13.7	15.1	3.3	34.2	259.8	12.7	10.1	0	17.4	28.1	9.3	32.2	5.8	17.9	14	14.3	24	11.6	13.4	1320.8	13.8	17.1	11.8	10	13.9	7.8	29	6.5	11.3	11.2	24.4	0	9	18	19.2	27	19.8	23.8	10.9	19.2	Late spermatids
CDKN3	CDI1, KAP	ENSG00000100526	Cyclin dependent kinase inhibitor 3	Q16667	14	54396849-54420218	Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins	Cell cycle	Hydrolase, Protein phosphatase	Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	4	testis: 80.3	Cell type enriched	Detected in many	4	Early spermatids: 2056.4	Low cancer specificity	Detected in all			Low region specificity	Detected in many			Cell type enhanced	Detected in many		T-reg: 16.1	Group enriched	Detected in all	5	NK-cells: 5.8;T-cells: 16.1	Low cell line specificity	Detected in all			Not detected	Not detected			Low region specificity	Detected in all			CAB005285, HPA039311, HPA058874			Enhanced	Cytosol			Yes			Cytosol		CAB005285: AB_2078884, HPA039311: , HPA058874: AB_2683842	unprognostic (3.46e-2)	unprognostic (9.95e-2)	unprognostic (5.79e-2)	unprognostic (6.78e-3)	unprognostic (2.73e-1)	unprognostic (6.08e-2)	unprognostic (1.51e-3)	prognostic unfavorable (4.52e-4)	unprognostic (2.50e-3)	unprognostic (2.85e-3)	prognostic unfavorable (7.46e-4)	unprognostic (5.89e-2)	prognostic unfavorable (0.00e+0)	unprognostic (1.71e-1)	unprognostic (7.30e-2)	unprognostic (7.92e-2)	unprognostic (4.31e-2)	2.4	1	1.6	6.5	1.7	12.8	1.5	1.5	2.5	1	4.5	0.2	0.2	3.8	0.9	1.1	4.4	0.7	0.9	3	1.4	1.9	1	1.1	1.1	8.8	1.7	1.9	0.9	0.7	0	1	2.3	2.8	0.9	5.8	0.9	1.7	0.1	3.9	1.8	4	2.2	1	2.3	1.8	80.3	0.3	18.3	1.1	6.4	9.5	2.1	1.8	2	1.6	1.1	1.4	5.8	16.1	2.9	55.2	21.2	16.3	16.3	2.7	3.3	9.4	13.2	19.5	28.2	31.2	16	27.6	27.2	9.7	20.6	29.7	40.7	24.7	16	52.7	32.6	11.9	13.8	15.3	26.4	2	17.2	9.8	1.2	1	17.6	30.7	9.9	17.9	26.4	6.9	34.8	33.8	39.3	23.8	14	5.7	54.1	46	14.8	14.4	5.9	14.9	12.1	6.7	8.5	24.2	14.3	10.5	12.8	29.6	14.7	6.5	12.5	42.9	19.7	31.2	8.4	9.7	18.7	20.9	24.9	22.8	0	1.3	1.1	1.2	1.4	0.6	2	5.2	4.3	1.6	0.9	2.7	2.2	0.9	5.8	0.9	1.2	16.1	2.9	1.6	1.7	1.5	2.5	1.4	1.9	1.7	1.9	2.8	0.3	0	0	0.8	3.1	8.2	1.4	9.3	0	0	1.2	1.8	2	9.8	0	2.8	2056.4	2	2.9	256.9	2.1	27	6.6	2.2	6.9	1.8	31.5	4.8	7.5	4.9	7.5	483.1	19.8	5.7	1.7	3.6	6.2	1.2	2	6.2	9.9	1.7	2.3	0	2.1	159.2	36.4	5.6	3.4	7	12.8	1.4	Early spermatids
CHGA		ENSG00000100604	Chromogranin A	P10645	14	92923080-92935293	Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins		Antibiotic, Antimicrobial, Fungicide	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	6	parathyroid gland: 577.6	Cell type enriched	Detected in many	49	Intestinal endocrine cells: 6314.9	Cancer enhanced	Detected in many		pancreatic cancer: 114.8	Region enhanced	Detected in many		cerebral cortex: 97.9	Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	134	SCLC-21H: 44.3;SH-SY5Y: 120.8	Low region specificity	Detected in all			Low region specificity	Detected in many			CAB000023, HPA017369, CAB040544, CAB055506, CAB058688	Enhanced		Supported	Vesicles	Intracellular and membrane			295000000	78000000	Vesicles		CAB000023: , CAB040544: , CAB055506: AB_2081135, CAB058688: AB_2665574, HPA017369: AB_1846698	prognostic favorable (7.85e-5)	unprognostic (4.89e-2)	unprognostic (5.96e-2)	unprognostic (1.17e-1)	unprognostic (1.43e-2)	unprognostic (5.95e-2)	prognostic unfavorable (2.40e-4)	unprognostic (1.74e-1)	unprognostic (2.23e-1)	unprognostic (4.56e-2)	prognostic favorable (4.07e-4)	unprognostic (1.85e-1)	unprognostic (8.81e-13)	unprognostic (1.07e-2)	unprognostic (1.77e-1)	unprognostic (9.17e-2)	prognostic unfavorable (3.99e-4)	2	81.9	6.6	3.1	18.7	1.3	1.3	0.5	97.9	1.9	36.1	4	0	15.8	1.3	1.3	1.2	1.3	1.3	1.2	11.2	14	1.3	1.2	1.4	1.2	8	36.1	1.2	15.9	577.6	81.1	1.2	17.1	2	7.9	0.4	1.3	1.3	1.2	1.3	38.8	1.3	2.5	1.3	51.9	32.5	0.7	0	5.9	0	1.2	1.3	0.2	0	0	0.2	0	0	0	0	0	0	0.2	0	0	0	0.1	0	0	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0.1	0	0	44.3	120.8	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	6.6	18.7	0.5	97.9	11.2	14	8	36.1	17.1	0.7	0	0	0	0.2	0.8	10.3	2.2	0	0	0	0	27.5	0.3	0	0	1	0.1	14.4	0	0.3	0.1	0.2	4	0	0	1.2	15.9	6314.9	0	0	3.6	36.8	0	6.8	3.6	28.7	3.2	76.4	23	129	0	11.3	0	0.3	4.9	2.2	0	0.2	0	9	0.1	Intestinal endocrine cells
GALNT16	GalNAc-T16, GALNTL1, KIAA1130	ENSG00000100626	Polypeptide N-acetylgalactosaminyltransferase 16	Q8N428	14	69259277-69357033	Enzymes, Predicted intracellular proteins		Glycosyltransferase, Transferase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in many			Cell type enriched	Detected in some	4	Cardiomyocytes: 38.2	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Low cell type specificity	Detected in single			Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		AF22: 7.4;ASC diff: 9.8;hTEC/SVTERT24-B: 13.9;hTERT-RPE1: 14.2;SCLC-21H: 7.3;U-2 OS: 16.7	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA059136, HPA075325	Approved		Approved	Vesicles,Cytosol					250000	Vesicles, Cytosol		HPA059136: AB_2683919, HPA075325: 	unprognostic (9.71e-3)	unprognostic (7.47e-2)	unprognostic (4.02e-1)	unprognostic (2.30e-2)	unprognostic (6.71e-2)	unprognostic (5.72e-3)	unprognostic (3.18e-3)	unprognostic (1.22e-1)	unprognostic (1.02e-1)	unprognostic (1.28e-2)	unprognostic (3.62e-4)	unprognostic (1.31e-2)	prognostic favorable (5.23e-6)	unprognostic (5.38e-3)	unprognostic (3.34e-2)	unprognostic (3.93e-2)	unprognostic (7.96e-5)	13.6	15.5	20	2.9	17.9	0.8	14.5	16.1	21.7	7.8	4.1	5	4	3.2	6.4	6	5.1	6.5	4.8	27.6	18.3	27.2	5.6	3	4.2	4.2	6.6	25.2	2.8	5.6	4	4.1	1.2	13	4.6	3.4	1.7	28.9	6.6	5.3	7	5	11.3	8.7	14.3	2.4	3.3	3.3	0	3.5	6.3	2.2	5	3.8	0.5	0.2	1.3	0.5	0.3	0.3	0.2	0	0.6	7.4	0.2	9.8	4.5	0	1	0	1.3	1.9	0.4	0	0	0.2	1.2	0.6	0	2.4	0	0.2	0.1	5.1	0	0.1	0.3	0.1	0	0.5	0.4	0	13.9	0	14.2	0.8	0	0	0	2.3	0.3	0	0	1.4	0	0.1	0	3.9	0	0.5	0	7.3	2.4	1.6	0.3	0	0.3	0.2	0	0.1	1.5	16.7	1.9	1.5	0	0	0	1.5	0	0	0.9	0.5	0.1	0.1	0.2	0.2	0.2	0.2	0.1	0	0.5	0.3	0.2	1.3	0.3	0.1	0.2	0.1	0.2	20	17.9	16.1	16.2	18.3	27.2	6.6	25.2	13	3.3	0	0	0	0.5	3.7	1.9	38.2	0	0	0	0	2	0.1	3.3	0	6.4	0.1	0	0	0	0	5.2	0.4	0	0	0.2	0	0	0	0	8.4	0.9	0	3.3	0	0	0.2	0	0	3.5	0	0.6	6.5	9.2	0.7	1.9	2.9	0	0	0	0.4	Cardiomyocytes
SLC10A1	NTCP	ENSG00000100652	Solute carrier family 10 member 1	Q14973	14	69775417-69797289	Predicted membrane proteins, Transporters	Host-virus interaction, Ion transport, Sodium transport, Symport, Transport	Host cell receptor for virus entry, Receptor		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	44	liver: 121.2	Cell type enriched	Detected in some	13	Hepatocytes: 130.2	Cancer enriched	Detected in some	79	liver cancer: 65.2	Not detected	Not detected			Cell type enhanced	Detected in some		neutrophil: 2.7	Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		CACO-2: 4.3	Not detected	Not detected			Not detected	Not detected			HPA042727	Approved											HPA042727: AB_10960691	unprognostic (3.42e-1)	unprognostic (9.39e-2)	unprognostic (1.51e-2)	unprognostic (2.11e-2)	unprognostic (1.93e-2)	unprognostic (6.51e-3)	prognostic favorable (9.53e-6)	unprognostic (6.07e-3)	unprognostic (8.95e-2)	unprognostic (2.17e-1)	unprognostic (5.75e-3)	unprognostic (1.22e-1)	unprognostic (1.71e-2)	unprognostic (1.05e-1)	unprognostic (3.21e-1)	unprognostic (2.45e-1)	unprognostic (5.69e-2)	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	121.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	1	0.3	2.7	0.5	0.1	0.6	0	0.2	0	0.2	0.4	0	0	0.4	0	0	0.1	0	4.3	0.1	0.6	0	0	0.1	0.4	0	0	0	0.2	0.5	0.6	0.3	0.6	0	0.8	0.5	0	0	0	0	0	0	0.1	0.1	0	0	0	0.2	0	0.1	0.1	0.1	0.1	0.3	0	0	0.9	0.1	0.1	0.8	0.5	0	0.1	0.4	0.5	1.1	0.1	0.6	0	0.3	0	0.1	0.9	0.1	0.6	0.1	0	0.3	1.7	0.5	0.3	0.4	0.8	0.5	0.2	0.3	1	0.6	0.4	2.7	0.1	0.5	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.6	0.4	10.2	0	0	0	0	0.1	0	0	1.2	0	0	0	0	0	0	0.1	0	130.2	0.1	0	0	1.8	2.7	3.6	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	Hepatocytes
SLC8A3	NCX3	ENSG00000100678	Solute carrier family 8 member A3	P57103	14	70044217-70189070	Predicted membrane proteins, Transporters	Antiport, Calcium transport, Ion transport, Sodium transport, Transport	Calmodulin-binding		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	5	brain: 17.0;skeletal muscle: 32.1	Cell type enriched	Detected in some	4	Bipolar cells: 33.9	Cancer enriched	Detected in single	8	glioma: 1.4	Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		AF22: 4.0;LHCN-M2: 7.3;SH-SY5Y: 23.9	Low region specificity	Detected in all			Low region specificity	Detected in all																unprognostic (1.65e-1)	unprognostic (5.53e-2)	unprognostic (1.18e-2)	unprognostic (1.51e-2)	unprognostic (2.41e-1)	unprognostic (1.95e-1)	unprognostic (1.69e-1)	unprognostic (3.46e-3)	unprognostic (4.74e-2)	unprognostic (1.64e-1)	unprognostic (1.45e-3)	unprognostic (8.53e-2)	unprognostic (5.86e-2)	unprognostic (1.14e-3)	unprognostic (1.48e-1)	unprognostic (1.48e-1)	unprognostic (3.38e-1)	0.7	2.8	6.1	1.2	6.1	1	0.9	3.8	17	1.4	1.1	3.1	0	1.1	0.9	1	1.1	0.7	1.3	1.5	5.8	8.2	0.6	0.6	1.6	1	4.7	7.1	0.6	1	0.6	1.5	0.7	6.4	1.2	1.1	1.5	0.6	0.8	32.1	0.8	1.2	1.2	2.8	0.7	1.2	0.8	1.9	0	0.6	4.9	0.9	1	0.3	0	0	0	0	0	0	0.7	0	0	4	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0.5	0	0	0	0	0.1	0	0	0	0	0	0	0	0	7.3	0	0	0	0	0	0	0	1.8	0	0	0	0	23.9	0.1	0.2	0	0	0	0	0	0	0	0	0	0.2	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.7	6.1	6.1	3.8	10.6	5.8	8.2	4.7	7.1	6.4	1.9	0	1.1	0	0	0.1	33.9	1.1	0	0	0	0	3.9	0	0	0	0.3	0	0	0	0	0.1	0.2	0	8.1	0	0.1	7.9	0	0	0	0	0	0	0	0	0	0.9	0	0	0	0	1	0	0	0	0	0	0	0	0	0	Bipolar cells
PLTP	BPIFE	ENSG00000100979	Phospholipid transfer protein	P55058	20	45898621-45912155	Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters	Lipid transport, Transport			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	4	Hofbauer cells: 1270.7	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enhanced	Detected in many		basophil: 19.6	Low lineage specificity	Detected in all			Cell line enhanced	Detected in many		ASC diff: 44.9;BEWO: 38.7;HHSteC: 47.5;HSkMC: 61.9;U-87 MG: 65.7	Low region specificity	Detected in all							CAB032873	Approved				Secreted to blood			9720000000	200000000			CAB032873: AB_2283977	unprognostic (1.27e-1)	unprognostic (3.50e-2)	unprognostic (1.51e-1)	unprognostic (2.01e-1)	unprognostic (2.60e-2)	unprognostic (1.02e-1)	unprognostic (1.72e-2)	unprognostic (4.19e-2)	unprognostic (8.30e-2)	unprognostic (3.19e-2)	unprognostic (2.65e-2)	unprognostic (3.87e-1)	prognostic unfavorable (9.52e-8)	unprognostic (3.04e-2)	unprognostic (3.21e-2)	unprognostic (1.21e-1)	unprognostic (9.68e-2)	126.5	44.6	20.2	21.8	20.1	5.4	27	10.3	21.1	41.5	35.4	30.9	6.9	11.8	28	74.6	23.9	41.5	49.9	37.8	18.1	15.9	32.2	13.9	22.6	96.5	15.1	12.2	38.6	83.6	7.4	9	117.5	19.5	28.7	12.5	36.4	36.8	22.5	19.8	17.7	14.4	50.1	11.1	25.7	18.7	30.9	11.5	74.7	13.7	11.4	9.5	40.5	26.7	4.7	10.4	19.6	6.7	2.5	1	1.6	2.6	0.3	18.6	0	44.9	13.7	38.7	1	3.2	3.7	2.2	15.2	3	0.6	31.2	4.5	0	30.7	5.7	0.1	1.7	0.3	0	5.5	0.6	7	47.5	0	6.9	61.9	1.5	9.6	0.1	14.7	8.1	0.6	1.7	8.7	1.2	0.7	0.5	22.9	3.3	2.3	15.2	0.2	0	0.3	0	0	2	7	0.7	21.6	31.1	3.2	0.2	21.6	1.7	9.2	0.2	4.7	0.1	3.8	0.9	0.9	65.7	6.3	1.5	19.6	1.6	16.1	1	3.8	0.8	4.7	0.2	1	1.4	2.1	0	0.6	0.7	2.5	6.7	10.4	0.4	1.6	20.2	20.1	10.3	18.2	18.1	15.9	15.1	12.2	19.5	11.5	0	2.9	0	24.8	36.1	0.4	0.8	5.1	41.5	7.9	26.2	0	13	1.7	2.5	12.9	11.7	0	0	90.6	73.4	153.4	2.1	0	1.9	1270.7	3.2	0	117.9	171.6	15	285.1	24.8	33.7	6.4	0.8	12.7	13.7	0	187	8.2	0.5	32.3	27.1	4.9	6.6	31.2	26.5	4.3	0.6	11.3	Hofbauer cells
VSX1	PPCD, PPCD1, PPD	ENSG00000100987	Visual system homeobox 1	Q9NZR4	20	25070885-25082365	Disease related genes, Predicted intracellular proteins, Transcription factors	Sensory transduction, Transcription, Transcription regulation, Vision	Developmental protein, DNA-binding	Corneal dystrophy, Disease mutation	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Group enriched	Detected in some	4	brain: 17.0;retina: 20.7	Cell type enriched	Detected in some	20	Bipolar cells: 345.7	Not detected	Not detected			Region enriched	Detected in many	7	cerebellum: 17.0	Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Cell line enriched	Detected in some	5	Karpas-707: 9.9	Not detected	Not detected			Not detected	Not detected																unprognostic (1.93e-1)	unprognostic (6.63e-2)		unprognostic (9.68e-3)	unprognostic (4.33e-2)		unprognostic (2.27e-1)	unprognostic (1.97e-1)	unprognostic (4.01e-1)	unprognostic (8.64e-3)	unprognostic (2.70e-2)	unprognostic (1.35e-1)	unprognostic (2.31e-9)	unprognostic (1.53e-2)	unprognostic (2.35e-1)	unprognostic (3.07e-4)	unprognostic (2.38e-1)	0.4	3	2.3	0.4	1.6	1.6	0.4	17	2.8	0.4	0.4	0.4	0.4	0.1	1	0.4	0.4	0.4	0.4	0.5	1.9	2.1	0.4	0.4	0.4	0.4	2.1	0.4	4.6	1.2	1.1	2.7	0.4	0.5	0.5	0.1	20.7	0.4	1	1	0.6	0.5	0.4	1.5	0.4	0.3	0.7	0.4	0.4	0.7	0.4	0.4	0.4	0.4	1	1.5	2.4	0.3	1.3	0.6	0.1	0.1	1.5	0.2	0.2	0	0	0.2	0	0	0	0	0	0.2	0.2	0.2	0	1.8	0.2	0	0	0	0.3	0.2	0.1	0.4	0.3	0	0.3	0.1	0	0	0.1	0	0.2	0	0.9	0	9.9	0	0.2	0	0	0.1	0	0.3	0.1	0.1	0	0	0.2	0.5	0.1	0	0.3	0	0.2	0.8	0.3	0.1	0.3	0	0.1	0	0.3	0	0.3	1	0.1	0.1	2.4	0.3	0.3	0.6	0.3	0.5	0.7	0.4	0.3	0	1	0.4	0.5	2.1	1.3	0.2	1.5	0.1	0.1	2.3	1.6	17	1.4	1.9	2.1	2.1	0.4	0.5	0.4	0	0	0	0	0	345.7	1.2	0	0	0	0	3.9	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	3.2	0	0	0	0	0.3	0	0	0	0	4.3	0.1	0	0	0	16.9	0	0	0.1	0.5	0	0	0	0	0	Bipolar cells
SALL4	dJ1112F19.1, ZNF797	ENSG00000101115	Spalt like transcription factor 4	Q9UJQ4	20	51782331-51802520	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	DNA-binding	Cancer-related genes, Disease mutation, Oncogene	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		parathyroid gland: 8.8;testis: 11.7;thyroid gland: 8.6	Cell type enriched	Detected in some	7	Horizontal cells: 25.4	Cancer enriched	Detected in many	11	testis cancer: 22.7	Not detected	Not detected			Cell type enriched	Detected in single	9	NK-cell: 6.3	Lineage enriched	Detected in single	9	NK-cells: 6.3	Cell line enhanced	Detected in some		AF22: 13.1;AN3-CA: 9.1;BEWO: 17.5;NTERA-2: 31.5;SiHa: 8.0;SuSa: 22.0	Not detected	Not detected			Low region specificity	Detected in all			HPA015291, HPA015791	Enhanced		Enhanced	Nucleoplasm		Yes	No			Nucleoplasm		HPA015291: AB_1856548, HPA015791: AB_1856547	unprognostic (1.30e-1)	unprognostic (2.35e-2)	unprognostic (1.11e-1)	unprognostic (1.09e-3)	unprognostic (3.55e-2)	unprognostic (7.43e-2)	unprognostic (3.63e-2)	unprognostic (1.47e-1)	unprognostic (1.20e-1)	unprognostic (9.23e-2)	unprognostic (2.50e-2)	unprognostic (2.39e-2)	unprognostic (2.42e-8)	unprognostic (5.90e-3)	unprognostic (1.82e-1)	unprognostic (5.00e-5)	unprognostic (7.41e-2)	0.3	0.4	0.3	0.3	0.9	1.2	0.3	0.8	0.9	0.4	0.7	0.3	2.2	0.1	0.3	0.8	0.3	0.2	0.3	0.3	0.3	0.1	0.5	1.9	0.3	0.3	0.3	0.3	0.3	4.6	8.8	0.6	0.3	0.9	3.1	0.2	4.5	2.2	0.4	0.3	0.3	0.7	0.3	0.3	0.8	0.3	11.7	0.3	0.3	8.6	0.3	0.3	0.9	0.3	0.1	0.1	0.6	0.1	6.3	0.2	0	0	0.8	13.1	9.1	0	0	17.5	0	0.1	0	0.1	4.5	0.1	0	0.1	0.1	0.1	2.2	0.1	0	0.1	0.2	0	0	3	0.2	0.1	0	1	0.4	0.2	0	0	0	0.2	0	0	0	0	0.9	0	0	31.5	0.1	0.2	1.2	0	0	0	0.2	3	1.6	8	0	0.7	22	0	0.5	0	0.5	1.8	0.2	0	0	0	0	0	0	0.1	0.2	0	0	0.2	0	0.1	0.1	0	0.1	0	0.1	0.1	0.1	0.6	6.3	0.1	0.1	0	0	0.3	0.9	0.8	0.9	0.3	0.1	0.3	0.3	0.9	0.3	0	1.3	0	0.7	0	0.1	0.3	0	0	0	0	0	0	0	3.5	0	0	0	0	0.2	0	0.4	1.1	0	0	0.2	25.4	1.2	0	0	0	0	0	0	0	0	0.1	0.1	0	0	0	0.4	0	0	0.5	1.7	0	0	0	0	1	Horizontal cells
TCFL5	bHLHe82, CHA, E2BP-1, Figlb	ENSG00000101190	Transcription factor like 5	Q9UL49	20	62841115-62861763	Predicted intracellular proteins, Transcription factors	Differentiation, Spermatogenesis, Transcription, Transcription regulation	Developmental protein, DNA-binding		Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		brain: 32.9;testis: 55.7	Cell type enriched	Detected in many	5	Spermatocytes: 62.7	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low cell line specificity	Detected in all			Low region specificity	Detected in many			Low region specificity	Detected in all			HPA055223, HPA076419	Enhanced		Supported	Nucleoplasm						Nucleoplasm		HPA055223: AB_2682745, HPA076419: 	unprognostic (4.05e-2)	unprognostic (3.14e-1)	unprognostic (2.19e-1)	prognostic unfavorable (3.24e-4)	unprognostic (2.78e-1)	unprognostic (2.72e-3)	unprognostic (3.95e-2)	unprognostic (1.09e-1)	unprognostic (2.10e-1)	unprognostic (2.79e-1)	unprognostic (1.14e-1)	unprognostic (3.88e-1)	unprognostic (1.54e-1)	unprognostic (9.77e-2)	unprognostic (4.89e-1)	unprognostic (1.33e-3)	unprognostic (1.01e-2)	5.4	3.9	18.6	4	18.9	3.7	6.4	4.6	14.8	6.5	4.1	22.5	6.1	3.2	5.7	6.6	6	5.9	5	5.5	20	15.5	5	4.6	3.6	4.7	25.4	10.7	8.3	4.8	7.5	3	4.8	17	4.9	3.8	6.3	4.9	6.3	4.5	10.9	3.5	5.5	32.9	4.1	3.7	55.7	12	8.3	14.9	2.1	5	4.6	3.2	1.4	1.9	2.9	1.6	1.2	3.2	0.7	12.9	3.9	8.6	9.9	18.6	18.9	7.7	8.4	11.7	16.4	9.2	9.5	8	6.6	9.7	7.4	8.8	14.3	8.6	9.5	14.4	4.6	7.2	5.4	11.2	14	7.3	7.9	6.6	6.9	14.2	4.6	9.7	7.1	7.4	10.2	6	2.5	7.6	15.7	34.7	10	5.6	10.8	12.4	19.2	15.1	9.2	4.4	3.8	12.4	6.7	14.9	6.1	22.7	6.3	10.4	14.8	7.9	13.1	8.6	11.4	9.8	6.4	4.3	5.5	7.9	9.9	7.1	0.5	1.6	2.9	3.2	1.5	1.9	1.3	2.3	2.1	1.2	1.4	2.5	1.7	2.8	1.2	1.5	1.9	2.3	0.7	18.6	18.9	4.6	14.8	20	15.5	25.4	10.7	17	12	0	1	0	1.2	9.3	9.2	3.6	2.5	0	1.2	7	5.9	0.5	1.7	1.2	11.4	3.6	1.4	0	1.1	0.8	3.1	1.4	0	2.9	0.9	7.9	2.4	3.1	4.4	5.9	7.2	1.7	3.3	1	2.4	9.7	0.8	1.9	6.7	1.7	6.7	0	2.1	62.7	8.4	12.4	0.2	1	2.6	0.9	Spermatocytes
CHRNA4	BFNC, EBN, EBN1	ENSG00000101204	Cholinergic receptor nicotinic alpha 4 subunit	P43681	20	63343223-63378401	Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters	Ion transport, Transport	Ion channel, Ligand-gated ion channel, Receptor	Disease mutation, Epilepsy, FDA approved drug targets	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	4	brain: 16.4;liver: 38.8;parathyroid gland: 21.6	Cell type enriched	Detected in some	5	Horizontal cells: 131.9	Cancer enhanced	Detected in some		liver cancer: 1.4	Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	5	U-2 OS: 7.6	Low region specificity	Detected in many			Group enriched	Detected in many	5	midbrain: 22.6;pons and medulla: 19.3;thalamus: 29.6	CAB034064	Uncertain											CAB034064: AB_2080535	unprognostic (3.40e-1)	unprognostic (1.71e-1)		unprognostic (2.87e-2)	unprognostic (3.98e-1)	unprognostic (8.03e-2)	unprognostic (1.75e-1)	unprognostic (1.22e-1)	unprognostic (1.74e-1)	unprognostic (2.10e-3)	unprognostic (5.72e-4)	unprognostic (9.02e-3)	unprognostic (9.79e-4)	unprognostic (6.77e-2)	unprognostic (1.08e-1)	unprognostic (3.81e-2)		0.6	0.8	5.2	0.6	8.7	0.6	0.6	3.1	14.5	0.6	0.6	11	0	0.6	0.6	0.6	0.6	2	0.6	0.6	5.1	6.8	2.1	38.8	0.7	0.6	11.3	8.2	0.7	0.6	21.6	1	0.6	16.4	1.3	0.6	5.7	0.6	0.6	0.6	0.6	0.6	0.6	3.9	4.8	0.6	1.9	3.9	0	1.2	0	0.6	0.6	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	7.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5.2	8.7	3.1	14.5	5.1	6.8	11.3	8.2	16.4	3.9	0	0	0	0	0	20.2	2.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	25.2	0	131.9	0	0	1	1	0	0	0	0	0	0.8	0	0	0	2.8	2.3	0	0	0	1.2	0	0	0	0	0	Horizontal cells
HAO1	GOX, GOX1	ENSG00000101323	Hydroxyacid oxidase 1	Q9UJM8	20	7882981-7940474	Enzymes, Predicted intracellular proteins		Oxidoreductase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	594	liver: 121.8	Cell type enriched	Detected in some	44	Hepatocytes: 293.3	Cancer enriched	Detected in some	184	liver cancer: 93.4	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HL-60: 1.7;RH-30: 2.3;U-251 MG: 2.5	Not detected	Not detected			Not detected	Not detected			HPA049552, HPA072442	Enhanced								200000			HPA049552: AB_2680814, HPA072442: 					unprognostic (4.88e-2)		unprognostic (2.87e-3)				unprognostic (1.08e-2)	unprognostic (1.25e-1)						0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	121.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0.3	0	0	0	0.1	0	0	0	0	0	0	0	0	0	1.7	0	0	0	0	0	0	0	0	0.3	0	0	0	0.1	0	0	0	0	0	2.3	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	2.5	0.1	0	0.8	0	0.4	0.1	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.5	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	293.3	0	0	0	6.7	6.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Hepatocytes
E2F1	RBBP3, RBP3	ENSG00000101412	E2F transcription factor 1	Q01094	20	33675683-33686404	Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors	Apoptosis, Cell cycle, Host-virus interaction, Transcription, Transcription regulation	Activator, DNA-binding	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		bone marrow: 32.5;lymphoid tissue: 21.9	Cell type enriched	Detected in many	5	Spermatogonia: 37.5	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enhanced	Detected in some		non-classical monocyte: 3.7	Low lineage specificity	Detected in many			Low cell line specificity	Detected in many			Low region specificity	Detected in many			Low region specificity	Detected in many			CAB000329, HPA008003, CAB019308, HPA029735	Enhanced		Supported	Nucleoplasm,Centrosome			Yes			Nucleoplasm, Centrosome		CAB000329: AB_627476, CAB019308: , HPA008003: AB_1847936, HPA029735: AB_2673176	unprognostic (7.46e-2)	prognostic favorable (9.22e-6)	unprognostic (2.11e-2)	prognostic unfavorable (4.33e-5)	unprognostic (1.51e-1)	unprognostic (1.21e-2)	prognostic unfavorable (3.83e-5)	unprognostic (1.25e-2)	unprognostic (8.23e-2)	unprognostic (9.66e-2)	prognostic unfavorable (4.18e-4)	unprognostic (3.15e-2)	prognostic unfavorable (8.99e-5)	unprognostic (1.05e-2)	unprognostic (7.50e-2)	prognostic favorable (1.62e-4)	unprognostic (1.91e-1)	2.4	5.3	6.8	12.7	9.7	32.5	2.1	1.1	6.4	1.2	4.4	5.1	0.7	3.9	1.4	0.8	5.1	1.5	4.1	2	7.1	3.6	0.9	1.7	8.1	9.3	6.2	2.9	3.4	1.2	2.3	0.3	3.3	5.9	1.7	4.8	0.3	1.6	1.4	1.4	5.4	4.9	3.3	6.2	4.8	3.4	12.1	6	21.9	1	4.9	7.7	1.9	3.1	2.2	0.6	0.7	3.7	1.4	1.2	0.6	16	15.6	18.1	14.1	1.8	1.3	13.8	15.4	7.5	19.7	16.6	27.6	16.6	29.6	15.6	6.9	23.9	12.1	8.8	8.2	8.8	8.9	12.6	24.2	23.2	16	0.1	11.3	15.3	1	0.5	10.8	1.9	2	5	18.6	6.4	20.9	12.1	14.2	24	24	5.4	16.2	22.5	23.9	49.4	12.2	3.3	9.8	27.1	19.1	18.8	13.1	7.6	5.4	16.4	14.3	2.7	23	13.5	15.9	21.8	20.5	13.8	24.4	19.2	6.7	13.6	0	0	0.7	0.1	0.9	0	2.2	0.6	0.4	0.2	0.2	0.2	1.2	0.3	1.4	3.7	0.6	0.8	0.6	6.8	9.7	1.1	6.4	7.1	3.6	6.2	2.9	5.9	6	0	0.6	2.9	0.7	2.6	2.2	0.4	0	0	2.3	0	0	2.6	0	0.9	0.7	0.1	0.5	0	0.2	7.9	1.1	0.6	0	0.8	3.8	0	0	0.6	0	2.3	2	0.9	1.7	0	2.9	1.2	0.5	0	1.1	0	2	0	0.9	3.8	37.5	1.5	1.5	0.7	4.6	0.9	Spermatogonia
SLC32A1	bA122O1.1, VGAT, VIAAT	ENSG00000101438	Solute carrier family 32 member 1	Q9H598	20	38724462-38729372	Predicted membrane proteins, Transporters	Neurotransmitter transport, Transport			Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	9	brain: 38.3	Cell type enriched	Detected in some	14	Horizontal cells: 55.6	Cancer enhanced	Detected in single		glioma: 1.0	Low region specificity	Detected in all			Cell type enriched	Detected in single	20	plasmacytoid DC: 1.9	Lineage enriched	Detected in single	20	dendritic cells: 1.9	Group enriched	Detected in some	12	MOLT-4: 5.5;SH-SY5Y: 1.7	Low region specificity	Detected in all			Low region specificity	Detected in all			CAB037156, HPA058859, HPA059985	Enhanced	Supported										CAB037156: AB_532294, HPA058859: AB_2683836, HPA059985: AB_2684187					unprognostic (1.13e-2)					unprognostic (2.09e-1)				unprognostic (1.17e-1)	unprognostic (6.57e-2)			1	1.1	4.6	1	38.3	1.5	1	4.9	25.8	1	1	0.8	0	1	1	1	1	1.1	1	1	3.9	9.7	1	1	1	1	4.4	6.8	1	1.1	1	4.1	1	10.4	1	1	0.7	1	1	1	1	1.1	1	4.4	1	1	1.6	7.9	0	1	0	1	1	0	0	1.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	5.5	0	0	0	0	0	0	0	0	0	0	1.7	0	0	0.1	0	0	0	0	0	0.1	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.9	0	0	4.6	38.3	4.9	11.9	3.9	9.7	4.4	6.8	10.4	7.9	0	0	0	0	0	1.3	0.3	0	0	0	0	3.9	0	0	0	1.5	0	0	0	0	0	0	0	0	0	0	55.6	1.7	0	0	0	0	0	0	0	0	0.9	0	0	0	0	3.1	0	0	0.9	0.4	0	0	0	0	0	Horizontal cells
CST4		ENSG00000101441	Cystatin S	P01036	20	23685640-23689040	Predicted secreted proteins		Protease inhibitor, Thiol protease inhibitor		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	94	salivary gland: 705.3	Cell type enriched	Detected in single	9	Collecting duct cells: 8.7	Low cancer specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	4	CACO-2: 6.8;RT4: 16.7									HPA043706, HPA044763	Supported				Secreted to digestive system				2700000			HPA043706: AB_2678627, HPA044763: AB_2679080	unprognostic (2.80e-1)		unprognostic (7.88e-2)	unprognostic (2.48e-1)		unprognostic (1.09e-1)		unprognostic (2.59e-1)		prognostic unfavorable (4.98e-5)	unprognostic (1.00e-2)	unprognostic (9.52e-2)		unprognostic (2.11e-2)	unprognostic (2.31e-1)	unprognostic (7.95e-2)	prognostic favorable (2.88e-4)	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	2.5	0.1	0.1	0	1.6	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.8	0	0.1	0.1	0.1	7.5	0	0.1	705.3	0.3	0.1	0	0.1	0.1	0.1	0.1	0	0.2	0.1	0.1	4.7	0.1	0.1	0.1	0.1	0	0.1	0.2	0.1	0	0	0	0	0	0	0	0	0.1	0	0	0.1	0	0	6.8	0	1.5	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	2.6	0	0.2	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	1	16.7	0	0	0	0.1	0	1.8	0	0	2.7	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0.1	0	0	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	0	0.1	0.1	0	0.4	0	0	0	8.7	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0.1	0	0.1	0	0	0	0	0.3	Collecting duct cells
MYOM1		ENSG00000101605	Myomesin 1	P52179	18	3066807-3220108	Predicted intracellular proteins		Muscle protein		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	6	heart muscle: 111.4;skeletal muscle: 153.1;tongue: 51.6	Cell type enriched	Detected in many	17	Cardiomyocytes: 1033.7	Cancer enhanced	Detected in many		liver cancer: 6.5	Low region specificity	Detected in many			Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Group enriched	Detected in some	9	HAP1: 16.6;HMC-1: 4.5;HSkMC: 8.1	Low region specificity	Detected in single			Not detected	Not detected			HPA014305, HPA049193	Enhanced								32000			HPA014305: AB_1854257, HPA049193: AB_2680670	unprognostic (2.51e-1)	unprognostic (2.08e-3)	unprognostic (2.19e-3)	unprognostic (8.01e-3)	unprognostic (8.94e-2)	unprognostic (4.31e-2)	unprognostic (9.10e-2)	unprognostic (1.59e-1)	unprognostic (9.27e-2)	unprognostic (1.87e-1)	unprognostic (2.38e-1)	unprognostic (1.63e-2)	unprognostic (2.01e-1)	unprognostic (9.15e-2)	unprognostic (4.90e-2)	unprognostic (1.73e-1)	unprognostic (2.62e-1)	6.2	0.6	1.3	0.9	1.2	0.3	0.8	0.6	0.7	1	2.4	0.3	0.4	0.5	2.9	10.1	6	1.3	3	111.4	1.1	1.3	0.4	16.6	0.4	0.4	2.2	0.1	0.9	6.4	0.3	0.3	0.5	0.9	2.6	0.7	3.4	4.6	1.1	153.1	0.3	0.9	9.3	2	0.3	0.7	1.2	0.1	0	1.6	51.6	4.6	5	0.5	0.7	3	0.6	0.4	0.8	2.1	1.1	0	0.1	0.3	0	0.9	1	0.4	0.5	0.6	0	0	0.1	0.1	0.5	0.1	0.2	0.2	0	16.6	0.1	0.2	0.5	0.1	0.1	0.1	0.1	0.1	0	4.5	8.1	0.4	0.3	0.1	0.4	0.1	0.3	0	0.5	0.3	0	0.2	0.4	0.1	0.3	0	0	0	0.1	0	0.1	0.2	0.2	0.6	0	0.1	0.4	0	0.2	0.3	0	0.7	0.3	0	0.5	0	0	0	0.1	0.7	0	0.4	0.6	0.9	0.4	0.5	0.7	0.6	0.5	0.5	0.6	1	2.1	0.5	0.8	0	3	0.2	1.1	1.3	1.2	0.6	0.7	1.1	1.3	2.2	0.1	0.9	0.1	0	0.3	4.6	2.1	1.4	1.7	1033.7	30.6	1.4	1.2	0	2	0.4	0	0.7	10.2	0.9	0.6	0	5.6	0	0.9	0.7	0	6	0.2	1.6	0	3.7	0.6	8.9	2	1	0	1	0.9	0	2	62.6	3.9	0	1.3	6.5	6.6	2.3	1.9	1.1	1.8	1.3	0.6	0.6	Cardiomyocytes
CEP76	C18orf9, FLJ12542, HsT1705	ENSG00000101624	Centrosomal protein 76	Q8TAP6	18	12661833-12702777	Cancer-related genes, Predicted intracellular proteins			Cancer-related genes	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	5	Early spermatids: 203.5	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Cell line enhanced	Detected in all		OE19: 36.9	Region enriched	Detected in many	11	cerebellum: 70.6					HPA039395	Approved											HPA039395: AB_10673357	unprognostic (3.39e-1)	unprognostic (2.99e-2)	unprognostic (2.26e-1)	unprognostic (9.31e-3)	unprognostic (1.65e-1)	unprognostic (1.37e-1)	unprognostic (2.57e-4)	unprognostic (2.99e-1)	unprognostic (4.00e-4)	unprognostic (7.88e-3)	unprognostic (2.45e-1)	unprognostic (8.70e-2)	unprognostic (1.67e-2)	unprognostic (4.39e-2)	unprognostic (2.37e-1)	unprognostic (5.70e-2)	unprognostic (8.21e-2)	6.1	7.5	6.2	6.8	9.9	10.4	7.9	18.6	10.2	7.8	5.9	4.4	5.2	5.3	7	11	12	5.9	5.4	5.4	5.4	6.3	6.5	9.6	5.6	7.1	5.3	9.1	7.9	6.7	6.5	9.9	6.9	8.8	6	8.3	5	8.2	7.9	11.4	10.3	6.4	7.1	5.3	6.1	6.8	18.4	5.9	15.7	7.6	6	9.3	7	7.4	4.4	3.6	3.5	7.1	6	6.6	3.7	4.3	4.5	7.7	3.6	4.5	2.4	7.4	5.1	5.9	10.2	7.8	10.1	5.3	5.9	4.6	3.3	5.9	3.5	7.3	3.3	8.7	3.6	6.1	5.3	5.5	8.7	3.4	11.8	6.1	1.9	3.3	6	3.9	2.8	5.3	8.3	8.6	9	6.5	3.3	10.4	8.5	5.6	36.9	3	7.3	6.6	6.3	5.3	4.4	5.7	5.1	6.5	4.1	4.1	5.3	3	6.7	4.9	6.9	13.9	6.6	6.1	5	8.7	6.9	3.5	5.9	4.5	0.8	3.9	3.5	4.9	7.1	6.6	3.4	5.3	5.8	3.6	4.4	5.3	6	1.4	6	2.9	2	5.8	3.7	6.2	9.9	18.6	10.2	5.4	6.3	5.3	9.1	8.8	5.9	6	5.1	3.7	3.3	8.7	5.7	1.6	2.5	4	6.8	0	11.8	4.5	1.7	2.6	203.5	2.4	5.1	0	2.2	6.3	3.5	3.8	5.7	3.9	3.5	3.2	5.8	3.1	2.5	39.5	3.4	3.5	6.8	2.8	5.5	2.3	3.2	0	4.2	2.1	7	6.5	2.2	21.9	21.5	7.2	5.1	3.2	3.3	3.3	Early spermatids
POLA1	NSX, p180, POLA	ENSG00000101868	DNA polymerase alpha 1, catalytic subunit	P09884	X	24693919-24996986	Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins	DNA replication, Host-virus interaction	DNA-binding, DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase	Disease mutation, Dwarfism, FDA approved drug targets, Mental retardation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	4	Erythroid cells: 46.7	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low cell line specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA002947, CAB012274	Supported		Supported	Nucleoplasm,Cytosol						Nucleoplasm	Cytosol	CAB012274: , HPA002947: AB_1079652	unprognostic (6.92e-2)	unprognostic (4.43e-3)	unprognostic (3.27e-3)	unprognostic (1.53e-2)	unprognostic (2.53e-1)	unprognostic (1.49e-1)	prognostic unfavorable (4.80e-5)	unprognostic (1.87e-1)	unprognostic (9.25e-3)	unprognostic (2.48e-2)	unprognostic (8.41e-2)	unprognostic (7.42e-2)	unprognostic (2.09e-1)	unprognostic (1.44e-1)	unprognostic (3.66e-2)	unprognostic (3.48e-2)	unprognostic (3.08e-1)	10.5	5.5	8	15	10.2	14.3	10.9	12	9.6	10.1	9.7	11.8	5.8	5.7	11.2	7.7	10.2	8.9	5.5	9.3	7.8	6.6	6.1	4.9	7.2	12.7	10.3	4.5	12.9	7.3	8.5	8.5	10.7	8.7	7.3	11	7.5	7.9	9.3	22.4	9.3	7.5	9.7	13.1	9	7.9	5.7	10	30.1	7	8.5	14.7	9.9	10.6	4.6	2.5	1.2	4.6	2.7	3.8	1.7	14.3	10.7	14.1	11.4	2.6	3.2	3.1	10.7	5.8	11.5	13.2	8.8	7.5	18.3	3.6	4.5	10.3	11.8	26.8	8.6	15.6	9.5	11.4	13.6	20.9	6.6	1.1	17.8	7.3	2	1.8	14.3	4.1	2.9	5.9	9.5	12.5	9.3	8	9.9	19.3	5.9	13.7	9.6	9	17.3	37	13.8	4.2	9.4	12.8	7.9	12.6	6	5.7	16.3	11.8	5.9	4.6	10.2	7	19.4	10.2	5.6	8.1	14.7	5.9	8.5	11.3	0	2	1.2	3	4.6	2.9	4.6	3.4	3.8	2.5	3.2	2.4	2.4	0.6	2.7	1.3	1.6	3.6	1.7	8	10.2	12	9.6	7.8	6.6	10.3	4.5	8.7	10	8.9	6.2	2.2	3.8	2.5	2.9	9.3	0	9.4	11.4	1.8	2	4.3	3.3	2.8	0.3	3.6	1.5	46.7	2.6	4.3	2.4	2	9.2	2.8	3.9	1.6	4.1	3.7	4.3	0.4	5.8	2.4	0	1.8	3.7	4.5	1.3	0	3.2	1.2	7.2	6.5	3.8	3.4	4.2	1.9	1.9	2.9	4.3	2.2	Erythroid cells
RHOXF1	OTEX, PEPP1	ENSG00000101883	Rhox homeobox family member 1	Q8NHV9	X	120109053-120115937	Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	DNA-binding		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	5	blood: 8.1;brain: 9.2;testis: 27.8	Cell type enriched	Detected in some	39	Spermatogonia: 154.2	Low cancer specificity	Detected in some			Region enhanced	Detected in many		cerebellum: 9.2	Cell type enriched	Detected in some	6	T-reg: 8.1	Lineage enriched	Detected in single	30	T-cells: 8.1	Cell line enhanced	Detected in some		HDLM-2: 3.2;HEK 293: 3.9;NB-4: 2.8									HPA052560, HPA056506	Approved		Enhanced	Nucleoplasm,Cytosol						Nucleoplasm	Cytosol	HPA052560: , HPA056506: AB_2683157	unprognostic (5.03e-3)	unprognostic (1.22e-2)	unprognostic (5.22e-2)	unprognostic (2.31e-2)	unprognostic (8.65e-2)	unprognostic (1.07e-3)	unprognostic (2.46e-1)	unprognostic (3.15e-1)	unprognostic (3.89e-1)	unprognostic (2.15e-1)	unprognostic (7.50e-4)	unprognostic (1.97e-1)	unprognostic (5.85e-4)	unprognostic (3.00e-1)	unprognostic (7.96e-2)	unprognostic (2.26e-1)	unprognostic (1.73e-3)	2.8	0.5	0.9	0.5	1.1	0.3	0.9	9.2	1.7	0.5	0.7	0.5	0.5	0.2	0.5	0.5	0.5	1.5	0.5	0.5	0.8	2.4	0.8	0.5	0.5	0.6	0.8	0.5	2.2	0.5	0.8	0.9	1.1	0.5	0.5	0.1	0.5	0.8	0.6	0.5	2.4	0.5	0.5	0.5	0.5	0.2	27.8	0.5	0.5	0.5	0.5	0.5	0.5	0.5	0.1	0.2	0	0	0	8.1	0	0	0	0.7	0.2	0.5	0	0	0	0	0	0	0	0.2	0	0.2	0	0	0	0.3	0	0	3.2	3.9	0.4	0	0	0.4	0	0.2	0	0	0	0	0.6	0	0.8	0	0.3	0	0	0	2.8	0	0	0	0	0	0	0	0	0.3	0.9	0	0	0	0.2	0	0	0	0	0	0	0	0	0.9	0	0	0.3	0	0	0	0	0	0	0	0.1	1.3	0	0.1	0.1	0.5	0	0	0	0	0.2	8.1	0	0.9	1.1	9.2	1.7	0.8	2.4	0.8	0.5	0.5	0.5	0	0	0	0	0.3	0.6	0.1	0	2.7	0	0	3.9	0.1	1.7	0.1	1	0.1	0	0	0.4	0.2	0	0.1	0	0	0.1	0	0	0	0	2.5	0.6	0	0	0	0.1	0.8	0	0	1.4	0	1.3	0	0	2.9	154.2	0.3	0	0	0.1	0	Spermatogonia
GUCY2F	CYGF, GC-F, GUC2DL, RetGC-2, ROS-GC2	ENSG00000101890	Guanylate cyclase 2F, retinal	P51841	X	109372906-109482072	Enzymes, Plasma proteins, Predicted membrane proteins	cGMP biosynthesis, Sensory transduction, Vision	Lyase		Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	10	retina: 23.1	Cell type enriched	Detected in some	33	Rod photoreceptor cells: 33.5	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	5	THP-1: 4.5;U-266/70: 1.6;U-937: 1.5	Not detected	Not detected			Region enhanced	Detected in single		hypothalamus: 0.4																	unprognostic (1.91e-1)	unprognostic (4.45e-2)									unprognostic (2.96e-1)	unprognostic (2.23e-1)			0	0.1	0	0	0.1	0	0	0	0.2	1.6	0	0	0	0	0.4	0	0	2.3	0	0	0	0.2	0	0	0.1	0	0	0	0	0.1	0	0.4	0	0	0	0	23.1	0	0	0	0	0	0	0	0	0	1.7	0	0	0	0	0	0	0.1	0	0	0	0	0	0.1	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0.1	0.3	0	0.1	0	0	0	0	0.2	0	0	0.2	0	0	0.4	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4.5	0	0	0	0	0.1	1.6	0	0.1	0	1.5	0.5	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0.6	0.2	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	33.5	0	0	0	0	0	0	0	0	0	Rod photoreceptor cells
ATP1B4		ENSG00000101892	ATPase Na+/K+ transporting family member beta 4	Q9UN42	X	120362085-120383249	Predicted intracellular proteins, Predicted membrane proteins	Transcription, Transcription regulation			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	9	skeletal muscle: 47.3;tongue: 26.1	Cell type enriched	Detected in single	16	Cardiomyocytes: 1.6	Not detected	Not detected			Not detected	Not detected			Low cell type specificity	Detected in some			Low lineage specificity	Detected in single			Cell line enriched	Detected in single	4	HSkMC: 3.1	Not detected	Not detected			Not detected	Not detected																				unprognostic (2.59e-2)	unprognostic (6.02e-4)						unprognostic (5.78e-1)		unprognostic (5.29e-2)				1.3	0	0.1	0	0.1	0	0	0	0.1	0.1	0	0	0	0	0	4.2	1.7	0.1	0	2.4	0.1	0.1	0	0.2	0	0	0.1	0	0	0	0	0.1	0	0	1	0	0	0.4	0	47.3	0.1	0	0	0.1	0	0	0.1	0	0	0.4	26.1	2.5	0	0	0.7	0.2	1.4	0.3	0.7	0.3	1	0.1	0.1	0.1	0.4	0	0.1	0.1	0.5	0	0	0.1	0	0.2	0	0.1	0.2	0.2	0.1	0	0	0.2	0.1	0.7	0.3	0.3	0.5	0.1	0.2	0.3	3.1	0	0.2	0	0.4	0	0	0.1	0.1	0	0.4	0.2	0.1	0.2	0.2	0	0.2	0.2	0.1	0	0.1	0.3	0.2	0.1	0.1	0	0.2	0.7	0	0.6	0.5	0.4	0.3	0.2	0	0	0.3	0.4	0.4	0.1	1.3	0.3	0.3	0.3	0.1	0.2	0.3	0.1	0.2	0.1	0.7	0.3	0.3	1.4	0.7	0.3	0.2	0.2	1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0	1.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Cardiomyocytes
MCF2	ARHGEF21, DBL	ENSG00000101977	MCF.2 cell line derived transforming sequence	P10911	X	139581770-139708227	Plasma proteins, Predicted intracellular proteins		Guanine-nucleotide releasing factor	Proto-oncogene	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		adrenal gland: 30.7;brain: 23.1;seminal vesicle: 18.8;testis: 18.2	Cell type enriched	Detected in some	12	Cone photoreceptor cells: 92.3	Not detected	Not detected			Low region specificity	Detected in all			Cell type enhanced	Detected in single		NK-cell: 1.0	Low lineage specificity	Detected in single			Cell line enriched	Detected in some	11	U-251 MG: 28.9	Low region specificity	Detected in many			Low region specificity	Detected in all																unprognostic (2.42e-1)	unprognostic (2.18e-2)	unprognostic (1.46e-2)	unprognostic (5.11e-4)	unprognostic (8.95e-2)	unprognostic (3.99e-2)	unprognostic (1.24e-1)	unprognostic (2.28e-1)	unprognostic (1.80e-1)	unprognostic (1.28e-1)	unprognostic (2.63e-2)	unprognostic (7.77e-2)	unprognostic (2.33e-3)	unprognostic (3.68e-2)	unprognostic (2.92e-2)	unprognostic (4.62e-4)	unprognostic (4.02e-2)	0.7	30.7	5.2	0.8	8.1	1	0.5	3.3	12.4	0.5	0.5	0.9	12.5	0.5	0.5	13.4	0.5	1.2	1.1	1.4	7.1	11.3	2	0.6	0.5	1	8.9	5.7	11.5	0.7	0.5	3.3	0.5	23.1	1.8	0.5	2.8	1.3	18.8	0.6	0.6	0.5	0.5	6.3	1.3	0.6	18.2	2.4	0	1.6	0	0.6	0.6	0.1	0.1	0.3	0.6	0.1	1	0.7	0	0	0	0.1	0.2	0	0	0	0	0	0	0.1	0	0	0.2	0.4	0	0	0	0.1	0	0.1	0.2	0.1	0	0.3	0	0	0	1.3	0	0.1	0	0.1	0	0	0.1	0	0.4	2.5	0	0.4	0.4	2	0	0	0.1	1.5	0	0	0	0.2	0	0	0	0	0.2	0	0.1	0	0	0.2	0.4	28.9	0	0.1	0	0.1	0	0	0	0.1	0	0	0	0	0	0	0.7	0	0.1	0.1	0.2	0.6	1	0	0.3	0	0	5.2	8.1	3.3	12.4	7.1	11.3	8.9	5.7	23.1	2.4	0	0	0	0.4	0.1	1.3	1.7	0	0	0	0	92.3	0	0	0	1	0	0	0	0	0	0	0.1	0	0	0.1	0	0	0	0.6	1.8	1.1	0	0	1.8	0	0.8	0.1	0	7.8	0.6	1.7	0	0	0.2	0.4	0	0	0	0	0.1	Cone photoreceptor cells
F9	FIX	ENSG00000101981	Coagulation factor IX	P00740	X	139530758-139563458	Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins	Blood coagulation, Hemostasis	Hydrolase, Protease, Serine protease	Disease mutation, FDA approved drug targets, Hemophilia, Thrombophilia	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	2334	liver: 233.6	Cell type enriched	Detected in some	20	Hepatocytes: 475.1	Cancer enriched	Detected in single	1354	liver cancer: 67.6	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HL-60: 1.8;RH-30: 2.0;SiHa: 1.6;U-698: 1.1	Low region specificity	Detected in single			Not detected	Not detected								Secreted to blood				11000000000										prognostic favorable (6.69e-4)											0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	233.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0.6	0	0	0	1.8	0.2	0	0.1	0	0	0	0	0	0.5	0	0	0	0	0	0.2	0	0	0	2	0	0	0	0	0	1.6	0.1	0	0	0	0	0.3	0	0	0	0	0.3	0	1.1	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	7	0	0	0	0.2	17.8	0	0	0	0	0	0	0	0	0	0	23.3	0	0	0	0	0	475.1	0	0	0	15.4	17.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Hepatocytes
LUZP4	CT-8, CT28, HOM-TES-85	ENSG00000102021	Leucine zipper protein 4	Q9P127	X	115289727-115307556	Predicted intracellular proteins	mRNA transport, Transport	RNA-binding		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	142	testis: 21.2	Cell type enriched	Detected in some	5	Spermatogonia: 24.3	Cancer enriched	Detected in some	9	testis cancer: 13.7	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		SK-MEL-30: 2.4;U-266/70: 1.1									HPA046436, HPA051999	Enhanced											HPA046436: AB_10964168, HPA051999: AB_2681688															unprognostic (1.84e-1)			0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	21.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.4	0.2	0	0	0	0.2	0	0.2	0	1.1	0.4	0.7	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.9	0.3	0	0	0	0	0	0	0	1.1	0	0	0	0	5	24.3	0	0	0	0	0	Spermatogonia
OPN1LW	CBBM, CBP, COD5, RCP	ENSG00000102076	Opsin 1, long wave sensitive	P04000	X	154144224-154159032	Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins, Transporters	Sensory transduction, Vision	G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer	Disease mutation	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in some	11	retina: 14.0	Cell type enriched	Detected in some	29	Cone photoreceptor cells: 683.3	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected																																	unprognostic (6.05e-2)								0.3	0.2	0	0	0	0.3	0.1	0	0	0.2	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	14	0	0	0	1	0	0.2	0	0.1	0	1.2	0	0	0.2	0	0.4	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5.9	0	0	0	0	0	683.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	6.4	0	0	0	0	0	0	0	0	0	7	0	0	0	0	23.8	0	0	0	0.1	0	0	0	0	0	Cone photoreceptor cells
CAB39L	bA103J18.3, FLJ12577, MO2L	ENSG00000102547	Calcium binding protein 39 like	Q9H9S4	13	49308650-49444126	Plasma proteins, Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	5	Early spermatids: 123.2	Cancer enhanced	Detected in all		prostate cancer: 28.8	Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Cell line enhanced	Detected in many		CACO-2: 24.4;RT4: 25.5	Low region specificity	Detected in all			Low region specificity	Detected in all			CAB003686, HPA045954, HPA076632	Approved		Approved	Vesicles						Vesicles		CAB003686: AB_426084, HPA045954: AB_2679512, HPA076632: 	unprognostic (3.90e-2)	unprognostic (1.09e-1)	unprognostic (4.13e-1)	unprognostic (5.01e-1)	unprognostic (3.29e-1)	unprognostic (1.94e-1)	unprognostic (2.82e-1)	unprognostic (2.94e-2)	unprognostic (2.78e-2)	prognostic unfavorable (2.28e-4)	unprognostic (3.08e-2)	prognostic favorable (7.91e-4)	prognostic favorable (1.94e-13)	unprognostic (6.59e-2)	unprognostic (8.31e-2)	unprognostic (4.96e-2)	unprognostic (8.05e-3)	19.6	32.1	18.4	5.6	18.2	2.1	32.6	17.6	22.6	12.9	33.2	13.1	19	5.5	11.5	14.8	25.6	12.5	13.6	14.5	22.2	16.3	12.8	5	12.2	3.7	29.6	19.5	17.6	10.2	17.9	10.7	10.3	26.4	35.8	10.2	7.6	13.8	20.7	4.9	10.6	8	21.1	23.3	3.8	18.8	24.1	24.9	2.5	8.9	9.1	4.6	21.3	13	3.8	3.9	9.9	3.8	2.7	5.3	3.2	1	1	6.7	1.9	6.6	6.6	9.2	6	12.8	3.7	3	24.4	3.5	8.3	0.8	4	4.2	1.9	3.5	4.3	7	2.9	3.2	2.2	1.5	1.7	3.4	1.8	1	4.9	3.8	3	4.7	5.2	4.7	1.4	0.3	2	5.7	1.6	1.9	1.6	5.2	3.2	1.7	1.6	0.9	1.3	5.8	25.5	0.8	2.6	3.2	7.2	7.8	7.8	11.2	3.4	4.8	1.7	1.7	3.4	4.9	1.5	1.4	9.6	1.9	1.8	4	9.9	3.8	7.9	4.4	3.5	3.2	3.8	5.2	5.3	3.9	2.9	4	3.7	8.4	2.7	2.9	0.5	5.2	3.2	18.4	18.2	17.6	22.2	22.2	16.3	29.6	19.5	26.4	24.9	14.9	11	0	11.2	2.7	5.6	13.7	5.1	24.1	11.4	10.4	5.9	22.7	10	8.3	123.2	2.9	1	0	9.4	10.1	12	23.2	4.6	1.9	5.6	1.6	2.4	5.5	2.2	17	14.4	4.3	11.8	7.2	2.3	11.5	7.7	0	11	3.7	5	6.5	11.7	8.2	3	3.9	24.3	1.8	1.9	20	Early spermatids
SGCG	A4, DAGA4, DMDA, DMDA1, LGMD2C, MAM, MGC130048, SCARMD2, SCG3, TYPE	ENSG00000102683	Sarcoglycan gamma	Q13326	13	23180952-23325165	Disease related genes, Plasma proteins, Predicted membrane proteins			Disease mutation, Limb-girdle muscular dystrophy	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	5	heart muscle: 40.9;skeletal muscle: 53.3;tongue: 44.3	Cell type enriched	Detected in some	10	Cardiomyocytes: 116.6	Low cancer specificity	Detected in some			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	5	fHDF/TERT166: 38.1	Low region specificity	Detected in some			Not detected	Not detected			HPA007476	Enhanced											HPA007476: AB_1079946	unprognostic (5.19e-2)	unprognostic (8.28e-2)	unprognostic (5.15e-3)	unprognostic (1.64e-4)	unprognostic (3.00e-3)	unprognostic (3.61e-2)		unprognostic (8.14e-3)	unprognostic (1.46e-1)	unprognostic (2.29e-1)	unprognostic (4.49e-1)	unprognostic (6.05e-2)	unprognostic (2.23e-2)	unprognostic (2.85e-2)	unprognostic (3.10e-1)	unprognostic (2.98e-3)	unprognostic (1.07e-1)	8.6	0.1	0.1	0.2	0.1	0	2.9	0.2	0.6	0.1	0.4	0.1	0.1	0	0.1	3.8	2.6	0.3	0.3	40.9	0.3	0.1	0.1	0.1	1.7	0.1	0.1	0.1	0.1	0.1	1.6	0.1	0.1	0.1	1.2	0.1	0.5	2.1	0.1	53.3	1.3	0.2	0.1	0.1	0.1	0.4	0.6	0.1	0.1	0.7	44.3	3.3	0.7	0.7	0	0	0	0	0	0.7	0	0	0	0.7	0	0.1	0	0	0	0	0	0	0	0	0	1.1	38.1	0	0	0.1	0	0	0	0.1	0	0	0	7.4	0	0.1	0.4	0.4	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0.1	0	0	0	0.1	0	0	0	0	1.5	0	0.3	0.2	0	0.1	0	0.1	0.2	0	0	2	0	0	0	0	0	0.7	0	0.4	0	0.2	0.5	0	0	0	0.4	0	0	0	0	0	0	0.1	0.1	0.2	0.6	0.3	0.1	0.1	0.1	0.1	0.1	0	0	0	0	3	0	116.6	0	0	0	0	0	0	0	0	1.5	0	0	0	0	0	2.6	0	0	0	1.2	0	0	0	0	1.4	6.9	0.2	5	0	0	0	0	0	1.1	0	0	0	1.4	1.4	12.1	0.9	0	0	0	0	Cardiomyocytes
ACOD1	CAD, IRG1	ENSG00000102794	Aconitate decarboxylase 1	A6NK06	13	76948497-76958642	Enzymes, Predicted intracellular proteins	Immunity, Inflammatory response, Innate immunity	Antimicrobial, Lyase		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		liver: 3.0;lymphoid tissue: 5.8	Cell type enriched	Detected in single	9	Distal tubular cells: 1.7	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	6	PC-3: 1.1;U-87 MG: 3.4	Not detected	Not detected			Low region specificity	Detected in all			HPA040143	Uncertain											HPA040143: AB_10793916	unprognostic (2.39e-1)	unprognostic (6.42e-2)	unprognostic (2.37e-1)			unprognostic (3.54e-2)		unprognostic (3.09e-1)	unprognostic (8.30e-2)	unprognostic (4.30e-2)			unprognostic (1.64e-5)	unprognostic (7.70e-2)	unprognostic (3.68e-2)		unprognostic (6.51e-3)	1.4	0.1	0	5.8	0	0.6	0	0.1	0	0	1.2	0	0	0	0	1.4	0	0.1	0.1	0.1	0	0	0.3	3	1.1	4.3	0	0	0	0	0	0	1.6	0	0	0	0.5	0	0	0	0	0.1	0.3	0	0.8	0.8	0.3	0	0.6	0	0	0.1	0.5	0	0	0	0	0.9	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0.1	0	0	0	0	0	0.2	0	0	0.2	0.3	0	0	0	0	0.2	0	0	0	0	0	0.3	0.2	0	0	0	0	0	0	0	0	0	0	0	1.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0.2	0	0	3.4	0	0	0	0.7	0	0	0.9	0	0	0	0	0	0	0	0	0	0	0.8	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.7	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Distal tubular cells
MT4	MTIV	ENSG00000102891	Metallothionein 4	P47944	16	56565049-56568957	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level	No human protein/transcript evidence	Evidence at transcript level		Tissue enriched	Detected in some	5	skin 1: 42.3	Cell type enriched	Detected in some	4	Suprabasal keratinocytes: 17.2	Group enriched	Detected in many	6	cervical cancer: 6.7;endometrial cancer: 11.6	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	19	HaCaT: 2.5;K-562: 1.2	Region enhanced	Detected in single		thalamus: 0.4	Not detected	Not detected																														unprognostic (8.81e-2)			0.8	0	0.1	0.1	0.1	0	0.1	0.1	0.2	1.5	0.1	0.1	0.1	0	0.1	0.1	1.8	0	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.7	42.3	0.1	0.1	0.1	0.1	0	2	0.1	0.6	0.1	8.5	0.1	0.1	6.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	0	0	4.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	17.2	0	0	0	0	Suprabasal keratinocytes
DHODH		ENSG00000102967	Dihydroorotate dehydrogenase (quinone)	Q02127	16	72008588-72027664	Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins	Pyrimidine biosynthesis	Oxidoreductase	Disease mutation, FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in all	5	liver: 72.4	Cell type enriched	Detected in many	5	Hepatocytes: 106.1	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low cell line specificity	Detected in all			Low region specificity	Detected in all							HPA010123, HPA011942	Approved		Enhanced	Nucleoplasm,Mitochondria,Cytosol						Mitochondria	Nucleoplasm, Cytosol	HPA010123: AB_1847648, HPA011942: AB_1847649	unprognostic (4.88e-2)	unprognostic (1.10e-1)	unprognostic (1.90e-1)	unprognostic (2.12e-2)	unprognostic (1.41e-3)	unprognostic (2.10e-1)	unprognostic (4.27e-2)	unprognostic (1.31e-2)	unprognostic (1.26e-1)	unprognostic (2.68e-1)	unprognostic (2.14e-1)	unprognostic (6.40e-2)	unprognostic (9.26e-3)	unprognostic (1.98e-1)	unprognostic (1.97e-1)	unprognostic (1.14e-1)	unprognostic (1.81e-1)	5.9	4.2	4.7	8.8	5.1	2.9	5	2.7	5	5.9	4.4	6.1	1.4	3.4	6.6	2.3	5.1	5.2	2.3	11.5	4.3	3	6.6	72.4	3.4	5.5	4.8	2.7	6.2	9.9	7.1	4	2.6	5.2	3.9	4.8	5.9	6	4.4	11.7	4	3	7.5	4	3.5	3.4	4.3	5.4	4	3.6	7.1	5.1	3.5	3.3	11.2	13.4	3.9	8.1	9.3	12.9	6.8	7.4	15.5	4.5	7.5	2.4	3.2	8.6	6.4	2.6	9.7	7.5	12.2	6.8	16.8	8.7	3.5	5.4	7.9	8.9	6.9	11.5	3.8	8.4	9.2	7.5	12	6.8	12.7	6.8	3.1	7.1	11.7	12.3	3.1	7	11.4	14	3.1	5.9	19.8	12	12.2	10.2	12.7	6.1	15.2	5.9	17.7	5.8	4.9	5.4	6.3	8.6	9.2	4.2	5.8	8.2	6.4	3	8.9	5.5	8.4	9.3	5.9	10.9	28.4	4.6	14	8.1	3.9	8.1	0.9	9.3	7.7	12.7	11.2	8.9	9	13.3	10.6	12.4	12.9	2.1	9.3	5.6	13.4	7.1	6.8	4.7	5.1	2.7	5	4.3	3	4.8	2.7	5.2	5.4	3	9.6	9.5	6.4	4.9	5.7	12.1	7.6	9.4	1.2	7	3.9	12	5	6.6	2.1	6.7	0.7	0	4.4	9.6	6	5	8.1	106.1	6.9	3.2	1.2	2.5	5.3	2.3	2.6	3.4	11.8	3.6	4.4	4.8	5.2	2.9	2.1	20.1	4.2	0	9.9	7.9	8	3.3	2.4	5	6.2	4.1	Hepatocytes
PARD6A	PAR-6, PAR-6A, PAR6alpha, TAX40, TIP-40	ENSG00000102981	Par-6 family cell polarity regulator alpha	Q9NPB6	16	67660946-67662778	Plasma proteins, Predicted intracellular proteins	Cell cycle, Cell division			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		brain: 26.8;pancreas: 31.0	Cell type enriched	Detected in many	5	Late spermatids: 203.1	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Cell line enhanced	Detected in many		REH: 17.4	Low region specificity	Detected in all			Low region specificity	Detected in all			CAB009733, HPA041551	Approved		Supported	Cell Junctions,Actin filaments,Cytosol		No	No			Cell Junctions, Actin filaments	Cytosol	CAB009733: AB_2159676, HPA041551: AB_2677545	prognostic favorable (5.40e-4)	unprognostic (6.18e-2)	unprognostic (1.77e-1)	unprognostic (1.33e-2)	unprognostic (7.63e-2)	unprognostic (4.08e-3)	unprognostic (1.23e-2)	unprognostic (1.27e-1)	unprognostic (6.59e-2)	unprognostic (2.09e-1)	unprognostic (1.98e-3)	unprognostic (9.13e-2)	prognostic favorable (3.08e-7)	unprognostic (9.22e-3)	unprognostic (6.69e-2)	unprognostic (1.25e-1)	unprognostic (1.39e-2)	2.7	6.1	11.7	3.5	12.4	2.1	2.8	26.8	16.1	2	3	2.2	3.7	2	2.4	3.6	2.7	2.5	3.1	2.3	13.8	7.2	5.5	3.1	3.5	4	7.9	5.7	3.3	31	5.3	13.9	1.5	7.4	2.7	2	1.4	3.8	4.6	7	1.5	2.5	2.7	3.7	3.7	3.2	16.9	3.4	2.5	2.3	1.4	3.4	2.9	3.1	11.4	5.3	3.7	1	1.2	8.5	2.1	5.5	6	1.7	14.8	1.2	0.2	3.1	0.1	0.7	2.2	2.1	3	2.3	9.4	2.8	0.1	0.8	4.4	3.4	0.7	0.5	4.4	3.2	3.8	2.8	3.4	1.6	1.5	8.9	0.1	0.3	2.1	0.8	1.4	1.1	14.1	0.3	2.2	0.4	5.5	9.6	2	2	7.7	3.9	17.4	1.1	15.2	5.9	3.2	14.3	7.7	0.9	2.1	2.3	0.5	12.9	0.6	0.9	0.2	0.5	1.4	2.9	2.3	7.3	8.4	1.7	3.4	0.6	2.1	1	0.4	4.5	0.5	8.5	11.4	6.4	5.9	1.2	7.4	3.2	2.4	3.7	1.2	0.1	5.3	6.1	2.1	11.7	12.4	26.8	16.1	13.8	7.2	7.9	5.7	7.4	3.4	3	4.3	8.1	1.4	0.8	9.7	1	12.7	4	2.3	19.2	3.9	4.6	28.2	6.6	42.8	2.7	2.1	0	13.1	0.2	2.4	2.1	5.7	3.8	4	30.2	32.6	1.3	3.2	203.1	3.4	3.1	5	1	2.4	15.2	5.2	2.6	1.4	12.9	7.6	0	2.1	4.6	2.6	1.4	2.4	9.6	2.9	1.4	Late spermatids
SMPD3	NSMASE2	ENSG00000103056	Sphingomyelin phosphodiesterase 3	Q9NY59	16	68358325-68448688	Enzymes, Predicted intracellular proteins, Predicted membrane proteins	Cell cycle, Lipid metabolism, Sphingolipid metabolism	Developmental protein, Hydrolase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		blood: 44.5;intestine: 46.4;lymphoid tissue: 73.0	Cell type enriched	Detected in many	6	Horizontal cells: 284.4	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Cell type enriched	Detected in some	7	plasmacytoid DC: 44.5	Lineage enriched	Detected in many	7	dendritic cells: 44.5	Cell line enhanced	Detected in some		HMC-1: 9.6;MOLT-4: 13.6;RPMI-8226: 11.3;SCLC-21H: 13.1	Region enhanced	Detected in many		basal ganglia: 103.1	Low region specificity	Detected in all			CAB033885, HPA065535, HPA069383	Approved		Supported	Endoplasmic reticulum						Endoplasmic reticulum		CAB033885: AB_1126788, HPA065535: , HPA069383: 	unprognostic (1.21e-1)	prognostic favorable (7.72e-4)	unprognostic (5.61e-3)	prognostic favorable (3.86e-4)	unprognostic (2.46e-1)	unprognostic (5.85e-4)	unprognostic (7.87e-2)	unprognostic (8.12e-3)	unprognostic (2.77e-2)	unprognostic (1.30e-1)	unprognostic (1.75e-1)	unprognostic (1.81e-1)	unprognostic (1.04e-3)	unprognostic (5.02e-3)	unprognostic (2.49e-1)	unprognostic (1.19e-1)	unprognostic (1.93e-3)	3.5	2.3	6	3.1	18.3	1.8	1.6	9.4	15.4	1	9.6	2.5	0	46.4	1.7	0.7	1.8	2.7	17.2	1.2	8.7	3.6	0.9	3.8	2.1	3.5	2.5	5	2.7	1.9	0.7	10.7	0.8	3.9	2.2	5.8	4.3	2.2	0.9	1.8	8.1	42.7	1.2	1.4	3	18.6	4.2	4.4	73	1.3	1.3	4.3	1.6	1.2	0.6	44.5	6.1	0	0	0.7	0.3	0.3	0.7	0.3	0.1	0	0	5.3	0.4	0	0.4	0.1	2.9	0.9	0.4	0.5	0.2	0.2	1.1	0	0	0.1	0.3	0.7	0.1	2.1	0.3	0	0	9.6	0	0	0	0.2	0.5	0	0.9	0.8	0.3	0.3	0.2	13.6	2.6	0.6	4.6	0.1	0.6	0.2	11.3	0	0.1	13.1	2.6	0.4	1.5	0.6	0.3	1	0.9	0	0.4	0.8	1.4	0.1	2.2	1.1	0.2	0.2	0.9	0.2	1	0	6.1	0.7	0	0.1	0.6	0	0.2	0	0.2	0.2	0.1	0	0	0	44.5	0.5	0.3	6	18.3	9.4	15.4	8.7	3.6	2.5	5	3.9	4.4	3	0.6	0	1.4	0.1	39.5	2.5	5.1	16	1.2	0	0	0	0	0.9	6	0	51.1	0	0.8	0.2	0.3	3.7	0	5	0.2	284.4	24.8	0	0.6	13	14.1	0	0	0	25.6	0.8	1.2	43	43.2	0	3.3	0	0	5.4	0.3	0.9	0	5	18.7	4.7	Horizontal cells
SEC14L5	KIAA0420, PRELID4B	ENSG00000103184	SEC14 like lipid binding 5	O43304	16	4958317-5019158	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	4	brain: 29.4;heart muscle: 7.5;skeletal muscle: 11.0	Cell type enriched	Detected in some	9	Cone photoreceptor cells: 80.5	Low cancer specificity	Detected in some			Low region specificity	Detected in all			Cell type enhanced	Detected in single		neutrophil: 1.6	Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		ASC TERT1: 4.2;RPMI-8226: 4.2;SCLC-21H: 6.5;T-47d: 4.3	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA041492, HPA041825			Uncertain	Golgi apparatus,Cytosol						Golgi apparatus, Cytosol		HPA041492: AB_10794519, HPA041825: AB_10794526	unprognostic (1.90e-3)	unprognostic (4.08e-2)	unprognostic (5.93e-2)	unprognostic (1.46e-1)	unprognostic (1.99e-1)	unprognostic (5.68e-2)	unprognostic (7.33e-3)	unprognostic (8.71e-4)	unprognostic (6.87e-2)	unprognostic (1.56e-4)	unprognostic (1.01e-3)	unprognostic (7.12e-2)	unprognostic (1.07e-1)	unprognostic (5.61e-2)	unprognostic (1.56e-1)	unprognostic (1.67e-1)	unprognostic (1.45e-2)	1.1	1.7	7.4	1.3	17.5	1.5	1.2	2.2	22.1	2.8	1.7	29.4	0	1.4	0.9	1.2	2	2.2	1.1	7.5	13.5	6.1	1.1	0.8	1	1.4	25.8	8.8	1.7	1.8	0.8	1.7	1.3	15.2	1.7	2.1	0.3	1.9	1.1	11	2.9	1.1	0.9	25.2	1.2	3.7	1.4	15.6	0	0.9	0.5	1.7	0.9	0.4	0.1	0.4	1.6	0	0.1	0.2	2.9	0	0.4	0.6	0.3	0.6	4.2	0.6	0.1	0	0.1	0	0.5	0.2	0.2	0.3	0.5	0.1	0.6	0.2	0.1	0	0	0.5	2	0.4	1.1	0.3	0	0.4	0.6	0.9	0.1	0.1	0.3	0.1	0.2	0.2	0.4	0.1	0.3	0	0.2	1.3	1	0.3	0.1	0.4	4.2	0.3	0.1	6.5	0.2	0.4	0.3	0.5	0.7	4.3	0	0.5	0.2	0.4	0.3	0	0.2	0	0.2	1.1	0.2	0.2	0.3	0	0	0.2	0	0.1	0	0.1	0.1	0	0.1	0.1	0.1	1.6	0.1	0	0.4	0	2.9	7.4	17.5	2.2	20	13.5	6.1	25.8	8.8	15.2	15.6	0	0	0	0.1	0.2	3.7	8.9	0	0	0	0	80.5	0.6	0	0.1	1.1	0	0	0	0.2	0.1	0.5	0	0	0	0.2	4.8	0	0	0	0.2	0.3	0	0	0	0.3	0	0	0	0.4	0	1.8	0	0	0	0.1	0.1	0.2	0	0.4	0	Cone photoreceptor cells
METRN	C16orf23, MGC2601	ENSG00000103260	Meteorin, glial cell differentiation regulator	Q9UJH8	16	715115-719655	Predicted intracellular proteins, Predicted secreted proteins	Differentiation, Neurogenesis	Developmental protein		Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		brain: 58.9	Cell type enriched	Detected in many	8	Muller glia cells: 554.6	Cancer enhanced	Detected in all		glioma: 69.7	Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		MCF7: 53.4;PC-3: 41.3	Region enriched	Detected in all	5	cerebellum: 549.1	Low region specificity	Detected in all			HPA051164	Approved		Approved	Nucleoplasm,Nuclear membrane,Cytosol	Secreted in brain					Nuclear membrane	Nucleoplasm, Cytosol	HPA051164: AB_2681369	unprognostic (1.60e-2)	unprognostic (3.49e-1)	unprognostic (4.47e-2)	unprognostic (2.96e-1)	unprognostic (1.45e-1)	unprognostic (7.49e-2)	unprognostic (1.82e-1)	unprognostic (2.59e-1)	unprognostic (8.13e-2)	unprognostic (2.35e-1)	unprognostic (2.12e-2)	unprognostic (3.32e-1)	unprognostic (5.03e-3)	unprognostic (3.62e-2)	unprognostic (1.26e-1)	unprognostic (3.09e-1)	unprognostic (2.17e-2)	7.7	14.9	44.7	5.1	58.9	2.6	4.6	14.2	45.4	4.1	7	24.1	19.8	5.6	5.3	7.8	3.1	27.4	6.4	12.4	39.6	31.6	10.5	8.5	6	4.2	45.7	15.1	2.7	43.1	5.2	15.1	5.3	15.3	7.4	2.5	9.2	27.3	16.8	21.5	3.9	5.9	4.4	39.5	5.4	8.3	4.6	19	2.5	6.6	3.4	3	3.9	5	3.2	0.9	0.8	1	1.7	2.9	0.5	2.6	22.5	4.4	22.5	7.9	4.4	7.2	5.3	2.7	2.1	1.4	3.3	6.6	0.4	12.5	3.7	8.2	9.9	0.6	5.2	0.3	1.4	9.9	0.9	4.1	17	4.8	1.9	2.9	10.7	5.7	0.6	1.3	6.7	0.7	6.3	1.5	0.5	1.6	53.4	0.7	6.5	1.6	2.9	41.3	7.3	5.1	7.3	5.5	0.7	7	8.9	2.1	5.9	27.4	0.5	8.9	3.8	2.4	6.1	11.7	7.1	4.6	3.4	0.9	0.4	9.6	1.4	14.4	0	0.3	0.8	2.9	1	1.7	3.2	1.5	2.7	0.2	0.5	0.9	1.9	0	1.7	1	0.9	2.8	0.5	44.7	58.9	14.2	27.4	39.6	31.6	45.7	15.1	15.3	19	0	2.1	4.2	14.7	3.4	38.6	14	50.9	2.7	0	15.7	13.7	0.6	43.1	6.3	6.5	12.6	15	0	4.2	1.8	8.7	28.3	0	27.2	5.2	66.7	26.2	19	5.1	14.5	10.3	4.8	10.1	0	8.1	554.6	5.4	14.7	8.9	43.5	29.1	25.8	15.3	3.9	11.3	2.6	0.3	6.4	8.6	14.2	Muller glia cells
CRYM	DFNA40	ENSG00000103316	Crystallin mu	Q14894	16	21238874-21303083	Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins		Oxidoreductase	Deafness, Disease mutation, Non-syndromic deafness	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		blood: 23.7;brain: 61.3;heart muscle: 45.9	Cell type enriched	Detected in many	4	Muller glia cells: 521.3	Cancer enhanced	Detected in many		prostate cancer: 14.6	Region enhanced	Detected in many		basal ganglia: 61.3	Cell type enriched	Detected in single	26	plasmacytoid DC: 23.7	Lineage enriched	Detected in single	26	dendritic cells: 23.7	Cell line enriched	Detected in some	4	RPTEC TERT1: 31.2	Group enriched	Detected in many	12	amygdala: 129.0;basal ganglia: 245.8;cerebral cortex: 127.4;hippocampal formation: 355.0	Low region specificity	Detected in all			HPA019086, HPA030619	Enhanced		Supported	Cytosol					110000	Cytosol		HPA019086: AB_1847260, HPA030619: AB_2673551	unprognostic (1.32e-1)	unprognostic (2.93e-3)	unprognostic (8.96e-2)	unprognostic (1.44e-1)	unprognostic (2.13e-1)	unprognostic (4.62e-2)	unprognostic (2.88e-1)	unprognostic (5.75e-3)	unprognostic (2.81e-1)	unprognostic (7.37e-2)	unprognostic (2.05e-2)	unprognostic (5.95e-2)	unprognostic (2.11e-3)	unprognostic (7.79e-3)	unprognostic (2.49e-2)	unprognostic (1.87e-3)	unprognostic (1.31e-1)	1.4	0.5	7.6	0.5	61.3	0.5	1	15.6	21.2	1.8	2.2	0	0	0.7	0.8	0.3	2.3	0.5	2.3	45.9	6.5	2.1	17.8	4.2	2.7	0.5	1	15.5	0.5	0.8	0.6	3.3	0.3	0.1	10.5	2.6	1	4.8	0.3	4	1.4	1	2	0.9	0.5	0.6	1.6	1.2	0	0.5	0	1.5	8.3	0.8	0.9	23.7	0	0	0	0	0.3	0	1.2	0	0	0	0.1	0.2	0	0.8	0	0	0	0	0.1	0.3	0	0.6	0.2	1.6	0	0	0	0.4	7.2	0	0.7	0	0	0.7	0.3	0	0.3	0.5	0	0	0.1	0	0.1	0.2	0.1	0	0.3	3.2	0.5	0.1	0	0	0.2	31.2	0	1.2	1.7	0	0	1	1.7	0	0	0	0.2	0.2	2.7	0	0	0	0.1	6.5	0	0	0	0	0	0	0	0	0.5	0	0	0	0.9	0	0	0	0	0	23.7	0	0.3	7.6	61.3	15.6	20.7	6.5	2.1	1	15.5	0.1	1.2	0	15.3	1.5	24.8	2.1	5.8	124.1	5.1	20.1	22.7	14	3.9	0	14.9	0.1	17	1	5.3	0	0	0	2.2	17.1	1.1	6	0.1	1.6	12.6	0.6	0	9.6	0	0.9	32.1	1	19.3	521.3	0.2	0	0	111.6	17.7	0	1	4.4	6.3	1.1	0.1	0	7.9	58.9	Muller glia cells
AQP9	HsT17287, SSC1	ENSG00000103569	Aquaporin 9	O43315	15	58138169-58185911	Predicted membrane proteins, Transporters	Transport			Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	9	blood: 127.8;liver: 147.0	Cell type enriched	Detected in some	4	Hepatocytes: 258.5	Cancer enriched	Detected in many	30	liver cancer: 132.4	Low region specificity	Detected in some			Cell type enriched	Detected in some	20	neutrophil: 127.8	Lineage enriched	Detected in many	20	granulocytes: 127.8	Cell line enriched	Detected in single	27	U-87 MG: 25.9	Low region specificity	Detected in all			Low region specificity	Detected in many			HPA074762, CAB075684	Enhanced											CAB075684: , HPA074762: AB_2732267	unprognostic (1.91e-1)	unprognostic (1.92e-1)	unprognostic (7.30e-2)	unprognostic (2.67e-1)	unprognostic (1.24e-2)	unprognostic (4.15e-2)	unprognostic (1.36e-3)	unprognostic (2.28e-2)	unprognostic (3.82e-2)	unprognostic (2.03e-1)	unprognostic (4.80e-3)	unprognostic (6.98e-2)	prognostic unfavorable (5.72e-11)	unprognostic (8.78e-2)	unprognostic (1.13e-2)	unprognostic (1.25e-1)	unprognostic (8.39e-2)	7.8	0.3	0.6	12.9	0.7	9.8	0.6	0.7	1.4	0.2	0.3	0.1	1	0	0.2	7.8	0.7	3	0.8	2	0.4	0.2	0.8	147	8.6	12	2.4	0.4	1.2	0.3	2.8	0.4	1.4	0.6	0.4	0	0.5	0.4	0.8	0.4	6.9	0.3	1	0.5	15.8	0.7	2.5	0.4	0.4	0.5	0.1	0.4	1.3	0.6	0	0.2	127.8	6.2	0	0	1.7	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.9	0	0	0	0	0	0	0.2	0	0	0	0	0.1	0	0	0	0	0.5	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0.3	0	0	0	0	25.9	0.1	0	0	6.2	0.1	0	1.9	0	0	0	0	0.2	0	0	0	127.8	0	2.3	0	0	1.7	0.6	0.7	0.7	1.4	0.4	0.2	2.4	0.4	0.6	0.4	0	19.3	4.3	0.1	0.3	0	1.2	5.1	2.7	5.7	0	0	0.3	0	0.1	1.9	0.1	0	0	0.2	0.5	0.4	0	7	258.5	43.2	0	0	8	34.5	0.8	0.3	57.7	0	2.8	0	0	0.8	0	0	0.3	0	0	0.1	0	0	0.5	0.7	1.3	0	0.1	Hepatocytes
ZNF106	SH3BP3, ZFP106, ZNF474	ENSG00000103994	Zinc finger protein 106	Q9H2Y7	15	42412823-42491123	Plasma proteins, Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		heart muscle: 64.8;skeletal muscle: 111.1	Cell type enriched	Detected in all	9	Cardiomyocytes: 1626.8	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enhanced	Detected in all		neutrophil: 48.5	Low lineage specificity	Detected in all			Low cell line specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA054267	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol						Nucleoli	Nucleoplasm, Cytosol	HPA054267: AB_2682431	unprognostic (2.15e-2)	unprognostic (3.31e-1)	unprognostic (7.10e-2)	unprognostic (2.61e-2)	unprognostic (4.01e-2)	unprognostic (1.34e-1)	unprognostic (9.32e-2)	unprognostic (2.49e-1)	unprognostic (3.96e-1)	unprognostic (1.33e-2)	unprognostic (2.27e-1)	unprognostic (2.07e-1)	unprognostic (1.76e-3)	unprognostic (8.71e-2)	unprognostic (1.78e-1)	unprognostic (4.36e-1)	unprognostic (4.09e-3)	14.9	5.4	8.8	6.6	10.4	9	10.3	6.3	9.1	7.1	7.8	4.5	4.5	3.9	7.4	6.3	12.7	5.4	6.1	64.8	9.2	6.3	6.4	3.7	7.8	6	7.6	6.4	6.6	4.4	8.4	7.1	5	11.9	7.8	5.6	11.3	6	5.7	111.1	4.3	5.9	10.9	8	6.3	6	5.7	7.2	3.4	5.7	46.9	6.8	7	17.7	8.3	10.8	48.5	19.6	3.9	5.1	4.5	14.4	8.4	14.7	16.2	37.2	32.8	9	11.8	11.2	10.3	11	19.7	4.2	9.7	10.5	14.4	11.8	16.6	15.2	12	15.8	15.7	7.3	18.6	19.6	7	10.7	22.2	11.1	24.7	8.1	15.7	17.5	9.2	16.5	12.2	22	1.3	16.7	5.7	8.5	5.4	6.2	11.4	8.6	8.1	26.7	5.3	5.4	16.3	9.4	5	23.8	11.2	13.2	12	10.3	14.5	24.9	11.1	17.1	14.7	17.2	8.1	15.6	36.4	9.9	17.8	19.2	19.9	19.6	7.6	5.1	15.9	4.5	6.7	4.2	4.2	10.5	8.3	3.8	3.4	48.5	3.9	18.5	10.8	3.8	4.5	8.8	10.4	6.3	9.1	9.2	6.3	7.6	6.4	11.9	7.2	125	90.2	37.8	49.6	34.2	58	1626.8	56	188.7	61.4	27.9	90.3	31.5	34.9	37	133.3	49.8	30.9	23.3	36.8	30.7	62.9	79.6	42.8	32.7	46.8	33.4	38.7	57.1	104.1	80	34.8	64.4	62.4	28.9	28.5	43.3	51.2	23	87	34.8	75.4	45.3	46.4	55.4	37.4	26.1	25.6	29.4	33.7	64.4	Cardiomyocytes
SLC39A14	KIAA0062, NET34, ZIP14	ENSG00000104635	Solute carrier family 39 member 14	Q15043	8	22367249-22434129	Disease related genes, Predicted intracellular proteins, Predicted membrane proteins	Ion transport, Transport, Zinc transport		Disease mutation, Dystonia, Neurodegeneration, Parkinsonism	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		liver: 135.5;pancreas: 77.2	Cell type enriched	Detected in many	8	Hepatocytes: 491.4	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in all		BJ hTERT+: 66.5	Low region specificity	Detected in all							HPA016508, HPA056732	Enhanced		Approved	Endoplasmic reticulum,Golgi apparatus,Plasma membrane					950000	Endoplasmic reticulum, Golgi apparatus, Plasma membrane		HPA016508: AB_1857148, HPA056732: 	unprognostic (1.67e-1)	unprognostic (6.67e-3)	prognostic favorable (5.00e-5)	unprognostic (9.83e-3)	unprognostic (9.21e-3)	unprognostic (8.99e-3)	unprognostic (1.99e-1)	unprognostic (2.91e-2)	unprognostic (4.95e-2)	unprognostic (5.66e-2)	unprognostic (6.64e-2)	unprognostic (1.53e-1)	prognostic unfavorable (3.79e-7)	unprognostic (4.88e-2)	unprognostic (8.73e-2)	unprognostic (1.63e-2)	unprognostic (1.11e-3)	15	16.1	2.6	7.7	5.4	0.1	45.5	2.4	6.1	3.6	13.7	1.9	2.8	31.6	6.7	2.8	3.9	5.6	9.8	41.1	2.8	2.4	10.4	135.5	4.8	5.3	3.7	1.9	10.6	77.2	3	6.4	4	9.2	5.1	11.4	4.1	20.2	4.4	46.1	4.4	18.2	14.1	4.7	2.3	16.2	5.9	2.8	0.7	25.1	2.1	1.4	11.3	19	5	1.8	2.5	0.5	2.9	8.7	3.9	10.4	13.9	3.9	7.8	14	11.8	8.5	15	66.5	23.5	37.1	46.2	9.9	10.4	8.5	17.6	61.2	11.5	19.2	18.7	38.8	10.8	11	8.3	11.1	46.5	33.3	5.7	9.1	12.5	15.3	41.6	29.1	11.9	10.4	7.5	7.2	10.7	11.9	4.8	8.6	3.6	23.7	16.6	10.7	12.3	7.3	22.2	8.6	4.5	6.6	10.3	15.3	6.6	31	8.7	5.2	8.3	5.7	29.2	14.9	18.4	15.4	6.2	5.6	13.6	41.3	7.6	17	0	0.5	2.5	8.3	0.1	8.7	5	4.8	6.3	1.8	2.6	5.7	7.6	0.2	2.9	0.1	0.8	3.8	3.9	2.6	5.4	2.4	6.1	2.8	2.4	3.7	1.9	9.2	2.8	3	4.8	3.7	8.8	29.7	7.1	50.1	50.9	0	3.4	7	2	0.2	1.7	48.7	0.4	31.6	63.6	0	63.9	2.1	30.9	17.2	0	491.4	1.5	46.1	32	31.9	15.9	1.8	22.2	1.6	42.2	4.6	51.4	4.6	55.6	28.8	39.3	21.4	7.4	0	46.7	0	2.4	18.3	0.5	4.9	33.7	9.8	Hepatocytes
ADAM2	CT15, FTNB, PH-30b, PH30	ENSG00000104755	ADAM metallopeptidase domain 2	Q99965	8	39743735-39838289	Predicted membrane proteins	Cell adhesion			Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	416	testis: 50.6	Cell type enriched	Detected in some	5	Spermatocytes: 72.7	Cancer enhanced	Detected in single		prostate cancer: 1.4	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	21	U-266/70: 2.1	Not detected	Not detected							CAB022390, HPA024621, HPA026581	Enhanced											CAB022390: , HPA024621: AB_1844576, HPA026581: AB_1844577				unprognostic (4.74e-2)								unprognostic (1.67e-3)					unprognostic (3.82e-1)	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	50.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	15	0	0	0	0	0	0	0	0	0	0	0	0	0	0	11.8	1.4	0	0	0	0	0	0	0	0.4	0	0	0	0	72.7	0.2	0	0.2	0	0	0	Spermatocytes
FGL1	HFREP-1	ENSG00000104760	Fibrinogen like 1	Q08830	8	17864380-17910365	Plasma proteins, Predicted secreted proteins	Adaptive immunity, Immunity			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	6	liver: 450.7	Cell type enriched	Detected in many	23	Hepatocytes: 6738.7	Cancer enriched	Detected in some	40	liver cancer: 399.3	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	15	A549: 22.2;Hep G2: 52.2	Low region specificity	Detected in some			Not detected	Not detected								Secreted to blood				1800000				unprognostic (3.62e-2)	unprognostic (1.14e-2)		unprognostic (1.75e-5)	unprognostic (3.00e-1)	unprognostic (3.54e-2)	unprognostic (7.89e-2)	unprognostic (2.15e-1)	unprognostic (2.62e-1)		unprognostic (2.71e-1)	unprognostic (1.09e-2)	unprognostic (2.86e-7)	prognostic unfavorable (5.38e-4)	unprognostic (3.62e-1)	unprognostic (2.58e-2)	unprognostic (1.35e-1)	0.1	0	0.1	0.2	0.2	0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0	0.2	0.1	0.1	0	0.1	0.1	0.1	0	0.1	450.7	0.2	0.1	0.1	0.1	0.1	71.3	0	0.1	0.6	0.2	0.2	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.3	0	0.3	0.1	0.1	0.2	0.1	0.1	0.1	0.2	0	0	0	0.4	0	0	0	0	22.2	0	2.4	0	0	0.8	0	0	0	0	0.2	0	0	0	0	0	0.1	0	0	0	0	0	0.1	0	52.2	0	0.3	0	1.2	0	0	0	0	0	0	0	0	0	0.1	0	0.8	0	0	0	0	0.2	0	0	0	0	0.5	0.3	0	0	0.1	0	0.2	0	0	0.1	0	0	0	0	0.1	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.2	0.1	0.2	0.1	0	0.1	0.1	0.2	0.1	0	3.4	104.9	0.1	0	0	1	298.1	0	0	0	0	0.2	0	4.2	35.8	0	0	140.2	59.6	0.4	0	8.5	0	6738.7	15.3	0	0	190.3	185.3	19	0.6	0	0	2.8	0	0	121.6	0	0.4	0	0	0	0.3	0.7	0.5	0	0.8	0	0	0.1	Hepatocytes
DHDH	HUM2DD	ENSG00000104808	Dihydrodiol dehydrogenase	Q9UQ10	19	48933682-48944969	Enzymes, Predicted intracellular proteins		Oxidoreductase		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Group enriched	Detected in some	4	intestine: 32.4;kidney: 18.0	Cell type enriched	Detected in many	5	Proximal tubular cells: 56.2	Low cancer specificity	Detected in all			Low region specificity	Detected in many			Cell type enhanced	Detected in many		basophil: 5.8;naive CD4 T-cell: 4.8	Group enriched	Detected in many	31	granulocytes: 5.8;T-cells: 4.8	Cell line enhanced	Detected in many		JURKAT: 6.3;U-266/70: 6.4;U-266/84: 5.0					Low region specificity	Detected in all			HPA044131	Approved		Approved	Nucleoplasm,Actin filaments						Nucleoplasm, Actin filaments		HPA044131: AB_10966968	unprognostic (1.54e-1)	unprognostic (2.72e-2)	unprognostic (1.07e-1)	prognostic unfavorable (9.91e-4)	unprognostic (3.33e-3)	unprognostic (1.45e-1)	unprognostic (5.81e-6)	unprognostic (1.56e-2)	unprognostic (5.88e-2)	unprognostic (4.96e-2)	unprognostic (3.30e-2)	unprognostic (5.08e-2)	prognostic favorable (3.15e-4)	unprognostic (2.93e-2)	unprognostic (1.23e-1)	unprognostic (1.67e-1)	unprognostic (1.54e-1)	0.3	0.5	1.5	0.1	2.1	0.1	0.2	1.8	1.5	0.1	8.2	0.2	0.1	10.6	0.2	0.4	0.8	0.3	0.8	0.1	2.7	2	18	0.7	1.9	0.2	0.4	0.4	0.5	0.4	0.2	2.1	1.3	0.6	3.5	0.1	1.2	0.8	0.2	0.3	0.2	32.4	0.1	0.9	1.8	0.7	2.8	0.1	0.4	0.1	0.5	0.7	1.1	0.3	0.1	0	5.8	0	0	4.8	0.5	2.8	0	0.2	1.4	0.8	0.6	1.1	0	0.4	0.5	1.4	2.7	2.2	0	0.5	0	1.8	0.8	0.9	2	0.9	1	2.2	3.9	0.9	1	0	0	0.9	0.5	0.2	1.1	0	0.7	0	6.3	1.2	0.4	0	0.6	0	0.2	0.6	4	1.8	1.4	0.2	1.9	0.3	0.9	4.2	2.3	0.5	0.3	0.9	0.3	1.9	0.1	0	0	1.7	0.6	0.1	6.4	5	1.6	1.3	0	0.4	5.8	0	0.9	1.6	0	0.8	0	1.6	0.7	0	0.1	4.8	3.1	0.1	0	0	0	1.2	0.5	1.5	2.1	1.8	1.5	2.7	2	0.4	0.4	0.6	0.1	3	5.4	0	2.6	0.7	1.3	0.4	0	0	4.5	3.5	0	0.1	8.3	1.3	0.5	0.6	1.7	0	0.3	0.1	0.5	5.2	1.1	0	10.9	0	0	0	0.8	1.4	0	0	0	0	0.7	1.5	1.2	2.9	0	56.2	4.3	0	0.1	0	0.6	0.1	0.1	0	0.6	2.6	Proximal tubular cells
CGB2		ENSG00000104818	Chorionic gonadotropin beta subunit 2		19	49031912-49033238	Predicted intracellular proteins, Predicted secreted proteins				Evidence at protein level	Evidence at protein level				Tissue enhanced	Detected in some		brain: 2.1;testis: 4.1	Cell type enriched	Detected in some	5	Syncytiotrophoblasts: 33.4	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	5	HMC-1: 25.4;U-266/70: 10.2;U-266/84: 12.3									HPA038925, HPA038934	Supported		Approved	Cytosol	Secreted in other tissues					Cytosol		HPA038925: AB_2676272, HPA038934: AB_2676277										unprognostic (3.05e-2)								0	0	0.2	0	2.1	0	0	0	0.6	0	0			0	0	0.7	0.3	0	0	1.1	1	0.9	0.2	0	0	0.4	0.1		0	0	0	1.1	1.4		0.4	0		0	0	0.5	0.6	0	0	0	0.1	0.3	4.1			0.1		0.1	0	0.2	0	0	0	0	0	0	0	1.3	0.5	0	0.2	0	0	1.3	0	0	0	0	0	0.3	0	0	0	0.1	0.1	0.2	0	0	3.4	0	0.4	0	0	0.1	0	25.4	0	0	0	0	0.4	0	0	0.3	0	0	0	0	0	0.1	0.8	0	0	0	0	0	0.1	0	0	0.2	0	0	0.2	0	0	0	0.4	0.7	0	3	10.2	12.3	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0	0	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	1.1	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0.7	0	0.4	0	0	6.5	0	0.5	1.1	0	33.4	0	0	0	Syncytiotrophoblasts
CGB3	CGB	ENSG00000104827	Chorionic gonadotropin beta subunit 3	P0DN86	19	49022869-49024333	Predicted secreted proteins		Hormone		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in some		pituitary gland: 6.7;placenta: 15.0	Cell type enriched	Detected in some	38	Syncytiotrophoblasts: 724.1	Cancer enhanced	Detected in some		pancreatic cancer: 2.9;testis cancer: 4.2					Cell type enhanced	Detected in single		T-reg: 1.0	Lineage enriched	Detected in single	6	T-cells: 1.0	Cell line enriched	Detected in some	20	BEWO: 39.7									CAB000042, CAB010884, HPA038925, HPA038934	Enhanced		Approved	Cytosol	Secreted to blood					Cytosol		CAB000042: , CAB010884: AB_259037, HPA038925: AB_2676272, HPA038934: AB_2676277									unprognostic (1.39e-1)		unprognostic (7.88e-2)				unprognostic (6.92e-2)		unprognostic (1.04e-2)	0	0	0	0	0	0	0	0	0	0	0			0.4	0	0	0	0	0	0	0	0	0	0	0	0	0		0	3.2	0	6.7	15		0	0		0.1	0	0	0	0.1	0	0	0	0.1	1			0		0	0	0	0.1	0	0	0.1	0	1	0	0.2	0	0	0.1	0	0	39.7	0	0	0	0	0	0.7	0.1	0	0.1	0	0	0	0	0	0.8	0.3	0	0	0	0.1	0	0.8	0	0	0	0	0	0	0.1	0.3	0.3	0	0	0	0.1	0.1	0	0	0.1	0.1	0.1	0	0.1	0.1	0	0.2	0	0	1.3	0.5	0	0	0.1	0.2	0	1.9	0.7	0.5	0.1	0	0.1	0	0	0.1	0	0.4	0	0	0.1	0.1	0	0	0	0	0	0	0	0	0	1	0											0	0	0	0	0	0	0	0	0	0	0	0	3.8	0	0	0	0	0	0	0	19.2	0	0	0	0	5.5	0	0	0	0	0	0	0	0	0	0	0	6.1	0	0	0	0	0	0	0	0	0	724.1	0	0	0	Syncytiotrophoblasts
KCNA7	HAK6, Kv1.7	ENSG00000104848	Potassium voltage-gated channel subfamily A member 7	Q96RP8	19	49067418-49072941	FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels	Ion transport, Potassium transport, Transport	Ion channel, Potassium channel, Voltage-gated channel	FDA approved drug targets	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enriched	Detected in some	9	skeletal muscle: 40.6	Cell type enriched	Detected in some	4	Alveolar cells type 2: 25.9	Not detected	Not detected			Not detected	Not detected			Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		HMC-1: 4.0;U-251 MG: 4.0	Not detected	Not detected			Not detected	Not detected																unprognostic (2.00e-1)	unprognostic (2.10e-2)		unprognostic (1.19e-1)	unprognostic (2.72e-1)	unprognostic (1.68e-1)		unprognostic (4.31e-2)	unprognostic (3.17e-2)	unprognostic (6.97e-2)	unprognostic (2.94e-2)	unprognostic (1.26e-1)	unprognostic (2.21e-8)	unprognostic (1.70e-1)	unprognostic (2.62e-1)	unprognostic (5.80e-2)	unprognostic (5.29e-2)	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0.3	0	0	3.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0.4	0	40.6	0.2	0	0	0	0	0	0	0	0	0.9	4.6	0.3	0	0	1.1	0.9	3.3	0.8	0.9	0.8	0.2	0.7	0.3	0.4	2	0	0.2	0.7	0.4	0	0.1	0	0.5	0.9	0.4	0.2	0.2	0.7	1.3	0.1	0.2	0	0.4	0.6	0.2	1.5	0.4	0.2	0.6	4	0.1	0.3	0.1	0.1	0.4	0	0.4	0.5	1.1	0.1	0.5	0.3	0.7	0.5	0.3	0.3	0.4	0.2	0.5	0.2	0.5	0.4	0.4	1.5	0.3	0.1	0.6	0.5	1.1	0.7	1.4	0.5	0.9	4	0.7	0.3	0.3	0.6	0.4	0.5	3.3	0.8	0.7	0.8	0.4	0.5	0.5	0.7	0.7	0.2	1.1	0.7	0.8	2.6	0.9	0.7	0.9	0.2	0.2	0	0	0	0	0	0	0	0	0	0	6	25.9	0	1.2	0.3	0.4	3.1	0	1.4	5.7	0	5.9	0	0	0	0.2	0.3	0	0	0.2	0.1	0.4	0.5	3.5	0	0.1	0	0	0	0	0	0	0.8	0	0	0	0.2	2.2	0	0	0	1.6	0	0.1	0.1	0.7	0.3	0.9	0	0	0.3	Alveolar cells type 2
CKM	CKMM	ENSG00000104879	Creatine kinase, M-type	P06732	19	45306414-45322977	Candidate cardiovascular disease genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins		Kinase, Transferase	FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	5	skeletal muscle: 1374.7;tongue: 354.9	Cell type enriched	Detected in some	137	Cardiomyocytes: 5083.5	Group enriched	Detected in many	33	head and neck cancer: 64.4;prostate cancer: 14.3	Not detected	Not detected			Group enriched	Detected in some	9	classical monocyte: 2.8;intermediate monocyte: 1.1;myeloid DC: 2.1	Group enriched	Detected in many	25	dendritic cells: 2.1;monocytes: 2.8	Cell line enriched	Detected in some	4	SCLC-21H: 37.6	Not detected	Not detected			Not detected	Not detected			HPA047859	Enhanced								190000000			HPA047859: AB_2680186	unprognostic (3.51e-1)	unprognostic (7.63e-2)	unprognostic (2.61e-2)	unprognostic (4.14e-1)	unprognostic (7.68e-3)	unprognostic (4.04e-3)	unprognostic (1.85e-2)	unprognostic (4.23e-2)	unprognostic (5.19e-2)	unprognostic (1.81e-1)	unprognostic (5.00e-1)	unprognostic (9.46e-3)	unprognostic (9.67e-8)	unprognostic (3.23e-1)	unprognostic (1.73e-1)	unprognostic (2.33e-1)	unprognostic (1.95e-1)	13.9	0.1	0.2	0.1	0.2	0.1	0.4	0.1	0.1	0.1	0.2	0	0	0.1	0.1	23.5	21.1	0.1	0.1	187.9	0.2	0.1	0.2	0.2	0.2	0.1	0.2	0	0.1	0.2	0.1	0.1	0.1	0	2.8	0.1	0.8	17.6	0.2	1374.7	0.2	0.2	0.2	0.3	0.1	0.5	0.3	0	0	11.1	354.9	24.8	0.2	0.1	0	2.1	0	2.8	0	0	1	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	1.2	0	3	0	0.1	8.9	6.8	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	3.3	0.1	0.1	0	0	37.6	0	0	0	0	0	0	8.6	0	0	0	0	0	0.2	0.1	0	0	0	0	0	2.8	0	0	1.1	0	0	0	0	2.1	0	0	0	0	0	0.2	0	0	1	0.2	0.2	0.1	0.1	0.2	0.1	0.2	0	0	0	0	0	0	0	0	0	5083.5	0	0	0	0	0	0.3	10	0	12.4	0	0	0	0	0.7	0	0	1.1	0	5.5	0	0	0.6	1.9	37	1.4	0.1	0	0	0	0	0	0	0.7	0	0	0	0.3	15.2	1.8	0.1	0.2	0	0	0.1	Cardiomyocytes
CLEC4M	CD209L, CD299, DC-SIGN2, DC-SIGNR, DCSIGNR, HP10347, LSIGN	ENSG00000104938	C-type lectin domain family 4 member M	Q9H2X3	19	7763149-7769605	CD markers, Predicted intracellular proteins, Predicted membrane proteins	Adaptive immunity, Endocytosis, Host-virus interaction, Immunity, Innate immunity	Host cell receptor for virus entry, Receptor		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	7	liver: 38.5;lymphoid tissue: 30.1	Cell type enriched	Detected in some	17	Ito cells: 378.7	Not detected	Not detected			Not detected	Not detected			Cell type enriched	Detected in single	7	memory B-cell: 1.7	Lineage enriched	Detected in single	18	B-cells: 1.7	Group enriched	Detected in some	7	GAMG: 3.5;HUVEC TERT2: 2.3;K-562: 3.1;Karpas-707: 1.2;RPMI-8226: 1.6									CAB033689, CAB033691, HPA042661	Supported				Intracellular and membrane				890000			CAB033689: AB_831088, CAB033691: AB_2081354, HPA042661: AB_2678101	unprognostic (1.56e-1)				unprognostic (3.03e-1)	unprognostic (1.00e-1)	unprognostic (1.71e-2)	unprognostic (1.26e-2)	unprognostic (1.64e-1)	unprognostic (6.58e-2)		unprognostic (1.27e-1)	unprognostic (4.58e-3)	unprognostic (4.60e-2)	unprognostic (5.15e-2)		unprognostic (1.43e-1)	0.9	0.9	0.1	0.5	0.1	0	0.1	0.2	0.1	0.1	0.3	0.1	0.1	0	0.3	0.1	1.2	0.6	0.1	0.1	0.1	0	0.1	38.5	2.5	30.1	0.1	0.1	2.7	0.1	0	0.1	4.8	0.2	0.1	0	0.1	0.8	0.1	0.1	0	0.5	0.1	0.1	0.2	0	1.4	0.1	0.1	0.2	0.1	0.2	0.1	0.1	1.7	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	3.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	2.3	0	3.1	1.2	0	0	0	0	0	0	0	0	0.2	1.6	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	1.7	0	0	0	0.2	0	0	0	0	0	0	0	0	0.1	0.1	0.2	0.1	0.1	0	0.1	0.1	0.2	0.1	0	0	0	0.1	0.1	0	0.3	5.1	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0.3	0	0.8	0.5	0	0	378.7	22.4	0.6	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0.3	0.1	0	0.2	0	0	0.1	Ito cells
RSPH6A	RSHL1, RSP4, RSP6, RSPH4B	ENSG00000104941	Radial spoke head 6 homolog A	Q9H0K4	19	45795710-45815319	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	14	testis: 48.1	Cell type enriched	Detected in some	10	Early spermatids: 57.7	Cancer enriched	Detected in single	5	thyroid cancer: 1.6	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	11	RPMI-8226: 8.0	Not detected	Not detected			Low region specificity	Detected in some			HPA045382	Enhanced											HPA045382: AB_10959735	unprognostic (1.99e-1)	unprognostic (3.23e-1)		unprognostic (6.55e-2)	unprognostic (1.57e-1)	unprognostic (2.72e-3)		unprognostic (4.16e-4)	unprognostic (2.33e-1)	unprognostic (5.89e-2)		unprognostic (1.72e-2)	unprognostic (7.84e-5)	unprognostic (1.38e-1)	unprognostic (1.09e-1)	unprognostic (1.05e-1)	unprognostic (5.99e-3)	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	48.1	0	0	3.4	0	0	0	0	0.1	0.2	0	0.1	0	0.2	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0.1	0.1	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0.1	0	0	0	0	0.2	0	0	0	0.1	0	8	0	0	0.1	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0.7	0	0	0	0	0	0	0	0.2	0.1	0.2	0.1	0	0	0.2	0	0.1	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.8	0	0	0	0	0	0	0	0	57.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5.7	0.9	0	0	0	0	0	0	0	0.7	0	0	0	0	2.8	0.6	0	0.1	0	0	0	Early spermatids
LILRA1	CD85i, LIR-6, LIR6	ENSG00000104974	Leukocyte immunoglobulin like receptor A1	O75019	19	54593582-54602090	CD markers, Predicted membrane proteins	Adaptive immunity, Immunity	Receptor		Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level		Group enriched	Detected in some	9	blood: 22.2;lymphoid tissue: 21.0	Cell type enriched	Detected in some	4	Kupffer cells: 35.6	Low cancer specificity	Detected in some			Low region specificity	Detected in many			Cell type enhanced	Detected in many		intermediate monocyte: 17.9;non-classical monocyte: 22.2	Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		REH: 1.3;THP-1: 2.4																						unprognostic (4.52e-2)	unprognostic (1.12e-1)	unprognostic (6.30e-2)	unprognostic (1.59e-1)	unprognostic (2.34e-1)	unprognostic (9.46e-3)	unprognostic (1.17e-1)	unprognostic (4.07e-2)	unprognostic (1.12e-1)	unprognostic (4.90e-2)	unprognostic (8.72e-2)	unprognostic (1.13e-1)	unprognostic (8.28e-3)	unprognostic (8.82e-2)	unprognostic (3.79e-4)	unprognostic (2.53e-1)	unprognostic (9.83e-2)	0.7	0.9	1	3.7	1.7	1	0.6	0.2	1.3	0.5	0.3	1.1	0	0.4	0.2	1.7	0.6	0.5	1	0.6	0.9	0.8	0.5	2.1	2.4	18.8	1.5	0.5	0.4	0.4	0.6	0.3	0.8	1.6	0.4	0.7	0.8	1	0.3	0.5	0.3	1	0.5	2.2	21	0.5	0.3	1.1	0.1	0.4	0.4	0.9	0.9	0.2	0	5.4	6.1	22.2	0	0	4.2	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0.2	0	0	0	0	0	0	0	0	0.3	0.1	0	0	0	0	0	0	0	1.3	0	0	0	0	0	0	0.1	0	0	0	0	2.4	0	0	0	0	0	0	0	0	0	0.8	0	0	7.4	6.1	0	17.9	0	0	0	0	5.4	0	0	0	5.3	0	22.2	0.7	0	4.2	1	1.7	0.2	1.3	0.9	0.8	1.5	0.5	1.6	1.1	0	3.4	0.5	0	0	0	0	0	1.4	3.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5.1	0	0	0.6	35.6	0	0	8.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Kupffer cells
PPP6R1	KIAA1115, SAP190, SAPS1	ENSG00000105063	Protein phosphatase 6 regulatory subunit 1	Q9UPN7	19	55229780-55258995	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	5	Early spermatids: 195.4	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enhanced	Detected in many		plasmacytoid DC: 21.2	Low lineage specificity	Detected in all			Low cell line specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA043989, HPA063681	Approved		Enhanced	Cytosol		No	No			Cytosol		HPA043989: AB_10987309, HPA063681: AB_2685087	unprognostic (1.15e-1)	unprognostic (2.34e-1)	unprognostic (1.20e-2)	unprognostic (1.11e-1)	unprognostic (1.65e-1)	unprognostic (1.36e-1)	prognostic unfavorable (3.82e-6)	unprognostic (2.22e-2)	unprognostic (5.44e-2)	unprognostic (5.41e-2)	unprognostic (3.35e-3)	unprognostic (1.63e-3)	unprognostic (2.04e-1)	unprognostic (1.23e-1)	unprognostic (3.65e-2)	unprognostic (3.30e-2)	unprognostic (2.20e-1)	13.2	18.4	27.8	30.8	26.2	49.7	9.8	12.5	28	11.2	20.7	14	9	22.9	13.5	11.3	17.5	16.8	17.7	12.8	27.3	12.4	12.5	25.1	14.6	45.2	13	14	11.9	12.5	13.9	15.3	15.8	9.8	11.7	7.8	11.5	13.7	14.4	18.4	13.3	22.9	11.3	9.2	31.6	25.1	39.9	13.4	57.3	14	13.4	31	17.7	12.6	2.6	21.2	4.4	3	6.1	9.2	4.2	20.3	29.6	6	9.6	7.2	6.7	15.5	13.1	11.5	13.8	11.8	19.5	14.1	53.2	7.2	11.6	10.2	10	2.1	13.6	5.4	19.8	50.5	40.3	14.2	14.3	12.5	59.5	39.9	9.8	7.9	13.6	9.3	7.4	8.8	37.3	21	23.6	8.8	13	43.5	21.4	8.2	16.7	24.4	26.7	11.9	44	9.7	26.1	17.4	9.6	12.1	14.7	12.8	5.4	8	44.9	11.4	21.7	10.7	8.3	19.6	11.8	21.3	37.7	19.7	49.2	16.5	0	2	4.4	9.2	3	5.3	2.6	3.8	7.2	3	2.3	4	5.9	2.3	6.1	2.4	21.2	2.7	4.2	27.8	26.2	12.5	28	27.3	12.4	13	14	9.8	13.4	11.9	23.2	31.3	6.8	2.5	16.6	2.2	17.8	20.1	10.3	17.4	9.8	9.6	0	20.1	195.4	11.7	24	0	24.5	7.5	9.9	16.6	7	18.1	27.5	28.6	14.6	16	29.7	28.2	17.3	25.3	0	13.6	17.4	13.7	32	21.2	18.4	9.8	14.2	19.4	2.1	31.4	32.1	3	9.5	27.3	13	36.9	Early spermatids
CASP14	MGC119078, MGC119079, MICE	ENSG00000105141	Caspase 14	P31944	19	15049384-15058293	Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins	Differentiation	Hydrolase, Protease, Thiol protease	Ichthyosis	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	6	skin 1: 109.4	Cell type enriched	Detected in some	5	Suprabasal keratinocytes: 83.9	Cancer enhanced	Detected in many		cervical cancer: 62.8	Not detected	Not detected			Cell type enhanced	Detected in single		neutrophil: 2.3	Low lineage specificity	Detected in single			Cell line enriched	Detected in some	7	hTCEpi: 33.1	Not detected	Not detected			Not detected	Not detected			CAB010059, HPA027062	Enhanced		Approved	Nucleoplasm,Mitochondria,Cytosol					2200000	Nucleoplasm, Cytosol	Mitochondria	CAB010059: AB_626800, HPA027062: AB_2672101	unprognostic (1.17e-2)	unprognostic (6.44e-3)		unprognostic (6.22e-2)		unprognostic (2.77e-1)		prognostic unfavorable (7.59e-4)	unprognostic (9.42e-2)	unprognostic (2.19e-2)	prognostic unfavorable (5.96e-4)	unprognostic (2.68e-1)		unprognostic (4.30e-2)	unprognostic (1.99e-1)		unprognostic (1.97e-1)	0.2	0.2	0.2	0	0.3	0	1.9	0.2	0.3	17.9	0.2	0	0.8	0	1.1	0.3	1.2	0.1	0	0.2	0.3	0.2	0.4	0.3	0.2	0	0.2	0	0.1	0.3	0	0.2	0.5	0	7.7	0	0	0.8	2.7	0.3	109.4	0.2	0	0.2	0.1	0.2	1.6	0	2.3	0.2	0.9	0	0.6	4	0.8	0.5	2.3	0.6	0.1	0.6	0	0.7	0.1	0	0	0	0	0.5	0	0	0	0	0	2	0	0	0	0	4.5	0	0	0	0	0	0	0	0	0	0	0	0	33.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0.6	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0.8	0.6	0.4	0.4	0.2	0.4	0.3	0.6	0.4	0.1	0.8	0.5	0.4	2.3	0.1	0.2	0.5	0.6	0	0.2	0.3	0.2	0.3	0.3	0.2	0.2	0	0	0	0	0	0	1	16.9	0	0.2	0	0	0	0	0	0	0	0	1.3	0	0	0	0	2.6	0	0.1	0	0	0.1	0	0	0	0	1.3	0	0	1.7	0	0	0	0	0	0	0	0	0	0.3	0	0	83.9	0.6	0	0	0.1	Suprabasal keratinocytes
CCNE1	CCNE	ENSG00000105173	Cyclin E1	P24864	19	29811898-29824308	Cancer-related genes, Predicted intracellular proteins	Cell cycle, Cell division	Cyclin	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		bone marrow: 23.3;placenta: 46.7	Cell type enriched	Detected in many	14	Extravillous trophoblasts: 1526.8	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		BEWO: 81.6	Low region specificity	Detected in all							CAB000308, CAB016682, HPA018169	Approved		Enhanced	Nucleoplasm		Yes	Yes			Nucleoplasm		CAB000308: , CAB016682: AB_1614564, HPA018169: AB_1847384	unprognostic (2.90e-3)	unprognostic (1.33e-2)	unprognostic (1.47e-3)	prognostic unfavorable (6.35e-6)	unprognostic (5.78e-2)	unprognostic (4.77e-2)	prognostic unfavorable (3.89e-5)	unprognostic (1.26e-3)	unprognostic (3.14e-3)	prognostic unfavorable (2.97e-4)	unprognostic (3.29e-2)	unprognostic (7.07e-2)	unprognostic (1.11e-16)	unprognostic (5.61e-2)	unprognostic (1.92e-1)	unprognostic (6.63e-2)	unprognostic (1.46e-1)	1.6	6.8	2.4	4.5	2.9	23.3	0.6	6.3	3.3	0.8	3	1.7	1.1	2.3	1.2	0.6	4.7	0.7	2.2	4.4	2.3	2.8	1.2	0.7	1.1	4.6	1.9	1.9	0.9	1.4	1.7	1	46.7	2.8	1.1	3.8	1.5	3.2	1.2	2.2	4.4	2.5	3	1.7	4.6	2	12.3	1.6	4.1	1.6	2.1	5.9	2.7	2.5	2.7	1.6	1.6	1.9	0	1.4	0.5	4.1	8.6	6.6	9.4	1.4	1.6	81.6	6.6	1.4	2.9	3.6	8.7	8.4	3.5	15.7	2.9	3.8	1.3	7.8	3.4	4.2	11.1	4.8	2.9	8.4	9.1	1.1	11.5	7.9	1.7	1.9	4	0.5	0.9	3.5	3.5	11.8	1.6	4.4	6.2	6.3	3.3	11	9.4	2	9.5	7.7	2.6	2.2	6.6	5.6	4.7	9.5	11.7	1	10.1	2.6	8.6	2	6.9	25.9	4.1	4.4	6.6	4.6	23.9	3.9	1.4	3.7	0	0.1	0	0.6	1.9	1.1	2.7	0.5	0.4	1.6	0.2	0.1	0.9	1.6	0	1.9	0	1.4	0.5	2.4	2.9	6.3	3.3	2.3	2.8	1.9	1.9	2.8	1.6	0	1.1	0.8	1	4.2	2.4	2.8	0	0	2.3	0	0	112.5	0	0.4	7.1	1.1	1.7	0	0.6	1526.8	4.8	1.9	0	0	37.5	3.2	2.9	1.3	0.3	2.6	1.1	1.1	1.7	0	2.7	1.8	1	2.9	2.1	0.2	0.8	6.5	3.1	14.1	19.5	5.3	96.8	2.2	3.8	2.4	Extravillous trophoblasts
LGALS13	PLAC8, PP13	ENSG00000105198	Galectin 13	Q9UHV8	19	39602501-39607476	Predicted intracellular proteins	Apoptosis	Hemagglutinin		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	29	placenta: 58.9	Cell type enriched	Detected in some	19	Syncytiotrophoblasts: 267.5	Cancer enhanced	Detected in single		thyroid cancer: 0.5	Group enriched	Detected in some	7	cerebellum: 1.5;hypothalamus: 1.2;midbrain: 2.0	Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	73	SuSa: 7.3									HPA046803			Supported	Nucleoplasm						Nucleoplasm		HPA046803: AB_10965990																		0	0	0.1	0	0.1	0	0	1.5	0.2	0	0	0	0	0	0	0	0	0	0	0	0	1.2	0	0	0	0	2	0	0	0	0	0	58.9	0.2	0	0	0	0	0	0	0	0	0.1	0.1	0	0.2	1.5	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	7.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	1.5	0.2	0	1.2	2	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	3.2	0	0	4.3	0	0	0	0	1.5	0	0	0	0	3.5	0	0	0	0	14.4	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	267.5	0	0	0	Syncytiotrophoblasts
ICAM5	TLCN, TLN	ENSG00000105376	Intercellular adhesion molecule 5	Q9UMF0	19	10289981-10296778	Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins	Cell adhesion			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	9	brain: 32.6	Cell type enriched	Detected in some	6	Cardiomyocytes: 33.3	Cancer enhanced	Detected in many		thyroid cancer: 4.8	Group enriched	Detected in many	15	amygdala: 22.5;basal ganglia: 24.3;cerebral cortex: 32.6;hippocampal formation: 23.0;olfactory region: 15.9	Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HEL: 13.5;K-562: 10.8;RPMI-8226: 12.3;U-266/70: 14.8;U-87 MG: 8.8	Group enriched	Detected in many	9	amygdala: 111.1;basal ganglia: 75.7;cerebral cortex: 76.7;hippocampal formation: 105.7;olfactory region: 63.4	Group enriched	Detected in many	13	amygdala: 58.8;basal ganglia: 55.2;cerebral cortex: 67.5;hippocampal formation: 103.7;olfactory region: 57.5	HPA008943, HPA009083, CAB025178	Enhanced								2400000			CAB025178: , HPA008943: AB_1079095, HPA009083: AB_1079094	unprognostic (7.76e-2)	unprognostic (1.91e-1)	unprognostic (1.66e-2)	unprognostic (4.24e-2)	unprognostic (8.23e-3)	unprognostic (2.58e-1)	unprognostic (8.12e-2)	unprognostic (9.99e-3)	unprognostic (2.58e-1)	unprognostic (2.44e-2)	unprognostic (3.90e-3)	unprognostic (9.89e-3)	unprognostic (5.29e-5)	unprognostic (6.47e-2)	unprognostic (4.86e-2)	unprognostic (5.44e-3)	unprognostic (6.28e-3)	0.8	0.9	22.5	0.8	24.3	2	0.9	0	32.6	0.8	0.8	1	0	0.8	0.8	0.8	0.8	0.9	0.8	1	23	1.4	1.1	0.8	3.6	1.2	0.9	15.9	1.4	0.8	0.8	0.1	1.1	0	0.9	0.8	0	0.8	0.9	0.8	0.8	1	0.8	0.1	1	1	1.9	1.6	0	0.8	0	0.9	0.8	0.3	0	0	0.4	0	0	0.4	0	2.9	0	0	6.2	0	0	0.1	4.4	0.7	0.1	0.4	0	0.1	4.7	2	0	0	5.4	0.2	0	0	0.1	0.9	13.5	4.3	0.4	0.1	0	2.7	0	0.5	0.1	0	0	0	1.7	10.8	0.1	0	0.6	0	1.9	0	0.2	4.4	0.1	0	12.3	0.2	0	0.8	0.1	2	0.1	0.3	0	2.2	0	0	1.3	0	0.6	0	14.8	2.4	2.7	8.8	0	1.3	0	0	0.4	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	22.5	24.3	0	32.6	23	1.4	0.9	15.9	0	1.6	6	3.2	0	0.2	0.2	0	33.3	0	0	2.3	0	0	0	0	0	0.4	0	0	0	0	0.1	0.4	0.4	2.3	0	0.1	0	0	0	0	0	0	1.5	0	0	0	0	0.1	0	0	0	0	0	0.5	1.1	1.6	0.1	0.1	0	0	0.1	Cardiomyocytes
SULT2A1	DHEA-ST, STD	ENSG00000105398	Sulfotransferase family 2A member 1	Q06520	19	47870466-47886397	Enzymes, Predicted intracellular proteins	Bile acid catabolism, Lipid degradation, Lipid metabolism, Steroid metabolism	Transferase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	5	liver: 211.7	Cell type enriched	Detected in some	24	Hepatocytes: 1127.7	Cancer enriched	Detected in some	52	liver cancer: 244.3	Not detected	Not detected			Cell type enhanced	Detected in many		basophil: 5.3	Low lineage specificity	Detected in many			Group enriched	Detected in some	34	Hep G2: 26.6;RT4: 18.1					Low region specificity	Detected in all			CAB018755, HPA041487, HPA063633	Enhanced		Supported	Cytosol					210000	Cytosol		CAB018755: AB_650242, HPA041487: AB_2677507, HPA063633: AB_2685066			unprognostic (2.14e-1)				unprognostic (6.79e-3)							unprognostic (6.82e-2)	unprognostic (1.36e-1)		unprognostic (1.31e-2)	0.1	46.9	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	11.4	1.1	1.1	8.2	0.1	0.2	0.1	0	0.1	0.1	0.1	0	0.1	211.7	0.1	0.1	0.1	0.1	0.1	0.1	1.1	0.1	0.1	0.2	0.6	0	0.1	0.1	3.9	0.1	0	42.7	0.1	0.1	0.1	2.8	0.7	0.1	0.1	0.2	0.1	0.1	0.6	0.2	1.3	1	5.3	0.8	2.3	1.3	0.4	0	0	0.1	0.1	0	0	0.4	0	0	0	0	0.6	0	0	0	0	0	0.1	0	0	0	0	0	0.1	0.2	26.6	0	0.6	0.4	0	0	0	0	0	0	0.1	0.1	0.2	0	0	0	0.2	0.1	0	0.1	0	0.3	0.2	0	18.1	0.1	0.1	0.1	0	0	0	0	0.2	0	0	0.1	0.2	0	0.1	0.1	0.1	0	0.1	0	5.3	0.8	0.7	0.9	0.4	0.6	0.7	1	0.6	0.3	1.3	1.3	1	3.1	2.3	0.4	1	0.6	0.4	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.2	0.1	0	0	7	0.5	0.1	0.6	0.6	10.2	0	0	0	0	0	0	0	0	0.1	0	46.7	0	0	0.1	0.3	0	1127.7	0	0	0	38.6	31.7	0	2.8	0	0	0	0.2	0.2	0	0	0.4	0	2.4	0	0	0	0	0	0.5	0.8	0	0.3	Hepatocytes
SYNGR4		ENSG00000105467	Synaptogyrin 4	O95473	19	48364395-48376376	Predicted intracellular proteins, Predicted membrane proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	10	testis: 41.5	Cell type enriched	Detected in some	5	Spermatocytes: 147.5	Low cancer specificity	Detected in some			Region enriched	Detected in single	4	cerebellum: 4.1	Cell type enhanced	Detected in single		memory B-cell: 1.3	Low lineage specificity	Detected in single			Group enriched	Detected in some	5	A549: 9.1;SCLC-21H: 22.9	Not detected	Not detected			Not detected	Not detected			HPA030075, HPA059286	Enhanced		Approved	Golgi apparatus						Golgi apparatus		HPA030075: AB_10610559, HPA059286: AB_2683965	unprognostic (1.58e-2)	unprognostic (3.44e-2)	unprognostic (3.18e-2)	unprognostic (9.49e-4)	unprognostic (2.51e-2)	unprognostic (7.10e-2)	unprognostic (2.52e-3)	unprognostic (3.72e-3)	unprognostic (2.87e-2)	unprognostic (6.19e-2)	unprognostic (6.69e-2)	unprognostic (2.41e-2)	unprognostic (2.02e-7)	unprognostic (1.06e-2)	unprognostic (1.74e-4)	unprognostic (1.58e-1)	unprognostic (9.77e-2)	0	0	0.2	0	0.7	0	0	4.1	2	0	0.2	0	0.9	0.1	0	0.4	0.3	0	0	0	0.2	0.1	0.1	0.2	0.1	0	0.3	0	0	0.7	3	0.2	0.2	0.3	0.1	0.2	0.1	0	0.5	0	0	0.1	0.1	0.1	0.1	0	41.5	0	0.3	0.1	0	0.2	0.2	0	1.3	0.7	0.1	0.5	0	0.9	0.6	0.1	9.1	0	0.1	0	0	0.3	0	0	0.2	0	0.6	0.2	0.4	0.5	0	0.3	0	0	0	0	0.5	2.9	0.5	0	0.4	0	0	0.2	0	0	0	0.4	0	0	1.1	0	3.4	0.1	0.2	0.5	0.2	0	0.6	1.7	0.6	0	2.6	0	0	22.9	0.6	0.1	0.4	0	0	0.4	0.1	0.1	0	0.8	0	0	3.1	1	0.7	0	0.2	0.4	0.1	0.5	0	0	0	0	1.3	0.9	0	0.7	0	0	0	0	0	0	0	0	0.6	0.2	0.7	4.1	0.9	0.2	0.1	0.3	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	27	0	0	0	0.2	0.1	0	0.4	0	0	0.1	0	8.7	0	0	18.9	0.9	0	0	0	1	0	0.5	0	0	0	0	6.5	0	147.5	4.5	0	0	0	0.1	0.1	Spermatocytes
CCDC114	CILD20, FLJ32926	ENSG00000105479	Coiled-coil domain containing 114	Q96M63	19	48296457-48321894	Disease related genes, Predicted intracellular proteins			Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		fallopian tube: 9.9;testis: 6.3	Cell type enriched	Detected in some	8	Ciliated cells: 109.7	Cancer enhanced	Detected in many		endometrial cancer: 5.4					Low cell type specificity	Detected in single			Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		CAPAN-2: 2.6;Karpas-707: 2.6;U-266/70: 4.8	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA042524	Approved											HPA042524: AB_10795706	unprognostic (8.55e-2)	unprognostic (2.40e-2)	unprognostic (2.70e-5)	unprognostic (1.54e-2)	unprognostic (5.09e-4)	unprognostic (1.16e-1)	unprognostic (2.33e-2)	unprognostic (3.02e-2)	unprognostic (1.46e-1)	unprognostic (1.82e-1)	unprognostic (7.93e-2)	unprognostic (1.30e-1)	unprognostic (7.50e-3)	unprognostic (4.35e-2)	unprognostic (4.25e-2)	unprognostic (1.30e-1)	unprognostic (5.15e-2)	0	0	0.8	0	1.9	0.8	0.1	0	0.2	1.1	0			0	0.4	0.3	0	9.9	0	0	1.6	2.3	0	0	1.5	0.2	0		0.4	0	0.2	0.4	0.1		0.1	0		0.2	0.5	0	1.3	0	0	0.2	0.2	0.2	6.3			0.4		0	0	0	0.5	0.3	1	0.4	0.3	0.4	0	0.2	0.7	0.2	0.8	0	0	0.4	0	0	0	0	0.1	2.6	0.4	0.9	0	0.1	0.4	0.1	0	0	1.1	0.2	1.6	0.2	0	0	0.1	1.2	0	0	0.1	0.4	0.5	0	1.2	0.5	2.6	0	0.2	0.4	1.7	0	0.2	0	0.4	0	0.3	0.1	0	0.5	0.1	0.5	0.6	0.4	0	1.6	0.2	0	0.4	0.3	0	0.3	4.8	1.5	0	0.3	0.2	0	0.9	0.2	0.4	0.3	0	0.4	0.5	0.3	0.3	0	0.2	0.2	0.3	1	0.3	0.4	0.3	0	0											0	4.3	0	0.1	0.1	0.5	0.4	0	109.7	10.3	0	0	0.1	0	0.1	5.6	0	0	0	0	0	0.1	0.3	3.5	0	0	1.6	0	0	0	5.5	0	0.1	0	0	0	0.5	0	0	0	0	0.5	0	0	13.4	1.3	0.1	0	0	0	0	Ciliated cells
CAPS	CAPS1, MGC126562	ENSG00000105519	Calcyphosine		19	5911707-5915877	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level				Tissue enhanced	Detected in many		brain: 71.4;fallopian tube: 116.0	Cell type enriched	Detected in many	8	Ciliated cells: 1030.6	Cancer enriched	Detected in all	5	endometrial cancer: 171.3	Region enhanced	Detected in all		pons and medulla: 71.4	Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Cell line enhanced	Detected in many		SK-BR-3: 36.6;U-266/70: 10.1					Low region specificity	Detected in many			HPA043520	Enhanced		Approved	Nucleoplasm,Plasma membrane,Cytosol						Plasma membrane	Nucleoplasm, Cytosol	HPA043520: AB_10964138	unprognostic (2.06e-1)	unprognostic (1.13e-2)	unprognostic (7.94e-3)	prognostic favorable (7.63e-5)	unprognostic (5.18e-1)	prognostic favorable (8.60e-4)	unprognostic (7.07e-2)	unprognostic (2.46e-3)	unprognostic (1.51e-1)	unprognostic (1.82e-1)	unprognostic (4.70e-2)	unprognostic (9.99e-2)	unprognostic (4.01e-2)	unprognostic (8.47e-2)	unprognostic (3.25e-1)	unprognostic (6.86e-3)	unprognostic (5.96e-3)	2.6	4.1	8	4.3	14.7	4.3	2.8	1.4	3.3	12.4	3.3	34.4	15.6	3.1	9.1	49.4	2.8	116	13.6	2	13.4	6.6	8.9	5	25.4	4.4	8	7.8	26.7	6.5	2.5	7.5	17.7	71.4	9.4	2	3.3	7.7	12.7	2	5.7	5	2.9	7.5	7.6	9.4	2.1	17.9	0.4	7.8	0.9	2.5	8.8	11.3	4.9	4	5.2	2.2	5.3	4.8	2.4	1.1	1.1	0.7	3.5	1.3	1.8	2.2	0.6	0.4	0.2	0.3	0.8	7.5	0.8	2.2	0.9	0.5	1.4	0.3	0.3	0.1	2.4	1	0.6	2.2	2	1.2	0.6	1.8	2.3	2.1	0.2	0.5	2.5	0.5	2.6	0.5	2.9	0.4	2.1	1.4	2	0.6	8.8	5.7	1.7	0.3	2.3	1	3.2	0.7	2.6	0.5	36.6	3.7	2	2.3	2.3	1	0.6	0.4	2.7	9.7	10.1	3.4	0.7	4.3	1	1.4	3.3	2.2	1.6	4.8	1.8	2.6	3.1	3	3.6	2.1	4.9	2.4	2	5.2	5.3	1.6	4	3.2	2.4	8	14.7	1.4	3.3	13.4	6.6	8	7.8	71.4	17.9	11.9	16.8	0.8	29.9	4.2	2.2	1.9	0	1030.6	124	115.1	3.9	21.6	29.9	26.7	4.7	3.8	3.9	0	5.2	16.2	21.6	27.6	5.8	0	4.6	6.4	18.4	0	0	4	4.4	4.4	10.1	1.8	19.7	7.2	24.2	2.9	4.6	3.6	3.9	6.5	4.2	0.5	0.4	3.6	17.2	0	7.4	100.9	Ciliated cells
FGF21		ENSG00000105550	Fibroblast growth factor 21	Q9NSA1	19	48755559-48758333	Predicted secreted proteins, RAS pathway related proteins		Growth factor		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	113	liver: 37.8	Cell type enriched	Detected in some	12	Cardiomyocytes: 67.7	Cancer enriched	Detected in single	315	liver cancer: 33.4	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	4	HHSteC: 3.1;U-2 OS: 10.5	Not detected	Not detected			Low region specificity	Detected in all			HPA061286	Supported				Secreted to blood			254000				HPA061286: AB_2684466				unprognostic (1.64e-2)		unprognostic (3.62e-1)	unprognostic (3.21e-2)			unprognostic (3.42e-1)				unprognostic (1.54e-1)	unprognostic (1.85e-2)			0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	37.8	0	0	0	0	0	0.1	0	0.3	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0	0.4	0	0	0	0	0.2	0	0	0	0.1	0	0	0	0.2	0	3.1	0	0	0	0.3	0	0.2	0	0	1.5	0	0.4	0	0	0	0	0	0.2	0	0	0	0	0	0	0.6	0	0	0	0.2	0	0.1	0	0	0	10.5	0	0	0.1	0.7	0	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	67.7	2.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Cardiomyocytes
CACNG7		ENSG00000105605	Calcium voltage-gated channel auxiliary subunit gamma 7	P62955	19	53909335-53943941	Predicted membrane proteins, Transporters	Calcium transport, Ion transport, Transport	Calcium channel, Ion channel, Voltage-gated channel		Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	29	brain: 54.4	Cell type enriched	Detected in some	17	Horizontal cells: 127.1	Cancer enriched	Detected in some	16	glioma: 29.4	Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		AF22: 26.8;GAMG: 7.5;HMC-1: 20.9;hTERT-RPE1: 26.3;SH-SY5Y: 16.5	Low region specificity	Detected in all			Low region specificity	Detected in all																			unprognostic (3.11e-2)	unprognostic (7.18e-2)	unprognostic (6.24e-2)				unprognostic (3.06e-1)	unprognostic (1.24e-1)		unprognostic (1.01e-5)	unprognostic (1.51e-1)	unprognostic (7.36e-2)			1.2	1.8	22.2	1.3	15.6	1.2	1.2	22.7	54.4	1.2	1.3	8.3	0	1.2	1.2	1.2	1.2	1.2	1.2	1.2	21.4	13.7	1.2	1.2	1.3	1.2	16.5	10.3	1.2	1.3	1.2	1.8	1.2	9.9	1.2	1.2	0.3	1.2	1.3	1.2	1.2	1.4	1.3	13.5	1.2	1.3	1.5	4.5	0	1.2	0	1.2	1.2	0	0	0	0	0	0	0	0	0	3.5	26.8	0	0.1	0	0	0.1	0	0	0	0	0	0	0.1	0	7.5	0	2.5	0	0	0	0	0	0	0	1.4	0	20.9	0.2	0	0	0	26.3	0.4	0	0	0	0	0	0	0	7.1	0	0	0	0	0	0	0	0	16.5	0	0	0	0.2	0	0	0	0.2	5.7	0	0	0	1.6	0	1.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	22.2	15.6	22.7	25.9	21.4	13.7	16.5	10.3	9.9	4.5	0	0	0	0	0	7.4	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	127.1	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	1.9	0	0	0.4	0.1	0	0	0	0	0	Horizontal cells
KLF1	EKLF	ENSG00000105610	Kruppel like factor 1	Q13351	19	12884422-12887199	Disease related genes, Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	Activator, DNA-binding	Congenital dyserythropoietic anemia, Disease mutation, Hereditary hemolytic anemia	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		bone marrow: 30.6;lymphoid tissue: 7.0;placenta: 9.0	Cell type enriched	Detected in some	146	Erythroid cells: 350.4	Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	5	classical monocyte: 1.7;intermediate monocyte: 4.7;non-classical monocyte: 2.9	Lineage enriched	Detected in single	8	monocytes: 4.7	Group enriched	Detected in some	28	HEL: 23.1;K-562: 55.4	Not detected	Not detected			Not detected	Not detected			HPA051850	Enhanced		Supported	Nucleoplasm						Nucleoplasm		HPA051850: AB_2616460	unprognostic (1.17e-1)	unprognostic (1.38e-4)	unprognostic (2.96e-1)	unprognostic (1.17e-3)	unprognostic (7.13e-2)	unprognostic (3.90e-4)	unprognostic (3.25e-2)	unprognostic (3.19e-2)	unprognostic (1.97e-1)	unprognostic (1.08e-2)	unprognostic (6.51e-2)	unprognostic (7.71e-2)	unprognostic (2.69e-3)	unprognostic (1.05e-1)	unprognostic (1.06e-1)	unprognostic (3.76e-1)	unprognostic (2.44e-1)	0	0	0.5	0	0.3	30.6	0	0.1	0.4	0	0	0.4	0	0	0	0	0	0	0	0	0.2	0.1	0.1	1	0.9	0	0.2	0	0	0	0	0.2	9	0.3	0	0	0	0.1	0	0.5	0	0	0	0.1	7	0	0.1	0	0	0.8	1.2	0	0.6	0	0.3	0.5	0.5	4.7	0	0.2	1.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0.4	0	23.1	0	0	0	0.3	0.3	0	0	0	0	0	0	0	55.4	0	0	0	0.1	0.1	0.3	0	0	0	0	0.1	0	0	0.2	0	0	0	0	0	0	0.2	0.1	0	0	0	0	0.3	0.1	0	0	1.3	0	0	1.7	0	0.2	4.7	0	0.3	0	0.1	0.5	0.1	0.1	0.2	0.5	0	2.9	0	0	1.6	0.5	0.3	0.1	0.4	0.2	0.1	0.2	0	0.3	0	0	0	2.2	0.1	0.1	0	0.4	0	0	0	0	0	0.1	0	0	0	0	0	350.4	0	1.2	0	0.2	0	0	2.2	0	0	0	2.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0.2	0	0	0	Erythroid cells
UPK1A	TSPAN21	ENSG00000105668	Uroplakin 1A	O00322	19	35666516-35678483	Predicted membrane proteins, Transporters				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		prostate: 20.3;urinary bladder: 80.6	Cell type enriched	Detected in some	4	Urothelial cells: 28.0	Cancer enriched	Detected in many	41	urothelial cancer: 148.1	Not detected	Not detected			Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Cell line enriched	Detected in some	5	RT4: 29.6	Low region specificity	Detected in single			Not detected	Not detected			HPA049879	Enhanced											HPA049879: AB_2680929	unprognostic (3.29e-1)	unprognostic (1.78e-1)	unprognostic (1.19e-3)	unprognostic (3.40e-4)	unprognostic (4.05e-2)	unprognostic (1.04e-1)	unprognostic (1.74e-2)	unprognostic (3.11e-3)	unprognostic (2.30e-1)	unprognostic (1.78e-1)	unprognostic (4.62e-2)	unprognostic (2.34e-1)	unprognostic (2.48e-9)	unprognostic (1.48e-1)	unprognostic (4.14e-2)	unprognostic (2.45e-2)	unprognostic (1.72e-1)	0.3	0	0.1	0.1	0.1	0	0.1	0.1	0.1	6	0.1	0.1	0.1	0	0.4	0.1	12.8	0.2	0.1	0.1	0.1	0	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	20.3	0	0.1	0.9	0.1	0.1	6.7	0.1	4.5	0.1	0.1	0	0.2	0.1	0.1	0.1	1.1	1	80.6	8.6	1.7	0.5	1.8	0.5	1.6	2	0.8	0.2	0.9	0.1	0.2	0.3	0.1	0.3	0.2	0	0.1	0.4	1	0.1	0	0.1	0.1	0.1	0.1	0.1	0	0.1	2.8	0.7	0	0.3	0.2	0.1	0.1	0.4	0	0.2	0.1	0	0.5	0	0	0	0	0	0.5	0	0.3	0.4	6.1	0.2	0	0.1	0	0	29.6	0.1	0.3	0.4	0.3	0.5	0.2	0.2	0.3	0.9	0	1.2	0.1	0.2	0.1	0.4	0	0.1	0.1	0.2	1.1	0.5	0.2	0.3	0.4	0.5	0.6	2	0.6	0.2	1.7	0.1	0.6	1.8	1.6	0.1	0.5	0	0.8	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	0	0.5	0.2	0	0.8	0	0	0	0	0	0	0	0	3	0	0	0	0	0.2	0	6.9	0	0	0	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0.1	0.2	1.1	0.4	0.1	0	0	28	Urothelial cells
GAPDHS	GAPD2, GAPDH-2, GAPDS	ENSG00000105679	Glyceraldehyde-3-phosphate dehydrogenase, spermatogenic	O14556	19	35533412-35545316	Enzymes, Plasma proteins, Predicted intracellular proteins	Glycolysis	Oxidoreductase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	35	testis: 154.6	Cell type enriched	Detected in some	4	Late spermatids: 6946.0	Cancer enriched	Detected in single	97	melanoma: 13.3	Not detected	Not detected			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		A549: 16.5	Not detected	Not detected			Low region specificity	Detected in all			HPA042666	Enhanced		Approved	Nucleoplasm,Centrosome						Nucleoplasm	Centrosome	HPA042666: AB_2678104	unprognostic (3.74e-1)	unprognostic (1.59e-1)			unprognostic (7.41e-2)			unprognostic (1.56e-1)	unprognostic (2.06e-1)	unprognostic (1.04e-1)	unprognostic (8.81e-2)			unprognostic (2.96e-1)	unprognostic (1.03e-1)	unprognostic (6.45e-3)	unprognostic (2.37e-1)	0.3	0.5	0.3	0.8	0.3	0.2	0.3	0.3	0.4	0.3	0.3	0.3	0.3	0.6	0.5	1.6	0.6	0.2	0.8	0.8	0.3	0.3	0.3	0.3	0.3	1.6	0.3	0.3	0.7	1.3	0	0.3	0.3	0.3	0.3	0	4.2	1.3	0.3	0.3	4.4	0.6	0.3	0.3	1.2	0.4	154.6	0.3	0.3	3.6	0.3	0.3	0.6	0.3	2.1	1	1.2	0.8	1.4	2	0.8	4.5	16.5	4.6	6.9	0	0	3.9	1.3	0	0	0	10	7.6	7.5	2.2	0	1.9	5.5	0	0	0	7.3	8	5	10.5	5.1	0.1	4.5	6	0	0	0	0	2.9	0	7.3	12	4.4	0	14.1	1.7	2.1	6.2	2.9	2.2	5.3	3.2	5.8	0	4.5	8.3	3.7	1.7	4.2	4.9	3.3	3.4	1.9	1.5	5.3	6	1.3	1.9	12.3	3.3	4.4	2.9	8.1	1.9	0	0.8	1.2	1.1	0.6	2	1.1	0.4	1.9	1	2.1	1.1	1.2	0	1.4	0.3	0.8	0.3	0.8	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0	0	0	0	2.2	0	0	0	0	0	0	0	0	0	0	1712.2	0	0	0	0.2	0	0.2	0	0	0	0.1	0	0	1.3	0	6946	23	0	42.2	0	0	0	0	0	26.9	0	0	25.8	0.2	30.4	13.5	0.1	0	0	0	0	Late spermatids
HAMP	HEPC, HFE2B, LEAP-1, LEAP1	ENSG00000105697	Hepcidin antimicrobial peptide	P81172	19	35280716-35285143	Disease related genes, Potential drug targets, Predicted secreted proteins, Transporters		Antibiotic, Antimicrobial, Fungicide, Hormone	Disease mutation	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	16	liver: 716.5	Cell type enriched	Detected in many	8	Hepatocytes: 1549.8	Group enriched	Detected in many	12	glioma: 6.5;liver cancer: 16.3	Low region specificity	Detected in many			Group enriched	Detected in some	9	myeloid DC: 2.5;plasmacytoid DC: 7.6	Lineage enriched	Detected in single	13	dendritic cells: 7.6	Cell line enriched	Detected in single	229	Hep G2: 69.9					Not detected	Not detected								Secreted to blood			1900000	3900000				unprognostic (5.53e-2)	unprognostic (5.02e-4)	unprognostic (2.10e-3)	unprognostic (4.69e-3)	unprognostic (5.35e-2)	unprognostic (2.24e-1)	unprognostic (3.92e-2)	unprognostic (9.36e-2)	unprognostic (2.73e-2)	unprognostic (1.06e-1)	unprognostic (4.61e-1)	unprognostic (1.86e-1)	unprognostic (3.68e-7)	unprognostic (4.11e-2)	unprognostic (3.93e-2)	unprognostic (4.08e-2)	unprognostic (7.77e-2)	0.4	0.5	1.8	0.6	10.8	1.2	0.7	0.2	4.4	0.6	0.3	0.2	0	0.5	0.4	0.4	0.4	0.9	0.4	45.1	10	1.8	0.3	716.5	0.4	1	4.2	0	1.1	8.7	0.4	0.5	0.7	6.7	0.6	0.3	0	0.4	0.6	0.5	0.4	0.3	0.4	13.9	0.3	0.4	0.5	4	0	0.3	0	1	0.4	0	0.5	7.6	0	0.1	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0.1	69.9	0	0.1	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0.1	0	0	0	0	0	0.1	0	0.4	0	0	2.5	0.5	0	0	0	0.5	0	7.6	0	0	1.8	10.8	0.2	4.4	10	1.8	4.2	0	6.7	4	0	0	9.3	0.9	0.5	0	1.1	30.6	0	1.2	0	0	0.6	0	0.4	0	0.6	0	23.3	82	0.9	0.5	5.2	69.8	1549.8	198.8	0	0	28.3	41.3	0	0	3.4	0	0	1	0.5	36.6	0	0	0	0.1	0	0.9	0	0	16.3	0.6	1.5	0.2	1.7	Hepatocytes
PON3		ENSG00000105852	Paraoxonase 3	Q15166	7	95359944-95396368	Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted secreted proteins		Hydrolase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	7	liver: 148.0	Cell type enriched	Detected in many	14	Hepatocytes: 460.4	Group enriched	Detected in many	9	liver cancer: 30.8;lung cancer: 7.8	Not detected	Not detected			Cell type enriched	Detected in single	12	NK-cell: 1.1	Lineage enriched	Detected in single	12	NK-cells: 1.1	Cell line enhanced	Detected in some		A549: 20.2;CACO-2: 6.5;CAPAN-2: 4.9;Hep G2: 22.4;T-47d: 12.6	Low region specificity	Detected in many			Not detected	Not detected			HPA014848, CAB025250	Enhanced				Secreted to blood			1760000000	350000000			CAB025250: , HPA014848: AB_1855540	unprognostic (2.67e-1)	unprognostic (1.03e-1)	unprognostic (6.28e-3)	unprognostic (5.52e-3)	unprognostic (1.36e-1)	unprognostic (4.87e-1)	unprognostic (1.44e-3)	unprognostic (6.32e-2)	unprognostic (1.11e-1)	unprognostic (6.44e-3)	unprognostic (9.14e-2)	unprognostic (7.18e-3)	unprognostic (8.30e-9)	unprognostic (1.66e-1)	unprognostic (1.04e-2)	unprognostic (8.29e-2)	unprognostic (5.12e-2)	0.4	0.7	0.3	0.1	0.6	0	6.9	0.2	0.5	0.9	1	0.3	2.3	1.5	0.2	1.2	0.2	0.4	0.7	0.4	0.7	0.3	0.7	148	4	0	0.4	0.2	2.4	7.1	0	15.5	0.2	0.5	0.2	0.4	0.8	21.4	5.5	0.1	1.8	1.7	0.1	0.3	0.2	0.5	3.6	0.4	0.4	1.5	0	1.1	0.5	0.3	0	0	0	0	1.1	0	0	2.2	20.2	0	0	0	0	0	0	0	0	0	6.5	4.9	0	0.3	0	0	0	0	0	0	0	0	0	0	22.4	0	0	0	0	1.2	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	3.9	0	0	12.6	0	0	0	0.1	0	0	1.3	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.1	0	0	0	0	0.3	0.6	0.2	0.5	0.7	0.3	0.4	0.2	0.5	0.4	6	32.1	1.4	0.7	0.8	0	0.3	25.5	8.1	14.8	3.5	0	1.5	1.7	0.2	9	0.5	4	0	1.8	1.9	2.6	2.2	0	460.4	0.2	0	0	8.6	7	3.6	7.5	0	13.5	0	2.3	3	1.5	0	2.8	5.2	0	0	0.1	17.7	13.6	1.1	1.1	0.5	2.3	0.3	Hepatocytes
DNAH11	CILD7, DNAHBL, Dnahc11, DNHBL, DPL11	ENSG00000105877	Dynein axonemal heavy chain 11	Q96DT5	7	21543215-21901839	Disease related genes, Predicted intracellular proteins		Motor protein	Ciliopathy, Disease mutation, Kartagener syndrome, Primary ciliary dyskinesia	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		epididymis: 22.2;parathyroid gland: 62.2	Cell type enriched	Detected in some	9	Ciliated cells: 111.1	Low cancer specificity	Detected in some			Group enriched	Detected in many	4	basal ganglia: 5.5;pons and medulla: 15.5	Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		GAMG: 7.6;HUVEC TERT2: 2.4;U-2 OS: 2.7;U-2197: 3.4	Low region specificity	Detected in some			Low region specificity	Detected in many			HPA045880, HPA056474	Approved											HPA045880: AB_10962003, HPA056474: AB_2683145	unprognostic (2.24e-2)	unprognostic (2.28e-1)	unprognostic (1.01e-2)	unprognostic (5.17e-3)	unprognostic (4.15e-2)	unprognostic (1.51e-1)	unprognostic (9.01e-2)	unprognostic (6.32e-2)	unprognostic (1.95e-1)	unprognostic (1.12e-1)	unprognostic (2.79e-2)	unprognostic (3.10e-1)	prognostic unfavorable (1.49e-7)	unprognostic (9.25e-2)	unprognostic (1.55e-1)	unprognostic (3.86e-3)	unprognostic (4.79e-3)	3.2	4.6	0.8	0.5	5.5	0.4	0.4	0.2	1	1.6	0.9	6.7	3	0.4	0.8	22.2	2.5	9.3	0.5	1.1	2.5	1.2	0.5	0.8	7.7	0.4	0.2	0.6	7.2	0.5	62.2	0.8	2.9	15.5	1.1	0.5	0	0.4	1	1.5	0.9	0.6	0.4	0.3	0.4	0.5	0.9	2.1	0.7	5.2	0.3	0.5	0.4	3.4	0.6	0.9	0	0	0	0.1	0	0	0.1	0.1	0	0.2	0.7	0	0.6	0.9	0	0.1	0.1	0	0.4	0	0.1	7.6	0.1	0	0.7	1.5	0	1.7	0	0.5	0	0.7	0.3	0	0	0	0	0	0.1	2.4	0.3	0	0	0	0.1	0.1	0	0.9	0	0.4	0.7	0.2	0.3	0	0	0.6	0	0.1	0.7	0	1.4	0	0	1.7	0.7	2.7	3.4	0.4	0.2	0.1	0.3	1	0.4	0	0	0	0	0	0	0	0.3	0	0	0	0.6	0.1	0	0	0	0	0.9	0	0	0.8	5.5	0.2	1	2.5	1.2	0.2	0.6	15.5	2.1	6	3.8	0	3.5	2.2	0	3.3	0	111.1	12.5	0	0	0	0	0.1	2.5	0.3	0	0	0	1.3	0.2	2.3	0	0.2	0.1	6.4	0	0	0	1.5	0.3	0	1.7	1	0	0	0.2	0	0.4	0	0	0	0.2	0.7	0.4	0.3	1.4	0	0	0.7	Ciliated cells
NPVF	C7orf9, RFRP	ENSG00000105954	Neuropeptide VF precursor	Q9HCQ7	7	25224570-25228486	Predicted secreted proteins		Neuropeptide		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	30	brain: 9.5;lymphoid tissue: 2.9;retina: 7.0	Cell type enriched	Detected in some	44	Muller glia cells: 336.5	Not detected	Not detected			Region enriched	Detected in single	95	hypothalamus: 9.5	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Region enriched	Detected in single	17	hypothalamus: 7.2	Region enriched	Detected in some	4	hypothalamus: 3.8	HPA041733	Enhanced				Secreted in other tissues							HPA041733: AB_10794524																		0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0.1	0	0	0	9.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	7	0	0	0	0	0	0	0	0.1	0	0.2	0	0	0	0	2.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0.7	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	9.5	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	336.5	0	0	0	0	7.7	0	0	0	0	0	0	0	0	0	Muller glia cells
CRHR2	CRF-RB, CRF2, HM-CRF	ENSG00000106113	Corticotropin releasing hormone receptor 2	Q13324	7	30651943-30700129	G-protein coupled receptors, Predicted membrane proteins, Predicted secreted proteins		G-protein coupled receptor, Receptor, Transducer		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in many		brain: 11.7	Cell type enriched	Detected in single	13	Horizontal cells: 12.7	Not detected	Not detected			Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HEK 293: 1.3;HeLa: 1.8;NTERA-2: 3.0;SCLC-21H: 1.7	Low region specificity	Detected in many			Low region specificity	Detected in all								Secreted - unknown location								unprognostic (7.14e-2)	unprognostic (4.20e-1)	unprognostic (1.68e-1)	unprognostic (1.24e-3)	unprognostic (5.69e-2)	unprognostic (8.58e-2)	unprognostic (6.00e-2)	unprognostic (1.86e-4)	unprognostic (2.01e-1)	unprognostic (3.07e-1)	unprognostic (5.90e-4)	unprognostic (4.02e-2)	unprognostic (8.29e-4)	unprognostic (3.73e-3)	unprognostic (2.84e-3)	unprognostic (1.81e-1)	unprognostic (3.84e-1)	1.4	0.7	0.9	0.5	4.1	0.4	1.6	0.5	11.7	0.8	0.6	0	3.6	2.1	1.1	0.5	1.7	2.1	1	3.2	4.3	3.2	0.8	0.4	0.6	0.6	0.9	3.2	1	3.9	0.9	8	0.4	3.1	0.9	0.9	1.7	0.7	6.2	5.5	0.8	1.2	1.1	0.8	0.3	1	1.8	1	0	1.7	3.2	0.6	0.9	0.5	0	0	0	0	0	0.3	0	0.1	0.1	0.1	0.7	0	0	0	0.3	0	0	0.2	0.1	0	0.5	0	0	0.1	0.2	0.1	0	0	0.2	1.3	0	1.8	0	0	0.4	0.2	0	0	0	0	0	0	0.6	0.1	0.3	0	0	0.2	0.2	3	0	0.4	0	0	0.6	0	0.9	1.7	0.1	0.2	0	0.2	0.6	0.1	0	0.5	0.4	1	0.3	0.2	0.8	0.3	0	0.2	0.1	0.4	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0.9	4.1	0.5	11.7	4.3	3.2	0.9	3.2	3.1	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0.8	0	0	0	0	0	0	0	0	0	0	12.7	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0.1	0	0	0	0.1	0	0	0	0	0	Horizontal cells
TFR2	HFE3, TFRC2	ENSG00000106327	Transferrin receptor 2	Q9UP52	7	100620416-100642779	Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters		Receptor	Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	20	liver: 112.6	Cell type enriched	Detected in many	4	Hepatocytes: 379.7	Cancer enriched	Detected in many	70	liver cancer: 136.2	Not detected	Not detected			Group enriched	Detected in some	46	basophil: 5.5;eosinophil: 3.9	Lineage enriched	Detected in single	54	granulocytes: 5.5	Group enriched	Detected in some	11	HEL: 28.5;HMC-1: 39.6;K-562: 26.3	Low region specificity	Detected in many			Not detected	Not detected			CAB016255, HPA017171, HPA073125	Enhanced		Approved	Golgi apparatus						Golgi apparatus		CAB016255: AB_628395, HPA017171: , HPA073125: 	unprognostic (4.18e-2)	unprognostic (1.97e-2)	unprognostic (2.74e-1)	unprognostic (1.04e-1)	unprognostic (1.26e-2)	unprognostic (4.13e-2)	prognostic favorable (2.48e-4)	unprognostic (2.29e-2)	unprognostic (4.49e-2)	unprognostic (9.26e-2)	unprognostic (1.93e-1)	unprognostic (2.90e-1)	unprognostic (1.18e-9)	unprognostic (6.51e-2)	unprognostic (1.68e-1)	unprognostic (3.28e-1)	unprognostic (8.18e-2)	0.1	0	0.1	0.1	0.1	5.3	0.1	0.8	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0	0.3	0.3	0.1	0	0.1	112.6	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.2	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.2	1.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	5.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	28.5	0	2.9	0	0.6	39.6	0	0	0	0	0	0	0	26.3	0	0	0	0	0	0	0.2	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	5.5	0	3.9	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.8	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	7.8	0.9	0.2	5.3	0.9	12.7	0	1.2	0	7.9	0.1	0	0.4	4	0	0	93.5	0.2	1.1	0.4	0.5	0	379.7	0.3	20.6	0	7.4	6.9	5.7	0	0.5	0	0	0.2	0.3	0.1	0	0	0	1.8	0	0.7	0.7	2	0.5	0.1	2.5	0.5	0.6	Hepatocytes
FSCN3		ENSG00000106328	Fascin actin-bundling protein 3	Q9NQT6	7	127591409-127602144	Predicted intracellular proteins		Actin-binding		Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	54	testis: 62.1	Cell type enriched	Detected in some	6	Late spermatids: 1905.7	Not detected	Not detected			Not detected	Not detected			Cell type enhanced	Detected in single		myeloid DC: 1.1	Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		hTCEpi: 2.5	Not detected	Not detected			Not detected	Not detected			HPA075174	Enhanced											HPA075174: 	unprognostic (7.77e-2)	unprognostic (1.57e-1)	unprognostic (2.17e-1)	unprognostic (9.59e-2)	unprognostic (1.39e-1)	unprognostic (3.87e-1)	unprognostic (5.69e-2)	unprognostic (1.50e-1)	unprognostic (2.91e-3)	unprognostic (2.00e-1)	unprognostic (1.68e-4)	unprognostic (1.34e-1)	unprognostic (1.14e-5)	unprognostic (1.27e-1)	unprognostic (9.21e-3)	unprognostic (2.01e-1)	unprognostic (7.34e-2)	0	0	0	0	0	0.2	0	0.2	0	0	0	0	0	0	0.1	0.7	0	0.1	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0.2	0	0	0	0	0	62.1	0	0	0	0	0	0	0	0.1	1.1	0.3	0	0	0.3	0	0	1.1	0.3	0.8	0	0	1.4	0.1	0.4	0.3	0	0.2	0.2	0	0.1	0	0	0	0.5	0	0	0.9	0	0	0.6	0	0	0	0	0.9	2.5	0.6	0	0	0	0.5	0.3	0.6	0	0.7	0.7	0.7	1.4	0	0	0.5	0.7	0.2	0	0.5	0.2	0.3	0	1.5	0	0.3	0	0.6	0	0.1	0.1	0.5	0	0.8	0.3	0.7	0	0.3	0.9	0	0	0	0	0	0	0	0	0.3	1.1	0.1	0	0	0.3	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	1.4	0	0.4	0.7	0	0.3	0	0	0	0	0	0.3	0	0.3	317.1	0.3	0	0	0.2	0.2	0.2	0.3	1.1	0	0.1	0	0	0	0	1905.7	8.6	0.9	1.7	0	0.1	0.2	0.2	0.6	7.8	0	0.4	0	0.3	9.8	5.8	1.1	0.2	0	0.1	0.1	Late spermatids
MOSPD3	CDS3, NET30	ENSG00000106330	Motile sperm domain containing 3	O75425	7	100612102-100615384	Predicted membrane proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	4	Late spermatids: 1149.7	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Cell line enhanced	Detected in many		U-937: 33.7	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA041137, HPA048240	Uncertain		Approved	Nucleoplasm,Cytosol		No	No			Nucleoplasm, Cytosol		HPA041137: AB_10803996, HPA048240: AB_2680325	unprognostic (1.24e-1)	unprognostic (8.98e-2)	unprognostic (1.06e-2)	unprognostic (1.08e-1)	unprognostic (1.25e-2)	unprognostic (1.80e-2)	unprognostic (1.19e-1)	unprognostic (5.94e-2)	unprognostic (9.88e-2)	unprognostic (1.66e-1)	unprognostic (2.46e-2)	unprognostic (8.65e-2)	unprognostic (2.24e-2)	unprognostic (7.55e-2)	unprognostic (2.25e-1)	unprognostic (1.09e-1)	unprognostic (3.20e-2)	13.8	22.3	13	7.7	12.8	17.4	9.8	9	16.9	14.7	9.1	14.5	13.9	9.9	12	12.9	22.5	12	14.9	10.2	11.2	10.8	19.3	29.8	11.1	18.5	10.6	11.6	13.1	17.1	6.7	9.8	7.8	12	12.9	4.8	14.9	19.1	11.3	11.3	24.4	10.6	10.3	9.5	11.8	14.7	37	9.9	16.6	12.2	13.6	16.8	12.4	13.4	11.6	17.9	22.2	16.7	20.9	29.7	8	6	8.2	6.6	11.4	3.5	2.6	4.7	4.6	5.5	4.8	4.9	7.6	8.1	3.8	10.2	4.2	6.8	4.7	3.8	6.6	0.9	9.8	5.1	3.9	6.1	11.4	4.5	3	15.1	7.4	5.7	4.1	2.4	4.2	8.2	6.4	9.1	7.8	4.9	17.9	8.4	23	6	7.9	12.4	7.9	6.9	9.1	7.6	9.1	3.6	21.7	8.6	13.4	4.6	2.8	8.1	8.9	9.2	9.3	14.7	19.3	4.4	6.2	5.8	2.6	9.3	33.7	11.4	18.5	16.7	22.2	18.8	12.4	22.2	11.6	21.8	21.8	17.9	11.3	13	13.5	12.3	20.9	8.5	12	29.7	8	13	12.8	9	16.9	11.2	10.8	10.6	11.6	12	9.9	8.9	6.5	11.9	14.9	10.8	6.6	3.2	17.8	9.4	4.5	19.2	5.9	6	36.5	33.9	271.2	15.7	8.7	0	37.6	23.2	22	20.1	3.5	26.2	25.2	6.4	20.7	19	23	1149.7	25.6	15.1	25.3	14.4	14.9	11.4	39	17.5	20.5	35.7	3.4	12.9	20	17.7	21.5	17.1	5.1	29.3	16.9	17.8	Late spermatids
PAX4	MODY9	ENSG00000106331	Paired box 4	O43316	7	127610292-127618114	Disease related genes, Predicted intracellular proteins, Transcription factors	Differentiation, Transcription, Transcription regulation	Developmental protein, DNA-binding, Repressor	Diabetes mellitus, Disease mutation	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Group enriched	Detected in some	4	intestine: 3.9;testis: 3.6	Cell type enriched	Detected in some	9	Intestinal endocrine cells: 81.6	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	62	SCLC-21H: 17.4	Not detected	Not detected			Not detected	Not detected								Intracellular and membrane										unprognostic (1.52e-1)								unprognostic (9.71e-2)			unprognostic (4.86e-3)	unprognostic (1.21e-1)			0.1	0	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	3.4	0.1	0.1	3.8	0.1	0.8	0.1	0	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0	0.1	0.1	0.1	0.1	3.9	0.1	0.1	0.1	0.1	0	2.1	0.1	0.1	0.1	0	3.6	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0.3	0.6	0	0	0	0	0	0.2	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.4	0	0	0.1	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0.6	0	0	0	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0.2	0	0	0	0	0	0.3	0	0	2.6	0	0	0	0	0	0	0	0	0	0.1	0	81.6	0	0	8.7	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	Intestinal endocrine cells
SFRP4	FRP-4, frpHE, FRZB-2	ENSG00000106483	Secreted frizzled related protein 4	Q6FHJ7	7	37905932-38025695	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins	Differentiation, Wnt signaling pathway	Developmental protein	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		cervix, uterine: 144.9;endometrium 1: 100.7;retina: 123.0	Cell type enriched	Detected in some	5	Peritubular cells: 177.1	Low cancer specificity	Detected in all			Low region specificity	Detected in single			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		ASC diff: 14.1;HSkMC: 5.5;U-937: 5.3	Low region specificity	Detected in many			Low region specificity	Detected in some			HPA009712, HPA050585	Enhanced				Secreted in female reproductive system				1500000			HPA009712: AB_1856778, HPA050585: AB_2681183	unprognostic (5.93e-2)	unprognostic (5.84e-3)	unprognostic (2.75e-2)	unprognostic (1.58e-3)	unprognostic (2.61e-1)	unprognostic (2.35e-2)	unprognostic (4.02e-2)	unprognostic (2.60e-1)	unprognostic (1.21e-1)	unprognostic (3.76e-2)	unprognostic (2.12e-1)	unprognostic (1.18e-1)	prognostic unfavorable (1.36e-5)	unprognostic (7.37e-3)	unprognostic (1.61e-1)	unprognostic (4.35e-3)	unprognostic (1.89e-3)	4.6	2.3	0.5	0.9	0.9	0	12.5	0.3	0.4	144.9	0.8	1.7	5.4	0	100.7	11.5	3.2	35.1	2.5	5.5	0.4	0.4	1.2	0.2	3.9	0.8	0.8	0.7	42.7	1.4	0.1	4	0.4	1.3	4.9	0.2	123	2.3	7.1	1.4	0.3	0.5	14.5	3.3	4.1	0.5	5.8	0.3	0.4	3.3	2.5	0.5	8.8	14.8	0.4	0.8	0.4	0.6	0.1	0.1	0	0	2.6	2.9	0	14.1	0.6	0.1	0	0.1	0	0	0.4	0	0.1	0.1	3	0.4	0.1	0	0.3	0.3	0	0	0.2	0.2	2	0.1	0.4	0	5.5	0.7	0.6	0	1	0.2	0.2	0	0.3	0.2	0.4	0	1.7	0.1	0	0	0.2	1.7	0	0.1	0.3	0.1	0.3	0	0	0.3	0.6	0	0	0.9	0	1.2	1.7	0.2	0.5	0.1	0.2	0.3	5.3	0.9	0	0.1	0	0	0.6	0	0.4	0	0	0.1	0.1	0.1	0	0.4	0.1	0	0.8	0	0	0.5	0.9	0.3	0.4	0.4	0.4	0.8	0.7	1.3	0.3	0	2.6	0	1.7	0.9	0	0.4	0	0	1.2	0	0	0	0	0	0.8	0.5	0	0	0.4	0.1	8.6	1.6	0	0	0.2	0	0	4.3	0	0.9	38.6	0.8	0	0	0	2.7	0.1	0	177.1	2.1	0.1	0	3.1	0.2	0.5	1.4	0.2	0	0	0	Peritubular cells
MYL7	MYL2A, MYLC2A	ENSG00000106631	Myosin light chain 7	Q01449	7	44138864-44141332	Predicted intracellular proteins		Motor protein, Muscle protein, Myosin		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	822	heart muscle: 639.9	Cell type enriched	Detected in single	8987	Cardiomyocytes: 8328.0	Cancer enriched	Detected in some	7	testis cancer: 3.6	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	19	BEWO: 14.8;CACO-2: 50.4;SuSa: 20.8	Not detected	Not detected							HPA013331, CAB033884, HPA039262	Enhanced											CAB033884: AB_2266773, HPA013331: AB_1854245, HPA039262: AB_2676418	unprognostic (1.00e-2)	unprognostic (7.99e-2)		unprognostic (4.36e-3)	unprognostic (2.31e-1)	unprognostic (2.51e-1)				unprognostic (1.28e-1)	unprognostic (7.85e-2)				unprognostic (1.67e-1)		unprognostic (7.28e-2)	0.1	0	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0	0.1	639.9	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.7	0	0.1	0.1	0.1	0.1	0	0.1	0.4	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	14.8	0	0	0.1	0	50.4	0	0	0.7	0	0	0.2	0	0	0.2	0	0	0	0.1	1.5	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0.8	0.1	0.4	0.1	0	20.8	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	0	0	0	0	8328	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0.1	0.9	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Cardiomyocytes
LHX2	hLhx2, LH-2	ENSG00000106689	LIM homeobox 2	P50458	9	124001670-124033301	Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	Activator, DNA-binding		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	5	brain: 44.7;retina: 17.0	Cell type enriched	Detected in some	9	Muller glia cells: 245.9	Group enriched	Detected in many	5	cervical cancer: 3.2;glioma: 10.7;melanoma: 3.5	Group enriched	Detected in many	6	amygdala: 30.7;basal ganglia: 20.5;cerebral cortex: 26.6;hippocampal formation: 23.6;olfactory region: 16.1	Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in many		AN3-CA: 15.7;GAMG: 12.3;HAP1: 15.7;HeLa: 10.9;NTERA-2: 19.5;U-138 MG: 10.2	Group enriched	Detected in many	5	amygdala: 41.7;basal ganglia: 25.3;cerebral cortex: 46.8;hippocampal formation: 47.4;olfactory region: 19.7	Group enriched	Detected in many	6	amygdala: 55.6;basal ganglia: 46.4;cerebral cortex: 70.9;hippocampal formation: 73.5;olfactory region: 35.5	HPA000838		Supported	Approved	Nucleoplasm						Nucleoplasm		HPA000838: AB_2666109	unprognostic (3.60e-3)	prognostic favorable (9.52e-4)	unprognostic (3.52e-1)	unprognostic (9.97e-2)	unprognostic (1.29e-1)	unprognostic (1.12e-2)	unprognostic (6.37e-3)	unprognostic (1.07e-1)	unprognostic (4.59e-2)	unprognostic (3.24e-1)	unprognostic (2.96e-1)	unprognostic (1.32e-2)	unprognostic (4.66e-15)	unprognostic (1.72e-1)	unprognostic (2.92e-1)	unprognostic (2.46e-2)	unprognostic (1.77e-1)	0.9	1	30.7	1.1	20.5	0.9	1.1	0	44.7	0.8	0.9	4.7	0	1	0.8	0.8	0.8	0.8	1	0.8	23.6	2.4	0.8	6.1	0.9	1.1	1.5	16.1	1.1	0.8	0.8	4.6	5.1	0	0.8	1.1	17	1.1	0.8	0.8	2.2	0.9	0.8	0.2	0.9	0.9	4	4.2	0	0.8	0	1.1	0.9	0	0	0	0.5	0.1	0	0.1	0	0	4.9	0.1	15.7	0	0.2	1.6	0.4	0.2	1.2	0.1	4.9	0	0.1	2.1	0.9	12.3	0.1	15.7	0	0.6	0	3.4	0	10.9	0.2	1	0	0.1	0	0	0	0	0	0	0	0	0	1.8	7.8	0	0.1	19.5	0	4.6	4.2	0	0	0	0	6.4	0	4	0	0	0.1	5.6	2	0	10.2	0.4	2.9	0.7	0.2	3.2	0	0.6	2.2	1.2	0	0	0.2	0	0.1	0	0	0.1	0	0	0	0	0.1	0.5	0	0	0	0.1	0	30.7	20.5	0	26.6	23.6	2.4	1.5	16.1	0	4.2	0	0	0	0	0	2.7	0.4	0	0	0	0	2	0	0	0	28.3	0	0	0	0	8.3	0	0	0	0	3	7.9	0	6.7	0	16	0	0	0	0	0	245.9	0	0	0	0	6.2	0	0	1	0.6	0	0.1	0	0	0	Muller glia cells
C5	C5a, C5b, CPAMD4	ENSG00000106804	Complement C5	P01031	9	120952335-121050276	Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins	Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Inflammatory response, Innate immunity		FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	55	liver: 259.9	Cell type enriched	Detected in many	12	Hepatocytes: 458.7	Cancer enriched	Detected in many	17	liver cancer: 73.0	Not detected	Not detected			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		A549: 20.5;Hep G2: 21.6	Low region specificity	Detected in some			Not detected	Not detected			HPA029339	Supported				Secreted to blood			113000000000	46000000000			HPA029339: AB_10601125	unprognostic (2.51e-1)	unprognostic (5.88e-3)	unprognostic (2.50e-3)	unprognostic (1.57e-2)	unprognostic (5.05e-2)	unprognostic (9.52e-3)	prognostic favorable (9.43e-4)	unprognostic (1.83e-1)	unprognostic (3.19e-2)	unprognostic (1.55e-1)	unprognostic (2.35e-2)	unprognostic (4.41e-2)	unprognostic (1.46e-5)	unprognostic (5.91e-2)	unprognostic (1.20e-1)	unprognostic (3.67e-2)	unprognostic (2.75e-1)	0.5	0.3	0.4	0.3	0.5	0.3	0.4	0.3	0.3	0.4	1.1	0.3	0.3	0.7	0.5	0.7	0.3	0.6	0.4	0.3	0.4	0.3	1.1	259.9	2.3	0.3	0.4	0.3	0.7	4.7	0.8	0.7	0.3	0.4	0.6	0.2	0.3	0.3	0.4	0.3	0.7	3.2	0.3	0.5	0.3	1.2	0.4	0.3	0.3	0.3	0.3	0.3	0.5	0.4	1.8	2.1	1.8	1.6	0.1	1.2	0.5	1.1	20.5	4.7	8.3	6.1	7.1	0.2	2.5	2.6	0.7	1.5	0.6	2	3	0.1	1.3	2.8	8.1	0.2	0.2	1.1	0.6	0	1.2	1	21.6	1.1	0.7	0.5	3.1	0.4	1.5	2.7	1.3	0.7	1.2	0.5	2.8	1.6	4	0.3	0.1	1.2	5	8	1.8	2.1	0.3	1.3	0.6	1.2	4.9	1.1	0	2	3.4	1.6	2.7	0.9	2.1	0.1	5.5	2.4	1.7	1.2	1.2	1.6	2.8	5	0	1.6	1.8	0.3	0.4	1.2	1.8	0.6	0.5	2.1	1	0.5	0.3	0.1	0.1	0.1	0.1	0.1	0.5	0.4	0.5	0.3	0.3	0.4	0.3	0.4	0.3	0.4	0.3	6	25.8	2.2	1	0.9	4.5	0.6	38.2	5.3	12.5	1.8	0	0.1	1.7	0.1	1.3	0.5	0	0	0.4	0	0.8	0.7	0	458.7	1.5	6.4	0	8	12.9	1.7	2.8	3.1	0	1.8	0.4	3.9	1.1	0	8.5	7.8	2.5	0	1.2	1.8	2.3	1.1	0	0.7	0.9	0.1	Hepatocytes
AMBP	EDC1, HCP, HI30, IATIL, ITI, ITIL, ITILC, UTI	ENSG00000106927	Alpha-1-microglobulin/bikunin precursor	P02760	9	114060127-114078472	Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Host-virus interaction	Protease inhibitor, Serine protease inhibitor		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	75	liver: 592.2	Cell type enriched	Detected in many	5	Hepatocytes: 9824.4	Cancer enriched	Detected in many	115	liver cancer: 2620.6	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	154	Hep G2: 168.4	Not detected	Not detected			Not detected	Not detected			HPA001497, CAB069436, HPA075585	Approved		Approved	Golgi apparatus,Vesicles,Cytosol	Secreted to blood				71000000000	Vesicles	Golgi apparatus, Cytosol	CAB069436: AB_1611916, HPA001497: AB_1078144, HPA075585: 	unprognostic (6.92e-2)	unprognostic (3.61e-1)	unprognostic (4.95e-3)	prognostic favorable (1.20e-4)	unprognostic (9.79e-2)	unprognostic (2.90e-1)	unprognostic (1.04e-3)	unprognostic (7.59e-2)	unprognostic (2.83e-2)	unprognostic (2.04e-1)	unprognostic (2.14e-1)	unprognostic (7.84e-2)	unprognostic (4.36e-2)	unprognostic (2.89e-3)	unprognostic (4.66e-2)	unprognostic (2.97e-3)	unprognostic (9.45e-3)	0	0	0	0.1	0	0	0.2	0	0.1	0	0.1	0.1	0	0	0	0.2	0	0	7.8	0.1	0	0	1.7	592.2	0.1	0	0	0	0	6.1	0	0	0	0.1	0	0	0.1	0.1	0	0	0	0.1	0	0	0.3	0.1	0.2	0	0.1	0.1	0	0	0	0	0	0	0	0.8	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0.2	0	0.2	0.3	0	0.1	0	0	0	0	0.5	0	0.3	0.1	168.4	0	0.6	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0.1	0.4	0	0	1	0	0.8	0	0.2	0	0.3	0.1	0	0	0	0	0.1	0	0.1	0	0	0.1	0	0.2	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.8	0	0	0	0	0	0	0.1	0	0	0	0	0.1	0	0	1	42	0.6	1.3	0	0	2035.7	0	1.2	1.8	0	0	3.3	105.1	19.2	0	0.4	256.9	25.3	0.3	0.1	0.4	0	9824.4	0.7	0	2.4	175.6	182.3	40.5	0.6	0	0	6.4	0.9	0	22.8	1.1	0	9.9	0	0	0	0.2	0.1	0.4	1.1	3.8	1	0.3	Hepatocytes
ELAVL2	HEL-N1, HuB	ENSG00000107105	ELAV like RNA binding protein 2	Q12926	9	23690104-23826337	Predicted intracellular proteins		RNA-binding		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	7	brain: 30.7;testis: 45.3	Cell type enriched	Detected in some	4	Spermatogonia: 154.0	Cancer enhanced	Detected in many		testis cancer: 7.1	Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		A-431: 10.1;AF22: 15.6;SCLC-21H: 52.1	Low region specificity	Detected in all			Low region specificity	Detected in all			CAB022222, HPA063001	Enhanced	Supported	Approved	Nucleoplasm,Cytosol						Nucleoplasm	Cytosol	CAB022222: , HPA063001: AB_2684918	unprognostic (3.51e-1)	unprognostic (4.18e-2)	unprognostic (2.05e-1)	unprognostic (1.47e-1)	unprognostic (6.67e-2)	unprognostic (1.79e-1)	unprognostic (4.26e-2)	unprognostic (8.94e-2)	unprognostic (3.23e-1)	unprognostic (1.01e-1)	unprognostic (9.74e-4)	unprognostic (3.98e-1)	unprognostic (9.08e-4)	unprognostic (8.30e-2)	unprognostic (1.91e-2)	unprognostic (2.12e-1)	unprognostic (2.65e-1)	1	2.4	8.7	1	13.4	1.4	1.1	18.3	27.5	1	1.3	0.7	0	1	1.5	1.4	1.1	1	1.1	1	8.1	19.2	1.4	0.8	1.1	1	16.3	18.9	2.1	0.8	1.2	2.5	0.9	30.7	1.2	1.5	0.5	1	1	1	1.5	1.1	1.1	5	1	1	45.3	1.1	0	1.2	0	1	1.6	0.3	1.8	1.1	5.1	0.9	1.4	1.3	0.1	10.1	0.1	15.6	0.1	0	0.1	0	0.1	0	0.1	0	0	0	0	0	0	0	3.2	4.2	6.5	0.1	0	2.9	0	0	0.1	0	0	0.3	0.3	4	0	4.7	0	0.1	0	0.3	0.5	2.2	0	0	0	4.1	0	4.9	0	5.6	0.1	0	0	52.1	4.9	0.1	0.1	0.1	4.2	0.2	0.7	0	0.1	3.4	0.1	0	0	0	0	0.6	0	0.6	2.7	0.9	1.6	0.5	0.6	0.6	1	0.5	0.4	0.4	1.8	1.1	1.3	5.1	1.4	0.5	1.1	0.6	0.1	8.7	13.4	18.3	27.5	8.1	19.2	16.3	18.9	30.7	1.1	0	0	0	0.3	0.9	3.6	0.8	0	0	0	0	0	0	1.7	0	34.9	1.1	0	0	0	0	0.2	0.3	0	0	0.1	15.9	4.1	0	0	30.7	2.8	0	0	0	0.7	2.7	0	0	1.4	0	9.6	0	0.3	12.2	154	0.6	0	0	0.8	0.8	Spermatogonia
NCS1	FREQ, NCS-1	ENSG00000107130	Neuronal calcium sensor 1	P62166	9	130172578-130237304	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 76.8	Cell type enriched	Detected in many	5	Horizontal cells: 106.5	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enhanced	Detected in some		gdT-cell: 1.2;MAIT T-cell: 1.2	Lineage enriched	Detected in single	13	T-cells: 1.2	Low cell line specificity	Detected in many			Low region specificity	Detected in all			Low region specificity	Detected in all			CAB018587, HPA019713	Enhanced	Supported	Enhanced	Plasma membrane						Plasma membrane		CAB018587: AB_649907, HPA019713: AB_1854404	prognostic unfavorable (5.40e-4)	unprognostic (1.57e-1)	unprognostic (4.64e-3)	prognostic unfavorable (8.69e-4)	unprognostic (1.29e-1)	unprognostic (9.23e-2)	prognostic unfavorable (1.11e-4)	unprognostic (1.61e-3)	unprognostic (4.27e-1)	unprognostic (1.21e-2)	unprognostic (8.45e-2)	unprognostic (1.58e-1)	unprognostic (3.71e-3)	unprognostic (8.59e-2)	unprognostic (1.69e-1)	prognostic unfavorable (8.25e-4)	unprognostic (1.65e-1)	5.8	12.6	76.8	7.9	56.6	4.6	2.8	18.6	66.2	7.7	20.1	6.4	5	3.6	12.6	4.1	24.9	13.5	8.7	4.6	74.3	25.7	8.7	1.6	2.5	1.6	20.6	28.1	4.6	3.5	1.5	2.7	1.6	17.7	14.9	6.8	4.2	5.3	41.6	0.9	10	4.3	34.3	6.8	1.1	5.1	2.2	7.1	0	20.1	0.7	2.7	16.4	4.6	0	0	0	0	0	1.2	0.1	7.8	16	8.3	16.6	5.2	11.7	4	20.3	9.4	15.6	10.4	7.6	4	0	7.4	25.6	18.3	14.2	13.5	17.8	7	23.2	4.1	0	10.6	8.1	8	0.7	9.8	13.6	9.1	17.6	11.2	13.9	14.7	3.1	5.7	0.1	22.5	22.6	1.4	7.8	12.7	4.2	6.7	0	26.3	5.4	15.2	5	22	20.7	12.5	6	12	6.6	11.1	5	11.5	30.3	24.7	24.3	26	0	0	0	35.4	2.2	32.6	0	0	0	1.2	0	1.2	0	0	0.9	0	0	0	0	0	0	0	0	0	0.1	76.8	56.6	18.6	59.9	74.3	25.7	20.6	28.1	17.7	7.1	0	0	0	8.5	8.7	2.7	3.6	0	5.3	7.9	10.4	3.9	0	5	6.6	0.3	0	0	0	2.5	1.5	7.1	4.5	3.5	0	3.6	106.5	1.2	1.3	0	0	1.1	2.3	5	17.2	0.5	18.7	4.9	0	1.4	12.4	3.1	0	20.2	0	0.9	6	0.5	0	0	2.6	Horizontal cells
KCNT1	KCa4.1, KIAA1422, SLACK, Slo2.2	ENSG00000107147	Potassium sodium-activated channel subfamily T member 1	Q5JUK3	9	135702185-135795508	Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels	Ion transport, Potassium transport, Transport	Ion channel, Potassium channel	Disease mutation, Epilepsy	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 29.7;skeletal muscle: 19.5	Cell type enriched	Detected in single	5	Cardiomyocytes: 4.5	Cancer enhanced	Detected in single		ovarian cancer: 0.8	Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		OE19: 5.6;RH-30: 1.9;RPMI-8226: 4.2;SCLC-21H: 6.3	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA059880	Uncertain											HPA059880: AB_2684149	unprognostic (1.50e-3)	unprognostic (1.72e-2)	unprognostic (2.07e-3)	unprognostic (2.98e-13)	unprognostic (9.26e-2)	unprognostic (7.73e-2)	unprognostic (9.60e-2)	unprognostic (1.67e-1)	unprognostic (1.15e-1)	unprognostic (1.30e-3)	unprognostic (9.89e-2)	unprognostic (6.20e-2)	unprognostic (4.89e-7)	unprognostic (9.15e-2)	unprognostic (2.70e-1)	unprognostic (2.26e-1)	unprognostic (1.66e-2)	1.4	0.8	7.3	1	12.4	1	0.7	29.7	29.3	0.7	0.9	0.2	0	1	0.8	0.9	1.2	0.9	1.1	1.8	5.3	4.2	0.7	0.7	0.9	0.8	1.8	12	7.3	0.8	0.7	4.7	1.2	6.1	0.8	0.8	0	0.7	0.8	19.5	0.8	0.8	0.8	2.1	9.6	1.4	1.9	3.1	0	0.8	0	0.7	1.1	0.1	0	0	0.7	0	0	0.9	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0.1	0	0.1	0	0	0.2	0.1	0	0	0	0	0	0	0.1	0	0.1	0	0.2	0	0	0.1	5.6	0	0	1.9	4.2	0	0	6.3	1.3	0	0	0	0	0.3	0.1	0	0	0.3	0	0	0.1	0.4	0	0.1	0	0	0.2	0	0	0.9	0	0	0	0	0.1	0	0	0	0.1	0.7	0	0	0	0	0	7.3	12.4	29.7	29.3	5.3	4.2	1.8	12	6.1	3.1	0	0	0	0	0	0.6	4.5	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0.7	0	0.7	0	0.5	0	0.9	0	0	0	0	0	Cardiomyocytes
TYRP1	b-PROTEIN, CAS2, CATB, GP75, OCA3, TRP, TYRP	ENSG00000107165	Tyrosinase related protein 1	P17643	9	12685439-12710290	Disease related genes, Predicted intracellular proteins, Predicted membrane proteins	Melanin biosynthesis	Monooxygenase, Oxidoreductase	Albinism, Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	5	retina: 277.3	Cell type enriched	Detected in some	19	Melanocytes: 2358.5	Cancer enriched	Detected in some	262	melanoma: 313.2	Region enriched	Detected in some	5	pons and medulla: 5.0	Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	52	SK-MEL-30: 177.7	Group enriched	Detected in some	5	olfactory region: 5.6;thalamus: 2.0	Low region specificity	Detected in all			HPA000937, CAB002520	Enhanced		Approved	Vesicles					16000	Vesicles		CAB002520: AB_564153, HPA000937: AB_1080437	unprognostic (7.48e-2)	unprognostic (1.10e-3)	unprognostic (2.28e-1)	unprognostic (3.16e-3)	unprognostic (8.10e-2)	unprognostic (3.82e-3)	unprognostic (1.53e-1)	unprognostic (2.25e-3)	unprognostic (4.46e-1)	unprognostic (8.71e-2)	unprognostic (6.17e-2)	unprognostic (2.42e-1)	unprognostic (2.68e-6)	unprognostic (1.27e-1)	unprognostic (5.99e-2)		unprognostic (1.95e-2)	0.2	0	0.2	0.2	0.3	0	1.7	0.2	1	0.2	0.5	1.3	0.2	1.6	0.2	0.3	3.6	0.2	1.4	21.5	0.9	0.1	5.7	0.2	2.1	0.2	0.2	0.3	0.2	0.2	0	0.2	0.2	5	0.2	1.8	277.3	1.1	0.2	1.3	51.1	1.4	0.4	1.1	0.2	0.6	0.5	0.2	0.2	0.2	0.9	0.3	0.4	0.3	0	0	0	0	0	0.3	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.4	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	177.7	0	2.5	0.1	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0.2	0.3	0.2	1	0.9	0.1	0.2	0.3	5	0.2	0	0	0	0	82	0.6	39.7	0	0	0	3.5	2	0	122.7	0.2	2.1	0	0	0	0	0	0.3	0.1	0	0	0	1.6	0	0	0	4.3	0.3	0	2358.5	0	0	15.4	0	0	0	0.8	1.3	0	3.1	0.5	0.7	14.6	0	0	0	0.1	Melanocytes
LHX3		ENSG00000107187	LIM homeobox 3	Q9UBR4	9	136196250-136205128	Disease related genes, Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	Activator, DNA-binding	Disease mutation, Dwarfism	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	13	pituitary gland: 33.4	Cell type enriched	Detected in some	7	Cardiomyocytes: 13.4	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		RPMI-8226: 1.7;U-266/70: 5.2;U-698: 1.6	Not detected	Not detected			Not detected	Not detected																	unprognostic (4.17e-2)			unprognostic (4.72e-1)	unprognostic (1.33e-1)	unprognostic (2.57e-1)							unprognostic (3.31e-2)	unprognostic (6.18e-2)			0	0	0	0.4	0	1.2	0	0	2.5	0	0	0.1	0	0	0	0	0	0	0	0.3	0	0	0	0.6	0	0.1	0	0	0	0	0	33.4	0	0.1	0	0	0.3	0	0	0	0.1	0	0	0	0.1	0	0.7	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0.2	0	0	0	0	0.9	0	0.3	0	0	0	0.1	0	0	0	0.3	0.2	0.1	0	0	0	0	0	0	0.2	0.1	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0.1	1.7	0	0	0.4	0	0	0	0	0	0	0.5	0	0.2	0	0	0	5.2	0.6	1.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	1.8	13.4	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	1	0	0	0	0.1	0	0	0	0	0	Cardiomyocytes
APBA1	D9S411E, MINT1, X11	ENSG00000107282	Amyloid beta precursor protein binding family A member 1	Q02410	9	69427530-69672306	Predicted intracellular proteins	Protein transport, Transport			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 21.7	Cell type enriched	Detected in many	5	Horizontal cells: 65.2	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		BJ: 7.1;BJ hTERT+: 6.0;HAP1: 17.1;SCLC-21H: 6.7;TIME: 7.7;U-138 MG: 7.1;U-266/70: 7.1	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA061287			Supported	Golgi apparatus						Golgi apparatus		HPA061287: AB_2684467	unprognostic (4.02e-2)	unprognostic (4.64e-2)	unprognostic (7.29e-2)	unprognostic (8.94e-3)	unprognostic (1.06e-1)	unprognostic (1.53e-1)	unprognostic (4.21e-3)	unprognostic (8.49e-3)	unprognostic (2.22e-1)	unprognostic (2.33e-1)	unprognostic (2.46e-5)	unprognostic (1.60e-1)	unprognostic (3.09e-2)	unprognostic (4.99e-3)	unprognostic (3.14e-2)	unprognostic (2.28e-1)	unprognostic (4.66e-3)	2.9	2.9	20.2	1.8	18.6	0.6	4	15.5	21.7	4.2	4.1	6.2	0.6	1.7	4	1.2	3.4	2.6	3	2.9	16	19.3	2.3	8.7	1.9	1.6	19.1	13.7	7.5	2.9	14.5	3.5	3.1	15.7	2.2	4.2	2.7	5.5	2.8	4	3.8	2.1	2.2	5.5	6	1.7	3.5	6.7	0	1.5	0.6	1.2	2.4	2	0	0.1	0.1	0.7	0	0.1	0	0	0	0.6	0	3.1	2.3	0.1	7.1	6	0.1	0.1	0	0	0	3.3	2.9	0	0.1	17.1	0	0	0	0.1	0	0	0	0.4	0	0	0.7	0	0	0	0.1	0.9	0.3	0	0	2.9	0.1	0	0	0.5	0.1	0	0	0.3	0	0	2.5	6.7	4.4	0.4	0.9	0.1	0.2	0	0	7.7	7.1	0.8	0	0.5	7.1	3.1	0	0.2	0.1	0.7	0	0.1	0	0	0.1	0	0	0	0	0.1	0	0.1	0	0.1	0	0.7	0.1	0	0	20.2	18.6	15.5	19.7	16	19.3	19.1	13.7	15.7	6.7	0	0	0	1.2	1.5	12.7	3.9	0	0	0	0	3.9	0.7	0	0.1	0.1	0.7	0	0	0	0.4	0.6	0.4	0	2.8	2.4	65.2	4.1	3.1	2.5	0	2.3	0.7	0	1	1.5	3.9	0.2	0	10.3	0.4	9.6	0	1.4	0.9	1.3	2	0.3	0	0.8	0.4	Horizontal cells
CUBN	gp280, IFCR, MGA1	ENSG00000107611	Cubilin	O60494	10	16823964-17129831	Disease related genes, Predicted intracellular proteins	Cholesterol metabolism, Endocytosis, Lipid metabolism, Protein transport, Steroid metabolism, Sterol metabolism, Transport	Receptor	Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	5	intestine: 28.9;kidney: 79.7	Cell type enriched	Detected in many	12	Proximal tubular cells: 301.3	Cancer enriched	Detected in some	15	renal cancer: 24.3	Not detected	Not detected			Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		AN3-CA: 18.2;ASC TERT1: 4.6;SK-MEL-30: 3.4;WM-115: 6.9	Low region specificity	Detected in some			Not detected	Not detected			HPA004133, HPA043854	Enhanced				Intracellular and membrane				240000			HPA004133: AB_2732398, HPA043854: AB_2732510	unprognostic (1.75e-1)	unprognostic (2.35e-1)	unprognostic (2.12e-3)	unprognostic (8.61e-4)	unprognostic (9.54e-2)	unprognostic (2.78e-2)	unprognostic (2.88e-2)	unprognostic (7.03e-2)	unprognostic (1.24e-1)	unprognostic (7.16e-2)	unprognostic (1.98e-2)	unprognostic (2.47e-1)	prognostic favorable (1.12e-4)	unprognostic (6.24e-3)	unprognostic (1.97e-1)	unprognostic (2.00e-1)	unprognostic (1.93e-1)	0.3	0.3	0.3	0.3	0.6	0.1	0.4	0.4	0.3	0.5	0.3	0.3	0.3	0	0.4	11.5	0.3	1.6	0.3	0.3	0.3	0.3	79.7	0.3	0.3	0.4	0.3	0.3	2	0.3	0.6	1.7	1.1	0.3	0.6	0.1	0.3	0.3	0.3	0.3	0.3	28.9	0.3	0.3	0.5	0.1	1.2	0.3	0.3	3.1	0.3	0.3	0.3	0.3	0.8	1.2	0.9	0.2	0.6	1.4	0	0	0.1	1.8	18.2	0.6	4.6	0.1	0.1	0.1	0.1	0.1	2.1	0	0	0.1	0.9	1.2	0	0	0.2	0.1	0.4	0	0.2	0.2	0	0.1	0	0.1	0.6	0	0.6	0.2	0.7	1.8	1	0.2	0.3	0.2	0	0.3	0.3	0.3	0	0.2	0.1	0.4	0	0.6	0	0	0.5	0	0	3.4	0.1	0	0.1	1.8	0.2	0.2	0.3	0.2	0.6	0.1	0	0.5	0.1	6.9	0.9	0.2	0	0.8	0	1	0.4	0.4	0.2	0	0.8	0.8	1.4	0.6	0.6	0	1.2	0.7	0	0.3	0.6	0.4	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0	1	0	0.4	0.5	0.9	1.1	0	2.7	5.7	5.2	2	0	11.6	0	25.3	2.7	0	0	0.2	0	0.6	0.4	0	0	0.1	0	0	0.6	0.8	25.4	2.6	0.4	6.8	0	0.3	8.7	0.1	0	1.1	301.3	3.7	0	1.2	0.7	0.2	0.6	0.1	0.5	0	0.1	Proximal tubular cells
MTPAP	FLJ10486, mtPAP, PAPD1, SPAX4	ENSG00000107951	Mitochondrial poly(A) polymerase	Q9NVV4	10	30309801-30374448	Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins	mRNA processing, Transcription	Nucleotidyltransferase, RNA-binding, Transferase	Disease mutation, Neurodegeneration	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	9	Early spermatids: 194.2	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low cell line specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA038620, HPA058232	Approved		Supported	Mitochondria						Mitochondria		HPA038620: AB_10673015, HPA058232: AB_2683646	unprognostic (2.76e-2)	unprognostic (2.04e-1)	unprognostic (1.73e-1)	unprognostic (3.43e-3)	unprognostic (3.05e-2)	unprognostic (1.01e-1)	prognostic unfavorable (4.20e-6)	unprognostic (1.16e-1)	unprognostic (2.04e-1)	unprognostic (4.78e-2)	unprognostic (1.77e-1)	unprognostic (3.56e-2)	unprognostic (9.02e-2)	unprognostic (6.28e-3)	unprognostic (3.77e-1)	unprognostic (1.14e-2)	unprognostic (4.39e-2)	10.9	12.7	9.9	10.2	12.4	32.8	11.1	12.4	16.1	9.6	9.9	7.3	6.5	11	10.4	7	12.6	9.5	7.6	11.5	7.8	7.2	10.6	11.1	9.4	10.5	11.9	13	11.4	18.9	9.5	7.2	10	11.4	8	12	8.2	10.7	10.2	22.3	13.1	10	14.3	9	9.3	9.7	10.6	8.3	6.7	11	12.4	10.5	11.7	9.1	15.6	22.9	18.4	24.4	16.9	17.1	8.3	14.2	14.3	9.1	13.1	9	8.5	11.8	10	3.5	10.2	10.7	15.1	20.1	20.4	7.1	6.5	9.4	16.9	17.5	11.6	12.5	10.3	13.7	20.7	13.5	15.2	9.4	13.5	16.3	8.3	10.8	11.4	6.8	5.7	11	19.2	22.3	16.1	7.6	11.9	16.2	12	6.1	10.8	7.7	16.4	16.1	19	9.4	9.5	15	12.1	9	9.4	13.9	8.9	9.1	8.7	10.6	10.8	13.9	15	11	3.6	8.7	27.9	9.2	24.8	3.8	16.4	18.5	18.4	16.2	24.4	17.1	15.6	15.4	15.6	22.9	13.1	16.7	16.8	3	16.9	18.1	12	15.5	8.3	9.9	12.4	12.4	16.1	7.8	7.2	11.9	13	11.4	8.3	8.9	6.1	9.7	10.8	22.3	0	15.3	5.1	10.7	11.4	3.5	0	12.2	16.6	7.7	194.2	12	7.8	0	7.9	9.8	11.5	8.6	4.7	12.1	12.7	0	4.1	10.4	12.3	17.1	11.2	11.5	8.5	10.8	13.7	0	8.4	0	15.6	11	0	12.9	11.4	21.9	17.2	21.8	9.6	9.6	16.6	14	Early spermatids
SORCS1	sorCS1	ENSG00000108018	Sortilin related VPS10 domain containing receptor 1	Q8WY21	10	106573663-107164534	Predicted membrane proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		thyroid gland: 18.5	Cell type enriched	Detected in some	4	Muller glia cells: 59.3	Cancer enhanced	Detected in some		melanoma: 3.2	Low region specificity	Detected in many			Cell type enriched	Detected in single	24	intermediate monocyte: 2.4	Lineage enriched	Detected in single	24	monocytes: 2.4	Group enriched	Detected in some	12	RH-30: 33.9;SH-SY5Y: 44.4	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA011948	Approved		Approved	Plasma membrane,Cytosol						Plasma membrane, Cytosol		HPA011948: AB_1857366	unprognostic (5.86e-3)	unprognostic (8.45e-3)	unprognostic (1.55e-2)	unprognostic (1.67e-1)	unprognostic (1.13e-1)	unprognostic (1.36e-1)	unprognostic (1.05e-2)	unprognostic (2.92e-2)	unprognostic (3.52e-2)	unprognostic (5.58e-2)	unprognostic (6.82e-3)	unprognostic (5.81e-2)	unprognostic (6.48e-4)	unprognostic (2.51e-2)	unprognostic (8.89e-3)	unprognostic (2.22e-1)	unprognostic (2.69e-4)	1.4	5.8	6	4.5	14.1	0.4	1.8	0.5	13.2	2.2	10.7	1.1	1.9	1.4	2.1	1.2	2	3.2	2.8	4.2	2.6	4.7	8	0.5	0.5	1.9	2.1	6.6	1.2	3	0.6	1.2	0.4	3.3	2.7	3.6	6.5	2.4	4.9	0.8	2.3	4.5	2.7	2.1	1.7	3.4	2.3	2.7	0.2	18.5	1.1	2.7	4.7	3.8	0	0	0	2.4	0	0	0	0	0	1.3	0	0	0	0	0.3	0.1	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0.6	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0.2	0.6	0	0	0	0	0.5	0	0	0	33.9	0	0	0	0	44.4	0	0	1.3	0.1	0	0	0	0	0.2	2.5	0	0	0	0	0	0	3.3	0	0	0	0	2.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	6	14.1	0.5	11.3	2.6	4.7	2.1	6.6	3.3	2.7	0	0.3	0	0	0.6	1.8	1.8	0	0	1.2	0	0	0	0	0.6	14.7	0	0	0	0	0	0.8	0	0	0	0.2	1.6	0	0	0.3	3.4	0	0	1.7	0	0	59.3	0.1	0	0.4	2.2	1.7	0	0	0	1.5	0.1	0	0	0	0	Muller glia cells
CCNY	C10orf9, CBCP1, CFP1	ENSG00000108100	Cyclin Y	Q8ND76	10	35247025-35572669	Predicted intracellular proteins	Cell cycle, Cell division, Wnt signaling pathway	Cyclin		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	4	Late spermatids: 2886.4	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enhanced	Detected in all		neutrophil: 18.5	Group enriched	Detected in all	5	dendritic cells: 5.5;granulocytes: 18.5;monocytes: 16.5	Low cell line specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA036290	Approved											HPA036290: AB_10600860	unprognostic (1.25e-2)	unprognostic (1.48e-1)	unprognostic (4.30e-2)	unprognostic (2.23e-3)	unprognostic (1.30e-1)	unprognostic (4.65e-1)	prognostic unfavorable (6.75e-5)	unprognostic (3.37e-2)	unprognostic (6.15e-3)	unprognostic (4.06e-2)	unprognostic (2.94e-1)	unprognostic (1.10e-1)	unprognostic (2.74e-2)	unprognostic (1.31e-1)	unprognostic (3.77e-2)	unprognostic (1.98e-1)	unprognostic (1.80e-1)	21.3	17.1	32.8	15.9	32.1	23.8	17	11.7	29.4	18.1	20.7	25	13.6	17.1	22.4	21.5	17.1	18.2	19.1	24.3	30	20.1	19.8	23.9	20.2	19.1	25.5	16.7	21.2	16.5	14	13.9	29.7	18.1	14.9	15.9	14.5	13.2	16.7	17.3	14.3	23.3	20.5	26.5	17.9	19	67	22.2	20.5	24	14.7	15.8	19	17.8	2.2	5.5	18.5	16.5	1.9	2.7	4.8	22.7	10.5	12.8	12.7	18.6	25.1	17.9	12.3	11.8	11.5	10.9	14.4	23.3	14.4	17.4	18.7	10.3	12.2	11.4	15.2	11.9	47.3	7.5	26.5	7.3	17.8	19.9	9.3	13	18.2	20.8	18	12	25.2	27.6	16.8	21.4	12.1	22.2	14.6	17	7.8	5	12.6	20.4	14.2	23.4	8.9	14	10.7	11.8	18	9.3	19.2	16.3	11.6	16.8	18.2	33	14.8	17.9	22.5	10.5	8.4	7.4	10.7	25.7	19.9	6.7	1	16.5	3.5	2.5	4.7	2.7	2.2	2.4	2.6	5.5	1.7	2.5	2.7	18.5	1.9	2.2	2.7	1.6	4.8	32.8	32.1	11.7	29.4	30	20.1	25.5	16.7	18.1	22.2	29.8	23.4	20.6	12.1	23.9	41.9	29.9	50.9	12	20.5	36.6	19.6	10.5	5	14	676.5	51.4	21.3	0	23.9	15	31	20.1	16.1	77.8	25.2	46.1	50.7	30.7	74.8	2886.4	38.3	32.7	15.1	16.2	33.9	44.2	23.1	14	36.4	18	32.1	6.5	24.7	26.3	38.7	25.7	7.9	21.8	24.7	17	Late spermatids
CYP2C18	CPCI, CYP2C, CYP2C17, P450IIC17	ENSG00000108242	Cytochrome P450 family 2 subfamily C member 18	P33260	10	94683621-94736190	Enzymes, Plasma proteins, Predicted intracellular proteins		Monooxygenase, Oxidoreductase		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		intestine: 62.9;liver: 56.1	Cell type enriched	Detected in some	6	Hepatocytes: 113.1	Cancer enhanced	Detected in many		liver cancer: 18.9	Not detected	Not detected			Cell type enriched	Detected in single	11	basophil: 1.7	Lineage enriched	Detected in single	11	granulocytes: 1.7	Cell line enhanced	Detected in some		BEWO: 7.9;hTCEpi: 2.3;OE19: 4.4														Intracellular and membrane								unprognostic (2.40e-1)	unprognostic (1.75e-2)	unprognostic (2.69e-1)	unprognostic (1.10e-2)		unprognostic (1.32e-2)	unprognostic (2.57e-1)	unprognostic (2.71e-1)	unprognostic (9.78e-2)	unprognostic (2.28e-1)	unprognostic (4.22e-3)		unprognostic (1.62e-3)	unprognostic (1.29e-1)	unprognostic (1.08e-1)		unprognostic (6.81e-3)	0.2	0	0.2	0.8	0.2	0	0.2	0.2	0.2	2.4	29.2	0.3	0.2	30.2	0.2	0.2	13.5	0	6.7	0.2	0.2	0	0.2	56.1	0.5	0.2	0.2	0.2	0.2	0.2	0	0.2	0.5	0.2	0.2	0.5	0.2	2.4	0.2	0.2	1.7	62.9	0.2	0.2	0.2	19	0.2	0.2	0.3	0.2	5	3.8	0.2	3.7	0	0	1.7	0	0	0.1	0.1	0	0.3	0.1	0.3	0	0	7.9	0	0	0	0	0.9	0	0	1.4	0	0	0	0	0	0	0	0.3	0	0.2	0.1	0	0	0.1	0	2.3	0.1	0.1	0	0	0	0	0	0	0	0.1	0.5	0	4.4	0	0	0	0.9	0.5	0.2	0.3	0.6	0.2	0	0	1.2	0	0	0	0	0.3	0.2	0.6	0.1	0.5	0	0.1	0.2	0	1.7	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0.1	0.2	0.2	0.2	0.2	0.2	0	0.2	0.2	0.2	0.2	0	3.5	0	0	0.1	0	0	17.8	0	0	0	0	0.1	0	0.6	0	0	14.7	0	6.4	0.1	0	0	0	113.1	0	0	0	1.8	1.9	0	0	0	0	0	0.4	0	5.3	3.5	0	0	0	0	0	0	0.2	1.5	1.3	0	1.5	0	Hepatocytes
SEPT4	ARTS, CE5B3, H5, hCDCREL-2, hucep-7, MART, PNUTL2	ENSG00000108387	Septin 4	O43236	17	58520250-58540818	Predicted intracellular proteins	Cell cycle, Cell division, Differentiation, Spermatogenesis			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		adrenal gland: 77.8;brain: 94.8	Cell type enriched	Detected in many	6	Horizontal cells: 2070.5	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Cell line enhanced	Detected in many		HHSteC: 11.0;hTERT-RPE1: 14.9;SK-MEL-30: 24.2	Low region specificity	Detected in all			Low region specificity	Detected in all			CAB006855, HPA021587, HPA022905	Enhanced		Supported	Nucleoplasm						Nucleoplasm		CAB006855: , HPA021587: AB_1856686, HPA022905: AB_1856687	unprognostic (1.12e-1)	unprognostic (5.54e-2)	unprognostic (8.36e-3)	unprognostic (8.01e-2)	unprognostic (1.19e-1)	unprognostic (2.96e-2)	unprognostic (6.88e-3)	unprognostic (2.73e-2)	unprognostic (2.76e-1)	unprognostic (8.02e-2)	unprognostic (1.97e-2)	unprognostic (2.10e-1)	prognostic unfavorable (3.28e-7)	unprognostic (6.40e-3)	unprognostic (1.58e-1)	unprognostic (8.26e-2)	unprognostic (8.75e-3)	14.8	77.8	70.5	2.6	80	0.9	7.2	44.3	82.7	4	3.3	92.4	0	2.7	3.5	3.9	3.2	2.7	8.3	14.3	84.8	49.9	8.5	25	9.5	5.9	94.8	32.3	5.4	3.9	4.8	2.4	9.9	49.7	2.5	3.1	10	4.4	3.8	4.2	3.9	2.9	6	84	18	2.8	7.3	56.5	0	4.5	0.5	3.8	5.1	1.3	1.7	5.5	2.9	5.5	1.4	7.6	5.6	0	0.4	0.9	2.6	1.1	0.1	0.4	0.1	0.3	1.6	1.9	0.1	0.1	0	3.9	0.6	2.4	0.2	1.4	1.1	0.4	0.1	0.7	0.9	0.2	5.5	11	0.1	0.5	5.7	2.2	0.4	2	14.9	0.5	1.4	0	2.6	0.1	0	0	0.1	0.5	0	0.7	0.1	0	1.2	0	0	2.8	1.6	0	0.1	24.2	1.3	0.4	0.3	0	0.1	1.2	0	1	0.8	0.4	0	0.9	0	0.3	0	5.5	1.1	7.6	0.7	2.4	1.7	1.6	2	5.5	0.6	2.9	2.3	2.9	1.4	0	0.3	1	5.6	70.5	80	44.3	50.5	84.8	49.9	94.8	32.3	49.7	56.5	0	0.6	0	0	5.5	93.8	45.3	0	0	0	7	329.9	3.6	14.9	0	62	12.7	0	23.3	0	0.3	7	0	1.1	20.8	4.7	2070.5	0	27.6	2.4	56.2	6.6	1.6	65.8	0	0	56.1	0	0	13.1	0.5	325.4	181.1	84.9	3.6	1.7	2.5	3.8	0	0	0	Horizontal cells
CHRNE	ACHRE	ENSG00000108556	Cholinergic receptor nicotinic epsilon subunit	Q04844	17	4897774-4903074	Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters	Ion transport, Transport	Ion channel, Ligand-gated ion channel, Receptor	Congenital myasthenic syndrome, Disease mutation	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Group enriched	Detected in some	6	heart muscle: 53.3;pituitary gland: 19.0	Cell type enriched	Detected in many	5	Late spermatids: 132.7	Low cancer specificity	Detected in some			Not detected	Not detected			Cell type enhanced	Detected in many		gdT-cell: 5.9	Low lineage specificity	Detected in many			Group enriched	Detected in some	13	HEL: 6.0;HMC-1: 15.1	Low region specificity	Detected in single			Region enriched	Detected in single	13	basal ganglia: 5.7														unprognostic (2.00e-3)	unprognostic (1.56e-1)	unprognostic (3.94e-2)	unprognostic (4.35e-3)	unprognostic (6.55e-2)	unprognostic (2.27e-3)	unprognostic (7.80e-4)	unprognostic (7.75e-2)	unprognostic (3.24e-1)	unprognostic (1.34e-1)	unprognostic (3.69e-2)	unprognostic (6.58e-2)	unprognostic (8.42e-4)	unprognostic (1.39e-3)	unprognostic (1.26e-1)	unprognostic (5.83e-2)	unprognostic (5.70e-2)	0.3	0.1	0.1	0.4	0.1	0.4	0.1	0.3	0.4	0.1	0.2	0.1	0.1	0.3	0.4	0.8	0.2	0.1	0.4	53.3	0.1	0	0.1	1.3	0.3	0.2	0.3	0.1	0.3	0.6	0.3	19	0.4	0.2	0.1	0	0.5	0.5	0.1	1	0.8	0.1	0.2	0.1	0.7	0.1	0.2	0.1	0.1	0.1	1.4	0.2	0.1	0.1	1	0.3	1	0.4	1.6	5.9	1.5	0	0	0.6	0	0	0	0.5	0.3	0	0	0.1	0	0	0.3	0.3	0.1	0	0	0	0	0	0.2	0.2	6	0	0.7	0.5	0	15.1	0.6	0	0	0	0.1	0	0.1	0	0	0	0	0	0.3	0	0	0.1	0	0.1	0.4	0	0	0	0	0	0	0	0.1	0	0.8	0	0.1	0	0	0	0.2	0	0	0	0	0.1	0	0.2	1	5.9	0.2	0	0	0	2.1	0.2	1	0.1	1.6	0.2	1.6	0.4	0.3	0	1.5	0.1	0.1	0.3	0.4	0.1	0	0.3	0.1	0.2	0.1	0	0	0	1.1	1.4	0.8	6.3	2.5	0	0	1.8	3.9	0.4	1.7	0.1	27.7	1.4	0	0	0.8	6.2	2.6	0.9	8.1	5.9	3.1	3.2	0	3.7	1.8	132.7	0.9	5.7	0	8.2	0	1.2	0.8	0	0.4	1.1	10	0	0.5	4.3	3	1	9.3	3.2	0.1	0.6	Late spermatids
CCL7	FIC, MARC, MCP-3, MCP3, NC28, SCYA6, SCYA7	ENSG00000108688	C-C motif chemokine ligand 7	P80098	17	34270221-34272242	Cancer-related genes, Predicted membrane proteins, Predicted secreted proteins	Chemotaxis, Inflammatory response	Cytokine, Heparin-binding	Cancer-related genes	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	6	adipose tissue: 11.5;bone marrow: 22.3	Cell type enriched	Detected in some	8	Hofbauer cells: 60.0	Low cancer specificity	Detected in many			Not detected	Not detected			Cell type enriched	Detected in single	12	classical monocyte: 1.1	Lineage enriched	Detected in single	12	monocytes: 1.1	Cell line enhanced	Detected in some		BJ hTERT+: 15.5;BJ hTERT+ SV40 Large T+: 3.2;BJ hTERT+ SV40 Large T+ RasG12V: 4.0;HSkMC: 4.7	Low region specificity	Detected in many												Secreted to blood			29700					unprognostic (7.66e-2)	unprognostic (1.05e-2)	unprognostic (8.53e-2)	unprognostic (4.65e-2)	unprognostic (2.54e-2)	unprognostic (9.54e-2)		unprognostic (4.18e-2)	unprognostic (2.13e-1)	unprognostic (2.63e-2)	unprognostic (2.27e-3)	unprognostic (7.04e-2)	unprognostic (1.99e-8)	unprognostic (2.83e-1)	unprognostic (8.74e-2)	unprognostic (3.74e-1)	unprognostic (1.79e-2)	11.5	0.6	0	2.6	0	22.3	0.3	0	0	0.3	0.6	0	0	0	0.3	0	0.1	0.5	0.7	0.9	0.1	0.1	0.5	0.2	1.2	0	0.1	0	1.3	0.4	0	0.1	1.7	0.3	0.5	1	0	0.2	0	0.1	0.2	0.2	2.2	0.1	0.1	1.2	0.5	0	1.4	0.3	0	0	0.5	0.4	0	0	0	1.1	0	0	0.3	0	0	0	0	0.2	2.4	0	1.7	15.5	3.2	4	0	0	0	0.5	1.1	0	1.4	0	0	1.6	0	0.2	0	0	0	0	0	1.9	4.7	0	1.3	0	0	1.4	0	0	1.3	0	0	0	0.1	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0.4	0.8	0	0	1.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0.1	0.1	0.1	0	0.3	0	0	0	0	7.8	0.2	0	0	0	0	0	0	0	0.1	0	0.8	0	0	0	0	0.2	0.1	0.2	0.5	0	0	60	0	0	0	0	0	0	0.6	0	0	0	0	0.2	0	0	0	0	0	0.9	0	0	0	0.2	0	0	0.6	Hofbauer cells
CCL8	HC14, MCP-2, SCYA8	ENSG00000108700	C-C motif chemokine ligand 8	P80075	17	34319036-34321402	Cancer-related genes, Predicted secreted proteins	Chemotaxis, Inflammatory response	Cytokine, Heparin-binding	Cancer-related genes	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		placenta: 19.7	Cell type enriched	Detected in some	13	Smooth muscle cells: 106.5	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Cell type enriched	Detected in single	8	classical monocyte: 5.8	Lineage enriched	Detected in single	8	monocytes: 5.8	Cell line enhanced	Detected in some		BJ hTERT+: 1.9;BJ hTERT+ SV40 Large T+ RasG12V: 1.8;EFO-21: 4.1;HSkMC: 6.1					Low region specificity	Detected in all								Secreted to blood			32000					unprognostic (7.51e-2)	unprognostic (3.20e-1)	unprognostic (1.90e-2)	unprognostic (4.03e-2)	unprognostic (8.00e-2)	unprognostic (1.59e-2)	unprognostic (1.52e-1)	unprognostic (1.65e-1)	unprognostic (9.97e-2)	unprognostic (1.67e-3)	unprognostic (1.46e-1)	unprognostic (2.13e-1)	prognostic unfavorable (1.05e-7)	unprognostic (1.39e-1)	unprognostic (1.88e-2)	unprognostic (5.65e-2)	unprognostic (3.41e-2)	10.6	2.8	1	7.2	1.2	0.2	4.4	0.6	1.6	0.8	12	1.4	1.1	6.9	3.4	3.8	1.2	2.9	3.7	2.4	0.8	0.7	2.8	2.1	8.4	1.3	0.8	0.9	5.3	0.8	6	1.6	19.7	1.1	1.5	8	5	1.1	2.9	1.5	1.3	13.1	4.1	2.4	3.1	1.9	1.6	0.2	2.1	3	4	2.7	4.4	0.8	0.7	0.2	0	5.8	0	0	0.9	0	0	0	0	0.9	0.5	0.1	0	1.9	0	1.8	0	0	0	4.1	0	0	0.2	0	0	0	0.1	0	0	0	0	0	0	0.4	6.1	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.2	0	0	0	0	0	0	0	0	5.8	0	0	0.2	0	0.7	0	0	0.2	0	0	0	0	0	0	0	0	0.9	1	1.2	0.6	1.6	0.8	0.7	0.8	0.9	1.1	0.2	0	0	0	0.2	3.8	0	1.2	0	0	0	0	0	0	0	1	1.7	0.5	0	0	1.6	0	2.8	0.1	0	0	7.7	0	0	0	0.6	0.8	0	4.6	5	0	0	0	7.9	0	0	0	0	0	106.5	0	0	4.6	0.1	0	0	0.1	Smooth muscle cells
HSD17B1	EDH17B2, EDHB17, HSD17, MGC138140, SDR28C1	ENSG00000108786	Hydroxysteroid 17-beta dehydrogenase 1	P14061	17	42549214-42555213	Enzymes, Predicted intracellular proteins	Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis	Oxidoreductase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	25	placenta: 217.6	Cell type enriched	Detected in many	5	Syncytiotrophoblasts: 1251.0	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Cell line enriched	Detected in many	8	BEWO: 89.7	Low region specificity	Detected in single							HPA021032, HPA065296	Enhanced		Supported	Cytosol						Cytosol		HPA021032: AB_1844345, HPA065296: AB_2685457	unprognostic (1.13e-1)	unprognostic (1.40e-2)	unprognostic (1.68e-2)	unprognostic (9.25e-2)	unprognostic (1.73e-1)	unprognostic (3.88e-2)	unprognostic (1.14e-1)	unprognostic (1.10e-1)	unprognostic (9.35e-2)	unprognostic (6.04e-2)	unprognostic (2.88e-5)	unprognostic (2.17e-1)	unprognostic (1.30e-1)	unprognostic (2.60e-2)	unprognostic (5.09e-1)	unprognostic (4.98e-1)	unprognostic (1.32e-2)	2.8	1.5	2	1.7	2.1	1.1	1.8	2.7	3.1	1.3	1.3	1.3	1.3	1.9	1.5	1.3	4.3	1.4	1.3	1.4	2.4	1.4	1.4	1.3	1.3	1.6	2.4	1.3	5.8	2.6	0.2	1.4	217.6	1.3	1.5	0.2	1.3	2.9	1.3	3.5	4.1	1.9	1.3	1.9	2.1	2	2.3	1.3	1.3	1.8	1.3	1.3	1.3	1.8	6	5.5	7.5	8.6	6.1	5.4	5.5	1.6	1.8	0.9	4.6	0.6	0.1	89.7	1.2	0	0	0	1	0.9	0	1.2	0	1	2.6	0.1	0.7	0	2.4	2.8	1.2	1.1	1.5	0.2	1	1.4	0.2	2.6	0.1	0.5	1.5	0	1.3	1.7	0.4	0	1.6	1.3	1.1	0.4	0.6	0.8	1.3	1.1	0.8	0.1	1.4	1.3	1.8	0.7	9.1	1.4	1	11	0.8	1.4	1.4	1.8	1	0.8	2.6	1.5	0.6	0.6	0.9	1.1	3.6	7.6	7.5	4.9	8.6	5.3	5.6	5.4	5.1	5.5	6	5.1	4.4	7.2	6.1	5.3	4.3	3.7	5.5	2	2.1	2.7	1.5	2.4	1.4	2.4	1.3	1.3	1.3	0	2.1	0.5	6.3	2.7	8.7	2.4	2.5	4	2.3	5.2	11.8	250.4	19.9	1.5	1	4.1	3.2	0	4.9	23.6	3.4	13	2.3	5.6	26.4	9.5	4.1	4.9	0.8	1.7	1.7	0.5	1.7	1	2.4	9	2	2.5	3.2	10.5	8.2	0	2.8	0.7	2.6	6.5	1251	1.3	1.9	8.4	Syncytiotrophoblasts
DLX4	BP1, DLX7, DLX8, DLX9	ENSG00000108813	Distal-less homeobox 4	Q92988	17	49968970-49974959	Disease related genes, Predicted intracellular proteins, Transcription factors		Developmental protein, DNA-binding		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in some		placenta: 14.7;skin 1: 6.0	Cell type enriched	Detected in some	5	Extravillous trophoblasts: 67.1	Low cancer specificity	Detected in many			Low region specificity	Detected in single			Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		BEWO: 18.6;CACO-2: 13.1;GAMG: 12.4;HAP1: 9.0;K-562: 10.3	Low region specificity	Detected in some			Not detected	Not detected			HPA059933	Uncertain		Supported	Nucleoplasm						Nucleoplasm		HPA059933: AB_2684169	unprognostic (8.12e-2)	unprognostic (2.48e-1)	unprognostic (1.26e-2)	unprognostic (2.29e-3)	unprognostic (7.49e-2)	unprognostic (2.71e-1)	unprognostic (9.35e-3)	unprognostic (2.85e-2)	unprognostic (8.73e-2)	unprognostic (5.93e-2)	unprognostic (1.29e-2)	unprognostic (4.34e-2)	unprognostic (2.88e-13)	unprognostic (8.79e-3)	unprognostic (2.77e-1)	unprognostic (5.00e-2)	unprognostic (6.86e-2)	0.4	0.3	0.2	1.2	0.7	0.4	0.7	0.3	0.8	0.8	0.6	0.8	0.2	0.2	0.2	0.6	1.5	0.5	0.2	0.2	0.2	0.2	0.2	0.2	1.3	0.5	0.2	0.2	0.2	0.7	0.1	0.2	14.7	1.4	0.5	0.3	0.5	2.7	0.6	0.2	6	1.5	0.2	0.2	0.8	0.3	0.5	0.2	0.2	0.6	3.8	1.2	0.4	0.8	0.1	0.9	0	1.3	1	0.8	0.3	0.4	1.1	0	0.1	0.1	0	18.6	0.1	0.1	0	0.3	13.1	0.8	0.5	2.7	0.2	12.4	1.8	9	0.3	0	3.5	4.7	0.3	4.5	1.3	0	0.7	3.1	0	2.3	0.1	0	0.1	0	2.7	10.3	0	0	2.2	0.3	4.7	0.2	2.4	0	0	4.2	0.4	0.1	0.6	1.5	0	0.3	1.6	0.8	2.9	3.3	3.1	0	0	0.9	0.2	0	0.7	0.1	0	0.3	2.4	0	0	0.3	0	0.8	1.3	0	0	0	0.4	0.7	0.1	0.2	0	0	1	1.3	0.9	0	0.3	0.2	0.7	0.3	0.8	0.2	0.2	0.2	0.2	1.4	0.2	6	0	0	0.3	2.3	0	2	0	2.7	0	0	0	10.5	0	0.1	0	0	0	0	0.2	67.1	0.2	0	0	0	1.8	0	0	0	0.3	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0.7	0.7	0.5	14.1	0	0	0.3	Extravillous trophoblasts
MYH3	HEMHC, MYHC-EMB, MYHSE1, SMHCE	ENSG00000109063	Myosin heavy chain 3	P11055	17	10628526-10657309	Disease related genes, Plasma proteins, Predicted intracellular proteins		Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin	Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		esophagus: 21.1;prostate: 25.6;skeletal muscle: 18.5	Cell type enriched	Detected in many	17	Early spermatids: 325.0	Low cancer specificity	Detected in many			Low region specificity	Detected in some			Low cell type specificity	Detected in single			Low lineage specificity	Detected in single			Cell line enriched	Detected in some	28	HSkMC: 37.9	Region enhanced	Detected in single		cerebral cortex: 1.7	Not detected	Not detected			HPA021808	Enhanced								17000000			HPA021808: AB_1854242	unprognostic (1.70e-2)	unprognostic (1.10e-3)	unprognostic (4.19e-4)	unprognostic (3.35e-1)	unprognostic (7.66e-2)	unprognostic (1.08e-1)	unprognostic (1.10e-2)	unprognostic (1.28e-1)	unprognostic (1.67e-2)	unprognostic (3.54e-1)	unprognostic (7.84e-4)	unprognostic (1.29e-1)	unprognostic (3.24e-4)	unprognostic (1.91e-2)	unprognostic (6.17e-3)	unprognostic (3.40e-2)	unprognostic (3.49e-1)	1	0.5	0.7	0.8	1	0.6	0.8	1.9	0.8	2.2	4.1	0.6	3.5	0.9	1.9	13.2	21.1	1	0.6	0.6	0.9	0.6	0.8	1.8	0.6	1	0.9	0.6	1.4	1.3	0.5	0.7	1.1	0.6	25.6	0.9	0.6	0.7	16.2	18.5	1.5	1.4	16.5	1.2	1.6	0.8	2.8	0.6	1.8	2.3	1.7	2	8.5	2.6	1	0.1	0	0.1	0.9	0.7	0	0.1	0.6	0.4	0.7	0.6	0.2	0.6	0.4	0.2	0.3	0.3	0.6	0.1	0.4	0.2	0.2	0.1	0.6	0.3	0.1	0.6	0.4	0.6	0.6	0.1	1	0.2	0.3	0.9	37.9	0.2	0.4	0.5	0.1	0	0.8	0.2	0	0.1	0.4	0.5	1.3	0.6	0.1	0.4	0.5	0.5	0.1	0.2	0.2	0	0.2	0.2	0	0.2	0.4	0.2	0.1	0.2	0	0.6	0.1	0	0.8	0.6	0.1	0.1	0.2	0.3	0	0.1	0	0.7	0	0.1	1	0	0	0	0.2	0	0.4	0	0.9	0	0.1	0.6	0	0.7	1	1.9	0.8	0.9	0.6	0.9	0.6	0.6	0.6	0	12.7	0	0.8	2.6	3.8	2.6	2.5	0	1.2	0	5.9	0.4	0	0.4	325	0.5	0.9	0	0.5	0.6	0.4	0.7	7	0.6	0.1	0	0	0.6	1.2	18.6	2.6	1.2	1.7	0	0.5	2.9	0.5	0	2.5	0	3.9	0	0.1	7.7	3.6	1.4	0.5	0.9	0.8	0.1	Early spermatids
VTN	VN	ENSG00000109072	Vitronectin	P04004	17	28367276-28373091	Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins	Cell adhesion	Heparin-binding	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	42	liver: 321.7	Cell type enriched	Detected in many	4	Hepatocytes: 4765.6	Cancer enriched	Detected in many	85	liver cancer: 2216.6					Cell type enhanced	Detected in some		naive CD8 T-cell: 2.1	Low lineage specificity	Detected in single			Cell line enriched	Detected in some	11	CACO-2: 168.9	Low region specificity	Detected in all			Not detected	Not detected			CAB016695, CAB016765, HPA060933, HPA068011	Supported		Supported	Endoplasmic reticulum,Vesicles	Secreted to blood			606000000000	32000000000	Endoplasmic reticulum, Vesicles		CAB016695: AB_1624536, CAB016765: , HPA060933: AB_2684389, HPA068011: 	unprognostic (1.19e-1)	unprognostic (2.12e-1)	unprognostic (2.29e-2)	unprognostic (6.13e-2)	unprognostic (9.74e-2)	unprognostic (8.42e-2)	prognostic favorable (3.74e-4)	unprognostic (6.20e-2)	unprognostic (3.97e-1)	unprognostic (8.95e-2)	unprognostic (3.24e-3)	unprognostic (1.01e-2)	prognostic unfavorable (4.10e-11)	unprognostic (8.82e-3)	unprognostic (2.27e-1)	unprognostic (4.86e-3)	unprognostic (7.09e-2)	0.2	7.6	0	0	0	0	0	0.7	0	0	0			0	0	0	0	0	3.6	2.2	0	0	0	321.7	0	0	0		0	0.6	0	0	2		0	0		0	0	0	0	0	0	0	0.1	0.1	0.4			0		0	0	0	0.3	0.2	0.6	0.2	0.7	2.1	0.1	0	3	0	0	0	0	0.7	0.2	0.1	0.1	0.1	168.9	0	0.1	0	0	0	0	0	0	0	0	0	0.1	0.1	8.7	0.2	0.8	0	0	0	0	0	0.5	0	0	0.2	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0.1	0.1	15.5	0.9	0	0.5	0	0	0.1	0	0	0	0	0.1	0	0.1	0	0.1	0	0	0.2	0	1	0	0.9	0	0.9	0.9	0.1	0.3	0.6	2.1	0.6	0.7	0	0.2	0	0.1											0	0.6	55.9	0	0	10.7	14.7	1151.5	0	0	0	72.6	2.6	3.3	14.8	0	0.7	0	233.6	17.1	1.6	7.6	0	0	4765.6	4.3	36.5	0	116	117.8	0	0	0	0	35.1	0	4.8	38.2	0	1.4	2.2	24.6	0	2	0.3	0.4	0	8	0.7	0	0	Hepatocytes
UGT2B10		ENSG00000109181	UDP glucuronosyltransferase family 2 member B10	P36537	4	68815993-68831196	Enzymes, Predicted membrane proteins		Glycosyltransferase, Transferase		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	277	liver: 120.4	Cell type enriched	Detected in some	15	Hepatocytes: 221.7	Cancer enriched	Detected in single	296	liver cancer: 93.8	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	39	Hep G2: 16.1									HPA045108	Uncertain											HPA045108: AB_2679218			unprognostic (3.50e-3)				unprognostic (1.92e-3)						unprognostic (4.17e-1)					0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0.4	0	0	0	0	120.4	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.1	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.4	0	0	0	0	12.7	0	0	0	0	0	0	0	15.1	0	0	0	0	0	0	0	0	221.7	0	0	0	1.3	4.7	1.7	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	Hepatocytes
SULT1E1	EST, STE	ENSG00000109193	Sulfotransferase family 1E member 1	P49888	4	69841212-69860152	Cancer-related genes, Enzymes, Predicted intracellular proteins		Transferase	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		intestine: 37.8;liver: 26.2;vagina: 15.8	Cell type enriched	Detected in some	4	Hepatocytes: 47.0	Low cancer specificity	Detected in many			Region enriched	Detected in single	8	pons and medulla: 3.3	Cell type enhanced	Detected in single		neutrophil: 1.7	Low lineage specificity	Detected in single			Group enriched	Detected in some	16	HHSteC: 38.0;HSkMC: 17.2;hTCEpi: 14.3;HUVEC TERT2: 10.4									HPA028213, HPA028728, CAB047344	Enhanced		Uncertain	Nuclear membrane,Cytosol						Nuclear membrane, Cytosol		CAB047344: , HPA028213: AB_10599848, HPA028728: AB_10601894	unprognostic (5.60e-2)	prognostic favorable (4.06e-4)	unprognostic (2.48e-1)	unprognostic (1.07e-3)	unprognostic (2.42e-1)	unprognostic (1.95e-1)	unprognostic (1.70e-1)	unprognostic (1.72e-1)	unprognostic (1.41e-1)	unprognostic (2.89e-1)	unprognostic (3.22e-3)	unprognostic (8.62e-2)	unprognostic (6.48e-5)	unprognostic (2.48e-1)	unprognostic (4.11e-2)		unprognostic (5.55e-2)	0.1	9.8	0.1	0.1	0.3	0.1	1.1	0.1	0.4	13.1	8.9	0.5	0.1	19.8	0.4	3.7	0.4	0.1	1.2	0.1	0.1	0	1.5	26.2	2	0.1	0.3	0.3	0.2	0.1	0	0.4	0.1	3.3	1	0.1	0.3	4.7	0.3	0.1	10.9	37.8	0.5	0.3	0.1	1.3	0.4	0.1	0.6	0.2	0.1	1	0.4	15.8	0.6	0.2	1.7	0.3	0.3	0.2	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0.2	38	0	0	17.2	14.3	0	0.4	0	10.4	0	0	0	0	0	0	0	0	1.2	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0.3	0	0.1	0.1	0.1	0.3	0.2	0.2	0.1	0.6	0.2	0.1	1.7	0.3	0.3	0.2	0	0	0.1	0.3	0.1	0.4	0.1	0	0.3	0.3	3.3	0.1	0	0	0	1	10.5	0	0	0	0	0	1.8	0	0.1	0	0	0	0	0.7	0	1.2	0.2	0.1	0	0	47	0.2	0	0	1.8	1	0	0.3	0	1.7	0	0.2	0	0.5	3.4	0	0	0	0	0.1	0	0	3	1.3	0	0	0.1	Hepatocytes
NKX3-2	BAPX1, NKX3.2, NKX3B	ENSG00000109705	NK3 homeobox 2	P78367	4	13540830-13545050	Disease related genes, Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	DNA-binding, Repressor	Dwarfism	Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		intestine: 18.3;lymphoid tissue: 6.5	Cell type enriched	Detected in single	31	Cardiomyocytes: 3.1	Low cancer specificity	Detected in some			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HAP1: 4.6;NB-4: 12.7;NTERA-2: 7.2;THP-1: 7.6	Not detected	Not detected			Not detected	Not detected			HPA027564	Approved		Approved	Nucleoplasm						Nucleoplasm		HPA027564: AB_10601973	unprognostic (3.26e-2)	unprognostic (1.26e-1)	unprognostic (7.42e-3)	unprognostic (5.97e-2)	unprognostic (9.15e-3)	unprognostic (5.72e-2)	unprognostic (2.24e-5)	unprognostic (3.49e-2)	unprognostic (1.12e-1)	unprognostic (4.06e-2)	unprognostic (9.95e-2)	unprognostic (1.80e-1)	unprognostic (1.93e-8)	unprognostic (5.81e-2)	unprognostic (2.14e-1)	unprognostic (3.08e-2)	unprognostic (2.15e-1)	1.7	0	0.1	6.5	0.1	0	0.1	0.1	0.1	1.1	18.3	0.1	0.1	1.6	0.9	0.1	2.3	0.2	0.4	1.8	0.1	0	0.4	0.1	0.1	2	0.1	0.1	2.9	0.2	0	0.9	0.1	0.1	0.6	2.4	0.1	1.5	0.6	0.1	0.1	2	3.2	0.1	5.3	2.8	0.9	0.1	0.1	0.3	0.9	0.1	0.8	1.7	0	0	0	0	0	0	0	0	0.5	2.3	1.9	0.1	0	1.4	0	0	0	0.1	0.8	0.8	0	0	0	1	0	4.6	0	0	0	2.6	0.6	1.7	0	0.1	0	0.9	0	0.1	0	0	1.9	0	0.7	1.7	0	0.7	0	0.4	12.7	7.2	0	0.5	0	0.7	0.1	0.1	0	0.1	0	0	0	0.1	2.3	1	7.6	0	0.5	3	0.1	0.5	2.2	0	0	0.4	0.2	2.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	0	0	0	0	3.1	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Cardiomyocytes
DNAJC4	HSPF2, MCG18	ENSG00000110011	DnaJ heat shock protein family (Hsp40) member C4	Q9NNZ3	11	64230278-64234286	Predicted intracellular proteins, Predicted membrane proteins		Chaperone		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Low tissue specificity	Detected in all			Cell type enriched	Detected in many	4	Late spermatids: 2560.6	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low cell line specificity	Detected in all			Low region specificity	Detected in all							HPA011947	Uncertain											HPA011947: AB_1847803	unprognostic (8.99e-3)	unprognostic (2.28e-2)	prognostic unfavorable (3.12e-4)	unprognostic (2.95e-2)	unprognostic (1.15e-1)	unprognostic (5.20e-2)	unprognostic (8.99e-2)	unprognostic (1.56e-2)	unprognostic (7.69e-2)	unprognostic (5.44e-3)	unprognostic (1.73e-3)	unprognostic (1.07e-1)	prognostic favorable (6.21e-4)	unprognostic (2.47e-1)	unprognostic (2.87e-1)	unprognostic (1.59e-1)	unprognostic (2.69e-1)	16.7	26.5	16.5	15.6	17.3	22.5	15.8	14.5	26.6	22.9	24.7	15.3	24.4	23.3	22.1	25.6	28.6	15.2	26.5	26.5	15	13.3	25.2	26.4	16.5	22.5	16.4	9.6	29.3	55.1	22.5	19.5	14.7	19	28.7	14.1	19.7	50	22.8	31	19.1	28.2	13.7	15	28.1	18.9	72.5	8.6	26.4	33.2	18	28.7	22.9	20.3	18.8	46.6	14.8	20.6	14.5	12.2	12	4.5	4.4	10.4	15.3	12.7	22.3	7.3	6.7	11.5	4.2	5.8	4.3	6.7	5.5	22.5	12	2.5	3.6	5.1	6.1	2.4	11.6	6	6.9	4.5	11.7	15.4	5	16.4	23.1	16.5	6.6	7.8	20.1	9.9	6.2	4.6	29.3	2.7	11.2	2	12.2	2.9	10.8	8.5	14.3	2.7	36.9	17.4	3.1	9	14.7	6.8	7.7	25.2	10.4	18.7	9.2	9.1	4.9	4.9	7.4	3.8	29	11.6	6.7	4.3	6.4	14	14.8	20.6	14.6	8.3	18.2	10.5	17.5	8.4	9.7	28.7	18.8	12.2	9.4	11.4	14.5	14.4	46.6	7.8	12	16.5	17.3	14.5	26.6	15	13.3	16.4	9.6	19	8.6	11.9	32.8	67.7	44.8	38.8	19.6	20.4	22.9	14.7	23.9	26.2	7.9	65.2	135.9	28.7	574	28.9	54.9	0	33.4	50.6	35	55.4	46.1	29.9	46.7	23.8	78.1	30.7	62.3	2560.6	58.1	54.9	45.5	123.6	63.7	20.3	28	59.6	43.9	75.2	13.6	19.4	29.9	26	24.9	44.7	45.5	42.7	59.3	49.1	Late spermatids
ST3GAL4	CGS23, FLJ11867, NANTA3, SAT3, SIAT4, SIAT4C, STZ	ENSG00000110080	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	Q11206	11	126355640-126440344	Enzymes, Predicted intracellular proteins, Predicted membrane proteins		Glycosyltransferase, Transferase		Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		placenta: 74.2	Cell type enriched	Detected in many	9	Syncytiotrophoblasts: 804.9	Cancer enhanced	Detected in all		melanoma: 57.2	Low region specificity	Detected in all			Group enriched	Detected in many	4	basophil: 31.3;neutrophil: 22.8;plasmacytoid DC: 29.6	Group enriched	Detected in many	11	dendritic cells: 29.6;granulocytes: 31.3	Cell line enhanced	Detected in many		SK-MEL-30: 45.3;WM-115: 102.8	Low region specificity	Detected in all			Low region specificity	Detected in many			HPA049827	Approved				Intracellular and membrane							HPA049827: AB_2680900	unprognostic (8.89e-2)	unprognostic (1.10e-2)	unprognostic (4.92e-2)	unprognostic (6.93e-2)	unprognostic (8.33e-2)	unprognostic (3.80e-2)	unprognostic (2.71e-3)	unprognostic (1.90e-3)	unprognostic (2.62e-1)	unprognostic (1.80e-2)	unprognostic (1.57e-1)	unprognostic (1.45e-1)	unprognostic (3.16e-3)	unprognostic (2.79e-2)	unprognostic (1.28e-1)	unprognostic (8.36e-3)	unprognostic (8.78e-3)	7.8	38	6.2	6.5	12.2	7.8	12.9	4	13.6	8.3	27	26.4	5.1	2	6	42.1	25.5	6	11.4	26.5	8.6	6.2	16.7	11.5	12.4	9	18.7	9	39.3	5.1	0.8	5.6	74.2	13.8	12.1	31.5	35.7	14.4	8	1.9	5.6	3.8	11	23	17	4.8	18.8	12.4	2.2	6.1	4.3	10.1	21.1	13.2	0.1	29.6	31.3	2.6	1.2	1.7	1.8	4.9	4.1	3.2	2.7	9.5	7.9	8	5.7	11.1	5.2	3.6	2.4	8.5	1.4	4.3	9	17.7	7.7	6.7	3.7	4.1	5.3	1.9	12.6	10.2	2.7	6.2	15	25.8	6.3	6	7.8	12.4	9.6	6.9	5.5	7.8	3.8	6.4	20.2	4.7	15.4	2	31.9	26.8	4.9	9.9	0.6	1.2	14.2	6.1	3.9	6.3	38.2	45.3	2.2	13.3	10	2.5	12.5	2.8	8.8	10.7	0.3	0.8	0.7	5.7	23	102.8	31.3	1.6	0.2	1.7	2.6	1.6	0.1	0.6	1.1	6.6	0	0.1	0.8	22.8	1.2	1.2	29.6	0	1.8	6.2	12.2	4	13.6	8.6	6.2	18.7	9	13.8	12.4	8.9	1.1	3.7	5.3	9.4	4.2	26.6	7.6	1.4	4.5	29.6	9.8	90.3	41.4	4.3	1.1	9.8	34.8	0	5.6	59	44	13.8	41.5	8.9	16.2	4.8	5.1	36.8	4.1	3.8	70.5	7.2	74.2	10.8	43.5	5	7.3	93	88.1	3.4	8.3	12.9	23.6	1.4	3.8	5.8	804.9	12.2	8.8	13.1	Syncytiotrophoblasts
HPX		ENSG00000110169	Hemopexin	P02790	11	6431049-6442617	Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins	Host-virus interaction, Transport			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	949	liver: 528.6	Cell type enriched	Detected in some	46	Hepatocytes: 5619.6	Cancer enriched	Detected in many	79	liver cancer: 571.1	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	7	Hep G2: 21.3	Low region specificity	Detected in some			Low region specificity	Detected in many			CAB016725, HPA065318, HPA068847	Approved				Secreted to blood			425000000000	230000000000			CAB016725: , HPA065318: , HPA068847: 	unprognostic (3.39e-2)	unprognostic (9.26e-2)	unprognostic (3.88e-1)	unprognostic (6.19e-4)	unprognostic (2.05e-2)	unprognostic (2.41e-1)	prognostic favorable (2.26e-4)	unprognostic (6.33e-2)	unprognostic (5.67e-3)	unprognostic (3.88e-1)	unprognostic (5.08e-3)	unprognostic (2.78e-2)	unprognostic (5.82e-12)	unprognostic (2.01e-1)	unprognostic (4.48e-1)	unprognostic (1.84e-2)	unprognostic (2.14e-2)	0	0	0.1	0	0.1	0	0.3	0.1	0.1	0.1	0	0.1	0	0	0.1	0.1	0	0	0.1	0.1	0	0	0	528.6	0.1	0	0	0	0	0.4	0	0.1	0	0.1	0	0	0.1	0.1	0	0.1	0	0.1	0	0	0.3	0	0.5	0	0	0.1	0	0	0.1	0	0.4	0	0	0	0	0	0	0.2	0.1	0.4	0.2	0	0.7	0	0	0.1	0.1	0.3	1.4	0	0.8	0.1	0	0.1	0.2	0	0.1	0.1	0.2	0.2	0.7	0.1	21.3	0	2.9	0	0.8	0.6	0.1	0	0.5	0.1	0.2	0.4	0.1	0.1	0.4	0	0	0.3	0.9	0	0.1	1.4	0.2	0	0.1	0.2	0	1	3.1	0.2	0.3	1.1	0	0.4	0.3	0.2	1.1	0.1	0.3	0.2	0.9	0.2	1	0.3	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0.1	0.1	0.1	0.1	0	0	0	0	0.1	0	3	0.3	49	0.1	0.6	0.9	0.4	73.9	0	0	0	2	0	0	0.1	2.5	0.3	0.3	116.8	0.5	0.1	0.2	1.8	0	5619.6	0.2	0	0	121.5	102.4	2.8	0.3	0.3	0	0	0.2	0.2	1.3	0	0	0	1.9	0	0.2	0	0.5	0.3	0	0	0.2	0.3	Hepatocytes
FOLR3	FR-G	ENSG00000110203	Folate receptor 3	P41439	11	72114869-72139892	Predicted secreted proteins		Receptor		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		blood: 73.4;bone marrow: 43.4;lymphoid tissue: 22.6	Cell type enriched	Detected in some	15	Distal tubular cells: 344.8	Cancer enhanced	Detected in some		ovarian cancer: 5.1	Not detected	Not detected			Group enriched	Detected in many	12	classical monocyte: 52.9;neutrophil: 73.4	Group enriched	Detected in many	12	granulocytes: 73.4;monocytes: 52.9	Group enriched	Detected in some	5	hTERT-HME1: 35.6;U-2197: 31.5														Secreted to blood				9600000				unprognostic (1.47e-2)	unprognostic (6.26e-3)	unprognostic (1.94e-2)	unprognostic (8.72e-3)	unprognostic (6.87e-3)	unprognostic (9.56e-2)	unprognostic (1.58e-1)	unprognostic (3.72e-1)	unprognostic (1.72e-1)	unprognostic (1.54e-1)	unprognostic (7.35e-2)	unprognostic (7.90e-2)	unprognostic (8.39e-2)	unprognostic (9.99e-4)	unprognostic (1.96e-1)	unprognostic (2.03e-6)	unprognostic (4.17e-1)	2.9	0.3	0.1	4.8	0.2	43.4	4.2	0.1	0.8	0.1	0.1	0.2	0	0.2	0.2	0.3	0.4	1	0.1	1.7	0.2	0.1	2.7	0.6	14.4	8.2	0.2	0	0.1	1.7	0	0.1	4.5	0.2	0.1	0	0.2	0.2	0	0.1	0.3	0.2	0.2	0.1	22.6	0.4	0.7	0.2	0.3	0.9	0.4	0.4	0.2	7.5	0	5.1	73.4	52.9	0	0.2	29.5	0	0	0	0	0	0.1	0.1	5	6.2	1.8	4.5	0	0	0	0.6	0.9	0.1	0.4	0	3.3	4.1	0	0	0	0	0.1	0	0	0	0	4.2	2.6	35.6	0.5	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0.1	0	0	0	0	0	4.3	0.1	31.5	0	0	0	0	1.3	0	0	1.2	52.9	4.3	0	3.5	0.2	0	0	0	5.1	0	0	0	73.4	0	0.1	0.9	0	29.5	0.1	0.2	0.1	0.8	0.2	0.1	0.2	0	0.2	0.2	0	12.2	0	0	0.2	0	0	0	2.7	3.4	22.7	0	0	344.8	0	3.9	0	0	0	0.2	0	0	0	3.5	0	1.6	0	0	0.6	8.7	8.6	0	11.2	0	0	0	0	0.2	0	0	5	0	0	0	0.2	0.2	0	0	0	0	0	Distal tubular cells
APOA5	APOA-V, RAP3	ENSG00000110243	Apolipoprotein A5	Q6Q788	11	116789367-116792420	Disease related genes, Plasma proteins, Predicted secreted proteins	Lipid transport, Transport		Disease mutation	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	209	liver: 112.2	Cell type enriched	Detected in some	55	Hepatocytes: 1283.4	Cancer enriched	Detected in single	489	liver cancer: 112.2	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	65	Hep G2: 36.7	Not detected	Not detected			Not detected	Not detected								Secreted to blood			114000000	15000000				unprognostic (1.57e-4)						unprognostic (4.67e-3)	unprognostic (5.57e-2)		unprognostic (2.60e-3)		unprognostic (2.40e-1)		unprognostic (2.31e-4)				0	0	0	0	0	0	0	0.1	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	112.2	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0.3	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0.2	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0.1	0	36.7	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0.2	0.1	0	0	0	0	0.1	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0.2	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	15.3	0	0	0	0	0	0	0	0	0	0	23.3	0.4	0	0	0	0	1283.4	0	0	0	13.5	13.3	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	Hepatocytes
APOA4		ENSG00000110244	Apolipoprotein A4	P06727	11	116820700-116823306	Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins	Lipid transport, Transport			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	6	intestine: 593.6	Cell type enriched	Detected in single	618	Hepatocytes: 61.8	Cancer enriched	Detected in some	29	liver cancer: 291.6	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		BEWO: 8.1;CACO-2: 8.2;Hep G2: 7.7;NB-4: 7.5;RPMI-8226: 12.0;SH-SY5Y: 11.1	Not detected	Not detected			Low region specificity	Detected in all			HPA001352, HPA002549, CAB068250, CAB068251, CAB068252	Enhanced		Approved	Vesicles	Secreted to blood			61200000000	140000000000	Vesicles		CAB068250: AB_2665657, CAB068251: AB_2665659, CAB068252: AB_2665658, HPA001352: AB_1078179, HPA002549: AB_1078177							unprognostic (8.81e-2)				unprognostic (2.12e-2)			unprognostic (1.75e-2)	unprognostic (7.91e-2)			0.1	0	0	0.1	0	0	0	0	0	0	293.8	0	0	175.5	0	0	0.1	0	0	0	0	0	0	93.3	0	0.1	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	593.6	0.1	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	8.1	0	0	0	0	8.2	0	0	0	0	0	0	0	0	0	0	0	0	0	7.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	7.5	0	0	0	0	0	12	0	0	3.3	11.1	0	0	0	0	0	0	0	0	0	1.6	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	61.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Hepatocytes
APOC3		ENSG00000110245	Apolipoprotein C3	P02656	11	116829706-116833072	Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins	Lipid degradation, Lipid metabolism, Lipid transport, Transport		Cancer-related genes, Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	8	liver: 714.1	Cell type enriched	Detected in some	60	Hepatocytes: 64257.6	Cancer enriched	Detected in many	643	liver cancer: 4021.9	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	19	CACO-2: 28.5;Hep G2: 77.0					Not detected	Not detected			HPA065365, HPA073918	Supported		Approved	Nucleoplasm,Nucleoli,Cell Junctions	Secreted to blood			106000000000	97000000000	Nucleoplasm	Nucleoli, Cell Junctions	HPA065365: AB_2732733, HPA073918: 							prognostic favorable (3.77e-4)				unprognostic (2.33e-1)		prognostic unfavorable (6.87e-5)	unprognostic (1.60e-2)	unprognostic (5.21e-2)			0.1	0	0.1	0.1	0.1	0	0.1	0.1	0.2	0.1	38.7	0.1	0.1	31.7	0.1	0.2	0.1	0	0.1	0.1	0.1	0	0.4	714.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.2	0.1	0	0.1	0.1	0.1	0.1	0	91.3	0.1	0.1	0.3	0	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0	0.2	0	0	0	0	0	0	0	1.1	0	0	0	0	28.5	0	0.4	0	0	0	0	0	0	0	0	0	0.8	0	77	0	2.7	0	0	0	0.1	0	0	0	0	0.3	0	0	0	0	0.6	0	0	0	0	1.7	0.9	0	0	0.3	1	1	0	0	0	0	0	0.3	0	0	0	0	0	0	1	0	0.8	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.1	0.2	0.1	0	0.1	0.1	0.2	0.1	0	0	100.1	0	0	0	0	858.6	0	0	0	0	0	3.3	0	3.8	0	0	1074.6	0.4	0.3	0	0	0	64257.6	1	0	0	825.6	1072.7	10.3	0	0	0	0	0	0	0	0	0	44	0	0	0	0.1	0	0	0.7	3.2	0	0	Hepatocytes
KIAA1549L	C11orf41, C11orf69, G2, MGC34830	ENSG00000110427	KIAA1549 like	Q6ZVL6	11	33376466-33674102	Predicted membrane proteins				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	24	brain: 30.4;parathyroid gland: 64.4	Cell type enriched	Detected in some	4	Melanocytes: 16.9	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in many		TIME: 23.0;U-138 MG: 30.4;WM-115: 20.5	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA010132, HPA051594			Approved	Nucleoplasm,Vesicles					27000	Nucleoplasm	Vesicles	HPA010132: AB_1078313, HPA051594: 	unprognostic (3.02e-1)	unprognostic (1.18e-1)	unprognostic (2.70e-2)	unprognostic (1.34e-5)	unprognostic (2.63e-1)	unprognostic (7.92e-2)	unprognostic (2.89e-2)	unprognostic (5.27e-3)	unprognostic (1.55e-2)	unprognostic (2.59e-4)	unprognostic (8.88e-2)	unprognostic (1.44e-1)	unprognostic (3.62e-3)	unprognostic (1.08e-3)	unprognostic (8.46e-2)	unprognostic (4.04e-1)	unprognostic (1.09e-1)	0.8	0.9	8.2	0.7	20.5	0.6	1.2	6.2	30.4	0.7	0.7	1.7	0	0.6	0.7	0.6	0.9	0.6	0.8	0.6	5.3	2.4	0.9	0.6	0.6	0.7	1.6	17.1	0.7	0.8	64.4	1	1.4	2.3	0.7	0.7	0	0.7	0.6	0.6	1.9	0.6	0.7	1.1	0.6	0.7	1.3	1.6	0	0.6	0	1.1	0.9	0.6	0	0	0	0.2	0	0	0	0	0.9	3.3	0.1	0.5	3.7	0	13.3	7.8	2.1	1.2	0	0.3	10.2	0.1	11.7	10.2	0.7	0.4	3.8	3.2	0	2	0	0	0	0	0	0	1.4	0	3.3	5.8	7.6	9.5	0.2	0	9.7	8.3	0	0.1	0	0.7	0	4.9	0	0.8	0	0	5.1	1.1	1.2	0.1	0	3.2	0.1	0	0	23	30.4	6.4	0.7	10.6	0	0	0	8	0	20.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	8.2	20.5	6.2	30.4	5.3	2.4	1.6	17.1	2.3	1.6	0	0	0	0.3	1.8	4	1.2	0	0	0	0	0	0	3.3	0.6	0.4	0.5	0	0	0	0.1	0.1	0.2	0	0	0.3	3.2	0	1.8	0	0.4	0	0.2	16.9	0	0	0	0.9	0	0.4	0	0.3	0	0	0	1.7	0.3	0	0	0	0.5	Melanocytes
SCGB2A2	MGB1, MGC71974, UGB2	ENSG00000110484	Secretoglobin family 2A member 2	Q13296	11	62270155-62273156	Cancer-related genes, Predicted secreted proteins			Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	4	breast: 300.8	Cell type enriched	Detected in some	38	Melanocytes: 1671.9	Cancer enriched	Detected in many	23	breast cancer: 823.4	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	118	SK-BR-3: 20.3									CAB026270	Enhanced				Secreted in female reproductive system							CAB026270: AB_912980	unprognostic (2.38e-1)	unprognostic (7.28e-2)		prognostic favorable (9.57e-8)						unprognostic (4.17e-1)				unprognostic (3.75e-1)				2.9	0	0.2	0.2	0.2	0	300.8	0.2	0.2	34.4	0.2	0.2	0.2	0	0.6	0.2	7.2	0	0.2	0.5	0.2	0	0.3	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0	0.2	0.2	0.2	0.2	0	0.2	13.9	0.2	0.2	75	0.2	0.2	0.2	0.2	0	0.2	0.2	0.4	0.2	0.6	5.9	0.2	0.9	0.1	0	0.1	0.2	0	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	20.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0.1	0.1	0	0.1	0.1	0	0	0	0	0	0	0	0.2	0	0	0.1	0.2	0.2	0.2	0.2	0.2	0	0.2	0.2	0.2	0.2	0	0	0	0	44.1	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	1.3	0.2	0	0	0.2	0	0	0	0	0	0	0	1671.9	0	0	0	0	0	0	0	0	0	0	0	0	9.5	0	0	0	0	Melanocytes
CALCA	CALC1	ENSG00000110680	Calcitonin related polypeptide alpha	P01258, P06881	11	14966668-14972354	Cancer-related genes, Plasma proteins, Predicted secreted proteins, Transporters		Hormone	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	4	parathyroid gland: 122.2;thyroid gland: 55.3	Cell type enriched	Detected in some	5	Collecting duct cells: 34.9	Cancer enriched	Detected in many	7	lung cancer: 64.7	Region enriched	Detected in single	48	pons and medulla: 19.8	Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		EFO-21: 2.9;hTERT-HME1: 1.8;Karpas-707: 1.8;SCLC-21H: 3.5	Region enriched	Detected in many	5	pons and medulla: 60.6					HPA059886, HPA064453	Enhanced	Supported			Secreted to blood			51500				HPA059886: , HPA064453: 			unprognostic (1.97e-1)	prognostic unfavorable (4.49e-5)	unprognostic (5.99e-2)		unprognostic (2.42e-1)	unprognostic (1.17e-1)		unprognostic (6.45e-2)	unprognostic (1.28e-1)	unprognostic (7.66e-2)	unprognostic (3.33e-2)	unprognostic (7.49e-2)	unprognostic (6.74e-2)	unprognostic (2.53e-3)	unprognostic (1.02e-2)	0.2	0	0.1	0.3	0.4	0	0.8	0.1	0.2	0	0.1	0	0	0	0	0	0	0	0.2	0.2	0	0.2	6.2	16.8	0.6	0	0.1	0	0	0.1	122.2	0.2	0	19.8	1.2	0	0.3	0.4	0	0.3	0	0	0.3	1.5	4.6	0	0	0	0.6	55.3	0	0	0.4	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0.5	0	0.7	0	0	2.9	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.8	0	0	0.1	0	1.8	0	0	0	0.5	0	0	0	0.2	0	0	0	0	3.5	0.1	0.4	0	0	0	0	0	0	0	0	0	0	0.3	0.3	0.1	0	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0.1	0.4	0.1	0.2	0	0.2	0.1	0	19.8	0	0	0	0	0.2	0.2	0	0.3	0	0	0	34.9	0	0	5	0	0	0	0	0	1.7	0	0.1	6.5	0	3.8	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	6.2	0.1	0	0.5	0	0	0	1.3	Collecting duct cells
MYL2	CMH10	ENSG00000111245	Myosin light chain 2	P10916	12	110910819-110920722	Candidate cardiovascular disease genes, Disease related genes, Predicted intracellular proteins		Motor protein, Muscle protein, Myosin	Cardiomyopathy, Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	11	heart muscle: 656.7;skeletal muscle: 672.9	Cell type enriched	Detected in some	10238	Cardiomyocytes: 17552.7	Group enriched	Detected in some	46	head and neck cancer: 31.5;prostate cancer: 25.5	Not detected	Not detected			Group enriched	Detected in some	31	memory B-cell: 3.8;naive B-cell: 2.4	Lineage enriched	Detected in single	38	B-cells: 3.8	Cell line enhanced	Detected in some		EFO-21: 4.3;HSkMC: 9.4;U-2 OS: 18.9	Not detected	Not detected			Not detected	Not detected			HPA019763, HPA039262	Supported		Uncertain	Microtubules					190000	Microtubules		HPA019763: AB_1854243, HPA039262: AB_2676418	unprognostic (2.07e-2)	unprognostic (1.37e-1)		unprognostic (1.39e-1)		prognostic unfavorable (2.60e-4)		unprognostic (1.32e-1)	unprognostic (4.05e-2)	unprognostic (4.82e-2)	unprognostic (2.05e-2)	unprognostic (2.20e-1)		unprognostic (1.76e-1)	unprognostic (2.84e-1)	unprognostic (3.55e-1)		3.6	0	0.1	0.1	0.1	0	0.8	0	0.1	0	0.1	0	0	0	0	6.4	8.9	0	0.2	656.7	0.1	0.1	0	0.1	0.1	0.2	0.1	0	0	0.1	0	0	0	0.1	6.1	0	0	7.7	0	672.9	0.1	0	0.1	0.2	0	0	0.4	0	0	2.4	59.4	10.5	0.3	0	3.8	0	0	0	0	0	0	0.1	0.5	0	0	0	0	0	0	0	0	0	0	0.3	0.2	4.3	0	0.1	0.2	0	0.3	0	0	0	0	0	0	0.1	0	0	9.4	0	0.1	0.3	0	0.2	0	0	0	0.1	0	0	0.1	0	0	0	0	0.1	0.3	0	0	0	0	0	0	0	0	0	0	0	0	18.9	0	0.1	0	0	1.7	0	1.9	0	0	0	0	0	0	0	3.8	0	0	0	2.4	0	0	0	0	0	0	0	0	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.1	0	0	0	0.8	0	0.1	0	17552.7	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.7	0	0	0	0.1	0	0	0	0	0	0.1	0.1	0.1	0	0	0	0	0	Cardiomyocytes
GSG1	MGC3146	ENSG00000111305	Germ cell associated 1	Q2KHT4	12	13083560-13103683	Predicted intracellular proteins, Predicted membrane proteins, Transporters				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	60	testis: 156.4	Cell type enriched	Detected in many	5	Late spermatids: 9027.4	Cancer enhanced	Detected in single		testis cancer: 1.9	Not detected	Not detected			Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		fHDF/TERT166: 9.6;LHCN-M2: 11.0;RPTEC TERT1: 13.7;U-2 OS: 6.9	Not detected	Not detected			Not detected	Not detected								Intracellular and membrane								unprognostic (1.50e-1)	unprognostic (2.21e-2)		unprognostic (6.33e-2)	unprognostic (2.36e-2)	unprognostic (1.34e-1)	unprognostic (8.01e-2)	unprognostic (1.04e-1)	unprognostic (4.52e-1)	unprognostic (6.85e-2)	unprognostic (8.23e-2)	unprognostic (5.91e-2)	unprognostic (3.20e-3)	unprognostic (1.48e-1)	unprognostic (3.65e-2)	unprognostic (1.79e-1)	unprognostic (6.32e-3)	0	0	0.1	0	0.1	0.1	0	0	0.2	0	1.3	0	0	0.3	0	1.6	0	0	0	0	0.1	0.1	0.1	0	0	0	0.1	0	0	1.4	0	0	0.2	0.2	0	0	1.8	0	0	0	0	0.5	0	0.1	0	0	156.4	0	0	0	0	0	0	0	1.3	0.7	2.6	0.7	0.5	1.2	0.1	0.1	0.5	0.3	0.1	2.3	1.4	0.5	0.2	0.4	0.4	0.5	0.2	0.1	0.2	0.2	9.6	0.8	0.1	0.2	0	0.9	0.2	0	0.2	0.6	0.3	0	0.2	0.1	0.9	0	1.8	0.1	0.1	0	0.1	0.1	1.8	11	0.3	0.1	1.1	2.3	0.1	0.2	0.1	4	0.2	13.7	0.2	0.6	0.3	0.2	0	0.1	0.3	0.1	1.6	0.1	0.6	6.9	0.3	0.3	0.6	0.4	0.1	3	0.3	0.2	1.3	0.5	0.9	1.2	0.4	0.6	0.8	0.6	1	0.4	1.3	0.8	0.9	2.6	0.5	0.7	0.7	0.5	0.1	0.1	0.1	0	0.2	0.1	0.1	0.1	0	0.2	0	3	1.4	0	0.1	0.1	9.4	0.4	0	0	0	0	5.9	0.1	1.7	0.4	1969	0	0	23.3	0	0.1	0	0.1	0	0	0.7	1.6	26.4	2.5	0	9027.4	49.5	0	0	0	0	5.7	0	0	37.4	0	14.7	6.5	0	51.2	19.7	0	0	0	0	0	Late spermatids
RASAL1	RASAL	ENSG00000111344	RAS protein activator like 1	O95294	12	113098819-113136239	Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins	Differentiation	GTPase activation		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		parathyroid gland: 64.0	Cell type enriched	Detected in many	9	Collecting duct cells: 34.9	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		Daudi: 8.5;EFO-21: 11.1;REH: 12.3;RPMI-8226: 27.4;RPTEC TERT1: 10.9;U-698: 23.3	Low region specificity	Detected in many			Group enriched	Detected in many	4	amygdala: 21.7;cerebral cortex: 20.9;hippocampal formation: 33.7	HPA041650	Enhanced		Approved	Plasma membrane,Cell Junctions,Cytosol						Plasma membrane, Cytosol	Cell Junctions	HPA041650: AB_2677598	unprognostic (9.95e-2)	unprognostic (1.11e-2)	unprognostic (5.44e-3)	prognostic unfavorable (3.26e-5)	unprognostic (1.27e-2)	unprognostic (7.73e-3)	unprognostic (1.57e-2)	unprognostic (1.43e-2)	unprognostic (2.65e-1)	unprognostic (3.02e-3)	unprognostic (3.16e-2)	unprognostic (2.53e-1)	unprognostic (1.74e-2)	unprognostic (2.85e-3)	unprognostic (1.15e-1)	unprognostic (3.34e-2)	unprognostic (2.64e-1)	0.9	10.4	8.6	2.5	11.2	1.2	1.6	0.4	18.2	2.5	2.1	18.8	3.7	1.2	0.9	0.9	16.9	2.2	1.8	0.8	11.8	4.9	7.4	0.9	0.9	1.7	7.3	10.9	0.8	1.4	64	3.9	1	4	0.9	1.7	0	22.4	7.4	0.8	8	1.1	0.9	1.8	1	9.6	1.1	8.4	0	8	6	5	1	3.7	0.4	0.2	1.3	0.2	0.3	1.6	0.3	0.4	0	0	0	0	0	0.8	0	0	0	0	0	2.2	8.5	11.1	0	0	0	0.1	0	0	0	0.2	0	0.1	0	0	0	0.4	0	0.1	0	0	0	0	0.7	0	0.1	0	2.3	0	0	0.3	3	0	12.3	0	27.4	10.9	0	0.3	0	0	4.1	0	0	1.7	0	0	0	1.2	0	0	0	0	23.3	0	0	0	1.3	0.2	0.1	0.1	0	1.6	0.2	0.9	0.4	0	0.4	1.2	0.5	0.4	0.3	0	0.2	0.4	0.3	8.6	11.2	0.4	18.2	11.8	4.9	7.3	10.9	4	8.4	0	0	0.5	0	0.5	0.5	3.5	2.5	0	0	34.9	0	1	0	0.9	0	0	0.2	0	0	0.1	0	0	2.3	0	0.3	0	1.2	0	0	0	0	2.1	1.7	1.8	4.1	2.3	3	3.5	0	3.9	0	0	0.1	0	0.3	1	1	0	2.3	0.4	Collecting duct cells
SLCO1B3	OATP1B3, OATP8, SLC21A8	ENSG00000111700	Solute carrier organic anion transporter family member 1B3	Q9NPD5	12	20810702-20916911	Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters	Ion transport, Transport			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	21	liver: 88.1	Cell type enriched	Detected in some	20	Hepatocytes: 91.8	Cancer enhanced	Detected in many		liver cancer: 5.4	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		A-431: 35.8;A549: 9.8;CAPAN-2: 7.1;GAMG: 7.8;HeLa: 8.1;PC-3: 9.8;U-2 OS: 8.5									HPA004943, HPA050892	Enhanced		Supported	Plasma membrane						Plasma membrane		HPA004943: AB_1854758, HPA050892: AB_2681265		unprognostic (5.36e-2)	unprognostic (1.25e-1)	unprognostic (6.95e-2)		unprognostic (1.63e-2)	unprognostic (1.89e-2)	unprognostic (7.09e-2)		unprognostic (3.08e-2)	unprognostic (1.54e-2)	unprognostic (7.37e-2)		unprognostic (1.50e-1)	unprognostic (6.61e-3)		unprognostic (2.36e-3)	0.1	0	0.1	0.1	0.1	0	0.1	0.1	0.1	4.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0	0.1	0.1	0.1	0	0.1	88.1	0.1	0.1	0.1	0.1	0.1	0.2	0	0.1	0.1	0.1	0.1	0	0.1	0.4	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0	35.8	9.8	0	0	0	0	0	0	0	0	0	0.3	7.1	0	2.5	0	7.8	0	0	0.2	0	0	0	0	8.1	0	0	0	0	0	0.3	0	1.7	0.8	0	0	0	0	0	0	0	0	0	0	9.8	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0.1	8.5	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4.5	0	0	0	0	0	0	0.1	0	91.8	0	0	0	0.6	1.9	4.1	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0.1	0	0	0	0	0.1	Hepatocytes
GYS2		ENSG00000111713	Glycogen synthase 2	P54840	12	21536189-21604847	Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins	Glycogen biosynthesis	Allosteric enzyme, Glycosyltransferase, Transferase	Disease mutation, Glycogen storage disease	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	9	liver: 75.1	Cell type enriched	Detected in some	46	Hepatocytes: 57.8	Cancer enriched	Detected in single	29	liver cancer: 12.6	Not detected	Not detected			Cell type enriched	Detected in single	7	naive CD4 T-cell: 1.4	Lineage enriched	Detected in single	8	T-cells: 1.4	Cell line enhanced	Detected in some		CACO-2: 5.2;HEL: 1.9;SuSa: 1.5	Not detected	Not detected			Low region specificity	Detected in many			HPA039482	Approved											HPA039482: AB_10795107	unprognostic (7.22e-3)	unprognostic (2.85e-2)	unprognostic (8.88e-2)	unprognostic (1.78e-2)	unprognostic (5.68e-2)	unprognostic (3.16e-1)	prognostic favorable (7.62e-5)	unprognostic (1.06e-1)	unprognostic (1.29e-1)	unprognostic (1.68e-1)	unprognostic (4.68e-2)	unprognostic (2.15e-1)	unprognostic (1.13e-1)	unprognostic (4.22e-2)	unprognostic (6.53e-2)	unprognostic (1.85e-1)	unprognostic (2.66e-4)	8.4	0	0	0	0	0	0.3	0	0	1.2	0.1	0	0	0	0	0	2.9	0	0.2	0	0	0	0.1	75.1	0	0	0	0	0.1	0.1	0	0	0	0	0.1	0	0	0.4	0	0.1	0	0	0	0	0	0	0	0	0	0	0.5	0.2	0.2	2.4	0	0.1	0	0	0	1.4	0	0	0	0.5	0	0.2	0.1	0.1	0	0.1	0	0	5.2	0	0.2	0	0	0.1	0	0.4	0	0.4	0.2	0.6	1.9	0.2	0	0.3	0.5	0.4	0.5	0.2	0	0.4	0.1	0	0.3	0	0.1	0.6	0	0.3	0.3	0.2	0	0	0.5	0.2	0	1	0.1	0	0	0.2	0	0	1.5	0	0.1	0.2	0.1	0.4	0	0.1	0.2	0.1	0.2	0.1	0.3	0.2	0	0	0	0	0	0	0	0.2	0	0.1	0	1.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	57.8	0	0	0	0	1.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Hepatocytes
RSPH4A	CILD11, dJ412I7.1, FLJ37974, RSHL3, RSPH6B	ENSG00000111834	Radial spoke head 4 homolog A	Q5TD94	6	116616479-116632985	Disease related genes, Predicted intracellular proteins			Ciliopathy, Disease mutation, Kartagener syndrome, Primary ciliary dyskinesia	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 19.8;fallopian tube: 35.9;pituitary gland: 16.7	Cell type enriched	Detected in many	10	Ciliated cells: 365.4	Cancer enhanced	Detected in many		endometrial cancer: 4.6	Group enriched	Detected in many	4	basal ganglia: 9.4;pons and medulla: 19.8	Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		RPMI-8226: 7.6;U-266/84: 5.5	Low region specificity	Detected in many							HPA031196, HPA031197, HPA031198	Enhanced		Approved	Nucleoplasm		No				Nucleoplasm		HPA031196: AB_10601612, HPA031197: AB_10671097, HPA031198: AB_10670025	unprognostic (9.83e-4)	unprognostic (1.26e-1)	unprognostic (6.94e-2)	unprognostic (9.69e-3)	unprognostic (9.37e-2)	unprognostic (1.13e-3)	unprognostic (4.52e-1)	unprognostic (1.07e-1)	unprognostic (1.06e-1)	unprognostic (5.08e-2)	unprognostic (9.56e-5)	unprognostic (2.87e-1)	unprognostic (2.69e-4)	unprognostic (1.96e-2)	unprognostic (2.51e-1)	unprognostic (3.55e-2)	unprognostic (5.21e-2)	0.5	0.7	1.8	0.5	9.4	0.9	0.7	1.2	0.9	2.2	0.4	10.2	0.4	0.5	1.9	13.3	0.4	35.9	0.8	0.5	3	3.3	0.7	0.4	11.1	0.5	0.5	1.1	13.7	0.6	2.8	16.7	0.3	19.8	0.6	0.4	0.2	0.4	0.5	1	0.6	0.4	0.6	0.7	1	0.8	6.6	1.8	0	1	0	0.5	0.4	0.1	0.8	0.1	1.3	0.2	0.2	1	0	0.1	0.2	1.4	3.2	0.1	0.1	0.3	0.4	0.8	0.6	0.8	0.7	1.1	1	0.3	0.1	1.2	0.2	0.3	0.6	0.6	0.8	1.1	0.4	0.5	1.2	0	0.8	1.1	0.4	0.2	1	0.2	0.1	0	0.9	0.2	0.1	0.6	0.2	0.7	0.1	0.6	0.1	0.1	0.8	1.6	7.6	3.2	0.4	2.8	1.2	0.2	0.2	0.5	0.3	0.5	0.6	0.5	0.4	0.7	0.5	0.5	0.5	5.5	0.4	0.1	0.4	0.5	1.3	0.2	0.8	1	0.1	0.1	0.4	0.3	0	0	0.8	0.2	0.5	0	0.2	0.1	0.1	0	0	1.8	9.4	1.2	0.7	3	3.3	0.5	1.1	19.8	1.8	3	4.3	0	0	0	3	0.4	0	365.4	35.2	0	2	0	1.7	0.4	18.2	0.1	0	0	0.3	0.1	0	0.1	2.3	0	0.1	1.6	0	2.5	0	8.7	0.3	0	1.7	0	0	1.7	0.2	0	0	0	3.2	0	0.4	4.4	1.5	0.1	0.2	0	0	0	Ciliated cells
GABRR2		ENSG00000111886	Gamma-aminobutyric acid type A receptor rho2 subunit	P28476	6	89257208-89315299	FDA approved drug targets, Predicted membrane proteins	Ion transport, Transport	Chloride channel, Ion channel	FDA approved drug targets	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enriched	Detected in some	12	retina: 18.8	Cell type enriched	Detected in some	13	Bipolar cells: 19.8	Not detected	Not detected			Not detected	Not detected			Cell type enhanced	Detected in single		plasmacytoid DC: 1.0	Lineage enhanced	Detected in single		dendritic cells: 1.0	Cell line enhanced	Detected in some		U-266/70: 4.4;U-266/84: 1.6	Low region specificity	Detected in single			Low region specificity	Detected in many																unprognostic (2.05e-2)	unprognostic (1.47e-4)	unprognostic (1.56e-1)	unprognostic (1.88e-4)	unprognostic (4.19e-1)	unprognostic (1.07e-1)	unprognostic (2.24e-2)	unprognostic (9.13e-2)	unprognostic (2.87e-1)	unprognostic (1.10e-2)	unprognostic (2.65e-1)	unprognostic (1.41e-1)	unprognostic (1.54e-6)	unprognostic (3.69e-2)	unprognostic (7.81e-2)	unprognostic (5.79e-2)	unprognostic (7.15e-3)	0.2	0.6	0.2	0.5	0.4	0.3	0.1	0.3	0.4	0.1	0.1	0.1	0.1	0	0.7	0.5	0.2	0.1	0.4	0.2	0.3	0.2	0.3	0.4	0.1	0.9	0.3	0.1	0.1	0.8	0	0.2	0.1	0.1	0.3	0	18.8	0.6	0.2	1.5	0.5	0.1	0.1	0.2	0.4	0.1	0.6	0.1	0.1	0.5	0.1	0.1	0.1	0.1	0.3	1	0	0	0	0.1	0.1	0	0.6	0	0.4	0.5	0	0	0	0.1	0	0.2	0	0.3	0.6	0.3	0.2	0.1	0.1	0	0	0.1	0	0.4	0.3	0	0	0.2	0	0	0.2	0.1	0	0	0	0	0.2	0.1	0.6	0	0.2	0.2	0	0	0	0.2	0.9	0.4	0	0.3	0.1	0	0	0	0.1	0	0	0.1	1	0	0.4	0	0	0	4.4	1.6	0	0.5	0.4	0.3	0	0	0	0	0	0	0	0.1	0	0	0.3	0	0	0	0	0	1	0	0.1	0.2	0.4	0.3	0.3	0.3	0.2	0.3	0.1	0.1	0.1	0	0	0	0	0	19.8	0.3	0	0	0	0	0	0	0	0	0.9	0	0	0	0	0	0	0	0	0	0	1.6	0	0	0	0.4	0	0	0	0	0	0	0.1	0	0	0	0.3	0	0	0	0	0	0	0	0	0	Bipolar cells
RHAG	CD241, RH50A, SLC42A1	ENSG00000112077	Rh associated glycoprotein	Q02094	6	49605158-49636884	CD markers, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters	Ammonia transport, Transport		Disease mutation, Hereditary hemolytic anemia	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	9	bone marrow: 54.1	Cell type enriched	Detected in some	50	Erythroid cells: 116.8	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	190	HEL: 87.8;K-562: 86.5	Not detected	Not detected			Not detected	Not detected			HPA046051, HPA055331	Approved		Approved	Endoplasmic reticulum						Endoplasmic reticulum		HPA046051: , HPA055331: AB_2682785					unprognostic (8.16e-2)						unprognostic (6.86e-2)	unprognostic (1.25e-3)		unprognostic (1.65e-1)				1.2	0.2	0	1.1	0.5	54.1	3.2	0	0.1	2.3	1	0.5	1.7	0.2	0.4	0.1	2.6	0.5	0.8	5.3	0	0	0.1	0.7	3.3	0.1	0	0	0.1	0.2	0.1	0.1	5.8	0.1	1.3	0.2	0	0.2	0.5	0.4	0.1	0.9	0.1	0	4.5	0.6	0.2	0	1.7	1.8	0	0.1	0.8	2.8	0	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	87.8	0	0	0	0	0	0	0	0	0	0	0	0	86.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.7	0	0.5	0	0	0	0	0	0	0.1	0	0	1.4	0	0	0	0	0.3	0	0	0	0	0	0	0	0	1.2	0	0	116.8	0.2	0.3	0	0	2.3	0	0.4	0	0	1.8	0	1.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	Erythroid cells
SOD2		ENSG00000112096	Superoxide dismutase 2		6	159669057-159745186	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level				Tissue enhanced	Detected in all		blood: 254.9;skeletal muscle: 475.1	Cell type enriched	Detected in some	8	Hofbauer cells: 286.7	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enriched	Detected in many	11	neutrophil: 254.9	Lineage enriched	Detected in many	11	granulocytes: 254.9	Cell line enhanced	Detected in all		BJ hTERT+: 182.1;GAMG: 70.6;HSkMC: 80.3									HPA001814, CAB002013	Supported		Enhanced	Mitochondria						Mitochondria		CAB002013: , HPA001814: AB_1080134	unprognostic (2.47e-2)	unprognostic (2.77e-3)	unprognostic (1.14e-1)	unprognostic (1.57e-2)	unprognostic (1.31e-1)	unprognostic (1.69e-1)	unprognostic (1.49e-1)	unprognostic (3.10e-2)	unprognostic (1.37e-1)	unprognostic (6.67e-2)	unprognostic (2.76e-2)	unprognostic (7.14e-2)	prognostic unfavorable (1.72e-4)	unprognostic (8.12e-2)	unprognostic (4.14e-2)	unprognostic (5.99e-2)	unprognostic (1.82e-1)	77.8	28.6	6.2	82.8	13.8	147.9	32.5	3.6	12.5	13.1	25.6	5.7	3.6	9.1	13.3	16.6	20.3	12.6	19.9	42.4	5.8	6.4	157.4	197.5	33.9	52.7	14.3	2.6	31.8	24.9	6.9	7	10	16.1	27.1	6.1	6.4	39.9	7.4	475.1	9	8.1	27.9	25.5	18.4	13.8	13.6	7.3	3	36.8	20.8	11.8	43.4	52.8	2.3	5.8	254.9	22.7	0.9	4.5	15	3.6	4.6	4.1	9.4	26.6	44.5	2.1	5.3	182.1	6.5	15.1	9.5	2.1	7.5	16	5.9	70.6	6.3	4.3	4.6	4.9	7.3	8.9	7.9	7.8	16.2	19.8	7.5	3.4	80.3	7.7	20.6	15.4	4.6	3.3	4.8	10.8	9	6.2	3.9	6.2	4.8	6.9	4.4	5.8	8.4	5.6	6.9	12.1	6	7.8	3	11.2	5.7	2.3	1.6	3.5	3.6	3.1	19.2	6.9	10.1	9.2	3.8	9.8	9	21.1	5.8	2.4	6.2	19.2	9.4	2.2	14.9	2.4	2.3	3.1	2.2	5.8	1.8	2.6	2.1	254.9	0.9	22.7	0.8	4.5	15	6.2	13.8	3.6	12.5	5.8	6.4	14.3	2.6	16.1	7.3	0	0	0	0	0	0	0	0	0	0	0	0	16	0	0	0	0	0	0	0	35.9	0	0	0	0	286.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	22.8	0	0	0	Hofbauer cells
BACH2	BTBD25	ENSG00000112182	BTB domain and CNC homolog 2	Q9BYV9	6	89926529-90296908	Plasma proteins, Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	Activator, DNA-binding, Repressor	Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		lymphoid tissue: 29.8	Cell type enriched	Detected in many	4	Horizontal cells: 187.5	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Cell type enriched	Detected in many	4	naive B-cell: 15.4	Lineage enriched	Detected in many	4	B-cells: 15.4	Group enriched	Detected in some	6	Daudi: 52.7;U-698: 30.9	Low region specificity	Detected in all			Low region specificity	Detected in many			HPA051384, HPA058384	Enhanced		Supported	Nucleoplasm,Cytosol						Nucleoplasm	Cytosol	HPA051384: AB_2681462, HPA058384: AB_2683700	unprognostic (4.00e-3)	unprognostic (3.17e-2)	unprognostic (1.07e-1)	unprognostic (2.47e-4)	unprognostic (1.49e-1)	unprognostic (2.29e-1)	unprognostic (3.42e-2)	unprognostic (8.92e-2)	unprognostic (2.36e-1)	unprognostic (1.06e-2)	unprognostic (3.12e-3)	unprognostic (4.22e-1)	unprognostic (9.87e-3)	unprognostic (2.10e-2)	unprognostic (1.83e-1)	unprognostic (2.03e-1)	unprognostic (3.87e-4)	2.9	2.1	5.3	29.8	5.6	18.5	4.1	11.4	6.9	5.4	2.2	6.3	1	1.3	6.8	2.1	1.9	3	2.3	2.6	5.2	2.9	1.7	5.8	5.8	26.7	5.2	4	6.3	4	5.8	1.9	2.4	4.9	3.7	1.7	0.9	5.2	2.2	7.9	5.4	6.5	2.8	5.2	7.6	1.8	3.4	6.9	26.9	2	2.4	20.6	4.8	3.3	15.4	0.2	1.8	0	1.5	3.7	0.4	0.3	0	1.9	0.1	0.1	0	0.3	0	0.1	0	0.2	0	0	52.7	0	0	0	0	0.3	0.6	0.1	0	0.6	0	0	0	0	0	0.1	0.4	0.1	0	1.2	0	0	3.4	2.1	4.6	0	0.1	1	0	0.5	0	0.4	7.2	1.3	0.9	0	0.1	1.7	4.9	0.1	0	0.3	0.6	0	0	0.1	0	0.7	0	0	3.5	0.1	30.9	0.2	0.5	0.4	1.8	0	0.7	0.4	0	0.8	2.1	0.8	0.7	0.2	15.4	3.7	2.4	0	1.5	0	0.2	0.1	0.4	5.3	5.6	11.4	6.9	5.2	2.9	5.2	4	4.9	6.9	0	0.3	43.2	8.5	6.6	5.6	2	0	0	3.4	3.5	39.3	0.1	0	4.4	17.2	1.1	0	0	2.4	0.2	5.3	14	0	2.4	0.5	187.5	0	2.5	0.3	5.3	5.5	0.9	3.3	0	0.1	0.6	3.8	0	4.2	0	1.9	0	1.7	0	1.5	6.8	0	5.1	0	3.1	Horizontal cells
RBM24	dJ259A10.1, FLJ30829, RNPC6	ENSG00000112183	RNA binding motif protein 24	Q9BX46	6	17281346-17293875	Predicted intracellular proteins	Differentiation, mRNA processing, mRNA splicing, Translation regulation	RNA-binding		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		heart muscle: 41.0;skeletal muscle: 153.8;tongue: 37.3	Cell type enriched	Detected in some	8	Cardiomyocytes: 165.8	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Cell type enhanced	Detected in single		MAIT T-cell: 2.4	Lineage enriched	Detected in single	25	T-cells: 2.4	Cell line enhanced	Detected in many		LHCN-M2: 29.0;RH-30: 29.8;T-47d: 13.9	Low region specificity	Detected in many			Low region specificity	Detected in many			HPA066927, HPA067231	Enhanced		Enhanced	Nucleoplasm,Cytosol						Nucleoplasm	Cytosol	HPA066927: AB_2685750, HPA067231: AB_2685808	unprognostic (9.05e-3)	unprognostic (2.57e-1)	unprognostic (2.24e-1)	unprognostic (1.67e-3)	unprognostic (1.53e-1)	unprognostic (4.54e-4)	unprognostic (3.34e-2)	unprognostic (1.33e-2)	unprognostic (2.97e-3)	unprognostic (3.38e-2)	unprognostic (2.98e-2)	unprognostic (1.43e-1)	unprognostic (1.45e-1)	unprognostic (1.16e-2)	unprognostic (3.06e-2)	unprognostic (1.08e-2)	unprognostic (2.33e-4)	3.4	0.2	1.4	0.9	2.2	0.1	1.1	0.3	1.9	7	2.7	0.1	3	0.5	9.7	7.3	3.4	7.8	1.7	41	1.5	1.7	0.3	0.4	0.4	0.2	0.5	1.1	2.1	0.2	0.1	1.8	0.2	0.3	3.6	2.4	1.6	2.5	2.2	153.8	0.4	1.2	9.3	0.5	0.4	0.8	1.3	0.1	0.1	1.4	37.3	1.9	5.1	2.9	0	0	0	0	0	2.4	0	0.7	4.5	6	0	0	0	0	9.1	3.3	6.2	6.6	0	0.5	0	2.9	6.5	9.8	0	5.6	0.2	11.3	0	0.2	0	0.5	3.1	0.2	0	0.5	3.3	0	1.2	0.2	8	0.7	0	0	0	29	1.3	0	0	2	0	0.7	0	29.8	0	0	0	3.9	0.4	0	0	0.1	4.9	13.9	0.2	0	2.1	5	0	7.8	0	0	0	0.1	0	1.9	0	0	0	0	0	2.4	0	0	0.6	0	0	0	0	0	0	0	0	0	0	1.4	2.2	0.3	1.9	1.5	1.7	0.5	1.1	0.3	0.1	0	0	0	0.2	1	1.6	165.8	0	20.1	2.3	0	0	0.1	0	0	0.5	0.5	0	0	0	9.2	0.8	0.2	1.1	0	0.2	1.6	4.6	0	0	1	0	0	1.7	0	3.9	0.6	0.2	0	0.7	0.1	0	6.5	16.2	0.3	7.7	0.9	0.7	0	1.5	0.1	Cardiomyocytes
TSPO2	BZRPL1, dJ34B21.2	ENSG00000112212	Translocator protein 2	Q5TGU0	6	41042554-41044337	Predicted intracellular proteins, Predicted membrane proteins	Transport	Receptor		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in some	7	bone marrow: 32.4	Cell type enriched	Detected in some	84	Erythroid cells: 210.2	Low cancer specificity	Detected in some			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	7	OE19: 15.8	Not detected	Not detected			Low region specificity	Detected in all			HPA060691, HPA066996			Approved	Plasma membrane						Plasma membrane		HPA060691: , HPA066996: AB_2685761	unprognostic (1.89e-3)	unprognostic (8.35e-3)	unprognostic (2.57e-3)	unprognostic (2.29e-2)	unprognostic (1.63e-1)	unprognostic (2.66e-2)	unprognostic (6.61e-3)	unprognostic (2.29e-1)	unprognostic (3.37e-1)	unprognostic (2.89e-1)	unprognostic (2.71e-1)	unprognostic (4.92e-2)	unprognostic (1.86e-2)	unprognostic (2.70e-2)	unprognostic (1.16e-1)	unprognostic (5.37e-2)	unprognostic (1.76e-2)	0.1	0	0.1	0.1	0.1	32.4	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.8	0.1	0.1	0.1	0	0.4	0.1	0.1	0	1.3	2.5	0.4	0.1	0.1	0.1	0.1	0.4	0	0.1	0.9	0.1	0.1	0	0.1	0.1	0.1	0.1	0.3	1.3	0.1	3.3	4.5	1.3	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0	0	0.1	0	0.4	0.2	0	0	0.4	0.1	0	0	0	0	0	0	0	2.3	0	0.1	0.4	0	0	0	0	0	0.1	0.3	0.2	0	0	1.5	0	0.1	0.1	0	0	0	0	0	0	0.6	0.2	0.1	0	0.3	0.2	0.5	0	15.8	0	0.4	0	0	0.3	0.1	0.5	0.2	0	0	0	0.1	0	0.2	0	0	0.1	0.4	0.2	0.8	0.2	0.2	0	0.4	0.1	0	0.1	0	0.4	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0.2	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0	2.5	0	0	0	0	0.1	0	0.7	0.3	0	0.3	210.2	0.8	0.1	0	0	0	0.5	0.1	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1.4	0	0	0	0	0	0	0.3	0	0	0	Erythroid cells
B3GAT2	GlcAT-S	ENSG00000112309	Beta-1,3-glucuronyltransferase 2	Q9NPZ5	6	70856679-70957038	Enzymes, Predicted membrane proteins		Transferase		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in many	9	brain: 27.2	Cell type enriched	Detected in many	9	Horizontal cells: 301.9	Group enriched	Detected in some	20	glioma: 4.7;testis cancer: 1.3	Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Cell line enriched	Detected in some	20	SCLC-21H: 22.7	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA012059	Uncertain											HPA012059: AB_2061050	unprognostic (7.10e-3)	unprognostic (7.81e-2)	unprognostic (1.63e-1)	unprognostic (1.10e-3)	unprognostic (2.21e-1)	unprognostic (1.22e-2)	unprognostic (1.96e-2)	unprognostic (4.88e-2)	unprognostic (4.22e-2)	unprognostic (9.16e-4)	unprognostic (8.09e-2)	unprognostic (7.43e-3)	unprognostic (6.88e-7)	unprognostic (2.72e-2)	unprognostic (3.35e-2)	unprognostic (2.53e-2)	unprognostic (3.45e-3)	1.8	1.5	9.5	1.9	7.8	1.6	1.1	3.2	27.2	0.8	1.1	26.2	0	2.3	1.4	1.1	1.4	1.1	1.4	1.5	19.2	11.5	1	1.3	1.2	2	9.7	13.6	1.1	2.2	0.8	0.5	1.2	21	1.3	0.9	0.4	1.5	0.9	1.5	1.9	2.4	1.1	17.3	2	1.5	2.9	16.3	0	1.5	0	0.9	1.3	0.9	1.2	1	2	1.2	1.1	2.2	0.2	0.3	0	0.6	0.4	0	0	0.3	0.1	0	0	0	0	0.1	0.2	0.1	0	0.1	0.2	0.1	0	0	0.2	1.1	0.1	0.3	0.2	0	0.1	0.4	0	0	0	0	0.2	0	0.6	0.1	0.5	0	0.2	0	0.5	0.7	0.1	0.1	0.2	0.3	0.2	0	0.2	22.7	0.2	0	0.1	0	0.4	0.1	0	0.1	0.1	0.2	0.1	0.3	0.5	0	0.1	0.1	0.1	0.1	1.3	1.2	1.2	1	1	0.9	1	1.5	2.1	0.4	1.2	1.7	1.8	2	1.1	1.1	1	2.2	0.2	9.5	7.8	3.2	11.2	19.2	11.5	9.7	13.6	21	16.3	0	2.1	16.6	7.9	22.7	12.4	0.8	7.6	0	0	15.7	21.6	5.1	0	5	6.6	7.5	11	0	3.3	2.8	10.3	14.9	0	7.7	7	301.9	0	3.7	5.3	4	18.4	11.1	13.5	11.8	4.1	17.1	7.1	7	12.7	0.5	21.5	12.9	8.2	17.4	32.2	17.3	5.9	13.1	3.8	9.9	Horizontal cells
NR2E1	TLL, TLX, XTLL	ENSG00000112333	Nuclear receptor subfamily 2 group E member 1	Q9Y466	6	108166058-108188809	Nuclear receptors, Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	Activator, Developmental protein, DNA-binding, Receptor, Repressor		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in some	6	brain: 19.0	Cell type enriched	Detected in single	50	Muller glia cells: 39.7	Cancer enriched	Detected in single	14	glioma: 6.2	Low region specificity	Detected in many			Cell type enriched	Detected in single	11	neutrophil: 1.0	Lineage enriched	Detected in single	11	granulocytes: 1.0	Cell line enhanced	Detected in some		BEWO: 6.4;GAMG: 3.0;HEK 293: 2.2;RH-30: 1.6;U-251 MG: 8.2	Low region specificity	Detected in many			Low region specificity	Detected in many			HPA036954, HPA055642	Uncertain		Approved	Nuclear bodies						Nuclear bodies		HPA036954: AB_10670958, HPA055642: AB_2682871	unprognostic (3.43e-1)	unprognostic (1.41e-1)			unprognostic (1.77e-1)	unprognostic (9.60e-2)	unprognostic (6.27e-2)	unprognostic (6.00e-1)	unprognostic (1.78e-2)		unprognostic (7.31e-2)	unprognostic (8.64e-2)	unprognostic (9.59e-8)	unprognostic (2.87e-1)	unprognostic (2.49e-1)		unprognostic (3.07e-1)	0.6	1.1	14.5	0.6	16	0.8	0.8	0	19	0.6	0.6	2.8	0	0.7	0.6	0.6	0.6	0.6	0.6	0.7	10.8	4.3	0.9	0.6	0.6	0.7	3.5	7.5	0.7	0.7	0.8	0.1	0.7	0	0.6	0.6	3.3	1	0.6	0.7	0.9	0.6	0.6	0	0.7	0.7	0.8	4.1	0	0.7	0	0.6	0.7	0	0	0	1	0	0	0	0	0.1	0	0	0	0	0	6.4	0	0	0	0	1.2	0	0	0.1	0	3	0.1	0	0	0	0	2.2	1	0.1	0	0	0	0	0	0.1	0	0.2	0.2	0	0.3	0	0	0	0.1	0	0	0	0	0	0	1.6	0	0	0.4	0	0.1	0	0	0	0.2	0.1	0.1	0.1	0	0	0	8.2	0	0	0.1	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	14.5	16	0	10	10.8	4.3	3.5	7.5	0	4.1	0	0	0	0	0	0.8	0.4	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	39.7	0	0	0	0	0.3	0	0	0	0.2	0	0	0	0	0	Muller glia cells
SLC17A2	NPT3	ENSG00000112337	Solute carrier family 17 member 2	O00624	6	25912754-25930726	Predicted membrane proteins, Transporters	Ion transport, Sodium transport, Symport, Transport			Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enriched	Detected in single	333	liver: 80.2	Cell type enriched	Detected in some	12	Hepatocytes: 29.7	Cancer enriched	Detected in some	8	liver cancer: 14.3	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	20	Hep G2: 9.2	Not detected	Not detected			Low region specificity	Detected in single			HPA038270	Uncertain											HPA038270: AB_10672511							prognostic favorable (8.54e-4)						unprognostic (1.90e-2)		unprognostic (4.14e-2)			0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	80.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0.1	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	9.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0.4	0	0.1	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	29.7	0	0	0	0.6	0.3	0	0	0	0	0	0	0	0	0	0	0.8	0	0	0	0	0.4	0	0	0	0	0	Hepatocytes
ADGRG6	FLJ14937, GPR126	ENSG00000112414	Adhesion G protein-coupled receptor G6	Q86SQ4	6	142301854-142446266	Disease related genes, G-protein coupled receptors, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins		G-protein coupled receptor, Receptor, Transducer	Disease mutation	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	4	liver: 51.9;placenta: 104.9	Cell type enriched	Detected in many	5	Hepatocytes: 118.8	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Cell type enriched	Detected in single	13	myeloid DC: 3.5	Lineage enriched	Detected in single	13	dendritic cells: 3.5	Cell line enhanced	Detected in many		A549: 25.7;Hep G2: 24.0;hTERT-HME1: 24.4;HUVEC TERT2: 47.1;MCF7: 44.2	Low region specificity	Detected in many			Low region specificity	Detected in many			HPA017346	Approved								70000000			HPA017346: AB_1849260	unprognostic (1.04e-2)	unprognostic (2.72e-2)	unprognostic (7.37e-2)	unprognostic (3.00e-2)	unprognostic (8.64e-4)	unprognostic (1.67e-1)	unprognostic (2.98e-1)	prognostic unfavorable (8.78e-4)	unprognostic (1.80e-1)	unprognostic (1.26e-1)	prognostic unfavorable (2.78e-5)	unprognostic (4.46e-1)	unprognostic (6.49e-2)	unprognostic (2.15e-1)	unprognostic (1.36e-2)	unprognostic (2.97e-2)	unprognostic (4.59e-2)	5.6	1.4	1.1	4.1	1	0	6.1	0.5	1.1	4.1	14	1	2.7	8.9	2.2	2.8	9.1	2.6	8.8	4.4	1.4	1.1	5.3	51.9	12	2.6	1.9	0.8	1.4	3.1	0.3	0.7	104.9	1.3	7.2	3.3	3.3	6.3	3.6	1.5	7.8	17.5	5	2.3	6.1	6.6	1.5	0.9	2.2	2.1	3.9	4.7	11.3	9.2	0	3.5	0	0.2	0	0.1	0	4.8	25.7	0.5	2.7	0.1	0	0	6.7	1.2	5.1	3.2	20.5	14.9	0	6	3.8	1.4	12.1	0.7	6.4	8.4	0	2	1	4.4	24	5	4	0	0	10.4	0.1	24.4	2.9	47.1	0.1	0.1	0	2	44.2	0	0	0.2	1.7	5.9	0	2.3	5	2.6	10.9	0	0	1.9	9	4.2	4.4	4.9	0	1.6	0	2.3	2.2	3.3	0	0	0	0	0	22.2	0	0	0	0	0.2	0	0	0	0	3.5	0	0.1	0	0	0	0.1	0	0	0	1.1	1	0.5	1.1	1.4	1.1	1.9	0.8	1.3	0.9	6	5.1	0.5	15.4	0	0	1.4	15.3	5.3	14.8	8.7	0	4.8	0	11.5	0	4.4	0.8	0	4.7	24.6	0.6	11.8	0	118.8	2	0	0	16.5	24.7	0.2	0.6	0.6	0	1	0.9	0	22.8	3.6	0.4	10.3	0	6.5	0.5	1.6	5.1	0	11.3	0	1.8	21	Hepatocytes
PTK7	CCK4	ENSG00000112655	Protein tyrosine kinase 7 (inactive)	Q13308	6	43076268-43161719	Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins	Cell adhesion, Wnt signaling pathway	Receptor		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in many			Cell type enriched	Detected in many	6	Early spermatids: 314.6	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enriched	Detected in some	9	plasmacytoid DC: 13.8	Lineage enriched	Detected in many	9	dendritic cells: 13.8	Low cell line specificity	Detected in many			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA003222	Approved				Secreted to blood				10000000			HPA003222: AB_1079713	unprognostic (1.80e-1)	unprognostic (7.49e-3)	unprognostic (6.22e-2)	unprognostic (2.03e-1)	unprognostic (1.65e-1)	unprognostic (1.15e-2)	unprognostic (5.85e-3)	unprognostic (9.81e-3)	unprognostic (1.47e-3)	unprognostic (7.15e-2)	unprognostic (5.11e-3)	unprognostic (8.17e-2)	unprognostic (3.37e-2)	unprognostic (1.73e-1)	unprognostic (3.61e-1)	unprognostic (9.12e-2)	unprognostic (5.70e-3)	5.4	1.8	1.4	3.5	3.4	0.8	12.2	3.5	4.9	30.9	4.8	3.4	8.9	2.1	37.7	36.9	11.7	14.3	14.5	3.5	2.2	3.9	10.1	0.8	18.7	4.3	1.3	2.7	42.6	16.3	9	9	20.9	4.2	18.2	3.3	13.9	15	10.9	0.4	13.6	3.4	16.4	3.2	12.4	4.6	14.9	1.4	28.7	19.3	8.1	6.2	9.5	17.6	0	13.8	0.3	0	0.7	1.5	0.8	2.1	0.6	21.1	35	22.7	23.3	30	22.6	36.5	19.8	25.4	19	7.6	0	17.9	26.3	14.4	24.5	9.4	21.5	12.6	0.1	11.7	2	4.3	25.5	34.5	0	0.1	33.3	19.5	26.1	8.3	34.6	2.5	8.5	1.3	0	9	1.6	7.6	3	9.8	0.2	1.7	7.7	30	0	15.3	10.5	12.1	23	3.6	0.3	11.7	23.2	12.9	4.6	1.6	21.2	13.4	0.1	12.2	0.1	0.2	0.7	4.9	0	3.5	0.3	0	0	0.1	0	0.1	0	0	0.1	0.4	0	0.1	1.5	0.2	0.7	0	13.8	0	0.8	1.4	3.4	3.5	4.9	2.2	3.9	1.3	2.7	4.2	1.4	14.9	12.5	0	16.8	15.3	1.4	1.6	2.5	2.7	6.8	12.2	53	18.9	1.7	19.2	314.6	1	0.2	0	6.2	1.9	31.6	10.9	1.1	0	3.1	0	20.7	1.8	0	38.8	17	1.1	15.1	1	1.2	19.8	8.6	3.5	17.3	0.5	1.7	12.9	9.5	2.4	18.5	9.2	6.9	0.7	2.6	9.7	Early spermatids
WISP3	CCN6	ENSG00000112761	WNT1 inducible signaling pathway protein 3	O95389	6	112054072-112070969	Disease related genes, Predicted intracellular proteins, Predicted secreted proteins		Growth factor	Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in many		epididymis: 9.5	Cell type enriched	Detected in some	9	Early spermatids: 82.4	Low cancer specificity	Detected in many			Group enriched	Detected in some	5	basal ganglia: 2.3;cerebellum: 5.9	Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		RT4: 11.2;THP-1: 3.6;U-2197: 2.6	Not detected	Not detected			Low region specificity	Detected in all			HPA064196			Supported	Mitochondria	Secreted to extracellular matrix					Mitochondria		HPA064196: AB_2685209	unprognostic (2.13e-2)	unprognostic (7.90e-3)	unprognostic (5.00e-2)	unprognostic (2.22e-2)	unprognostic (3.76e-1)	unprognostic (6.52e-2)	unprognostic (1.98e-3)	unprognostic (4.07e-3)	unprognostic (1.82e-1)	unprognostic (3.90e-1)	unprognostic (1.02e-2)	unprognostic (4.81e-2)	unprognostic (1.80e-2)	unprognostic (1.50e-2)	unprognostic (3.11e-1)	unprognostic (4.91e-2)	unprognostic (2.93e-2)	0.4	0.5	0.3	0.4	2.3	0.8	4.2	5.9	0.5	1.9	0.3	0.3	0.3	0.1	0.6	9.5	0.9	3.2	1.4	0.4	0.3	0.5	5.3	0.8	0.4	0.5	0.4	0.3	1.6	0.3	0	0.3	0.4	0.3	1.1	0	0.3	0.6	0.3	0.6	4.8	0.3	0.3	0.4	0.4	0.4	5.8	0.9	0.3	0.3	2.8	2.2	0.3	1.5	1.1	0.6	2	0.5	1.7	1.2	0.2	0.1	0	0.3	1.1	0	0	0.4	0.2	0	0	0	0.2	0.1	0.4	0.2	0	0.1	0.3	0	0	0	0.2	0.9	0.2	0.3	0.3	0	0.6	0.5	0	0	0	0	0.4	0	0.9	0.7	0.3	0.1	0	0.2	0.9	0.4	0.1	0.2	0.3	0.1	0.3	0	11.2	0.5	0.6	0.1	0.2	0.9	0.4	0.2	3.6	0.2	0.2	0.2	2.6	0.3	0.3	0	0.3	0.4	1.1	0.2	1.4	0.4	0.6	0.5	0.3	0.6	0.8	0.9	0.9	0.3	1.1	1.2	1.1	2	1.7	0.5	0.6	0.6	0.2	0.3	2.3	5.9	0.5	0.3	0.5	0.4	0.3	0.3	0.9	0	0	0	2.7	0.7	0.2	2	0	0	0	0	0	0	1.7	0	82.4	0	0	0	0	0.2	0	1.2	0	0	0	0	0	0	0	9.1	0.9	0	0	0	0	0.2	0.2	0	0	0.2	0.2	6.5	0	0.6	0.7	0.6	0.1	0	0	2.1	Early spermatids
CEP72	FLJ10565, KIAA1519	ENSG00000112877	Centrosomal protein 72	Q9P209	5	612272-667168	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	5	Melanocytes: 128.2	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Group enriched	Detected in many	5	B-cells: 3.2;NK-cells: 7.7;T-cells: 3.2	Cell line enhanced	Detected in many		HDLM-2: 27.0;HeLa: 21.8	Region enriched	Detected in single	8	cerebellum: 15.8	Not detected	Not detected			HPA058235, HPA074879	Approved		Supported	Centrosome						Centrosome		HPA058235: AB_2683649, HPA074879: AB_2686720	unprognostic (2.06e-1)	unprognostic (3.15e-2)	unprognostic (1.50e-1)	prognostic unfavorable (2.90e-4)	unprognostic (8.50e-2)	unprognostic (9.74e-2)	unprognostic (2.94e-3)	unprognostic (3.20e-1)	unprognostic (1.58e-2)	unprognostic (1.29e-1)	unprognostic (3.38e-2)	unprognostic (4.38e-3)	unprognostic (1.81e-3)	unprognostic (3.60e-2)	unprognostic (2.93e-1)	unprognostic (4.68e-2)	unprognostic (1.24e-2)	2.5	2.3	4.7	6.5	6.5	7.1	4	7.3	5.9	5.4	3	6.6	2	3.8	4.8	3.1	4.6	4.5	9.1	2.2	4.5	2.7	2.8	4.2	4.8	6.4	3.8	3.5	7.6	6.2	3.7	4.5	4	3.3	3.5	2.5	4.8	4.6	3.2	2.6	6	3.4	4.9	3.3	4	4.9	18.8	4.3	9.4	4.9	2.6	7.9	2.9	3.6	3.2	0.7	0.6	1	7.7	3.2	1.4	4.3	7.2	6.5	9.1	0.6	0.6	11.7	1.9	0.8	4.4	3.8	6.4	6.7	5.2	5	0.8	8.1	4.3	4.5	3.3	1.7	27	7.1	5.7	21.8	2.5	0.8	6.6	3.9	0.7	1.4	3.8	2.5	0.8	1.7	10.3	5.8	6.2	2.1	3.4	9.8	5.8	4.2	3.8	6.8	7.5	3.7	7.2	1.4	3.5	5	3.8	14	4.6	1.2	2.1	4.6	5.1	0.5	4.2	6.2	3.9	2.7	3.9	3.7	5.2	2.6	9.3	4.4	0	0.6	0.6	2.4	0.2	3.2	2.6	2.1	2.2	0.2	3.2	3	3	0	7.7	1	0.7	2.6	1.4	4.7	6.5	7.3	5.9	4.5	2.7	3.8	3.5	3.3	4.3	3	1	1.3	0.9	5	2	2	2.5	4	0	0	0	0.9	0	2.5	2.1	1.1	0.5	0	0.7	4.6	0.8	0.4	0	0.8	1.2	3.2	0	0.6	1.2	1.5	1.1	0.8	128.2	1.8	0.7	0.8	1.6	0	2.5	0.3	2	0	1	25.7	8.5	3.1	1.4	0	1.1	2.4	Melanocytes
HAND1	bHLHa27, eHand, Hxt, Thing1	ENSG00000113196	Heart and neural crest derivatives expressed 1	O96004	5	154474972-154478264	Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	Activator, Developmental protein, DNA-binding		Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level		Tissue enhanced	Detected in some		heart muscle: 25.9;intestine: 35.1;smooth muscle: 14.2	Cell type enriched	Detected in some	8	Cardiomyocytes: 13.6	Group enriched	Detected in some	5	colorectal cancer: 0.6;testis cancer: 2.8	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	11	SH-SY5Y: 36.0;SuSa: 67.0	Not detected	Not detected			Not detected	Not detected			HPA040925	Uncertain		Uncertain	Nucleoplasm,Nuclear membrane						Nucleoplasm	Nuclear membrane	HPA040925: AB_10796563			unprognostic (2.37e-2)					unprognostic (8.29e-2)		unprognostic (2.46e-3)	unprognostic (7.23e-2)				unprognostic (5.21e-2)		unprognostic (6.38e-3)	0.2	6	0.1	9.7	0.1	0	0.1	0.1	0.1	0.1	35.1	0	0	4.4	0.1	0	0.1	0.1	5.3	25.9	0.1	0.1	0.1	0.1	0.1	0	0.1	0	0.1	0.1	0	0.2	3.6	0	5.4	2.6	0.1	0.1	0	0.1	0.1	20.8	14.2	0.1	0.1	0.1	0.2	0	0.7	0.1	0	0	9.1	0.2	0	0	0	0.1	0	0	0	0	0	0	0	0	0	4.8	0	0	0	0	0	0	0	0	0.1	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	36	0	0	0	67	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0	0.1	0	13.6	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0.4	1.1	0	0	0	0.1	0	0	0	0	0	0	0	1.7	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.9	0	0	0	Cardiomyocytes
PCDHB3	PCDH-BETA3	ENSG00000113205	Protocadherin beta 3	Q9Y5E6	5	141100473-141103827	Predicted intracellular proteins, Predicted membrane proteins	Cell adhesion			Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		pituitary gland: 17.3	Cell type enriched	Detected in some	4	Horizontal cells: 7.9	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		EFO-21: 12.4;HAP1: 3.8;SH-SY5Y: 16.5;U-138 MG: 5.8	Low region specificity	Detected in all							HPA050296	Uncertain		Supported	Vesicles						Vesicles		HPA050296: AB_2681078	unprognostic (2.72e-2)	unprognostic (7.47e-4)	unprognostic (1.22e-1)	unprognostic (1.95e-4)	unprognostic (9.34e-3)	unprognostic (3.42e-2)	unprognostic (2.29e-2)	unprognostic (3.17e-1)	unprognostic (1.37e-1)	unprognostic (3.34e-1)	unprognostic (8.52e-3)	unprognostic (3.45e-2)	unprognostic (1.82e-2)	unprognostic (2.37e-3)	unprognostic (1.24e-1)	unprognostic (1.82e-2)	unprognostic (5.18e-4)	5.7	4.6	3.1	2.6	9.3	0.4	5.9	3.8	6.2	4.8	2.5	2.2	1.3	1.4	8	3	1.3	3.1	3.1	3.6	3.8	3	4.9	0.8	3.3	1	3	3.8	5.6	3.9	4.4	17.3	1.8	4	5.4	2.1	3.4	2.4	2.4	1.9	2	2.1	3.8	3	1.5	1.8	11.6	2	0	2.1	2.3	0.7	2.4	3.8	0	0	0	0	0	0	0	0	0	1.2	3.4	2.1	0.4	0.5	0.4	0	0	0	0	0	0	12.4	0.2	1.8	0	3.8	0.1	0	0.3	0	0	0.1	0	0	0	0.4	0.2	0	0	0	0.1	0	0	0	0.7	1.3	0	0.5	0	0.2	0	0	0.1	0.7	0	0	0	0.6	16.5	0	0.2	0	0.6	2.1	0.1	0	5.8	0.8	0.6	0.3	0.3	0	0	0.3	0	1.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.1	9.3	3.8	6.2	3.8	3	3	3.8	4	2	0	0	0	0.1	0	1.1	0.4	0	0	0	0	2	0	1.7	0.3	0.7	0.6	0	0	0.2	0	0.5	0.6	0	0	0	7.9	0	0.6	0	0	0.6	0	1.7	0	0	0.8	0.5	0	0.7	0	0.2	0	0.5	1.4	0.9	0.3	0	0	0	0.3	Horizontal cells
PCDHB6	PCDH-BETA6	ENSG00000113211	Protocadherin beta 6	Q9Y5E3	5	141150022-141153287	Predicted membrane proteins	Cell adhesion			Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level		Tissue enhanced	Detected in many		parathyroid gland: 13.4	Cell type enriched	Detected in some	7	Spermatocytes: 9.9	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		EFO-21: 16.9;SH-SY5Y: 7.2;T-47d: 5.4;U-2197: 7.6;WM-115: 10.5	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA029566, HPA075308	Uncertain		Approved	Nucleoplasm						Nucleoplasm		HPA029566: AB_10601385, HPA075308: 	unprognostic (3.25e-2)	unprognostic (1.54e-2)	unprognostic (1.81e-1)	unprognostic (8.05e-2)	unprognostic (7.65e-3)	unprognostic (2.82e-1)	unprognostic (1.73e-3)	unprognostic (9.64e-3)	unprognostic (8.62e-2)	unprognostic (1.54e-3)	unprognostic (2.28e-2)	unprognostic (6.33e-2)	prognostic unfavorable (5.52e-4)	unprognostic (8.60e-4)	unprognostic (2.31e-2)	unprognostic (7.08e-3)	unprognostic (6.52e-2)	2.5	2.4	3.9	1	5.1	0.4	2.5	4.2	8.4	2.3	1.5	2.6	0	0.6	4.5	3.7	0.7	2.1	1.4	1.6	3.5	1.9	1.6	1.4	1.7	0.7	2.6	3.6	3.7	1.5	13.4	6.4	1.5	2.9	1.5	0.9	0.7	2.5	1.5	1.4	2.4	1	3	3.3	1.5	0.9	5.4	3.1	0	1.1	1	0.7	1.8	1.7	0	0	0	0	0	0	0	0	0.4	0.3	0.1	0.2	0	0	0.2	0.2	0	0	0	0	0	16.9	0.2	1.3	0	0.1	0	0	0	0	0	0	0.2	0	0	0.2	0.1	0.1	0	0	0.2	0	0	0	1.2	0.2	0	0	0	0	0.4	0	0	0	0	0.2	0	0.3	7.2	0	0.1	3.6	0.4	5.4	2.2	0	0.6	1.3	7.6	0	0	0	0	3.9	0	10.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.9	5.1	4.2	8.4	3.5	1.9	2.6	3.6	2.9	3.1	0	0	0	0	0	0.6	0.2	0	0	0	0	0	0	0	0	0.4	0.4	0	0	0.7	0	0.2	0.1	0	0	0	0	0	0	0	0.4	0	0	0	0	0	1.4	0	0	0.4	0	0.2	0	1.2	9.9	0.1	0.4	0	0	0	0	Spermatocytes
GRM6	CSNB1B, GPRC1F, mGlu6, MGLUR6	ENSG00000113262	Glutamate metabotropic receptor 6	O15303	5	178978327-178996206	Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins	Sensory transduction, Vision	G-protein coupled receptor, Receptor, Transducer	Congenital stationary night blindness, Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	8	retina: 22.0	Cell type enriched	Detected in some	31	Bipolar cells: 422.6	Not detected	Not detected			Low region specificity	Detected in some			Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Low cell line specificity	Detected in some			Not detected	Not detected			Not detected	Not detected			HPA014511	Enhanced											HPA014511: AB_2669025	unprognostic (1.85e-1)	unprognostic (1.54e-1)	unprognostic (8.41e-2)	unprognostic (1.27e-1)	unprognostic (4.16e-1)	unprognostic (2.25e-3)	unprognostic (7.72e-2)	unprognostic (2.32e-2)	unprognostic (2.12e-3)	unprognostic (6.27e-2)	unprognostic (3.34e-4)	unprognostic (2.58e-1)	unprognostic (3.36e-4)	unprognostic (1.23e-1)	unprognostic (6.45e-2)	unprognostic (7.59e-3)	unprognostic (1.97e-1)	0.3	0.5	0.6	0.4	0.6	1.6	0.3	1.9	1.6	0.4	0.4	0.3	0.3	0.3	0.6	0.5	0.3	0.5	0.7	0.4	0.5	1.2	0.4	0.4	0.4	0.5	0.8	0.3	0.7	0.9	0.1	2.9	0.3	1.2	1.1	0.1	22	0.6	0.3	1.3	1.8	0.3	0.3	0.3	0.5	0.3	2.2	0.3	0.3	0.9	0.3	0.3	0.3	0.3	0.9	1.1	2.4	0.4	0.6	0.6	0.1	0.5	0.3	0.7	1.3	0.3	0.1	0.7	0.2	0	0.1	0	0.5	0.9	0.9	0.6	0	0.6	0.7	0	0.1	0	0.2	0.7	0.5	0.7	1	0.2	0.8	1	0.1	0.3	0.1	0.5	0.3	0	0.9	0.9	1.7	0	1	0.2	0.8	0.6	0.5	0.6	0.6	0.3	0.8	0.1	0.6	0.9	1.2	0.5	0.7	0.5	1.1	0.9	1.1	0.9	0.5	0.5	0.4	0.5	0.7	0.6	0.4	0.4	0.7	0.3	1.9	0.4	0.5	0.6	0.3	0.4	0.4	0.4	0.3	0.2	0.9	0.4	0.4	2.4	0.6	0.2	1.1	0.2	0.1	0.6	0.6	1.9	0.5	0.5	1.2	0.8	0.3	1.2	0.3	0	0.3	0	0.1	0.3	422.6	1.4	0	0	0	0	2	0	0	0	0.8	0.5	0	0	0	0	0	0.3	0	0	0.1	3.2	0	0	0	0.9	0	0.2	0	1	0	3.7	0.1	0	0	0	13.7	0	0	0.5	0	0	0.1	0	0	0.1	Bipolar cells
THBS4		ENSG00000113296	Thrombospondin 4	P35443	5	79991311-80083287	Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Cell adhesion, Tissue remodeling, Unfolded protein response	Growth factor, Mitogen	Cancer-related genes	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		adipose tissue: 69.8;heart muscle: 59.0;skeletal muscle: 61.7;smooth muscle: 94.0	Cell type enriched	Detected in many	9	Sertoli cells: 485.0	Low cancer specificity	Detected in all			Low region specificity	Detected in many			Cell type enriched	Detected in single	51	eosinophil: 8.0	Lineage enriched	Detected in single	51	granulocytes: 8.0	Cell line enhanced	Detected in some		AF22: 5.1;SCLC-21H: 4.0;THP-1: 10.9;U-2 OS: 4.7;U-266/70: 4.2	Low region specificity	Detected in some			Not detected	Not detected			CAB004597, HPA042426	Approved		Approved	Vesicles	Secreted to extracellular matrix				420000000	Vesicles		CAB004597: AB_628352, HPA042426: AB_2677992	unprognostic (1.41e-1)	unprognostic (5.33e-2)	unprognostic (4.26e-3)	unprognostic (3.64e-2)	unprognostic (9.94e-2)	unprognostic (8.10e-2)	unprognostic (5.64e-2)	unprognostic (7.12e-2)	unprognostic (1.66e-1)	unprognostic (2.25e-1)	unprognostic (2.06e-1)	unprognostic (2.14e-1)	unprognostic (1.96e-3)	unprognostic (2.74e-2)	unprognostic (3.98e-2)	unprognostic (1.76e-3)	prognostic unfavorable (3.33e-4)	69.8	1	7.6	2.1	8.3	3.7	9.7	0.8	4.6	1.1	21.4	2.6	1.2	1.3	12.2	13.6	6.5	1.4	4.1	59	6.4	6.4	0.8	0.6	1	0.9	8.5	1.9	2.1	23	5.5	7.8	0.6	10.7	3.7	3.7	4.9	19.8	2.6	61.7	1.5	1.4	94	11.5	0.6	4	5.5	2.6	2	9.9	39.3	4.1	3.4	2.7	0.1	0	8	0	0	0.1	0	0.2	0	5.1	0.3	0.4	2.2	0.5	0.1	0.2	1.5	0.5	0.1	0.6	0.2	0.2	0.4	1.3	0.2	0.2	0.6	1.3	0.2	0.7	0.5	0	0.3	2.8	0	0.1	1.6	0.3	0.1	0.3	0.5	0	0.1	0	0.3	0.3	0.7	0.1	0.1	3.9	0	0.1	0	1.6	0	0.4	0.1	4	1.2	0.1	0	0.4	2.3	0	10.9	0	0.1	4.7	0.3	0.3	4.2	0.1	0.7	1.8	3.5	0.9	0	0	8	0	0	0	0	0.1	0	0	0.1	0	0.1	0	0	0	0	0	0	7.6	8.3	0.8	4.6	6.4	6.4	8.5	1.9	10.7	2.6	0	0.6	0	0	0.2	1.2	5	0	0	1.2	3.5	53	0	0	0.1	28	2.2	0	0	0	0	2.7	0.8	0	0	0.1	1.6	8.6	0.6	0	3.2	0.9	0	1.7	0	0	1.9	0	0	41.1	0.6	1.9	485	2.2	16.9	1.4	0.9	0	0	0	0	Sertoli cells
BTNL8	BTN9.2, FLJ21458	ENSG00000113303	Butyrophilin like 8	Q6UX41	5	180899077-180950906	Predicted membrane proteins	Adaptive immunity, Immunity			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Group enriched	Detected in some	9	blood: 57.9;intestine: 111.7	Cell type enriched	Detected in some	4	Enterocytes: 87.2	Group enriched	Detected in some	12	colorectal cancer: 2.6;liver cancer: 1.5;pancreatic cancer: 2.8;stomach cancer: 3.9	Not detected	Not detected			Cell type enriched	Detected in some	13	neutrophil: 57.9	Lineage enriched	Detected in single	213	granulocytes: 57.9	Group enriched	Detected in some	28	CACO-2: 22.3;OE19: 31.8									HPA039738	Enhanced											HPA039738: AB_2676656	unprognostic (4.31e-1)	unprognostic (6.85e-6)	unprognostic (6.99e-2)	unprognostic (1.48e-1)	unprognostic (6.33e-2)	unprognostic (1.91e-1)	unprognostic (6.27e-3)	unprognostic (6.07e-2)	unprognostic (3.08e-3)	unprognostic (3.28e-1)	unprognostic (1.67e-1)	unprognostic (9.02e-2)	unprognostic (4.96e-3)	unprognostic (2.93e-1)	unprognostic (1.42e-1)	unprognostic (4.43e-1)	unprognostic (1.17e-2)	1.1	0.2	0.1	2.2	0.4	2.3	0.5	0.3	0.7	0.2	37.6	0.1	0.1	43.8	0.2	0.2	0.2	0.6	9.3	0.3	0.3	0.1	0.4	0.3	1.9	2	0.3	0.2	0.2	0.5	0	0.2	0.2	0.5	0.1	9.7	0.4	0.1	0.1	0.3	0.1	111.7	0.1	0.5	2.2	2.5	3.5	0.3	0.3	0.9	0.2	0.1	0.1	0.7	0	0	57.9	0.2	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	22.3	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0.1	0	0	0	0.5	0.2	31.8	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0.9	0	0.1	0.2	0	0	0.2	4.6	0	0	0	0	0	0	0	0	0	0	57.9	0	0.1	0	0	0	0.1	0.4	0.3	0.7	0.3	0.1	0.3	0.2	0.5	0.3	0	0	0	0	0	0	0.8	10.2	1.4	0	0	0	0	0	0.1	0.2	0.1	87.2	0	2.4	0	0	0	0	0	0.6	0	3.5	15.4	5.3	0	0	0	0	0	21.5	0	0.4	20.1	0	0	0	0	0	0	0.2	0	0	0	9.2	0	Enterocytes
GABRG2		ENSG00000113327	Gamma-aminobutyric acid type A receptor gamma2 subunit	P18507	5	162000057-162162977	Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters	Ion transport, Transport	Chloride channel, Ion channel	Disease mutation, Epilepsy, FDA approved drug targets	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	6	brain: 47.1	Cell type enriched	Detected in some	4	Bipolar cells: 81.7	Cancer enhanced	Detected in single		glioma: 1.4	Low region specificity	Detected in all			Cell type enhanced	Detected in many		basophil: 7.3	Group enriched	Detected in many	5	B-cells: 2.9;granulocytes: 7.3;T-cells: 3.2	Cell line enhanced	Detected in many		CACO-2: 10.6;RPMI-8226: 10.2;SuSa: 11.4;U-266/70: 17.8;U-266/84: 14.1	Low region specificity	Detected in all			Low region specificity	Detected in all			CAB079060		Supported										CAB079060: 					unprognostic (2.88e-2)			unprognostic (1.56e-2)			unprognostic (6.31e-3)			unprognostic (3.07e-3)	unprognostic (1.52e-1)			1.1	5.7	9.7	1.2	28.8	3.3	0.9	21.7	47.1	0.7	1.5	1.1	0	2.2	1.2	1.3	1.3	1.3	3.8	1.6	10.6	19.6	1	1.2	1.9	1.2	7.5	19.1	1.5	1	0.8	5.3	2.9	17.6	1	1.3	0.6	1.3	0.8	1.2	3.3	1.9	1.6	2.6	1.2	3.3	1.7	1.8	0	1.8	0	1.3	1.5	0.3	2.9	0.7	7.3	0.3	0.9	3.2	0.2	3.6	1.7	1.9	0.3	0	0	2	0.6	0	0	0	10.6	4.7	0.7	5.2	0	0.4	1.6	1.2	0	0	0.8	1.1	0	2.1	1.3	0	0.2	0.5	0.3	0	0	0	0.5	0	1	1.8	8.5	0	2.5	0.4	0.1	6.1	3.4	2.9	0.4	0.1	10.2	0	3.4	0.9	0.8	0.3	0.6	3.4	11.4	5.6	5.7	0.2	0.3	4.5	0.3	0.5	17.8	14.1	0.5	0.2	0.4	0.4	7.3	0.3	0.6	0.4	0.3	2.7	2.9	0.7	0.6	0	2.5	3.2	0.7	1.6	0.9	0.2	0.7	0.6	0.2	9.7	28.8	21.7	38.1	10.6	19.6	7.5	19.1	17.6	1.8	17.9	19.7	0	0	0	81.7	0.2	0	12	19.4	0	11.8	0	0	0	0	0	0	0	0	0	0	0	8.1	0	0.1	15.9	0	0	0	0	0	0	0	0	0	1.4	0.1	0	0	0	8.4	0	0	0	1.1	0	0	0	0	0	Bipolar cells
SLC12A7	DKFZP434F076, KCC4	ENSG00000113504	Solute carrier family 12 member 7	Q9Y666	5	1050376-1112035	Plasma proteins, Predicted membrane proteins, Transporters	Ion transport, Potassium transport, Symport, Transport			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	7	Horizontal cells: 265.4	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		REH: 25.3	Low region specificity	Detected in many			Low region specificity	Detected in many			HPA041652	Approved		Uncertain	Cytosol						Cytosol		HPA041652: AB_10793971	unprognostic (2.22e-2)	unprognostic (1.56e-1)	unprognostic (8.92e-2)	unprognostic (2.86e-1)	unprognostic (1.69e-2)	unprognostic (8.72e-2)	prognostic unfavorable (2.12e-6)	unprognostic (1.67e-1)	unprognostic (1.71e-3)	unprognostic (4.40e-2)	unprognostic (4.50e-2)	unprognostic (3.44e-2)	unprognostic (1.65e-3)	unprognostic (1.17e-3)	unprognostic (1.26e-1)	unprognostic (3.93e-2)	prognostic favorable (3.16e-5)	10.1	6.4	5.7	14.1	7.3	4.3	13	2.4	8.3	6.5	11.5	5.6	6.6	28	7.2	7.6	4.7	8.9	29.4	27.9	6.1	3.8	20.4	31.3	10	10.3	5.8	3.2	8.5	12.4	8.2	11.5	3.8	7.9	10.2	7	15.5	10.9	8.7	3.2	7.9	20.3	8.2	4.9	17.9	15.2	14.5	7.4	12.2	13.3	5.5	6.9	7.1	34.5	1.4	4.2	0.5	6.9	2.5	2.7	2.2	2.1	6	3.3	10.4	0.5	0.5	5.2	0.1	0.7	0.5	0	14.3	3.8	0	11.8	0.2	4.1	4.4	2.7	3.6	0	13	3.6	2.8	7.5	4.9	7.6	0	6.3	1.1	0.5	0	1.1	0.2	3.3	1.3	4	0.1	0	6.9	8.4	0	7.2	8.4	9.6	25.3	14.4	11.8	4	8.7	1.8	2.3	3.2	0	3.6	2.1	5.8	1.6	2.8	0	3.4	0	0	0.2	0	1.4	0	0.4	1.7	0.5	3.4	0	2.5	5.4	2.6	1.1	2.4	2.7	4.2	1.4	2.5	2.5	0	2.5	6.9	1.8	2.4	2.2	5.7	7.3	2.4	8.3	6.1	3.8	5.8	3.2	7.9	7.4	8.9	17.5	5.4	5.2	6.3	17.7	32.1	40.8	10.7	14.8	27.9	2	0.2	1.7	23	0.3	14.9	28.8	0	15.7	0.3	7.3	14.6	8.1	29.2	15.8	265.4	12.7	9.2	20.4	1.3	3.4	12.2	15.1	1.8	16.5	6.6	28	17.5	5.3	26.1	2.9	19.4	7.2	0.7	4.5	5.9	0.2	3.3	14.2	13.2	Horizontal cells
IL5	EDF, IL-5, TRF	ENSG00000113525	Interleukin 5	P05113	5	132541444-132556838	Cancer-related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins		Cytokine, Growth factor	Cancer-related genes, FDA approved drug targets	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in some		blood: 3.8;testis: 10.6	Cell type enriched	Detected in some	9	Spermatocytes: 24.7	Not detected	Not detected			Low region specificity	Detected in some			Cell type enriched	Detected in single	6	memory B-cell: 3.8	Lineage enriched	Detected in single	6	B-cells: 3.8	Cell line enhanced	Detected in some		CACO-2: 2.5;HEK 293: 2.2;Hep G2: 7.2;TIME: 3.4	Low region specificity	Detected in single			Low region specificity	Detected in all			CAB010304	Approved				Secreted to blood			4130				CAB010304: AB_2296159	unprognostic (1.66e-1)	unprognostic (4.76e-2)	unprognostic (5.30e-3)	unprognostic (2.35e-1)	unprognostic (9.07e-2)		unprognostic (7.98e-2)	unprognostic (2.03e-2)		unprognostic (3.51e-2)	unprognostic (1.97e-1)	unprognostic (1.44e-2)	unprognostic (1.53e-1)	unprognostic (2.09e-1)	unprognostic (5.27e-2)	unprognostic (5.84e-3)	unprognostic (1.91e-1)	0.1	0.1	0.3	0.3	1	0	0.1	0.3	1.3	0.2	0.1	0	0	1	0.5	0	0.1	0.7	1.1	0.4	1	0.3	0.1	0.3	0.1	0	0.3	0	0.2	0.1	0	2	0	0.9	0.1	0.3	0	0.1	0	0.1	0.1	1.8	0.1	0.3	0.1	0.3	10.6	0	0.4	0.7	0	0.2	0.2	0.2	3.8	0.6	0	0	0	0.5	0	0	0	0	0.6	0	0	0	0	0	0	0	2.5	0.8	0	0.6	0	1	0	0	0	0	0.1	2.2	0	0.2	7.2	0	0	0	0	0.9	0	0	0	0	0.9	0.6	0.8	0	0	0	0	0.2	1	0	0.5	0.1	0	0	0	0.6	0.1	0	0	0	0	0	0	3.4	0	0.3	0	0.4	0.9	0.4	0.8	0	0.2	0.8	0	0	0	0.5	0	0	3.8	0.2	0	0	0	0	0	0	0	0	0.6	0	0	0.3	1	0.3	1.3	1	0.3	0.3	0	0.9	0	0	0	0	0	0.2	1.1	0	0	2.7	0	0	0	0	0	0	0.6	0	0	0	0	0	0	0	2.3	0	0	1.6	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	24.7	0.7	0.1	0	0	0	0	Spermatocytes
LIFR	CD118	ENSG00000113594	LIF receptor alpha	P42702	5	38474963-38608354	Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins		Receptor	Cancer-related genes, Disease mutation	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in many			Cell type enriched	Detected in many	6	Ito cells: 765.5	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in many		AF22: 40.6;HHSteC: 17.3;SCLC-21H: 26.6	Low region specificity	Detected in all			Low region specificity	Detected in all								Intracellular and membrane				74000				unprognostic (6.00e-3)	unprognostic (2.53e-1)	unprognostic (1.05e-1)	unprognostic (2.81e-3)	unprognostic (8.80e-2)	unprognostic (7.13e-2)	unprognostic (1.11e-1)	prognostic favorable (1.92e-4)	unprognostic (1.78e-1)	unprognostic (9.80e-2)	unprognostic (2.73e-3)	unprognostic (1.06e-1)	prognostic favorable (1.40e-7)	unprognostic (3.69e-2)	unprognostic (1.15e-1)	unprognostic (2.03e-2)	unprognostic (1.65e-1)	35.3	14.7	15.8	8.2	19.2	0.5	33.9	10.1	21.3	27.7	10.4	25.3	22.8	4.9	34.8	14.8	10.4	26	10.2	16.3	19.1	11	20.3	23.9	21.7	20.2	24.3	11.8	17.9	17.8	13.5	12.5	41.5	23.4	23.6	7.5	17.1	24.9	24.7	24	10.5	11.7	26.9	21.4	22.5	18.8	9.3	25.3	4.7	31.4	7.3	8.1	13.6	15.8	0	0	0	0	0	0.2	0	0.6	2.3	40.6	3	11.4	12.7	0.3	3.4	1.9	2.7	1.7	0.4	2.2	0	0.5	4.8	6.9	0.3	2.6	0.9	4.7	0	3.7	0	4.3	1.6	17.3	0	0.2	10.6	0.7	6.6	0.7	2.6	3.8	0.4	1.1	6.5	3.4	0.5	0	0.1	1	0	7.2	0	8.6	0	2.6	1	26.6	3.3	14	0.7	0	5.3	0.9	0	0.8	4.4	8.7	10.3	2	0	0	0	7.2	0	2.5	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	15.8	19.2	10.1	21.3	19.1	11	24.3	11.8	23.4	25.3	11.9	34.9	9.3	5.9	20.6	5.8	24.6	10.2	10.7	10.3	14	7.9	7.7	5	1.9	12.6	122.5	0	0	7.8	22.5	46.1	21.1	1.1	6.8	3.2	1.6	0	765.5	62	21.6	105.3	2.6	16.9	0	0	5.1	6.9	0	18.7	13.5	35.3	38.8	42.2	8.9	6.1	15.8	23.9	7.5	0	4.7	Ito cells
C9		ENSG00000113600	Complement C9	P02748	5	39284262-39424868	Disease related genes, Plasma proteins, Predicted secreted proteins	Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Innate immunity		Age-related macular degeneration, Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	577	liver: 419.5	Cell type enriched	Detected in some	39	Hepatocytes: 1782.7	Cancer enriched	Detected in single	244	liver cancer: 90.4	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	5	JURKAT: 15.0	Not detected	Not detected			Not detected	Not detected			CAB002151, HPA029577	Uncertain				Secreted to blood			69600000000	97000000000			CAB002151: AB_563670, HPA029577: AB_10603779	unprognostic (1.00e-1)	unprognostic (1.57e-1)	unprognostic (1.50e-1)		unprognostic (2.01e-1)	unprognostic (6.58e-2)	unprognostic (1.30e-1)	unprognostic (2.91e-1)	unprognostic (5.49e-3)		unprognostic (1.91e-2)	unprognostic (1.29e-2)	unprognostic (2.19e-2)	unprognostic (9.43e-5)	unprognostic (1.36e-1)	unprognostic (1.80e-1)	unprognostic (2.04e-1)	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0	0	0	419.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0.5	0	0.3	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0.2	0	0	0	0.1	0	0	0	0	0	0.1	0	0	0	1.2	0	0	0	0	0	0	0	15	0.1	0	0.1	0	0.4	0	0	0	0	0	0.7	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	3	0	0.1	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14	0	0	0	0.3	22.9	0	0	0	0	0	1.7	0	0.5	0	0	23.3	0	0	0.4	0	0	1782.7	0.9	0	0	46.1	41.4	0	0	0	0	0	0	0	0	0	0	1.8	0	0	0	2.1	1.4	0	0.2	1.3	0	0	Hepatocytes
PDGFRB	CD140b, JTK12, PDGFR, PDGFR1	ENSG00000113721	Platelet derived growth factor receptor beta	P09619	5	150113837-150155872	Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins	Chemotaxis	Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase	Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in many			Cell type enriched	Detected in many	5	Sertoli cells: 1267.6	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enhanced	Detected in some		gdT-cell: 2.9;non-classical monocyte: 4.1	Group enriched	Detected in many	8	monocytes: 4.1;T-cells: 2.9	Group enriched	Detected in some	4	ASC diff: 173.0;ASC TERT1: 59.9	Low region specificity	Detected in all			Low region specificity	Detected in all			CAB003842, CAB018144, HPA028499	Enhanced		Supported	Golgi apparatus,Vesicles					35000000	Vesicles	Golgi apparatus	CAB003842: AB_562328, CAB018144: AB_2162497, HPA028499: AB_10602018	unprognostic (4.75e-2)	unprognostic (2.48e-1)	unprognostic (5.21e-2)	unprognostic (3.60e-2)	unprognostic (3.27e-1)	unprognostic (5.61e-2)	unprognostic (1.02e-1)	unprognostic (3.36e-2)	unprognostic (2.12e-2)	unprognostic (2.57e-3)	unprognostic (6.72e-2)	unprognostic (1.25e-1)	prognostic unfavorable (5.87e-8)	unprognostic (3.13e-3)	unprognostic (1.25e-2)	unprognostic (5.47e-2)	prognostic unfavorable (8.11e-4)	61.8	10.4	8.3	11	9.1	0.5	66.1	4.6	10.4	73.1	15.7	6.7	6.9	5.1	44.3	17.3	21.7	26.1	51.7	24.2	8.2	3.9	17	4.6	28.9	21.5	7.9	8.1	46.5	7.5	10.4	7.7	46.4	7.7	24.2	6.3	22.9	11.2	19.3	29.8	20.3	11.2	29.8	5	19.6	9.2	21.5	6.7	1.4	21.4	16	7.3	23.6	35.1	0.4	0.1	0	4.1	0	2.9	0.6	0	0	1	0	173	59.9	0.4	6	25.1	4.2	7.1	0.6	0	0	0.8	17.3	2.4	0	0	0	2	0	0	0	0.4	0.4	24.5	0	0	27	0	5.8	0	13.5	0	0	0	0.6	0.6	0	0	0	1.1	0	0	0.4	0.3	0	0	0	0	3.2	0	0	0	5	0	0	0	6.8	2.2	2.9	0.3	0	0	0	4.2	0	0.1	0	0	0	2.9	0.6	0	0.4	0.1	0.8	0.1	0.1	0	1.3	0	0	4.1	0	0	0.6	8.3	9.1	4.6	10.4	8.2	3.9	7.9	8.1	7.7	6.7	0	0.6	0	0.5	21.3	5	13.4	0	1.4	0	1.8	3.9	0.6	0	0	0.8	16.2	0	0	0	1	68.8	0.6	0	1.5	1.4	0	0	6.7	0	4.7	153.1	2.2	23.6	1	0	74.9	0.1	0	191.6	0	1.1	1267.6	273.4	1.1	1.5	13.4	0.7	1	0.4	0.9	Sertoli cells
HRG	HPRG, HRGP	ENSG00000113905	Histidine rich glycoprotein	P04196	3	186660216-186678240	Disease related genes, Plasma proteins, Predicted secreted proteins	Angiogenesis, Blood coagulation, Chemotaxis, Fibrinolysis, Hemostasis	Heparin-binding	Disease mutation, Thrombophilia	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	205	liver: 425.4	Cell type enriched	Detected in some	17	Hepatocytes: 394.5	Cancer enriched	Detected in some	262	liver cancer: 406.7	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HEL: 1.8;HL-60: 5.9;RH-30: 6.9;RPTEC TERT1: 1.7;SiHa: 2.4	Not detected	Not detected			Not detected	Not detected			HPA050269, HPA054598	Supported				Secreted to blood			120000000000	30000000000			HPA050269: AB_2681068, HPA054598: AB_2682539		unprognostic (2.67e-1)		unprognostic (1.74e-2)		unprognostic (7.58e-5)	prognostic favorable (9.64e-5)	unprognostic (1.44e-1)		unprognostic (2.98e-3)	unprognostic (2.22e-1)		unprognostic (1.55e-2)	unprognostic (1.14e-1)	unprognostic (5.50e-2)	unprognostic (1.05e-1)	unprognostic (1.46e-2)	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	2	425.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	1.2	0.8	0	0.2	0.1	0	0	0	0	0	1.8	0	0	0	5.9	0.4	0	0	0	0	0	0	0.2	1.1	0	0	0	0	0	0.3	0.7	0	0	6.9	0	1.7	0	0	0	2.4	0	0	0	0	0	0.6	0	0.1	0	0	0.8	0	1.1	0	1.4	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	7	0	0	0	0.1	2.5	0	0	3.5	0	0	5	0	0	0	0	23.3	0	0	0	0	0	394.5	0	0	0	13.5	15.4	0	0	0	0	0	0	0	0	0	0	1.9	0	0	0	0	0	0.1	0.1	0.5	0	0	Hepatocytes
CLDN16	HOMG3, PCLN1	ENSG00000113946	Claudin 16	Q9Y5I7	3	190322541-190412143	Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters	Ion transport, Transport		Disease mutation, Primary hypomagnesemia	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	16	kidney: 55.9	Cell type enriched	Detected in many	7	Distal tubular cells: 159.2	Group enriched	Detected in many	15	ovarian cancer: 39.8;thyroid cancer: 29.6	Not detected	Not detected			Low cell type specificity	Detected in some			Low lineage specificity	Detected in single			Group enriched	Detected in some	131	EFO-21: 101.3;RPTEC TERT1: 35.6	Not detected	Not detected			Not detected	Not detected			HPA056020	Enhanced											HPA056020: AB_2683011	unprognostic (5.01e-2)	unprognostic (7.83e-3)	unprognostic (1.96e-1)	prognostic unfavorable (1.99e-5)	unprognostic (6.06e-4)	unprognostic (1.30e-1)	unprognostic (2.07e-1)	unprognostic (2.39e-2)	unprognostic (3.31e-1)	unprognostic (4.20e-1)	unprognostic (2.76e-3)	unprognostic (3.70e-1)	unprognostic (1.96e-1)	unprognostic (5.76e-2)	unprognostic (8.08e-2)	unprognostic (1.62e-2)	unprognostic (1.15e-1)	0.2	0.8	0.4	0.2	0.3	0	0.2	0.2	0.5	0.3	0.2	0.2	0.2	0	0.2	0.2	0.2	1.6	0.2	0.2	0.3	0.4	55.9	1.2	0.2	0.7	0.3	0.2	0.2	0.2	0	0.2	0.2	0.2	0.2	0	0.2	0.6	0.5	0.2	1.8	0.2	0.2	0.2	0.2	0	0.2	0.2	0.4	3.4	0.2	0.4	0.3	0.2	0.5	0.4	1.4	0.2	0.3	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	101.3	0	0	0.1	0	0	0	0.1	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	35.6	0.1	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0.2	0.1	0.5	0	0	0	1.4	0.1	0.2	0.2	0.2	0.1	0.4	0.2	0.1	0	0.5	0.3	0.2	1.2	0.3	0.2	0.4	0.1	0	0.4	0.3	0.2	0.5	0.3	0.4	0.3	0.2	0.2	0.2	0	0	0	4.8	6.3	0.2	0.3	5.1	22.7	1.2	8.7	0	0.2	159.2	2.2	0.6	0	0	0	0.3	0.1	0.3	1.2	1.1	1.5	0.1	3.2	0	0	0.3	0	0	1	5	0	0	0	0.4	0	0.4	0.6	0.1	0	0	0.1	0.1	11	5.1	0	0	3.1	Distal tubular cells
GRK7	GPRK7	ENSG00000114124	G protein-coupled receptor kinase 7	Q8WTQ7	3	141778148-141818490	Enzymes, Predicted intracellular proteins	Sensory transduction, Vision	Kinase, Serine/threonine-protein kinase, Transferase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		blood: 2.4	Cell type enriched	Detected in some	168	Cone photoreceptor cells: 310.2	Not detected	Not detected							Cell type enhanced	Detected in single		neutrophil: 2.4	Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		BEWO: 4.1;HeLa: 1.5;U-937: 1.8					Not detected	Not detected			HPA075093, HPA078232	Enhanced		Approved	Mitochondria						Mitochondria		HPA075093: , HPA078232: 	unprognostic (1.11e-1)	unprognostic (1.70e-2)	unprognostic (3.35e-3)	unprognostic (1.22e-2)	unprognostic (1.13e-1)	unprognostic (1.60e-1)	unprognostic (1.39e-2)	unprognostic (5.08e-2)	unprognostic (1.21e-1)	unprognostic (1.31e-2)	unprognostic (3.46e-2)	unprognostic (1.20e-1)	unprognostic (2.53e-8)	unprognostic (3.08e-1)	unprognostic (1.99e-1)	unprognostic (3.11e-1)	unprognostic (2.91e-1)	0.2	0.5	0.3	0.5	0.4	1.5	0.2	0.9	0.3	0.2	0.1			0.4	0.3	0	0.3	0.3	0	0.2	0.3	0.3	0.2	0	0.2	0.2	0.2		0.6	0.3	0.7	0.2	0.2		0.3	0		0.4	0.2	1.6	1.5	0.4	0	0.2	0.4	0.1	1			0.1		0.3	0.1	0.3	0.7	0.2	2.4	0.4	0.5	0.6	0.1	0	0.1	0.1	0.6	0.4	0	4.1	0.1	0	0	0.1	0.2	0.6	0.2	0.2	0.1	0	0.1	0.1	0	0.1	0.5	0.5	0.2	1.5	0.2	0	0.4	0.3	0.1	1.1	0	0.1	0	0	0.3	0.2	0.2	0	0.2	0.2	0.7	0.4	0.2	0.2	0.2	0.1	0.2	0	0.5	0.3	0.4	0.2	0	0	0.2	0.5	0.2	0.2	0.2	0.2	0	0	0.2	0	0.2	0.1	1.8	0.2	0.2	0.4	0.3	0.4	0.2	0.6	0.6	0.5	0.3	0.1	0.7	0.5	0.5	2.4	0.5	0.3	0.2	0.2	0.1											0	0	0	0.1	0.3	1	0.2	0	0	0	0	310.2	0	0	0	0.9	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	1.8	0	0	0	0	0	1	0.1	0	0	0	1.3	0	0	0	0	0.3	0	0	0	0	Cone photoreceptor cells
BCHE	CHE1, CHE2, E1	ENSG00000114200	Butyrylcholinesterase	P06276	3	165772904-165837472	Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins		Hydrolase, Serine esterase	Disease mutation, FDA approved drug targets	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	6	liver: 145.4	Cell type enriched	Detected in many	10	Hepatocytes: 360.7	Group enriched	Detected in many	6	glioma: 24.0;liver cancer: 13.7;melanoma: 18.9	Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	9	Karpas-707: 131.7	Low region specificity	Detected in all							HPA001560	Approved				Secreted to blood				13000000000			HPA001560: AB_1078271	unprognostic (4.74e-2)	unprognostic (2.00e-1)	unprognostic (9.21e-4)	unprognostic (8.19e-8)	unprognostic (2.66e-2)	prognostic unfavorable (1.06e-4)	unprognostic (1.44e-1)	unprognostic (5.04e-2)	unprognostic (6.15e-2)	unprognostic (9.59e-2)	unprognostic (5.15e-2)	unprognostic (3.65e-2)	unprognostic (3.18e-3)	unprognostic (4.46e-5)	unprognostic (2.17e-2)	unprognostic (5.92e-2)	unprognostic (4.26e-4)	14	3.9	6.7	6.2	4.3	0.4	1.9	3.6	9.1	24.4	15.5	4.7	8.3	1.8	20.2	13.4	20	18	2.2	7.8	6.1	4.4	2.8	145.4	3.7	0.7	5.5	2.7	10.3	1.1	0.4	1.2	0.5	4.7	4.7	5.3	0.7	1	10.5	1.1	2.8	6.4	13.9	3.4	3.7	1.9	1.8	6.1	1	0.8	0.4	0.5	9.7	2.9	0	0	0	0	0	0	0	0	0.4	14.3	0	0	0	0	0	0.2	0.1	1.2	0	0	0	5.4	0	0	0.1	0.9	0	1	0	0.1	0	0	0	1.1	0	0	4.2	0.2	0	1.4	4.4	0.6	5.2	0	131.7	0	0	0	0	0.3	0	0.1	0	4.8	10.9	0.1	0	0	0.1	0	0	7.5	0	5.8	0	0	3.2	0	0	1.3	0.5	0	0.2	1.3	0	14.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	6.7	4.3	3.6	4.3	6.1	4.4	5.5	2.7	4.7	6.1	0	0	0	0.3	4.8	0.9	4.3	12.7	0	0	0	0	0	0	0	22.1	1.5	0	0	0	0	2.2	0.2	0	360.7	0.1	1.6	0	6.2	5.3	5.5	2	0	18.6	0	0	34.4	0	0	0	2.9	1	0	4.6	0.3	0.1	3	0	0	0	0.1	Hepatocytes
FGF12	FGF12B, FHF1	ENSG00000114279	Fibroblast growth factor 12	P61328	3	192139395-192767764	Disease related genes, Predicted intracellular proteins		Growth factor	Disease mutation, Epilepsy	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	6	adrenal gland: 21.5;brain: 31.9;heart muscle: 75.7	Cell type enriched	Detected in many	5	Cardiomyocytes: 381.1	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		AF22: 11.8;NTERA-2: 8.1;SCLC-21H: 18.9;U-251 MG: 11.3;WM-115: 13.7	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA071557			Approved	Nucleoplasm,Cytosol						Nucleoplasm	Cytosol	HPA071557: AB_2686417	unprognostic (1.67e-3)	unprognostic (1.29e-1)	unprognostic (2.26e-2)	unprognostic (2.50e-5)	unprognostic (1.75e-1)	unprognostic (5.66e-2)	unprognostic (1.04e-1)	unprognostic (1.80e-1)	unprognostic (8.03e-2)	unprognostic (2.11e-2)	unprognostic (4.00e-2)	unprognostic (9.19e-2)	unprognostic (1.87e-7)	unprognostic (2.41e-2)	unprognostic (5.36e-2)	unprognostic (5.59e-2)	unprognostic (5.99e-2)	1.2	21.5	8.8	0.7	15.8	0.6	1	17.7	31.9	0.9	0.9	1.9	0	1	1.2	0.7	1.5	1.5	0.9	75.7	6.8	4.1	2	0.9	1.2	0.7	5.1	15.8	1.1	4.9	0.7	2.9	0.8	22.3	1.3	0.8	1.1	3.6	4.2	1.1	0.7	0.7	1	2.7	6.8	0.9	1.7	2.8	0	1.4	0	0.7	0.8	0.8	1.1	0.3	1.2	0.4	0.5	0.4	0.1	0	0.8	11.8	0	0	0	0.1	0	0.1	1.1	1.4	0	0.1	0.6	5.7	0.2	0.2	0.1	0	0	1.3	0.1	0.1	2.4	5	0	0	0	0.7	0	0.2	0	0	2.9	0.1	0	0	0.1	0	3.3	0	0	8.1	5.4	0.2	0	0.1	0	3.7	1.4	18.9	0	0	0.4	0	1.4	0.9	0.2	0.3	4.9	2.5	0	11.3	0.1	1.8	0	1	0	13.7	1.2	0.2	0.5	0.2	0.3	0.4	1.1	0.2	0.2	0.1	0.5	0.4	0.3	0.6	0.5	0.4	0.3	0.3	0.1	8.8	15.8	17.7	31.9	6.8	4.1	5.1	15.8	22.3	2.8	0	0	0	4.3	0.6	77.1	381.1	0	1.4	3.4	5.2	3.9	0.1	6.6	0.7	15.9	4.9	0	0	11.4	0.2	0.8	1	0	0	0.1	31.8	0	8.6	0.3	21.4	6.4	0	1.7	0	0	2.9	4	0.2	1.1	0.2	13	0	0.5	2.1	6.1	0.1	0	0	0	1.4	Cardiomyocytes
GNAT1	CSNBAD3	ENSG00000114349	G protein subunit alpha transducin 1	P11488	3	50191612-50196516	Disease related genes, Predicted intracellular proteins	Sensory transduction, Vision	Transducer	Congenital stationary night blindness, Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	39	retina: 171.9	Cell type enriched	Detected in some	7	Rod photoreceptor cells: 1622.9	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		Hep G2: 1.4;MCF7: 2.4;RT4: 2.6;SCLC-21H: 1.1	Not detected	Not detected							HPA045393	Enhanced											HPA045393: AB_2679310	unprognostic (3.08e-1)	unprognostic (1.81e-1)		unprognostic (8.56e-3)	unprognostic (3.32e-2)	unprognostic (2.13e-1)	unprognostic (7.72e-2)	unprognostic (2.82e-3)		unprognostic (6.10e-2)				unprognostic (1.07e-1)	unprognostic (1.87e-1)	unprognostic (3.02e-1)	unprognostic (9.48e-3)	0.3	0.5	0.3	0	0.3	0.1	0	0.1	1.3	0	0	0	0	0	0.1	0	1.1	0.1	0.2	0	0.3	0.3	0.1	0.7	0.2	0	0.2	0	0	0	0	0.4	0	0	0	0	171.9	0	0	0	0.8	0	0	0.5	0	0.1	4.3	0	0	0	0	0	0	0	0	0	0	0	0	0.8	0	0	0	0.5	0.1	0	0	0	0	0.1	0	0	0.5	0	0	0.3	0	0	0	0.1	0	0	0	0	0	0.8	1.4	0	0	0.1	0	0	0	0	0	0.1	0	0	0	0	2.4	0	0	0	0	0	0	0	0	0	2.6	1.1	0	0	0.5	0	0.1	0.1	0	0	0	0.3	0	0.3	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.8	0	0	0	0	0	0	0.3	0.3	0.1	0.3	0.3	0.3	0.2	0	0	0	0	0	0	0	0	177.2	0.3	0	0	0	0	227.8	0	0	0	10.8	0	0	0	0	0	0	0	0	0	0	85.8	0	0	0	26.2	0.6	0	0	0	0	228.8	0.1	0	0	0	1622.9	0	0	1.7	0.4	0	0.1	0	0	0.1	Rod photoreceptor cells
HHLA2	B7-H5, B7H7, B7y	ENSG00000114455	HERV-H LTR-associating 2	Q9UM44	3	108296490-108378285	Predicted intracellular proteins, Predicted membrane proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	15	intestine: 125.2	Cell type enriched	Detected in many	5	Enterocytes: 168.4	Group enriched	Detected in many	12	colorectal cancer: 9.2;lung cancer: 5.0;pancreatic cancer: 5.1;renal cancer: 16.6;stomach cancer: 6.2	Not detected	Not detected			Cell type enhanced	Detected in some		myeloid DC: 5.1	Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		HDLM-2: 8.1;Karpas-707: 5.9					Low region specificity	Detected in all			HPA055478	Enhanced											HPA055478: AB_2682830	unprognostic (1.12e-2)	unprognostic (2.29e-1)	unprognostic (1.03e-1)	unprognostic (3.11e-1)	unprognostic (2.30e-1)	unprognostic (1.59e-2)	unprognostic (8.14e-5)	unprognostic (1.76e-1)	unprognostic (2.28e-1)	unprognostic (1.08e-1)	unprognostic (6.42e-3)	unprognostic (1.24e-1)	unprognostic (1.62e-3)	unprognostic (1.47e-1)	unprognostic (2.31e-1)	unprognostic (2.67e-1)	unprognostic (1.66e-2)	0.2	0.2	0.3	4.3	0.3	0	0.2	0.2	0.3	0.3	39.6	0.2	0.2	25.5	0.2	0.5	0.2	0.9	8.5	0.2	0.3	0.3	7.8	0.4	2.2	0.2	0.3	0.2	0.6	1.2	0	0.3	0.2	0.2	0.2	25.2	0.2	0.2	0.2	0.2	0.1	125.2	0.3	0.5	0.3	2.5	1.9	0.2	0.2	0.2	0.2	0.3	0.2	0.2	0.3	5.1	1.2	1.5	0.3	0.5	0.7	0.4	0.6	0.4	0.5	0	0	1.6	0.1	0	0	0.5	3.5	0.5	0.3	0.4	0.1	0.2	0.4	1.2	0	0	8.1	0.3	0.2	2.7	0.5	0	1.7	1	0	0	0	0	0.1	0.1	0.7	0.7	5.9	0	0.5	0.8	3	1.2	0.4	0.6	0.7	0.3	1.7	0.1	0.4	1.5	1.4	1.4	0.1	0.4	1.1	0.3	0.4	0.3	0.3	1.5	0.5	0.4	3.1	1.4	0.8	0.1	1	0.2	1.2	0.3	1.1	0.1	0.4	0.1	0.3	0.2	0.5	5.1	0.3	0.2	0.1	0.5	0.3	1.5	0.1	0	0.7	0.3	0.3	0.2	0.3	0.3	0.3	0.3	0.2	0.2	0.2	0	1.3	0	0.1	0	0	0.1	20.4	24.1	2.3	0	0	0	0	5.2	2.6	0	168.4	0	32	0.1	0	0.1	2.3	0	0.1	0	1.7	0	0	3.1	0.3	0.2	0	1.8	9.4	0	36.5	9.5	0	19.5	0	0	0	0.7	0.2	0	0.1	0	13.6	0	Enterocytes
PEX5L	PEX5R, PXR2, TRIP8b	ENSG00000114757	Peroxisomal biogenesis factor 5 like	Q8IYB4	3	179794958-180037053	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	5	brain: 41.9;parathyroid gland: 60.1	Cell type enriched	Detected in some	10	Cone photoreceptor cells: 237.6	Cancer enhanced	Detected in some		glioma: 0.9	Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	4	HDLM-2: 5.8;MOLT-4: 20.2;RPMI-8226: 16.1;SCLC-21H: 9.9;U-266/70: 13.0	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA058026	Enhanced											HPA058026: AB_2683582	unprognostic (5.21e-2)	unprognostic (1.52e-1)	unprognostic (1.53e-1)	unprognostic (1.36e-2)	unprognostic (2.93e-1)	unprognostic (1.82e-3)	unprognostic (2.68e-2)	unprognostic (1.52e-2)	unprognostic (2.10e-1)	unprognostic (3.33e-4)	unprognostic (9.67e-5)	unprognostic (3.84e-1)	unprognostic (2.66e-10)	unprognostic (2.27e-3)	unprognostic (1.45e-2)	unprognostic (1.69e-2)	unprognostic (4.03e-3)	1.3	1.4	17	1.3	26.6	1.2	1.2	1.8	41.9	1.3	1.2	24.5	0	1.3	1.2	1.5	1.3	1.4	1.2	1.3	16.9	8.1	1.3	1.2	1.3	1.2	38.4	18.9	2.9	10.6	60.1	5.3	1.1	24.1	1.4	1.2	0	1.3	1.2	1.4	1.2	1.3	1.1	32.3	1.2	1.3	5.4	36.5	0	1.3	0	1.2	1.2	0.4	0.8	0.4	0.8	0.1	0.4	0.6	0	0	0	0.1	0.1	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0.1	1.8	0	5.8	0	0	0.1	0	0	1.1	0.1	0.1	0	0	1	0.5	0	0.5	0	2.9	0	0	20.2	0	1.2	0	0.2	0.1	0	16.1	0	0	9.9	0.6	0	0	0	0	0	1.6	0	2.1	0.1	0	0.5	13	0.4	0	0.3	0.1	0.5	0.6	0.1	0.2	0.6	0.1	0.5	0	0.1	0	0	0.8	0.2	0.3	0.8	0.4	0.1	0.4	0	0	17	26.6	1.8	26	16.9	8.1	38.4	18.9	24.1	36.5	0	0	0	0.2	0	6.9	2.8	0	0	0	0	237.6	0	0	0	23.1	0.4	0	0	0.5	0	0.2	0.3	0	0	0.1	9.5	0	0	0	15.4	0.3	0	0	1	0	2	0	0	0	0	9.8	0	0	0.7	0.9	0.3	0	0	0	0	Cone photoreceptor cells
AADAC	CES5A1, DAC	ENSG00000114771	Arylacetamide deacetylase	P22760	3	151814037-151828488	Enzymes, Predicted intracellular proteins		Hydrolase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		adrenal gland: 66.2;intestine: 81.7;liver: 123.1	Cell type enriched	Detected in some	10	Hepatocytes: 610.4	Cancer enriched	Detected in many	22	liver cancer: 153.4	Region enriched	Detected in single	7	basal ganglia: 1.6	Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		A549: 11.9;ASC diff: 4.5;EFO-21: 6.4;HBEC3-KT: 5.7	Not detected	Not detected							HPA002911	Approved											HPA002911: AB_1078074	unprognostic (1.26e-1)	unprognostic (1.82e-2)	unprognostic (8.11e-2)	unprognostic (4.41e-2)		unprognostic (9.23e-2)	unprognostic (7.82e-2)	unprognostic (2.15e-1)	unprognostic (9.89e-2)	prognostic favorable (5.58e-6)	prognostic unfavorable (5.02e-4)			prognostic unfavorable (2.19e-4)	unprognostic (1.22e-1)		unprognostic (1.27e-1)	3.9	66.2	0.1	0.1	1.6	0	2.1	0.1	0.1	0.1	26.1	0.5	0.4	29.6	0.1	0.3	0.3	0.2	4.3	0.2	0.1	0	0.1	123.1	1.7	0.1	0.1	0.1	0.1	22.7	0	0.1	1.7	0.2	0.3	0	0.1	0.3	0.1	0.2	1.7	81.7	0.1	0.1	0.1	7.3	0.3	0.1	0.1	0.2	4.8	1.3	0.6	0.1	0	0	0.2	0	0	0	0	0	11.9	0	0	4.5	0.2	0.3	0	0	0.1	0	1.1	0.1	0.2	6.4	0	0.1	0.4	0	5.7	0	0	0	0	0	0.5	0.4	0.7	0.1	0.1	0.1	0.6	0	0.1	0	0	0	0	0.1	0	0.2	1.3	0.2	1.4	0.3	0.2	0.4	2.1	0	2.3	0.2	1.9	0.3	0.1	0	0	0	0	2.5	0	2.4	1.4	0	0.4	0	0.5	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0.1	1.6	0.1	0.1	0.1	0	0.1	0.1	0.2	0.1	0	11	0	0	0.2	0	1.1	58.6	4	12.5	0	0	0	0	0	0	0	0	0	44	0	0.2	0	0	610.4	0.2	0	0	3.7	10.8	0	0	0	3.3	0	0	0	3.7	0	0	0	0	0	0	0	0.1	3	0.2	0	0	0.1	Hepatocytes
ARHGEF26	DKFZP434D146, SGEF	ENSG00000114790	Rho guanine nucleotide exchange factor 26	Q96DR7	3	154121003-154257827	Predicted intracellular proteins		Guanine-nucleotide releasing factor		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in many			Cell type enriched	Detected in many	4	Alveolar cells type 1: 315.6	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in many		RH-30: 10.0;U-251 MG: 18.1	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA017722, HPA049195	Approved		Supported	Nucleoplasm,Plasma membrane,Cytosol						Plasma membrane	Nucleoplasm, Cytosol	HPA017722: AB_1856800, HPA049195: AB_2680671	unprognostic (1.41e-1)	unprognostic (1.43e-3)	unprognostic (3.55e-1)	unprognostic (7.99e-3)	unprognostic (2.82e-1)	unprognostic (9.42e-3)	prognostic favorable (9.74e-4)	unprognostic (7.06e-2)	unprognostic (1.16e-1)	unprognostic (6.01e-5)	unprognostic (1.44e-3)	unprognostic (4.36e-2)	unprognostic (2.22e-1)	unprognostic (5.53e-3)	unprognostic (3.11e-1)	unprognostic (1.07e-1)	unprognostic (5.24e-3)	11.2	4	9.1	5.8	8.7	1	9.8	5.6	17.8	9.2	20	6.5	3.3	10.3	5.9	3.1	12	8.3	17.6	4.1	8.7	4.6	3.1	22	18.6	1	5.4	6.3	5.3	27.1	13.9	2.9	4.7	12.2	5.3	3.7	4.4	4.1	5.5	1.5	7	11.5	12.7	9.7	1.6	12.3	7.4	5.5	0	4.1	2.5	2	7.4	11.4	0	0.3	0	0.5	0	0.1	0	5.3	3.1	6.1	4.2	2.7	0.4	0.1	0.3	0	1.6	1.8	2.5	0.4	2.5	0.4	0.1	2.8	6.3	3.1	1.5	2.8	0	8.1	0	2.3	0.8	2.5	0.8	0.1	0.9	0.1	1.9	0.3	0.9	0.1	2.6	0	0	1	6.2	1.1	0.1	3.9	1.2	2.7	0	10	0	0.5	3.5	2.3	0.7	0.7	8.8	1.3	3.3	5.4	0.4	0	0.9	4	0	18.1	2.6	0.4	0	1.6	0	6.2	0	0.1	0	0	0.5	0	0	0	0	0.3	0	0.1	0	0	0	0.1	0	0	0	9.1	8.7	5.6	10.1	8.7	4.6	5.4	6.3	12.2	5.5	315.6	29.8	0.9	7.9	17.3	9.4	1.2	20.4	21.4	17	3.5	3.9	1.4	0	1.9	9.1	3	2.6	0	2.2	1	8.1	6.7	4.7	44.5	0.6	4.8	0	8.6	2.8	1.7	9.8	0.9	3.3	1.8	4.5	70.3	1.7	2.9	17.7	0	50.2	0	4.2	2.9	32.4	20.7	5.1	5.7	1.7	5.3	Alveolar cells type 1
PLCH1	DKFZp434C1372, KIAA1069, MGC117152, PLCeta1, PLCL3	ENSG00000114805	Phospholipase C eta 1	Q4KWH8	3	155375580-155745067	Enzymes, Predicted intracellular proteins	Lipid degradation, Lipid metabolism	Hydrolase, Transducer		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 14.7;testis: 15.8	Cell type enriched	Detected in many	6	Early spermatids: 148.2	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Cell type enhanced	Detected in single		MAIT T-cell: 1.2	Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		A549: 8.4;AF22: 27.2;NTERA-2: 14.5	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA036176, HPA057978	Uncertain		Enhanced	Vesicles						Vesicles		HPA036176: AB_10671837, HPA057978: AB_2683569	unprognostic (1.08e-2)	unprognostic (3.68e-1)	unprognostic (2.17e-2)	unprognostic (1.55e-2)	unprognostic (3.50e-4)	unprognostic (6.41e-2)	unprognostic (2.94e-5)	unprognostic (5.04e-2)	unprognostic (2.41e-1)	unprognostic (2.24e-3)	unprognostic (4.84e-2)	unprognostic (1.76e-2)	prognostic favorable (3.03e-5)	unprognostic (3.28e-2)	unprognostic (1.62e-1)	unprognostic (1.47e-1)	unprognostic (1.37e-2)	0.3	0.3	3.9	0.7	14.1	0.5	3.9	7.4	14.7	2.1	3.9	5.7	4.1	3.9	1.4	12.9	0.5	12.4	2.4	2.5	4.5	3.6	2.1	0.4	6.1	0.3	3.4	7.3	0.5	2.5	0.8	3.2	0.8	6.5	0.8	3.9	5.6	2.3	3.4	0.6	0.5	3.9	0.5	1.9	0.3	5.8	15.8	2.9	0	8.9	0	0.4	1.3	0.4	0.1	0.3	0.7	0	0	1.2	0.9	0	8.4	27.2	1	0	0	0	0	0	0.2	0.1	1.6	6.7	0	0.6	0	0.1	0	4.8	0	0	0	2.5	6.8	0	0.9	0	4	0	0	0	0	0	0.1	0	2.2	0.2	0	0	2.9	1.6	6.2	14.5	0.9	1.1	0.6	0	0	1.7	0.1	2.5	0.6	0	6.5	0	4.2	2.9	0	0	0	0.1	0	1.1	0.3	0	0	0	0.9	0.2	0	0	0	0	0	1.2	0.1	0	0.2	0	0	0	0	0.7	0	0	0.3	0	0.9	3.9	14.1	7.4	14.7	4.5	3.6	3.4	7.3	6.5	2.9	3	12.8	0	0.3	0	10	0.5	7.6	25.4	3.4	1.8	3.9	0	0	1.9	148.2	0.1	2.4	0	2	0.2	0	0.1	0	0	0.2	23.8	2.9	0	0.3	10	1.1	0	0	0	4.3	19.3	1.5	2.9	0.4	1.9	3	0	0	2.1	1.1	0.1	0	0	4.7	0.1	Early spermatids
TNNC1	TNNC	ENSG00000114854	Troponin C1, slow skeletal and cardiac type	P63316	3	52451102-52454070	Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins		Muscle protein	Cardiomyopathy, Disease mutation, FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	7	heart muscle: 431.6;skeletal muscle: 765.7	Cell type enriched	Detected in many	8	Cardiomyocytes: 2506.5	Low cancer specificity	Detected in many			Not detected	Not detected			Cell type enhanced	Detected in some		MAIT T-cell: 4.0	Lineage enriched	Detected in single	7	T-cells: 4.0	Cell line enhanced	Detected in some		CACO-2: 24.3;CAPAN-2: 12.2;EFO-21: 24.4;HeLa: 16.0;Hep G2: 16.2;HSkMC: 25.3;U-2 OS: 37.5	Region enriched	Detected in many	4	cerebral cortex: 88.3	Not detected	Not detected			CAB002450, HPA044848, HPA056897	Enhanced		Approved	Nucleoplasm,Actin filaments,Mitochondria					260000	Nucleoplasm, Actin filaments, Mitochondria		CAB002450: AB_564152, HPA044848: AB_2679110, HPA056897: AB_2683269	unprognostic (2.18e-2)	unprognostic (1.70e-1)	unprognostic (8.66e-2)	unprognostic (3.43e-1)	unprognostic (4.00e-2)	unprognostic (1.88e-2)	unprognostic (1.11e-1)	unprognostic (1.43e-1)	unprognostic (1.53e-1)	unprognostic (3.92e-1)	unprognostic (1.03e-1)	unprognostic (1.07e-1)	unprognostic (2.15e-2)	unprognostic (4.95e-2)	unprognostic (2.31e-1)	unprognostic (4.15e-2)	unprognostic (4.86e-1)	2	0.3	0.1	0	0.1	0	0.7	0.2	0.1	0.2	0.1	0	0	0	0.1	17.8	12.8	0.1	0	431.6	0.1	0.1	0.6	0.1	2.6	0	0.1	0	0.1	0.2	0	0.6	0.2	0.5	5.5	0.1	0.7	10.4	0	765.7	0.4	0.1	0.1	0.7	0.1	0.1	0.7	0	0	3	86.9	8.7	0.4	0.2	0.2	0.6	0	0	0	4	0.5	0.2	1.8	1.3	0.2	0	0.2	2.9	0.1	0.1	0.1	0.1	24.3	12.2	0.2	24.4	3.5	0	0.1	0	0.1	0	0.4	0.6	0.1	16	16.2	0.1	0.1	0	25.3	0.4	0	0.2	0.2	0	0.7	0	1.9	0.7	0	0	0.2	0.2	5.4	0.2	0	1	0.8	1.2	4.6	0	0	0.1	2.5	0	1.5	9.8	0.2	0	0	37.5	0.3	0	1	0.4	0.3	0.1	0.2	0	0	0	0	0.7	0	4	0.2	0.9	0.5	0	0.1	1.4	0.5	0	0	0	0.6	2.5	0.5	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0	0.5	0	116.1	13	0	0.6	1.3	0.2	2506.5	0	0	7.9	3.5	2	44.2	23.2	6.6	0.6	0	0.7	0	11.8	4	14	0.6	0	0.6	4.1	0	318.5	0.6	0	3.6	20.8	1	5	0	0.3	1.5	4.4	0	166.9	0.5	0	0	15.5	1.2	0.4	0.6	26	0.8	1.5	4.1	Cardiomyocytes
EPB41L5	BE37, FLJ12957, KIAA1548, YMO1, YRT	ENSG00000115109	Erythrocyte membrane protein band 4.1 like 5	Q9HCM4	2	120013005-120179119	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	4	Alveolar cells type 1: 202.5	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		CACO-2: 25.1;MCF7: 37.6	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA037563, HPA037564	Uncertain		Enhanced	Plasma membrane						Plasma membrane		HPA037563: AB_2675546, HPA037564: AB_2675547	unprognostic (1.27e-2)	unprognostic (2.15e-1)	unprognostic (2.56e-2)	unprognostic (2.31e-1)	unprognostic (3.33e-2)	unprognostic (1.47e-2)	unprognostic (1.53e-1)	unprognostic (9.06e-3)	unprognostic (5.93e-2)	unprognostic (8.76e-2)	unprognostic (2.20e-2)	unprognostic (9.51e-2)	prognostic favorable (2.28e-6)	unprognostic (1.99e-1)	unprognostic (3.88e-1)	unprognostic (9.59e-2)	unprognostic (2.61e-1)	4.6	5	7.4	6	11.6	1.1	13.3	19.4	12.6	7.4	8.6	6.9	4.3	10.6	7.2	4.9	7	10.2	6.2	4.9	8.5	7.4	25.6	42.3	36.3	3.8	7.6	6.5	9.4	20.3	13	15.8	7.5	12.2	9.9	7	7.1	10.8	6.6	8.6	6.6	9.5	7.5	14.8	2.2	7	22	6.1	2.9	25.2	6.4	5	5.3	8.4	4.7	0.4	1.8	1.4	1.5	3.2	1.4	8	2.7	11.2	8.6	7.8	5.7	9.7	1.7	1.7	3.6	3.3	25.1	5.4	0.1	6.1	2.1	4.6	5.5	15	6.8	5.4	1.6	4.6	2.3	1.3	14	9.1	1	2.5	5.1	13	6.8	4.9	3.2	10.2	4.8	5.4	0.6	7.2	37.6	1.9	3.5	10	3.7	2.6	0	3.3	2.2	11.4	7.8	5.8	11.1	7.6	13.5	3.7	16	6.5	1.9	8.4	0.3	5.4	5.7	1.7	0.8	1.5	4.2	0.9	0	2.1	0.3	1.4	1.5	1.1	0.3	0.3	4.7	1.2	1.1	0.4	3.6	3.2	2.4	1.8	1.5	0.9	0	0.5	1.4	7.4	11.6	19.4	12.6	8.5	7.4	7.6	6.5	12.2	6.1	202.5	30.3	2.9	19.7	21.8	31.4	12	15.3	20.1	25	31.4	23.6	11.9	18.3	15.8	22.4	5.8	17.7	0	19.5	10	13.3	24	0	47.8	2.7	7.9	14.9	16.5	1.9	16.2	8.3	3.3	13.5	1	10.2	18.1	20.4	17.3	8.9	23.7	33.6	19.4	7.7	33.8	43.9	19.1	22.1	2.5	9.7	30.4	Alveolar cells type 1
REEP6	C19orf32, DP1L1, FLJ25383, Yip2f	ENSG00000115255	Receptor accessory protein 6	Q96HR9	19	1490747-1497927	Disease related genes, Predicted membrane proteins			Disease mutation, Retinitis pigmentosa	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		intestine: 90.8;liver: 119.0;testis: 71.2	Cell type enriched	Detected in many	5	Late spermatids: 2546.7	Cancer enhanced	Detected in all		liver cancer: 114.0	Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		CACO-2: 16.1;Hep G2: 15.4;K-562: 42.7;T-47d: 35.7	Not detected	Not detected			Low region specificity	Detected in many			HPA003895, HPA048015	Enhanced		Supported	Endoplasmic reticulum					26000	Endoplasmic reticulum		HPA003895: AB_1845723, HPA048015: AB_2680233	unprognostic (1.21e-1)	unprognostic (1.56e-1)	unprognostic (7.76e-2)	unprognostic (1.63e-3)	unprognostic (3.24e-1)	unprognostic (2.43e-2)	unprognostic (1.92e-1)	unprognostic (6.85e-2)	unprognostic (7.38e-2)	unprognostic (4.56e-1)	unprognostic (1.49e-1)	unprognostic (1.93e-1)	unprognostic (1.40e-2)	unprognostic (2.17e-1)	unprognostic (8.08e-2)	unprognostic (2.83e-1)	unprognostic (5.38e-2)	2.4	20.1	4.1	0.7	5.9	0.6	3.9	3.1	6	1.4	41.7	2.8	4.4	60.2	1	5.7	2.7	1.4	7.6	0.9	4.5	1.9	6.1	119	0.6	0.7	2.6	2.1	1.7	10.1	0.5	2.2	0.7	2.1	4.9	0.7	27.4	5.6	11.8	0.7	1.7	90.8	1.1	1.6	0.6	1.3	71.2	1.1	0.3	1.6	1.1	2.1	3.2	1.2	1	4.2	0.1	4.8	5.8	7.1	2.3	2	2.5	0.8	10.5	1.6	0.5	11.7	0.5	0.1	0.5	0.5	16.1	6.6	1.1	3.7	0.3	0.7	2.1	2.7	0.1	0.2	0.5	1.1	6.1	0.3	15.4	1.2	0.4	2	1.3	1.1	0	0.3	0.9	0.3	1.4	42.7	1.5	0.1	8.1	0.5	1.3	3.9	5.9	5.7	1.6	0.3	2.7	3	0.9	0.2	5.8	2.8	4.1	1.7	0.4	35.7	1.6	0.9	0.8	1.7	2.5	0.4	5.1	1.4	0.1	3.6	2.6	2.3	0	1.5	0	7.1	1.7	3.8	0.1	2.1	1.5	2.5	1	2.8	3.2	0.1	5.8	4.8	4.2	2	2.3	4.1	5.9	3.1	6	4.5	1.9	2.6	2.1	2.1	1.1	3	2.7	3.4	6.8	6.1	23.2	1.6	86.6	5.3	6.8	5.2	31.4	55	6.6	28.9	512.6	2.8	17	0	61.1	7.5	2.5	15.7	10.3	229.1	8.2	22.3	5.8	4.3	5.7	2546.7	31.7	4.3	28.7	1.8	10.4	27.6	24.6	6	15.6	36	217.9	19.4	2.6	24.2	30.4	5.8	30.1	5.1	11	11.2	Late spermatids
GCG	GLP-1, GLP1, GLP2, GRPP	ENSG00000115263	Glucagon	P01275	2	162142873-162152404	Predicted secreted proteins		Hormone		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	16	pancreas: 202.8	Cell type enriched	Detected in some	14	Intestinal endocrine cells: 5260.0	Cancer enriched	Detected in some	209	pancreatic cancer: 428.4	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	5	EFO-21: 38.0;U-2 OS: 54.1	Region enriched	Detected in single	10	pons and medulla: 3.7	Region enhanced	Detected in single		midbrain: 2.0	CAB000040, HPA036760, HPA036761	Enhanced		Approved	Endoplasmic reticulum,Vesicles	Secreted to blood			127000		Endoplasmic reticulum	Vesicles	CAB000040: AB_10013726, HPA036760: AB_2675296, HPA036761: AB_2675297			unprognostic (3.13e-3)								unprognostic (9.99e-2)	unprognostic (1.16e-2)		unprognostic (1.26e-2)				1	0.1	0.2	0.6	0.2	1.1	0.2	0.2	1.8	0.2	6.6	0.2	0.2	0	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.1	3.4	0.2	0.2	0.2	0.2	0.2	0.2	202.8	0	0.2	0.2	0.5	0.2	12.6	0.2	0.2	0.2	0.2	2.5	11	0.2	0.2	0.2	2.4	0.3	0.2	0.3	0.2	0.2	0.2	0.2	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	38	0	0	0	0	0	0	1.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	54.1	0	2.9	0	1.4	9	0	1.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0.2	0.2	0.3	0.2	0.1	0.2	0.2	0.5	0.2	0	0	0	0	0	0	0.8	0	0	0	0	0	0	0	0.2	0	0	5.4	0	0.4	0	0	0	0	0	0.1	0	5260	0	0	0	0	0	0	1	8.5	0	378.9	6.8	0	0	0	0	0	0	0	0	0	0	9	0	Intestinal endocrine cells
SMYD1	BOP, KMT3D, ZMYND22	ENSG00000115593	SET and MYND domain containing 1	Q8NB12	2	88067780-88113387	Enzymes, Predicted intracellular proteins	Transcription, Transcription regulation	DNA-binding, Methyltransferase, Repressor, Transferase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	10	heart muscle: 45.9;skeletal muscle: 103.7;tongue: 36.4	Cell type enriched	Detected in single	1107	Cardiomyocytes: 207.9	Cancer enhanced	Detected in some		stomach cancer: 1.6	Region enriched	Detected in single	4	cerebral cortex: 1.4	Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	5	HSkMC: 5.6	Low region specificity	Detected in many			Not detected	Not detected			HPA062282	Enhanced											HPA062282: AB_2684736	unprognostic (1.93e-2)		unprognostic (2.49e-1)		unprognostic (4.09e-2)	unprognostic (8.51e-3)			unprognostic (2.74e-1)		unprognostic (3.91e-1)			unprognostic (8.81e-3)	unprognostic (1.40e-1)			2.7	0	0.1	0.1	0.3	0	1.2	0	1.4	0	4.6	0	0	0.4	0	3.4	2.5	0	0.2	45.9	0.1	0	0	0	0	0	0.1	0.1	0	0	1.8	0	0	0	0.9	0.4	0	1.5	0	103.7	0	4.4	6.3	0.1	0	2.6	0.1	0	0	0.2	36.4	2.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5.6	0	0	0	0	0	0	0	0	1.1	0	0	0	0.5	0	0	0	0.2	0.2	0	0	0	0	0	0	0.4	0.4	0	0	0	0	0	0.1	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.3	0	1.4	0.1	0	0.1	0.1	0	0	0	0	0	0	0	0	207.9	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Cardiomyocytes
WNT6		ENSG00000115596	Wnt family member 6	Q9Y6F9	2	218859821-218874233	Predicted secreted proteins	Wnt signaling pathway	Developmental protein		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 23.4	Cell type enriched	Detected in some	9	Sertoli cells: 90.5	Cancer enhanced	Detected in many		ovarian cancer: 8.7	Group enriched	Detected in many	7	basal ganglia: 23.4;thalamus: 7.4	Cell type enhanced	Detected in some		myeloid DC: 1.1;NK-cell: 1.5	Low lineage specificity	Detected in many			Cell line enriched	Detected in some	7	BEWO: 28.1	Low region specificity	Detected in many			Low region specificity	Detected in many			HPA070759	Approved				Secreted to extracellular matrix							HPA070759: AB_2732164	unprognostic (1.86e-2)	unprognostic (6.03e-2)	unprognostic (5.14e-2)	unprognostic (2.06e-1)	unprognostic (5.32e-2)	unprognostic (7.34e-2)	unprognostic (8.08e-3)	unprognostic (4.73e-2)	unprognostic (1.27e-2)	unprognostic (1.19e-1)	unprognostic (1.21e-2)	unprognostic (2.66e-1)	unprognostic (1.24e-3)	unprognostic (5.26e-2)	unprognostic (4.82e-2)	unprognostic (1.55e-1)	unprognostic (2.07e-1)	2.5	3.5	0.8	1.4	23.4	0.6	15	0.9	2.1	4	5.7	0.2	1.1	1.3	2.3	2	3.1	2.3	2.1	4.8	0.9	0.3	1.6	0.7	0.7	1.3	2.1	0.1	2.9	1.7	0.6	1.7	9.8	1.4	4	0.9	4.3	1.9	2.1	2.4	2.3	2.3	2	2.4	6.4	2.3	3.7	7.4	0	0.7	0.8	1.2	1.5	11.1	0.7	1.1	0	0.6	1.5	0.1	0	0	0	0	0.9	0	0	28.1	0	0	0	0	2.6	0.4	0	3	0	0.1	0.4	0	0	0	0	0.2	0.2	0	0	0	1.5	0	0	0	0	0	0	0	0	0	0.4	0	0.4	0	0.7	0	0	0	0	0	2.8	0.1	0	0	4.1	1.3	0	0	3.2	0.1	3.7	0	0	2.3	0	0	0	0	0	0	2.4	0.1	0	0.6	0	0	0	0	0	0.1	0	1.1	0.7	0	0	0	1.5	0	0.7	0	0	0.8	23.4	0.9	0.9	0.9	0.3	2.1	0.1	1.4	7.4	0	0	0.5	10.5	0.5	0.8	0.4	0	0	0	0	0	4.6	0	0.2	1.6	0	0	0	0	1.5	0.8	3.2	0	0	0.7	1.6	0	3.1	0	3.4	0	0	1.7	0	0	0.8	0	0	0.4	0	1.8	90.5	3.3	2.1	0.3	0.1	0.6	0	0	0.9	Sertoli cells
PROC		ENSG00000115718	Protein C, inactivator of coagulation factors Va and VIIIa	P04070	2	127418427-127429246	Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Blood coagulation, Hemostasis	Hydrolase, Protease, Serine protease	Cancer-related genes, Disease mutation, FDA approved drug targets, Thrombophilia	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	5	liver: 137.5	Cell type enriched	Detected in many	4	Hepatocytes: 348.7	Cancer enriched	Detected in many	22	liver cancer: 118.3	Not detected	Not detected			Cell type enriched	Detected in some	9	plasmacytoid DC: 29.2	Lineage enriched	Detected in many	9	dendritic cells: 29.2	Cell line enriched	Detected in some	16	Hep G2: 58.9	Not detected	Not detected			Not detected	Not detected			HPA005550, CAB016721, CAB016792	Supported				Secreted to blood				6400000000			CAB016721: , CAB016792: , HPA005550: AB_1079687	unprognostic (2.46e-2)	unprognostic (1.08e-1)	unprognostic (1.38e-1)	unprognostic (1.58e-1)	unprognostic (6.64e-2)	unprognostic (3.13e-2)	unprognostic (4.90e-3)	unprognostic (2.63e-1)	unprognostic (1.67e-1)	unprognostic (3.29e-1)	unprognostic (3.74e-3)	unprognostic (2.56e-2)	unprognostic (8.12e-3)	unprognostic (2.01e-2)	unprognostic (1.71e-1)	unprognostic (4.60e-3)	unprognostic (8.06e-2)	0	0	0.4	0.1	0.1	0.2	0	0.1	0.2	0.1	0.2	0	0.1	0.2	0	0.1	0	0	0.6	0	0.4	0.2	4.2	137.5	0.2	0.1	0.1	0.1	0	0	0	0	0.1	0.4	0.1	0.1	0	0	0.1	0	0.1	0.5	0	0.1	0	0.6	0	0	0.7	0	0	0.1	0.1	0	0.4	29.2	3.1	0	0	0	0.1	0	0.8	0	0	0	0	0	0	0	0	0	0.9	1.6	0	0.3	0	0.1	3.7	0	0.1	0	0	0	0	2.8	58.9	0	0.1	0	0	0	0	0	0.1	0	0.2	0	0	0	0	0.1	0.6	0.1	0.9	0.2	0	0	0	0	0.3	0.1	0	0.4	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0.1	0	0	0	3.1	0	0	29.2	0	0.1	0.4	0.1	0.1	0.2	0.4	0.2	0.1	0.1	0.4	0	0	0	4.3	0.6	0.7	0	0.3	40.8	1.4	0	0	0	0	5	0.4	0	0	2.6	0	0.2	0	0.2	0	0	348.7	3.9	0	9.9	9.8	4.5	0	0	1.7	0	0	8.1	0	1.2	8.7	0	78.1	0	0	0	0	0.1	0.1	0.1	2.5	1.5	0.1	Hepatocytes
PCYOX1	KIAA0908, PCL1	ENSG00000116005	Prenylcysteine oxidase 1	Q9UHG3	2	70257386-70281191	Enzymes, Plasma proteins, Predicted intracellular proteins		Oxidoreductase		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	4	Alveolar cells type 1: 556.9	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Cell line enhanced	Detected in many		ASC diff: 80.3	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA035193	Approved				Intracellular and membrane				480000000			HPA035193: AB_10602017	unprognostic (1.09e-1)	unprognostic (1.72e-2)	unprognostic (7.91e-2)	unprognostic (1.15e-2)	unprognostic (1.44e-1)	unprognostic (2.05e-1)	unprognostic (6.87e-2)	unprognostic (6.28e-2)	unprognostic (1.14e-1)	unprognostic (1.80e-1)	unprognostic (1.61e-1)	unprognostic (4.38e-2)	prognostic favorable (1.89e-4)	unprognostic (3.26e-2)	unprognostic (1.55e-1)	unprognostic (1.13e-1)	unprognostic (1.54e-2)	36.6	20.6	12.9	13.5	17	2.1	21.7	12.5	19.7	32.2	20.1	13.2	27.2	12.9	31.3	26.5	24.5	23	26.5	22.5	12.3	24.1	48.9	53.3	29.2	10.6	14.9	17.4	22.1	12.9	47.7	29.8	18.8	23.2	24.2	12.8	30.5	55.8	31.4	42	17.2	18.3	24.6	13.8	10.8	17.3	11.3	10.8	5	31.8	22.8	13.7	24.5	23.1	4.6	8.4	13.5	7.2	6.6	13.4	6.8	9.2	13.4	10.8	12	80.3	41.4	9.5	15.9	14.7	8.9	6.7	21	8.3	0.9	6.9	21.7	14.6	15.3	7.8	12.3	10.2	5.3	6.6	3.5	10.5	18.2	8	3.3	3.2	39.7	13.6	11.8	3.3	23.7	10.5	3.4	6.3	6.9	12.5	5.6	2.4	5.4	6.5	13.5	5.7	4.7	22.5	8.2	12.6	10.4	2.8	6	23.9	11.8	11.1	16	9.6	4.3	13	15	8.4	13.2	8.2	5.7	12.8	1.2	18	4.6	5.4	13.5	7.2	7.4	10	6.3	12.5	4.6	9.8	8.1	6.7	3.7	13.4	11.2	5	6.6	6.4	8.4	8.6	6.8	12.9	17	12.5	19.7	12.3	24.1	14.9	17.4	23.2	10.8	556.9	69.3	10.4	20.6	18.9	44.9	69	38.2	22.7	48.9	50.6	41.2	33.8	6.6	21.9	1.4	32.9	23	0	8.9	29.3	41.9	33.6	9.3	137.7	18.8	54	8.2	36.2	16.7	2	82.6	10.9	23.6	5.4	24.2	94.5	14	26.9	113.5	50.9	29.8	71.1	35	4.9	30.4	24.7	18.4	11.7	20.7	15.9	Alveolar cells type 1
KISS1R	AXOR12, GPR54, HOT7T175	ENSG00000116014	KISS1 receptor	Q969F8	19	917287-921015	Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins, Transporters		G-protein coupled receptor, Receptor, Transducer	Disease mutation, Hypogonadotropic hypogonadism	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		brain: 6.8;lymphoid tissue: 12.4	Cell type enriched	Detected in some	18	Extravillous trophoblasts: 31.2	Cancer enhanced	Detected in many		renal cancer: 3.6	Low region specificity	Detected in many			Cell type enhanced	Detected in some		naive CD4 T-cell: 2.0;neutrophil: 1.8	Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		K-562: 10.8;RPMI-8226: 26.3;SCLC-21H: 5.5;SH-SY5Y: 14.7	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA007156, HPA071913	Approved		Supported	Vesicles,Plasma membrane						Plasma membrane	Vesicles	HPA007156: , HPA071913: AB_2686471	unprognostic (1.54e-1)	unprognostic (3.01e-2)	unprognostic (9.42e-2)	unprognostic (2.15e-1)	unprognostic (8.46e-3)	unprognostic (9.23e-2)	unprognostic (1.65e-2)	unprognostic (3.23e-1)	unprognostic (1.37e-1)	unprognostic (1.16e-1)	unprognostic (1.48e-2)	unprognostic (7.17e-2)	prognostic unfavorable (3.33e-6)	unprognostic (1.87e-1)	unprognostic (8.09e-3)	unprognostic (1.05e-1)	unprognostic (2.05e-2)	0.2	0.2	2.1	2.1	4.1	0.2	0.3	0.1	4.7	0.1	0.3	0.1	0.1	0.4	0.2	0.1	0.1	0.2	0.1	0.1	1	6.8	1.4	0.1	0.3	12.4	1.1	0.1	0.4	3.6	0.1	2	1	0.8	0.2	0.2	0.3	0.3	0.1	0.1	0.1	0.7	0.5	1	2.4	0.4	0.1	0.1	0.1	0.1	0.1	0.6	0.5	0.1	0.6	0	1.8	0	0	2	0	0	0.5	0.1	0	0	0	0.1	0	0	0	0	1.7	0	0	0.1	0	0	0	0.8	0	0	0.2	2.9	0	0	3.3	0	0	0	0	0	0	0	0	0	0.1	10.8	0	0	0.2	0.1	0	0.4	0.8	0.3	0.7	0	26.3	0	0	5.5	14.7	0	0	0	0	0.2	0.6	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0.6	0.7	0	0	0.1	2	0.6	1.8	0	0	0	0.1	0	2.1	4.1	0.1	1.5	1	6.8	1.1	0.1	0.8	0.1	0	0	1.4	0.1	0.1	0.7	0.4	0	0	0	0	0	0.3	0	0.7	0	0	0	0	0.2	31.2	0	0.3	0	0	0.7	0	0	0	0	0	0	0	1.7	0	0	0.1	0.1	0	0	0	1.6	0	0	0	0.4	0.3	1.4	0	0	0	Extravillous trophoblasts
TNR		ENSG00000116147	Tenascin R	Q92752	1	175315194-175743770	Predicted intracellular proteins, Predicted secreted proteins	Cell adhesion			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	19	brain: 56.4	Cell type enriched	Detected in some	168	Horizontal cells: 548.2	Cancer enriched	Detected in single	46	glioma: 9.9	Low region specificity	Detected in all			Cell type enhanced	Detected in single		NK-cell: 1.9	Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		SH-SY5Y: 5.8;THP-1: 2.3;U-937: 4.3	Low region specificity	Detected in all			Low region specificity	Detected in all			CAB022343, HPA027134, HPA027150, HPA029859	Enhanced				Secreted in brain				230000			CAB022343: , HPA027134: AB_1851983, HPA027150: AB_1851985, HPA029859: AB_10600916	unprognostic (1.04e-1)	unprognostic (7.43e-2)	unprognostic (3.11e-2)	unprognostic (1.12e-3)	unprognostic (2.38e-1)	unprognostic (1.51e-2)	unprognostic (9.66e-2)	unprognostic (2.57e-2)	unprognostic (5.79e-2)	unprognostic (5.06e-2)	unprognostic (3.03e-3)	unprognostic (7.26e-4)	unprognostic (4.48e-4)	unprognostic (3.26e-3)	unprognostic (3.83e-1)	unprognostic (1.07e-1)	unprognostic (5.83e-2)	1.2	3	21.8	1.4	14.2	1.3	1.2	9.1	56.4	1.2	1.2	17.2	0	1.2	1.3	1.4	1.3	1.2	1.3	1.2	18.1	14.4	1.2	1.7	1.7	1.4	16.5	13.3	1.2	1.7	1.2	2	1.2	16.1	1.2	1.3	0.1	1.2	1.2	1.2	1.2	1.3	1.3	8.2	1.4	1.6	1.6	14.3	0	1.3	0	1.6	1.3	0.1	0.4	0.1	0.6	0	1.9	0.1	0	0	0.3	1.2	0.2	0.1	0.1	0.7	0.3	0.2	0.3	0.1	0.8	0.2	0.4	0.7	1.1	0.1	0.7	0	0.6	0.2	0.3	0	0.1	0.6	0.4	0	0.4	0.1	0.5	0.8	0.1	0.4	0.1	0.2	0.2	0.3	0.4	0	0.6	0.2	0.6	0	0.1	0.1	0.1	0	0.1	0	0.3	0.3	5.8	0.6	0.3	0.2	0.4	0.4	2.3	0.1	0.1	0.3	0.2	0	0	0	0.1	0.5	4.3	0.3	0.6	0	0.6	0	0	0	0.3	0.1	0	0	0.4	0.1	0.1	0.4	1.9	0	0.1	0	0	21.8	14.2	9.1	23.7	18.1	14.4	16.5	13.3	16.1	14.3	0	0	0	0	0	1.2	0.6	0	0	0	0	0	0	0	0	1.1	0	0	0	0	0	0	0	0	0	0	548.2	0	0	0	1	0	0	0	0	0	1.5	0	0	0	0.6	3.3	0	0	0	0	0	0.2	0	0	0	Horizontal cells
TPSG1	PRSS31, TMT	ENSG00000116176	Tryptase gamma 1	Q9NRR2	16	1221651-1225257	Enzymes, Predicted membrane proteins		Hydrolase, Protease, Serine protease		Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in many		intestine: 16.0	Cell type enriched	Detected in some	6	Mucus-secreting cells: 264.6	Cancer enhanced	Detected in many		colorectal cancer: 5.2	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	9	HMC-1: 22.8;MCF7: 7.4	Not detected	Not detected							HPA060458	Enhanced											HPA060458: AB_2684283	unprognostic (1.86e-1)	unprognostic (3.46e-1)	unprognostic (5.21e-3)	unprognostic (1.27e-1)	unprognostic (5.58e-2)	unprognostic (1.18e-2)	unprognostic (3.45e-2)	unprognostic (4.60e-2)	unprognostic (9.97e-2)	unprognostic (1.34e-1)	unprognostic (8.92e-2)	unprognostic (6.39e-2)	prognostic unfavorable (1.76e-8)	unprognostic (2.19e-1)	unprognostic (1.70e-1)	unprognostic (8.65e-4)	unprognostic (5.70e-2)	1.3	0.6	0.4	4.5	0.4	0	3.1	0.4	0.4	0.6	14.4	0.4	0.4	14	1.2	0.4	0.7	0.5	1	0.4	0.4	0	0.4	0.4	0.6	0.4	0.4	0.4	2	0.4	0	3.2	0.4	0.4	1.1	8.8	0.4	0.4	0.4	0.4	1.1	16	1.2	0.4	0.4	1	1.3	0.4	0.4	0.4	1.1	0.4	1.4	2.4	0	0	0	0	0	0	0	0	1.2	0	0.8	0	0	0	0	0	0	0	0.3	1	0	0.9	0	0	0.1	0	0	0	0	0.1	1.2	0	0	0	0	22.8	0	0	0	0	0	0	0	0	0	0	7.4	0	0	0.7	0.2	0.2	0	0	0	0	0	0	0	0	0	0	0.1	1.6	0	0	0	0.1	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0.4	0.4	0.4	0.4	0	0.4	0.4	0.4	0.4	0	1.1	0	0	0.1	0	0.4	0	0	0	0	0	0	0	0	0	0	5.3	0	0	0	0	0	41.5	0	0	0	3.5	0	0	0	0	0	0	0	264.6	0	0	4	0	0	0	0	0	0	0	0.1	0	0	3.6	0	Mucus-secreting cells
CEP104	CFAP256, GlyBP, JBTS25, KIAA0562, ROC22, RP1-286D6.4	ENSG00000116198	Centrosomal protein 104	O60308	1	3812081-3857214	Disease related genes, Plasma proteins, Predicted intracellular proteins			Ciliopathy, Joubert syndrome	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	6	Cone photoreceptor cells: 432.0	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low cell line specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA010126	Approved											HPA010126: AB_10601583	unprognostic (3.60e-2)	unprognostic (1.39e-1)	unprognostic (8.83e-2)	unprognostic (2.00e-2)	unprognostic (1.38e-1)	unprognostic (1.98e-1)	unprognostic (1.49e-3)	unprognostic (8.35e-2)	unprognostic (4.85e-1)	unprognostic (2.16e-1)	unprognostic (4.90e-1)	unprognostic (2.89e-1)	prognostic favorable (1.70e-5)	unprognostic (7.06e-3)	unprognostic (2.62e-1)	unprognostic (1.46e-1)	unprognostic (3.55e-1)	15.9	20.2	15.5	11.3	22.7	8.9	13.2	21.9	18.8	14	13.6	28.5	14.6	11.3	14.4	17.7	17	15.8	10.5	14.6	17.5	14.9	21.1	17.9	15.6	14.8	26.4	8.8	16.8	19.4	29.6	25.1	12.4	21.6	14.5	13.7	23.5	14.8	19.6	18.4	16.1	14.2	16.6	23.6	13.4	14.3	24.2	23.2	19.8	17.9	7.9	16.9	17.3	15.7	4.6	4	8.8	2.6	3.2	4.2	0.8	13.3	13.7	8	13	21.1	13.8	6.3	11.1	8.9	15	10.7	10.5	12.8	13.3	16	12.1	11.2	13.1	16.9	14.5	19.1	16.7	16.4	12.3	18.1	17	16.6	13.8	13	9.5	14.2	17.2	25.2	12.9	14.9	17.5	15.3	16.1	14.2	12.4	18.9	7.4	4.9	18.1	16.7	13.6	13.6	15.4	9.6	9.5	21.4	5.7	17.1	21	13.4	9.8	9.4	4.2	11.7	12	5.5	22.7	8.9	15.7	17.5	16.9	6.5	14.1	4.4	8.8	2.6	5.2	4.2	2.3	3.3	2.8	3	2.9	1.5	4.6	2.6	2.3	3.8	3.2	1.5	4	2.9	0.8	15.5	22.7	21.9	18.8	17.5	14.9	26.4	8.8	21.6	23.2	23.8	20.4	15.2	11.9	14.2	18	12.7	10.2	34.8	14.8	24.4	432	14.6	6.6	21.9	55.2	11.1	13.8	0	16.7	20.7	8.4	11.7	10.4	15.3	11.4	55.6	10.9	6.7	14.9	70	11.5	15.1	18.6	18	12.6	13.5	19.4	10.5	19.4	15.1	54.9	19.4	15	43.7	16.2	17.6	9.5	12.9	11.3	12.3	Cone photoreceptor cells
QSOX1	QSCN6	ENSG00000116260	Quiescin sulfhydryl oxidase 1	O00391	1	180154834-180204030	Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins		Oxidoreductase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		placenta: 172.2	Cell type enriched	Detected in many	8	Extravillous trophoblasts: 1528.4	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Cell line enhanced	Detected in many		HHSteC: 197.7	Low region specificity	Detected in all			Low region specificity	Detected in many			HPA056243			Supported	Golgi apparatus,Vesicles	Secreted to extracellular matrix				3200000000	Golgi apparatus	Vesicles	HPA056243: AB_2683077	unprognostic (1.13e-1)	unprognostic (2.62e-3)	unprognostic (2.46e-1)	unprognostic (2.49e-2)	unprognostic (2.00e-2)	unprognostic (2.73e-1)	unprognostic (5.47e-2)	unprognostic (2.22e-1)	unprognostic (3.94e-1)	unprognostic (3.12e-2)	unprognostic (5.07e-2)	unprognostic (2.80e-3)	prognostic unfavorable (1.86e-5)	unprognostic (3.25e-1)	unprognostic (2.14e-1)	unprognostic (3.53e-2)	unprognostic (1.40e-1)	15.9	18.7	8	14.5	9.5	30.1	12.6	7.3	13.6	23.5	25.3	13.8	24.9	19.8	17.8	44.9	36.8	18.9	91.9	54.4	10.1	9	15.4	23.1	42.3	19.5	8.5	9.1	46.5	59.8	6.2	13.5	172.2	13.4	28	24.5	12.1	20.6	19.4	18.4	12.3	19	33.9	15.5	13.4	52.8	50.3	9.1	6.7	7.8	18.2	18.3	35.8	26.1	2.9	19.2	20.4	25.5	8	7.1	11.4	42.1	6	1.4	18	18.4	38.1	71.7	44.9	45.4	38.4	27.1	0.7	13.6	0.6	27.9	35.9	5.3	9.2	1.7	12.1	18.8	2.5	2.7	1.3	3.5	1.8	197.7	4.6	13	20.3	5.5	40.9	49.1	50.6	56.5	3.1	1.9	6.6	25.2	7.3	0.9	8.6	4.9	29.2	17.3	1.8	3.3	1.1	6.3	12	5.2	5.3	13.1	17.9	8.7	3.4	3.2	21.9	66.5	48.1	18.9	32.2	37.9	4.8	7.9	1.1	18.3	14.8	14.4	5.8	25.5	9.5	7.1	14.7	5.3	2.9	4.8	5	19.2	1.8	4.4	4.3	20.4	8	13.1	3.9	5.5	11.4	8	9.5	7.3	13.6	10.1	9	8.5	9.1	13.4	9.1	53.6	87.2	7.8	26.2	12.2	9.8	43.7	68.8	14.7	43.3	68	23.6	13.2	0	189.3	48.3	38.6	47.7	0	114.6	1528.4	54.2	30.1	25.3	1.5	63.8	6.4	44.4	101.9	45.4	16.5	164.5	43.6	42.2	44.1	163.8	43.9	172.2	143.8	66.8	9.5	6.5	32.3	17.5	20.9	25.4	8.7	129.1	15	96.4	58	Extravillous trophoblasts
FBXO2	Fbg1, Fbs1, FBX2, Nfb42, OCP1	ENSG00000116661	F-box protein 2	Q9UK22	1	11637018-11655785	Predicted intracellular proteins	Ubl conjugation pathway			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 49.7;pancreas: 52.5	Cell type enriched	Detected in many	5	Exocrine glandular cells: 606.0	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Group enriched	Detected in many	15	B-cells: 1.4;T-cells: 3.1	Cell line enhanced	Detected in some		CACO-2: 21.1;HBEC3-KT: 18.5;Hep G2: 44.2;SiHa: 83.5	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA005472	Enhanced		Approved	Nucleoplasm,Cytosol						Nucleoplasm, Cytosol		HPA005472: AB_2667332	unprognostic (2.02e-2)	unprognostic (1.28e-1)	unprognostic (2.10e-1)	unprognostic (8.13e-3)	unprognostic (1.80e-1)	unprognostic (2.61e-2)	unprognostic (4.01e-2)	unprognostic (1.30e-2)	unprognostic (1.18e-2)	unprognostic (1.41e-1)	unprognostic (5.44e-2)	unprognostic (1.68e-2)	prognostic favorable (3.45e-6)	unprognostic (5.26e-2)	unprognostic (5.21e-2)	unprognostic (4.82e-2)	unprognostic (1.64e-1)	1.7	21.8	49.7	2.6	39.2	1.2	7.9	21.1	48.3	2.1	1.8	13.2	2.1	13.7	1.5	6.4	3.6	3.6	2.9	2.6	33.1	32.6	6.9	11	3	2.5	40	23	2.2	52.5	17.7	20.2	1.3	25.7	5.1	1.3	2.7	21.7	7.6	1.3	6.6	4.9	1.7	31.4	2.2	3.8	4.4	24.3	1.1	3.7	0	3.8	2.6	2.9	1.4	0.1	0	0	0	3.1	0.6	6.9	2.1	0	6.8	0.1	0	1	0.3	0.6	0.1	0	21.1	2	0	8.7	0	1.8	0	0.7	18.5	0	0.1	0.2	0	0.2	44.2	0.9	0	0	0.6	3.4	0	0.1	0.2	0.1	0	0	0	0	0	0	0	0.2	2.8	0.2	0	0	0	1.6	0.5	0.7	0.9	83.5	0	0.8	0.7	4.1	0	0	0	0.7	0	0	0.5	0.4	0.3	0.1	0	0.2	0	0	0	1.9	0	3.1	1.4	1.2	2.9	0.1	1.1	1.8	2.6	0	0	0	0	0.8	0.6	49.7	39.2	21.1	30.3	33.1	32.6	40	23	25.7	24.3	0	1	6.6	52.3	17.4	10.7	2.4	17.8	5.3	5.7	45.4	2	0.6	72.9	20.7	1.7	0.6	0	0	606	3.5	2.4	21.4	4.6	87.3	0.4	27	1.2	2.5	1.6	1.8	32.2	1.2	42.2	5.4	0	65.1	127.3	0	38.2	5.8	10.3	0	1.9	11.4	10.4	8.7	0.8	12.9	0	22.5	Exocrine glandular cells
MFN2	CMT2A2, CPRP1, KIAA0214, MARF	ENSG00000116688	Mitofusin 2	O95140	1	11980181-12013514	Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters	Apoptosis, Autophagy, Unfolded protein response	Hydrolase	Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		heart muscle: 100.9;skeletal muscle: 111.1	Cell type enriched	Detected in all	8	Cardiomyocytes: 308.6	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low cell line specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA030554, CAB079902	Uncertain		Supported	Mitochondria						Mitochondria		CAB079902: AB_2724683, HPA030554: AB_10603018	unprognostic (9.52e-2)	unprognostic (1.80e-1)	unprognostic (1.42e-1)	unprognostic (4.38e-2)	unprognostic (8.36e-2)	unprognostic (9.71e-2)	unprognostic (1.89e-1)	unprognostic (2.44e-1)	unprognostic (3.45e-1)	unprognostic (2.19e-2)	unprognostic (1.43e-1)	unprognostic (3.55e-1)	prognostic favorable (2.36e-8)	unprognostic (4.69e-2)	unprognostic (2.76e-1)	unprognostic (8.84e-3)	unprognostic (2.12e-1)	12.8	10.1	16.4	8.9	20.3	17.2	10.1	15.9	32.1	8.7	17	17	11.2	16.5	12.1	8.7	20.1	9	9	100.9	17.9	16	14.8	20.4	10.6	8	18.8	19.3	10.2	9	22	9.3	12.9	20.8	14.1	13.2	16.5	10.7	23.7	111.1	18.8	25.7	22.9	15.7	10.2	14	11.3	10.9	7.3	18.7	28.5	12.1	16.3	10.6	7.3	8.9	18.5	16.9	5.8	10.2	13.4	26	15.9	18.1	23.8	18.3	13.8	21	20.6	19.1	28.3	22.1	26.3	17.4	19.1	22.4	24.9	18.6	27.9	29.9	47.8	25.4	69.2	22.7	27.3	25.6	20.4	19	27.7	17.2	17.4	36.9	39.8	36.9	12.2	19.9	10.3	28.2	16.8	20.9	13.1	16.8	12.7	12.5	17.5	23.5	19.7	26.4	17.8	17	17.4	21.1	13.8	24.2	25.8	23.9	14.2	13.9	16.7	19.9	19	19	28.8	21.5	20.1	21.1	31.3	22.5	31.2	20.5	8.5	10.3	7.1	9.6	13.5	10.2	7.3	7.2	8.6	8.9	6.6	6.3	8	18.5	5.8	16.9	4.6	8	13.4	16.4	20.3	15.9	32.1	17.9	16	18.8	19.3	20.8	10.9	20.8	18.6	11.5	8.2	20.3	24.8	308.6	12.7	12	14.8	14	11.8	12.2	18.3	12.7	3.6	12	31.1	23.3	17.3	13.2	9.3	12.5	10.4	39.2	14.2	28.6	17.3	13.5	18.1	4.4	6.6	11.8	16.9	10	20.9	11.6	13.9	14	14.2	13.3	18.6	12.9	14.4	27.7	16.8	26.3	21.1	9.6	22.1	12.9	Cardiomyocytes
PRG4	bG174L6.2, CACP, FLJ32635, HAPO, JCAP, MSF, SZP	ENSG00000116690	Proteoglycan 4	Q92954	1	186296279-186314562	Disease related genes, Plasma proteins, Predicted secreted proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		adipose tissue: 20.9;liver: 76.0	Cell type enriched	Detected in some	8	Hepatocytes: 298.2	Cancer enriched	Detected in many	10	liver cancer: 28.4	Not detected	Not detected			Cell type enriched	Detected in single	4	T-reg: 4.0	Lineage enriched	Detected in single	33	T-cells: 4.0	Cell line enriched	Detected in some	7	ASC diff: 81.7	Low region specificity	Detected in many							HPA028523	Uncertain				Secreted to extracellular matrix				4300000000			HPA028523: AB_10669642	unprognostic (8.67e-2)	unprognostic (2.28e-1)	unprognostic (1.82e-3)	unprognostic (1.98e-1)	unprognostic (1.77e-1)	unprognostic (7.87e-2)	unprognostic (7.33e-2)	unprognostic (1.78e-1)	unprognostic (1.28e-1)	unprognostic (1.53e-1)	unprognostic (5.03e-2)	unprognostic (4.11e-1)	unprognostic (1.91e-13)	unprognostic (1.40e-2)	unprognostic (2.60e-1)	unprognostic (1.60e-3)	unprognostic (7.05e-3)	20.9	0.7	0.1	1	0.1	0.2	5.1	0.2	0.3	0.2	2.8	0.4	0.1	0.1	0.2	1.7	0.9	6.8	0.3	11	0.1	0.3	0.2	76	7.2	0.3	0.3	0.1	0.7	1.1	0.1	0.3	0.1	0.3	0.3	0.2	2.6	1	0.2	13.8	1.6	0.2	0.7	0.1	0.3	0.2	1.1	0.1	0.2	0.7	1.9	0.3	0.7	0.1	0.1	0	0	0	0	4	0.1	0	0	0	0	81.7	3.4	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0.3	0	0	0	0	7.5	0	12.4	0	0	0	0	0	0	0	0.4	0.4	0	0	0	0	0	0	0	0	0	0	0	8.9	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.9	0	0	0.1	0.6	0.2	0	0	0	0	4	0.1	0.1	0.1	0.2	0.3	0.1	0.3	0.3	0.1	0.3	0.1	20.8	14.4	8.2	0	0.6	0	0.8	7.6	20.1	38.7	0	0	0	0	0	0.9	0.7	0	0	0	0	2.2	0.1	15.1	298.2	0.1	0	0	7.4	8.8	0	0	0	1.7	0	0	0	4.3	0	0	0	0	0	0.3	0	0	1	0	0.5	0	0.1	Hepatocytes
CTH		ENSG00000116761	Cystathionine gamma-lyase	P32929	1	70411218-70439851	Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins	Amino-acid biosynthesis, Cysteine biosynthesis	Calmodulin-binding, Lyase	Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in all	6	liver: 104.5	Cell type enriched	Detected in many	6	Hepatocytes: 130.7	Group enriched	Detected in all	5	liver cancer: 30.0;testis cancer: 8.1	Low region specificity	Detected in all			Low cell type specificity	Detected in many			Group enriched	Detected in many	4	B-cells: 4.5;T-cells: 6.4	Cell line enhanced	Detected in many		HHSteC: 20.2;Karpas-707: 31.3;SK-MEL-30: 40.8	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA021591, HPA023300	Enhanced								25000			HPA021591: AB_1847321, HPA023300: AB_1847322	unprognostic (3.41e-2)	unprognostic (1.36e-1)	unprognostic (1.48e-1)	unprognostic (2.76e-1)	unprognostic (7.66e-2)	unprognostic (2.45e-3)	prognostic favorable (8.69e-4)	unprognostic (1.71e-1)	unprognostic (1.95e-1)	unprognostic (1.00e-1)	unprognostic (1.43e-3)	unprognostic (5.05e-3)	unprognostic (3.25e-2)	unprognostic (1.03e-1)	unprognostic (8.97e-2)	unprognostic (3.05e-3)	unprognostic (1.26e-1)	2.2	8.3	2.3	1	3.2	2.2	2	3.7	3.6	1.9	3.3	2.2	1.8	3.3	1.7	1.4	2.7	2.3	1.5	1.6	2.1	2.7	8.2	104.5	2.2	1	2.4	2.2	18.3	11.6	1.5	1.7	1	3.2	2.9	4.1	11.2	4.8	2.8	2.1	1	3.2	1.2	2.4	0.8	3.7	5.4	1.3	0	11.4	1.2	1.5	2.7	1.2	4.5	1.3	1.1	0.6	0.6	6.4	1.1	5.1	0.7	3.5	4.9	4.3	2.4	7.8	2.1	1.9	1.8	7.8	1.4	3.2	2.8	1.6	1.5	4.6	2.4	13.5	1.4	3.6	8.6	3	3.3	2.6	4.4	20.2	3.7	0.8	3.7	12.2	3.7	4.3	0.7	1.6	5.6	6.5	31.3	1.1	1.4	1.3	0.8	3.6	1.9	2.7	1.3	1.9	7.8	3.6	0	1.9	1.6	3.2	3.8	40.8	6.9	1.3	2.1	0.5	0.6	4	2.8	1.9	12.1	7.1	1.5	4.8	7.7	1.4	1.1	0.6	0.2	2.5	0.4	4.6	4.5	2.3	3.5	1	2.9	6.4	3.1	0.9	0.6	0.5	1.3	0.7	1.1	2.3	3.2	3.7	3.6	2.1	2.7	2.4	2.2	3.2	1.3	6	3.5	5.6	6.2	2.3	6.8	1.6	5.1	0	1.2	5.2	9.8	0.6	10	1.6	14.9	2	11.9	0	3.5	1.3	2.8	5.2	0	130.7	1	0	2.9	4.3	2.9	3.4	1.1	1.3	18.6	0	5.9	4.3	6.4	11	3.9	22	10.1	0	5.5	1.6	0.5	1.8	0.7	4.3	4.3	2.8	Hepatocytes
AGMAT	FLJ23384	ENSG00000116771	Agmatinase	Q9BSE5	1	15572353-15585110	Enzymes, Predicted intracellular proteins	Putrescine biosynthesis, Spermidine biosynthesis	Hydrolase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		intestine: 21.3;kidney: 54.7;liver: 66.1	Cell type enriched	Detected in many	7	Proximal tubular cells: 278.6	Group enriched	Detected in all	5	colorectal cancer: 18.5;liver cancer: 25.3;renal cancer: 11.2;stomach cancer: 11.1	Low region specificity	Detected in single			Low cell type specificity	Detected in many			Group enriched	Detected in many	5	B-cells: 4.6;T-cells: 10.5	Cell line enhanced	Detected in many		CACO-2: 19.0;Hep G2: 46.0;RPMI-8226: 11.4	Low region specificity	Detected in many			Not detected	Not detected			HPA026443, HPA028321	Enhanced								250000			HPA026443: AB_1844644, HPA028321: AB_10600779	unprognostic (2.27e-2)	unprognostic (3.45e-1)	unprognostic (1.79e-3)	unprognostic (3.60e-2)	unprognostic (8.72e-2)	unprognostic (6.66e-3)	unprognostic (9.48e-2)	unprognostic (1.19e-2)	unprognostic (2.06e-2)	unprognostic (2.37e-2)	unprognostic (1.13e-2)	unprognostic (2.35e-1)	prognostic favorable (5.13e-4)	unprognostic (4.43e-3)	unprognostic (2.44e-1)	unprognostic (1.33e-1)	unprognostic (2.45e-2)	0.7	0.8	0.7	2.8	0.5	0.1	0.4	0.2	1	0.2	14.9	0.3	0	7.1	0.3	1.2	0.5	0.2	3.6	0.3	0.6	0.8	54.7	66.1	0.2	1.3	0.7	0.3	0.2	1.1	1.3	0.4	0.2	0.6	0.3	2.8	0.1	9.6	0	12.3	0.2	21.3	0.1	0.3	1	0.5	0.5	0.1	1	0.3	1.7	1.5	0.4	0.2	4.6	0.4	1.4	0.3	0.4	10.5	2.8	4	3.2	0.2	0.1	0	0.4	0.1	0.7	0.7	0.4	0.2	19	2.6	0	0.1	0.5	0	0	0	0	0.5	3.9	0	2.5	2.7	46	0.5	2	0	0.5	0.2	1.3	0	0.3	0.4	0	0	5.4	1	4.3	0	1.9	4.3	3.2	1.8	0	0	11.4	0.1	1	0.7	0.6	5.5	0.2	0.6	0.2	0.7	3.8	0.5	0.1	0.1	1	0	0.1	3	2.6	0.2	0	0	0.9	0.3	0.2	2.4	0.3	3.1	4.6	5.7	3	0.2	3.2	10.5	5.9	1.4	0.4	0.2	0.4	7.1	2.8	0.7	0.5	0.2	1	0.6	0.8	0.7	0.3	0.6	0.1	0	0	3.2	1.5	0.2	1.2	0.4	5.1	1.4	0	3.5	0	0.7	26.6	0.8	6.9	0.1	12.9	0	0.8	0.7	0.7	0.9	0	38.9	0.9	3.2	1.2	1.8	2.2	3.6	0.3	0.4	1.7	1	6.7	0.8	2	3.5	0	278.6	1.7	0	0.4	1.6	2.9	0.5	0.7	5	13.8	2.6	Proximal tubular cells
ST6GALNAC5	MGC3184, SIAT7E, ST6GalNAcV	ENSG00000117069	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 5	Q9BVH7	1	76867441-77065711	Predicted intracellular proteins		Glycosyltransferase, Transferase		Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 29.4	Cell type enriched	Detected in some	7	Alveolar cells type 1: 50.6	Cancer enhanced	Detected in many		ovarian cancer: 10.9	Group enriched	Detected in many	4	amygdala: 22.1;basal ganglia: 22.3;cerebral cortex: 12.7;hippocampal formation: 29.4;olfactory region: 14.2	Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		AF22: 9.1;fHDF/TERT166: 10.9;HaCaT: 5.2;SH-SY5Y: 7.9;U-2 OS: 9.0;U-251 MG: 5.0	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA065593, HPA070354	Uncertain		Approved	Vesicles	Intracellular and membrane					Vesicles		HPA065593: AB_2685515, HPA070354: AB_2686260	unprognostic (1.32e-1)	unprognostic (5.96e-2)	unprognostic (1.72e-1)	unprognostic (1.49e-2)	unprognostic (2.82e-2)	unprognostic (2.04e-2)	unprognostic (4.67e-2)	unprognostic (2.72e-2)	unprognostic (3.60e-2)	unprognostic (1.99e-1)	unprognostic (1.61e-2)	unprognostic (1.58e-1)	unprognostic (2.10e-2)	unprognostic (5.90e-3)	unprognostic (9.66e-2)	unprognostic (6.88e-2)	unprognostic (1.69e-2)	0.7	10.1	22.1	5.2	22.3	0.4	4.2	0.6	12.7	2.9	3.4	0.3	0	1.4	0.9	0.7	3.7	6.9	12.6	1.4	29.4	2.7	0.7	0.6	12.1	1.6	3	14.2	6.5	0.8	0.4	8.5	0.9	4.7	4.2	2.7	5.8	1.5	1.6	0.6	1	2.1	10.2	0.8	1	3.7	1.2	0.2	0	0.6	0	1.4	4.2	1.6	0	0	0	0	0	0.1	0.4	2.4	0	9.1	0	0	0	0	0.8	3.2	2.6	0.8	0	0.2	0	0	10.9	0	5.2	0	0.1	2.8	0	0.2	0	0	0	1.6	0	0	0.2	0.1	0	0.6	0	0	0	0	0	1.7	0	0	0	3.6	0	0	0	0.7	0.6	0	0.1	2.5	7.9	0	0	0	0.2	0	0	0	1.3	9	0	5	0	0.2	0	0.3	0	0.3	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0.4	22.1	22.3	0.6	12.7	29.4	2.7	3	14.2	4.7	0.2	50.6	0.3	0	0	0	7.3	0.4	0	1.4	1.2	0	0	0.1	0	0	2.1	0	0	0	0	0.1	0.6	0.1	1.1	0	0.1	0	0	0	0	1.1	0.6	0	0	0	0	0.5	0	0	0	0	1.4	0	0.3	0	0.5	0	0.1	0	0	0.1	Alveolar cells type 1
ACTL8	CT57	ENSG00000117148	Actin like 8	Q9H568	1	17755313-17827063	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	42	testis: 23.6	Cell type enriched	Detected in some	6	Spermatogonia: 42.7	Low cancer specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	8	U-266/84: 72.4									HPA027176			Approved	Cytosol						Cytosol		HPA027176: AB_1844553	unprognostic (1.79e-3)	unprognostic (3.18e-2)	unprognostic (4.62e-2)	prognostic unfavorable (1.62e-6)	unprognostic (6.18e-2)	prognostic unfavorable (7.02e-4)	unprognostic (1.63e-3)	unprognostic (2.33e-2)	unprognostic (3.18e-1)	unprognostic (2.01e-1)	unprognostic (3.69e-1)	unprognostic (4.89e-1)		unprognostic (1.43e-1)	unprognostic (5.49e-2)		unprognostic (4.68e-2)	0.1	0	0	0	0	0	0	0	0.2	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	23.6	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0.2	0.4	0	0	0	0	0	0	0	0	0	0	0	3.3	0	0	0.2	0	0.4	0	0	0	0.4	0	0.1	0.4	0	1	0.4	0	0	0	0	0	0	0	0.7	4.2	0	0.7	0	0	2.9	1.8	0	0	0	8.5	0	0	0.1	0	0	1.6	0.1	0	0.1	0.1	0	0	0	0.6	0	0	72.4	0	1.5	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	6.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.1	0.9	0	0	0	0	0	0	0	0.4	0	0	0	0	1.2	42.7	0	0	0	0.6	0	Spermatogonia
IGSF21	MGC15730, RP11-121A23.1	ENSG00000117154	Immunoglobin superfamily member 21	Q96ID5	1	18107746-18378483	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 48.5;lymphoid tissue: 16.5	Cell type enriched	Detected in some	17	Bipolar cells: 179.6	Group enriched	Detected in many	5	breast cancer: 4.1;glioma: 8.6;prostate cancer: 3.6	Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	5	SCLC-21H: 20.3	Low region specificity	Detected in all			Low region specificity	Detected in all								Intracellular and membrane				7900				unprognostic (1.87e-1)	unprognostic (1.73e-1)	unprognostic (1.50e-3)	unprognostic (7.06e-2)	unprognostic (3.29e-1)	unprognostic (1.01e-1)	unprognostic (1.45e-1)	unprognostic (1.66e-2)	unprognostic (7.87e-2)	unprognostic (2.77e-3)	unprognostic (4.34e-2)	unprognostic (2.33e-1)	unprognostic (7.85e-4)	unprognostic (3.76e-5)	unprognostic (2.10e-1)	unprognostic (1.23e-2)	unprognostic (2.63e-2)	3.1	9	14.1	1.7	12.3	1.6	6	48.5	32.7	3	1.8	7.2	0	0.9	1.9	1.8	2.6	1.8	2.4	1.8	21.1	10.4	1.7	1.7	2.5	1.3	10.9	13.9	2	4.1	1.8	1.1	3.3	10.1	4.5	1.5	5.5	1.9	3	1.4	1.5	1.2	2.7	6.5	16.5	1.6	1.8	4.5	0	1.4	0	2.1	4.1	0.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.8	0	0	0	0	0	0	0	20.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.1	12.3	48.5	27.4	21.1	10.4	10.9	13.9	10.1	4.5	0	0	0.9	0	0.2	179.6	0.4	2.5	0	0	0	0	0	0	0	4	0	0	0	0	0	0	1.2	0	0	0.6	1.6	2.9	0	10.5	8.3	0.6	1.6	0	0	0	3.7	0.2	0.6	0	0	10.8	6.5	0.3	0.2	0.4	0.1	0	0	0	0.1	Bipolar cells
ARTN	ENOVIN, EVN, NBN	ENSG00000117407	Artemin	Q5T4W7	1	43933320-43937241	Predicted intracellular proteins, Predicted secreted proteins		Growth factor		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in many		parathyroid gland: 18.3	Cell type enriched	Detected in some	10	Urothelial cells: 56.7	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	4	A-431: 29.8;HaCaT: 31.5;HBEC3-KT: 28.0;hTCEpi: 11.8;hTERT-HME1: 9.0	Region enriched	Detected in single	9	olfactory region: 4.0	Region enhanced	Detected in single		olfactory region: 1.0						Secreted in other tissues								unprognostic (1.98e-1)	unprognostic (1.25e-1)	unprognostic (3.60e-2)	unprognostic (1.86e-1)	unprognostic (1.55e-1)	unprognostic (1.01e-1)	unprognostic (3.07e-3)	unprognostic (1.18e-1)	unprognostic (3.08e-1)	prognostic favorable (8.18e-4)	unprognostic (2.34e-1)	unprognostic (1.70e-1)	unprognostic (9.59e-6)	unprognostic (2.35e-2)	unprognostic (3.04e-2)	unprognostic (1.48e-3)	unprognostic (1.53e-1)	2.4	1.1	0.7	2.2	2.5	1.2	2.1	4.3	1.7	3.9	3.7	0.5	7.6	0.6	3.6	5.6	4.1	2	5.1	2	0.6	1.6	6.2	0.4	2.1	0.5	1	0.1	2.4	14.4	18.3	8	10.4	4.8	10	2.5	0.7	5.3	12.4	1	1.2	1.1	2	2	0.6	1.7	2.2	0.7	0.6	1.8	4.4	1.5	4.7	4.7	0	0	0	0	0	0.1	0	29.8	0.7	0.5	0.4	0.1	0.1	0.1	1.2	0.2	1.2	1.2	0.1	0.7	0.3	0.1	0.4	0.3	31.5	0	28	0.2	0.1	0.9	0.4	3	0	0	0.1	0.6	0	11.8	0.5	9	5.4	0	0.4	0.3	0.9	0.1	2.1	0.1	1.7	2.6	0	1.1	0.5	0	0.4	0.1	0.5	0.6	0.2	0.1	0	0.6	0.5	5	4.5	0.3	0.5	0.2	0.2	1.2	3	2.2	0.3	4	1.4	1.2	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.7	2.5	4.3	1.7	0.6	1.6	1	0.1	4.8	0.7	0	0	0	2.6	0	1.7	0.6	0	0	0	0	0	0.1	3.3	0.1	5.6	0	0.8	0	0.2	0	0.2	3.4	0	0	0.1	0	0	0	0	1.1	0.3	0	0	0	0.5	0.1	0	0	0.4	0.8	4.7	0	0.3	0	0	0	0	0	0.6	56.7	Urothelial cells
ERI3	FLJ22943, PINT1, PRNPIP	ENSG00000117419	ERI1 exoribonuclease family member 3	O43414	1	44221070-44355260	Predicted intracellular proteins		Exonuclease, Hydrolase, Nuclease		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	4	Late spermatids: 823.2	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low cell line specificity	Detected in all			Low region specificity	Detected in all							HPA027147, HPA029895	Approved		Approved	Nucleoplasm,Cytosol		Yes	No			Nucleoplasm, Cytosol		HPA027147: AB_1855725, HPA029895: AB_2673239	unprognostic (1.31e-1)	unprognostic (2.39e-2)	unprognostic (3.26e-1)	prognostic unfavorable (1.18e-4)	unprognostic (5.94e-2)	unprognostic (6.21e-2)	prognostic unfavorable (2.04e-6)	unprognostic (6.48e-2)	unprognostic (2.67e-1)	unprognostic (6.70e-3)	unprognostic (5.30e-2)	unprognostic (2.49e-1)	unprognostic (1.49e-2)	unprognostic (2.07e-1)	unprognostic (7.47e-2)	unprognostic (1.08e-1)	unprognostic (2.07e-3)	12.6	15.4	30.7	8.3	32	12.4	15.2	19.7	43.7	15.1	13.4	23.2	10.8	12.3	14.7	22.2	13.4	23.4	12.7	21.1	28.9	25.1	25.3	15.5	11.7	10	23.9	26.8	18.6	15.7	24	17.2	13.5	22.9	16.7	14.1	14.8	14.7	16.9	35.7	13.3	8.6	17.7	17.9	9.5	10.6	24.4	21.9	9.7	17.6	11.9	11	12.5	12.1	18.8	25.3	9.6	22.2	14.8	18.2	15.2	28.6	22.2	28.2	31.2	18.5	23.3	17.7	18.8	25	33.4	31.2	14.3	30.7	20.5	31.8	23.1	17.1	16.6	25.2	32	23.6	22.9	48.6	22.9	37.5	20.2	27.1	23.1	13.2	23.7	30.1	25.3	34.8	24.8	22.9	22.9	22.3	16.7	21.9	19.3	25.6	21.6	33.4	25.5	35.2	24.7	25.9	30	25.9	15.1	48.1	22.7	20.5	28.1	33.2	23.3	18.4	19.1	13.9	22.1	23.1	24	28.4	15.9	18.5	22	27.4	20.1	27.8	9.4	16.3	9.6	16.7	22.2	18.2	18.8	14	16.2	25.3	18.3	16.7	17.2	1.5	14.8	21.3	18.9	18.1	15.2	30.7	32	19.7	43.7	28.9	25.1	23.9	26.8	22.9	21.9	23.8	16.8	23.4	29.6	28	20.9	13.7	10.2	10.7	9.1	27.9	2	80	82.9	48.6	192.5	20.2	20	0	54.5	67.1	42.9	35.8	15	21.3	39.5	23.8	113.7	19.6	24.3	823.2	33.6	22.4	45.5	35.1	48.9	30.3	33	25.9	34.3	131.8	13.5	6.5	31.1	46.2	48.7	30.2	51.5	15.4	35.1	23.5	Late spermatids
HSD11B1	HSD11, HSD11B, SDR26C1	ENSG00000117594	Hydroxysteroid 11-beta dehydrogenase 1	P28845	1	209686178-209734950	Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins	Lipid metabolism, Steroid metabolism	Oxidoreductase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	7	liver: 183.4	Cell type enriched	Detected in many	13	Hepatocytes: 560.1	Cancer enriched	Detected in all	28	liver cancer: 197.4	Low region specificity	Detected in many			Cell type enhanced	Detected in some		memory CD4 T-cell: 9.2	Lineage enriched	Detected in single	20	T-cells: 9.2	Cell line enriched	Detected in some	5	ASC diff: 151.9	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA047729	Enhanced								77000			HPA047729: AB_2680135	unprognostic (1.08e-3)	unprognostic (2.13e-1)	unprognostic (2.32e-1)	unprognostic (1.40e-1)	unprognostic (1.57e-1)	unprognostic (3.68e-1)	unprognostic (2.02e-2)	unprognostic (1.12e-1)	unprognostic (1.30e-1)	unprognostic (3.63e-2)	unprognostic (8.35e-3)	unprognostic (8.69e-2)	prognostic unfavorable (1.97e-10)	unprognostic (3.41e-2)	unprognostic (3.91e-2)	unprognostic (6.45e-2)	unprognostic (1.59e-2)	4.6	1.6	1.1	3	3.1	0.3	2.4	9.9	3.9	0.6	1	1.6	2.7	0.5	0.8	8.7	1.5	0.9	1.9	3	1.8	0.9	2.6	183.4	7.2	1.3	8.2	2	12.6	0.9	0.3	1.5	26.5	3.3	7.1	0.9	1.5	0.6	3	1.5	6.3	0.9	2.7	1.3	3.5	1.4	2.3	2.5	0	1	0.6	0.6	3.9	1.4	0.2	0	0.2	0.1	0.4	9.2	0.8	0	0	0	0	151.9	15.8	0	0	5.2	0	0	0	0	0	0	0	0	0	0	6.4	0	0	0	0	0	0	31.7	0	0	0.8	0	1	0	0.1	0	0	0	7.6	0	0	0	0	0	0	0	0	0.1	2.2	0	0	0	0	0	0	0	0	0	4.9	1.2	0.6	0	0	0	0.2	0	0	0.8	0.2	0	0	0.1	0	0.3	0	0.6	0.2	9.2	2	0	0	0.2	0	0.2	0.4	0	0	2.4	0.8	1.1	3.1	9.9	3.9	1.8	0.9	8.2	2	3.3	2.5	3	0	2.4	0.5	0.1	0	0.8	43.3	0	0	0	0	0	0	0	4.6	0	0	0	0	0	10.8	0.5	0	560.1	8.7	0	0	8.6	8.9	2.2	27	2.2	0	1	0	15.4	0.2	0	7.4	0	0.3	0	2.1	0	0.2	0.1	0.2	0.5	0	1.6	Hepatocytes
SERPINC1	AT3, ATIII, MGC22579	ENSG00000117601	Serpin family C member 1	P01008	1	173903804-173917378	Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins	Blood coagulation, Hemostasis	Heparin-binding, Protease inhibitor, Serine protease inhibitor	Disease mutation, FDA approved drug targets, Thrombophilia	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	203	liver: 450.5	Cell type enriched	Detected in some	54	Hepatocytes: 2236.3	Cancer enriched	Detected in some	871	liver cancer: 1504.0	Not detected	Not detected			Cell type enhanced	Detected in single		eosinophil: 2.2	Lineage enhanced	Detected in single		granulocytes: 2.2	Cell line enriched	Detected in some	35	Hep G2: 42.6	Not detected	Not detected			Not detected	Not detected			HPA001816, CAB016790, HPA024007	Supported				Secreted to blood				210000000000			CAB016790: , HPA001816: AB_1079926, HPA024007: AB_1856732	unprognostic (1.28e-2)	unprognostic (2.22e-1)	unprognostic (3.83e-2)	unprognostic (5.98e-2)	unprognostic (6.91e-2)	unprognostic (1.93e-2)	prognostic favorable (3.40e-5)	unprognostic (1.75e-2)	unprognostic (8.67e-2)	unprognostic (3.48e-2)	unprognostic (4.74e-2)	unprognostic (1.91e-1)	unprognostic (2.36e-2)	unprognostic (5.28e-3)	unprognostic (5.80e-2)	unprognostic (6.35e-2)	unprognostic (8.21e-2)	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0.2	450.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	2.2	0	0	0.5	0	0	0	0	0.1	0	0	1.2	0	0	0	0	0.3	0	0.2	0	0	0	0	0	0	0	0	0	0.2	0.1	42.6	0	0.8	0.1	0	0.1	0	0	0	0	0	0.2	0	0	0	0	0	0.2	0.1	0	0.1	0.9	0	0	0	0	0.1	0.6	0	0	0.1	0	0.1	0.1	0	0	0	0	0.2	0	0.5	0.1	0.5	0	0	0	2.2	0.5	0	0	0	0.4	0	0	0	0.2	0	0	0	0	0	0.1	0	0	0	0	0.1	0	0	0	0	0	0	3	0	14	0	0	0	0.1	38.2	0	0	0	0	0	0	0	0.2	0	0	0	0.3	0	0	0.2	0	2236.3	0.2	0	0	37.4	41.2	0	0	0	0	0	0	0	0	0	0	2.1	0	0	0	0.2	0	0.3	0.2	0	0	0.1	Hepatocytes
MUC5B	MG1, MUC5	ENSG00000117983	Mucin 5B, oligomeric mucus/gel-forming	Q9HC84	11	1223066-1262172	Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		gallbladder: 301.7;lymphoid tissue: 155.1;salivary gland: 192.8	Cell type enriched	Detected in some	4	Cholangiocytes: 591.1	Low cancer specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	7	OE19: 41.8;PC-3: 45.1									HPA008246, CAB009396	Enhanced		Supported	Vesicles	Secreted in other tissues				590000	Vesicles		CAB009396: AB_2282256, HPA008246: AB_1854203	unprognostic (2.01e-2)	unprognostic (1.46e-1)	unprognostic (9.39e-2)	unprognostic (2.76e-3)	unprognostic (5.46e-2)	unprognostic (1.22e-1)	unprognostic (4.89e-2)	unprognostic (7.80e-3)	unprognostic (3.75e-1)	unprognostic (1.11e-1)	unprognostic (4.18e-2)	unprognostic (8.95e-2)	unprognostic (2.57e-7)	unprognostic (2.71e-1)	unprognostic (1.61e-1)	unprognostic (1.07e-1)	unprognostic (8.13e-2)	0.1	0.1	0.1	0.7	0.1	0	0.2	0.1	0.1	67.4	8.4	0	0	0	1.9	0	11.6	0.2	301.7	0.1	0.1	0.1	0.1	0.6	2	0	0.1	0	0.1	2.2	0	0.1	0	0	0.1	4.6	0	192.8	0	0.7	0.1	0.3	0.1	0.1	0.1	1.5	0.1	0	0	0.1	31.6	155.1	0.1	0.1	0	0	0	0	0	0	0	0	6.3	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4.2	0	0	0	41.8	45.1	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	32.8	0.9	0	0	0	10.5	591.1	34.8	46.6	0	0	0.1	0	0	0	0	14.6	0	0	0.1	0	1.2	4.6	0	0.2	0	23.5	0	0	0	0	0	0	0	127.1	0	0.5	48.9	0	0	0	0	0	0	0	0	0.1	0	131.5	0.3	Cholangiocytes
A4GNT	alpha4GnT	ENSG00000118017	Alpha-1,4-N-acetylglucosaminyltransferase	Q9UNA3	3	138123718-138132387	Predicted intracellular proteins		Glycosyltransferase, Transferase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Group enriched	Detected in some	8	gallbladder: 25.9;pancreas: 7.0;stomach 1: 25.0	Cell type enriched	Detected in single	9	Cholangiocytes: 2.5	Group enriched	Detected in some	6	pancreatic cancer: 2.5;stomach cancer: 3.6	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		A549: 2.6;BJ: 3.7;hTERT-RPE1: 1.6	Not detected	Not detected			Low region specificity	Detected in some			HPA008017	Enhanced				Intracellular and membrane							HPA008017: AB_1078073	unprognostic (1.21e-1)	unprognostic (2.52e-1)			unprognostic (2.14e-1)	unprognostic (1.18e-2)	unprognostic (1.48e-2)	unprognostic (8.79e-2)	unprognostic (9.35e-2)	unprognostic (1.97e-1)	unprognostic (1.81e-1)	unprognostic (1.85e-1)	unprognostic (4.03e-2)	unprognostic (1.03e-1)	unprognostic (7.79e-2)	unprognostic (2.55e-2)	unprognostic (6.48e-3)	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	2.5	0.1	0.1	0.1	0.1	25.9	0.1	0.1	0.1	1.5	0.4	0.3	0.1	0.1	0.1	0.2	7	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	25	0.1	0.1	0.1	0.3	0.1	0.1	0.3	0.1	0	0	0	0	0	0.8	0	0.3	2.6	0	0	0	0	0	3.7	0	0	0.1	0	0.2	0	0	0	0.1	0.1	0	0	0	0	0	0.2	0.1	0	0	0.1	0.3	0.2	0	0	0	1.6	0	0.1	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0.1	0.1	0	0.1	0	0	0.1	0.4	0.6	0	0.2	0.1	0.8	0	0	0	0	0.1	0.6	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0.8	0	0	0	0	0	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0.3	2.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Cholangiocytes
TREH	MGC129621, TRE, TREA	ENSG00000118094	Trehalase	O43280	11	118657316-118679690	Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins		Glycosidase, Hydrolase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	8	intestine: 51.8	Cell type enriched	Detected in some	6	Late spermatids: 233.7	Low cancer specificity	Detected in some			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		BEWO: 5.4;Hep G2: 2.1;RPMI-8226: 1.9;SiHa: 1.8;SK-MEL-30: 1.5;U-2 OS: 2.5	Not detected	Not detected			Low region specificity	Detected in some			HPA039913, HPA042045	Enhanced				Intracellular and membrane				12000000			HPA039913: AB_10674988, HPA042045: AB_2677817	unprognostic (1.29e-1)	unprognostic (1.58e-1)	unprognostic (1.01e-2)	unprognostic (5.22e-4)	unprognostic (2.52e-1)	unprognostic (9.83e-2)	prognostic favorable (3.76e-4)	unprognostic (1.17e-1)	unprognostic (1.34e-1)	unprognostic (2.42e-1)	unprognostic (1.04e-1)	unprognostic (1.63e-2)	prognostic favorable (2.33e-6)	unprognostic (2.09e-2)	unprognostic (6.30e-2)	unprognostic (1.22e-1)	unprognostic (1.15e-1)	0.1	0.1	0.1	0.2	0.1	0	0.1	0.2	0.1	0.1	24.1	0	0	28.9	0.1	3.3	0.6	0.1	3.7	0.1	0.1	0.1	6.1	2.6	0.1	0	0.1	0	0.1	0.5	0	0.1	0	0.1	0.2	0.4	0	0.2	0	0.1	0.1	51.8	0	0.1	0.1	0.6	0.3	0	0	0.1	0	0.3	0.1	0.1	0	0.5	0	0	0	0	0.1	0	0	0.2	0	0.1	0.3	5.4	0	0	0	0	0.8	0.7	0	0.5	0	0	0.1	0	0	0	0	0.1	0	0	2.1	0	0	0.1	0	0	0	0.1	0	0.2	0	0	0	0	0.1	0	0.3	0.1	0	0	0	0.1	1.9	0	0	0.2	0.9	1.8	0.3	1.5	0.1	0.7	0	0.8	0.1	2.5	0.4	0.2	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0	0.1	0	0	0	0	0.7	0	0	0	0	0	0	1.8	0	0	6.6	0.1	37.2	0	2.9	0	2.3	0	0	0.2	0	0	0.1	0	2.9	0	0	233.7	2	0	0	0	0.9	0	0.6	5.8	1.8	16.5	0	0	0.1	1.8	0.8	0	0	0	1.2	0	Late spermatids
MMP8	CLG1	ENSG00000118113	Matrix metallopeptidase 8	P22894	11	102711795-102727050	Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Collagen degradation	Hydrolase, Metalloprotease, Protease	Cancer-related genes, FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	6	bone marrow: 119.3	Cell type enriched	Detected in single	32	Hofbauer cells: 4.3	Cancer enriched	Detected in single	17	melanoma: 5.7	Region enhanced	Detected in single		cerebral cortex: 1.7	Group enriched	Detected in some	32	neutrophil: 1.4;non-classical monocyte: 4.9	Group enriched	Detected in many	32	granulocytes: 1.4;monocytes: 4.9	Cell line enriched	Detected in some	8	WM-115: 40.1	Not detected	Not detected			Not detected	Not detected			HPA021221, HPA022935	Enhanced				Secreted to extracellular matrix				83000			HPA021221: AB_1854043, HPA022935: AB_1854044	unprognostic (3.03e-1)	unprognostic (8.49e-5)	unprognostic (1.08e-2)	unprognostic (3.95e-3)	unprognostic (1.80e-1)	unprognostic (1.01e-2)		unprognostic (7.68e-3)	unprognostic (1.27e-1)	unprognostic (4.92e-2)	unprognostic (6.64e-3)		unprognostic (2.45e-6)	unprognostic (2.33e-4)	unprognostic (1.33e-1)	unprognostic (4.97e-1)	unprognostic (2.30e-2)	1.9	0.1	0.2	0.2	0.4	119.3	0.3	0.1	1.7	0.1	0.2	0	0	0.1	0.6	0.1	0.1	0.1	0.1	9	0.2	0.3	0.4	0.8	12.6	2.6	0.3	0	0.9	0.9	0.1	0.6	1.4	0.2	0.1	0.1	0.1	0.3	0.1	0.6	0.3	0.1	0.2	0.3	18.7	0.2	0.1	0.1	5.2	1.9	0	0.1	0.2	7.6	0	0	1.4	4.9	0	0	1.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5.1	0	0	0	0	2.8	0	0	0	0	0	0	0	0	40.1	0	0	0	0	0	0	0	0	0	0	0	0	0	1.4	0	4.9	0	0	1.7	0.2	0.4	0.1	1.7	0.2	0.3	0.3	0	0.2	0.1	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Hofbauer cells
APOA1		ENSG00000118137	Apolipoprotein A1	P02647	11	116835751-116837950	Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport		Amyloidosis, Atherosclerosis, Cancer-related genes, Disease mutation, Neuropathy	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	4	liver: 573.5	Cell type enriched	Detected in many	33	Hepatocytes: 19896.2	Cancer enriched	Detected in many	48	liver cancer: 4515.8	Not detected	Not detected			Cell type enhanced	Detected in some		plasmacytoid DC: 3.6	Group enriched	Detected in many	4	dendritic cells: 3.6;T-cells: 2.4	Cell line enriched	Detected in some	18	Hep G2: 253.4	Low region specificity	Detected in some			Low region specificity	Detected in all			CAB016778, HPA046715	Supported		Approved	Vesicles,Cytosol	Secreted to blood			1450000000000	220000000000	Vesicles	Cytosol	CAB016778: , HPA046715: AB_2679768	unprognostic (1.88e-3)	unprognostic (4.53e-2)	unprognostic (7.46e-2)	unprognostic (4.00e-3)	unprognostic (3.70e-2)	unprognostic (1.41e-1)	prognostic favorable (5.05e-4)	unprognostic (5.40e-2)	unprognostic (1.89e-1)	unprognostic (9.60e-3)	unprognostic (1.59e-3)	unprognostic (7.02e-2)	prognostic unfavorable (1.67e-8)	unprognostic (3.46e-3)	unprognostic (1.15e-1)	unprognostic (6.24e-2)	unprognostic (9.54e-2)	0.2	0	0.2	0.2	0.2	0	0.2	0.2	0.2	0.2	24.6	0.2	0.2	55.6	0.2	0.3	0.2	0.1	0.3	1.3	0.2	0	0.2	573.5	0.2	0.2	0.2	0.2	0.7	0.2	0	0.2	0.2	0.2	0.2	0	0.2	0.3	0.2	0.2	0	127.9	0.2	0.2	0.4	0.3	11.8	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.5	3.6	0	0.7	0.7	2.4	0.5	0	0	0	0	0	0	1.3	0	0	0	0	14.1	0	0.2	0.4	0	0	0	0	0	0	0	0	0.6	0.1	253.4	0	1.3	0	0	0	0	0	0	0	0	0.1	0	0	0	0	1.2	0.1	0	0	0	1.3	1.6	0	0.2	0.4	1.7	0.7	0	0	0.3	0	0	0.2	0	0	0.1	0	0.1	0	0.4	0	0.4	0	0	0.2	0	2.4	0.7	0.3	0	0.2	1.8	0.8	0.5	0.8	1.7	0	0.7	0	3.6	2.1	0.5	0.2	0.2	0.2	0.2	0.2	0	0.2	0.2	0.2	0.2	3	3.5	174.9	0.2	0.1	0.6	24.6	596.2	0	2.3	0	0	0.4	0	0.1	30.6	1.9	0.9	256.9	1	1.1	1.5	0.1	2.3	19896.2	3.1	0	1.7	472.6	569.9	110.5	20.8	0.6	0	0	0.5	0.1	0.2	0.3	4.6	2.2	0.6	6.5	0.7	10.3	9.1	0.5	3.5	2.9	0.3	0.3	Hepatocytes
SLC8A2	KIAA1087, NCX2	ENSG00000118160	Solute carrier family 8 member A2	Q9UPR5	19	47428017-47472168	Plasma proteins, Predicted membrane proteins, Transporters	Antiport, Calcium transport, Ion transport, Sodium transport, Transport	Calmodulin-binding		Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	5	brain: 50.9	Cell type enriched	Detected in some	8	Bipolar cells: 16.2	Low cancer specificity	Detected in some			Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	6	NTERA-2: 4.4;SCLC-21H: 12.5;SH-SY5Y: 6.7;SiHa: 5.2;U-2 OS: 8.1	Group enriched	Detected in many	4	amygdala: 80.3;basal ganglia: 95.4;cerebral cortex: 125.2;hippocampal formation: 110.1	Low region specificity	Detected in all			HPA050818, HPA054671	Enhanced											HPA050818: AB_2681248, HPA054671: AB_2682568	unprognostic (3.75e-2)	unprognostic (1.84e-1)	unprognostic (1.42e-1)	unprognostic (4.32e-2)	unprognostic (1.34e-1)	unprognostic (6.00e-3)	unprognostic (1.38e-1)	unprognostic (2.79e-1)	unprognostic (1.34e-1)	unprognostic (8.95e-2)	unprognostic (4.77e-2)	unprognostic (2.04e-2)	unprognostic (2.81e-3)	unprognostic (6.13e-2)	unprognostic (9.40e-2)	unprognostic (1.53e-1)	unprognostic (1.63e-2)	1.2	4	16.6	1	18.1	0.9	0.9	50.9	50.7	1	2.4	1.8	1	1.3	5.4	1	2.3	2.2	1.1	0.9	21.4	6.8	1	0.9	0.9	0.9	2.1	21.1	0.9	10.3	0.9	3.2	1	2	1.4	1.4	0	1.2	4.4	0.9	1	1.2	5.5	2	1	1.3	1.9	1.2	0	1	0	0.9	1.2	0.4	0	0	0	0	0	0.3	0	0	0.5	0.1	0.2	0	0	0	0	0	0	0	0	0.1	0.2	0.1	0	0.4	0.2	0	0	0	0	0.1	0	0	0	0	0	1.2	0	0.2	0	0	0.1	0	0.1	0.2	0.1	0	0	0	0.1	4.4	0.6	0	0	0	0	0.4	0.1	12.5	6.7	5.2	0.6	0.4	0.4	0.2	0	0	0	8.1	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.6	18.1	50.9	34.6	21.4	6.8	2.1	21.1	2	1.2	0	0	0	0.1	0	16.2	1.4	0	0	0	0	2	0	0	0.3	1.6	0	0	0	0	0	0	0.1	0	0	0.1	0	1.7	0	0	0.2	0	0	0	0	0	0.3	0.5	0	0	0	0.9	0	0.3	1.1	1.7	0	0.1	0	0	0.1	Bipolar cells
TNNT2	CMD1D, CMH2, CMPD2	ENSG00000118194	Troponin T2, cardiac type	P45379	1	201359008-201377762	Candidate cardiovascular disease genes, Disease related genes, Predicted intracellular proteins		Muscle protein	Cardiomyopathy, Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	241	heart muscle: 679.2	Cell type enriched	Detected in many	289	Cardiomyocytes: 11884.8	Low cancer specificity	Detected in many			Low region specificity	Detected in some			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	18	RH-30: 189.8	Low region specificity	Detected in many			Not detected	Not detected			CAB015371, HPA015774, HPA017888	Enhanced		Uncertain	Nucleoplasm,Nucleoli,Focal adhesion sites		No	No		50000	Nucleoplasm, Nucleoli	Focal adhesion sites	CAB015371: AB_630390, HPA015774: AB_1858354, HPA017888: AB_1858355	unprognostic (1.45e-1)	unprognostic (2.74e-1)	unprognostic (2.33e-4)	unprognostic (1.85e-1)	unprognostic (7.29e-2)	unprognostic (1.79e-1)	unprognostic (1.80e-1)	unprognostic (1.24e-1)	unprognostic (1.42e-1)	unprognostic (2.91e-2)	unprognostic (1.38e-1)	unprognostic (8.63e-2)	unprognostic (5.50e-3)	unprognostic (2.94e-1)	unprognostic (1.61e-1)	unprognostic (4.76e-2)	unprognostic (9.98e-2)	0.1	0.3	0.1	0.1	0.7	0	0.8	0	2.1	0	0	0	0	0	0.1	0.1	0.3	0	1.2	679.2	0.9	0	1.9	0	0.7	0.3	0.1	1.1	0.1	0.3	0	0.2	0.7	0.1	0.7	0	0	0.2	0.1	2	1.3	0	2.8	0.3	0	0	0	0	0	0.2	0.4	0	2.7	0.2	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0.3	0	0	0	0	0.2	0	0	0	0	0	0.9	0	0	0	0	0	0	0.1	0.1	0	0.1	0	7.2	0	0	0	0	0	0	0	0	4	0.1	0	0	0.4	0.5	0	0	189.8	0	0	0	0.2	0.1	0	0.2	0	10.5	0	0	0	0	5.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.7	0	2.1	0.9	0	0.1	1.1	0.1	0	3	4	0	1.1	3.1	1	11884.8	0	0	1.2	1.8	0	2.3	0	0.5	9.4	0	1.6	0	0.3	0.9	41.1	0.5	0	0	2.7	0	0	0	0	13.6	0.6	0	0	4.6	0.5	0	0.7	0.8	1.1	0.8	0.5	0	0.4	0	0.2	6.4	3.5	0	2.8	1.4	Cardiomyocytes
CREB1		ENSG00000118260	CAMP responsive element binding protein 1	P16220	2	207529737-207603431	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors	Biological rhythms, Differentiation, Host-virus interaction, Transcription, Transcription regulation	Activator, DNA-binding	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	6	Early spermatids: 355.9	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low cell line specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			CAB003803, HPA019150	Supported		Enhanced	Nucleoplasm						Nucleoplasm		CAB003803: AB_562092, HPA019150: AB_1847220	unprognostic (1.20e-1)	unprognostic (3.15e-1)	unprognostic (3.30e-2)	unprognostic (2.69e-2)	unprognostic (3.16e-2)	unprognostic (1.03e-1)	prognostic unfavorable (2.77e-5)	unprognostic (8.41e-2)	unprognostic (1.04e-2)	unprognostic (2.53e-1)	unprognostic (9.58e-2)	unprognostic (1.74e-2)	unprognostic (4.82e-3)	unprognostic (5.53e-3)	unprognostic (1.06e-1)	unprognostic (1.77e-1)	unprognostic (8.45e-2)	21.2	12.9	19.4	24.8	17	22.9	16.7	25.5	18.7	17.6	15.7	14.3	14.7	12.6	19.3	14.9	17.9	15.4	15.5	14.4	15.4	14.5	14.6	13.1	17.7	21.7	15.8	17.7	20.5	12.9	19.8	20	19.8	16.1	16.3	16.2	11.2	16.2	14.9	11.6	14.3	15.2	19.5	19.8	19	13.3	39.2	18.5	38.4	19.7	13.3	27.7	16.1	23.6	22.1	20.7	34.8	19.1	28.4	22.5	14.5	15.3	13.8	25.5	9.8	15	15.4	14.6	9.9	14.8	17.2	18.1	13.9	15.6	10	13.3	14.5	20.2	13.4	23.1	13.5	25.3	15.9	8.3	18.3	12.3	14.2	12.6	17.3	13.5	11.1	10	14.2	21.1	17.2	24.1	18.7	12.8	14.6	21.2	10.6	26.2	10.2	18.2	15.4	8.4	20.5	13.9	13.1	15.4	15.9	17.6	15.3	13.7	10.1	11.9	25.5	11.3	18.9	11.5	14.1	15.1	14.7	12.6	13.2	16.7	23	17.3	15.9	14.7	16.9	17	16.8	17.3	18	15.4	22.1	16.6	16.7	20.7	20.2	19.9	13.5	34.8	28.4	19.1	11.3	22.5	14.5	19.4	17	25.5	18.7	15.4	14.5	15.8	17.7	16.1	18.5	17.9	12.8	45.4	39.6	63	36.1	22.1	12.7	9.4	25	12.2	31.4	24.5	19.9	20.2	355.9	44.6	20	0	17.9	21.7	32.3	41.9	42.7	14.3	25.7	38.1	31.2	31.3	43.4	27.4	24.2	38	42.2	36.9	24.2	40	21.9	23.5	27.6	15.6	36.9	38.8	34.1	24.7	27.5	50.6	15.6	31.9	23	54.8	Early spermatids
TTR	CTS, CTS1, HsT2651, PALB	ENSG00000118271	Transthyretin	P02766	18	31591726-31599021	Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins	Transport	Hormone, Thyroid hormone	Amyloidosis, Cancer-related genes, Disease mutation, Neuropathy	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	11	brain: 1008.0;liver: 680.8;retina: 332.4	Cell type enriched	Detected in many	24	Hepatocytes: 22945.1	Group enriched	Detected in many	28	liver cancer: 928.2;pancreatic cancer: 666.0	Region enriched	Detected in many	9	pons and medulla: 1008.0	Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		CACO-2: 31.4;EFO-21: 11.1;Hep G2: 48.2;U-2 OS: 14.5	Group enriched	Detected in many	5	basal ganglia: 1513.1;hippocampal formation: 5269.0;pons and medulla: 5831.5;thalamus: 3501.9	Region enhanced	Detected in many		pons and medulla: 1006.9	CAB002517, HPA002550, CAB062567, CAB073406	Supported		Approved	Golgi apparatus	Secreted to blood			345000000000	180000000000	Golgi apparatus		CAB002517: AB_563965, CAB062567: AB_2665620, CAB073406: , HPA002550: AB_1080419	unprognostic (6.79e-3)		unprognostic (3.38e-2)	unprognostic (4.10e-1)	unprognostic (1.74e-1)		unprognostic (1.84e-2)	unprognostic (8.15e-2)	unprognostic (3.74e-2)		unprognostic (9.66e-3)	unprognostic (8.72e-2)	unprognostic (1.23e-2)	unprognostic (8.35e-3)	unprognostic (5.26e-1)		unprognostic (3.52e-2)	0.5	0.4	3.6	0.4	3	0.6	0.4	5.8	60.8	0.4	0.6	361.3	0	0.9	0.4	0.4	0.4	0.4	3.3	0.4	115.6	4.4	1	680.8	0.4	0.4	7.1	0	0.4	62.3	1.6	0.5	0.4	1008	0.4	0.5	332.4	0.4	0.4	0.4	1	0.6	0.4	4.9	0.5	2	0.4	0.6	0	0.4	0	0.4	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	31.4	0	0.6	11.1	0	0	0	0	0	0	0.5	0	1.2	0	48.2	0	2.7	0.1	0	0	0	0	0	0	0	0.6	0	0	0	0	0	0	1	0	0	2.3	0	0	0	0	0	1.6	0	0	0.1	0	0	0.3	0	14.5	0	1.1	0	0.6	4.5	0	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.6	3	5.8	60.8	115.6	4.4	7.1	0	1008	0.6	0	0	32.7	0	0.5	25.4	1.4	973.2	0	0	5.2	153.2	0.2	5	2.7	5.4	0.1	1.1	163.5	1.6	0.6	0.6	0.2	0	22945.1	2.3	25.4	342.4	228.9	289.5	6.6	0.3	0	0	0	1.5	13.2	212.8	2.9	0	1.1	45.2	0	0.4	3.4	0.6	0.1	3.3	0.5	1.6	0	Hepatocytes
FILIP1	FILIP, KIAA1275	ENSG00000118407	Filamin A interacting protein 1	Q7Z7B0	6	75291859-75493738	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		heart muscle: 37.6;smooth muscle: 44.7	Cell type enriched	Detected in many	5	Cardiomyocytes: 542.5	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		EFO-21: 10.7;HUVEC TERT2: 2.7;RPTEC TERT1: 3.0;U-266/70: 10.7	Low region specificity	Detected in many			Low region specificity	Detected in many			HPA053564	Enhanced		Approved	Plasma membrane,Actin filaments		No				Plasma membrane, Actin filaments		HPA053564: AB_2682192	unprognostic (4.90e-2)	unprognostic (3.77e-2)	unprognostic (9.77e-3)	unprognostic (3.83e-1)	unprognostic (1.52e-1)	unprognostic (4.98e-1)	unprognostic (2.27e-2)	unprognostic (1.51e-1)	unprognostic (1.06e-1)	unprognostic (5.17e-3)	unprognostic (3.29e-2)	unprognostic (2.23e-1)	unprognostic (1.30e-3)	unprognostic (3.97e-3)	unprognostic (2.34e-1)	unprognostic (4.65e-2)	unprognostic (7.66e-3)	11	1.3	2	6.3	3	0.2	2.5	0.6	2.5	8.2	10.9	0	4.1	1.3	8.8	4.1	10.5	4.5	5.9	37.6	3.7	1.2	2.7	2.4	7.5	1.2	1.1	0.7	4.4	1.4	5.4	5.1	3.7	0.8	14.9	2.6	4.3	1.5	2.8	29.4	0.9	4.1	44.7	1.4	0.6	3.9	2.8	0	0	2.3	10.8	0.7	30.7	6	1.4	0.9	1.8	0.8	0.6	0.9	0	0.1	1.9	0.3	0.1	0.1	0.3	0.2	0.3	0.1	0.1	0	0	0.2	0.2	10.7	0	0.1	0.1	0.1	0	0.1	0.3	0.2	0.2	0.2	0.1	0	0.3	0.2	1.4	0.1	0.2	0.1	0.1	2.7	0.4	0.1	0.4	0	0.1	0	0.1	0.2	0	0	0.1	0	0.1	3	0.6	0.2	0.2	0	0.1	0.1	2.5	0.1	0.4	0	0.1	0	0.1	0.1	10.7	1	0.1	0.1	0.5	0.1	1.2	0.6	0.6	0.6	0.6	0.5	0.6	0.5	0.4	0.2	1.4	0.9	0.6	1.8	0.6	0.8	0.9	0.3	0	2	3	0.6	1.9	3.7	1.2	1.1	0.7	0.8	0	119.1	78.3	0	0.6	0.6	3.3	542.5	0	83	14.8	0	0	0.7	1.7	0	36.1	36.8	0	0	0.3	0.3	26.7	0.6	1.1	0.6	1.2	0	0	58.3	1.9	16.2	2.3	2	1.7	0	0	4.5	0	0	4.2	0	3.8	90.5	88.2	4.5	6.4	0.6	0.7	0	0	0.4	Cardiomyocytes
CNR1	CANN6, CB-R, CB1, CB1A, CB1K5, CNR	ENSG00000118432	Cannabinoid receptor 1	P21554	6	88139864-88166359	Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters		G-protein coupled receptor, Receptor, Transducer	FDA approved drug targets, Obesity	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 30.5	Cell type enriched	Detected in some	14	Sertoli cells: 97.0	Cancer enriched	Detected in many	13	glioma: 12.5	Low region specificity	Detected in all			Group enriched	Detected in some	5	memory B-cell: 2.9;naive B-cell: 2.1	Lineage enriched	Detected in single	6	B-cells: 2.9	Group enriched	Detected in some	7	ASC diff: 40.3;HSkMC: 26.6	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA042256, HPA069945	Enhanced	Supported	Supported	Plasma membrane,Actin filaments						Plasma membrane	Actin filaments	HPA042256: AB_2677917, HPA069945: 	unprognostic (1.28e-1)	unprognostic (7.04e-2)	unprognostic (4.61e-2)	unprognostic (4.08e-3)	unprognostic (1.21e-1)	unprognostic (1.07e-3)	unprognostic (1.37e-1)	unprognostic (2.07e-2)	unprognostic (2.49e-1)	unprognostic (1.16e-2)	unprognostic (2.74e-2)	unprognostic (2.68e-1)	unprognostic (1.70e-1)	unprognostic (5.59e-3)	unprognostic (2.68e-3)	unprognostic (5.88e-2)	unprognostic (7.00e-2)	19.4	6.4	18	5.2	15.8	1.5	14.9	13.8	30.5	3.9	5.5	0.8	0.8	2.3	3.1	4.7	3.7	5.5	3.6	1.4	17.6	7.7	0.9	0.7	6.4	6.5	2.3	14.7	4.1	1.8	1.3	18.3	5.2	4.2	1.5	5.1	0	4.3	4	1.7	2.4	4.2	5.8	3.2	2.3	2.3	2.7	2.8	0	2.6	0	9.9	2.7	3.1	2.9	0	0.4	0	0	0	0.1	0	0	1.8	0	40.3	4.8	0	0	0	0	0	0	0	0.1	0	0	0	0	2.9	0	0	0	0.1	0.9	1.4	0	2.6	0	0	26.6	0	0	0	0	0	0	0.8	0	0	0	0	0	0.6	0	0	0.1	0.2	0	3.3	0	0.8	0	0	0	0	0.1	0	0.6	2.3	0	0	0	0	0	0.7	3.3	0	0	1.3	0	0	0	0	0	0	2.9	0	0	0	2.1	0	0	0.4	0	0	0	0	0.1	18	15.8	13.8	21.4	17.6	7.7	2.3	14.7	4.2	2.8	0	7.2	2.7	0.4	0.6	0.2	0.5	0	0	0	0	0	0	0	0.1	0.2	0.6	0	0	0	0	0.5	0	0	0	0.1	0	0	0	0.3	0	1.4	0	0	0	0	0	0	0	0.4	0	0.1	97	2.3	0	0.1	0.1	0.1	0	0	0.7	Sertoli cells
SPACA1	SAMP32	ENSG00000118434	Sperm acrosome associated 1	Q9HBV2	6	88047789-88066832	Predicted membrane proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	99	testis: 49.2	Cell type enriched	Detected in some	26	Early spermatids: 646.7	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in single		HSkMC: 1.0	Not detected	Not detected			Not detected	Not detected			HPA026744, HPA043297	Enhanced											HPA026744: AB_2194642, HPA043297: AB_2678413															unprognostic (4.15e-2)			0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	49.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	646.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	24.8	5.2	0	0	0	0	0	0	0	2.5	0	0	6.5	0	22.2	4.4	0	0	0	0	0	Early spermatids
ARG1		ENSG00000118520	Arginase 1	P05089	6	131573144-131584332	Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins	Adaptive immunity, Arginine metabolism, Immunity, Innate immunity, Urea cycle	Hydrolase	Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	8	liver: 284.1	Cell type enriched	Detected in some	19	Hepatocytes: 867.5	Cancer enriched	Detected in some	45	liver cancer: 167.7	Not detected	Not detected			Cell type enriched	Detected in some	5	neutrophil: 24.4	Lineage enriched	Detected in many	5	granulocytes: 24.4	Cell line enhanced	Detected in some		Daudi: 1.5;Hep G2: 1.7;HL-60: 4.0;RH-30: 1.6;SiHa: 1.8;U-698: 2.2	Region enhanced	Detected in single		cerebellum: 2.7	Not detected	Not detected			HPA003595, CAB009434, HPA024006, CAB056159	Enhanced								15000000			CAB009434: AB_2058955, CAB056159: AB_2665582, HPA003595: AB_1078190, HPA024006: AB_1844987	unprognostic (2.00e-1)	unprognostic (2.09e-1)	unprognostic (2.49e-1)	unprognostic (1.74e-1)	unprognostic (9.95e-2)	unprognostic (7.96e-2)	unprognostic (7.73e-2)	unprognostic (1.68e-1)	unprognostic (1.22e-1)	unprognostic (1.56e-2)	unprognostic (7.55e-3)	unprognostic (8.35e-2)	unprognostic (1.25e-2)	unprognostic (2.90e-2)	unprognostic (2.75e-1)	unprognostic (1.11e-2)	unprognostic (1.79e-2)	1	0	0.1	0.1	0.1	34.3	0.6	0.1	0.2	0.1	0.1	0.1	0.1	0	0.1	0.2	0.2	0.3	0.1	3	0.2	0	0.1	284.1	5.1	0.8	0.2	0.1	0.4	0.2	0	0.1	1	0.1	0.1	0	0.1	0.1	0.1	0.3	14.6	0.1	0.1	0.1	3.5	0	0.3	0.1	0.5	0.3	1.7	0.3	0.3	0.7	0.1	0.1	24.4	0.4	0	4.7	0.1	0	0	0.1	0.4	0	0	0.8	0	0	0	0	0.3	0.1	1.5	0	0	0	0.1	0	0	0	0	0.3	0.3	0.2	1.7	0	4	1.3	0	0	0	0	0	0	0.2	0.5	0.6	0	0.5	0.1	0.4	0.1	0	0	0	1.6	0.4	0	0.3	0.2	0.1	1.8	0.4	0.3	0.2	0.1	0.5	0	0	0.2	0.3	0.1	1	0.2	2.2	0.1	0.5	0.4	0	0	0	0	0	0	0	0.5	0	0	0.1	0.4	0.1	24.4	0	0.4	0.1	4.7	0.1	0.1	0.1	0.1	0.2	0.2	0	0.2	0.1	0.1	0.1	0	0	13.9	0	0	0	0	17.8	0	0	0	0	0	0	0	0	0	0	46.7	0	0	0	0	0	867.5	0	0	0	25.2	17.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.9	0	0	Hepatocytes
GHRH	GHRF	ENSG00000118702	Growth hormone releasing hormone	P01286	20	37251082-37261835	Predicted secreted proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in some	5	brain: 37.3	Cell type enriched	Detected in single	4	Cardiomyocytes: 1.1	Cancer enriched	Detected in some	7	urothelial cancer: 8.5	Region enriched	Detected in some	15	hypothalamus: 37.3	Cell type enhanced	Detected in single		eosinophil: 2.7	Low lineage specificity	Detected in single			Group enriched	Detected in some	7	NTERA-2: 3.6;U-266/84: 12.7	Region enriched	Detected in some	9	hypothalamus: 38.7	Low region specificity	Detected in all								Secreted in other tissues								unprognostic (4.78e-2)				unprognostic (2.57e-2)									unprognostic (1.58e-1)	unprognostic (3.10e-1)			0.1	2.7	0.3	0.1	2.4	0	0.6	0.1	1	0.1	4	0.1	0.1	8.1	0.1	0.1	0.7	0	0.1	6.5	0.1	37.3	0.1	0.1	0.1	0.1	0.1	0.8	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0	7.7	0.1	0.1	0.1	1.9	0.1	0.1	7.5	0.4	0.1	0.1	0.1	0.1	0	0.7	2.7	0.6	0	0	0	0	0	0.7	0	0	0	0.7	0	0	0	0	0.9	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0.3	0	0	0	0	3.6	0	0	0.1	0.1	0	0	0	1.2	0	0	0.2	0	0.1	0	0	0	0	0	0	0.1	0	12.7	0	0	0	0	0	0.6	2.7	0	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0.3	2.4	0.1	1	0.1	37.3	0.1	0.8	0.1	0.1	0	0	0	0	0	0	1.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	Cardiomyocytes
CASQ2	PDIB2	ENSG00000118729	Calsequestrin 2	O14958	1	115700007-115768781	Disease related genes, Predicted intracellular proteins		Muscle protein	Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		heart muscle: 172.4;skeletal muscle: 46.5;smooth muscle: 45.9	Cell type enriched	Detected in some	8	Cardiomyocytes: 697.0	Low cancer specificity	Detected in many			Low region specificity	Detected in single			Cell type enhanced	Detected in single		neutrophil: 1.7	Lineage enriched	Detected in single	12	granulocytes: 1.7	Cell line enriched	Detected in single	19	HSkMC: 17.7	Region enriched	Detected in many	5	cerebellum: 48.4	Low region specificity	Detected in single			HPA027285, HPA055298	Enhanced				Intracellular and membrane							HPA027285: AB_1845933, HPA055298: AB_2682777	unprognostic (1.13e-1)	unprognostic (1.52e-1)	unprognostic (9.70e-3)	unprognostic (1.28e-1)	unprognostic (3.41e-2)	prognostic unfavorable (2.30e-4)	unprognostic (1.03e-4)	unprognostic (1.78e-1)	unprognostic (2.37e-1)	unprognostic (1.92e-1)	unprognostic (1.34e-1)	unprognostic (8.92e-2)	unprognostic (7.20e-3)	unprognostic (1.82e-2)	unprognostic (1.80e-1)	unprognostic (2.83e-1)	prognostic unfavorable (2.25e-5)	4.9	0.6	0.4	1.8	0.7	0.1	1.6	0.7	0.5	4.3	11.1	0.6	1.1	0.6	6.2	6.3	13.6	3	1.9	172.4	0.4	0.5	0.7	0.2	1.1	0.2	0.6	0.5	5	0.3	0.5	0.2	0.3	1	12.1	3.1	4.6	1.8	3.6	46.5	1	3.2	45.9	0.5	0.2	3.5	1.9	0	0	1.4	17.2	1.8	36.4	1.8	0	0.1	1.7	0	0	0.1	0	0	0	0.1	0	0.2	0.1	0.3	0	0	0	0	0.1	0.1	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	17.7	0.3	0	0.1	0.1	0	0.1	0	0.2	0	0.7	0	0.1	0	0	0	0	0	0	0	0.1	0	0	0	0	0.2	0.9	0.4	0	0	0.1	0	0	0	0.1	0	0	0	0	0.8	0.7	0	0.1	0	0	0	0	0	0.1	0	0	0	0	1.7	0	0	0.1	0	0	0.4	0.7	0.7	0.5	0.4	0.5	0.6	0.5	1	0	0	0	0	0.1	0.6	0	697	0	0	0	1.8	0	0.1	0	0	15.5	0	0	0	0	0.1	0.4	0.1	0	0	0	0	0	0	0	16.5	0	0	0	0	0	0	0	0	0.7	0	0	90.5	23.9	0.1	0.2	0.3	0	0	0	0	Cardiomyocytes
OLFM3	NOE3	ENSG00000118733	Olfactomedin 3	Q96PB7	1	101802574-101997030	Predicted intracellular proteins, Predicted secreted proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	9	brain: 30.0	Cell type enriched	Detected in some	5	Bipolar cells: 25.0	Low cancer specificity	Detected in single			Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	11	AF22: 9.5;HAP1: 6.6;HEL: 5.8;SCLC-21H: 3.8;SH-SY5Y: 3.8	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA050297			Uncertain	Vesicles	Secreted in brain					Vesicles		HPA050297: 			unprognostic (4.19e-1)	unprognostic (4.19e-4)	unprognostic (1.26e-1)				unprognostic (4.61e-2)	unprognostic (2.93e-1)	unprognostic (1.47e-2)			unprognostic (3.58e-4)	unprognostic (2.48e-1)	unprognostic (5.68e-2)		0.7	3.2	5	1.4	13.7	0.7	0.8	24.2	30	0.9	1.8	0.4	0	1	0.9	1.2	0.7	0.8	0.8	0.7	4.8	7.4	1.5	0.8	0.7	0.7	6	11.9	0.8	0.7	0.7	2.4	0.8	16.6	0.7	1.7	0.3	0.8	0.7	0.7	0.7	2.1	1.3	1.5	0.9	1	0.9	0.7	0	1.2	0	0.7	0.7	0.1	0	0	0	0	0	0	0	0	0	9.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	6.6	0	0	0	0	5.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0.1	0	0	0	0.5	0.3	0	0	3.8	3.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5	13.7	24.2	26.7	4.8	7.4	6	11.9	16.6	0.7	0	0	0	0	0	25	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0	5.5	0	0	0	0	0	0	0	0	0	Bipolar cells
SPP1	BNSP, BSPI, ETA-1, OPN	ENSG00000118785	Secreted phosphoprotein 1	P10451	4	87975650-87983426	Cancer-related genes, Plasma proteins, Predicted secreted proteins	Biomineralization, Cell adhesion	Cytokine	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		gallbladder: 303.9;kidney: 700.7;placenta: 331.0	Cell type enriched	Detected in many	9	Hofbauer cells: 50179.8	Cancer enhanced	Detected in all		glioma: 1690.9	Low region specificity	Detected in all			Cell type enriched	Detected in some	11	neutrophil: 19.2	Lineage enriched	Detected in single	192	granulocytes: 19.2	Cell line enhanced	Detected in some		EFO-21: 218.9;Hep G2: 107.8;RPTEC TERT1: 477.9	Region enhanced	Detected in all		pons and medulla: 331.4	Low region specificity	Detected in all			HPA027540, HPA027541	Enhanced		Enhanced	Golgi apparatus	Secreted to blood			114000000	54000000	Golgi apparatus		HPA027540: AB_10600222, HPA027541: AB_10601446	unprognostic (4.74e-2)	prognostic unfavorable (9.52e-4)	unprognostic (1.13e-3)	unprognostic (2.04e-1)	unprognostic (2.31e-2)	unprognostic (6.96e-3)	prognostic unfavorable (2.84e-6)	unprognostic (2.46e-3)	unprognostic (7.86e-2)	unprognostic (1.90e-2)	prognostic unfavorable (5.89e-4)	unprognostic (4.31e-2)	unprognostic (2.55e-1)	unprognostic (7.19e-2)	unprognostic (1.57e-1)	unprognostic (3.48e-1)	unprognostic (2.63e-2)	20.7	4.1	25.5	8.3	42.7	1.1	8.7	4.3	61	4.7	2.7	27.3	0	2.1	17.3	2.3	1.5	4.2	303.9	2.6	37.2	26.4	700.7	3.9	3.2	2	97	9.1	3.1	23.6	1.3	1.5	331	52.3	2.4	1.9	3.9	7.3	3.9	2.5	1.1	2.1	5.6	147.9	2.1	2	2.4	58.9	0	1.7	0	1.6	5.3	0.3	0	0	19.2	0	0	0	0	0	6.2	0.8	0	0	0	0	0.2	0.1	0	0.4	0	0	0	218.9	0.1	17.1	0	0	0	0.1	0.4	0	0	0	107.8	0	0.3	0.2	0	0	1.5	0	5.5	0.1	0	0	0.4	0	0	0	0.9	10.1	0	0	0.1	0	51.4	477.9	0	0	0	0	0	14.4	21.2	0	0.2	0	0.5	1.1	0	1.1	0	0.3	0.4	20	0	20.4	1.7	0	0	0	0	0	0	0	0	0	0	0	0	19.2	0	0	0	0	0	25.5	42.7	4.3	28.8	37.2	26.4	97	9.1	52.3	58.9	3	6.6	20	2.2	1.3	34.3	4.3	1834.4	2.7	0	2071	25.5	256.7	850.5	3124.6	0	17.5	0	0	59.8	221.1	15.4	0.3	0	2.9	50179.8	742.1	0	6.7	63.8	0.4	0.9	93.6	1.7	120.8	0	3889.3	343.9	0	0	5328.4	135.9	0	4.4	0.3	0.2	0.9	558.5	1.5	0	12.7	Hofbauer cells
TRIM67	TNL	ENSG00000119283	Tripartite motif containing 67	Q6ZTA4	1	231162112-231221556	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	7	brain: 14.4	Cell type enriched	Detected in some	7	Horizontal cells: 65.2	Not detected	Not detected			Region enriched	Detected in many	7	cerebellum: 13.3	Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		ASC diff: 1.4;HMC-1: 1.6;HSkMC: 1.4;SCLC-21H: 7.2;SH-SY5Y: 1.9	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA034776	Uncertain											HPA034776: AB_10603997	unprognostic (1.56e-3)	unprognostic (1.54e-1)	unprognostic (5.20e-2)	unprognostic (5.39e-3)	unprognostic (2.95e-1)	unprognostic (3.82e-2)	unprognostic (6.02e-2)	unprognostic (4.63e-3)	unprognostic (1.84e-2)	unprognostic (1.74e-1)	unprognostic (4.93e-10)	unprognostic (1.45e-1)	unprognostic (2.88e-3)	unprognostic (4.25e-2)	unprognostic (1.53e-1)	unprognostic (2.30e-2)	unprognostic (5.10e-3)	0.3	0.7	1.3	0.2	1.3	0.1	0.1	13.3	14.4	0.2	0.2	0.1	0	0.5	0.1	0.1	0.1	0.1	0.2	0.3	1.2	1.9	0.2	0.1	0.1	0.2	1.5	0	0.2	0.2	0.1	1.9	0.4	1.9	0.1	0.2	1.7	0.2	0.1	0.1	0.4	0.3	0.2	0.9	0.2	0.2	0.5	0.2	0.1	0.2	0	0.1	0.2	0	0	0	0	0	0	0.6	0	0	0.8	0	0	1.4	0	0.2	0	0	0.1	0	0.5	0	0	0	0	0	0	0	0	0	0.1	0.1	0.3	0	0.1	0	0	1.6	1.4	0	0	0	0	0	0.1	0	0.2	0	0.1	0	0	0.5	0.2	0.1	0.1	0	0.1	0	0	7.2	1.9	0	0.1	0.5	0	0	0	0	0.5	0	0	0	0.1	0	0	0.1	0	0.4	0	0	0	0	0	0	0	0	0.6	0	0	0.1	0.1	0	0	0	0	0	0	1.3	1.3	13.3	1.9	1.2	1.9	1.5	0	1.9	0.2	0	0	0	0	0	9.5	0.9	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	65.2	0	0	0	0	0	0	0	0	0	0.5	0.1	0	0	0	0.4	0	0	0.2	0	0	0	0	0	0	Horizontal cells
ONECUT2	OC-2	ENSG00000119547	One cut homeobox 2	O95948	18	57435685-57491297	Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	Activator, DNA-binding		Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		brain: 18.6;gallbladder: 60.7;intestine: 18.0	Cell type enriched	Detected in many	6	Horizontal cells: 910.5	Group enriched	Detected in many	7	liver cancer: 4.3;pancreatic cancer: 4.3;stomach cancer: 5.4	Region enhanced	Detected in many		basal ganglia: 18.6	Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HDLM-2: 18.7;HeLa: 11.9;RT4: 6.3;SCLC-21H: 9.8	Low region specificity	Detected in some			Group enriched	Detected in many	5	basal ganglia: 10.6;cerebellum: 9.9;cerebral cortex: 6.6;hippocampal formation: 4.3;hypothalamus: 4.3	HPA057058	Enhanced		Supported	Nucleoplasm,Actin filaments						Nucleoplasm	Actin filaments	HPA057058: AB_2683323	unprognostic (3.02e-2)	unprognostic (5.36e-2)	unprognostic (9.06e-3)	unprognostic (3.79e-5)	unprognostic (1.13e-2)	unprognostic (4.48e-4)	unprognostic (2.10e-2)	unprognostic (1.81e-1)	unprognostic (3.75e-1)	unprognostic (4.56e-3)	unprognostic (8.66e-3)	unprognostic (1.16e-2)	unprognostic (5.34e-4)	unprognostic (3.83e-2)	unprognostic (2.58e-1)	unprognostic (1.13e-1)	unprognostic (3.21e-1)	0.3	0.4	0.3	0.3	18.6	0.2	0.3	3	3.7	0.2	16.5	0	0	15	0.3	0.3	0.3	0.2	60.7	0.2	0.5	0.9	0.3	12.8	0.3	0.3	0.5	0.9	0.3	4.3	3.2	5.1	0.2	1.1	0.3	0.3	0.7	0.3	0.3	0.3	0.3	18	0.3	0.3	0.3	0.5	0.6	6.6	0	0.3	0	0.2	0.3	0.2	0	0	0	0	0	0	0	0.5	0.9	1.1	3	0	0	1.2	0	0	0	0	0	0.2	0	0.8	0	1.4	0	3.3	0	0.1	18.7	3	0.7	11.9	2.7	0	0	0.5	0	0	0	0.2	0	0	2.2	3.6	0.6	0	0.4	1.7	0	0.1	1.5	0.7	0	1.1	0	1.6	6.3	9.8	1.6	0.1	0	0.2	0.1	0.4	0.7	0	1	1.3	0.2	0.2	0.3	2.7	0	0	0.8	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	18.6	3	3.7	0.5	0.9	0.5	0.9	1.1	6.6	0	0	0	0.2	0.1	3	2.6	155.4	0	0	7	13.7	0	0	69.5	2	0.6	0.3	0	7.6	0.1	0	0.3	0	44.2	0.8	910.5	8.5	9.2	0.6	2.8	0.3	0	0	0	0.7	2.9	24.1	3.1	0	0	4.9	0	0.7	1.4	1.7	0.1	0	0	0.4	0	Horizontal cells
COQ6	CGI-10	ENSG00000119723	Coenzyme Q6, monooxygenase	Q9Y2Z9	14	73949926-73963670	Disease related genes, Predicted intracellular proteins	Ubiquinone biosynthesis	Monooxygenase, Oxidoreductase	Deafness, Disease mutation, Primary mitochondrial disease	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	5	Early spermatids: 157.7	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low cell line specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA051371	Uncertain											HPA051371: AB_2681459	unprognostic (1.41e-1)	unprognostic (1.35e-2)	unprognostic (2.26e-2)	unprognostic (2.22e-1)	unprognostic (1.12e-1)	unprognostic (2.88e-1)	unprognostic (1.75e-2)	unprognostic (2.77e-1)	unprognostic (1.21e-1)	unprognostic (8.33e-3)	unprognostic (9.45e-3)	unprognostic (2.90e-1)	prognostic favorable (1.05e-6)	unprognostic (1.19e-1)	unprognostic (1.94e-1)	unprognostic (7.46e-2)	unprognostic (1.89e-1)	8.5	30.9	6.9	6.9	11.8	4.6	10.8	10.6	15.8	9.3	9	11.3	11.4	9.1	7.9	11	7.9	8	9.5	26.5	10.1	6.4	20.8	20.9	6.5	7.4	8.8	10.2	8.6	6.2	12.5	11.4	8.8	9.9	9.2	8.9	11.7	11	12.2	30.5	6.4	8.5	9.1	6.1	8.1	9.6	15.6	5.3	6.3	8.9	13.2	7.7	9.8	7.5	9.8	11.8	8.6	13.3	13.3	16.7	8.5	7.7	14.2	7.4	17	9	7.4	10.3	9.7	9.1	14.7	12.5	10.6	13.9	6.8	9.2	10	10.1	12.5	11	9.7	14	10.3	8.8	4.7	8.9	9.2	12.4	4.6	16.1	12.5	12.9	13.3	13.2	9.5	9.2	14.2	4.1	6.3	12.7	21.3	7.4	7.4	2.6	15.9	17.3	7.5	9.4	4.9	15.3	9.8	11.2	5.9	16.6	14.3	9.2	5	24.2	8.6	6.1	16.8	15.5	12.5	6.9	6	5.6	5.8	9.2	6.8	11.1	5.3	11.3	8.6	11.8	13.3	11.5	9.8	11.7	11.8	11.8	5.8	16.7	10	2.2	13.3	12	8.9	7.3	8.5	6.9	11.8	10.6	15.8	10.1	6.4	8.8	10.2	9.9	5.3	23.8	30.5	9.3	7.7	4.1	17.9	9.6	10.2	10.7	20.5	12.2	11.8	23.4	16.6	9.2	157.7	6.7	8.5	0	9.7	10.4	10.4	5.9	24.3	13.9	14.2	19.1	4.6	11.1	4.1	29.2	10	7.7	10.1	8.2	8	11.8	6.4	6.5	11.7	29.8	27.1	19.4	11.3	21.4	18.3	5.3	19.9	10	9.3	4.2	Early spermatids
PRLHR	GPR10, PrRPR	ENSG00000119973	Prolactin releasing hormone receptor	P49683	10	118589989-118595699	G-protein coupled receptors, Predicted membrane proteins		G-protein coupled receptor, Receptor, Transducer		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in some		adrenal gland: 11.3;brain: 10.6;cervix, uterine: 8.3;pituitary gland: 11.8;smooth muscle: 8.1	Cell type enriched	Detected in single	15	Horizontal cells: 12.7	Not detected	Not detected			Low region specificity	Detected in many			Low cell type specificity	Detected in single			Low lineage specificity	Detected in single			Cell line enriched	Detected in single	4	SH-SY5Y: 3.6	Low region specificity	Detected in some			Low region specificity	Detected in many			HPA039361	Enhanced											HPA039361: AB_10673527					unprognostic (1.83e-1)						unprognostic (2.62e-3)	unprognostic (1.22e-1)		unprognostic (2.15e-2)	unprognostic (1.48e-1)	unprognostic (9.09e-2)		0.2	11.3	1.4	0.2	3	0.2	0.1	3.2	5.1	8.3	0.2	0.8	0	0.3	5.4	0.2	0.2	0.4	0.2	0.1	0.6	4	0.1	0.2	0.2	0.1	3.4	0.9	0.1	0.5	0.1	11.8	0.1	10.6	0.3	0.2	0.1	0.2	1.4	0.2	0.2	0.2	8.1	0.5	0.2	0.5	0.2	1	0	0.2	0	0.1	0.1	5.4	0.5	0.4	1.3	0.3	0.7	0.3	0	0	0.1	0.1	0	0	0	0.2	0	0	0	0	0	0	0.1	0.1	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0.1	0.8	0	0.1	0	0.1	0	0	0.1	3.6	0	0.1	0	0.1	0	0	0	0	0.4	0.1	0	0.1	0	0	0.3	0	0.1	0.5	0.3	0.2	0.2	0.1	0.2	0.2	0.1	0.2	0	0.5	0.3	0.2	1.3	0.7	0.3	0.4	0	0	1.4	3	3.2	1.9	0.6	4	3.4	0.9	10.6	1	0	0	0	0.1	0	0.1	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	12.7	0	0	0	0	0	0	0	0	0	0.2	0.1	0	0	0	0.4	0	0	0	0	0	0	0	0	0.1	Horizontal cells
CPN1		ENSG00000120054	Carboxypeptidase N subunit 1	P15169	10	100042193-100081877	Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins		Carboxypeptidase, Hydrolase, Metalloprotease, Protease	Disease mutation	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	127	liver: 76.8	Cell type enriched	Detected in some	12	Hepatocytes: 24.6	Group enriched	Detected in some	12	liver cancer: 26.6;melanoma: 7.9	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	17	SK-MEL-30: 56.6	Low region specificity	Detected in some			Low region specificity	Detected in all								Secreted to blood				22000000000						unprognostic (2.97e-2)	unprognostic (2.23e-2)			unprognostic (3.93e-2)		unprognostic (1.64e-1)		unprognostic (6.75e-2)		unprognostic (2.93e-2)	unprognostic (5.26e-2)	unprognostic (2.63e-1)			0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	76.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0.1	0	0.1	0	0	0.2	0	0	0.6	0	0	0	0	0	0	0	0	0	3.3	0	0	0	0	0	0	0	0	0	0	0	0	0	2.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	56.6	0	0	0	0	0	0	0	0	0	0	0	0	0	1.3	0	0	0	0.1	0	0.2	0.1	0.1	0	0	0.1	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	1.2	0	0	0	0	0	0	0	0	24.6	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	1.6	2.1	0	0.1	0	0.1	0	Hepatocytes
SFRP5	SARP3	ENSG00000120057	Secreted frizzled related protein 5	Q5T4F7	10	97766751-97771952	Predicted secreted proteins	Differentiation, Wnt signaling pathway	Developmental protein		Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	5	gallbladder: 34.9;heart muscle: 27.1;intestine: 17.8;pancreas: 70.4;retina: 67.6	Cell type enriched	Detected in some	15	Cholangiocytes: 226.7	Cancer enhanced	Detected in many		pancreatic cancer: 30.4	Group enriched	Detected in some	5	hypothalamus: 1.8;midbrain: 4.5;pons and medulla: 5.6	Cell type enriched	Detected in some	5	naive CD8 T-cell: 7.4	Lineage enriched	Detected in many	5	T-cells: 7.4	Cell line enhanced	Detected in some		A549: 3.3;CACO-2: 16.3;RPMI-8226: 5.8;SCLC-21H: 2.7	Low region specificity	Detected in many			Low region specificity	Detected in many								Secreted in other tissues								unprognostic (2.63e-4)	unprognostic (3.03e-3)	unprognostic (6.74e-2)	unprognostic (3.43e-2)	unprognostic (9.85e-2)	unprognostic (1.03e-1)	unprognostic (1.25e-1)	unprognostic (3.19e-1)	unprognostic (2.85e-1)	unprognostic (8.83e-2)	unprognostic (1.11e-1)	unprognostic (1.78e-1)	unprognostic (4.51e-9)	unprognostic (1.67e-2)	unprognostic (1.57e-1)	unprognostic (9.17e-2)	unprognostic (1.62e-1)	0.9	5.1	0	1.3	0.8	0.4	0.6	0.5	0.4	1.8	10.9	1.1	9.1	14.7	1.1	2.8	4.3	0.6	34.9	27.1	0.7	1.8	0.2	3.2	1.9	0.4	4.5	0.1	0.3	70.4	0.2	0.1	0.2	5.6	1.9	0.5	67.6	9.2	2.4	0.4	0.9	17.8	1	1.9	0.3	3.4	0.4	0.3	0	0.2	1.6	0.3	1.3	1.4	0	1.5	0	0	0	7.4	0.5	0	3.3	0	0	0	0	0.2	0	0	0	0	16.3	0	0	0.6	0	0.5	0	0	0	0	0	0.1	1.6	0	0.7	0	0	0	1.3	0	0	0	0	0	0.3	0.1	0	0	0	0	0.1	0.6	0	0	0	0.1	5.8	0	0	2.7	0.2	0.1	0	0.1	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0.6	7.4	0	0	0	1.5	0	0.5	0	0.8	0.5	0.3	0.7	1.8	4.5	0.1	5.6	0.3	3	2.2	0	0	0	0.2	6.7	226.7	0	1.2	0	0	0	0	13.1	0	0	0	0	15.1	0	0.5	0	0	0	0	0	0	1.3	0.8	0	1.7	0	0	1.8	0	0	4.3	0	0	0	0	0	0.3	0.1	6.1	0	0	0	0	0	Cholangiocytes
EQTN	AFAF, C9orf11, equatorin, SPACA8	ENSG00000120160	Equatorin	Q9NQ60	9	27284659-27297139	Predicted intracellular proteins, Predicted membrane proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	54	testis: 39.9	Cell type enriched	Detected in some	26	Early spermatids: 558.1	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		AF22: 1.0;BEWO: 2.2;HaCaT: 1.2;HAP1: 1.3;HSkMC: 1.8;K-562: 1.3;RT4: 1.1									HPA015089, HPA015504	Enhanced				Intracellular and membrane							HPA015089: AB_1845795, HPA015504: AB_2067598	unprognostic (7.83e-2)	unprognostic (1.55e-1)	unprognostic (5.64e-2)	unprognostic (8.12e-3)	unprognostic (1.34e-3)	unprognostic (4.41e-2)	unprognostic (3.21e-1)	unprognostic (1.06e-1)	unprognostic (4.32e-1)	unprognostic (1.89e-1)	unprognostic (5.67e-2)		unprognostic (1.14e-1)	unprognostic (4.59e-2)	unprognostic (8.46e-2)	unprognostic (3.90e-2)	unprognostic (1.42e-1)	0.1	0	0.1	0.1	0.1	0	0.1	0.3	0.1	0.1	0.1	0.2	0.1	0.3	0.1	0.4	0.1	0	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.2	0.1	0.4	0.3	0	0.1	0.1	0.2	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.4	0.1	0.1	39.9	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.7	0	0	0.3	0	0	0	0	0	1	0	0	0	2.2	0	0	0	0	0	0	0	0.4	0	0	1.2	1.3	0.8	0	0.4	0	0	0	0	0	0	0	1.8	0	0	0	0	0	0	1.3	0	0	0	0	0	0	0.2	0	0.2	0	0	0.6	1.1	0	0.6	0	0.9	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0.3	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.3	0.1	0.1	0	0.2	0.1	0.2	0.2	0	0	0	0.2	0.1	0	0	0	0	0	0	0	0.1	0	0	558.1	0	0.3	0	0	0.2	0	0.1	0	0	0.1	0	0	0	0	21.8	4.9	0	0	0	0	0	0	0	0.7	0	0	0	0	3.1	1.9	0.3	0.1	0	0.2	0.1	Early spermatids
INSL6	RIF1	ENSG00000120210	Insulin like 6	Q9Y581	9	5131979-5185668	Predicted secreted proteins		Hormone		Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	6	testis: 22.3	Cell type enriched	Detected in some	5	Early spermatids: 106.7	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HEL: 1.1;HL-60: 1.6					Low region specificity	Detected in single			HPA021364	Enhanced				Secreted to blood							HPA021364: AB_1851807	unprognostic (3.85e-4)	unprognostic (7.41e-4)						unprognostic (1.28e-1)		unprognostic (1.94e-1)	unprognostic (2.22e-1)	unprognostic (6.92e-2)	unprognostic (2.31e-2)	unprognostic (3.82e-2)	unprognostic (2.30e-1)		unprognostic (2.52e-3)	0	0	0	0	0	0.4	0	0.3	0.1	0	0	0	0	0	0	1.3	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	3.9	0.2	0.1	0	0.1	0.7	0	0	0	0.1	0	0	0.1	0	22.3	0	0	0.2	0.4	0	0	0	0.3	0	0	0.2	0	0.5	0	0	0	0.5	0	0	0	0.8	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	1.1	0	0	0	1.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0.5	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0.3	0.1	0	0	0	0	0.2	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0.3	0	0	106.7	0	0	0	0	0.1	0	0	0	0	0.1	0	0	0	0	11.3	1.1	0	0	0	0	0	0	0	0.7	0	0	6.5	0	20.6	9	0	0.2	0	0	0	Early spermatids
INSL4	EPIL	ENSG00000120211	Insulin like 4	Q14641	9	5231419-5235304	Predicted secreted proteins		Hormone		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	47	placenta: 88.0	Cell type enriched	Detected in some	11	Syncytiotrophoblasts: 2990.3	Cancer enhanced	Detected in some		lung cancer: 1.5	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	11	A549: 23.6									HPA065145			Approved	Vesicles	Secreted to blood					Vesicles		HPA065145: 		unprognostic (9.77e-2)						unprognostic (2.02e-1)		unprognostic (4.66e-1)				unprognostic (7.74e-2)				0.1	0.1	0	0	0.1	0.3	0.2	0	0.1	0.1	0.1	0	0	0	0.2	1.8	0.1	0	0	0.2	0	0.1	0.8	0.1	0.2	0	0.1	0	0.1	0.1	0	0	88	0	0.1	0	0.1	0	0	0.3	0.2	0.1	0	0.1	0.2	0.3	0.3	0	0	0.1	0	0	0	0.1	0.2	0	0.1	0.3	0	0.1	0	0	23.6	0	0	0	0	2.2	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0.1	2.1	0.3	0	0	0	0	0.2	0	0	0	0	0	0.1	0.1	0	0	0	0	0	0.2	0	0	0	0	0.2	0.1	0	0.1	0	0.4	0	2.1	0	0	0	0	0.4	0.1	0	0	0	0	0	0	0	0	0.3	0	0.1	0.3	0	0.2	0	0	0	0	0.1	0.1	0.1	0	0.1	0	0	0	0	0.1	0	0.1	0	0.1	0.1	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	269	0	0	0.7	0	0	0	0	19.9	0	0	0	0	34.6	0	0	0	0	0.4	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	2990.3	0	0	0	Syncytiotrophoblasts
MLANA	MART1	ENSG00000120215	Melan-A	Q16655	9	5890802-5910606	Predicted membrane proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	6	retina: 191.5	Cell type enriched	Detected in some	25	Melanocytes: 1629.7	Cancer enriched	Detected in single	556	melanoma: 277.0	Not detected	Not detected			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Cell line enriched	Detected in single	385	SK-MEL-30: 123.4	Not detected	Not detected			Low region specificity	Detected in many			CAB000057, HPA048662	Enhanced											CAB000057: AB_442107, HPA048662: AB_2680485	unprognostic (2.52e-2)	unprognostic (6.87e-2)	unprognostic (5.20e-2)	unprognostic (5.61e-2)	unprognostic (2.58e-2)	unprognostic (1.46e-1)	unprognostic (4.53e-1)	unprognostic (3.32e-1)	unprognostic (2.82e-2)	unprognostic (1.71e-3)	unprognostic (3.60e-3)	unprognostic (1.20e-1)	unprognostic (1.45e-2)	unprognostic (1.60e-1)	unprognostic (8.01e-2)	unprognostic (5.78e-2)	unprognostic (9.43e-2)	0.1	0.1	0.1	0.2	0.1	0.6	1.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.2	0.2	0	0.1	0.1	0.1	0	0.2	0.2	0.1	0.2	0.1	0.1	0.1	0.1	0	0.1	0.1	0.3	0.1	0	191.5	1.2	0.1	0.2	31.5	0.1	0.1	0.8	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.2	0.3	2.1	1.6	3.5	1.2	1.8	1.5	0.3	0.1	0.1	0	0.1	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0.2	0	0.3	0.2	0.1	0	0.1	0.1	0	0	0	0	0	0	0	0	0.2	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	123.4	0	0	0	0.1	0	0	0	0.1	0	0.1	0	0	0	0	3.5	1.2	0.8	1.4	0.8	1.1	1.4	1.3	1.2	0.4	2.1	1.4	1.5	2.9	1.8	1.1	1.6	0.6	0.3	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.3	0.1	0	0	0	0	65.5	0	0.6	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	1629.7	0	0	0	0	0	0	0.7	0	0	0.7	0	0	12.7	0	0	0	0	Melanocytes
CCDC170	bA282P11.1, C6orf97, FLJ23305	ENSG00000120262	Coiled-coil domain containing 170	Q8IYT3	6	151494030-151621193	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		epididymis: 19.4;fallopian tube: 33.0	Cell type enriched	Detected in many	8	Ciliated cells: 481.8	Low cancer specificity	Detected in many			Region enhanced	Detected in many		pons and medulla: 16.1	Cell type enhanced	Detected in many		eosinophil: 8.6	Low lineage specificity	Detected in many			Group enriched	Detected in some	5	MCF7: 14.2;T-47d: 8.3	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA027114, HPA027185	Enhanced		Approved	Golgi apparatus,Cell Junctions						Golgi apparatus	Cell Junctions	HPA027114: AB_2732435, HPA027185: AB_2672151	unprognostic (7.46e-2)	unprognostic (3.54e-2)	unprognostic (6.93e-2)	prognostic favorable (3.64e-4)	unprognostic (2.13e-1)	unprognostic (8.79e-3)	unprognostic (2.74e-3)	unprognostic (1.34e-1)	unprognostic (1.77e-1)	unprognostic (1.96e-1)	unprognostic (2.36e-1)	unprognostic (2.18e-2)	unprognostic (3.56e-2)	unprognostic (1.40e-2)	unprognostic (3.93e-2)	unprognostic (2.17e-1)	unprognostic (5.21e-2)	3	6.2	2.1	1.4	6.7	0.3	4	0.4	2.4	3.9	0.9	6.5	0.3	2.6	5.2	19.4	0.6	33	1.5	3.3	3.7	3.6	1.6	1.5	9.7	3.6	1.3	1.4	14.4	0.5	0.3	1.5	1.6	16.1	1.2	0.7	3.9	0.5	0.6	0.8	0.6	1.2	1.5	1.2	2.9	1.8	5.9	1.5	0.7	5.7	0.6	0.8	1.7	1.2	0.1	1.8	8.6	4.1	0.1	0.1	0.9	0	0.2	0.5	0	0.5	0.4	0	0.1	0.5	0	0	0.3	0.4	0	0	0.3	0.1	0	0	0	0	0	0	0	0.1	2.1	0	0.1	0.1	1.5	0	0	0	0.7	0.3	0	0	0.1	0.1	14.2	0	0	0	0	0	0	0	0	0	0.3	0.9	0	0.1	0	0	0.1	8.3	0.1	0.9	0.3	0.1	0.1	0	0	0	0	0.1	0.2	0.1	0.5	3.1	8.6	0.1	4.1	0.1	0.1	0	0	1.8	0.1	0.1	0.1	2.9	0.1	3.7	0.1	0.1	0.9	2.1	6.7	0.4	2.4	3.7	3.6	1.3	1.4	16.1	1.5	3	1	0.5	0.2	0.6	0.3	0.8	0	481.8	62.6	0	21.6	0.1	0	0.2	38.6	0.3	0.4	0	1	0.1	1.7	1	3.5	1.1	9.6	0	0	1.3	14.3	64.1	6.6	18.9	0	1.8	0	2.5	1.7	2.9	0	3.5	0.7	0	1.2	2.4	1	0.9	0	0	0	0.4	Ciliated cells
TNFSF18	AITRL, hGITRL, TL6	ENSG00000120337	TNF superfamily member 18	Q9UNG2	1	173039960-173050963	Predicted membrane proteins	Adaptive immunity, Immunity	Cytokine		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		brain: 7.3;tongue: 9.9	Cell type enriched	Detected in single	8	Hofbauer cells: 4.9	Low cancer specificity	Detected in some			Region enhanced	Detected in many		hippocampal formation: 7.3	Cell type enriched	Detected in single	19	non-classical monocyte: 1.8	Lineage enriched	Detected in single	19	monocytes: 1.8	Group enriched	Detected in some	11	EFO-21: 21.0;HUVEC TERT2: 31.6;TIME: 43.8					Low region specificity	Detected in many																unprognostic (2.78e-1)	unprognostic (7.40e-2)	unprognostic (3.08e-3)	unprognostic (1.32e-2)	unprognostic (3.39e-2)	unprognostic (5.72e-2)	unprognostic (2.16e-3)	unprognostic (7.03e-2)	unprognostic (2.22e-2)	unprognostic (3.53e-2)	unprognostic (1.13e-1)	unprognostic (6.34e-2)	unprognostic (2.71e-4)	unprognostic (8.42e-3)	unprognostic (6.21e-2)	unprognostic (1.99e-1)	unprognostic (8.74e-2)	0.9	0.4	0.4	0.3	0.8	0	0.4	1.1	4.6	0.4	0.4	3.2	0	1.1	0.3	0	3.6	0.3	5	1.5	7.3	0.4	0.7	1.9	1	0.2	0.4	1	0.3	0.3	2.2	0.7	1.3	1.4	0.4	1	0.2	0.3	0	0.3	0.4	3.5	0.1	0.6	0.6	0.4	0.3	0	0	0.7	9.9	1.4	0.6	0.3	0	0	0	1.8	0	0	0.1	0	0	0	0	0	0.1	0	0.4	1	0.2	0	0	0	0	21	0	0	0.7	0	0	0	0	0	0	0	0	2.9	0	0	0	0	0	2.8	0	31.6	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	43.8	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.8	0	0	0.1	0.4	0.8	1.1	2.4	7.3	0.4	0.4	1	1.4	0	0	0	0	0.3	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0.1	Hofbauer cells
ARR3	ARRX	ENSG00000120500	Arrestin 3	P36575	X	70268305-70281840	Predicted intracellular proteins	Sensory transduction, Vision		Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	11	retina: 62.9	Cell type enriched	Detected in some	14	Cone photoreceptor cells: 1449.0	Not detected	Not detected			Not detected	Not detected			Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		hTERT-RPE1: 3.7;Karpas-707: 5.8	Not detected	Not detected			Not detected	Not detected			HPA063129	Enhanced											HPA063129: AB_2732696	unprognostic (1.48e-2)	unprognostic (1.65e-1)	unprognostic (1.70e-2)	unprognostic (5.37e-2)	unprognostic (2.82e-1)	unprognostic (1.37e-2)	unprognostic (2.06e-2)	unprognostic (1.22e-1)	unprognostic (1.35e-2)	unprognostic (8.09e-2)	unprognostic (1.33e-1)	unprognostic (4.02e-3)	unprognostic (2.77e-7)	unprognostic (8.64e-2)	unprognostic (6.53e-2)	unprognostic (6.06e-2)	unprognostic (1.43e-1)	0.3	0.5	0.3	1	0.3	0.7	0.3	0.3	0.3	0.3	1.2	0.3	0.3	1.4	0.7	0.3	0.3	0.4	0.7	0.7	0.3	0.2	0.4	0.3	0.3	1.9	0.3	0.3	0.6	0.7	0	0.4	0.4	0.3	0.4	0.2	62.9	0.4	0.3	0.5	5.6	3.6	0.3	0.3	0.9	0.8	0.4	0.3	0.3	0.9	0.3	0.3	0.8	0.3	1.3	0.7	0.5	0.4	0	1.6	0.3	0.4	0.7	3.2	2.1	0	0	1.8	1.7	0	0	0	0.6	1.1	1.2	0.3	0	0.3	0.7	0	0	0	1.4	3.2	0.4	1.1	0	0	0.7	1.6	0.1	0	0	0	3.7	0	1	0.4	5.8	0	0.5	1.2	0.6	0.9	0.5	0.6	1.1	0.6	0.1	0	1.5	0.4	0.9	0.6	0.2	0.1	2.1	0.1	0.4	2.4	1.5	2	1.4	0.1	1.4	0.8	0.8	1.3	2	1.4	0	0.4	0.5	0.9	0.2	0	1.3	0.4	0	0.5	0.4	1.6	0.1	0.1	0	0	0.7	0.2	0.3	0.3	0.3	0.3	0.3	0.3	0.2	0.3	0.3	0.3	0.3	0	0	0	0	0	45.6	0.2	0	0	0	0	1449	0	0	0	0	0	0	0	0	0	0	0	0	0	0	22.3	0	0	0	0	0	0	0	0	0	41.1	0	0	0	0	102.8	0	0	0	0	0	0	0	0	0	Cone photoreceptor cells
MYOT	LGMD1, LGMD1A, TTID	ENSG00000120729	Myotilin	Q9UBF9	5	137867791-137887851	Disease related genes, Predicted intracellular proteins		Actin-binding, Muscle protein	Disease mutation, Limb-girdle muscular dystrophy, Myofibrillar myopathy	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	30	skeletal muscle: 297.3;tongue: 85.1	Cell type enriched	Detected in some	8	Cardiomyocytes: 25.7	Cancer enhanced	Detected in some		head and neck cancer: 3.7	Low region specificity	Detected in single			Cell type enhanced	Detected in single		plasmacytoid DC: 1.0	Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		HEK 293: 1.6;HeLa: 2.4;U-266/70: 1.7	Not detected	Not detected			Not detected	Not detected			HPA037733, HPA037734	Enhanced											HPA037733: AB_10697082, HPA037734: AB_2675638	unprognostic (5.85e-2)	unprognostic (2.38e-2)	unprognostic (6.93e-2)	unprognostic (3.08e-1)	unprognostic (1.27e-1)	prognostic unfavorable (8.85e-4)	unprognostic (8.03e-2)	unprognostic (1.17e-2)	unprognostic (1.54e-2)	unprognostic (2.02e-2)	unprognostic (6.44e-2)	unprognostic (1.14e-1)	unprognostic (7.56e-4)	unprognostic (1.72e-2)	unprognostic (2.42e-1)	unprognostic (2.10e-1)	unprognostic (1.40e-1)	2.8	0.3	0.6	0.2	1.4	0.1	0.1	0.1	0.4	0.3	1	0	0	0.3	0.1	6	6.2	0.1	0.2	6.2	0.7	0.4	0.2	0.1	0.1	0.1	0.9	0	0.1	0.1	0.1	0	0.1	0.1	2.4	0.3	0	3.6	0.6	297.3	0.1	0.4	0.2	0.7	0.1	0.2	0.1	0.6	0	2.2	85.1	6	0.2	0.4	0.8	1	0	0.1	0.4	0.6	0	0.5	0.3	0	0	0.3	0.2	0.1	0.1	0	0	0	0	1.2	1.1	1.1	0	0	0.1	0	0.3	0	0.5	1.6	0.4	2.4	0	0	0	0.3	1.4	0.4	0	0	0.4	0	1.1	0.2	1.1	1.2	0	0.5	0.1	0	0	0	0	0.1	0.1	0	0.3	0	0.1	0.7	0	0.8	0	0	0.2	0.6	0.1	0.5	0	0	1.7	0.7	0	0.7	0.3	0.3	0	0	0	0.2	0	0	0	0.6	0.1	0	0.8	0.5	0.2	0	0.4	0.1	1	0	0	0.6	1.4	0.1	0.4	0.7	0.4	0.9	0	0.1	0.6	0	0	0	0.5	0.2	0	25.7	0	0	0	0	2	0	0	0	0.7	0	0	0	0	0	0	0.3	0	0.2	0	0	0	1.3	0	0	0.9	0	3.3	0	0	0	0	0	0	0	0.5	0	0	0.2	0.1	0	0	0	0.1	0	Cardiomyocytes
NFYB	CBF-A, HAP3, NF-YB	ENSG00000120837	Nuclear transcription factor Y subunit beta	P25208	12	104117077-104138289	Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	Activator, DNA-binding		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		ductus deferens: 107.1	Cell type enriched	Detected in all	4	Syncytiotrophoblasts: 362.3	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Cell line enhanced	Detected in all		SK-BR-3: 60.4	Low region specificity	Detected in all			Low region specificity	Detected in all			CAB004211, HPA065646	Supported		Supported	Nucleoplasm						Nucleoplasm		CAB004211: AB_628018, HPA065646: 	unprognostic (5.82e-2)	unprognostic (2.44e-3)	unprognostic (4.90e-2)	unprognostic (7.10e-3)	unprognostic (2.67e-1)	unprognostic (4.65e-2)	unprognostic (2.10e-2)	unprognostic (2.44e-1)	unprognostic (7.36e-2)	unprognostic (2.63e-1)	unprognostic (9.39e-2)	unprognostic (8.51e-2)	prognostic unfavorable (9.28e-5)	unprognostic (1.62e-3)	unprognostic (4.98e-2)	unprognostic (1.36e-1)	unprognostic (4.81e-3)	16.1	23.4	22.2	13.9	21.3	10.8	17.5	18.5	17.5	16.1	28.2	13.6	107.1	9.9	16.8	25.8	13.7	16	13.7	20	22.6	16.9	15.4	21.8	16	17.4	21.9	12.4	15.9	11.3	17.3	19	16.3	15.6	23.5	14.4	10.1	10.3	53.7	18.5	11.2	10.6	20	24.9	10.1	13.8	13.7	20.4	21.4	19.2	13.5	18.5	20.2	27.9	15.6	7.4	22.8	10.2	15.1	21.1	10.7	13.7	11.9	22.7	13.8	15.3	16.7	21.4	13.8	11.4	15.3	10.5	8.8	6.5	18.5	6.7	12.3	10	9.1	18.2	8.8	16.6	12.6	5.7	11.2	13.3	8.1	16.1	15.9	7.8	24.1	12	6.2	12	27.8	9.9	16.8	10.8	7.5	12.7	15.6	20	16	21.4	10	12.9	18.8	13.1	8.1	10.8	14	13.6	11.2	24.2	60.4	7.8	17.6	22.6	16.4	7.4	9	6.1	8.1	9.9	14.4	12.3	20.6	5.7	9.8	9.2	17.3	7.5	22.8	16.3	9.5	21.1	15.6	15.7	17.1	7.4	11.3	17.5	17.4	10.5	15.1	10.2	6.8	20.5	10.7	22.2	21.3	18.5	17.5	22.6	16.9	21.9	12.4	15.6	20.4	50.6	26.1	11.9	86.4	33.2	21.7	32.7	10.2	25.4	27.3	17.4	3.9	51.6	31.5	20.9	2.8	30.3	11.3	23.3	15.8	71.2	32.7	42.2	20.8	28	20.2	14.3	11.5	52.2	13	4.5	31.7	23	27	18	15.1	27.5	22.7	14.4	28.7	28.6	23.3	19.4	31.9	67.7	31.1	32.4	362.3	27.7	13.4	49.2	Syncytiotrophoblasts
FAM117A		ENSG00000121104	Family with sequence similarity 117 member A	Q9C073	17	49710332-49789180	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	5	Erythroid cells: 93.5	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enhanced	Detected in many		basophil: 24.3	Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		U-266/70: 35.4;U-266/84: 24.3	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA022531	Approved		Approved	Nucleoplasm						Nucleoplasm		HPA022531: AB_2101087	prognostic favorable (5.30e-5)	unprognostic (8.06e-3)	unprognostic (2.82e-2)	unprognostic (1.77e-2)	unprognostic (2.00e-1)	unprognostic (3.90e-3)	unprognostic (1.69e-1)	prognostic favorable (8.25e-7)	unprognostic (4.05e-1)	unprognostic (3.58e-1)	prognostic favorable (1.81e-4)	unprognostic (1.99e-2)	unprognostic (3.73e-2)	unprognostic (9.12e-2)	unprognostic (1.45e-1)	unprognostic (4.07e-2)	unprognostic (4.66e-2)	9.9	5.7	7.6	15.5	9.4	42.9	9.6	12.4	5.7	17.4	15.8	5.6	12.2	7.2	21.2	9.6	11.3	12.4	13.3	12.5	5.6	3.7	8.3	10	9	14.2	2.8	5.4	16	17.6	8.6	11.9	4.4	10.8	16.4	6	24.3	11.9	21.3	4	13.6	13.7	20.7	2.1	26.7	10.3	18.4	3.6	30	14.2	6.5	24.1	21.8	8.5	13.9	2.1	24.3	0.9	6.7	5.5	1.8	3	0.7	4.9	0	2.2	0.4	8.8	1	1.7	1.8	3.1	21.7	5	14.3	5.4	0.6	8.3	1.7	3.8	3.6	1.4	1	6.2	15.8	0	6.9	2.4	2.4	12.6	2.1	3	3.1	1.7	1.9	3.3	12.4	19.2	12.2	1.7	8.1	15.2	12.7	7.3	4.1	2.4	4.8	4.1	7.5	2.8	2.7	4.9	3.2	1	0.4	3.5	5	7.2	9.1	0.3	1.8	1.5	1.9	0.8	35.4	24.3	9.5	1.6	3.5	1.5	24.3	0.9	4.9	5	0.6	5.5	13.9	3.3	4.2	0.7	9.3	2.7	3.7	1.9	6.7	0.1	2.1	3.2	1.8	7.6	9.4	12.4	5.7	5.6	3.7	2.8	5.4	10.8	3.6	6	5.7	11	1.2	8	12.6	16.1	2.5	1.4	5.7	7	13.7	0.9	5	1.3	2.3	6.5	0.9	93.5	3.1	1.6	6.1	2.6	2.3	5	1.1	4.8	10.3	6.7	3.2	4.5	13.3	3.4	6.8	11.8	4.4	3.9	3.2	0	14.5	2.8	3.1	0	7.2	17.2	12.4	12.3	0.7	13.1	2.6	0.9	Erythroid cells
A1BG		ENSG00000121410	Alpha-1-B glycoprotein	P04217	19	58345178-58353499	Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	180	liver: 299.6	Cell type enriched	Detected in many	11	Hepatocytes: 1227.5	Cancer enriched	Detected in single	85	liver cancer: 22.3	Not detected	Not detected			Cell type enhanced	Detected in some		plasmacytoid DC: 1.6	Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		HEK 293: 5.1;Hep G2: 4.9;REH: 6.6;U-266/70: 4.9					Not detected	Not detected			CAB016673, HPA044252	Supported				Secreted to blood			200000000000	49000000000			CAB016673: AB_1611892, HPA044252: AB_2678876	unprognostic (9.95e-2)	unprognostic (5.31e-2)	unprognostic (3.67e-2)	unprognostic (3.44e-2)	unprognostic (1.18e-1)	unprognostic (1.66e-2)	prognostic favorable (3.97e-4)	unprognostic (1.09e-1)	unprognostic (2.59e-1)	unprognostic (2.10e-1)	unprognostic (1.47e-2)	unprognostic (1.37e-2)	unprognostic (4.19e-5)	unprognostic (2.37e-2)	unprognostic (1.94e-1)	unprognostic (1.72e-1)	unprognostic (6.72e-2)	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	299.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0.6	1.6	0	0.1	0	1	0.7	0	0.7	0.1	1.3	0	0.3	0.6	2	0	0	0	0.2	0	1.8	0.9	0	0.5	0	0	0	0	0.9	5.1	2.6	0	4.9	0	1	0.4	0.2	0.4	0	0	1.2	0	1.5	0.8	0	0	1.8	0.9	1.7	0.3	0.2	0.4	6.6	3.2	1.3	0	0	0	0.4	0.7	0.2	0.8	0	1.1	1.1	0	1.8	0.3	0	0	4.9	2.2	1.6	0	1.1	0	0	0.1	0	0	0	0.5	0.1	0.4	0.5	0.5	0.6	0	0.3	0	0	0	1.6	1	0.7	0	0	0	0	0	0	0	0	0	0	11.9	13.1	48	2.3	7.8	2.9	0.4	17.8	14.7	14.8	21	2	0.9	6.6	0.8	0.5	9.8	0	0	7.9	7.4	27.9	11	16.3	1227.5	26.2	7.9	1.2	36.8	96.4	1.9	1.1	50.1	109.6	47.7	0	2.2	8.5	0	1.1	1.3	5.2	25.8	52.4	1.4	5.1	3.1	1.6	34.8	0.1	0.6	Hepatocytes
POPDC2	POP2	ENSG00000121577	Popeye domain containing 2	Q9HBU9	3	119636457-119665324	Predicted membrane proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	6	heart muscle: 90.5	Cell type enriched	Detected in many	4	Cardiomyocytes: 250.7	Low cancer specificity	Detected in many			Not detected	Not detected			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enriched	Detected in some	10	SH-SY5Y: 26.1	Not detected	Not detected			Not detected	Not detected			HPA024255	Enhanced											HPA024255: AB_1855545	unprognostic (1.13e-1)	unprognostic (1.17e-3)	unprognostic (8.91e-3)	unprognostic (9.48e-2)	unprognostic (5.56e-2)	unprognostic (7.64e-2)	unprognostic (2.73e-2)	unprognostic (2.43e-1)	unprognostic (3.18e-2)	unprognostic (1.72e-2)	unprognostic (5.86e-3)	unprognostic (1.80e-1)	unprognostic (1.24e-2)	unprognostic (6.26e-3)	unprognostic (1.66e-2)	unprognostic (2.12e-1)	unprognostic (2.06e-2)	1.3	0.3	0.2	1	0.2	0	0.6	0.3	0.2	1.8	16	0.2	7.6	0.6	2	1.3	3.3	1.8	6.1	90.5	0.2	0	0.5	0.3	0.3	1.4	0.2	0.3	0.8	0.7	0.1	0.2	0.3	0.3	5	1.5	0.3	0.6	13.4	12.1	0.4	2.2	12.6	0.2	0.5	2.4	0.5	0.2	0.3	0.5	3.8	0.8	10.2	1.1	0.9	0.7	2.1	3	0.3	2.2	0.4	0	0.1	0.4	0	0.2	0.1	0	0.2	0.1	0	0	0	0	0	0.2	0	0	0	0.2	0	0.3	0.9	0	0.1	0.1	0.1	0.1	0	0.5	0.2	0.1	0	0.1	0	0	0.1	0	0.9	0	0	0	0.2	0.2	0	0.1	0.1	0	0	0.1	0	0.2	26.1	0	0	0.4	2.5	0	0.2	0.1	0.1	0	0.2	0.1	0.7	0	0.1	0.1	0.2	0.5	2.1	0.1	1.3	0.9	0.1	1.1	0.3	1.1	1	0.1	0.9	2.2	0.7	0.1	0.3	3	0.7	1.6	0.4	0.2	0.2	0.3	0.2	0.2	0	0.2	0.3	0.3	0.2	0	0.3	0	0.2	0.3	2.4	250.7	0	2.7	1.2	0	0	0.4	0	0.4	0.2	3.6	0.3	0	0.2	0.1	1.4	0.7	1.1	0	1.3	1.6	2.9	1.3	1.2	0.4	1.1	2.2	0	2.8	0.6	1.2	0.7	0	1.8	0.3	2.8	58.2	8.5	0.5	0.4	0.5	1	1	0.4	0.2	Cardiomyocytes
GJA3	CX46, CZP3	ENSG00000121743	Gap junction protein alpha 3	Q9Y6H8	13	20138255-20161049	Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters			Cataract, Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		heart muscle: 23.1;parathyroid gland: 6.2	Cell type enriched	Detected in some	10	Cardiomyocytes: 12.5	Cancer enhanced	Detected in some		melanoma: 3.0	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in many		A-431: 5.6;CAPAN-2: 10.2;HL-60: 8.4;U-266/84: 5.9	Not detected	Not detected			Not detected	Not detected			HPA014821	Supported											HPA014821: AB_2669097	unprognostic (2.32e-1)	unprognostic (1.01e-1)	unprognostic (4.37e-2)	unprognostic (2.58e-3)	unprognostic (2.98e-2)	unprognostic (1.04e-2)	unprognostic (6.87e-3)	unprognostic (1.84e-1)	unprognostic (1.73e-1)	unprognostic (7.52e-2)	unprognostic (7.70e-2)	unprognostic (4.02e-2)	unprognostic (9.65e-8)	unprognostic (2.87e-1)	unprognostic (1.91e-1)	unprognostic (2.55e-2)	unprognostic (8.04e-3)	0.2	0	0.1	0.1	0.9	0	0.1	0.1	0.1	0.2	0.1	0.2	0.1	0	0.3	0.1	0.8	0.1	0.5	23.1	0.1	0	1.2	0.1	0.2	0.1	0.1	0.1	0.1	0.3	6.2	0.1	3.9	0.2	0.4	0	0.2	0.1	0.1	0.1	0.5	0.2	0.1	0.1	0.2	0	4.2	0.1	0.2	0.1	1	1.6	0.1	0.4	0.6	0	0	0	0	0.4	0	5.6	0.3	0	5	0.2	1.5	0	0.7	4.7	0.8	1	0.5	10.2	0	0.2	1.7	1.7	0.1	3.3	2.8	0.7	0.2	2.6	2.4	0	0	0.1	8.4	0	0.3	1.6	0.2	0.5	0	0	3.8	0.6	0	0.2	0	0	0	0.7	0.1	2	0.4	0	0	0	0.7	0	0	0.4	0	5	0.2	1.1	1.9	0	0	0	2	0.3	2.3	5.9	0	0	0.1	4	0	0	0	0.4	0	0	0.6	0.1	0	0	0	0	0.2	0	0	0	0	0	0	0.1	0.9	0.1	0.1	0.1	0	0.1	0.1	0.2	0.1	0	0	0	0	0.1	0	12.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	1.3	0	0	0	0	0	Cardiomyocytes
FABP3	FABP11, H-FABP, MDGI, O-FABP	ENSG00000121769	Fatty acid binding protein 3	P05413	1	31365625-31376850	Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins	Transport			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	9	heart muscle: 420.9;skeletal muscle: 129.4	Cell type enriched	Detected in many	6	Cardiomyocytes: 2447.6	Cancer enhanced	Detected in all		renal cancer: 92.9	Low region specificity	Detected in all			Low cell type specificity	Detected in single			Low lineage specificity	Detected in single			Cell line enriched	Detected in some	5	ASC TERT1: 120.7	Low region specificity	Detected in all							CAB017830, HPA055754	Enhanced		Uncertain	Golgi apparatus,Plasma membrane,Focal adhesion sites				1640000	4400000	Focal adhesion sites	Golgi apparatus, Plasma membrane	CAB017830: , HPA055754: AB_2682909	unprognostic (2.07e-2)	unprognostic (2.50e-2)	unprognostic (1.32e-3)	unprognostic (1.73e-2)	unprognostic (2.05e-1)	unprognostic (1.62e-1)	unprognostic (6.07e-3)	unprognostic (1.04e-1)	unprognostic (6.86e-2)	unprognostic (1.18e-1)	unprognostic (2.85e-1)	unprognostic (1.67e-1)	prognostic favorable (1.54e-7)	unprognostic (5.80e-3)	unprognostic (3.45e-1)	unprognostic (7.38e-3)	unprognostic (9.76e-3)	2.3	5.2	8.1	0.7	6	0.5	22.7	1.4	14.6	3.9	1.3	0.8	3.4	0.7	6.8	5.3	3.1	2.8	1.1	420.9	11	5.3	21.3	1.9	4.3	1.3	9.8	6	2.2	0.4	0.3	0.7	1.1	13.7	5	1.5	3	4.4	14	129.4	0.9	0.6	13	3.4	3.9	3.6	2	1.3	0.1	1.7	31.6	2.2	2.5	2.5	1.4	0.5	0	0.9	0.2	0.9	0.6	0.1	0	3.3	0.2	23.1	120.7	1.1	0.9	8.9	0.1	3.2	0.2	0.9	0.2	12.8	2.5	0	0.3	0.9	0	0.1	0.1	0.5	0.4	1.1	2.4	1.5	0.2	0	10.7	0	2.4	0	0.3	0	0.1	0.2	0	1.1	0	0	0.2	6.1	0	0.4	0.1	1.2	0	2.9	0	0.3	0	0.5	0	13.9	7.1	0.1	1.4	0.3	0.2	0.1	2.1	0.2	0.1	0.4	0.1	0.5	0.1	0.3	0	0.4	0	0.9	0.9	0.6	0.2	0.5	0.5	0.5	1.4	0	0.9	0	0.2	0.1	0.4	0.6	0.6	8.1	6	1.4	13.3	11	5.3	9.8	6	13.7	1.3	0	1.7	0.8	1	3.2	3.1	2447.6	5.1	2.7	2.3	26.2	2	2.1	383	0.3	2.1	0.8	0	0	0.3	1.3	14.9	3.8	1.1	0	96.1	7.9	0	3.7	20	4.2	6.4	17.6	8.5	0	0	2.7	0.5	3.6	7.4	399.5	8.1	0	32.3	0.3	0.1	2.6	1.4	1	0.1	5.2	Cardiomyocytes
CCR2	CC-CKR-2, CD192, CKR2, CMKBR2, FLJ78302, MCP-1-R	ENSG00000121807	C-C motif chemokine receptor 2	P41597	3	46353734-46360928	CD markers, G-protein coupled receptors, Predicted membrane proteins	Host-virus interaction, Inflammatory response	G-protein coupled receptor, Receptor, Transducer		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	6	blood: 96.3;lymphoid tissue: 36.1	Cell type enriched	Detected in some	6	Kupffer cells: 61.3	Low cancer specificity	Detected in many			Low region specificity	Detected in some			Cell type enhanced	Detected in many		basophil: 96.3	Low lineage specificity	Detected in all			Cell line enhanced	Detected in some		Karpas-707: 48.6;THP-1: 23.0;U-266/70: 111.8;U-266/84: 44.5	Low region specificity	Detected in some			Low region specificity	Detected in single			CAB003793	Approved											CAB003793: AB_344889	unprognostic (1.09e-2)	unprognostic (6.28e-4)	unprognostic (3.49e-2)	unprognostic (6.35e-4)	unprognostic (1.89e-2)	unprognostic (4.16e-4)	unprognostic (8.06e-2)	prognostic favorable (5.87e-4)	unprognostic (6.33e-2)	unprognostic (3.27e-2)	unprognostic (3.12e-1)	unprognostic (1.56e-1)	unprognostic (5.52e-3)	unprognostic (1.29e-1)	unprognostic (3.35e-2)	unprognostic (4.88e-2)	unprognostic (4.19e-1)	2.5	1.3	0.6	20.7	0.8	0.9	1.9	0.5	0.8	4.3	5.8	0.5	1.5	5.6	2.6	2.4	6.1	2.2	2.5	1.8	0.6	0.6	3.7	1.8	8.6	30.1	1.6	0.1	1.7	1.7	0	0.8	2.1	1.8	3.7	4	2.6	10.2	3.5	0.8	1.3	7.3	5.6	1.5	36.1	3.7	1.5	0.5	3.6	2	3.5	5.9	5.8	1.7	1.6	29	96.3	28.4	2.5	19.3	13.5	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	48.6	0	0	0	0.2	0	0	0	0	0	0.4	0	0	0	0	0	0.2	0	0	0	23	0	0	0	0	0	111.8	44.5	0	0	0.8	0	96.3	28.4	0.4	2.5	2.6	19.3	1.6	5.2	4.2	29	0.3	0.1	0.1	0.7	2.5	0	23	2.3	13.5	0.6	0.8	0.5	0.8	0.6	0.6	1.6	0.1	1.8	0.5	0	2.2	7.8	0	0.2	0	0.3	2.5	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0.2	0	0	0	0.8	0	0	3.1	61.3	0.4	0	10.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4.4	0	0	Kupffer cells
SV2C		ENSG00000122012	Synaptic vesicle glycoprotein 2C	Q496J9	5	76083172-76353939	Predicted membrane proteins, Transporters	Neurotransmitter transport, Transport			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	9	brain: 52.2	Cell type enriched	Detected in some	4	Intestinal endocrine cells: 19.0	Not detected	Not detected			Group enriched	Detected in many	4	basal ganglia: 52.2;pons and medulla: 26.6	Cell type enriched	Detected in single	14	basophil: 4.2	Lineage enriched	Detected in single	21	granulocytes: 4.2	Group enriched	Detected in some	5	Karpas-707: 12.2;SCLC-21H: 5.0;SH-SY5Y: 11.4	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA040722, HPA040770	Supported		Supported	Nucleoplasm,Vesicles						Nucleoplasm, Vesicles		HPA040722: AB_10795624, HPA040770: AB_10805828	unprognostic (7.91e-2)	unprognostic (2.33e-1)	unprognostic (2.05e-1)	unprognostic (2.41e-2)	unprognostic (1.07e-1)	unprognostic (9.93e-2)	unprognostic (1.09e-2)	unprognostic (2.57e-1)	unprognostic (2.57e-1)	unprognostic (2.14e-1)	unprognostic (1.44e-1)	unprognostic (2.34e-2)	unprognostic (1.60e-3)	unprognostic (1.90e-1)	unprognostic (2.12e-1)	unprognostic (6.66e-2)	unprognostic (1.16e-1)	0.5	5.5	0.8	1.3	52.2	0.7	1.2	1.2	9.5	0.7	0.8	0.5	0	1	0.7	0.9	0.6	1.8	0.6	0.8	0.6	8.3	0.4	0.4	0.4	0.5	5.6	1.9	2.6	0.8	0.9	0.8	0.4	26.6	1	1.1	1.1	1.7	1.2	0.3	0.7	1.3	1	5.8	0.6	1.6	1	6.7	0	0.5	0	0.4	0.6	0.4	0.1	0.1	4.2	0.2	0.1	0.2	0.2	0	0	1.9	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0.2	0	0	0	0	0	0	0.4	0	12.2	0	0	0	0.2	1	0	0	0	0	0	0	0.3	5	11.4	0	0	0	0.3	0	0	0	0	0.1	0	0	0.1	0	0	0	0	0.8	4.2	0.2	0	0	0	0	0	0	0	0	0.1	0	0.1	0.3	0.1	0	0.1	0.2	0.2	0.8	52.2	1.2	9.5	0.6	8.3	5.6	1.9	26.6	6.7	0	0	0	0.5	0	3.9	0.8	0	0	0	0	0	0	0	0	0.5	0	0	0	0.2	0	0.1	1.1	0	0	0.1	0	19	0.6	0	0.7	0	0	3.3	0	0.5	0.8	0	0	0	0	4.4	0	0.2	0.1	0.1	0.1	0	0	0	1.1	Intestinal endocrine cells
PLG		ENSG00000122194	Plasminogen	P00747	6	160702238-160753315	Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins	Blood coagulation, Fibrinolysis, Hemostasis, Tissue remodeling	Hydrolase, Protease, Serine protease	Cancer-related genes, Disease mutation, FDA approved drug targets, Thrombophilia	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	11	liver: 269.9	Cell type enriched	Detected in some	7	Hepatocytes: 1391.0	Cancer enriched	Detected in some	84	liver cancer: 180.7					Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HEL: 1.2;HL-60: 3.6;RH-30: 4.0;U-698: 2.0;U-937: 1.6									CAB000668, CAB016678, HPA021602, HPA048823	Supported				Secreted to blood			140000000000	41000000000			CAB000668: , CAB016678: AB_1621208, HPA021602: AB_1855453, HPA048823: AB_2680532		unprognostic (1.70e-1)		unprognostic (2.16e-3)	unprognostic (2.44e-1)		unprognostic (8.54e-3)	unprognostic (1.41e-1)		unprognostic (1.76e-3)	unprognostic (6.28e-2)	unprognostic (7.25e-2)	prognostic favorable (4.22e-4)	unprognostic (3.97e-3)	unprognostic (5.21e-2)		unprognostic (2.33e-2)	0	0	0	0	0	0	0	0	0	0	0			0	0	0	0	0	0	0	0	0	24	269.9	0	0	0		0	0	0	0	0		0	0		0	0	0	0	0	0	0	0	0	0			0		0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0.1	0	0	0.1	0	0	0	0	0	1.2	0	0.5	0	3.6	0.6	0	0	0	0	0	0	0	0.9	0.4	0	0	0.3	0.2	0.9	0	0	0.4	4	0	0	0	0	0	1	0	0	0	0	0	0.5	0	0.1	0	0	1	0	2	0	1.6	0	0.5	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	2.2	0	0	0	0.6	28.1	2.7	0	1.8	0	0	16.6	0	0.1	0	0	23.3	0	0	0	0	1.1	1391	0.1	0	0	26.4	26.6	0	0	0	0	0	0	0	0	0	0	203.6	0	0	0	0.4	0	0	0	4.9	0	0	Hepatocytes
PRM2	CT94.2	ENSG00000122304	Protamine 2	P04554	16	11275639-11276480	Predicted intracellular proteins	Differentiation, DNA condensation, Spermatogenesis	Developmental protein, DNA-binding		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	99	testis: 699.5	Cell type enriched	Detected in some	5	Late spermatids: 355121.5	Cancer enriched	Detected in single	187	testis cancer: 11.0	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	8	BEWO: 3.5;NB-4: 3.8;U-2197: 5.7									CAB032738, HPA056386	Enhanced											CAB032738: AB_2171312, HPA056386: AB_2683111															unprognostic (3.88e-2)			0	0	0	0	0	0	0.2	0	0.3	0	0	0	0.3	0	0	7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0.1	0.1	0.1	0.1	0	0.1	0	0	0	0	699.5	0	0.1	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	3.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.8	0	0	0	0	0	0	0	0	0.5	0.2	0	0	0	0	0	0	0	0	0	5.7	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	67214.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	355121.5	1424.2	0	0	0	0	0	0	0	1572.7	0	0	899	0	1873	751	0	0	0	0	0	Late spermatids
LDB3	CMD1C, KIAA0613, PDLIM6, ZASP	ENSG00000122367	LIM domain binding 3	O75112	10	86668449-86736068	Disease related genes, Plasma proteins, Predicted intracellular proteins			Cardiomyopathy, Disease mutation, Myofibrillar myopathy	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	21	heart muscle: 213.9;skeletal muscle: 329.7;tongue: 110.3	Cell type enriched	Detected in some	41	Cardiomyocytes: 1579.0	Low cancer specificity	Detected in some			Low region specificity	Detected in many			Low cell type specificity	Detected in some			Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		HSkMC: 5.9;hTERT-RPE1: 5.8;SCLC-21H: 9.6;SK-MEL-30: 4.6	Low region specificity	Detected in all							HPA048955	Enhanced		Supported	Nucleoplasm,Focal adhesion sites,Cytosol					450000	Focal adhesion sites, Cytosol	Nucleoplasm	HPA048955: AB_2680568	unprognostic (1.60e-1)	unprognostic (9.01e-2)	unprognostic (4.87e-2)	unprognostic (6.92e-2)	unprognostic (5.55e-2)	unprognostic (1.50e-2)	unprognostic (2.57e-2)	unprognostic (1.36e-1)	unprognostic (2.79e-2)	unprognostic (7.61e-2)	unprognostic (2.54e-3)	unprognostic (3.55e-2)	unprognostic (4.72e-4)	unprognostic (3.07e-2)	unprognostic (1.60e-1)	unprognostic (1.62e-2)	unprognostic (3.16e-1)	6.4	0.4	0.9	1.3	1.6	0.2	0.5	0.1	1.3	2.8	2.3	0	4.9	0.4	4.2	9.9	9.9	1.3	1	213.9	1.7	1	0.3	0.2	0.4	0.2	2.6	0	1.5	0.3	0.3	0.1	0.5	0	4.4	0.8	4.7	7.6	3.1	329.7	0.3	1.2	3.6	6.7	0.2	0.7	0.5	0	0	2.8	110.3	10.2	1.9	0.9	0.9	0.6	1.8	0.4	0.6	0.6	0	0.3	0.2	0.4	3.1	0.4	0.1	0.3	0.4	0.3	0.1	0.2	0.3	0.3	0.2	0.6	0	0.7	0.4	0.2	0	0.1	0.9	0.7	0.7	0.9	0.1	0.1	0.1	1.6	5.9	0.5	0.1	0	5.8	0	0.7	0.2	1.8	0.3	1.5	0.4	0.2	0.4	0.4	0.3	0	2	0.1	0	1.1	9.6	1.8	0.3	0.2	4.6	1.4	0.3	0.2	0	0.3	0.5	0.4	0.1	0.2	0.6	0.4	0.7	0.3	0.5	1.8	0.4	0.4	0.4	0.3	0.4	0.3	0.3	0.3	0.2	0.9	0.5	0.6	1.4	0.6	0.4	0.6	0.3	0	0.9	1.6	0.1	0.6	1.7	1	2.6	0	0	0	0	0	0	0.5	0.9	1.7	1579	0	0	0	1.8	0	0.1	0	0	18.3	0.7	0	0	1	0	0.7	0.3	0	0	0.1	0	0	0	0	13.2	10.3	0.4	1.7	0	0	1	0.1	0	6.3	0	3.4	38.8	33	0.6	1	0	0	0	0	0.1	Cardiomyocytes
OPN4	melanopsin, MOP	ENSG00000122375	Opsin 4	Q9UHM6	10	86654557-86666848	G-protein coupled receptors, Predicted membrane proteins, Transporters	Biological rhythms, Sensory transduction	G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Group enriched	Detected in some	5	brain: 21.2;skeletal muscle: 14.6	Cell type enriched	Detected in single	34	Cardiomyocytes: 3.4	Not detected	Not detected			Region enhanced	Detected in many		basal ganglia: 21.2	Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in single		PC-3: 1.1	Not detected	Not detected			Not detected	Not detected			HPA039147	Approved											HPA039147: AB_10673304	unprognostic (3.67e-3)	unprognostic (1.40e-2)	unprognostic (3.02e-2)	unprognostic (1.62e-1)	unprognostic (7.03e-3)	unprognostic (2.89e-2)		unprognostic (3.26e-1)	unprognostic (9.54e-2)	unprognostic (5.68e-2)	unprognostic (8.88e-3)		unprognostic (1.93e-6)	unprognostic (4.10e-2)		unprognostic (5.58e-2)	unprognostic (6.76e-2)	3.5	0.3	5.4	0.4	21.2	0.2	1.1	0	5.1	0.6	0.9	0	0	0.5	0.4	0.4	0.6	0.4	0.5	3.1	3	0.1	0.3	0.2	0.3	0.2	0.2	3.3	0.3	0.4	3.6	0.6	0.5	0	0.2	0.7	1.2	1.6	0.2	14.6	1.2	1.1	0.5	0	0.3	0.5	0.5	2	0	1.4	2.7	0.3	0.5	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0.2	0	0	0	0	0	0.9	0.1	0	0	0	0	0	0.5	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	1.1	0	0	0.3	0	0	0.7	0	0	0	0	0	0	0	0	0.7	0.4	0	0	0	0	0	0.3	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5.4	21.2	0	3.5	3	0.1	0.2	3.3	0	2	0	0	0	0	0	0	3.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Cardiomyocytes
NPY	PYY4	ENSG00000122585	Neuropeptide Y	P01303	7	24284163-24291865	Plasma proteins, Predicted secreted proteins		Neuropeptide		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	6	adrenal gland: 50.5;brain: 63.6;prostate: 131.2	Cell type enriched	Detected in some	5	Glandular cells: 55.9	Cancer enriched	Detected in many	187	prostate cancer: 1214.9	Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	36	SH-SY5Y: 124.0	Low region specificity	Detected in all			Low region specificity	Detected in many			CAB016733, CAB034368, HPA036636, HPA044572, HPA056798	Supported	Supported	Enhanced	Golgi apparatus	Secreted to blood			30700000		Golgi apparatus		CAB016733: , CAB034368: AB_2298657, HPA036636: , HPA044572: AB_2678996, HPA056798: AB_2630371			unprognostic (2.00e-1)	prognostic unfavorable (5.78e-4)	unprognostic (4.15e-1)					unprognostic (3.76e-2)	unprognostic (1.59e-2)	unprognostic (1.87e-1)	unprognostic (6.30e-2)	unprognostic (1.24e-2)	unprognostic (1.78e-1)	unprognostic (2.52e-1)		1.6	50.5	27.2	5.5	63.6	2.8	1	0.1	55.9	1	1.8	2.8	1.4	4.7	1.1	1.1	2.5	1	1.4	1	11.9	20.6	1.1	1	1.1	1	2.6	18.3	1	4	1	0.5	1	1.9	131.2	1.7	0	1	14.7	1	1	5	1.4	1.4	1	1.7	1.3	13.9	0	1.1	0	1	3.9	4.5	0.5	0	0	0	0	0.7	0.4	0	0	0.4	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0.3	0	0	3.4	0	0.1	0	0	0.1	124	0	0	0	0	0	0.2	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.7	0	0	0.5	0	0	0	0	0	0	0	0.4	27.2	63.6	0.1	31.2	11.9	20.6	2.6	18.3	1.9	13.9	0	0	0	1.3	0.1	1	0.2	0	0	0	0	0	3.2	0	0	10.4	0	0	0	0	0.2	0.2	55.9	0	0	2.2	0	0	0	0	8.5	0.3	0	1.7	0	0	0.4	0.5	0	0.4	0	0.5	0	0	2.3	2.1	0	4.2	0	0	0.7	Glandular cells
SPINK4	MGC133107, PEC-60	ENSG00000122711	Serine peptidase inhibitor, Kazal type 4	O60575	9	33218365-33248567	Predicted intracellular proteins, Predicted secreted proteins		Protease inhibitor, Serine protease inhibitor		Evidence at protein level	Evidence at protein level	No human protein/transcript evidence	Evidence at transcript level		Tissue enhanced	Detected in some		gallbladder: 35.8;intestine: 120.9;lymphoid tissue: 24.3	Cell type enriched	Detected in some	24	Mucus-secreting cells: 2251.6	Group enriched	Detected in many	20	colorectal cancer: 237.5;pancreatic cancer: 269.7;stomach cancer: 111.0	Not detected	Not detected			Cell type enriched	Detected in single	5	basophil: 5.1	Lineage enriched	Detected in single	5	granulocytes: 5.1	Group enriched	Detected in some	11	HMC-1: 38.2;OE19: 100.1	Region enhanced	Detected in single		pons and medulla: 1.1	Not detected	Not detected			HPA007286	Enhanced		Approved	Nucleoplasm,Golgi apparatus,Vesicles	Secreted to digestive system					Golgi apparatus, Vesicles	Nucleoplasm	HPA007286: AB_1080083	unprognostic (3.49e-2)	unprognostic (2.32e-1)	prognostic favorable (8.85e-5)	unprognostic (3.09e-4)		unprognostic (1.49e-1)		unprognostic (1.00e-1)		unprognostic (9.66e-2)	unprognostic (2.43e-1)			unprognostic (1.24e-1)	unprognostic (3.25e-1)		unprognostic (2.42e-3)	0.2	0.4	0.2	24.3	0.3	0	0.2	0.2	0.2	0.2	69.3	0.2	0.2	28.8	0.2	0.2	0.3	0.2	35.8	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.4	0	0.4	0.2	0.2	0.3	110.5	2.5	0.2	0.2	0.3	0.2	120.9	4.6	0.2	0.3	0.5	0.3	0.2	0.2	0.2	0.2	0.2	3.4	0.2	0	0	5.1	0.9	0	0.3	0	0	0	0	0	0	0	0.1	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	2.4	6.2	0.2	0	0	38.2	0	0	0	0.1	0.1	0	0	0.8	0	0	0.8	0	0.4	0	100.1	0.1	0	0	0	0	0.1	0.1	0.3	3.2	0.6	0	0	3	0	0	0	0	0.3	0	0	0	0	0.3	0	0	5.1	0.2	0	0	0.9	0.3	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0.2	0.3	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0	0	0	0	0.2	20.7	0	0	0	0	5.2	11.8	0	0	0.1	0.7	0	94.7	0	0	0	0	0.2	0	0	0	0	84.6	0	0	2.4	0	0	0	0	2251.6	15.3	0.1	40.3	0	0	80.2	0	0	0	0	0	0	0	69.8	0.1	Mucus-secreting cells
SFTPA1	COLEC4, SFTP1, SP-A, SP-A1	ENSG00000122852	Surfactant protein A1	Q8IWL2	10	79610939-79615455	Disease related genes, Predicted secreted proteins	Gaseous exchange			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in some	66	lung: 411.8	Cell type enriched	Detected in some	12	Alveolar cells type 2: 12618.9	Cancer enriched	Detected in some	25	lung cancer: 706.4	Not detected	Not detected			Cell type enriched	Detected in single	63	plasmacytoid DC: 6.2	Lineage enriched	Detected in single	63	dendritic cells: 6.2	Cell line enriched	Detected in some	6	RPMI-8226: 30.8									CAB016793, HPA042638, HPA045752, HPA049368	Supported				Secreted in other tissues							CAB016793: , HPA042638: AB_2678095, HPA045752: AB_2679442, HPA049368: AB_2680731						unprognostic (5.83e-4)		unprognostic (1.17e-1)			unprognostic (3.38e-2)	unprognostic (4.24e-1)		unprognostic (3.47e-2)		unprognostic (9.09e-2)		0.1	0.3	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0	0.1	0.1	0.1	0	0.1	0.1	411.8	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.2	0.1	0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	6.2	0	0	0	0	0	0	0	0	0	0	0	2.5	0	0	0	0	0	0.1	0.1	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0.1	2.8	0.1	0	0	0	0	30.8	0	0	0.2	0.1	0	0	0	0	0	0	0	0	0	5.5	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	6.2	0	0	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	1077.9	12618.9	0	0	0	0	0	0	156.6	337.8	0	0	0	0	0	0	0	0	0	0	0	0	0	418.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Alveolar cells type 2
NEUROD4	ATH-3, Atoh3, bHLHa4, MATH-3	ENSG00000123307	Neuronal differentiation 4	Q9HD90	12	55019945-55030014	Predicted intracellular proteins, Transcription factors	Differentiation, Neurogenesis, Transcription, Transcription regulation	Activator, Developmental protein, DNA-binding		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in some	6	pituitary gland: 54.8	Cell type enriched	Detected in some	16	Bipolar cells: 170.1	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	6	AF22: 3.7;SCLC-21H: 7.7	Not detected	Not detected			Not detected	Not detected			HPA015545	Enhanced											HPA015545: AB_2669215					unprognostic (1.78e-2)													0	7	0	0	0	0	0	0	1.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	54.8	0	0.7	0	0	9.5	0	0	0	0	0	0	0.2	0	0	1.1	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0	0	3.7	0	0	0	0	0	0	0.2	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0.9	7.7	0	0	0	0	0	0	0	0	0	0	0	0	0.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0.3	0	0	0.4	0	0.7	0	0	0	0	0	0	170.1	2	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.2	0	0	0	0	0	0	0	0	0	3.4	0	0	0	0	10.4	0	0	0	0	0	0	0	0	0	Bipolar cells
SARDH	DMGDHL1, SDH	ENSG00000123453	Sarcosine dehydrogenase	Q9UL12	9	133663560-133739955	Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins		Oxidoreductase	Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	4	epididymis: 25.3;liver: 52.8;pancreas: 39.4	Cell type enriched	Detected in some	6	Hepatocytes: 94.3	Cancer enriched	Detected in many	8	liver cancer: 18.7	Low region specificity	Detected in many			Group enriched	Detected in many	5	memory CD4 T-cell: 4.1;naive CD4 T-cell: 8.4;T-reg: 9.7	Lineage enriched	Detected in single	15	T-cells: 9.7	Cell line enhanced	Detected in many		AN3-CA: 11.1;Hep G2: 18.7;JURKAT: 8.3;MOLT-4: 13.5;RH-30: 11.6;RPMI-8226: 23.4;SH-SY5Y: 9.3	Low region specificity	Detected in all			Not detected	Not detected			HPA057267, HPA058086	Approved		Approved	Mitochondria					190000	Mitochondria		HPA057267: AB_2683388, HPA058086: AB_2683601	unprognostic (3.64e-2)	unprognostic (4.87e-2)	unprognostic (2.31e-2)	unprognostic (1.38e-1)	prognostic unfavorable (4.62e-4)	unprognostic (5.83e-2)	unprognostic (1.42e-3)	unprognostic (2.21e-1)	unprognostic (1.58e-1)	unprognostic (1.43e-1)	unprognostic (2.23e-1)	unprognostic (1.74e-1)	unprognostic (7.74e-3)	unprognostic (2.78e-1)	unprognostic (3.48e-1)	unprognostic (9.73e-2)	unprognostic (1.30e-2)	0.5	1.1	1.7	1	1.8	0.3	0.4	0.8	1.9	0.9	0.5	1.1	2.9	0.8	1.4	25.3	0.3	0.9	1.2	1.1	1.1	1.4	5.8	52.8	1.3	1.7	1.2	2.1	3.4	39.4	2	1.9	0.3	1.2	1.4	0.1	3.7	8.2	0.9	0.3	0.2	0.6	0.6	0.6	0.7	1.2	1.1	0.8	2.2	0.8	0.2	1.2	0.6	0.6	0.4	0.3	0.6	0.1	0.1	9.7	1.6	0	0.1	0.9	11.1	0	0.3	1.5	0.1	0.4	0.5	0.7	0.2	0.1	0	1.5	0.2	1.4	0	0	0.2	0.4	0	0.2	1.5	0	18.7	1.2	0	0.2	2.6	0	1.3	0	0.3	0.1	8.3	0	0.2	7	1.9	13.5	1.4	1.7	1	0.1	0.9	11.6	23.4	0	0.1	1	9.3	0	0.3	2.3	0.5	1.5	0.1	0	2.1	2	0.2	0	0.1	0	0.8	1.3	0.8	0	0.1	0.1	0.1	0.4	0	1	0	4.1	1	0	0.4	8.4	1.5	0.6	0.1	0	0.3	9.7	1.6	1.7	1.8	0.8	1.9	1.1	1.4	1.2	2.1	1.2	0.8	0	3.4	0	0.3	0.2	0	0.6	0	0	0	1.8	0	0	0	0	0	0.1	0	0	0.9	0.1	1	0.2	1.1	94.3	0.1	0	1.2	2.5	2.4	0.2	4.4	0.2	0	0	0	2.1	0.2	0	2.8	14.7	0.2	0	1	0.1	0.9	0.1	0	2.9	0	0.1	Hepatocytes
DBH	DBM	ENSG00000123454	Dopamine beta-hydroxylase	P09172	9	133636360-133659344	Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins	Catecholamine biosynthesis	Monooxygenase, Oxidoreductase	Disease mutation, FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	9	adrenal gland: 86.6;brain: 36.2;liver: 35.6	Cell type enriched	Detected in single	43	Ito cells: 17.2	Low cancer specificity	Detected in some			Region enriched	Detected in single	45	pons and medulla: 36.2	Cell type enhanced	Detected in single		naive CD4 T-cell: 2.0	Lineage enriched	Detected in single	21	T-cells: 2.0	Cell line enriched	Detected in single	340	SH-SY5Y: 206.1	Region enriched	Detected in some	6	pons and medulla: 23.2	Region enriched	Detected in single	38	pons and medulla: 25.1	HPA002130, HPA005960, HPA070789	Enhanced		Supported	Endoplasmic reticulum,Vesicles	Intracellular and membrane				2000000000	Vesicles	Endoplasmic reticulum	HPA002130: AB_2666554, HPA005960: AB_1078628, HPA070789: AB_2686312	unprognostic (1.93e-3)	unprognostic (7.52e-3)	unprognostic (8.53e-2)	unprognostic (2.10e-2)	unprognostic (2.18e-3)	unprognostic (3.38e-3)	unprognostic (3.39e-3)	unprognostic (3.97e-2)	unprognostic (1.71e-1)	unprognostic (8.99e-2)	unprognostic (5.80e-2)	unprognostic (7.69e-2)	unprognostic (2.81e-7)	unprognostic (9.31e-2)	unprognostic (6.77e-2)	unprognostic (1.49e-2)	unprognostic (5.06e-3)	0.7	86.6	0.1	0.3	0.1	0	0	0.1	0.8	0.3	0	1.9	0.7	0.1	0.1	0	0	0.1	0.1	0.1	0	0.1	0.5	35.6	0.3	0.6	0	0	0.1	1.3	0	0.6	0.4	36.2	0.8	0	1	0.2	5.9	0	0	0.2	0	1.4	0.4	0.1	0	0	0.1	0.1	0	0	0.8	0.5	0	0	0	0	0	2	0	0	0	0	0.1	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0.3	0.1	0	0	0	0	0.6	0.5	0	0	0.2	206.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	2	0	0	0	0	0	0	0	0.1	0.1	0.1	0.8	0	0.1	0	0	36.2	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.2	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Ito cells
PLP1	GPM6C, PLP, SPG2	ENSG00000123560	Proteolipid protein 1	P60201	X	103773718-103792619	Cancer-related genes, Disease related genes, Predicted membrane proteins			Cancer-related genes, Disease mutation, Hereditary spastic paraplegia, Leukodystrophy, Neurodegeneration	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	26	brain: 463.6	Cell type enriched	Detected in some	16	Melanocytes: 376.2	Group enriched	Detected in many	22	glioma: 160.5;melanoma: 75.4	Low region specificity	Detected in all			Cell type enriched	Detected in single	9	plasmacytoid DC: 2.3	Lineage enriched	Detected in single	9	dendritic cells: 2.3	Group enriched	Detected in some	5	SK-MEL-30: 67.9;WM-115: 40.5	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA004128	Enhanced											HPA004128: AB_1079635	unprognostic (5.72e-2)	unprognostic (1.77e-2)	unprognostic (2.27e-2)	unprognostic (4.09e-3)	unprognostic (1.32e-1)	unprognostic (3.95e-2)		unprognostic (2.57e-2)	unprognostic (1.02e-1)	unprognostic (5.92e-2)	unprognostic (2.28e-2)	unprognostic (1.21e-1)	unprognostic (1.62e-5)	unprognostic (4.91e-2)	unprognostic (1.86e-1)	unprognostic (3.46e-2)	unprognostic (1.16e-2)	3.6	5.6	90.6	2.8	109.9	1.9	3.1	8.9	463.6	3.9	5.7	208.1	0	3.3	3.6	3.5	4.2	2.5	4	5	143.8	73.8	2.1	2.1	2.1	2	174.8	42.2	3	2.2	17.9	0.3	1.9	124.4	3.6	5.4	0	3.4	9.3	2.2	7.3	5.1	7	453.8	2	2.8	9.2	145.2	0	2	0	2	2.7	0.8	0	2.3	0	0	0	0.2	0	0	0	6.1	0	0	0.1	0	0	0.1	0	0.2	0.5	0	0	0	0.2	0	0.6	0	0	0	0	0	0	0	0	0	0	0.4	1.2	0	0	0	0.2	0	0	0	0.8	0	0	0	0	11	0	0	0	0	0	0	0	0	0	0	0	67.9	1.9	0	0	0	0	0.1	0	0	0	0	0	1.2	0	40.5	0	0	0	0.2	0	0	0	0	0	0.1	0	0	0	0	0	0	2.3	0	0	90.6	109.9	8.9	68.1	143.8	73.8	174.8	42.2	124.4	145.2	0	0	0	0.4	14.2	1.4	1.4	0	0	0	0	0	0	0	0	0.9	0.3	0	0	0	0	3.8	0.9	0	0	0.1	0	0	5.5	0	2	6.9	0	376.2	0	0	23.1	0	0	2.8	0	1.2	0	1	0.5	0.2	2.3	0	0	0	0	Melanocytes
SERPINA7	TBG	ENSG00000123561	Serpin family A member 7	P05543	X	106032442-106038738	Plasma proteins, Predicted secreted proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	414	liver: 101.8	Cell type enriched	Detected in some	19	Hepatocytes: 129.6	Cancer enriched	Detected in single	203	liver cancer: 82.4	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	478	Hep G2: 48.5	Not detected	Not detected			Not detected	Not detected			HPA002803	Approved				Secreted to blood			39800000000	49000000000			HPA002803: AB_1079915			unprognostic (6.22e-2)				unprognostic (1.63e-3)				unprognostic (3.34e-1)	unprognostic (2.62e-1)	unprognostic (2.15e-3)		unprognostic (2.95e-1)			0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0.1	101.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	48.5	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.9	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	129.6	0	0	0	6.2	6.9	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	Hepatocytes
ESX1	ESX1L, ESXR1	ENSG00000123576	ESX homeobox 1	Q8N693	X	104250038-104254933	Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	DNA-binding, Repressor		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in single	99	testis: 25.4	Cell type enriched	Detected in some	37	Spermatogonia: 71.7	Cancer enriched	Detected in single	5	testis cancer: 0.8	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	11	TIME: 23.7									HPA051992	Enhanced		Supported	Nuclear speckles						Nuclear speckles		HPA051992: AB_2681684															unprognostic (1.87e-1)			0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0.1	0	0	0	0	0	0	0	0	0	0	0	0	25.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	2.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	23.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	1	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	1.7	1.1	0	0	0	0	0	0.1	0	0	0	0	0	0	1.9	71.7	0	0	0	0	0	Spermatogonia
TNFAIP6	TSG-6, TSG6	ENSG00000123610	TNF alpha induced protein 6	P98066	2	151357592-151380048	Plasma proteins, Predicted secreted proteins	Cell adhesion			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		blood: 50.9	Cell type enriched	Detected in many	5	Early spermatids: 341.4	Cancer enhanced	Detected in many		renal cancer: 27.2	Low region specificity	Detected in many			Cell type enriched	Detected in some	22	neutrophil: 50.9	Lineage enriched	Detected in many	22	granulocytes: 50.9	Cell line enhanced	Detected in some		BJ hTERT+: 31.1;HHSteC: 19.3;HSkMC: 9.3;hTEC/SVTERT24-B: 25.7;SH-SY5Y: 10.2;U-2197: 20.6	Low region specificity	Detected in all			Low region specificity	Detected in many			CAB032719, HPA050884	Approved				Secreted to blood				15000			CAB032719: AB_2204650, HPA050884: AB_2681261	unprognostic (1.31e-1)	prognostic unfavorable (8.18e-5)	unprognostic (8.66e-2)	unprognostic (2.51e-2)	unprognostic (1.15e-3)	unprognostic (3.26e-3)	unprognostic (3.75e-4)	unprognostic (4.49e-3)	unprognostic (1.22e-1)	unprognostic (1.90e-1)	unprognostic (5.87e-3)	unprognostic (1.08e-1)	prognostic unfavorable (5.59e-4)	unprognostic (1.06e-2)	unprognostic (1.25e-2)	unprognostic (5.46e-2)	prognostic unfavorable (9.16e-5)	14	0.6	4.8	23.7	5.6	5.8	10.3	0.3	3.8	9.4	6.8	0.4	0.2	0.7	2	4	8.2	2.4	17.9	17.3	6.3	1.9	0.8	1.1	17.3	2.2	9.9	1.2	1.4	1.1	0.7	0.6	1.8	5.6	4.3	2.6	2.2	2.8	1	4.7	3.2	2.5	7.8	4.3	3.9	3.8	9.7	5.8	0.7	1.9	6.6	0.5	13.5	2.8	0	0	50.9	2.3	0	0	0.6	0	0	0	0	1.8	7.4	0	1.1	31.1	1.2	5.8	0	0	0	0.4	0.5	0.7	0	0	0	1.2	0	0	0	0.1	0	19.3	0	0	9.3	0	25.7	1.8	1.1	0	0	0	0	2.8	0	0	0	0.1	0	7.1	0	0.5	0	0	0	0	10.2	0.2	0	0	0.2	0	0	0	1	2.1	20.6	0.3	0	0	0	2.3	0.3	1.5	0	2.3	0	0	0.5	0	0	0	0	0	0	0	0	50.9	0	0.5	0	0	0.6	4.8	5.6	0.3	3.8	6.3	1.9	9.9	1.2	5.6	5.8	3	1.7	0.5	0.5	57.6	0	1.2	0	0	0	0	0	0.1	0	2.5	341.4	1	0	0	0	0.7	52.2	1.5	2.3	0	1.4	0	0	2.5	5	13.5	2.3	37.7	70.9	7.2	0	0	1.8	0	0.4	0	0	0	34	1.4	2	46.3	1.5	0	0	4.6	Early spermatids
KCNJ2	IRK1, Kir2.1, LQT7	ENSG00000123700	Potassium voltage-gated channel subfamily J member 2	P63252	17	70168673-70180048	Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels	Ion transport, Potassium transport, Transport	Ion channel, Voltage-gated channel	Atrial fibrillation, Disease mutation, Long QT syndrome, Short QT syndrome	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 23.7;parathyroid gland: 34.8	Cell type enriched	Detected in many	8	Horizontal cells: 227.2	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Cell type enriched	Detected in many	4	neutrophil: 20.8	Lineage enriched	Detected in many	4	granulocytes: 20.8	Cell line enhanced	Detected in some		hTERT-RPE1: 7.5;HUVEC TERT2: 5.2;REH: 6.0;RH-30: 24.5;U-138 MG: 9.0	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA029109	Approved											HPA029109: AB_10602913	unprognostic (1.32e-1)	unprognostic (1.24e-1)	unprognostic (1.18e-1)	unprognostic (6.22e-2)	unprognostic (3.50e-1)	unprognostic (6.36e-3)	unprognostic (1.22e-2)	unprognostic (3.14e-1)	unprognostic (1.09e-1)	unprognostic (1.62e-1)	unprognostic (3.64e-2)	unprognostic (1.03e-1)	unprognostic (1.74e-3)	unprognostic (6.15e-3)	unprognostic (9.60e-3)	unprognostic (4.89e-2)	unprognostic (5.49e-3)	3	1.5	6.2	6.3	17.9	2.5	6.6	1.3	12.8	1.8	5	23.7	5.1	1.6	1.5	1.2	4.7	8.4	2.2	11.4	6.4	4.4	1.7	1.9	3.9	4.4	22.4	8.5	1.4	1	34.8	1.6	9	11.7	2.6	4.3	3.1	2.7	2.9	10.3	6	2.1	1.6	14.9	10.4	2	0.9	18.2	0.5	1.9	6	2.2	2.6	3.3	0.1	0.7	20.8	4.7	0	0	0.4	0	0.7	1.5	0	1.6	0.4	0	0.5	3.7	0	0.1	0	0	0	0.3	0.4	1	0.4	0.1	0.2	0.1	0	0.2	0	0.5	0	4.7	0	0	1.7	0.1	2.3	0.2	7.5	5.2	0	0	0	1.6	0	0.5	0	0.1	0.6	0.1	6	24.5	0	0.6	0	0.3	0.7	0.4	0.1	0	3.1	0.2	0.4	0.1	9	0.1	0	2	0	0	0.1	1.9	0	1.2	1.8	2.5	3.6	0	4.7	0	0.1	0	0	0.7	0	0	0	20.8	0	4.6	0.1	0	0.4	6.2	17.9	1.3	12.8	6.4	4.4	22.4	8.5	11.7	18.2	0	2.7	0.8	5.2	7.2	6.6	14.2	0	5.3	1.2	1.8	0	0.5	0	0	0.2	8.7	2.6	0	0	0.1	0.8	1.7	0	0	5.7	227.2	10.3	3.7	28.3	0	1.4	5.2	3.3	1	2.8	5	0	11.2	1.1	0	4.6	0	2.2	0	0.4	2.9	1.1	0	6.6	0.1	Horizontal cells
C4BPB	C4BP	ENSG00000123843	Complement component 4 binding protein beta	P20851	1	207088842-207099993	Plasma proteins, Predicted secreted proteins	Complement pathway, Immunity, Innate immunity			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	16	liver: 156.5	Cell type enriched	Detected in many	7	Hepatocytes: 556.0	Cancer enriched	Detected in many	19	liver cancer: 83.7	Not detected	Not detected			Cell type enhanced	Detected in some		naive CD4 T-cell: 2.5;plasmacytoid DC: 3.6	Group enriched	Detected in many	16	dendritic cells: 3.6;T-cells: 2.5	Group enriched	Detected in some	16	CACO-2: 38.6;HeLa: 16.0;Hep G2: 50.1;OE19: 18.8					Low region specificity	Detected in all			HPA051620	Approved				Secreted to blood			265000000000	1300000000			HPA051620: AB_2681554	unprognostic (1.73e-1)	unprognostic (2.62e-1)	unprognostic (3.26e-1)	unprognostic (2.07e-3)	unprognostic (1.72e-1)	unprognostic (2.54e-2)	unprognostic (4.58e-3)	unprognostic (9.49e-2)	unprognostic (1.37e-1)	unprognostic (4.25e-1)	unprognostic (6.39e-2)	unprognostic (2.64e-2)	unprognostic (1.21e-2)	unprognostic (1.55e-1)	unprognostic (1.03e-1)	unprognostic (1.05e-2)	unprognostic (8.25e-2)	0.5	0	0.1	0.5	0.1	0	0.3	0.1	0.1	0.5	2	0.1	0.1	0.6	0.1	0.9	0.2	0.1	1	0.6	0.1	0	0.2	156.5	0.6	0.1	0.1	0.1	9.9	2.2	0	0.1	1.3	0.1	0.3	0.3	0.1	0.2	0.1	0.2	0	0.9	0.2	0.1	0.1	1.5	0.2	0.1	0.2	0.1	0.1	0.1	0.2	0.1	0.1	3.6	0	0	0	2.5	0.4	0	0.2	0	0	0	0	0	0	0	0	0	38.6	1.9	0	0.1	0	0	0	0	0	0	0	0	0	16	50.1	0.3	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.8	0	0	0	0	0	0.1	0	0	0.2	0.1	0	0	0.7	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0.1	2.5	0.8	0	0	0	3.6	0	0.4	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	11.9	1.3	1.5	0	0	0	0.4	45.9	2.7	4.5	0	0	0.7	1.7	11	3.9	0	3.1	0	76.8	0.1	0.2	0.2	0	556	1.6	0	1.7	9.8	9.4	1.8	0	0.4	0	1	3.4	0	52	11.5	0	0	0	0	0.1	0	0	0	0.1	0.9	2.3	0	Hepatocytes
INHA		ENSG00000123999	Inhibin alpha subunit	P05111	2	219569162-219575713	Predicted secreted proteins		Growth factor, Hormone		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	5	adrenal gland: 24.2;ovary: 31.5;placenta: 39.3;testis: 77.6	Cell type enriched	Detected in many	9	Syncytiotrophoblasts: 276.8	Low cancer specificity	Detected in many			Region enriched	Detected in some	5	basal ganglia: 8.4	Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		BEWO: 4.5;HEL: 5.6;SK-BR-3: 12.8;SuSa: 6.6	Low region specificity	Detected in all			Not detected	Not detected			CAB000047, HPA019141, HPA048834	Enhanced		Approved	Golgi apparatus,Vesicles	Secreted to blood					Vesicles	Golgi apparatus	CAB000047: AB_322161, HPA019141: AB_1851789, HPA048834: 	unprognostic (8.90e-3)	unprognostic (2.91e-2)	unprognostic (2.82e-1)	unprognostic (7.55e-2)	unprognostic (1.02e-3)	unprognostic (1.45e-1)	unprognostic (3.57e-1)	unprognostic (9.61e-3)	unprognostic (4.15e-3)	unprognostic (6.71e-2)	unprognostic (3.73e-1)	unprognostic (7.34e-2)	prognostic unfavorable (4.03e-5)	unprognostic (4.85e-2)	unprognostic (7.20e-2)	unprognostic (1.93e-1)	unprognostic (4.43e-2)	0.5	24.2	0.8	0.5	8.4	0	0.5	1.7	0.9	0.5	0.5	1.4	0.5	0	0.5	1.2	0.5	0.6	0.6	4.8	0.8	0.9	0.5	0.5	0.5	0.5	0.5	0.6	31.5	6.5	0.2	1.5	39.3	0.6	0.5	0	0.5	0.9	0.7	0.5	1.1	0.5	0.5	0.5	0.5	0.1	77.6	0.5	0.5	0.5	0.5	0.5	0.5	0.5	0	0	0	0	0	0	0	0.5	0.4	0.1	2.5	0.8	0.2	4.5	0.5	0.4	0.7	0.2	0.3	4.3	0	0.3	1	0.7	2.6	0.3	0.7	0	0	0.8	5.6	2	3	0.4	0	0	0.9	1.3	0	0.7	2.5	0	0	3.3	0	0.1	3	0	0.2	1.7	0.2	1.1	0.1	0.2	0	0.7	0.3	0.4	1	1.6	12.8	0.4	6.6	0.8	0	0.1	0.5	0.2	0.2	0	0	0	0	0.3	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.8	8.4	1.7	0.9	0.8	0.9	0.5	0.6	0.6	0.5	0	0	0	0.1	0	3.4	1.4	0	0	0	7	2	6	0	1.5	0.7	0	0	0	7.9	29.6	0.2	0	0	0	2.3	6.4	0	1.3	0.3	4.1	3.7	0	0	0	0	3.3	3.3	0	1.4	0	0	0	0	1.1	0.4	0	276.8	0	0	0	Syncytiotrophoblasts
CTCFL	BORIS, CT27, dJ579F20.2	ENSG00000124092	CCCTC-binding factor like	Q8NI51	20	57495966-57525652	Predicted intracellular proteins, Predicted membrane proteins, Transcription factors	Cell cycle, Transcription, Transcription regulation	Activator, Chromatin regulator, DNA-binding, Repressor		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	8	testis: 35.4	Cell type enriched	Detected in some	6	Spermatogonia: 114.6	Cancer enhanced	Detected in some		ovarian cancer: 4.3	Not detected	Not detected			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Group enriched	Detected in some	33	HMC-1: 33.3;K-562: 45.5	Not detected	Not detected			Not detected	Not detected			HPA001472	Enhanced		Approved	Nucleoplasm,Nuclear bodies,Cytosol						Nucleoplasm, Nuclear bodies	Cytosol	HPA001472: AB_1078583	unprognostic (2.50e-1)	unprognostic (4.01e-2)	unprognostic (7.70e-2)	unprognostic (1.85e-5)	unprognostic (9.58e-2)	unprognostic (2.89e-1)	unprognostic (6.44e-2)	unprognostic (5.26e-3)	unprognostic (3.60e-1)	unprognostic (2.20e-1)	unprognostic (9.00e-2)	unprognostic (4.16e-2)	unprognostic (4.75e-4)	unprognostic (2.03e-1)	unprognostic (2.20e-1)	unprognostic (4.84e-2)		0.2	0.1	0.1	0.1	0.4	1.3	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.3	0.4	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.4	0.1	0.3	0.1	0.1	0.1	0.4	0	0.5	0.2	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.5	0.2	0.1	0.1	0.3	0.1	35.4	0.1	0.1	0.4	0.1	0.1	0.1	0.1	2.1	1	4.3	0.8	0.8	0.8	0.2	0	0	0	0.2	0	0	0.1	0	0	0	0	0	0.1	0.1	0	0	0.1	0.1	0	0.1	0	0.1	0	0.1	0.3	0.1	0	0.1	33.3	0	0	0	0	0	0	0	45.5	0.3	0	0	0.1	0.2	0.1	0	0	0.1	0.1	0.1	0	0.2	0.1	0.1	0	0.1	0.1	0.2	0.1	0	0.2	0.1	0.1	0.1	0	0.1	0	1.2	0.1	0.1	0.2	1.8	0.7	1.2	0.6	0.7	0.5	1.3	0.4	0.5	0.3	2.1	0.7	0.8	4.3	0.8	0.8	1	0.5	0.2	0.1	0.4	0.1	0.1	0.1	0.2	0.1	0.1	0.3	0.1	0	0	0	0.2	0	0	1.4	0	0	0	0	0	0	0	0	2.1	0	0	0	0	0	0.2	0.2	0	0	0.1	0	0	0	0	2.3	0.6	0.1	0	0	0	0	0	0	0.7	0	0	6.5	0.4	18.5	114.6	0	0	0	0	0.1	Spermatogonia
FAM209A	C20orf106, dJ1153D9.3	ENSG00000124103	Family with sequence similarity 209 member A	Q5JX71	20	56517187-56526142	Predicted membrane proteins				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	5	testis: 40.3	Cell type enriched	Detected in some	15	Early spermatids: 1951.2	Not detected	Not detected							Cell type enhanced	Detected in some		gdT-cell: 1.9;neutrophil: 2.3	Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		HMC-1: 5.5;Karpas-707: 3.0;U-266/84: 3.9																						unprognostic (1.03e-1)	unprognostic (1.01e-2)	unprognostic (2.19e-2)	unprognostic (1.58e-1)	unprognostic (1.75e-1)	unprognostic (8.58e-3)	unprognostic (1.06e-2)	unprognostic (2.12e-1)	unprognostic (2.10e-1)	unprognostic (9.83e-2)	unprognostic (5.56e-3)	unprognostic (7.68e-2)	unprognostic (1.86e-9)	unprognostic (2.98e-2)	unprognostic (2.07e-1)	unprognostic (1.34e-1)	unprognostic (3.22e-2)	0.2	0	0	0.3	0	8.1	0.1	0.1	0	0.1	0.1			0	0	0	0	0.1	0	0	0	0	0	0.1	0.2	0.5	0		0	0.1	0	0.2	0		0.1	0		0.1	0	0	0.5	0.4	0	0	0.9	0.1	40.3			0		0.5	0	0.1	0.6	0.3	2.3	0.2	0	1.9	0	0.1	0	0.3	0	0.7	0	0	0.4	0	0.3	0.3	0.3	0.2	1.9	0.3	0.5	0.2	0.2	0.5	0.2	0.2	0.3	0.3	0.6	0.4	0	0.2	1.5	5.5	0.3	1.6	0	0.2	0.2	0	1.7	0	3	0	1.3	0.2	1.9	0.2	0.1	0.2	1	0.9	1.2	0	0.7	0.5	0	0	2.1	0.5	0	0.4	0.9	0	0.5	0.3	0.8	0.3	1.4	3.9	2	0	0.2	0.1	0	0.2	0.6	1.9	0	0	0.6	0	0	0	0.2	0	0.1	2.3	0	0.2	0.3	0	0											0	2.9	0	0.1	0.1	0	0.4	0	1.4	1.2	0	0	0	0	0	1951.2	0	0	0	0	0.2	0.1	0.1	1.1	0	0.1	0	1.2	1.8	0.3	132.6	8.1	0.8	0	0	0	0	0.4	0	6	0	0	0	0	7.5	4.1	0	0.2	0	0.1	0.1	Early spermatids
KCNS1	Kv9.1	ENSG00000124134	Potassium voltage-gated channel modifier subfamily S member 1	Q96KK3	20	45092310-45101112	Predicted membrane proteins, Transporters, Voltage-gated ion channels	Ion transport, Potassium transport, Transport	Ion channel, Potassium channel, Voltage-gated channel		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in some		brain: 27.0	Cell type enriched	Detected in some	6	Cholangiocytes: 10.2	Cancer enhanced	Detected in many		cervical cancer: 6.1	Region enhanced	Detected in many		cerebral cortex: 27.0	Cell type enhanced	Detected in single		neutrophil: 2.5	Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		HBF TERT88: 3.2;HHSteC: 4.9;hTEC/SVTERT24-B: 2.7;THP-1: 4.1;U-87 MG: 7.0	Low region specificity	Detected in many			Low region specificity	Detected in all																unprognostic (2.46e-2)	unprognostic (2.95e-3)	unprognostic (2.03e-1)	unprognostic (3.11e-4)	unprognostic (8.91e-3)	unprognostic (6.01e-3)	unprognostic (7.47e-2)	unprognostic (8.94e-2)	unprognostic (4.37e-2)	prognostic unfavorable (6.45e-4)	unprognostic (6.74e-2)	unprognostic (4.65e-2)	unprognostic (6.35e-2)	unprognostic (5.62e-2)	unprognostic (3.06e-2)	unprognostic (1.15e-1)	unprognostic (1.39e-1)	0.3	0.8	1.4	0.2	4.6	0.4	0.7	0.4	27	0.6	0.3	0	5.9	0.2	0.2	0.2	0.4	0.3	5.2	0.4	2.1	1.1	0.5	0.3	0.7	0.3	1	7.2	0.2	0.3	0.1	0.4	0.3	0	0.9	0.2	0	3.4	7	0.2	2.6	0.3	0.2	0.4	0.3	0.3	2	0	0	0.3	0	0.5	0.4	0.6	0.6	0.2	2.5	0.1	0	0.5	0	0	0	0.1	0.2	0	0	1.1	0.5	0	0.3	0.3	1	0.9	0.1	0.4	1.4	0	0	0	0	3.2	0	0	0	0	0	4.9	0	0.2	0.9	0	2.7	0	0	0.9	0	0	0	0	0	0.2	0.1	1.1	0	0	0	0	0	0.4	0	0.8	0.3	1.8	0	2.1	0.5	0	4.1	0	0	0.2	0.1	0.1	0	0	0	7	0	0.3	0	0.1	0	0.2	0	0	0.3	0	0.5	0.2	0.6	0	0	2.5	0	0	0	0	0	1.4	4.6	0.4	27	2.1	1.1	1	7.2	0	0	0	1.3	0	0	0.3	0	0.9	10.2	0	0	1.8	0	0	0	0.2	0.2	0	0	0	0.2	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0.1	0.9	0	0.1	0	0	0.1	Cholangiocytes
PEPD		ENSG00000124299	Peptidase D	P12955	19	33386950-33521794	Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins	Collagen degradation	Dipeptidase, Hydrolase, Metalloprotease, Protease	Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		intestine: 92.9;kidney: 106.0	Cell type enriched	Detected in many	5	Proximal tubular cells: 1020.8	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low cell line specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA015599, HPA072045	Enhanced		Approved	Nucleoplasm					1000000000	Nucleoplasm		HPA015599: AB_1855192, HPA072045: AB_2732194	unprognostic (1.39e-1)	unprognostic (2.62e-2)	unprognostic (2.27e-1)	unprognostic (4.01e-2)	unprognostic (2.98e-1)	unprognostic (6.77e-2)	unprognostic (2.82e-1)	unprognostic (3.64e-2)	unprognostic (3.96e-1)	unprognostic (5.10e-2)	unprognostic (1.11e-2)	unprognostic (1.99e-1)	prognostic favorable (6.50e-9)	unprognostic (4.38e-2)	unprognostic (1.99e-1)	unprognostic (1.65e-1)	unprognostic (1.29e-1)	23.5	17.2	9.8	8.9	10.4	4.1	21.8	7.6	14.9	9.8	60.1	18.7	6.9	58.1	14.3	11.5	14.9	9.6	13.6	8	10.8	9.1	106	48.6	11.1	10.6	16	7.7	12.6	9	9.6	12.5	10.4	13	9.2	6.6	13.3	9.6	9	9.7	11.4	92.9	10.4	17.4	13.4	9.3	8.4	11.5	8.4	15	9.7	10.6	11.9	11.9	17.1	32.3	27.5	39.1	16.8	25.8	32.6	13.3	36.3	10.7	17.3	45.7	17.6	24.8	11.9	24.4	15.2	17.3	31.6	11.8	5.4	17.8	29.8	11.7	3.5	15.4	9.7	12.5	15.4	15.2	34.7	7.4	32.1	31.3	10.1	42.1	21.7	9.2	13.8	8.6	11.2	20.3	10.7	6.6	15.8	16.5	16.3	7.7	3.4	14.7	26.6	14.8	15.2	14.6	15	13.1	35.3	13.2	33.8	22.2	11	17.9	9.4	7.6	11	16.9	14.7	15.9	19	13.7	14.5	21.5	4.8	15.7	14.6	20.9	27.5	36.1	2.5	25.8	39.1	22.6	17.1	25.7	23.8	32.3	16.3	16.9	19.6	1.9	16.8	27.2	9.9	23.6	32.6	9.8	10.4	7.6	14.9	10.8	9.1	16	7.7	13	11.5	20.8	24.3	20.2	26.1	17.2	33.9	11.7	43.3	26.8	11.4	69.8	3.9	19.3	167.5	63.4	7.6	44.9	37.6	0	38.3	59.7	34.6	21.4	55.5	161.7	189.6	58.8	16.6	35	46.9	8.9	45.8	63.2	64.1	131.7	14.5	69.3	37.3	28.5	57	1020.8	23.8	38.8	38.8	11.4	48.3	17.8	25.4	31	16.7	18	Proximal tubular cells
IL17C	CX2, IL-17C, IL-21, MGC126884, MGC138401	ENSG00000124391	Interleukin 17C	Q9P0M4	16	88638591-88640473	Predicted secreted proteins	Inflammatory response	Cytokine		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in many		endometrium 1: 7.6	Cell type enriched	Detected in single	6	Exocrine glandular cells: 3.6	Low cancer specificity	Detected in some			Region enhanced	Detected in single		cerebellum: 1.2	Cell type enhanced	Detected in single		naive B-cell: 1.1	Lineage enhanced	Detected in single		B-cells: 1.1	Cell line enhanced	Detected in some		MCF7: 3.6;RPMI-8226: 1.6;SCLC-21H: 2.6	Not detected	Not detected			Not detected	Not detected			HPA065051	Supported				Secreted to blood			30500				HPA065051: AB_2685413	unprognostic (1.60e-1)	unprognostic (1.69e-1)	unprognostic (7.31e-2)	unprognostic (4.45e-1)	unprognostic (5.58e-2)	unprognostic (2.93e-2)		unprognostic (3.50e-2)	unprognostic (1.73e-1)	unprognostic (2.31e-2)	unprognostic (3.46e-1)	unprognostic (1.89e-2)	unprognostic (3.04e-3)	unprognostic (2.73e-2)	unprognostic (7.91e-2)	unprognostic (3.56e-3)	unprognostic (8.37e-3)	0.1	0	0.1	0.1	0.6	0.8	0.1	1.2	0.1	1	0.1	0.1	0.1	0	7.6	0.1	0.8	0.2	1.4	2.3	0.1	0	0.1	0.1	3.6	0.2	0.1	0.1	0.1	0.1	0.2	0.3	1.2	0.1	0.1	0	0.1	0.1	0.1	0.1	1.9	0.5	0.1	0.1	1.3	0.9	2	0.1	0.1	0.1	2.5	0.1	1.2	0.1	1.1	0	0	0	0	0.4	0	0	0	0	0	0	0	0.2	0	0.4	0	0	0	0	0.4	0.3	0	0.3	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.9	0	3.6	0	0.2	0	0.1	0	0.2	0	1.6	0	0	2.6	0.1	0	0	0	0.3	0	0	0	0	0.2	0	0	0	0.5	0.6	0	0.4	0	0	0	0	0.4	0	0	0	0	0	0	1.1	0	0	0	0	0	0	0	0	0.1	0.6	1.2	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0.6	0	0	0	0	3.6	0	0	0.3	0	0	0.1	0	0	0	0.3	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0.5	0	0.2	0	0	0.3	Exocrine glandular cells
PSG8		ENSG00000124467	Pregnancy specific beta-1-glycoprotein 8	Q9UQ74	19	42752686-42855691	Predicted intracellular proteins, Predicted secreted proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at transcript level		Tissue enriched	Detected in some	88	placenta: 142.2	Cell type enriched	Detected in some	12	Syncytiotrophoblasts: 28.7	Cancer enriched	Detected in single	17	thyroid cancer: 0.8	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		A-431: 1.8;CAPAN-2: 1.1;HBF TERT88: 1.3;SuSa: 1.7;U-2197: 2.5									HPA046327	Supported				Secreted in female reproductive system							HPA046327: AB_2679624																unprognostic (1.85e-2)		0	0	0	0	0	0	0.1	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	1	0.2	142.2	0	0	0	0	0.4	0	0	0	0	0	0	0	0	1.6	0	0	0.1	0	0	0.1	0	0	0	0	0	0	0	0	1.8	0	0	0	0	0	0	0.8	0.6	0.4	0	0	1.1	0	0.1	0.1	0.7	0	0.2	0	1.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	1.7	0	0	0.5	0	0	2.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0.1	0	0.7	2.4	0	0	0	0	0.2	0	0	0	0	0.1	0	0	0	0	2.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	28.7	0	0	0	Syncytiotrophoblasts
NDP	EVR2, norrin	ENSG00000124479	NDP, norrin cystine knot growth factor	Q00604	X	43948776-43973504	Disease related genes, Predicted secreted proteins	Sensory transduction, Vision, Wnt signaling pathway		Deafness, Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		ovary: 40.4	Cell type enriched	Detected in some	8	Muller glia cells: 100.6	Cancer enhanced	Detected in many		glioma: 25.8	Low region specificity	Detected in all			Cell type enriched	Detected in single	14	memory CD4 T-cell: 1.7	Lineage enriched	Detected in single	14	T-cells: 1.7	Cell line enriched	Detected in some	17	U-87 MG: 41.2	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA003095			Supported	Nucleoplasm,Nucleoli,Vesicles	Secreted to extracellular matrix					Vesicles	Nucleoplasm, Nucleoli	HPA003095: AB_1079457	unprognostic (1.12e-1)	unprognostic (7.12e-2)	unprognostic (2.27e-2)	unprognostic (2.55e-3)	unprognostic (6.84e-3)	unprognostic (1.51e-1)		unprognostic (9.09e-2)	unprognostic (2.29e-1)	unprognostic (1.22e-1)	unprognostic (1.86e-1)	unprognostic (1.40e-1)	unprognostic (3.02e-2)	unprognostic (2.22e-2)	unprognostic (1.47e-1)	unprognostic (1.13e-1)	unprognostic (2.87e-3)	0.9	0.6	17.3	0.6	18.6	0.5	3.6	14.6	15	19.1	0.7	12.6	0.2	0.6	13.6	19.9	0.6	18	0.9	1.4	14	7.8	0.7	0.5	0.6	0.7	11	10.9	40.4	0.6	0.8	0.2	5.3	13.1	6.8	0.7	1.4	0.6	12.4	1.5	1.1	0.6	10.7	7.5	0.6	0.7	1.4	12.2	0	1.2	0	0.7	1	1.7	0.1	0	0.1	0	0	1.7	0	0	0	0.1	0.1	0	0.4	0.6	0	0	0	0	0.1	0	0	0.1	0.1	0	0	0	0	0.3	0.1	0	0	0.2	0	0	0	0	0.1	0	0.7	0	0	0.9	0	0	0.1	1.1	0.7	0	0	1.1	0	2.4	0	0	0	0	0.3	0	0	0	0	0	0.2	0	0	0	0.1	0	0.1	1.2	0	0	0	41.2	0.4	2.4	0	0	0.1	0.1	0	0	0	1.7	0	0	0.1	0	0	0.1	0	0	0	0	0	17.3	18.6	14.6	15	14	7.8	11	10.9	13.1	12.2	0	0	0	0	0.1	0.5	0.2	0	0	0	0	0	0	0	1.6	0	0	0	0	0	0.2	0.3	0	0	0	0.1	0	0	0	0	0.4	12.4	0	0	0	0	100.6	0.7	0	9.2	0	3.3	0	0.2	0	0	0.1	0	0	0	0.1	Muller glia cells
F13A1	F13A	ENSG00000124491	Coagulation factor XIII A chain	P00488	6	6144085-6321013	Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Blood coagulation, Hemostasis	Acyltransferase, Transferase	Cancer-related genes, Disease mutation, FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		placenta: 110.1	Cell type enriched	Detected in many	6	Hofbauer cells: 646.4	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Group enriched	Detected in many	5	classical monocyte: 27.6;myeloid DC: 33.7	Group enriched	Detected in many	5	dendritic cells: 33.7;monocytes: 27.6	Cell line enhanced	Detected in some		AF22: 15.7;LHCN-M2: 5.8;RH-30: 29.5	Low region specificity	Detected in all			Not detected	Not detected			HPA001804, CAB002155	Enhanced				Secreted to blood				1400000000			CAB002155: AB_564077, HPA001804: AB_1078792	unprognostic (4.44e-1)	unprognostic (5.90e-2)	unprognostic (2.65e-2)	unprognostic (3.93e-2)	unprognostic (5.02e-2)	unprognostic (3.75e-2)	unprognostic (5.27e-2)	unprognostic (1.96e-1)	unprognostic (2.68e-2)	unprognostic (6.84e-3)	unprognostic (4.96e-2)	unprognostic (1.97e-1)	prognostic unfavorable (6.61e-6)	unprognostic (2.79e-2)	unprognostic (1.52e-1)	unprognostic (1.57e-1)	unprognostic (2.54e-3)	56.6	19.4	2.2	11.4	6.5	3.1	57.9	2.2	1.8	13.3	21.8	2.6	2.5	2.2	4.7	35.6	13.4	16.8	12.6	55.4	2	2.2	17.5	1.3	14.5	52.7	5.8	1.4	10.2	8.9	5.3	9.3	110.1	7.5	16.4	15.1	11.6	11.5	3.3	18.5	10.4	10.6	20.1	5	5.1	11.5	16.7	2.5	2.7	22.4	8.3	6.1	23.7	6.5	0	33.7	6.6	27.6	0	0.1	63.5	0	0	15.7	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0.8	0	1.6	0	0	0	0	0	0.2	0	0	5.8	0	0	0.1	0	0	0	0	29.5	0.5	0	0	0.2	0.2	0.1	0	0	0.1	0	2.6	0	0	0.3	0	0	0	0	0	0	0.1	0	5.7	27.6	0.2	0.1	4.9	0.1	0	0	0	33.7	0	0	0	6.6	0	0.1	2.4	0	63.5	2.2	6.5	2.2	1.8	2	2.2	5.8	1.4	7.5	2.5	0	3.4	0.8	0	16.7	0	7.5	10.2	4	0	0	0	4	0	0	3.8	4.7	0	0	0	3.4	16.5	0	1.1	0.8	646.4	0	0	4.3	113.2	4.2	4	57.6	18.6	1	0	0.7	0.1	0	0.7	3.1	4.1	58.2	9.2	1.4	1	13.2	8.5	0	0	0	Hofbauer cells
SLC17A3	NPT4	ENSG00000124564	Solute carrier family 17 member 3	O00476	6	25833066-25882286	Predicted membrane proteins, Transporters	Ion transport, Sodium transport, Symport, Transport			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	5	kidney: 62.3	Cell type enriched	Detected in some	10	Proximal tubular cells: 127.1	Cancer enriched	Detected in some	17	renal cancer: 57.0	Not detected	Not detected			Group enriched	Detected in some	6	gdT-cell: 1.1;MAIT T-cell: 1.9;memory CD4 T-cell: 1.6	Lineage enriched	Detected in single	19	T-cells: 1.9	Cell line enriched	Detected in single	217	RPTEC TERT1: 51.8	Not detected	Not detected			Low region specificity	Detected in all																unprognostic (5.31e-3)				unprognostic (1.56e-2)		unprognostic (2.51e-1)	unprognostic (4.65e-2)			unprognostic (5.05e-2)	unprognostic (1.88e-1)	unprognostic (1.07e-1)	unprognostic (2.34e-1)	unprognostic (1.34e-1)	unprognostic (4.49e-1)		0.1	0.3	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.2	0.1	0	0.1	0.1	0.1	0	62.3	13.6	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0	1.9	0.3	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	51.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.1	0	1.9	0	1.6	0.2	0	0	0	0.1	0	0	0	0	0	0.3	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	0.5	0.2	0	0	0.2	0	0	0	1.8	0	0	6.6	0	0.9	0	0	0	0	0	0	0.1	0	12.4	0	0	0	1.3	0	0.4	0	0	0	0	0	0	0	0	0	127.1	0	0	0	0	0	0	0	0	0	0	Proximal tubular cells
SLC17A1	NAPI-1, NPT1	ENSG00000124568	Solute carrier family 17 member 1	Q14916	6	25782897-25832059	Predicted membrane proteins, Transporters	Ion transport, Sodium transport, Symport, Transport			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Group enriched	Detected in some	56	kidney: 67.6;liver: 17.9	Cell type enriched	Detected in some	4	Proximal tubular cells: 44.6	Group enriched	Detected in some	150	liver cancer: 7.6;renal cancer: 19.2	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	389	RPTEC TERT1: 38.8	Not detected	Not detected			Low region specificity	Detected in all			HPA050513			Approved	Golgi apparatus						Golgi apparatus		HPA050513: AB_2681152			unprognostic (6.98e-2)		unprognostic (2.99e-1)		unprognostic (1.03e-1)				unprognostic (1.26e-1)		unprognostic (2.71e-3)	unprognostic (1.32e-1)	unprognostic (2.37e-1)	unprognostic (4.74e-1)		0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	67.6	17.9	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	38.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.5	0	0	1.8	0	0	0	0	10.9	0	0	0	0	0	0	0	0	9	0	0	0	0	0	1.3	0.3	0	0	0	0	0	0	0	0.4	44.6	0	0	0	0	0	0	0	0	0	0	Proximal tubular cells
HIST1H1A	H1.1, H1a, H1F1	ENSG00000124610	Histone cluster 1 H1 family member a	Q02539	6	26017085-26017732	Predicted intracellular proteins		DNA-binding		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		testis: 57.2	Cell type enriched	Detected in some	9	Spermatogonia: 131.8	Not detected	Not detected			Low region specificity	Detected in some			Cell type enhanced	Detected in many		T-reg: 4.9	Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		AN3-CA: 2.1;REH: 4.4;RPTEC TERT1: 1.5;U-2 OS: 3.9	Not detected	Not detected							HPA043753, HPA056830	Enhanced		Supported	Nucleoplasm			Yes			Nucleoplasm		HPA043753: AB_2678654, HPA056830: 		unprognostic (3.80e-1)					unprognostic (1.82e-1)			unprognostic (1.15e-1)				unprognostic (1.96e-1)	unprognostic (1.21e-1)	unprognostic (3.05e-1)		0.8	1.4	1	3.9	0.9	1.1	0.8	0.9	3.3	3.5	0.8	0	0.4	0.7	3.6	3.9	6.2	1.1	3.4	2.8	1	0.8	3.7	5.3	0.7	1.3	0.8	0.6	7.9	0.8	0.7	1	0.7	0.6	0.9	0.9	0.9	0.7	1.5	0.7	2	0.8	0.7	0.7	0.9	0.8	57.2	0	15.1	2.7	10.6	12.4	1.2	0.8	1.4	1.2	0	0.1	0	4.9	0.4	0.1	0	0	2.1	0	0	0	0	0	0.7	1.3	0	0	0	0.5	0	0	0.8	0	0.6	0	0.9	0.5	0	0	0	0	0	0	0	0	1.3	0	0	0.8	0	0.2	0.6	0	0	0	0.4	0	0	0	4.4	0	0	1.5	0	0.9	0	0	0	0	0.1	0	0	0	0.5	3.9	0.5	0	0.2	0.5	0	0.5	0	0.5	0	0	0	1.5	0.1	0	1.4	2.8	0.3	0.6	0	1.7	0.1	0	0	0	1.2	4.9	0.4	1	0.9	0.9	3.3	1	0.8	0.8	0.6	0.6	0	0	0.3	0	1	0.1	0	3.4	0	1.4	1.2	0	0	0.1	14.9	0	0.3	0	0	0	0.2	3.6	0.6	0.2	1.1	2.1	1.6	0	0	4.3	0.3	0.9	0.9	0.2	1.7	0	0	0.5	0.2	0	1.8	0.3	1	0	0.4	4.9	131.8	0.4	0.3	0	0	0.3	Spermatogonia
APOBEC2	ARCD1, ARP1	ENSG00000124701	Apolipoprotein B mRNA editing enzyme catalytic subunit 2	Q9Y235	6	41053304-41064511	Enzymes, Predicted intracellular proteins	mRNA processing	Hydrolase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	13	heart muscle: 58.4;skeletal muscle: 163.0;tongue: 53.9	Cell type enriched	Detected in many	5	Cardiomyocytes: 89.6	Cancer enhanced	Detected in some		pancreatic cancer: 4.9	Not detected	Not detected			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Cell line enhanced	Detected in some		BEWO: 2.2;CACO-2: 9.0;HSkMC: 3.1;SuSa: 2.4	Not detected	Not detected			Low region specificity	Detected in all			HPA014252, HPA017957	Enhanced											HPA014252: AB_1844932, HPA017957: AB_1844933	unprognostic (5.05e-2)	unprognostic (5.55e-2)	unprognostic (1.87e-1)	unprognostic (2.77e-1)	unprognostic (2.51e-2)	unprognostic (8.16e-3)	unprognostic (1.43e-1)	unprognostic (7.22e-2)	unprognostic (1.24e-1)	unprognostic (2.50e-2)	unprognostic (1.21e-1)	unprognostic (3.87e-1)	unprognostic (2.01e-2)	unprognostic (7.02e-2)	unprognostic (3.69e-1)	unprognostic (1.31e-3)	unprognostic (2.19e-2)	1.1	0.2	0	0	0	0.2	0.1	0	0	0	0.1	0	0	0.3	0	6.1	2.8	0	0	58.4	0	0	0	0	0.1	0	0	0	0	6.8	0	0	0.1	0	1.6	0	0.1	3.2	0	163	0.2	0.2	0.4	0	0	2.2	0.5	0	1.3	0.5	53.9	4.2	0.1	0	5.5	5.5	3.6	2.4	1.5	4.8	0.4	0.1	0	0.5	0.3	0	0	2.2	0	0	0	0	9	0	0.4	0.2	0	0	0	0	0	0	0.4	0.8	0.1	0	0.6	0	1	0.1	3.1	0	0	0	0.1	0	1.4	0.5	0.4	0	0	0.2	1	0.1	1.3	0.1	0.5	0.5	0.1	0.1	0	1.2	0.3	0	0	0.1	2.4	0.2	0.1	0	0	0.3	0.4	0.1	1.7	0.3	0.8	0.2	0.5	0	1.3	2	3.6	4.4	1.3	3.5	4.3	4	4.8	1.1	5.5	4.2	4.6	1.6	1.5	2.4	5.5	3.3	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0.2	2.3	89.6	0	0	0	0	2	1.4	0	2.5	9.7	0	0	0	18.9	5	0	0	0	0	0.3	1.6	0	0	0	19	0.3	0	1.7	0	0	1	3.5	0	0	1.1	2.6	0	0.1	0.2	0.2	0	1.1	0	0	0	Cardiomyocytes
GNMT		ENSG00000124713	Glycine N-methyltransferase	Q14749	6	42960758-42963880	Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins		Methyltransferase, Transferase	Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	11	liver: 83.9;pancreas: 100.1	Cell type enriched	Detected in many	34	Hepatocytes: 729.0	Group enriched	Detected in many	20	liver cancer: 69.6;prostate cancer: 49.8	Not detected	Not detected			Cell type enhanced	Detected in some		plasmacytoid DC: 3.2	Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		Hep G2: 10.5;SCLC-21H: 12.4;T-47d: 7.9	Region enriched	Detected in some	4	cerebellum: 17.7	Not detected	Not detected			HPA027501	Enhanced		Approved	Cytosol					150000	Cytosol		HPA027501: AB_1849879	unprognostic (1.53e-2)	unprognostic (8.02e-4)	unprognostic (3.11e-2)	unprognostic (4.24e-3)	unprognostic (3.91e-2)	unprognostic (6.40e-4)	prognostic favorable (1.86e-4)	unprognostic (4.08e-6)	unprognostic (1.01e-1)	unprognostic (2.67e-2)	unprognostic (1.63e-3)	unprognostic (2.52e-1)	unprognostic (3.50e-3)	unprognostic (1.03e-1)	unprognostic (1.99e-1)	unprognostic (2.49e-2)	unprognostic (4.92e-2)	0.3	0.1	0.2	0.2	0.2	0.7	1.8	0.5	0.5	0.3	0.5	0.2	1.3	0	0.2	0.9	0.3	0.1	0.2	1.3	0.2	0.2	0.3	83.9	1.3	0.1	0.1	0.2	0.4	100.1	0	2.5	0.1	0.4	5.2	0	0.9	8.2	0.9	0.6	0.1	0.2	0.4	0.1	0.3	6.5	0.6	0.1	0.2	0.9	0.3	0.4	0.2	0.1	0.7	3.2	2	0.9	0	1.2	0.3	0.5	0.4	1.8	5.1	0.6	0.2	0.3	0.4	2	0.8	1.2	0.1	0.1	1.7	0.2	0.4	0.9	0.6	0.3	0.3	0.2	2	1.6	1.3	1	10.5	0	1.1	2.4	0.4	0	0.4	0.2	1.2	0	3.8	1.5	1.9	0.3	2.3	2	3.7	0.2	0.5	0.5	1.7	1.6	1	0.9	0.2	12.4	1.7	0.1	1.7	0.6	0.5	7.9	3.6	0.4	0.9	0.9	0.5	1	1.3	1.2	1.5	0.2	2.1	1	0	0.8	0.1	0.2	0.9	0.1	0.7	0.3	0.3	0.9	0.1	0.6	1.2	2	0	0.1	3.2	0.3	0.3	0.2	0.2	0.5	0.5	0.2	0.2	0.1	0.2	0.4	0.1	0	2.1	3.4	4.2	0.2	1.2	4.5	15.3	5.3	0	1.8	0	0.1	3.3	0.4	0.2	0.1	0	0	0.7	0.1	0.2	16.1	0	729	0.5	1.6	0	16.5	21.5	0	0.9	0.3	0	0	0	0.3	0.9	0	2.5	2.2	0.3	0	0.7	0.5	0.6	0.1	0.1	0	0	1.6	Hepatocytes
KLHL31	bA345L23.2, BKLHD6, KBTBD1	ENSG00000124743	Kelch like family member 31	Q9H511	6	53647901-53665708	Predicted intracellular proteins	Transcription, Transcription regulation	Repressor		Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	4	heart muscle: 77.7;skeletal muscle: 57.7;tongue: 40.9	Cell type enriched	Detected in single	284	Cardiomyocytes: 217.1	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		RH-30: 2.8;SCLC-21H: 3.7	Not detected	Not detected			Not detected	Not detected																unprognostic (7.27e-2)	unprognostic (6.18e-2)	unprognostic (2.31e-1)	unprognostic (1.10e-1)	unprognostic (1.67e-1)	unprognostic (7.67e-4)	unprognostic (2.23e-2)	unprognostic (1.25e-1)	unprognostic (2.55e-1)	unprognostic (3.98e-2)	unprognostic (5.50e-2)	unprognostic (4.24e-1)	unprognostic (1.09e-4)	unprognostic (8.73e-2)	unprognostic (2.88e-1)	unprognostic (1.23e-1)	unprognostic (1.40e-1)	13.1	0.5	0.1	0.3	0.3	0	2	0	0	0.1	0.2	0	0	0.2	0.2	1.2	1.3	0.6	0.1	77.7	0.2	0.1	0.1	0.2	0.1	0.4	0.1	0	0.1	0.2	0	0.2	0	0.1	0.6	0.1	0	1.6	0	57.7	0.6	0.2	0	0.1	0	0.1	0.4	0	0	0.5	40.9	2.2	0.3	0.2	0.7	0	0	0.1	0.9	0.6	0	1	0.7	0.2	0.2	0	0	0.5	0	0.2	0.2	0.1	1.2	2.5	0	0.2	0	0.7	1.9	0.8	0.4	0.1	0.1	1.3	0.4	1.7	1.6	0.1	0.6	0	2.1	2.6	0	0.5	0.5	0	1.4	0	0.2	0	0.8	0.9	0	0.3	1.3	0.8	0.1	2.8	0.1	0.8	0.9	3.7	0.4	0.2	0.6	0	0.3	1.2	0	0	0.1	0.5	0	0.2	0.5	0.1	0	0.3	2.1	0.1	0	0	0	0.4	0	0.6	0.7	0	0.2	0	0.3	0.2	0.2	0	0.9	0.1	0	0	0	0.1	0.3	0	0	0.2	0.1	0.1	0	0.1	0	0	0	0	0.8	0.6	0.3	217.1	0	0	0	0	0	0.7	0	0.1	0.2	0	0	0	0.3	0.2	0.2	0.5	0	0.4	0.2	0	0	0	0	0	0.3	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0.1	0.4	0.7	0	0	0.4	Cardiomyocytes
SCGB1D2	LIPB, LPHB	ENSG00000124935	Secretoglobin family 1D member 2	O95969	11	62242210-62244808	Cancer-related genes, Predicted secreted proteins			Cancer-related genes	Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		breast: 101.5;cervix, uterine: 315.2	Cell type enriched	Detected in some	25	Melanocytes: 781.1	Group enriched	Detected in many	6	breast cancer: 625.1;endometrial cancer: 226.0	Region enriched	Detected in some	6	pons and medulla: 7.3	Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	6	SCLC-21H: 14.7									HPA035318	Approved				Secreted in other tissues							HPA035318: AB_10610421	unprognostic (8.76e-2)	unprognostic (2.14e-1)		prognostic favorable (3.46e-6)	unprognostic (2.39e-2)				unprognostic (5.89e-2)	unprognostic (4.72e-2)	unprognostic (1.99e-1)	unprognostic (6.43e-2)	prognostic favorable (8.03e-6)		unprognostic (1.55e-1)	unprognostic (1.15e-2)		1.8	0.4	0.8	0.2	0.6	0	101.5	0.9	0.5	315.2	0.2	0.9	6.2	0	18.4	43.8	0.8	8.5	0.4	1	1.2	0.4	1.1	0.2	0.2	0.2	1	0.5	1.1	2.9	0	1	0.6	7.3	1.1	0	1.2	9.5	0.5	2.4	59.6	0.2	0.2	0.4	0.2	0	1.6	0.5	0.2	0.3	2.1	1.2	0.2	1.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0.5	0	0.1	0	0	0	0	0	2.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.3	0	0	0	0	0	0.2	0	0	14.7	0.2	0	2.5	0.1	0.4	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.8	0.6	0.9	0.5	1.2	0.4	1	0.5	7.3	0.5	0	0	0	5	24.4	0.5	6.5	0	0	0	7	0	0	19.9	0	0	0	0	0	0.2	0	0.7	31.3	0	0	0.2	0	0	0	0	0	0	0.3	781.1	0	0	17	0	0	0	13.2	0.6	0	0.3	0	0	6	0.1	0	0	1	Melanocytes
WNT1	INT1	ENSG00000125084	Wnt family member 1	P04628	12	48978453-48981676	Cancer-related genes, Disease related genes, Predicted secreted proteins	Wnt signaling pathway	Developmental protein	Cancer-related genes, Disease mutation, Osteogenesis imperfecta, Proto-oncogene	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		blood: 7.7;brain: 6.5;placenta: 17.5	Cell type enriched	Detected in single	36	Cardiomyocytes: 3.6	Not detected	Not detected			Group enriched	Detected in some	7	basal ganglia: 6.5;cerebral cortex: 1.8	Group enriched	Detected in some	8	gdT-cell: 5.3;MAIT T-cell: 7.7;memory CD4 T-cell: 3.0;memory CD8 T-cell: 4.8;naive CD8 T-cell: 3.2	Lineage enriched	Detected in single	24	T-cells: 7.7	Cell line enhanced	Detected in some		CACO-2: 1.7;JURKAT: 2.9	Not detected	Not detected			Group enriched	Detected in many	4	cerebral cortex: 1.3;hippocampal formation: 1.5;midbrain: 3.5;olfactory region: 2.1						Secreted to extracellular matrix								unprognostic (2.02e-2)	unprognostic (5.80e-3)	unprognostic (1.23e-1)	unprognostic (1.64e-2)	unprognostic (1.03e-1)	unprognostic (7.65e-3)	unprognostic (5.29e-3)	unprognostic (5.68e-2)	unprognostic (1.63e-1)	unprognostic (1.20e-1)	unprognostic (4.08e-2)	unprognostic (4.97e-2)	unprognostic (1.32e-2)	unprognostic (1.67e-2)	unprognostic (1.70e-1)	unprognostic (7.35e-3)	unprognostic (2.76e-2)	0.3	0.1	0.4	1.5	6.5	2.3	0.3	0.3	2.9	0.3	0.3	0.3	0.3	1.5	0.3	0.3	0.5	0.1	0.7	0.3	0.6	0.5	0.3	0.3	0.7	2.9	0.3	0.3	0.3	0.3	0	0.3	17.5	0.3	0.3	0	0.3	1.2	0.3	0.3	0	1.8	0.3	0.3	1.9	1.2	1.4	0.3	0.3	0.3	0.3	0.3	0.6	0.3	0.3	0	0	0	0	7.7	0.8	0	0	0	0	0	0	0.7	0	0	0	0	1.7	0	0	0.1	0	0	0.2	0	0	0	0	0	0.4	0.3	0	0	0	0.6	0	0	0	0	0	0	2.9	0	0	0	0.3	0.2	0	0	0	0.5	0.1	0	0.4	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0.1	0	0.2	0	0	0	0	0	0	0	5.3	0	7.7	0.3	3	4.8	0	0	0.5	3.2	0	0	0	0	0.4	0.8	0.4	6.5	0.3	1.8	0.6	0.5	0.3	0.3	0.3	0.3	0	0	0	0	0	0	3.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Cardiomyocytes
MYH2	IBM3, MYH2A, MYHas8, MyHC-2A, MyHC-IIa, MYHSA2	ENSG00000125414	Myosin heavy chain 2	Q9UKX2	17	10521148-10549957	Disease related genes, Plasma proteins, Predicted intracellular proteins		Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin	Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	34	skeletal muscle: 559.4;tongue: 232.5	Cell type enriched	Detected in single	38	Cardiomyocytes: 3.8	Cancer enriched	Detected in single	60	head and neck cancer: 27.6	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		fHDF/TERT166: 6.1;HSkMC: 3.0;NTERA-2: 13.0;SuSa: 2.8	Not detected	Not detected			Not detected	Not detected			HPA001349, CAB010760	Enhanced								42000000			CAB010760: AB_477190, HPA001349: AB_1079437	unprognostic (6.50e-2)					unprognostic (1.86e-2)		unprognostic (4.76e-2)	unprognostic (1.92e-2)	unprognostic (1.05e-4)	unprognostic (2.89e-1)	unprognostic (9.51e-2)	unprognostic (2.03e-2)	unprognostic (1.09e-2)	unprognostic (4.30e-2)			10	0	0	0	0	0	0.1	0	0	0	0.2	0	0	0	0	2	8	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	1	0	0	11.6	0.1	559.4	0.1	0	0.1	0.1	0	0	0.1	0	0	1.1	232.5	11.4	0	0	0	0.2	0	0	0	0.1	0	0	0	0	0.1	0	0	0	0	0	0.1	0.2	0	0	0.2	0	6.1	0	0	0	0	0	0	0	0	0	0	0	0.1	0	3	0	0	0.1	0	0	0	0.1	0	0.6	0	0	0.1	13	0	0	0	0.5	0	0	0	0	0	0	0	0	2.8	0	0	0.1	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Cardiomyocytes
FNDC11	C20orf195, MGC5356	ENSG00000125531	Fibronectin type III domain containing 11	Q9BVV2	20	63547891-63556708	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	8	testis: 52.5	Cell type enriched	Detected in some	5	Ciliated cells: 12.0	Low cancer specificity	Detected in some			Not detected	Not detected			Group enriched	Detected in some	5	memory B-cell: 3.2;naive B-cell: 6.6	Lineage enriched	Detected in many	6	B-cells: 6.6	Cell line enhanced	Detected in some		CAPAN-2: 9.5;EFO-21: 4.9;HaCaT: 2.7;OE19: 3.2;SH-SY5Y: 6.0	Not detected	Not detected			Not detected	Not detected			HPA041341			Approved	Nucleoplasm,Vesicles,Aggresome						Nucleoplasm, Vesicles	Aggresome	HPA041341: AB_10794991	unprognostic (2.01e-1)	unprognostic (6.63e-2)	unprognostic (6.06e-2)	unprognostic (1.26e-1)	unprognostic (1.51e-2)	unprognostic (1.15e-1)	unprognostic (2.36e-1)	unprognostic (9.99e-3)	unprognostic (7.94e-2)	unprognostic (8.30e-4)	unprognostic (3.68e-1)	unprognostic (8.33e-2)	unprognostic (3.56e-2)	unprognostic (1.18e-1)	unprognostic (1.05e-1)	unprognostic (3.75e-1)	unprognostic (6.81e-2)	0.1	0	0.1	0.2	0.1	0.3	0.1	0.1	0.2	0.2	0.1	0.2	0.1	0	0.1	2.2	0.2	1.1	0.2	0.1	0.1	0.3	0.2	0.1	0.5	0.4	0.1	0.1	0.1	0.1	0	0.3	0.1	0.4	0.1	0	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.5	0.3	52.5	0.2	0.1	0.1	0.1	0.3	0.2	0.2	6.6	0	1	0	0	0.8	0.2	0.3	0	1.8	0	0.1	0.1	0	0.3	0.6	0	0	0.1	9.5	0.6	4.9	0.1	0.2	2.7	0.2	0.3	0	0	0	0.2	0.6	0	0.2	0	1.2	0	0.2	0.7	0	0	0.9	0	0.7	0	0	1	0	0.1	0.2	3.2	0.8	0	0	0.1	1.7	0	0.4	6	0	0	0.3	0.4	0.1	0	0.6	0.1	0.2	0	0	0	0.3	0.1	0	0.6	0.3	0	0	1	0.1	0	0	3.2	0.2	0.6	0	6.6	0.4	0.2	0	0	0	0	0.8	0.2	0.1	0.1	0.1	0.2	0.1	0.3	0.1	0.1	0.4	0.2	0	0	0	0	0	0	0	0	12	2.3	1.8	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0.1	0	0	0	Ciliated cells
BHLHE23	bA305P22.3, Beta4, BHLHB4, bHLHe23	ENSG00000125533	Basic helix-loop-helix family member e23	Q8NDY6	20	63005927-63007035	Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	DNA-binding		Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	4	brain: 1.0;lymphoid tissue: 4.1;retina: 1.3;testis: 1.8	Cell type enriched	Detected in single	34	Cardiomyocytes: 3.4	Cancer enriched	Detected in single	11	testis cancer: 0.5	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	20	MOLT-4: 16.8	Not detected	Not detected			Region enhanced	Detected in some		midbrain: 3.0	HPA030575	Uncertain											HPA030575: AB_10601459															unprognostic (1.74e-1)			0.1	0	0.1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.3	0	0	0	0.1	0	0	0	0	0.2	1.8	0	4.1	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0.8	0	0	0	0	16.8	0.7	0.6	0	0	0.2	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Cardiomyocytes
PLGLB2	PLGP1	ENSG00000125551	Plasminogen-like B2	Q02325	2	87748087-87758793	Predicted secreted proteins				Evidence at transcript level	Evidence at transcript level	No human protein/transcript evidence	No human protein/transcript evidence		Tissue enriched	Detected in some	28	liver: 105.2	Cell type enriched	Detected in some	9	Hepatocytes: 67.4	Cancer enriched	Detected in single	25	liver cancer: 1.2					Cell type enhanced	Detected in some		memory CD4 T-cell: 2.7;T-reg: 3.7	Lineage enriched	Detected in single	16	T-cells: 3.7	Cell line enhanced	Detected in many		hTERT-RPE1: 6.1;U-266/84: 4.9														Secreted to blood								unprognostic (1.10e-2)	unprognostic (8.78e-2)			unprognostic (3.42e-2)	unprognostic (7.03e-4)	unprognostic (1.68e-2)	unprognostic (3.77e-1)		unprognostic (1.82e-2)	unprognostic (5.74e-2)	unprognostic (2.94e-1)	unprognostic (5.04e-4)	unprognostic (6.39e-2)	unprognostic (4.06e-2)	unprognostic (3.22e-2)	unprognostic (7.11e-2)	0	0	0	0	0	0	0	0	0	0	0			0	0	0	0	0	0	0	0	0.1	0	105.2	0	0.1	0.1		0.1	0.1	0	0	0		0	0		0	0	0	0.1	0	0	0	0	0	0			0		0	0	0	0.1	0	0	0.2	0	3.7	0.2	0	1.3	4.3	1.4	0	1.3	0	3.7	2.2	0.6	2.5	0	1.4	2.7	2.6	0.5	0.1	1	0.5	0	0.8	0	1.1	0.9	3.2	0	0.3	0.6	0.5	0	0	0.3	0.4	6.1	0.5	2.6	0.3	0	0.9	0	2.5	0	0	0.4	0	2.4	0	0	4.3	0.3	0	3.2	0.8	1	0.1	0.6	0.2	1.7	0	0	1.9	0.9	1.3	2.8	4.9	0.4	1.5	0	1.1	0	0.2	0	0.1	0	0.1	0	2.7	0.8	0	0.1	1.1	0	0	0	0	0	3.7	0.2											0	0	0	0	0	0	0.4	7.6	1.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	67.4	0.1	0	0	1.3	2.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Hepatocytes
POLR1B	FLJ10816, FLJ21921, RPA2, Rpo1-2	ENSG00000125630	RNA polymerase I subunit B	Q9H9Y6	2	112541915-112577150	Enzymes, Plasma proteins, Predicted intracellular proteins, RNA polymerase related proteins	Transcription	Nucleotidyltransferase, Transferase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	5	Early spermatids: 133.9	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low cell line specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA037528			Supported	Nucleoli,Cytosol						Nucleoli	Cytosol	HPA037528: AB_10671627	unprognostic (1.66e-1)	unprognostic (3.17e-2)	unprognostic (2.55e-1)	prognostic unfavorable (2.71e-5)	unprognostic (2.07e-1)	unprognostic (1.16e-2)	unprognostic (1.98e-3)	unprognostic (1.98e-1)	unprognostic (2.05e-1)	unprognostic (1.13e-1)	prognostic unfavorable (5.52e-4)	unprognostic (6.12e-2)	unprognostic (1.29e-2)	unprognostic (1.18e-1)	unprognostic (2.19e-1)	unprognostic (1.08e-1)	unprognostic (3.56e-2)	8.8	11	6.4	10.6	6.8	4.9	15.7	8	8.2	7.6	7	7.7	8.6	5.8	9.3	7.4	12.8	9.2	9.2	6.1	5.7	6.1	11.3	20.5	8	11.3	6.8	3.7	11.3	25.2	20.7	11.5	7.2	5.2	7.7	8.5	7.3	10	8.3	14.7	9.2	8	7.9	4.8	11.4	8.1	15.7	5	9.6	15.7	11.5	14.6	8.9	11.8	9.4	11	2.5	6.3	10.2	17.1	7.3	9.5	10	6.3	13.1	6.9	6.6	11.9	7.2	5.5	12.2	10.6	22.4	5.7	22.9	10.7	4.7	9.5	13.5	26.7	14.6	14.1	10.3	13.5	13.2	9.9	16.9	7.3	21.1	9.2	6.3	10.6	12.6	19.5	5.1	9.4	4.8	23.9	8.3	6.3	8.4	9.5	13.7	30.9	14.1	19.8	14.3	10.5	24.3	8.4	9.1	16.1	14.9	6.6	16.6	9	7.1	7.7	7.5	8.5	7.5	11	6.8	10.5	11.2	18.4	19.8	5.7	13.6	6.2	0.2	6	2.5	8.3	6.3	17.1	9.4	8.4	8.9	11	9.3	10.3	10.4	0.4	10.2	4.8	2.6	11.3	7.3	6.4	6.8	8	8.2	5.7	6.1	6.8	3.7	5.2	5	14.9	5.1	8.2	2.2	13.4	3.4	5.7	10.2	2.7	7.9	8.7	2	2.9	5	4	133.9	5.6	1.2	0	3.9	2.3	2.8	2.2	4.7	8.5	3.3	1.6	3.5	1.8	2.5	29.4	2.8	2.9	1.7	1.8	4.4	3.8	2.9	6	2.8	4.1	2.9	0	2.8	9.5	7.5	15.1	0.5	6.4	4.5	3.4	Early spermatids
PSPN	PSP	ENSG00000125650	Persephin	O60542	19	6375148-6379058	Predicted secreted proteins		Growth factor		Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Low tissue specificity	Detected in all			Cell type enriched	Detected in many	5	Late spermatids: 18.9	Low cancer specificity	Detected in all							Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low cell line specificity	Detected in all			Not detected	Not detected			Low region specificity	Detected in some			CAB025366	Uncertain				Secreted in other tissues							CAB025366: 	unprognostic (3.21e-1)	unprognostic (3.36e-2)	unprognostic (1.12e-1)	unprognostic (1.52e-2)	unprognostic (3.67e-1)	unprognostic (2.05e-2)	unprognostic (5.80e-3)	unprognostic (1.14e-1)	unprognostic (1.69e-1)	unprognostic (6.27e-2)	unprognostic (1.54e-6)	unprognostic (5.39e-3)	unprognostic (1.01e-3)	unprognostic (4.25e-2)	unprognostic (2.26e-1)	unprognostic (2.44e-1)	unprognostic (1.60e-1)	1	1.7	2.5	1.1	2.7	1.6	1.1	6.4	3.4	1.8	1.4			1.1	1.6	3.5	1.3	2.5	1.3	1.1	2.3	2.1	2.5	2.2	1.1	1.2	1.5		2.8	1.6	2.7	2.4	1.1		1.8	1.5		1.8	1.6	1.3	1.7	1.8	1.4	0.8	1.9	1.5	1.5			2.5		1.5	1.1	1	2.6	2.8	4.6	2.6	1.8	3	1.6	1.6	3.8	2.2	5.5	5.1	3.4	1.2	1.9	1.9	2.1	2.3	3.7	1.4	2	3.1	2.4	1.9	2.4	3.7	1.4	2.4	3	2.9	2	2.2	2.9	3.7	1.6	2.9	4	4.3	1.7	2.8	5.7	1.4	3.2	2.4	2.5	2.4	2.9	3.7	3.3	2.2	3.8	4.3	3.2	2.6	1.3	3.5	2.2	3	4.6	3.2	3	2.5	3	3.4	1.9	1.8	2.7	2.6	4.7	1.2	4.4	7	1.1	5	3.3	2.6	4.6	2.1	1.8	2.1	1.6	3	2	1.5	2.6	1.2	2.6	2.3	2.3	3.6	1.8	2.6	2.8	1.7	1.6											0	1.7	0	0.8	0.6	1.8	1.5	0	0	0	1.8	0	0.8	0	1	3.6	1.2	4.1	0	0.2	0.6	1.3	1.4	1.1	2.6	1.8	1.6	2.9	1.8	2.2	18.9	0.9	0.2	1.7	1	2	1.5	1.1	2.9	2.1	2.2	1.8	0	0.9	1.4	0.7	0.9	1.1	0.5	2.4	0.9	Late spermatids
GRIA3	GluA3, GLUR3, GLURC, MRX94	ENSG00000125675	Glutamate ionotropic receptor AMPA type subunit 3	P42263	X	123184153-123490915	Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters	Ion transport, Transport	Ion channel, Ligand-gated ion channel, Receptor	Disease mutation, Mental retardation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 40.8	Cell type enriched	Detected in some	22	Horizontal cells: 187.5	Cancer enriched	Detected in some	11	glioma: 10.2	Low region specificity	Detected in all			Cell type enriched	Detected in single	9	naive CD4 T-cell: 1.0	Lineage enriched	Detected in single	10	T-cells: 1.0	Cell line enhanced	Detected in some		BJ: 14.4;BJ hTERT+: 20.9;fHDF/TERT166: 27.5;U-2197: 9.2	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA058659, HPA073344	Enhanced				Intracellular and membrane							HPA058659: AB_2683791, HPA073344: 	unprognostic (2.14e-2)	unprognostic (6.00e-2)	unprognostic (2.02e-2)	unprognostic (2.94e-3)	unprognostic (5.09e-2)	unprognostic (4.29e-4)	unprognostic (2.42e-1)	unprognostic (6.74e-2)	unprognostic (1.44e-1)	unprognostic (2.36e-1)	unprognostic (1.65e-3)	unprognostic (1.31e-1)	unprognostic (3.78e-3)	unprognostic (8.05e-3)	unprognostic (6.40e-2)	unprognostic (1.57e-1)	unprognostic (2.03e-1)	1.5	10.7	31.4	1	27.4	0.7	2.3	3.5	40.8	9.1	1.3	3.7	0.1	0.9	3	4.9	1.1	2	1.9	2.7	26.1	8.1	3.4	9.3	1	1.1	10.2	21.2	5.6	2.6	0.6	0.6	1.1	4.9	2.1	1.5	0.7	0.9	3	0.9	1.2	1	2.9	8.4	0.7	3	1.4	7.8	0	0.8	0	1.5	1.3	1.8	0	0	0.1	0	0	1	0	0	0	0	0	1.3	0.2	0	14.4	20.9	0.2	0.5	0	0	0	0	27.5	0	0	0.1	0	0.3	0	0	0	0	0	0	0	0	0.1	4.9	0	0.1	0	0	0	0	0	0	0	0	0	0.8	0	0.4	0	0	0	0	0	0.3	0.9	0	0	0	0.5	0	0	0	4.1	0	9.2	0.1	0	0	0	4.1	0	0	0.1	0	0	0	0	0	0	0.1	0	0	0	1	0	0	0	0	0	0	0	31.4	27.4	3.5	27.5	26.1	8.1	10.2	21.2	4.9	7.8	0	0	0	0	0.2	4.6	1.5	0	0	0	0	0	0	0	0.1	0.1	0	0	0	0.2	0	3.1	0.5	0	4.7	0.1	187.5	0	0.6	0	0	8.6	0	1.7	0	0	1.5	0.5	0	3.9	6	3.1	0	0.5	0	0	0.9	0.1	0	0	0	Horizontal cells
C3	ARMD9, C3a, C3b, CPAMD1	ENSG00000125730	Complement C3	P01024	19	6677704-6730562	Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Complement alternate pathway, Complement pathway, Fatty acid metabolism, Immunity, Inflammatory response, Innate immunity, Lipid metabolism		Age-related macular degeneration, Disease mutation, FDA approved drug targets, Hemolytic uremic syndrome	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in all	10	liver: 611.7	Cell type enriched	Detected in many	5	Hepatocytes: 4080.2	Cancer enhanced	Detected in all		liver cancer: 1213.6	Low region specificity	Detected in many			Cell type enhanced	Detected in many		non-classical monocyte: 13.3	Group enriched	Detected in many	4	granulocytes: 4.2;monocytes: 13.3	Group enriched	Detected in many	7	BJ hTERT+: 48.5;EFO-21: 102.2;Hep G2: 105.6;HSkMC: 75.4;SiHa: 28.2	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA003563, CAB004209, HPA020432	Enhanced				Secreted to blood			1260000000000	250000000000			CAB004209: AB_627277, HPA003563: AB_1847117, HPA020432: AB_1847118	unprognostic (3.26e-3)	unprognostic (3.91e-1)	unprognostic (3.92e-1)	unprognostic (5.98e-3)	unprognostic (3.31e-1)	unprognostic (1.04e-1)	prognostic favorable (8.11e-4)	unprognostic (1.99e-1)	unprognostic (9.26e-2)	unprognostic (5.80e-2)	unprognostic (8.12e-3)	unprognostic (5.48e-2)	prognostic unfavorable (1.09e-5)	unprognostic (2.63e-2)	unprognostic (2.49e-2)	unprognostic (6.03e-3)	unprognostic (3.88e-1)	59.7	34.1	9.3	20	19.6	1	47.3	0.7	10.2	28.3	17.8	13.9	3.7	3.2	9.1	19.9	17.9	38.8	37.9	57.6	7	4.1	21.6	611.7	22.6	25.2	12.3	2.2	42.4	22.2	3.1	3	2.7	12.8	12.7	9.6	3.9	18.7	7.6	6.8	5.8	15.1	19.1	29.6	1.6	12.6	11.2	10.7	0.1	10.3	3.2	14.1	25.2	38.2	1.2	0.8	4.2	13.3	2	0.4	0.8	8.4	3	0	0	1.5	5.1	10.3	0.7	48.5	0.9	1.7	0.5	6.7	0.2	102.2	0	7.5	6.3	0	5.8	0.9	3.1	0	0.4	4.5	105.6	2.3	0.8	1.2	75.4	1.7	8.4	3.8	1.3	0	0	0.2	0.1	0	0.1	0	0.2	0.2	0	0	0	0.7	0	4.4	0.8	0	0	28.2	0	0	0	2.3	1.1	0.4	0.8	1	0.6	0.4	0.2	0.5	0.5	10.4	0.6	0	1.7	1.5	0.9	0.4	2.7	0.3	0.7	0.3	0.2	0.8	1.2	0.4	0.4	4.2	2	13.3	0.7	0.2	0.8	9.3	19.6	0.7	10.2	7	4.1	12.3	2.2	12.8	10.7	71.5	405.7	102.4	11.5	24.5	0	13.3	822.9	29.4	84.2	15.7	0	1.2	5	273.3	34	21.5	0.3	70	114.7	2.1	60.9	11.5	4.7	4080.2	36.1	0	0	120.9	123.3	75.5	209.4	25.1	33.7	25.2	0.6	0.5	589.9	0	10.3	39.2	3.7	6.5	22.8	3.2	7.9	19.2	2.3	24.5	0.4	12.3	Hepatocytes
TGM3	TGE	ENSG00000125780	Transglutaminase 3	Q08188	20	2296001-2341078	Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins	Keratinization	Acyltransferase, Transferase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	8	esophagus: 195.0;lymphoid tissue: 152.6;tongue: 206.5	Cell type enriched	Detected in some	6	Intestinal endocrine cells: 44.4	Cancer enriched	Detected in many	9	head and neck cancer: 81.6	Not detected	Not detected			Cell type enriched	Detected in single	205	neutrophil: 20.4	Lineage enriched	Detected in single	205	granulocytes: 20.4	Cell line enriched	Detected in some	6	EFO-21: 11.9	Low region specificity	Detected in some			Not detected	Not detected			HPA004728	Enhanced								14000000			HPA004728: AB_1080360	unprognostic (7.14e-2)	unprognostic (8.93e-2)	unprognostic (2.18e-2)	unprognostic (3.23e-3)	unprognostic (4.27e-2)	unprognostic (4.20e-2)	unprognostic (8.62e-2)	unprognostic (4.21e-2)	unprognostic (1.50e-1)	unprognostic (8.00e-2)	unprognostic (4.88e-3)	unprognostic (1.35e-1)	unprognostic (7.78e-8)	unprognostic (1.56e-1)	unprognostic (1.61e-1)	unprognostic (1.45e-2)	unprognostic (9.67e-2)	0	0	0.1	0	0	0.2	0.6	0	0	4.9	0.1	0	0	0	0.1	0.1	195	0.5	0.3	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0.1	0.1	0	24.5	0	0.1	7.7	0	0	0	0	0	0.1	0	0.1	0	206.5	152.6	0	2.8	0	0	20.4	0	0	0	0	0	1	0.6	0	0	0	0	0	0	0	0	0	0	0.4	11.9	0	0	0	0	0	0	0	0	0.1	0	0	0	0.4	0	0	0	0	0	0	0	0	0.3	0	0	0.1	0	0.2	0.4	0	0	0	0	0	0	0	1.3	0	0	0.2	0	0.1	0.1	0.6	0.5	0	0	0	0	0.1	0	0.2	0	1.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	20.4	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	1.1	0	0	1.4	0	0.3	0	4	0	0	0	0	0	0	1.6	0	0	0	0	0	0.2	0.3	0	0	0	0	44.4	0	0	2.5	0	0	0	0	2.7	0	0.1	0	0	0	0	0	0	0.5	0.4	7.2	0	0	0	0	Intestinal endocrine cells
GNRH2		ENSG00000125787	Gonadotropin releasing hormone 2	O43555	20	3043622-3045747	Predicted secreted proteins		Hormone		Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in many		epididymis: 10.2	Cell type enriched	Detected in single	7	Sertoli cells: 6.5	Cancer enhanced	Detected in some		testis cancer: 1.9	Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in many		U-266/84: 7.5									HPA004338	Uncertain				Secreted to blood							HPA004338: AB_1079012	unprognostic (1.29e-1)	unprognostic (1.88e-1)	unprognostic (1.20e-2)	unprognostic (2.51e-1)	unprognostic (2.26e-2)	unprognostic (1.87e-2)	unprognostic (1.36e-2)	unprognostic (4.04e-3)	unprognostic (7.00e-2)	unprognostic (1.93e-2)	unprognostic (2.47e-4)	unprognostic (2.69e-1)	unprognostic (2.98e-2)	unprognostic (1.72e-1)	unprognostic (3.29e-2)	unprognostic (3.43e-2)	unprognostic (2.21e-2)	0.8	0.9	0.6	1.2	0.9	0.4	0.5	5.1	1.7	1.6	0.5	0.5	0.5	0.3	1.3	10.2	0.5	2.4	2	1.1	0.7	1.2	1.7	3.3	0.5	0.6	1.5	0.5	5.6	0.5	0.5	1.8	0.5	1.2	4.2	0.1	1	1.6	2	0.5	0.1	0.5	0.5	0.5	0.5	2.2	3.9	0.5	0.5	2.8	0.5	0.5	0.5	0.5	0.4	0	0	0	0	0	0	1	1.2	3.2	4	2	0.5	0.6	0.8	0	0.5	0.8	1.9	0.8	1.5	0.1	0.2	1.2	3.3	1.3	1.1	0.9	1.2	3.6	1.3	1.1	2.5	0	0.2	2.2	2.5	2.6	2.5	0	0.4	0.8	2.6	1.5	0.5	1.3	1.1	0.8	2.5	1.4	0	0	0.9	0.4	0.8	0.5	2.8	4.5	2.1	0.2	2.7	1.5	1.5	2.9	1.4	0	1.9	0.9	1.6	1.8	1.1	7.5	1	1.7	1.5	1.1	0	0	0	0	0	0	0.3	0	0	0	0.4	0	0	0	0	0	0	0	0	0.6	0.9	5.1	1.7	0.7	1.2	1.5	0.5	1.2	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.8	0	0	0	0	0.1	0.1	0	0	0	0.1	0	0	0	0	1	0	0	0	0	0	0	0.1	0	0.4	0	0	6.5	0	0	0	0	0	0	0	0	Sertoli cells
NKX2-2	NKX2.2, NKX2B	ENSG00000125820	NK2 homeobox 2	O95096	20	21511010-21514026	Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	Activator, Developmental protein, DNA-binding		Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		brain: 30.6;pancreas: 12.1	Cell type enriched	Detected in some	68	Intestinal endocrine cells: 159.5	Group enriched	Detected in many	5	glioma: 9.5;pancreatic cancer: 7.4	Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HAP1: 4.5;T-47d: 5.3;U-138 MG: 18.9;U-2 OS: 3.9;WM-115: 7.5	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA003468	Approved											HPA003468: AB_1079490	unprognostic (5.13e-3)		unprognostic (5.54e-2)		unprognostic (3.10e-1)	unprognostic (2.29e-1)			unprognostic (1.75e-2)		unprognostic (2.93e-3)	unprognostic (1.10e-1)		unprognostic (3.24e-2)	unprognostic (3.29e-1)			0.6	0.6	6.5	0.7	8.1	0.7	0.6	3.4	15.5	0.6	1.4	19.1	0	6.2	0.6	0.6	0.6	0.6	0.6	0.6	7.8	6.9	0.6	0.6	0.6	0.7	14.2	6.4	0.6	12.1	1	4.6	0.6	10.9	0.7	1.4	0	0.6	0.6	0.6	0.8	2.5	0.6	30.6	0.6	7	0.6	9.4	0	0.6	0	0.6	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0.2	0	0	0	4.5	0	0	0	2	0	0	0	0	0	0.5	0	0	0	0	0	0	0.7	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5.3	0.3	0	18.9	3.9	0	0	0	0	0	0	0	7.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	6.5	8.1	3.4	7.6	7.8	6.9	14.2	6.4	10.9	9.4	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	159.5	0	0	0	0.3	0	0	0	2.4	0	2.1	0	0.4	0	0	0	0	0	0	0	0	0	0.6	0	Intestinal endocrine cells
CST11	CST8L, CTES2, dJ322G13.6	ENSG00000125831	Cystatin 11	Q9H112	20	23450403-23452857	Predicted secreted proteins		Antibiotic, Antimicrobial, Protease inhibitor, Thiol protease inhibitor		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in some	25	epididymis: 76.3	Cell type enriched	Detected in single	10	Distal tubular cells: 1.7	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in single		RT4: 2.8	Not detected	Not detected			Not detected	Not detected			HPA053399	Enhanced				Secreted in male reproductive system							HPA053399: AB_2682136						unprognostic (9.42e-2)				unprognostic (2.21e-2)								0	0	0	0	0	0	0.1	0	0	0	0.6	0	0	0	0	76.3	0.5	0.1	0	0	0	0	0.3	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0.2	0	0	0.1	0	0	0	0	3	0.9	0	0	0	0	0	0.6	0.4	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0.8	0	0	0	0	0.9	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	2.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.7	0	0.2	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Distal tubular cells
LAMP5	BAD-LAMP, C20orf103, dJ1119D9.3, UNC-46	ENSG00000125869	Lysosomal associated membrane protein family member 5	Q9UJQ1	20	9514358-9530524	Predicted membrane proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		blood: 42.1;brain: 105.2	Cell type enriched	Detected in some	7	Horizontal cells: 57.2	Low cancer specificity	Detected in all			Region enriched	Detected in all	5	basal ganglia: 105.2	Cell type enriched	Detected in some	15	plasmacytoid DC: 42.1	Lineage enriched	Detected in many	30	dendritic cells: 42.1	Cell line enhanced	Detected in some		Karpas-707: 95.0;SH-SY5Y: 17.4;THP-1: 33.1	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA004802, HPA070765	Enhanced		Uncertain	Mitotic spindle,Centriolar satellite,Cytosol						Cytosol	Mitotic spindle, Centriolar satellite	HPA004802: AB_10603682, HPA070765: AB_2686309	unprognostic (2.78e-2)	unprognostic (3.90e-3)	unprognostic (5.73e-4)	unprognostic (5.47e-2)	unprognostic (7.89e-2)	unprognostic (2.67e-1)	unprognostic (3.80e-3)	unprognostic (1.45e-1)	unprognostic (1.54e-2)	unprognostic (1.91e-1)	unprognostic (1.94e-1)	unprognostic (1.95e-1)	prognostic unfavorable (6.46e-6)	unprognostic (5.12e-3)	unprognostic (3.74e-2)	unprognostic (1.08e-2)	unprognostic (4.49e-3)	0.5	4.1	21.6	1.5	105.2	2	1	2.3	28.6	9.1	1.3	0.6	1.8	1.3	4.6	6	0.6	9.7	2.9	0.6	18.7	4.1	0.9	0.5	1.1	4.8	4.5	7.7	21.2	1.3	0.3	2	0.4	23.2	2.3	1.4	2.6	1.4	3.6	0.3	0.5	1.4	3.8	6.7	1.4	1.6	1.1	4.8	0	1.1	0	4.7	1.2	0.6	1.4	42.1	0.9	0.5	0	0	0.7	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4.8	0.1	0	0	0	0	0	0	0	0	95	0	0	0	0	0.4	0	0	0.4	0	0	0	0	0	17.4	0	0	0	0.1	0	33.1	0	0	0	0	0	0	0	0	0	4.1	0	0.9	0.5	0	0	0.1	0	1.4	0	0	2.8	0.1	0	0	0.1	0	0	42.1	0	0.7	21.6	105.2	2.3	19.1	18.7	4.1	4.5	7.7	23.2	4.8	0	1.4	2.2	0	0.1	7.5	0.2	0	0	0	0	7.9	0	0	0.6	5.8	0.1	0	0	0	0	0.6	0.8	0	0	1.1	57.2	0	0	1.2	5.6	0.6	0.2	3.3	8.2	0	4	0.2	0	0	0	4.9	0	1.4	0.2	0.1	0	0	0	0	0	Horizontal cells
TMEM53	FLJ22353, NET4	ENSG00000126106	Transmembrane protein 53	Q6P2H8	1	44635238-44674555	Predicted intracellular proteins, Predicted membrane proteins				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		blood: 38.7;liver: 44.7	Cell type enriched	Detected in all	5	Late spermatids: 845.8	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enriched	Detected in many	4	plasmacytoid DC: 38.7	Lineage enriched	Detected in all	4	dendritic cells: 38.7	Low cell line specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA021134	Approved		Approved	Golgi apparatus,Focal adhesion sites						Golgi apparatus	Focal adhesion sites	HPA021134: AB_2205162	unprognostic (5.28e-2)	unprognostic (2.60e-1)	unprognostic (5.37e-2)	unprognostic (4.62e-2)	unprognostic (3.93e-2)	unprognostic (1.14e-1)	unprognostic (2.82e-2)	unprognostic (2.88e-2)	unprognostic (2.19e-2)	prognostic favorable (6.96e-4)	unprognostic (3.00e-1)	unprognostic (1.34e-1)	prognostic favorable (1.02e-5)	unprognostic (1.15e-3)	unprognostic (1.84e-2)	unprognostic (4.07e-2)	unprognostic (2.29e-2)	8.3	9	6	4.4	8.7	6	7	2.4	11.8	4.9	11	8.8	4.6	16.6	5.7	7.2	4.5	5.3	7.6	9.3	6.2	6.1	14.8	44.7	7.3	6.4	6.8	6.2	7.7	5.4	3.3	6.4	4.3	8	5.2	7.2	13.9	6	3.8	4.2	3.9	16.4	4.5	6.1	4.8	7.7	18.8	4.4	3.6	8.2	3.1	4	7.3	3.7	5.3	38.7	3.6	8.6	2.8	3.1	2.8	7.6	8.8	8	5.8	10.4	7.9	9.6	2.2	6.7	4.4	6.6	2.8	24.2	2.4	7.3	2.1	17	6.9	2.2	4.7	2.3	3.8	5.6	2.8	3.6	13.4	10.4	2.2	10.3	9.3	7.3	8.8	1.9	4.8	2.4	5.5	1.2	3.1	2.6	4.5	2.5	6.5	4.6	5.9	5.2	4	1.1	23.6	13.1	8	5.6	5.4	2.4	9.6	12.4	5.9	3	5.8	1	3.2	5.5	4.6	2.8	2.2	2.6	1.3	8.4	5.7	3.7	3.6	5.2	2.3	3	8.6	2.6	5.3	3.1	2.5	2.6	5	1.5	2	0.5	2.8	6	38.7	3	2.8	6	8.7	2.4	11.8	6.2	6.1	6.8	6.2	8	4.4	6	11.8	2.4	6.7	1.4	5.6	24.6	10.2	18.7	9.1	19.2	3.9	11.6	38.1	14.3	155.5	8.7	50.1	23.3	22.5	13.2	5.6	7.8	5.8	81.3	29.8	17.5	13.8	8	8.3	845.8	8.3	7.2	8.5	1.8	18.4	12.9	16	56.1	11.7	39.8	12.4	25.8	7.3	5.1	8.3	1.9	7.8	4.1	15.4	10.3	Late spermatids
PROZ	PZ	ENSG00000126231	Protein Z, vitamin K dependent plasma glycoprotein	P22891	13	113158654-113172383	Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted secreted proteins	Blood coagulation, Hemostasis	Serine protease homolog		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	5	liver: 45.0	Cell type enriched	Detected in some	6	Hepatocytes: 56.9	Cancer enriched	Detected in single	27	liver cancer: 12.1	Not detected	Not detected			Cell type enhanced	Detected in some		intermediate monocyte: 2.7;T-reg: 1.5	Group enriched	Detected in many	12	monocytes: 2.7;T-cells: 1.5	Cell line enhanced	Detected in many		HaCaT: 4.9;Hep G2: 7.7	Not detected	Not detected							HPA052006	Supported				Secreted to blood			1720000000	510000000			HPA052006: AB_2681691	unprognostic (5.03e-2)	unprognostic (4.05e-2)	unprognostic (1.11e-1)	unprognostic (2.36e-1)	unprognostic (6.48e-2)	unprognostic (1.39e-1)	prognostic favorable (3.46e-4)	unprognostic (4.10e-1)	unprognostic (2.21e-1)	unprognostic (2.50e-1)	unprognostic (5.20e-2)	unprognostic (2.87e-1)	unprognostic (9.83e-2)	unprognostic (5.63e-2)	unprognostic (1.41e-1)	unprognostic (9.99e-2)	unprognostic (2.51e-4)	0.1	0.1	0.1	0.1	0.1	0	0.1	0.2	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.5	0.1	0	0.1	0.1	0.1	0	9.3	45	0.1	0.1	0.1	0.1	0.1	0.2	0	0.5	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.6	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0	0.1	0	2.7	0	1.5	0.2	0.9	1.5	0.7	1	0	0	0.6	1.5	0	0	0	3	1.8	0.8	0	0	0.3	4.9	0	0	0	0.8	2.4	1	2.9	7.7	0.1	0.8	0.4	0	0	0	0	0.2	0	2.5	1.1	0.6	0	1	0.6	0.8	1.8	3.1	0.4	1.3	0.2	0.3	0	1.1	2.9	0.2	0	0.3	1.3	1.7	0	1	0.7	0.8	0.1	0.8	0.3	1.6	0.9	0.8	1.6	0.9	0.7	0	0	0	0.3	2.7	0.4	0	0	0	0	0	0.1	0.1	0	0	0.6	0.1	1.5	0.2	0.1	0.1	0.2	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	56.9	0	0	0	0.6	1.2	0	0	0	0	0	0	0	0	0	0	9.8	0	0	0	0.1	0.1	0	0	0	0	0	Hepatocytes
SLURP1	ANUP, ARS, ArsB, LY6LS, MDM	ENSG00000126233	Secreted LY6/PLAUR domain containing 1	P55000	8	142740944-142742411	Disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters		Cytokine	Disease mutation, Palmoplantar keratoderma	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	5	esophagus: 137.6;lymphoid tissue: 93.7;skin 1: 91.2;tongue: 107.5	Cell type enriched	Detected in some	24	Suprabasal keratinocytes: 57.5	Cancer enhanced	Detected in many		head and neck cancer: 66.3	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	4	HaCaT: 3.4;hTCEpi: 2.3;MCF7: 3.8;RT4: 2.7;T-47d: 6.6	Not detected	Not detected							HPA050967	Approved				Secreted in other tissues				5400000			HPA050967: AB_2681293	unprognostic (1.22e-2)	unprognostic (5.08e-2)		unprognostic (1.16e-2)		unprognostic (1.42e-2)		unprognostic (1.84e-1)	unprognostic (7.32e-2)	unprognostic (5.99e-2)	unprognostic (1.33e-4)	unprognostic (1.58e-1)		unprognostic (2.98e-1)			unprognostic (1.43e-1)	0.1	0.1	0.1	0.1	0.1	0.1	2.5	0.1	0.1	17.3	0.1	0.1	0.1	0.1	1.1	0.1	137.6	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	7.7	0.1	0.4	91.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	107.5	93.7	0.1	19.8	0	0	0	0	0	0.7	0	0.2	0.8	0	0.4	0	0	0.3	0	0	0	0	0	0.5	0.2	0	0	0	3.4	0	0.5	0	0	0	0	0	0	0	0	0	0	2.3	0	0	0	0	0.1	0.1	0	0	3.8	0	0	0	0	0	0	0	0	0	2.7	0	0.1	0	0	0	0	6.6	0	0	0	0	0.2	0	0	0	0.1	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0.7	0	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	0	0.2	2.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	57.5	0	0	0	0.7	Suprabasal keratinocytes
GPR42	FFAR3L, GPR41L, GPR42P	ENSG00000126251	G protein-coupled receptor 42 (gene/pseudogene)	O15529	19	35370929-35372962	G-protein coupled receptors, Predicted membrane proteins		G-protein coupled receptor, Receptor, Transducer		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in some		adipose tissue: 2.3;blood: 2.1;intestine: 2.1	Cell type enriched	Detected in single	4	Alveolar cells type 2: 3.4	Not detected	Not detected							Group enriched	Detected in some	5	eosinophil: 1.9;neutrophil: 2.1	Lineage enriched	Detected in single	5	granulocytes: 2.1	Cell line enhanced	Detected in some		HHSteC: 1.0;RPMI-8226: 1.1									HPA044681	Uncertain											HPA044681: AB_2679043											unprognostic (1.73e-3)			unprognostic (1.31e-4)				2.3	0	0	1.5	0.1	0.1	1.2	0	0.2	0	1.7			0	0	0	0	0	0.3	0	0.1	0	0	0.2	0.1	0.1	0.1		0	0.1	1.3	0.1	0.4		0.1	0.3		0	0	0	0	2.1	0.2	0.4	0.8	1.3	0			0.5		0	0.3	0	0	0.1	2.1	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0.4	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0.9	0	0	0	1.9	0	0.4	0	0	0	0	0.1	0	0	0	2.1	0	0.3	0	0	0											0	3.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0.6	0	0	0	0.8	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	Alveolar cells type 2
KIRREL2	DKFZp564A1164, FILTRIN, MGC15718, NEPH3, NLG1	ENSG00000126259	Kirre like nephrin family adhesion molecule 2	Q6UWL6	19	35855861-35867109	Predicted intracellular proteins, Predicted membrane proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	18	pancreas: 38.5	Cell type enriched	Detected in some	4	Bipolar cells: 27.4	Low cancer specificity	Detected in some			Low region specificity	Detected in single			Cell type enhanced	Detected in single		memory CD8 T-cell: 1.3	Lineage enriched	Detected in single	5	T-cells: 1.3	Cell line enhanced	Detected in some		HDLM-2: 15.1;HMC-1: 24.4;JURKAT: 14.1;U-937: 5.4	Low region specificity	Detected in many			Low region specificity	Detected in many			HPA071587, HPA074326	Enhanced		Supported	Centriolar satellite	Intracellular and membrane					Centriolar satellite		HPA071587: AB_2732182, HPA074326: AB_2732251	unprognostic (1.28e-2)	unprognostic (1.80e-1)	unprognostic (3.29e-2)	unprognostic (3.16e-3)	unprognostic (2.05e-3)	unprognostic (2.29e-1)	unprognostic (2.00e-1)	unprognostic (1.72e-3)	unprognostic (3.30e-2)	unprognostic (5.56e-2)	unprognostic (4.85e-2)	unprognostic (2.62e-2)	unprognostic (2.43e-6)	unprognostic (1.72e-1)	unprognostic (4.44e-1)	unprognostic (1.48e-2)	unprognostic (2.62e-2)	0.2	0	0.4	0.3	0.8	0	0	0.2	1.2	0.1	0	0.1	0	0.1	0	0	0.1	0	0	0	0.7	0	0.4	0	0	0.5	0.2	0.4	0	38.5	0	0.9	0.1	0.5	0	0.1	2.1	0	0	0	0	0	0	0.1	0	0.4	0.3	0.2	0.5	0	0	0.4	0	0	0	0	0	0	0.2	1.3	0	0	0.4	0.8	0	0	0	1.2	0	0	0.1	0	0.7	0.5	0	0.1	0	2.6	0.1	2.1	0	0	15.1	0	0	0	0.2	0	0	24.4	0.1	0	0	0	0	0	14.1	0.1	0.2	0	0.1	0.4	0	0.1	0	0	3.9	0	0	0	0	3	0.9	0	0	0	0.1	0	3.8	0	0.6	1	0.2	0	0	0	0.2	0	5.4	0.5	0	0	0	0.1	0	0	0	0.2	1.3	0	0	0.2	0.9	0	0.2	0	0	0	0	0.4	0.8	0.2	1.2	0.7	0	0.2	0.4	0.5	0.2	0	0	0	0	0	27.4	0.6	0	0	0	0	0	0	1.7	0	1.3	0	0	0	5.3	0.1	0	0	0	0	2.1	0	0	0	0	0	0	0	0	0	0	0.9	6.8	0	0	0	2.9	0	0	0.7	0.9	0	0	0	0	0	Bipolar cells
CSN1S1	CASA, CSN1	ENSG00000126545	Casein alpha s1	P47710	4	69931081-69946574	Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins		Milk protein	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	4	breast: 184.8	Cell type enriched	Detected in single	11	Cardiomyocytes: 1.6	Cancer enriched	Detected in some	10	breast cancer: 17.1	Low region specificity	Detected in single			Group enriched	Detected in some	6	NK-cell: 1.6;plasmacytoid DC: 3.2	Group enriched	Detected in many	11	dendritic cells: 3.2;NK-cells: 1.6	Cell line enhanced	Detected in some		ASC diff: 2.4;HL-60: 1.4;U-266/70: 1.5									HPA035659, HPA057031	Enhanced				Secreted in female reproductive system							HPA035659: AB_10696356, HPA057031: AB_2683315					unprognostic (1.52e-2)										unprognostic (1.01e-1)			44.7	0	0	0	0.1	0	184.8	0	0.9	0	0.1	0	0	0	0	0	0.1	0	0.4	0	0.1	1.2	0	0	0	0.5	0.6	0	0	0.1	0	0	0	0.1	0.1	0	0	0.1	0.1	0	0.1	0	0	0.2	0	0	0.1	0	0.2	0	0	0	0.1	0	0	3.2	0.2	0.1	1.6	0	0.2	0	0	0	0	2.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.4	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0	1.5	0.5	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0.3	0	0	0	0.2	1.6	0	3.2	0	0.2	0	0.1	0	0.9	0.1	1.2	0.6	0	0.1	0	0	0	0	0	0	0	1.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	Cardiomyocytes
STATH	STR	ENSG00000126549	Statherin	P02808	4	69995930-70002570	Plasma proteins, Predicted secreted proteins, Transporters	Biomineralization			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	162	salivary gland: 5940.6	Cell type enriched	Detected in single	7	Early spermatids: 2.1	Group enriched	Detected in some	14	head and neck cancer: 3.5;lung cancer: 0.9	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in single		HHSteC: 1.4									HPA044569	Enhanced				Secreted to digestive system							HPA044569: AB_10966146						unprognostic (2.00e-2)												0.1	0.1	0.1	0	0.1	0	0.1	0.5	0.1	0.1	0.1	0	0	0	0.1	0	0.6	0.1	0	0.2	0.1	0.1	0.1	0.1	0.1	0	0.1	0	0.3	1.5	0	0.1	0.1	0	0.5	0	0	5940.6	0	0.1	0.1	0.1	0	0.1	0.1	0.1	0.2	0	0	0.1	36.5	5	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.4	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.5	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0	0.2	0	0.3	0	0	0	0	0	0	0	0	2.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Early spermatids
TRMT5	KIAA1393, TRM5	ENSG00000126814	TRNA methyltransferase 5	Q32P41	14	60971451-60981358	Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins	tRNA processing	Methyltransferase, Transferase	Disease mutation, Primary mitochondrial disease	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	5	Early spermatids: 162.4	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Low cell line specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA000943	Supported		Approved	Nucleoplasm,Nucleoli						Nucleoplasm, Nucleoli		HPA000943: AB_1080388	unprognostic (1.58e-2)	unprognostic (3.62e-2)	unprognostic (6.63e-3)	unprognostic (1.11e-2)	unprognostic (7.70e-3)	unprognostic (2.26e-2)	unprognostic (7.82e-3)	unprognostic (4.50e-2)	unprognostic (3.95e-1)	unprognostic (1.78e-1)	unprognostic (1.47e-1)	unprognostic (2.84e-2)	unprognostic (1.60e-3)	unprognostic (1.82e-1)	unprognostic (1.97e-2)	unprognostic (2.10e-2)	unprognostic (1.40e-1)	15.8	10.1	7.9	13.8	12.1	5.4	12.9	9.3	11.8	10.9	8.6	5.7	11.9	7.5	12	10.9	11.1	10	6.7	6.8	7.7	7.1	12.5	13.9	6.6	7.3	6.7	8.3	17.1	11.1	15.9	13.1	10.8	9	10.6	8.1	4.8	11.5	9.9	14.8	9.7	7.4	9.2	6.3	8.6	8.1	24.9	5.9	12.4	10.4	12.1	7.2	13.3	9	7.2	7.4	0.9	7.5	2	6	3.7	28.9	7.4	10.9	15.2	9.7	14.5	11.9	10.9	8.4	11.7	9.4	5.4	17.4	14.9	12.2	7.9	8.8	13.4	13.7	15.8	15.4	14.7	6.9	10.9	5	6	15.8	19.3	6.1	11.4	15.3	10.6	15.8	10.4	10.2	13	14.2	5.4	17.1	10.9	9.9	9.7	10	11.3	12.3	3.2	25.3	12.6	9.9	9.9	13.4	13.3	12.1	12.2	9.7	9.9	20.4	11.6	9.6	13.6	16.5	9.6	10.4	3.3	6.1	7	9.5	4.2	12.6	0.1	4.6	0.9	3.5	7.5	5	7.2	5.2	5.2	4.2	4.9	5.6	5.1	0.4	2	7.5	7.4	6	3.7	7.9	12.1	9.3	11.8	7.7	7.1	6.7	8.3	9	5.9	6	7.5	8.3	16.7	5.7	5	7.1	0	18.7	25	10.4	3.9	11	1.7	7.1	162.4	8.6	2.9	0	6.5	11.6	7.7	5.7	5.8	5.9	9.5	3.2	5.2	11.6	6.1	35.3	10.3	8.2	6.8	4.6	7.3	10.4	7.2	3.5	7.1	8.8	4.5	12.9	6.2	10.9	10.9	3.8	16	4.6	7.1	10.7	Early spermatids
OMG	OMGP	ENSG00000126861	Oligodendrocyte myelin glycoprotein	P23515	17	31272013-31297539	Plasma proteins, Predicted intracellular proteins	Cell adhesion			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	40	brain: 89.6	Cell type enriched	Detected in some	5	Ciliated cells: 335.9	Group enriched	Detected in some	7	endometrial cancer: 3.5;glioma: 9.0	Low region specificity	Detected in all			Cell type enhanced	Detected in single		basophil: 1.6	Lineage enriched	Detected in single	6	granulocytes: 1.6	Cell line enhanced	Detected in some		HAP1: 3.6;U-87 MG: 1.4	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA008206, HPA012693	Enhanced				Intracellular and membrane							HPA008206: AB_1854240, HPA012693: AB_1854239	unprognostic (8.05e-4)	unprognostic (2.11e-2)	unprognostic (1.27e-1)	unprognostic (3.03e-3)	unprognostic (1.85e-1)	unprognostic (4.16e-2)	unprognostic (1.63e-1)	unprognostic (3.81e-2)	unprognostic (9.54e-2)	unprognostic (8.60e-2)	unprognostic (7.03e-2)	unprognostic (1.52e-1)	unprognostic (3.96e-13)	unprognostic (7.80e-3)	unprognostic (6.00e-2)	unprognostic (3.24e-1)	unprognostic (2.42e-2)	1.6	1.8	25.2	1.6	25.4	2.2	1.6	10.2	89.6	1.6	1.7	20.3	0	1.7	1.6	1.6	1.6	1.6	1.6	1.6	26.8	20.6	1.6	1.6	1.6	1.6	30.8	23.2	1.6	1.6	1.6	0.1	1.6	36.8	1.6	1.7	1.4	1.6	1.6	1.7	1.6	1.7	1.6	23	1.7	1.6	1.6	39.6	0	1.6	0	1.6	1.6	0	0	0.1	1.6	0	0	0.2	0	0	0.3	0	0	0	0	0.1	0	0	0	0.1	0.5	0.1	0	0	0.2	0	0.2	3.6	0	0	0	0	0.3	0.4	0.1	0	0	0.6	0.2	0	0.1	0	0	0	0	0	0.6	0	0	0	0	0.1	0	0.2	0	0.2	0	0	0	0	0	0.4	0.1	0.5	0	0	0	0	0	0.1	0.1	0.2	0	0	0.6	1.4	0	0.7	1.6	0	0	0.2	0	0	0	0.1	0	0.1	0	0	0	0.6	0	0	0	0	0	25.2	25.4	10.2	34.1	26.8	20.6	30.8	23.2	36.8	39.6	0	3	0	0	0.3	3.7	0.7	0	335.9	6.8	0	0	0.1	0	0	0.1	0.2	0	0	0	0.4	0.4	0	0	0	0.4	0	0	1.3	11.2	0	0	0	0	0	0	68.6	0	0	0	0	1.8	0	0	0	0	0.1	9.8	0.7	0	0	Ciliated cells
CTAG2	CAMEL, CT6.2a, CT6.2b, ESO2, LAGE-1, LAGE-1a, LAGE-1b, LAGE1, MGC138724, MGC3803	ENSG00000126890	Cancer/testis antigen 2	O75638	X	154651972-154653579	Cancer-related genes, Predicted intracellular proteins			Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		heart muscle: 8.5;skeletal muscle: 5.7;testis: 11.9	Cell type enriched	Detected in some	4	Spermatogonia: 72.0	Low cancer specificity	Detected in many							Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		GAMG: 22.0;K-562: 27.8;OE19: 41.0;RPMI-8226: 61.9;SK-BR-3: 40.5;U-266/84: 70.1									HPA071467, HPA076586	Enhanced		Enhanced	Nucleoplasm,Nuclear bodies,Vesicles						Nucleoplasm, Vesicles	Nuclear bodies	HPA071467: AB_2686402, HPA076586: 							prognostic unfavorable (2.35e-4)		unprognostic (3.87e-1)						unprognostic (1.00e-1)		unprognostic (1.25e-2)	0.2	1	0.4	0	0	0.2	0.1	0.2	0.5	0	0.2			0	0	0	1	2.9	0	8.5	0	0	0.1	0.8	0.2	0	0.2		0.8	3.6	0	0.4	4.4		0.2	0		0.1	0	5.7	0.2	0	0	0	0.3	0.6	11.9			0		0	0	0.6	0.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	22	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	27.8	0.6	0	0	0	0	0	41	0	0	0	61.9	0	0	0	0	0	40.5	0	0	0	0.1	0	1.3	0	0.1	0	0.5	70.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.9	0	0	0	0	0	0	0	0											0	0	0	0	0	0	0	0	0	0	0	0	0.8	3.3	0	0.1	0	0	0	0	6.7	0	0	0	0	0.1	0	0	0	0	1.9	0.3	0	0	0	0	0.5	0	0	0	0.2	0	0	0	16.8	72	0	0.9	0	0	0	Spermatogonia
AVPR2	DIR, DIR3, V2R	ENSG00000126895	Arginine vasopressin receptor 2	P30518	X	153902531-153907166	Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters		G-protein coupled receptor, Receptor, Transducer	Diabetes insipidus, Disease mutation, FDA approved drug targets	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		adipose tissue: 8.9	Cell type enriched	Detected in some	8	Collecting duct cells: 47.1	Low cancer specificity	Detected in many							Group enriched	Detected in some	26	intermediate monocyte: 6.2;non-classical monocyte: 5.3	Lineage enriched	Detected in single	28	monocytes: 6.2	Cell line enhanced	Detected in some		EFO-21: 5.7;SCLC-21H: 6.6;U-266/84: 6.0;U-698: 6.3	Not detected	Not detected			Region enriched	Detected in single	18	cerebellum: 7.9														unprognostic (3.05e-2)	unprognostic (5.62e-2)	unprognostic (1.99e-4)	unprognostic (2.50e-4)	unprognostic (2.76e-1)	unprognostic (7.10e-6)	unprognostic (3.80e-3)	unprognostic (1.17e-1)	unprognostic (2.20e-1)	unprognostic (2.56e-2)	unprognostic (4.21e-2)	unprognostic (1.91e-1)	unprognostic (1.33e-1)	unprognostic (1.08e-2)	unprognostic (1.87e-1)	unprognostic (4.38e-1)	unprognostic (9.83e-2)	8.9	0.1	0	0.1	0	0.9	7.1	1.2	0	2.1	1.5			0.7	2.7	0	0.8	2.6	1.4	6.3	0	0	4.7	0	1.9	1.1	0		0.1	0.6	0.2	0	0.1		1.1	0		1.2	0.8	4.3	2.2	1.3	1	0	0	1.2	0			1.9		0.2	1.8	2.1	0	0.2	0	6.2	0	0	0.2	0.2	0	0	0.1	0	0	0.1	0	0	0.2	0	0	0.4	2.8	5.7	0	0.9	0	0	0	0	1.9	0.2	2.2	0.9	0	0.1	2.8	2.2	0	0	0	0	0	0.1	0.5	0	2.7	0	0.1	1.4	1.6	0.2	0	0.1	2.5	1.1	2.5	0.1	0	6.6	1.2	0.1	0	0.1	0	0	2.4	0	0	0	0	0.2	1.1	6	6.3	0	1.6	0.1	0	0.1	0	0	6.2	0	0	0	0	0.2	0	0	0	0	0	5.3	0	0	0.2											3	2.2	0	0	0.9	0	1.4	0	1.4	0	47.1	0	0	0	0	0.1	5.8	0	0	0	0	0.2	0	1.1	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	1.1	0	0	0	0.1	Collecting duct cells
HRASLS	H-REV107, HRASLS1	ENSG00000127252	HRAS like suppressor		3	193241125-193277738	Predicted membrane proteins				Evidence at transcript level	Evidence at transcript level				Group enriched	Detected in many	7	skeletal muscle: 40.9;testis: 42.1	Cell type enriched	Detected in many	4	Early spermatids: 449.3	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Cell type enriched	Detected in single	7	neutrophil: 1.7	Lineage enriched	Detected in single	7	granulocytes: 1.7	Cell line enhanced	Detected in some		HAP1: 8.7;NTERA-2: 7.6;PC-3: 16.8;RH-30: 7.4;SCLC-21H: 15.3;U-2 OS: 9.3;U-251 MG: 11.7	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA051179	Uncertain		Approved	Focal adhesion sites,Cytosol		No	No			Focal adhesion sites	Cytosol	HPA051179: AB_2681375	unprognostic (3.01e-2)	unprognostic (4.21e-2)	unprognostic (7.93e-3)	unprognostic (4.82e-3)	unprognostic (2.79e-1)	unprognostic (1.87e-1)	unprognostic (9.97e-3)	unprognostic (9.68e-3)	unprognostic (1.84e-1)	unprognostic (3.55e-1)	unprognostic (1.77e-4)	unprognostic (5.09e-2)	unprognostic (1.38e-5)	unprognostic (1.61e-2)	prognostic favorable (4.36e-4)	unprognostic (2.98e-3)	unprognostic (1.13e-2)	0.6	1.1	1.8	0.2	3.1	0.1	1	0.6	3.3	0.5	0.6	1.7	0	0.1	0.6	3.1	2.4	0.5	0.2	4.3	2	1.1	0.6	0.6	0.5	0.1	1.5	2.1	0.6	0.8	0.5	0.7	0.1	2.4	0.5	0.1	3.1	6.1	0.5	40.9	1.7	0.6	0.7	0.6	0.6	0.6	42.1	1.7	0.2	3.7	6.2	0.2	0.5	0.6	0	0.2	1.7	0.1	0	0	6.2	0	0	1.7	0	0	0	0	0.1	0	1.5	0.3	0	0.1	0	0.1	0	3.7	0	8.7	0.2	0.4	0	3.9	4.5	0	0	0	0	0.1	0	0.6	0	0	0	0	0	0.2	0	0	0	0	0	7.6	0.2	16.8	0	7.4	0	2.5	0	15.3	2.9	1	2.2	0	1.4	4.4	0	0.1	0	9.3	0	11.7	0	0	0	4.8	0	2.5	0	0.1	0	0	0	0	0	0	0	0.2	0	0	0	1.7	0	0	0	0	6.2	1.8	3.1	0.6	3.3	2	1.1	1.5	2.1	2.4	1.7	0	0	0	0.1	0.9	10.8	10.6	2.5	0	1.2	0	31.4	0.7	0	0.7	449.3	0.6	0	0	0.2	0.8	0.4	0.1	0	0	0.1	1.6	0	0	0.3	85.3	6.9	0.8	1.7	0	0	1.6	0.5	0	4.6	0.1	5.6	0	0.4	112.1	25.2	5.4	0.3	0	0	0	Early spermatids
YEATS4	GAS41, NuBI-1, YAF9	ENSG00000127337	YEATS domain containing 4	O95619	12	69359703-69390796	Predicted intracellular proteins	Growth regulation, Transcription, Transcription regulation	Chromatin regulator		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in all	5	Spermatocytes: 352.0	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low cell line specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA072532			Approved	Nucleoplasm,Nuclear membrane						Nucleoplasm	Nuclear membrane	HPA072532: AB_2686530	unprognostic (7.23e-2)	unprognostic (8.50e-3)	unprognostic (2.05e-3)	unprognostic (8.07e-3)	unprognostic (1.64e-1)	unprognostic (1.06e-1)	prognostic unfavorable (3.52e-6)	unprognostic (1.77e-2)	unprognostic (3.03e-3)	unprognostic (1.80e-2)	unprognostic (6.15e-2)	unprognostic (2.13e-1)	unprognostic (7.19e-2)	unprognostic (8.47e-2)	unprognostic (2.04e-1)	unprognostic (1.96e-1)	unprognostic (1.78e-1)	10	13.4	10.7	12.9	11.7	33.1	15.6	21.2	16	9.4	10.3	8.2	5.6	11.4	10.6	13.6	12.7	10.8	7.3	10.2	10.2	11.4	13	12.6	8.8	17.6	13.8	8.1	10.7	19.2	6	14.7	9.2	11.5	9.6	12.1	12.1	12.1	9	12.5	9.5	11.2	9.7	11.7	12.1	10.3	51.6	10.9	22.6	12.2	13.4	16.7	10.1	9.8	13.5	10.7	14.7	15.1	12.8	23.1	13	17.3	8.9	17.5	10.8	4.1	6.6	14.1	10.5	11.3	18.7	15.6	10.3	5.2	35.4	10.3	5.7	9.5	13.5	13.9	10.7	18.4	17.3	15.2	20.3	7.1	12.5	5.7	29.4	18	4.8	13.7	9.9	14.8	9.5	10.6	29.4	17.1	43.3	9.1	8.7	41.3	32.2	24.5	11.7	12.3	22	16.5	17.2	10.4	15.8	19.5	13.3	10.9	10.6	17.1	11.5	20.3	17.4	6.2	7.7	7.8	21.3	12.8	11.5	14	38.6	8.3	14.1	13.4	5.2	7.8	14.7	13.5	11	15.1	13.2	18.9	14.1	10.7	13.5	23.1	19.5	4	12.8	15.1	8.9	18.3	13	10.7	11.7	21.2	16	10.2	11.4	13.8	8.1	11.5	10.9	6	19.6	31.4	31.2	26.4	23.3	22.2	15.3	24.1	25	10.4	11.8	38.5	39.7	23.6	5.4	14.6	15.1	46.7	33.9	48.2	16.2	30.4	18.5	16.6	33	17.5	16.9	9.8	10	12	17.3	24	11.8	56.9	25.2	21.7	26.2	17.5	22.6	28.7	21.9	19.4	14.6	352	74.5	28	19.7	33.1	35.3	31	Spermatocytes
TRPV5	CaT2, ECAC1	ENSG00000127412	Transient receptor potential cation channel subfamily V member 5	Q9NQA5	7	142908101-142933808	Predicted membrane proteins, Transporters, Voltage-gated ion channels	Calcium transport, Ion transport, Transport	Calcium channel, Calmodulin-binding, Ion channel		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in some	7	kidney: 26.0	Cell type enriched	Detected in single	8	Collecting duct cells: 1.8	Not detected	Not detected			Low region specificity	Detected in some			Cell type enriched	Detected in single	5	neutrophil: 1.2	Lineage enriched	Detected in single	5	granulocytes: 1.2	Cell line enhanced	Detected in single		RT4: 1.0	Not detected	Not detected			Low region specificity	Detected in many			HPA063175	Uncertain											HPA063175: AB_2684954	unprognostic (7.44e-2)	unprognostic (3.93e-2)		unprognostic (1.22e-2)	unprognostic (4.20e-2)	unprognostic (1.98e-1)		unprognostic (3.26e-1)	unprognostic (3.05e-1)	unprognostic (2.78e-2)	unprognostic (1.07e-1)	unprognostic (7.95e-2)	unprognostic (7.73e-4)	unprognostic (4.87e-2)	unprognostic (3.41e-1)	unprognostic (4.58e-1)	unprognostic (7.76e-3)	0.1	0	0.8	0.4	0.7	0.5	0.5	0.1	0.8	0.1	0.1	0.1	0.1	0.7	0.1	0.3	0.1	0.1	0.1	0.1	1.1	0.7	26	0.1	0.1	0.2	1.6	0.4	0.1	0.3	0	0.1	0.1	0.7	0.1	0	0.1	0.3	0.1	0.2	0.1	0.1	0.1	3.5	0.2	0	0.8	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	1.2	0.2	0	0	0	0.1	0	0	0.1	0	0	0.5	0	0	0	0	0.1	0.2	0.2	0	0	0	0.4	0	0	0	0	0	0.5	0	0	0	0.6	0	0	0.2	0	0	0	0	0.2	0	0	0	0	0.9	0.2	0.3	0	0.1	0.2	0	0	0	1	0	0.1	0.6	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0.1	0	0	0.1	0	0	0.2	0	0	0	0	0	0	0	0	1.2	0	0	0	0	0	0.8	0.7	0.1	0.5	1.1	0.7	1.6	0.4	0.7	0.1	0	0	0	0	0	0	0.2	0	0	0	1.8	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Collecting duct cells
GNG13	G(gamma)13, h2-35	ENSG00000127588	G protein subunit gamma 13	Q9P2W3	16	798041-800733	Predicted intracellular proteins, RAS pathway related proteins		Transducer		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	9	brain: 78.6;retina: 22.9	Cell type enriched	Detected in some	20	Bipolar cells: 323.3	Low cancer specificity	Detected in some			Region enriched	Detected in many	7	cerebellum: 78.6	Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in many		CACO-2: 11.2;HEK 293: 9.9;HeLa: 5.9;MCF7: 13.9	Region enhanced	Detected in all		cerebellum: 1054.1	Group enriched	Detected in many	6	cerebellum: 43.5;olfactory region: 18.2	HPA046272	Enhanced											HPA046272: AB_10960062	unprognostic (1.84e-1)	unprognostic (2.75e-1)	unprognostic (3.78e-2)	unprognostic (2.48e-1)	unprognostic (2.57e-2)	unprognostic (5.41e-2)		unprognostic (8.47e-2)	unprognostic (9.16e-3)	unprognostic (4.04e-2)	unprognostic (1.78e-1)	unprognostic (6.77e-2)		unprognostic (7.12e-2)	unprognostic (1.55e-1)		unprognostic (3.38e-1)	0.2	0.2	1.8	0.7	3.3	0.9	0.3	78.6	11.3	0.2	2.9	3.4	0	5.4	0.2	0.7	0.2	0.2	0.3	0.2	1.1	1.6	0.2	0.2	0.3	0.6	1.3	2.7	0.3	0.2	0.2	0.3	0.4	2.7	0.4	0.6	22.9	0.2	0.2	0.2	0.5	5.1	0.4	1.9	0.4	0.8	1.5	0.2	0.2	0.3	0	0.6	0.2	0.1	0	0	0	0	0	0	0	0.2	3.9	0.5	1.2	0	0	0.9	1	0	0	0	11.2	0.3	1.2	0.3	0	0.1	1.7	0	0	0	1.3	9.9	1.4	5.9	0	0	2.3	0.4	0	0	0	0	0	0	1.3	1.9	0.9	0	13.9	1.3	0.8	1.3	0.1	1.2	3	3.2	0.7	0	1.7	1	0.9	1	0.4	0.2	0.4	0.8	0.1	0	1.5	1.4	1.9	0.3	0.5	2.5	4.5	0.1	2.2	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.8	3.3	78.6	11.3	1.1	1.6	1.3	2.7	2.7	0.2	0	0	0	0.1	0	323.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	1.6	5.1	0	0	0	0	0	0	0	0	4.9	0	0	0	0	15.9	0	0	0	0	0	0	0	0	0	Bipolar cells
GNGT1	GNG1	ENSG00000127928	G protein subunit gamma transducin 1	P63211	7	93591573-93911265	Predicted intracellular proteins, RAS pathway related proteins		Transducer		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	13	retina: 107.2	Cell type enriched	Detected in some	5	Rod photoreceptor cells: 1939.7	Low cancer specificity	Detected in many			Not detected	Not detected			Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		EFO-21: 12.5;HeLa: 4.2;SK-BR-3: 4.0;SuSa: 6.1;T-47d: 6.8;U-266/70: 3.9;U-266/84: 5.2	Not detected	Not detected							HPA042721	Enhanced											HPA042721: AB_10806370		unprognostic (1.30e-1)	unprognostic (2.55e-4)	unprognostic (3.32e-4)		unprognostic (5.01e-2)		unprognostic (2.54e-2)	unprognostic (1.84e-1)	unprognostic (3.73e-2)	unprognostic (4.55e-1)		unprognostic (2.23e-4)	unprognostic (1.40e-2)	unprognostic (1.69e-1)		unprognostic (1.35e-1)	0.2	0.1	0	0	0	0	0	0	0	0.1	0	0	0	0	0.2	0	0.2	0.1	0	0.5	0.3	0.1	1.9	0	0	0	0.4	0	2.6	0.1	0.1	0.1	7.9	0.3	0	0	107.2	1	0	0	0.4	0	0.1	0.3	0.1	0.4	0.7	0	0	0.1	0	0	1.4	0	0.5	0.5	1.6	0.2	0.1	1.2	0.6	1.4	0.2	0.2	0	0	0	0.2	0	0	0	0	0.9	0	0.1	12.5	0	0.2	0.1	0.2	0	0	0.1	0.4	0	4.2	0	0.2	0	0	0	0	0	0	0.2	0	0	1.2	0.6	0.1	1.9	0.1	0	2	0.2	0.1	0	0	0.6	0.3	1.5	3.6	1.3	0.2	4	0.1	6.1	6.8	0.2	0.2	0	3.7	0.2	0	3.9	5.2	0	0.2	0	0	1.6	0	0.1	0.7	0.1	0.9	0.5	1	0.9	0.3	0.4	0.8	0.8	1.3	0.1	0.2	0.5	1.2	0.6	0	0	0	0	0.3	0.1	0.4	0	0.3	0	0	0	0	0	0	300.7	0	0	1.4	1.2	0	363.2	0.4	1.7	0.2	0	0	0	0	0	0.4	0	0	0	0	0.2	187.5	0	0	0	0	0	0	0	0	0	352.7	0	0	0	3.7	1939.7	0	0	0	0.2	0	5.9	0	0	0	Rod photoreceptor cells
HIP1	ILWEQ	ENSG00000127946	Huntingtin interacting protein 1	O00291	7	75533300-75738962	Cancer-related genes, Disease related genes, Predicted intracellular proteins	Apoptosis, Differentiation, Endocytosis, Transcription, Transcription regulation	Actin-binding, Activator	Cancer-related genes, Neurodegeneration	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	5	Late spermatids: 1171.7	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		A549: 27.3	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA013606, CAB015334, CAB016402, HPA017964	Enhanced		Supported	Vesicles						Vesicles		CAB015334: AB_2117565, CAB016402: AB_627725, HPA013606: AB_1850717, HPA017964: AB_1850719	unprognostic (8.23e-2)	unprognostic (1.22e-1)	unprognostic (2.20e-2)	unprognostic (1.64e-1)	unprognostic (1.04e-1)	unprognostic (2.59e-1)	unprognostic (2.73e-3)	unprognostic (1.03e-2)	unprognostic (1.11e-2)	unprognostic (2.02e-2)	unprognostic (2.70e-2)	unprognostic (7.98e-2)	unprognostic (1.73e-3)	unprognostic (9.67e-2)	unprognostic (1.75e-1)	unprognostic (1.00e-2)	unprognostic (1.09e-1)	16.5	8.7	14.6	7.2	25.9	5.1	13.5	13.2	20.8	13.2	5.3	34.4	4.9	2.9	13.4	10.1	5.7	13.8	8.7	9.2	17.5	11.9	14.6	9.6	17.7	4.6	27.2	11.8	8.1	4	4.9	3.6	20	16.1	6.8	4.5	9.9	4	12.4	3.9	10.8	4.6	12.6	24.8	10.8	4.6	18.5	29.7	1.6	15.8	5.7	4.6	9.7	8.8	0.5	4	8.8	1.1	3.3	1.5	0.3	2.5	27.3	18.6	17.5	7.9	10.7	5.6	4.8	3.1	3.1	2.3	1.5	2.4	1.8	5.6	11.8	10.9	3.1	18.8	3.9	4.2	1.5	3.5	1.4	3.2	2.5	7.8	0.4	7.4	8.2	2.4	10.2	2.1	5.8	13	2	1.9	1.8	5	10.4	1.2	10.6	20.2	0.2	3.3	2.1	7.8	0.1	2.4	9.7	0.9	8.2	4.4	2.8	6.3	17.3	17.2	6.7	4.6	9.2	7.1	3.1	6.6	2	0.2	4.4	9.2	3.9	6.2	8.8	1.1	7.6	1.1	1.1	1	0.4	0.2	0.9	1.6	0.5	0.1	0.7	7.7	3.3	0.8	4	1.5	0.3	14.6	25.9	13.2	16.9	17.5	11.9	27.2	11.8	16.1	29.7	56.6	35.7	6	6.3	15.7	7.1	12.5	5.1	0	17	26.2	11.8	1.3	11.6	10.2	240.8	40.7	0.7	0	5.3	7.5	15.4	4	13.9	20.2	11.7	22.3	4.6	30.1	15.1	1171.7	20.8	22.9	10.1	1	1.4	18.6	2.6	8.5	23.3	2.2	8.2	84.1	37.2	9.3	4.1	8	0.7	17	2.6	3.1	Late spermatids
DGCR6L	FLJ10666	ENSG00000128185	DiGeorge syndrome critical region gene 6 like	Q9BY27	22	20314276-20320080	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	4	Late spermatids: 2083.4	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low cell line specificity	Detected in all																								unprognostic (1.91e-1)	prognostic favorable (3.82e-5)	unprognostic (2.74e-2)	unprognostic (4.61e-3)	unprognostic (3.97e-2)	unprognostic (2.46e-1)	unprognostic (2.61e-1)	prognostic favorable (5.37e-4)	unprognostic (1.44e-1)	unprognostic (4.39e-2)	unprognostic (3.29e-3)	unprognostic (9.07e-3)	unprognostic (6.72e-3)	unprognostic (4.37e-2)	unprognostic (2.91e-1)	unprognostic (1.26e-1)	unprognostic (2.97e-1)	12.2	14.4	25.4	8.5	24.2	15.2	15.1	14.8	26.2	16.2	12.4	13.4	17.7	11.7	10.9	19.4	14.3	18.2	15.8	25.6	21	18.1	16.7	41.7	13.3	24.1	18.1	17.7	16.1	27.1	12.4	13.6	10.4	15.1	15.4	6.8	15	26.9	18.8	41.8	19.2	13	17.2	13.4	11	12.3	45.7	11.7	13.1	18.1	17.3	11.6	11.2	10.6	28	33.2	49.1	37	45.6	49.8	39.3	12.8	14.6	10	25.1	14.6	14.7	10.5	12.5	14.8	23.2	17	7.5	6.3	3.4	16.5	13.6	9.3	13.1	7.4	15.1	3.8	16.7	38.3	8.3	10.2	13.8	17.5	17.8	8.4	16.5	13.9	9.2	9.7	8.9	16.2	16.5	37.7	15.4	14.8	29.8	13	15.8	7.3	25.4	21.9	23.5	23.2	6.6	12	10.1	20	14.7	20.6	13.5	22.9	4.4	19.6	14.2	12.5	27.7	32.5	14.7	12.2	13.8	14.6	7.8	22.3	22.2	18.5	32.3	37	49.1	39.9	31.9	39.5	28	49.8	44.2	33.2	25.9	47	44	12.3	45.6	30.3	30.9	44.2	39.3	25.4	24.2	14.8	26.2	21	18.1	18.1	17.7	15.1	11.7	26.8	27.5	37.6	30.6	38.8	18.2	68.3	35.7	36.1	29.6	33.2	3.9	60.6	112.7	63.6	484.3	41.6	60.3	0	55.1	69	54.6	29.9	39.2	139.4	71.5	27	50.7	47.3	62.7	2083.4	65	47	54	29.7	57.3	26.9	46	51.6	66.4	103.1	16.9	45.3	61.7	112.8	79.9	53.2	18.3	66	62.4	21	Late spermatids
RFPL2	RNF79	ENSG00000128253	Ret finger protein like 2	O75678	22	32190435-32203477	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Group enriched	Detected in some	7	brain: 7.9;prostate: 10.8	Cell type enriched	Detected in single	4	Glandular cells: 3.1	Cancer enriched	Detected in single	15	prostate cancer: 5.6					Low cell type specificity	Detected in some			Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		A549: 2.5;OE19: 1.1;REH: 1.0;SCLC-21H: 1.8;SK-MEL-30: 1.2									HPA046608, HPA048320, HPA072380	Approved		Approved	Nuclear speckles,Plasma membrane						Nuclear speckles	Plasma membrane	HPA046608: , HPA048320: AB_2680356, HPA072380: AB_2686515	unprognostic (3.81e-2)	unprognostic (4.05e-2)	unprognostic (8.29e-2)	unprognostic (9.66e-3)	unprognostic (2.54e-1)	unprognostic (9.90e-2)	unprognostic (2.59e-1)	unprognostic (6.02e-3)	unprognostic (2.22e-2)	unprognostic (3.44e-2)	unprognostic (8.64e-3)	prognostic favorable (4.16e-4)	unprognostic (2.04e-4)	unprognostic (6.02e-2)	unprognostic (3.28e-2)	unprognostic (5.62e-7)	unprognostic (3.50e-2)	0.1	0.3	2.3	0.2	3.9	1.1	0.1	2.7	7.9	0.1	0.1			0.2	0.1	0.1	0.3	0.1	0.1	0.1	3.1	5.6	0.2	0.5	0.1	0.4	1.9		0.1	0.1	0.1	0	0.1		10.8	0.1		0.1	0.1	0.1	0.4	0.2	0.1	0.4	0.2	0.2	0.2			0.2		0.1	0.1	0	0	0.5	0	0.8	0	1.2	0.2	0	2.5	0	0.8	0	0	0.2	0	0	0	0	0	0	0	0.2	0	0.1	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0.2	0.1	0	0.4	0	0.3	0	1.1	0	1	0.1	0	0	0.2	1.8	0	0.3	0	1.2	0	0	0	0	0	0	0	0	0.3	0.1	0.1	0	0.1	0.1	0	0.8	0	0	0.1	0.8	0	1.2	1.2	0.5	0	0.7	0	0	0	0.2	0	0	0.2											0	0	0	0.1	0	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.1	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Glandular cells
RFPL3	RNF120	ENSG00000128276	Ret finger protein like 3	O75679	22	32354885-32361161	Predicted intracellular proteins	Host-virus interaction			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in some	21	testis: 23.4	Cell type enriched	Detected in single	7	Early spermatids: 1.7	Not detected	Not detected							Cell type enhanced	Detected in single		memory CD4 T-cell: 1.1	Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		BEWO: 3.8;NB-4: 4.8;U-266/70: 5.6;U-266/84: 5.5									HPA048320, HPA072380			Approved	Nuclear speckles,Plasma membrane						Nuclear speckles	Plasma membrane	HPA048320: AB_2680356, HPA072380: AB_2686515	unprognostic (1.63e-1)				unprognostic (9.90e-2)			unprognostic (1.10e-1)		unprognostic (1.05e-1)	unprognostic (1.52e-2)	unprognostic (1.97e-1)	unprognostic (3.25e-2)	unprognostic (4.31e-2)	unprognostic (1.90e-1)	unprognostic (6.32e-2)		0	0	0.3	0	0.3	1	0	0.7	0.4	0.2	0			0	0.1	0	0	0	0.2	0	0.2	0.2	0.1	0.1	0	0.4	0.2		0.6	0.5	0	0.2	0		0.3	0		0.4	0	0.3	1.1	0.2	0	0.1	0.5	0	23.4			0		0	0.2	0	0	0	0.2	0.3	0	1.1	0.2	0.1	0.8	2.4	0.7	0	0	3.8	0.1	0	0	0	0	0	0	0.3	0	0.5	0.1	0	0	0	0.3	2.4	1.1	0.1	0.1	0	1.5	0.5	0	0	0	0	1.4	0	1.8	0.1	1.8	0	0.9	1.4	4.8	0.2	0.3	0.1	2.4	0.5	0.6	0	0.4	1.8	0.5	0.1	0.4	1.3	0.6	0	0.4	0	0	0.9	0.4	0	5.6	5.5	0.1	0.1	1.7	0.8	0	0.3	0	0	0	0.1	0	1.1	0.3	0	0	0	0	0.2	0	0	0	0	0.2											0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0.2	0	0	0	0	0	Early spermatids
APOBEC3A	ARP3, PHRBN	ENSG00000128383	Apolipoprotein B mRNA editing enzyme catalytic subunit 3A	P31941	22	38952741-38992778	Predicted intracellular proteins	Antiviral defense, Immunity, Innate immunity	Hydrolase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		blood: 113.5;bone marrow: 42.7;lymphoid tissue: 31.5	Cell type enriched	Detected in many	5	Urothelial cells: 223.8	Cancer enhanced	Detected in many		head and neck cancer: 15.8	Low region specificity	Detected in single			Cell type enhanced	Detected in many		intermediate monocyte: 113.5	Lineage enriched	Detected in many	7	monocytes: 113.5	Cell line enhanced	Detected in some		Karpas-707: 3.5									HPA043237, HPA056980, HPA066719	Approved		Uncertain	Nucleoplasm						Nucleoplasm		HPA043237: AB_10795980, HPA056980: AB_2683298, HPA066719: AB_2685711	unprognostic (6.45e-3)	unprognostic (1.44e-2)	unprognostic (1.12e-1)	unprognostic (5.21e-3)	unprognostic (1.31e-1)	unprognostic (2.72e-2)	unprognostic (1.91e-1)	unprognostic (1.91e-1)	unprognostic (3.52e-1)	unprognostic (2.59e-3)	unprognostic (9.01e-3)	unprognostic (2.00e-1)	unprognostic (1.13e-2)	unprognostic (1.76e-1)	unprognostic (4.98e-2)	unprognostic (3.41e-1)	unprognostic (1.91e-1)	4.3	0.2	0.3	11	0.4	42.7	0.5	0.2	0.7	1.7	0.8	0.2	0	0.6	1.3	1.4	7.2	3.3	3.4	0.9	0.2	0.3	0.7	1.3	16	15.8	1.9	0.5	0.7	0.7	0.1	0.3	4.9	0.7	0.3	0.2	2	5.9	0	1.2	0.3	0.8	0.8	1.7	31.5	0.8	0.4	0.2	1.4	0.7	22.3	29	2.7	6.4	0.2	1.2	15.3	113.5	0.1	0.1	15.2	0.7	0.3	0.5	2.5	0.2	0.4	1.1	0.3	0	0	0.1	0.2	1.6	0.6	1.7	0.2	0.3	2.1	0.6	0.4	0	0.8	0.2	0.2	1.7	0.2	0.2	0.3	1.1	0.2	0.9	0.3	0.2	0.3	0.1	0.5	0.3	3.5	0.1	1.3	0.5	0.5	1.1	0.5	0.2	0.9	0.5	0.7	0.6	1.3	1.2	0.6	0.4	1.4	0.2	0.3	1.1	0.1	1.5	1.1	0.9	0.4	0.4	0.5	0.8	1	1.4	2.5	1.2	3.5	26.8	0.9	0	113.5	0.1	0.2	0	0	1.2	0.1	0	0	15.3	0.1	31.1	0.1	0.1	15.2	0.3	0.4	0.2	0.7	0.2	0.3	1.9	0.5	0.7	0.2	26.8	47.2	0	9	1.1	0.5	0	0	14.7	33	1.8	3.9	0.2	0	0	0.5	0.1	4.3	23.3	0.2	0.2	0.5	4.8	24.4	0	15.6	0	0	0.6	18	0	0.3	11.3	15.1	0	0	0.8	0.8	0	0.4	0	0.8	0	0.9	0.1	0.5	5.9	0.2	1	0	223.8	Urothelial cells
CDHR3	CDH28, FLJ23834, FLJ44366	ENSG00000128536	Cadherin related family member 3	Q6ZTQ4	7	105876796-106033773	Disease related genes, Predicted intracellular proteins, Predicted membrane proteins	Cell adhesion, Host-virus interaction	Host cell receptor for virus entry, Receptor	Asthma	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		fallopian tube: 51.9;lung: 28.9;ovary: 22.3	Cell type enriched	Detected in many	6	Ciliated cells: 341.3	Low cancer specificity	Detected in many			Region enhanced	Detected in many		pons and medulla: 15.9	Group enriched	Detected in some	5	memory B-cell: 2.9;naive B-cell: 6.9;neutrophil: 1.8	Group enriched	Detected in many	6	B-cells: 6.9;granulocytes: 1.8	Cell line enhanced	Detected in some		AF22: 7.9;Daudi: 10.1;WM-115: 6.8	Low region specificity	Detected in many							HPA011218	Supported		Approved	Nucleoli fibrillar center						Nucleoli fibrillar center		HPA011218: AB_1078886	unprognostic (4.38e-4)	unprognostic (9.18e-2)	unprognostic (8.16e-3)	unprognostic (8.08e-3)	unprognostic (5.23e-2)	unprognostic (1.55e-1)	unprognostic (3.43e-2)	unprognostic (1.18e-3)	unprognostic (2.99e-2)	unprognostic (1.92e-1)	unprognostic (2.28e-2)	unprognostic (1.73e-2)	unprognostic (1.16e-1)	unprognostic (3.18e-1)	unprognostic (2.77e-2)	unprognostic (3.70e-3)	unprognostic (3.51e-3)	0.4	0.6	2.2	0.6	3.3	0.5	2.5	4.4	1.4	2.4	7.6	4.9	1.1	1.1	2.4	14.9	5.9	51.9	0.2	3.3	3.1	2.1	0.7	0.6	28.9	0.4	1.1	0.3	22.3	0.3	0.1	1.4	0.1	15.9	0.3	0.9	0.1	0.3	0.6	0.5	0.4	12	1.7	0.6	0.2	4.6	2.2	1.2	0.1	1.4	0.4	0.7	0.3	0.1	6.9	0.2	1.8	0.2	0.3	0.7	0.1	0.1	0.4	7.9	1.4	2.8	2.7	0.2	0.7	0.6	0.3	0.2	0	0.1	10.1	0	0.5	1.1	0.1	1.9	0	0.3	0.9	1.2	0	0.2	0.7	0	0.2	0.4	1	0.3	0.5	0	0.2	0	0	0.1	0.3	0.3	0	0.2	0.1	1.8	2.8	0.6	0	0	0.4	0.1	0.1	0.6	2.9	0	0.8	0.5	1.4	0	0	0.4	1.4	0.5	1.5	0	0	0	3.3	0.2	0.3	6.8	0.1	0.1	0	0	0.1	0	2.9	0	0	0	6.9	0.3	0.1	1.8	0.3	0.2	0.2	0.7	0.1	2.2	3.3	4.4	1.4	3.1	2.1	1.1	0.3	15.9	1.2	3	7.2	0	1.6	2.4	4.5	1.2	2.5	341.3	55.7	0	0	0.5	5	0.5	5.4	1	2.8	0	0.5	0.2	1.5	0.5	3.5	1.7	0.1	0	28.7	0	0	2.5	2.6	0.6	8.5	0	3.6	9.5	0.2	2.9	1.4	4.4	1	6.5	1.7	1.4	3.1	1.8	0.2	0.7	2.9	0.4	Ciliated cells
FLNC	ABP-280, ABPL, FLN2	ENSG00000128591	Filamin C	Q14315	7	128830377-128859274	Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters		Actin-binding	Cardiomyopathy, Disease mutation, Myofibrillar myopathy	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	8	skeletal muscle: 546.8	Cell type enriched	Detected in many	40	Cardiomyocytes: 1815.4	Low cancer specificity	Detected in all			Low region specificity	Detected in some			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in many		BJ: 80.1;fHDF/TERT166: 36.4;hTEC/SVTERT24-B: 39.6;U-2 OS: 34.2	Low region specificity	Detected in many			Low region specificity	Detected in many			HPA006135, HPA071007	Enhanced		Supported	Plasma membrane,Cytosol					54000000	Plasma membrane, Cytosol		HPA006135: AB_1848602, HPA071007: 	unprognostic (1.25e-1)	unprognostic (7.38e-2)	unprognostic (4.47e-2)	unprognostic (1.40e-2)	prognostic unfavorable (2.80e-4)	unprognostic (1.64e-3)	unprognostic (4.42e-3)	prognostic unfavorable (2.17e-5)	unprognostic (1.03e-3)	unprognostic (2.35e-2)	unprognostic (1.35e-3)	unprognostic (6.37e-2)	prognostic unfavorable (5.69e-4)	unprognostic (5.68e-3)	unprognostic (1.15e-1)	unprognostic (1.52e-3)	prognostic unfavorable (3.73e-5)	2.6	0.8	0.5	7.1	0.7	0.2	0.7	0.3	1	5.2	24.4	1.4	18.4	1.9	14	10.1	16	4.8	13.3	70	0.8	0.5	0.4	0.3	1.4	0.3	1.4	0.5	3.1	0.6	1	0.3	0.6	1.9	11.9	2.1	1.7	3.1	20.2	546.8	1	5.2	69	4.7	0.3	10	1.3	0.6	0	4.7	40	2.2	39.6	20.5	0	0	0	0	0	0	0	0	0.1	0.8	0	7.3	8.8	0.8	80.1	15.2	22.8	11	24.9	0.2	0	13.5	36.4	9.3	0	4.8	0.1	13.6	0	2.7	0	4.1	0	9.2	0	0	16.6	0	39.6	0	9.3	14.2	0	9.6	0	15.5	0	0	0.3	13.3	0	4.6	0	26.5	0.2	0	0	0.4	1.4	0.1	0	0	19.2	0.1	0.3	29.3	8	34.2	2	0	0	0	0	27.1	0	1.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0.7	0.3	0.6	0.8	0.5	1.4	0.5	1.9	0.6	3	0.3	0	0.1	3.3	0.4	1815.4	0	0	3.4	1.8	0	0.3	0	0.6	0.2	6.2	0	0	0.2	0.7	11.9	1.4	0	0	0.8	0	0	1.8	0	0	4.9	0.8	5	0	0	0.1	1.8	0	9.9	1	0.1	0	45.3	0.2	0.4	4	1.6	0	0	0.4	Cardiomyocytes
FEZF1	ZNF312B	ENSG00000128610	FEZ family zinc finger 1	A0PJY2	7	122301394-122310691	Disease related genes, Predicted intracellular proteins, Transcription factors	Differentiation, Neurogenesis, Transcription, Transcription regulation	Developmental protein, DNA-binding, Repressor	Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	4	brain: 16.7;testis: 11.0	Cell type enriched	Detected in single	5	Spermatocytes: 2.7	Low cancer specificity	Detected in many			Region enhanced	Detected in many		hypothalamus: 16.7	Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	10	NTERA-2: 58.8;SCLC-21H: 25.7	Region enriched	Detected in single	11	hypothalamus: 13.7	Region enriched	Detected in some	9	hypothalamus: 6.9	HPA064639, HPA073693	Approved		Supported	Nucleoplasm,Cytosol						Nucleoplasm	Cytosol	HPA064639: AB_2685308, HPA073693: AB_2686626		unprognostic (8.48e-2)	unprognostic (3.41e-2)	unprognostic (3.64e-1)	unprognostic (3.43e-2)	unprognostic (4.17e-1)	unprognostic (4.10e-2)	unprognostic (2.64e-3)			unprognostic (2.54e-1)	unprognostic (1.34e-1)		unprognostic (2.96e-2)	unprognostic (2.55e-1)		unprognostic (1.48e-2)	0.6	0.2	6.4	0.2	4.9	0.2	0.2	0	2	0.2	0.2	0	0	0.2	0.2	0.2	0.2	0.2	0.2	0.3	1	16.7	0.2	0.2	0.2	0.2	2	0	0.3	0.2	0.2	3.1	0.2	0	0.3	0.2	1.4	0.6	0.2	0.2	0.3	0.2	0.2	0	0.2	0.3	11	3.5	0	0.2	0	0.2	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	1	0	0	0	0	0	4.3	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.9	0	0	0	0	58.8	1.4	1	0	0	0	0	0.1	25.7	0	0	0	0	0	0.2	0	0	2.8	0.1	0	0	0.8	0	0	0.4	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	6.4	4.9	0	2	1	16.7	2	0	0	3.5	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0.4	0	0	0	0	2.7	0.2	0	0	0	0	0	Spermatocytes
OPN1SW	BCP, BOP, CBT	ENSG00000128617	Opsin 1, short wave sensitive	P03999	7	128772491-128775790	Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins	Sensory transduction, Vision	G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer	Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	4	heart muscle: 11.4;retina: 23.9	Cell type enriched	Detected in some	12	Cone photoreceptor cells: 39.3	Low cancer specificity	Detected in all			Low region specificity	Detected in some			Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		U-87 MG: 37.6	Not detected	Not detected			Not detected	Not detected			HPA013562, HPA014083	Enhanced		Approved	Nucleoplasm,Nuclear bodies,Cytokinetic bridge,Cytosol						Nucleoplasm	Nuclear bodies, Cytokinetic bridge, Cytosol	HPA013562: AB_2668850, HPA014083: AB_2668938	unprognostic (2.88e-1)	unprognostic (5.17e-2)	unprognostic (2.22e-2)	unprognostic (1.33e-2)	unprognostic (2.55e-2)	unprognostic (2.16e-1)	prognostic unfavorable (8.50e-5)	unprognostic (1.13e-1)	unprognostic (1.27e-1)	unprognostic (6.33e-2)	unprognostic (3.79e-1)	unprognostic (6.05e-2)	prognostic unfavorable (2.26e-8)	prognostic unfavorable (5.98e-8)	unprognostic (2.53e-1)	unprognostic (8.99e-2)	prognostic unfavorable (9.33e-4)	0.9	1.8	0.7	3.7	0.9	1.7	0.7	1	2.3	0.7	2.2	0.7	0.7	0.5	2.6	0.7	2.4	0.8	4.2	11.4	0.7	0.8	0.7	0.7	0.9	1	0.7	1.3	0.7	0.7	0	0.7	0.7	0.7	1.4	0	23.9	1.1	0.7	1.9	0.9	0.9	0.7	0.7	1.1	1.4	1.1	0.7	0.7	2.3	0.7	0.7	4.3	0.7	0.5	1.2	0.6	1.4	0	1.4	0.3	1.7	2.2	5.2	1.7	0	0	1.5	9.8	0	0	0	5	2.1	2.6	1.5	0	1.6	1.4	0	0	0	0.3	3.6	1.6	3	2.5	0	2	1.6	0	0	0	0	7	0	1.7	2.2	0.6	1.1	0.7	2	3.6	4.7	1.7	3	1	5.4	3	0	0.6	0.7	6.9	2.3	5.2	4.4	7.3	0.5	2	4	10	1	7.7	8.7	2.1	2.2	1.6	37.6	4.6	9.3	0	0.3	0.6	1.4	1.4	0.9	0.2	0.8	1	1.2	0.5	0.3	0.9	0	0	1	0.7	0.4	0.3	0.7	0.9	1	0.9	0.7	0.8	0.7	1.3	0.7	0.7	0	0.6	0	0	0	0.9	0.4	0	0	0	0	39.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.2	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	Cone photoreceptor cells
CALML4	MGC4809, NY-BR-20	ENSG00000129007	Calmodulin like 4	Q96GE6	15	68190705-68206110	Predicted intracellular proteins, RAS pathway related proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	4	blood: 44.0;gallbladder: 28.4;intestine: 91.6	Cell type enriched	Detected in many	5	Ciliated cells: 174.0	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Group enriched	Detected in some	6	intermediate monocyte: 39.2;non-classical monocyte: 44.0	Lineage enriched	Detected in many	10	monocytes: 44.0	Low cell line specificity	Detected in many			Low region specificity	Detected in many			Low region specificity	Detected in many			HPA051109	Enhanced		Approved	Nucleoplasm,Golgi apparatus,Cytosol		Yes	No			Golgi apparatus	Nucleoplasm, Cytosol	HPA051109: AB_2681346	unprognostic (1.69e-2)	unprognostic (1.78e-1)	unprognostic (4.97e-2)	unprognostic (8.50e-2)	unprognostic (1.63e-1)	unprognostic (3.71e-2)	unprognostic (4.05e-2)	unprognostic (6.53e-2)	unprognostic (6.77e-2)	unprognostic (2.10e-1)	unprognostic (4.19e-3)	unprognostic (6.24e-2)	unprognostic (3.85e-2)	unprognostic (7.92e-3)	unprognostic (2.46e-1)	unprognostic (7.49e-2)	unprognostic (1.32e-1)	2.4	2.5	1.8	12	1.1	0.8	2.2	2.6	1	3.2	40.3	2.2	7.7	34	1.5	7.8	5.1	7.3	28.4	1.4	2.6	0.7	12.6	12.3	3.1	2.6	0.9	1.3	2.3	5.3	0	3.1	2.1	8.4	4.3	21.8	3.1	1.9	6.7	1.4	1.7	91.6	2.7	1	5.3	5.4	2.4	0.6	1.1	1.5	1.3	1.3	1.9	2	0	4.5	1.8	44	0	0	2.8	2.5	7.8	5.7	3.5	0.6	1	4	1.6	1.5	2.6	2.6	14.9	16.1	2.5	2	1.1	2.3	10.8	12.8	2.3	1	2.1	12.4	4.1	13.3	5.2	2.3	3.5	5.5	1.1	3.4	1.5	2.2	2.1	2.9	5.2	3.9	2.9	0.6	7.2	5.7	7.7	4.9	12	2.3	8.5	5.6	5.1	0.9	4.3	2.9	3.4	2.5	2.3	6.8	1.8	1.7	3.4	2.5	3.8	3.5	6.6	6.3	10.6	6.3	7	2.4	6.9	1.3	0	6.5	0	0	39.2	0	0	0	0	4.5	0	0	0	1.8	0	44	0.2	0	2.8	1.8	1.1	2.6	1	2.6	0.7	0.9	1.3	8.4	0.6	0	1	0.9	0.6	1.3	8.8	0.3	15.3	174	26.1	3.5	0	0.4	0	2	4.8	1.9	38.6	0	3.9	0.4	1	1.2	0	7.2	3.1	7.9	7.5	6.7	11.9	0	3.4	3.4	0	0	15	1.7	1.8	38.6	6.3	5.8	2.2	0	0.3	0	0.5	1.8	0.1	1.8	18.3	1.1	Ciliated cells
BBOX1	BBH, BBOX, G-BBH, gamma-BBH	ENSG00000129151	Gamma-butyrobetaine hydroxylase 1	O75936	11	27040725-27127809	Enzymes, Predicted intracellular proteins	Carnitine biosynthesis	Dioxygenase, Oxidoreductase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	5	kidney: 139.4;liver: 39.3	Cell type enriched	Detected in many	5	Proximal tubular cells: 1023.7	Group enriched	Detected in many	6	glioma: 23.7;renal cancer: 59.4	Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	4	hTCEpi: 16.2;RPTEC TERT1: 10.0	Low region specificity	Detected in many			Low region specificity	Detected in many			HPA007600, HPA027823	Enhanced	Approved	Uncertain	Vesicles,Actin filaments					25000	Vesicles	Actin filaments	HPA007600: AB_1845284, HPA027823: AB_10602394	unprognostic (9.96e-3)	unprognostic (1.80e-2)	unprognostic (8.17e-2)	prognostic unfavorable (6.65e-4)	unprognostic (7.03e-2)	unprognostic (6.66e-2)	unprognostic (7.05e-3)	unprognostic (1.13e-2)	unprognostic (3.03e-1)	unprognostic (6.89e-2)	unprognostic (2.03e-2)	unprognostic (1.60e-1)	prognostic favorable (1.45e-5)	unprognostic (1.71e-2)	unprognostic (2.70e-1)	unprognostic (3.22e-1)	unprognostic (1.73e-3)	0.9	0.5	9.2	0.5	7.1	0.5	8.2	3.9	7.5	1.5	0.6	4.9	0.1	0.5	0.6	3.6	5.7	3.8	3.6	0.5	7.9	6.3	139.4	39.3	0.6	0.6	10.9	4.3	0.5	0.8	0.5	8.3	1.3	9.2	0.7	0.5	0	2.2	2	0.6	16.4	0.5	0.5	7.1	0.5	0.6	0.6	5.8	0	8.9	1.6	0.7	0.6	3.3	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	1.4	0	0	0	0	0	0	0	0	0	0.7	0	1	16.2	0	0	3.2	0	0	0	0.1	0	0	0	0.1	0	0.1	0	0	0	0	10	0	0	0	0.5	2.5	0	0.2	0	0	0	0	0	0.1	0	0.2	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	9.2	7.1	3.9	7.5	7.9	6.3	10.9	4.3	9.2	5.8	0	1.1	0	5.5	7.2	0	0	17.8	6.7	2.3	43.6	0	0.1	189	0.3	0.7	0	0	0	0	0	0.3	0.1	0	25.4	0	0	0	0.6	1.2	1.1	0	0	1.7	0	0	11.3	0.1	0	0.4	1023.7	0.3	0	0.4	0	0.1	31.2	0.2	0	0	2.2	Proximal tubular cells
MYOD1	bHLHc1, MYF3, MYOD, PUM	ENSG00000129152	Myogenic differentiation 1	P15172	11	17719568-17722131	Cancer-related genes, Predicted intracellular proteins, Transcription factors	Differentiation, Myogenesis, Transcription, Transcription regulation	Activator, Developmental protein, DNA-binding	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in some	7	skeletal muscle: 31.8	Cell type enriched	Detected in single	7	Spermatogonia: 3.0	Cancer enhanced	Detected in single		ovarian cancer: 0.7	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	15	RH-30: 103.7	Not detected	Not detected			Not detected	Not detected			HPA055436, HPA078647			Enhanced	Nucleoplasm						Nucleoplasm		HPA055436: , HPA078647: 						unprognostic (1.07e-3)				unprognostic (2.10e-1)					unprognostic (1.01e-1)			1.3	0	0	0	0	0	0	0.1	0	0.2	0	0	0	0	0	0.2	0.2	0	0	0	0.7	0	0	0.1	0	0	0	0	0	0	0	0	0.3	0	0.6	0	0	0.5	0	31.8	0	0	0	0	0	0	0.3	0	0	0.2	4.6	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	6.9	0	0	0	0	0	0	0	103.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0.4	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	3	0	0	0	0	0	Spermatogonia
KCNC1	Kv3.1	ENSG00000129159	Potassium voltage-gated channel subfamily C member 1	P48547	11	17734774-17856804	Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels	Ion transport, Potassium transport, Transport	Ion channel, Potassium channel, Voltage-gated channel	Disease mutation, Epilepsy, FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	12	brain: 67.5	Cell type enriched	Detected in some	4	Bipolar cells: 36.6	Cancer enhanced	Detected in some		glioma: 1.1	Region enhanced	Detected in all		cerebellum: 67.5	Cell type enhanced	Detected in some		basophil: 5.8	Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		RH-30: 7.5;SCLC-21H: 7.1;SH-SY5Y: 4.4	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA047634, HPA048249	Enhanced		Approved	Nucleoplasm,Nuclear membrane,Vesicles,Cytosol						Nucleoplasm, Nuclear membrane	Vesicles, Cytosol	HPA047634: AB_2680109, HPA048249: 	unprognostic (1.79e-2)	unprognostic (2.68e-1)	unprognostic (1.33e-1)	unprognostic (4.09e-3)	unprognostic (1.12e-1)	unprognostic (8.02e-2)	unprognostic (2.40e-1)	unprognostic (1.27e-1)	unprognostic (8.37e-2)	unprognostic (2.14e-1)	unprognostic (7.04e-5)	unprognostic (5.89e-2)	unprognostic (7.32e-4)	unprognostic (1.29e-1)	unprognostic (5.44e-2)	unprognostic (1.05e-2)	unprognostic (7.83e-2)	0.7	2.3	8.2	1	10	2.9	0.9	67.5	33.3	3	1	1	0	1.4	1.5	0.6	1.1	0.9	1.3	0.6	5.6	4.9	0.9	1.1	1	1.2	3.3	12.6	1.1	0.9	0.6	1.4	0.7	19.5	1.2	0.8	0.7	1.2	0.7	1.7	1.8	1.2	0.8	1.9	1	1.3	2.9	2	0	1.5	0	0.8	2.4	0.5	1.7	0.8	5.8	0.8	0.7	1.1	0.3	0.4	0.1	3.1	1.2	0.5	0	0.1	0	0	0.1	0	0.2	1	0	0.2	0	0.9	1.1	1.8	0	0.3	0.3	2.1	0.6	3	0.2	0.4	0.5	0.2	0	0	0	0.1	0	0	0.8	0.5	1.4	0	0.5	0.5	1.2	1.5	0	0	0.8	7.5	0.9	0	0.4	7.1	4.4	0.4	0.5	0	0.4	0.6	0.5	0.1	0.2	2.3	0.3	0.3	0.5	0.6	1	0.5	0.3	1	5.8	0.7	1.1	1.1	0.7	0.7	0.7	0.9	0.5	0.2	1.7	0.7	0.8	3.8	0.7	0.8	0.8	0.4	0.3	8.2	10	67.5	33.3	5.6	4.9	3.3	12.6	19.5	2	0	0	0	0	0	36.6	1.7	0	0	0	0	0	0	0	0.5	7.4	0	0	0	0.2	0	0	0	0	0	0	1.6	7.5	0	0	8.4	0.3	0	0	1	0	1.5	0.2	0	0	0.1	7.4	0	0.4	5.4	4.5	0	0	0	0	0	Bipolar cells
TPH1	TPH, TPRH	ENSG00000129167	Tryptophan hydroxylase 1	P17752	11	18017564-18042426	Enzymes, FDA approved drug targets, Predicted intracellular proteins	Serotonin biosynthesis	Monooxygenase, Oxidoreductase	FDA approved drug targets	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	6	brain: 4.2;intestine: 16.2;pituitary gland: 5.4;stomach 1: 13.3	Cell type enriched	Detected in many	164	Intestinal endocrine cells: 1412.4	Low cancer specificity	Detected in some			Region enriched	Detected in single	6	cerebral cortex: 4.2	Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		HL-60: 4.5	Low region specificity	Detected in some							CAB010767, HPA022483	Approved		Uncertain	Cytosol						Cytosol		CAB010767: AB_261587, HPA022483: AB_1858378	unprognostic (2.14e-4)	unprognostic (9.97e-2)	unprognostic (6.92e-2)	unprognostic (6.78e-2)	unprognostic (1.55e-1)	unprognostic (6.26e-5)	unprognostic (1.73e-1)	unprognostic (5.33e-2)	unprognostic (1.60e-1)	unprognostic (2.12e-2)	unprognostic (1.19e-4)	unprognostic (6.72e-2)	unprognostic (5.40e-8)	unprognostic (3.76e-2)	unprognostic (7.42e-2)	unprognostic (3.10e-1)	unprognostic (2.46e-5)	0.7	0	0.7	0.7	0.7	0.6	0.9	0.7	4.2	0.7	7.1	0.7	0.7	8.2	0.7	0.7	0.7	1.5	0.7	0.7	0.7	0.3	0.7	0.7	0.7	0.7	0.7	0.7	1	0.7	0	5.4	0.7	0.7	1.3	16.2	0.7	0.7	0.7	0.7	1	9.1	0.7	0.7	1	13.3	0.9	0.7	0.7	0.7	0.7	0.7	0.7	0.7	1.4	0.8	1.5	0.5	0.9	1.6	0.2	0.4	0.1	1.7	1.5	0.1	0	0.6	0.6	0.5	0.2	1.1	1.8	0.3	1.4	0.3	0	0.1	0.6	0.4	1.5	0.7	1.3	3.1	2.2	0.8	3.5	0	4.5	1.2	0	1.8	0.2	0.6	0.3	0.7	2.7	0.9	0.8	0.1	0.5	1	0.7	0.5	0.1	0.3	1.7	0.3	0	0	1	1.3	0.9	0.2	0.4	0.9	0.2	0.3	2.9	0.2	0.4	1.3	0.5	1.7	0.2	0.3	1.1	0.2	1	1.4	1.5	0.4	0.4	1.6	0.2	0.8	0.5	0.5	0.4	0.1	1.4	0.6	0.6	1.5	0.9	0.5	0.8	0.6	0.2	0.7	0.7	0.7	4.2	0.7	0.3	0.7	0.7	0.7	0.7	0	0	0	0.4	0.3	4.7	0.4	0	1.4	0	5.2	2	0.2	0	0.2	0.7	0.3	1	0	0.5	0	0.7	2	0	0	0.2	1.6	1412.4	0	0	0.4	0.9	0.9	0	0	2.8	1.5	0.4	8.6	1.1	0.2	6	6.5	1	2.7	3.4	1.3	0	0.5	1.7	0	Intestinal endocrine cells
CSRP3	CLP, CMD1M, MLP	ENSG00000129170	Cysteine and glycine rich protein 3	P50461	11	19182030-19210573	Disease related genes, Plasma proteins, Predicted intracellular proteins	Differentiation, Myogenesis, Transcription, Transcription regulation	Actin-binding, Developmental protein	Cardiomyopathy, Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	4	heart muscle: 223.9;skeletal muscle: 156.7	Cell type enriched	Detected in some	655	Cardiomyocytes: 3256.5	Cancer enriched	Detected in some	6	head and neck cancer: 18.9	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HSkMC: 3.6;RH-30: 1.5;U-2 OS: 2.8	Not detected	Not detected			Not detected	Not detected			HPA042581	Enhanced								240000			HPA042581: AB_2678061				unprognostic (1.62e-2)	unprognostic (1.10e-1)	unprognostic (1.55e-2)				unprognostic (4.72e-2)				unprognostic (5.99e-2)	unprognostic (1.08e-1)			0.4	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	7.9	3.4	0	0	223.9	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	2.5	0	0	4.5	0	156.7	0	0	0	0	0	0	0.1	0	0	0.8	46.9	2.3	0	0	0.4	0	0.3	0.2	0.2	0.2	0	0	0	0	0.1	0	0	0.1	0.1	0	0	0	0.6	0.2	0	0.3	0	0.2	0	0	0	0	0.1	0.2	0.2	0.2	0.2	0	0.1	0.6	3.6	0	0	0	0.1	0	0.3	0.2	0.8	0	0.8	0	0	0	0	0	0.3	1.5	0	0	0.3	0	0	0	0.1	0	0.1	0	0.9	0	0.2	2.8	0.6	0.7	0	0.2	0.4	0.9	0.9	0.1	0.2	0.1	0.3	0.1	0	0	0	0.1	0	0	0.4	0.1	0.2	0.3	0.2	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3256.5	0	0	0	0	0	0	0	0	1.1	0	0	0	5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.9	0	0	0	0	0	0	0	0	0	0	0	0	0	Cardiomyocytes
PIMREG	CATS, FAM64A, FLJ10156, FLJ10491, RCS1	ENSG00000129195	PICALM interacting mitotic regulator	Q9BSJ6	17	6444415-6451469	Predicted intracellular proteins	Cell cycle, Cell division, Mitosis			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	4	lymphoid tissue: 27.3	Cell type enriched	Detected in some	4	Hofbauer cells: 5.5	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Cell type enhanced	Detected in some		NK-cell: 3.3	Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		AF22: 50.8	Low region specificity	Detected in single			Low region specificity	Detected in many			HPA043783, HPA049934	Uncertain		Enhanced	Nucleoplasm		Yes	Yes			Nucleoplasm		HPA043783: AB_2678669, HPA049934: AB_2680959	unprognostic (5.32e-3)	unprognostic (1.14e-2)	unprognostic (2.33e-1)	unprognostic (4.37e-3)	unprognostic (1.46e-1)	unprognostic (1.24e-2)	unprognostic (6.55e-3)	unprognostic (1.23e-3)	unprognostic (1.80e-1)	unprognostic (5.88e-2)	unprognostic (1.47e-3)	unprognostic (1.50e-2)	unprognostic (0.00e+0)	unprognostic (8.65e-2)	unprognostic (1.04e-1)	unprognostic (1.01e-1)	unprognostic (1.11e-1)	1.9	4.5	1.2	1.6	1.1	3.1	2.2	1	0.8	1.3	4.7	0.6	0.4	4.3	1.6	1.7	6	0.3	2.5	1.6	0.5	0.5	0.8	0.9	2.1	1.7	0.6	0.4	1.6	0.4	0	1	0.9	1.2	0.8	6.2	0.4	1.3	0.4	0.4	3.7	4.5	2.7	1	9.5	1.8	1	0.4	27.3	0.4	3.9	3.6	2.3	2	0.4	0	0.8	0.4	3.3	1.5	1.2	12.6	17.1	50.8	22.8	0.4	1.5	3.9	14.9	9.2	24.5	16.6	10.1	5.5	0	6	12.1	12.1	9.3	25.6	6.6	13.2	19.5	10.2	0	10.2	12.2	0	0.5	15.5	0.8	0.4	10.1	3.9	2.3	7.7	11.3	3	7.2	15.3	9.1	2.7	0.1	22.2	10.2	11.2	22.7	20.4	8.9	4	1.9	11.6	16.3	12.9	13.4	12.6	6.4	6.2	1.2	3.6	19.2	15.6	11.3	24.3	2.6	9.2	0	7.5	6.2	29.4	0	0	0	0	0	0	0	1.5	1.3	0	0.4	0.2	0.7	0.8	3.3	0.4	0	1.3	1.2	1.2	1.1	1	0.7	0.5	0.5	0.6	0.4	1.2	0.4	0	0	0	0	0	0	0	0	1.4	0	0	0	0.1	0	0.3	0	0	0	0	0	0.4	0	0	1.1	0	5.5	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0.1	0	0	0	Hofbauer cells
NRL	D14S46E, NRL-MAF, RP27	ENSG00000129535	Neural retina leucine zipper	P54845	14	24080107-24115014	Disease related genes, Predicted intracellular proteins, Transcription factors	Sensory transduction, Transcription, Transcription regulation, Vision	Activator, Developmental protein, DNA-binding	Disease mutation, Retinitis pigmentosa	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in many	16	retina: 124.5	Cell type enriched	Detected in many	6	Rod photoreceptor cells: 2618.0	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Cell line enhanced	Detected in many		U-266/70: 7.6	Not detected	Not detected			Not detected	Not detected			CAB026066, HPA064599	Enhanced		Supported	Nucleoplasm,Cytosol						Nucleoplasm	Cytosol	CAB026066: , HPA064599: AB_2685295	unprognostic (2.71e-2)	unprognostic (8.17e-4)	unprognostic (4.60e-2)	unprognostic (1.80e-1)	unprognostic (7.23e-2)	unprognostic (1.99e-2)	unprognostic (5.29e-2)	unprognostic (1.88e-5)	unprognostic (3.59e-2)	unprognostic (7.84e-3)	unprognostic (1.75e-3)	unprognostic (3.49e-2)	unprognostic (2.38e-5)	unprognostic (2.56e-2)	unprognostic (1.10e-1)	unprognostic (1.73e-1)	unprognostic (1.35e-3)	1.5	2.7	4.4	2.3	4.1	1	1.8	2.1	2.8	1.9	1.3	1.7	1.7	3.2	1.4	7.9	1.3	1.4	1.2	2.7	3.8	3.1	3.5	3.9	1.7	1.9	3.9	1.4	1.8	3.4	5.4	2.8	1.8	2.1	1.8	1	124.5	1.6	2.4	4.1	0.9	1.9	1	4.4	2.6	1.3	4.3	1.2	3.3	4.3	1.8	1.6	1.5	2.2	3.8	1.4	4.1	1.3	2	2.7	1.2	0.8	1.7	0.5	1.8	0.5	0.5	1.6	0.4	0.4	2.2	1	1.1	0.8	2.5	0.8	1	1.6	1	1	1.2	0.3	1.8	1.5	0.7	0.5	3.7	1.2	1.9	3.3	0.7	1	0.6	1.2	0.4	1.1	3.1	1.6	3	0.8	2.6	2.2	1.8	0.6	3.4	1.8	2.2	2.1	0.7	1.2	1.7	2	2	1.3	1.5	1.6	0.7	1.1	2.6	0.4	1.4	0.8	0.6	1.2	7.6	3.2	2.7	0.2	1.6	1.5	0	1.1	4.1	1.1	1.2	0.7	3.8	1.1	1.6	1.3	2.4	2.7	2.3	0.2	2	1.3	1.4	1	1.2	4.4	4.1	2.1	2.8	3.8	3.1	3.9	1.4	2.1	1.2	0	0.3	4.4	1.7	0.7	340	1.6	0	0	1.2	7	406.4	1	11.6	0.5	1.7	0.6	2.1	23.3	1	0.8	0.5	2.4	0	2.6	1.7	236.8	1.7	0	0.6	2.8	1.1	0.2	1.7	1	1.8	381.3	0.4	0.9	1.8	6.8	2618	0	0.5	8.2	3.4	0.4	2.1	1.5	0.9	1.6	Rod photoreceptor cells
FOXJ1	FKHL13, HFH-4, HFH4	ENSG00000129654	Forkhead box J1	Q92949	17	76136333-76141299	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors	Cilium biogenesis/degradation, Transcription, Transcription regulation	Activator, DNA-binding	Cancer-related genes, Ciliopathy, Disease mutation, Primary ciliary dyskinesia	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 19.9;epididymis: 20.4;fallopian tube: 45.9	Cell type enriched	Detected in many	5	Ciliated cells: 93.7	Cancer enhanced	Detected in many		endometrial cancer: 73.7	Low region specificity	Detected in many			Cell type enhanced	Detected in single		naive CD8 T-cell: 2.6	Lineage enriched	Detected in single	9	T-cells: 2.6	Group enriched	Detected in some	9	BEWO: 23.0;CAPAN-2: 19.2	Low region specificity	Detected in many			Region enhanced	Detected in many		midbrain: 55.6	HPA005714	Enhanced											HPA005714: AB_1078902	prognostic favorable (9.39e-4)	unprognostic (4.97e-3)	unprognostic (1.22e-1)	unprognostic (2.77e-3)	unprognostic (1.19e-1)	unprognostic (2.54e-3)	unprognostic (1.71e-3)	unprognostic (6.15e-2)	unprognostic (1.00e-2)	unprognostic (7.84e-3)	unprognostic (1.43e-2)	unprognostic (1.63e-1)	prognostic unfavorable (2.03e-5)	unprognostic (7.49e-2)	unprognostic (1.94e-1)	unprognostic (2.27e-1)	unprognostic (1.91e-1)	0.4	0.4	4.1	0.5	8.9	0.6	0.4	0.1	2.2	5.1	0.9	19.9	0.4	0.6	2.4	20.4	0.4	45.9	0.4	0.4	6.5	6.6	1.5	0.4	17	0.4	2	1.2	14.7	1.2	0.4	1.2	0.4	19.6	0.6	0.6	0.1	0.4	2.8	0.4	0.8	0.6	0.5	1.8	0.4	0.9	15.2	3.4	0	2.9	0	0.4	1.1	0.2	0	0	0	0	0.2	2.6	0.1	0	0.4	1.3	0	0	0	23	0	0	0	0	2.3	19.2	0	0.3	0	0	0	0	0	0	0.2	0	0	0	1.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	1.2	0	0.4	0	0	0.1	0	0.1	0.7	0	0	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0.1	0.7	0	0	0.6	2.6	0	0.2	0	0	0	0.1	4.1	8.9	0.1	2.2	6.5	6.6	2	1.2	19.6	3.4	8.9	1.9	0.9	1	0.7	0.4	0.8	2.5	93.7	13.6	8.7	3.9	0.1	0	0.5	19.5	0.1	0	0	0	0.5	0.3	0.3	1.1	0	0.1	0	1.7	0.6	0	11.7	0.3	0	0	0	1.1	2.5	0.2	0	0.4	0.7	6.7	0	0	8.8	1.7	0.6	0.2	1.3	1.8	0	Ciliated cells
AANAT	SNAT	ENSG00000129673	Aralkylamine N-acetyltransferase	Q16613	17	76453351-76470117	Enzymes, Predicted intracellular proteins	Biological rhythms, Melatonin biosynthesis	Acyltransferase, Transferase	Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Group enriched	Detected in some	5	retina: 27.7;testis: 8.2	Cell type enriched	Detected in some	9	Bipolar cells: 269.2	Not detected	Not detected			Low region specificity	Detected in many			Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		A549: 4.6;Daudi: 3.8;SCLC-21H: 5.7;U-266/70: 4.6;U-266/84: 4.8;U-698: 6.8	Not detected	Not detected							HPA054321			Supported	Cytosol	Intracellular and membrane					Cytosol		HPA054321: AB_2682449	unprognostic (7.89e-2)	unprognostic (2.62e-1)	unprognostic (1.41e-1)	unprognostic (2.44e-1)	unprognostic (1.83e-2)	unprognostic (2.03e-2)	unprognostic (1.05e-2)	unprognostic (3.09e-1)	unprognostic (1.01e-2)	unprognostic (3.61e-1)	unprognostic (9.30e-2)	unprognostic (4.19e-1)	unprognostic (2.81e-7)	unprognostic (1.04e-1)	unprognostic (6.00e-2)	unprognostic (4.47e-2)	unprognostic (1.34e-2)	0.3	0.2	1.2	3.8	0.8	2.7	0.3	1.3	1.6	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.8	0.4	1.8	0.3	1.2	1.5	0.3	0.3	0.3	3.3	1.7	0.7	0.4	0.3	0	0.9	0.3	1.9	0.3	0	27.7	0.3	0.3	1.8	3.3	0.7	0.3	1.2	2.2	0.2	8.2	0.3	0.3	0.8	0.3	0.3	0.9	0.3	1.3	1.3	2.2	0.1	1.8	0.2	0	0.9	4.6	0.7	0.5	0	0.1	0.5	0	0.4	0.3	0.1	0.1	3.3	3.8	0.5	0	0.7	1.2	0	0	0.3	0	1.2	0.1	0.7	0	0	0	0	0	0	0.1	0	0.2	1.2	0.4	0	2	0.4	0.6	0.1	0.1	1.2	1.5	0.4	0.2	0.2	2	0	0.1	5.7	0.4	0.1	0.2	1.6	0.6	2.8	0.7	0	0	1.8	0.2	0.1	4.6	4.8	6.8	1.2	0.4	0.8	2	0.1	2.2	0.2	0	0	0.6	0.1	0	0	1.3	0	0.2	0.6	1.8	0	1.3	0.1	0	1.2	0.8	1.3	0.9	1.2	1.5	1.7	0.7	1.9	0.3	0	0	0	0	0	269.2	0.3	0	0	0	0	11.8	0.1	0	0	5.4	0	0	0	0	0	0	0	0	0	0.1	6.4	1.2	0	0	12.3	0.3	0	0	0	0	6.6	0.2	0	0	0.3	29.7	0	0	1.7	1	0	0.1	0	0	0	Bipolar cells
LBP	BPIFD2	ENSG00000129988	Lipopolysaccharide binding protein	P18428	20	38346356-38377023	Plasma proteins, Predicted secreted proteins, Transporters	Immunity, Innate immunity, Lipid transport, Transport	Antibiotic, Antimicrobial		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	33	liver: 429.7	Cell type enriched	Detected in some	15	Hepatocytes: 356.7	Cancer enriched	Detected in many	20	liver cancer: 356.7	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	10	ASC diff: 12.4;HSkMC: 14.7	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA001508, CAB025905	Approved				Secreted to blood			25000000000	910000000			CAB025905: , HPA001508: AB_1079241	unprognostic (4.20e-2)	prognostic unfavorable (5.56e-4)	unprognostic (4.54e-2)	unprognostic (2.47e-1)	unprognostic (3.80e-2)	unprognostic (2.53e-2)	unprognostic (5.50e-2)	unprognostic (2.48e-3)	unprognostic (6.15e-2)	unprognostic (2.12e-1)	unprognostic (7.93e-2)	unprognostic (2.62e-1)	prognostic unfavorable (3.62e-12)	prognostic unfavorable (5.76e-4)	unprognostic (1.69e-1)	unprognostic (1.22e-1)	unprognostic (1.67e-1)	12.8	0	0.1	4.7	0.1	0	0.7	0.1	0.1	0.6	0.4	0.1	0.1	0	0.4	0.2	0.1	0	0.1	0.4	0.1	0	3.1	429.7	0.1	0.5	0.1	0.1	0.2	0.2	0	0.1	0.4	0.1	0.1	0	0.1	0.1	0.1	4	0	0.1	0.2	0.1	0.1	0	0.1	0.1	0.1	1.4	0.1	0.1	0.3	0.1	0	0	0	0.9	0	0	0.1	0	0.1	0.1	0	12.4	0	0.1	0	0	0.1	0	0.1	0	0.4	0.2	0	0.3	0	0	0	0	0	0	0.4	0	0	0	0.4	0.1	14.7	0.1	0	0	0	0	0	0.2	0	0	0.1	0	0.1	1.4	0	0	0	0.1	0	0	0	0	0	0.2	1.1	0	0.1	0	0.1	0.2	0.2	0.1	0.1	0	0.1	0	0.2	0.1	0.1	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0.9	0	0	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0.3	12.7	0	0	0	0	0.1	6.6	0.3	0.6	0	0	23.3	9.1	0.1	0	0	0	356.7	0.3	0	0	11.1	8.6	0	0.6	0	0	1	0	0	8.2	0	0	10.6	0	0	0	0	0.1	0	0.1	0	0	0	Hepatocytes
TNNI3	CMD2A, CMH7, TNNC1	ENSG00000129991	Troponin I3, cardiac type	P19429	19	55151767-55157773	Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins		Actin-binding, Muscle protein	Cardiomyopathy, Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	367	heart muscle: 419.3	Cell type enriched	Detected in many	56	Cardiomyocytes: 9185.5	Low cancer specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HEK 293: 7.1;HMC-1: 11.9;K-562: 21.6;OE19: 30.9	Low region specificity	Detected in many			Not detected	Not detected			CAB009349, HPA046428	Enhanced		Approved	Vesicles,Cytosol					1700000	Cytosol	Vesicles	CAB009349: AB_793465, HPA046428: AB_2679661	unprognostic (2.12e-2)	unprognostic (3.05e-2)	unprognostic (2.44e-2)	unprognostic (1.36e-1)	unprognostic (2.08e-2)	unprognostic (2.81e-2)	unprognostic (1.37e-3)	unprognostic (2.13e-1)	unprognostic (9.62e-3)	unprognostic (9.40e-2)	unprognostic (3.34e-2)	unprognostic (2.17e-3)	unprognostic (4.02e-3)	unprognostic (8.89e-2)	unprognostic (8.54e-2)	unprognostic (1.05e-1)	unprognostic (9.82e-2)	0.1	0	0.1	0.1	0.1	0	1.1	0.1	0.2	0.1	0.1	0.1	0.1	0	0.1	0.2	0.1	0.2	0.1	419.3	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.6	0	0.1	0.1	0.1	0.1	0	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0.4	0.4	0	0	0.7	0.7	0.3	0	0	0	0	2.4	0	0	0	0.2	0	0.1	0.9	3.7	0	0.6	0.5	0.7	0.1	0	0	7.1	1.7	0	1	0.3	0	11.9	0	0.3	0	0.1	0	0	0.4	21.6	0.4	0	0.3	0.1	0	0.4	30.9	0.2	0.9	0.2	0	1.1	0	0	1.2	0	0	0.1	0	1.6	5.4	0.2	0	0.6	0	0	0	0	0	0.3	2	0	0	0.4	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0.7	0.1	0.1	0.1	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0	0	0	0	6.2	0	9185.5	10.2	6.7	2.3	5.2	0	0.9	0	0.6	46.9	0.1	0	0	0.2	0.4	3.1	0	0	0	1.9	1.6	1.7	0	0	164.8	0.3	0.2	1.7	0	0.2	1.8	1.1	0	1.8	0	0.2	0	0	4.2	10.3	2.5	2.1	0	0.4	0	Cardiomyocytes
KCNA5	HK2, HPCN1, Kv1.5	ENSG00000130037	Potassium voltage-gated channel subfamily A member 5	P22460	12	5043989-5046788	Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels	Ion transport, Potassium transport, Transport	Ion channel, Potassium channel, Voltage-gated channel	Atrial fibrillation, FDA approved drug targets	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		heart muscle: 33.0	Cell type enriched	Detected in some	8	Bipolar cells: 153.4	Low cancer specificity	Detected in some			Low region specificity	Detected in many			Cell type enriched	Detected in single	134	plasmacytoid DC: 13.3	Lineage enriched	Detected in single	134	dendritic cells: 13.3	Cell line enriched	Detected in single	12	NTERA-2: 10.0	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA021516, CAB022562	Approved											CAB022562: , HPA021516: AB_2670732	unprognostic (3.87e-1)	unprognostic (9.91e-3)	unprognostic (1.94e-1)	unprognostic (3.23e-1)	unprognostic (2.64e-1)	unprognostic (7.06e-3)	unprognostic (1.20e-1)	unprognostic (4.61e-3)	unprognostic (1.34e-1)	unprognostic (2.14e-1)	unprognostic (2.37e-2)	unprognostic (5.08e-3)	unprognostic (6.73e-4)	unprognostic (1.92e-3)	unprognostic (1.90e-1)	unprognostic (2.86e-2)	unprognostic (3.08e-2)	3.4	1.4	1.9	0.9	8.6	0.7	1.2	0.4	2.3	1.6	3.3	7.2	0	1.1	1.7	2.6	7.6	2.1	2.3	33	3.5	5.8	1.9	0.8	2.3	0.9	2.3	2.2	3.2	2.4	0.6	7.5	3.4	8.8	3.7	1.3	7.2	0.9	2	5.3	0.6	1.1	3	3.9	1.2	3.3	0.8	4.9	0	1.1	3.4	1.2	4.5	3.4	0	13.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	10	0	0	0.2	0	0	0	0	0	0	0	0	0	0.8	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.3	0	0	1.9	8.6	0.4	2.3	3.5	5.8	2.3	2.2	8.8	4.9	0	0	0	0	0.8	153.4	8.6	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0.2	0	3.4	0	0	0	0	0	0	0	0	1	0.1	0	0.4	0	3.4	12.9	19.1	0	0	0.3	0.1	0	0	0	Bipolar cells
FAM155B	CXorf63, TED, TMEM28	ENSG00000130054	Family with sequence similarity 155 member B	O75949	X	69505241-69532508	Predicted membrane proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in some		heart muscle: 25.0;seminal vesicle: 6.7;thyroid gland: 10.4	Cell type enriched	Detected in some	10	Cardiomyocytes: 18.2	Low cancer specificity	Detected in many							Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		AN3-CA: 6.9;HAP1: 15.4;Hep G2: 5.6;NTERA-2: 21.3;OE19: 6.0;SCLC-21H: 10.2	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA036093	Uncertain											HPA036093: AB_10673613	prognostic unfavorable (4.61e-5)	unprognostic (1.17e-1)	unprognostic (2.14e-1)	unprognostic (5.14e-3)	unprognostic (1.45e-1)	unprognostic (2.49e-2)	unprognostic (3.09e-4)	unprognostic (7.07e-2)	unprognostic (1.19e-2)	unprognostic (4.67e-2)	unprognostic (4.94e-3)	prognostic unfavorable (1.83e-4)	prognostic favorable (6.63e-4)	unprognostic (1.46e-2)	unprognostic (3.50e-2)	unprognostic (2.21e-1)	unprognostic (8.21e-2)	0	0.5	1.4	0	1.1	0	0.1	3.5	1.4	0.1	0			0	0.2	0.3	0	0.7	0.1	25	1.1	2.1	0.5	0	0	0	1.3		0	1.8	0.9	1.1	0		0.9	0		1.1	6.7	0	0	0	0	0.4	0.6	0.5	0.8			10.4		0	0	0	0	0	0	0	0	0	0	0	2.5	0.1	6.9	0	0	0	0	0	0	0	3	0.6	0	4.3	0	0	0	15.4	0.6	0	0	4.2	0	0	5.6	0	0	0.1	0	0	0	0	0	0	0	0.7	0	0	4.8	0	0	21.3	6	0	0	0	0	0.2	0	10.2	0.7	0.1	0	0	0.7	1.1	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0.2	0	0.4	18.2	0	0	0	1.8	0	0	0	0.4	0	0	0	0	1	0	0	1.2	0	0	0.1	0	1.2	0.6	0	0	0	0	0	0	0.6	0	0.8	0	0	0.4	0.8	0	0	0.1	1.3	0	0	0	0	0.2	Cardiomyocytes
TSPAN16	TM-8, TM4-B, TM4SF16	ENSG00000130167	Tetraspanin 16	Q9UKR8	19	11296139-11326996	Predicted membrane proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	14	blood: 21.8;testis: 46.1	Cell type enriched	Detected in some	5	Late spermatids: 4024.1	Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	10	basophil: 6.9;eosinophil: 10.8;neutrophil: 21.8	Lineage enriched	Detected in many	16	granulocytes: 21.8	Cell line enhanced	Detected in some		MCF7: 3.0;THP-1: 1.1;U-937: 3.0					Not detected	Not detected			HPA076551	Enhanced											HPA076551: 	unprognostic (1.06e-1)	unprognostic (2.82e-2)	unprognostic (1.73e-2)	unprognostic (4.74e-3)	unprognostic (1.53e-1)	unprognostic (2.06e-3)		unprognostic (1.37e-1)	unprognostic (2.21e-1)	unprognostic (7.68e-2)	unprognostic (1.90e-1)	unprognostic (8.69e-4)	unprognostic (8.81e-8)	unprognostic (1.98e-1)	unprognostic (1.12e-1)	unprognostic (1.95e-3)	unprognostic (2.67e-1)	0	0	0.2	0	0	2.5	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	46.1	0	0	0	0	0	0	0	0	0.3	21.8	1.3	0	0	0.1	0	0	0	0.4	0	0	0	0	0	0	0	0	0.2	0.1	0.1	0	0.1	0	0	0	0	0	0	0.4	0	0	0	0	0.3	0	0	0	0	0.2	0	0.1	0.4	0.7	0	3	0	0.9	0.3	0	0.4	0.1	0.2	0	0	0	0	0	0	0.2	0	0.2	0.6	1.1	0	0.2	0	0.2	0.1	0	0.2	0	0	3	0	6.9	1.3	10.8	0	0.5	0	0	0	0	0.3	0	0	0	21.8	0	0.2	0	0	0.1	0.2	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	2.2	0	0	0	0	0	0	0	0	855.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4024.1	14.4	0	0	0	0	0	0	0	15.2	0	0	6.5	0	18.6	10.1	0	0	0	0	0	Late spermatids
ANGPTL8	C19orf80, RIFL, TD26	ENSG00000130173	Angiopoietin like 8	Q6UXH0	19	11237450-11241943	Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Lipid metabolism	Hormone	Diabetes mellitus	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	10	liver: 81.0	Cell type enriched	Detected in some	14	Hepatocytes: 96.9	Cancer enriched	Detected in some	37	liver cancer: 84.6	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	27	Hep G2: 26.8;MCF7: 15.5	Not detected	Not detected			Not detected	Not detected			HPA042131			Approved	Nucleoplasm,Golgi apparatus	Secreted to blood			836000	320000	Golgi apparatus	Nucleoplasm	HPA042131: AB_10794413	unprognostic (2.37e-2)	unprognostic (1.86e-1)	unprognostic (1.15e-1)	unprognostic (1.31e-2)	unprognostic (1.17e-1)	unprognostic (1.00e-1)	unprognostic (3.73e-1)	unprognostic (2.80e-1)	unprognostic (3.49e-1)	unprognostic (1.02e-1)	unprognostic (9.67e-2)	unprognostic (1.35e-1)	prognostic unfavorable (1.84e-6)	unprognostic (1.09e-1)	unprognostic (3.55e-1)	unprognostic (4.57e-1)	unprognostic (1.75e-2)	8	0.1	0	0.6	0	0	5.1	0	0.1	0.1	5.7	0	0	0.2	0.1	0.8	0.1	0.1	1	0.6	0	0	1.5	81	0.1	3	0.2	0	0.3	0.1	0	0	0.1	0	0.2	0	0	4.8	0.1	0.7	0.3	0.1	0.1	0	0.2	0.1	0.1	0	0	0.3	0	0	1.6	0.1	0	0	0	0	0	0	0	0.1	0.4	0	0.1	0	0	0	0	0	0	0	0.3	0.1	0.1	0	0	0.1	0.2	0	0	0	0.1	0.1	0.2	0.7	26.8	0.4	0	0.5	0	0	0	0	0.4	0	0	0.1	0	0	15.5	0	0.5	0.1	0	0	0.1	0.3	0.7	0	0.2	0	0.2	0.3	0.7	0	0.3	0.4	0	0	0.3	0.1	0	0	0.1	0	0.2	0.4	0.2	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0.2	0	0	0	0	0	0	0.1	0	0	0	2.5	0	0	0	0	0	0	0	0.4	0	0	0	0.2	0	0	0.1	0	96.9	0.1	0	0	6.7	5.9	1.3	0.9	0	0	0	0	1.2	0.3	0	0.4	1.8	0	0	0	0	0	0	0.2	0	0	0	Hepatocytes
APOC1		ENSG00000130208	Apolipoprotein C1	P02654	19	44914247-44919349	Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins	Lipid transport, Transport		Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	12	liver: 702.7	Cell type enriched	Detected in many	5	Hepatocytes: 27093.4	Cancer enriched	Detected in all	21	liver cancer: 3253.7	Low region specificity	Detected in many			Cell type enriched	Detected in some	8	myeloid DC: 8.9	Lineage enriched	Detected in single	13	dendritic cells: 8.9	Cell line enhanced	Detected in many		Hep G2: 100.3;HSkMC: 62.1;K-562: 26.1;SK-MEL-30: 46.2	Low region specificity	Detected in many							HPA051518	Supported				Secreted to blood			20300000000	26000000000			HPA051518: AB_2681519	unprognostic (3.51e-2)	unprognostic (3.31e-3)	unprognostic (1.14e-1)	unprognostic (2.59e-2)	unprognostic (2.06e-1)	unprognostic (1.47e-1)	prognostic favorable (1.15e-7)	unprognostic (9.51e-3)	unprognostic (1.30e-1)	unprognostic (4.18e-2)	unprognostic (1.11e-1)	unprognostic (2.52e-1)	unprognostic (7.13e-3)	unprognostic (3.48e-3)	unprognostic (1.65e-1)	unprognostic (2.01e-3)	unprognostic (1.65e-1)	1.5	58.9	6.6	1.6	30	2.4	3.6	0.6	4.4	1.5	1.8	4.9	0.3	0.9	0.6	2.5	0.4	0.8	1.8	0.4	4.1	7.8	0.6	702.7	12.6	6.1	20.2	1	4.1	1.1	0.4	2.6	2.3	6.6	0.6	1.1	1.3	2	0.4	1.2	1.4	1	0.5	11.7	9.6	1.3	1	5.2	1	0.7	0.5	1.9	1.2	0.3	0.2	8.9	0	0.6	0.2	0	0.6	0.4	4.7	2.1	0.9	6.9	7.2	20.3	0.2	0.3	0.8	1.3	9.9	8.9	1.4	1.7	0.1	0.6	0.3	2.8	0.3	0.4	0	11.4	6.4	0.6	100.3	6.1	4.7	3.3	62.1	0.5	0.8	0.3	1.7	0.2	0.3	26.1	0.1	0.3	0.6	0.2	0.3	20.4	1.8	1	1	2.9	0.1	1.3	0.3	0.9	0.6	3.3	0	46.2	7.2	0.4	17.4	0.7	0	0.3	0	0.2	0.8	0.8	1.5	0.1	1.3	0.5	0	0.1	0	0	0.6	0	0	0	0	8.9	0.2	0	0	0	0.2	0	1	0	0.6	6.6	30	0.6	3.1	4.1	7.8	20.2	1	6.6	5.2	107.2	247.1	115.1	4.2	15	1.6	0.7	451	44.2	99	1.8	0	32.3	41.4	3.4	0.9	5.6	0.5	186.9	3.5	299	64.1	1.9	139.7	27093.4	5056	0	2.4	451.8	716.3	1.3	250.8	243.1	28.7	215.6	2.2	120.9	3.3	0	244	10.9	8.3	19.4	5.9	1.4	3	15.6	59.8	137.1	2.1	4.9	Hepatocytes
GADD45G	CR6, DDIT2, GADD45gamma, GRP17	ENSG00000130222	Growth arrest and DNA damage inducible gamma	O95257	9	89605013-89606555	Cancer-related genes, Plasma proteins, Predicted intracellular proteins	Apoptosis, Differentiation	Developmental protein	Cancer-related genes	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in all		placenta: 65.6	Cell type enriched	Detected in many	8	Syncytiotrophoblasts: 1345.9	Cancer enhanced	Detected in all		prostate cancer: 79.8	Low region specificity	Detected in all			Cell type enriched	Detected in some	7	eosinophil: 8.0	Lineage enriched	Detected in single	22	granulocytes: 8.0	Group enriched	Detected in some	4	HDLM-2: 47.8;SCLC-21H: 25.2	Low region specificity	Detected in all			Low region specificity	Detected in many			HPA023606	Approved											HPA023606: AB_1849409	unprognostic (5.84e-2)	unprognostic (1.61e-2)	unprognostic (1.08e-2)	prognostic favorable (7.06e-4)	unprognostic (4.45e-2)	unprognostic (1.85e-1)	unprognostic (1.77e-3)	unprognostic (3.75e-2)	unprognostic (7.65e-3)	unprognostic (4.16e-3)	prognostic favorable (3.80e-5)	unprognostic (1.11e-1)	unprognostic (1.63e-2)	unprognostic (4.95e-1)	unprognostic (3.88e-2)	unprognostic (3.41e-1)	unprognostic (1.22e-1)	7	23.6	4.6	4.4	7.7	8.4	6.7	4.8	5.4	23.3	7.4	2.8	12	4.2	21.3	6.5	6.1	6.4	5.9	53.4	4.1	3.8	6.7	48.4	4.6	1.5	5.3	3.7	14.1	28.7	4.9	25.4	65.6	7.4	12.7	1.6	3	14.7	10.2	58	5.5	6	5.5	6.7	1.3	6.5	13	3	0.8	8.4	26.8	2.6	5.1	6.2	0	0.2	8	0.3	0	0.1	0.1	1.2	0	6.8	0	0	0	9	0.4	0	0	0	1	0.1	0	1.1	0	0.3	1	2.2	0	0	47.8	0.4	0.1	0.1	0	0.3	0	0.1	0.2	0.8	0	0	0	0.1	0	0.1	0	0	1.9	0.1	0.4	6.3	1.1	0.1	0.5	2	0.4	0	0.3	25.2	5.7	0.4	2.6	0	1.3	1	0	0.8	0	0.1	0	0	0	0	0	0	0	0	0	0.3	8	0	0	0	0	0.1	0	0.2	0	0	0	1.2	0	0	0.2	0.1	0.1	4.6	7.7	4.8	5.4	4.1	3.8	5.3	3.7	7.4	3	6	50.9	0.5	17.9	25.3	38.5	139.3	68.8	34.8	33	10.4	5.9	64.8	77.9	10.9	1.3	20.7	22.6	0	37.3	9.4	67.6	115.9	18.5	161.3	53.6	3.2	52.5	8.6	11.6	7.4	78.2	47.7	33.7	19	25.9	28.3	24.6	5.7	42.8	35.3	19.1	129.4	86.5	1.1	1.6	17.1	1345.9	12.1	9.3	8.4	Syncytiotrophoblasts
IQCN	KIAA1683	ENSG00000130518	IQ motif containing N	Q9H0B3	19	18257097-18274509	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	11	testis: 59.9	Cell type enriched	Detected in some	13	Alveolar cells type 2: 58.5	Low cancer specificity	Detected in many			Low region specificity	Detected in single			Cell type enhanced	Detected in many		neutrophil: 5.3	Low lineage specificity	Detected in all			Cell line enhanced	Detected in many		A549: 5.9									HPA042409	Enhanced											HPA042409: AB_10794421	unprognostic (1.36e-3)	unprognostic (5.42e-3)	unprognostic (2.21e-1)	unprognostic (1.70e-1)	unprognostic (1.05e-1)	unprognostic (2.15e-4)	unprognostic (9.79e-2)	unprognostic (9.53e-3)	unprognostic (5.44e-2)	unprognostic (1.12e-1)	unprognostic (1.64e-4)	unprognostic (4.17e-2)	unprognostic (2.58e-1)	unprognostic (1.88e-1)	unprognostic (7.68e-2)	unprognostic (1.30e-1)	unprognostic (4.92e-3)	0.8	0.2	0.7	0.7	0.7	2.3	1.2	1.5	0.7	1.7	0.7	0.7	0.7	0	2.7	1.6	0.7	2.4	0.7	0.7	0.7	0.6	1	2.7	1.5	0.7	0.7	0.7	2.7	0.8	0.4	1.6	0.7	0.7	0.8	0.4	0.7	0.7	0.7	1.3	2.2	1	1	0.7	1.4	0.8	59.9	0.7	0.7	2	0.7	0.7	0.7	0.9	2.4	2	5.3	1	1.3	1.2	0.4	0	5.9	0.9	3.6	1.6	2.8	1	0.8	0.7	0	0.4	1.9	2	1.5	0.6	1.8	1	0.1	0	0.6	0	1.6	0.4	2.2	2.2	1.2	0.2	0.4	0.7	1.5	0.5	0.5	1.1	3.3	0.7	0.3	0.3	1.7	0	2.3	0.7	1	0.7	1.5	0	0.5	0	0.6	0.9	1.4	2.7	0.6	0.5	0.9	1.3	2	2	0.7	0	0.2	0.7	2.1	0	0.8	0.5	0.5	1.2	0.1	0	1.4	1	0.8	1.1	0.4	0.5	1	1	0.4	0.3	2.4	1.2	0.9	5.3	1.3	0.4	2	0.7	0.4	0.7	0.7	1.5	0.7	0.7	0.6	0.7	0.7	0.7	0.7	3	58.5	0	0	0	0	0	0	4	2.3	1.8	0	1.2	0	1.6	0	0	0	0	0.8	0.3	0	0	4.7	0	2.4	0	0	0	0	0	0	0	0	1.8	0	0	0.8	0	0	0.2	0	0	0	0	0	0	1.5	0	0	0	Alveolar cells type 2
HRC	MGC133236	ENSG00000130528	Histidine rich calcium binding protein	P23327	19	49151198-49155424	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	5	heart muscle: 155.8;skeletal muscle: 82.1	Cell type enriched	Detected in some	18	Cardiomyocytes: 1159.6	Low cancer specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	6	Hep G2: 6.4;HSkMC: 6.6;K-562: 8.7;THP-1: 15.6;U-266/84: 4.7	Not detected	Not detected			Not detected	Not detected			HPA004833	Enhanced				Intracellular and membrane				23000			HPA004833: AB_1079083	unprognostic (1.06e-1)	unprognostic (1.04e-3)	unprognostic (1.46e-2)	unprognostic (4.94e-2)	unprognostic (5.66e-2)	unprognostic (9.75e-3)	unprognostic (3.44e-1)	unprognostic (1.74e-1)	unprognostic (4.09e-1)	unprognostic (1.62e-1)	unprognostic (7.41e-3)	unprognostic (5.85e-3)	unprognostic (4.04e-2)	unprognostic (6.68e-2)	unprognostic (1.07e-1)	unprognostic (1.86e-1)	unprognostic (1.46e-1)	2.4	0.8	0.2	0.1	0.5	0	0.8	0	0.6	1.6	0.3	0.3	0.3	0.2	1.8	4.3	1.3	1	0.5	155.8	0.2	0.2	0.7	0.4	0.3	0.4	0.4	0.3	0.7	0.3	0.4	0.2	0.4	0.3	1.4	0.2	1.3	1.4	0.6	82.1	0.3	0.3	0.5	0.2	0.1	0.2	0.7	0.1	0	1.7	25.9	2	0.4	0.6	0.5	0.1	0.9	0.5	0.2	0.3	0	0.1	0	0.5	0	0	0	0.1	0	0	0	0	1.1	0	0.1	0	0	0.1	0.1	0	0	0	0	0.8	0.1	0.5	6.4	0	0	1.3	6.6	0	0	0	0	0	0	8.7	0	0	0.1	0	0	0.3	0.7	0.1	0.2	0.1	0	0	0	0	0	0	0.1	0	0	0.3	15.6	0.2	0	0	0.3	0	0.1	4.7	0	0	0	0.3	0.9	0	0.3	0	0.5	0.3	0	0	0	0	0.5	0	0.2	0.2	0.2	0.4	0.1	0.2	0	0.2	0.5	0	0.6	0.2	0.2	0.4	0.3	0.3	0.1	0	0	0	0.2	0.2	0	1159.6	0	0	0	0	0	0.1	0	0	0	0.6	1.3	0	0.2	0	0.7	0.1	0	0.4	0.1	3.2	1.2	0.6	0	0	7.8	0	3.3	0	2.8	1	0.1	0	7.8	0	0.1	64.7	36.8	0	0.1	0.1	0.1	0	1.2	0.1	Cardiomyocytes
SAG	ARRESTIN, RP47	ENSG00000130561	S-antigen visual arrestin	P10523	2	233307816-233347055	Disease related genes, Predicted intracellular proteins			Congenital stationary night blindness, Retinitis pigmentosa	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	26	retina: 215.8	Cell type enriched	Detected in some	6	Rod photoreceptor cells: 5320.5	Not detected	Not detected			Region enriched	Detected in single	39	basal ganglia: 8.4	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			HPA004946	Enhanced											HPA004946: AB_2667304	unprognostic (4.76e-2)	unprognostic (1.94e-2)	unprognostic (4.52e-3)	unprognostic (3.95e-1)	unprognostic (8.54e-2)	unprognostic (2.89e-2)	unprognostic (3.86e-2)	unprognostic (2.26e-2)	unprognostic (1.78e-1)	unprognostic (4.54e-1)	unprognostic (4.57e-2)	unprognostic (3.02e-1)	unprognostic (1.12e-9)	unprognostic (2.56e-1)	unprognostic (1.61e-1)	unprognostic (2.85e-1)	unprognostic (1.03e-5)	0	0	0.2	0	8.4	0	0	0	0	0.3	0	0	0	0	0.5	4.3	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	215.8	0	0	0	0.4	0	0	0	0	0	4.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	8.4	0	0	0	0	0.1	0	0	0	0	0	0	1.1	0.2	490.5	0.8	0	0	0	0	818.8	1.4	0	0	32.2	0.4	0.6	0	0	0.1	0.2	0.9	0	0	0.1	319.4	0	0	1.9	85	0.9	0.3	0	0	0	667.1	0	0	0	0	5320.5	12.9	0.5	1.5	1.1	0.5	0.3	1	0	1.3	Rod photoreceptor cells
CYP2E1	CYP2E	ENSG00000130649	Cytochrome P450 family 2 subfamily E member 1	P05181	10	133520406-133561220	Cancer-related genes, Enzymes, Predicted intracellular proteins	Fatty acid metabolism, Lipid metabolism	Monooxygenase, Oxidoreductase	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	87	liver: 802.4	Cell type enriched	Detected in many	65	Hepatocytes: 5979.1	Cancer enriched	Detected in some	278	liver cancer: 265.3	Not detected	Not detected			Cell type enhanced	Detected in some		MAIT T-cell: 3.9;myeloid DC: 9.1	Group enriched	Detected in many	17	dendritic cells: 9.1;T-cells: 3.9	Cell line enhanced	Detected in many		HaCaT: 9.8;HL-60: 7.6;HMC-1: 8.1;NB-4: 20.6	Not detected	Not detected			Not detected	Not detected			HPA009128, HPA029564	Enhanced		Approved	Endoplasmic reticulum,Mitochondria	Intracellular and membrane					Endoplasmic reticulum, Mitochondria		HPA009128: AB_1078613, HPA029564: AB_10602213	unprognostic (6.32e-2)	unprognostic (1.51e-2)	unprognostic (3.83e-5)	unprognostic (1.27e-1)	unprognostic (3.37e-2)	unprognostic (1.26e-1)	unprognostic (2.92e-3)	unprognostic (6.36e-3)	unprognostic (2.41e-2)	unprognostic (1.49e-1)	unprognostic (1.63e-1)	unprognostic (3.21e-2)	unprognostic (1.70e-4)	unprognostic (1.72e-1)	unprognostic (8.36e-2)	unprognostic (3.78e-1)	unprognostic (9.59e-2)	0.1	0	0.1	0.1	0.2	0	0.1	0.6	0.3	0.1	0.1	0.2	0.7	0	0.1	0.3	0.8	0.2	1.3	0.1	0.1	0.1	0.3	802.4	0.1	0.1	0.1	0.1	0.1	0.4	0	0.1	0.1	0.3	0.1	0	0.2	0.1	1.1	0.1	0.6	0.1	0.1	0.1	0.4	0.1	0.3	0.1	0.1	0.2	0.2	1.5	0.1	0.1	0	9.1	0	0.3	0.2	3.9	0.3	0.1	0	0.3	0.9	3.2	1.8	0.7	1.4	4	0	0.3	0	2.4	1.3	0.2	0.4	0	9.8	0	0.2	0.3	0.2	1.4	1.5	0.1	1.1	0.5	7.6	8.1	0.9	0.2	0	0.6	1.7	0	2.8	0.5	0.4	0.9	0.6	0.5	20.6	5.6	3.7	0.4	0.3	5.5	0	1.8	0	0	0	3.7	0	0.6	0.1	0.2	0.8	0	1.3	0.4	2	0.9	2	0.8	2.8	1.3	6.4	0.1	0	0	0	0.1	0	3.9	0	1.7	1	9.1	0	0.1	0	0	0.2	0.3	0.1	0	0.3	0.1	0.2	0.6	0.3	0.1	0.1	0.1	0.1	0.3	0.1	0	0.6	21	0.2	2.1	4.5	2.2	50.9	2.7	2.3	0	2	0	0	0.3	1.3	0.4	0	23.3	1.2	0.1	0.4	0.5	1.1	5979.1	0	7.9	0	68.2	91.8	1.9	1.4	0	0	0	0	1	2.6	0	2.5	0	5.2	0	0.5	3.6	2.2	6.6	0.1	8.7	0	0	Hepatocytes
HSD17B3	SDR12C2	ENSG00000130948	Hydroxysteroid 17-beta dehydrogenase 3	P37058	9	96235306-96302152	Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins	Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis	Oxidoreductase	Disease mutation, Pseudohermaphroditism	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	7	testis: 41.9	Cell type enriched	Detected in some	8	Leydig cells: 100.1	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	5	HBEC3-KT: 5.0;HEL: 4.4;U-2 OS: 8.6	Not detected	Not detected			Not detected	Not detected			HPA056833	Enhanced		Approved	Vesicles						Vesicles		HPA056833: AB_2683252	unprognostic (2.78e-1)	unprognostic (6.61e-3)	unprognostic (1.03e-1)	unprognostic (5.76e-2)	unprognostic (1.15e-1)	unprognostic (1.55e-1)	unprognostic (3.08e-2)	unprognostic (6.15e-2)	unprognostic (1.74e-1)	unprognostic (5.13e-2)	unprognostic (3.26e-4)	unprognostic (3.45e-1)	unprognostic (5.48e-8)	unprognostic (8.47e-3)	unprognostic (1.15e-1)	unprognostic (7.24e-2)	unprognostic (3.11e-2)	0.5	0.4	1	0.5	1	0.4	0.5	0.5	0.9	0.8	0.5	0.5	0.5	0.4	0.5	0.5	0.5	1.3	0.5	0.5	1.7	0.5	1	6.3	0.5	0.5	1.6	0.5	0.5	1.3	0.4	0.5	0.5	0.5	0.8	0.4	0.5	0.5	0.5	0.5	0.5	1.1	0.5	1.9	0.5	0.4	41.9	0.5	0.5	4.5	0.5	0.5	0.5	0.5	0	0.3	0	0	0	0	2.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5	0	0	0	4.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0.2	0	1.2	0	0	0	0	0	0	0	0	0	0	0	0	0	8.6	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	2.1	1	1	0.5	0.9	1.7	0.5	1.6	0.5	0.5	0.5	0	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0	3.5	0.4	0.3	0	0.4	0	0.2	0.1	0	1.6	0	0	1.7	0	0	7.8	100.1	0	0	0	0.2	0.5	0.1	0	12	0	0.2	0	0.5	0.3	1.9	0.3	0.1	0	0.2	0	Leydig cells
C1QL1	C1QRF, C1QTNF14, CRF	ENSG00000131094	Complement C1q like 1	O75973	17	44959693-44968071	Plasma proteins, Predicted secreted proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 42.5	Cell type enriched	Detected in some	51	Horizontal cells: 635.6	Cancer enriched	Detected in all	7	glioma: 116.0	Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in many		SCLC-21H: 18.2;SH-SY5Y: 13.0;U-2 OS: 45.6;U-251 MG: 13.7;U-87 MG: 14.7	Low region specificity	Detected in many			Low region specificity	Detected in all								Secreted in brain								unprognostic (6.37e-2)	unprognostic (1.13e-1)	unprognostic (2.29e-1)	unprognostic (3.63e-3)	unprognostic (3.15e-2)	unprognostic (2.05e-2)	unprognostic (7.65e-2)	unprognostic (3.40e-3)	unprognostic (2.34e-1)	unprognostic (6.64e-3)	unprognostic (1.49e-2)	unprognostic (1.44e-1)	prognostic unfavorable (1.31e-8)	unprognostic (2.67e-2)	unprognostic (1.05e-1)	unprognostic (1.61e-2)	unprognostic (3.04e-1)	2.5	2.3	20.2	2	9.7	1.3	1.5	4.9	42.5	1.6	2.9	12.7	0	5.2	5	2	2.5	1.8	1.8	1.8	14.4	16.3	6.4	1.4	1.3	1.3	13.3	10.4	1.3	4.3	1.2	0.7	1.3	35.2	11.6	1.8	10.3	1.4	1.4	1.2	1.6	3.9	2.5	12.8	1.3	4.4	1.6	8.5	0	1.4	0	1.2	2.3	0.4	0	0	0	0	0	0	0	2.2	2.6	0.6	9.2	0.2	0	0.2	0.3	0.4	0.3	0.8	0.3	0.3	0.1	1.5	0.2	2.8	0.3	1.5	0.1	0.1	5.9	3.9	0	4.2	0	1.1	0	1.1	0.2	0	0.4	0.1	3.2	0	1.6	0	0.1	0.2	0.5	1.9	0	1.5	0.2	5.6	3.2	0.1	0.1	0	0.2	18.2	13	7.8	0.7	0.6	0.5	2.1	0.1	0	0.7	45.6	0.5	13.7	0.5	0	0	14.7	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	20.2	9.7	4.9	13.9	14.4	16.3	13.3	10.4	35.2	8.5	0	0	0	0.2	0.2	6.4	0.8	5.1	0	0	0	9.8	0	0	0	0	0	0	0	0	0.1	0.7	0.2	0	0	0	635.6	5.1	0	0	0	0.3	0	0	0	0	12.4	0.1	0	0	0	10.6	0	0.3	0.2	1	0	0	0	0	0	Horizontal cells
GFAP	FLJ45472	ENSG00000131095	Glial fibrillary acidic protein	P14136	17	44903161-44916937	Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins			Disease mutation, Leukodystrophy	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	61	brain: 595.5	Cell type enriched	Detected in some	8	Muller glia cells: 48.9	Cancer enriched	Detected in some	368	glioma: 2468.0	Low region specificity	Detected in all			Cell type enhanced	Detected in many		neutrophil: 9.8	Group enriched	Detected in many	5	granulocytes: 9.8;NK-cells: 2.9	Cell line enhanced	Detected in many		U-87 MG: 9.6	Low region specificity	Detected in all			Low region specificity	Detected in all			CAB000039, HPA056030, HPA063513	Enhanced	Supported	Supported	Intermediate filaments		No	No		220000000	Intermediate filaments		CAB000039: AB_10013382, HPA056030: AB_2683015, HPA063513: AB_2685027	unprognostic (1.79e-2)	unprognostic (2.74e-1)	unprognostic (9.83e-2)	unprognostic (2.12e-5)	unprognostic (4.08e-1)	unprognostic (5.09e-1)	unprognostic (1.26e-1)	unprognostic (6.53e-2)	unprognostic (6.57e-3)	unprognostic (7.35e-2)	unprognostic (5.86e-2)	unprognostic (1.24e-1)	unprognostic (7.63e-2)	unprognostic (2.75e-5)	unprognostic (1.49e-1)	unprognostic (1.66e-1)	unprognostic (1.64e-1)	3	2.9	122.2	3.2	105.4	5.8	3	33.9	595.5	2.7	3	171	0	2.8	2.9	3	3.6	3.2	3.1	4	143	175.1	3	2.8	3	3.1	227	67.3	3	3	3.4	1.3	2.8	212.7	3	2.9	0	3.1	2.9	3.2	3.3	2.8	2.9	482	3	3	2.9	119	0	3	0	2.9	3.4	0	1.1	0.8	9.8	1.2	2.9	0.8	0.3	1.7	1.1	2	3.8	0	0.8	0.5	1.7	2.1	2.5	2.1	2.2	2.5	3.5	3.2	0.9	1.4	4.3	2.2	0.7	3	4.3	1.9	2.9	2.9	1.5	0.1	0.8	4.3	0.2	1.3	1.7	0	2.6	0	3.7	1.3	8.5	0.6	2.2	3	4.2	2.8	0.2	5.3	1.2	1.3	2.8	1.1	1.5	2.7	3	0.5	3.5	0.3	1.7	2.3	2.2	1.2	2.1	1.6	1.9	2.6	1.2	2.3	2.8	9.6	3.5	3.4	1.9	1.2	0.5	0.5	1.1	0.4	0.4	0.5	0.7	0.3	1.1	0.6	0.8	9.8	2.9	0.7	0.8	0.4	0.3	122.2	105.4	33.9	69.4	143	175.1	227	67.3	212.7	119	0	0	0	0	0	0.7	4.2	0	0	0	0	5.9	0	0	0.1	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	48.9	0	0	0	0	3.3	0	0	0	0.1	0	0	0	0	0.1	Muller glia cells
PYY	PYY1	ENSG00000131096	Peptide YY	P10082	17	43952738-44004469	Predicted secreted proteins		Hormone		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	9	intestine: 40.0	Cell type enriched	Detected in some	360	Intestinal endocrine cells: 18684.3	Group enriched	Detected in many	8	endometrial cancer: 7.9;ovarian cancer: 15.2;testis cancer: 18.0	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in many		HMC-1: 7.9	Region enriched	Detected in single	22	pons and medulla: 1.4	Not detected	Not detected			HPA010973, CAB016734	Enhanced				Secreted to blood			87100				CAB016734: AB_876471, HPA010973: AB_1855194	unprognostic (8.17e-3)	unprognostic (5.41e-2)	unprognostic (9.93e-2)	unprognostic (1.81e-3)	unprognostic (2.48e-4)	unprognostic (5.26e-2)	unprognostic (4.14e-2)	unprognostic (1.80e-2)	unprognostic (1.75e-2)	unprognostic (1.54e-2)	unprognostic (2.91e-1)	unprognostic (1.29e-1)	unprognostic (5.69e-3)	unprognostic (3.77e-2)	unprognostic (1.79e-1)	unprognostic (1.41e-1)	unprognostic (1.20e-1)	0.1	0.8	0.1	2	0.2	0	0.2	0.1	0.1	0.1	40	0.1	0.1	1.2	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.2	0.6	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0	0.1	0.1	0.5	0.1	20.6	0.1	0.1	0.3	0.1	0	24.8	0.1	0.1	0.1	0.1	1	0.1	4.2	0.2	0.1	0.1	0.1	0.1	0.9	0.1	0	0.1	0	0.4	0	0.2	0.6	0.7	1.3	1	1.7	0.2	1.2	0.3	1.4	0.8	1.3	0.9	0.7	1.6	1.4	1.1	0.7	1.1	0.4	0.9	3.2	0.6	1.8	0.5	0.2	1.2	0.5	7.9	2.3	0.4	1.3	0.6	1.7	0.3	0.7	0.4	1.3	1.2	1.7	0.5	1	1.6	1.2	0.7	0.4	0.3	0.2	2.1	0.1	1.3	0.3	0.7	0	2.1	1.1	1.2	0.1	1.3	1.6	1.4	0.3	1.1	0.1	1.2	0.2	1.8	0.1	0.6	0	0.1	0	0	0	0	0	0	0	0.1	0.9	0	0.4	0	0	0	0	0	0	0.1	0.2	0.1	0.1	0.1	0.2	0.1	0.1	0.5	0.1	0	0	0	0	0	0	0.6	0	0	0	0	0	0	1.7	0	0.8	0	27.6	0	0	0	0	0	9.2	0	0	0	18684.3	0	0	0.8	0	0	0	0	51.9	0	0	25.9	0	0	0	0	0	2.3	4.5	0.1	0	0	32.3	0	Intestinal endocrine cells
TEX101	CT131, MGC4766, SGRG, SPATA44	ENSG00000131126	Testis expressed 101	Q9BY14	19	43401496-43418597	Predicted membrane proteins, Predicted secreted proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	62	blood: 24.5;testis: 56.6	Cell type enriched	Detected in some	15	Spermatocytes: 911.6	Low cancer specificity	Detected in some			Not detected	Not detected			Cell type enriched	Detected in single	246	basophil: 24.5	Lineage enriched	Detected in single	246	granulocytes: 24.5	Cell line enhanced	Detected in many		THP-1: 4.9									HPA041915, HPA042513	Enhanced				Secreted in male reproductive system							HPA041915: AB_10795268, HPA042513: AB_10795507	unprognostic (2.50e-2)	unprognostic (5.67e-4)	unprognostic (2.64e-1)	unprognostic (6.89e-2)	unprognostic (1.87e-1)	unprognostic (5.78e-4)		unprognostic (1.70e-1)	unprognostic (2.84e-2)	unprognostic (6.54e-2)	unprognostic (4.06e-1)	unprognostic (2.49e-2)	unprognostic (1.67e-7)	unprognostic (8.83e-2)	unprognostic (2.24e-1)	unprognostic (7.49e-2)	unprognostic (7.04e-2)	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0	0.1	0.1	0.5	0	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.6	0	0.1	0.1	0.1	0.1	0.1	0.1	0.4	0.1	0.1	0.5	0.2	0.1	0.1	0.1	0	56.6	0.1	0.1	0.1	0.1	0.4	0.1	0.3	0	0	24.5	0	0	0	0	0.9	0.6	1.3	0.7	1	2.4	0.7	0.4	0.6	1	1	0.2	0.4	0.4	1	1.6	1.1	0.4	0.4	1	0.7	1.2	0	0.3	1.3	0.4	2	0.4	0.9	1.2	1.6	0.1	1	0.9	2	1.1	0.3	1	1.1	0.2	0.6	1	0.7	0.8	1	2.7	0.2	1.3	2.3	0.2	0.9	0.4	0.3	0.8	2.3	0.7	0.3	4.9	0.4	0.8	0.8	0.8	1.4	1	1.2	0.6	0.9	0.7	0.6	24.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	13.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	25.7	6.1	0	0	0	0	0	0	0	2.1	0	0	32.3	0	911.6	62.4	0	0	0	0	0	Spermatocytes
SLC34A1	NAPI-3, NPT2, NPTIIa, SLC11, SLC17A2	ENSG00000131183	Solute carrier family 34 member 1	Q06495	5	177379235-177398848	Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters	Ion transport, Sodium transport, Symport, Transport		Disease mutation	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	79	kidney: 94.5	Cell type enriched	Detected in some	16	Proximal tubular cells: 128.7	Cancer enriched	Detected in single	12	renal cancer: 1.8	Not detected	Not detected			Cell type enhanced	Detected in single		naive CD8 T-cell: 1.1	Lineage enriched	Detected in single	12	T-cells: 1.1	Group enriched	Detected in some	12	HEL: 6.7;U-937: 4.4	Not detected	Not detected			Not detected	Not detected			HPA051255, HPA077175	Approved		Approved	Nucleoplasm,Nuclear speckles,Plasma membrane,Mitotic spindle,Cytosol		Yes				Nuclear speckles, Plasma membrane	Nucleoplasm, Mitotic spindle, Cytosol	HPA051255: AB_2681409, HPA077175: 	unprognostic (1.17e-1)	unprognostic (3.33e-3)	unprognostic (1.49e-1)	unprognostic (3.49e-2)		unprognostic (1.56e-3)	unprognostic (2.28e-1)	unprognostic (4.50e-2)	unprognostic (4.43e-3)	unprognostic (1.91e-1)	unprognostic (1.14e-1)	unprognostic (5.95e-2)	unprognostic (1.23e-3)	unprognostic (1.38e-1)	unprognostic (2.01e-1)	unprognostic (1.28e-2)	unprognostic (4.66e-2)	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	94.5	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.1	0.6	0	0	0.2	0	0	0	0	0	0	0	0	0.1	0.1	0.1	0.1	0	0.1	0.4	0	0.1	0	0.2	0	6.7	0	0.1	0	0	0	0	0	0	0	0	0	0.3	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	4.4	0.1	0	0	0	0.5	0	0	0	0	0	0	0	0	1.1	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0.9	0	0	0	7	0	0	8.3	0	0	0	0	0	0	0	0	0	0	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	128.7	0	0	0	0	0	0.5	0	0	0	0	Proximal tubular cells
F12		ENSG00000131187	Coagulation factor XII	P00748	5	177402140-177409576	Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins	Blood coagulation, Fibrinolysis, Hemostasis	Hydrolase, Protease, Serine protease	Disease mutation, FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	26	liver: 180.1	Cell type enriched	Detected in many	8	Hepatocytes: 391.6	Cancer enriched	Detected in many	21	liver cancer: 171.0	Not detected	Not detected			Group enriched	Detected in some	5	classical monocyte: 2.5;eosinophil: 6.9	Group enriched	Detected in many	5	granulocytes: 6.9;monocytes: 2.5	Cell line enhanced	Detected in some		HDLM-2: 8.7;MCF7: 11.1;PC-3: 8.2;SH-SY5Y: 5.6;U-937: 5.8	Low region specificity	Detected in some			Low region specificity	Detected in some			HPA003825	Approved				Secreted to blood			1040000	6600000000			HPA003825: AB_1078790	unprognostic (9.75e-2)	unprognostic (1.71e-1)	unprognostic (2.93e-1)	unprognostic (4.47e-2)	unprognostic (1.01e-1)	unprognostic (2.32e-1)	prognostic favorable (4.63e-5)	unprognostic (6.97e-2)	unprognostic (1.26e-2)	unprognostic (3.96e-2)	unprognostic (4.41e-1)	unprognostic (6.54e-2)	prognostic unfavorable (7.09e-4)	unprognostic (4.11e-2)	unprognostic (3.69e-1)	unprognostic (3.40e-6)	unprognostic (6.48e-2)	0.1	0	0.1	0.1	0.1	0.7	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0	0.1	0.1	0.1	0.1	0.2	180.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.5	1	6.9	2.5	0.7	0.3	1	0.8	2	0	0.6	0	0	0.2	0	0.1	0	0	2.3	1.4	0	0.4	0	0.3	1.4	0.7	0.4	0	8.7	1.9	1.4	0.3	0.9	0.2	0.7	3.1	0.2	1.3	0.1	0.4	0.1	0.2	2.1	0.4	3.3	0	11.1	0.1	2.6	0	2.6	8.2	0.6	0.2	1.9	1.1	0	2.6	5.6	0.3	1	0.7	0	0.4	0	0	0.2	1.1	0	0.3	0.5	0	0.1	0.1	5.8	0.6	0	2.5	6.9	0.3	0.1	0.2	0.5	0.3	0.2	0.1	0.2	0	0.1	0.9	0.7	0.9	1	0	1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	8.5	7.4	29.5	0.4	0.8	17.8	0	0	1.8	3.9	0	0	6.1	19.4	0.7	34.8	0	3.5	0.2	0.9	2	0	391.6	0.5	0	9.9	17.8	13.2	32.7	0.6	1.8	8.5	1	5.5	0.2	9.4	20.1	0	9.1	0.5	0	0.7	13	12.8	47.4	0.1	0.7	30.8	5.8	Hepatocytes
NAPSA	KAP, Kdap, NAP1, NAPA	ENSG00000131400	Napsin A aspartic peptidase	O96009	19	50358477-50365830	Enzymes, Plasma proteins, Predicted secreted proteins		Aspartyl protease, Hydrolase, Protease		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	10	kidney: 47.5;lung: 153.3	Cell type enriched	Detected in many	5	Alveolar cells type 2: 2552.8	Cancer enriched	Detected in many	18	lung cancer: 249.9	Not detected	Not detected			Cell type enhanced	Detected in some		plasmacytoid DC: 10.5	Group enriched	Detected in many	9	B-cells: 5.1;dendritic cells: 10.5	Cell line enriched	Detected in some	24	U-698: 29.8	Low region specificity	Detected in single			Low region specificity	Detected in all			CAB009591, HPA045280, HPA047236, HPA047744	Enhanced				Secreted in other tissues				380000			CAB009591: , HPA045280: AB_2679283, HPA047236: AB_2679993, HPA047744: AB_2680143	unprognostic (5.36e-2)	unprognostic (4.77e-2)	unprognostic (1.64e-3)	unprognostic (1.78e-1)	unprognostic (1.93e-1)	unprognostic (4.65e-2)	unprognostic (1.02e-1)	unprognostic (8.30e-3)	unprognostic (2.29e-1)	unprognostic (2.23e-2)	unprognostic (1.76e-3)	unprognostic (7.67e-3)	prognostic favorable (1.21e-4)	unprognostic (4.08e-4)	unprognostic (3.29e-1)	unprognostic (9.83e-3)	unprognostic (7.26e-5)	0.1	0.1	0.1	0.2	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	5	0.1	0.1	0.1	0.1	0.1	0	47.5	0.1	153.3	0.1	0.1	0.1	0.1	0.1	0	0.1	0.5	0.3	0.1	0	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.3	0.1	0.1	0.1	0.1	5.1	10.5	0.5	0.9	0.5	0.6	1.1	0.2	0.4	0	0.2	0.2	0.2	0.1	0.1	0	0	0.1	0.1	0.4	0.2	0.2	0.1	0	0.5	0.1	0	0	0.2	0.6	0	0	0	0.2	0	0.2	0.3	1.2	0.1	0	0.1	0	0	0.3	0.1	0	0.6	0.1	0.3	0.2	0.3	0.3	0.6	0	0.1	0.9	0	0	0.1	0.3	0	0.1	0.1	0.1	0.3	0.1	0	0.1	0.8	0	0.2	0.4	29.8	0	0.1	0	0	0.4	0	0.1	0.9	0	5.1	0.2	0.4	3	1.9	0.6	0.5	0.5	0.5	0.9	10.5	0	1.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.3	0.1	485.3	2552.8	8	0.4	0.1	1.3	0.4	0	29.4	84.2	43.6	3.9	0.4	8.3	0.4	34.9	0.1	0.9	0	0.7	0.2	0.2	0.6	64	0	0.3	0	0	0	0.3	4.5	0.9	4	0	0	0.9	1.3	0.1	2.8	0.4	230.9	0.7	0	0.3	0.5	0.7	0.5	0.1	0	0.8	0	Alveolar cells type 2
AOC2	DAO2, RAO	ENSG00000131480	Amine oxidase, copper containing 2	O75106	17	42844600-42850707	Enzymes, Predicted intracellular proteins	Catecholamine metabolism	Oxidoreductase		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	11	retina: 133.5	Cell type enriched	Detected in some	9	Early spermatids: 28.8	Cancer enhanced	Detected in some		testis cancer: 3.8	Low region specificity	Detected in many			Cell type enriched	Detected in single	4	neutrophil: 4.0	Lineage enriched	Detected in single	6	granulocytes: 4.0	Cell line enhanced	Detected in many		ASC diff: 14.3	Low region specificity	Detected in all			Not detected	Not detected			HPA057779	Uncertain				Intracellular and membrane							HPA057779: 	unprognostic (3.79e-2)	unprognostic (2.33e-1)	unprognostic (5.10e-4)	unprognostic (1.90e-2)	unprognostic (1.48e-2)	unprognostic (2.42e-1)	unprognostic (4.63e-2)	unprognostic (2.63e-2)	unprognostic (1.39e-1)	unprognostic (3.64e-2)	unprognostic (2.16e-2)	unprognostic (8.27e-3)	unprognostic (4.55e-5)	unprognostic (3.55e-2)	unprognostic (2.73e-1)	unprognostic (1.63e-2)	prognostic favorable (2.47e-4)	11.6	1.2	0.9	1.3	3.2	1.8	3.1	3.2	1.6	1.5	1.1	0.9	0.9	0.6	1.5	1.2	1	1.5	1.5	1.3	1.2	1.8	0.9	3.6	2.2	1	0.9	0.9	1	1.2	0.8	2.1	0.9	0.9	1.3	0.5	133.5	1.2	1.2	1.4	1.2	1	1.3	1	1.7	0.7	6.5	0.9	1	1	0.9	1.2	1.6	0.9	0.1	0	4	0	0	0.6	0	0.2	2.8	0.6	3.1	14.3	1.4	7.4	0.9	0.9	2	2.8	2.2	0.3	1.1	1.4	0.3	0.9	1.2	2.7	0.7	4.1	2.3	7.3	0.4	1.3	2.2	0.9	0.4	2.8	2.2	2.5	1.9	2.9	0.4	0.5	3.8	0.7	2.6	0.6	0.3	0.6	1.1	1.1	0.3	0.9	1.4	2.9	2.3	0.4	4.4	1	0.6	0.1	1	4	6	0.5	0.2	0.5	1.9	4.1	2.5	1.2	5.7	5.6	1.1	0.5	2.6	1	0	0	0.8	0	0	0.6	0.1	0	0	0	0	0.2	0	4	0	0	0	0	0	0.9	3.2	3.2	1.6	1.2	1.8	0.9	0.9	0.9	0.9	0	0.3	0	0.5	0.9	0.2	0.3	0	0	1.2	0	2	0.1	0	0.4	28.8	0.7	0	0	0.3	0.1	0.2	0.7	0	0.8	0.1	0	0	0.6	0.8	3.3	0.3	0	0	0	0.1	0.3	0.2	0	0	0.2	0.6	0	0.9	2.1	2.7	1.4	0	0	0	0.5	Early spermatids
G6PC	G6PT, GSD1a	ENSG00000131482	Glucose-6-phosphatase catalytic subunit	P35575	17	42900797-42913369	Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins	Gluconeogenesis	Hydrolase	Disease mutation, Glycogen storage disease	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	9	liver: 305.4	Cell type enriched	Detected in some	5	Hepatocytes: 125.4	Cancer enriched	Detected in some	72	liver cancer: 151.8	Not detected	Not detected			Cell type enhanced	Detected in some		naive B-cell: 2.2	Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		RH-30: 2.2	Not detected	Not detected			Low region specificity	Detected in many			HPA052324	Enhanced											HPA052324: AB_2681790				unprognostic (4.23e-2)	unprognostic (1.49e-2)		prognostic favorable (5.42e-5)				unprognostic (8.37e-2)		prognostic favorable (3.79e-5)	unprognostic (4.79e-2)	unprognostic (6.46e-2)		unprognostic (2.56e-3)	0.1	0.1	0.1	0	0.1	0	0.1	0.1	0.1	0.1	5	0	0	5.8	0.1	0	0.1	0.1	1.9	0.1	0.1	0.1	23.7	305.4	0.1	0	0.1	0	0.1	0.1	0	0.1	0	0	0.1	0	0	0.1	0	0.1	0.1	33.7	0	0.1	0.2	0.1	0.1	0	0	0.1	0	0	0.1	0.1	2.2	0.5	1.1	0.2	0.5	0.4	0	0.4	0.2	0.2	0.5	0.6	0	0.7	0.2	0.2	0	0.1	0.2	0.3	0.7	0.2	0.3	0.2	0.4	0	0	0.2	0.3	0.1	0.1	0.5	0.8	0	1.3	0	0.1	0	0.1	0.1	0.1	0	0.4	0.5	0.7	0	0.1	0.5	1.2	0.3	0	0.3	0.6	2.2	0.2	0.1	0.7	0.4	0.6	0.7	0.3	0	0.5	0.1	0	0	0	0.3	0.3	0	0.7	0.2	1	0.3	1.4	0.2	1.1	0.2	0.1	0.3	0.1	0.2	1	0.2	0.2	0	2.2	0.4	0.4	1.1	0.5	0.1	0.5	0.4	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0	1.9	0	0	0	0.3	22.9	0	0	1.8	0	0	1.7	0.2	0.1	0	0	0	0.2	0	0	0	0	125.4	0.1	0	0	3.7	4.1	0	0	0	0	0	0	0	0	0	0	23.4	0	0	0	0	0	0	0	0	0	0.1	Hepatocytes
CA6		ENSG00000131686	Carbonic anhydrase 6	P23280	1	8945867-8975092	Enzymes, Predicted secreted proteins		Lyase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	50	salivary gland: 1237.9	Cell type enriched	Detected in single	404	Melanocytes: 170.4	Low cancer specificity	Detected in some			Not detected	Not detected			Cell type enhanced	Detected in some		naive CD8 T-cell: 15.4	Lineage enriched	Detected in many	10	T-cells: 15.4	Cell line enhanced	Detected in many		Daudi: 5.5;U-2197: 4.8					Not detected	Not detected			HPA028550, HPA028692	Enhanced				Secreted to digestive system				34000000			HPA028550: AB_10600105, HPA028692: AB_10601883	unprognostic (2.54e-5)	unprognostic (1.09e-1)	unprognostic (1.10e-1)	unprognostic (2.37e-1)	unprognostic (2.90e-1)	unprognostic (9.28e-2)		unprognostic (2.70e-3)	unprognostic (1.24e-1)	unprognostic (1.73e-1)	unprognostic (5.93e-2)	unprognostic (4.41e-2)	unprognostic (4.29e-5)	unprognostic (1.14e-1)	unprognostic (1.31e-1)	unprognostic (2.35e-1)		0.3	0	0.1	0	0.1	0	0.9	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0.1	0.1	0	0	0	0	0.1	0	0	0.2	0	0.1	0	0	0	0	0	1237.9	0	0.1	24.9	0	0	0.1	0.2	0	0.1	0	0	0	0.8	0.2	0	0.1	0.6	0.4	1.5	0.3	0.4	15.4	1.6	1.2	0.5	0.9	1.8	0.3	0.3	1.4	0.9	0.1	0.2	0.6	1	1.6	5.5	0.6	0.5	1.3	1.6	0.4	0.1	0.8	0.6	0.6	0.8	2	1.1	0.4	2	2	0	1	0.9	0.1	1.2	0.7	1.4	0.7	3.4	0.1	0.8	1	1.5	1.1	1	0.8	1.5	0.6	0.3	0.2	1	1	0.9	0.2	0.9	0.3	0.9	1.5	0.8	0.3	2.8	1.5	4.8	1.2	1.5	0.5	1.7	0.6	1.8	1.4	1.1	0.3	0.2	0.4	0.2	0.4	0.3	0.8	2.8	0	0.6	5.6	15.4	1.5	0.4	0.2	0.4	0.3	1.6	0.1	0.1	0	0	0.1	0.1	0.1	0	0	0	0	0	0	0	0.1	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	170.4	0	0	0	0	0	0	0	0	0	0.4	0	0	0.1	0	0	0	0	Melanocytes
CKMT2	SMTCK	ENSG00000131730	Creatine kinase, mitochondrial 2	P17540	5	81233285-81266397	Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins		Kinase, Transferase	FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	13	heart muscle: 153.2;skeletal muscle: 182.4;tongue: 103.6	Cell type enriched	Detected in some	25	Cardiomyocytes: 792.8	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Cell type enriched	Detected in single	9	NK-cell: 3.8	Lineage enriched	Detected in single	9	NK-cells: 3.8	Cell line enhanced	Detected in some		ASC diff: 3.7;BEWO: 6.0;Hep G2: 5.2;HHSteC: 4.0;T-47d: 9.7	Not detected	Not detected			Low region specificity	Detected in many			HPA051880	Enhanced								3200000			HPA051880: AB_2681650	unprognostic (3.64e-3)	unprognostic (1.15e-1)	unprognostic (2.82e-3)	unprognostic (1.88e-2)	unprognostic (1.21e-2)	unprognostic (2.41e-2)	unprognostic (1.73e-2)	unprognostic (3.57e-2)	unprognostic (2.12e-1)	unprognostic (1.03e-1)	unprognostic (2.82e-1)	unprognostic (1.84e-1)	unprognostic (1.60e-2)	unprognostic (5.34e-2)	unprognostic (2.28e-1)	unprognostic (1.76e-1)	unprognostic (2.75e-3)	2.5	5	1.3	0.3	1.9	0.2	0.8	0.4	1.2	1.2	0.5	1.2	2.5	0.3	1.3	11.5	3	1.2	1.5	153.2	1.5	0.9	2.7	0.3	0.4	0.3	2.3	1.4	1.6	1.3	1.1	0.7	0.3	4.1	2	0.3	2.5	9.1	2.1	182.4	0.5	0.6	1.4	2.8	0.4	2.1	0.9	1.5	0	3.3	103.6	2.9	1	0.6	0.4	0.1	0	0.4	3.8	0.3	0	0.1	0.9	0	0.9	3.7	0.8	6	0.1	0	0	0	0.3	0.3	0.7	0.4	0	0.9	0.1	0	0	0	0.5	3.2	0	0.7	5.2	4	0.5	0.2	1.4	0	0	0	0.5	0	0.8	0	0.6	0	0.7	0.2	0.1	0.8	0	0.4	0.8	0.9	0	0	0.1	0.7	0.7	0.5	0.4	0.9	2.3	9.7	0.4	0.8	0.5	0.9	0.5	0.3	0.1	0.1	0.8	0.4	0.5	0.9	0	0.2	0	0.1	0.4	0	0.1	0.3	0	0	0.4	0.1	0.2	0	3.8	0	0.1	0.2	0	1.3	1.9	0.4	1.2	1.5	0.9	2.3	1.4	4.1	1.5	0	0.3	0	0.4	0.1	0.7	792.8	7.6	1.4	1.2	12.2	0	0.1	31.5	1.6	16.2	5.3	0	0	0.5	0.4	0.6	0.3	0	0	0.1	0	0	0	0	0.8	6.6	0	3.3	0	0	1.3	0.2	0	14.2	0.6	0.9	0	5.9	0.2	0.4	0.1	0.2	0	0.2	0.1	Cardiomyocytes
ABHD12B	BEM46L3, C14orf29	ENSG00000131969	Abhydrolase domain containing 12B	Q7Z5M8	14	50872160-50904970	Predicted intracellular proteins		Hydrolase		Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in some		brain: 10.0;retina: 10.0;skin 1: 21.6	Cell type enriched	Detected in some	8	Muller glia cells: 136.7	Cancer enriched	Detected in many	5	testis cancer: 7.6	Low region specificity	Detected in many			Cell type enhanced	Detected in some		eosinophil: 2.3;neutrophil: 5.4	Lineage enriched	Detected in single	6	granulocytes: 5.4	Cell line enhanced	Detected in some		HEK 293: 1.3;Hep G2: 1.4;NB-4: 2.4;NTERA-2: 1.6;RH-30: 2.0;SH-SY5Y: 1.3;SuSa: 2.9;T-47d: 1.3;THP-1: 1.9	Region enriched	Detected in single	5	thalamus: 2.3	Low region specificity	Detected in many			HPA002873	Uncertain		Uncertain	Nucleoplasm						Nucleoplasm		HPA002873: AB_2220573	unprognostic (6.61e-2)	unprognostic (3.49e-2)	unprognostic (2.92e-3)	unprognostic (1.99e-3)	unprognostic (4.63e-2)	unprognostic (1.17e-2)	unprognostic (1.62e-2)	unprognostic (2.09e-1)	unprognostic (4.31e-2)	unprognostic (6.27e-2)	unprognostic (3.30e-1)	unprognostic (3.35e-1)	unprognostic (1.70e-3)	unprognostic (3.16e-2)	unprognostic (9.62e-2)	unprognostic (3.18e-3)	unprognostic (1.68e-1)	1.1	0.2	2.4	0.4	10	2.4	2.8	0.3	5.2	0.2	1.5	5.4	0.3	0.2	0.8	0.4	0.7	2	0.4	0.5	1.4	1.2	0.6	0.2	0.8	0.4	2.2	2.7	0.3	1.1	1.3	0.3	0.4	2.2	0.3	2.4	10	0.2	0.2	0.2	21.6	0.3	0.2	0.7	0.2	0.2	1.2	3.9	0	0.4	0	0.3	0.2	0.2	0	0.1	5.4	0.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0.6	0	0	0	0	0	0	0	1.3	0	0	1.4	0.5	0.7	1	0	0	0	0	0	0	0	0	0	0	0	0	2.4	1.6	0	0	0	2	0	0	0	0	1.3	0	0	0	2.9	1.3	1.9	0	0	0	0	0	0	0	0.2	0	0	0	0.8	0.9	2.3	0	0.1	0	0	0	0	0.1	0	0	0	5.4	0	0.1	0	0	0	2.4	10	0.3	5.2	1.4	1.2	2.2	2.7	2.2	3.9	0	0	0	0	0.3	3.3	1.4	0	14.7	0	1.8	2	0	0	0	6.1	0	0	0	0	0	0.2	0	1.1	0	0.1	0	0	0	0	2.8	1.1	0	0	0	0.9	136.7	0	0	0	0	16.9	0	0	0.2	0.2	1.3	0.2	0	1.6	0.1	Muller glia cells
IQCA1	DRC11, FLJ22527, IQCA	ENSG00000132321	IQ motif containing with AAA domain 1	Q86XH1	2	236324147-236507542	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		pituitary gland: 27.8;thyroid gland: 30.0	Cell type enriched	Detected in many	5	Ciliated cells: 163.3	Cancer enhanced	Detected in many		thyroid cancer: 9.4	Low region specificity	Detected in all			Cell type enhanced	Detected in some		naive CD8 T-cell: 4.4	Group enriched	Detected in many	4	NK-cells: 1.2;T-cells: 4.4	Cell line enhanced	Detected in some		EFO-21: 4.0;HBEC3-KT: 3.7;HeLa: 4.4;hTERT-RPE1: 8.7;SuSa: 5.5;U-2 OS: 15.3	Low region specificity	Detected in some			Low region specificity	Detected in many			HPA057320			Uncertain	Nucleoplasm						Nucleoplasm		HPA057320: 	unprognostic (1.73e-2)	unprognostic (6.38e-2)	unprognostic (3.75e-3)	unprognostic (1.62e-2)	unprognostic (6.27e-3)	unprognostic (1.73e-2)	unprognostic (3.23e-5)	unprognostic (1.55e-1)	unprognostic (7.23e-3)	unprognostic (1.39e-1)	unprognostic (3.03e-2)	unprognostic (1.62e-1)	prognostic favorable (2.54e-4)	unprognostic (1.19e-3)	unprognostic (1.67e-3)	unprognostic (1.91e-3)	unprognostic (5.30e-2)	1.8	2.7	13.4	1.4	19.2	0.8	3.5	3.8	11.6	2.2	1	6.7	0.4	0.9	3.4	9.1	1.6	17.8	3.5	1.1	12.9	10	6.6	0.8	5.1	1.3	8.8	9.3	4.7	2.4	0.9	27.8	1.1	13	3.1	1	2.7	2.6	2.8	0.8	0.9	1.2	1.5	3.2	5.5	1.1	7.4	8	1.4	30	0	1.6	3	1	0.7	0	0	0	1.2	4.4	0.1	0	0	0.3	0.2	0	0	0.4	0.2	0	0.1	0.3	0.1	0	0	4	0	1.1	0	0	3.7	0	0	0.1	0	4.4	0	0.1	0	0	0.3	2	0	0	8.7	0.9	0	0	0	0	0	0	0	1.8	0	0.4	0	0	0	0	0.8	0	0	0	0.1	0	5.5	0	0	0.1	0	15.3	0	0.1	0.1	0	0	0	0	0	0	0	0	0	0	1.3	0.5	0.2	0.8	0	0.7	1.1	4.4	0	1.2	0	0	0.3	0.1	13.4	19.2	3.8	10	12.9	10	8.8	9.3	13	8	14.9	15.9	0	6.7	0.5	20.3	0.8	12.7	163.3	30.7	3.5	15.7	0.4	0	10.2	19.7	3.8	0	0	1.4	3.6	0.9	1.1	1.1	0	0.3	0	0	1.3	0	11	2	0.5	0	0	0	0.2	1.7	0	5.6	7.9	1.8	0	0.3	23.3	27.1	0.3	0.2	0	0	2.6	Ciliated cells
FTHL17	CT38	ENSG00000132446	Ferritin heavy chain like 17	Q9BXU8	X	31071241-31072053	Predicted intracellular proteins	Iron storage			Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	17	testis: 12.7	Cell type enriched	Detected in single	23	Spermatocytes: 14.2	Cancer enhanced	Detected in some		testis cancer: 2.3	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	14	hTERT-HME1: 1.4;T-47d: 1.2																																				unprognostic (5.67e-2)			0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0	12.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	14.2	0.5	0	0	0	0	0	Spermatocytes
ENAM	AIH2	ENSG00000132464	Enamelin	Q9NRM1	4	70628744-70686816	Disease related genes, Predicted secreted proteins	Biomineralization		Amelogenesis imperfecta, Disease mutation	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in some		epididymis: 10.1;heart muscle: 5.0;kidney: 7.9	Cell type enriched	Detected in some	7	Melanocytes: 32.1	Cancer enhanced	Detected in some		renal cancer: 1.7					Group enriched	Detected in some	18	memory B-cell: 1.2;naive B-cell: 1.7;plasmacytoid DC: 2.2	Group enriched	Detected in many	20	B-cells: 1.7;dendritic cells: 2.2	Group enriched	Detected in some	4	Daudi: 2.4;RPTEC TERT1: 1.5;U-266/70: 2.5;U-266/84: 3.4;U-698: 1.0	Not detected	Not detected			Low region specificity	Detected in many								Secreted to extracellular matrix								unprognostic (1.52e-2)	unprognostic (2.80e-3)	unprognostic (1.87e-1)	unprognostic (1.02e-2)	unprognostic (2.78e-2)	unprognostic (1.02e-1)	unprognostic (7.94e-3)	unprognostic (4.73e-2)	unprognostic (2.06e-1)	unprognostic (9.06e-4)	unprognostic (1.01e-2)	unprognostic (1.14e-1)	prognostic favorable (1.81e-14)	unprognostic (1.26e-1)	unprognostic (2.56e-1)	unprognostic (2.12e-1)	unprognostic (1.45e-1)	0	0	0	0	0	0	0	0	0	0	0			0	0.2	10.1	0	0.1	1.5	5	0	0	7.9	0.5	0	0	0		0	2.5	0.8	0.5	0		0	0		0	0	3.6	0	0.2	0	0	0	1.3	1.2			0		0	0	0	1.7	2.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.4	0	0.1	0.4	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0.4	0	0	0	0	0	0.1	0	0	0.3	1.5	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	2.5	3.4	1	0.3	0	0	0	0	0	0	0	0	1.2	0	0	0	1.7	0	0	0	0	0	2.2	0	0											0	0	0	0	0	0	4.3	2.5	0	0	3.5	0	0	3.3	0.7	4.5	0	0	0	0.7	0	0	0	0	0.8	0	0	0	0	0	1.3	0.3	0	32.1	0	0	0	0.8	0	0	3.3	0	0	0	0	0	0	0	0	0	0	Melanocytes
SLC52A1	FLJ10060, GPCR42, GPR172B, hRFT1, PAR2, RFVT1	ENSG00000132517	Solute carrier family 52 member 1	Q9NWF4	17	5032600-5052009	Disease related genes, Predicted membrane proteins	Transport	Host cell receptor for virus entry, Receptor		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Group enriched	Detected in some	4	intestine: 25.6;placenta: 34.6	Cell type enriched	Detected in some	5	Syncytiotrophoblasts: 685.8	Low cancer specificity	Detected in many			Not detected	Not detected			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		A549: 4.5;BEWO: 3.8;EFO-21: 3.6;HMC-1: 9.0;SK-BR-3: 5.1;T-47d: 3.0																						unprognostic (8.81e-3)	prognostic favorable (9.54e-4)	unprognostic (9.34e-2)	unprognostic (7.30e-4)	unprognostic (6.31e-2)	unprognostic (1.24e-1)	unprognostic (1.05e-1)	unprognostic (3.82e-3)	unprognostic (1.72e-1)	unprognostic (2.36e-1)	unprognostic (1.15e-1)	unprognostic (7.19e-2)	unprognostic (5.17e-5)	unprognostic (1.37e-1)	unprognostic (1.03e-1)	unprognostic (4.07e-2)	unprognostic (6.60e-2)	0.1	0	0.1	0.1	0.2	0.1	0.3	0.3	0.6	1	20	0.2	0.6	24.4	0.5	0.1	1.5	0.8	0.1	0.1	0.1	0.1	0.2	0.1	0.5	0.1	0.1	0.1	0.2	0.1	1	0.1	34.6	0.3	1.4	0.1	0.1	0.5	0.3	0.1	7.4	25.6	0.1	0.1	0.6	0	0.7	0.1	0.6	0.2	0.4	0.7	2.5	1	1.4	0.6	3.7	0.6	1.4	1.2	0.3	0.2	4.5	0.1	0.2	0.2	0.2	3.8	0	0	0.6	0.6	0.1	0.2	0.3	3.6	0.1	0.7	0.4	0	0.3	0.1	0.1	0.2	0	0.7	0.3	0.1	0.1	9	0.1	0.1	0.2	0.1	0.2	0.2	0.7	0.1	1.2	0	0.3	0.5	0.4	0.4	0.1	0.2	0.1	0	0.3	0.1	1.4	0.1	0.3	0.8	5.1	0.1	0.2	3	1.4	0.6	0.3	1.1	0.1	0.2	0.3	0.1	0.3	0.2	0.1	0.5	2.6	0.6	0.9	0.7	0.4	0.6	0.6	0.9	1.2	0.2	1.4	1.1	0.8	3.7	1.4	0.4	0.6	0.5	0.3	0.1	0.2	0.3	0.6	0.1	0.1	0.1	0.1	0.3	0.1	0	0.3	0	1.3	1	0	0.6	0	8.1	0	0	0	134.6	0	0	0.1	0.1	5.7	0	0	10.3	1.1	0.3	0	0	13.6	0	1.2	2.5	0	0	0	0	0	0	1.3	0	0	0.8	0	0	0	0	0	0.9	0.9	1.5	685.8	0	1.1	0.7	Syncytiotrophoblasts
RIDA	HRSP12, P14.5, PSP, UK114	ENSG00000132541	Reactive intermediate imine deaminase A homolog	P52758	8	98102344-98117241	Enzymes, Plasma proteins, Predicted intracellular proteins		Hydrolase, RNA-binding		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in all	9	kidney: 81.4;liver: 248.6	Cell type enriched	Detected in many	5	Proximal tubular cells: 1135.9	Cancer enhanced	Detected in all		liver cancer: 162.2	Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Cell line enhanced	Detected in all		OE19: 61.2	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA022856, HPA023489	Enhanced								5700000			HPA022856: AB_1858253, HPA023489: AB_1858252	unprognostic (1.67e-2)	unprognostic (3.73e-1)	unprognostic (1.29e-1)	unprognostic (1.10e-1)	unprognostic (4.16e-1)	unprognostic (2.20e-2)	prognostic favorable (9.61e-6)	unprognostic (6.08e-2)	unprognostic (1.13e-1)	unprognostic (3.15e-1)	unprognostic (2.81e-1)	unprognostic (4.46e-1)	unprognostic (1.55e-1)	unprognostic (1.73e-1)	unprognostic (2.04e-1)	unprognostic (2.08e-2)	unprognostic (1.51e-2)	8.3	9.4	16.8	2.5	18.8	1.6	4.2	5.6	11.6	2.6	4.7	4.5	2.7	5.8	2.1	4.8	2.8	2.2	4.3	5.2	11.7	12.5	81.4	248.6	2.2	2.1	19.1	9.5	4.6	5.2	3.5	1.8	2.4	11.8	4	4.8	2.3	3.2	2.7	6.8	2.3	4.2	2.5	7.9	1.8	4.6	3.3	9.5	0.6	3.2	3.5	2.6	3.2	1.8	12.1	10	5	8.3	8.4	12.8	7.1	13.9	12.1	9.8	11.9	22.2	17.3	10.7	12.9	9.1	8.6	10.4	16.4	9.4	19.8	16.6	9.4	11.5	9.9	21.4	18.3	17.5	6.9	9.2	14.4	8.2	17.5	10.1	5.3	2.3	14.9	6.3	12.1	13.3	10.9	11.1	21.4	25.6	4.3	11.5	18.1	11.2	14.4	15.5	61.2	22.1	13	7.1	5.7	20.8	10	10.6	5.3	8.2	5.7	8.9	13	14.5	7	6.7	6.7	4.2	11.3	5.1	10.3	14.1	9.7	11.7	11.2	4.3	0.1	8.3	5	6.5	7	8.3	12.1	9.4	9.5	10	9.5	12.2	12.8	1.5	8.4	7	7.6	12.3	7.1	16.8	18.8	5.6	11.6	11.7	12.5	19.1	9.5	11.8	9.5	23.8	15.3	0	0	0	0	0	0	10.7	3.4	45.4	0	25.5	242.1	13.4	0	0	0	0	7.5	23.7	0	0	2.3	0	21.3	0	0	0	0	0	0	2.2	0	10	0	0	14.6	0	0	1135.9	0	0	0	0	0	0	12	0	0	0	Proximal tubular cells
CRP	PTX1	ENSG00000132693	C-reactive protein	P02741	1	159712289-159714589	Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Acute phase		Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	66	liver: 1139.7	Cell type enriched	Detected in some	14	Hepatocytes: 2991.5	Cancer enriched	Detected in some	13	liver cancer: 1010.0	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		EFO-21: 8.2;HDLM-2: 7.8;SiHa: 2.7;U-2 OS: 5.5;U-266/84: 13.1	Not detected	Not detected			Low region specificity	Detected in all			CAB005036, HPA027367, HPA027396	Supported		Approved	Nucleoplasm,Vesicles,Intermediate filaments	Secreted to blood			2920000000	5400000000	Nucleoplasm, Vesicles	Intermediate filaments	CAB005036: AB_562362, HPA027367: AB_1847216, HPA027396: AB_1847217	unprognostic (3.74e-1)	unprognostic (5.31e-2)				unprognostic (2.97e-2)	unprognostic (1.27e-1)	unprognostic (3.57e-2)			unprognostic (1.33e-2)	unprognostic (3.13e-1)	prognostic unfavorable (4.17e-10)	unprognostic (3.39e-2)	unprognostic (3.48e-1)	unprognostic (5.60e-2)	unprognostic (6.61e-2)	0.4	0	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0.4	0.1	0.1	0	17.2	0.1	0.1	0	0.1	1139.7	0.1	0.1	0.1	0.1	0.1	7	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.3	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	8.2	0	0	0.3	0	0	0	7.8	0	0.3	0	0	0	0.3	0.1	1.1	0	0	0.2	0	0	0	0.3	0	0	0	0	0	0.1	0	0	0	1.1	0	0	0	0	0	2.7	0	0	0	0	0	0.1	0	5.5	0.1	0.9	0	13.1	2	0	1.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	55.9	0	0	0	0	109.5	0	0	0	0	0	0	220.4	1.2	0	0	23.3	52.3	0	0	0	0	2991.5	0.1	0	0	82.9	72.1	0	0	0	0	17.2	0	0	97.4	0	0	0	0	0	0	0	0	0	0	0	0	0	Hepatocytes
HAPLN2	BRAL1	ENSG00000132702	Hyaluronan and proteoglycan link protein 2	Q9GZV7	1	156619294-156625725	Predicted secreted proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	39	brain: 108.1	Cell type enriched	Detected in some	4	Sertoli cells: 32.3	Cancer enriched	Detected in some	10	glioma: 7.6	Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		SH-SY5Y: 1.1;U-266/70: 4.6;U-87 MG: 1.3	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA045765	Enhanced				Secreted in brain							HPA045765: AB_10964781	unprognostic (3.19e-3)	unprognostic (1.06e-1)	unprognostic (1.02e-2)	unprognostic (3.41e-1)	unprognostic (1.88e-1)	unprognostic (2.44e-1)	unprognostic (1.92e-1)	unprognostic (2.04e-3)	unprognostic (1.31e-1)	unprognostic (8.25e-2)	unprognostic (5.54e-3)	unprognostic (2.72e-2)	unprognostic (2.70e-2)	unprognostic (1.08e-1)	unprognostic (2.25e-1)	unprognostic (1.05e-1)	unprognostic (4.17e-3)	1.5	1.5	11	1.3	21.1	1.3	1.3	4.4	45.3	1.3	1.3	43.6	0	2.7	1.6	1.3	1.3	1.4	1.3	1.3	21.2	13.9	1.4	1.3	1.4	1.3	49.3	9.3	1.3	1.3	1.6	0	1.3	43.1	1.9	1.3	0	1.4	1.5	1.9	1.6	1.7	1.3	108.1	1.3	1.3	1.7	31.5	0	1.3	0	1.3	1.3	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0.7	0	0.5	0	0	0	0	0	0	0.3	0.4	0.7	0.3	0	0	0	0.4	0	0	0	0	0	0	0.3	0.7	0.2	0	0	0.2	0.1	0	0	0	0	0.4	0	0	0	0	1.1	0	0	0	0	0.2	0	0	0	0.5	0.2	0	4.6	0.1	0.2	1.3	0	0.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	11	21.1	4.4	15.1	21.2	13.9	49.3	9.3	43.1	31.5	0	0	0	0	0.1	1.3	0.8	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0.1	0	0	0	1.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	32.3	7.6	0.7	1.9	0	0	0	0	0.1	Sertoli cells
APCS	MGC88159, PTX2, SAP	ENSG00000132703	Amyloid P component, serum	P02743	1	159587825-159588865	Disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	81	liver: 316.6	Cell type enriched	Detected in some	8	Hepatocytes: 3479.3	Cancer enriched	Detected in some	25	liver cancer: 826.2	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HL-60: 3.3;RH-30: 4.3;SiHa: 2.2;U-937: 1.3	Not detected	Not detected			Low region specificity	Detected in many			CAB007817, HPA053294	Supported				Secreted to blood			27700000000	76000000000			CAB007817: AB_598185, HPA053294: AB_2682104							unprognostic (3.19e-3)				unprognostic (2.30e-2)							0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0.1	0	0	3.8	0	0	0	0.7	316.6	0	0	0	0	0	2	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0.7	0	0	0.8	0	0	0	0.3	0	1.3	0	0	0	3.3	0.5	0	0	0	0	0	0	0	0.9	0	0	0	0.5	0	1	0	0	0.7	4.3	0	0	0	0	0	2.2	0	0	0	0	0.2	0	0	1.1	0	0	0.7	0.2	1.1	0	1.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	21	0	0	0	0	451	0	0	0	0	0	0	77.6	0	0	0	70	5.1	0	0	0	0	3479.3	0	0	0	63.8	73.6	0	0	0	0	5.4	0	0	16.5	0	0	2.1	0	0	0	0	0	0	0	0	0	0	Hepatocytes
ACY3	ACY-3, HCBP1, MGC9740	ENSG00000132744	Aminoacylase 3	Q96HD9	11	67642555-67650659	Enzymes, Predicted intracellular proteins	Host-virus interaction	Hydrolase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		intestine: 72.2;kidney: 28.9	Cell type enriched	Detected in many	6	Proximal tubular cells: 163.1	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Cell type enhanced	Detected in many		non-classical monocyte: 21.1	Group enriched	Detected in many	6	dendritic cells: 5.9;monocytes: 21.1	Cell line enhanced	Detected in some		CACO-2: 6.1;CAPAN-2: 9.5;Daudi: 34.5;OE19: 9.6;RPMI-8226: 6.0	Low region specificity	Detected in all							HPA039219, HPA048187	Enhanced											HPA039219: AB_10671872, HPA048187: AB_2680306	unprognostic (8.37e-3)	unprognostic (1.29e-1)	unprognostic (1.04e-1)	prognostic favorable (4.80e-4)	unprognostic (1.07e-1)	unprognostic (1.99e-2)	unprognostic (1.38e-2)	unprognostic (1.43e-1)	unprognostic (7.37e-4)	unprognostic (2.44e-3)	unprognostic (1.15e-1)	unprognostic (3.21e-1)	unprognostic (2.63e-3)	unprognostic (1.07e-1)	unprognostic (8.24e-2)	unprognostic (2.68e-2)	unprognostic (1.48e-3)	0.1	0.1	3.4	1.8	5.5	0.6	0.5	0.8	7.8	5.5	13	15.3	0.2	38.2	0.3	2.1	0.7	0.4	6.1	0.1	3.1	2.9	28.9	18.3	0.2	3.1	4.6	5.1	0.1	11.2	0	0.3	0.1	7.1	0.4	2.2	0.3	1.2	0.2	0.1	0.1	72.2	0.1	5.2	0.9	5.9	0.1	2.8	0.7	0.2	0	4.2	0.2	0.2	1.1	5.9	0	21.1	2.3	0.9	1.2	0.1	0.8	0	0	0	0	0.2	0	0	0	0	6.1	9.5	34.5	0.4	0	0.9	0	0	0	0	1.3	0	0	0	3.3	0	0	0.2	0	0	0	0	0	0	0.6	0	0.3	0	0	1.2	1.5	0	9.6	0	1.1	0	6	0	0	0	0.1	0.2	0.8	0	0	0	1.7	0.1	0	0	0	0	0	0	0.5	0	3.8	0.3	0	0.5	0	0.1	4.9	0.5	1	0.2	0.1	2.6	1.1	0.9	0.6	0	2.3	21.1	5.9	0	1.2	3.4	5.5	0.8	7.8	3.1	2.9	4.6	5.1	7.1	2.8	0	1.7	6.3	0.1	0	0	0.4	10.2	0	1.2	21	0	0.2	26.6	3.5	0	0	11.8	0	9	0.2	0	0.6	0	17.9	1.7	0	1.2	0	0.3	0	0	0.9	5	0	25.1	0	6.8	5.9	0	163.1	0	0	0	0	0	0.1	0.1	0.9	6.6	0.8	Proximal tubular cells
SLC14A2	HUT2, UT2	ENSG00000132874	Solute carrier family 14 member 2	Q15849	18	45212995-45683686	Plasma proteins, Predicted membrane proteins, Transporters	Transport			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in some		blood: 3.3;kidney: 5.7	Cell type enriched	Detected in some	5	Collecting duct cells: 73.3	Cancer enhanced	Detected in some		thyroid cancer: 1.1					Cell type enhanced	Detected in some		eosinophil: 3.3	Low lineage specificity	Detected in single			Cell line enriched	Detected in some	6	U-266/70: 7.2	Region enriched	Detected in some	4	basal ganglia: 17.9	Not detected	Not detected																unprognostic (2.33e-1)	unprognostic (1.42e-1)	unprognostic (1.85e-2)	unprognostic (2.54e-2)	unprognostic (7.80e-2)	unprognostic (1.11e-2)	unprognostic (7.89e-3)	unprognostic (3.76e-3)	unprognostic (1.85e-1)	unprognostic (1.31e-1)	unprognostic (1.27e-3)	unprognostic (8.96e-2)	unprognostic (3.50e-3)	unprognostic (1.20e-1)	unprognostic (7.64e-2)	unprognostic (7.52e-2)	unprognostic (6.62e-2)	1.8	1	0	0.1	0.4	0.6	0.9	0	0.7	0.1	0			0.3	0.1	0.3	0	0	0.1	0.3	0.1	0.1	5.7	0	0.2	0.1	0		0.1	0	0.3	0.1	0		0.2	0		0.2	0	0.3	0.4	1.2	0	0	0.2	0.1	1.3			1		0	0.1	0.1	0.4	0.4	3.3	0.3	0.4	0.8	0.1	0.2	0.4	0.4	0.2	0.1	0.1	0.4	0.2	0.1	0.1	0	0.4	0.4	0.8	0.2	0.1	0.4	0.3	0	0	0.1	0.4	0.2	0.4	0.7	0	0.1	1.1	0.4	0.1	0.1	0.1	0.1	0.4	0.2	0.4	0.3	0.6	0	0.3	0.4	0.5	0.3	0.2	0.4	0.3	0.1	0.7	0.1	0.4	0.6	0.1	0.2	0.1	0.1	0.2	0.1	0.3	0.3	0.4	0.3	1	0.4	7.2	0.4	0.3	0.4	1.1	0.3	1.4	0.3	3.3	0.3	0.2	0.2	0.4	0.2	0.3	0.1	0.4	0.2	0.3	0.8	0.4	0.2	0.4	0.8	0.1											6	14.8	0	0.5	0.6	1.2	0.5	0	2.7	3.4	73.3	2	0.3	0	0	0.9	0.7	1.1	0	0	0.2	1.1	0.3	3.5	0	0.3	1.6	0	1.8	0.3	1	0.6	0.8	1.7	0	0.3	0.8	0.1	0	0.7	0	1.7	0	0	0.5	0.4	0.1	0.7	0	0	0.4	Collecting duct cells
PDE6A	PDEA, RP43	ENSG00000132915	Phosphodiesterase 6A	P16499	5	149857955-149944793	Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins	Sensory transduction, Vision	Hydrolase	Disease mutation, FDA approved drug targets, Retinitis pigmentosa	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	8	retina: 153.4	Cell type enriched	Detected in many	12	Rod photoreceptor cells: 2864.0	Not detected	Not detected			Not detected	Not detected			Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Cell line enriched	Detected in some	4	CACO-2: 7.6	Not detected	Not detected			Not detected	Not detected			HPA016970, HPA074677	Enhanced											HPA016970: AB_1855125, HPA074677: AB_2732264	unprognostic (6.85e-2)	unprognostic (8.84e-2)	unprognostic (1.70e-2)	unprognostic (4.11e-2)	unprognostic (1.12e-2)	unprognostic (5.72e-2)	unprognostic (4.39e-3)	unprognostic (8.83e-2)	unprognostic (6.54e-2)	unprognostic (5.91e-3)	unprognostic (1.77e-2)	unprognostic (9.21e-2)	unprognostic (7.57e-5)	unprognostic (9.93e-2)	unprognostic (3.08e-1)	unprognostic (1.31e-1)	unprognostic (2.26e-2)	0.2	2.3	0.2	0.2	0.2	0.9	0.2	0.3	0.2	0.2	1.8	0.2	0.3	0.2	0.2	20.1	2.4	0.1	0.2	0.2	0.2	0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	4.6	0.2	0.2	0.2	1	153.4	1.4	0.2	0.2	1.6	0.2	0.2	0.2	0.2	0.1	3.1	0.2	0.2	0.4	0.3	0.5	0.2	0.2	1.5	0.8	3.3	0.8	1.2	0.8	0.1	0.4	0.8	0.6	0.6	0.3	0.3	0.6	0.3	0.1	0.4	0.1	7.6	0.8	0.9	1.4	0.2	1.4	0.7	0.2	0.4	0.5	0.6	0.3	1	1.1	0.6	0.2	0.8	0.6	0.3	1.1	0.9	0.6	0.6	0.2	0.4	0.3	1.4	1.5	0.4	0.5	0.9	0.5	0.2	0.5	0.3	0.8	0.7	0.5	1	0.8	1.1	0	0.7	0.2	0.6	1	0.5	1.4	0.8	1.7	0.8	0.5	0.6	0.4	0.5	0.8	0.8	0.6	3.3	0.8	0.5	0.6	0.4	0.5	0.7	0.6	0.5	0.2	1.5	0.7	0.8	2.8	1.2	0.5	0.8	0.4	0.1	0.2	0.2	0.3	0.2	0.2	0	0.2	0.2	0.2	0.2	0	7.2	0	0.5	1	117.9	3.6	0	5.3	4.5	0	229.7	0.9	0	0	7	0.6	3.9	0	0.2	1.9	0.6	0.3	3.5	0.8	0.3	71.5	0	2.5	0.3	4	1.1	0.5	0	1	0.2	162.2	0.1	2.9	0.4	0	2864	0	1	1.1	0.9	0.5	2.4	0.5	0.9	0.1	Rod photoreceptor cells
MTUS2	CAZIP, ICIS, KIAA0774, TIP150	ENSG00000132938	Microtubule associated scaffold protein 2	Q5JR59	13	28820348-29505947	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		heart muscle: 46.8;pituitary gland: 19.3	Cell type enriched	Detected in some	18	Cardiomyocytes: 122.0	Low cancer specificity	Detected in some			Low region specificity	Detected in many			Cell type enhanced	Detected in some		eosinophil: 1.9;intermediate monocyte: 1.7	Group enriched	Detected in many	4	dendritic cells: 1.3;granulocytes: 1.9;monocytes: 1.7	Group enriched	Detected in some	4	HaCaT: 16.7;HeLa: 7.0	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA031473, HPA031474, HPA031475	Enhanced		Supported	Microtubules,Cytokinetic bridge		Yes				Microtubules, Cytokinetic bridge		HPA031473: AB_2673901, HPA031474: AB_10600109, HPA031475: AB_10600442	unprognostic (1.67e-1)	unprognostic (3.07e-1)	unprognostic (1.96e-1)	unprognostic (3.33e-3)	unprognostic (1.00e-1)	unprognostic (1.22e-2)	unprognostic (2.79e-1)	unprognostic (1.35e-1)	unprognostic (2.87e-1)	unprognostic (4.97e-2)	unprognostic (1.30e-3)	unprognostic (3.45e-2)	unprognostic (3.91e-5)	unprognostic (2.51e-2)	unprognostic (5.46e-2)	unprognostic (5.93e-2)	unprognostic (9.62e-2)	0.6	0.8	2.3	0.7	6.1	0.7	0.6	12.2	8.8	1.1	0.8	0.1	0	0.7	2.1	0.6	0.8	1.4	0.7	46.8	3.4	1.9	0.6	1.1	0.7	1	1.2	4.6	8.2	4.7	0.5	19.3	0.5	2.3	0.8	0.8	2	1	0.7	0.6	0.7	0.9	1.7	0.7	1	1.5	1.6	0.9	0	1.1	0	0.6	2.6	0.7	0	1.3	1.9	1.7	0	0.4	0	0	0	1	0	0	0.5	0	0	0	0	0	0	0	2	0	0.2	0.3	16.7	0.5	0	0	0.1	0.7	0	7	0	0	0	0	0.3	0	0.1	0	0	0	0	0	0.5	0	0.1	0	0.7	0.1	0	0	0	0	1.2	0	2.9	2.1	0.1	0.6	0	0.3	0.3	0.1	0	0	0.1	0.3	0	0	0.9	0.3	0.1	0.4	0	0	0	0.2	1.9	0	1.7	0.1	0	0.4	0	1.3	0	0	0	0	0	0.9	0.3	0	0	2.3	6.1	12.2	8.8	3.4	1.9	1.2	4.6	2.3	0.9	0	0.3	0	0.5	0.5	0	122	0	6.7	2.3	0	0	0	0	0	5.5	0	0	0	0.5	0	1	0.2	0	0.6	0.1	0	0	0.6	0	2.5	0.9	0	1.7	0	0	0	0.7	0	0	0	0	0	0.1	0	1.9	0.1	0.2	0	0	0.9	Cardiomyocytes
MYH8	MyHC-peri, MyHC-pn	ENSG00000133020	Myosin heavy chain 8	P13535	17	10390322-10421950	Disease related genes, Plasma proteins, Predicted intracellular proteins		Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin	Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	10	esophagus: 16.5;skeletal muscle: 18.3;tongue: 10.0	Cell type enriched	Detected in some	4	Proximal tubular cells: 29.1	Cancer enhanced	Detected in some		head and neck cancer: 0.7;renal cancer: 0.9	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	14	HSkMC: 13.1	Low region specificity	Detected in single			Not detected	Not detected			HPA001349, CAB016527	Enhanced											CAB016527: AB_2147291, HPA001349: AB_1079437	unprognostic (5.87e-2)					unprognostic (5.13e-3)		unprognostic (4.12e-2)	unprognostic (1.25e-2)		unprognostic (2.29e-3)	unprognostic (1.08e-1)	unprognostic (5.02e-3)	unprognostic (7.87e-2)	unprognostic (1.61e-1)		unprognostic (3.56e-1)	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.5	0	0	0	0	0.1	1.3	0	0	0	0	0	0	0	0	0	0	0	1.4	0	0	1.4	0	18.3	0	0	0	0	0.1	0	0.2	0	0.8	0	10	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0.2	0	0	0	0	0	0	0	0	0.9	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	1.5	0	0	0	3.5	0	0	6.6	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	29.1	0	0	0	0.3	0.2	0	0	0	0	0	Proximal tubular cells
CHI3L1	GP39, YKL40	ENSG00000133048	Chitinase 3 like 1	P36222	1	203178931-203186749	Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Apoptosis, Inflammatory response	Antimicrobial	Asthma, Cancer-related genes, Schizophrenia	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	4	liver: 336.4	Cell type enriched	Detected in many	7	Hofbauer cells: 335.7	Cancer enriched	Detected in all	8	glioma: 1313.7	Low region specificity	Detected in all			Cell type enriched	Detected in single	490	neutrophil: 81.3	Lineage enriched	Detected in single	490	granulocytes: 81.3	Cell line enhanced	Detected in some		ASC diff: 40.7;ASC TERT1: 90.8;HSkMC: 80.6;THP-1: 128.4;U-138 MG: 38.1;U-87 MG: 37.9	Low region specificity	Detected in all			Region enriched	Detected in single	14	olfactory region: 10.7	HPA077365			Approved	Golgi apparatus,Vesicles	Secreted to blood			25100000	230000000	Golgi apparatus	Vesicles	HPA077365: 	unprognostic (2.11e-3)	unprognostic (1.21e-1)	unprognostic (1.29e-1)	unprognostic (1.07e-1)	unprognostic (6.01e-3)	unprognostic (8.81e-2)	unprognostic (2.09e-1)	unprognostic (1.48e-1)	unprognostic (4.46e-2)	unprognostic (1.30e-1)	unprognostic (7.98e-2)	unprognostic (1.43e-1)	unprognostic (1.20e-2)	unprognostic (1.98e-2)	unprognostic (3.43e-2)	unprognostic (1.14e-2)	unprognostic (9.39e-3)	19	0.8	20.3	53.4	58	81.6	23.9	1.2	69.4	4.3	2.1	5	0	0.9	4.3	25.5	3.5	10.2	1.9	2.6	9.1	17.8	11.9	336.4	10	12.4	32.3	3.6	4.5	2.5	0.8	22.9	4.7	66.4	1.5	1.6	9.1	19.3	1.1	10.5	10	2.2	3.3	23.5	2.9	1.7	3.4	6.5	0.9	2	1.7	14.6	61.5	4	0	0	81.3	0.1	0	0	0.1	0	0	0	0	40.7	90.8	0	0	0	0	0	9	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0.1	1	0	0	80.6	0	0.2	0	3.8	0	0	0	0.1	0	0	0	0.6	0.3	0	0	0	0	1.7	0	0	0	0	0	0	0	0	0	128.4	0	38.1	0.2	0	0	0.2	4.8	0	37.9	0.1	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	81.3	0	0.1	0	0	0.1	20.3	58	1.2	28.9	9.1	17.8	32.3	3.6	66.4	6.5	6	39.7	0	19.4	3.8	0	0.8	2.5	4	15.9	26.2	0	1.2	0	49.4	0	0.4	0	0	0	0.9	2.2	2.2	0	28.7	335.7	0	0	0	0.3	0	0.9	3.9	13.5	1.8	0	40.4	3.1	0	0	0.1	1.8	0	1.7	0	0	1	0.7	0	0	1.6	Hofbauer cells
CHIT1	CHI3, CHIT	ENSG00000133063	Chitinase 1	Q13231	1	203212827-203273641	Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted secreted proteins	Carbohydrate metabolism, Chitin degradation, Polysaccharide degradation	Glycosidase, Hydrolase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		adipose tissue: 99.9;lymphoid tissue: 106.5	Cell type enriched	Detected in single	44	Hofbauer cells: 42.8	Cancer enhanced	Detected in many		testis cancer: 31.9	Not detected	Not detected			Group enriched	Detected in some	4	neutrophil: 2.9;non-classical monocyte: 1.1	Group enriched	Detected in many	4	granulocytes: 2.9;monocytes: 1.1	Cell line enhanced	Detected in some		EFO-21: 2.8;LHCN-M2: 1.7;RH-30: 1.8;U-266/70: 2.3	Low region specificity	Detected in single			Not detected	Not detected			HPA010575, HPA074844	Enhanced				Secreted to blood			26400000	58000000			HPA010575: AB_1078512, HPA074844: 	unprognostic (5.80e-3)	prognostic favorable (2.02e-4)	unprognostic (2.58e-2)	unprognostic (2.19e-1)	unprognostic (7.87e-2)	unprognostic (2.28e-2)	unprognostic (7.55e-2)	unprognostic (6.36e-3)	unprognostic (1.17e-1)	unprognostic (3.25e-2)	unprognostic (1.38e-1)	unprognostic (1.03e-1)	unprognostic (1.56e-3)	unprognostic (3.37e-1)	unprognostic (1.52e-1)	unprognostic (1.06e-1)	unprognostic (2.95e-1)	99.9	0.2	0.2	0.4	0.3	26.7	5.5	0.1	0.3	5.9	0.6	0.5	0.1	0	2.5	0.2	0.3	0.1	0.2	0.6	0.2	0.1	0.1	0.4	22.1	106.5	0.4	0.1	1.4	1.1	0	0.2	0.4	0.5	0.6	0.5	0.3	0.3	0.1	0.1	0.3	0.7	0.2	9.4	4.3	0.1	0.1	0.1	2.3	0.9	0.2	0.5	0.1	0.3	0.5	0.2	2.9	1.1	0	0	1.3	0	0	0	0	0	0	0.1	0.1	0	0	0	0.2	0	0.1	2.8	0	0	0.2	0	0	0	0.1	0	0	0	0	0	0.2	0	0	0	0	0	0.2	0	0	0	0.8	1.7	0.2	0	0	0.1	0	0.2	0	1.8	0.9	0	0	0.1	0	0.3	0	0	0	0	0.1	0	0.1	0.3	0	0	2.3	0	0.1	0.1	0	0	0	0.1	0	0	0	0	0	0	0	0	0.5	0	0	2.9	0	1.1	0.2	0	1.3	0.2	0.3	0.1	0.3	0.2	0.1	0.4	0.1	0.5	0.1	0	0	0	0.1	0	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0.1	0	0	42.8	0	0	0	0.6	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	Hofbauer cells
DCLK1	DCAMKL1, DCDC3A, DCLK, KIAA0369	ENSG00000133083	Doublecortin like kinase 1	O15075	13	35768652-36131306	Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins	Differentiation, Neurogenesis	Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	4	brain: 76.5	Cell type enriched	Detected in many	4	Muller glia cells: 84.2	Cancer enhanced	Detected in many		glioma: 12.4	Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		ASC diff: 16.7;ASC TERT1: 15.8;fHDF/TERT166: 12.9;GAMG: 19.8;HAP1: 10.0;HSkMC: 14.6;NTERA-2: 20.7	Low region specificity	Detected in all			Low region specificity	Detected in all			CAB012405, HPA015040, HPA015655	Enhanced		Approved	Nucleoplasm,Cytosol					11000	Nucleoplasm	Cytosol	CAB012405: , HPA015040: AB_2669141, HPA015655: AB_2669265	unprognostic (2.29e-1)	unprognostic (2.56e-1)	unprognostic (7.45e-2)	unprognostic (1.30e-2)	unprognostic (1.99e-1)	unprognostic (2.35e-2)	unprognostic (1.48e-1)	unprognostic (3.30e-2)	unprognostic (1.66e-1)	unprognostic (1.74e-1)	unprognostic (7.72e-2)	unprognostic (2.85e-1)	prognostic unfavorable (4.42e-4)	unprognostic (1.93e-3)	unprognostic (1.29e-1)	unprognostic (1.34e-1)	unprognostic (1.14e-4)	13.9	3.3	14.3	4.2	25	1.1	8.6	8.6	76.5	12.2	3.5	8.6	0.5	2	6.4	5.8	5.8	3.3	7.1	5.8	21.9	21.9	1.9	1.2	3	4.3	11.9	22.5	6.4	2.1	1.5	7.4	1.1	13.9	4.7	4.4	0.5	2.5	4.7	1.9	4.7	2.7	17	10.4	4.6	2.5	2.2	8.5	0	2.1	1.4	2.9	5	3.5	0	0	0	0	0	0	0	0	0.2	3.8	0	16.7	15.8	0	0.1	0.2	0.1	0.1	0	0	0	0	12.9	19.8	0	10	0.2	0	0	0.6	0	0.4	0	0.6	0	0	14.6	7.3	0.3	0.2	0	0.1	0	0	0	0.2	0	0	0	20.7	0	0.2	0	1.1	0	0.5	0	4.1	2.5	0	0	1.2	6.1	0	0	0	0	3.4	4.3	0.7	0.1	0	0	1.4	0	3.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.3	25	8.6	45.8	21.9	21.9	11.9	22.5	13.9	8.5	8.9	1.1	0	1	13.5	2.2	5.1	0	4	4.5	3.5	3.9	0	0	0	1.3	2.9	0	0	0	0	9.3	0.5	0	0	0.1	9.5	0	0.6	0.3	0.9	19.2	0	13.5	0	0	84.2	0.3	0	3.9	0.2	2.1	6.5	16.8	1.6	0.7	8.4	0	0	0	1.3	Muller glia cells
RXFP2	GPR106, GREAT, INSL3R, LGR8, RXFPR2	ENSG00000133105	Relaxin/insulin like family peptide receptor 2	Q8WXD0	13	31739542-31803388	Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins		G-protein coupled receptor, Receptor, Transducer	Disease mutation	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in some		brain: 8.3;epididymis: 28.4	Cell type enriched	Detected in single	32	Early spermatids: 5.5	Not detected	Not detected			Region enriched	Detected in some	5	basal ganglia: 8.3	Cell type enriched	Detected in single	11	classical monocyte: 5.0	Lineage enriched	Detected in single	23	monocytes: 5.0	Group enriched	Detected in some	6	U-2197: 2.1;U-87 MG: 4.1	Low region specificity	Detected in single			Region enriched	Detected in single	7	basal ganglia: 2.0																													unprognostic (1.77e-2)		0.5	3.3	1.5	0.1	8.3	2	0.6	0	0.5	0	0	0	0	0	2.9	28.4	0	1.5	0.1	0.5	0.6	0.5	0.3	0	0.8	0	0	0	1.8	0	0	0	0	0.5	0	0	0	0	0	0.2	0.2	0	1.6	0	0.2	0	3.1	0	0	0.7	0	0	0	0	0	0.2	0.1	5	0	0	1	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0.5	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.1	0	0	0	0	4.1	0	0	0	5	0	0	0.4	0	0	0	0	0.2	0	0	0	0.1	0	0	0	0	1	1.5	8.3	0	0.5	0.6	0.5	0	0	0.5	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	5.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Early spermatids
POSTN	OSF-2, periostin, PN	ENSG00000133110	Periostin	Q15063	13	37562583-37598844	Cancer-related genes, Plasma proteins, Predicted secreted proteins	Cell adhesion	Heparin-binding	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in many			Cell type enriched	Detected in many	4	Basal keratinocytes: 262.6	Cancer enhanced	Detected in all		breast cancer: 231.9	Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	5	hTEC/SVTERT24-B: 75.1;SuSa: 71.0;U-138 MG: 96.0;U-2197: 65.3	Low region specificity	Detected in many			Low region specificity	Detected in many			HPA012306	Enhanced		Approved	Nucleoplasm,Golgi apparatus	Secreted to extracellular matrix				740000000	Golgi apparatus	Nucleoplasm	HPA012306: AB_1854827	unprognostic (7.73e-2)	unprognostic (1.44e-3)	unprognostic (2.19e-2)	unprognostic (2.57e-2)	unprognostic (4.73e-2)	unprognostic (2.22e-2)	unprognostic (4.19e-3)	prognostic unfavorable (2.93e-4)	unprognostic (3.05e-3)	unprognostic (7.10e-2)	unprognostic (1.32e-2)	unprognostic (5.93e-2)	prognostic unfavorable (1.83e-7)	prognostic unfavorable (4.86e-4)	unprognostic (1.15e-1)	unprognostic (1.20e-1)	unprognostic (8.32e-3)	60.9	2	5.3	12.7	4	0	26.9	0.5	2.7	17.6	14.1	0.6	11.7	0.6	29	20	16.5	20.3	14.5	34.1	6.2	0.5	47.5	3	28.4	19.5	0.5	1.1	21	3.1	8.2	1.7	17.3	2.5	12.4	19.7	0.8	10.8	10.2	14.2	46.1	9.6	14.5	1.7	0.7	37.3	21.5	0.1	3.1	8	5.5	1.7	23.5	12.4	0	0	0	0	0	0	0	0	0	10.8	0.2	13.3	8	0	3.4	0	0.8	0.1	0	0.2	0	0	2.7	0	0	0.1	0	0.4	0	0	0	0	0	2.2	0	0	14.2	0	75.1	0.3	2.4	0.1	0	0	0	1.7	0	0	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0	71	0.1	0	0	96	0	65.3	0.5	0	0	0	0	0	0.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5.3	4	0.5	2.7	6.2	0.5	0.5	1.1	2.5	0.1	6	18.3	0	1.4	262.6	0	19.4	0	9.4	33	0	0	1.5	0	0	0.4	27.7	0	0	0	0.2	42.9	0.3	3.5	0	3.2	0	0	16.5	0	0.2	6.1	0.2	28.7	0	0	0	0.2	0	0.7	0	0	0	62.4	1.1	0.2	42.3	2.9	0	0	0	Basal keratinocytes
STOML3	Epb7.2l, SRO	ENSG00000133115	Stomatin like 3	Q8TAV4	13	38965925-38991066	Predicted membrane proteins, Transporters				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		brain: 9.7;epididymis: 8.1;fallopian tube: 31.7;lung: 9.2	Cell type enriched	Detected in some	24	Ciliated cells: 133.8	Cancer enhanced	Detected in some		endometrial cancer: 2.4	Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	39	AF22: 19.0	Region enriched	Detected in some	6	olfactory region: 29.0	Low region specificity	Detected in all			HPA012892, HPA071011	Enhanced		Supported	Plasma membrane						Plasma membrane		HPA012892: AB_1857610, HPA071011: AB_2732169		unprognostic (2.64e-1)	unprognostic (1.91e-2)	prognostic favorable (1.49e-4)	unprognostic (1.82e-1)	unprognostic (1.17e-1)		unprognostic (4.24e-2)	unprognostic (1.19e-1)	unprognostic (2.14e-1)	unprognostic (2.14e-1)	unprognostic (1.07e-2)	unprognostic (1.35e-2)	unprognostic (3.07e-2)	unprognostic (1.74e-1)		unprognostic (1.22e-1)	0.1	0.1	2.9	0.1	3.8	0.1	0.2	0	0.2	1.7	0.2	6.6	0	0.2	1.1	8.1	0.1	31.7	0.1	0.1	4.4	4.1	0.1	0.1	9.2	0.1	0	0	7.6	0.1	0.1	0	0.3	9.7	0.2	0.2	0	0.1	0.1	0.1	0.2	0.1	0.1	0.3	0.1	0.1	0.6	2.1	0	0.1	0.4	0.1	0.1	0	0	0	0	0	0	0	0	0	0	19	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.9	3.8	0	0.2	4.4	4.1	0	0	9.7	2.1	0	1	0	0	0.1	0	0	0	133.8	5.7	0	0	0.4	0	0	0.2	0	0	0	0	0.4	0	0.2	0	0	0.1	0	0	0	0	1.1	0.3	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0.1	0.6	0	0	0	Ciliated cells
KL		ENSG00000133116	Klotho	Q9UEF7	13	33016433-33066145	Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters		Glycosidase, Hormone, Hydrolase	Disease mutation	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	5	kidney: 64.3;parathyroid gland: 76.9;placenta: 25.5	Cell type enriched	Detected in some	6	Proximal tubular cells: 99.7	Group enriched	Detected in many	6	prostate cancer: 5.9;renal cancer: 17.8	Region enhanced	Detected in some		pons and medulla: 11.6	Cell type enhanced	Detected in single		classical monocyte: 1.0	Low lineage specificity	Detected in single			Group enriched	Detected in some	5	HMC-1: 5.1;SK-BR-3: 9.6	Low region specificity	Detected in many												Secreted to blood			510000					unprognostic (1.32e-1)	unprognostic (3.10e-1)	unprognostic (2.35e-1)	unprognostic (2.73e-3)	unprognostic (3.37e-1)	unprognostic (1.15e-4)	unprognostic (3.06e-2)	unprognostic (6.50e-2)	unprognostic (2.22e-2)	unprognostic (2.60e-1)	prognostic favorable (4.44e-4)	unprognostic (9.46e-2)	prognostic favorable (1.29e-9)	unprognostic (4.76e-3)	unprognostic (1.91e-1)	unprognostic (2.86e-2)	unprognostic (1.07e-1)	4.8	0.6	0.8	0.9	4.3	0.1	7.4	0	0.8	0.7	2.1	3.3	0.2	1	1	3.2	0.8	0.7	0.9	0.9	2.4	0.8	64.3	0.2	10.4	0.9	0.5	0.3	0.4	1.6	76.9	0.3	25.5	11.6	3.3	0.4	0.3	0.7	1	0.9	0.4	3.2	0.7	0.4	3.1	1.9	0.6	0.3	0	1.4	1.3	0.3	1.5	1.1	0	0	0	1	0.3	0.6	0.1	0	0	0	0	0	0	0	0	0	0	0	0	1.6	0	0	0.1	0	0	0.7	0	0	0	0	0	0	0	0	0	5.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	9.6	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0.1	0	0	0	0	0	0	0.6	0	0	0.3	0	0	0	0.1	0.8	4.3	0	0.8	2.4	0.8	0.5	0.3	11.6	0.3	0	0.3	0	0.1	0.1	0	0.8	0	1.4	1.2	12.2	0	0.1	5	0	1.7	1.8	0.9	0	0	0.1	0.7	4.4	0	0	2.1	0	15.6	0	0.8	0	0.3	0.7	0	1	0	0	0	0	0.4	99.7	0	0	0.3	0.5	0.2	0.1	0.1	0	0.6	0.1	Proximal tubular cells
PDE6B	CSNB3, CSNBAD2, PDEB, rd1, RP40	ENSG00000133256	Phosphodiesterase 6B	P35913	4	625584-670782	Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins	Sensory transduction, Vision	Hydrolase	Congenital stationary night blindness, Disease mutation, FDA approved drug targets, Retinitis pigmentosa	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 30.2;retina: 64.2	Cell type enriched	Detected in many	6	Rod photoreceptor cells: 453.5	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Cell line enhanced	Detected in some		EFO-21: 8.0;JURKAT: 11.8;MOLT-4: 20.5;REH: 11.1;SCLC-21H: 14.0;SH-SY5Y: 8.2;U-266/84: 15.2	Not detected	Not detected			Not detected	Not detected			HPA054148, HPA059929	Enhanced		Approved	Cytosol						Cytosol		HPA054148: AB_2682401, HPA059929: AB_2684166	unprognostic (2.43e-2)	unprognostic (1.33e-4)	unprognostic (2.45e-4)	unprognostic (7.18e-3)	unprognostic (1.88e-2)	unprognostic (5.04e-3)	unprognostic (7.32e-3)	prognostic favorable (5.34e-4)	unprognostic (9.70e-2)	unprognostic (1.14e-1)	unprognostic (1.37e-2)	unprognostic (2.33e-2)	unprognostic (4.09e-2)	unprognostic (1.67e-2)	unprognostic (2.26e-1)	unprognostic (2.41e-3)	unprognostic (1.85e-1)	1.6	1.9	12.1	4.6	19.1	6.7	3.8	2.3	13.2	2.3	1.3	30.2	1.5	0.8	2.5	3.9	1.4	9.6	3.2	5.2	18.1	10.2	4.6	0.7	4.2	12	29.6	9.8	2.6	1.4	9.1	3.2	2.6	14.5	2.5	1	64.2	3.5	2.9	0.7	1.8	2.2	2.1	20.2	8.7	2.5	3.6	22.4	4.3	11.4	0.2	8.3	4.1	1.1	16.5	14.1	11.2	5.8	10.2	13.1	7.1	0	0.2	0.8	0.4	0.2	0.3	0.2	0	0	0.5	1.4	0	0.1	0.2	8	0.2	0.7	0.1	1.7	0.4	0	0.1	0	0.6	0.2	0	4.1	0.1	0.3	0.5	0.1	2.4	0	0.5	0.7	11.8	0.1	0.6	0	0.2	20.5	0.2	6.5	0.4	0.2	11.1	0.2	0.4	1.4	0.9	14	8.2	0	0.3	0.1	3.3	0.4	0	0.2	0.1	0.8	0.1	0.3	5.4	15.2	0.2	0.2	0.2	0.1	11.2	4.2	0.6	11.5	5.8	10.5	10	7.7	7.9	6.6	16.5	12.2	13.1	1.1	10.2	5.6	14.1	11.4	7.1	12.1	19.1	2.3	10	18.1	10.2	29.6	9.8	14.5	22.4	3	5.3	4.5	1.2	0.3	18.2	3.7	0	16	5.7	0	78.5	0.1	1.7	5.1	0.4	1.8	0	0	0.6	0.2	0.8	0.9	3.5	0	9.2	11.1	1.7	2.5	3.9	0	1.4	3.4	3.3	7.2	0.2	20.9	0.7	0	1.4	6.7	453.5	0	0.2	3.9	2.7	0.3	0.2	7	0.1	0.6	Rod photoreceptor cells
C1QTNF6	CTRP6, ZACRP6	ENSG00000133466	C1q and TNF related 6	Q9BXI9	22	37180167-37199385	Predicted intracellular proteins, Predicted secreted proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	6	endometrium 1: 23.7;placenta: 79.5	Cell type enriched	Detected in many	12	Extravillous trophoblasts: 349.8	Low cancer specificity	Detected in all			Low region specificity	Detected in many			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		MCF7: 45.0;RT4: 20.8	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA002042	Enhanced		Approved	Nucleoplasm	Secreted to blood	No	No	354000000		Nucleoplasm		HPA002042: AB_1078342	unprognostic (9.65e-2)	unprognostic (1.21e-2)	unprognostic (2.32e-1)	unprognostic (2.23e-3)	unprognostic (1.25e-3)	unprognostic (3.01e-2)	unprognostic (3.17e-2)	prognostic unfavorable (9.60e-6)	unprognostic (6.96e-2)	unprognostic (5.11e-2)	unprognostic (2.61e-2)	unprognostic (1.72e-1)	prognostic unfavorable (0.00e+0)	unprognostic (1.61e-2)	unprognostic (5.36e-2)	unprognostic (1.08e-3)	unprognostic (1.52e-2)	3.3	4.4	1.2	4.2	1.6	0.8	2.5	1.2	1.8	7.8	2.5	1.3	1.6	1	23.7	7.2	1.6	5.2	6.2	3.1	1.4	0.7	3.9	7.9	9.2	3.1	1.2	1.3	5.9	2.3	1.4	1.4	79.5	1.7	4.3	2.5	4.4	2.2	3.4	1.5	3.1	3.2	5.7	1.8	4.6	1.8	3.5	1.2	1.6	2.4	1.7	1.8	5.1	2.7	2.4	1.1	1.8	0.5	4	3.8	1	6.7	8.4	4.4	1.5	0.8	8.9	13.4	1.4	2.8	1.1	0.8	1.5	9.9	0	5.7	2.3	0.6	14	0.1	3.4	0.5	1.9	1.1	1.1	3.2	1.5	3.1	0	0.9	12.3	1.9	0.9	0.2	3	10.6	0.3	0	3.1	0.4	45	0	0.2	2.8	1	0.1	0.1	0	1.1	10.2	20.8	0.7	5.7	0.4	8.1	1.1	2.4	2.8	0.2	3.6	0.4	2.3	0.1	0	6.5	0.1	0	0.9	0.8	1.2	1	0.5	1.5	0.7	0.5	0.8	0.8	1.3	1	0.5	2.4	2.9	2.2	1.8	4	0.3	1.1	3.8	1	1.2	1.6	1.2	1.8	1.4	0.7	1.2	1.3	1.7	1.2	0	0	3	1.4	1.3	0.9	1.1	2.5	4	2.3	1.8	0	4.2	1.7	1.9	1.7	1.4	2.6	0	1	349.8	8.9	0.6	1.1	5	8.4	0	0	11.6	1	6.2	0.6	0.9	5	1	2.1	4.2	2	3.5	0.4	1.3	0.7	0	3.3	7	4	0.3	28.8	2.5	3.9	1	Extravillous trophoblasts
DYDC2	bA36D19.6, MGC16186	ENSG00000133665	DPY30 domain containing 2	Q96IM9	10	80344745-80368073	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		brain: 16.3;fallopian tube: 56.4	Cell type enriched	Detected in some	9	Ciliated cells: 337.3	Cancer enhanced	Detected in some		endometrial cancer: 3.2	Group enriched	Detected in many	5	amygdala: 6.3;basal ganglia: 9.1;hippocampal formation: 7.7;hypothalamus: 6.8;pons and medulla: 16.3	Cell type enhanced	Detected in some		basophil: 2.4	Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		AF22: 4.4;NTERA-2: 7.0;SCLC-21H: 6.0;SH-SY5Y: 4.0;U-2197: 4.4					Low region specificity	Detected in all			HPA038006, HPA038007	Enhanced											HPA038006: AB_10672734, HPA038007: AB_2675783	unprognostic (1.60e-3)	unprognostic (7.35e-2)	unprognostic (1.89e-2)	unprognostic (9.26e-3)	unprognostic (8.85e-2)	unprognostic (3.26e-1)	unprognostic (1.25e-1)	unprognostic (1.26e-2)	unprognostic (1.55e-1)	prognostic favorable (3.54e-4)	unprognostic (1.87e-2)	unprognostic (2.43e-1)	unprognostic (2.34e-2)	unprognostic (5.28e-2)	unprognostic (1.41e-4)	unprognostic (9.86e-2)	unprognostic (5.40e-2)	0.2	0.2	6.3	0.2	9.1	0.6	0.4	0.1	1.7	1.6	0.3	3	0.1	0.3	1.3	10	0.5	56.4	0.4	0.2	7.7	6.8	0.3	0.3	3.6	0.2	0.2	0.4	4.3	0.6	0.2	0.1	0.4	16.3	0.3	0.2	0.1	0.3	0.3	0.3	0.3	0.2	0.2	0.6	0.2	0.4	5.2	0.7	0.1	0.3	0.1	0.2	0.2	0.1	0.6	0.6	2.4	0.3	1.2	0.4	0	0.2	0.1	4.4	0.1	0.5	0	0.1	0	0.6	0.4	0.1	0.4	0.7	0.1	0.9	0.1	1	0.2	0.3	0.1	0.1	0.2	0.6	0.3	0.2	1.5	0	0	0.4	0.2	1.1	0	0.1	0	0	1.4	0.2	0.3	0.3	0.3	0.7	0	7	0	0	1.8	0.5	1.6	0	0.1	6	4	0.2	0	0.7	1.7	0	2.7	0.1	0.1	0.3	4.4	0	0.1	0.1	0.3	0.4	0	0	2.4	0.3	0.1	0.3	0.1	0.4	0.3	0.3	0.2	0	0.6	0.3	0.4	0.5	1.2	0.2	0.6	0	0	6.3	9.1	0.1	1.6	7.7	6.8	0.2	0.4	16.3	0.7	0	1.9	0	0	0	0	0.2	0	337.3	30.7	0	0	0	1.7	0.4	35.5	0	0	0	0.4	0	0	0.2	0	0.6	0.1	0	0	0	0	24.4	1.1	0.1	0	0	0	0	0.1	0	0.7	0	0	0	0	1.9	2.2	0	0	0	0	0.1	Ciliated cells
CA1	Car1	ENSG00000133742	Carbonic anhydrase 1	P00915	8	85327608-85379014	Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins		Lyase	FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	6	bone marrow: 156.0;intestine: 203.6	Cell type enriched	Detected in some	19	Erythroid cells: 11890.7	Group enriched	Detected in some	10	colorectal cancer: 3.4;stomach cancer: 0.9	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	1207	HEL: 169.2	Low region specificity	Detected in single			Not detected	Not detected			HPA006558, CAB025790	Enhanced								7800000000			CAB025790: , HPA006558: AB_1845989	unprognostic (1.44e-1)	unprognostic (7.56e-2)	unprognostic (1.70e-1)	unprognostic (3.57e-3)	unprognostic (2.08e-2)	unprognostic (1.66e-1)	unprognostic (2.84e-2)	unprognostic (2.03e-2)		unprognostic (1.73e-2)	unprognostic (6.12e-2)	unprognostic (1.63e-1)	unprognostic (1.04e-1)	unprognostic (5.61e-2)	unprognostic (3.01e-2)	unprognostic (2.38e-1)	unprognostic (3.95e-2)	1.8	0.4	0.5	11.5	0.5	156	0.4	0.3	0.4	0.3	95.4	1.5	0	0	0.3	0	0.6	0.7	0	17.6	0.5	0.4	0.8	2.9	32.2	0.2	0.9	0	0.8	0.5	0	1	24	0.6	1.1	203.6	2.6	0.3	0.1	3.1	0.2	0.4	3.2	0.5	14.3	0.3	0.3	0	0.2	7.5	0	0.2	4.5	16	0.7	0.7	0	0.3	0	0.1	7.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	169.2	0	0	0	0	0	0	0.1	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0.1	0	0	0.7	0	0	0.3	0.3	0	0	0	0	0	0.7	0	7.5	0.5	0.5	0.3	0.4	0.5	0.4	0.9	0	0.6	0	0	0	1.5	0	0	0	0.3	0	0	0	0	0	0	0	0	0.4	0	624.8	11890.7	0	0	0	0.1	23	0.6	0	0	44	1.3	1.6	0	0	0	0	0	89.9	0	0	422.3	0	0	0	0	0	0	0	0	0	0	79.4	0	Erythroid cells
ADAM20		ENSG00000134007	ADAM metallopeptidase domain 20	O43506	14	70522358-70535015	Predicted membrane proteins		Hydrolase, Metalloprotease, Protease		Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at transcript level		Tissue enriched	Detected in some	18	testis: 18.7	Cell type enriched	Detected in some	9	Early spermatids: 36.8	Not detected	Not detected			Not detected	Not detected			Cell type enhanced	Detected in single		MAIT T-cell: 1.0	Low lineage specificity	Detected in single			Low cell line specificity	Detected in single							Not detected	Not detected			HPA059377	Enhanced											HPA059377: AB_2683997	unprognostic (4.13e-3)	unprognostic (3.45e-2)	unprognostic (1.14e-1)	unprognostic (8.34e-2)	unprognostic (2.06e-1)	unprognostic (1.57e-2)	unprognostic (5.61e-2)	unprognostic (2.89e-2)	unprognostic (1.58e-3)	unprognostic (1.77e-1)	unprognostic (1.18e-1)	unprognostic (3.03e-1)	unprognostic (2.46e-3)	unprognostic (2.64e-1)	unprognostic (6.83e-2)	unprognostic (5.06e-2)	unprognostic (9.52e-3)	0.1	0	0.1	0.1	0.1	0.1	0.1	0.7	0.4	0.2	0.1	0.1	0.1	0	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0	0.1	0.1	0.1	0.4	0.2	0.1	0.1	0.1	0.1	0	18.7	0.1	0.1	0.2	0.1	0.1	0.1	0.2	0.1	0	0.1	0.6	0	1	0	0.3	0.3	0.4	0.2	0	0	0.3	0.2	0.1	0.3	0.3	0	0	0.3	0.3	0	0	0.4	0	0	0.1	0.1	0	0.5	0.4	0.2	0	0	0.3	0.6	0.6	0.2	0.5	0.3	0	0.2	0	0.1	1.1	0.6	0.4	0.7	0.3	0.4	0.9	0.4	0.2	0	0.3	0.5	0.6	0.1	0.2	0	0.3	0.1	0.1	0	0	0.7	0.4	0	0.1	0.2	0	0.5	0.3	0.4	0.1	0.1	0	0	0.2	0	1	0.1	0	0	0	0.1	0.4	0	0	0	0.6	0	0	0	0.1	0.1	0.7	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0.1	0.2	4.2	0.4	0	0	0	0	3.9	0.1	0	0.1	36.8	0	0	0	0	0.1	0.1	0.3	0	0	0.1	3.2	0	0	0	4.1	0.3	0	0	0	0	0.4	0.2	0	0.7	0	3.7	0	0.3	2.3	0.1	0.1	0.1	0	0	0.3	Early spermatids
CCNB1	CCNB	ENSG00000134057	Cyclin B1	P14635	5	69167010-69178245	Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters	Cell cycle, Cell division, Mitosis	Cyclin	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		lymphoid tissue: 71.4	Cell type enriched	Detected in many	9	Extravillous trophoblasts: 610.8	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low cell line specificity	Detected in many			Low region specificity	Detected in single			Low region specificity	Detected in all			CAB000115, CAB003804, HPA030741, HPA061448	Enhanced		Enhanced	Cytosol		Yes	Yes			Cytosol		CAB000115: , CAB003804: AB_562272, HPA030741: AB_2673586, HPA061448: AB_2684522	unprognostic (4.12e-2)	unprognostic (2.75e-2)	unprognostic (1.91e-3)	unprognostic (4.08e-3)	unprognostic (2.78e-1)	unprognostic (1.39e-1)	prognostic unfavorable (1.54e-7)	prognostic unfavorable (3.38e-4)	unprognostic (1.43e-2)	unprognostic (1.63e-2)	unprognostic (2.49e-3)	unprognostic (1.40e-1)	prognostic unfavorable (1.11e-16)	unprognostic (2.44e-1)	unprognostic (3.73e-1)	unprognostic (1.44e-1)	unprognostic (5.15e-3)	3.2	4.6	2.7	23.9	4.8	20.5	4.6	6.5	5.6	4.4	9.9	1.6	1.6	9.3	3.5	2.8	28.8	3.3	3.5	1.9	3.5	4.2	4.6	2.9	3.4	23.6	4	4.2	3.7	4	1.6	2.6	12.1	11.5	2.6	14.2	1.7	5.3	1.7	2	6.4	8.7	6.4	2.5	9.1	7.1	21.7	1.3	71.4	6.3	23.3	30.1	5.3	7.5	13.2	5.1	2.4	4.1	6.5	14.7	5.5	58.6	40.6	55.8	49.6	2.9	5	131.7	26	19.5	68.6	58.1	60	55.4	36.1	31.7	23.9	78.7	37	56.1	56.8	77	35.4	27.7	22.9	33.9	41.4	0.9	19.9	26.2	2.2	3.6	39.3	27.4	6.3	36.6	35.4	27.6	28.7	55.8	55.9	27.2	23.7	31	19.5	25.8	28.7	40.2	37	25.1	21.7	28.4	17.9	44.7	21.1	19.2	32.8	40.3	20.9	15.3	15.3	49.7	27.6	64.9	14.4	26.6	50.4	21.2	34.9	47	2.4	1.8	1.2	2.8	4.1	4	13.2	7.6	6.7	5.1	8.6	2.5	2.4	1	6.5	1.9	4.2	14.7	5.5	2.7	4.8	6.5	5.6	3.5	4.2	4	4.2	11.5	1.3	0	0.3	5.2	4.8	10.2	4.2	1.5	2.5	13.4	4.5	5.2	2	53.5	1.7	5.3	63.8	1.8	2.9	46.7	1.2	610.8	11.3	3.6	2.3	3	50.4	0	1.2	6.2	6	9.4	2.8	4.4	3.3	3.6	4.6	2.8	2.5	0	2.5	4.3	2.9	6.5	3.1	28.8	70.2	6.4	34.7	4.4	11.5	2.7	Extravillous trophoblasts
CNTN6	NB-3	ENSG00000134115	Contactin 6	Q9UQ52	3	1092576-1404217	Predicted membrane proteins	Cell adhesion, Notch signaling pathway			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	5	brain: 41.4;thyroid gland: 18.9	Cell type enriched	Detected in some	6	Alveolar cells type 1: 32.8	Group enriched	Detected in some	15	renal cancer: 2.7;thyroid cancer: 3.2	Region enriched	Detected in many	5	cerebellum: 41.4	Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	45	AF22: 5.1;GAMG: 2.4;SH-SY5Y: 5.9;SuSa: 4.4	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA016645	Uncertain								2100000			HPA016645: AB_1847149	unprognostic (1.09e-1)	unprognostic (3.70e-1)		unprognostic (2.27e-1)	unprognostic (3.99e-1)	unprognostic (3.16e-1)	unprognostic (1.05e-4)	unprognostic (1.45e-1)	unprognostic (1.86e-1)	unprognostic (3.80e-2)	unprognostic (2.61e-2)	unprognostic (4.65e-2)	unprognostic (1.26e-3)	unprognostic (5.45e-2)	unprognostic (5.23e-2)	unprognostic (1.15e-1)	unprognostic (4.46e-2)	0.2	4.7	1.6	0.2	2.2	0.2	0.4	41.4	6.3	0.3	0.3	0.1	0	0.2	0.3	0.8	0.3	0.4	0.2	0.4	1.5	3	0.5	0.2	5.6	0.2	2.4	2.6	0.2	0.3	0.2	0.5	3.4	7.8	0.2	0.3	0.4	0.3	0.3	0.2	0.2	0.2	0.3	1.7	0.2	0.2	0.4	0.3	0	18.9	0	0.2	0.3	0.1	0	0	0	0	0	0	0	0	0	5.1	0	0	0	0	0	0	0	0	0	0	0	0	0	2.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5.9	0	0	0	4.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.6	2.2	41.4	6.3	1.5	3	2.4	2.6	7.8	0.3	32.8	2.2	0	0	0	2.6	0.4	0	1.4	5.7	0	0	0.2	0	0	1.5	0	0	0	0	0.1	0	0	0	0	0.3	0	0	0	0	1.1	0	0	0	0	0	0	0.1	0	0	0	0.2	0	0	0	0	0	0.5	0	0	0	Alveolar cells type 1
TRPM1	CSNB1C, LTRPC1, MLSN1	ENSG00000134160	Transient receptor potential cation channel subfamily M member 1	Q7Z4N2	15	31001061-31161273	Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels	Ion transport, Sensory transduction, Transport, Vision	Ion channel, Ligand-gated ion channel, Receptor	Congenital stationary night blindness, Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	9	retina: 99.0	Cell type enriched	Detected in some	5	Bipolar cells: 705.2	Cancer enriched	Detected in single	179	melanoma: 14.6	Low region specificity	Detected in single			Cell type enhanced	Detected in single		naive B-cell: 1.0	Low lineage specificity	Detected in single			Cell line enriched	Detected in single	113	SK-MEL-30: 16.3	Not detected	Not detected			Not detected	Not detected			HPA014779, HPA071139	Enhanced		Uncertain	Golgi apparatus,Plasma membrane,Centriolar satellite						Centriolar satellite	Golgi apparatus, Plasma membrane	HPA014779: AB_2669090, HPA071139: 	unprognostic (5.28e-2)	unprognostic (1.35e-1)		unprognostic (9.89e-2)	unprognostic (3.07e-1)	unprognostic (1.97e-1)	unprognostic (1.70e-1)	unprognostic (1.29e-3)	unprognostic (2.83e-1)	unprognostic (2.89e-2)	unprognostic (1.67e-1)	unprognostic (1.45e-2)	unprognostic (2.58e-1)	unprognostic (7.84e-2)	unprognostic (6.20e-4)	unprognostic (1.48e-1)	unprognostic (2.63e-2)	0.1	0	0.4	0	0.6	0	0.1	0.1	0.3	0.4	0	0	0	0.2	0	0	0	0	0	0.1	0.7	0.2	0.3	0.1	0.1	0.1	1.6	0	0	0	0	0	0.1	0.3	0	0	99	0.4	0	0.2	10.4	0	0.1	1.9	0	0	2.9	0.1	0	0	0	0.1	0	0	1	0	0.3	0	0	0	0.1	0.1	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	16.3	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0.1	0	0	0	1	0	0	0.3	0	0	0	0	0.1	0.4	0.6	0.1	0.3	0.7	0.2	1.6	0	0.3	0.1	0	0	0	0	3.8	705.2	0.4	0	0	0	0	0	0.2	0	0	30.8	0.1	0	0	0	0.1	0.3	0	0	0	0.1	12.7	0	0	0	2.4	0	0	150.1	0	0	10	0	0	0	0.6	18.1	0	0	7.9	3.8	0.9	0.8	0	0	0	Bipolar cells
GNAT2	ACHM4	ENSG00000134183	G protein subunit alpha transducin 2	P19087	1	109603267-109619929	Disease related genes, Predicted intracellular proteins	Sensory transduction, Vision	Transducer		Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	4	retina: 27.6	Cell type enriched	Detected in some	14	Cone photoreceptor cells: 56.9	Not detected	Not detected			Not detected	Not detected			Cell type enriched	Detected in single	5	eosinophil: 3.0	Lineage enriched	Detected in single	7	granulocytes: 3.0	Cell line enhanced	Detected in some		HAP1: 5.5;U-698: 3.9	Not detected	Not detected			Low region specificity	Detected in all																																	0.1	0.4	0.1	0.1	0.3	0	0.4	0.2	0.3	0.1	0.1	0.1	0.1	0	0.2	0.1	0.2	0.4	0.6	0.2	0.2	0.2	0.1	2.5	0.5	0.3	0.1	0.1	0.1	0.4	0.4	0.8	1.2	0.3	0.2	0.5	27.6	0.4	0.3	0.1	0.1	0.6	0.2	0.1	0.4	0.1	6.4	0.1	0.1	0.2	0.1	0.4	0.3	0.1	0.2	0.3	3	0.4	0	0.3	0	0.9	0.2	0.3	0.9	0.4	0.3	0.1	0.5	0.3	0.6	0.1	2.2	0.8	2.4	2.1	0.1	0.8	0.2	5.5	0.1	0.9	0	0.1	0.1	0.5	0.9	0	2.2	0.3	1.1	0.8	1.3	1	0	1.4	0.5	1.4	1.5	0.8	1.8	0.7	0.2	1	1.1	0.5	0.7	0	1.1	0.7	0.6	1.8	0	1.9	0.5	2.9	0	0.4	0	0	0.4	0.6	1	0.5	2.7	1.6	3.9	0.7	0.4	0.5	0	0	3	0	0.4	0	0.2	0	0.3	0	0	0	0	0.5	0	0.1	0.3	0	0	0.1	0.3	0.2	0.3	0.2	0.2	0.1	0.1	0.3	0.1	0	0	0	0	0	0.8	0	0	0	0	0	56.9	0.1	0	0	2.8	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	4.1	0	0	0	0	0	0.8	0	0	0.4	0	1.5	0	0	3.2	0.5	0	0.1	0	0	0	Cone photoreceptor cells
CHIA	AMCase, CHIT2, TSA1902	ENSG00000134216	Chitinase, acidic	Q9BZP6	1	111290862-111320566	Enzymes, Predicted intracellular proteins	Apoptosis, Carbohydrate metabolism, Chitin degradation, Immunity, Inflammatory response, Polysaccharide degradation	Glycosidase, Hydrolase		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in some	5	stomach 1: 66.6	Cell type enriched	Detected in some	8	Alveolar cells type 2: 22.2	Cancer enhanced	Detected in some		lung cancer: 1.8;stomach cancer: 2.0	Not detected	Not detected			Cell type enhanced	Detected in single		naive B-cell: 1.6	Low lineage specificity	Detected in single			Group enriched	Detected in some	4	ASC diff: 6.0;HAP1: 3.1					Low region specificity	Detected in single			HPA059193	Approved				Intracellular and membrane							HPA059193: AB_2683942				unprognostic (8.00e-2)	unprognostic (7.08e-2)			unprognostic (2.02e-2)					unprognostic (4.99e-2)	unprognostic (7.93e-2)	unprognostic (1.46e-1)	unprognostic (1.06e-2)		0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0	0.7	0.5	0.8	0.3	0.1	0.1	0.1	0	0.5	1	13.2	0.2	0.1	0.1	0.1	0.1	0.6	0.5	0.1	0.1	0.1	0	0.1	0.1	0.5	0.1	0	0.1	0.1	0.1	0.1	66.6	0.5	0.1	0.1	0.5	0.1	0.1	0.1	0.1	1.6	0.7	0	0.1	0.6	0.6	0.3	0	0	0	0	6	0	0	0	0.1	0	0.1	0	0	0	0	0	0	0	3.1	0	0	1	0	0	0	0	0.4	0	0.6	0.5	0	0	0.2	0.5	0.1	0.2	0	0	0.3	0	0.2	0	0.1	0	0	0	0	0	0.3	0	0	0	0	0	0.2	0.6	0	0.1	0.5	0	0	0	0	0.2	0	0	0.1	0	0	0	0.1	0	0.3	0.1	0.1	0.7	0.2	0.2	0	1.6	0.6	0	0	0.6	0	0.7	0	0.3	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	22.2	0	0	0	0	0.2	0	0	1.2	0	0	0	0	0	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Alveolar cells type 2
ADAM30	svph4	ENSG00000134249	ADAM metallopeptidase domain 30	Q9UKF2	1	119893533-119896495	Plasma proteins, Predicted membrane proteins		Hydrolase, Metalloprotease, Protease		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	301	testis: 30.0	Cell type enriched	Detected in some	8	Early spermatids: 53.8	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			HPA026080	Uncertain											HPA026080: AB_1844581																		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	30	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	53.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4.5	1.1	0	0	0	0	0	0	0	0.4	0	0	6.5	0	1.6	0.4	0	0	0	0	0	Early spermatids
MYCN	bHLHe37, MYCNOT, N-myc, NMYC	ENSG00000134323	MYCN proto-oncogene, bHLH transcription factor	P04198	2	15940564-15947007	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	Activator, DNA-binding	Cancer-related genes, Disease mutation, Proto-oncogene	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		placenta: 16.8	Cell type enriched	Detected in some	8	Extravillous trophoblasts: 75.4	Cancer enhanced	Detected in many		testis cancer: 45.5	Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		AF22: 12.9;BEWO: 70.2;HMC-1: 16.9;NTERA-2: 26.6;RH-30: 18.6;SuSa: 12.6	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA057420			Approved	Nucleoplasm,Nucleoli						Nucleoli	Nucleoplasm	HPA057420: AB_2683434	unprognostic (8.04e-2)	unprognostic (1.96e-1)	unprognostic (1.29e-1)	unprognostic (2.07e-2)	unprognostic (4.11e-1)	unprognostic (2.46e-2)	unprognostic (1.23e-2)	unprognostic (3.03e-2)	unprognostic (1.81e-1)	unprognostic (3.35e-3)	unprognostic (3.09e-2)	unprognostic (2.09e-1)	unprognostic (1.12e-3)	unprognostic (8.89e-2)	unprognostic (2.47e-1)	unprognostic (4.90e-2)	unprognostic (1.23e-1)	0.9	1.9	5.1	1.8	5.5	1.6	1.2	1.4	8.4	3.1	1.2	12.1	0	3	1.9	0.8	1.3	1.4	2.6	2.3	7	4.7	6	1.5	1.6	2.9	6	2.2	10.3	0.7	0.4	0.7	16.8	6.8	0.6	1.3	1.1	6.6	0.7	1	2.4	1.7	0.9	8.9	0.9	8.5	6.5	4	5.7	5.1	2.3	3.5	2	0.9	0	0	0	0	0	0	0	0	0	12.9	0	0	0	70.2	0	0	0	0	1	0	0	1.2	0	0	0	0.5	0	0	0	0	4.7	0	0	0	0	16.9	0	0	0	0	0	0	0.2	0	0	0	0.2	0.1	0	26.6	0.6	0	0	18.6	3.5	0	0.9	0.2	4.7	0	0	0	12.6	0	0	0	0	0.3	0	0	0.8	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5.1	5.5	1.4	7	7	4.7	6	2.2	6.8	4	0	0	0	0.1	0.5	2.6	0.7	0	0	0	0	0	4.4	0	0	1.2	0.2	0	0	0	75.4	0.6	0	0	0.5	2	0	0	0	0	0	0	0	0	0	0.7	0.8	0.2	0	0.4	2.1	0.1	0	0	0.5	3.6	0	9.6	0	0.2	0	Extravillous trophoblasts
LPIN1	KIAA0188	ENSG00000134324	Lipin 1	Q14693	2	11677595-11827409	Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins	Fatty acid metabolism, Lipid metabolism, Transcription, Transcription regulation	Hydrolase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		skeletal muscle: 88.4	Cell type enriched	Detected in many	4	Late spermatids: 1310.7	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Cell line enhanced	Detected in all		U-266/70: 38.8	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA024591, HPA038021	Approved		Approved	Plasma membrane,Cytosol						Cytosol	Plasma membrane	HPA024591: , HPA038021: AB_10669514	unprognostic (1.97e-1)	unprognostic (2.47e-1)	unprognostic (1.32e-1)	unprognostic (1.87e-2)	unprognostic (9.17e-2)	unprognostic (2.69e-2)	unprognostic (8.20e-2)	unprognostic (5.28e-3)	unprognostic (1.09e-1)	unprognostic (1.07e-2)	unprognostic (2.45e-3)	unprognostic (2.55e-2)	unprognostic (1.06e-1)	unprognostic (5.58e-3)	unprognostic (1.25e-1)	unprognostic (9.60e-2)	unprognostic (4.02e-1)	18.1	10.1	13	10.7	18.3	6	22.1	20	16.4	10.5	8.6	10.9	7.3	8.9	11	15	20	7	10.4	12.8	11.6	11.9	7.6	13.2	8	15.4	13.2	11.2	19.3	7.5	17.2	32	9	17.9	9.6	7.1	9	14.4	11.6	88.4	6.5	9.2	11	10.3	8.4	7.6	39	13.2	8.3	8.1	14	19.2	10.4	21.7	6.5	9.6	11.6	2.8	8	11.1	3.2	5.5	6.6	5.5	12.3	25.5	28.4	2.8	7.8	13.4	5	8.7	2.4	5.5	2.7	1	6.6	14.8	6	6.2	17	4.6	11.4	3.4	6.8	3.7	3.5	9	4.7	32.1	25.6	7.7	20.8	7.9	14.7	9.7	6.7	9.4	24.7	3.7	2.1	4.4	4.1	5.7	1.8	6.7	6.1	10.1	17.3	12.7	3.6	15.3	12.1	2.8	6.8	17.5	5.5	1.7	2.6	6.8	8	7.2	5.1	6.7	38.8	30	5.2	11.3	8.4	5.9	9.5	2.8	11.6	10.3	2.1	11.1	6.5	9.6	9.7	2.5	5	8.4	7.1	1.1	8	2.1	9.6	10.5	3.2	13	18.3	20	14.4	11.6	11.9	13.2	11.2	17.9	13.2	20.8	49.1	22.9	38.9	16.9	40.6	49.5	25.5	61.6	63.7	10.4	80.5	7.3	6.6	18.7	314.7	24.6	9.7	0	24.2	5.3	24.6	29.2	33.6	21.9	8.1	46.1	34.7	15.4	15.7	1310.7	110.1	27.2	16.9	7.2	23.9	16.4	25.5	11.6	169	3.4	47.2	32.3	20.6	18.4	17.8	10.5	10.3	57.5	13.6	26.8	Late spermatids
CMPK2	NDK, TYKi, UMP-CMPK2	ENSG00000134326	Cytidine/uridine monophosphate kinase 2	Q5EBM0	2	6840570-6866635	Enzymes, Predicted intracellular proteins	Pyrimidine biosynthesis	Kinase, Transferase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	4	Erythroid cells: 70.0	Low cancer specificity	Detected in all			Low region specificity	Detected in many			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		BJ hTERT+ SV40 Large T+: 14.2;BJ hTERT+ SV40 Large T+ RasG12V: 12.9;HEL: 20.1;MOLT-4: 11.0	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA041430	Approved		Supported	Nucleoplasm,Mitochondria						Mitochondria	Nucleoplasm	HPA041430: AB_10796674	unprognostic (2.37e-1)	unprognostic (6.07e-2)	unprognostic (5.71e-2)	prognostic unfavorable (4.71e-4)	unprognostic (1.82e-1)	unprognostic (5.08e-2)	unprognostic (3.80e-2)	unprognostic (8.93e-2)	unprognostic (6.63e-2)	unprognostic (4.54e-3)	unprognostic (7.39e-3)	unprognostic (1.43e-1)	unprognostic (1.09e-3)	unprognostic (1.28e-1)	unprognostic (1.77e-2)	unprognostic (7.69e-2)	unprognostic (4.32e-2)	8.8	3.8	3	6.8	8.1	14.5	4.2	0.9	5	2.7	4.2	4	1.3	5	2.5	6.4	1.8	2.3	3.4	3.7	3.3	3.9	4	3.1	17.9	13.4	3.2	5.7	1.3	3.7	2.9	3	4.7	3.6	2.1	2.2	4.7	20.8	4.3	3	1.2	6.1	3.1	3.8	7.9	7.4	9.2	0.4	8.8	3.1	1.6	2.6	2.7	1.6	1.4	1.9	7.8	6.4	0.9	0.7	1.2	0.2	0	0	0	0	0	2.7	0	0.2	14.2	12.9	0	1.4	3.1	0.8	0	3.7	0.2	0	0	0	0.3	0.2	20.1	0	0	0	0.7	1.4	0	0	0.1	0	0	0	2	4.9	0.1	0	0.1	11	3.7	0.3	0	1.1	3.5	0	0	0	0.4	0.3	0.5	0.2	0	1.7	0	0	1.3	0	0	0.2	0	0	3.3	0.4	0	0	3.7	0.9	5.5	2.8	7.8	0.7	6.4	0.4	1.4	0.5	0.4	1.9	0.2	0.5	0.5	1.8	0.9	3.2	0.1	0.6	1.2	3	8.1	0.9	5	3.3	3.9	3.2	5.7	3.6	0.4	3	6.9	2.7	0.8	0.3	1.6	1.4	0	4	0	1.8	0	2	1.7	2.4	2.5	4.7	5.3	70	5.8	2.4	1.9	0.7	2.3	1.3	15.9	0	6.9	7.4	6.7	1.1	1.4	5.1	0	5.4	1.7	4.6	4.1	1.9	5.3	0.6	0.2	0	2	0.1	4.1	0.4	0.7	4.3	0.9	1.6	Erythroid cells
SAA2		ENSG00000134339	Serum amyloid A2	P0DJI9	11	18239223-18248643	Disease related genes, Predicted secreted proteins	Acute phase		Amyloidosis	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	11	liver: 752.1	Cell type enriched	Detected in many	23	Hepatocytes: 22104.6	Cancer enriched	Detected in many	22	liver cancer: 150.5	Not detected	Not detected			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		A-431: 15.5;EFO-21: 11.9;GAMG: 11.3;HaCaT: 14.6;HBEC3-KT: 31.6;HSkMC: 10.3														Secreted to blood				11000000000				unprognostic (1.73e-3)	unprognostic (4.42e-2)	unprognostic (2.63e-1)	unprognostic (5.03e-2)	unprognostic (1.40e-3)	unprognostic (7.12e-2)	unprognostic (7.45e-2)	unprognostic (2.15e-2)	unprognostic (1.57e-1)	unprognostic (2.86e-2)	unprognostic (2.78e-2)	unprognostic (6.13e-2)	prognostic unfavorable (1.30e-8)	unprognostic (1.53e-1)	unprognostic (9.72e-2)	unprognostic (7.62e-3)	unprognostic (1.28e-1)	68.6	1.7	0.7	16.3	0.7	0	9.8	0.7	0.7	33.1	0.7	0.7	0.7	0	0.7	0.7	0.7	0.3	1.2	0.7	0.7	0	0.7	752.1	0.8	0.7	0.7	0.7	0.7	0.7	0	0.7	0.7	0.7	0.8	0	0.7	46	0.7	5.2	0.3	0.7	0.7	0.7	0.7	0.2	0.7	0.7	1.1	0.7	0.7	0.7	1.1	0.7	2	1	3.1	1.2	0.6	0.9	0.4	15.5	0	0.1	0.1	0.6	0	2.2	0	0.5	0	0.2	0	6.9	0.1	11.9	0.1	11.3	14.6	0	31.6	0.1	0.6	0	0.5	0.2	0	4.6	0.4	0.1	10.3	4.4	0	5.2	0.3	0.1	0	0	0.7	0.8	0	0.1	0	0.2	0.3	0	0	0.4	0	7.1	0.7	0.1	0	1.1	4.9	0	0.3	0.2	0.3	0.1	0.1	0.7	0.3	0.6	0.2	0.4	1	0	0.6	0.2	3	1.2	1	0.6	0.6	0.9	0.8	0.6	0.4	0.3	2	0.4	0.6	3.1	0.6	1	1	0.9	0.4	0.7	0.7	0.7	0.7	0.7	0	0.7	0.7	0.7	0.7	0	1	517.5	4.2	0.9	0	0.2	578.4	18.7	30.7	3.5	0	0.2	0	35.2	1.3	0	1.4	864.3	29.6	1.8	0.2	32.1	0	22104.6	0.3	0	0	951.4	647.2	0.4	0	0.4	8.5	1.8	0	0	30.1	0	0	0	0	0	0.1	0.1	0	0.1	0.5	4.8	0	62.9	Hepatocytes
CFHR4	CFHL4, FHR-4, FHR4	ENSG00000134365	Complement factor H related 4	Q92496	1	196850241-196918972	Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	188	liver: 61.3	Cell type enriched	Detected in some	10	Hepatocytes: 31.7	Cancer enriched	Detected in single	145	liver cancer: 13.3	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		Karpas-707: 3.0;RPMI-8226: 2.0;U-2197: 2.5;U-266/70: 5.0;U-266/84: 2.1														Secreted to blood				180000000									unprognostic (5.97e-1)	prognostic favorable (1.57e-6)	unprognostic (1.89e-1)	unprognostic (4.79e-2)	unprognostic (1.26e-1)				unprognostic (1.68e-2)			unprognostic (4.71e-1)	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	61.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0.1	3	0	0.1	0	0	0	0	0	0.1	0	2	0	0.2	0	0	0	0	0	0.4	0.9	0	0	0	0.6	2.5	0	5	2.1	0	0	0	0.1	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	31.7	0	0	0	3.1	2.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Hepatocytes
CFHR5	CFHL5, FHR-5, FHR5	ENSG00000134389	Complement factor H related 5	Q9BXR6	1	196977556-197009674	Disease related genes, Plasma proteins, Predicted secreted proteins			Disease mutation, Hemolytic uremic syndrome	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	241	liver: 85.5	Cell type enriched	Detected in some	24	Hepatocytes: 88.3	Cancer enriched	Detected in single	396	liver cancer: 57.1	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in single		HL-60: 1.0									HPA038915, HPA040726	Supported				Secreted to blood				1700000000			HPA038915: AB_2676269, HPA040726: AB_2677101							unprognostic (9.12e-3)											0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	85.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0.1	0	0	0.4	0	0	0	0	0	0	0.2	0	0	1	0.4	0	0	0	0	0	0	0	0.1	0	0	0	0.5	0	0.2	0	0	0.7	0.6	0	0	0	0.3	0	0.3	0	0	0	0.1	0	0	0	0.1	0	0	0.3	0	0.2	0.1	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	88.3	0	0	0	3.7	3.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Hepatocytes
RAX	RX	ENSG00000134438	Retina and anterior neural fold homeobox	Q9Y2V3	18	59267035-59274086	Disease related genes, Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	Developmental protein, DNA-binding	Disease mutation, Microphthalmia	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	14	pituitary gland: 12.9;retina: 45.2	Cell type enriched	Detected in some	6	Muller glia cells: 461.5	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HAP1: 1.4;HEK 293: 1.4;HMC-1: 6.1;SH-SY5Y: 3.2;THP-1: 1.4	Not detected	Not detected			Not detected	Not detected																	unprognostic (4.14e-2)				unprognostic (1.79e-1)		unprognostic (3.76e-3)	unprognostic (2.28e-1)	unprognostic (2.22e-1)				unprognostic (1.33e-1)	unprognostic (3.46e-1)			0	0	0	0	0.1	0	0	0	0.6	0	0	1.4	0	0	0	0	0.1	0	0	0	0.4	0.2	0	0	0.1	0.1	0	0	0	0	0	12.9	0	0.1	2.1	0	45.2	0	0	0	0.5	0	0	0.9	0	0	0.5	0.1	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.4	0	0	0	1.4	0	0	0	0	0	6.1	0	0	0	0	0	0	0.1	0.2	0	0	0	0	0	0.4	0	0.1	0	0	0	0	0	0	3.2	0	0	0	0.1	0	1.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0.6	0.4	0.2	0	0	0.1	0.1	0	0	0	0	0.5	3	1	0	0	0	0	78.5	0	0	0	0.1	0	0	0	0.2	0	0	0	0	0	0	1.6	0	0	0	0	0	0	0	0	0	461.5	0	0	0	0	16	0	0	0	0.1	0	0	0	0	0	Muller glia cells
SLCO1B1	LST-1, OATP-C, OATP1B1, SLC21A6	ENSG00000134538	Solute carrier organic anion transporter family member 1B1	Q9Y6L6	12	21131202-21239246	Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters	Ion transport, Transport			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	618	liver: 121.0	Cell type enriched	Detected in some	39	Hepatocytes: 71.0	Cancer enriched	Detected in some	96	liver cancer: 52.6	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		A-431: 2.2;A549: 1.9;HeLa: 2.9;NTERA-2: 2.6;RPMI-8226: 3.5;SuSa: 5.6									HPA050892	Supported											HPA050892: AB_2681265			unprognostic (5.45e-1)			unprognostic (1.82e-4)	unprognostic (2.43e-3)	unprognostic (1.96e-3)		unprognostic (1.80e-1)	unprognostic (2.41e-1)	unprognostic (8.82e-2)		unprognostic (5.63e-2)	unprognostic (3.86e-2)		unprognostic (3.49e-1)	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	121	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.2	1.9	0.3	0	0	0	0	0	0	0	0	0.1	0.7	0.1	0.1	0	0.4	0	0	0	0	0	0	0	2.9	0	0	0.1	0	0	0	0	0.3	0.1	0	0	0	0	0	0	0	0	2.6	0	0.6	0	0.7	3.5	0	0	0	0	0.1	0	0	5.6	0.8	0	0.4	0	0.8	0	0	1	0.4	0.1	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	71	0	0	0	1.8	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	Hepatocytes
LRP4	CLSS, LRP-4, MEGF7, SOST2	ENSG00000134569	LDL receptor related protein 4	O75096	11	46856868-46918642	Disease related genes, Predicted intracellular proteins, Predicted membrane proteins	Differentiation, Endocytosis, Wnt signaling pathway	Developmental protein, Receptor	Congenital myasthenic syndrome, Disease mutation	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 23.7;skin 1: 33.0	Cell type enriched	Detected in many	4	Cone photoreceptor cells: 39.3	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in many		AF22: 17.0;SuSa: 13.6	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA011934, HPA012300	Approved		Uncertain	Nucleoplasm,Nucleoli,Mitochondria						Nucleoplasm, Nucleoli, Mitochondria		HPA011934: AB_1853286, HPA012300: AB_1853288	unprognostic (1.46e-1)	unprognostic (4.07e-2)	unprognostic (2.86e-1)	unprognostic (1.33e-2)	unprognostic (4.39e-2)	unprognostic (9.73e-3)	unprognostic (5.29e-4)	unprognostic (8.61e-2)	unprognostic (2.29e-2)	unprognostic (2.77e-1)	unprognostic (1.92e-1)	unprognostic (1.33e-1)	unprognostic (7.59e-2)	unprognostic (7.95e-2)	unprognostic (2.76e-2)	unprognostic (9.90e-3)	unprognostic (6.79e-2)	1.2	1.9	16	1.3	20.3	0.5	2.1	7.3	23.7	3	5.4	11.6	0.6	3.9	2.1	1.3	2.4	2	2.5	7.2	20.4	5.8	1.2	0.7	3.4	0.5	9.6	12.6	5.4	2.7	9.3	3.3	3.1	14.5	2.7	4.1	1.3	2.1	3	4.4	33	5.3	2	9.7	4.2	9.6	1.6	19	0	2.9	1	0.8	1.3	1.7	0	0	0	0	0	0	0	0.1	7.5	17	5.2	10.6	2.9	3.9	0.7	1.5	2.3	2.5	2.2	0	0	1.1	8.7	2.4	3	9.5	5.8	1.8	0	7.9	0.8	3	5.2	2.2	0.1	1.5	3.6	3.4	3.5	0.9	2	1.9	2.1	0.7	0	1.3	0.6	0.1	0.2	9.2	0	0.7	1.2	5.8	0	0.2	2.2	0	11.2	0.9	0	2.8	13.6	0.2	0.4	0.1	4.6	2.9	5.2	1.6	0	0	0.3	3.4	0.6	1.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16	20.3	7.3	17.3	20.4	5.8	9.6	12.6	14.5	19	0	3.4	0	2.5	7.2	0.4	4.8	0	0	2.3	1.8	39.3	1.8	1.7	0	0.4	0.7	6.3	0	0.3	0.4	4.3	0.3	4.7	0	0.2	0	0	1.3	0	0	1.7	0	1.7	1	2.2	8.7	0.5	2.3	1.1	0.2	2.6	0	1.2	0.1	0.7	9.5	1.1	0	1.8	0.7	Cone photoreceptor cells
MYBPC3	CMH4, FHC, MYBP-C	ENSG00000134571	Myosin binding protein C, cardiac	Q14896	11	47331397-47352702	Disease related genes, Plasma proteins, Predicted intracellular proteins	Cell adhesion	Actin-binding, Muscle protein	Cardiomyopathy, Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	108	heart muscle: 199.6	Cell type enriched	Detected in some	61	Cardiomyocytes: 1683.6	Not detected	Not detected			Not detected	Not detected			Cell type enhanced	Detected in single		neutrophil: 1.8	Lineage enhanced	Detected in single		granulocytes: 1.8	Cell line enriched	Detected in single	17	U-937: 12.0	Region enriched	Detected in single	33	cerebellum: 38.5	Not detected	Not detected			HPA040147, HPA043898	Enhanced								44000			HPA040147: AB_2676861, HPA043898: AB_2678720	unprognostic (1.06e-1)	unprognostic (1.47e-6)	unprognostic (2.17e-1)	unprognostic (6.16e-2)	unprognostic (3.00e-3)	unprognostic (1.40e-4)	unprognostic (7.47e-2)	unprognostic (2.72e-2)	unprognostic (2.53e-1)	unprognostic (1.62e-1)	unprognostic (9.53e-2)	unprognostic (4.22e-2)	unprognostic (1.11e-3)	unprognostic (2.11e-1)	unprognostic (1.96e-1)	unprognostic (4.15e-1)	unprognostic (3.21e-2)	0	0.2	0	0	0	0.1	0	0	0.1	0	0	0	0	0	0	0.1	0	0	0	199.6	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0.3	0.2	0	0	0	0	0	0	0	0	0	0.1	1.8	0.6	0	0	0	0	0.1	0	0	0	0	0.1	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0.1	0	0.1	0	0	0	0	0	0	0	0.1	0	0	0	0.3	0	0	0	0	0	0	0	0.1	0	12	0	0	0.4	0	0	0.2	0	0	0	0	0.1	0	0	0	1.8	0	0.6	0	0	0	0	0	0	0.1	0	0	0	0	0.1	0	0	2.2	0	0	0	0	1683.6	0	0	0	0	0	0	0	0	27.7	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0.3	14.7	0.3	0.8	0	1.8	1	0	0	0	0.7	0	0	0	0	0.1	0.2	0	0.2	0	0.6	0	Cardiomyocytes
USP26		ENSG00000134588	Ubiquitin specific peptidase 26	Q9BXU7	X	133024631-133097109	Enzymes, Plasma proteins, Predicted intracellular proteins	Ubl conjugation pathway	Hydrolase, Protease, Thiol protease		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in single	7	testis: 3.8	Cell type enriched	Detected in single	14	Spermatogonia: 3.7	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Low cell line specificity	Detected in some							Not detected	Not detected			HPA000424, HPA027310	Approved		Supported	Nucleoplasm						Nucleoplasm		HPA000424: , HPA027310: 	unprognostic (7.92e-4)		unprognostic (3.59e-2)											unprognostic (1.99e-2)	unprognostic (2.08e-1)			0.1	0.1	0.1	0.1	0.1	0.3	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0	0.2	0.4	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.2	0.2	0.4	0.1	0.1	0.1	0.1	0.1	3.8	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.2	0.1	0.5	0.1	0.2	0.3	0	0	0.5	0.4	0.5	0.4	0.1	0.1	0.2	0.2	0.7	0.1	0.2	0.1	0.7	0.1	0.1	0	0.1	0.7	0.1	0.2	0.3	1	0.3	1	0.3	0.1	0.1	0	1.5	0.6	0.4	0.1	0.3	0.1	0.4	0.4	0.4	0.2	0.2	0.1	0.8	0.4	0.2	0.3	0.4	0.1	0	0.9	0.5	0.5	0.2	0.1	0.1	0.2	1	0.1	0.7	0.3	0.9	0.1	0.3	0.4	0.9	0.3	0.1	0.2	0.4	0.3	0.2	0.1	0.2	0.1	0.1	0	0	0.1	0	0.1	0.2	0	0	0.5	0.2	0	0	0.3	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	3.7	0	0	0	0	0	Spermatogonia
SOX3	PHP	ENSG00000134595	SRY-box 3	P41225	X	140502985-140505116	Disease related genes, Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	Developmental protein, DNA-binding	Disease mutation, Mental retardation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		fallopian tube: 18.2;testis: 12.4	Cell type enriched	Detected in single	8	Muller glia cells: 4.3	Cancer enhanced	Detected in some		glioma: 2.0	Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		AF22: 7.8;HEK 293: 8.3;NTERA-2: 18.6;SuSa: 3.7	Low region specificity	Detected in many			Low region specificity	Detected in many			HPA054720, HPA075003			Enhanced	Nucleoplasm						Nucleoplasm		HPA054720: AB_2682584, HPA075003: AB_2686727					unprognostic (6.04e-2)					unprognostic (3.75e-1)			unprognostic (8.62e-3)	unprognostic (8.03e-2)	unprognostic (1.57e-1)	unprognostic (5.27e-3)		0.3	0.5	2.6	0.3	2.7	0.3	0.3	0.6	2.6	1.5	0.3	5	0	0.3	0.6	0.3	0.3	18.2	0.3	0.3	2.2	5	0.3	0.3	0.3	0.3	2	1.8	4.7	0.3	0.4	3.2	0.3	3.6	0.3	0.3	0.5	0.3	0.3	0.4	0.3	0.3	0.3	2.3	0.3	0.3	12.4	0.6	0	0.5	0	0.3	0.3	0	0	0	0	0	0	0	0	0	0	7.8	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	8.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	18.6	0	0	0	0	0	0	0	0	0	0	0	0	3.7	0	0	0	0	0	0	1.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.6	2.7	0.6	2.6	2.2	5	2	1.8	3.6	0.6	0	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0.4	0	0	0	0.2	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	4.3	0.1	0	0	0	0	0	0	0.2	0.2	0	0	0	0	0	Muller glia cells
DSC1	CDHF1	ENSG00000134765	Desmocollin 1	Q08554	18	31129236-31162856	Plasma proteins, Predicted membrane proteins	Cell adhesion			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	5	skin 1: 78.4	Cell type enriched	Detected in some	5	Suprabasal keratinocytes: 145.5	Group enriched	Detected in some	17	head and neck cancer: 7.3;melanoma: 4.1	Region enriched	Detected in single	13	cerebral cortex: 7.0	Group enriched	Detected in some	8	naive CD4 T-cell: 5.7;naive CD8 T-cell: 5.2	Lineage enriched	Detected in single	8	T-cells: 5.7	Cell line enriched	Detected in single	4	hTERT-RPE1: 4.3	Not detected	Not detected			Low region specificity	Detected in many			HPA075379	Enhanced								18000000			HPA075379: AB_2732290	unprognostic (1.41e-1)	unprognostic (1.38e-1)	unprognostic (2.12e-1)	unprognostic (1.10e-1)	unprognostic (6.95e-2)	unprognostic (2.48e-2)	unprognostic (3.71e-2)	unprognostic (8.19e-3)	unprognostic (1.56e-1)	unprognostic (1.89e-1)	unprognostic (1.27e-1)	unprognostic (1.78e-1)	unprognostic (5.65e-6)	unprognostic (5.08e-2)	unprognostic (2.91e-1)	unprognostic (6.99e-2)	unprognostic (4.74e-5)	0.2	0.1	0.1	0.3	0.5	0	3.5	0.1	7	0.2	0.1	0	0	0	0.1	0.1	2.8	0.1	0	9.1	0.1	0.1	0.1	0.1	0.1	0.8	0.1	0.1	0.1	0.1	0.4	0.1	1.3	0	0.1	0	1.3	1.2	0	0.2	78.4	0.1	0	0.2	0.1	0.1	0.1	0	1.1	0.1	16.6	1.5	0.1	0.2	0	0	0.7	0	0	5.7	0.9	0	0	0	0	0	0	0.8	0	0	0	0	0.6	0.2	0.3	0	0	0	0.6	0	0	0	0	0	0.9	0	0.2	0	0	0	0	0.6	0	0	4.3	0	0	0.1	0	0	0.6	0	0.1	0.1	0.3	0.1	0	0	0	0	0	0	0	0	0.3	0	0.2	0.1	0	0	0	0.1	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0.2	0.4	0	0	5.7	5.2	0.7	0	0	0	0	0.9	0.1	0.5	0.1	7	0.1	0.1	0.1	0.1	0	0	0	0	0	0.3	12.6	0.4	29.1	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0.1	0.3	0.2	0	0	0	0	0	0	0	0	0	0	3.3	0	0	1.9	0	0	0	0	0.1	0	0	0	0	145.5	0.3	0	0	0.1	Suprabasal keratinocytes
GIF	IF, IFMH, INF, TCN3	ENSG00000134812	Gastric intrinsic factor	P27352	11	59829268-59845501	Disease related genes, Predicted secreted proteins	Cobalt transport, Ion transport, Transport		Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	25	stomach 1: 185.6	Cell type enriched	Detected in single	108	Exocrine glandular cells: 10.8	Cancer enriched	Detected in some	11	stomach cancer: 10.0	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	4	THP-1: 3.9	Not detected	Not detected			Low region specificity	Detected in all			HPA039908, HPA040774	Enhanced				Secreted to digestive system							HPA039908: AB_10796335, HPA040774: AB_10795626			unprognostic (2.78e-4)								unprognostic (1.04e-1)		unprognostic (2.45e-1)	unprognostic (3.59e-1)	unprognostic (1.66e-1)			0	0	0	0	0	0	0	0	0.6	0	0.4	7.1	0	0	0	0	3.2	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	7.4	0	0	0	185.6	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.9	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	3.9	0	0	0	0.1	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	10.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Exocrine glandular cells
TCN1	TC1, TCI	ENSG00000134827	Transcobalamin 1	P20061	11	59852800-59866575	Plasma proteins, Predicted secreted proteins	Cobalt transport, Ion transport, Transport			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	6	blood: 152.9;salivary gland: 172.4	Cell type enriched	Detected in some	6	Exocrine glandular cells: 340.9	Cancer enhanced	Detected in many		pancreatic cancer: 124.3	Not detected	Not detected			Cell type enriched	Detected in some	95	basophil: 152.9	Lineage enriched	Detected in single	1202	granulocytes: 152.9	Cell line enriched	Detected in some	21	OE19: 59.1					Low region specificity	Detected in all								Secreted to blood				3300000				prognostic favorable (1.90e-4)	unprognostic (1.17e-1)	unprognostic (5.89e-2)	unprognostic (3.61e-3)	unprognostic (2.49e-2)	unprognostic (5.28e-3)	unprognostic (4.52e-3)	unprognostic (3.11e-3)	unprognostic (1.13e-1)	unprognostic (7.56e-2)	unprognostic (9.07e-3)	unprognostic (3.88e-1)	prognostic unfavorable (1.56e-8)	unprognostic (2.50e-1)	unprognostic (8.80e-2)	unprognostic (1.40e-1)	unprognostic (3.76e-2)	0.2	0.1	0.1	0.1	0.1	27.6	2.1	0.1	0.2	5.5	0.2	0.1	0	1.3	1.5	0	4.6	0.2	26.7	1.1	0.1	0.1	0.7	0.4	1.8	0	0.2	0	0.2	3.8	0.1	0.4	0.2	0.1	0.4	0	0.1	172.4	0.3	0.2	0.3	0.2	0.1	0.2	1	12.7	0.2	0	0.3	0.2	28.4	10	3.8	1.9	0	0	152.9	0.1	0	0	0.2	0	0.6	0	0	0	0	0	0	0	0	0	0	2.1	0	0.8	0	0.3	2	0	0	0	0	0	0	0.3	0	0	0.5	0.4	0	0	0	0	0.3	0	0	0.3	0	0	0	0	0.6	0	59.1	2.7	0	0	0	0.5	0	0	0	2.8	0	0.7	0	0	1	0	0	0.2	0	0.2	0	0	0	0	0	0	152.9	0	0	0	0	0	0	0	0	0	0	0	0	1.6	0	0.1	0	0	0.2	0.1	0.1	0.1	0.2	0.1	0.1	0.2	0	0.1	0	0	0	0	12.2	0	0	0.2	61.1	12	3.4	22.7	0	0	0	17.4	0.3	0	0	0	340.9	0	0	0.7	0	0	0.2	0	0	0	0.6	0	0.3	0	0	1	0	0	46.4	0	0	0	0	0	0	0	0	0.1	0	0	0	40.3	Exocrine glandular cells
TBX3	TBX3-ISO, UMS, XHL	ENSG00000135111	T-box 3	O15119	12	114670254-114684164	Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	Developmental protein, DNA-binding, Repressor	Cancer-related genes, Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		seminal vesicle: 117.7	Cell type enriched	Detected in many	6	Syncytiotrophoblasts: 513.4	Low cancer specificity	Detected in all			Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in many		BJ: 34.0;BJ hTERT+: 32.4;RT4: 42.4	Low region specificity	Detected in single			Not detected	Not detected			HPA005799, HPA075876			Supported	Nucleoplasm,Cytosol						Nucleoplasm	Cytosol	HPA005799: AB_1857817, HPA075876: 	unprognostic (3.27e-1)	unprognostic (2.64e-1)	unprognostic (2.84e-1)	unprognostic (1.11e-1)	unprognostic (3.40e-2)	unprognostic (5.97e-3)	unprognostic (1.56e-1)	unprognostic (2.99e-2)	unprognostic (9.43e-2)	unprognostic (1.15e-1)	unprognostic (3.35e-1)	unprognostic (3.06e-1)	unprognostic (3.64e-3)	unprognostic (1.09e-3)	unprognostic (1.43e-1)	unprognostic (1.01e-1)	prognostic favorable (3.28e-4)	4.3	60.5	0.9	3.3	1.9	0	19.9	0.7	2.3	18.2	12.2	1.7	69.6	14.2	13.1	18.7	1.9	7.5	5	6.2	1.2	1.5	4.1	15.1	12.6	0.8	1.2	0.5	15.6	1.1	0.3	5.3	67.8	1.6	32.3	1.5	2.6	7.3	117.7	4.2	4.8	19.4	9.7	1.4	2.6	2.2	3.5	1.2	0.5	36.3	7.3	3.5	24.6	25.2	0	0	0	0.3	0	0	0	0.7	6	0	0	9	12.4	13.5	34	32.4	13.2	13.1	5.3	1.4	0	0.5	5.9	0.8	1.5	2.8	1.2	16.3	0	4.1	0	1.5	15.5	2.9	0	0	5.5	0.8	4.4	9.1	0	0.1	0	1.2	0	1.1	0.5	0	0.1	0	17.2	1.8	0	0	0.8	0	42.4	2.2	6.6	4.8	2.2	1.1	15.8	1.7	0	0	4	2.6	2.3	11	0	0	0	8.5	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.9	1.9	0.7	2.3	1.2	1.5	1.2	0.5	1.6	1.2	0	3.4	0.9	88	8.8	6.3	9.8	0	0	0	33.2	3.9	39.8	0	0.4	1.3	26.5	25.4	0	0	5.9	9.5	74	0	31	5.4	1.6	4.7	0.6	1.6	1.8	4.9	0.8	3.3	0	13.8	1.5	0.5	23	5.6	0	2	38.8	34.1	0.1	4.7	8.5	513.4	0.7	4.5	62.6	Syncytiotrophoblasts
OASL	OASL1, p59OASL, TRIP14	ENSG00000135114	2'-5'-oligoadenylate synthetase like	Q15646	12	121019111-121039242	Predicted intracellular proteins	Antiviral defense, Immunity, Innate immunity	RNA-binding		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		blood: 44.5;bone marrow: 33.1	Cell type enriched	Detected in many	4	Urothelial cells: 72.1	Low cancer specificity	Detected in all			Low region specificity	Detected in many			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		BJ hTERT+ SV40 Large T+: 52.2;BJ hTERT+ SV40 Large T+ RasG12V: 26.9;GAMG: 14.8;hTEC/SVTERT24-B: 20.9	Not detected	Not detected							HPA001474	Approved		Supported	Nucleoplasm,Cytosol						Nucleoplasm, Cytosol		HPA001474: AB_1079518	unprognostic (2.39e-2)	unprognostic (7.50e-2)	unprognostic (1.07e-1)	unprognostic (2.47e-2)	unprognostic (2.76e-1)	unprognostic (1.50e-1)	unprognostic (1.03e-1)	unprognostic (1.62e-2)	unprognostic (6.22e-2)	unprognostic (5.93e-3)	prognostic unfavorable (9.20e-4)	unprognostic (4.61e-1)	prognostic unfavorable (3.70e-9)	unprognostic (2.52e-1)	unprognostic (2.72e-2)	unprognostic (1.18e-1)	unprognostic (3.17e-2)	20.5	0.5	1	8.3	1.4	33.1	2.7	0.4	1.9	3.6	5.9	1.7	0.1	1.6	1.7	1.3	4.7	0.6	3.1	2.2	0.7	0.9	4	22.6	16.5	1.9	1.3	1.2	1.4	0.4	0.2	0.8	3.6	2.3	2.5	3	2.3	3.4	0.3	1.1	0.8	2	1.1	1.9	5.2	15.7	2.1	0.6	6	3.2	3.7	7.6	2.9	1.5	0.8	3.2	44.5	10.8	6.9	23.6	10.8	1	0.2	0	0.3	0.4	0.9	0	0.1	0.5	52.2	26.9	0	5	0.3	1.5	0	14.8	2.7	0	0.3	3.8	9.2	0	0	5.2	0	0.3	0	0.7	0.3	0.2	20.9	0	0.1	0.1	0.3	0	1.8	0.2	0.5	0	2.7	0	1.8	1.1	0	0.1	0.6	0.2	4.9	0	0	0.4	0.2	8.2	0	0.1	0.8	0	0.2	0.4	0.6	0.1	2	3.7	0	7.8	0.4	0.1	4.2	10.3	22.4	20.4	10.8	5.3	0.8	14.1	23.6	3.2	0.3	4	15.7	44.5	6.9	7.4	0.1	9.9	10.8	1	1.4	0.4	1.9	0.7	0.9	1.3	1.2	2.3	0.6	0	6.2	0	3.8	1.9	0	0.3	0	4	3.4	0	0	0.2	0	2.7	3.1	2.1	4.2	0	3.4	0.6	0.5	1.1	11.5	3.9	12.3	0	1.7	0	4	2.5	0.3	6.8	0	4.6	15.9	0	7.4	3.5	0	0.3	0	0	2.2	1.9	0.1	0.9	0.1	17.3	1.2	72.1	Urothelial cells
DTX1	hDx-1, RNF140	ENSG00000135144	Deltex E3 ubiquitin ligase 1	Q86Y01	12	113056709-113098028	Enzymes, Predicted intracellular proteins	Notch signaling pathway	Transferase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		adipose tissue: 9.7;lymphoid tissue: 13.3	Cell type enriched	Detected in many	15	Horizontal cells: 162.1	Low cancer specificity	Detected in all			Low region specificity	Detected in many			Cell type enhanced	Detected in some		naive B-cell: 2.3	Low lineage specificity	Detected in many			Group enriched	Detected in some	12	Daudi: 40.9;REH: 16.8;U-698: 41.6	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA051249, HPA055275	Approved		Supported	Nucleoplasm,Nuclear bodies,Cytosol						Nucleoplasm, Cytosol	Nuclear bodies	HPA051249: , HPA055275: AB_2682769	unprognostic (2.13e-3)	unprognostic (3.20e-3)	unprognostic (4.24e-4)	unprognostic (2.01e-1)	unprognostic (7.48e-3)	unprognostic (1.59e-3)	unprognostic (2.49e-3)	unprognostic (1.81e-1)	unprognostic (9.55e-2)	unprognostic (6.87e-2)	unprognostic (2.19e-1)	unprognostic (1.58e-1)	prognostic unfavorable (3.02e-5)	unprognostic (2.41e-2)	unprognostic (4.70e-1)	unprognostic (1.63e-1)	unprognostic (4.78e-3)	9.7	2.3	6.1	8.9	7	3.2	3.9	7.3	8.3	0.8	0.7	1.1	0.5	1.6	2	0.5	1.2	1.7	1	2.7	5.4	5.9	1.7	6.4	0.5	13.3	3.7	4.2	0.5	2	0	2.2	0.9	4.6	0.8	0.2	1.4	3.2	0.5	0.5	0.5	2.2	0.5	1.1	9.8	1	4.9	0.5	0.5	1.3	0.5	8.1	0.5	0.5	2.3	0	0	0	1	0.6	0.2	0	0	0	0	0.1	0	0	0	0	0	0	0	0	40.9	0.3	0	0	0	0	0	0	0	0	0.1	0	0	0	0.1	0.1	0	0	0	0	0	0	0.9	0.2	0	0	0.1	1.7	0	0.8	0	0	16.8	0	1	0	0	1	2.7	0.1	0.1	1	0	0	0.1	0.4	0	1.6	0	0	0.2	0	41.6	0	0	0	0	0	0	0	0	0.4	0.7	0.5	0	0	2.3	0.6	0	0	1	0	0	0	0.2	6.1	7	7.3	7.1	5.4	5.9	3.7	4.2	4.6	0.5	0	0	2.9	0	0.9	1.5	0.7	0	0	0	1.8	7.9	0	6.6	1.6	0.6	0.7	0	0	0	0	0.8	0.1	6.9	10.5	0.6	162.1	0	0	0	1.1	7.2	0	3.3	0	0	10.3	0.2	0	7.1	0	2.1	0	0.9	0.7	1.2	0.4	0	0	0	0	Horizontal cells
UGT2B28		ENSG00000135226	UDP glucuronosyltransferase family 2 member B28	Q9BY64	4	69280499-69295050	Enzymes, Predicted intracellular proteins, Predicted membrane proteins		Glycosyltransferase, Transferase		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Group enriched	Detected in some	11	breast: 71.7;salivary gland: 25.6	Cell type enriched	Detected in single	178	Cholangiocytes: 17.8	Cancer enriched	Detected in single	8	breast cancer: 1.9	Not detected	Not detected			Group enriched	Detected in some	12	basophil: 2.5;eosinophil: 4.0	Lineage enriched	Detected in single	14	granulocytes: 4.0	Group enriched	Detected in some	10	Daudi: 7.1;NB-4: 6.5									HPA045108	Uncertain				Intracellular and membrane							HPA045108: AB_2679218	unprognostic (1.81e-1)						unprognostic (1.40e-1)	unprognostic (7.20e-3)				unprognostic (1.51e-2)	unprognostic (4.37e-5)				unprognostic (9.79e-4)	0	0	0	0	0	0	71.7	0	0	0	0	0	0	0	0	0	0.1	0	4.4	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0.2	0	0	25.6	0	0	1.8	0	0	0	0	0	0	0	0	0	0	0	4.2	0.1	0	0.2	4	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	7.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0.1	0	0	0	0	6.5	0	0	0	0	0	0	0	0.4	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.5	0	4	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.8	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Cholangiocytes
MTO1		ENSG00000135297	Mitochondrial tRNA translation optimization 1	Q9Y2Z2	6	73461578-73509236	Disease related genes, Predicted intracellular proteins	tRNA processing		Cardiomyopathy, Disease mutation, Primary mitochondrial disease	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	4	Early spermatids: 108.3	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low cell line specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA030230, HPA030232	Approved		Approved	Nucleoplasm,Cytosol						Nucleoplasm	Cytosol	HPA030230: AB_10598910, HPA030232: AB_10600891	unprognostic (2.17e-2)	unprognostic (5.29e-2)	unprognostic (1.05e-2)	unprognostic (3.22e-2)	unprognostic (6.47e-2)	unprognostic (8.58e-2)	unprognostic (6.28e-2)	unprognostic (5.48e-2)	unprognostic (2.97e-1)	unprognostic (2.12e-3)	unprognostic (9.01e-3)	unprognostic (1.55e-1)	unprognostic (9.17e-2)	unprognostic (1.11e-1)	unprognostic (1.67e-1)	unprognostic (8.08e-3)	unprognostic (1.64e-1)	10.4	11	11.1	13.5	13.7	14.7	11.5	21.8	13.6	14	14	11.3	12.4	12.7	12.6	11.2	12.1	10	8.1	13.3	10	10.9	19.7	28.4	9.8	15.8	19.3	10	14.5	12.1	24.6	15.6	8.7	13.9	12.2	12.7	10.1	10.7	12.3	15.8	9.8	13.6	11.9	12.1	18.6	11.9	20.5	15	13	14	11	16.6	12.1	15	10.4	7.4	5.3	7.8	10.5	14	8.7	5.1	4.7	6.5	5.3	9.4	11	5.9	10.7	9.8	10.5	12.8	9.7	3.9	13.5	8.4	10	8.2	8.8	11.9	8.6	16.1	7.8	7.8	10.3	11.4	10.5	12.4	18.5	7	9.5	13.6	11.3	12.7	7.4	7.9	12	17.6	13	10.9	8.9	5.1	16	4.8	7.7	4.8	8.5	18.7	22.4	8.4	8.1	5.5	3.3	5.5	9.3	9.6	6.2	6.1	19.6	5	6.2	6.1	3.5	10.1	8.5	13.1	5.4	3.2	13.8	8.2	1.7	6.4	5.3	9.7	7.2	11.9	10.4	11.7	9.8	7.4	7.9	12.9	10.5	1.8	10.5	7.8	5.5	14	8.7	11.1	13.7	21.8	13.6	10	10.9	19.3	10	13.9	15	14.9	17	14.3	13.5	6.9	0	12.9	7.6	6.7	11.4	10.4	0	10.2	18.3	6.5	108.3	9	9	0	6.4	6.5	6.9	10.3	5.8	18.4	7.8	0	8.1	9.2	5.9	11	10.3	10.8	0	8.2	8.1	0	6.1	7	9.2	12.6	0	6.5	10.2	21.7	10.2	8.8	8.6	24.2	9.8	9.7	Early spermatids
LCA5	C6orf152	ENSG00000135338	LCA5, lebercilin	Q86VQ0	6	79484991-79537458	Disease related genes, Predicted intracellular proteins	Protein transport, Transport		Disease mutation, Leber congenital amaurosis	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		parathyroid gland: 42.4	Cell type enriched	Detected in many	4	Ciliated cells: 121.8	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Cell type enhanced	Detected in single		naive CD4 T-cell: 1.0	Low lineage specificity	Detected in single			Cell line enhanced	Detected in many		HEL: 15.3	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA029053, HPA029055	Supported											HPA029053: AB_10602020, HPA029055: AB_2672889	unprognostic (8.96e-2)	unprognostic (1.04e-1)	unprognostic (3.06e-2)	unprognostic (2.65e-1)	unprognostic (1.13e-1)	unprognostic (1.45e-1)	unprognostic (6.58e-2)	unprognostic (1.34e-3)	unprognostic (6.83e-2)	unprognostic (2.73e-2)	unprognostic (4.11e-1)	unprognostic (1.51e-1)	prognostic unfavorable (4.69e-4)	unprognostic (7.09e-3)	unprognostic (1.39e-1)	unprognostic (5.39e-2)	unprognostic (3.21e-2)	5.2	3.4	8.8	2.9	9.9	4.7	7.4	16.4	9.7	7.6	4.3	5.7	9.1	2.2	8.2	6	4.9	13.9	4.9	3.9	9.1	7.8	4.8	2.4	6.2	2.6	7.4	7.7	11	4.3	42.4	11.4	5.1	17.2	7.5	3	4.4	7.6	9.3	2.7	2	2.5	6.6	13.6	2.9	2.9	9.5	8	0.1	13.4	2.1	2.2	7.6	8.8	0.3	0.1	0	0.6	0	1	0.2	1.8	1.4	4.3	2.4	5.3	6	1.9	3.1	3.8	2	4	10.4	2	0.5	4.3	2.5	3.7	2	3.2	1.9	3.6	0	2.4	15.3	2.1	1.4	5.6	0.3	1.3	5.6	2.2	3.4	4.4	7.7	5.9	0.1	2.3	0.9	3.2	0	0	0	1.2	1.1	1.6	0	7.4	0.7	4.2	0.6	3.2	3.8	2.9	0.5	2	5.5	0.3	0.9	4.1	2.1	2.5	0.6	2.7	4	1.4	0	1	0	1.6	0	0.2	0	0.5	0.6	0	0	0.2	0	0.1	0.3	1	0.6	0	0	0	0	0	0.2	8.8	9.9	16.4	9.7	9.1	7.8	7.4	7.7	17.2	8	14.9	7.8	0.5	10.9	0.9	11.4	4.6	7.6	121.8	26.1	10.4	21.6	6.6	0	12.2	7.7	12.2	0	0	4.3	3.1	6.9	4.6	1.1	0	0.9	9.5	2.4	8.6	1.3	3.6	16.7	0.9	3.3	0	0	12.8	6.3	0	14.9	2.2	28	6.5	9.2	14	2.9	0.9	10.3	0	0	9	Ciliated cells
CGA	FSHA, GPHa, GPHA1, HCG, LHA, TSHA	ENSG00000135346	Glycoprotein hormones, alpha polypeptide	P01215	6	87085498-87095406	Cancer-related genes, Plasma proteins, Predicted secreted proteins		Hormone	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	62	pituitary gland: 398.8;placenta: 489.3	Cell type enriched	Detected in some	30	Syncytiotrophoblasts: 71349.9	Cancer enhanced	Detected in many		testis cancer: 13.0	Not detected	Not detected			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Group enriched	Detected in some	28	BEWO: 73.5;SuSa: 141.5	Not detected	Not detected			Region enriched	Detected in single	11	hypothalamus: 69.2	CAB023350, HPA029698	Enhanced				Secreted to blood							CAB023350: AB_617281, HPA029698: AB_2673153	unprognostic (1.66e-1)	unprognostic (2.10e-1)		unprognostic (3.22e-5)	unprognostic (1.46e-2)	unprognostic (1.51e-1)	unprognostic (2.69e-2)	unprognostic (3.17e-1)			unprognostic (7.04e-3)	unprognostic (1.51e-1)		unprognostic (2.85e-1)	unprognostic (4.32e-2)	unprognostic (8.32e-2)	unprognostic (9.15e-3)	0.1	0.1	0	0.1	0	0.3	0	0	0	0	0	0	1.1	0	0.1	3.1	0	0	0	0.1	0	0	0.2	0.1	0.1	0	0	0	0	0.1	0	398.8	489.3	0.2	0.1	0	0	0.1	0.1	0.2	0.2	0	0.6	0	0.1	7.1	0	0	0	0.1	0	0	0.1	0	2.2	1.9	3.5	1.5	1.1	2.1	0.2	0	0.1	0	0	0	0	73.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0.1	0	3.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0.1	0	0	2.1	0	141.5	0	0	0	0.1	0	0	0	0.3	0	0	0	0	0	2.3	1.1	1	1.7	0.5	0.7	1.3	0.8	1.4	0.6	2.2	1.2	2.1	3.5	1.1	1.5	1.9	0.6	0.2	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	1.1	0	0	0	7	0	1223.9	0	0	0.1	0	0	0	0	2346.5	0.1	1.5	0	0	567.6	0	1.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0.1	0	71349.9	0	0	0.3	Syncytiotrophoblasts
GJA10	CX62	ENSG00000135355	Gap junction protein alpha 10	Q969M2	6	89894469-89921760	Predicted membrane proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enriched	Detected in single	12	testis: 2.3	Cell type enriched	Detected in single	148	Horizontal cells: 17.5	Cancer enriched	Detected in single	7	testis cancer: 1.9					Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	5	HAP1: 2.8;NTERA-2: 1.6	Not detected	Not detected			Low region specificity	Detected in single			HPA021145	Uncertain											HPA021145: AB_2670600															unprognostic (1.09e-1)			0	0.1	0	0	0	0	0	0	0	0	0			0	0	0	0	0	0	0	0	0	0	0	0.1	0	0		0	0	0	0	0		0	0		0	0	0	0	0	0	0	0	0	2.3			0		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	2.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.6	0	0	0	0	0	0	0	0.2	0	0	0	0	0.4	0	0	0	0	0	0	0	0.1	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	Horizontal cells
GLS2	GA, GLS, hLGA, LGA	ENSG00000135423	Glutaminase 2	Q9UI32	12	56470944-56488414	Enzymes, Predicted intracellular proteins		Hydrolase		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	6	liver: 92.2	Cell type enriched	Detected in many	5	Hepatocytes: 52.1	Cancer enhanced	Detected in single		liver cancer: 1.7	Low region specificity	Detected in all			Low cell type specificity	Detected in many			Group enriched	Detected in many	29	B-cells: 1.8;T-cells: 3.8	Cell line enhanced	Detected in some		Daudi: 25.6;RPMI-8226: 4.6;SCLC-21H: 7.3	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA038608	Uncertain											HPA038608: AB_10673176	unprognostic (5.59e-2)	unprognostic (1.51e-2)	unprognostic (8.73e-2)	unprognostic (7.15e-2)	unprognostic (1.23e-2)	unprognostic (9.56e-2)	unprognostic (3.27e-3)	unprognostic (1.98e-6)	unprognostic (1.55e-1)	unprognostic (5.33e-2)	unprognostic (1.29e-2)	unprognostic (1.52e-1)	unprognostic (5.65e-5)	unprognostic (1.42e-2)	unprognostic (2.59e-1)	unprognostic (9.02e-2)	unprognostic (4.44e-2)	0.9	1.7	5.7	1	8.6	0.9	1.4	12.8	15	1	1.2	0.2	0	1	1.2	2	1.4	2.8	0.9	1	4.2	4.1	1.6	92.2	1.4	1.2	1.9	9.7	1.2	15.8	3	6.2	0.8	8.6	1.4	1.7	2.5	1.4	2	0.9	2	1	1.1	3.2	1.1	1.4	1.1	1.4	0	1.4	0	1.4	1.1	0.8	1.8	0	0	0	0	3.8	1.4	4.1	0	0.1	0	0	0	0.1	0	0	0	0.3	3.5	0.9	25.6	0.5	0	0	0.6	0	3.8	0	0	3.8	0	0.3	4.1	0	0	0	0	1.8	0	0	0.1	0	0	0	0.1	0	0	0.5	0	1.8	0.8	0.4	0	0.1	4.6	2.7	1.8	7.3	0.4	0.8	0.3	0	0.7	3.6	0.1	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	1.1	0	3.3	1.8	3.3	1	0	0.6	3.8	3.5	0	0	0	0	0.6	1.4	5.7	8.6	12.8	15	4.2	4.1	1.9	9.7	8.6	1.4	0	2.4	1.9	4.2	1.4	9.5	0	0	2.7	6.8	0	5.9	0.1	6.6	0.4	0	0.3	0	0	1.6	0	0.1	1.5	1.1	52.1	0.1	3.2	1.2	1.3	1.5	0	0.9	0	1.7	0	0	2.3	0.8	0	0	0.5	10.2	0	0	0	1	1	0.2	0	0.2	0.3	Hepatocytes
PPP1R1A		ENSG00000135447	Protein phosphatase 1 regulatory inhibitor subunit 1A	Q13522	12	54575387-54588659	Predicted intracellular proteins	Carbohydrate metabolism, Glycogen metabolism	Protein phosphatase inhibitor		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		adipose tissue: 67.0;skeletal muscle: 227.2	Cell type enriched	Detected in many	5	Distal tubular cells: 1142.3	Cancer enhanced	Detected in many		liver cancer: 17.8	Low region specificity	Detected in all			Cell type enriched	Detected in single	10	memory B-cell: 1.0	Lineage enriched	Detected in single	10	B-cells: 1.0	Group enriched	Detected in some	4	ASC diff: 6.5;NTERA-2: 21.2;RPTEC TERT1: 23.4	Low region specificity	Detected in all			Low region specificity	Detected in many			CAB007811, HPA041542	Approved											CAB007811: AB_598171, HPA041542: AB_2677542	unprognostic (6.39e-3)	unprognostic (2.61e-1)	unprognostic (4.61e-3)	prognostic unfavorable (2.36e-5)	unprognostic (1.55e-1)	unprognostic (1.85e-1)	unprognostic (8.19e-3)	unprognostic (1.01e-1)	unprognostic (1.09e-1)	unprognostic (7.04e-2)	unprognostic (2.71e-3)	unprognostic (1.76e-3)	unprognostic (2.88e-3)	unprognostic (7.68e-3)	unprognostic (2.17e-1)	unprognostic (8.49e-3)	unprognostic (7.49e-2)	67	2.1	9.9	1.6	33.2	1.3	51.8	2.2	8.2	1.6	4	2.9	0.5	2.2	1.7	1.8	4.3	1.6	1.9	34.6	6.6	3.7	35.4	27.5	1.3	1.4	6.4	4.8	3.3	5.6	3.9	0.1	1.2	4.8	2.9	1.8	0.1	3.1	2.3	227.2	1.3	2.4	2.3	2.7	1.3	4.7	1.7	7.8	0	1.4	16.6	1.4	1.4	4.5	1	0	0	0	0	0	0	0	0	2.8	0	6.5	0	0	0	0	0	0	0	0	0	0.6	0	0	0	3.9	0	0	0.1	1.5	0	0	0	0	0.1	0.8	0	0	0	0	0	0	0.2	0	0	0	0	0	0.1	21.2	0	0	0	0	0.1	23.4	0	0	0	0	0	0	3.5	0	0.2	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	9.9	33.2	2.2	8.2	6.6	3.7	6.4	4.8	4.8	7.8	0	0	1.9	0	0.1	0.7	215.5	2.5	0	0	17.4	0	0	1142.3	2.9	1.5	0	0	0	0.3	0.1	0	0.2	0	215.6	0.7	106.5	2.4	6.2	3.8	1.3	1.1	0	0	0	0.3	1.4	4.1	0	1.1	55.9	2.9	0	9.8	0	1.7	0.3	0	0	0.5	0.1	Distal tubular cells
EGR4	NGFI-C, PAT133	ENSG00000135625	Early growth response 4	Q05215	2	73290929-73293705	Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	DNA-binding		Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at transcript level		Tissue enriched	Detected in some	4	brain: 20.0	Cell type enriched	Detected in some	10	Intestinal endocrine cells: 95.4	Low cancer specificity	Detected in some			Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	6	HMC-1: 6.0	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA028983	Enhanced											HPA028983: AB_10603665	unprognostic (7.75e-2)	unprognostic (1.17e-1)	unprognostic (1.39e-4)	unprognostic (2.43e-3)	unprognostic (2.68e-2)	unprognostic (8.37e-2)	unprognostic (1.75e-1)	unprognostic (5.03e-2)	unprognostic (5.20e-2)	unprognostic (4.00e-1)	unprognostic (2.29e-4)	unprognostic (2.41e-1)	unprognostic (1.75e-2)	unprognostic (3.20e-2)	unprognostic (1.77e-1)	unprognostic (1.21e-2)	unprognostic (4.07e-3)	1.1	0.8	4.9	1	15.9	0.9	0.6	17.2	20	0.6	0.6	1.2	0	0.5	0.6	0.5	0.6	0.6	0.6	0.6	8.8	1.9	0.6	0.6	0.6	0.6	0.3	4.4	0.6	0.5	0.6	2.3	0.6	0	0.7	0.6	0	0.5	0.5	0.6	0.6	0.6	0.6	0.3	0.6	0.7	4.9	2.6	0	0.5	0	0.6	0.8	0	0	0	0	0.3	0	0	0	0.2	0	0	0	0	0	0.2	1	0	0	0	0.2	0.2	0	0	0	0	0.1	0	0	0	0	0	0	0	0.4	0	0.1	6	0	0	0	0	0	0	0.1	0	0.2	0	0.4	0.1	0	0	0.8	0	0	0	0	0	0.2	0.2	0	0.7	0	0.2	0	0	0	0	0	0	0	0	0.6	0.9	0	0.2	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4.9	15.9	17.2	20	8.8	1.9	0.3	4.4	0	2.6	0	0	0.5	1.6	2.4	1.3	1	0	0	0	0	0	0	0	0.2	0	0	0	0	0.9	0.2	0.2	2	9.2	0	0.2	0	95.4	0	0.6	0	0	1.4	0	0	0	0	0.2	0	0	0	0.9	0	0.4	0	3	1.9	0.7	0	0.1	0.1	Intestinal endocrine cells
SLC9A5	NHE5	ENSG00000135740	Solute carrier family 9 member A5	Q14940	16	67237683-67272190	Predicted intracellular proteins, Predicted membrane proteins, Transporters	Antiport, Ion transport, Sodium transport, Transport			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in many		brain: 13.5;lymphoid tissue: 14.5	Cell type enriched	Detected in some	5	Horizontal cells: 15.9	Low cancer specificity	Detected in some			Low region specificity	Detected in all			Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		U-138 MG: 8.8	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA041004, HPA041329	Uncertain		Uncertain	Plasma membrane,Cytosol						Cytosol	Plasma membrane	HPA041004: AB_10794433, HPA041329: AB_10794373	unprognostic (8.90e-2)	unprognostic (9.70e-2)	unprognostic (3.39e-3)	unprognostic (1.37e-1)	unprognostic (1.44e-1)	unprognostic (1.43e-1)	unprognostic (2.24e-2)	unprognostic (5.17e-2)	unprognostic (1.50e-1)	unprognostic (1.12e-1)	unprognostic (2.50e-3)	unprognostic (4.84e-2)	unprognostic (9.85e-11)	unprognostic (9.21e-2)	unprognostic (1.95e-1)	unprognostic (8.12e-3)	unprognostic (9.07e-2)	1.7	1.7	2.9	1.1	8.8	0.5	1.1	13.5	8.6	0.9	1.4	0.5	3.6	1.3	1.1	3.2	0.6	0.6	1.9	2.3	2.9	3.6	1.1	0.6	2.9	2.1	2.1	2.3	1.4	1.5	0.5	0.6	1.7	4.3	1	1.1	0.5	1	2.5	1.7	4.2	0.9	0.6	2.7	14.5	0.8	3.3	1.2	0	1	0	1.3	1.6	0.4	1.5	0.8	1	0.5	0.6	0.9	0.1	0.5	4.1	3.7	1.2	6.8	4.7	0.4	1.3	5.8	3.4	3.1	0.2	2.9	0	0.8	1.6	1.7	0.2	1	0.7	1.3	1.2	1.2	3.2	0.3	0.9	0.8	1.4	6.7	5.3	1.4	1.9	0.4	6.3	0.7	1.2	0.7	1.9	2.2	2.3	0.1	0.3	2.5	0.2	0.4	0	0.8	0.9	0.6	0.7	2.1	0.9	3.5	0.2	1.8	0.9	1.4	0.3	1	8.8	1.4	1.6	0.6	3.6	0.9	1.8	6.3	0.7	2.2	0	0.4	0	0	0	0.6	1.5	0.4	0.9	0.1	0	0.4	0.4	1	0.6	0.5	0.8	0	0.1	2.9	8.8	13.5	8.6	2.9	3.6	2.1	2.3	4.3	1.2	3	3.2	0	0.1	0.6	1.9	1.2	2.5	0	0	0	0	0.2	0	0.3	0.6	0.7	0	0	0.2	0.1	0.6	0.4	0	0	0.1	15.9	1.2	2.5	0	0	0.3	0	0	1	0	0.3	0.4	0	2.1	0	0.6	0	0.7	1.7	1.1	0.6	0	0	0.2	0.1	Horizontal cells
ABCB10	EST20237, M-ABC2, MTABC2	ENSG00000135776	ATP binding cassette subfamily B member 10	Q9NRK6	1	229516582-229558695	Plasma proteins, Predicted membrane proteins, Transporters	Transport			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	9	Erythroid cells: 140.2	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Cell line enhanced	Detected in all		HL-60: 42.4	Low region specificity	Detected in all			Low region specificity	Detected in all			CAB044063, CAB044065, HPA055175	Uncertain											CAB044063: AB_353262, CAB044065: AB_2220666, HPA055175: AB_2682727	unprognostic (1.00e-1)	unprognostic (1.29e-2)	unprognostic (5.56e-3)	unprognostic (5.64e-2)	unprognostic (2.04e-1)	unprognostic (8.06e-3)	unprognostic (9.38e-2)	unprognostic (2.05e-1)	unprognostic (4.15e-2)	unprognostic (5.61e-2)	unprognostic (2.81e-1)	unprognostic (3.13e-1)	unprognostic (8.32e-2)	unprognostic (2.58e-1)	unprognostic (3.83e-1)	unprognostic (5.29e-2)	unprognostic (3.37e-2)	13.2	6.4	5.5	6.7	6	37.1	14	15.1	6.1	7.9	18.8	5.4	3.7	12.6	9.9	6.9	10.7	6.1	11.9	8.3	5.5	5.4	10.9	24.7	9.8	15.5	5.2	3.8	6.3	8.2	9	4.2	11.4	4.9	9.9	8.6	5.3	7.1	5.9	13.9	6	30.1	14.7	5	15	7.8	4	4.2	9.4	9.6	8.3	12.1	10	9.1	2.4	3.2	2.9	2.7	1.3	4.1	1.3	10.4	6.2	5.2	4.2	8.9	7.7	22.7	9.7	7.3	8.8	8	6.4	8	11.5	8.9	8.8	3.6	9.1	11.1	8	8.9	7.8	14.1	12.6	5.6	8.1	6.4	42.4	7.1	5.3	6.9	5.3	6.2	5.3	9.4	20.7	26.9	26.6	9	3.3	10.7	24.3	6.9	12.2	5.3	9.8	10.3	12.2	7.1	6.8	3.8	5.8	7.5	8.4	11.8	3.3	6.5	14.8	7.2	9.5	6	5.9	13.1	6.5	4.8	10	5	7.4	6	1.7	2.4	2.9	2.8	2.7	3.6	1.8	3.3	4.1	2.8	2.4	3	4	0.4	1.3	1.9	3.2	2.7	1.3	5.5	6	15.1	6.1	5.5	5.4	5.2	3.8	4.9	4.2	8.9	1.3	0.8	2.5	2.9	5.8	11.8	2.5	9.4	5.7	0	11.8	5.1	1.7	4.1	0	4.5	8	140.2	4.5	9.3	4.8	7.1	5.7	15.3	8.1	9.5	9.8	5.5	11	0.2	4.6	6.4	8.5	15.4	12.8	2.9	4.3	10.5	4.2	4.5	4.5	6.5	5.2	2.9	2.9	4.4	3	3.9	10.5	3.5	Erythroid cells
RGS8	MGC119067, MGC119068, MGC119069	ENSG00000135824	Regulator of G protein signaling 8	P57771	1	182641816-182684576	Predicted intracellular proteins		GTPase activation, Signal transduction inhibitor		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		brain: 29.8;thyroid gland: 15.0	Cell type enriched	Detected in some	5	Bipolar cells: 66.1	Group enriched	Detected in some	13	glioma: 0.6;testis cancer: 0.8;thyroid cancer: 0.9	Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		AF22: 6.7;Daudi: 2.4;SCLC-21H: 18.6;U-698: 3.8	Region enhanced	Detected in all		cerebellum: 477.3	Low region specificity	Detected in all			HPA076764	Enhanced											HPA076764: AB_2732321	unprognostic (6.75e-2)	unprognostic (2.62e-1)	unprognostic (1.03e-1)	unprognostic (9.29e-5)	unprognostic (2.60e-1)	unprognostic (2.37e-1)		unprognostic (9.29e-3)		unprognostic (1.16e-1)	unprognostic (3.78e-1)	unprognostic (2.40e-1)	unprognostic (3.23e-2)	unprognostic (7.08e-2)	unprognostic (2.98e-2)	unprognostic (6.37e-2)	unprognostic (1.02e-1)	0.3	2.6	2	0.4	23.3	0.3	0.3	3.7	7.5	0.3	0.3	2.7	0	0.5	0.3	0.4	0.5	0.3	0.5	0.3	1.4	3.3	0.4	0.4	0.4	0.6	3.9	2	1.2	0.3	0.3	0.5	0.3	29.8	0.3	0.4	1.3	0.6	0.3	0.3	0.3	0.3	0.6	2.6	0.3	0.4	5.7	7.1	0	15	0	0.9	0.3	0	0	0	0	0.1	0	0	0	0	0	6.7	0	0	0	0	0	0	0	0	0	0	2.4	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0.9	0	0	0	0	0	0	0	18.6	0.6	0	0	0	0.1	0	0.3	0	0	0	0	0.1	0.3	0	3.8	0	0	0.8	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	23.3	3.7	3.5	1.4	3.3	3.9	2	29.8	7.1	0	0	0	0	0	66.1	1	0	0	0	0	0	0	0	0	11.2	0	0	0	0	0	0	0	0	0	0	1.6	0	0	0	14.7	0	0	0	0	0	0.5	0	0	0	0	3.7	0	0	0.2	0.2	0	0	0	0	0	Bipolar cells
CHRND	ACHRD	ENSG00000135902	Cholinergic receptor nicotinic delta subunit	Q07001	2	232525993-232536667	Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters	Ion transport, Transport	Ion channel, Ligand-gated ion channel, Receptor	Congenital myasthenic syndrome, Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in some	9	skeletal muscle: 49.1	Cell type enriched	Detected in single	11	Muller glia cells: 4.3	Cancer enriched	Detected in single	7	head and neck cancer: 1.5	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	72	RH-30: 43.8	Not detected	Not detected			Region enriched	Detected in single	7	olfactory region: 1.4	HPA056404, HPA065404			Supported	Nucleoplasm,Plasma membrane,Cytosol						Plasma membrane	Nucleoplasm, Cytosol	HPA056404: AB_2732603, HPA065404: AB_2732734				unprognostic (1.69e-2)	unprognostic (7.93e-2)	unprognostic (3.28e-3)	unprognostic (7.75e-3)	unprognostic (6.04e-2)	unprognostic (1.10e-1)	unprognostic (7.25e-2)	unprognostic (1.90e-1)		unprognostic (4.97e-8)	unprognostic (7.52e-2)	unprognostic (2.86e-1)	unprognostic (2.46e-1)		2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5.2	1.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0.3	0	49.1	0.1	0	0	0	0	0	0.3	0	0	0	1.9	0.1	0	0	0	0.3	0.1	0	0.1	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	43.8	0	0	0	0.4	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0.1	0.1	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Muller glia cells
STAB2	DKFZP434E0321, FEEL-2, FELL, HARE, SCARH1, STAB-2	ENSG00000136011	Stabilin 2	Q8WWQ8	12	103587273-103766727	Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins	Endocytosis	Receptor		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	6	lymphoid tissue: 71.3	Cell type enriched	Detected in some	10	Ito cells: 196.4	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		BEWO: 16.1;HaCaT: 4.4;RH-30: 2.5	Not detected	Not detected							HPA026871, HPA072699	Enhanced		Supported	Cytosol					210000	Cytosol		HPA026871: AB_1857536, HPA072699: 	unprognostic (5.66e-3)	unprognostic (7.51e-2)	unprognostic (3.31e-1)	unprognostic (3.84e-2)	unprognostic (8.47e-2)	unprognostic (2.15e-2)	unprognostic (1.23e-1)	unprognostic (2.81e-1)	unprognostic (5.72e-2)	unprognostic (1.92e-1)	unprognostic (4.24e-2)	unprognostic (1.05e-1)	unprognostic (9.72e-4)	unprognostic (1.37e-2)	unprognostic (5.00e-1)	unprognostic (1.26e-1)	unprognostic (2.06e-1)	0.6	0.2	0.1	0.5	0.1	0.4	0.5	0.1	0.1	0.7	1.4	0.1	0.1	0.1	1.1	1.1	2.5	0.9	0.6	0.4	0.1	0.1	0.1	11.7	0.5	19.9	0.1	0.1	0.4	0.2	0	0.2	0.4	0.2	0.5	0.2	0.1	2.1	0.3	0.1	0.2	0.3	0.2	0.1	71.3	0.3	1.5	0.1	0.2	0.7	0.5	0.4	0.3	0.4	0.9	0.1	0	0	0.1	0	0	0.2	0.7	0.8	0.2	0	0	16.1	0.7	0	0	0	0	0	0.4	0.1	0	0.3	4.4	0	0	0	0	1.1	0.4	0.7	1	0	0	0	0.1	0	0	0	0.6	0	0.3	1	0	0	0	0	0.1	0.7	0.4	0.5	0.1	2.5	0	0	0.2	0.2	0.1	0	0.2	0.1	0.9	0.3	0.1	0.6	0.8	0.4	0	1.1	0.2	0.2	0	0.3	0.9	0.2	0	0	0	0	0	0	0.2	0	0	0.1	0.9	0	0	0	0.1	0	0	0	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0	0	0	0	0.2	0	0.8	7.6	0	0	0	0	0	0	0	4.6	0.4	0	0	0	0.2	0	0	0	1.5	0.1	0	0	196.4	19.9	9.4	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0.1	0	0	0	0	Ito cells
USP44	FLJ14528	ENSG00000136014	Ubiquitin specific peptidase 44	Q9H0E7	12	95516560-95551490	Enzymes, Predicted intracellular proteins	Cell cycle, Cell division, Mitosis, Ubl conjugation pathway	Hydrolase, Protease, Thiol protease		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		testis: 26.8	Cell type enriched	Detected in many	4	Early spermatids: 343.6	Cancer enhanced	Detected in some		testis cancer: 3.0	Region enriched	Detected in many	5	cerebellum: 10.9	Cell type enhanced	Detected in many		naive CD4 T-cell: 8.6	Group enriched	Detected in many	39	B-cells: 5.6;T-cells: 8.6	Cell line enhanced	Detected in some		HEL: 10.0;JURKAT: 22.6;NTERA-2: 54.2					Low region specificity	Detected in some			HPA026543			Approved	Nucleoli fibrillar center,Microtubules						Nucleoli fibrillar center, Microtubules		HPA026543: AB_1858692	unprognostic (2.12e-2)	unprognostic (1.14e-1)	unprognostic (4.68e-2)	unprognostic (1.01e-3)	unprognostic (1.83e-4)	unprognostic (7.18e-4)	unprognostic (5.55e-2)	unprognostic (1.85e-2)	unprognostic (2.16e-1)	unprognostic (3.73e-2)	unprognostic (6.88e-2)	unprognostic (2.97e-2)	unprognostic (8.12e-2)	unprognostic (1.41e-2)	unprognostic (1.08e-1)	unprognostic (7.41e-2)	unprognostic (7.07e-2)	1.3	1	0.7	1.2	1.3	0.5	1.4	10.9	2.1	1.7	1.7	1.7	1.4	0.5	3	1	0.9	1.6	1.1	1	0.7	0.6	1.9	0.2	4.7	1.9	1.3	1.2	1.6	3.6	4.8	4	0.3	1.8	1.7	0.6	2.3	1.8	2.6	0.4	0.6	1.3	1.2	0.6	1.9	1	26.8	1.2	0.8	1.7	0	1.6	1.1	2.3	5.6	0.1	0.1	0	0.1	8.6	1.3	0	0.1	4.5	0	0	0	0.1	0.4	1.3	0.5	0.2	0	0	0	1.3	0	0	0	0	0	0.7	0	2.2	10	0	0	2.3	4	0.2	0	0	0.3	0	0.2	0.2	22.6	1.5	0	0	0	5.1	0	54.2	0	0	0	0	0	0.9	0.3	3.5	2.3	0	0	0	5.4	0	0.3	0	0	0	0	0	0	0.1	1.7	0	0.3	0.1	0	0	0	1.5	0	3.4	5.6	2.3	2	0	4.4	8.6	5.5	0.1	0.1	0	0.1	0.3	1.3	0.7	1.3	10.9	2.1	0.7	0.6	1.3	1.2	1.8	1.2	11.9	19.9	0	2.9	0.9	6.2	1.2	0	0	6.8	7	5.9	2.1	0	3.9	343.6	2.3	0	0	2.7	0.3	1	2.7	0	0	0.1	0	0	1.3	0.3	78.5	5.2	0.4	3.3	1	0	3.4	1.3	0	3.2	1.1	8.6	6.5	3.1	10	5.2	0.6	0.9	1.7	0	1.6	Early spermatids
PCDH8	ARCADLIN, PAPC	ENSG00000136099	Protocadherin 8	O95206	13	52842889-52848641	Plasma proteins, Predicted membrane proteins	Cell adhesion			Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	9	brain: 20.6	Cell type enriched	Detected in some	7	Muller glia cells: 31.8	Cancer enhanced	Detected in some		glioma: 1.9	Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	4	AF22: 23.1	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA010509	Uncertain		Uncertain	Golgi apparatus,Cytosol						Golgi apparatus	Cytosol	HPA010509: AB_10601384	unprognostic (3.50e-3)	unprognostic (6.48e-2)	unprognostic (1.40e-1)	unprognostic (9.11e-4)	unprognostic (2.12e-2)	unprognostic (1.97e-2)		unprognostic (7.01e-2)		unprognostic (1.13e-1)	unprognostic (1.17e-1)	unprognostic (3.59e-1)		unprognostic (1.21e-2)	unprognostic (1.07e-1)	unprognostic (1.32e-1)		0.8	0.9	11.5	1.1	18.6	0.8	0.8	0.4	20.6	0.9	1	1.1	0	0.9	1	0.8	0.8	0.8	0.8	0.8	18.2	4.8	0.8	0.8	0.9	0.8	3.6	8.4	0.8	0.8	0.8	1.4	0.8	0.8	1.7	0.9	0.8	0.8	0.8	1.4	0.8	1.1	0.9	0.9	0.8	1.2	2.3	2.5	0	1.4	0	0.8	0.9	0.9	0	0	0.8	0	0	0	0	0	0	23.1	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	4.8	0	0	1.7	0	0	0	0	5.2	0	0	0	0	0.9	0	0.2	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	11.5	18.6	0.4	20.6	18.2	4.8	3.6	8.4	0.8	2.5	0	0	0	2.5	0.1	4.4	1	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0	0	0.1	0	0	0.1	0	0	0	0	0.5	0	0	0	0	0	31.8	0	0	0.4	0	0.9	0	0	1.4	0.9	0	0	0	0	1.3	Muller glia cells
SCEL	FLJ21667, MGC22531	ENSG00000136155	Sciellin	O95171	13	77535674-77645263	Plasma proteins, Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		esophagus: 145.6;skin 1: 70.8;tongue: 62.2	Cell type enriched	Detected in many	13	Alveolar cells type 1: 631.3	Low cancer specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		CAPAN-2: 12.4;HaCaT: 23.3;HBEC3-KT: 11.1;OE19: 31.1;RPTEC TERT1: 45.3	Low region specificity	Detected in many			Not detected	Not detected			HPA039737, HPA040154	Enhanced		Supported	Nucleoplasm,Plasma membrane,Cytosol		No	No			Plasma membrane	Nucleoplasm, Cytosol	HPA039737: AB_10805485, HPA040154: AB_10795359	unprognostic (1.18e-1)	unprognostic (1.17e-1)	unprognostic (2.00e-1)	prognostic unfavorable (4.07e-4)	unprognostic (5.91e-2)	unprognostic (4.54e-2)		unprognostic (6.62e-2)	unprognostic (3.51e-1)	unprognostic (8.08e-3)	prognostic unfavorable (1.24e-4)	unprognostic (4.57e-2)	prognostic favorable (6.87e-4)	unprognostic (1.81e-1)	unprognostic (2.82e-1)	unprognostic (1.75e-3)	prognostic unfavorable (1.73e-5)	0.4	0	0.1	0.2	0.4	0	4.9	0.1	0.2	15.2	0.2	0.2	0.1	0	0.8	0.2	145.6	0	0.3	0.1	0.1	0	0.4	0.1	27.8	0.1	0.1	0.1	0.2	0.1	0	0.1	3.7	0.2	0.1	0.4	0.1	11.8	0.1	0.3	70.8	0.2	0.1	0.2	0.1	0	0.5	0.1	0.4	0.5	62.2	35.1	0.4	22.4	0	0	0	0	0	0	0	6.9	0.1	0	0	0	0	0	0	0	0	0	0	12.4	0	0.7	0	0	23.3	0	11.1	0	0	0	0	0	0	0	0	0	0	6.4	0	0	0	0	0	0	0	0	0	0	0	0	31.1	6.3	0	0	0	45.3	0	1	0	0	0.6	0	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.4	0.1	0.2	0.1	0	0.1	0.1	0.2	0.1	631.3	30.6	0	0	9.5	0	0.2	0	6.7	42.1	0	0	0.3	0	4.1	5.8	0	0	0	0.2	0	0.3	0.1	1.1	0	0	0	0	0	0	12.4	0	0.6	1.7	0	4.3	1.5	26.6	0	0	0	0	0	0	1.7	2.7	48.8	0.1	0	0	2.6	Alveolar cells type 1
NUPL2	CG1, H_RG271G13.9, hCG1, NLP_1	ENSG00000136243	Nucleoporin like 2	O15504	7	23181827-23201011	Predicted intracellular proteins, Transporters	mRNA transport, Protein transport, Translocation, Transport			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	7	Early spermatids: 230.4	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low cell line specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA049036, HPA057251			Supported	Nucleoplasm		No	No			Nucleoplasm		HPA049036: , HPA057251: 	unprognostic (3.81e-2)	unprognostic (2.53e-1)	unprognostic (3.97e-1)	unprognostic (3.87e-1)	unprognostic (4.16e-1)	unprognostic (1.10e-1)	unprognostic (1.33e-3)	unprognostic (2.16e-1)	unprognostic (1.09e-2)	unprognostic (1.42e-2)	unprognostic (1.30e-3)	unprognostic (2.07e-2)	unprognostic (4.74e-3)	unprognostic (1.32e-1)	unprognostic (2.00e-3)	unprognostic (3.59e-1)	unprognostic (1.32e-2)	13.3	21.1	19.4	27	17.1	23.3	14.4	25.9	30.4	15.4	16.4	12.3	26.8	15.4	19.5	26.5	17.9	17.7	18.7	24.3	16.1	16.1	17.8	16.2	14.7	23.2	14.9	19.9	16.7	14.6	22.3	19.7	10.8	15.2	16.5	16.9	12.5	20.3	20.8	16.9	21.6	14.9	19.1	14.6	20.1	15.2	32.2	16.9	19.7	20.8	16.8	19.6	17.7	16.7	16.4	13.8	22.9	8.7	13.9	12.3	9.8	12.1	7	9	17	8.9	11.4	6.6	10.1	7.6	10.8	11.4	9	13.6	20.4	9	7	24.3	14.7	15.5	8.8	13.5	5.9	16.4	14.1	14.9	8.9	11.1	28.7	17.2	5.5	10.7	10.3	6.6	8.3	11.3	11.5	23.7	14.4	10.7	3.5	13.7	16.7	17.1	14.9	10	12.6	8.1	15.3	11.9	9.3	11.9	11.4	10.6	5.6	15.6	15.1	7.1	31.4	11.5	7.8	9.8	13.4	16.2	19	28.6	22.5	7.3	21.5	17.8	22.9	8.7	7.6	11.4	8.4	10.2	16.4	12.2	11.3	11.5	14	11.5	12.3	8.5	13.9	7.1	13.8	12.3	9.8	19.4	17.1	25.9	30.4	16.1	16.1	14.9	19.9	15.2	16.9	14.9	8.6	15.3	14.1	11.9	20.9	15.4	5.1	17.4	12.5	22.7	19.6	14.9	33.2	19.5	230.4	12.2	7.4	0	11.6	11	12.2	10	13.9	5	23.6	22.3	15	14.1	16.5	25.9	23.3	16.2	8.5	24.4	10.9	16	15.1	14.4	19.4	22.3	23	12.9	19.8	24.4	11.8	11.8	5.5	20.2	16.8	11.9	Early spermatids
IL6	BSF2, HGF, HSF, IFNB2, IL-6	ENSG00000136244	Interleukin 6	P05231	7	22725884-22732002	Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Acute phase	Cytokine, Growth factor	Cancer-related genes, FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		adipose tissue: 60.1;lymphoid tissue: 48.0	Cell type enriched	Detected in many	9	Smooth muscle cells: 589.1	Low cancer specificity	Detected in many			Group enriched	Detected in many	4	basal ganglia: 10.0;cerebral cortex: 4.4;hippocampal formation: 3.9;pons and medulla: 12.8	Group enriched	Detected in some	70	memory B-cell: 6.1;naive B-cell: 7.7	Lineage enriched	Detected in single	77	B-cells: 7.7	Group enriched	Detected in some	4	BJ hTERT+: 208.4;GAMG: 141.1					Low region specificity	Detected in single			CAB023406, CAB072821	Supported		Approved	Vesicles	Secreted to blood			5700		Vesicles		CAB023406: AB_617317, CAB072821: 	unprognostic (1.13e-1)	unprognostic (1.55e-2)	unprognostic (1.47e-1)	unprognostic (1.35e-1)	unprognostic (3.59e-2)	unprognostic (9.88e-3)	unprognostic (1.35e-1)	unprognostic (3.07e-3)	unprognostic (3.25e-1)	unprognostic (2.17e-1)	unprognostic (2.48e-2)	unprognostic (8.57e-2)	prognostic unfavorable (1.10e-11)	unprognostic (2.45e-3)	unprognostic (2.10e-1)	unprognostic (4.31e-2)	unprognostic (7.80e-2)	60.1	5.6	1.4	48	10	15.3	11.5	0.7	4.4	2.9	8.1	1.2	0.4	0.7	2.1	4.6	14.3	7.8	16.1	21.6	3.9	1.5	1.3	5.2	34.9	3	1.8	0.2	5.3	8.3	5.7	14.2	4.5	12.8	6.5	7.5	3.3	3.1	0.8	6.9	2.8	4.5	8.2	7	3.5	6.5	3.2	1.2	0.1	4.5	12.7	3.5	34.9	8.4	7.7	0	0	0	0	0	0.2	0	0	0	0	0	0.2	0.6	0.8	208.4	3.9	13.4	0	0	0	6.8	1.3	141.1	0.1	0	0	5.3	8.2	0	0	0.3	0	4.4	0	0	0.5	0	39.8	5.7	3.8	1.4	0	0.8	0	0.1	0	0	0	0.1	0	0	0	0	0	10.4	0	0	0	13.5	0	0	0.7	0	0	1.2	1.3	0.1	2.4	0.4	0	2.3	0	9.8	0	0	0	0	0	0	0	0	6.1	0	0	0	7.7	0	0	0	0	0	0	0	0.2	1.4	10	0.7	4.4	3.9	1.5	1.8	0.2	12.8	1.2	6	27.2	7.2	1.9	39.6	0	0.9	0	13.4	20.5	3.5	0	0.5	0	5.8	0.3	40.7	0	0	2.4	3.1	63.9	7.3	5.8	0	4.2	0	0	3.1	6.1	0	0	46.2	38.8	7.2	0	0	4.8	0	0	0	0	0	589.1	0	0	29.2	1.1	0	0	9	Smooth muscle cells
CIDEB		ENSG00000136305	Cell death-inducing DFFA-like effector b	Q9UHD4	14	24305096-24311430	Predicted intracellular proteins	Apoptosis			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	7	intestine: 123.9;liver: 215.9	Cell type enriched	Detected in many	5	Hepatocytes: 219.7	Low cancer specificity	Detected in single			Low region specificity	Detected in many			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		HDLM-2: 15.2;HEL: 7.8;Hep G2: 17.0;HL-60: 10.9;Karpas-707: 7.8;U-266/84: 10.1;U-937: 12.8	Low region specificity	Detected in all			Not detected	Not detected			HPA001272	Approved											HPA001272: AB_2666255	unprognostic (2.62e-2)	unprognostic (6.55e-2)	unprognostic (2.62e-3)	unprognostic (9.35e-2)	unprognostic (2.38e-3)	unprognostic (1.83e-2)	unprognostic (1.57e-1)	unprognostic (8.48e-4)	unprognostic (1.36e-1)	unprognostic (3.06e-2)	unprognostic (3.39e-3)	unprognostic (2.36e-2)	unprognostic (6.43e-2)	unprognostic (6.04e-2)	unprognostic (5.15e-2)	unprognostic (2.09e-2)	unprognostic (2.64e-1)	2.3	5.6	0.9	1.9	1.2	3.9	2.2	3.1	0.9	2.7	43.4	1.1	1.9	26	2.2	2.7	7.1	2.5	3.1	1.2	1	0.6	24.2	215.9	2	3.3	1.2	0.9	5.5	3.9	0.5	2.5	0.8	1.3	3.1	1.3	2.4	2.8	2.2	0.6	4	123.9	1.5	1	19.5	1.4	0.9	0.9	0.8	1.4	3.2	4.5	1.3	3.8	0.7	7.1	8.7	7.1	6.3	4.9	2.5	0	0	0	0	1	0.5	0.2	0.3	0.1	0.1	0	1	0.4	0	0	0.4	0	1.4	0	0.1	0	15.2	0	7.8	0	17	0	10.9	0	0.4	0	0	0	0	3.5	0	0	7.8	0	0	0	5.1	0	4	0	1.2	0.1	3.9	0	0.5	3.3	0	4.3	0.1	0	0.1	0	3.8	0.1	0	0	0	0	6.2	10.1	0.1	0	12.8	0	0.9	7.1	8.7	4.9	2.4	4.5	0.7	3.2	3.1	7.1	0.6	2	2.6	4.1	6.3	1.2	1.7	1.6	2.5	0.9	1.2	3.1	0.9	1	0.6	1.2	0.9	1.3	0.9	0	1.7	9.5	5	6.3	0.2	0	7.6	13.4	4.5	1.8	2	0	8.3	1.4	0.1	2.8	20.6	23.3	8.5	0.2	2.5	0.9	8.1	219.7	6.4	0	1.7	13.5	28.5	0	5.8	5.6	5	0	2.5	0.5	10.4	20.1	2.8	43.4	0.6	0	1.7	0.2	1.3	5.4	0.2	8.7	1.6	0.9	Hepatocytes
CALCOCO2	MGC17318, NDP52	ENSG00000136436	Calcium binding and coiled-coil domain 2	Q13137	17	48830988-48866522	Predicted intracellular proteins	Autophagy			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in all	6	Early spermatids: 1039.6	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low cell line specificity	Detected in all							Low region specificity	Detected in all			HPA022989, HPA023019, HPA023195	Enhanced		Supported	Vesicles,Cytosol						Cytosol	Vesicles	HPA022989: AB_1845914, HPA023019: AB_1845915, HPA023195: AB_1845916	unprognostic (3.71e-1)	unprognostic (2.87e-1)	unprognostic (3.84e-2)	unprognostic (3.37e-2)	unprognostic (4.90e-2)	unprognostic (4.46e-2)	unprognostic (2.05e-1)	unprognostic (2.28e-1)	unprognostic (3.88e-1)	unprognostic (2.15e-1)	unprognostic (2.41e-1)	unprognostic (4.03e-2)	unprognostic (3.52e-2)	unprognostic (1.06e-1)	unprognostic (3.80e-2)	unprognostic (7.57e-2)	unprognostic (5.65e-2)	70.5	30.8	20.6	21	29.5	22.2	50.8	22.1	28.1	38.5	40.2	26.8	32.7	27	39.4	35.6	41.3	36.1	28.4	55.5	24.8	16.6	36.6	48.7	42.6	28.2	36.8	24.8	37.7	22.7	24.6	46.3	26.5	32.3	37.3	42.1	46.9	30	31.8	70.1	31.3	35.2	47.8	42.8	29.5	35.5	51.8	37.3	25	48.4	32.3	26	46.4	74.2	18	22	44.4	40.7	33.2	34.2	24.7	26.1	17	7.1	13.8	53.4	38.8	20.7	25.4	34.2	29.5	33.1	31.7	17.2	8.8	25.5	30.9	25.3	14.5	17.4	21.6	35.6	40.4	14.4	8.4	10.7	12.3	61.5	28.3	42.8	57.1	32.2	31.2	22.8	28.2	21.6	27.8	15.3	26.9	25.5	7.6	24.3	15.1	2.2	58.1	20.9	16.2	35.1	16.6	11.3	8.4	2.9	6.1	7.9	5.2	22.6	15.2	33.2	15.9	20.8	32.3	9.8	19.7	17.9	23.9	33.2	6.2	19.5	14.4	13.1	30.2	36.2	36.3	19.8	39.5	18.9	18	17.7	20.3	22	16.6	18.1	19.6	44.4	33.2	40.7	11.1	34.2	24.7	20.6	29.5	22.1	28.1	24.8	16.6	36.8	24.8	32.3	37.3	107.2	75.4	30.8	67.1	32.4	15.1	160.6	33.1	26.8	58	31.4	47.1	45.2	31.5	40.5	1039.6	77.2	83.2	46.7	36.8	36.5	44.4	46.5	96	48.3	25.2	7.9	48.4	86.5	94.6	158	65	55.1	25.3	5.4	41	41.8	31.7	46.5	69.6	36.5	63.8	71.1	51.5	110.9	26.2	40.9	68	44.8	56.5	57.2	Early spermatids
CFC1	CRYPTIC, HTX2	ENSG00000136698	Cripto, FRL-1, cryptic family 1	P0CG37	2	130592168-130599575	Disease related genes, Predicted secreted proteins	Gastrulation	Developmental protein	Disease mutation, Heterotaxy	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Group enriched	Detected in some	12	brain: 13.0;pancreas: 21.9;pituitary gland: 22.4;prostate: 7.6;stomach 1: 9.4	Cell type enriched	Detected in some	5	Intestinal endocrine cells: 19.8	Cancer enriched	Detected in some	7	pancreatic cancer: 4.3					Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	16	RPMI-8226: 19.3;SCLC-21H: 11.0;SuSa: 5.1									HPA041773	Uncertain				Secreted - unknown location							HPA041773: AB_2677664					unprognostic (6.65e-2)						unprognostic (2.19e-3)	unprognostic (1.11e-3)			unprognostic (2.01e-1)			0.1	0.1	0.9	0	2.1	0	0	2.3	1.1	0.1	0.5			0.1	0.1	0.1	0	1.2	0.1	0.3	0.2	13	0.1	0	0	0	2.5		0.1	21.9	0	22.4	0		7.6	0.3		0	0.1	0	0.2	0	0	0.2	0	9.4	0.2			0		0	0	0	0	0	0	0	0	0.7	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	19.3	0	0	11	0	0	0	0	5.1	0	0.1	0	0	0.7	0	0	0	0	0.2	0	0	0	0	0	0	0.7	0	0	0	0	0.1	0	0	0	0.6	0	0	0	0	0	0.1											0	0	0	0	0	3.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	19.8	0	0	0	0	0	0	0	0	0.5	1.4	0	0	0	3.3	0	0	0	0	0	0	0	0	0	Intestinal endocrine cells
GAD2	GAD65	ENSG00000136750	Glutamate decarboxylase 2	Q05329	10	26216307-26304558	Enzymes, Predicted intracellular proteins	Neurotransmitter biosynthesis	Decarboxylase, Lyase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	5	brain: 66.2	Cell type enriched	Detected in some	11	Pancreatic endocrine cells: 35.1	Group enriched	Detected in some	21	glioma: 0.7;pancreatic cancer: 3.0;testis cancer: 1.2	Region enhanced	Detected in all		basal ganglia: 66.2	Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	12	MOLT-4: 5.2;SCLC-21H: 11.7	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA044637, CAB078177	Enhanced											CAB078177: AB_2665779, HPA044637: AB_10794053		unprognostic (8.67e-2)			unprognostic (1.11e-1)						unprognostic (4.93e-2)		unprognostic (2.52e-5)	unprognostic (5.44e-2)	unprognostic (8.08e-2)			1	0.9	6.3	0.9	66.2	1	0.9	5.6	28.7	0.9	0.9	1.4	0	1.2	0.9	1.1	0.9	0.9	0.9	0.9	5.2	13.2	1	0.9	0.9	0.9	5.4	10	0.9	12.9	0.9	0.4	0.9	6.8	1.2	1	0	0.9	0.9	0.9	1.3	1.1	0.9	1.3	0.9	1.2	1.7	8.1	0	0.9	0	0.9	1	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0.3	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	5.2	0	0.1	0	0	0	0	0	0	0	11.7	0.1	0	0	0	0.6	0	0	0	0	0.6	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	6.3	66.2	5.6	18.2	5.2	13.2	5.4	10	6.8	8.1	0	0	0	0	0	2	0.4	0	0	0	0	0	0	0	0	1.4	0	0	0	0.6	0	0	0	0	0	0	3.2	1.7	0	0	0	0	0	0	0	0	0.5	35.1	0	0	0	0.4	0	0	0.4	0.1	0	0	0	0	0	Pancreatic endocrine cells
BAAT	BAT	ENSG00000136881	Bile acid-CoA:amino acid N-acyltransferase	Q14032	9	101360417-101383519	Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins	Fatty acid metabolism, Lipid metabolism	Acyltransferase, Hydrolase, Serine esterase, Transferase	Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	6	liver: 128.4	Cell type enriched	Detected in some	8	Hepatocytes: 745.7	Cancer enriched	Detected in many	42	liver cancer: 181.1	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		A549: 6.1;CACO-2: 3.4;Hep G2: 2.4;OE19: 2.6	Not detected	Not detected			Not detected	Not detected			HPA021251, HPA021330	Enhanced		Uncertain	Vesicles					470000	Vesicles		HPA021251: AB_1845247, HPA021330: AB_2670674	unprognostic (2.53e-2)	unprognostic (1.81e-1)	unprognostic (9.97e-2)	unprognostic (9.33e-2)	unprognostic (7.75e-3)	unprognostic (4.68e-2)	prognostic favorable (4.97e-4)	unprognostic (2.14e-2)	unprognostic (6.19e-2)	unprognostic (4.43e-4)	unprognostic (3.65e-1)	unprognostic (2.15e-1)	prognostic unfavorable (4.24e-7)	unprognostic (1.74e-1)	unprognostic (2.12e-1)	unprognostic (2.17e-2)	unprognostic (1.75e-1)	0	0	0.1	0	0.2	0.1	0	0.1	0.2	0	0	0	0	0	0	0.3	0	0	22.8	0	0.1	0.1	0.2	128.4	0.2	0	0	0	0	1.7	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0.3	0.2	0	0.7	0.1	0.1	6.1	0.4	0.3	0	0	0	0.3	0.1	0.1	0.3	3.4	0.1	0.6	0.2	0	0.3	0.3	0.1	0.2	0.5	0.3	0.1	0.5	0.2	2.4	0	0.9	0.3	0	1	0.1	0	0.1	0	0.8	0.7	0.4	0.5	0.1	0.2	0.3	1	2.6	0.7	0.2	1.1	0.2	0.6	0.2	0.3	0.4	0.4	0.2	0.5	0.2	0	0.2	0.1	0.6	0.6	0.2	0.4	0.4	0.6	0.5	0.5	0.2	0.6	0.3	0.2	0	0.7	0.1	0.1	0.5	0.1	0.1	0	0	0.3	0	0	0	0	0	0	0.1	0.1	0.2	0.1	0.2	0.1	0.1	0	0	0	0	0	0	11.5	0	0	0.8	0.4	89.2	0	0	0	0	0	0	8.1	0	0	0	0	0.2	0	0	0	0	745.7	0	0	0	11.1	12.7	0	0	0	0	0	0	0	2.7	0	0	0	0.1	0	0	0	0.1	0	0	0	0	0	Hepatocytes
MDC1	Em:AB023051.5, KIAA0170, NFBD1	ENSG00000137337	Mediator of DNA damage checkpoint 1	Q14676	6	30699807-30717889	Cancer-related genes, Predicted intracellular proteins	Cell cycle, DNA damage, DNA repair		Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	4	Spermatocytes: 75.3	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enhanced	Detected in many		NK-cell: 3.8	Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		A-431: 15.7;AN3-CA: 12.3;HEK 293: 29.8					Low region specificity	Detected in all			HPA006915	Enhanced		Supported	Nucleoplasm,Nuclear bodies		No	No			Nuclear bodies	Nucleoplasm	HPA006915: AB_1853669	unprognostic (8.52e-2)	unprognostic (4.32e-1)	unprognostic (4.11e-2)	unprognostic (2.66e-2)	unprognostic (1.60e-1)	unprognostic (1.61e-1)	unprognostic (5.40e-3)	unprognostic (1.13e-1)	unprognostic (1.09e-2)	unprognostic (9.44e-2)	unprognostic (2.74e-3)	unprognostic (1.31e-1)	unprognostic (1.62e-2)	unprognostic (3.86e-2)	unprognostic (2.99e-1)	unprognostic (4.39e-3)	unprognostic (3.23e-1)	10.8	3.6	5.7	9.5	5.9	4.9	5.5	10.2	8	6.9	6.3	8.5	3.8	3.8	9.9	5.1	3.7	8.3	5	5	5.2	2.4	5.1	6.2	5.1	5.4	4.9	3.7	11.3	5.7	3.1	12.5	3.1	6	6.4	2.9	9.4	5.5	3.5	11.1	11.7	6.4	6.1	5.5	7.1	7.7	26.7	5.3	11.4	11.9	2.4	13	5.2	5.4	2	1.8	0.4	0.2	3.8	1.2	0.3	15.7	1.1	1.2	12.3	3.9	3.9	1	1.3	0.7	2.7	1.1	1	1.7	2.6	6.7	7.8	6.4	1.6	2.4	4.5	2.5	2.2	29.8	1.9	3	0.7	0.5	1.1	1.4	1	0.9	4.2	2	0.3	0.4	6.4	3.9	2.9	0.4	1.5	0.7	0.2	0.9	0.8	0.8	2.2	1.3	2.9	4.5	3.4	2.6	1.3	0.6	3.2	0.5	2.2	2.9	2.2	1	1	1.5	2	1.5	1.9	7.3	6.8	0.3	4.4	2.1	0.4	0.1	0.3	1.1	0.2	0.9	0.8	0.9	1.2	0.2	2	1	0.8	0.1	3.8	0.1	1.8	0	0.3	5.7	5.9	10.2	8	5.2	2.4	4.9	3.7	6	5.3	14.9	15.4	9.7	4.8	3.9	10.7	6.3	7.6	8.1	6.8	5.2	7.9	4.4	3.3	3.8	3.4	5.6	1	0	5.4	9.5	7.3	2.5	16.2	11.4	5.6	4.8	6.4	5.5	5.9	2.1	7.2	4.5	1.7	8.2	2.6	10	4.8	0	5.6	2.8	17	12.9	5	75.3	17.2	3.1	1.6	6.9	4.4	0.8	Spermatocytes
CLPS		ENSG00000137392	Colipase	P04118	6	35794982-35797344	Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Digestion, Lipid degradation, Lipid metabolism		Diabetes mellitus	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	1551	pancreas: 4260.9	Cell type enriched	Detected in some	9	Exocrine glandular cells: 19853.4	Cancer enriched	Detected in many	188	pancreatic cancer: 1726.0	Not detected	Not detected			Cell type enhanced	Detected in some		neutrophil: 2.7	Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		EFO-21: 2.6;HDLM-2: 1.3;T-47d: 3.4;U-2 OS: 3.0;U-266/84: 2.4	Not detected	Not detected			Not detected	Not detected			HPA010512	Enhanced				Secreted to digestive system				1100000			HPA010512: AB_1846979	unprognostic (2.00e-1)			unprognostic (1.11e-1)						unprognostic (8.12e-3)	unprognostic (2.47e-1)			unprognostic (1.33e-1)	unprognostic (1.61e-1)			0.3	0	0.1	0.1	0.1	0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.3	0.2	0.1	0.1	0	0.1	0.3	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	1.6	4260.9	0	0.1	0.1	0.1	0.1	0	0.1	0.3	0.1	0.1	0	0.1	0.1	0.1	0.1	0.2	0.6	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.5	0.4	2.7	0.4	1.3	1.1	0.1	0.6	0	0	0.4	0	0	0	0	0	0	0	0	0	0	2.6	0	0.5	0	0	0	0	1.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0.5	0	0	0	0	0	0	0	0	0	1.1	0	0	0	0	0	0	0	0.3	3.4	0	0	0	3	0	1	0	2.4	1	0	0.9	0	0.5	0.4	1.3	0.1	0.2	0	0.3	1.1	0.1	0.4	0.5	0.3	0	2.7	1.3	0	0.1	0	0.1	0.1	0.1	0.1	0.2	0.1	0	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	23.4	0	0	0	0	19853.4	0	0	0	0	0	0	0	11.3	0	0	0	0	0	0	228.2	0	0	2154.9	0	0	0	0	0	0	0	0.6	0	0	0	0	0	Exocrine glandular cells
FAM8A1	AHCP	ENSG00000137414	Family with sequence similarity 8 member A1	Q9UBU6	6	17600355-17611719	Predicted membrane proteins, Transporters				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	5	Early spermatids: 685.5	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enhanced	Detected in many		neutrophil: 9.0	Low lineage specificity	Detected in many			Low cell line specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA044698, HPA073675	Approved		Approved	Golgi apparatus						Golgi apparatus		HPA044698: AB_2679051, HPA073675: AB_2732236	unprognostic (4.06e-1)	unprognostic (2.32e-1)	unprognostic (9.11e-2)	unprognostic (6.90e-2)	unprognostic (1.99e-2)	unprognostic (5.17e-3)	unprognostic (6.13e-2)	unprognostic (1.93e-2)	unprognostic (2.04e-2)	unprognostic (1.09e-3)	unprognostic (4.44e-2)	unprognostic (3.50e-1)	unprognostic (1.56e-2)	unprognostic (3.85e-2)	unprognostic (3.71e-1)	unprognostic (7.59e-2)	unprognostic (2.98e-1)	14.7	13	19.8	8.3	21.1	21.1	15.2	23.7	22.6	17.2	16.2	10.8	23.8	12.9	21.4	15.4	11.1	16.7	16.4	11.8	17.7	17.8	18.8	58.7	14.5	14.6	17.3	16.5	22.6	17.8	19	16.2	11.5	17.5	16.9	18.1	8.7	16.3	31.4	17.5	13.1	15.9	19.7	17.9	10.5	12	28.4	16.4	15.1	18.3	10.5	6.4	15	16.2	0.2	0.4	9	0.6	2.6	2	0.5	4.8	1.9	7.2	17.1	25	23.6	5.9	7.9	10.8	4	7.1	11.1	1.6	4.2	19	13.3	4.4	4	10.8	6.8	5.4	3.5	15.4	5	6.8	23.7	11.1	3.1	5.2	12.4	11.1	4.6	3.3	13.1	9	4.7	10.1	8.6	6.4	5.9	2.3	9.8	3	6	3	6.2	7	12.6	13.8	3.9	2.2	11.5	6.1	13.3	12	13	15.4	4.9	6.9	5.2	1.8	8	2.8	7.2	6	4.1	4.7	3.7	7.1	4.2	0.5	1.5	1.9	0.6	2	0	0.9	1.6	0.3	0.2	1.2	1.9	9	2.6	0.4	0.4	0.6	0.5	19.8	21.1	23.7	22.6	17.7	17.8	17.3	16.5	17.5	16.4	17.9	19	3	8.6	11.8	26.8	12.2	15.3	12	14.8	27.9	13.7	8.4	5	7.4	685.5	9.3	26.4	0	6.8	10.4	12.6	10.7	1.1	67.4	5.4	14.3	11.5	23.9	20	149.2	33.9	6.5	5	1	11.3	17.4	7.3	17.5	29	11.4	15.3	32.3	17.5	30.6	16.8	13.9	10.2	10.2	13.4	7	Early spermatids
TTPA	AVED	ENSG00000137561	Alpha tocopherol transfer protein	P49638	8	63048553-63086053	Disease related genes, Plasma proteins, Predicted intracellular proteins	Transport		Disease mutation	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	19	liver: 74.1	Cell type enriched	Detected in some	6	Hepatocytes: 67.2	Cancer enriched	Detected in some	9	liver cancer: 21.3	Low region specificity	Detected in all			Low cell type specificity	Detected in some			Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		GAMG: 3.6;SK-BR-3: 10.3;T-47d: 3.8;U-2 OS: 5.4;U-2197: 6.4	Low region specificity	Detected in all																				unprognostic (1.48e-1)	unprognostic (3.42e-1)	unprognostic (7.82e-3)	unprognostic (1.30e-7)	unprognostic (1.78e-1)	unprognostic (8.44e-2)	unprognostic (1.25e-2)	unprognostic (7.84e-2)	unprognostic (4.04e-2)	unprognostic (3.50e-1)	unprognostic (5.40e-2)	unprognostic (3.28e-1)	unprognostic (1.14e-2)	unprognostic (1.49e-2)	unprognostic (3.57e-2)	unprognostic (5.46e-3)	unprognostic (6.16e-3)	0.9	0.4	2.4	0.4	3.3	0.3	2.5	3.5	2	0.3	1.6	2.1	0	0.4	0.3	0.3	0.3	0.3	0.4	0.3	3.9	1.1	1.4	74.1	0.6	0.3	2.4	1.8	0.3	0.8	0.4	0.3	1	3.8	0.3	2.3	0	0.3	0.3	0.3	0.4	0.4	0.4	3.1	0.3	0.4	0.4	2.4	0	0.3	0	0.3	0.3	0.2	0.9	0.3	2	0.5	0.3	0.4	0	0.1	1.5	1	0.2	0.5	0	0	0.1	0	0.4	0.1	0.2	2.4	0	0.1	0	3.6	0	2.7	0.2	0.5	0	0.1	0.1	0.2	0.6	0	0	0.1	0.1	0	0.5	0	0.3	0	0.1	0.1	0.2	0.4	1.2	0.1	0.2	1	0.1	0.7	0.1	0	0	0	0.7	0.4	0.1	1	10.3	1	0.1	3.8	0.4	0.3	0.1	5.4	6.4	1.1	0.4	0	0.1	2.3	0.1	2	2	0.5	0.3	0.4	0.1	0.3	0.4	0.3	0.2	0.2	0.9	0.3	0.3	1.6	0.3	0.2	0.3	0.2	0	2.4	3.3	3.5	2	3.9	1.1	2.4	1.8	3.8	2.4	3	0.6	0	0	0	0	0.1	5.1	0	2.3	0	0	8.1	1.7	0.4	0	0	0	0	0.2	0	0.3	0	0	67.2	0.6	0	2.4	2.5	1	0	0	0	0	0	1.7	10.6	0.1	0	0	4.4	0.2	0	0.1	0	0.1	0.1	8.2	0	6.6	0.1	Hepatocytes
MMP7	MPSL1, PUMP-1	ENSG00000137673	Matrix metallopeptidase 7	P09237	11	102520508-102530753	Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins	Collagen degradation	Hydrolase, Metalloprotease, Protease	Cancer-related genes, FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		gallbladder: 93.0;kidney: 129.5;salivary gland: 79.3	Cell type enriched	Detected in many	6	Ductal cells: 5335.6	Cancer enhanced	Detected in all		pancreatic cancer: 352.1	Region enriched	Detected in single	5	pons and medulla: 1.3	Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		A549: 23.2;CAPAN-2: 129.5;EFO-21: 30.7;RPTEC TERT1: 56.0	Not detected	Not detected			Not detected	Not detected			CAB025869, HPA051358	Supported		Approved	Nucleoplasm,Vesicles	Secreted to extracellular matrix			2810000		Nucleoplasm, Vesicles		CAB025869: , HPA051358: AB_2681452	unprognostic (1.06e-3)	unprognostic (9.51e-2)	unprognostic (4.15e-2)	unprognostic (1.38e-1)	unprognostic (7.70e-3)	unprognostic (7.28e-2)	prognostic unfavorable (2.53e-4)	prognostic unfavorable (3.38e-4)	unprognostic (3.96e-2)	unprognostic (5.63e-2)	unprognostic (6.59e-3)	unprognostic (1.51e-1)	unprognostic (6.36e-3)	unprognostic (1.42e-2)	unprognostic (5.54e-2)	unprognostic (1.48e-1)	unprognostic (1.46e-1)	6.8	0.2	0.2	1.2	0.2	0	28.8	0.2	0.2	5.2	0.2	0.2	2.1	0	17.2	12.3	3.3	16.4	93	0.2	0.2	0.2	129.5	1.4	5	0.9	0.2	0.2	3.9	23.5	0	0.7	2.7	1.3	42	0	0.2	79.3	6.7	0.2	7.8	0.3	0.5	0.2	0.2	0.9	9.4	0.2	1.2	0.3	1.4	4.5	19.9	0.8	0.8	0	0	0	0	0	0.1	0	23.2	0	0	0	0	0	0	0.3	0	0	0.3	129.5	0	30.7	0	0	0.1	0	0	0	0.1	0	0	0	0.1	0.1	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	1.8	0	0	0	0	56	0.1	0	0	0	0	0	0.6	0	0	0	0.1	0.4	0	0.2	0	0	0	0.1	1	0	0	0	0	0	0	0	0	0	0	0	0.8	0	0	0	0	0	0	0	0.1	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	1.3	0.2	80.4	30.5	0	310.5	0.9	0	0.6	119.8	113.8	646	964.8	0	0.3	0	5335.6	3.9	0.3	0	0	184.1	0.2	0.4	323.2	2.3	0	103.8	0	0	0	0	6.5	10.9	7.3	0	113.6	0	0	723.2	0	0	6	0	0	0.4	0	0.1	2	0.7	0	0	640.3	Ductal cells
MMP20		ENSG00000137674	Matrix metallopeptidase 20	O60882	11	102576835-102625332	Disease related genes, Enzymes, FDA approved drug targets, Predicted secreted proteins		Hydrolase, Metalloprotease, Protease	Amelogenesis imperfecta, FDA approved drug targets	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in some		lymphoid tissue: 1.0;testis: 3.5	Cell type enriched	Detected in some	10	Early spermatids: 66.1	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	7	OE19: 7.4	Not detected	Not detected			Not detected	Not detected								Secreted to extracellular matrix								unprognostic (4.62e-3)		unprognostic (2.61e-2)	unprognostic (1.68e-3)		unprognostic (1.75e-1)		unprognostic (2.13e-1)		unprognostic (3.06e-1)	unprognostic (2.97e-2)	unprognostic (6.75e-2)	unprognostic (9.58e-5)	unprognostic (6.10e-2)		unprognostic (2.35e-1)		0	0	0	0.3	0	0	0.8	0	0	0	0			0.2	0	0	0	0	0.2	0	0	0	0.5	0	0	0.2	0		0	0	0	0	0		0	0		0.3	0	0	0	0	0	0	0	0	3.5			0		1	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0.3	1.1	0	0.2	0	0.2	0	0	0	0	0.1	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	7.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	66.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	6.6	0.3	0	0	0	0	0	0	0	0.4	0	0	6.5	0	0	0.3	0	0.5	0	0	0.5	Early spermatids
MMP27		ENSG00000137675	Matrix metallopeptidase 27	Q9H306	11	102691487-102705806	Enzymes, FDA approved drug targets, Predicted intracellular proteins	Collagen degradation	Hydrolase, Metalloprotease, Protease	FDA approved drug targets	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in many		breast: 10.4;tongue: 10.0	Cell type enriched	Detected in single	5	Suprabasal keratinocytes: 1.1	Not detected	Not detected			Not detected	Not detected			Cell type enriched	Detected in single	7	neutrophil: 1.0	Lineage enriched	Detected in single	7	granulocytes: 1.0	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			HPA069097	Approved				Intracellular and membrane							HPA069097: AB_2686085	unprognostic (3.99e-2)	unprognostic (2.37e-4)				unprognostic (1.25e-3)			unprognostic (1.63e-1)					unprognostic (4.60e-1)				3.2	0	0	0	0.5	2.4	10.4	0	0	1.5	0.8	0	0	0.3	0.9	4.7	0.8	0.1	0.1	0	0	0	0	0.1	0	0	0	0	0	0	0	0	1.2	0	0	0.6	0	5.1	0	0.8	5.4	2.6	2	0	0.1	0.4	0.4	0	0.9	0.1	10	2.2	0.4	0.3	0	0	1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.7	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.8	0	0	0	0	0	0.2	0	0.2	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0.2	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	1.1	0	0	0	0	Suprabasal keratinocytes
SMAD6	HsT17432, MADH6, MADH7	ENSG00000137834	SMAD family member 6	O43541	15	66702228-66782848	Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	DNA-binding	Craniosynostosis, Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		lung: 37.1	Cell type enriched	Detected in many	6	Ito cells: 107.4	Low cancer specificity	Detected in all			Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in many		EFO-21: 21.2;HaCaT: 12.6;HeLa: 17.4;U-2197: 12.3	Low region specificity	Detected in many			Low region specificity	Detected in many			HPA061917			Supported	Nucleoplasm,Nuclear bodies,Golgi apparatus						Nucleoplasm	Nuclear bodies, Golgi apparatus	HPA061917: AB_2684637	unprognostic (1.20e-1)	unprognostic (7.43e-3)	unprognostic (5.62e-2)	unprognostic (1.26e-1)	unprognostic (3.02e-1)	unprognostic (3.50e-3)	unprognostic (9.59e-2)	unprognostic (4.50e-1)	unprognostic (3.47e-2)	unprognostic (1.50e-1)	unprognostic (1.10e-3)	unprognostic (1.68e-1)	unprognostic (1.67e-2)	unprognostic (1.55e-3)	unprognostic (4.30e-2)	unprognostic (1.33e-1)	prognostic favorable (5.45e-5)	9.8	1.9	2.5	3.1	4.6	0.6	5.1	0.8	2.8	6.3	4.7	2.6	2.1	3.8	5.2	1.9	3.1	4.4	11.6	21.6	3	2	6.1	6.2	37.1	1.2	3.6	2.3	5.1	3.1	2.3	2.8	13.8	4.5	9.7	2.5	18.5	1.6	22.1	1.8	1.6	3.8	3.1	2.9	3.2	8	1.7	2	0	16.7	0.6	0.8	6.8	7.3	0	0.2	0	0.3	0	0	0	0.9	7	1.1	2.4	4.3	1.1	6.7	4.9	0.1	0.8	0	1.4	3.1	0.5	21.2	4.2	0.6	12.6	1.5	0	0.1	1.5	5.8	10.9	17.4	1.1	0.5	0	0.8	1.4	0	0	0	2.4	0.9	3.6	0.9	0.7	0.3	1.3	0.1	3	2.1	7.1	2.6	0	1.3	1.5	2.4	5.5	2.6	1.1	2.7	3	0.5	4.3	1	2	4.2	3.1	4	12.3	0.9	0.4	1.2	0.2	2.2	3.9	0.1	0	0.3	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0.2	0	0	0	2.5	4.6	0.8	2.8	3	2	3.6	2.3	4.5	2	11.9	5.9	1.4	1	0.7	0	4.5	5.1	0	4.5	1.8	2	0.5	3.3	4.3	2.8	19.4	2.8	0	5	0.7	4.3	1.5	4.6	2.8	1.7	0	0	107.4	9.5	1	2.6	0.8	0	1	2	11.1	5.6	0	7.8	1.5	0.3	0	1	0.2	0.6	0.1	0.7	0.5	5.3	0.3	Ito cells
CYP19A1	ARO, ARO1, aromatase, CPV1, CYAR, CYP19, P-450AROM	ENSG00000137869	Cytochrome P450 family 19 subfamily A member 1	P11511	15	51208057-51338610	Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins		Monooxygenase, Oxidoreductase	Cancer-related genes, Disease mutation, FDA approved drug targets, Pseudohermaphroditism	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	49	placenta: 440.1	Cell type enriched	Detected in some	36	Syncytiotrophoblasts: 1678.9	Low cancer specificity	Detected in single			Region enriched	Detected in single	8	basal ganglia: 5.9	Cell type enriched	Detected in single	17	neutrophil: 1.7	Lineage enriched	Detected in single	17	granulocytes: 1.7	Cell line enhanced	Detected in some		ASC TERT1: 45.7;HDLM-2: 7.9;HSkMC: 15.3;SuSa: 8.1	Low region specificity	Detected in many			Low region specificity	Detected in all			CAB000355, HPA051194	Enhanced		Uncertain	Mitochondria						Mitochondria		CAB000355: , HPA051194: AB_2681381	unprognostic (9.41e-2)	unprognostic (7.44e-2)	unprognostic (9.52e-5)	unprognostic (6.81e-2)	unprognostic (2.72e-1)	unprognostic (4.25e-4)	unprognostic (5.18e-5)	unprognostic (1.54e-3)	unprognostic (2.38e-2)	unprognostic (2.52e-1)	unprognostic (1.97e-1)	unprognostic (5.37e-2)	unprognostic (1.54e-5)	unprognostic (2.52e-3)	unprognostic (2.11e-1)	unprognostic (1.40e-2)	unprognostic (1.11e-1)	9	4.6	0.2	0.2	5.9	0.1	2.1	0.2	0.3	0.9	0.3	0.3	0.2	0.4	0.2	0.3	0.3	0.2	0.3	1.3	0.2	0.7	0.3	0.2	0.6	0.2	0.2	0.2	4.4	0.6	0.1	0.2	440.1	0.2	0.5	0.1	0.2	0.9	1.4	0.8	2.3	0.2	0.7	0.5	0.5	0.1	3	0.2	0.3	3	0.2	0.2	1.2	0.5	0	0	1.7	0	0	0	0	0	0	0	0	0.8	45.7	2.8	0	0.1	0	0	0.1	0	0	0.1	0.2	0.1	0	0	0	0	7.9	0	0.3	0.1	3.7	0.3	0	0	15.3	0	0.1	1.9	0.1	0	0	0	0.3	0.1	0.3	0	0	0	0.3	0	0	0	0	0	0	0	0	0.1	1.1	0	8.1	0	0.2	0	0.1	0	0.1	0	1.4	0.6	0	0.3	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	1.7	0	0	0	0	0	0.2	5.9	0.2	0.3	0.2	0.7	0.2	0.2	0.2	0.2	0	0	0	0	0	0	2	0	0	0	0	0	46.8	0	0	2.2	0	0	0	0	6.9	1.4	0	0	0	13.4	0	0	0	1.6	4.5	0.6	0	0	0	0	0	0.1	0	0.4	0	0	6.5	0.3	7.7	0.2	0	1678.9	0	0	0	Syncytiotrophoblasts
ABCG5	STSL	ENSG00000138075	ATP binding cassette subfamily G member 5	Q9H222	2	43812472-43838865	Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters	Lipid transport, Transport	Translocase	Disease mutation	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	85	intestine: 54.3;liver: 40.9	Cell type enriched	Detected in some	9	Hepatocytes: 47.3	Cancer enriched	Detected in some	23	liver cancer: 11.7	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	47	Hep G2: 14.7	Not detected	Not detected			Not detected	Not detected																unprognostic (1.71e-1)	unprognostic (5.47e-2)	unprognostic (4.01e-1)	unprognostic (6.92e-2)	unprognostic (2.24e-1)	unprognostic (9.97e-2)	prognostic favorable (2.60e-5)	unprognostic (4.59e-2)	unprognostic (3.10e-1)	unprognostic (1.38e-3)	unprognostic (3.07e-4)	unprognostic (1.86e-1)	unprognostic (3.07e-1)	unprognostic (5.52e-3)	unprognostic (8.29e-2)	unprognostic (5.31e-2)	unprognostic (3.08e-2)	0.1	0.1	0.1	0	0.1	0	0.1	0.1	0.1	0.1	19.5	0	0	27.6	0.1	0.2	0.1	0.1	0.5	0.1	0.1	0.1	0.1	40.9	0.1	0	0.1	0.1	0.1	0.1	0	0.1	0	0	0.1	0	0	0.1	0	0.1	0.1	54.3	0	0.1	0.2	0.1	0.1	0	0	0.1	0	0	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.7	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0.1	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0	0.4	1.3	5.1	0	0	0	0	0	1.7	0	0	0	0.7	0	0	0	0	0	0	47.3	0	0	0	0.6	1.5	0	0	0	0	0	0	0.1	0	0.2	0	0	0.7	0	0	0	0.2	0	0	0	0.8	0	Hepatocytes
SLC3A1	ATR1, CSNU1, D2H, NBAT, RBAT	ENSG00000138079	Solute carrier family 3 member 1	Q07837	2	44275458-44321494	Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters	Amino-acid transport, Transport		Cystinuria, Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		intestine: 66.0;kidney: 191.5;pancreas: 36.8	Cell type enriched	Detected in many	4	Proximal tubular cells: 256.0	Cancer enriched	Detected in many	7	renal cancer: 61.9	Not detected	Not detected			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Cell line enriched	Detected in some	17	RPTEC TERT1: 49.9	Not detected	Not detected			Low region specificity	Detected in all			HPA038360, HPA071102	Enhanced		Approved	Nuclear bodies,Mitochondria						Mitochondria	Nuclear bodies	HPA038360: AB_2675975, HPA071102: AB_2732171	unprognostic (1.67e-2)	unprognostic (1.74e-1)	unprognostic (1.39e-1)	unprognostic (1.43e-2)	unprognostic (6.14e-2)	unprognostic (9.45e-2)	unprognostic (2.76e-2)	unprognostic (1.34e-1)	unprognostic (3.90e-1)	unprognostic (8.73e-2)	unprognostic (1.16e-1)	unprognostic (3.17e-1)	prognostic favorable (3.67e-7)	unprognostic (6.10e-2)	unprognostic (1.26e-1)	unprognostic (3.77e-1)	unprognostic (1.58e-4)	0.2	0.1	0.2	0.7	0.2	0	0.2	0.7	0.2	0.3	28.4	0.1	0.1	18.8	1.3	4.6	0.2	0.2	17.9	0.1	0.2	0.2	191.5	5.3	0.2	0.1	0.2	0.1	0.2	36.8	0	0.2	0.5	0.1	0.3	3.7	0.2	0.1	0.1	0.2	0.2	66	0.1	0.2	0.2	0.3	0.5	0.1	0.1	0.2	0.1	0.1	0.2	0.2	4	1.3	2	1.3	1.6	2.7	0.3	0	0.9	0	0.1	0.1	0.1	0.2	0	0	0	0	2.6	0	0	2.8	0	0	0.1	0	0.1	0.1	0	0	0.1	0	0.1	0	0	0.1	0	0	0	0.1	0.2	0	0.1	0	0.1	0.1	0	0	0.3	0	0.9	0.2	0	0.1	0.2	49.9	0	0.1	0.1	0.1	0	0	0	0.1	0	0	0.1	0.2	0.1	0	0.2	0	0.2	0	0.1	0.1	1.3	1.3	1	2.6	1.3	1.9	1.9	2.5	1.4	0.4	4	2.5	2.7	2	1.6	0.6	1.3	0.9	0.3	0.2	0.2	0.7	0.2	0.2	0.2	0.2	0.1	0.1	0.1	3	1	1.5	0.2	0	12.5	0.3	63.7	0	0	40.1	9.8	0	53	18.3	10.9	0	32.7	0	12.6	0	0.2	1.4	0	2.8	0.1	20.6	0	0.6	0	3.3	1.1	0	0	2.8	3.8	1.6	3.4	7.2	0.4	256	11.9	0	0.1	0.7	0.3	0.1	0.1	0	8	0.5	Proximal tubular cells
CYP2C9	CYP2C10, P450IIC9	ENSG00000138109	Cytochrome P450 family 2 subfamily C member 9	P11712	10	94938658-94989391	Enzymes, Predicted intracellular proteins	Lipid metabolism, Steroid metabolism, Sterol metabolism	Monooxygenase, Oxidoreductase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	5	liver: 233.0	Cell type enriched	Detected in some	48	Hepatocytes: 1765.4	Cancer enriched	Detected in some	41	liver cancer: 118.4	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HL-60: 3.5;NB-4: 1.7;RPMI-8226: 2.5;SiHa: 1.6									HPA015066, CAB016123	Enhanced				Intracellular and membrane							CAB016123: AB_629363, HPA015066: AB_1847433	unprognostic (3.37e-1)	unprognostic (5.68e-2)	unprognostic (9.67e-2)	unprognostic (4.16e-2)		unprognostic (1.83e-2)	prognostic favorable (2.83e-6)	unprognostic (2.37e-1)	unprognostic (2.05e-2)		unprognostic (4.93e-2)		unprognostic (1.26e-4)	unprognostic (7.55e-2)	unprognostic (1.12e-1)	unprognostic (2.45e-2)	unprognostic (1.24e-2)	0	0	0	0	0	0	0	0	0.1	0.2	45.8	0	0	13.6	0	0.6	1.1	0	1	0	0	0	0.5	233	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0.2	0	0	0.2	43.8	0	0	0.1	2.7	0.1	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0.8	0	0.5	0	0	1.1	0.4	0	0	0	0	0.1	1	0	0.1	0	3.5	0	0	0	0	0	0	0	0	0.9	0	0	0	0	1.7	0.4	0.9	0	0	0.3	2.5	0.4	0	0.1	0.1	1.6	0	0	0.3	0	0	0	0	0.3	0	0	0	0	0.9	0.1	0.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0.2	0	0	0	7	0	0	0	0	30.6	0	0	1.8	0	0	0	4.7	0	0	4.2	23.3	0.6	0	0	0	0	1765.4	0	0	0	36.8	31.7	0	0	0	0	0	0.1	0	0.6	0.3	0	1.5	0	0	0	0	0	0	0.1	0.7	0.3	0	Hepatocytes
CYP2C8	CPC8	ENSG00000138115	Cytochrome P450 family 2 subfamily C member 8	P10632	10	95036772-95069497	Enzymes, Plasma proteins, Predicted intracellular proteins	Lipid metabolism, Steroid metabolism	Monooxygenase, Oxidoreductase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	131	liver: 247.5	Cell type enriched	Detected in some	10	Hepatocytes: 1616.5	Cancer enriched	Detected in some	82	liver cancer: 102.3	Not detected	Not detected			Cell type enriched	Detected in single	9	gdT-cell: 1.8	Lineage enriched	Detected in single	9	T-cells: 1.8	Cell line enhanced	Detected in some		Daudi: 1.8;HL-60: 2.7;SiHa: 3.0;U-266/70: 3.0;U-266/84: 2.3									HPA013547, HPA013970, HPA015066	Enhanced				Intracellular and membrane							HPA013547: AB_1847435, HPA013970: AB_1847434, HPA015066: AB_1847433	unprognostic (3.33e-2)	unprognostic (1.38e-1)	unprognostic (1.53e-1)	unprognostic (1.55e-1)	unprognostic (4.41e-2)	unprognostic (1.09e-2)	unprognostic (1.80e-3)	unprognostic (4.29e-2)	unprognostic (1.03e-1)	unprognostic (3.38e-1)	prognostic favorable (9.82e-4)	unprognostic (2.85e-1)	unprognostic (1.44e-3)	unprognostic (2.63e-1)	unprognostic (7.88e-2)	unprognostic (1.39e-1)	unprognostic (4.05e-4)	0.1	0.1	0.1	0.1	0.2	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	1	0.1	0.1	0.2	0.3	247.5	0.1	0.1	0.1	0.1	0.1	0.1	0	0.3	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.6	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0	0	0	1.8	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0.1	1.8	0	0	0.1	1.1	0.2	0	0.2	0	0.7	1	0	1	0.5	2.7	0.1	0	0.2	0	0	0	0	0.1	0.3	0.4	0.3	0.7	0.1	0	0.2	0	0	0	0.8	0	0	0.4	0	0	3	0.2	0	0	0	0.4	0	0	0	0	0	3	2.3	1.2	0	0.9	0	0	0	0	1.8	0	0	0.2	0	0	0	0	0	0	0	0	0	0.1	0	0	0.1	0.2	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0	0	21	0	0	0.9	0.2	155.4	0	0	0	0	0.1	0	0	4.9	0	0	70	0.2	0	0	0.1	0	1616.5	0	4.8	1.7	61.4	65.7	5.1	0	0	0	0	0	0.2	0.6	0	0	0	1.6	0	0	2.1	0.6	0	0	0	0	0.1	Hepatocytes
RBP4		ENSG00000138207	Retinol binding protein 4	P02753	10	93591687-93601744	Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Sensory transduction, Transport, Vision		Cancer-related genes, Disease mutation, Microphthalmia	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	23	liver: 897.1	Cell type enriched	Detected in many	13	Hepatocytes: 11448.6	Cancer enriched	Detected in all	27	liver cancer: 3135.4	Low region specificity	Detected in many			Group enriched	Detected in some	14	classical monocyte: 1.2;myeloid DC: 1.5	Group enriched	Detected in many	14	dendritic cells: 1.5;monocytes: 1.2	Cell line enriched	Detected in some	4	Hep G2: 155.4	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA001641, CAB004555	Supported				Secreted to blood			46100000000	420000000000			CAB004555: AB_670938, HPA001641: AB_1079795	unprognostic (9.42e-3)	unprognostic (3.40e-2)	unprognostic (1.90e-1)	prognostic unfavorable (1.50e-4)	unprognostic (2.60e-2)	unprognostic (6.69e-4)	prognostic favorable (1.74e-8)	unprognostic (2.39e-1)	unprognostic (5.76e-2)	unprognostic (3.26e-2)	unprognostic (3.26e-1)	unprognostic (3.44e-1)	unprognostic (7.14e-3)	unprognostic (9.88e-3)	unprognostic (2.31e-1)	unprognostic (1.03e-1)	unprognostic (8.60e-2)	39	2	1.4	2.4	3.1	0.3	27	0	2.1	0.3	1.8	0	0.1	0.5	0.4	0.4	0.3	0.4	2.1	1.2	1.4	2.2	7.9	897.1	1.5	1	0.2	1.1	0.5	4.7	0.3	28.3	1.8	0.4	0.9	0.6	5.6	1.8	0.5	0.4	0.4	0.6	0.3	0.1	0.3	0.7	0.4	0	0	0.3	0.5	0.2	0.6	1.6	0	1.5	0	1.2	0	0	0.4	0	2.1	0	0	0.4	0	0	0	0	0.3	0	37.5	0	0.2	0.4	0	0	0.1	0	0	0	0	0	0.3	0.1	155.4	0	1.2	0	2.7	0	0.1	0	0	0	0	0.1	0	0.1	0	0	1	0.2	0.3	17.6	0	1	0	0	0	0.1	0	1.3	0	0	0.1	0	0.1	0	0	1.1	0	0	0.1	0	0.5	0	0.5	0	0	1.2	0	0	0	0	0	0	0	1.5	0	0	0	0	0	0	0	0	0.4	1.4	3.1	0	2.1	1.4	2.2	0.2	1.1	0.4	0	0	3.4	60.7	0.2	0.7	0	0.4	853.5	1.4	1.2	22.7	5.9	0.2	82.9	7.1	2.2	0.7	2.1	46.7	0.2	11.9	6.8	1.7	0	11448.6	18.7	0	60	171.2	183.3	1.9	2.8	2	1.7	0	33	0.7	46.4	10.5	5.3	393.5	0.2	0	0.8	2.8	13.4	0.6	1.1	19.1	1.1	0.9	Hepatocytes
PLA2G12B	PLA2G13	ENSG00000138308	Phospholipase A2 group XIIB	Q9BX93	10	72935170-72954778	Plasma proteins, Predicted secreted proteins, RAS pathway related proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	6	intestine: 47.8;liver: 42.8	Cell type enriched	Detected in some	5	Hepatocytes: 47.8	Cancer enriched	Detected in many	8	liver cancer: 35.4	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	9	CACO-2: 12.1;Hep G2: 20.0	Not detected	Not detected			Not detected	Not detected			HPA057745, HPA059562	Approved				Secreted to blood							HPA057745: AB_2683514, HPA059562: AB_2684064			unprognostic (1.11e-2)				unprognostic (2.66e-2)	unprognostic (2.02e-3)			unprognostic (3.41e-1)		unprognostic (1.68e-1)	unprognostic (1.89e-1)	unprognostic (1.26e-1)	unprognostic (3.14e-2)		0.1	0.1	0.1	0	0.1	0	0.1	0.1	0.1	0.1	25.6	0	0	15.4	0.1	0.3	0.1	0.1	0	3.5	0.1	0.1	8	42.8	0.9	0	0.1	0	0.1	0.1	0	0.1	0	0.1	0.1	0.7	0.1	0.1	0	0.1	0.1	47.8	0	0.1	0.1	0.1	0.5	0	0	0.1	0	0	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	12.1	0	0.1	0	0	0	0	0	0	0.2	0.1	0	0	0	20	0	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0.1	0	0.1	0	0	0	0	0	0.2	0	0.1	0.1	0.1	1.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0	0	2.6	0.9	0	0	0.5	1.2	0	0	0	0	0	0	0	0	7.9	0	10.3	0	0	0	0	0	0	47.8	0	0	0	1.8	0.6	0.5	0	0	0	0	0.1	0.3	0	2.9	0	9.8	0.2	0	0	0	0.1	0	0	0	0	0	Hepatocytes
OIT3	FLJ39116, LZP	ENSG00000138315	Oncoprotein induced transcript 3	Q8WWZ8	10	72893581-72933033	Plasma proteins, Predicted secreted proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	8	liver: 49.1	Cell type enriched	Detected in some	10	Ito cells: 487.3	Cancer enhanced	Detected in many		liver cancer: 4.6	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	6	CACO-2: 5.8;Hep G2: 6.1	Not detected	Not detected			Not detected	Not detected								Secreted to blood				150000000				unprognostic (2.42e-2)	unprognostic (6.76e-2)	unprognostic (7.98e-4)	unprognostic (9.26e-2)	unprognostic (9.47e-4)	unprognostic (3.05e-1)	unprognostic (4.33e-2)	unprognostic (1.99e-2)	unprognostic (1.00e-1)	unprognostic (1.11e-1)	unprognostic (8.50e-3)	unprognostic (1.41e-1)	unprognostic (4.11e-2)	unprognostic (1.35e-1)	unprognostic (2.44e-1)	unprognostic (3.68e-3)	unprognostic (1.19e-1)	0.1	0	0.1	0.1	0.1	0	0.1	0.3	0.1	0.1	0.1	0.1	0.1	2.2	0.1	0.1	0.3	0	0.1	2	0.1	0	0.6	49.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0	0.1	0.1	0.1	0.1	0	2.5	0.1	0.1	6	0	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0.2	0	0	0.2	0	0.3	0	0.2	0.3	0.3	0	0.1	0	0	0	5.8	0.2	0.1	0.1	0	0.1	0	0.1	0	0	0.2	0.1	0.4	0.3	6.1	0.2	0.2	0.1	0.4	0.2	0	0.1	0	0.1	0	0	0	0.5	0	0	0	0	0.3	0	0	0.1	0.1	0	0.3	0.1	0.1	1	0	0	0	0	0	0.2	0	0.2	0	0	0	0	0	0	0.1	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0.1	0.1	0.3	0.1	0.1	0	0.1	0.1	0.3	0.1	0	0	0	0	0	0	0.3	15.3	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	2.4	0	0	0	487.3	50.7	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0.2	0	0	0	0	0	0	Ito cells
DNA2	DNA2L, KIAA0083	ENSG00000138346	DNA replication helicase/nuclease 2	P51530	10	68414064-68472121	Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins	DNA damage, DNA repair, DNA replication	DNA-binding, Endonuclease, Helicase, Hydrolase, Multifunctional enzyme, Nuclease	Disease mutation, Dwarfism, Mental retardation, Primary mitochondrial disease, Progressive external ophthalmoplegia	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	7	lymphoid tissue: 49.1	Cell type enriched	Detected in many	5	Erythroid cells: 70.0	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Cell type enriched	Detected in single	6	NK-cell: 5.5	Lineage enriched	Detected in single	6	NK-cells: 5.5	Low cell line specificity	Detected in many			Not detected	Not detected			Low region specificity	Detected in all			HPA037487, HPA057526	Approved		Supported	Mitochondria		No	No			Mitochondria		HPA037487: AB_10672493, HPA057526: AB_2683456	unprognostic (1.79e-1)	unprognostic (1.35e-1)	unprognostic (4.37e-3)	unprognostic (4.60e-3)	unprognostic (1.53e-1)	unprognostic (1.86e-2)	unprognostic (4.50e-5)	unprognostic (3.36e-2)	unprognostic (4.70e-2)	unprognostic (3.72e-2)	unprognostic (1.30e-2)	unprognostic (3.29e-4)	unprognostic (1.09e-10)	unprognostic (3.43e-2)	unprognostic (1.98e-1)	unprognostic (9.36e-2)	unprognostic (1.23e-2)	1.6	1.2	2	13.7	2.4	7	3	6.2	3.8	1.6	4.5	1.1	0.8	3.5	3	1.8	3.2	1	2.4	2	2.5	2.2	3.4	6.2	3.3	8.4	2.9	5	1.9	2.4	1.1	2.3	4	1.7	3	5	0.9	2.3	0.8	2.3	2.9	5.2	1.9	3	5.2	2.6	7	1.4	49.1	1.5	5.1	10.8	2.3	2	0.4	0.1	0.9	0.1	5.5	0.6	0.1	13.9	7.2	16.5	11.6	1.9	1.3	11.6	6.9	5.8	9.9	12.2	17.2	9.1	14.3	2.6	2.1	3.8	8.6	9.4	3.6	12	8.8	7.1	8.7	4.5	6.6	0.5	14.9	9.4	1	1.5	7	2.1	2.5	4.4	9.5	12.7	13	5.7	4.9	23	10.8	11.6	5.9	13.6	18	11.4	4.6	4.2	6.5	7.5	9	9.5	12.1	2.3	12.2	9.3	6.3	1.8	3.8	11.9	4.8	13.1	6.6	7.4	21.4	3.2	14.3	5	0	0	0.9	0.2	0	0.2	0.4	0.2	0.6	0.1	0.4	0.3	0.3	0.1	5.5	0.1	0	0.4	0.1	2	2.4	6.2	3.8	2.5	2.2	2.9	5	1.7	1.4	6	0.6	0	0.7	2.1	2.2	7.3	2.5	0	1.2	1.8	5.9	2	0	0.5	1.6	0.7	1.3	70	0.8	3.8	1.9	3.2	0	4.4	1.8	0	1.2	1.3	2.2	3.1	0.6	0	0	0	1.3	0.2	0.7	0	0.7	0.4	3.6	0	1	5	14.2	1.5	1	1.5	2.3	0.9	Erythroid cells
MYPN	MYOP	ENSG00000138347	Myopalladin	Q86TC9	10	68106117-68212017	Disease related genes, Predicted intracellular proteins		Actin-binding	Cardiomyopathy, Disease mutation, Nemaline myopathy	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		heart muscle: 23.6;skeletal muscle: 114.9;tongue: 46.3	Cell type enriched	Detected in some	4	Cardiomyocytes: 94.6	Cancer enriched	Detected in single	7	head and neck cancer: 0.9	Not detected	Not detected			Cell type enhanced	Detected in single		basophil: 3.8	Lineage enriched	Detected in single	12	granulocytes: 3.8	Cell line enhanced	Detected in some		BJ: 16.6;fHDF/TERT166: 46.6;GAMG: 9.2;HBF TERT88: 11.0;LHCN-M2: 20.1	Low region specificity	Detected in many			Not detected	Not detected			HPA036299, HPA061494	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol		No	No			Nucleoplasm, Vesicles	Cytosol	HPA036299: , HPA061494: AB_2684539	unprognostic (4.75e-2)	unprognostic (2.20e-1)	unprognostic (8.14e-3)	unprognostic (8.62e-3)	unprognostic (3.91e-1)	unprognostic (3.36e-3)	unprognostic (4.62e-2)	unprognostic (3.86e-2)	unprognostic (2.82e-1)	unprognostic (2.26e-3)	unprognostic (3.94e-3)	unprognostic (3.10e-1)	unprognostic (2.88e-8)	unprognostic (4.63e-5)	unprognostic (9.94e-2)	unprognostic (2.01e-1)	unprognostic (3.47e-1)	4.5	0.1	0.1	0	0.1	0.2	0.1	0.1	0	0	0.1	0	0	0	0	3.1	2.1	0	0	23.6	0.4	0.1	0	0.1	0.1	0	0.1	0	0.1	0.2	0	0.1	0	0.2	0.5	0	0.1	2.1	0	114.9	0.1	0	0	0.1	0	0.2	0.3	0	0	0.9	46.3	3.4	0	0	0.3	0.1	3.8	0.1	0.2	0.1	0	1.2	0.5	0	0	0.3	1.8	0	16.6	8.3	6.3	2.3	0	0	0	0	46.6	9.2	0.3	0	0.1	11	0.1	0	0	5.9	0	0.1	0	0	0.8	0	3.3	0.4	1.5	0.1	0	0	0.1	20.1	3.5	0	0	0	0	0.5	0	0.9	0	0	0	0	0	2.3	0.4	0	0	0	0	0.4	0.3	0	1.7	0	0	0	0	2	0	1.8	3.8	0.1	0.5	0.1	0	0.1	0.2	0.1	0	0	0.3	0.1	0.1	0.9	0.2	0.1	0.1	0	0	0.1	0.1	0.1	0	0.4	0.1	0.1	0	0.2	0	0	0	0	0.1	0	1.5	94.6	0	0	0	0	23.6	0	0	0	0.7	0	0.7	0	0.2	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0	0	0.3	0.2	0	0	0	0	0	0	0	0	0	0	0	0.1	Cardiomyocytes
AOX1	AO, AOH1	ENSG00000138356	Aldehyde oxidase 1	Q06278	2	200585868-200677064	Enzymes, Plasma proteins, Predicted intracellular proteins		Oxidoreductase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	4	liver: 228.8	Cell type enriched	Detected in many	6	Hepatocytes: 649.9	Cancer enriched	Detected in many	9	liver cancer: 122.5	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in many		ASC diff: 85.8;ASC TERT1: 44.1;HSkMC: 17.7;hTERT-HME1: 17.7	Low region specificity	Detected in all			Low region specificity	Detected in many			HPA040199, HPA040215	Enhanced								410000			HPA040199: AB_10795273, HPA040215: AB_10795360	unprognostic (4.39e-2)	unprognostic (1.03e-3)	unprognostic (1.96e-1)	unprognostic (3.15e-2)	unprognostic (1.17e-4)	unprognostic (1.92e-2)	unprognostic (2.34e-2)	unprognostic (3.54e-1)	unprognostic (1.15e-1)	unprognostic (4.93e-2)	unprognostic (5.48e-2)	unprognostic (2.00e-2)	prognostic favorable (6.05e-5)	unprognostic (1.33e-2)	unprognostic (8.16e-3)	unprognostic (3.38e-2)	unprognostic (4.99e-3)	12.8	55.6	0.1	1.8	0.4	0.2	10.5	0.3	0.2	2.9	3.2	1.3	18.6	0.3	2	11.1	3.9	8.1	4	3.5	0.3	0	20.8	228.8	3.6	7.5	0.2	0.2	12.2	28.5	0.2	0.8	1.9	0.6	4.4	1	1.6	2.7	20.1	2.5	3.2	1.7	6.9	0.4	1.7	2.4	10.8	0.2	0.1	4.8	2.7	0.6	7.1	10.6	0	0	0	0.5	0	0.2	0.1	0.1	0	0	0	85.8	44.1	0	1.4	2.6	1.1	2.1	0	0	0	0.1	1.7	0.5	0	0	3.9	4.8	0	0.1	0	1	4.3	5.7	0.2	0	17.7	1	5.6	17.7	1.1	0	0	0	0	3.9	0.1	0	0	1.7	0	1.1	0	0.1	0	0	0	0	0	1	0	0	0.1	0	0	6.8	3	2.4	0	0.5	0	0	0.6	2.3	0.1	0.3	0	0.5	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.4	0.3	0.2	0.3	0	0.2	0.2	0.6	0.2	3	0.6	13.7	0.5	1.5	0	0.7	12.7	0	0	3.5	0	0	10	0.6	0.5	1.3	0	0	22.4	0.1	10.2	8.3	0	649.9	0.4	0	2.9	15.4	20.2	0.9	68.4	1.6	3.3	0	0	0.4	18.4	0	77.1	111.5	0	0	2.8	0.7	0.6	1.4	0	0	0	0.3	Hepatocytes
HECW2	KIAA1301, NEDL2	ENSG00000138411	HECT, C2 and WW domain containing E3 ubiquitin protein ligase 2	Q9P2P5	2	196189099-196593692	Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins	Ubl conjugation pathway	Transferase	Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in many			Cell type enriched	Detected in many	7	Ito cells: 134.4	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Cell type enhanced	Detected in some		neutrophil: 7.7;non-classical monocyte: 5.2	Group enriched	Detected in many	9	granulocytes: 7.7;monocytes: 5.2	Cell line enhanced	Detected in many		HDLM-2: 27.2;HUVEC TERT2: 15.3;SCLC-21H: 17.8;TIME: 20.1;U-138 MG: 12.3	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA034609	Enhanced											HPA034609: AB_10669993	unprognostic (2.65e-2)	unprognostic (3.89e-1)	unprognostic (1.42e-1)	unprognostic (9.00e-3)	unprognostic (2.55e-1)	unprognostic (4.28e-2)	unprognostic (7.63e-3)	unprognostic (1.23e-1)	unprognostic (2.61e-2)	unprognostic (7.05e-2)	unprognostic (4.16e-2)	unprognostic (2.27e-1)	prognostic unfavorable (5.18e-5)	unprognostic (8.05e-3)	unprognostic (5.20e-2)	unprognostic (1.49e-1)	unprognostic (4.48e-2)	8.8	3.3	6.7	2.6	12.6	0.6	4.2	15.7	17.2	4.6	1.2	11.6	0	1.1	3	1	5.5	6.3	4.8	14	6.7	4.3	3.4	5.6	16.4	3.5	8.2	9.3	1.3	2.1	14.7	5.9	15.5	9.5	1.5	1.3	1.2	2.2	1.3	2.7	2.7	1.7	3.1	5.8	11.6	2.1	5.8	8.8	0	7.9	1.6	4.2	2.4	2.5	0.6	0.7	7.7	5.2	0	0.1	0.1	0	0.8	1.2	0	0.7	2.4	0.9	1.5	4	1.2	1.5	0.1	0	0.7	0.3	7.3	1.9	1.7	0.5	0.1	2.5	27.2	0.9	0	1.1	0.1	0.1	0.2	0.2	0.6	0.7	9.1	3.2	2.3	15.3	0	0.1	0	3.7	1	0	0.3	1.4	0.1	0.6	0	0.3	0	0	0	17.8	1.4	1.1	0.2	0	0.2	0	0.1	20.1	12.3	0.8	2.6	0.3	0.1	0	0.7	3.1	0	0.1	0.2	0.5	1.3	0	1.9	0	0.5	0.1	0	0.7	0.6	0.1	0	7.7	0	5.2	0	0.1	0.1	6.7	12.6	15.7	17.2	6.7	4.3	8.2	9.3	9.5	8.8	0	8.9	2.7	0.2	1.9	7.8	14.2	0	1.4	0	0	0	0.1	0	0	9.7	18	0	0	0	0.2	1	0.1	1.1	1.5	0.1	0	2.4	134.4	11.6	3.6	0	1.1	3.3	1	0	12.5	0.1	0	2.5	0	0.9	0	2.1	0.5	6.4	1.4	0.1	1.9	0	0.4	Ito cells
GUCA1C	GCAP3	ENSG00000138472	Guanylate cyclase activator 1C	O95843	3	108907792-108953895	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Group enriched	Detected in some	4	heart muscle: 10.2;pancreas: 31.0;retina: 15.7	Cell type enriched	Detected in some	6	Cone photoreceptor cells: 117.8	Cancer enriched	Detected in single	7	pancreatic cancer: 0.5	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	84	RPTEC TERT1: 18.0									HPA041597	Uncertain		Approved	Focal adhesion sites						Focal adhesion sites		HPA041597: AB_10795501						unprognostic (7.56e-2)					unprognostic (6.56e-2)							0	0	0.5	0	0.1	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	10.2	0.7	0	0.5	0	0	0	0.7	0	0.7	31	0	0.2	0	0.5	0	0	15.7	0	0	0	0	0	0	0	0	4.3	0.7	0	0	0	0	0	2.8	1.9	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0.1	0	0.2	0.7	0	0.7	0	0.5	0	0	0	0	0	0	7.4	5.5	0	0	0	0	117.8	0	0	0	9.6	0	0	0	0.5	0	0	0	0	0	0	1.6	0	0	0	6.9	0	0	0	0	0	8.2	0.5	0	0	0	19.2	0	0	0.5	0.1	0	0	0	0	0	Cone photoreceptor cells
APH1B	APH-1B, DKFZp564D0372, PSFL	ENSG00000138613	Aph-1 homolog B, gamma-secretase subunit	Q8WW43	15	63276018-63309126	Predicted membrane proteins	Notch signaling pathway			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		blood: 37.1;testis: 75.6	Cell type enriched	Detected in many	5	Early spermatids: 1096.5	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low cell line specificity	Detected in many																								unprognostic (9.92e-2)	unprognostic (1.03e-2)	unprognostic (1.49e-1)	unprognostic (1.75e-1)	unprognostic (3.55e-2)	unprognostic (3.57e-1)	unprognostic (7.86e-2)	unprognostic (1.78e-1)	unprognostic (3.86e-1)	unprognostic (4.56e-2)	prognostic favorable (1.05e-4)	unprognostic (8.44e-2)	prognostic favorable (2.25e-4)	unprognostic (4.29e-3)	unprognostic (2.54e-1)	unprognostic (1.01e-1)	unprognostic (1.62e-1)	6.7	8	5.3	5.9	7.8	4.5	6.9	6.1	7.1	5	3.4	12.6	4.8	2.4	6.3	8	3	10.4	5.1	5.6	5.6	5.8	5.1	2.2	5.8	15	6.8	6.2	9.6	2.9	4.3	5.6	5	7.4	7.7	2.9	8.6	5	5.4	2.5	3.4	4.5	4.6	7.5	9.2	3.2	75.6	3.4	8	12.3	2	5	5.3	4.2	8.4	5.7	16.6	37.1	2.3	4.9	6.5	0.7	4.8	5.3	4.3	12.2	21.5	1.9	6.3	12.9	4.8	8.1	4.4	7	6.2	3	7	9	0.7	9	2.5	9.1	4.2	1.4	10.8	1.1	0.1	10.1	2.3	17.9	13.5	4	7.1	4.8	8.2	10.1	7.9	3.6	4.7	14.9	2.1	3.2	7.3	5	1.5	2.5	3.2	2.9	0.1	2.5	4.9	4.7	2.6	2.6	2.1	0	5.9	7.8	14	6.7	14.3	5.6	2.3	0.9	11.4	18.9	8.4	10.4	14.1	8.3	10.6	12	14.8	4.2	22.9	3.4	8.4	4.4	3.8	5.7	6.4	4.8	4.9	16.6	2.3	37.1	2.1	4.2	6.5	5.3	7.8	6.1	7.1	5.6	5.8	6.8	6.2	7.4	3.4	8.9	19.7	15.7	9.4	4.6	7	4.5	7.6	22.7	14.8	21	2	5.2	1.7	24.3	1096.5	10	0.5	0	5.5	34.4	12.8	9.1	22	1.5	48.6	1.6	19.5	17.2	45.1	235.2	22.7	28.9	10.1	26.2	3.8	23.7	13.2	0	15.6	5.6	13.6	12.9	13.3	231.2	16.4	3	5	10.2	2.4	5.2	Early spermatids
HERC5	CEB1	ENSG00000138646	HECT and RLD domain containing E3 ubiquitin protein ligase 5	Q9UII4	4	88457117-88506163	Predicted membrane proteins	Antiviral defense, Immunity, Innate immunity, Ubl conjugation pathway	Transferase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		testis: 48.9	Cell type enriched	Detected in many	9	Spermatogonia: 510.0	Cancer enhanced	Detected in all		testis cancer: 31.8	Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Cell line enhanced	Detected in many		BJ hTERT+ SV40 Large T+: 32.6;BJ hTERT+ SV40 Large T+ RasG12V: 45.1;SK-MEL-30: 19.3					Low region specificity	Detected in all			HPA043929	Supported											HPA043929: AB_10962492	unprognostic (2.87e-1)	unprognostic (2.10e-3)	unprognostic (1.97e-1)	prognostic unfavorable (4.46e-5)	unprognostic (3.00e-1)	unprognostic (1.06e-1)	unprognostic (3.00e-2)	unprognostic (2.58e-1)	unprognostic (9.00e-2)	unprognostic (9.89e-2)	unprognostic (1.35e-1)	unprognostic (2.54e-2)	unprognostic (2.56e-1)	unprognostic (2.23e-2)	unprognostic (3.18e-2)	unprognostic (7.54e-2)	unprognostic (1.61e-1)	12.3	4.8	4.1	6.8	6.1	11.6	6.6	1.2	4	9.8	5.2	4	2.6	2.8	19.1	5.9	3.1	6	4.2	3.5	4.2	3.4	5.1	6.8	6	11.3	3.9	3.7	13.3	8.7	8.9	7.4	7.6	5.3	7.8	1.9	4.5	7.7	4.4	2.9	2.5	4.7	9.9	5.3	8	4.4	48.9	4.1	13.2	5.9	1.5	5.2	7.3	8.7	5.2	5.8	18.1	6	5.6	19.5	3.7	2.5	1.2	0.7	0.1	0.1	0.3	10	0.2	3.8	32.6	45.1	0.3	7	0.1	1.7	0	14.8	0.5	4.8	0.7	2.8	15.9	3	4.2	4.7	0.1	0.3	5	2	0.3	0.2	8.1	0	1.7	0.2	8.6	0.1	10.1	0.6	0.3	15.5	6.2	2.7	0.1	0.8	15.6	12.9	0.6	0.5	0.6	0.2	4.2	5.3	0.1	19.3	8.8	0.4	2.8	0.1	0.4	0.1	0.1	2	14	12.2	0.1	3.1	3.7	0.3	7.7	5.2	8	6	6	6.6	5.2	6.8	4.9	1.9	3.7	4.3	3.7	18.1	5.6	5.2	5.8	19.5	3.7	4.1	6.1	1.2	4	4.2	3.4	3.9	3.7	5.3	4.1	0	0.3	2.7	4.4	3.5	2.3	1.7	5.1	1.4	1.2	1.8	17.7	19.2	19.9	2.4	56.1	18.6	0.3	0	4.3	9.4	4	6.3	2.3	5.5	13	0	0	8.6	7	12.8	9.2	9.9	6.8	2.8	0.4	9.2	4.2	2.9	8.5	6.9	2.5	19.4	8	51.1	510	1.6	10	8.6	0.1	1.6	Spermatogonia
IL21	IL-21, Za11	ENSG00000138684	Interleukin 21	Q9HBE4	4	122612628-122621069	Disease related genes, Plasma proteins, Predicted secreted proteins		Cytokine	Disease mutation	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	5	lymphoid tissue: 16.1	Cell type enriched	Detected in some	7	Early spermatids: 11.9	Not detected	Not detected							Group enriched	Detected in some	16	memory CD4 T-cell: 2.2;T-reg: 1.0	Lineage enriched	Detected in single	22	T-cells: 2.2	Group enriched	Detected in some	4	HeLa: 4.3;Karpas-707: 1.1;SiHa: 3.5	Not detected	Not detected			Not detected	Not detected								Secreted to blood			55700												unprognostic (2.42e-1)						unprognostic (2.12e-1)	unprognostic (6.80e-2)			0	0	0	1.9	0	0	0	0	0	0	0.1			0	0	0	0.1	0	0	0	0	0	0	0	0.1	16.1	0		0	0	0	0	0		0	0		0	0	0	0	0.5	0	0	0.1	0.1	3.5			0.1		7.4	1.1	0	0	0	0	0	0	2.2	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4.3	0	0	0	0	0	0	0	0	0	0	0	0.1	1.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.5	0	0	0.4	0	0	0	0	0.6	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	2.2	0	0	0	0	0	0	0	0	0	1	0.1											0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	11.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.6	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Early spermatids
EGF		ENSG00000138798	Epidermal growth factor	P01133	4	109912884-110012266	Cancer-related genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins		Growth factor	Cancer-related genes, Disease mutation, FDA approved drug targets, Primary hypomagnesemia	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	4	kidney: 48.4;pancreas: 41.2;skeletal muscle: 19.8	Cell type enriched	Detected in some	6	Muller glia cells: 38.3	Low cancer specificity	Detected in many			Low region specificity	Detected in some			Cell type enriched	Detected in single	4	neutrophil: 1.7	Lineage enriched	Detected in single	4	granulocytes: 1.7	Cell line enhanced	Detected in some		EFO-21: 8.2;SK-BR-3: 14.9;U-251 MG: 4.7	Low region specificity	Detected in single			Low region specificity	Detected in many											209000	25000				unprognostic (2.83e-2)	unprognostic (1.02e-2)	unprognostic (8.50e-3)	unprognostic (1.88e-3)	unprognostic (4.24e-2)	unprognostic (1.64e-3)	unprognostic (5.06e-4)	unprognostic (8.30e-2)	unprognostic (2.21e-3)	unprognostic (4.25e-2)	unprognostic (1.80e-2)	unprognostic (2.95e-1)	unprognostic (7.72e-3)	unprognostic (4.64e-5)	unprognostic (2.63e-1)	unprognostic (9.80e-5)	unprognostic (3.92e-3)	0.8	0.1	0.4	0	0.4	0	5.9	0.1	0.9	0.2	0.2	0.3	0.3	0	0.3	2.6	0.9	0.2	0.3	2.3	0.8	0.3	48.4	0	0.6	0	1.2	0.7	0	41.2	0	0.4	0	1.4	0.6	0.4	3.9	8.4	0.1	19.8	0.5	0.2	1.9	0.6	0.2	0	0.2	0.2	0	1.2	4.5	0.4	0.4	0.5	0	0.4	1.7	0	0	0	2.6	0.2	0.3	2.4	0.1	0	0.1	0	0.6	1.5	0.8	0.5	0.1	0.1	0	8.2	0.8	2.1	0	0.3	0	0.6	0.1	0.4	0.1	0.9	1.5	0	0	0	0.2	0	0	0	1.8	0	0	1.6	0.2	0.8	0.1	0	0	2.9	0	0.6	0.2	0.1	0.7	0.7	0.2	0	0	0	14.9	0.5	1.8	3.5	0	0	1.3	2	0	4.7	0	0	0	1.4	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	1.7	0	0	0.4	0	2.6	0.4	0.4	0.1	0.9	0.8	0.3	1.2	0.7	1.4	0.2	0	0	0	0.1	0.9	0.6	6.2	0	0	0	0	0	0	6.6	0.2	2.2	0	0.4	0	4.9	0	0	1.5	0	0	0.1	1.6	0	0	0	1.4	0	0	0	0	0	38.3	1.6	0	0	1.2	1.1	0	0	0.5	0.3	1.3	0	0	1.6	0.1	Muller glia cells
C4orf17	DKFZP434G072	ENSG00000138813	Chromosome 4 open reading frame 17	Q53FE4	4	99511004-99542303	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	115	testis: 31.8	Cell type enriched	Detected in some	48	Early spermatids: 129.2	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in single		HHSteC: 2.0					Low region specificity	Detected in all			HPA060374, HPA060564	Uncertain											HPA060374: AB_2684268, HPA060564: AB_2684319																unprognostic (1.34e-1)		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	31.8	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0.3	0	0.6	0.4	0	0	0	0	0.2	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	129.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.7	1.4	0	0	0	0	0	0	0	0.4	0	0	0	0	1.4	1	0	0	0	0	0	Early spermatids
MTTP	ABL, MTP	ENSG00000138823	Microsomal triglyceride transfer protein	P55157	4	99563761-99623999	Disease related genes, FDA approved drug targets, Predicted intracellular proteins	Lipid transport, Transport		Disease mutation, FDA approved drug targets	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	49	intestine: 211.4;liver: 60.8	Cell type enriched	Detected in some	8	Hepatocytes: 201.1	Cancer enriched	Detected in many	13	liver cancer: 28.7	Not detected	Not detected			Cell type enhanced	Detected in single		naive B-cell: 1.0	Lineage enriched	Detected in single	10	B-cells: 1.0	Group enriched	Detected in some	6	AF22: 12.8;Hep G2: 14.0	Low region specificity	Detected in all			Not detected	Not detected			HPA051170, HPA054862	Uncertain		Uncertain	Cytosol	Intracellular and membrane				450000	Cytosol		HPA051170: , HPA054862: AB_2682628	unprognostic (1.66e-2)	unprognostic (1.14e-1)	unprognostic (5.64e-2)	unprognostic (5.33e-2)	unprognostic (3.49e-3)	unprognostic (7.38e-2)	unprognostic (1.05e-1)	unprognostic (2.74e-2)	unprognostic (1.08e-1)	unprognostic (3.66e-2)	unprognostic (1.00e-2)	unprognostic (1.62e-1)	unprognostic (1.27e-3)	unprognostic (2.02e-2)	unprognostic (3.64e-1)	unprognostic (1.53e-2)	unprognostic (1.31e-1)	0.1	0.1	0.3	0	0.3	0	0.1	0.1	0.2	0	53.2	0.2	0.1	53.4	0	0	0.2	0.2	0.4	0.4	0.3	0.4	2.7	60.8	0.1	0	0.4	0.1	1.1	0.1	0	0.3	0	0.3	0.2	0	0	0	0	0.1	0.1	211.4	0.7	0.4	0.1	0.2	1.8	0.2	0.1	0.1	0.1	0	0.3	0	1	0	0	0	0	0	0	0	0.3	12.8	0	0	0.1	1.1	0.1	0	0	0.3	0.5	0	0.4	0.2	0	0.1	0	0.1	0	0	2.3	0.2	0.3	0.1	14	0	0.1	0	0	0.1	0	0.3	0	0	0.2	0	0.1	0	0	0.1	0.7	0.6	0	0.3	0.3	0.2	1.3	0	0	0.8	1	0.2	0.1	0.4	0	0	0.1	0	0	0	0.4	0.1	0.1	0	0.1	0.5	0	0	0	0	0	0	0	0	0.4	0	0	0	1	0	0	0	0	0	0	0	0	0.3	0.3	0.1	0.2	0.3	0.4	0.4	0.1	0.3	0.2	0	0	0	0	0	0	2.5	7.6	0	0	1.8	0	0.1	0	0	25.5	0	0.7	0	0	0	0	0	0	201.1	0.1	0	0	5.5	3.3	7.9	0.9	0	0	1	0	0	0.3	0	0.4	18.6	0	6.5	0	21.9	1.5	0	0	0	0	0	Hepatocytes
SHISAL1	KIAA1644	ENSG00000138944	Shisa like 1	Q3SXP7	22	44243667-44312851	Predicted membrane proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in many		cervix, uterine: 22.5;endometrium 1: 34.2;smooth muscle: 31.9	Cell type enriched	Detected in single	4	Ciliated cells: 1.4	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		SiHa: 17.0;U-2197: 38.7;U-87 MG: 22.5;WM-115: 12.9	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA051178	Uncertain		Approved	Vesicles,Cytosol		No	No			Vesicles, Cytosol		HPA051178: AB_2681374	unprognostic (4.07e-3)	unprognostic (9.01e-2)	unprognostic (1.83e-1)	unprognostic (1.14e-1)	unprognostic (6.54e-2)	unprognostic (1.22e-1)	unprognostic (7.79e-2)	unprognostic (2.64e-2)	unprognostic (8.10e-3)	unprognostic (1.93e-3)	unprognostic (1.33e-1)	unprognostic (1.99e-1)	unprognostic (1.51e-7)	unprognostic (1.48e-2)	unprognostic (2.41e-1)	unprognostic (1.99e-4)	unprognostic (1.10e-4)	0.7	1.3	13.8	1.3	3.6	0	0.5	1.6	13	22.5	7.7	0.5	6.9	1.4	34.2	4.5	1.5	1.9	2.3	0.5	5.4	9.1	0.5	0.5	0.6	0.5	3.6	0.5	1.7	0.6	0.1	0.8	5.7	0.5	5.8	1.5	0.5	0.5	8.9	0.5	0.4	0.8	31.9	0.5	0.5	0.5	1.5	0.5	0.5	0.5	0.5	0.5	11.9	3.3	0	0.1	0.7	0	0.2	0.1	0	0	0.1	1.7	0.6	0	0	0	0.4	1.1	1.1	0.6	0	0	0	0	1	7	0	2.3	0.1	0.1	0	1	0	5.7	0	0	0	0	0	0.2	2.1	0.9	5.4	0.2	0	0	0	0	0	0.1	0	1.6	0	0.4	0	0	0	0	0	6.2	0	17	0	0.1	0.2	0	0.1	0	6.4	1	38.7	0.2	0	0	0	22.5	0	12.9	0.7	0	0.1	0	0	0	0	0	0.1	0	0	0	0.1	0.4	0.2	0	0.1	0	0	13.8	3.6	1.6	11.8	5.4	9.1	3.6	0.5	0.5	0.5	0	0	0	0	0	0	0	0	1.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	Ciliated cells
PDE6H		ENSG00000139053	Phosphodiesterase 6H	Q13956	12	14973022-14981865	Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins	Sensory transduction, Vision	Hydrolase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in some	7	retina: 67.4	Cell type enriched	Detected in some	6	Cone photoreceptor cells: 783.4	Not detected	Not detected			Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		AN3-CA: 4.2;JURKAT: 1.0;MOLT-4: 2.9	Not detected	Not detected			Not detected	Not detected			HPA045118	Supported		Uncertain	Vesicles						Vesicles		HPA045118: AB_2732517					unprognostic (1.47e-3)										unprognostic (1.07e-2)			0.1	1.3	1.2	0.2	1.5	9.4	0.1	0.1	4.2	0.2	0.1	0.1	0.1	0	0.1	0.1	0.1	0	0.2	0.1	1	2.1	0.1	0.1	0.2	0.2	2.2	0.1	0.1	0.1	0	0.1	2.5	0.7	0.1	0.1	67.4	0.1	0.1	0.1	0	0.1	0.1	0.5	0.8	0	0.1	0.1	0.2	0.1	0.1	0.2	0.3	0.1	0	0	0.6	0.7	0	0	1.4	0.2	0	0.8	4.2	0	0	0	0	0	0	0	0	0.2	0.6	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.9	0	1	0	0	0	0	2.9	0	0	0	0	0.8	0	0.3	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0.2	0	0	0	0.8	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0	1.4	1.2	1.5	0.1	4.2	1	2.1	2.2	0.1	0.7	0.1	0	0	0	0	0	47.5	0	0	0	0	0	783.4	0.1	0	0	0	0	0	0	0	17.5	0	0	0	0	1	22.3	0	0	0	0	0	0	0	0	0	55	0	0	0	0	141.6	0	0	0	0	0	0.2	0	0	0	Cone photoreceptor cells
RBP5	CRBPIII	ENSG00000139194	Retinol binding protein 5	P82980	12	7123684-7128942	Plasma proteins, Predicted intracellular proteins	Transport			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	6	kidney: 99.9;liver: 74.2;lymphoid tissue: 54.3	Cell type enriched	Detected in many	7	Proximal tubular cells: 2221.9	Group enriched	Detected in all	8	liver cancer: 70.1;renal cancer: 126.4	Not detected	Not detected			Cell type enhanced	Detected in some		memory CD8 T-cell: 1.5;T-reg: 2.4	Group enriched	Detected in many	12	granulocytes: 1.3;T-cells: 2.4	Cell line enhanced	Detected in many		HEL: 7.0;Hep G2: 15.6;K-562: 32.0					Low region specificity	Detected in all			HPA038723	Enhanced		Approved	Golgi apparatus,Vesicles						Golgi apparatus	Vesicles	HPA038723: AB_2676175	unprognostic (5.70e-3)	unprognostic (7.34e-2)	unprognostic (2.72e-2)	unprognostic (1.53e-2)	unprognostic (1.87e-2)	unprognostic (1.39e-3)	unprognostic (2.49e-2)	prognostic favorable (8.37e-4)	unprognostic (1.04e-1)	unprognostic (2.65e-1)	unprognostic (1.13e-2)	unprognostic (1.13e-1)	unprognostic (1.04e-1)	unprognostic (1.83e-2)	unprognostic (3.33e-2)	unprognostic (4.22e-1)	prognostic favorable (3.68e-4)	1.5	2.6	0.3	18.2	0.3	0.7	1.3	0.6	0.3	2.8	1.7	0.1	2.3	1.4	5.3	13.3	2.3	1.5	3.6	2.3	0.3	0.3	99.9	74.2	3.6	54.3	0.2	0	3.5	1.3	0.2	1.6	0.1	0.1	2.6	1.6	0.7	5.9	3.3	0.4	0.7	4.4	1.8	0.2	44.3	1.2	1.2	0	6.2	2	0.7	10.1	2.3	1.4	0.1	0	1.3	0	0	2.4	0.1	1.8	3.2	0	1	0	0	0.7	1.2	0	0	0.2	1.7	2	1.1	0.5	0	0.2	2.3	0.1	0	0	2.8	0	7	5	15.6	0	0.4	2	0.3	0.1	0	0	3.2	0	1.1	32	1.5	0	0	0.1	0.4	0.4	0	0.1	0.4	0	0.1	0.1	2.7	0.1	0.3	2.8	1.1	0	0.9	0.6	1.1	1.1	1.3	1.3	3.7	0.5	0.6	0.2	0.2	0.9	1.5	0.2	1.3	0	0	0.4	0	0	0.1	0.1	1.5	0	0	0	0.1	0.2	0	0	0	2.4	0.1	0.3	0.3	0.6	0.3	0.3	0.3	0.2	0	0.1	0	0	1.1	1.4	0.4	1.3	1.2	0	2.5	1.4	0	76.8	0	0	298.4	0.2	3.2	9	0	0	0.4	0	0.9	0.4	0	302.4	0.1	4.8	0	10.4	6.4	5.4	2.3	0	0	0	0	1.7	0.3	0	0.4	2221.9	1.6	0	1	0.2	0.4	1.9	0	2.1	0	0.3	Proximal tubular cells
PEX5	PTS1R, PXR1	ENSG00000139197	Peroxisomal biogenesis factor 5	P50542	12	7188685-7218574	Disease related genes, Predicted intracellular proteins	Protein transport, Transport		Disease mutation, Peroxisome biogenesis disorder, Rhizomelic chondrodysplasia punctata, Zellweger syndrome	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	7	Early spermatids: 256.2	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Cell line enhanced	Detected in all		Daudi: 66.8	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA039259, HPA039260	Enhanced		Supported	Golgi apparatus,Cytosol						Golgi apparatus, Cytosol		HPA039259: AB_10673419, HPA039260: AB_2676417	unprognostic (7.44e-2)	unprognostic (2.54e-2)	unprognostic (1.41e-1)	unprognostic (1.86e-1)	unprognostic (1.27e-1)	unprognostic (4.46e-1)	unprognostic (1.48e-1)	unprognostic (2.20e-2)	unprognostic (5.14e-2)	unprognostic (3.72e-2)	unprognostic (1.63e-2)	unprognostic (2.92e-1)	unprognostic (5.70e-2)	unprognostic (7.31e-3)	unprognostic (1.96e-1)	unprognostic (2.13e-2)	unprognostic (1.13e-1)	24.8	20.7	24.5	13.4	27.3	7.8	16.9	23.4	28.8	14.4	12.2	20.8	13.2	12.3	15.1	12.6	13.7	17.3	20.2	15.6	25.5	22.2	22.5	27	14.4	17.6	28.3	21	25.2	26.7	22	26.5	10.6	17.4	13.3	12.5	13.1	16.5	15.4	41.4	17.3	12.4	16.6	26.3	9.7	11.4	31.4	15.1	22.3	15.7	13.5	19.4	12.3	18.4	4.5	9.2	4.6	7.3	5.2	7.8	4.2	6.5	13.3	5.7	15.1	13.6	9	11.4	6.7	8.6	8.4	8.4	16.8	10.3	66.8	3.5	8.1	11.9	8.9	10.6	9.4	8.2	10	9.9	6.2	8.7	11.5	7.2	8.8	6.1	11.3	15.6	5.9	16.5	10.8	6.7	35.6	12.1	2.4	6.4	8.5	22.2	8.5	18.4	12.5	7.1	10.5	12.2	9.7	6.3	9.4	5.1	11	9.3	20.6	8.5	13.4	4.9	5.3	6.2	8.6	14.7	6.8	7.6	4.1	4.8	23.8	8.4	9.3	5.6	0.1	3.3	4.6	6.5	2.9	7.8	4.5	4.8	5.7	5.3	3.7	6.5	5.8	2.9	5.2	7.3	9.2	1.9	4.2	24.5	27.3	23.4	28.8	25.5	22.2	28.3	21	17.4	15.1	11.9	16.1	4.7	6.3	12.9	7.1	9.3	17.8	12	6.8	7	7.9	9.7	8.3	6.9	256.2	9.3	7.3	0	12.8	4.9	7.3	6.1	3.5	13.9	4	12.7	6.9	4.9	4.6	30.1	13.3	4.3	5	2.8	7.3	12.3	9.4	12.4	13.1	13.4	6.5	19.4	11.4	37.9	16.2	13.4	6.4	5.7	9.4	4.6	Early spermatids
SLC38A4	ATA3, NAT3, PAAT	ENSG00000139209	Solute carrier family 38 member 4	Q969I6	12	46764761-46832408	Predicted membrane proteins, Transporters	Amino-acid transport, Ion transport, Sodium transport, Symport, Transport			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	22	liver: 128.2	Cell type enriched	Detected in some	16	Hepatocytes: 251.9	Cancer enriched	Detected in many	14	liver cancer: 61.0	Not detected	Not detected			Group enriched	Detected in some	8	basophil: 3.0;NK-cell: 1.9	Group enriched	Detected in many	8	granulocytes: 3.0;NK-cells: 1.9	Cell line enhanced	Detected in some		ASC diff: 8.8;LHCN-M2: 21.7;RH-30: 7.2;RT4: 42.4	Low region specificity	Detected in many			Not detected	Not detected																unprognostic (3.81e-2)	unprognostic (7.46e-3)	unprognostic (5.22e-3)	unprognostic (1.75e-2)	unprognostic (3.12e-1)	unprognostic (1.11e-1)	prognostic favorable (5.37e-4)	unprognostic (3.06e-2)	unprognostic (2.57e-3)	unprognostic (1.75e-2)	unprognostic (1.95e-1)	unprognostic (6.06e-2)	unprognostic (2.84e-2)	unprognostic (1.89e-2)	unprognostic (8.28e-2)	unprognostic (6.31e-3)	unprognostic (2.21e-2)	0.2	0.1	0.1	1.4	0	0	0.1	0.1	0.2	0.1	0.9	0	0.3	0	1.7	0.1	0.6	0.1	0.3	1.1	0	0	5.9	128.2	0.1	0	0	0	0.1	2.1	0	0	1	0.1	0.4	0.2	0.1	0.3	0	2.9	0.4	0.1	1.4	0	0.3	0	0.2	0	0.2	0.2	0.4	0.2	0.7	0	0.1	0.3	3	0	1.9	0.1	0	0	0	0	0	8.8	1.1	1.7	1	2.8	0.9	0.9	0.5	2	0	1.7	3.7	0	0.5	0	0.3	0.9	0	0	0	0	0.1	0.3	0.2	0	2.1	0	0	0.7	0	0	0	0.1	0	21.7	0	0	0	0.6	0	0	0	7.2	0	0	42.4	0.1	0	0.1	0	0	0.2	0	0	0	0	0.4	0	0	0.1	0	0.1	0.2	0.1	0	3	0	0	0.1	0	0	0	0	0	0	0.1	0	0	0	1.9	0	0.3	0	0	0.1	0	0.1	0.2	0	0	0	0	0.1	0	0	0	0	0	0.7	0	1.3	15.3	0	0	1.8	0	2	0	0	0.2	0.1	1	0	0	0.4	1.9	0.4	0	251.9	0.4	0	0	3.1	3.9	0.2	0.3	0	0	0	0.2	0	0.3	0.2	0	0.3	0	0	0	0	0	0.5	0.7	0	0.6	0	Hepatocytes
ANP32D	PP32R2	ENSG00000139223	Acidic nuclear phosphoprotein 32 family member D	O95626	12	48472665-48473624	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at transcript level		Low tissue specificity	Detected in single			Cell type enriched	Detected in single	6	Cardiomyocytes: 1.4	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		NB-4: 1.3;REH: 1.2									HPA063133, HPA067561	Uncertain		Enhanced	Nucleoplasm,Centrosome,Cytosol						Nucleoplasm, Centrosome	Cytosol	HPA063133: AB_2684947, HPA067561: AB_2685861		unprognostic (2.20e-1)	unprognostic (3.75e-1)	unprognostic (3.18e-1)	unprognostic (3.23e-2)	unprognostic (5.11e-2)		unprognostic (1.72e-3)		unprognostic (2.30e-2)		unprognostic (3.62e-3)		unprognostic (2.76e-2)		unprognostic (3.48e-1)		0.1	0.9	0.3	0	0.2	0.1	0.2	0.2	0.6	0	0.5			0	0.6	0.8	0.2	0.1	0.2	0	0.1	0.2	0.1	0.1	0.7	0	0.2		1.1	0.1	0	0.2	0.5		0.3	0.2		0.4	0.3	0.2	0	0.1	0.2	0.2	0.5	0.2	0.9			0.8		0	0.4	0.1	0.1	0.1	0.6	0.3	0.2	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0.1	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0.8	0	0	0	0	0	0	0	0.4	1.3	0	0	0	1.2	0	0	0	0.5	0.2	0.2	0	0	0.3	0	0	0.9	0	0	0	0	0.2	0	0.1	0.7	0.4	0.4	0	0	0	0.2	0.1	0.3	0.1	0.1	0	0.1	0.1	0.1	0	0.1	0.6	0.2	0	0	0.3	0											0	0	0	0	0	0	1.4	0	0	0	0	0	0.1	0	0	0	0	0	0	0.2	0	0	0.1	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	Cardiomyocytes
INHBE	activin, MGC4638	ENSG00000139269	Inhibin beta E subunit	P58166	12	57452323-57459280	Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins		Growth factor, Hormone		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	40	liver: 127.6	Cell type enriched	Detected in single	51	Hepatocytes: 32.6	Cancer enriched	Detected in some	27	liver cancer: 34.4	Not detected	Not detected			Cell type enhanced	Detected in some		neutrophil: 3.1	Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		HHSteC: 15.2;Karpas-707: 22.8;RH-30: 10.7;U-266/70: 76.9	Not detected	Not detected			Not detected	Not detected			HPA016843, CAB034017	Enhanced		Supported	Vesicles	Secreted to blood				1400000	Vesicles		CAB034017: AB_2233745, HPA016843: AB_1851796	unprognostic (7.34e-2)	unprognostic (6.73e-2)	unprognostic (3.45e-1)	unprognostic (4.69e-5)	unprognostic (2.61e-1)	unprognostic (2.50e-1)	unprognostic (3.13e-1)	unprognostic (1.24e-1)	unprognostic (8.79e-3)	unprognostic (1.44e-1)	unprognostic (3.22e-1)	unprognostic (2.70e-1)	prognostic unfavorable (5.66e-8)	unprognostic (4.09e-3)	unprognostic (1.56e-1)	unprognostic (3.57e-2)	unprognostic (7.52e-3)	0	0	0	0	0	0.1	0	0.2	0	0	0	0	0	0	0	0.1	0.1	0	0	0	0	0	0.1	127.6	0	0	0	0	0	0.7	0	0.3	0	0.2	0.1	0	0	0.2	0	0.6	0	0	0	0	0.1	0	0	0	0	0.6	0.2	0	0.1	0	1	0.9	3.1	0.6	0.6	0.5	0.1	0	0.1	0	0.1	0	0.1	0.1	0.8	2.2	0	2.7	0.1	0	1.1	0.5	0.2	0	0.1	0.5	0	0.3	5.1	0	0	0	3.3	15.2	0.6	0.7	1.4	1.5	0.3	3.3	0.1	0	0.5	1.3	22.8	0	0	0	0	0.1	0	0	0	10.7	2.3	0	0	5.7	0.2	0	0	2.1	0.1	0.1	2.4	0	0	1.2	0	0.1	76.9	2.4	1	0.4	0.1	0.1	1.9	0.5	0.5	0.3	0.4	0.4	0.9	0.1	0.2	0.1	1	0.2	0.5	3.1	0.6	0.6	0.9	0.2	0.1	0	0	0.2	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	32.6	0	0	0	0	0.6	0	0	0	0	0	0	0	0.3	0	0	0.3	0	0	0	0	0	0	0.1	0	0	0	Hepatocytes
AMDHD1	MGC35366	ENSG00000139344	Amidohydrolase domain containing 1	Q96NU7	12	95943293-95968716	Enzymes, Predicted intracellular proteins	Histidine metabolism	Hydrolase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	9	liver: 99.0	Cell type enriched	Detected in many	5	Hepatocytes: 125.2	Cancer enriched	Detected in many	14	liver cancer: 23.4	Low region specificity	Detected in single			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Cell line enhanced	Detected in many		A-431: 19.5;HMC-1: 21.5;Karpas-707: 26.6;SiHa: 17.8;SK-BR-3: 20.0;U-266/70: 21.5;U-266/84: 25.2	Not detected	Not detected			Low region specificity	Detected in many			HPA039720, HPA040149	Uncertain		Approved	Nucleoplasm,Plasma membrane,Cytosol		No			410000	Cytosol	Nucleoplasm, Plasma membrane	HPA039720: AB_10672967, HPA040149: 	unprognostic (4.81e-2)	unprognostic (2.91e-1)	unprognostic (1.53e-1)	unprognostic (2.09e-2)	unprognostic (1.80e-2)	unprognostic (2.88e-2)	unprognostic (2.33e-2)	unprognostic (6.62e-3)	unprognostic (1.06e-1)	unprognostic (7.01e-2)	unprognostic (3.35e-3)	unprognostic (1.17e-1)	unprognostic (4.63e-3)	unprognostic (3.98e-2)	unprognostic (1.70e-1)	unprognostic (4.08e-3)	unprognostic (2.61e-1)	1.1	5.7	0.5	2.4	0.8	2	0.9	0.5	1.3	0.7	0.7	0.6	0.4	1.9	0.9	0.5	0.8	0.5	0.7	1.1	0.6	0.5	4.4	99	1.3	1.4	0.5	0.4	0.7	1.1	0	1.2	0.6	1	0.7	0	0.8	1.3	0.7	11.3	2.2	1.9	0.6	0.6	2.9	1.9	6.2	0.5	0.7	0.6	0.7	0.7	0.8	0.9	1.5	1.2	3.7	3.8	5.7	1.6	1.4	19.5	4.3	0.3	2.8	0.1	0	4.4	0.6	0.2	0.3	0.6	1.9	2.5	1.7	1.9	0	1.1	3.7	0.1	0	0.1	6.8	0.7	1.9	3	3.8	0	2.5	21.5	0	0.1	0.3	0	0.1	0.1	1.7	1.3	26.6	0	3	1.6	4.8	2	0.7	1	3.5	0.1	2.2	0	1.8	2.2	3.2	17.8	20	2.3	0	2.1	3.6	0	2.8	9.7	3.5	2.4	21.5	25.2	2.7	1.9	5.2	3.1	0.3	1.6	3.7	1.2	1.4	1.1	1.5	0.6	1.6	1.2	1	1	1.1	1.2	5.7	3.8	0.6	0.3	1.4	0.5	0.8	0.5	0.6	0.6	0.5	0.5	0.4	1	0.5	0	0.3	2.2	0.2	0.3	0	0.4	0	0	1.2	3.5	0	0.5	3.3	0.1	0.6	0.3	0	0	1	0.1	0.3	0	0	125.2	4.1	1.6	1.7	11.1	3.7	0	0.3	1.1	3.3	0	0	1.9	0.3	0	0	23.2	0	0	0	1.2	1.9	0.3	0.2	2.9	0	0.1	Hepatocytes
SYCP3		ENSG00000139351	Synaptonemal complex protein 3	Q8IZU3	12	101728648-101739472	Disease related genes, Predicted intracellular proteins	Cell cycle, Cell division, Meiosis	DNA-binding		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	14	testis: 47.0	Cell type enriched	Detected in some	5	Spermatocytes: 654.5	Cancer enriched	Detected in single	16	testis cancer: 5.7	Not detected	Not detected			Cell type enhanced	Detected in some		basophil: 3.2	Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		Karpas-707: 5.2;RPMI-8226: 2.6	Low region specificity	Detected in many			Not detected	Not detected			CAB032978, HPA039635, HPA043938	Enhanced											CAB032978: AB_656732, HPA039635: AB_2676607, HPA043938: AB_2678740	unprognostic (2.86e-3)	unprognostic (3.91e-1)	unprognostic (3.18e-1)	unprognostic (9.61e-3)	unprognostic (1.40e-1)	unprognostic (1.22e-2)	unprognostic (7.49e-2)	unprognostic (1.65e-1)	unprognostic (1.82e-1)	unprognostic (2.86e-2)	unprognostic (7.15e-3)	unprognostic (7.81e-3)	unprognostic (4.85e-2)	unprognostic (1.93e-2)	unprognostic (2.24e-1)	unprognostic (4.07e-2)	unprognostic (5.86e-4)	0	0	0	0.1	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	47	0	0	0	0	0	0	0	1.5	0.5	3.2	0.6	0.2	0.6	0.1	0	1.4	0	0.1	0	0	0	0.9	0.6	0	0.2	0.6	0.1	1.3	0.1	0	0.1	0.7	0.2	0.7	0.5	0.3	0	0.3	0.4	0	0	1.6	1.3	0.4	0.6	0.2	0	0.7	0.2	0.7	0.4	5.2	1.2	0	1.3	0.9	0	0.6	0.2	0.3	1	2.6	2	0.8	0.1	0.6	0	0.2	2.2	0.5	1	0	0	0.6	0	0.1	0	0.1	1	0.3	0	0.2	0	3.2	0.6	0.4	0.1	0.2	0	0.2	0.1	0.1	0.1	1.5	0	0.6	0.5	0.2	0.1	0.5	0	0.1	0	0	0.4	0	0	0	0	0	0	0	0	1.3	0.9	0.6	0	2	1.1	0	1.4	0	1.8	0	0.2	0	0.1	19.5	0.4	0.5	0	0.3	0.1	0.4	0.9	3.5	0	0.5	0	1.2	0	0.6	24.2	8.3	0.6	0	0	0.7	0.6	0.2	0	1.8	0	1.6	64.7	0	654.5	144.1	0.3	0.1	0	0.8	0.4	Spermatocytes
ASCL1	ASH1, bHLHa46, HASH1	ENSG00000139352	Achaete-scute family bHLH transcription factor 1	P50553	12	102957686-102960516	Predicted intracellular proteins, Transcription factors	Differentiation, Neurogenesis, Transcription, Transcription regulation	Activator, Developmental protein, DNA-binding		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in many		brain: 19.3;liver: 23.0;pituitary gland: 29.4	Cell type enriched	Detected in some	7	Intestinal endocrine cells: 34.9	Group enriched	Detected in many	6	glioma: 21.4;lung cancer: 11.2	Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	22	SCLC-21H: 33.4;SH-SY5Y: 18.0	Low region specificity	Detected in single			Low region specificity	Detected in all			HPA029217, HPA076307	Enhanced		Approved	Nucleoplasm,Cytosol	Intracellular and membrane					Nucleoplasm	Cytosol	HPA029217: AB_10669595, HPA076307: 	unprognostic (7.92e-2)	unprognostic (4.37e-3)		unprognostic (4.55e-2)	unprognostic (5.02e-2)	unprognostic (3.12e-1)	unprognostic (1.22e-2)	unprognostic (1.56e-1)	unprognostic (2.09e-1)	unprognostic (4.84e-2)	unprognostic (1.31e-2)	unprognostic (1.31e-1)	unprognostic (7.10e-6)	unprognostic (3.40e-1)	unprognostic (2.17e-1)	unprognostic (3.76e-1)	unprognostic (5.52e-2)	0.9	2.8	11.1	0.7	6.9	0.7	0.7	3.3	19.3	1.3	0.9	6.6	0	0.9	1	0.8	0.7	2.2	0.8	0.7	8.5	5.8	0.8	23	1.7	1.4	7.6	4.7	1.6	0.9	0.7	29.4	0.8	13.9	1.1	1	0	0.7	0.8	0.8	0.7	0.8	0.9	18.7	0.7	3.2	0.9	7.3	6	1	0	0.8	1	0.2	0	0	0	0	0	0	0	0	0	1.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	33.4	18	0	0	0	0.2	0	0	0	0	0	0	0	0.2	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	11.1	6.9	3.3	10.7	8.5	5.8	7.6	4.7	13.9	7.3	0	0	0	0	0	1.3	0.2	0	0	0	0	0	0.1	0	0	0.2	0	0	0	0	0	0	0.4	0	0.8	0.1	4.8	34.9	0	0	0	0	0	0	0	0	2.1	0.3	0	0.4	0	0.2	0	0	0.1	0.1	0	0.2	0	0	0	Intestinal endocrine cells
RDH16	RODH-4, SDR9C8	ENSG00000139547	Retinol dehydrogenase 16 (all-trans)	O75452	12	56951431-56959374	Predicted membrane proteins	Lipid metabolism, Steroid metabolism	Oxidoreductase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	59	liver: 114.6	Cell type enriched	Detected in some	12	Hepatocytes: 276.0	Cancer enriched	Detected in many	20	liver cancer: 44.0					Cell type enhanced	Detected in single		gdT-cell: 1.9	Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		HaCaT: 3.4;hTCEpi: 7.7;OE19: 1.8					Low region specificity	Detected in single			HPA038518	Enhanced											HPA038518: AB_10672713	unprognostic (5.42e-3)	unprognostic (4.20e-2)	unprognostic (2.99e-2)	unprognostic (1.14e-1)	unprognostic (1.88e-1)	unprognostic (2.92e-2)	prognostic favorable (2.16e-5)	unprognostic (8.83e-3)	unprognostic (1.04e-1)	unprognostic (2.84e-1)	unprognostic (6.85e-2)	unprognostic (6.10e-1)	unprognostic (7.99e-12)	unprognostic (2.24e-1)	unprognostic (1.29e-2)	unprognostic (1.62e-1)	unprognostic (2.01e-2)	0	0	0	0	0	0	0	0	0	0	0			0	0	0	0.1	0	0	0	0	0	0	114.6	0	0	0		0	0	0	0	0		0.8	0		0	0.2	0	0.3	0	0	0	0.3	0	0			0		0.1	0	0.1	0.2	0	0	0.8	0	1.9	0.2	0	0	0	0	0.4	0	0.1	0	0.1	0	0	0.1	0	0	0	0	0	3.4	0.1	0.1	0.1	0	0	0.3	0	0.1	0	0.6	0.1	0	7.7	0	0.8	0	0	0.1	0.1	0.2	0	0.4	0	0.2	0	1.8	0	0	0.4	0.6	0	0	0	0	0.3	0.2	0.1	0.2	0.9	0	0	0	0	0	0	0.7	0.1	0.1	0	0	0	0	0	0	1.9	0	0.3	0.2	0.2	0.5	0	0	0.3	0.1	0	0	0.8	0	0	0.2											0	0	4.5	1	0	2.2	2	5.1	0	0	0	0	0.1	0	0	5.3	0.1	0	23.3	0.3	0	0.1	4.2	0	276	0.2	1.6	0	3.1	5.1	4.1	0	0.1	0	0	0	0.2	0.1	0	0	0	0.8	0	0	0.9	0.4	0.3	0	0	0	0.4	Hepatocytes
SMIM2	C13orf44, MGC5590	ENSG00000139656	Small integral membrane protein 2	Q9BVW6	13	44143543-44161257	Predicted membrane proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in some	5	testis: 15.9	Cell type enriched	Detected in some	8	Early spermatids: 36.4	Not detected	Not detected							Cell type enhanced	Detected in single		NK-cell: 1.8	Low lineage specificity	Detected in single			Cell line enhanced	Detected in many		BJ hTERT+: 4.4;OE19: 12.1					Low region specificity	Detected in many			HPA026891, HPA077071	Enhanced		Uncertain	Nucleoplasm,Nuclear bodies						Nucleoplasm, Nuclear bodies		HPA026891: AB_10602924, HPA077071: 	unprognostic (4.34e-2)	unprognostic (8.70e-2)	unprognostic (1.07e-1)	unprognostic (4.87e-5)	unprognostic (2.40e-1)	unprognostic (1.68e-1)	unprognostic (3.26e-1)	unprognostic (1.26e-1)	unprognostic (2.32e-1)	unprognostic (1.85e-2)	unprognostic (2.75e-2)	unprognostic (3.11e-1)	unprognostic (1.00e-1)	unprognostic (2.10e-1)	unprognostic (4.80e-2)	unprognostic (2.39e-2)	unprognostic (1.05e-2)	0.1	0.1	0.2	0	0.3	0	0.1	0.1	0.2	0.2	0.8			0.9	0.1	2.9	0.1	0.2	0.3	1.2	0.2	0.2	0.9	0.4	0.1	0	0.2		0.1	0.7	0	0.3	0.2		0.2	0		0.6	0	1	0.1	2.2	0.2	0.2	0.1	0.4	15.9			0.1		0	0.2	0.1	0.5	0	0	0.2	1.8	0.4	0	0.9	0.8	0.9	0.2	0	0	1.1	0	4.4	1	0	1.5	0.2	1.7	1.1	0	1.2	2.7	0	1.7	1.2	0	1.7	0	1.9	0	1.7	0.2	0.1	0	0	0	0	0	0	0.8	0	0.4	0	0.2	1.1	0	0.7	12.1	1.2	1	0	0.2	0	0.5	2.3	1.2	3.4	1.5	2.2	1.9	0	0.2	0.4	0	0.8	1.2	0.2	0	0	0.7	1.3	0.4	0.8	0	0	0	0.4	0.2	0	0.1	0.3	0	0	0.5	0	0.1	0	1.8	0.1	0	0	0											0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	36.4	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	4.5	0.6	0	0	0	0	0	0	0	0.4	0	0	0	0	0.4	0.2	0	0.5	0	0	0	Early spermatids
MORN3		ENSG00000139714	MORN repeat containing 3	Q6PF18	12	121648742-121672631	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	7	placenta: 30.1;testis: 51.5	Cell type enriched	Detected in many	5	Late spermatids: 1766.8	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Group enriched	Detected in some	9	BEWO: 12.6;CACO-2: 6.8	Low region specificity	Detected in many			Low region specificity	Detected in many			HPA038709, HPA038710	Uncertain		Approved	Nucleoplasm						Nucleoplasm		HPA038709: AB_2676164, HPA038710: AB_2676165	prognostic favorable (1.16e-4)	unprognostic (2.70e-3)	unprognostic (5.56e-2)	unprognostic (5.13e-2)	unprognostic (7.38e-3)	unprognostic (3.46e-3)	unprognostic (7.44e-2)	unprognostic (3.70e-2)	unprognostic (4.31e-2)	unprognostic (3.09e-2)	unprognostic (3.65e-3)	unprognostic (3.11e-2)	unprognostic (1.39e-2)	unprognostic (3.06e-1)	unprognostic (2.21e-1)	unprognostic (8.85e-2)	unprognostic (1.18e-1)	0.3	0.2	1.2	0.5	1.4	0.9	0.3	0.3	1.6	0.4	0.3	0.3	0.3	0.2	0.3	1.4	0.3	5.6	0.4	0.3	1.4	1.2	0.4	0.3	1	1.4	0.3	0.3	0.3	0.4	3.4	0.7	30.1	0.3	0.3	0	0.3	0.3	0.3	0.3	2.5	0.3	0.3	0.3	0.8	0.8	51.5	0.3	0.3	0.5	0.3	0.6	0.3	0.3	1.2	1.2	3.1	0.6	2.2	2.3	0.6	0.1	0.2	0.4	0.2	0	0.3	12.6	0.2	0	0.1	0.1	6.8	0.3	0.2	0.2	0.1	0.2	0.4	0.1	0.1	0.1	0.1	0.1	0.5	0.3	0.4	0.3	0.4	0.9	0.1	0.3	0.3	0	0.1	0.2	0.8	0.2	0.3	0.1	0.2	0.8	0.6	0.2	0	0.1	0.3	0	0.1	0.4	0.2	1.1	1.1	0.1	0.2	0	0.5	0.9	0.1	0.1	0.2	0.2	0.3	0.1	0.2	0.1	0.4	0.9	0.3	0.1	2.3	0.6	0.4	2.1	0.3	2	0.8	2.3	1.3	0.2	1.2	2.1	1.4	3.1	2.2	0.5	1.2	2	0.6	1.2	1.4	0.3	1.2	1.4	1.2	0.3	0.3	0.3	0.3	3	2.2	0.5	1.1	2.9	1.1	1.1	5.1	50.9	11.4	1.8	0	0.2	6.6	3.3	357	1.5	0	0	1.2	0.4	1.3	0.3	2.3	0	0.8	0	0	0.6	0	1766.8	8.6	0.1	0	1.8	0	3.7	1.7	0	8.9	0.8	1.7	0	0	7	5.6	3.4	6.1	3.3	0.1	1	Late spermatids
DIAPH3	AN, AUNA1, DRF3, FLJ34705, NSDAN	ENSG00000139734	Diaphanous related formin 3	Q9NSV4	13	59665583-60163987	Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins			Cancer-related genes, Deafness, Neuropathy, Non-syndromic deafness	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		lymphoid tissue: 35.2;testis: 19.6	Cell type enriched	Detected in many	6	Early spermatids: 290.3	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Cell type enriched	Detected in single	4	plasmacytoid DC: 2.0	Lineage enriched	Detected in single	4	dendritic cells: 2.0	Cell line enhanced	Detected in many		HBF TERT88: 39.7	Low region specificity	Detected in all			Low region specificity	Detected in some			HPA032151			Supported	Plasma membrane,Microtubules			Yes			Plasma membrane, Microtubules		HPA032151: AB_2674181	unprognostic (3.78e-2)	unprognostic (1.28e-2)	prognostic favorable (9.04e-4)	prognostic unfavorable (4.18e-4)	unprognostic (2.78e-1)	unprognostic (4.69e-2)	unprognostic (1.27e-4)	prognostic unfavorable (3.72e-4)	unprognostic (1.74e-2)	unprognostic (2.19e-1)	unprognostic (5.22e-5)	unprognostic (3.59e-3)	unprognostic (5.31e-5)	unprognostic (4.30e-2)	unprognostic (2.37e-1)	unprognostic (4.07e-1)	unprognostic (2.74e-3)	1.8	0.4	1.7	11.5	1.8	6.7	1.6	0.1	1.4	0.9	4.7	0.2	0.4	2	1.4	1.1	7.1	0.3	2.5	1.1	1	1.6	1.7	0.4	4.1	2.9	1	0	0.4	0.4	0.5	0.2	9.4	0.2	0.4	2.3	0	1.6	0	0.1	1.8	4.3	2.7	0.3	2.5	3.1	19.6	0	35.2	0.2	5.3	5.9	0.8	1.5	0.4	2	0.4	0.2	0	0.5	0.2	18.3	6.1	6.4	3.6	1.1	2.9	10.8	25.7	11.4	26	22.7	16.2	12.5	6.1	2.1	13.1	6.8	12.6	10.3	10.1	39.7	6.9	7.1	8.8	15.7	3.6	1.7	11.9	7	1.1	0.2	15.8	10.7	6.6	11.6	5.6	6.7	8.8	24.7	2.6	10.6	5.1	5.9	8.7	3.5	7.2	15.7	5	8.5	3.8	3.3	5.8	13.1	9.1	3.9	14.3	6.6	6.5	11.5	16.5	10.6	5.5	21.2	5.9	6.5	9.6	4.4	5.9	12.4	0	0	0	0.2	0	0	0.4	0.4	0	0	0	0	0	0.4	0	0.2	2	0.5	0.2	1.7	1.8	0.1	1.4	1	1.6	1	0	0.2	0	50.6	4.3	0.8	0.3	3.3	0	0.4	2.5	0	2.3	0	0	8.7	5	0.6	290.3	0.7	1.3	23.3	3.7	26.7	3.3	0.3	0	0.4	5.2	0	0	2.5	0.6	34.3	0.6	1.2	0	0	1.1	2.3	1.3	0	0	3.1	0	0	0	34.2	17.3	1	6.1	0.9	1.7	0.6	Early spermatids
TSSK4	C14orf20, STK22E	ENSG00000139908	Testis specific serine kinase 4	Q6SA08	14	24205697-24208362	Enzymes, Predicted intracellular proteins, Predicted membrane proteins	Differentiation, Spermatogenesis	Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	10	testis: 46.1	Cell type enriched	Detected in some	15	Early spermatids: 178.8	Low cancer specificity	Detected in many			Low region specificity	Detected in single			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low cell line specificity	Detected in many			Not detected	Not detected			Low region specificity	Detected in all			HPA060660, HPA077103	Approved		Approved	Cell Junctions						Cell Junctions		HPA060660: AB_2684339, HPA077103: AB_2732332	unprognostic (1.95e-1)	unprognostic (4.30e-2)	unprognostic (1.52e-1)	unprognostic (5.69e-2)	unprognostic (2.36e-1)	unprognostic (3.38e-5)	unprognostic (1.06e-1)	unprognostic (6.25e-3)	unprognostic (1.64e-1)	unprognostic (3.39e-1)	unprognostic (7.03e-3)	unprognostic (1.27e-3)	unprognostic (3.42e-1)	unprognostic (4.30e-2)	unprognostic (6.28e-2)	unprognostic (8.98e-2)	unprognostic (7.26e-2)	0.6	0.9	0.6	1.7	0.6	3.1	0.6	1.5	1.8	0.6	0.6	0.6	0.6	1.5	0.8	0.9	1.4	0.8	1.7	0.6	0.6	0.4	0.6	0.6	0.8	2.8	0.6	0.6	0.8	0.9	0	0.6	0.6	0.6	0.6	0	0.6	1.4	0.6	1	4.7	1.6	0.6	0.6	1.5	0.6	46.1	0.6	0.6	1.4	0.6	0.6	1	0.6	2.1	1.7	2	1	1.8	2	0.7	1	4.1	4	1.5	0.1	0	4.3	1.6	0.1	0	0	2.1	3.7	3.1	0.9	0.1	0.8	3.8	0	0.1	0	1.6	3.1	3.5	4.8	3	0	1.5	3.8	0	0	0	0.6	3.6	0.1	3.7	1.3	2	0	3.8	3.6	1.7	0.7	0.9	3.2	3	1.6	2.7	0	5.3	2.2	2.1	2.7	2.5	0.8	1.8	1.6	1.8	1.4	2.9	1.8	3.8	1.3	4.3	4.8	4.8	1	2.8	0.9	0	1	2	2	1	0.7	2	1.6	1.6	0.6	2.1	1.6	1.7	2	1.8	0.9	1.7	0.7	0.7	0.6	0.6	1.5	0.6	0.6	0.4	0.6	0.6	0.6	0.6	0	0.3	0	0	0	0	0.1	0	1.4	0	0	0	0	0	0	178.8	0	0	0	0.2	0	0	0.2	0	0	0.1	0	0	0	0	11.8	1.1	0	0	0	0	0	0	0	1.1	0	0	0	0	1.2	0.7	0	0.1	0	0	0	Early spermatids
FITM1	FIT1	ENSG00000139914	Fat storage inducing transmembrane protein 1	A5D6W6	14	24131275-24132849	Predicted membrane proteins				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	6	heart muscle: 56.1;skeletal muscle: 94.7;tongue: 79.9	Cell type enriched	Detected in some	9	Cardiomyocytes: 228.0	Low cancer specificity	Detected in some			Not detected	Not detected			Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Cell line enriched	Detected in some	17	RH-30: 27.1	Not detected	Not detected			Low region specificity	Detected in some			HPA019842	Uncertain											HPA019842: AB_1853025	unprognostic (1.81e-2)	unprognostic (4.29e-7)	unprognostic (2.77e-1)	unprognostic (2.02e-3)	unprognostic (2.24e-2)	unprognostic (6.68e-2)	prognostic favorable (1.00e-3)	unprognostic (1.20e-4)	unprognostic (4.57e-1)	unprognostic (2.12e-2)	unprognostic (2.84e-2)	unprognostic (3.68e-2)	unprognostic (2.47e-1)	unprognostic (2.86e-2)	unprognostic (5.62e-1)	unprognostic (1.96e-1)	unprognostic (2.12e-3)	0.8	1.7	0	0.2	0	0.6	0.3	0.4	0.2	0.2	0.3	0	0	0.5	0.2	2.2	1.2	0.2	0.2	56.1	0	0	0.2	13.1	0.2	0.3	0	0	0.2	11.9	0.2	0.2	0.2	0	0.7	0.2	0.1	2.9	0.3	94.7	0.5	0.4	0.2	0	2.5	0.3	0.3	0	0	0.5	79.9	3.6	0.3	0	0.8	0.3	0	1.1	0.4	1.5	0.3	0	0	0	0.1	0	0	0.2	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0.1	0.3	0	0	1.6	0.1	0	0.7	0.7	0.2	0	0.1	0	0	0.4	0	0.3	0.3	0	0.2	0.3	0	0	0.3	0.2	27.1	0.1	0	0	0	0.2	0	0.1	0	0	0	0.1	0.2	0	0	0.1	0	0.2	0.1	0	0.1	0.1	0	0	0.5	0	0.5	1.1	0.3	0.2	1.1	1.5	0.3	0.8	0.6	0.6	0	0.4	0.4	0	0.1	0.3	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0.2	0.1	1.4	228	0	0	0	0	0	0.2	0	0.8	1.9	0.3	2	0	2.6	0.1	0.5	0.4	0	26.1	0.2	0	1.2	0.6	1.5	2.7	0	0.1	0	1	1	0.8	1.1	0	0.7	0.1	0.3	0	0.4	1.2	0.2	0.5	0.6	0.8	0.8	0.1	Cardiomyocytes
RTN1	NSP	ENSG00000139970	Reticulon 1	Q16799	14	59595976-59870966	Plasma proteins, Predicted membrane proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	8	brain: 144.6	Cell type enriched	Detected in many	4	Horizontal cells: 227.2	Cancer enhanced	Detected in many		glioma: 19.0	Low region specificity	Detected in all			Group enriched	Detected in some	6	classical monocyte: 4.5;intermediate monocyte: 4.6;myeloid DC: 7.9	Group enriched	Detected in many	15	dendritic cells: 7.9;monocytes: 4.6	Group enriched	Detected in some	4	HEL: 23.2;SCLC-21H: 28.7;SH-SY5Y: 46.0	Low region specificity	Detected in all			Low region specificity	Detected in all			CAB002745, HPA040945, HPA044249	Enhanced		Supported	Nuclear bodies,Endoplasmic reticulum					140000	Endoplasmic reticulum	Nuclear bodies	CAB002745: , HPA040945: AB_2677217, HPA044249: AB_2678874	unprognostic (9.40e-3)	unprognostic (1.43e-3)	unprognostic (3.20e-2)	unprognostic (2.61e-1)	unprognostic (4.24e-2)	unprognostic (3.04e-3)	unprognostic (8.67e-2)	unprognostic (1.23e-2)	unprognostic (2.49e-1)	unprognostic (2.79e-1)	prognostic favorable (3.69e-4)	unprognostic (5.79e-2)	unprognostic (2.23e-1)	unprognostic (4.00e-2)	unprognostic (1.75e-1)	unprognostic (6.71e-2)	unprognostic (1.62e-2)	6.3	8.3	27.4	6.1	46.3	1.6	3	98.5	144.6	2.6	2.9	11	0	2.7	2.1	1.6	2.3	8.6	4.4	1.9	32.3	50.7	2.3	1.9	4.8	2.7	21.3	45.9	1.7	3.6	19.2	10.3	2.7	35.1	5	3	1.2	2.3	2.6	1.6	2.3	3.4	2.7	12.1	10.6	3.6	2.6	10.5	0	2.7	0	2.3	2.5	0.9	0	7.9	0.4	4.6	0	0	1	0	0	0.3	0.4	1.2	0	0	0	0	0.6	0	0	0	0	0	0	0.2	0	0.3	0	0.1	0	0.8	23.2	0	0	1.3	0	0.1	0	0	0	0.8	0	0.2	0.1	0	0.1	0.2	0.1	0	0	1.9	0	0	0	0.2	0	0	0	28.7	46	5.7	0	0	0	0	0	0	3.9	1.1	0	2.1	0	0	0	7.7	1.6	0.2	0	4.5	0	0	4.6	0	0	0	0	7.9	0	0	0	0.4	0	0.9	0	0	1	27.4	46.3	98.5	94.7	32.3	50.7	21.3	45.9	35.1	10.5	0	0.6	0	0.4	4.2	26.8	0.8	2.5	1.4	1.2	0	23.6	0.8	0	0	13.2	0.5	0.2	0	0	0.7	2.1	6.2	0	0.4	15.8	227.2	51.9	0	15.9	14.4	2.6	24.4	10.1	1.8	0	13.1	2.2	0	1.1	0.3	29.4	0	2.1	2.1	2.5	5.6	2.1	0	0.2	0.3	Horizontal cells
KCNH5	eag2, H-EAG2, Kv10.2	ENSG00000140015	Potassium voltage-gated channel subfamily H member 5	Q8NCM2	14	62699454-63102037	Predicted membrane proteins, Voltage-gated ion channels	Ion transport, Potassium transport, Transport	Calmodulin-binding, Ion channel, Potassium channel, Voltage-gated channel		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in some		adrenal gland: 4.6;brain: 9.2;retina: 5.7	Cell type enriched	Detected in some	15	Bipolar cells: 64.7	Not detected	Not detected			Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	5	HeLa: 10.1;RT4: 13.4	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA030487, HPA072351	Uncertain		Approved	Nucleoplasm,Centrosome,Cytosol						Centrosome	Nucleoplasm, Cytosol	HPA030487: AB_10609995, HPA072351: 		unprognostic (1.16e-1)		unprognostic (7.23e-2)	unprognostic (1.25e-1)	unprognostic (4.23e-2)		unprognostic (2.70e-1)	unprognostic (1.12e-1)	unprognostic (1.50e-1)	unprognostic (1.76e-2)	unprognostic (8.45e-2)		unprognostic (2.66e-1)	unprognostic (1.70e-3)		unprognostic (3.11e-1)	0.9	4.6	1.7	0.5	3.6	0.3	0.4	0.2	9.2	0.3	0.4	0.4	0	0.3	0.4	0.5	0.3	0.3	0.3	0.3	1.3	3	0.4	0.3	0.3	0.3	1.2	4.2	0.3	0.3	0.3	1.5	1.2	6.5	0.7	0.3	5.7	0.3	0.3	0.3	0.3	0.3	0.3	1.6	0.3	0.3	1.7	0	0	0.3	0	0.3	0.5	0.4	0	0	0	0	0	0.2	0	0	0	0	0	0	0	2.2	0	0.2	0	0	0	0	0	0	0	1.1	0.8	1	0	0	0	0	0	10.1	0	0	0	0	0	0	0	0	0	0	0	0.4	0.2	0	0	0	0	0.4	0	0	0	0	0	0	13.4	0.1	0	1.7	0	0	0.2	0.4	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	1.7	3.6	0.2	9.2	1.3	3	1.2	4.2	6.5	0	0	0	0	0.1	0	64.7	0.4	0	0	0	0	0	1.7	0	0	3.7	0	0	0	0	0.8	0.3	0	0	0	0.1	0	0	0	0	1.9	0	0	0	0	0	0.7	0	0	0	0	4.5	0	0	1.4	0.7	0	1	0	0	0	Bipolar cells
AK7	FLJ32864	ENSG00000140057	Adenylate kinase 7	Q96M32	14	96392111-96489427	Enzymes, Predicted intracellular proteins	Cilium biogenesis/degradation	Kinase, Transferase	Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		fallopian tube: 29.0	Cell type enriched	Detected in many	7	Ciliated cells: 175.3	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Cell type enriched	Detected in single	17	basophil: 10.6	Lineage enriched	Detected in single	22	granulocytes: 10.6	Cell line enhanced	Detected in some		BEWO: 10.6;CAPAN-2: 9.2;MCF7: 29.4;REH: 20.9	Low region specificity	Detected in many			Low region specificity	Detected in many			HPA003543	Enhanced											HPA003543: AB_1078117	unprognostic (4.18e-3)	unprognostic (1.14e-1)	unprognostic (9.40e-3)	prognostic favorable (3.18e-4)	unprognostic (4.98e-5)	unprognostic (8.41e-2)	unprognostic (9.81e-3)	unprognostic (1.29e-1)	unprognostic (9.02e-2)	unprognostic (3.65e-4)	unprognostic (8.64e-2)	unprognostic (1.89e-1)	prognostic favorable (1.14e-4)	unprognostic (2.00e-2)	unprognostic (1.23e-2)	unprognostic (4.01e-2)	unprognostic (2.25e-3)	1.5	3.4	4	0.9	12.6	2	2.1	0.7	3.1	2.7	2.8	8.4	5.1	2.5	2.8	13.1	2.4	29	5	1.2	6.7	9.2	7.6	3	9.2	1.4	2.3	2.6	4.9	2.9	11.7	17.5	0.9	16.7	1.4	2.2	1.5	1.6	2.9	0.5	7.5	3.1	1.6	2.7	4.3	3.5	17.6	4.2	1.1	4.8	1.3	0.8	1.1	1.5	0.4	0.1	10.6	0.3	0.3	0.4	0.2	0.1	2.9	1.2	1	0.5	1.8	10.6	0.2	0.3	0.2	0.1	0.3	9.2	0.2	0.2	0.1	0.2	1.1	2.9	0.1	0.1	1.3	0.2	0.2	1.4	0.1	0.5	0.1	0.2	0.1	0.4	1.5	0	0.5	0.1	0.9	0.1	0.2	0.2	29.4	0.2	0.2	0.5	1.3	0.6	20.9	0.3	0.3	4.6	0.2	2	4.2	1.1	0.4	0	1.2	2.5	0.1	0	0.3	0.1	0.3	0.1	0.4	1.3	0.1	0.1	0	0.4	10.6	0.2	0.1	0.2	0	0.1	0.1	0.1	0.4	0.1	0.4	0.2	0.2	0.6	0.3	0.3	0.1	0.1	0.2	4	12.6	0.7	3.1	6.7	9.2	2.3	2.6	16.7	4.2	6	2.6	0.5	0.7	1.5	0	0.3	2.5	175.3	18.2	7	2	0.7	3.3	2.4	14.5	0.9	1.1	0	1	1.5	0.4	0.4	0	0.6	0.2	0	1.2	0.6	0.3	2.2	0	0.6	1.7	0	0.4	0.9	0.3	0	0	3	1.5	0	0.2	24.1	9.4	2.6	2.4	0	1.3	0.4	Ciliated cells
SERPINA10	PZI, ZPI	ENSG00000140093	Serpin family A member 10	Q9UK55	14	94280455-94293271	Plasma proteins, Predicted membrane proteins, Predicted secreted proteins	Blood coagulation, Hemostasis	Heparin-binding, Protease inhibitor, Serine protease inhibitor		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	223	liver: 169.5	Cell type enriched	Detected in some	9	Hepatocytes: 200.2	Cancer enriched	Detected in some	51	liver cancer: 40.6	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in many	8	Hep G2: 21.2	Not detected	Not detected							HPA048739			Approved	Nucleoplasm,Cytosol	Secreted to blood			3960000000	5900000000	Nucleoplasm	Cytosol	HPA048739: AB_2797237	unprognostic (7.14e-2)	unprognostic (2.03e-1)	unprognostic (2.69e-2)	unprognostic (2.01e-1)	unprognostic (1.21e-1)	unprognostic (1.45e-1)	prognostic favorable (9.00e-4)	unprognostic (6.11e-2)		unprognostic (2.81e-4)	unprognostic (2.31e-4)	unprognostic (2.77e-2)	unprognostic (2.91e-3)	unprognostic (1.38e-1)	unprognostic (1.58e-1)	unprognostic (1.11e-1)	unprognostic (7.93e-3)	0.1	0	0.1	0.1	0.1	0.6	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0	0.1	0.1	0.1	0	0.1	0.1	0.1	0	0.1	169.5	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.7	0.1	0.1	0.2	0	0.6	0.3	2.1	0.8	0.8	0.8	0.5	0.6	0.6	1	0.9	2.6	0.6	2.3	0.4	0.4	0.2	0.3	2.4	0.6	1.5	0.9	1.5	2.1	0.7	21.2	0.5	1.7	1.2	0.7	0.5	0.3	0.8	1.2	1.1	1.1	0.6	1.4	1.1	0.3	1.4	1.1	0.9	0.2	0.6	1	1.1	0.9	0.6	0.7	1	0.9	0.5	0.5	0.2	1.2	1.5	0.9	0.6	0.8	0.4	0.7	0.6	1.2	0.5	1	1	1.9	0.5	0.7	0.1	0	0.1	0.1	0.2	0.1	0	0	0	0.2	0	0.1	0.5	0.1	0	0.2	0	0	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	1.9	0	0	0.2	0.4	2.5	0	0	0	13.7	0	0	0	0	0	0	23.3	0	0	0	0	0	200.2	0	0	6.3	4.3	4.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Hepatocytes
SLC25A47	C14orf68	ENSG00000140107	Solute carrier family 25 member 47	Q6Q0C1	14	100323337-100330378	Predicted membrane proteins, Transporters	Transport			Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enriched	Detected in some	88	liver: 127.2	Cell type enriched	Detected in some	21	Hepatocytes: 185.9	Cancer enriched	Detected in single	273	liver cancer: 56.9	Not detected	Not detected			Cell type enhanced	Detected in single		neutrophil: 1.4	Lineage enhanced	Detected in single		granulocytes: 1.4	Cell line enhanced	Detected in some		Hep G2: 5.7;HL-60: 1.4;RH-30: 1.4;SCLC-21H: 2.0	Low region specificity	Detected in all			Not detected	Not detected																unprognostic (2.54e-3)	unprognostic (2.57e-3)	unprognostic (5.12e-2)	unprognostic (2.27e-2)	unprognostic (6.07e-2)	unprognostic (1.30e-2)	unprognostic (4.25e-2)	unprognostic (1.14e-1)	unprognostic (2.89e-2)	unprognostic (2.50e-1)	unprognostic (1.96e-3)	unprognostic (4.46e-1)	unprognostic (1.44e-1)	unprognostic (4.50e-1)	unprognostic (5.64e-2)	unprognostic (1.02e-2)	unprognostic (1.94e-1)	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0.1	127.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.4	0.3	0	0	0	0	0	0	0	0	0	0.4	0	0	0.1	0	0.2	0	0	0	0	0.1	0.2	0	0.1	0	0.2	0	0.1	0	5.7	0	1.4	0	0.1	0	0.1	0	0	0	0.1	0.1	0	0	0	0.1	0.4	0	0	0	0.1	1.4	0	0	0.1	2	0.2	0.6	0.2	0.2	0	0	0	0	0	0	0.2	0	0	0.1	0.5	0	0.3	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	1.4	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	3.2	0	0	0	0.3	0	0	0	1.8	0	0.1	0	0	0.4	0	0	0	0.3	0	0	0	0	185.9	0	0	0	4.3	8.8	0.4	0	0	0	0	0.3	0	0.1	0	0	1.4	0	0	0	0.2	0.1	0	0.6	0	0	0	Hepatocytes
TPM1	C15orf13, CMH3	ENSG00000140416	Tropomyosin 1	P09493	15	63042632-63071915	Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins		Actin-binding, Muscle protein	Cancer-related genes, Cardiomyopathy, Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		heart muscle: 544.2;skeletal muscle: 589.5	Cell type enriched	Detected in many	5	Cardiomyocytes: 12627.3	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enhanced	Detected in all		basophil: 23.8	Group enriched	Detected in all	4	dendritic cells: 8.4;granulocytes: 23.8;monocytes: 11.6	Cell line enhanced	Detected in many		hTERT-RPE1: 206.7;SuSa: 259.0	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA000261, HPA009066, CAB017698, HPA047089, HPA053624	Supported		Approved	Actin filaments,Cytosol					280000000	Actin filaments	Cytosol	CAB017698: AB_2272017, HPA000261: AB_1080339, HPA009066: AB_1080342, HPA047089: AB_2679928, HPA053624: AB_2682210	unprognostic (1.07e-1)	unprognostic (4.20e-2)	unprognostic (1.00e-2)	unprognostic (6.20e-2)	unprognostic (1.28e-1)	unprognostic (1.45e-2)	unprognostic (1.18e-1)	unprognostic (1.08e-1)	unprognostic (1.35e-2)	unprognostic (3.27e-1)	unprognostic (1.27e-2)	unprognostic (1.20e-1)	unprognostic (1.66e-3)	unprognostic (3.38e-2)	unprognostic (1.78e-1)	unprognostic (5.53e-2)	prognostic unfavorable (7.30e-4)	17.9	5.7	5.5	32.4	5.2	1.2	15.2	5.6	5.1	48.1	119.7	2.4	84.2	14.6	72.4	38.3	121.6	36.2	75.3	544.2	4.1	2.6	14.5	4.4	10.5	3.3	3.3	7	27	29.3	1.9	3.2	17.7	4.1	72.5	28	19.1	12.9	81.3	589.5	6.5	39.5	245.2	2.7	6.5	51.7	9.6	2.3	0.4	7.7	121.7	5.9	193.8	38.7	2.7	8.4	23.8	11.6	1.2	3.4	9.9	33.8	22.3	27	1.3	9.4	5.9	88.9	95.4	35.1	58.7	43.6	15.7	6.7	0.1	43.8	95.3	39.4	18.8	22.9	15.3	39.1	0.8	3.2	5	24.1	7.6	26.5	0.2	1.1	8.3	8.8	48.2	12.8	206.7	15.3	0.8	0.5	1.2	44.8	17.5	1.5	0.4	32.1	8	3.8	0.5	9.5	0.9	83.8	18.7	6.4	4.4	11.4	18.1	4	259	13.2	0.9	70.7	77.6	38.1	11.5	67.6	0.3	0.2	0.4	21.9	1.3	53.7	23.8	6.1	2.9	2.5	11.6	2	2.7	2.4	2.7	8.4	2.6	2.6	2.3	6.7	1.2	7.9	1.7	3.4	9.9	5.5	5.2	5.6	5.1	4.1	2.6	3.3	7	4.1	2.3	53.6	87.9	11.7	166.6	63.8	52.3	12627.3	392.4	116.4	116	301.8	361.3	128.4	159.2	2265.1	4.5	128.8	537.1	0	1464	2646.2	335.9	214.6	50.8	122.9	165.5	49.3	257.1	251.7	29.3	13.2	189.8	54.2	77.6	57.7	811.2	43.7	1740.7	585.7	1062.5	207.5	461.5	1021.9	1520.7	21.6	75.4	44.2	86.2	21.9	280.4	186.5	Cardiomyocytes
GOLGA6D		ENSG00000140478	Golgin A6 family member D	P0CG33	15	75282835-75295807	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	No human protein/transcript evidence	Evidence at transcript level		Tissue enriched	Detected in some	4	testis: 14.2	Cell type enriched	Detected in some	6	Early spermatids: 8.6	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HMC-1: 2.6;Karpas-707: 1.1;NTERA-2: 1.5;SuSa: 3.2;U-266/70: 2.9;U-266/84: 1.3									HPA044978, HPA050087, HPA072134	Supported		Approved	Nucleoplasm,Vesicles,Centrosome						Vesicles	Nucleoplasm, Centrosome	HPA044978: AB_2679165, HPA050087: AB_2681010, HPA072134: 															unprognostic (7.95e-3)			0	0	0	0	0	0	0	0	0	0	0			0	0	0	0	0	0	0	0	0	0	3.2	0	0	0		0	0	0	0	0		0	0		0	0	1.1	0	0	0	0	0	0	14.2			0		0	0	0	0	0	0	0	0	0	0	0	0	0.3	0.4	0.1	0.1	0	0	0	0	0	0	0.1	0.1	0.4	0	0.1	0.1	0	0	0	0	0.4	0	0	0.2	0	0.1	2.6	0	0	0.1	0	0	0	0.1	0	1.1	0	0	0	0.2	1.5	0	0	0	0	0.1	0	0	0	0	0	0	0	3.2	0	0.1	0	0.2	0.3	0	0	2.9	1.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	8.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	Early spermatids
CYP1A2	CP12, P3-450	ENSG00000140505	Cytochrome P450 family 1 subfamily A member 2	P05177	15	74748844-74756202	Cancer-related genes, Enzymes, Predicted membrane proteins	Fatty acid metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism	Lyase, Monooxygenase, Oxidoreductase	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	31	liver: 143.0	Cell type enriched	Detected in some	18	Hepatocytes: 44.0	Group enriched	Detected in some	22	liver cancer: 25.3;urothelial cancer: 6.5	Not detected	Not detected			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		SK-BR-3: 6.0	Not detected	Not detected			Not detected	Not detected			CAB016531	Enhanced											CAB016531: AB_629359				unprognostic (1.54e-4)			unprognostic (1.29e-1)	unprognostic (1.98e-1)	unprognostic (1.74e-1)	unprognostic (1.59e-2)		unprognostic (1.76e-1)	unprognostic (1.17e-2)	unprognostic (5.48e-2)	unprognostic (2.33e-2)	unprognostic (7.41e-2)	unprognostic (2.53e-1)	0	0	0	0	0	0.1	0	0	0.1	0	0	0.1	1.1	0	0	0.1	0	0	0	0	0	0	0	143	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0.5	0	0	0	0	1.7	1.1	4.5	1.2	1.1	0.7	0.3	1.1	0.9	2.7	2.1	0.2	0	1.6	0.7	0	0	0.2	0.6	1.3	2.2	0.5	0	1.8	1.2	0.1	0.2	0.1	0.5	1.2	2.8	1.6	0.8	0.1	1.9	1.1	0.4	0.3	0.1	0	0.7	0.2	3.9	1.9	4	0	0.8	2.5	1.3	1.7	0.9	0.6	2.6	2.4	0.9	0	2.2	2.2	1.1	2.1	6	0.4	2.3	1.6	1	0.4	1.1	1.4	1.1	1.2	1	0.7	1.6	1.1	2.4	1.2	3.2	1.2	1.2	0.6	0.6	0.5	0.8	0.7	0.5	0.4	1.7	0.7	0.7	4.5	1.1	0.8	1.1	0.4	0.3	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0.3	2.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	44	0.1	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	Hepatocytes
HAPLN3	EXLD1, HsT19883	ENSG00000140511	Hyaluronan and proteoglycan link protein 3	Q96S86	15	88877288-88895626	Predicted membrane proteins, Predicted secreted proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		blood: 25.4;lymphoid tissue: 23.6	Cell type enriched	Detected in many	8	Extravillous trophoblasts: 899.6	Low cancer specificity	Detected in all			Low region specificity	Detected in many			Cell type enhanced	Detected in many		T-reg: 25.4	Lineage enriched	Detected in many	5	T-cells: 25.4	Cell line enhanced	Detected in many		HDLM-2: 21.0;U-2 OS: 21.0	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA039237	Approved		Approved	Plasma membrane,Cytosol	Secreted to extracellular matrix					Plasma membrane, Cytosol		HPA039237: AB_10805357	unprognostic (1.67e-2)	unprognostic (1.04e-3)	unprognostic (2.57e-1)	unprognostic (2.53e-2)	unprognostic (3.27e-1)	unprognostic (2.24e-2)	unprognostic (4.21e-1)	unprognostic (3.82e-1)	unprognostic (3.37e-3)	unprognostic (7.37e-3)	unprognostic (1.13e-3)	unprognostic (4.30e-1)	prognostic unfavorable (4.18e-13)	unprognostic (1.95e-1)	unprognostic (3.01e-2)	unprognostic (6.12e-2)	unprognostic (1.12e-1)	9.9	1.3	1.1	20.6	2.7	4.4	8.7	1	2.3	5.3	2.6	1.1	0.3	1.4	4.4	4.9	5.7	6	4.7	9.8	3.2	1	3	0.8	8.7	23.6	3.1	0.9	5.2	2.3	0.9	2.2	2.7	3.6	5.2	1.1	3.2	6.4	1.6	4.2	6	4.1	4.7	6.2	6.9	3.6	1.9	1.8	5.7	7.2	7.6	10.9	6	5.6	0.8	1.1	0.7	0.6	4.8	25.4	3.2	1.2	4.4	0.9	9.8	2.8	3	3.1	2.7	0.6	1	1.3	2.8	4.1	0	7.8	3.4	1.6	1	9.3	1.2	0	21	8.2	3	0.2	0	0.4	0	0.1	1.1	0.5	2	0.1	0.1	4.6	0.4	0	6	0.4	0.1	0	0	7.3	0	0.1	0	0.4	7.3	1.8	0.1	0.1	2.7	0.5	0.5	3.7	1.2	0	0.4	0.8	7.1	21	5.3	0.4	0.9	0	0	2.5	0	6.1	0.7	0.6	0	0.6	0.3	3	0.1	10	4.1	1.1	0.8	10.2	4.5	0.1	4.8	0.1	0.4	25.4	3.2	1.1	2.7	1	2.3	3.2	1	3.1	0.9	3.6	1.8	0	4.3	0.9	6	28.4	2.6	7.7	0	1.4	5.7	1.8	9.8	5.6	0	5.7	0	18.6	0	0	1.8	899.6	9.3	3.9	1.1	0	17.6	0	0	3.1	0	0	0.9	2.9	16.9	16.2	0.2	2.4	8.7	0	0.7	0.1	108.4	12.9	38.9	0.5	1.7	21.1	17	3.2	0.2	6.8	Extravillous trophoblasts
RLBP1	CRALBP	ENSG00000140522	Retinaldehyde binding protein 1	P12271	15	89209869-89221751	Disease related genes, Predicted intracellular proteins	Sensory transduction, Transport, Vision		Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	14	retina: 164.1	Cell type enriched	Detected in some	43	Muller glia cells: 2424.2	Group enriched	Detected in some	30	glioma: 3.7;melanoma: 7.4	Group enriched	Detected in many	4	amygdala: 6.9;basal ganglia: 10.6;cerebral cortex: 7.0;hippocampal formation: 3.7	Group enriched	Detected in some	7	basophil: 3.3;neutrophil: 1.9	Lineage enriched	Detected in single	9	granulocytes: 3.3	Cell line enriched	Detected in single	48	SK-MEL-30: 21.9	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA042051, HPA044083	Enhanced	Approved	Supported	Nucleoplasm,Centrosome,Cytosol						Cytosol	Nucleoplasm, Centrosome	HPA042051: AB_2732495, HPA044083: AB_2678802	unprognostic (3.19e-2)	unprognostic (2.66e-1)	unprognostic (1.86e-1)	unprognostic (1.25e-1)	unprognostic (8.68e-2)	unprognostic (1.76e-1)		unprognostic (8.24e-3)	unprognostic (5.21e-2)	unprognostic (3.17e-1)	unprognostic (2.63e-2)	unprognostic (1.76e-1)		unprognostic (2.78e-1)	unprognostic (1.13e-1)		unprognostic (8.42e-2)	0.2	0.7	6.9	0.6	10.6	0.6	0.2	0.6	11.5	0.2	0.8	0.3	0.1	0.9	0.2	1	0.3	0.2	0.3	0.2	3.7	1.3	0.2	0.2	0.3	0.3	1.6	0.6	0.2	0.2	0.2	1.7	0.3	0.4	0.2	0.8	164.1	0.2	0.2	0.5	0.3	0.6	0.5	0.5	0.3	0.2	1.1	0.1	0.1	0.2	0.1	0.2	0.2	0.1	0	0	3.3	0.3	0	0	0.1	0	0	0	0	0	0	0.3	0.1	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0.1	0	0	0	0.3	0	0	0	0	0.4	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	21.9	0.2	0	0	0	0	0	0	0	0	0.1	0	0	0	0.1	3.3	0.3	0	0	0	0	0	0	0	0	0	0	0	1.9	0	0	0	0	0.1	6.9	10.6	0.6	7	3.7	1.3	1.6	0.6	0.4	0.1	0	0	0	0	0	17.2	0.3	0	0	0	0	37.3	3	0	0	0.2	0	0	0	0	0.1	0	0	0	0	0.3	4.8	0	0	0	0	0	0	0	3.6	0	2424.2	0	0	0	0	56.9	0	0	0.1	0	0	16.7	0	0	0	Muller glia cells
SEPT12	FLJ25410	ENSG00000140623	Septin 12	Q8IYM1	16	4777669-4788521	Cancer-related genes, Disease related genes, Predicted intracellular proteins	Cell cycle, Cell division, Differentiation, Spermatogenesis		Cancer-related genes, Disease mutation	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	69	testis: 99.8	Cell type enriched	Detected in some	5	Early spermatids: 274.5	Cancer enhanced	Detected in single		testis cancer: 0.5	Region enriched	Detected in single	8	cerebellum: 1.4	Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	5	BEWO: 2.6;SCLC-21H: 1.3;SK-BR-3: 2.1	Not detected	Not detected			Low region specificity	Detected in many			HPA041128			Uncertain	Microtubules						Microtubules		HPA041128: AB_10796568	unprognostic (2.11e-2)	unprognostic (1.11e-1)	unprognostic (1.56e-2)	unprognostic (2.29e-2)	unprognostic (2.71e-1)	unprognostic (5.45e-2)		unprognostic (7.40e-2)		unprognostic (1.39e-1)	unprognostic (3.80e-2)	unprognostic (1.61e-1)	unprognostic (1.49e-8)	unprognostic (7.41e-2)	unprognostic (9.87e-2)		unprognostic (8.36e-3)	0	0	0	0	0.1	0.1	0	1.4	0	0	0	0	0	0	0	0.7	0	0	0	0	0.1	0.1	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	99.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.6	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	1.3	0	0	2.1	0	0.4	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	1.4	0	0.1	0.1	0.1	0	0	0	0	0	0	0	0	1.3	0.1	0	0	0	0	3.9	0	0	0	274.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	60.5	1.7	0	0	0	0	0.5	0	0	1.4	0	1	0	0	56.9	1.5	0	0.1	0	0	0	Early spermatids
MYLK3	caMLCK, MLCK	ENSG00000140795	Myosin light chain kinase 3	Q32MK0	16	46703369-46790407	Enzymes, Predicted membrane proteins		Kinase, Serine/threonine-protein kinase, Transferase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	6	heart muscle: 62.2;skeletal muscle: 20.8;tongue: 31.1	Cell type enriched	Detected in some	10	Cardiomyocytes: 162.4	Not detected	Not detected			Region enhanced	Detected in many		pons and medulla: 6.6	Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		BEWO: 9.7;HEL: 29.1;K-562: 4.5;SK-BR-3: 6.1	Group enriched	Detected in some	7	cerebral cortex: 9.8;hippocampal formation: 5.7	Region enriched	Detected in single	5	hippocampal formation: 5.2	HPA073447	Enhanced		Approved	Nucleoplasm,Vesicles						Nucleoplasm	Vesicles	HPA073447: AB_2732225	unprognostic (6.01e-4)	unprognostic (2.19e-1)	unprognostic (2.64e-1)	unprognostic (1.77e-2)	unprognostic (1.84e-1)	unprognostic (2.94e-3)	unprognostic (2.60e-1)	unprognostic (4.73e-2)	unprognostic (3.33e-2)	unprognostic (2.41e-2)	unprognostic (6.58e-3)	unprognostic (1.83e-1)	unprognostic (4.16e-2)	unprognostic (2.57e-2)	unprognostic (2.52e-1)	unprognostic (1.08e-2)	unprognostic (2.97e-1)	0	0.1	0.7	0	1.7	0.1	0	0.1	0.2	0.2	0	3.8	0	0	0.1	3.4	2	0.8	0.1	62.2	1.5	1.4	0.4	0	0.2	0.1	0.1	0.4	0.2	0.1	0.1	0.5	0.2	6.6	1	0	0	1.3	0	20.8	0	0	0	0.3	0	0	2.9	0.3	0	0.1	31.1	1.1	0.1	0	1.2	0.9	2.6	0.7	1.2	0.7	0.2	0	0.1	0.1	0.1	0	0	9.7	0	0	0	0	0.7	0.1	0.2	0.1	0	0	0	0	0	0	0	0	29.1	1.6	0.1	0.1	0.1	0.2	0	0	0	0	0	0	0	4.5	0.2	0	0	0	0.2	0	0	0	0.1	0.1	0	0	0	0.3	0.3	0	6.1	0.2	2.9	0.1	0.1	0.1	0.1	0.1	0.1	0	0.4	0	0.3	0	0.1	0	2.5	0.7	0.6	0.6	0.4	0.4	0.7	0.5	0.5	0.3	1.2	0.7	0.7	2.6	1.2	0.5	0.9	0.3	0.2	0.7	1.7	0.1	0.2	1.5	1.4	0.1	0.4	6.6	0.3	0	3.5	0	0.7	0	0.5	162.4	0	16	6.8	0	2	1.4	0	0	7.4	0	0	0	0.2	0.4	1.4	0.6	1.1	0	0.4	0	0	0.6	0	3.2	0.6	0.5	0	0	0	0.5	0.1	0	0	0	1.4	0	0	0.9	0.2	0	0.2	0	0	0.2	Cardiomyocytes
CHST4	HEC-GLCNAC-6-ST, LSST	ENSG00000140835	Carbohydrate sulfotransferase 4	Q8NCG5	16	71525233-71538746	Predicted intracellular proteins	Carbohydrate metabolism, Inflammatory response	Transferase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	5	gallbladder: 46.9	Cell type enriched	Detected in some	40	Cholangiocytes: 152.8	Cancer enriched	Detected in many	6	pancreatic cancer: 10.1	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		CAPAN-2: 11.2;HL-60: 3.4;NB-4: 6.3;NTERA-2: 9.7;SCLC-21H: 4.7	Not detected	Not detected			Low region specificity	Detected in all			HPA021955	Enhanced				Intracellular and membrane							HPA021955: AB_1846723	unprognostic (2.22e-3)	unprognostic (1.41e-1)	unprognostic (8.87e-2)	unprognostic (3.35e-2)	unprognostic (4.76e-3)	unprognostic (6.86e-2)	prognostic unfavorable (9.24e-4)	unprognostic (1.26e-1)		unprognostic (1.70e-1)	unprognostic (1.15e-2)	unprognostic (1.00e-1)	unprognostic (2.27e-6)	unprognostic (1.46e-2)	unprognostic (1.08e-1)	unprognostic (5.46e-2)	unprognostic (1.73e-1)	0.6	1.7	0	0.7	0.1	0	0.1	0	0.3	1.4	0	0.1	0	0	0	0	0.4	2.9	46.9	0	0.3	0	0	5.9	0.3	0.5	0	0.2	0.7	9.6	0	0.6	0	0.4	0.1	0	0.1	1.3	0	0	0	0	0	0.1	0.2	0.1	0.2	0	0.3	0.1	0.2	1.4	0	0	0	0	0	0	0	0	0.4	1.7	0	0	0	2.1	0	0	0	0	0	0	0	11.2	0.5	0.1	0	0.4	0.1	0	0.8	0.1	0	0.2	0	0	0	0	3.4	0	0	0	0	0	0	0	0	0	0	0.1	0	0	6.3	9.7	0	0	0	0.1	0	0	0	4.7	0	0	0	0	2.9	0.1	1.9	0	0.1	2.2	0	0.1	0.1	0	0.2	0.2	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0.1	0	0.3	0.3	0	0	0.2	0.4	0	0	0	0	0.2	0	0	0	152.8	1.4	1.2	0	0	0	0	3.8	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.2	0	0	0	0	0	0	0	0	0	0	0	0	0.1	Cholangiocytes
CLEC18B	MRCL2	ENSG00000140839	C-type lectin domain family 18 member B	Q6UXF7	16	74408270-74421953	Predicted secreted proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enriched	Detected in some	5	kidney: 28.1	Cell type enriched	Detected in some	11	Proximal tubular cells: 18.2	Group enriched	Detected in some	12	glioma: 2.7;ovarian cancer: 1.2;renal cancer: 5.6					Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		AF22: 2.9;JURKAT: 4.1;K-562: 7.3;U-266/70: 2.7									HPA048976	Uncertain				Secreted to blood							HPA048976: AB_2680582	unprognostic (5.69e-2)	unprognostic (1.46e-1)	unprognostic (5.30e-3)	unprognostic (9.37e-2)	prognostic unfavorable (2.07e-4)	unprognostic (7.15e-2)	unprognostic (7.51e-2)	unprognostic (4.49e-3)	unprognostic (2.17e-1)	unprognostic (2.28e-1)	unprognostic (9.91e-2)	unprognostic (3.58e-2)	unprognostic (1.42e-2)	unprognostic (2.31e-2)	unprognostic (5.87e-2)	unprognostic (5.43e-2)	unprognostic (4.27e-2)	0.1	1.1	1.1	0.3	1.4	0.1	0.1	2.5	1.2	0.1	0.1			0.4	0.1	0.6	1.2	0.1	0.3	0	1	1	28.1	0.1	0	0.1	1		0.1	0.3	0.1	0.1	0.1		0.2	0.1		0.2	0	0.2	0	0.2	0.1	2	0.1	0.1	6.1			0.1		0.1	0	0.6	0	0	0	0.9	0.6	0	0	0	1.6	2.9	1.8	0	0.1	0.2	0.2	0	0	0	0	0.7	0.2	1.1	0.5	0.5	1	0.9	0	0.1	0.3	0.2	0.4	0.3	0.1	0.7	0	0.3	1.7	0.4	0.1	0.1	0.7	0	4.1	7.3	0	0.3	0	0	0	1.2	0.3	0.8	0.4	0	1.6	0	0.3	0.6	0.3	0	0	0	0.3	0.3	0	0	0.3	0.4	0.2	0.9	2.7	1.6	0.3	0.5	0.2	0.4	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0.6	0.9	0	0	0											0	0	0	0	0.1	0.4	0.1	0	0	0	0	0	0	1.7	0	0.1	0	0	0	0	0	0	0	0	0	0.1	0	1.2	0	0	1.1	0.3	0	0	0	0.3	0.6	0.4	0	0	18.2	1.1	0	0.1	0.3	0.2	0.1	0	0	0	0	Proximal tubular cells
RPL3L		ENSG00000140986	Ribosomal protein L3 like	Q92901	16	1943974-1957606	Predicted intracellular proteins, Ribosomal proteins		Ribonucleoprotein, Ribosomal protein		Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		heart muscle: 49.0;skeletal muscle: 148.3;tongue: 36.7	Cell type enriched	Detected in some	18	Cardiomyocytes: 115.5	Low cancer specificity	Detected in some			Not detected	Not detected			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		CACO-2: 7.8;Karpas-707: 5.8	Not detected	Not detected			Not detected	Not detected			HPA049136	Enhanced		Approved	Nuclear speckles						Nuclear speckles		HPA049136: AB_2680648	unprognostic (2.53e-1)	unprognostic (2.63e-2)	unprognostic (9.27e-4)	unprognostic (6.38e-4)	unprognostic (4.36e-2)	unprognostic (3.48e-3)	unprognostic (3.46e-2)	unprognostic (2.14e-1)	unprognostic (1.17e-1)	unprognostic (1.19e-2)	unprognostic (2.00e-1)	unprognostic (2.46e-2)	unprognostic (4.53e-3)	unprognostic (3.32e-1)	unprognostic (4.24e-1)	unprognostic (8.32e-3)	unprognostic (4.60e-2)	1.1	0.1	0	0	0	0.3	0.3	0	0	0	0	0	0	0.1	0	4.5	1.4	0	0.1	49	0	0	0	0	0	0	0	0	0	7	0	0	0	0	0.7	0	0.4	2.8	0	148.3	0.1	0.1	0	0	0	0	1.2	0	0	1.4	36.7	2.1	0	0	1.8	1.7	4.9	1.5	0.9	1.4	0.5	2.1	2.5	0.6	2.3	0.1	0.1	1.5	1	0	0.1	0	7.8	4.2	1.3	1.4	0	1.9	2.1	0.2	0.2	0	1	1.3	0.8	1.7	2.7	0	0.5	0.9	0.2	0.3	0.2	0.2	1.5	0	1.4	0.8	5.8	0.1	1.3	1.6	1.9	1.3	2.3	5	0.7	0.7	1.8	0.3	0.8	3.4	1	1	2.8	1.2	1.5	1.4	1.1	1.2	1.2	2.9	1.6	0.8	2.5	1.2	1.2	1.7	0.6	0.4	1.6	1.5	1.3	1.4	1.1	0.9	1.4	1.1	1.2	0.5	1.8	1.2	1.4	4.9	0.9	1	1.7	0.7	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0.6	0	115.5	0	0	0	0	0	0.1	0	0	6.6	0	0	0	0	0.2	0.2	0.9	0	0	0	0	0	0	0	4.6	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0.5	1.3	0.4	0	0	0	0.4	Cardiomyocytes
RANBP10	KIAA1464	ENSG00000141084	RAN binding protein 10	Q6VN20	16	67723066-67806652	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	5	Erythroid cells: 93.5	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low cell line specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all																unprognostic (2.64e-1)	unprognostic (1.35e-1)	unprognostic (3.37e-1)	unprognostic (2.46e-3)	unprognostic (4.51e-2)	unprognostic (8.00e-3)	unprognostic (9.04e-2)	unprognostic (2.27e-2)	unprognostic (1.31e-1)	unprognostic (4.06e-1)	unprognostic (2.77e-3)	unprognostic (7.46e-3)	prognostic favorable (7.52e-4)	unprognostic (2.80e-1)	unprognostic (1.17e-1)	unprognostic (1.17e-2)	unprognostic (2.16e-1)	10.8	21.9	11.8	14.5	11.4	44.4	14.1	29.9	14.8	11.2	10.2	10.6	25.3	9.1	14.1	11.3	14	16.6	10.3	11.4	10.1	8.1	12.7	29.1	17.7	15.5	8.3	13.4	16.5	13.9	17.3	12.4	16.8	9.5	12.2	10.5	11.4	12.3	34.3	31	17	10.5	12.7	9.3	16.8	9.5	9.7	11.1	13.1	11.2	10.8	13.2	9.6	13.5	2	3.4	3.2	2.6	2	3.7	1.8	6.3	8.9	8.9	8.8	10.8	6.1	13.8	5.9	10.2	11.4	11.3	9.2	5.7	10.8	8.6	6.3	4.4	9.8	9	7.9	9.3	5.8	7	4.5	7	7.9	8.4	9.1	25.6	6.4	9.2	10.2	11.3	8.7	10.3	14.3	12	3.4	5.8	9.2	8.5	9.4	7	7	4.8	14.9	5.6	8.8	6.3	7.7	6	6.7	28.5	5.4	10.5	6	11.2	8.7	8.9	6.5	6.5	7.9	6.3	7.6	9.4	17.4	5.8	9.7	10.1	0	2.2	3.2	2.4	2.6	3.7	1.6	2.7	2.2	3.4	2	2.1	3.2	1.1	2	2.2	2.7	3.6	1.8	11.8	11.4	29.9	14.8	10.1	8.1	8.3	13.4	9.5	11.1	11.9	6.2	4.2	2.8	3.9	5.2	6.9	7.6	14.7	3.4	1.8	15.7	4.6	3.3	6.5	3.2	5	5.3	93.5	4.3	3.3	3.1	4.6	0	18.7	4.8	9.5	4.7	9.2	6.7	3.9	4	2.6	0	5.4	8	3.9	5.6	7	3.5	2.9	9.5	0	2.3	4.8	4.1	4.8	7.1	1.5	5.6	3.1	Erythroid cells
UNC45B	CMYA4, UNC45	ENSG00000141161	Unc-45 myosin chaperone B	Q8IWX7	17	35147817-35189345	Disease related genes, Predicted intracellular proteins	Differentiation, Myogenesis	Chaperone, Developmental protein	Cataract, Disease mutation	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	13	heart muscle: 48.8;skeletal muscle: 62.5;tongue: 23.2	Cell type enriched	Detected in some	4	Cardiomyocytes: 181.6	Group enriched	Detected in some	5	head and neck cancer: 0.9;testis cancer: 1.0	Not detected	Not detected			Cell type enhanced	Detected in some		gdT-cell: 3.5	Lineage enriched	Detected in single	10	T-cells: 3.5	Group enriched	Detected in some	11	BEWO: 4.7;HSkMC: 7.1	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA017861			Approved	Cytosol						Cytosol		HPA017861: AB_1847012	unprognostic (7.17e-2)	unprognostic (6.47e-3)	unprognostic (9.36e-3)	unprognostic (2.93e-1)	unprognostic (1.49e-3)	unprognostic (5.30e-2)	unprognostic (3.07e-1)	unprognostic (1.09e-2)	unprognostic (5.46e-2)	unprognostic (2.40e-2)	unprognostic (8.46e-2)	unprognostic (6.73e-2)	unprognostic (1.13e-6)	unprognostic (6.77e-2)	unprognostic (5.05e-3)	unprognostic (2.20e-1)	unprognostic (2.21e-1)	2.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.7	0.9	0	0.3	48.8	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0.7	0	0	1.9	0.2	62.5	0	0	0	0	0.4	0.2	0.2	0	0	0.2	23.2	1	0	0	0	0	0.2	0.3	0.3	3.5	0.5	0	0	0	0	0	0	4.7	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0.1	0	0	0.1	7.1	0	0	0	0	0	0.2	0	0.1	0	0	0	0.2	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	3.5	0.2	2.9	0	0.7	1.8	0	0	0.4	2	0.2	0.3	0.3	0	0.4	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	181.6	0	0	0	0	0	0	1.7	0	25	0	0	0	0	0.4	0	0	0	0	0.1	0	0	0	0	42	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0.6	0.1	0	0	0	0	Cardiomyocytes
SPATA22	NYD-SP20	ENSG00000141255	Spermatogenesis associated 22	Q8NHS9	17	3440019-3513852	Predicted intracellular proteins	Meiosis			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	28	testis: 75.9	Cell type enriched	Detected in some	5	Spermatocytes: 958.8	Cancer enriched	Detected in single	10	testis cancer: 3.1	Not detected	Not detected			Cell type enhanced	Detected in some		naive CD8 T-cell: 2.6	Low lineage specificity	Detected in many			Group enriched	Detected in some	8	K-562: 9.8;TIME: 14.4					Not detected	Not detected																unprognostic (4.09e-2)				unprognostic (9.31e-2)	unprognostic (2.54e-2)		unprognostic (7.07e-2)	unprognostic (9.05e-2)		unprognostic (1.98e-2)		unprognostic (6.79e-4)	unprognostic (4.33e-1)	unprognostic (1.87e-1)	unprognostic (1.27e-1)		0.4	0.2	0.3	0.1	0.3	0	0.4	0.4	0.6	0.2	0.1	0.3	0	0	0.1	0.6	0.1	0.1	0.1	0.2	0.3	0.3	0.3	0.1	0.1	0.1	0.4	0	0.1	0.1	0	0.1	1.2	0.4	0.2	0	0	0	0.7	0.7	0	0.1	0.1	0.4	0.2	0	75.9	0.2	0.1	0	0.2	0.1	0.1	0.1	0.1	0.8	0	1.3	0.9	2.6	0.4	0	0	0.2	1.1	0	0	0.4	0	0	0	0	0	0	0.1	0	0.2	0.1	0	0.7	0	0	0	0	0	0	0	0.6	0	0	1.1	0	0	0	0	0	0	9.8	0	0	0	0	0	0.2	0	1.5	0	0	0.7	0	0	0	0	0	0	0	0.1	0	0	14.4	0	0	0.2	0	0	0	0.1	0	0	0	0	0.2	0	0.2	1.3	1	0	0.4	0.1	0	0.1	2.3	2.6	0	0.9	0.4	0.8	0	0.4	0.3	0.3	0.4	0.6	0.3	0.3	0.4	0	0.4	0.2	0	0	0	0	0	0	1.4	0	0	0	0	0	3.1	0	0	175.6	0	0	0	0	14.5	0.7	0	0	0	0.9	0	0	0	1.2	154.8	13.3	0	0	0	0	0	0	0	8.1	0	0	12.9	0	958.8	28.8	0.1	1	0	0	0	Spermatocytes
SCRN2		ENSG00000141295	Secernin 2	Q96FV2	17	47837692-47841333	Enzymes, Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	5	Proximal tubular cells: 296.5	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low cell line specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA022934, HPA023434	Enhanced		Supported	Nucleoplasm,Golgi apparatus					350000	Nucleoplasm	Golgi apparatus	HPA022934: AB_1856638, HPA023434: AB_1856639	unprognostic (2.35e-2)	unprognostic (1.42e-2)	unprognostic (2.86e-1)	unprognostic (6.14e-2)	unprognostic (2.46e-2)	unprognostic (1.73e-1)	prognostic favorable (3.86e-4)	unprognostic (4.63e-2)	unprognostic (3.25e-2)	unprognostic (5.77e-2)	unprognostic (1.28e-3)	unprognostic (8.72e-2)	unprognostic (3.43e-2)	unprognostic (5.28e-3)	unprognostic (1.64e-1)	unprognostic (1.20e-1)	prognostic favorable (5.83e-4)	43.4	10.3	8.3	14.2	14.1	6.7	20.8	17.7	13.1	10.6	17.3	11.2	23.6	25.1	11.4	18.1	8.9	15.4	13.3	17.9	8.6	8.9	29.3	17.4	8.3	8.7	8.1	9.6	11.8	25.3	11.4	14.5	7.8	10.5	13.6	6.1	14.8	20.1	19.2	20	10.9	20.1	9.7	7.3	15	9.8	4	10.9	8.5	18.1	9	11	10.7	10	16.9	19.2	25.9	13.4	16.5	22.1	10.8	12	19.2	5.3	5.1	15.7	12.2	16.3	6.1	12.5	9.4	9.6	14.4	14.4	6.7	12.3	3.2	5	6.6	1.7	10.7	3.2	15.9	13.2	6.8	14.1	12.4	5.6	3.2	5.4	11.7	8.1	5.7	4.5	14	10.5	16.2	2.3	7.6	12.8	10.9	10.7	5.6	2.7	5.2	7.6	14.3	4	26.9	7.4	5.5	4.1	17.2	3.4	7.3	8	3.8	16.6	6.4	4.8	8.6	9.2	2.4	2.8	31.5	4.1	3.1	23.3	5.7	1.9	12.3	12.8	25.9	16.9	13.4	16.3	16.9	14	16.4	16.3	15.6	22.1	12.2	3.2	16.5	6.5	19.2	13.9	10.8	8.3	14.1	17.7	13.1	8.6	8.9	8.1	9.6	10.5	10.9	35.7	25.1	11.2	25.9	14	11.3	19.8	12.7	26.8	14.8	15.7	9.8	38.7	63	22.9	2.8	20.3	52	0	53.1	8.3	23.5	18.8	16.1	25.3	19.4	19.1	21.5	23.9	8.1	2.1	30.8	12.7	40.5	11.8	30.3	26.6	27.6	34.5	15.6	296.5	15.6	6.5	17	5.2	14.9	10	28.3	26.1	34.7	16.9	Proximal tubular cells
BCAS3	FLJ20128	ENSG00000141376	BCAS3, microtubule associated cell migration factor	Q9H6U6	17	60677453-61392838	Disease related genes, Plasma proteins, Predicted intracellular proteins	Angiogenesis, Transcription, Transcription regulation		Proto-oncogene	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	4	Late spermatids: 203.3	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Cell line enhanced	Detected in all		MCF7: 43.3	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA052409, HPA057289	Approved		Approved	Nucleoli						Nucleoli		HPA052409: AB_2681821, HPA057289: AB_2683399	unprognostic (2.84e-2)	prognostic favorable (2.04e-4)	unprognostic (1.20e-1)	unprognostic (3.52e-1)	unprognostic (5.52e-1)	unprognostic (3.60e-2)	unprognostic (5.69e-2)	unprognostic (1.39e-1)	unprognostic (1.20e-1)	unprognostic (2.47e-1)	prognostic favorable (1.23e-5)	unprognostic (2.55e-1)	prognostic favorable (1.73e-5)	unprognostic (1.49e-1)	unprognostic (2.54e-1)	unprognostic (1.12e-1)	unprognostic (2.32e-1)	12.1	15.9	13.9	8.3	24.1	8.8	11.6	21.5	30.8	12.9	11.4	32.2	12.6	7.1	20.6	18.6	14.3	21.1	11.3	11.7	15.8	14.3	17.1	18.3	13.6	8.5	19.2	18.6	11.9	13.5	26.5	16.9	14.7	24.3	17.1	9.3	16.1	13.6	14.3	20.3	17	8.4	13.6	16.3	10.8	11.7	20.2	20	16.6	13.7	7.6	13.9	17	11.9	9.1	6.9	26.8	8	11.7	12.9	6.4	3.3	8.2	4.2	14.1	8.6	7.3	4.9	3.5	4.8	3.6	4.6	5.5	7.4	1.3	6	5.9	5	2.6	2.4	2.9	4.7	3	9.4	3.2	4.6	5	4.8	1.6	2.8	8.6	3.4	3	5.5	7.2	4.2	5.1	2.7	6.6	3.2	43.3	4.6	1.2	4.4	16.2	9.3	5.7	5.7	6	3	12.7	6.3	5.3	7.1	2.1	5	14.8	7.7	2.4	3.9	4.8	4.1	2	1.6	15.4	12.7	5.6	5.7	1.2	3.7	15.8	7.8	11.7	12.1	6.7	9.8	9.1	8.4	9.2	6.9	8.4	9.3	7.5	26.8	11.7	8	4.9	12.9	6.4	13.9	24.1	21.5	30.8	15.8	14.3	19.2	18.6	24.3	20	6	12.2	2.7	7.8	4.5	13	11.2	5.1	48.2	12.5	15.7	9.8	5.9	8.3	3.6	38.8	8.5	3.6	0	3.1	4.3	5	3.6	16.1	8.6	3.7	3.2	6.9	12.9	5.6	203.3	6.9	4.7	1.7	7.2	4.6	30.3	3.2	4.8	19.8	23	13.4	12.9	14.4	11.1	4.7	4.8	6.3	11.8	2.6	6.9	Late spermatids
SLC13A5	INDY, NACT	ENSG00000141485	Solute carrier family 13 member 5	Q86YT5	17	6684713-6713567	Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters	Ion transport, Sodium transport, Symport, Transport		Amelogenesis imperfecta, Disease mutation, Epilepsy	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	65	liver: 150.4;salivary gland: 153.9	Cell type enriched	Detected in some	16	Hepatocytes: 374.3	Cancer enriched	Detected in some	15	liver cancer: 27.8	Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	61	Hep G2: 35.9	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA044343	Approved		Supported	Nucleoplasm,Plasma membrane,Cytosol						Plasma membrane	Nucleoplasm, Cytosol	HPA044343: AB_10961771	unprognostic (8.46e-3)	unprognostic (3.89e-2)	unprognostic (3.24e-2)	unprognostic (1.75e-2)	unprognostic (7.33e-2)	unprognostic (1.07e-1)	unprognostic (6.79e-2)	unprognostic (8.79e-3)	unprognostic (1.32e-1)	unprognostic (3.23e-1)	unprognostic (1.26e-3)	unprognostic (1.30e-3)	unprognostic (3.78e-11)	unprognostic (2.42e-2)	unprognostic (2.46e-1)	unprognostic (2.05e-2)	unprognostic (2.04e-1)	0.2	0.8	1	0.1	1.9	0.1	0.2	0.6	2.3	0.2	0.1	0	0	0.1	0.3	0.1	0.3	0.9	0.1	0.1	0.9	0.7	0.4	150.4	0.1	0.2	0.8	1.2	0.3	0.2	0.1	0.2	0.1	0.6	0.1	0.1	0	153.9	0.1	0.1	0.1	0.1	0.1	0.2	0.9	0.1	0.8	0	0	0.1	0	0.1	0.1	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0.1	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	35.9	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0.2	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	1	1.9	0.6	2.3	0.9	0.7	0.8	1.2	0.6	0	0	0	7	0.6	0.5	0.2	0.6	7.6	0	0	0	0	0	0	0	0.1	0.6	0	23.3	0.4	0.1	0	0.3	0	374.3	0	0	0	15.4	21	0	0.6	0.3	0	0	0	7.4	9.8	0	0	0	1.4	0	0	0.9	1.5	0.4	0.1	0	0	0.2	Hepatocytes
ASGR1	CLEC4H1	ENSG00000141505	Asialoglycoprotein receptor 1	P07306	17	7173431-7179564	Predicted intracellular proteins	Endocytosis, Host-virus interaction	Receptor		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	4	liver: 171.0	Cell type enriched	Detected in many	5	Hepatocytes: 1020.7	Cancer enriched	Detected in many	90	liver cancer: 131.6	Low region specificity	Detected in some			Group enriched	Detected in many	5	classical monocyte: 39.1;intermediate monocyte: 17.9;myeloid DC: 13.7	Group enriched	Detected in many	13	dendritic cells: 13.7;monocytes: 39.1	Cell line enriched	Detected in some	30	Hep G2: 104.5	Region enriched	Detected in many	9	cerebellum: 49.4	Not detected	Not detected			HPA011954, HPA012852	Enhanced		Supported	Vesicles,Cell Junctions	Intracellular and membrane					Vesicles	Cell Junctions	HPA011954: AB_1845079, HPA012852: AB_1845080	unprognostic (3.56e-3)	unprognostic (3.57e-1)	unprognostic (8.76e-2)	unprognostic (4.05e-2)	unprognostic (1.88e-1)	unprognostic (1.22e-1)	unprognostic (1.86e-2)	unprognostic (5.37e-2)	unprognostic (2.15e-1)	unprognostic (2.39e-1)	unprognostic (8.55e-5)	unprognostic (1.55e-1)	unprognostic (8.33e-11)	unprognostic (1.45e-1)	unprognostic (2.00e-1)	unprognostic (1.73e-3)	unprognostic (4.46e-3)	0.2	0.1	0.8	0.9	0.6	0.6	0.2	2.8	1.8	0.1	0.2	0.2	0.2	0.5	0.2	0.1	0.1	0.1	0.7	0.1	0.8	0.8	0.1	171	0.7	0.3	0.4	1.2	0.1	0.3	0.9	0.2	0.1	0.7	0.1	0.1	0.1	0.1	0.1	0.3	0.7	0.3	0.3	0.3	0.5	0.2	2.9	0.2	0.1	1.4	0.1	0.1	0.3	0.1	0.2	13.7	2.1	39.1	0.1	0.3	10.1	0	0.1	2	0.9	0	0	0.1	0.1	0.2	0.2	0.3	3.5	0.1	0	0.2	0	0.1	0	0	0	0.1	0	0.2	0.2	0.3	104.5	0	0.1	0.4	0.2	0	0.1	0	0.1	1.8	1.6	0.2	0.1	0.1	0	0.1	0.2	0.3	0	0.1	0.1	0.8	0	0	0.1	0.1	0.8	0.1	0	0.1	0.3	0.1	0	0.2	0.2	0.7	0.1	0.1	0	0	0.1	0.1	0.1	0	2.1	39.1	0.1	0.1	17.9	0.3	0.1	0	0	13.7	0.2	0.1	0.1	1.1	0.1	4.5	0.6	0.1	10.1	0.8	0.6	2.8	1.8	0.8	0.8	0.4	1.2	0.7	0.2	0	6.6	13	1	2.9	31.7	1.2	73.9	1.4	2.3	3.5	151.2	3.2	3.3	0.8	212.5	12.7	0.3	23.3	0.2	3.6	2	0.8	0	1020.7	41.3	14.3	15	23.9	110.6	80.2	2.3	18.3	0	0	0.7	2.6	0.4	0.6	1.1	1.6	39.8	0	0.4	4.5	7.8	4.3	10.4	0.7	1	2.4	Hepatocytes
CBLN2		ENSG00000141668	Cerebellin 2 precursor	Q8IUK8	18	72536680-72638521	Predicted intracellular proteins, Predicted secreted proteins				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	4	brain: 33.8	Cell type enriched	Detected in some	7	Intestinal endocrine cells: 36.4	Cancer enriched	Detected in single	7	breast cancer: 3.1	Low region specificity	Detected in many			Cell type enriched	Detected in single	13	naive B-cell: 1.3	Lineage enriched	Detected in single	13	B-cells: 1.3	Cell line enriched	Detected in some	9	SH-SY5Y: 35.5	Low region specificity	Detected in many			Low region specificity	Detected in many								Secreted in brain				1300000				unprognostic (2.03e-2)	unprognostic (3.52e-1)	unprognostic (1.13e-3)	unprognostic (9.09e-5)	unprognostic (7.10e-2)	unprognostic (6.27e-3)		unprognostic (7.39e-2)	unprognostic (2.17e-1)	unprognostic (1.37e-4)	unprognostic (5.01e-4)	unprognostic (8.15e-2)	unprognostic (6.07e-4)	unprognostic (7.19e-2)	unprognostic (1.63e-1)	unprognostic (1.18e-1)	unprognostic (4.93e-2)	0.6	0.7	5.4	0.8	10.4	0.4	0.6	0.8	33.8	1	2.9	0.9	0	2.5	0.5	0.4	0.5	0.5	0.4	0.4	4.5	9.5	1.5	0.9	0.4	0.5	7	16.4	0.6	0.4	0.4	0.3	0.4	17.8	1.8	2.6	1.9	0.4	8.2	0.4	0.9	3.8	1.5	2.6	0.4	0.6	0.6	0	0	0.4	0	1.3	0.5	0.3	1.3	0	0	0	0	0	0	0	0.1	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4	35.5	0	0	0	0	0	0	0.2	0.1	0.4	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	1.3	0	0	0	0	0	0	0	0	5.4	10.4	0.8	33.8	4.5	9.5	7	16.4	17.8	0	0	0	0	0	0	5.6	0.3	0	0	0	0	0	0	0	0	0.9	0	0	0	0	0	0	0.1	0	0	0	0	36.4	0	0	0.2	0.6	0	0	0	0	0.4	0	0	0	0	0.7	0	0.4	0.1	1	0.1	0	0	0	0	Intestinal endocrine cells
ARL5C	ARL12	ENSG00000141748	ADP ribosylation factor like GTPase 5C	A6NH57	17	39156894-39167484	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level	No human protein/transcript evidence	No human protein/transcript evidence		Tissue enriched	Detected in some	7	lymphoid tissue: 21.1	Cell type enriched	Detected in single	4	Bipolar cells: 1.6	Not detected	Not detected			Not detected	Not detected			Cell type enriched	Detected in single	28	plasmacytoid DC: 2.7	Lineage enriched	Detected in single	28	dendritic cells: 2.7	Cell line enhanced	Detected in some		HMC-1: 1.4;JURKAT: 1.5;MOLT-4: 3.6;SuSa: 1.0	Low region specificity	Detected in many							HPA069849	Uncertain											HPA069849: AB_2686213	unprognostic (2.57e-1)				unprognostic (2.34e-1)								unprognostic (1.60e-7)	unprognostic (7.60e-2)	unprognostic (1.11e-2)			0.2	0.2	0.2	0.2	0.6	0	0.6	0.2	0.5	1.3	0.2	0	0	0	0	0.7	0.1	0.1	0	0.1	0.6	0.2	0.1	0.4	0.1	1.5	0.2	0	0.1	3	0	0.1	0.7	0.4	0.1	0.2	0.8	0.1	1.1	0.3	0.1	0.1	0	0.4	0.1	0.1	0.1	0	21.1	0.1	0	1.3	1.2	0.1	0	2.7	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0.6	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	1.4	0	0	0	0	0	0	1.5	0	0	0	0	3.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0.6	0	0	0.2	0.5	0	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.7	0	0	0.2	0.6	0.2	0.5	0.6	0.2	0.2	0	0.4	0	0	0	0	0.1	0	1.6	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	Bipolar cells
STAC2	24b2	ENSG00000141750	SH3 and cysteine rich domain 2	Q6ZMT1	17	39210536-39225872	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		ductus deferens: 94.0;seminal vesicle: 101.5	Cell type enriched	Detected in many	11	Muller glia cells: 446.6	Group enriched	Detected in many	7	breast cancer: 15.0;endometrial cancer: 3.2;glioma: 10.4;ovarian cancer: 4.2;renal cancer: 10.7	Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		GAMG: 8.3;HeLa: 25.8;hTEC/SVTERT24-B: 3.8;U-87 MG: 11.8	Low region specificity	Detected in all			Low region specificity	Detected in many			HPA076925			Approved	Plasma membrane,Cytosol						Plasma membrane, Cytosol		HPA076925: 	unprognostic (1.70e-3)	unprognostic (1.05e-1)	unprognostic (3.09e-2)	prognostic unfavorable (4.05e-5)	prognostic unfavorable (5.61e-4)	unprognostic (1.42e-1)	unprognostic (8.66e-2)	unprognostic (2.94e-2)	unprognostic (1.17e-2)	prognostic unfavorable (6.66e-4)	unprognostic (1.12e-2)	unprognostic (5.16e-2)	unprognostic (2.35e-3)	unprognostic (2.05e-2)	unprognostic (1.94e-1)	unprognostic (3.54e-2)	unprognostic (3.17e-1)	2.4	0.9	4.2	1	7.4	0.7	29.7	9.5	21.9	4	0.9	0	94	0.9	2.5	13.9	0.8	1.4	0.8	1	6.8	3.2	4.8	0.7	0.9	0.8	3.5	6.6	1.2	1.1	0.7	0.5	1	13.1	1.8	0.9	8.2	7.8	101.5	0.8	20.1	0.8	1.7	1.4	0.8	0.8	0.9	0.2	0	0.7	0	0.8	0.8	0.9	0	0	0	0	0	0	0	0	0	0.4	0.7	0	0	0	0	0	0	0.2	0	0	0	0.4	0	8.3	0	3.3	0	0	0	0.4	0	25.8	0	0	0	0	0	0	3.8	0	0.1	0	0.7	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0.2	2	0.2	2.7	0	0.2	0	0	0	0	0.2	0	0	0	0	0	11.8	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4.2	7.4	9.5	21.7	6.8	3.2	3.5	6.6	13.1	0.2	3	8	0	1.2	0.3	4.8	2.9	0	2.7	4.5	3.5	9.8	0.1	5	0	0.1	0.4	0	0	0	0.2	0.6	0.3	0	0	0.1	17.5	0	0	0	0	2.6	0	40.5	0	0	446.6	0	0	0	0	11.1	0	3.4	0.2	0.9	1.5	0.2	0	0	0.1	Muller glia cells
DMRTC2		ENSG00000142025	DMRT like family C2	Q8IXT2	19	41844743-41852333	Predicted intracellular proteins, Transcription factors	Differentiation, Sexual differentiation, Transcription, Transcription regulation	DNA-binding		Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	39	testis: 53.5	Cell type enriched	Detected in some	7	Spermatocytes: 176.3	Not detected	Not detected			Not detected	Not detected			Cell type enhanced	Detected in some		neutrophil: 1.3	Group enriched	Detected in many	4	granulocytes: 1.3;monocytes: 1.1	Cell line enhanced	Detected in some		HMC-1: 1.6	Not detected	Not detected							HPA045016	Uncertain											HPA045016: AB_10960404	unprognostic (6.80e-3)			unprognostic (4.38e-2)								unprognostic (5.36e-2)		unprognostic (2.69e-1)	unprognostic (1.02e-1)			0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0.1	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	53.5	0	0	0.1	0	0	0	0	0.3	0	1.3	1.1	0.2	0.2	0	0.2	0	0.5	1	0	0	0.3	0.4	0	0.5	0	0.7	1.1	0.1	0.1	0.2	0.2	0.6	0	0	0	1.2	0.6	0	0.8	0.2	0	0.6	1.6	0.3	0	0.2	0	1.2	0	0.3	0.2	0	0.2	0	0	0	0	0.1	1	0	0.2	0	0.4	0.3	0	0	0	1.1	0	0.5	1.1	0.7	1.3	0.9	0.1	0.3	0.3	0.4	0.2	0.2	0.9	0.1	1	1.2	0.1	0.3	0	0	0.1	0.2	0.1	0.1	0	0.3	0.2	0.2	1.3	0.2	1.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	2.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4.1	1.1	0	0	0	0	0	0	0	0.7	0	0	0	0	176.3	24.5	0	0	0	0	0	Spermatocytes
IL19	IL-10C, IL-19, MDA1, NG.1, ZMDA1	ENSG00000142224	Interleukin 19	Q9UHD0	1	206798870-206842981	Predicted membrane proteins, Predicted secreted proteins	Apoptosis	Cytokine		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	7	cervix, uterine: 17.8;esophagus: 6.0;salivary gland: 6.7	Cell type enriched	Detected in single	4	Exocrine glandular cells: 1.5	Cancer enhanced	Detected in some		endometrial cancer: 1.8					Cell type enhanced	Detected in single		basophil: 1.4	Low lineage specificity	Detected in single			Cell line enriched	Detected in some	9	BJ hTERT+: 11.8	Not detected	Not detected			Not detected	Not detected								Secreted to blood			172000					unprognostic (6.21e-2)	unprognostic (3.84e-2)	unprognostic (3.55e-1)	unprognostic (2.17e-2)		unprognostic (2.48e-5)		unprognostic (1.07e-1)	unprognostic (8.72e-3)	unprognostic (8.42e-2)	unprognostic (2.04e-3)			unprognostic (9.17e-2)	unprognostic (7.20e-2)	unprognostic (4.91e-2)	unprognostic (2.78e-1)	0.1	0	0	0	0	0	0	0	0	17.8	0			0	0.1	0	6	0	0.2	0	0	0	0.9	0	0	0.5	0		0	0	0	0.2	0		0	0		6.7	0.2	0	0.1	0	0	0	0	1.3	0.2			0.3		0.3	0.9	0.8	0.7	0.6	1.4	0.2	0	0.6	0	0	0	0	0	0.1	0	0.1	0	11.8	0.2	0.1	0.1	0	0.2	0	0	0.1	0.2	0	0	0.1	0	0	0	0.2	0	0.3	0	0.1	0	0.1	0	0	0.1	0.2	0.1	0	0.3	0.1	0	0	0.1	0	0	0.1	0	0	1.2	0.1	0	0.1	0.2	0	0.2	0.3	0.1	0.1	0	0	0.2	0.2	0.2	0.1	0.1	0	0	0	0	0.1	1.4	0.2	0.1	0.2	0.1	0.2	0.7	0.1	0.6	0.1	0.3	0.4	0.2	0.1	0	0.2	0.6	0	0											0	0	0	0	0.1	0	0.1	0	0	0	0	0	0	0	0	0.3	0	0	0	1.5	0	0	0.1	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0.3	Exocrine glandular cells
SLC6A3	DAT, DAT1	ENSG00000142319	Solute carrier family 6 member 3	Q01959	5	1392790-1445430	Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters	Neurotransmitter transport, Symport, Transport		Disease mutation, Dystonia, FDA approved drug targets, Neurodegeneration, Parkinsonism	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	14	brain: 48.4	Cell type enriched	Detected in single	5	Alveolar cells type 2: 2.9	Cancer enriched	Detected in some	18	renal cancer: 25.7	Region enriched	Detected in some	47	midbrain: 48.4	Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	5	NTERA-2: 1.2;RPMI-8226: 2.1;SCLC-21H: 3.8	Group enriched	Detected in some	8	midbrain: 96.4;thalamus: 31.8	Region enriched	Detected in single	138	midbrain: 362.2	HPA012763, HPA013602, CAB016249, CAB078172	Enhanced	Supported	Approved	Vesicles						Vesicles		CAB016249: AB_627402, CAB078172: AB_2665810, HPA012763: AB_2732405, HPA013602: AB_1847484	unprognostic (2.25e-4)	unprognostic (2.22e-1)	unprognostic (8.45e-2)	unprognostic (5.24e-2)	unprognostic (7.75e-2)	unprognostic (1.41e-2)	unprognostic (4.64e-5)	unprognostic (9.31e-2)	unprognostic (7.89e-2)	unprognostic (4.81e-2)	unprognostic (1.30e-1)	unprognostic (2.12e-2)	prognostic unfavorable (3.40e-7)	unprognostic (6.98e-2)	unprognostic (1.64e-1)	unprognostic (2.22e-2)	unprognostic (4.74e-2)	0.2	0.1	0	0	0.7	0	0.1	0	0.3	0.7	0	0	0	0.3	1.1	0.8	0.1	0.8	0.6	0.1	0	0.6	0.3	0	3.4	0	48.4	0	1.5	0	0	0	0.1	1	0.7	0	1.7	0	0.1	0	0	0	1.3	0	0.1	0	0.8	0	2.4	2.2	0	0.3	0.2	0	0.2	0	0	0	0	0.4	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	1.2	0	0	0	0	2.1	0	0.1	3.8	0	0	0.1	0	0.4	0	0.1	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0.2	0.1	0.4	0	0	0	0	0	0	0	0.7	0	0.3	0	0.6	48.4	0	1	0	0	2.9	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	Alveolar cells type 2
CACNG8		ENSG00000142408	Calcium voltage-gated channel auxiliary subunit gamma 8	Q8WXS5	19	53963040-53990215	Predicted membrane proteins, Transporters	Calcium transport, Ion transport, Transport	Calcium channel, Ion channel, Voltage-gated channel		Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	10	blood: 7.9;brain: 22.8	Cell type enriched	Detected in many	7	Horizontal cells: 47.7	Cancer enriched	Detected in single	5	glioma: 1.6	Group enriched	Detected in many	5	amygdala: 9.4;basal ganglia: 9.1;cerebral cortex: 13.6;hippocampal formation: 20.3;hypothalamus: 5.4	Cell type enriched	Detected in some	7	basophil: 7.9	Lineage enriched	Detected in single	17	granulocytes: 7.9	Group enriched	Detected in some	5	AF22: 6.4;HMC-1: 21.3;hTERT-RPE1: 7.6;TIME: 13.0	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA041351	Enhanced											HPA041351: AB_10796666	unprognostic (7.01e-2)	unprognostic (6.27e-2)	unprognostic (3.06e-1)	unprognostic (5.29e-4)	unprognostic (9.66e-2)	unprognostic (2.17e-2)	unprognostic (1.38e-1)	unprognostic (9.40e-3)	unprognostic (6.13e-2)	unprognostic (2.03e-1)	unprognostic (7.63e-2)	unprognostic (2.58e-1)	unprognostic (2.82e-8)	unprognostic (1.10e-1)	unprognostic (1.35e-1)	unprognostic (1.63e-1)	unprognostic (1.17e-1)	0.4	0.4	9.4	0.4	9.1	0.6	0.4	0.7	22.8	0.3	0.3	2.1	0	0.4	0.5	0.4	0.3	0.4	0.4	0.3	20.3	5.4	0.3	0.3	0.4	0.4	2.3	2	0.4	0.3	0.5	0	0.3	1.5	0.4	0.4	0	0.4	0.3	0.9	0.7	0.4	0.4	0.9	0.4	0.6	1.5	0	0	0.4	0	0.3	0.3	0	0.4	0.3	7.9	0.2	0.3	0.3	0.1	0	2.1	6.4	0.2	0	0.1	0.1	0.1	0.3	0	0.2	0.4	0.3	0	0.2	0	0.3	0.2	0.1	0.1	0	0	0.9	2.4	0.5	0	1	0	21.3	0.3	0	0	0.2	7.6	2.1	0.1	0.1	0.2	0	0.1	0	0	1.3	0.2	2.6	0	0	0	0	0.1	0.1	1.4	0.1	0.1	0	0.2	0.2	0	13	0.1	1.2	0	0	0.1	0	0	2.1	0	0.1	7.9	0.2	1.1	0.2	0.1	0.2	0.2	0.2	0.2	0	0.4	0.3	0.2	0.5	0.3	0.1	0.3	0.1	0.1	9.4	9.1	0.7	13.6	20.3	5.4	2.3	2	1.5	0	0	0	0	1	1.4	0.9	2.8	0	4	1.2	1.8	0	0	0	1.4	0.4	1.9	0	0	0	0	0.5	1.3	0	0	0.1	47.7	0	3.1	1.5	1.1	0	0	0	0	0.4	1	0.1	0	0.4	0	1.5	0	0.8	5	6.4	1	0.1	0	0.5	1	Horizontal cells
KLK3	APS, PSA	ENSG00000142515	Kallikrein related peptidase 3	P07288	19	50854915-50860764	Cancer-related genes, Enzymes, Plasma proteins, Predicted secreted proteins		Hydrolase, Protease, Serine protease	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	115	prostate: 447.4	Cell type enriched	Detected in some	62	Glandular cells: 3142.6	Cancer enriched	Detected in some	3905	prostate cancer: 4241.6	Region enriched	Detected in single	8	cerebral cortex: 1.0	Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	138	BEWO: 22.4;NB-4: 18.9;RPMI-8226: 12.5;SH-SY5Y: 7.4;U-2197: 7.6									CAB000070, HPA000764	Enhanced				Secreted in male reproductive system							CAB000070: , HPA000764: AB_1079700	unprognostic (5.06e-3)	unprognostic (5.60e-2)	unprognostic (9.93e-2)	unprognostic (3.90e-2)		unprognostic (1.09e-2)				unprognostic (1.26e-2)	unprognostic (1.88e-2)	unprognostic (1.54e-1)	unprognostic (5.13e-3)	unprognostic (1.94e-1)	unprognostic (4.64e-1)	unprognostic (3.15e-1)		0.1	0.3	0	0.1	0	0	0.7	0	1	0.1	0.1	0	0.2	0.1	0.1	0.5	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	447.4	0	0.1	3.8	1.3	0	0	0.1	0.3	0	0	0	1	0	0.1	0	0	0.1	0.3	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0	22.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.9	0	0	0	0	0	12.5	0	0	0	7.4	0	0	0	0	0	0	0	0	0	7.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0	0	0	0	1	0	0	0	0	0.1	0	0	0	0	50.4	0	0	0.3	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	3142.6	0	0	0	0	0	0	0	0.9	0	0	0	0	5.7	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	32.4	Glandular cells
CELA2A	ELA2A	ENSG00000142615	Chymotrypsin like elastase family member 2A	P08217	1	15456728-15472091	Enzymes, Predicted secreted proteins		Hydrolase, Protease, Serine protease	Diabetes mellitus, Disease mutation, Obesity	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	1559	pancreas: 2376.3	Cell type enriched	Detected in some	19	Exocrine glandular cells: 6761.1	Cancer enriched	Detected in single	3819	pancreatic cancer: 463.9	Not detected	Not detected			Cell type enriched	Detected in single	15	neutrophil: 1.5	Lineage enriched	Detected in single	15	granulocytes: 1.5	Cell line enhanced	Detected in some		HDLM-2: 1.1;HEL: 1.2;HL-60: 1.0;HMC-1: 5.0;K-562: 1.1;U-2 OS: 1.6														Secreted to digestive system								unprognostic (9.78e-2)	unprognostic (3.33e-2)		unprognostic (5.60e-2)	unprognostic (5.27e-2)	unprognostic (3.63e-3)		unprognostic (2.35e-1)	unprognostic (4.14e-1)	unprognostic (1.96e-2)	unprognostic (1.38e-1)	unprognostic (2.48e-1)	unprognostic (3.94e-9)	unprognostic (4.10e-2)		unprognostic (3.42e-1)	unprognostic (3.55e-2)	0.2	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.2	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.8	2376.3	0	0.1	0.1	0.1	0.1	0	0.1	0.2	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	1.5	0	0	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0	0	0.8	0	0	0	0	0	0	1.1	0.7	1.2	0	0	0	1	5	0	0	0	0	0	0	0	1.1	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	1.6	0	0.4	0	0.4	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.5	0	0	0	0	0	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	6.7	0.1	0	0	0	6761.1	0	0	0.1	0	0	0	0	0	0	0	0	0	0.2	0	36.1	0	0	361.1	0	0	0	0	0	0.1	0	0	0	0	0	0	0.1	Exocrine glandular cells
MYOM3	FLJ35961	ENSG00000142661	Myomesin 3	Q5VTT5	1	24056035-24112175	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	7	heart muscle: 59.5;skeletal muscle: 104.6;tongue: 39.7	Cell type enriched	Detected in some	6	Cardiomyocytes: 168.2	Cancer enhanced	Detected in some		renal cancer: 6.8	Not detected	Not detected			Cell type enhanced	Detected in single		neutrophil: 2.3	Low lineage specificity	Detected in single			Group enriched	Detected in some	6	A549: 5.2;Hep G2: 19.8	Not detected	Not detected			Not detected	Not detected			HPA028132, HPA028340			Approved	Golgi apparatus,Vesicles,Cytokinetic bridge		Yes	No		680000	Vesicles	Golgi apparatus, Cytokinetic bridge	HPA028132: AB_10599293, HPA028340: 	unprognostic (8.59e-2)	unprognostic (2.85e-2)	unprognostic (2.39e-1)	unprognostic (8.60e-3)	unprognostic (1.52e-2)	unprognostic (7.31e-2)	unprognostic (3.00e-2)	unprognostic (1.40e-2)	unprognostic (4.66e-1)	unprognostic (2.21e-1)	unprognostic (2.73e-4)	unprognostic (2.09e-1)	prognostic favorable (4.28e-6)	unprognostic (2.77e-2)	unprognostic (1.60e-3)	unprognostic (7.75e-2)	unprognostic (1.68e-1)	1.5	0	0	0	0	0	0.1	0	0.1	0	0.1	0	0	0.3	0.1	6.3	2.7	0.2	0	59.5	0	0	9.7	0	0	0	0	0	0	0.2	0	0	0	0	1.3	0.1	0	2.7	0	104.6	0.4	1.5	0	0	0	0	1.9	0.1	0	2.7	39.7	2.8	0.2	0.1	0.8	0.4	2.3	0.4	0.2	0.4	0	0.1	5.2	0	0.1	0	0	0.5	0	0	0	0	0.6	1.5	0	2.2	0.6	0.2	0.1	0	0	0	0.1	0.1	0.1	0.8	19.8	0	0.1	0.1	0.6	0	0.2	0	0.1	0.1	0.1	0.1	0	0	0	0	0	0.1	0.8	0.4	0	0.2	0	0	0.1	0	0.1	0	0.3	0	0.2	0.2	0.1	1.1	0.2	0.6	0.7	0.1	0.2	0	0	0.4	0	0	0.8	0.4	0.1	0.3	0.4	0.1	0.4	0.2	0.2	0	0.8	0.3	0.4	2.3	0.2	0.3	0.4	0.2	0	0	0	0	0.1	0	0	0	0	0	0.1	0	0	0	0.2	0.6	0	168.2	0	0	0	3.5	0	0	1.7	0.1	15.5	0.1	4.3	0	0.4	0	0	0.2	0	0	0	0	1.2	0	0	6.6	0.6	0	0	0	0	0	1.4	2.9	0	25.9	2.8	6.5	0	0	0	0.5	0	0	0.4	0.3	Cardiomyocytes
FCN3	FCNH, HAKA1	ENSG00000142748	Ficolin 3	O75636	1	27369112-27374824	Disease related genes, Plasma proteins, Predicted secreted proteins	Complement activation lectin pathway, Immunity, Innate immunity			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	5	liver: 83.2;lung: 153.7	Cell type enriched	Detected in many	14	Ito cells: 3886.1	Low cancer specificity	Detected in many			Low region specificity	Detected in single			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		hTCEpi: 2.8;MCF7: 2.2;U-2197: 2.2									CAB025945	Approved				Secreted to blood			22800000000	33000000000			CAB025945: 	unprognostic (1.59e-1)	unprognostic (5.25e-2)	unprognostic (1.55e-2)	unprognostic (8.27e-2)	unprognostic (1.45e-3)	unprognostic (1.27e-2)	unprognostic (1.87e-3)	unprognostic (1.21e-1)	unprognostic (6.28e-4)	unprognostic (7.07e-2)	unprognostic (2.86e-2)	unprognostic (3.23e-2)	unprognostic (3.87e-3)	unprognostic (4.14e-2)	unprognostic (1.02e-1)	unprognostic (6.97e-2)	unprognostic (1.61e-2)	7.2	5	0.1	1.7	0.2	0	21.2	0.1	0.3	0.3	0.6	0.4	0.1	0.2	0.3	0.1	1	0.5	0.5	25	0.4	0	13	83.2	153.7	1	0.1	0.1	0.3	2.3	0.7	2.1	6.7	1.1	0.5	0.2	0.8	0.4	0.2	1	0.3	0.7	0.6	0.2	2.7	0.8	0.5	0.2	0.1	9.1	0.3	0.3	1	0.7	0	0	0	0	0	0.1	0	0.5	1.2	0.8	0	0	0	1.2	1.2	0	0	0	0	0.8	0.4	0.6	0	1	1.1	0	0.4	0	0	0.8	0.8	0	0	0	0.3	0.2	0	2.8	0	0	0.1	0	0	0	0	0	2.2	0	0.4	0	0.3	0	0	0.7	0	0	0	0	0	1.1	0	0	0.7	0.6	0	0	0.4	0.3	2.2	0.2	0.3	0.1	0.5	0.4	0.4	1	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0.1	0.2	0.1	0.3	0.4	0	0.1	0.1	1.1	0.2	0	15.2	66.2	0.3	0.7	0	2	81.5	4	0	0	0	0	0	0.1	1.1	99.1	0	93.5	0	0	0.2	0.4	3.5	6.8	0.3	0	0	3886.1	270.1	2.2	3.1	0.7	0	1	0	0	0	0	0.4	0	0	0	0.9	0.4	0.6	1	0	8.6	0	0.3	Ito cells
CELA3A	ELA3, ELA3A	ENSG00000142789	Chymotrypsin like elastase family member 3A	P09093	1	22001656-22012539	Enzymes, Predicted intracellular proteins, Predicted secreted proteins		Hydrolase, Protease, Serine protease		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	2051	pancreas: 2541.2	Cell type enriched	Detected in some	31	Exocrine glandular cells: 30160.2	Cancer enriched	Detected in some	2497	pancreatic cancer: 1481.6	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	24	MOLT-4: 21.6									HPA028086, HPA045650	Supported		Approved	Cytosol	Secreted to digestive system					Cytosol		HPA028086: AB_2672482, HPA045650: AB_2679407			unprognostic (1.27e-1)	unprognostic (2.71e-1)							unprognostic (1.79e-1)			unprognostic (6.32e-2)	unprognostic (2.67e-1)			0.2	0	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.3	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	1.2	2541.2	0	0.1	0.1	0.1	0.1	0	0.1	0.3	0.1	0.1	0	0.1	0.1	0.1	0.1	0.4	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0.5	0	0.1	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0.7	0	0	0.2	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	21.6	0	0	0	0.2	0	0	0	0.2	0	0	0	0	0.2	0	0.1	0.2	0	0	0	0.9	0	0	0	0.4	0	0	0	0	0	0	0	0.1	0.5	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	11.4	29.3	0	0	0	30160.2	0	0	0	0	0	0	0	0	0	0	85.8	0.3	0	0	164.1	0	0	964.1	0	0	0	0	0	0	0.2	0	0	0	0	0	0	Exocrine glandular cells
HSPG2	perlecan, PRCAN, SJS1	ENSG00000142798	Heparan sulfate proteoglycan 2	P98160	1	21822245-21937297	Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Angiogenesis		Disease mutation	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		smooth muscle: 104.4	Cell type enriched	Detected in many	7	Ito cells: 621.2	Low cancer specificity	Detected in all			Low region specificity	Detected in many			Cell type enriched	Detected in single	12	plasmacytoid DC: 3.0	Lineage enriched	Detected in single	12	dendritic cells: 3.0	Cell line enhanced	Detected in many		EFO-21: 46.8;HUVEC TERT2: 103.4;TIME: 82.5	Low region specificity	Detected in many			Low region specificity	Detected in many			CAB009820, HPA018892, CAB020718, HPA072690	Approved		Approved	Nucleoplasm,Plasma membrane,Cytosol	Secreted to extracellular matrix				1700000000	Nucleoplasm, Plasma membrane, Cytosol		CAB009820: AB_2119229, CAB020718: , HPA018892: AB_1850597, HPA072690: 	unprognostic (1.61e-1)	unprognostic (1.57e-2)	unprognostic (4.93e-2)	unprognostic (9.60e-2)	unprognostic (2.38e-2)	unprognostic (8.56e-2)	unprognostic (4.55e-1)	unprognostic (1.90e-2)	unprognostic (9.35e-2)	unprognostic (2.19e-3)	unprognostic (5.82e-2)	unprognostic (2.83e-1)	unprognostic (1.21e-3)	unprognostic (1.17e-2)	unprognostic (4.86e-2)	unprognostic (1.46e-2)	prognostic unfavorable (2.82e-4)	54.8	12.8	1.1	22.9	1.5	0.2	19.8	0.8	1.5	37.3	32.3	2.4	37.2	6.2	62.8	37.6	32.7	20.6	60	30.2	1.2	1.2	15.7	8.9	12.5	7.8	2.5	1.2	19.8	9.4	4.6	3.4	24.6	3.8	32	2.5	24.6	15.5	22.3	20.8	12.2	13.7	104.4	1.8	16.4	18.9	11.4	0.7	3.4	16.9	20.1	8.5	66.2	28.2	0.2	3	0	0	0	0.2	0	7	6.5	2.2	7.7	22.6	17.2	8.6	10.7	2.7	3.1	2.8	7.9	14.5	0.5	46.8	16.5	0.1	4.4	0.5	5.2	0.7	0.1	0.7	2.4	7	5.7	4.7	0	0.6	10.4	1.6	3.2	0.9	4.7	103.4	0	3.1	0.9	4.2	1.9	0	3.2	1.9	3.2	2.9	1	9.2	0.9	6	0.9	0.2	0.6	8.1	3.4	4.7	2	1.3	1.2	82.5	6.1	8	4.7	0.3	0	1	0.4	1.6	0	9.1	0	0	0	0	0	0	0.2	0	0	0.1	0.1	0.2	0.1	0	0	0	3	0	0	1.1	1.5	0.8	1.5	1.2	1.2	2.5	1.2	3.8	0.7	65.5	28.7	5.2	10.9	23.5	0.7	4.5	40.8	1.4	12.5	87.2	0	9.4	0	63.1	1	75	34.2	0	21.9	85.1	58.4	6.6	22	2.8	6.1	3.2	2.4	621.2	31.6	2.2	69.6	3.5	57.3	2.8	12.8	1.4	55.1	20.7	65	0.5	0.5	32.3	38.8	0.4	4.1	15.6	7.8	6.4	13.9	8.3	Ito cells
BEST4	VMD2L2	ENSG00000142959	Bestrophin 4	Q8NFU0	1	44783585-44787705	Predicted membrane proteins	Ion transport, Transport	Chloride channel, Ion channel		Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	5	intestine: 34.3	Cell type enriched	Detected in some	35	Paneth cells: 745.7	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		Hep G2: 7.4;U-698: 5.3					Low region specificity	Detected in all			HPA058564	Uncertain											HPA058564: AB_2683759	unprognostic (5.76e-2)	unprognostic (1.22e-1)	unprognostic (3.15e-2)	unprognostic (6.20e-2)	unprognostic (6.51e-3)	unprognostic (1.09e-1)	unprognostic (8.39e-2)	unprognostic (1.45e-3)	unprognostic (1.04e-1)	unprognostic (8.97e-2)	unprognostic (5.72e-2)	unprognostic (1.29e-1)	unprognostic (2.69e-5)	unprognostic (1.43e-1)	unprognostic (3.72e-1)	unprognostic (1.28e-1)	unprognostic (4.13e-3)	0.5	1.1	0.6	1.4	2.5	0.4	0.5	2.1	0.7	1.2	32.7	0.5	0.5	8.8	0.7	2.6	0.5	7.2	0.5	0.5	1	3.2	0.5	0.5	1.1	0.5	0.5	0.5	0.5	0.5	0.4	1.8	0.5	0.5	0.5	15.9	0.5	0.5	0.5	0.5	1.8	34.3	0.5	0.5	0.5	0.2	0.5	0.5	0.5	0.5	0.5	0.5	0.5	0.5	3	0.9	0.7	0.1	0.9	2.8	0.4	0.2	0.6	1.1	1.2	0.4	0.4	3.5	0.8	0.4	0.3	0.1	0.4	1.5	0.3	1.5	0.4	0.8	1.6	0.3	0.2	0.4	0.8	0.7	0.2	1.9	7.4	0.4	0	0.9	0.7	0.9	0.4	0.7	1.8	1	1.3	0.2	0.6	0.2	0.2	0	0.5	2.4	0.2	0.2	0.4	0.3	0.7	0.5	0.1	2.5	0.9	0.3	0.2	0.3	0.8	1.2	0.1	1.7	0.5	0.5	0.5	0.5	1.2	0.3	5.3	1.2	0.3	0.2	0.1	0.1	0.5	1.1	0.1	2.7	3	1.9	2.8	0	2	1	1.8	0.7	0.9	0	0.9	2.2	0.4	0.6	2.5	2.1	0.7	1	3.2	0.5	0.5	0.5	0.5	0	0	0.8	0.7	0.2	0.7	0.4	0	21.4	3.4	5.2	0	0.3	1.7	0.5	0	0.3	15.8	0	0.7	0.1	0.2	0.4	0	0	0.2	0	2.4	0	0	0	0.9	0.3	0	0	3.4	1	0.4	745.7	0.4	0.6	0.1	0	0.3	0.5	0.7	0.5	0.2	1.3	5	0.4	Paneth cells
BARHL2		ENSG00000143032	BarH like homeobox 2	Q9NY43	1	90711539-90717237	Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	DNA-binding		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in some	4	brain: 29.3	Cell type enriched	Detected in some	5	Horizontal cells: 22.3	Not detected	Not detected			Region enriched	Detected in single	42	cerebellum: 29.3	Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HAP1: 2.5;HEK 293: 8.9;HEL: 1.3;HMC-1: 2.5;JURKAT: 1.5	Region enriched	Detected in some	5	cerebellum: 14.5	Region enriched	Detected in many	20	cerebellum: 48.3																		unprognostic (1.83e-1)				unprognostic (1.73e-1)	unprognostic (6.80e-2)				unprognostic (3.10e-1)	unprognostic (1.60e-1)			0	0	0	0	0	0	0	29.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	1.4	0	0	0	0	0.4	0	0	0	0	0	0	0.2	0	0	7.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.5	0	0	0	8.9	1.3	0	0	0	0	2.5	0	0	0	0	0	0	1.5	0.1	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0.8	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	29.3	0	0	0.7	0	0	0	0	0	0	0	0	0	0.6	0.2	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	22.3	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0.6	0	0	4.1	3.6	0	0	0	0	0	Horizontal cells
GPR161	RE2	ENSG00000143147	G protein-coupled receptor 161	Q8N6U8	1	168079543-168137667	G-protein coupled receptors, Predicted membrane proteins, Transporters		Developmental protein, G-protein coupled receptor, Receptor, Transducer		Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		endometrium 1: 27.1;smooth muscle: 21.0	Cell type enriched	Detected in many	8	Horizontal cells: 149.4	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		CACO-2: 24.0	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA015576, HPA072047	Uncertain		Approved	Nucleoplasm,Nucleoli		Yes	No			Nucleoplasm	Nucleoli	HPA015576: AB_1849283, HPA072047: AB_2686484	unprognostic (1.45e-1)	unprognostic (3.78e-2)	unprognostic (2.68e-2)	unprognostic (1.58e-3)	unprognostic (1.87e-1)	unprognostic (6.84e-2)	unprognostic (3.24e-3)	unprognostic (1.48e-1)	unprognostic (1.19e-1)	unprognostic (5.04e-2)	unprognostic (5.45e-2)	unprognostic (1.31e-2)	unprognostic (5.57e-6)	unprognostic (3.93e-2)	unprognostic (1.84e-2)	unprognostic (1.03e-2)	unprognostic (6.34e-2)	2.4	0.9	2.1	3.6	1.7	0	1.9	1.2	4	7.3	4.9	3.1	8.5	0.8	27.1	8.2	7.4	7.7	5.6	2.4	2.8	1.5	1.1	0.4	2.8	0.4	3	1.2	7.6	11	4.9	1.3	1.3	3	8.2	2.3	3.4	2.3	9.4	0.8	1.5	2.1	21	3	1.2	2.2	3	0.8	1.4	1.2	1.7	0.7	2.8	6.8	0.3	1.2	1.5	0.5	0.2	0.3	0.2	6.1	3.8	15.5	9.9	3.7	6.6	0	5.9	6.5	5.1	5.4	24	1	0	3.3	8.9	9.6	18.4	3.7	5.8	3	2.3	4.8	2.2	3	0.1	1.6	0.6	1.5	2.3	3.8	4.4	7.1	11.9	10.2	1.9	2	0.1	7.7	0.5	0.7	0.1	6.3	10.3	6	1.8	6.7	0	2.7	1.7	3.1	13.7	6.5	0.2	17.8	6.1	3.4	0.7	13.7	10.5	5.5	14.1	6.7	0	0	0	2.8	0	2.7	1.5	0.3	0.2	0.1	0.3	0.1	0.1	0.1	0	1.2	0.3	0.1	0.3	1.3	0.2	0.5	0.3	0	0.2	2.1	1.7	1.2	4	2.8	1.5	3	1.2	3	0.8	3	0.6	0	5	1.9	1.7	2	0	1.4	1.2	0	0	0.4	0	3.6	0.4	6.3	0	0	7.2	0.2	6.3	4.6	0	0	0.7	149.4	0	4.3	1.8	0.6	6.9	1.3	1.7	1.8	1.7	2.7	2.9	0	15.9	0	1.5	19.4	12.2	0	0.7	1.3	0.3	0	2.3	2.3	Horizontal cells
ILDR2	C1orf32	ENSG00000143195	Immunoglobulin like domain containing receptor 2	Q71H61	1	166895711-166975482	Predicted intracellular proteins, Predicted membrane proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 14.6;testis: 18.0	Cell type enriched	Detected in some	8	Muller glia cells: 116.0	Cancer enhanced	Detected in some		glioma: 4.3	Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		AF22: 9.7;JURKAT: 7.4;MOLT-4: 5.1;U-2 OS: 12.5;U-251 MG: 6.6	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA012545, HPA012815	Uncertain		Approved	Plasma membrane						Plasma membrane		HPA012545: AB_2126894, HPA012815: 	unprognostic (9.14e-2)	unprognostic (5.05e-2)	unprognostic (8.27e-2)	unprognostic (2.16e-1)	unprognostic (5.89e-2)	unprognostic (5.33e-2)	unprognostic (2.89e-5)	unprognostic (2.09e-1)	unprognostic (8.55e-2)	unprognostic (4.51e-2)	unprognostic (1.52e-1)	unprognostic (2.58e-1)	unprognostic (9.17e-2)	unprognostic (5.87e-3)	unprognostic (4.92e-2)	unprognostic (1.64e-1)	unprognostic (1.36e-1)	0.8	1.1	9.8	0.9	6.4	1.4	0.5	2.1	14.6	0.7	2.9	3.6	0.1	0.7	0.9	1.4	0.9	0.8	1.3	3.1	7.2	7.7	6.3	1.3	1.4	1	2.7	8	0.8	0.7	0.5	3.3	0.8	3.1	2.3	1.2	2.8	0.8	2.8	0.8	0.7	0.8	2	2.3	0.7	0.7	18	3.1	1.9	0.9	0	1.1	0.9	0.3	0	0.4	0.3	0	0	0.3	0.5	0	0	9.7	0	0	0	0.3	0	0	0	0	1.2	1	1.8	0.3	0	0.4	0	0	0	0	2.2	1.9	0	0	0.2	0	3.1	0.7	0	0	0	0	0	0	7.4	0	0.1	0.2	0	5.1	0	3.3	0.1	0	0	0.3	0.7	0.7	0.2	1.3	0	0	0	0	1	0	0.9	0	0	12.5	0	6.6	2.3	0	0.5	1.4	1.3	0.4	0.2	0	0	0	0	0	0	0	0.1	0.4	0	0.3	0	0.3	0	0	0.1	0	0.5	9.8	6.4	2.1	11.4	7.2	7.7	2.7	8	3.1	3.1	0	0	0	0	0	3.9	3.2	0	0	1.2	0	5.9	0	0	0	9.4	0	0	0	0.2	0.1	0	0	0	1.1	0.1	1.6	1.2	0	0	13.8	0.6	0	0	1	0	116	0.1	0	0	4.6	6.5	0	0.1	3.3	1.3	0	0.2	0	0.2	0	Muller glia cells
NECTIN4	LNIR, nectin-4, PRR4, PVRL4	ENSG00000143217	Nectin cell adhesion molecule 4	Q96NY8	1	161070995-161089599	Disease related genes, Predicted membrane proteins, Predicted secreted proteins	Cell adhesion, Host-virus interaction	Host cell receptor for virus entry, Receptor	Disease mutation, Ectodermal dysplasia	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		esophagus: 40.1;placenta: 46.6;skin 1: 39.3	Cell type enriched	Detected in some	7	Syncytiotrophoblasts: 321.3	Low cancer specificity	Detected in many			Not detected	Not detected			Group enriched	Detected in some	7	basophil: 1.5;eosinophil: 1.2;neutrophil: 3.6	Lineage enriched	Detected in single	12	granulocytes: 3.6	Cell line enhanced	Detected in some		BEWO: 28.2;HaCaT: 18.2;MCF7: 11.4;OE19: 11.8;SK-BR-3: 23.7;T-47d: 15.3	Low region specificity	Detected in all			Not detected	Not detected			HPA010775	Enhanced		Supported	Plasma membrane	Secreted in other tissues	No	No		11000	Plasma membrane		HPA010775: AB_1079720	unprognostic (1.09e-3)	unprognostic (1.52e-1)	unprognostic (3.51e-1)	unprognostic (1.11e-2)	unprognostic (5.69e-3)	unprognostic (2.09e-2)	unprognostic (6.69e-3)	unprognostic (1.02e-1)	unprognostic (1.69e-1)	unprognostic (1.18e-1)	unprognostic (6.49e-3)	unprognostic (1.13e-1)	unprognostic (2.24e-8)	unprognostic (2.98e-2)	unprognostic (2.43e-1)	unprognostic (3.68e-2)	unprognostic (4.97e-2)	0.2	0.1	0.1	0.8	0.1	0.1	7.7	0.1	0.1	9.8	0.6	0.1	5.4	0.2	1.5	3.7	40.1	1.4	5.6	0.1	0.1	0.1	1.3	0.2	3.1	0	0.1	0	0.5	4.4	0	0.3	46.6	0.1	7.8	0.7	0.1	13.5	5.5	0.1	39.3	0.4	2	0.1	0.1	4.5	0.2	0	0.5	0.1	22.7	23.1	12.6	18.5	0.2	0.3	3.6	0.1	0.1	0.2	0	5.2	0.1	0	0	0	0	28.2	0	0	0	0.1	0	7.1	0	0.1	0	0	18.2	0	0.6	0.1	0	0.2	0	0.4	5.3	0	0	0.3	0	7.2	1.5	1.8	0	0	0	0	0	0	11.4	0	0	0	11.8	0	0	0	0	0	8.5	0	0.1	0.1	23.7	0	3.3	15.3	0	0	0	1.2	0.2	0.1	0.1	0	0	0	0	0.1	1.5	0.1	1.2	0.2	0	0.1	0.2	0.2	0	0.3	0.2	0.1	0.1	3.6	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0	6	8.1	0	0	0	0	0	0	18.7	14.8	15.7	0	24.1	0	34.7	0	0	0	0	26.2	43.5	0	0	0	0	5.7	0	0	0	0	0	0	0.6	0	1.8	0	0	47.9	0	0	0	0	0	0	0	0	0	321.3	0	0	0	Syncytiotrophoblasts
NUF2	CDCA1, CT106, NUF2R	ENSG00000143228	NUF2, NDC80 kinetochore complex component	Q9BZD4	1	163266576-163355764	Plasma proteins, Predicted intracellular proteins	Cell cycle, Cell division, Mitosis			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		lymphoid tissue: 38.6;testis: 29.0	Cell type enriched	Detected in many	5	Spermatocytes: 232.2	Low cancer specificity	Detected in many			Not detected	Not detected			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Low cell line specificity	Detected in many			Low region specificity	Detected in all			Low region specificity	Detected in many			HPA059692, HPA076604			Supported	Nucleoplasm,Kinetochore,Cytosol		Yes	Yes			Nucleoplasm	Kinetochore, Cytosol	HPA059692: AB_2684103, HPA076604: 	unprognostic (9.41e-2)	unprognostic (2.61e-1)	unprognostic (2.56e-1)	unprognostic (5.32e-3)	unprognostic (6.20e-2)	unprognostic (3.77e-2)	prognostic unfavorable (1.04e-5)	prognostic unfavorable (9.16e-4)	prognostic unfavorable (4.83e-4)	unprognostic (8.45e-2)	prognostic unfavorable (9.75e-4)	unprognostic (3.70e-2)	unprognostic (0.00e+0)	unprognostic (9.79e-2)	unprognostic (7.88e-2)	unprognostic (2.69e-1)	unprognostic (5.96e-2)	1.3	0.9	0.8	9.8	0.9	14.1	0.6	0.5	0.9	1.4	2.5	0.6	0.9	2.3	0.6	2.1	6.1	0.5	0.7	1.5	0.8	0.6	0.7	0.6	1.9	9.9	0.8	0.6	0.7	0.4	0.3	0.4	3.6	0.7	0.6	2.9	0.8	1.3	0	0.5	2.2	3.2	1	1.4	4.4	1.6	29	0.3	38.6	0.5	5.1	9.2	1.5	1.8	1.4	0.6	2.6	0.2	3	7.7	1	26.3	9.2	24.5	10.2	0.7	2.5	13.3	16.7	11.8	27.2	23.9	7	23.3	22.7	14	6.7	11.3	15.5	14.9	6.3	34.5	23.7	10.7	8.9	10.6	10	0	15.3	18.4	0.3	0.6	13.7	9.7	5.1	12.3	22.3	16.7	31.5	25.7	5.1	27.9	20.6	13.3	19.4	14.2	19	21.4	20.1	7.7	3.6	18.3	21.1	8.9	9.7	9.2	15.9	14.9	32.1	8.7	20.3	22.8	15.2	33.6	22.6	31.8	43.3	6.7	12.6	22.4	2.6	0.2	2.5	2.4	0.1	1	1.2	3.6	2.4	0.5	1.4	2.5	2.1	0.9	3	0.2	0.6	7.7	1	0.8	0.9	0.5	0.9	0.8	0.6	0.8	0.6	0.7	0.3	0	0.3	3.7	1.8	5.3	1	0.8	0	0	4.5	0	0	2.7	0	0.7	15.8	0.1	0.8	46.7	0.2	23.9	1.8	0.4	4.6	0.2	11.3	0	0	1.8	3.7	10.7	2.3	2.5	0	1	0.9	2.5	0.2	0	2.1	0	2	6.5	0.5	232.2	40.5	2	3.3	3.8	2.2	1.4	Spermatocytes
RGS5		ENSG00000143248	Regulator of G protein signaling 5	O15539	1	163111121-163321791	Predicted intracellular proteins		Signal transduction inhibitor		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in many			Cell type enriched	Detected in many	8	Sertoli cells: 5031.8	Cancer enhanced	Detected in all		renal cancer: 226.3	Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Group enriched	Detected in some	4	HUVEC TERT2: 92.7;SH-SY5Y: 307.8	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA001821		Supported										HPA001821: AB_1079806	unprognostic (3.75e-1)	unprognostic (3.93e-3)	unprognostic (2.31e-1)	unprognostic (6.91e-2)	unprognostic (2.50e-2)	unprognostic (1.32e-3)	unprognostic (1.65e-2)	unprognostic (7.38e-2)	unprognostic (3.54e-3)	unprognostic (2.19e-1)	unprognostic (1.53e-2)	unprognostic (1.48e-1)	prognostic unfavorable (9.17e-4)	unprognostic (3.81e-3)	unprognostic (7.05e-2)	unprognostic (6.08e-2)	unprognostic (1.41e-1)	38.3	96.6	23.8	16.1	42.1	0.5	18.4	11.9	28.6	62.6	28.5	11.6	20.8	19.5	23.3	19.8	28.1	22.7	43.5	67.8	28.3	22	32.4	10.3	24.9	9.2	37.9	20.8	15.5	9.3	19.5	18.3	6.3	41.7	34.4	13.8	59.3	8.8	59.9	37.1	6.8	48.6	83.1	19.7	5.7	27.3	13.4	20.8	4.1	53.6	35	11.7	77.5	20.7	2.2	0.4	0.5	0.5	0.6	2.3	0.5	0	0	4.5	0.5	0	0.2	0.1	0	0.3	0.1	0.1	0.3	0.1	0	0.6	0	0	0	0	0	0.2	0.2	0	0	0	0	0.1	0	0	0.1	0.1	0.1	0.1	1	92.7	0	0	0	0.3	0	0	0.1	2.7	48.3	0.1	0	0	0.2	0	0	0.3	307.8	0	0	0.1	14.1	0	0	0.3	0.1	0.1	0	0.1	0.1	0	0	0.1	0	0.2	0	0.2	0	0.4	0.4	2.3	2.2	2.1	1	0.4	1.2	2.1	2	0.5	0.6	0.5	0.2	1.1	0.5	23.8	42.1	11.9	28.6	28.3	22	37.9	20.8	41.7	20.8	3	9.3	0	5	15.1	0.7	0	0	8.1	12.5	1.8	3.9	1.1	1.7	0.8	16	24.8	0	0	1	0.7	13.7	10.9	1.1	0	1	0	0	0	0	12.4	6.4	10.2	21.9	1	0.2	2.4	2.4	0	2.5	1.9	4.6	5031.8	595	4.1	1.8	11	1	0.5	0.2	5.7	Sertoli cells
NR1I3	CAR, CAR1, MB67	ENSG00000143257	Nuclear receptor subfamily 1 group I member 3	Q14994	1	161229666-161238302	Nuclear receptors, Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	Activator, DNA-binding, Receptor		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in some	18	liver: 63.1	Cell type enriched	Detected in many	4	Hepatocytes: 124.3	Cancer enriched	Detected in single	67	liver cancer: 17.6	Region enriched	Detected in single	6	basal ganglia: 1.9	Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in many		CACO-2: 9.4	Not detected	Not detected			Low region specificity	Detected in single			HPA051365			Approved	Nucleoplasm						Nucleoplasm		HPA051365: AB_2616454	unprognostic (2.59e-3)	unprognostic (1.06e-2)	unprognostic (9.33e-2)	unprognostic (6.92e-4)	unprognostic (2.55e-1)	unprognostic (1.88e-2)	unprognostic (1.91e-2)	unprognostic (5.51e-2)	unprognostic (8.69e-2)	unprognostic (1.85e-1)	unprognostic (6.23e-2)	unprognostic (5.63e-3)	unprognostic (2.71e-1)	unprognostic (5.79e-2)	unprognostic (6.44e-2)	unprognostic (5.48e-3)	unprognostic (2.62e-2)	0.1	0	0.2	0.1	1.9	0.1	0.1	0.1	0.2	0.1	0.7	0.1	0.1	0.9	0.1	0.1	0.1	0	0.1	0.1	0.2	0.1	3.5	63.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0.5	0.1	0.1	0.1	0	0.1	0.1	0.1	0.5	0.3	2.3	0.1	0.1	0.1	0	0.2	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0	0.2	0.7	0.3	0	0.6	0.3	0.3	0.9	1.1	0.6	0	0	0.9	0.4	0	0	0	9.4	0.3	1	0.6	0	0.3	0.6	0	0	0	1	0.9	0	0.2	2.2	0	1.7	1.7	0	0	0	0	0.6	0	0.9	1.2	0.4	0	0.8	0.3	0.6	1.7	1.8	1.3	0.9	0.8	0.6	0	1.8	2.3	1.4	0.3	2.9	0.4	1.4	2.1	1.2	2.2	0.7	0.7	1.5	0.2	1.5	2.2	1.3	0.5	2.9	0.5	0.7	0.2	0	0.6	0.3	0	0	0.1	0	0.2	0	0	0.4	0	0	0	0.2	0	0.3	0.2	1.9	0.1	0.2	0.2	0.1	0.1	0.1	0.1	0.3	20.8	16	2.2	1.1	0.6	0.7	0.3	2.5	8.1	9.1	3.5	0	0.1	3.3	0.1	1.7	0.3	0	0	0	0.1	0.4	0.4	12.7	124.3	0.3	0	0	3.1	5.3	1.2	0.3	0.6	0	0	0	0.3	0.1	0	0.4	28.7	1.7	0	0.4	0.2	0	0	0	0.5	0	0.8	Hepatocytes
F13B	FXIIIB	ENSG00000143278	Coagulation factor XIII B chain	P05160	1	197039191-197067267	Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins	Blood coagulation, Hemostasis		Cancer-related genes, Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	95	liver: 76.3	Cell type enriched	Detected in some	19	Hepatocytes: 49.0	Cancer enriched	Detected in single	816	liver cancer: 46.3	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		A549: 1.8;Hep G2: 2.3	Not detected	Not detected			Low region specificity	Detected in all			HPA003827, HPA052139	Supported				Secreted to blood				3400000000			HPA003827: AB_1078794, HPA052139: AB_2681744					unprognostic (1.46e-1)		prognostic favorable (6.78e-5)							unprognostic (1.21e-2)				0	0	0	0	0	0	0	0	0	0	0.5	0	0	0.3	0	0	0	0	0.2	0	0	0	0	76.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.8	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.8	0.1	0	0	0	0.2	0	0	0	0	0	0	0.3	0	0	0	0.1	0.1	0	0	0	0	0	0.3	2.3	0	0.5	0.1	0	0.1	0	0	0	0	0.1	0.2	0.1	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0.5	0	0.1	0	0.1	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	2.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	49	0	0	0	0	1.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	Hepatocytes
OAZ3		ENSG00000143450	Ornithine decarboxylase antizyme 3	Q9UMX2	1	151762899-151771334	Predicted intracellular proteins	Polyamine biosynthesis			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	20	testis: 102.2	Cell type enriched	Detected in many	4	Late spermatids: 9340.9	Low cancer specificity	Detected in many			Not detected	Not detected			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low cell line specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			HPA030136, HPA045808			Enhanced	Nucleoplasm						Nucleoplasm		HPA030136: AB_2673331, HPA045808: 	unprognostic (2.12e-1)	unprognostic (3.86e-1)	unprognostic (1.53e-1)	unprognostic (5.44e-3)	unprognostic (1.71e-1)	unprognostic (1.01e-2)	unprognostic (1.48e-3)	unprognostic (1.08e-1)	unprognostic (1.73e-2)	unprognostic (1.01e-4)	unprognostic (1.57e-2)	unprognostic (2.89e-1)	unprognostic (8.05e-6)	unprognostic (3.94e-2)	unprognostic (1.32e-1)	unprognostic (2.50e-2)	unprognostic (8.36e-2)	0.4	0.3	0.5	0.7	0.5	0	0.6	0.6	0.6	0.3	0.4	0.4	0.7	0.1	0.3	2	0.4	0.2	0.3	0.6	0.5	0.5	0.5	0.8	0.6	0.8	0.5	0.5	0.3	0.6	1.4	0.6	0.3	0.4	4	0.5	0.3	3.1	0.7	1	0.3	0.3	0.5	0.6	0.6	0.2	102.2	0.2	0.3	0.8	0.7	0.4	0.4	0.6	1.4	3.2	2.2	5	2.6	2.4	1.6	1.2	2.3	1.4	3.3	1.1	3.3	2.9	2.3	0.6	2.2	1	1.3	3.1	1	2	0.7	1.6	1.2	1.3	2.3	0.7	7.3	6.9	1.1	4.4	1.8	1.3	0.6	1.3	5.1	1.4	2.6	3.5	1.4	3.4	3	1.4	3.7	2.3	9.7	0.9	1.6	3.3	4.6	2.5	0.4	1.1	1.7	0.4	2.9	1.5	3.6	1	5.2	4.6	3.2	10.4	2.7	3	1.3	0.7	2.6	1.3	5.1	9.5	2.6	1.7	1.6	3.5	2.2	3	0.6	1.4	1.5	1.3	1.4	1.3	2.4	3.2	1.2	1.5	2.2	2.1	2.6	5	1.3	2.2	1.6	0.5	0.5	0.6	0.4	0.5	0.5	0.5	0.5	0.4	0.2	0	1.7	0	2.1	0.7	0.6	1.2	0	2.7	1.2	0	2	1.4	1.7	1.8	2210.4	2.7	3	0	2.7	2.3	1.1	27.3	1.1	2.6	4	0	3.5	1.8	4	9340.9	42.6	1.1	1.7	2.8	7.2	1.6	2.5	4.2	40	2.8	1.6	0	0.8	57.9	27.9	0.5	1.3	0	1.8	3.1	Late spermatids
HORMAD1	CT46, DKFZP434A1315	ENSG00000143452	HORMA domain containing 1	Q86X24	1	150698060-150720888	Predicted intracellular proteins	Differentiation, Meiosis, Oogenesis, Spermatogenesis			Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	18	testis: 78.1	Cell type enriched	Detected in some	6	Spermatocytes: 709.1	Cancer enhanced	Detected in many		testis cancer: 6.9	Not detected	Not detected			Group enriched	Detected in some	4	classical monocyte: 1.2;neutrophil: 4.4	Group enriched	Detected in many	4	granulocytes: 4.4;monocytes: 1.2	Cell line enhanced	Detected in some		A549: 5.7;HeLa: 4.5;hTCEpi: 19.4;SiHa: 5.9;SuSa: 6.8;THP-1: 11.2;U-2 OS: 3.8	Not detected	Not detected			Low region specificity	Detected in many			HPA028346, HPA037850	Enhanced		Approved	Nucleoplasm,Nucleoli		Yes	No			Nucleoplasm	Nucleoli	HPA028346: AB_2672564, HPA037850: AB_10696358	unprognostic (7.21e-2)	unprognostic (7.88e-2)	unprognostic (1.05e-1)	unprognostic (8.15e-2)	unprognostic (9.06e-2)	unprognostic (3.91e-3)	unprognostic (4.08e-2)	unprognostic (1.76e-1)	unprognostic (1.50e-1)	unprognostic (1.72e-1)	unprognostic (1.56e-2)	unprognostic (5.17e-3)	unprognostic (3.79e-9)	unprognostic (3.32e-2)	unprognostic (1.18e-1)	unprognostic (1.27e-1)	unprognostic (3.49e-2)	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.4	1.8	0	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.1	0.2	0.1	0.1	3.2	0.1	0.1	0.1	0.4	0	78.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.2	0.6	4.4	1.2	0	0.2	0.1	0	5.7	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0.1	2.5	0	0	0	0.1	0	0.1	4.5	0	0	0	0.1	0	19.4	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0.1	0	0	0	5.9	0	0.1	6.8	0	11.2	0	0	3.8	0	0	0	0	0.2	0	0	0.5	0	1.2	0.3	0.2	0.4	0	0.2	0.1	0	0.6	0.1	0	0	4.4	0	0.5	0.3	0	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	0	0	4.7	0	0	0	0	0	0	0	3	0	0	54.2	0.1	0	0	0	1.7	0.5	0	0	0	0.7	0	0	0.6	0.6	22.1	4.9	0.3	0	0	0	0	0	0	4.6	0	0	32.3	0.1	709.1	118.4	8.2	1.8	0	0	0	Spermatocytes
DYRK3	hYAK3-2, RED, REDK	ENSG00000143479	Dual specificity tyrosine phosphorylation regulated kinase 3	O43781	1	206635536-206684419	Enzymes, Predicted intracellular proteins	Cell cycle, Cell division, Mitosis	Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		testis: 38.2	Cell type enriched	Detected in many	6	Early spermatids: 160.9	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enriched	Detected in single	15	plasmacytoid DC: 6.1	Lineage enriched	Detected in single	15	dendritic cells: 6.1	Cell line enhanced	Detected in many		hTERT-HME1: 35.7	Low region specificity	Detected in all			Low region specificity	Detected in many			HPA075041			Supported	Nucleoplasm,Cytosol						Nucleoplasm	Cytosol	HPA075041: AB_2686730	unprognostic (6.51e-2)	unprognostic (1.24e-2)	unprognostic (3.36e-2)	unprognostic (2.03e-1)	unprognostic (2.81e-2)	unprognostic (1.23e-1)	unprognostic (1.20e-4)	unprognostic (2.69e-1)	unprognostic (3.91e-1)	unprognostic (2.71e-1)	unprognostic (2.79e-3)	unprognostic (2.52e-1)	prognostic unfavorable (9.41e-7)	unprognostic (2.38e-1)	unprognostic (2.04e-1)	unprognostic (1.99e-2)	unprognostic (7.62e-3)	7.1	2.7	4.2	4.2	3.5	6.2	7.7	1.3	2.7	5.6	2.7	2.6	3.7	1.2	7.6	5.1	2.7	6.2	12.8	16.3	6	3.4	3.4	7.4	5	1.6	2.6	2	7.6	5.2	2.8	11.2	1.2	4.6	4.5	1.5	4.1	5.5	3	2.1	2	2.1	7.5	2.7	1.8	3.7	38.2	3.1	5.1	11.9	3	1.7	5.4	7.6	0	6.1	0	0.1	0	0.3	0	2.5	3.5	0.8	4.9	8.7	7.8	0.1	8.2	18.1	7.5	9.7	0.2	1.3	3.7	1.2	9.6	13.2	0.7	4.2	6.6	8	0	2.8	5.4	4.4	0.8	13.8	3.7	3.5	5.5	4.3	12.9	35.7	7.7	5.8	5.7	10.4	0.7	11.5	0.9	8.2	2.1	6.9	0.2	6.5	20.4	2.6	0	2.4	0.1	5	3.7	7.3	0.3	10	1	0.9	0.9	4.3	15.7	5.9	7.6	6.8	2.9	1.1	4.4	9.3	4.1	1.4	0	0	0	0	0.1	0	0	0.3	0	0	0	0	0	0	0	0	6.1	0	0	4.2	3.5	1.3	2.7	6	3.4	2.6	2	4.6	3.1	3	5.1	0.5	10.3	5.8	0.1	10.3	2.5	13.4	5.7	1.8	9.8	0	0	3	160.9	4.2	0	0	1.9	0.1	7.3	3.2	0	1.1	0.9	0	2.4	2.5	1.5	27.7	3.7	1.9	8.5	1.8	0.3	3	1.4	0	1.8	1	7.4	6.5	10.3	17.6	3.4	3.1	0.3	0	0.2	3.5	Early spermatids
FLG2	IFPS	ENSG00000143520	Filaggrin family member 2	Q5D862	1	152348735-152360006	Plasma proteins, Predicted intracellular proteins			Disease mutation	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	5	skin 1: 107.4	Cell type enriched	Detected in some	11	Suprabasal keratinocytes: 21.1	Cancer enriched	Detected in some	8	melanoma: 7.6	Not detected	Not detected			Cell type enhanced	Detected in single		basophil: 1.2	Low lineage specificity	Detected in single			Cell line enhanced	Detected in single		HaCaT: 1.7					Not detected	Not detected			HPA028699	Approved								19000000			HPA028699: AB_10601905		unprognostic (2.58e-1)				unprognostic (2.33e-1)		unprognostic (3.08e-1)	unprognostic (6.85e-2)	unprognostic (6.59e-3)	unprognostic (1.34e-1)	unprognostic (2.25e-1)	unprognostic (1.09e-1)	unprognostic (2.08e-2)	unprognostic (1.12e-1)	unprognostic (1.96e-1)		0.1	0	0.1	0.1	0.1	0	7.7	0.1	0.1	0.1	0.1	0.1	0.1	0	0.6	0.1	0.2	0	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.8	0.1	0.1	0	0.1	0.1	0.1	0.3	107.4	0.1	0.1	0.1	0.1	0	0.1	0.1	2.9	0.1	19.6	0.4	0.1	0.2	0.3	0.3	1.2	0.2	0.3	0.3	0	0	0.1	0	0	0	0	0.2	0	0	0	0	0.3	0.1	0.1	0	0	0	1.7	0	0	0	0.2	0	0.7	0.2	0.1	0	0	0.2	0	0.4	0	0	0	0	0.2	0	0.3	0	0.1	0	0.2	0.4	0.1	0	0	0	0	0.1	0	0	0	0	0	0.2	0	0.2	0	0.1	0.3	0.3	0	0.1	0.4	0	0	0	0	0.1	1.2	0.2	0.1	0.1	0	0	0.2	0.1	0.1	0	0.3	0.2	0.3	0.9	0.3	0.1	0.3	0.1	0	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	0	0.3	0.8	0.4	0.4	0	0	0	0	2	0	0	0	0.4	0	0	0	0	0	0.3	0.1	1.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	1.4	0	0	0	0.2	21.1	0	0	0	0.3	Suprabasal keratinocytes
CRNN	C1orf10, SEP53	ENSG00000143536	Cornulin	Q9UBG3	1	152409243-152414263	Predicted intracellular proteins			Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		esophagus: 459.6;lymphoid tissue: 187.9;tongue: 139.6	Cell type enriched	Detected in single	6	Late spermatids: 2.2	Group enriched	Detected in many	18	cervical cancer: 19.3;head and neck cancer: 74.0;stomach cancer: 22.9	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		Daudi: 2.9;HaCaT: 1.1;HL-60: 1.2;hTCEpi: 1.0;K-562: 2.1;TIME: 1.2;U-266/84: 1.1;U-698: 1.5;U-937: 1.8	Not detected	Not detected			Low region specificity	Detected in many			HPA024343, CAB026182	Enhanced								36000			CAB026182: , HPA024343: AB_1847162		unprognostic (1.96e-2)		unprognostic (1.74e-6)		unprognostic (4.20e-2)			unprognostic (3.43e-1)	unprognostic (6.43e-3)								0.2	0.2	0	0.2	0	0.2	0.2	0	0.2	57.1	0.2	0	0	0.2	6.2	0.2	459.6	0.2	0.3	0.3	0	0	0.2	0.2	0.2	0.2	0	0	0.2	0.2	0.2	0	0.2	0	0.2	0.2	0	49.6	0.2	0.2	0.6	0.2	0.2	0	0.2	0.2	0.2	0	0	0.2	139.6	187.9	0.3	81.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.9	0	0	0	1.1	0	0	0	0	0	0.9	0	0	0	1.2	0	0	1	0	0	0	0	0	2.1	0	0	0	0	0	0.4	0	0	0	0.6	0	0	0	0	0	0.1	0	0	0	0	0	1.2	0	0.1	0	0	0	1.1	1.5	0	1.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Late spermatids
S100A8	60B8AG, CAGA, CFAG, CGLA, MRP8, P8	ENSG00000143546	S100 calcium binding protein A8	P05109	1	153390032-153391188	Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Apoptosis, Autophagy, Chemotaxis, Immunity, Inflammatory response, Innate immunity	Antimicrobial	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		blood: 720.9;bone marrow: 718.8;esophagus: 532.3;tongue: 597.1	Cell type enriched	Detected in many	13	Kupffer cells: 10543.8	Cancer enhanced	Detected in all		cervical cancer: 2290.9;head and neck cancer: 2382.0	Low region specificity	Detected in many			Group enriched	Detected in many	8	classical monocyte: 320.7;neutrophil: 720.9	Group enriched	Detected in many	8	granulocytes: 720.9;monocytes: 320.7	Group enriched	Detected in some	28	hTCEpi: 28.2;SK-BR-3: 103.3;THP-1: 54.9	Low region specificity	Detected in some			Not detected	Not detected			CAB002791, HPA024372	Enhanced		Supported	Intermediate filaments,Cytosol	Secreted to blood			10900000	530000000	Intermediate filaments	Cytosol	CAB002791: , HPA024372: AB_1856536	unprognostic (1.98e-1)	unprognostic (1.13e-1)	unprognostic (3.79e-2)	unprognostic (1.58e-2)	unprognostic (8.60e-3)	unprognostic (9.26e-3)	unprognostic (4.92e-2)	unprognostic (1.32e-1)	unprognostic (1.83e-1)	unprognostic (6.13e-2)	unprognostic (3.77e-2)	unprognostic (2.24e-2)	prognostic unfavorable (8.94e-7)	unprognostic (1.17e-1)	unprognostic (8.90e-2)	unprognostic (8.27e-2)	unprognostic (8.94e-3)	14	0.8	0.8	30.5	2.6	718.8	1.1	0.5	1.6	123	2.8	0.7	0.4	0.4	12	1.2	532.3	5.5	2.1	36.7	1.5	0.5	1.4	4.3	26.2	37.3	3.3	0.4	2.1	2.7	0.1	0.9	4.7	3.3	1.4	0.4	1.3	92.4	0.3	2.5	6.2	1	9	1.8	72.4	2	1.9	0.9	2.6	4.6	597.1	257.6	5	224.1	0.6	63.7	720.9	320.7	0.3	0.6	244.7	0	0	0	0	0	0	0	0	0	0	0	0	0	1.1	0.1	0	0	1.7	0	2.2	0	0	0	0.4	0	0	0	0.8	0	0	28.2	0	0.9	0	0	0	1.2	0.1	0	0.1	0	0.2	0	0	0	0	0.8	0.1	0	0	0	0	0.4	103.3	0	0	0.7	54.9	1.5	0	0	0.1	0	0	0.1	0.3	0	1.6	0	8.2	320.7	38.9	0.4	26.5	0.6	0.6	0.3	0.2	63.7	0.3	0.3	0.3	720.9	0.3	6.4	2.5	0.4	244.7	0.8	2.6	0.5	1.6	1.5	0.5	3.3	0.4	3.3	0.9	208.4	808.2	43.2	0.7	17.4	0	2.9	56	117.8	215	14	0	4.1	0	0.1	217.1	1.6	0	23.3	0.8	8.6	1.6	0.4	209.3	16.4	431.8	0	0	84.7	10543.8	69.5	3.7	783.2	0	0	0	0	0.9	0	1.4	14.7	0	0	1	2.2	0.5	99	5.6	20.3	0	19.6	Kupffer cells
FLG		ENSG00000143631	Filaggrin	P20930	1	152302175-152325203	Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins		Developmental protein	Cancer-related genes, Ichthyosis	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		esophagus: 21.9;skin 1: 109.7;tongue: 38.6	Cell type enriched	Detected in some	13	Suprabasal keratinocytes: 38.5	Cancer enriched	Detected in some	7	melanoma: 11.6	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HaCaT: 14.3;NTERA-2: 4.5;TIME: 3.0;U-2 OS: 3.5;U-2197: 3.7;WM-115: 2.8									CAB002210, HPA027505, HPA030188, HPA030189	Enhanced		Enhanced	Cytoplasmic bodies					500000	Cytoplasmic bodies		CAB002210: AB_563731, HPA027505: AB_10600107, HPA030188: AB_10601749, HPA030189: AB_10601999	unprognostic (3.37e-2)	unprognostic (3.76e-1)	unprognostic (8.83e-2)	unprognostic (2.96e-3)	unprognostic (9.65e-2)	unprognostic (1.17e-1)	unprognostic (2.02e-1)	unprognostic (4.03e-2)	unprognostic (1.12e-1)	unprognostic (9.98e-2)	unprognostic (1.73e-1)	unprognostic (2.40e-1)	unprognostic (2.35e-2)	unprognostic (1.45e-1)	unprognostic (4.28e-2)	unprognostic (4.15e-2)	unprognostic (7.41e-3)	0.1	0	0	0	0	0	4.1	0	0.1	2.1	0	0	0	0	0.8	0	21.9	0	0	0	0	0	0.2	0	0	0	0	0	0.2	0	0	0	0.3	0.1	0	0	0	0.5	0	0.4	109.7	0	0	0	0	0	0	0	6.3	0	38.6	7.3	0	1.1	0	0	0	0	0	0	0	0	1.9	0	0	0	0	0	0.4	0	0	0	0.1	0.5	0	0	0.7	0	14.3	0	0	0	1.5	0.1	1.1	0.1	0.5	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0.1	0	4.5	0.4	1.1	0	0	0	0	0	0	0	0	0	2	0.1	0	0.1	3	1.2	3.5	3.7	2.6	0	0	0	0.1	0	2.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	2.9	0.6	0.3	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0.4	0	0	0	0	0	0	38.5	0	0	0	0	Suprabasal keratinocytes
ACTA1	ACTA, NEM3	ENSG00000143632	Actin, alpha 1, skeletal muscle	P68133	1	229431245-229434098	Disease related genes, Plasma proteins, Predicted intracellular proteins		Muscle protein	Disease mutation, Nemaline myopathy	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	10	skeletal muscle: 1935.3;tongue: 523.6	Cell type enriched	Detected in some	448	Cardiomyocytes: 1758.3	Group enriched	Detected in many	18	head and neck cancer: 133.1;prostate cancer: 34.7	Not detected	Not detected			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Cell line enriched	Detected in some	22	BEWO: 104.7	Low region specificity	Detected in many			Not detected	Not detected			CAB000045, HPA041264, HPA041271	Enhanced								6100000000			CAB000045: AB_2242301, HPA041264: AB_2677383, HPA041271: AB_2677386	unprognostic (5.59e-2)	unprognostic (1.60e-2)	unprognostic (1.77e-1)	unprognostic (3.07e-4)	unprognostic (5.75e-3)	unprognostic (3.84e-3)	unprognostic (1.86e-1)	unprognostic (7.61e-2)	unprognostic (1.32e-1)	unprognostic (2.24e-1)	unprognostic (2.64e-3)	unprognostic (2.50e-1)	unprognostic (1.56e-3)	unprognostic (9.40e-4)	unprognostic (2.61e-1)	unprognostic (1.58e-2)	unprognostic (1.01e-1)	29.6	0.2	0.2	0.2	0.2	0.2	0.5	0.2	0.3	0.2	0.2	0	0.8	0.2	0.2	48.6	30	0.2	0.2	122.5	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0	0.2	0.2	0.2	0.1	0.2	0	2.7	0.2	0	40.4	0.2	1935.3	0.5	0.2	1.2	0.4	0.2	0.2	0.2	0	0	5.3	523.6	39.9	0.2	0.1	4.4	14.7	20.5	15.5	5.1	9.7	20.8	0	0	0	0	0	0	104.7	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0.3	0	0	4.5	0	0.1	0.1	4.7	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0.1	0	0.9	0	0	0	0	0.1	0	0	0.1	0.1	0.1	0.2	0	0	0.1	0	8.9	9.3	20.5	7.6	15.5	5.7	4.4	6.4	7.4	14.7	4.3	5	7.7	12.1	5.1	14	4.7	9.7	20.8	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0	0	0	0	0	0	0.4	0.5	0.7	1758.3	0	0	0	0	3.9	0.2	0	0.3	0.3	0	0	0	0	1.1	0.4	0.1	0	0	0.1	0	0	0	0	0	0	0.6	0	0	0	0.4	0.5	0	0.4	0	0	0	1	0.7	0	0.4	0.2	0	0	0	Cardiomyocytes
PPFIA4		ENSG00000143847	PTPRF interacting protein alpha 4	O75335	1	203026498-203078740	Plasma proteins, Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	10	brain: 72.6;heart muscle: 26.2;skeletal muscle: 20.4	Cell type enriched	Detected in some	5	Cardiomyocytes: 32.2	Low cancer specificity	Detected in many			Group enriched	Detected in all	4	cerebellum: 72.6;cerebral cortex: 21.1	Cell type enhanced	Detected in some		myeloid DC: 1.4	Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		A-431: 7.4;hTERT-RPE1: 12.8;RH-30: 13.2;U-266/70: 8.3;U-87 MG: 12.1	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA053419, HPA054132	Enhanced											HPA053419: AB_2682143, HPA054132: AB_2682393	unprognostic (2.83e-1)	unprognostic (2.34e-3)	unprognostic (3.38e-5)	unprognostic (3.19e-1)	unprognostic (6.58e-2)	unprognostic (5.36e-2)	unprognostic (7.49e-8)	unprognostic (4.65e-1)	unprognostic (6.01e-4)	unprognostic (1.29e-1)	unprognostic (7.70e-2)	unprognostic (2.60e-2)	prognostic unfavorable (1.73e-8)	unprognostic (6.82e-3)	unprognostic (9.96e-2)	unprognostic (1.11e-1)	unprognostic (4.28e-2)	0.6	1.3	9.2	1	10.9	1.6	0.9	72.6	21.1	1.8	1	1.4	0	1.1	1.7	3.5	1.3	1.2	2.6	26.2	6.6	5	1.9	0.6	1.2	0.8	3	10.8	0.9	0.6	1.3	0.7	3.9	11.4	1.5	0.8	0.6	1.4	1.3	20.4	2.9	1.3	2	2	2.2	0.8	3.3	2.3	0	0.9	0.4	0.8	0.9	0.9	0	1.4	1.3	0.9	0	0.6	0	7.4	0	0.1	1.9	0	0.3	0.3	0.4	0.9	0.7	3.1	0.3	0.3	0.3	1.6	1.7	0.2	0.8	0.6	1.4	1.5	0	0.6	0.1	0	0	0.1	0	1	2.4	0.1	0.4	0	12.8	0	1.5	0.1	0.3	6.2	1	0.5	0.9	0.9	0	0.3	1.3	13.2	2.1	0	0	2.5	3.2	0.8	0.1	1	1.2	0.2	0.6	0	4.7	2.8	0.1	0	8.3	0.2	0.1	12.1	0.6	0.5	0	0.9	1.3	0	0.5	0	0	0	0	1.4	0	0	0	0.3	0	0.9	0	0.6	0	9.2	10.9	72.6	21.1	6.6	5	3	10.8	11.4	2.3	0	0	0	0.1	0	2.4	32.2	0	0	0	0	5.9	0	0	0.9	1.6	0	0	0	0	0.1	0.7	0	0	0	0.3	6.4	0	1.3	0	1.9	0.3	0	0	0	0	2.6	0.5	0	1.8	0	0.8	0	0.9	0.5	1.2	0	0.2	0	0	0	Cardiomyocytes
ABCG8	GBD4	ENSG00000143921	ATP binding cassette subfamily G member 8	Q9H221	2	43831942-43882987	Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters	Lipid transport, Transport	Translocase	Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	30	intestine: 62.4;liver: 64.4	Cell type enriched	Detected in some	5	Hepatocytes: 24.1	Cancer enriched	Detected in some	30	liver cancer: 21.6	Not detected	Not detected			Low cell type specificity	Detected in some			Low lineage specificity	Detected in single			Cell line enriched	Detected in single	47	Hep G2: 14.7	Not detected	Not detected			Low region specificity	Detected in all			HPA019556	Uncertain		Approved	Vesicles						Vesicles		HPA019556: AB_1844444	unprognostic (1.99e-1)	unprognostic (4.49e-1)	unprognostic (3.22e-1)	unprognostic (1.37e-1)	unprognostic (3.09e-2)	unprognostic (2.43e-1)	unprognostic (1.99e-3)	unprognostic (1.27e-1)	unprognostic (6.28e-1)	unprognostic (6.14e-3)	unprognostic (4.69e-1)	unprognostic (1.76e-1)	unprognostic (2.68e-1)	unprognostic (7.86e-3)	unprognostic (5.03e-1)		unprognostic (1.50e-1)	0.1	0.1	0.2	0	0.3	0	0.1	0.1	0.4	0.1	21.2	0	0	24	0.1	0.1	0.1	0.1	1.7	0.1	0.2	0.3	0.2	64.4	0.1	0	0.2	0	0.1	0.1	0	0.1	0	0	0.1	0	0	0.1	0	0.1	0.1	62.4	0	0.1	0.2	0.1	0.1	0	0	0.1	0	0	0.1	0.1	0.7	0.6	2.1	0.3	0.5	0.8	0.2	0	0.1	0	0.1	0	0	0.2	0	0	0	0	0.1	0.1	0.1	0.1	0	0	0.1	0	0	0	0.1	0.1	0.1	0.2	14.7	0	0.1	0.3	0	0	0	0	0	0	0.1	0.1	0.2	0	0.1	0.1	0.2	0.1	0	0	0	0.1	0.1	0	0.2	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0	0.1	0.1	0	2.1	0.3	0.4	0.7	0.3	0.5	0.5	0.6	0.5	0.1	0.7	0.8	0.7	1.7	0.5	0.3	0.6	0.3	0.2	0.2	0.3	0.1	0.4	0.2	0.3	0.2	0	0	0	0	0	0	0	0	0	0.2	5.1	0	1.2	1.8	0	0	1.7	0	0	0	0	0	0	0	0	0	0	24.1	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Hepatocytes
TRIM43	TRIM43A	ENSG00000144015	Tripartite motif containing 43	Q96BQ3	2	95592018-95599778	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in some		brain: 2.8;stomach 1: 1.5;testis: 2.8	Cell type enriched	Detected in single	4	Early spermatids: 1.0	Not detected	Not detected			Region enhanced	Detected in single		olfactory region: 2.8	Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	5	U-2 OS: 3.6									HPA042223, HPA042772	Uncertain											HPA042223: AB_10962361, HPA042772: AB_10964436				unprognostic (7.17e-3)						unprognostic (1.42e-1)					unprognostic (9.27e-2)			0	0	0.4	0	0.7	0	0.1	0.9	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	2.8	0	0	0.8	0	0	0	0	0.2	0	0.1	0	0	0	0	0	0	0	1.5	2.8	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0	3.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0.7	0.9	0	0	0	0	2.8	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0.2	0	0	0	0	0	Early spermatids
NAT8	ATase2, GLA, Hcml1, TSC501	ENSG00000144035	N-acetyltransferase 8 (putative)	Q9UHE5	2	73640832-73642393	Enzymes, Predicted membrane proteins		Acyltransferase, Transferase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	9	kidney: 140.4	Cell type enriched	Detected in some	12	Proximal tubular cells: 1951.9	Cancer enriched	Detected in some	5	renal cancer: 242.1	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	15	Hep G2: 16.9					Low region specificity	Detected in all			HPA067855, HPA074519	Enhanced		Approved	Endoplasmic reticulum						Endoplasmic reticulum		HPA067855: AB_2732774, HPA074519: AB_2686699	unprognostic (4.51e-2)	unprognostic (6.36e-2)	unprognostic (1.95e-1)	unprognostic (1.81e-1)	unprognostic (1.98e-1)	unprognostic (4.95e-3)	unprognostic (2.46e-1)	unprognostic (1.90e-2)	unprognostic (9.42e-2)	unprognostic (1.82e-1)	unprognostic (2.13e-2)	unprognostic (8.60e-2)	unprognostic (1.37e-3)	unprognostic (2.07e-2)	unprognostic (4.11e-3)	unprognostic (2.13e-2)	unprognostic (8.36e-5)	0.2	0	0.2	0.2	0.2	0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.7	0.2	0.2	0.2	0	0.2	0.2	0.2	0	140.4	15.8	0.2	0.2	0.2	0.2	0.3	0.2	0	0.2	0.2	0.2	0.2	0	0.2	0.2	0.2	0.2	0	1.2	0.2	0.2	0.2	0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0	0	0	0.1	0	0	0.9	0	0.1	0	0.1	0	0	0.1	0	0	0	0	1.1	0	0.1	0.4	0	0.1	0	0	0	0	0.2	0.1	0	0	16.9	0	0.1	0.2	0	0	0	0.1	0	0	0.1	0	0	0	0	0	0.3	0.1	0	0.1	0	0.1	0	0.2	0	0.3	0.2	0.1	0	0.6	0	0	0	0	0	0.4	0	0	0.1	0.1	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.9	0.2	0.2	0.2	0.2	0.2	0	0.2	0.2	0.2	0.2	0	0	1.9	0	0	0	0	0	0	0	34.9	0	0	159.2	0	0	0	1.3	0	0	0	0	0	0	40.4	0	0	0	22.7	1	0	0	0	0	0	0	0	0	2.9	0	1951.9	0	0	0	0	0	0	0	0	0	0	Proximal tubular cells
NT5DC4		ENSG00000144130	5'-nucleotidase domain containing 4	Q86YG4	2	112721486-112742879	Predicted intracellular proteins		Hydrolase		Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		blood: 3.0;testis: 6.0	Cell type enriched	Detected in some	4	Early spermatids: 20.8	Cancer enhanced	Detected in single		testis cancer: 0.5					Cell type enhanced	Detected in single		eosinophil: 3.0	Lineage enriched	Detected in single	7	granulocytes: 3.0	Cell line enriched	Detected in some	7	K-562: 18.7					Low region specificity	Detected in all			HPA046856	Uncertain											HPA046856: AB_2679841	unprognostic (2.49e-2)	unprognostic (1.16e-1)	unprognostic (1.46e-2)	unprognostic (1.34e-2)	unprognostic (2.20e-4)	unprognostic (2.26e-1)	unprognostic (3.66e-2)	unprognostic (2.40e-1)	unprognostic (1.19e-1)	unprognostic (5.38e-4)	unprognostic (1.38e-1)	unprognostic (2.66e-1)	unprognostic (1.60e-4)	unprognostic (9.02e-2)	unprognostic (1.33e-1)	unprognostic (1.11e-1)	unprognostic (1.78e-4)	0.1	0	0	0.4	0	1.6	0	0	0	0	0			0	0	0	0	0	0	0	0	0	0	0	0.2	1.2	0		0	0	0	0	0.1		0	0		0	0	0	0	0.3	0	0	0.9	0	6			0		1	0	0	0	0	3	0.4	0	0	0.1	1	0	0.1	0.1	0	0	0.2	0.2	0	0	0	0.3	0.2	0.2	0.1	0	1.3	0.4	0	0	0	0.2	0.1	0.5	0.2	0.7	0	0.1	1.4	0	0	0	0	0.1	0	0	18.7	1.5	0	0	0.2	2.6	0	1.4	0.1	0.1	0	0	0	0.5	0.1	0	0	0.1	0	0	0.1	0	0.2	0.4	0.1	0.1	0	0.2	0.6	0	0.2	0.1	0.1	0	0.2	3	0	0.4	0	0	0	0	0	0	0	0	0.8	0	0	0	0	0.1											0	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0.5	20.8	0	0	0	0.5	0	0	0	0	0	0.2	0	0	0	0	4.7	0	0	0	0	0	0	0.8	0.2	0.4	0	0	0	0	0.1	0.2	0	0.1	0	0	0	Early spermatids
RABL2A		ENSG00000144134	RAB, member of RAS oncogene family like 2A	Q9UBK7	2	113627229-113643396	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in many		fallopian tube: 29.3	Cell type enriched	Detected in many	6	Ciliated cells: 119.1	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Cell line enhanced	Detected in many		MOLT-4: 12.2									HPA042642, HPA042700, HPA044007	Approved		Approved	Vesicles,Centrosome						Centrosome	Vesicles	HPA042642: , HPA042700: AB_2678120, HPA044007: AB_2678770	unprognostic (7.76e-3)	unprognostic (7.79e-3)	unprognostic (7.00e-2)	unprognostic (2.94e-2)	unprognostic (1.99e-1)	unprognostic (4.23e-2)	unprognostic (4.89e-2)	unprognostic (6.77e-3)	unprognostic (6.61e-2)	unprognostic (7.36e-2)	unprognostic (5.78e-3)	unprognostic (4.29e-2)	prognostic unfavorable (1.20e-4)	unprognostic (1.89e-2)	unprognostic (1.50e-1)	unprognostic (7.87e-2)	unprognostic (3.19e-5)	2.2	1.7	6	5.9	9.5	1.7	3.3	6.3	20.9	4.3	3.4	4.2	0.4	2.4	4.7	9	2.7	29.3	2.8	3.3	7	6	3.5	3.4	12.9	1.8	4	7.5	7.4	2.6	1.2	6.3	1.6	6.4	3.8	2	3.8	5.2	12.2	2.2	2.1	2.2	3.6	4.8	2.7	2.1	4.8	4.3	2	5.5	2	3.1	2.1	2.7	8.8	9.8	2.5	7.6	12.2	10.4	5.5	2.6	4.3	6	4.8	5	7.3	4.6	2.4	2	3.5	2.5	3.8	1.6	3.7	10.4	0.8	2.5	2.7	3	0.3	2.3	5.1	5.8	1.8	0.1	0.5	4.1	0.8	1.3	2.6	5.2	0.7	1.5	5.1	2.5	5.5	1.7	0.9	2.1	2.1	12.2	0.9	3.3	2.2	1.5	2.3	2.3	1.6	2.4	0.6	2.5	8.5	2.3	2.6	2.2	1.9	0.5	3.5	0.6	0.5	0.8	0.9	1.7	3.6	3.8	0.8	7.1	2.7	1.2	0	4.8	2.5	7.1	7.6	7.7	8.8	10.4	7.2	7.5	8	8.6	6.8	0.5	12.2	7.2	9.8	5	5.5	6	9.5	6.3	20.9	7	6	4	7.5	6.4	4.3	8.9	7.2	7.5	4.3	3.9	7	4	0	119.1	12.5	7	9.8	2.8	11.6	6.7	9.4	3	5.2	0	2.7	2.2	7.3	3	11.5	3.9	3.1	15.9	6.9	6.7	2.8	9.8	7.5	4.6	6.8	6.4	3.7	6.5	4	3.5	6.7	5	17.6	0	6.6	20.4	8.3	4.3	2.1	5.7	4.3	3.4	Ciliated cells
CNGA3	ACHM2, CCNC1, CCNCa, CNCG3, CNG3	ENSG00000144191	Cyclic nucleotide gated channel alpha 3	Q16281	2	98346155-98398601	Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels	Ion transport, Sensory transduction, Transport, Vision	Ion channel, Ligand-gated ion channel	Disease mutation, Leber congenital amaurosis	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	5	pituitary gland: 32.0	Cell type enriched	Detected in some	39	Cone photoreceptor cells: 41.2	Cancer enriched	Detected in some	9	glioma: 7.9	Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	7	U-87 MG: 12.8	Group enriched	Detected in some	6	basal ganglia: 1.9;hypothalamus: 2.2	Not detected	Not detected			HPA049378, CAB079025	Approved	Approved										CAB079025: , HPA049378: AB_2732551	unprognostic (2.34e-2)	unprognostic (1.83e-2)	unprognostic (4.96e-2)	unprognostic (4.81e-2)	unprognostic (1.13e-1)	unprognostic (2.18e-1)		unprognostic (4.17e-4)		unprognostic (4.65e-2)	unprognostic (1.86e-3)	unprognostic (2.88e-1)		unprognostic (3.85e-3)	unprognostic (8.98e-2)	unprognostic (5.90e-2)	unprognostic (3.71e-2)	0.1	0	0.3	1.4	0.7	0	0.7	0.1	2.9	0.1	6.1	2.4	0.1	2.8	0.1	0.1	4.6	0.8	0.4	0.1	1.2	4	0.1	0.1	0.2	0.1	0.8	0.4	0.1	1.5	0	32	0.1	4.9	0.1	3.2	1.2	0.2	0.5	0.1	0	4	2.2	4.3	0.1	3	1.1	0.3	0.1	0.1	0.1	0.1	1.6	0.2	0	0	0	0	0	0	0	0	0	0.4	0	0	0.1	0	0.1	0.3	0	0	0	0	0	0	0.2	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0.2	0	0	0.5	0	0	0	0.3	0	0	0	0	0	0	0	1.4	0	0	0	0	0	0	0	0	0.3	0	1.7	0	0	0	0	12.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0.7	0.1	1.5	1.2	4	0.8	0.4	4.9	0.3	0	0	0	0	0	0.2	0.5	0	0	0	0	41.2	0	0	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0.3	0	0	0	1.1	0.1	0	0	0	0	0.8	0	0	0	0.1	0	0	0	0	0	Cone photoreceptor cells
NXPH2	NPH2	ENSG00000144227	Neurexophilin 2	O95156	2	138670772-138780348	Predicted secreted proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Group enriched	Detected in some	15	brain: 23.0;kidney: 8.0;ovary: 19.3	Cell type enriched	Detected in single	7	Distal tubular cells: 1.7	Low cancer specificity	Detected in single			Region enriched	Detected in many	4	pons and medulla: 23.0	Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		AF22: 6.3;SCLC-21H: 2.4;SiHa: 6.1;SuSa: 3.9;U-2 OS: 10.0;U-251 MG: 3.3	Low region specificity	Detected in many			Low region specificity	Detected in many			HPA034759	Approved				Secreted in brain		Yes					HPA034759: AB_10669732	unprognostic (5.83e-2)				unprognostic (8.83e-2)			unprognostic (1.41e-1)		unprognostic (2.72e-1)	unprognostic (1.80e-1)							0.4	0.5	3.1	0.6	3.7	0.2	0.4	0.8	6	0.6	0.3	0	0	0.2	1.1	0.5	0.2	0.6	0.2	0.2	1.9	1.5	8	0.3	0.3	0.2	2.4	2	19.3	0.2	0.4	0.4	0.4	23	0.3	0.3	0.5	0.2	1.1	0.2	0.2	0.4	0.3	0.7	0.2	0.2	0.4	0.8	0	0.2	0	0.2	0.2	0	0	0	0	0	0	0	0	0	0	6.3	0	0	0	0	0	0	0	0.5	0	0	0	0.8	0	0	0.1	0	0	0	0	0.1	0	2.2	0	0	0	0	0	0	0	0	0.8	0	0	0	0	0.5	0	0	0	0	0	0.1	0	0	0	0.8	0	2.4	1.6	6.1	0	0	3.9	0	0	0	0	10	0	3.3	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.1	3.7	0.8	5.6	1.9	1.5	2.4	2	23	0.8	0	0	0	0	0	0.2	0	0	0	0	0	0	0	1.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	Distal tubular cells
SLC4A10	NBCn2, NCBE	ENSG00000144290	Solute carrier family 4 member 10	Q6U841	2	161424332-161985282	Predicted membrane proteins, Transporters	Antiport, Ion transport, Sodium transport, Symport, Transport			Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	9	blood: 31.2;brain: 48.1	Cell type enriched	Detected in some	12	Bipolar cells: 116.7	Cancer enhanced	Detected in single		glioma: 1.3	Low region specificity	Detected in all			Cell type enriched	Detected in some	8	MAIT T-cell: 31.2	Lineage enriched	Detected in single	78	T-cells: 31.2	Cell line enriched	Detected in some	11	Karpas-707: 14.0	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA034755, HPA076725	Enhanced											HPA034755: AB_10670296, HPA076725: 	unprognostic (4.64e-4)	unprognostic (3.88e-1)	unprognostic (2.88e-2)	unprognostic (3.65e-2)	unprognostic (1.19e-2)	unprognostic (7.89e-3)	unprognostic (5.99e-4)	unprognostic (1.12e-1)	unprognostic (2.27e-1)	unprognostic (1.64e-1)	unprognostic (2.50e-2)	unprognostic (9.27e-2)	unprognostic (5.65e-2)	unprognostic (9.23e-3)	unprognostic (1.87e-1)	unprognostic (2.10e-3)	unprognostic (2.26e-1)	1	3.7	21.6	1.9	24.1	1.2	1.3	14.9	48.1	1.1	3.3	2.1	0	1.4	1	2.8	1	1.8	1.5	1	20.4	10.8	1	1.3	1.1	1.1	4.3	29.6	1	2.9	1	4.4	1	17.7	1.3	2.7	1.7	1	1.1	1	1	1.5	1.1	1.9	3	1.3	1.4	3.5	0	1	0	1.5	1.3	0.3	0	0	0	0	0.4	31.2	0.2	0	0	0	0	0	0	0	0	1.2	0	0.1	0	0.9	0.1	0	0	0	0	0	0	0.1	0.4	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	14	0.2	0.2	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0.1	0.1	0	0	0	0	0	0.5	0	0.1	0	0	0	1.2	0	31.2	0	0.6	3.8	0	0	0	0	0	0.4	0	0	0	0.2	21.6	24.1	14.9	37.9	20.4	10.8	4.3	29.6	17.7	3.5	0	0	0	0	0	116.7	0.4	0	0	0	0	7.9	0	0	0	9.6	0	0	0	0	0	0	0	2.3	0.6	0	0	0	1.8	1.2	8.4	0	0	0	0	2.2	2.4	0.1	0	0	0	6.7	0	0	0.9	0.2	0	0	4.4	0	0	Bipolar cells
FAM171B	FLJ34104, KIAA1946	ENSG00000144369	Family with sequence similarity 171 member B	Q6P995	2	186693971-186765965	Predicted intracellular proteins, Predicted membrane proteins				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 62.0	Cell type enriched	Detected in many	6	Bipolar cells: 137.0	Cancer enriched	Detected in many	5	glioma: 15.9	Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		Karpas-707: 25.4;U-138 MG: 17.6	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA010639, HPA013434	Approved		Approved	Nucleoplasm,Mitochondria						Nucleoplasm, Mitochondria		HPA010639: AB_1852447, HPA013434: AB_2262499	unprognostic (2.52e-1)	unprognostic (7.75e-3)	unprognostic (1.27e-1)	unprognostic (1.04e-2)	unprognostic (4.03e-2)	unprognostic (9.43e-2)	unprognostic (6.78e-3)	unprognostic (2.68e-1)	unprognostic (1.88e-2)	unprognostic (1.52e-1)	unprognostic (4.24e-3)	unprognostic (1.47e-1)	prognostic unfavorable (9.51e-7)	unprognostic (4.63e-3)	unprognostic (1.52e-1)	unprognostic (2.24e-3)	prognostic unfavorable (5.03e-4)	3.1	13.1	32	2	32.6	1.1	3.7	12.7	62	6.7	2.1	5.8	0.1	1.6	7.1	2.6	2.4	3.2	4.9	1.9	25.5	13.1	1.8	1.1	2	1.6	9.1	23	9.7	1.6	11.4	13.4	3.5	9.7	3.2	2.5	1.4	17.8	2.8	1.3	3.8	1.9	4.5	8.4	2	2.4	1.6	10.4	0	2.7	0	1.7	2.9	1.8	0.3	1.3	1.1	1.7	2.4	1.1	0.5	2.3	2.8	4.2	13.1	12.5	9.5	0.1	2.6	4.6	3.2	4.6	7.7	12.6	0	0.9	7.3	5.5	0.3	5.7	2.5	4.6	0	3.3	2.8	1.3	0	1	0.8	1	12.1	1	2.5	2	4.2	7	2.2	0	25.4	6.1	1.6	1.6	0	5.6	0	2.8	0	8.1	0.6	5	9	13.2	7.2	1.3	0.8	3.5	2.6	1	0.6	4.1	17.6	2.3	0.3	1.6	6.8	6.5	0	5.4	0	2.4	1.1	0.7	0.3	0.8	1.7	0.7	0.3	1	0.9	0.6	0.2	0.6	1.1	0.4	2.4	1.6	1.3	0.1	0.5	32	32.6	12.7	30.4	25.5	13.1	9.1	23	9.7	10.4	0	0	0	2.1	7.9	137	0.8	10.2	0	2.3	0	13.7	7.9	0	0.7	1.4	10.5	0	0	0.3	0.8	6.6	1.2	0	0	1.7	22.3	4.6	8	0.3	2.5	7.2	1.1	3.3	1	0	16.5	0.5	0	13.1	0.1	15.5	0	4.1	0.1	1.4	4.5	6.9	0	0	0.5	Bipolar cells
CPO		ENSG00000144410	Carboxypeptidase O	Q8IVL8	2	206939554-206969474	Enzymes, Predicted intracellular proteins		Carboxypeptidase, Hydrolase, Metalloprotease, Protease		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	7	intestine: 71.1	Cell type enriched	Detected in single	6	Early spermatids: 1.8	Not detected	Not detected			Not detected	Not detected			Cell type enriched	Detected in single	17	basophil: 10.3	Lineage enriched	Detected in single	42	granulocytes: 10.3	Cell line enhanced	Detected in some		ASC diff: 2.8;hTCEpi: 2.1;hTERT-RPE1: 2.4;NB-4: 3.9;SuSa: 2.5					Low region specificity	Detected in single								Intracellular and membrane								unprognostic (9.39e-2)	unprognostic (2.64e-1)	unprognostic (2.95e-2)	unprognostic (5.21e-2)	unprognostic (2.28e-1)	unprognostic (1.27e-2)	unprognostic (1.16e-1)	unprognostic (9.06e-2)	unprognostic (4.03e-1)	unprognostic (1.33e-1)	unprognostic (3.75e-3)	unprognostic (1.22e-1)	unprognostic (3.60e-2)	unprognostic (2.52e-1)	unprognostic (6.56e-2)	unprognostic (4.03e-2)	unprognostic (4.89e-2)	0.2	0.4	0.2	0.1	0.9	0	0.3	0.1	0.4	0.2	0.6	0.1	1.1	0.1	0.1	9.4	0.1	0.1	0.1	0.1	0.2	0.5	0.5	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.6	0.5	0.1	0.1	0.3	0.1	0.1	0.3	0.3	0.2	0.1	71.1	0.2	0.1	0.1	0.1	0.3	0.1	0.1	0.4	0.1	0.1	0.1	0.1	0	0	10.3	0	0	0.2	0	0	0.3	0.3	0	2.8	1	1.6	0.4	0	0	0.1	0.3	0.2	0.1	0.7	0	0	0	0.3	0.2	0.1	0.2	0.5	0	0	0.2	0	0.7	0.2	0.8	2.1	0	0	2.4	0	0.7	0	0	0.2	0	0.1	3.9	0.2	0.3	0.6	0.1	0	0.2	1.4	0.1	0.3	0	0	0.3	0	2.5	0.2	0.5	0	0	1	0.6	0.3	0.1	0.9	0	0	0.2	0.5	10.3	0	0.5	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0.2	0.9	0.1	0.4	0.2	0.5	0.2	0.1	0.1	0.1	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	1.8	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0.1	0	0	0.1	0	0	0	0	0	0	0	Early spermatids
NYAP2	KIAA1486	ENSG00000144460	Neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adaptor 2	Q9P242	2	225399710-225654018	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	6	brain: 17.9;pituitary gland: 13.5	Cell type enriched	Detected in some	6	Bipolar cells: 17.8	Not detected	Not detected			Low region specificity	Detected in all			Cell type enhanced	Detected in some		basophil: 2.1	Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		HeLa: 1.9;SH-SY5Y: 2.0;SiHa: 6.2;U-2 OS: 2.4	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA045531, HPA056945	Uncertain		Approved	Mitochondria,Cytosol						Mitochondria	Cytosol	HPA045531: AB_10960749, HPA056945: 	unprognostic (2.49e-1)	unprognostic (3.34e-1)		unprognostic (1.24e-1)	unprognostic (2.63e-1)	unprognostic (2.35e-1)		unprognostic (6.13e-3)		unprognostic (3.33e-1)	unprognostic (2.08e-1)		unprognostic (1.32e-8)	unprognostic (9.83e-2)	unprognostic (2.92e-1)	unprognostic (6.46e-2)	unprognostic (1.27e-1)	0.8	1.1	10.8	1	16.4	1.4	0.7	17.9	11.9	0.6	0.7	0.8	0	1	0.7	0.7	1.2	0.6	0.8	0.7	8.5	2.5	0.7	0.7	1.9	1.1	2.6	8.5	0.6	0.8	0.6	13.5	0.7	2.5	0.7	0.8	0	0.7	0.6	2.6	1.2	0.9	0.6	2.7	0.9	0.8	1	2.9	0	0.6	0	0.8	1.2	0.6	0.5	0.5	2.1	0.3	0.2	0.4	0.1	0	0.6	0	0.1	0	0	0	0	0	0	0	0.1	0.1	0	0	0	0.1	0	0	0	0	0.4	0	0	1.9	0	0	0.1	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0.8	0	0	0	0.1	0	0.7	1	2	6.2	0	0	0.1	0	0	0	0.1	2.4	0.1	0	0.1	0	0.1	0.1	0	0	2.1	0.3	0.2	0.3	0.2	0.4	0.3	0.2	0.1	0	0.5	0.3	0.4	1.2	0.2	0.2	0.5	0.1	0.1	10.8	16.4	17.9	11.9	8.5	2.5	2.6	8.5	2.5	2.9	0	2.9	0	1.1	1.1	17.8	0.3	0	0	1.2	0	2	0.2	0	0.4	0.4	0	0	0	1	0.1	0.4	0.8	0	0	0.1	0	0	0	0	0.2	0	0.8	0	0	0	0.1	1.8	0	0	0	1.7	0	1	0	0.2	0.9	0.1	0	0	0.8	Bipolar cells
MARCH4	KIAA1399, MARCH-IV, RNF174	ENSG00000144583	Membrane associated ring-CH-type finger 4	Q9P2E8	2	216257865-216372027	Enzymes, Predicted membrane proteins	Ubl conjugation pathway	Transferase		Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in some		brain: 16.6;pituitary gland: 13.1	Cell type enriched	Detected in some	6	Intestinal endocrine cells: 15.6	Low cancer specificity	Detected in some			Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in many		BJ: 33.8;fHDF/TERT166: 21.5;TIME: 15.9	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA014348	Approved											HPA014348: AB_1853578	unprognostic (4.84e-2)	unprognostic (1.02e-4)	unprognostic (1.63e-1)	unprognostic (5.42e-2)	unprognostic (3.31e-2)	unprognostic (1.88e-1)	unprognostic (1.38e-1)	unprognostic (1.26e-2)	unprognostic (1.24e-2)	unprognostic (6.49e-2)	unprognostic (5.55e-3)	unprognostic (1.07e-1)	unprognostic (6.81e-5)	unprognostic (4.82e-2)	unprognostic (2.06e-1)	unprognostic (1.23e-1)	unprognostic (1.09e-3)	0.7	2.9	7	0.7	11.9	0.7	0.6	1	16.6	0.6	1.1	0.3	0	1.5	0.7	0.7	0.6	2.5	0.6	0.6	5.8	5.6	0.6	0.6	0.8	0.6	2	4.8	0.6	1.5	0.6	13.1	3.1	3.4	0.7	1.2	0.1	0.6	0.6	0.6	0.7	1.4	0.6	1.6	0.6	5.1	0.7	1.1	0	0.6	0	0.6	0.6	0.1	0	0	0	0	0.5	0.4	0	5.6	1.2	0	0	0.1	0.8	0	33.8	11.6	7.3	2.6	0	0.5	0	5.2	21.5	12.2	0	0	13.3	7.2	0	0	2.5	0	0	1.7	0	0	0	0	6.6	10	4.7	9.5	0	0	0	11.2	0	0	0	0.5	0	0	0	0	0	0	0	5.6	0.9	0	0	0	1.1	0	0	15.9	11.3	11.8	0	9	0	0	0	2.6	0	8	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	7	11.9	1	16.6	5.8	5.6	2	4.8	3.4	1.1	0	0	0	0	0	2.5	0.3	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	15.6	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	Intestinal endocrine cells
CAND2	KIAA0667, TIP120B, Tp120b	ENSG00000144712	Cullin associated and neddylation dissociated 2 (putative)	O75155	3	12796472-12871916	Predicted intracellular proteins	Transcription, Ubl conjugation pathway			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	4	skeletal muscle: 76.2	Cell type enriched	Detected in many	6	Early spermatids: 98.3	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		HEK 293: 18.4;REH: 11.4	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA005777	Approved		Approved	Nuclear bodies,Cytosol						Nuclear bodies	Cytosol	HPA005777: AB_2667431	unprognostic (6.11e-3)	unprognostic (3.44e-2)	unprognostic (1.52e-3)	unprognostic (6.09e-2)	unprognostic (4.22e-1)	unprognostic (2.35e-1)	unprognostic (1.12e-2)	unprognostic (1.67e-2)	unprognostic (2.00e-2)	unprognostic (9.03e-2)	unprognostic (6.36e-3)	unprognostic (1.03e-1)	unprognostic (4.78e-5)	unprognostic (1.31e-2)	unprognostic (2.21e-2)	unprognostic (1.75e-1)	unprognostic (2.96e-3)	2.9	2.8	6.4	1.4	7.6	1.4	1.4	7.2	11.8	2.3	3.2	3.7	0.5	1.5	3.7	2.6	2.6	3.6	2.1	17.8	4.7	4.3	1.7	1.7	1.9	1.4	2.7	5.5	3.3	2.5	6.4	4.9	1.4	3.1	3	1.4	4.2	2.2	3.4	76.2	1.6	1.7	5.2	2.2	2.2	2.1	11.4	2.6	0.1	2.4	11.1	1.2	3	5	1.2	0.2	0.7	0.5	0	2.2	0.6	0.7	1.5	5.8	0.2	0.2	0.1	0.3	1.7	0.6	3.1	4.3	0.8	0.3	0.9	1.7	0.8	0.8	0.2	6.4	0.1	2.8	1.6	18.4	1.3	2.2	1.2	4.9	0.1	0.1	1.3	0.3	3.1	0.1	3.3	0.7	6.8	4.7	0.9	0.9	3	2.3	0.7	4.1	0.4	1.8	11.4	1.1	0.9	0.2	1.3	3.9	5.2	0.1	0.8	1	1.1	1.7	5.6	0.4	0.9	1	0.9	1.2	1.5	9	8.7	0.5	1.1	1.9	0	0.5	0	1.2	0.2	0.6	1.2	0.6	2.2	0.1	0.5	1.3	0.9	0.7	0	0.1	0.2	1.6	0.6	6.4	7.6	7.2	11.8	4.7	4.3	2.7	5.5	3.1	2.6	3	0.6	0	0.7	0.3	13.3	3.6	0	0	1.2	1.8	9.8	0.1	0	0.6	98.3	1	0	0	0	0.1	1.3	0.4	0	2.1	3.2	12.7	0	1.8	0	17.8	4.4	0	0	0	0	1.7	0	0	9.6	0.5	2.5	0	1.7	1.4	3.8	0.1	0.1	0.7	0	0.3	Early spermatids
LRTM1	HT017	ENSG00000144771	Leucine rich repeats and transmembrane domains 1	Q9HBL6	3	54918237-54967088	Predicted membrane proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Group enriched	Detected in some	5	lymphoid tissue: 12.2;retina: 18.8;skeletal muscle: 22.5;tongue: 15.3	Cell type enriched	Detected in many	14	Bipolar cells: 403.4	Cancer enhanced	Detected in single		urothelial cancer: 0.5	Region enriched	Detected in single	7	pons and medulla: 2.9	Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		HEL: 4.3	Not detected	Not detected			Low region specificity	Detected in many																				unprognostic (2.28e-1)	unprognostic (1.58e-2)								unprognostic (9.56e-2)	unprognostic (2.16e-1)		unprognostic (1.87e-3)	0.3	0.1	0.3	0	0.3	0	0.3	0.1	0.2	0.1	0.2	0	0	0	0.1	0.3	3.6	0.1	0.4	0.1	0.3	0.2	0.1	0.2	0.1	0	0.3	0	0.1	0.1	0.3	0.1	0.4	2.9	1.2	0	18.8	2.1	0.4	22.5	0.1	0.3	0	1	12.2	0.1	0.3	0	0	0.1	15.3	0.5	0.1	0.1	0.7	1	2.3	1.9	0.7	0.9	0.5	0.5	0.3	1.7	0.2	0.2	0	1.8	0	0.5	0.9	1.6	0.3	1.3	0	0.8	0.8	0	1	0.4	1.5	0.6	1	0.2	4.3	1.1	0.9	0.2	0.5	1.1	1.8	0.4	0.7	0.2	0.1	0.1	0.3	0.1	1.6	0.3	0.2	0.4	2.3	1.5	0	0.5	0.1	0.3	1.3	0.2	0.7	0.5	0.7	0.5	2.3	0.3	0.7	1.2	0.3	0	0.7	0.9	0.7	0.1	0	1	0.1	0.4	0.6	0.9	2.3	0.5	0.6	0.7	0.6	0.9	0.7	0.6	0.3	1	0.3	0.8	0.6	1.5	0.7	1.9	0.6	0.7	0.5	0.3	0.3	0.1	0.2	0.3	0.2	0.3	0	2.9	0	0	0	0	0.7	0.3	403.4	0.4	0	0	0	1.8	15.7	7.8	0	0	2	0.2	0	0	0.3	1.1	0.8	0.4	0	0	0.5	1.6	0	0	0	0	5.5	0	0	0	0	16.2	1.4	0	4.2	0	28.5	0	1	3	2.2	0.4	18.5	0	0	0.4	Bipolar cells
AC073896.1		ENSG00000144785			12	56285916-56316059	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level				Low tissue specificity	Detected in all			Cell type enriched	Detected in single	7	Club cells: 2.3	Not detected	Not detected			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Cell line enhanced	Detected in many		U-266/84: 25.7									HPA038466, HPA068007	Uncertain		Approved	Nucleoplasm,Centriolar satellite						Nucleoplasm, Centriolar satellite		HPA038466: AB_10672646, HPA068007: 	unprognostic (3.07e-2)	unprognostic (9.89e-3)	unprognostic (8.23e-2)	unprognostic (3.45e-2)	unprognostic (8.20e-3)	unprognostic (1.63e-1)		unprognostic (2.13e-1)	unprognostic (1.38e-1)	unprognostic (3.74e-3)	unprognostic (2.83e-1)	unprognostic (1.04e-1)	unprognostic (9.26e-4)	unprognostic (2.22e-1)	unprognostic (3.01e-1)		unprognostic (1.93e-1)	6.4	12.2	6.7	7.8	7.4	4.5	5.4	12.4	13.6	7.2	20.3	7.2	13.3	15.3	6.5	10.9	6.9	5.7	5.9	8.3	5	5.5	8.5	18.1	5.3	5.1	6.4	6.6	8.5	20.5	6.9	12.5	13.2	6.6	7.1	4.8	5.6	15.5	10.9	8.6	5.9	8.3	2.9	7.5	10.6	10	5.8	6.1	3.4	12.5	4.3	4.6	5.4	4.8	22.5	19.3	7.9	13.2	9.7	12.5	18.8	6.5	3.8	4.9	6.7	3	1.9	5.1	9.7	3.1	3.3	1.8	0.8	5.6	3	22.7	2.3	2.1	14.4	6.3	1	2	7.8	4.3	1	4.4	2.9	0.2	7.5	11.8	3.4	0.4	2.4	0.2	3.9	4	6.4	2.8	3.3	1.6	1.8	4.1	4.1	14.4	1.6	11.3	18.6	7	4.8	0.6	1.8	8.5	11.3	2.8	9.6	9.4	1.2	5.1	15.4	0	9	5.8	5	14.3	11	25.7	7.7	15.2	6.5	11.1	7.9	7.6	4.1	12.4	13.2	10	22.5	7.7	12.5	15.1	19	9	11.8	1.6	9.7	6.6	19.3	11.4	18.8	6.7	7.4	12.4	8.3	5	5.5	6.4	6.6	6.6	6.1	0	0.3	0	0	0	0	0	0	0	2.3	0	0	0.1	0	0	0	0	0	0	0	0.1	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	Club cells
RABL3	MGC23920	ENSG00000144840	RAB, member of RAS oncogene family like 3	Q5HYI8	3	120686681-120742993	Predicted intracellular proteins			Disease mutation	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	5	Cone photoreceptor cells: 110.0	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low cell line specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA035150, HPA035151	Uncertain		Approved	Nucleoplasm						Nucleoplasm		HPA035150: AB_2674493, HPA035151: AB_10601154	unprognostic (1.69e-2)	unprognostic (5.10e-2)	unprognostic (8.32e-2)	unprognostic (3.96e-2)	unprognostic (1.88e-1)	unprognostic (7.22e-2)	unprognostic (1.37e-1)	unprognostic (1.27e-1)	unprognostic (7.19e-2)	unprognostic (2.94e-1)	unprognostic (2.11e-3)	unprognostic (2.78e-1)	prognostic favorable (2.79e-5)	unprognostic (2.33e-1)	unprognostic (6.15e-2)	unprognostic (8.44e-3)	unprognostic (3.65e-1)	21.5	26.7	16.5	9.3	19.5	8.8	14.8	15.7	19.9	12.2	14.1	16.6	13.6	10.6	11.8	12.2	16.6	11	9.9	11.9	14.6	16.6	19.7	20.5	10.3	10.3	19.2	16.2	18.7	13.9	23.3	14.7	13.4	20.9	14.4	15.1	12.8	11.2	14.9	19.6	10.3	13	11.6	22.5	11.3	11.4	8.2	14	11.2	22.9	12.6	11.8	13.8	11.9	7.8	11.4	5.7	11.8	13.1	10.9	5.6	16.6	12.9	11.6	3.7	12.6	17.1	9.7	15	11.3	8.7	8.1	8.8	6.9	13.5	7.8	13.2	13.7	6.8	11.7	8.2	16.5	11.3	5.5	13.7	9.2	11.3	8.1	24	8.7	8.9	15.8	7.4	8.9	11.6	13	8.8	11.1	9.1	11.4	14.4	18.4	6.3	7.1	18.9	7.7	8.6	14.2	7.5	11.4	7.5	5.5	7.4	7.1	6.4	8.3	4.7	11.8	15.7	17.7	6.7	6	4.9	15.7	6.7	6.3	11.4	19	23.8	8.2	5.6	5.8	4.2	10.9	11.8	9	7.8	9.7	10.3	10.7	6.8	9.3	10.8	5.7	13.1	6.6	11.4	10.3	5.6	16.5	19.5	15.7	19.9	14.6	16.6	19.2	16.2	20.9	14	8.9	9.4	9.3	14.5	5.7	16.9	11.6	20.4	17.4	14.8	8.7	110	11.8	6.6	14.2	16.2	11.9	9.8	0	13.9	15.5	8.2	11.6	8.1	14.7	12.8	7.9	5.2	4.3	8.3	6.9	5.5	9.5	10.1	10.8	12.2	15.7	13.4	13.6	5.6	20.3	18	0	5.9	9.7	7.5	9.7	18.4	6.9	10.2	13.1	Cone photoreceptor cells
UCN2	SRP, UCN-II, UCNI, URP	ENSG00000145040	Urocortin 2	Q96RP3	3	48561727-48563773	Predicted secreted proteins		Hormone		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in some		skin 1: 18.6;vagina: 6.3	Cell type enriched	Detected in single	5	Basal keratinocytes: 2.6	Cancer enhanced	Detected in many		melanoma: 18.9	Low region specificity	Detected in single			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in many		hTCEpi: 15.7;hTEC/SVTERT24-B: 12.4;SiHa: 10.8;U-251 MG: 11.4;WM-115: 31.6	Not detected	Not detected			Not detected	Not detected			HPA066841	Uncertain		Approved	Vesicles	Secreted to blood			98600		Vesicles		HPA066841: AB_2685735	unprognostic (7.98e-2)	unprognostic (1.35e-1)	unprognostic (4.80e-2)	unprognostic (1.96e-2)	unprognostic (2.39e-2)	unprognostic (4.26e-2)	unprognostic (1.92e-3)	unprognostic (2.02e-3)	unprognostic (1.62e-1)	unprognostic (2.93e-3)	unprognostic (2.52e-3)	unprognostic (1.09e-1)	unprognostic (3.34e-14)	unprognostic (4.39e-2)	unprognostic (2.75e-1)	unprognostic (1.36e-1)	unprognostic (2.88e-2)	1.7	0	0.3	0.5	0.9	0.1	0.6	0.3	0.3	2	0.3	0.3	0.3	0.1	1.8	1.1	3.7	0.1	0.6	0.3	0.3	0.5	0.9	0.3	0.3	0.3	1.6	0.3	0.3	0.3	0	0.3	0.3	0.9	3.3	0.1	0.3	1.6	0.7	0.3	18.6	0.3	0.4	0.3	0.5	0.1	1.1	0.3	0.3	0.3	0.3	0.3	0.3	6.3	0	0	0	0	0	0	0	0	1.7	0.3	0	1	0.6	1.5	5.4	6.8	3.4	2.5	0	0	0	0.2	1.3	4.1	1	0	6.5	1.8	5	0.1	0.1	8.9	0.8	1.1	0	0.3	0.7	15.7	12.4	2.5	2.4	0	0.1	0	0.1	0.5	0	0	1	0.4	0	0.1	0.1	0.1	0	1	0	0	0	10.8	0	8.1	1	0.1	0.2	0	1.5	1	0.1	11.4	0	0.1	0	5.1	0	31.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0.9	0.3	0.3	0.3	0.5	1.6	0.3	0.9	0.3	0	0	0	0.3	2.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0.1	0	0	0	0	0	0.3	0	0	0	0	0	0.4	0	0	0	0	0	0.5	0	0	0	0	0	0	0	Basal keratinocytes
CCDC39	CILD14, DKFZp434A128, FAP59	ENSG00000145075	Coiled-coil domain containing 39		3	180614008-180870933	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level				Tissue enhanced	Detected in many		skeletal muscle: 12.4	Cell type enriched	Detected in single	16	Cardiomyocytes: 1.7	Low cancer specificity	Detected in some			Not detected	Not detected			Low cell type specificity	Detected in single			Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		ASC diff: 1.9;ASC TERT1: 2.7;HSkMC: 3.8;HUVEC TERT2: 1.2																						unprognostic (3.37e-1)	unprognostic (1.24e-1)	unprognostic (3.40e-2)	unprognostic (1.09e-1)	unprognostic (4.03e-2)	unprognostic (1.35e-4)	unprognostic (1.34e-1)	unprognostic (6.62e-2)	unprognostic (6.88e-2)	unprognostic (9.65e-2)	unprognostic (1.33e-1)	unprognostic (5.76e-2)	unprognostic (1.88e-4)	unprognostic (7.40e-2)	unprognostic (2.33e-1)	unprognostic (1.22e-3)	unprognostic (1.16e-4)	7.9	0.5	0.4	1	0.4	1.5	2.6	0.4	0.4	10.7	2.2	0	0.7	0.1	5.2	4.8	1.1	1	2.2	2.3	0.4	0.4	0.4	0.8	1.1	0.3	0.4	0	7.5	0.5	0	1.1	0.3	0.2	2	0.3	4.7	1.6	0.1	12.4	0.8	0.6	6	0.4	4.5	0.6	8.3	0	0	0.6	1.8	0	2.4	0.9	0.5	0.1	1.1	0.8	0.1	0.7	0	0	0	0	0.2	1.9	2.7	0	0	0	0	0	0	0	0	0.1	0	0.1	0	0	0	0	0	0	0	0.3	0	0	0.6	0.4	3.8	0	0	0	0.4	1.2	0	0	0	0	0	0	0.9	0	0	0.6	0	0	0	0	0.6	0	0.1	0	0	0	0.6	0	0	0	0.2	0.3	0.5	0.1	0	0	0	0	0.4	0	0.3	0.8	0.4	0.7	0.1	0.6	0.4	0.6	0.2	0	0.5	0.4	0.5	1.1	0.1	0.1	0.1	0.1	0	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0	0.2	0	0	0	0	0	0	0	1.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Cardiomyocytes
TM4SF19		ENSG00000145107	Transmembrane 4 L six family member 19	Q96DZ7	3	196319342-196338503	Predicted intracellular proteins, Predicted membrane proteins, Transporters				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enriched	Detected in many	5	adipose tissue: 69.9	Cell type enriched	Detected in some	9	Hofbauer cells: 78.9	Cancer enhanced	Detected in some		head and neck cancer: 3.4	Not detected	Not detected			Group enriched	Detected in some	6	gdT-cell: 14.8;memory CD8 T-cell: 3.8;naive CD8 T-cell: 5.4	Lineage enriched	Detected in single	19	T-cells: 14.8	Cell line enriched	Detected in some	12	GAMG: 100.5																						unprognostic (9.90e-2)	unprognostic (1.17e-2)	unprognostic (3.60e-2)	unprognostic (1.89e-2)	unprognostic (1.67e-1)	unprognostic (7.19e-2)	unprognostic (8.90e-5)	unprognostic (8.86e-3)	unprognostic (1.30e-1)	unprognostic (3.21e-2)	unprognostic (1.85e-1)	unprognostic (2.86e-1)	unprognostic (1.06e-3)	unprognostic (4.23e-2)	unprognostic (4.20e-3)	unprognostic (2.60e-1)	unprognostic (1.18e-3)	69.9	0.4	0.4	0.7	0.4	0.9	4.5	0.4	0.5	2.1	0.4	0.4	0.4	0	0.4	0.6	5	0.3	0.8	0.4	0.4	0.1	0.4	0.8	4.9	0.6	0.4	0.4	1.2	0.4	0	0.4	1.1	0.4	0.6	0.1	0.4	2.2	0.4	2.1	3.2	0.4	0.4	0.4	0.8	0.6	8.2	0.4	0.5	1	2	1.3	0.9	2.1	0.3	0.5	0.6	0.4	0.8	14.8	1.4	3.4	1.6	0.1	0.1	0.2	1.1	0.1	0	1	0.3	0.7	0	1.9	0	0.6	0	100.5	0.5	0	0.3	0.2	0.1	0	0.1	0.4	0	0.2	0.2	0.1	0.1	0.3	4.4	7.4	0	0	0.2	2.1	0.2	1.1	0.2	0	0.1	0	0	8.4	0	0.7	0.2	0	0	0	0	0.6	0	0.1	0.1	0.1	0	0.3	4.4	3.6	0.6	2	0.1	1.2	0	4.7	0.1	0.1	0.6	0.3	0.4	14.8	0.4	0.1	0.1	1.4	3.8	0.1	0.3	0.8	5.4	0.6	0.8	0.1	0.5	0.3	1.4	0.4	0.4	0.4	0.5	0.4	0.1	0.4	0.4	0.4	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	1.4	0	0	0	0.2	0.2	0	0	0	0	78.9	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	8.8	3.8	0	0.3	0	0	0	Hofbauer cells
AHSG	A2HS, FETUA, HSGA	ENSG00000145192	Alpha 2-HS glycoprotein	P02765	3	186612923-186621318	Cancer-related genes, Plasma proteins, Predicted secreted proteins	Mineral balance		Cancer-related genes, Disease mutation, Hypotrichosis, Mental retardation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	269	liver: 402.0	Cell type enriched	Detected in some	21	Hepatocytes: 986.2	Cancer enriched	Detected in some	284	liver cancer: 1231.6	Not detected	Not detected			Cell type enhanced	Detected in single		NK-cell: 1.4	Lineage enhanced	Detected in single		NK-cells: 1.4	Cell line enriched	Detected in some	77	Hep G2: 215.4	Not detected	Not detected			Not detected	Not detected			HPA001524, HPA001525, CAB026209	Enhanced		Enhanced	Golgi apparatus	Secreted to blood			864000000000	140000000000	Golgi apparatus		CAB026209: , HPA001524: AB_1078851, HPA001525: AB_1078849		unprognostic (6.40e-2)	unprognostic (1.31e-1)	unprognostic (2.03e-2)	unprognostic (3.20e-2)	unprognostic (1.07e-2)	unprognostic (1.16e-2)	unprognostic (7.47e-3)	unprognostic (3.05e-1)	unprognostic (5.27e-2)	unprognostic (8.64e-2)		unprognostic (3.99e-7)	unprognostic (5.21e-2)	unprognostic (5.21e-2)	unprognostic (1.04e-1)		0	0	0	0.1	0	0	0	0	0.1	0	0	0	0	0	0	0.6	0	0	0	0	0	0	0	402	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0.1	0	0.1	0	0	0.1	0	0	0	0	0	0	0	0	1.4	0.4	0	0	0	0	0	0	0	0	0	0	0	0	2.7	0	0	0	0	0	0	0	0	0	0	0	0	0.1	215.4	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0.1	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0.1	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	1.4	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	7.2	0	0	0	0.2	10.2	0	0	0	0	0.1	3.3	0.1	4.6	0	0	46.7	0.5	0.6	0	0	0	986.2	1.2	0	0	29.4	29.9	16.4	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0.1	0	1.6	0	0	0.1	Hepatocytes
VWA5B2	DKFZp761K032, LOC90113	ENSG00000145198	Von Willebrand factor A domain containing 5B2	Q8N398	3	184230429-184242329	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	5	adrenal gland: 35.9;brain: 10.1;pancreas: 11.0	Cell type enriched	Detected in some	34	Intestinal endocrine cells: 107.9	Low cancer specificity	Detected in some			Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	10	SCLC-21H: 27.1	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA036823, HPA036824, HPA061412	Enhanced		Approved	Nucleoplasm,Golgi apparatus						Golgi apparatus	Nucleoplasm	HPA036823: AB_10672269, HPA036824: AB_2675334, HPA061412: AB_2684507	unprognostic (3.92e-4)	unprognostic (1.70e-1)	unprognostic (1.69e-2)	unprognostic (2.56e-3)	unprognostic (3.37e-1)	unprognostic (1.60e-1)	unprognostic (1.70e-2)	unprognostic (1.21e-1)	unprognostic (3.80e-1)	unprognostic (1.21e-1)	unprognostic (4.32e-3)	unprognostic (3.73e-2)	unprognostic (1.12e-4)	unprognostic (3.13e-1)	unprognostic (3.65e-2)	unprognostic (2.36e-1)	unprognostic (1.83e-1)	0.4	35.9	9.2	0.4	4.8	0.2	0.4	9.8	10.1	0.5	2.5	0.4	0.4	1.7	0.4	0.4	0.4	1.2	0.4	0.4	9.5	3.3	0.4	0.4	2.4	0.4	1.9	0.4	3.7	11	1.6	3.4	0.4	0.4	0.9	0.4	0.4	0.5	2.4	0.4	0.1	2.4	0.4	0.4	0.4	2.8	1.1	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0	0	0	0	0	0	0	0	0.5	0	1.4	0	0	0	0	0	0	0	0.4	0	0	0.3	0	0	1.5	0.3	0	0	0	1	0	0.1	0	0	0	0.4	0	0	0	0	0	0	0.3	0	0.1	0	0.7	0	0	0	0	0	0.6	0.3	0.3	0	0	27.1	1.9	0	0	0	0	1.3	0	0	0	2.7	0.1	0	1.5	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	9.2	4.8	9.8	10.1	9.5	3.3	1.9	0.4	0.4	0.4	0	0	0	0	0	0.4	0.8	0	0	0	0	0	0	0	0	0.1	0	0	0	0.2	0	0	0	0	0	0.2	3.2	107.9	1.8	0	0	0	0	0	0	0.7	0.1	0.2	0.6	0	0	0.3	0	0	0	0.4	0	0	0	0.5	0	Intestinal endocrine cells
CORIN	ATC2, CRN, Lrp4, PRSC, TMPRSS10	ENSG00000145244	Corin, serine peptidase	Q9Y5Q5	4	47593998-47838106	Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins		Hydrolase, Protease, Serine protease		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	5	epididymis: 11.6;heart muscle: 39.5	Cell type enriched	Detected in some	5	Cardiomyocytes: 50.9	Low cancer specificity	Detected in some			Region enriched	Detected in single	5	pons and medulla: 1.6	Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	4	ASC TERT1: 32.6	Region enhanced	Detected in some		basal ganglia: 2.7	Low region specificity	Detected in single			HPA070941			Approved	Nuclear bodies,Plasma membrane,Actin filaments	Intracellular and membrane	Yes	No			Plasma membrane	Nuclear bodies, Actin filaments	HPA070941: AB_2686324	unprognostic (1.05e-1)	unprognostic (2.52e-1)	unprognostic (1.14e-1)	unprognostic (1.93e-1)	unprognostic (2.10e-1)	unprognostic (3.18e-1)	unprognostic (3.58e-4)	unprognostic (3.19e-1)	unprognostic (3.67e-2)	unprognostic (8.22e-2)	unprognostic (9.78e-2)	unprognostic (6.53e-2)	unprognostic (1.18e-1)	unprognostic (2.86e-2)	unprognostic (5.18e-2)	unprognostic (7.22e-2)	unprognostic (1.33e-2)	0.3	0.1	0.3	0	0.1	0	0.8	0.1	0.1	3.1	0.1	0.1	2.6	0	3.4	11.6	0.7	1.2	4.5	39.5	0	0.2	2	0	1.3	0	0.2	0	0.6	0.1	0	1.5	0.6	1.6	1.7	0	0.4	0.3	4.6	0.2	5.3	0.4	0.5	0	3.5	0.3	3.7	0	0.2	0.1	1.7	0.4	0.8	3.2	0.2	0	0.5	0.5	0	0.3	0	0	0	0	0.2	7.5	32.6	0	1.4	2.6	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0.1	0.1	0	0	1.5	0.2	0	0	0.1	0	0	0	0	1.2	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0.1	0	0	0	0.6	1	0	0.2	0.1	0.7	0	0	0	0	0	0	0.4	0	0.5	0.3	0	0.1	0	0	0.2	0	0	0.5	0	0.1	0	0	0	0.3	0.1	0.1	0.1	0	0.2	0.2	0	1.6	0	0	6.9	0	0.2	3.4	0.8	50.9	0	0	0	1.8	0	0	0	0	4.5	0.3	0	0	0	0	9.3	0.6	0	0	0.1	0	0	0	0.8	0.8	4.4	0	5	0	0	0.7	0	0	2.5	0	0.1	0	4.2	3	4.6	2.4	0	0	0	0.2	Cardiomyocytes
KLHL8	KIAA1378	ENSG00000145332	Kelch like family member 8	Q9P2G9	4	87160103-87240314	Cancer-related genes, Plasma proteins, Predicted intracellular proteins	Ubl conjugation pathway		Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		epididymis: 56.2	Cell type enriched	Detected in many	5	Muller glia cells: 205.6	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low cell line specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA013856, HPA017762	Approved		Enhanced	Nucleoplasm						Nucleoplasm		HPA013856: AB_1852594, HPA017762: AB_2669660	unprognostic (2.93e-2)	unprognostic (4.91e-3)	unprognostic (3.44e-2)	unprognostic (4.66e-2)	unprognostic (1.18e-1)	unprognostic (3.27e-2)	unprognostic (2.12e-1)	unprognostic (4.46e-3)	unprognostic (3.27e-2)	unprognostic (2.06e-2)	unprognostic (1.13e-1)	unprognostic (3.46e-1)	prognostic favorable (1.53e-5)	unprognostic (4.24e-3)	unprognostic (3.05e-1)	unprognostic (3.57e-3)	unprognostic (1.57e-3)	6.8	7.3	6.9	5.6	8.1	3	12	10	10.7	9.2	7.5	5.3	3.8	7.3	8.3	56.2	5.3	5.4	5	7.4	7.7	7.2	11.4	10.3	9	8.1	6.3	5.6	6.1	6.3	7.1	14.2	6.6	7.3	5.7	8.5	4.6	6.5	7.7	23.4	4.8	8.2	6.6	8	6.9	5.5	4.2	6.5	7	17.3	2.9	4.7	6.8	10.9	3.8	10.3	8.6	12.1	8.7	4.9	5	6.5	5.8	10.5	4.7	9.6	7	5.6	8.4	4.5	5.6	6.6	9.2	5	9.5	6.8	6.2	4.6	2.8	11.1	8.3	12.2	9.1	7	11.6	4.4	5.4	8.2	19	7.3	8.8	6	8.6	8.7	5.5	6.7	7.3	14.9	8.7	5.8	7.2	22.7	9.6	2.6	14.8	2.3	8.6	9	5.8	9.5	6.8	22	7.7	5.5	13.5	6.2	4.1	4.7	14.1	6.2	7.2	8.8	7.6	7	13.1	8.5	16.9	5.4	9.1	7.8	1.9	12.1	7.3	3	9.2	4.9	3.3	2.4	2.5	10.3	3.8	4.4	4.3	8.6	8.7	9	2.7	0.9	5	6.9	8.1	10	10.7	7.7	7.2	6.3	5.6	7.3	6.5	3	18.5	11.3	9.5	12.2	18.4	11.7	5.1	6.7	10.3	41.8	39.3	3.2	10	4.5	2.8	9.5	12.2	0	3.9	4.6	8.6	10.5	7	17.1	8.6	22.3	8.6	5.5	30.8	2.4	8.9	13.4	10.1	2.8	12	205.6	5	8.6	7.8	16.5	44.7	12.9	9.2	11.2	19.4	12.9	19.9	7.7	13.3	9.8	Muller glia cells
SPATA5	AFG2, SPAF	ENSG00000145375	Spermatogenesis associated 5	Q8NB90	4	122923074-123319450	Disease related genes, Predicted intracellular proteins	Differentiation, Spermatogenesis	Chaperone, Developmental protein, Hydrolase	Deafness, Disease mutation, Epilepsy, Mental retardation	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	8	Early spermatids: 147.3	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low cell line specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA036450, HPA036451	Approved		Approved	Cytosol						Cytosol		HPA036450: AB_2675131, HPA036451: AB_10670107	unprognostic (4.28e-1)	unprognostic (7.54e-2)	unprognostic (7.37e-3)	unprognostic (1.26e-1)	unprognostic (5.16e-1)	unprognostic (1.18e-1)	unprognostic (7.65e-4)	unprognostic (1.95e-3)	unprognostic (9.00e-2)	unprognostic (2.78e-1)	unprognostic (4.43e-3)	unprognostic (4.62e-2)	unprognostic (1.26e-2)	unprognostic (1.52e-1)	unprognostic (5.68e-1)	unprognostic (2.63e-2)	unprognostic (1.79e-1)	8.2	4.7	5.8	8.5	9.3	6	7.8	20.7	8	8.3	6.1	6.4	5.6	3.8	12.8	5.5	5.7	6	4.4	5.3	5.5	4.6	5.9	5.2	5.3	8	7.1	5.2	6.4	5.1	11.2	13.5	5.9	6.9	6	6.1	7.4	6.1	5.3	6.4	7.4	4.8	9.1	7.4	7.3	11.6	11.3	9	13.6	6.7	5	9.3	6.2	7	2.9	2.8	2.3	1.9	2.5	2.8	0.7	2.9	3.2	4	8	3.1	2.1	2.6	4.2	1.8	3.2	3.1	2.1	4.3	4.4	2.8	2.6	2.3	2.7	5.2	2.8	6.3	6.2	1.3	3.8	5.9	3.4	1.4	6.5	4.8	1.5	1.5	4.5	4.2	2	3.1	3	7.4	7.8	5.5	3.2	10.9	4.5	2.3	4.8	1.6	3.8	8.4	2.4	2.6	2.1	5.9	4.2	3.9	3.4	2.4	5.5	2.4	2.5	3.8	8.5	5.6	5.4	5	5.1	5.2	3.1	4.4	5.9	7.3	2.3	1.2	1.1	2.7	1.9	1.6	2	2.2	2.3	0.9	2.9	2.4	2.8	1.8	2.5	1.1	2.8	1.1	0.7	5.8	9.3	20.7	8	5.5	4.6	7.1	5.2	6.9	9	14.9	5.3	4.4	5.1	4.5	5.1	3.4	17.8	9.4	11.4	1.8	13.7	3.9	0	2.3	147.3	8	2	0	3.1	3.5	3.7	3	4.7	2.1	3	3.2	2.4	5.5	3.7	13.2	6.6	4.8	0	1	1.6	4.9	3.4	2.6	4.2	2.7	11.6	0	3.6	13.3	10	4.6	1.8	5.3	3.7	2.6	Early spermatids
RNF175	FLJ34190	ENSG00000145428	Ring finger protein 175	Q8N4F7	4	153710125-153760235	Predicted membrane proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in many		brain: 17.3	Cell type enriched	Detected in some	5	Early spermatids: 52.2	Low cancer specificity	Detected in some			Low region specificity	Detected in all			Group enriched	Detected in many	26	classical monocyte: 2.4;intermediate monocyte: 1.7;myeloid DC: 1.7;naive CD4 T-cell: 4.0;neutrophil: 4.5;non-classical monocyte: 3.6;T-reg: 1.1	Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		AF22: 7.9;HSkMC: 5.2;REH: 6.7;SH-SY5Y: 6.7;THP-1: 16.1;U-87 MG: 3.9									HPA035837	Uncertain											HPA035837: AB_10601609	unprognostic (3.23e-2)	unprognostic (4.12e-2)	unprognostic (3.34e-1)	unprognostic (1.48e-2)	prognostic unfavorable (3.11e-4)	unprognostic (9.00e-2)	unprognostic (2.65e-1)	unprognostic (7.15e-4)	unprognostic (1.17e-1)	unprognostic (2.96e-3)	unprognostic (6.30e-3)	unprognostic (1.42e-1)	unprognostic (3.63e-4)	unprognostic (7.25e-3)	unprognostic (3.27e-1)	unprognostic (1.28e-1)	unprognostic (7.66e-2)	2.7	4.8	8.6	5.4	14.3	9.5	1.3	9.3	17.3	5.4	0.8	1.4	0.8	0.8	0.8	2	1.5	0.6	2.2	4.4	9	12.1	0.6	0.5	2.2	2.2	6.4	9.8	0.5	1.1	0.4	3	0.6	13	4.7	0.6	0.6	3.4	6.7	0.5	1.6	0.9	0.6	2.5	3.4	0.8	2.8	1.8	0	0.6	0.3	1.3	1.8	1.5	0	1.7	4.5	3.6	0	4	1.2	0.1	0	7.9	0	0	0.6	0	0	2	0	0.1	0	0	0	0	0	0.1	0.1	0	0	0	0	0	0	0	0	0	0.2	0	5.2	0	0	0.1	0	0	0	0	0	0	0	0	1.5	2.7	0	0	6.7	0	0.3	0	0.1	0	6.7	0	0	0.2	0.1	0	16.1	0	0	0	0	0	0	0	0	3.9	0.9	0	0	2.4	0	0	1.7	0	0	0.1	0	1.7	0	4	0.1	4.5	0	3.6	0	1.1	1.2	8.6	14.3	9.3	17.3	9	12.1	6.4	9.8	13	1.8	0	0.3	0	0	0.3	0.2	1.7	0	1.4	0	0	0	0	0	0	52.2	0.2	0	0	0	0	1	0	0	0	0.5	0	0	0	4.1	10.2	0	1.4	1.7	0	0	0.6	0	0	0	0	1.3	0	0.3	1.4	1.4	0.3	0	0	0	0.1	Early spermatids
CDH18	CDH14, EY-CADHERIN	ENSG00000145526	Cadherin 18	Q13634	5	19472951-20575873	Predicted intracellular proteins, Predicted membrane proteins	Cell adhesion			Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	9	brain: 105.4	Cell type enriched	Detected in some	5	Early spermatids: 68.6	Low cancer specificity	Detected in some			Region enriched	Detected in all	7	cerebellum: 105.4	Low cell type specificity	Detected in some			Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		EFO-21: 5.8;GAMG: 10.1;hTERT-RPE1: 5.3;U-2 OS: 9.1;U-2197: 8.0	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA014416	Uncertain				Intracellular and membrane							HPA014416: AB_2668996	unprognostic (1.57e-1)	unprognostic (1.68e-1)		unprognostic (5.26e-7)	unprognostic (6.36e-2)	unprognostic (1.10e-1)		unprognostic (1.44e-2)		unprognostic (1.20e-1)	unprognostic (8.78e-2)	unprognostic (3.30e-2)		unprognostic (1.51e-2)	unprognostic (8.69e-2)		unprognostic (1.76e-2)	0.7	9.3	6.9	0.7	7.1	0.7	0.6	105.4	23.2	1	0.6	0	0	0.7	0.6	0.6	0.7	0.7	0.7	0.6	4.6	8.1	0.9	0.6	0.7	0.8	1.8	8.3	0.7	1.2	2.1	11.3	0.6	7.1	0.8	0.7	2.2	0.6	0.8	0.9	0.8	0.7	0.6	2.2	0.7	0.6	3.7	1.3	0	0.6	0	0.6	0.6	0.3	0.7	0.3	1.2	0.5	0.6	0.4	0.5	1.5	0	0.3	0	0.9	3.8	3.4	0.2	2.1	0.1	0.6	0	0	0	5.8	0	10.1	0.1	0	0	0.4	0	0	0.2	0	0	0	0	0.5	0.2	0.1	0.1	2.3	5.3	0	0.1	0.2	0.7	0.4	0.2	0	0.2	0.2	0	0.2	0	0.1	1.1	0	0	0.7	0.2	0.1	0.1	0	0.2	0.1	0	0	1.8	9.1	8	0	2.2	0	0	2.6	0	0	1.1	0.5	0.3	0.4	0.1	0.2	0.3	0.2	0.2	0.2	0.7	0.4	0.4	1.2	0.6	0.4	0.3	0.2	0.5	6.9	7.1	105.4	14.1	4.6	8.1	1.8	8.3	7.1	1.3	0	0	0	0.8	0	3	0.4	0	0	0	0	0	1.5	0	0	68.6	0	0	0	0	2.7	0	0.1	0	0	0.2	0	0	0	0	13.2	0.3	0	0	0	0	0.2	0	0	0.7	0	1.3	0	0	2.1	2.4	0	0.2	0	0	0	Early spermatids
ADAMTS16	ADAMTS16s	ENSG00000145536	ADAM metallopeptidase with thrombospondin type 1 motif 16	Q8TE57	5	5140330-5320304	Predicted secreted proteins		Hydrolase, Metalloprotease, Protease		Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 20.4;ovary: 16.3	Cell type enriched	Detected in some	6	Collecting duct cells: 7.0	Low cancer specificity	Detected in many			Group enriched	Detected in many	5	cerebellum: 20.4;cerebral cortex: 5.2	Cell type enriched	Detected in single	10	NK-cell: 3.6	Lineage enriched	Detected in single	10	NK-cells: 3.6	Cell line enhanced	Detected in some		hTEC/SVTERT24-B: 6.1;SuSa: 5.6;U-2 OS: 4.8;U-2197: 8.9	Low region specificity	Detected in many			Low region specificity	Detected in some			HPA067668			Approved	Nucleoplasm,Nuclear membrane,Midbody ring,Mitochondria	Secreted to extracellular matrix	Yes	No			Nuclear membrane, Mitochondria	Nucleoplasm, Midbody ring	HPA067668: 	unprognostic (8.48e-2)	unprognostic (1.19e-1)	unprognostic (2.86e-2)	unprognostic (1.98e-4)	unprognostic (1.91e-2)	unprognostic (5.04e-2)	unprognostic (7.64e-2)	unprognostic (7.80e-3)	unprognostic (2.12e-2)	unprognostic (5.44e-2)	unprognostic (1.51e-2)	unprognostic (2.18e-1)	prognostic favorable (3.29e-5)	unprognostic (1.20e-4)	unprognostic (1.46e-1)	unprognostic (4.59e-3)	unprognostic (2.86e-3)	7.4	0.4	1.8	0.5	2.8	0.6	1	20.4	5.2	2.6	0.9	0.1	3.7	0.6	2.3	11	1.9	1.1	8.8	0.9	1.7	0.5	5.4	0.6	0.9	0.2	0.5	1.9	16.3	6.3	0	0.5	0.2	2.2	0.7	0.4	0	0.4	0.8	0.5	0.5	0.6	10.4	0.6	0.4	0.6	0.8	0	0	0.8	0	0.1	3.4	1.5	0.2	0.1	0.3	0	3.6	0.2	0	2.5	2.7	2.7	0.1	0.2	0.6	0.2	0.1	0.1	0.6	0.9	0.1	2.4	0.1	3.3	0	4.7	0.2	0	0	0.8	0.1	1.6	0.1	3.8	0	0	0.3	0.1	0	0	6.1	0.2	0.7	0	0.3	0.8	0.4	1.1	0.1	0.1	0.3	1.7	0.1	2.5	0.5	3.2	0.1	0.1	0	1.1	0.1	0.1	0.1	0.2	5.6	0.1	0.2	0.1	3.2	4.8	8.9	2.1	0.5	0.2	0.1	4.6	0.1	0.4	0.3	0	0.1	0.2	0	0.2	0	0.2	0.1	0.1	0.2	0.2	0.1	0.3	3.6	0	0	0	0	1.8	2.8	20.4	5.2	1.7	0.5	0.5	1.9	2.2	0	0	1.1	0	0	0	1.2	0.4	0	0	0	7	0	0	0	0.1	0.2	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.6	0	0	0	0	0	0	0	0	0	Collecting duct cells
SHISAL2B	FAM159B	ENSG00000145642	Shisa like 2B	A6NKW6	5	64690308-64718090	Predicted membrane proteins				Evidence at protein level	Evidence at protein level	No human protein/transcript evidence	No human protein/transcript evidence		Tissue enhanced	Detected in some		brain: 7.3;pancreas: 16.1;stomach 1: 7.7	Cell type enriched	Detected in single	16	Pancreatic endocrine cells: 1.6	Cancer enriched	Detected in some	7	pancreatic cancer: 3.9	Group enriched	Detected in some	14	basal ganglia: 1.9;hypothalamus: 7.3;pons and medulla: 4.9	Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	4	NTERA-2: 5.9;RPTEC TERT1: 12.4	Not detected	Not detected			Low region specificity	Detected in all			HPA011778	Enhanced											HPA011778: AB_1848382	unprognostic (5.83e-2)	unprognostic (9.32e-2)	unprognostic (1.40e-1)	unprognostic (1.84e-2)	unprognostic (3.25e-1)	unprognostic (5.01e-2)		unprognostic (1.49e-1)		unprognostic (9.12e-2)	unprognostic (2.97e-1)	unprognostic (4.84e-2)	unprognostic (5.36e-5)	unprognostic (1.44e-1)	unprognostic (1.98e-1)	unprognostic (5.60e-1)	unprognostic (6.99e-2)	0.1	0	0.3	0	1.9	0	0	0	0.3	0	0.2	0	0	0.6	0	0	0	0	0	0	0.3	7.3	0.2	0	0.2	0	0.2	0	0.2	16.1	0	0.1	0.5	4.9	0.1	0	3.2	0	0	0	0	0.2	0	0	0	7.7	0.6	0.2	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5.9	0	0	0	0	0	12.4	0	2.1	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	1.9	0	0.2	0.3	7.3	0.2	0	4.9	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	1.6	0	0	0	0	0	0	0	0	0	0	0	0	0	Pancreatic endocrine cells
ANKRD31	FLJ40191	ENSG00000145700	Ankyrin repeat domain 31	Q8N7Z5	5	75068275-75236878	Predicted intracellular proteins	DNA recombination, Meiosis			Evidence at protein level	Evidence at protein level				Tissue enhanced	Detected in some		pituitary gland: 5.7;testis: 13.2	Cell type enriched	Detected in some	6	Spermatocytes: 136.0	Not detected	Not detected			Low region specificity	Detected in many			Cell type enhanced	Detected in some		naive CD4 T-cell: 2.1	Lineage enhanced	Detected in single		T-cells: 2.1	Cell line enhanced	Detected in some		AN3-CA: 4.4	Not detected	Not detected							HPA057566	Enhanced											HPA057566: AB_2683470	unprognostic (1.37e-1)	unprognostic (4.28e-2)	unprognostic (5.25e-2)	unprognostic (5.57e-2)	unprognostic (1.65e-1)	unprognostic (5.72e-2)	unprognostic (4.81e-2)	unprognostic (2.52e-2)	unprognostic (3.63e-1)	unprognostic (1.83e-1)	unprognostic (1.02e-2)	unprognostic (1.69e-1)	unprognostic (3.00e-2)	unprognostic (4.46e-2)	unprognostic (5.48e-2)	unprognostic (1.24e-2)	unprognostic (1.40e-1)	0.5	0.6	1.7	0.3	2.4	0.3	0.8	0.5	2.8	1.7	0.4	0.8	0	0.5	0.6	1	2.1	0.9	0.7	0.8	1.1	0.5	0.9	0.5	0.4	1	0.5	2.2	0.9	0.6	1.5	5.7	0.3	4.3	0.5	0.3	0.8	1.7	0.5	0.3	0.5	0.6	0.9	1.1	0.6	0.5	13.2	0.4	1.7	0.5	0	0.7	0.5	1.8	0.5	0.1	0	0	0	2.1	0.2	1.1	0.4	0.7	4.4	0.1	0.4	2.1	0.3	0.3	0.3	0.3	1.1	1.1	0.5	0.5	0	1.6	0.1	0.7	0.3	0.5	0.5	0.9	0.6	0.1	0	0.1	0.2	0.2	0.3	0.4	0.1	0.6	0.1	0	2.1	0.6	1.2	0	0.8	1.1	0.1	1	0.3	0	0.3	0.1	0	0.1	0.3	1.2	1.5	0.1	0.1	0.8	0.1	0.9	0.1	0	0.9	0.6	0.6	0.3	1.3	1	0.8	0.8	0.3	0.3	0	0	0	0.2	0	1	0	0.8	0.6	0	0.5	2.1	1.4	0	0	0	0.1	1.8	0.2	1.7	2.4	0.5	2.8	1.1	0.5	0.5	2.2	4.3	0.4	0	0.3	0	0.3	0.3	2.2	0.8	0	1.4	0	0	0	0.3	0	0.3	3	0	0	0	0.2	0.4	0.2	0	11.5	0	0.1	1.6	0	0	0	4.4	1.4	0	0	0	0	1.1	0.1	0	0.4	0	1.6	12.9	0	136	21.5	0.1	0.2	0	0	0	Spermatocytes
CRHBP	CRF-BP, CRFBP	ENSG00000145708	Corticotropin releasing hormone binding protein	P24387	5	76952713-76981158	Plasma proteins, Predicted secreted proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 24.9;liver: 99.9	Cell type enriched	Detected in some	15	Ito cells: 1768.4	Cancer enhanced	Detected in some		testis cancer: 2.5	Region enhanced	Detected in many		hypothalamus: 24.9	Cell type enriched	Detected in single	4	neutrophil: 1.2	Lineage enriched	Detected in single	4	granulocytes: 1.2	Cell line enhanced	Detected in some		BJ hTERT+ SV40 Large T+: 5.0;BJ hTERT+ SV40 Large T+ RasG12V: 4.9;HBF TERT88: 8.9;RPMI-8226: 3.0;U-698: 9.7;U-87 MG: 5.4;WM-115: 4.6	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA036234, HPA046120	Approved	Supported			Secreted to blood				43000000			HPA036234: , HPA046120: AB_10959760	unprognostic (1.41e-1)	unprognostic (2.00e-2)	unprognostic (1.14e-1)	unprognostic (1.78e-3)	unprognostic (1.18e-1)	unprognostic (1.65e-1)	unprognostic (2.36e-3)	unprognostic (4.44e-5)	unprognostic (2.16e-1)	unprognostic (7.08e-2)	unprognostic (4.98e-4)	unprognostic (1.09e-1)	unprognostic (6.63e-5)	unprognostic (2.76e-2)	unprognostic (4.64e-1)	unprognostic (1.74e-1)	unprognostic (2.95e-2)	8.4	5.6	3.5	0.4	5.4	1.2	2.6	0	7.8	1.6	0.3	3.2	1.8	0.4	1.2	0.7	0.2	0.9	0.5	3.2	4	24.9	16.1	99.9	0.3	0.4	2.7	5.4	0.8	0.2	0.4	0	18.1	1.8	0.6	0.3	1.5	0.6	1.9	0.5	0.2	0.3	0.8	2.2	13.9	0.3	0.5	1.2	0	1.9	0.9	0.4	0.5	0.2	0	0	1.2	0.1	0	0.2	0.8	0	0	0.6	0	0.1	0.1	0	0	0.1	5	4.9	0	0	0	0	0	0.2	0	0	0	8.9	0	0	0.1	0	0	0	0.2	0.7	0	0	3	0.1	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0.3	3	0	0	0	0	0	0	0	0.3	0	0	0	0.5	0	2.6	0	0.1	0	9.7	5.4	0	4.6	0	0.1	0	0.2	0	0	0	0	0	0	0	0	0	1.2	0	0	0	0	0.8	3.5	5.4	0	7.8	4	24.9	2.7	5.4	1.8	1.2	0	0	23.4	0	0.3	0	0.6	22.9	0	0	0	0	0.2	0	0	0.2	18.4	0	0	0.2	0.3	0.4	0	0	4.9	1.6	0	0	1768.4	116.1	0.6	0.3	1	0	0	0	0	0	0	0	1.7	0	0	0	0.1	0.2	0	0	1.3	0	0	Ito cells
LIX1	C5orf11, Lft	ENSG00000145721	Limb and CNS expressed 1	Q8N485	5	97091867-97142872	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enriched	Detected in many	4	brain: 35.9	Cell type enriched	Detected in some	16	Muller glia cells: 199.8	Cancer enhanced	Detected in many		glioma: 13.0	Low region specificity	Detected in all			Cell type enriched	Detected in some	5	naive B-cell: 5.9	Lineage enriched	Detected in single	9	B-cells: 5.9	Group enriched	Detected in some	11	RPTEC TERT1: 24.5;SuSa: 19.2	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA058426	Uncertain		Approved	Vesicles,Cytokinetic bridge,Cytosol		Yes				Cytosol	Vesicles, Cytokinetic bridge	HPA058426: AB_2683715	unprognostic (3.18e-1)	unprognostic (4.53e-2)	unprognostic (9.46e-2)	prognostic unfavorable (2.48e-4)	unprognostic (8.96e-2)	unprognostic (6.60e-2)		unprognostic (1.34e-1)	unprognostic (4.70e-1)	unprognostic (7.63e-2)	unprognostic (1.58e-2)	unprognostic (3.52e-1)	unprognostic (2.01e-1)	unprognostic (4.88e-2)	unprognostic (2.16e-1)	unprognostic (1.26e-1)	unprognostic (9.61e-2)	1	1.2	14.9	1.3	16.9	1.4	1.1	6.1	35.9	1	1.3	19.2	1	1.2	1.2	1.2	1	1.2	1.1	1.1	24.6	10.7	4.9	1	1.1	1.6	11.7	13.2	1	1	1	1.2	1.4	12.4	3	1.4	3.3	1.1	8.3	1.1	1.1	1.2	1.2	10.1	1.2	1.2	1.1	13	0	6.5	0	1	1	0.2	5.9	0.1	0.6	0.1	0	0.2	0	0	0	2	0	0	0	0	0	0	0	0	0.3	0	0	0.2	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0.9	0	0	0	0	0	24.5	0	0	0	0	0	0	19.2	0	0	0	0	0	0	0	0	0	0.1	0.1	0	0	0.6	0.1	0	0.1	0	0.2	1.2	0.1	0	0	5.9	0.1	0.1	0.3	0	0	0.1	0	0	14.9	16.9	6.1	11.9	24.6	10.7	11.7	13.2	12.4	13	0	0	0	0	0	1.9	0.5	0	0	0	12.2	0	0	0	0	0	0	0	0	0	0	1.2	0.1	0	0	0.1	3.2	0	0	0	0	0	0	0	0	0	199.8	0	0	0	1.4	4.9	0	0.1	0	0	0	0	0	0	0	Muller glia cells
MEGF10	KIAA1780	ENSG00000145794	Multiple EGF like domains 10	Q96KG7	5	127290831-127465737	Disease related genes, Predicted intracellular proteins, Predicted membrane proteins	Cell adhesion, Myogenesis, Phagocytosis		Disease mutation	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 25.8	Cell type enriched	Detected in some	6	Muller glia cells: 48.7	Cancer enhanced	Detected in some		glioma: 3.8	Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	5	AF22: 21.6;RH-30: 26.5	Low region specificity	Detected in all												Intracellular and membrane				27000000				unprognostic (7.02e-2)	unprognostic (4.50e-2)	unprognostic (1.02e-1)	unprognostic (2.26e-3)	unprognostic (8.91e-3)	unprognostic (1.59e-2)	unprognostic (1.35e-1)	unprognostic (1.16e-1)	unprognostic (1.99e-1)	unprognostic (2.13e-1)	unprognostic (1.52e-1)	unprognostic (1.41e-1)	unprognostic (1.76e-4)	unprognostic (5.28e-3)	unprognostic (2.59e-1)	unprognostic (9.36e-4)	unprognostic (1.17e-1)	1.3	5.1	9.8	1.2	12.9	0.9	2.8	3.3	24.6	1.8	1.4	25.8	0	1.2	2.8	2	1.2	1.2	1.1	1.5	11.6	5.6	1.1	1.8	1	1	21.7	10.4	1.2	0.9	0.9	2.4	1.2	12.2	2.8	1.5	2.4	5	3.7	7.3	1.1	1.3	1.6	14.8	1.2	1	1.9	23.1	0	1.1	2	1.5	1	0.4	0	0.3	0	0	0	0	0	0	0	21.6	0	0	0	0	0	1	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.8	0	4.7	0	0.1	0.1	0	0	0	1.7	0	0	0	2.3	0	0	0	26.5	0	0	0	0	0	0	0	1.7	0.5	0	0	0	0	1.4	0	0	0	0	0	1	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	9.8	12.9	3.3	10.8	11.6	5.6	21.7	10.4	12.2	23.1	0	0	0	0	0	2	0.8	0	0	0	0	0	0	0	0	1.7	0	0	0	0	0	0.1	0.5	0	0	0	7.9	0	0	0.3	0.8	0	0	0	0	0	48.7	0	0	0	0	1.6	0	0	0.3	0.4	0.1	0	0	0	0	Muller glia cells
N4BP3	LZTS4	ENSG00000145911	NEDD4 binding protein 3	O15049	5	178113443-178126087	Predicted intracellular proteins	Neurogenesis	Developmental protein		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		placenta: 31.5	Cell type enriched	Detected in many	4	Extravillous trophoblasts: 120.1	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Group enriched	Detected in some	4	memory B-cell: 4.0;naive B-cell: 4.0;naive CD8 T-cell: 2.6;plasmacytoid DC: 4.4	Group enriched	Detected in many	18	B-cells: 4.0;dendritic cells: 4.4;T-cells: 2.6	Cell line enhanced	Detected in many		BEWO: 8.0;MCF7: 10.9;RH-30: 10.9;SK-BR-3: 38.8	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA030972, HPA030973, HPA061387	Approved		Supported	Nucleoplasm,Centrosome						Nucleoplasm	Centrosome	HPA030972: AB_2673680, HPA030973: AB_10603574, HPA061387: 	unprognostic (1.84e-1)	unprognostic (1.70e-2)	unprognostic (4.96e-3)	unprognostic (6.64e-3)	unprognostic (2.06e-1)	unprognostic (3.18e-3)	unprognostic (1.88e-6)	unprognostic (1.45e-1)	unprognostic (1.61e-1)	unprognostic (1.92e-2)	unprognostic (3.28e-3)	unprognostic (9.55e-2)	prognostic favorable (2.38e-4)	unprognostic (2.62e-1)	unprognostic (1.16e-1)	unprognostic (1.22e-1)	unprognostic (1.06e-1)	6.6	1.3	1.9	2.6	2.1	3.5	13.9	6.5	4.3	2.5	1.8	0.7	0.5	0.8	1.1	0.6	16.2	1.5	1.3	3.2	1.8	2.6	2.5	0.2	8.4	4	2.1	1.2	1.4	1.1	10.1	2.5	31.5	3.1	2	0.6	1.5	9.5	1.3	5.7	7.8	1.9	1.3	1.2	5.9	3.1	1.4	1.3	0.4	2	4.7	11.2	4.9	3.8	4	4.4	0	0	0.2	2.6	0.5	0	0	1.2	0.9	0.1	0	8	0	0	0	0	1.7	0.6	0.7	1.1	0	0.1	2.5	0.2	0	0	1.2	0.4	2.1	0.8	0	0	0.1	0	0.1	0.2	0	0	0	6.4	0.7	1.3	0.5	0	10.9	0.1	0.1	6	1.8	0	6	10.9	2.7	0.6	1.2	0.9	0.4	0.3	38.8	2.5	1.6	1.4	0	1.2	0	0.9	0	0	1.7	1.2	6.8	0	0	0.4	0	0	0	0.4	0	0.3	4	0.2	0.2	0	4	0.9	2.6	0	0.2	0	4.4	0	0.5	1.9	2.1	6.5	4.3	1.8	2.6	2.1	1.2	3.1	1.3	3	1.1	5.9	11.5	8.4	27.3	1.5	2.5	0	0	1.8	11.8	1.7	11.6	3.4	0.1	4	2.6	0	0.7	120.1	0.9	9.9	4.6	0	2	1.6	4.1	0	0	0.4	0.6	1.1	11.8	1.8	1.8	1.9	4.7	5.3	1.8	0.3	8.9	0	0.9	0.1	6.9	5.9	19.3	1	1.9	10.6	Extravillous trophoblasts
KCNMB1	hslo-beta	ENSG00000145936	Potassium calcium-activated channel subfamily M regulatory beta subunit 1	Q16558	5	170374671-170389677	FDA approved drug targets, Predicted membrane proteins, Transporters	Ion transport, Transport	Ion channel	FDA approved drug targets	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		smooth muscle: 55.5	Cell type enriched	Detected in many	6	Peritubular cells: 333.0	Low cancer specificity	Detected in many			Low region specificity	Detected in some			Low cell type specificity	Detected in many			Group enriched	Detected in many	5	dendritic cells: 7.0;monocytes: 7.1	Cell line enhanced	Detected in some		REH: 13.0;SK-BR-3: 3.2;U-937: 5.4	Low region specificity	Detected in some			Low region specificity	Detected in single																unprognostic (2.06e-2)	unprognostic (2.70e-4)	unprognostic (1.69e-2)	unprognostic (1.27e-1)	unprognostic (3.37e-2)	unprognostic (8.88e-2)	unprognostic (1.61e-2)	unprognostic (3.46e-1)	unprognostic (2.28e-1)	unprognostic (4.68e-2)	unprognostic (5.37e-1)	unprognostic (1.00e-1)	prognostic unfavorable (4.13e-6)	unprognostic (1.08e-1)	unprognostic (2.49e-1)	unprognostic (4.31e-2)	unprognostic (1.04e-2)	3.2	1	0.6	7.7	0.5	0.7	4.2	0.4	0.6	26.8	34.7	0.8	12.6	2.2	31.3	10.6	29.8	10.9	32.4	2.6	0.6	0.7	1.9	0.4	2.2	1.3	1.1	0.9	8.7	0.5	0.1	0.5	0.9	2.2	29.4	5	5.6	5.3	29.3	0.9	1.6	11.4	55.5	1.5	1.1	13.4	8	0.6	0.3	1	1.5	1.6	43.4	6.4	0.5	7	1.4	7.1	0.6	0.3	1	0.1	0.2	2.3	0.6	0.2	0	0.4	0.3	0.1	0.1	0.1	0.5	0.4	0.2	1.6	0.1	0.6	0.2	0.1	0.1	0.1	0.5	0.1	1.5	0.8	0.3	0	0.6	0.4	0.4	0	0.2	0.4	0.2	0.2	0.7	0.5	1.1	0.1	1	0	1.4	0.4	0.1	0.2	13	0.1	0.3	0.1	0.4	0.5	0.3	0.1	3.2	0	1.1	0.2	1.4	0.8	0.3	0.5	0.5	0.1	0.8	0.3	0.2	0.2	5.4	0.2	1.3	4.3	0.4	0.2	7.1	0.1	0.2	0.3	0.2	7	0.5	0.2	0.2	1.4	0.6	6	2.6	0.2	1	0.6	0.5	0.4	0.5	0.6	0.7	1.1	0.9	2.2	0.6	0	7.5	1.3	1	1.8	1.5	2.6	2.5	8.1	7.9	1.8	5.9	0.5	0	0.1	0.5	2.7	0	0	0.4	0.6	14.4	1	19.6	0	7.7	1.6	0	1.8	9.1	1.6	35.6	21.4	3.3	29.7	0	1.1	0	0	333	0	1.8	45.3	59.8	0.7	0.9	1.5	0.5	0	0	0.5	Peritubular cells
PLA2G7	LDL-PLA2, PAFAH	ENSG00000146070	Phospholipase A2 group VII	Q13093	6	46704201-46735693	Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins	Lipid degradation, Lipid metabolism, Phospholipid degradation, Phospholipid metabolism	Hydrolase	Asthma, Disease mutation	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		adipose tissue: 57.0;lymphoid tissue: 32.9	Cell type enriched	Detected in some	13	Hofbauer cells: 332.5	Cancer enhanced	Detected in all		prostate cancer: 37.2	Low region specificity	Detected in all			Cell type enhanced	Detected in some		classical monocyte: 24.2	Group enriched	Detected in many	56	dendritic cells: 7.9;monocytes: 24.2	Cell line enhanced	Detected in some		GAMG: 2.2;NTERA-2: 3.9;PC-3: 7.9;RT4: 3.6;U-2 OS: 3.7	Low region specificity	Detected in all			Low region specificity	Detected in all								Secreted to blood			7380000	170000000				unprognostic (3.63e-3)	unprognostic (2.82e-3)	unprognostic (8.69e-2)	unprognostic (3.00e-1)	unprognostic (1.47e-1)	unprognostic (6.26e-2)	unprognostic (9.45e-2)	unprognostic (1.79e-1)	unprognostic (1.95e-1)	unprognostic (1.43e-1)	unprognostic (2.06e-2)	unprognostic (5.33e-2)	unprognostic (2.35e-2)	unprognostic (2.47e-1)	unprognostic (9.20e-2)	unprognostic (1.93e-1)	unprognostic (7.08e-2)	57	2.1	2.8	14	5.8	1.1	2.9	2	2.7	1.5	4.4	2	0.4	2.3	2.9	1.6	0.8	1.4	3.6	2	2.1	1.7	1	4.3	19	22.2	3.2	1.8	4	0.9	0.1	3.1	15.8	2.3	8.5	6.6	2.8	2.5	1.6	0.9	2.3	3.7	1.5	7.1	32.9	1.4	0.7	2	6.4	13.1	0.6	6	7.2	0.8	0.1	7.9	0.2	24.2	0	0.2	6.1	0	0.5	0.3	0	0	0	0.2	0	0	0	0	0.2	0	0.1	0.5	0	2.2	1.6	0	0.1	0	0.2	2	0	1	0	0.1	0	0	0.1	0	0	0.2	0.1	0	0	0	0.1	0.1	0	0	0.3	3.9	0	7.9	0	0	0.1	0	3.6	0.1	0.5	0	0	0	1.1	1	1	0	0	3.7	0.1	0.9	0.1	0	0	0	0.2	1.3	0	24.2	0.1	0	5	0.2	0.1	0	0	7.9	0	0	0	0.2	0	0.2	0.1	0	6.1	2.8	5.8	2	2.7	2.1	1.7	3.2	1.8	2.3	2	0	2.2	0	3.6	0.7	0	0.2	0	0	0	0	0	1.4	0	0.4	0	0	0	0	0	2.8	0.9	8.7	0	0	332.5	1.6	3.4	0	19	0	0	25.7	10.1	22.6	0	0	0.2	0	0	0	0	0	0	0	0	0.1	2.6	0	0	3.3	Hofbauer cells
DAAM2	KIAA0381	ENSG00000146122	Dishevelled associated activator of morphogenesis 2	Q86T65	6	39792298-39904877	Predicted intracellular proteins	Wnt signaling pathway			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		brain: 83.3	Cell type enriched	Detected in many	5	Sertoli cells: 148.8	Cancer enhanced	Detected in all		melanoma: 21.5	Low region specificity	Detected in all			Cell type enriched	Detected in single	29	neutrophil: 2.8	Lineage enriched	Detected in single	29	granulocytes: 2.8	Cell line enhanced	Detected in some		HSkMC: 25.8;JURKAT: 13.8;LHCN-M2: 25.3;SK-MEL-30: 31.3;WM-115: 12.2	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA051300, HPA054630	Approved		Supported	Nucleoplasm,Vesicles,Cytosol						Nucleoplasm	Vesicles, Cytosol	HPA051300: AB_2681430, HPA054630: AB_2682549	unprognostic (7.53e-2)	unprognostic (6.02e-3)	unprognostic (4.49e-2)	unprognostic (7.93e-2)	unprognostic (8.24e-2)	unprognostic (4.28e-2)	unprognostic (2.43e-2)	unprognostic (1.05e-3)	unprognostic (1.33e-1)	unprognostic (5.89e-2)	unprognostic (2.17e-1)	unprognostic (5.24e-2)	prognostic unfavorable (2.79e-4)	unprognostic (2.67e-2)	unprognostic (8.54e-2)	unprognostic (7.94e-2)	unprognostic (8.54e-4)	21.5	17.8	34.8	6.7	43	1.7	7.8	4.4	52.2	9.3	6.4	83.3	8	7.6	7.5	8.5	28.3	8.9	5.9	6.1	40.4	25.2	5.9	4	8.4	2.8	42.8	24.8	7.3	5.2	3.5	2.1	9.4	41.3	8.7	7.1	5.1	4.3	17.6	23.8	4.4	8.9	13.7	48.8	15.5	7	8.7	51.9	0	5	2.1	2.2	4.6	4.1	0	0	2.8	0	0	0	0	0	0	2.6	0	5.7	0.1	0.1	4.4	5.9	1	0.5	0.4	0	0	0.2	6.6	2.1	0	0	0	0.4	0	1	0	0	0	4.1	0	0	25.8	0	0.1	0	7.2	0	13.8	0	0	25.3	0	0.6	0	0.7	1.3	0	0	4.6	3.5	0	0	0.9	1	0	0.3	31.3	5.6	0	0	0.2	9.6	2.8	0.1	0.1	0	0	0	0.1	0	12.2	0	0	0	0	0	0	0	0	0	0	0	0	0	2.8	0	0	0	0	0	34.8	43	4.4	28.9	40.4	25.2	42.8	24.8	41.3	51.9	8.9	9.8	0	0.8	1.5	1.7	2.1	0	2.7	6.8	0	0	0.4	0	0.4	3.6	2	0	0	3	0.4	11.3	0.8	0	1	0.2	0	0	3.1	15.2	4.2	21.9	3.1	8.5	0	0	8.2	0.4	0	20.8	0	1.5	148.8	28.3	0.7	1.1	1	0.2	0	0	1	Sertoli cells
MLIP	C6orf142, CIP, MGC18257	ENSG00000146147	Muscular LMNA interacting protein	Q5VWP3	6	53929982-54266280	Disease related genes, Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	5	heart muscle: 61.7;liver: 47.4;skeletal muscle: 101.9;tongue: 31.6	Cell type enriched	Detected in some	10	Cardiomyocytes: 190.6	Cancer enhanced	Detected in some		liver cancer: 1.9	Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	8	HUVEC TERT2: 18.1;SK-MEL-30: 17.4					Low region specificity	Detected in many			HPA029252, HPA046654	Approved		Approved	Nucleoplasm						Nucleoplasm		HPA029252: AB_2732446, HPA046654: 	unprognostic (7.95e-3)	unprognostic (4.39e-2)	unprognostic (2.36e-1)	unprognostic (1.06e-4)	unprognostic (2.38e-2)	unprognostic (1.26e-2)	unprognostic (5.60e-2)	unprognostic (2.74e-2)	unprognostic (1.89e-2)	unprognostic (1.78e-1)	unprognostic (1.03e-1)	unprognostic (1.32e-1)	unprognostic (1.91e-5)	unprognostic (7.49e-2)	unprognostic (2.65e-2)	unprognostic (5.27e-2)	unprognostic (3.29e-3)	5.7	1.9	4.2	0.2	5.2	0.1	1.6	0.8	11.5	0.8	0.5	0	0	0.3	0.4	3.5	4.9	0.5	0.8	61.7	1.8	0.8	0.5	47.4	0.4	0.2	7.2	8.3	0.4	0.6	0.3	0.5	0.2	1.8	0.8	0.4	1.3	2.6	0.3	101.9	6.5	1.1	0.3	2.9	0.3	0.4	0.5	0	0	2.7	31.6	2.2	0.6	1	0	0	0.1	0	0	0.3	0	0	0	0.3	0	0.1	0	0	0	0	0	0	0.5	0	0	0.1	0	0	0.4	2.1	0.1	0	0	0.1	0.2	0	0	0	0	0	0.7	2.2	0	0	0	18.1	0.1	0	0	1.8	0	0	0	0	0.3	0	0.3	1.2	0	0.1	0.6	1.3	0	0	0.5	17.4	0.2	0	0	0	0	0.1	0	0.1	1.4	0	0	0	0.1	0.2	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0.1	0	0	0	0	0	4.2	5.2	0.8	11.5	1.8	0.8	7.2	8.3	1.8	0	0	0	0	0	0.3	0	190.6	0	0	0	0	0	0	1.7	0	11.7	0.5	0	0	0	0	0.3	0.1	0	18.3	0	12.7	0	0.6	1.5	8.2	0.3	0	6.8	0	0.3	0	0	0	0	1.1	0	0	0.3	0.2	0.1	1.8	0	0	0	0.1	Cardiomyocytes
HMGCLL1	bA418P12.1, DKFZP434G1411	ENSG00000146151	3-hydroxymethyl-3-methylglutaryl-CoA lyase like 1	Q8TB92	6	55434369-55579214	Enzymes, Predicted intracellular proteins		Lyase		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 18.4;pituitary gland: 14.8	Cell type enriched	Detected in some	4	Bipolar cells: 14.1	Low cancer specificity	Detected in single			Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	5	SCLC-21H: 11.7	Low region specificity	Detected in all			Low region specificity	Detected in all																unprognostic (2.74e-3)		unprognostic (1.54e-2)	unprognostic (4.08e-3)	unprognostic (6.11e-2)	unprognostic (1.41e-1)	unprognostic (9.54e-3)	unprognostic (8.97e-3)		unprognostic (2.12e-2)	unprognostic (9.27e-3)	unprognostic (4.11e-2)	unprognostic (1.18e-4)	unprognostic (3.13e-3)	unprognostic (7.57e-2)	unprognostic (2.55e-1)	unprognostic (1.52e-1)	2.2	7.7	7.7	0.9	14.5	0.5	3.4	10.1	18.4	2.2	1.7	3.1	0.3	0.8	0.8	0.6	2.5	1.5	1.8	4.1	8.7	12.6	2.2	1.8	5.7	1.1	9.1	10	1.3	3.6	0.8	14.8	12.5	14.6	7	2.2	4.8	2.1	2.9	2.4	0.6	2.4	1.6	10.1	0.6	2.9	5.5	3.3	0	0.9	0	1	2.7	1.1	0	0	0	0	0	0	0	0	0.7	1	0	0	0	0	0	0	0	0	0	0	0	0	0	1.7	0	0	0	0	0	0.3	0	0.6	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0.7	0	0	1.2	0	0	0	0	0	0	0	11.7	0.3	0	0	0	2.3	0.9	0	0	0	0.6	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	7.7	14.5	10.1	12.6	8.7	12.6	9.1	10	14.6	3.3	0	2.2	0	0	0	14.1	0.4	0	0	0	0	0	0	0	0	1.9	0	0	0	0	0	1.3	0	0	0	0.1	0	0	3.1	0	0.4	0.3	0	0	0	0	1.5	0.5	0	0	0	1.4	0	3.4	0.7	0	0	0	0	0	0	Bipolar cells
PRSS35	C6orf158, dJ223E3.1, MGC46520	ENSG00000146250	Serine protease 35	Q8N3Z0	6	83512538-83525704	Enzymes, Predicted secreted proteins		Serine protease homolog		Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		blood: 17.1;ovary: 16.3	Cell type enriched	Detected in some	55	Muller glia cells: 458.8	Cancer enhanced	Detected in some		testis cancer: 4.7	Low region specificity	Detected in many			Cell type enriched	Detected in some	9	MAIT T-cell: 17.1	Lineage enriched	Detected in single	172	T-cells: 17.1	Cell line enhanced	Detected in some		BJ hTERT+: 5.2;CACO-2: 42.7;HAP1: 6.4;RPTEC TERT1: 12.6;SuSa: 9.6	Low region specificity	Detected in all			Group enriched	Detected in many	4	amygdala: 4.2;cerebellum: 7.0;cerebral cortex: 7.5;hippocampal formation: 6.8;olfactory region: 5.7	HPA038787, HPA038788	Uncertain				Secreted in female reproductive system							HPA038787: AB_10675951, HPA038788: AB_2676208	unprognostic (6.17e-2)	unprognostic (8.75e-2)	unprognostic (1.19e-2)	unprognostic (2.63e-2)	unprognostic (1.16e-1)	unprognostic (4.03e-2)	unprognostic (3.70e-4)	unprognostic (6.08e-2)	unprognostic (1.18e-3)	unprognostic (2.33e-2)	unprognostic (7.01e-2)	unprognostic (9.07e-2)	unprognostic (3.88e-6)	unprognostic (7.15e-3)	unprognostic (5.81e-2)	unprognostic (2.82e-2)	unprognostic (3.54e-4)	2	3.8	7.7	1.3	11.3	0	0.6	0.2	9.3	4.8	0.4	2.5	0.3	0.5	2.2	2.1	0.6	2.2	6.2	5.6	4.8	1.1	4.9	0.7	2	3	1.1	5.4	16.3	0.6	0.9	1.5	5.2	2.7	2.7	0.6	11.1	0.4	0.7	0.4	0.5	0.4	2.2	1.4	1.1	0.6	4.6	1.3	0	0.7	0.4	0.2	2	0.9	0	0	0	0	0	17.1	0.1	0	0.2	0.9	0	0	0	0	0.2	5.2	0.5	1	42.7	0	0	0	0.2	0	0	6.4	0	0.3	0	0.2	0	0	0	0.1	0	0	1.6	0	0.6	0	0.1	0	0	0	0	0.1	0	0	0	0.8	0.2	4.1	0	0	0	12.6	0	0	0.5	0	0	0	9.6	0	0	0	0.1	0.4	0	0	0	0	0	0.1	0	0	0	0	0	1	0	17.1	0	0.3	1.8	0	0	0	0	0	0	0	0	0	0.1	7.7	11.3	0.2	7.1	4.8	1.1	1.1	5.4	2.7	1.3	3	0.3	0	0	0	2.3	1.2	0	0	0	1.8	0	0.1	8.3	0.1	0	0	0	0	0	0	3.1	0	0	0	0.3	6.4	1.7	0	0	0	1.1	0	0	0	0	458.8	0	0	8.1	0	7.1	6.5	1.2	0	0.2	0	0.1	0	0	0	Muller glia cells
GABRR1		ENSG00000146276	Gamma-aminobutyric acid type A receptor rho1 subunit	P24046	6	89177501-89231278	FDA approved drug targets, Predicted membrane proteins, Transporters	Ion transport, Transport	Chloride channel, Ion channel	FDA approved drug targets	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in some		retina: 12.3;testis: 4.6	Cell type enriched	Detected in some	11	Bipolar cells: 53.4	Not detected	Not detected			Region enriched	Detected in single	6	amygdala: 2.2	Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	5	NTERA-2: 3.3;OE19: 6.7;SuSa: 4.6	Not detected	Not detected																				unprognostic (5.75e-2)	unprognostic (3.92e-2)	unprognostic (1.12e-1)	unprognostic (2.90e-2)	unprognostic (5.78e-2)	unprognostic (4.90e-2)		unprognostic (8.32e-3)	unprognostic (2.52e-3)	unprognostic (1.74e-1)	unprognostic (1.82e-1)	unprognostic (1.43e-1)	unprognostic (1.62e-5)	unprognostic (1.18e-1)	unprognostic (9.90e-2)	unprognostic (2.12e-2)	unprognostic (2.29e-1)	0.4	0	2.2	0.1	0.1	0	0.2	0.3	0.1	0.2	0.3	0.1	0.1	0.1	0.1	0.2	1	0.1	0.1	0.1	0.1	0.2	0.4	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0	0.2	1	0.3	0.2	0.1	12.3	0.2	0.1	0.7	0.6	0.7	0.1	0.1	0.1	0	4.6	0.1	0.1	0.1	0.1	0.2	0.6	0.2	0	0.1	0.2	0.2	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0.1	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	3.3	6.7	0	0	0.2	0	0	0.1	0.1	0	0	0	0	4.6	0	1	0	0.1	0.2	0	0	0.1	0.2	0	0	0	0	0	0.1	0.2	0	0	0.1	0	0	0.1	0	0	0	0	0	0	0.2	0.1	0	0	2.2	0.1	0.3	0.1	0.1	0.2	0.1	0.1	0.3	0.1	0	0	0	0	0.2	53.4	0.3	0	0	0	0	3.9	0.3	0	0	2.1	0	0	0	0	0	0	0	0	0	0	4.8	0	0	0	0.4	0	0	0	0	0	0.5	0	0	0.4	0	3.8	0	0.3	0	0.2	0	0.2	0	0	0.1	Bipolar cells
CLVS2	bA160A10.4, C6orf212, C6orf213, RLBP1L2	ENSG00000146352	Clavesin 2	Q5SYC1	6	122995971-123072927	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	5	brain: 39.9	Cell type enriched	Detected in some	5	Muller glia cells: 71.4	Cancer enhanced	Detected in single		glioma: 0.5	Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	8	HEL: 14.7;SCLC-21H: 11.5	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA043764	Uncertain											HPA043764: AB_10960281	unprognostic (1.35e-1)		unprognostic (3.28e-2)		unprognostic (4.68e-2)				unprognostic (3.60e-1)		unprognostic (2.38e-1)	unprognostic (7.04e-2)	unprognostic (1.43e-2)	unprognostic (5.72e-3)	unprognostic (9.60e-2)		unprognostic (8.71e-2)	0.7	2.8	5	0.9	9.6	0.7	0.8	39.9	22.6	2.1	1.1	0.6	0	0.9	3.1	0.7	0.8	0.7	0.8	0.7	5.8	3.9	0.7	0.8	0.7	0.8	3	10.2	0.7	0.7	0.7	6.3	0.7	8.5	7.9	1.1	0.1	0.8	1.1	0.7	0.8	0.9	2.8	1.3	0.7	0.8	1	1.8	0	0.7	0	0.7	1.3	0.6	0	0	0	0	0	0	0	0	0	0.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	1.6	0	0	0	0	0	0	0	11.5	0	0	0	0	0	0	0	0	0	0.9	0	0.1	0	0	0	0.5	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5	9.6	39.9	22.6	5.8	3.9	3	10.2	8.5	1.8	0	0	0	13.8	0	3	1.1	0	0	0	0	0	0	0	0	4.9	0	0	0	0	0	0	2.8	0	0	0	0	0	0	0	0.4	0.3	0	0	0	0	71.4	0	0	0.4	0	4.5	0	0.5	0.1	0	0	0	0	0	1.8	Muller glia cells
IGFBP1	AFBP, hIGFBP-1, IBP1, IGF-BP25, PP12	ENSG00000146678	Insulin like growth factor binding protein 1	P08833	7	45888357-45893668	Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins		Growth factor binding		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	21	liver: 157.6;placenta: 292.3	Cell type enriched	Detected in some	23	Hepatocytes: 863.0	Cancer enriched	Detected in many	29	liver cancer: 385.9	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	8	Hep G2: 18.0;U-2197: 29.5;U-87 MG: 51.0	Not detected	Not detected			Not detected	Not detected			CAB004445, HPA046972, HPA050640	Enhanced		Approved	Golgi apparatus	Secreted to blood			28100000	22000000	Golgi apparatus		CAB004445: AB_627782, HPA046972: AB_2679884, HPA050640: AB_2681197	unprognostic (8.66e-3)	unprognostic (1.45e-1)	unprognostic (9.41e-2)	unprognostic (7.80e-2)	unprognostic (7.04e-2)	unprognostic (2.93e-1)	unprognostic (1.01e-1)	prognostic unfavorable (1.03e-4)	unprognostic (1.89e-2)	unprognostic (2.09e-3)	unprognostic (8.95e-2)		prognostic unfavorable (6.90e-11)	prognostic unfavorable (6.64e-4)	unprognostic (7.20e-2)	unprognostic (7.98e-2)	unprognostic (3.43e-1)	0.4	0	0.1	0.1	0.1	0	0.2	0	0.1	0	0.1	0	0.1	0	10.7	0	0	0.4	0.1	0.1	0.1	0.1	0.2	157.6	0.1	0	0.1	0	9.3	0	0	0.2	292.3	0.2	0	0	0	0	0	0	0	0	0	0.1	0.2	0	0	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0.1	0	0	0	0	0	1.9	0.1	0.5	0	0.5	0.1	0	0	0.2	0	0	0.1	0.1	18	0.1	0.3	0	0	0.2	3.9	0	0.2	0.1	0	0	0	0.4	0	0	0	0	0	0.9	0	0.1	0	0.7	0	0.1	0	0.1	0	0	0	0	0	0.1	0	0	29.5	0	0	0	0	51	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.2	0.1	0	0.3	0	0	0	0	0.8	38.2	0	1.2	0	0	0.7	0	6.7	0.1	0	0	23.3	0	2	1	0	0	863	1.6	0	3.4	9.2	11.5	0	0	0	0	0	0	0	0.9	0	0	0	0	0	0	0	0.2	0	2.9	0	0	0	Hepatocytes
CNPY1		ENSG00000146910	Canopy FGF signaling regulator 1	Q3B7I2	7	155474206-155555450	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level	No human protein/transcript evidence	No human protein/transcript evidence		Group enriched	Detected in some	7	brain: 21.1;pancreas: 8.5	Cell type enriched	Detected in single	17	Spermatogonia: 4.9	Cancer enriched	Detected in single	10	glioma: 1.6	Region enriched	Detected in some	17	cerebellum: 21.1	Cell type enhanced	Detected in single		basophil: 1.5	Low lineage specificity	Detected in single			Cell line enriched	Detected in some	8	AF22: 26.6	Region enriched	Detected in single	29	cerebellum: 215.6					HPA047400	Uncertain											HPA047400: AB_10960413					unprognostic (4.28e-3)	unprognostic (2.12e-1)					unprognostic (4.18e-2)		unprognostic (8.27e-12)	unprognostic (1.44e-1)	unprognostic (2.16e-1)			0.1	0	0.2	0.1	0.3	0.7	0.1	21.1	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.8	0.1	0.1	0.1	0.1	0.2	0.2	0.1	0.1	0.1	0.3	0.9	0.1	0.2	8.5	0	0.2	0.1	1.2	0.1	0.1	0.5	0.2	0.1	0.1	1.2	0.5	0.1	0.5	0.1	0.2	2.1	0.4	0.1	0.3	0.1	0.1	0.1	0.1	0.3	0	1.5	0	0	0.5	0	0	0	26.6	0	0	0	0.3	0	0.3	0	0.1	0	0	0	0.7	0	0.4	0	2.3	0	0	0	2.5	0	0.1	0	0	0	0.1	0.2	0.2	0	0	0	0	0.4	0	0.1	0	0	0	0	0	0.1	0.1	0	0	3.2	0	0	0.2	0	0	0.1	0.6	0.1	0.1	0.5	0	0	0.7	0	0	0.1	0	0	0	0	0.4	1.5	0	0.3	0	0	0.1	0.1	0.2	0.1	0	0.3	0.1	0.3	0	0	0	0	0.5	0	0.2	0.3	21.1	0.5	0.2	0.2	0.9	0.1	1.2	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0.3	4.9	0	0	0	0	0	Spermatogonia
ASB10	GLC1F	ENSG00000146926	Ankyrin repeat and SOCS box containing 10	Q8WXI3	7	151175698-151187832	Disease related genes, Predicted intracellular proteins	Ubl conjugation pathway		Disease mutation, Glaucoma	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Group enriched	Detected in some	10	heart muscle: 12.3;skeletal muscle: 44.0;tongue: 15.3	Cell type enriched	Detected in single	122	Cardiomyocytes: 12.2	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			HPA079685	Enhanced											HPA079685: 						unprognostic (6.72e-3)				unprognostic (1.96e-1)								0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.3	0.3	0	0.2	12.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0.2	0.5	0	44	0	0	0	0	0	0	0	0	0	0.6	15.3	1.2	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	12.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Cardiomyocytes
RAB19	RAB19B	ENSG00000146955	RAB19, member RAS oncogene family	A4D1S5	7	140404043-140426250	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		pancreas: 14.5	Cell type enriched	Detected in single	12	Intestinal endocrine cells: 1.7	Low cancer specificity	Detected in many			Not detected	Not detected			Low cell type specificity	Detected in some			Lineage enriched	Detected in single	4	T-cells: 3.5	Cell line enhanced	Detected in some		CAPAN-2: 5.9;HDLM-2: 12.8;MCF7: 5.7;RPTEC TERT1: 4.2;RT4: 8.3;SK-BR-3: 6.5;T-47d: 7.3	Not detected	Not detected			Low region specificity	Detected in all			HPA051077	Uncertain											HPA051077: AB_2681336	unprognostic (3.40e-1)	unprognostic (2.07e-2)	unprognostic (2.26e-1)	unprognostic (3.10e-2)	unprognostic (1.54e-1)	unprognostic (6.48e-2)	unprognostic (1.65e-1)	unprognostic (2.35e-2)	unprognostic (3.17e-2)	unprognostic (2.72e-2)	unprognostic (7.91e-2)	unprognostic (2.53e-1)	prognostic favorable (2.36e-8)	unprognostic (1.73e-3)	unprognostic (6.42e-2)	unprognostic (3.44e-1)	unprognostic (6.09e-3)	0.4	0.3	0.3	2.8	0.3	6.7	0.8	0.3	0.3	0.6	5.2	0	0.8	4	0.4	2.8	0.7	1.2	8.7	0.3	0.3	0.3	8.9	0.5	2.4	4.7	0.3	0	0.3	14.5	5.6	10.5	1.5	0	2.6	5	0	5.7	0.2	0.3	0.7	12.1	0	0.3	1.1	2.4	0.5	0	3.6	11.3	1.7	3.6	1.7	0.4	0.8	0	0.3	0	0.6	3.5	0.4	0.8	0	0	0.3	0	0	1.3	0	0	0	0	2.1	5.9	0	0.6	0	0	0.9	0	1.6	0	12.8	0.3	0	0	0.3	0	0	0	0	0.3	0	0.1	0	0	0.3	0	0	0	5.7	0.7	0	0	0.7	0	0	0	0	4.2	8.3	1.1	0	0	6.5	0	0.3	7.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.9	0	3.1	0.8	0.9	3.2	0	0	1.4	1.4	0.3	0.6	0	0	3.5	0.4	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	1.7	0	0	0	0	0	0	0	0	0	0.1	0	0	0.1	0	0	0	0	0	0	0	0	0	0	Intestinal endocrine cells
CLTRN	NX17, TMEM27	ENSG00000147003	Collectrin, amino acid transport regulator	Q9HBJ8	X	15627318-15665031	Predicted membrane proteins, Transporters				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	18	kidney: 204.4	Cell type enriched	Detected in some	15	Proximal tubular cells: 679.1	Cancer enriched	Detected in many	35	renal cancer: 106.2	Region enriched	Detected in single	9	pons and medulla: 5.0	Cell type enhanced	Detected in some		naive CD4 T-cell: 3.0	Low lineage specificity	Detected in single			Cell line enhanced	Detected in many		HaCaT: 10.6;hTERT-HME1: 6.1;RPTEC TERT1: 9.8;SuSa: 6.5	Not detected	Not detected			Not detected	Not detected			HPA048543	Enhanced		Approved	Endoplasmic reticulum,Vesicles						Endoplasmic reticulum, Vesicles		HPA048543: AB_2680436	unprognostic (1.27e-1)	unprognostic (4.77e-2)	unprognostic (2.45e-2)	unprognostic (2.66e-2)	unprognostic (5.20e-2)	unprognostic (5.23e-2)	unprognostic (1.25e-1)	unprognostic (8.50e-2)	unprognostic (1.90e-2)	prognostic favorable (5.65e-4)	unprognostic (1.05e-2)	unprognostic (3.03e-1)	prognostic favorable (6.78e-9)	unprognostic (1.77e-1)	unprognostic (2.60e-2)	unprognostic (2.58e-1)	unprognostic (1.33e-2)	0.1	0.2	0.3	0.1	0.4	0	0.3	0.1	0.2	0.2	0.2	0.5	0.1	0.1	0.2	1.6	0.2	0.4	0.6	0.2	0.5	0.4	204.4	11.5	0.6	0.1	0.3	0.1	0.8	1.2	4	0.2	0.7	5	0.3	0	11.3	0.3	0.1	0.1	0.2	0.2	0.1	0.2	0.1	2.4	0.3	0.1	0.2	0.7	0.1	0.1	0.4	0.2	0.9	0.6	0	0.5	0	3	0.4	3	2.1	1.5	0.6	0.8	1.2	1	0.1	0	0.1	0.1	0.2	0.5	0.3	2.1	0.1	0.2	10.6	0.9	2.5	0	0.4	1.4	0.3	0	1	1.6	0	0	0.2	2.4	0.4	6.1	0.7	0	2.4	0.7	0.6	0.3	3.5	0.2	0.4	3.5	0.9	3.1	0.3	0.5	1.3	9.8	0.2	1.4	1.3	0.8	0.2	2	6.5	1	0.3	0.1	0.2	0.5	0.4	0	0.5	0.3	0.4	0.9	0.1	0.1	0	0.5	0	0.6	0.2	1.3	0.4	0.8	0.5	0.6	0.9	3	0.9	0	0	0	0	0.8	0.4	0.3	0.4	0.1	0.2	0.5	0.4	0.3	0.1	5	0.1	0	2.6	0	0	0	0	0	0	4	3.4	26.2	0	1.9	46.4	19.8	0	0	0	0	0.5	0.3	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	1.2	0	0	679.1	0	0	0	0	0	0	2.5	0	0	0	Proximal tubular cells
CXorf36	DIA1R, FLJ14103	ENSG00000147113	Chromosome X open reading frame 36	Q9H7Y0	X	45148374-45200901	Disease related genes, Predicted secreted proteins			Autism, Autism spectrum disorder	Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in many			Cell type enriched	Detected in some	7	Endothelial cells: 94.9	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enriched	Detected in single	5	neutrophil: 2.4	Lineage enriched	Detected in single	5	granulocytes: 2.4	Cell line enriched	Detected in single	59	HUVEC TERT2: 43.3	Low region specificity	Detected in single			Low region specificity	Detected in many			HPA002806	Uncertain				Secreted - unknown location				370000			HPA002806: AB_1078595	unprognostic (2.12e-1)	unprognostic (1.32e-2)	unprognostic (8.51e-3)	unprognostic (2.05e-1)	unprognostic (4.65e-2)	unprognostic (4.07e-3)	unprognostic (7.30e-2)	unprognostic (1.61e-1)	unprognostic (1.50e-1)	unprognostic (3.39e-1)	unprognostic (6.06e-2)	unprognostic (1.32e-1)	unprognostic (1.75e-3)	unprognostic (3.79e-3)	unprognostic (1.98e-1)	unprognostic (8.47e-2)	unprognostic (3.11e-2)	42.1	3.2	3.8	6.2	4.4	0.8	47.7	1.4	3.2	17.9	7.3	2.9	6.7	2.4	28.5	10.2	8	9.9	7.5	23.6	4.7	3.7	4.5	2.1	9.3	12.1	6.8	1.2	7.9	4.2	4.3	3.7	39.6	4.2	12	3.5	4.3	4.4	7.7	14.4	4.9	4.7	17.7	6.4	5	4.2	5.6	2	0.3	12.3	12	3.7	10.6	26.5	0.5	0.2	2.4	0.2	0.1	0.4	0.1	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0.1	0	0	0	0	0	0	43.3	0	0	0.2	0	0	0	0.1	0	0.7	0	0	0	0	0	0	0.1	0	0	0	0.1	0	0	0	0.3	0	0.1	0	0	0.1	0.1	0	0	0	0	0.1	0.2	0.4	0.3	0.1	0.3	0.4	0.4	0.4	0	0.5	0.4	0.3	2.4	0.1	0	0.2	0.1	0.1	3.8	4.4	1.4	3.2	4.7	3.7	6.8	1.2	4.2	2	3	2.2	0	0.4	3.9	0	4.5	0	0	2.3	0	0	0.1	0	0	0.2	94.9	0	0	0.2	0.1	1	0.1	1.1	0	0.2	0	0	13.5	1.2	1.5	0.9	1.3	6.8	0	0	0	0.1	0	0	0	0.7	0	2.1	0	0.1	4.1	0.2	0	0	0.5	Endothelial cells
RAB41		ENSG00000147127	RAB41, member RAS oncogene family	Q5JT25	X	70282093-70285002	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		brain: 6.4;testis: 7.3	Cell type enriched	Detected in some	22	Cone photoreceptor cells: 502.6	Cancer enhanced	Detected in some		glioma: 2.5					Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		U-2197: 7.0;U-87 MG: 8.8									HPA001510	Uncertain											HPA001510: AB_1079733	unprognostic (1.32e-1)	unprognostic (1.39e-1)	unprognostic (3.36e-3)	unprognostic (4.25e-3)	unprognostic (1.18e-1)	unprognostic (3.46e-2)	unprognostic (6.33e-3)	unprognostic (1.85e-3)	unprognostic (1.38e-1)	unprognostic (2.68e-2)	unprognostic (2.20e-2)	unprognostic (1.04e-3)	unprognostic (7.63e-2)	unprognostic (2.39e-1)	unprognostic (9.78e-3)	unprognostic (8.42e-2)	unprognostic (9.89e-2)	0.2	1.6	2.4	0.9	2.7	0.5	0	1.3	6.4	0	0.3			0.5	0.3	0	0.4	0.1	0.9	0.9	1.8	2.1	0.4	0	0.5	0.7	2.6		1.6	0	0	0.2	0.2		0.3	0		1.9	0	0.7	2.5	1.3	0	1.8	0.8	0.2	7.3			1.4		0	1	0	1.5	1.6	0.1	0.9	0	2	0.4	1	1	2.5	0.9	0	0	0.9	0.9	0	0	0	1.1	0.9	1.1	2	0	2.1	1.1	0	0	0	1.4	2.5	0.2	2.1	0.1	0	0.3	1.1	0	0	0	0	3.2	0	1.4	1	2.2	0	0.6	1.5	1	1.6	3.2	3.1	0.6	1.8	1.5	0	0.8	1.6	2.9	1	0.6	2.7	1.2	0.7	2.5	2.9	1.2	1.3	7	1.5	1.3	1.9	1.4	8.8	2.1	2	0	0.4	0.1	0.7	0.9	2	1.5	0.6	0.6	1.6	1.5	1.2	1	0	0	0.3	0.4	1.1	0.4											0	0	0	0	0	0.6	0.3	0	0	0	0	502.6	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0	0.7	0	0	0	0	3.9	0	0	23.1	6.6	0	0	0	0	0	Cone photoreceptor cells
LPAR4	GPR23, LPA4, P2RY9, P2Y5-LIKE, P2Y9	ENSG00000147145	Lysophosphatidic acid receptor 4	Q99677	X	78747709-78757094	G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters		G-protein coupled receptor, Receptor, Transducer		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in many		brain: 15.8;ovary: 10.0	Cell type enriched	Detected in some	7	Leydig cells: 18.7	Cancer enhanced	Detected in single		glioma: 0.9	Low region specificity	Detected in all			Cell type enriched	Detected in single	12	basophil: 7.4	Lineage enriched	Detected in single	12	granulocytes: 7.4	Cell line enhanced	Detected in some		AF22: 10.3;NTERA-2: 16.7;RH-30: 7.0;SuSa: 4.0;U-937: 4.0	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA046563, HPA054951, HPA055571	Uncertain		Supported	Nuclear bodies,Vesicles,Plasma membrane						Plasma membrane	Nuclear bodies, Vesicles	HPA046563: AB_2732529, HPA054951: AB_2682646, HPA055571: AB_2682853	unprognostic (1.62e-1)	unprognostic (3.53e-1)	unprognostic (1.58e-1)	unprognostic (5.81e-4)	unprognostic (3.12e-2)	unprognostic (4.85e-3)	unprognostic (2.81e-1)	unprognostic (2.57e-1)	unprognostic (6.75e-2)	unprognostic (6.73e-2)	unprognostic (8.91e-2)	unprognostic (4.86e-4)	unprognostic (2.99e-5)	unprognostic (9.27e-3)	unprognostic (1.00e-1)	unprognostic (3.58e-2)	unprognostic (6.03e-3)	1.5	0.2	6	1	2.1	0.6	2	4.9	3.7	1.8	0.9	7.4	0.7	0.2	2.9	0.8	1.8	1.1	2.1	1.9	15.8	1.4	0.3	0.3	0.3	0.2	2.4	4	10	0.7	0.1	0.7	0.2	3.6	0.6	1.2	0.5	1	1.6	0.2	1.6	0.9	1.3	3.8	0.4	1.5	0.8	5.6	0	0.6	0.8	1.2	1.4	0.9	0	0.5	7.4	0	0	0	0.1	0	0	10.3	0	0	0	0	0	0.6	1.1	1.4	0	0	0	0.1	0.1	0.6	0	0.7	0	1.3	0	0	0.2	0	0	0	1.1	0	0.5	0	0.3	0	0	0	0.8	0	0.1	2.3	0	0.5	1.8	16.7	0	0.2	0.9	7	0	0.3	0	0	0	0	0	0.1	4	0	2.7	0	0	0.2	0	0.7	1.4	0	0.7	0.7	4	1.6	7.4	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0.1	6	2.1	4.9	3.5	15.8	1.4	2.4	4	3.6	5.6	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0.2	0.1	0	0	0.1	0	0	0	0	0	18.7	0	1.7	1	0	0.5	0	0	2.5	0	0	0	0.3	0	0	0.4	0	0	0	0.1	Leydig cells
ITGB1BP2	CHORDC3	ENSG00000147166	Integrin subunit beta 1 binding protein 2	Q9UKP3	X	71301734-71305371	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		heart muscle: 43.0;skeletal muscle: 21.3;smooth muscle: 18.6;tongue: 19.6	Cell type enriched	Detected in some	9	Cardiomyocytes: 69.8	Low cancer specificity	Detected in some			Not detected	Not detected			Cell type enhanced	Detected in single		eosinophil: 1.5	Low lineage specificity	Detected in single			Cell line enhanced	Detected in many		HMC-1: 14.0	Not detected	Not detected			Not detected	Not detected			HPA040721			Approved	Cytosol						Cytosol		HPA040721: AB_10805827	unprognostic (1.87e-1)	unprognostic (2.65e-2)	unprognostic (6.91e-5)	unprognostic (1.95e-2)	unprognostic (7.92e-2)	unprognostic (1.54e-1)	unprognostic (3.81e-2)	unprognostic (9.02e-2)	unprognostic (4.69e-2)	unprognostic (2.15e-2)	unprognostic (4.85e-2)	unprognostic (3.17e-1)	unprognostic (3.08e-11)	unprognostic (4.38e-2)	unprognostic (3.63e-2)	unprognostic (2.99e-1)	unprognostic (2.64e-1)	0.7	0.3	0.2	1	0.3	0.6	0.3	0.6	0.2	2.7	2.8	0	2.3	0.4	12.8	3.4	4	1.8	4.8	43	0.2	0.2	0.4	0.6	0.5	0.5	0.3	0	2.4	0.3	0	0.3	0.2	0.2	3.2	0.9	3.5	0.7	5.8	21.3	0.3	1	18.6	0.3	0.6	1.1	1.6	0.1	0	0.4	19.6	0.7	5.6	0.8	0.2	0.2	1.5	0.2	0	0.5	0	0.7	2.1	3.2	2.8	0.1	0.1	0.7	1	1.4	0.7	0.9	1.6	1.6	3.1	0.4	1.6	0.8	1.5	2.9	0.8	1.8	1	1.3	1.9	1.9	0.6	0.4	0.7	14	1.7	1.3	0.5	0.5	0.7	1.2	3.4	1.4	0.8	1.6	0.9	1.2	3.5	4.7	2.1	1.3	2.1	2.5	1.2	1.6	2	1.5	0.5	0.7	0.1	0.8	2.2	0.9	0.4	0	1.4	2.8	0.3	0.6	2.9	3.8	4.8	0.4	2.4	0.6	0	0.2	1.5	0.2	0	0	0	0	0	0.2	0.2	0.5	0.1	0	0	0	0	0	0	0.2	0.3	0.6	0.2	0.2	0.2	0.3	0	0.2	0.1	0	0	0	0	0.2	1.5	69.8	0	0	0	0	0	0	0	0.4	0.1	0.1	0	0	0	0	0.4	0.2	0	0	0.2	0	0	1.3	0	0	0.3	0	0	0	0	0	0.2	0	8.1	0.3	0.9	0	1.7	0.3	0.3	0.3	0	0	0.3	0	Cardiomyocytes
CPXCR1	CT77	ENSG00000147183	CPX chromosome region, candidate 1	Q8N123	X	88747225-88754785	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enriched	Detected in single	54	testis: 12.1	Cell type enriched	Detected in some	10	Early spermatids: 56.8	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HDLM-2: 1.5;Karpas-707: 3.5;U-266/70: 1.9																																							0	0	0	0	0	0	0	0	0	0	0			0	0	0	0	0.2	0	0	0	0	0	0	0	0	0		0	0	0	0	0		0	0		0	0	0	0	0	0	0	0	0	12.1			0		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0.6	0	1.5	0	0	0	0	0	0.3	0	0	0.4	0.2	0	0	0	0	0	3.5	0	0	0.1	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.3	0	0	1.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	56.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5.4	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0.5	0.2	0	0	0	0	0	Early spermatids
RIPPLY1		ENSG00000147223	Ripply transcriptional repressor 1	Q0D2K3	X	106900063-106903335	Predicted intracellular proteins	Transcription, Transcription regulation	Developmental protein, Repressor		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in some		kidney: 6.4;liver: 11.5	Cell type enriched	Detected in single	4	Hepatocytes: 2.9	Group enriched	Detected in some	6	liver cancer: 2.2;renal cancer: 3.6;testis cancer: 0.7	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	8	RH-30: 12.3					Low region specificity	Detected in many			HPA052284	Uncertain				Intracellular and membrane							HPA052284: AB_2681785	unprognostic (1.48e-1)	unprognostic (4.35e-2)	unprognostic (1.67e-1)	unprognostic (9.52e-3)	unprognostic (7.00e-3)	unprognostic (1.13e-2)	unprognostic (1.66e-3)	unprognostic (1.50e-1)	unprognostic (2.42e-1)	unprognostic (5.37e-2)	unprognostic (2.53e-1)	unprognostic (1.36e-1)	unprognostic (2.49e-3)	unprognostic (1.97e-1)	unprognostic (1.97e-1)	unprognostic (1.97e-3)	unprognostic (1.31e-1)	0.2	0.9	0.2	0.2	0.2	0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0	0.2	0.4	0.2	0.1	0.2	0.2	0.2	0	6.4	11.5	0.2	0.2	0.2	0.2	0.2	0.4	0	0.2	0.2	0.2	0.2	0	2.4	0.2	1.8	0.4	0	0.2	0.2	0.2	0.2	0	0.4	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0	0	0	0	0	0.2	0	0	0.1	0	0	0	0	0	0	0	0	0	0.9	0	0	0	0	0	0	0.1	0	0	0	0.4	0	0	1.4	0	0	0	0	0	0.1	0	0.5	0	0	0	0	0	0	0.1	0	0	0.3	0	0	12.3	0	0.3	0	0	0	0	0.1	0.2	0	0	0	0	0	0	0	0	0	0.1	0	0.3	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0.2	0.2	0.2	0.2	0	0.2	0.2	0.2	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0	0	0	0.1	0	0	0	Hepatocytes
MAGEA4	CT1.4, MAGE-41, MAGE-X2, MAGE4, MAGE4A, MAGE4B, MGC21336	ENSG00000147381	MAGE family member A4	P43358	X	151912509-151925170	Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins		Tumor antigen	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	32	placenta: 12.1;testis: 23.5	Cell type enriched	Detected in some	7	Spermatogonia: 190.5	Low cancer specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		A-431: 62.8;AN3-CA: 39.2;HMC-1: 74.8;U-2 OS: 20.0;U-266/84: 116.4									HPA021942, CAB040535	Enhanced		Approved	Nuclear speckles,Cytosol						Nuclear speckles	Cytosol	CAB040535: , HPA021942: AB_1853490						unprognostic (7.90e-3)		unprognostic (6.66e-3)	unprognostic (5.39e-1)	unprognostic (1.36e-1)				unprognostic (5.81e-2)	unprognostic (2.94e-2)		unprognostic (4.10e-1)	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	12.1	0	0	0	0	0	0	0	0	0	0	0	0	0	23.5	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	62.8	0	0	39.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0.1	0	0	0	0	0	0	74.8	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0.6	0	0	20	0	0.3	15.9	116.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.4	0	0	2.4	0	0	0	0	10.7	0	0	0	0	1.1	0	0	0	0	3.3	2	0	0	0	0	0	0	0	0.4	0	0	6.5	0	23.4	190.5	0	27.6	0	0	0	Spermatogonia
SLC25A37	HT015, MFRN, MFRN1, MSCP	ENSG00000147454	Solute carrier family 25 member 37	Q9NYZ2	8	23528805-23575463	Predicted intracellular proteins, Transporters	Ion transport, Iron transport, Transport			Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		bone marrow: 88.8	Cell type enriched	Detected in all	5	Erythroid cells: 3550.9	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enriched	Detected in many	18	neutrophil: 28.9	Lineage enriched	Detected in many	18	granulocytes: 28.9	Cell line enhanced	Detected in many		HEL: 47.7;hTERT-RPE1: 27.9	Low region specificity	Detected in all							HPA045680	Uncertain		Approved	Mitochondria,Cytosol						Mitochondria	Cytosol	HPA045680: AB_10963693	unprognostic (6.15e-3)	unprognostic (7.33e-3)	unprognostic (2.04e-1)	unprognostic (1.40e-1)	unprognostic (1.38e-1)	unprognostic (5.12e-2)	unprognostic (1.35e-1)	unprognostic (1.68e-1)	unprognostic (3.58e-2)	unprognostic (1.40e-1)	unprognostic (1.02e-2)	unprognostic (2.24e-1)	prognostic unfavorable (4.37e-6)	unprognostic (8.27e-2)	unprognostic (1.71e-1)	unprognostic (2.37e-1)	unprognostic (7.40e-2)	8.2	18.3	5.8	13.7	8.3	88.8	13.1	4.2	8.2	13.4	16.4	6.5	11.7	39.7	10.3	6.8	8.2	9.5	8.5	16.8	6.2	5.2	9.4	11.8	25.7	18.5	12.2	5.1	17.2	14.8	15.6	8.8	23.9	10.3	17.1	5.8	7.9	21.1	17.4	13.8	7.6	17.6	7.9	10.2	28.7	8	15	8.6	1.9	9	5.9	5.7	13.9	33	1.2	1.4	28.9	1.6	0.7	1.2	0.8	3.8	4.2	4.5	4.1	5.9	7.3	6.6	3	3.9	2.2	2.5	4.1	8.2	6.2	3.7	2.5	14.5	4.9	4.1	8.2	3	1	2.2	47.7	7	1.4	4.9	2.7	1.9	6.2	8	4.8	4.8	27.9	3.4	5	10.5	3.1	3.5	1.6	3.2	11.3	2.3	4.7	3.3	3.3	2.2	2.4	6.8	2.1	1.4	1.9	4.1	6.4	3	4.4	1.8	4.1	5.5	10.9	1.6	6.4	5.8	2.5	0.9	3.9	10.2	6.5	6.8	0.6	1.6	1.4	0.6	0.6	0.6	1.2	0.4	0.3	1.4	0.8	1.2	0.7	28.9	0.7	0.8	0.4	0.7	0.8	5.8	8.3	4.2	8.2	6.2	5.2	12.2	5.1	10.3	8.6	35.7	79.2	39.5	104.8	82.9	35.3	31.5	48.4	21.4	84.2	73.3	64.8	32.1	13.3	81.9	645.6	82.4	66.7	3550.9	197.4	63.8	90.2	258.9	35.8	34.3	36.1	6.4	19.5	100.7	50.6	772.4	48.6	101.8	65.8	8.2	33.2	41.6	177.5	34.5	35	24.5	60.7	19.4	95.7	12.5	47.1	47	15.3	22.7	43.1	139.3	Erythroid cells
STAR	StAR, STARD1	ENSG00000147465	Steroidogenic acute regulatory protein	P49675	8	38143649-38151265	Disease related genes, Predicted intracellular proteins	Lipid transport, Steroidogenesis, Transport		Congenital adrenal hyperplasia, Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	7	adrenal gland: 311.3;ovary: 124.6	Cell type enriched	Detected in some	5	Leydig cells: 46.3	Cancer enhanced	Detected in some		testis cancer: 3.0	Region enriched	Detected in some	8	basal ganglia: 10.6	Cell type enriched	Detected in single	11	basophil: 5.7	Lineage enriched	Detected in single	11	granulocytes: 5.7	Cell line enriched	Detected in some	5	K-562: 101.9	Low region specificity	Detected in all			Not detected	Not detected			HPA023644, HPA027318, CAB032598	Enhanced											CAB032598: AB_2115937, HPA023644: AB_10598916, HPA027318: AB_10601574	unprognostic (1.60e-4)	unprognostic (3.20e-2)	unprognostic (9.17e-2)	unprognostic (3.28e-2)	unprognostic (9.22e-2)	unprognostic (1.32e-3)	unprognostic (1.96e-2)	unprognostic (2.12e-5)	unprognostic (3.30e-2)	unprognostic (2.36e-1)	unprognostic (1.77e-3)	unprognostic (6.65e-2)	unprognostic (4.75e-9)	unprognostic (1.58e-1)	unprognostic (1.33e-1)	unprognostic (9.48e-2)	unprognostic (6.16e-2)	0.2	311.3	0.5	0.3	10.6	0.3	0	0	1	0	0	11.6	0	0	0.1	0.8	0.2	0.4	0	0.1	0.3	0.5	0	0	0	0.3	0.2	0.9	124.6	0	0	0.2	0	1.2	0	0	0	0.1	0	0	0.5	0	0.2	0.4	0	0	29.5	0.1	0	0	0	0.2	0	0.2	0.3	0.1	5.7	0.1	0	0.5	0.1	0	0	0.2	0	0	0.9	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0.1	0	0	0	21.9	0.1	1.3	0.3	1	0	3.5	0	0	0	0.2	0	0	101.9	0	0	0	0	12	2.8	0	0	0	0	0	0	0	0.2	0.2	0	0	0	0	0	12.2	0.3	0	0	0	0	0	0	0	0	2.5	0	5.7	0.1	0.4	0	0	0	0	0	0	0.1	0.3	0	0.2	0.3	0	0	0	0.5	0.1	0.5	10.6	0	1	0.3	0.5	0.2	0.9	1.2	0.1	0	0	0	0.6	8.4	1.2	0.4	0	0	0	0	0	0	0	0	1.3	0	0	0	0	0	0.2	0.2	0	0	0.2	0	0	0	0	5.6	46.3	0	3.3	0	0	0.5	0.1	0	3.9	0	0.7	0	0.2	1.4	0.7	9.8	0.1	0	0	0.1	Leydig cells
CRH	CRF, CRH1	ENSG00000147571	Corticotropin releasing hormone	P06850	8	66176382-66178725	Plasma proteins, Predicted secreted proteins		Hormone		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	7	placenta: 209.9	Cell type enriched	Detected in some	6	Syncytiotrophoblasts: 134.3	Cancer enriched	Detected in some	28	urothelial cancer: 34.5	Region enhanced	Detected in many		hypothalamus: 28.4	Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	4	SCLC-21H: 1.4;SuSa: 5.0	Low region specificity	Detected in many			Low region specificity	Detected in many								Secreted to blood			10000									unprognostic (1.62e-1)						unprognostic (9.68e-2)				unprognostic (1.00e-1)	unprognostic (9.55e-2)	unprognostic (7.22e-3)	2.7	0.2	4.1	0.2	2.1	0.3	0.2	0	6.7	0.2	0.2	0.4	0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	2.7	28.4	0.2	0.2	0.3	0.2	0.4	1.1	0.2	1.3	0.2	0.1	209.9	13.8	0.2	0.2	0	0.2	0.2	0.3	0.2	0.2	0.5	0.1	0.2	0.4	0.9	0	0	0.5	0	0.2	0.2	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0.7	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0.1	1.4	0	0	0.1	0	5	0.2	0	0	0	0	0	0	0.1	0	0	0.3	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4.1	2.1	0	6.7	2.7	28.4	0.4	1.1	13.8	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0.3	0	0	20.7	0	0	0	0	0.2	0	0	0	0	0.5	0	0	0	0	11.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	134.3	0	0	0.1	Syncytiotrophoblasts
PMP2	FABP8, M-FABP, MP2	ENSG00000147588	Peripheral myelin protein 2	P02689	8	81440326-81447523	Predicted intracellular proteins	Transport		Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	30	brain: 124.8	Cell type enriched	Detected in some	18	Muller glia cells: 30.0	Cancer enriched	Detected in some	59	glioma: 239.5	Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HaCaT: 1.0;Karpas-707: 1.4;U-87 MG: 1.6;WM-115: 5.4	Not detected	Not detected			Group enriched	Detected in some	26	midbrain: 78.0;pons and medulla: 111.5															unprognostic (5.87e-2)			unprognostic (5.81e-2)	unprognostic (1.12e-2)		unprognostic (1.95e-1)	unprognostic (8.03e-3)	unprognostic (1.10e-2)	unprognostic (8.45e-2)	unprognostic (4.43e-2)		unprognostic (7.21e-2)	unprognostic (4.41e-1)		unprognostic (3.27e-3)	2.7	2.5	39.2	2.4	36.9	1.5	1.6	13.4	124.8	2.5	2.2	14.5	0	1.8	1.6	2.8	2	1.7	2.2	2.4	30.4	31.2	1.6	1.6	1.5	1.5	48.3	18.3	1.7	1.8	1.5	0	1.5	66.6	2	2	0	2.2	4.2	1.7	1.7	1.9	1.7	106.3	1.5	1.6	1.6	45.8	0	1.5	0	1.5	1.8	0.1	0	0	0	0	0	0	0	0	0	0.1	0	0	0.2	0	0	0.1	0	0	0	0	0.1	0.1	0	0	1	0	0	0	0	0	0	0.2	0	0	0	0.6	0	0	0	0	0	0	0	0	1.4	0	0	0	0	0.1	0	0	0	0	0	0	0	0.1	0.3	0	0.1	0.8	0	0	0	0.1	0	0	0	0	0	0	0	1.6	0.1	5.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	39.2	36.9	13.4	27.8	30.4	31.2	48.3	18.3	66.6	45.8	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	1.7	0	0	30	0	0	0	0	1.2	0	0	0	0	0.1	0	0	0	0	Muller glia cells
ATP6V0D2	ATP6D2, FLJ38708, VMA6	ENSG00000147614	ATPase H+ transporting V0 subunit d2	Q8N8Y2	8	85987323-86154228	Predicted intracellular proteins	Hydrogen ion transport, Ion transport, Transport			Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	5	kidney: 56.8	Cell type enriched	Detected in some	6	Distal tubular cells: 177.4	Cancer enriched	Detected in many	9	renal cancer: 36.7	Not detected	Not detected			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Cell line enhanced	Detected in some		SK-MEL-30: 5.6;SuSa: 9.2;U-87 MG: 8.6	Not detected	Not detected			Not detected	Not detected			HPA055327, HPA058496	Enhanced		Approved	Vesicles						Vesicles		HPA055327: AB_2682784, HPA058496: 	unprognostic (3.79e-2)	unprognostic (1.59e-1)	unprognostic (1.78e-1)	unprognostic (1.22e-1)	unprognostic (8.50e-2)	unprognostic (8.43e-3)	unprognostic (5.36e-5)	unprognostic (4.02e-2)	unprognostic (1.16e-1)	unprognostic (7.75e-3)	unprognostic (2.32e-2)	unprognostic (1.61e-1)	prognostic favorable (2.20e-6)	unprognostic (8.58e-2)	unprognostic (1.77e-2)	unprognostic (3.67e-1)	unprognostic (1.97e-2)	6.6	0.3	0.2	1.3	0.3	0.8	0.3	0.2	0.2	0.2	1.5	0	11.9	0.7	0.2	1	0.2	0.2	0.1	0.2	0.3	0.3	56.8	0.3	12.2	1.2	0.5	0	0.8	0.2	0.3	0.2	0.2	0	0.8	2	5.7	1.1	1.2	0.2	0.9	1	0	0.3	0.4	0.3	0.2	0	1	0.4	0.3	0.6	0.3	0.2	2.2	1.7	4.6	1	2	1.5	0.3	0.5	1.2	0.6	0.7	0	0.5	2.3	0	0	1	0.3	0.3	0.4	0.3	0.2	0	1.6	2.5	0.7	1.6	0.4	0.4	0.1	0.8	1.7	0.1	0	0.7	1.4	0.6	0.1	0.9	0.7	1.9	0.4	0.3	0.4	0.7	0.5	0.9	0	0.7	0.2	0.3	0.2	0.2	0.2	0.3	0	1.1	3.4	0.3	0.1	0.8	5.6	9.2	1.8	0.1	0.3	0.6	0.8	0.7	0.5	0.4	0.2	0.6	8.6	0.6	0.7	2.6	1	0.8	1.1	0.5	0.8	1.2	1	0.9	0.5	2.2	1.5	1.3	4.6	2	1	1.7	0.9	0.3	0.2	0.3	0.2	0.2	0.3	0.3	0.5	0	0	0	0	0	0	1	0	0	0.4	0	0	0	7	29.5	0	177.4	0	0	0	0	0	0	0	0	0.2	0	0	3.1	0	0	0	0	0	0	1.9	0	0	0	1.3	0.2	0	0	0.5	10.6	0	0.1	0	0	0	0	0	0	0	Distal tubular cells
ACTL7B	Tact1	ENSG00000148156	Actin like 7B	Q9Y614	9	108854589-108856967	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	437	testis: 43.6	Cell type enriched	Detected in some	5	Early spermatids: 1482.4	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in single		BEWO: 1.2	Not detected	Not detected			Not detected	Not detected			HPA021803, HPA024664	Enhanced											HPA021803: AB_1844551, HPA024664: AB_1844552					unprognostic (7.64e-2)	unprognostic (1.62e-1)								unprognostic (3.09e-1)	unprognostic (3.83e-2)			0	0	0	0	0	0	0	0	0	0	0			0	0	0	0	0	0	0	0	0	0	0	0	0	0		0	0	0	0	0		0	0		0	0	0	0	0	0	0	0	0	43.6			0		0	0	0	0	0	0	0	0	0	0	0	0.5	0	0.1	0.5	0	1.2	0	0.2	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0.4	0	0	0.2	0.4	0	0.3	0	0	0	0.1	0	0	0	0.3	0	0	0	0.2	0.3	0	0	0.4	0	0	0.3	0.1	0	0	0	0	0	0	0	0	0.1	0	0.2	0	0.2	0	0	0.2	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0	0	0.8	0	0	0	0	0	0	0	0	1482.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	301.1	8.3	0	0	0	0	0	0.1	0	5.6	0	0	0	0	7.9	3.2	0	0	0	0	0	Early spermatids
SLC39A12	FLJ30499	ENSG00000148482	Solute carrier family 39 member 12	Q504Y0	10	17951839-18043292	Predicted membrane proteins, Transporters	Ion transport, Transport, Zinc transport			Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	13	brain: 42.3;retina: 19.2	Cell type enriched	Detected in some	30	Muller glia cells: 85.4	Cancer enriched	Detected in single	8	glioma: 3.0	Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in single		U-2 OS: 1.3	Low region specificity	Detected in all			Low region specificity	Detected in all																unprognostic (1.43e-2)				unprognostic (2.67e-1)	unprognostic (3.30e-1)		unprognostic (8.70e-2)	unprognostic (1.02e-1)		unprognostic (8.35e-2)	unprognostic (1.33e-1)	unprognostic (3.40e-6)	unprognostic (1.94e-1)	unprognostic (8.11e-2)	unprognostic (3.76e-2)		1.2	1	13.7	1	14.6	0.9	2.3	2.2	31.2	0.9	1	14.8	0	0.9	0.9	0.9	0.9	0.9	0.9	1	21.4	5.5	0.9	0.9	1	0.9	9.9	5.6	0.9	1.2	0.9	1.5	1.1	42.3	1	1.1	19.2	1	0.9	0.9	0.9	0.9	1	1.5	1	0.9	1.4	8.7	0	0.9	0	0.9	1	0.1	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0.2	0	0	0	0	0	0	0.4	0.3	0.1	0.5	0	0.5	0	0	0	0	0	0	0	0.1	0.4	0	0	0	0	0	0	0	0.2	0	0	0	0	0.1	0	0.3	0.1	0	0	0	0	0.1	0	0	0.2	0	0	0	0	0	0	1.3	0.4	0.3	0.1	0	0	0.6	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.7	14.6	2.2	17.5	21.4	5.5	9.9	5.6	42.3	8.7	0	0	0	0	0	0.3	0.2	0	0	0	0	0	0	0	0	1.5	0	0	0	0	0	0	0	0	0	0.1	0	0	0.6	0	0.5	0.3	0	0	0	0	85.4	0	0	0	0	2.9	0	0	0	0.6	0.1	0	0	0	0	Muller glia cells
RGR	RP44	ENSG00000148604	Retinal G protein coupled receptor	P47804	10	84245053-84259960	Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins	Sensory transduction, Vision	G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer	Disease mutation, Retinitis pigmentosa	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	13	retina: 228.3	Cell type enriched	Detected in some	36	Muller glia cells: 1479.5	Cancer enhanced	Detected in single		glioma: 0.9	Low region specificity	Detected in many			Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		TIME: 4.0	Not detected	Not detected			Group enriched	Detected in many	5	midbrain: 30.1;olfactory region: 95.6;thalamus: 30.2														unprognostic (9.28e-2)		unprognostic (1.05e-1)	unprognostic (1.37e-1)	unprognostic (9.53e-2)				unprognostic (4.57e-2)	unprognostic (1.57e-1)				unprognostic (1.59e-1)	unprognostic (1.97e-1)			0.4	0.4	6.6	0.5	6.1	1.3	0.6	0.4	18.1	0.5	0.4	0.6	0	0.3	0.5	1.1	0.6	0.3	0.3	0.3	3	2.2	0.4	0.4	0.4	0.6	3.2	1.3	0.5	0.3	0.2	0.4	0.4	1.1	0.5	0.6	228.3	0.6	0.4	0.6	1.1	0.5	0.2	0.2	0.5	0.4	1.2	0.7	0	0.4	0	0.3	0.3	0	0.9	0.9	2.2	0.8	1	0.7	0.1	0.6	0.7	0.8	1.6	0.5	0.5	0.4	0.4	0.4	1	0.4	1.5	0.2	0.8	0.7	1.2	1.3	1.2	0.3	0.7	0.2	0.5	0.2	0.3	3	1	0.2	1.4	1.7	0.3	0.7	0.5	1.2	2.6	0.3	0.7	0.6	1.4	0	1.2	0.5	0.9	1.5	0.2	0.2	0.5	0.5	1.5	0	1.5	0.3	0.4	1	0.7	1.4	1.2	0.2	0.1	4	1.6	2.1	0.8	0.3	1.2	0.2	1.2	0.3	1.3	1	1	0.8	0.8	0.6	0.8	0.4	0.8	0.7	0.5	0.3	0.9	0.6	0.6	2.2	1	0.4	0.9	0.2	0.1	6.6	6.1	0.4	7.3	3	2.2	3.2	1.3	1.1	0.7	0	0	0	0	0	19.7	0.3	0	0	0	0	29.5	0	0	0	7.1	0	0	0	0	0	0	0	0	0	0	3.2	0	0	0	7.9	0.3	0	0	0	0	1479.5	0	0	0	0	40.8	0	0	0.2	0.2	0	0	0	0	0	Muller glia cells
ANKRD1	ALRP, C-193, CARP, CVARP, MCARP	ENSG00000148677	Ankyrin repeat domain 1	Q15327	10	90912096-90921276	Disease related genes, Predicted intracellular proteins			Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	81	heart muscle: 398.9;skeletal muscle: 333.3	Cell type enriched	Detected in some	15	Cardiomyocytes: 12578.5	Cancer enhanced	Detected in many		head and neck cancer: 7.5	Not detected	Not detected			Low cell type specificity	Detected in single			Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		EFO-21: 104.9;hTERT-RPE1: 57.1;LHCN-M2: 128.8;SuSa: 41.0;TIME: 179.4	Not detected	Not detected			Not detected	Not detected			HPA038736	Enhanced		Approved	Nucleoplasm,Nucleoli fibrillar center			Yes			Nucleoli fibrillar center	Nucleoplasm	HPA038736: AB_2676184	unprognostic (2.45e-1)	unprognostic (6.14e-3)	unprognostic (2.24e-1)	unprognostic (4.39e-1)	unprognostic (9.14e-3)	prognostic unfavorable (1.95e-4)	unprognostic (1.28e-2)	unprognostic (6.63e-3)	unprognostic (2.19e-1)	unprognostic (3.27e-1)	unprognostic (4.51e-2)	unprognostic (3.40e-1)	unprognostic (2.72e-5)	unprognostic (3.40e-2)	unprognostic (2.79e-1)	unprognostic (7.22e-2)	unprognostic (3.16e-3)	1.5	0.1	0	0.1	0	0.1	0.2	0	0.1	0.1	0.1	0	0	0.1	0.1	2.1	1.5	0.1	0.1	398.9	0	0	0.1	0.1	4.5	0.2	0	0	0.1	0.4	0.1	0.1	0.7	0.1	0.9	0.1	0	0.8	0.1	333.3	0.1	0.1	0.2	0	0.1	0.1	0.1	0	0	2.9	1.6	0.5	0.3	0	0.4	0.5	1.9	0.6	0.9	0.4	0.2	2.9	0.8	0.5	0	0.4	0.5	0	1.7	0.1	0.5	0.9	38	1.4	0	104.9	0.1	4	1	0.1	0.2	1.3	0.1	0.1	0	0.2	11.7	2.3	0	0	3.7	0	0.7	1.8	57.1	35.8	0	0	0	128.8	0	0	0	0.1	0.2	0	0	8.7	0	0.3	0	0	0	0	0	0.1	41	0	0.1	179.4	0.3	13.8	0.2	14.1	0	0	0.2	0	0	0	1.9	0.2	0.5	0.2	0.3	0.3	0.3	0.2	0.2	0.2	0.4	0.4	0.3	0.7	0.9	0.6	0.5	0.4	0.2	0	0	0	0	0	0	0	0	0.1	0	848.6	37.7	0	1.3	0	0	12578.5	10.2	1.4	9.1	0	0	0.1	0	19	2	0	0	0	0.2	0.2	0.2	0.4	3.5	0	0	0	0	1.3	0	0.2	0	0	0	1	0	0	3.7	0	0	0	0	0	1.4	0	0	0	0.5	0	0	0.1	Cardiomyocytes
NPFFR1	GPR147, NPFF1R1, OT7T022	ENSG00000148734	Neuropeptide FF receptor 1	Q9GZQ6	10	70247329-70283676	G-protein coupled receptors, Predicted membrane proteins		G-protein coupled receptor, Receptor, Transducer		Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enriched	Detected in many	6	brain: 34.9	Cell type enriched	Detected in some	6	Muller glia cells: 15.1	Cancer enhanced	Detected in some		ovarian cancer: 1.2	Group enriched	Detected in all	5	basal ganglia: 10.2;cerebellum: 34.9	Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		U-2 OS: 4.8	Group enriched	Detected in some	6	basal ganglia: 16.1;hypothalamus: 7.3	Low region specificity	Detected in many			HPA037521	Uncertain											HPA037521: AB_2675520	unprognostic (1.73e-3)	unprognostic (7.29e-4)	unprognostic (2.12e-1)	unprognostic (3.50e-2)	unprognostic (2.07e-1)	unprognostic (8.66e-3)	unprognostic (1.37e-1)	unprognostic (1.48e-1)	unprognostic (4.14e-2)	unprognostic (3.51e-1)	unprognostic (9.62e-2)	unprognostic (6.78e-2)	unprognostic (5.84e-5)	unprognostic (1.37e-1)	unprognostic (3.93e-2)	unprognostic (1.78e-3)	unprognostic (1.04e-1)	0.6	0.5	1.9	1.8	10.2	1.3	0.9	34.9	2.6	0.9	0.6	2.6	0	0.8	1	1.2	0.4	1.6	0.6	0.4	2.7	4.1	0.5	0.5	1.3	2.5	2.2	4.1	0.8	0.3	0.9	0.4	0.4	4.7	0.6	0.8	5.4	0.4	1.1	1	1	0.8	0.4	4	1	1.4	4.7	2	0	0.6	0	1.4	0.6	0.7	1	1.2	2.4	2.2	1.3	0.6	2.6	1.1	0.8	0.9	0.7	0.8	1.3	0.7	0.3	0.4	0.3	0.3	1.3	2.3	0.8	0.7	1	0.4	1	2.2	1.2	0.7	0.7	0.9	1.1	1	1	0.8	0.8	1.3	0.7	1.1	0.5	0.8	0.9	0.9	1	0.9	0.9	0.5	0.9	0.7	0.9	0.8	1.9	0.3	0.9	0.8	0.5	0.8	0.8	0.8	0.8	0.8	1.2	0.4	0.8	0.5	0.6	1	0.9	4.8	0.8	1	0.7	0.8	0.5	0.6	0.9	0.7	2.4	2.2	0.4	0.5	0.7	0.5	0.5	0.5	0.4	1.2	1	0.6	0.6	1.9	1.3	0.4	0.9	0.4	2.6	1.9	10.2	34.9	2.6	2.7	4.1	2.2	4.1	4.7	2	0	1.3	0	1.2	1.4	0.7	0.8	2.5	0	0	1.8	0	0.1	0	0	0.3	0.3	0	0	0.2	0.1	1	1	2.3	0	0.1	0	0	0	0.3	1.1	0.6	1.1	0	0	0	15.1	0.1	0	0.4	0	1.5	0	1.4	0.2	0.4	1.8	0.9	0	0	0.8	Muller glia cells
SLC5A12	MGC52019, SMCT2	ENSG00000148942	Solute carrier family 5 member 12	Q1EHB4	11	26667019-26723427	Predicted membrane proteins, Transporters	Ion transport, Sodium transport, Symport, Transport			Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	4	intestine: 60.8;kidney: 90.3	Cell type enriched	Detected in some	18	Proximal tubular cells: 145.9	Cancer enriched	Detected in single	26	renal cancer: 9.0	Region enriched	Detected in single	7	basal ganglia: 1.2	Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		Karpas-707: 5.2;NTERA-2: 3.8;SuSa: 7.8;T-47d: 2.8	Not detected	Not detected			Not detected	Not detected			HPA060904	Enhanced		Supported	Nucleoplasm,Plasma membrane						Plasma membrane	Nucleoplasm	HPA060904: AB_2684385	unprognostic (3.69e-3)	unprognostic (6.92e-2)	unprognostic (1.79e-1)	unprognostic (2.86e-1)	unprognostic (2.01e-2)	unprognostic (9.35e-3)	unprognostic (4.21e-3)	unprognostic (4.49e-2)	unprognostic (2.36e-3)	unprognostic (1.71e-1)	unprognostic (2.03e-2)	unprognostic (3.43e-1)	unprognostic (2.91e-3)	unprognostic (1.34e-1)	unprognostic (8.53e-2)	unprognostic (1.42e-2)	unprognostic (9.40e-3)	0	0	0.1	0	1.2	0.2	0	0	0.1	0	11.3	0	0.2	1.7	0	18.5	0	0	0	3.4	0.1	0.1	90.3	0.4	0	0	0.1	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	60.8	0	0.1	0.1	0	0.1	0	0	0	0	0	0.1	0	1.5	0.8	1	0.7	0.9	0.7	0.1	0.4	0.1	0.2	0.6	0.1	0	0.5	0.1	0	0	0	0.6	0.2	0.6	0.8	0.2	0.1	0.2	0.2	0.1	0.1	0	0	0.1	0.7	0.1	0.2	0	0.2	0.1	0	0.1	0	0.2	0.1	0.3	0.4	5.2	0.1	0.3	0.2	0.5	3.8	0.7	0.1	0.1	0	0.6	0.1	1.1	2	0.3	1.7	0.2	0	7.8	2.8	0.5	0.6	0.4	0.2	0.4	0.2	2.3	0.7	0.2	0.2	0	0	1	0.5	0.1	0.6	0.7	0.4	1.1	0.4	0.4	0.5	1.5	0.7	0.6	0.4	0.9	0.6	0.8	0.1	0.1	0.1	1.2	0	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0	3.8	0	0	0	3.5	0	0.1	8.3	0	0.7	0	1.7	0	0	0.2	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0.4	0.8	0	0.3	0	145.9	0.2	0	0	0	0.4	0	0.1	0	0.4	0	Proximal tubular cells
SAA4	C-SAA, CSAA	ENSG00000148965	Serum amyloid A4, constitutive	P35542	11	18231349-18236893	Plasma proteins, Predicted secreted proteins	Acute phase			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	132	liver: 263.3	Cell type enriched	Detected in some	47	Hepatocytes: 1790.2	Cancer enriched	Detected in many	141	liver cancer: 118.6	Not detected	Not detected			Cell type enriched	Detected in single	20	memory B-cell: 1.9	Lineage enriched	Detected in single	20	B-cells: 1.9	Cell line enriched	Detected in some	18	Hep G2: 22.6	Not detected	Not detected			Not detected	Not detected			CAB026061, HPA060139	Supported				Secreted to blood			65000000000	72000000000			CAB026061: , HPA060139: AB_2684210	unprognostic (4.70e-4)	unprognostic (1.17e-1)	unprognostic (1.17e-1)	unprognostic (4.83e-1)	unprognostic (4.15e-2)	unprognostic (6.05e-2)	unprognostic (3.63e-3)	unprognostic (5.94e-2)		unprognostic (2.40e-2)	unprognostic (1.41e-1)	unprognostic (7.35e-2)	unprognostic (2.54e-8)	unprognostic (2.49e-1)			unprognostic (6.46e-2)	0.7	0	0.1	0.1	0.1	0	0.6	0.1	0.1	1.6	0.1	0.1	0.1	0	0.1	0.1	0.1	0	0.1	0.1	0.1	0	0.1	263.3	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.1	1.2	0.1	0.3	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.9	0	0	0	0	0	0	1.2	0	0	0	0	0	0.1	0	0	0	0	0	0.5	0	0.6	0	0.2	0.7	0	0.1	0	0	0	0.2	0	22.6	0.2	0.1	0	0	0.1	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0.1	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	1.9	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	14.7	0	0	0	0	25.5	0	4.5	0	0	0	0	3.5	0.4	0	0	23.3	1.1	0	0	0.1	0	1790.2	0.1	0	0	32.5	38.1	0.7	0	0	1.7	0	0	0	2.5	0	0	0	0	0	0	0	0	0.1	0	0	0	0.5	Hepatocytes
DRD2		ENSG00000149295	Dopamine receptor D2	P14416	11	113409615-113475691	FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters		G-protein coupled receptor, Receptor, Transducer	Disease mutation, FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Group enriched	Detected in many	8	adrenal gland: 17.3;brain: 52.0;pituitary gland: 51.6	Cell type enriched	Detected in some	12	Horizontal cells: 57.2	Low cancer specificity	Detected in some			Region enriched	Detected in many	5	basal ganglia: 52.0	Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	9	SCLC-21H: 45.2	Region enriched	Detected in many	10	basal ganglia: 183.8	Group enriched	Detected in many	8	basal ganglia: 126.7;midbrain: 41.7	HPA015139, HPA015691	Supported	Supported										HPA015139: , HPA015691: AB_1847834	unprognostic (8.49e-2)	unprognostic (2.11e-1)	unprognostic (1.69e-1)	unprognostic (1.29e-4)	unprognostic (2.32e-2)	unprognostic (1.15e-1)		unprognostic (1.97e-2)	unprognostic (5.89e-2)	unprognostic (4.40e-2)	unprognostic (8.33e-4)	unprognostic (1.10e-1)	unprognostic (6.65e-3)	unprognostic (2.29e-1)	unprognostic (1.71e-1)	unprognostic (4.82e-2)	unprognostic (8.49e-3)	0.6	17.3	0.9	0.5	52	0.2	2.1	0.2	3.3	1.3	0.6	1.5	0	0.3	2.3	0.4	0.9	2.1	0.6	0.5	0.3	4.1	0.3	0.2	0.6	0.2	9.9	0.2	0.3	0.4	0.3	51.6	0.2	2.4	1.5	0.9	3.9	5.1	1.7	1.7	0.3	0.5	3.2	0.2	0.2	0.5	1.6	9.5	0	0.2	0	0.3	0.3	0.3	0	0	0.2	0	0	0.6	0	0	0	0.1	0	0	0	0	0	0	0	0	3.7	0.1	0	0	0	3.1	0	0	0	0	2.3	0	0	0	0	0	0	5.1	0	0.8	0	0.6	0	0	0	0	0	1.5	0.2	0	0	0.5	0	0	0	4.8	0	0	0	45.2	5.1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0.6	0	0.9	52	0.2	3.3	0.3	4.1	9.9	0.2	2.4	9.5	0	0	0	0	0	4.9	1.1	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	57.2	0	0	0	0.2	0	0	0	0	0	0.1	0	0	0	0	1.1	0	0	0	0	0	0	0	0	0	Horizontal cells
AASDHPPT	AASD-PPT, ACPS, CGI-80, LYS5	ENSG00000149313	Aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase	Q9NRN7	11	106075501-106098710	Predicted intracellular proteins		Transferase		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in all	4	Early spermatids: 308.4	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low cell line specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA026687	Approved											HPA026687: AB_1844414	unprognostic (1.96e-2)	unprognostic (4.40e-1)	unprognostic (8.71e-3)	unprognostic (2.12e-1)	unprognostic (1.11e-1)	unprognostic (9.04e-3)	unprognostic (2.82e-3)	unprognostic (1.41e-1)	unprognostic (2.44e-2)	unprognostic (7.92e-2)	unprognostic (2.09e-1)	unprognostic (1.32e-1)	prognostic favorable (4.27e-4)	unprognostic (2.13e-1)	unprognostic (2.15e-1)	unprognostic (1.19e-1)	unprognostic (1.43e-1)	10.9	15.9	27.9	11.7	32.9	9.2	14	33	41.7	12.6	8.7	14.2	8.2	9	13.4	17	14.7	13.7	8.8	17.5	29.9	33.7	22.7	20.9	10	13.5	21.7	26.4	14.4	22.3	15.9	17.8	17.6	30.5	12.7	9.4	8.9	14.8	11.9	20.5	10.6	7.7	11.9	20.1	10.7	8.7	24.4	14.7	13.2	14.6	9.3	15.3	12.9	9.6	18.6	14.4	30.6	18.3	19.9	21	11.9	11.1	11.6	32.6	23.8	15.4	21.4	13.8	16.8	13.8	22.4	17.4	23.7	19.8	34	39.1	9.8	22.2	14.2	27.6	21	22.1	21.5	14.6	31.5	8.5	16.5	24.1	25.7	13.4	20	26.1	17.8	23.6	15.3	17.6	15.3	34.6	8.3	21.3	6.5	28.9	21.6	14.2	14.9	15.2	20.6	30.7	37.8	24.9	12.6	24.3	22.7	17.9	17.3	16.4	19.6	22.6	17.9	14.7	19.2	18.4	13.4	17.2	11.8	19.6	33.5	8.6	35.8	21.8	30.6	14.7	15.1	14.8	18.3	21	18.6	17.2	16.1	14.4	14.2	20.3	19.1	4.5	19.9	17.3	12.6	20.1	11.9	27.9	32.9	33	41.7	29.9	33.7	21.7	26.4	30.5	14.7	29.8	24.8	33.6	24.5	17.7	33.3	20.6	22.9	57.6	27.3	17.4	2	69.8	33.2	27.8	308.4	19.6	8.1	23.3	21.4	57.3	31	17.5	28.9	32.6	33.9	20.6	17.9	17.8	18.1	42.4	30	23.4	30.4	25.2	11.7	62.8	20	8.6	25.1	59.2	16.3	12.9	18.4	43.1	38.9	21.3	33	29.9	14.1	15.6	Early spermatids
GLB1L2		ENSG00000149328	Galactosidase beta 1 like 2	Q8IW92	11	134331874-134378341	Predicted secreted proteins		Glycosidase, Hydrolase		Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		retina: 36.2	Cell type enriched	Detected in many	4	Rod photoreceptor cells: 158.9	Low cancer specificity	Detected in many			Region enhanced	Detected in many		pons and medulla: 11.2	Cell type enhanced	Detected in many		gdT-cell: 5.8;NK-cell: 5.8	Group enriched	Detected in many	23	NK-cells: 5.8;T-cells: 5.8	Cell line enhanced	Detected in many		CAPAN-2: 19.6;HaCaT: 20.7;OE19: 47.6;SCLC-21H: 14.0	Not detected	Not detected			Low region specificity	Detected in single			HPA054808, HPA059955	Uncertain		Approved	Nucleoplasm,Vesicles	Secreted - unknown location					Nucleoplasm	Vesicles	HPA054808: AB_2682608, HPA059955: AB_2684178	unprognostic (2.63e-2)	unprognostic (9.77e-3)	unprognostic (2.32e-2)	unprognostic (2.20e-2)	unprognostic (8.07e-2)	unprognostic (1.54e-1)	unprognostic (5.98e-2)	unprognostic (2.08e-2)	unprognostic (1.51e-1)	unprognostic (8.31e-2)	unprognostic (1.67e-1)	unprognostic (1.48e-1)	unprognostic (4.73e-2)	unprognostic (1.22e-2)	unprognostic (2.64e-1)	unprognostic (3.88e-3)	unprognostic (1.01e-1)	0.8	1.2	1.6	4.4	4.2	0.1	4.5	0.3	2.5	6	13.5	4.5	8.7	3.6	20.5	6.6	3	17.1	15.7	0.8	2.2	2.7	13.8	0.3	4.1	1.3	0.9	1.4	9.5	6.5	22.7	8.6	5.4	11.2	23.5	7.8	36.2	5.2	17.4	0.8	5.9	2.7	5.6	0.7	0.2	5.7	7	0.3	1.4	15	5.2	2.6	5.1	2.9	0.2	0	0	0	5.8	5.8	0.8	6	0.6	3.3	1.8	0	0	2.2	0	0	0	0	5.1	19.6	0	6.5	0	2.7	20.7	9.9	0.1	0	0	9.4	0	2.6	0.2	0.9	0	11.4	0.1	0.3	0	0	0	0	3	9.9	0	0	5.8	1.6	1.1	1.8	47.6	7.2	0	0	0.5	5.6	4.3	14	5.2	4.4	5.6	0	0.5	7.3	0	0	0	0	0	0	0	0	0	1.6	0	1.2	0	0	0	5.8	0	2.3	0	1.3	2.3	0	0.2	1.6	2.6	0	5.8	0	0	0	0.8	1.6	4.2	0.3	2.5	2.2	2.7	0.9	1.4	11.2	0.3	0	2.6	0	4.2	1.9	6.1	1	2.5	8.1	3.4	0	39.3	0.2	0	2	1.7	0.6	9.7	0	2.1	0.9	1.5	7.6	0	0	0.2	4.8	8.6	0	0	4.9	1.1	0	5	0	5.8	8.1	1.7	8.2	0.7	8.1	158.9	0	1.9	2.3	4.2	0.6	0.1	1.3	10.7	2.6	Rod photoreceptor cells
GRIK4	GluK4, GRIK, KA1	ENSG00000149403	Glutamate ionotropic receptor kainate type subunit 4	Q16099	11	120511700-120988904	Predicted membrane proteins, Transporters	Ion transport, Transport	Ion channel, Ligand-gated ion channel, Receptor		Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in many		brain: 19.3;ovary: 8.5	Cell type enriched	Detected in some	8	Cone photoreceptor cells: 33.4	Cancer enriched	Detected in some	5	glioma: 3.1	Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	4	HDLM-2: 6.4;HEL: 19.7;T-47d: 5.1	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA074453	Enhanced											HPA074453: AB_2732255	unprognostic (9.63e-2)	unprognostic (4.96e-2)	unprognostic (1.58e-1)	unprognostic (2.49e-1)	unprognostic (2.37e-1)	unprognostic (6.64e-4)	unprognostic (1.48e-2)	unprognostic (7.26e-2)	unprognostic (3.16e-1)	unprognostic (2.38e-1)	unprognostic (4.53e-2)	unprognostic (2.50e-1)	unprognostic (4.84e-11)	unprognostic (1.35e-1)	unprognostic (2.81e-1)	unprognostic (4.47e-3)	unprognostic (2.58e-2)	1	5.4	11.3	1	9	0.8	1.3	3.9	19.3	1.2	1.1	9.4	0	1.2	1.1	0.9	1.2	1.7	1.1	1.6	13.9	7.2	1	0.8	3.1	1	8.7	11	8.5	0.8	0.8	2.6	1.5	12.3	1.5	1.1	0	1.1	1	1	1.3	1.2	1	6.3	1.4	0.9	2	8.2	0	6.3	0	1	1.2	0.4	0	0	0	0	0.7	0.5	0.1	0	0	0.7	0	0	0	0	0	0	0	0	0.2	0	0	0.5	0	0	0	0.5	0	0	6.4	0.6	19.7	0	0	0	0	2.2	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0.9	0.2	0	0	0	0.6	5.1	0	0.2	0	0.2	0	0	2.4	0.1	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0.7	0	0	0	0.1	11.3	9	3.9	14	13.9	7.2	8.7	11	12.3	8.2	0	1.1	0	0	0	0.4	1.2	0	0	0	0	33.4	0	0	0	3.2	0	0	0	0	0	0	0.1	1.1	0	0	0	0	0	0.3	4.1	0.3	0	0	0	0	0	0.1	0	0	0	0	0	0	0.5	2.7	0	0.1	0	0	0.4	Cone photoreceptor cells
SLC22A8	OAT3	ENSG00000149452	Solute carrier family 22 member 8	Q8TCC7	11	62989154-63015839	FDA approved drug targets, Predicted membrane proteins, Transporters	Detoxification, Ion transport, Transport		FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	341	brain: 33.7;kidney: 127.3;retina: 93.5	Cell type enriched	Detected in some	30	Proximal tubular cells: 197.4	Cancer enhanced	Detected in single		renal cancer: 0.6	Region enriched	Detected in some	25	pons and medulla: 33.7	Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	13	EFO-21: 1.3	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA044174	Enhanced											HPA044174: AB_10963058							unprognostic (5.35e-4)					unprognostic (4.66e-1)	unprognostic (6.88e-3)	unprognostic (1.72e-1)	unprognostic (2.20e-1)			0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.4	1	0.1	0.1	3.8	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.7	0.1	127.3	0.1	0.1	0.1	0.1	1.3	0.1	0.1	0.1	0.2	0.1	33.7	0.1	0.1	93.5	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0	0	0.1	0	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.4	1	0.7	0.1	0.1	1.3	33.7	0	0	0	0	0	0	3.7	0.8	0	0	0	5.2	0	0	6.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	197.4	0.9	0	0	0	0	0	0	0	0	0	Proximal tubular cells
TMC2	C20orf145, dJ686C3.3	ENSG00000149488	Transmembrane channel like 2	Q8TDI7	20	2536607-2641784	Predicted membrane proteins	Ion transport, Transport	Ion channel		Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in some		brain: 8.1;pituitary gland: 3.2	Cell type enriched	Detected in some	6	Late spermatids: 9.5	Not detected	Not detected							Cell type enhanced	Detected in single		gdT-cell: 1.4	Lineage enhanced	Detected in single		T-cells: 1.4	Cell line enhanced	Detected in single		ASC diff: 3.2	Not detected	Not detected			Low region specificity	Detected in single																unprognostic (4.73e-2)	unprognostic (1.87e-1)	unprognostic (5.88e-2)	unprognostic (8.30e-4)	unprognostic (2.86e-3)	unprognostic (3.00e-1)	unprognostic (1.13e-2)	unprognostic (1.07e-2)	unprognostic (4.54e-1)	unprognostic (1.41e-2)	unprognostic (4.05e-5)	unprognostic (2.90e-1)	unprognostic (3.21e-7)	unprognostic (2.47e-2)	unprognostic (2.56e-1)	unprognostic (1.93e-1)	unprognostic (5.74e-2)	2.3	0.4	0.3	0.3	0.8	0	0.7	8.1	0.4	0	0			0.4	0	0	0.2	0.2	0.9	0	0.2	0.9	0	0	3	0.2	0.1		0.5	0.1	0.1	3.2	0.1		0	0.1		0.3	0	0.1	0.2	0.1	0.1	0.1	0.2	0	2.5			0.2		0	0.8	0	0	0	0	0	0.3	1.4	0.1	0.2	0.4	0.3	0.2	3.2	0.9	0	0	0	0	0	0	0.3	0.3	0	0	0.2	0.4	0	0	0	0.3	0	0	0	0.2	0.3	0.1	0	0	0	0	0	0	0	0.3	0.1	0	0	0	0.2	0	0.1	0	0	0.1	0	0.3	0	0	0.1	0.1	0.1	0	0	0.4	0	0	0	0	0	0.1	0	0.1	0	0	0	0	0.2	0	0	0	1.4	0	0	0	0	0	0	0	0	0.3	0	0.3	0	0	0	0.1											0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	1.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	9.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	Late spermatids
ROM1	ROM, TSPAN23	ENSG00000149489	Retinal outer segment membrane protein 1	Q03395	11	62611722-62615120	Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins	Cell adhesion, Sensory transduction, Vision		Disease mutation, Retinitis pigmentosa	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	5	retina: 108.1	Cell type enriched	Detected in many	4	Rod photoreceptor cells: 2384.7	Cancer enriched	Detected in all	6	glioma: 14.9	Low region specificity	Detected in all			Cell type enhanced	Detected in many		NK-cell: 5.6	Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		HSkMC: 17.9;U-266/84: 18.8	Not detected	Not detected			Low region specificity	Detected in all			HPA028910, HPA073279	Enhanced		Approved	Plasma membrane,Cytosol		No	No			Plasma membrane, Cytosol		HPA028910: AB_2672824, HPA073279: 	unprognostic (1.54e-2)	unprognostic (1.37e-2)	unprognostic (4.24e-2)	unprognostic (1.11e-1)	unprognostic (1.65e-1)	unprognostic (2.02e-1)	unprognostic (4.05e-1)	prognostic favorable (2.20e-4)	unprognostic (2.20e-1)	unprognostic (9.87e-2)	unprognostic (7.65e-3)	unprognostic (3.50e-2)	prognostic unfavorable (2.85e-6)	unprognostic (2.61e-1)	unprognostic (4.65e-1)	unprognostic (1.02e-1)	unprognostic (7.24e-2)	9.4	4.6	16.3	2.3	15	0.9	3.6	5.7	18.8	4.9	3.1	5.1	3.3	2	3.8	5.7	4.7	7.4	5.2	2.7	14.7	9.2	2.4	3.2	3	2.3	18.1	4.7	13.2	3.2	4.8	2.1	1.6	8.7	3.8	3	108.1	2.5	5.9	2.2	3.7	1.7	6.3	21.6	2.5	2.4	3.7	7.7	0.7	3	2.2	2.6	3.1	9.2	1.1	0.8	0.8	1.2	5.6	3.2	1.4	2.1	1.2	2.2	4.6	3.2	15.7	0.4	1.4	2.5	3.1	2	0.6	3.6	2	10	8.1	1.3	2.8	1	2.8	0.8	3.6	1.8	1.8	5.4	2.6	9.3	0.7	0.6	17.9	4.1	3.2	6.4	10.5	4.8	0.9	2.7	4.6	6.2	5.4	1.1	1.5	0.5	1.1	3.3	1.1	1.8	12.8	3.4	1.2	2.3	3.4	3.5	4.1	1.6	0.3	5.6	0.9	5.4	5.1	1.9	6	1.6	2.1	18.8	1.6	9.5	2.1	1	0	1.2	0.8	0.9	0.3	2.4	0.7	3.2	0.8	0.6	1.1	1.5	1.8	0.4	5.6	1.1	0.8	0.9	1.4	16.3	15	5.7	8.4	14.7	9.2	18.1	4.7	8.7	7.7	0	4.1	0	4.4	3.3	268.3	2.4	0	2.7	1.2	5.2	559.6	0.8	1.7	1.3	2.1	8	1.6	0	2.7	0.2	3.5	2.6	1.1	0.6	1	162.1	4.1	11.1	1.8	5.9	17.5	1	3.3	1	2.8	315.6	1.7	3.4	5.3	4	2384.7	0	3.4	0.9	2.7	0.9	0.6	0	2.9	2	Rod photoreceptor cells
OOSP2	FLJ36198, PLAC1L, TMEM122	ENSG00000149507	Oocyte secreted protein 2	Q86WS3	11	60040275-60048044	Predicted intracellular proteins, Predicted secreted proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	15	testis: 48.6	Cell type enriched	Detected in single	4	Late spermatids: 3.8	Not detected	Not detected			Not detected	Not detected			Cell type enriched	Detected in single	32	basophil: 3.2	Lineage enriched	Detected in single	32	granulocytes: 3.2	Not detected	Not detected							Not detected	Not detected			HPA050914	Enhanced				Secreted in male reproductive system							HPA050914: AB_2681271																		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	48.6	0	0	0	0	0	0	0	0	0	3.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0.4	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0.3	0	0	0	0	0	0.6	0	0	0	0	0	0	0	3.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.8	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0.4	0	0	0	0	0	Late spermatids
SPATA25	C20orf165, dJ337O18.8, TSG23	ENSG00000149634	Spermatogenesis associated 25	Q9BR10	20	45886489-45887635	Predicted intracellular proteins	Differentiation, Spermatogenesis			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in many		testis: 18.4	Cell type enriched	Detected in some	6	Early spermatids: 226.8	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Cell type enhanced	Detected in single		memory B-cell: 1.2	Low lineage specificity	Detected in single			Cell line enhanced	Detected in many		CACO-2: 10.2	Not detected	Not detected							HPA041386			Approved	Golgi apparatus						Golgi apparatus		HPA041386: AB_2677446	unprognostic (1.88e-1)	unprognostic (2.66e-1)	unprognostic (1.60e-1)	unprognostic (4.92e-3)	unprognostic (2.36e-1)	unprognostic (1.84e-2)	unprognostic (2.75e-3)	unprognostic (1.57e-2)	unprognostic (2.57e-2)	unprognostic (3.45e-1)	unprognostic (1.92e-3)	unprognostic (1.67e-2)	unprognostic (3.14e-1)	unprognostic (5.07e-2)	unprognostic (2.62e-1)	unprognostic (5.93e-5)	unprognostic (1.12e-1)	2.4	1.4	1.6	1.6	1.6	0	1.6	2.8	1.6	1.8	1.7	1.6	1.6	3.7	2.5	1.6	1.6	2.2	1.6	2.3	1.6	0.8	2.5	3.8	1.6	1.6	1.6	1.6	5.8	1.6	2.3	1.6	1.6	1.6	1.6	1.4	1.6	1.7	2.5	7.9	1.8	2.3	2.9	1.6	1.6	1.1	18.4	1.6	1.6	2.2	1.6	1.6	2.7	1.6	1.2	0.5	0	0.1	0	0.7	0	0.9	3.2	2.4	2.7	3.7	2.2	2.8	0.7	2.8	1.5	0.5	10.2	5.7	1.9	0.9	1.2	3	4.4	1.2	0.8	0.5	0.6	2.2	0.9	7.9	6.6	2.8	0.2	1.7	5.2	1.5	0.6	0.8	3.8	1	3.1	1.3	2.4	1.1	2.1	1.2	0.1	1.4	0.9	1.8	2.4	1.6	1.2	0.2	1.4	4.6	2.6	2.9	2.1	2.9	1	3.5	2.4	0.8	1.8	2	1.3	0.9	2.2	1.3	0.5	2.4	1.8	0.3	0	0.1	0	0	0	0	1.2	0	0	0.5	0.4	0.7	0	0	0	0	0	0	0	1.6	1.6	2.8	1.6	1.6	0.8	1.6	1.6	1.6	1.6	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	226.8	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	35.4	2	0	0	0	0	0	0	0	0.4	0	0.7	0	0	1.4	0.6	0	0	0	0	0	Early spermatids
OCSTAMP	C20orf123, dJ257E24.3	ENSG00000149635	Osteoclast stimulatory transmembrane protein	Q9BR26	20	46540946-46550574	Predicted membrane proteins, Transporters	Differentiation			Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in some		adipose tissue: 6.9;blood: 2.6	Cell type enriched	Detected in single	5	Melanocytes: 1.7	Not detected	Not detected			Not detected	Not detected			Cell type enriched	Detected in single	26	plasmacytoid DC: 2.6	Lineage enriched	Detected in single	26	dendritic cells: 2.6	Cell line enhanced	Detected in some		AF22: 2.7;HMC-1: 5.2;Karpas-707: 3.0;NB-4: 5.7;RPMI-8226: 2.4;U-266/70: 1.9;U-266/84: 5.2	Low region specificity	Detected in some			Low region specificity	Detected in all			HPA031116	Uncertain											HPA031116: AB_10600758	unprognostic (2.77e-1)		unprognostic (3.04e-1)		unprognostic (8.80e-2)	unprognostic (5.02e-2)		unprognostic (2.42e-1)	unprognostic (2.71e-1)					unprognostic (2.65e-1)	unprognostic (9.59e-2)	unprognostic (2.08e-1)		6.9	0	0.1	0.1	0.4	0	0.1	0	0.1	0	0	0	0	0.5	0	0	0	0	0	0	0.3	0.2	0.6	0	0	0.1	0.5	0	1.1	0	0	0	0	0	0	0.1	0	0.1	0	0	1.2	0.1	0.2	0.6	0	0.2	1.9	0	0	0	0	0.5	0	0	0	2.6	0	0	0	0	0	0	0	2.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5.2	0	0	0	0	0	0	0	0	3	0	0	0	5.7	0.4	0	0	0	0	2.4	0	0	0	0	0	0	0	0	0	0.9	0	0	0	0	0	1.9	5.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.6	0	0	0.1	0.4	0	0.1	0.3	0.2	0.5	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	1.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Melanocytes
SPINT4	C20orf137, dJ601O1.1	ENSG00000149651	Serine peptidase inhibitor, Kunitz type 4	Q6UDR6	20	45722351-45725830	Predicted secreted proteins		Protease inhibitor, Serine protease inhibitor		Evidence at protein level	Evidence at protein level	No human protein/transcript evidence	Evidence at transcript level		Tissue enriched	Detected in some	12	epididymis: 134.6	Cell type enriched	Detected in single	11	Rod photoreceptor cells: 1.8	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	5	NB-4: 4.6;U-87 MG: 2.0									HPA046703	Enhanced				Secreted in male reproductive system							HPA046703: AB_2732530														unprognostic (3.61e-1)				0.1	0.1	0.1	0	0.1	0	0.1	0.1	0.1	0.1	0.1	0	11.5	0	0.1	134.6	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0	0.1	0.1	0	0.1	0	0	0.3	0	0	0.1	0	0.1	0.4	0.1	0	0.1	0.1	0.1	2.1	0	0	0.1	0	0	0.8	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4.6	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.8	0	0	0	0	0	0	0	0	0	Rod photoreceptor cells
FXYD4	CHIF	ENSG00000150201	FXYD domain containing ion transport regulator 4	P59646	10	43371642-43376335	Predicted membrane proteins	Ion transport, Transport	Ion channel		Evidence at protein level	Evidence at protein level	No human protein/transcript evidence	Evidence at transcript level		Tissue enriched	Detected in some	27	kidney: 119.5	Cell type enriched	Detected in some	120	Collecting duct cells: 4780.5	Group enriched	Detected in many	5	renal cancer: 10.7;urothelial cancer: 20.0	Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	32	SuSa: 15.9	Not detected	Not detected							HPA058421	Enhanced											HPA058421: AB_2683714	unprognostic (2.92e-3)	unprognostic (5.25e-1)	unprognostic (9.46e-2)	unprognostic (2.60e-2)	unprognostic (2.56e-1)	unprognostic (1.85e-1)		unprognostic (2.32e-1)		unprognostic (2.00e-1)	unprognostic (5.17e-2)	unprognostic (2.19e-1)	unprognostic (6.12e-2)	unprognostic (7.88e-2)	unprognostic (1.26e-1)	unprognostic (3.20e-1)	unprognostic (2.09e-2)	0.1	0	0.4	0	2.2	0	0	0.1	1	0	0.1	2	0.1	0	0.1	0.8	0.1	0	0	0.1	0.6	0.3	119.5	0	1.3	0	1.6	0.4	0	0	0	0.1	0	1	0.6	0	0	4.4	1.5	0.6	0	0	0	0.5	0	2.4	0.2	1.4	0	0	0	0	1.3	0	0	0	0	0.1	0	0.4	0.3	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0.2	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0.2	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0.2	0	0	0	0.2	0	15.9	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0.1	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0.4	2.2	0.1	1	0.6	0.3	1.6	0.4	1	1.4	6	0.6	0	0	0	0	0	0	0	0	4780.5	0	0.4	39.7	0	1.1	0	0	0	0.2	0.1	0	0.1	0	0	0.1	0	0	0	0	7.9	0	0	0	0	0.7	0	0	0	0	4.9	0	0	0	1	0.1	0	0.3	0	0.1	0.9	Collecting duct cells
C11orf53	MGC50104	ENSG00000150750	Chromosome 11 open reading frame 53	Q8IXP5	11	111245805-111286401	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in some		testis: 7.6	Cell type enriched	Detected in some	5	Exocrine glandular cells: 51.6	Low cancer specificity	Detected in many							Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	7	OE19: 9.4	Not detected	Not detected			Low region specificity	Detected in all			HPA056128, HPA073101	Uncertain		Approved	Nucleoplasm,Vesicles						Nucleoplasm	Vesicles	HPA056128: AB_2683046, HPA073101: 	unprognostic (3.51e-2)	unprognostic (3.60e-2)	unprognostic (4.84e-2)	unprognostic (5.84e-2)		unprognostic (1.94e-1)		unprognostic (8.07e-3)		unprognostic (5.60e-3)	unprognostic (3.09e-1)	unprognostic (2.50e-1)		unprognostic (9.95e-2)	unprognostic (8.66e-2)		unprognostic (3.52e-2)	1.4	0	0	0	0	0	4.6	0	0	0.1	2.6			1.2	1.6	0	0	1.8	2.6	0	0	0	0.1	0	0.1	0	0		0.9	0.8	0	0.6	1.2		0.4	2.4		4.1	0	3.2	0	3	0	0	0	4.5	7.6			0		0	0.3	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	1.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	9.4	0	0	0	0	0	0.2	0	0.5	1.3	1	0	0	0	0	0	0	0	0	0	0.4	0.1	0.4	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0.1	0	0	0	0	0	0	0	0											0	0	0	0.8	0	0	0.1	7.6	0	0	0	0	0	0	1.5	11.2	0	2.1	0	51.6	0	0	0.1	0	0	0	0	7.5	0	0	6.6	0.3	0	0	0	2.5	0	0.4	0	0.4	0	0	0	0	0.5	0.9	0	0	0	1.7	3.5	Exocrine glandular cells
TEX12		ENSG00000150783	Testis expressed 12	Q9BXU0	11	112167372-112172559	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	19	testis: 29.9	Cell type enriched	Detected in some	7	Spermatocytes: 158.2	Not detected	Not detected			Not detected	Not detected			Cell type enhanced	Detected in single		eosinophil: 1.5	Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		U-698: 4.9	Not detected	Not detected			Low region specificity	Detected in many			HPA038289, HPA038290	Enhanced											HPA038289: AB_10672742, HPA038290: AB_2675934	unprognostic (1.49e-1)	unprognostic (6.57e-2)	unprognostic (1.01e-1)	unprognostic (2.92e-2)	unprognostic (1.07e-1)	unprognostic (2.93e-3)	unprognostic (2.03e-1)	unprognostic (1.55e-1)	unprognostic (1.26e-1)	unprognostic (1.21e-1)	unprognostic (2.91e-1)	unprognostic (9.20e-4)	unprognostic (1.71e-2)	unprognostic (2.97e-1)	unprognostic (6.54e-2)	unprognostic (4.10e-2)	unprognostic (3.16e-3)	0.3	0	0.1	0.6	0.2	0.3	0.4	0.1	0.4	0.2	0.2	0.3	0.1	0.6	0.2	0.5	0.1	0.2	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0	0.1	0.1	0.1	0.4	0.2	0.1	0.1	0.1	0.9	0.7	0.4	0.2	0.1	0.2	0.2	29.9	0.1	0.1	0.1	0.1	0.2	0.2	0.2	0.5	0.5	1.5	0.5	0	0.9	0.3	0.1	0	0.6	0.3	1.1	0.7	0.2	0.3	0.4	0.5	1.1	0.4	1.5	2.5	0.6	0.7	0.5	0	0.5	0.4	0.8	1.5	0	1.2	0	0	1.5	1.4	0.9	0.9	0.6	1	0.4	0.2	0.1	0.8	0.3	1.2	0	0	1.1	2.5	0.1	1.3	0.9	0.8	0.3	2.2	1.1	0.1	0.3	0.4	0	1.5	0	0	0.1	2.6	0	0.4	1.5	0.8	0.5	0.3	0.2	4.9	0.6	1.3	0	0	0.1	1.5	0.1	0.5	0	0.5	0.5	0.9	0	0	0	0.3	0.8	0	0.4	0.5	0	0.3	0.1	0.2	0.1	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0.2	0.6	0.5	0	0	0	0	0	3.9	0.1	0	0.1	0.9	0	0	0	0.2	0.1	0	0.1	0	0.2	0.2	0	0	0	0	4.3	0.9	0	0	0	0	0	0.1	0	0.7	0	0.3	6.5	0.1	158.2	23.2	0.4	0	0	0	0.1	Spermatocytes
C2orf50	FLJ25143	ENSG00000150873	Chromosome 2 open reading frame 50	Q96LR7	2	11133053-11146790	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in some		brain: 17.3;fallopian tube: 21.1	Cell type enriched	Detected in some	5	Ciliated cells: 38.8	Low cancer specificity	Detected in some			Region enriched	Detected in many	4	pons and medulla: 17.3	Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		CAPAN-2: 4.1;JURKAT: 3.3;T-47d: 3.6					Not detected	Not detected			HPA062894	Enhanced											HPA062894: AB_2684897	unprognostic (6.29e-2)	unprognostic (1.33e-1)	unprognostic (3.53e-4)	unprognostic (1.92e-3)	unprognostic (3.35e-2)	unprognostic (6.19e-2)	unprognostic (3.55e-1)	unprognostic (1.31e-1)	unprognostic (3.32e-1)	unprognostic (2.98e-2)	unprognostic (2.00e-2)	unprognostic (2.45e-1)	unprognostic (3.97e-4)	unprognostic (7.03e-2)	unprognostic (2.92e-1)	unprognostic (8.25e-3)	unprognostic (7.36e-2)	0.4	0.5	2.1	0.5	2.7	0.7	0.6	0.5	4	1.2	0.3	2.2	0	0.6	0.7	5.5	0.2	21.1	0.4	0.2	4.1	3.2	0.6	0.3	4	0.6	1	1.7	5	0.5	0.3	3.8	0.4	17.3	0.5	0.3	0	1.1	0.3	0.4	0.6	0.4	0.4	0.6	0.6	0.4	0.6	0.5	0	0.5	0	0.5	0.2	0	1.1	0.8	2	0.7	1.3	2.4	0.4	0.3	1.7	0.8	0.4	0.1	0.2	0.8	0.2	0.4	0.6	0.5	0.8	4.1	0.3	0.6	0.3	0.6	0.8	2.5	0.2	0.5	1.7	0.5	0.3	0.2	0.5	0	0.2	0.8	0.1	0.3	0.1	0.3	0.6	0	3.3	0.2	1.4	0	2.9	0.7	0.4	0.6	0.7	0.5	1.7	0	0.3	0.4	0.6	1.2	0.7	0.2	0.8	0.6	0.6	3.6	0.7	1.2	0.4	0.5	0.2	0.4	1.2	0.4	0.2	0.6	0.2	0.6	1.8	0.6	0.5	0.5	0.3	0.4	0.9	0.8	0.7	0.8	1.1	2.4	0.7	2	1.3	0.7	0.5	0.8	0.4	2.1	2.7	0.5	4	4.1	3.2	1	1.7	17.3	0.5	0	2.6	0	0.4	0	0.2	0.3	0	38.8	5.7	0	7.9	0	0	0.2	0.2	0	0	0	0.2	0	0.1	0.1	0	0	0.1	0	0	0	0.3	0	0	0	0	0	0	0.9	0.3	0	1.4	0	3.2	0	0	0.4	1.4	0	0	0	0	0.1	Ciliated cells
ENKUR	C10orf63, CFAP106, enkurin, MGC26778	ENSG00000151023	Enkurin, TRPC channel interacting protein	Q8TC29	10	24981979-25062279	Predicted intracellular proteins		Calmodulin-binding		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 18.7;fallopian tube: 46.2	Cell type enriched	Detected in many	8	Ciliated cells: 400.2	Cancer enhanced	Detected in some		glioma: 4.7	Low region specificity	Detected in all			Cell type enriched	Detected in single	5	neutrophil: 4.1	Lineage enriched	Detected in single	9	granulocytes: 4.1	Cell line enhanced	Detected in some		AN3-CA: 4.1;CAPAN-2: 7.1	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA037593, HPA037594, HPA061503	Enhanced											HPA037593: AB_10672387, HPA037594: AB_2675568, HPA061503: AB_2684543	unprognostic (2.33e-3)	unprognostic (4.86e-2)	unprognostic (1.13e-2)	unprognostic (6.52e-3)	unprognostic (3.31e-2)	unprognostic (2.91e-2)	unprognostic (1.38e-2)	unprognostic (7.35e-2)	unprognostic (1.18e-1)	unprognostic (8.69e-2)	unprognostic (6.85e-2)	unprognostic (3.17e-1)	unprognostic (1.20e-6)	unprognostic (3.94e-1)	unprognostic (3.35e-2)	unprognostic (3.45e-3)	unprognostic (8.43e-3)	0.7	1.1	8.4	1.2	13.4	1	0.7	1.1	10.6	2.2	0.9	6.2	0	2	2.5	7	0.7	46.2	1	0.8	8.8	10.8	1.2	2.4	6.7	0.7	9.2	3.5	6.5	0.6	0.8	10.4	1.4	18.7	0.7	0.8	0	0.8	0.7	0.9	0.8	4.6	0.9	6.5	1	0.9	8.4	8.6	0	1.2	0	0.8	0.7	0	0	0.4	4.1	0.3	0	0	9.9	0.4	1.2	1.2	4.1	0.2	0.3	0.1	0.4	0	0	0	0.7	7.1	0.7	1	0.2	1.2	0.6	0	0.7	0.1	0.4	0.5	0.8	1	0.4	0.1	0	0.2	0	0	0.4	0.6	0.1	0.1	0	0.1	0.1	0.2	0	0	0	0	0.9	0	0.1	0	0	1.1	0.3	1	2.3	0.4	0.2	0.2	0.3	0.6	0	0.2	0.4	1.2	0.6	1	0	0.1	0	2.1	0.2	0.1	0.1	0.3	0.9	0	0	0	0	0	0	0.2	0	0	0	4.1	0	0.1	0.4	0	9.9	8.4	13.4	1.1	5.2	8.8	10.8	9.2	3.5	18.7	8.6	0	0.6	0	0.5	0	0.3	0.3	0	400.2	38.7	1.8	0	0.2	0	2	50.2	0.3	1.3	0	4.5	1.5	0.4	0.5	1.1	0	0	0	2.4	0	0	6.6	1.1	0	0	1	0.1	17.6	8.5	0	0.7	0.7	1.8	0	0.1	10.8	4.8	0.1	0.2	0	0.2	0.1	Ciliated cells
GPR158	KIAA1136	ENSG00000151025	G protein-coupled receptor 158	Q5T848	10	25175062-25602226	G-protein coupled receptors, Predicted membrane proteins		G-protein coupled receptor, Receptor, Transducer		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 28.4;seminal vesicle: 11.2	Cell type enriched	Detected in some	5	Horizontal cells: 136.7	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	5	HEL: 21.2;T-47d: 5.8	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA013185	Uncertain											HPA013185: AB_2113957	unprognostic (4.43e-2)	unprognostic (3.14e-2)	unprognostic (7.42e-2)	unprognostic (2.66e-5)	unprognostic (5.67e-2)	unprognostic (9.37e-2)	unprognostic (4.73e-2)	unprognostic (1.85e-1)	unprognostic (1.22e-1)	unprognostic (4.37e-2)	unprognostic (8.09e-3)	unprognostic (1.72e-1)	unprognostic (2.60e-6)	unprognostic (8.36e-2)	unprognostic (1.78e-1)	unprognostic (1.21e-3)	unprognostic (3.90e-1)	0.9	2.4	3.6	1	16.2	0.8	0.8	28.4	25.2	0.8	1.1	1.6	6.1	0.9	0.8	1	0.8	0.8	0.8	0.8	1.9	2.8	0.8	0.9	0.9	0.8	2.4	4.8	0.8	0.9	1.5	8.9	1.5	14.9	1.2	1.1	1.4	0.8	11.2	0.8	0.8	1.2	0.8	4	0.9	1.1	1.9	2.9	0	1	0	0.8	0.8	0.4	0	0	0	0	0	0	0	0	0	0.1	0.4	0	0	0	0	0	0	0	0	0	1.7	0.1	0	0.2	0	0	0	0	2.6	0	21.2	0	0	0	0	1.2	0	0	0	0	0	0	0	0.7	0	0.2	0.4	0	0	0.1	0	0.5	0	0.4	0.2	0	0	1.2	0	0.5	1.1	1.9	0	5.8	0	0	0	0.5	0.3	0	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.6	16.2	28.4	11.6	1.9	2.8	2.4	4.8	14.9	2.9	0	0	0	0	0	2.1	0.4	0	0	0	0	0	0.4	0	0	15.5	0	0	0	0	0.6	0	0.5	0	0	0.1	136.7	0	0	0	8.8	0	0	0	0	0	27.6	0	0	0	0	3.4	0	0	1.8	0.7	0	0.2	0	0	0	Horizontal cells
CACNA1C	CACH2, CACN2, CACNL1A1, Cav1.2, CCHL1A1, LQT8, TS	ENSG00000151067	Calcium voltage-gated channel subunit alpha1 C	Q13936	12	1970786-2697950	Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels	Calcium transport, Host-virus interaction, Ion transport, Transport	Calcium channel, Calmodulin-binding, Ion channel, Voltage-gated channel	Autism, Autism spectrum disorder, Brugada syndrome, Disease mutation, FDA approved drug targets, Long QT syndrome	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		heart muscle: 32.5	Cell type enriched	Detected in many	4	Horizontal cells: 284.4	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Cell type enhanced	Detected in some		NK-cell: 4.2	Group enriched	Detected in many	19	NK-cells: 4.2;T-cells: 1.2	Cell line enriched	Detected in some	17	HDLM-2: 47.6	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA039796, CAB079031	Enhanced	Approved										CAB079031: , HPA039796: AB_10673019	unprognostic (1.76e-1)	unprognostic (1.19e-1)	unprognostic (6.29e-2)	unprognostic (9.35e-2)	unprognostic (3.71e-2)	unprognostic (1.60e-2)	unprognostic (4.68e-2)	unprognostic (7.99e-2)	unprognostic (3.07e-2)	unprognostic (1.03e-5)	unprognostic (1.93e-2)	unprognostic (1.01e-1)	unprognostic (4.02e-7)	unprognostic (8.85e-2)	unprognostic (3.60e-2)	unprognostic (6.90e-2)	unprognostic (3.39e-2)	3.8	2.5	8.6	6	7.7	1.4	2.4	7.1	11.7	11.2	26.5	1.3	7.4	2.4	29.7	4.5	5.2	4.3	7.1	32.5	5.5	4	2.7	1.4	4.7	2	2.4	6.6	2.7	3.2	1.5	8.1	5.1	3.9	7.9	3.8	6.5	2.4	8.1	2.3	1.7	5.2	28.8	1.9	3.5	7.2	11.3	1.7	0	2	1.1	1.7	12.6	5.4	0	0.1	0	0.1	4.2	1.2	0.2	0	0	0	0	1.6	1.1	0.1	1.7	2	1.1	0.8	0	0	0	0	1.1	0	0	0	0	0.5	47.6	0.4	0.6	0	0	1.2	0	0	2.7	0	0.6	0	0.1	0	0.2	0	0.1	0	0	0.1	0	0.4	0	0	0.1	0	0	0	0	0.6	0.2	0	0	0	0.6	0	0	0	2.7	0.3	2.6	0	0	0	0	2.2	0.1	0.6	0	0	0	0.6	0	1.2	0	0.5	0.7	0	0	0.9	0.7	0	4.2	0.1	0.1	0.4	0.2	8.6	7.7	7.1	11.7	5.5	4	2.4	6.6	3.9	1.7	0	0	0	1.2	0.6	15.3	42.8	0	0	0	0	2	0.1	0	0	27.5	2.9	0	0	0	0.2	2.5	1.4	0	0	0.2	284.4	35.2	2.5	0	64.7	0.9	0	0	0	0.6	6.1	0.3	0.2	3.9	0	1.2	12.9	17.5	2.6	5.8	0.1	0.1	0	0.4	2.4	Horizontal cells
RAD9B	FLJ40346	ENSG00000151164	RAD9 checkpoint clamp component B	Q6WBX8	12	110501655-110532086	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	5	testis: 31.8	Cell type enriched	Detected in some	6	Spermatocytes: 63.2	Low cancer specificity	Detected in some			Not detected	Not detected			Cell type enhanced	Detected in many		basophil: 6.7	Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		JURKAT: 6.1;SiHa: 5.6	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA040643	Approved											HPA040643: AB_10805716	unprognostic (2.32e-1)	unprognostic (2.55e-5)	unprognostic (4.76e-2)	unprognostic (1.30e-3)	unprognostic (2.93e-1)	unprognostic (6.27e-3)	unprognostic (5.44e-2)	unprognostic (2.00e-1)	unprognostic (1.56e-2)	unprognostic (1.22e-1)	unprognostic (5.92e-2)	unprognostic (2.26e-1)	unprognostic (2.68e-3)	unprognostic (7.33e-2)	unprognostic (1.99e-1)	unprognostic (2.15e-2)	unprognostic (1.80e-2)	0.3	0.1	0.5	0.1	0.7	0.2	0.4	0.6	0.5	0.3	0.2	0.5	0.1	0	0.6	0.9	0.5	0.4	0.1	0.9	0.4	0.3	0.1	0.4	0.3	1.7	0.5	0.1	0.8	0.1	0.3	0.4	0.1	0.6	0.3	0.1	0.4	0.1	0.6	1	0.1	0.2	0.5	0.8	0.3	0.1	31.8	0.4	0.6	0.2	0.4	0.5	0.3	0.2	0.9	2	6.7	2	0.5	0.6	0.8	3.6	0.2	0	0.6	0.2	0.1	0.1	1.1	0.2	1.7	1.4	3.3	0.1	2	0.8	0.4	0.7	0.2	0.4	0.1	0.4	0.3	0.5	2.5	0.1	0	0.5	3.8	0.7	0.3	0.4	1.4	1.3	0.3	0.1	6.1	0.7	1.9	2.1	0.5	0.8	0.8	0.1	1.1	1.2	0.3	0.8	0.5	0.1	0.3	0.6	0.1	5.6	0.8	0.6	0	1.3	2.3	0.6	0.7	0	0.6	0.4	0.8	0.5	1.5	0.2	1.6	2.3	6.7	1.2	0.5	0.6	0.8	0.3	0.9	0.5	0.3	2	0.8	0.6	0.2	1.1	0.5	2	1.1	0.3	0.8	0.5	0.7	0.6	0.5	0.4	0.3	0.5	0.1	0.6	0.4	0	0	0	0.2	0.5	0.2	1.2	0	4	0	0	0	0	1.7	0.3	2.2	0.1	0	0	0	0.1	0	0.1	0	0	1.1	0	0	0	1.2	1.9	1.4	0.1	0	2.8	0	0.5	0.3	0	0	0	0.9	0	0.3	63.2	11.3	0.4	0.1	0	0	0.1	Spermatocytes
MAT1A	MAT, MATA1, SAMS, SAMS1	ENSG00000151224	Methionine adenosyltransferase 1A	Q00266	10	80271820-80289684	Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins	One-carbon metabolism	Transferase	Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	14	liver: 178.8	Cell type enriched	Detected in many	51	Hepatocytes: 4835.7	Cancer enriched	Detected in many	54	liver cancer: 209.8	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	15	Hep G2: 45.9	Not detected	Not detected			Not detected	Not detected			HPA048627	Supported								530000			HPA048627: AB_2680465	unprognostic (6.92e-2)	unprognostic (2.63e-1)	unprognostic (2.88e-2)	unprognostic (9.43e-2)	unprognostic (3.79e-2)	unprognostic (2.49e-2)	unprognostic (2.03e-3)	unprognostic (1.46e-1)	unprognostic (1.09e-1)	unprognostic (2.58e-2)	unprognostic (1.76e-1)	unprognostic (8.66e-2)	unprognostic (1.11e-16)	unprognostic (8.59e-3)	unprognostic (9.90e-2)	unprognostic (3.58e-1)	unprognostic (5.98e-2)	0	0.1	0	0	0.1	0	0	0.1	0	0	0	0	1.2	0	0	12.5	0.1	0.2	0.2	0.1	0	0	0.3	178.8	0.1	0.1	0.1	0	0.7	9.9	0	0.6	0	0.2	0	0	0.3	0	0.2	0	0.7	0	0	0.4	0.2	0	0.6	0	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0	0	3.1	0	0	0	0	0	0.1	0	0	0	0	0.2	0	0.1	0.1	0	1.6	0	0	0	0	0.1	0.2	0.7	0	45.9	0	0.2	0	0	0	0	0	0.1	0	1	0.1	0	0	0	0.1	0	0	0	0	0.1	0.5	0.1	0	0.2	0	0	0.1	0	0.6	0	0	0	0	0	0.2	0	0	0.1	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0	0	0	0.1	0	0.2	0	0	0.3	14	0	1.8	0	0.5	76.5	8.1	1.2	1.8	0	0	1.7	0	22.5	0	0	46.7	3.8	0	0	0	0	4835.7	0.1	0	0	88.4	94.8	4.2	0.3	0	0	0	0	0	3.9	0	0.4	0	0	0	0	2.4	0.1	2.4	0	0	0	0	Hepatocytes
ALLC	ALC	ENSG00000151360	Allantoicase		2	3658195-3702671	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level				Tissue enriched	Detected in single	35	testis: 34.9	Cell type enriched	Detected in some	4	Early spermatids: 105.5	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	18	U-266/84: 11.4	Low region specificity	Detected in single			Not detected	Not detected																			unprognostic (5.47e-2)	unprognostic (3.24e-2)		unprognostic (2.91e-3)	unprognostic (4.75e-1)	unprognostic (2.17e-1)	unprognostic (1.06e-1)	unprognostic (9.83e-3)	unprognostic (5.42e-2)	unprognostic (1.74e-4)	unprognostic (1.01e-2)	unprognostic (2.73e-1)			0	0.1	0.1	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0.9	0	0	0	0.5	0.8	0	0	0	0	0.2	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	34.9	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0.1	0.5	0	0	0	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0.6	0	0	0	0.1	0	0	0	0	0	0	0	0.1	11.4	0.1	0	0	0.1	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	105.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	26.1	3.1	0	1.7	0	0	0	0	0	20.8	0.4	0	12.9	0	1.5	0.7	0	0	0	0	0	Early spermatids
THRSP	Lpgp, LPGP1, S14, SPOT14, THRP	ENSG00000151365	Thyroid hormone responsive	Q92748	11	78063861-78068351	Predicted intracellular proteins	Lipid biosynthesis, Lipid metabolism, Transcription, Transcription regulation			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		adipose tissue: 62.0;liver: 92.5;salivary gland: 45.6	Cell type enriched	Detected in some	8	Hepatocytes: 65.3	Cancer enhanced	Detected in many		liver cancer: 44.1	Region enriched	Detected in single	10	cerebellum: 1.0	Cell type enhanced	Detected in some		NK-cell: 1.5	Low lineage specificity	Detected in many			Cell line enriched	Detected in some	13	ASC diff: 42.5	Low region specificity	Detected in all							HPA040642	Approved		Approved	Nucleoplasm						Nucleoplasm		HPA040642: AB_10794878	unprognostic (1.19e-1)	unprognostic (2.88e-1)	unprognostic (2.84e-1)	unprognostic (2.73e-2)	unprognostic (3.07e-1)	unprognostic (9.91e-3)	unprognostic (1.59e-2)	unprognostic (9.60e-2)	unprognostic (1.07e-2)	unprognostic (8.23e-2)	unprognostic (1.68e-1)	unprognostic (2.58e-1)	prognostic unfavorable (1.16e-4)	unprognostic (9.64e-2)	unprognostic (1.57e-1)	prognostic favorable (3.28e-4)	unprognostic (1.69e-3)	62	1.6	0	18.3	0	0	22.7	1	0	0	12.2	0	2.8	0	0.1	1.2	0.1	0.3	16.5	11.7	0	0	2.1	92.5	0	2.9	0.1	0	0	1.1	0.3	0	0	0.1	0	0.1	0.2	45.6	2	9.3	7.2	1.3	0.2	0.1	0	0.1	0	0	0	1.6	4.3	0.3	5.7	0.3	0.5	0.1	0	0.2	1.5	1	0	0	0	0	0	42.5	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0.1	0	0	0	0.1	0	0.1	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	3.2	0	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0	0.4	0.1	0.5	0.1	0.5	0.2	1	0	1.5	0.2	0	0	0	0	0	1	0	0	0	0.1	0	0.1	0	0	0	0.5	0	0.1	2	0	0	0	0	0	0	0	8.3	0	0	0	0	0	0	0	0	0.1	0	65.3	0	0	0	0.6	3.1	0	0	0	0	0	0.1	0.5	0	0	0	0.4	0.6	0	0	0	0.1	0	0	0	0	0	Hepatocytes
ATP6V1G3	ATP6G3, Vma10	ENSG00000151418	ATPase H+ transporting V1 subunit G3	Q96LB4	1	198523222-198540945	Predicted intracellular proteins, Transporters	Hydrogen ion transport, Ion transport, Transport			Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	13	ductus deferens: 16.9;kidney: 33.4	Cell type enriched	Detected in some	43	Distal tubular cells: 376.4	Cancer enriched	Detected in single	140	renal cancer: 11.2	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		BJ: 2.9;BJ hTERT+: 1.8;fHDF/TERT166: 6.8;hTERT-RPE1: 2.2;TIME: 1.5;U-2197: 2.1	Not detected	Not detected			Low region specificity	Detected in all			HPA028701	Enhanced											HPA028701: AB_10611681																		0	0	0	0	0	0	0	0	0	0	0	0	16.9	0	0	1.9	0	0	0	0	0	0	33.4	0	0	0.1	0	0	0	0	0	0	0	0	0.7	0	0	0.8	1.9	0	0	0	0	0	0	0	0.3	0	0	0	0	0.1	0.2	0	0.2	0	0	0	0	0.8	0	0	0	0	0	0	0.2	0	2.9	1.8	1.3	0.4	0	0	0	0.6	6.8	0	0	0	0	1	0	0	0	0.4	0	0	0	0	0	0	0	0	2.2	0.3	0	0	0	0.4	0	0	0	0	0.2	0	0	0	0	0.3	0	1	0	0.3	0	0	0	0.1	0	1.5	0.1	1	2.1	0	0	0	0.4	0	0	0.5	0	0	0	0	0	0	0	0.5	0	0	0.2	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	8.7	0	0	376.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	Distal tubular cells
SLC25A31	ANT4, DKFZP434N1235	ENSG00000151475	Solute carrier family 25 member 31	Q9H0C2	4	127730378-127774299	Predicted membrane proteins, Transporters	Transport			Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	687	testis: 68.6	Cell type enriched	Detected in some	9	Spermatocytes: 113.2	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in single		hTCEpi: 1.5	Not detected	Not detected			Not detected	Not detected			HPA015064, HPA016841, HPA046835, HPA071684	Uncertain		Enhanced	Mitochondria						Mitochondria		HPA015064: AB_1847691, HPA016841: AB_1847690, HPA046835: AB_2679831, HPA071684: AB_2686431					unprognostic (8.15e-2)									unprognostic (1.62e-1)	unprognostic (2.70e-1)	unprognostic (5.32e-1)		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	68.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0.4	0.2	0.6	0	0.3	0	0	0	0	0	0.2	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0.2	0	1.5	0	0	0	0	0	0	0.2	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0.2	0	0.2	0.3	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	7.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	10.7	3.1	0	0	0	0	0	0	0	1.1	0	0	0	0	113.2	11.9	0	0	0	0	0	Spermatocytes
ITIH2	H2P	ENSG00000151655	Inter-alpha-trypsin inhibitor heavy chain 2	P19823	10	7703269-7749520	Plasma proteins, Predicted secreted proteins		Protease inhibitor, Serine protease inhibitor		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	202	liver: 249.0	Cell type enriched	Detected in some	5	Hepatocytes: 455.1	Cancer enriched	Detected in many	279	liver cancer: 626.9	Low region specificity	Detected in single			Low cell type specificity	Detected in single			Low lineage specificity	Detected in single			Cell line enriched	Detected in single	445	Hep G2: 155.6	Low region specificity	Detected in many			Not detected	Not detected			HPA059150	Supported		Approved	Golgi apparatus	Secreted to blood				22000000000	Golgi apparatus		HPA059150: AB_2683930	unprognostic (4.82e-2)	unprognostic (6.10e-2)	unprognostic (2.48e-2)	unprognostic (1.21e-2)	unprognostic (2.01e-2)	unprognostic (2.55e-3)	prognostic favorable (1.48e-4)	unprognostic (1.37e-1)	unprognostic (1.79e-1)	unprognostic (1.47e-2)	unprognostic (2.28e-1)	unprognostic (2.02e-1)	unprognostic (2.10e-8)	unprognostic (9.91e-3)	unprognostic (1.70e-1)	unprognostic (2.35e-1)	unprognostic (4.46e-4)	0	0	0.1	0	0.6	0	0.3	0.1	0.4	0	0	0.5	0	0	0	0	0	0	0	0	0.4	0.3	0.2	249	0.1	0	0.5	0.5	0	0	0	0.3	0	1.1	0	0	0.2	0	0	0	0	0	0	0.8	0.1	0	0.2	0.1	0	0	0	0	0	0	0.5	1.2	0.4	0.3	0.8	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	155.6	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0.3	0.1	0.6	0.1	0.4	0.4	0.6	0.4	0.1	0.5	0.3	0.6	0.2	0.8	0.2	1.2	0.1	0	0.1	0.6	0.1	0.4	0.4	0.3	0.5	0.5	1.1	0.1	0	2.1	0	0	0	0	0.3	94.3	0	0	0	0	0	0	1.1	3.9	0	0	0	0.2	0	0	0	0	455.1	0.1	0	0	11.1	9.2	0.7	0	0	0	0	0	0	0.1	0	0.4	0	0	0	0	0	0	0	0.1	0	0	0	Hepatocytes
KCNJ1	Kir1.1, ROMK1	ENSG00000151704	Potassium voltage-gated channel subfamily J member 1	P48048	11	128836315-128867373	Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels	Ion transport, Potassium transport, Transport	Ion channel, Voltage-gated channel	Bartter syndrome, Disease mutation, FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	51	kidney: 123.2	Cell type enriched	Detected in some	5	Distal tubular cells: 165.8	Cancer enriched	Detected in some	7	renal cancer: 3.4	Region enriched	Detected in single	4	basal ganglia: 2.3	Cell type enhanced	Detected in single		memory B-cell: 1.3	Low lineage specificity	Detected in single			Cell line enriched	Detected in some	40	RPTEC TERT1: 51.8	Not detected	Not detected			Not detected	Not detected			HPA026962	Enhanced											HPA026962: AB_10601934	unprognostic (1.75e-1)	unprognostic (4.38e-2)	unprognostic (1.14e-1)	unprognostic (3.19e-1)	unprognostic (7.55e-2)	unprognostic (1.29e-1)	unprognostic (3.01e-2)	unprognostic (2.69e-1)	unprognostic (1.46e-1)	unprognostic (2.44e-2)	unprognostic (6.47e-2)	unprognostic (2.78e-1)	unprognostic (6.05e-2)	unprognostic (4.99e-2)	unprognostic (1.61e-1)	unprognostic (1.28e-1)	unprognostic (7.81e-3)	0.1	0	0.5	0.2	2.3	0	0.1	0.1	0.1	0.4	0.1	0.1	0.1	0	0.1	0.5	0.1	0	0.1	0.1	0.1	0	123.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.3	0.1	0.3	0.1	0.1	0.1	0.1	0	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.1	1.3	0	0	0.4	0	0.9	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0.4	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0.1	0	0	0	0	0	0	51.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	1.3	0	0.2	0	0	0.1	0	0	0.4	0.9	1.3	0	0	0	0.5	0	0	0	0	0.1	0	0	0	0.5	2.3	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	0	0	0.3	0	0.3	0	0	0	36.6	0	0	165.8	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	1.5	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0	0.1	0	0	0	0	Distal tubular cells
WWC2	BOMB, FLJ22029	ENSG00000151718	WW and C2 domain containing 2	Q6AWC2	4	183099293-183320777	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in many			Cell type enriched	Detected in many	4	Alveolar cells type 1: 244.2	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in some			Group enriched	Detected in many	5	monocytes: 1.9;T-cells: 2.1	Cell line enhanced	Detected in many		SiHa: 33.8	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA044005	Uncertain		Approved	Microtubules						Microtubules		HPA044005: AB_10960552	unprognostic (1.07e-1)	prognostic unfavorable (8.61e-4)	unprognostic (7.16e-4)	unprognostic (1.70e-1)	unprognostic (2.00e-2)	unprognostic (4.48e-3)	unprognostic (2.05e-1)	unprognostic (3.93e-2)	unprognostic (4.42e-2)	unprognostic (1.97e-1)	unprognostic (9.52e-3)	unprognostic (2.22e-1)	prognostic favorable (9.29e-4)	unprognostic (3.27e-2)	unprognostic (3.44e-1)	unprognostic (3.23e-1)	unprognostic (2.52e-2)	10.8	6.7	8.2	4.8	9.1	0.9	12.3	3.5	7.4	11.6	8.5	8.6	9.8	2.4	17.6	7.1	6.7	8.6	9.7	12.3	9.6	4.8	20.3	19.9	28.8	3.3	10	7.2	12.8	13.1	15.5	5.9	14.9	9.1	8.9	3.4	16.5	11.3	9.9	5.5	5.4	4	11.2	9.9	6.4	8.9	15.4	8.5	0	16.8	4.5	3.1	9.8	17	0	0.4	0	1.9	0.4	2.1	0.3	10.1	4.3	9.4	8.4	7.1	7.9	10.9	13.8	11	15.3	11	19.1	9.9	0	7	22.2	5.3	3.7	14.5	5.7	19.5	0	4.4	10.3	10	9.8	7.3	4.8	11.4	6	4.4	10.1	9.5	12.7	10.1	1.5	7.3	0.5	11.6	2.9	0	3.2	9	0.3	3.7	0	8.6	5.5	21.8	2.7	0.6	4.8	33.8	29.7	4.4	15.7	7.2	1.6	15.1	5.7	16	3.3	9.9	0	0	0.1	5.6	2.2	10	0	1.4	0	0.6	1.1	1	0	0.6	0.2	0.4	0	2.1	0.6	0	0.4	1.9	0	0	0.3	8.2	9.1	3.5	7.4	9.6	4.8	10	7.2	9.1	8.5	244.2	50.8	0	6.7	21.3	3.2	25.8	43.3	14.7	37.5	7	60.9	11.9	23.2	13.2	30.2	20.4	0	0	12.4	7.5	16.9	19.6	18.5	33.7	8.5	0	1.2	16.5	13.1	16.8	16.4	7.1	11.8	7.2	0.1	11.8	23	0	19.8	19	60.1	25.8	18	29.8	16.8	13.4	5.5	1	0.1	7.6	Alveolar cells type 1
SLC25A4	ANT1, PEO2, PEO3, T1	ENSG00000151729	Solute carrier family 25 member 4	P12235	4	185143241-185150382	Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters	Host-virus interaction, Transport		Cardiomyopathy, Disease mutation, FDA approved drug targets, Primary mitochondrial disease, Progressive external ophthalmoplegia	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in all	5	heart muscle: 163.7;skeletal muscle: 92.5;tongue: 62.4	Cell type enriched	Detected in many	5	Cardiomyocytes: 4236.1	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Group enriched	Detected in many	5	B-cells: 3.5;dendritic cells: 3.0;T-cells: 4.1	Low cell line specificity	Detected in many			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA046835, HPA071684	Approved		Supported	Mitochondria						Mitochondria		HPA046835: AB_2679831, HPA071684: AB_2686431	unprognostic (4.19e-2)	unprognostic (1.06e-2)	unprognostic (3.11e-1)	unprognostic (8.85e-2)	unprognostic (1.37e-1)	unprognostic (2.90e-3)	unprognostic (8.25e-2)	unprognostic (1.26e-2)	unprognostic (7.87e-2)	unprognostic (1.60e-1)	prognostic favorable (3.41e-4)	unprognostic (2.05e-1)	prognostic favorable (0.00e+0)	unprognostic (1.98e-1)	unprognostic (1.05e-1)	unprognostic (1.73e-1)	unprognostic (8.28e-3)	3	4.2	6.9	2	10.8	1.4	3.1	19.4	14.4	2.6	6.6	3.7	2.9	2.8	3	3.4	6.7	3.7	3.5	163.7	7.4	7.3	8.3	4.3	3	2	6.3	6.1	3.6	3	4.6	4.6	2.2	12.8	6.2	3.4	7.9	4.4	8.5	92.5	2.3	4.1	5.5	4.5	2.1	5.3	3.1	2.3	0	4.6	62.4	3.4	4.4	2.1	3.5	3	0.4	0	0.7	4.1	1.5	0.7	3.3	2.7	5.5	3	0.3	5	2.7	0.9	3.3	3.3	7.1	1.8	2.4	2	3.3	2.6	2.6	10.4	2.9	2.2	4	8.9	1.6	4.9	8.3	6.1	1.4	1.6	2.2	7.1	5.1	1.4	7.8	2.4	4.2	3.8	1.9	2	5.1	1.6	3.2	4.4	2.3	7.1	2.6	1.4	3.3	7.5	5.1	8.8	6.7	3.2	1.4	12.6	5.1	2.6	1.2	1.8	0.2	1.5	1.7	3.5	7.9	3.6	3.1	2.4	0.3	3	0	0	0	4.1	0	3.1	3.5	1.4	3.5	0.1	2.2	1.2	3	0.4	0.7	0	3	1.2	1.5	6.9	10.8	19.4	14.1	7.4	7.3	6.3	6.1	12.8	2.3	80.4	55.4	33.5	125.8	39.2	174.4	4236.1	140.1	112.4	42.1	68	98.2	59.7	837.3	68.4	15.8	25.9	41.2	0	65.1	47.9	24.6	55	11.5	83.9	50.1	151	51.6	24.5	7.6	7.7	43.1	7.9	180.5	15.4	35.7	473.2	51.1	24.6	106.1	140.9	178.4	103.5	194.8	24	35.3	15.8	33.9	10.7	48.8	46.9	Cardiomyocytes
TDO2	TDO, TPH2	ENSG00000151790	Tryptophan 2,3-dioxygenase	P48775	4	155854738-155920406	Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins	Tryptophan catabolism	Dioxygenase, Oxidoreductase	Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	32	liver: 187.9	Cell type enriched	Detected in some	8	Hepatocytes: 1048.1	Cancer enriched	Detected in many	18	liver cancer: 35.7	Low region specificity	Detected in some			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		EFO-21: 8.6;HDLM-2: 16.7;U-87 MG: 9.8	Group enriched	Detected in some	9	cerebellum: 7.0;hippocampal formation: 5.9	Not detected	Not detected			HPA039611	Uncertain		Uncertain	Plasma membrane,Cytosol						Plasma membrane, Cytosol		HPA039611: 	unprognostic (1.10e-1)	unprognostic (3.00e-3)	unprognostic (3.84e-2)	unprognostic (1.95e-1)	unprognostic (7.06e-2)	unprognostic (3.50e-1)	unprognostic (1.18e-1)	unprognostic (1.03e-1)	unprognostic (1.00e-1)	unprognostic (2.13e-2)	unprognostic (1.42e-1)	unprognostic (1.01e-1)	unprognostic (4.68e-8)	unprognostic (7.99e-2)	unprognostic (9.29e-3)	unprognostic (1.28e-1)	unprognostic (1.95e-2)	0.2	0.5	0.2	2.5	0.5	0	0.1	0.1	2	0.1	0.2	0	0.1	0.6	0.1	0.2	0.2	0.1	0.3	0.1	1.5	0.2	0.2	187.9	0.8	2.9	0.2	0.7	0.1	0.1	0	5.8	0.1	0.1	0.1	0.2	0	0.1	0	0.1	0.1	1.1	0.4	0.2	1.5	0.3	0.1	0	0	0.1	0	0.4	1.2	0.1	0	0	0.2	0.1	0	0.2	0	0	1.8	0	0	0.1	0	0	0	1.5	0	0	0.1	0	0	8.6	0	0.2	0	0.1	0	0	16.7	0	0.1	0	0	0.3	0.2	0	0.9	0	0	0	0.8	0	0	0.1	2.9	0.3	0	0	0	0.8	0	0	0	0.1	1.3	0	0.3	0	0	0	0.4	0	0	0	0.1	0	1.1	0.4	0.4	0	2.7	0	0	9.8	0.1	0	0	0.1	0	0.2	0.1	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0.2	0.5	0.1	2	1.5	0.2	0.2	0.7	0.1	0	0	0	7	0	0	0	0.4	132.5	0	0	0	0	0.1	0	0.4	0.4	0	0	23.3	0	0	0.1	0.3	0	1048.1	0.9	0	0	25.2	23.8	0	0	0	0	0	0	0	0	0	0	0	0	6.5	0.8	0.2	0.2	0	0.2	0	0	0	Hepatocytes
MCHR2	GPR145, MCH2, MCH2R, SLT	ENSG00000152034	Melanin concentrating hormone receptor 2	Q969V1	6	99919910-99994247	G-protein coupled receptors, Predicted membrane proteins		G-protein coupled receptor, Receptor, Transducer		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Group enriched	Detected in some	15	brain: 14.9;testis: 5.5	Cell type enriched	Detected in single	5	Early spermatids: 1.0	Not detected	Not detected			Group enriched	Detected in many	4	basal ganglia: 6.3;cerebral cortex: 14.9;olfactory region: 4.4	Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HDLM-2: 2.1;HMC-1: 1.9;U-266/70: 1.8					Region enhanced	Detected in single		cerebral cortex: 0.9																		unprognostic (5.76e-2)													0.2	0.2	1.9	0.3	6.3	0.3	0.2	0.2	14.9	0.2	0.5	0	0	0.3	0.2	0.2	0.4	0.2	0.2	0.2	0.7	0.6	0.2	0.2	0.2	0.3	0.5	4.4	0.3	0.2	0.2	0.2	0.2	0	0.2	0.4	0	0.2	0.2	0.2	0.3	0.5	0.2	0.2	0.2	0.3	5.5	0	0	0.3	0	0.2	0.3	0.2	0.3	0.2	0.6	0.2	0.5	0.3	0.1	0	0	0.4	0.1	0	0	0.2	0.1	0.1	0	0.2	0	0.4	0	0.1	0.2	0	0.1	0	0.2	0	2.1	0.2	0.1	0	0	0	0.1	1.9	0	0	0	0	0	0	0.2	0.2	0.1	0.5	0	0.1	0.2	0.1	0	0	0.3	0.3	0.4	0	0	0	0	0.3	0.2	0	0.1	0.2	0	0.4	0.1	0.1	0.2	0.2	1.8	0.9	0.3	0	0.1	0	0.6	0.2	0.2	0.2	0	0.1	0.1	0.2	0.3	0	0.3	0.1	0.1	0.3	0.5	0	0.2	0.2	0.1	1.9	6.3	0.2	14.9	0.7	0.6	0.5	4.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	Early spermatids
G6PC2	IGRP	ENSG00000152254	Glucose-6-phosphatase catalytic subunit 2	Q9NQR9	2	168901240-168910000	Enzymes, Predicted intracellular proteins, Predicted membrane proteins	Gluconeogenesis	Hydrolase		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Group enriched	Detected in some	35	pancreas: 28.8;retina: 12.1	Cell type enriched	Detected in some	13	Muller glia cells: 70.6	Cancer enriched	Detected in single	92	pancreatic cancer: 9.4	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		EFO-21: 1.0;SCLC-21H: 1.2	Not detected	Not detected			Low region specificity	Detected in many																unprognostic (6.42e-2)				unprognostic (2.39e-2)		unprognostic (6.04e-2)		unprognostic (9.05e-2)		unprognostic (2.97e-1)		unprognostic (3.10e-2)	unprognostic (1.54e-2)	unprognostic (1.87e-1)			0	0	0.1	0	0.1	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	28.8	0	0	0	0.1	0	0	12.1	0	0	0	0.1	0.3	0	0	0	0.1	0.5	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.8	0	0	0	1.2	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0	0.6	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0.1	0.1	0	0	0	0.1	0	0	0.1	0	0	0	0	0	0	0.8	0	0	0	0	0	0	0	0	0	5.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.1	0	0	0	0	0	70.6	0.5	0	0	0	0.9	0	0	0	0	0	0	0	0	0	Muller glia cells
OLAH	FLJ11106, SAST, THEDC1	ENSG00000152463	Oleoyl-ACP hydrolase	Q9NV23	10	15032227-15073852	Enzymes, Predicted intracellular proteins	Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism	Hydrolase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	5	placenta: 61.3;testis: 24.0	Cell type enriched	Detected in some	10	Early spermatids: 347.4	Group enriched	Detected in some	7	testis cancer: 3.6;thyroid cancer: 0.8	Not detected	Not detected			Cell type enriched	Detected in some	4	neutrophil: 6.6	Lineage enriched	Detected in many	6	granulocytes: 6.6	Cell line enhanced	Detected in some		HSkMC: 5.8;hTCEpi: 7.4;LHCN-M2: 5.6;SK-BR-3: 8.8;SuSa: 4.8;U-266/70: 4.9									HPA037947, HPA037948	Enhanced											HPA037947: AB_10795028, HPA037948: AB_10805352	unprognostic (2.01e-1)	unprognostic (6.12e-2)	unprognostic (8.20e-3)	unprognostic (4.04e-3)	unprognostic (1.92e-1)	unprognostic (8.09e-2)	unprognostic (7.12e-2)	unprognostic (5.12e-2)	unprognostic (4.55e-1)	unprognostic (3.74e-2)	unprognostic (4.70e-1)	unprognostic (1.69e-1)	unprognostic (5.22e-10)	unprognostic (4.55e-2)	unprognostic (2.09e-1)	unprognostic (5.11e-2)	unprognostic (9.78e-2)	1	1.1	0.2	0.2	0.7	1.2	5.2	0.3	0.7	0.8	0.5	0.3	0.1	0	0.2	0.4	2.7	1.4	1.1	0.8	0.2	0.2	0.8	0.4	1.9	4.3	0.9	0.1	0.2	0.1	0.1	1.5	61.3	0.4	0.1	0	0.3	3	0.1	0.5	0.4	0.3	0.1	0.5	8	0.2	24	0.3	0.2	1.2	0.1	0.3	0.3	1.1	0.5	1.1	6.6	0.4	1	0.6	0.1	0.2	0.6	0.7	0.5	0.3	1.1	2.2	0.4	0.4	0.2	0.1	0.4	0	0.2	0	0	0.6	0.2	0	0.2	0.7	0.4	0.2	0.3	0.4	0	0.9	0	0.6	5.8	7.4	0.9	0.1	0.1	0.7	0.2	0.5	0.3	5.6	0	0.5	0.7	0.7	0.2	0.4	0.7	1.3	1.8	0	0	0	0.4	0.3	8.8	0.1	4.8	0.2	0.5	1	0.1	2.9	1.3	0.1	4.9	1.6	0.4	2.7	0.5	0	1.4	0.4	0.4	0.4	0.2	0.3	0.2	0.6	0.2	0.2	0.5	0.3	0.3	6.6	1	0.2	1.1	0.4	0.1	0.2	0.7	0.3	0.3	0.2	0.2	0.9	0.1	0.4	0.3	3	1.1	0	0.2	0.2	0	0.3	0	1.4	0	0	0	0.3	0	0.9	347.4	0	0	0	0	1.4	0.5	0.3	0	0	0.1	0	0	0	2.2	35.4	4	0.6	0	0	0	0	0.3	0	7.8	0	0.7	6.5	0.4	1.7	1.7	0.3	9.5	0.5	0	0.1	Early spermatids
GRIA4	GluA4, GLUR4, GLURD	ENSG00000152578	Glutamate ionotropic receptor AMPA type subunit 4	P48058	11	105609994-105982092	Predicted intracellular proteins, Predicted membrane proteins	Ion transport, Transport	Ion channel, Ligand-gated ion channel, Receptor	Disease mutation, Mental retardation	Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	7	brain: 55.4	Cell type enriched	Detected in some	22	Horizontal cells: 444.9	Group enriched	Detected in some	18	glioma: 5.9;renal cancer: 1.2	Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		AF22: 15.8;NTERA-2: 5.2;RPMI-8226: 3.0;SCLC-21H: 5.8	Low region specificity	Detected in all			Low region specificity	Detected in all								Intracellular and membrane								unprognostic (1.45e-1)	unprognostic (2.63e-1)	unprognostic (4.09e-4)	unprognostic (4.45e-3)	unprognostic (1.92e-3)	unprognostic (4.14e-4)	unprognostic (1.40e-2)	unprognostic (3.73e-4)	unprognostic (1.62e-1)	unprognostic (3.89e-1)	unprognostic (2.04e-1)	unprognostic (1.53e-1)	unprognostic (1.70e-1)	unprognostic (2.48e-1)	unprognostic (1.38e-1)	unprognostic (3.35e-2)	unprognostic (1.28e-1)	1.1	7.4	11.4	1.5	13.1	0.9	4.5	55.4	52.9	2.6	1.8	8.1	0	0.9	1.5	2.9	1	2.2	1.2	0.9	9.3	16	1.4	0.9	1	1.6	12.1	17.4	1.3	1.6	0.9	2.2	1.3	24.8	1.2	2	2.8	4.1	1.5	1	1.5	4.5	1	11.5	0.9	6.6	1.1	6.9	0	1	0	1.3	1	0.2	0.2	0	0	0	0	0.2	0	0	0	15.8	0	0	0	0	0	0.6	0	0	0	0	0	0.1	0	0.2	0.1	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0.1	0	0.1	0	0	5.2	0	0.2	0	0	3	0	0	5.8	1.9	0	0.1	0	0	0	0	0	0	0.3	0	0	0	0	0	0.2	0	0.1	0	0	0	0	0	0	0.1	0	0	0	0.2	0.2	0	0	0	0	0	0	0	11.4	13.1	55.4	23.3	9.3	16	12.1	17.4	24.8	6.9	0	0	0	0	0.1	18.9	1.1	0	0	0	0	2	0	0	0.3	0.4	0	0	0	0	0	0.2	0	0	0	0.8	444.9	0	0	0	0	0.6	0	0	0	0	20.1	0	0	0	0.5	7.7	0	0	0	0	0.1	0.2	0	0	0	Horizontal cells
SPEF2	CT122, FLJ23577, KPL2	ENSG00000152582	Sperm flagellar 2	Q9C093	5	35617844-35814611	Predicted intracellular proteins	Differentiation, Spermatogenesis			Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in many			Cell type enriched	Detected in many	5	Ciliated cells: 327.9	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Group enriched	Detected in many	6	gdT-cell: 5.2;MAIT T-cell: 6.5;memory CD4 T-cell: 3.1;memory CD8 T-cell: 5.4;naive CD4 T-cell: 3.5;naive CD8 T-cell: 4.2;NK-cell: 4.1	Group enriched	Detected in many	8	NK-cells: 4.1;T-cells: 6.5	Cell line enhanced	Detected in many		HDLM-2: 14.2;T-47d: 8.4					Low region specificity	Detected in many			HPA039606, HPA040343	Enhanced											HPA039606: AB_10671044, HPA040343: AB_2676930	unprognostic (3.81e-2)	unprognostic (3.17e-1)	unprognostic (6.23e-2)	unprognostic (8.71e-2)	unprognostic (4.55e-2)	unprognostic (8.23e-2)	unprognostic (8.11e-4)	unprognostic (1.23e-1)	unprognostic (2.35e-1)	unprognostic (9.96e-2)	unprognostic (1.01e-4)	unprognostic (4.50e-2)	unprognostic (6.34e-3)	unprognostic (1.53e-2)	unprognostic (1.63e-1)	unprognostic (2.52e-2)	unprognostic (2.12e-2)	2.4	5.4	5.9	4.1	14.5	2.1	7.6	3.6	10.3	15.8	2.6	5.3	8.8	1.5	17.3	19.1	1.8	21.7	4.5	2.8	4.7	7	10.9	2.1	6.8	2.7	3	6.1	9.1	6.4	13.3	22.5	6.5	12.9	8.3	3.1	4.9	4.7	9.4	1	1.9	2.3	6.4	3	3.6	3.3	9	3.1	2.3	11.9	0.6	1.5	3.7	7.9	0.6	0.6	0.4	0.5	4.1	6.5	1.3	0.9	1.4	1.7	4.7	1.2	1.4	0.2	2.2	1.4	5.3	3.5	0	2.5	0	1.2	3.1	5.9	0.1	1.5	2.1	5.3	14.2	0.5	0	6.2	0.5	1.6	3.7	0	2.1	3.8	2.9	1.6	6.4	0.1	0.9	1.7	0.9	0.8	2.4	0	0	0.1	3.4	1.3	3.2	0	0	3.7	0.4	0.1	1.3	0	2.6	0.4	1	8.4	7.2	0	1.5	2	3	0.8	0	0	0.3	4.3	0.1	0	0	0.5	0	5.2	0.5	6.5	0.2	3.1	5.4	0.6	0.6	3.5	4.2	0.4	4.1	0.2	0.2	0.7	1.3	5.9	14.5	3.6	10.3	4.7	7	3	6.1	12.9	3.1	8.9	5.4	0	2.5	1.4	15	5.3	5.1	327.9	46.6	5.2	35.3	1.3	5	3.1	59.7	3.2	0.4	0	1.5	0.7	6.8	2.4	5.7	0.9	1	19.1	2.4	6.2	0.6	15.5	9.5	2.4	1.7	34.3	3.4	14.6	1.3	0	6.7	9.9	39.9	0	1.9	18.2	9.1	0.9	0.7	7.5	2.6	0.2	Ciliated cells
TCTEX1D1	FLJ40873	ENSG00000152760	Tctex1 domain containing 1	Q8N7M0	1	66752459-66778787	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 28.4;fallopian tube: 18.2;liver: 13.5	Cell type enriched	Detected in some	4	Ciliated cells: 97.7	Cancer enriched	Detected in single	10	glioma: 3.8	Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	6	HEL: 14.1;HUVEC TERT2: 14.2;THP-1: 15.9	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA028420	Uncertain											HPA028420: AB_10603995	unprognostic (3.54e-2)	unprognostic (2.32e-2)	unprognostic (3.72e-4)	unprognostic (1.22e-1)	unprognostic (9.65e-3)	unprognostic (1.81e-2)	unprognostic (1.40e-1)	unprognostic (3.60e-2)	unprognostic (1.01e-1)	unprognostic (2.15e-1)	unprognostic (2.09e-2)	unprognostic (1.97e-1)	unprognostic (3.53e-6)	unprognostic (9.28e-4)	unprognostic (2.78e-2)	unprognostic (6.13e-3)	unprognostic (3.65e-2)	1.8	1.1	5.3	1.2	7.2	7.4	1.1	2.1	3.7	1.5	1	9.5	0	0.8	0.8	7.5	0.8	18.2	1.1	1.9	8.2	10.4	0.7	13.5	4	0.4	3.3	2.4	3.4	0.8	0.7	0.9	11.5	28.4	0.8	1.1	0.7	0.5	1.7	1.9	1.3	1.1	1.3	2.6	0.4	0.8	0.5	2.2	0	0.6	0.2	0.6	1.5	0.8	0	0.1	0.9	0.6	0	0	0.6	0	0	0.2	0	0.3	2.5	0	0.3	0.7	0.3	0.3	0	0	0	0	1.4	0	0	0	0	0.8	0	0	14.1	0	0	0	0	0	1.6	0	0.6	0	0	14.2	0	0	0	2.4	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.9	1.3	0	0	0	0	0	0	0	0.1	0	0	0	0.6	0	0	0.4	0	0	0	0	0.1	0	0	0	0.9	0	0.5	0	0	0.6	5.3	7.2	2.1	3.7	8.2	10.4	3.3	2.4	28.4	2.2	0	2.7	0	0	1.1	0	0.4	0	97.7	15.9	0	0	0	1.7	0	0.2	6.7	0	0	0	0	0.5	0.3	24.4	3.4	2.3	0	0	0.6	0	0	0	3.3	0	0	0	5.7	0	0	0.4	0	0.2	0	0	0	0	0.5	0	0	0	0.1	Ciliated cells
PRDM8	KMT8D	ENSG00000152784	PR/SET domain 8	Q9NQV8	4	80183879-80204329	Disease related genes, Predicted intracellular proteins, Transcription factors	Neurogenesis, Transcription, Transcription regulation	DNA-binding, Methyltransferase, Transferase	Disease mutation, Epilepsy	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 31.0;prostate: 30.9;seminal vesicle: 34.0	Cell type enriched	Detected in many	31	Bipolar cells: 289.0	Cancer enhanced	Detected in many		prostate cancer: 4.6	Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		hTERT-RPE1: 12.2;LHCN-M2: 18.2;NB-4: 20.4;SCLC-21H: 44.1	Region enhanced	Detected in many		hippocampal formation: 31.4	Group enriched	Detected in all	4	amygdala: 15.7;cerebral cortex: 21.5;hippocampal formation: 24.7	HPA057253			Approved	Nuclear bodies		No				Nuclear bodies		HPA057253: AB_2683382	unprognostic (2.33e-2)	unprognostic (1.08e-1)	unprognostic (1.23e-1)	unprognostic (2.67e-1)	unprognostic (1.15e-1)	unprognostic (1.68e-1)	unprognostic (1.65e-1)	unprognostic (7.95e-2)	unprognostic (1.19e-1)	unprognostic (1.76e-1)	unprognostic (2.34e-1)	unprognostic (2.80e-2)	unprognostic (1.89e-11)	unprognostic (4.64e-2)	unprognostic (1.69e-1)	unprognostic (1.39e-1)	unprognostic (2.56e-1)	3.6	3.5	17.6	6.3	10.1	4.4	3.3	3.6	31	9.3	8.2	10.9	1.8	2.1	8.2	3	2.8	3.7	2.7	1.9	30.9	6	1.4	0.9	2	6.1	12.3	18.1	5.5	1.1	0.8	4.5	5.6	7.5	30.9	2.6	4.3	1.5	34	3	2.1	4.4	8.6	15.2	2.5	4.4	1.9	9	0	1.1	0	3.5	9	8.2	2.2	0.5	2.1	0	0.7	2.4	0.4	0.9	0	0.3	0	0.9	3.3	0	2.5	9	1.2	1.4	0	0.9	0	0	3.1	0.8	0.3	0	1	5.4	3.7	0.8	0.3	0	0	1.9	3.7	1.1	2	0	4.9	1.4	12.2	0.1	1	0	1.6	18.2	0	1.7	20.4	0	0	7.4	0.6	0	0	0.5	0.1	44.1	6.1	0.1	0	0	0	0	1.9	3.8	3.2	0.4	2.3	0.1	0.7	0	0	7.9	1.8	0.4	0	0	0	1.6	0	2.4	0.3	2.1	2	0.3	2.2	1.3	0.7	2.1	0.7	0	0.5	0.9	0.4	17.6	10.1	3.6	31	30.9	6	12.3	18.1	7.5	9	0	0.3	3.5	3.2	0.6	289	1.8	0	6.7	9.1	1.8	2	0	0	0	1.4	1	0	0	0.2	0.1	3	2.3	0	0	0.5	3.2	0	0	0	3.3	2.8	0.7	1.7	1	0	4.1	0.4	0	3.2	0	9.2	0	1.7	0.4	0.5	0.1	0.1	1	0	0.6	Bipolar cells
GRM1	GPRC1A, mGlu1, MGLUR1, PPP1R85	ENSG00000152822	Glutamate metabotropic receptor 1	Q13255	6	146027646-146437598	Disease related genes, G-protein coupled receptors, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters		G-protein coupled receptor, Receptor, Transducer	Disease mutation, Neurodegeneration, Spinocerebellar ataxia	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	5	brain: 39.9	Cell type enriched	Detected in some	7	Rod photoreceptor cells: 113.7	Not detected	Not detected			Region enhanced	Detected in many		cerebellum: 39.9	Cell type enriched	Detected in single	4	NK-cell: 1.1	Lineage enriched	Detected in single	4	NK-cells: 1.1	Cell line enhanced	Detected in some		AF22: 1.4;GAMG: 2.5;HeLa: 1.2;hTERT-RPE1: 1.5;Karpas-707: 1.2	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA015701	Approved	Supported	Approved	Vesicles						Vesicles		HPA015701: AB_1853917	unprognostic (1.04e-2)	unprognostic (7.33e-2)	unprognostic (3.73e-3)	unprognostic (9.77e-3)	unprognostic (6.75e-2)	unprognostic (2.13e-1)	unprognostic (1.09e-1)	unprognostic (5.78e-2)	unprognostic (4.31e-2)	unprognostic (2.93e-2)	unprognostic (9.48e-3)	unprognostic (7.92e-2)	unprognostic (1.84e-2)	unprognostic (1.03e-1)	unprognostic (3.50e-2)	unprognostic (8.33e-3)	unprognostic (9.76e-2)	0.5	0.5	6.6	0.4	6	0.4	0.5	39.9	13	0.5	0.5	0.9	0	0.4	0.5	0.7	0.5	0.7	0.5	7.7	6	2.7	2.7	0.5	0.6	0.5	2.6	4.1	0.5	0.5	0.4	0.2	0.5	3.6	0.5	0.4	2.6	0.5	0.8	0.4	0.5	0.5	0.5	1	0.6	0.5	1.3	0.9	0	0.8	0	0.4	0.5	0.1	0	0	0.2	0	1.1	0	0	0	0.1	1.4	0.2	0	0.1	0	0.1	0	0	0.1	0	0	0.4	0.2	0.1	2.5	0	0	0	0.1	0.1	0	0.3	1.2	0	0.2	0	0	0.4	0	0	0	1.5	0.6	0	0	1.2	0.1	0	0	0.3	0.2	0	0.7	0	0	0	0.1	0	0.9	0.5	0.1	0.1	0.4	0.1	0	0.4	0.1	0	0.1	0.6	0.2	0.2	0	0.1	0.4	0.7	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	1.1	0	0	0	0	6.6	6	39.9	10.5	6	2.7	2.6	4.1	3.6	0.9	0	0	0	0	0	13.4	3.9	0	0	0	1.8	15.7	0	1.7	0	5.6	0	0	0	0	0	0	0	0	0	0.4	6.4	0	0	0	0.4	0	0	0	0	0	4	0	0	0	0	113.7	0	0	0.7	0.7	0	0	0	0	0	Rod photoreceptor cells
NRSN1	p24, VMP	ENSG00000152954	Neurensin 1	Q8IZ57	6	24126122-24154900	Predicted intracellular proteins, Predicted membrane proteins, Transporters				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in many	5	brain: 67.2	Cell type enriched	Detected in some	5	Horizontal cells: 114.4	Cancer enriched	Detected in single	17	glioma: 3.1	Low region specificity	Detected in all			Cell type enhanced	Detected in some		basophil: 1.8	Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		SCLC-21H: 14.6;SH-SY5Y: 11.7	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA019681, HPA061006	Uncertain		Approved	Plasma membrane,Cytosol						Plasma membrane, Cytosol		HPA019681: , HPA061006: AB_2684413	unprognostic (1.22e-1)		unprognostic (4.26e-2)	unprognostic (8.00e-3)	unprognostic (8.01e-3)					unprognostic (1.70e-1)	unprognostic (4.53e-3)	unprognostic (7.29e-2)	unprognostic (1.36e-3)	unprognostic (2.40e-3)	unprognostic (1.45e-1)	unprognostic (1.57e-1)		1.3	6.9	21.5	1.7	27.7	1.7	1.3	5.3	67.2	1.3	1.7	2.1	0	1.7	1.5	1.4	1.4	1.3	1.5	1.4	15.3	25	1.5	1.4	1.4	1.5	12.4	25.4	1.3	2.6	1.4	12.9	1.3	27.4	1.4	1.7	0.3	1.5	1.3	3.3	1.5	1.6	1.6	6.7	1.5	1.9	1.6	5	0	1.4	0	1.3	1.3	0.1	0.5	0.2	1.8	0.2	0.1	0.3	0	0.7	0	0.3	0.7	0	0	0	1.4	0	0	0	0.2	0.7	0.1	1.7	0	0	0.3	0.1	0	0.1	1.7	0.6	0	0.1	0.2	0	0.1	0.2	0.1	0	0.1	0	0.1	0	0.3	2	1.3	0.1	0.2	0.3	0.9	0.7	0.2	2.5	0.5	0.2	0.5	0	0	14.6	11.7	0	0.1	0.9	0.2	1.7	3.5	0.2	0.5	0.6	0.1	0.4	0.8	2.3	0.9	0.7	0	1.3	1.8	0.1	0.3	0.2	0.2	0.1	0.2	0.1	0.1	0	0.5	0.1	0.3	1	0.1	0.2	0.2	0	0	21.5	27.7	5.3	34.1	15.3	25	12.4	25.4	27.4	5	0	0	0	0	0	24.4	0.4	0	0	0	0	0	0	0	0	0.8	0	0	0	0	0	0	0	0	0	0	114.4	0	0	0	0	0	0	0	0	0	18.6	0	0	0	0	4	0	0	0	0	0	0	0	0	0	Horizontal cells
JAKMIP1	FLJ31564, Gababrbp, JAMIP1, MARLIN1	ENSG00000152969	Janus kinase and microtubule interacting protein 1	Q96N16	4	6026199-6200591	Predicted intracellular proteins, Predicted membrane proteins	Protein transport, Transport			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		blood: 19.5;brain: 37.4	Cell type enriched	Detected in some	7	Muller glia cells: 57.2	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Group enriched	Detected in many	21	gdT-cell: 14.9;MAIT T-cell: 6.5;memory CD4 T-cell: 6.7;memory CD8 T-cell: 13.0;naive CD8 T-cell: 6.2;T-reg: 19.5	Lineage enriched	Detected in single	37	T-cells: 19.5	Cell line enhanced	Detected in some		Daudi: 9.8;JURKAT: 9.1;MOLT-4: 27.3;SCLC-21H: 12.3;U-266/70: 17.0	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA044570	Uncertain											HPA044570: AB_2678995	unprognostic (4.79e-2)	unprognostic (3.46e-3)	unprognostic (4.90e-2)	unprognostic (1.73e-2)	unprognostic (5.34e-2)	unprognostic (3.86e-3)	unprognostic (6.16e-2)	unprognostic (6.69e-3)	unprognostic (4.25e-4)	unprognostic (7.14e-2)	unprognostic (4.57e-3)	unprognostic (1.13e-1)	unprognostic (3.70e-8)	unprognostic (1.85e-2)	unprognostic (3.15e-1)	unprognostic (4.23e-2)	unprognostic (2.96e-3)	1.3	8.5	15.7	2.3	35	2.6	1	2.5	37.4	1	1.5	2.7	0	1.2	1.1	1	1.1	1	1.7	1	15.6	14.7	1	1.1	1.9	4.7	10.8	13.3	1.6	1.6	1	3.8	1	7.2	7.4	1.3	0.1	2	1.1	1	1	1.7	1.3	4.3	2.9	1.7	5.9	7.6	0	1.4	0	1.8	2.3	0.1	0.1	0	0	0	0.5	19.5	2.5	0	0	0	0	0	0	0	0	0	0	0	0	0	9.8	0	0	1.7	0	0	0	0	5.5	0.1	0	0	0	0	0	0	0	0	0	0	0	0	9.1	0	0	0	0.2	27.3	0	2.2	0	1.7	1.4	0	0.7	0	0	12.3	4	0	0	0	0	0	0	0	0	0	0	0	17	2.8	0	0	0	0	0	0	0	14.9	0	6.5	0.1	6.7	13	0	0.1	0.5	6.2	0	0.5	0	0	19.5	2.5	15.7	35	2.5	21.2	15.6	14.7	10.8	13.3	7.2	7.6	0	0	0	0	0	1	0.8	0	0	0	0	2	0	0	0	1	0	0	0	0	0	0	1.4	0	0	0.1	3.2	0	0	1.5	2.2	0	0	0	0	0	57.2	0.2	0	0	0	5.9	0	0	0.9	3.7	0.1	0	8.7	0	0	Muller glia cells
CPB1		ENSG00000153002	Carboxypeptidase B1	P15086	3	148791102-148860187	Enzymes, Plasma proteins, Predicted secreted proteins		Carboxypeptidase, Hydrolase, Metalloprotease, Protease		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	590	pancreas: 3628.4	Cell type enriched	Detected in some	7	Exocrine glandular cells: 6332.0	Group enriched	Detected in some	312	breast cancer: 293.8;pancreatic cancer: 641.4	Not detected	Not detected			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Cell line enhanced	Detected in some		ASC diff: 2.8;EFO-21: 2.9;HDLM-2: 3.1;U-2 OS: 5.2;U-251 MG: 1.5;U-266/84: 2.4	Low region specificity	Detected in some			Not detected	Not detected			CAB026158, HPA038069, HPA046340	Enhanced				Secreted to digestive system				6600000			CAB026158: , HPA038069: AB_2675816, HPA046340: AB_2679628	unprognostic (6.90e-2)	unprognostic (3.79e-2)	unprognostic (3.34e-2)	unprognostic (2.64e-2)	unprognostic (5.58e-2)	unprognostic (3.27e-2)	unprognostic (6.26e-4)	unprognostic (1.90e-1)	unprognostic (1.82e-1)	unprognostic (1.07e-1)	unprognostic (7.59e-2)	unprognostic (4.51e-2)	unprognostic (5.50e-8)	unprognostic (3.08e-1)	unprognostic (1.60e-1)		unprognostic (4.93e-2)	0.2	1.7	0.1	0.1	0.2	0	0.7	0.1	0.2	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0	0.1	0.2	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	1.2	3628.4	0	0.1	0.1	0.1	0.1	0	0.1	0.2	0.1	0.1	0	0.1	0.1	0.1	0.7	0.2	0.4	0.2	0.1	0.1	0.1	0.1	0.1	0.1	1.8	1.1	6.1	1	3.1	3.5	0.9	0	0	0	0	2.8	0.7	0	0	0.3	0	0	0	0	0.8	2.9	0	0	0	0	0	0.1	3.1	0.5	0.6	0	0	0	0	0	1.1	0	0.4	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0.1	0	0	0	0	0.2	5.2	0	1.5	0	2.4	0.6	0	0	0	6.1	0.7	1.1	3	0.9	2.2	0.9	1.3	2.6	0.3	1.8	0.9	3.5	4.5	3.1	1	1.1	0.6	0.9	0.1	0.2	0.1	0.2	0.1	0	0.1	0.1	0.1	0.2	0	0	0	0.2	0.6	0	0.3	0	0	0	0	0	0	0	10.2	9.9	0.1	0	0	6332	0	1.4	6.8	0	0	0.8	0	158.6	0	0	1.9	0.6	0	0	31.5	0	0	954.7	0	0	0	0	0	0.4	0	0	0.3	0.2	0	0	0.1	Exocrine glandular cells
TEKT5	CT149, FLJ32871	ENSG00000153060	Tektin 5	Q96M29	16	10627501-10694945	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	28	testis: 30.4	Cell type enriched	Detected in some	4	Early spermatids: 505.4	Low cancer specificity	Detected in single			Not detected	Not detected			Cell type enhanced	Detected in single		myeloid DC: 1.0	Lineage enhanced	Detected in single		dendritic cells: 1.0	Cell line enriched	Detected in some	13	BEWO: 17.0	Low region specificity	Detected in many			Not detected	Not detected			HPA043578			Approved	Actin filaments						Actin filaments		HPA043578: AB_10795772	unprognostic (5.90e-2)	unprognostic (1.37e-2)	unprognostic (1.39e-2)	unprognostic (7.53e-2)	unprognostic (2.69e-2)	unprognostic (9.76e-2)	unprognostic (2.00e-1)	unprognostic (1.39e-2)	unprognostic (1.89e-1)	unprognostic (5.09e-2)	unprognostic (5.88e-2)	unprognostic (5.02e-2)	unprognostic (3.24e-7)	unprognostic (3.80e-2)	unprognostic (2.31e-1)	unprognostic (3.76e-2)	unprognostic (8.12e-5)	0.1	0	0.2	0.1	0.2	0	0.1	0.1	0.3	0.1	0.2	0.1	0.1	0	0.1	0.4	0.1	0	0.1	0.1	0.2	0.2	0.1	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.9	30.4	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0	1	0	0	0	0.3	0	0	0	0.2	0	0	0	17	0	0	0.1	0	0	0	0.1	0.1	0	0	0.2	0	0	0	0	0.2	0.1	0	0	0	0.1	0	0.2	0	0	0	0.2	0	0	0.1	0.1	0	0.2	0	0	0.2	0.2	0	0.2	0	0.1	0	0.6	0.2	0.9	0.2	0.4	0.2	0	0.2	1.3	0.3	0	0.3	0.1	0	1.1	0.2	0	0	0	0	0	0	0	0.3	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0.2	0.2	0.1	0.3	0.2	0.2	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	505.4	0	0	0	0	0	0	0.7	0	0	0	0	1.7	0	0	114.5	3.7	0	0	0	0	0	0.1	0	2.1	0	0	0	0	3.2	1.1	0.3	0	0	0	0.3	Early spermatids
ACOXL	FLJ11042	ENSG00000153093	Acyl-CoA oxidase like	Q9NUZ1	2	110732573-111118222	Predicted intracellular proteins		Oxidoreductase		Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in many		epididymis: 29.7;lung: 20.8;placenta: 23.8	Cell type enriched	Detected in some	5	Alveolar cells type 2: 27.4	Group enriched	Detected in some	6	lung cancer: 0.6;prostate cancer: 1.1;testis cancer: 2.1;urothelial cancer: 2.0	Not detected	Not detected			Cell type enhanced	Detected in some		neutrophil: 4.1	Low lineage specificity	Detected in many			Group enriched	Detected in some	4	A-431: 9.1;RPMI-8226: 16.5;RT4: 21.3;U-266/70: 14.4	Not detected	Not detected			Low region specificity	Detected in some			HPA035392, HPA035393			Supported	Nucleoli,Cytosol						Cytosol	Nucleoli	HPA035392: AB_2674604, HPA035393: AB_2674605	unprognostic (1.62e-1)	unprognostic (7.30e-2)	unprognostic (6.77e-4)	unprognostic (2.93e-7)	unprognostic (1.32e-2)	unprognostic (7.84e-5)	unprognostic (1.28e-1)	unprognostic (1.53e-2)	unprognostic (1.29e-1)	unprognostic (7.31e-2)	unprognostic (7.24e-2)	unprognostic (3.24e-1)	unprognostic (1.72e-1)	unprognostic (2.11e-1)	unprognostic (2.73e-1)	unprognostic (1.72e-1)	prognostic favorable (6.48e-4)	0.3	0.3	0.2	0.5	0.4	1.6	0.3	0.2	0.4	0.4	0.4	0.2	2.3	0	0.3	29.7	0.2	0.5	0.4	0.3	0.2	0.2	0.6	0.2	20.8	0.6	0.2	0.2	0.2	0.4	4.9	0.7	23.8	0.4	4.1	0.1	0.2	0.5	0.2	0.3	0.4	0.3	2.6	0.2	1.3	0.4	4.6	0.2	0.6	1.5	0.2	0.9	8.5	5.2	1	0.6	4.1	1.1	0.7	0.6	0.3	9.1	0	0.2	0.3	0.1	0	0.4	0.1	0	0	0	0.6	0.6	0.2	0.2	0.1	0.2	1	0	0	0	0.2	3.2	0.2	0.4	0.2	0	0.1	0.2	0.1	1	0	0.1	0.3	0	0.4	1.4	1.4	0.1	3.3	0.7	0.4	3.1	0.1	0.4	0.1	0.2	16.5	0	21.3	2	0.4	0.1	0.4	0.1	0.7	0.2	1	0.3	0.2	0.4	0.2	0.1	14.4	3.7	0.5	0.1	0.2	0.2	2.2	1.1	0.5	0.4	0.7	0.2	1	0.4	0.6	0.2	0.8	0.5	0.4	4.1	0.7	0.4	0.6	0.4	0.3	0.2	0.4	0.2	0.3	0.2	0.2	0.2	0.2	0.4	0.2	0	27.4	0	0.2	0.2	0.6	0.4	0	0	1.2	0	0	0	0	0.1	4.3	0	0	0	0	0	0.4	0.9	0	0	0.1	0	1.2	0	0	5.9	0	0	0	0	0	0	0.1	0.2	0	0	0.4	0	0.3	0.9	2.2	0.3	0	0	0	0.7	Alveolar cells type 2
CETN3	CEN3	ENSG00000153140	Centrin 3	O15182	5	90392261-90409786	Predicted intracellular proteins	Cell cycle, Cell division, Mitosis, mRNA transport, Protein transport, Translocation, Transport			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		testis: 63.1	Cell type enriched	Detected in all	5	Spermatocytes: 417.2	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low cell line specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA035608, HPA063704	Enhanced		Supported	Centrosome						Centrosome		HPA035608: AB_10601098, HPA063704: AB_2685097	unprognostic (2.08e-1)	unprognostic (7.31e-2)	unprognostic (2.41e-1)	unprognostic (1.86e-1)	unprognostic (2.53e-1)	unprognostic (1.58e-2)	prognostic unfavorable (2.22e-4)	unprognostic (1.27e-1)	unprognostic (2.18e-2)	unprognostic (8.77e-2)	unprognostic (5.03e-1)	unprognostic (5.64e-2)	unprognostic (1.14e-1)	unprognostic (2.21e-1)	unprognostic (1.53e-1)	unprognostic (5.21e-2)	unprognostic (2.35e-1)	8.6	11.6	13.7	8	16.3	3.6	12.4	11.5	17.9	11.5	8.9	8.7	8.9	5.2	11	11.5	11.4	12	5.6	14.4	15.6	11.4	10.6	6.9	12.1	9.3	18.2	13.2	17.1	5.8	11.8	34.3	10	20.6	10.3	10.7	5.9	7.8	9.7	11.7	8.2	5.6	7.7	37.2	7.6	6.7	63.1	16.5	7.3	7.9	6.1	10.5	7.5	9.6	17.2	19.9	9.4	10.5	11.4	14.9	4.7	16.1	7.1	29	5.9	16.3	22.2	17.4	17.7	10.9	17	21.2	10.8	19.9	30.6	17.7	8.3	32.8	11.6	24.7	23.9	28.1	24.5	11.4	15.6	10.7	13.5	11.7	11.4	9.7	13.9	15.7	12.4	20.6	17.6	10.6	23.9	19.6	13.7	19	10.7	18.9	18.1	10.2	5.7	18.5	17.2	20.2	15.6	15	6	15.9	16.2	17.2	8.8	12.5	26.9	16.7	15.5	11.9	10.2	14.6	14.2	23.6	12.8	22.7	27.2	12	25.9	10.3	7.8	6.7	9.4	9.3	8.1	9.7	17.2	10.3	9.9	7.4	14.6	14.9	11.9	0.8	11.4	10.5	19.9	8	4.7	13.7	16.3	11.5	17.9	15.6	11.4	18.2	13.2	20.6	16.5	17.9	31.4	22.9	31.3	12.7	17.9	44.5	22.9	77.6	27.3	34.9	17.7	56.1	81.2	17.8	15.5	19.2	7.9	46.7	8.9	55.5	21.6	16.4	5.8	38.4	22.1	20.6	23.1	49.1	23.8	25	40.9	8.8	18.6	19.8	18.7	79.2	11.7	18.4	30.4	29.3	24.5	58.2	23.1	417.2	55.6	13.8	34.9	20.8	22.4	16.2	Spermatocytes
RGPD3	RGP3	ENSG00000153165	RANBP2-like and GRIP domain containing 3	A6NKT7	2	106391290-106468376	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	No human protein/transcript evidence	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	8	testis: 11.6	Cell type enriched	Detected in some	5	Early spermatids: 14.8	Not detected	Not detected							Cell type enhanced	Detected in single		T-reg: 1.2	Lineage enriched	Detected in single	5	T-cells: 1.2	Cell line enhanced	Detected in some		HEL: 3.3;MOLT-4: 10.3;RPMI-8226: 3.3									HPA049497, HPA051675, HPA067564	Uncertain		Approved	Nuclear membrane,Vesicles						Nuclear membrane, Vesicles		HPA049497: AB_2680794, HPA051675: AB_2681570, HPA067564: AB_2685862	unprognostic (2.91e-1)	unprognostic (1.62e-1)	unprognostic (5.51e-2)	unprognostic (6.61e-2)	unprognostic (2.53e-1)	unprognostic (1.33e-1)	unprognostic (1.26e-1)	unprognostic (6.86e-2)	unprognostic (3.10e-1)	unprognostic (2.49e-2)	unprognostic (3.70e-1)	unprognostic (3.44e-1)	unprognostic (4.74e-3)	unprognostic (5.05e-2)	unprognostic (3.70e-1)	unprognostic (3.42e-1)	unprognostic (1.34e-1)	0.2	0.1	0.3	0	0.5	0.4	0.4	0.3	0.9	0.2	0			0.1	0.1	0.4	0	0	0	0	0.4	0.4	1.4	0.7	0.1	0.1	0.6		0.2	0.2	0.7	0.7	0.2		0.2	0		0	0.3	0	0.3	0.1	0.1	0.4	0.7	0.1	11.6			0.1		0.2	0.2	0	0.1	0.2	0.2	0.2	0	1.2	0.2	0.4	0.5	0.5	0.4	0.3	0.5	0.1	0.4	0.5	0.4	0.3	0.5	0	0	0.1	0.4	1.4	0.3	1.2	0.1	0.7	0.3	0.1	3.3	0.3	0.6	0.3	0.1	0.1	0.1	0.3	1.1	0.4	0.4	0.3	0.7	0.6	0	0.5	0.2	10.3	0.1	0.4	0	0.1	0	0.1	3.3	0.1	0.6	0.5	0.1	0.4	0	0.2	0.3	0.1	0.3	0.2	0.3	0.2	0.6	0.5	0.7	0.6	0	0.1	0.2	0	0.2	0	0	0.1	0.1	0.3	0.1	0.6	0.5	0	0.1	0.7	0.2	0	0	0.2	0.2	1.2	0.2											0	1.4	0	0	0.1	0	1.7	0	1.4	2.3	0	0	0	0	0	14.8	0	0	0	0.2	0	0	0	1.1	0	0.1	0	0	0	0	3.2	0	0	0	0	0	0	0	0	0	0	0.2	0	0	2.8	2.1	0	0	0	0	0	Early spermatids
SCN3A	Nav1.3	ENSG00000153253	Sodium voltage-gated channel alpha subunit 3	Q9NY46	2	165087522-165204067	FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels	Ion transport, Sodium transport, Transport	Ion channel, Sodium channel, Voltage-gated channel	Disease mutation, Epilepsy, FDA approved drug targets	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	5	blood: 13.6;brain: 28.5;pituitary gland: 13.7	Cell type enriched	Detected in some	4	Early spermatids: 55.3	Cancer enriched	Detected in some	6	glioma: 3.4	Low region specificity	Detected in all			Group enriched	Detected in some	31	memory B-cell: 8.4;naive B-cell: 13.6	Lineage enriched	Detected in single	38	B-cells: 13.6	Cell line enhanced	Detected in some		JURKAT: 4.9;Karpas-707: 8.7;MOLT-4: 24.4;RPTEC TERT1: 12.3;SH-SY5Y: 5.5	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA035396	Approved											HPA035396: AB_2674607	unprognostic (1.80e-3)	unprognostic (1.84e-2)	unprognostic (1.20e-3)	unprognostic (1.50e-2)	unprognostic (6.69e-2)	unprognostic (1.10e-2)	unprognostic (4.96e-4)	unprognostic (2.46e-1)	unprognostic (1.48e-1)	unprognostic (1.90e-1)	unprognostic (1.21e-4)	unprognostic (4.55e-2)	unprognostic (5.87e-3)	unprognostic (2.88e-2)	unprognostic (6.85e-2)	unprognostic (2.66e-1)	unprognostic (4.93e-2)	2.6	4	16.7	1.9	28.5	1	2.5	19.6	19.7	2.1	2.1	0.8	0	1.2	1.4	0.7	1.5	1.4	1.8	2.1	9.8	11.3	1.8	1	1	2.7	4.8	9.8	1.8	1.7	2.3	13.7	0.8	9.1	0.9	2.1	0	0.7	1.4	0.9	0.5	1.9	1.7	4	1.8	2.7	1.8	4.9	2	1.3	0	3.5	1.7	0.5	13.6	0.3	0	0	0.1	0.1	0.1	0	0.1	2.4	0	0	0.1	0	0	0.2	0.5	1.6	0	0	0	0	0	0.2	0	0	0	0	0.2	0	0	0	0	0	0	0.5	0	0	0	0	4.3	0	4.9	0	8.7	0.1	0	24.4	0	0	0.1	2	0.1	1.1	0	12.3	0	3.1	5.5	0	0	0	0	0	0	0	1.7	0.1	0.7	0	1.3	0.4	0	0.6	0	0.3	0	0	0	0	0	0	8.4	0	0	0	13.6	0.1	0	0	0.1	0	0.3	0	0.1	16.7	28.5	19.6	17.2	9.8	11.3	4.8	9.8	9.1	4.9	0	0.3	1.9	0.1	0	0.8	3.2	0	0	0	1.8	11.8	0	0	0.1	55.3	0	0	0	0	0	0	0	0	0	0.1	4.8	8.5	0	0	5.4	0.3	0	1.7	0	0	0.6	0.2	0	0.7	0	0.7	12.9	5.2	0.2	0.4	0.1	0	0	0	0	Early spermatids
TEX29	bA474D23.1, C13orf16, MGC35169	ENSG00000153495	Testis expressed 29	Q8N6K0	13	111316184-111344249	Predicted membrane proteins				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	6	testis: 36.8	Cell type enriched	Detected in some	5	Early spermatids: 596.2	Low cancer specificity	Detected in some			Region enhanced	Detected in some		cerebral cortex: 6.1	Cell type enhanced	Detected in some		eosinophil: 1.8;memory B-cell: 1.3	Low lineage specificity	Detected in many			Cell line enriched	Detected in single	54	U-698: 22.4																						unprognostic (2.93e-1)	unprognostic (2.26e-2)	unprognostic (8.62e-4)	unprognostic (4.56e-1)	unprognostic (7.26e-2)	unprognostic (4.93e-1)	unprognostic (2.08e-2)	unprognostic (8.51e-2)	unprognostic (5.45e-2)	unprognostic (2.43e-1)	unprognostic (2.78e-2)	unprognostic (7.86e-2)	unprognostic (1.13e-9)	unprognostic (3.41e-1)	unprognostic (1.51e-1)	unprognostic (5.07e-2)	unprognostic (4.21e-2)	0.3	0.2	2.7	0.3	1.7	0	0.3	0.3	6.1	0.3	0.3	0.3	0.3	0.1	0.3	0.5	0.4	0.1	0.3	0.3	0.9	0.2	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.6	0.1	0.5	0.3	0.3	0.3	0.1	0.3	0.3	0.3	0.5	0.1	0.4	0.3	0.3	0.3	0.2	36.8	0.3	0.3	0.3	0.3	0.3	0.3	0.3	1.3	0.6	1.8	0	0	0.5	0.1	0	0.2	0	0	0	0	0.1	0.1	0	0	0	0.2	0	0.2	0.2	0	0.2	0.4	0	0	0	0	0	0.2	0	0	0	0.2	0.3	0	0.1	0	0	0.2	0	0.1	0	0	0.2	0.3	0.1	0.3	0.1	0	0	0	0	0	0	0.2	0	0	0	0	0	0.3	0.1	0	0	0	0.1	0.2	0	0	0.4	22.4	0.3	0.1	0	0	0	1.8	0	0	0	1.3	0	0	0.6	0.1	0.5	0.1	0	0	0	0.3	0	0.1	2.7	1.7	0.3	6.1	0.9	0.2	0.3	0.3	0.3	0.3	0	0	0	0.2	0.2	0.1	0.3	0	0	0	0	0	0	0	0.1	596.2	0.1	0	0	0.6	0	0	0.3	0	0	0.1	0	0	0	0	114.3	4.4	0	0	0	0.2	0	1.7	0.2	3.9	0	0	0	1.2	1.9	3.1	0.4	0.5	0	0	0.4	Early spermatids
ADPRHL1	ARH2	ENSG00000153531	ADP-ribosylhydrolase like 1	Q8NDY3	13	113399610-113453524	Predicted intracellular proteins		Hydrolase		Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		heart muscle: 89.6;skeletal muscle: 68.1	Cell type enriched	Detected in many	15	Cardiomyocytes: 122.4	Low cancer specificity	Detected in many			Low region specificity	Detected in some			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Cell line enhanced	Detected in many		SCLC-21H: 14.7;T-47d: 26.4	Region enhanced	Detected in single		cerebellum: 2.6	Not detected	Not detected			HPA066478, HPA072123	Enhanced		Approved	Nucleoplasm						Nucleoplasm		HPA066478: AB_2685673, HPA072123: 	unprognostic (3.03e-1)	unprognostic (1.38e-2)	unprognostic (2.31e-1)	unprognostic (8.88e-3)	unprognostic (1.50e-1)	prognostic unfavorable (4.88e-4)	prognostic unfavorable (2.55e-5)	unprognostic (1.57e-1)	unprognostic (1.63e-1)	unprognostic (2.35e-1)	unprognostic (2.56e-1)	unprognostic (1.58e-1)	unprognostic (1.62e-1)	unprognostic (2.14e-2)	unprognostic (1.53e-2)	unprognostic (4.99e-3)	unprognostic (1.02e-1)	1.8	1	0.6	0.2	1.1	0	0.8	0.5	3	0.4	1.4	0.3	0	0.9	0.4	4	2.2	1.9	0.7	89.6	0.5	0.8	0.2	0.4	0.5	0.1	0.7	1.1	0.5	1.5	0	1.8	1.4	0.3	0.9	0.5	0	1.9	0.1	68.1	0.9	3	0.2	0.5	0.3	1	1.3	0	0.1	0.7	21.8	0.6	0.3	0.5	1.9	2.8	1.7	1.6	1.1	2.5	1	4	9.6	1	3	3.1	5	2.7	1.5	0.7	0.5	0.4	2.7	9.9	1.4	5.7	1.7	2.8	2.2	3.8	0.2	0.4	1.4	1.6	4.1	2.3	0.7	1	0.3	1.7	1.7	2.3	3.2	0.4	0.4	0.1	3.6	1.2	0.4	4	8.7	0.6	2.4	2.2	10.4	5.1	6.3	2.5	3.6	1	0.4	14.7	3.4	1	4.8	1.2	1.2	26.4	0.5	0.3	0.1	1.8	4.4	0.5	1.4	1.1	4.7	2.9	0.8	2.1	0.4	1.2	0.1	0.1	1.6	1.8	1.9	0.8	2.5	2.8	0.8	1.4	1.5	1.7	1.1	1.3	0.5	1.3	1	0.6	1.1	0.5	3	0.5	0.8	0.7	1.1	0.3	0	0	5.8	0	1.9	1.1	1.3	122.4	0	8.1	4.5	0	0	3.2	0	2.8	1.1	1.6	3.8	0	2.9	2.2	1.5	2.3	0	1	0.5	1.6	4.1	1.3	0.3	1.3	0	0.5	1.7	0	5.1	2.1	1.4	5.8	1.4	0.3	1.7	0	0.5	1.8	2.6	2.3	2.1	0	3.2	2.8	Cardiomyocytes
FAM92B	FLJ44299	ENSG00000153789	Family with sequence similarity 92 member B	Q6ZTR7	16	85098358-85112508	Predicted intracellular proteins	Cilium biogenesis/degradation			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		brain: 14.2;fallopian tube: 50.7;lung: 13.8	Cell type enriched	Detected in some	10	Ciliated cells: 281.1	Group enriched	Detected in some	5	endometrial cancer: 5.4;lung cancer: 1.5	Low region specificity	Detected in many			Cell type enhanced	Detected in some		NK-cell: 2.5	Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		SCLC-21H: 7.6;TIME: 2.2	Low region specificity	Detected in some			Low region specificity	Detected in single			HPA041022	Enhanced											HPA041022: AB_10795500	unprognostic (1.77e-4)	unprognostic (7.44e-3)	unprognostic (1.61e-1)	unprognostic (2.11e-3)	unprognostic (5.09e-3)	unprognostic (1.14e-3)	unprognostic (1.13e-1)	unprognostic (1.28e-1)	unprognostic (9.81e-2)	unprognostic (3.70e-1)	unprognostic (3.84e-2)	unprognostic (2.05e-1)	unprognostic (5.10e-13)	unprognostic (2.76e-2)	unprognostic (1.56e-1)	unprognostic (2.47e-1)	unprognostic (1.29e-1)	0.1	0.9	2	0.7	8.3	0.3	0.3	0.7	0.6	2	0.5	6.3	0	0.9	0.9	10.8	0.1	50.7	0.2	0.1	2.7	5	0.1	0.1	13.8	0.3	0	0	8.8	0.1	0.1	13.5	0.1	14.2	0.2	0.4	0	0.3	0.2	0.1	0.3	0.5	0.1	0.4	0.6	0.3	0.7	1.8	0	0.1	0	1.2	1.3	0	1.2	0.2	0.9	0.3	2.5	0.4	0.2	0.4	0	0.5	0.3	0	0	0.7	0.2	0.1	0.2	0	0.4	0.3	0.6	0.3	0.1	0.6	0	0	0	0.2	0.1	0.3	0.2	0.1	0.2	0	0.2	0.3	0.1	0	0	0	0.4	0.2	0.1	0	0.3	0	0.6	0	0.1	0.5	0.1	0.2	0.2	0.5	0.2	0.3	0.4	7.6	0.9	0	0.1	0.2	0.3	0.8	0.7	2.2	0.6	0.5	0.1	0.2	0.2	0.2	0.4	0.4	0.2	1.6	0.1	0.2	0.1	0.4	0.3	0.2	1.2	0.2	0.1	0.2	0.3	0.2	0.2	0.9	2.5	0.1	0.2	0	0.2	2	8.3	0.7	0.6	2.7	5	0	0	14.2	1.8	0	2.4	0	0	0	0	0.2	0	281.1	27.3	0	0	0	0	0	1.8	0	0	0	0	0	0	0.1	1.1	0	0.1	0	3.4	0	0.3	0.4	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Ciliated cells
TMPRSS11D		ENSG00000153802	Transmembrane serine protease 11D	O60235	4	67820876-67884032	Enzymes, Predicted intracellular proteins, Predicted membrane proteins		Hydrolase, Protease, Serine protease		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	4	cervix, uterine: 18.1;esophagus: 41.2;lymphoid tissue: 20.3;tongue: 67.6;vagina: 23.1	Cell type enriched	Detected in single	32	Urothelial cells: 8.6	Group enriched	Detected in many	5	cervical cancer: 36.0;head and neck cancer: 30.0	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in single		RH-30: 1.3	Not detected	Not detected			Not detected	Not detected			HPA077704	Enhanced				Intracellular and membrane							HPA077704: 	unprognostic (1.19e-1)	unprognostic (6.83e-2)		unprognostic (8.82e-2)	unprognostic (2.10e-2)	unprognostic (1.21e-2)		unprognostic (1.12e-1)	unprognostic (3.22e-1)	unprognostic (2.88e-1)	unprognostic (1.32e-1)	unprognostic (4.79e-1)	unprognostic (4.38e-3)	unprognostic (1.96e-1)	unprognostic (6.91e-2)	unprognostic (4.48e-2)	unprognostic (2.19e-3)	0	0	0	0	0	0	0	0	0	18.1	0	0	0	0	0.6	0	41.2	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	7.6	0	0	0.1	0	0	0	0.1	0	0.1	0	0.1	0	67.6	20.3	0.4	23.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.9	0	0	0	0	0.5	0	0	0	0	1.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	8.6	Urothelial cells
SPHKAP	SKIP	ENSG00000153820	SPHK1 interactor, AKAP domain containing	Q2M3C7	2	227979950-228181645	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	15	brain: 64.0;heart muscle: 33.2	Cell type enriched	Detected in some	13	Cardiomyocytes: 75.1	Not detected	Not detected			Region enriched	Detected in many	4	cerebellum: 64.0	Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	17	BJ hTERT+: 32.5	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA042499, HPA048168	Enhanced											HPA042499: AB_2678027, HPA048168: AB_2680296	unprognostic (4.91e-3)				unprognostic (6.46e-2)						unprognostic (1.33e-1)	unprognostic (2.59e-2)		unprognostic (2.95e-2)	unprognostic (2.09e-1)	unprognostic (1.01e-3)		0.5	0.6	10.7	0.5	5.1	0.4	1.4	64	14.8	0.5	0.5	2.1	0	0.5	0.5	0.4	0.5	0.5	0.5	33.2	15.1	3.7	0.5	0.4	0.6	0.5	1.6	4.5	3.2	0.5	0.4	0.1	0.5	3.8	0.5	0.5	0.5	2.7	0.5	0.4	0.5	0.5	0.5	1.1	1	0.5	0.7	0.9	0	0.5	0	0.4	0.4	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.8	32.5	0	0	0	0	0	0	1.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	10.7	5.1	64	8.5	15.1	3.7	1.6	4.5	3.8	0.9	0	0	0	0	0.1	5.6	75.1	0	0	0	0	2	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	Cardiomyocytes
ASB17		ENSG00000154007	Ankyrin repeat and SOCS box containing 17	Q8WXJ9	1	75918873-75932431	Plasma proteins, Predicted intracellular proteins	Ubl conjugation pathway			Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	51	testis: 33.3	Cell type enriched	Detected in some	4	Early spermatids: 933.4	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected																												unprognostic (7.27e-2)					0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	33.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	933.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	226.4	2.3	0	0	0	0	0	0	0	6	0.7	0	0	0	3.2	1.7	0	0	0	0	0	Early spermatids
CHST9	GALNAC-4-ST2, GALNAC4ST-2	ENSG00000154080	Carbohydrate sulfotransferase 9	Q7L1S5	18	26906481-27185317	Predicted intracellular proteins, Predicted membrane proteins	Carbohydrate metabolism	Transferase		Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		salivary gland: 23.4	Cell type enriched	Detected in many	5	Ciliated cells: 422.9	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		CACO-2: 6.4;Hep G2: 9.5;RPTEC TERT1: 30.0;SCLC-21H: 6.5	Low region specificity	Detected in some			Low region specificity	Detected in all			HPA011393	Uncertain				Intracellular and membrane							HPA011393: AB_1846733	unprognostic (9.24e-3)	unprognostic (1.13e-2)		unprognostic (4.81e-3)	unprognostic (6.63e-3)	unprognostic (4.53e-3)	unprognostic (9.98e-3)	unprognostic (9.21e-3)	unprognostic (7.92e-2)	unprognostic (1.61e-1)	unprognostic (2.04e-2)	unprognostic (3.54e-2)	unprognostic (2.72e-2)	unprognostic (2.17e-2)	unprognostic (1.38e-1)		unprognostic (3.93e-3)	0.3	0.4	1.7	0.3	2.4	0.2	3.7	1	2.6	4	2.1	4.5	0.7	0.4	0.3	0.9	2.2	13.6	4.5	3.4	3.7	2.7	2.4	12.1	8.6	0.1	2.6	0.8	1.2	11.9	0.1	4.3	0.1	4.9	4.8	0.4	5.3	23.4	2.7	0.4	0.4	0.7	0.3	5.3	7.1	1	8.5	4.2	0	0.3	3.9	7	2.6	10.5	0.5	0.1	0.8	0.1	0.3	0.3	0	0	0	1.3	0	0	0	0	0	0	0	0	6.4	0.1	0	0.1	0	0	0	0	0.1	0	0	1.5	0	0	9.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	30	0	6.5	0.3	0	0	0	1.5	0	0	0	0	0.2	0	0	0	0	0	0	0	0.5	0.8	0	0.2	0.1	0.1	0	0.1	0.1	0.2	0	0.5	0.2	0.3	0.5	0.3	0	0.1	0.1	0	1.7	2.4	1	2.6	3.7	2.7	2.6	0.8	4.9	4.2	0	2.4	0	29.8	0.6	1.3	7.7	38.2	422.9	93.3	5.2	0	0.2	10	8.9	6.1	0	0	0	0.5	0.1	1.1	6.5	4.7	8.9	0.3	0	3.4	0	0	2.4	0.6	0	6.8	0	0	72.3	2.1	0	0.4	0.1	1.8	0	0.5	0.7	0.7	0	0.2	0	0	37.1	Ciliated cells
DNAAF1	CILD13, FLJ25330, LRRC50, ODA7, swt	ENSG00000154099	Dynein axonemal assembly factor 1	Q8NEP3	16	84145287-84178767	Disease related genes, Predicted intracellular proteins			Ciliopathy, Disease mutation, Kartagener syndrome, Primary ciliary dyskinesia	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		fallopian tube: 21.3;testis: 49.6	Cell type enriched	Detected in many	4	Ciliated cells: 520.6	Cancer enhanced	Detected in many		endometrial cancer: 3.1	Group enriched	Detected in many	5	amygdala: 3.5;basal ganglia: 9.4;hippocampal formation: 4.6;hypothalamus: 6.5;pons and medulla: 11.1	Cell type enhanced	Detected in some		neutrophil: 5.5	Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		Hep G2: 3.5;Karpas-707: 8.8;PC-3: 2.7;SK-BR-3: 2.5;U-266/70: 7.4;U-266/84: 4.8	Low region specificity	Detected in single			Low region specificity	Detected in some			HPA041166, HPA074239	Enhanced		Approved	Nuclear speckles,Plasma membrane,Cytosol						Plasma membrane, Cytosol	Nuclear speckles	HPA041166: AB_10794190, HPA074239: AB_2732250	unprognostic (5.25e-3)	unprognostic (2.40e-2)	unprognostic (2.77e-2)	prognostic favorable (2.14e-4)	unprognostic (1.42e-1)	unprognostic (9.99e-2)	unprognostic (1.25e-1)	unprognostic (4.48e-2)	unprognostic (7.71e-2)	unprognostic (1.58e-1)	unprognostic (3.31e-5)	unprognostic (2.70e-2)	unprognostic (4.61e-3)	unprognostic (1.77e-1)	unprognostic (1.56e-1)	unprognostic (1.27e-4)	unprognostic (7.51e-4)	0.8	1.2	3.5	0.6	9.4	1.5	0.5	0.1	1.5	2.1	0.6	5.3	1.5	0.4	1	13.3	0.9	21.3	0.5	0.4	4.6	6.5	0.7	2	3.7	0.9	0.5	1.5	4.2	0.4	0.7	6.1	1.5	11.1	0.4	0.4	0.9	0.5	0.6	0.6	0.5	0.6	0.4	1	7.2	0.5	49.6	1.2	0	1.2	0	0.4	0.8	0	0.5	1	5.5	0.8	0.9	2.1	0.9	0	0	0.7	0	0	0	0	0	0	0	0.1	0	0.4	0	0	0	0.3	0	0	0	0	0	0	0.2	0.7	3.5	0	0.5	0	0	0	0	0	0	0	0	0	8.8	0	0	0	0	0	0	2.7	0	0.3	0	0.1	1.3	0.2	0	0	2.5	0.1	0.1	0.9	0	0	0.4	0	0	0	7.4	4.8	0.7	0.2	0.4	0	3.6	0.8	0.4	0.4	0.6	0.1	0	0.2	0.1	0.4	0.5	0.8	0.8	5.5	0.9	0.4	1	2.1	0.9	3.5	9.4	0.1	1.5	4.6	6.5	0.5	1.5	11.1	1.2	0	17.2	2.2	1.6	0.6	1.4	0.6	2.5	520.6	108.1	3.5	51.1	0.2	0	1	67.6	1.4	0	0	0.3	0.4	0.9	0.8	3.5	0.4	1.9	0	0	3.1	2.7	16.2	1.1	4.8	82.7	1	0	2.1	1.3	0	0.4	0.7	53.5	0	0.4	118.6	19.6	0.3	0.3	0	0	0.7	Ciliated cells
OBSCN	ARHGEF30, KIAA1556, KIAA1639, UNC89	ENSG00000154358	Obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF	Q5VST9	1	228208130-228378874	Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins	Differentiation	Calmodulin-binding, Developmental protein, Kinase, Muscle protein, Serine/threonine-protein kinase, Transferase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	5	skeletal muscle: 180.2;tongue: 48.4	Cell type enriched	Detected in many	14	Cardiomyocytes: 136.5	Low cancer specificity	Detected in many			Low region specificity	Detected in some			Cell type enhanced	Detected in some		naive CD4 T-cell: 3.2	Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		HeLa: 16.0	Low region specificity	Detected in single							HPA021186, HPA065801	Enhanced		Approved	Plasma membrane,Cytosol						Plasma membrane, Cytosol		HPA021186: AB_1854761, HPA065801: 	unprognostic (8.47e-3)	unprognostic (1.56e-1)	unprognostic (9.99e-2)	prognostic unfavorable (1.64e-4)	unprognostic (5.30e-3)	unprognostic (6.36e-2)	unprognostic (4.54e-3)	unprognostic (1.82e-1)	unprognostic (8.81e-2)	unprognostic (1.93e-2)	unprognostic (3.38e-1)	unprognostic (1.45e-1)	unprognostic (1.57e-3)	unprognostic (1.34e-1)	unprognostic (1.77e-1)	unprognostic (3.53e-1)	unprognostic (1.16e-2)	2.5	0.9	0.5	0.9	4.4	0.6	0.7	3.1	0.6	0.6	0.8	0.5	0.5	0.6	0.8	4.4	2.4	1	0.6	21.2	0.5	0.7	1.6	0.5	1	1	0.5	0.5	1.7	1.4	0.4	2.4	0.5	0.9	1.7	0.3	5.2	2.6	1.1	180.2	1.1	0.8	0.5	0.6	1.4	0.5	0.7	0.6	0.5	2.2	48.4	3.5	0.6	0.7	1	1.1	0.1	0.4	0.6	3.2	0.7	2.9	2.8	8	4.5	0.2	0.1	5.6	1.5	0.5	1	0.9	2	2.1	5.7	8.1	0.5	0.6	1	0.4	1.1	0.2	2.2	5.1	1.9	16	0	2	1.3	6.1	3	1	0.4	0.2	5.4	0.4	9.4	5.3	1.3	0.3	5	2.1	1.6	8.8	0.8	1.8	8.1	0.1	1.3	4.6	1.5	3	9	0.2	2.9	1.1	2.4	8	3.7	0.7	0	9.3	0.2	0.1	4.7	0.9	1.4	0	0.8	2.1	0.1	0.4	0	0.9	0.1	0.9	0.5	0.9	0.7	0.9	1	3.2	0.5	0.1	0.6	0.1	1.1	0.8	0.7	0.5	4.4	3.1	0.6	0.5	0.7	0.5	0.5	0.9	0.6	0	5.6	0	5.9	1.9	3.2	136.5	2.5	1.4	4.5	5.2	9.8	0.1	10	2.9	3.8	1.6	0.4	0	0.4	0.4	1.5	1.9	6.9	0.5	0.1	0	0	1.3	0	4	2.8	0.3	1.7	0	1.7	9.7	1	0	4.2	4.2	2.8	0	1.2	0.1	2.5	1.5	1	1.8	1.1	3.4	Cardiomyocytes
PPP1R3A	GM, PPP1R3	ENSG00000154415	Protein phosphatase 1 regulatory subunit 3A	Q16821	7	113876777-114075920	Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins	Carbohydrate metabolism, Glycogen metabolism		Diabetes mellitus, Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	20	heart muscle: 24.1;skeletal muscle: 69.4;tongue: 75.4	Cell type enriched	Detected in some	13	Cardiomyocytes: 136.5	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	64	THP-1: 18.1	Region enriched	Detected in single	19	thalamus: 1.2	Not detected	Not detected			HPA070440, HPA073138	Enhanced											HPA070440: , HPA073138: 						unprognostic (8.96e-3)												1.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.7	1.7	0	0	24.1	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0.6	0	0	1.4	0	69.4	0	0	0	0	0	0	0.4	0	0	0.1	75.4	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.1	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	136.5	0	0	0	0	0	0	0	0	10.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	1.1	0	0	0	0	0	Cardiomyocytes
ASZ1	ALP1, ANKL1, C7orf7, CT1.19, GASZ, Orf3	ENSG00000154438	Ankyrin repeat, SAM and basic leucine zipper domain containing 1	Q8WWH4	7	117363222-117428123	Predicted intracellular proteins, Predicted membrane proteins	Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis	Developmental protein		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	27	testis: 15.7	Cell type enriched	Detected in some	4	Spermatocytes: 87.1	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	24	Daudi: 4.0;U-266/70: 2.0	Not detected	Not detected			Not detected	Not detected			HPA020558	Enhanced		Approved	Nucleoplasm,Cytosol						Cytosol	Nucleoplasm	HPA020558: AB_1845123								unprognostic (4.30e-1)				unprognostic (1.87e-1)			unprognostic (1.42e-1)			0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0.2	0	0	0	0	0	0	0	0	2.1	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	2.2	0	0	0	0	0	0	0	0	0.4	0	0	6.5	0	87.1	20.1	0	0	0	0	0.1	Spermatocytes
PSMA8	MGC26605, PSMA7L	ENSG00000154611	Proteasome subunit alpha 8	Q8TAA3	18	26133852-26193355	Enzymes, Plasma proteins, Predicted intracellular proteins	Differentiation, Spermatogenesis	Hydrolase, Protease, Threonine protease		Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	6	testis: 36.5	Cell type enriched	Detected in some	26	Spermatocytes: 183.4	Not detected	Not detected			Not detected	Not detected			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Group enriched	Detected in some	80	Daudi: 23.7;JURKAT: 6.8;U-266/70: 14.7;U-266/84: 15.4	Low region specificity	Detected in many			Not detected	Not detected																unprognostic (5.39e-3)	unprognostic (7.45e-5)			unprognostic (2.94e-1)	unprognostic (3.04e-2)		unprognostic (1.59e-1)	unprognostic (2.72e-1)	unprognostic (1.99e-1)	unprognostic (8.30e-2)		unprognostic (7.54e-4)	unprognostic (4.80e-2)	unprognostic (1.15e-1)	unprognostic (2.56e-1)		0.1	0.1	0.1	1.2	0.1	0	0.1	0	0.1	0	0.2	0	0	0	0	0.2	0	0	0	0.1	0.1	0.1	0	0	0	1.6	0.1	0	0.1	0	0	0.1	0.2	0.7	0.1	0	0	0.1	0	0.1	0	0.2	0	0.1	1.1	0	36.5	0.2	0.7	0.1	0	2.2	0.1	0	4	1.9	0.2	0.1	1.2	5.8	1.4	0	0	0	0	0	0	0	0	0	0	0	0	0	23.7	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	6.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.7	15.4	0.1	0	0	0	0	0.1	0	2	0.1	2.2	4	2.1	3.9	0.3	3.1	2.4	5.8	0.2	1.2	0.1	1.9	4.3	1.4	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.7	0.2	0	0	1.5	0	0.1	0	0.4	0	0	0	0	0	2.4	0	0	6.3	0	0	0	0	2.2	0	0	0	0	0.2	0	0	0.6	0	3.6	1.1	0	1.7	0	0	0	0	0	1.4	0	0	6.5	0	183.4	7	0	0.8	0	0	0	Spermatocytes
C21orf91	C21orf14, C21orf38, CSSG1, EURL, YG81	ENSG00000154642	Chromosome 21 open reading frame 91	Q9NYK6	21	17788967-17819386	Predicted intracellular proteins	Differentiation, Neurogenesis			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	4	Early spermatids: 269.6	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Cell line enhanced	Detected in many		Karpas-707: 46.8	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA018288, HPA049030	Approved		Approved	Microtubules,Cytokinetic bridge						Microtubules	Cytokinetic bridge	HPA018288: AB_1845710, HPA049030: AB_2680605	unprognostic (3.28e-1)	unprognostic (3.41e-2)	unprognostic (3.12e-2)	unprognostic (4.51e-2)	unprognostic (6.19e-2)	unprognostic (1.11e-3)	unprognostic (2.42e-1)	unprognostic (8.81e-3)	unprognostic (2.79e-1)	unprognostic (1.97e-1)	unprognostic (3.25e-1)	unprognostic (5.49e-2)	unprognostic (1.24e-2)	unprognostic (6.80e-2)	unprognostic (1.59e-1)	unprognostic (6.49e-2)	unprognostic (9.90e-3)	7.2	5.6	9.6	9.3	21.7	7.4	8.3	2.9	14.1	6.9	5.2	31.7	2	5.1	9.7	4.6	9.4	7	6.1	5.4	15.7	8.8	5.5	8.8	8.8	14.3	27.3	8	8.6	4	6.9	5.3	19.1	23.6	5.6	5.4	2	8.1	4.2	4.6	19	5.9	7.7	34.2	9.4	6.2	23.9	25.8	22.2	5.8	5.2	12.8	9.9	6.5	6	5.8	34.2	5	8.8	15.1	4.9	2.9	0.5	6.8	0	1.7	3.3	3	4.4	7.9	4.4	3.9	2.5	1.5	10.4	2.2	1.7	6.1	2.3	7.2	5.7	3.8	11.3	3.8	6.9	6	1.7	3.9	8.4	4	2.3	6.2	5.7	9.3	3	1.2	4.3	4.8	46.8	3.1	1.9	11.6	2.5	7.1	0.7	2.4	9.1	12.9	4.2	2.9	5.1	2.7	6.2	5	4.3	19.8	3.1	2.6	4.7	2	19.4	6.1	0.1	2.8	12.4	15.1	9	1.5	7.9	7.3	34.2	4.8	23.4	9.6	5	13.7	6	8.9	10.2	5.8	5.1	7	9.2	10.7	8.8	4.9	1.4	15.1	4.9	9.6	21.7	2.9	14.1	15.7	8.8	27.3	8	23.6	25.8	17.9	12	14.2	10	24.7	9.5	5.5	2.5	5.3	7.9	5.2	15.7	13.1	1.7	4	269.6	11.7	3.1	0	6	9.5	11.3	8.1	38.2	6.4	5	14.3	10.3	8.6	7.9	52.3	21.9	9.1	20.3	3.6	4.7	3.4	3.6	2.9	15.9	5.3	10.9	6.5	8	25.6	19.2	24.1	67.1	30.6	3.8	6.4	Early spermatids
TMPRSS15	ENTK, MGC133046, PRSS7	ENSG00000154646	Transmembrane serine protease 15	P98073	21	18269116-18485879	Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins		Hydrolase, Protease, Serine protease		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	67	intestine: 154.6	Cell type enriched	Detected in single	11	Early spermatids: 4.2	Group enriched	Detected in some	12	liver cancer: 0.7;pancreatic cancer: 1.5;stomach cancer: 1.5	Not detected	Not detected			Cell type enhanced	Detected in single		naive B-cell: 2.3	Low lineage specificity	Detected in single			Group enriched	Detected in some	20	U-138 MG: 20.3;U-87 MG: 56.6	Not detected	Not detected			Region enriched	Detected in single	5	olfactory region: 9.3	HPA015611, HPA034857, HPA072934	Enhanced		Approved	Nucleoli,Plasma membrane						Plasma membrane	Nucleoli	HPA015611: AB_1855791, HPA034857: , HPA072934: AB_2732214					unprognostic (9.26e-2)	unprognostic (4.14e-1)		unprognostic (3.52e-1)	unprognostic (8.33e-2)	unprognostic (1.19e-1)	unprognostic (7.20e-2)	unprognostic (4.70e-2)		unprognostic (6.35e-2)	unprognostic (5.92e-2)			0.1	0	0.1	0.1	0.1	0	0.1	0	0	0	80.5	0	0	154.6	0.1	0	0	0	0	0.1	0.1	0.1	0.1	0	0	0	0.1	0	0	0.1	0	0.1	0	0	0.1	0	0	0	0	0	0.1	42.4	0	0.1	0.1	0	0.6	0	0	0	0	0	0	0.1	2.3	0	0.5	0.1	0.6	0.3	0	0	0.1	0	0	0	0	0.1	0	0	0	0	0	0	0.6	0.1	0	0.1	0	0	0	0	0	0	1.8	0	0	0	0	0	0	0	0	1.5	0	0	0	0	1.9	0	0	0	0.1	0	0	0	0.1	0	1.6	0	0	0	0.1	0	0	0	0	0	0	0	20.3	0	0.1	0	0.3	0	0.1	56.6	0	0	0	0.1	0.1	0	0	0	0	0	0	0	2.3	0.3	0.1	0.5	0.6	0	0	0	0	0.1	0.1	0	0	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	4.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0.1	0	0	0	0	0	Early spermatids
GPR78		ENSG00000155269	G protein-coupled receptor 78	Q96P69	4	8558725-8619761	G-protein coupled receptors, Predicted membrane proteins		G-protein coupled receptor, Receptor, Transducer		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in some	13	placenta: 53.3	Cell type enriched	Detected in some	5	Extravillous trophoblasts: 4.8	Cancer enhanced	Detected in single		urothelial cancer: 1.2	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	202	BEWO: 21.7									HPA013209	Uncertain											HPA013209: AB_10601657	unprognostic (6.41e-2)	unprognostic (1.77e-2)	unprognostic (1.17e-2)	unprognostic (2.51e-1)	unprognostic (1.81e-2)	unprognostic (3.70e-2)		unprognostic (3.82e-4)	unprognostic (6.46e-3)	unprognostic (1.20e-1)	unprognostic (3.80e-2)	unprognostic (2.29e-1)	unprognostic (4.88e-15)	unprognostic (5.55e-3)	unprognostic (3.93e-2)	unprognostic (9.90e-3)	unprognostic (8.15e-2)	0	0	0	0.1	0.1	0	0	0.2	0.5	0.1	0	0	0	0	0	0	3.9	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	53.3	0	0	0	0	0.2	0	0	0.2	0	0	0	0	0	0	0	0.2	0	0	0	0.3	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	21.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.2	0.5	0.1	0	0	0	0	0	0	0	0	0	0	0	0.8	0	0	0	0	0	0.2	0	0	0	0	0	0	0	4.8	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	Extravillous trophoblasts
TTN	CMD1G, CMH9, CMPD4, FLJ32040, LGMD2J, MYLK5, TMD	ENSG00000155657	Titin	Q8WZ42	2	178525989-178830802	Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins		Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase	Cardiomyopathy, Disease mutation, Limb-girdle muscular dystrophy	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		heart muscle: 136.5;skeletal muscle: 713.8;tongue: 227.0	Cell type enriched	Detected in many	134	Cardiomyocytes: 19161.7	Cancer enhanced	Detected in single		head and neck cancer: 1.3	Not detected	Not detected			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		RH-30: 4.9	Not detected	Not detected							HPA007042, CAB022682, HPA030048	Enhanced								25000000			CAB022682: , HPA007042: AB_1080292, HPA030048: AB_2732451	unprognostic (1.00e-2)	unprognostic (3.92e-1)	unprognostic (1.77e-1)	unprognostic (7.11e-2)	unprognostic (3.71e-2)	unprognostic (1.49e-2)	unprognostic (6.62e-2)	unprognostic (1.84e-1)	unprognostic (2.49e-2)	unprognostic (1.86e-1)	unprognostic (2.79e-1)	unprognostic (2.65e-1)	unprognostic (3.49e-4)	unprognostic (1.99e-1)	unprognostic (1.15e-1)	unprognostic (1.09e-1)	unprognostic (1.34e-2)	23.7	0.3	0.2	0.3	0.3	0.9	0.3	0.2	0.4	0.2	0.2	0	0	0.2	0.2	21.3	8.3	0.2	0.3	136.5	0.2	0.2	0.2	0.2	0.4	0.4	0.2	0	0.3	0.4	0.2	0.3	0.3	0	0.7	0.2	0	11.6	0.2	713.8	0.3	0.2	0.2	0.3	0.3	0.2	0.4	0	0	5.6	227	15.8	0.3	0.2	7	0.3	1.9	0.3	5	7.3	0.1	0.7	0.3	1.9	1	0	0	3.4	0.6	0	0	0	1.8	0.3	2.4	0.6	0	1.8	1.8	0	0	0	2.4	2	3.7	2.7	1.1	0	0.3	0.8	2.4	0	0	0	1.7	1.4	1.8	2.2	1.2	0.4	0.4	1.6	2.5	0.4	0.2	1.8	1.3	4.9	1.3	0	0.6	1.1	1.7	0.4	1.3	0	1.7	0.8	2.4	1.6	0	0	0.9	0.4	3.6	0.4	3.5	0.1	1.1	0.9	1.9	0.3	0.7	0.5	0.2	0.2	6.9	1.2	0.9	0.2	7	2.7	3.5	1.3	5	0.2	0.3	7.3	0.1	0.2	0.3	0.2	0.2	0.2	0.2	0.2	0	0	0	14.9	142.6	2.2	0.2	0.8	28.9	19161.7	17.8	5.3	11.4	0	19.6	0.4	1.7	7.7	35.3	0.7	0	0	23.6	0.2	0.5	0.1	9.3	0.5	0.2	15.9	4.1	2.5	0	4.3	1.1	0.4	0	0	0	10.3	0.9	0	4.2	0	26.3	0	1.4	5.7	0.2	0.1	0.3	4.9	0	0	Cardiomyocytes
KDM8	FLJ13798, JMJD5	ENSG00000155666	Lysine demethylase 8	Q8N371	16	27203495-27221768	Enzymes, Predicted intracellular proteins	Biological rhythms, Cell cycle, Transcription, Transcription regulation	Aminopeptidase, Chromatin regulator, Dioxygenase, Hydrolase, Oxidoreductase, Protease		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		liver: 44.9	Cell type enriched	Detected in many	5	Hepatocytes: 46.0	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low cell line specificity	Detected in many			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA026545	Uncertain		Approved	Nucleoplasm,Cytosol						Nucleoplasm	Cytosol	HPA026545: AB_1852015	unprognostic (1.39e-1)	unprognostic (1.37e-3)	unprognostic (2.80e-1)	unprognostic (2.16e-2)	unprognostic (3.21e-1)	unprognostic (1.22e-2)	unprognostic (2.41e-3)	unprognostic (1.33e-2)	unprognostic (7.95e-2)	unprognostic (3.41e-1)	prognostic favorable (1.75e-4)	unprognostic (1.22e-1)	unprognostic (2.75e-2)	unprognostic (5.33e-2)	unprognostic (2.71e-1)	unprognostic (2.04e-1)	unprognostic (3.92e-3)	1.9	3.2	2.7	3.6	3.5	1.4	2.1	5.9	5.9	2.2	4.2	3.7	3.2	12	3.1	2.2	2.1	2.5	2.5	2	2.7	3.2	2.3	44.9	2	3.3	2.3	5.1	3	4.5	2.8	3.3	1.7	3.7	2.9	1.9	2.1	2.6	2.5	4	1.9	16.8	1.9	2.2	3.7	2.3	2.2	2.2	5.9	2.9	2	3.7	2.8	2.2	5.6	6.5	1.3	3.4	2.2	8.2	3.5	1.6	3.7	6.4	3.3	1.6	1.9	3.4	2.1	2.4	4.8	4.3	3.1	2.9	9.6	3.7	3.5	2.4	1.9	3.7	3.2	2.8	11	5.5	6.1	4.1	7.3	3.4	4.3	7.3	2.5	2.6	3.2	2.1	2.8	3.7	4.6	7.7	5.9	2.9	2.8	4.3	7.7	11.1	1.3	2.2	6.3	3.9	8.6	1.8	1.9	6	3.8	0.9	3	2.3	2.2	3.2	5.7	4.1	5.7	3	2.1	2.2	3.7	3.8	7.7	2.3	4	0.5	0.4	3.2	1.3	4.2	3.4	3.6	3.2	6.2	6	3	5.6	6	8.2	0.1	2.2	2.9	6.5	3.6	3.5	2.7	3.5	5.9	5.9	2.7	3.2	2.3	5.1	3.7	2.2	0	1.7	0.5	0.2	0.2	1	1	0	9.4	2.3	0	2	1.3	3.3	0.9	0.4	1	1.6	0	0.6	0.4	0.8	0.4	0	46	1.6	0	5.2	1.3	1.3	0	0.3	1.2	0	1	1.3	1.6	0.7	0	1.1	1.2	2.5	0	0.8	0.9	2.5	0	1.1	0.5	1.1	0.1	Hepatocytes
SLC26A2	DTD, DTDST	ENSG00000155850	Solute carrier family 26 member 2	P50443	5	149960737-149993455	Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters	Transport		Disease mutation, Dwarfism	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		intestine: 81.9	Cell type enriched	Detected in many	4	Syncytiotrophoblasts: 676.5	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Cell line enhanced	Detected in many		EFO-21: 24.2;RPTEC TERT1: 55.5;TIME: 28.5	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA041957, HPA058090	Enhanced		Approved	Vesicles						Vesicles		HPA041957: AB_10795646, HPA058090: AB_2683602	unprognostic (6.64e-2)	unprognostic (1.53e-1)	unprognostic (3.03e-2)	prognostic favorable (7.29e-4)	unprognostic (2.59e-2)	unprognostic (5.64e-2)	prognostic unfavorable (4.66e-4)	unprognostic (2.59e-1)	unprognostic (5.64e-2)	unprognostic (1.19e-1)	unprognostic (7.43e-2)	unprognostic (2.10e-1)	prognostic unfavorable (3.27e-4)	unprognostic (1.70e-1)	unprognostic (1.77e-1)	unprognostic (8.12e-2)	unprognostic (1.06e-1)	8.5	15.6	2.6	23.2	3.7	1.3	4.7	6.3	2.3	3.8	81.9	3	29.4	5.4	4.8	14.2	8.3	3.1	2.6	3.1	2.5	2.6	3.8	1.6	6.8	5.3	3.7	2.3	5.1	2.9	21.4	11.1	16.9	7.6	6.1	75	4.9	27.9	36.7	11.2	6	13.4	4.3	5.5	3	2.4	2.8	3	5.2	2.7	4.4	13	4.1	2.8	1.6	1.7	7	3.3	2.5	3	1.1	3.3	3	3.8	6.2	4.6	3.3	0.9	3.1	2.8	2.5	3.1	15.7	1.8	2.5	24.2	3.3	6.1	2.4	3.6	7.3	4.6	2	2.3	3.2	2.4	1.8	3.5	5.9	5.5	3.6	4.3	4.2	5.5	6.3	6	3.2	0.8	2.6	10.6	1	2.2	3.1	1.2	1.1	4.8	3.3	5.9	1.3	55.5	14.7	1.1	2.9	5.5	1.3	9.4	3.1	2.6	3.5	28.5	5.9	4.4	5.1	3.7	1.8	2.4	1.5	5.4	7.2	8.4	7	1.1	0.8	2.5	0.8	3	1.3	1.5	2.1	1.7	1.6	2.1	2.2	1	2.5	3.3	1.7	2.6	1.1	2.6	3.7	6.3	2.3	2.5	2.6	3.7	2.3	7.6	3	41.7	13.7	7.5	12.5	4	16.1	6.7	7.6	6.7	14.8	31.4	15.7	160.9	1.7	5.2	17.7	15.3	151.8	0	8.6	5.2	16	21.5	87.8	2.4	26.4	6.4	20.3	16.5	13.8	9.9	16.1	12.2	86	16.2	37.7	15	9.4	147.9	11.7	4.4	80.3	0	10.2	9.2	10.2	4.4	676.5	9.6	53.2	4.9	Syncytiotrophoblasts
SAXO1	C9orf138, FAM154A, MGC35182	ENSG00000155875	Stabilizer of axonemal microtubules 1	Q8IYX7	9	18927658-19049354	Predicted intracellular proteins	Cilium biogenesis/degradation			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	15	testis: 47.2	Cell type enriched	Detected in some	14	Early spermatids: 471.8	Not detected	Not detected			Not detected	Not detected			Cell type enhanced	Detected in some		naive CD8 T-cell: 2.1	Lineage enriched	Detected in single	5	T-cells: 2.1	Cell line enhanced	Detected in some		HEL: 1.8;T-47d: 1.0	Not detected	Not detected			Not detected	Not detected			HPA023899	Enhanced											HPA023899: AB_1845813	unprognostic (4.23e-4)	unprognostic (1.59e-1)	unprognostic (3.38e-1)	unprognostic (3.17e-2)	unprognostic (5.28e-3)	unprognostic (8.64e-2)	unprognostic (3.89e-1)	unprognostic (2.90e-3)	unprognostic (1.38e-2)	unprognostic (4.97e-3)	unprognostic (1.51e-1)	unprognostic (3.61e-1)	unprognostic (1.24e-1)	unprognostic (8.02e-2)	unprognostic (2.79e-1)	unprognostic (4.36e-2)	unprognostic (5.40e-2)	0.2	0.2	0.2	0.5	0.5	0.1	0.2	0.2	0.8	0.2	0.2	1.5	0	0.2	0.3	3.1	0.2	0.4	0.3	0.2	0.3	0.2	0.2	0.2	0.2	0.6	0.2	0	0.2	0.3	0.2	1.7	0.1	0.8	0.5	0.1	1.3	0.6	1	0.2	0.3	0.2	0.1	0.6	0.2	0.2	47.2	0.3	0.5	0.2	0	0.5	0.2	0.2	0.2	0.4	0.1	0.1	0.2	2.1	0.1	0.4	0	0.2	0.1	0	0	0	0.2	0.8	0.2	0	0	0	0.1	0	0	0	0	0	0	0.2	0.3	0.7	1.8	0.3	0	0	0	0.1	0.4	0	0	0	0.1	0.2	0.6	0	0.6	0	0	0.1	0.1	0	0.3	0	0.3	0	0	0	0	0.6	0	0	0	0.1	0.9	1	0.6	0	0.1	0	0.9	0	0.1	0	0.2	0.5	0	0	0	0.1	0.1	0.6	0	1.1	0.2	0.5	0.8	0.2	0.2	1.1	2.1	0	0.2	0	0.4	0.3	0.1	0.2	0.5	0.2	0.8	0.3	0.2	0.2	0	0.8	0.3	0	0	0	0.1	0	0.1	0.2	0	0	0	0	0	0.1	0	0.1	471.8	0	0	0	0.3	0	0	0	0	0.8	0.2	0	0	0	1.5	33.4	4.4	0	0	0	0	0.2	0.1	0	2.5	0.5	0	0	0	6.1	2.3	0	0.1	0	0	0.1	Early spermatids
CARNMT1	C9orf41, FLJ25795	ENSG00000156017	Carnosine N-methyltransferase 1	Q8N4J0	9	74981020-75028423	Enzymes, Predicted intracellular proteins		Methyltransferase, Transferase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	7	Early spermatids: 178.1	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low cell line specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA026756	Uncertain											HPA026756: AB_1845824	unprognostic (1.59e-1)	unprognostic (1.02e-1)	unprognostic (2.99e-2)	unprognostic (4.81e-2)	unprognostic (3.48e-1)	unprognostic (1.56e-1)	unprognostic (3.22e-2)	unprognostic (4.92e-2)	unprognostic (3.94e-2)	unprognostic (1.15e-1)	unprognostic (2.42e-2)	unprognostic (1.54e-1)	unprognostic (1.25e-2)	unprognostic (1.45e-2)	unprognostic (3.00e-1)	unprognostic (1.85e-1)	unprognostic (4.62e-2)	7.7	8.3	8	12.9	17.5	8.4	8.5	22.9	11.6	11.3	13.5	5.7	11.3	14.6	10	10.7	15.8	7.8	10.9	7.5	7.6	6	14.9	20.2	7.3	10.6	6.3	7.9	8.8	16.5	16.1	12.5	7.6	5.4	10.7	10.5	7.7	13.9	12.3	9.6	10.2	23.3	8.7	6.6	9.9	9	22.1	8.6	15.1	16.6	8.7	11	9.7	12.8	3.5	1.5	2.1	1.7	3.1	4.7	1.4	14.5	8.8	3.7	9.6	6.2	13.2	13.8	12.9	5.6	5.1	4.7	2.2	10	23.1	6.9	9.6	11	14.6	11.3	14.2	14.7	20.1	8.7	11.7	9	10.2	7.5	21.2	11.6	8.9	7.2	9.7	10.1	7.7	10.4	8.7	9.9	20.9	10	4	15.5	5.9	17.2	18.2	7.9	7.5	11.1	13.9	13.6	10.5	3.7	2	9.9	26.4	5	7.1	13.3	6.5	8	8.5	11.1	10.2	11.3	14.9	18.9	7	13.3	14.8	5.4	0	1	2.1	3.2	1.7	4.5	3.5	3.2	4.7	1.2	1.9	3.6	3.8	0.4	3.1	1	1.5	4.1	1.4	8	17.5	22.9	11.6	7.6	6	6.3	7.9	5.4	8.6	6	9.4	2.2	10.8	0	13.1	0	17.8	8.1	12.5	26.2	9.8	6.1	21.6	6.2	178.1	6	5.4	0	10.2	10.9	4.3	11.6	2.3	27	7.4	19.1	7	9.2	9.8	25.4	6.9	5.1	0	4.6	17	5	8.4	10.5	10.3	25.3	9.8	0	0	13.1	9.1	0	4.2	13.8	14.9	13.2	Early spermatids
CFAP70	FLJ25765, TTC18	ENSG00000156042	Cilia and flagella associated protein 70	Q5T0N1	10	73253759-73358859	Predicted intracellular proteins			Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		pituitary gland: 27.2;testis: 22.3	Cell type enriched	Detected in many	5	Ciliated cells: 329.2	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		PC-3: 9.0	Low region specificity	Detected in many			Low region specificity	Detected in many			HPA037582, HPA070304	Enhanced											HPA037582: AB_2675560, HPA070304: AB_2732153	unprognostic (2.29e-3)	unprognostic (4.42e-2)	unprognostic (1.12e-1)	unprognostic (1.43e-2)	unprognostic (2.41e-1)	unprognostic (9.94e-2)	unprognostic (2.81e-1)	unprognostic (4.60e-2)	unprognostic (2.97e-2)	unprognostic (1.32e-2)	unprognostic (1.67e-3)	unprognostic (5.95e-3)	unprognostic (1.98e-1)	unprognostic (1.05e-1)	unprognostic (2.10e-2)	unprognostic (1.02e-1)	unprognostic (2.16e-1)	1.6	3.8	3.8	1.1	7.1	0.6	3.9	3.3	4.3	2.6	0.8	8.2	8.7	1.6	2.1	13.8	0.9	17.3	1.8	1.4	4.2	5.3	4	2.2	3.3	1	3.7	3.8	4	2.4	10.1	27.2	0.8	14.7	4.2	0.9	4	2.9	8.5	1.2	3.5	0.8	1.3	4.4	1.4	1.7	22.3	6.5	0.5	6.1	0.5	1.1	0.8	1	2.7	1.2	1.1	0.5	1.5	4.1	1	1.8	2.1	2.5	2.1	4.2	3.6	0.7	0.9	0.3	0.6	0.6	1.7	7.7	0.9	1.3	0.3	1.6	1.2	1.3	1.7	0.9	1.7	3.7	1.5	1.9	1.8	0.4	0.8	0.9	2.2	4.1	1.3	1.1	3.1	0	5.2	0.7	5	0.7	3	2	1.6	0.8	1.7	9	1.3	2	3.9	3.8	0.6	3.4	0.3	0.8	1.6	1.3	1.5	3.1	1.3	1.4	0.6	2.1	0.9	2.2	5.1	2.8	2.2	2.9	1.7	0.6	0.2	0.1	1.1	1	0.5	2.2	1.8	2	1.6	0.6	2.7	4.1	3.6	0.3	1.5	0.4	1.2	1.8	1	3.8	7.1	3.3	4.3	4.2	5.3	3.7	3.8	14.7	6.5	8.9	6.7	0.5	3.6	0	14.8	1.9	2.5	329.2	67.1	5.2	27.5	1	3.3	1.1	45.6	1.1	0	0	0.5	0.1	0.4	6	2.3	1.1	0.4	6.4	4.7	1.8	0.3	32.5	4.4	0.4	0	0	0.6	23.4	0.3	0	2.8	1.8	30.3	6.5	0.2	52.5	12.2	0	0.2	0	0.8	2.5	Ciliated cells
WIF1		ENSG00000156076	WNT inhibitory factor 1	Q9Y5W5	12	65050626-65121566	Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins	Wnt signaling pathway	Developmental protein	Cancer-related genes	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 35.2;lung: 67.7;retina: 29.6	Cell type enriched	Detected in many	15	Muller glia cells: 2337.6	Cancer enhanced	Detected in many		endometrial cancer: 16.9	Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HEK 293: 5.4;LHCN-M2: 2.5;NTERA-2: 7.0;SCLC-21H: 1.5	Low region specificity	Detected in many			Not detected	Not detected								Secreted to extracellular matrix								unprognostic (5.96e-3)	unprognostic (2.00e-1)	unprognostic (4.29e-3)	unprognostic (3.26e-3)	unprognostic (9.66e-2)	unprognostic (1.91e-1)		unprognostic (1.26e-2)	unprognostic (7.94e-2)	unprognostic (2.44e-1)	unprognostic (2.92e-2)	unprognostic (3.17e-1)	unprognostic (2.30e-5)	unprognostic (3.02e-1)	unprognostic (2.02e-1)	unprognostic (1.22e-1)	unprognostic (7.24e-3)	0.9	2.4	23.3	0.8	35.2	0.6	14.2	1.6	20.6	1.6	0.8	1	1.9	0.6	5.5	14.5	3.4	1.5	0.6	0.7	10.4	3.9	1	0.6	67.7	0.7	1.4	8.2	0.8	0.8	0.6	21.4	0.6	0.4	9.5	0.8	29.6	24.8	2.3	0.6	4.2	1.8	1.2	0.7	0.7	0.9	1	3.5	0	0.6	3.6	0.6	0.8	0.7	0	0	0	0	0	0	0	0	0	0.9	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	5.4	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0.3	2.5	0.1	0	0.9	7	0	0	0	0	0	0	0	1.5	0.3	0	0.4	0	0	0.2	0	0	0	0	0.5	0	0	0.2	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	23.3	35.2	1.6	20.6	10.4	3.9	1.4	8.2	0.4	3.5	32.8	159.2	0	31.4	11.2	20.4	1.1	0	62.9	48.9	1.8	7.9	0	0	0	0.1	1.2	0	0	0	0	1.9	16	7	0	0	14.3	0	0	0	0	0	3.1	21.9	0	0	2337.6	0	0	0.4	0.8	66.4	0	3.6	0.5	0.2	9.3	0	0	0	0.5	Muller glia cells
UGT2B4	UGT2B11	ENSG00000156096	UDP glucuronosyltransferase family 2 member B4	P06133	4	69480165-69526014	Enzymes, Predicted intracellular proteins, Predicted membrane proteins		Glycosyltransferase, Transferase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	105	liver: 175.1	Cell type enriched	Detected in some	12	Hepatocytes: 831.9	Cancer enriched	Detected in some	96	liver cancer: 351.5	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	9	RH-30: 10.4									CAB033260, HPA045108	Enhanced				Intracellular and membrane							CAB033260: AB_2241496, HPA045108: AB_2679218	unprognostic (7.46e-2)						unprognostic (1.50e-1)	unprognostic (9.37e-2)			unprognostic (1.51e-1)	unprognostic (2.47e-2)	unprognostic (1.47e-1)	unprognostic (9.43e-3)	unprognostic (3.52e-1)			0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0.1	0	0	0	1.6	0	0	0.1	175.1	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0.1	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0.2	0	0	0.1	0	0	0	0	0	0.3	0	0.7	0	1.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0	0	10.4	0.1	0.3	0	0	0	0.5	0	0	0	0	0	0.3	0	0	0.3	0	0	0	0.1	0.1	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4.3	0	0	0	34.2	15.3	0	0	0	0	0	0	0	0	0	0	70	0	0	0	0	0	831.9	0.1	0	0	14.7	12.7	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	Hepatocytes
KCNMA1	KCa1.1, mSLO1, SLO	ENSG00000156113	Potassium calcium-activated channel subfamily M alpha 1	Q12791	10	76869601-77638369	Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels	Ion transport, Potassium transport, Transport	Ion channel, Potassium channel, Voltage-gated channel	Disease mutation, Epilepsy, FDA approved drug targets	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in many			Cell type enriched	Detected in many	7	Bipolar cells: 372.4	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Group enriched	Detected in some	5	intermediate monocyte: 5.5;memory B-cell: 1.7;non-classical monocyte: 3.7	Group enriched	Detected in many	5	B-cells: 1.7;monocytes: 5.5	Cell line enhanced	Detected in many		BJ: 27.4;hTERT-HME1: 32.2;PC-3: 43.8;U-138 MG: 31.6;U-87 MG: 30.8	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA054648	Approved											HPA054648: AB_2682556	unprognostic (1.25e-1)	unprognostic (2.23e-2)	unprognostic (1.86e-2)	unprognostic (5.29e-2)	unprognostic (9.43e-2)	unprognostic (2.25e-1)	unprognostic (1.77e-1)	unprognostic (2.81e-2)	unprognostic (1.87e-1)	unprognostic (1.34e-1)	unprognostic (4.12e-3)	unprognostic (1.20e-1)	unprognostic (2.26e-2)	unprognostic (1.42e-2)	unprognostic (5.19e-2)	unprognostic (1.42e-2)	unprognostic (3.99e-3)	6	8.1	12.5	8.8	13.6	1.1	7.1	8.2	18.5	36.3	39	5.7	27.9	4.8	54	19.7	20.7	18.3	15.6	2.7	10.8	8.2	2	6.6	4	6.2	7.4	16.5	7	4.1	0.7	10.1	3.3	10.1	30.1	13.2	6.6	24	47.6	37.1	1.8	8.6	55.1	6.8	10.4	14.8	2.6	4.9	0.4	1.4	2.7	2.5	21.7	12.6	1.7	0.6	0.3	5.5	0	0	0.3	0	8.2	0	0.1	1.3	7.1	0.1	27.4	24.5	6.6	3.3	1.8	0.1	0	0.2	20.4	15.8	0	0	16	4.1	16.2	0.1	0	0	0	12.8	0	0.1	4.9	2.9	10.6	32.2	23.5	2.6	0.1	0	0	11.6	0.3	0.5	0	0.5	0	43.8	0	1	0	4.2	0	2.5	0.3	0	0.7	0	3.4	3.3	0	17.7	31.6	3.5	5.6	24.2	0	0	0	30.8	0	12.3	0	0.2	0	0	5.5	0	1.7	0	0	0.6	0.3	0	0	0.3	0	3.7	0	0	0.3	12.5	13.6	8.2	18.5	10.8	8.2	7.4	16.5	10.1	4.9	0	7	2.7	41.2	1.8	372.4	2.5	2.5	0	6.8	1.8	56.9	0.3	24.9	2.9	55.5	0.9	1.5	0	9.7	0.1	4.1	44.9	0	23.7	11.3	6.4	4.7	2.5	53.8	46.9	3.4	19.8	45.5	4.6	52.9	48	11.6	0.8	1.1	0.8	15.2	6.5	17.9	1.4	1.6	0.3	0.2	0.7	1.1	1.4	Bipolar cells
CLDN17	MGC126552, MGC126554	ENSG00000156282	Claudin 17	P56750	21	30165564-30166756	Predicted membrane proteins, Transporters	Ion transport, Transport	Chloride channel, Ion channel		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Group enriched	Detected in some	4	esophagus: 12.8;salivary gland: 6.7;tongue: 24.4;vagina: 9.0	Cell type enriched	Detected in single	6	Early spermatids: 3.5	Cancer enhanced	Detected in single		head and neck cancer: 2.1	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	15	HaCaT: 2.2;hTCEpi: 2.5	Not detected	Not detected			Not detected	Not detected			HPA045903	Enhanced											HPA045903: AB_2679491						unprognostic (2.41e-1)												0	0	0	0	0	0	0	0	0	3.1	0	0	0	0	0	0	12.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	6.7	0	0	0.5	0	0	0	0	0	0.7	0	0	0	24.4	2.8	0	9	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.2	0	0	0	0	0	0	0	0	0	0	0	0	2.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Early spermatids
CLDN8		ENSG00000156284	Claudin 8	P56748	21	30214006-30216073	Predicted membrane proteins, Transporters				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		breast: 26.2;kidney: 48.4	Cell type enriched	Detected in some	8	Collecting duct cells: 212.9	Cancer enhanced	Detected in many		prostate cancer: 31.0	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	18	HaCaT: 27.9	Not detected	Not detected			Not detected	Not detected			HPA060605	Supported											HPA060605: AB_2684331	unprognostic (3.74e-2)	unprognostic (3.12e-2)	unprognostic (1.33e-1)	unprognostic (1.02e-1)		unprognostic (3.04e-2)		unprognostic (1.17e-1)		unprognostic (1.87e-1)	unprognostic (1.62e-1)	unprognostic (2.52e-1)	prognostic favorable (3.32e-4)			unprognostic (2.55e-1)	unprognostic (1.48e-2)	0.6	0.6	0.6	0.1	0.6	0	26.2	0.7	0.6	2.5	10	0	6.9	0	0.7	14	4.2	0.8	0	0.7	0.6	0.6	48.4	0.9	1.7	0	0.6	0	0.6	1.5	0	1.3	5.9	0	4.6	19.5	0	14.2	8.7	0.6	2.2	0.8	0	0.6	0.6	0.7	1	0	0	12.2	1.2	1.8	1.2	0.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	27.9	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0.3	0	0	1.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0.6	0.7	0.6	0.6	0.6	0.6	0	0	0	0	0	0	9.1	0.9	0	0	0	26.8	4.5	212.9	0	0	10	0	0	0	4.2	0	0	0	0.1	17.5	0	0	0	0	0	0	0	0	0	0	3.3	0	13.5	0	0	17.3	0	0.1	0	0	0	0	0	7.3	0	0	6.6	18.2	Collecting duct cells
SORCS3	KIAA1059, SORCS	ENSG00000156395	Sortilin related VPS10 domain containing receptor 3	Q9UPU3	10	104641101-105265235	Predicted intracellular proteins, Predicted membrane proteins				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	4	adrenal gland: 5.8;brain: 19.1	Cell type enriched	Detected in some	7	Early spermatids: 11.2	Group enriched	Detected in some	13	glioma: 1.8;renal cancer: 2.0	Low region specificity	Detected in all			Cell type enriched	Detected in single	12	naive CD4 T-cell: 2.9	Lineage enriched	Detected in single	29	T-cells: 2.9	Cell line enhanced	Detected in some		HaCaT: 1.6;RPTEC TERT1: 4.6;SH-SY5Y: 1.0;SuSa: 3.3	Low region specificity	Detected in all			Low region specificity	Detected in all																unprognostic (2.39e-2)			unprognostic (8.47e-2)	unprognostic (1.39e-1)	unprognostic (3.20e-1)		unprognostic (1.98e-1)	unprognostic (3.63e-1)	unprognostic (4.78e-1)	unprognostic (1.84e-1)	unprognostic (3.01e-1)	prognostic unfavorable (5.72e-4)	unprognostic (2.63e-2)	unprognostic (1.97e-1)			1.1	5.8	5.4	0.8	15.5	0.7	0.9	2.9	19.1	1.2	0.9	2.3	0	0.7	1	0.7	0.8	0.7	1.1	0.7	6.3	8.5	1.3	0.6	0.6	0.7	2	8.1	2.7	0.6	0.6	3	0.6	3.4	0.8	0.9	0	0.9	0.9	0.6	1	1.1	1.1	2.3	0.6	0.9	2.9	2	0	0.6	0	0.8	0.6	0.2	0	0	0	0	0	2.9	0.2	0	0	0.4	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	1.6	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0.6	0	0	0	0	0.5	0	0	0	0	0	4.6	0	0.1	1	0	0	0.1	3.3	0	0	0	0	0.7	0	0	0	0	0	0.1	0	0	0	0	0	0.2	0	0	0	0	0	0	0	2.9	0.1	0	0	0	0	0	0.2	5.4	15.5	2.9	12.7	6.3	8.5	2	8.1	3.4	2	0	0	0	0	0	0.5	0.6	0	0	0	0	0	0	0	0	11.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	1.4	0	0	0	0	0	Early spermatids
SH3RF2	FLJ23654, Hepp1, POSHER, PPP1R39, RNF158	ENSG00000156463	SH3 domain containing ring finger 2	Q8TEC5	5	145936579-146081791	Enzymes, Predicted intracellular proteins	Ubl conjugation pathway	Protein phosphatase inhibitor, Transferase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		gallbladder: 40.8	Cell type enriched	Detected in many	5	Late spermatids: 7204.3	Low cancer specificity	Detected in many			Group enriched	Detected in many	6	basal ganglia: 11.5;cerebral cortex: 2.9	Low cell type specificity	Detected in some			Group enriched	Detected in many	4	dendritic cells: 1.4;T-cells: 1.6	Cell line enhanced	Detected in many		CACO-2: 34.6;GAMG: 15.3;hTERT-RPE1: 17.2	Region enriched	Detected in single	14	basal ganglia: 23.9	Region enhanced	Detected in some		basal ganglia: 14.5	HPA035903, HPA058119	Uncertain		Enhanced	Nucleoplasm			Yes			Nucleoplasm		HPA035903: AB_10696515, HPA058119: AB_2683611	unprognostic (8.90e-3)	unprognostic (2.00e-3)	unprognostic (5.11e-3)	unprognostic (1.66e-2)	unprognostic (1.45e-3)	unprognostic (1.47e-2)	unprognostic (9.96e-3)	unprognostic (8.22e-2)	unprognostic (3.92e-1)	unprognostic (7.37e-3)	unprognostic (2.44e-3)	unprognostic (1.66e-1)	unprognostic (2.98e-2)	unprognostic (5.21e-2)	unprognostic (1.46e-1)	unprognostic (2.64e-2)	unprognostic (4.13e-3)	2.6	0.6	1.2	6.2	11.5	0	2.9	0.2	2.9	6.4	19.1	0.4	0.4	9.2	2.9	2.2	22.2	3.6	40.8	23.5	0.8	0.3	0.8	4.6	1.9	0	0.3	1.1	1	14.3	0	3.3	0.3	0.1	2.2	8.5	0.9	16.9	1	21.7	33.1	21.4	1.2	0.5	0.2	11.9	6.4	0.6	0.6	3.8	19.6	16.1	0.9	10	0	1.4	0.3	0.1	0	1.6	0.3	10.2	2.8	0.1	0.6	0	0	0	0.1	0.8	2.1	0.8	34.6	9.5	0	5.4	0.4	15.3	9.5	0	11.2	2	0.1	0.1	0	4.1	4.6	0.6	0	0	0.1	6	3.2	7.6	17.2	0.1	0.2	0	0	0.9	0	0	0	0.8	8.5	0.7	0	0.1	0	4.4	1	0	0	0.6	0.2	0.2	0.5	3.3	0	4.9	0.4	8.9	0.7	3.3	0	0	0	5.5	0	0	0.3	0	0	1.2	0	0	0	1.6	0.7	1.4	0	0	1.5	0.2	0	0.1	0	0.8	0.3	1.2	11.5	0.2	2.9	0.8	0.3	0.3	1.1	0.1	0.6	14.9	2.9	0	4.5	48.9	0.6	414.9	2.5	2.7	2.3	1.8	0	0	0	6.5	1412.5	1.5	27.7	0	7.6	0	0.5	1.3	1.1	8.3	0.2	0	1.2	0.6	0	7204.3	23.9	0	8.5	1	12.2	1.9	13.6	17.5	32.5	0.6	0	12.9	1.4	32	16.2	43.7	0	0	27.1	6.4	Late spermatids
FBXO43	Fbx43	ENSG00000156509	F-box protein 43	Q4G163	8	100133360-100145800	Predicted intracellular proteins	Meiosis, Ubl conjugation pathway			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	11	lymphoid tissue: 17.1;testis: 12.4	Cell type enriched	Detected in some	5	Spermatocytes: 39.9	Low cancer specificity	Detected in single			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in many		HBF TERT88: 4.8;Karpas-707: 5.4;NB-4: 4.5	Not detected	Not detected			Low region specificity	Detected in all			HPA024292, HPA024295, HPA024824	Uncertain											HPA024292: AB_1848462, HPA024295: AB_1848463, HPA024824: AB_1848464	unprognostic (4.94e-2)	unprognostic (4.35e-2)	unprognostic (2.09e-2)	unprognostic (4.34e-2)	unprognostic (5.06e-2)	unprognostic (3.51e-2)	unprognostic (1.07e-5)	unprognostic (4.31e-2)	unprognostic (1.63e-2)	unprognostic (1.36e-1)	unprognostic (4.84e-2)	unprognostic (1.46e-1)	unprognostic (0.00e+0)	unprognostic (7.97e-2)	unprognostic (2.52e-2)	unprognostic (5.91e-2)	unprognostic (8.09e-2)	0.1	0.1	0.3	4.9	0.2	0.4	1.3	0.1	0.1	0.2	0.1	0.2	0	0	0.2	0.6	0.3	0.2	0	0.7	0.3	0.2	0.1	0.2	0.4	0.7	0.2	0	0.2	0.2	0	0.1	0	0.6	0.2	0.1	0	0.7	0.2	0	0.3	0.2	0.3	0.8	0.5	0.2	12.4	0.1	17.1	0.1	0	1.2	0.1	0.1	0	0	0	0	0	0.4	0	0	2.7	1.2	3.9	0	0.4	0	0	1.9	3.4	4.3	0	0.3	1.8	0.1	0.5	0.6	0	0	0	4.8	3.9	0	1.1	0.5	0.4	0	0.5	0.7	0	0.2	1.7	1.5	0	0.9	1.5	0	5.4	1.7	0	0.6	4.5	0.3	0.5	0.7	3.7	0	0.7	1.7	0	0.5	0	0	0	1.7	0.2	0.1	0.9	0	0	0	0.7	0	0.8	1	1.4	1.4	3.9	1.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0.3	0.2	0.1	0.1	0.3	0.2	0.2	0	0.6	0.1	3	2.6	0	0.5	0.8	1.3	0.3	0	1.4	5.7	0	0	0.3	0	0	8.8	0.1	0	0	0.3	0.2	0.9	0.2	1.1	0	0.4	0	1.2	0	0.8	5.6	0	0.5	0	0	0	0.3	0.1	0	0.4	0	0.7	0	0.3	39.9	4.4	0.4	0.2	1	0.1	0.1	Spermatocytes
LRFN2	FIGLER2, KIAA1246, SALM1	ENSG00000156564	Leucine rich repeat and fibronectin type III domain containing 2	Q9ULH4	6	40391586-40587465	Predicted membrane proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	7	brain: 21.7	Cell type enriched	Detected in some	5	Cone photoreceptor cells: 58.9	Not detected	Not detected			Low region specificity	Detected in many			Cell type enhanced	Detected in some		gdT-cell: 1.8;plasmacytoid DC: 1.3	Group enriched	Detected in many	4	dendritic cells: 1.3;T-cells: 1.8	Group enriched	Detected in some	5	REH: 3.5;SH-SY5Y: 10.2	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA076660	Enhanced		Supported	Vesicles						Vesicles		HPA076660: AB_2686812	unprognostic (1.93e-2)	unprognostic (2.04e-1)	unprognostic (3.61e-2)	unprognostic (4.58e-4)	unprognostic (3.10e-1)	unprognostic (1.21e-1)	unprognostic (2.69e-1)	unprognostic (5.75e-3)	unprognostic (4.94e-2)	unprognostic (1.80e-1)	unprognostic (9.05e-2)	unprognostic (1.35e-1)	unprognostic (1.51e-1)	unprognostic (1.64e-1)	unprognostic (2.98e-1)	unprognostic (1.16e-1)	unprognostic (2.66e-4)	0.5	1.4	5.9	0.5	7.6	1.3	0.6	4.5	21.7	0.5	0.8	0	0	0.5	0.6	0.4	1.8	0.6	0.6	0.4	5	5.2	0.5	0.4	0.4	0.5	2.3	7.4	2.1	0.7	0.4	0.6	0.5	0.9	0.5	0.7	2.7	0.4	0.4	0.4	0.5	0.5	0.5	0.8	3.1	0.7	2.5	0.5	0	0.7	0	0.6	0.5	0.2	0	1.3	0	0	0.3	1.8	0.2	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0.6	0.2	0	3.5	0	0	0	0.3	1.4	10.2	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	1.8	0	0	0	0.3	0	0	0	1	0.4	0	0.3	0	1.3	0	0.2	5.9	7.6	4.5	21.7	5	5.2	2.3	7.4	0.9	0.5	0	0	0	0	0	11.6	0.6	0	0	0	0	58.9	0.2	0	0	0.7	0	0	0	0.2	0	0	0	0	0	0	0	4.1	0	0	0.9	0.3	0	0	0	0.5	0.8	0	0	0	0	9.1	0	0	0.7	0	0	0.2	0	0	0	Cone photoreceptor cells
COX6A2		ENSG00000156885	Cytochrome c oxidase subunit 6A2	Q02221	16	31427731-31428428	Predicted intracellular proteins, Transporters		Oxidoreductase		Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	28	heart muscle: 398.6;skeletal muscle: 421.1;tongue: 230.8	Cell type enriched	Detected in some	64	Cardiomyocytes: 3924.5	Group enriched	Detected in many	5	head and neck cancer: 9.3;liver cancer: 2.9;prostate cancer: 3.6	Not detected	Not detected			Cell type enriched	Detected in single	125	NK-cell: 12.5	Lineage enriched	Detected in single	125	NK-cells: 12.5	Cell line enriched	Detected in some	4	U-266/84: 14.6	Low region specificity	Detected in many			Low region specificity	Detected in all																unprognostic (1.66e-1)	unprognostic (1.73e-3)			unprognostic (2.09e-2)	unprognostic (1.25e-2)	unprognostic (1.68e-2)		unprognostic (3.88e-1)	unprognostic (5.61e-2)	unprognostic (7.20e-2)	unprognostic (8.71e-2)	unprognostic (6.20e-2)	unprognostic (1.68e-1)	unprognostic (2.65e-1)			3	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0	0	0.2	0.1	9.3	5.6	0.1	0.1	398.6	0.1	0.3	0.2	0.9	0.1	0.1	0.2	0	0.1	0.2	0.2	0.8	0.1	0	2.3	0.1	0.9	8.4	0.1	421.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0	0	5.5	230.8	11.4	0.1	0.1	0	0	0	0	12.5	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	1.5	0	0	0	0	0	0	0	0.2	0	0	0	14.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	12.5	0	0	0	0.2	0.1	0.1	0.1	0.1	0.1	0.3	0.2	0	0	0	0	0	0	0.1	0	0.6	3924.5	0	0	0	3.5	0	0	5	0	0	0	0	0	0.3	0	0	0.1	0	61.4	2.1	3.2	0	0.6	2.1	0.8	0.3	0	0	0	0	0.8	0.5	0	0.7	20.3	3.9	19.4	0	0.2	0.6	0	0	0	0	0	Cardiomyocytes
ADGRG4	GPR112, PGR17, RP1-299I16	ENSG00000156920	Adhesion G protein-coupled receptor G4	Q8IZF6	X	136300963-136416888	G-protein coupled receptors, Plasma proteins, Predicted membrane proteins		G-protein coupled receptor, Receptor, Transducer		Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enriched	Detected in some	21	intestine: 23.6	Cell type enriched	Detected in some	10	Horizontal cells: 39.7	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in single		TIME: 3.3									HPA035324	Uncertain											HPA035324: AB_10671512											unprognostic (3.40e-3)		unprognostic (7.68e-5)	unprognostic (7.61e-2)				0.4	0.1	0	0	0	0	0.3	0	0	0	12.9	0	0	7.1	0.7	1.1	0	0.9	0	0.1	0	0	0	0	0.2	0	0	0	1.1	0	0	0	0	0	0.1	0	0.5	0	0.1	0.1	0	23.6	0	0	0	0.4	0.2	0	0	0	0	0	0.8	0.6	0	0.1	0	0	0.1	0.2	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0.1	0	0	0	0	0	0	0.1	0	0	0	0	0	0.2	0	0	0	0.1	0	0	0	0	0	0	3.3	0	0.8	0	0.1	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0.1	0	0	0	0	0	0.1	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	39.7	0	0	0	0	4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Horizontal cells
SST	SMST	ENSG00000157005	Somatostatin	P61278	3	187668906-187670399	Cancer-related genes, Plasma proteins, Predicted secreted proteins		Hormone	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	5	brain: 102.8;intestine: 105.2;pancreas: 105.6;stomach 1: 90.4	Cell type enriched	Detected in some	213	Intestinal endocrine cells: 1353.8	Group enriched	Detected in many	7	ovarian cancer: 249.9;pancreatic cancer: 1039.3	Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		EFO-21: 15.6;U-2 OS: 29.0;U-251 MG: 4.8;U-698: 6.1	Low region specificity	Detected in many			Low region specificity	Detected in all			CAB000075, HPA019472, CAB034105	Enhanced	Supported			Secreted to blood							CAB000075: AB_2688022, CAB034105: AB_2271061, HPA019472: AB_1857360		unprognostic (2.44e-1)	unprognostic (2.05e-1)	prognostic unfavorable (1.93e-5)	unprognostic (5.12e-3)	unprognostic (1.54e-2)			unprognostic (4.69e-1)	unprognostic (3.31e-2)	unprognostic (8.16e-3)	unprognostic (1.63e-1)	unprognostic (1.07e-3)	unprognostic (8.47e-2)	unprognostic (4.19e-1)	unprognostic (3.27e-1)	unprognostic (1.45e-1)	2	13	28.6	1.9	53.8	1.7	0.7	0.1	47.9	0.7	45.1	1.8	21.9	105.2	0.9	0.7	1.1	0.7	1	0.9	17.5	102.8	2.5	0.7	0.7	1	6.2	15.4	0.8	105.6	0.7	1.5	0.7	16.1	1.5	7.4	0.4	0.7	7.5	0.7	3.1	36.1	1.4	18.4	0.7	90.4	0.7	8.6	0	0.9	0	0.7	4.6	0.2	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0.5	0	0	0	0	0	0	0	15.6	0	0	0	0	0	0	1.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	1.1	0	0	0.2	0.3	0	0	0	1.5	0	0.1	0	0	29	0.3	4.8	0	1.7	6.1	0.1	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	28.6	53.8	0.1	47.9	17.5	102.8	6.2	15.4	16.1	8.6	0	0	0	0	0	0	0	0	0	0	5.2	0	0	0	0	0.2	0	2.4	0	0	0.1	0	0	0	0	0.2	0	1353.8	0	0	0	0	0	0	6.4	6.1	0	0	0	0	0	0	0	0	0	0	0	0.1	0	2.2	0	Intestinal endocrine cells
C8A		ENSG00000157131	Complement C8 alpha chain	P07357	1	56854806-56918221	Disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters	Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Innate immunity			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	305	liver: 210.3	Cell type enriched	Detected in some	11	Hepatocytes: 254.8	Cancer enriched	Detected in single	279	liver cancer: 85.3	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	5	Hep G2: 5.5	Low region specificity	Detected in single			Not detected	Not detected								Secreted to blood				3400000000										unprognostic (3.73e-3)	unprognostic (2.44e-1)			unprognostic (1.28e-1)			unprognostic (6.40e-2)		unprognostic (9.82e-2)		0	0	0	0	0	0	0	0	0	0	0.1	0	0	0.1	0	0.1	0	0	0.6	0	0	0	0	210.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0.5	0	0	0	0	0	0	0	0	0	0	0.1	0	0.2	0	0	0	0.3	0	0	0	0	0	0.1	0	5.5	0	1.1	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0.2	0	0	0	1.1	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0.4	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	5.1	0	0	0	0	0	0	0.1	0	0	0	23.3	4.3	0	0	0	0	254.8	0	0	0	6.2	6	0	0	0	0	0	0	0	1.8	0	0	0.2	0	0	0	0	0	0	0	0	0	0	Hepatocytes
STEAP2	IPCA-1, PCANAP1, STAMP1, STMP	ENSG00000157214	STEAP2 metalloreductase	Q8NFT2	7	90167590-90238137	Predicted intracellular proteins, Predicted membrane proteins, Transporters	Electron transport, Ion transport, Iron transport, Transport	Oxidoreductase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in all	5	prostate: 100.2	Cell type enriched	Detected in many	4	Glandular cells: 110.4	Cancer enriched	Detected in many	12	prostate cancer: 88.1	Low region specificity	Detected in all			Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		A549: 13.4;CAPAN-2: 28.9;U-138 MG: 16.8	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA029115, HPA055603	Uncertain		Supported	Vesicles						Vesicles		HPA029115: AB_10603894, HPA055603: 	unprognostic (6.26e-3)	unprognostic (2.48e-1)	unprognostic (2.55e-1)	unprognostic (1.65e-1)	unprognostic (8.20e-4)	unprognostic (2.34e-1)	unprognostic (1.13e-1)	unprognostic (3.67e-3)	unprognostic (7.91e-2)	unprognostic (1.70e-1)	unprognostic (9.92e-2)	unprognostic (1.34e-1)	unprognostic (2.71e-2)	unprognostic (9.73e-2)	unprognostic (6.11e-2)	unprognostic (9.86e-5)	unprognostic (3.69e-2)	10.7	4.1	6.2	9.7	14.5	1.3	13.6	8.7	18.2	7	8.3	2.3	2.2	5.7	5.4	3.6	9.1	7.5	8.8	9.4	5.1	5.2	6.5	3.6	10.8	1.6	3.2	11.1	19.5	6.4	10.3	17.6	1.4	6	100.2	7	3.8	6.8	6.7	2.3	3.5	5.9	9	2.9	3	9.2	2.3	1.6	1.6	5.8	1.2	2.5	10.4	19.9	1.1	0.4	1.3	0.4	0.3	0.2	0	1.8	13.4	0.3	3.8	7.2	7	0.2	1.6	3.5	0.2	0.5	2.5	28.9	0	0.2	4.4	5.4	1.1	2.9	2.1	0.5	0	2.9	0	0	0.7	0.6	0	0	5.1	0.4	7	1.4	5.8	3.6	0	0	0.2	4	0	0	0.4	5.5	0	1.5	0	0	0.1	6.3	3.9	0.3	1.3	2.1	0	0.1	0.6	10.2	0	3	16.8	3.8	2.3	1.4	0	0	0	7.3	0	0.7	1.3	0.4	0.5	0.2	0.2	0.1	1.1	0.1	0.1	0	0.4	0.2	0.2	1.2	0.3	0.2	0.4	0	0	6.2	14.5	8.7	18.2	5.1	5.2	3.2	11.1	6	1.6	0	0.6	0	20.8	4.2	5.1	11.6	17.8	16	13.6	12.2	2	0	0	0.6	0.4	1.8	11.8	0	6.6	0	17.5	110.4	0	4.9	0	1.6	15.1	2.5	0	0.4	14.4	1.7	0	0	12.5	26.2	8.6	25.8	14.5	8.6	1.2	0	6.2	1	3.4	4.6	0	0	12.7	19.6	Glandular cells
CLDN12		ENSG00000157224	Claudin 12	P56749	7	90383721-90513402	Predicted membrane proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Low tissue specificity	Detected in all			Cell type enriched	Detected in many	5	Early spermatids: 274.0	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Low cell line specificity	Detected in many			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA026945	Approved											HPA026945: AB_10603786	unprognostic (1.45e-2)	prognostic unfavorable (6.36e-4)	unprognostic (3.84e-2)	unprognostic (4.87e-2)	unprognostic (7.28e-2)	unprognostic (1.86e-2)	unprognostic (6.47e-2)	unprognostic (3.41e-2)	unprognostic (3.67e-1)	unprognostic (9.06e-2)	unprognostic (1.67e-2)	unprognostic (1.07e-1)	unprognostic (2.19e-2)	unprognostic (7.66e-2)	unprognostic (2.37e-1)	unprognostic (9.49e-2)	unprognostic (1.30e-1)	7.3	18.2	10.4	5.5	22.5	2.3	17.1	20.5	21.5	11.9	17.2	7.3	9.8	14.9	15	16.5	11.6	13	15.2	17.2	9.5	13.7	19.7	40.4	9.7	1.5	9.2	12.4	18.4	16.7	16.2	42.4	8.2	14.5	20.1	19.5	19.1	19.3	11.2	15.7	6.7	22.6	11.6	12.3	4.3	16.9	10.4	8	3.3	14	9.4	7	12.1	10.1	1.1	3.6	0	0.9	0	2.4	0.9	10.9	9.8	11.8	8	13.3	10.9	6.5	14	15.2	9.5	15.9	9.8	28.8	1.8	11.2	8.3	20.9	9.7	10.9	12.7	18.9	2.5	9.8	1.1	8.6	10.2	12.4	2.2	1.2	13	13.6	15.9	26	17	4.7	2.2	6.6	6.6	14	5.3	2.9	5.1	19.9	14	6.8	1.4	17.1	2.7	13.9	7.3	9.7	17.7	7.7	6.9	22.2	20.4	8.1	7	12.4	22.7	13.6	16.6	14.5	3.5	3.3	0.2	15.6	1.6	10.6	0	0.7	0	1.4	0.9	1.4	1.1	2.4	0.5	3.6	0.6	1	1.2	0	0	0.1	1.1	1.7	0.9	10.4	22.5	20.5	21.5	9.5	13.7	9.2	12.4	14.5	8	29.8	6.4	1.5	13.4	8.8	34	12.1	28.1	14.7	9.1	17.4	19.6	6.9	6.6	16.9	274	3.8	15.1	0	35.2	7.5	12.4	40.7	0	44.8	6	19.1	16	9.8	1	13	9.8	3.4	18.6	4.6	12.7	52.7	27.4	10.7	9.9	23.8	19.9	12.9	11.4	16.8	5.5	9.5	4.2	0	14	22.9	Early spermatids
CLEC18A	MRCL	ENSG00000157322	C-type lectin domain family 18 member A	A5D8T8	16	69950705-69964452	Predicted intracellular proteins, Predicted secreted proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in some	6	kidney: 19.6	Cell type enriched	Detected in some	18	Proximal tubular cells: 57.3	Cancer enriched	Detected in single	7	renal cancer: 1.5					Cell type enhanced	Detected in single		neutrophil: 1.6	Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		AF22: 2.8;BEWO: 3.6									HPA048976	Uncertain				Secreted to blood							HPA048976: AB_2680582	unprognostic (1.68e-1)	unprognostic (3.06e-2)	unprognostic (1.19e-2)	unprognostic (1.48e-1)	unprognostic (3.14e-2)	unprognostic (4.62e-2)	unprognostic (1.36e-1)	unprognostic (4.14e-2)	unprognostic (1.04e-1)	unprognostic (4.40e-2)	unprognostic (6.77e-4)	unprognostic (6.73e-2)	unprognostic (4.58e-2)	unprognostic (2.06e-1)	unprognostic (9.03e-4)	unprognostic (1.52e-1)	unprognostic (2.53e-2)	0.1	1.3	0.3	0	0.8	0.3	0.1	0.1	0.1	0.1	0.2			0	0	0	0.1	0.3	0.1	0.1	0.3	0.5	19.6	0.1	0.1	0.1	0.3		0.1	0.3	0	0.1	0		0.1	0.1		0.7	0.1	0	0.1	0.5	0	1	0.7	0.5	3.4			0.1		0.1	0.4	0	0.9	0.3	1.6	0	0.5	0.1	0	0.3	0.3	2.8	0.2	0	0.8	3.6	0	0	0.6	0.2	0.6	0.1	0.5	0.3	0	0.5	0	0	0.4	0.3	0.6	0.9	0	0	1.5	0	0.7	1.8	0	1.4	1.4	0	0.9	0	0	0	0.5	0	0	0	0.1	0.7	0.1	0	0.2	0.4	0	0	1	1.6	0.1	0.8	0	0.1	0.5	0.7	1.6	0	0.7	1.9	0.2	0	0.7	0.8	0	0.6	0	1.1	0	0	0	0	0	0.1	0	0	0	0.3	0.9	0	0	1.6	0.5	0	0	0	0											0	1.4	0.5	0	0.1	1.2	0.4	0	0	0	0	2	0.1	1.7	0.2	0.2	0.2	1.1	0	0.2	0	0.1	0.3	0	0	0.3	3.2	0	1.3	0	0.6	0.3	0.1	0	0	0.9	1.5	0.5	0	0	57.3	1.1	0	0.2	0.5	0.1	0	0.2	0	1.6	0.1	Proximal tubular cells
CLEC18C	MGC34761, MRCL3	ENSG00000157335	C-type lectin domain family 18 member C	Q8NCF0	16	70173322-70187361	Predicted secreted proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Group enriched	Detected in some	13	kidney: 16.5;testis: 4.6	Cell type enriched	Detected in single	48	Proximal tubular cells: 18.8	Cancer enriched	Detected in single	9	renal cancer: 1.4	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		CACO-2: 1.0;RT4: 1.3;TIME: 3.0									HPA048976	Uncertain				Secreted to blood							HPA048976: AB_2680582		unprognostic (3.90e-1)		unprognostic (3.03e-1)	unprognostic (1.20e-4)					unprognostic (5.55e-2)	unprognostic (5.72e-3)	unprognostic (2.92e-1)	unprognostic (7.64e-2)	unprognostic (3.79e-2)	unprognostic (3.61e-3)		unprognostic (6.98e-2)	0.1	0	0.1	0.1	0.1	0	0.1	0.5	0.1	0.1	0.1	0.1	0.1	0.4	0.1	0.1	0.1	0	0.1	0.1	0.1	0	16.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	4.6	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0.8	0	0.2	0	0.8	0	0	0	0	0.3	0.6	0	0	0.2	1	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0.4	0	0.3	0.3	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0.5	0.6	0	0	0.6	0.3	1.3	0.5	0.2	0	0	0	0.3	0	0.6	3	0	0.1	0	0.2	0.4	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.8	0	0	0	0.2	0.1	0.1	0.5	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.8	0	0	0	0.1	0	0	0	0	0	0	Proximal tubular cells
KCNJ6	BIR1, GIRK2, hiGIRK2, KATP2, KCNJ7, Kir3.2	ENSG00000157542	Potassium voltage-gated channel subfamily J member 6	P48051	21	37607376-38121345	Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels	Ion transport, Potassium transport, Transport	Ion channel, Voltage-gated channel	Congenital generalized lipodystrophy, Disease mutation, Mental retardation	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 24.0;pituitary gland: 12.2	Cell type enriched	Detected in some	6	Horizontal cells: 232.0	Not detected	Not detected			Low region specificity	Detected in many			Group enriched	Detected in some	9	basophil: 4.2;eosinophil: 3.6;neutrophil: 2.0	Lineage enriched	Detected in single	12	granulocytes: 4.2	Cell line enriched	Detected in some	7	LHCN-M2: 25.6	Low region specificity	Detected in many			Low region specificity	Detected in all																unprognostic (1.43e-1)	unprognostic (1.96e-1)	unprognostic (7.71e-2)	unprognostic (1.26e-3)	unprognostic (6.75e-2)	unprognostic (3.59e-1)	unprognostic (1.33e-1)	unprognostic (1.25e-1)	unprognostic (3.68e-1)	unprognostic (8.76e-2)	unprognostic (1.64e-2)	unprognostic (3.49e-1)	unprognostic (1.96e-10)	unprognostic (2.42e-1)	unprognostic (1.46e-1)	unprognostic (9.87e-2)	unprognostic (1.21e-1)	2	1.2	7.7	0.9	8.4	1	1.1	24	15.6	0.9	1.4	0.8	0	1.1	1.4	0.6	0.7	0.7	0.8	1.2	14.6	1.1	1.2	0.9	1	1.4	1.3	10.8	0.8	2.7	0.7	12.2	7.4	13.5	1.5	0.9	0	0.8	0.6	2.2	1.1	1.1	0.5	1.5	1.6	2.7	2	0.4	0	0.8	0	0.6	0.8	0.8	0.3	0.3	4.2	0.3	0.3	0.2	0	0	0	0.6	0.3	0	0.2	1.6	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0.5	0.2	0	0	0	0.1	0.2	0	0.8	1.4	0	0	0	2.9	0.1	25.6	0.1	0	0	0.3	0	2.5	0	0.1	0.8	3.6	0	1.5	0	0	0	0	0.1	0	0	3.8	0.3	0	0.1	0.2	3.8	1	0	0	0	0	4.2	0.3	3.6	0.2	0.1	0.1	0.2	0.1	0.1	0	0.3	0.1	0.2	2	0.3	0.2	0.3	0.1	0	7.7	8.4	24	15.6	14.6	1.1	1.3	10.8	13.5	0.4	0	0.6	0	0.4	0.1	31.8	21.5	0	0	0	0	0	0.1	0	0	0.1	0	0	0	0	0.3	0.2	0.4	0	0	0	232	39.7	0	0	0	0.6	0	3.3	0	0	0.9	1	0	0	0	2.3	0	0	0	1.1	0.1	0.2	0	0.1	0.3	Horizontal cells
SNX22	FLJ13952	ENSG00000157734	Sorting nexin 22	Q96L94	15	64151715-64157481	Predicted intracellular proteins	Protein transport, Transport			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in many		brain: 23.2;thyroid gland: 41.1	Cell type enriched	Detected in many	5	Erythroid cells: 140.2	Cancer enriched	Detected in many	7	thyroid cancer: 47.7	Low region specificity	Detected in all			Group enriched	Detected in some	7	memory B-cell: 6.6;naive B-cell: 11.5	Lineage enriched	Detected in many	9	B-cells: 11.5	Cell line enriched	Detected in some	4	Daudi: 19.9	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA038470			Approved	Nucleoplasm,Vesicles						Vesicles	Nucleoplasm	HPA038470: AB_10673174	prognostic favorable (2.89e-5)	unprognostic (8.93e-3)	unprognostic (2.89e-1)	unprognostic (3.55e-2)	unprognostic (3.24e-1)	unprognostic (5.38e-3)	unprognostic (2.29e-1)	unprognostic (3.05e-2)	unprognostic (1.94e-1)	unprognostic (5.29e-2)	unprognostic (2.28e-3)	unprognostic (1.09e-1)	unprognostic (1.27e-4)	unprognostic (3.92e-1)	unprognostic (2.52e-1)	prognostic favorable (2.19e-4)	unprognostic (1.74e-2)	1.1	1.5	11.9	7.6	8.9	10.2	1.2	3.4	16.5	0.7	1.1	23.2	11.8	1.5	1.2	3.5	0.9	0.8	1.3	7.9	13.4	9	1.1	1.9	4.7	11.4	13.7	8.1	1.3	1.6	0.4	2.2	1	12.3	3	0.7	0	3.6	8.4	0.7	2	2.2	0.9	17	6.1	2.1	1	6.6	1.6	41.1	0	13.3	2.1	0.3	11.5	1.2	0	0.2	0.1	0.1	1.6	0.2	0.4	0.9	0.8	0.1	0	0.7	0.8	0	0	0.2	0.4	0.9	19.9	0.5	0.1	0.5	0.4	1.7	0	0	0.1	2.4	0.4	2.2	2.5	0	0.4	0.4	0	0	0	0	0.7	0	2.5	0.6	3.3	0	1.2	0.2	0	1.4	0.5	0.3	4.1	0.3	1.2	0.8	0.8	4.6	0.9	0.2	0.7	0	0.8	2	0	0	1.1	1.4	0.3	0.5	4.3	1.8	4.3	0.5	0.1	0	0	0	0	0	0	0	6.6	0	0	1.2	11.5	0	0	0	0.1	0.2	0	0.1	1.6	11.9	8.9	3.4	9.3	13.4	9	13.7	8.1	12.3	6.6	26.8	9.1	15.2	1.7	1.3	0.8	14.2	0	0	1.2	0	3.9	2.7	0	0.4	1.1	0.7	0.7	140.2	3.2	6.1	3.6	3.9	2.3	3.4	4	0	0	2.5	2.2	1.7	0.6	2.7	3.3	1.8	0.8	0.5	1.8	0	0.4	1.8	1.8	0	1	1.1	1.2	2.5	3.3	2.1	0.6	1.4	Erythroid cells
ACAN	AGC1, CSPG1, CSPGCP, MSK16	ENSG00000157766	Aggrecan		15	88803442-88875354	Predicted intracellular proteins, Predicted secreted proteins				Evidence at protein level	Evidence at protein level				Low tissue specificity	Detected in many			Cell type enriched	Detected in some	28	Extravillous trophoblasts: 120.0	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Cell type enhanced	Detected in single		basophil: 1.5	Low lineage specificity	Detected in single			Cell line enriched	Detected in some	5	WM-115: 22.9	Low region specificity	Detected in many			Not detected	Not detected			CAB016377, HPA038241, HPA038242	Enhanced				Secreted to extracellular matrix							CAB016377: AB_626650, HPA038241: AB_2675909, HPA038242: AB_2675910	unprognostic (2.69e-3)	unprognostic (4.09e-2)	unprognostic (2.52e-1)	unprognostic (1.82e-1)	unprognostic (4.43e-2)	unprognostic (2.13e-2)	unprognostic (1.40e-2)	unprognostic (1.15e-1)	unprognostic (7.12e-2)	unprognostic (8.57e-2)	unprognostic (2.34e-1)	unprognostic (2.38e-2)	prognostic unfavorable (1.47e-6)	unprognostic (7.79e-2)	unprognostic (1.53e-1)	unprognostic (7.71e-2)	unprognostic (7.27e-2)	5	1.2	2.7	3.2	4.6	0.8	0.9	0.6	6.6	9.2	1.6	3.4	0.1	0.9	5.3	3.9	1	1.4	3	6.5	2	6.2	6.3	0.8	4.2	0.8	2.5	0.9	2.2	1.2	0.6	2.1	1.9	3.7	2.4	1.7	1.1	1.1	11.2	1.8	1.5	0.8	2.1	5.7	1.3	1.2	4.9	2.3	0	1.9	1.8	0.6	5.9	4.4	0.2	0.3	1.5	0.4	0.5	0.3	0.1	0	0	0	0	0.9	0	4.7	0.3	0	0	0	0	0.1	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.8	0	0	0	0	0	0	0	0	0	0	0	0	1.7	0	0	0	0.2	3.5	0	0	0	0	0	0	0	22.9	1.5	0.2	0.2	0.3	0.4	0.2	0	0.1	0.2	0.1	0.2	0.2	0.2	0.6	0.5	0.1	0.3	0.2	0.1	2.7	4.6	0.6	6.6	2	6.2	2.5	0.9	3.7	2.3	0	0	0	0.4	0.3	0	1.9	0	0	0	0	0	0.5	0	0	0	0.4	0	0	0	120	0.8	0.2	1.1	0	2.3	0	0	0	0	1.9	0	0.1	1.7	0	0	0	0	0	0	0	0	0	4.3	0.3	2.8	0.4	3	0	0	0.3	Extravillous trophoblasts
CIB4		ENSG00000157884	Calcium and integrin binding family member 4	A0PJX0	2	26581202-26641368	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	6	testis: 22.5	Cell type enriched	Detected in some	7	Early spermatids: 115.3	Cancer enhanced	Detected in some		thyroid cancer: 0.9	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		CAPAN-2: 1.0;EFO-21: 1.6;SCLC-21H: 1.5	Not detected	Not detected			Low region specificity	Detected in all			HPA036130, HPA036131	Uncertain											HPA036130: AB_10670709, HPA036131: AB_2674959	unprognostic (3.63e-3)		unprognostic (1.78e-1)	unprognostic (2.61e-4)	unprognostic (1.63e-1)			unprognostic (1.66e-1)		unprognostic (1.27e-1)	unprognostic (4.29e-4)	unprognostic (1.57e-1)	unprognostic (3.19e-5)	unprognostic (1.20e-2)	unprognostic (3.63e-1)	unprognostic (1.76e-3)	unprognostic (3.50e-1)	0.1	1.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0	0.1	0.1	0.1	0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0	0.5	1.1	0.3	0.5	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	22.5	0.1	0.1	3.7	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	1	0	1.6	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.9	0.5	0	0	0	0	0	0	1.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.3	0.1	0	0	0	0	0	0	16.8	0	0	0	5.2	2	0	0	0	115.3	0	0	0	0.4	0	0	0	0	0	0.1	0	1.7	0	0	14.1	0.6	0	0	0	0	0	0.1	0	0.4	0	0.1	0	0	1.7	0.2	0	0.7	0	0	0	Early spermatids
TRIM63	IRF, MURF-1, RNF28, SMRZ	ENSG00000158022	Tripartite motif containing 63	Q969Q1	1	26051304-26068436	Enzymes, Predicted intracellular proteins	Ubl conjugation pathway	Muscle protein, Transferase		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	7	skeletal muscle: 271.4	Cell type enriched	Detected in some	11	Cardiomyocytes: 236.2	Cancer enriched	Detected in some	10	melanoma: 31.0	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	38	ASC diff: 10.7;SK-MEL-30: 34.3	Not detected	Not detected			Low region specificity	Detected in all																unprognostic (1.10e-1)	unprognostic (4.80e-4)	unprognostic (1.45e-2)	unprognostic (7.52e-3)	unprognostic (1.44e-1)	unprognostic (2.05e-2)	unprognostic (3.42e-1)	unprognostic (1.12e-1)	unprognostic (2.71e-1)	unprognostic (1.06e-1)	unprognostic (3.17e-1)	unprognostic (1.01e-1)	unprognostic (2.16e-2)	unprognostic (5.90e-2)	unprognostic (1.33e-2)	unprognostic (2.32e-1)	unprognostic (5.58e-2)	3.4	0	0	0	0.1	0	0.1	0	0	0.3	0	0	0	0	1	1.2	1.7	0	0.6	38.2	0	0	0.3	0	0.2	0	0	0	0	0.1	0	0	0.9	0.1	0.5	0	3.6	1	0	271.4	0.6	0.1	0.9	0.1	0	0.1	0.1	0	0	1.7	12.7	0.8	1.2	0.3	0	0.9	0	0	0	0	0.1	0	0	0	0	10.7	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0.2	0	0	0.6	0	0.1	0.3	0	0	0	0	0	0	0.4	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	34.3	0.1	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.9	0	0	0	0	0	0	0	0	0.1	0	0.1	0	0	0	0	0	0	0.1	0	0	1.1	0	0.1	0.8	0	236.2	10.2	0	0	1.8	0	0.4	1.7	0.7	0	0	0	0	0	0.1	0.3	0	9.3	0	0.5	0	0	0	0	0	0	0	11.8	0	0	0	0.2	0	0	21.6	0	0	0	0	0	0.1	1.4	0	0	0	Cardiomyocytes
WDR66	CaM-IP4, MGC33630	ENSG00000158023	WD repeat domain 66	Q8TBY9	12	121917862-122003927	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		fallopian tube: 24.6;pituitary gland: 28.4;testis: 35.0	Cell type enriched	Detected in many	5	Ciliated cells: 228.8	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Cell type enriched	Detected in single	10	plasmacytoid DC: 4.9	Lineage enriched	Detected in single	10	dendritic cells: 4.9	Cell line enhanced	Detected in some		HBEC3-KT: 21.9;hTCEpi: 20.7;hTERT-HME1: 14.0	Low region specificity	Detected in many			Low region specificity	Detected in many			HPA039902, HPA040005	Supported		Uncertain	Plasma membrane,Cytosol						Plasma membrane, Cytosol		HPA039902: AB_10795236, HPA040005: AB_10795160	unprognostic (4.92e-3)	unprognostic (9.05e-2)	unprognostic (7.99e-3)	prognostic favorable (3.11e-4)	unprognostic (5.58e-3)	unprognostic (6.89e-3)	unprognostic (1.44e-2)	unprognostic (2.45e-1)	unprognostic (2.89e-1)	unprognostic (2.34e-1)	unprognostic (7.72e-2)	unprognostic (1.55e-1)	unprognostic (2.43e-2)	unprognostic (4.29e-2)	unprognostic (1.37e-1)	unprognostic (1.79e-2)	unprognostic (1.35e-1)	1.3	1.2	6.3	1	13.2	0.4	1.7	0.4	4	4.4	0.5	4.5	1.5	0.4	2.5	11.3	0.5	24.6	2	1.5	6.4	3.7	3.2	1.8	6.4	0.9	0.7	3.2	3.9	2.1	4.7	28.4	1.3	18	0.8	0.4	1.3	1.3	2.2	0.5	1.8	0.5	1	0.9	2	0.8	35	2.4	0	6.7	0	1.2	0.8	1.7	0.2	4.9	0.4	0	0.1	0.3	0	1.8	0.2	0.3	0.1	0.3	0.3	0.3	0.2	1.7	0.8	2.1	0.2	0.9	0.1	2.5	0.1	0.5	0.6	0.2	21.9	3.1	0.1	0.3	0.1	0.4	0.2	2.6	0	6	1.2	20.7	1.7	14	0.4	0.9	0.3	5	0	1.3	0.6	0.2	0.4	0.3	0.3	0.1	0.3	0.5	0	3.8	0.3	1.7	0.1	0.2	0	0.1	0.6	0.5	0.1	0.7	1.8	2.7	0.3	0.3	0.3	0.1	2.6	2	0	0.4	0.4	0	0	0.1	0	0.1	0.1	0.2	0.2	0	0.2	0.1	0.1	0.4	0.1	0	4.9	0.3	0	6.3	13.2	0.4	4	6.4	3.7	0.7	3.2	18	2.4	6	10	1.5	5.9	5.5	5	2.2	5.1	228.8	36.4	10.4	29.5	0.2	3.3	3.1	38.6	1.3	0	0	0.4	0.1	1.9	1.9	8.1	0.8	0.5	7.9	1.7	28.3	2.2	49.3	6.9	1.8	1.7	1	0	1.8	0.7	0	7.1	1.1	16.8	6.5	1	34.9	14.4	3.1	0.5	0.8	0	2.2	Ciliated cells
DZIP1L	DZIP2, FLJ32844	ENSG00000158163	DAZ interacting zinc finger protein 1 like	Q8IYY4	3	138061990-138115818	Disease related genes, Predicted intracellular proteins			Ciliopathy, Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	5	Ciliated cells: 93.7	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Group enriched	Detected in some	13	classical monocyte: 1.8;eosinophil: 1.7;intermediate monocyte: 1.3;myeloid DC: 1.5	Group enriched	Detected in many	17	dendritic cells: 1.5;granulocytes: 1.7;monocytes: 1.8	Low cell line specificity	Detected in many			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA030404	Approved		Supported	Nucleoplasm,Microtubules,Cytokinetic bridge		Yes	No			Microtubules	Nucleoplasm, Cytokinetic bridge	HPA030404: AB_10601548	unprognostic (3.65e-2)	unprognostic (8.37e-2)	unprognostic (2.87e-2)	unprognostic (3.71e-2)	unprognostic (8.22e-2)	unprognostic (6.50e-2)	unprognostic (6.47e-4)	unprognostic (1.54e-1)	unprognostic (3.21e-2)	unprognostic (3.13e-1)	unprognostic (3.26e-1)	unprognostic (1.69e-1)	unprognostic (1.51e-2)	unprognostic (2.35e-3)	unprognostic (2.72e-1)	unprognostic (9.98e-2)	unprognostic (2.77e-2)	5.3	2	2.2	6.1	2.5	10.9	5.5	12.1	3.3	17.4	5.1	5.3	3.1	2.9	14.8	6.5	4.3	15.2	7.9	3.8	2.4	2.1	5.1	1.2	6.4	2	2.6	1.6	12.4	8.3	6.2	5.6	2.7	6.1	9.3	2.1	10.9	2.5	5	1.7	10.4	2.3	11.3	3.4	3.1	10	4.2	3.4	0.1	4.2	4.2	2.5	8	17.8	0	1.5	1.7	1.8	0	0	0.4	5.2	3.1	6.2	5.2	4	5.3	1.4	8.6	5.2	5.1	6.5	2.1	0.4	0	4.4	7.9	7.1	1.7	4.5	2	2.5	1.1	4.4	2.3	6.4	0.3	3.2	1.7	4	5.6	2.1	5.6	2.7	5.2	2.8	1.4	1.7	0	6.9	0.3	0	0.7	7.5	0	1.1	0	7.2	0	2.3	8.4	2.2	4.9	8.8	0	4.4	3.6	2.3	3.6	2.1	12.7	5.8	6.1	4.4	0	0	0.1	5	2.5	4.9	0	1.8	1.7	0	1.3	0	0	0	0	1.5	0	0	0	0.1	0	0	0	0	0.4	2.2	2.5	12.1	3.3	2.4	2.1	2.6	1.6	6.1	3.4	3	1.3	0	0.6	3.2	6.5	2.7	2.5	93.7	11.4	1.8	7.9	0	5	3.1	15.6	1.8	0	0	1.1	0.1	3.5	0.5	0	0	1.4	3.2	0	0	1	1	5.8	2.7	0	1	0	2.3	3.7	0	3.9	0.5	17.8	0	4.7	0.4	1.5	3.8	0	0	0	0.1	Ciliated cells
CPA2		ENSG00000158516	Carboxypeptidase A2	P48052	7	130266827-130289798	Enzymes, Predicted secreted proteins		Carboxypeptidase, Hydrolase, Metalloprotease, Protease		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	529	pancreas: 1357.9	Cell type enriched	Detected in some	6	Exocrine glandular cells: 4303.0	Cancer enriched	Detected in many	60	pancreatic cancer: 411.4	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		AN3-CA: 4.5;CACO-2: 7.5;RH-30: 6.2;SCLC-21H: 3.4	Low region specificity	Detected in some			Not detected	Not detected			HPA020342, HPA021317	Enhanced		Approved	Golgi apparatus	Secreted to digestive system				1500000	Golgi apparatus		HPA020342: AB_1846007, HPA021317: AB_1846008	unprognostic (1.12e-1)	unprognostic (3.97e-1)	unprognostic (4.21e-2)	unprognostic (1.82e-2)	unprognostic (1.38e-1)	unprognostic (6.76e-2)		unprognostic (4.65e-2)	unprognostic (1.08e-1)	unprognostic (1.40e-1)	unprognostic (1.84e-1)	unprognostic (2.66e-1)	unprognostic (3.84e-5)	unprognostic (7.52e-2)	unprognostic (1.42e-1)	unprognostic (7.12e-2)	unprognostic (8.48e-2)	0.1	0	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.4	0.1	0.1	0.3	0.1	0.1	0.1	0	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.4	1357.9	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	1	0.1	0.2	0.1	2.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0.2	0	0	0	0	0.1	0	0.9	4.5	0	0.1	0	0	0	0.7	0	7.5	0	0	1	0	0.6	0	1.4	0	0.1	1	0	0	0.8	0	0.1	0	0	0.1	0.1	0.1	0.2	0	0	0	0	0	0	0	0	0.3	0.9	0	0.4	0	6.2	0.1	0.1	0.7	3.4	0	0.2	0	2.1	0.3	0	0.2	0	0	1.1	0.8	0.6	0	0.7	0.2	0.8	0	0.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	0	0.1	0	0	0.2	0	0	0	0	0	0.3	1.7	6.6	3.8	0	0.8	0	4303	0	0.4	0	0	0	0.1	0	0	0	0	6.8	0.3	0	0	24.4	0	2.8	764.8	8.6	0	0	0.3	0	0	0.3	1.5	0.1	0.2	0	0.2	0.1	Exocrine glandular cells
PFKFB1	PFRX	ENSG00000158571	6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1	P16118	X	54932961-54998534	Enzymes, Predicted intracellular proteins		Hydrolase, Kinase, Multifunctional enzyme, Transferase		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		adipose tissue: 24.2;liver: 24.4;skeletal muscle: 48.3	Cell type enriched	Detected in some	10	Hepatocytes: 15.5	Cancer enriched	Detected in some	11	liver cancer: 7.9	Not detected	Not detected			Cell type enhanced	Detected in some		MAIT T-cell: 2.1	Low lineage specificity	Detected in many			Group enriched	Detected in some	4	ASC diff: 13.9;Hep G2: 5.5	Low region specificity	Detected in many			Low region specificity	Detected in all																unprognostic (2.51e-1)	unprognostic (2.39e-2)	unprognostic (1.17e-2)	unprognostic (4.38e-3)	unprognostic (1.64e-1)	unprognostic (6.12e-2)	unprognostic (1.18e-3)	unprognostic (1.51e-1)	unprognostic (2.50e-1)	unprognostic (3.33e-1)	unprognostic (3.26e-3)	unprognostic (2.88e-1)	unprognostic (5.36e-3)	unprognostic (5.06e-1)	unprognostic (4.87e-2)	unprognostic (1.16e-4)	unprognostic (1.96e-3)	24.2	0.2	0.1	1.6	0.1	0.1	13.1	0.1	0.2	0.1	1.7	0.1	0.1	0	0.1	0.2	0.5	0	0.1	0.1	0.1	0.1	0.4	24.4	0.1	1.6	0.1	0.1	0.1	0.6	0.2	0.2	0.1	0.1	0.3	0.2	0.1	1.3	0.1	48.3	0.3	0.2	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.5	8.3	0.6	0.2	2	1.5	0.1	0	0.7	1.3	2.1	0.3	0.3	0.2	0.4	0.6	13.9	0.3	1	0	0.1	0.2	0	0.9	0.2	0.6	0.3	0.1	0.6	0.5	0.1	0.3	0.5	0.4	1.1	0.4	0.1	5.5	0	0.1	0.6	0.2	0.6	0.1	0.4	0	0	1.3	0.1	2.2	0.2	0.7	0.6	0.3	0.4	0.4	0.3	0.5	0.2	0.2	0	0.4	0.4	0.3	0.5	1.6	0.2	1.2	0.4	0	0.2	0.1	0.5	0.4	0.2	1.1	1.7	0.4	0.2	0.4	0.1	0	0	0	0.2	0.7	2.1	1.5	0.2	0	0	0.8	0	0.8	0	1.3	0.1	0.1	0	0.3	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0.3	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0.2	0	0	0	15.5	0.1	0	0	0.6	1.6	0	0	0	0	0	0	0	0.1	0	0	0.2	0	0	0	0	0.2	0	0.1	0	0	0	Hepatocytes
ALAS2	ASB	ENSG00000158578	5'-aminolevulinate synthase 2	P22557	X	55009055-55031064	Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins	Heme biosynthesis	Acyltransferase, Transferase	Disease mutation	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	4	bone marrow: 130.9;placenta: 53.5	Cell type enriched	Detected in some	86	Erythroid cells: 1168.1	Low cancer specificity	Detected in single			Low region specificity	Detected in some			Cell type enriched	Detected in single	6	plasmacytoid DC: 2.0	Lineage enriched	Detected in single	6	dendritic cells: 2.0	Group enriched	Detected in some	87	HEL: 32.8;K-562: 36.8	Low region specificity	Detected in all			Low region specificity	Detected in some								Intracellular and membrane								unprognostic (7.82e-2)	unprognostic (2.01e-1)	unprognostic (6.41e-2)	unprognostic (1.14e-2)	unprognostic (2.98e-3)	unprognostic (5.59e-2)	unprognostic (1.37e-1)	unprognostic (1.47e-1)	unprognostic (8.68e-2)	unprognostic (4.07e-2)	unprognostic (2.72e-1)	unprognostic (3.45e-1)	unprognostic (2.32e-2)	unprognostic (6.63e-3)	unprognostic (4.39e-1)	unprognostic (1.23e-1)	unprognostic (1.89e-1)	1.7	0.4	0.8	0.4	0.8	130.9	0.5	0.2	0.5	0.3	0.4	0.5	0	0.4	0.3	0.3	2.3	1	0.5	2.9	0.7	0.7	1.6	2.4	17.3	0.3	1.3	0.7	6.1	2.3	0.3	1	53.5	2.3	2.6	0.3	1	0.5	0.3	3.7	0.4	0.4	1.1	0.9	22.3	0.3	0.5	0	0.4	3.2	0	0.3	7	6.5	0.3	2	0.3	0.1	0	0.3	10.7	0	0	0	0.3	0	0	0.2	0	0	0	0	0.1	0.1	0	0	0	0	0.2	0	0	0	0	0.2	32.8	0	0	0	0.1	0.1	0	0	0	0	0	0	0	36.8	0	0	0	0	0	0.1	0	0	0.2	0	0	0.1	0	0.2	0	0.1	0	0	0.2	0	0	0	0	0	0	0	0.2	0.1	0	0	0.1	0	0	0.1	0	0.1	0	0.3	0.3	0	0	0.1	0.1	0	0.2	0.3	0	0	2	0	10.7	0.8	0.8	0.2	0.5	0.7	0.7	1.3	0.7	2.3	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0.1	0	5.8	0	0	0	1168.1	0.2	0.6	0.2	0	0	0.8	1.9	0	1.7	0	1.3	0	0	0	13.5	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0.6	0	0	0	Erythroid cells
ITLN2	HL-2	ENSG00000158764	Intelectin 2	Q8WWU7	1	160945025-160954799	Predicted secreted proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	29	intestine: 88.4	Cell type enriched	Detected in some	9	Alveolar cells type 1: 71.5	Cancer enhanced	Detected in many		testis cancer: 4.2	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HEL: 15.4;HHSteC: 2.6;HMC-1: 4.6;SK-MEL-30: 4.9;SuSa: 5.4									HPA006683, HPA067326	Enhanced				Secreted to digestive system							HPA006683: AB_2129681, HPA067326: AB_2732764		unprognostic (1.42e-1)	unprognostic (9.62e-3)	unprognostic (4.61e-2)	unprognostic (7.45e-2)	unprognostic (2.25e-1)	unprognostic (6.84e-4)	unprognostic (2.47e-2)	unprognostic (5.74e-2)	unprognostic (1.31e-2)	unprognostic (1.36e-1)	unprognostic (5.01e-1)		unprognostic (1.84e-1)	unprognostic (1.49e-1)	unprognostic (2.31e-1)	unprognostic (4.91e-2)	3	0	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	27.4	0.1	0.1	53.3	0.1	0.1	0.1	0	0.1	0.2	0.1	0	0.1	0.1	2.5	0.1	0.1	0.1	0.6	0.1	0	0.1	0.1	0.1	0.2	0	0.1	0.1	0.1	0.1	0.1	88.4	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0	0.5	0	0	0	1.4	0	0	0	0	0.3	0	0	0	0	0	0.2	0	0	0	0	0	15.4	0	0	2.6	0	4.6	0	1.5	0	0	0	0	0	0	0	0	0	0	0.5	0.1	0.6	0	0	0	1.5	0	0	0	1	0	0	4.9	5.4	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	71.5	7.7	0	0.4	0	0	0	0	0	1.2	0	0	0	0	0	0	0	0	0	0.3	0.2	0	0.6	0	0	0.1	0	0	8	0	0	1.1	0	0	0	3.1	0	0	0	4.9	0	0	0	0	0	0.1	0	0	0	0.1	0.1	Alveolar cells type 1
ADAMTS4	ADAMTS-2, ADMP-1, KIAA0688	ENSG00000158859	ADAM metallopeptidase with thrombospondin type 1 motif 4	O75173	1	161184308-161199056	Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters		Hydrolase, Metalloprotease, Protease	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		adipose tissue: 58.0	Cell type enriched	Detected in many	7	Smooth muscle cells: 356.4	Low cancer specificity	Detected in all			Group enriched	Detected in all	5	basal ganglia: 20.7;cerebral cortex: 10.0;midbrain: 28.6;pons and medulla: 20.5;thalamus: 15.7	Cell type enriched	Detected in some	8	plasmacytoid DC: 8.0	Lineage enriched	Detected in many	8	dendritic cells: 8.0	Cell line enhanced	Detected in some		hTEC/SVTERT24-B: 10.9;HUVEC TERT2: 13.2;SH-SY5Y: 7.4;TIME: 11.1;U-138 MG: 6.9;U-251 MG: 9.8	Low region specificity	Detected in all			Low region specificity	Detected in many			CAB025876, HPA051296, HPA068374	Uncertain		Supported	Nuclear speckles	Secreted to extracellular matrix					Nuclear speckles		CAB025876: , HPA051296: AB_2681426, HPA068374: AB_2685978	unprognostic (2.70e-2)	unprognostic (8.10e-3)	unprognostic (3.00e-3)	unprognostic (2.75e-1)	unprognostic (9.95e-3)	unprognostic (1.19e-1)	unprognostic (1.07e-1)	prognostic unfavorable (5.00e-4)	unprognostic (1.20e-2)	unprognostic (9.59e-3)	unprognostic (2.48e-2)	unprognostic (1.59e-1)	prognostic unfavorable (7.27e-7)	unprognostic (1.10e-2)	unprognostic (1.04e-1)	unprognostic (1.44e-3)	unprognostic (3.13e-2)	58	9.7	2.6	18.1	20.7	1.8	14.6	1.5	10.7	7.8	6.3	33.4	0	1.9	5.8	2	7.7	14.2	16.4	19.5	3.4	2.3	3.1	11	15.7	2.7	28.6	3.5	35.7	10.6	4.7	4.9	4.4	20.5	5.8	3.4	0	1.7	1.7	7.7	1.7	3	12	15.5	1.9	8.1	1.7	15.7	0	7.5	1.2	1.4	8.7	4	0.5	8	1	0.2	0.4	0.6	0.2	0	0	0.2	0.1	6.1	3.9	0.6	4.9	0.2	0.4	2.8	0.2	0.1	0.2	4.1	1.5	0	0.1	0	0	1.7	0.1	0.3	0.1	0.4	1.2	0.6	0	0.1	4.3	0	10.9	0.1	0	13.2	0.1	0.1	0.3	0.3	0.1	0	0.2	4.9	0	0	0.1	4.8	0.1	0	0.1	0.1	7.4	0	0.1	0.1	0.3	0.2	0.5	11.1	6.9	0.1	0.3	9.8	0.2	0.1	0.1	2.1	0.1	0.1	0.7	0.2	0.2	0.6	0.1	0.3	0.3	0.3	0.3	0.1	0.5	0.4	0.4	1	0.4	0.1	8	0.3	0.2	2.6	20.7	1.5	10	3.4	2.3	28.6	3.5	20.5	15.7	0	5.5	0	2.3	27.7	2.2	2.8	0	0	1.2	0	0	0.2	0	0.3	0	43	0	0	0	0.2	33.3	8.7	0	0.8	0.8	3.2	0	48.5	1.5	0	0.3	6	33.7	1.8	0	0.3	0	0	1.1	0	1	51.8	356.4	2.3	0.6	16.7	0.3	1.5	0	4.4	Smooth muscle cells
APOA2		ENSG00000158874	Apolipoprotein A2	P02652	1	161222292-161223631	Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Host-virus interaction, Lipid transport, Transport		Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	321	liver: 932.2	Cell type enriched	Detected in some	61	Hepatocytes: 43650.4	Cancer enriched	Detected in many	329	liver cancer: 11230.1	Not detected	Not detected			Cell type enhanced	Detected in some		intermediate monocyte: 2.1;neutrophil: 2.9	Group enriched	Detected in many	20	dendritic cells: 1.0;granulocytes: 2.9;monocytes: 2.1	Cell line enriched	Detected in some	9	Hep G2: 610.7	Low region specificity	Detected in all			Not detected	Not detected			CAB025885, HPA072575	Supported				Secreted to blood			115000000000	210000000000			CAB025885: , HPA072575: 		unprognostic (2.05e-1)	unprognostic (4.70e-2)	unprognostic (1.12e-1)	unprognostic (2.99e-1)		unprognostic (9.82e-2)	unprognostic (1.92e-1)	unprognostic (3.16e-1)	unprognostic (2.79e-1)	unprognostic (1.57e-2)		unprognostic (4.40e-3)	unprognostic (3.16e-2)	unprognostic (2.22e-1)	unprognostic (1.60e-1)	unprognostic (6.09e-2)	0.1	0	0.1	0.1	0.1	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.2	0.1	0	0.1	0.1	0.1	0	0.2	932.2	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.2	0	0.1	0.1	0.1	0.3	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	1	2.9	2.1	0	0	0.1	0	0	0	0	0	0	0.8	0	0	0	0	67.2	0	0.1	0	0	0	0	0	0	0	0	0	0.2	0.3	610.7	0	0.6	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0.5	0	0	0.4	0	0	0.2	0	0	0.2	0	0	0.1	0	0	0	0	0.1	0	0.2	0	0.2	0	0	1.1	0	0	2.1	0	0	0	0	1	0	0	0	2.9	0	0.8	0.7	0	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	153.8	0	0	0	0	647.1	0	0	0	0	0.5	1.7	0	1.2	0	0	186.9	0.5	1.1	0	0	0	43650.4	4.6	0	0	550	711.3	5.3	0	0	0	0	0	0	0.8	0	0	1.4	0	0	0	0.6	0.5	0	4.7	0	0	0	Hepatocytes
TNNI1		ENSG00000159173	Troponin I1, slow skeletal type	P19237	1	201403768-201429866	Predicted intracellular proteins		Actin-binding, Muscle protein		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	7	skeletal muscle: 559.6	Cell type enriched	Detected in some	10	Cardiomyocytes: 50.9	Group enriched	Detected in many	5	head and neck cancer: 9.6;prostate cancer: 3.4	Not detected	Not detected			Low cell type specificity	Detected in some			Low lineage specificity	Detected in single			Cell line enriched	Detected in some	9	RH-30: 106.3	Low region specificity	Detected in all			Not detected	Not detected			HPA028190	Approved		Uncertain	Nucleoplasm,Nucleoli					25000	Nucleoplasm	Nucleoli	HPA028190: AB_10600831	unprognostic (2.82e-2)	unprognostic (2.27e-1)	unprognostic (2.91e-1)	unprognostic (5.39e-2)	unprognostic (2.31e-2)	prognostic unfavorable (9.27e-4)	unprognostic (1.93e-2)	unprognostic (2.37e-1)	unprognostic (4.25e-1)	unprognostic (3.81e-2)	unprognostic (1.75e-1)	unprognostic (2.92e-2)	unprognostic (1.05e-2)	unprognostic (2.59e-2)	unprognostic (3.52e-1)	unprognostic (2.11e-1)	unprognostic (1.71e-1)	1.4	0	0	0	0.1	0	0.1	0	0	0	0	0	0	0.1	0.1	22.9	9.5	0	0.1	6.6	0.1	0	0.5	0.1	0.1	0	0	0	0	0.1	0	0	0	0	4	0	0	6.8	0	559.6	0.1	0.1	0	0.1	0	0.1	0.2	0	0	2.7	83.8	10.7	0	0.1	0.2	0.6	1.7	0.4	0.4	0.5	0.1	0.2	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0.1	0	0	0	0	0	0	0	0.1	0	0.1	0	12.4	0	0	0	0	0	0	0	0	0.1	0.1	0	0	0.1	0	0	0	106.3	0.1	0	0.1	0	0	0	0	0	1.1	0.1	0	0	0	0.1	0	0	0	0	0	0	0	0	1.2	0.4	0.3	0.3	0.3	0.1	0.2	0.2	0.2	0.6	0.2	0.3	0.5	1.7	0.4	0.3	0.4	0.1	0.1	0	0.1	0	0	0.1	0	0	0	0	0	0	0	0	0	0.1	0	50.9	0	0	0	0	0	0.2	5	0	2.7	0	0.8	0	0	0.1	0.5	0	0	0	0.6	0	0	0	0	1.4	0	0	0	1.8	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0.4	0	Cardiomyocytes
ACTC1	ACTC, CMD1R	ENSG00000159251	Actin, alpha, cardiac muscle 1	P68032	15	34788096-34796139	Disease related genes, Plasma proteins, Predicted intracellular proteins		Muscle protein	Atrial septal defect, Cardiomyopathy, Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	19	heart muscle: 243.9	Cell type enriched	Detected in some	285	Cardiomyocytes: 8201.7	Group enriched	Detected in many	6	head and neck cancer: 20.7;prostate cancer: 5.1;testis cancer: 6.9;urothelial cancer: 7.3					Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		fHDF/TERT166: 37.2;LHCN-M2: 151.1;RH-30: 72.4	Not detected	Not detected			Not detected	Not detected			CAB037330, HPA041264, HPA041271	Enhanced								6200000000			CAB037330: , HPA041264: AB_2677383, HPA041271: AB_2677386	unprognostic (8.18e-3)	unprognostic (3.74e-2)	unprognostic (4.82e-3)	unprognostic (1.19e-2)	unprognostic (3.04e-2)	prognostic unfavorable (3.72e-5)	unprognostic (3.26e-1)	unprognostic (2.05e-3)	unprognostic (2.26e-1)	unprognostic (7.98e-2)	unprognostic (1.14e-2)	unprognostic (2.10e-3)	unprognostic (5.68e-4)	unprognostic (8.79e-2)	unprognostic (1.65e-1)	unprognostic (1.48e-2)	prognostic unfavorable (9.32e-4)	1	0	0	0.3	0	0	0.1	0	0	0.5	0			0	0.1	0	0.2	0	0	243.9	0	0	0	0	0	0	0		0	0	0	0	0		1.9	0		0.6	12.5	8.7	0	0	0	0	0	0.6	0			0		0	9.5	0.9	0	0	0.1	0.1	0	0	0.4	0	0	0	0	0	0.1	0	0	0	0.2	0	0	0	0	0	37.2	0	0	0	0	0	0	0	0	0.8	0	0	0	0	16.1	0	0	0	0	0	0	0	0	151.1	0	0	0	0.1	0	0	0	72.4	0	0	0	0	0	0.1	0	0	1.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0.1	0	0	0.4											0	0	0	0.2	0.5	5.9	8201.7	0	0	0	0	19.6	0	1.7	0	4.3	0.3	0	0	0.2	0.9	0.7	0.1	0	0	0.1	0	0	0.6	0	1.9	0	0	0	0	0	2.3	0.1	0	0	0	6.2	0	28.8	0.5	0.1	0.4	0.2	0	0	0	Cardiomyocytes
GOLGA6A	GLP, GOLGA6	ENSG00000159289	Golgin A6 family member A	Q9NYA3	15	74069857-74082550	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at transcript level		Group enriched	Detected in some	29	liver: 6.2;testis: 15.7	Cell type enriched	Detected in some	16	Early spermatids: 37.0	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		NTERA-2: 1.9;SuSa: 2.3;U-266/70: 5.2									HPA044978, HPA050087, HPA072134	Supported		Approved	Nucleoplasm,Vesicles,Centrosome						Vesicles	Nucleoplasm, Centrosome	HPA044978: AB_2679165, HPA050087: AB_2681010, HPA072134: 					unprognostic (1.68e-1)		unprognostic (2.09e-2)			unprognostic (9.50e-2)				unprognostic (9.67e-2)	unprognostic (6.70e-2)			0	0	0	0	0.1	0	0	0.1	0.1	0	0			0	0	0.3	0	0.1	0	0	0	0	0	6.2	0	0	0		0	0	0	0	0		0	0		0	0	0.2	0.1	0	0	0.1	0	0	15.7			0		0	0	0	0	0	0	0	0	0	0	0	0	0.8	0.1	0	0.2	0	0	0	0	0	0.3	0.3	0	0.2	0	0	0	0	0	0	0	0	0.1	0.1	0.3	0	0.1	0	0.2	0.1	0	0.2	0	0	0	0	0	0	0.3	0	0	1.9	0	0	0	0	0	0	0	0.1	0	0	0	0.1	2.3	0.1	0.1	0	0	0.2	0.3	0	5.2	0.8	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	37	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.4	0.3	0	0	0	0	0	0	0	0.4	0	0	0	0	1	0.2	0	0	0	0	0	Early spermatids
SCUBE1		ENSG00000159307	Signal peptide, CUB domain and EGF like domain containing 1	Q8IWY4	22	43197283-43343388	Predicted intracellular proteins, Predicted secreted proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		ovary: 35.8;retina: 48.1	Cell type enriched	Detected in many	5	Peritubular cells: 42.8	Low cancer specificity	Detected in some			Low region specificity	Detected in many			Cell type enhanced	Detected in some		basophil: 2.4	Lineage enriched	Detected in single	5	granulocytes: 2.4	Group enriched	Detected in some	4	HMC-1: 32.9;THP-1: 13.0	Low region specificity	Detected in many			Low region specificity	Detected in many			HPA003190	Approved				Secreted to blood			2170000	130000			HPA003190: AB_1079882	unprognostic (5.29e-2)	unprognostic (7.15e-6)	unprognostic (6.03e-3)	unprognostic (8.33e-2)	unprognostic (3.65e-1)	unprognostic (4.55e-2)	unprognostic (1.34e-1)	unprognostic (5.76e-2)	unprognostic (1.10e-1)	unprognostic (1.99e-1)	unprognostic (3.74e-2)	unprognostic (1.22e-1)	unprognostic (1.23e-2)	unprognostic (1.02e-2)	unprognostic (2.70e-1)	unprognostic (2.30e-1)	unprognostic (6.87e-3)	3.3	5.3	0.4	1.1	2	0.1	3.5	0.3	2.3	1.3	5.5	0.9	1.3	5.9	1.3	0.7	14.8	1.2	0.8	1	0.5	0.7	3.4	4.6	7.5	0.1	3.4	1.9	35.8	0.4	0.3	3.8	3.5	1.9	6.4	2	48.1	5.3	0.5	8	0.6	7.6	1	3.5	6.9	7.3	8.5	0.1	0	3.1	0.5	0.1	4.2	6.3	0.3	0.3	2.4	0.3	0.5	0.3	0.1	0	0	1.4	5.1	0	0	3.2	0	0	0	0	0	2.2	0	0	0	0.2	0	0.4	0	0	0	0.4	0	0	0.4	0.1	0.1	32.9	0	0	0	0	0	0.1	0	0	1.7	0	0	0	0.1	0.5	0	0	0	0	0.9	0	0	0.2	0.8	0	0.1	0	0.2	0	13	0	0.2	0.1	0.4	0	1.4	2.5	0	0.3	0	0.1	2.4	0.2	0.3	0.2	0.3	0.3	0.3	0.3	0.2	0.1	0.3	0.3	0.3	1	0.5	0.3	0.3	0.2	0.1	0.4	2	0.3	2.3	0.5	0.7	3.4	1.9	1.9	0.1	8.9	1.7	0	0	0.2	0	1.1	0	1.4	1.2	0	0	0.1	1.7	0	2.3	0.6	0	0	0	8.9	0.9	0	1.1	1.1	0.7	0	0	0.6	0	2.6	7.2	0	0	0	0	5.2	0.1	0	42.8	0.1	0.2	0	0	3	1.5	0.1	0.3	0	0	0	Peritubular cells
LCE2B	LEP10, SPRL1B, XP5	ENSG00000159455	Late cornified envelope 2B	O14633	1	152686123-152687401	Predicted intracellular proteins	Keratinization			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in some	10	skin 1: 101.7	Cell type enriched	Detected in some	16	Suprabasal keratinocytes: 27.6	Cancer enriched	Detected in some	5	melanoma: 11.5					Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		BJ hTERT+: 1.1;BJ hTERT+ SV40 Large T+: 2.1																											unprognostic (3.04e-2)			unprognostic (1.36e-1)									0	0	0	0	0	0	9.8	0	0	0	0			0	0	0	0	0	0	0	0	0	0	0	0	0	0		0	0	0	0	0		0	0		0	0	1	101.7	0	0	0	0	0	0			0		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.1	2.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.7	0	0	0	0	0	0	0	0	0	0	0	0	27.6	0	0	0	0	Suprabasal keratinocytes
TGM7	TGMZ	ENSG00000159495	Transglutaminase 7	Q96PF1	15	43276280-43302255	Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins		Acyltransferase, Transferase	Cancer-related genes	Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		lymphoid tissue: 5.9;testis: 2.9	Cell type enriched	Detected in some	5	Early spermatids: 60.4	Cancer enriched	Detected in single	13	endometrial cancer: 2.1					Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	78	EFO-21: 9.1	Not detected	Not detected			Not detected	Not detected																	unprognostic (2.45e-2)		unprognostic (2.04e-1)		unprognostic (2.82e-2)				unprognostic (1.71e-2)		unprognostic (1.07e-1)			unprognostic (2.01e-1)			0	0	0	0	0	0	0	0	0	1.1	0			0	0	0	1.8	0	0	0	0	0	0.1	0	0	0	0		0	0	0	0	0		0.3	0		0.2	0.1	1.5	0	0	0	0	0	0	2.9			0		5.9	0	1.6	0	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	9.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0	0											0	0	0	1.2	0	0	0	0	0	0	0	0	0	0	0	60.4	0	0	0	0	0	0	1.6	0	0	0	0	0	0	0	12.3	0.3	0	0	0	0	0	0.2	0	0	0	0	0	0	0.4	0.7	0	0	0	0	2.8	Early spermatids
ISL2	FLJ10160	ENSG00000159556	ISL LIM homeobox 2	Q96A47	15	76336724-76342476	Predicted intracellular proteins, Transcription factors		Developmental protein, DNA-binding		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		blood: 11.3;pituitary gland: 12.6;salivary gland: 11.8	Cell type enriched	Detected in some	8	Cone photoreceptor cells: 25.5	Low cancer specificity	Detected in many			Low region specificity	Detected in some			Group enriched	Detected in many	6	neutrophil: 11.3;non-classical monocyte: 3.9	Group enriched	Detected in many	6	granulocytes: 11.3;monocytes: 3.9	Cell line enhanced	Detected in many		HEK 293: 15.7	Not detected	Not detected			Not detected	Not detected			HPA075192			Approved	Rods & Rings						Rods & Rings		HPA075192: AB_2686738	unprognostic (7.30e-2)	unprognostic (7.96e-2)	unprognostic (9.01e-3)	unprognostic (4.44e-3)	unprognostic (1.44e-1)	unprognostic (7.77e-2)	unprognostic (1.25e-2)	unprognostic (1.45e-1)	unprognostic (1.67e-1)	unprognostic (2.84e-1)	unprognostic (9.03e-2)	unprognostic (3.93e-2)	unprognostic (3.55e-15)	unprognostic (1.78e-1)	unprognostic (4.19e-1)	unprognostic (4.07e-1)	unprognostic (2.26e-1)	0.9	0.2	0	0.8	1.1	0.3	0.3	0	0.9	2.8	3.8	2	0	2.9	0.2	0.2	1.2	0.2	1.9	0.7	0.3	0	0.2	0.2	0.4	0.9	0.7	0	0.2	0.2	0.2	12.6	0.3	1	4.1	0.5	1.9	11.8	0.3	0.2	1.1	2	0.4	1.8	1	3.2	2.7	1.9	0	0.2	4	1.2	0.2	6.4	1.2	0.2	11.3	3.9	0	0.6	0.5	1.4	1.7	0	1.6	0.1	0.1	1.5	4.4	2	1.1	1.5	3.4	0.7	3.3	2.1	0	1.1	1.8	6.3	0.1	0.2	3.1	15.7	1.5	3.6	4	1.4	3.3	4.2	0	0.9	0	0	0	0	4.9	4.8	2.5	0.4	0.1	4.1	8.1	0	0.6	3	2.7	2	4	0	0.6	4.8	5.3	2.8	0	0	0.9	0.3	7.6	0	1.4	3.2	0.6	4.2	3.7	3.9	1.9	1	2.4	0	0	1	0	0.2	1	0	1	0	0.6	0.2	1.2	0.2	0.1	11.3	0	3.9	0	0	0.5	0	1.1	0	0.9	0.3	0	0.7	0	1	1.9	0	0	0	1.5	0	0	0.4	0	0	0	0	25.5	0	0	0	0.4	0	0	0	0.2	0.2	0	0.5	0	0	0	0	0	0	0.8	0	0	0	0	0	0	0	0	0	0	0	2.2	0	0.2	1.7	0	0	0.2	0	0	3	Cone photoreceptor cells
CCDC17	FLJ33084	ENSG00000159588	Coiled-coil domain containing 17	Q96LX7	1	45620044-45624057	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	7	epididymis: 24.5;fallopian tube: 31.0;lung: 23.0;ovary: 9.6	Cell type enriched	Detected in many	12	Ciliated cells: 291.7	Cancer enhanced	Detected in many		endometrial cancer: 4.4	Region enriched	Detected in single	4	pons and medulla: 1.4	Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		BJ: 2.3;HAP1: 2.3;MOLT-4: 1.8;RPMI-8226: 3.0;U-138 MG: 2.0	Low region specificity	Detected in some			Not detected	Not detected			HPA028338	Enhanced											HPA028338: AB_10669641	unprognostic (3.53e-5)	unprognostic (7.40e-2)	unprognostic (3.08e-3)	unprognostic (3.55e-3)	unprognostic (3.31e-1)	unprognostic (9.21e-3)	unprognostic (6.97e-2)	unprognostic (1.30e-2)	unprognostic (8.55e-2)	unprognostic (1.07e-1)	unprognostic (4.46e-3)	unprognostic (2.91e-1)	unprognostic (8.37e-7)	unprognostic (1.20e-1)	unprognostic (1.96e-1)	unprognostic (2.92e-1)	unprognostic (5.91e-3)	0	0	0.1	0.1	0.2	0.4	0	0	0	3.2	0.1	0.4	0	0.2	0.5	24.5	0	31	0	0	0.2	0.1	0	0.1	23	0.1	0	0	9.6	0.1	0	1.6	0.2	1.4	0.1	0.1	0	0	0	0.2	0.1	0.1	0.3	0	0.1	0.1	1.1	0.3	0	0	0.2	0.2	0	0	0.4	0	0.1	0.4	0	0.6	0	0	0	0.7	0	0	0	0.5	2.3	0.1	0.4	1	1.3	0.3	0	0.1	0	0.4	0.3	2.3	1.1	0	0	0	0.8	0	0	0.6	0	0.3	0.2	0	0	0	0.1	0.4	0	0	0.1	0.1	0.3	1.8	0.1	1	0.2	0	0.1	0	3	1.1	0	0.2	0.4	0	0	0.2	0.3	0.9	0	0	2	1.2	0.7	0	0	0.4	1.5	0	0	0.1	0	0	0	0.6	0.4	0.4	0	0	0	0	0.4	0	0	0.1	0	0	0	0	0	0.1	0.2	0	0	0.2	0.1	0	0	1.4	0.3	3	2.6	0	0.2	1	0	1.6	0	291.7	25	0	0	0.3	5	0.4	0	0.7	3.2	0	0.8	0.1	0.4	0.4	1.1	0.9	0.6	0	1.2	0.6	0.8	0.2	1.1	1.4	0	1	1.6	0.3	0.9	1.9	2.1	0.6	0.5	0	0	0.5	0	0.5	0.5	0	1.5	0.3	Ciliated cells
UROC1	FLJ31300, HMFN0320	ENSG00000159650	Urocanate hydratase 1	Q96N76	3	126481281-126517773	Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins	Histidine metabolism	Lyase	Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	32	liver: 50.7	Cell type enriched	Detected in some	17	Hepatocytes: 31.8	Cancer enriched	Detected in single	100	liver cancer: 12.1	Not detected	Not detected			Cell type enhanced	Detected in single		neutrophil: 1.5	Lineage enhanced	Detected in single		granulocytes: 1.5	Cell line enriched	Detected in some	8	NB-4: 9.5	Not detected	Not detected			Low region specificity	Detected in all			HPA069863	Enhanced								510000			HPA069863: AB_2732143	unprognostic (1.28e-1)	unprognostic (2.74e-2)	unprognostic (1.08e-1)	unprognostic (7.43e-2)	unprognostic (6.43e-2)	unprognostic (1.43e-1)	unprognostic (2.23e-3)	unprognostic (2.95e-1)	unprognostic (2.57e-2)	unprognostic (7.71e-2)	unprognostic (9.97e-2)	unprognostic (3.04e-1)	unprognostic (3.65e-5)	unprognostic (3.97e-2)	unprognostic (2.66e-1)		unprognostic (5.52e-2)	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	50.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.5	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	1.1	0	0.1	0	0	0	0	0	0	0	0.3	0	0	0	0	0.1	9.5	0	0	0	0.1	0	0.4	0	0	0.5	0	0.1	0	0	0	0	0	0.1	0	0	0	0	0	0	0.1	0	1.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	1.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	31.8	0.3	0	0	1.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Hepatocytes
ZNF222		ENSG00000159885	Zinc finger protein 222	Q9UK12	19	44025342-44033112	Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	DNA-binding		Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	7	Early spermatids: 43.5	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low cell line specificity	Detected in many											HPA004086	Approved		Approved	Nucleoplasm,Nuclear bodies						Nucleoplasm	Nuclear bodies	HPA004086: AB_2273259	unprognostic (1.91e-3)	unprognostic (3.41e-2)	unprognostic (8.08e-2)	unprognostic (1.02e-1)	unprognostic (3.81e-2)	unprognostic (7.45e-2)	unprognostic (1.75e-3)	unprognostic (6.75e-2)	unprognostic (1.58e-2)	unprognostic (7.58e-2)	prognostic favorable (5.56e-7)	unprognostic (2.19e-3)	unprognostic (1.36e-1)	unprognostic (2.44e-1)	unprognostic (8.42e-2)	unprognostic (2.05e-2)	unprognostic (1.16e-3)	4.8	7.7	8.1	5.1	9.1	8	8.3	18.3	12.6	6.2	4.4	7.5	5.3	2.9	5.1	7.3	3.5	5.5	6.4	7.5	11.5	8.2	5.9	5.1	5.7	7.2	8.8	7.8	8.9	5.4	6.6	12.7	5.4	10.7	6.6	5	5.7	6.9	6.4	3.7	4.5	5	6	9.3	8.8	5.5	15.4	11.1	10.3	7.6	5	7.3	8.5	6.6	7.6	4	8.9	3.6	6.1	9.7	4	3.9	4.6	7.9	7.1	6.1	6.2	0.4	4.2	7.6	5	7.8	2.4	2.6	1.4	6.6	4.7	6	1.3	5.4	4	6.3	5.8	5.9	6.5	5.8	3.8	7.6	0.2	5.9	4.7	5.5	4.1	7.1	8	4.6	5.8	1.2	2.8	6.2	0.5	4.4	2.6	4.7	1.8	2.3	0.1	8.4	2.1	4.2	12.4	4.2	9.7	6.9	1.3	5.7	7.2	1.7	6.3	3.4	5.5	5.3	3.2	5.2	11.3	9.2	0.1	2.9	0.1	6.1	8.9	3.6	7	9.2	2.3	7.7	7.4	8.7	8.9	3.6	7.6	9.7	7.3	7.5	6.1	2.8	4	6	4	8.1	9.1	18.3	12.6	11.5	8.2	8.8	7.8	10.7	11.1	0	1	0	1.7	2.3	4.9	1.9	0	0	1.2	5.2	0	1.8	6.6	2.3	43.5	1.8	0.7	0	1.1	0.9	2.1	1	4.6	1	2	6.4	2.9	1.3	1.2	1.5	1.7	1.2	1.7	1	1.7	6.5	0.8	0	2.1	1.2	2.6	0	2.7	5.1	1.2	1.5	0.9	4.1	1.2	0.6	Early spermatids
OR3A3	OR17-137, OR17-16, OR17-201, OR3A6, OR3A7, OR3A8P	ENSG00000159961	Olfactory receptor family 3 subfamily A member 3	P47888	17	3411370-3424070	G-protein coupled receptors, Predicted membrane proteins	Olfaction, Sensory transduction	G-protein coupled receptor, Receptor, Transducer		Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Group enriched	Detected in some	5	blood: 10.6;bone marrow: 2.6	Cell type enriched	Detected in single	11	Alveolar cells type 2: 1.1	Not detected	Not detected							Cell type enriched	Detected in single	17	plasmacytoid DC: 10.6	Lineage enriched	Detected in single	17	dendritic cells: 10.6	Cell line enriched	Detected in single	5	HDLM-2: 4.4																																				unprognostic (2.01e-1)			0.1	0	0.6	0.2	0.9	2.6	0.1	1.2	0.4	0.2	0.2			0.5	0.4	0.1	0	0.2	0.5	0.2	0.6	0.5	0.2	0.2	0.1	0.8	1.1		0.1	0	0	0.3	0.4		0.1	0		0.1	0.1	0.5	1	0	0	0.5	0.4	0.4	1.1			0.2		0.4	0.3	0.2	0.3	10.6	0.6	0.2	0.2	0.2	0	0.2	0.1	0.3	0.2	0	0.1	0.4	0	0	0	0.1	0.5	0.1	0.3	0.1	0	0.1	0.2	0.1	0	0	4.4	0.5	0.4	0.6	0.2	0	0.3	0.2	0	0	0	0.4	0.3	0	0.2	0.4	0.4	0	0.3	0.4	0.4	0	0	0.1	0	0	0	0	0.1	0.2	0	0.1	0.2	0.2	0.3	0.1	0.2	0.9	0.3	0.2	0.1	0	0.3	0.2	0.3	0.3	0.3	0.2	0.4	0.2	0.2	0.2	0.1	0.1	0.1	0.2	0.1	0	0.3	0.2	0.2	0.6	0.2	0.1	10.6	0.1	0											0	1.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Alveolar cells type 2
TFF3	HITF, ITF	ENSG00000160180	Trefoil factor 3		21	42311667-42315651	Predicted intracellular proteins, Predicted secreted proteins				Evidence at protein level	Evidence at protein level				Tissue enhanced	Detected in many		gallbladder: 230.9;thyroid gland: 258.3	Cell type enriched	Detected in many	21	Mucus-secreting cells: 36697.4	Low cancer specificity	Detected in all			Not detected	Not detected			Cell type enriched	Detected in single	30	eosinophil: 9.5	Lineage enriched	Detected in single	63	granulocytes: 9.5	Cell line enhanced	Detected in some		MCF7: 28.4;OE19: 44.4;SCLC-21H: 8.7;T-47d: 13.3;TIME: 36.9	Region enriched	Detected in single	20	cerebellum: 1.7	Not detected	Not detected			CAB020681, HPA035464	Enhanced		Approved	Nucleoplasm,Nucleoli	Secreted to blood	No		151000000		Nucleoplasm	Nucleoli	CAB020681: , HPA035464: AB_2674636	unprognostic (2.84e-2)	unprognostic (3.61e-3)	unprognostic (1.07e-1)	prognostic favorable (5.60e-6)	unprognostic (1.28e-1)	unprognostic (2.35e-2)	unprognostic (2.13e-1)	unprognostic (5.03e-2)	unprognostic (1.58e-1)	unprognostic (1.05e-1)	unprognostic (3.71e-1)	unprognostic (6.90e-2)	unprognostic (4.31e-2)	unprognostic (1.25e-1)	unprognostic (2.04e-1)	unprognostic (2.44e-2)	unprognostic (3.86e-2)	2.2	1.2	0.2	16.8	0.2	0	4.3	0.2	0.2	45.1	66.3	0.2	0.5	40.8	2.8	1.2	5.1	8	230.9	0.7	0.2	0.3	1	0.6	12.6	0.6	0.4	0.2	2	4.8	0	0.5	0.5	0.2	3.6	63.3	0.3	54.8	0.7	0.6	1.6	70.6	1.5	0.5	5	1.1	0.4	0.2	0.3	258.3	14.4	72.6	1.1	1.6	0	0	9.5	0.1	0	0	0.3	0	0	0	0	0	0	0.6	0	0	0	0	0.6	0	0	0	0	0	0	0	0.3	0	0	0	0	0	2.1	0	0	0	0	0	0	0	0	0.3	0	0	0	0	28.4	0	0.5	0.1	44.4	4.3	0	3.2	0.3	0	0	8.7	0.1	0	0.8	0	0	13.3	0	36.9	0	0	0.3	0.1	0	0.1	0	0	0	0.1	0	0.1	9.5	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0.3	0.2	0.2	0.2	0.2	0.2	0.3	0.4	0.2	0.2	0.2	14.9	22.3	0.9	17	37	0	13.4	1110.8	464.4	316.2	21	0	0.3	0	9	0	51.4	1768.3	0	62.1	0.6	20.3	103	60.8	0.9	1.9	4.8	740.8	82.9	2.6	0.8	2.3	2.5	91.1	0	36697.4	0	28	1779.2	7.4	0	0	0	6.1	0.3	0.3	33.8	0.7	1	1243.2	29.6	Mucus-secreting cells
TFF2	SML1	ENSG00000160181	Trefoil factor 2	Q03403	21	42346357-42351128	Cancer-related genes, Predicted secreted proteins			Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	6	gallbladder: 361.8;stomach 1: 332.4	Cell type enriched	Detected in some	7	Cholangiocytes: 3630.5	Group enriched	Detected in many	11	pancreatic cancer: 320.9;stomach cancer: 244.9	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	14	CAPAN-2: 14.7;OE19: 21.5;PC-3: 52.9	Not detected	Not detected			Not detected	Not detected			CAB025834, HPA036705	Enhanced				Secreted to digestive system				670000			CAB025834: , HPA036705: AB_2675263	unprognostic (3.95e-2)	unprognostic (9.87e-2)	unprognostic (1.82e-1)	unprognostic (1.30e-1)			prognostic unfavorable (1.99e-4)	unprognostic (1.68e-1)	unprognostic (1.33e-1)	unprognostic (4.89e-2)	unprognostic (5.55e-2)		unprognostic (1.27e-9)	unprognostic (1.99e-1)	unprognostic (2.07e-1)	unprognostic (1.28e-1)	unprognostic (5.26e-3)	0.1	0	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.5	0.1	62.9	0.1	0.1	0.5	0	361.8	0.2	0.1	0	0.1	0.5	0.1	0.1	0.1	0.1	0.1	3.2	0	0.1	0.1	0.1	0.1	0	0.1	0.3	0.1	0.1	0	0.1	0.1	0.1	0.1	332.4	0.1	0.1	0.1	0.3	0.1	0.5	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.7	0	0.1	0	0.1	0.3	0	0	0	0	0	0	0	0	0	0	0.8	0	0	0	0	0	0	0	0	2.1	0	0	0.8	0	0.7	21.5	52.9	0.2	0	2	0	0.4	0	0.2	0	0	0	0	0	0.2	0	0	0.6	0	0	0.8	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	0	0	0.2	0	0.2	3630.5	0	0	0	0	0	0	2.1	0	0	0.3	0	85.8	0.2	0	0.6	0	1	0	0	1.2	0	0	0	0	0	5	1	17.1	0	484.9	3.1	0	0	0	0	0	0	0.2	0	0	0	0	0.8	Cholangiocytes
TFF1	BCEI, D21S21, HP1.A, HPS2, pNR-2, pS2	ENSG00000160182	Trefoil factor 1	P04155	21	42362282-42366594	Cancer-related genes, Plasma proteins, Predicted secreted proteins		Growth factor	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	34	gallbladder: 247.7;stomach 1: 375.3	Cell type enriched	Detected in many	10	Pancreatic endocrine cells: 8493.3	Group enriched	Detected in many	10	breast cancer: 402.1;colorectal cancer: 268.3;pancreatic cancer: 805.7;stomach cancer: 744.5	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	41	MCF7: 478.7;OE19: 196.0	Not detected	Not detected							CAB002170, HPA003425	Enhanced				Secreted to digestive system				990000			CAB002170: AB_563985, HPA003425: AB_1848260	prognostic favorable (5.00e-4)	unprognostic (8.81e-3)	unprognostic (9.82e-2)	prognostic favorable (5.67e-4)		unprognostic (2.42e-1)	unprognostic (1.72e-3)	unprognostic (8.14e-2)		unprognostic (2.45e-1)	unprognostic (1.52e-1)	unprognostic (6.62e-2)		unprognostic (1.01e-1)	unprognostic (1.19e-1)	unprognostic (7.72e-3)	unprognostic (1.07e-1)	0.1	0	0.1	1	0.2	0	3.5	0.1	0.1	0.5	4.9	1.4	0.1	1.4	0.1	0.1	1.1	0.1	247.7	0.1	0.1	0	0.1	0.3	0.5	0.1	0.1	0.1	0.1	0.9	0	0.1	0.1	0.1	1.9	4.7	0.1	5	0.2	0.1	0	5.6	0.1	0.1	0.1	375.3	0.1	0.1	0.1	0.2	1.1	9.2	1	0.2	0	0	0	0	0	0	0	0	1.5	0	0	0	0	0.1	0	0	0	0	0.5	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	478.7	0.1	0	0.2	196	8.2	0	0	0	0	0	0	0	0	0.1	0	0	0.1	0	0	0	0.1	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.2	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	0	6.4	0	0	0	830.5	0	0	33.2	0	0	0	88.4	0	0	116.3	0	741.5	3	0	273.3	13.8	0	0.2	0	413.6	0	0	0	0	0	0	18	404.2	0	8493.3	152.5	0	0	0	0	0	0	0	0	0.2	0	47.2	76.6	Pancreatic endocrine cells
RSPH1	CILD24, FLJ32753, RSP44, RSPH10A, TSGA2	ENSG00000160188	Radial spoke head 1 homolog	Q8WYR4	21	42472486-42496354	Disease related genes, Predicted intracellular proteins	Meiosis		Ciliopathy, Disease mutation, Primary ciliary dyskinesia	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 38.4;fallopian tube: 85.5	Cell type enriched	Detected in many	8	Ciliated cells: 938.2	Cancer enhanced	Detected in many		endometrial cancer: 15.2	Low region specificity	Detected in all			Cell type enriched	Detected in single	11	plasmacytoid DC: 6.7	Lineage enriched	Detected in single	11	dendritic cells: 6.7	Group enriched	Detected in some	4	MCF7: 7.6;OE19: 27.9;RPTEC TERT1: 11.4	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA016816, HPA017382	Enhanced		Supported	Centrosome						Centrosome		HPA016816: AB_1858393, HPA017382: AB_1858392	unprognostic (1.76e-3)	unprognostic (2.34e-1)	unprognostic (3.02e-2)	unprognostic (1.12e-3)	unprognostic (5.48e-2)	unprognostic (2.43e-1)	unprognostic (7.59e-3)	unprognostic (1.97e-1)	unprognostic (2.53e-1)	unprognostic (1.46e-1)	unprognostic (4.37e-3)	unprognostic (2.77e-1)	unprognostic (1.10e-2)	unprognostic (8.41e-2)	unprognostic (2.58e-2)	unprognostic (5.22e-3)	unprognostic (1.99e-1)	0.6	2.5	11.5	0.9	16.4	0.7	1.7	1.2	4.7	4.5	2.6	15.9	3.1	4.5	3.6	22.5	1	85.5	3.8	0.6	11.6	15	3.8	0.8	17.4	0.7	4.8	4.5	12.9	2.2	4.8	21.4	0.6	38.4	2.2	2.5	1	0.9	2.4	0.9	2.4	4.1	1.1	4.6	0.6	3.4	21.9	7.7	0.2	4.8	0	0.7	1.5	0.2	0.6	6.7	0.5	0.3	0	0.3	0.3	1.1	0.9	0	2.8	0	0	0.1	0	0	0	0	0.2	2.4	0.1	0.4	0	0.3	1.4	0	0.4	0	0.1	0	3.8	0.4	0	0	0	0.1	0.2	0.7	0	0	0	0	0.6	0	0.2	0	7.6	0.1	0.2	0.2	27.9	0.4	0	0.2	0	11.4	0.9	1.8	0.7	1.8	2.7	0.2	0	3.1	0.3	0.1	0	0.1	0.1	0	0.3	1.7	0.1	0	0	0	0.1	0.3	0.5	0.3	0.2	0.1	0.4	0.3	0.3	0.3	0.6	0.3	0.2	0.2	0	0.1	6.7	0.2	0.3	11.5	16.4	1.2	4.7	11.6	15	4.8	4.5	38.4	7.7	0	3.8	0.5	4.2	4.5	10.6	0.6	22.9	938.2	117.2	17.4	35.3	0	33.2	9.3	60	0.8	10.6	0	3.4	0	0.4	12.6	0	0	0.1	3.2	8.6	0	0	85.8	1.7	0.3	0	1.8	9.8	10.5	2.3	10.5	2.5	14.3	26.5	0	0.3	90.5	12.3	4	0.7	0	8.5	5.8	Ciliated cells
LRRC3	C21orf102	ENSG00000160233	Leucine rich repeat containing 3	Q9BY71	21	44455486-44462196	Plasma proteins, Predicted membrane proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		gallbladder: 35.3;liver: 19.1	Cell type enriched	Detected in many	5	Hepatocytes: 26.8	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		BEWO: 11.2;U-2 OS: 8.4	Low region specificity	Detected in many			Low region specificity	Detected in many			HPA017975	Uncertain											HPA017975: AB_1853307	unprognostic (1.36e-2)	unprognostic (5.48e-3)	unprognostic (1.49e-2)	unprognostic (2.10e-4)	unprognostic (1.55e-1)	unprognostic (1.74e-2)	unprognostic (7.20e-3)	unprognostic (2.59e-1)	unprognostic (4.61e-1)	unprognostic (7.43e-2)	unprognostic (1.37e-1)	unprognostic (1.38e-2)	unprognostic (1.74e-5)	unprognostic (6.44e-2)	unprognostic (2.01e-1)	unprognostic (7.51e-2)	unprognostic (6.66e-3)	3.7	2.7	1.1	2.5	1.6	1	3.9	0.3	1	4.5	7.6	1.1	2.5	3.1	2.1	3.3	3.7	1.9	35.3	2.8	1.2	1.4	1.1	19.1	3.8	3.7	0.5	0.2	5.7	2.3	0.1	2	1.8	0.9	4.1	1.6	2.1	2.6	1.3	1	3.3	3	5.2	0.8	1.9	5.4	5.4	0	2.2	1	2.2	1.6	4.5	5.8	0.9	0.5	2.1	0.8	0.5	1.1	0.1	0.7	0.5	4.5	3.7	0	0	11.2	1.9	0	0.2	0	1.7	1.5	0	3.4	0.9	2.5	0.2	2.1	0	0.1	0.3	4.9	0	0.5	5	0.8	0	2.9	1.4	1.8	0	0	0	1.8	0.7	0.4	5.7	0	1.6	0.7	0.2	1.2	5.5	1.8	2.4	0	1.8	0.1	0.2	3.7	4.1	1.7	0.3	0.7	2.6	1.1	2.3	3.5	0	8.4	0	0	3.2	6.2	0	0	2	0.6	1.8	0.8	0.2	0.3	0.7	1.1	0.6	0.5	0.2	0.3	0.9	0.4	0.4	2.1	0.5	0.6	0.5	0.2	0.1	1.1	1.6	0.3	1	1.2	1.4	0.5	0.2	0.9	0	0	1	1.4	0.5	0.6	0.7	1.5	2.5	0	0	1.8	0	0.2	0	0.4	0.2	0.2	1.3	0	0.3	4.7	1.3	1.1	1.1	26.8	2.2	0	4.1	0	2.1	1.4	0.6	1.1	0	5.4	2.2	1.5	1.2	0	0.7	0	0	0	1	0.5	1.3	0.5	0.2	0	1.5	0.7	Hepatocytes
CLDND2	MGC33839	ENSG00000160318	Claudin domain containing 2	Q8NHS1	19	51367098-51369003	Predicted intracellular proteins, Predicted membrane proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in all		testis: 31.4	Cell type enriched	Detected in many	15	Early spermatids: 230.3	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Cell line enhanced	Detected in many		Hep G2: 11.7									HPA056971	Uncertain		Approved	Nucleoplasm						Nucleoplasm		HPA056971: AB_2683294	unprognostic (2.86e-1)	unprognostic (4.29e-5)	unprognostic (2.29e-2)	unprognostic (3.40e-2)	unprognostic (1.19e-1)	unprognostic (9.42e-2)	unprognostic (5.74e-3)	unprognostic (1.79e-1)	unprognostic (2.67e-1)	unprognostic (1.09e-1)	unprognostic (1.25e-3)	unprognostic (1.13e-2)	unprognostic (1.94e-9)	unprognostic (4.00e-2)	unprognostic (3.95e-1)	unprognostic (1.85e-1)	unprognostic (8.70e-2)	7.7	7.8	6.8	3.2	11.1	13.3	3.3	10.9	16.5	2.6	3.6	1.4	8.4	7.7	3	2.5	2.9	2.8	4.5	2.5	9.9	4.7	2.8	3.5	4	3.2	19.6	5.2	6.7	9.1	1.5	2.9	1.8	7.4	3.8	2.4	1.7	7.5	6	11.9	1.5	7.1	3.8	10.2	7.3	3.3	31.4	10.6	0	2.9	2.2	1.2	3.2	3	1.7	3	5.8	2	5.3	4.5	0.7	2.1	6	2.2	3	3.3	2.9	1.2	1	0.5	1	1.3	0.7	7.1	5.6	1.2	0.6	0.7	2.7	0.7	0.3	0.2	3.9	9.7	4.9	9.4	11.7	1.3	1.4	1.4	2.2	1	0.2	0.6	1.5	0.7	2.8	3.1	4.1	0.9	1.3	1.2	8.1	0.9	6.1	7.6	1.1	5.1	2.2	1.6	1.6	1.3	1.5	2.6	0.5	2.1	1.1	1.5	0.4	1.4	2.2	4.4	2.3	0.9	3.8	4	2	5.4	5.6	1.3	5.8	0.9	4.1	3.5	2	2	1.7	0.8	4.5	1.4	1.1	0.6	1.5	0.5	5.3	0.7	3	1.2	0.7	6.8	11.1	10.9	16.5	9.9	4.7	19.6	5.2	7.4	10.6	0	5.9	7.8	5	1.4	5.5	3.6	12.7	9.4	1.2	15.7	0	1.9	3.3	0.7	230.3	1.7	6.6	0	0.6	1.1	2.3	4.4	15.1	13.4	2.3	3.2	9.9	7.4	2.4	9.1	5.8	4.6	1.7	1.8	14.5	2.3	0.8	5.8	6	3	1.9	0	2.7	2.3	1.3	2.4	0.7	4.5	10.5	4.6	Early spermatids
FCN2	EBP-37, FCNL, ficolin-2, P35	ENSG00000160339	Ficolin 2	Q15485	9	134880812-134887520	Plasma proteins, Predicted secreted proteins	Complement activation lectin pathway, Immunity, Innate immunity			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	7	liver: 77.4	Cell type enriched	Detected in some	16	Ito cells: 1725.4	Group enriched	Detected in some	8	breast cancer: 1.0;liver cancer: 2.0;prostate cancer: 1.1;renal cancer: 0.5	Not detected	Not detected			Cell type enhanced	Detected in some		classical monocyte: 6.0;intermediate monocyte: 5.6	Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		RH-30: 1.3;SCLC-21H: 1.1;T-47d: 1.3;U-698: 1.2														Secreted to blood			8100000000	1800000000				unprognostic (1.91e-1)	unprognostic (1.07e-1)			unprognostic (6.96e-4)		unprognostic (3.73e-2)	unprognostic (2.09e-2)		unprognostic (3.81e-1)	unprognostic (2.82e-1)	unprognostic (3.13e-2)	unprognostic (1.06e-2)		unprognostic (1.05e-1)	unprognostic (3.07e-1)		2	11.4	0.2	0.2	0.2	0	4	0.2	0.3	0.2	0.3	0.3	0.5	0	0.3	0.6	0.2	0	0.2	0.5	0.2	0	2.2	77.4	0.2	0.2	0.2	0.2	0.2	0.2	0.2	1.5	0.2	0.3	1.5	0	0.2	1.4	0.2	0.2	0	0.2	0.2	0.2	1.4	0	0.3	0.2	0.2	0.9	0.2	0.2	0.3	0.2	0	3.3	1.3	6	0	0	7.2	0	0	0	0	0	0	0.4	0	0	0.4	0	0	0	0	0	0	0.6	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0.4	0	0	0	1.3	0	0	0	1.1	0	0	0	0	0	1.3	0	0	0	0	0	0	0.4	0	1.2	0	0.9	0	0	6	0	0	5.6	0	0	0	0	3.3	0	0	0	1.3	0	2.5	0	0	7.2	0.2	0.2	0.2	0.3	0.2	0	0.2	0.2	0.3	0.2	0	0	0	0	0	0	0	17.8	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0.4	0	5.9	0	0	0	1725.4	106.9	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Ito cells
CFAP157	C9orf117	ENSG00000160401	Cilia and flagella associated protein 157	Q5JU67	9	127706989-127716002	Predicted intracellular proteins	Differentiation, Spermatogenesis			Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	5	brain: 30.2;epididymis: 24.0;fallopian tube: 44.8;testis: 11.5	Cell type enriched	Detected in some	6	Ciliated cells: 348.0	Low cancer specificity	Detected in many			Group enriched	Detected in many	4	basal ganglia: 19.8;pons and medulla: 30.2	Cell type enriched	Detected in single	11	MAIT T-cell: 1.2	Lineage enriched	Detected in single	12	T-cells: 1.2	Cell line enhanced	Detected in many		A549: 9.3;HeLa: 7.6;MCF7: 6.6;SCLC-21H: 6.4	Low region specificity	Detected in some			Low region specificity	Detected in all			HPA021474, HPA021786	Enhanced		Enhanced	Plasma membrane,Cytosol						Plasma membrane, Cytosol		HPA021474: AB_1845801, HPA021786: AB_1845802	unprognostic (1.69e-1)	unprognostic (2.80e-2)	unprognostic (2.41e-2)	prognostic favorable (1.45e-4)	unprognostic (3.02e-1)	unprognostic (1.58e-1)	unprognostic (4.71e-3)	unprognostic (1.49e-1)	unprognostic (3.14e-4)	unprognostic (7.72e-2)	unprognostic (4.93e-4)	unprognostic (9.32e-3)	unprognostic (4.95e-3)	unprognostic (5.71e-4)	unprognostic (4.34e-2)	unprognostic (7.38e-2)	unprognostic (1.28e-1)	0.4	0.4	3.1	0.3	19.8	0.3	0.3	0.1	0.4	5.3	0.3	7	1.6	0.2	1	24	0.8	44.8	0.6	0.4	4.6	5.8	0.4	0.3	6.1	0.4	0	0	4.4	0.9	0.2	4.4	0.3	30.2	0.4	0.2	0	0.5	1.3	0.4	0.6	0.3	0.2	0.5	0.4	0.4	11.5	3.5	0	0.4	0	0.2	0.9	0	0	0	0	0	0	1.2	0	1.5	9.3	0.9	1.2	0	0	1.2	1.2	0	0	0	0.9	1.3	1.4	1.4	0	2.3	4.6	0	0	0	3.4	1.1	0.9	7.6	2.3	0	0.7	2.1	0	0	0	0	0.5	0	2.8	3.1	0.7	0	6.6	1.3	0.5	0.9	1.7	4.9	2	0.9	1.5	0	0.4	6.4	1.1	1.9	3.6	0.7	0.2	3.2	0.3	1.7	1.9	1.5	5	0.8	1	2.6	1.2	0.8	0.7	1.2	0	0	0	0	0	1.2	0	0	0.1	0	0	0.1	0	0	0	0	0	0	0	3.1	19.8	0.1	0.3	4.6	5.8	0	0	30.2	3.5	8.9	10.9	0	0.2	0	0.6	0	0	348	51.2	0	0	0	1.7	0.3	44.7	0	0	0	0	0.1	0	0.3	2.3	0.2	0.2	0	0	0	0.3	61.4	0.3	0.4	0	0	0.6	0.8	0	0	0.7	0.3	0.2	0	0	11.4	1.1	0	0	0	0.2	0.1	Ciliated cells
PAQR6	FLJ22672, PRdelta	ENSG00000160781	Progestin and adipoQ receptor family member 6	Q6TCH4	1	156243321-156248117	Predicted intracellular proteins, Predicted membrane proteins		Receptor		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in many	12	brain: 138.1	Cell type enriched	Detected in some	7	Muller glia cells: 71.8	Cancer enriched	Detected in all	6	glioma: 34.8	Low region specificity	Detected in all			Cell type enriched	Detected in some	6	NK-cell: 10.5	Lineage enriched	Detected in many	6	NK-cells: 10.5	Cell line enhanced	Detected in many		U-266/70: 20.9																No						unprognostic (1.64e-1)	unprognostic (2.27e-1)	prognostic unfavorable (1.60e-5)	unprognostic (7.42e-2)	unprognostic (5.52e-2)	unprognostic (4.50e-3)	unprognostic (4.75e-1)	unprognostic (2.25e-1)	unprognostic (2.57e-1)	unprognostic (3.13e-1)	unprognostic (4.25e-3)	prognostic unfavorable (1.99e-4)	prognostic unfavorable (1.58e-8)	unprognostic (1.26e-2)	unprognostic (1.34e-1)	unprognostic (8.82e-2)	prognostic favorable (1.86e-4)	2.1	3.6	42.5	2.2	38	7.6	2.2	8.7	71.6	2	2.7	102.9	0	2.8	2.3	2.9	2.5	2.2	2.9	2	48.1	37.6	2	2.1	2.1	2.1	82.7	16.1	1.6	1.6	2.4	1.2	2.2	72.5	3.5	2.3	0	3.2	3	2.1	11.5	3	2	138.1	2.3	3.1	2.5	46	0	2	0	2	2.5	0.3	0.8	1.6	0	0	10.5	1.2	0.1	1.8	2	3.3	3.4	0.6	0.5	8.2	0.2	0.5	0	0.2	1	6.4	3.3	1.5	0.5	0.2	5.8	0	0.7	0.4	1.9	2.7	2	1.7	0.9	0.3	0.6	5.3	1.6	2.6	2.4	2.4	3.3	0.3	6.7	1.5	9.5	0.6	6.7	0.2	1	3.8	1.1	0.9	1.4	0.7	1.5	2.3	10.7	2.9	5.8	0.7	0.7	3.8	6.9	10.8	1.1	0.5	1	5.3	1.7	0.5	20.9	4.6	2	0.2	7.5	0.9	0	0	0	0.4	0	1.2	0.8	0.6	0.2	0	0.1	0	0	0	10.5	0	1.6	0.1	0.1	42.5	38	8.7	34.4	48.1	37.6	82.7	16.1	72.5	46	0	0.3	0	0.2	1.1	3.2	2.8	0	0	0	0	0	0.1	0	0.5	0.2	0.7	0.7	0	3	0.1	0.6	0.7	1.1	0.9	0.5	6.4	4.1	0.6	0.6	0.6	0.3	0.7	0	0	0.4	71.8	1.3	0	2.1	0	10.3	0	0.2	0.7	0.4	1.3	0.2	4.6	0.9	0.4	Muller glia cells
MYL3	CMH8, MLC1SB, MLC1V, VLC1	ENSG00000160808	Myosin light chain 3	P08590	3	46857872-46882169	Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins		Motor protein, Muscle protein, Myosin	Cardiomyopathy, Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	12	heart muscle: 398.1;skeletal muscle: 319.8	Cell type enriched	Detected in some	65	Cardiomyocytes: 3031.1	Cancer enhanced	Detected in many		renal cancer: 8.8	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	5	RPTEC TERT1: 28.5	Not detected	Not detected			Not detected	Not detected			HPA016564, CAB018662, HPA046859, HPA063034	Enhanced		Approved	Nucleoli,Mitochondria					15000000	Nucleoli, Mitochondria		CAB018662: AB_627952, HPA016564: AB_1854244, HPA046859: AB_2679842, HPA063034: AB_2684927	unprognostic (3.11e-1)	unprognostic (2.64e-2)	unprognostic (5.55e-2)	unprognostic (1.51e-1)	unprognostic (1.77e-1)	unprognostic (4.44e-2)	unprognostic (9.67e-3)	unprognostic (3.37e-2)	unprognostic (4.72e-3)	unprognostic (3.63e-2)	unprognostic (1.08e-1)	unprognostic (7.88e-2)	prognostic favorable (1.22e-8)	unprognostic (1.16e-3)	unprognostic (9.45e-3)	unprognostic (7.18e-5)	unprognostic (2.53e-3)	0.9	0.2	0.5	0.2	0.4	0	0.6	0.2	0.4	0.5	0.1	0.3	0	0	0.2	10.1	10.5	0.1	0.2	398.1	0.7	0.4	2.3	0.1	0.2	0.1	0.7	0.3	0.3	0.1	0	0	0.3	0.3	1.6	0	0.3	5.5	0	319.8	0.1	0	0.1	0.8	0.4	0	0.1	0.4	0	1.1	30.1	3.1	0.2	0.2	0	0	0.7	0	0	0	0	0	0	0	0	3.2	0.9	1.6	0.3	0.1	0	0.1	5.9	0	0	0.9	0	0	0	0.3	0	0.1	0	0	0.1	0	0	0.2	0	0	6.2	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	28.5	0	0	0	0	0	0	0.3	0	0.2	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0	0.5	0.4	0.2	0.4	0.7	0.4	0.7	0.3	0.3	0.4	0	0	0	0.1	0.7	0.1	3031.1	0	0	0	1.8	0	0.4	46.4	0	2	0.3	0	0	0	5	7.1	0	0	0	0.3	0	0	0	0	8.5	1.1	0	0	0	0	2.2	0	0	0.7	46.2	0.4	6.5	1.3	0	0.4	0.4	0.7	0	0	0	Cardiomyocytes
CYP3A4	CYP3A3	ENSG00000160868	Cytochrome P450 family 3 subfamily A member 4	P08684	7	99756960-99784265	Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins	Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol metabolism	Monooxygenase, Oxidoreductase	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	45	intestine: 145.3;liver: 464.6	Cell type enriched	Detected in some	45	Hepatocytes: 2276.5	Cancer enriched	Detected in some	240	liver cancer: 351.3	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		BEWO: 4.2;NB-4: 4.5;RPMI-8226: 6.7;SCLC-21H: 2.6;SH-SY5Y: 5.0									CAB033671, HPA072245, HPA075539	Enhanced		Approved	Vesicles,Cytosol						Cytosol	Vesicles	CAB033671: AB_782375, HPA072245: , HPA075539: 	unprognostic (4.55e-2)	unprognostic (8.95e-2)	unprognostic (8.08e-2)	unprognostic (1.63e-1)	unprognostic (5.89e-2)	unprognostic (5.37e-2)	unprognostic (7.07e-3)	unprognostic (9.09e-2)	unprognostic (8.27e-3)	unprognostic (4.92e-2)	unprognostic (3.78e-2)	unprognostic (6.42e-2)	unprognostic (1.89e-8)	unprognostic (2.59e-1)	unprognostic (1.75e-2)	unprognostic (9.79e-2)	unprognostic (6.82e-2)	0.1	0.4	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	145.3	0.1	0.1	56	0.1	0.1	0.1	0	0.1	0.1	0.1	0	0.2	464.6	0.1	0.1	0.1	0.1	0.1	6.8	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.2	126.7	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.4	0.2	0.6	0.2	0.6	0.2	0.2	0	0.1	0	0	0	0	4.2	0	0	0	0	0	0	1	0	0	0	0.3	0	0	0	0	0	1.4	0.1	0.2	0	1.9	0.4	0	1.2	0	0.4	0	0	0.1	0.5	0	0.5	0	0.1	4.5	0.3	0	0	0	2.2	6.7	0	0.5	2.6	5	0.5	0	0	0	0.1	0	0.8	0	0	1.4	0	0.7	0.1	0.7	0.1	0.7	0.1	0.3	0.2	0	0	0	0	0	0.1	0	0	0.4	0.1	0.2	0.6	0.6	0	0.2	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	4.3	1	0.3	0	0.3	40.8	0	0	0	0	0.1	0	0.1	0.3	0	2.6	46.7	0.8	0	0	0.5	0	2276.5	0	0	0	39.3	50.2	0	0	0	0	0	0.7	0	0.1	0.3	0	1.4	0	0	0	0	0	0.6	0.1	0	0.4	0.9	Hepatocytes
CYP3A7	CP37, P450-HFLA	ENSG00000160870	Cytochrome P450 family 3 subfamily A member 7	P24462	7	99684957-99735196	Enzymes, Predicted membrane proteins	Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis	Monooxygenase, Oxidoreductase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	21	liver: 82.6	Cell type enriched	Detected in some	7	Cholangiocytes: 135.0	Cancer enriched	Detected in some	43	liver cancer: 38.0	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	4	BEWO: 1.9;BJ hTERT+: 3.3;Hep G2: 6.4;HHSteC: 3.7;RT4: 1.9									HPA072245, HPA075539			Approved	Vesicles,Cytosol						Cytosol	Vesicles	HPA072245: , HPA075539: 	unprognostic (8.10e-3)	unprognostic (1.45e-1)	unprognostic (3.12e-1)	unprognostic (5.47e-2)	unprognostic (1.73e-1)	unprognostic (1.44e-1)	unprognostic (4.41e-2)	unprognostic (1.50e-1)	unprognostic (1.34e-2)	unprognostic (8.28e-2)	unprognostic (8.18e-2)	unprognostic (1.97e-1)	unprognostic (1.06e-11)	unprognostic (2.02e-2)	unprognostic (5.87e-2)	unprognostic (2.97e-1)	unprognostic (1.34e-3)	0.1	0.4	0.1	0.1	0	0	2.6	0.1	0.1	0	0.7	0	0	0.1	0.3	0.1	0.2	0	3.9	0	0.1	0	2.8	82.6	0.6	0	0	0.1	0.1	0.3	0	0	0.2	0	0.4	0	0	0.1	0	0	0.1	1.5	0	0	0	0	0.1	0.1	0	0	0	0	0.1	0.4	0	0	0	0	0	0.3	0	0	0	0.3	0	0	0.4	1.9	0	3.3	0	0	0	0	0	0.3	0	0	0.6	0	0	0	0	0	0	0.3	6.4	3.7	0.5	0	0	0	0.1	0	0	0	0	0	0	0.2	0	0	0.3	0	0	0	0	0	0	0	1.9	0	0	0.1	0	0	0.8	0	0	0	0.3	0	0	0	0.1	0.2	0	0	0.1	0	0	0	0	0.1	0	0	0	0.3	0.3	0	0	0.2	0	0	0	0	0	0	0	0.1	0	0.1	0.1	0.1	0	0	0.1	0	0.1	0	0	0	1.1	0	0	0	135	0	0	0	0	0	1.7	0	0	0	0	0	0	0	0	0.5	0	18.4	0.1	0	0	4.9	3.7	0	0	0	3.3	0	0	0	0.2	0	0	2.2	0	0	0	0	0	0	0.3	0	0	0.1	Cholangiocytes
PTGER1	EP1	ENSG00000160951	Prostaglandin E receptor 1	P34995	19	14472466-14475362	FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters		G-protein coupled receptor, Receptor, Transducer	FDA approved drug targets	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in many		kidney: 13.6;lymphoid tissue: 14.2	Cell type enriched	Detected in some	75	Collecting duct cells: 188.5	Cancer enhanced	Detected in many		ovarian cancer: 4.1	Low region specificity	Detected in many			Cell type enhanced	Detected in some		intermediate monocyte: 1.5;NK-cell: 2.6	Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		HEL: 5.4;NB-4: 2.9;PC-3: 7.2;SH-SY5Y: 4.2	Low region specificity	Detected in single			Not detected	Not detected																unprognostic (3.44e-2)	unprognostic (3.31e-1)	unprognostic (2.68e-1)	unprognostic (3.50e-4)	unprognostic (8.69e-2)	unprognostic (5.58e-2)	unprognostic (2.39e-2)	unprognostic (3.19e-2)	unprognostic (2.05e-1)	unprognostic (3.53e-2)	unprognostic (1.41e-1)	unprognostic (1.42e-1)	unprognostic (7.74e-8)	unprognostic (1.19e-1)	unprognostic (4.41e-2)	unprognostic (4.27e-3)	unprognostic (4.88e-2)	0.7	1.4	1.1	2.7	1.3	0.2	1.5	0.6	1.2	1.3	1.5	0.1	0	1.2	0.4	0.3	1.7	1	0.4	3.1	0.4	0.4	13.6	0.5	4.9	6.7	1.8	0	1.6	1.8	0.2	1.4	0.3	1	0.5	0.3	0.3	0.3	0.4	0.7	0.2	1.9	1.4	0.1	14.2	3.2	0.4	0.6	0	0.7	0	0.3	0.6	1.3	0	0.4	0	1.5	2.6	1.1	0.2	0.2	0.1	0	0	0	0	0.3	1.4	0	0	0	0.1	0	0	0.2	0.1	0	0.1	0	0	0	0	0.3	5.4	0	0.3	0.6	0	0.1	0.1	0	0.2	0	0.1	0	0.2	0.6	0	0	0	0	2.9	0.3	0	7.2	0.8	0	0.2	0	0.1	0.5	4.2	0.1	0.1	0.2	0	0.2	0.4	1.3	0.1	0.1	0.2	0.1	0	0.1	0	0.2	0	0	0	0.1	0	0.1	1.5	0	0	0	1.1	0.4	0	0	0	0	2.6	0.5	0	0	0.2	1.1	1.3	0.6	1.2	0.4	0.4	1.8	0	1	0.6	0	0	0	0.2	0	0.4	0.8	2.5	0	0	188.5	0	0.1	0	0	0.1	0	0	0	0	0.1	0.2	0.8	0	0.5	0.3	0	0	0.6	0	0	0.3	0	0	0	0	0.3	1.1	0	0	0.3	0	0	0.6	0.2	0.7	0	0	0	0	0.2	Collecting duct cells
CCDC105	FLJ40365	ENSG00000160994	Coiled-coil domain containing 105	Q8IYK2	19	15010744-15023269	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	94	testis: 38.7	Cell type enriched	Detected in some	8	Early spermatids: 149.8	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Low region specificity	Detected in some			Low region specificity	Detected in many			HPA058585	Approved											HPA058585: AB_2683763																		0	0	0	0	0.4	0	0	0	0.1	0	0	0	0	0	0	0.2	0	0	0	0	0.1	0	0	0	0	0	0	0.1	0	0.2	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	38.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0.1	0.1	0	0	0.1	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	149.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	19.4	0.6	0	0	0	0	0	0	0	0.7	0	0	0	0	2.1	0.9	0	0	0	0	0	Early spermatids
PGLYRP2	PGLYRPL, PGRP-L, PGRPL, tagL, tagL-alpha, tagl-beta, TAGL-like	ENSG00000161031	Peptidoglycan recognition protein 2	Q96PD5	19	15468645-15498956	Enzymes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins	Immunity	Hydrolase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	13	liver: 95.8	Cell type enriched	Detected in some	16	Hepatocytes: 136.1	Cancer enriched	Detected in some	16	liver cancer: 42.9	Not detected	Not detected			Low cell type specificity	Detected in many			Group enriched	Detected in many	7	granulocytes: 3.6;monocytes: 7.1;T-cells: 3.7	Group enriched	Detected in some	6	MCF7: 10.9;T-47d: 10.9	Not detected	Not detected			Not detected	Not detected			CAB033468, HPA046311, HPA075237	Supported		Approved	Cell Junctions	Secreted to blood				160000000000	Cell Junctions		CAB033468: AB_1127187, HPA046311: AB_2679621, HPA075237: AB_2686739	unprognostic (7.39e-3)	unprognostic (1.52e-2)	unprognostic (5.22e-2)	unprognostic (8.79e-2)	unprognostic (3.97e-1)	unprognostic (4.88e-4)	unprognostic (5.93e-3)	unprognostic (6.48e-2)	unprognostic (1.99e-1)	unprognostic (1.18e-2)	unprognostic (3.15e-2)	unprognostic (2.40e-1)	unprognostic (6.66e-16)	unprognostic (6.35e-3)	unprognostic (2.80e-1)	unprognostic (2.45e-2)	unprognostic (2.81e-4)	0	0	0	0	0	0	0.5	0	0	0.3	0	0	0	0	0	0.3	0	0	0	0	0	0	0	95.8	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	7	0	0	0	0	0	0	0	0.3	0.2	3.6	7.1	0.6	3.7	1.3	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0.2	0	0.1	0	0	0	0	0	0	0	0	1.7	0	0.1	0	0	0	0	0	0	0	0	0.1	0	0	10.9	0	0	0.1	0	0	0	0.5	0.1	0	0.7	0	0	0.2	0	0	0	10.9	0	0.1	0	0	0	0	0	0	0.2	0	0.4	0	3.6	0.7	0.3	2.6	2.4	2.5	0.3	1.6	1.3	0.2	0	3.6	3.7	2.5	0.6	7.1	0	0.1	1.3	0	0	0	0	0	0	0	0	0	0	0	0	0.9	0.2	0	0	0.2	2.5	0	0	0	0	0	0	0	2	0	0	0	0	0.1	0	0.3	0	136.1	0.3	0	0	3.1	1.3	2.5	0.3	0	8.5	0	0	0	0	0	0	0	0	0	0	0.1	0.2	0.1	0	2.9	0	0	Hepatocytes
CELF5	BRUNOL5	ENSG00000161082	CUGBP Elav-like family member 5	Q8N6W0	19	3224703-3297076	Predicted intracellular proteins	mRNA processing	RNA-binding		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	5	brain: 35.8	Cell type enriched	Detected in some	6	Bipolar cells: 91.5	Cancer enhanced	Detected in some		glioma: 2.6	Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		NTERA-2: 6.1;REH: 7.5;SCLC-21H: 7.8;SH-SY5Y: 4.7	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA042012, HPA060336	Enhanced	Supported										HPA042012: AB_10796896, HPA060336: AB_2684256	unprognostic (1.09e-1)	unprognostic (9.24e-2)	unprognostic (9.25e-3)	unprognostic (3.48e-2)	unprognostic (1.69e-1)	unprognostic (5.44e-2)	unprognostic (2.06e-1)	unprognostic (1.17e-1)	unprognostic (1.22e-3)	unprognostic (1.35e-1)	unprognostic (4.70e-3)	unprognostic (1.11e-2)	unprognostic (1.74e-3)	unprognostic (1.23e-2)	unprognostic (2.63e-2)	unprognostic (1.25e-1)	unprognostic (8.07e-2)	0.8	1.1	16.2	0.8	21.2	0.7	1.5	19.6	35.8	0.8	1	0.8	0	0.8	1.3	1.1	0.8	1.5	0.7	0.8	9.5	12.2	0.8	0.8	0.8	0.7	2.6	15.5	7.1	1.1	2.6	0.5	0.8	3.4	0.9	1	0	2	1	1.3	0.8	0.9	0.8	0.9	0.8	1.2	2.5	2.7	0.2	0.8	0	0.7	0.7	0	0.1	0	0.1	0.2	0	0.2	0	0	0.4	1.3	1.7	0	0	1.3	0	0.1	0.1	0	0	0.3	0	1	0	0.4	0.1	0.2	0	0	0.4	0.3	0	0	0.1	0	0	0.1	0	0	0	0	0	0	1.3	2.1	0.1	0	1	0.1	0	6.1	2.4	0.1	7.5	0	0	0	0	7.8	4.7	0.3	0.5	0	0.3	0.8	0	0	0	0.2	0.1	0	0	0	0	0.2	0	0	0	0.2	0.1	0.2	0	0	0	0	0	0	0.1	0	0	0.1	0	0	0	0	0	16.2	21.2	19.6	19.6	9.5	12.2	2.6	15.5	3.4	2.7	0	0	0	1.7	0.3	91.5	1.7	5.1	0	0	0	0	0.3	0	0.5	15	0	0.2	0	0.2	0.1	0.2	1.6	0	0.4	0.1	7.9	1.2	0	0	10.5	0.3	0	0	0	0.9	2	0.7	0	2.1	0	3.5	0	0.5	1.1	8.3	0.3	0	0	1.2	0.8	Bipolar cells
DMKN	ZD52F10	ENSG00000161249	Dermokine	Q6E0U4	19	35497220-35513658	Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	6	skin 1: 365.3	Cell type enriched	Detected in many	5	Suprabasal keratinocytes: 7442.2	Low cancer specificity	Detected in many			Region enhanced	Detected in many		pons and medulla: 9.5	Cell type enhanced	Detected in many		NK-cell: 11.1	Group enriched	Detected in many	5	NK-cells: 11.1;T-cells: 7.0	Cell line enhanced	Detected in many		A-431: 32.0;CACO-2: 39.6;CAPAN-2: 34.0;HBEC3-KT: 51.9;RPTEC TERT1: 51.3									HPA029406	Enhanced		Approved	Nucleoplasm,Cytosol	Secreted in other tissues				29000000	Nucleoplasm, Cytosol		HPA029406: AB_10603661	unprognostic (5.70e-2)	unprognostic (2.36e-2)	unprognostic (3.64e-2)	unprognostic (1.03e-1)	unprognostic (1.28e-2)	unprognostic (2.48e-2)	unprognostic (3.82e-2)	unprognostic (3.23e-1)	unprognostic (1.03e-1)	unprognostic (8.82e-2)	unprognostic (2.54e-1)	unprognostic (9.93e-2)	prognostic favorable (5.37e-6)	unprognostic (3.50e-1)	unprognostic (1.58e-1)	unprognostic (1.29e-1)	unprognostic (2.08e-1)	1.4	1.1	0.6	0.5	4.7	0.6	23.9	0.7	2	54.8	1.2	1.1	2.5	1	5.6	9.2	25.3	8.7	0.6	1.4	0.7	1.1	11.3	0.8	8.8	0.5	0.9	0.6	11.7	29.5	4.7	13.3	1.7	9.5	5	1	9.5	8.2	9.1	2.4	365.3	1.2	0.9	0.9	0.6	1.8	0.8	2.3	3.1	25.9	62.9	16.9	3.5	27.5	1.7	0.2	0	0	11.1	7	1.2	32	5.2	0	0	1.3	2	9	0.1	4.3	0.2	0.3	39.6	34	0	13	0.3	1.6	18	9.8	51.9	0.4	0.1	9.5	0	0	8.8	1.5	0	0.1	17.8	14	0.9	30.2	3	0	0	0.1	0	0.1	28	0	0	28.8	23.3	2.1	0	0	1.3	51.3	21.2	0.1	0	7.8	0	3.1	8.6	13	0	0	5	15.2	0.1	0.1	0.2	0	0.2	4.2	0	0.3	0	0	0	7	0	6.1	1.7	0.6	3.4	0	0.2	0.1	2.4	0	11.1	0	0.2	0	1.2	0.6	4.7	0.7	2	0.7	1.1	0.9	0.6	9.5	2.3	98.3	94.2	3.7	121.7	1442.2	1.4	15.2	94.3	261	92.1	193.7	0	0.7	195.6	125.9	15	6	1.3	0	120.1	1.1	57.3	55.5	7	2	1	0	47.4	5.5	0.8	67.8	12	5.1	290.1	4.6	4.2	9.3	137.6	5.8	14.9	4.4	0.7	0	14.2	7.1	16.4	7442.2	1.9	5.3	11	72.7	Suprabasal keratinocytes
COX7A1	COX7A, COX7AH	ENSG00000161281	Cytochrome c oxidase subunit 7A1	P24310	19	36150922-36152869	Predicted intracellular proteins, Predicted membrane proteins, Transporters		Oxidoreductase		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in all	4	heart muscle: 114.9;skeletal muscle: 404.3	Cell type enriched	Detected in many	28	Cardiomyocytes: 19391.7	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enhanced	Detected in some		classical monocyte: 1.9	Group enriched	Detected in many	8	dendritic cells: 1.3;granulocytes: 1.4;monocytes: 1.9	Cell line enhanced	Detected in some		ASC diff: 24.5;ASC TERT1: 18.0;BJ: 16.5;BJ hTERT+: 13.7;fHDF/TERT166: 25.1;HHSteC: 16.3;HSkMC: 16.9	Low region specificity	Detected in all			Low region specificity	Detected in all																unprognostic (5.48e-2)	unprognostic (1.19e-1)	unprognostic (6.13e-3)	unprognostic (6.46e-3)	unprognostic (5.33e-2)	unprognostic (3.87e-2)	unprognostic (3.77e-2)	unprognostic (9.93e-2)	unprognostic (1.92e-1)	unprognostic (1.41e-1)	unprognostic (9.49e-2)	unprognostic (1.46e-1)	unprognostic (7.84e-3)	unprognostic (7.27e-3)	unprognostic (9.44e-2)	unprognostic (6.23e-2)	unprognostic (1.54e-2)	15.7	8.1	5.3	2.5	3.6	1.2	8.8	2.1	13.1	4.1	8	0.8	2.6	2	3.9	6.1	6.6	3.1	5	114.9	3.3	2.4	5	1.6	4	2.7	2.6	4.6	4.2	3.5	6	7.9	2.6	1.7	5.9	2.3	5.9	6.2	7.1	404.3	2	2.2	12.3	1.4	3.1	3.6	1.6	1.5	1.6	5.1	59.7	2.6	7	4.7	0	1.3	1.4	1.9	0	0.1	0.3	0.1	2.6	0.2	0	24.5	18	0.1	16.5	13.7	0.5	0	0	0.8	0.6	6.9	25.1	0	0.3	0	0	0.1	0.1	0.9	0.1	0.9	0.1	16.3	0	0.2	16.9	0	0	0	0	1.9	0	0.2	0.2	0	0.3	0	0.1	0.4	0.3	0.6	0	0	0	0	0.7	0	0.2	0	0	0	0	0.2	0.1	3.7	0	0.6	0.2	0.1	0.4	0.4	0.3	0.1	0.3	0.5	0	1.9	0	0	1.6	0	0	0	0	1.3	0	0.1	0	1.4	0	0.5	0.4	0.1	0.3	5.3	3.6	2.1	13.1	3.3	2.4	2.6	4.6	1.7	1.5	0	9	5.9	1.3	23.5	71.7	19391.7	25.5	1.4	3.4	21	43.2	1	693	10.8	13.4	160.8	0	0	12.2	0.9	86.2	2.4	43.9	4.4	18.4	63.5	0	239.4	11.6	76	207.9	6	269.9	0	0	16.2	9.2	0	264.5	128.7	56.3	181.1	233.8	1.5	3.2	16.7	1.6	2.5	0	0.6	Cardiomyocytes
PLXDC1	TEM3, TEM7	ENSG00000161381	Plexin domain containing 1	Q8IUK5	17	39063303-39154394	Predicted intracellular proteins, Predicted membrane proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	7	Bipolar cells: 313.9	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		BJ hTERT+: 13.2;MOLT-4: 4.1;U-87 MG: 8.6	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA012805	Approved				Intracellular and membrane				6000000			HPA012805: AB_1857893	unprognostic (4.28e-1)	unprognostic (3.55e-1)	unprognostic (2.56e-2)	unprognostic (2.15e-1)	unprognostic (9.50e-2)	unprognostic (1.13e-2)	unprognostic (2.35e-2)	unprognostic (2.23e-2)	unprognostic (4.07e-3)	unprognostic (6.07e-3)	unprognostic (4.62e-3)	unprognostic (8.69e-2)	prognostic unfavorable (9.15e-8)	unprognostic (9.37e-3)	unprognostic (1.72e-2)	unprognostic (2.42e-1)	unprognostic (2.33e-2)	6.1	3.5	6.6	5.7	13.8	1.4	10	13.3	13.8	6.9	5.1	5	5.9	2.4	15.1	7.8	14.6	10.4	17.1	18.4	7.6	6.3	3.7	1	5	6	7.8	6.3	18.2	4.3	1.3	3.1	2.7	7.5	5.2	3.7	19.7	4	6.6	8.4	5.1	5	13.2	3.7	2.3	4.5	6	4.8	27.8	3.4	10.5	10.8	5.9	5.2	0.3	2	1	0.3	2.2	4.9	1.6	0.1	0	0.2	2.1	0.4	0	0.3	0.2	13.2	1	0.6	0.2	3.1	0.2	0.3	0.4	0.1	0.3	0.3	0.2	0.7	0.1	1.1	0.4	1	0.1	0.3	0.5	0.1	0.5	0.2	0.5	0.1	0.2	0	1.3	0.1	0.9	0.1	1.5	4.1	0.4	0.5	0.1	0	0.5	0.7	0.5	0	0.1	2.1	0.2	0.1	0.3	0	0.3	0.3	0.3	0	1.6	0.9	0.6	0.3	0.2	0.1	0.2	8.6	0.6	0.2	0.5	0.3	0.2	3.8	0.1	3.3	0.2	1.3	1.4	0	0.3	4.9	4.9	1	2.2	0.1	2	0.1	1.6	6.6	13.8	13.3	13.8	7.6	6.3	7.8	6.3	7.5	4.8	0	12.2	0	0.8	4.6	313.9	3.2	0	2.7	3.4	0	19.6	0.1	0	0	1.8	3.4	0	0	0.2	0.1	12.1	0.8	1.1	0	0.1	6.4	0	0.6	1	5.5	0.6	3.5	6.8	8.2	0	12	0.1	0	1.1	0	23	45.3	22.1	0.5	0.6	3.9	0	4.3	0	0.4	Bipolar cells
DCD	AIDD, DCD-1, DSEP, HCAP, PIF	ENSG00000161634	Dermcidin	P81605	12	54644591-54648493	Plasma proteins, Predicted secreted proteins, Transporters		Antibiotic, Antimicrobial, Fungicide, Hydrolase, Protease		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	19	breast: 84.3;skin 1: 197.7	Cell type enriched	Detected in some	386	Melanocytes: 7747.1	Cancer enriched	Detected in some	9	breast cancer: 91.2	Not detected	Not detected			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Cell line enhanced	Detected in some		Karpas-707: 3.9									HPA063967	Enhanced				Secreted in other tissues				370000000			HPA063967: AB_2685163	unprognostic (3.55e-2)													unprognostic (1.61e-1)				7.3	0	0.1	0.1	0.1	0.2	84.3	0.1	0.1	0.1	0.1	0.1	4.4	0	0.1	0.1	0.3	0	0.1	0.1	0.1	0	0.6	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.1	4.6	0.1	2.7	197.7	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	1.3	0.1	0.1	0.1	1.8	1.8	5.2	2.2	3.2	2.5	0.8	0.7	0.9	1.6	1.4	0.8	1.2	1.7	1.9	0.3	0	1.1	0	1.8	0.7	0.6	0	0.1	0	0	0	0	0.6	2.4	2.1	0.8	0.5	0	0.4	1.4	0.7	0.4	0	0	0.2	0.4	0.2	1.1	3.9	0	0	0	1.5	0.6	0	0.7	1	0.7	0.3	0	0.8	1.6	1.1	0	1.4	0.4	1.3	0.5	0.6	0	1.1	0.9	0.9	0.1	0	0.6	0.3	0.3	1	0.2	5.2	1.6	2	1.4	1.2	2.5	1.8	1.7	1.4	1	1.7	2.1	2.3	3.6	3.2	2.2	1.8	1.9	0.8	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	0	0	11.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	7747.1	0	0	0	0	0	0	0	0	0	0.1	0.1	0.1	20.1	0	0	0	0	Melanocytes
ITGA5	CD49e, FNRA	ENSG00000161638	Integrin subunit alpha 5	P08648	12	54395261-54419460	Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins	Cell adhesion, Host-virus interaction	Host cell receptor for virus entry, Integrin, Receptor	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		smooth muscle: 137.7	Cell type enriched	Detected in many	4	Extravillous trophoblasts: 377.0	Low cancer specificity	Detected in all			Low region specificity	Detected in many			Cell type enhanced	Detected in many		neutrophil: 31.5	Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		hTERT-RPE1: 67.2;HUVEC TERT2: 141.7;TIME: 134.9;U-87 MG: 67.3	Region enriched	Detected in single	7	basal ganglia: 9.3	Not detected	Not detected			HPA002642, CAB009008	Enhanced								23000000			CAB009008: AB_647474, HPA002642: AB_1078469	unprognostic (7.51e-3)	prognostic unfavorable (4.07e-6)	prognostic unfavorable (8.43e-4)	unprognostic (1.58e-1)	unprognostic (8.51e-3)	prognostic unfavorable (2.91e-4)	prognostic unfavorable (2.23e-5)	prognostic unfavorable (2.44e-4)	unprognostic (2.76e-2)	unprognostic (6.19e-2)	unprognostic (8.99e-2)	unprognostic (8.28e-2)	prognostic unfavorable (1.32e-8)	unprognostic (2.11e-3)	unprognostic (3.35e-2)	prognostic unfavorable (8.89e-4)	unprognostic (2.18e-3)	23.3	7.9	2.1	32.2	2.8	9.2	30.5	1.2	2.2	16	66.9	2.2	19	3.4	19.3	13.8	18.2	12	12.4	20.3	2.9	0.8	4.6	15.2	20.4	9.2	3.2	1.2	13.6	5.3	3.7	1.8	57.7	3.3	26.6	10.2	4.9	4.4	28.9	10	8.8	14.9	137.7	3.5	3.1	19.7	6.6	2.5	3	7.3	5.8	4.5	82.1	20.6	0.1	22.2	31.5	22.9	9.1	5.6	12.4	6.6	2.4	4.6	0	14.4	30.6	12.1	30.2	31.4	31.1	23	1.7	1.5	0	22	31.5	15.7	1	1.2	8.4	21.6	0	1.2	2.9	3.4	0.1	19.9	9	4.6	22.1	4.2	36.5	28	67.2	141.7	1.5	2.4	0	17.6	0.6	1.4	10.1	1.9	0.4	2	1.4	3.1	0.6	4.9	0.1	0	0	6	0.4	0.2	10.6	0.7	8.2	134.9	37.9	6.7	9.2	12.5	0	0.3	0	67.3	8.6	12.3	5.6	22.9	0.1	5.6	10	4.4	0	4.2	4.2	22.2	0.1	3.1	2.6	31.5	9.1	7.6	1.2	1.7	12.4	2.1	2.8	1.2	2.2	2.9	0.8	3.2	1.2	3.3	2.5	3	4.1	1.4	2.7	12.7	0.8	13.2	5.1	1.4	4.5	0	0	2.7	0	32.2	0.1	93.4	0	0	3	377	54.1	3.6	19.6	20.7	27.5	0	0	77.3	18.7	0.4	6.1	35.5	10.1	9	0	0	7.2	0	4.2	0	1.3	12.9	33.1	0	0.7	9.4	28.9	8.2	0	1.7	Extravillous trophoblasts
SPC24	FLJ90806, SPBC24	ENSG00000161888	SPC24, NDC80 kinetochore complex component	Q8NBT2	19	11131520-11155808	Predicted intracellular proteins	Cell cycle, Cell division, Mitosis			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		lymphoid tissue: 58.0	Cell type enriched	Detected in many	5	Erythroid cells: 70.0	Low cancer specificity	Detected in all			Low region specificity	Detected in many			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low cell line specificity	Detected in many			Low region specificity	Detected in many			Low region specificity	Detected in single			HPA051234	Approved		Supported	Nucleoplasm,Nucleoli			Yes			Nucleoplasm	Nucleoli	HPA051234: AB_2681397	unprognostic (1.57e-1)	prognostic favorable (3.59e-4)	unprognostic (6.79e-2)	unprognostic (1.07e-3)	unprognostic (4.04e-1)	unprognostic (2.98e-2)	prognostic unfavorable (1.46e-4)	unprognostic (1.21e-2)	unprognostic (1.69e-2)	unprognostic (1.12e-2)	prognostic unfavorable (1.22e-4)	unprognostic (6.12e-2)	prognostic unfavorable (0.00e+0)	unprognostic (1.62e-2)	unprognostic (3.52e-2)	unprognostic (2.25e-1)	unprognostic (8.82e-2)	2.8	3.2	1.1	9	1	19.4	3.8	0.4	1.9	2.8	4	0.8	0.9	3.5	2.2	2.8	8.4	1.4	2.4	8.2	1	0.4	1.8	2.6	4.2	4.9	0.6	1	1.1	1	0.1	1	5.9	0.6	1.4	3.5	0.8	2.4	1.5	2.7	3.2	4.4	6.7	0.7	5.5	4	13.3	0.7	58	0.9	12.8	12.2	2.3	3.2	1.9	1.3	7.2	1.4	4.2	3.7	0.7	26.2	9.9	13.7	11.1	1.9	3.6	6.2	15.4	5.7	14.6	16.6	10.4	9	20.8	17.6	6.8	8.5	14.3	10.6	11	10.8	11	9.1	28	23	15.4	0.4	19.6	12.5	0.7	0.4	10.4	4.8	3.8	12.8	23	14.9	43.9	10.1	17.3	26.7	11.9	9.6	7.3	16	21.4	21	6.7	4.3	8.7	14.3	10.3	13.5	8.4	3.6	6.8	8.3	7.1	12.1	13.8	14.7	18.5	18.4	26.8	13.8	20	10.2	19.4	11.2	4.1	1.4	1.5	1.4	1.2	1.2	1.9	2.3	3.4	0.5	1.9	2.7	1.7	7.2	4.2	1.3	1.3	3.7	0.7	1.1	1	0.4	1.9	1	0.4	0.6	1	0.6	0.7	0	0.3	0	0.8	1	0	7	2.5	0	1.2	5.2	5.9	3	0	0.2	0.1	0.1	0.7	70	0	13.5	4	0.3	5.7	0	11.2	0	2.4	2.5	2.8	1.7	0.6	1.3	0	0	1.1	0.9	0.2	0	0.4	0.4	0.3	0	0.3	6.5	10.1	0.3	1.7	2.2	2.9	0.4	Erythroid cells
ALOX15	15-LOX-1	ENSG00000161905	Arachidonate 15-lipoxygenase	P16050	17	4630902-4642294	Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins	Fatty acid metabolism, Lipid metabolism	Dioxygenase, Oxidoreductase		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		adipose tissue: 27.9;blood: 89.8;lung: 24.4	Cell type enriched	Detected in some	15	Ciliated cells: 210.1	Low cancer specificity	Detected in many			Low region specificity	Detected in single			Cell type enriched	Detected in single	183	eosinophil: 89.8	Lineage enriched	Detected in single	183	granulocytes: 89.8	Group enriched	Detected in some	7	HMC-1: 16.5;MCF7: 14.3;T-47d: 4.4	Not detected	Not detected			Low region specificity	Detected in many			CAB004962, CAB004963, HPA013859	Approved											CAB004962: , CAB004963: , HPA013859: AB_1844758	unprognostic (5.31e-4)	unprognostic (1.43e-2)	unprognostic (2.81e-2)	unprognostic (8.36e-3)	unprognostic (2.22e-1)	unprognostic (8.60e-2)	unprognostic (2.36e-1)	unprognostic (2.66e-2)	unprognostic (1.70e-2)	unprognostic (1.84e-2)	unprognostic (2.51e-2)	unprognostic (3.77e-1)	unprognostic (1.31e-3)	unprognostic (1.88e-2)	unprognostic (1.30e-1)	unprognostic (2.78e-1)	unprognostic (1.59e-1)	27.9	0.1	0.2	4.5	1.1	0.2	4.2	0.2	0.3	0.5	2.8	0.2	0.2	1.9	0.2	8.1	0.4	14.4	1.5	2.7	0.3	0.4	0.2	1.7	24.4	1.7	0.5	0.2	3	0.2	0	6.3	1.5	0.4	0.3	0.9	0.2	1	0.2	0.2	2.2	3.7	0.5	0.7	1.1	1	1.4	0.4	2	0.2	0.2	0.4	1.9	0.2	0	0.4	89.8	0	0	0	0	1.6	0	0	0	0	0	0.2	0	0	0.1	0	0.4	0	0.6	0	0	0	0.7	0	0	0	0.1	0.2	0	0	0.2	0.1	0	16.5	0	0	0	0	0	0	1.2	0	0.2	0	14.3	0	0.3	1.2	1.4	0	0	0	0.5	0	0	0	0	0	1.4	0	0	4.4	0.6	0	0	0	0	0	0	0.1	0.5	0	0.1	0	0	0	89.8	0	0	0	0	0	0	0.4	0	0	0	0.1	0	0	0.4	0	0	0.2	1.1	0.2	0.3	0.3	0.4	0.5	0.2	0.4	0.4	0	0.6	0	0	1.3	0	0.4	0	210.1	5.7	0	0	1.6	0	0	13.6	0	0	0	0	0.1	0.2	0.1	1.1	0	0.4	0	0	0	0	1.3	0	0.6	0	6.4	0	0	0	0	0	0	0	0	0.1	0.2	1.1	0.6	6.2	0	0	0.2	Ciliated cells
ASGR2	CLEC4H2	ENSG00000161944	Asialoglycoprotein receptor 2	P07307	17	7101322-7115700	Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins	Endocytosis, Host-virus interaction	Receptor		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	4	liver: 154.1	Cell type enriched	Detected in some	4	Hepatocytes: 660.0	Cancer enriched	Detected in many	66	liver cancer: 214.2	Not detected	Not detected			Group enriched	Detected in some	8	classical monocyte: 36.9;myeloid DC: 21.7	Group enriched	Detected in many	52	dendritic cells: 21.7;monocytes: 36.9	Cell line enriched	Detected in some	8	Hep G2: 107.9	Not detected	Not detected			Not detected	Not detected			HPA014899, HPA015998	Enhanced		Supported	Endoplasmic reticulum,Plasma membrane					4700000	Endoplasmic reticulum, Plasma membrane		HPA014899: AB_1845085, HPA015998: AB_1845084	unprognostic (6.76e-2)	unprognostic (7.45e-7)	unprognostic (1.61e-1)	unprognostic (2.55e-2)	unprognostic (1.03e-2)	unprognostic (4.99e-2)	unprognostic (1.16e-3)	unprognostic (1.32e-1)	unprognostic (1.81e-1)	unprognostic (9.74e-2)	unprognostic (1.63e-1)	unprognostic (1.66e-1)	unprognostic (9.35e-4)	unprognostic (1.54e-3)	unprognostic (6.95e-2)	unprognostic (1.86e-1)	unprognostic (7.31e-2)	0.2	0	0.3	1.4	0.1	1	0.1	0.1	0.2	0.1	0.1	0	0	0	0.1	0.5	0.1	0.1	3.4	0.2	0.2	0	0.2	154.1	0.5	4.1	0.1	0.1	0.2	0	0	0	0.1	0.2	0	0	0.1	0.1	0	0.2	0.9	0.1	0.1	0.1	1.6	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0	21.7	0.5	36.9	0	0.1	9.5	0	0	0	0	0	0	0	0	0	0	0	12.9	0	0	0	0	0	0	0	0	0	0	0	0	0	107.9	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	8.6	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0.2	0	0.3	36.9	0.2	0	3.8	0	0	0	0	21.7	0	0	0	0.5	0	0	0.5	0.1	9.5	0.3	0.1	0.1	0.2	0.2	0	0.1	0.1	0.2	0.1	0	9	14	0	0	0	0	152.8	0	0	0	0	0.1	1.7	0	0.3	0	0	23.3	0	0.1	0	0.1	2.3	660	6.9	0	6.8	16	35.5	0.4	0	9.9	0	0	0	0	0	0	0	2.8	0	0	0	0	0	0.3	0.3	1.5	0	0	Hepatocytes
PRR35	C16orf11	ENSG00000161992	Proline rich 35	P0CG20	16	560422-565528	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at transcript level		Tissue enriched	Detected in some	6	brain: 51.1	Cell type enriched	Detected in some	16	Collecting duct cells: 34.9	Not detected	Not detected			Region enriched	Detected in some	27	cerebellum: 51.1	Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HEK 293: 2.3;HMC-1: 1.0;K-562: 2.1;NTERA-2: 1.0;RT4: 1.3;U-2 OS: 1.4	Region enriched	Detected in single	5	cerebellum: 4.8	Region enhanced	Detected in single		cerebellum: 0.9	HPA069297	Uncertain											HPA069297: AB_2686113		unprognostic (6.96e-2)		unprognostic (3.08e-2)	unprognostic (5.25e-1)	unprognostic (8.11e-2)				unprognostic (2.56e-1)				unprognostic (3.38e-2)	unprognostic (1.17e-1)			0	0	0	0	0	0.1	0	51.1	0.2	0	0	0	0	0	0.1	0.2	0.1	0	0	0	0	0	9	0	0	0	0	0	0	2.5	0	0	0	1.8	0	0	1.1	0.1	0.2	0	0	0	0	0.6	0	0	1.4	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	2.3	0.1	0.1	0	0.1	0	1	0	0	0	0	0	0	0.1	2.1	0	0	0.2	0	0.1	1	0	0	0.1	0	0	0	1.3	0.1	0.1	0	0	0	0	0	0	0	0	1.4	0.5	0	0.6	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	51.1	0.2	0	0	0	0	1.8	0	0	0	0	0	0	0.4	0.9	0	0	0	34.9	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0.1	0	0	0	1.1	0	0	0	2.1	0	0	0	0	0	Collecting duct cells
CCDC78	C16orf25, FLJ34512	ENSG00000162004	Coiled-coil domain containing 78	A2IDD5	16	722582-726954	Disease related genes, Predicted intracellular proteins	Cilium biogenesis/degradation			Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	4	brain: 20.1;epididymis: 21.3;fallopian tube: 47.9;lung: 13.3	Cell type enriched	Detected in some	10	Ciliated cells: 57.6	Cancer enhanced	Detected in many		endometrial cancer: 7.9	Low region specificity	Detected in many			Cell type enhanced	Detected in some		MAIT T-cell: 3.2	Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		HDLM-2: 8.8;RPMI-8226: 10.3;SCLC-21H: 12.4;U-266/70: 10.2																						unprognostic (1.10e-1)	unprognostic (6.48e-2)	unprognostic (2.62e-4)	unprognostic (1.02e-2)	unprognostic (1.24e-1)	unprognostic (2.58e-2)	unprognostic (3.47e-2)	unprognostic (2.06e-2)	unprognostic (9.39e-2)	unprognostic (1.48e-1)	unprognostic (7.82e-3)	unprognostic (6.14e-2)	unprognostic (2.02e-2)	unprognostic (2.45e-3)	unprognostic (5.20e-1)	unprognostic (1.44e-1)	unprognostic (7.22e-3)	0.3	1.1	3.6	1.1	11.3	1.2	0.5	2	1.2	2.5	0.4	6.4	1.3	0.3	1.1	21.3	0.3	47.9	0.6	0.4	4.3	4.7	0.4	0.4	13.3	1.1	1.9	0.1	5.7	0.3	0.7	2.3	0.6	20.1	0.6	0.5	0.3	0.7	1	0.4	0.4	0.6	0.4	2.6	0.9	0.9	1.1	1.7	0.2	0.5	0.1	1.6	1	0.1	0.4	1.2	1.3	0	1.2	3.2	0.1	0.5	1	1.2	2.9	1.3	1.2	1.4	1.1	2.5	0.6	0.4	0.4	4.8	1	1.1	0.6	0.8	0.8	2.7	1.5	0.1	8.8	0	2.4	1.4	0	1.5	0.8	1.6	3.8	0.9	0.4	4.4	3.1	0.4	2.9	0.3	3.3	0.9	6.1	0	2.1	1.8	2.2	0.3	2.1	0.9	10.3	4.2	1.8	12.4	1.2	1.1	7.3	0.6	0.6	4.7	1.6	1	1	0.4	0	0.1	10.2	0.2	2.7	1	1.2	2.8	0	0	1.3	0.2	0	3.2	0.4	0.1	1.9	0	0.1	0	0	0	1.2	0	1.2	0.1	0.1	3.6	11.3	2	1.2	4.3	4.7	1.9	0.1	20.1	1.7	0	0	0.5	0.1	0	3.2	0.4	0	57.6	5.7	0	0	0	1.7	0	0	0	0	0	0.2	0.1	0.2	0.4	0	0	0.8	3.2	0	0	0.3	0	0.3	0	0	0	0	0.5	0.2	0	0	0	0.1	0	0	0.7	0.7	0.1	0	1.3	0	0	Ciliated cells
MEIOB	C16orf73, MGC35212	ENSG00000162039	Meiosis specific with OB domains	Q8N635	16	1833987-1884294	Disease related genes, Predicted intracellular proteins	Meiosis	DNA-binding, Exonuclease, Hydrolase, Nuclease		Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	44	testis: 41.2	Cell type enriched	Detected in some	9	Spermatocytes: 383.1	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	7	HMC-1: 12.5;K-562: 40.4;THP-1: 34.5	Not detected	Not detected			Low region specificity	Detected in all																unprognostic (7.18e-2)	unprognostic (1.91e-1)			unprognostic (3.04e-2)		unprognostic (9.73e-2)	unprognostic (1.67e-1)	unprognostic (7.68e-3)	unprognostic (2.00e-2)		unprognostic (2.68e-2)	unprognostic (7.30e-3)	unprognostic (1.34e-1)	unprognostic (3.80e-1)		unprognostic (2.18e-3)	0.1	0.1	0.8	0	0.9	0.1	0	0	0.7	0	0.2	0	0	0.2	0.1	0.1	0	0.1	0	0.1	0.6	0.3	0.9	0.3	0	0	0.1	0.8	0.3	0.1	0	0.2	0.2	0.2	0	0	0.5	0	0	0	0.6	0.1	0	0.3	0	0.1	41.2	0.1	0.5	0.1	0	0	0	0.1	0.2	0.2	0	0.4	0	0.4	0	0	0.4	0	0.1	0	0	0	0.1	0	0	0	0	0	0	0.1	0.6	0	0	0	0	0	0	0	0	0	0	0	0	12.5	0	0	0	0	0	0	0	40.4	0	0	0.6	0	0	2	0	0	0	0	0.1	0	0	0.2	0.3	4.2	0.4	0	0.2	0.4	34.5	0.5	0	0	0	0	0.1	0.1	0	0	0	0	0	0	0	0.4	0.3	0	0.1	0.1	0.3	0.2	0.2	0.1	0	0	0	0.4	0	0	0	0.8	0.9	0	0.7	0.6	0.3	0.1	0.8	0.2	0.1	0	0	0	0.2	0	0.1	0.8	0	0	0	0	0	0	0	0.2	37.8	0	0	0	0	0.1	0.2	0	4.6	0	0.1	3.2	0	0	0	10.8	1.7	0	0	0	0	0	0.1	0	1.4	2.3	0.2	6.5	0	383.1	43.7	0.4	0	0	0	0.4	Spermatocytes
CCNF	FBX1, FBXO1	ENSG00000162063	Cyclin F	P41002	16	2429394-2458854	Predicted intracellular proteins	Cell cycle, Cell division, Mitosis, Ubl conjugation pathway	Cyclin		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		lymphoid tissue: 35.7	Cell type enriched	Detected in many	6	Erythroid cells: 70.0	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Low cell line specificity	Detected in many			Low region specificity	Detected in many			Low region specificity	Detected in many			HPA060596, HPA070495, HPA071600	Enhanced		Supported	Centrosome			Yes			Centrosome		HPA060596: AB_2684329, HPA070495: AB_2686273, HPA071600: AB_2686424	unprognostic (3.87e-2)	unprognostic (2.21e-2)	unprognostic (1.57e-3)	unprognostic (3.70e-3)	unprognostic (1.24e-1)	unprognostic (1.13e-1)	prognostic unfavorable (7.46e-7)	unprognostic (2.45e-2)	unprognostic (1.75e-2)	unprognostic (1.99e-1)	unprognostic (1.01e-2)	unprognostic (1.58e-2)	unprognostic (0.00e+0)	unprognostic (1.22e-2)	unprognostic (1.10e-2)	unprognostic (4.25e-2)	unprognostic (2.74e-1)	2.1	1.8	4.1	6	3.2	9.2	5.1	11.6	4.9	2.1	3	1.9	3.6	4.4	1.5	3.4	8.1	1.5	1.5	1.8	4.3	3.9	1.7	1.6	2.2	10.5	1.9	3.1	1.8	1.7	0.8	1.8	3.8	2.4	3	3.2	0.7	3.2	3.4	2.5	7.2	3.2	1.8	1.7	4.7	2.6	5.1	2.3	35.7	1.6	3.4	14.2	5	2.9	2.7	1.4	0.1	1.1	4.1	3.1	1.7	8.4	13.4	12.9	11.8	0.8	1.2	10.1	10.2	5	14.3	11	26.6	10.4	17.9	3.5	5.7	4.2	14.4	21.3	7.9	6.8	12.7	10.1	19.6	13.9	8.1	1	12.8	12.9	0.8	1	10.1	4.8	1.8	10.6	15.1	20.8	11.7	7.2	18.4	18.7	8.5	12.7	9.1	6.1	31.4	15.1	16	3.9	3.7	12.5	7	15.2	13.3	2.8	6.7	14.2	6.6	7.3	7.9	20.5	5.6	10.6	7.2	8.6	30.9	2.3	12.8	10.7	0	1.1	0	2.8	0.6	1.7	2.7	1.5	3.1	0.5	2.6	1.2	1.7	0.1	4.1	0.9	1.4	2.2	1.7	4.1	3.2	11.6	4.9	4.3	3.9	1.9	3.1	2.4	2.3	0	4.6	0.8	2.1	2.5	4.6	1.7	0	0	2.3	1.8	11.8	0.8	0	1	0.8	1.3	0.7	70	0.5	10.5	0.9	1.2	1.1	0.8	5	7.9	1.2	1.8	1.6	0	1.7	1	5	1	1.9	0.6	0.9	0	2.5	0.2	1.3	0	2.7	2.1	5.1	1	1.6	1.5	1.8	1.4	Erythroid cells
CLPB	ANKCLB, FLJ13152, HSP78, SKD3	ENSG00000162129	ClpB homolog, mitochondrial AAA ATPase chaperonin	Q9H078	11	72285495-72434680	Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins		Hydrolase	Cataract, Disease mutation, Epilepsy	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in all	5	testis: 87.9	Cell type enriched	Detected in many	4	Late spermatids: 4145.4	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enhanced	Detected in many		myeloid DC: 18.3	Low lineage specificity	Detected in all			Low cell line specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA039005, HPA039006, HPA064571	Enhanced											HPA039005: AB_2676305, HPA039006: AB_10672767, HPA064571: AB_2685290	unprognostic (9.36e-2)	unprognostic (1.06e-2)	unprognostic (2.51e-1)	unprognostic (1.23e-1)	unprognostic (2.99e-1)	unprognostic (2.05e-2)	unprognostic (8.22e-2)	unprognostic (8.37e-2)	unprognostic (2.61e-1)	unprognostic (1.02e-1)	unprognostic (1.01e-2)	unprognostic (1.18e-1)	prognostic favorable (8.36e-8)	unprognostic (9.29e-2)	unprognostic (1.25e-1)	unprognostic (5.83e-2)	unprognostic (3.28e-2)	4.4	6.1	5.7	4.8	7.2	7.9	3.4	5.6	10.5	3.1	3.1	6.7	2.5	3.2	3.8	3.1	3.7	2.9	2.9	4.1	4.9	4.1	6.7	8.5	3.7	3	5.7	5.9	3.2	5.5	8.6	3.4	6.5	7.9	2.7	3.1	3.1	4.2	3.3	6.5	2.8	2.9	4.5	3.9	3.9	3.7	87.9	6.4	2.7	4.7	1.8	2.9	3.7	3	1.6	18.3	4	11.7	1.8	2.4	5.2	6.4	18.3	5.7	11.8	7.8	5.8	14.8	6.9	4.2	10.4	7.8	24.4	9.7	16.5	16	6.5	18.2	13.7	15.3	15.1	12.8	14.9	11.5	13.9	19	14.5	6.7	14	24.8	7.6	5	18.4	18.6	4.1	11.6	14.6	18.9	11.7	7.4	16.9	12.5	13.3	6	21.9	18.3	11.4	8.6	7.1	6	11	14.4	11	9.4	21.7	16.1	7.9	11.2	12.1	9.1	14.8	9.6	15	13.3	5.6	8	9.4	7.9	11.9	11.3	4	11.7	0.6	2.4	9.3	2.4	1.5	1.4	2.1	18.3	1.6	1.8	1.4	1	1.8	5.2	3.3	0.8	5.2	5.7	7.2	5.6	10.5	4.9	4.1	5.7	5.9	7.9	6.4	14.9	8.9	9	3.7	0.3	2.5	3.1	5.1	6.7	9.1	8.7	3.9	12.5	5	12.7	991	7.2	4	0	14.2	13.7	3.1	2.7	3.5	9.7	19.2	3.2	0	1.3	10.6	4145.4	23.3	12.7	1.7	7.2	1	1.3	10.6	0.8	17.3	17.4	5.7	12.9	2.1	35.9	21.3	1	27.7	2.5	1.9	5.1	Late spermatids
ITIH3	H3P	ENSG00000162267	Inter-alpha-trypsin inhibitor heavy chain 3	Q06033	3	52794768-52809009	Plasma proteins, Predicted secreted proteins		Protease inhibitor, Serine protease inhibitor		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	233	liver: 326.9	Cell type enriched	Detected in some	10	Hepatocytes: 931.8	Cancer enriched	Detected in some	247	liver cancer: 273.1	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	24	Hep G2: 19.7	Low region specificity	Detected in all			Not detected	Not detected			HPA017373	Approved				Secreted to blood				4500000000			HPA017373: AB_1851954	unprognostic (2.07e-2)	unprognostic (5.79e-2)	unprognostic (1.89e-1)	unprognostic (3.30e-4)	unprognostic (4.28e-2)	unprognostic (3.26e-2)	unprognostic (5.97e-2)	unprognostic (6.07e-2)	unprognostic (1.49e-1)	unprognostic (7.05e-2)	unprognostic (1.04e-1)	unprognostic (3.19e-1)	prognostic unfavorable (4.49e-8)	unprognostic (2.09e-4)	unprognostic (1.70e-1)	unprognostic (2.55e-2)	unprognostic (9.31e-2)	0.9	0	0.1	0.2	0.1	0	0.2	0.1	0.1	0.8	0.3	0.1	0.3	0	0.5	0.5	0.3	0.3	0.5	0.2	0.1	0	0.2	326.9	0.4	0.3	0.2	0.1	0.6	0	0	0.1	0.3	0.2	0.2	0.1	0.2	0.2	0.4	0.3	0.1	0.1	0.1	0.1	1.4	0.1	0.4	0.1	0.1	0.3	0.2	0.2	0.2	0.3	0	0	0	0	0	0	0	0	0	0.2	0	0.5	0	0	0	0	0	0	0	0	0.1	0	0	0	0.2	0	0	0	0	0	0	0	19.7	0.2	0.2	0.1	0	0	0	0	0.2	0	0	0	0	0.4	0	0	0	0	0	0	0.8	0.4	0	0	0	0	0	0.2	0	0.1	0	0	0	0.1	0	0	0	0	0.2	0	0.2	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.1	0.1	0.1	0	0.2	0.1	0.2	0.1	0	0	35	0	0.1	0.5	0.4	91.7	0	0	0	0	0	0	0	17.1	0.5	0	23.3	0	0	0.1	0	0	931.8	0	0	0	69.3	71.7	90.2	1.1	0	1.7	0	0	0.2	0	0	11	0	0	0	6.7	0.2	0.1	0.1	0.2	0.5	0	0	Hepatocytes
FGF19		ENSG00000162344	Fibroblast growth factor 19	O95750	11	69698232-69704642	Cancer-related genes, Predicted secreted proteins, RAS pathway related proteins		Growth factor	Cancer-related genes	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	13	gallbladder: 62.4	Cell type enriched	Detected in some	5	Cholangiocytes: 38.2	Low cancer specificity	Detected in many							Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	7	CAPAN-2: 47.6	Region enhanced	Detected in single		basal ganglia: 0.8	Region enriched	Detected in single	19	basal ganglia: 0.9	HPA036082	Approved				Secreted to blood			133000				HPA036082: AB_10669665	unprognostic (7.46e-3)	unprognostic (2.43e-3)	unprognostic (5.52e-3)	unprognostic (1.22e-1)		unprognostic (4.68e-3)	unprognostic (6.45e-2)	unprognostic (5.72e-3)		unprognostic (2.26e-1)	unprognostic (6.39e-3)			unprognostic (1.66e-2)	unprognostic (8.82e-3)			0	0	0	0	0	0	0	0.8	0	0	0			0	0	0	0	0	62.4	0	0	0.4	0	2.8	0	0	0		0	0.1	0.4	0.4	0		0	0		0	0	0	0	4.8	0	0	0	0	0.5			0		0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	47.6	0	0	0	0	0	0.6	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.9	6.5	0	0	0	0	0	0	0.2	0.3	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0.4	0.5	0	0.4	38.2	0	0	0	0	0	0	8.1	0	0	0.3	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0.5	0	0	0	0	0	0.3	0	0.7	1.1	0	0	0.1	1.6	Cholangiocytes
CYP4A22		ENSG00000162365	Cytochrome P450 family 4 subfamily A member 22	Q5TCH4	1	47137435-47149741	Enzymes, Predicted membrane proteins		Monooxygenase, Oxidoreductase		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	5	liver: 71.0	Cell type enriched	Detected in some	13	Hepatocytes: 99.2	Cancer enriched	Detected in some	13	liver cancer: 20.0	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		RH-30: 5.1;SuSa: 2.6																						unprognostic (5.34e-2)	unprognostic (1.24e-1)		unprognostic (3.19e-2)			unprognostic (2.88e-3)	unprognostic (2.76e-3)		unprognostic (1.50e-3)	unprognostic (2.21e-1)	unprognostic (2.75e-1)	unprognostic (1.93e-2)	unprognostic (5.29e-3)	unprognostic (1.02e-1)	unprognostic (1.71e-1)	unprognostic (8.59e-4)	0.1	0	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0	0.1	1.2	0.1	0	0.1	0.1	0.1	0	14.4	71	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.6	0.1	0.4	0.2	0.1	0.6	0	0	0.1	0.5	0.1	0	0.1	0.2	0.1	0	0	0	0.4	0.5	0.5	0.2	0.1	0	0.2	0.3	0	0.1	0.2	0.2	0.1	0.5	0	0	0.6	0.6	0.2	0	0.1	0.2	0	0.1	0.3	0.2	0.5	0.1	0.1	0.4	0.4	0.4	0	0	0	5.1	0	0	0.4	0.5	0.2	0.3	0.1	0	2.6	0.4	0.6	0.7	0.2	0.1	0.2	0	0	0.5	0.6	0.2	1.1	0	0	0.2	0.4	0.5	0	0.4	0.5	0.5	0.6	0.1	0.6	0.5	0.6	0	0.1	0	0.1	0.2	0	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0.2	5.1	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	99.2	0	0	0	1.8	1.6	0	0	0	0	0	0	0	0	0	0	7.8	0	0	0	0	0	0	0	0	0	0	Hepatocytes
PDZK1IP1	DD96, MAP17, SPAP	ENSG00000162366	PDZK1 interacting protein 1	Q13113	1	47183593-47191044	Predicted membrane proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	7	kidney: 281.3	Cell type enriched	Detected in many	4	Proximal tubular cells: 4006.8	Cancer enhanced	Detected in all		renal cancer: 340.7	Not detected	Not detected			Cell type enhanced	Detected in some		neutrophil: 2.1	Low lineage specificity	Detected in many			Group enriched	Detected in some	6	EFO-21: 31.5;RPTEC TERT1: 104.5	Not detected	Not detected							HPA014907	Enhanced		Approved	Nuclear speckles,Cytosol						Cytosol	Nuclear speckles	HPA014907: AB_1855166	unprognostic (2.97e-1)	unprognostic (3.33e-2)	unprognostic (1.03e-1)	unprognostic (9.16e-2)	prognostic unfavorable (6.92e-4)	unprognostic (8.14e-3)	unprognostic (2.32e-1)	unprognostic (1.46e-1)	unprognostic (2.65e-1)	unprognostic (2.31e-1)	prognostic unfavorable (3.45e-4)	unprognostic (2.64e-2)	unprognostic (7.90e-3)	unprognostic (1.22e-1)	unprognostic (2.07e-1)	unprognostic (1.75e-3)	unprognostic (1.89e-1)	2.7	1.2	0.6	2.4	0.6	3.9	4.1	0.6	0.6	9.2	9.1	0.6	0.6	2.2	1.3	4.8	30.4	2.9	23.9	0.7	0.5	0	281.3	1.6	7.2	0.5	0.6	0.5	2.3	16.8	0	0.6	3.2	0.6	2.1	3.4	0.8	33.9	12.4	0.7	19.9	9.5	0.5	0.5	0.7	9	1.4	0.6	1.1	1	18.3	18.5	4.1	8.3	0.1	0.5	2.1	1.1	0.2	0.3	42.4	11	0.6	0	0	0	0	0	0	0	0	0	0.6	8.6	0	31.5	0	0	0.1	0	0.1	0	0.1	0	0.1	0	0.1	0	0	0	0	0	0	0.1	0	0.1	0	0	0.6	0	0	0	0	0	0	0	0	0	0.5	104.5	0	0	0	0.1	0.9	0	0	0.2	0	0	0	0.2	0	0	0	0.1	0	0	0	0	0	1.1	0.1	0.2	0.3	0	0	0	0	0.5	0.1	0	0	2.1	0.2	0	0.5	0.3	42.4	0.6	0.6	0.6	0.6	0.5	0	0.6	0.5	0.6	0.6	71.5	39.6	6.7	11.1	12.6	0	0	359.2	6.7	34.2	221.6	0	0	351.5	818	0	1.6	60.9	140.2	656.9	0	0.9	37.3	10.4	1	0.2	0	38.1	2.5	0.3	0	3.1	1.5	8.5	21.6	123.8	0.5	959.8	81.8	0	4006.8	0	0	2.3	0	0.1	47.2	0.7	1.5	119.5	16.8	Proximal tubular cells
FAM151A	C1orf179, MGC27169	ENSG00000162391	Family with sequence similarity 151 member A	Q8WW52	1	54609182-54623556	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	9	intestine: 45.8;kidney: 59.3	Cell type enriched	Detected in some	7	Proximal tubular cells: 116.1	Group enriched	Detected in many	5	liver cancer: 2.3;renal cancer: 3.2;testis cancer: 5.2	Not detected	Not detected			Cell type enriched	Detected in single	6	eosinophil: 2.4	Lineage enriched	Detected in single	6	granulocytes: 2.4	Cell line enriched	Detected in single	45	CACO-2: 41.7	Not detected	Not detected			Not detected	Not detected			HPA016840	Approved											HPA016840: AB_2669461	unprognostic (1.89e-1)	unprognostic (6.90e-3)	unprognostic (3.73e-2)	unprognostic (1.97e-6)	unprognostic (1.71e-2)	unprognostic (4.84e-3)	unprognostic (1.02e-1)	unprognostic (3.46e-2)	unprognostic (2.87e-1)	unprognostic (1.05e-2)	unprognostic (4.91e-3)	unprognostic (9.99e-2)	prognostic favorable (4.09e-5)	unprognostic (5.85e-2)	unprognostic (8.97e-2)	unprognostic (1.13e-1)	unprognostic (1.40e-3)	0.1	0	0.1	0.6	0.1	0	0.1	0.1	0.1	0.1	0.8	0.1	0.1	0.6	0.1	0.1	0.2	0	0.1	0.8	0.1	0	59.3	5.6	0.1	1.6	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.3	0.2	0.1	0.1	0.1	0	45.8	0.1	0.1	0.5	0	0.3	0.1	0.3	0.1	0.1	0.9	0.1	0.1	0	0.4	2.4	0	0	0	0	0.3	0	0	0	0	0	0.1	0.1	0	0	0	41.7	0.5	0	0.2	0	0.1	0.6	0	0	0	0.2	0	0.9	0.2	0.2	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0.2	0.8	0	0	0.4	0	0	0.8	0.2	0.2	0	0	0	0.2	0	0.2	0.2	0	0	0	0	0	0	0	0	0.8	0	0	0	2.4	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	0.5	0.1	0	0	0.3	0	0	0	7	0	0	11.6	0	4.1	0	12	0	0	0	0	0	0	16.2	0	0	0	0	0.3	9.3	0	0	0	0	0	0.3	0	5.8	0	116.1	0	0	0	0	0	0	0	0	1.4	0	Proximal tubular cells
CTRC	CLCR, ELA4	ENSG00000162438	Chymotrypsin C	Q99895	1	15438439-15449242	Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins		Hydrolase, Protease, Serine protease	Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	417	pancreas: 1443.7	Cell type enriched	Detected in some	5	Exocrine glandular cells: 5617.8	Cancer enriched	Detected in some	168	pancreatic cancer: 236.0	Not detected	Not detected			Cell type enhanced	Detected in some		basophil: 3.4	Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		A-431: 3.6	Not detected	Not detected			Not detected	Not detected			HPA046920	Enhanced				Secreted to digestive system							HPA046920: AB_2679865	unprognostic (2.62e-2)	unprognostic (2.58e-1)	unprognostic (1.34e-1)	unprognostic (2.81e-1)	unprognostic (8.60e-2)	unprognostic (1.06e-1)	unprognostic (1.02e-1)	unprognostic (1.23e-1)	unprognostic (2.94e-2)	unprognostic (7.60e-2)	unprognostic (3.34e-1)	unprognostic (2.00e-1)	unprognostic (9.55e-11)	unprognostic (4.98e-2)	unprognostic (1.84e-1)	unprognostic (1.50e-1)	unprognostic (5.99e-3)	0.1	0	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.6	1443.7	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.1	0.4	3.4	0.7	1.5	0.6	0.1	3.6	0.6	0.5	0.7	0.2	0	0.2	0.3	0.4	0	0	0	1.7	0.5	1.1	0	0.5	0.5	0	0.1	0.2	1.1	0.6	0.4	0.3	0.1	0.9	0.2	1.7	0.3	0	0	0	0.6	0	0.7	0.1	1.8	0.2	0.5	1.1	1.7	0.5	0	0	0.5	0.1	0.3	0	0.1	0.4	1	0.4	0.2	0.2	0.2	0.3	0.1	0.9	0.4	1.4	0.9	0.3	0.8	1.6	0.3	0.8	0.8	0.3	3.4	0.4	0.4	0.4	0.2	0.2	0.3	0.3	0.6	0.1	1.1	0.3	0.4	1.7	1.5	0.7	0.4	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.3	0	0.1	0.1	0	0.3	0	0	0	0	0	0	0	12.4	0	0.1	0	0	5617.8	0.1	0	0.1	0	0	0.1	0	0	0	0	0	0	0.9	1.7	41.5	0	0	1090.5	0	0	0	0	0	0.4	0	0	0.3	0	0	0	0.1	Exocrine glandular cells
NEXN	NELIN, nexilin	ENSG00000162614	Nexilin F-actin binding protein	Q0ZGT2	1	77888513-77943895	Disease related genes, Predicted intracellular proteins		Actin-binding	Cardiomyopathy, Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		heart muscle: 110.8;skeletal muscle: 198.5	Cell type enriched	Detected in many	6	Cardiomyocytes: 2090.8	Low cancer specificity	Detected in many			Low region specificity	Detected in single			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		BJ: 43.5;LHCN-M2: 40.0;RH-30: 31.7	Low region specificity	Detected in many							HPA011185, HPA011904	Approved		Supported	Plasma membrane,Actin filaments					12000000	Plasma membrane, Actin filaments		HPA011185: AB_1854409, HPA011904: 	unprognostic (9.73e-2)	unprognostic (6.72e-2)	prognostic unfavorable (5.60e-4)	unprognostic (1.72e-2)	unprognostic (1.11e-1)	unprognostic (1.42e-2)	unprognostic (1.62e-2)	unprognostic (1.09e-1)	unprognostic (3.03e-2)	unprognostic (2.22e-1)	unprognostic (1.46e-1)	unprognostic (3.25e-1)	unprognostic (5.41e-2)	unprognostic (5.60e-2)	unprognostic (2.48e-1)	unprognostic (9.65e-3)	unprognostic (3.68e-2)	8.9	4.3	0.4	10.4	0.8	0	5	0.5	0.4	14.1	17	0.2	12.5	1.9	16.6	12.5	24.1	9.9	8.7	110.8	0.4	0.5	4	1.2	6.2	3.8	0.6	0.5	8.2	2	0.3	0.5	2.6	0.7	13.1	3.2	0.9	4.1	14.8	198.5	1.4	5.5	45.8	0.8	3.9	10.6	4.2	1.2	0	5.1	40.1	1	29.7	10.3	1.4	1.7	2.9	3.4	0.6	0.6	7	7.1	0.4	1.3	0	23.5	22.8	3.5	43.5	19.3	8.9	6	1.2	0	0	2.5	15.8	10.1	0.9	0.9	4.1	16	0.2	0.9	1.7	2.2	0.4	17.6	0.3	0	17	0.9	12.3	6.9	19	6.7	1.7	0	0	40	0	8.1	0.5	6.9	0	5.3	6.8	31.7	0	10.4	0.3	0	0.3	3.8	0	0.2	9.1	0	0.9	6.8	21.3	15.6	9	21.6	0	0	0	1.2	0.8	0	0	3.4	0	0.4	2	0.1	1.4	0.3	0.4	1.7	1.1	0.6	0.2	2.9	0.6	1.4	1.2	0	7	0.4	0.8	0.5	0.4	0.4	0.5	0.6	0.5	0.7	1.2	98.3	8.2	0	0.8	1.5	2.8	2090.8	0	0	9.1	0	3.9	0.3	1.7	15.9	15.1	11.3	0.9	0	27.4	2.8	19	0.9	1.1	0.8	1.1	1.6	0	53.4	2.6	5.4	67.9	5.3	0	0	0	0.2	23.5	0	325.3	0.5	2.6	213.4	98.6	0.7	2.1	0.6	0.2	2.2	0.3	0.2	Cardiomyocytes
LRRC53		ENSG00000162621	Leucine rich repeat containing 53	A6NM62	1	74469878-74512614	Predicted membrane proteins				Evidence at transcript level	Evidence at transcript level	No human protein/transcript evidence	No human protein/transcript evidence		Tissue enhanced	Detected in single		brain: 2.9	Cell type enriched	Detected in single	11	Intestinal endocrine cells: 6.4	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	17	SCLC-21H: 3.6									HPA054062	Uncertain											HPA054062: AB_2682364					unprognostic (3.67e-1)													0	0	0.4	0	0.2	0	0	0.6	2.9	0	0.2			0	0	0	0	0.2	0	0.8	0.5	0.3	0	0	0.1	0	0.1		0	0	0	0.1	0		0	0.7		0	0	0.1	0	0.1	0	0	0	0	0.8			0		0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	3.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0											0	0	0	0	0	0.6	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	6.4	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Intestinal endocrine cells
AKNAD1	C1orf62, MGC26989	ENSG00000162641	AKNA domain containing 1	Q5T1N1	1	108815898-108858228	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enriched	Detected in single	57	testis: 12.1	Cell type enriched	Detected in some	4	Early spermatids: 58.5	Cancer enhanced	Detected in single		glioma: 0.6	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HAP1: 3.5;HBEC3-KT: 1.3;hTCEpi: 4.0;hTERT-HME1: 2.2;LHCN-M2: 1.2									HPA030270, HPA030271, HPA030272	Uncertain		Approved	Microtubules,Cytokinetic bridge,Cytosol						Cytosol	Microtubules, Cytokinetic bridge	HPA030270: AB_10610980, HPA030271: AB_10600873, HPA030272: AB_10601342	unprognostic (4.93e-2)	unprognostic (1.72e-1)	unprognostic (5.52e-2)	unprognostic (2.00e-3)	unprognostic (7.22e-2)	unprognostic (1.08e-1)	unprognostic (1.09e-5)	unprognostic (8.15e-2)	unprognostic (5.95e-2)	unprognostic (2.83e-2)	unprognostic (1.89e-1)	unprognostic (2.24e-1)	unprognostic (3.00e-8)	unprognostic (1.08e-1)	unprognostic (4.69e-2)	unprognostic (5.75e-2)	unprognostic (8.22e-2)	0	0.1	0	0	0	0	0.1	0	0	0.1	0	0	0	0	0.1	0	0.2	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	12.1	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0.3	0	0.7	0.9	0.6	0	0.9	0.1	0.2	0.1	0	0	0	0	0.9	0	3.5	1.3	0.4	0	0	0	0	0	0	0	0	0	4	0.2	2.2	0	0	0	0	0	1.2	0	0	0	0	0.1	0.4	0	0	0	0	0	0	0.1	0.1	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0.3	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	1.3	2.7	0.2	0	0	0	0	0	0.4	0	0.1	58.5	1	0	0	0.2	0.7	0.5	0	0	0	0.1	0	0	0	0	14.6	2.3	0	1.7	0	0.3	0.6	0.3	0	1.1	0	0	0	0.7	0.5	0.7	0.1	0.6	0	0.4	0	Early spermatids
WDR63	DIC3, FLJ30067, NYD-SP29	ENSG00000162643	WD repeat domain 63	Q8IWG1	1	84999147-85133138	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		adrenal gland: 21.3;brain: 39.7;testis: 31.0	Cell type enriched	Detected in some	5	Ciliated cells: 167.3	Cancer enhanced	Detected in some		melanoma: 2.9	Region enriched	Detected in many	9	pons and medulla: 39.7	Cell type enhanced	Detected in some		gdT-cell: 2.2	Lineage enriched	Detected in single	4	T-cells: 2.2	Cell line enhanced	Detected in some		ASC TERT1: 10.9;HBEC3-KT: 5.4;HSkMC: 7.2;hTCEpi: 8.7;LHCN-M2: 7.8	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA038526	Enhanced											HPA038526: AB_2676063	unprognostic (3.12e-2)	unprognostic (1.33e-1)	unprognostic (1.34e-1)	unprognostic (1.61e-2)	unprognostic (1.09e-4)	unprognostic (1.10e-3)	unprognostic (2.34e-1)	unprognostic (1.69e-1)	unprognostic (3.56e-1)	unprognostic (2.53e-1)	unprognostic (1.82e-3)	unprognostic (2.31e-1)	unprognostic (1.14e-5)	unprognostic (8.57e-3)	unprognostic (2.60e-1)	unprognostic (2.35e-2)	unprognostic (1.82e-1)	0.3	21.3	2	0.4	4.6	0.1	0.9	0.1	0.9	1.3	0.6	4.2	1	0.3	0.7	11.7	0.6	14	0.4	0.9	3	2.9	2.5	0.1	3.7	0.3	0.4	0.9	4.9	0.5	3.9	14.6	0.5	39.7	0.3	0.6	0.3	1.8	0.3	0.3	1.9	0.2	0.4	0.9	0.2	0.2	31	1.9	0	1.1	1	0.2	0.7	0.3	0	0.5	0	0	0	2.2	0.4	0.2	0.5	0.1	0.4	3.9	10.9	2	2.1	4.3	0.7	1.1	0	0.6	0.5	0	0.4	2.6	0	0.4	5.4	0.9	0.1	0.4	0.3	0	0	0.6	0	0	7.2	8.7	3.6	0.2	0.4	0.1	0.6	0	0	7.8	0.1	0.2	0	0.1	0.1	0	0	0.1	0	1.8	0.2	0.2	0	0	0.2	1.3	2.2	0	3.4	0	0.6	0.3	0	0.5	0	0	0.4	4.2	0.2	1.4	0	0	0	2.2	0	1.3	0	1.2	0.9	0.1	0	0.8	1.9	0	0	0	0.5	0	0.4	2	4.6	0.1	0.9	3	2.9	0.4	0.9	39.7	1.9	0	1.7	0	0.4	0.9	0	0.7	0	167.3	18.2	0	3.9	0.1	3.3	0	12.4	0	0	0	0	0	0.3	0.2	0	0	0.4	0	5.1	0	0	3.6	1.7	0	18.6	4.6	0	0.5	0	0	0	0.7	0.4	0	0	36.6	2.9	0.1	0.1	0	0	0.1	Ciliated cells
BRINP3	DBCCR1L, DBCCR1L1, FAM5C	ENSG00000162670	BMP/retinoic acid inducible neural specific 3	Q76B58	1	190097662-190478404	Predicted intracellular proteins, Predicted secreted proteins	Cell cycle, Growth arrest			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 30.4;intestine: 18.6	Cell type enriched	Detected in some	7	Early spermatids: 35.8	Group enriched	Detected in some	14	breast cancer: 3.4;glioma: 8.6;prostate cancer: 3.5	Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	4	SCLC-21H: 18.1	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA054693	Uncertain				Secreted in other tissues							HPA054693: AB_2682575	unprognostic (3.18e-2)		unprognostic (1.22e-1)	unprognostic (1.34e-1)	unprognostic (1.40e-1)			unprognostic (1.72e-1)			unprognostic (8.25e-2)	unprognostic (3.65e-1)		unprognostic (2.38e-2)	unprognostic (2.62e-1)	unprognostic (9.84e-2)	unprognostic (4.58e-3)	0.7	2.4	11.3	1	11.9	0.3	2	18.4	30.4	0.5	7.2	2.1	0	5.3	0.6	3.7	2.2	0.9	2	5.6	8.9	12.2	2.8	0.4	1.6	0.3	6	12.7	0.4	0.3	0.4	0.4	0.3	7.4	7.8	7.6	0	1.6	6.3	0.4	0.4	18.6	1	6.8	0.3	0.7	3.7	2.7	0	2.4	0	0.5	1.1	0.3	0.1	0	0.2	0.1	0.1	0.1	0	0	0	0.1	0	0	0	0	0	4.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0.1	0	0	0.1	0	0	0	0	0.4	0	0	0	0	0.1	0	0	0	0	0	0	0	0	18.1	0.3	0	0.4	0	0	0	0	0	0	0	0.1	0	1.7	0	0	0.2	0	0	0.2	0	0	0	0	0	0	0	0	0	0.1	0.1	0	0	0.1	0.1	0	0	0	11.3	11.9	18.4	19.1	8.9	12.2	6	12.7	7.4	2.7	0	0	0	0	0	0.1	1	0	0	0	3.5	0	0	3.3	0	35.8	0	4.2	0	0	0	0	0.5	0	0	0.1	0	1.2	0	0	5.3	0	0	0	0	0.9	0	0	2.3	0	0.2	0	0	0	1.4	0.5	0	0	0	1.9	0	Early spermatids
TRIM58	BIA2	ENSG00000162722	Tripartite motif containing 58	Q8NG06	1	247857199-247878205	Enzymes, Predicted intracellular proteins	Ubl conjugation pathway	Transferase		Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		bone marrow: 24.8;placenta: 22.4;thyroid gland: 15.2	Cell type enriched	Detected in many	16	Erythroid cells: 186.9	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		HAP1: 8.0;HEL: 21.4;K-562: 11.8;PC-3: 20.7;U-2 OS: 16.8;WM-115: 21.8	Low region specificity	Detected in single			Low region specificity	Detected in all			HPA023637	Uncertain								310000			HPA023637: AB_1858309	unprognostic (3.85e-1)	unprognostic (5.24e-3)	unprognostic (7.00e-2)	unprognostic (6.52e-4)	unprognostic (1.46e-1)	unprognostic (3.47e-2)	unprognostic (1.10e-1)	unprognostic (4.14e-5)	unprognostic (3.59e-1)	unprognostic (2.07e-1)	unprognostic (1.27e-1)	unprognostic (5.00e-2)	unprognostic (3.31e-1)	unprognostic (1.08e-2)	unprognostic (3.34e-1)	unprognostic (1.00e-2)	unprognostic (2.57e-2)	0.7	0.8	1.3	1	4.4	24.8	0.7	0.3	3.7	0.6	1.3	0.2	0	0.3	0.5	0.4	0.5	1.4	0.5	0.8	1.5	3.2	0.5	0.6	3.4	0.4	2.4	1.2	1.1	0.4	0.3	0.7	22.4	6.9	1.7	1	1.1	0.5	0.4	0.5	1.2	0.6	0.8	1.3	5.8	0.7	4.9	0.1	0	15.2	0	0.4	1.9	0.7	3.1	0.6	3.7	0.7	1.7	0.3	1.9	0	0	0	0	0.3	1.2	0	0.1	0	0	0	0	0	0	1.4	0	0.2	1	8	0	0	0	0.8	21.4	0	0	0	2.8	1.6	0	0	0.1	0	0	0	0.8	11.8	0.1	0	0	0	0.1	1.4	0	20.7	0	0	1.6	0	0	0	0	0	0.1	0	0.8	0.1	2.1	0	0	16.8	0	0	3.6	0	0	0	6.1	21.8	2.8	0.7	1.8	0.3	0.5	0.2	3.1	0.2	0.2	0.6	1	0.3	0.2	3.7	1.7	0.6	0.6	0.2	1.9	1.3	4.4	0.3	3.7	1.5	3.2	2.4	1.2	6.9	0.1	3	4	1.7	0.6	0.9	2.3	0.4	0	6.7	10.3	1.8	11.8	2.4	0	0.1	3.1	0.8	0	186.9	0	3.3	1.5	2.9	8.1	0	2	0	1.2	1.8	2.6	0.5	0.9	1.6	1.7	0	0.4	1.5	0.2	0	0.7	0	3.5	0	0.8	2.8	10.9	0.6	4.1	1.3	0.8	0.9	Erythroid cells
LRRC52	FLJ25811	ENSG00000162763	Leucine rich repeat containing 52	Q8N7C0	1	165544007-165563961	Predicted membrane proteins	Ion transport, Transport	Ion channel		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	28	testis: 31.9	Cell type enriched	Detected in some	5	Early spermatids: 118.1	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	10	U-937: 3.9	Not detected	Not detected			Not detected	Not detected																unprognostic (9.09e-2)			unprognostic (1.76e-2)	unprognostic (6.48e-2)			unprognostic (3.79e-2)	unprognostic (8.45e-2)	unprognostic (6.70e-4)						unprognostic (6.05e-4)		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0.2	0	0	0.6	0	0.2	0	0	0	0	0	0.7	0.2	0	0	0	0	0	0.2	0	1.1	0	0	0	0	0	0	31.9	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	118.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	24.6	0.6	0	0	0	0	0	0	0	0.7	0	0	0	0	0.6	0.7	0	0	0	0	0	Early spermatids
B3GALNT2	MGC39558	ENSG00000162885	Beta-1,3-N-acetylgalactosaminyltransferase 2	Q8NCR0	1	235449923-235504481	Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins		Glycosyltransferase, Transferase	Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy, Lissencephaly	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		pancreas: 35.7	Cell type enriched	Detected in many	7	Cone photoreceptor cells: 237.6	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low cell line specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA012502, HPA050662	Approved		Approved	Nucleoplasm,Golgi apparatus	Intracellular and membrane					Nucleoplasm	Golgi apparatus	HPA012502: AB_1845228, HPA050662: AB_2681209	unprognostic (5.50e-2)	unprognostic (3.16e-3)	unprognostic (6.60e-2)	unprognostic (1.63e-1)	unprognostic (1.36e-2)	unprognostic (1.28e-1)	unprognostic (7.59e-3)	unprognostic (1.96e-2)	unprognostic (3.39e-2)	unprognostic (3.38e-1)	unprognostic (7.19e-3)	unprognostic (2.89e-1)	unprognostic (1.99e-1)	unprognostic (5.52e-2)	unprognostic (3.40e-1)	unprognostic (3.53e-3)	unprognostic (8.34e-3)	5	6.3	3.9	4.3	5.1	1.3	8.4	4.7	4.5	5.4	7.6	3.5	5.1	3.3	8	8.7	10.3	6.1	9.7	7.9	2.8	2.9	3.7	4.6	3.7	3.1	3	3.2	5.9	35.7	9.8	8.9	4.5	4.7	8.3	5.8	8.5	8.7	7.3	21.6	6.1	6.9	16.9	2.5	3.3	9.2	5.8	3.9	4.7	7.1	7	5	9.7	5.9	1.5	5.7	2.4	2.7	1.9	1.9	1.3	9.9	6.5	7.2	10.7	11.7	9.9	17.4	8.7	7.9	6.6	6.1	5	8.9	5.2	11.5	9.9	4.3	12.6	14	10.2	8.2	10.2	9.7	3.3	8.3	5.7	7.4	10.7	3.7	7.1	6.6	6.8	16.5	5	10.1	14.1	8	7	6.2	4.7	6.7	3.9	10.3	6.3	3.7	7.4	12	13.2	4.2	11.8	9.3	11.9	15.1	5.7	7.5	3.1	11	10.9	9.9	5.8	9.6	9.8	11.6	10.2	8.4	3.2	3.8	7.7	13.4	2.4	2.3	1.1	1.1	2.7	1.7	1.5	0.8	1.9	5.7	1.1	1	1.3	0.2	1.9	2.5	3.1	0.5	1.3	3.9	5.1	4.7	4.5	2.8	2.9	3	3.2	4.7	3.9	8.9	5.3	6.4	25.1	27.7	18.9	5.4	2.5	5.3	4.5	5.2	237.6	17	0	5.8	13	6.7	7.3	0	6.1	5.6	8.1	23.5	5.7	4.4	3.5	27	8.6	4.3	3.1	4.5	9.8	7.9	1.7	9	4.6	7.8	7.6	4.3	15.2	0.8	17.3	0	14.4	16.6	34.1	26	18.8	5.3	5.2	31	Cone photoreceptor cells
IL20	IL-20, IL10D, ZCYTO10	ENSG00000162891	Interleukin 20	Q9NYY1	1	206865354-206869223	Predicted secreted proteins		Cytokine		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	4	seminal vesicle: 19.5	Cell type enriched	Detected in some	7	Basal keratinocytes: 61.8	Cancer enhanced	Detected in some		breast cancer: 3.7	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		BJ hTERT+: 2.9;GAMG: 1.6;hTCEpi: 1.0;SiHa: 5.9;SK-MEL-30: 2.6	Not detected	Not detected			Not detected	Not detected			CAB025802	Uncertain				Secreted to blood			109000				CAB025802: 	unprognostic (3.08e-2)	unprognostic (1.91e-1)		unprognostic (1.82e-1)		unprognostic (1.16e-2)		unprognostic (6.45e-2)	unprognostic (3.36e-2)	unprognostic (1.01e-1)	unprognostic (3.46e-1)	unprognostic (1.60e-1)		unprognostic (3.38e-2)	unprognostic (1.67e-1)		unprognostic (1.71e-1)	4.6	2.2	0.2	0.2	0.2	0	1.3	0.2	0.2	0.2	0.2	0.2	0.2	0	0.8	0.2	0.4	0.7	1.3	0.2	0.2	0	0.2	0.4	0.2	0.2	0.2	0.2	0.2	0.2	0	0.4	0.2	0.2	0.3	0	0.2	0.6	19.5	0.2	3.8	0.2	3.2	0.2	0.2	0	1	0.2	0.2	0.2	0.2	0.2	0.4	0.2	0.4	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	2.9	0	0.1	0	0	0	0	0	1.6	0	0	0	0	0	0	0	0	0	0.1	0	0.2	0	1	0	0.1	0	0	0	0	0	0	0.8	0	0	0	0	0	0	0	0.2	0	0	0	0	5.9	0	2.6	0.3	0.4	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0.2	0.2	0.2	0.2	0.2	0	0.2	0.2	0.2	0.2	0	0	0	5.3	61.8	0	0.1	0	0	3.4	0	0	0	0	0	0.6	0	0	0	0.2	0	0.4	3.4	0	0	0	0	0	0	0	0	0	0	1.7	0	0	0	0	0	0	0	0	0	0.8	0.5	0.2	8.7	0	0	0	5.8	Basal keratinocytes
FCAMR	CD351, FCA/MR, FKSG87	ENSG00000162897	Fc fragment of IgA and IgM receptor	Q8WWV6	1	206957965-206970625	CD markers, Predicted membrane proteins	Adaptive immunity, Immunity	Receptor		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	8	kidney: 23.9;liver: 7.6;lymphoid tissue: 23.0	Cell type enriched	Detected in some	8	Proximal tubular cells: 26.5	Cancer enhanced	Detected in some		renal cancer: 5.6	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		CACO-2: 1.9;HMC-1: 1.0									HPA056505	Enhanced								3600000			HPA056505: AB_2732604	unprognostic (2.94e-1)	unprognostic (1.06e-1)	unprognostic (8.53e-2)	unprognostic (2.92e-1)	unprognostic (7.44e-2)	unprognostic (4.55e-3)	unprognostic (2.69e-3)	unprognostic (1.08e-4)	unprognostic (3.61e-2)	unprognostic (1.25e-1)	unprognostic (1.82e-1)	unprognostic (1.23e-1)	unprognostic (1.11e-1)	unprognostic (1.29e-1)	unprognostic (3.88e-2)	unprognostic (2.08e-1)	unprognostic (1.26e-1)	0.1	0.1	0.1	23	0.1	0	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.6	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.1	23.9	7.6	0.1	8.3	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.1	2.4	0.1	0.1	0.1	1	0.1	0.5	0.6	0.1	0.2	0.1	0.2	0.2	0.1	9.1	0.1	0.1	0	0.4	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0.2	0.3	0	1.9	0.3	0.1	0.1	0	0	0.1	0	0	0.4	0	0	0.2	0	0	0	0	1	0	0.2	0	0.2	0	0	0.1	0.1	0	0	0	0.3	0.4	0.1	0.3	0	0.2	0.5	0	0.2	0	0	0	0	0.8	0	0	0	0.5	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0.1	0	0	0	0	0	0	3.3	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	26.5	0	0	0	0	0	0	0	0	0.6	0	Proximal tubular cells
DISC1		ENSG00000162946	Disrupted in schizophrenia 1	Q9NRI5	1	231626815-232041272	Disease related genes, Plasma proteins, Predicted intracellular proteins	Neurogenesis, Wnt signaling pathway	Developmental protein	Schizophrenia	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in many			Cell type enriched	Detected in many	6	Rod photoreceptor cells: 105.2	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		THP-1: 12.4;TIME: 9.7;WM-115: 9.9					Low region specificity	Detected in all			HPA048911			Approved	Intermediate filaments						Intermediate filaments		HPA048911: AB_2732549	unprognostic (1.08e-1)	unprognostic (1.40e-1)	unprognostic (1.58e-1)	unprognostic (2.98e-1)	unprognostic (2.57e-2)	unprognostic (3.36e-2)	unprognostic (6.69e-3)	unprognostic (1.41e-1)	unprognostic (9.49e-2)	unprognostic (1.71e-1)	unprognostic (8.89e-2)	unprognostic (9.53e-2)	unprognostic (1.31e-4)	unprognostic (1.74e-2)	unprognostic (2.02e-1)	unprognostic (5.94e-2)	unprognostic (1.94e-1)	5.3	3.3	9.1	6.4	10.6	5.3	7.6	2.5	7.6	4.9	3.1	11.6	0	2.6	4.2	1.6	3.1	2.9	5.6	19.2	9.2	5.9	2.7	3.1	3.9	11.3	10.5	4.8	9.6	2.1	2.7	2.8	14.3	9.2	3.9	2.9	13.1	4	2.4	3.2	2.9	3.1	3.4	10.2	6.1	2.4	2.2	9.3	4.2	4.1	2.5	3.9	4.5	7.2	0.5	3.3	2.6	2.9	0.7	1.6	0.7	0	0.5	4.5	0.1	0.1	0.4	3.3	1.7	4.1	4.8	4	1.6	1	0.1	5.4	1.5	1.1	0	0.4	0.1	4.2	2.8	1.9	2.4	0.4	4.4	0.6	4	6	2.5	0.8	1.5	1.3	3.2	4.2	3.1	0	1.8	5.2	0.4	1.1	6.1	2.3	0	1.7	3	1.3	0.5	0.2	0	0.8	2.5	1.6	0	2.7	1.2	0	12.4	9.7	2.5	2.6	1.2	1	1.1	0.8	0	1.9	6.2	9.9	0.3	2.7	0.1	0.9	2.9	0.5	0.1	1.4	0.3	3.3	0.5	1.6	0.5	2.6	0.7	1.2	1.9	0.5	0.7	9.1	10.6	2.5	6.3	9.2	5.9	10.5	4.8	9.2	9.3	0	1.4	0	0.5	0.8	10.7	4.6	0	1.4	1.2	3.5	7.9	6	0	0.6	12.9	5.3	0	0	1	0.6	3.3	0.4	6.9	0	9.3	0	0	9.8	13.5	17.3	0.9	8.9	3.3	0	0	2.5	1.4	0	1.4	0	105.2	0	1.3	0.4	1.1	1	2.1	3.1	0.2	0.5	Rod photoreceptor cells
FRZB	FRE, FRITZ, FRP-3, FRZB-1, FRZB-PEN, FRZB1, FZRB, hFIZ, SFRP3, SRFP3	ENSG00000162998	Frizzled related protein	Q92765	2	182833275-182867162	Disease related genes, Predicted secreted proteins	Differentiation, Wnt signaling pathway	Developmental protein	Disease mutation	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	6	retina: 265.8	Cell type enriched	Detected in many	12	Muller glia cells: 3160.2	Low cancer specificity	Detected in all			Region enriched	Detected in all	4	pons and medulla: 21.7	Group enriched	Detected in some	9	memory B-cell: 3.0;naive B-cell: 1.5	Lineage enriched	Detected in single	12	B-cells: 3.0	Cell line enhanced	Detected in some		AF22: 17.7;ASC diff: 8.6;NTERA-2: 7.2;SH-SY5Y: 6.1	Region enhanced	Detected in many		olfactory region: 69.9	Low region specificity	Detected in all								Secreted in other tissues				27000				unprognostic (5.39e-2)	unprognostic (1.48e-2)	unprognostic (1.18e-1)	unprognostic (1.79e-2)	unprognostic (1.93e-1)	unprognostic (2.09e-3)	unprognostic (1.64e-2)	unprognostic (2.38e-2)	unprognostic (4.67e-2)	unprognostic (8.58e-2)	unprognostic (5.41e-2)	unprognostic (2.34e-1)	prognostic unfavorable (8.97e-6)	unprognostic (3.53e-2)	unprognostic (1.05e-2)	unprognostic (6.04e-2)	unprognostic (3.21e-1)	4.4	1.4	2.8	4.8	5.4	0	5.1	2.9	3.5	7.1	5.1	3.3	2.6	4.5	5.5	3.5	3.6	2.8	12.9	8.4	2.8	2.8	5.5	2.2	3.7	4.8	3.6	3.4	4.4	2.4	0.6	11.3	44.3	21.7	4	6.6	265.8	5.1	5.4	8.4	4.3	4.7	10.5	2.9	28.2	12	4.2	2.3	3.1	5	3.1	3.4	3.5	6.2	3	0	0	0	0	0.2	0	0	0	17.7	0.2	8.6	0.2	0.1	0	0.8	3.1	2	0.3	0	0	0	0	0	0.1	0	0	3.2	0	0.1	0	0	0	2.3	0	0	0.7	0.6	0.2	0	0	0	0	0	0	1.8	0	0	0.1	7.2	0	0	0.6	0.7	0	0	0	1.1	6.1	0	0	0.1	0.5	0	0	0	0.3	0.1	0	0.2	0	0	0.3	0.1	0	0	0	0	0	0	0	0.2	3	0	0	0	1.5	0	0	0	0	0	0	0	0	2.8	5.4	2.9	3.5	2.8	2.8	3.6	3.4	21.7	2.3	0	0.3	0	0.4	7.2	34	2.2	0	0	2.3	0	31.4	4.3	0	0.1	0.3	2.1	1	0	7.5	3	28.8	1.7	0	0.9	6.8	25.4	1.2	4.3	1.5	1.9	3.4	0.8	232.8	0	99.8	3160.2	0.1	0	13.8	0	101	271.7	137	0.2	0	2.8	10.4	0	3.3	0.4	Muller glia cells
ACTG2	ACTA3, ACTL3, ACTSG	ENSG00000163017	Actin, gamma 2, smooth muscle, enteric	P63267	2	73892314-73919865	Disease related genes, Predicted intracellular proteins		Muscle protein	Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		intestine: 404.6;smooth muscle: 581.1;urinary bladder: 568.2	Cell type enriched	Detected in many	9	Smooth muscle cells: 243.6	Cancer enhanced	Detected in all		prostate cancer: 255.0;stomach cancer: 237.2	Not detected	Not detected			Cell type enriched	Detected in some	9	T-reg: 10.9	Lineage enriched	Detected in single	17	T-cells: 10.9	Cell line enhanced	Detected in some		BEWO: 16.7;BJ hTERT+: 13.6;BJ hTERT+ SV40 Large T+: 54.0;HHSteC: 14.0;SuSa: 14.4;U-251 MG: 58.0	Low region specificity	Detected in single			Not detected	Not detected			HPA041264, HPA041271	Supported											HPA041264: AB_2677383, HPA041271: AB_2677386	unprognostic (5.79e-3)	unprognostic (2.25e-1)	unprognostic (2.36e-2)	unprognostic (2.91e-1)	unprognostic (4.56e-3)	unprognostic (2.50e-1)	unprognostic (8.05e-2)	unprognostic (6.53e-2)	unprognostic (4.48e-2)	unprognostic (2.93e-1)	unprognostic (7.23e-2)	unprognostic (4.75e-2)	prognostic unfavorable (3.95e-7)	unprognostic (9.30e-3)	unprognostic (6.84e-2)	unprognostic (2.29e-2)	unprognostic (7.57e-3)	8.7	1.2	0.3	57.4	0.4	0	6.8	0.3	0.4	90	404.6	0.8	187.4	15.9	188.2	76.1	348.3	45.5	122.5	5.6	0.3	0.3	2.9	0.6	7	3.6	0.4	0.6	25.9	1.1	0	0.4	10	0.9	160.8	52.4	2.8	9.4	271.2	2.4	4.7	80.2	581.1	0.4	0.9	134.9	14.5	0.1	0.1	1.8	2	2.3	568.2	35.2	0.2	0.5	0.4	0.6	0.2	10.9	2.3	0.1	0	5.6	0	0	0	16.7	3.6	13.6	54	10	1.8	0	0	0.2	0	0.1	0	9.7	0	7.8	0	0	0	0.8	0.1	14	0	0.1	0.1	0	7.2	0	0.4	0	0	0	0	0.1	0	0.7	2.1	0	0	0	0	0.1	0.8	0.1	3.5	0.1	0.6	0.1	0.7	0.3	14.4	0	0	0	0.3	0.6	0.7	58	0	0	0.2	0.2	0.2	0.2	0.2	0.5	0.4	0.4	0.4	0.2	0.2	1.1	0.4	0.5	0.2	0.6	0.7	0.2	0.2	0.6	0.2	10.9	2.3	0.3	0.4	0.3	0.4	0.3	0.3	0.4	0.6	0.9	0.1	0	0.3	0	2.6	3.9	0	11.8	0	1.4	0	0	0	2.8	0	0	5.5	2.7	0	0	0	27.8	6.6	5.5	0	0	4.7	0	0	23.9	0	16.8	0.3	0.3	6.8	0	0	0	0	0	19.8	0	0	6.5	243.6	0.2	0.2	6.8	5.4	0	0	2	Smooth muscle cells
ANKRD30BL	ANKRD30BP3, NCRNA00164	ENSG00000163046	Ankyrin repeat domain 30B like	A7E2S9	2	132147591-132257969	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	21	testis: 6.4	Cell type enriched	Detected in some	6	Spermatocytes: 23.3	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		MOLT-4: 1.2;U-266/70: 1.1																									unprognostic (1.67e-1)	unprognostic (1.42e-1)					unprognostic (5.57e-2)		unprognostic (2.15e-1)		unprognostic (2.99e-1)	unprognostic (2.17e-1)	unprognostic (1.42e-1)		0	0	0.1	0.2	0.2	0	0	0	0.1	0	0			0	0	0	0	0.1	0	0	0.2	0.3	0	0	0	0	0		0	0	0	0	0		0	0		0	0	0	0	0	0	0	0	0	6.4			0		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	1.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	1.4	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	3.9	0	0	0	0	0	0.3	0	0	0.4	0	0	0	0	23.3	0.5	0.1	0	0	0	0	Spermatocytes
EN1		ENSG00000163064	Engrailed homeobox 1	Q05925	2	118842171-118847678	Predicted intracellular proteins, Transcription factors		Developmental protein, DNA-binding		Evidence at protein level	Evidence at protein level	No human protein/transcript evidence	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	4	adipose tissue: 5.6;brain: 11.4;skeletal muscle: 20.1;skin 1: 10.0	Cell type enriched	Detected in some	5	Melanocytes: 11.8	Cancer enhanced	Detected in many		breast cancer: 5.6	Group enriched	Detected in some	10	midbrain: 11.4;pons and medulla: 8.8	Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		ASC diff: 14.4;ASC TERT1: 6.5;fHDF/TERT166: 11.3;HSkMC: 12.1;PC-3: 6.8;U-138 MG: 8.8;U-2197: 9.8	Region enriched	Detected in single	5	midbrain: 5.9	Region enriched	Detected in some	5	midbrain: 23.9	CAB014884, HPA073141	Enhanced		Approved	Nucleoplasm,Nucleoli rim						Nucleoli rim	Nucleoplasm	CAB014884: , HPA073141: AB_2686573	unprognostic (5.20e-2)	unprognostic (1.61e-1)	unprognostic (5.78e-2)	unprognostic (4.84e-7)	unprognostic (1.87e-3)	unprognostic (1.90e-1)		unprognostic (1.95e-3)	unprognostic (1.16e-1)	unprognostic (2.06e-2)	unprognostic (1.19e-2)	unprognostic (4.46e-1)	unprognostic (3.38e-9)	unprognostic (2.15e-2)	unprognostic (1.88e-1)	unprognostic (1.70e-1)	unprognostic (9.30e-3)	5.6	0.1	0	0.1	0.4	0	2.7	0.9	0.4	0	0.1	0.1	0	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.2	0.1	0	0	0	2.4	11.4	0	0.1	0	0.1	0	0	8.8	0.1	0.1	0.2	0.7	0.1	20.1	10	0.1	0.1	2.7	0.1	0.1	0.4	0.1	0.2	0.3	0	0.1	0.3	0	0	0	0	0	0	0	0	3.4	0.2	0.5	0.2	14.4	6.5	0	0	0	0	0	0	0	0	0	11.3	4.2	0.4	0.5	0	0	0	1.1	0	0.6	0	0.1	0	0	12.1	0	0	0	0	0	0	0	0	2.1	0	0	0	0.1	0	6.8	0	0	0	0	0	0	0	2	0	0	2.1	0	0	0	8.8	0.9	9.8	0.8	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0.9	0.4	0.2	0.1	11.4	0	8.8	0.1	0	0	0	0	2.1	0	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	11.8	0	0	0	0	0	0	0	0	0	0.8	0	0.2	2.3	0	0	0	0	Melanocytes
XIRP2	CMYA3	ENSG00000163092	Xin actin binding repeat containing 2	A4UGR9	2	166888487-167259753	Cancer-related genes, Plasma proteins, Predicted intracellular proteins		Actin-binding	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in some	6	skeletal muscle: 292.8	Cell type enriched	Detected in some	66	Cardiomyocytes: 1858.5	Cancer enriched	Detected in some	5	head and neck cancer: 3.4	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		AN3-CA: 3.3;HEL: 1.5;HUVEC TERT2: 8.7;U-2197: 6.1	Not detected	Not detected			Not detected	Not detected			HPA034813, HPA074599	Enhanced		Approved	Nucleoplasm,Plasma membrane						Plasma membrane	Nucleoplasm	HPA034813: AB_10602588, HPA074599: 					unprognostic (5.27e-4)	unprognostic (5.96e-3)		unprognostic (7.42e-2)	unprognostic (2.42e-1)					unprognostic (1.74e-1)	unprognostic (2.56e-1)			7.3	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	3.6	3.3	0	0	24.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.1	0	0	4.3	0	292.8	0	0	0	0	0.1	0	0.6	0	0	2.3	51	2.9	0.1	0	0	0	0	0	0	0	0.6	0	0	0	3.3	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0.1	0.1	0	0	1.5	0	0.2	0.2	0	0	0.9	0	0.2	0.7	0	8.7	0	0	0	0	0	0	0	0	0	0.5	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	6.1	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1858.5	0	0	0	0	0	0	0	0	28	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	20.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0.7	0.4	0	0	0	0	0	Cardiomyocytes
PDLIM5	Enh, LIM	ENSG00000163110	PDZ and LIM domain 5	Q96HC4	4	94451857-94668227	Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		heart muscle: 129.6;skeletal muscle: 173.0	Cell type enriched	Detected in all	8	Cardiomyocytes: 1784.7	Cancer enriched	Detected in all	8	prostate cancer: 132.0	Low region specificity	Detected in all			Cell type enriched	Detected in all	4	basophil: 51.1	Lineage enriched	Detected in all	4	granulocytes: 51.1	Cell line enhanced	Detected in all		hTERT-RPE1: 51.4	Low region specificity	Detected in all			Low region specificity	Detected in all			CAB013511, HPA016740, HPA020026	Enhanced		Supported	Nucleoplasm,Plasma membrane,Focal adhesion sites					2200000	Nucleoplasm, Plasma membrane, Focal adhesion sites		CAB013511: AB_2533388, HPA016740: AB_1855153, HPA020026: AB_1855154	unprognostic (6.20e-2)	unprognostic (1.94e-1)	unprognostic (2.81e-2)	unprognostic (1.08e-2)	unprognostic (6.61e-2)	unprognostic (2.24e-1)	unprognostic (1.33e-1)	unprognostic (2.46e-2)	unprognostic (7.60e-2)	unprognostic (2.65e-1)	unprognostic (1.18e-2)	unprognostic (1.47e-1)	unprognostic (1.24e-1)	unprognostic (2.11e-2)	unprognostic (3.15e-2)	unprognostic (1.91e-1)	unprognostic (1.04e-1)	11.6	4.8	6.2	4.2	6.1	8.7	9.8	3.4	5.8	12.7	11	3.7	7.1	5.6	37.5	12.9	14	10.2	11	129.6	5.3	5.2	12.9	13.9	5.6	5.3	5.4	4.5	10.3	8.1	3.4	6.8	18.9	10.2	15.3	5.4	12.6	15.3	12.5	173	5.6	15.8	22.1	4.9	7	5.6	5.5	3.7	1	5.3	52.9	9.5	17.7	7.1	3.2	5.6	51.1	12.2	2.7	3.9	3.8	8.2	24.4	9.5	3.7	21	14.4	3.7	20.1	16.7	11.5	9.3	22.5	18.3	3.3	20.6	20.1	5.9	8.5	12.9	18.8	19.3	5.8	5.4	12	15.9	8.5	30.3	3.9	10.8	19.3	16.6	27.6	21.5	51.4	25.9	3.4	5.1	3.6	24.5	8.1	4	1.3	3.2	18.1	10.2	1.9	7	2.9	12.9	26.4	4.7	6.3	11	25.1	5.6	8	2.9	1.2	32.4	30.1	4.8	13	12.2	2.5	3.2	3.3	16.4	2.8	7	51.1	6.8	5.9	3.8	11.8	3.1	3.2	3.7	3.9	5.6	2.5	2.5	3.2	6.8	2.7	12.2	1.9	3.4	3.8	6.2	6.1	3.4	3.9	5.3	5.2	5.4	4.5	10.2	3.7	41.7	23.4	12.7	232.1	172.6	4.3	1784.7	58.6	30.8	37.5	47.1	29.5	9.2	11.6	82.1	14.6	128.1	146.3	23.3	81.9	91.7	90.4	234.4	50.8	159.4	34.4	1.6	105	135.1	57.1	6.8	38.3	60.2	59.1	29.7	89.1	79.1	115.5	83.5	62.6	63.8	35.6	77.6	141.3	13.2	30.2	137.1	19.9	15	51	185.7	Cardiomyocytes
LCE3D	LEP16, SPRL6A, SPRL6B	ENSG00000163202	Late cornified envelope 3D	Q9BYE3	1	152579381-152580504	Predicted intracellular proteins	Keratinization			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in some		cervix, uterine: 53.2;lymphoid tissue: 48.6;tongue: 96.6;vagina: 48.5	Cell type enriched	Detected in single	36	Pancreatic endocrine cells: 5.0	Group enriched	Detected in many	9	head and neck cancer: 126.9;melanoma: 47.1	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	6	hTCEpi: 8.7;hTERT-HME1: 8.1																							unprognostic (1.34e-1)				unprognostic (1.09e-1)			unprognostic (2.87e-1)									0.3	0	0.1	0.1	0.1	0	0.3	0.1	0.1	53.2	0.1	0.1	0.1	0	3.7	0.1	7.8	0.1	0.2	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	8.5	0.1	0.1	17	0.1	0.1	0.1	0.1	0	0.1	0.1	0.9	0.1	96.6	48.6	0.1	48.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.4	0	0	0	0	0	0	0	0	0	1.4	0	0	0	0.2	0	0	0	0	0	0	8.7	0	8.1	0	0	0	0.1	0	0.2	0	0	0	0	0	0.3	0	0.1	0	0	0	0	0	0	0	0	0	0.1	0	1.3	0	0	0.1	0	0	0	0	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5	0	0	0	0	0	0	0	0	0	0	0	0	0	Pancreatic endocrine cells
IVL		ENSG00000163207	Involucrin	P07476	1	152908545-152911886	Plasma proteins, Predicted intracellular proteins	Keratinization			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		esophagus: 97.1;tongue: 152.1	Cell type enriched	Detected in some	8	Suprabasal keratinocytes: 62.0	Group enriched	Detected in many	5	cervical cancer: 44.0;head and neck cancer: 145.4;melanoma: 50.9;urothelial cancer: 47.7	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	25	HaCaT: 78.9;RT4: 20.7;SK-BR-3: 23.8									CAB002243, HPA055211	Enhanced		Supported	Nuclear bodies,Centrosome,Cytosol					8000000	Cytosol	Nuclear bodies, Centrosome	CAB002243: AB_563785, HPA055211: AB_2682739	unprognostic (3.29e-4)	unprognostic (1.91e-1)		unprognostic (2.92e-2)		unprognostic (2.31e-2)		unprognostic (7.60e-2)	unprognostic (2.22e-1)		unprognostic (4.82e-2)	unprognostic (3.11e-1)		unprognostic (3.66e-1)		unprognostic (1.22e-2)	unprognostic (1.32e-1)	0.1	0.1	0	0.1	0	0.1	2	0	0.1	39	0.1	0	0.4	0.1	4.2	11.5	97.1	0.1	0.1	0.1	0	0	0.1	0.1	0.1	0.1	0	0	0.1	0.1	0.1	0	0.4	0	1.8	0.1	0	18.7	0.1	0.2	34.2	0.1	1	0	0.1	0.1	0.1	0	1.9	0.1	152.1	49.1	4.9	43.8	0	0	0	0	0	0.3	0	0.3	0	0	0	0	0	0	0	0.1	0	0	0	1.6	0	0	0	0	78.9	0	0.2	0	0	0	0	0	0	0	0	0	0	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	20.7	0	0	0	23.8	0	0	1	0	0	0	0	0.2	0	0	0	0	0.1	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	4.9	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	3.3	0	0	0	0.1	0	0	0	0	0	0	0	0	62	0	0	0	7.4	Suprabasal keratinocytes
SPRR3		ENSG00000163209	Small proline rich protein 3	Q9UBC9	1	153001747-153003856	Cancer-related genes, Predicted intracellular proteins	Keratinization		Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		esophagus: 855.8;lymphoid tissue: 537.4;tongue: 389.6	Cell type enriched	Detected in some	5	Urothelial cells: 109.5	Cancer enhanced	Detected in many		head and neck cancer: 423.4	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		CAPAN-2: 6.8;hTCEpi: 11.1;OE19: 4.2;RT4: 14.1;TIME: 4.0									HPA044467	Enhanced								15000			HPA044467: AB_2678952		unprognostic (2.78e-2)	unprognostic (3.54e-1)	unprognostic (8.77e-2)		unprognostic (7.50e-3)		unprognostic (9.67e-3)	unprognostic (2.36e-1)		prognostic unfavorable (6.27e-5)			unprognostic (9.70e-2)	unprognostic (4.66e-2)		unprognostic (1.58e-2)	0.2	0.2	0	0.2	0	0.2	0.2	0	0.2	157.6	0.2	0	0	0.2	11.5	0.2	855.8	0.2	1.8	0.5	0	0	0.2	0.3	0.2	0.2	0	0	0.2	0.2	0.2	0	1.2	0	0.2	0.2	0	93.4	0.2	0.4	0.2	0.2	0.3	0	0.2	0.2	0.2	0	0	0.2	389.6	537.4	0.6	163.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.7	6.8	3.5	0	0	0	0.2	0	0.6	0	0	0	1.1	0	0	0	1.2	0	0	11.1	0	0	0	0	0	2.9	0	0	0.3	0	0	0	4.2	0	0	1.3	0	0	14.1	0	0	0.4	3.3	0	0.7	0	0	4	0	0	0	0	0	1.5	1.2	0	2.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0	2.9	0	0.9	0	0	0	0	3.4	1.1	0	0.2	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	23.6	0	0	0	0	0	0	0	0	0	6.3	0	0	109.5	Urothelial cells
SPRR2D		ENSG00000163216	Small proline rich protein 2D	P22532	1	153039725-153041931	Predicted intracellular proteins	Keratinization			Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Group enriched	Detected in some	4	esophagus: 246.4;tongue: 317.8	Cell type enriched	Detected in some	6	Suprabasal keratinocytes: 13.7	Group enriched	Detected in many	5	cervical cancer: 80.9;head and neck cancer: 353.3	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	5	hTCEpi: 26.2;hTERT-HME1: 23.0;SK-MEL-30: 11.3																							unprognostic (7.50e-2)	unprognostic (1.84e-1)	unprognostic (5.17e-2)		unprognostic (5.14e-2)		unprognostic (1.49e-3)	unprognostic (3.58e-1)		unprognostic (1.37e-3)			unprognostic (6.85e-2)	unprognostic (1.90e-2)		prognostic unfavorable (1.62e-4)	0.1	0.1	0.1	0.1	0.1	0.1	0.6	0.1	0.1	30.2	0.1	0.1	0.1	0.1	0.4	0.1	246.4	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	29.9	0.1	0.1	14.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	317.8	63.5	0.1	40.4	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0.1	0	0.4	0	0	0.1	0	0.5	0.1	0	0	1.4	0	0	0	0	0	0.2	0	0	0	0.3	0	0	26.2	0	23	0	0	0	0.5	0.7	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	11.3	0.1	0	0	0.7	0	0.6	0	0	0.7	0.1	0.1	4.3	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	0	0	1.5	0	0	0	0	2.3	0	0	0	0	0.4	0	0	0	0	0	0.3	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	13.7	0.2	0	0	0.7	Suprabasal keratinocytes
S100A9	60B8AG, CAGB, CFAG, CGLB, LIAG, MAC387, MIF, MRP14, NIF, P14	ENSG00000163220	S100 calcium binding protein A9	P06702	1	153357854-153361027	Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Apoptosis, Autophagy, Chemotaxis, Immunity, Inflammatory response, Innate immunity	Antimicrobial, Antioxidant	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		blood: 638.3;bone marrow: 820.1;esophagus: 642.6;tongue: 477.6	Cell type enriched	Detected in many	7	Kupffer cells: 11072.0	Cancer enhanced	Detected in all		cervical cancer: 5468.0;head and neck cancer: 6692.8	Low region specificity	Detected in many			Group enriched	Detected in many	6	classical monocyte: 381.5;neutrophil: 638.3	Group enriched	Detected in many	6	granulocytes: 638.3;monocytes: 381.5	Cell line enriched	Detected in some	6	SK-BR-3: 233.1	Low region specificity	Detected in some			Not detected	Not detected			HPA004193, CAB009441	Enhanced		Supported	Nucleoplasm,Cell Junctions,Cytosol	Secreted to blood			10600000	1400000000	Nucleoplasm, Cell Junctions, Cytosol		CAB009441: AB_2184420, HPA004193: AB_1856537	unprognostic (1.72e-1)	unprognostic (3.33e-2)	unprognostic (2.40e-1)	unprognostic (3.94e-3)	unprognostic (1.36e-2)	unprognostic (5.45e-3)	prognostic unfavorable (1.13e-6)	unprognostic (1.10e-2)	unprognostic (4.31e-1)	unprognostic (3.06e-1)	unprognostic (1.35e-2)	unprognostic (5.59e-2)	prognostic unfavorable (8.10e-4)	unprognostic (1.48e-1)	unprognostic (7.52e-2)	unprognostic (5.39e-2)	unprognostic (1.75e-2)	19.5	2.1	1.3	41.9	4.2	820.1	4.1	0.9	2.1	143.6	4.4	0.7	0.4	0.7	4.9	4	642.6	9.9	4.4	51.2	2.5	0.4	2.8	4.8	29.2	169	5.3	0.6	3.4	4.4	0.1	0.9	10.4	5.2	2.2	0.7	2	109.6	0.5	3.4	7.5	1.4	13.1	2.1	103.2	3.5	2.9	1.4	3.8	6.7	477.6	228	24.3	237	0.5	87.5	638.3	381.5	0.3	1	323.2	2.2	0	0	0	0	0	0.2	0	0	0	0	0.1	0	0.8	36.6	0	0	2.2	0	15	0	0	0	0.5	0	0	0	0.7	0	0	12.7	0	0.8	0	0	0	0.7	0.3	0	2.9	0	0.3	0	0.2	0	0	0.5	7.7	0	9.5	0.1	0	0.3	233.1	0.1	0.1	3.6	29.6	0.6	0	0.3	0	0	0	0.1	0.2	0	6.7	0	5.3	381.5	46.4	0.5	31.6	1	0.4	0.4	0.3	87.5	0.5	0.3	0.3	638.3	0.3	15	2.9	0.5	323.2	1.3	4.2	0.9	2.1	2.5	0.4	5.3	0.6	5.2	1.4	214.4	574.2	57.1	52.5	17.7	0	2.5	66.2	112.4	185.4	34.9	0	111	5	49.4	1.3	7	0.5	23.3	32.9	44.2	7.1	19.6	151.1	16.4	1627.6	0	0	71.2	11072	2.2	5.5	1162.8	0	4.6	2.1	0	10.3	0.8	0	16.3	0.2	0	2.5	0.3	1.3	29.1	1033.7	24.9	1.9	291.7	Kupffer cells
S100A12	CAAF1, CAGC, CGRP, ENRAGE, MRP6, p6	ENSG00000163221	S100 calcium binding protein A12	P80511	1	153373706-153375649	Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Immunity, Inflammatory response, Innate immunity	Antibiotic, Antimicrobial, Fungicide		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	5	blood: 139.8;bone marrow: 329.6;lymphoid tissue: 94.7	Cell type enriched	Detected in some	33	Kupffer cells: 1264.6	Cancer enhanced	Detected in many		head and neck cancer: 51.4	Low region specificity	Detected in many			Group enriched	Detected in some	12	classical monocyte: 91.9;neutrophil: 139.8	Group enriched	Detected in many	12	granulocytes: 139.8;monocytes: 91.9	Group enriched	Detected in some	7	hTCEpi: 6.6;SK-BR-3: 2.2;THP-1: 4.2					Not detected	Not detected			HPA002881, CAB025872	Enhanced				Secreted to blood			28500000	6200000			CAB025872: , HPA002881: AB_1848175	unprognostic (1.33e-1)	unprognostic (4.51e-2)	unprognostic (7.49e-2)	unprognostic (1.36e-1)	unprognostic (7.30e-2)	unprognostic (4.36e-2)	unprognostic (3.79e-2)	unprognostic (8.79e-3)	unprognostic (9.04e-2)	unprognostic (3.14e-2)	unprognostic (1.58e-1)	unprognostic (8.08e-3)	prognostic unfavorable (5.03e-4)	unprognostic (3.68e-3)	unprognostic (1.05e-1)	unprognostic (1.31e-2)	unprognostic (7.70e-2)	6.7	0.5	0.9	8.9	1.7	329.6	0.8	0.3	1	3.5	1.1	0.2	0	0.6	0.5	0.4	9.2	3.3	1.1	41.2	0.7	0.8	1.6	4	34.4	27.4	3.3	0	1.5	5	0.4	0.7	3.9	2.8	0.8	0.4	0.7	1.9	0.4	1.3	0.8	0.5	4.4	0.8	94.7	1.4	3.4	0.5	3.9	4.5	15.3	4.9	1.7	36	0.2	9.6	139.8	91.9	0	0.1	59.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0.5	0	0.6	0	0	0	0	0	0	0	0	0	0	6.6	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0.4	0	0.2	0	2.2	0	0	0	4.2	0	0	0	0	0	0	0	0	0	0	0	0.5	91.9	0.3	0.1	3.3	0	0.2	0	0.1	9.6	0	0	0	139.8	0	0.7	0.6	0.1	59.2	0.9	1.7	0.3	1	0.7	0.8	3.3	0	2.8	0.5	17.9	38.5	0	0.2	0.1	0	0.4	7.6	13.4	10.3	1.8	0	0.3	0	0	1.2	0	0	0	0.2	0.7	0	0	12.8	3	9	0	0	11.1	1264.6	0.7	0	35	0	1	0	0	0	0	0	1	0	0	0	0	0.2	0	0.5	0	0	0.1	Kupffer cells
GABRB1		ENSG00000163288	Gamma-aminobutyric acid type A receptor beta1 subunit	P18505	4	46993723-47426444	Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins	Ion transport, Transport	Chloride channel, Ion channel, Ligand-gated ion channel, Receptor	Disease mutation, Epilepsy, FDA approved drug targets	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	4	brain: 34.5;pituitary gland: 14.7	Cell type enriched	Detected in some	25	Muller glia cells: 39.0	Cancer enhanced	Detected in single		glioma: 0.7	Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		CACO-2: 2.4;REH: 4.2;SCLC-21H: 1.1;U-87 MG: 6.8	Low region specificity	Detected in all			Low region specificity	Detected in all																unprognostic (3.11e-2)		unprognostic (7.56e-3)		unprognostic (5.10e-2)	unprognostic (1.83e-1)			unprognostic (1.11e-1)		unprognostic (4.98e-3)		unprognostic (8.16e-3)	unprognostic (6.22e-2)	unprognostic (2.72e-2)	unprognostic (2.34e-1)		1	1.3	19.9	1	34.5	0.9	1	14.7	27.9	1	1.2	2.7	0	1.6	1.2	1	1	1.2	1.2	6	16.3	4.2	1.8	1.1	1.1	0.9	2.8	18.5	1.1	0.9	0.9	14.7	1.3	5.6	1	1.2	0	0.9	0.9	0.9	0.9	1.3	1	3.4	1	1	1.1	6.7	0	1.3	0	0.9	0.9	0.5	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.4	0	0	0	0	0	0	0.5	0	0.3	0	0	0	0	0	0.5	0	0	0	0	0.2	0	0.9	0	0	0	0	0	0	0	0	0	0	0	4.2	0	0	0	0	1.1	0	0	0	0	0	0	0	0	0.3	0.1	0	0.7	0	0	0	6.8	0	0.1	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	19.9	34.5	14.7	16.6	16.3	4.2	2.8	18.5	5.6	6.7	0	0	0	0	0	0.6	1.6	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	1.2	0	0	0	0	0	0	0	0	39	0	0	0	0	1	0	0	0.3	1.4	0	0.1	0	0	0	Muller glia cells
DAPL1		ENSG00000163331	Death associated protein like 1	A0PJW8	2	158795317-158862781	Predicted intracellular proteins, Predicted membrane proteins	Apoptosis, Differentiation			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		epididymis: 53.5;esophagus: 75.6;retina: 63.9;skin 1: 61.3	Cell type enriched	Detected in many	5	Muller glia cells: 522.1	Group enriched	Detected in all	7	cervical cancer: 16.2;head and neck cancer: 14.5;lung cancer: 19.7;ovarian cancer: 62.5;thyroid cancer: 30.1	Low region specificity	Detected in many			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Cell line enhanced	Detected in some		HaCaT: 3.7;hTCEpi: 22.1;SCLC-21H: 5.7;U-87 MG: 8.1	Not detected	Not detected							HPA046937, HPA058635	Enhanced		Approved	Nucleoplasm,Nuclear bodies,Microtubules						Nucleoplasm, Nuclear bodies, Microtubules		HPA046937: AB_2679870, HPA058635: AB_2732625	unprognostic (3.95e-5)	prognostic favorable (8.43e-4)	unprognostic (2.05e-1)	unprognostic (1.55e-1)	unprognostic (2.98e-1)	unprognostic (4.63e-2)		unprognostic (8.59e-2)	unprognostic (5.24e-2)	unprognostic (4.59e-2)	unprognostic (2.44e-1)	unprognostic (1.41e-1)	unprognostic (2.44e-3)	unprognostic (4.09e-2)	unprognostic (6.68e-2)	unprognostic (3.00e-2)	unprognostic (2.30e-3)	0.3	14.7	1.4	0.4	1.3	0	7.4	0.4	1	11.7	1	0.8	1.6	0	2.1	53.5	75.6	21.1	0.6	0.2	1.5	3.6	1.3	0.2	0.8	0.4	2.8	0.3	3.8	5.7	0	5.6	0.2	1.5	2.3	0	63.9	6.8	0.4	0.2	61.3	0.5	1.1	0.4	0.2	0.2	2.1	0.8	0.8	21.5	37.3	16.9	2	21.1	1.4	4	2.9	2.6	2.8	1.3	0.5	0	0	0	0.2	0	0	0.4	0	0	0.1	0	0.3	0.1	0	0.1	0	0	3.7	0	0	0	0.1	0	0.1	2.3	0	0	0	0	0.2	22.1	0	0	0.8	0	0.3	0	0	0.1	0	0	0.3	0.1	0	0.1	0	0.8	0	0	0.3	5.7	0	0	0	0.6	0	0.6	1.1	0	0.2	0.1	0	0.2	0	0	0	8.1	0	0	2.9	2.6	1.6	0.5	1.9	1	1.2	0.8	0.4	1	1.4	0.4	0.5	2.2	2.8	0.6	4	1.3	0.5	1.4	1.3	0.4	1	1.5	3.6	2.8	0.3	1.5	0.8	0	0	14.6	31.4	94.9	6.8	0	5.1	1.4	17	8.7	5.9	5.5	3.3	8	10.6	0.5	2.5	0	5.1	10.7	4.1	10.8	4.6	12.1	12.9	3.2	2.9	0.6	7.9	43.8	3.7	5.5	11.8	2.8	1.6	522.1	5.7	3.5	2.1	5.8	16.3	0	5.1	9.8	4.1	110.7	3.8	1.9	2.5	25.5	Muller glia cells
FAM19A4	TAFA-4	ENSG00000163377	Family with sequence similarity 19 member A4, C-C motif chemokine like	Q96LR4	3	68731766-68953297	Predicted intracellular proteins, Predicted secreted proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		adrenal gland: 26.0;brain: 10.9	Cell type enriched	Detected in some	7	Cone photoreceptor cells: 31.4	Low cancer specificity	Detected in some			Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HAP1: 2.7;NTERA-2: 13.9;SuSa: 4.1	Region enriched	Detected in some	5	thalamus: 14.7	Low region specificity	Detected in all								Secreted in brain								unprognostic (1.92e-1)			unprognostic (9.97e-3)	unprognostic (2.28e-1)			unprognostic (8.19e-3)		unprognostic (8.78e-2)	unprognostic (2.00e-2)	unprognostic (3.01e-2)	unprognostic (1.22e-1)	unprognostic (3.66e-2)	unprognostic (8.06e-2)	unprognostic (2.50e-1)		0.5	26	2.3	0.9	7.3	0.5	0.6	0.4	7.5	0.5	0.7	10.8	0	0.6	0.5	0.5	1.1	0.6	2.7	0.5	2.9	4.2	0.7	0.5	0.6	0.6	10.9	1.8	1	0.5	0.5	1.8	1.8	8.7	2.2	0.6	5	0.7	1.1	0.5	0.5	0.5	1	10.4	0.6	8.3	2.1	8.2	0	0.6	0	0.6	0.6	0.1	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.7	0	0	0	0.1	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	13.9	0	0	0	0	0	0	0	1.5	0.6	0	0	0	4.1	0	0	0	0	1.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.3	7.3	0.4	7.5	2.9	4.2	10.9	1.8	8.7	8.2	0	0	0	0	0	4.3	0.3	0	0	0	0	31.4	0	0	0	4.5	0	0	0	0	0	0	0.3	0	0	0	1.6	0	0	0	4.5	0	0	0	0	0	1.2	0	0	0	0	3.9	0	0	0	0.4	0	0	0	0	0	Cone photoreceptor cells
LMOD3		ENSG00000163380	Leiomodin 3	Q0VAK6	3	69106872-69123032	Disease related genes, Predicted intracellular proteins			Disease mutation, Nemaline myopathy	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		heart muscle: 28.3;skeletal muscle: 121.1;tongue: 53.1	Cell type enriched	Detected in many	6	Cardiomyocytes: 241.3	Cancer enriched	Detected in single	6	head and neck cancer: 1.6	Not detected	Not detected			Cell type enhanced	Detected in some		basophil: 4.1	Low lineage specificity	Detected in many			Cell line enriched	Detected in some	5	HSkMC: 8.2	Not detected	Not detected			Not detected	Not detected			HPA036034	Uncertain											HPA036034: AB_10673494	unprognostic (1.66e-1)	unprognostic (2.65e-1)	unprognostic (1.04e-2)	unprognostic (1.32e-2)	unprognostic (1.93e-1)	unprognostic (2.50e-3)	unprognostic (1.96e-2)	unprognostic (2.77e-2)	unprognostic (1.39e-1)	unprognostic (6.57e-2)	unprognostic (3.63e-1)	unprognostic (4.33e-1)	unprognostic (2.98e-4)	unprognostic (3.67e-3)	unprognostic (1.29e-1)	unprognostic (8.86e-2)	unprognostic (2.96e-1)	0.8	0.1	0.1	0	0.2	0	0.1	0.1	0.3	0.1	0.1	0	0	0	0.1	4.8	1.9	0.1	0	28.3	0.1	0.1	0.1	0.1	0.1	0	0.4	0	0.1	0.1	0	0.5	0.1	0	0.9	0	0	4.4	0.1	121.1	0.1	0.1	0.3	0.1	0.2	0.2	0.1	0.1	0	1.4	53.1	0.7	0.6	0.1	0.9	0.3	4.1	1.1	0.4	1	0.2	0.3	0.1	0.9	0.2	0.1	0	0.2	0.2	0	0	0	0.1	0.7	0.2	0.1	0	0.2	0.2	0	0	0	0.3	0.2	0	0.7	0.6	0	0.2	0.7	8.2	0	0.1	0.2	0.2	0	0.1	0.1	0.6	1.8	0.1	0	0.3	0.1	0	0.2	0.1	0.6	0.1	0	0.8	0.2	0.3	0.2	0.2	0.1	0.1	0.1	0.1	1.1	0.3	0.1	0.3	0.1	0.4	0.5	0.2	0.3	0.2	0.3	4.1	0.6	0.8	0.5	0.4	0.6	0.6	0.9	0.7	0.1	0.9	0.6	0.7	0.8	0.4	1.1	0.3	1	0.2	0.1	0.2	0.1	0.3	0.1	0.1	0.4	0	0	0.1	0	0	3.7	1.4	2.1	4.5	241.3	10.2	0	0	0	37.3	0.7	0	0.8	0.7	0.7	2.4	0	0	1.6	2.2	1.9	18.4	1	0.7	6.4	0	1.3	1	0.2	0.3	1.7	11.8	1.8	1.5	1.6	1	0	1.1	0.3	14.1	0	1.9	0.4	0.1	1.3	0.3	7.5	0.6	1.8	Cardiomyocytes
FEV	Pet-1	ENSG00000163497	FEV, ETS transcription factor	Q99581	2	218981087-218985657	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors	Differentiation, Neurogenesis, Transcription, Transcription regulation	Developmental protein, DNA-binding	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in some		brain: 6.9;intestine: 7.0;pituitary gland: 5.4;stomach 1: 6.1	Cell type enriched	Detected in some	123	Intestinal endocrine cells: 716.0	Group enriched	Detected in some	10	pancreatic cancer: 3.0;prostate cancer: 9.9;stomach cancer: 2.4	Region enhanced	Detected in many		pons and medulla: 6.9	Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	6	HMC-1: 19.1;SH-SY5Y: 24.5	Group enriched	Detected in some	13	midbrain: 2.3;pons and medulla: 0.9	Group enriched	Detected in some	35	midbrain: 7.3;pons and medulla: 3.9	HPA067679		Supported	Supported	Nuclear speckles						Nuclear speckles		HPA067679: AB_2685884			unprognostic (4.58e-1)		unprognostic (1.60e-1)					unprognostic (7.21e-2)	prognostic favorable (4.85e-4)	unprognostic (2.87e-1)	unprognostic (3.96e-1)	unprognostic (1.52e-1)	unprognostic (2.15e-1)			0.1	4.1	0	1.2	3.5	0	0	0	2.6	0	2	0.7	0	7	0.1	0	0	0.1	0	0	1.1	0.2	0	0	0	0	0.2	0	0	4.2	0	5.4	0	6.9	4	3.2	0	0	0	0	0	5.4	0	0.1	0	6.1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.9	0	0	0	0	19.1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	2.7	24.5	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.5	0	2.6	1.1	0.2	0.2	0	6.9	1	0	0	0	0	0.1	0	0.4	0	0	0	0	0	0	0	0	0	0	0.9	0	0	0	0	3.3	0	0	0	0	716	0	0	0	0	0	0	0	1.3	0	0.3	5.8	0	0	0.6	0	0	0	0.2	0	0	0	1.2	0.1	Intestinal endocrine cells
CRYBA2		ENSG00000163499	Crystallin beta A2	P53672	2	218990189-218993421	Disease related genes, Predicted intracellular proteins		Eye lens protein	Cataract, Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	4	adrenal gland: 4.6;intestine: 5.8;pancreas: 16.2;pituitary gland: 12.2;stomach 1: 6.1	Cell type enriched	Detected in some	69	Intestinal endocrine cells: 827.9	Cancer enriched	Detected in some	15	pancreatic cancer: 16.0	Low region specificity	Detected in single			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	7	BEWO: 40.9	Not detected	Not detected			Not detected	Not detected			HPA062293	Supported											HPA062293: AB_2732680	unprognostic (5.29e-2)	unprognostic (1.24e-1)	unprognostic (2.15e-1)	unprognostic (4.19e-1)	unprognostic (6.19e-2)	unprognostic (1.77e-1)	unprognostic (2.72e-1)	unprognostic (1.66e-2)	unprognostic (3.75e-1)		prognostic favorable (7.62e-4)	unprognostic (2.91e-1)		unprognostic (1.90e-1)	unprognostic (2.19e-1)			0.3	4.6	0.3	0.3	2	0	0.3	0.3	0.8	0.3	5.8	0.3	0.3	3.5	0.3	0.3	0.3	0	0.3	0.3	0.6	0.5	0.3	0.3	0.3	0.3	0.6	0.3	0.3	16.2	0.1	12.2	0.3	0.7	0.5	2.8	0.8	0.3	0.3	0.3	0.1	4.7	0.3	0.3	0.3	6.1	1.6	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0	0	0	0	0	0	0	0.1	0	0	0	0	0	40.9	0	0	0	0	0	0.3	0	0.7	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	3.3	0	0	0	0	0	5.9	1.4	1.1	0	0.3	0	0	0	0	0	1	0	0.1	0	0	0.4	0	0	1.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	2	0.3	0.8	0.6	0.5	0.6	0.3	0.7	0.3	0	0	0	0	0	0.6	0.2	0	0	0	0	0	0.1	0	0	2.2	0	2.7	0	1.1	3.3	0	1.3	0	0	0.2	0	827.9	0	0	6.2	0	0	1.7	0	3.6	0	11.9	8.6	0	0	0.8	0	0	0.5	3	0.3	0.2	0	1.5	0	Intestinal endocrine cells
SPTA1	EL2	ENSG00000163554	Spectrin alpha, erythrocytic 1	P02549	1	158610706-158686715	Disease related genes, Plasma proteins, Predicted intracellular proteins	Cell shape	Actin capping, Actin-binding	Disease mutation, Elliptocytosis, Hereditary hemolytic anemia, Pyropoikilocytosis	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	5	bone marrow: 41.0	Cell type enriched	Detected in some	42	Erythroid cells: 70.0	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	4	K-562: 28.6	Not detected	Not detected			Not detected	Not detected			CAB016193, HPA028048, HPA028253, CAB037246	Enhanced								45000000			CAB016193: AB_669050, CAB037246: AB_261445, HPA028048: AB_10603341, HPA028253: AB_2672537	unprognostic (3.39e-1)	unprognostic (1.03e-1)	unprognostic (2.25e-2)	unprognostic (1.94e-1)	unprognostic (2.99e-1)	unprognostic (1.34e-1)	unprognostic (3.65e-3)	unprognostic (1.50e-3)	unprognostic (9.08e-2)	unprognostic (2.58e-2)	unprognostic (2.29e-1)	unprognostic (9.09e-2)	unprognostic (6.73e-8)	unprognostic (6.08e-2)	unprognostic (6.33e-2)	unprognostic (1.76e-2)	unprognostic (5.85e-3)	0.6	0	0	1.1	0	41	0.4	0	0	0	0	0	0	0	0.1	0	0	0	0	0.1	0	0	0.1	0.7	4.1	0	0	0	0	0	0	2	8.1	0	0	0	0.5	0	0	0.4	0	0	0	0.6	4.6	0	2.2	0	0.3	0.9	0	0	0	2.8	0.9	0	0	0.4	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	6.5	0	0	0	0	0	0	0	0	0	0	0.3	0	28.6	0	0	0	0	0	0	0	0	2.4	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0.4	0	0.9	0	0	0	0.4	0	0	0	0	0.1	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0	0	1.7	0	1.5	0.1	0	70	0	0.2	0	0	0	0	0.3	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Erythroid cells
SLC2A2	GLUT2	ENSG00000163581	Solute carrier family 2 member 2	P11168	3	170996348-171026750	Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters	Sugar transport, Transport		Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	8	intestine: 77.4;liver: 172.8	Cell type enriched	Detected in some	5	Hepatocytes: 433.3	Cancer enriched	Detected in some	12	liver cancer: 105.2	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	68	CACO-2: 7.3;Hep G2: 24.3	Not detected	Not detected			Low region specificity	Detected in some			CAB010444, HPA028997	Enhanced		Supported	Plasma membrane						Plasma membrane		CAB010444: AB_641068, HPA028997: AB_2672860			unprognostic (9.56e-2)		unprognostic (1.24e-1)		prognostic favorable (2.63e-5)				unprognostic (3.10e-1)		unprognostic (1.02e-1)	unprognostic (2.95e-2)	unprognostic (6.31e-2)			0.1	0.1	0.1	0	0.1	0	0.1	0.1	0.1	0.1	27.9	0	0	10.8	0.1	0.2	0.1	0.1	3.8	0.1	0.1	0.1	15.3	172.8	0.1	0	0.1	0	0.1	0.6	0	0.1	0	0	0.1	0	0	0.1	0	0.1	0.1	77.4	0	0.1	0.1	0.1	0.1	0	0	0.1	0	0	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	7.3	0	0	0	0	0	0	0	0	0	0	0	0	0.2	24.3	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0	0	86.6	0	0	0	0	0	1.7	0.2	4.6	0	0	0	0	0	0	0	0	433.3	0	0	0	6.7	8.9	0.4	0	0	0	0	0.3	0	0.1	0	0	49.1	0	0	0	0	0	0	0.1	1.9	0	0	Hepatocytes
ALB		ENSG00000163631	Albumin	P02768	4	73397114-73421412	Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins			Cancer-related genes, Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	81	liver: 3075.8	Cell type enriched	Detected in many	4	Hepatocytes: 49859.9	Cancer enriched	Detected in many	384	liver cancer: 14213.7	Not detected	Not detected			Cell type enriched	Detected in single	13	naive CD4 T-cell: 1.3	Lineage enriched	Detected in single	13	T-cells: 1.3	Cell line enriched	Detected in some	39	Hep G2: 315.9	Not detected	Not detected			Not detected	Not detected			CAB006262, HPA031024, HPA031025	Enhanced		Enhanced	Endoplasmic reticulum,Golgi apparatus	Secreted to blood			40000000000000		Golgi apparatus	Endoplasmic reticulum	CAB006262: AB_425297, HPA031024: AB_2673703, HPA031025: AB_2673704	unprognostic (1.38e-1)	unprognostic (8.72e-2)	unprognostic (1.73e-1)	unprognostic (2.60e-1)	unprognostic (4.44e-1)	unprognostic (2.46e-1)	unprognostic (9.53e-3)	unprognostic (2.16e-2)	unprognostic (2.40e-1)	unprognostic (6.43e-2)	unprognostic (3.84e-2)	unprognostic (5.37e-2)	unprognostic (1.25e-1)	prognostic unfavorable (7.87e-4)	unprognostic (7.23e-2)	unprognostic (1.05e-3)	unprognostic (1.02e-2)	0.1	0	0.1	0.2	0.1	0	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0	0.1	0.8	0.1	0	0.1	0.1	0.1	0	4.9	3075.8	0.1	0.1	0.1	0.1	0.1	38	0	0.1	0.1	0.2	0.1	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	1	0	0.3	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0	0	0	0	0	1.3	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	1.3	0	0	0	0.1	0	0	0	0	0	2.2	0.1	315.9	0	8.1	0.2	0	0	0	0	0	0	0	1.1	0	0	0	0.1	0	0.2	0	0	0.1	7	0	0	0.2	0	0	3.7	0	0	0	0	0	0.9	0	0.1	0	0	0.5	0	2.6	0	2.4	0	0	0	0	0	0	0	0	0	0	0	0	1.3	0	0	0	0	0	0	0	0.1	0.1	0.1	0.3	0.1	0	0.1	0.1	0.2	0.1	0	0	683.8	0	0	0	0.1	12066.1	0	0	36.6	0	0.8	61.3	4.3	2	0	0	1612	237.4	2.3	0.2	0.1	0	49859.9	8.2	0	1.7	1417.3	1529.6	0	0	0	0	1.8	0	0	261.7	0	0	442.7	0	0	0.4	0.2	0.2	0.1	17.7	22.3	0	0	Hepatocytes
ATXN7	ADCAII, OPCA3, SCA7	ENSG00000163635	Ataxin 7	O15265	3	63898399-64003453	Disease related genes, Plasma proteins, Predicted intracellular proteins	Transcription, Transcription regulation		Disease mutation, Neurodegeneration, Spinocerebellar ataxia	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		lymphoid tissue: 55.4	Cell type enriched	Detected in some	4	Syncytiotrophoblasts: 51.1	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enhanced	Detected in many		basophil: 11.1	Low lineage specificity	Detected in many			Low cell line specificity	Detected in all											HPA034989			Approved	Nucleoplasm,Cytosol						Nucleoplasm, Cytosol		HPA034989: AB_10602596	unprognostic (1.51e-2)	unprognostic (2.44e-1)	unprognostic (5.98e-2)	unprognostic (2.18e-1)	unprognostic (1.92e-1)	prognostic favorable (1.22e-4)	unprognostic (9.65e-2)	unprognostic (2.76e-2)	unprognostic (2.46e-1)	unprognostic (2.12e-1)	unprognostic (7.82e-2)	unprognostic (9.77e-3)	unprognostic (2.56e-1)	unprognostic (8.04e-2)	unprognostic (1.74e-1)	unprognostic (9.19e-2)	unprognostic (3.45e-2)	8.8	6.4	4.9	14.5	7.4	19.7	8.9	10.2	6.5	9.5	10.7	4.9	6.7	8	10.9	9.2	9.2	7.5	11.4	7.5	5	4.3	6.3	8.2	10.2	19.9	6.1	3.1	12.4	21.7	15.3	10.9	15.1	6	8.2	8.1	15.1	12.2	7.8	9.6	10.6	12.5	9.2	5.7	11.1	7.2	14.6	6.7	55.4	8.8	8.5	24.2	8.4	10.2	0.9	0.5	11.1	0.5	2.6	5.9	1.1	6	4.9	5	4.1	5.8	6.6	6.6	3.5	6.5	7.5	6.1	6.9	5.9	5.8	2.1	6.8	8.1	4	6.4	6.6	8	15.2	2.6	10.1	5.8	2.1	2.9	4.2	12.2	6.3	3.6	11.1	12.4	5.6	5.6	9.6	3.8	17.7	4.6	14.4	8.9	3.5	3.4	4.1	2.2	3.8	4.6	7	3.7	7.2	2	3.7	7.8	5.2	7.1	4.2	3.6	6.1	7.7	6.5	8.9	9.5	8.1	8	8.1	6.4	7.7	7.1	6.2	11.1	0.3	0.9	3.2	0.5	2.6	0	5.9	3.4	0.1	0.9	5.7	3.7	1.2	2.6	0.1	0.5	4.7	1.1	4.9	7.4	10.2	6.5	5	4.3	6.1	3.1	6	6.7	0	0	0	0	0	0	9	0	0	0	0	0	10.8	0	0	0	0	0	0	0	11.7	0	0	0	0	12.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	51.1	0	0	0	Syncytiotrophoblasts
CLRN1	RP61, USH3, USH3A	ENSG00000163646	Clarin 1	P58418	3	150926163-150972999	Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters	Hearing, Sensory transduction, Vision		Deafness, Disease mutation, Retinitis pigmentosa, Usher syndrome	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Group enriched	Detected in some	4	adrenal gland: 11.2;retina: 16.2	Cell type enriched	Detected in some	6	Muller glia cells: 150.4	Not detected	Not detected			Not detected	Not detected			Cell type enhanced	Detected in single		plasmacytoid DC: 1.8	Low lineage specificity	Detected in single			Cell line enriched	Detected in single	32	NTERA-2: 8.9																						unprognostic (1.00e-3)				unprognostic (1.26e-1)					unprognostic (5.54e-1)					unprognostic (9.68e-2)			0	11.2	0	0	0	0	0	0	0	0.1	0	0	0	3.2	0.1	0.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.9	0	0	0	0	16.2	0	0	0.1	0	1.6	0	2	0.1	0	0.7	0	0	0	0	0	0	0.1	0.2	1.8	0.7	0.1	0.1	0	0	0	0.1	0.1	0	0	0	0.1	0.1	0	0.1	0	0	0	0	0	0	0.1	0.1	0.1	0.1	0.1	0	0	0	0.2	0	0	0	0	0	0	0	0.1	0	0	0.1	0.1	0.1	0	0	0	0	8.9	0	0.2	0	0.1	0.1	0	0	0.2	0.2	0	0	0	0.1	0.1	0	0	0.1	0	0	0	0.1	0	0	0	0.1	0	0.1	0	0	0	0	0	0.1	0	0	0	0.2	0	0	0.7	0.1	0.1	1.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.9	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	23.8	0	0	0	0	0	0	0	0	0	150.4	0	0	0	0	3.6	0	0	0	0	0	0	0	0	0	Muller glia cells
DCLK3	DCAMKL3, DCDC3C, KIAA1765	ENSG00000163673	Doublecortin like kinase 3	Q9C098	3	36712422-36764349	Enzymes, Predicted membrane proteins		Kinase, Serine/threonine-protein kinase, Transferase		Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in some		brain: 10.0;testis: 8.0	Cell type enriched	Detected in some	5	Early spermatids: 24.4	Cancer enhanced	Detected in single		testis cancer: 1.2	Region enhanced	Detected in many		basal ganglia: 10.0	Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		NTERA-2: 3.4;SCLC-21H: 3.3;SH-SY5Y: 2.7;U-2 OS: 1.9;U-2197: 2.6	Low region specificity	Detected in many			Low region specificity	Detected in many			HPA040685	Approved											HPA040685: AB_2732487	unprognostic (9.09e-3)	unprognostic (1.41e-3)	unprognostic (2.75e-1)	unprognostic (2.66e-2)	unprognostic (2.41e-1)	unprognostic (1.80e-1)	unprognostic (1.40e-2)	unprognostic (1.08e-2)	unprognostic (1.96e-2)	unprognostic (1.86e-2)	unprognostic (2.05e-1)	unprognostic (7.07e-2)	unprognostic (6.11e-5)	unprognostic (7.94e-3)	unprognostic (5.80e-2)	unprognostic (3.25e-3)	unprognostic (1.36e-2)	1.1	0.4	2.6	1.4	10	0.3	0.1	0.1	2.3	0.5	0.2	0.3	0	0.5	0.3	0.1	0.1	0.2	0.6	0.9	1.4	0.9	0	0.1	0.3	0.2	0.6	0	0	0.2	0.4	1.8	1.1	0.4	0.3	0.3	1.3	1.7	0.2	2.7	0.4	0.4	0.9	0.7	0.1	0	8	3.2	0	0.9	0	0.3	0.5	0	0	0	0	0.1	0	0.2	0	0	0	0.1	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0.4	0	0.2	0	0	0	0	0	0	0.1	0	0	0	0.5	0	0	0	0.2	0.9	0	3.4	0	0	0	0	0	0	0.2	3.3	2.7	0.1	0.3	0	0.2	0	0.4	0.3	0	1.9	2.6	0	0	0	0	0	0	0	0	0	0	0	0.1	0.2	0	0	0	0	0	0.2	0	0	0	0	0	0.1	0	2.6	10	0.1	2.3	1.4	0.9	0.6	0	0.4	3.2	0	0	0	0	0	5	1.1	0	0	0	0	0	0.4	0	0	24.4	0	0	0	0	0	0	0	0	0	1.5	0	0	0	0	5.2	0.3	0	0	0	0	0.3	0	0	0	0	1.7	0	0.7	0.7	0.2	0	0	0	0	0	Early spermatids
DNASE1L3	DNAS1L3, LSD	ENSG00000163687	Deoxyribonuclease 1 like 3	Q13609	3	58192257-58214697	Disease related genes, Predicted intracellular proteins, Predicted secreted proteins	Apoptosis, Necrosis	Endonuclease, Hydrolase, Nuclease	Systemic lupus erythematosus	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		blood: 78.1;liver: 72.3;lymphoid tissue: 46.9	Cell type enriched	Detected in many	11	Ito cells: 2006.5	Low cancer specificity	Detected in many			Not detected	Not detected			Cell type enriched	Detected in some	13	plasmacytoid DC: 78.1	Lineage enriched	Detected in many	20	dendritic cells: 78.1	Cell line enhanced	Detected in some		BEWO: 5.4;Karpas-707: 3.2;RPMI-8226: 5.6	Not detected	Not detected			Not detected	Not detected			HPA019955	Approved				Secreted to blood							HPA019955: AB_1847805	unprognostic (7.49e-3)	unprognostic (3.08e-3)	unprognostic (9.75e-3)	unprognostic (3.92e-3)	unprognostic (2.93e-3)	unprognostic (1.01e-2)	prognostic favorable (1.20e-6)	unprognostic (4.74e-4)	unprognostic (2.10e-1)	unprognostic (9.71e-2)	unprognostic (1.91e-3)	unprognostic (6.95e-2)	prognostic favorable (1.06e-7)	unprognostic (7.57e-2)	unprognostic (2.47e-1)	unprognostic (1.57e-1)	unprognostic (5.64e-3)	3.5	7.2	0.5	27.8	0.5	0.1	3.8	0.6	0.5	2.7	6.1	0.5	1.1	6.1	0.9	1.1	4.2	0.8	1.7	3.4	0.5	0.5	14.3	72.3	5.7	38.5	0.5	0.1	1.5	0.8	0	6	2	0.4	1.4	9.2	12	3.3	1.2	0.9	1.8	14	0.4	1.3	46.9	0.8	1.5	0	11	3.9	20.1	17	3.6	3.2	3.8	78.1	0.1	0	0.1	0	0.6	0.2	0.8	0.5	0.3	0.1	0.1	5.4	0.3	0.2	0.3	0.1	1	0.3	0.5	0.4	0	1.3	1.6	0.2	0	0.1	0.2	0.1	0.5	0.8	2.1	0.2	1.1	1.2	0.2	1.1	0.5	0.7	0.2	1.1	0.1	0.5	3.2	0	0.7	0.3	1.3	0.5	0.1	0.4	0.6	0.7	5.6	0.2	0.3	0.8	0.5	0.4	0.4	0.6	0.5	0.4	0.6	0.9	0.7	0.3	0.4	0.3	0.9	0.5	0.8	0.6	0.9	0.3	0	0	0	0	0	0	2.9	0	0	6.1	3.8	0	0	0.1	0.1	0	78.1	0	0.6	0.5	0.5	0.6	0.5	0.5	0.5	0.5	0.1	0.4	0	0	15.6	31.8	0.3	8.1	0	0.6	48.4	0	2.3	0	0	0.1	3.3	0	1.3	29.5	0	46.7	0.3	0.7	3.1	0.4	1.1	21.7	0.4	1.6	0	2006.5	176.2	3.1	3.7	12.8	3.3	55.1	0	0	0	0	24.1	1.8	0.1	0	1.3	0.1	0	14.3	0.2	13.8	0	0.9	Ito cells
SPDYA	Ringo3, SPDY1, SPY1	ENSG00000163806	Speedy/RINGO cell cycle regulator family member A	Q5MJ70	2	28782517-28850611	Predicted intracellular proteins	Cell cycle, DNA damage	Developmental protein		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in some	50	testis: 93.4	Cell type enriched	Detected in many	5	Spermatocytes: 226.6	Not detected	Not detected			Low region specificity	Detected in single			Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		NB-4: 6.1;THP-1: 5.7	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA035162, HPA066214	Enhanced		Supported	Nucleoplasm						Nucleoplasm		HPA035162: AB_2674501, HPA066214: AB_2685636	unprognostic (3.41e-2)	unprognostic (3.20e-3)	unprognostic (2.45e-1)	unprognostic (3.53e-2)	unprognostic (4.21e-2)	unprognostic (4.04e-3)	unprognostic (1.10e-4)	unprognostic (3.04e-3)	unprognostic (1.95e-2)	unprognostic (6.54e-3)	unprognostic (1.45e-1)	unprognostic (1.99e-2)	unprognostic (1.66e-13)	unprognostic (8.56e-2)	unprognostic (1.07e-1)	unprognostic (1.85e-1)	unprognostic (5.55e-5)	0.4	0.7	0.7	0.4	0.8	0.7	0.4	1.8	0.6	0.7	0.4	0.5	0.4	0.6	0.4	0.8	0.4	0.3	0.7	0.4	0.8	0.6	0.5	0.6	0.4	0.7	0.6	0.4	0.9	0.6	0.1	0.8	0.4	0.4	1	0.2	0.4	0.6	0.4	0.5	1.8	0.5	0.5	0.5	1.1	0.3	93.4	0.4	0.8	0.7	0.4	0.4	0.6	0.4	0.6	1.4	0	0.3	0.6	1	0	1	0.5	1.7	3.8	0	0	2.1	0.9	0.1	0.3	0.1	1	0.8	0.9	1.2	0	1	2.4	0.4	0	0.4	0.5	1.1	0.8	2.2	3	0.1	1.1	1.7	0.3	0.2	0.2	0.5	0.9	0	0.7	0.5	1.5	0.8	0.4	0.4	6.1	0.5	0.3	0.4	0.8	2.9	0.9	1.1	0.7	1.3	0.8	1.9	2.5	0.7	1.7	0.7	5.7	0.2	3	2.3	1.6	1.4	0.9	1.5	1.5	0.8	0.8	0.6	0	0.3	0	1	0.3	0.2	0.5	0.5	0.5	0.1	0.6	0.7	0.8	0	0.6	0.2	1.4	0.1	0	0.7	0.8	1.8	0.6	0.8	0.6	0.6	0.4	0.4	0.4	3	0.3	0.5	0.9	0.2	0.6	0.5	0	0	1.2	1.8	5.9	0.1	0	0.4	42.2	1.1	0.6	0	0.4	0.1	0.4	1.2	2.3	0	0.3	0	0	1.8	0	22.3	2.3	1	0	0	0	0	0.8	0	2.1	0	1.3	6.5	0.2	226.6	2.6	0.1	0.5	0	0.3	1.7	Spermatocytes
TGM4	TGP	ENSG00000163810	Transglutaminase 4	P49221	3	44874608-44914990	Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins		Acyltransferase, Transferase	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	4	prostate: 107.8	Cell type enriched	Detected in some	37	Glandular cells: 201.3	Cancer enriched	Detected in single	312	prostate cancer: 75.4	Region enriched	Detected in single	254	cerebral cortex: 25.4	Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		BEWO: 9.7;hTERT-HME1: 2.6;NB-4: 5.2;RPMI-8226: 3.7;SH-SY5Y: 2.9	Not detected	Not detected							CAB033571, HPA073290	Enhanced											CAB033571: AB_2287329, HPA073290: 	unprognostic (4.40e-2)	unprognostic (4.68e-2)	unprognostic (1.92e-1)	unprognostic (2.17e-3)	unprognostic (2.84e-1)	unprognostic (2.19e-2)	unprognostic (1.37e-1)	unprognostic (1.92e-1)	unprognostic (2.41e-2)	unprognostic (1.65e-1)	unprognostic (8.56e-3)	unprognostic (5.08e-2)	unprognostic (1.44e-8)	unprognostic (1.10e-1)	unprognostic (1.98e-2)	unprognostic (3.68e-1)	unprognostic (6.41e-2)	0	0.2	0	0	0	0.1	0.1	0	25.4	0	0	0	0.4	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	107.8	0	0	2.3	0	0	0	0	1	0	0	0	0.4	0	0	0	0	0	0	0	0.3	0.3	0.2	0	0.6	0.2	0	0.3	0	0	0	0	0	9.7	0	0	0.1	0	0	0	0	0	0	0	0.5	0	0.7	0	0	0	0	0	0.6	0	0	0	0	0.5	0.1	2.6	0	0.3	0	0	0	0.1	0	0	5.2	0	0	0.2	0	0	3.7	0	0	0	2.9	0	0	0	0.1	0	1.5	0.5	0	0.7	0.7	0.1	0.2	0.2	0	0	0	0	0	0	0	0.2	0	0.2	0	0	0	0	0.3	0.2	0	0.2	0.6	0	0.3	0	0	0	0	0	25.4	0	0	0	0	0	0	0	0	0.5	3.5	0.5	0	0.8	0	0	0	0	0	0.3	0	0	4.8	0	0	0	0	0.2	0.2	201.3	0	0	0.1	0	0	0.6	0	5.5	0	0	0	0	0	0	0.1	0	0.4	0	0	0	0	0	0.3	0.4	0.8	0	0	2.6	Glandular cells
RTP3	LTM1, TMEM7, Z3CXXC3	ENSG00000163825	Receptor transporter protein 3	Q9BQQ7	3	46497491-46500949	Predicted membrane proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	91	liver: 43.3	Cell type enriched	Detected in some	19	Hepatocytes: 59.6	Group enriched	Detected in some	17	liver cancer: 22.9;testis cancer: 5.0	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	7	SiHa: 15.1									HPA075932			Uncertain	Mitochondria						Mitochondria		HPA075932: 		unprognostic (2.09e-1)				unprognostic (1.64e-1)	prognostic favorable (3.11e-6)								unprognostic (1.08e-1)	unprognostic (1.58e-1)		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0.2	43.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0.4	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0.1	0	0	0	0	0	0	0	0.3	0	0	0	0.2	0	0.1	0.2	0	1.7	0	0	0	0	0	0	0.7	0	0	0	0	15.1	0	0	2.2	0	0	0	0	0.4	0.9	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0.2	0	0	0	0	59.6	0	0	0	3.1	0.6	0	0	0	0	0	0	0	0.1	0	0	0.8	0	0	0	0.5	1.3	0	0	0	0	0	Hepatocytes
LRRC2		ENSG00000163827	Leucine rich repeat containing 2	Q9BYS8	3	46515423-46580099	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	5	heart muscle: 53.9;skeletal muscle: 70.3;tongue: 20.0	Cell type enriched	Detected in many	17	Cardiomyocytes: 175.7	Cancer enhanced	Detected in some		thyroid cancer: 5.6	Low region specificity	Detected in many			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		fHDF/TERT166: 10.8;HEL: 6.2;LHCN-M2: 6.2;TIME: 4.9	Low region specificity	Detected in many			Not detected	Not detected			HPA039138, HPA064844			Approved	Nucleoplasm,Nuclear bodies,Cytosol						Nucleoplasm	Nuclear bodies, Cytosol	HPA039138: AB_10795461, HPA064844: 	unprognostic (1.32e-4)	unprognostic (3.44e-3)	unprognostic (2.29e-2)	unprognostic (3.38e-2)	unprognostic (4.17e-2)	unprognostic (1.44e-1)	unprognostic (7.38e-3)	unprognostic (1.61e-1)	unprognostic (7.42e-2)	unprognostic (1.45e-1)	unprognostic (3.72e-3)	unprognostic (2.17e-1)	unprognostic (2.23e-2)	unprognostic (1.09e-1)	unprognostic (2.53e-1)	unprognostic (1.96e-2)	unprognostic (1.24e-1)	1.8	0.5	1.9	0.4	1.4	0.4	1	1.4	3	2.6	1.1	0.2	0	0.4	3.9	1.4	1.1	1.1	1.4	53.9	1.3	0.4	2.2	2.5	0.6	0.3	0.5	2.3	2.8	0.7	0.1	2.2	0.5	1	1.2	0.8	0.4	1.4	0.2	70.3	1.2	0.6	2.3	0.4	1.3	1	0.4	0	1.4	10.1	20	1.2	1.7	1.8	1.2	0.8	2.6	0.7	1.1	2.5	0.3	0.2	0.1	0.2	0.3	1	2.3	0.1	0.8	1.5	0.6	0.8	0	0.2	0.3	0.2	10.8	0.1	0.2	3.8	0	1.4	0.5	0.1	6.2	0.4	0.2	0.3	0.2	0.1	0.2	0.1	4.3	0	3.6	0.2	0.8	0.1	0.4	6.2	0.1	0.8	0.1	1.5	0.5	0.2	0.1	0.1	0.3	0.1	0.3	0.5	1.2	0.8	0.2	1.6	1.3	0.2	0.8	4.9	0.3	0.6	2.5	1.6	0.4	0.3	2.9	0.2	0.1	1.4	2.2	0.7	0.6	0.6	0.4	0.4	0.7	1.6	0.3	0.2	1.2	0.8	0.6	2.6	1.1	0.5	0.8	2.5	0.3	1.9	1.4	1.4	3	1.3	0.4	0.5	2.3	1	0	8.9	0.6	0	0.8	1.6	0	175.7	2.5	1.4	0	1.8	0	0.1	8.3	0.2	2	1.5	0	0	0.8	0	4.3	0.4	10.3	8.9	1.5	0	2.9	5.5	0	1.7	0.6	1.1	10.1	0	1.5	0.3	1.5	0	0	0.5	0.1	0	3.9	0.6	0.2	2	0.1	0.7	1.7	0.4	Cardiomyocytes
FBXO40	Fbx40, KIAA1195	ENSG00000163833	F-box protein 40	Q9UH90	3	121593119-121630295	Plasma proteins, Predicted intracellular proteins	Ubl conjugation pathway			Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	12	heart muscle: 48.3;skeletal muscle: 58.2;tongue: 38.0	Cell type enriched	Detected in single	2762	Cardiomyocytes: 346.6	Not detected	Not detected			Low region specificity	Detected in single			Cell type enhanced	Detected in single		neutrophil: 2.8	Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		Karpas-707: 2.5;U-266/70: 3.0;U-266/84: 1.9	Region enhanced	Detected in some		pons and medulla: 1.8	Low region specificity	Detected in single																unprognostic (1.67e-2)	unprognostic (1.23e-4)			unprognostic (9.17e-2)	unprognostic (6.65e-2)	unprognostic (2.62e-1)	unprognostic (1.43e-2)	unprognostic (1.22e-1)	unprognostic (7.01e-2)	unprognostic (2.91e-1)	unprognostic (2.50e-1)	unprognostic (3.48e-2)	unprognostic (1.01e-1)	unprognostic (4.14e-1)		unprognostic (4.30e-2)	1	0.1	0.2	0	0.1	0.3	0.1	0.1	1	0.1	0.1	0	0	0.1	0.1	0.6	1.1	0.1	0.1	48.3	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.5	0.1	0.1	0	0.1	0	0.2	0.4	0	1.3	2.3	0	58.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0.9	38	3.9	0.1	0.1	0.5	0.6	2.8	0.8	0.2	0.9	0.1	0.1	0	0.1	0	0.2	0.1	0.8	0	0	0.1	0	0.1	0.1	0.2	0.1	0.1	0.4	0.1	0	0	0	0.1	0.1	0.3	0.4	0.1	0	0.4	0.6	0.1	0	0	0	0.1	0	0.1	0.1	2.5	0	0	0.1	0.2	0.2	0.1	0	0.2	0	0.6	0.1	0.3	0	0.1	0.2	0.2	0	0	0.1	0.3	0.5	0.4	0	0	0	3	1.9	0.8	0.2	0.1	0	0.2	0.8	0.8	0.9	0.6	0.3	0.2	0.8	0.2	0.2	0.5	0.4	0.6	2.8	0.2	0.4	0.6	0.9	0.1	0.2	0.1	0.1	1	0.1	0.1	0.2	0.5	0.2	0	0	0	0	0	0	0	346.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	Cardiomyocytes
CAMK2N2	CaM-KIIN	ENSG00000163888	Calcium/calmodulin dependent protein kinase II inhibitor 2	Q96S95	3	184259213-184261463	Predicted intracellular proteins		Protein kinase inhibitor		Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	12	adrenal gland: 14.2;brain: 38.3;pancreas: 37.0;pituitary gland: 12.5	Cell type enriched	Detected in some	11	Horizontal cells: 58.8	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in many		A-431: 11.3;REH: 19.0;SCLC-21H: 20.0;U-138 MG: 20.8	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA050835, HPA075200	Approved		Supported	Nucleoplasm,Centrosome						Nucleoplasm, Centrosome		HPA050835: AB_2681253, HPA075200: 	unprognostic (7.28e-2)	prognostic favorable (9.77e-4)	unprognostic (1.24e-1)	unprognostic (4.69e-2)	unprognostic (1.32e-1)	unprognostic (6.09e-2)	unprognostic (2.20e-1)	unprognostic (1.29e-2)	unprognostic (1.88e-1)	unprognostic (4.21e-2)	unprognostic (5.98e-2)	unprognostic (9.72e-3)	unprognostic (5.17e-9)	unprognostic (3.47e-1)	unprognostic (2.39e-1)	unprognostic (1.07e-1)	unprognostic (1.76e-3)	1.3	14.2	22.2	1.3	9.6	1.1	1.3	29.7	38.3	1.3	1.3	3.2	0	1.4	1.2	1.2	1.2	1.3	1.3	1.2	12.3	32.7	1.3	1.7	1.2	1.2	18	8.2	1.1	37	2	12.5	1.3	25.1	1.4	1.3	1.1	1.2	1.4	1.1	1.2	1.4	1.4	9.3	1.2	1.7	1.3	4.5	0	1.3	0	1.2	1.2	0	0	0.5	0	0.2	0	0.3	0	11.3	0.2	1.4	0.6	0.4	0.4	1	0.3	4.2	2.7	2.8	0.4	0.5	0.4	2.8	0.2	5.5	1.5	0.7	0.5	1.5	9.3	0.4	0.3	0.2	0.4	0.1	0.2	1.4	0.3	0.7	0.4	1.9	0.6	0	0.3	0	3.3	0.4	6	0.1	0.1	8.1	0.2	3.7	19	5.5	1.6	0.6	2.2	20	4.3	1.8	0.5	0.1	0.1	6.1	0.1	0	20.8	9.1	1.9	3.3	2.2	3.3	2.7	4.8	1.2	1.7	0	0.2	0	0	0	0.3	0	0	0	0.5	0	0	0	0	0	0.1	0	0	0	22.2	9.6	29.7	38.3	12.3	32.7	18	8.2	25.1	4.5	0	0	0	0	0	5.3	0.3	0	0	0	0	2	0	0	0	0.2	0	0	0	3.6	0	0	0.1	0	0	0	58.8	3.5	0	0	0.2	0	0	0	0	0	1.8	1	0	0	0	4.8	0	0.1	0.1	0.2	0	0	0	0	0	Horizontal cells
RHO	CSNBAD1, OPN2, RP4	ENSG00000163914	Rhodopsin	P08100	3	129528640-129535169	Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins, Transporters	Sensory transduction, Vision	G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer	Congenital stationary night blindness, Disease mutation, Retinitis pigmentosa	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	151	retina: 415.0	Cell type enriched	Detected in some	7	Rod photoreceptor cells: 2822.4	Not detected	Not detected			Group enriched	Detected in some	6	cerebellum: 1.6;cerebral cortex: 2.7	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			HPA013440, CAB022486, CAB034887, CAB034888	Enhanced											CAB022486: , CAB034887: AB_785511, CAB034888: AB_785512, HPA013440: AB_2668844	unprognostic (4.32e-2)			unprognostic (1.21e-1)	unprognostic (1.68e-1)		unprognostic (1.83e-1)	unprognostic (2.87e-1)		unprognostic (1.94e-1)			unprognostic (9.19e-11)	unprognostic (4.24e-2)	unprognostic (1.84e-1)	unprognostic (2.91e-1)		0.2	0	0	0	0.3	0	0.1	1.6	2.7	0.1	0	0	0	0	0.1	0.7	0	0.5	0	0	0.2	0.2	0.2	0.1	0.1	0.1	0	0	0.3	0	0	0.4	0.2	0	0	0.1	415	0.3	0.2	0	1.8	0	0.3	0	0.1	0.1	0.5	0	0	0.1	0	0	0.1	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0.2	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0.2	0	0	0	0	0.1	0	0.9	0	0	0	0	0	0.9	0.1	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0.3	1.6	2.7	0.2	0.2	0	0	0	0	0	0	0	0	0	290.1	0.6	0	0	0	0	428	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	206.6	0	0	0	0	0	0	0	0	0	393.2	0	0	0	0	2822.4	0	0	0	0	0	0	0	0	0	Rod photoreceptor cells
CLDN19		ENSG00000164007	Claudin 19	Q8N6F1	1	42733093-42740254	Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters	Sensory transduction, Vision		Disease mutation, Primary hypomagnesemia	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	9	brain: 13.8;kidney: 22.5;placenta: 20.9;retina: 37.0	Cell type enriched	Detected in some	7	Extravillous trophoblasts: 192.3	Cancer enhanced	Detected in some		testis cancer: 2.6	Group enriched	Detected in some	54	midbrain: 13.8;pons and medulla: 9.5	Low cell type specificity	Detected in some			Low lineage specificity	Detected in single			Group enriched	Detected in some	5	CACO-2: 5.1;Hep G2: 10.6;SuSa: 6.4	Region enhanced	Detected in some		olfactory region: 6.7	Low region specificity	Detected in all																unprognostic (6.23e-4)	unprognostic (1.80e-1)		unprognostic (1.85e-6)	unprognostic (5.30e-2)	unprognostic (1.73e-1)	unprognostic (3.21e-2)	unprognostic (3.22e-1)	unprognostic (9.45e-2)	unprognostic (1.95e-1)	unprognostic (2.68e-1)	unprognostic (7.22e-2)	unprognostic (8.76e-3)	unprognostic (1.08e-1)	unprognostic (1.12e-1)		unprognostic (3.29e-3)	1	0.2	0.1	0.1	0.2	0.2	1.6	0.2	0.1	0.2	0.1	0.2	0	0.2	0.2	0.9	0.6	0.3	0.1	0.4	0.2	0.1	22.5	0.2	0.2	0.1	13.8	0	0.2	0.2	0.1	0.2	20.9	9.5	0.4	0.1	37	1.2	2.7	0.4	0.8	0.3	1	6.2	0.1	0.5	0.2	0	1.3	0.1	2.6	0.1	0.8	1	0.5	0.4	1.4	0.3	0.2	0.5	0.1	0	0	0	0	0.1	0	1.3	0	0	0	0	5.1	0	0	0	0	0	0	0	0	0	0	0	0	0.2	10.6	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0.8	0	0	0	0	0	0	0	0.1	0	0	0	0	6.4	0	0	0	0	0	0	0	0.1	0	0	0	0	0	1	0.3	0.3	0.2	0.2	0.2	0.5	0.2	0.2	0.2	0.5	0.5	0.5	1.4	0.2	0.2	0.4	0.3	0.1	0.1	0.2	0.2	0.1	0.2	0.1	13.8	0	9.5	0	0	0	0	0.2	0	0.2	0.3	0	0	1.2	12.2	0	9.1	28.2	0	0	0	0	0	0	192.3	0.2	0.1	0	0	4.4	0	0	0.6	0.6	0	0	0.4	0	0	0	0	0	0	0	1.9	0.1	0	0	0	0.1	0	10.4	0	0	0	Extravillous trophoblasts
CDC25A		ENSG00000164045	Cell division cycle 25A	P30304	3	48157146-48188402	Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins	Cell cycle, Cell division, Mitosis	Hydrolase, Protein phosphatase	Cancer-related genes	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		bone marrow: 13.0;lymphoid tissue: 23.0;testis: 19.4	Cell type enriched	Detected in some	5	Cardiomyocytes: 106.0	Cancer enhanced	Detected in many		testis cancer: 19.0	Low region specificity	Detected in many			Cell type enhanced	Detected in some		memory B-cell: 1.7	Low lineage specificity	Detected in many			Low cell line specificity	Detected in many			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA005855, HPA008803			Approved	Nucleoplasm,Golgi apparatus						Nucleoplasm	Golgi apparatus	HPA005855: AB_1846364, HPA008803: 	unprognostic (1.49e-1)	unprognostic (8.13e-2)	unprognostic (1.20e-2)	unprognostic (1.43e-3)	unprognostic (2.14e-1)	unprognostic (9.51e-2)	unprognostic (7.05e-7)	unprognostic (1.35e-2)	unprognostic (4.32e-3)	unprognostic (8.92e-3)	unprognostic (4.41e-2)	unprognostic (9.09e-2)	unprognostic (4.41e-3)	unprognostic (1.57e-3)	unprognostic (1.07e-1)	unprognostic (1.29e-1)	unprognostic (2.72e-1)	0.8	1.2	1.1	5.5	1.1	13	0.8	0.7	1.2	1.1	3.3	0.6	1	1.8	0.6	0.9	3.9	0.4	2.2	0.7	1.3	2.4	1.2	0.9	0.7	4.1	1.4	0.2	2.1	3.6	0.4	2.3	4.2	1.2	1	4	1.5	1.8	0.5	0.7	0.8	2.1	0.8	0.7	3.6	1.3	19.4	0.2	23	1.6	8.8	7.4	0.8	1.3	1.7	0.9	0.5	0.1	0	1	0.1	7.6	3.8	18.1	9.7	0.6	1.2	12.5	10.6	4	13.4	10.9	16.4	4	22.8	4.2	2.8	8.5	5.8	30.9	7.3	14.2	7.4	16.3	29.1	6.9	8.1	0.6	20.5	8.5	0.6	1.1	16.6	7.2	1.6	5	17	23.1	12.1	7.2	4.1	25.6	16	26.4	7	8.7	11.5	11.9	12.4	3.4	7.2	8.5	10.6	6.6	7.7	3.4	12	4	14.6	2.5	6.6	10.2	7.3	14.5	6.1	18.2	35.8	4.9	22.9	5.5	0	0	0.5	0.4	0	0	1.7	0.6	0.2	0.9	0	0	1	0	0	0.1	0.5	0	0.1	1.1	1.1	0.7	1.2	1.3	2.4	1.4	0.2	1.2	0.2	0	0	0	0.4	0.3	0	106	0	0	0	0	2	1.9	0	0.5	14.7	0.1	0.3	0	0.8	5.7	0.5	0.4	0	0.2	2.5	0	1.2	1.3	0.3	22.9	1.4	0	0	0	1.5	0.5	0.9	0	1.8	0.2	0.4	0	0.4	15.8	13.7	0	0.2	0	3.2	0.3	Cardiomyocytes
SCRG1	SCRG-1	ENSG00000164106	Stimulator of chondrogenesis 1	O75711	4	173384701-173406380	Predicted secreted proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 33.4	Cell type enriched	Detected in many	4	Muller glia cells: 148.4	Cancer enriched	Detected in many	6	glioma: 35.7	Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Group enriched	Detected in some	13	HSkMC: 6.8;WM-115: 19.8	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA012882	Approved				Secreted in brain							HPA012882: AB_1856635	unprognostic (1.09e-1)	unprognostic (1.83e-2)	unprognostic (2.60e-5)	unprognostic (2.58e-1)	unprognostic (3.22e-2)	unprognostic (7.51e-2)	unprognostic (3.58e-2)	unprognostic (1.14e-3)	unprognostic (2.08e-1)	unprognostic (2.25e-2)	unprognostic (2.19e-1)	unprognostic (1.49e-1)	unprognostic (3.95e-10)	unprognostic (4.86e-2)	unprognostic (2.21e-1)	unprognostic (4.34e-3)	unprognostic (8.74e-4)	5.8	3.1	19.2	2.6	18.6	2.2	2.3	6	30.6	2.1	2.9	15.9	4	2.5	2.5	7.7	2.3	2.1	5.1	3.6	19.9	12	1.5	1.4	1.5	1.5	24.9	12.9	1.6	1.8	1.2	1.1	1.6	20.5	6.4	2.7	0	3.4	11.6	1.9	2	2	15.6	33.4	2.4	2.8	16.3	22.5	0	1.5	0.3	1.3	4.1	1	1.4	1.3	4.4	1.8	1.6	1	0.4	0.1	0	0.9	0.3	0.4	0	0.2	0.1	0	0	0	0.2	0.1	0.1	0	0.2	0	0.2	0	0	0	0.1	0	0.2	0.4	0.1	0.8	0.2	0.2	6.8	0	0	0.1	0.2	0	0.1	0.1	0.6	0	0.2	0.1	0.3	0.2	0	0	0.1	0	0	0	0.2	0.2	0.2	0	0.2	0.1	0	0.1	0.1	0.1	0.2	0.2	0.2	0.3	0.1	0	0.1	0.1	0.1	19.8	3.9	1.8	1.2	0.8	1.2	0.6	0.8	0.6	0.7	0.7	1.4	0.8	1	4.4	1.6	1.3	1.3	0.5	0.4	19.2	18.6	6	16.7	19.9	12	24.9	12.9	20.5	22.5	0	4	0.5	1	3.2	11.8	0.8	0	1.4	1.2	0	35.3	0.2	0	0.2	14.9	2	0	0	0	0.2	5.2	1.4	9.2	0	0.5	15.9	1.2	6.2	3.1	21.8	24.2	1.6	21.9	0	0	148.4	0.1	0	19.4	0	30.2	12.9	10.9	1.9	2.2	2.3	0.6	3.9	0.2	0.7	Muller glia cells
TMEM155	FLJ30834	ENSG00000164112	Transmembrane protein 155	Q4W5P6	4	121758933-121765427	Predicted secreted proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enriched	Detected in some	4	brain: 25.6	Cell type enriched	Detected in some	4	Cytotrophoblasts: 15.1	Low cancer specificity	Detected in single			Region enhanced	Detected in many		cerebral cortex: 25.6	Cell type enhanced	Detected in some		memory CD8 T-cell: 2.3;T-reg: 1.1	Lineage enhanced	Detected in single		T-cells: 2.3	Group enriched	Detected in some	5	fHDF/TERT166: 7.4;HAP1: 3.4;LHCN-M2: 10.5;MOLT-4: 6.3									HPA077585	Approved				Secreted in brain							HPA077585: AB_2732353	unprognostic (9.67e-3)	unprognostic (3.25e-3)	unprognostic (3.13e-2)	unprognostic (1.09e-1)	unprognostic (1.61e-1)	unprognostic (5.73e-3)	unprognostic (3.63e-2)	unprognostic (1.49e-2)	unprognostic (1.19e-1)	unprognostic (2.42e-3)	unprognostic (4.40e-3)	unprognostic (1.38e-1)	unprognostic (3.82e-7)	unprognostic (1.06e-1)	unprognostic (1.81e-1)	unprognostic (1.02e-2)	unprognostic (2.04e-1)	0.6	0.3	5.9	0.5	8.3	0.3	0.3	0.3	25.6	0.4	1.3	0	0	0.4	0.3	0.3	0.5	0.3	0.4	0.4	7.9	1.6	0.3	0.3	0.6	4	0.9	8.9	0.3	0.3	0.2	0.2	6.1	0.7	0.5	0.7	0.9	0.5	0.6	0.3	0.3	0.6	0.9	0.3	0.8	0.5	0.7	0	0	0.3	0	0.6	0.5	0.3	0	0	0.7	0	0	2.3	0.3	0	0	0.1	0	1.4	0.3	1	0.7	0.2	0.3	0.5	0	0	0	0	7.4	0	0	3.4	0.1	0.9	0	0	0	0	0	0.5	0	0	0.8	0	0.2	0	0.6	0.3	0	0	0	10.5	0	6.3	0	1.2	0	0	0	0.3	0	0	0	0.1	0	0.2	0.1	0	0.3	0	0.1	0.3	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	2.3	0	0	0	0	0.7	0	0	0	1.1	0.3	5.9	8.3	0.3	25.6	7.9	1.6	0.9	8.9	0.7	0	0	0	0	0	0	0.2	0.2	0	0	0	0	0	15.1	0	0	0	0	0	0	0	0.9	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0.8	0	3.8	0	0	0	Cytotrophoblasts
ASB5		ENSG00000164122	Ankyrin repeat and SOCS box containing 5	Q8WWX0	4	176213673-176277571	Predicted intracellular proteins, Predicted membrane proteins	Ubl conjugation pathway			Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enriched	Detected in many	4	skeletal muscle: 133.4	Cell type enriched	Detected in some	5	Late spermatids: 229.8	Cancer enhanced	Detected in some		prostate cancer: 1.6	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	16	LHCN-M2: 165.0	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA028870			Approved	Plasma membrane						Plasma membrane		HPA028870: AB_10611679					unprognostic (1.76e-1)	prognostic unfavorable (5.67e-4)		unprognostic (1.90e-1)			unprognostic (7.38e-2)	unprognostic (1.32e-1)	unprognostic (1.06e-2)	unprognostic (4.28e-2)	unprognostic (1.65e-1)		unprognostic (6.80e-3)	2.3	0	0.3	0.3	0.2	0	0	0.2	0.2	0.3	3.5	0	0	0.1	0.2	6.3	7.9	0	0.4	1.3	0.2	0.2	0.3	0	0.1	0	0.5	0	0	0	0.1	0.2	0	0	9.6	1.3	0	8	0.1	133.4	0	0.5	23.5	1	0	2	2.2	0	0	2.3	31.4	2.2	15	3.3	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	4	0	3.6	7.8	0	0	0	0	0	0.3	0	0	0	8.8	0	0	0	0	0	0	0	0	0.8	0	0	0	0	0	0	0	0	165	0	0	0	0	0	0	0	10.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0.2	0.2	0.2	0.2	0.2	0.5	0	0	0	0	0	0	0	0	0	3.9	0	0	0	0	0	0	0	0	46.8	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	229.8	1.1	0	0	0	0	0	0	0	1.1	0	0	0	0	0.9	0.7	0	0	0	0	0	Late spermatids
C4orf45	FLJ25371	ENSG00000164123	Chromosome 4 open reading frame 45	Q96LM5	4	158893134-159038760	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	20	testis: 16.1	Cell type enriched	Detected in some	5	Early spermatids: 290.0	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HMC-1: 1.7;U-2197: 1.0	Not detected	Not detected			Not detected	Not detected																unprognostic (1.64e-1)				unprognostic (1.14e-1)			unprognostic (2.13e-1)	unprognostic (9.87e-2)	unprognostic (5.71e-2)	unprognostic (2.55e-1)	unprognostic (2.17e-1)	unprognostic (7.82e-2)	unprognostic (1.21e-1)	unprognostic (3.09e-1)	unprognostic (5.45e-2)		0.1	0	0	0	0	0.8	0	0	0.1	0.1	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.1	0	0	0.1	0	0	0	0	0.1	0.4	0	0.4	0.2	0.6	0	0	0	0	0.7	0	0	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	1.7	0	0	0	0	0.2	0	0.1	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0.3	0	1	0	0.2	0.3	0.2	0.3	0	0.3	0	0.4	0	0.6	0.1	0	0	0.1	0	0.4	0.1	0	0	0	0.2	0.4	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	290	0	0	0	0	0	0	0	0	0	0	0	0	0	0	60.8	2.3	0	0	0	0	0.9	0.1	0	1.4	0	0	6.5	0	2.4	2.1	0	0	0	0	0	Early spermatids
EDIL3	DEL1	ENSG00000164176	EGF like repeats and discoidin domains 3	O43854	5	83940554-84384793	Predicted secreted proteins	Cell adhesion	Developmental protein		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 85.3	Cell type enriched	Detected in many	6	Bipolar cells: 147.4	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in many		hTERT-RPE1: 105.9;LHCN-M2: 32.2;TIME: 38.1;U-2 OS: 32.4;U-87 MG: 21.8	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA020415	Approved				Secreted to blood							HPA020415: AB_2670434	unprognostic (9.93e-3)	unprognostic (2.38e-1)	unprognostic (2.71e-2)	unprognostic (8.63e-2)	unprognostic (2.22e-1)	unprognostic (1.01e-1)	unprognostic (1.16e-2)	unprognostic (9.19e-2)	unprognostic (6.64e-3)	unprognostic (2.98e-1)	unprognostic (1.56e-1)	unprognostic (1.04e-1)	unprognostic (1.03e-3)	unprognostic (2.52e-2)	unprognostic (1.05e-1)	unprognostic (1.52e-2)	unprognostic (1.28e-3)	7.9	12.6	29.3	7.2	45.3	0.2	3.6	5.5	46.2	10.9	20.1	77	0.3	9.3	15.6	26.2	9.9	4.9	19.2	10.8	42.6	24.7	6.5	1.1	11.7	0.5	67.3	22.5	6.1	2	0.9	2.1	2.6	37.1	8.1	21.8	5	2.5	13.5	1.2	5.5	14.3	14.4	85.3	1.8	10.6	1.4	61.6	0	2.4	0.1	2.1	7.7	5.1	0	0	0	0.7	0	0	0	0	0.2	0.2	0	0.7	0	0	0.9	0	2.4	3.2	0	4	0	0	0	1.7	3.7	0	0.1	1.8	0	1.7	0	11.5	0	19.7	0.1	0	5	0.5	11.7	1.6	105.9	4.1	0	0	0	32.2	0	0	0	1.6	0	7.5	0	7.9	0	5.4	0	0.8	0.1	0	0	0	5.2	0	0	38.1	11.8	32.4	0.4	10.5	0.3	0	0	21.8	0	3	0	0.1	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0	29.3	45.3	5.5	30.1	42.6	24.7	67.3	22.5	37.1	61.6	8.9	5.9	0	1.5	10.8	147.4	10	0	1.4	2.3	3.5	2	0.2	0	0.1	25.1	3.5	0	0	0	0	17.5	0.7	5.7	0	0.2	4.8	22	2.5	0	12.5	2.3	0	3.3	0	8.3	4.1	0.7	5.8	3.5	0.7	9.6	6.5	24.5	1.1	0.6	14.1	0.3	0	9.7	0.4	Bipolar cells
ANKRD33B		ENSG00000164236	Ankyrin repeat domain 33B	A6NCL7	5	10564330-10657816	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	No human protein/transcript evidence	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 25.3	Cell type enriched	Detected in many	5	Cone photoreceptor cells: 329.9	Cancer enhanced	Detected in many		renal cancer: 7.4	Low region specificity	Detected in all			Cell type enhanced	Detected in some		eosinophil: 2.1;memory B-cell: 1.4	Group enriched	Detected in many	4	B-cells: 1.4;granulocytes: 2.1	Cell line enhanced	Detected in many		HDLM-2: 27.4;HMC-1: 18.5	Group enriched	Detected in many	9	amygdala: 13.6;basal ganglia: 16.9;cerebral cortex: 26.5;hippocampal formation: 22.4;olfactory region: 16.5	Group enriched	Detected in all	6	amygdala: 13.7;basal ganglia: 24.2;cerebral cortex: 30.1;hippocampal formation: 25.2;olfactory region: 26.0	HPA056974	Uncertain		Approved	Mitochondria						Mitochondria		HPA056974: AB_2683295	unprognostic (6.19e-2)	unprognostic (2.61e-1)	unprognostic (1.09e-2)	unprognostic (5.65e-3)	unprognostic (2.84e-2)	unprognostic (1.21e-1)	unprognostic (1.99e-1)	unprognostic (4.50e-3)	unprognostic (4.41e-1)	unprognostic (2.42e-3)	unprognostic (1.14e-1)	unprognostic (1.00e-1)	prognostic favorable (4.16e-5)	unprognostic (1.17e-1)	unprognostic (4.80e-2)	unprognostic (2.39e-2)	unprognostic (5.47e-2)	3.8	1.1	6.3	8.6	9.3	13.2	3.6	1.4	25.3	5.2	3.2	0.1	0.4	0.9	7.8	1.1	3.3	5.4	1.9	7	8.4	2.3	10	1.5	3	5.4	2	7.5	1.7	2.7	0.5	1.7	3.5	1.3	3.5	2	12.7	2.3	4.4	9	11.3	3.3	6.9	1.7	11.1	3.1	5.2	1.1	7.2	1.6	12.5	7.2	4.9	16.6	1.4	0	2.1	0	0	0.4	0.4	2.5	3.8	0.2	0.3	9	4.3	11.4	0.7	1.2	1.5	1.8	4.7	2.1	14	12.8	2.4	1.8	2.6	1.3	1.3	1.7	27.4	0.9	5.5	3.4	0	4.1	4.2	18.5	2.1	1	0.8	5.2	0.3	1.9	1	1.2	6.8	0.4	0	0.2	5	3	0	1.1	1.1	2.9	0.4	5.1	1.8	0	0.1	0	0.2	0.4	10	0	5.2	5.4	0.9	5.6	4.6	1.3	8	8.7	1.2	0.2	6.8	0.3	0	0	2.1	0.2	0	0	1.4	0.4	0.1	0	0.8	0.1	0	0.2	0	0	0	0.2	0.4	6.3	9.3	1.4	25.3	8.4	2.3	2	7.5	1.3	1.1	11.9	1	1.9	1.7	0.3	14.4	4.5	0	0	1.2	3.5	329.9	1	1.7	1.8	4.9	2.3	0	0	0.2	0.8	5	3.1	0	0	0.2	6.4	0	2.5	0	0	1.4	0.7	1.7	26.2	0	5.8	0.2	0	0	18.3	67.9	0	0.2	0	1.9	1	0.5	0.5	0	1.7	Cone photoreceptor cells
CDC20B	FLJ37927	ENSG00000164287	Cell division cycle 20B	Q86Y33	5	55112995-55173175	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	6	endometrium 1: 1.8;fallopian tube: 5.5;kidney: 2.9;lung: 4.9;testis: 6.3	Cell type enriched	Detected in some	12	Ciliated cells: 33.5	Cancer enhanced	Detected in some		endometrial cancer: 4.8	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		Karpas-707: 4.5;T-47d: 3.3;U-87 MG: 1.3	Region enriched	Detected in single	4	hypothalamus: 0.4					HPA053900	Uncertain											HPA053900: AB_2682299	unprognostic (7.39e-3)	unprognostic (1.02e-1)	unprognostic (8.19e-2)	unprognostic (1.78e-3)	unprognostic (9.94e-2)	unprognostic (1.59e-2)	unprognostic (3.12e-1)	unprognostic (1.59e-2)	unprognostic (5.60e-2)	unprognostic (7.84e-3)	unprognostic (2.83e-2)	unprognostic (3.06e-1)	unprognostic (5.15e-4)	unprognostic (1.99e-2)	unprognostic (2.27e-1)	unprognostic (6.10e-2)	unprognostic (1.29e-2)	0.1	0	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	1.8	0.1	0.1	5.5	0.1	0.1	0.1	0.1	2.9	0.1	4.9	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	6.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0.2	0	0	0	0.2	0	0.2	0	0.2	0	0.1	0	0.3	0	0	0	0.5	0	0	0	0	0.2	0.7	0.2	0	0	0.1	0	0.4	0.5	0	4.5	0	0	0	0	0	0	0	0	0	0	0	0	0.8	0	0	0.4	0.3	0	3.3	0	0.4	0	0.2	0.8	0.1	0	0	0	1.3	0	0.1	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0.8	0.1	0	0	0.4	0	33.5	0	0	0	0	0	0	0.1	0	0.9	0	0	0	0.2	1	0	0	0.1	0	0	0	0.3	0	0	0.2	1.7	0	0	0	0	2.9	0	0.5	0	0	0	0.7	0.5	0.1	0.1	0	0.2	0.1	Ciliated cells
CMYA5	C5orf10, DKFZp451G223, myospryn, SPRYD2, TRIM76	ENSG00000164309	Cardiomyopathy associated 5	Q8N3K9	5	79689877-79800240	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	4	heart muscle: 119.1;skeletal muscle: 329.3	Cell type enriched	Detected in many	15	Cardiomyocytes: 3073.8	Low cancer specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		MCF7: 2.6;RT4: 3.1;THP-1: 10.7	Low region specificity	Detected in many			Not detected	Not detected			HPA074081, HPA077831	Enhanced		Approved	Nuclear speckles,Vesicles,Plasma membrane,Cytosol						Nuclear speckles, Cytosol	Vesicles, Plasma membrane	HPA074081: , HPA077831: 	unprognostic (5.53e-2)	unprognostic (9.91e-3)	unprognostic (1.21e-2)	unprognostic (1.49e-2)	unprognostic (9.01e-4)	unprognostic (7.00e-2)	unprognostic (7.39e-2)	unprognostic (1.20e-1)	unprognostic (1.64e-1)	unprognostic (1.75e-1)	unprognostic (5.04e-1)	unprognostic (1.93e-1)	unprognostic (1.93e-2)	unprognostic (6.30e-3)	unprognostic (3.88e-2)	unprognostic (7.69e-2)	unprognostic (9.74e-2)	2.4	0.2	0.3	0	0.3	0	0.9	0.3	0.4	0.4	0.4	0	0	0	1.4	2.6	2	0.5	0.2	119.1	0.3	0.3	0.6	0.3	0.3	0	0.3	0	3.6	0.2	2.2	1.1	0.3	0.3	1.4	0	0	2.4	0.5	329.3	0.5	0.2	1.1	0.4	0.2	0.3	0.2	0.1	0	2.3	54	2.5	0.8	1.3	0	0	0	0	0	0	0	0.1	0	0	0.3	1	1	1.3	0.4	0.1	0.1	0.2	0.2	0.4	0.1	0	1.9	0.1	0	0.1	0	0.2	0	0.1	0.1	0.4	0	0.2	0	0.1	1.6	0.4	0.1	0	0	0	0.6	0	0.1	0	2.6	0.1	0.1	0.5	0	0	0.1	0	0	0.1	3.1	0.1	0	0.1	0	0.2	0.2	2	10.7	0	0.1	0.4	0	0.3	0.2	0.1	0.1	0	0.1	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0.3	0.3	0.4	0.3	0.3	0.3	0	0.3	0.1	8.9	3.2	0	15.7	1.1	1.4	3073.8	2.5	8.1	15.9	24.4	0	14.8	14.9	0.5	0.1	0.7	0	0	0.4	2.5	3.7	5.2	1.1	2	1.8	205	1.7	0.6	0.3	1.1	13.8	1.1	0	0	0	10.8	0.4	0	12.7	11.5	2.6	0	0.9	0.2	1.1	4.6	27.5	0.5	0	12	Cardiomyocytes
TMEM174	FLJ31268, MGC13034	ENSG00000164325	Transmembrane protein 174	Q8WUU8	5	73173195-73175143	Predicted membrane proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in single	282	kidney: 61.5	Cell type enriched	Detected in some	11	Proximal tubular cells: 143.8	Cancer enriched	Detected in single	126	renal cancer: 6.2	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		Daudi: 2.7;RPTEC TERT1: 1.5	Low region specificity	Detected in single			Not detected	Not detected			HPA037975	Enhanced											HPA037975: AB_10672732					unprognostic (8.11e-2)								prognostic favorable (3.30e-6)					0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	61.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	2.7	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.5	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5.2	0	0	13.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	143.8	0	0	0	0	0	0	0	0	0	0	Proximal tubular cells
KLKB1	KLK3	ENSG00000164344	Kallikrein B1	P03952	4	186208979-186258471	Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Blood coagulation, Fibrinolysis, Hemostasis, Inflammatory response	Hydrolase, Protease, Serine protease	Disease mutation, FDA approved drug targets	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	76	liver: 102.9	Cell type enriched	Detected in some	11	Hepatocytes: 203.0	Cancer enriched	Detected in some	17	liver cancer: 27.6	Low region specificity	Detected in single			Cell type enriched	Detected in single	7	gdT-cell: 1.3	Lineage enriched	Detected in single	8	T-cells: 1.3	Cell line enhanced	Detected in some		NTERA-2: 7.3;SCLC-21H: 5.0;SK-MEL-30: 2.2;U-937: 2.5	Not detected	Not detected			Low region specificity	Detected in many								Secreted to blood			28900000000	4900000000				unprognostic (4.80e-2)	unprognostic (4.53e-3)	unprognostic (4.36e-2)	unprognostic (4.17e-2)	unprognostic (5.93e-2)	unprognostic (1.90e-2)	unprognostic (1.15e-2)	unprognostic (2.83e-1)	unprognostic (8.14e-2)	unprognostic (1.35e-1)	unprognostic (1.38e-2)	unprognostic (1.15e-1)	unprognostic (1.45e-2)	unprognostic (6.01e-2)	unprognostic (7.30e-2)	unprognostic (1.20e-1)	unprognostic (1.59e-2)	0.3	0.3	0.8	0.3	1.2	0	0.3	0.7	0.5	0.3	0.4	0.3	0.3	0.7	0.4	0.4	0.3	0.2	0.7	0.5	0.6	0.5	1.3	102.9	0.3	0.3	0.5	0.5	0.3	1.3	0.5	1	0.4	0.4	0.3	0.3	0.5	0.3	0.3	0.5	0.1	0.6	0.3	0.3	0.5	0	0.3	0.3	0.4	0.3	0.3	0.4	0.3	0.3	0.1	0.1	0	0	0	1.3	0	0	0	0	0	0.2	0.8	0.2	0	0	0	0.2	0	0.4	0.3	0.3	0	0.2	0.2	0	0	0	0.7	0	0	0	0	0	0.2	0.2	0.2	0	0	0	0.1	0	0.6	0	0.2	0	0	0.4	0	7.3	0.1	0	0.1	0	0.2	1.3	0	5	0.4	0.2	0	2.2	0.1	0	0	0	0	0	0	0	0	0	0	0	2.5	0.1	0	0	0	1.3	0	0	0.1	0	0	0	0	0.1	0.1	0	0	0	0.1	0	0	0.8	1.2	0.7	0.5	0.6	0.5	0.5	0.5	0.4	0.3	0	0	0	0	0	4.2	3.9	17.8	1.4	0	1.8	15.7	0	0	1.1	2.2	0.4	0.2	0	0.5	0	0	0	0	203	0.2	0	2.9	5.5	3.2	0.8	0.6	0	0	0	0.3	14.6	0.7	0.3	0	0.9	3.6	0	0.2	1.4	0.9	0	0	0	0.4	0	Hepatocytes
LEAP2	LEAP-2	ENSG00000164406	Liver enriched antimicrobial peptide 2	Q969E1	5	132872322-132875046	Plasma proteins, Predicted secreted proteins		Antibiotic, Antimicrobial		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	12	liver: 52.4	Cell type enriched	Detected in many	19	Hepatocytes: 1416.7	Cancer enriched	Detected in many	17	liver cancer: 40.0					Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Low cell line specificity	Detected in many			Not detected	Not detected			Low region specificity	Detected in all								Secreted to blood				1300000				unprognostic (2.14e-2)	unprognostic (8.78e-2)	unprognostic (4.75e-1)	unprognostic (2.16e-1)	unprognostic (2.82e-1)	unprognostic (1.06e-2)	unprognostic (2.78e-3)	unprognostic (6.53e-2)	unprognostic (3.86e-2)	unprognostic (1.62e-1)	unprognostic (7.08e-3)	unprognostic (2.91e-2)	unprognostic (1.02e-1)	unprognostic (2.39e-1)	unprognostic (3.97e-1)	unprognostic (1.11e-1)	prognostic favorable (2.68e-4)	0.1	0.1	0	0.2	0.1	0	0.2	1.5	0	0.2	0.3			1.5	0.1	0.1	0.3	0.2	0.4	0.2	0.1	0	1.4	52.4	0.2	0.3	0.1		0.2	0.5	0.5	0.2	0		0.7	0.5		0.3	0.1	0.9	0.4	2.6	0	0.1	0.7	0.5	0.1			0.6		0.5	1.8	0.4	1.6	0.9	4.2	1.3	0.9	2	0.3	0.5	2.3	2.4	4.8	2.7	1.3	1.8	1	0.2	0.7	1.6	2.4	2.8	2	0.4	0.3	0.8	4.2	3.8	1.1	0.5	3.6	1.7	1.7	5.7	1.7	0.7	0.9	1.3	1.1	1.9	0.7	1.3	2	0.7	3.5	1.4	4.9	0.7	1.2	1.6	3.9	1.4	1.9	1.1	1.4	1.6	1.5	1	2	1.6	1.1	1	1	0.8	1.1	1.5	1.2	0.4	2.7	1.6	1.2	0.6	5.8	4.3	1.7	0.7	2.7	1.1	4.2	1.3	0.2	1.3	0.9	1.4	1.5	0.9	0.6	0.9	1.6	1.1	1.2	3.2	0.9	0.5	0.8	2	0.3											0	1.6	16.9	9.6	9	15.8	1.2	76.5	1.4	1.2	0	31.4	2.7	8.3	2.3	3.7	3.8	75.4	0	8.7	4.9	6.7	7.2	6.9	1416.7	1.2	12.7	4.6	21.5	19.4	0.2	1.4	3.4	5	0	3.4	4.6	2.5	34.5	1.8	36.3	23.1	0	6.2	4.1	1.9	6.8	6.1	10	4.4	7.8	Hepatocytes
FABP7	B-FABP, BLBP	ENSG00000164434	Fatty acid binding protein 7	O15540	6	122779475-122784074	Predicted intracellular proteins	Transport			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	4	brain: 62.7;breast: 26.8	Cell type enriched	Detected in some	5	Muller glia cells: 827.1	Group enriched	Detected in many	6	glioma: 139.3;renal cancer: 51.2	Low region specificity	Detected in all			Cell type enhanced	Detected in some		basophil: 3.1	Group enriched	Detected in many	5	granulocytes: 3.1;NK-cells: 1.1	Group enriched	Detected in some	8	AF22: 38.7;U-251 MG: 10.5;WM-115: 23.3	Region enriched	Detected in all	6	olfactory region: 1471.1	Low region specificity	Detected in all			CAB025488, HPA028825, CAB058697	Enhanced		Approved	Nucleoplasm,Golgi apparatus,Cytosol						Nucleoplasm	Golgi apparatus, Cytosol	CAB025488: , CAB058697: AB_2665600, HPA028825: AB_10602130	prognostic favorable (2.49e-4)	unprognostic (1.56e-2)		unprognostic (2.53e-3)	unprognostic (5.80e-2)	unprognostic (2.29e-1)		unprognostic (1.14e-1)	unprognostic (7.11e-2)		unprognostic (2.09e-2)	unprognostic (3.42e-2)	prognostic unfavorable (1.65e-6)	unprognostic (9.83e-2)	unprognostic (1.30e-2)	unprognostic (2.50e-1)	unprognostic (8.66e-2)	2.1	1.3	34.8	1.1	15.5	1.3	26.8	51.6	62.7	1.1	1.5	13	0	1.2	1.2	1.3	1.6	1.2	1.2	1.2	32	16.4	1.6	1.4	1.1	1.1	11.4	30.3	1.1	1.1	1	2.1	1.3	11.2	1.3	1.2	5.7	7	3.7	6.7	10.5	1.1	1.1	8.1	1.1	1.3	1.2	6.9	0	1.1	0	1.1	1.4	0	0.4	0.2	3.1	0.3	1.1	0.4	0	0	0	38.7	0	0	0	1.4	0	0.3	0	0	0	0	0	0.1	0	0.1	0	0	0	0	0	0	0.3	0.4	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	2.9	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0.1	0	0.1	0	0	10.5	0	0	0	0.4	0	23.3	3.1	0.3	0.1	0.3	0.1	0.3	0.2	0.3	0.4	0.1	0.4	0.3	0.3	0.5	1.1	0.2	0.2	0.1	0	34.8	15.5	51.6	27.3	32	16.4	11.4	30.3	11.2	6.9	0	0	0	0.1	10.9	6.8	0.4	0	0	0	0	11.8	4.7	0	0	0	0.1	0	0	0	162.7	1.1	0	0	0	2.5	4.8	0	0	0	0	0	0	28.7	0	0	827.1	0	0	0	0.2	37.4	0	0.8	0	0	16.6	5.9	0	0	0	Muller glia cells
TLX3	HOX11L2, RNX	ENSG00000164438	T cell leukemia homeobox 3	O43711	5	171309284-171312134	Cancer-related genes, Predicted intracellular proteins, Transcription factors		Developmental protein, DNA-binding	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	59	brain: 46.6	Cell type enriched	Detected in some	5	Extravillous trophoblasts: 5.2	Cancer enhanced	Detected in some		cervical cancer: 1.7	Region enriched	Detected in some	22	cerebellum: 46.6	Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	5	SH-SY5Y: 24.6	Region enriched	Detected in single	7	cerebellum: 2.5	Region enriched	Detected in some	10	cerebellum: 48.1	HPA030504, HPA060957, HPA069359	Enhanced		Enhanced	Nucleoplasm						Nucleoplasm		HPA030504: AB_2732458, HPA060957: AB_2732655, HPA069359: AB_2732130		unprognostic (3.52e-2)		unprognostic (2.43e-2)					unprognostic (2.09e-1)	unprognostic (3.11e-1)				unprognostic (9.80e-2)	unprognostic (2.76e-2)		unprognostic (4.48e-2)	0.4	0.5	0	0	0	0	0	46.6	0	0.3	0	0	0	0	0	0	0.4	0	0	0.3	0	0	0.1	0	0	0	0	0	0	0	0	0.2	0.4	2	0	0	0	0	0	0	0	0.7	0	1.6	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0.1	0	0	0	0.2	0	0	0	0	0	0	0	4.5	0	0	0	0.3	0	0	0	1.3	0	4.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.9	0	0.2	0	0	24.6	0	0	0	0	0	1.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	46.6	0	0	0	0	0	2	0	0	0	0	0	0	0	1.1	0	0	0	0	0	0.1	0	0	0	0	0	0	0	5.2	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0.2	0	0	0	Extravillous trophoblasts
TXLNB	C6orf198, dJ522B19.2, DKFZp451A175, MDP77	ENSG00000164440	Taxilin beta	Q8N3L3	6	139240061-139292139	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	14	heart muscle: 37.9;skeletal muscle: 131.5;tongue: 49.7	Cell type enriched	Detected in many	5	Cardiomyocytes: 228.7	Low cancer specificity	Detected in some			Not detected	Not detected			Cell type enhanced	Detected in some		memory B-cell: 5.3	Group enriched	Detected in many	4	B-cells: 5.3;granulocytes: 2.1	Cell line enhanced	Detected in some		Daudi: 7.3;HSkMC: 4.7;REH: 3.9;RPMI-8226: 5.4;U-698: 10.2	Low region specificity	Detected in many			Not detected	Not detected			HPA030401, HPA030402, HPA030403	Enhanced											HPA030401: AB_2673459, HPA030402: AB_10602486, HPA030403: AB_2673461	unprognostic (1.54e-1)	unprognostic (7.01e-3)	unprognostic (1.50e-1)	unprognostic (1.32e-1)	unprognostic (5.75e-3)	unprognostic (2.94e-1)	unprognostic (1.09e-2)	unprognostic (6.00e-2)	unprognostic (2.06e-1)	unprognostic (8.10e-3)	unprognostic (4.79e-1)	unprognostic (5.15e-2)	unprognostic (2.16e-4)	unprognostic (2.19e-2)	unprognostic (2.21e-1)	unprognostic (2.65e-1)	unprognostic (8.05e-4)	4.5	0.9	0.4	1.1	0.6	0.1	0.7	0.2	0.5	1	0.7	0.6	0	0.2	1.3	5.1	3.4	0.6	0.7	37.9	0.5	0.5	0.3	0.3	0.6	0.9	0.5	0.4	3.8	0.2	2.3	0.7	0.2	0.8	0.9	0.3	0.1	2.1	0.1	131.5	0.3	0.8	1.1	1.5	1	0.4	1.2	0.1	3.4	0.9	49.7	2.7	1	0.5	5.3	0.3	2.1	0.3	0.3	0.8	0.3	0	0	1.5	0	0	0	0	0.2	0.6	0	0.1	0	0	7.3	0	0.1	0.4	0	0.3	0	0	0.1	0.8	1	0.1	0	0	2	0.3	4.7	0	0	0	0	0	2.8	0	2.2	0.4	0.3	0.7	0.8	0.2	0	0.5	3.9	1.7	5.4	0	0	2.9	0	0	0	0	0.1	0.9	2.2	1.4	0.1	0.1	0	0.1	1.2	2.1	10.2	0.3	2	0	0	0.2	0	0.4	0.2	0.6	5.3	0.4	0.8	0.1	1.9	0.4	0.2	2.1	0.3	0.3	0.3	0.3	0.3	0.4	0.6	0.2	0.5	0.5	0.5	0.5	0.4	0.8	0.1	0	0	5.2	0.1	0.5	0	228.7	0	21.4	2.3	1.8	0	0.1	0	0	30.5	3.8	0	0	0	0	0.8	0	0	0	1.6	0	0	1.3	5.8	49.6	0.6	2.2	5	0	0	7.5	0	0	2.1	0	0	0	0.4	4.7	0.5	0.4	0	1.3	0	0	Cardiomyocytes
CALHM4	C6orf78, FAM26D, FLJ32239	ENSG00000164451	Calcium homeostasis modulator family member 4	Q5JW98	6	116529013-116558868	Predicted intracellular proteins, Predicted membrane proteins, Transporters	Ion transport, Transport	Ion channel		Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	14	placenta: 29.7;skin 1: 9.1	Cell type enriched	Detected in some	5	Syncytiotrophoblasts: 45.7	Not detected	Not detected			Region enriched	Detected in single	5	pons and medulla: 1.4	Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	4	CACO-2: 2.8;SuSa: 6.2														Intracellular and membrane																	unprognostic (7.95e-2)			unprognostic (3.44e-4)		unprognostic (1.99e-1)	unprognostic (1.44e-2)		0.5	0	0	0	0.2	0	0.1	0	0.1	0	0.1	0.2	0.6	0	0	0.2	0.1	0	0	0.3	0.2	0.2	0.3	0	0	0	0.1	0	0	0	0.2	0	29.7	1.4	0	0	0.2	0	0	0.5	9.1	0	0	0	0	0	0.4	0	0	0	1	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	1	0.5	0.3	0.1	0	2.8	0	0.3	0.2	0.2	0.3	0	0.3	0.6	0.9	0	0	0	0	0.6	0	0	0	0.2	0	0	0	0.4	1	0	0	0	0.8	0	0	0	0.6	0	0	0	0	0	0	0	0	0.2	0	0.1	0	6.2	0.3	0	0	0.1	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0.2	0	0.1	0.2	0.2	0.1	0	1.4	0	0	0	0	0	0	0	0	0	0	0	0	0	10.1	0	0	0	0	0	0	0	0.3	0	0	0	0	1.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	45.7	0	0	0	Syncytiotrophoblasts
IL22RA2	CRF2-S1, IL-22BP	ENSG00000164485	Interleukin 22 receptor subunit alpha 2	Q969J5	6	137143820-137173648	Predicted secreted proteins		Receptor		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Group enriched	Detected in some	5	breast: 6.9;lymphoid tissue: 6.2;placenta: 11.5	Cell type enriched	Detected in single	6	Syncytiotrophoblasts: 1.5	Low cancer specificity	Detected in single			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	15	HL-60: 2.8;U-937: 5.0	Not detected	Not detected			Not detected	Not detected			HPA030582, CAB034906	Uncertain				Secreted to blood			40500000				CAB034906: AB_2124501, HPA030582: AB_10600716	unprognostic (1.09e-1)	unprognostic (7.97e-4)	unprognostic (1.32e-3)	unprognostic (1.24e-2)		unprognostic (4.03e-3)		unprognostic (1.11e-1)	unprognostic (4.51e-1)	unprognostic (1.92e-1)	unprognostic (1.07e-1)	unprognostic (1.10e-1)		unprognostic (7.58e-2)	unprognostic (1.32e-1)	unprognostic (1.62e-1)	unprognostic (6.61e-2)	0.1	0	0.1	2.5	0.1	0	6.9	0.1	0.1	0.3	0.2	0.1	0.1	0.2	0.1	0.1	0.5	0	0.2	0.3	0.1	0	0.1	0.1	0.1	2	0.1	0.1	0.1	0.1	0	0.1	11.5	0.1	0.2	0.5	0.1	0.1	0.1	0.1	1.4	1.5	0.1	0.1	1.9	0.3	0.1	0.1	0.1	0.1	0.1	6.2	0.8	0.8	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	2.8	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	0	0	0.2	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	1.5	0	0	0	Syncytiotrophoblasts
DACT2	bA503C24.7, C6orf116, DAPPER2	ENSG00000164488	Dishevelled binding antagonist of beta catenin 2	Q5SW24	6	168292830-168319754	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at transcript level		Group enriched	Detected in many	6	brain: 14.2;placenta: 54.8	Cell type enriched	Detected in many	5	Syncytiotrophoblasts: 180.9	Cancer enhanced	Detected in many		endometrial cancer: 14.1	Region enriched	Detected in many	8	basal ganglia: 14.2	Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		A549: 4.5;CACO-2: 3.6;hTCEpi: 2.5;NTERA-2: 3.2;OE19: 15.1;SCLC-21H: 3.5	Low region specificity	Detected in many							HPA030251	Enhanced	Supported										HPA030251: AB_10611108	unprognostic (5.22e-6)	unprognostic (3.13e-2)	unprognostic (1.04e-2)	prognostic favorable (1.07e-5)	unprognostic (1.21e-1)	unprognostic (1.41e-1)	unprognostic (1.64e-2)	unprognostic (1.08e-1)	unprognostic (4.04e-1)	unprognostic (1.31e-1)	unprognostic (7.05e-3)	unprognostic (2.48e-1)	prognostic favorable (5.76e-5)	unprognostic (1.51e-2)	unprognostic (1.66e-2)	unprognostic (2.03e-4)	unprognostic (4.23e-2)	1	1.3	0.5	0.4	14.2	0	0.4	1.5	1.4	2.3	1.1	1.2	1	0.9	3.7	2.2	0.7	2.2	2.9	2.7	0.9	0.5	2.2	2.4	2	0.4	1.1	0.9	0.9	1.6	0	0.4	54.8	1.7	6.1	0.4	1.6	5.3	0.5	0.4	5.6	0.8	0.8	0.7	0.4	0.5	1	0.7	0.9	0.4	0.4	0.8	1	0.4	0	0	0	0	0	0	0	0	4.5	0.1	0	0	0	0.1	0	0	0	0	3.6	0	0	2	0	0.1	0	0	0	0	0	0	0	0	2	0.6	0	0	0	2.5	0	0	0	0	0	0	0	0	0	0	0.1	3.2	15.1	0	0	0	0	0	0	3.5	0	0	0	0	1.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	14.2	1.5	1.4	0.9	0.5	1.1	0.9	1.7	0.7	0	1.3	0	1.8	2.7	9.8	0.5	2.5	0	2.3	1.8	0	38.3	0	1.5	0	0.1	0	0	0.2	4.7	1.1	0.8	0	0	4.6	0	5.1	0	0	0	0	0	3.3	0	1.1	22.6	0.4	0	0	4.9	0.7	0	0	0	0	1.3	180.9	0	1.8	0	Syncytiotrophoblasts
MYOZ3	CS-3, CS3, FRP3	ENSG00000164591	Myozenin 3	Q8TDC0	5	150660874-150679365	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	19	skeletal muscle: 81.2;tongue: 79.7	Cell type enriched	Detected in some	15	Peritubular cells: 41.8	Low cancer specificity	Detected in some			Low region specificity	Detected in some			Cell type enriched	Detected in single	5	plasmacytoid DC: 2.2	Lineage enriched	Detected in single	5	dendritic cells: 2.2	Cell line enhanced	Detected in some		HAP1: 5.9;NTERA-2: 10.5;REH: 16.1;SuSa: 3.0	Not detected	Not detected			Not detected	Not detected			HPA039166	Enhanced											HPA039166: AB_10671871	unprognostic (2.74e-1)	unprognostic (2.46e-3)	unprognostic (9.57e-3)	unprognostic (1.41e-2)	unprognostic (1.26e-1)	unprognostic (3.46e-2)	unprognostic (2.59e-2)	unprognostic (8.77e-2)	unprognostic (9.19e-4)	unprognostic (6.99e-2)	unprognostic (5.19e-2)	unprognostic (7.21e-3)	unprognostic (7.31e-9)	unprognostic (2.19e-2)	unprognostic (2.79e-1)	unprognostic (8.46e-2)	unprognostic (4.20e-2)	0.7	0.3	0.3	0.1	1.4	0.4	0.2	0.2	0.9	0.8	0.2	0.1	0	0.2	0.6	3.4	2.3	0.4	0.6	2	0.3	2.1	0.2	0.1	0.4	0.1	1.1	0.7	0.4	0.1	0.1	0.7	0.1	0.8	1.7	0.1	1.3	3.8	0.5	81.2	0.1	0.4	0.4	1.9	0.1	0.3	1.8	0.1	0	0.3	79.7	4.3	0.2	0.2	0	2.2	0	0	0	0.4	0	0	0	2.6	0	0	0	0.1	0	0.2	0.1	0.5	0	0.2	0	0.2	0	0	0	5.9	0	0.2	0	0	1.3	0.1	0	0	0	0	0.3	0	0.3	0	0.1	0.5	0.8	0	0	0.1	0	0.6	1.5	10.5	0	0	16.1	0	0	0	0	0	1.5	0	0	0	3	0	0.3	0.4	0.1	0	0	0	0	0.4	0	0.7	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	2.2	0	0	0.3	1.4	0.2	0.9	0.3	2.1	1.1	0.7	0.8	0.1	0	0	0	0.2	0.3	0.4	2.5	0	0	0	0	0	0.4	0	0	0.1	1	0	0	0.2	0.3	1	0.3	0	0	0.2	0	0	2.5	0.3	1.1	2.8	0	0	0	0	0.7	0	0	41.8	0	0	0	0.1	0.3	1.7	0.4	0.6	0	0.4	0	Peritubular cells
BMPER	CRIM3, Cv2	ENSG00000164619	BMP binding endothelial regulator	Q8N8U9	7	33904911-34155872	Disease related genes, Plasma proteins, Predicted secreted proteins			Disease mutation	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in many			Cell type enriched	Detected in some	17	Ito cells: 97.6	Cancer enhanced	Detected in some		glioma: 2.6	Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		ASC diff: 11.8;BJ: 11.2;fHDF/TERT166: 14.5;HBF TERT88: 15.9;HSkMC: 11.9;hTEC/SVTERT24-B: 10.6;U-138 MG: 16.6	Low region specificity	Detected in many			Low region specificity	Detected in many								Secreted to extracellular matrix								unprognostic (4.50e-2)	unprognostic (2.68e-1)	unprognostic (2.83e-2)	unprognostic (3.19e-2)	unprognostic (1.93e-1)	unprognostic (1.96e-4)	unprognostic (5.34e-3)	unprognostic (3.10e-1)	unprognostic (9.98e-3)	unprognostic (3.50e-3)	unprognostic (8.01e-4)	unprognostic (1.96e-1)	unprognostic (5.67e-5)	unprognostic (2.54e-1)	unprognostic (2.62e-1)	unprognostic (2.06e-2)	unprognostic (3.47e-3)	7	1.1	2.2	8.5	6.3	0.3	2.2	9.5	9.7	5	2.4	0.6	0	1.3	3.4	6.7	1.6	1.6	2	2.7	2.4	1.9	1.1	12.9	5.7	7.8	1.6	4.7	3.3	1	0.4	5.3	11.3	6	9.5	2	1.8	1.9	0.9	3.7	1	3.8	2	1.7	1	4.2	1.4	0	0	1.1	2	0.3	1.6	2.1	0	0	0	0	0	0.3	0	0	0.5	0	0	11.8	6.3	0	11.2	2.8	7.1	6.2	0	0	0.1	0	14.5	3.9	5.3	0	0	15.9	0	0.5	0	0.5	0	1.2	0	0	11.9	0	10.6	0	0.6	0	0	0	0	4	0	0	0	0.1	0	0	0	0	0	0	0	0.1	0	1.8	0	0	2.1	0.9	0	0	16.6	1.4	8.2	0	1.4	0	0	6	0	2.8	0	0	0	0	0	0	0	0.1	0	0	0	0.3	0	0	0	0	0	0	0	2.2	6.3	9.5	9.7	2.4	1.9	1.6	4.7	6	0	0	0	0	0.5	0	0.2	4.2	0	0	0	0	5.9	0.4	0	0.1	1.5	0.6	0	0	0	0.2	0.2	0.1	0	0	0.1	0	4.1	97.6	4	0.7	0	0	0	0	0	0.2	0	0	1.1	0	0.3	0	0.8	0	3.9	0.1	0.1	0	0	0.2	Ito cells
FNDC1	bA243O10.1, dJ322A24.1, FNDC2, KIAA1866	ENSG00000164694	Fibronectin type III domain containing 1	Q4ZHG4	6	159169397-159272109	Predicted intracellular proteins, Predicted secreted proteins				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		thyroid gland: 36.6	Cell type enriched	Detected in some	5	Fibroblasts: 15.5	Cancer enhanced	Detected in many		thyroid cancer: 32.5	Region enriched	Detected in single	6	hippocampal formation: 4.8	Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		EFO-21: 2.4;fHDF/TERT166: 6.6;SuSa: 7.4	Low region specificity	Detected in many			Low region specificity	Detected in single			HPA030962, HPA030963	Approved		Approved	Nuclear speckles	Secreted to extracellular matrix					Nuclear speckles		HPA030962: AB_10696212, HPA030963: AB_2673676	unprognostic (4.59e-2)	unprognostic (9.17e-3)	unprognostic (7.62e-2)	prognostic favorable (6.10e-5)	unprognostic (4.57e-1)	unprognostic (2.11e-1)	unprognostic (5.52e-2)	unprognostic (1.18e-1)	unprognostic (1.30e-1)	unprognostic (1.08e-1)	unprognostic (4.18e-2)	unprognostic (1.74e-1)	prognostic unfavorable (1.93e-6)	unprognostic (6.49e-3)	unprognostic (1.12e-1)	unprognostic (3.10e-1)	unprognostic (1.76e-3)	5.2	0.6	0.5	7.6	0.7	0	2.5	0.3	0.7	9.7	12.9	3.2	0	2.1	4.8	2.2	2.2	0.9	13.1	3.5	4.8	0.5	1	1.5	1.2	2.1	0.7	0	4.8	1.2	0	0.4	0.7	0.5	0.7	1.6	1	2.5	0.6	6.2	1.2	7	10.2	1.5	0.7	0.7	2.1	0.1	1	36.6	11.8	3.6	1.5	2.3	0	0	0	0	0	0	0	0	0	0	0	0.2	0.2	0	0.4	0	0.3	0.1	0	0	0.1	2.4	6.6	0.3	0	0.1	0	0	0	1.3	0	0.3	0	0.2	0	0	0.9	0	0.4	0	0.8	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0.9	0	1	0	0	7.4	0	0	0	0.5	0.2	0.2	0	0	0	0.2	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0.7	0.3	0.7	4.8	0.5	0.7	0	0.5	0.1	0	1.1	0	0	2.9	0	1.4	0	0	1.2	0	0	0.1	1.7	0	0.3	0	0	0	0	0.1	15.5	0	0	0	0.2	0	0	2.5	0	0	0.3	0	1.7	0	0	0	0	0	0	0	0.3	0	1.9	0.4	0.3	1.3	0.1	0	0	0	Fibroblasts
SLC13A4	SUT-1, SUT1	ENSG00000164707	Solute carrier family 13 member 4	Q9UKG4	7	135681237-135729258	Predicted membrane proteins, Transporters	Ion transport, Sodium transport, Symport, Transport			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Group enriched	Detected in some	9	brain: 85.4;placenta: 44.8;retina: 23.5	Cell type enriched	Detected in some	7	Syncytiotrophoblasts: 657.3	Low cancer specificity	Detected in single			Region enriched	Detected in many	7	pons and medulla: 85.4	Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	6	HDLM-2: 25.7	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA048582	Enhanced											HPA048582: AB_2680450	unprognostic (2.40e-1)	unprognostic (2.51e-1)	unprognostic (9.70e-3)	unprognostic (1.78e-1)	unprognostic (7.69e-2)	unprognostic (3.96e-6)	unprognostic (3.33e-2)	unprognostic (1.32e-1)	unprognostic (8.56e-3)	unprognostic (9.23e-2)	unprognostic (2.89e-1)	unprognostic (1.87e-1)	unprognostic (2.30e-6)	unprognostic (1.53e-1)	unprognostic (3.07e-2)	unprognostic (2.00e-1)	unprognostic (6.73e-2)	0.3	0.4	0.7	0.3	1.4	0.3	0.4	4	8.9	1.2	0.3	34	0	0.3	0.4	0.3	4.1	0.8	0.4	0.4	12.3	0.8	0.3	0.4	0.4	0.3	1.4	5.4	0.4	0.5	0.4	1.4	44.8	85.4	0.3	0.3	23.5	1	0.4	0.3	0.4	0.3	0.4	5.1	0.3	0.3	5.4	0.5	0	0.3	0	1.9	0.3	1.8	0	0.2	0.1	0.1	0	0.4	0	0	0	0	0	0	0.3	4.5	0.2	0.2	0	0	0	0	0	0.7	0.2	0	0	0	0	0	25.7	1.8	0	0	0	0	0	0	0.2	0	0.1	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0.1	0.1	0	0	0	0.1	0	0	0	2.8	0	0	0	0.1	0	2.1	0.1	0.1	2.1	0	0	0	0	0	0.1	0.1	0.1	0	0.4	0	0	0	0.1	0	0	0	0	0	0	0.2	0	0	0.7	1.4	4	8.9	12.3	0.8	1.4	5.4	85.4	0.5	0	0	0	0.5	0	2.6	1.6	0	6.7	0	0	3.9	99.4	0	0.1	0.4	0.3	0	0	0	5.3	1.1	0.4	0	0	13.1	3.2	0	0	0	0	0.3	0	0	0	0	1	0.2	0	0	0	13.2	0	0	0	0.2	0.1	657.3	0	0	0.3	Syncytiotrophoblasts
SLC35G3	AMAC1, FLJ40154, TMEM21A	ENSG00000164729	Solute carrier family 35 member G3	Q8N808	17	35192520-35194523	Predicted membrane proteins, Transporters				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in some		blood: 3.1;skeletal muscle: 1.4;testis: 6.5	Cell type enriched	Detected in some	8	Early spermatids: 16.5	Not detected	Not detected							Cell type enhanced	Detected in some		naive CD8 T-cell: 3.1	Lineage enriched	Detected in single	31	T-cells: 3.1	Not detected	Not detected																									unprognostic (1.88e-1)		unprognostic (2.67e-1)		unprognostic (6.17e-3)				unprognostic (3.83e-1)				unprognostic (6.24e-2)	unprognostic (3.06e-1)			0	0	0	0	0	0	0	0	0	0	0			0	0	0	0	0	0	0.3	0	0	0	0	0	0.3	0		0	0	0	0	0		0	0		0	0	1.4	0	0	0	0	0.3	0	6.5			0		0	0	0	0	0	0	0	0	3.1	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0.1	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0.4	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0.3	0.1	0	0	0.9	3.1	0	0	0	0	1.1	0.2											0	0	0	0	0	0	0.8	0	0	0	0	0	0	0	0	16.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0.7	0.9	0	0	0	0	0	Early spermatids
SUN3	MGC33329, SUNC1	ENSG00000164744	Sad1 and UNC84 domain containing 3	Q8TAQ9	7	47987148-48029119	Predicted intracellular proteins, Predicted membrane proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	20	testis: 30.9	Cell type enriched	Detected in some	8	Early spermatids: 435.2	Cancer enhanced	Detected in single		testis cancer: 2.1	Not detected	Not detected			Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Group enriched	Detected in some	4	GAMG: 7.2;U-2 OS: 21.5	Low region specificity	Detected in single			Low region specificity	Detected in all			HPA008344, HPA076890	Enhanced		Approved	Golgi apparatus						Golgi apparatus		HPA008344: AB_1857656, HPA076890: 	unprognostic (5.11e-2)	unprognostic (4.96e-2)	unprognostic (1.13e-1)	unprognostic (1.61e-4)	unprognostic (2.31e-2)	unprognostic (5.62e-2)	unprognostic (1.35e-2)	unprognostic (2.24e-2)	unprognostic (1.59e-5)	unprognostic (4.88e-1)	unprognostic (1.47e-1)		unprognostic (2.65e-1)	unprognostic (1.81e-2)	unprognostic (1.64e-1)	unprognostic (3.48e-1)	unprognostic (2.58e-1)	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	30.9	0	0	0	0	0	0	0	0.8	0.2	1.5	0.1	0.7	1.2	0.3	0.2	0	0.1	0	0	0	2.2	0	0	0	0.1	0	3.2	0.1	0	0	7.2	0	0	0	0.1	0.2	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0	0	0.1	0.1	0	0	0	0	0.1	0	0.2	0	0	0.1	0	0	0.2	0	0	0	0.1	0.7	0	0.3	0	1.3	21.5	0	0	0.8	0.1	0.1	0	0	0	1.3	0	0.4	1.2	0.1	0.1	0.7	0.4	0.4	0	0.8	0.5	0.2	1.5	0.7	0.1	0.2	0.2	0.3	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0.1	1.7	0	435.2	0	0	0	0	21.7	0	0	0	0	0.8	0	0	0.6	0	54.9	2	0	0	0	0	0	0.1	0	1.4	0.2	0	6.5	0.1	6.7	7.4	0	0.7	0	0	0	Early spermatids
C7orf57		ENSG00000164746	Chromosome 7 open reading frame 57	Q8NEG2	7	48035511-48061304	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		brain: 20.0;fallopian tube: 20.9;testis: 11.4	Cell type enriched	Detected in some	6	Ciliated cells: 143.2	Low cancer specificity	Detected in many			Region enhanced	Detected in many		pons and medulla: 20.0	Cell type enhanced	Detected in single		MAIT T-cell: 2.3	Lineage enhanced	Detected in single		T-cells: 2.3	Cell line enhanced	Detected in some		GAMG: 6.2;hTERT-HME1: 9.8;U-266/70: 5.8;U-698: 3.3	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA021286	Enhanced											HPA021286: AB_1845760	unprognostic (1.74e-2)	unprognostic (4.82e-2)	unprognostic (3.13e-2)	unprognostic (1.28e-2)	unprognostic (2.77e-3)	unprognostic (3.22e-2)	unprognostic (1.21e-2)	unprognostic (1.32e-1)	unprognostic (3.29e-1)	unprognostic (1.37e-1)	unprognostic (4.98e-2)	unprognostic (2.88e-1)	unprognostic (3.93e-5)	unprognostic (5.17e-3)	unprognostic (6.18e-2)	unprognostic (3.42e-3)	unprognostic (1.20e-1)	0.2	0.2	2.3	0.2	5	0.5	0.3	0.1	1	0.8	0.2	3.5	0	0.3	0.9	7.1	1.4	20.9	0.2	0.3	3.7	4	0.3	0.2	4.3	0.3	0.1	0.4	1.6	0.1	0.7	0.4	0.2	20	0.2	0.2	0	0.2	0.2	0.2	0.3	0.2	0.2	0.7	0.2	0.2	11.4	2.1	0	0.5	1.8	0.4	0.2	0.5	0	0.1	0	0	0.6	2.3	0.1	0.7	0.2	0.1	0.1	0	0	0.2	0.1	0.5	0.3	0.4	0	2.4	0	0.2	0.1	6.2	0.3	0	1	0.7	0	0.3	0	0.2	0	0	0	0	0	0	0.2	9.8	0.1	0	0	0	0.1	0.4	0.1	0.1	0	0.2	0	1	0	0	0	0.1	0.1	0.9	0.1	0.1	0	0.3	0.8	0	0	0.1	0.6	0.9	0.4	0.6	5.8	0.8	3.3	1.4	0	0.9	0	0	0	0.6	0	2.3	0	0.6	0.6	0.1	0	0.4	0.2	0	0.6	0	0	0	0.1	2.3	5	0.1	1	3.7	4	0.1	0.4	20	2.1	0	4.8	0	0	0	0	0.8	0	143.2	22.7	0	0	0	0	0	3.4	0	0	0	0	0.1	0.2	0.1	2.3	0	0.1	0	0	0	0	2.7	0	0.2	0	0	0	0.9	0	0	0	0	0.8	0	0	9.4	0.4	0	0	0	0	0	Ciliated cells
KCNV1	Kv8.1	ENSG00000164794	Potassium voltage-gated channel modifier subfamily V member 1	Q6PIU1	8	109963645-109975847	Predicted membrane proteins, Voltage-gated ion channels	Ion transport, Potassium transport, Transport	Ion channel, Potassium channel, Voltage-gated channel		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in some	9	brain: 22.4	Cell type enriched	Detected in single	7	Intestinal endocrine cells: 6.8	Cancer enhanced	Detected in single		renal cancer: 0.5	Low region specificity	Detected in many			Low cell type specificity	Detected in some			Low lineage specificity	Detected in single			Low cell line specificity	Detected in many			Low region specificity	Detected in many			Low region specificity	Detected in many																		unprognostic (1.41e-1)		unprognostic (1.81e-2)			unprognostic (5.01e-4)		unprognostic (2.30e-1)	unprognostic (3.76e-2)		unprognostic (1.13e-2)	unprognostic (3.89e-2)	unprognostic (2.27e-1)	unprognostic (4.17e-2)		0.5	0.5	10.6	0.6	10.2	1.1	0.6	0.2	22.4	0.4	1.1	0	0	0.5	0.6	1.2	0.5	0.4	0.5	0.5	3.9	1.6	0.6	0.5	0.5	0.7	0.9	8.2	0.8	1	0.4	0.7	0.6	0.9	0.7	0.9	0	0.6	0.5	0.5	1.1	0.8	0.4	0.4	0.6	0.5	0.7	0	0	0.9	0	0.5	0.4	0.2	0.8	0.6	2.5	0.9	0.6	0.5	0.1	2.1	2.7	1.9	0.8	0.3	0.3	0.7	0.6	0	0.4	0.4	0.5	0.8	0.8	0.6	0.1	1.7	2.1	0.7	0.3	0.5	1	0.3	1.3	2	0.5	0.1	1.1	1.5	0.3	0.4	0.6	0.5	0.8	0.4	1.1	1	2.6	0.3	0.6	0.8	1.3	0.9	0.5	1.2	0.2	1	0.3	3.4	1.1	1.5	0.7	0.5	0.4	0.6	2.1	1	0.5	1.3	2.3	2	1.5	0.6	0.9	0.5	0.4	1	0.9	0.9	2.5	0.8	0.3	0.5	0.9	0.4	0.6	0.5	0.5	0.5	0.8	0.5	0.5	1.1	0.6	0.8	0.6	0.3	0.1	10.6	10.2	0.2	19.5	3.9	1.6	0.9	8.2	0.9	0	0	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	6.8	0	0	0	0	0	0	0	0.9	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0.6	0	Intestinal endocrine cells
DEFA6	DEF6, HD-6	ENSG00000164822	Defensin alpha 6	Q01524	8	6924693-6926076	Plasma proteins, Predicted secreted proteins		Antibiotic, Antimicrobial, Defensin, Fungicide		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	189	intestine: 316.3	Cell type enriched	Detected in some	5	Mucus-secreting cells: 29.8	Cancer enhanced	Detected in many		colorectal cancer: 75.8	Not detected	Not detected			Cell type enhanced	Detected in single		memory B-cell: 1.6	Lineage enriched	Detected in single	17	B-cells: 1.6	Group enriched	Detected in some	12	BEWO: 12.8;NB-4: 13.4;RPMI-8226: 15.7;SH-SY5Y: 10.8;U-2197: 5.0									HPA019462	Enhanced				Secreted to digestive system							HPA019462: AB_1847595			unprognostic (7.48e-3)											unprognostic (1.63e-1)	unprognostic (1.34e-1)			0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0	262.3	0	0	181.7	0.1	0	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0	0.1	0.1	0	0.1	0	0	0.1	0	0	0.1	0	0.1	0.1	316.3	0	0.1	0.1	0.1	0.1	0	0.2	0.1	0.1	0	0.1	0.1	1.6	0	0	0	0	0	0	0	0	0	0	0	0	12.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.4	0	0	0	0	0	15.7	0	0	0.9	10.8	0	0	0	0	0	0.3	0	0	0	5	0	0	0	0	0	0	0	0	0	0	0	0	0	1.6	0	0	0	0.9	0	0	0	0	0	0	0	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0	1.6	0	0	0	0	0	0	0	0	0	0	0.8	0	6.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	1.7	0	29.8	0	0	0	0	0	0	0	0	0	0	0.1	0	0	1.1	0	Mucus-secreting cells
DEFB1	BD1, DEFB-1, DEFB101, HBD-1, HBD1, MGC51822	ENSG00000164825	Defensin beta 1	P60022	8	6870575-6878022	Predicted secreted proteins, Transporters		Antibiotic, Antimicrobial, Defensin		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	4	kidney: 121.1;pancreas: 219.9;salivary gland: 173.0	Cell type enriched	Detected in many	5	Distal tubular cells: 11270.5	Cancer enhanced	Detected in many		renal cancer: 522.9	Not detected	Not detected			Group enriched	Detected in some	8	classical monocyte: 1.4;intermediate monocyte: 1.6	Lineage enriched	Detected in single	9	monocytes: 1.6	Cell line enriched	Detected in some	7	SCLC-21H: 27.8					Not detected	Not detected								Secreted in other tissues								unprognostic (2.31e-2)	unprognostic (8.35e-3)	unprognostic (1.24e-1)	unprognostic (1.75e-1)	unprognostic (1.89e-1)	unprognostic (2.16e-3)	unprognostic (4.41e-2)	prognostic unfavorable (5.62e-4)	unprognostic (2.77e-1)	unprognostic (2.38e-2)	prognostic unfavorable (5.94e-4)	unprognostic (3.24e-1)	prognostic favorable (1.90e-5)	unprognostic (9.62e-2)	unprognostic (2.86e-2)	unprognostic (2.21e-2)	unprognostic (1.16e-1)	1.1	0	0.2	0.5	0.3	0.5	10.5	0.6	0.3	38.7	2.3	0.3	1.6	0.6	2.6	3.1	14.9	2.7	6.5	0.7	0.3	0	121.1	22.3	0.7	0.2	0.4	0.3	0.8	219.9	0	1.6	4.3	0.8	3.8	1.5	0.5	173	3.2	0.8	14.6	0.7	0.5	0.7	0.3	4	0.7	0.3	0.3	0.8	10.4	8.8	1.8	10.6	0	0.1	0	1.6	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	3.2	0.1	0	0.3	0	1.2	1.7	0	0	0	0	0	0	0	4.1	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0.3	2.2	0	0.1	0.2	0	1.3	0.6	27.8	0.2	0.7	0	0	0	0	0.2	0	0	0.3	0	0.1	0	0	0.2	0	0	0	0	1.4	0	0	1.6	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0.2	0.3	0.6	0.3	0.3	0	0.4	0.3	0.8	0.3	3	5	2.9	372.3	80	0.3	0	2435.7	5.3	4.5	931.7	0	6.7	11270.5	1231.2	0	0.6	52.3	0	250.8	0.3	5	291.3	0	169.8	3.4	0	15.1	4.9	6	0	16.1	5.3	6.8	26.2	10.3	0.5	226.2	20.7	0	94.9	0.6	0	4.1	0	0	470	3.1	3.8	11.3	236.2	Distal tubular cells
CA3	CAIII, Car3	ENSG00000164879	Carbonic anhydrase 3	P07451	8	85373436-85449040	Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins		Lyase	FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	12	skeletal muscle: 347.5	Cell type enriched	Detected in some	14	Erythroid cells: 280.4	Group enriched	Detected in many	7	glioma: 23.1;prostate cancer: 9.4	Not detected	Not detected			Cell type enhanced	Detected in single		plasmacytoid DC: 1.8	Low lineage specificity	Detected in single			Group enriched	Detected in some	9	HEL: 23.8;RH-30: 40.1	Low region specificity	Detected in some			Not detected	Not detected			CAB004967, HPA021775, HPA026700	Enhanced								31000000			CAB004967: AB_437014, HPA021775: AB_1845990, HPA026700: AB_1845991	prognostic favorable (4.24e-6)	unprognostic (1.40e-1)	unprognostic (1.50e-2)	unprognostic (2.22e-3)	unprognostic (4.71e-2)	unprognostic (8.43e-3)	unprognostic (3.56e-2)	unprognostic (4.04e-2)	unprognostic (1.11e-1)	unprognostic (3.68e-1)	unprognostic (4.71e-2)	unprognostic (3.54e-1)	unprognostic (3.19e-2)	unprognostic (1.18e-1)	unprognostic (9.96e-2)	unprognostic (1.39e-1)	unprognostic (2.19e-1)	18	0.4	0.2	0.1	0.2	0.5	0.6	0.2	0.1	0.5	0.3	0	0.1	0.1	0.6	29	9.5	1	0.2	1.3	0.2	0.1	0.2	0.2	4.1	0	0.1	0	0.1	0.1	0	0.3	0	0	6.6	0	0	5.5	0.2	347.5	0.3	0.4	1.4	0.1	0.1	0.3	0.5	0	0	0.3	14.1	3.4	0.7	0.5	0.5	1.8	0	0	0	0.8	0.2	0.9	0	0.5	0	0	0	0	0	0	0	0	0.4	0.5	0	0	0	0	0	0.1	0.1	0	0.2	0.1	23.8	0	0.5	0	0	0	0	0.1	0	0	0	0	0	0	0.1	0	0	0	0	0	3.7	0	0	40.1	0	0.7	0	0	0	0	0	0	0.7	0	0.9	0	0	0.3	0	0	0	0	0	0.2	0	0.1	0	0	0	0	0	0	0.5	0	0	0	0.3	0	0.8	0	0	0	1.8	0	0.2	0.2	0.2	0.2	0.1	0.2	0.1	0.1	0	0	0	3	3.4	0	0.9	0.5	0	0.8	7.6	0	0	0	5.9	0.6	0	0.7	20.2	0	0.7	280.4	0.2	0	0.6	0.5	0	0	0.4	0	0	1.8	0.3	4.7	0.3	0	0	0	0.3	16	0.2	1.7	0	0.5	1.4	0	0.1	0.5	0.9	0.9	1.4	0	0.6	0.3	Erythroid cells
GEM	KIR	ENSG00000164949	GTP binding protein overexpressed in skeletal muscle	P55040	8	94249253-94262350	Predicted intracellular proteins		Calmodulin-binding		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		gallbladder: 78.5	Cell type enriched	Detected in many	10	Smooth muscle cells: 879.6	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enriched	Detected in single	5	myeloid DC: 4.4	Lineage enriched	Detected in single	5	dendritic cells: 4.4	Cell line enhanced	Detected in many		BJ hTERT+: 27.9;U-266/70: 48.0;U-87 MG: 36.1	Low region specificity	Detected in some			Low region specificity	Detected in many			HPA024798	Approved											HPA024798: AB_10602137	unprognostic (1.24e-1)	unprognostic (2.12e-1)	unprognostic (4.82e-3)	unprognostic (1.22e-1)	unprognostic (4.76e-1)	unprognostic (3.94e-1)	unprognostic (2.17e-1)	unprognostic (4.00e-1)	unprognostic (1.45e-1)	unprognostic (9.04e-2)	unprognostic (7.92e-2)	unprognostic (9.15e-2)	prognostic unfavorable (1.56e-5)	unprognostic (1.65e-2)	unprognostic (3.93e-2)	prognostic unfavorable (4.29e-4)	unprognostic (2.93e-3)	24.5	20.3	5	15.7	8.9	0.8	19.6	1.1	4.8	20.1	39	7.8	9.5	5.6	32.6	15.8	20.2	13.2	78.5	24.3	7.1	3.9	9.5	8.2	11.1	7.4	10	2.9	13.3	5.2	1.5	10.5	2.4	10.7	31.1	12.8	32.1	4.7	6.5	5.2	4.1	15.3	53.7	9.5	6.9	21.1	10.8	7.7	1.2	9.3	5.7	8.9	44	30.7	0	4.4	0	0.1	0.2	0.9	0.3	0.5	2	0.9	0.2	8	10.7	0.1	5.3	27.9	7.3	10.3	0.7	1.4	0	0.3	2	13.8	0.1	0.9	0.4	9.7	3.9	0.5	0	0.2	0	1	0	9	4.6	0	11.7	6.5	8.4	0.3	0.4	0.2	0.9	4.3	0.2	0.3	0	1.3	1.1	6.1	0	1.6	0	2.6	0	7	4.1	0	0	0.9	1.2	0.6	0	0.4	10.1	2.8	6.5	10.9	48	0.2	0	36.1	0	1.8	0	0.1	0	0	0	0	0	0	0	4.4	0	0	0	0	0.2	0.1	0.2	0.9	0.3	5	8.9	1.1	4.8	7.1	3.9	10	2.9	10.7	7.7	6	23.1	0.5	88.6	60.6	20.9	84.4	2.5	1.4	4.5	1.8	17.7	0.3	0	6.2	0.5	4	4.7	0	0.3	1.1	53.6	17.7	13.8	0	2.8	28.6	24	11.1	0.6	0	3.1	4	87.7	1	1.1	40	1.6	3.5	5.3	2.1	20	32.3	879.6	0.4	1.1	43.5	2.9	0.7	2.4	7.6	Smooth muscle cells
SSMEM1	C7orf45, FLJ40316	ENSG00000165120	Serine rich single-pass membrane protein 1	Q8WWF3	7	130207860-130216843	Predicted membrane proteins				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	68	testis: 31.7	Cell type enriched	Detected in some	13	Early spermatids: 346.5	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		hTEC/SVTERT24-B: 1.7;U-87 MG: 3.7	Not detected	Not detected			Not detected	Not detected																				unprognostic (3.08e-1)				unprognostic (1.79e-1)					unprognostic (5.24e-1)	unprognostic (2.24e-1)			0	0	0	0	0.2	0	0	0	0.1	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	31.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.9	0	0.3	0.2	0.5	0.7	0	0.4	0	0	0	0	0	0.2	0	0.2	0	0	0	0	0	0	0	0	0.2	0	0	0.2	1.7	0	0	0	0	0.5	0	0	0	0	0	0.3	0.2	0	0	0	0	0	0	0.1	0	0	0	0.4	0.1	0	0.4	0.8	0.9	0.1	0.2	0.2	0.3	0.2	0.1	3.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	346.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	26.3	3.7	0	0	0	0	0	0	0	2.5	0	0	0	0	9.3	2.7	0	0	0	0	0	Early spermatids
DEUP1	CCDC67, FLJ25393	ENSG00000165325	Deuterosome assembly protein 1	Q05D60	11	93329971-93438487	Predicted intracellular proteins, Predicted membrane proteins	Cilium biogenesis/degradation			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	7	fallopian tube: 6.0;pituitary gland: 13.0;testis: 19.9	Cell type enriched	Detected in some	12	Ciliated cells: 40.2	Not detected	Not detected			Low region specificity	Detected in single			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		AF22: 1.4;Karpas-707: 1.0;NTERA-2: 4.0;SCLC-21H: 1.6;SuSa: 1.2;U-2 OS: 2.0	Low region specificity	Detected in single			Low region specificity	Detected in all																unprognostic (4.68e-1)	unprognostic (3.25e-1)	unprognostic (3.93e-1)	unprognostic (7.24e-3)	unprognostic (2.09e-1)	unprognostic (4.13e-1)	unprognostic (2.29e-1)	unprognostic (1.79e-2)		unprognostic (1.16e-1)	unprognostic (1.84e-1)	unprognostic (1.25e-1)	unprognostic (1.41e-3)	unprognostic (1.33e-1)	unprognostic (6.03e-3)	unprognostic (8.59e-2)	unprognostic (2.25e-1)	0	0.7	0.2	0	0.8	0	0.4	0	0.2	0.1	0.1	0.8	0.8	0	0.2	1.5	0.2	6	0.1	0	0.3	1	1	0	0.6	0	0.3	0	1.6	0.9	0.1	13	0	0.7	1.1	0.1	0.1	1.6	1.8	1.3	0.2	0.1	0.1	1	0	0.1	19.9	0	0	1.2	0	0	0	0	0	0.3	0	0.7	0	0	0	0	0	1.4	0	0	0	0	0	0	0	0.2	0	0.4	0.4	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0.6	0	0	0	0	0	0.2	1	0	0	0	0.2	4	0.1	0	0.2	0.2	0	0	0	1.6	0.1	0	0	0	1.2	0	0.8	0	0	2	0	0	0.9	0	0.3	0	0	0	0	0.6	0	0	0.7	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0.2	0.8	0	0.2	0.3	1	0.3	0	0.7	0	0	0	0	0	0	0	0	0	40.2	3.4	0	0	0	3.3	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	Ciliated cells
LRRC18	MGC34773, UNQ933, UNQ9338, VKGE9338	ENSG00000165383	Leucine rich repeat containing 18	Q8N456	10	48909483-48914232	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		fallopian tube: 9.1;testis: 15.5	Cell type enriched	Detected in some	4	Early spermatids: 174.5	Cancer enhanced	Detected in single		endometrial cancer: 1.0					Cell type enhanced	Detected in some		memory B-cell: 1.4;naive B-cell: 1.2	Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		Daudi: 1.3;HDLM-2: 1.4;HL-60: 2.1;JURKAT: 3.1;NB-4: 3.6	Low region specificity	Detected in many			Low region specificity	Detected in many			HPA039256	Enhanced											HPA039256: AB_10671873	unprognostic (1.31e-2)		unprognostic (3.66e-2)	unprognostic (9.83e-4)	unprognostic (3.10e-1)	unprognostic (4.82e-2)		unprognostic (1.98e-1)	unprognostic (2.00e-1)	unprognostic (8.11e-2)	unprognostic (1.11e-1)	unprognostic (3.16e-2)		unprognostic (8.57e-3)	unprognostic (4.08e-1)		unprognostic (1.13e-1)	0	0	0.3	0.2	0.7	0.2	0.2	0	0	0.6	0.2			0.1	0	0	0.2	9.1	0.1	0.2	0.8	0.9	0	0	3.1	0.1	0		0	0	0	0	0		0.6	0.6		0	0	0	0.8	0.3	0	0.1	0	0	15.5			0		0	0.3	0	1.4	0.5	0.3	0.1	0	0	0	0	0	0.4	0	0	0.2	0.2	0	0.1	0.2	0	0.4	0.1	1.3	0	0.1	0	0.2	0.1	0	0	1.4	0	0.4	0.2	0	0	2.1	0.6	0.4	0.4	0	0.2	0.3	0.7	3.1	0.2	0	0	0	0.1	3.6	0.3	0	0	0.1	0	0	0	0.2	0	0	0	0.1	0	0.1	0	0.2	0.4	0	0.1	0.2	0.1	0.4	0	0.3	0.2	0.2	0.1	0	0.1	0	0	0	0	1.4	0	0	0.2	1.2	0	0	0.3	0	0	0.5	0	0											0	0	0	0	0	0	0	0	26.8	2.3	0	0	0	0	0	174.5	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	41.4	1.7	0	0	0	0	0	0	0	2.1	0	0	0	0	0.2	0.5	0.1	0	0	0	0	Early spermatids
SLC16A9	C10orf36, FLJ43803, MCT9	ENSG00000165449	Solute carrier family 16 member 9	Q7RTY1	10	59650761-59736002	Predicted membrane proteins, Transporters	Symport, Transport			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	5	adrenal gland: 58.0;kidney: 70.9	Cell type enriched	Detected in many	7	Proximal tubular cells: 218.2	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in many		HAP1: 8.7;NTERA-2: 16.4;SH-SY5Y: 7.9;SuSa: 8.8;U-251 MG: 8.3;U-937: 14.8	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA049286	Approved		Approved	Nucleoplasm,Cell Junctions						Nucleoplasm	Cell Junctions	HPA049286: AB_2680699	unprognostic (3.39e-2)	unprognostic (6.91e-2)	unprognostic (1.30e-1)	unprognostic (1.27e-1)	unprognostic (1.60e-3)	unprognostic (1.76e-2)	unprognostic (5.96e-2)	unprognostic (3.50e-3)	unprognostic (5.01e-2)	unprognostic (2.11e-3)	unprognostic (5.99e-2)	unprognostic (4.60e-2)	prognostic favorable (2.56e-6)	unprognostic (7.57e-3)	unprognostic (1.27e-2)	unprognostic (3.72e-1)	unprognostic (1.94e-1)	0.7	58	5.7	2	4.6	0.7	0.9	9.9	4.4	8.2	4.6	9.6	1.6	0.3	12.6	2.2	5.3	8.6	3.3	1.4	10	2.6	70.9	1.1	0.6	0.8	6.7	5.5	13.4	1.3	11.8	6.4	0.2	8.2	3.2	6.4	5.2	1.6	4.2	9.2	0.5	0.8	3	6	14.3	2.4	3.4	6.5	0	11.2	4.4	3.1	0.9	4.8	0	0	0	0	0	0.3	0.3	0	0.2	4.2	5.6	0	0	0	0	0	0.2	0.3	0	0.2	0	0.6	0	0	0.7	8.7	0	0	0	1.4	0.1	0.2	0	0.1	1.8	0	0.4	0.1	0	2.3	0.1	0.3	4.4	6.1	0.1	0.4	3.3	2.3	0	16.4	1.6	7.5	2.7	0.2	5.7	0	0.2	2.8	7.9	0.1	0.3	0	8.8	2.8	3.6	2.6	0.4	0.9	0.1	8.3	0	0	0	0	14.8	1.6	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0.3	5.7	4.6	9.9	4.3	10	2.6	6.7	5.5	8.2	6.5	0	0	0	1.1	0.1	4.7	2.8	0	4	9.1	7	0	0	21.6	0.7	0.1	0	17.7	0	0	0.8	1.2	12.7	0	0	0.1	3.2	19.3	0	10.5	0.4	12.7	0	3.3	1	15.5	11.2	0.2	30.3	11.3	218.2	0.8	0	2.8	0.3	0.1	0.1	0	0	12.8	5.7	Proximal tubular cells
FOLR2		ENSG00000165457	Folate receptor beta	P14207	11	72216601-72221950	Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins	Transport	Receptor		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	5	Hofbauer cells: 838.4	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enhanced	Detected in many		classical monocyte: 27.8;intermediate monocyte: 20.3	Group enriched	Detected in many	4	dendritic cells: 7.8;monocytes: 27.8	Cell line enriched	Detected in some	5	U-698: 20.1	Low region specificity	Detected in all			Low region specificity	Detected in many								Secreted to blood				12000000				unprognostic (2.03e-1)	unprognostic (6.58e-3)	prognostic unfavorable (8.42e-4)	unprognostic (1.47e-1)	unprognostic (2.76e-1)	unprognostic (2.83e-1)	unprognostic (1.39e-1)	unprognostic (3.36e-1)	unprognostic (3.38e-1)	unprognostic (2.51e-1)	unprognostic (8.11e-2)	unprognostic (1.16e-1)	unprognostic (3.91e-3)	unprognostic (6.16e-3)	unprognostic (1.14e-1)	prognostic favorable (8.41e-4)	unprognostic (7.98e-3)	59.4	17.7	5.4	7.4	4.5	2	16.3	1	4.7	8.3	17.3	6.3	2	5	9.1	32.3	10.3	12.3	22.4	28.8	4.3	3	11.9	19.9	15.4	21.3	5	2.9	7.9	4.9	2.6	4.3	57.8	5.4	14.9	13.1	12.2	9.3	4.6	17.4	6.5	11.9	12.4	4.8	21.3	8.6	11.2	2	9.5	7.3	9.7	9.6	20.9	4.7	4.2	7.8	0.4	27.8	0.6	0.1	7.8	0	0	0	0	0.1	0	0.2	0	0	0	0	0	0	4	0.1	0	0	0	0	0	0	0	0	1.4	0.3	0	0	0.1	0.5	0	0	0	0	0	0	0	0.1	0.1	0	0	0	0.6	0	0	0	0.8	0.2	0.2	0.4	0	0.2	0.2	0	0	0	0	0	0.7	0.2	0	0	0.2	0	0.3	0	20.1	0.5	0.9	0	0	27.8	0	0.1	20.3	0	4.2	0	0	7.8	1.2	0	0	0.4	0.6	5.1	0.1	0	7.8	5.4	4.5	1	4.7	4.3	3	5	2.9	5.4	2	0	1.1	3.2	0	7	0	1.9	2.5	0	0	0	0	6.5	0	0	0.8	1.6	0	0	0	4.2	5.3	0.2	2.3	0.8	838.4	0	0	3.1	177.7	1.6	1.4	49.8	0	0	0	0	0	0	0.4	0	0.1	0	0.2	0.6	0.2	4.4	13.4	0.7	0	0.1	Hofbauer cells
PHOX2A	ARIX, CFEOM2, FEOM2, PMX2A	ENSG00000165462	Paired like homeobox 2a	O14813	11	72239077-72245664	Disease related genes, Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	Activator, DNA-binding	Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		adrenal gland: 24.6;brain: 12.1;lymphoid tissue: 9.7	Cell type enriched	Detected in single	9	Spermatogonia: 3.6	Cancer enriched	Detected in some	9	ovarian cancer: 9.3	Region enriched	Detected in single	96	pons and medulla: 12.1	Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	228	SH-SY5Y: 115.5	Region enriched	Detected in single	9	pons and medulla: 0.8	Not detected	Not detected			HPA053810, HPA065621, HPA078004	Enhanced		Supported	Nucleoplasm		No				Nucleoplasm		HPA053810: , HPA065621: AB_2685522, HPA078004: AB_2732367			unprognostic (5.84e-2)		unprognostic (8.51e-2)					unprognostic (5.07e-2)	unprognostic (2.19e-1)		unprognostic (2.13e-1)	unprognostic (9.92e-4)	unprognostic (3.03e-2)			0.4	24.6	0	9.7	0	0	0	0	0.1	0.2	3.3	0.5	0	0.4	0.1	0	1.4	0.1	0.3	0.1	0	0.1	0.1	0	0	0	0	0	0.1	0.3	0	0.8	0	12.1	0.9	0.7	1.7	0.7	3.7	0	0	3.2	0.3	2.1	0.1	1.6	5.2	0	0	0	0	0	2.6	0.6	0	0	0	0.2	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0.1	115.5	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0.2	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0.1	0	0	12.1	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.6	0	0	0	0	0	Spermatogonia
MBL2	COLEC1, MBL	ENSG00000165471	Mannose binding lectin 2	P11226	10	52765380-52771700	Plasma proteins, Predicted secreted proteins	Complement activation lectin pathway, Complement pathway, Immunity, Innate immunity			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	825	liver: 82.5	Cell type enriched	Detected in some	62	Hepatocytes: 190.6	Cancer enriched	Detected in single	275	liver cancer: 22.6	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	10	Hep G2: 7.0	Region enriched	Detected in single	5	pons and medulla: 0.5	Not detected	Not detected			HPA002027, CAB016782	Enhanced				Secreted to blood			1220000000	1700000000			CAB016782: , HPA002027: AB_1079324							unprognostic (1.72e-2)		unprognostic (3.03e-1)									0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	82.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0.1	0	0	0	0.7	0	0	0	0	0	0.1	0	0	0	7	0	0.6	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0.1	0	0.5	0	0.3	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	190.6	0	0	0	3.1	2.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Hepatocytes
SSX5		ENSG00000165583	SSX family member 5	O60225	X	48186220-48196763	Predicted intracellular proteins	Transcription, Transcription regulation			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in some		testis: 4.3;thyroid gland: 2.9	Cell type enriched	Detected in single	14	Spermatogonia: 3.8	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	4	BEWO: 10.8									HPA045683	Uncertain		Approved	Nucleoplasm,Nucleoli						Nucleoplasm, Nucleoli		HPA045683: AB_2679418									unprognostic (1.20e-1)						unprognostic (2.96e-1)	unprognostic (1.23e-1)		0.4	0	0.1	0.1	0.4	1	0.1	0.1	0.1	0.1	1.2	0.1	0.1	0	0.5	0.2	0.1	0.8	0.1	0.8	0.1	0.1	0.1	0.1	0.2	0.3	0.1	0.1	0.3	0.1	1.6	0.7	0.1	0.1	0.1	0	0.1	0.1	0.1	0.2	0.6	0.2	0.1	0.1	0.8	0	4.3	0.1	0.1	2.9	0.1	0.1	0.1	0.1	0.5	0.2	0.9	0.2	0.6	0.4	0	0.1	0	0	0.2	0	0	10.8	0	0	0	0	0	0	0	0.2	0	0.2	0	0.1	0	0	0	0.1	0	0	0	0	0.1	0	0.1	0	0	0	0	0.2	0	0	2.4	0	0	0	0	0	0.1	0	0.5	0	0.1	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0.4	0	0.7	1.3	0.1	0	0	0	0.5	0	0	0.1	0.2	0.2	0.4	0.3	0.4	0.1	0.5	0.1	0.4	0.9	0.6	0	0.2	0.2	0	0.1	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	3.8	0	0	0	0	0	Spermatogonia
SSX3	CT5.3	ENSG00000165584	SSX family member 3	Q99909	X	48346428-48356707	Predicted intracellular proteins	Transcription, Transcription regulation			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	11	testis: 18.0	Cell type enriched	Detected in some	9	Spermatogonia: 144.8	Not detected	Not detected			Not detected	Not detected			Low cell type specificity	Detected in single			Low lineage specificity	Detected in single			Cell line enriched	Detected in some	4	Karpas-707: 6.9									HPA045683	Approved		Approved	Nucleoplasm,Nucleoli						Nucleoplasm, Nucleoli		HPA045683: AB_2679418															unprognostic (1.86e-1)	unprognostic (2.13e-2)		0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18	0	0	0.2	0	0	0	0	0.9	0	1.6	0.2	0.4	0.4	0	0.1	0	0.2	0.4	0	0	0	0	0	0	0	0	0	0.2	0	0	0.9	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0.1	0	6.9	0	0	0.1	0.4	0	0	0	0.4	0.2	0	0	0.4	0	0	0	0.1	0	0.1	0	0	0	0.1	0.1	0.4	0	1.6	0.5	0.2	0.2	0	0	1.6	0.2	0.8	0.3	0.1	0.2	0.8	0.3	0.4	0	0.9	0.4	0.4	0.2	0.4	0.1	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.4	0.6	0	0	0	0	0	0	0	1.1	0	0	0	0	16.7	144.8	0	0	0	0	0	Spermatogonia
DRGX	DRG11, PRRXL1	ENSG00000165606	Dorsal root ganglia homeobox	A6NNA5	10	49364181-49396016	Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	Developmental protein, DNA-binding		Evidence at transcript level	Evidence at transcript level	No human protein/transcript evidence	No human protein/transcript evidence		Group enriched	Detected in some	8	adrenal gland: 13.9;brain: 8.0	Cell type enriched	Detected in single	4	Melanocytes: 1.7	Low cancer specificity	Detected in single			Group enriched	Detected in some	5	cerebral cortex: 3.3;midbrain: 2.0;pons and medulla: 4.8	Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		RH-30: 8.2;SH-SY5Y: 37.4;U-2197: 13.5	Region enriched	Detected in single	6	pons and medulla: 4.1	Low region specificity	Detected in all			HPA043978	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol						Nucleoplasm, Nucleoli	Cytosol	HPA043978: AB_10961154		unprognostic (1.42e-2)	unprognostic (5.68e-2)		unprognostic (3.92e-2)	unprognostic (1.23e-2)	unprognostic (1.74e-3)	unprognostic (1.58e-1)		unprognostic (4.54e-2)	unprognostic (3.74e-2)			unprognostic (8.91e-2)	unprognostic (1.60e-1)	unprognostic (4.09e-2)		0.2	13.9	0	0.4	0.2	0.3	0.1	0.4	3.3	0	0.4	0.8	0	0	0.1	0	0.1	0	0.2	0	0.2	0.3	0	0	0.5	0.1	2	0.6	0	0	0	0.9	0	4.8	0	0.9	0	0	0	0	1.3	0.3	0	8	0	0	0.2	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.3	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	8.2	0	0	0	0	37.4	0	0	0	0	0	0	0	0.4	0	13.5	0	0	0	0	1.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0.4	3.3	0.2	0.3	2	0.6	4.8	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	1.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Melanocytes
OXGR1	aKGR, GPR80, GPR99, P2RY15, P2Y15	ENSG00000165621	Oxoglutarate receptor 1	Q96P68	13	96985719-96994730	G-protein coupled receptors, Predicted membrane proteins		G-protein coupled receptor, Receptor, Transducer		Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in many		kidney: 7.0	Cell type enriched	Detected in some	11	Extravillous trophoblasts: 35.1	Low cancer specificity	Detected in many							Group enriched	Detected in some	5	myeloid DC: 2.9;plasmacytoid DC: 5.2	Lineage enriched	Detected in single	6	dendritic cells: 5.2	Cell line enhanced	Detected in some		RT4: 7.8;SK-BR-3: 3.6;T-47d: 1.7;U-2 OS: 4.1	Low region specificity	Detected in some			Not detected	Not detected			HPA067673			Supported	Plasma membrane						Plasma membrane		HPA067673: AB_2685883	unprognostic (1.83e-1)	unprognostic (1.01e-2)	unprognostic (1.33e-1)	unprognostic (6.97e-4)	unprognostic (7.23e-2)	unprognostic (1.52e-1)		unprognostic (8.38e-2)	unprognostic (2.16e-1)	unprognostic (1.16e-1)	unprognostic (2.22e-2)	unprognostic (4.14e-2)	unprognostic (3.88e-2)	unprognostic (1.89e-1)	unprognostic (2.75e-1)	unprognostic (1.54e-1)	unprognostic (9.68e-2)	2.1	0	0.7	1.7	0.2	0	6.7	0	2	1.6	3			0.1	0.6	4	3.2	2.5	0	0	0.8	0.8	7	0	0.5	0	0.7		0	0.6	0	0.3	1.2		0.5	2.4		4.9	0.3	0.1	4.3	0.5	0.5	1.6	0.3	0.1	0			0.8		0.9	1.8	0.9	0	5.2	0.1	0.5	0	0.8	0.1	0	0	0	0	0	0	0	0	0	0	0	0.1	0.2	0	0	0	0	0.5	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0.1	0	0	0.7	0	0	0	0.3	0	0	0	0.2	0	7.8	0	0.2	0	3.6	0	0.2	1.7	0	0	0	4.1	0	0.2	0.2	0	0	0.2	0	0.3	0	0.5	0.1	0	0.1	0.8	0	0	0	2.9	0	0.1	0	0.1	0	0	5.2	0	0.1											0	0.3	0	0	0	0	0.1	0	1.4	0	0	0	1.1	1.7	0	0.2	0.1	0	0	0	35.1	0.1	0	0	0	1.6	0	1.2	0	0	0	0	0	3.3	0	0.3	0	0	0	0	0	0	0	0.1	0	0	0	3.1	0	0.8	0	Extravillous trophoblasts
SOHLH1	bA100C15.3, bHLHe80, C9orf157, NOHLH, SPATA27, TEB2	ENSG00000165643	Spermatogenesis and oogenesis specific basic helix-loop-helix 1	Q5JUK2	9	135693407-135699528	Disease related genes, Predicted intracellular proteins, Transcription factors	Differentiation, Spermatogenesis, Transcription, Transcription regulation	Developmental protein, DNA-binding	Disease mutation	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	16	brain: 21.1;testis: 21.5	Cell type enriched	Detected in some	10	Spermatogonia: 82.1	Low cancer specificity	Detected in some			Region enhanced	Detected in many		cerebral cortex: 21.1	Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	10	CACO-2: 14.8;U-266/84: 22.8									HPA059439			Approved	Nuclear speckles						Nuclear speckles		HPA059439: AB_2684017	unprognostic (2.93e-1)			unprognostic (1.23e-3)	unprognostic (9.85e-3)	unprognostic (2.84e-2)		unprognostic (3.55e-1)		unprognostic (2.59e-3)				unprognostic (4.98e-3)	unprognostic (2.17e-1)		unprognostic (1.63e-1)	0.2	0.1	4.4	0.2	3.2	0.1	0.2	1.7	21.1	0.2	0.2	0.2	0.2	0.1	0.2	0.6	0.2	0.1	0.2	0.2	9.4	1.4	0.2	0.2	0.2	0.2	2	0.2	0.3	0.2	0.3	1.3	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.7	0.2	0.2	0.4	0.2	0.2	21.5	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	14.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	1.8	0	0	0.3	0	0	0	0.3	0	0	0.4	0	0	0	0	0	0	0	0	0	0.1	22.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4.4	3.2	1.7	21.1	9.4	1.4	2	0.2	0.2	0.2	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	1.7	0	0	0	0.2	0.6	0	0	0	0	0.1	0	0	0	0	5.1	0.6	0	0	0	0	0	0.1	0	0.7	0	0	0	0	8	82.1	0	0	0	0	0	Spermatogonia
CLEC1B	CLEC2	ENSG00000165682	C-type lectin domain family 1 member B	Q9P126	12	9985642-10013424	Predicted intracellular proteins, Predicted membrane proteins	Host-virus interaction	Receptor		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	6	blood: 12.5;liver: 44.1	Cell type enriched	Detected in some	10	Ito cells: 718.7	Not detected	Not detected			Not detected	Not detected			Cell type enhanced	Detected in many		basophil: 7.8	Group enriched	Detected in many	37	dendritic cells: 2.1;granulocytes: 7.8;monocytes: 4.9	Group enriched	Detected in some	6	Karpas-707: 10.1;U-266/84: 23.9	Low region specificity	Detected in single			Not detected	Not detected												1500000				unprognostic (2.03e-1)	unprognostic (2.59e-2)	unprognostic (1.45e-1)		unprognostic (4.63e-3)	unprognostic (1.51e-1)	unprognostic (1.15e-3)	unprognostic (1.26e-2)	unprognostic (7.71e-2)	unprognostic (4.98e-2)	unprognostic (1.58e-1)	unprognostic (8.13e-2)	unprognostic (1.49e-3)	unprognostic (1.46e-2)	unprognostic (1.27e-1)	unprognostic (2.11e-1)	unprognostic (2.91e-2)	0.1	0.3	0	0.4	0.1	4.6	0	0	0	0	0	0	0	0	0	0	0	0.1	0.2	2	0	0	0.1	44.1	2.1	0.2	0	0	0.1	0	0	0.3	0.3	0.2	0	0	0	0	0	0	0.1	0.1	0	0	3.2	0	4.5	0	0	0.2	0	0	0.1	0	0	2.1	7.8	4.9	0.1	0.1	12.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	1.8	0	0	0	1	0	0	0	0	0	0	0	0	0	10.1	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0.2	0	0	0	0	0	0	23.9	0	0	2.9	0	7.8	4.9	6.7	0	4	0	0	0	0	2.1	0	0.1	0	3.3	0.1	3.7	1.2	0	12.5	0	0.1	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0.4	10.2	0	0	0	0	0	0	0	4.9	0.1	0	0	0	0	0.2	0	0	3.9	0.1	0	0	718.7	73.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	Ito cells
TMEM52B	C12orf59, FLJ31166	ENSG00000165685	Transmembrane protein 52B	Q4KMG9	12	10170542-10191801	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at transcript level		Tissue enriched	Detected in some	23	kidney: 85.1	Cell type enriched	Detected in some	16	Distal tubular cells: 603.5	Cancer enriched	Detected in some	5	renal cancer: 6.9	Not detected	Not detected			Cell type enhanced	Detected in some		myeloid DC: 3.7	Low lineage specificity	Detected in many			Cell line enriched	Detected in some	8	CACO-2: 46.3	Not detected	Not detected			Low region specificity	Detected in many			HPA058096	Enhanced		Approved	Focal adhesion sites						Focal adhesion sites		HPA058096: AB_2683603	unprognostic (1.10e-2)	unprognostic (7.61e-2)	unprognostic (1.37e-3)	unprognostic (1.22e-1)	unprognostic (1.67e-1)	unprognostic (5.33e-3)	unprognostic (1.37e-1)	unprognostic (8.65e-2)	unprognostic (7.14e-4)	unprognostic (2.23e-1)	unprognostic (6.36e-2)	unprognostic (7.33e-2)	unprognostic (3.24e-2)	unprognostic (5.80e-2)	unprognostic (5.51e-2)	unprognostic (1.66e-1)	unprognostic (3.18e-1)	0.1	0	0.1	0.1	0.6	0.9	0.1	0.1	0.6	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0	0.1	0.1	0.2	0.1	85.1	0.1	0.2	0.1	0.3	0.1	0.1	0.1	0	0.1	2	0.1	0.1	0	0.1	0.5	0.1	0.1	0	0.1	0.1	0.5	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.9	3.7	1.4	1.3	0.6	0.5	0.4	1.1	0	0	0	0	0	0.5	1	0	0	0	46.3	0	0	0	0.3	2.4	0.4	0	0	0.1	0	0	0	0.2	0	6	0.2	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.9	0	0	3.4	4.4	0	1.6	2.5	0.7	0	0.1	0.2	0	0	0	0	0	0.1	2.3	0	1.4	1.3	1	0.4	0.2	0.4	0.4	0.4	0.5	3.7	0.9	0.5	0.5	1	0.6	0.2	0.6	0.4	0.4	0.1	0.6	0.1	0.2	0.2	0.1	0.3	0.1	0.1	0.1	0	0.3	0	0	0.1	0	0.2	0	0	0	12.2	0	38.1	603.5	0	0.4	0	0	0	0	1.6	0.2	0	0	0	10.6	0	0	0	0.6	0	0.3	4.2	1.7	2.8	0	0	0	0	0	3.7	0	0	0	0.1	0.2	0	16.2	0	0	0	Distal tubular cells
FRMD7	FLJ43346, NYS, NYS1	ENSG00000165694	FERM domain containing 7	Q6ZUT3	X	132076993-132128020	Cancer-related genes, Disease related genes, Predicted intracellular proteins	Neurogenesis		Cancer-related genes, Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Group enriched	Detected in some	6	endometrium 1: 7.4;kidney: 6.6;smooth muscle: 5.5	Cell type enriched	Detected in single	30	Distal tubular cells: 8.3	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		AF22: 1.1;HSkMC: 1.6;SuSa: 3.6;U-87 MG: 5.5	Region enriched	Detected in single	29	olfactory region: 80.8	Region enriched	Detected in single	103	olfactory region: 45.5	HPA000886	Uncertain		Supported	Nucleoplasm,Plasma membrane,Cytosol						Plasma membrane, Cytosol	Nucleoplasm	HPA000886: AB_1079269	unprognostic (3.08e-2)	unprognostic (1.27e-1)			unprognostic (1.36e-1)	unprognostic (3.07e-1)	unprognostic (4.02e-2)	unprognostic (1.64e-2)	unprognostic (2.28e-1)	unprognostic (2.18e-2)	unprognostic (3.84e-1)	unprognostic (3.54e-2)			unprognostic (3.00e-1)			0.2	0	0	0	0.2	0	0.1	0	0	0.3	0			0	7.4	1.1	0	1.1	0	0.1	0	0.1	6.6	1	0	0	0		0	0	0	0	0		0.5	0		0	1.1	0	0.5	0	5.5	0	0	0	0			0		0	0	0.1	0.2	0	0	0.3	0	0.3	0	0	0	1.1	0	0.1	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	1.6	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0.1	0	0	0	0.3	0	0	0	3.6	0.1	0.1	0	0.1	0	0	0	0	0	0	5.5	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0.3	0	0	0	0.3	0	0	0											0	0	0	0	0	0	0.3	0	0	0	0	0	0.1	8.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Distal tubular cells
SPACA9	C9orf9, Mast	ENSG00000165698	Sperm acrosome associated 9	Q96E40	9	132878027-132890201	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in all	5	epididymis: 55.8;fallopian tube: 29.1;testis: 53.8	Cell type enriched	Detected in some	4	Ciliated cells: 116.4	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Cell line enriched	Detected in many	4	JURKAT: 32.5	Low region specificity	Detected in many			Low region specificity	Detected in many			HPA022243, HPA051600	Enhanced		Approved	Mitochondria		No	No			Mitochondria		HPA022243: AB_1845844, HPA051600: AB_2681546	unprognostic (2.69e-1)	unprognostic (2.14e-3)	unprognostic (8.00e-3)	prognostic favorable (8.61e-4)	unprognostic (1.59e-1)	unprognostic (5.73e-2)	unprognostic (3.76e-3)	unprognostic (2.60e-1)	unprognostic (6.43e-2)	unprognostic (1.12e-1)	unprognostic (1.15e-2)	unprognostic (9.51e-2)	prognostic favorable (8.31e-4)	unprognostic (5.11e-2)	unprognostic (1.22e-2)	unprognostic (1.20e-1)	unprognostic (1.22e-2)	2.7	6	7.8	1.6	8.4	1.7	3.9	4.3	9.3	5.1	4.8	8.5	7.9	1.7	5.3	55.8	5.3	29.1	4.5	7	7	8.9	7	1.8	4.6	2.1	7.2	7.3	9.2	2.8	2.7	5.8	3	6.9	4.1	2.1	5.7	7.7	6.2	1.5	8	1.7	4.3	7.7	2.3	3.1	53.8	5.1	6.2	10.2	3.6	3	2.9	3.8	6	3	5.6	3.3	7.8	3.5	1.6	1.9	2.1	3.2	2.7	4.6	5.9	3.9	1.2	2.3	1.7	1.9	0.5	6.1	0.5	2.9	5.7	3.7	2.8	1.3	3.6	1.6	2.3	2.6	0.5	1.5	0.7	6.7	1.4	0.2	6.7	7.7	4.3	4.8	7.3	2	32.5	0.5	1.7	4.7	4.2	4.9	5.6	0.7	3.7	2	2.3	0.7	1.4	7.1	0.7	0.9	3.2	5.3	0.9	4.2	2.5	7	0.5	1.9	3.8	2.6	3.6	0.5	0.7	1.1	1.7	7	0.5	1.8	5.6	2.2	3.6	2.2	2	2.5	6	2.4	1.3	3	4.7	2.9	2.6	3.1	7.8	3.3	1	3.5	1.6	7.8	8.4	4.3	9.3	7	8.9	7.2	7.3	6.9	5.1	3	1.3	0	0	0	0	0	0	116.4	9.1	22.7	0	14.2	28.2	6.2	0	0	0	0	6.2	10.9	0	0	0	0	5.8	0	0	0	0	0	0	0	0	1.8	0	0	5.4	0	0	16.2	0	0	0	0	0	0	6.1	0	0	0	Ciliated cells
GFI1B	ZNF163B	ENSG00000165702	Growth factor independent 1B transcriptional repressor	Q5VTD9	9	132944000-132991687	Disease related genes, Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	Activator, Chromatin regulator, Developmental protein, DNA-binding, Repressor	Proto-oncogene	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	8	blood: 71.0;bone marrow: 29.2	Cell type enriched	Detected in some	5	Erythroid cells: 70.0	Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	19	basophil: 31.2;eosinophil: 71.0	Lineage enriched	Detected in many	26	granulocytes: 71.0	Group enriched	Detected in some	5	HEL: 55.6;HMC-1: 36.0;K-562: 17.1	Not detected	Not detected			Low region specificity	Detected in all			CAB004420, HPA006291	Enhanced		Approved	Nucleoplasm,Plasma membrane						Nucleoplasm, Plasma membrane		CAB004420: AB_2110132, HPA006291: 	unprognostic (1.79e-2)	unprognostic (2.90e-4)	unprognostic (6.54e-2)	unprognostic (1.76e-1)	unprognostic (2.33e-1)	unprognostic (1.54e-2)		unprognostic (2.53e-3)	unprognostic (1.05e-1)	unprognostic (2.47e-1)	unprognostic (1.54e-1)	unprognostic (4.61e-2)	unprognostic (3.71e-2)	unprognostic (2.17e-1)	unprognostic (2.53e-1)	unprognostic (1.53e-2)	unprognostic (1.41e-1)	0.2	0	0.2	2.2	0.2	29.2	0.1	0.1	0.2	0.9	4.2	0.2	0	0.8	0.4	0.7	0.8	0.2	3.5	0.8	0.2	0.1	0.3	0.4	2.5	0	0.1	0	0.1	0.2	0	0.1	1.2	0	4.2	0.3	0.2	0.1	0.1	0.3	0.8	6.3	1	0.2	3.3	0.3	4	0	1	0.2	0	0.5	0.4	0.2	0	0.3	71	2.7	0.1	0.1	2.4	0.2	0	0	0	0	0.2	0.1	0	0	0	0	0.6	0.1	7.8	0	0	0	0.6	0	0.2	0	0	0	55.6	0.1	0	0	0	36	0	0.6	0	0.1	0	0	0	17.1	0	0	0	0	5.8	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0.1	0	0	0.1	0	0.5	0	0	0	31.2	0	71	0	0.3	0	0	0	0	0.3	0	0.1	0	0.8	0.1	2.7	0.1	0	2.4	0.2	0.2	0.1	0.2	0.2	0.1	0.1	0	0	0	0	1.1	0	0.2	0	0	0.8	0	0	3.4	0	0	0	0	0	2.6	0	0	70	0	0.1	0	0.5	13.9	0	0.1	0	1.2	0	0.8	9.3	0	0	0	0	0	0	0	14.4	0	0	0	0	0	0.3	0.5	0	0.2	0	0.3	0.1	Erythroid cells
STOX1	C10orf24, FLJ25162	ENSG00000165730	Storkhead box 1	Q6ZVD7	10	68827541-68895432	Disease related genes, Predicted intracellular proteins	Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation	Activator, DNA-binding	Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 17.8;fallopian tube: 19.1	Cell type enriched	Detected in many	4	Ciliated cells: 48.2	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Cell type enhanced	Detected in some		naive CD4 T-cell: 3.0;plasmacytoid DC: 3.5	Group enriched	Detected in many	4	dendritic cells: 3.5;T-cells: 3.0	Cell line enhanced	Detected in many		AN3-CA: 10.9;HAP1: 10.1	Low region specificity	Detected in many			Low region specificity	Detected in many			HPA037844, HPA037845	Uncertain		Supported	Nucleoplasm,Nucleoli fibrillar center,Cytosol	Intracellular and membrane	No				Nucleoplasm	Nucleoli fibrillar center, Cytosol	HPA037844: AB_2675700, HPA037845: AB_10671369	prognostic favorable (3.37e-5)	unprognostic (5.53e-3)	unprognostic (6.62e-2)	unprognostic (1.06e-1)	unprognostic (4.63e-3)	unprognostic (1.95e-2)	unprognostic (2.24e-3)	prognostic favorable (2.08e-4)	unprognostic (1.52e-1)	unprognostic (2.45e-3)	unprognostic (5.33e-3)	unprognostic (5.29e-2)	unprognostic (3.87e-2)	unprognostic (8.77e-2)	unprognostic (3.06e-2)	unprognostic (2.33e-1)	unprognostic (3.46e-2)	8.7	6.4	17.8	1.7	13.4	0.6	4.8	1.8	13.4	2	2.6	6.8	1.3	2	2.8	11.9	2.5	19.1	1.7	0.9	16.1	9.3	4.5	0.9	2.2	1.8	11.5	10.2	1.9	1.6	6.1	8.8	1.5	5.6	2.3	2.8	5	2.6	2.1	1.9	1.4	2.8	2.5	2.4	0.9	2.2	3.8	7.3	3.3	8.7	0	1.7	1.6	0.9	0.7	3.5	0	0	0.2	3	0.2	2.2	2.4	5.4	10.9	2.3	0	3.2	0.2	0.1	1.6	1.7	2.3	3.3	2.1	3.1	0	4.2	0.6	10.1	0	0.8	2.5	4.2	0.2	0.5	3.1	0.3	2.7	3.9	0.2	0.2	0.3	0	0.3	0.1	5.6	0.5	0.3	0.2	2.2	4.6	3.4	1.8	0.5	1.5	3.4	0.1	0	3.2	5.8	1.7	5	3.9	1	0.7	3.6	2.4	2.2	0	0	0.3	0	1.5	1	1.9	2.2	0	0.6	0.1	0	0	0	0.3	0	0.7	0.4	0.8	0.6	0	0.7	3	1.4	0	0.2	0	3.5	0.3	0.2	17.8	13.4	1.8	12.5	16.1	9.3	11.5	10.2	5.6	7.3	0	0.3	0.5	3.2	1.3	0.9	0.3	0	48.2	9.1	1.8	0	1.1	3.3	0	0.2	0.1	0.4	0	0.3	0.2	0.6	1.8	2.3	0	0.1	0	0	0	0.3	0	1.1	0	0	0	1.6	1.5	0.2	0	0	1.2	0.3	6.5	5.7	1.6	11.1	0.4	1	0	5.6	1.7	Ciliated cells
RET	CDHF12, CDHR16, HSCR1, MEN2A, MEN2B, MTC1, PTC, RET51	ENSG00000165731	Ret proto-oncogene	P07949	10	43077027-43130351	Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins	Cell adhesion	Kinase, Transferase, Tyrosine-protein kinase	Cancer-related genes, Disease mutation, FDA approved drug targets, Hirschsprung disease, Proto-oncogene	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		parathyroid gland: 63.9	Cell type enriched	Detected in some	44	Horizontal cells: 74.7	Cancer enhanced	Detected in many		breast cancer: 11.0	Low region specificity	Detected in many			Cell type enhanced	Detected in some		non-classical monocyte: 6.7	Group enriched	Detected in many	13	dendritic cells: 2.1;monocytes: 6.7	Cell line enhanced	Detected in some		MCF7: 18.0;NB-4: 11.8;SH-SY5Y: 91.8;THP-1: 27.4	Low region specificity	Detected in many			Region enriched	Detected in all	6	midbrain: 95.5	CAB002581, HPA008356, HPA008495	Approved	Supported	Approved	Golgi apparatus,Plasma membrane,Cytosol		No			260000	Golgi apparatus, Cytosol	Plasma membrane	CAB002581: AB_563673, HPA008356: AB_1847232, HPA008495: 	unprognostic (7.94e-2)	unprognostic (3.68e-2)	unprognostic (4.49e-1)	prognostic unfavorable (5.02e-4)	unprognostic (1.15e-1)	unprognostic (9.13e-4)	unprognostic (1.27e-2)	unprognostic (3.62e-2)	unprognostic (2.86e-1)	unprognostic (2.01e-1)	unprognostic (1.54e-3)	unprognostic (4.43e-1)	unprognostic (9.35e-5)	unprognostic (1.64e-3)	unprognostic (8.28e-2)	unprognostic (3.67e-3)	unprognostic (2.02e-2)	1.8	15.2	1.1	1.8	1.3	0.7	1.2	4.1	9	1.9	3.1	0.9	1.1	1.5	0.9	0.6	1.2	0.7	1	1.2	1.5	5.8	1	11.7	0.7	0.8	17.5	1.2	0.8	1.3	63.9	6.3	0.8	16.8	2.2	1.5	2.8	13.6	2	4.5	1.1	2.6	1.1	2.8	0.6	2.1	2	0	0.1	0.8	5.1	0.6	1.9	1.4	0.2	2.1	0	6.7	0	0.3	0.4	0	0.1	0	0.5	0	0	0	0.2	0	0.1	0	0	0	0	0	0	0.2	0	1.3	0	0	0	0	0	0	0	0	2.4	0	0	0.1	0	0	0	0	0	0	0	0	18	0	11.8	2.1	0	0	0	0	0	0	0	1.3	91.8	0	0	0	0.1	1.3	27.4	0	0	0.1	0	0	0	0	0	0	0	0	0	0.1	0	0	1.8	0	0.2	0	0	0.9	0	0	0	0	0	6.7	2.1	0.3	0.4	1.1	1.3	4.1	9	1.5	5.8	17.5	1.2	16.8	0	0	0.3	0	0.5	0.2	0.1	1.6	0	1.4	0	0	0	0	0	0	1.3	0.1	0	0	0.2	1.7	1	1.2	1.1	0.8	0.1	74.7	0	0	0	1.4	0.3	0	0	0	0.8	0.3	0	0	0	0	0.4	0	1.4	0.4	1.1	0.5	0	0	0	0.1	Horizontal cells
STK32C	MGC23665, PKE, YANK3	ENSG00000165752	Serine/threonine kinase 32C	Q86UX6	10	132207492-132331847	Enzymes, Predicted intracellular proteins		Kinase, Serine/threonine-protein kinase, Transferase		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	4	Early spermatids: 222.3	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low cell line specificity	Detected in all			Low region specificity	Detected in many			Low region specificity	Detected in all			HPA017894	Uncertain											HPA017894: AB_1857591	unprognostic (2.11e-1)	unprognostic (8.40e-2)	unprognostic (4.80e-3)	prognostic unfavorable (1.09e-4)	unprognostic (1.65e-2)	unprognostic (5.52e-2)	prognostic unfavorable (1.68e-6)	unprognostic (2.03e-1)	unprognostic (7.79e-2)	unprognostic (2.14e-1)	unprognostic (1.18e-2)	unprognostic (1.13e-1)	prognostic unfavorable (5.31e-6)	unprognostic (8.65e-2)	unprognostic (3.20e-1)	unprognostic (5.05e-2)	unprognostic (1.36e-1)	6.8	8.2	23.5	6.4	23.5	6.1	7.1	8.3	31.6	4.1	4.9	6.3	6	5	4.6	15.5	3.4	9.4	7.8	7	17.9	12.8	6.3	4.2	7.3	8.5	9.2	16.1	5.8	7	6.2	6.7	4.8	7.7	4.6	4.7	3.2	5.6	5.5	11.3	7.1	4.7	4.9	7.7	10.7	4.8	26.1	8.1	8.7	4.9	3	6.1	4.6	3.6	5.5	14.5	25	11.2	3.2	4.9	3.6	32.1	21.1	6.5	16.3	9.1	11.6	1.3	6.8	5.3	8.6	11.1	4.7	22.5	7.1	5.1	7.8	10.9	7.4	9.4	2.7	8.4	4.2	15.1	4.1	21.6	22.3	11.5	3.7	15.5	8.7	10.3	7.8	8.9	11	7.5	12.1	7.2	5	9.2	9.7	4.7	14.2	4.2	5.9	15.4	5.7	4.1	2.2	11.2	5.6	17	13.3	4.8	4.5	9.5	4	5.2	9	5	7.1	7.1	8.9	5.3	9.3	1.7	17.7	15.5	3.6	3.4	25	10.7	9.2	3.5	11.2	4.5	3.6	2.9	4	14.5	5.5	3.6	2.9	1.4	3.2	9.5	8.3	4.9	3.6	23.5	23.5	8.3	31.6	17.9	12.8	9.2	16.1	7.7	8.1	0	11.1	5.2	5.5	4.6	8.8	2.9	2.5	14.7	5.7	12.2	11.8	2.8	16.6	5	222.3	8.3	2.6	0	7.5	2	7.3	7.5	15.1	4.9	13.1	35	18.4	11.1	20.5	53	8.3	18.4	11.8	6.4	5.5	7.3	6	4	6.3	9.7	14.6	6.5	5.3	31.4	17.2	4.4	1.3	9.2	7.9	6.2	Early spermatids
SLC39A2	ZIP2	ENSG00000165794	Solute carrier family 39 member 2	Q9NP94	14	20999255-21001871	Predicted membrane proteins	Ion transport, Transport, Zinc transport			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in many		ductus deferens: 44.3;seminal vesicle: 50.6;skin 1: 23.8	Cell type enriched	Detected in some	4	Muller glia cells: 21.3	Low cancer specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	67	HaCaT: 23.1	Low region specificity	Detected in single			Low region specificity	Detected in many			HPA030489, HPA073231	Uncertain		Approved	Plasma membrane,Cytoplasmic bodies						Plasma membrane	Cytoplasmic bodies	HPA030489: AB_10601488, HPA073231: 	unprognostic (2.76e-2)	unprognostic (4.86e-2)	unprognostic (9.72e-2)	unprognostic (2.37e-1)	unprognostic (2.46e-1)	unprognostic (2.71e-1)	unprognostic (3.42e-1)	unprognostic (1.70e-1)	unprognostic (4.43e-1)	unprognostic (6.20e-3)	unprognostic (3.31e-1)	unprognostic (2.80e-1)	unprognostic (3.62e-2)	unprognostic (1.91e-1)	unprognostic (5.80e-2)	unprognostic (3.71e-1)	unprognostic (2.30e-3)	0.1	0.1	0.1	0	0.1	0	1.3	0.3	0.4	5.6	1.2	0	44.3	0	0.8	0	13	0.3	0.1	0.2	0.4	0	0.1	0.1	0.1	0	0.2	0.1	0.1	0	0.4	0.2	1	0.2	8.5	0.8	0.4	2.7	50.6	0.1	23.8	0.1	0.2	0.1	0.1	0	0.1	0	1.3	0.1	6.1	3.3	1.2	9.4	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.2	0	0.1	0	0	0	0	0.2	0	0	0	23.1	0.1	0	0	0.1	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0.2	0	0	0	0.1	0	0.3	0.2	0	0.2	0	0	0.2	0	0.1	0	0	0	0	0	0.3	0.3	0	0	0	0.1	0	0	0	0.1	0.1	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.3	0.4	0.4	0	0.2	0.1	0.2	0	0	0	0	1.5	0.7	0	0.4	0	0	0	0	2	0	0	0	0.1	0	0	0	0	0	0.4	3.5	0	0	0.1	0	0	0	0	0	0	0	0	0	0	21.3	0.1	0	0	0	0.7	0	0	0	0	5.3	0.2	0	0.8	4.2	Muller glia cells
BTNL9	BTN8, FLJ32535	ENSG00000165810	Butyrophilin like 9	Q6UXG8	5	181040225-181061523	Predicted membrane proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		adipose tissue: 128.2;breast: 76.8	Cell type enriched	Detected in many	5	Ito cells: 138.7	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Cell type enhanced	Detected in some		memory B-cell: 3.8	Group enriched	Detected in many	6	B-cells: 3.8;granulocytes: 1.3	Group enriched	Detected in some	4	OE19: 7.5;U-698: 28.3	Not detected	Not detected							HPA043429			Approved	Nuclear membrane,Vesicles						Nuclear membrane	Vesicles	HPA043429: AB_10961264	unprognostic (2.69e-1)	unprognostic (1.44e-2)	unprognostic (5.76e-2)	prognostic unfavorable (7.51e-4)	unprognostic (2.07e-1)	unprognostic (1.43e-1)	prognostic favorable (1.55e-9)	unprognostic (2.15e-2)	unprognostic (8.51e-2)	unprognostic (1.78e-1)	unprognostic (1.93e-3)	unprognostic (1.38e-1)	unprognostic (1.03e-1)	unprognostic (2.71e-2)	unprognostic (3.43e-1)	unprognostic (2.50e-1)	unprognostic (4.56e-2)	128.2	2.5	1.5	5.3	1.7	0.3	76.8	1	1.8	3.2	11.3	0.8	3.5	0.7	3.9	3.7	2.9	6	3.7	11	3.4	1.3	3.4	3	25.4	2.7	2.5	1.2	1	2	3	1.6	4.3	1.5	3.4	1.5	3.8	3	3.5	34.4	2	1.9	3.2	2.1	12.7	2	3	0.9	1.1	6.1	4	5.5	3.1	18.3	3.8	0.4	1.3	0.3	0.3	0.2	0.1	0	0.1	0.1	0.1	0	0	1.4	0	0	0	0	2.6	0.1	0.2	1.1	0	0	0.2	0.5	0	0	0.2	2.9	1.1	0.2	0.1	0	0.5	3.3	0	0.1	0	0	0	0	2.8	0.7	0.3	0	0.1	0.1	0.1	0.1	7.5	1.8	0	0.2	0.1	0	0.5	0.1	0	0.1	0	0	0.2	0.4	0	0	0.1	4.4	0.1	0	0.2	0.1	28.3	0.1	0	0	1	0.3	0.5	0.2	0.1	0.1	3.8	0.2	0.2	0.1	1.9	0.2	0.2	1.3	0.3	0.1	0.4	0	0.1	1.5	1.7	1	1.8	3.4	1.3	2.5	1.2	1.5	0.9	0	6.7	3	0.6	2.1	0.4	27.4	0	4	1.2	0	0	0	3.3	0	0.3	29.2	0	0	0.2	0.1	0.2	0.3	1.1	0.4	0.1	0	4.1	138.7	12.7	1.1	2	1	3.3	0	4	0.2	0.1	0	0.4	0	0.3	12.9	2.1	4.3	11.1	1.9	0.1	0.5	1.1	0.6	Ito cells
METTL3	M6A, MT-A70, Spo8	ENSG00000165819	Methyltransferase like 3	Q86U44	14	21498133-21511375	Enzymes, Plasma proteins, Predicted intracellular proteins	Biological rhythms, Differentiation, DNA damage, Immunity, Innate immunity, Spermatogenesis	Methyltransferase, RNA-binding, Transferase		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in all	4	Early spermatids: 132.7	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low cell line specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all																unprognostic (1.62e-1)	unprognostic (1.65e-1)	unprognostic (5.75e-2)	unprognostic (1.70e-1)	unprognostic (1.22e-1)	unprognostic (1.01e-1)	prognostic unfavorable (2.19e-5)	unprognostic (1.02e-3)	unprognostic (1.85e-1)	prognostic favorable (2.78e-4)	prognostic favorable (2.72e-4)	unprognostic (4.52e-2)	unprognostic (4.64e-3)	unprognostic (2.98e-2)	unprognostic (7.14e-2)	unprognostic (5.36e-2)	unprognostic (1.22e-1)	13.1	21	15.7	18.3	20.4	6.8	17.4	27.1	16.4	13.5	12.8	16.3	20.4	7.7	17.1	19.8	14.3	20.9	11.2	17.3	16.3	8.6	14.6	14	14.2	18.4	21.7	15.2	18.2	14.2	25.8	21.3	16	16.3	19.3	13.9	12.2	17	19.3	18.8	17	11.9	17.6	13.8	17.5	12.9	21.6	20.6	15.4	19.2	13.3	21.8	15.1	14.8	13	12.6	7.7	10.3	15.3	14.3	8.1	16.6	24.9	23.7	9.5	18.4	15.2	11.9	15.3	11.3	18.4	21.6	9.4	19.7	17.4	9.9	9.5	24.1	17.7	29	15.1	29.2	16.4	17.1	10.8	13.8	37.2	7.5	14.5	12.3	11.4	13.3	11.4	13.4	8.1	24	9	13.2	10	24.3	12.2	12.9	11.6	20.2	28.2	30.8	12.9	18.8	15.4	16.8	11.2	14.7	15.9	16.7	22	15.6	19.7	17.4	9.6	15.6	6.5	11	12	10.4	10.6	13.2	12.1	8	11.7	13.8	5.1	8.1	7.7	8.7	10.3	12.7	13	10.5	9.6	10.5	10.3	11	9.7	0.9	15.3	8.4	12.6	14.3	8.1	15.7	20.4	27.1	16.4	16.3	8.6	21.7	15.2	16.3	20.6	11.9	15.3	14.3	20.7	13.3	23.6	30.5	12.7	16	12.5	12.2	13.7	26.1	3.3	12.6	132.7	11.7	4.2	23.3	8.6	12.2	16.4	16.1	8.1	9.5	14.4	20.6	10.4	10.4	7.1	15.9	15.8	12.9	15.1	19.8	7.6	16.2	9	3.5	18.7	7.2	18.7	32.3	14.2	32.6	17.9	10.8	21.2	13.8	11.1	17.6	Early spermatids
CYP2C19	CPCJ, CYP2C, P450IIC19	ENSG00000165841	Cytochrome P450 family 2 subfamily C member 19	P33261	10	94762681-94853205	Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins	Fatty acid metabolism, Lipid metabolism	Monooxygenase, Oxidoreductase	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	16	intestine: 47.7;liver: 76.4	Cell type enriched	Detected in single	31	Hepatocytes: 10.5	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		CACO-2: 1.8;RPMI-8226: 1.6									HPA015066	Supported				Intracellular and membrane							HPA015066: AB_1847433			unprognostic (3.15e-2)			unprognostic (2.13e-1)	unprognostic (2.48e-1)				unprognostic (1.83e-2)			unprognostic (1.53e-1)				0	0	0	0	0	0	0	0.1	0.1	0.2	30	0	0	14.7	0	0	1	0	3.7	0	0	0	0	76.4	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0.2	0	0	0.1	47.7	0	0	0	0.5	0.1	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0.5	1.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0.1	0	0	0	1.6	0	0	0.1	0	0	0	0	0.4	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	10.5	0	0	0	0	0.3	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	Hepatocytes
ANKRD2	ARPP	ENSG00000165887	Ankyrin repeat domain 2	Q9GZV1	10	97572499-97583884	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	10	skeletal muscle: 472.2	Cell type enriched	Detected in some	6	Cardiomyocytes: 151.7	Cancer enhanced	Detected in many		testis cancer: 5.3	Not detected	Not detected			Cell type enriched	Detected in single	18	neutrophil: 1.7	Lineage enriched	Detected in single	18	granulocytes: 1.7	Cell line enhanced	Detected in some		A-431: 14.8;A549: 5.1;BJ hTERT+ SV40 Large T+: 5.5;HaCaT: 11.7;RPTEC TERT1: 13.1	Low region specificity	Detected in some			Low region specificity	Detected in all			HPA040842, HPA040884	Enhanced		Enhanced	Vesicles						Vesicles		HPA040842: AB_10963794, HPA040884: AB_10969453	unprognostic (1.27e-2)	unprognostic (9.99e-2)	unprognostic (2.86e-1)	unprognostic (1.39e-2)	unprognostic (1.37e-1)	unprognostic (1.61e-2)	unprognostic (2.53e-1)	unprognostic (5.60e-3)	unprognostic (2.17e-1)	unprognostic (3.12e-1)	unprognostic (4.91e-2)	unprognostic (2.22e-1)	unprognostic (1.05e-2)	unprognostic (3.69e-3)	unprognostic (4.56e-2)	unprognostic (1.39e-1)	unprognostic (2.13e-1)	2.3	0.2	0.1	0	0.2	0	0.1	0	0.3	0.1	0	0	0.1	0	0	1.2	2.7	0	0.1	47.2	0	0.1	1.6	0	0.1	0	0	0	0	0.3	0	0	0	0	0.8	0	0	1.1	0.3	472.2	0.4	0	0.1	0	0	0	0.1	0	0	3	1.2	1.1	0.3	0	0	0	1.7	0	0	0	0	14.8	5.1	0	0	0.2	0	0.4	0.7	0	5.5	3.6	0.2	4.6	0	0.6	0.1	0.3	11.7	0	4	3.7	0.1	0.2	0	0.2	0	0.4	0	0	0.6	1.7	3.3	0.2	0.1	0	0	0	0	0.2	0.4	0	0	0	0.3	0	0	0.3	0	13.1	0.7	0	0	0	3.8	0	0.3	1.8	0.3	0	0.1	1.3	0	0.1	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.7	0	0	0	0	0	0.1	0.2	0	0.3	0	0.1	0	0	0	0	0	0	0	0.5	0.1	0	151.7	0	0	0	3.5	0	0.2	26.6	1.2	0.4	0	0	0	0.2	0.3	0.4	0	0	0	0.1	0	0	0.6	0	0	0	0	0	2.8	0	0	0.6	0	1.8	2.2	0	0	0	2.2	3.2	0.3	0.2	0	0	0.1	Cardiomyocytes
RAPSN	CMS1D, CMS1E, RNF205	ENSG00000165917	Receptor associated protein of the synapse	Q13702	11	47437757-47449178	Disease related genes, Predicted intracellular proteins			Congenital myasthenic syndrome, Disease mutation	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Group enriched	Detected in some	11	skeletal muscle: 45.3;tongue: 14.8	Cell type enriched	Detected in some	4	Late spermatids: 10.0	Low cancer specificity	Detected in some			Not detected	Not detected			Cell type enhanced	Detected in single		neutrophil: 2.6	Low lineage specificity	Detected in single			Cell line enriched	Detected in some	4	RH-30: 72.9	Low region specificity	Detected in single							HPA039475	Approved		Approved	Plasma membrane,Centrosome,Cytosol						Plasma membrane, Centrosome, Cytosol		HPA039475: AB_10794196	unprognostic (5.37e-2)	unprognostic (1.02e-1)	unprognostic (7.34e-2)	unprognostic (4.58e-2)	unprognostic (2.95e-2)	unprognostic (1.44e-1)	unprognostic (2.62e-2)	unprognostic (1.77e-3)	unprognostic (1.35e-1)	unprognostic (5.38e-2)	unprognostic (4.81e-2)	unprognostic (2.89e-2)	unprognostic (1.08e-2)	unprognostic (1.64e-4)	unprognostic (3.83e-1)	unprognostic (4.73e-3)	unprognostic (4.48e-2)	1.7	0.8	0.2	0.1	0.2	0.2	0.1	0	0.2	0	0.4	0	0	0.1	0	2.7	0.7	0.1	0.1	1.4	0.4	0	0.1	0.2	0.2	0.1	0.7	0	0	0.1	0	0	1.2	0.3	0.4	0	0.3	0.8	0	45.3	0.2	0.2	0.1	0.2	0.3	0.1	0.2	0.1	0.1	0.4	14.8	0.4	0	0	0.2	0.1	2.6	0.5	0	0.7	0	0	0	0	0.1	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0.3	1.5	0.1	0	0	0	0	0	0	0	17.5	0	0	0	0	0	0	0	72.9	0	0	0.1	0	0	0	0	0	0	0	0	0.1	0	0.1	0	0.1	0.1	0	0	0	0	0	0.1	0.5	0.2	0.6	0	0.2	0	0.1	0.1	0	0.2	0.7	0	2.6	0	0.1	0.1	0	0	0.2	0.2	0	0.2	0.4	0	0.7	0	0.3	0.1	0	0	0	0.1	0	0	1.1	0	0	1.2	0	0	0	0	0.4	2.4	0	0	0	0.2	0.1	0.2	0	0	0.9	0.2	0	0	0	0.3	10	0	0	0	1	0	1	0.4	0	0	0	0	0	0	0	0.4	0	0.2	0	0	0.1	Late spermatids
AGBL2	CCP2, FLJ23598	ENSG00000165923	ATP/GTP binding protein like 2	Q5U5Z8	11	47659591-47715389	Enzymes, Predicted intracellular proteins		Carboxypeptidase, Hydrolase, Metalloprotease, Protease		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		testis: 34.0	Cell type enriched	Detected in some	5	Ciliated cells: 107.1	Low cancer specificity	Detected in some			Low region specificity	Detected in many			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		CAPAN-2: 6.1;T-47d: 3.5	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA007718	Uncertain											HPA007718: AB_1078110	unprognostic (3.44e-5)	unprognostic (1.16e-1)	unprognostic (5.84e-2)	unprognostic (5.33e-4)	unprognostic (1.13e-1)	unprognostic (3.00e-1)	unprognostic (2.05e-1)	unprognostic (1.38e-2)	unprognostic (9.83e-3)	unprognostic (4.11e-2)	unprognostic (5.56e-2)	unprognostic (1.79e-1)	unprognostic (8.24e-6)	unprognostic (1.01e-2)	unprognostic (1.28e-1)	unprognostic (9.62e-2)	unprognostic (1.17e-3)	0.4	1.7	0.8	6.6	2.7	0.7	1.1	3.6	1.1	1.9	2	2.8	1.5	1.1	1.6	11.2	0.5	12.2	2.4	0.4	1.3	1.4	1.8	3	6.4	1.4	0.3	0.3	2.1	4.7	1.2	3.8	0.7	3.4	1.6	0.8	0.7	1.1	1.7	0.4	0.6	3.3	0.6	0.7	1.7	0.8	34	0.7	4.4	1.9	0.5	2.6	2.1	1.4	2.6	1.5	0.4	0.2	1.4	2.2	0.6	1.2	0	0	0	0.3	1.7	0.1	0.4	0.8	0.5	1.7	0.6	6.1	0.1	0.4	0.4	0.8	1.6	0	0.1	0.8	1.8	0.4	0.3	2.9	2.2	0.9	0	1	1.8	0.7	0.9	0.5	0.6	0.1	2.1	0.4	1.3	0.9	2.4	1.2	0.6	0	0.3	0.1	1.7	0.1	0.5	0.9	2.7	2.2	0.5	0.7	0	0.7	0	3.5	0	0.2	0.2	0.5	0.3	0	0	0.1	0.1	0.3	0.3	0.3	0	0.1	0	1.5	0	1.3	1	1.6	1.2	0.1	2.6	1.9	1.7	0.4	1.4	0.2	1.5	2.2	0.6	0.8	2.7	3.6	1.1	1.3	1.4	0.3	0.3	3.4	0.7	0	2.4	0	1.2	0.1	0	0.4	0	107.1	10.3	7	0	0.4	0	0.2	23.4	0	1	0	0	0.2	0.6	0.3	0	0.6	0.1	0	1.2	0.6	0.3	6.6	0.3	0.3	0	1.8	0.6	0.5	0.2	0	1.4	0	0.4	0	0.1	19.6	1	0	0.3	0.7	0.8	0.3	Ciliated cells
LIPC	HL, HTGL	ENSG00000166035	Lipase C, hepatic type	P11150	15	58410569-58569843	Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins	Lipid degradation, Lipid metabolism	Heparin-binding, Hydrolase	Disease mutation	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	20	liver: 91.7	Cell type enriched	Detected in some	10	Hepatocytes: 125.3	Group enriched	Detected in some	14	liver cancer: 20.4;renal cancer: 10.4	Low region specificity	Detected in some			Low cell type specificity	Detected in many			Group enriched	Detected in many	8	granulocytes: 3.7;NK-cells: 3.0;T-cells: 4.5	Cell line enhanced	Detected in some		CACO-2: 7.0;EFO-21: 5.3;Hep G2: 20.0;HMC-1: 5.9;MOLT-4: 4.5;U-2197: 15.8	Not detected	Not detected			Low region specificity	Detected in all								Secreted to blood				3200000				unprognostic (1.76e-2)	unprognostic (9.15e-3)	unprognostic (7.89e-2)	unprognostic (7.15e-4)	unprognostic (1.40e-1)	unprognostic (1.33e-2)	unprognostic (9.93e-3)	unprognostic (6.25e-2)	unprognostic (3.79e-2)	unprognostic (1.10e-2)	unprognostic (3.06e-1)	unprognostic (2.31e-1)	unprognostic (2.82e-2)	unprognostic (1.41e-1)	unprognostic (2.87e-2)	unprognostic (1.80e-2)	unprognostic (2.27e-2)	0.2	0.1	0.4	1.1	0.7	0	0.7	0.1	0.4	0.3	0.2	0.6	0	0.7	0.1	0.4	0.2	0.4	0.3	0.3	0.4	0.2	3	91.7	0.3	0.2	1.2	0.2	0.3	1	0	1	0.1	1.5	0.3	0.3	0.5	0.1	1.5	0.1	0.3	0.3	0.1	1.2	0.4	0.2	0.1	0.5	2.7	0.5	0	0.1	1.1	0.2	0.1	0.2	3.7	0.4	3	4.5	2.5	0	0	0	0	0.2	0.9	0	0	0.7	0	0	7	0	0	5.3	0.2	0.2	0	0	0	0	0.4	0	2.5	0	20	0.4	0	5.9	0	0	0	0	0	0	1	0.1	0	0.1	0.1	4.5	0.6	0	0	0	0.9	0.3	0	2.2	0.4	0	0	0	0.1	0	0	0	0	0.2	0	0.1	15.8	0	0	0	0.1	0.1	0.4	0	3.7	0.3	0	3	0.2	4.5	0	0.8	2.2	0.2	0.1	1	3.2	0.4	3	0.4	0.1	2.1	2.5	0.4	0.7	0.1	0.4	0.4	0.2	1.2	0.2	1.5	0.5	0	0	5.1	0	0.2	0	0.8	12.7	0	1.2	3.5	0	0	5	3.7	0	0	0	0	3.3	0	1.2	0.2	0	125.3	0.1	0	0	5.5	4	0	0.3	0	1.7	1	0	0	0.3	0	0	9.6	0	0	0.9	0	0	0.5	0	0	0	0	Hepatocytes
PASD1	CT63	ENSG00000166049	PAS domain containing repressor 1	Q8IV76	X	151563622-151676739	Predicted intracellular proteins	Biological rhythms			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	301	testis: 30.0	Cell type enriched	Detected in some	8	Spermatogonia: 63.0	Low cancer specificity	Detected in some			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	7	BEWO: 20.0;HMC-1: 31.8;U-266/84: 14.8									HPA011122, HPA011152	Enhanced		Enhanced	Nuclear speckles						Nuclear speckles		HPA011122: AB_1854990, HPA011152: AB_1854991										unprognostic (3.34e-1)					unprognostic (1.02e-1)			0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	30	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	20	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	31.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0.7	14.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.1	0.6	0	0	0	0	0	0	0	0.4	0	0	6.5	0	8	63	0	0	0	0	0	Spermatogonia
IL25	IL-17E, IL-25, IL17E	ENSG00000166090	Interleukin 25	Q9H293	14	23372809-23376403	Predicted intracellular proteins, Predicted secreted proteins		Cytokine		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		heart muscle: 2.2;testis: 2.3	Cell type enriched	Detected in single	40	Cardiomyocytes: 13.5	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in single		HEL: 1.9	Low region specificity	Detected in some			Low region specificity	Detected in many			CAB024864	Uncertain				Secreted to blood			4230000				CAB024864: 	unprognostic (1.49e-1)				unprognostic (6.82e-2)													0.5	0.2	0.4	0.3	0.6	0	0.6	0.1	0.7	0.4	0			0	0	0	0	0.3	0	2.2	0.5	0.3	0	0	0	1.4	0.3		0.1	0	0.5	0	0		0.8	0		0.3	0.5	0.8	1	0.2	0.7	0.5	0.5	0	2.3			0.1		0	0.1	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0	0	13.5	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	Cardiomyocytes
CMTM5	CKLFSF5, FLJ37521	ENSG00000166091	CKLF like MARVEL transmembrane domain containing 5	Q96DZ9	14	23376808-23379772	Predicted membrane proteins	Chemotaxis	Cytokine		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	7	blood: 19.4;brain: 67.3	Cell type enriched	Detected in some	6	Muller glia cells: 28.7	Group enriched	Detected in some	37	glioma: 8.4;melanoma: 3.4	Low region specificity	Detected in all			Group enriched	Detected in some	8	basophil: 7.6;neutrophil: 2.8	Lineage enriched	Detected in single	11	granulocytes: 7.6	Cell line enriched	Detected in some	6	HEL: 42.7	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA052338	Enhanced		Approved	Golgi apparatus,Vesicles						Golgi apparatus, Vesicles		HPA052338: AB_2681793	unprognostic (2.73e-3)	unprognostic (1.51e-1)	unprognostic (5.24e-1)	unprognostic (2.43e-3)	unprognostic (2.63e-1)	unprognostic (6.40e-2)		unprognostic (8.34e-3)	unprognostic (1.78e-1)	unprognostic (2.27e-2)	unprognostic (8.40e-2)	unprognostic (6.24e-4)	unprognostic (3.03e-3)	unprognostic (1.97e-3)	unprognostic (1.17e-1)	unprognostic (1.93e-1)	unprognostic (1.11e-2)	1.7	1.8	14.1	1.3	19.4	6.6	1.3	4.8	55.4	2.6	1.9	47	0	1.3	1.6	1.6	2.1	1.7	2.5	5.8	19.6	12.1	1.1	1	1.7	1.1	26.9	10.3	1.7	1.1	0.9	0.1	1.5	18.4	1.9	1.6	0.6	3.1	4.2	1.4	1.5	2	1.7	67.3	1.9	1.1	1.1	12.7	0	1	0	1	1.3	0.7	0.1	0.7	7.6	0.4	0	0.3	19.4	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0	0	0	0	0	42.7	0	0	0	0	7	0	0	0	0	0	0	0	0.1	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0.4	0	1.1	7.6	0.4	0.2	0.1	0.2	0	0.1	0.1	0	0.2	0	0	0	2.8	0	0	0.7	0.3	19.4	14.1	19.4	4.8	24.8	19.6	12.1	26.9	10.3	18.4	12.7	0	0	0	0.1	0.9	0	3.4	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	1.3	0	0	0	0.1	0	0	0.6	1.2	0	0	0	5	0	0	28.7	0	0	0	0	1	0	3.4	0	0	0.1	0	0	0	0.1	Muller glia cells
SPIC	MGC40611, SPI-C	ENSG00000166211	Spi-C transcription factor	Q8N5J4	12	101475421-101486997	Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	DNA-binding		Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enriched	Detected in some	16	lymphoid tissue: 74.6	Cell type enriched	Detected in single	12	Kupffer cells: 11.2	Cancer enhanced	Detected in single		testis cancer: 0.9	Not detected	Not detected			Group enriched	Detected in some	5	intermediate monocyte: 4.1;non-classical monocyte: 1.2	Lineage enriched	Detected in single	7	monocytes: 4.1	Not detected	Not detected			Not detected	Not detected																				unprognostic (9.82e-2)	unprognostic (2.43e-2)					unprognostic (9.03e-3)	unprognostic (2.51e-1)		unprognostic (4.85e-2)			unprognostic (5.78e-2)	unprognostic (5.30e-2)	unprognostic (1.77e-1)			0.1	0.1	0.1	1.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0	0	0	0.1	0	0.5	0.1	0	0.1	0.1	0.1	0.1	4.7	0.1	16.7	0.1	0	0.1	0.1	0	0.1	0	0	0.1	0	0	0.3	0	0.1	0.1	0.3	0	0.1	74.6	0.1	0.1	0	3.1	0.1	0	2.4	0.1	0.1	0	0	0	4.1	0	0.5	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0.4	0.5	0	0	0	0	4.1	0	0	0.1	0	0	0	0.2	0.5	0	0	1.2	0	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	11.2	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Kupffer cells
SYNPO2L	FLJ12921	ENSG00000166317	Synaptopodin 2 like	Q9H987	10	73644881-73663803	Plasma proteins, Predicted intracellular proteins		Actin-binding		Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	15	heart muscle: 69.3;skeletal muscle: 72.8;tongue: 29.3	Cell type enriched	Detected in some	220	Cardiomyocytes: 650.0	Group enriched	Detected in some	6	breast cancer: 1.5;head and neck cancer: 1.4;prostate cancer: 0.5	Not detected	Not detected			Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		CACO-2: 7.7;HSkMC: 6.2;RH-30: 5.9;SK-BR-3: 6.3	Low region specificity	Detected in single			Low region specificity	Detected in all			HPA055192, HPA057142	Enhanced		Supported	Nuclear speckles,Cell Junctions,Cytosol						Nuclear speckles	Cell Junctions, Cytosol	HPA055192: AB_2682732, HPA057142: AB_2683348	unprognostic (2.75e-1)	unprognostic (1.58e-1)	unprognostic (1.20e-3)	unprognostic (3.65e-3)	unprognostic (1.27e-1)	unprognostic (1.05e-1)	unprognostic (1.33e-1)	unprognostic (4.54e-2)	unprognostic (3.30e-1)	unprognostic (2.49e-2)	unprognostic (4.50e-2)	unprognostic (2.32e-1)	unprognostic (7.44e-4)	unprognostic (1.09e-1)	unprognostic (1.01e-1)	unprognostic (1.72e-2)	unprognostic (1.34e-1)	3.8	0.1	0	0	0.1	0.1	1.1	0	0.2	0.1	0	0.3	0	0	0	3.2	3.3	0	0	69.3	0	0	0	0	0.3	0.1	0	0	0	0.1	0	0	0.6	0.1	0.8	0	0	1.6	0	72.8	0.1	0	0	0.2	0	0	0.2	0	0	1.3	29.3	3.4	0	0.3	0.7	1	3	0.7	0.7	0.7	0.1	0.5	0.1	0.8	0.3	0.1	0	1.1	0.9	1.2	0.2	0	7.7	0.7	0.4	0.5	0.9	0.1	0.1	0.1	0	0.4	0.2	0.2	0.3	0.6	0.4	0.6	0.2	0.3	6.2	0.1	1.2	0.1	0.3	0	0.5	0.3	0.3	0.3	0.3	0.2	1.9	0.2	0	0.7	0.2	5.9	0.3	0	0.6	0.3	0.4	0.1	6.3	0.1	0.3	0.4	0.7	0	0.6	1	0.2	0.3	1	0.3	0.3	0.2	0.6	0	2.9	0.7	0.7	0.7	0.4	0.3	0.5	0.3	0.3	0.2	0.7	0.4	0.4	3	0.7	0.4	1	0.2	0.1	0	0.1	0	0.2	0	0	0	0	0.1	0	3	0	0	1.4	1.3	1.4	650	0	1.4	1.2	0	2	0.1	0	0	1	1	0	0	0	0.1	0.9	0.7	1.1	0.2	0.2	0	0	0	0.3	1	0.9	0.8	1.7	0	0	0.8	0	0	0.4	0	1.3	0	0.5	0.7	0.6	0.4	0	0.7	0	0.9	Cardiomyocytes
C11orf65	MGC33948	ENSG00000166323	Chromosome 11 open reading frame 65	Q8NCR3	11	108308519-108467531	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	7	testis: 45.0	Cell type enriched	Detected in many	5	Early spermatids: 513.5	Not detected	Not detected			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Low cell line specificity	Detected in many			Low region specificity	Detected in some			Low region specificity	Detected in all																unprognostic (8.05e-2)	unprognostic (4.89e-2)	unprognostic (1.62e-1)	unprognostic (2.11e-2)	unprognostic (4.15e-2)	unprognostic (3.79e-2)	unprognostic (2.07e-1)	unprognostic (5.78e-2)	unprognostic (3.54e-5)	unprognostic (2.72e-1)	unprognostic (2.48e-1)	unprognostic (1.02e-1)	unprognostic (1.04e-2)	unprognostic (1.25e-1)	unprognostic (1.84e-1)	unprognostic (8.87e-2)	unprognostic (2.50e-2)	1	1.7	2.6	1.1	3.8	0.6	1.1	3.5	2.6	1	0.9	3.6	1.4	0.6	0.9	3.3	1	2	1.3	1.2	2	1.2	2.7	2.9	1.6	1.1	2	2.5	1.2	3.1	2.2	6.3	0.9	3.1	1.1	0.9	2	1.6	2.4	0.9	1.2	1	0.8	2.2	1.2	1.1	45	3.5	2.4	2.2	0.2	0.9	1	1.1	1.2	1.9	1.8	1.6	0.8	2.7	0.5	1.3	0.4	1	1.7	1.9	3.6	2.7	1.1	0.5	0.4	0.3	1.9	4.2	1.4	4.1	1.1	1.7	2.1	2.8	2.2	1.2	1.6	1.4	1.9	0.6	0.2	1.3	1.6	0.3	3.9	1.2	0.8	4.7	1	1.1	6.2	3.5	1.6	3.1	2	1.8	1.2	0.7	3.3	1.5	1.4	1.3	1.8	2.3	1.2	3.7	0.6	1.7	0.8	1.6	0.8	7.1	0.3	1.8	1.5	1.9	0.6	0.2	2.5	1.3	5.4	1.4	1.8	1.3	1.8	0.4	0	0.5	1.6	2.7	0.6	0.6	0.6	0.2	1.2	1.6	0.8	0.1	0.8	0.5	1.9	1.4	0.5	2.6	3.8	3.5	2.6	2	1.2	2	2.5	3.1	3.5	0	0.6	0	1.4	0.3	15.9	0.9	0	6.7	2.3	3.5	29.5	1.3	3.3	1.5	513.5	0.6	0	0	1.8	0.7	0.6	0.3	2.3	1.8	0.6	6.4	1.2	0.6	0	49.6	4.9	0.1	3.3	0	0.6	7.6	0.9	0	3.9	4.4	47.4	6.5	0	106.7	32.6	0.1	0.8	0	0.6	0.8	Early spermatids
NETO1	BCTL1, BTCL1	ENSG00000166342	Neuropilin and tolloid like 1	Q8TDF5	18	72742314-72868146	Predicted intracellular proteins, Predicted membrane proteins, Transporters		Receptor		Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	12	brain: 47.9	Cell type enriched	Detected in some	38	Bipolar cells: 163.9	Cancer enhanced	Detected in some		glioma: 1.2	Low region specificity	Detected in many			Group enriched	Detected in some	27	memory B-cell: 1.6;naive B-cell: 3.7	Lineage enriched	Detected in single	38	B-cells: 3.7	Cell line enhanced	Detected in some		MOLT-4: 15.1;NTERA-2: 6.9;REH: 14.9;RPMI-8226: 23.7;RT4: 15.7;SCLC-21H: 20.9;U-2 OS: 7.7	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA064630			Approved	Golgi apparatus	Intracellular and membrane					Golgi apparatus		HPA064630: AB_2685305	unprognostic (4.02e-2)	unprognostic (4.08e-3)	unprognostic (2.75e-1)	unprognostic (1.55e-2)	unprognostic (6.04e-2)	unprognostic (1.35e-5)	unprognostic (4.05e-1)	unprognostic (4.73e-2)	unprognostic (3.09e-1)	unprognostic (1.56e-1)	unprognostic (6.63e-2)	unprognostic (1.20e-1)	unprognostic (1.73e-2)	unprognostic (3.70e-2)	unprognostic (3.35e-2)	unprognostic (1.59e-1)	unprognostic (9.13e-3)	2	0.8	9.1	1.3	18.3	1	1.7	0.4	47.9	0.9	0.9	0.7	0	0.8	0.9	0.9	1	0.8	0.9	1.4	15.9	3.9	1	0.8	0.9	3.8	3	15.1	0.8	0.8	1	0.3	0.8	5	0.9	1.1	3.9	1.1	0.8	0.8	1.2	0.8	0.8	1.1	4	0.9	2	2.8	0.8	2.3	0	2.7	1.2	0.2	3.7	0	0	0	0	0	0	0	0	1.3	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	4	0	0	0	0	0	0	0	0	0	1	0	0	0.1	0	0	0	0	0	0	0	15.1	0	6.9	0	0	14.9	0	23.7	3.7	15.7	20.9	0	0	0.1	0	0.2	0	0	0	0	7.7	0	0	0	0	0	0.2	0	1	0	0	0	0	0	0	1.6	0	0	0	3.7	0	0	0	0	0	0	0	0	9.1	18.3	0.4	22.8	15.9	3.9	3	15.1	5	2.8	0	0	0	0	0	163.9	0.4	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.5	0	0	0	0	4.3	0	0	0	0.2	0	0	0	0	0	Bipolar cells
CRABP1	CRABP, CRABP-I, CRABPI, RBP5	ENSG00000166426	Cellular retinoic acid binding protein 1	P29762	15	78340324-78348230	Cancer-related genes, Plasma proteins, Predicted intracellular proteins	Transport		Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 40.1;retina: 73.2;thyroid gland: 80.6	Cell type enriched	Detected in some	23	Muller glia cells: 4142.9	Cancer enhanced	Detected in many		ovarian cancer: 117.2	Low region specificity	Detected in all			Cell type enriched	Detected in single	13	myeloid DC: 1.2	Lineage enriched	Detected in single	13	dendritic cells: 1.2	Group enriched	Detected in some	8	AF22: 146.8;NTERA-2: 43.9	Group enriched	Detected in many	5	amygdala: 6.6;basal ganglia: 20.9;hypothalamus: 15.5;olfactory region: 15.7;pons and medulla: 7.8	Low region specificity	Detected in many			HPA017203	Enhanced	Supported										HPA017203: AB_1846512	unprognostic (1.23e-1)	unprognostic (3.76e-3)	unprognostic (1.46e-1)	prognostic unfavorable (4.72e-4)	unprognostic (2.01e-1)	unprognostic (4.35e-2)		unprognostic (1.05e-1)	unprognostic (1.35e-1)	unprognostic (2.45e-2)	unprognostic (9.79e-2)	unprognostic (1.21e-1)	unprognostic (2.79e-2)	unprognostic (9.37e-2)	unprognostic (2.17e-1)	unprognostic (1.07e-1)	unprognostic (2.69e-1)	0.7	1.3	6.3	1.8	25.6	0.6	24.8	2.8	12.4	1.2	1.9	3.3	0.3	0.9	1.5	1.9	0.7	0.5	1.2	0.7	1.1	21.9	4.2	0.5	0.8	0.6	16.9	4.5	0.7	0.7	0.5	6.3	7	40.1	1	1.3	73.2	0.6	24.8	0.5	12.3	2.3	1.3	7.3	21.1	1.9	0.6	2.4	0.4	80.6	2.4	1	0.7	0.4	0	1.2	0	0	0	0	0	0	0	146.8	0	0	0	0	0	0	0	0	9	0.1	0	0.9	0	0	0	1.3	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.8	7.8	0	43.9	0.1	0.1	0	0	0	0	0.2	12.3	8.3	0	0	0	3.7	0.2	5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.2	0	0	0	0	0	0	0	0	0	6.3	25.6	2.8	12.4	1.1	21.9	16.9	4.5	40.1	2.4	0	0	0	0	8.7	31.5	0	0	0	0	0	31.4	0.7	59.7	0	0	0	0.2	0	0	0.4	7.4	0.3	0	0	1.3	9.5	0	0	0	0	0	0	182.2	0	0	4142.9	0	0	0	0.5	73.8	0	0	0	1.5	2.3	1.1	0	0	0	Muller glia cells
TMEM130	DKFZp761L1417, FLJ42643	ENSG00000166448	Transmembrane protein 130	Q8N3G9	7	98846488-98870771	Predicted intracellular proteins, Predicted membrane proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	5	adrenal gland: 28.2;brain: 82.2;pituitary gland: 24.0;testis: 26.4	Cell type enriched	Detected in some	8	Bipolar cells: 49.7	Cancer enhanced	Detected in many		renal cancer: 9.1	Low region specificity	Detected in all			Cell type enhanced	Detected in some		neutrophil: 4.8	Lineage enriched	Detected in many	5	granulocytes: 4.8	Cell line enhanced	Detected in some		BJ hTERT+: 7.6;EFO-21: 7.4;GAMG: 8.0;hTERT-RPE1: 12.8;NTERA-2: 4.4;SH-SY5Y: 9.1	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA012928	Uncertain		Supported	Golgi apparatus						Golgi apparatus		HPA012928: AB_1858085	unprognostic (1.36e-2)	unprognostic (1.33e-3)	unprognostic (3.85e-2)	unprognostic (1.56e-2)	unprognostic (3.61e-3)	unprognostic (3.23e-2)	unprognostic (2.97e-1)	prognostic favorable (7.84e-4)	unprognostic (1.07e-2)	unprognostic (1.17e-2)	unprognostic (4.69e-2)	unprognostic (5.65e-2)	unprognostic (1.86e-3)	unprognostic (7.90e-3)	unprognostic (1.22e-1)	unprognostic (1.17e-2)	unprognostic (1.73e-1)	1.3	28.2	27.3	2	53.8	1.4	1.8	14.1	82.2	3.5	1.8	2.8	0	1.6	1.8	8	2.2	1.7	2.2	1.4	29.3	47	2.8	1.1	5.4	2.4	13.4	35.1	1.7	1.6	1.5	24	1.3	25.8	2.7	1.9	1	1.3	6.2	2.1	1.3	2.1	1.6	9.2	1.4	1.4	26.4	3.9	0.1	1.4	0	1.2	1.7	1.2	1	0.6	4.8	0.9	1	0.7	0.3	0	0.6	0	0	0.2	0	0.2	3.4	7.6	0.6	0.5	0.1	0.1	0.1	7.4	1.9	8	0.1	0	0	0.1	0.2	0.4	0.1	0.2	0.1	0	0	0.5	0.1	0	0	0	12.8	0.3	0.1	0.1	0.6	0.4	0.6	0.1	0.1	4.4	0	0	0.1	0	0.7	0.1	0	0.5	9.1	0.1	0.1	0	3	0	0	0	0.1	0.6	0	0.2	0.4	0.2	0.1	0.3	0.4	0.1	2.2	0.9	0.6	0.5	0.4	0.4	0.7	0.5	0.4	0.2	1	0.7	0.6	4.8	1	0.6	0.6	0.4	0.3	27.3	53.8	14.1	44.2	29.3	47	13.4	35.1	25.8	3.9	0	0	0	0.3	0.3	49.7	0.8	2.5	0	3.4	1.8	2	0.1	0	0	1.3	0.3	0	0	0.2	0.1	1.1	0.3	0	0	0.1	0	0	0.6	0	1.9	0.9	0.2	0	0	0	1.3	0	0	6.3	0	3.7	0	0.3	0.4	0.7	0.3	0.2	0	0	0.1	Bipolar cells
CLEC4D	CD368, CLECSF8, Dectin-3, MCL, Mpcl	ENSG00000166527	C-type lectin domain family 4 member D	Q8WXI8	12	8509475-8522366	Predicted intracellular proteins	Adaptive immunity, Immunity, Innate immunity			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	4	blood: 35.0;bone marrow: 38.4;lymphoid tissue: 15.0	Cell type enriched	Detected in some	5	Kupffer cells: 13.9	Cancer enriched	Detected in single	50	testis cancer: 11.9	Low region specificity	Detected in some			Group enriched	Detected in some	18	classical monocyte: 20.9;neutrophil: 35.0	Group enriched	Detected in many	32	granulocytes: 35.0;monocytes: 20.9	Cell line enhanced	Detected in some		NB-4: 2.9;NTERA-2: 11.6;SuSa: 12.4;U-937: 6.6	Not detected	Not detected							HPA004906	Approved											HPA004906: AB_1078535	unprognostic (1.10e-1)	unprognostic (4.94e-2)	unprognostic (4.78e-2)	unprognostic (1.27e-1)	unprognostic (4.39e-1)	unprognostic (3.84e-2)	unprognostic (7.61e-2)	unprognostic (1.16e-1)	unprognostic (1.90e-1)	unprognostic (2.21e-1)	unprognostic (2.70e-1)	unprognostic (3.81e-1)	unprognostic (7.91e-5)	unprognostic (1.12e-2)	unprognostic (8.57e-2)	unprognostic (7.89e-2)	unprognostic (2.18e-1)	1.7	0.2	0.1	4.8	0.6	38.4	0.4	0.1	1.8	2.2	0.3	0.1	0	0	0.2	0.3	0.3	1.4	0.3	3.6	1.1	0.2	0.4	0.7	6.7	10.4	0.6	0	0.4	0.3	0	0.4	0.4	0.7	0.2	0	0.1	0.3	0	1.3	0.1	0.5	0.5	0.5	15	0.5	0.5	0.4	0.1	0.7	0.4	0.4	0.5	4.2	0.1	0.8	35	20.9	0	0	4.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.6	0	0.2	0	0	0	0.4	1.5	0	0	0	0	0	0	0.1	0	0	0	0	0	2.9	11.6	0	0	0.1	0	0	0.3	0	0	0	0	0	0	12.4	0	0	0	0	0	0	0	0	0	0	0	6.6	0	0.3	20.9	0	0	1.5	0	0.1	0	0	0.8	0	0	0	35	0	0.3	0.2	0	4.4	0.1	0.6	0.1	1.8	1.1	0.2	0.6	0	0.7	0.4	0	0.3	0	0	0	0	0	0	1.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.3	0	0.6	0	0	0	13.9	0	0	2.7	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0.1	0	0	0	Kupffer cells
CDH16		ENSG00000166589	Cadherin 16	O75309	16	66908122-66918984	Predicted intracellular proteins, Predicted membrane proteins	Cell adhesion			Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	9	kidney: 139.7	Cell type enriched	Detected in some	6	Collecting duct cells: 586.2	Cancer enriched	Detected in many	15	renal cancer: 96.2	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	96	RPTEC TERT1: 71.0	Low region specificity	Detected in many			Not detected	Not detected			CAB013526, HPA036260	Enhanced											CAB013526: , HPA036260: AB_2675027		unprognostic (1.07e-1)	unprognostic (2.47e-1)	unprognostic (1.96e-1)		unprognostic (9.81e-2)	unprognostic (4.24e-3)	unprognostic (5.81e-2)	unprognostic (5.58e-1)	unprognostic (1.02e-1)	unprognostic (1.23e-2)		prognostic favorable (1.02e-7)	unprognostic (2.19e-1)	unprognostic (1.99e-1)	unprognostic (7.36e-3)	unprognostic (2.34e-2)	0	0	0	0	0	0	0	0	0	0.8	1.6	0	0	0.3	0	3.5	0.1	3.4	0.2	0	0	0	139.7	0	0	0	0	0	0.3	0	0	0	0	0	0.2	0	0	0.1	1.3	0.1	0	1.1	0	0	0	0	0.4	0	0	15	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0.7	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0.1	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	71	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	6.2	0	0	0	586.2	0	0	63	0.1	2.5	0	0.9	0	0	0.1	0.2	0.1	0	0	0	0	0	0	0	10	0	0	0	0	0.1	0	0.1	0	0	105.4	0	0	0.4	0	0.1	0	0.8	0	0.4	0	Collecting duct cells
CFAP52	FLJ37528, WDR16, WDRPUH	ENSG00000166596	Cilia and flagella associated protein 52	Q8N1V2	17	9576627-9643459	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	5	brain: 29.5;fallopian tube: 46.9;testis: 26.8	Cell type enriched	Detected in some	6	Ciliated cells: 149.9	Low cancer specificity	Detected in some			Region enhanced	Detected in many		pons and medulla: 29.5	Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		CAPAN-2: 3.9;MCF7: 4.8;OE19: 6.2;REH: 3.3;T-47d: 2.9	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA023247, HPA030635	Enhanced		Approved	Nucleoplasm,Mitochondria						Mitochondria	Nucleoplasm	HPA023247: AB_1858797, HPA030635: 	unprognostic (1.76e-2)	unprognostic (2.31e-1)	unprognostic (1.38e-1)	unprognostic (1.68e-2)	unprognostic (2.09e-1)	unprognostic (2.04e-1)	unprognostic (3.99e-1)	unprognostic (3.16e-2)	unprognostic (2.11e-1)	unprognostic (3.66e-1)	unprognostic (2.22e-2)	unprognostic (2.66e-1)	unprognostic (7.85e-2)	unprognostic (1.85e-1)	unprognostic (9.23e-2)	unprognostic (4.50e-2)	unprognostic (7.09e-2)	0.4	0.6	3.7	0.4	8.4	0.4	0.4	0.3	2.5	2.6	0.4	8.5	0.1	0.9	1.3	6.4	0.4	46.9	0.5	0.4	5.9	6	0.5	0.4	3.9	0.3	0.5	0.5	4.8	0.3	0.7	5.4	0.5	29.5	0.5	0.3	0.7	1.3	0.5	0.3	0.5	0.9	0.3	1.1	0.4	0.4	26.8	3.5	0	0.8	0	0.3	0.5	0	0	0.7	0	0.2	0	0	0	1.6	1.9	0	0.7	1.3	0.9	0.9	0	0.1	0	0	0.1	3.9	0	0.4	0	1.4	2.2	0	0	0	0.5	0	0	2.6	0.4	0.1	0.1	0	0.2	0	0.5	0	0	0	0.5	0	0	0.2	4.8	0	0.7	0.3	6.2	0.2	3.3	0	0.1	0.4	0.9	0.8	0	0.7	1.3	0	0.9	2.9	0.2	0	0.1	0.5	0	0	0.1	0.3	0	0.2	0.9	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.7	0	0	3.7	8.4	0.3	2.5	5.9	6	0.5	0.5	29.5	3.5	0	2.9	0	0.2	0	0.4	0.3	0	149.9	18.2	0	5.9	0.5	1.7	0	21.1	0	0	0	0.2	0.1	0	0.3	0	0	0.1	0	0	0	0	3.6	1.7	0	0	0	0	0.5	0.1	0	1.8	0.2	2	0	0	25.2	0.3	0	0.8	0	0	0.1	Ciliated cells
NNMT		ENSG00000166741	Nicotinamide N-methyltransferase	P40261	11	114257787-114313285	Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins		Methyltransferase, Transferase	FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		liver: 97.7	Cell type enriched	Detected in many	9	Hepatocytes: 3284.1	Low cancer specificity	Detected in all			Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in many		HSkMC: 68.8;LHCN-M2: 40.9;RPTEC TERT1: 105.9	Low region specificity	Detected in many			Not detected	Not detected			HPA059180	Approved		Approved	Golgi apparatus,Cytosol					15000	Golgi apparatus	Cytosol	HPA059180: AB_2683940	unprognostic (1.62e-1)	unprognostic (2.33e-2)	unprognostic (1.61e-2)	unprognostic (6.14e-2)	unprognostic (3.51e-1)	prognostic unfavorable (2.07e-4)	unprognostic (1.76e-1)	unprognostic (5.84e-2)	unprognostic (2.71e-2)	unprognostic (2.48e-2)	unprognostic (1.20e-1)	unprognostic (1.69e-2)	prognostic unfavorable (1.02e-6)	prognostic unfavorable (1.75e-4)	unprognostic (1.11e-1)	unprognostic (3.37e-3)	unprognostic (2.77e-2)	23.7	1.4	0.6	8.8	0.9	0.1	14.6	0.6	1.7	13.1	8.5	0.7	4.9	0.5	15.8	8.7	12	8.3	15.3	8.2	1.6	0	4.7	97.7	10	3.4	1.1	0.6	11.2	2	0.6	2.6	8.6	3.3	9.6	3.3	1.6	3.6	6.7	18.3	8.2	4.3	12.4	1.5	5.8	5.1	7.3	0.6	1.3	5.3	2.2	3.1	10.9	35.3	0.6	0.1	0.7	0.2	0	0.9	0	0	4.8	0	4.3	24.8	32.2	0	6.1	16.3	9.8	19.5	0	6.6	0	21.8	12.5	1.3	0	0	2.2	9.9	0	0	0	7.6	0	33.8	0	0	68.8	23.8	6.9	10.3	8.2	13.5	0	0	0	40.9	0	0	0	0	0	0.1	0	27.4	0	105.9	0	0	0	30.7	0	0	1.5	0	0	9.5	5.6	22.6	8.7	1	0	0	0	1.7	0	0.4	0	0.2	0	0.2	0.1	0.9	0.2	0	0.2	0.1	0.6	0	0.2	0.7	0	0	0.1	0	0	0.6	0.9	0.6	1.7	1.6	0	1.1	0.6	3.3	0.6	41.7	380.8	30.2	10.6	92	0.5	4	76.5	18.7	20.5	76.8	0	0.9	8.3	207.6	0.2	191.1	0	163.5	133.3	1.9	375.3	11.6	12.8	3284.1	21.8	0	5.1	176.1	103.2	1	68.7	12.7	91.1	10	0	0	366	0	12.4	27.9	0.1	0	113.1	0.3	0.4	80.5	1.8	46	0	2.4	Hepatocytes
PLIN1	PLIN	ENSG00000166819	Perilipin 1	O60240	15	89664365-89679427	Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins	Lipid metabolism			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	12	adipose tissue: 187.5;breast: 62.6	Cell type enriched	Detected in some	9	Hepatocytes: 49.1	Cancer enhanced	Detected in many		breast cancer: 8.4	Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	176	ASC diff: 70.4	Low region specificity	Detected in single			Not detected	Not detected			HPA024299, CAB033821, CAB037333	Enhanced		Uncertain	Peroxisomes					8900	Peroxisomes		CAB033821: AB_2252681, CAB037333: , HPA024299: AB_1855467	unprognostic (4.62e-2)	unprognostic (2.22e-1)	unprognostic (2.13e-1)	unprognostic (1.67e-1)	unprognostic (1.90e-1)	unprognostic (3.51e-3)	unprognostic (9.89e-3)	unprognostic (3.54e-1)	unprognostic (7.01e-2)	unprognostic (2.13e-2)	unprognostic (8.00e-3)	unprognostic (2.28e-3)	unprognostic (2.62e-6)	unprognostic (5.56e-2)	unprognostic (1.22e-1)	unprognostic (1.63e-1)	unprognostic (4.85e-2)	187.5	2.6	1.8	7.1	1.3	0.3	62.6	0.8	0.8	0.3	10.6	1.6	0.4	0.4	0.3	1.9	0.5	0.4	7.4	8.3	2.7	0.6	0.6	5.8	0.3	2.8	0.8	1.5	0.4	1.4	0.3	0.1	0.3	1	0.4	1.1	0	7.6	1.5	7.2	2.2	2.2	0.6	0.4	0.3	0.5	1.6	1.8	0	0.7	8	0.3	1.5	1.5	0	0	0.6	0.1	0	0.1	0.1	0	0	0	0	70.4	0.2	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0.1	0.2	0.1	0	0.2	0	0	0	0.2	0.2	0	0	0.1	0	0.1	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0.1	0	0	0.1	0.4	0	0.1	0	0	0	0	0	0	0	0.1	0.1	0	0	0	0	0	0	0.6	0.1	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0.1	1.8	1.3	0.8	0.7	2.7	0.6	0.8	1.5	1	1.8	0	0	0	0.2	0.1	0.1	0.8	0	0	0	0	0	0	0	0.1	5.6	0.1	0	0	0.2	0	0	0.3	0	49.1	0	0	0	1.8	1.3	4.9	0.9	0	0	0	0	0.2	0.2	0.2	0	0	0	0	0	5.4	0.2	0.4	0	0	0	0.7	Hepatocytes
RBPMS2		ENSG00000166831	RNA binding protein, mRNA processing factor 2	Q6ZRY4	15	64739892-64775587	Predicted intracellular proteins		Developmental protein, RNA-binding		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		heart muscle: 75.1;smooth muscle: 69.6;urinary bladder: 51.6	Cell type enriched	Detected in many	4	Cardiomyocytes: 203.2	Cancer enhanced	Detected in all		testis cancer: 37.2	Low region specificity	Detected in many			Cell type enhanced	Detected in some		memory B-cell: 1.6;naive B-cell: 3.0	Lineage enhanced	Detected in single		B-cells: 3.0	Cell line enhanced	Detected in many		AF22: 15.1;AN3-CA: 21.3;HEL: 32.1;NTERA-2: 29.5;SuSa: 35.3	Low region specificity	Detected in many			Low region specificity	Detected in many																unprognostic (1.68e-1)	unprognostic (2.29e-1)	unprognostic (1.07e-2)	unprognostic (6.79e-2)	unprognostic (1.08e-1)	unprognostic (1.51e-1)	unprognostic (1.61e-1)	unprognostic (4.51e-2)	unprognostic (6.41e-2)	unprognostic (5.86e-2)	unprognostic (2.21e-2)	unprognostic (4.47e-2)	prognostic favorable (1.48e-4)	unprognostic (2.05e-2)	unprognostic (1.12e-1)	unprognostic (1.23e-1)	unprognostic (4.68e-3)	6.9	1.1	0.7	5.8	0.9	0.5	8.3	0.6	1.2	7	32.2	1.2	11.5	2.2	13.5	5.7	17.4	7.2	20.5	75.1	1.5	0.6	9.5	3.8	1.7	0.3	1.1	1.1	6	1.1	5.5	1	2.8	2.1	19.8	3.1	5.9	1.8	17.9	2.4	1.2	7.3	69.6	1	1.1	14.7	3.2	0.5	0.2	3.5	2.2	0.3	51.6	12.8	3	0	0	0	0.7	0.4	1.8	0	2.4	15.1	21.3	0	0	2.2	0.4	0	2.7	0.6	1.8	0.2	0	2	0.4	2.5	0	11	0	1	0	3.5	32.1	3.6	3.6	1.5	0	0.3	0	0	1.7	0	0.5	0.2	0.7	0.1	0	0.2	1	0	0.1	29.5	0	0	0.8	0	0	0	0	0	5.2	3.2	0	0.6	35.3	3	0.1	0	0	11.3	1.5	1.3	0.1	0	0	0	0	0.1	0	0	0	0.1	0	0	1.6	0	0.4	0	3	0	0.2	0	0.7	0	0	0	1.8	0.7	0.9	0.6	1.2	1.5	0.6	1.1	1.1	2.1	0.5	0	0	0	0.2	0.7	0.2	203.2	0	0	0	3.5	0	0.4	8.3	0.3	4.1	3.6	0	0	1.4	1	3.6	1.6	0	7.3	0.3	0	0	3.1	1.2	0.4	3.4	0.5	1.7	0	0	3.2	2	0	6	22.3	0.9	45.3	49.2	0.7	12	1	2.6	0	0	0.1	Cardiomyocytes
ELFN2	dJ63G5.3, KIAA1904, LRRC62, PPP1R29	ENSG00000166897	Extracellular leucine rich repeat and fibronectin type III domain containing 2	Q5R3F8	22	37367960-37427470	Predicted membrane proteins		Protein phosphatase inhibitor		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	7	brain: 30.0	Cell type enriched	Detected in some	11	Bipolar cells: 43.2	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		A-431: 8.7;CAPAN-2: 8.4;GAMG: 9.4;RPMI-8226: 8.4;RPTEC TERT1: 16.4;U-2 OS: 18.7	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA000781	Approved		Approved	Nucleoplasm,Vesicles						Nucleoplasm, Vesicles		HPA000781: AB_1079280	unprognostic (2.74e-1)	unprognostic (6.81e-2)	unprognostic (2.80e-2)	unprognostic (1.31e-5)	unprognostic (3.28e-1)	unprognostic (2.51e-2)	unprognostic (7.76e-2)	unprognostic (4.25e-2)	unprognostic (6.05e-2)	unprognostic (2.80e-2)	unprognostic (2.02e-1)	unprognostic (4.51e-1)	prognostic unfavorable (7.21e-4)	unprognostic (1.29e-1)	unprognostic (1.95e-1)	unprognostic (1.77e-1)	unprognostic (1.95e-1)	1	2.1	26.8	0.9	10.9	0.9	0.9	0.7	30	0.9	0.9	1.9	0	0.9	0.9	0.9	0.9	1	1.9	0.8	16.2	8.7	1.2	0.8	2	1	6.7	15	0.8	1.1	0.8	0.1	0.8	5.8	2.2	0.9	0.9	0.9	0.9	0.9	1.5	0.9	0.8	3.8	0.9	1.1	4.2	3.9	0.1	0.8	0	0.9	0.9	0.1	0.4	0	0	0	0	0	0	8.7	3.7	0	0	0	0.7	0	4	2.1	0.9	0	1.4	8.4	0.2	5.2	2.8	9.4	6.1	0.4	0.8	0.1	0.2	0	0	3.9	0	0.2	0	0.1	0.7	0.1	0.3	1.2	3.5	0.3	0.1	0	0	0.3	0.4	0	0	0.2	5.2	8	0.1	0	8.4	16.4	0	0.7	0	3.6	4.6	0	0	0	0.1	0.4	0	18.7	0.1	2.5	0	0	0	1.2	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	26.8	10.9	0.7	16.8	16.2	8.7	6.7	15	5.8	3.9	0	3.2	0	0	0.1	43.2	0	2.5	0	0	0	3.9	0	0	0	0.6	0	0	0	0	0	0	0.1	0	0	0	3.2	0	0	0	0.6	0	0	0	0	0	0.8	0.1	0	0	0.3	1.6	0	0	2.1	0.4	0	0	0	0	0	Bipolar cells
SCG5	7B2, SGNE1, SgV	ENSG00000166922	Secretogranin V	P05408	15	32641676-32697098	Predicted secreted proteins	Transport	Chaperone, Neuropeptide		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 71.1;pancreas: 63.5;parathyroid gland: 60.1;pituitary gland: 74.6	Cell type enriched	Detected in many	6	Intestinal endocrine cells: 452.1	Cancer enhanced	Detected in many		pancreatic cancer: 82.9	Low region specificity	Detected in all			Group enriched	Detected in some	5	memory CD4 T-cell: 2.8;naive CD4 T-cell: 1.0	Lineage enriched	Detected in single	28	T-cells: 2.8	Cell line enhanced	Detected in some		HHSteC: 15.0;HSkMC: 18.6;NTERA-2: 8.4;SCLC-21H: 17.2;SH-SY5Y: 19.9;U-87 MG: 26.1	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA013136, HPA074618	Enhanced				Secreted to blood				22000			HPA013136: AB_1856657, HPA074618: AB_2732262	unprognostic (1.71e-1)	unprognostic (9.87e-2)	unprognostic (7.94e-2)	unprognostic (1.30e-2)	unprognostic (3.59e-3)	prognostic unfavorable (9.64e-4)	unprognostic (2.69e-1)	unprognostic (1.27e-3)	unprognostic (4.69e-2)	unprognostic (1.97e-1)	unprognostic (5.62e-3)	unprognostic (3.92e-1)	prognostic unfavorable (4.51e-9)	unprognostic (3.57e-2)	unprognostic (8.13e-2)	unprognostic (3.08e-3)	unprognostic (8.88e-2)	1.2	30.7	24	2.2	47.2	0.9	2.5	36.4	71.1	1	4.4	13	0	9	3.4	21.8	1	2.4	3.4	1	30.5	36.9	1.2	2.2	2.5	1.3	25.2	23.1	2	63.5	60.1	74.6	0.9	30.5	3.2	5.5	15.4	0.7	1.2	0.7	1.3	3.3	3.9	24.1	1	21	3	9.5	0	1.8	0	0.9	2.5	0.5	0	0	0	0	0	2.8	0.2	0.2	0.1	0.1	0.1	0.3	2.5	0	2.2	0.2	0.2	0.2	0.1	0	0.2	1.1	0.2	0.9	0.6	0.3	0.1	0.6	0.3	0.1	0.3	0	0	15	0.1	0.4	18.6	0.1	0.4	0.2	0.5	0.3	0.5	0.1	0.3	0.4	0	0.1	0.2	8.4	0	0.4	0	0.2	0.3	0.2	0	17.2	19.9	0.1	0	0.1	0.2	0	0.2	0	2.9	1.9	0.1	0.2	0.3	1.2	0.2	26.1	0.8	0.6	0	0	0	0	0	0	0	2.8	0	0	0	1	0.4	0	0	0	0	0.3	0.2	24	47.2	36.4	50.8	30.5	36.9	25.2	23.1	30.5	9.5	0	0.3	0	0.2	0.6	53.1	0.3	0	0	4.5	0	2	0.1	0	0.5	43.4	0.1	0.4	0	71.7	0.2	2.6	1.8	2.3	13	6.3	47.7	452.1	0.6	1.2	72.8	2	1.2	3.3	1	3.1	11.2	35	0	7.4	0	20.6	0	0.4	6.4	0.9	0.3	0.2	0	0.7	0.1	Intestinal endocrine cells
GREM1	CKTSF1B1, CRAC1, DAND2, DRM, gremlin, HMPS	ENSG00000166923	Gremlin 1, DAN family BMP antagonist	O60565	15	32717974-32745107	Disease related genes, Predicted secreted proteins		Cytokine		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		gallbladder: 66.8;smooth muscle: 42.5	Cell type enriched	Detected in many	7	Collecting duct cells: 62.8	Cancer enhanced	Detected in many		stomach cancer: 24.6	Low region specificity	Detected in many			Low cell type specificity	Detected in some			Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		BJ: 32.8;BJ hTERT+: 50.3;BJ hTERT+ SV40 Large T+ RasG12V: 31.6;fHDF/TERT166: 100.9;hTEC/SVTERT24-B: 31.6	Group enriched	Detected in some	5	hippocampal formation: 3.6;olfactory region: 13.4	Low region specificity	Detected in single			HPA007526	Uncertain				Secreted to blood			242000000				HPA007526: AB_1849971	unprognostic (4.74e-2)	unprognostic (2.78e-1)	unprognostic (4.63e-2)	unprognostic (6.80e-2)	unprognostic (3.58e-1)	unprognostic (1.72e-1)	unprognostic (3.19e-1)	prognostic unfavorable (4.46e-4)	unprognostic (5.33e-2)	unprognostic (2.32e-1)	unprognostic (7.20e-3)	unprognostic (2.79e-1)	unprognostic (2.13e-11)	unprognostic (1.77e-2)	unprognostic (6.60e-2)	unprognostic (3.29e-2)	unprognostic (1.16e-3)	14.9	1.2	3.1	23.1	10.2	1.1	11.7	0.8	5.6	31.3	15.2	6.6	1.1	2.6	5.1	1	15.4	1	66.8	1.1	4.4	2	1.2	1.5	1.2	8	6.6	6.4	1	1.5	1	0.2	1.1	5.5	6.4	15.2	0	1	5.1	2.4	4.1	24.4	42.5	4.8	1.3	23.7	1.1	9.3	0	1.4	2.2	2.3	27.3	32.2	0.4	0.5	1.4	0.4	0.7	0.3	0	0	0.5	0	0	1.3	1.7	0	32.8	50.3	12.4	31.6	0	0	0	0	100.9	0	0	0	0	12.2	0	0	0	0	0	0.3	0	0	0.4	0	31.6	0	7	0	0	0	0	17.5	0	0	0	0.1	0	0.1	0	2.1	0	0	0	0	0	0	0	0	0.2	0	0	6.7	0	0	0.1	0	0	0	0	0.4	0	0	1.2	0.4	0.5	0.3	0.2	0.3	0.3	0.3	0.2	0.1	0.4	0.3	0.3	1.4	0.7	0.4	0.5	0.2	0	3.1	10.2	0.8	5.6	4.4	2	6.6	6.4	5.5	9.3	0	0	0	6.2	6	1.9	2.6	0	0	0	62.8	2	0.1	0	0.4	0.1	0.7	0	0	0	0.1	2.8	8.5	0	1	1	1.6	0	0.6	0.3	0	0	0	3.3	4.6	0.1	0.2	0.2	0	0.4	0.3	0.5	0	4.7	0	0.2	4	0.2	1	0	6.3	Collecting duct cells
TSC22D4	THG-1, TILZ2	ENSG00000166925	TSC22 domain family member 4	Q9Y3Q8	7	100463359-100479279	Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	Repressor		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		brain: 97.2	Cell type enriched	Detected in many	4	Muller glia cells: 493.0	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Cell line enhanced	Detected in all		NB-4: 60.8	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA006757	Uncertain		Approved	Cytosol						Cytosol		HPA006757: AB_1080403	unprognostic (2.34e-2)	unprognostic (3.06e-2)	prognostic unfavorable (2.66e-4)	unprognostic (5.77e-2)	unprognostic (1.69e-1)	unprognostic (3.06e-1)	prognostic unfavorable (9.45e-4)	unprognostic (9.96e-2)	unprognostic (1.27e-1)	unprognostic (1.62e-2)	unprognostic (2.31e-2)	unprognostic (3.36e-1)	unprognostic (1.09e-1)	unprognostic (1.54e-2)	unprognostic (3.84e-2)	unprognostic (7.36e-2)	unprognostic (3.81e-3)	11.2	11.9	77.8	16.4	83.5	32.4	7.7	17.8	92.4	9.7	9.9	96.1	3.4	12.4	9.1	6.2	10.3	9.9	8	10.2	69.5	53.8	8.9	5.1	10.2	18.7	97.2	40.6	11.7	9.7	8.8	7.1	12.2	60.5	11.5	6.2	11.8	49.2	13	7.8	17.2	12.5	8	89.8	24	11.7	8	62.3	6.7	5.8	1.7	12.2	8.6	5.7	6.9	7.5	32.2	11.4	10.2	13.8	8.8	12.3	9.3	3.2	10.6	11.3	13.5	6	9.4	15.9	9.1	8.4	4.9	7.6	11.2	11.2	7.6	20.8	9.6	3.8	8.5	3.2	19.2	7.7	10	9.8	4.2	18.1	13.2	26.8	15.2	7.7	10.5	10.5	10.8	18.7	9	22.1	20.7	7.3	22.5	16.5	60.8	4.3	10.9	13.3	27.3	2.5	15.5	7.5	6.8	2.7	7.5	13	25	19.6	5.5	7	19.6	15.5	12.4	12.6	30.2	6.9	13	12.3	7.9	11.4	20.4	14.9	5	10.9	15.6	11.7	11.4	9.1	6.9	10	10.8	7.2	6.6	9.6	10	32.2	10.2	10.8	7.5	13.8	8.8	77.8	83.5	17.8	65.4	69.5	53.8	97.2	40.6	60.5	62.3	11.9	6.2	54.1	32.3	29.1	13.9	11.6	45.9	4	4.5	38.4	5.9	27.8	116	50.9	1.4	25.1	57.3	0	29.7	30.6	33.2	48.6	16.1	9.5	68	17.5	32.2	43.6	53.1	3.1	42.3	43.7	52.3	86.6	28.4	493	47.4	43.5	37.4	15.9	11.6	45.3	36	0.9	3.6	29.5	66.1	90.8	30.2	50.5	Muller glia cells
MS4A6E		ENSG00000166926	Membrane spanning 4-domains A6E	Q96DS6	11	60334831-60396596	Predicted membrane proteins		Receptor		Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enriched	Detected in some	9	testis: 28.2	Cell type enriched	Detected in some	21	Early spermatids: 1123.1	Not detected	Not detected							Cell type enriched	Detected in single	5	intermediate monocyte: 1.2	Lineage enriched	Detected in single	6	monocytes: 1.2	Group enriched	Detected in some	7	K-562: 2.1;SuSa: 4.2									HPA076623			Approved	Vesicles						Vesicles		HPA076623: AB_2686809					unprognostic (2.58e-1)	unprognostic (3.35e-1)		unprognostic (3.47e-1)			unprognostic (6.81e-3)		unprognostic (4.55e-4)	unprognostic (1.08e-1)	unprognostic (1.71e-1)	unprognostic (1.76e-1)		2	0	0	0.9	0	0	0.5	0	0	0	0			0	0	0	0	1.3	0	0	0	0	0	0	0.5	0	0		0	0	0	0	0.1		0	0.1		0.2	0	0	0	0	0.1	0	3.2	0	28.2			0		0	0.3	0	0	0.1	0	1.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4.2	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0.2	0	0	1.2	0	0	0	0	0.1	0	0	0	0	0	0	0.1	0	0											0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1123.1	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	53.6	5.8	0	0	0	0	0	0	0	4.9	0	0	0	0	5.1	2.5	0	0	0	0	0	Early spermatids
EPB42	MGC116735, MGC116737, PA	ENSG00000166947	Erythrocyte membrane protein band 4.2	P16452	15	43197227-43221125	Disease related genes, Plasma proteins, Predicted intracellular proteins	Cell shape, Erythrocyte maturation		Disease mutation, Hereditary hemolytic anemia	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	5	bone marrow: 54.8;placenta: 16.1	Cell type enriched	Detected in many	15	Erythroid cells: 186.9	Not detected	Not detected			Region enriched	Detected in some	4	cerebellum: 4.3	Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	92	HEL: 43.5	Not detected	Not detected			Low region specificity	Detected in all			HPA040261	Supported		Uncertain	Nucleoplasm,Cytosol					7500000	Nucleoplasm, Cytosol		HPA040261: AB_10673441	unprognostic (8.45e-2)	unprognostic (4.66e-1)	unprognostic (4.15e-1)	unprognostic (1.13e-1)	unprognostic (2.28e-1)	unprognostic (1.99e-1)	unprognostic (1.54e-1)	unprognostic (1.59e-3)	unprognostic (2.95e-1)	unprognostic (6.05e-2)	unprognostic (5.27e-3)	unprognostic (1.31e-1)	unprognostic (1.48e-5)	unprognostic (1.70e-2)	unprognostic (1.20e-1)	unprognostic (5.88e-2)	unprognostic (3.47e-3)	7.5	0.4	0.4	0.4	0.9	54.8	1.3	4.3	1	0.3	0.4	0.3	0.3	0.3	0.3	0.3	0.4	0.5	0.6	1.9	0.4	0.9	0.5	0.9	5.5	0.3	0.5	0.3	0.8	0.3	0.3	0.3	16.1	0.7	0.5	0.3	0.3	0.3	0.3	1.3	1.1	1	0.3	0.3	5.3	0.5	2.4	0.3	0.5	1.2	0.3	0.5	1.6	4.5	0	0.3	0.2	0	0	0.1	4.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	43.5	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.2	0	0	0.3	0	4.2	0.4	0.9	4.3	1	0.4	0.9	0.5	0.3	0.7	0.3	0	0	0.5	1.2	1.6	3.7	0.3	2.5	0	0	0	5.9	3.3	0	0	7.7	0.6	1.1	186.9	0	1.9	1.7	1	4.6	0.5	1	6.4	0	1.3	0.3	8	2.6	0.8	1.7	0	0.8	2.8	0	1.7	0.7	0	7.8	6.5	1.2	12.1	3.8	2.5	5.6	4.4	0.6	1.6	Erythroid cells
MS4A15		ENSG00000166961	Membrane spanning 4-domains A15	Q8N5U1	11	60756953-60776732	Predicted membrane proteins		Receptor		Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Group enriched	Detected in some	9	blood: 9.9;lung: 32.4	Cell type enriched	Detected in some	8	Alveolar cells type 1: 89.3	Cancer enhanced	Detected in many		lung cancer: 6.3	Not detected	Not detected			Cell type enhanced	Detected in some		T-reg: 9.9	Lineage enriched	Detected in single	15	T-cells: 9.9	Cell line enhanced	Detected in some		HEL: 9.2;JURKAT: 3.4;Karpas-707: 3.8;MOLT-4: 4.1;U-266/70: 13.5;U-266/84: 5.7	Region enriched	Detected in single	28	olfactory region: 205.0	Region enriched	Detected in single	30	olfactory region: 39.1	HPA054563			Approved	Plasma membrane,Cytosol						Plasma membrane	Cytosol	HPA054563: 	unprognostic (1.85e-1)	unprognostic (4.31e-3)	unprognostic (8.59e-2)	unprognostic (5.89e-4)	unprognostic (4.49e-1)	unprognostic (1.09e-3)		unprognostic (3.92e-3)	unprognostic (5.43e-3)	unprognostic (1.20e-1)	unprognostic (7.30e-2)	unprognostic (3.14e-1)	unprognostic (1.04e-9)	unprognostic (7.02e-2)	unprognostic (8.63e-2)	unprognostic (2.75e-1)	unprognostic (1.47e-1)	0.3	0.2	0.3	0.3	0.3	0	1.3	0.3	0.3	0.3	0.3	0.3	0.3	0.6	1.8	0.3	0.4	1	0.3	0.3	0.3	0.2	0.3	0.3	32.4	0.3	0.3	0.3	2.4	0.3	0	0.3	1.1	0.3	0.3	0.5	0.3	0.3	1.9	0.3	0.2	1.4	1.7	0.3	0.3	0.2	0.6	0.3	0.3	0.3	0.3	1	0.7	0.3	0.2	0	0	0	0.6	9.9	0.7	0	0	0	0	0	0	0.8	0	0	0	0	0	0	0	1.6	0.1	0	0	0	0	0	0.2	0.1	9.2	0	0	0	0.1	0.2	0.1	0	0	0	0	0	3.4	1.6	3.8	0	0	4.1	0.1	0.1	0	0	0	0	0.1	0	0	0	0	0	0.1	0	0.3	1.1	0	0	0	0.5	0	0	13.5	5.7	0.9	0.1	0	0	0	0	0	0.1	0	0.1	0.2	2.9	0.5	0	0	1.8	0.7	0	0.6	0	0	9.9	0.7	0.3	0.3	0.3	0.3	0.3	0.2	0.3	0.3	0.3	0.3	89.3	4.8	0	0	0	0	0.2	0	2.7	11.4	0	0	0.7	0	0	4.7	0	0	0	0	2.2	0	0	1.1	0	0.2	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	1.9	0	1.7	0	0	0	Alveolar cells type 1
TCP10L2	bA517H2.3	ENSG00000166984	T-complex 10 like 2	B9ZVM9	6	167146414-167196913	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level	No human protein/transcript evidence	No human protein/transcript evidence		Group enriched	Detected in some	9	epididymis: 5.2;testis: 14.8	Cell type enriched	Detected in some	5	Spermatocytes: 45.1	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in single		U-2 OS: 1.1									CAB034197, HPA044709	Uncertain											CAB034197: AB_2202388, HPA044709: AB_10961410			unprognostic (5.07e-2)	unprognostic (1.22e-2)	unprognostic (1.35e-1)		unprognostic (2.52e-1)			unprognostic (1.24e-1)	unprognostic (1.12e-1)		unprognostic (5.40e-4)	unprognostic (1.73e-1)	unprognostic (1.19e-1)			0	0	0	0	0.1	0	0	0	0.4	0.2	0.4	0	0	0.6	0	5.2	0	0.1	0	0	0.1	0	0.3	0.1	0	0.2	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	1.1	0	0	0.1	0	14.8	0	0	0.1	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0	8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	8.6	0	0	0	0	0.6	0	0	0.6	0	0	0	0	0	45.1	0.5	0	0	0	0.3	0	Spermatocytes
NAT16	C7orf52, FLJ39237	ENSG00000167011	N-acetyltransferase 16 (putative)	Q8N8M0	7	101170493-101180276	Predicted intracellular proteins		Acyltransferase, Transferase		Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in some		brain: 9.1;pancreas: 6.0;pituitary gland: 5.8;thyroid gland: 4.6	Cell type enriched	Detected in some	45	Horizontal cells: 276.5	Cancer enhanced	Detected in some		melanoma: 2.1	Group enriched	Detected in many	4	amygdala: 3.1;basal ganglia: 9.1;cerebral cortex: 2.9;hypothalamus: 4.8	Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		RPMI-8226: 4.6;SH-SY5Y: 6.9;SK-MEL-30: 5.2;U-2 OS: 6.1;U-87 MG: 3.4									HPA021918	Uncertain		Approved	Nucleoplasm						Nucleoplasm		HPA021918: AB_1848922	unprognostic (4.32e-2)	unprognostic (1.75e-1)	unprognostic (2.69e-3)	unprognostic (4.58e-3)	unprognostic (2.93e-2)	unprognostic (2.61e-2)	unprognostic (6.14e-2)	unprognostic (1.40e-2)	unprognostic (2.25e-3)	unprognostic (2.35e-2)	unprognostic (4.23e-2)	unprognostic (2.62e-2)	unprognostic (5.53e-5)	unprognostic (7.65e-2)	unprognostic (2.48e-1)	unprognostic (5.02e-5)	unprognostic (1.59e-1)	0.2	0.4	3.1	0.2	9.1	0.7	0.1	0.4	8.2	0.1	0.2	0	0	0.2	0	0.3	0.1	0.2	0.1	0.1	0.9	4.8	0.1	0.5	0.1	0.2	0.7	0.6	0.1	6	0.2	5.8	0.1	0.8	0.2	0.3	0.5	0.3	0.1	0.3	0.4	0.2	0.2	0.4	0.3	1.2	0.4	1.2	0	4.6	0	0	0.1	0	1.2	0.7	2.2	0.6	1.3	0.8	0	0.5	0	0.1	0.3	0	0	0.3	0.1	0	0	0	0.4	0.1	0	0.1	0.2	0.2	0.3	0.1	0	0	0	0	0	0.7	0	0	0.1	0.7	0.3	0	0	0.1	0.2	0	0.1	0	1.3	0.5	0.5	0.1	0.1	0.8	0	0.6	0.2	0.1	4.6	0.1	0.5	0.1	6.9	0	0.3	5.2	0.5	0.3	0	0	0.4	6.1	0.5	0.1	0.1	0	0.1	3.4	0	1.6	0.4	0.6	0.3	0.3	0.4	0.3	0.2	0.2	0.1	0.2	1.2	0.8	0.4	2.2	1.3	0.3	0.7	0.3	0	3.1	9.1	0.4	2.9	0.9	4.8	0.7	0.6	0.8	1.2	0	0	0	0	0	1	6.2	0	0	0	0	0	0	1.7	0	0	0	0	0	0	0	0	0	0	0	0	276.5	0	0	0	0	0	0	0	0	0	1.7	0.5	0	0	0	2.3	0	0	0	0	0	0	0	0	0.1	Horizontal cells
SUN5	dJ726C3.1, SPAG4L, TSARG4	ENSG00000167098	Sad1 and UNC84 domain containing 5	Q8TC36	20	32983773-33004433	Disease related genes, Predicted intracellular proteins, Predicted membrane proteins	Differentiation, Spermatogenesis		Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	361	testis: 36.1	Cell type enriched	Detected in some	8	Early spermatids: 390.6	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			HPA048529	Enhanced											HPA048529: AB_2680428																		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	36.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	390.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	50.5	2	0	0	1	0	0	0	0	2.5	0	0	0	0	1.7	1.7	0	0	0	0	0	Early spermatids
LINC00483	C17orf73, FLJ20694	ENSG00000167117	Long intergenic non-protein coding RNA 483		17	50761029-50767557	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level				Tissue enriched	Detected in some	11	intestine: 73.0	Cell type enriched	Detected in single	20	Intestinal endocrine cells: 3.4	Group enriched	Detected in some	12	colorectal cancer: 3.3;pancreatic cancer: 0.8;stomach cancer: 2.0					Cell type enhanced	Detected in some		neutrophil: 6.5	Lineage enriched	Detected in many	4	granulocytes: 6.5	Cell line enhanced	Detected in some		CACO-2: 12.8;HDLM-2: 9.6	Region enhanced	Detected in single		basal ganglia: 0.4	Low region specificity	Detected in many																unprognostic (2.98e-1)		unprognostic (1.96e-2)	unprognostic (2.02e-3)			unprognostic (2.76e-1)	unprognostic (4.52e-1)		unprognostic (1.95e-1)	unprognostic (2.09e-2)	unprognostic (8.37e-2)	unprognostic (1.57e-2)	unprognostic (6.81e-2)	unprognostic (1.67e-1)		unprognostic (1.05e-3)	0.1	0	0.1	4.6	0.1	0.7	0.1	0.1	0.1	0.1	28.3	0.1	0.1	27.1	0.1	0.1	0.1	0	2.2	0.1	0.1		0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	9.7	0.1	0.1	0.1	0.1	0.2	73	0.1	0.1	0.1	0.8	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.1	0.8	6.5	1.5	0.9	0.9	0.4	0.6	1.1	0.6	1.4	0	0.6	1.3	0.5	0	0	0	12.8	0.8	0.3	0.4	0.3	0.2	0.8	0	0.2	0.1	9.6	0.8	0.8	2.1	1.6	0	0.7	2	0.6	0.1	0.2	0	0.6	0	1.1	0.2	0.9	0	0.5	0.4	1.3	0.2	2.8	0.6	0.9	0.6	0.5	0.2	2.1	0.4	1.1	0.5	1	0.1	0.7	1.2	0	1	1.2	0.8	0.8	0.5	0.6	0.4	1	0.4	0.4	0.5	4.6	1.5	0.8	0.7	0.8	0.4	0.7	0.7	0.7	0.2	1.1	0.9	0.6	6.5	0.9	0.8	0.8	0.5	0.4											0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Intestinal endocrine cells
CCDC103	CILD17, FLJ13094, FLJ34211, PR46b	ENSG00000167131	Coiled-coil domain containing 103	Q8IW40	17	44899142-44905390	Disease related genes, Predicted intracellular proteins	Cilium biogenesis/degradation		Ciliopathy, Disease mutation, Kartagener syndrome, Primary ciliary dyskinesia	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	4	fallopian tube: 19.6;testis: 35.5	Cell type enriched	Detected in single	14	Ciliated cells: 13.4	Not detected	Not detected			Low region specificity	Detected in many			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		A549: 12.8;RPTEC TERT1: 10.0;U-87 MG: 11.3									HPA043131			Approved	Cytosol						Cytosol		HPA043131: AB_10796686	unprognostic (9.40e-3)	unprognostic (1.75e-1)			unprognostic (5.60e-2)	unprognostic (1.99e-2)		unprognostic (4.50e-2)	unprognostic (7.43e-2)	unprognostic (2.80e-1)	unprognostic (2.34e-1)	unprognostic (1.27e-1)	unprognostic (4.35e-2)		unprognostic (4.69e-1)	unprognostic (1.05e-1)	unprognostic (3.60e-1)	0.6	2.3	2.6	0.9	6.3	0.6	1.2	0.5	4.7	1.4	0.9	2.9	1.6	0.5	1.7	2.8	0.4	19.6	2.8	0.4	2.5	3	2.7	0.7	1.9	0.3	1.5	3.9	3.5	0.8	1.9	2.1	0.5	4.3	0.9	0.7	1.6	1.2	1.5	0.3	0.7	0.4	1.2	1	0.4	0.9	35.5	1	0.2	3.5	0.1	0.5	0.7	0.4	0.8	2.5	3	3.7	0.7	0.4	2.4	2.2	12.8	1.9	2.4	2.8	2.3	1.6	1	3.8	1.8	1.3	2.4	4.2	0.3	2.1	0.9	5.5	3.9	0.8	1.8	1	7.9	1.4	0.6	2.7	0	1.8	1.6	0.3	1.6	3	1.9	0.7	3.7	1.3	0.9	1.7	0.3	0.1	2.4	0	0.7	0.4	2.1	1.9	0.3	0.7	0.5	10	1.3	5.1	1	0.5	0.4	2.3	1.1	3.4	1.7	1	0.8	2	1	1.9	0.4	0.5	0.4	11.3	0.8	0.3	1.2	3.7	3	0.3	1.9	0.4	0	0	0.4	2.5	0.8	0.4	0.3	0.5	0.7	1.7	0.8	0.1	2.4	2.6	6.3	0.5	4.7	2.5	3	1.5	3.9	4.3	1	0	0	0	0	0.1	0	0	0	13.4	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	Ciliated cells
GOLGA6C		ENSG00000167195	Golgin A6 family member C	A6NDK9	15	75258599-75270199	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	No human protein/transcript evidence	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	17	testis: 12.5	Cell type enriched	Detected in single	72	Early spermatids: 7.2	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HEL: 1.3;SuSa: 1.6									HPA044978, HPA050087, HPA072134	Supported		Approved	Nucleoplasm,Vesicles,Centrosome						Vesicles	Nucleoplasm, Centrosome	HPA044978: AB_2679165, HPA050087: AB_2681010, HPA072134: 															unprognostic (6.53e-3)			0	0	0	0	0	0	0	0	0	0	0			0.1	0	0.1	0	0	0	0	0	0	0	0.7	0	0	0		0	0	0	0	0		0	0		0	0	0.6	0	0	0	0	0	0	12.5			0		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0.5	0.2	0	0.1	0	0.3	0	0.2	0.2	0	0.1	0	0	0.3	0	0.3	0	1.3	0	0.1	0.3	0	0.4	0.4	0	0	0	0	0	0.1	0	0.3	0	0	0	0	0	0.1	0	0.2	0	0	0	0.2	0	0.1	0	0	0.3	1.6	0.3	0	0.7	0	0.1	0.1	0	0.8	0.2	0	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	7.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Early spermatids
TBC1D16	FLJ20748, MGC25062	ENSG00000167291	TBC1 domain family member 16	Q8TBP0	17	79932343-80035848	Predicted intracellular proteins		GTPase activation		Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	4	Horizontal cells: 290.8	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Group enriched	Detected in some	7	intermediate monocyte: 4.6;naive B-cell: 1.5;non-classical monocyte: 4.7	Group enriched	Detected in many	6	B-cells: 1.5;monocytes: 4.7	Cell line enhanced	Detected in many		ASC diff: 52.5;SK-MEL-30: 55.7	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA024482, HPA065839	Approved		Approved	Intermediate filaments						Intermediate filaments		HPA024482: AB_1857790, HPA065839: AB_2685566	unprognostic (4.53e-3)	unprognostic (1.36e-2)	unprognostic (1.80e-2)	unprognostic (2.06e-2)	unprognostic (4.92e-2)	unprognostic (7.21e-2)	unprognostic (1.05e-3)	unprognostic (1.72e-1)	unprognostic (5.92e-2)	unprognostic (1.13e-1)	unprognostic (2.23e-2)	unprognostic (9.76e-2)	unprognostic (1.52e-3)	unprognostic (3.02e-1)	unprognostic (1.28e-1)	unprognostic (3.65e-3)	unprognostic (3.99e-3)	32.2	8.1	10.1	7.8	18.2	1	32.6	25.5	11.2	10.7	8.6	6	28.4	7.5	11.9	20.9	9.8	12.8	9.3	10	8.1	7.8	18.1	13.2	8.5	13.7	8.7	5.6	11.8	18.7	9.3	6.6	7.1	8.2	17.3	5.8	15.4	25.5	24.2	4.5	15.8	7.9	10.8	8.1	8.7	7.6	5.2	9.5	2.7	9.7	7	3.9	9.2	14.6	1.5	0.3	0.1	4.7	0.1	0.5	0.3	8.2	7.9	12.3	14.4	52.5	27.7	2.3	4.8	4.8	3	3.5	14.8	2.9	0	3.4	8.1	5.8	2.6	12.9	4.5	2.3	0.4	6.1	0	3.6	6.8	8.9	0.1	1.1	31.1	8	6.6	4.8	4.9	13	5.6	1.9	5.6	5.7	5.1	2.1	0.7	14.7	10.8	4.3	6.9	7.8	4.7	3.6	10.2	12.6	16.3	4.3	12.1	55.7	8	7.9	3.7	8.7	10.7	7.7	8.4	4.2	17.2	3	0.9	4.6	3.1	13.5	0	0.3	0	0.1	4.6	0.5	0	0.1	0.2	0.3	1.5	0.2	0.3	0.1	0.1	4.7	0	0	0.3	10.1	18.2	25.5	11.2	8.1	7.8	8.7	5.6	8.2	9.5	0	9.3	0.8	3.6	4.8	6.6	7.2	17.8	2.7	2.3	7	9.8	5.2	8.3	13.8	1	9	3.2	0	19.3	1.1	12.8	9.6	7	16.2	3	290.8	30.5	15.4	43	1.6	5.5	3.8	72.6	1	6.4	21.5	16.9	2.8	7.4	10	7.4	6.5	10.5	0.2	3.4	4	1.6	3.8	5	5.7	Horizontal cells
OR51E2	PSGR	ENSG00000167332	Olfactory receptor family 51 subfamily E member 2	Q9H255	11	4680171-4697854	Cancer-related genes, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins	Olfaction, Sensory transduction	G-protein coupled receptor, Receptor, Transducer	Cancer-related genes	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in many		prostate: 42.1;retina: 14.6	Cell type enriched	Detected in some	13	Intestinal endocrine cells: 74.5	Cancer enriched	Detected in some	274	prostate cancer: 217.5	Not detected	Not detected			Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		ASC TERT1: 5.9;BJ hTERT+: 3.3;hTERT-RPE1: 4.3	Low region specificity	Detected in single			Not detected	Not detected																unprognostic (1.98e-3)	unprognostic (1.91e-1)	unprognostic (6.09e-3)	unprognostic (1.57e-2)	unprognostic (8.00e-4)	unprognostic (3.61e-2)	unprognostic (6.27e-2)	unprognostic (1.66e-1)	unprognostic (3.05e-2)	unprognostic (3.46e-2)	unprognostic (2.97e-1)	unprognostic (3.61e-1)	unprognostic (5.04e-5)	unprognostic (3.34e-2)	unprognostic (4.66e-2)	unprognostic (5.76e-2)	unprognostic (3.29e-1)	0.7	0.2	0.2	5	0.2	0.1	1.7	0.1	0.5	0.6	8.2	0	0.5	0.2	1.6	1.3	0.6	0.6	0.3	1.1	0.2	0.2	0.4	0.1	0.1	0	0.2	0	1.1	0.2	0.1	0.2	5.1	0.4	42.1	2.2	14.6	0.2	2.4	0.5	0.3	0.9	2	0.2	0.1	0.5	0.7	0	0	0.2	0.4	0	1.6	0.3	1.6	0.9	2.2	0.6	0.8	1.2	0.4	0	0	0.1	0.1	0.7	5.9	0.2	0	3.3	0	0.2	0.2	0.3	0.3	0.1	0	0.1	0.1	0	0	0.1	0.1	1.1	1.1	0.3	0	0	0.3	0.4	0	0	0.1	0	4.3	0	0.1	0.1	0.4	0	0.1	0	0.5	0.1	0	0.1	0.3	0	0.3	0.1	0.2	0.2	0.2	0.2	0.1	0.2	0.1	0.1	0	0.5	0.4	0.7	0.3	0	0.4	0	0.1	0.4	0	0	1.5	0.6	0.5	1.2	0.5	0.8	0.8	0.8	0.6	0.3	1.6	0.8	1.1	2.2	0.8	0.5	0.9	0.4	0.4	0.2	0.2	0.1	0.5	0.2	0.2	0.2	0	0.4	0	0	0	0	0	0.1	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	5.6	0	0	0.1	0	74.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.6	0	0	0	0	0	0	0	Intestinal endocrine cells
CA4	CAIV, Car4, RP17	ENSG00000167434	Carbonic anhydrase 4	P22748	17	60149936-60170899	Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins		Lyase	Disease mutation, FDA approved drug targets, Retinitis pigmentosa	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		intestine: 81.7	Cell type enriched	Detected in many	43	Paneth cells: 2128.8	Low cancer specificity	Detected in many			Region enriched	Detected in many	4	cerebellum: 50.1	Cell type enriched	Detected in some	7	neutrophil: 37.0	Lineage enriched	Detected in single	370	granulocytes: 37.0	Cell line enhanced	Detected in some		HUVEC TERT2: 1.5;NTERA-2: 3.4;OE19: 3.9;RPTEC TERT1: 1.9;SuSa: 2.6	Region enriched	Detected in all	5	cerebellum: 336.9	Low region specificity	Detected in many			HPA011089, HPA017258	Enhanced								190000			HPA011089: AB_1845996, HPA017258: AB_1845997	unprognostic (2.07e-2)	unprognostic (7.85e-2)	unprognostic (1.55e-2)	unprognostic (7.78e-3)	unprognostic (8.42e-2)	unprognostic (1.19e-1)	unprognostic (3.19e-2)	unprognostic (5.84e-2)	unprognostic (7.76e-2)	unprognostic (9.74e-2)	unprognostic (1.54e-1)	unprognostic (1.71e-2)	unprognostic (2.68e-3)	unprognostic (8.59e-2)	unprognostic (1.43e-1)	unprognostic (2.45e-1)	unprognostic (4.57e-2)	32.2	0.9	3.4	9.8	4.4	5.7	46.4	50.1	11.8	2.3	81.7	2	31.5	1.4	2.3	17.4	0.9	1.7	12.2	8.8	4.7	2.6	12	0.3	33.3	2.4	3.5	5.2	1.9	9.5	3.3	5.1	3.2	3	2.4	54.9	20.3	4.8	24	10	1	3.2	1.1	2.1	4.9	2.5	1.2	0.3	0.2	23.1	5	0.2	1.7	7.9	0	0	37	0	0	0	0	0	0	0	0	0	0.2	0	0	0.6	0.1	0.3	0	0	0	0.5	0.8	0.1	0	0.3	0	0	0.3	1.3	0	0	0.7	0	0	0	0.3	0	0	0	0.3	1.5	0	0	0	0	0	0	0.3	3.4	3.9	0	0	0.2	1.3	1.9	0	0.7	0.3	0.2	0	0	2.6	0	0.6	0	0.2	0.7	0.4	0.1	0	0	0	0.3	0	0	0	0	5.4	0	0	0	0	0	0	0	0	0	0	37	0	0	0	0	0	3.4	4.4	50.1	11.8	4.7	2.6	3.5	5.2	3	0.3	0	3.7	0	0.2	1.3	0	9.2	0	1.4	1.2	14	0	0	28.2	3.1	0.2	15.8	49.7	0	0.2	0	1.5	0.1	11.5	0	0.5	0	18.6	1.8	0	0	0.6	0.8	0	0	27.9	0	0.1	2128.8	0	18.6	0	6.5	17.9	0	0	1	0	0	32.8	0.3	Paneth cells
GPX4	MCSP, PHGPx	ENSG00000167468	Glutathione peroxidase 4	P36969	19	1103926-1106791	Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins		Developmental protein, Oxidoreductase, Peroxidase	Dwarfism	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in all	4	Late spermatids: 13901.3	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low cell line specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			CAB008630, HPA047224, HPA058546	Enhanced		Approved	Nucleoplasm,Mitochondria	Intracellular and membrane				220000	Nucleoplasm, Mitochondria		CAB008630: AB_1616685, HPA047224: AB_2679990, HPA058546: AB_2683749	unprognostic (8.42e-3)	prognostic favorable (7.18e-4)	unprognostic (8.14e-3)	prognostic favorable (1.84e-5)	unprognostic (1.00e-1)	unprognostic (8.72e-2)	unprognostic (2.53e-3)	unprognostic (8.49e-2)	unprognostic (2.69e-2)	unprognostic (1.47e-1)	prognostic favorable (7.72e-4)	unprognostic (1.29e-1)	prognostic favorable (8.61e-4)	unprognostic (1.61e-2)	unprognostic (2.20e-1)	unprognostic (6.67e-3)	unprognostic (2.96e-2)	163	76.4	63.3	27.1	73.7	33.3	102.3	33.5	83.7	53.3	49.1	42.4	33.8	56.9	27.2	74.7	35.6	38.4	46.9	64.4	54.2	60.2	75.3	119	44.7	41.7	74.6	47.3	47.1	35.1	33.1	54.7	46.4	49.3	44.7	25.5	82.3	61.6	46.9	98.2	36.3	58.5	43.6	46.5	32.4	27.7	170.4	36.5	29.9	52.8	49.8	39.2	51.2	47	56.7	64	85.2	85.2	28.4	58.5	110.5	28.7	32.7	47.3	100	143.5	85.1	52.7	22.8	82.3	43.5	44.4	66.7	39	10.4	24.9	46	36.8	32.4	27.6	33	21.3	58.3	49.9	19.6	29.4	94.1	83.5	23	31.5	84.4	50.3	22	37.1	78.5	60.8	36.5	27.4	26.3	35.9	73.8	38.9	39.5	44.8	64.1	52.8	53.9	6.4	30.1	47.2	71.5	40.8	25.8	44.7	42.4	46.4	30.3	41.4	56.3	51.4	46.3	30.8	79.3	28.5	92.2	62.5	24.3	43.6	46.2	26.5	75.6	85.2	85.2	37	62	43	56.7	54.3	38.6	64	47.8	58.5	41.7	42.4	28.4	68.3	44.1	46.8	110.5	63.3	73.7	33.5	83.7	54.2	60.2	74.6	47.3	49.3	36.5	166.7	171	287.8	409.7	453	334.7	225.6	313.4	467.1	233.2	448.4	92.3	508.2	1349.6	448.1	3338.1	251.8	690.8	163.5	318.5	1086.5	512.4	561.5	339.3	667.2	1047.6	197	381.4	302	479.7	13901.3	356.4	828.7	642.7	2643.8	270.1	239.3	473.5	361.2	294.2	2040.3	183.4	239.3	381.6	862.4	171.8	408.3	818	223.7	258.1	558.8	Late spermatids
ZNF610	FLJ36040	ENSG00000167554	Zinc finger protein 610	Q8N9Z0	19	52336245-52367778	Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	DNA-binding		Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in many			Cell type enriched	Detected in many	4	Early spermatids: 28.1	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		U-266/84: 11.7									HPA055771, HPA078134	Enhanced		Approved	Nucleoplasm						Nucleoplasm		HPA055771: AB_2682914, HPA078134: AB_2732372	unprognostic (1.13e-1)	unprognostic (5.48e-3)	unprognostic (1.52e-1)	unprognostic (8.75e-2)	unprognostic (3.65e-2)	unprognostic (1.27e-1)	unprognostic (3.34e-1)	unprognostic (2.84e-1)	unprognostic (1.83e-1)	prognostic favorable (3.38e-4)	unprognostic (5.54e-2)	unprognostic (1.14e-2)	prognostic favorable (1.05e-7)	unprognostic (2.46e-2)	unprognostic (1.11e-2)	unprognostic (1.88e-2)	unprognostic (5.73e-3)	2.3	4.8	7.9	2.1	11.9	0.8	5.5	11	9.7	5.5	3	6.9	3.3	1.5	5.1	11.7	2.1	7.4	4.3	4.2	7.6	7.7	5.9	1	3.3	2.6	7.5	7.2	14.3	2.9	7.5	6.8	4.5	10	7.6	2.9	5.7	2.2	4.1	1.9	1.6	1.8	4.4	8.5	4.1	2.7	18.1	7.3	3.6	7.7	0.2	2.1	3.6	2.4	3.6	1.5	4	0.5	2.5	4.8	1.6	0.2	0	6	4.9	4	3.4	4.6	1.8	3.3	1.1	3.3	0	0.4	0.4	3.7	0.8	7.4	0.2	0	0	2.8	0.1	2.9	0.1	0.3	0.2	4.8	0	1.5	4.6	0.1	1.2	0.2	2.9	3.4	3.3	0.3	0.2	5.4	1.2	3.1	0.9	5.7	0	0.4	2.2	4.5	0.6	2.1	4.3	7.5	4.3	0.1	0.4	1.8	8.9	3.6	2.6	2.7	0.3	2	0.1	2.3	0.2	11.7	0	0	0.1	2.3	4	0.5	1.1	2.9	0.1	4.4	2.5	2.4	2.3	1.4	3.6	4.8	2	1.4	2.5	0.1	1.5	3.2	1.6	7.9	11.9	11	9.7	7.6	7.7	7.5	7.2	10	7.3	0	0.3	0	0.8	0	2.9	2.6	2.5	2.7	3.4	3.5	3.9	1.2	5	1.6	28.1	1.1	0	0	0	1.4	0.8	0.9	2.3	0	0.5	0	0	0.6	0.8	7	0.9	0	1.7	0	0	3.8	0.2	0	1.1	0.6	2.4	6.5	0.4	5	2.3	0.3	0.6	0	0.4	0.3	Early spermatids
AQP2		ENSG00000167580	Aquaporin 2	P41181	12	49950741-49958881	Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters	Transport		Diabetes insipidus, Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	38	ductus deferens: 178.6;kidney: 96.5;seminal vesicle: 108.2	Cell type enriched	Detected in some	444	Collecting duct cells: 3930.9	Group enriched	Detected in some	6	renal cancer: 1.7;stomach cancer: 1.8	Not detected	Not detected			Group enriched	Detected in some	14	intermediate monocyte: 1.4;non-classical monocyte: 1.3	Lineage enriched	Detected in single	14	monocytes: 1.4	Cell line enhanced	Detected in some		CAPAN-2: 1.5;EFO-21: 6.9;HEL: 2.0;HMC-1: 4.2;OE19: 7.3	Not detected	Not detected			Not detected	Not detected			HPA046834	Enhanced											HPA046834: AB_2679830	unprognostic (2.10e-1)	unprognostic (3.77e-2)	unprognostic (6.96e-3)	unprognostic (4.48e-3)	unprognostic (3.60e-2)			unprognostic (9.51e-2)	unprognostic (2.21e-1)	unprognostic (1.43e-2)	unprognostic (2.65e-2)	unprognostic (7.38e-3)	unprognostic (5.92e-2)	unprognostic (4.60e-2)	unprognostic (2.01e-2)	unprognostic (1.11e-1)		0.1	1.1	0.1	0	0.1	0	0.1	0.1	0.1	0.1	0.1	0	178.6	0	0.1	3.3	0.1	0.1	0	0.6	0.1	0.1	96.5	0.1	0.1	0	0.1	0	0.1	0.1	0	0.1	0	0	2.9	0	0	0.2	108.2	0.1	0.2	0.1	0	0.1	0.1	0.1	0.4	0	0	0.1	0	0	0.5	0.1	0	0	0	1.4	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	1.5	0	6.9	0	0	0	0	0	0	0	0	2	0	0	0	0	4.2	0	0	0	0	0.1	0	0	0.2	0	0	0	0	0.5	0	7.3	0	1.1	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.4	0	0	0	0	0	0	0	0	0	0	1.3	0	0	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0	0.2	0	0	0	3930.9	0	0	0	0	0.1	0	0	0	0.2	0.4	0	0	4.6	0	0	0	0	0	0	0	8.3	0	0	0	0	0	0	0	8.9	1.7	0	0	0	0	0	0	0	0	0	0	Collecting duct cells
LENG8	KIAA1932, MGC40108, pp13842	ENSG00000167615	Leukocyte receptor cluster member 8	Q96PV6	19	54448887-54462037	Predicted intracellular proteins, Predicted membrane proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in all	5	Rod photoreceptor cells: 564.9	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Cell line enhanced	Detected in many		HEK 293: 102.5	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA042004, HPA042056, HPA061571	Uncertain		Approved	Nucleoplasm,Cytosol						Nucleoplasm	Cytosol	HPA042004: AB_10794642, HPA042056: AB_10795389, HPA061571: AB_2684562	unprognostic (2.09e-2)	unprognostic (3.24e-3)	unprognostic (5.14e-3)	unprognostic (2.19e-1)	unprognostic (4.42e-2)	prognostic favorable (7.59e-4)	unprognostic (1.38e-2)	unprognostic (1.77e-1)	unprognostic (1.92e-2)	unprognostic (4.45e-3)	unprognostic (5.11e-3)	unprognostic (8.85e-3)	prognostic unfavorable (3.30e-7)	unprognostic (3.64e-2)	unprognostic (6.92e-2)	unprognostic (1.71e-1)	prognostic favorable (2.73e-6)	58.7	37.3	45.7	53.2	47.3	48.4	30.7	81.5	55.3	37.9	32.9	48.1	54.4	78.1	56.3	66.3	22.9	44.8	39.2	24.1	42.2	21.6	35	22.7	36.2	45.8	52.1	30.2	50.3	62.7	13.8	46.4	27.4	38.1	41.9	22.1	48.9	66.7	59.1	36.5	37.2	75.5	35.6	34.3	80	53.2	32.6	57.5	24.8	42.2	18.7	33.5	31.5	32	4	5.6	8	1.9	1.7	1.6	0.6	14.5	11.4	14.6	7.4	4.6	7.5	7.8	12.2	1.9	2.3	4.5	9.2	21.1	11.4	5.3	9.9	0.6	19.3	4.7	5.6	1.7	19.2	102.5	17.4	31.4	6.4	5	2.6	14	16.8	8.7	1.4	5.8	20	3.5	8.8	13.2	16.5	2.9	5	10.7	13.6	3.4	3.3	2.6	17.3	4.3	16.1	6	4.3	11.8	6.1	1.3	9	2.8	7.8	8.8	3.8	16.9	10.3	10.7	1.6	12.9	15.6	7.3	4.6	8.4	18.6	6.7	3.9	1.9	2.3	1.6	1.2	1.6	1.4	0.8	1.5	1	4	1.5	1.1	8	1.7	0.9	5.6	1	0.6	45.7	47.3	81.5	55.3	42.2	21.6	52.1	30.2	38.1	57.5	17.9	30.7	24.9	18.7	25.5	123.6	1.7	45.9	21.4	29.6	38.4	106	15.1	1.7	17.8	25.8	24.8	65.9	23.3	27.1	10.2	22.7	34.5	10.5	37.6	22.3	90.6	100.9	44.2	43.7	9.1	40.3	25.1	23.6	18	78.8	36.3	27	52.6	34.6	5.3	564.9	19.4	19.6	16.7	13.6	33.6	17.6	19.5	50.5	29.3	Rod photoreceptor cells
LAIR2	CD306	ENSG00000167618	Leukocyte associated immunoglobulin like receptor 2	Q6ISS4	19	54497879-54510687	CD markers, Predicted intracellular proteins, Predicted secreted proteins		Receptor		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	4	blood: 12.8;lymphoid tissue: 19.6;pituitary gland: 7.1;placenta: 15.5	Cell type enriched	Detected in some	9	Extravillous trophoblasts: 233.4	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Cell type enriched	Detected in some	4	T-reg: 12.8	Lineage enriched	Detected in single	21	T-cells: 12.8	Group enriched	Detected in some	5	BEWO: 6.9;Hep G2: 3.3														Secreted - unknown location								unprognostic (1.99e-3)	unprognostic (7.49e-2)	unprognostic (4.19e-2)	unprognostic (1.02e-2)	unprognostic (1.42e-1)	unprognostic (4.86e-4)	unprognostic (1.06e-2)	unprognostic (8.37e-2)	unprognostic (1.16e-1)	unprognostic (3.93e-1)	unprognostic (2.21e-1)	unprognostic (9.52e-2)	unprognostic (3.68e-9)	unprognostic (1.21e-2)	unprognostic (3.15e-3)	unprognostic (3.40e-5)	unprognostic (6.71e-2)	0.9	0.5	0.6	5.9	1.7	1.6	0.5	0.2	1.3	0.4	0.6	1.3	0	0.4	0.5	1.3	0.7	0.5	1.3	0.4	1.4	3	0.6	0.8	3.2	12.3	0.6	0.5	0.2	0.9	0.1	7.1	15.5	1.3	0.8	1.3	0.4	0.5	0.4	0.6	0.5	1.2	0.5	1.5	6.6	1	1.2	0.4	19.6	0.5	0	2	0.3	0.3	0	0	0.1	0.1	0.6	12.8	1.8	0	0	0	0	0	0	6.9	0	0	0	0	0	0	0.2	0	0	0.1	0	0	0	0	0.1	0	0.2	0	3.3	0	0.3	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0.6	0	0	0	0	0	0	0	0	0.1	0	0	0	0.3	0.5	0	0.4	0	0	0.3	0	0	0.7	0.3	0.1	0	1.1	0	0	0.1	0	0.2	0	0.4	0	3	2	0	0	0.8	2.7	0.1	0.6	0.1	0	12.8	1.8	0.6	1.7	0.2	1.3	1.4	3	0.6	0.5	1.3	0.4	0	0.3	0	0	0.1	0	0	0	0	0	0	0	8.1	0	0	0.1	0	0	0	0.2	233.4	0.5	0	0	0	21.7	0	0	0	0.3	0	0	0	1.7	0	0	0	0.5	0	0	0	0	0	0	0	0.2	0.1	26.9	24.5	0	0	Extravillous trophoblasts
UBXN6	UBXD1, UBXDC2	ENSG00000167671	UBX domain protein 6	Q9BZV1	19	4444999-4457822	Plasma proteins, Predicted intracellular proteins	Ubl conjugation pathway			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in all	4	Late spermatids: 1030.1	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low cell line specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA040906, HPA041313, HPA061872	Approved		Approved	Golgi apparatus,Cytosol						Golgi apparatus, Cytosol		HPA040906: AB_10794997, HPA041313: AB_10795004, HPA061872: AB_2684629	unprognostic (1.53e-1)	unprognostic (3.18e-2)	unprognostic (2.50e-2)	prognostic favorable (5.68e-5)	unprognostic (1.67e-1)	unprognostic (2.65e-3)	unprognostic (1.83e-2)	unprognostic (1.41e-2)	unprognostic (1.09e-1)	unprognostic (3.48e-1)	prognostic favorable (6.95e-4)	unprognostic (3.93e-2)	prognostic favorable (2.78e-5)	unprognostic (4.61e-2)	unprognostic (2.67e-1)	unprognostic (1.43e-1)	unprognostic (1.79e-1)	29.1	47.7	29	20	38	38.4	22.9	30.5	45.9	21	21.8	12.4	42.3	26.2	23.3	45.9	26.3	24.9	35.6	35.1	29.7	21.8	29.2	37.6	23.4	26.6	25.4	30.5	35.1	45.3	18.9	35.6	22.9	23.3	23.7	8.1	20.8	42.1	46.7	72	25.4	28.9	30.3	21.7	22.2	22.8	41.5	18.4	11.9	38.8	42.2	12	26.9	22.5	7.4	13.6	12.9	10.3	3.6	8.7	6.1	21.1	14.9	7.2	15.5	18.2	22.7	10.8	21.7	25.9	15.9	16.9	9.2	17.9	9.5	19.8	21.3	8.1	12.3	5.5	16.6	5.8	16.6	12	7.9	15.8	12.2	30	9.9	15.9	20.6	22	12.4	12.1	19.4	19.3	13.1	16.2	25.8	11.7	13.4	19.6	16.8	11.5	8.2	13.1	9	10.3	22.3	15	13.3	20.9	30.3	12.1	12.6	35.2	3.5	14.9	16.2	23.2	21.1	16.3	44.9	14.2	58.1	22.8	9.4	40.4	18.6	18.7	8.5	9.2	12.9	5.5	10.3	8.7	6.8	6.5	7.3	8.9	7.4	7.7	6.1	9.1	3.6	6	13.6	6.9	6.1	29	38	30.5	45.9	29.7	21.8	25.4	30.5	23.3	18.4	38.7	26.7	33.5	31.1	33.1	37.4	40.3	53.5	13.4	14.8	41.8	25.5	47.8	68	49.1	229.6	25.1	103.4	163.5	56.3	38	42.3	43.5	34.5	55.5	48	12.7	45	38.1	35.1	1030.1	92.6	36.5	50.6	50.5	58.2	45.3	60	59.6	68.6	86.4	28.5	71.1	28.3	142.6	29.6	35.9	66.6	27.7	54.3	44.3	Late spermatids
SERPINF2	A2AP, AAP, ALPHA-2-PI, API, PLI	ENSG00000167711	Serpin family F member 2	P08697	17	1742836-1755268	Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins	Acute phase	Protease inhibitor, Serine protease inhibitor	Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	21	liver: 417.7	Cell type enriched	Detected in many	11	Hepatocytes: 830.3	Cancer enriched	Detected in all	6	liver cancer: 450.6	Not detected	Not detected			Cell type enriched	Detected in some	4	plasmacytoid DC: 19.8	Lineage enriched	Detected in single	27	dendritic cells: 19.8	Cell line enriched	Detected in some	32	Hep G2: 57.1	Low region specificity	Detected in single			Not detected	Not detected			HPA001885, CAB024863	Approved				Secreted to blood			11900	110000000000			CAB024863: , HPA001885: AB_1079922	unprognostic (2.17e-3)	unprognostic (2.56e-3)	unprognostic (2.48e-1)	unprognostic (7.57e-3)	unprognostic (3.69e-2)	unprognostic (1.45e-2)	prognostic favorable (2.26e-5)	unprognostic (1.44e-1)	unprognostic (2.32e-2)	unprognostic (1.38e-1)	unprognostic (1.88e-3)	unprognostic (2.18e-1)	unprognostic (1.09e-3)	unprognostic (7.05e-2)	unprognostic (2.81e-1)	unprognostic (7.68e-3)	unprognostic (2.93e-1)	0.9	0	0.2	0.6	0.2	0	1.8	0.2	0.2	0.6	0.3	0.2	6.6	0	0.7	17.2	0.2	2.1	0.2	0.3	0.2	0	10.2	417.7	1.3	3.4	0.2	0.2	0.7	0.8	0	0.2	0.2	0.8	2.1	0	1.8	0.5	9	0.2	0.4	1	0.2	0.2	0.6	0.2	1.7	0.2	0.2	0.7	0.2	0.5	0.6	0.4	0.2	19.8	0.5	0.7	0.4	0	0.4	0.3	1.7	0	0	0.1	0.1	0	0	0	0	0	0	1.1	0.2	0.3	0	0	0.1	0	0.6	0	0	0	0	0.2	57.1	0.4	0.1	0	0.5	0.4	0	0.1	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0.3	0.2	0	0	0	0	0.2	0	0.4	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0.7	0.5	0	0.2	0	0.2	0	0	4.6	0.1	0	0	0	0.4	0	19.8	0	0.4	0.2	0.2	0.2	0.2	0.2	0	0.2	0.2	0.8	0.2	3	15.8	13.7	5.7	1.3	0.1	0.6	25.5	5.3	4.5	1.8	5.9	0.1	8.3	0	0.5	0.6	1	23.3	4.4	0.1	1.9	2.5	1.1	830.3	7.4	0	4.1	10.4	21.5	0	31.4	11.4	1.7	16.2	1	0	5.7	3.5	25.1	73.8	0.4	0	2.3	0.2	0.5	1.4	0.2	4.4	1.7	1	Hepatocytes
KLK4	EMSP, EMSP1, KLK-L1, PRSS17, PSTS	ENSG00000167749	Kallikrein related peptidase 4	Q9Y5K2	19	50906352-50910738	Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins	Biomineralization	Hydrolase, Protease, Serine protease	Amelogenesis imperfecta, Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in some	9	prostate: 79.3	Cell type enriched	Detected in some	23	Glandular cells: 120.1	Cancer enriched	Detected in many	55	prostate cancer: 463.7	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in many		CAPAN-2: 8.0;HaCaT: 9.8;OE19: 8.8;SK-BR-3: 6.3	Not detected	Not detected			Low region specificity	Detected in many			HPA051839	Enhanced				Secreted in male reproductive system							HPA051839: AB_2681632	unprognostic (3.58e-2)	unprognostic (2.26e-1)	unprognostic (1.23e-3)	unprognostic (1.66e-3)	unprognostic (3.11e-2)	unprognostic (4.35e-1)	unprognostic (3.18e-1)	unprognostic (6.66e-2)	unprognostic (9.69e-2)	unprognostic (8.23e-3)	unprognostic (1.26e-1)	unprognostic (1.07e-1)	unprognostic (4.20e-3)	unprognostic (3.27e-3)	unprognostic (2.21e-2)	unprognostic (1.64e-2)	unprognostic (1.34e-1)	0.2	0.8	0.1	0.3	0.1	0.1	0.7	0.2	0.5	2	1.2	0	3.8	1.8	1.5	7.7	0.4	0.2	0.1	0.1	0.3	0.2	0.2	0.1	0.2	0	0.2	0	0.1	0.1	0	0.1	0.1	0.5	79.3	0.8	0.2	3.2	2.1	0.7	2.4	1.2	0.6	0.1	0.1	0.3	0.6	0.1	0	8.7	0	0	0.2	0.2	0.1	0.4	0.6	0.1	0	0.3	0	4.9	2	0.2	0.3	0	0	4.4	0.1	0	0	0	4.5	8	0.5	0.4	0.1	0.2	9.8	0	5.3	0	1.3	1.3	1.5	3.6	1.7	0	1.6	2.2	0	2.5	0	0	0.3	0	0.4	0.9	4.1	0	1.2	0.1	2.4	0.1	8.8	0.4	0.3	0.5	1.1	0	3.2	0	0.6	0.3	6.3	0	0.2	5.1	0.4	1.1	0.3	0.3	1.3	0.3	2.6	1	0.5	0.1	0.3	0	0	0	0	0.3	0.1	0	0.1	0	0	0	0	0	0	0.6	0	0	0.4	0	0	0.1	0.1	0.2	0.5	0.3	0.2	0.2	0	0.5	0.1	0	0	0	2.9	0.2	0.5	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0.2	0	0	120.1	0	0	0	0	0	0	0	0	0.9	0	0	0	2.2	0	0	0	5.3	0	0	0	0	0	0.2	0.5	0	0	0.6	1.7	Glandular cells
KLK2		ENSG00000167751	Kallikrein related peptidase 2	P20151	19	50861568-50880567	Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins		Hydrolase, Protease, Serine protease	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	29	prostate: 163.5	Cell type enriched	Detected in some	36	Glandular cells: 729.8	Cancer enriched	Detected in some	1666	prostate cancer: 989.9	Not detected	Not detected			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Cell line enhanced	Detected in many		BEWO: 5.0;NB-4: 10.2									HPA000764	Supported				Secreted in male reproductive system							HPA000764: AB_1079700	unprognostic (3.05e-2)	unprognostic (2.40e-1)	unprognostic (1.69e-1)	unprognostic (8.53e-2)		unprognostic (1.15e-1)		unprognostic (8.97e-2)	unprognostic (3.22e-1)	unprognostic (6.44e-2)	unprognostic (8.06e-2)	unprognostic (3.61e-1)	unprognostic (2.11e-3)	unprognostic (7.56e-2)	unprognostic (8.10e-2)	unprognostic (1.68e-1)	unprognostic (2.04e-1)	0	0.1	0	0.1	0	1.1	0.2	0	0.6	0	0	0	0.6	0.1	0.1	0.5	0	0.1	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	163.5	0	0.1	2.3	0	0.2	0	0.1	0.2	0	0	0	0.6	0	0	1.1	0	0	0.2	0	2.2	1.9	5.7	2.2	1.6	1.3	0.5	1.7	1.1	0.6	1.6	0	0.9	5	0.5	0.3	0.2	0.2	0.6	0.8	1.8	0.2	0	0.8	2	0.2	0	0.3	1.7	1.1	0	1.3	0.4	0	0.3	3.1	0.5	0.3	0.3	0.4	0.5	0	1.1	1.5	2	0.3	1.8	1.2	10.2	1.1	1.7	0	0.9	0	2.9	0	1.7	0.9	1.6	0.3	1.4	1.3	0.2	1.3	0.4	0.8	1.3	1.9	4.9	1.7	1.8	3.2	0.8	1.9	1.7	1.4	0.9	2.2	1.6	1.2	1	1	1	0.8	1	0.5	2.2	0.8	1.3	5.7	1.6	0.8	1.9	0.4	0.5	0	0	0	0.6	0	0	0	0	0	0	0	1.1	0	13.7	0.2	0	0.3	0	0	0	0	0	0	0	0	1.9	0	0	0	0	0.1	0	729.8	0	0	0.1	0	0	0	0	3.7	0	0	0	0	0	0	0	0	0	0	0	0	0	20.4	5	0.6	0	0	0	9.2	Glandular cells
KLK13	KLK-L4	ENSG00000167759	Kallikrein related peptidase 13	Q9UKR3	19	51056206-51065114	Cancer-related genes, Enzymes, Predicted secreted proteins		Hydrolase, Protease, Serine protease	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	5	esophagus: 100.5	Cell type enriched	Detected in some	7	Late spermatids: 184.3	Cancer enhanced	Detected in many		head and neck cancer: 42.3	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	11	HaCaT: 20.8	Not detected	Not detected							HPA062136	Enhanced				Secreted in other tissues							HPA062136: AB_2684694	unprognostic (1.99e-3)	unprognostic (1.89e-1)	unprognostic (1.25e-1)	unprognostic (3.66e-2)		unprognostic (3.43e-1)		unprognostic (2.99e-2)	unprognostic (1.69e-1)	unprognostic (6.76e-2)	unprognostic (2.18e-2)	unprognostic (8.30e-2)	unprognostic (7.07e-6)	unprognostic (7.33e-2)	unprognostic (2.53e-1)	unprognostic (6.38e-2)	unprognostic (7.06e-2)	0.1	0.1	0.1	0.1	0.1	0	0.3	0.1	0.2	15.7	0.4	0.2	0.1	0.2	0.3	0.1	100.5	0.2	0.9	0.1	0.1	0	0.1	0.1	0.2	0.1	0.1	0.1	0.4	1.7	0	0.5	0.1	0.2	0.1	0	0.3	12.4	0.1	1.2	2.1	0.4	0.1	0.1	0.1	0.2	6.1	0.1	0.1	0.1	17.9	12.8	0.1	19.4	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	1.8	0	0	20.8	0.4	0	0	0	0	0	0	0	0	0	0.5	0.3	0	0	0	0	0	0.2	1.9	0	0	0	0	0	0.3	0	0	0	0.1	0	0	0	0	0	0	0	0.1	0.2	0.4	1.1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0.7	0	0	0	0.2	0.3	0	0	0	0	0	0	0.1	0.1	0.1	0.2	0.1	0	0.1	0.1	0.2	0.1	0	0	0	0.6	1.8	0	0.4	0	0	6.8	0	0	0	0	0	27.9	0.1	0	0	1.2	0	0	0.7	0	0	0	0	1.7	0	0	184.3	0.3	0	1.7	0	0	0	0.3	0	0.4	0	0	0	0	0.7	0.7	1.1	0	0	0	2	Late spermatids
KRT1	EHK1, KRT1A	ENSG00000167768	Keratin 1	P04264	12	52674736-52680407	Disease related genes, Plasma proteins, Predicted intracellular proteins			Disease mutation, Ichthyosis, Palmoplantar keratoderma	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	5	skin 1: 606.8	Cell type enriched	Detected in some	6	Suprabasal keratinocytes: 8767.9	Group enriched	Detected in many	5	head and neck cancer: 313.8;melanoma: 478.9	Not detected	Not detected			Group enriched	Detected in some	25	memory CD4 T-cell: 5.8;memory CD8 T-cell: 2.1;naive CD4 T-cell: 1.8	Lineage enriched	Detected in single	59	T-cells: 5.8	Group enriched	Detected in some	14	HaCaT: 44.9;hTCEpi: 19.0									CAB002153, HPA017917, HPA062908	Enhanced								65000000000			CAB002153: AB_563790, HPA017917: AB_1852192, HPA062908: AB_2684901	unprognostic (8.05e-2)	unprognostic (8.49e-3)	unprognostic (5.06e-3)	unprognostic (6.44e-2)	unprognostic (1.25e-2)	unprognostic (1.53e-1)	unprognostic (2.07e-1)	unprognostic (3.24e-1)	unprognostic (1.30e-1)	unprognostic (2.16e-1)	unprognostic (9.24e-2)	unprognostic (6.63e-2)	unprognostic (3.23e-4)	unprognostic (1.58e-1)	unprognostic (3.40e-2)	unprognostic (1.36e-1)	unprognostic (1.09e-2)	0.3	0	0.1	0.1	0.1	0.4	24.2	0.1	0.3	63.4	0.1	0.1	0.1	0	38.6	0.1	2.5	0.1	0.2	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.7	0.1	0.1	0	0.1	16.2	0.1	2	606.8	0.1	0.1	0.2	0.1	0	0.1	0.1	24.1	0.1	114.6	0.4	0.1	46.2	0	0	0	0	0	5.8	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	44.9	0	0	0	0	0	0.1	0	0	0	0	0.8	0	19	0	0	0	0	2.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	5.8	2.1	0	0	1.8	0.1	0	0	0	0	0.1	0.5	0.1	0.1	0.1	0.3	0.1	0	0.1	0.1	0.1	0.1	0	2.2	0	0	1493.7	0	0.2	0	1.4	1.2	0	0	0	0	0	0	0	0	0	0	0	0.2	0	239	0	0.2	0	0	0	0	0	0	0.5	251.4	0	0	0	0	0	0	0	0	0	0.3	0	0	8767.9	0	0	0	0.1	Suprabasal keratinocytes
RCOR2		ENSG00000167771	REST corepressor 2	Q8IZ40	11	63911221-63916844	Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	Repressor		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 16.6	Cell type enriched	Detected in some	4	Bipolar cells: 15.7	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in many		AF22: 18.1;NTERA-2: 23.4;SCLC-21H: 36.7;SH-SY5Y: 24.4	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA021638	Uncertain		Approved	Nucleoplasm,Vesicles,Midbody		Yes				Nucleoplasm	Vesicles, Midbody	HPA021638: AB_10960885	unprognostic (1.96e-2)	unprognostic (1.15e-1)	unprognostic (4.10e-2)	unprognostic (1.98e-3)	unprognostic (3.10e-2)	unprognostic (5.86e-2)	unprognostic (2.33e-4)	unprognostic (8.64e-2)	unprognostic (1.46e-1)	unprognostic (4.80e-2)	unprognostic (1.67e-1)	unprognostic (1.72e-3)	unprognostic (2.62e-1)	unprognostic (1.75e-1)	unprognostic (3.51e-1)	unprognostic (9.93e-2)	unprognostic (6.06e-3)	0.8	1.4	3.3	0.7	8	0.3	0.7	9.3	16.6	3	1.4	3.4	0	2	3.5	2.6	1.2	3.7	1.6	5.9	4	2.6	0.7	0.4	1	0.3	2.4	3.8	5.2	1.4	3.2	5	1.8	1.8	1.7	1.7	3.3	2.3	1.7	3.1	0.6	1.6	2.5	2.2	0.5	1.2	7	2.5	4.1	0.6	0.6	0.3	2.5	0.8	0.2	0	0	0	0	0	0	0	0.5	18.1	1.2	0.3	1.5	5.4	0.1	0.3	0.2	0.6	0.7	0.1	0.1	0.2	0.4	0.3	0.2	7.9	0	0.2	0.2	1	0.2	0.1	5.8	3	0	0.1	1.8	0	0.3	0	0	0.1	2.4	0.9	0	0	1.6	1.6	6.4	23.4	2.3	0	5.8	1	0.5	0	0	36.7	24.4	0.1	1.6	0.9	4.6	1.3	2.2	0.1	0	1.2	0	0	0.1	0	0.2	0	0.1	0.8	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	3.3	8	9.3	11	4	2.6	2.4	3.8	1.8	2.5	0	0	0	0	0	15.7	1.7	0	0	0	0	0	0.4	0	0	0	0	0.4	0	0.2	3.7	0.5	0	0	0	0.2	3.2	1.2	0	0	0	1.4	0	0	0	1.1	0.9	0.3	0	0.4	0	2.1	0	0.2	0.7	2.6	0.3	0.7	0	1.1	0	Bipolar cells
CABP2	DFNB93	ENSG00000167791	Calcium binding protein 2	Q9NPB3	11	67518912-67524517	Disease related genes, Predicted intracellular proteins	Hearing, Sensory transduction, Vision		Deafness, Disease mutation, Non-syndromic deafness	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in some	8	retina: 10.7	Cell type enriched	Detected in some	8	Bipolar cells: 54.5	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in single		AF22: 1.9	Region enriched	Detected in single	22	cerebellum: 5.2	Not detected	Not detected																																	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0.1	0	0	0.3	0.5	0	0	0	0	0	0.1	0	0	0	0	0	0	10.7	0	0	0	0	0.1	0	0	0	0	1.3	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	1.9	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	54.5	0	0	0	0	0	3.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.2	0	0	0	0	0	0	0	0	0	1.9	0	0	0	0	6.5	0	0	0	0.1	0	0	0	0	0	Bipolar cells
CYP7A1	CYP7	ENSG00000167910	Cytochrome P450 family 7 subfamily A member 1	P22680	8	58490178-58500236	Enzymes, Predicted intracellular proteins	Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism	Monooxygenase, Oxidoreductase		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	70	liver: 50.4	Cell type enriched	Detected in single	12	Hepatocytes: 4.7	Cancer enriched	Detected in single	96	liver cancer: 28.4	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in single		BJ hTERT+: 1.4	Not detected	Not detected			Low region specificity	Detected in many																unprognostic (5.20e-2)			unprognostic (1.93e-2)	unprognostic (1.77e-2)		prognostic favorable (3.19e-4)	unprognostic (7.60e-2)	unprognostic (5.31e-2)	unprognostic (1.50e-1)	unprognostic (1.18e-1)	unprognostic (2.64e-1)	unprognostic (8.43e-3)	unprognostic (3.01e-1)	unprognostic (1.57e-2)	unprognostic (1.51e-1)		0.2	0	0	0	0	0	0.1	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	50.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.2	0	0	0.1	0	0.1	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0	0	0.1	0.3	0.3	0.5	0	0	1.4	0.1	0.1	0	0.1	0	0	0	0.5	0.1	0	0	0	0	0	0.2	0	0.2	0.2	0	0.1	0.9	0	0.2	0.5	0	0.4	0.1	0.2	0	0.2	0.2	0	0.1	0	0.1	0	0.1	0	0	0	0	0.1	0	0.5	0	0	0.3	0	0.1	0	0	0	0	0	0	0	0	0.3	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0.2	0	0	0	0	0	0	Hepatocytes
SOST	DAND6, VBCH	ENSG00000167941	Sclerostin	Q9BQB4	17	43753731-43758788	Disease related genes, Predicted secreted proteins	Wnt signaling pathway	Heparin-binding	Disease mutation	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		kidney: 17.1;retina: 7.2	Cell type enriched	Detected in single	6	Collecting duct cells: 1.8	Group enriched	Detected in some	8	head and neck cancer: 1.2;lung cancer: 6.2;urothelial cancer: 2.5	Group enriched	Detected in some	6	basal ganglia: 1.0;cerebral cortex: 3.1	Cell type enhanced	Detected in single		eosinophil: 2.3	Lineage enriched	Detected in single	23	granulocytes: 2.3	Group enriched	Detected in some	34	HaCaT: 10.2;SuSa: 6.3	Group enriched	Detected in some	11	basal ganglia: 1.7;cerebellum: 1.1	Region enhanced	Detected in some		basal ganglia: 1.1						Secreted to extracellular matrix								unprognostic (1.26e-1)	unprognostic (4.06e-2)		unprognostic (6.57e-2)	unprognostic (2.55e-3)	unprognostic (3.37e-1)		unprognostic (4.67e-2)	unprognostic (1.16e-1)	unprognostic (8.35e-2)	unprognostic (1.38e-2)		unprognostic (1.20e-1)	unprognostic (8.92e-2)	unprognostic (1.56e-1)		unprognostic (7.90e-2)	0.3	0.1	0.1	1.4	1	0.1	0.1	0.1	3.1	0.2	0.1	0	1.1	0.1	0.1	0.1	0.1	0.1	0.1	2.9	0.1	0.1	17.1	0.1	2.4	0.1	0.1	0.3	0.1	0.1	0.1	0.2	0.1	0.2	0.1	0.1	7.2	1.1	0.4	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0.3	0.5	0.1	0.1	0.2	0	0	2.3	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	10.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	6.3	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0.9	0	2.3	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0.1	1	0.1	3.1	0.1	0.1	0.1	0.3	0.2	0	0	0	0	0	0	0	0.3	0	0	0	1.8	0	0	0	0	0	0	0	0	0	0.1	0	0.1	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	Collecting duct cells
ABCA3	ABC-C, ABC3, EST111653, LBM180	ENSG00000167972	ATP binding cassette subfamily A member 3	Q99758	16	2275881-2340746	Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters	Transport		Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 30.8;lung: 75.8	Cell type enriched	Detected in many	6	Alveolar cells type 2: 382.0	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		AN3-CA: 15.1;HDLM-2: 15.2;SCLC-21H: 21.2;SH-SY5Y: 15.3;T-47d: 34.9	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA007884	Enhanced		Approved	Nucleoplasm,Cytosol						Nucleoplasm, Cytosol		HPA007884: AB_1078077	unprognostic (2.64e-1)	unprognostic (2.19e-2)	unprognostic (6.09e-3)	unprognostic (2.61e-3)	unprognostic (2.20e-1)	unprognostic (1.35e-1)	unprognostic (2.90e-2)	unprognostic (1.86e-1)	unprognostic (6.58e-3)	unprognostic (3.67e-2)	unprognostic (1.71e-3)	unprognostic (2.22e-2)	unprognostic (5.33e-2)	unprognostic (3.32e-2)	unprognostic (7.85e-2)	unprognostic (2.91e-1)	unprognostic (1.30e-1)	6.3	6.2	12.9	3.4	15.3	1.6	7	21.9	30.8	3	3.8	13.1	1.8	2.7	3.2	4.2	3.6	4.9	3.3	5.6	14.6	13.8	3.9	1.5	75.8	3.9	11.4	13.1	3.2	9.6	14.8	6	4.7	18.3	5.3	2.1	4.9	8.5	5	5	4.2	2.5	5	11.3	3.7	3	7.2	6.1	5.6	16.2	0.5	6.4	3	1.3	0.2	0.5	0	0.6	2	1.5	0.4	0.3	9.7	1.8	15.1	0.4	0	0.1	2.6	0.6	1	1.1	1.3	1.5	0.1	3.8	1.2	0.9	0.2	8.7	0.1	0.3	15.2	5.8	1	1.1	0.2	1.3	0.1	1.6	0.1	0.2	0.1	0.5	6.2	14.7	0.1	10.4	0	0	12.9	0	1	2	2.3	4.7	2.4	0.3	1.7	8.7	0.3	21.2	15.3	1.8	10.7	0.2	0.8	34.9	0.9	4.2	0.1	0.5	4.1	4.3	2.8	1.2	0	2.1	5.2	0.1	0	0.1	0	1.5	0.1	0.8	0.2	0.6	1.4	0.5	0.1	0.6	1.5	0	2	0.6	0	0.3	0.4	12.9	15.3	21.9	30.8	14.6	13.8	11.4	13.1	18.3	6.1	65.5	382	0	0.4	0.6	16.5	5.1	2.5	4	17	17.4	11.8	0	0	4.6	7.7	4.2	0.2	0	3.3	0	1.4	1.9	27.8	0.9	0.9	17.5	5.2	2.5	2.7	2.7	1.7	1.6	1.7	2.8	0.7	6.9	2.4	0	3.2	1.5	9.5	6.5	3.1	1.9	14	1.4	0	2.5	0.6	0.1	Alveolar cells type 2
SCARA5	FLJ23907, MGC45780, NET33	ENSG00000168079	Scavenger receptor class A member 5	Q6ZMJ2	8	27869882-27992727	Predicted intracellular proteins, Predicted membrane proteins	Ion transport, Iron transport, Transport	Receptor		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in many			Cell type enriched	Detected in some	9	Leydig cells: 125.7	Low cancer specificity	Detected in many			Low region specificity	Detected in some			Cell type enriched	Detected in single	117	plasmacytoid DC: 17.3	Lineage enriched	Detected in single	173	dendritic cells: 17.3	Cell line enriched	Detected in some	20	ASC diff: 73.9	Low region specificity	Detected in some			Low region specificity	Detected in many			HPA024661	Approved								1500000			HPA024661: AB_1853902	unprognostic (2.76e-2)	unprognostic (7.20e-3)	unprognostic (1.44e-2)	unprognostic (3.53e-2)	unprognostic (2.34e-2)	unprognostic (4.62e-2)	unprognostic (2.01e-1)	unprognostic (2.15e-1)	unprognostic (9.13e-2)	unprognostic (2.40e-1)	unprognostic (4.21e-2)	unprognostic (1.10e-1)	unprognostic (7.09e-6)	unprognostic (3.48e-2)	unprognostic (2.29e-1)	unprognostic (7.62e-2)	unprognostic (1.97e-1)	26.9	1.7	0.7	4.6	0.5	0	18.5	0.6	1.1	9.2	17.3	0.4	14.3	3.8	2.3	31	23.6	8.8	13.5	42.4	0.7	0.1	0.8	1.6	8.2	3.6	2.8	0.6	5.2	2.6	0	2.3	18.5	4.1	9.8	16.4	34.3	11.4	3.6	6.1	13	9.8	37.2	1.4	1.1	11	12.3	0.3	0.5	9.1	15.9	2.2	28.4	54.6	0	17.3	0	0	0	0	0.1	0	2.4	0	0	73.9	3.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0.4	0	0	0	0	3.5	1.3	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0.2	0	0	0	0	0	0	0	0.8	0.1	0	0	0	0	0	2.1	0	0	0	0	0	0	0.8	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	17.3	0	0.1	0.7	0.5	0.6	1.1	0.7	0.1	2.8	0.6	4.1	0.3	0	0	0	0	5.8	0	3.1	0	0	0	0	0	0.1	0	0	1.3	2.9	0	0	0	0.3	13.4	0.1	0	0	0.3	0	0	0	0	2.7	125.7	0.3	6.8	0	0	2	0	0	10.6	0	0	0	2.7	0.9	0.9	5.3	0.1	0	0	0.1	Leydig cells
FOXI1	FKHL10, FREAC6	ENSG00000168269	Forkhead box I1	Q12951	5	170105897-170109725	Plasma proteins, Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	Activator, DNA-binding		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		kidney: 37.0;salivary gland: 12.4	Cell type enriched	Detected in some	13	Distal tubular cells: 23.2	Group enriched	Detected in many	7	breast cancer: 5.8;renal cancer: 23.1	Not detected	Not detected			Cell type enriched	Detected in single	48	eosinophil: 4.7	Lineage enriched	Detected in single	48	granulocytes: 4.7	Group enriched	Detected in some	5	MCF7: 4.0;SuSa: 6.6	Not detected	Not detected			Not detected	Not detected			HPA071469	Enhanced		Uncertain	Nucleoli,Vesicles						Nucleoli, Vesicles		HPA071469: AB_2686403	unprognostic (3.06e-1)	unprognostic (1.24e-1)	unprognostic (2.09e-1)	unprognostic (2.48e-2)		unprognostic (8.06e-2)		unprognostic (7.47e-2)		unprognostic (2.73e-1)	unprognostic (1.52e-2)	unprognostic (9.71e-3)	unprognostic (4.88e-3)	unprognostic (6.20e-2)	unprognostic (1.34e-2)		unprognostic (2.22e-1)	0	0	0	0	0	0	7.7	0	0	0.1	0	0	7.5	0	0	0.8	0	0	0.3	0	0	0	37	0	0.4	0	0	0	0	0.2	0	0.3	0	0	3.3	0	0	12.4	3.7	0	2.2	0.1	0	0	0	0	0.1	0	0.3	0	0	0.8	0.1	0	0	0	4.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	1.1	0	0.9	1	0	0	0	0.2	0	0.1	0.1	0	0	0.1	0.6	0	0	0	0	0	0	0	0	0.1	0	4	0	0	0	0	0	0	0	0	0	0	0.8	0	0	0.6	0	6.6	0	0	0	0	0	0	0	0.1	0.7	0	0	0	0	0	0	4.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0.2	0	0	0	1.8	0	0	23.2	0	0	0	0	0	0	0	0	0.7	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0.1	0	0.8	0	0	0	Distal tubular cells
XIRP1	CMYA1, DKFZp451D042, Xin	ENSG00000168334	Xin actin binding repeat containing 1	Q702N8	3	39183210-39192596	Predicted intracellular proteins		Actin-binding		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	9	heart muscle: 95.0;skeletal muscle: 219.0	Cell type enriched	Detected in single	1478	Cardiomyocytes: 827.4	Cancer enhanced	Detected in some		head and neck cancer: 2.0	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HSkMC: 9.3;LHCN-M2: 2.3;RH-30: 6.2;SuSa: 1.9									HPA016750, HPA018458, CAB026391	Enhanced		Approved	Nucleoplasm,Plasma membrane,Actin filaments						Plasma membrane, Actin filaments	Nucleoplasm	CAB026391: , HPA016750: AB_1858884, HPA018458: AB_1858885	unprognostic (2.19e-1)	unprognostic (6.40e-2)	unprognostic (1.13e-1)	unprognostic (9.75e-2)	unprognostic (2.76e-1)	unprognostic (2.43e-2)	unprognostic (4.94e-2)	unprognostic (2.66e-3)	unprognostic (1.66e-3)	unprognostic (1.46e-1)	unprognostic (5.30e-2)	unprognostic (6.26e-2)	unprognostic (1.02e-5)	unprognostic (2.08e-2)	unprognostic (2.78e-2)	unprognostic (6.86e-4)	unprognostic (4.12e-2)	1	0.1	0	0.4	0	0	0	0	0.1	0	0.1	0.2	0	0	0	1.7	1.9	0	0.4	95	0	0	0	0	0.2	0	0.1	0	0	0.4	0	0.1	0.2	0.3	1.1	0	0	1.3	0	219	0	0.1	0.1	0	0.2	0	0	0	0.1	4.9	18.2	2.7	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0.1	0	0	0.2	0	0	0	0.1	0	0	0	0	0.3	0.6	0.1	0	0	0	0	0	1.1	9.3	0	0	0	0	0	0	0.1	0	2.3	0	0	0	0	0	0	0	6.2	0.2	0	0	0	0	0	0	0.1	1.9	0	0	0	0	0.7	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0.1	0	0.3	0	0	0	0	0	0	0	827.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0.1	0	0	0	0	Cardiomyocytes
KCNG4	Kv6.4	ENSG00000168418	Potassium voltage-gated channel modifier subfamily G member 4	Q8TDN1	16	84218667-84239750	Predicted membrane proteins, Transporters, Voltage-gated ion channels	Ion transport, Potassium transport, Transport	Ion channel, Potassium channel, Voltage-gated channel		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in some		retina: 8.8	Cell type enriched	Detected in some	18	Bipolar cells: 29.7	Not detected	Not detected			Low region specificity	Detected in many			Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		AN3-CA: 3.2	Region enhanced	Detected in many		cerebellum: 101.5	Low region specificity	Detected in many																				unprognostic (3.54e-1)									unprognostic (6.67e-2)				0.7	2.8	2.6	0.2	1.8	1.8	0.1	0.7	3.5	0	0.1	1.6	0	0.1	0.3	0.8	0.4	0.2	0.3	0.1	2.8	2	0.2	0.1	0.1	0.5	2.8	0	0.6	0.3	0	1.1	0.2	2.3	0.4	0.2	8.8	0.4	0.1	1	2.1	0.4	0.1	1.3	0.4	0.4	0.7	1	0	0.4	0	0.1	0.4	0	0.9	0.8	2.4	0.6	1.3	0.6	0.2	0.3	0.3	0.9	3.2	0.3	0.3	0.9	0.6	0	0	0	0.6	0.7	0.5	0.4	0.2	0.1	0.4	0	0	0.2	0.2	0.7	0.5	1.1	1	0.2	0.1	0.3	0.1	0	0.1	0.3	0.6	0.1	0.5	0.6	1.4	0	0.8	0.3	1	0.8	0	0.8	0.4	0.9	0.1	0	0.8	0.8	0.7	0.7	0.4	1.8	0.3	0.6	0.3	0.5	0.5	0.4	0.9	0.4	0.6	0.3	0.4	0.7	0.5	0.6	2.4	0.6	0.6	0.4	0.3	0.3	0.4	0.4	0.3	0.2	0.9	0.4	0.6	2.1	1.3	0.3	0.8	0.4	0.2	2.6	1.8	0.7	3.5	2.8	2	2.8	0	2.3	1	0	0	0	0	0	29.7	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	1.6	0	0	0	0	0	0	0	0	0	Bipolar cells
SFTPC	BRICD6, PSP-C, SFTP2, SMDP2, SP-C	ENSG00000168484	Surfactant protein C	P11686	8	22156913-22164479	Disease related genes, Predicted intracellular proteins, Predicted secreted proteins	Gaseous exchange		Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	718	lung: 664.5	Cell type enriched	Detected in some	10	Alveolar cells type 2: 80228.9	Cancer enriched	Detected in some	218	lung cancer: 226.3	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		BEWO: 8.4;NB-4: 10.7;SCLC-21H: 4.6;U-2197: 22.7	Low region specificity	Detected in many			Not detected	Not detected			HPA010928	Enhanced				Secreted in other tissues							HPA010928: AB_1857425		unprognostic (1.84e-1)			unprognostic (1.96e-1)	unprognostic (1.44e-1)		unprognostic (1.13e-1)	unprognostic (2.97e-1)		unprognostic (4.97e-2)	unprognostic (1.08e-1)		unprognostic (1.50e-1)		unprognostic (1.32e-2)		0.1	0.8	0.2	0.3	0.5	0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0	0.2	0.1	0.3	0.1	0.1	0.1	664.5	0.1	0.4	0.1	0.1	0.1	0	0.1	0.1	0.9	0.1	0	0.1	0.2	0.3	0.1	0	0.1	0.1	0.5	0.4	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0.1	0	0	0.4	0	8.4	0	0	0	0	0	0	0	0	0	0.1	0.2	0	0	0	0	0	0	0.8	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0.1	10.7	0.3	0	0	0.4	0	0	0	0	4.6	0.3	0	0	1.3	0	0	0	0	0	0.1	22.7	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0.5	0.1	0.2	0.3	0.1	0.4	0.1	0.9	0.1	7929.7	80228.9	0	0	1.5	0	0.3	0	623.7	2602.4	0	0	0	0	0	6.2	0	0	0	0	0	0	0	909.1	0	0	0	0	0	0	20.2	0	0	21.9	0	0	0	0	0	0	0	0	6.5	0.1	0	0.1	0.5	0	0	0	0	Alveolar cells type 2
HFE2	haemojuvelin, hemojuvelin, HFE2A, HJV, JH, RGMC	ENSG00000168509	Hemochromatosis type 2 (juvenile)	Q6ZVN8	1	146017468-146036746	Disease related genes, Predicted intracellular proteins, Predicted membrane proteins			Disease mutation	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		liver: 49.4;skeletal muscle: 128.9;tongue: 28.2	Cell type enriched	Detected in some	21	Hepatocytes: 163.4	Cancer enriched	Detected in some	96	liver cancer: 87.9	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		CACO-2: 1.1;HSkMC: 5.0;K-562: 4.8;RH-30: 1.7	Low region specificity	Detected in many																42000				unprognostic (2.30e-1)			unprognostic (6.98e-4)	unprognostic (7.06e-2)	unprognostic (1.11e-2)	unprognostic (2.77e-3)	unprognostic (2.55e-1)	unprognostic (8.50e-2)	unprognostic (2.36e-1)	unprognostic (7.14e-2)	unprognostic (1.18e-1)	unprognostic (8.96e-8)	unprognostic (6.61e-2)	unprognostic (2.72e-1)		unprognostic (1.76e-2)	2.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.4	2.5	0	0	14	0	0	0	49.4	0	0	0	0	0	0	0	0	0	0	0.4	0	0	1.9	0	128.9	0	0	0	0	0	0	0.3	0	0	0.8	28.2	2	0.1	0	0	0.2	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0.1	0	0	1.1	0	0	0.1	0	0	0	0	0.2	0	0	0.1	0.1	0	0.1	0	0.4	0.1	5	0	0	0	0	0	0	4.8	0.1	0.7	0	0	0	0.5	0	0	0.1	1.7	0	0	0	0	0	0.5	0.2	0	0	0	0.1	0	0	0	0	0	0	0	0.8	0	0.1	0	0	0	0	0.1	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.9	0	0	0	0	7.6	0	0	0	0	0	0	0	0.8	0	0	0	0	0.1	0	0	0	163.4	0	0	0	2.5	5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Hepatocytes
COL3A1	EDS4A	ENSG00000168542	Collagen type III alpha 1 chain	P02461	2	188974320-189012746	Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins			Aortic aneurysm, Disease mutation, Ehlers-Danlos syndrome	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		cervix, uterine: 304.2;endometrium 1: 208.0	Cell type enriched	Detected in many	4	Fibroblasts: 1855.8	Low cancer specificity	Detected in all			Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		AF22: 81.7;ASC diff: 151.5;ASC TERT1: 263.7;fHDF/TERT166: 106.1;HHSteC: 104.2;HSkMC: 196.1	Low region specificity	Detected in many			Low region specificity	Detected in some			HPA007583, CAB016766, CAB059993	Approved		Approved	Endoplasmic reticulum	Secreted to extracellular matrix				16000000	Endoplasmic reticulum		CAB016766: , CAB059993: AB_2314211, HPA007583: AB_1078548	unprognostic (1.12e-1)	unprognostic (2.03e-2)	unprognostic (1.02e-1)	unprognostic (6.01e-2)	unprognostic (2.78e-1)	unprognostic (2.04e-1)	unprognostic (6.94e-2)	unprognostic (6.77e-3)	unprognostic (3.57e-3)	unprognostic (2.60e-2)	unprognostic (1.89e-2)	unprognostic (1.99e-1)	prognostic unfavorable (3.59e-10)	unprognostic (1.70e-3)	unprognostic (3.76e-2)	unprognostic (7.61e-2)	unprognostic (6.17e-3)	41.7	9.7	0.7	34.1	3.4	0	29.7	0.8	1.2	304.2	41.3	1.3	23.8	3.9	208	82	31.3	32.3	116.3	41	1	0.3	14.4	12.1	32.9	39.3	1.3	1.1	54.9	14.4	1.7	2.3	161.2	3.2	27.4	18.3	32	15.1	22.4	14.5	28.3	24.2	114.1	1.7	29.5	25.3	45.5	0.7	9.5	12.8	44.8	15.4	64.8	51.9	0	0	0	0	0	0	0	0	0	81.7	3.1	151.5	263.7	0	32.9	29.3	14.4	12.9	0.4	0	0	0	106.1	0	0	0	0	1.6	0	0	0	13.9	0	104.2	0.1	0	196.1	0	17.5	2.8	0	0.7	0	0	0	8.6	0	0	0	0.1	0	0.1	0	2.3	0	0	0.4	0	1.2	0.8	0	0	60.2	0	0	0	0.1	1.7	7	0	0.1	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.7	3.4	0.8	1.2	1	0.3	1.3	1.1	3.2	0.7	3	20.2	0	0.4	152.4	0	9.8	0	2.7	2.3	0	0	40.3	0	2.5	21.6	52.5	0	0	0	34.9	1855.8	0.5	5.8	0.9	81.7	0	5.8	358.5	0.8	11.8	299.1	3.8	163.6	0	0	0	6.1	0	221.7	0	0	446.3	215.4	1.1	1	136.1	105.6	0	0	0.3	Fibroblasts
CA7		ENSG00000168748	Carbonic anhydrase 7	P43166	16	66844379-66854153	Enzymes, FDA approved drug targets, Predicted intracellular proteins		Lyase	FDA approved drug targets	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in some	5	intestine: 37.2	Cell type enriched	Detected in some	58	Paneth cells: 2512.0	Cancer enhanced	Detected in some		colorectal cancer: 0.9	Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		CACO-2: 1.3;HAP1: 1.8;NTERA-2: 1.6;REH: 3.4;SCLC-21H: 2.7;THP-1: 5.6	Low region specificity	Detected in many			Low region specificity	Detected in many			HPA047237	Uncertain											HPA047237: AB_2679994	unprognostic (8.77e-4)	unprognostic (5.23e-4)	unprognostic (1.57e-1)	unprognostic (1.96e-2)	unprognostic (2.19e-1)	unprognostic (2.16e-2)		unprognostic (7.90e-2)	unprognostic (1.59e-1)	unprognostic (1.84e-2)	unprognostic (9.62e-2)	unprognostic (1.69e-2)	unprognostic (7.12e-3)	unprognostic (8.47e-2)	unprognostic (5.20e-1)	unprognostic (1.90e-2)	unprognostic (6.46e-2)	0.2	0.2	3.2	0.4	7.5	0.2	0.2	3.9	7.7	0.2	37.2	0.3	0	4.8	0.3	0.9	0.3	0.2	0.2	0.2	6.3	0.5	0.2	0.2	0.2	0.2	0.7	2.9	0.2	0.2	0.2	0	0.2	1.8	0.2	32	0	1.1	0.4	0.2	0.2	22.8	1	0.1	0.2	0.2	0.5	1.3	0.1	0.2	0	0.2	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.3	0.2	0	0.4	0	0	0	1.8	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.6	0	0.9	3.4	0	0	0	0	2.7	0	0	0	0	0	0	5.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.2	7.5	3.9	7.7	6.3	0.5	0.7	2.9	1.8	1.3	0	0	0	0.1	0	0	0.4	0	0	0	0	0	0	0	0	0	0	43.2	0	0	0	0	0.4	0	0	0	0	15.6	0	0	0	0	0	0	0	19.1	0	0	2512	0	0	0	0	0	0	0.2	0	0	0	25.5	0	Paneth cells
TSPY2	TSPYQ1	ENSG00000168757	Testis specific protein, Y-linked 2	A6NKD2	Y	6246223-6249019	Predicted intracellular proteins	Differentiation, Gonadal differentiation, Spermatogenesis	Developmental protein		Evidence at protein level	Evidence at protein level	No human protein/transcript evidence	Evidence at transcript level		Tissue enriched	Detected in single	104	testis: 13.5	Cell type enriched	Detected in some	8	Spermatogonia: 26.0	Cancer enriched	Detected in single	7	testis cancer: 0.9					Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	426	U-266/70: 41.9;U-266/84: 43.2									HPA049384, HPA067289	Supported		Approved	Cytosol						Cytosol		HPA049384: AB_2680738, HPA067289: 															unprognostic (3.69e-1)			0.1	0	0	0	0	0	0	0	0	0	0			0	0	0	0	0	0	0	0	0	0	0	0	0	0		0	0	0	0	0		0	0		0	0	0	0	0	0	0	0	0	13.5			0		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	41.9	43.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.3	26	0	0	0	0	0	Spermatogonia
SHOX2	OG12, OG12X, SHOT	ENSG00000168779	Short stature homeobox 2	O60902	3	158095954-158106503	Predicted intracellular proteins, Transcription factors		Developmental protein, DNA-binding		Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in many			Cell type enriched	Detected in some	7	Early spermatids: 89.3	Low cancer specificity	Detected in many			Group enriched	Detected in some	4	pons and medulla: 10.1;thalamus: 2.9	Cell type enriched	Detected in single	4	neutrophil: 2.9	Lineage enriched	Detected in single	4	granulocytes: 2.9	Cell line enhanced	Detected in many		ASC diff: 15.5;SH-SY5Y: 15.0;THP-1: 24.8	Group enriched	Detected in some	5	midbrain: 43.1;thalamus: 60.0	Group enriched	Detected in some	36	midbrain: 13.2;pons and medulla: 15.8;thalamus: 28.2														unprognostic (2.62e-1)	unprognostic (6.32e-2)	unprognostic (3.32e-2)	unprognostic (1.08e-3)	unprognostic (1.51e-1)	unprognostic (1.69e-3)	unprognostic (2.28e-3)	unprognostic (7.66e-2)	unprognostic (7.35e-2)	unprognostic (2.23e-1)	unprognostic (6.31e-2)	unprognostic (8.75e-3)	unprognostic (0.00e+0)	unprognostic (4.20e-3)	unprognostic (2.12e-1)	unprognostic (3.95e-2)	unprognostic (2.76e-3)	10	0.3	0.1	0.1	0.1	0.4	6.6	0.1	0.2	10	0.5	3	2.8	0	1.1	1.4	2.5	0.2	0.6	9.9	0.1	1.5	0.1	0.2	0.4	4.1	0.4	0.1	1	1.5	0	0.4	1.3	10.1	1.5	0.1	0.3	2.8	1.1	3.6	2.5	0.3	1.3	0.3	0.1	0.3	4.4	2.9	0	0.7	2.4	1.1	1.7	4.6	0.3	0	2.9	0.7	0	0.1	0	3.2	0.3	0.1	5.3	15.5	9.7	0.9	5.9	2.1	2.9	5.5	1.1	0.4	0.7	0.1	7.6	6.3	0.1	6.2	0	1.2	3.6	1.9	8.9	1.3	0	0	0.7	7.3	4.4	0.1	2.9	0.3	9.5	0	0.4	2.4	0.5	1.4	0.2	0	0.4	0	0	0.2	3.7	4.9	0.8	0	0	1.8	15	0.7	0.1	3.2	0.1	0.1	24.8	0.3	9.7	2.1	10.7	9.4	0.7	1.6	0.5	9.3	4.9	9.7	0	0.2	0	0	0.2	0	0	0.1	0	0	0.3	0	0	2.9	0	0.7	0	0	0	0.1	0.1	0.1	0.2	0.1	1.5	0.4	0.1	10.1	2.9	0	0	0	0	1.3	0	1.6	0	0	0	0	0	0	0	0	89.3	0.1	0	0	0.2	0.6	1.1	0	0	0	0.3	0	0	0	1.9	7.9	2	0	0	0	0	0	0	0	0	0	0	12.9	4.7	5.5	1.4	0.4	0.2	0	0	0	Early spermatids
HTR1E	5-HT1E	ENSG00000168830	5-hydroxytryptamine receptor 1E	P28566	6	86937306-87016683	FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins		G-protein coupled receptor, Receptor, Transducer	FDA approved drug targets	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in some		brain: 16.4;ovary: 13.3	Cell type enriched	Detected in some	4	Early spermatids: 6.1	Not detected	Not detected			Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	11	PC-3: 2.9;SH-SY5Y: 11.6					Low region specificity	Detected in many			HPA004931	Approved											HPA004931: AB_1856706					unprognostic (2.25e-2)					unprognostic (1.32e-1)		unprognostic (6.29e-2)			unprognostic (4.52e-2)	unprognostic (1.25e-1)		0.5	0.6	8.9	0.6	13.3	0.5	0.5	5.4	16.4	1.6	0.5	0	0	0.5	5.1	1.1	0.6	0.5	0.8	0.5	4.1	2.8	0.5	0.5	0.5	0.5	1.8	11.4	13.3	0.8	0.5	0.3	0.5	2.2	1.1	0.5	0	0.5	1.2	0.5	0.5	0.5	2.9	0.6	0.5	3.6	1.4	1.5	0	2.7	0	0.5	0.5	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0.3	0	0	0	0	2.9	0	0	0	0	0	0.3	11.6	0	0	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	8.9	13.3	5.4	16.4	4.1	2.8	1.8	11.4	2.2	1.5	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	6.1	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	1.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.4	0	0	0	0	0	Early spermatids
SOX14	SOX28	ENSG00000168875	SRY-box 14	O95416	3	137764284-137766338	Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	DNA-binding, Repressor		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		brain: 5.4;placenta: 15.1;prostate: 3.1	Cell type enriched	Detected in some	4	Cytotrophoblasts: 12.6	Cancer enhanced	Detected in many		prostate cancer: 2.8	Group enriched	Detected in many	15	hypothalamus: 5.4;midbrain: 1.6;pons and medulla: 4.4;thalamus: 3.3	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	6	hypothalamus: 2.1;midbrain: 5.9	Group enriched	Detected in many	7	midbrain: 10.3;pons and medulla: 5.6;thalamus: 16.5																unprognostic (1.43e-1)	unprognostic (1.63e-1)								unprognostic (1.88e-2)		unprognostic (2.49e-3)	unprognostic (5.08e-1)			0	0	0	0	0.1	0	0	0	0.2	0.1	0.1	1.9	0	0	0	0	0.1	0	0	0	0.1	5.4	0	0	0	0	1.6	0	0	0	0	0.4	15.1	4.4	3.1	0.1	0	0	0	0	0	0.3	0	0.2	0	0	0.4	3.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0.8	0	0	0	0	0	0	0	0.2	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0.2	0.1	5.4	1.6	0	4.4	3.3	0	0	0	0	0	0	0.2	0	0	0	0	0	12.6	0	0	0	0	0	0	0	0.8	0	0.2	0	0	1.1	0	1.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.9	0	0	0	Cytotrophoblasts
PLA2G4F	PLA2G4F/Z	ENSG00000168907	Phospholipase A2 group IVF	Q68DD2	15	42139034-42156636	Enzymes, Predicted intracellular proteins, RAS pathway related proteins	Lipid degradation, Lipid metabolism, Phospholipid degradation, Phospholipid metabolism	Hydrolase		Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		lung: 30.4;skin 1: 48.1	Cell type enriched	Detected in many	5	Alveolar cells type 2: 54.9	Low cancer specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	5	OE19: 14.1;RT4: 10.6	Not detected	Not detected			Low region specificity	Detected in some			HPA042713, HPA056752	Enhanced		Approved	Nucleoplasm,Vesicles						Vesicles	Nucleoplasm	HPA042713: AB_10793982, HPA056752: AB_2683226	unprognostic (1.99e-1)	unprognostic (6.21e-3)	unprognostic (1.59e-1)	prognostic unfavorable (2.00e-4)		unprognostic (1.06e-2)	unprognostic (2.32e-3)	unprognostic (1.48e-2)	unprognostic (5.85e-2)	unprognostic (2.25e-1)	unprognostic (4.79e-2)	unprognostic (6.65e-2)	unprognostic (1.21e-2)	unprognostic (9.32e-2)	unprognostic (1.11e-1)	unprognostic (4.55e-2)	unprognostic (1.63e-1)	0.1	0.1	0	2.5	0.3	0.3	1.8	0	0.1	4.5	11	0	4.7	4.2	0.4	9.7	10.4	0.2	3.1	1	0	0	10.8	0.2	30.4	0.1	0	0	0.1	0.1	0.7	4.1	0.3	0	3.3	2.5	0	5.3	2.8	8.6	48.1	12.3	1.1	0.1	0.2	1.6	0.1	0	6.2	1.6	14.9	3.4	2.2	6.3	0.6	0.3	0.2	0.1	0	0.3	0.2	0.2	0	0.1	0	0	0	0.2	0	0	0.1	0	1.4	0.4	0.1	0.1	0	0	0.1	0	0	0	0.1	0	0.1	0.1	0.1	0	0.2	0.1	0	2.5	0	0	0	0	0.1	0	0.1	0	1	0	0.1	0	14.1	0.1	0	0	0.1	0	10.6	0.6	0.1	0	1.1	0	0.1	1.1	0	0.1	0.1	0	0.1	0	0.1	0.2	0	0	0.1	0	0.1	0	0	0	0.1	0.3	0.2	0	0	0	0.6	0	0	0.2	0	0	0.3	0.2	0.2	0	0.3	0	0	0	0	0	0	0	0	8.9	54.9	0	3.3	4.8	0	3.2	0	0	0	5.2	0	1.5	3.3	0.2	0	0	12	0	1.2	0.7	0.2	2.7	2.3	0	0.1	0	0	0	0	0	0	0.1	1.7	0	4	0	0.2	4.8	0	0	0	0	0	0	0	12	1	0	4.3	1.6	Alveolar cells type 2
ENHO	C9orf165, UNQ470	ENSG00000168913	Energy homeostasis associated	Q6UWT2	9	34521040-34523041	Predicted secreted proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enriched	Detected in many	4	brain: 79.6	Cell type enriched	Detected in many	5	Muller glia cells: 53.5	Cancer enhanced	Detected in many		glioma: 44.8	Low region specificity	Detected in all			Cell type enriched	Detected in some	7	myeloid DC: 19.4	Lineage enriched	Detected in many	7	dendritic cells: 19.4	Cell line enhanced	Detected in many		AN3-CA: 13.4;NTERA-2: 18.5;SCLC-21H: 9.4;SH-SY5Y: 8.9	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA042575	Approved				Secreted to blood			4240000				HPA042575: AB_10794914	unprognostic (2.63e-2)	unprognostic (9.53e-3)	unprognostic (2.46e-1)	prognostic unfavorable (3.71e-4)	unprognostic (1.30e-1)	unprognostic (7.51e-2)	unprognostic (9.93e-2)	unprognostic (1.34e-2)	unprognostic (5.86e-2)	unprognostic (2.19e-2)	unprognostic (2.78e-4)	unprognostic (1.75e-1)	unprognostic (2.57e-3)	unprognostic (6.47e-2)	unprognostic (1.87e-1)	unprognostic (5.50e-2)	unprognostic (8.76e-2)	1.5	1.9	58	1.9	59.3	1.7	3.7	15.5	79.6	2.9	3.9	13.9	0	3	1.4	1.4	1.5	3.6	1.8	1.8	36.3	37.5	1.5	12	2	1.4	52	27.1	1.5	2.6	1.2	1	1.3	13.7	5.2	3.2	0.1	1.8	1.7	1.6	3.8	3.6	1.3	17.1	1.6	5.3	6.4	13.4	0	1.4	0	1.4	1.5	0	0	19.4	0	2.5	2.7	0	0.4	0.1	1	5.3	13.4	0.1	0	0.3	0	0	2.1	2.2	0.5	0.2	2.2	3.7	0	4.3	0.2	6.1	0.4	0.4	0.3	5.9	0	0.1	1.2	0.2	0	3	0	0.1	0	0.2	0	0	4.3	0	1.9	0.5	0.3	0	0	18.5	1	3.7	0.1	0	0.3	0.5	0	9.4	8.9	0.7	4.1	0.4	0.7	0.3	1.7	0	0.4	2.1	0.1	0.1	1.1	1.3	0.1	0.5	0	3.1	0	0.1	0	0	2.5	0	0	0	0	19.4	0	0	0	0	2.7	0.7	1	0	0.4	58	59.3	15.5	37	36.3	37.5	52	27.1	13.7	13.4	0	0.3	0	2.5	2.5	4.3	0.4	0	0	0	0	2	0.1	0	0.7	0.7	0	0	0	0.2	0.2	1	10.2	0	2.6	2.6	4.8	1.7	1.3	0.3	2.7	0.3	3.2	1.7	1	0	53.5	0	0	0.4	0.3	2.8	0	0.1	0.5	5.9	2.8	0	0	0	0.5	Muller glia cells
CTRB1	CTRB	ENSG00000168925	Chymotrypsinogen B1	P17538	16	75219000-75226338	Enzymes, Predicted intracellular proteins, Predicted secreted proteins	Digestion	Hydrolase, Protease, Serine protease		Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level		Tissue enriched	Detected in single	2272	pancreas: 1908.8	Cell type enriched	Detected in some	12	Exocrine glandular cells: 26371.2	Cancer enriched	Detected in some	1905	pancreatic cancer: 962.5	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		EFO-21: 6.4;HDLM-2: 5.0;U-2 OS: 2.5;U-251 MG: 1.6														Secreted to digestive system												unprognostic (1.76e-1)				unprognostic (2.62e-1)	unprognostic (3.55e-1)	unprognostic (1.57e-1)	unprognostic (5.22e-2)	unprognostic (4.43e-3)	unprognostic (2.96e-1)		unprognostic (1.17e-2)		0.2	0	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0.2	0.2	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.8	1908.8	0	0.1	0.1	0.1	0.1	0	0.1	0.2	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0	0.7	0.2	0	0	0	0	0	0	0.2	0	0	0	0.3	0	0	0	6.4	0	0.4	0	0	0	0	5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0.1	0	0	0	0.2	0	0.2	0	0	0	0	2.5	0.2	1.6	0	0.1	1.1	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0.2	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	26	0	0	0	0	26371.2	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	265.1	0	0	2264.9	0	0	0	0	0	0	0	0	0	0	0	0	0	Exocrine glandular cells
CTRB2		ENSG00000168928	Chymotrypsinogen B2	Q6GPI1	16	75204096-75207185	Enzymes, Predicted intracellular proteins, Predicted secreted proteins	Digestion	Hydrolase, Protease, Serine protease		Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	5240	pancreas: 3761.5	Cell type enriched	Detected in some	5	Exocrine glandular cells: 45669.7	Cancer enriched	Detected in single	1696	pancreatic cancer: 540.0	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		EFO-21: 5.1;HDLM-2: 1.9;U-2 OS: 9.3;U-251 MG: 1.9;U-266/84: 2.6;U-698: 2.4														Secreted to digestive system									unprognostic (9.41e-4)			unprognostic (2.20e-1)	unprognostic (1.28e-2)		unprognostic (2.10e-1)	unprognostic (2.92e-2)	unprognostic (2.77e-1)	unprognostic (5.95e-2)	unprognostic (9.56e-2)	unprognostic (3.54e-3)	unprognostic (7.06e-2)	unprognostic (2.17e-1)	unprognostic (7.57e-2)		0.1	0	0.1	0.1	0.1	0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.6	3761.5	0	0.1	0.1	0.1	0.1	0	0.1	0.2	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.7	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0	0.1	0	0	0.3	0	0.1	0	0	0	0.2	0	0	0	0	0.3	0	5.1	0	0.1	0	0	0	0	1.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.8	0	0.3	0	0	0	0	0.1	0	0	0.2	0	0	0	0	0.2	0.3	0	0	0	0	9.3	0	1.9	0.1	2.6	2.4	0.2	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0.1	0.1	0.1	0.2	0.1	0	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0.9	0	0	0	0	0	0	0	107.9	1	0	0	0	45669.7	0	0	0.1	0	0	0.3	0	0	0	0	6.3	0.3	0	0	376.1	0	0	8606.5	0	0.7	0	0	0	0	0	0	0	0	0	0	0	Exocrine glandular cells
GOT1L1	MGC33309	ENSG00000169154	Glutamic-oxaloacetic transaminase 1 like 1	Q8NHS2	8	37934281-37940129	Predicted intracellular proteins		Aminotransferase, Transferase		Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	16	testis: 16.4	Cell type enriched	Detected in some	7	Early spermatids: 100.0	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in single		SuSa: 1.6	Low region specificity	Detected in many			Not detected	Not detected			HPA028778	Uncertain											HPA028778: AB_10602138														unprognostic (6.93e-3)	unprognostic (5.46e-1)			0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0.2	0	0	0	0	0	0	0	0	0	1	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	16.4	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.6	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	100	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.6	0.6	0	0	0	0	0	0	0	0.4	0	0	0	0	0.2	0.4	0	0	0	0	0	Early spermatids
HSPB3	HSPL27	ENSG00000169271	Heat shock protein family B (small) member 3	Q12988	5	54455601-54456384	Disease related genes, Predicted intracellular proteins	Stress response		Disease mutation, Neurodegeneration, Neuropathy	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		heart muscle: 106.0;skeletal muscle: 46.1;tongue: 22.3	Cell type enriched	Detected in some	55	Cardiomyocytes: 353.4	Cancer enriched	Detected in many	6	head and neck cancer: 7.9	Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		BJ hTERT+: 37.9;fHDF/TERT166: 17.0;HSkMC: 7.4;LHCN-M2: 5.5	Low region specificity	Detected in many			Not detected	Not detected			HPA062124			Supported	Nuclear speckles						Nuclear speckles		HPA062124: AB_2684690		unprognostic (1.44e-1)	unprognostic (2.21e-1)	unprognostic (1.78e-3)	unprognostic (3.06e-1)	unprognostic (2.25e-3)		unprognostic (1.13e-1)	unprognostic (4.41e-3)	unprognostic (6.42e-2)	unprognostic (1.85e-1)	unprognostic (2.70e-2)		unprognostic (2.73e-1)	unprognostic (2.82e-2)		unprognostic (7.15e-2)	0.7	0.1	1.1	0.1	1	0	0.5	0	2.7	0.2	1	0	0.1	0.1	1.8	4.3	3.7	0.7	0.1	106	0.5	0.4	0	0	0.5	0	0.1	1.1	0.3	0	0	0.9	0	0.2	2	0.5	0.1	2.1	0.2	46.1	0.5	0.2	2.4	0	0.2	0.2	0.3	0	0	0.1	22.3	0.9	1.1	0.1	0	0	0	0	0	0	1.5	0	0	0	0	0	0	0	0.7	37.9	0	0	0.1	0	0	0.1	17	0	2.2	0	0	0	0	0	0	1	0	0.1	0	0	7.4	2.3	0	0	0	0	0	0.1	0	5.5	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0.1	0	0	0.1	0	0	0	2	0	0	0	0	0	0	1.2	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.5	1.1	1	0	2.7	0.5	0.4	0.1	1.1	0.2	0	0	0	0	0.2	5.7	0	353.4	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	1	0	0	0	0.1	1.6	0	0	0	0	0.6	0	3.3	0	0	0	0	0	0	0	0.1	6.5	5.7	0.5	0	4.5	0.1	0	0	0.3	Cardiomyocytes
PGM2	FLJ10983	ENSG00000169299	Phosphoglucomutase 2	Q96G03	4	37826633-37862937	Enzymes, Predicted intracellular proteins	Carbohydrate metabolism, Glucose metabolism	Isomerase		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	5	Muller glia cells: 345.3	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low cell line specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA040676	Uncertain		Approved	Intermediate filaments					1900000	Intermediate filaments		HPA040676: AB_2677076	unprognostic (3.11e-2)	unprognostic (1.01e-2)	prognostic favorable (2.14e-5)	unprognostic (2.29e-1)	unprognostic (3.94e-1)	unprognostic (5.44e-2)	unprognostic (1.70e-2)	unprognostic (2.09e-3)	unprognostic (5.32e-2)	unprognostic (7.02e-2)	unprognostic (5.37e-2)	unprognostic (2.22e-2)	unprognostic (6.72e-3)	unprognostic (3.21e-2)	unprognostic (1.88e-1)	unprognostic (9.97e-2)	unprognostic (1.02e-1)	11.2	10.8	7.7	11.6	5.9	7.5	13.5	9.8	5.7	14.7	10.3	4.2	6.5	6.1	15	7.6	41.3	7	11	8.3	7.1	4	11.1	13.3	7.5	13.2	4.4	5.7	10	9	9.5	6.4	27.9	10.4	11.1	8.4	6.8	11	5	2.4	17.7	8.6	12.2	6.9	13.4	9	9	3.9	17.3	8.8	31.7	22.9	13.6	18.9	4.5	15.3	30.8	13.1	13.2	7	7.2	11.7	4.1	6.3	6.7	4.7	5.3	8.3	14.2	8.4	11.7	12	7.2	8.6	15.5	7.1	7.7	15.6	6.1	15.3	13.3	29.8	9.9	8.8	17	6.9	5.1	10.3	17.8	11.9	7.7	16.1	9.5	8.6	7.3	18.6	13.7	22.1	2.8	10.2	6.2	20.3	21.1	7.3	8.5	6.4	15.5	10	6.4	7.2	22.7	13.3	4.5	7.1	10.5	4.9	9.1	9.1	19.2	16.2	8.8	10.8	11.8	28.8	6.3	16.4	17.6	4.6	23.4	14.6	8	13.1	30.8	4.9	10.5	5.8	4.5	4.1	5.6	15.3	2.8	4	5	16.3	13.2	8	3.4	7	7.2	7.7	5.9	9.8	5.7	7.1	4	4.4	5.7	10.4	3.9	0	8	10.3	13.2	13.1	5.8	4.5	7.6	5.3	4.5	3.5	0	26.6	5	13	0.8	25.5	7.9	0	10.4	30.7	6.7	18.4	12.7	7.3	33.4	6.4	6.9	44.8	19.6	0.9	7.8	24.9	5	52.3	9	345.3	11.4	3.5	9.2	7.4	13.5	12.9	23.7	0.7	0.5	28.1	66.7	12.9	12.3	17.9	Muller glia cells
C22orf15	FLJ36561, N27C7-3	ENSG00000169314	Chromosome 22 open reading frame 15	Q8WYQ4	22	23763021-23765861	Predicted secreted proteins				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level		Tissue enriched	Detected in some	6	fallopian tube: 22.3	Cell type enriched	Detected in some	13	Ciliated cells: 200.8	Cancer enhanced	Detected in single		endometrial cancer: 1.7					Cell type enhanced	Detected in some		plasmacytoid DC: 2.9	Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		AF22: 3.0;BJ: 2.2;BJ hTERT+: 4.8;HSkMC: 2.0;hTERT-RPE1: 6.5;MOLT-4: 3.0														Secreted in female reproductive system								unprognostic (2.37e-2)	unprognostic (3.28e-3)	unprognostic (1.28e-1)	prognostic favorable (8.53e-5)	unprognostic (1.86e-2)	unprognostic (2.07e-2)	unprognostic (4.38e-2)	unprognostic (6.14e-2)	unprognostic (3.60e-2)	unprognostic (7.70e-2)	unprognostic (4.58e-2)	unprognostic (2.60e-1)	unprognostic (9.79e-2)	unprognostic (2.29e-1)	unprognostic (3.02e-1)	unprognostic (3.28e-2)	unprognostic (3.08e-3)	0	0.1	1	0	1.7	0.4	0.1	0	0	0.8	0.1			0	0.2	0	0	22.3	0.2	0	1.4	1.9	0	0	2.7	0.2	0		0.5	0	0	1.5	0.2		0.1	0		0	0.2	0	0	0	0.2	0.1	0.1	0	3.6			0		0	0	0	0.6	2.9	0	0	0	1.8	0.2	0	0	3	0	0	0	0	2.2	4.8	0	0.5	0	0	0	0.1	0.5	0	0	0	0	0	0	0	0	0	0	0.6	0	0	2	0	0	0	6.5	0.8	0	0	0	0	0	3	0	0.3	0	0	0.9	0	0	0	0	0	0	0	0	0	0	0	0	1.1	0	0.4	0	0	0	0	0.1	0	0	0	0	0	0	1.5	0	1	0.6	1	0.8	0.4	0.5	1.8	0.5	0	0	0	2.9	0	0.2											0	2.6	0	0	0.1	0.5	0	0	200.8	15.9	0	0	0	0	0	4.7	0	0	0	0	0	0.6	0.1	2.3	0	0	0	0	1.3	0	2.8	0	0.2	0	0	0	0.2	0	0	0	0	1.8	0	0.1	12.7	3.8	0.3	0	0	0	0	Ciliated cells
PDILT	PDIA7	ENSG00000169340	Protein disulfide isomerase like, testis expressed	Q8N807	16	20359170-20404737	Predicted intracellular proteins	Differentiation, Spermatogenesis	Chaperone, Developmental protein, Isomerase		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	5	stomach 1: 42.3;testis: 26.5	Cell type enriched	Detected in some	7	Early spermatids: 103.9	Not detected	Not detected			Not detected	Not detected			Cell type enhanced	Detected in some		plasmacytoid DC: 6.4	Low lineage specificity	Detected in many			Group enriched	Detected in some	8	HBEC3-KT: 15.0;hTCEpi: 12.4;hTERT-HME1: 3.8	Not detected	Not detected			Low region specificity	Detected in many			HPA041913	Approved				Intracellular and membrane							HPA041913: AB_10795644							unprognostic (1.99e-1)					unprognostic (6.09e-2)	unprognostic (2.05e-3)	unprognostic (2.63e-1)				0.1	0	0.1	0.1	0.1	0	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.4	0.1	0.5	0.1	0	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.4	0	0.1	0.1	0.6	0.1	0	0.6	0.1	0.1	0.1	42.3	26.5	0.1	0.1	0.2	0.1	0.1	0.1	0.1	1.2	6.4	3	0.9	2.2	0.8	0.4	0.1	0.3	1.2	0	0.2	0	0.3	0.1	0	0.1	0.2	0	0.4	0.1	0	0.2	0.2	0.3	0	15	0.1	0.1	0	0.3	0.4	0	0	0	0.2	0.2	12.4	0	3.8	0	0	0	0.6	0.4	0	0.2	0.3	0.2	0.2	0.1	0.5	0.1	0	0.2	0.1	0.1	0.3	0.4	0	0.2	0.2	0	0.2	0.1	0	0.1	0.2	0.4	0.2	0.2	0.3	0.1	0.1	0	1.1	1.8	0.5	0.3	0.3	0.4	0.4	1.2	0.7	0.5	0.4	0.9	0.4	0.8	3	2.2	0.9	6.4	0.2	0.4	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	103.9	0	0	0	0	0	0	0.5	0	0	0	0	0	1.3	0	14	0	0	0	0	0	0	0	0	0.4	0	0	0	0	1.1	0.4	0	0	0	0	0	Early spermatids
RNASE2	EDN, RAF3, RNS2	ENSG00000169385	Ribonuclease A family member 2	P10153	14	20955452-20956436	Enzymes, Plasma proteins, Predicted secreted proteins	Chemotaxis	Endonuclease, Hydrolase, Lyase, Nuclease		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	10	blood: 137.2;bone marrow: 236.7	Cell type enriched	Detected in some	11	Kupffer cells: 219.4	Cancer enriched	Detected in many	7	glioma: 14.1	Low region specificity	Detected in many			Group enriched	Detected in many	4	basophil: 37.8;eosinophil: 137.2	Lineage enriched	Detected in many	7	granulocytes: 137.2	Group enriched	Detected in some	318	HL-60: 54.9;NB-4: 54.8;THP-1: 147.0;U-937: 133.3									HPA044983	Enhanced				Secreted to blood				300000000			HPA044983: AB_10963689	unprognostic (6.66e-2)	unprognostic (3.00e-1)	unprognostic (6.85e-2)	unprognostic (7.68e-2)	unprognostic (2.73e-2)	unprognostic (9.26e-2)	unprognostic (4.94e-3)	unprognostic (6.77e-2)	unprognostic (9.54e-2)	unprognostic (3.24e-2)	unprognostic (3.25e-2)	unprognostic (3.45e-1)	prognostic unfavorable (3.28e-13)	unprognostic (2.27e-2)	unprognostic (7.14e-3)	unprognostic (5.33e-2)	unprognostic (1.50e-1)	2.7	3.2	4.8	2	9.3	236.7	0.5	0.9	3.7	0.9	0.6	1.4	0.1	0.5	0.7	0.5	0.5	3.2	0.9	3.7	3.9	1.8	1.2	1.3	6.6	7.2	4.7	0.1	0.5	2.5	0.5	0.6	0.8	4.9	0.5	0.6	0.1	0.7	0.5	0.9	0.9	0.6	2.1	10.5	19.4	0.9	0.6	3.7	0.1	0.5	0.1	0.6	1.4	0.3	0	20	137.2	11.5	0	0	3.3	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	54.9	0.2	0	0	0	0	0	0	0	0	0	0	0	0	54.8	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	147	0	0	0	0	0.1	0	0	0	0	133.3	0	37.8	11.5	137.2	0	2	0	0	0	0	20	0	0	0	1	0	0.2	0.2	0	3.3	4.8	9.3	0.9	3.7	3.9	1.8	4.7	0.1	4.9	3.7	3	0.3	0.8	0	0	0	0	2.5	0	0	0	0	0.1	1.7	0	0.4	0	0	0	0	0.1	0.1	0	0	0.9	13.1	0	0	1.8	219.4	1.1	0.3	20.1	0	0	0	0	0	0	0	0	0.3	19.4	0	0	0.1	0	0	0	0	0	Kupffer cells
NPR1	ANPa, ANPRA, GUCY2A, NPRA	ENSG00000169418	Natriuretic peptide receptor 1	P16066	1	153678637-153693992	Enzymes, FDA approved drug targets, Predicted membrane proteins	cGMP biosynthesis	Lyase, Receptor, Vasoactive	FDA approved drug targets	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		breast: 98.4	Cell type enriched	Detected in many	10	Ito cells: 136.2	Cancer enhanced	Detected in all		ovarian cancer: 39.2	Low region specificity	Detected in single			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	6	ASC diff: 60.5	Region enriched	Detected in many	5	olfactory region: 23.0	Region enhanced	Detected in single		olfactory region: 11.1	HPA031087			Approved	Nucleoplasm,Nucleoli,Plasma membrane						Nucleoli	Nucleoplasm, Plasma membrane	HPA031087: AB_10601975	unprognostic (2.54e-1)	unprognostic (3.03e-3)	unprognostic (6.31e-2)	prognostic unfavorable (3.97e-4)	unprognostic (1.55e-1)	unprognostic (6.60e-2)	unprognostic (1.54e-2)	unprognostic (2.03e-1)	unprognostic (2.46e-1)	unprognostic (3.27e-2)	prognostic favorable (2.49e-4)	unprognostic (1.27e-1)	unprognostic (6.69e-2)	unprognostic (1.16e-2)	unprognostic (1.09e-1)	unprognostic (4.06e-1)	unprognostic (1.74e-2)	41.1	4.3	0.5	5.9	0.9	0.1	98.4	0.5	0.8	8.1	8.2	0.3	7.3	1.2	16.8	11.1	8.7	25	9.3	19.6	0.9	0.5	28.7	3.7	34.8	8.6	0.7	0	19.5	4.2	7.8	4.5	11.8	2.5	4.9	1.5	2	2	9	6.9	3.4	4.6	15.6	2.2	1.2	5	6.4	0.2	0.8	7.6	5.1	1.1	11.6	26.5	0	0.5	0	0.3	0	0	0	0	0.4	0	0	60.5	0.2	0	0	0	0	0	0	0.2	0	0.2	0	0	0	0	0	0	0	0.2	0	10	0	7.2	0	0	0.1	0	0.1	0	0	1.2	0	0	0	0	0	0	0	0.3	0	0	5.7	0	0	0.8	0	0	0	0.6	0	2	0.4	0	0	0	0	0	3	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0.5	0.9	0.5	0.8	0.9	0.5	0.7	0	2.5	0.2	0	5.8	0	0.4	1.3	0	4.8	5.1	0	0	14	0	0.1	0	0.6	8	14.2	0	0	0	0.9	3.9	0.4	0	1.5	0.2	0	0	136.2	6	7.9	9.5	0	0	9	0	0	0.7	0	3.9	2.8	0	0	0.9	0.2	0.1	0.9	0.6	0	0	0	Ito cells
SPRR1A		ENSG00000169474	Small proline rich protein 1A	P35321	1	152985231-152985500	Predicted intracellular proteins	Keratinization			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	4	esophagus: 495.3	Cell type enriched	Detected in some	10	Suprabasal keratinocytes: 126.6	Cancer enhanced	Detected in many		head and neck cancer: 1736.0	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	7	HaCaT: 13.0;hTCEpi: 38.1;RT4: 14.5									CAB011237	Enhanced											CAB011237: 		unprognostic (1.39e-1)	unprognostic (5.45e-2)	unprognostic (2.64e-2)		unprognostic (1.19e-2)		unprognostic (1.25e-2)	unprognostic (2.92e-1)		prognostic unfavorable (1.03e-4)			unprognostic (1.96e-1)			unprognostic (1.04e-1)	0.4	0	0.4	0.4	0.4	0	0.7	0.4	0.4	72.3	0.4	0.4	0.4	0	0.4	0.4	495.3	0	3.8	0.4	0.4	0	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0	0.4	0.4	0.4	0.4	0	0.4	52.5	0.4	0.4	11.7	0.4	0.4	0.4	0.4	0	0.4	0.4	0.4	0.4	70.7	47.3	0.5	111.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3	1.5	0	0	0	13	0	1.4	0	0	0	0.3	0	0	0	0	0	0	38.1	0	0	0	0	0	1.2	0.8	0	0	0	0	0	0.5	0	0	0.7	0	0	14.5	0.2	0	1.2	0.1	0	0	0	0	0.7	0	0	0	0	0	0.9	0.3	0	1.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0.4	0.4	0.4	0.4	0	0.4	0.4	0.4	0.4	0	0	0	0.1	5.8	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.3	0	0	0	0.6	0	0	0	0	0	0.3	0	0	126.6	0	0	0	13.1	Suprabasal keratinocytes
HTRA4	FLJ90724	ENSG00000169495	HtrA serine peptidase 4	P83105	8	38974164-38988662	Enzymes, Predicted secreted proteins		Hydrolase, Protease, Serine protease		Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	13	placenta: 55.2	Cell type enriched	Detected in some	9	Extravillous trophoblasts: 319.8	Cancer enhanced	Detected in some		testis cancer: 2.5	Not detected	Not detected			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Cell line enriched	Detected in some	23	BEWO: 72.8	Region enhanced	Detected in some		hippocampal formation: 2.3	Low region specificity	Detected in some			HPA045402	Enhanced				Secreted in female reproductive system							HPA045402: AB_2679316	unprognostic (1.20e-1)	unprognostic (5.83e-4)	unprognostic (8.02e-2)	unprognostic (2.13e-2)	unprognostic (8.20e-2)	unprognostic (2.42e-2)	unprognostic (1.80e-1)	unprognostic (7.40e-3)	unprognostic (1.40e-1)	unprognostic (5.14e-4)	unprognostic (1.01e-1)	unprognostic (8.68e-2)	unprognostic (1.42e-1)	unprognostic (4.58e-1)	unprognostic (5.19e-3)	unprognostic (2.39e-3)	unprognostic (1.19e-3)	2.6	1.1	0.2	0.3	0.2	3.4	0.9	0.2	0.4	1.2	0.5	0.2	1.9	0	2.3	0.5	0.5	0.1	0.2	0.2	0.2	0	0.2	0.2	4.3	1	0.2	0.2	0.4	0.3	0.4	0.5	55.2	0.4	0.5	0.3	1.8	0.8	0.5	0.6	0.4	0.6	0.3	1.8	2.5	0.1	0.4	0.2	0.2	0.6	0.2	0.8	0.5	0.9	3.1	2.2	2.5	1	1	1.7	0	0.1	0.1	0.1	0.2	0.3	0.2	72.8	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0	0.3	0.2	0.1	0.1	0.2	0.1	0	0.1	0.1	0.1	0.1	0	0.2	0.2	0.3	0.1	0.1	0.5	0.1	0.1	0	0.1	0.4	0.2	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.2	0.1	0.1	0	3.1	0.1	0.2	0	0.3	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.3	0.1	1.5	0.8	2.3	1.4	0.7	1.7	1.5	1.3	1.2	0.6	3.1	1.3	1.4	2.5	1	1	2.2	1.4	0	0.2	0.2	0.2	0.4	0.2	0	0.2	0.2	0.4	0.2	0	0	0	1.1	0.1	0.5	0.4	0	0	0	0	2	2.1	0	0	0	0.1	0	0	0	319.8	0.2	1.2	0	0	10.7	1.6	0	2.5	0.3	0	0	1.5	1.7	0	0	0.6	0.2	0	0	0	0.1	0	0	0	0	0.1	33.8	0	0.2	0.7	Extravillous trophoblasts
GKN1	AMP18, BRICD1, CA11	ENSG00000169605	Gastrokine 1	Q9NS71	2	68974573-68980974	Plasma proteins, Predicted secreted proteins		Mitogen		Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	41	stomach 1: 918.9	Cell type enriched	Detected in some	61	Pancreatic endocrine cells: 201.5	Cancer enriched	Detected in some	116	stomach cancer: 255.8	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HaCaT: 5.2;HMC-1: 14.2;MOLT-4: 9.9;NTERA-2: 13.5;REH: 5.8;U-2 OS: 8.8;U-266/70: 8.8	Low region specificity	Detected in single			Not detected	Not detected			HPA047684	Enhanced				Secreted to digestive system				26000000			HPA047684: AB_2680120						unprognostic (5.40e-2)					prognostic unfavorable (1.54e-4)			unprognostic (4.54e-1)			prognostic favorable (4.53e-4)	0	0	0	0	0.1	0	0	0	0.4	0	0	11.9	0	0	0	0	0.8	0	0.7	0	0	0	0	0.3	0	0	0	0	0	0.3	0	0	22.4	0	2	0	0	3	0	0	0	0	1.4	0	0.2	918.9	0	0	1	0	0	0	5.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0.4	0	0	0	0	0.2	0	0	5.2	0	0.1	0	0	0	0	0.6	0	0	0	14.2	0	0	0	0	0	0	0	0	0	0.2	0	9.9	0	13.5	0	0	5.8	0	0	0	0	0.1	0	0	0	0	0	0	1	0.2	0	8.8	0	0	8.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	3.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	201.5	0	0	0	0	0	0	0	0	0	0.1	0	0	0	Pancreatic endocrine cells
BUB1	BUB1A, BUB1L, hBUB1	ENSG00000169679	BUB1 mitotic checkpoint serine/threonine kinase	O43683	2	110637698-110678114	Enzymes, Predicted intracellular proteins	Apoptosis, Cell cycle, Cell division, Chromosome partition, Host-virus interaction, Mitosis	Kinase, Serine/threonine-protein kinase, Transferase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	5	lymphoid tissue: 56.5;testis: 30.9	Cell type enriched	Detected in many	5	Spermatocytes: 68.0	Low cancer specificity	Detected in all			Low region specificity	Detected in some			Cell type enhanced	Detected in many		T-reg: 6.1	Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		HEL: 68.1	Not detected	Not detected							HPA006123			Supported	Nucleoplasm,Cytosol			Yes			Nucleoplasm	Cytosol	HPA006123: AB_1845498	unprognostic (7.74e-2)	unprognostic (3.45e-2)	unprognostic (9.72e-3)	prognostic unfavorable (3.65e-4)	unprognostic (1.61e-1)	unprognostic (5.62e-3)	prognostic unfavorable (1.03e-5)	prognostic unfavorable (3.94e-4)	unprognostic (1.26e-3)	unprognostic (1.15e-1)	prognostic unfavorable (2.37e-5)	unprognostic (1.76e-1)	unprognostic (0.00e+0)	unprognostic (2.45e-2)	unprognostic (3.64e-1)	unprognostic (5.01e-2)	unprognostic (1.28e-1)	1.1	0.9	0.5	15.8	1	8.9	0.6	0.3	1	1.2	2.8	0.4	0	2.4	0.7	2.3	5.8	0.5	1	1.1	0.5	0.5	0.9	0.8	2.1	11.6	0.6	0.2	1	0.7	0	0.4	2.4	0.5	0.7	4.3	0.4	1.4	0	0.5	1.8	3.1	1.4	1.3	7.9	1.8	30.9	0.1	56.5	0.6	5.7	12.1	2.5	2	1.8	2.4	3	0.2	1.4	6.1	1.1	30.3	8.9	23.4	14.7	1	1.7	12.4	15.8	10.4	27.5	20.8	18.7	17.5	20.6	9.8	9.1	25.8	13.3	29.9	11.5	34.2	16.3	14.6	68.1	9.5	14.9	0.2	19.6	19.3	0.4	0.7	21.2	10.5	3.9	16.1	23.1	29.8	43	22.5	10	32.8	16.4	22.6	10.8	16.9	21.8	20	31.4	5.6	9.6	15.7	6.8	11.2	9.6	8.5	14.9	7.5	16.6	6.6	12.5	20.5	9.4	21.9	22.5	21.1	25.3	8.5	15.2	22	3	0	0.7	0.6	0.2	0.9	1.8	2.5	1	0.8	1.4	1.6	1.5	0	1.4	0.1	2.4	6.1	1.1	0.5	1	0.3	1	0.5	0.5	0.6	0.2	0.5	0.1	0	1	7.8	0.2	0.5	0	0.8	0	1.4	2.3	0	0	1.3	0	0.2	8.3	0	0	0	0	8.1	0.3	0.2	0	0.2	6.6	0	0	1.3	1.3	4.7	0.3	1.7	0	1	0.9	0	0.1	0	0.4	0	0	6.5	0	68	14.1	0.4	0.6	2.5	2	0.9	Spermatocytes
ONECUT1	HNF-6, HNF6, HNF6A	ENSG00000169856	One cut homeobox 1	Q9UBC0	15	52756989-52791078	Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	Activator, DNA-binding		Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	14	gallbladder: 40.1;liver: 59.9;pancreas: 46.3	Cell type enriched	Detected in some	17	Horizontal cells: 611.8	Group enriched	Detected in some	7	liver cancer: 2.9;pancreatic cancer: 0.8	Low region specificity	Detected in single			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		AF22: 3.3;Hep G2: 4.0;MCF7: 5.1;RT4: 4.1;WM-115: 3.7	Region enhanced	Detected in single		hypothalamus: 1.1	Low region specificity	Detected in all			HPA003457	Enhanced											HPA003457: AB_1079525		unprognostic (5.12e-2)		unprognostic (2.45e-2)	unprognostic (2.64e-2)	unprognostic (4.82e-2)	unprognostic (9.19e-2)	unprognostic (7.05e-2)	unprognostic (5.73e-2)	unprognostic (2.59e-3)	unprognostic (1.03e-1)		unprognostic (1.70e-7)	unprognostic (9.76e-3)	unprognostic (2.11e-1)		unprognostic (1.17e-1)	0.1	0.1	0.5	0	0.1	1.2	0.1	0.9	0.3	0.1	0.1	0	0	0	0.1	0	0.1	0.1	40.1	0.1	0.2	0.2	0.1	59.9	0.1	0	0.1	0	0.1	46.3	0	0.1	0	1.4	0.1	0	3.5	0.1	0.1	0.1	0.2	0.1	0	0.2	0.1	0.1	2.4	0	0	0.1	0	0	0.1	0.1	0.1	0.2	0	0	0	0.1	0	0.3	1.2	3.3	1.5	0	0	1.5	0	0	0	0.1	1.4	0.2	2.1	0.1	0	0.1	0.2	0.2	0	0	0.3	0.2	0.2	1.4	4	0	0.7	0.1	0	0	0.1	0	0.1	0	1.1	0.3	0.4	0	5.1	0	0	2.5	0.4	0.3	0.9	0.3	0	0	4.1	1.7	0	0.6	0.1	0.4	2.9	1	0.2	0	2.1	2.7	0	0.4	0.3	0.1	0.3	0.4	0.4	3.7	0	0	0	0	0	0.1	0	0	0	0	0.1	0	0	0	0	0	0.2	0	0	0.5	0.1	0.9	0.3	0.2	0.2	0.1	0	1.4	0	0	0	0	0	0	0.8	1	35.7	0	0	0	0	0	1.7	10.3	0.9	0	0	0	11.2	0	0	0	0	8.2	0	611.8	0	0	0.3	1.8	0	0	0	0	0	1	5.3	0	0	0	3.6	0	0.3	2.3	0.5	0	0	0	0	0	Horizontal cells
MUC17		ENSG00000169876	Mucin 17, cell surface associated	Q685J3	7	101020072-101058745	Cancer-related genes, Predicted membrane proteins			Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	299	intestine: 125.2	Cell type enriched	Detected in some	5	Enterocytes: 59.0	Group enriched	Detected in some	29	colorectal cancer: 6.1;pancreatic cancer: 4.9;stomach cancer: 22.8	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		BEWO: 1.2;OE19: 1.0									HPA031634	Enhanced				Intracellular and membrane							HPA031634: AB_10603021			unprognostic (2.37e-2)	unprognostic (2.41e-1)		unprognostic (8.17e-3)					unprognostic (5.57e-3)	unprognostic (6.07e-2)	unprognostic (8.79e-8)	unprognostic (1.28e-1)	unprognostic (2.47e-2)			0.1	0.1	0	0	0.1	0	0	0.1	0	0	64.7	0	0	15.8	0	0	0.1	0	0.4	0.1	0.1	0	0	0.1	0.1	0	0	0	0	0.1	0	0.1	0	0	0.1	2.5	0	0.1	0	0.1	0.1	125.2	0.1	0	0	0.4	0.1	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	1.2	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0.1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0.8	0	0	0	0	0	0	0	0	0	0	59	0	0.2	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	5.3	0	3.5	11.5	0	0	0	0	0	0	0	0	0	0	5.2	0	Enterocytes
AHSP	EDRF, ERAF	ENSG00000169877	Alpha hemoglobin stabilizing protein	Q9NZD4	16	31527864-31528803	Plasma proteins, Predicted intracellular proteins		Chaperone		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	6	bone marrow: 189.3	Cell type enriched	Detected in some	394	Erythroid cells: 8947.3	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		hTCEpi: 7.7;K-562: 3.3;MOLT-4: 2.1;NTERA-2: 1.4					Low region specificity	Detected in all			HPA040940	Enhanced								8400000			HPA040940: AB_10796231		unprognostic (3.00e-1)			unprognostic (2.01e-1)	unprognostic (8.44e-2)	unprognostic (3.76e-1)	unprognostic (1.53e-1)		unprognostic (3.10e-1)	unprognostic (2.16e-1)		unprognostic (3.70e-3)	unprognostic (2.04e-2)	unprognostic (9.02e-2)	unprognostic (3.25e-2)		0.6	0.1	0.3	0.3	0.4	189.3	0.9	0	0.1	0.1	0.1	0.8	0	0.1	0.3	0.1	0.2	0.1	0.1	4	0.2	0.2	1	3.5	20	0.1	0.7	0	0.8	1.1	0.1	1.1	30.2	0.2	0.5	0.1	1	0.1	0.1	0.7	0.3	0.1	0.1	0.3	18.9	0.1	2.8	0.1	1.1	2.1	0	0.1	1.5	0.8	0.3	0.2	0.8	0.1	0	0.2	9.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	7.7	0	0	0	0	0	3.3	0	0	0	2.1	0	1.4	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0.3	0	0.1	0.2	0	0	0.2	0.8	0	0	0	0	9.2	0.3	0.4	0	0.1	0.2	0.2	0.7	0	0.2	0.1	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	22.7	0	0	8947.3	0.2	0	0	0	0	0	0	0	0	0	1.9	18	0.3	0	10.1	0	0	0	0	0	0	0	0	0	0	3.2	0.4	0	0	0	0	0	Erythroid cells
WNT10B	SHFM6, WNT-12	ENSG00000169884	Wnt family member 10B	O00744	12	48965340-48971763	Disease related genes, Predicted secreted proteins	Wnt signaling pathway	Developmental protein	Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 23.4	Cell type enriched	Detected in some	11	Extravillous trophoblasts: 12.8	Low cancer specificity	Detected in some			Low region specificity	Detected in many			Cell type enhanced	Detected in some		gdT-cell: 1.6	Lineage enriched	Detected in single	17	T-cells: 1.6	Cell line enhanced	Detected in many		K-562: 8.1;T-47d: 9.7;U-266/84: 8.7	Low region specificity	Detected in some			Low region specificity	Detected in all			HPA055048, HPA062539	Enhanced		Approved	Golgi apparatus	Secreted to extracellular matrix					Golgi apparatus		HPA055048: AB_2682683, HPA062539: AB_2684793	unprognostic (1.13e-1)	unprognostic (2.14e-2)	unprognostic (5.73e-4)	unprognostic (2.27e-2)	unprognostic (3.09e-2)	unprognostic (3.33e-2)	unprognostic (6.08e-2)	unprognostic (1.38e-1)	unprognostic (2.12e-1)	unprognostic (1.14e-1)	unprognostic (4.99e-3)	unprognostic (3.05e-2)	unprognostic (5.39e-6)	unprognostic (4.29e-2)	unprognostic (3.74e-2)	unprognostic (4.50e-1)	unprognostic (1.25e-1)	2.3	0.6	10.9	2.6	23.4	2.1	1.8	0	14.3	0.5	1.7	0.5	3	2.8	0.4	3.2	1.5	0.6	1.1	1.2	7.3	4.9	0.2	0.3	1.3	3	3	7.2	1.2	0	0.1	1.1	7	4.1	1	1.6	0.7	1.7	1.4	1.6	5	3.3	2	0.8	2.9	2	1.7	0.3	0.2	0.5	1.2	2.9	1.8	1.6	0	0	0	0	0	1.6	0.2	2.1	1.4	0	2	0	0	5.4	1.5	2.8	0.6	0.2	4.2	4.7	0	0.4	0.3	1.8	2.6	5.6	0.4	0.2	1.2	7.4	2.4	1.8	0.1	0	0.8	3.5	0	0.4	0.1	2.5	4.9	0	1.8	8.1	0.3	0.8	2.8	0.1	2.8	0	1.5	3	0	0.7	2.6	0	0.5	0.1	0	0.3	0.2	0.7	2.8	9.7	3.1	0	3.1	6	0.4	0.7	3.1	8.7	0	1.2	6.2	0.2	0	0	0	1.6	0	0.9	0	0	0.5	0	0	0.7	1	0	0	0	0	0	0.2	10.9	23.4	0	13.9	7.3	4.9	3	7.2	4.1	0.3	0	0	0	0	0.3	0	0.3	0	0	0	0	0	0.2	0	0	0.7	0	0	0	0	12.8	0.7	0	0	0	0.3	0	0	0.6	0	0.2	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.4	1.1	1.1	0.9	0	0	Extravillous trophoblasts
PYDC1	ASC2, POP1	ENSG00000169900	Pyrin domain containing 1	Q8WXC3	16	31215962-31217359	Predicted intracellular proteins		Signal transduction inhibitor		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		brain: 12.4;skin 1: 10.1	Cell type enriched	Detected in single	14	Suprabasal keratinocytes: 5.5	Cancer enriched	Detected in some	8	breast cancer: 8.0					Cell type enhanced	Detected in single		memory B-cell: 1.0	Low lineage specificity	Detected in single			Group enriched	Detected in some	7	SCLC-21H: 2.5;T-47d: 2.5;U-266/70: 1.3																						unprognostic (9.72e-3)	unprognostic (1.00e-2)		unprognostic (2.05e-2)	unprognostic (1.61e-1)	unprognostic (1.32e-2)		unprognostic (1.49e-1)	unprognostic (2.85e-1)	unprognostic (2.62e-1)	unprognostic (5.34e-2)	unprognostic (3.15e-2)	unprognostic (2.60e-10)	unprognostic (3.62e-1)	unprognostic (1.74e-1)	unprognostic (1.70e-1)	unprognostic (9.47e-2)	0.1	0.1	7.7	0.2	9	0.2	1	12.4	2.7	0	0			0	0.1	0	0	0.1	0	0	1.5	2.4	0.1	0	0	0.1	0.9		0	0	0	0	0		0.1	0		0.5	0	3	10.1	0.1	0	0.1	0.2	0.3	0.1			0		0.5	0	0	1	0	0	0.7	0	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	2.5	0	0	0	0	0	2.5	0	0	0	0	0	0	1.3	0	0	0	0	0	0	0.1	0	0.3	0	0	1	0.1	0.5	0	0	0	0.8	0	0	0.7	0	0	0											0	0	0	0	0.3	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5.5	0	0	0	0	Suprabasal keratinocytes
TM4SF4	il-TMP	ENSG00000169903	Transmembrane 4 L six family member 4	P48230	3	149473974-149503281	Predicted membrane proteins, Transporters				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	6	gallbladder: 196.0;intestine: 126.4;liver: 81.8	Cell type enriched	Detected in many	5	Cholangiocytes: 2236.9	Group enriched	Detected in many	10	liver cancer: 249.4;pancreatic cancer: 130.5	Not detected	Not detected			Cell type enhanced	Detected in single		intermediate monocyte: 1.3	Lineage enriched	Detected in single	13	monocytes: 1.3	Group enriched	Detected in some	6	A549: 15.4;OE19: 14.2;RPTEC TERT1: 24.0	Not detected	Not detected			Low region specificity	Detected in all			HPA046430	Enhanced		Approved	Plasma membrane,Cytosol						Plasma membrane	Cytosol	HPA046430: AB_2679662	unprognostic (1.91e-2)	unprognostic (1.71e-1)	unprognostic (2.15e-1)	unprognostic (1.66e-1)		unprognostic (2.27e-1)	unprognostic (1.67e-1)	unprognostic (1.33e-1)		unprognostic (4.96e-2)	unprognostic (2.73e-1)	unprognostic (1.98e-1)	unprognostic (7.60e-2)	unprognostic (1.83e-1)	unprognostic (4.66e-2)	unprognostic (1.91e-2)	unprognostic (4.97e-1)	0.3	0.3	0.2	0.2	0.2	0	0.3	0.2	0.2	0.2	68.2	0	0	70.3	0.2	0.1	0.3	0.3	196	0.2	0.2	0.2	0.4	81.8	0.3	0	0.2	0	0.2	24.2	0	0.3	0.1	0	0.2	0	0.1	0.2	0	0.2	0.2	126.4	0	0.2	0.3	2.3	0.3	0	0	0.3	0.1	0	0.2	0.2	0	0	0	1.3	0	0	0	0	15.4	0	0	0	0	1.1	0.5	0	0	0	0.3	0.2	0.2	3	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0.1	0	0.5	0	0.1	0.6	0.1	14.2	0	0	0.3	0.9	24	0	0.5	0.9	0.7	0	0	0	0	0	0	0	1.8	0	0.1	0	0.3	0.6	0	0	0	0	0.2	0	0	1.3	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0	0	0	3	0.3	0	0	0.1	0	3.4	2236.9	0	1.2	0	0	0	0	20.8	0.8	0	2.6	23.3	1.7	0.1	0	0	0	475.7	0.1	0	2.9	8	11	0	0	0	0	1.8	0.9	0	7.6	0	0	2.1	0	0	1.1	3.6	0.1	0	0.1	0	0.1	0.1	Cholangiocytes
FRMPD4	KIAA0316, PDZD10, PDZK10	ENSG00000169933	FERM and PDZ domain containing 4	Q14CM0	X	12138466-12724523	Disease related genes, Predicted intracellular proteins			Disease mutation, Mental retardation	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	10	brain: 16.4;parathyroid gland: 28.3	Cell type enriched	Detected in some	54	Horizontal cells: 158.9	Not detected	Not detected			Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		BJ hTERT+ SV40 Large T+ RasG12V: 4.3;LHCN-M2: 6.1;U-2197: 9.5;U-266/70: 8.7;U-266/84: 3.9	Low region specificity	Detected in all			Low region specificity	Detected in all																unprognostic (2.05e-1)	unprognostic (3.70e-2)			unprognostic (3.50e-2)	unprognostic (2.68e-3)		unprognostic (8.84e-2)	unprognostic (1.05e-2)	unprognostic (3.56e-2)	unprognostic (2.09e-2)	unprognostic (1.62e-2)	unprognostic (6.32e-2)	unprognostic (3.39e-1)	unprognostic (1.62e-1)	unprognostic (1.96e-1)	unprognostic (2.25e-1)	0.6	0.6	5.5	0.6	10.9	0.5	0.6	3.8	16.4	0.7	1.1	1	0	0.6	0.7	1	0.7	0.6	0.6	2.1	8.1	3.5	0.6	0.6	0.6	0.5	2.7	6.9	0.6	0.5	28.3	0.6	0.5	2.9	1.1	0.8	1.9	0.5	0.6	1.1	0.6	0.6	0.6	0.8	0.5	0.6	1	1.5	0	0.6	0	0.6	0.6	0.2	0	0	0	0	0	0	0	0	0.2	0.3	0	0.3	0.8	0	1.1	2.1	3.4	4.3	0	0	0	0	0.3	0	0	0	0	2.4	2.2	3.5	0	0.2	0	0.1	0	0	1.5	0	1.3	2.4	0.3	0	0	0	0.7	6.1	0	0	0	0.3	0	0	0	0	0	0	0.6	0	0	0	0	0	0.5	0	0	0	1	1.1	9.5	1	8.7	3.9	0	2.4	0	3.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5.5	10.9	3.8	14.6	8.1	3.5	2.7	6.9	2.9	1.5	0	0	0	0	0.1	2.9	2.8	0	0	2.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	158.9	0	0	0	0	1.4	0	0	0	0	0.3	0	0	1.8	0	1.6	0	0	0	0.2	0	0	0	0	0	Horizontal cells
KCNAB3	AKR6A9, KCNA3B	ENSG00000170049	Potassium voltage-gated channel subfamily A regulatory beta subunit 3	O43448	17	7921859-7929803	Predicted intracellular proteins	Ion transport, Potassium transport, Transport	Ion channel, Voltage-gated channel		Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in many		brain: 36.1;endometrium 1: 17.2	Cell type enriched	Detected in some	5	Horizontal cells: 123.9	Low cancer specificity	Detected in many			Group enriched	Detected in all	5	cerebellum: 36.1;cerebral cortex: 31.6	Cell type enhanced	Detected in some		myeloid DC: 1.5;plasmacytoid DC: 1.7	Low lineage specificity	Detected in single			Cell line enhanced	Detected in many		REH: 14.9;SH-SY5Y: 8.1	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA077993			Approved	Mitochondria						Mitochondria		HPA077993: AB_2686872	unprognostic (3.02e-2)	unprognostic (5.59e-2)	unprognostic (6.95e-2)	unprognostic (2.62e-2)	unprognostic (6.13e-2)	unprognostic (5.84e-4)	unprognostic (2.19e-1)	unprognostic (5.72e-2)	unprognostic (8.50e-2)	unprognostic (8.55e-2)	unprognostic (3.27e-4)	unprognostic (7.47e-3)	unprognostic (3.03e-6)	unprognostic (2.12e-1)	unprognostic (5.00e-2)	unprognostic (4.97e-2)	unprognostic (9.54e-3)	1.4	0.7	4.2	2.7	5.2	5.5	1.2	36.1	31.6	1.8	1.4	0.8	0	1.3	17.2	2.2	0.8	3.5	2.1	0.7	4.7	2.9	1.7	1.1	1.5	3.8	2.4	6.3	2.1	1	0.8	4.9	1.6	5.9	2.3	2	3.8	1.3	1.4	1	3.3	1.9	11.4	5.2	2.6	2.2	1.7	1.9	0.8	1.6	0	3.3	1	1	0.1	1.7	0.5	0.2	0	0.7	0.1	1.3	1.1	5.5	1.4	0.6	1.4	2	4.9	3.1	4.2	4.8	0.7	0.3	2.2	0.3	0.8	0.2	0.4	1.5	0.7	6	1.8	2.3	0.7	0.9	0	5.1	0.2	3	2.2	1.6	4.6	0.2	0.2	0.3	6.1	0.5	0.3	0.7	1	0.8	2.6	0.8	0	0.7	14.9	1.5	0.6	0.5	1.7	0.3	8.1	0.4	0	0.9	0.2	1.4	0.1	0.3	0.7	2.8	1.1	0.4	1.1	1.2	1.2	2.1	3	1	0	0.2	0	0.5	0	0.7	0	0	0	1.5	0.1	0.2	0.2	0.5	0	0	1.7	0	0.1	4.2	5.2	36.1	31.6	4.7	2.9	2.4	6.3	5.9	1.9	3	2.4	0	0.6	0.5	22.9	0.8	0	0	1.2	0	3.9	0.2	0	0.5	0.3	0.1	0.4	0	0.5	0.2	1.1	0.6	1.1	0.2	0.7	123.9	0	0.6	0	0	1.7	0.8	0	1.8	0.3	12	0.5	0	0.7	0	6.3	0	0.3	3.1	1.5	0.4	0.1	0	0.2	0.1	Horizontal cells
GPR37L1	ETBR-LP-2	ENSG00000170075	G protein-coupled receptor 37 like 1	O60883	1	202122858-202133592	G-protein coupled receptors, Predicted membrane proteins		G-protein coupled receptor, Receptor, Transducer		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	18	brain: 44.0	Cell type enriched	Detected in some	11	Muller glia cells: 51.7	Cancer enriched	Detected in some	57	glioma: 36.2	Low region specificity	Detected in all			Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Group enriched	Detected in some	4	HaCaT: 2.9;MCF7: 3.3;T-47d: 9.0	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA064454	Enhanced											HPA064454: AB_2685268	unprognostic (2.12e-2)	unprognostic (1.83e-1)	unprognostic (2.96e-1)	unprognostic (1.61e-3)	unprognostic (4.52e-1)	unprognostic (8.20e-2)	unprognostic (2.26e-4)	unprognostic (5.83e-2)	unprognostic (3.46e-3)	unprognostic (2.07e-1)	unprognostic (1.83e-1)	unprognostic (3.28e-2)	unprognostic (4.86e-3)	unprognostic (1.14e-1)	unprognostic (4.58e-2)	unprognostic (1.18e-3)	unprognostic (3.49e-1)	1.6	2	20.5	1.6	25.2	1.9	1.6	13.2	44	2	2.4	33.4	0	1.9	1.8	1.8	1.7	1.8	1.7	1.6	22.3	12.6	1.5	1.6	1.6	1.5	17.7	22.1	1.7	1.5	1.5	0.4	1.6	23.8	1.7	1.9	0.9	1.9	2.3	1.7	1.8	2.1	1.7	11.1	1.6	1.6	1.9	15.7	0	1.8	0	1.5	1.6	0.2	0.9	0.9	1.8	0.9	0.6	1.4	0.2	0.1	0.6	0	0	0	0	0.3	0	0.2	0	0	0.2	0.6	0	0.2	0	0.1	2.9	0	0	0.4	0.1	0.1	0	0.1	0	0	0	0	0	0.1	0	0	0	0	0	0	0.2	0	3.3	0	0.1	0.2	0.1	0	0	0	0	0	0.2	0.1	0.5	0.1	1.2	0	0.1	9	0.1	0	0	0	0.1	0	0.1	0	0.1	0.1	0	0	1	0.8	0.7	0.5	0.9	0.7	0.6	0.3	0.2	0.6	0.9	0.7	0.5	1.8	0.6	0.4	0.9	1.4	0.2	20.5	25.2	13.2	39.3	22.3	12.6	17.7	22.1	23.8	15.7	0	0	0	0.5	0.3	1.1	0.8	0	0	2.3	0	3.9	0	0	2.5	3.5	0	1	0	1.1	0.8	0.1	0.7	0	0	0	0	0	0	0	0.5	0.9	0	0	0	0.5	51.7	1.5	2.9	1.8	0	4.7	0	0.2	0	0.1	0.1	0.6	0	0.4	0.8	Muller glia cells
HOXD12	HOX4H	ENSG00000170178	Homeobox D12	P35452	2	176099730-176101193	Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	Developmental protein, DNA-binding		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in some		brain: 4.3;intestine: 3.5;seminal vesicle: 4.8;vagina: 3.7	Cell type enriched	Detected in single	17	Cardiomyocytes: 1.7	Not detected	Not detected			Region enriched	Detected in single	41	basal ganglia: 4.3	Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		JURKAT: 4.0;REH: 6.9;SCLC-21H: 1.9	Not detected	Not detected			Not detected	Not detected			HPA059444	Uncertain											HPA059444: AB_2684020		unprognostic (1.00e-1)	unprognostic (2.40e-3)		unprognostic (1.32e-2)	unprognostic (3.53e-2)		unprognostic (1.71e-2)	unprognostic (1.36e-2)			unprognostic (7.11e-2)		unprognostic (4.54e-2)	unprognostic (7.29e-2)		unprognostic (1.44e-2)	0.1	0	0.1	0.1	4.3	0	0.1	0.1	0.1	1.4	3.5	0.1	0.1	0	0.1	0.1	0.1	0	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	1.8	3.4	0.1	0.1	4.8	0.1	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	3.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0.4	0.2	0.1	0	0.1	0	0.4	0	0.3	0	0.5	0	0.1	0.1	0.9	0.4	0	0	0	0.6	0	0	0	0	0	0	0	4	0	0.1	0	0.9	0.1	1	0.5	0	0.1	6.9	0	0	0	0.1	1.9	0.1	0.6	0	0.9	0	0.9	0	0	0.1	0.1	0.2	0.4	0	0	0	0	0.7	1.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	4.3	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	0	0	0	0	1.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Cardiomyocytes
GYPA	CD235a, GPA, MN, MNS	ENSG00000170180	Glycophorin A (MNS blood group)	P02724	4	144109303-144140786	Blood group antigen proteins, CD markers, Predicted membrane proteins	Host-virus interaction	Blood group antigen, Host cell receptor for virus entry, Receptor		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	9	bone marrow: 56.9	Cell type enriched	Detected in some	311	Erythroid cells: 1331.6	Not detected	Not detected			Not detected	Not detected			Cell type enhanced	Detected in single		naive B-cell: 1.5	Low lineage specificity	Detected in single			Cell line enriched	Detected in some	4	HEL: 57.0									CAB002658, HPA014811	Enhanced		Approved	Nucleoplasm,Plasma membrane,Cytosol						Nucleoplasm, Plasma membrane, Cytosol		CAB002658: , HPA014811: AB_1849827					unprognostic (1.60e-1)								unprognostic (2.47e-2)					0.1	0	0.2	0.1	0.4	56.9	0.1	0.1	0.5	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0	0.1	0.1	0.2	0.3	1.7	1.3	3.2	0.1	0.3	0.1	0.1	0.1	0	0.3	4.8	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	6.2	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.5	0.3	0.4	0.2	0.2	0.6	0.8	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	57	0	0	0	0	0	0	0	0	0	0	0	0	14.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0.2	0	0.4	0	0.2	0.9	0.1	0.2	0.2	1.5	0.2	0.6	0.2	0.2	0.2	0.3	0	0.8	0.2	0.4	0.1	0.5	0.2	0.3	0.3	0.1	0.1	0.1	0	0	0	0	0	0	0.4	0	0	0	0	0	0.3	1.7	0	0.3	0	0	1331.6	0	1	0	0	0	0	1.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4.3	0	0	0	0	0	0	0.2	0	0	0	Erythroid cells
FABP6	I-15P, I-BABP, I-BALB, I-BAP, ILBP, ILBP3, ILLBP	ENSG00000170231	Fatty acid binding protein 6	P51161	5	160187367-160238735	Predicted intracellular proteins	Lipid transport, Transport			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	68	intestine: 299.2	Cell type enriched	Detected in some	6	Ciliated cells: 208.8	Low cancer specificity	Detected in many			Low region specificity	Detected in single			Cell type enriched	Detected in single	8	neutrophil: 1.0	Lineage enriched	Detected in single	8	granulocytes: 1.0	Cell line enhanced	Detected in some		Daudi: 20.6;EFO-21: 19.8;HDLM-2: 8.7;NB-4: 8.1;RPMI-8226: 9.5;RT4: 9.1;U-2197: 8.6	Not detected	Not detected			Not detected	Not detected			HPA012601, CAB024713	Enhanced				Intracellular and membrane				650000			CAB024713: , HPA012601: AB_1848435	unprognostic (3.03e-2)	unprognostic (7.55e-2)	unprognostic (1.27e-1)	unprognostic (5.00e-3)	unprognostic (1.48e-2)	unprognostic (3.53e-1)	unprognostic (5.35e-7)	unprognostic (3.05e-1)	unprognostic (1.97e-1)	unprognostic (2.41e-2)	unprognostic (2.16e-1)	unprognostic (2.56e-1)	prognostic unfavorable (4.35e-9)	unprognostic (2.10e-2)	unprognostic (1.21e-2)	unprognostic (2.48e-1)	unprognostic (1.85e-3)	0.1	0.9	0.2	0.1	0.4	0	0.1	0.1	0.1	0.5	0.1	0.3	0.1	0.2	0.3	0.1	0.1	4.3	0.1	0.1	0.4	0.5	0.1	0.1	1.3	0.1	0.4	0.1	0.5	0.1	0	0.2	0.1	1	0.1	0	0.1	0.4	0.1	0.1	0	299.2	0.1	0.2	0.1	0	0.1	0.2	1.2	0.1	0.5	0.2	0.2	0.1	0.1	0	1	0	0	0	0	0.1	0.4	0	0.1	0	0	6.5	0	0	0	0	3.4	0.6	20.6	19.8	0	0.1	0	0	0	0	8.7	1.1	0	0	0	0	0	0	0	1.2	0	0.2	0	0	1.5	0.8	0.2	0	0	0	8.1	0	0	1.8	0	0.6	9.5	0	9.1	1.8	0.4	0	5.2	0.1	0.1	0	0.1	0	0	0	8.6	1	1.1	4.5	2.3	0.2	1.8	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	1	0	0	0	0	0	0.2	0.4	0.1	0.1	0.4	0.5	0.4	0.1	1	0.2	0	1	0	0.2	0.5	0	2	0	208.8	34.2	0	0	0	0	0.9	0.3	0	2.6	0	0	0.1	0.2	0.1	0	0	0.1	1.6	0	0	0	0	0.3	0.5	0	1	0	0	0.2	0	0	0	0.5	0	0	0.1	0.2	0.1	0	0	0.6	1.4	Ciliated cells
MRAP	B27, C21orf61, FALP	ENSG00000170262	Melanocortin 2 receptor accessory protein	Q8TCY5	21	32291813-32314784	Disease related genes, Predicted membrane proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Group enriched	Detected in some	9	adipose tissue: 28.3;adrenal gland: 52.7;breast: 68.6	Cell type enriched	Detected in some	4	Horizontal cells: 41.3	Not detected	Not detected			Region enriched	Detected in single	7	basal ganglia: 2.6	Cell type enhanced	Detected in many		NK-cell: 5.5	Low lineage specificity	Detected in many			Group enriched	Detected in some	6	Hep G2: 4.7;HSkMC: 5.4									HPA011024, HPA011093	Uncertain		Supported	Endoplasmic reticulum,Vesicles						Endoplasmic reticulum	Vesicles	HPA011024: AB_10599292, HPA011093: AB_10600889	unprognostic (1.38e-1)	unprognostic (1.55e-3)	unprognostic (1.53e-1)		unprognostic (1.11e-1)	unprognostic (9.53e-2)	unprognostic (1.31e-1)	unprognostic (1.38e-1)	unprognostic (2.27e-1)	unprognostic (1.18e-1)	unprognostic (1.80e-2)	unprognostic (4.12e-1)	unprognostic (6.30e-6)	unprognostic (3.32e-2)	unprognostic (2.37e-1)	unprognostic (1.18e-1)	unprognostic (5.76e-2)	28.3	52.7	0	1.6	2.6	0	68.6	0.3	0.1	0	3	0.7	0	0.1	0.1	0.2	0	0	0.4	1.6	0	0	0.1	0.6	0.2	1.8	0.2	0.1	0.8	0.1	0	0	1.1	0.3	0.1	0.1	0.2	1.7	0	0.9	0.2	1.1	0	0.3	0	0	0.2	0	0	0.2	0.8	0.1	0.6	4.3	1.8	1.5	0	0.5	5.5	1.8	0.1	0	0.4	0	0.1	0.4	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	4.7	0	0.9	0	5.4	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0.2	0	0	0.2	0	0.1	0	0.7	0.1	0	0.1	0	0	0	0	0.4	0	0	0	0.4	0	0.9	0.5	0.7	1.8	0.7	1.2	0.5	1.4	0.8	1.6	0	5.5	0.3	1.5	1.8	0.1	0	2.6	0.3	0.1	0	0	0.2	0.1	0.3	0	0	0.3	0	0	0.1	0	0	0	0	0	0	0	0	0	0	10	0	0	0	0	0.1	0.2	0	0	1.3	0.1	41.3	0	0	0	4.6	0.6	0	0	0	0	0.1	0	0	0	0	0.2	0	0	0.7	0	0	0	0	0	0	Horizontal cells
CNGB3	ACHM1, ACHM3, RMCH	ENSG00000170289	Cyclic nucleotide gated channel beta 3	Q9NQW8	8	86553977-86743675	Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels	Ion transport, Sensory transduction, Transport, Vision	Ion channel, Ligand-gated ion channel	Disease mutation, Stargardt disease	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in some	9	retina: 68.9	Cell type enriched	Detected in some	21	Cone photoreceptor cells: 149.2	Not detected	Not detected			Low region specificity	Detected in some			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	7	SCLC-21H: 21.6	Not detected	Not detected			Not detected	Not detected			HPA057244	Enhanced											HPA057244: AB_2683380	unprognostic (5.35e-1)	unprognostic (1.68e-3)	unprognostic (1.22e-1)	unprognostic (2.42e-1)	unprognostic (3.62e-2)	unprognostic (2.58e-1)	unprognostic (6.25e-2)	unprognostic (1.18e-1)	unprognostic (2.91e-1)	unprognostic (2.17e-1)	unprognostic (3.82e-1)	unprognostic (9.28e-2)	unprognostic (2.77e-4)	unprognostic (1.40e-4)	unprognostic (1.66e-2)	unprognostic (8.76e-2)	unprognostic (1.84e-1)	0.2	0.1	0.4	0.4	0.2	7.9	0.2	0.2	1	0.9	0.1	0.1	0.1	0.9	0.7	0.4	0.2	2.8	0.1	0.3	0.2	0.2	0.2	0.1	0.1	0.3	0.6	0.1	1	1.5	0	0.6	0.1	1.8	0.1	0	68.9	0.3	0.1	0.1	2.4	0.4	0.1	0.8	0.1	0.6	5.4	0.1	0.1	0.1	0.1	0.1	0.3	0.2	0.2	0	0	0	0	0.8	0	0.5	0	0	0.2	0	0	0.1	0.1	0	0	0	0.4	0.1	0.1	0.4	0	0	0.2	0	0	0	0.1	0.2	0	0.9	0.8	0	0	0	0	0	0	0	0.1	0	0	0.4	0.4	0	1.4	0.1	0	0	3.1	0.3	0	0	0.4	0	1.6	21.6	0	0	0.7	0	0.1	0.1	0	0	0.1	0.1	0	0.3	0.5	0.2	0	0.1	0	0.6	0	0	0	0	0	0.8	0	0	0.2	0	0.2	0.1	0	0	0	0	0	0.7	0	0.4	0.2	0.2	1	0.2	0.2	0.6	0.1	1.8	0.1	0	0	0	0	0	0.8	0.8	0	0	0	0	149.2	0	0	0	4.5	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	7.2	0	0	0	0	0	1.3	0	0	0	0	3.2	0	0.1	1	0	0.3	0	0	0	0	Cone photoreceptor cells
FABP4	A-FABP, aP2	ENSG00000170323	Fatty acid binding protein 4	P15090	8	81478419-81483263	Cancer-related genes, Plasma proteins, Predicted intracellular proteins	Transport		Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	9	adipose tissue: 492.7;breast: 545.8	Cell type enriched	Detected in many	4	Sertoli cells: 705.0	Group enriched	Detected in all	7	breast cancer: 42.1;cervical cancer: 141.7;head and neck cancer: 133.8;urothelial cancer: 65.5	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	145	ASC diff: 282.1;RT4: 139.6	Not detected	Not detected			Not detected	Not detected			HPA002188, CAB024961	Enhanced								30000000			CAB024961: , HPA002188: AB_1078822	unprognostic (4.81e-2)	unprognostic (2.30e-3)	unprognostic (1.64e-3)	unprognostic (2.63e-2)	unprognostic (2.58e-1)	unprognostic (8.70e-3)	unprognostic (1.78e-3)	unprognostic (1.67e-1)	unprognostic (2.00e-1)	unprognostic (2.36e-1)	unprognostic (9.32e-2)	unprognostic (1.56e-1)	unprognostic (8.76e-2)	unprognostic (1.13e-3)	unprognostic (4.48e-2)	unprognostic (2.26e-2)	unprognostic (1.39e-1)	492.7	3.5	0.3	16.1	0.3	0.1	545.8	0.2	0.2	0.9	42.2	0	1.8	0.2	0.6	2.9	4.8	1	7.6	15.6	0.3	0.3	1.2	0.4	9.3	4.7	0.3	0	0.7	1.3	2.2	0.3	15.9	0.3	7.7	2.9	0.1	7.6	1.7	13	5.5	4.5	3.3	0.3	0.7	2.2	6.1	0	0.7	7.4	7.3	0.1	15.4	60.2	0	0	0	0	0	0	0	0	0	0	0	282.1	0	0	0	0	0	0	0	0	0	0	0	1.4	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0.2	0	0.6	0	0	0	0.2	0	0	0	0	0	0.1	0	0	0	0	139.6	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0.3	0.2	0.2	0.3	0.3	0.3	0	0.3	0	32.8	75	1.5	0.4	12.8	0.2	16.2	0	40.2	48.9	0	0	0.3	0	0.1	0.9	172.1	0	0	4.6	0.6	7.6	0.4	25.6	0	120.8	0	0	12.9	57	0.6	1.4	13.8	15.1	1	0	0.7	0.1	0	1.1	0	1.7	705	59.7	0	0.1	12.2	0.6	0	0	61.1	Sertoli cells
CST5		ENSG00000170367	Cystatin D	P28325	20	23875935-23879750	Plasma proteins, Predicted secreted proteins		Protease inhibitor, Thiol protease inhibitor		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	268	salivary gland: 1065.3	Cell type enriched	Detected in single	22	Alveolar cells type 1: 8.9	Cancer enriched	Detected in many	5	breast cancer: 17.3	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		CAPAN-2: 1.1;RPTEC TERT1: 3.6;RT4: 1.9;SuSa: 2.3;U-2 OS: 1.6									CAB024944, HPA061449	Enhanced				Secreted to digestive system							CAB024944: , HPA061449: AB_2684523	unprognostic (2.43e-1)		unprognostic (8.83e-2)	unprognostic (3.20e-1)	unprognostic (3.19e-1)			unprognostic (1.51e-2)	unprognostic (4.73e-1)	unprognostic (4.31e-2)	unprognostic (1.76e-2)	unprognostic (2.32e-1)	unprognostic (1.35e-1)	unprognostic (4.83e-3)		unprognostic (5.14e-2)	unprognostic (2.31e-1)	0	3.9	0	0	0	0	0	0.1	0	0	0.1	0	0	0	0	0	0.5	0	0	0	0	0	0.9	0	3.8	0	0	0	0	1.5	0	0.1	0	0	0.6	0	0	1065.3	0	0	0	0.2	0.1	0	0	0	0.1	0	0	0	0.5	0.8	0.1	0	0	0.3	0	0.3	0	0.9	0.5	0.1	0	0	0	0	0	0	0	0.4	0	0	0	1.1	0	0	0	0	0.5	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0.5	0	0	0	0	0	0	0	3.6	1.9	0	0	0	0	0.6	2.3	0	0	0	0	1.6	0	0	0	0	0	0	0	0	0	0.2	0	0.7	0.3	0.8	0	0.6	0.9	0.3	0	0	0.5	0	0	0.1	0.2	0	0.5	0	0	0.1	0	0	0	0	0	0	0	8.9	0	0	0	0	0	0.4	0	0	0	0	0	0.2	0	0.3	0	0	0	0	0.2	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0.1	0	0	0	0	Alveolar cells type 1
CST2		ENSG00000170369	Cystatin SA	P09228	20	23823769-23826731	Predicted secreted proteins		Protease inhibitor, Thiol protease inhibitor		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	230	salivary gland: 1538.3	Cell type enriched	Detected in single	16	Melanocytes: 15.1	Low cancer specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	12	RT4: 39.1									CAB024963, HPA043706, HPA044763	Enhanced				Secreted to digestive system				110000			CAB024963: , HPA043706: AB_2678627, HPA044763: AB_2679080	unprognostic (1.57e-2)	unprognostic (3.23e-2)	unprognostic (1.04e-1)	unprognostic (3.10e-1)	unprognostic (1.64e-2)	unprognostic (5.17e-3)	unprognostic (1.28e-2)	unprognostic (2.75e-3)	unprognostic (2.73e-1)	unprognostic (4.82e-3)	unprognostic (6.43e-3)	unprognostic (2.51e-1)	unprognostic (4.58e-11)	unprognostic (1.29e-3)	unprognostic (3.22e-1)	unprognostic (4.30e-1)	unprognostic (1.71e-1)	1.6	6.6	0.1	0.1	0.1	0	0.1	0.3	0.1	3.8	0.1	0.1	0.1	0	0.2	0.1	0.1	0.1	0.3	0.1	0.1	0	0.1	0.1	1.3	0.1	0.1	0.1	0.1	0.7	0	5.9	0.7	0.1	2.6	0	0.1	1538.3	0.1	0.1	0.2	0.1	0.3	0.1	0.1	0.2	0.2	0.1	0.1	0.1	0.1	0.8	0.1	0.5	0	0	0	0.2	0	0	0	0	0.3	0	0	0.2	0	0	0	0.1	0	0	2.1	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	1.4	0	0.5	0	0	0	0	0	0	0	0	0	0.3	0.1	0	0	0	1	39.1	0	0	0	0	3.1	0.5	0	0	2.7	0	0	0	0	0.6	0	0	0.1	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.3	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0.2	0.1	0	0	0	0	0	0	0	0.2	0	0	15.1	1	0	0	0.3	0	0	0	0	0	0	0	0	0.1	0	0	0	0	Melanocytes
LRRN2	FIGLER7, GAC1, LRANK1, LRRN5	ENSG00000170382	Leucine rich repeat neuronal 2	O75325	1	204617170-204685733	Predicted membrane proteins				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 20.3	Cell type enriched	Detected in some	5	Horizontal cells: 49.3	Group enriched	Detected in many	6	breast cancer: 6.1;endometrial cancer: 10.6;glioma: 16.8;ovarian cancer: 18.2	Low region specificity	Detected in all			Cell type enhanced	Detected in single		basophil: 1.7	Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		HEL: 7.1;NTERA-2: 14.3;RPMI-8226: 22.2;SuSa: 8.2;T-47d: 7.9	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA029124	Uncertain		Approved	Endoplasmic reticulum						Endoplasmic reticulum		HPA029124: AB_10601545	unprognostic (2.16e-2)	unprognostic (1.93e-1)	unprognostic (1.35e-1)	prognostic unfavorable (2.59e-7)	unprognostic (1.40e-1)	unprognostic (1.17e-1)	unprognostic (2.89e-2)	unprognostic (1.21e-1)	unprognostic (4.63e-2)	unprognostic (1.15e-1)	unprognostic (1.52e-3)	unprognostic (1.16e-2)	unprognostic (1.68e-2)	unprognostic (1.43e-2)	unprognostic (7.33e-2)	unprognostic (1.88e-1)	unprognostic (1.59e-3)	4.9	6.6	11.8	3.7	16.5	2.4	3.3	9.7	20.3	1.9	7.9	5.3	1	1.9	3.9	0.8	2.4	10.2	6.1	6	11.7	12.8	7.3	0.7	2.5	2.9	6.3	13.8	3.3	1.4	19.1	9.7	1.3	8.1	1.6	7.5	12.2	2.8	3.7	2.2	0.7	3.3	9.9	3.1	6.3	1.4	3.8	6.1	3.2	2.8	0	1.3	2.1	1.5	0.4	0.1	1.7	0.3	0.7	0.8	0.2	0	3.3	2.7	0.1	0	0	0.3	0	0	0.1	0	0	0	0	0.2	0	0.1	0.3	0	0	0	0.1	0.1	7.1	0.5	0	0.2	0	0.7	0	0	0	0	0	0	0.1	0	0.3	0	0.7	1.1	0	14.3	0	0.1	0.2	0	22.2	0	0.1	1.9	0.3	4.4	0.1	0	8.2	7.9	0	0	0	3.2	0	0	0.5	0	0	0	0	0	1.7	0.3	0.2	0.1	0	0	0.3	0.1	0.1	0	0.4	0.1	0.2	0.7	0.7	0	0.1	0.8	0.2	11.8	16.5	9.7	15.7	11.7	12.8	6.3	13.8	8.1	6.1	0	0	0	0.5	0.3	4.6	1	0	0	0	1.8	2	0.1	0	2.7	0	0.7	1.7	0	0.8	0.1	1.1	0.3	0	0	5.3	49.3	10.9	4.9	0	0	0	0	0	0	1.9	3.9	3.3	0.3	0	2.7	0.9	0	0.4	0	0.2	0.1	0.3	0	0.7	0.3	Horizontal cells
ZNF804A	C2orf10	ENSG00000170396	Zinc finger protein 804A	Q7Z570	2	184598366-184939492	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Group enriched	Detected in many	4	brain: 31.6;lymphoid tissue: 9.6	Cell type enriched	Detected in some	5	Bipolar cells: 31.9	Cancer enhanced	Detected in single		glioma: 0.9	Region enriched	Detected in many	4	cerebellum: 31.6	Cell type enhanced	Detected in some		memory B-cell: 2.0	Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		Daudi: 20.8;RH-30: 14.3;THP-1: 10.5;U-698: 15.5	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA029195	Uncertain		Approved	Endoplasmic reticulum						Endoplasmic reticulum		HPA029195: AB_10603011	unprognostic (1.10e-1)	unprognostic (1.00e-1)	unprognostic (1.06e-2)	unprognostic (2.05e-2)	unprognostic (1.08e-2)	unprognostic (1.26e-2)	unprognostic (1.50e-1)	unprognostic (2.41e-1)	unprognostic (4.45e-1)	unprognostic (2.38e-2)	unprognostic (2.83e-2)	unprognostic (5.20e-2)	unprognostic (4.98e-4)	unprognostic (6.21e-2)	unprognostic (4.04e-1)	unprognostic (8.45e-2)	unprognostic (4.93e-2)	0.4	1	4.3	9.6	7.2	1.8	0.4	31.6	10.7	0.6	0.8	0.1	0.8	1.5	0.4	0.3	0.6	0.4	4.8	0.3	5.2	7.3	1.8	0.6	1.2	2.7	2.2	3	0.8	0.3	0.2	0.4	0.5	5.4	4.1	1.1	2.4	1.1	4.4	0.3	0.3	3.3	0.5	1.5	1.8	1.2	0.9	0.4	0	4.4	0	2.9	1.8	2.1	2	1.2	1	1.7	0	0	0.3	0	0	1.2	0	0	0	0	2.1	4.9	1.6	1.5	0	0	20.8	0	0	2.1	0	0.3	0	3.7	0.1	0	5.5	0.8	0.1	8.2	5.2	0	2.5	0	0	1.3	2.5	3.9	0	0	0.9	0	0	0	4.9	0	0	3.3	0	14.3	0.8	0	0	0.3	2.4	0	0	0	0.1	0	10.5	0	5.3	0.1	0.2	2.1	2.2	0	15.5	6.1	1.5	1.7	0	1.1	0	0	1.7	0	2	0	0	1.2	0.3	0	0	1	0	0.6	0	0	0.3	4.3	7.2	31.6	7.5	5.2	7.3	2.2	3	5.4	0.4	0	1.1	3.4	0	0	31.9	0.8	0	0	0	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0	2.9	3.2	0	0	2.7	0.4	0.3	3.2	0	1	0	0.7	0	0	0	0	2.6	6.5	0.2	0.5	1.4	0	0	0	0	0	Bipolar cells
TMEM182	FLJ30294	ENSG00000170417	Transmembrane protein 182	Q6ZP80	2	102736905-103019900	Predicted intracellular proteins, Predicted membrane proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	6	heart muscle: 40.3;skeletal muscle: 53.9;tongue: 37.8	Cell type enriched	Detected in many	6	Cardiomyocytes: 134.4	Low cancer specificity	Detected in all			Low region specificity	Detected in many			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Low cell line specificity	Detected in many			Low region specificity	Detected in some			Low region specificity	Detected in some			HPA045861			Approved	Nucleoplasm,Vesicles						Nucleoplasm, Vesicles		HPA045861: AB_2679475	unprognostic (1.39e-1)	unprognostic (3.42e-2)	unprognostic (5.10e-2)	unprognostic (1.12e-4)	unprognostic (5.35e-2)	unprognostic (7.01e-2)	unprognostic (1.13e-2)	unprognostic (1.10e-1)	unprognostic (7.03e-3)	unprognostic (2.34e-1)	unprognostic (4.19e-2)	unprognostic (3.42e-2)	unprognostic (9.88e-2)	unprognostic (4.61e-2)	unprognostic (1.10e-1)	unprognostic (3.53e-1)	unprognostic (2.36e-2)	2.4	1.1	1.2	1	1.3	0.3	1.1	1.7	1.8	1.4	1	0.5	1.5	1	0.6	2.3	1.8	1.1	0.8	40.3	1.2	1.9	1.4	1.7	0.6	0.8	1.2	0.5	1	1.1	1.5	6.8	0.8	2.8	1.9	1	0.9	3.8	1.2	53.9	0.5	0.9	1.1	1.2	0.8	1	0.8	0.4	1.8	2	37.8	4	1.2	0.7	4.4	3.1	0.3	0.3	2.4	4.1	1.1	4.9	2.8	2.1	6.6	2.7	2.7	7.7	2.7	2.4	2.7	3.9	9.2	6.9	4.1	9.2	0.9	4.4	2.9	2.3	3.7	5.7	9.1	1.8	6.1	1.3	5.8	3.2	5.5	4.9	3.4	6.8	4.3	3.8	1.9	0.4	5.9	4.3	1.6	2.7	3.6	2.9	5.3	3.6	4.7	3	3.1	5.6	3.9	3.8	4.3	5.5	1.9	3.6	3.9	8.6	2.9	3.3	2.9	0.3	4.3	3.1	3.3	3.3	4	10	3.4	4.4	9.1	6.5	0	0	0.3	3.9	0.3	3.2	4.4	2.8	2.2	1.3	1.9	3.8	4.1	0.1	2.4	0.3	3.1	0.8	1.1	1.2	1.3	1.7	1.8	1.2	1.9	1.2	0.5	2.8	0.4	20.8	10.5	5.9	0.8	0.3	0.1	134.4	0	17.4	23.9	3.5	0	1.9	0	1.3	0.6	0	0.4	23.3	2.9	2.1	1	1	3.5	1.9	1	0	6.3	0	0.6	0.4	0.6	0.7	6.8	0	2.2	2.3	1.7	0	0.7	2.4	0.3	0	0.9	0.9	2.2	0.5	0.9	1	1.7	2.7	Cardiomyocytes
VSTM2A	MGC33530, VSTM2	ENSG00000170419	V-set and transmembrane domain containing 2A	Q8TAG5	7	54542325-54571080	Plasma proteins, Predicted secreted proteins	Differentiation			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		adrenal gland: 13.7;brain: 51.7;prostate: 13.7	Cell type enriched	Detected in some	5	Bipolar cells: 38.3	Cancer enhanced	Detected in some		breast cancer: 4.6	Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	6	Karpas-707: 3.4;SCLC-21H: 10.5;SH-SY5Y: 7.2	Low region specificity	Detected in all			Low region specificity	Detected in all								Secreted in other tissues								unprognostic (1.15e-1)		unprognostic (1.02e-1)		unprognostic (1.89e-1)						unprognostic (1.14e-2)	unprognostic (4.66e-1)	prognostic favorable (5.34e-4)	unprognostic (4.34e-2)	unprognostic (6.79e-2)		unprognostic (7.15e-2)	0.7	13.7	18.4	0.7	22.7	0.7	1.1	0.5	51.7	0.7	6	1.4	0	2.4	0.7	0.7	0.7	0.7	0.9	0.7	9.4	15.5	0.8	0.7	0.8	0.7	4.4	13.6	0.7	1.8	0.7	0.4	0.7	6.7	13.7	5.8	1.1	0.7	0.7	0.8	0.7	1.1	0.8	3.2	0.7	7.2	1.2	3	0	0.7	0	0.7	0.9	0.3	0	0	0.1	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	3.4	0	0	0	0	1.1	0	0.2	0	0	0	0	0	10.5	7.2	0	0	0	0.2	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0.1	0	0	0	0	0.1	0	0	0	0	0	18.4	22.7	0.5	51.7	9.4	15.5	4.4	13.6	6.7	3	0	0	0	0	0	38.3	0.4	0	1.4	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0.1	0	0	0	0	7	0	0	0	0.3	0	0	0	0	2.3	0	0	0	0	3.6	0	0	0.2	0.1	0	0	0	0	0	Bipolar cells
KRT74	K6IRS4, KRT5C, KRT6IRS4	ENSG00000170484	Keratin 74	Q7RTS7	12	52565782-52573825	Disease related genes, Predicted intracellular proteins			Disease mutation, Ectodermal dysplasia, Hypotrichosis	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	8	epididymis: 11.9;skin 1: 17.2	Cell type enriched	Detected in single	4	Late spermatids: 2.0	Not detected	Not detected			Not detected	Not detected			Cell type enriched	Detected in single	4	memory CD8 T-cell: 1.0	Lineage enriched	Detected in single	10	T-cells: 1.0	Cell line enhanced	Detected in single		HaCaT: 2.6					Not detected	Not detected			HPA048596	Enhanced											HPA048596: AB_2680457		unprognostic (6.75e-3)		unprognostic (3.93e-1)		unprognostic (1.60e-1)		unprognostic (2.49e-2)		unprognostic (9.46e-2)		unprognostic (2.29e-1)			unprognostic (8.54e-2)		unprognostic (1.02e-1)	0.4	0	0.1	0.1	0.1	0	1.8	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	11.9	0.2	0	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	17.2	0.1	0.1	0.4	0.1	0	0.8	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0	1	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	2.6	0	0.2	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0.2	0	0	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0.1	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0.2	0	0	0	0	0	0	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	0	0.1	0	0	0.3	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	Late spermatids
KISS1		ENSG00000170498	KiSS-1 metastasis suppressor	Q15726	1	204190341-204196486	Cancer-related genes, Disease related genes, Predicted secreted proteins			Cancer-related genes, Disease mutation, Hypogonadotropic hypogonadism	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	24	placenta: 267.2	Cell type enriched	Detected in many	41	Syncytiotrophoblasts: 1117.8	Cancer enhanced	Detected in many		urothelial cancer: 9.2	Group enriched	Detected in some	8	basal ganglia: 11.3;hypothalamus: 4.2	Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	22	BJ: 55.9;U-2 OS: 22.8					Low region specificity	Detected in all			CAB017775, HPA035542	Enhanced		Approved	Vesicles	Secreted in female reproductive system					Vesicles		CAB017775: , HPA035542: AB_2674677	unprognostic (9.64e-2)	unprognostic (1.78e-2)	unprognostic (1.86e-2)	unprognostic (1.18e-2)	unprognostic (3.89e-1)	unprognostic (6.87e-2)	unprognostic (1.87e-1)	unprognostic (3.28e-2)		unprognostic (1.28e-2)	unprognostic (4.51e-2)	unprognostic (1.63e-1)	unprognostic (8.98e-12)	unprognostic (2.25e-1)	unprognostic (2.91e-2)	unprognostic (1.76e-1)	prognostic favorable (6.29e-6)	0.2	0	0.2	0.2	11.3	0	0.2	1	0.2	0.2	0.2	0.2	0.2	0.4	0.2	0.2	0.2	0	0.2	0.2	0.2	4.2	1.1	2.7	0.5	0.2	0.2	0.2	0.2	0.4	0.1	2.5	267.2	0.2	0.2	0	0.2	0.2	0.2	0.2	0	0.5	0.2	0.2	0.7	1.4	3.6	0.2	0.2	0.2	0.2	0.2	0.5	0.2	0	0	0	0	0	0.4	0	0.1	0	0	0	0	0	0.9	55.9	0.7	1	0.2	0	0.3	0	0.5	0	0	0	0	0	1.7	0	0.1	0	0	0	0	0	0	0.1	0	0	0	0	0.1	0	0	0	0	0.2	0	0	0.3	0.1	0	0	0	0	0	0.3	0	0	0	0.2	0	0.3	0.1	0.1	0	0	22.8	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	11.3	1	0.2	0.2	4.2	0.2	0.2	0.2	0.2	0	0	0	4	0	0.5	0	0	0	0	0	0	6.3	0	3.3	27	0.3	5.1	0	4	4.1	0.4	1.8	0	2.9	14.5	0	0	1.3	0	3.1	0.3	0	0	0	0.6	0	2.9	0.8	0	1.2	0	0	0.1	0.1	0.4	0	1117.8	0	1.9	2.2	Syncytiotrophoblasts
TMC7	FLJ21240	ENSG00000170537	Transmembrane channel like 7	Q7Z402	16	18983934-19063942	Predicted membrane proteins	Ion transport, Transport	Ion channel		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 24.8;testis: 14.9	Cell type enriched	Detected in many	4	Early spermatids: 117.6	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		OE19: 12.1	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA029465	Uncertain		Approved	Vesicles						Vesicles		HPA029465: AB_10600914	unprognostic (1.80e-4)	unprognostic (6.13e-2)	unprognostic (1.82e-1)	unprognostic (2.07e-3)	unprognostic (1.25e-1)	unprognostic (1.19e-3)	unprognostic (7.60e-5)	prognostic unfavorable (3.20e-4)	unprognostic (7.60e-2)	unprognostic (1.29e-1)	prognostic unfavorable (7.64e-4)	unprognostic (3.39e-1)	unprognostic (1.00e-1)	unprognostic (1.75e-1)	unprognostic (1.94e-1)	unprognostic (5.66e-2)	prognostic favorable (9.20e-4)	3.6	0.7	6.2	1.9	11.4	0.7	2	8.5	11.1	1.1	6.7	24.8	0	4.4	1.5	1.3	0.9	1	2.6	1.6	9.7	5.3	1	0.7	5.2	0.7	15.7	6.6	0.7	0.9	1.4	0.7	7.7	12.8	2.8	8.2	0.6	0.7	1.9	1.6	2	4.9	2.2	15.7	1.1	5.4	14.9	12.8	0	1.6	0	0.6	9.6	1.3	1.6	1.2	2.9	0.8	1.6	1	0.2	1.9	4	1.2	2	0.2	1.7	5.3	0.7	1.1	0.7	1.8	1.3	9.3	0.2	8.9	0.7	2	7.3	3.2	3.1	0.9	0.1	2.3	0.2	3.2	5.7	0.2	0.2	0.1	0.4	4.5	7.2	8.1	2.4	3	4.1	2.2	0.7	3.2	4.5	0.3	0.3	3.4	12.1	5.9	0.2	3.5	0.3	1.3	9.7	0.7	2	2.2	6.1	0.6	5.6	1.8	0.7	2.6	1.2	2	1.4	3.5	0.5	1	0.3	6.2	0.3	1	2.5	0.8	0.8	0.9	0.6	0.5	0.9	0.9	0.7	0.3	1.6	0.9	1	2.9	1.6	0.4	1.2	0.5	0.2	6.2	11.4	8.5	8.3	9.7	5.3	15.7	6.6	12.8	12.8	3	3.8	0	2.5	0.3	0.6	0.8	2.5	0	1.2	0	0	0.1	0	2.8	117.6	3	3.9	0	10	1.5	0.4	2	0	0.2	0.2	0	1.2	4.3	0	29.3	1.1	1.2	0	0	5.4	0.2	9.6	6.8	0.4	0	2.5	0	1	5.4	10	0.9	0.2	0	3.3	15.2	Early spermatids
GPR37	EDNRBL, hET(B)R-LP, PAELR	ENSG00000170775	G protein-coupled receptor 37	O15354	7	124745997-124765627	G-protein coupled receptors, Predicted membrane proteins, Transporters		G-protein coupled receptor, Receptor, Transducer		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	4	brain: 62.4	Cell type enriched	Detected in many	36	Muller glia cells: 779.4	Cancer enhanced	Detected in many		glioma: 19.2	Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in many		AF22: 9.4;fHDF/TERT166: 22.0;hTCEpi: 9.8;SK-BR-3: 8.5;SuSa: 10.6;TIME: 15.3	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA042903, HPA068009	Approved		Approved	Nuclear membrane,Cytosol		No	No		48000	Nuclear membrane, Cytosol		HPA042903: AB_2678219, HPA068009: AB_2685940	unprognostic (2.47e-1)	unprognostic (2.57e-1)	unprognostic (2.46e-1)	unprognostic (3.30e-2)	unprognostic (7.29e-2)	unprognostic (1.06e-1)	unprognostic (2.45e-1)	prognostic unfavorable (6.00e-5)	unprognostic (6.19e-2)	prognostic favorable (7.26e-4)	unprognostic (6.54e-2)	unprognostic (2.58e-1)	unprognostic (3.16e-2)	unprognostic (6.12e-3)	unprognostic (2.10e-1)	unprognostic (1.88e-1)	unprognostic (1.71e-4)	1.6	1	14.5	1.1	19.6	0.9	1.7	2.3	52.6	1.5	1.4	62.4	0	1	2.1	1.4	7.8	2.1	1.4	0.9	23.9	11.3	1.2	8.8	1.3	1.1	33.5	12.3	1	3	0.8	0.3	10	23.3	1.8	1.5	3.5	1.6	1.8	1.1	4.1	1.3	3	49.4	4.3	1.2	15.5	26.5	0	0.9	0	0.9	1.2	0.5	0	0	0	0	0	0	0	0.1	1.7	9.4	0	0	0	2.7	0.5	2.5	2.4	0.6	0.4	0.8	0	0	22	0.3	0.2	2.8	0	0.5	0.4	1.2	0.1	5.9	0	2.8	0	0.4	0	9.8	0	0.1	0	4.5	0	0	4.3	0	0.5	0	0	1.4	0	4.5	0	0	0	0	0.1	2.2	3.3	0	8.5	3.2	10.6	2.2	0	15.3	2	0.7	0	0	1.3	0	0	1	0	4.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.5	19.6	2.3	19.6	23.9	11.3	33.5	12.3	23.3	26.5	0	0	0	0.3	4	21.7	0.4	2.5	0	0	1.8	5.9	7.1	0	4.3	0.2	0.5	0	0	0.5	15.1	2.7	2.1	0	21.5	1	17.5	0	0	0.3	0.9	2.6	0	3.3	1	0.4	779.4	0.4	0	0.7	0	12.5	0	0.9	0.6	0.7	8.9	2.5	0	0	0.1	Muller glia cells
OR10A2	OR10A2P, OST363	ENSG00000170790	Olfactory receptor family 10 subfamily A member 2	Q9H208	11	6863057-6874717	G-protein coupled receptors, Predicted membrane proteins	Olfaction, Sensory transduction	G-protein coupled receptor, Receptor, Transducer		Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in some		blood: 2.9	Cell type enriched	Detected in single	14	Ciliated cells: 1.4	Not detected	Not detected							Cell type enhanced	Detected in some		neutrophil: 2.9	Low lineage specificity	Detected in single			Not detected	Not detected																																					unprognostic (5.04e-2)				0	0.3	0.2	0.4	0.6	1	0	0	0.3	0.2	0			0.5	0.2	0	0	0.2	0.3	0	0.2	0.3	0	0	0	0.5	0.1		0	0.2	0	0	0		0.1	0		0.1	0	0.5	0.8	0	0	0.2	0.4	0	0.6			0.1		0.1	0.3	0	0.6	0.8	2.9	0.4	0.5	0.3	0	0.3	0	0.1	0.4	0	0	0.3	0.1	0	0.1	0	0.3	0.1	0.8	0.1	0	0	0.5	0.1	0.3	0	0	0.6	0.3	0.5	0.3	0	0.8	0.4	0.1	0.1	0.2	0	0.1	0.1	0.1	0.8	0.2	0.1	0	0.1	0.1	0.4	0	0.3	0.2	0.2	0.1	0.1	0.8	0.3	0	0.4	0.6	0	0.4	0.5	0	0.3	0.1	0.4	0.2	0	0.4	0.2	0.2	0.4	0.1	0.3	1.2	0.4	0.3	0.3	0.2	0.2	0.4	0.2	0.1	0	0.6	0.3	0.3	2.9	0.5	0.3	0.8	0.2	0											0	0	0	0	0	0	0	0	1.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Ciliated cells
LMOD2		ENSG00000170807	Leiomodin 2	Q6P5Q4	7	123655807-123664290	Predicted intracellular proteins		Actin-binding		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	44	heart muscle: 117.3;skeletal muscle: 297.2;tongue: 100.1	Cell type enriched	Detected in some	1164	Cardiomyocytes: 1233.0	Group enriched	Detected in some	20	head and neck cancer: 3.5;prostate cancer: 1.4	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	6	HSkMC: 5.7;SuSa: 2.0	Not detected	Not detected			Not detected	Not detected			HPA046370, HPA051039	Enhanced		Uncertain	Plasma membrane,Actin filaments,Cytosol						Plasma membrane	Actin filaments, Cytosol	HPA046370: , HPA051039: AB_2681321	unprognostic (2.55e-1)			unprognostic (1.14e-1)	unprognostic (1.43e-1)	unprognostic (2.38e-3)	unprognostic (1.18e-1)	unprognostic (5.50e-1)	unprognostic (5.69e-2)	unprognostic (6.98e-2)		unprognostic (2.13e-2)	unprognostic (1.43e-3)	unprognostic (3.37e-2)	unprognostic (1.51e-1)		unprognostic (1.82e-3)	3.3	0	0.1	0	0.1	0	0.1	0.1	0.1	0	0.1	0	0	0	0	3.2	3.8	0	0	117.3	0.1	0.1	0	0.1	0.1	0	0.1	0	0.1	0.1	0	0	0.1	0	1.5	0	0	2.6	0	297.2	0.1	0.1	0	0.1	0	0.1	0.1	0	0	1.4	100.1	3.8	0.1	0	0	0	0	0	0	0.4	0	0	0	0.1	0.5	0.1	0	0.1	0	0.6	0	0	0.1	0	0.2	0	0.1	0	0	0	0	0	0	0.2	0	0.4	0	0	0.1	0	5.7	0	0	0	0.1	0	0	0.2	0.3	0	0	0	0	0.2	0	0.1	0	0	0	0	0.3	0.1	0.3	0	0.3	0	2	0	0.1	0	0	0	0	0	0.2	0	0	0	0.1	0.1	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0	1233	0	0	0	0	0	0	0	0	1.1	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0.5	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Cardiomyocytes
CEL	BSSL, MODY8	ENSG00000170835	Carboxyl ester lipase		9	133061978-133071861	Predicted secreted proteins				Evidence at protein level	Evidence at protein level				Tissue enriched	Detected in some	348	pancreas: 1584.8	Cell type enriched	Detected in some	19	Exocrine glandular cells: 809.5	Cancer enriched	Detected in many	29	pancreatic cancer: 469.3	Region enriched	Detected in single	9	cerebral cortex: 2.3	Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in many		JURKAT: 9.9	Not detected	Not detected			Low region specificity	Detected in single			HPA008023, HPA052701	Enhanced				Secreted to digestive system							HPA008023: AB_1846509, HPA052701: AB_2681921	prognostic unfavorable (4.14e-4)	unprognostic (2.30e-2)	unprognostic (4.49e-2)	unprognostic (3.14e-2)	unprognostic (2.22e-1)	unprognostic (2.48e-1)	unprognostic (1.49e-1)	unprognostic (6.27e-2)	unprognostic (3.04e-2)	unprognostic (1.47e-2)	unprognostic (2.51e-1)	unprognostic (5.55e-2)	unprognostic (2.26e-3)	unprognostic (2.98e-1)	unprognostic (4.41e-1)	unprognostic (4.37e-2)	unprognostic (1.02e-1)	0.2	0	0.2	0.2	0.2	0	0.2	0.2	2.3	0.2	0.2	0.2	0.2	0.1	0.2	2.9	0.2	0	0.2	0.2	0.2	0	0.2	0.2	3.5	0.2	0.2	0.2	0.8	1584.8	0	4.5	0.2	0.2	0.2	0	0.2	0.2	4.5	0.2	0	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.2	1.6	0.2	0.2	0.2	0	0	0.4	0	0.3	0	0.4	1.1	4.2	2.6	1.4	1	4.2	0.8	0.5	0.6	0.8	1.2	0.8	1.2	2	0.8	0.7	2.9	0.9	7.8	0.2	2.5	1.6	2.1	0.5	2.7	0.6	0.9	7.9	2.1	5.1	0.7	0.5	1.8	0.8	9.9	1.3	1	0.7	1.7	1.2	4.1	6.9	0.9	1.3	2.3	1.2	0.9	0.5	3.6	7.2	1.7	0.9	0.9	0.4	6.3	1.3	3.7	0.6	2	2.6	2.3	0.5	0.5	4.2	1	0	2	1	0	0	0	0	0.3	0.2	0.2	0	0	0	0	0.3	0	0	0	0.4	0	0	0	0.2	0.2	0.2	2.3	0.2	0	0.2	0.2	0.2	0.2	0	0	0	1.7	0	0.7	1.6	2.5	0	0	0	0	0.1	3.3	1.7	0.2	0	3.3	0	809.5	0.1	0	0.3	0	0	0	0	0	0	0	2.7	0.3	0	0	11.8	0	1.1	42	0	0	0	0.8	0	0.2	0	0	0.3	0.3	0	1.2	1.7	Exocrine glandular cells
PSG6		ENSG00000170848	Pregnancy specific beta-1-glycoprotein 6	Q00889	19	42902079-42919563	Predicted intracellular proteins, Predicted secreted proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	124	placenta: 330.8	Cell type enriched	Detected in some	204	Syncytiotrophoblasts: 304.0	Not detected	Not detected			Not detected	Not detected			Cell type enriched	Detected in single	27	neutrophil: 2.6	Lineage enriched	Detected in single	27	granulocytes: 2.6	Cell line enriched	Detected in some	17	U-2197: 57.9									HPA046327	Supported				Secreted in female reproductive system							HPA046327: AB_2679624						unprognostic (4.23e-1)												0.1	0.1	0.2	0	0.1	0.8	0.1	0.4	0.1	0.4	0	0	0	0	0.1	0	0.1	0.2	0	0	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0	0	330.8	0	0	0	0	0.1	0	0	0.1	0	0.1	0.1	0	0	1.3	0	0	0	0	0	0	0	0	0	2.6	0	0	0	0.1	0	0	0	0	0	0	0	3.4	0.2	0.2	0.4	0	0.1	0	0	0.7	0	0.1	0	0	2.9	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.7	0	0	0	0	0.1	57.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.6	0	0	0	0	0.1	0.2	0.1	0.4	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0.3	1.5	0	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0.6	0	0	0	0	1.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	304	0	0	0	Syncytiotrophoblasts
PLA2G1B	PLA2, PLA2A, PPLA2	ENSG00000170890	Phospholipase A2 group IB	P04054	12	120322111-120327789	Candidate cardiovascular disease genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins	Lipid metabolism, Phospholipid metabolism	Hydrolase	FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	933	pancreas: 2360.6	Cell type enriched	Detected in many	10	Exocrine glandular cells: 17927.2	Cancer enriched	Detected in many	185	pancreatic cancer: 763.5	Not detected	Not detected			Cell type enhanced	Detected in some		naive CD4 T-cell: 2.5	Group enriched	Detected in many	19	NK-cells: 1.3;T-cells: 2.5	Cell line enhanced	Detected in some		EFO-21: 2.2;Hep G2: 6.4;U-2 OS: 4.7	Not detected	Not detected			Low region specificity	Detected in all			HPA047822, HPA060803	Enhanced				Secreted to digestive system				3900000			HPA047822: AB_2680169, HPA060803: AB_2684369	unprognostic (1.28e-4)	unprognostic (6.02e-2)	unprognostic (1.84e-2)	unprognostic (2.86e-2)	unprognostic (2.74e-2)	unprognostic (2.41e-1)	unprognostic (1.05e-1)	unprognostic (1.13e-1)	unprognostic (2.63e-2)	unprognostic (3.61e-2)	unprognostic (1.27e-1)	unprognostic (1.03e-1)	unprognostic (2.80e-4)	unprognostic (2.15e-1)	unprognostic (1.97e-1)	unprognostic (3.60e-1)	unprognostic (8.61e-4)	0.1	0	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.2	0.1	0	0.1	0.1	1.1	0.1	0.1	0.1	1.1	2360.6	0	0.1	0.1	0.1	0.1	0	0.1	0.2	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	1.3	2.5	0.9	0.2	0	1.2	0.2	0	0	0	0	0	0.3	1.6	0	0	0	2.2	0	0	0	0.3	0	0	1.4	0	0	0	6.4	0	0	0	0	0	0.4	0	0	0	1.8	0.2	0	0	0	0.7	0.4	0	0	0	0.5	0	0.3	1.3	0.3	1.6	0	0	0.3	0	0.1	0.6	0	1	0.2	4.7	0.6	0.6	0	1.2	0.4	0	0.6	0	0	0	0	0.9	0	1.7	0	0	0.3	0	0	2.5	0.9	0	1.3	0	0	0	0.9	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	11.9	65.5	0	0.1	0	0	0.3	0	1.4	1.2	0	0	0	1.7	16.1	7.5	0	0.7	0	17927.2	0	0	0.2	0	1.6	0	0	1.2	0	0	27.8	2.8	0.3	0	76.7	1	0	1839.8	1.1	3.2	2.1	0	0	0	0.2	0.2	0.1	0	0.7	1.2	0	Exocrine glandular cells
TRH		ENSG00000170893	Thyrotropin releasing hormone	P20396	3	129974305-129977938	Predicted secreted proteins		Hormone		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		brain: 33.9;cervix, uterine: 23.6;endometrium 1: 17.5	Cell type enriched	Detected in some	31	Muller glia cells: 222.3	Cancer enhanced	Detected in some		breast cancer: 13.3;endometrial cancer: 10.2	Group enriched	Detected in many	14	hypothalamus: 33.9;pons and medulla: 33.8	Group enriched	Detected in some	11	intermediate monocyte: 1.1;non-classical monocyte: 1.0	Lineage enriched	Detected in single	12	monocytes: 1.1	Cell line enhanced	Detected in some		REH: 2.6;SuSa: 4.0;T-47d: 2.4	Group enriched	Detected in many	5	hypothalamus: 204.6;olfactory region: 182.2	Low region specificity	Detected in many			HPA035596	Enhanced				Secreted in other tissues							HPA035596: AB_2674695	unprognostic (1.22e-1)	unprognostic (8.94e-2)		unprognostic (5.82e-3)	unprognostic (5.24e-2)	unprognostic (2.82e-1)		unprognostic (1.11e-1)	unprognostic (1.84e-1)	unprognostic (4.44e-2)	unprognostic (3.86e-2)	unprognostic (1.50e-1)	unprognostic (1.71e-2)	unprognostic (2.85e-1)	unprognostic (1.95e-1)	unprognostic (2.57e-2)	unprognostic (2.82e-2)	0.3	0.1	0.4	0.2	2.4	2.8	0.9	0.3	1.7	23.6	0.1	0.1	0.6	0.2	17.5	0.1	0.1	2.3	0.1	0.5	2	33.9	0.1	0.1	0.6	0.1	0.4	0.8	3.2	0.1	0.1	0.1	0.3	33.8	0.1	0.1	6.3	1	0.2	0.2	0.5	0.1	0.4	3.6	0.1	0.1	0.8	0	0.8	0.1	0	0.1	0.1	0.3	0	0	0	1.1	0	0	0	0.1	0	0.7	0	0	0	0	0.1	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0.2	0	0	0.1	0	0	0.1	0	0	0	0	0	0.1	0.3	0.2	0	0	2.6	0	0	0	0	0.4	0.1	0.3	0	0	4	2.4	0.2	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	1.1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0.4	2.4	0.3	1.7	2	33.9	0.4	0.8	33.8	0	0	0	0	0.5	0.7	6.8	0.8	0	0	0	0	0	0	0	0	1.3	0.3	0	0	0	0	0.4	0	0	0	0.1	4.8	0	0	0	1.5	0	0	0	0	0	222.3	0	0	0	0	7.1	0	0.4	0.4	0.4	0.1	0.1	0	0	0.5	Muller glia cells
CEACAM3	CD66d, CGM1	ENSG00000170956	Carcinoembryonic antigen related cell adhesion molecule 3	P40198	19	41796437-41811553	CD markers, Predicted intracellular proteins, Predicted membrane proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		blood: 60.0;bone marrow: 35.4	Cell type enriched	Detected in some	12	Paneth cells: 35.1	Not detected	Not detected			Low region specificity	Detected in single			Cell type enriched	Detected in some	7	neutrophil: 60.0	Lineage enriched	Detected in many	7	granulocytes: 60.0	Cell line enhanced	Detected in some		CACO-2: 1.0;PC-3: 3.8									HPA011041	Approved											HPA011041: AB_1078481	unprognostic (1.60e-1)	unprognostic (1.14e-1)	unprognostic (2.23e-2)	unprognostic (2.95e-2)	unprognostic (2.19e-1)	unprognostic (8.09e-3)	unprognostic (1.44e-1)	unprognostic (2.85e-1)	unprognostic (1.49e-1)	unprognostic (3.19e-2)	unprognostic (1.62e-1)	unprognostic (8.07e-2)	unprognostic (1.32e-2)	unprognostic (1.32e-1)	unprognostic (4.68e-2)	unprognostic (8.44e-2)	unprognostic (2.83e-1)	0.9	0.3	0.3	3.6	0.8	35.4	0.7	0.2	0.8	0.6	1	0	0	0.2	0.4	0.2	1.2	0.7	0.4	5.1	0.4	0.3	0.4	1.1	14	11.5	1.8	0.1	0.7	1	0.2	0.3	4.6	0.5	0.3	0.3	1.4	0.8	0.2	1.5	0.2	0.6	0.4	0.3	10.7	0.4	0.9	0.2	1.6	0.5	0.3	2.7	0.8	0.6	0	0.8	60	8.9	0	0	0.6	0	0.6	0	0	0	0	0	0	0	0	0	1	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.7	3.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0.1	0	0.6	0.8	0	0	3.9	0	0	0	0	0.8	0	0	0	60	0	8.9	0	0	0.6	0.3	0.8	0.2	0.8	0.4	0.3	1.8	0.1	0.5	0.2	3	1.4	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0.1	0	0.8	0	0	0	0	0.3	1.1	0	0.8	0	0	0	1.2	0.9	0	1.7	0	0	0	0	0.1	35.1	0	0	0	0	0	0	0	0	0	0	0	0	Paneth cells
MUC7	FLJ27047, MG2	ENSG00000171195	Mucin 7, secreted	Q8TAX7	4	70430492-70482997	Disease related genes, Predicted secreted proteins			Asthma	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	6	salivary gland: 1562.5	Cell type enriched	Detected in single	60	Melanocytes: 11.8	Group enriched	Detected in some	12	head and neck cancer: 8.1;melanoma: 2.1	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		BJ hTERT+: 4.2;GAMG: 1.4									HPA006411	Enhanced				Secreted to digestive system							HPA006411: AB_1854204	unprognostic (5.49e-2)					unprognostic (3.20e-1)			unprognostic (1.06e-1)									0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0.1	0	0	0	0	0.2	0.9	0	0	0.1	0	0	0	0	1562.5	0	0.1	0.1	0	0	0	0	0	0	0	0	0	265.3	2.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	4.2	0.6	0	0	0	0	0	0	1.4	0.1	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	11.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Melanocytes
LRG1	LRG	ENSG00000171236	Leucine rich alpha-2-glycoprotein 1	P02750	19	4536409-4540474	Plasma proteins, Predicted secreted proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	11	liver: 636.5	Cell type enriched	Detected in many	9	Hepatocytes: 728.6	Cancer enriched	Detected in many	9	liver cancer: 160.9	Not detected	Not detected			Cell type enriched	Detected in some	19	neutrophil: 58.9	Lineage enriched	Detected in many	42	granulocytes: 58.9	Cell line enhanced	Detected in some		Hep G2: 8.2;HMC-1: 8.3;SK-BR-3: 8.8;THP-1: 14.8;U-937: 27.4	Low region specificity	Detected in some			Low region specificity	Detected in all			HPA001888, HPA001889	Enhanced		Approved	Vesicles	Secreted to blood			21000000000	74000000000	Vesicles		HPA001888: AB_1079276, HPA001889: AB_1079275	unprognostic (5.54e-3)	unprognostic (1.78e-1)	unprognostic (1.78e-1)	unprognostic (1.42e-1)	unprognostic (2.64e-2)	unprognostic (1.05e-1)	unprognostic (1.88e-1)	unprognostic (1.13e-1)	unprognostic (1.01e-1)	unprognostic (1.16e-2)	unprognostic (1.46e-3)	unprognostic (9.83e-2)	prognostic unfavorable (3.66e-6)	unprognostic (4.06e-2)	unprognostic (1.45e-1)	prognostic favorable (3.49e-4)	unprognostic (2.60e-2)	1.7	0.9	0.2	3.3	0.4	5.4	0.9	0.2	0.3	1.7	1.3	0.2	2.2	1.1	0.3	1.1	4.5	1.9	3	0.9	0.4	0.2	3.5	636.5	2.2	5.7	0.7	0.1	1.5	8.1	0	0.7	0.4	0.4	1.1	0.8	0.3	4.1	3	0.5	0.8	0.6	0.2	0.3	4.3	2.3	0.5	0.3	0.3	0.9	1.7	3.4	1.4	1.3	0.1	0.3	58.9	1.4	0	0.2	0.4	5.9	0.1	0	0	0	0	4.6	0	0	0	0	0.6	4.3	2.1	7.7	0	0.3	0.8	0	1	0	7.7	0.2	0.1	0.1	8.2	0	0.2	8.3	2.3	0	0	0	0	0	0	5.4	0.1	0	0.3	0	6	0.1	4.7	0	0	0.1	6.2	0.6	1.1	0	0	0	8.8	0.1	0.8	2.6	14.8	0.1	0	0.1	0	0.1	0.1	0.1	0.1	0	27.4	0	0.5	1.4	3	0	0.4	0	0.1	0	0	0.3	0.1	0	0	58.9	0	0.2	0	0.2	0.4	0.2	0.4	0.2	0.3	0.4	0.2	0.7	0.1	0.4	0.3	11.9	51.2	16.5	26.9	7.1	0	0.4	58.6	78.9	39.8	14	0	0.5	1.7	54.6	0	8.3	25.4	0	54.4	10.6	1.4	2.9	11.5	728.6	5.4	1.6	4.7	42.4	17.4	0	0	7.6	1.7	10	20	0	55.9	7	0	3.6	0	0	2.1	0	0.2	5.1	1.1	2.9	16.7	29.6	Hepatocytes
NPTX1		ENSG00000171246	Neuronal pentraxin 1	Q15818	17	80467148-80477843	Predicted secreted proteins, Transporters				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	8	brain: 68.9	Cell type enriched	Detected in some	6	Cone photoreceptor cells: 164.9	Cancer enhanced	Detected in many		glioma: 4.8	Low region specificity	Detected in many			Cell type enriched	Detected in single	4	NK-cell: 1.5	Lineage enriched	Detected in single	4	NK-cells: 1.5	Cell line enhanced	Detected in some		HAP1: 12.4;HeLa: 9.7;SiHa: 15.8;U-138 MG: 33.8;WM-115: 46.3	Low region specificity	Detected in all			Group enriched	Detected in all	4	amygdala: 74.8;cerebellum: 228.3;cerebral cortex: 119.6;hippocampal formation: 173.6	HPA077062	Enhanced	Approved			Secreted in brain				1000000			HPA077062: AB_2732329	unprognostic (2.37e-2)	unprognostic (1.18e-1)	unprognostic (1.81e-2)	unprognostic (6.95e-2)	unprognostic (4.16e-3)	unprognostic (2.43e-2)	unprognostic (1.48e-2)	unprognostic (3.63e-1)	unprognostic (1.31e-2)	unprognostic (2.07e-1)	unprognostic (1.81e-2)	unprognostic (9.63e-3)	unprognostic (1.05e-6)	unprognostic (1.41e-4)	unprognostic (1.35e-1)	unprognostic (8.86e-6)	unprognostic (2.71e-3)	1	3.4	28.8	1.4	14.7	0.8	1.1	68.9	62.5	0.8	9.1	0.2	0	1.3	1.3	2.5	1.4	1.4	1.7	0.7	15.5	3	0.8	0.7	1	1.4	1	18.2	0.7	0.7	0.7	0.8	1.6	4.6	1.3	2.5	0.6	0.7	2.9	1	3.2	1.5	1.4	1.9	2.3	1.5	1.3	0	0.9	0.7	0	0.7	0.9	0.2	0	0	0	0	1.5	0.3	0.1	0	0.7	0.2	0	0.1	0.2	0	0.7	0	0	0	0.2	0.1	0	0.1	0.1	1.3	0	12.4	0	0	0	7.7	0	9.7	0	0	0	0.5	0	0	0.5	0.1	0	0	0	0	0	0.1	0.1	0	0	0	0	2.5	0	0	3.2	0	0	8.4	0	15.8	0	0	0.1	0	0.2	0.1	33.8	0	1.6	0	0	0	0	0.1	0	46.3	0	0	0	0	0	0	0	0.3	0.3	0	0	0	0	0	1.5	0	0	0	0.1	28.8	14.7	68.9	29.9	15.5	3	1	18.2	4.6	0	0	0	0	0.1	1.3	8.7	2.8	0	0	1.2	0	164.9	0	0	0	4.3	0.1	0	0	0	0.1	0	0.3	0	0	0	0	0	0	0	28.2	0.9	0	0	0	0	0.8	0.3	0	2.1	0	2.6	0	0.9	1.1	0.5	2.6	0.1	0	0	0	Cone photoreceptor cells
KRT13	CK13, K13, MGC161462, MGC3781	ENSG00000171401	Keratin 13	P13646	17	41500981-41505705	Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins			Cancer-related genes, Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		esophagus: 1075.6;lymphoid tissue: 404.8;tongue: 499.8	Cell type enriched	Detected in some	11	Urothelial cells: 2979.9	Group enriched	Detected in many	5	cervical cancer: 899.2;head and neck cancer: 758.7;urothelial cancer: 504.9	Not detected	Not detected			Cell type enriched	Detected in single	12	neutrophil: 1.1	Lineage enriched	Detected in single	12	granulocytes: 1.1	Group enriched	Detected in some	100	A-431: 216.9;HaCaT: 144.9	Not detected	Not detected			Not detected	Not detected			CAB000133, HPA030877, HPA069771	Enhanced		Enhanced	Intermediate filaments					1100000000	Intermediate filaments		CAB000133: , HPA030877: AB_2673641, HPA069771: AB_2732141	unprognostic (1.45e-1)	unprognostic (6.23e-2)	unprognostic (1.37e-1)	unprognostic (2.19e-2)	unprognostic (9.30e-5)	unprognostic (7.30e-3)		unprognostic (1.95e-1)	unprognostic (1.77e-1)	unprognostic (5.81e-3)	prognostic unfavorable (1.02e-4)	unprognostic (3.16e-1)	prognostic unfavorable (1.45e-6)	unprognostic (1.80e-1)	unprognostic (2.76e-1)	unprognostic (3.04e-2)	unprognostic (4.33e-1)	0.3	0.3	0	0.3	0	0.5	0.3	0	0.3	250.9	0.3	0	0	0.3	13.7	0.3	1075.6	0.3	0.6	0.5	0	0	0.3	0.3	0.3	0.3	0	0	0.3	0.3	0.3	0	0.3	0	2.4	0.3	0.1	134.9	0.4	0.4	0.3	0.3	1.7	0	0.3	0.3	0.4	0	0.6	0.3	499.8	404.8	14.9	222.2	0	0	1.1	0	0	0	0	216.9	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0	144.9	0	0	0	0.1	0	0.3	1.8	0	0	0.1	0.1	0	0	0	0	0	0	0	0.4	0.1	0	0.1	0	0	0	1.4	0	0	0.1	0	0	0.9	0	0	0.1	0.1	0.7	0	0.2	0.5	0.4	0	0	0	0.6	0	0.5	0.4	0.1	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.9	0.6	1.3	250.4	2.5	0	0.6	0	1.4	14.8	0	0	0.1	0	0	0.7	0	0	0	0	0.4	0.2	66.7	0	0	0.1	0	1.2	0	0	0.2	51.8	0	0	0	0.4	0	0.1	2.5	269.4	0	0	0	0.2	0.2	0.4	1.4	0.3	0	0.2	2979.9	Urothelial cells
XAGE5	CT12.5, GAGED5, XAGE-5	ENSG00000171405	X antigen family member 5	Q8WWM1	X	52812204-52818301	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level	No human protein/transcript evidence	No human protein/transcript evidence		Tissue enriched	Detected in single	6	testis: 5.1	Cell type enriched	Detected in some	6	Spermatogonia: 9.6	Cancer enhanced	Detected in single		liver cancer: 0.7					Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	34	U-2 OS: 22.7									HPA052507, HPA055941	Uncertain		Approved	Nucleoplasm,Vesicles		No	No			Nucleoplasm, Vesicles		HPA052507: AB_2681855, HPA055941: AB_2682978															unprognostic (1.89e-1)			0	0	0	0	0	0	0	0	0	0	0			0	0	0	0	0	0	0	0	0	0	0	0	0.2	0		0	0.1	0	0	0		0	0		0	0	0	0.8	0	0	0	0	0	5.1			0		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	22.7	0.1	0.1	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0.3	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.7	9.6	0	1.6	0	0	0	Spermatogonia
DLK2	EGFL9, MGC2487	ENSG00000171462	Delta like non-canonical Notch ligand 2	Q6UY11	6	43450352-43456632	Predicted membrane proteins				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		skin 1: 19.3	Cell type enriched	Detected in some	7	Basal glandular cells: 79.5	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		HaCaT: 16.5;HBEC3-KT: 9.0;hTCEpi: 27.2	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA061223, HPA068672, HPA070955	Uncertain		Approved	Nucleoplasm,Nucleoli,Vesicles		No	No			Nucleoplasm	Nucleoli, Vesicles	HPA061223: AB_2684454, HPA068672: AB_2686017, HPA070955: 	unprognostic (4.65e-5)	unprognostic (1.27e-1)	unprognostic (1.69e-1)	unprognostic (9.68e-4)	unprognostic (2.87e-1)	unprognostic (3.80e-1)	unprognostic (4.19e-3)	unprognostic (1.65e-1)	unprognostic (2.65e-3)	unprognostic (4.04e-1)	unprognostic (1.88e-2)	unprognostic (1.88e-1)	unprognostic (9.27e-12)	unprognostic (7.71e-4)	unprognostic (8.92e-2)	unprognostic (1.55e-1)	unprognostic (6.43e-2)	1	1.1	4.5	1.4	7.9	1.7	4.3	12.2	8.2	2.2	0.7	0.9	6.4	1.1	1.4	3.8	10.5	1.1	0.9	1.8	4.1	4.6	0.7	0.7	1.1	1.7	1.5	4.8	1.7	1.5	0.4	0.5	1.3	0.9	10.4	0.5	0.3	12.4	13	0.7	19.3	1	0.6	1.5	1.5	1.1	1.1	1.2	1.3	0.8	4.7	3.9	2.2	5.3	0.8	1.8	1	0.5	2.5	3.2	0.3	5.2	1.9	0.5	7.9	0	0.4	1.8	1.9	2.1	2.2	1	1.8	0.2	1	1.2	0.4	2.7	16.5	5.6	9	0.5	1	2.1	0.4	0.9	2.8	0.6	0.3	1.1	0.9	27.2	0.6	5.1	0.7	0	3.1	0.4	0.8	0.8	2	0.4	0.4	0.7	2	2	1.1	1	0.5	0.3	1.8	5.9	0.6	0.6	0.2	0.3	0.4	0.5	1.6	0.5	0.8	2.5	0.6	3.8	1.2	0.3	1.7	0.1	0.7	0.5	0.9	0.4	0.4	0.7	0.3	3.2	0.6	2.2	2.2	0.1	0.8	0.9	0.4	1	2.5	0.5	1.8	0.3	0.3	4.5	7.9	12.2	8.2	4.1	4.6	1.5	4.8	0.9	1.2	0	0.3	0	79.5	9	0.6	0.5	0	0	7.9	0	0	0.8	0	0.1	0.2	0.3	0	0	0	2.1	0.2	4.3	0	0	0.1	11.1	1.2	0	0	0.2	0.3	0	1.7	0	0	0.5	0.1	0	0	0	0.9	0	0.3	1.2	5.5	2.3	0.2	0	0	3.9	Basal glandular cells
SPACA5B	LYZL5B	ENSG00000171478	Sperm acrosome associated 5B	Q96QH8	X	48130657-48132613	Enzymes, Predicted secreted proteins		Glycosidase, Hydrolase		Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	10	testis: 18.3	Cell type enriched	Detected in single	12	Early spermatids: 1.2	Not detected	Not detected							Cell type enriched	Detected in single	19	T-reg: 1.9	Lineage enriched	Detected in single	19	T-cells: 1.9	Not detected	Not detected											HPA044747, HPA047149	Supported				Secreted in male reproductive system							HPA044747: AB_2679071, HPA047149: AB_2679955																		0	0	0	0	0	0	0	0	0	0	0			0	0	0	0	0	0	0	0	0	0	0	0	0	0		0	0	0	0	0		0	0		0.2	0	0	0	0	0	0	0	0	18.3			0		0	0	0	0	0	0	0	0	1.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.9	0											0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Early spermatids
SPACA5	dJ54B20.3, LYC5, LYZL5, PNPK6288, SLLP2, UNQ6288	ENSG00000171489	Sperm acrosome associated 5	Q96QH8	X	48004336-48009729	Enzymes, Predicted secreted proteins		Glycosidase, Hydrolase		Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	8	testis: 15.1	Cell type enriched	Detected in single	29	Early spermatids: 2.9	Not detected	Not detected							Cell type enhanced	Detected in some		T-reg: 1.9	Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		CACO-2: 1.3;JURKAT: 1.3;NB-4: 3.9;U-266/70: 1.2;U-266/84: 2.1									HPA044747, HPA047149	Supported				Secreted in male reproductive system							HPA044747: AB_2679071, HPA047149: AB_2679955																		0	0	0.3	0	0.3	0.1	0	0.2	0.4	0	0			0	0.2	0.8	0	0.3	0	0	0.2	0.2	0.1	0	0	0.5	0.4		0.3	1.4	0	0	0		0.2	0		0	0	0	0.8	0.1	0	0.2	0	0	15.1			1.3		0	0	0	0	0.8	0	0	0	1.9	0.3	0	0	0	0.3	0	0	0	0	0	0	0	1.3	0	0	0.9	0	0.1	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	1.3	0	0	0	0	0.3	3.9	0.9	0	0	0.4	0	1.1	0	0	0.5	0	0	0.4	0	0.5	1.1	0	0	0.4	0	0.7	0	1.2	2.1	0.3	0	0.1	0	0	0	0	0.2	0	1	0	0.1	0	0	0	0.5	0	0	0	0	0.8	1.9	0.3											0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Early spermatids
COL24A1		ENSG00000171502	Collagen type XXIV alpha 1 chain	Q17RW2	1	85729233-86156943	Predicted secreted proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 18.0	Cell type enriched	Detected in some	6	Muller glia cells: 59.8	Low cancer specificity	Detected in single			Low region specificity	Detected in all			Cell type enriched	Detected in single	10	plasmacytoid DC: 6.2	Lineage enriched	Detected in single	10	dendritic cells: 6.2	Cell line enhanced	Detected in some		ASC diff: 3.4;HSkMC: 3.2;Karpas-707: 6.0;NTERA-2: 3.1;RH-30: 4.4;SuSa: 4.6;U-266/70: 11.2	Low region specificity	Detected in some												Secreted to extracellular matrix				12000				unprognostic (3.00e-1)	unprognostic (6.19e-2)	unprognostic (2.21e-2)	unprognostic (6.76e-3)	unprognostic (1.82e-3)	unprognostic (2.45e-2)	unprognostic (2.44e-5)	unprognostic (1.37e-1)	unprognostic (4.08e-2)	unprognostic (6.59e-2)	unprognostic (3.89e-2)	unprognostic (1.46e-1)	unprognostic (3.48e-6)	unprognostic (2.79e-5)	unprognostic (5.07e-1)	unprognostic (1.19e-1)	unprognostic (9.90e-2)	1.1	0.4	6.2	3.4	7.1	2.3	1.1	1.7	18	7	9.5	0.3	0	4.1	3.6	2.4	2.2	0.6	4.4	4.1	12.1	1.2	1.5	0.3	1.7	1	1.1	5.2	6.9	0.3	0.2	2	0.3	1.7	2.3	2.4	2.4	1.2	4.3	1.4	1.6	3.7	2.8	1	0.8	3.4	1.9	2.9	0	0.8	2.6	0.8	8.3	4.9	0	6.2	0	0.1	0.6	0	0	0	0	1.5	0	3.4	0.6	0	0.6	0.1	0.2	0.5	0	0	0	0.2	0.1	0.4	0	0.9	0	1.4	0	0.8	0	1	0.1	0.1	0	0	3.2	0	0.2	0	0.1	0	0	0	6	0.9	0	0	0.2	3.1	0	0	0	4.4	0.5	0.6	1.1	0.1	0	0	0.2	0.5	4.6	0	0.9	0	2	0.2	0	0	11.2	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0.1	6.2	0	0	6.2	7.1	1.7	18	12.1	1.2	1.1	5.2	1.7	2.9	0	1.1	1.9	0	0.3	2.2	1.6	0	2.7	0	5.2	0	0	0	0	0	0	0	0	0	0	1	0	1.1	0	1.8	0	0	0	0	0	0.9	0.3	10.1	0	0	59.8	0	0	0.7	0	1.1	0	0	1.1	0.4	0.1	0	0	0	0	Muller glia cells
FGG		ENSG00000171557	Fibrinogen gamma chain	P02679	4	154604134-154612967	Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Blood coagulation, Hemostasis		Cancer-related genes, Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	495	liver: 2225.7	Cell type enriched	Detected in many	15	Hepatocytes: 7797.1	Cancer enriched	Detected in many	19	liver cancer: 1503.5	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	55	Hep G2: 128.7	Not detected	Not detected			Not detected	Not detected			HPA027529, CAB033120, HPA074638	Supported		Approved	Endoplasmic reticulum	Secreted to blood			267000000000	68000000000	Endoplasmic reticulum		CAB033120: AB_2103818, HPA027529: AB_10601322, HPA074638: 	unprognostic (1.26e-2)				unprognostic (4.77e-3)	unprognostic (6.33e-3)	unprognostic (3.69e-3)	unprognostic (2.18e-3)		unprognostic (9.63e-2)	unprognostic (7.57e-3)		prognostic unfavorable (1.00e-6)	unprognostic (1.75e-3)	unprognostic (3.21e-1)		unprognostic (1.14e-1)	0	1.5	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0.1	0	0	0.9	0	0	0	2.7	2225.7	4.4	0	0	0	0.2	0.7	0	0	1	0.1	0	0	0	0	0	0	0	0	0	0	0.4	0.2	0.1	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	2.3	0	0	0	0	0	0	0	0	0	1.8	0	0.2	0	0	0	0.1	0	0	0	0	0	0.6	0	128.7	0	1.4	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0.1	0	0	0	1.1	0	0	0.1	0	0	0.9	0	0	0	0	0	0.2	0	0	0	0	0.2	0	0.7	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0.1	0	17.9	218.6	146.9	0	0	0	0.2	507	2.7	4.5	0	0	0	0	3.8	2.8	0	0	327.1	40	0.1	0	0	10.5	7797.1	0.2	0	0	232.7	240.6	0	0	0	0	3.6	0	0	266.1	0	0	0.3	0	0	0	0.5	0.6	0	0.3	20.1	0	0	Hepatocytes
FGA		ENSG00000171560	Fibrinogen alpha chain	P02671	4	154583126-154590766	Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins	Adaptive immunity, Blood coagulation, Hemostasis, Immunity, Innate immunity		Amyloidosis, Cancer-related genes, Disease mutation, FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	740	liver: 2009.3	Cell type enriched	Detected in many	40	Hepatocytes: 16694.6	Cancer enriched	Detected in many	43	liver cancer: 2431.6	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	15	Hep G2: 96.9	Not detected	Not detected							CAB016776, HPA051370, HPA064755	Supported		Approved	Endoplasmic reticulum	Secreted to blood			407000000	170000000000	Endoplasmic reticulum		CAB016776: , HPA051370: AB_2681458, HPA064755: AB_2685345		unprognostic (5.95e-2)	unprognostic (6.25e-2)	unprognostic (2.02e-1)		unprognostic (5.68e-2)	prognostic favorable (7.33e-4)	unprognostic (1.29e-3)			unprognostic (1.84e-1)		prognostic unfavorable (4.23e-6)	unprognostic (4.20e-1)	unprognostic (1.41e-1)			0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0.1	0	0	0.4	0	0	0	2.7	2009.3	0.1	0	0	0	0	1.4	0	0	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0.4	1.5	0	0	0	0.1	0	0	0	0	0.9	0	0	0	0	0	0	0	6.6	0	0	0	0	0	0	0	0	0	5.5	0	0.6	0	0	0	0.1	0	0	0	0	0	0.7	0	96.9	0	1.4	0.1	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0.1	0	0	0.1	1.4	0	0	0.1	0	0	0.8	0	0	0	0	0	0.4	0	0	0	0	0.2	0	0.5	0	0.4	0	0	0	0	0	0	0	0.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0.1	0	0	24.4	83.9	0	0	0	0.4	420.4	17.4	5.7	0	0	0	1.7	5.5	23.9	0	0	256.9	1.5	0	0	0	0	16694.6	0.1	0	0	255.3	257.1	29.3	0.6	0	0	0	0	0	31.5	0	1.1	1	0	0	0	14.4	0.6	0	0.1	4.3	0	0	Hepatocytes
FGB		ENSG00000171564	Fibrinogen beta chain	P02675	4	154562956-154571086	Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Adaptive immunity, Blood coagulation, Hemostasis, Immunity, Innate immunity		Cancer-related genes, Disease mutation, FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	189	liver: 1908.6	Cell type enriched	Detected in some	33	Hepatocytes: 15347.2	Cancer enriched	Detected in many	42	liver cancer: 2262.6	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	12	Hep G2: 77.7	Not detected	Not detected			Not detected	Not detected			HPA001900, HPA001901, CAB008624	Enhanced		Enhanced	Endoplasmic reticulum	Secreted to blood				120000000000	Endoplasmic reticulum		CAB008624: AB_1615610, HPA001900: AB_1078865, HPA001901: AB_1078864	unprognostic (1.16e-1)	unprognostic (3.89e-2)	unprognostic (4.65e-2)	unprognostic (3.44e-1)			unprognostic (2.20e-3)	unprognostic (1.42e-2)			unprognostic (1.79e-1)		prognostic unfavorable (5.72e-5)	unprognostic (2.48e-2)	unprognostic (7.91e-2)			0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	10.1	1908.6	0	0	0	0	0	0.1	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0.6	0.1	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	6.5	0	0	0	0	0	0	0	0	0	4.5	0	0.6	0.1	0	0	0.1	0	0	0	0	0	0.7	0	77.7	0	1.8	0.1	0	0	0	0	0	0	0	0.4	0	0	0.5	0	0	0.1	0	0	0	1.3	0	0	0	0	0	1	0.1	0	0	0	0	0.4	0	0	0.2	0	0.2	0	0.7	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	8.4	153.8	0	0	0	0.4	257.4	0	0	3.5	0	0	1.7	3	0.4	0	0	467.2	3.2	0.1	0	0	0	15347.2	0.3	0	1.7	349.9	342.6	0	0	0	0	0	0	0	1.3	0	0	19.3	0	0	0	0	0	0	0.1	3.8	0	0	Hepatocytes
ANO5	GDD1, LGMD2L, TMEM16E	ENSG00000171714	Anoctamin 5	Q75V66	11	22193176-22283357	Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters			Disease mutation, Limb-girdle muscular dystrophy, Osteogenesis imperfecta	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		heart muscle: 37.7;parathyroid gland: 26.9;skeletal muscle: 43.7	Cell type enriched	Detected in many	11	Cardiomyocytes: 82.0	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Cell type enhanced	Detected in single		classical monocyte: 1.5	Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		A549: 6.6;HAP1: 7.2;HEK 293: 9.0;NTERA-2: 5.0;U-266/84: 5.2	Low region specificity	Detected in some			Low region specificity	Detected in all			HPA058857	Uncertain											HPA058857: AB_2683835	unprognostic (5.25e-3)	unprognostic (1.36e-3)	unprognostic (2.43e-1)	unprognostic (7.67e-3)	unprognostic (3.50e-2)	unprognostic (5.85e-2)	unprognostic (8.17e-3)	unprognostic (2.30e-2)	unprognostic (1.68e-1)	unprognostic (3.89e-2)	unprognostic (2.54e-4)	unprognostic (8.55e-2)	prognostic favorable (2.50e-7)	unprognostic (3.65e-3)	unprognostic (2.84e-1)	unprognostic (2.77e-4)	unprognostic (7.94e-2)	1	3.8	3.9	0.9	3.8	0.3	0.9	0.9	7.9	1.7	2.6	1.1	1	2.9	1.5	1.6	2.4	1.1	1.6	37.7	4.5	4.2	3.1	2.3	1.4	0.6	3.4	6.3	1	3.3	26.9	5	0.4	3.5	3.8	2.9	2.7	3.4	3.7	43.7	0.5	3.1	4.1	1.9	1	3	2.3	1.7	0	3.9	14.2	0.6	3.2	1.9	0	0.9	0	1.5	0	0.1	0.1	0	6.6	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	7.2	0	0	0	9	0	0	0	0	0	0.2	0	0	0	0	1.3	0	1.7	2.4	4.3	0	0	0	0	5	3.5	0	0.1	0	0	4.5	0.1	4	3.7	0	0	0	3.2	3.3	2.5	0	0	2.9	0	0	2.9	5.2	0	4	0	0.9	0	1.5	0	0	0	0	0	0	0	0.9	0	0.1	0	0	0	0	0	0	0.1	3.9	3.8	0.9	7.9	4.5	4.2	3.4	6.3	3.5	1.7	0	5.1	0.5	0.3	0.2	7.2	82	0	1.4	0	1.8	0	0	1.7	0.9	4.8	2.7	2.6	0	2.4	0	0.2	1.6	0	4.9	0.5	1.6	5.2	3.7	0.8	1.9	0	1.3	1.7	0	7.5	2.4	1.1	3.5	1.1	2.4	0.4	0	0.4	4.1	0.5	0.1	0	0	3	0.1	Cardiomyocytes
WDR87	NYD-SP11	ENSG00000171804	WD repeat domain 87	Q6ZQQ6	19	37884823-37906677	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	94	testis: 48.4	Cell type enriched	Detected in some	6	Spermatocytes: 104.6	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	5	U-266/70: 2.0;U-266/84: 1.1																						unprognostic (6.37e-3)	unprognostic (1.26e-2)		unprognostic (5.59e-2)	unprognostic (1.11e-1)	unprognostic (1.00e-1)		unprognostic (1.89e-2)	unprognostic (2.60e-1)	unprognostic (4.22e-1)	unprognostic (5.43e-2)	unprognostic (2.58e-2)	unprognostic (1.78e-8)	unprognostic (1.19e-1)	unprognostic (2.42e-1)	unprognostic (5.48e-2)	unprognostic (4.12e-3)	0	0	0	0	0.1	0	0	0	0.2	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0.2	0	0	0	0	0	0	0	0	0.1	0	0	0	0.1	0	48.4	0.1	0	0.5	0	0	0	0	0.5	0	0	0.1	0	0	0	0	0.2	0	0	0	0	0.1	0	0	0	0	0	0.1	0.3	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0.1	0.2	0	0	0	0	0	0	0.2	0	0	0	0.1	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0.1	0	0	0	0	2	1.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0.1	0	0	0	0	0.1	0	0.2	0	0	0	0.1	0	0.1	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	17	0	0	0	0	0	0	0	0	0	0	0	0	0	0	6.2	0.3	0	0	0	0	0	0	0	0.7	0	0	0	0	104.6	4.4	0	0	0	0	0	Spermatocytes
IFNB1	IFB, IFF, IFNB	ENSG00000171855	Interferon beta 1	P01574	9	21077105-21077963	Cancer-related genes, Predicted secreted proteins	Antiviral defense	Cytokine	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	6	blood: 1.8;bone marrow: 3.7;breast: 5.9	Cell type enriched	Detected in single	21	Hofbauer cells: 2.4	Not detected	Not detected			Not detected	Not detected			Cell type enhanced	Detected in single		naive CD8 T-cell: 1.8	Lineage enriched	Detected in single	8	T-cells: 1.8	Cell line enhanced	Detected in some		BJ hTERT+ SV40 Large T+: 2.3;BJ hTERT+ SV40 Large T+ RasG12V: 4.8;GAMG: 1.2;NB-4: 1.2					Low region specificity	Detected in many			HPA073843	Supported				Secreted to blood			3750				HPA073843: 	unprognostic (2.38e-1)									unprognostic (2.60e-4)								0.1	0.3	0	0	0	3.7	5.9	0.1	0.1	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0.3	0.1	0.1	0	0.3	0	0	0.2	0	0	0	0	0	0.1	0	0.3	0	0.1	0	0.1	0.6	0	0.2	0	0	0.3	0	0	0.4	0	0	0	0	0.2	0	1.8	0	0	0	0	0	0	0	0	0	0	2.3	4.8	0	0	0.1	0.3	0	1.2	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0.3	0	0.8	0	0	0.2	0	0.5	0	0	0.2	1.2	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0	0.2	0	0	0	0	0.2	0	0	0.6	0	0	0	0	0.2	0	0.5	0	0.4	0	0	0.5	0	0	0	1.8	0	0	0	0	0	0	0	0	0.1	0.1	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	2.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	Hofbauer cells
AQP4	MIWC	ENSG00000171885	Aquaporin 4	P55087	18	26852038-26865818	Predicted membrane proteins, Transporters	Transport			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	5	brain: 185.1;lung: 53.5	Cell type enriched	Detected in some	4	Alveolar cells type 1: 1024.3	Cancer enriched	Detected in some	22	glioma: 223.7	Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		AF22: 6.9;Karpas-707: 2.0;RPTEC TERT1: 3.9;SCLC-21H: 1.3;U-87 MG: 1.8	Low region specificity	Detected in all			Low region specificity	Detected in all			CAB005079, HPA014784, CAB058689	Enhanced	Supported	Supported	Plasma membrane,Cell Junctions						Plasma membrane	Cell Junctions	CAB005079: AB_2274338, CAB058689: AB_2665579, HPA014784: AB_1844967	unprognostic (7.23e-5)	unprognostic (1.55e-1)		unprognostic (3.19e-8)	unprognostic (3.68e-1)	unprognostic (1.96e-1)	unprognostic (2.69e-2)	unprognostic (1.74e-1)	unprognostic (2.34e-1)	unprognostic (5.38e-3)	unprognostic (1.64e-3)	unprognostic (8.98e-2)	unprognostic (1.22e-1)	unprognostic (4.14e-2)	unprognostic (1.35e-1)	unprognostic (4.10e-2)		1.7	1.7	60.7	1.6	57.1	1.6	1.8	21.8	185.1	1.9	1.6	41.3	0	1.6	1.6	2	1.9	2.1	1.6	2.7	64.3	27.1	2.7	2	53.5	1.7	39.8	36.4	2.8	1.7	2.9	0.8	1.6	39.1	1.8	1.6	0	1.8	1.7	25.4	1.6	1.6	1.6	67.2	1.8	6.1	1.7	42.2	0	8.4	0.1	1.6	1.6	0.1	0	0	0	0	0	0	0	0	0	6.9	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	1	0	0	0	0	0.2	0	0.1	0.5	0	0	0.5	0	0	0	0	0	0	0	0	2	0	0	0.5	0.2	0.9	0	0	0	0	0	3.9	0	1.3	0.3	0	0	0	0.1	0.3	0	0	0	0	0.3	0	0	0	0	1.8	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	60.7	57.1	21.8	31.7	64.3	27.1	39.8	36.4	39.1	42.2	1024.3	245.1	0	0.6	0	2.1	8.5	0	37.5	138.8	3.5	5.9	0	3.3	0.3	0	0	0	0	0	0	0.2	0.5	3.5	0.5	0	1.6	0	0	0	0	4.6	0	0	0	0	224.7	0	0	0	0	4.9	0	0	0	0	0	0.1	0	0	1.6	Alveolar cells type 1
FOXB1	FKH5, HFKH-5	ENSG00000171956	Forkhead box B1	Q99853	15	60004222-60061730	Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	DNA-binding		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in some	4	brain: 16.7	Cell type enriched	Detected in some	6	Early spermatids: 18.1	Cancer enhanced	Detected in some		endometrial cancer: 1.2	Region enhanced	Detected in many		pons and medulla: 16.7	Cell type enriched	Detected in single	4	T-reg: 3.8	Lineage enriched	Detected in single	38	T-cells: 3.8	Cell line enhanced	Detected in some		AF22: 7.0;HDLM-2: 15.3;HEK 293: 11.7;JURKAT: 6.1	Region enhanced	Detected in some		hypothalamus: 7.7	Low region specificity	Detected in many			HPA073369			Approved	Nucleoplasm,Mitochondria						Nucleoplasm, Mitochondria		HPA073369: AB_2686597	unprognostic (1.69e-1)	unprognostic (3.33e-2)	unprognostic (1.14e-1)	unprognostic (7.40e-3)	unprognostic (1.33e-3)	unprognostic (1.17e-2)		unprognostic (1.47e-2)	unprognostic (5.32e-4)	unprognostic (1.06e-1)	unprognostic (9.21e-2)	unprognostic (3.21e-1)	unprognostic (8.12e-9)	unprognostic (8.74e-2)	unprognostic (1.74e-1)		unprognostic (9.38e-2)	0	0	0.3	0.5	4.1	0.2	0.2	0.6	0	0.1	0.1	0.6	0	0	0.6	0	0.2	0.9	0.1	0.2	0.1	6.2	0	0.1	0.1	1.8	6.5	0	0	0.4	0	0	1.9	16.7	0	0	0	0.1	0	0.7	0.1	0	0	8.4	0.1	1.8	2.6	3.7	0	0.1	0.3	0.4	0.3	0	0	0	0	0	0	3.8	0.1	2.6	0	7	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	15.3	11.7	0.1	0	0	0	0	0	0	0	0	0	0	0	6.1	0	0	0	0	1.1	0	1.2	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.8	0	0	0	0.6	0	0	0	0	0	3.8	0.1	0.3	4.1	0.6	0	0.1	6.2	6.5	0	16.7	3.7	0	0	0	0	0	0	0.8	0	0	0	0	0	0.5	0	0	18.1	0	0	0	0	0.3	0	0	0	0	0.1	0	0	0	0	3.1	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0.9	0.4	0	0	0	0	0	Early spermatids
LDHAL6B	LDH6B, LDHAL6, LDHL	ENSG00000171989	Lactate dehydrogenase A like 6B	Q9BYZ2	15	59206823-59208515	Enzymes, Predicted intracellular proteins		Oxidoreductase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	69	testis: 56.6	Cell type enriched	Detected in some	20	Spermatocytes: 103.7	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		A549: 1.2;CAPAN-2: 1.5;HaCaT: 1.6;HeLa: 4.4	Region enriched	Detected in single	6	olfactory region: 1.7					HPA053962	Enhanced											HPA053962: AB_2682324	unprognostic (1.59e-1)	unprognostic (9.41e-2)	unprognostic (2.37e-1)	unprognostic (4.46e-2)	unprognostic (6.59e-2)	unprognostic (2.23e-1)	unprognostic (1.34e-1)	unprognostic (1.58e-1)	unprognostic (2.29e-1)	unprognostic (1.66e-1)	unprognostic (5.13e-3)	unprognostic (1.64e-1)	unprognostic (3.12e-7)	unprognostic (3.47e-2)	unprognostic (1.49e-2)	unprognostic (8.53e-2)	unprognostic (7.80e-2)	0.1	0	0	0.1	0	0	0.1	0	0.2	0.1	0.1	0	0	0	0.1	0.3	0	0	0.2	0	0	0	0.1	0.2	0	0.1	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0.1	0.2	0	0	0	0	56.6	0	0	0	0	0	0	0.1	0.4	0.8	0	0.4	0	0	0	0.4	1.2	0	0	0	0	0.2	0.3	0	0.1	0	0	1.5	0.4	0	0	0.3	1.6	0	0	0	0.1	0	0	4.4	0	0	0	0	0	0	0	0	0.6	0	0.1	0	0.2	0	0	0	0	0.1	0.2	0	0	0.1	0.3	0	0.2	0	0	0.1	0.5	0	0.5	0.1	0	0	0.4	0.4	0.8	0.3	0	0.1	0	0.4	0	0.1	0	0.4	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0.8	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	5.2	1.4	0	0	0	0	0	0	0	1.4	0	0	0	0	103.7	0.6	0	0	0	0	0	Spermatocytes
SYNPO	KIAA1029	ENSG00000171992	Synaptopodin	Q8N3V7	5	150601080-150659220	Predicted intracellular proteins		Actin-binding		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	5	heart muscle: 66.1;placenta: 63.4;skeletal muscle: 222.7	Cell type enriched	Detected in many	4	Cardiomyocytes: 219.1	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Group enriched	Detected in some	25	memory B-cell: 2.9;naive B-cell: 3.3	Lineage enriched	Detected in single	27	B-cells: 3.3	Cell line enhanced	Detected in many		BEWO: 26.4;EFO-21: 21.8;HUVEC TERT2: 21.3;TIME: 51.7;U-87 MG: 45.9	Group enriched	Detected in many	6	amygdala: 75.9;basal ganglia: 61.9;cerebral cortex: 93.2;hippocampal formation: 69.5;olfactory region: 42.1	Low region specificity	Detected in all			CAB033265, HPA034631, CAB037325, HPA071347	Enhanced		Approved	Nucleoplasm,Actin filaments,Cytosol						Nucleoplasm, Cytosol	Actin filaments	CAB033265: AB_2201163, CAB037325: , HPA034631: AB_10669994, HPA071347: AB_2732179	unprognostic (2.09e-2)	unprognostic (7.72e-3)	unprognostic (3.95e-2)	unprognostic (2.78e-3)	unprognostic (3.07e-2)	unprognostic (1.66e-2)	unprognostic (1.76e-1)	unprognostic (1.41e-2)	unprognostic (1.90e-1)	unprognostic (1.21e-1)	unprognostic (1.17e-1)	unprognostic (4.86e-2)	prognostic unfavorable (1.53e-6)	unprognostic (1.23e-1)	unprognostic (5.72e-2)	unprognostic (2.21e-2)	unprognostic (6.35e-2)	17.3	14.6	17.7	4.4	18.9	0.6	5.7	1.4	24.9	4.3	5.5	2.4	0.8	6.6	5.1	4.8	6.7	4.4	6.8	66.1	16.6	4	15.8	7.8	11.7	2.4	4.5	5.6	23.3	6.8	2.5	2.8	63.4	3.7	7.6	4.1	16.4	2.6	6.7	222.7	1.8	7.6	8.2	4.8	14.5	4.7	17.4	3.9	0.5	4	5.7	2.6	6.2	17	3.3	0	0.1	0	0	0	0	0.1	7	0	0.1	1	0.9	26.4	4	5.5	1.4	1.1	6.2	2.8	0	21.8	5.7	8.7	2.6	0	3.9	0.5	0	0	0	10.6	1.3	6	0	0.2	1.1	6.3	1.5	1.1	8.2	21.3	0	0	0	1.3	0.4	0	0.2	0.8	2.6	3.4	0.1	0.2	0	1	0.5	2.5	11.7	5.8	6.4	0.2	9.7	0.4	1.9	51.7	5.2	16.3	0.1	1	0.2	0	0.3	45.9	0	3.4	0	0	0	0	0	0	2.9	0	0	0	3.3	0	0	0.1	0	0	0	0	0	17.7	18.9	1.4	24.9	16.6	4	4.5	5.6	3.7	3.9	32.8	13.5	0.9	2.8	4	1.3	219.1	35.7	5.3	14.8	7	2	9.9	0	44.4	1.6	40.9	50.6	0	30.5	5.8	12.3	1.6	0	38	1.9	0	13.3	42.4	6.7	1.9	2.6	1.1	5	41.5	9.9	6.1	29.3	25.9	26.2	3.3	0.6	45.3	32	0.7	0.4	1.9	21.6	1.3	9.1	3	Cardiomyocytes
ANKRD20A4		ENSG00000172014	Ankyrin repeat domain 20 family member A4	Q4UJ75	9	64369394-64413142	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	No human protein/transcript evidence	No human protein/transcript evidence		Low tissue specificity	Detected in many			Cell type enriched	Detected in many	7	Spermatocytes: 40.3	Not detected	Not detected							Cell type enhanced	Detected in some		eosinophil: 1.7;plasmacytoid DC: 1.4	Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		HDLM-2: 4.4;Karpas-707: 4.3									HPA043239, HPA047112, HPA047167, HPA047766, HPA051753, HPA054389	Uncertain		Approved	Nucleoplasm						Nucleoplasm		HPA043239: , HPA047112: , HPA047167: , HPA047766: , HPA051753: AB_2681592, HPA054389: 	unprognostic (3.40e-2)	unprognostic (1.02e-1)	unprognostic (2.69e-2)		unprognostic (2.56e-1)		unprognostic (9.24e-2)	unprognostic (1.11e-2)	unprognostic (3.97e-3)	unprognostic (8.99e-2)	unprognostic (2.88e-1)	unprognostic (4.12e-1)	unprognostic (4.01e-2)	unprognostic (1.82e-2)	unprognostic (1.16e-1)	unprognostic (8.10e-2)	unprognostic (5.84e-2)	1.5	1	0.7	0.2	1.6	3.9	0.9	2.3	1.9	0.3	0.9			0.6	0.5	0.2	1.7	0.5	0.2	1.7	0.8	1	0.7	0.1	1.1	0.1	0.6		1.4	2.4	0	0.9	1		0.4	1.4		0.9	0	0.4	0.6	1.2	0	0.3	1	0.9	2.1			0.7		0	0.3	0.6	0	1.4	1.7	0	0	0.8	0	0.7	0.4	2.3	0.2	0	0	0.1	0.1	0	0	0	0	0	2.8	0.2	0	1	0.3	1.9	0.2	0	4.4	1.4	1.3	0.4	0.7	0	1	2	0	0	0.1	0.1	0.5	0.6	2.8	3	4.3	0.1	0.3	0.8	0.2	0.3	2.5	0.9	0	1	0.6	0.8	0.5	1.9	0.6	0.2	0.1	2	0.5	1.9	0.2	0.9	0	1.8	0.5	0.1	0.9	0.6	1	0.4	0	0.4	0	0	1.7	0.3	0	0	0	0	0.3	0	0	0	0.8	0	0	0	1.4	0	0											3	0	0	0.8	0.5	1.5	5.5	0	2.7	0	0	2	0.3	0	0.1	2.3	0.4	5.9	0	3.2	0.1	0.4	0.4	1.1	0	0	1.6	2.9	0.6	1.2	0.8	0	0.7	0	0	2.5	0.6	0.8	3.5	1.1	0.1	0.3	0	0.9	40.3	2.7	0.5	0.2	1.7	1.7	2.3	Spermatocytes
REG3A	HIP, PAP, PAP1, PBCGF, REG-III, REG3	ENSG00000172016	Regenerating family member 3 alpha	Q06141	2	79157003-79159753	Plasma proteins, Predicted secreted proteins, Transporters	Acute phase, Inflammatory response	Antimicrobial		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	62	intestine: 354.2;pancreas: 502.4	Cell type enriched	Detected in some	5	Pancreatic endocrine cells: 8841.0	Cancer enhanced	Detected in some		pancreatic cancer: 710.7	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		BEWO: 12.4;EFO-21: 11.8;HDLM-2: 10.9;NB-4: 12.2;RPMI-8226: 15.7;SH-SY5Y: 10.2;U-2 OS: 19.4;U-251 MG: 7.2;U-266/84: 10.2									HPA047894, HPA048334, HPA060705	Supported		Approved	Cytosol	Secreted to digestive system				22000000	Cytosol		HPA047894: AB_2680202, HPA048334: AB_2680363, HPA060705: AB_2684346			unprognostic (2.43e-2)				unprognostic (2.12e-1)				unprognostic (3.62e-2)			unprognostic (1.42e-1)				0.2	0.4	0.2	0.4	0.2	0	0.2	0.2	0.2	0.2	73.1	0.2	0.2	276.3	0.2	0.2	0.2	0	1.1	0.2	0.2	0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	502.4	0	0.2	0.2	0.2	0.2	0	0.2	0.2	0.2	0.2	0	354.2	0.2	0.2	0.2	6.9	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	12.4	0	0	0	0	0	0	0	11.8	0	0	0	0	0	0	10.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	12.2	0.1	0.2	0	0	0	15.7	0	0	1.2	10.2	0	0	0	0	0	0.1	0	0	19.4	3.8	7.2	0	10.2	2.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0.2	0.2	0.2	0.2	0	0.2	0.2	0.2	0.2	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	121.8	4.3	0	5.2	0	1666.7	0	0	0	0	0	0	0	0	0	0	3.1	0	0	0	97.4	19.1	0	8841	0	0	0	0	0	0	0	0	0	0	0	0.6	0	Pancreatic endocrine cells
SLC9C1	NHE, SLC9A10	ENSG00000172139	Solute carrier family 9 member C1	Q4G0N8	3	112140887-112294258	Predicted membrane proteins, Transporters	Antiport, Differentiation, Ion transport, Sodium transport, Spermatogenesis, Transport	Developmental protein		Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	6	testis: 25.5	Cell type enriched	Detected in some	6	Spermatocytes: 12.7	Not detected	Not detected			Not detected	Not detected			Cell type enhanced	Detected in single		naive B-cell: 1.2	Lineage enriched	Detected in single	12	B-cells: 1.2	Cell line enhanced	Detected in some		AF22: 1.0;HaCaT: 1.5;Karpas-707: 1.0;REH: 1.3	Not detected	Not detected			Not detected	Not detected																unprognostic (1.21e-2)	unprognostic (3.63e-1)	unprognostic (4.79e-2)	unprognostic (2.92e-1)	unprognostic (1.57e-3)	unprognostic (9.56e-2)	unprognostic (3.92e-2)	unprognostic (1.24e-1)	unprognostic (4.40e-2)	unprognostic (2.41e-1)	unprognostic (1.85e-1)	unprognostic (1.98e-2)	unprognostic (1.65e-2)	unprognostic (8.32e-2)	unprognostic (5.89e-2)	unprognostic (9.62e-3)	unprognostic (3.25e-1)	0.3	0.1	0.1	1.4	0.2	0.1	0.1	0.1	0.1	0.3	0.2	0	0.4	0	0.2	0.1	0.1	0.3	1.7	0.5	0.1	0.1	0.2	0.1	0.2	0	0.1	0.1	0.3	1.2	0	0.8	0.7	0.4	0.1	0.1	0.3	0.2	1.1	0.1	4	1	0.2	0.3	0.4	0.3	25.5	0	1	0.5	0.5	0.4	0.3	0.8	1.2	0	0	0	0	0	0	0.2	0	1	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0.2	1.5	0	0	0	0	0	0	0.1	0	0	0	0	0	0.7	0	0	0.6	0	0	0	1	0	0	0	0.3	0	0.5	0.3	1.3	0	0	0	0.2	0	0	0.1	0	0	0.1	0.5	0.1	0	0	0.4	0	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	1.2	0	0	0	0	0	0	0	0	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.4	0	0	0	0	0.1	0	0	0.4	0	0	0	0	0	0.1	0	0	2.3	0	0	0	0	0.2	0	0.1	0	0	0	0	0	0	0	1.6	0	0	0	0	0	0	0.1	0	0	0	0	0	0	12.7	0.4	0	0.3	0	0	0	Spermatocytes
LCE1D	LEP4	ENSG00000172155	Late cornified envelope 1D	Q5T752	1	152796751-152798181	Predicted intracellular proteins	Keratinization			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in some	6	skin 1: 46.0	Cell type enriched	Detected in single	48	Suprabasal keratinocytes: 11.0	Cancer enriched	Detected in single	8	melanoma: 4.0	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	16	HaCaT: 1.7;Karpas-707: 1.5																														unprognostic (7.67e-2)									0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	46	0	0	0	0	0	0	0	1.1	0	7.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	11	0	0	0	0	Suprabasal keratinocytes
ATOH1	bHLHa14, HATH1, MATH-1, Math1	ENSG00000172238	Atonal bHLH transcription factor 1	Q92858	4	93828753-93830964	Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors	Differentiation, Neurogenesis, Transcription, Transcription regulation	Activator, Developmental protein, DNA-binding	Cancer-related genes	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enriched	Detected in some	5	intestine: 29.5	Cell type enriched	Detected in some	36	Mucus-secreting cells: 198.8	Cancer enhanced	Detected in some		colorectal cancer: 9.1	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HAP1: 3.7;HL-60: 2.4	Not detected	Not detected			Not detected	Not detected			HPA049400			Approved	Nucleoplasm,Mitochondria,Cytosol						Mitochondria	Nucleoplasm, Cytosol	HPA049400: 			prognostic favorable (3.26e-5)								unprognostic (5.20e-1)	unprognostic (2.69e-1)		unprognostic (1.26e-1)	unprognostic (2.70e-1)			0	0	0.1	6.4	0.1	0	0.1	0.1	0.1	0.1	22.5	0	0	8.8	0.1	0	0.1	0.1	2.7	0.1	0.1	0.1	0	0.1	0	0	0.1	0	0.1	0.1	0	0.1	0	0	0.1	15	0	0.1	0	0	0.1	29.5	0.2	0.1	0.1	0.1	0.1	0	0.2	0	0	0	0.1	0.1	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	3.7	0	0	0	0	0.6	0.3	0	0	2.4	0.8	0	0	0	0	0	0	0	0	0	0	0	0.1	0.3	0.8	0.2	0.5	0	0.2	0.1	0	0	0.4	0.1	0	0	0	0.2	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	3.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	198.8	0	0	2.8	0	0	0	0	0	0	0	0	0	0	5.5	0	Mucus-secreting cells
MYOZ2	C4orf5, CS-1	ENSG00000172399	Myozenin 2	Q9NPC6	4	119135784-119187789	Disease related genes, Predicted intracellular proteins			Cardiomyopathy, Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	15	heart muscle: 219.1;skeletal muscle: 188.6	Cell type enriched	Detected in some	343	Cardiomyocytes: 2214.4	Cancer enhanced	Detected in some		head and neck cancer: 1.7	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		ASC TERT1: 3.3;HSkMC: 3.7;SK-MEL-30: 9.5;U-87 MG: 10.0	Not detected	Not detected			Not detected	Not detected			HPA035763, HPA035764	Enhanced		Approved	Nucleoplasm,Cytosol						Nucleoplasm, Cytosol		HPA035763: AB_2674770, HPA035764: AB_10696509	unprognostic (2.53e-1)	unprognostic (9.20e-2)	unprognostic (6.94e-2)	unprognostic (2.14e-1)	unprognostic (2.57e-1)	unprognostic (2.34e-2)	unprognostic (5.71e-1)	unprognostic (2.18e-1)	unprognostic (4.77e-2)	unprognostic (4.04e-1)	unprognostic (8.25e-2)	unprognostic (5.07e-2)	unprognostic (6.19e-7)	unprognostic (6.66e-4)	unprognostic (2.43e-1)	unprognostic (3.06e-1)	unprognostic (2.83e-2)	3.7	0	0.1	0	0.1	0	0.4	0	0.1	0.1	0.2	0	0	0	0.4	2.4	2.6	0.2	0.1	219.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0	0.1	0	0	0	0.1	0	0.9	0	0	1.9	0.1	188.6	0	0.1	0.2	0	0.1	0.1	0.6	0	0	2	13.9	3.2	0.2	0.1	0.1	0.1	0	0	0.2	0.6	0	0	0	0	0	0.2	3.3	0	0.4	0.5	0	0	0.2	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0	1.1	0	0	3.7	0	0.6	0	0.1	0.7	0	0	0	0.8	0	0	0	0.2	0	0	0	2	0	0	0	0	0.6	0	0	9.5	1.7	0	0	0.2	0.1	0.2	0.5	0	0	0	0	10	0	1.3	0	0	0	0	0	0	0	0	0	0	0.1	0.6	0	0	0.2	0	0.1	0	0	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0.1	0	0	2214.4	0	0	0	0	0	0	0	0.1	0.4	0	0	0	1.9	0	0.2	0.1	0	0	0.6	0	0	0	0	0.4	0.3	0	0	0	0	0	1.8	0	0.7	0.7	0	6.5	0.3	0.3	0.1	0	0	0	0	0	Cardiomyocytes
DNAJB7	HSC3	ENSG00000172404	DnaJ heat shock protein family (Hsp40) member B7	Q7Z6W7	22	40859549-40862126	Predicted intracellular proteins		Chaperone		Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enriched	Detected in some	10	testis: 24.9	Cell type enriched	Detected in some	8	Early spermatids: 549.9	Not detected	Not detected			Low region specificity	Detected in single			Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Low cell line specificity	Detected in many			Not detected	Not detected			Low region specificity	Detected in many			HPA000534	Approved											HPA000534: AB_1078693	unprognostic (3.89e-2)	unprognostic (1.12e-2)	unprognostic (9.61e-2)	unprognostic (1.27e-1)	unprognostic (5.45e-2)	unprognostic (2.66e-2)	unprognostic (1.16e-2)	unprognostic (5.56e-3)	unprognostic (1.62e-1)	unprognostic (7.42e-2)	unprognostic (1.22e-3)	unprognostic (2.81e-2)	unprognostic (4.46e-4)	unprognostic (3.32e-3)	unprognostic (3.06e-2)	unprognostic (7.05e-2)	unprognostic (2.45e-2)	0.1	0.1	0.1	0.2	0.2	0.9	0.1	1.1	0.3	0.2	0.1	0.1	0.1	0.9	0.2	1.3	0.1	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.4	0.1	0	0.3	0.1	0.3	0.2	0.1	0.1	0.2	0.1	0.6	0.3	0.9	0.1	0.1	0.2	0.3	24.9	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.9	0.5	2.4	0.6	0.5	1.6	0.1	0.4	0.1	1	1.5	0	0	1.7	1	0	0	0	0.3	0.3	1.6	0.2	0.1	0.8	0.6	0	0	0	0.1	0.8	0.6	2.3	0.6	0	1.5	0.5	0	0	0.2	0	0.4	0	0.6	1.1	1.8	0.1	0.6	1.9	1.9	1.3	0.5	0.3	1.1	1.1	0.7	0	0.6	1.7	0.4	0.5	0.7	0.3	1	0.3	1	0	1.1	1.6	1.4	0.5	1.7	0.9	1	0.1	0.5	1.3	1.9	0.5	0.3	0.7	0.4	0.7	0.3	0.6	0.6	0.3	0.9	1.6	0.9	2.4	0.5	0.6	0.5	0.2	0.1	0.1	0.2	1.1	0.2	0.1	0.1	0.1	0.1	0.3	0.1	0	0	0	0.1	0	3.6	0	0	0	0	0	3.9	0	0	0	549.9	0	0.9	0	0	0	0	0.1	4.6	0	0.1	1.6	0	0	0	68.8	2.6	0	0	0	0	0.9	0	0	2.5	0	9.9	0	0	2.7	1.4	0	0.2	0	0.8	0	Early spermatids
INSL5		ENSG00000172410	Insulin like 5	Q9Y5Q6	1	66797741-66801256	Predicted secreted proteins		Hormone		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	28	intestine: 52.9	Cell type enriched	Detected in some	577	Intestinal endocrine cells: 8520.8	Group enriched	Detected in some	5	colorectal cancer: 1.2;prostate cancer: 0.7					Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HEK 293: 1.4;hTCEpi: 1.1	Not detected	Not detected			Not detected	Not detected			HPA030100, CAB033849	Enhanced				Secreted to blood			38500000				CAB033849: AB_2264904, HPA030100: AB_10601915	unprognostic (2.48e-1)		unprognostic (4.41e-2)	unprognostic (2.91e-1)	unprognostic (1.18e-1)					unprognostic (2.76e-2)		unprognostic (1.30e-1)	unprognostic (2.62e-2)			unprognostic (7.53e-2)		0	0	0.8	0	1.3	0	0	0.1	1	0	30.8			0	0	0	0	0.7	0	0	1.1	1.8	0.4	0	0	0	0.5		0	0	0	0.5	0		0.2	52.9		0	0	0	0	0	0	0.2	0	0	0.9			0.2		0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0.9	0	0	0	0	0.1	0	0	0	0	0	0	0	1.4	0	0	0	0	0	0	0	1.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	2.6	0	0	0	0	0.1	0	0	0	0	8520.8	0	0	0	0	0	0	0	8.3	0	0	14.8	0	0	0	0	0	0.1	0	0	0	0	2.3	0	Intestinal endocrine cells
EFCAB3	FLJ25818	ENSG00000172421	EF-hand calcium binding domain 3	Q8N7B9	17	62343941-62416479	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	16	testis: 11.3	Cell type enriched	Detected in some	8	Early spermatids: 41.4	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		SH-SY5Y: 2.1;T-47d: 2.2					Not detected	Not detected			HPA046862	Uncertain											HPA046862: AB_2679844													unprognostic (2.99e-6)					0.7	0	0	0	0	0	0	0	0.1	0	0			0	0	0.1	0.1	0	0	0	0	0	0	0	0	0	0		0	0	0	0	0		0	0		0	0	0	0	0	0	0	0	0	11.3			0		0	0	0	0.1	0	0	0	0	0.1	0	0.4	0	1.2	1.9	0.3	0.5	1.3	0.4	0	0.1	0.3	0	0.4	0.8	0.1	0	0.1	0.5	0.3	0	0	0.4	0	0	0	0.2	0	0.8	0.5	0	0	0.1	0	0.3	0	0.7	0.1	0.6	0.2	0.9	0.6	1.5	1.4	0.1	0	1.5	0	1.1	0.5	0.6	0.7	2.1	0	1.9	0.3	0.5	2.2	0	0.5	0.2	0.4	0.5	0.1	0	0.5	0.2	0.5	0.4	0.5	0	0	0	0	0	0	0	0.1	0	0	0.1	0	0	0	0	0	0	0	0											0	0.6	0	0	0.1	0.2	0.1	0	5.3	0	0	0	0.2	0	0	41.4	0.1	0	0	0	0.1	0	0	1.1	0	0	1.6	0	0.6	0	4.9	0.9	0.2	0	0	0	0	0.1	0	0.4	0	0.3	0	0	0	0.4	0	0.3	0	0	0	Early spermatids
RAB40A	Rar-2, RAR2A	ENSG00000172476	RAB40A, member RAS oncogene family	Q8WXH6	X	103499130-103519489	Cancer-related genes, Predicted intracellular proteins	Ubl conjugation pathway		Cancer-related genes	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in many		epididymis: 34.0	Cell type enriched	Detected in single	7	Peritubular cells: 5.6	Low cancer specificity	Detected in single			Region enriched	Detected in single	5	basal ganglia: 4.2	Cell type enriched	Detected in single	5	memory B-cell: 1.2	Lineage enriched	Detected in single	5	B-cells: 1.2	Cell line enhanced	Detected in many		AF22: 6.5;NTERA-2: 7.2									HPA076172			Uncertain	Vesicles						Vesicles		HPA076172: 	unprognostic (3.49e-1)	unprognostic (6.01e-2)	unprognostic (4.33e-2)	unprognostic (4.49e-3)	unprognostic (8.73e-2)	unprognostic (1.08e-1)	unprognostic (8.21e-2)	unprognostic (1.72e-1)	unprognostic (1.24e-1)	unprognostic (4.05e-1)	unprognostic (3.82e-2)	unprognostic (4.43e-1)	unprognostic (7.36e-4)	unprognostic (7.85e-3)	unprognostic (9.39e-5)	unprognostic (1.43e-1)	unprognostic (1.11e-3)	2	1.4	0.6	0.6	4.2	0	0.8	0.6	1.1	2.8	0.8	0.6	11.9	0.5	5.5	34	10.6	2.6	2.9	0.6	0.6	0.9	1.3	0.6	2	1.7	0.6	0.6	5.4	0.6	0.6	2.4	0.8	0.8	5.5	0.4	0.6	0.6	6.2	0.6	0.7	0.9	1.3	0.6	0.8	0.5	7.8	0.6	0.6	0.6	0.6	0.6	1.5	2	1.2	0.2	0	0	0	0.1	0	0.4	1.7	6.5	0.2	1.5	1.9	3.2	1.9	0.4	0.3	0.5	1.3	0.9	1.6	2.5	0.3	2	0.1	0.4	0.1	0.3	0	3.8	0.5	3	0.3	0.6	0.1	0.3	1.5	0.3	0.6	0.4	2.5	0.3	0.5	2.3	1	0.6	0.4	0.4	0.2	7.2	0	1	0	0.5	0.1	0.1	0.6	2.7	3.4	0.6	0.1	1.4	2	0	0.2	3.2	2.7	1.5	4.1	1.8	1.2	0.7	1.2	3	0	1.2	0	0	0	0	0	0	1.2	0	0	0	0	0.1	0.1	0	0	0	0.2	0.1	0	0.6	4.2	0.6	0.6	0.6	0.9	0.6	0.6	0.8	0.6	0	0	0	0.1	0	0	0.2	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0.1	0.2	0	0	0	0.1	0	0	0	0	0.2	0.9	0	0	0	0	0	0	0	5.6	0	0.2	0	0.1	0	0	0.1	0.2	0	0	0	Peritubular cells
AGXT	AGT, AGT1, AGXT1, PH1, SPAT, SPT	ENSG00000172482	Alanine-glyoxylate aminotransferase	P21549	2	240868479-240880502	Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins		Aminotransferase, Transferase	Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	172	liver: 247.3	Cell type enriched	Detected in many	17	Hepatocytes: 1878.6	Cancer enriched	Detected in some	425	liver cancer: 253.1	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	5	Hep G2: 13.4	Not detected	Not detected			Not detected	Not detected			HPA035370, HPA035371	Enhanced		Supported	Vesicles					5200000	Vesicles		HPA035370: AB_10673218, HPA035371: AB_2674593	unprognostic (3.14e-2)	unprognostic (2.58e-1)	unprognostic (3.37e-4)	unprognostic (1.04e-1)	unprognostic (1.23e-2)	unprognostic (9.56e-2)	prognostic favorable (5.92e-5)	unprognostic (8.28e-2)	unprognostic (2.77e-1)	unprognostic (5.39e-2)	unprognostic (1.55e-1)	unprognostic (7.57e-3)	unprognostic (2.54e-1)	unprognostic (9.22e-2)	unprognostic (1.37e-1)		unprognostic (3.26e-2)	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	1.4	247.3	0	0	0	0	0	0	0	0	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0.2	0	0.1	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.6	0	0	0	0	0	0	0.2	0	0	0	0.4	0	0	0	0	0	0.5	0	13.4	0	1	0.1	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0.2	0	0	0.2	1.3	0	0	0	0.1	0	0.8	2.6	0	0	0	0	0.3	0	0	0	0	0.2	0	0.4	0	0.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0.1	0	0	0	11.5	0	0	0	0.8	28.1	0	0	7	0	0.5	19.9	0	0	0	2.6	46.7	1.6	22.7	0	0.5	0	1878.6	0.2	0	8.6	45.4	38.8	0	0.9	0	0	0	3.9	0	0.2	7	0.4	108	0	0	0	0	0	0	1.6	8.2	1.2	0	Hepatocytes
ACOT12	Cach, STARD15, THEAL	ENSG00000172497	Acyl-CoA thioesterase 12	Q8WYK0	5	81330005-81394179	Enzymes, Predicted intracellular proteins, Transporters	Fatty acid metabolism, Lipid metabolism	Hydrolase, Serine esterase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	38	liver: 49.6	Cell type enriched	Detected in some	7	Hepatocytes: 37.1	Cancer enriched	Detected in single	76	liver cancer: 13.9	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		AN3-CA: 1.0;CACO-2: 2.5;Karpas-707: 1.8;SK-MEL-30: 4.2	Not detected	Not detected			Low region specificity	Detected in single			HPA037723, HPA037724			Approved	Nucleoplasm,Cytosol						Nucleoplasm	Cytosol	HPA037723: AB_10672606, HPA037724: AB_2675631	unprognostic (6.06e-2)				unprognostic (1.39e-1)		prognostic favorable (5.30e-4)		unprognostic (7.68e-2)	unprognostic (8.22e-2)	unprognostic (5.68e-3)	unprognostic (2.46e-1)	unprognostic (6.86e-2)	unprognostic (1.46e-2)	unprognostic (3.07e-1)	unprognostic (1.06e-1)		0	0	0.3	0	0.1	0	0	0	0.2	0	0	0.2	0	0.1	0	0.1	0	0	0	0	0.1	0.1	1.2	49.6	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	1	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0.7	0	0.5	0.1	0	0.1	2.5	0	0	0.1	0	0	0	0.1	0	0.2	0	0	0	0	0	0.1	0	0.9	0	0.1	0	0	0.3	0	0.4	0	1.8	0	0	0	0.1	0.5	0	0	0.3	0	0	0	0	0.3	0	0	0	4.2	0.4	0	0	0	0	0	0	0	0.9	0.3	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0.1	0	0.2	0.1	0.1	0	0	0.1	0	0	0	0.9	0	0	0	0.3	5.1	0	0	1.8	0	0	0	0	1.6	0	0	0	0	0	0	0	0	37.1	0.4	0	0	0.6	1.2	0.4	0	0	0	0	0	0	0	0	0.4	2.2	0	0	0	0.2	0.1	0	0	0	0	0	Hepatocytes
FAM170B	C10orf73, Em:AC084727.4	ENSG00000172538	Family with sequence similarity 170 member B	A6NMN3	10	49131154-49134008	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Group enriched	Detected in some	51	blood: 5.3;testis: 10.0	Cell type enriched	Detected in some	7	Early spermatids: 79.0	Not detected	Not detected							Cell type enriched	Detected in single	40	eosinophil: 5.3	Lineage enriched	Detected in single	40	granulocytes: 5.3	Cell line enhanced	Detected in some		Daudi: 3.2;HDLM-2: 2.4;U-266/84: 1.1;U-87 MG: 1.1					Not detected	Not detected			HPA043899, HPA050610	Uncertain											HPA043899: AB_2678721, HPA050610: AB_2681189													unprognostic (8.01e-2)					0	0	0	0	0	0	0	0	0	0	0			0.1	0	0	0	0	0	0	0	0	0	0	0	0	0		0	0	0	0	0		0	0		0	0	0	0	0	0	0	0	0	10			0		0.1	0	0	0	0	5.3	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.2	0	0	0	0	0	0	0	2.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0.1	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.1	0	1.1	0.6	0	0	0	5.3	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	79	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	11.2	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0.2	0	0	0	0	0	Early spermatids
MUCL1	SBEM	ENSG00000172551	Mucin like 1	Q96DR8	12	54830519-54858393	Predicted intracellular proteins, Predicted secreted proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	75	breast: 283.5;salivary gland: 277.2;skin 1: 99.4	Cell type enriched	Detected in some	6	Melanocytes: 1005.5	Cancer enriched	Detected in many	30	breast cancer: 298.9	Not detected	Not detected			Cell type enhanced	Detected in some		memory CD4 T-cell: 1.5;memory CD8 T-cell: 1.1;naive CD8 T-cell: 1.1	Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		EFO-21: 2.0;hTCEpi: 2.2;MCF7: 3.7;SK-BR-3: 9.2;SuSa: 6.2									HPA039093	Enhanced				Secreted in other tissues							HPA039093: AB_10795577	unprognostic (2.26e-1)	unprognostic (3.38e-1)	unprognostic (1.90e-1)	unprognostic (1.47e-1)	unprognostic (2.53e-1)	unprognostic (8.34e-3)		unprognostic (5.55e-2)	unprognostic (2.00e-1)	unprognostic (3.11e-2)	unprognostic (2.31e-2)	unprognostic (2.03e-1)		unprognostic (1.37e-1)	unprognostic (4.04e-1)		unprognostic (9.90e-2)	2.9	0	0.1	0.1	0.1	0	283.5	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.5	0.1	0	0.2	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0	0.1	0.8	0.1	0.1	0	0.1	277.2	0.1	0.2	99.4	0.1	0.1	0.1	0.1	0	0.1	0.1	0.4	0.1	0.2	0.2	0.2	0.3	0	0	0	0	0.9	1.5	0.1	0	0	0	0	0	0	1.4	0	0	0	0	0	0	0.2	2	0	0.2	0	0	0.5	0	0	0	0	0	0	0	0	0	0	2.2	0	0	0	0	0	0	0	0	3.7	0	0	0	0	0.6	0	0	0	0	0.8	0	0	0	9.2	0	6.2	0.2	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0.2	0	0	0	1.5	1.1	0	0	0	1.1	0	0.9	0	0	0	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.6	0	0.4	167.3	0	0	0	1.4	0	0	0	0	3.3	0	0	0	0	0	0.2	0	0	6.8	0	0	0.1	0	0	0	0	0	0	0.2	1005.5	0	0	0	0.5	0	0	0	0	0	0	0	0.4	8.8	0	0	0	0.6	Melanocytes
FNDC9	C5orf40, MGC27121	ENSG00000172568	Fibronectin type III domain containing 9	Q8TBE3	5	157341600-157345721	Predicted membrane proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Group enriched	Detected in some	7	adrenal gland: 9.4;brain: 24.0;pituitary gland: 10.0	Cell type enriched	Detected in single	5	Bipolar cells: 3.4	Cancer enriched	Detected in single	16	glioma: 0.8	Low region specificity	Detected in many			Low cell type specificity	Detected in some			Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		Daudi: 1.7;HeLa: 1.8;Karpas-707: 3.0;U-266/70: 1.6	Group enriched	Detected in many	5	basal ganglia: 21.9;hypothalamus: 28.4	Low region specificity	Detected in all			HPA011115	Uncertain											HPA011115: AB_1079374	unprognostic (2.35e-3)	unprognostic (3.80e-2)	unprognostic (2.93e-1)		unprognostic (3.53e-3)	unprognostic (4.90e-3)		unprognostic (3.40e-1)	unprognostic (1.95e-1)	unprognostic (1.68e-1)	unprognostic (2.10e-2)	unprognostic (1.86e-1)	unprognostic (6.35e-6)	unprognostic (3.63e-2)	unprognostic (6.39e-2)	unprognostic (1.57e-1)	unprognostic (1.12e-3)	0.6	9.4	3.9	1.5	21.1	2	0.6	9.1	24	0.5	1.1	0	0	0.6	0.6	0.9	0.5	0.6	0.6	0.7	1.9	22	0.7	0.6	0.5	0.9	1.3	3.8	0.5	0.5	0.5	10	0.6	5.8	0.6	1.2	0	0.5	0.6	0.6	0.6	0.8	0.8	1.3	0.6	0.6	0.5	0.4	0	0.6	0	0.5	0.6	0	0.5	0.3	0.8	0.8	0	1.9	0.1	0	0.2	0.4	0.4	0	0	0.4	1	0	0.2	0	0.2	0	1.7	0	0	0.1	0.1	0	0	0	0.1	0.1	0	1.8	0	0	0.4	0.8	0	0	0	0	1	0	0.5	0	3	0	0	0.9	0	0	0	0	0.3	0	0.3	0	0.2	0.4	0.1	0	0.3	0	0.9	0	0	0	0.6	1	0.3	0.3	1.6	0	1	0.4	0	0.1	0	0	0.8	1.9	0.2	0.1	0	0.6	1.3	0	0.5	0.8	1.5	0.2	0	0.8	0.3	0	0.1	3.9	21.1	9.1	13.3	1.9	22	1.3	3.8	5.8	0.4	0	0	0	0	0	3.4	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0	0.1	0	0	0	Bipolar cells
AGAP5	CTGLF2, Em:AC073389.1	ENSG00000172650	ArfGAP with GTPase domain, ankyrin repeat and PH domain 5	A6NIR3	10	73674285-73698159	Predicted intracellular proteins		GTPase activation		Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Low tissue specificity	Detected in all			Cell type enriched	Detected in many	5	Early spermatids: 66.3	Not detected	Not detected							Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Low cell line specificity	Detected in all											HPA042490	Uncertain											HPA042490: AB_2678022	unprognostic (1.84e-1)	unprognostic (3.59e-2)	unprognostic (1.27e-2)	unprognostic (1.07e-1)	unprognostic (1.61e-1)	unprognostic (4.45e-3)	unprognostic (1.40e-1)	unprognostic (4.52e-1)	unprognostic (1.41e-1)	unprognostic (1.98e-2)	unprognostic (4.04e-3)	unprognostic (4.33e-3)	unprognostic (5.83e-5)	unprognostic (3.33e-2)	unprognostic (2.87e-1)	unprognostic (7.29e-2)	unprognostic (1.17e-2)	2.8	4.3	1.7	3.4	2.5	2.7	4.6	4.7	1.7	3.3	2.4			3.4	3.3	4.4	2.6	3.1	2.3	4.1	2	1.9	3.3	5.4	2.9	4	1.8		5.3	9.2	3	5	2.4		4.3	3.1		6.4	2.5	8.5	6.9	3.7	2	2.3	4.4	3.5	7.5			4.1		2.6	2.4	3	1.4	1.8	2.9	0.8	0	2	0.2	3	3.9	5	5.6	4.1	3.1	7.5	3.9	2.8	2.7	2.2	5	4.3	3.7	3.1	3	1.1	7.7	3.8	3.1	1.8	4.4	4.3	2.9	7.6	5.6	3.4	7.4	4.9	3.4	3.5	3	8.2	7	2.2	5.5	3.8	7.6	2.3	2.9	2.8	9.6	1.4	3.3	10.6	3.8	2.2	2.8	2.7	3	2.3	2	2.2	8.1	4.5	3.8	4.5	6.1	3.6	3.5	4.6	3.4	4.8	9	4.5	2.2	3.4	8.6	1.4	2.9	0.7	0.4	2	0.8	0.5	0.8	0.8	0.3	0.5	1.4	0.4	0.5	0.3	0	0.3	1.8	0.1	0.2											0	7	0	0.3	1.6	2	0	0	8.1	5.7	3.5	5.9	1.2	0	1.2	66.3	1.9	1.6	0	1.8	0.7	0.9	1.1	3.5	3.9	1.3	3.2	0	4.9	1.3	13.7	1.1	1.3	1.7	1.8	2	1.9	2.3	0	3.5	0.3	2.6	0	0.4	2.5	1.9	1.1	0.6	1	1.9	0.4	Early spermatids
MOS		ENSG00000172680	MOS proto-oncogene, serine/threonine kinase	P00540	8	56112942-56113982	Enzymes, Predicted intracellular proteins		Kinase, Serine/threonine-protein kinase, Transferase	Proto-oncogene	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	5	testis: 3.5	Cell type enriched	Detected in single	8	Early spermatids: 5.0	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in single		HAP1: 1.0	Not detected	Not detected			Low region specificity	Detected in all																														unprognostic (3.28e-1)			0	0	0.6	0	0.5	0	0	0	0.3	0	0			0	0	0	0	0	0	0	0.7	0.1	0	0	0	0	0.2		0	0	0	0	0		0	0		0	0	0	0	0	0	0	0	0	3.5			0		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.7	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0	0	0	Early spermatids
KRT2	KRT2A, KRTE	ENSG00000172867	Keratin 2	P35908	12	52644558-52652164	Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins			Disease mutation, FDA approved drug targets, Ichthyosis	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	15	skin 1: 289.9	Cell type enriched	Detected in some	15	Suprabasal keratinocytes: 232.0	Group enriched	Detected in some	35	head and neck cancer: 4.7;melanoma: 23.4	Not detected	Not detected			Group enriched	Detected in some	7	naive CD4 T-cell: 4.4;naive CD8 T-cell: 2.1	Lineage enriched	Detected in single	45	T-cells: 4.4	Group enriched	Detected in some	4	HEL: 6.3;HMC-1: 2.7;JURKAT: 2.4;OE19: 2.9	Group enriched	Detected in some	6	amygdala: 1.8;hippocampal formation: 2.9	Not detected	Not detected			HPA006299, CAB037321	Enhanced		Approved	Golgi apparatus,Intermediate filaments,Cytosol					14000000000	Intermediate filaments, Cytosol	Golgi apparatus	CAB037321: , HPA006299: AB_1079180	unprognostic (1.22e-1)	unprognostic (1.60e-1)	unprognostic (1.34e-1)	unprognostic (2.56e-1)	unprognostic (8.47e-3)	unprognostic (1.69e-2)		unprognostic (1.84e-1)	unprognostic (3.59e-1)		unprognostic (2.12e-1)	unprognostic (4.76e-2)	unprognostic (3.56e-7)	unprognostic (6.43e-2)	unprognostic (5.98e-3)	unprognostic (6.69e-2)	unprognostic (3.46e-1)	0.1	0	0.1	0.1	0.1	0	9.5	0.1	0.1	18.3	0.1	0.1	0.1	0	2	0.1	0.4	0	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	4.4	289.9	0.1	0.1	0.1	0.1	0	0.1	0.1	6.8	0.1	19.2	1	0.1	0.3	0	0	0	0	0	4.4	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0.4	0	0	0	0	0	6.3	0	0	0	0	2.7	0	0	0	0	0	0	2.4	0	0	0	0	0	0	0	2.9	0	0	0	0.7	0	0	0	0	0	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0.1	0.4	0	0	4.4	2.1	0	0	0	0	0	0.8	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	0	0	15.9	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.3	0	0	0	0	1.2	0.6	0.8	0	0	0	8.5	0	0	0	0.1	0	0	0	0	0	0	0	0	232	0.1	0	0.1	0	Suprabasal keratinocytes
MYEOV	OCIM	ENSG00000172927	Myeloma overexpressed	Q96EZ4	11	69294138-69367726	Predicted membrane proteins			Proto-oncogene	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in many		adipose tissue: 29.4;breast: 16.9;esophagus: 17.3	Cell type enriched	Detected in some	8	Pancreatic endocrine cells: 116.0	Low cancer specificity	Detected in many			Not detected	Not detected			Cell type enhanced	Detected in single		NK-cell: 1.0	Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		A-431: 59.2;A549: 28.4;CAPAN-2: 8.7;U-2 OS: 13.1									HPA012949	Uncertain		Approved	Nucleoplasm,Vesicles						Nucleoplasm	Vesicles	HPA012949: AB_1854241	unprognostic (1.42e-2)	unprognostic (8.56e-2)	unprognostic (7.07e-2)	unprognostic (3.36e-1)	unprognostic (5.60e-2)	unprognostic (7.28e-3)	unprognostic (7.58e-3)	prognostic unfavorable (2.00e-4)	unprognostic (3.49e-1)	unprognostic (6.33e-2)	prognostic unfavorable (1.54e-7)	unprognostic (2.83e-1)	prognostic unfavorable (1.48e-5)	unprognostic (2.08e-1)	unprognostic (1.16e-1)	unprognostic (3.35e-1)	unprognostic (3.69e-2)	29.4	0.2	0	2.4	0	0.2	16.9	0.1	0	2.6	1.1	0	0.4	0.4	0.5	8.1	17.3	0	1.3	0.1	0	0.2	0.2	8.6	0.1	0.2	0	0.1	0.1	2.1	0	0.1	0	0	0.1	0.6	0.9	2	0	0.6	4.9	0.8	0.1	0	0.3	10.7	0.4	0	0.1	0.1	5.3	13.6	0.2	4.7	0.5	0	0	0.1	1	0.3	2.1	59.2	28.4	0	0	0	0	0.8	0.1	0	0	0	0.2	8.7	0.2	2.6	0	0	0.8	0	0	0	0	0	0	0.2	0.1	0	0	2.4	0	0	0	0	0	2.8	0	0.8	0	0	1.2	0	0	0	1	2.3	0	0	1	0.2	0	0	0	0	0.8	0.1	0	1	0.1	0.8	0	13.1	0	0.6	0.1	0.6	0.1	0	0.2	1.1	0	0.1	0	0.2	0	0.3	0.5	0	0.1	0	0	0	0.1	0	1	0	0	0	2.1	0	0	0.1	0	0	0.2	0	0.1	0	0	0	0	0	0.6	0.7	0	0.3	0	0	0	3.5	0	0	0	15.5	10.5	0	0.4	0	8.4	0.2	0.2	1.2	0	0	2.4	0	0	0	0	4.7	0.3	0	0	0	1	0	116	12.5	0	0	0	0	1.4	0	0.4	1.1	0.1	0	0.5	6.8	Pancreatic endocrine cells
SLC22A13	OAT10, OCTL1, OCTL3, ORCTL3	ENSG00000172940	Solute carrier family 22 member 13	Q9Y226	3	38265812-38278315	Predicted membrane proteins, Transporters				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	7	kidney: 16.4	Cell type enriched	Detected in single	23	Proximal tubular cells: 6.5	Cancer enriched	Detected in single	7	renal cancer: 0.7	Not detected	Not detected			Cell type enriched	Detected in single	5	T-reg: 2.3	Lineage enriched	Detected in single	5	T-cells: 2.3	Cell line enhanced	Detected in some		HeLa: 2.2					Low region specificity	Detected in all			HPA035603, HPA035962	Enhanced											HPA035603: AB_10672869, HPA035962: AB_2674890	unprognostic (2.73e-2)	unprognostic (6.70e-2)	unprognostic (2.80e-1)	unprognostic (5.68e-2)	unprognostic (7.13e-3)	unprognostic (3.50e-3)	unprognostic (6.83e-2)	unprognostic (1.49e-1)	unprognostic (3.48e-1)	unprognostic (2.09e-1)	unprognostic (3.04e-1)	unprognostic (1.92e-1)	unprognostic (8.65e-5)	unprognostic (3.39e-1)	unprognostic (1.96e-2)	unprognostic (5.24e-2)	unprognostic (2.74e-1)	0	0	0	0	0	0.1	0	0.6	0.1	0	0	0	0	0	0	0	0.4	0	0.1	0	0	0	16.4	0.1	0	0	0	0	0	0.1	0	0.7	0	0	0	0.1	0	1.3	0	0.2	0	0.3	0	0	0	0.1	0.5	0	0	0	0	0	0.2	0.2	0.4	0	0.1	0.3	0	2.3	0	0.2	0.5	0.1	0.7	0.4	0.5	0.1	0.3	0	0.2	0.3	0	0.5	0.9	0.2	0.1	0.6	0.8	0.5	0.7	0.1	0.4	0.1	0	2.2	0	0.1	0	0.8	0	0.5	0.1	1.5	0.8	0	0.9	0	0.1	1.1	0.1	0.1	0	0	0.2	0.5	0	0	0.2	0	1.2	0.1	0.1	0	0.5	0	0.4	0.1	0.1	0	0.3	0.7	1.2	0.3	0.3	0.4	0.4	0.9	0	0	0	0.2	0	0	0.3	0.3	0.4	0.1	0.3	0	0.3	0.3	0	0.1	0	0	0	2.3	0	0	0	0.6	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	6.5	0	0	0	0	0	0	0	0	0	0	Proximal tubular cells
XKR3	MGC57211, XTES	ENSG00000172967	XK related 3	Q5GH77	22	16783412-16821699	Predicted membrane proteins, Transporters				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	44	blood: 4.7;testis: 13.5	Cell type enriched	Detected in some	15	Early spermatids: 93.9	Not detected	Not detected							Group enriched	Detected in some	8	basophil: 1.5;neutrophil: 4.7	Lineage enriched	Detected in single	13	granulocytes: 4.7	Cell line enriched	Detected in some	16	Karpas-707: 73.1									HPA003379, HPA035081	Uncertain											HPA003379: AB_10602682, HPA035081: AB_2674451	unprognostic (4.57e-1)				unprognostic (3.37e-1)								unprognostic (3.11e-2)	unprognostic (3.13e-2)	unprognostic (5.77e-2)			0	0.1	0	0	0	0	0	0	0.1	0	0			0	0	0	0	0	0	0	0	0	0	0	0	0	0		0	0	0	0	0		0	0		0	0	0	0	0	0	0	0.2	0	13.5			0		0	0	0	0	0.2	4.7	0.3	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0.1	0.1	0	0	4.5	73.1	0	0	0	0	0	0	0	0	0	0.4	0.2	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	1.4	0	0	0.3	0	0	1.5	0.3	0.3	0	0	0	0	0	0	0.2	0	0	0	4.7	0	0	0	0	0.1											0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	93.9	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	6.4	0.3	0	0	0	0	0	0	0	0	0	0	0	0	1.1	0.5	0	0.1	0	0	0	Early spermatids
RXFP4	GPCR142, GPR100, RLN3R2, RXFPR4	ENSG00000173080	Relaxin/insulin like family peptide receptor 4	Q8TDU9	1	155941710-155942949	G-protein coupled receptors, Predicted membrane proteins		G-protein coupled receptor, Receptor, Transducer		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Group enriched	Detected in some	4	blood: 1.8;bone marrow: 1.3;intestine: 5.4	Cell type enriched	Detected in some	16	Intestinal endocrine cells: 56.0	Cancer enhanced	Detected in some		colorectal cancer: 2.4					Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		Hep G2: 1.5;NB-4: 2.0;OE19: 2.7;SK-MEL-30: 1.9;T-47d: 2.1	Not detected	Not detected			Low region specificity	Detected in many																unprognostic (4.90e-2)	unprognostic (2.17e-1)	unprognostic (3.64e-2)	unprognostic (1.84e-3)	unprognostic (2.19e-1)	unprognostic (5.94e-2)	unprognostic (3.17e-2)	unprognostic (4.73e-2)	unprognostic (2.87e-1)	unprognostic (8.33e-2)	unprognostic (2.53e-2)	unprognostic (1.19e-1)	unprognostic (3.08e-3)	unprognostic (1.40e-1)	unprognostic (1.65e-1)	unprognostic (1.12e-1)	unprognostic (3.86e-2)	0.2	0	0	0.5	0.1	1.3	0.1	0.7	0	0	5.2			3.5	0.1	0	0	0.2	0	0	0	0	0.2	0	0.2	0	0		0	0.1	0	0	0		0	5.4		0.1	0.1	0	0	2.8	0	0	0.2	0	0.2			0		0	0.6	0	0.6	0.4	1.8	1.4	0.7	0.8	0.2	0	0.8	0	0.2	0	0	0	0	0	0	0	0.8	0.6	0.3	1.1	0	0	0.9	0	0.3	0	0	0.3	0.5	0.2	1.5	0	0	0.1	0	0	0	0	0	0	0.6	0.1	0.5	0	0.2	0.1	2	0.2	2.7	0	0.2	0	0.9	0	0	0.1	0	0	0.9	1.9	0	2.1	0	0.6	0.1	0	0	0	0.1	1.2	0.6	1.1	0.2	0.1	0	0.9	1.8	0	1.1	0	0	0.5	0.8	0.4	0.6	0	0.1	1.1	0.7	1.4	0	0	0.2											0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	56	0	0	0	0	0	0	0	1.7	0	0.1	3.5	0	0	0	0	0	0	0	0	0	0	1.3	0	Intestinal endocrine cells
ABCD2	ALDL1, ALDR, ALDRP	ENSG00000173208	ATP binding cassette subfamily D member 2	Q9UBJ2	12	39550033-39619751	Predicted membrane proteins, Transporters	Transport			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		adipose tissue: 24.1;brain: 30.1	Cell type enriched	Detected in some	6	Bipolar cells: 55.5	Cancer enriched	Detected in single	7	glioma: 1.9	Low region specificity	Detected in all			Low cell type specificity	Detected in many			Lineage enriched	Detected in many	4	T-cells: 6.5	Group enriched	Detected in some	5	ASC diff: 9.2;HDLM-2: 12.4;Karpas-707: 22.2;SH-SY5Y: 13.4;U-266/70: 7.5	Low region specificity	Detected in all			Low region specificity	Detected in all																unprognostic (1.26e-3)	unprognostic (4.06e-4)	unprognostic (9.27e-2)	unprognostic (1.15e-2)	unprognostic (2.06e-1)	unprognostic (7.31e-5)	unprognostic (3.42e-2)	unprognostic (2.90e-2)	unprognostic (8.06e-3)	unprognostic (3.43e-2)	unprognostic (1.24e-2)	unprognostic (1.20e-1)	unprognostic (3.47e-4)	unprognostic (5.04e-2)	unprognostic (8.04e-2)	unprognostic (1.13e-1)	unprognostic (6.74e-2)	24.1	3.6	6.8	3.5	6.8	0.9	5.5	30.1	13.4	10.6	1.7	1.3	0	1.4	5.4	1	1.3	5.2	1.4	7.4	5.1	4.1	1.4	0.7	1.4	4.8	4.8	8.4	0.7	0.7	0.7	5.1	0.5	11.4	1.2	1.7	2.9	4.6	1.6	0.7	0.7	1.7	5.1	2.1	3	1.6	0.9	2.6	0.9	1	0.6	3.2	2.8	1.9	0.8	0.8	0.1	0	1.4	6.5	1.8	0	0	0.1	0	9.2	0.4	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	12.4	0	0.1	0	0	0.4	0.1	0	2.3	0	0	0	0	0	0	0	22.2	0	0	0.2	0	0	0	0	0.1	0	1.2	0	0	0	13.4	0	0	0	0	0	0.3	0	0	0	0	0	7.5	0.9	0.1	0	0.2	0	0	0	0	2.4	0	1.9	0.8	4.3	5.7	0.2	0.4	5	6.5	0.1	1.4	0	0.8	5.1	1.8	6.8	6.8	30.1	13.4	5.1	4.1	4.8	8.4	11.4	2.6	0	0	0.8	0	0	55.5	8.9	0	4	0	0	5.9	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	9.5	0	0	0	0	0	0	0	1.8	0	1.7	0	0	0.7	0.5	1.8	0	0.3	0.1	0	0	0	3.5	0	0	Bipolar cells
C11orf86	FLJ22675	ENSG00000173237	Chromosome 11 open reading frame 86	A6NJI1	11	66975277-66977004	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level	No human protein/transcript evidence	Evidence at transcript level		Tissue enriched	Detected in some	14	intestine: 57.7	Cell type enriched	Detected in some	5	Enterocytes: 358.1	Low cancer specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	5	HeLa: 6.9;SiHa: 23.3	Not detected	Not detected			Not detected	Not detected			HPA039348	Uncertain											HPA039348: AB_10673421		unprognostic (1.54e-2)	unprognostic (7.67e-3)		unprognostic (3.02e-2)	unprognostic (1.20e-1)	unprognostic (3.90e-4)	prognostic unfavorable (8.97e-4)		unprognostic (4.17e-1)	prognostic unfavorable (6.97e-5)		prognostic unfavorable (1.02e-5)	unprognostic (7.04e-2)	unprognostic (1.51e-1)	unprognostic (1.69e-2)	unprognostic (3.58e-3)	0.1	4	0.1	1.1	0.1	0	0.1	0.1	0.1	0.1	24.4	0.1	0.1	33.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0	0.5	1.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	2.1	0.1	0.1	3	0.1	0.1	0.1	0.1	0	57.7	0.2	0.1	0.1	1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0	0	1.7	0	0	0	0	0.1	0	0	0	0	0.1	0.2	0	0.1	0	1.2	0	0	0	0	0	0	0	6.9	0.2	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.2	0	0	0	0.2	0	0	0	0	23.3	3.1	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	358.1	0	0.6	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	3	0	0.7	66.6	0	1.3	0	0	0	0	0	0	0.2	0	1.5	0.1	Enterocytes
LIPM	bA304I5.1, LIPL3	ENSG00000173239	Lipase family member M	Q5VYY2	10	88802730-88820546	Predicted intracellular proteins, Predicted secreted proteins	Lipid degradation, Lipid metabolism	Hydrolase		Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enriched	Detected in some	14	skin 1: 30.1	Cell type enriched	Detected in single	9	Suprabasal keratinocytes: 1.0	Low cancer specificity	Detected in many							Cell type enhanced	Detected in single		intermediate monocyte: 1.0	Lineage enhanced	Detected in single		monocytes: 1.0	Cell line enhanced	Detected in some		A-431: 2.1;CAPAN-2: 6.9;HL-60: 3.9;NB-4: 3.3;OE19: 6.1;RT4: 2.9;T-47d: 3.3;U-937: 3.1	Not detected	Not detected			Low region specificity	Detected in many								Secreted in other tissues								unprognostic (7.72e-2)	unprognostic (8.49e-4)	unprognostic (1.42e-2)	unprognostic (2.23e-4)	unprognostic (6.70e-3)	unprognostic (3.01e-3)	unprognostic (5.75e-2)	unprognostic (6.63e-2)	unprognostic (5.61e-2)	unprognostic (1.45e-2)	prognostic unfavorable (6.47e-4)	unprognostic (1.59e-2)	unprognostic (5.93e-2)	unprognostic (7.05e-3)	unprognostic (4.17e-2)	unprognostic (9.02e-2)	unprognostic (9.70e-6)	0	0	0	0.8	0	0.2	1.9	0	0	0	0.1			0.1	0	0	1.5	0	0.3	0	0	0	0	0	0	0.3	0		0	0.8	0	0	0		0	0		0.1	0	0	30.1	0	0	0	0.1	2.2	0			0		0	0.1	0.5	0	0	0.2	1	0	0.1	0.1	2.1	0.1	0.4	0	0	0	0	0	0	0	0	0	6.9	0	0	0	0	2	0	0	0	0	0	0	0	0	0	3.9	0	0	0	0	0	0	0	0.1	0	0	0	0	0	3.3	0	6.1	0.3	0	0	0	0	2.9	0	0	0	0.7	0	0.3	3.3	0.6	0	0	0	0	0	0	0	0	0.1	3.1	0	0	0.8	0	0	1	0	0	0.1	0	0	0	0	0	0.2	0	0.1	0	0	0.1											0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	Suprabasal keratinocytes
DMRT2		ENSG00000173253	Doublesex and mab-3 related transcription factor 2	Q9Y5R5	9	1049858-1057552	Predicted intracellular proteins, Predicted membrane proteins, Transcription factors	Transcription, Transcription regulation	DNA-binding		Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in many		kidney: 27.3;lymphoid tissue: 18.4;parathyroid gland: 52.9	Cell type enriched	Detected in some	23	Distal tubular cells: 97.8	Cancer enhanced	Detected in many		renal cancer: 9.7	Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HaCaT: 3.9;RH-30: 5.3;RPMI-8226: 19.8;SCLC-21H: 3.1;SK-MEL-30: 5.4;THP-1: 3.8;WM-115: 3.8	Region enhanced	Detected in some		cerebral cortex: 1.8	Region enhanced	Detected in single		cerebral cortex: 2.3	HPA029297	Uncertain											HPA029297: AB_10600905	unprognostic (5.67e-2)	unprognostic (2.20e-3)	unprognostic (3.24e-2)	unprognostic (8.88e-2)	unprognostic (1.32e-1)	unprognostic (7.10e-2)		unprognostic (1.46e-1)	unprognostic (1.65e-1)	unprognostic (3.13e-1)	unprognostic (7.43e-2)	unprognostic (1.74e-1)	unprognostic (1.43e-3)	unprognostic (8.93e-2)	unprognostic (8.62e-2)	unprognostic (4.93e-2)	unprognostic (1.27e-3)	3.8	0.5	1.9	0.5	6.5	0.4	4.5	0.5	4.5	0.5	1.6	11	2.6	0.4	0.5	1.3	0.6	0.6	0.4	0.5	3.2	1.3	27.3	0.4	2.4	0.6	7	2.5	0.4	0.4	52.9	0.7	0.6	3.6	0.6	1.1	0	1.4	1.5	9	0.6	0.4	0.5	3	0.4	0.4	0.9	6.2	18.4	0.4	6.6	0.5	0.4	0.5	0	0	0	0	0	0.6	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0.1	0	0.6	3.9	0.9	0	0	0	0.5	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	1.1	0	0	0	0	5.3	19.8	0	0.9	3.1	0	0	0	5.4	0.3	0.1	3.8	0	0	0	0	0	0.8	0	0	1.1	0	3.8	0	0	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.9	6.5	0.5	4.5	3.2	1.3	7	2.5	3.6	6.2	0	0	0	0.4	0.5	0	0.4	0	0	0	0	0	0	97.8	0	2.8	0	0	0	0	0	0.2	0.1	0	0	0	0	0	0	0	0	0.6	0	3.3	0	0.7	0.3	0	2.3	0	0	1.7	0	0	4.2	1.5	0.1	0.1	0	1.5	0.1	Distal tubular cells
SLC2A14	GLUT14, SLC2A3P3	ENSG00000173262	Solute carrier family 2 member 14	Q8TDB8	12	7812512-7891148	Predicted intracellular proteins, Predicted membrane proteins, Transporters	Differentiation, Spermatogenesis, Sugar transport, Transport	Developmental protein		Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	7	testis: 52.4	Cell type enriched	Detected in many	7	Spermatocytes: 60.6	Cancer enriched	Detected in single	35	testis cancer: 7.1	Not detected	Not detected			Cell type enhanced	Detected in many		neutrophil: 6.9	Lineage enriched	Detected in many	4	granulocytes: 6.9	Cell line enhanced	Detected in some		BEWO: 12.6;CACO-2: 20.4;Hep G2: 5.3;SuSa: 25.2									HPA006539	Supported		Approved	Plasma membrane						Plasma membrane		HPA006539: AB_1078984	unprognostic (2.52e-1)	unprognostic (4.74e-3)	unprognostic (1.79e-1)	unprognostic (1.29e-1)	unprognostic (3.35e-2)	unprognostic (1.82e-3)	unprognostic (8.62e-2)	unprognostic (7.15e-2)	unprognostic (1.89e-1)	unprognostic (9.91e-3)	unprognostic (1.23e-1)	unprognostic (1.27e-1)	unprognostic (8.46e-4)	unprognostic (3.92e-2)	unprognostic (3.41e-1)	unprognostic (3.26e-2)	unprognostic (1.22e-2)	0.4	3.1	0.1	0.1	0.6	3	0.4	0.1	0.2	0.4	0.4	0.3	0.1	0	0.3	0.8	0.8	0.1	0.3	0.1	0.2	0.3	0.1	2	0.2	0.2	0.1	0.1	2.7	7.4	0	0.6	0.5	0.3	0.6	0.2	0.1	0.1	0.1	0.1	0.1	0.7	0.2	0.1	0.1	0	52.4	0.2	0.1	0.1	0.1	0.1	0.6	0.1	0.6	0.4	6.9	0.7	1.3	1.7	0.2	0	0.3	0.3	0.2	0.2	0.6	12.6	0	0	0	0.2	20.4	0.1	0	0.2	0	0	0.1	0	0	0	0.2	0	2.1	0.5	5.3	0	0	3	0	0.1	0	0	0.1	0	0.5	0.9	0.1	0	0.1	0.1	0.1	2.3	0	0	0.1	0.1	0.1	0	0.3	0.1	0	0	0.4	0	25.2	0	1.3	0.3	0.1	0.5	0.3	0.1	0.1	0.1	0.2	0.3	0	0.3	5.5	0.7	1.8	1	0.2	1.2	0.5	1	0.8	0.4	0.6	0.7	0.9	6.9	1.3	0.2	0.3	1.7	0.2	0.1	0.6	0.1	0.2	0.2	0.3	0.1	0.1	0.3	0.2	0	0.6	0	0	0.6	0	1.4	0	0	0	0	3.9	0.2	0	0	3.7	2.3	0	0	1.3	0.9	1.9	0	9.2	0.4	0.2	0	0	8	4.4	0.9	0.3	3.1	1.7	0	0	0	0.5	5.8	2.5	0	0.4	0	4.2	60.6	2.7	0.1	0.3	3.2	0	0	Spermatocytes
KCNK7	K2p7.1	ENSG00000173338	Potassium two pore domain channel subfamily K member 7	Q9Y2U2	11	65592855-65595996	Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels	Ion transport, Potassium transport, Transport	Ion channel, Potassium channel, Voltage-gated channel		Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in some		skin 1: 35.0;tongue: 20.7	Cell type enriched	Detected in some	5	Suprabasal keratinocytes: 90.7	Cancer enhanced	Detected in many		head and neck cancer: 4.4	Low region specificity	Detected in some			Group enriched	Detected in some	12	basophil: 4.8;naive B-cell: 2.9;neutrophil: 3.6	Group enriched	Detected in many	12	B-cells: 2.9;granulocytes: 4.8	Cell line enhanced	Detected in many		SCLC-21H: 12.4	Low region specificity	Detected in single			Not detected	Not detected			HPA077577			Approved	Plasma membrane						Plasma membrane		HPA077577: AB_2686845	unprognostic (1.12e-2)	unprognostic (1.21e-1)	unprognostic (6.08e-2)	unprognostic (5.71e-2)	unprognostic (8.59e-2)	unprognostic (1.34e-1)	unprognostic (1.68e-3)	unprognostic (8.53e-2)	unprognostic (1.69e-1)	unprognostic (2.87e-1)	unprognostic (6.90e-2)	unprognostic (4.88e-2)	unprognostic (1.49e-2)	unprognostic (2.65e-1)	unprognostic (3.57e-1)	unprognostic (1.16e-1)	unprognostic (8.11e-2)	0.6	0.6	0.8	0.3	0.7	3.9	2.6	1.6	2.1	1.4	0.5	0.8	0.3	0.4	0.4	0.3	10.8	0.6	0.3	0.5	0.8	0.4	0.3	0.3	0.3	0.3	0.6	1.1	0.6	0.3	0.1	0.3	0.5	0.4	0.3	0.1	0.3	0.8	0.4	1.8	35	0.5	0.3	0.7	0.5	0.3	0.3	0.5	0.7	0.3	20.7	5.7	0.3	3.4	2.9	0	4.8	0.2	0.2	0.3	0.1	0.5	2.3	0.1	0.7	0	0	0.2	0.3	0	0.5	0.1	0.3	1.7	0.8	0.7	0.2	0.4	3.8	0	0	0	0.8	2.6	0.8	1.2	1	0	0	0.6	0.1	0	0.2	0	0.4	0	1.6	1.4	2.2	0.7	1.7	0.9	0.7	1	1	2.2	1.6	0	0.4	1	0.2	12.4	2.8	0.5	0.7	1.2	0.1	0.7	2.2	0	0.6	1.9	1.9	0.1	2	1.3	0.5	1.4	1.1	1	4.8	0.2	0	0	0	0	0	0.3	0.2	0	2.9	0.1	0	3.6	0.2	0.2	0	0	0.1	0.8	0.7	1.6	2.1	0.8	0.4	0.6	1.1	0.4	0.5	0	0.3	0	0.4	16.9	2.3	0.1	0	1.4	0	0	0	0.1	0	0	0.6	0.5	0.3	0	0	0	0.2	0.3	0	0	0.4	0	1.2	0	1.5	1.3	0.6	0	3.3	0	0.3	0.2	0.1	2.8	0	0	0.8	6.5	1.9	0.1	0.5	90.7	0	0	0.5	1	Suprabasal keratinocytes
GLIPR1L1	MGC26856	ENSG00000173401	GLIPR1 like 1	Q6UWM5	12	75334639-75370560	Predicted intracellular proteins, Predicted secreted proteins	Fertilization			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	19	testis: 45.6	Cell type enriched	Detected in some	11	Early spermatids: 154.9	Not detected	Not detected			Not detected	Not detected			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enriched	Detected in some	7	NTERA-2: 50.2					Low region specificity	Detected in all			HPA042095	Enhanced				Secreted in male reproductive system							HPA042095: AB_10796898	unprognostic (2.45e-3)	unprognostic (1.56e-1)	unprognostic (4.40e-2)	unprognostic (1.72e-1)	unprognostic (7.47e-2)	unprognostic (3.04e-1)	unprognostic (2.70e-1)	unprognostic (4.79e-2)	unprognostic (3.01e-1)	unprognostic (2.89e-1)	unprognostic (7.90e-3)	unprognostic (1.08e-1)	unprognostic (9.13e-3)	unprognostic (1.02e-1)	unprognostic (1.65e-1)	unprognostic (2.00e-1)	unprognostic (2.11e-2)	0.1	0.7	0.1	0.1	0.1	0.1	0.1	0.4	0.8	0.1	0.1	0.1	0.1	0	0.3	0.1	0.5	0.1	0.5	0.9	0.1	0.1	0.3	0.1	0.2	0.2	0.1	0.1	0.5	0.1	0	0.3	0.1	0.3	0.1	0	0.1	0.4	0.1	0.2	0.8	0.1	0.1	0.1	0.2	0.2	45.6	0.1	0.1	0.2	0.1	0.1	0.1	0.1	2.4	1.5	0.4	1.7	0.5	1.5	0.4	0.2	0.3	0.4	0	0	0	0	0	0	0	0	0	0	0.3	0.3	0	0	0.1	0	0	0	0.5	0	0.1	0.1	0	0	0	0	0	0	0.1	0	0.4	0	0	0	0.1	0	0	0.2	0.2	50.2	0	0	0	0.1	0.1	0	0	0.4	0.2	0	0	0.1	7	0	0.1	0	0.2	0.1	0.1	0	0.2	0	0	0.4	0	0.2	0	0.2	0.4	1.5	0.4	0.8	1.3	1.1	0.3	0.2	2.4	0.5	0.9	0	0.5	1.7	1.5	0.6	0.4	0.1	0.1	0.4	0.8	0.1	0.1	0.1	0.1	0.3	0.1	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	154.9	0	0	0	0	0	0.2	0	0	0	0.1	0	0	0	0	14.3	4.9	0	0	0	0	0.3	0	0	2.5	0.1	0.3	6.5	0	12.1	1.8	0	0	0	0	0	Early spermatids
INSM1	IA-1, IA1	ENSG00000173404	INSM transcriptional repressor 1	Q01101	20	20368121-20370949	Predicted intracellular proteins, Transcription factors	Cell cycle, Differentiation, Neurogenesis, Transcription, Transcription regulation	Developmental protein, DNA-binding, Repressor		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		adrenal gland: 13.2;brain: 15.5;pituitary gland: 29.2	Cell type enriched	Detected in some	23	Intestinal endocrine cells: 486.9	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Cell type enriched	Detected in single	13	plasmacytoid DC: 1.3	Lineage enriched	Detected in single	13	dendritic cells: 1.3	Cell line enriched	Detected in some	20	SCLC-21H: 93.4	Low region specificity	Detected in some			Low region specificity	Detected in all																unprognostic (1.86e-2)	unprognostic (5.25e-4)	unprognostic (7.59e-2)	unprognostic (3.49e-2)	unprognostic (1.07e-1)	unprognostic (1.07e-3)		unprognostic (4.34e-2)	unprognostic (2.89e-2)	unprognostic (1.40e-1)	unprognostic (2.38e-3)	unprognostic (1.33e-1)	unprognostic (1.52e-1)	unprognostic (2.77e-1)	unprognostic (1.33e-1)	unprognostic (5.23e-1)	unprognostic (1.22e-1)	0.4	13.2	2.4	1.2	4.6	0.2	0.5	15.5	3.8	0.1	6.2	2.8	0.2	5.5	0.1	0.1	0.1	0.1	0.2	0.1	3.4	4.4	0.2	0.1	0.3	1.1	1.8	1.4	0.1	5.5	0.1	29.2	0.1	1	0.6	3.6	0	0.1	0.6	0.1	0.3	3.7	0.2	0.4	0.5	10.4	0.7	1.4	8.3	0.2	0	0.7	0.6	0	0	1.3	0	0	0	0	0	0	0	1.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0.3	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0.8	4.6	0	0	93.4	0	0	0	0	0.2	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.3	0	0	2.4	4.6	15.5	3.8	3.4	4.4	1.8	1.4	1	1.4	0	0	0	0	0.5	0	0.6	0	0	0	0	0	0	1.7	0	0	0	0.3	0	0	0	0	0.2	0	0	0.1	0	486.9	0	0	0	0	0	3.3	20.8	2.3	0	2.5	0.2	0	0	0	0	0	0.2	0.9	0	0	0	2.1	0	Intestinal endocrine cells
SAA1	PIG4, SAA, TP53I4	ENSG00000173432	Serum amyloid A1	P0DJI8	11	18266174-18269977	Disease related genes, Predicted secreted proteins	Acute phase	Heparin-binding	Amyloidosis	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	11	adipose tissue: 216.6;liver: 849.2	Cell type enriched	Detected in many	26	Hepatocytes: 59557.7	Cancer enriched	Detected in many	16	liver cancer: 1249.6	Not detected	Not detected			Group enriched	Detected in some	6	gdT-cell: 1.1;intermediate monocyte: 2.6;memory B-cell: 2.1	Group enriched	Detected in many	6	B-cells: 2.1;monocytes: 2.6;T-cells: 1.1	Cell line enriched	Detected in some	5	HBEC3-KT: 163.9														Secreted to blood			300000000	22000000000				unprognostic (2.86e-3)	unprognostic (1.41e-1)	unprognostic (2.82e-1)	unprognostic (1.50e-1)	unprognostic (4.54e-3)	unprognostic (1.79e-2)	unprognostic (1.63e-2)	unprognostic (7.04e-2)	unprognostic (1.54e-1)	unprognostic (1.08e-2)	unprognostic (8.95e-2)	unprognostic (1.90e-2)	prognostic unfavorable (4.57e-12)	unprognostic (5.15e-2)	unprognostic (9.78e-2)	unprognostic (9.23e-3)	unprognostic (1.64e-1)	216.6	4.3	0.8	17.4	0.8	0	31.9	0.8	0.8	28.5	3.2	0.8	0.8	0	0.8	1.1	1	1	2.9	1	0.8	0	1.1	849.2	1.7	2.4	0.8	0.8	0.8	4.7	0	1	0.9	0.8	1.1	0.3	0.8	50.3	1	11.5	1.2	1.2	1.5	0.8	0.8	0.6	0.8	0.8	1	1	1.1	1.1	1.1	1.3	2.1	0.3	0	2.6	0	1.1	0	11.1	0	0	0	8.1	0	4.4	0.3	0.2	0	0	0	3.9	0	9	0	3	10.5	0	163.9	0	0.1	0	0.1	0	0	35.7	0.2	0	14.5	19.5	0	18.9	0	0	0	0	0	2.3	0	0	0	0	0	0	0	0.4	0	6.6	0.2	0	0	0.9	1.2	0	0	0.1	0	0	0	1.2	0	0.3	0	0.2	0.3	0	0.1	0	0	0	0	1.1	2.6	0	2.1	0	0	0.3	0.1	0	0.3	0	0	0	0	0	0	0.8	0.8	0.8	0.8	0.8	0	0.8	0.8	0.8	0.8	6	3.2	650.1	44.2	8.2	0	0	1340.1	38.8	118.3	52.4	0	0.9	0	161.5	0	0	2.5	1565.2	69.5	20.1	0.8	164.4	2.3	59557.7	0.9	0	1.7	2316.5	1468.3	0	0	0.1	49	4.6	0	0	82.2	0	0	0	0	0	1	0	0	0.1	1.7	34.8	0	187.8	Hepatocytes
TMEM196	MGC42090	ENSG00000173452	Transmembrane protein 196	Q5HYL7	7	19719310-19773598	Predicted intracellular proteins, Predicted membrane proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in some		brain: 15.0;pituitary gland: 12.6	Cell type enriched	Detected in some	10	Bipolar cells: 51.1	Cancer enhanced	Detected in single		glioma: 0.6	Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	9	ASC diff: 8.8;ASC TERT1: 8.7	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA043163	Uncertain		Uncertain	Nucleoplasm,Golgi apparatus	Intracellular and membrane					Nucleoplasm, Golgi apparatus		HPA043163: AB_10794772					unprognostic (6.08e-3)					unprognostic (1.88e-2)	unprognostic (2.14e-2)		unprognostic (9.30e-2)	unprognostic (5.63e-2)				0.7	3.7	8	0.6	8.6	0.4	0.4	0.3	15	1.2	0.6	0.3	0	0.4	3.8	1.5	0.5	1.2	0.4	0.4	3.6	10.1	0.6	0.4	0.4	0.4	2.9	7.4	0.4	3	0.7	12.6	0.4	5	0.5	0.5	0.5	0.4	0.4	0.4	0.4	0.4	1	1.4	0.4	2.6	0.5	2.8	0	0.4	0	0.4	0.4	0.1	0	0	0	0	0	0	0	0	0	0.8	0	8.8	8.7	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.9	0	0	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	8	8.6	0.3	7.3	3.6	10.1	2.9	7.4	5	2.8	0	0	0	0	0	51.1	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	3.2	0	0	0	0	2.6	0	0	0	0	1.8	0.4	0	0	0	5.3	0	0	0	0	0	0	0	0	0	Bipolar cells
MST1	D3F15S2, DNF15S2, HGFL, MSP, NF15S2	ENSG00000173531	Macrophage stimulating 1		3	49683947-49689501	Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins			Cancer-related genes	Evidence at transcript level	Evidence at transcript level				Tissue enriched	Detected in many	8	liver: 117.0	Cell type enriched	Detected in many	7	Hepatocytes: 361.8	Cancer enriched	Detected in many	7	liver cancer: 42.6	Low region specificity	Detected in all			Cell type enhanced	Detected in some		gdT-cell: 1.1;memory B-cell: 1.2	Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		Hep G2: 42.3;NB-4: 8.6;U-266/70: 11.5	Not detected	Not detected			Low region specificity	Detected in all			HPA024036	Approved				Secreted to blood							HPA024036: AB_1854147	unprognostic (5.13e-3)	unprognostic (1.45e-1)	unprognostic (1.58e-1)	unprognostic (1.04e-1)	unprognostic (1.83e-1)	unprognostic (2.00e-2)	unprognostic (1.16e-2)	unprognostic (9.42e-3)	unprognostic (8.24e-2)	unprognostic (2.97e-1)	prognostic favorable (7.14e-4)	unprognostic (3.07e-2)	unprognostic (1.57e-2)	unprognostic (1.11e-1)	unprognostic (2.48e-1)	unprognostic (8.03e-2)	unprognostic (1.68e-3)	3.7	3.5	4	0.3	4.8	1.4	1	4.9	5.4	0.9	1.4	2.5	1.9	14.4	1.2	3.3	0.8	1.7	1.9	0.5	6.5	1.1	8.8	117	1.6	0.7	2	2.9	1.7	1.9	3.8	4.8	1.5	4.8	1.5	0.5	1.6	3.4	3.7	2.8	4	8.2	1.3	4.2	1.7	0.8	9.9	2.3	0.9	5	0.3	1.1	0.8	0.7	1.2	0.9	0	0.2	0	1.1	0.2	0.1	0.2	0.6	1	1.9	4.1	1.9	0.5	0.7	0.3	0.4	2	0.6	0.1	1.3	0.6	0.3	0.4	0.3	0.8	0.3	0.6	0.3	0.3	0.9	42.3	3.1	0	0.8	5.5	1.3	0.3	1.1	7.5	0.7	1.8	0.3	5.2	1	0.3	0.2	8.6	0.1	0.5	0.5	0.2	0.2	1.1	2.3	0.3	0.1	1.5	0	0.9	0.2	1.3	0.7	2.8	0.5	1	0.3	0	0.1	11.5	1.4	0.2	1.1	1.6	0.7	0	0	0	1.1	0	0	1.2	0	0	0.3	0.4	0	0	0	0	0.2	0.9	0	0.2	4	4.8	4.9	5.4	6.5	1.1	2	2.9	4.8	2.3	6	3.8	6	4.8	2.6	7.2	1.7	38.2	5.3	4.5	26.2	7.9	3.6	53	5.4	4.2	2.1	4.6	46.7	3.3	13.8	3.3	1.1	1.1	361.8	1.2	1.6	7.9	11.6	9.5	0.5	2.8	1.4	3.3	0	7.3	7.7	2.3	7	1.8	54.1	6.9	0	2	18.7	4.4	4.1	4.2	2.1	12.1	2.7	Hepatocytes
PC	PCB	ENSG00000173599	Pyruvate carboxylase	P11498	11	66848233-66958376	Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins	Gluconeogenesis, Lipid biosynthesis, Lipid metabolism	Ligase, Multifunctional enzyme	Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		adipose tissue: 41.1;liver: 76.0	Cell type enriched	Detected in many	5	Hepatocytes: 192.6	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Group enriched	Detected in many	5	dendritic cells: 2.6;monocytes: 3.8;T-cells: 2.9	Cell line enhanced	Detected in many		HeLa: 28.3	Low region specificity	Detected in all			Low region specificity	Detected in all			CAB033742, HPA043922, HPA058765	Enhanced		Enhanced	Mitochondria		Yes	No		96000	Mitochondria		CAB033742: AB_2283532, HPA043922: AB_2678732, HPA058765: AB_2683812	unprognostic (2.10e-1)	unprognostic (1.51e-1)	unprognostic (1.36e-2)	unprognostic (8.24e-3)	unprognostic (3.67e-1)	unprognostic (3.18e-2)	unprognostic (2.97e-1)	unprognostic (3.00e-1)	unprognostic (3.63e-1)	prognostic unfavorable (7.86e-5)	unprognostic (1.54e-1)	unprognostic (1.17e-1)	prognostic favorable (8.22e-5)	unprognostic (8.58e-3)	unprognostic (5.67e-2)	unprognostic (9.15e-3)	unprognostic (1.05e-1)	41.1	10.7	11.1	2.8	14.6	3.1	12.9	13.1	14.9	2.4	3.8	10.7	21.4	5.6	2.1	2.4	5	2.7	2.9	4	11.3	8.9	18.7	76	2.1	1.6	15.5	11.5	4.4	4.3	19.4	4	4.1	10.9	5.4	3.1	3.4	24.2	24.4	5.7	2.8	6.7	1.8	9.4	1.5	3.3	6.1	13.1	0.6	4.2	2.5	2.5	2.2	2.1	0.6	2.6	0	3.8	0.3	2.9	2	2.9	9.1	3.4	8.3	13.9	5.5	3.5	1.9	7.9	3.6	3.5	4.5	3.3	0	3.8	2.9	4.8	3.9	3.8	21	1.1	1.8	5.3	4.5	28.3	17.3	10.9	0	5.9	21	5.4	2.9	6.6	2.3	2.9	7.9	8.5	0	1.2	19.4	5.1	2.4	6.4	7.7	7.6	3.8	7	1.8	3.3	0.9	7.4	10.5	17.6	9.4	7.2	2.6	7.7	1.2	3.2	4	3.7	4.7	2.1	2	2.3	0	4.1	2.9	3.4	0	3.8	0	1.2	0.9	1.4	0.2	0.5	1.9	2.6	0.6	2.9	1.6	0	0.3	0.5	1	1.5	2	11.1	14.6	13.1	13.6	11.3	8.9	15.5	11.5	10.9	13.1	0	4.8	2.2	1.1	1.1	4.7	3.7	10.2	0	1.2	3.5	2	15.6	1.7	3.1	15.2	1.4	18.6	0	1.6	3.5	1.9	2.4	9.2	192.6	11.2	0	8.6	4.3	6.9	39.9	0.6	1.6	5	32.5	4.2	9.2	2.3	7	3.9	37.8	4.7	0	1.4	6	4.2	0.5	21.3	1.3	6	1.1	Hepatocytes
UGT2A1		ENSG00000173610	UDP glucuronosyltransferase family 2 member A1 complex locus	Q9Y4X1	4	69588417-69653249	Enzymes, Predicted intracellular proteins, Predicted membrane proteins	Olfaction, Sensory transduction	Glycosyltransferase, Transferase		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	6	kidney: 10.6;liver: 14.5;pituitary gland: 21.2	Cell type enriched	Detected in some	6	Proximal tubular cells: 32.3	Cancer enhanced	Detected in some		liver cancer: 0.7	Region enriched	Detected in single	17	pons and medulla: 1.7	Cell type enhanced	Detected in some		neutrophil: 2.0	Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		ASC diff: 3.2;HUVEC TERT2: 1.9;U-266/70: 3.6									HPA017261, HPA045108	Uncertain											HPA017261: AB_10963582, HPA045108: AB_2679218							unprognostic (3.93e-3)	unprognostic (5.62e-1)					unprognostic (1.28e-4)	unprognostic (1.74e-1)	unprognostic (2.76e-2)			0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	10.6	14.5	2.4	0	0	0	0	0	0	21.2	0	1.7	0	0	1.5	0	0.2	0	0.9	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.3	0.5	2	0.5	0.9	0.4	0	0	0	0.1	0	3.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0.1	0	0.1	0	0	0	0	0	0.9	0	0	0	1.9	0	0	0.2	0	0	0	0.1	0.4	0.3	0	0	0	0	0	0	0	0	0.3	0.1	0	0.9	0	0	0	0.1	0	0.1	0	3.6	0	0	0	0	0.2	1.7	0.5	0.4	0.2	0.2	0.1	0.1	0.4	0.2	0.1	0.3	0.2	0.1	2	0.9	0.2	0.5	0.1	0	0	0	0	0	0	0	0	0	1.7	0	0	0	0	0	0	0	0	2.5	0	0	3.5	0	0	5	0	0	0	0	0	0	0	0	0	0	3.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	32.3	0	0	0	0	0	0	0	0	0	0	Proximal tubular cells
HSPB7	cvHSP	ENSG00000173641	Heat shock protein family B (small) member 7	Q9UBY9	1	16014028-16019594	Predicted intracellular proteins	Stress response	Chaperone		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	8	heart muscle: 524.6;skeletal muscle: 551.1	Cell type enriched	Detected in many	48	Cardiomyocytes: 2261.8	Low cancer specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	4	fHDF/TERT166: 83.9	Not detected	Not detected			Not detected	Not detected			HPA027639	Approved		Approved	Nucleoplasm					43000	Nucleoplasm		HPA027639: AB_10601756	unprognostic (1.11e-1)	unprognostic (1.05e-1)	unprognostic (1.28e-3)	unprognostic (7.44e-3)	unprognostic (8.35e-2)	prognostic unfavorable (5.29e-4)	unprognostic (1.02e-1)	unprognostic (5.32e-2)	unprognostic (2.47e-3)	unprognostic (3.19e-3)	unprognostic (6.94e-2)	unprognostic (1.55e-1)	unprognostic (1.20e-2)	unprognostic (1.18e-2)	unprognostic (1.51e-2)	unprognostic (9.98e-2)	prognostic unfavorable (1.26e-4)	32.3	9.6	0.1	3.3	0.1	0.1	9	0.9	0.2	7	8.4	0.3	1.3	0.7	12.6	8	15.7	4.5	8.2	524.6	0.1	0	4.1	0.2	1.2	2.7	0.2	0.3	4.8	1	1.1	0.2	0.7	0.9	4.7	0.9	1.7	4.4	2.7	551.1	1	2.1	20.1	0.4	0.3	6.1	1.3	0	0	9.6	70.1	7.2	12	4.6	0	0.3	0	0	0	0	0	0	0	0	0.4	19.6	0.8	0.4	4.9	0.3	0	0	0	0	0	0	83.9	0	0	0	0	0	0	0.1	0	0.1	0	1.2	0	0	0.5	0	0	0	2	0	0	0	0	1.1	0	0	0.1	0	0	0	0	1	0.8	0	0	0	0.4	0	3	0	0.3	0	0.3	0	3.9	0.1	0.4	0	2.6	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0.1	0.1	0.9	0.2	0.1	0	0.2	0.3	0.9	0	0	0	0	0.1	2.9	0.2	2261.8	0	0	0	3.5	0	2.4	11.6	1.1	29.5	0.7	0	0	0.2	1.4	11.2	0.3	0	0	1.4	1.6	0	0	0	47.4	13.3	0.3	0	0	0	3	0	0	6.3	0	0.4	0	43.4	1.7	1	2.3	2.7	0	0	0.1	Cardiomyocytes
SPATA3	TSARG1	ENSG00000173699	Spermatogenesis associated 3	Q8NHX4	2	230990324-231025055	Predicted intracellular proteins, Predicted membrane proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	42	testis: 82.0	Cell type enriched	Detected in some	5	Late spermatids: 3891.5	Not detected	Not detected			Not detected	Not detected			Cell type enhanced	Detected in single		neutrophil: 1.5	Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		BEWO: 3.6;U-698: 1.7	Low region specificity	Detected in many			Region enriched	Detected in single	11	cerebellum: 11.0	HPA018254	Enhanced											HPA018254: AB_1857419					unprognostic (6.94e-3)									unprognostic (6.98e-2)	unprognostic (9.62e-2)			0	0	0	0	0	0	0	0	0.1	0	0	0	0.2	0	0	1.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	82	0	0	0	0	0	0	0	0.5	0.4	1.5	0.2	0.2	0.3	0	0.1	0.3	0.2	0.1	0	0.2	3.6	0.1	0	0	0	0.3	0.1	0.1	0.2	0.2	0	0	0.1	0.5	0.1	1.1	0	0.2	0.3	0	0	0	0.1	0.6	0	0	0.2	0.4	0.3	0.1	0	0.1	0	0.9	0	0.2	0.7	0	0.2	0	0.1	0	0	0.3	0.1	0.1	0.2	0.8	0	0.3	0.2	0	1.1	0.3	0.1	0.1	0	0	0	1.7	0.1	0.1	0	0.4	0.2	0.3	0.2	0.2	0.1	0.3	0.3	0	0.2	0.5	0	0	1.5	0.2	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	761.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3891.5	20.8	0	0	0	0	0	0	0	12.4	0	0	6.5	0	21.5	10.9	0	0	0	0	0	Late spermatids
PHOSPHO1		ENSG00000173868	Phosphoethanolamine/phosphocholine phosphatase	Q8TCT1	17	49223362-49230766	Enzymes, Predicted intracellular proteins	Mineral balance	Hydrolase		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	4	blood: 80.0;testis: 52.3	Cell type enriched	Detected in some	6	Late spermatids: 1098.7	Low cancer specificity	Detected in some			Group enriched	Detected in many	4	cerebral cortex: 10.2;pons and medulla: 8.2	Group enriched	Detected in some	171	eosinophil: 30.6;neutrophil: 80.0	Lineage enriched	Detected in single	248	granulocytes: 80.0	Cell line enhanced	Detected in some		Daudi: 8.6;EFO-21: 5.8;HDLM-2: 6.1;SuSa: 8.9	Low region specificity	Detected in all							HPA065025			Approved	Plasma membrane,Actin filaments						Actin filaments	Plasma membrane	HPA065025: AB_2732727	unprognostic (1.37e-1)	unprognostic (3.01e-3)	unprognostic (7.53e-2)	unprognostic (4.41e-3)	unprognostic (1.57e-1)	unprognostic (4.70e-2)	unprognostic (1.44e-1)	unprognostic (1.39e-2)	unprognostic (2.04e-1)	unprognostic (6.88e-2)	unprognostic (1.02e-2)	unprognostic (2.88e-1)	unprognostic (2.03e-1)	unprognostic (1.45e-1)	unprognostic (1.62e-1)	unprognostic (1.08e-1)	unprognostic (1.87e-1)	2.5	1.3	1.1	2.9	1.9	15.3	0.7	1	10.2	0.6	0.6	0.2	0.2	2.5	0.9	2.7	0.9	1.3	2.1	1	1.7	1.3	1	0.9	2.5	2	2.1	1.5	1.1	1	0.1	0.8	7.6	8.2	0.9	0	1.6	0.9	0.5	2.2	1.1	2.6	0.3	1.5	12.6	0.7	52.3	0.1	0	0.8	0.1	0.1	1.4	1.3	0	0	80	0.3	0	0	0.1	0	1.1	0	2	0.1	0.2	0	0.3	0.4	0	0.1	2.7	0	8.6	5.8	0	3.3	0	1.6	0.5	0.1	6.1	0.2	1.2	1.1	0.4	0	0	1.1	0.4	0	0.6	0	0.6	0	1.1	0	0	0.6	0.1	0	0.4	0	0.3	1.6	1.7	3.2	0	0.1	0	0	0	0.3	0.1	0	8.9	0.2	0.1	3.5	0.4	2.8	1.9	0	0.2	0.3	0.6	2.5	3.3	0.3	0	0.1	30.6	0	0.3	0	0	0	0	0	0	0	0	80	0	0.3	0	0	0.1	1.1	1.9	1	10.2	1.7	1.3	2.1	1.5	8.2	0.1	0	0	0	0	0.2	0.3	0.4	0	0	0	0	0	7.5	0	0	185.3	0.1	0	0	0	0.9	0.1	0	0	0	2.3	0	0	0.6	0	1098.7	7.2	0	0	0	0	0.2	0	0	5.6	0	0.4	0	0	8.2	3.8	0	198.7	0	0	0	Late spermatids
TCAP	CMD1N, LGMD2G, T-cap, TELE, telethonin	ENSG00000173991	Titin-cap	O15273	17	39664187-39666555	Disease related genes, Predicted intracellular proteins			Cardiomyopathy, Disease mutation, Limb-girdle muscular dystrophy	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	34	heart muscle: 298.7;skeletal muscle: 708.2;tongue: 249.2	Cell type enriched	Detected in many	230	Cardiomyocytes: 2189.2	Group enriched	Detected in many	8	head and neck cancer: 20.2;prostate cancer: 11.4	Not detected	Not detected			Cell type enriched	Detected in single	5	naive CD8 T-cell: 2.4	Lineage enriched	Detected in single	6	T-cells: 2.4	Cell line enhanced	Detected in many		NB-4: 7.0;SK-BR-3: 12.1	Region enhanced	Detected in many		cerebral cortex: 15.0	Not detected	Not detected			CAB004591, HPA026477	Enhanced								68000			CAB004591: AB_628340, HPA026477: AB_1857888	unprognostic (5.29e-2)	unprognostic (9.29e-2)	unprognostic (2.40e-3)	unprognostic (4.32e-3)	unprognostic (8.79e-2)	unprognostic (3.68e-2)	unprognostic (1.61e-1)	unprognostic (3.34e-1)	unprognostic (3.46e-1)	unprognostic (1.12e-2)	unprognostic (1.12e-4)	unprognostic (2.62e-1)	unprognostic (4.51e-2)	unprognostic (8.59e-2)	unprognostic (1.13e-1)	unprognostic (2.78e-1)	prognostic favorable (4.55e-4)	3.2	0.2	0.2	0.1	0.5	0.2	0.2	0.4	0.2	0.1	0.1	0	0.1	0.1	0.1	11.1	8.6	0.1	0.1	298.7	0.2	0.2	0.1	0.1	0.2	0.2	0.6	0	0.1	0.2	0.1	0.2	0.1	0	4.1	0.1	0	12.3	0.1	708.2	0.1	0.1	0.1	0.3	0.1	0.1	0.2	0	0	5.8	249.2	11.5	0.2	0.1	0.3	0	0	0.2	0.3	2.4	0.1	0.2	3.2	2.5	3.6	0.5	0.5	0.8	0.5	0.2	0.5	0.8	1.2	2.1	1.3	2.6	0.3	2.7	1.3	1.1	0.1	0.2	1.1	3.2	1.4	1.6	0.4	0.7	0.7	0.4	1	0.6	1	0.3	1.4	0.2	1.7	2.4	0.8	0.2	1.4	1	7	1.7	1.3	0.8	1.1	2.5	0.8	0.5	0.4	1.6	2.5	1.7	12.1	1.4	2.4	0.9	1.4	1.2	1	1.8	2.2	0.8	5.3	3	0.7	1.1	1.8	0.9	0	0	0	0.4	0	0	0.3	0	0	0	0.2	0.4	2.4	0	0.3	0.2	0	0	0.1	0.2	0.5	0.4	0.2	0.2	0.2	0.6	0	0	0	0	0	0.5	0.5	1.4	1.3	2189.2	2.5	0	0	1.8	0	0	1.7	0.2	0	1.9	0	0	0	0	0.5	0.8	0	0	0.4	9.5	2.9	1.3	1.2	0	0.3	0.6	1.7	0	1.5	0.6	0.4	0	0.4	0	1.1	6.5	1.9	0.9	0.7	1.8	0.3	0	1.1	0.7	Cardiomyocytes
FAM46D	CT1.26, CT112, MGC26999	ENSG00000174016	Family with sequence similarity 46 member D	Q8NEK8	X	80335504-80445311	Predicted intracellular proteins		Nucleotidyltransferase, Transferase		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	53	testis: 8.9	Cell type enriched	Detected in some	6	Early spermatids: 13.5	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	12	AN3-CA: 4.6;K-562: 2.5;U-2 OS: 1.8	Not detected	Not detected			Not detected	Not detected			HPA059362	Uncertain											HPA059362: AB_2683991	unprognostic (3.49e-1)			unprognostic (1.14e-2)					unprognostic (4.36e-1)	unprognostic (1.59e-1)		unprognostic (4.64e-1)		unprognostic (4.28e-2)	unprognostic (8.21e-3)	unprognostic (2.95e-3)		0	0.1	0	0	0	0	0	0	0	0	0			0	0	0.1	0	0	0	0	0	0	0	0	0	0	0		0	0	0	0	0		0.1	0		0	0	0	0	0	0	0	0	0	8.9			0.1		0	0	0	0	0	0	0	0	0	0	0	0	0	4.6	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.5	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	1.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.1	1.9	0	0	0	0	0	Early spermatids
MSRB3	DFNB74, DKFZp686C1178, FLJ36866	ENSG00000174099	Methionine sulfoxide reductase B3	Q8IXL7	12	65278643-65491430	Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins		Oxidoreductase	Deafness, Disease mutation, Non-syndromic deafness	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		smooth muscle: 75.9	Cell type enriched	Detected in many	16	Cardiomyocytes: 2030.9	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enhanced	Detected in some		eosinophil: 23.4	Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		fHDF/TERT166: 37.2;hTERT-RPE1: 33.8;U-937: 31.3	Low region specificity	Detected in all			Low region specificity	Detected in many			HPA014432	Enhanced				Intracellular and membrane							HPA014432: AB_1854146	unprognostic (1.40e-2)	prognostic unfavorable (3.84e-4)	unprognostic (2.86e-3)	unprognostic (1.94e-1)	unprognostic (2.74e-2)	unprognostic (1.74e-2)	unprognostic (2.63e-2)	unprognostic (1.23e-1)	unprognostic (1.84e-2)	unprognostic (5.33e-2)	unprognostic (8.28e-2)	unprognostic (2.10e-1)	prognostic unfavorable (8.85e-8)	unprognostic (3.29e-3)	unprognostic (7.80e-2)	unprognostic (2.08e-2)	prognostic unfavorable (2.17e-4)	15.2	3.8	4.5	11.6	5.3	6.4	26.8	5.1	5.2	19	39.4	3.6	20.4	4	40.3	15	23	16.1	23.4	30.9	4.8	4.3	4.1	1.4	11.7	4.4	5	5	13.3	2.5	0.8	3.1	8.7	4.7	19.8	10.2	11.8	4.7	38.4	32.2	3.8	10	75.9	5	6.5	17.2	6.1	4.8	0.4	6	11.2	2.5	33.9	20.9	0.2	6.5	23.4	0.6	4.4	0.1	0.8	2.5	5.6	4.9	22.8	22.2	19.7	0.1	25.8	27.8	10.1	6.1	0.2	0.3	0	5.6	37.2	3.2	0.5	2.3	6.5	9.2	0	4.7	0	5	0.2	14.5	13.5	0.1	10.3	3.6	8.5	11.9	33.8	20.4	0	0.1	0.1	23	0.8	0	3.1	1.6	0	3.1	0	6.7	0.1	2.3	0.3	0.1	2.4	8.9	0.5	6.3	5.3	4.2	13	23.4	12.9	7	5.8	10	2.4	1.8	0	3.5	31.3	8	6.3	0.3	23.4	0.1	0.6	0.1	0.1	0	0	0.1	0.2	0.1	0.1	4	4.4	0.2	6.5	0	0.8	4.5	5.3	5.1	5.2	4.8	4.3	5	5	4.7	4.8	11.9	4.3	0.5	13	5.7	20.7	2030.9	7.6	10.7	1.2	3.5	0	0.4	0	8.7	4.5	40.9	0	0	0.8	0.3	27.9	2.8	2.3	0	0.5	20.6	0	23.4	0	1.3	11.5	3.9	10.1	1	0	36.4	1.5	0	109.6	0.3	10.3	103.5	126	4.1	1.4	4	0.6	0	0	2.6	Cardiomyocytes
SNX31	MGC39715	ENSG00000174226	Sorting nexin 31	Q8N9S9	8	100572882-100663415	Predicted intracellular proteins, Transporters	Protein transport, Transport			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in many		lymphoid tissue: 21.4;prostate: 13.8;urinary bladder: 25.4;vagina: 16.0	Cell type enriched	Detected in some	5	Early spermatids: 73.9	Cancer enriched	Detected in many	22	urothelial cancer: 24.2	Not detected	Not detected			Cell type enhanced	Detected in some		neutrophil: 3.0	Low lineage specificity	Detected in many			Cell line enriched	Detected in single	50	RT4: 42.9	Region enriched	Detected in single	5	thalamus: 2.9	Region enhanced	Detected in single		olfactory region: 3.1	HPA024284, HPA053466	Uncertain		Approved	Nucleoplasm,Golgi apparatus,Cytosol						Nucleoplasm, Golgi apparatus	Cytosol	HPA024284: AB_1853894, HPA053466: AB_2682161	unprognostic (1.39e-1)	unprognostic (3.83e-2)	unprognostic (7.99e-2)	unprognostic (1.52e-1)	unprognostic (7.20e-5)	unprognostic (1.04e-1)	unprognostic (1.01e-2)	unprognostic (2.44e-2)	unprognostic (1.02e-1)	unprognostic (2.21e-1)	unprognostic (2.09e-2)	unprognostic (1.69e-1)	unprognostic (7.79e-3)	unprognostic (1.66e-1)	prognostic favorable (1.47e-4)	unprognostic (2.54e-1)	unprognostic (4.05e-2)	0.5	0	0.6	0.1	0.7	0.1	0.4	0.6	2.3	1.7	0.3	0.3	0.1	0.2	0.3	0.2	6.2	0.3	0.9	1.8	0.8	0.7	0.3	0.4	0.3	0.3	0.9	0.3	0.3	0.2	0.1	0.2	0.1	0.6	13.8	0.1	0.4	1.4	0.1	1	0.5	0.1	7.4	0.8	0.1	0.6	3.3	0.5	0.1	0.4	2.6	21.4	25.4	16	1.1	0.3	3	0.5	1.6	0.3	0	0	0	0	0.2	0.2	0	0	0	0	0	0	0	0	0.1	0.1	0	0	0	0	0	0	0	0	0.1	0.1	0	0	0.2	0	0	0.2	0	0.2	0.1	0	0.1	0	0	0	0	0	0.3	0	0	0	0	0	0	0	42.9	0.2	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0.2	0.8	0.1	2.5	0.5	0.2	0.3	0.2	0.1	1.1	0.1	0.2	0.2	0.5	0.1	0.3	3	1.6	0	0.3	0	0	0.6	0.7	0.6	0.3	0.8	0.7	0.9	0.3	0.6	0.5	0	0	0	3.6	0.3	0	0.3	0	0	0	0	0	0	1.7	0	73.9	0	0	0	0	0	0.2	0.5	0	0	0	0	0	0	0	15.4	0.6	0	0	0	0	0	0	0	1.1	0	0	0	1	0.4	0.4	0.4	0	0	0	1	Early spermatids
REP15	RAB15EP	ENSG00000174236	RAB15 effector protein	Q6BDI9	12	27696519-27697596	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	7	intestine: 27.2;stomach 1: 35.4	Cell type enriched	Detected in many	47	Mucus-secreting cells: 406.8	Low cancer specificity	Detected in some			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in many		SuSa: 15.6	Low region specificity	Detected in many							HPA040448, HPA059868	Approved											HPA040448: AB_10964206, HPA059868: AB_2684148	unprognostic (4.13e-2)	unprognostic (4.32e-3)	prognostic favorable (9.43e-5)	unprognostic (7.29e-2)	unprognostic (7.42e-5)	unprognostic (4.63e-2)	unprognostic (2.31e-1)	unprognostic (1.87e-3)	unprognostic (1.10e-1)	unprognostic (1.40e-1)	unprognostic (5.13e-3)	unprognostic (3.00e-1)	unprognostic (5.30e-2)	unprognostic (3.52e-1)	unprognostic (2.76e-1)	unprognostic (5.27e-5)	unprognostic (1.77e-1)	0.8	0.6	0.6	4.2	0.6	0	0.6	0.6	0.6	0.6	16.2	0.6	0.6	6	0.6	0.6	0.6	0.3	3.5	2.2	0.7	0.2	0.8	1.3	1	0.6	0.6	0.6	1.6	0.6	0	0.7	0.6	0.6	1.1	27.2	0.6	0.6	0.6	0.6	0.3	26.1	0.6	0.6	1.4	35.4	0.7	0.6	0.6	1	0.6	0.6	0.6	0.6	0.3	0	0	0.2	0	0.3	0.2	0.6	1.2	1.1	2.3	2.2	3.5	2	3.6	1.7	1.5	1.3	4.8	0.9	0.6	1.1	4.5	1.6	1.3	1.2	2.2	3.8	1.6	0.9	1.4	1.5	1.3	0.4	0.5	0.8	1.7	2.3	4.4	1.2	2.1	4.7	0.5	0.6	0.2	6.7	0.6	2.3	0.3	3.4	0.8	3.2	0.3	2.3	4.7	4.1	0.6	0.1	0.3	1.1	0.6	1.7	15.6	0.2	0.8	4.3	8.2	3.7	0.9	3.1	0	0	0	6	0.7	8.1	0	0.2	0	0.3	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0.2	0.6	0.6	0.6	0.6	0.7	0.2	0.6	0.6	0.6	0.6	3	0.3	0	1.9	1	0	0.3	2.5	0	0	0	0	0.5	0	0.6	0	2.9	7.3	0	0.4	0.6	1.1	1	0	0.5	0.1	0	8.7	7.4	0.8	0	0.3	0	1.7	0	406.8	0	0.4	7	0.7	1	0	0	0.5	0	0.2	0.3	1.1	0	8	2.2	Mucus-secreting cells
ATP2A2	ATP2B, DAR, SERCA2	ENSG00000174437	ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2	P16615	12	110280756-110351093	Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters	Calcium transport, Ion transport, Transport	Translocase	Disease mutation, Epilepsy	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in all	5	heart muscle: 188.3;skeletal muscle: 319.7	Cell type enriched	Detected in all	12	Cardiomyocytes: 1592.4	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Low cell line specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA062605	Enhanced								38000000			HPA062605: AB_2684805	unprognostic (4.81e-2)	unprognostic (2.16e-2)	unprognostic (1.87e-1)	unprognostic (3.41e-3)	unprognostic (2.50e-1)	unprognostic (3.98e-3)	unprognostic (1.91e-2)	unprognostic (6.20e-2)	unprognostic (4.69e-2)	unprognostic (2.42e-1)	unprognostic (1.20e-2)	unprognostic (1.00e-1)	unprognostic (3.47e-2)	unprognostic (1.36e-3)	unprognostic (2.26e-1)	unprognostic (5.62e-2)	unprognostic (9.93e-2)	8.4	8.8	7.3	8.5	14.5	5.7	7.5	7.4	20.8	8.2	9.6	8	8.3	7.3	9.4	10.3	24.1	9.4	9.3	188.3	10.1	5	6.7	11.8	8.9	5.6	5.6	13.1	8.5	7.6	8.7	6.1	8.1	10.2	13	11.2	22.3	18.3	9.6	319.7	9.3	9.3	14.3	7.4	5.4	7.9	11.9	7.1	3.1	12.6	51.3	12.7	13.4	11.4	0.8	2.2	0.2	4.4	1.7	1.7	0.7	35.5	70.9	35.9	28.8	23.9	30.6	51.8	44.3	55.8	45	30.3	51.2	37.9	43.9	37.5	42.1	34	52	59.4	70	51.2	36.3	29.7	38.3	28.4	29.9	40.6	43.7	37.1	32.1	49.4	57.1	55.4	43.3	34.7	23	44.6	21.5	36.6	34.1	23.6	27.1	40.9	36.5	35.9	24.9	32.3	36.2	22.2	73.4	38	28.5	55.8	45.8	25.9	34.2	61.6	23.6	37.2	41.7	22.4	27.7	33.8	44.2	53.8	49.2	38	18.9	47.2	0	1.9	0	1.7	4.4	0.9	0.7	1.3	1.1	1.9	0.8	1.3	1.2	0.2	1.7	2.3	2.2	1.2	0.7	7.3	14.5	7.4	20.8	10.1	5	5.6	13.1	10.2	7.1	41.7	53.9	23.1	78.3	101.7	60.4	1592.4	45.9	96.4	83	48.8	60.9	28	1.7	40.8	10.7	37.6	123.8	23.3	60.6	31.5	51.2	89.3	43.9	110.5	56	79.4	131.8	41.1	50.1	9	28.1	40.7	64.1	19	80.6	24	82.4	70.2	78.1	23.9	39	51.8	126	61.6	55.1	95.2	25.6	17	66.5	93.6	Cardiomyocytes
GOLGA6L2	CT105, FLJ36144	ENSG00000174450	Golgin A6 family-like 2	Q8N9W4	15	23439498-23447234	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in single	125	testis: 29.9	Cell type enriched	Detected in some	13	Early spermatids: 300.5	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	6	U-266/70: 18.6																							unprognostic (1.45e-1)	unprognostic (4.86e-2)	unprognostic (4.12e-1)	unprognostic (1.92e-2)	unprognostic (1.24e-1)								unprognostic (5.52e-2)	unprognostic (8.71e-2)			0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	29.9	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18.6	2.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.8	0	0	0	0	0	0	0	0	300.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	23.9	0.9	0	0	0	0	0	0	0	1.4	0	0	0	0	1	2.2	0	0.1	0	0	0	Early spermatids
VWC2L		ENSG00000174453	Von Willebrand factor C domain containing protein 2 like	B2RUY7	2	214411065-214578959	Predicted secreted proteins		Developmental protein		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	10	brain: 8.9;pituitary gland: 2.3	Cell type enriched	Detected in single	9	Bipolar cells: 3.4	Not detected	Not detected			Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in single		AF22: 1.1	Low region specificity	Detected in many			Low region specificity	Detected in many			HPA044815, HPA059414	Uncertain				Secreted - unknown location							HPA044815: AB_10962359, HPA059414: AB_2684007	unprognostic (8.77e-2)				unprognostic (2.83e-3)			unprognostic (2.05e-2)		unprognostic (8.49e-2)	unprognostic (1.51e-3)	unprognostic (4.36e-1)	unprognostic (2.56e-2)	unprognostic (2.05e-1)		unprognostic (3.89e-1)		0.3	0.3	1.9	0.3	3.2	0.3	0.3	0.2	8.9	0.3	0.3	0	0	0.3	0.3	0.5	0.3	0.4	0.3	0.3	2.4	6.6	0.3	0.3	0.5	0.3	3.9	2.9	0.3	0.3	0.3	2.3	0.3	6.6	0.4	0.3	0.1	0.3	0.4	0.5	0.4	0.3	0.3	1	0.3	0.4	0.5	0	0	0.3	0	0.3	0.3	0	0	0	0	0	0	0.2	0	0	0	1.1	0	0	0	0	0	0.3	0.3	0	0	0.1	0	0	0	0	0	0	0	0	0	0.2	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0.5	0	0	0.6	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	1.9	3.2	0.2	8.5	2.4	6.6	3.9	2.9	6.6	0	0	0	0	0	0	3.4	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Bipolar cells
CNTNAP2	Caspr2, KIAA0868, NRXN4	ENSG00000174469	Contactin associated protein like 2	Q9UHC6	7	146116002-148420998	Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins	Cell adhesion		Autism, Autism spectrum disorder, Epilepsy, Mental retardation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 25.8	Cell type enriched	Detected in many	32	Horizontal cells: 974.1	Cancer enhanced	Detected in many		prostate cancer: 10.0	Low region specificity	Detected in many			Group enriched	Detected in some	31	memory B-cell: 1.8;naive B-cell: 6.1	Lineage enriched	Detected in single	48	B-cells: 6.1	Group enriched	Detected in some	4	AF22: 7.5;CACO-2: 6.3;NTERA-2: 11.2;SCLC-21H: 20.2	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA002739	Enhanced											HPA002739: AB_1078545	unprognostic (2.49e-2)	unprognostic (1.49e-2)	unprognostic (4.05e-1)	unprognostic (3.08e-3)	unprognostic (1.77e-1)	unprognostic (2.29e-1)	unprognostic (2.51e-2)	unprognostic (1.45e-2)	unprognostic (1.18e-1)	unprognostic (2.19e-1)	unprognostic (3.67e-2)	unprognostic (2.68e-1)	unprognostic (1.41e-1)	unprognostic (1.78e-1)	unprognostic (1.37e-1)	unprognostic (2.33e-1)	unprognostic (1.00e-3)	0.9	2	14	1.2	16.6	0.9	2.2	4.4	25.8	0.7	2.3	1.2	0	0.7	0.9	0.7	1.4	2.2	0.8	1	9.6	6.4	1	3.5	0.8	1.6	7.5	16.2	1.7	1.1	0.7	2.7	1.9	17	8.7	1.6	2.5	0.9	1	0.7	0.8	2	0.8	18.1	1.7	1.2	1.4	0.5	2.4	1.5	0	1.3	0.8	0.5	6.1	0	0.1	0	0	0	0.2	0	0	7.5	1.5	0	0	2.6	0	0	0	0	6.3	0.1	0	0	0.2	0	1.8	1.6	0.5	0	0	0	0.5	0	0.2	0	0	0	0.1	2.7	0	0	0	0	0	0	0	0	0	0	0	11.2	1.3	0	0	0	2.1	0	0	20.2	1	0	0	0	0.3	0.8	0	0	0	0.1	0	0	0.1	0	0.7	0	0	0	0	0	0	0	0	0	1.8	0	0	0	6.1	0	0	0.1	0	0	0	0	0.2	14	16.6	4.4	25.8	9.6	6.4	7.5	16.2	17	0.5	0	0	2	0.2	0.1	29.8	1.1	12.7	0	0	0	2	30	0	0.9	5.7	0	1.3	0	0.6	2.5	0.6	7.2	0	8.9	2.7	974.1	2.4	0	1.2	2.1	1.1	0.4	0	0	3.6	7	3.6	2.5	0	0.5	13.9	0	0.2	1.9	1.5	0	5.3	0	6.5	0.1	Horizontal cells
LEP	OB, OBS	ENSG00000174697	Leptin	P41159	7	128241284-128257628	Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins			Cancer-related genes, Diabetes mellitus, Disease mutation, Obesity	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	15	adipose tissue: 85.2;breast: 63.7;placenta: 24.3	Cell type enriched	Detected in some	28	Syncytiotrophoblasts: 361.5	Cancer enhanced	Detected in some		breast cancer: 1.6	Not detected	Not detected			Cell type enriched	Detected in single	4	neutrophil: 3.8	Lineage enriched	Detected in single	7	granulocytes: 3.8	Group enriched	Detected in some	11	BEWO: 5.6;HSkMC: 2.3;SuSa: 7.1	Not detected	Not detected			Not detected	Not detected			CAB010490	Approved				Secreted to blood			17000000	26000000			CAB010490: AB_2296951	unprognostic (8.19e-3)	unprognostic (5.33e-1)	unprognostic (1.60e-4)	unprognostic (1.19e-1)	unprognostic (7.99e-3)	unprognostic (1.83e-1)		unprognostic (6.56e-3)	unprognostic (1.98e-2)	unprognostic (1.42e-2)	unprognostic (2.45e-2)	unprognostic (2.63e-1)	unprognostic (1.02e-3)	unprognostic (2.83e-1)	unprognostic (1.92e-1)	unprognostic (2.23e-2)	unprognostic (6.84e-2)	85.2	0.3	0	1.5	0	0	63.7	0	0	0	0.6	0	0	0	0	0.4	0	0	0.5	0.7	0	0	0.1	0	0.4	2	0	0	0.1	0.7	0	0	24.3	0	0	0.1	0	0.4	0	0.6	1.1	0.4	0.2	0	0	0.2	0.1	0	0	0	0.1	0	1.5	2.1	0.4	0.4	3.8	0.5	0.5	0.3	0.2	0	0.2	0.1	0.3	0.2	0	5.6	0.1	0	0	0	0	0.2	0.3	0.1	0	0	0.2	0	0	0	0.1	0	0.2	0.1	0	0	0	0.2	2.3	0	0	0	0.1	0	0	0	0.3	0	0.3	0.1	0.1	0.1	0	0.1	0.2	0.1	0.1	0	0.3	0.1	0.2	0.1	0.3	0.1	7.1	0.2	0.1	0	0.2	0.2	0.4	0.2	0.2	0.1	0.2	0.3	0.1	0.3	0.9	0.5	0.3	0.3	0.3	0.2	0.2	0.2	0.2	0.1	0.4	0.2	0.3	3.8	0.5	0.4	0.4	0.1	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0.1	0.9	0.2	0	0	0	0	0	0.4	0	0	0	0	0	0	0	13	0.2	0.1	0	0	5	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0.2	0.1	361.5	0	0	0.1	Syncytiotrophoblasts
PCP2	GPSM4, MGC41903	ENSG00000174788	Purkinje cell protein 2	Q8IVA1	19	7631611-7633748	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	5	brain: 45.5;retina: 20.2;testis: 80.7	Cell type enriched	Detected in many	5	Late spermatids: 3770.2	Low cancer specificity	Detected in many			Region enriched	Detected in some	14	cerebellum: 45.5	Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		HMC-1: 9.1;Karpas-707: 4.6;NB-4: 18.4	Region enriched	Detected in some	43	cerebellum: 2422.3	Region enriched	Detected in some	18	cerebellum: 135.0	HPA057428			Approved	Nuclear speckles,Vesicles		Yes				Nuclear speckles	Vesicles	HPA057428: AB_2683436	prognostic favorable (7.93e-4)	unprognostic (6.06e-2)	unprognostic (1.19e-2)	unprognostic (4.43e-2)	unprognostic (1.49e-1)	unprognostic (1.79e-4)	unprognostic (1.19e-1)	unprognostic (4.88e-5)	unprognostic (1.11e-1)	unprognostic (6.23e-2)	unprognostic (9.15e-3)	unprognostic (6.01e-2)	unprognostic (1.36e-2)	unprognostic (8.17e-2)	unprognostic (1.18e-1)	unprognostic (8.70e-2)	prognostic favorable (2.76e-5)	0.5	0.4	0.5	0.5	0.5	1.9	3.3	45.5	0.6	1	0.5	0.5	0.5	0.6	0.5	2	0.5	1.3	1.2	0.5	0.5	0	2.5	1	1.2	1.4	0.5	0.5	0.5	1.6	0.3	0.5	0.5	3.2	2	0	20.2	10.6	1	0.5	4.2	0.5	0.5	1.9	1.1	0.9	80.7	0.5	0.5	1.9	0.5	0.6	0.5	0.5	1	1.7	2.6	0.3	0.7	1.2	5.2	1.8	0.4	0	0.2	0	0	0.8	0	0	0	0	1.7	1.7	0.8	1.2	0	0	1.4	0	0.2	0	0.8	0.6	2.8	2.5	0.1	0	0.3	9.1	0	0.6	0	0	0	0	0.7	0.2	4.6	0	0.3	0.4	18.4	0.4	0.3	0	0.8	0.2	0.7	0.9	0.1	0.1	0	1.5	1.6	0	0.4	4	3.4	0.2	0	0.6	0.4	0.1	1.6	0.6	0.2	0	2.1	0	0	0.3	0	0.9	0.1	1.2	0.4	0.5	0.5	0.5	1	0.8	1	2.6	0.7	0	1.7	0.2	5.2	0.5	0.5	45.5	0.6	0.5	0	0.5	0.5	3.2	0.5	0	2.9	0	0.8	0.7	166.8	0	0	0	2.3	5.2	21.6	0.2	8.3	0.6	765.5	0	0.6	0	0.2	0	0	1.2	1.1	0	0.4	22.3	0	0	1.2	3770.2	9.8	1	1.7	1.8	0.2	24.5	0.5	0	12.4	0.3	79.8	19.4	0	11.1	6.4	1	0	1.5	0.5	0.6	Late spermatids
PDZK1	NHERF3, PDZD1	ENSG00000174827	PDZ domain containing 1	Q5T2W1	1	145670852-145708148	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		intestine: 49.2;kidney: 124.3	Cell type enriched	Detected in some	6	Proximal tubular cells: 758.4	Group enriched	Detected in many	12	breast cancer: 8.9;liver cancer: 27.6;renal cancer: 44.3	Region enriched	Detected in single	17	cerebellum: 10.0	Cell type enriched	Detected in many	4	NK-cell: 7.6	Lineage enriched	Detected in many	4	NK-cells: 7.6	Group enriched	Detected in some	4	RPTEC TERT1: 43.1;T-47d: 112.0	Low region specificity	Detected in some			Low region specificity	Detected in all			HPA005755, HPA006155, CAB008971	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol						Nucleoplasm, Vesicles	Cytosol	CAB008971: , HPA005755: AB_1855164, HPA006155: AB_1855163	unprognostic (4.56e-3)	unprognostic (3.07e-1)	unprognostic (8.79e-2)	unprognostic (4.41e-2)	unprognostic (9.15e-2)	unprognostic (2.09e-1)	unprognostic (2.18e-1)	unprognostic (3.42e-1)	unprognostic (2.08e-1)	unprognostic (3.27e-1)	unprognostic (2.34e-2)	unprognostic (9.87e-3)	prognostic favorable (2.54e-7)	unprognostic (9.90e-2)	unprognostic (3.02e-1)	unprognostic (1.00e-3)	unprognostic (8.87e-2)	0.1	0.6	0.2	0.2	0.3	0	5.8	10	0.2	0.3	16.5	0.2	0.8	13.2	0.3	6.7	0.1	0.1	10.6	0.1	0.2	0.2	124.3	25.7	0.4	0.1	0.3	0.2	0.2	4.2	0	0.1	0.9	0.5	0.1	1.3	1.2	0.1	0.1	0.1	0.7	49.2	0.1	0.4	0.2	0.4	0.3	0.1	0.2	0.1	0.1	0.1	0.1	0.1	1	1.1	0.5	0.2	7.6	1.8	0.5	1.3	0.2	0.1	0.1	0	0	0.5	0.2	0	0	0.1	18.9	0.1	0.1	0.2	1.1	0	0.6	0	0.1	0.1	1.8	0.3	0.1	0.4	7.8	0	0.1	0.1	0	0.1	0	0	0.1	0	0	0.1	0.3	0.1	1.1	0.1	0.2	0.2	0.2	0.5	0	1.3	0.2	43.1	0	0.1	1.2	0.3	0.3	0	1.2	112	0.1	0.1	0.2	0.2	0.1	0.1	1.6	0.1	0.1	0.1	0.1	0	0.5	0.2	0.1	1.5	0.2	0.6	1	0.4	1.8	0.2	1	0.4	0.7	0.4	7.6	0.1	1.1	0.1	0.5	0.2	0.3	10	0.2	0.2	0.2	0.3	0.2	0.5	0.1	0	0	0.9	0	0.1	0.4	0.4	61.1	0	0	54.1	0	0	117.7	1.7	8.9	0	18	0	1.6	0.1	0.2	0.1	0	45.6	0.2	0	6.3	1.8	1.2	5.2	0	0	0	0	0.5	0	1.8	2.9	0	758.4	0.3	0	0.3	0.2	0.2	0	0.1	0	1	0	Proximal tubular cells
ADGRE1	EMR1, TM7LN3	ENSG00000174837	Adhesion G protein-coupled receptor E1	Q14246	19	6887566-6940459	G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters	Adaptive immunity, Immunity	G-protein coupled receptor, Receptor, Transducer		Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	10	blood: 64.1;lymphoid tissue: 50.0	Cell type enriched	Detected in some	9	Kupffer cells: 25.9	Low cancer specificity	Detected in some			Low region specificity	Detected in many			Cell type enhanced	Detected in many		eosinophil: 64.1	Group enriched	Detected in many	17	granulocytes: 64.1;monocytes: 20.2	Cell line enhanced	Detected in some		A549: 5.8;BJ hTERT+: 7.9;GAMG: 8.3;HDLM-2: 19.2;HMC-1: 13.7;Karpas-707: 16.8	Low region specificity	Detected in many			Not detected	Not detected			HPA052809	Uncertain								9100			HPA052809: AB_2681959	unprognostic (2.06e-2)	unprognostic (3.45e-1)	unprognostic (1.32e-1)	unprognostic (7.88e-2)	unprognostic (1.02e-1)	unprognostic (6.93e-5)	unprognostic (6.77e-2)	unprognostic (1.18e-1)	unprognostic (5.75e-2)	unprognostic (1.09e-1)	unprognostic (2.55e-2)	unprognostic (1.26e-1)	unprognostic (1.37e-7)	unprognostic (6.69e-2)	unprognostic (3.33e-4)	unprognostic (1.11e-2)	unprognostic (1.35e-1)	1.8	0.5	0.7	7.2	2.4	5.9	0.5	0.3	1.7	0.5	0.6	0.3	0	2.8	0.4	0.9	0.4	0.6	0.7	1.3	1.5	0.7	0.7	4.1	4.6	6.6	1.7	0	0.3	0.4	0	1	1.8	0.9	0.5	0.5	0.5	0.5	0	0.4	0.3	2.8	1.7	1.9	50	0.7	1.2	1	6.9	0.5	0	1.7	2.8	0.4	0	2.4	64.1	20.2	0.1	2	1.9	2	5.8	0	0	0	0	0	0	7.9	0	0	0	0.1	0.1	0	0	8.3	0	0	0	0	19.2	0	0.1	0	0	0	0.4	13.7	0	0	0	0	0.3	0	0.7	0	16.8	0	0.1	0.5	1.9	0	0	0	0.1	0	0	0	0.5	0	0	0	0	0	0	0	1.5	0	0.3	0.2	0.3	0.1	0.9	3	0.1	3.9	3.7	0	27.2	4.3	64.1	0	12	0	0	1.5	0.2	2.4	0	2	0.1	1.6	0.1	20.2	0.1	0.4	1.9	0.7	2.4	0.3	1.7	1.5	0.7	1.7	0	0.9	1	3	0	0	0	0	0	1.2	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	1.8	0	0	1.8	25.9	0	0	1.6	0	0	0	0	0	0	0	0	0	0	0	0.5	0.7	0	0.1	0	0	0	Kupffer cells
DNAH12	DHC3, DLP12, DNAH12L, DNAH7L, Dnahc3, DNHD2, FLJ40427, FLJ44290, hdhc3, HL-19	ENSG00000174844	Dynein axonemal heavy chain 12	Q6ZR08	3	57293699-57544344	Cancer-related genes, Predicted intracellular proteins	Ubl conjugation pathway	Motor protein	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		brain: 23.0;fallopian tube: 16.7;lung: 17.5;testis: 17.6	Cell type enriched	Detected in some	6	Ciliated cells: 439.0	Cancer enhanced	Detected in single		endometrial cancer: 0.6	Region enriched	Detected in many	8	pons and medulla: 23.0	Cell type enhanced	Detected in single		NK-cell: 1.2	Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		CACO-2: 3.1;GAMG: 1.9;LHCN-M2: 2.1									HPA037493, HPA058203, HPA061365	Enhanced											HPA037493: AB_10671758, HPA058203: AB_2683637, HPA061365: AB_2684493	unprognostic (4.85e-2)	unprognostic (1.29e-2)	unprognostic (2.23e-1)	unprognostic (2.18e-3)	unprognostic (2.96e-2)	unprognostic (2.17e-1)	unprognostic (2.80e-2)	unprognostic (1.51e-3)	unprognostic (3.06e-2)	unprognostic (3.21e-1)	unprognostic (4.40e-2)	unprognostic (5.90e-2)	unprognostic (3.43e-5)	unprognostic (2.82e-2)	unprognostic (1.34e-1)	unprognostic (2.53e-2)	unprognostic (5.47e-2)	0.2	0.3	0.6	0.1	3	0.1	0.4	0.2	0.5	1.3	0.2	5.3	0	0.1	1.4	11.6	0.2	16.7	0.5	0.1	2.9	0.8	0.2	0.3	17.5	0.2	0.4	0	7.6	3.1	0.1	8.9	0.1	23	0.2	0.2	0	0.3	0.2	0.2	0.3	0.2	0.2	0.4	0.2	0.2	17.6	1	0	0.3	0	0.1	0.2	0.2	0.5	0.5	0	0	1.2	0.9	0.1	0.3	0.7	0	0	0.9	0.3	0.1	0	0.2	0.3	0	3.1	0.3	0.1	0	0.4	1.9	0.4	0	0.3	0.2	0.7	0.2	0	0	0	0.3	0.2	0	0.2	0.6	0.1	0.4	0.4	0.2	0.6	0.2	0.1	2.1	0	0	0.4	0	0.4	0.5	0	0.2	0	0.4	0	0	0.1	0	0.1	0.1	0.2	0	0.1	0.3	0	0.9	0.1	0	0.8	0.3	0.1	0	0	0	0	0	0	0	0	0.9	0.3	0.1	0	0	0.5	0.2	0	0	1.2	0	0.5	0	0.1	0.6	3	0.2	0.3	2.9	0.8	0.4	0	23	1	3	1.4	0	0.2	0	0.2	0.8	0	439	70.5	0	0	0.1	0	0.1	38.2	0	0	0	0	0	0.1	0.3	1.1	0	0.1	0	1.7	0	0	5.6	0.9	0	0	0	0	1.5	0.1	0	0.4	0.4	0	0	0	24.4	2.6	0	0	0	0	0	Ciliated cells
AMY1B	AMY1	ENSG00000174876	Amylase, alpha 1B (salivary)	P04745	1	103687415-103696680	Enzymes, Predicted secreted proteins	Carbohydrate metabolism	Glycosidase, Hydrolase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	13	salivary gland: 302.4	Cell type enriched	Detected in some	10	Ciliated cells: 34.8	Cancer enhanced	Detected in single		ovarian cancer: 0.5	Not detected	Not detected			Low cell type specificity	Detected in single			Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		NTERA-2: 1.2;SH-SY5Y: 2.1;U-266/70: 1.8									HPA045394, HPA045399, HPA046980	Supported				Secreted to digestive system				68000000			HPA045394: AB_2679311, HPA045399: AB_2679313, HPA046980: AB_2679889					unprognostic (7.34e-2)			unprognostic (2.59e-1)		unprognostic (6.05e-2)				unprognostic (6.08e-2)		unprognostic (1.96e-1)		0.2	0	0.2	0.2	0.2	0	0.2	0.2	0.2	6.5	0.2	0.2	0.2	0	0.2	0.2	0.2	4	0.2	0.2	0.2	0	0.2	0.2	0.7	0.2	0.2	0.2	0.2	23	0	0.2	0.2	0.2	0.2	0	0.2	302.4	0.2	0.2	0	0.2	0.2	0.2	0.2	0	0.4	0.2	0.2	1.1	0.2	0.2	0.2	0.2	0.1	0.3	0.3	0.6	0	1.1	0.7	0	0.3	0	0.1	0	0	0	0	0	0.1	0.1	0	0	0	0.1	0	0	0.7	0	0	0	0.2	0	0	0.5	0	0	0.1	0	0	0	0	0	0	0	0	0.3	0	0	0	0.3	0.5	1.2	0	0	0.7	0.1	0.4	0	0	0	2.1	0	0	0	0	0	0	0	0.2	0.3	0.2	0	1.8	0	0	0	0	0.1	0	0.3	0.3	0.2	0.6	0	0.1	1.1	0.1	0.3	0.1	0	0.7	0.2	0	0.5	0	0.1	0.7	0.2	0.2	0.2	0.2	0.2	0	0.2	0.2	0.2	0.2	3	3.2	0	0.1	0.2	0	0.7	0	34.8	3.4	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	Ciliated cells
CD164L2		ENSG00000174950	CD164 molecule like 2	Q6UWJ8	1	27379176-27383380	Predicted membrane proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in many		fallopian tube: 26.8	Cell type enriched	Detected in some	8	Ciliated cells: 62.9	Low cancer specificity	Detected in many			Low region specificity	Detected in single			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		CAPAN-2: 7.6;HaCaT: 3.6;HBEC3-KT: 3.9;hTCEpi: 5.4;SK-BR-3: 4.9;T-47d: 2.5	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA062915	Enhanced		Approved	Plasma membrane,Cytosol						Cytosol	Plasma membrane	HPA062915: AB_2684903	unprognostic (8.97e-3)	unprognostic (2.15e-2)	unprognostic (3.56e-2)	unprognostic (1.36e-2)	unprognostic (1.04e-1)	prognostic favorable (1.64e-5)		unprognostic (7.81e-3)	unprognostic (4.47e-2)	unprognostic (1.39e-1)	unprognostic (1.65e-2)	unprognostic (4.07e-2)	unprognostic (5.91e-6)	unprognostic (1.33e-2)	unprognostic (6.42e-2)	unprognostic (1.34e-2)	unprognostic (2.71e-2)	0.1	0.1	0.2	0.1	0.5	0	2.3	0.1	0.4	3.2	0.4	0.7	1.2	0	0.4	12.6	13.4	26.8	0.1	0.1	0.4	0.4	0.4	0.3	7.4	0.1	0.1	0.6	3.3	0.3	0.4	5.8	0.1	1.1	2.4	0.2	1	12.9	0.3	0.1	8.1	0.1	0.1	0.1	0.1	0.2	1	0.4	0.1	0.9	5.9	6	0.1	5.5	0	0	0	0	0	0.5	0	2.2	0	0	0	0	0	0	0	0	0	0	0	7.6	0	0	0	0	3.6	0	3.9	0	0	0	0	0	0	0	0	1.1	0	5.4	0	0.6	0	0	0	0.1	0	0	0.8	0	0	0.7	2	0.1	0	0	0.1	1	0	1	0	0	4.9	0	0	2.5	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0.2	0.5	0.1	0.4	0.4	0.4	0.1	0.6	1.1	0.4	0	3	0	8	2.6	0	0.6	0	62.9	4.5	0	0	0	0	0.1	0.1	0	0	0	0.2	0	0	3.2	0	0	0.1	0	0	0	0	1.3	0	0	1.7	0	0	0	0.4	0	0	0	0	0	0	0.1	1	2.5	0	0	0	3.1	Ciliated cells
CA5A	CA5, CAV, CAVA	ENSG00000174990	Carbonic anhydrase 5A	P35218	16	87881546-87936529	Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins		Lyase	Disease mutation	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	6	liver: 26.4	Cell type enriched	Detected in many	6	Hepatocytes: 35.0	Cancer enriched	Detected in single	26	liver cancer: 2.0					Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Cell line enhanced	Detected in some		Hep G2: 6.8	Low region specificity	Detected in many			Not detected	Not detected																unprognostic (1.91e-1)	unprognostic (8.64e-3)	unprognostic (3.36e-2)	unprognostic (6.11e-2)	unprognostic (2.49e-2)	unprognostic (2.96e-1)	unprognostic (8.39e-3)	unprognostic (3.50e-3)	unprognostic (1.42e-2)	unprognostic (1.12e-1)	unprognostic (6.55e-2)	unprognostic (4.23e-2)	unprognostic (7.99e-3)	unprognostic (1.77e-1)	unprognostic (5.03e-3)	unprognostic (3.37e-2)	unprognostic (2.76e-2)	0	0	0.3	0.8	0.4	2.7	0	0.1	0.7	0	0			0.1	0.1	0.6	0	0	0	0	0.4	0.3	0	26.4	0.2	0.3	0.4		0	0	0	0	0.1		0	0.1		0	0	0.3	0.7	0.1	0	0.3	0.8	0	0.3			0.1		0	0	0	1.9	1.6	4.7	1.1	1.9	1.1	0.4	0.2	0.3	0.3	0.7	0.1	0	0.5	0.4	0.1	0	0.1	0.5	0.6	0.6	0.2	0.2	0.3	0.6	0.2	0.3	0.1	0.4	0.3	0.4	1.1	6.8	0	0.4	1.7	0.8	0	0.2	0.4	0.5	0.3	0.5	0.4	1.6	0.1	0.5	0.2	1	0.5	0.3	0.6	0.4	0.4	0.2	0.2	0.6	0.4	0.2	0.2	0.3	0.1	0.5	0.6	0.3	0.4	0.8	0.2	0.5	0.3	0.7	0.4	0.4	0.6	0.9	0.4	4.1	1.1	1	0.8	0.7	0.8	0.9	0.8	0.6	0.3	1.9	1.1	1.1	4.7	1.9	0.7	1.6	0.5	0.4											0	4.3	0	2.5	0.3	1.7	1.4	0	2.7	2.3	1.8	3.9	0.3	0	0	0.2	0	0	0	0	0.2	0.4	1.4	5.8	35	0.1	3.2	0	1.3	0.6	0.8	0.3	1.9	0	0	0	0.9	0	0	1.1	0	2.6	0	0	0.3	0.6	0.3	0.2	0	0	1.3	Hepatocytes
ZG16	hZG16, JCLN, JCLN1, ZG16A	ENSG00000174992	Zymogen granule protein 16	O60844	16	29778240-29782973	Predicted secreted proteins	Protein transport, Transport			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	6	intestine: 84.6	Cell type enriched	Detected in some	11	Mucus-secreting cells: 6838.5	Cancer enriched	Detected in some	6	colorectal cancer: 21.7	Not detected	Not detected			Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		MCF7: 1.9;SK-BR-3: 7.0	Not detected	Not detected							HPA052066, HPA052512	Enhanced				Secreted to digestive system				250000			HPA052066: AB_2681716, HPA052512: AB_2681857	unprognostic (1.64e-2)	unprognostic (2.05e-1)	unprognostic (2.60e-3)	unprognostic (8.20e-2)		unprognostic (3.50e-2)	unprognostic (1.93e-2)	unprognostic (5.14e-2)		unprognostic (1.65e-1)	unprognostic (7.77e-2)	unprognostic (3.27e-1)		unprognostic (2.56e-2)	unprognostic (9.99e-2)	unprognostic (1.22e-1)	unprognostic (2.42e-1)	0.2	0	0.2	13.3	0.2	0	0.2	0.2	0.2	0.2	67.8	0.2	0.2	9.9	0.2	0.2	0.2	0.1	0.4	0.2	0.2	0	0.2	3.6	0.2	0.2	0.2	0.2	0.2	8.9	0	0.2	0.2	0.2	0.2	84.6	0.2	0.2	0.2	0.2	0	51.6	2.3	0.2	0.2	0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.7	0.2	0.4	0.7	1.1	1	0.1	0.8	0.2	0.1	0.1	0	0	1.2	0	0	0	0	1.2	0.1	0.1	0.2	0	0	1.1	0	0	0	0	0	0	0.3	0.4	0	0	0.2	0	0	0	0	0	0	0	0	0.1	0	1.9	0	1.3	0.1	0	0.1	0	0.1	0.7	0	0.3	0.2	0.4	0	7	0	0.1	0.4	0	0.1	0	0	0.7	0.2	0.1	0.1	0	0	0.1	0	0.4	0.7	0.1	0.5	0.3	0.6	0.3	0.6	0.5	0	0.7	0.9	1	0.4	1.1	0.3	0.2	0.5	0.1	0.2	0.2	0.2	0.2	0.2	0	0.2	0.2	0.2	0.2	0	0	1.4	0.2	0.2	0	0.3	0	0	0	0	0	0.2	0	0	0	0	602	0	10.5	0	0	0.2	41.3	24.1	0	0	139.9	0.6	0.6	0	0	0	0	0	6838.5	0	0.5	331.1	0	0	0	0	0	0	0	0	0.5	0	287.1	0.1	Mucus-secreting cells
SLC22A1	OCT1	ENSG00000175003	Solute carrier family 22 member 1	O15245	6	160121789-160158718	Predicted intracellular proteins, Predicted membrane proteins, Transporters	Ion transport, Transport			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	24	liver: 175.8	Cell type enriched	Detected in some	16	Hepatocytes: 709.2	Cancer enriched	Detected in some	81	liver cancer: 83.0	Not detected	Not detected			Cell type enriched	Detected in single	13	neutrophil: 7.3	Lineage enriched	Detected in single	13	granulocytes: 7.3	Low cell line specificity	Detected in many			Region enhanced	Detected in single		cerebral cortex: 0.7	Not detected	Not detected			HPA029846	Approved											HPA029846: AB_10603026	unprognostic (8.28e-2)	unprognostic (2.10e-1)	unprognostic (7.80e-2)	unprognostic (2.68e-1)	unprognostic (1.93e-1)	unprognostic (2.10e-2)	prognostic favorable (1.35e-5)	unprognostic (2.28e-1)	unprognostic (8.61e-2)	unprognostic (3.35e-1)	unprognostic (9.11e-2)	unprognostic (9.94e-2)	unprognostic (1.46e-7)	unprognostic (1.58e-1)	unprognostic (1.24e-1)	unprognostic (4.72e-2)	unprognostic (8.07e-4)	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0.1	0	0	0.2	0	0	0	0.1	175.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0.3	0	0.1	0	0	0.1	0	0	0	0	0.3	0.2	7.3	0.3	0	0.5	0	0	0.9	0.9	1.8	1.6	0.6	0.7	0.4	0.2	0.5	0.5	1.4	0.4	0.5	1	0.1	3.1	0.3	0	1.8	0.7	1.5	0.9	0.6	0.6	2.4	0	1.5	1.1	0	2	0	1	0.3	0.1	0.9	0.5	0.3	0.3	0.2	0	1.1	0	0.3	0.7	0	1.8	1.5	0.2	0.9	0.6	0	2.5	0	1.6	1.5	0.3	0.1	0	0.6	0.7	1.7	1.2	1.4	2.8	0.9	0.2	1	0.3	0	0.3	0	0.5	0	0	0	0.1	0.4	0	0.3	0	0.1	7.3	0	0	0.2	0.2	0	0	0	0	0.1	0	0	0	0	0	0	0	2.2	0	0.1	0	0	0.3	43.3	0	0	0	2	0	0	0.5	0.1	0	0	0	0.2	0	0.2	0.3	0	709.2	0.1	0	0	14.1	12.6	0	0.3	0	0	0	0	1	0.1	0	0.7	1.1	0	0	0.2	0	0	0.3	0.1	2.9	0	0.1	Hepatocytes
ZDHHC14	FLJ20984, NEW1CP	ENSG00000175048	Zinc finger DHHC-type containing 14	Q8IZN3	6	157381133-157678146	Enzymes, Predicted membrane proteins		Acyltransferase, Transferase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	5	Horizontal cells: 116.0	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enhanced	Detected in some		plasmacytoid DC: 4.2	Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		HDLM-2: 33.4	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA063754	Approved		Approved	Nucleoli,Mitochondria						Nucleoli	Mitochondria	HPA063754: AB_2685113	unprognostic (1.66e-2)	unprognostic (1.27e-2)	unprognostic (1.58e-2)	unprognostic (3.98e-2)	unprognostic (1.59e-1)	unprognostic (6.78e-3)	unprognostic (1.84e-1)	unprognostic (6.02e-2)	unprognostic (2.87e-2)	unprognostic (1.63e-1)	prognostic favorable (6.93e-4)	unprognostic (3.94e-2)	unprognostic (5.01e-3)	unprognostic (1.89e-1)	unprognostic (7.95e-2)	unprognostic (4.43e-1)	unprognostic (2.63e-1)	6.4	3.9	9	4.4	10.8	4.8	3.6	15.6	16.2	7.4	5.3	22.1	2.9	6.2	22.6	2.6	4.2	4.8	5.3	11.1	10.6	8.8	6.9	8.7	6.4	4.8	15.8	7.1	3.3	5.7	12.7	3.7	5.1	15.3	7.9	4	9.1	4.6	3.8	4.7	3.3	8.6	13.7	22	6.4	8.1	6.3	11.8	0.7	3.8	1.5	5.7	5.3	5	1.5	4.2	0	0.1	0.4	0.9	0.4	1.7	1.8	0.6	2.6	1.4	1.1	5.9	2.7	2.5	1.9	1.7	2.2	1.3	4.3	0.9	2.2	3.7	0.9	1.5	1.5	1.8	33.4	2.1	8.4	0.7	1	1.9	1.1	1.9	0.7	1.6	2	0.8	1.7	2.9	1.9	6.7	3.2	1.1	1.1	0.7	2.8	1.1	3.4	2.2	0.1	0.3	2.5	4	0.7	4.3	1.3	3.2	2.1	2.3	1.2	0.3	1.3	4	2.9	2.1	5.7	3.5	0.7	0.8	0.6	1	3	3.2	0	0.1	0	0.5	0	0.9	1.5	0.4	0.4	0	0.8	0	0.3	0	0.4	0	4.2	0	0.4	9	10.8	15.6	16.2	10.6	8.8	15.8	7.1	15.3	11.8	3	0	2.7	2.3	11.4	14.5	14.4	15.3	0	1.2	7	5.9	8.9	10	5.2	7.8	10.5	6.6	0	2.8	1.8	7.9	14.3	0	21.2	9.2	116	2.4	24.5	12.1	4	7.5	3.6	10.1	1.8	12.2	4.8	2.5	9.9	9.6	3.3	5.7	0	7.2	2.4	4.1	7.3	17.6	5	9.7	2.4	Horizontal cells
DES	CMD1I, CSM1, CSM2	ENSG00000175084	Desmin	P17661	2	219418377-219426739	Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins		Muscle protein	Cancer-related genes, Cardiomyopathy, Desmin-related myopathy, Disease mutation, Limb-girdle muscular dystrophy, Myofibrillar myopathy	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		heart muscle: 531.0;skeletal muscle: 600.8;smooth muscle: 439.9	Cell type enriched	Detected in many	12	Cardiomyocytes: 2379.6	Cancer enhanced	Detected in all		prostate cancer: 562.1	Not detected	Not detected			Group enriched	Detected in some	4	classical monocyte: 2.7;intermediate monocyte: 1.9;non-classical monocyte: 1.4	Lineage enriched	Detected in single	6	monocytes: 2.7	Cell line enhanced	Detected in some		HSkMC: 18.1;LHCN-M2: 36.0;NB-4: 9.4;RH-30: 83.8	Not detected	Not detected			Region enhanced	Detected in single		midbrain: 45.7	CAB000034, HPA018803	Enhanced		Supported	Intermediate filaments					1300000	Intermediate filaments		CAB000034: , HPA018803: AB_1847616	unprognostic (1.75e-1)	unprognostic (1.95e-3)	unprognostic (3.43e-2)	unprognostic (8.76e-2)	unprognostic (7.75e-3)	unprognostic (6.61e-3)	unprognostic (1.55e-1)	unprognostic (2.72e-2)	unprognostic (4.67e-1)	unprognostic (3.84e-2)	unprognostic (2.57e-1)	unprognostic (7.43e-2)	prognostic unfavorable (5.08e-4)	unprognostic (3.49e-2)	unprognostic (1.34e-1)	unprognostic (1.22e-1)	unprognostic (9.25e-3)	9.1	2.5	0.1	35.1	0.2	0.1	1.9	0.1	0.3	41.3	238.3	0.4	69.1	12.6	95.6	80.2	209.7	33	149.8	531	0.1	0.1	2.1	0.3	4.8	3	0.3	0.8	20.3	0.7	0	0.1	2.4	0.8	101	11.2	3.8	11.9	104.2	600.8	4.2	43.2	439.9	0.3	0.6	72.6	10.9	0	0	9.4	161.2	12.5	343.7	34.4	0	0.2	0.4	2.7	0	0	0.7	0	0	0	0	0	0.5	1.3	0	0	0	0	0.1	0	0	2.4	0.1	0	0	0	0	0	0	0	0	0	0	4.4	0	0.3	18.1	0	0	0	0	0	0	0.6	0	36	0	0	9.4	0.1	0	0	0	83.8	0.4	0	0	0	0.3	0	0	0	2.4	0	1.2	0	0	0	0.4	0	0	0	0	0	0.1	0	0	2.7	0	0	1.9	0	0	0	0	0.2	0	0	0	0.4	0	1.4	0	0	0.7	0.1	0.2	0.1	0.3	0.1	0.1	0.3	0.8	0.8	0	0	0	0	2.4	3.7	0	2379.6	0	0	0	0	0	2.2	0	0	70.8	4.5	0	0	0	3.6	31.7	3.6	0	0	4.8	0	0	0.6	0	43.3	26.7	0.4	11.8	0	0.5	0	0.8	0	47.4	0	0	45.3	204.9	1.8	1.7	8.5	7.1	0	0	0.4	Cardiomyocytes
RAG2		ENSG00000175097	Recombination activating 2	P55895	11	36575574-36598279	Disease related genes, Predicted intracellular proteins	DNA recombination	Chromatin regulator	Disease mutation, SCID	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in some	7	lymphoid tissue: 165.8	Cell type enriched	Detected in single	6	Early spermatids: 1.4	Cancer enriched	Detected in single	21	thyroid cancer: 1.0	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		JURKAT: 14.0;MOLT-4: 15.6;REH: 62.6	Not detected	Not detected			Low region specificity	Detected in many			HPA065704			Approved	Nucleoplasm						Nucleoplasm		HPA065704: AB_2732737				unprognostic (4.30e-2)					unprognostic (9.09e-2)	unprognostic (1.21e-1)		unprognostic (1.77e-1)	unprognostic (4.58e-2)	unprognostic (2.17e-1)	unprognostic (8.11e-2)	unprognostic (1.68e-3)		0	0.1	0	0	0	1.3	0	0.1	0.1	0.2	0	0	0.3	0	0	2.6	0	0	0	0.1	0	0	0.3	0	0	0.1	0.1	0	0.1	0.1	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	165.8	24.8	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14	0	0	0	0	15.6	0	0	0	0	62.6	0	0.2	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	Early spermatids
INHBC		ENSG00000175189	Inhibin beta C subunit	P55103	12	57434760-57450828	Plasma proteins, Predicted secreted proteins		Growth factor, Hormone		Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	256	liver: 121.3	Cell type enriched	Detected in some	4	Hepatocytes: 5.0	Cancer enriched	Detected in single	85	liver cancer: 22.1	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		Hep G2: 9.7;Karpas-707: 10.0;RH-30: 5.0;U-266/70: 5.1	Not detected	Not detected			Not detected	Not detected								Secreted to blood				11000000				unprognostic (5.26e-2)	unprognostic (4.58e-1)	unprognostic (3.43e-3)	unprognostic (4.08e-3)	unprognostic (3.76e-1)	unprognostic (1.98e-2)	unprognostic (1.03e-2)	unprognostic (1.10e-1)	unprognostic (1.34e-1)	unprognostic (1.23e-1)	unprognostic (6.10e-2)	unprognostic (2.48e-2)	unprognostic (1.68e-4)	unprognostic (2.90e-2)	unprognostic (1.52e-1)	unprognostic (3.55e-3)	unprognostic (5.05e-2)	0	0	0.1	0	0	0	0	0.2	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	121.3	0	0	0	0	0	0	0	0.1	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0.1	0	0	0	0	0	0.1	0	0	0.2	0.4	0	0.1	0.1	0.1	0.1	0	0	0.1	0	0.1	0.1	0	0.1	0	2.3	0.1	0	0	0.2	0.2	0.1	0.1	1.5	0.1	0.5	0	9.7	0	0.4	0.1	0.4	0	0	0.7	0	0	2.7	0.1	10	0	0.2	0.1	0	0	0	0.1	0.3	5	0.7	0	0	1.2	0.1	0.1	0	0	0	0	0	0	0	0.4	0	0	5.1	0.5	0.9	0	0.2	0.2	0	0	0	0	0	0	0	0	0	0.1	0	0	0.4	0	0.2	0	0	0	0	0.1	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	1.2	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	5	0	0	0	0.6	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	Hepatocytes
NPPA	ANP, PND	ENSG00000175206	Natriuretic peptide A	P01160	1	11845709-11848345	Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins		Hormone, Vasoactive, Vasodilator	Atrial fibrillation, Cardiomyopathy, Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	418	heart muscle: 1267.7	Cell type enriched	Detected in some	14450	Cardiomyocytes: 19644.9	Cancer enriched	Detected in some	9	glioma: 7.2	Not detected	Not detected			Cell type enhanced	Detected in single		memory B-cell: 1.3	Low lineage specificity	Detected in single			Cell line enhanced	Detected in many		SCLC-21H: 12.5;SH-SY5Y: 12.0	Region enriched	Detected in some	8	olfactory region: 28.1	Not detected	Not detected			HPA058269, HPA064007	Enhanced				Secreted to blood				190000			HPA058269: AB_2683660, HPA064007: 	unprognostic (1.27e-3)	unprognostic (3.12e-2)	unprognostic (2.15e-1)	unprognostic (1.30e-1)	unprognostic (1.94e-1)	unprognostic (1.95e-1)	unprognostic (2.02e-1)	unprognostic (2.01e-1)	unprognostic (1.48e-1)	unprognostic (3.25e-2)	unprognostic (9.72e-3)	unprognostic (2.21e-1)	unprognostic (5.93e-4)	unprognostic (2.31e-1)	unprognostic (1.59e-1)	unprognostic (1.20e-1)	unprognostic (6.70e-2)	0.1	0	0.1	0.1	0.1	0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0	0.1	0.3	0.1	0	0.1	1267.7	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.2	1.7	0	0.1	0.1	0.1	0.1	0	0.1	0.6	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.3	0	0.3	0.8	0	0.5	3	1.1	1.7	2.6	2.1	0	0	1.6	0.9	0	0	0	6.7	2.7	4.3	0.3	0	1.5	4	0	0	0	1	2.6	2.7	1.5	6.6	0	1.4	4.6	0	0	0	0	0.6	0	1.2	5.9	5.1	0	0.9	0.5	7.7	1.9	0.1	0.7	0.6	0.8	0.8	0	1.8	12.5	12	0.7	0	2.2	1.2	1.6	0.2	0.4	2.1	4.3	3.4	0.3	1.3	3.2	4.9	0.3	3.5	1.1	0	0.4	0	0.1	0.8	0.4	1.3	0	0	0	0	0.1	0.5	0.3	0	0.5	0	0	3	0.1	0.1	0.1	0.2	0.1	0	0.1	0.1	0.1	0.1	0	0	0	0	0	0	19644.9	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.4	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	Cardiomyocytes
C1orf127	FLJ37118	ENSG00000175262	Chromosome 1 open reading frame 127		1	10946471-10982037	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level				Tissue enhanced	Detected in some		pancreas: 5.1;skeletal muscle: 17.3	Cell type enriched	Detected in some	11	Intestinal endocrine cells: 19.5	Cancer enriched	Detected in single	9	pancreatic cancer: 2.8					Group enriched	Detected in some	4	classical monocyte: 1.7;myeloid DC: 4.2	Group enriched	Detected in many	30	dendritic cells: 4.2;monocytes: 1.7	Cell line enriched	Detected in some	4	THP-1: 7.6									HPA027654	Uncertain		Approved	Nuclear speckles,Cytosol						Nuclear speckles, Cytosol		HPA027654: AB_10611814	unprognostic (1.82e-2)	unprognostic (8.57e-2)	unprognostic (1.62e-2)	unprognostic (1.05e-1)	unprognostic (1.17e-2)	unprognostic (2.03e-2)	unprognostic (3.81e-2)	unprognostic (1.32e-2)	unprognostic (9.93e-2)	unprognostic (1.21e-1)	unprognostic (1.82e-2)	unprognostic (8.47e-2)	unprognostic (1.59e-2)	unprognostic (3.31e-1)	unprognostic (1.34e-1)	unprognostic (1.04e-1)	unprognostic (4.03e-1)	0.1	0.6	0	0	0.4	0	0	3.3	0	0	0.2			0.6	0	0	0.5	0	0.2	0.4	0	0.1	0	0	0.3	0.5	0.8		0	5.1	0	0.2	0.1		0	0.5		0.2	0	17.3	0	0.2	0	0.1	0.5	2.5	0.6			0.1		0	0	0	0	4.2	0	1.7	0	0	0.2	0	0	0.1	0	0.1	0	0	0	0	0	0	0.2	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0.4	0	0	0	0.5	0.4	0	0	0	0	0	0	0	0.6	0.1	0	1.4	0.5	0	0	7.6	0	0	0.3	0	0	0	0.3	0	0	1.7	0	0	1.7	0	0	0.6	0	0	0	0	4.2	0	0	0	0	0	0	0.6	0	0.2											0	1	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.8	0	19.5	0	0.3	0	0	0.1	0	0	0	0	0.9	0	0	0	0	0	0	0.2	1.4	0	0	0	0	0	Intestinal endocrine cells
TP53I11	PIG11	ENSG00000175274	Tumor protein p53 inducible protein 11	O14683	11	44885903-44951306	Predicted intracellular proteins, Predicted membrane proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	4	Late spermatids: 322.1	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enhanced	Detected in many		neutrophil: 23.7	Low lineage specificity	Detected in all			Cell line enhanced	Detected in many		SCLC-21H: 85.0;T-47d: 47.9	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA059727, HPA061276	Uncertain		Supported	Endoplasmic reticulum,Golgi apparatus						Endoplasmic reticulum, Golgi apparatus		HPA059727: AB_2684113, HPA061276: AB_2684461	prognostic unfavorable (7.33e-5)	unprognostic (1.87e-1)	unprognostic (4.03e-2)	unprognostic (3.44e-1)	unprognostic (1.38e-1)	unprognostic (2.66e-1)	unprognostic (1.26e-1)	unprognostic (1.50e-1)	prognostic unfavorable (6.12e-4)	unprognostic (6.55e-2)	unprognostic (2.55e-1)	unprognostic (1.92e-1)	prognostic unfavorable (4.65e-4)	unprognostic (2.14e-2)	unprognostic (1.64e-1)	unprognostic (2.09e-1)	unprognostic (1.10e-1)	33.3	8	20	13.3	10.7	19	27.6	36	26.2	14.7	21.1	8.6	17.6	13.6	16.8	10.4	15.6	21.5	28.5	33.1	8.4	12.3	12.5	7.8	21.4	12.8	5.8	8.6	18.2	18.5	3	9.5	16.6	14.1	20.6	19.4	17.6	18.9	11.9	12.6	14.5	21.1	23.5	7.4	28.2	18.4	9.9	5.5	6.7	18.9	12.7	14.9	15.1	19.1	5.2	14.1	23.7	11.1	4.6	4.4	2.1	0	17.7	6	8.6	6.5	0.5	0.1	5.7	11.1	2	2.6	1	0.1	3	4.9	1.5	4.8	3.4	3.4	0.1	0.7	6.5	3.5	0.2	0.2	0	12	0.1	23.9	27.7	0.4	2.8	1.2	0.4	6.6	6.9	0.4	0	2.5	15.1	0.3	27.8	11.1	11	5.9	13.5	3.7	1.4	0	1.1	85	3.1	9.9	21.6	0	7.7	47.9	1.7	1.6	13.3	9.4	20.4	0	0.1	0	0	0	1.7	3.7	0	3.1	0	3.1	3.2	4.4	4.9	0.6	3.2	2.6	5.2	0	1.1	23.7	4.6	11.1	14.1	0.5	2.1	20	10.7	36	26.2	8.4	12.3	5.8	8.6	14.1	5.5	20.8	25.7	5.4	31.5	9.6	0.6	6.7	22.9	9.4	14.8	40.1	0	47	1.7	26	74.9	13.5	12.7	0	18.6	15.1	11.8	25.6	0	0.9	32	0	34.5	80.4	10.5	322.1	11.2	9.6	10.1	13.6	24.2	0.5	28.8	7	7.1	0	0.9	12.9	12.6	2.1	6	3.9	57.1	4.4	45.7	36	Late spermatids
CCNE2	CYCE2	ENSG00000175305	Cyclin E2	O96020	8	94879770-94896678	Cancer-related genes, Predicted intracellular proteins	Cell cycle, Cell division	Cyclin	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		bone marrow: 24.2;brain: 22.2;testis: 18.9	Cell type enriched	Detected in many	6	Spermatocytes: 50.4	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Cell type enhanced	Detected in many		T-reg: 8.8	Group enriched	Detected in many	4	NK-cells: 2.2;T-cells: 8.8	Cell line enhanced	Detected in many		Karpas-707: 39.7	Low region specificity	Detected in all			Low region specificity	Detected in all			CAB007825, CAB019374	Enhanced						Yes					CAB007825: AB_598148, CAB019374: 	unprognostic (1.80e-2)	unprognostic (4.81e-2)	unprognostic (7.49e-2)	unprognostic (2.08e-2)	unprognostic (2.36e-1)	prognostic favorable (5.87e-4)	unprognostic (8.37e-4)	prognostic unfavorable (8.77e-4)	unprognostic (3.18e-2)	unprognostic (2.19e-2)	unprognostic (3.64e-2)	unprognostic (1.04e-2)	unprognostic (7.01e-12)	unprognostic (1.81e-2)	unprognostic (1.50e-1)	unprognostic (1.06e-2)	unprognostic (3.03e-1)	1.3	0.9	3.1	4.9	11.3	24.2	1.5	3.3	6.3	1.7	4	10.4	0	2.6	1.3	0.1	3.6	1	1.7	0.9	5.7	3.5	0.9	1.6	1.7	7.9	8	6.5	1.4	2.3	0.5	1.1	3.1	11.8	1.3	4.3	0.6	1.5	0	0.8	4.4	3.1	1.4	22.2	1.9	2.9	18.9	4.9	12.7	1.1	2.4	7	1.9	1.9	1.1	1.3	1.1	0.3	2.2	8.8	1.1	17.9	2.4	9.6	5.9	1.2	2.2	6.6	18.5	6.4	11.6	11.5	4.3	8.1	9.4	12.6	7.8	3.6	9.5	7.4	6.7	15.8	6.6	6.8	19	10.1	1.6	0.1	7.6	11.6	0.6	0.4	8.4	0.8	2.5	5.9	11.7	8.1	39.7	16.5	5.2	29	3.5	3.2	14.4	5.5	20.7	16.5	4.5	3.2	10.1	13.9	5.8	12.4	3.3	2.3	1.2	16.7	8	5	12.4	8.1	9.1	16.5	7.6	7.9	22.9	10	13.9	9	0	0.3	0.2	1.6	0.3	0.5	0.7	2	2.3	1.3	1.1	0.6	1.3	1.1	2.2	0.3	0.1	8.8	1.1	3.1	11.3	3.3	5.7	5.7	3.5	8	6.5	11.8	4.9	6	1.7	0	0.8	3.8	2	1.7	0	1.4	2.3	1.8	5.9	2.6	0	0.2	5.6	2.1	8.2	0	0.2	7	1.1	1	0	0.9	3.8	7.9	0	3.1	2.7	6.1	1.1	1.7	0	0	2.4	1	0.1	0.6	0.4	0	4.2	6.5	2.1	50.4	5	3.3	1.6	6.9	1.7	0.4	Spermatocytes
APOF		ENSG00000175336	Apolipoprotein F	Q13790	12	56360569-56362823	Plasma proteins, Predicted secreted proteins	Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	53	liver: 114.0	Cell type enriched	Detected in some	42	Hepatocytes: 377.1	Cancer enriched	Detected in some	6	liver cancer: 34.8	Not detected	Not detected			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enriched	Detected in some	10	Hep G2: 9.9	Not detected	Not detected												Secreted to blood			18000000000	4000000000				unprognostic (3.55e-2)	unprognostic (1.13e-1)	unprognostic (1.48e-2)	unprognostic (8.99e-3)	unprognostic (9.84e-2)	unprognostic (3.29e-2)	unprognostic (2.08e-3)	unprognostic (7.84e-2)	unprognostic (4.22e-1)	unprognostic (5.69e-2)	unprognostic (2.68e-3)	unprognostic (8.55e-2)	unprognostic (2.42e-2)	unprognostic (2.77e-1)	unprognostic (5.57e-2)	unprognostic (2.87e-1)	unprognostic (4.43e-2)	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	114	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0.3	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	2.1	0.9	1.8	0.5	1.1	1.4	0.1	0.2	0.3	0.1	0.3	0	0	0.1	0	0	0	0	0.2	0.5	0.7	0.1	0	0	0.5	0	0	0	0.3	0.3	0.7	1	9.9	0	0.9	0.3	0.2	0	0.1	0.1	0.1	0	0.5	0.6	0.4	0.1	0.3	0.2	0.1	0.6	0.1	0.4	0.3	0.5	0.6	0.5	0.4	0.3	0.1	0.4	0.4	0.1	0.2	0.2	0	0	0.1	0.1	0.3	0	0.8	0.4	0.5	0.2	0.4	0.4	1.8	0.5	0.3	0.5	0.2	0.8	1.6	0.7	0.6	0.1	2.1	1.4	1.1	1.3	1.1	0.4	0.9	0.7	0.1	0	0	0	0	0	0	0	0	0	0	0	0	7	0.2	0	0	0.2	7.6	0	0	0	2	0	0	0	0	0	0.1	0	0.2	0	0	0.9	0	377.1	0	0	0	4.9	9.1	0	0	0	0	0	0	0	0	0	0	0	0.8	0	0	0	0	0.1	0	0	0	0.1	Hepatocytes
PCSK1	NEC1, PC1, PC3, SPC3	ENSG00000175426	Proprotein convertase subtilisin/kexin type 1	P29120	5	96390415-96434143	Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins		Hydrolase, Protease, Serine protease	Disease mutation, Obesity	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 36.6	Cell type enriched	Detected in some	39	Intestinal endocrine cells: 215.9	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Cell type enhanced	Detected in single		basophil: 1.8	Lineage enhanced	Detected in single		granulocytes: 1.8	Group enriched	Detected in some	5	SCLC-21H: 19.0;U-138 MG: 16.1;U-87 MG: 13.4	Low region specificity	Detected in all			Low region specificity	Detected in many			HPA048564, HPA079656	Approved				Secreted in other tissues							HPA048564: AB_2680444, HPA079656: 	unprognostic (1.86e-2)	unprognostic (2.13e-2)	unprognostic (4.66e-3)	unprognostic (8.20e-5)	prognostic unfavorable (9.13e-5)	unprognostic (8.47e-4)	unprognostic (1.46e-1)	unprognostic (5.84e-3)	unprognostic (4.71e-1)	unprognostic (3.07e-3)	unprognostic (1.89e-3)	unprognostic (1.01e-1)	unprognostic (7.90e-6)	unprognostic (5.25e-2)	unprognostic (9.96e-2)	unprognostic (1.33e-3)	unprognostic (9.37e-3)	2.3	8.5	1.3	6	10.1	0.5	1.3	0.5	36.6	1.2	3.3	0.5	0	6.7	0.5	8.8	0.4	0.4	0.6	1	2.8	27.1	0.5	0.4	0.8	0.4	3.1	14	0.6	9.8	0.3	10.9	0.4	7.5	0.5	3.3	0.1	2.8	0.5	0.5	1.7	4.6	1	1.3	0.5	8.4	0.5	0.4	0	1.9	0	0.3	0.9	0.6	0	0	1.8	0.5	0	0	0	0	0	0.3	0	2	0.6	0	0.2	0.1	0	0	0	0	0	0.1	0.8	3.2	0	0	0	0	0	0	0.6	2.1	0	0	0	0	1.7	0.9	0.3	0.1	0.1	0.8	0	0	0.1	0.2	0	0	0	0.2	0	0	0	0	0	0	0	19	0	2.7	0	0	0.4	0	0	1	16.1	0.5	0.2	0.1	0	0	0.1	13.4	0	0.3	1.8	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.3	10.1	0.5	36.6	2.8	27.1	3.1	14	7.5	0.4	0	0	0	0.1	0	5.5	0.6	0	0	0	0	2	0	0	0	0.2	0	0	0	0	0	0	0.2	0	0	0	0	215.9	0.6	0	0.4	0	0	0	0	0.6	0.1	2.4	0	0	0	0.7	0	0.7	0	0	0	0.1	0	0.2	0	Intestinal endocrine cells
RFESD		ENSG00000175449	Rieske Fe-S domain containing	Q8TAC1	5	95646754-95684773	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		bone marrow: 28.3	Cell type enriched	Detected in many	4	Erythroid cells: 163.5	Low cancer specificity	Detected in some			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Group enriched	Detected in many	4	B-cells: 3.7;NK-cells: 5.0;T-cells: 12.7	Cell line enhanced	Detected in many		HEL: 21.2;K-562: 39.4	Low region specificity	Detected in all			Low region specificity	Detected in all			CAB016546	Uncertain		Approved	Nucleoplasm						Nucleoplasm		CAB016546: AB_630417	unprognostic (1.15e-1)	unprognostic (5.40e-2)	unprognostic (1.06e-1)	unprognostic (1.37e-2)	unprognostic (6.07e-3)	unprognostic (2.72e-1)	unprognostic (1.33e-3)	unprognostic (1.04e-1)	unprognostic (1.14e-1)	unprognostic (9.91e-2)	unprognostic (8.24e-3)	unprognostic (4.89e-2)	unprognostic (5.83e-3)	unprognostic (6.78e-2)	unprognostic (9.03e-2)	unprognostic (9.35e-2)	unprognostic (1.09e-1)	2.4	3.8	2.8	2.8	5.5	28.3	8.6	4.9	5.1	3.5	2.6	3.1	3.3	1.8	3.1	6.2	3.4	2.8	1.9	5.4	3.8	3.1	3.4	4.4	3.7	3.8	4.5	4.1	4.2	10.7	6.9	9.7	2.9	5.5	4.5	2.2	2.8	8.1	4.9	6.8	9.7	2.3	2.1	8.6	3.7	3.4	16	3.9	8.6	4.5	1.4	4.1	3.3	2.9	3.7	1.6	0.3	0.9	5	12.7	2.8	1.8	2.9	0.5	1.8	1.9	3.4	0	1	1.5	1.6	1.7	2.3	2	3	2.1	0.8	3.9	2.7	2	1.5	1.8	4.4	1.7	21.2	2.9	0.8	2.3	1.9	2.2	1.5	2.9	2.1	1.9	1.5	1.6	8.9	39.4	2.3	2.6	1.2	6.2	8.4	2.3	0.8	2.7	3	0.3	1.3	0.6	1.1	2.8	2	2.8	1.3	0	0.2	1.4	1	0.8	2.1	1.6	1.5	1.7	2.1	5	2.3	1.8	2.3	1.1	0	0.7	0.3	3.5	0.9	9.4	3.7	8.5	6	1.5	2.9	12.7	7.2	0	5	0.8	1.6	4.9	2.8	2.8	5.5	4.9	5.1	3.8	3.1	4.5	4.1	5.5	3.9	11.9	3.5	4.5	3.7	2.9	2.2	8.3	0	6.7	5.7	1.8	0	2.9	1.7	2	11.8	1.1	0.1	163.5	1.5	10.4	1.9	1.5	3.5	1.6	3.3	1.6	0	2.5	1	6.3	1.7	0.8	0	3.6	1	2.7	2.1	0	1.1	2.1	1.2	6.5	1.1	39.4	10.8	5.9	1.7	2.2	1.3	2.5	Erythroid cells
PNLIP	PL	ENSG00000175535	Pancreatic lipase	P16233	10	116545931-116567855	Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins	Lipid degradation, Lipid metabolism	Hydrolase	Disease mutation, FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	1895	pancreas: 3207.8	Cell type enriched	Detected in some	4	Exocrine glandular cells: 3478.1	Cancer enriched	Detected in some	4854	pancreatic cancer: 2731.7	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		EFO-21: 3.1;HDLM-2: 2.8;U-2 OS: 4.6;U-251 MG: 1.1;U-266/84: 1.5	Low region specificity	Detected in some			Not detected	Not detected			HPA062430, HPA062494	Enhanced				Secreted to digestive system				13000000			HPA062430: AB_2684761, HPA062494: AB_2684782											unprognostic (2.05e-2)	unprognostic (4.46e-2)						0.2	0	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.2	0.1	0.1	0	0.1	0.4	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	1.6	3207.8	0	0.1	0.1	0.1	0.1	0	0.1	0.4	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.1	0	0	0	0.1	0	0	2.8	0.1	0	0	0	0	0	0	0	0.3	0	0.2	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0.2	0	0	0	0.1	0	0	0	0	0	0	0	0	4.6	0	1.1	0	1.5	0.7	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	7.2	0.5	0	0	0	3478.1	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	25.2	0	0	826.8	0	0	0	0	0	0	0	0	0	0	0	0	0	Exocrine glandular cells
RBMXL3	CXorf55, FLJ40249	ENSG00000175718	RNA binding motif protein, X-linked like 3	Q8N7X1	X	115189427-115192868	Predicted intracellular proteins		RNA-binding		Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	68	testis: 6.8	Cell type enriched	Detected in some	4	Spermatogonia: 15.8	Cancer enriched	Detected in single	25	testis cancer: 1.2					Not detected	Not detected			Not detected	Not detected			Not detected	Not detected											HPA051842	Supported											HPA051842: AB_2681634															unprognostic (1.05e-1)			0	0	0	0	0	0	0	0	0	0	0			0	0	0	0	0	0	0	0	0	0	0	0	0	0		0	0	0	0	0		0	0		0	0	0	0	0	0	0	0	0	6.8			0		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0.3	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0	0	2.2	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	3.7	15.8	0	0	0	0	0	Spermatogonia
PRIMA1	PRIMA	ENSG00000175785	Proline rich membrane anchor 1	Q86XR5	14	93718298-93788481	Predicted membrane proteins	Neurotransmitter degradation			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in many		intestine: 26.2	Cell type enriched	Detected in some	11	Muller glia cells: 33.7	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HAP1: 7.5;Hep G2: 4.8;NTERA-2: 3.0;SCLC-21H: 13.2;SH-SY5Y: 7.5	Region enhanced	Detected in many		basal ganglia: 16.2	Low region specificity	Detected in all			HPA046671, HPA060047	Approved		Approved	Nucleoli,Plasma membrane,Cytosol						Plasma membrane	Nucleoli, Cytosol	HPA046671: AB_2679744, HPA060047: AB_2684194	unprognostic (3.60e-2)	unprognostic (1.97e-1)	unprognostic (7.54e-2)	prognostic unfavorable (6.99e-5)	unprognostic (1.03e-2)	unprognostic (3.73e-2)	unprognostic (1.07e-1)	unprognostic (5.81e-2)	unprognostic (2.93e-1)	unprognostic (1.05e-1)	unprognostic (8.94e-2)	unprognostic (6.61e-3)	prognostic unfavorable (2.62e-7)	unprognostic (2.33e-2)	unprognostic (2.67e-1)	unprognostic (7.94e-4)	unprognostic (4.57e-3)	4.6	6	4.2	5.9	16.7	0.4	2.4	4.5	8.2	7.7	26.2	21.7	4.2	4.6	7.9	7.9	13.7	10.7	3.3	4.8	5.8	3.3	1.2	0.7	1	0.7	20.2	4	6.9	1.2	0.6	0.3	2.2	15.5	8.6	7.6	9.9	4.6	10.2	0.7	2.1	11.6	14.9	24.3	0.7	12.1	1.8	14.7	0	1.3	0.9	4.4	4.7	7.5	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0.3	0	7.5	0	0	0.2	0.4	0	0	4.8	0	0	0	0	0.2	0	0	0	0	0	0	0	0	1.7	0	0	3	0	0	0	0	0.3	0	0	13.2	7.5	0.4	0	0	0.5	1.5	0	0	0	0.3	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4.2	16.7	4.5	8.2	5.8	3.3	20.2	4	15.5	14.7	0	0	0	1	0.5	0.5	1.6	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0.5	0.5	0	0	0.1	0	0	3.1	0	0.4	2.6	0	0	0	0	33.7	0.1	0	0	0	0.2	0	0.1	0.1	0.2	0.3	0	0	0	0.1	Muller glia cells
MSRA		ENSG00000175806	Methionine sulfoxide reductase A	Q9UJ68	8	10054268-10428891	Enzymes, Predicted intracellular proteins		Oxidoreductase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		brain: 78.4	Cell type enriched	Detected in many	6	Proximal tubular cells: 597.4	Low cancer specificity	Detected in all			Region enriched	Detected in all	6	cerebellum: 78.4	Cell type enhanced	Detected in many		eosinophil: 9.0	Group enriched	Detected in many	4	dendritic cells: 2.3;granulocytes: 9.0;monocytes: 3.2	Cell line enhanced	Detected in many		HMC-1: 15.2	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA023804, HPA075766	Approved		Supported	Nucleoplasm,Plasma membrane,Actin filaments,Cytosol	Intracellular and membrane	No	No		25000	Nucleoplasm, Plasma membrane, Cytosol	Actin filaments	HPA023804: AB_1853826, HPA075766: 	unprognostic (1.55e-1)	unprognostic (4.30e-3)	unprognostic (1.45e-3)	unprognostic (1.00e-2)	unprognostic (4.21e-2)	unprognostic (1.62e-2)	unprognostic (1.49e-2)	unprognostic (6.40e-2)	unprognostic (9.69e-2)	unprognostic (1.08e-1)	unprognostic (1.80e-1)	unprognostic (4.58e-2)	unprognostic (1.07e-3)	unprognostic (6.43e-3)	unprognostic (4.02e-1)	unprognostic (6.36e-3)	unprognostic (3.07e-1)	7	8.1	8	5.2	7.5	36.1	5.9	78.4	13.7	3.6	5.9	4.3	2.2	5.9	4.8	3.7	5.5	4.2	4.4	8.5	8.9	5.5	32.4	22.9	5.7	6.8	6.8	9.5	4.2	10.2	2.9	3.4	4.6	8.1	3.4	4	3.9	6	5	4.7	3.8	12.7	4.9	6.7	7.2	4.9	8.5	5.5	3.5	4.4	2.6	3.8	3.9	2.7	1.1	2.3	9	3.2	1.1	0.8	0.3	0.1	1.1	1.8	5.4	1.6	1.8	0.6	3.3	0.7	0.5	2.2	0.7	2.7	0	0.8	3	7.2	2.9	0.5	0.2	1.7	0.4	0	0.5	1.7	2.5	5.3	1	15.2	0.5	3.9	0.4	0	1.8	0.9	0.3	0.5	0.3	5.9	0.2	0	0.3	0.8	3.9	1	1.8	1.7	2.3	1.3	1.3	3.1	2	5.4	0.2	0.7	0.6	2.8	3.3	3.2	2.2	2.6	0.5	1.6	0.2	0.1	0.9	5.9	1	4.1	0.8	3.2	9	0.7	2.2	0.6	1.1	0.8	0.5	2.3	0.4	0.6	0.5	3.8	1.1	1.6	0.3	0.5	0.3	8	7.5	78.4	13.7	8.9	5.5	6.8	9.5	8.1	5.5	0	9	10	24.1	14.5	10.7	18.1	17.8	5.3	4.5	24.4	29.5	5.8	77.9	27	64.1	26.4	29	0	41.4	4.5	11.3	16.9	81.6	82.9	42.3	15.9	9.2	16.5	31	107.2	8.6	33.1	28.7	14.4	19.7	13.4	40.7	28.8	9.2	597.4	5.8	12.9	17.6	27.7	18.8	12.3	7	15.3	17.4	28.6	Proximal tubular cells
CCDC168	C13orf40, FLJ40176	ENSG00000175820	Coiled-coil domain containing 168	Q8NDH2	13	102729369-102759070	Predicted membrane proteins				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	10	testis: 23.7	Cell type enriched	Detected in some	32	Early spermatids: 828.1	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HL-60: 1.6;MOLT-4: 1.3;NB-4: 1.0;THP-1: 2.0									HPA048184, HPA058793, HPA078547	Uncertain		Approved	Nucleoli,Centrosome,Cytosol						Nucleoli, Centrosome	Cytosol	HPA048184: AB_2680303, HPA058793: AB_2683823, HPA078547: 	unprognostic (2.06e-1)	unprognostic (7.95e-2)	unprognostic (3.90e-2)	unprognostic (1.38e-1)	unprognostic (2.39e-4)	unprognostic (2.09e-2)	unprognostic (3.68e-2)	unprognostic (2.74e-1)	unprognostic (5.05e-2)	unprognostic (3.61e-1)	unprognostic (2.89e-3)	unprognostic (1.73e-1)	unprognostic (1.44e-5)	unprognostic (2.56e-1)	unprognostic (2.01e-1)	unprognostic (2.85e-1)	unprognostic (6.94e-2)	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.3	0	0	0	0.3	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	23.7	0	0	0	0	0	0	0	0.1	0	0.5	0	0.9	0	0	0.1	0	0.4	0.1	0	0	0	0.2	0	0	0.1	0.2	0	0.7	0.1	0	0	0	0.3	0	0.2	0.4	0.2	0.7	0.1	0	0	1.6	0.3	0	0.2	0.1	0	0	0	0.9	0.1	0	0	0	1.3	1	0	0.1	0.3	0.4	0	0	0.1	0.1	0.3	0.1	0.1	0.1	0	0.1	0	2	0	0	0.1	0.3	0.3	0	0.3	0	0	0.2	0.2	0	0	0.5	0	0	0	0	0	0	0	0.1	0	0	0.1	0.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3	0	0	0.5	0	0	3.1	0	0	3.4	0	0	0.2	0	0.3	828.1	0	0	0	0.3	0.4	0	0.2	0	0	0.2	0	0	0.6	0.8	26.2	2	0	0	2.8	0	0	0.2	0	0.7	0	0	0	0.1	1.1	1.4	0	0.3	0	0	0.1	Early spermatids
TSPEAR	C21orf29, DFNB98, MGC11251, TSP-EAR	ENSG00000175894	Thrombospondin type laminin G domain and EAR repeats	Q8WU66	21	44497892-44711580	Disease related genes, Predicted intracellular proteins, Predicted secreted proteins	Hearing		Deafness, Disease mutation, Ectodermal dysplasia, Non-syndromic deafness	Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		pituitary gland: 14.9	Cell type enriched	Detected in single	4	Early spermatids: 3.4	Low cancer specificity	Detected in single			Region enhanced	Detected in some		basal ganglia: 2.5	Cell type enriched	Detected in single	10	neutrophil: 1.4	Lineage enriched	Detected in single	10	granulocytes: 1.4	Cell line enhanced	Detected in some		BEWO: 2.7;Hep G2: 2.6;HMC-1: 2.6;SH-SY5Y: 5.1;U-2 OS: 3.6	Region enhanced	Detected in single		basal ganglia: 0.5	Region enhanced	Detected in some		olfactory region: 2.0	CAB034203, CAB034204, HPA052995	Uncertain				Secreted in other tissues							CAB034203: AB_1567654, CAB034204: AB_1567655, HPA052995: AB_2682008	unprognostic (8.61e-3)	unprognostic (2.45e-1)	unprognostic (1.86e-4)	unprognostic (7.87e-3)	unprognostic (4.08e-2)	unprognostic (1.00e-3)	unprognostic (7.92e-3)	unprognostic (1.56e-1)	unprognostic (1.34e-1)	unprognostic (1.15e-2)	unprognostic (3.86e-4)	unprognostic (2.13e-2)	unprognostic (4.80e-7)	unprognostic (2.08e-1)	unprognostic (1.69e-1)	unprognostic (1.88e-2)	unprognostic (2.98e-2)	0.3	0.1	0.2	0.3	2.5	0	0.5	0.2	0.9	0.2	0.2	0.2	0.2	0.7	0.2	0.4	0.2	1.1	0.2	2.7	0.2	0.1	0.5	1.4	1.4	0.8	0.2	0.2	0.2	0.2	2.6	14.9	0.2	1	0.2	0	0.2	0.2	0.2	0.2	3.9	0.5	0.2	0.2	0.6	0.3	4.6	0.2	0.5	2.8	0.2	0.4	0.2	0.2	0	0	1.4	0	0	0.1	0	0	0.2	0	1.2	0	0	2.7	0.1	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	2.6	0	0	2.6	0	0	0	0	0	0	0.3	1.6	0.1	0	0	0	0	0	0.3	0.8	0	0	1.1	0	0	1.1	5.1	0	0.1	0	0.4	0.1	0.3	1.4	0	3.6	0	0	0.7	0.4	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	1.4	0	0	0	0	0	0.2	2.5	0.2	0.9	0.2	0.1	0.2	0.2	1	0.2	0	0	0	0	0.1	0	0.8	0	0	0	0	0	0	0	0	3.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.3	0	0	0	0	Early spermatids
PLEKHD1	UPF0639	ENSG00000175985	Pleckstrin homology and coiled-coil domain containing D1	A6NEE1	14	69484692-69531551	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		blood: 7.4;brain: 16.0	Cell type enriched	Detected in some	5	Horizontal cells: 217.7	Low cancer specificity	Detected in single			Region enriched	Detected in many	7	cerebellum: 16.0	Cell type enriched	Detected in single	12	plasmacytoid DC: 7.4	Lineage enriched	Detected in single	12	dendritic cells: 7.4	Cell line enhanced	Detected in some		OE19: 2.8;SK-BR-3: 6.2;T-47d: 6.0;U-266/70: 2.8	Region enhanced	Detected in many		cerebellum: 33.7	Low region specificity	Detected in all			HPA051875	Uncertain											HPA051875: AB_2681648	unprognostic (8.73e-2)	unprognostic (4.64e-3)	unprognostic (3.73e-2)	unprognostic (4.03e-2)	unprognostic (7.58e-2)	unprognostic (3.15e-3)	unprognostic (1.44e-1)	unprognostic (1.64e-3)	unprognostic (3.28e-1)	unprognostic (1.83e-1)	unprognostic (4.56e-3)	unprognostic (1.22e-1)	unprognostic (5.49e-2)	unprognostic (8.08e-2)	unprognostic (2.28e-1)	unprognostic (2.74e-2)	unprognostic (1.42e-2)	0.3	0.3	0.4	0.1	1.5	1.1	1.4	16	2.2	0.5	0.2	0.5	2.5	0.3	0.2	4.2	0.2	0.2	0.2	0.3	0.6	0.5	1.8	0.1	0.4	2	0.8	0.1	0.2	0.5	4.5	0.6	0.1	1.4	0.2	0	4.1	3.9	4	0.2	2	0.2	0.1	0.6	0.4	0.3	1.8	0.4	0.8	4	0.1	0.5	0.2	0.2	0.2	7.4	0.6	0.1	0.1	0.1	0	0.3	0.3	0.5	0.9	0.2	0.1	0.4	0.1	0.1	0.1	0.1	0.1	0.7	0.5	0.5	0.1	0.2	0.5	0.8	0.1	0.1	0.5	0.4	0.1	0.4	0.1	0.1	0.5	0.8	0.1	0.3	0	0.1	0.1	0	0.3	0.2	1.2	0.1	0.9	0.4	0.4	0.7	2.8	0.1	0.3	0.1	0.2	0.5	0.5	0.8	1.9	0.2	6.2	0.1	0.2	6	0.2	0.2	0.3	0.8	0.4	0.3	2.8	0.6	0.3	0.2	0.2	0.3	0.2	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0	0.2	0.1	0.1	0.6	0.1	0.1	7.4	0.1	0	0.4	1.5	16	2.2	0.6	0.5	0.8	0.1	1.4	0.4	0	8.2	0	1.7	0.3	46.2	0.8	0	1.4	3.4	0	3.9	0	3.3	0.1	0.3	0.7	0	0	0.2	0.1	0.4	1.4	1.1	0	0.1	217.7	0	0.6	0	0	0	0.6	0	1	0	1.7	0.2	0	0	0.1	5.3	0	0.4	0.5	0.2	0.3	0.1	0.5	0	0.6	Horizontal cells
C11orf16		ENSG00000176029	Chromosome 11 open reading frame 16	Q9NQ32	11	8920076-8933006	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in some		fallopian tube: 19.1;lymphoid tissue: 10.8	Cell type enriched	Detected in some	17	Ciliated cells: 135.1	Cancer enhanced	Detected in some		endometrial cancer: 1.8	Region enhanced	Detected in some		pons and medulla: 2.9	Cell type enhanced	Detected in some		intermediate monocyte: 1.0;T-reg: 1.6	Group enriched	Detected in many	9	monocytes: 1.0;T-cells: 1.6	Cell line enhanced	Detected in some		BEWO: 1.5;CACO-2: 1.6;EFO-21: 1.6	Low region specificity	Detected in some																				unprognostic (5.32e-3)	unprognostic (1.03e-2)	unprognostic (4.09e-3)	prognostic favorable (3.32e-4)	unprognostic (1.73e-1)	unprognostic (1.35e-2)	unprognostic (1.94e-5)	unprognostic (6.40e-4)	unprognostic (1.58e-2)	unprognostic (9.99e-2)	unprognostic (4.87e-2)	unprognostic (1.05e-1)	unprognostic (1.84e-1)	unprognostic (1.39e-1)	unprognostic (1.23e-1)	unprognostic (1.71e-1)	unprognostic (1.13e-3)	0	0.2	0.5	0	0.8	0	0.2	0	0.3	2.3	0	0.7	0	0.1	0.6	3.1	0	19.1	0	0	0.8	1.3	0.4	0	5.2	0	0	0	2.8	0	0	1.6	0	2.9	0	0	0	1.4	0.1	0.1	0	0	0	0	0.1	0.2	2.7	0	10.8	0.1	0	0.3	0.1	0	0	0	0	1	0.1	1.6	0	0.9	1.3	1.3	0.5	0	0	1.5	0.4	0	0	0	1.6	0.2	0.1	1.6	0	0.1	0.4	0	0	0	0.4	0.4	0	0.7	0.2	0	0.3	0.1	0	0	0	0	0.2	0	0.6	1.2	0.1	0	0	0.6	0.9	0.6	0.2	0	0.2	0.1	0	0	0.1	0.7	0	1.1	0	0	0.3	0.4	0	0.7	1	0.5	0.3	0.2	0	0.3	0	0.2	0.6	1.1	0	0.1	0	0	1	0.3	0	0.1	0.2	0	0	0.1	0	0	0.1	0	0	1.6	0	0.5	0.8	0	0.3	0.8	1.3	0	0	2.9	0	0	0.6	0	0	0	0	0	0	135.1	7.9	5.2	0	0	0	0	1.3	0	0	0	0	0	0	0.2	0	0	0.1	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	1.1	0	0	0	0	0	0	Ciliated cells
CRYBG2	AIM1L, FLJ38020	ENSG00000176092	Crystallin beta-gamma domain containing 2	Q8N1P7	1	26321698-26360080	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		esophagus: 43.9;placenta: 55.0	Cell type enriched	Detected in some	5	Syncytiotrophoblasts: 40.6	Low cancer specificity	Detected in many			Not detected	Not detected			Cell type enhanced	Detected in some		neutrophil: 2.4	Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		A-431: 7.1;BEWO: 15.5;CACO-2: 25.1;CAPAN-2: 16.9;HaCaT: 6.3	Not detected	Not detected			Not detected	Not detected			HPA029629			Approved	Nucleoplasm						Nucleoplasm		HPA029629: AB_10601331	unprognostic (2.20e-1)	unprognostic (2.07e-2)	unprognostic (2.08e-1)	prognostic unfavorable (5.11e-6)	unprognostic (1.45e-1)	unprognostic (1.02e-1)	unprognostic (6.39e-4)	unprognostic (1.88e-3)	unprognostic (1.83e-1)	unprognostic (1.43e-1)	prognostic unfavorable (3.53e-4)	unprognostic (2.94e-2)	unprognostic (4.83e-9)	unprognostic (9.12e-3)	unprognostic (3.40e-1)	unprognostic (6.44e-2)	unprognostic (1.63e-2)	0	0	0	0.4	0	0	0.2	0	0	8	4.4	0	0	4.9	0.9	0.6	43.9	0.2	2	0	0	0	0.2	0	0.7	0	0	0	0.1	0	0	0	55	0	0.8	1.4	0.1	5.1	0	0	13.8	10.4	0	0	0	0.9	1.2	0	0.1	0	22	19.8	4.9	16.1	0.7	0	2.4	0.1	0.2	1.7	0.3	7.1	0	0	0	0	0	15.5	0	0	0	0.1	25.1	16.9	0.1	5.1	0	0.1	6.3	0	4.5	0	0	0.1	0	0	1	0	0	0	0	5.7	0.1	0	0	0	0.1	0	0	0	0.9	0	0	1.2	4	0	0	0	0.1	0.3	1.6	0.3	0	0	3	0	1.2	4.5	0	0	0	0.2	0	0	0	0.1	0.1	0	0	0	0	0.1	0.5	1	0.1	0.5	0.7	1.7	0.7	0	0.6	0.5	0.5	2.4	0.2	0.1	0	0.2	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.8	0	4.9	1.7	1.8	0	0	0	0	1.2	4.3	0	0	0	0	1.2	0	0	0	0	0	0	0	0	0	0	0	7.7	0	0	1.2	0	0	0	0	0	0	40.6	0	0	0	Syncytiotrophoblasts
CCDC57	FLJ00130, FLJ23754	ENSG00000176155	Coiled-coil domain containing 57	Q2TAC2	17	82101460-82212830	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	5	Late spermatids: 565.2	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Group enriched	Detected in some	4	naive CD4 T-cell: 5.2;naive CD8 T-cell: 10.7	Lineage enriched	Detected in many	6	T-cells: 10.7	Low cell line specificity	Detected in many											HPA023315, HPA023326, HPA023342, HPA023344	Approved		Approved	Microtubules,Centriolar satellite,Cytosol						Microtubules	Centriolar satellite, Cytosol	HPA023315: AB_1846159, HPA023326: AB_1846160, HPA023342: AB_2275460, HPA023344: AB_1846162	unprognostic (2.51e-3)	unprognostic (8.22e-2)	unprognostic (1.41e-1)	unprognostic (9.92e-3)	unprognostic (1.25e-1)	unprognostic (2.11e-3)	unprognostic (1.33e-1)	unprognostic (1.56e-2)	unprognostic (3.19e-2)	unprognostic (2.16e-1)	prognostic favorable (5.55e-5)	unprognostic (2.07e-1)	prognostic unfavorable (2.28e-6)	unprognostic (5.19e-2)	unprognostic (1.53e-1)	unprognostic (2.04e-1)	unprognostic (3.80e-3)	5.5	9	12.9	10.4	14.1	12.1	14.1	20.3	16.6	9.9	8.5	7.6	17.1	11.8	14.2	13.7	4.2	14.9	11.2	4.7	9.3	6.8	13	6.8	8.8	7.9	5.4	13.7	14	13.7	15.9	22.7	5.8	8.9	14.9	5.2	16.7	13.6	13.8	6.2	8.9	8.9	11.3	3.8	7.7	11.4	23.7	8.8	10.6	19.8	5.2	9.6	7.9	7.2	0.6	1.6	1.9	0.6	0.4	10.7	1.5	4.4	9.1	4.8	6.3	2.9	5.3	5.7	3.5	3.5	2.6	2.2	2.7	7.1	2.4	3.3	2.8	2.6	10.6	1.3	6.3	1.4	2.5	9.5	3.9	15.2	5.8	3.8	3.8	5	5.3	5	4.9	6.4	5.9	3.1	3.5	5	1.3	1.7	6.6	7.2	7.3	1.6	2.6	3.7	4.1	2	3.3	4.9	5.6	16.5	10.3	3.1	15	5.9	3.1	8.8	4.4	3.2	10.1	9.2	4.3	6.9	9.7	1	0.8	7.8	4.3	3.9	0.5	0.6	0.7	0.9	0.2	0.4	0.6	0.8	1.2	0.5	0.6	5.2	10.7	1.9	0.4	0.1	1.6	0.3	1.5	12.9	14.1	20.3	16.6	9.3	6.8	5.4	13.7	8.9	8.8	23.8	60.8	37.4	20.2	10.4	19.7	3.1	17.8	48.2	48.9	27.9	39.3	31.4	8.3	13.7	115.3	5.7	26.4	0	15.5	30.4	7.5	25.4	34.6	86.9	26.3	23.8	41	8	35.8	565.2	7.5	30.7	32.1	26.2	34.7	9.8	13.9	23.2	9.6	7.5	66.2	6.5	10.3	10.8	5.3	15.9	10.4	40.5	26.6	15.3	Late spermatids
FOXG1	BF1, FKH2, FKHL1, FKHL2, FKHL3, FKHL4, FOXG1A, FOXG1B, FOXG1C, HBF-3, HFK1, HFK2, HFK3, QIN	ENSG00000176165	Forkhead box G1	P55316	14	28760330-28770277	Disease related genes, Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	Developmental protein, DNA-binding	Disease mutation, Mental retardation	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	6	brain: 32.4	Cell type enriched	Detected in some	7	Spermatocytes: 20.2	Cancer enriched	Detected in some	10	glioma: 15.9	Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HEK 293: 8.5;SCLC-21H: 22.1;U-138 MG: 13.6;U-251 MG: 13.6	Group enriched	Detected in many	7	amygdala: 34.1;basal ganglia: 45.4;cerebral cortex: 40.1;hippocampal formation: 49.3;olfactory region: 31.7	Group enriched	Detected in many	5	amygdala: 84.2;basal ganglia: 118.5;cerebral cortex: 107.8;hippocampal formation: 165.6;olfactory region: 132.9														unprognostic (2.92e-2)			unprognostic (2.22e-1)	unprognostic (1.92e-1)	unprognostic (3.49e-1)		unprognostic (1.17e-3)		unprognostic (2.14e-2)			unprognostic (1.27e-11)	unprognostic (4.10e-2)	unprognostic (1.08e-1)	unprognostic (1.60e-2)		0.8	0.8	15	0.8	22.4	0.8	0.8	0	32.4	0.8	0.8	8.3	0	0.8	0.8	0.8	1.2	0.8	0.8	0.8	16.7	2.2	0.8	0.8	0.8	1.5	1	14.2	1.3	0.8	0.9	2.1	0.8	0	0.8	0.8	0	0.8	0.8	0.8	0.8	0.8	0.8	0	0.8	0.8	5.4	7.8	0	0.8	0	0.9	0.8	0	0	0.1	0	0.3	0	0	0	0	0	0	0	4.3	3.5	2.4	0.1	0	0	0	0	0	0	0	0.1	1.8	0	2	0	0	0	8.5	0	0	0	0	0	0	0.1	0	0	5	0	0	0	3.1	0	0	0	0	0	0	0	0	0	0	0	0	0	22.1	0	0	0	0	1.4	0	0	0	13.6	0	1.3	13.6	0	0	0	4.8	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0.1	0	0	15	22.4	0	18.8	16.7	2.2	1	14.2	0	7.8	0	0	0	0	0	0	1.4	0	0	0	0	2	0	0	0	2.9	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	2.1	0.3	0	0	0	0	1.5	0	0	0	0	0.2	0	0	20.2	0.2	0	0.1	0	0	0	Spermatocytes
OR4M1		ENSG00000176299	Olfactory receptor family 4 subfamily M member 1	Q8NGD0	14	19773504-19783696	G-protein coupled receptors, Predicted membrane proteins	Olfaction, Sensory transduction	G-protein coupled receptor, Receptor, Transducer		Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enriched	Detected in single	32	testis: 3.5	Cell type enriched	Detected in some	5	Early spermatids: 31.7	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Not detected	Not detected											HPA058889	Uncertain											HPA058889: AB_2683845																		0	0	0	0	0	0	0	0	0	0	0			0	0	0	0	0	0	0	0	0	0	0	0	0	0		0	0	0	0	0		0	0		0	0	0	0	0	0	0	0.1	0	3.5			0		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	31.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5.9	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	Early spermatids
HORMAD2	CT46.2, MGC26710	ENSG00000176635	HORMA domain containing 2	Q8N7B1	22	30080174-30177075	Predicted intracellular proteins	Meiosis			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	6	testis: 21.3	Cell type enriched	Detected in some	4	Spermatocytes: 115.1	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		THP-1: 1.2;U-2197: 3.1	Low region specificity	Detected in single			Not detected	Not detected			HPA003074, HPA043880	Enhanced		Supported	Nucleoplasm,Centrosome,Cytosol						Nucleoplasm	Centrosome, Cytosol	HPA003074: AB_1850916, HPA043880: 					unprognostic (1.43e-1)		unprognostic (6.77e-3)	unprognostic (2.33e-1)		unprognostic (1.36e-2)			unprognostic (8.19e-3)	unprognostic (1.96e-1)	unprognostic (2.50e-2)	unprognostic (2.12e-1)		0.1	0	0.4	0	0.4	0	0	0	0.3	0	0	0.2	0	0	0	0	0	0	0	0	0.1	0.1	0	3.4	0	0	0.2	0	0	0	0.3	0	0	0.2	0	0	0.2	0	0	0	0	0	0	0.1	0	0	21.3	0.3	0	0	0	0	0	0	0.6	0	0	0	0.1	0.1	0	0	0	0.6	0	0	0.2	0	0	0	0	0.1	0.2	0	0.9	0	0	0.5	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0.1	0	0	0	0.3	0	0	0.7	0	0	0	0.1	0	0	0	0	0.1	0	0	1.2	0	0	0	3.1	0	0.1	0	0	0	0	0	0	0	0	0	0	0.1	0.6	0.1	0	0	0	0	0	0	0.1	0	0	0	0	0.4	0.4	0	0.3	0.1	0.1	0.2	0	0.2	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	27.3	0	0	0	0	0	0	0	0	3.2	0	0	0	1.3	0	4.7	0	0	0	0	0	0	0	0	0	0	0	6.5	0	115.1	2.7	0	0	0	0	0	Spermatocytes
LRRC37A	KIAA0563	ENSG00000176681	Leucine rich repeat containing 37A	A6NMS7	17	46292733-46337794	Predicted membrane proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	5	skeletal muscle: 9.4;testis: 15.2	Cell type enriched	Detected in some	5	Early spermatids: 18.2	Not detected	Not detected							Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Cell line enhanced	Detected in many		Daudi: 8.0									HPA042121, HPA043056, HPA045090, HPA049080	Supported		Approved	Vesicles						Vesicles		HPA042121: AB_2677858, HPA043056: AB_2678294, HPA045090: AB_2679211, HPA049080: AB_2680624	unprognostic (1.29e-1)	unprognostic (2.72e-1)	unprognostic (7.22e-2)	unprognostic (3.75e-2)	unprognostic (6.02e-1)	unprognostic (2.94e-1)	unprognostic (1.78e-1)	unprognostic (3.06e-2)	unprognostic (5.23e-2)	unprognostic (5.20e-2)	unprognostic (8.22e-2)	unprognostic (2.05e-1)	unprognostic (2.65e-3)	unprognostic (3.37e-1)	unprognostic (4.35e-1)	unprognostic (1.70e-2)	unprognostic (4.30e-2)	0.9	0.4	1.4	2	1.8	1.4	1.7	2.6	1.7	0.7	0.9			0.5	1.1	0.4	1.1	1	0.5	1.1	1.5	1.2	0.9	0.6	0.9	1.5	0.6		1.2	0.9	0.5	2.1	0.7		1.3	1		1	0.9	9.4	1.8	1.3	0.6	0.8	1.2	0.8	15.2			1.2		0.9	1.1	1.1	1.4	1.7	2.1	1.4	2.1	1.5	0.2	0.2	0.2	1.6	0.2	0.3	0	0.5	0.1	0.4	0.1	0.2	3.6	0.3	8	0.3	0.3	2.5	0.3	0	0	0	0.5	1.2	0.4	4	2.7	0.6	0	0.2	0	1	0	0	0.2	0.5	0.3	0.2	0.6	0.9	0	0.3	0.7	1.2	0	0	2.7	2.9	1.8	0	1.9	0.5	1.1	0.2	0.6	0.1	0	0.5	3.6	1.2	1.4	2.4	0.4	0.2	3.6	2.5	0.5	1.3	2.4	2.3	2.1	1.1	1	1	1	0.9	0.8	0.8	1.5	1.1	1.4	1.3	1.1	1.9	2.1	1.4	1.7	1	0.2											3	0.3	0	0.3	0.1	0.6	3.6	0	1.4	0	0	0	0.1	1.7	0.2	18.2	0	1.3	0	0.4	0	0.2	0.1	1.1	0	0.3	0	1.2	0	2.7	1	0	0.4	0	0	1.1	0	0.2	0	0.4	0	0.5	0	0	0.7	0.2	0.1	0.1	0.5	1	0	Early spermatids
TCERG1L	FLJ38950	ENSG00000176769	Transcription elongation regulator 1 like	Q5VWI1	10	131092391-131311721	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in some		brain: 9.7;thyroid gland: 24.1	Cell type enriched	Detected in some	10	Horizontal cells: 96.9	Cancer enriched	Detected in some	14	thyroid cancer: 20.3	Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		BEWO: 9.4;NTERA-2: 1.4;RPMI-8226: 2.2;SuSa: 4.3;U-2 OS: 2.4	Low region specificity	Detected in many			Low region specificity	Detected in many			HPA030816			Approved	Nucleoplasm,Cytosol						Nucleoplasm	Cytosol	HPA030816: AB_10601721	unprognostic (6.61e-2)	unprognostic (1.29e-1)	unprognostic (8.99e-2)	unprognostic (1.45e-2)	unprognostic (3.03e-1)	unprognostic (6.69e-2)		unprognostic (1.62e-1)	unprognostic (4.96e-1)	unprognostic (9.71e-2)	unprognostic (2.02e-1)	unprognostic (5.01e-2)	unprognostic (1.08e-5)	unprognostic (1.28e-1)	unprognostic (2.83e-1)	unprognostic (2.96e-2)	unprognostic (2.03e-1)	0.4	1.9	2.7	0.4	4.1	0.4	0.6	3	9.7	0.5	0.4	0	0	0.4	0.6	1.1	0.6	0.4	0.4	0.4	3.8	3.5	0.4	0.4	0.5	0.4	0.9	3.9	5.5	0.8	0.4	4.8	0.4	1.5	1.4	0.4	3.8	0.3	1.3	0.3	1.2	0.4	0.4	2.2	0.6	0.5	1.8	0	0.6	24.1	0	0.6	0.7	0.1	0	0.1	0	0	0	0.9	0	0	0	0	0	0	0	9.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.4	0	0	0	0	2.2	0	0	1.2	0	0	0	0	4.3	0.1	0	0	0	2.4	0	0	0	0	0	0.1	0	0	0	0	0	0.9	0	0	0	0.3	0.5	0	0	0	0.4	0	0	0	0.1	0	0	2.7	4.1	3	9.7	3.8	3.5	0.9	3.9	1.5	0	0	0	0	0.1	0.6	4.5	1.1	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0.6	0.4	0.6	0	0	0	96.9	0	0	0	0	4.4	0	10.1	0	0	0.8	0.1	0	4.2	0	3.6	0	0	0.1	4.7	0.5	0.1	0	0	0	Horizontal cells
MAGEB18	MGC33889	ENSG00000176774	MAGE family member B18	Q96M61	X	26138343-26140735	Predicted intracellular proteins	Ubl conjugation pathway	Tumor antigen		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	12	testis: 4.2	Cell type enriched	Detected in single	9	Spermatocytes: 3.6	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	29	Karpas-707: 10.0	Not detected	Not detected							HPA046141	Enhanced											HPA046141: AB_2679554															unprognostic (1.66e-1)			0	0	0	0	0	0	0	0	0	0	0			0	0	0	0	0	0	0	0	0	0	0	0	0	0		0	0	0	0	0		0	0		0	0	0	0	0	0	0	0	0	4.2			0		0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0.1	10	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0											0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.6	0.4	0	0	0	0	0	Spermatocytes
C8G		ENSG00000176919	Complement C8 gamma chain	P07360	9	136945246-136946974	Plasma proteins, Predicted secreted proteins	Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Innate immunity			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	11	liver: 165.8	Cell type enriched	Detected in some	19	Hepatocytes: 942.4	Cancer enriched	Detected in all	58	liver cancer: 260.0	Not detected	Not detected			Cell type enhanced	Detected in some		gdT-cell: 3.4	Group enriched	Detected in many	18	dendritic cells: 1.5;T-cells: 3.4	Cell line enriched	Detected in some	13	HMC-1: 61.0	Low region specificity	Detected in all			Low region specificity	Detected in some			HPA046269	Approved				Secreted to blood				1500000000			HPA046269: AB_2679606	unprognostic (5.00e-2)	unprognostic (4.05e-3)	prognostic unfavorable (2.99e-4)	unprognostic (3.94e-1)	unprognostic (4.53e-1)	unprognostic (2.75e-2)	unprognostic (1.71e-3)	unprognostic (2.79e-1)	unprognostic (1.88e-1)	unprognostic (3.67e-1)	unprognostic (2.96e-2)	unprognostic (3.00e-1)	unprognostic (5.02e-3)	unprognostic (2.16e-1)	unprognostic (7.67e-2)	unprognostic (1.65e-1)	unprognostic (1.05e-2)	0.2	0.7	0.2	0.3	0.2	0	0.2	0.2	0.2	0.2	6	0.2	0.2	14.6	0.2	0.2	0.2	0.2	2.7	0.2	0.2	0.1	0.4	165.8	0.2	0.2	0.2	0.2	0.2	0.2	0	0.2	0.2	0.2	0.2	0	0.2	0.2	0.2	0.8	0.3	12.1	0.2	0.2	0.6	0.6	0.5	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0	1.5	0	0.1	0	3.4	0.3	0.1	0.9	0.1	0.2	0.1	0	0.6	0.3	0	0	0	1.1	0.6	1.1	0.7	0	0.2	1	0	0.1	0	1.1	0.1	0.4	1.7	4.6	0	0.1	61	0	0.2	0.2	0	0.2	0.2	0.4	0.1	0.6	0.2	0.8	0.1	0.5	0	0.1	0.2	0.1	0.2	0.9	0.2	0.5	0.2	0.2	0.2	1.7	0.3	0.1	1.5	0.4	0.7	0.3	0.1	0.1	0.2	0.3	0.5	0	0.2	0.5	0.2	0	0.1	0	3.4	0	0.4	0	0.7	1.8	0	0	0	2.2	0	0	0	1.5	0	0.3	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0	0	0	0.1	0.3	0	0.3	48.4	0	0	0	2	0.3	0	0.2	0.8	0.4	38.4	0	0.7	0.8	0.2	0.1	9.2	942.4	0.2	0	1.7	22.7	24.1	0.9	0	0	0	0	0.7	0.8	0.6	3.5	0.7	1.4	0.5	0	0	0.7	0.7	0.4	2.9	3.8	1.7	0.1	Hepatocytes
C19orf18	MGC41906	ENSG00000177025	Chromosome 19 open reading frame 18	Q8NEA5	19	57958437-57974534	Predicted membrane proteins				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	4	testis: 22.6	Cell type enriched	Detected in many	5	Early spermatids: 83.6	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		AN3-CA: 4.6;HEK 293: 6.6;RT4: 4.4									HPA014527, HPA079195	Approved		Approved	Golgi apparatus						Golgi apparatus		HPA014527: AB_1845612, HPA079195: 	unprognostic (5.38e-2)	unprognostic (6.36e-3)	unprognostic (3.70e-2)	prognostic favorable (5.07e-4)	unprognostic (4.85e-2)	unprognostic (9.50e-2)	unprognostic (2.75e-1)	unprognostic (5.40e-3)	unprognostic (5.78e-2)	unprognostic (1.64e-1)	unprognostic (4.08e-5)	unprognostic (1.11e-2)	unprognostic (8.75e-5)	unprognostic (1.53e-1)	unprognostic (1.15e-1)	unprognostic (6.41e-2)	unprognostic (1.05e-3)	1.1	1.7	1.4	1.1	1.8	0.4	3.6	1.1	1.1	1.1	1.3	1.1	1.1	0.8	1.4	5.6	1.1	1.8	1.4	4.2	1.9	1.8	1.1	1.1	1.1	1.1	2.1	1.1	1.3	1.1	1	3.6	1.1	3.1	2.7	0.8	1.1	1.2	1.6	4.2	1.2	1.1	1.1	2.3	1.1	0.8	22.6	1.1	1.1	1.3	1.1	1.1	1.1	1.1	2.8	1.6	0.7	0.9	0.8	1.2	0.4	0.2	0	1.9	4.6	1.1	1.5	1.4	2.2	0.5	0.6	1.4	0	0.4	0.5	1	0.6	0.5	0.1	0.1	0	1.5	0	6.6	0.4	0	1.5	1.7	0	1.1	1.8	2.7	0.1	0.4	1.6	0.3	1	0.2	0	3.3	0	0.9	0	0.1	0	0.4	1.3	0	1.2	1.1	4.4	2	0.5	0.9	0	0.6	1.5	1.6	1.5	0.9	0.3	0.5	0.6	0.5	0.9	3.9	0.1	0	0	0.5	0	0.6	0.7	0.1	0.2	0	2.8	1	0.6	1.6	1.3	0.6	1.2	0.5	0.8	0.9	1	0	0.4	1.4	1.8	1.1	1.1	1.9	1.8	2.1	1.1	3.1	1.1	3	2.1	0	0.4	0.3	0.5	3.2	0	2.7	2.3	0	0	0.3	0	1.7	83.6	1	0.4	0	0.2	0.5	0.8	0.5	0	1.3	0.4	0	0	3.7	1	16	2	0	1.7	1	1.8	1.8	0.7	0	0.7	0.2	2.8	6.5	1.2	3.5	2.2	0.5	0.2	0	1.1	0.3	Early spermatids
SCN4B	LQT10	ENSG00000177098	Sodium voltage-gated channel beta subunit 4	Q8IWT1	11	118133377-118152888	Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters	Ion transport, Sodium transport, Transport	Ion channel, Sodium channel, Voltage-gated channel	Atrial fibrillation, Disease mutation, FDA approved drug targets, Long QT syndrome	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 36.4;skeletal muscle: 25.6	Cell type enriched	Detected in some	4	Sertoli cells: 45.3	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		AN3-CA: 3.9;HBEC3-KT: 3.0;NTERA-2: 4.4;SH-SY5Y: 1.7;U-2 OS: 4.0	Region enriched	Detected in many	11	basal ganglia: 731.2	Region enhanced	Detected in many		basal ganglia: 122.8	HPA017293	Approved											HPA017293: AB_2184174	unprognostic (1.98e-1)	unprognostic (1.13e-1)	unprognostic (1.13e-1)	unprognostic (2.43e-1)	unprognostic (1.45e-1)	unprognostic (1.07e-1)	unprognostic (9.82e-3)	unprognostic (9.17e-3)	unprognostic (1.20e-2)	unprognostic (1.23e-2)	unprognostic (1.03e-2)	unprognostic (3.27e-2)	unprognostic (1.07e-1)	unprognostic (2.07e-2)	unprognostic (2.18e-3)	unprognostic (1.53e-1)	unprognostic (5.31e-4)	20.5	5.4	1.9	1.2	36.4	0.1	6.1	11.7	21.7	2.4	2.6	2	0.5	2.4	3.7	1.8	5.4	5.5	3.2	11	3.1	2.9	1.4	0.6	8.7	2	5.3	2.1	0.7	5	6.4	2.4	1.9	28.7	2.1	2.2	4.3	2.8	2.6	25.6	3.8	4.6	7	5.5	0.5	3	0.8	8.7	1.5	10.4	9.5	1.1	3.4	1.5	0	0	0	0	0	0	0	0.2	0	0	3.9	0	0	0.2	1	0	0	0	0	0	0	0.1	0	0.6	0.6	0.3	3	0	0	0.8	0	0	0	0	0	1.1	0.5	0	0	0.4	0	0	0	0	0	0	0	0	0	4.4	0	0	0	0	0.1	0	0	0.1	1.7	0.4	0	0	1.1	0	0	0	0	4	0	0	0	0	0.1	0	0.1	1.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.9	36.4	11.7	21.7	3.1	2.9	5.3	2.1	28.7	8.7	0	0	0	0.3	1.1	1.1	2.8	0	6.7	1.2	0	0	0	0	0	1.3	0.7	0	0	0	0	1.6	0.1	0	0	0.1	0	0	0	0.3	3.3	2	0.8	0	0	0	0.3	0	0	1.4	0	0.3	45.3	10.8	0	0.6	1	0	0	0	0.1	Sertoli cells
SPACA4	SAMP14	ENSG00000177202	Sperm acrosome associated 4	Q8TDM5	19	48606743-48607714	Predicted intracellular proteins	Cell adhesion			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	22	testis: 65.9	Cell type enriched	Detected in some	7	Early spermatids: 804.3	Low cancer specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		A549: 2.1;AN3-CA: 1.8;MCF7: 2.7;NTERA-2: 2.4;OE19: 3.2	Not detected	Not detected			Not detected	Not detected			HPA041927, HPA061302	Enhanced											HPA041927: AB_10794162, HPA061302: AB_2684475	unprognostic (2.48e-2)	unprognostic (6.37e-4)	unprognostic (6.59e-2)	unprognostic (4.52e-2)	unprognostic (2.09e-3)	unprognostic (9.43e-6)		unprognostic (6.67e-3)		unprognostic (1.05e-1)	unprognostic (2.87e-1)	unprognostic (2.78e-1)		unprognostic (3.43e-1)	unprognostic (2.88e-1)	unprognostic (4.47e-1)	unprognostic (2.01e-2)	0.1	0	0.1	0.1	0.1	0	0.1	0.1	0.1	0.2	1.1	0.1	0.1	2.3	0.1	0.4	0.7	0	0.8	0.1	0.1	0	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.2	0	0.1	0.1	0.1	0.1	0	0.1	1	0.1	0.1	1	1.8	0.1	0.1	0.1	2.9	65.9	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0	0	0	0	0	0.4	0	0	2.1	0.5	1.8	0	0	0	0	0	0	0	0.4	1.1	1.2	0.1	0	0.1	0.1	0	0	0	0	0	0	0.5	0	0	0	0.7	0	0	0	0	0	0	0.6	0	1	0	2.7	0	1.1	2.4	3.2	1.4	0.1	0.1	0	0	0.2	0.5	0.1	0	0	0	0	0.3	0.4	0	0	0.6	0.5	0	0.6	1.1	0.3	0	0.1	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	804.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	123.2	4.4	0	0	0	0	0	0	0	6.7	0	0	6.5	0	4.2	2.5	1.4	0	0	0	0.1	Early spermatids
KCNA2	HK4, Kv1.2	ENSG00000177301	Potassium voltage-gated channel subfamily A member 2	P16389	1	110519837-110631474	Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels	Ion transport, Potassium transport, Transport	Ion channel, Potassium channel, Voltage-gated channel	Disease mutation, Epilepsy, FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	5	brain: 28.0	Cell type enriched	Detected in some	5	Muller glia cells: 24.2	Cancer enhanced	Detected in some		glioma: 1.2	Low region specificity	Detected in all			Cell type enhanced	Detected in some		T-reg: 4.1	Lineage enriched	Detected in single	8	T-cells: 4.1	Cell line enhanced	Detected in some		Karpas-707: 10.9;SCLC-21H: 2.8;U-2 OS: 2.4;U-266/70: 3.6;U-266/84: 5.4;WM-115: 2.9	Low region specificity	Detected in all			Low region specificity	Detected in all			CAB001976	Enhanced											CAB001976: 	unprognostic (1.84e-2)	unprognostic (9.70e-3)	unprognostic (1.97e-1)	unprognostic (2.98e-1)	unprognostic (7.17e-3)	unprognostic (6.68e-3)		unprognostic (5.05e-3)	unprognostic (2.02e-1)	unprognostic (1.29e-1)	unprognostic (4.50e-3)	unprognostic (3.08e-3)	unprognostic (2.93e-4)	unprognostic (2.15e-1)	unprognostic (3.55e-1)	unprognostic (6.41e-2)	unprognostic (2.83e-1)	3.2	1.4	7.1	2.2	13.1	0.8	1.2	17.2	28	1.2	1.6	3.1	0	1.4	1	1.3	1.7	1.1	1.6	1.6	7.2	6.1	0.9	0.9	1	1.9	7.2	14.5	1.1	1.9	0.8	1.4	0.7	21.1	1.8	2	1.4	1.8	2.4	2.1	1.6	1.6	1.6	2.8	1.3	1.3	2.5	3.8	0.3	5.3	0	3.5	1.4	0.5	0.5	0	0	0	0	4.1	0.1	0	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	10.9	0	0	0	0	1	0	0	0.5	0	1.4	0	0	2.8	0	0	0	1.2	0.6	0	0	0	0.1	2.4	0	0	3.6	5.4	0.2	0.1	0	2.9	0	0	0	0.4	0	0.3	0.5	1.8	1.3	0	0	0.7	0.3	0	0	0	0	4.1	0.1	7.1	13.1	17.2	26.3	7.2	6.1	7.2	14.5	21.1	3.8	0	0	0	0	0	3.7	0.8	0	0	0	0	0	0	0	0	2.9	0	0	0	0	0	0	0	0	0	0	3.2	0	0	0	0.8	0	0	0	0	0	24.2	0	0	4.9	0	2.9	0	0.5	0	1.4	0	0	0	0	0	Muller glia cells
C10orf71	FLJ45913	ENSG00000177354	Chromosome 10 open reading frame 71	Q711Q0	10	49299193-49327487	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	5	skeletal muscle: 104.2;tongue: 35.0	Cell type enriched	Detected in single	478	Cardiomyocytes: 47.8	Cancer enhanced	Detected in single		head and neck cancer: 0.8	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	21	K-562: 9.2;RH-30: 14.0	Not detected	Not detected			Not detected	Not detected			HPA057556			Approved	Nucleoplasm,Mitochondria						Nucleoplasm	Mitochondria	HPA057556: AB_2683467				unprognostic (1.25e-2)		unprognostic (3.97e-2)		unprognostic (4.16e-2)		unprognostic (5.58e-2)		unprognostic (1.66e-1)		unprognostic (1.17e-1)	unprognostic (1.81e-1)			2	0.1	0.1	0	0.1	0	0.1	0.1	0.1	0.1	0.1	0	0	0	0.1	2	1.7	0.1	0	13.3	0.1	0.1	0.1	0.1	0.1	0	0.1	0	0.1	3.3	15.3	0.1	0	0	0.3	0	0	1.1	0	104.2	0.1	0.1	0	0.1	0.1	0.1	0.2	0	0	0.5	35	3.9	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	9.2	0	0	0	0	0	0	0	0	0	14	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0	47.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Cardiomyocytes
ZBED2	MGC10796	ENSG00000177494	Zinc finger BED-type containing 2	Q9BTP6	3	111592900-111595443	Predicted intracellular proteins, Transcription factors				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	4	lymphoid tissue: 21.0;thyroid gland: 74.5	Cell type enriched	Detected in some	5	Alveolar cells type 1: 41.7	Cancer enriched	Detected in many	5	thyroid cancer: 64.0	Region enriched	Detected in single	6	basal ganglia: 1.4	Cell type enhanced	Detected in many		naive B-cell: 4.0	Group enriched	Detected in many	6	B-cells: 4.0;T-cells: 2.5	Group enriched	Detected in some	5	CAPAN-2: 20.1;EFO-21: 14.0;HaCaT: 19.4;HBEC3-KT: 43.6;RPTEC TERT1: 29.0					Not detected	Not detected			HPA029786			Approved	Nuclear bodies,Mitochondria,Cytosol		No	No			Mitochondria, Cytosol	Nuclear bodies	HPA029786: AB_10601028	unprognostic (7.31e-3)	unprognostic (1.67e-1)	unprognostic (1.98e-3)	unprognostic (1.66e-1)		unprognostic (2.39e-3)	unprognostic (3.49e-1)	unprognostic (7.61e-2)	unprognostic (1.47e-1)	unprognostic (2.84e-1)	prognostic unfavorable (8.83e-4)	unprognostic (2.59e-1)	unprognostic (1.47e-6)	unprognostic (3.81e-2)	unprognostic (4.34e-1)	unprognostic (4.69e-2)	unprognostic (3.29e-2)	0.1	0	0.1	0.9	1.4	0	0.1	0.1	0.1	3.7	0.1	0.1	0.1	0	0.2	0.2	8.1	11.1	0.2	0.1	0.1	0	0.3	0.1	5.6	3.4	0.1	0.1	1.2	0.1	0	0.4	4	0.1	0.1	0	0.1	1.7	0.1	0.1	1.3	0.3	0.1	0.1	0.1	0.1	0.2	0.2	21	74.5	7.5	7.4	0.2	6.2	4	0	0.1	0	0.5	2.5	0.3	5.4	0	0	0	0	0	0	0	0	0	0	0	20.1	0.1	14	0	0	19.4	0	43.6	0	0	0	0	0.3	0	0	0	0	0	4	0	2.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	29	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	1.4	0	1	3.6	0.6	0.3	0	4	1.9	2.5	0.1	0.5	0	0	1.1	0.3	0.1	1.4	0.1	0.1	0.1	0	0.1	0.1	0.1	0.2	41.7	1.4	0	0.2	3.9	0	0	0	0	7.9	0	0	0	0	0	0	0	0	0	0	0	0	0	4.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0.9	0	0	0	0	0	0	0	0	3.3	0	0.7	0	0.1	Alveolar cells type 1
CD163	M130, MM130, SCARI1	ENSG00000177575	CD163 molecule	Q86VB7	12	7470813-7503893	CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins	Acute phase, Inflammatory response			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		lymphoid tissue: 113.6	Cell type enriched	Detected in many	7	Kupffer cells: 1509.4	Low cancer specificity	Detected in all			Low region specificity	Detected in many			Group enriched	Detected in some	10	classical monocyte: 28.2;myeloid DC: 25.3	Group enriched	Detected in many	40	dendritic cells: 25.3;monocytes: 28.2	Cell line enhanced	Detected in some		ASC diff: 1.8;CACO-2: 1.7;GAMG: 5.4;HSkMC: 5.3	Low region specificity	Detected in many			Low region specificity	Detected in single			CAB002432, HPA046404, HPA051974	Enhanced		Supported	Plasma membrane	Secreted to blood			903000000	1600000000	Plasma membrane		CAB002432: AB_563510, HPA046404: AB_2679655, HPA051974: AB_2681678	unprognostic (1.13e-1)	unprognostic (2.13e-1)	unprognostic (5.02e-3)	unprognostic (2.72e-1)	unprognostic (6.17e-3)	unprognostic (2.09e-1)	unprognostic (1.02e-1)	unprognostic (1.21e-1)	unprognostic (2.78e-1)	prognostic unfavorable (7.27e-4)	unprognostic (1.04e-1)	unprognostic (6.50e-2)	unprognostic (1.84e-2)	unprognostic (8.77e-2)	unprognostic (4.95e-2)	unprognostic (1.61e-1)	unprognostic (1.20e-2)	66.7	23.8	2.1	44.6	7.2	4.1	23.2	2.8	4.9	11.3	25.3	1.6	1.4	3.5	7.2	16.8	11.3	20.1	13.2	15.7	2.8	1.8	43.9	38.9	81	99.8	6.9	0.5	10.3	6.7	3.1	11.7	31.9	9.9	6.8	6.5	9.8	8.6	2.2	15.2	4	12.5	37.2	5.7	113.6	10.2	19.6	4.3	3.4	15.5	2.9	3.5	20.1	8.3	0	25.3	0.6	28.2	0	0	6.3	0	0	0	0	1.8	1	0.4	0	0.1	0	0	1.7	0	0	0	0	5.4	0.3	0	0	0	0	0	0.1	0	0.5	0	0.5	0.3	5.3	0	0.3	0.5	0	0	0	0	0	0.1	0	0.1	0.6	0.5	0.1	0	0.1	0.9	0.1	0	0	0.2	0.5	0.1	0.1	0	0.5	0	0.3	0	0.9	0.3	0.2	0	0.3	0	0	0.2	0	0.1	0.5	28.2	0.1	0	2.5	0	0	0	0	25.3	0	0	0	0.6	0	0	0.3	0	6.3	2.1	7.2	2.8	2.4	2.8	1.8	6.9	0.5	9.9	4.3	3	8.8	9.3	0.2	1.3	0	3.4	10.2	2.7	9.1	0	2	1.3	0	0	2.5	1.9	0	0	0	1.5	1.6	0.1	4.7	5.9	221.9	0	0	28.3	1509.4	3.9	4.6	104.2	0	0	0	0.8	0	0	1.1	0	0.1	116.4	0.3	3.9	1.7	0.9	2.5	5	0	0	Kupffer cells
HASPIN	GSG2	ENSG00000177602	Histone H3 associated protein kinase	Q8TF76	17	3723903-3726699	Enzymes, Predicted intracellular proteins	Cell cycle	Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	6	bone marrow: 7.5;lymphoid tissue: 26.7;testis: 26.7	Cell type enriched	Detected in single	5	Extravillous trophoblasts: 2.7	Low cancer specificity	Detected in many			Not detected	Not detected			Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Low cell line specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			HPA027422, HPA030698	Approved		Supported	Nucleoplasm						Nucleoplasm		HPA027422: AB_10601812, HPA030698: AB_2673575	unprognostic (1.15e-2)	unprognostic (2.78e-2)	unprognostic (7.06e-2)	unprognostic (2.14e-2)	unprognostic (8.05e-2)	unprognostic (2.81e-1)	unprognostic (1.01e-4)	unprognostic (1.57e-2)	unprognostic (6.60e-2)	unprognostic (1.77e-1)	unprognostic (2.75e-3)	unprognostic (3.82e-3)	unprognostic (0.00e+0)	unprognostic (5.65e-3)	unprognostic (3.09e-2)	unprognostic (1.31e-1)	unprognostic (1.73e-1)	1.2	0.3	0.3	11.8	0.6	7.5	1.8	0.5	0.3	0.5	1.5	0.2	0	2.2	0.3	0.4	2.8	0.6	1.3	0.6	0.2	0.2	0.8	0.4	2.6	5.8	0.4	0	0.4	0.5	0	0.3	1.3	0.2	0.7	1.5	0.2	1	0	1.2	0.9	3.6	0.4	1.2	4.9	1.7	26.7	0.3	26.7	0.7	1.7	7.3	0.8	1	2.8	1.5	2.1	0.6	0	1.2	0.4	7.5	8.3	7.7	8.6	0.5	1	6.4	7	5.3	13.8	13.6	6.5	3.1	18.6	4	3.8	5.5	12.3	13.8	6.7	13.2	0.1	11.5	9.2	6.7	3.8	0.3	5.3	9.5	0.6	0.5	10.3	6.4	1.6	6.3	14.8	8.1	16.4	6.9	3.9	10.7	3.1	6.7	5.8	5.7	11.2	9.7	5	2	5.3	3.1	4.5	6.1	4.2	2.4	7	4.2	5	3.2	6.1	7	6.8	12.1	3.1	3.5	9	3.6	7.7	7.3	0.4	0.6	2.1	0.2	0.5	0.2	0.7	0.8	0	1.1	2.8	1.2	0.2	0.2	0	0	1.5	0.1	0.4	0.3	0.6	0.5	0.3	0.2	0.2	0.4	0	0.2	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	2.7	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0.2	0	0	0	Extravillous trophoblasts
C12orf54	MGC35033	ENSG00000177627	Chromosome 12 open reading frame 54	Q6X4T0	12	48482503-48496512	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enriched	Detected in single	38	testis: 34.8	Cell type enriched	Detected in many	5	Late spermatids: 2100.5	Group enriched	Detected in some	9	cervical cancer: 2.9;head and neck cancer: 2.1;lung cancer: 1.6;urothelial cancer: 0.7	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	4	HaCaT: 2.8;HBEC3-KT: 9.4;hTCEpi: 2.6;hTERT-HME1: 5.6									HPA073090			Approved	Intermediate filaments						Intermediate filaments		HPA073090: 	unprognostic (2.59e-3)	unprognostic (5.49e-2)	unprognostic (7.94e-3)	unprognostic (2.60e-2)	unprognostic (2.48e-2)	unprognostic (8.99e-2)		unprognostic (5.96e-2)	unprognostic (1.62e-1)	unprognostic (8.01e-2)	unprognostic (1.36e-4)	unprognostic (2.37e-1)	unprognostic (5.06e-3)	unprognostic (7.53e-2)	unprognostic (1.34e-1)	unprognostic (1.97e-1)	unprognostic (1.92e-1)	0.1	0.3	0.2	0.1	0.1	0	0.1	0.1	0.3	0.2	0.1	0.1	0.1	0	0.3	0.1	0.6	0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.6	0.1	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.2	0.1	0.1	0.1	0.3	0.1	0.1	0	34.8	0.1	0.1	0.1	0.1	0.9	0.1	0.2	0	0	0	0.5	0	0	0	0	0	0	0.2	0.3	0	0	0	0	0	0	0	0	0	0	0	0	2.8	0	9.4	0	0	0	0	0.9	0	0	0	0	0	2.6	0	5.6	0.2	0	0	0	1.1	0	0	0	0	0	0	0	0	0.2	0	0	0.4	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0.2	0.1	0.1	0.3	0.2	0.1	0.3	0.1	0.1	0.1	0	1.6	0	22.3	4.5	0	0.4	0	0	0	0	0	0.1	1.7	0.1	444.4	0.1	0	0	0	0.1	0.4	4.3	0	0	0.1	0	0	0	0	2100.5	10	1.2	0	0	0	0.2	0	0	12.4	0.2	0	6.5	1.4	12.9	6.4	1.9	0	0	0	8.4	Late spermatids
MAGEB10	FLJ32965	ENSG00000177689	MAGE family member B10	Q96LZ2	X	27807990-27823014	Predicted intracellular proteins		Tumor antigen		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	5	blood: 1.9;testis: 7.1	Cell type enriched	Detected in some	6	Spermatogonia: 12.1	Not detected	Not detected							Low cell type specificity	Detected in some			Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		U-2 OS: 4.2					Not detected	Not detected			HPA000611	Uncertain											HPA000611: AB_2138307															unprognostic (2.77e-1)			0	0.1	0	0	0	0.9	0	0	0.1	0	0			0	0	0	0	0	0	0	0	0	0	0	0	0.2	0		0.1	0	0	0	0		0	0		0.2	0	0	0.6	0	0	0	0.1	0.1	7.1			0		0	0.1	0	0.7	0.5	1.9	0.4	0.6	0.5	0	0	0.6	0	0.2	0	0	0.4	0.1	0	0	0.1	0.2	0.5	0.5	0	0.2	0.3	0.2	0.2	0.2	0	0	0.1	0.9	1	0	0	0.3	0.9	0.2	0	0.1	0.1	0.1	0.4	0.3	1.1	0.8	0	0.4	0.3	0.3	0.1	0	0.1	0.5	0.4	0.7	0	0.1	0.2	1.3	0	1.1	0	0	0.1	0.2	0	0.4	4.2	0.4	0	0.3	0.1	0.2	0.3	0.4	0.5	1.9	0.4	0.5	0.4	0.3	0.2	0.3	0.3	0.5	0.1	0.7	0.4	0.3	1.7	0.6	0.3	0.5	0.1	0											0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.1	12.1	0.4	0	0	0	0.1	Spermatogonia
NECTIN3	CD113, CDw113, DKFZP566B0846, nectin-3, PPR3, PVRL3, PVRR3	ENSG00000177707	Nectin cell adhesion molecule 3	Q9NQS3	3	111070071-111275563	CD markers, Predicted intracellular proteins, Predicted membrane proteins	Cell adhesion			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		placenta: 94.2	Cell type enriched	Detected in some	4	Syncytiotrophoblasts: 98.1	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enhanced	Detected in some		memory CD4 T-cell: 1.7	Lineage enriched	Detected in single	4	T-cells: 1.7	Cell line enhanced	Detected in many		AF22: 33.5;TIME: 47.5	Low region specificity	Detected in all			Low region specificity	Detected in all			CAB009869, HPA011038	Approved		Approved	Cell Junctions,Cytosol					20000000	Cytosol	Cell Junctions	CAB009869: AB_2284699, HPA011038: AB_1079719	unprognostic (3.76e-2)	unprognostic (3.81e-3)	unprognostic (1.74e-1)	unprognostic (1.97e-2)	unprognostic (1.02e-1)	unprognostic (9.77e-2)	unprognostic (3.26e-3)	unprognostic (3.77e-1)	unprognostic (7.58e-2)	unprognostic (3.94e-2)	unprognostic (5.33e-2)	unprognostic (7.04e-2)	prognostic favorable (9.82e-7)	unprognostic (2.01e-1)	unprognostic (1.97e-1)	unprognostic (2.67e-1)	unprognostic (1.05e-1)	5.6	4	5.4	4.4	6	0	4.5	1.3	8.9	4.6	12.6	6.5	2.8	17.8	5	2.2	3.5	5.4	4.4	4.8	6.3	5	6.9	16.4	5.6	1.9	6	4.1	9.2	4.7	1.9	1.9	94.2	5.5	6.9	12.6	10.7	3.4	4.8	2.3	1.8	18.9	7.2	8.9	1.8	13.2	27.6	4.5	0.4	24.1	2	1.4	5.4	7.7	0.1	0	0.3	0	0.2	1.7	0.7	0	10.1	33.5	2.2	13.6	25.2	2	22	23.3	13.7	11.7	9.3	4.7	0	7.3	31.3	7.6	0.1	9.3	3.2	25.2	0.2	2.5	0	3.6	0.7	23	1.6	0.3	12.7	1.4	9	8.7	12.3	11.5	0.4	0	8.8	29.5	0	2.2	0	9.4	3.1	3.6	0	16.6	0	8.5	5.3	0.8	6.1	0.4	0	4.6	11.7	0.3	0.1	47.5	17.4	7.2	3.1	13.1	4.9	0	0	11	0	16	0	0	0.3	0.1	0	1.2	0	1.7	1	0	0.1	0.3	0.4	0	0.2	0	0	0.1	0.7	5.4	6	1.3	8.9	6.3	5	6	4.1	5.5	4.5	23.8	7.3	0	0	0	0	0	0	1.4	5.7	12.2	0	3.3	0	3.9	0	0	0	0	16.4	7.6	0	0	1.1	0	0.8	0	0	0	0	0	0	0	0	1.8	0	0	13.3	0	0	6.6	0	0	0	0	0	0	98.1	0	0	0	Syncytiotrophoblasts
TMEM78	FLJ40168	ENSG00000177800	Transmembrane protein 78	Q5T7P6	1	229249636-229251810	Predicted membrane proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in some		blood: 5.3;bone marrow: 2.5	Cell type enriched	Detected in single	5	Melanocytes: 1.7	Not detected	Not detected							Cell type enhanced	Detected in some		basophil: 5.3	Low lineage specificity	Detected in many			Low cell line specificity	Detected in some											HPA042351	Uncertain											HPA042351: AB_10961259	unprognostic (2.45e-2)		unprognostic (3.07e-1)		unprognostic (1.23e-1)			unprognostic (1.51e-1)		unprognostic (3.33e-1)		unprognostic (9.45e-2)		unprognostic (5.59e-2)	unprognostic (1.29e-1)			0.1	0.4	0.5	0.2	0.5	2.5	0.4	0.7	0.7	0.1	0.1			0.1	0.5	0.6	0.1	0.3	0.2	0.1	0.4	0.3	0.1	0.6	0	0.7	0.3		0.2	0.7	0.5	0.2	0		0.4	0.3		0.7	0	1.8	1.2	0.2	0	0.3	0.6	0.1	0.7			0.3		0.2	0.1	0.1	1.3	2.6	5.3	0.5	1.3	0.9	0.1	0.4	1.3	0.8	2.1	0.2	0	0.6	0.4	0	0.1	0.1	0.2	1.9	0.5	0.5	0.4	0.2	1	0	0	0.3	0.6	0.6	0.8	1.8	0.3	0	0.6	0.5	0.2	0	0.1	0	0.5	0.1	0.5	0.3	0.7	0	0.3	0.6	1.5	0.6	0.4	0.6	0.4	0.4	0.2	0.3	1.1	0.4	0.5	0.5	0.2	0	1.1	0.5	0.1	0	0.6	0.5	0.5	0.3	0.9	0.6	0.8	0.5	0.6	0.8	5.3	0.5	0.7	0.7	0.3	0.5	0.8	0.6	0.5	0.1	1.3	0.9	0.8	2.6	1.3	0.5	2.6	0.4	0.1											0	0	0	0.3	0.2	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	1.7	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0.2	Melanocytes
KCNJ10	Kir1.2, Kir4.1	ENSG00000177807	Potassium voltage-gated channel subfamily J member 10	P78508	1	159998651-160070483	Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels	Ion transport, Potassium transport, Transport	Ion channel, Voltage-gated channel	Deafness, Disease mutation, Epilepsy, Mental retardation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	5	brain: 74.1;kidney: 28.1	Cell type enriched	Detected in some	8	Muller glia cells: 83.5	Cancer enriched	Detected in some	6	glioma: 27.4	Low region specificity	Detected in all			Cell type enhanced	Detected in some		T-reg: 2.5	Group enriched	Detected in many	6	NK-cells: 1.7;T-cells: 2.5	Cell line enhanced	Detected in some		Hep G2: 11.7;SK-MEL-30: 3.7;U-266/70: 3.8	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA078302	Enhanced											HPA078302: AB_2732378	unprognostic (2.64e-2)	unprognostic (3.54e-3)	unprognostic (6.19e-2)	unprognostic (1.33e-1)	unprognostic (2.84e-1)	unprognostic (6.98e-4)	unprognostic (1.96e-1)	unprognostic (7.13e-2)	unprognostic (3.43e-1)	unprognostic (1.28e-3)	unprognostic (5.80e-4)	unprognostic (9.52e-2)	unprognostic (2.09e-2)	unprognostic (2.08e-2)	unprognostic (1.41e-1)	unprognostic (3.77e-1)	unprognostic (6.70e-3)	1.4	1.5	23.6	3	28.1	1.3	1.3	10.5	74.1	1.4	1.7	37.9	0	1.5	1.3	1.3	1.4	1.3	1.3	1.3	21.8	13.2	28.1	3.1	1.3	7.1	28.1	15.1	1.3	1.3	1.3	0.3	1.3	25.5	1.3	1.5	0.5	1.5	1.5	1.2	1.6	1.7	1.3	42.9	10.3	2	1.8	25.5	0	1.5	0	2.9	1.5	0.1	0	0	0	0.3	1.7	2.5	0.2	0	0	0.1	0	0	0.4	0.3	0	0	0.3	0.3	0	0.2	1.7	0.2	0	1.1	0.4	0.3	0	0.2	0	0.2	0.1	0.1	11.7	0	0	0.1	0	0	0	0.2	0.1	0	0.9	0	0.3	0	0	0	0	0.2	0.2	0.6	0	2.2	0.1	0	0	0.2	0.4	0	0.3	3.7	1	0.1	0.5	0.1	0.1	0.3	0.9	0	3.8	1.7	0	0.2	0.2	1.8	0	0.3	0	0.4	0.3	0	0	0.1	0.5	0	0	0	1.8	0	1.7	0.3	0	2.5	0.2	23.6	28.1	10.5	22.2	21.8	13.2	28.1	15.1	25.5	25.5	0	0	0	0	0	0.6	0.4	0	0	0	3.5	3.9	0	10	0	0.4	0	0	0	0	0	0	0	0	0	0.2	0	0	0	6.4	1	0	0	0	0	0	83.5	0	0	0	0.2	2	0	0	0.2	0.1	0	0	0	0	0	Muller glia cells
ODF3	CT135, hSHIPPO, SHIPPO1	ENSG00000177947	Outer dense fiber of sperm tails 3	Q96PU9	11	196738-200261	Predicted intracellular proteins	Differentiation, Spermatogenesis	Developmental protein		Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	15	testis: 12.5	Cell type enriched	Detected in some	6	Early spermatids: 76.5	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in single		U-266/70: 1.1	Not detected	Not detected			Not detected	Not detected			HPA038919, HPA039241	Enhanced											HPA038919: AB_2676270, HPA039241: AB_10673417					unprognostic (4.17e-1)					unprognostic (2.41e-1)				unprognostic (1.24e-2)	unprognostic (1.99e-1)			0	0	0	0	0	0	0	0	0	0	0			0	0	0	0	0	0	0	0	0	0	0	0	0	0		0	0.1	0	0	0		0	0		0	0	0	0	0	0	0	0	0	12.5			0		0	0	0	0	0	0.8	0	0	0.3	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0.8	0	0	0	0	0	0	0	0.2	0	0.4	1.1	0.3	0	0	0.3	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0.3	0.8	0	0	0	0	0.6											0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	76.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	12.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0.5	0	0	0	0	0	Early spermatids
LCN15	PRO6093, UNQ2541	ENSG00000177984	Lipocalin 15	Q6UWW0	9	136759634-136766255	Predicted secreted proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	5	brain: 4.9;ductus deferens: 12.0;intestine: 16.5;seminal vesicle: 5.3	Cell type enriched	Detected in some	54	Intestinal endocrine cells: 377.4	Cancer enriched	Detected in some	19	colorectal cancer: 23.0	Group enriched	Detected in some	6	amygdala: 2.4;cerebral cortex: 4.9;hippocampal formation: 1.7	Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	7	Hep G2: 19.7					Low region specificity	Detected in all			HPA060584	Enhanced				Secreted in other tissues							HPA060584: AB_2684327			unprognostic (5.24e-1)	unprognostic (2.61e-1)	unprognostic (2.14e-1)					unprognostic (3.67e-1)		unprognostic (3.45e-2)		unprognostic (3.28e-2)	unprognostic (2.39e-1)		unprognostic (1.83e-1)	0.1	0	2.4	0.1	0.4	0	0.1	0.1	4.9	0.1	12.8	0.1	12	16.5	0.1	2	0.1	0	0.1	1.9	1.7	0.1	0.1	0.1	2	0.1	0.5	0.1	0.1	0.1	0	0.1	0.1	0.1	0.6	2.6	0.1	0.1	5.3	1.3	0	5.2	0.1	0.7	0.3	0	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	19.7	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	2.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	2.4	0.4	0.1	4.9	1.7	0.1	0.5	0.1	0.1	0.1	0	0	0	0.2	0	0	0.2	0	0	0	0	0	0	0	0	0	0	3.1	0	0	0	0	0.3	0	0	0.1	0	377.4	0	0.8	1.7	0	0	1.7	0	0.7	0	0	7	0	0	1	0	0	0	0.2	0.1	0	0	0.6	0.3	Intestinal endocrine cells
PRSS42	TESSP2	ENSG00000178055	Serine protease 42	Q7Z5A4	3	46829542-46834095	Enzymes, Predicted secreted proteins	Differentiation, Spermatogenesis	Hydrolase, Protease, Serine protease		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at transcript level		Group enriched	Detected in some	5	heart muscle: 12.9;skeletal muscle: 19.2	Cell type enriched	Detected in single	4	Cardiomyocytes: 2.5	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		CAPAN-2: 2.3;Daudi: 4.0;Karpas-707: 2.5;NTERA-2: 3.7									HPA046925	Uncertain				Secreted - unknown location							HPA046925: AB_10961401	unprognostic (6.53e-2)	unprognostic (2.72e-2)	unprognostic (3.57e-3)	unprognostic (9.14e-2)	unprognostic (3.26e-1)		unprognostic (2.37e-2)	unprognostic (1.85e-1)	unprognostic (6.54e-2)	unprognostic (4.26e-2)	unprognostic (1.14e-1)	unprognostic (1.12e-1)	unprognostic (1.45e-1)	unprognostic (1.09e-2)	unprognostic (1.38e-1)	unprognostic (1.62e-1)	unprognostic (7.98e-2)	0.2	0.1	0	0	0	0	0.2	0	0	0.6	0.2			0	0.2	3.4	0	0.2	0	12.9	0	0	1.3	0.5	0.2	0	0		0.2	0.2	1.6	0	0.1		0.4	0		0.3	0.2	19.2	0	0	0	0	0.4	0	0.7			0.8		0	0	0.6	0.4	0	0	0.1	0	0.6	0	0	0	0.1	0	0.8	0.2	1.6	0	0	0	0.7	0.2	2.3	4	0.4	0	0.1	0	0	0.2	1.4	0.1	0	0	0.2	0	0	0	0	0.5	0	0	0	0	0	0	0.1	2.5	0	0	0	0.4	3.7	0.5	0	1.3	0	0	0.1	0	0.6	0.5	0.5	0	0.3	1.2	0	0.5	0	1	0.7	0	0	0	0.3	0.9	0.1	0	0.3	0	0.1	0	0.3	0	0	0	0.6	0	0	0.4	0	0	0	0	0	0	0	0											0	0	0	0.2	0	0	2.5	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0	0	0.1	Cardiomyocytes
HTR3C		ENSG00000178084	5-hydroxytryptamine receptor 3C	Q8WXA8	3	184053047-184060671	FDA approved drug targets, Predicted membrane proteins	Ion transport, Transport	Ion channel, Ligand-gated ion channel, Receptor	FDA approved drug targets	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in some	4	lung: 6.8	Cell type enriched	Detected in single	7	Intestinal endocrine cells: 1.7	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	5	GAMG: 3.8					Not detected	Not detected																			unprognostic (4.56e-2)		unprognostic (2.01e-1)		unprognostic (1.39e-1)		unprognostic (1.61e-1)	unprognostic (2.88e-2)	unprognostic (1.68e-2)		unprognostic (8.72e-2)	unprognostic (1.75e-1)		unprognostic (3.88e-1)	0	0	0	0	0	0	0.1	0	0	0	1.3			1.5	0	0	0	0.1	0.1	0	0	0	0	0	6.8	0	0		0	0	0	0	0		0.1	0.2		0	0	0	0	0.4	0	0	0	0	0.1			0.2		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0.6	0.1	0	0.3	0	0.1	0.2	0	3.8	0	0	0	0	0	0	0.7	0	0	0	0	0.1	0	0	0.1	0	0	0	0	0	0.1	0	0	0	0	0.2	0.1	0	0	0.1	0.3	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0.2	0	0	0	0	1.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0	0	0	0.1	Intestinal endocrine cells
TSSK6	CT72, FLJ24002, SSTK	ENSG00000178093	Testis specific serine kinase 6	Q9BXA6	19	19512418-19515685	Enzymes, Predicted intracellular proteins	Differentiation, Spermatogenesis	Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	13	testis: 50.8	Cell type enriched	Detected in some	5	Late spermatids: 5597.9	Low cancer specificity	Detected in all			Low region specificity	Detected in many			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		BEWO: 8.0	Not detected	Not detected			Not detected	Not detected																unprognostic (2.12e-1)	unprognostic (7.89e-2)	unprognostic (7.26e-2)	unprognostic (6.64e-2)	unprognostic (3.39e-1)	unprognostic (7.20e-5)	unprognostic (3.38e-1)	unprognostic (5.51e-3)	unprognostic (5.17e-2)	unprognostic (1.46e-1)	unprognostic (3.98e-4)	unprognostic (2.28e-2)	unprognostic (5.34e-3)	unprognostic (2.74e-3)	unprognostic (2.78e-2)	unprognostic (1.52e-3)	unprognostic (9.89e-2)	0.9	1.2	1	1.2	1.5	1.3	1	0.9	1.9	0.9	1.1	2.2	1.6	2.1	0.9	3.7	1.1	1.1	1	0.7	1.2	0.8	1.8	2.2	0.7	1.2	2.5	1	0.9	3.3	1.1	1	0.6	1.3	1.4	0.6	0.9	1.3	1	1	2.7	1.9	1.2	1.9	2.1	1.7	50.8	1.7	3.1	2	0.1	1.7	1.1	1	3.1	1	2.2	0.7	0.4	3.8	0.8	1.6	2.7	0.1	1.1	0.4	1	8	1.1	0.5	0.6	0.3	4.2	1.3	1.4	2	0	0.5	1.4	0.5	1.1	0.2	1	1.9	0.7	1.7	0.9	1.2	0.9	3.2	0.6	1	0.6	1.9	0.6	0.3	5.4	1.9	0.8	0	0.5	3.4	2	3.7	0.8	4.4	2.7	0.7	1.2	0.1	0.5	0.6	2.9	1.6	0.4	1.4	0.4	2.6	0.7	0.3	2	0.6	3.9	1.7	3.5	1.4	0.8	2.2	1.2	1.9	0	0.6	2.2	0.8	0.2	1.1	3.1	1.7	2	0.3	1.9	3.8	2.1	1.1	0.4	0.7	1	1	0.8	1	1.5	0.9	1.9	1.2	0.8	2.5	1	1.3	1.7	0	0	0	0.2	0.3	0	1.2	0	0	0	0	0	0.1	0	0.1	1053.4	0	0	0	0.2	0.1	0	0.2	0	0	0.1	0	0	1.3	0.6	5597.9	44.3	0	1.7	0	0	0	0.1	0	53.7	0.1	0	19.4	0.6	51.3	21.7	0.1	0.1	0	0	0	Late spermatids
GOLGA8Q		ENSG00000178115	Golgin A8 family member Q		15	30552078-30562501	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level				Tissue enriched	Detected in many	5	thyroid gland: 18.7	Cell type enriched	Detected in some	5	Early spermatids: 30.6	Not detected	Not detected							Cell type enriched	Detected in single	8	NK-cell: 2.0	Lineage enriched	Detected in single	8	NK-cells: 2.0	Group enriched	Detected in some	7	THP-1: 9.4;U-937: 12.8																						unprognostic (2.65e-2)				unprognostic (6.48e-2)			unprognostic (2.24e-1)			unprognostic (5.52e-4)	unprognostic (9.86e-3)	unprognostic (1.26e-1)	unprognostic (7.17e-2)	unprognostic (3.26e-1)	unprognostic (2.31e-1)		1.3	0.4	0	0.2	0.1	2.9	0.9	0	0.1	1.4	0.7			0.1	1.7	3	0.3	1.3	0.2	1.1	0.1	0	0.5	0.5	1.1	0.1	0.2		2.7	2.1	2.7	2.3	0.1		0.8	0.5		0.8	0.4	0.4	0.6	0.6	1	0.5	0.3	0.7	4.1			18.7		0.2	1.2	0.9	0	0	0	0	2	0.2	0.1	0	0.3	0.2	0	0	0	0	0	0	0.1	0	0	0.3	0	0.5	0	0.4	0	0	0	0	0	0	1.3	0	0	0.5	0.6	0	1.5	0	0.3	0.4	0	0	0	0	0	0	0.3	0	0.9	0.1	0	0	0	0.1	0	0.3	0.1	0	0	1.2	0	0	0	0.4	9.4	0.1	1.3	0	0.1	0	0	0	0.1	0	12.8	0.8	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0.1											0	0.3	0	0.2	0	0.7	1.2	0	0	0	0	0	0.1	0	0	30.6	0	0	0	0.2	0	0.3	0.1	0	0.8	0.4	4.8	1.2	0.6	1.3	0.7	2	0.8	1.7	0	0	0.3	0	0	1.4	0	0.6	6.5	0.9	3.3	1.7	0.1	0	1	0	0.1	Early spermatids
SLITRK1	KIAA1910, LRRC12	ENSG00000178235	SLIT and NTRK like family member 1	Q96PX8	13	83877205-83882393	Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	10	brain: 30.6	Cell type enriched	Detected in some	6	Bipolar cells: 6.6	Cancer enriched	Detected in single	8	glioma: 1.8	Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	4	A-431: 7.6;AF22: 3.2;LHCN-M2: 2.8	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA074835	Enhanced				Secreted in brain				270000			HPA074835: 	unprognostic (2.29e-1)				unprognostic (4.32e-1)					unprognostic (4.71e-2)	unprognostic (1.01e-1)			unprognostic (1.65e-2)	unprognostic (7.95e-2)			0.9	1.3	16.7	0.9	9.5	0.9	1	2	30.6	1.2	1	6.3	0	1	1	1	0.9	0.9	1	0.9	16.9	7.3	1	0.9	0.9	0.9	7.3	14.9	0.9	3.1	0.9	3.1	0.9	5.8	0.9	1	0.1	1	1.4	1	0.9	0.9	0.9	3.7	0.9	1	1	8.5	0	0.9	0	0.9	0.9	0.2	0	0	0	0	0	0	0	7.6	0	3.2	0	0.1	0.8	0	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0.6	2.8	0	0	0	0.7	0	0	0	0	0.8	0	0	0.7	0	0	0	0	0	0	0.1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.7	9.5	2	21.5	16.9	7.3	7.3	14.9	5.8	8.5	0	0	0	0	0	6.6	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	1	0	0	0	0	0	0	0	0	0	Bipolar cells
KCNG2	KCNF2, Kv6.2	ENSG00000178342	Potassium voltage-gated channel modifier subfamily G member 2	Q9UJ96	18	79863668-79900184	Predicted membrane proteins, Voltage-gated ion channels	Ion transport, Potassium transport, Transport	Ion channel, Potassium channel, Voltage-gated channel		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in some	4	brain: 5.3	Cell type enriched	Detected in some	16	Horizontal cells: 108.1	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		NB-4: 3.5;U-2 OS: 1.1;U-937: 1.0	Low region specificity	Detected in many			Region enriched	Detected in all	4	hippocampal formation: 31.7	HPA048628	Enhanced											HPA048628: AB_2680466	unprognostic (1.07e-2)	unprognostic (1.34e-2)	unprognostic (8.39e-2)	unprognostic (4.41e-1)	unprognostic (1.99e-1)	unprognostic (9.69e-2)	unprognostic (1.79e-1)	unprognostic (1.99e-1)	unprognostic (2.40e-1)	unprognostic (3.78e-1)	unprognostic (3.61e-3)	unprognostic (1.09e-1)	unprognostic (3.18e-5)	unprognostic (1.05e-1)	unprognostic (7.72e-2)	unprognostic (4.08e-2)	unprognostic (3.63e-2)	0.2	0.1	1.5	0.8	2.2	0.6	0	0.1	2.4	0	0.3			1.1	0.3	0	0.1	0	0	0	5.3	1	0.9	0.1	0.2	0.4	0		0.2	0	0	0.1	0.6		0	0		0.3	0	0	0.1	1.1	0	0.2	0.3	0.3	1.2			0		0	0.5	0	0.6	0.8	0	0.2	0	0	0	0	0	0	0	0	0	0.1	0.5	0	0	0	0	0	0	0	0	0.1	0.3	0	0	0	0	0.4	0	0	0	0.9	0	0.9	0.3	0	0	0	0	0	0	0	0	0	0.2	0	3.5	0	0	0.7	0.3	0	0.3	0	0.4	0	0	0.2	0	0	0	0	0	0.6	0	1.1	0	0	0	0.7	0.1	0.1	1	0.3	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0	0.2	0.8	0	0											0	0	0	0	0	0.5	0.6	0	0	0	0	0	4.2	0	0	0.2	0	0	0	0	6.7	0	0	0	0	1.2	108.1	0	0	2.4	0	0.3	0	0	0	0	0	0	0	0	0.2	0.9	0	0	0.3	2.1	0	5.3	0	0	0	Horizontal cells
CALML5	CLSP	ENSG00000178372	Calmodulin like 5	Q9NZT1	10	5498697-5499555	Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	9	salivary gland: 129.5;skin 1: 212.5	Cell type enriched	Detected in some	6	Suprabasal keratinocytes: 341.5	Group enriched	Detected in many	6	breast cancer: 97.6;cervical cancer: 189.1;head and neck cancer: 206.0;melanoma: 222.1;urothelial cancer: 82.4	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	21	A-431: 95.2					Not detected	Not detected			HPA040725	Enhanced		Approved	Plasma membrane,Cytosol					75000000	Plasma membrane, Cytosol		HPA040725: AB_10793863	unprognostic (7.68e-3)	unprognostic (5.06e-3)		unprognostic (5.64e-2)		prognostic favorable (2.59e-5)		unprognostic (4.82e-2)	unprognostic (2.67e-1)	unprognostic (1.37e-1)	unprognostic (8.27e-2)	unprognostic (1.14e-1)		unprognostic (2.79e-1)	unprognostic (1.71e-1)		unprognostic (4.99e-2)	0.2	0	0.2	0.2	0.2	0	8	0.3	0.2	6.7	0.2	0.2	0.2	0	1	0.2	4.8	0	0.2	0.2	0.2	0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0	0.2	0.2	0.2	0.2	0	0.2	129.5	0.2	1.8	212.5	0.2	0.2	0.2	0.2	0	0.2	0.2	3.1	0.2	10.9	8.2	0.2	19.4	0	0	0	0	0	0	0	95.2	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	1.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0	0	0.3	0.1	0	0	0	0.2	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0.2	0.3	0.2	0.2	0	0.2	0.2	0.2	0.2	0	0	0	0.2	24.3	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0	0	54	0	0	0	0	0	0	0	0	0	0.3	0.2	0.2	341.5	0	0	0	1.4	Suprabasal keratinocytes
CCDC185	C1orf65, FLJ35728	ENSG00000178395	Coiled-coil domain containing 185	Q8N715	1	223393417-223395470	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	150	testis: 31.6	Cell type enriched	Detected in some	15	Early spermatids: 545.7	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in single		SCLC-21H: 3.0	Not detected	Not detected			Not detected	Not detected																unprognostic (1.71e-1)	unprognostic (1.55e-2)		unprognostic (2.41e-6)	unprognostic (9.69e-2)	unprognostic (1.79e-2)		unprognostic (1.12e-2)		unprognostic (1.53e-1)	unprognostic (4.65e-1)	unprognostic (2.58e-1)		unprognostic (1.37e-3)		unprognostic (3.13e-1)	unprognostic (2.61e-2)	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	31.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0.3	0	0	0	0	0	0	0	0.1	0	0	0	0	0.5	0.4	0.1	0.8	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0.4	0	0	0	0.7	0	3	0	0.6	0.1	0	0	0.2	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0.1	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	545.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	36	4.4	0	0	0	0	0	0	0	1.4	0	0	0	0	1.6	1	0	0	0	0	0	Early spermatids
NEUROG2	Atoh4, bHLHa8, Math4A, ngn-2, NGN2	ENSG00000178403	Neurogenin 2	Q9H2A3	4	112513516-112516172	Predicted intracellular proteins, Transcription factors	Differentiation, Neurogenesis, Transcription, Transcription regulation	Activator, Developmental protein, DNA-binding		Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in some		brain: 4.1;testis: 5.1	Cell type enriched	Detected in some	5	Muller glia cells: 8.2	Cancer enhanced	Detected in single		endometrial cancer: 0.7	Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	8	SH-SY5Y: 68.9	Low region specificity	Detected in some			Region enriched	Detected in some	18	hippocampal formation: 17.3	CAB012342	Uncertain											CAB012342: 	unprognostic (1.09e-1)	unprognostic (2.52e-2)	unprognostic (7.51e-2)	unprognostic (4.10e-1)	unprognostic (1.62e-1)	unprognostic (7.75e-2)		unprognostic (1.04e-1)	unprognostic (1.13e-3)						unprognostic (1.02e-1)	unprognostic (3.30e-1)		0.4	0.1	3	0	3.6	0.1	1.2	4.1	1.6	0	0.1	0.5	0	0	0.1	0	0	0.1	0	0.4	3.9	0.1	0	0.1	0.1	0.2	0	0	0.1	0	0	0	0	0.9	0	0	0.5	0.2	0.1	0.2	0.1	0.6	0	0.1	0	0	5.1	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	8.3	0	0	0	0.1	0	0	0	0	0.8	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0.7	68.9	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0.3	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3	3.6	4.1	0.8	3.9	0.1	0	0	0.9	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	1.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	8.2	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	Muller glia cells
UCN3	SPC, UCNIII	ENSG00000178473	Urocortin 3	Q969E3	10	5365009-5374692	Predicted secreted proteins		Hormone		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	5	intestine: 14.9;pancreas: 10.6;pituitary gland: 5.6;stomach 1: 4.6	Cell type enriched	Detected in some	89	Intestinal endocrine cells: 233.1	Group enriched	Detected in many	5	lung cancer: 5.1;pancreatic cancer: 15.4;stomach cancer: 3.7	Low region specificity	Detected in some			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	8	SCLC-21H: 5.5	Region enhanced	Detected in some		hypothalamus: 5.9	Region enriched	Detected in single	7	hypothalamus: 4.7	HPA038281	Uncertain				Secreted to blood							HPA038281: AB_10672408			unprognostic (2.00e-2)	unprognostic (2.31e-1)				unprognostic (1.60e-1)		unprognostic (2.10e-1)	unprognostic (3.18e-3)	unprognostic (8.42e-2)	unprognostic (3.55e-2)	unprognostic (2.91e-2)				0.1	0.9	0.1	0.1	0.4	0	0.1	0.4	0.4	0.1	14.4	0.1	0.1	11.6	0.1	0.1	0.1	1.2	1.2	0.1	0.1	1.7	0.8	0.1	1.3	0.1	0.1	0.5	0.1	10.6	0	5.6	0.1	1.6	0.2	3.1	0.3	0.1	0.1	0.1	0	14.9	0.1	0.5	0.1	4.6	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0.5	0	0	0.1	0	0	0	0.1	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0.1	0.1	0	0	0	0	0.6	0.1	0	0	5.5	0.2	0	0	0	0	0.1	0	0	0	0.4	0.1	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.4	0.4	0.4	0.1	1.7	0.1	0.5	1.6	0.1	0	0	0	0.2	0	0	0.4	0	1.4	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0.2	0	0	0	0	233.1	0	0	0	0	0	0	0	1.3	0	2.6	0.2	0	1	0	0	0	0	0	0	0	0	0.4	0.2	Intestinal endocrine cells
PSAPL1		ENSG00000178597	Prosaposin like 1 (gene/pseudogene)	Q6NUJ1	4	7430294-7434973	Predicted secreted proteins	Lipid metabolism, Sphingolipid metabolism			Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	9	skin 1: 42.2;stomach 1: 23.9;testis: 19.9	Cell type enriched	Detected in single	14	Suprabasal keratinocytes: 2.8	Low cancer specificity	Detected in some			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	4	CACO-2: 11.9;OE19: 23.0;RPMI-8226: 17.4	Not detected	Not detected			Not detected	Not detected			HPA038013, HPA038482	Approved		Enhanced	Cytosol	Secreted - unknown location					Cytosol		HPA038013: AB_10673652, HPA038482: AB_2676037		unprognostic (2.64e-2)				unprognostic (2.40e-1)		unprognostic (9.33e-2)	unprognostic (2.40e-1)	unprognostic (2.61e-1)	unprognostic (7.90e-3)	unprognostic (2.52e-1)		unprognostic (2.08e-2)	unprognostic (2.75e-1)		unprognostic (2.63e-3)	0.1	0	0.1	0.1	0.1	0	3.2	0.1	0.1	0.1	0.5	0.1	0.1	0	0.1	1.4	0.6	0	1.7	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	42.2	0.1	0.1	0.1	0.1	23.9	19.9	0.1	2.5	0.1	0.1	2.1	0.1	0.1	0	0	0.4	0.1	0	0	0	0	0.4	0	0	0	0	0.1	0	0	0	0	11.9	0	0	0	0	0	3.2	0	0	0	0	0	0	0	0	0	0	1.8	0	4.1	0	0	0	0	0	0	0	0	0	0	0	0	23	0	0	0	17.4	0	0	0	0	0	1.1	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0.4	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	0	0	0.1	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.8	0	0	0	0	Suprabasal keratinocytes
CPN2	ACBP	ENSG00000178772	Carboxypeptidase N subunit 2	P22792	3	194339765-194351328	Plasma proteins, Predicted secreted proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	26	liver: 225.5	Cell type enriched	Detected in some	12	Hepatocytes: 157.2	Cancer enriched	Detected in some	32	liver cancer: 72.7	Not detected	Not detected			Cell type enhanced	Detected in single		neutrophil: 2.5	Low lineage specificity	Detected in single			Cell line enriched	Detected in some	25	Hep G2: 37.1	Not detected	Not detected			Low region specificity	Detected in single			HPA004732	Uncertain				Secreted to blood				42000000000			HPA004732: AB_1078561	unprognostic (4.27e-2)	unprognostic (3.04e-1)	unprognostic (1.42e-1)			unprognostic (4.12e-2)	prognostic favorable (2.05e-4)	unprognostic (1.27e-1)	unprognostic (8.65e-2)	unprognostic (8.56e-2)	unprognostic (1.64e-1)		prognostic unfavorable (4.59e-4)	unprognostic (2.91e-2)	unprognostic (2.40e-1)	unprognostic (6.90e-5)	unprognostic (8.42e-2)	0.2	1.1	0	0	0.1	0.3	0.3	0	0	0	0	0	0	0	0	0.1	0	0	0	0.5	0	0	8.5	225.5	0	0	0	0	0	0	0	0	0	0.1	0	0	0.5	0	0	0	0.1	0	0	0.1	0.3	0	0.1	0	0	0	0	0	0	0	0.6	0.4	2.5	0.3	0.2	0.6	0	0.1	0	0.2	0.2	0	0.5	0.1	0.2	0	0	0	0.2	0.1	0.1	0.1	0.5	0.3	0.3	0	0	0.1	0	0.1	0.2	0.3	37.1	0	0.1	0.1	0.1	0	0.1	0	0.2	0	0.1	0.3	0.4	0	0.1	0.1	0.2	0.2	0.1	0	0.1	0.3	0	0.1	0.2	0.2	0.1	0.2	0.1	0.2	0.2	0.1	0.9	1.1	0.1	1.4	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0	0.1	0.3	0.5	0.5	0.2	0.4	0.2	0.5	0.4	0	0.6	0.3	0.6	2.5	0.2	0.1	0.4	0.3	0	0	0.1	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	157.2	0.2	0	0	3.7	2.2	0	0	0	0	0	0	0	0	0	0	13.2	0	0	0	0	0	0	0	0	0	0	Hepatocytes
H1FOO		ENSG00000178804	H1 histone family member O oocyte specific	Q8IZA3	3	129543214-129551467	Predicted intracellular proteins	Meiosis	DNA-binding		Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at transcript level		Tissue enriched	Detected in single	80	testis: 10.8	Cell type enriched	Detected in some	11	Early spermatids: 20.0	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		Hep G2: 1.1;SCLC-21H: 1.5					Low region specificity	Detected in many			HPA037992	Enhanced											HPA037992: AB_10671517															unprognostic (5.43e-2)			0	0	0	0	0	0	0	0	0	0	0			0	0	0	0	0	0	0	0	0	0	0	0	0	0		0	0	0	0.1	0		0	0		0	0	0	0	0	0	0	0	0	10.8			0		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0.9	0	0	0	0	0	0	0	0	0	0	1.5	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	20	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.9	0.3	0	0	0	0	0	0	0	0.4	0	0	0	0	0.2	0.2	0	0	0	0	0	Early spermatids
RFLNA	Cfm2, FAM101A, FLJ44614, RefilinA	ENSG00000178882	Refilin A	Q6ZTI6	12	123973241-124316024	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	6	stomach 1: 118.3	Cell type enriched	Detected in some	24	Pancreatic endocrine cells: 66.2	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	5	hTEC/SVTERT24-B: 9.0;HUVEC TERT2: 12.8;LHCN-M2: 22.4;OE19: 23.3;RH-30: 7.3					Low region specificity	Detected in all			HPA058911, HPA078021	Enhanced		Approved	Nucleoplasm,Golgi apparatus						Nucleoplasm	Golgi apparatus	HPA058911: AB_2683853, HPA078021: AB_2732368	unprognostic (1.71e-1)	unprognostic (6.85e-2)	unprognostic (1.63e-2)	unprognostic (1.36e-1)	unprognostic (3.15e-2)	unprognostic (8.78e-4)	unprognostic (2.01e-1)	prognostic unfavorable (3.16e-5)	unprognostic (8.87e-2)	unprognostic (1.59e-1)	unprognostic (1.71e-3)	unprognostic (1.15e-3)	unprognostic (1.77e-8)	unprognostic (2.48e-1)	unprognostic (1.36e-1)	unprognostic (6.27e-2)	unprognostic (1.37e-2)	5.5	3	6.4	5.2	8.6	2.6	8.2	10.8	6.6	11.7	20.9	9.7	7	19.5	4.8	4.8	3	5.5	3.7	5.1	6.3	6.3	5.4	5.3	3.2	2.8	9.8	5.2	5.2	7.6	2.7	9.4	3.4	9	6.3	15.4	6.3	8.7	5.4	8.5	4.2	20.7	3.4	8.3	2.8	118.3	2.7	8.3	1.9	9.6	2.3	2.8	3.3	4.3	0	0	0	0	0	0.3	0	0	0	1.7	0	0	0	2.3	0	0	0.3	0.3	1.1	0.8	0	0.1	3.1	0.1	0	1.3	0	0.1	0	0.1	0	0	0	0.6	0	0.1	0.5	0	9	0	0.5	12.8	1.3	0	0	22.4	0	0	0	1.9	23.3	0	0	7.3	0.1	0	0	0.9	0.6	0	0	0	0.5	0	0	0.1	0	0.1	0.1	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	6.4	8.6	10.8	6.6	6.3	6.3	9.8	5.2	9	8.3	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	2.7	0	0	0	0	2.3	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	66.2	0	0	0	0	0	0	0	0	0	0	0	0	0	Pancreatic endocrine cells
TPRX1	FLJ40321	ENSG00000178928	Tetrapeptide repeat homeobox 1	Q8N7U7	19	47801243-47819051	Predicted intracellular proteins, Transcription factors		DNA-binding		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at transcript level		Tissue enriched	Detected in single	14	testis: 4.6	Cell type enriched	Detected in single	7	Rod photoreceptor cells: 1.8	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Not detected	Not detected											HPA044922	Uncertain											HPA044922: AB_10962509															unprognostic (8.56e-2)			0	0	0	0	0	0	0.1	0	0	0	0			0	0.1	0	0	0	0	0	0	0	0	0.1	0	0	0		0.1	0	0	0	0		0	0.1		0	0	0	0	0	0.3	0	0	0	4.6			0		0.1	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0.6	0	0	0	0.7	0.6	0.3	0	0	0	0	0.5	0.4	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0.4	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0											0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	1.8	0	0	0	0.2	0	0	0	0	0	Rod photoreceptor cells
C14orf39	SIX6OS1	ENSG00000179008	Chromosome 14 open reading frame 39	Q8N1H7	14	60396469-60515543	Plasma proteins, Predicted intracellular proteins	DNA recombination, Meiosis	Developmental protein		Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		pituitary gland: 16.9;salivary gland: 6.7;testis: 14.9	Cell type enriched	Detected in some	6	Spermatocytes: 70.5	Low cancer specificity	Detected in single			Region enhanced	Detected in single		hypothalamus: 1.4	Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HEL: 4.7;JURKAT: 21.7;MOLT-4: 17.6;RH-30: 4.8;U-2 OS: 9.9	Low region specificity	Detected in some			Not detected	Not detected			HPA059518	Uncertain		Approved	Nucleoplasm,Nucleoli		Yes	No			Nucleoplasm, Nucleoli		HPA059518: AB_2684049	unprognostic (6.17e-2)	unprognostic (1.73e-3)		unprognostic (3.00e-6)	unprognostic (2.78e-1)	unprognostic (6.97e-2)		unprognostic (7.55e-4)	unprognostic (2.12e-1)	unprognostic (1.71e-1)	unprognostic (2.17e-1)	unprognostic (1.78e-1)		unprognostic (7.46e-2)	unprognostic (4.35e-1)	unprognostic (1.50e-1)	unprognostic (2.09e-1)	1	2.7	0	0.6	0.2	0	0.1	0	0.5	0.5	0.8	0	0	0.3	0.6	0	0.7	0	0	0	0	1.4	0	0	0	0	0.1	0.4	1.7	0	0.6	16.9	0	0.2	1.6	0	1.6	6.7	0.1	3.8	0	0.3	0.1	0.5	0	0.6	14.9	0	0	0.4	1	0	0.5	0.2	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0.1	0.1	0.1	0	0	0	0	0	0	0	1	0	0	0	0.6	4.7	0	0	0	0	0.3	3.6	0	0.6	0	0.1	0	21.7	0	0	1.6	0	17.6	0.2	2.3	0	1.1	0	4.8	0	0.3	1.2	0	2	0	0	0	0.4	0	0.1	0	0	9.9	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0.5	0	1.4	0.1	0.4	0.2	0	0	0	0	0.8	0	0.3	0.6	0	1.4	5.7	0	0	0	0	0	7.6	0	0	0	0	0	0	0.7	1.1	0	0	3.2	0	0	0	5.1	0.3	0	0	0	0	11.8	0	0	0.7	0	1	0	0	70.5	6.1	0	0	0	0	0.1	Spermatocytes
CCDC89	FLJ38159	ENSG00000179071	Coiled-coil domain containing 89	Q8N998	11	85684866-85686277	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		testis: 40.6	Cell type enriched	Detected in some	11	Early spermatids: 332.2	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		EFO-21: 5.4;GAMG: 5.2;LHCN-M2: 6.2;SCLC-21H: 7.3;U-2197: 8.3	Low region specificity	Detected in many			Low region specificity	Detected in many			HPA040628	Enhanced		Approved	Nucleoplasm						Nucleoplasm		HPA040628: AB_2677053	unprognostic (5.81e-2)	unprognostic (1.93e-1)	unprognostic (1.99e-1)	unprognostic (3.04e-2)	unprognostic (5.37e-2)	unprognostic (6.38e-2)	unprognostic (1.40e-1)	unprognostic (4.92e-2)	unprognostic (8.22e-2)	unprognostic (2.87e-1)	unprognostic (9.16e-2)	unprognostic (2.00e-1)	unprognostic (2.41e-3)	unprognostic (7.75e-3)	unprognostic (5.10e-2)	unprognostic (8.47e-2)	unprognostic (3.52e-1)	0.7	0.9	0.9	0.1	1.8	0	1.3	6.4	1.3	1.5	0.6	2	0.9	0.1	2.8	0.9	0.3	10.5	1.1	1	1.2	1.2	1.4	0.3	1.2	0.6	0.9	1.2	5.9	0.2	2.7	5.2	0.7	3.7	1.7	0.7	0.9	0.4	1.9	0.7	0.5	0.5	2.6	1.2	0.4	1.1	40.6	0.9	0.1	0.4	0.2	0	0.7	0.7	0	0	0	0.3	0	0.8	0	0	0.1	0	0.1	3.8	5	0.2	1.4	0	0	0.1	0.2	0	0.1	5.4	4.2	5.2	1.9	0	0	0.1	0	1.4	0	0	0.3	2.6	0	0	2.8	0.1	4	0	0	0	0	0	0	6.2	0.3	0	0	0	0.6	0	0	4.3	0	0.3	2.8	7.3	1.8	0	0.9	0	0.1	0.6	0	0	3.7	0	8.3	3.4	0	3.7	0	3.2	0	0	0	0.3	0	0.8	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0.9	1.8	6.4	1.3	1.2	1.2	0.9	1.2	3.7	0.9	0	1.1	0	0	0.2	0.1	0	0	29.4	1.2	0	0	0	0	0	332.2	0	0	0	0	0.1	0.7	0	0	0	1.3	6.4	0	0.6	1.2	13.3	2.8	0	0	0	0	0.9	0	0	4.2	1.2	0.5	0	0.1	3.4	0.9	0.3	0	0	0	0.1	Early spermatids
DAND5	CER2, CKTSF1B3, Coco, DANTE, DTE, FLJ38607, GREM3	ENSG00000179284	DAN domain BMP antagonist family member 5	Q8N907	19	12965159-12974762	Predicted secreted proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in some		blood: 5.3;heart muscle: 13.7	Cell type enriched	Detected in single	29	Cardiomyocytes: 13.8	Low cancer specificity	Detected in single			Low region specificity	Detected in some			Cell type enhanced	Detected in many		neutrophil: 5.3	Low lineage specificity	Detected in many			Cell line enriched	Detected in some	15	SH-SY5Y: 21.0	Low region specificity	Detected in all							HPA043493, HPA049472	Uncertain		Approved	Mitochondria	Secreted in other tissues					Mitochondria		HPA043493: AB_2732505, HPA049472: AB_2680781	unprognostic (1.18e-2)	unprognostic (4.63e-2)	unprognostic (7.51e-2)	unprognostic (4.63e-2)	unprognostic (3.82e-2)	unprognostic (8.71e-2)	unprognostic (2.29e-2)	unprognostic (3.18e-1)	unprognostic (5.95e-3)	unprognostic (7.27e-3)	unprognostic (8.17e-2)	unprognostic (2.15e-1)	unprognostic (2.48e-10)	unprognostic (4.43e-1)	unprognostic (2.48e-2)	unprognostic (6.77e-2)	unprognostic (1.37e-1)	0.2	2	0.9	0.9	2.5	3	0.4	1.4	1.4	0.2	3.6	2.1	0	0.4	0.4	0.4	0.3	0.1	0.7	13.7	0.4	0.3	0.1	0.1	0.2	0.3	0.5	0	0.4	0.4	0.4	0.2	0	3.8	0.2	0.5	3.6	2.6	0	0.2	0.7	2.5	0.4	1.6	0.1	0.7	0.8	0.3	0	0.5	0	0	0.3	0.2	1.6	1.4	5.3	0.6	1.4	1.2	0.3	0.4	0	0.1	0	0	0.1	0.1	0.1	0	0.1	0.1	0	0.2	0.2	0	0.1	0.1	0.3	0	0	0.2	0.1	0.4	0	0.7	0.3	0	0.1	0.2	0.2	0	0.3	0	0.2	0.1	0.8	0.4	1.3	0	0.5	0.3	0.1	0.2	0.1	0.3	0.2	0	0.3	0.2	0.1	1.1	21	0	0	0.2	0.2	0.2	0	0	0.2	0.3	0.1	0.2	0.5	0.1	0.1	0	0.3	0.1	2.7	0.6	1.3	0.7	0.4	0.6	0.9	0.4	0.4	0.2	1.6	0.7	1.2	5.3	1.4	0.3	1.4	0.2	0.3	0.9	2.5	1.4	0.8	0.4	0.3	0.5	0	3.8	0.3	0	0	0	0.2	0.1	0	13.8	0	0	0	0	0	0.2	0	0.1	0.1	0	0	0	0.3	0	0	0.2	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0.5	0.1	0	0	0	0.4	0	0	0	0	0.3	0	0	0.1	0.1	Cardiomyocytes
FAM156B	TMEM29B	ENSG00000179304	Family with sequence similarity 156 member B	Q8NDB6	X	52891306-52908560	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		placenta: 34.3	Cell type enriched	Detected in some	7	Cardiomyocytes: 7.7	Not detected	Not detected			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low cell line specificity	Detected in all											HPA056640, HPA056643	Uncertain											HPA056640: AB_2683200, HPA056643: AB_2683201		unprognostic (2.91e-1)			unprognostic (1.31e-1)					unprognostic (2.66e-1)			unprognostic (3.24e-5)	unprognostic (2.97e-1)				6.4	7.4	6.5	10.9	6.9	5.2	7.9	13.7	12.3	4.6	5	5.6	13.9	5	8.8	9.3	4.6	8.7	5.4	6.4	10.1	5.7	5.9	4.9	5.3	3.8	4.7	11.4	7.7	5	3.9	13.9	34.3	5.6	6.2	4.4	7.2	6.1	9.8	5.1	20.6	4.8	7	5.5	7.6	4.5	4.6	2.4	3.5	7	3	4.7	5.9	5.1	1.1	8	1.2	7.3	3.1	2.6	3.3	3.7	7	4.6	6.6	5	4.2	13.5	3.9	6.1	5.9	4.2	3.5	3.7	3.3	2.8	11.6	4.9	4.8	7.9	6.2	1.7	1	8.8	2.4	13.6	14.1	17	2.2	2.2	9.8	6.5	6.7	5.4	8.8	5.1	9	2.6	2.1	7.7	8.5	5.2	12.5	5	6.1	12	3.5	4.8	5.6	7.1	4.8	4.4	5.2	3.3	8.9	4.3	10.8	5	5.8	4.3	3.1	3.5	6	4.2	4.7	6.7	6.2	4.4	9.6	1.9	0	4.6	1.2	1.2	7.3	1.8	1.1	0.7	1.2	8	1	2.6	0.6	1.1	3.1	6.8	4.5	2.4	3.3	6.5	6.9	13.7	12.3	10.1	5.7	4.7	11.4	5.6	2.4	0	0.6	0	0.1	0.1	0	7.7	0	0	1.2	0	0	0.3	0	0	0	0	0	0	0	0.2	0.2	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0.1	0	0	0	1.1	0	0	0	Cardiomyocytes
CATSPERE	C1orf101, MGC33370	ENSG00000179397	Catsper channel auxiliary subunit epsilon	Q5SY80	1	244454377-244641177	Predicted membrane proteins				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	6	testis: 26.9	Cell type enriched	Detected in some	5	Ciliated cells: 16.0	Not detected	Not detected			Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		ASC TERT1: 2.7;hTERT-RPE1: 2.6					Low region specificity	Detected in many																unprognostic (3.22e-1)	unprognostic (4.50e-2)	unprognostic (2.02e-1)	unprognostic (7.31e-2)	unprognostic (3.32e-1)	unprognostic (2.50e-3)	unprognostic (3.76e-3)	unprognostic (5.39e-4)	unprognostic (1.96e-2)	unprognostic (3.41e-2)	unprognostic (4.37e-4)	unprognostic (4.43e-2)	unprognostic (9.09e-2)	unprognostic (1.76e-1)	unprognostic (5.79e-2)	unprognostic (6.74e-3)	unprognostic (5.85e-2)	0.9	1.1	1.3	0.5	3.2	1.1	1.2	1.7	2.7	1.2	0.5	4.6	0.4	0.5	1.6	4.1	0.6	2.1	0.9	0.5	3.1	1.3	1.4	1.5	1	1.8	1.2	1.3	1.4	2.4	2.6	2.2	0.9	3.2	1	0.5	1.3	0.9	1.1	1	0.7	0.7	1.5	2.8	0.9	0.7	26.9	0.7	0.5	1.6	0	0.6	1	0.8	0.8	0.9	0.8	0.1	0.1	0.8	0.1	0.3	0	0.6	0	1.3	2.7	0.2	1.5	1.5	0.2	0.2	0	0.7	0.5	1.8	1.7	0	0.7	0.4	0.2	0.5	0	1.5	0	0.4	0.1	0.9	0	1.4	2.2	0.7	0.2	0	2.6	0.7	0.7	0.2	0.5	0.2	0	0.2	0.3	0.3	0	0.2	1.4	0	0	0.8	0	1.6	1	0.7	0	0.3	0.4	0.1	0.8	1.8	0.1	0	0	1	0.9	0.1	0	0	0.2	0	0.8	0	0	0.7	0	0.2	0.8	0.1	0.3	0	0.6	0.8	0.1	0	0.1	0.1	0.9	0.2	0.1	1.3	3.2	1.7	2.7	3.1	1.3	1.2	1.3	3.2	0.7	3	1.1	0	0	0	0	0	0	16	2.3	1.8	0	0.1	0	0.3	0	0	0	0	0.6	0.2	0	0	0	0	0.2	0	0	0	0	0	0	0	0	1	0	0	0.1	0	0	1.1	0	0	0	0	0	0	0.3	0	0	0	Ciliated cells
GPC5		ENSG00000179399	Glypican 5	P78333	13	91398607-92873682	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 19.4;kidney: 14.8;testis: 11.3	Cell type enriched	Detected in some	23	Distal tubular cells: 54.7	Cancer enhanced	Detected in some		glioma: 2.1	Low region specificity	Detected in all			Cell type enhanced	Detected in some		NK-cell: 2.0	Low lineage specificity	Detected in many			Group enriched	Detected in some	11	CACO-2: 31.4;HeLa: 18.0	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA040152, HPA044081	Enhanced		Approved	Nucleoplasm,Cytosol	Intracellular and membrane					Nucleoplasm	Cytosol	HPA040152: AB_2676863, HPA044081: AB_2678801	unprognostic (4.99e-3)	unprognostic (2.20e-2)	unprognostic (1.00e-1)	unprognostic (9.93e-5)	prognostic unfavorable (4.37e-4)	unprognostic (4.46e-1)	unprognostic (1.93e-1)	unprognostic (1.80e-2)	unprognostic (9.49e-3)	unprognostic (3.52e-2)	unprognostic (1.21e-5)	unprognostic (2.19e-2)	unprognostic (1.82e-6)	unprognostic (3.03e-2)	unprognostic (2.43e-1)	unprognostic (1.11e-1)	unprognostic (6.69e-3)	0.8	3.8	11.8	1.1	18.3	0.8	0.7	3.1	18.9	0.6	1.5	2.9	0.1	0.7	0.6	0.9	0.6	0.8	1.6	2.3	11.8	6	14.8	2.9	6.5	1	7.3	5.6	1.5	0.8	0.6	7.7	1.4	19.4	0.9	1.5	0	0.8	1.5	0.6	0.7	0.8	0.8	4.4	0.7	0.9	11.3	6.6	0	2.7	0	0.7	0.6	0.3	0.5	0.4	0.3	1.8	2	1.2	0.2	0	0	0.2	0	0	0	0	0	0	0	0	31.4	0	0	0	0	0	0	0.2	0	0	0	0.2	0	18	0	0	0	0	0.2	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0.2	0	0.2	0.3	0	1	0	0.5	0	0.1	0	0	0.7	0	0.1	0	0	0	2.2	0.1	0.3	0	0	0	0.7	0.4	0	0.5	0.1	1.2	0.4	0.2	0	0.5	0.3	2	1.8	0	0	0.2	11.8	18.3	3.1	8.6	11.8	6	7.3	5.6	19.4	6.6	0	2.4	0	0.1	0	0	0.4	0	0	2.3	0	0	0.1	54.7	0	1.1	0	0	0	0	0	0.3	0	0	0	0.1	0	0	0	0	1.1	0.3	0	0	1	0	0	0.1	0	0	0	0	0	0	0.4	0	0	0.1	0	0	0	Distal tubular cells
HTR1D	5-HT1D, HT1DA, HTRL, RDC4	ENSG00000179546	5-hydroxytryptamine receptor 1D	P28221	1	23191895-23194729	FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins		G-protein coupled receptor, Receptor, Transducer	FDA approved drug targets	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in some		brain: 3.9;intestine: 12.2	Cell type enriched	Detected in single	12	Cholangiocytes: 7.6	Low cancer specificity	Detected in many							Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		A549: 8.5;hTERT-RPE1: 8.2;OE19: 11.4;TIME: 21.3;U-2 OS: 7.2	Region enhanced	Detected in some		basal ganglia: 7.6	Low region specificity	Detected in many																unprognostic (1.73e-2)	unprognostic (8.69e-3)	unprognostic (8.86e-3)	unprognostic (2.03e-1)	unprognostic (2.65e-2)	unprognostic (5.97e-4)	prognostic unfavorable (1.86e-4)	unprognostic (3.87e-3)	unprognostic (8.88e-2)	unprognostic (4.00e-2)	prognostic unfavorable (5.30e-4)	unprognostic (3.17e-2)	unprognostic (3.28e-6)	unprognostic (9.14e-2)	unprognostic (2.27e-1)	unprognostic (2.45e-1)	unprognostic (8.02e-3)	0	0	0.3	0	3.9	0.1	0	0	0.2	0	0.1			12.2	0	0	0	0.5	1.9	0	0.2	0.4	0	0	0.2	0	0.2		0	0.1	0	0.1	0		0.1	0.1		0	0	0	0.1	10.4	0	0.2	0	0	0.4			0		0	0.5	0	1	0.7	2.2	1.2	1.2	0.9	0.2	2.5	8.5	0	0	0	0.2	0.7	0	0.6	0.3	0.3	0.5	6.1	0	2.5	0.3	4.3	1.8	1.7	0	0.4	0	0.7	0	5	0.1	0.3	0	0	0.1	0.1	1	0.3	8.2	5	0.1	0	0	0.2	1	0	0	2	11.4	0.1	0	0	0	0.2	0	2.1	0	5.7	0.3	0.1	0.7	0.1	0	21.3	0	7.2	0.1	2	0	0	0	0	0	0.1	1.7	1.2	0.5	0.6	0.8	0.4	1	0.9	0.6	0.4	1	0.6	0.6	2.2	1.2	1	0.7	0.4	0.2											0	0	0	0.2	0	0	0.3	7.6	0	0	0	0	0.1	0	0.4	0.4	0	0.3	0	0	0.1	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0	0.2	0	0	0.5	Cholangiocytes
LSMEM2	C3orf45, FLJ38608	ENSG00000179564	Leucine rich single-pass membrane protein 2	Q8N112	3	50279027-50288114	Predicted membrane proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Group enriched	Detected in some	6	heart muscle: 26.6;skeletal muscle: 16.3;tongue: 7.2	Cell type enriched	Detected in some	5	Late spermatids: 197.4	Not detected	Not detected			Low region specificity	Detected in many			Cell type enhanced	Detected in single		MAIT T-cell: 1.2	Lineage enriched	Detected in single	13	T-cells: 1.2	Cell line enhanced	Detected in some		HeLa: 3.7;WM-115: 3.5					Low region specificity	Detected in many			HPA079523			Approved	Nucleoplasm,Plasma membrane						Plasma membrane	Nucleoplasm	HPA079523: 	unprognostic (2.84e-3)	unprognostic (6.54e-2)	unprognostic (2.36e-2)	unprognostic (1.09e-1)	unprognostic (1.03e-1)	unprognostic (2.30e-1)	unprognostic (8.96e-2)	unprognostic (1.02e-1)	unprognostic (1.55e-2)	unprognostic (2.65e-1)	unprognostic (3.17e-2)	unprognostic (2.82e-1)	unprognostic (1.82e-1)	unprognostic (2.46e-2)	unprognostic (2.48e-1)	unprognostic (6.49e-3)	unprognostic (1.71e-1)	0.6	0.3	1.2	0.2	2.1	0.4	0.2	0.7	1.9	1.1	0.3	2.1	0.1	0.4	1.4	0.4	0.7	0.8	0.4	26.6	1.4	0.7	0.3	0.1	0.3	0.1	1.3	0.6	0.9	0.3	0.1	0.1	0.2	1.3	0.4	0.3	1.6	1.4	0.5	16.3	0.1	0.5	0.5	1.6	0.2	0.2	3	0.9	0.1	0.2	7.2	0.2	0.3	0.7	0	0	0	0	0	1.2	0	0.1	0.3	0.2	0.3	0	0	0.4	0.4	0.4	0.4	0.2	0.3	0.5	0.1	0.1	0	0.5	0.1	0.1	1.1	0.1	0	0.5	0.2	3.7	0.2	0	0.3	0.2	0.2	0	0.1	0.2	0.5	0	1.1	0	1	0	0.2	0.1	0.7	0.5	0.4	0	0	0.3	0	0.3	0.3	0.1	0.5	0	0.8	1	0.4	0	0	0	0.2	1.3	0.4	0.4	0.9	0.6	0.6	0.1	0.9	3.5	0	0	0	0	0	1.2	0	0.1	0.3	0	0	0.8	0.1	0	0	0	0	0	0	1.2	2.1	0.7	1.9	1.4	0.7	1.3	0.6	1.3	0.9	0	1.1	0	0.1	0.9	0.1	3	0	0	1.2	1.8	0	0	0	0.1	41.7	0	0.9	0	0.2	0.1	0.3	0.3	4.7	0	0.1	0	0	0	0	197.4	1.1	0	1.7	0	0.4	0.5	0.1	0	0.7	0	0.2	0	0.7	1.6	1	1.1	0.1	0	0.6	0.1	Late spermatids
TPPP2	C14orf8, CT152, p18, p25beta	ENSG00000179636	Tubulin polymerization promoting protein family member 2	P59282	14	21024109-21036276	Predicted intracellular proteins	Differentiation, Spermatogenesis			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	21	testis: 99.4	Cell type enriched	Detected in some	4	Late spermatids: 7275.7	Cancer enhanced	Detected in single		liver cancer: 0.5	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		CACO-2: 2.6;HAP1: 1.8;Hep G2: 1.3;RT4: 1.7	Not detected	Not detected			Not detected	Not detected			HPA004120	Enhanced											HPA004120: AB_2303582	unprognostic (2.91e-2)	unprognostic (2.49e-3)	unprognostic (2.54e-1)		unprognostic (1.66e-2)	unprognostic (2.14e-2)	unprognostic (2.57e-3)	unprognostic (4.63e-4)		unprognostic (3.83e-1)	unprognostic (3.16e-1)	unprognostic (1.09e-1)	unprognostic (4.64e-4)	unprognostic (2.51e-4)	unprognostic (1.22e-1)	unprognostic (1.06e-1)	unprognostic (3.21e-1)	0.1	0	0.1	0.1	0.1	0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0	0.1	1.8	0.1	0	0.1	0.1	0.1	0	0.2	4.8	0.1	0.1	0.1	0.1	0.2	0.1	0	0.1	0.1	0.1	0.1	0	0.1	0.5	0.1	0.9	0	0.1	0.1	0.1	0.1	0	99.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0.4	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	2.6	0	0	0	0	0	0	1.8	0	0	0	0	0	0	1.3	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	1.7	0	0.7	0	0	0	0.6	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0.1	0.1	0.1	0.2	0.1	0	0.1	0.1	0.1	0.1	0	0	0	0	0	0	1.4	0	0	0	1.8	0	0	0	0.1	1716.6	0	0	0	0	0	0	0	0	4.3	0	0	0	0	0	7275.7	44	0	0	0	0	0.8	0	0	32.9	0	0	0	0	48.1	24.2	0	0.1	0	0	0	Late spermatids
RPRML	MGC43894	ENSG00000179673	Reprimo like	Q8N4K4	17	46978156-46979248	Predicted membrane proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enriched	Detected in some	7	brain: 27.0	Cell type enriched	Detected in some	9	Intestinal endocrine cells: 30.5	Cancer enhanced	Detected in some		testis cancer: 1.7	Low region specificity	Detected in many			Cell type enriched	Detected in single	13	naive B-cell: 1.3	Lineage enriched	Detected in single	13	B-cells: 1.3	Cell line enhanced	Detected in some		AF22: 2.6;Daudi: 16.2;HEK 293: 5.0;NTERA-2: 2.5;SCLC-21H: 2.5	Group enriched	Detected in many	13	amygdala: 44.0;basal ganglia: 29.6;cerebral cortex: 41.6;hippocampal formation: 38.9;olfactory region: 24.9	Region enhanced	Detected in many		basal ganglia: 311.4	HPA062668	Uncertain											HPA062668: AB_2684827			unprognostic (7.79e-4)		unprognostic (1.66e-2)		unprognostic (8.35e-2)	unprognostic (2.42e-2)		unprognostic (2.31e-1)	unprognostic (8.93e-4)	unprognostic (2.78e-2)		unprognostic (1.00e-1)	unprognostic (1.65e-1)			0.8	0.6	6.6	0.6	27	0.6	0.8	3.6	16.5	0.6	0.8	0	0	0.8	0.6	2.5	0.6	0.7	0.6	0.6	4.9	1.3	0.7	0.6	0.6	0.6	0.8	10.1	0.6	0.6	0.6	0.1	0.6	0	0.8	0.6	0.4	0.7	0.6	3.9	1	0.8	0.6	0	0.7	1.3	0.7	2.7	0	0.6	0	0.6	0.6	0	1.3	0	0	0	0	0	0	0	0.1	2.6	0	0	0	0	0	0	0	0	0	0	16.2	0	0	0	0	0	0	0	0.1	5	0	0	0.1	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0.1	0.2	0	2.5	0	0.6	0.9	0.3	0	0	0	2.5	0.1	0	0	0	0	0	0	0	0	1	0.1	0.1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.3	0	0	0	0	0	0	0	0	6.6	27	3.6	11.6	4.9	1.3	0.8	10.1	0	2.7	0	0	0	0	0.3	0	0.4	0	0	0	0	0	0	0	0	0	0.2	0	0	3.5	0.1	0	0.3	0	0	0	0	30.5	0.6	0	0	0.3	0	1.7	0	0.3	0	0.2	0	0	0	0	0	0	0	0.1	1	0	0	0.2	0	Intestinal endocrine cells
NLRP8	CLR19.2, NALP8, NOD16, PAN4	ENSG00000179709	NLR family pyrin domain containing 8	Q86W28	19	55947832-55988629	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in some		blood: 1.7;breast: 1.9;heart muscle: 1.5	Cell type enriched	Detected in some	6	Cardiomyocytes: 10.6	Not detected	Not detected							Cell type enhanced	Detected in single		basophil: 1.7	Low lineage specificity	Detected in single			Not detected	Not detected							Not detected	Not detected			HPA056989	Uncertain											HPA056989: AB_2683301	unprognostic (2.43e-2)											unprognostic (3.35e-1)		unprognostic (3.13e-1)	unprognostic (6.96e-2)			0	0	0	0	0	0.2	1.9	0	0	0.1	0			0	0	0.4	0	0	0	1.5	0	0	0	0	0	0	0		0.1	0	0	0	0		0.9	0		0.8	0	0	0.2	0	0	0	0	0	1			0		0	0.1	0	0.7	0.3	1.7	0.2	0.4	0.3	0	0.1	0	0	0	0	0.4	0.2	0	0	0.2	0	0.2	0.2	0.2	0.2	0	0.1	0.2	0	0.4	0.1	0	0	0.2	0.6	0.4	0	0	0.2	0	0	0	0	0	0	0.2	0	0.2	0	0	0	0	0.1	0.1	0.2	0.4	0	0.2	0	0.4	0.4	0	0	0.1	0	0.3	0.7	0.5	0	0.7	0.7	0.4	0.1	0.2	0	0	0.1	0.1	0.3	1.7	0.2	0.2	0.2	0.2	0.2	0.3	0.1	0.2	0	0.7	0.3	0.3	0.8	0.4	0.1	0.3	0.1	0											0	0	0	0.1	0	0	10.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	1.7	0	0	0	0	0	0	0	0	0	0	0.5	0	0.1	0	0	0	0.1	Cardiomyocytes
SYCN	FLJ27441, INSSA1, SYL	ENSG00000179751	Syncollin	Q0VAF6	19	39202831-39204266	Predicted intracellular proteins	Exocytosis			Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	681	pancreas: 1347.2	Cell type enriched	Detected in some	4	Exocrine glandular cells: 3381.8	Cancer enriched	Detected in single	842	pancreatic cancer: 369.8	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		U-2 OS: 1.3;U-266/84: 2.5	Not detected	Not detected			Not detected	Not detected			HPA047654	Enhanced				Intracellular and membrane				1100000			HPA047654: AB_2680112											unprognostic (8.02e-2)							0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	1347.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.8	0	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.8	0	0	0	0	0	0	1.3	0	0.3	0	2.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	7.1	4.3	0	0	0	3381.8	0	0	0	0	0	0	0	0	0	0	5.9	1.1	0	0	17.2	0	0	825.3	0	0	0	0	0	0	0.5	0.9	0	0	0	0	0	Exocrine glandular cells
LRRC3B	LRP15	ENSG00000179796	Leucine rich repeat containing 3B	Q96PB8	3	26622806-26710776	Predicted intracellular proteins, Predicted membrane proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	6	brain: 21.3;skeletal muscle: 17.4;testis: 12.0	Cell type enriched	Detected in some	28	Early spermatids: 56.9	Group enriched	Detected in some	9	endometrial cancer: 0.7;glioma: 2.6;ovarian cancer: 1.1	Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		NTERA-2: 3.8;REH: 1.8;SuSa: 9.0;THP-1: 2.2	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA015568	Approved											HPA015568: AB_1853282	unprognostic (1.22e-2)			unprognostic (2.94e-1)	unprognostic (1.87e-1)		unprognostic (7.42e-2)	unprognostic (8.82e-4)		unprognostic (2.84e-2)	unprognostic (1.55e-1)	unprognostic (2.77e-1)	unprognostic (1.91e-4)	unprognostic (3.31e-2)	unprognostic (2.63e-1)	unprognostic (1.60e-1)	unprognostic (2.82e-1)	0.8	0.9	15.5	0.7	13.6	0.6	1.6	18.5	21.3	0.8	1.2	2.2	0	0.8	2.3	0.7	1.5	1.6	0.7	1.4	9.5	7.3	0.8	0.8	0.8	0.6	8.7	5.6	2.9	0.6	0.7	0.8	0.7	5.7	0.8	1.9	3	1.9	1.1	17.4	0.7	1.2	2	4.9	0.8	1.5	12	1.7	0	0.7	0.1	0.7	2.4	0	0	0.4	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0.1	0	0.6	0	0	0	0	3.8	0	0	1.8	0	0	0	0	0	0	0	0	0	9	0	2.2	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	15.5	13.6	18.5	10.1	9.5	7.3	8.7	5.6	5.7	1.7	0	0	0	0	0.1	1.3	0.4	0	0	0	0	0	0	0	0	56.9	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	2	0.6	0	0	0	0	0	0	0	0	0	0.3	0	0	1.7	0.5	0.1	0	0	0	0	Early spermatids
FAM216B	C13orf30, FLJ40919	ENSG00000179813	Family with sequence similarity 216 member B	Q8N7L0	13	42781550-42791549	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in some		brain: 21.0;epididymis: 18.2;fallopian tube: 51.3;lung: 28.5;ovary: 18.3	Cell type enriched	Detected in some	8	Ciliated cells: 348.0	Group enriched	Detected in some	10	endometrial cancer: 4.4;lung cancer: 1.4;ovarian cancer: 0.9	Group enriched	Detected in many	5	basal ganglia: 9.5;pons and medulla: 21.0	Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	12	U-87 MG: 6.5	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA040118	Uncertain											HPA040118: AB_10674429	unprognostic (1.03e-2)		unprognostic (2.24e-1)	prognostic favorable (9.77e-4)	unprognostic (4.35e-2)	unprognostic (1.32e-1)		unprognostic (1.19e-1)	unprognostic (2.54e-2)	unprognostic (5.44e-3)	unprognostic (1.32e-1)	unprognostic (2.27e-1)		unprognostic (8.14e-3)	unprognostic (1.37e-1)		unprognostic (1.30e-2)	0.3	0.2	1.7	0.9	9.5	0.2	0.2	0.1	0.6	3	0.3	8	0	0.3	1.3	18.2	0.2	51.3	0.4	10	3.1	3.2	0.2	0.2	28.5	2.2	0.1	0	18.3	0.3	0.2	2	0.2	21	0.2	0.5	0	0.7	0.2	0.2	0.2	1.5	0.2	0.5	0.3	0.3	1	1.7	0	0.2	0	3.9	0.4	0.1	0.1	0	0	0.1	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0.3	0	0.5	0	0	0	0	0	0	0	0	0.2	0	0.1	0.1	0	0	0.1	0	0	0	0	0	0	0	0	0.2	0	0	0	0.1	0	0	0.1	0	0	0	0.5	0	0	0	0	6.5	0.1	0.1	0	0.1	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	1.7	9.5	0.1	0.6	3.1	3.2	0.1	0	21	1.7	0	3.8	0	0	0	0	7.7	0	348	42.1	0	0	0	0	0	1.5	0	0	0	0	0	0	0.1	1.1	0	0.3	0	0	0	0	6.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	Ciliated cells
NKPD1	FLJ33600	ENSG00000179846	NTPase KAP family P-loop domain containing 1	Q17RQ9	19	45149750-45158737	Predicted membrane proteins				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	7	skin 1: 17.5	Cell type enriched	Detected in some	4	Horizontal cells: 4.8	Low cancer specificity	Detected in some							Cell type enhanced	Detected in single		naive CD4 T-cell: 1.8	Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		hTCEpi: 4.0;SiHa: 3.5;U-266/70: 7.3	Low region specificity	Detected in some			Not detected	Not detected			HPA043339	Uncertain											HPA043339: AB_10962493	unprognostic (3.98e-2)	unprognostic (5.94e-2)	unprognostic (2.14e-1)	unprognostic (8.30e-4)	unprognostic (2.23e-1)	unprognostic (4.60e-2)	unprognostic (2.41e-3)	unprognostic (2.01e-2)	unprognostic (2.60e-1)	unprognostic (2.35e-2)	unprognostic (7.73e-4)	unprognostic (1.30e-1)	unprognostic (2.77e-5)	unprognostic (1.00e-1)	unprognostic (1.26e-1)	unprognostic (8.90e-2)	unprognostic (2.13e-1)	0	0.1	0	0	0.1	0.2	0.8	0.5	0.2	0.9	0			0	0	0.3	0.8	0.1	0	0	0	0.1	0	0	0	0	0		0	0	0	0.3	0		0.5	0		0.6	0.8	0.1	17.5	0	0	0	0	0	0.6			0.1		0	0	2.4	0.2	0.2	0.5	0.1	0.2	1.8	0	0.2	0.2	0.1	0.1	0.1	0.2	0.3	0	0	0	0	1.5	0.4	0.3	0.7	0	0.1	0.4	0	0	0	0.5	0.6	1.5	0.1	0.1	0.1	0	0	0.2	4	0	0.1	0.1	0.1	0.2	0.4	0.7	0	1.1	0.7	0.5	0.3	1.8	0.4	0.1	0	0.3	0	0.1	0.6	0.3	3.5	1.8	0.1	0.5	1.3	0.3	0	0	0	0	0	7.3	1.7	0.3	0.1	0	0	0.5	0.1	0	0.1	0	0	0.1	0.5	0.6	0	0.2	1.8	0.1	0.4	0.2	0	0.2	0	0											0	0	0	0.2	0.1	0.8	0.4	0	0	0	0	0	0	0	0	0.5	0	0	0	0.2	0	0	0.1	0	0	0.1	4.8	0	0	0	0.8	0	0	0	0	0	0	0.1	0	0	0	0	0	0.1	0.7	0.2	1.1	0.1	0	0	0	Horizontal cells
ABCA13	FLJ33876, FLJ33951	ENSG00000179869	ATP binding cassette subfamily A member 13		7	48171458-48647496	Predicted membrane proteins				Evidence at transcript level	Evidence at transcript level				Tissue enhanced	Detected in many		bone marrow: 35.4;lung: 15.7;lymphoid tissue: 14.4	Cell type enriched	Detected in some	7	Ciliated cells: 64.3	Low cancer specificity	Detected in some			Low region specificity	Detected in some			Cell type enhanced	Detected in some		basophil: 3.2	Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		HDLM-2: 8.7;LHCN-M2: 3.7;U-2 OS: 10.4;U-266/84: 4.2	Not detected	Not detected			Low region specificity	Detected in all			HPA063601			Approved	Vesicles,Centrosome,Cytosol						Vesicles	Centrosome, Cytosol	HPA063601: AB_2685057	unprognostic (8.97e-2)	unprognostic (5.82e-2)	unprognostic (3.18e-1)	unprognostic (6.48e-2)	unprognostic (2.65e-2)	unprognostic (5.59e-2)	unprognostic (5.19e-2)	unprognostic (2.33e-3)	unprognostic (1.90e-1)	unprognostic (1.86e-3)	unprognostic (6.03e-3)	unprognostic (3.26e-1)	unprognostic (1.89e-2)	unprognostic (1.99e-1)	unprognostic (1.25e-1)	unprognostic (2.04e-1)	unprognostic (3.62e-2)	0.3	0.2	0.1	0.3	1	35.4	0.7	0	1.1	1.2	0.3	0.4	0	0.3	0.3	1.1	10.3	1.8	0.5	3.5	1.8	0.2	1.1	0.7	15.7	0.2	0.1	0	0.4	1.2	0.1	8.7	1.2	0.4	0.2	0.4	0	1.7	0.4	0.8	1.3	0.3	0.2	0.9	1.3	0.2	4.2	0	4.6	7.1	5.4	14.4	0.5	0.3	0.6	0.6	3.2	0.7	1	0.4	0.2	0	0	0.4	0	0	0.4	0	0.3	1	0	0.3	0	0	0	2.2	0	1.9	0.6	1.2	2.1	0	8.7	0	0	0.1	0	0	0	0.1	0	0.2	0.1	1	0.8	0	0.3	0	0.1	3.7	0	0	0.1	0.1	0	2.1	0.3	0	0	0.5	0	0.7	0	0	0.7	0	0.1	0.1	0.1	0	0.6	10.4	0.4	1.5	3.1	4.2	0	1.3	0.4	0.4	3.2	0.7	0.6	0.3	0.4	0.3	0.4	0.2	0.2	0.1	0.6	0.4	0.4	1.6	1	0.3	0.6	0.1	0.2	0.1	1	0	1.1	1.8	0.2	0.1	0	0.4	0	0	0.3	0	0	0	0	9	0	64.3	9.1	1.8	0	0	0	0	7.8	0	0	0	0.3	0	0.1	0	0	0.8	0.2	0	0	0	0	3.6	0	0	0	0	0.1	0	0.2	0	0	0	0	0	0	1.5	3.2	0	0	0	0.3	0.1	Ciliated cells
ITLN1	FLJ20022, hIntL, HL-1, ITLN, LFR	ENSG00000179914	Intelectin 1	Q8WWA0	1	160876539-160885170	Plasma proteins, Predicted secreted proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	5	adipose tissue: 119.2;heart muscle: 48.6;intestine: 157.9;lymphoid tissue: 40.1	Cell type enriched	Detected in many	16	Mucus-secreting cells: 1345.2	Cancer enhanced	Detected in many		colorectal cancer: 61.1	Not detected	Not detected			Group enriched	Detected in some	11	intermediate monocyte: 6.9;non-classical monocyte: 17.3	Lineage enriched	Detected in many	15	monocytes: 17.3	Group enriched	Detected in some	4	HEL: 3.8;HL-60: 2.8;OE19: 10.5;U-937: 10.6	Not detected	Not detected							CAB012652, HPA063275, HPA067326	Enhanced				Secreted to blood			294000000	160000000			CAB012652: , HPA063275: AB_2684974, HPA067326: AB_2732764	unprognostic (9.69e-2)	unprognostic (2.48e-2)	unprognostic (1.31e-3)	unprognostic (2.28e-1)		unprognostic (1.79e-2)	unprognostic (1.11e-1)	unprognostic (1.59e-2)	unprognostic (1.70e-1)	unprognostic (5.22e-3)	unprognostic (1.66e-2)	unprognostic (4.38e-1)	unprognostic (9.96e-2)	unprognostic (3.67e-1)	unprognostic (8.99e-2)	unprognostic (1.92e-1)	unprognostic (2.34e-2)	119.2	0	0.2	40.1	0.2	0	0.2	0.2	0.2	0.4	52.5	0.2	1	31.9	0.5	8.8	0.7	1.2	8.7	48.6	0.2	0	0.5	2.6	13.9	0.2	0.2	0.3	4.3	0.2	0	0.4	0.4	0.3	3	157.9	0.2	2.6	0.6	1.5	0.1	48.6	0.8	0.2	0.6	1.9	2.7	0.2	0.4	0.2	1.4	1.5	1.6	0.8	0	1.1	0.1	17.3	0	0.1	0.3	0	0	0	0	0	0	0.8	0	0	0	0	0.5	0	0	0.2	0	0.6	0	0	0	0	0	0.1	3.8	0	0	1.7	2.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0.7	0	10.5	0	0	0	1.5	0	0.3	0.1	0.6	0	0	0	0.2	0	0	0	0	0	0.2	0.1	0	0	0.1	0	10.6	0	0	0.3	0	0	6.9	0	0	0	0.1	1.1	0	0	0	0.1	0	17.3	0	0	0.3	0.2	0.2	0.2	0.2	0.2	0	0.2	0.3	0.3	0.2	0	6.7	0.9	0.1	0	0	6.1	2.5	1.4	3.4	3.5	0	0	0	0	0.5	0	20.4	0	3.3	0.7	0	0.3	1.1	0	0.8	0	17.2	81	86	0.4	13.6	0	0	0	1345.2	0	4.3	11.5	2.8	0	0	0	0	0	0	0	0.2	3.2	43.2	0.1	Mucus-secreting cells
CCR8	CDw198, CKR-L1, CMKBR8, CMKBRL2, CY6, GPR-CY6, TER1	ENSG00000179934	C-C motif chemokine receptor 8	P51685	3	39329706-39333511	CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins		G-protein coupled receptor, Receptor, Transducer		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Group enriched	Detected in some	7	blood: 19.8;lymphoid tissue: 19.3;urinary bladder: 5.3	Cell type enriched	Detected in single	11	Alveolar cells type 2: 1.1	Low cancer specificity	Detected in some			Not detected	Not detected			Cell type enriched	Detected in some	5	T-reg: 19.8	Lineage enriched	Detected in single	30	T-cells: 19.8	Cell line enriched	Detected in some	22	HDLM-2: 50.0	Not detected	Not detected			Low region specificity	Detected in all			HPA042383	Enhanced											HPA042383: AB_2732497	unprognostic (2.16e-1)	unprognostic (2.12e-2)	unprognostic (2.91e-2)	unprognostic (1.04e-1)	unprognostic (2.38e-2)	unprognostic (7.63e-4)	unprognostic (3.31e-1)	unprognostic (1.27e-1)	unprognostic (2.30e-3)	unprognostic (3.37e-2)	unprognostic (7.40e-2)	unprognostic (2.99e-1)	unprognostic (4.65e-8)	unprognostic (7.96e-2)	unprognostic (2.24e-2)	unprognostic (2.56e-1)	unprognostic (4.14e-1)	0.3	0.2	0.2	3.1	0.2	0	0.3	0.2	0.2	0.3	0.5	0.1	0.1	0	0.3	0.1	0.8	0.1	2.1	0.2	0.2	0.2	0.5	0.3	1.4	2.8	0.1	0.1	0.2	0.3	0	0.2	0.1	0.1	0.4	1.3	0.1	0.5	0.1	0.2	1	1.2	0.1	0.4	1.7	0.8	0.3	0.1	19.3	0.4	1.2	3.5	5.3	0.3	0	0	0	0	0.6	19.8	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	50	0	0	0	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0.1	1.3	2.2	0	0	0	0	0	0	0	0	0	0	0	0	1.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4	1.8	0	0	0.2	0	0	0.6	0	0	19.8	0.6	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.1	0.1	0.1	0	1.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Alveolar cells type 2
AC087498.1		ENSG00000180042			17	3385930-3386874	Predicted membrane proteins				Evidence at transcript level	Evidence at transcript level				Group enriched	Detected in some	8	blood: 5.2;testis: 2.8	Cell type enriched	Detected in single	18	Collecting duct cells: 1.8	Not detected	Not detected							Cell type enriched	Detected in single	16	plasmacytoid DC: 5.2	Lineage enriched	Detected in single	16	dendritic cells: 5.2	Cell line enriched	Detected in single	6	HDLM-2: 5.5	Not detected	Not detected			Low region specificity	Detected in many																														unprognostic (5.24e-2)			0	0		0		0	0		0.1	0	0			0	0	0.4	0	0	0	0			0	0	0	0			0	0	0		0		0	0		0	0	0	0	0	0		0	0	2.8			0		0.3	0		0	5.2	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	5.2	0	0											0	0	0	0	0	0	0	0	0	0	1.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Collecting duct cells
TMEM150B	TMEM224, TTN2	ENSG00000180061	Transmembrane protein 150B	A6NC51	19	55312801-55334048	Predicted membrane proteins	Autophagy			Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in many		intestine: 37.0	Cell type enriched	Detected in some	5	Enterocytes: 30.4	Cancer enhanced	Detected in many		colorectal cancer: 11.6	Low region specificity	Detected in many			Cell type enhanced	Detected in some		classical monocyte: 9.3	Group enriched	Detected in many	8	granulocytes: 3.7;monocytes: 9.3	Cell line enhanced	Detected in some		CACO-2: 9.1;HMC-1: 4.7;U-937: 20.5	Not detected	Not detected			Low region specificity	Detected in all																unprognostic (3.19e-2)	unprognostic (1.00e-1)	unprognostic (5.76e-2)	unprognostic (4.94e-2)	unprognostic (5.33e-2)	unprognostic (6.70e-2)	unprognostic (5.51e-2)	unprognostic (1.35e-1)	unprognostic (5.35e-2)	unprognostic (4.00e-2)	unprognostic (4.74e-2)	unprognostic (3.06e-1)	prognostic unfavorable (6.14e-6)	unprognostic (1.48e-1)	unprognostic (1.63e-3)	unprognostic (2.45e-1)	unprognostic (1.18e-2)	10.5	2.2	0.5	3.1	1.5	0.3	8.3	0.4	1.1	0.8	6.1	0.4	1.2	37	0.7	3	1	1.4	1.7	3.5	1.8	0.6	2.4	5.4	12.7	7.3	0.6	0.3	2.3	0.8	0	0.8	5.4	2.1	2.7	4.2	1.2	1.1	0.2	1.5	0.6	31.5	2.3	1.2	14.1	1.2	1.7	0.4	0.3	1.2	0.2	2	1.8	3	0	0.8	3.7	9.3	0	0	1.2	0.1	0	0	0	0	0	0.2	0	0	0	0	9.1	1	0	0	0	0	0	0	0	0	0	0.5	1.6	0	1.2	0	0	4.7	0	0	0	0	0	0	0.1	0.1	2	0	0	0.1	0.1	0.1	2.1	0	0.1	0	2.2	0	0	0	0.1	0	0	0.1	0.1	0	2.8	0	0	0	0	0	0.1	1.6	0	0	20.5	0.1	3.7	9.3	0	0	1.8	0	0	0	0	0.8	0	0	0	0.3	0	0.5	0.1	0	1.2	0.5	1.5	0.4	1.1	1.8	0.6	0.6	0.3	2.1	0.4	0	0	0	1.7	0.1	0	0.3	2.5	0	0	1.8	0	0	0	0	0	0	30.4	0	0	0	0	0.4	0	0	6	0	0	0	5.4	0	0	2	0	1	2	0	0.2	0.3	0	0.5	0	0	0.1	0	0.1	0	0	0	1.1	0.1	Enterocytes
WFDC11	WAP11	ENSG00000180083	WAP four-disulfide core domain 11	Q8NEX6	20	45648563-45670270	Predicted secreted proteins				Evidence at transcript level	Evidence at transcript level	No human protein/transcript evidence	Evidence at transcript level		Tissue enriched	Detected in some	5	epididymis: 46.2	Cell type enriched	Detected in some	25	Early spermatids: 50.2	Not detected	Not detected							Cell type enhanced	Detected in some		basophil: 4.7	Low lineage specificity	Detected in many			Group enriched	Detected in some	5	HeLa: 13.0;RPMI-8226: 7.9														Secreted in male reproductive system																									0.1	0	0	0	0.1	1	0	0	0	0	0			0	0.1	46.2	0	0	0	0	0.1	0	0	0	0.1	0	0		0	0	0	0	0		0	0		0.1	0	0	0.5	0	0	0	0	0	8.6			0		0	0.4	0	0.8	0.7	4.7	0.4	1.3	0.8	0.1	0.2	1.1	0.1	0.2	0.6	0.8	1.2	1.1	0.1	0	0	0.7	0.3	0.7	0.4	0	0.1	0.6	0	0.2	0	0	0.8	1.1	13	0.8	0	0.6	0.8	0.3	0	0	0.2	0.2	0	0.4	0.6	0.2	0	0.2	0.5	1.1	1.1	0.4	0.6	0.2	0.5	7.9	0	0.4	0.1	0	0	0.4	0	1	0.1	1.1	0	0.2	0.7	0.3	0.1	0.5	0.5	0	0.1	2.2	0.3	4.7	0.4	0.2	0.4	0.2	0.4	0.3	0.3	0.3	0.1	0.8	0.4	0.8	1.2	1.3	0.2	0.7	0	0.1											0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	50.2	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0.4	0	1.1	0	0	0.6	0.1	0	0	0	0	0	Early spermatids
F2		ENSG00000180210	Coagulation factor II, thrombin	P00734	11	46719180-46739506	Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Acute phase, Blood coagulation, Hemostasis	Hydrolase, Protease, Serine protease	Cancer-related genes, Disease mutation, FDA approved drug targets, Thrombophilia	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	593	liver: 324.8	Cell type enriched	Detected in some	37	Hepatocytes: 904.6	Cancer enriched	Detected in some	110	liver cancer: 508.2	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	21	Hep G2: 78.4	Not detected	Not detected			Not detected	Not detected			CAB016780, HPA051476, HPA054698	Enhanced				Secreted to blood			108000000000	43000000000			CAB016780: , HPA051476: AB_2681498, HPA054698: AB_2682578	unprognostic (1.98e-1)	unprognostic (2.52e-1)	unprognostic (2.64e-2)	unprognostic (1.85e-1)	unprognostic (2.29e-1)	unprognostic (2.81e-1)	unprognostic (2.23e-2)	unprognostic (3.94e-2)		unprognostic (5.79e-2)	unprognostic (8.29e-2)	unprognostic (4.46e-2)	prognostic unfavorable (6.75e-12)	unprognostic (5.65e-3)	unprognostic (5.80e-2)		unprognostic (1.54e-3)	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0.2	0	0	0.1	0	0	0	0	324.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0.1	0	0	0	0	0	0	0	0.2	0	0	0.1	0.1	0.5	0	0	0.1	0	0	0	0	0	0	0	0	0	3.7	0	0	0.6	0	0	0	0	0	0	0	0	0.1	0	78.4	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0.3	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0.1	0	0	0.1	0	0.5	0	0.5	0	0.1	0.4	0	0.2	0	0	0	0.1	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	7	0	0	0	0.6	22.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	904.6	0	0	0	24.5	19.3	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0.1	0	0	0.2	0	0	0	Hepatocytes
RRH	peropsin	ENSG00000180245	Retinal pigment epithelium-derived rhodopsin homolog	O14718	4	109827994-109844604	G-protein coupled receptors, Predicted membrane proteins	Sensory transduction	G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	18	retina: 66.3	Cell type enriched	Detected in single	53	Muller glia cells: 36.0	Not detected	Not detected			Low region specificity	Detected in many			Cell type enhanced	Detected in single		T-reg: 1.3	Lineage enriched	Detected in single	7	T-cells: 1.3	Cell line enhanced	Detected in some		hTCEpi: 4.1;U-266/84: 4.7	Not detected	Not detected			Low region specificity	Detected in all																unprognostic (1.59e-1)	unprognostic (2.47e-2)	unprognostic (4.94e-2)	unprognostic (1.96e-2)	unprognostic (1.48e-1)	unprognostic (5.25e-2)	unprognostic (7.56e-2)	unprognostic (8.47e-2)	unprognostic (2.33e-1)	unprognostic (1.86e-2)	unprognostic (2.03e-2)	unprognostic (1.62e-3)	unprognostic (4.65e-1)	unprognostic (4.38e-3)	unprognostic (1.22e-1)	unprognostic (2.27e-1)	unprognostic (3.18e-2)	0.4	1.4	1.3	0.5	1.2	0.3	2.1	3.7	1.8	0.8	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.9	0.4	0.4	1.2	1.2	1.9	1	0.4	0.5	1.2	0.6	0.6	0.5	0.7	0.5	0.4	0.4	0.9	0.8	66.3	0.5	0.7	0.7	2.3	0.4	0.4	0.8	0.5	0.4	0.7	0.4	0.4	0.9	0.4	0.4	0.4	0.4	0.1	0	0	0	0	1.3	0.1	0	0.2	0.9	0.7	0	0.1	0	0.2	0.7	0.1	0.1	0.2	0.3	0.9	0.8	0.3	0	0	2.2	0.1	0.2	1	0.9	0.1	0	0.3	0.1	1.5	0	0	4.1	0	0.3	0.4	0.2	0.7	1	0.3	0.7	0.1	1.2	1.6	0.5	0.7	0.2	1	0.2	0.6	2.1	0.2	1.1	0.3	0	0.4	0.1	0.5	0.8	0.5	0.4	0	0.3	0.5	0.1	0.6	4.7	0	0.3	0.5	1.1	0	0	0	0.2	0	0.4	0.1	0.3	0.2	0	0.1	0.1	0	0	0	0	0	1.3	0.1	1.3	1.2	3.7	1.4	1.2	1.2	1.2	0.6	0.4	0.4	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	36	0	0	0	0	0.7	0	0	0.3	0	0	0	0	0	0	Muller glia cells
SLC9A4	NHE4	ENSG00000180251	Solute carrier family 9 member A4	Q6AI14	2	102473303-102533972	Predicted membrane proteins, Transporters	Antiport, Ion transport, Sodium transport, Transport			Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at transcript level		Group enriched	Detected in some	6	gallbladder: 23.2;kidney: 12.3;stomach 1: 33.9	Cell type enriched	Detected in some	8	Collecting duct cells: 24.4	Low cancer specificity	Detected in some			Not detected	Not detected			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		HDLM-2: 3.9;OE19: 11.4;RT4: 7.1	Group enriched	Detected in some	18	hippocampal formation: 11.6;olfactory region: 8.3	Not detected	Not detected			HPA036096	Supported		Approved	Nucleoplasm,Plasma membrane						Nucleoplasm, Plasma membrane		HPA036096: AB_2674939	unprognostic (1.41e-1)	unprognostic (3.76e-2)	unprognostic (9.31e-2)	unprognostic (3.09e-3)	unprognostic (7.58e-2)	unprognostic (1.46e-1)		unprognostic (7.17e-2)	unprognostic (5.35e-1)	unprognostic (9.44e-3)	unprognostic (3.26e-2)	unprognostic (1.30e-1)	unprognostic (2.46e-2)	unprognostic (3.12e-1)	unprognostic (5.04e-1)	unprognostic (2.50e-1)	unprognostic (1.98e-2)	0	0.1	0.1	0	0.1	0.4	0.1	0.1	0.1	0.2	0.1	0.3	0	1.1	0.1	0	1.3	0.1	23.2	0.2	0.1	0.1	12.3	0.1	0.1	0.2	0.1	0	0.1	0.1	0	0.1	0	0.1	0.7	0	0	3.7	2.4	0.7	0.2	0.2	0	0.1	0.1	33.9	0.3	0	0.2	0.1	0.5	0.4	0.6	0.2	1.5	0.9	1.8	0.8	1.2	1.2	0.1	0.2	0.2	0.2	0.6	0	0	0.1	0.2	0	0	0	1.1	0.4	0.1	2.4	0	0.3	0.3	0	0	0	3.9	0.1	0.2	0.4	0.1	0	0.1	0.3	0	0	0	0	0.3	0	0.1	0.2	0.9	0	0.4	0.1	0.1	1.1	11.4	0.4	0.2	0.5	0.3	0	7.1	0.2	0.2	0.1	0.4	0	0.3	0.2	0.1	0.5	0.4	1.1	0.7	0.2	0.2	0.2	0	0.5	0.1	0.1	1.6	0.7	1.1	1.2	0.6	0.8	0.8	0.9	0.9	0.5	1.5	1	1.2	1.8	1.2	0.8	0.9	0.6	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0	3	2.7	0	0	0	0	0.2	0	2.7	1.2	24.4	0	0	0	0	1.4	0	0	0	0	0	0	0	1.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0.1	0.1	0	0.1	0	0	0.3	Collecting duct cells
ALX1	CART1	ENSG00000180318	ALX homeobox 1	Q15699	12	85280107-85301784	Disease related genes, Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	Activator, Developmental protein, DNA-binding, Repressor		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		retina: 13.9	Cell type enriched	Detected in some	6	Melanocytes: 30.4	Cancer enriched	Detected in some	10	melanoma: 16.2	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HAP1: 6.9;HEK 293: 15.4;HUVEC TERT2: 11.3;SK-MEL-30: 18.7;THP-1: 12.2;WM-115: 9.8	Not detected	Not detected			Not detected	Not detected			HPA001598, HPA018905	Uncertain		Supported	Nucleoplasm,Nuclear bodies,Golgi apparatus						Nuclear bodies	Nucleoplasm, Golgi apparatus	HPA001598: AB_1078400, HPA018905: AB_1844783	unprognostic (4.92e-3)	unprognostic (8.09e-2)		unprognostic (1.09e-3)	unprognostic (1.84e-1)	unprognostic (6.24e-2)		unprognostic (2.05e-2)	unprognostic (9.27e-2)	unprognostic (1.22e-1)	unprognostic (3.57e-1)	unprognostic (2.01e-1)	unprognostic (1.55e-5)		unprognostic (8.97e-2)		unprognostic (1.43e-1)	1.9	0	0.1	0	0.2	0	4.8	0	0.2	5.4	0.1	0	0.8	0	5.4	8.5	0.1	4.7	0	0.1	0.2	0.2	8.3	0	0.1	0	0.2	0	3.6	0.1	0	1.6	0.1	0	1.6	0	13.9	3.8	2	0.4	3.3	0.1	1.1	0	0	0.1	1.5	0	0	0.2	4	0	2.4	5.7	0	0	0	0	0	0	0	0	3.9	0	0	0.5	0.5	0	0	0.1	0	0.1	0	0	0	0.3	0	2.5	0	6.9	0.3	0	0	15.4	0	2.7	0	0.2	0	0	0	0	2.1	0	6.3	11.3	0	0	0	0	0	0	0	4	0	0	0	5.7	0	0	0	1.8	4	0	0	18.7	2.9	0	12.2	0	0	0	0	0	0.2	0	0	4.3	0	9.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.2	0	0.2	0.2	0.2	0.2	0	0	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0	0	4.7	0	0	0	0	1	0.2	0.1	0	0	0	0	0	0	0	1.5	0	0	30.4	0	0	0	0	0	0	0	0	0	0	0.1	0	0.5	0	0	0	0	Melanocytes
KCTD4	bA321C24.3	ENSG00000180332	Potassium channel tetramerization domain containing 4	Q8WVF5	13	45192853-45194717	Plasma proteins, Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	7	brain: 45.5	Cell type enriched	Detected in single	4	Melanocytes: 1.7	Group enriched	Detected in some	5	glioma: 1.2;renal cancer: 0.6	Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		GAMG: 15.8;hTERT-RPE1: 9.6;RPTEC TERT1: 8.9;U-138 MG: 10.7;U-87 MG: 21.2	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA040734	Uncertain		Approved	Centriolar satellite						Centriolar satellite		HPA040734: AB_10963227	unprognostic (1.36e-1)		unprognostic (1.02e-1)		unprognostic (2.08e-1)	unprognostic (1.19e-2)		unprognostic (1.70e-1)	unprognostic (4.68e-2)	unprognostic (1.74e-1)	unprognostic (1.66e-3)	unprognostic (1.63e-1)	unprognostic (1.73e-1)	unprognostic (2.15e-1)	unprognostic (2.98e-2)			0.5	0.6	33.1	0.6	45.5	0.7	1.5	0.2	22	0.7	1.1	1.5	0	0.9	0.5	0.6	0.5	0.5	1.8	0.9	9.8	4	0.9	0.5	0.5	0.5	3.6	4.8	0.5	0.9	0.5	1.1	0.9	3.9	0.5	0.9	1.8	1.5	0.8	0.5	6.4	1	1.8	2.7	0.5	0.5	0.5	7	0	0.5	0	0.5	0.5	0	0	0	0.5	0.4	0	0.7	0	0	0	0	0	0	0	0	1.1	0.4	0	0.1	0	0	0	0.3	0.5	15.8	0	0	2.1	1	0	0	0	0	0	0	0	0	0	0	1.1	4.4	9.6	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0	8.9	0	0	0	0	0	0	0	0	0	0.2	10.7	0	0	2.2	0	0	0	21.2	0	0	0	0.4	0	0	0.1	0	0	0.7	0.6	0	0	0.3	0	0.5	0	0	0	0	0	33.1	45.5	0.2	9.3	9.8	4	3.6	4.8	3.9	7	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0.4	0	0	0.4	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	1.7	0	0	0	0	0	0	0.4	0	0	0	0	0	0.1	0	0	0	0	Melanocytes
CYP8B1	CYP12	ENSG00000180432	Cytochrome P450 family 8 subfamily B member 1	Q9UNU6	3	42856005-42876165	Enzymes, Predicted intracellular proteins, Predicted membrane proteins		Monooxygenase, Oxidoreductase		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	20	liver: 132.7	Cell type enriched	Detected in some	57	Hepatocytes: 737.2	Cancer enriched	Detected in some	46	liver cancer: 69.6	Not detected	Not detected			Cell type enhanced	Detected in single		basophil: 1.4	Lineage enriched	Detected in single	5	granulocytes: 1.4	Group enriched	Detected in some	5	BEWO: 6.8;HEL: 1.7;Hep G2: 2.6;SK-BR-3: 3.1	Not detected	Not detected			Not detected	Not detected																unprognostic (1.58e-2)	unprognostic (5.41e-2)	unprognostic (6.38e-2)	unprognostic (1.15e-2)	unprognostic (8.95e-2)	unprognostic (1.42e-3)	unprognostic (4.47e-3)	unprognostic (1.49e-1)	unprognostic (9.85e-2)	unprognostic (4.04e-3)	unprognostic (5.86e-3)	unprognostic (2.74e-1)	unprognostic (3.37e-1)	unprognostic (1.03e-1)	unprognostic (3.63e-1)	unprognostic (3.19e-1)	unprognostic (1.24e-1)	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0.7	0	0	0.1	0	0	0	6.7	132.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0.1	1.4	0.2	0.1	0.2	0.1	0.4	0.7	0.3	0.2	0	0	6.8	0.1	0	0	0	0.5	0.3	0.2	0.3	0	0.4	0.3	0	0	0	0	0.2	1.7	0.2	2.6	0	0.7	0.2	0	0	0	0	0.2	0	0.4	0.4	0.2	0	0.4	0.2	0	0.3	0.1	0.4	0.5	0.6	0.3	0.3	0.5	0.1	0	0.6	3.1	0.3	0.4	0.3	0.1	0.3	0.3	0.6	0.3	0.2	0.4	0.1	0.3	0.3	0.4	0.1	1.4	0.2	0.3	0.1	0.1	0.1	0	0.1	0.2	0	0.2	0.1	0.1	0.9	0.1	0	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	10.2	0	0	0	0	0.2	0	0	0.1	0	0	0	0	0.1	0	0.1	0	737.2	0.1	0	0	10.4	10.5	0.5	0	0	0	0	0	0	0	0	0	13	0	0	0	0	0	0	0.3	0	0	0	Hepatocytes
SERTM1	C13orf36	ENSG00000180440	Serine rich and transmembrane domain containing 1	A2A2V5	13	36673912-36697839	Predicted membrane proteins				Evidence at protein level	Evidence at protein level	No human protein/transcript evidence	Evidence at transcript level		Tissue enhanced	Detected in many		brain: 30.2;endometrium 1: 30.9;fallopian tube: 25.3	Cell type enriched	Detected in some	5	Alveolar cells type 1: 8.9	Cancer enhanced	Detected in some		ovarian cancer: 3.7	Group enriched	Detected in many	7	amygdala: 13.9;basal ganglia: 10.1;cerebral cortex: 21.6;hippocampal formation: 26.5;olfactory region: 11.6	Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	5	HAP1: 2.7;HEK 293: 3.2;NTERA-2: 8.0;SH-SY5Y: 4.7	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA054814, HPA070485	Uncertain		Enhanced	Vesicles						Vesicles		HPA054814: AB_2682611, HPA070485: AB_2686272	unprognostic (8.71e-2)	unprognostic (2.11e-1)		unprognostic (5.58e-3)	unprognostic (4.66e-3)			unprognostic (4.05e-3)		unprognostic (5.06e-2)	unprognostic (2.79e-2)	unprognostic (1.63e-2)	unprognostic (1.00e-8)	unprognostic (2.51e-2)	unprognostic (5.60e-2)	unprognostic (4.44e-2)		5	1.8	13.9	0.5	10.1	0.5	1.2	0.3	30.2	16.4	0.7	1.3	1.8	0.6	30.9	13.5	0.5	25.3	0.5	0.6	26.5	2	0.6	0.5	5.6	0.5	1.5	11.6	14.5	0.8	1	11.2	0.5	2.4	0.9	0.5	8.2	0.5	1.2	0.5	0.6	0.6	17.4	0.9	0.5	0.9	1.5	0	0	9.3	0	0.5	1.1	6.4	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0.1	0	2.7	0	0	0	3.2	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	8	0	0	0	0	0	0	0	0.4	4.7	0	0	0	0.8	0	0	0	0.1	0.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.9	10.1	0.3	21.6	26.5	2	1.5	11.6	2.4	0	8.9	0	0	0	0	1	0.9	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0.6	0	0	0	0	1.6	0	0	0	0	0.3	0	1.7	0	0	0	0	0	0	0	1	0	0.1	0	0.4	0	0	0	0	0	Alveolar cells type 1
SLC47A2	FLJ31196, MATE2, MATE2-K	ENSG00000180638	Solute carrier family 47 member 2	Q86VL8	17	19678288-19718979	Predicted membrane proteins, Transporters	Transport			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	4	kidney: 55.5	Cell type enriched	Detected in some	13	Proximal tubular cells: 69.0	Cancer enhanced	Detected in some		renal cancer: 4.0	Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HaCaT: 1.9;HeLa: 1.5;hTCEpi: 6.7					Not detected	Not detected																unprognostic (4.52e-3)	unprognostic (8.28e-3)	unprognostic (1.54e-1)	unprognostic (4.99e-2)	prognostic unfavorable (8.95e-4)	unprognostic (5.22e-2)	unprognostic (2.72e-1)	unprognostic (1.99e-2)	unprognostic (3.29e-2)	unprognostic (1.51e-1)	unprognostic (1.36e-3)	unprognostic (7.77e-2)	unprognostic (1.04e-3)	unprognostic (4.33e-2)	unprognostic (1.61e-1)	unprognostic (6.44e-2)	unprognostic (5.71e-2)	0.2	0.3	3	0.1	4.4	0.1	0.3	0.2	0.4	0.1	0.2	10.3	0.6	0.2	0.2	6.5	0.2	8.6	0.1	0.3	6.2	5.5	55.5	0.1	0.1	0.1	1.1	0.1	0.6	0.1	0.1	0	0.1	12.8	0.1	0.1	0.7	0.1	0.3	0.7	1.8	0.4	0.2	2	0.1	0.1	0.2	2.8	0	0.3	0.5	0.1	0.2	0	0	0	0	0	0.3	0.6	0	0	0.5	0	0.1	0	0	0	0	0	0	0	0.4	0.6	0	1.2	0	0.2	1.9	0	0.1	0	0	0	0	1.5	1	0	0	0	0	6.7	0	0.3	0.1	0	0	0	0	0	0	0	0	0.5	1.2	0.8	0	0.3	0	0.1	0.3	0.5	0.2	0.4	0	0	1	0	0	0	0	0	0	0.1	0	0	0	0.8	0	0	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0.3	0	0	0.4	0	3	4.4	0.2	0.4	6.2	5.5	1.1	0.1	12.8	2.8	0	0	0	0.2	0.2	0	0.6	0	0	0	5.2	0	0.1	5	0	0.3	0	0	0	0	0	0.2	0.3	0	0	0	0	0	0	0	0.4	0.3	0	0	0	0	2.1	0.1	0	0	69	0.2	0	0.3	0.5	0.2	0.3	0	0	0	0.1	Proximal tubular cells
C3orf22	MGC34728	ENSG00000180697	Chromosome 3 open reading frame 22	Q8N5N4	3	126526999-126558965	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at transcript level		Tissue enriched	Detected in some	25	testis: 28.3	Cell type enriched	Detected in some	5	Late spermatids: 1235.7	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	13	MCF7: 1.5;SCLC-21H: 1.0					Not detected	Not detected			HPA059199	Enhanced											HPA059199: AB_2683946	unprognostic (2.10e-1)			unprognostic (5.14e-5)	unprognostic (2.55e-1)		unprognostic (9.21e-2)			unprognostic (2.01e-1)		unprognostic (2.75e-1)	unprognostic (1.08e-3)		unprognostic (1.34e-1)			0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	28.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.5	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	232.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1235.7	9.5	0	0	0	0	0	0	0	5.3	0	0	0	0	8.6	3.8	0	0	0	0	0	Late spermatids
AGTR2	AT2, MRX88	ENSG00000180772	Angiotensin II receptor type 2	P50052	X	116170722-116174972	G-protein coupled receptors, Predicted membrane proteins		G-protein coupled receptor, Receptor, Transducer		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in some		endometrium 1: 20.8;lung: 26.7;smooth muscle: 13.6	Cell type enriched	Detected in some	15	Alveolar cells type 2: 17.8	Group enriched	Detected in some	12	endometrial cancer: 3.0;lung cancer: 1.9	Region enriched	Detected in single	10	cerebellum: 1.0	Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	6	HSkMC: 1.4	Low region specificity	Detected in many			Region enriched	Detected in single	9	cerebellum: 3.8																	unprognostic (2.13e-1)				unprognostic (1.71e-1)			unprognostic (3.22e-2)				unprognostic (4.37e-2)			0.3	1.6	0.1	0.8	0.1	0	0.1	1	0.1	5.3	0.4	0.1	0.1	0	20.8	3.3	0.2	3.6	0.4	1.7	0.1	0	0.4	0.1	26.7	0.8	0.1	0.1	1.1	1.4	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.1	13.6	0.1	0.1	0.6	0.2	0.1	0.4	0.1	1.1	0.1	0.1	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.4	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	17.8	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Alveolar cells type 2
BHLHE22	Beta3, BHLHB5, bHLHe22, CAGL85, TNRC20	ENSG00000180828	Basic helix-loop-helix family member e22	Q8NFJ8	8	64580367-64583628	Predicted intracellular proteins, Transcription factors	Neurogenesis, Transcription, Transcription regulation	Repressor		Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	6	brain: 30.7	Cell type enriched	Detected in some	5	Bipolar cells: 28.7	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	23	THP-1: 41.9	Group enriched	Detected in many	5	amygdala: 31.9;cerebellum: 34.4;cerebral cortex: 22.4;hippocampal formation: 50.8	Group enriched	Detected in all	8	amygdala: 37.8;cerebellum: 21.5;cerebral cortex: 22.5;hippocampal formation: 63.6	HPA064128, HPA064872, HPA067500	Enhanced											HPA064128: AB_2685195, HPA064872: AB_2685377, HPA067500: AB_2685855	unprognostic (9.17e-2)	unprognostic (1.11e-2)	unprognostic (5.44e-2)	unprognostic (2.28e-5)	unprognostic (7.22e-3)	unprognostic (6.47e-4)	unprognostic (2.41e-1)	unprognostic (1.08e-1)	unprognostic (1.30e-1)	unprognostic (6.58e-2)	unprognostic (1.52e-1)	unprognostic (3.71e-2)	unprognostic (2.86e-7)	unprognostic (3.20e-2)	unprognostic (2.29e-1)	unprognostic (6.72e-3)	unprognostic (1.86e-1)	2.9	1.3	30.7	2.9	1.4	0.3	1.7	21.1	15.8	1.7	1.7	1.2	0.3	1.1	0.5	0.4	2.2	0.6	1.1	0.8	27.2	2.1	0.5	1.3	1.4	2.4	1.7	6.5	0.4	1.3	0.5	1.2	0.2	3.4	0.5	1.4	2.5	1.2	5.4	0.5	0.8	1.7	1.1	2.6	2.9	1.1	0.7	0.2	0	0.6	0	1.3	2.5	2.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.8	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	41.9	0	0	0	0	0	0.6	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	30.7	1.4	21.1	10.6	27.2	2.1	1.7	6.5	3.4	0.2	0	0	0	0	1	28.7	0.6	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	3.1	0	0	1	0	1.3	0	0	0.4	0	2.5	0	6.2	0	0	1.4	0	0	0	0	Bipolar cells
GREM2	CKTSF1B2, DAND3, FLJ21195, Prdc	ENSG00000180875	Gremlin 2, DAN family BMP antagonist	Q9H772	1	240489573-240612149	Disease related genes, Predicted secreted proteins		Cytokine, Developmental protein, Heparin-binding	Disease mutation	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		gallbladder: 90.3;parathyroid gland: 31.4	Cell type enriched	Detected in many	14	Syncytiotrophoblasts: 249.2	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Cell type enhanced	Detected in some		MAIT T-cell: 2.2;memory CD4 T-cell: 2.5	Lineage enriched	Detected in single	5	T-cells: 2.5	Cell line enriched	Detected in some	5	fHDF/TERT166: 26.5	Low region specificity	Detected in many			Low region specificity	Detected in many			CAB009920	Approved				Secreted to blood							CAB009920: AB_2279266	unprognostic (2.01e-1)	unprognostic (2.49e-1)	unprognostic (7.41e-2)	unprognostic (7.58e-3)	unprognostic (2.82e-3)	unprognostic (1.34e-1)	unprognostic (8.18e-2)	unprognostic (1.90e-1)	unprognostic (1.31e-2)	unprognostic (6.40e-2)	unprognostic (2.78e-1)	unprognostic (1.97e-2)	unprognostic (3.07e-8)	unprognostic (1.22e-1)	unprognostic (2.36e-1)	unprognostic (5.13e-2)	unprognostic (1.38e-2)	0.6	0.9	3	9.5	4.5	0	2.2	0.7	5.1	0.8	14.2	0.5	0.9	6.5	8.2	1.9	10.7	1.3	90.3	0.2	2.1	3.6	1.1	21.9	1.3	0.6	1.4	4.8	4.2	0.3	31.4	5.2	5.2	3	2.8	12.8	1.7	7.5	1.1	6.5	2.3	11.7	3.8	1.8	1.7	6.4	0.5	0.9	0	0.7	3	4.1	2.2	0.7	0	0	0.5	0	0.1	2.5	0.2	0	0	0.1	0	1.6	2.1	0	5.1	5.4	0	0	0	0	0	0	26.5	0	0	1.4	0	0	0	0.2	0	0.4	0	0	0	0	0.4	0	0.1	0	0.2	0	0	0	1	0.1	0	0	0	1.2	0	0	0	0	0	0	0	0	1.2	0	1.9	0	2.5	1.1	0	0	3.3	0.4	0.7	0.3	0.9	0	0	2.8	0	1.6	0	0	0	0	0	2.2	0	2.5	1.3	0	0	0.6	0	0.5	0.1	0	0	0	0.2	3	4.5	0.7	5.1	2.1	3.6	1.4	4.8	3	0.9	0	0	0	0	4.1	17.3	0.3	0	1.4	0	0	11.8	4.3	0	0	0	0	0	0	0	1.1	1	0.3	0	10.5	1.5	0	1.2	0	0.3	0	0	0	1.7	0	0	0.8	0.1	0	4.2	0	6.1	0	2.2	0.4	0.4	3.1	249.2	0	0	0.1	Syncytiotrophoblasts
CAPS2		ENSG00000180881	Calcyphosine 2	Q9BXY5	12	75275979-75390928	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in many		fallopian tube: 21.7	Cell type enriched	Detected in many	4	Ciliated cells: 96.4	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Cell type enhanced	Detected in some		T-reg: 1.8	Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		hTERT-RPE1: 12.1	Not detected	Not detected			Low region specificity	Detected in all			HPA039542, HPA040004	Uncertain		Approved	Nucleoplasm,Nucleoli,Vesicles,Centrosome		Yes	No			Nucleoli	Nucleoplasm, Vesicles, Centrosome	HPA039542: , HPA040004: AB_10794758	unprognostic (1.38e-2)	unprognostic (1.21e-1)	unprognostic (7.26e-2)	unprognostic (5.10e-2)	unprognostic (3.05e-2)	unprognostic (1.55e-2)	unprognostic (2.66e-1)	unprognostic (2.36e-1)	unprognostic (9.61e-2)	unprognostic (1.24e-1)	unprognostic (2.02e-3)	unprognostic (1.01e-1)	unprognostic (1.32e-2)	unprognostic (3.07e-1)	unprognostic (1.75e-1)	unprognostic (4.52e-2)	unprognostic (2.69e-1)	2.6	4.2	8	1.2	5.8	1.6	3.7	15.5	11.2	3.7	2.5	5.5	2.1	1.8	5	8.8	3.6	21.7	3.4	5.4	6.3	6.6	6.6	4.2	5.8	1.3	5.4	5.6	4.5	2.6	7.3	15.8	0.9	7.8	5.1	2	4.4	5.5	3.6	3.8	2.6	1.9	2	8.7	2.6	3.2	8	9.5	1.4	9.3	2.2	1.4	2.6	2	0.1	0.6	0	0.7	1.1	1.8	0.1	1.3	3.7	1	0.3	1.9	1.4	0.1	0.7	0.2	2	2.2	0	1.7	0.3	3.3	0.5	0.8	0.8	0	1.6	1.4	1.2	0.6	1.5	0.6	0	0	0.2	0	0.6	1	1.7	0.3	12.1	0.2	1.3	0.3	0.6	2.6	0	1.8	1.4	0.5	0	0.5	0	0	0.2	2.6	0	2.1	1	0.2	0.1	1.2	0.2	1.2	0.5	0.8	1.9	0.8	0.4	0.3	0.2	0	0	1.6	0	1.5	0	0	0	0.2	0.2	0.1	0	0.7	0	0	0.1	0.6	0.9	0	1.1	0.7	0.6	1.8	0.1	8	5.8	15.5	11.2	6.3	6.6	5.4	5.6	7.8	9.5	8.9	3.2	0	2.5	1.5	0.7	7.1	2.5	96.4	17	5.2	3.9	1	5	0.8	21.6	1.7	0	0	1.5	0.5	1.7	1.5	0	1.5	0.5	1.6	0	2.5	1.8	11.5	5.8	0.9	0	0	1.7	5.8	0.4	0	6.7	2.5	20.8	0	1.4	9.1	0.9	0.5	0.2	0	0.6	0.5	Ciliated cells
OXTR		ENSG00000180914	Oxytocin receptor	P30559	3	8750408-8769628	FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters		G-protein coupled receptor, Receptor, Transducer	FDA approved drug targets	Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	5	breast: 42.5	Cell type enriched	Detected in some	8	Ciliated cells: 93.7	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Cell type enhanced	Detected in single		neutrophil: 1.6	Lineage enriched	Detected in single	5	granulocytes: 1.6	Cell line enhanced	Detected in some		BJ: 81.2;BJ hTERT+: 24.9;BJ hTERT+ SV40 Large T+: 23.6;fHDF/TERT166: 81.3;HBF TERT88: 18.4	Low region specificity	Detected in many			Low region specificity	Detected in all																unprognostic (1.18e-1)	unprognostic (7.94e-2)	unprognostic (4.76e-2)	unprognostic (1.29e-2)	unprognostic (2.02e-2)	unprognostic (2.02e-1)	unprognostic (1.46e-2)	unprognostic (2.56e-3)	unprognostic (2.12e-1)	unprognostic (3.42e-1)	unprognostic (2.76e-1)	unprognostic (3.80e-2)	unprognostic (4.24e-4)	unprognostic (8.25e-2)	unprognostic (4.60e-2)	unprognostic (2.71e-1)	unprognostic (1.84e-1)	0.5	0.4	1.8	0.3	6.5	0.6	42.5	0.9	2.2	0.5	0.3	0.1	0	0.3	2.8	0.5	1.1	2.7	1	0.6	1.8	4	0.6	0.4	1	0.4	8.6	0.8	2.8	0.3	0.3	0.3	1.3	3.7	0.9	0.3	1.6	0.4	0.9	0.3	0.4	0.4	0.6	2.5	0.5	0.3	0.5	1.2	0.1	0.4	0	0.4	0.4	0	0	0.2	1.6	0.1	0.1	0.3	1	0.2	0.8	0.4	0.1	0.1	0.2	0.1	81.2	24.9	23.6	12.6	0.1	2.1	0	0.1	81.3	0.3	0.1	0.3	0.1	18.4	0.7	0.4	0.2	0.3	0.1	0.4	0.1	0.2	0.1	0.1	0.3	0.1	7.1	0	0.2	0	0.1	13.1	0	0.1	0.6	0.5	0.2	3.6	0.1	0.3	4.8	0.9	0	0.1	0.1	0.1	0.1	0	1.6	0	0.1	0.1	1.1	0.3	0.2	0.2	0.1	0.2	0	0.1	0.2	0.2	0.5	0	0.1	0.2	0.1	0.2	0	0.2	0.2	0.2	0	0.2	0.3	1.6	0.1	0	0.1	0.1	1	1.8	6.5	0.9	2.2	1.8	4	8.6	0.8	3.7	1.2	8.9	1.4	0	0.4	0.3	0.2	1.2	0	93.7	11.4	0	0	0	0	2.6	0.9	0	0	0	0	0.1	0.5	1.7	0	0	0.2	0	0	0	0	1.5	0	0.2	0	0	0	5.8	1	0	0.4	0	0	0	0.5	0.7	1.3	0.1	0	0	0	0.1	Ciliated cells
C1orf105		ENSG00000180999	Chromosome 1 open reading frame 105	O95561	1	172420688-172468831	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in some		heart muscle: 28.8;testis: 23.0	Cell type enriched	Detected in some	5	Early spermatids: 112.5	Not detected	Not detected			Not detected	Not detected			Cell type enhanced	Detected in single		basophil: 2.6	Lineage enriched	Detected in single	5	granulocytes: 2.6	Cell line enriched	Detected in some	8	BEWO: 25.0	Not detected	Not detected																				unprognostic (2.50e-2)	unprognostic (2.48e-4)	unprognostic (7.11e-2)	unprognostic (1.12e-2)	unprognostic (7.07e-4)	unprognostic (1.27e-3)	unprognostic (3.02e-2)	unprognostic (1.47e-2)		unprognostic (8.22e-2)	unprognostic (1.92e-1)		unprognostic (1.18e-1)	unprognostic (7.65e-4)	unprognostic (3.85e-1)		unprognostic (1.94e-1)	0	0.1	0	0	0	1.5	0	0	0.1	0	0	0	0.7	0	0	7	0.3	0	0	28.8	0	0	0.1	0.1	0	0	0	0	0	0.3	0	0	2.5	0.1	1.1	0	0.1	1.2	0	1.7	0.6	0.4	0	0.1	0	0	23	0	0.2	0.1	3.6	0.3	0	0	0.1	0	2.6	0.2	0	0.5	0.2	0	0.2	0.3	0.1	0	0	25	0	0	0	0	0.4	0.1	0	0	0	0	0.1	0	0	0	0.1	0	0	0	0.9	0	0.7	0	0.1	0	0	0	0.2	0	0.1	0.4	0.2	0.1	0	0	0	0.2	0.4	0	0	2.1	0	0	0	0.1	0	0	0.4	0	3.1	0	0	0	0.1	0.1	0	0	0	0	0.1	0	0	0.3	2.6	0.2	0	0.3	0	0.4	0.1	0.2	0	0	0.1	0.5	0.4	0.8	0	0	0	0.2	0.2	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	9.1	0	0	0	0	0	6	0	0	112.5	0	0	0	0.5	8.2	0	0	0	0	0.4	0	0	0	0	12.9	1.7	0	0	0	0	0	0	0	1.1	1.4	0	0	0	24.1	2	0	1.5	0	0	0	Early spermatids
CHRM2		ENSG00000181072	Cholinergic receptor muscarinic 2	P08172	7	136868669-137020255	Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins		G-protein coupled receptor, Receptor, Transducer	FDA approved drug targets	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		gallbladder: 25.5;heart muscle: 35.0;smooth muscle: 32.8	Cell type enriched	Detected in some	6	Cardiomyocytes: 45.4	Cancer enhanced	Detected in single		stomach cancer: 0.8	Region enhanced	Detected in many		pons and medulla: 15.7	Cell type enhanced	Detected in single		neutrophil: 1.3	Low lineage specificity	Detected in single			Cell line enriched	Detected in some	5	fHDF/TERT166: 44.8	Low region specificity	Detected in many			Low region specificity	Detected in all			CAB022338, HPA029795	Approved											CAB022338: , HPA029795: AB_10601357			unprognostic (3.51e-2)	unprognostic (3.73e-4)	unprognostic (5.77e-2)			unprognostic (1.78e-2)		unprognostic (1.97e-1)	unprognostic (4.00e-1)	unprognostic (2.69e-1)		unprognostic (1.43e-2)	unprognostic (1.80e-1)		unprognostic (1.35e-3)	0.8	0.9	3.6	7.2	1.9	0.3	0.8	0.8	6	0.9	8.9	0	0	0.9	0.8	0.3	0.8	0.8	25.5	35	0.9	0.9	0.8	1.2	1	0.2	0.9	2.2	0.8	0.8	0.2	0.9	1.7	15.7	5.4	3.9	0	0.8	0.2	0.8	0.8	3.7	32.8	5	0.8	2.7	2.3	1.5	0	0.8	0	0.2	14	1.8	0	0.2	1.3	0.7	0	0	0	0	0	0	0	0	0	0	8.2	9.2	0.1	0	0	0	0	0	44.8	0	0	0	0	0	0	0	0	0	0	6.6	0	0	0	0	0	0	0.3	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	1.4	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0.3	0.2	0	0.4	0	0	0	0	0	0	0	0	1.3	0	0.7	0.2	0	0	3.6	1.9	0.8	6	0.9	0.9	0.9	2.2	15.7	1.5	0	0	0	0	0	4.9	45.4	0	0	0	0	2	0	0	0	8.2	0	0	0	0	0	0	0	0	0	0.1	0	0	2.5	0	5.9	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0.1	0	0	0.2	0	0	0	Cardiomyocytes
MAPK15	ERK7, ERK8	ENSG00000181085	Mitogen-activated protein kinase 15	Q8TD08	8	143716259-143722458	Enzymes, Predicted intracellular proteins		Kinase, Serine/threonine-protein kinase, Transferase		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 26.9;epididymis: 27.6;fallopian tube: 29.5	Cell type enriched	Detected in some	6	Ciliated cells: 85.6	Low cancer specificity	Detected in many			Region enhanced	Detected in many		pons and medulla: 26.9	Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		CAPAN-2: 7.2;HaCaT: 5.4;HeLa: 14.3;MCF7: 13.9;T-47d: 12.5	Low region specificity	Detected in some			Low region specificity	Detected in all			HPA002704			Approved	Nucleoplasm,Cell Junctions,Cytosol						Nucleoplasm, Cytosol	Cell Junctions	HPA002704: AB_1079307	unprognostic (9.11e-2)	unprognostic (1.38e-1)	unprognostic (8.04e-3)	unprognostic (2.94e-1)	unprognostic (2.54e-2)	unprognostic (1.14e-2)	unprognostic (1.22e-1)	unprognostic (6.09e-2)	unprognostic (2.59e-2)	unprognostic (1.48e-1)	unprognostic (3.88e-1)	unprognostic (9.51e-2)	unprognostic (2.64e-2)	unprognostic (1.54e-2)	unprognostic (5.78e-1)	unprognostic (6.35e-2)	unprognostic (1.62e-2)	0.6	0.1	3.6	0.3	8.1	0.1	1.1	0.2	2.1	4.5	0.4	8.7	5.2	0.5	2.2	27.6	1.3	29.5	0.4	1.1	5.4	4.6	3.9	0.2	7.4	0.5	0.2	1.5	4.7	2	9.1	4.2	0.6	26.9	0.9	0.4	1.6	3	2.4	0.2	4.9	0.7	0.5	0.4	0.5	0.9	7.3	2.4	0.1	8.4	0.5	0.4	0.5	0.9	0.5	0	0	0	0	0	0	0.4	0.4	1.7	0	0	0	0.6	1.3	0	0	0	0.2	7.2	0	1.3	0	0	5.4	0.1	0.2	0	1.1	1.6	0	14.3	0	0.1	0	0.1	0	0	0	0	1	0	0.3	2.7	0	0	13.9	0	0	2	1.2	1.1	0	3	0.4	0.9	1.3	4	4	0	2.8	0	0.2	12.5	0	0.1	0	0.1	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	3.6	8.1	0.2	2.1	5.4	4.6	0.2	1.5	26.9	2.4	0	8.3	0	0.2	0.3	0	0.8	0	85.6	13.6	0	0	0	0	0.6	12.6	0	0	0	0	0.6	0	0.3	0	0	0.1	0	0	0	0	8.9	0	0	0	0	0.5	0	0.5	0	0	0.8	0	0	0	2.7	0.7	0.3	0.1	0	0.1	0	Ciliated cells
ADIPOQ	ACDC, ACRP30, adiponectin, AdipoQ, apM1, GBP28	ENSG00000181092	Adiponectin, C1Q and collagen domain containing	Q15848	3	186842690-186858463	Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters		Hormone	Diabetes mellitus, Disease mutation, Obesity	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	6	adipose tissue: 176.7;breast: 79.4	Cell type enriched	Detected in single	12	Distal tubular cells: 1.7	Group enriched	Detected in some	8	breast cancer: 6.5;pancreatic cancer: 1.9	Not detected	Not detected			Low cell type specificity	Detected in some			Low lineage specificity	Detected in single			Cell line enriched	Detected in single	670	ASC diff: 86.2	Not detected	Not detected			Not detected	Not detected			CAB046467, HPA051767	Uncertain				Secreted to blood			8360000000	1000000000			CAB046467: AB_1078104, HPA051767: AB_2681598	unprognostic (1.76e-2)									unprognostic (1.53e-1)	unprognostic (2.20e-2)			unprognostic (6.99e-3)	unprognostic (1.87e-1)			176.7	1.9	0	16.7	0	0.1	79.4	0	0.1	0.1	23.2	0	0.4	0.1	0.1	1.3	0.3	0.1	13.2	5.8	0	0	0.5	0.1	0.1	6.1	0	0	0.2	1.3	0.1	0	0.1	0	0.4	1.4	0	14.7	0.6	2	1.5	2.1	0.4	0	0.1	0.6	0.1	0	0	0.7	9.5	0.3	1	0.9	0.8	0.6	2.4	0.4	0.7	0.5	0.1	0	0	0	0	86.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	2.4	0.4	0.6	0.4	0.3	0.3	0.4	0.3	0.3	0.1	0.8	0.3	0.5	1.9	0.7	0.4	0.6	0.2	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	1.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Distal tubular cells
F2R	CF2R, PAR-1, PAR1, TR	ENSG00000181104	Coagulation factor II thrombin receptor	P25116	5	76716043-76735781	FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins	Blood coagulation, Hemostasis	G-protein coupled receptor, Receptor, Transducer	FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		lymphoid tissue: 67.5	Cell type enriched	Detected in many	9	Ito cells: 323.5	Low cancer specificity	Detected in all			Low region specificity	Detected in many			Cell type enhanced	Detected in many		gdT-cell: 17.6	Lineage enriched	Detected in many	4	T-cells: 17.6	Cell line enhanced	Detected in many		hTERT-RPE1: 39.1;HUVEC TERT2: 71.3;WM-115: 67.2	Low region specificity	Detected in many			Low region specificity	Detected in all			CAB008973, CAB012962	Approved											CAB008973: , CAB012962: AB_2533198	unprognostic (3.03e-1)	unprognostic (7.76e-2)	unprognostic (5.55e-2)	unprognostic (7.76e-2)	unprognostic (7.14e-2)	unprognostic (3.46e-1)	unprognostic (2.51e-1)	unprognostic (3.75e-2)	unprognostic (5.37e-2)	unprognostic (1.36e-1)	unprognostic (1.36e-1)	unprognostic (2.22e-1)	prognostic unfavorable (2.21e-7)	unprognostic (2.72e-3)	unprognostic (1.30e-1)	unprognostic (1.12e-1)	unprognostic (6.74e-3)	12.3	11.2	1.5	7.5	2.2	1.1	8.9	0.8	3.5	11.7	14	3.3	20.1	5.9	17.6	8.6	9.3	3.5	20.8	19.2	1.4	1.7	19.5	22.6	24.4	10.4	1.5	1.8	6.2	4	1.6	4.7	32	2.5	9.6	5.1	9.6	26.4	14	7.2	23.7	15.5	8.4	3.5	67.5	4.5	16.6	1.4	4	9.1	11.4	13.5	10.7	4.7	0.4	0.2	0.8	0.3	4.2	17.6	6.4	1	3.3	10.5	1.7	19.8	34.7	0.5	5.8	20	3.8	13.9	0.7	9.1	0	9.9	2.5	17.4	2.5	4.5	3.5	7.3	0.8	3.7	22.8	0.7	2.8	29.9	0.1	0.9	19.5	11.9	7.3	2	39.1	71.3	4.1	4.2	4.3	7.8	0.4	1.7	0	3.3	0	18.2	3.2	6.3	0.8	18.1	0.1	1.2	5.7	1.7	0	8.5	9.9	0.1	0.2	32.6	24.3	5.4	0.2	10.8	11.7	3.4	0	6.4	0.4	67.2	0.5	0.2	0.3	17.6	0.3	4.4	0.4	4.1	12.1	0	0.1	0.7	9.1	0.8	4.2	0.1	0.2	0.4	6.4	1.5	2.2	0.8	2.1	1.4	1.7	1.5	1.8	2.5	1.4	0	11.6	1.5	0.5	15.2	2.5	2	10.2	4	3.4	7	0	0.1	0	1.9	8.8	22.6	0.2	0	1.9	0.3	28.8	1.2	5.8	2.5	1.6	0	6.3	323.5	25.7	3.6	0.9	1.3	11.8	0	3.2	0	6.7	0	9.9	2.2	1.6	0	17.5	6.7	4.1	35	0.2	30.2	1	0.4	Ito cells
SLC25A41	APC4, FLJ40442, MGC34725	ENSG00000181240	Solute carrier family 25 member 41	Q8N5S1	19	6426037-6433779	Predicted intracellular proteins, Transporters	Transport			Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	10	brain: 8.1;testis: 26.5	Cell type enriched	Detected in some	8	Early spermatids: 91.3	Not detected	Not detected			Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HaCaT: 2.3;HMC-1: 7.1;K-562: 2.1;U-937: 4.2	Low region specificity	Detected in single							HPA043591	Uncertain											HPA043591: AB_10964585	unprognostic (1.87e-3)	unprognostic (2.52e-3)	unprognostic (6.81e-2)	unprognostic (8.75e-2)	unprognostic (2.67e-1)	unprognostic (8.29e-4)	unprognostic (4.43e-3)	unprognostic (2.81e-2)	unprognostic (9.26e-2)	unprognostic (6.85e-2)	unprognostic (2.19e-3)	unprognostic (3.11e-2)	unprognostic (2.03e-1)	unprognostic (1.56e-1)	unprognostic (3.63e-2)	unprognostic (2.11e-1)	unprognostic (1.24e-1)	0.3	0.2	2.4	0.3	6.3	0	0.5	8.1	3.2	0.3	0.5	0.3	0.3	0.4	0.3	0.8	1.7	0.4	0.3	1.6	2.6	1.3	0.3	0.3	0.3	0.3	0.6	0.3	0.3	0.3	0	0.3	0.3	0.3	0.3	0	0.3	0.5	0.9	1.3	1.2	0.3	0.5	0.6	0.3	0	26.5	0.3	0.3	0.4	0.3	0.3	1.3	0.3	0	0	0	0	0	0	0	0.5	0.3	1.1	0.4	0	0	0.7	0	0	0.4	0.2	0	0	0.3	0.4	0	0	2.3	1.6	0	0	0	1.4	0	0	0	0	0	7.1	0.7	1.7	0	0	0.4	0	0.4	2.1	0	0	0.9	0	1.7	0	0	1.4	0.1	0	0	0.1	0	0	0.2	0.4	0	0	0	0.4	1.7	0	0	0.5	0	0	0	0	0.6	0	4.2	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.4	6.3	8.1	2.7	2.6	1.3	0.6	0.3	0.3	0.3	0	0	0	0.1	0	0.3	0.4	0	0	0	0	2	0.4	0	0.2	91.3	0	0.1	0	0	0.1	0.2	0.3	0	0	0.1	3.2	0	0	0	11.5	0.9	0	0	0	0.1	0.9	0.4	0	0	0.1	1.2	0	0	0.2	0.2	0.3	0.5	0	0.2	0.1	Early spermatids
TMEM132E	DFNB99	ENSG00000181291	Transmembrane protein 132E	Q6IEE7	17	34579487-34639318	Disease related genes, Predicted membrane proteins			Deafness, Disease mutation, Non-syndromic deafness	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		brain: 20.0;kidney: 8.8	Cell type enriched	Detected in some	7	Proximal tubular cells: 9.0	Group enriched	Detected in some	8	glioma: 7.6;renal cancer: 1.8	Low region specificity	Detected in all			Cell type enhanced	Detected in some		naive CD4 T-cell: 2.6	Group enriched	Detected in many	20	NK-cells: 1.4;T-cells: 2.6	Cell line enriched	Detected in some	9	RPMI-8226: 31.6	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA070608	Approved		Approved	Nucleoplasm,Nuclear bodies,Golgi apparatus,Cytosol					140000	Nucleoplasm, Golgi apparatus	Nuclear bodies, Cytosol	HPA070608: AB_2686286	unprognostic (1.92e-1)	unprognostic (1.68e-1)	unprognostic (3.29e-5)	unprognostic (3.37e-1)	unprognostic (1.37e-1)	unprognostic (8.61e-2)	unprognostic (1.06e-3)	unprognostic (1.72e-1)	unprognostic (1.80e-1)	unprognostic (1.56e-2)	unprognostic (2.16e-3)	unprognostic (1.25e-1)	prognostic unfavorable (1.55e-4)	unprognostic (1.67e-2)	unprognostic (1.51e-2)	unprognostic (2.65e-1)	unprognostic (8.71e-2)	0.4	0.5	4.9	0.4	4.1	0.2	0.3	17.3	8.7	1.2	0.4	1.7	0.3	4.9	0.6	0.5	0.4	0.4	0.8	0.5	2.9	5.1	8.8	1.3	0.4	0.7	4.5	2.8	0.5	0.2	0.3	0	0.9	5.3	0.4	0.5	0	0.8	0.8	0.3	0.8	2.8	0.6	20	0.7	0.6	2.4	2.2	0	0.4	0	0.6	0.7	0.1	0	0	0	0	1.4	2.6	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0.8	3.4	0	0	0	0	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	31.6	0	0	0.4	0	0	0	0	0	0.1	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	1.2	0	1.2	0	0.4	0.5	0	0	2.6	1.8	0	1.4	0	0	0	0.4	4.9	4.1	17.3	6.9	2.9	5.1	4.5	2.8	5.3	2.2	0	0	0	0	0.2	0	1.2	0	0	0	0	0	0	0	0	1.3	0	0	0	0	0	0.1	0	0	0	0.1	0	0	0.6	1	1.4	0	0	0	0	0	0	0	0	0	9	0	0	0.4	0.7	1.3	0	0	0	0	0	Proximal tubular cells
NME9	NM23-H9, TXL-2, TXNDC6	ENSG00000181322	NME/NM23 family member 9	Q86XW9	3	138261437-138329886	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		fallopian tube: 30.4	Cell type enriched	Detected in some	12	Ciliated cells: 64.3	Low cancer specificity	Detected in some			Low region specificity	Detected in all			Cell type enhanced	Detected in some		MAIT T-cell: 4.2	Lineage enriched	Detected in single	4	T-cells: 4.2	Cell line enhanced	Detected in many		HMC-1: 4.9	Low region specificity	Detected in many			Low region specificity	Detected in many			CAB020943, HPA040000, HPA043881	Enhanced		Approved	Centriolar satellite,Cytosol						Cytosol	Centriolar satellite	CAB020943: , HPA040000: AB_2676793, HPA043881: AB_2678712	unprognostic (2.71e-5)	unprognostic (1.68e-1)	unprognostic (5.09e-2)	unprognostic (3.01e-3)	unprognostic (3.67e-1)	unprognostic (1.69e-3)	unprognostic (4.58e-2)	unprognostic (5.19e-2)	unprognostic (1.66e-1)	unprognostic (1.12e-2)	unprognostic (1.03e-2)	unprognostic (1.72e-2)	unprognostic (3.82e-2)	unprognostic (1.39e-2)	unprognostic (9.14e-2)	unprognostic (4.89e-2)	unprognostic (7.17e-3)	1	1.7	5.3	1.3	11.3	4.4	1	6.2	8.3	1.5	0.8	4.1	3.5	1.1	1.6	3.6	0.8	30.4	1.3	0.9	5.6	8.2	1.7	0.8	4	1.1	3.6	3.1	2.5	3.3	1.8	7.5	1.1	10.3	1.7	0.8	0.9	3.4	1.9	4.3	1.8	1.1	1	3.6	1.2	1.5	6	3.9	0.9	2.3	0	1	0.8	0.5	0.6	0.6	0.3	0.9	0.3	4.2	0.5	1.1	1.6	1.1	0.5	0	0	1.7	0.7	0	0.2	0.1	0.9	1.9	2.5	1.2	0	1.3	1.3	0.2	0	0	0.5	1.8	2.1	1.6	0.6	0	2.7	4.9	0.9	0	0.1	0	2.9	0.1	3.2	0.6	1.4	0.2	0.4	0.6	2.5	0.7	0.5	1.2	1	0	0.7	1.7	2.6	3.7	1	1.6	0.6	0.4	0.9	0.9	0.1	3	0.5	0.8	0.8	0.6	0.9	1.2	1.1	1	1.1	0.5	0.1	0.9	0	0.5	0	4.2	0.2	1.7	0.4	0.3	0.6	2.8	1.2	0.3	0.3	0.2	0.6	0.7	0.5	5.3	11.3	6.2	8.3	5.6	8.2	3.6	3.1	10.3	3.9	0	0.3	0	0.2	0	1.3	1.1	2.5	64.3	3.4	1.8	0	0.1	0	0.1	2	0	0	0	0	0	0	0.1	0	0	0	3.2	0	0	0	1.1	0.3	0	0	0	0	2.5	0	0	0	0.4	2.3	0	0	5.5	0.5	0	0.2	0	0	0	Ciliated cells
SPEM1	C17orf83, FLJ40081	ENSG00000181323	Spermatid maturation 1	Q8N4L4	17	7420360-7421632	Predicted membrane proteins	Differentiation, Spermatogenesis	Developmental protein		Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	69	testis: 61.9	Cell type enriched	Detected in some	5	Late spermatids: 3850.1	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		CACO-2: 1.0;hTEC/SVTERT24-B: 1.2;U-2 OS: 3.3	Low region specificity	Detected in single																																		unprognostic (1.28e-1)			0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	61.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.4	0	0	0	0	0	0.1	0.1	1	0	0	0.1	0.5	0.2	0	0.3	0	0.2	0.4	0.2	0	0	0	0	0	0.2	0	0	1.2	0	0	0	0	0	0	0	0.9	0	0	0	0	0	0.3	0.2	0	0	0	0	0.6	0	0	0	0.1	0	0	0	0.5	3.3	0.4	0	0.4	0.1	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	833.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3850.1	10.9	0	0	0	0	0	0	0	11.7	0	0	6.5	0	11.5	4	0	0	0	0	0	Late spermatids
HEPHL1	DKFZp686F22190	ENSG00000181333	Hephaestin like 1	Q6MZM0	11	94021361-94113751	Predicted membrane proteins	Copper transport, Ion transport, Transport	Oxidoreductase	Disease mutation	Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	4	tongue: 68.0	Cell type enriched	Detected in some	5	Basal keratinocytes: 9.3	Cancer enriched	Detected in some	5	head and neck cancer: 20.9	Not detected	Not detected			Cell type enhanced	Detected in single		naive B-cell: 1.1	Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		BEWO: 1.4;HaCaT: 4.2;HBEC3-KT: 7.5	Region enriched	Detected in single	21	olfactory region: 1.4	Not detected	Not detected			HPA031517	Uncertain								51000000			HPA031517: AB_10603769	unprognostic (9.16e-2)	prognostic unfavorable (4.94e-4)	unprognostic (2.40e-1)	unprognostic (3.26e-6)	unprognostic (3.17e-1)	unprognostic (3.45e-1)	unprognostic (1.72e-2)	unprognostic (6.71e-2)	unprognostic (5.34e-1)	unprognostic (1.09e-1)	unprognostic (7.66e-2)	unprognostic (1.48e-1)	unprognostic (1.20e-2)	unprognostic (1.00e-1)	unprognostic (2.02e-1)	unprognostic (3.33e-1)	unprognostic (1.25e-1)	0.1	0	0	0	0	0	0.5	0	0	3.9	0	0	0	0	0.1	0	8.1	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0.8	0	0.1	6.5	0.1	0	0	0	0	0.5	0	0	0.4	68	16.2	0	4.8	1.1	0.3	0.1	0	0.9	0.1	0	0.9	0.1	0	0	0	0	1.4	0.2	0.1	0	0	0.1	0.5	0	0.3	0	0.1	4.2	0	7.5	0	0	0	0.7	0	0.1	0	0	0	0	0.4	0	0.4	0	0	0	0	0.3	0	0.5	0	0	0.4	0	0.5	0	0	0	0	0.2	0.1	0.2	0	0	0	0.1	0.2	0	0	0.2	0.9	0	0.3	0	0.1	0	0	0	0.1	0	0	0	0	0	0.1	0.4	0	0.1	0.3	1.1	0	0.1	0.1	0.9	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	9.3	0	0.2	0	0	0	1.8	0	0.4	0	0	0.8	0	0	0	0	0	0.2	0.1	0	0	0.1	0	0	0	0	0.2	0	0	1.7	0	0	0	0	0	0	0	0	0	0	0	0	1.4	0	0	0	0	Basal keratinocytes
SAGE1	CT14, SAGE	ENSG00000181433	Sarcoma antigen 1	Q9NXZ1	X	135889205-135913061	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	13	testis: 10.9	Cell type enriched	Detected in single	26	Spermatogonia: 8.6	Low cancer specificity	Detected in some							Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		AN3-CA: 15.1;K-562: 10.9;Karpas-707: 18.8;U-2 OS: 5.3;U-266/70: 6.6;U-266/84: 16.4									HPA003033, HPA003208	Enhanced		Enhanced	Nucleoplasm,Nuclear bodies						Nucleoplasm	Nuclear bodies	HPA003033: AB_1079865, HPA003208: AB_1079863				unprognostic (1.11e-1)	unprognostic (5.26e-2)			unprognostic (1.15e-1)		unprognostic (1.02e-2)	unprognostic (2.37e-1)		unprognostic (7.12e-4)	unprognostic (1.45e-2)	unprognostic (1.10e-1)			0	0	0.2	0	0.2	0	0.1	0	0.2	0	0			0	0	0	0	0	0	0	0.3	0.2	0	0	0	0	0.3		0	0	0	0.4	0		0	0		0	0	0	0	0	0	0.8	0	0	10.9			0		0	0	0	0	0	0	0	0	0.1	0	0	0	0	15.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	10.9	18.8	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	5.3	0	0	6.6	16.4	0	0.9	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	8.6	0	0	0	0	0	Spermatogonia
SOX2		ENSG00000181449	SRY-box 2	P48431	3	181711924-181714436	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	Activator, Developmental protein, DNA-binding	Cancer-related genes, Disease mutation, Microphthalmia	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	5	brain: 80.1	Cell type enriched	Detected in some	9	Muller glia cells: 455.6	Cancer enhanced	Detected in many		glioma: 136.5	Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		AF22: 68.9;HAP1: 29.3;NTERA-2: 56.2;U-251 MG: 12.9	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA045725, HPA062851, HPA071379, CAB079745	Enhanced	Supported	Enhanced	Nucleoplasm						Nucleoplasm		CAB079745: , HPA045725: AB_2679431, HPA062851: , HPA071379: 	unprognostic (1.80e-2)	unprognostic (3.18e-3)	unprognostic (5.69e-2)	unprognostic (6.96e-2)	unprognostic (2.74e-3)	unprognostic (1.60e-1)	unprognostic (1.79e-2)	unprognostic (4.48e-3)	unprognostic (1.71e-1)	unprognostic (4.38e-3)	unprognostic (1.83e-1)	unprognostic (7.68e-2)	unprognostic (3.81e-9)	unprognostic (1.12e-1)	unprognostic (2.12e-1)	unprognostic (1.26e-1)	unprognostic (1.12e-2)	1.8	2.5	30.3	2	25.8	1.5	1.6	13.9	80.1	1.8	2.3	24.3	0	2	1.5	1.8	15.9	5	1.8	1.7	36	19.2	1.5	1.5	3.4	1.5	19.4	18.5	1.7	1.6	1.5	5.8	1.5	18.6	3.9	2	1	6.3	1.9	1.6	1.8	2.3	1.7	18.4	1.6	9.7	3	22.4	0	1.5	2.1	6.9	2.3	1.7	0	0	0	0	0	0.3	0	0	2.2	68.9	0	0	0	0	0	0	0	0	3.7	0	0	0	0	0	0.1	29.3	0.7	0	0	4.4	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0.1	0	0	56.2	2.9	0.1	0	0.1	0	7.6	0.1	0.1	0.3	0	0	0	11.9	0.4	0	0	0	1	0	12.9	0	0	0	0	0	8.6	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	30.3	25.8	13.9	20	36	19.2	19.4	18.5	18.6	22.4	0	5.9	0	41.2	0.2	3.5	0.4	0	52.2	38.7	3.5	0	0	0	0	0.7	0	0	0	0	0	0.2	4.9	1.1	0	0.1	0	0	1.3	0	0	0.6	0.2	3.3	0	0	455.6	0	0	0	0	8.2	0	0.1	1.5	0.2	0.4	0.2	0	0	7	Muller glia cells
EDDM3A	FAM12A, HE3-ALPHA	ENSG00000181562	Epididymal protein 3A	Q14507	14	20745892-20748380	Predicted secreted proteins				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	7	ductus deferens: 61.8;epididymis: 129.9	Cell type enriched	Detected in some	22	Collecting duct cells: 27.9	Not detected	Not detected			Not detected	Not detected			Cell type enriched	Detected in single	13	naive B-cell: 1.2	Lineage enriched	Detected in single	13	B-cells: 1.2	Cell line enhanced	Detected in some		BEWO: 2.9;NB-4: 3.4;SH-SY5Y: 1.5									HPA049952	Approved				Secreted in male reproductive system							HPA049952: AB_2680970	unprognostic (1.42e-1)				unprognostic (9.88e-2)								unprognostic (8.56e-3)		unprognostic (2.10e-1)			0.1	0.1	0.1	0	0.1	0	0.2	0.1	0.1	0.1	0.1	0	61.8	0	0.1	129.9	0.1	0.2	0	0.1	0.1	0.1	1.5	0.1	0.1	0	0.1	0	0.1	0.1	0	0.1	0	0	1.2	0	0	0.2	14.7	0.1	0.1	0.1	0	0.1	0.4	0.4	4.7	0	0	0.1	0	0	0.2	0.1	1.2	0	0	0	0	0	0	0	0	0	0	0	0	2.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.4	0	0	0	0	0	0.9	0	0	0	1.5	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.2	0	0	0	0	0	0	0	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	27.9	0	0.1	0	0	0.3	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	1.3	0	0	0	0.4	0	0	0.2	0	0	0	Collecting duct cells
FDCSP	C4orf7, FDC-SP	ENSG00000181617	Follicular dendritic cell secreted protein	Q8NFU4	4	70226071-70235252	Predicted secreted proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	9	lymphoid tissue: 176.5;salivary gland: 452.5	Cell type enriched	Detected in single	38	Ductal cells: 37.2	Cancer enhanced	Detected in many		head and neck cancer: 336.0	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		Daudi: 2.2;GAMG: 10.9;HL-60: 2.0;RH-30: 3.0;U-87 MG: 8.0									HPA014326, CAB014890	Enhanced				Secreted in other tissues							CAB014890: , HPA014326: AB_1845719	unprognostic (1.26e-3)	unprognostic (2.32e-1)	unprognostic (8.73e-3)	unprognostic (9.62e-2)		prognostic favorable (2.38e-4)	unprognostic (5.99e-3)	prognostic favorable (1.32e-4)	unprognostic (2.04e-1)	unprognostic (2.11e-1)	unprognostic (1.74e-1)	unprognostic (3.79e-1)		unprognostic (1.96e-1)	unprognostic (3.68e-2)	unprognostic (2.80e-1)	unprognostic (7.83e-2)	0.4	0.4	0.4	95.4	0.4	0	9.7	0.4	0.4	0.4	1	0	0	0	0.4	0	1.9	0.4	0	0.4	0.4	0.4	0.4	0.4	0.5	124.7	0.4	0	0.4	0.4	0	0.4	0	0	0.4	0.7	0	452.5	0	0.5	0.4	3.7	0	0.4	12.1	0.4	0.4	0	0.4	0.5	35.9	176.5	0.7	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	2.2	0	0	10.9	0	0	0	0	0	0	0.8	0	0	0	2	0	0	0	0	0	0	0	0	1.8	0	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0.8	0	0	0	0	0	0.6	0.7	0	0.1	0	0	0	0.2	8	0.8	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	37.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	Ductal cells
SLX1B	GIYD2, MGC5178	ENSG00000181625	SLX1 homolog B, structure-specific endonuclease subunit	Q9BQ83	16	29454501-29458219	Predicted intracellular proteins	DNA damage, DNA recombination, DNA repair	Endonuclease, Hydrolase, Nuclease		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		blood: 26.5	Cell type enriched	Detected in some	6	Cardiomyocytes: 10.4	Not detected	Not detected							Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low cell line specificity	Detected in many											HPA047038	Uncertain		Approved	Nucleoplasm						Nucleoplasm		HPA047038: AB_2679913	unprognostic (2.93e-1)	unprognostic (1.11e-1)	unprognostic (2.16e-2)	unprognostic (5.12e-2)	unprognostic (7.05e-2)	unprognostic (1.78e-1)	unprognostic (7.20e-2)	unprognostic (2.72e-2)	unprognostic (2.35e-3)	unprognostic (3.63e-1)	unprognostic (1.22e-1)	unprognostic (3.64e-2)	unprognostic (2.51e-7)	unprognostic (4.84e-2)	unprognostic (1.96e-1)	unprognostic (4.44e-1)	unprognostic (5.25e-3)	4.6	2.9	0.2	3.9	0.5	8.8	4.9	2	2.7	5.6	6.6			14.1	5.4	2.7	3	4.4	1.1	2.2	0.4	0.5	3.3	11.1	5.7	3	0.6		4.2	3.1	3.4	2.2	5.4		4	4.6		8	5.4	11.2	5.7	13.4	2.9	1.8	6.3	4.7	0			6.1		6.6	5.7	3.9	3.2	20.8	26.5	24.7	3.7	6.5	6.7	6.8	5.9	15.4	0.7	3.2	4.6	21.2	6.4	15	14.6	12.4	1.6	10.5	17.3	5.6	4.5	2.3	2.6	5.7	9.2	3.5	1	4.3	7.1	3.1	9.2	9.9	7.2	2.9	6.1	6.6	9.6	6.5	9.2	16.2	20.4	3.7	7.1	6.8	9.7	1.3	7.2	1.3	15.4	8.6	7	12.2	15.5	12.3	4.2	2.5	14.8	2.7	30.2	1.4	2.4	1.4	4.1	10.8	4.9	1.5	2.9	1.1	3.2	20.1	11	5.4	5.5	2.1	3.3	24.7	26.5	2.8	20.7	0.8	3.2	2.5	2.8	20.8	2.5	1.2	1.6	14.8	3.7	11.9	1.2	6.5	6.7											0	0.3	0	0	0	0	10.4	0	0	0	0	0	1.4	0	0.6	0	0.1	1	0	1.3	0.6	0.4	0.2	0	0.5	1	0	0	0.6	1.2	0	0	0.2	0	1.8	0	0	0.8	0	0.4	0.3	0	0	0	0	0	0.1	1.1	0.9	0.1	0.1	Cardiomyocytes
TMEM252	C9orf71, MGC34760	ENSG00000181778	Transmembrane protein 252	Q8N6L7	9	68536580-68540867	Predicted membrane proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at transcript level		Group enriched	Detected in some	5	intestine: 16.0;kidney: 64.2	Cell type enriched	Detected in some	9	Proximal tubular cells: 15.1	Cancer enriched	Detected in many	17	renal cancer: 35.7	Not detected	Not detected			Cell type enriched	Detected in single	8	neutrophil: 7.6	Lineage enriched	Detected in single	37	granulocytes: 7.6	Group enriched	Detected in some	6	EFO-21: 1.6;PC-3: 3.4;RH-30: 1.9;RPTEC TERT1: 6.5;SK-BR-3: 3.7	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA079457	Enhanced											HPA079457: 	unprognostic (2.64e-1)		unprognostic (3.28e-3)	unprognostic (3.72e-1)	unprognostic (1.51e-1)	unprognostic (2.53e-2)	unprognostic (4.00e-2)	unprognostic (7.79e-3)		unprognostic (6.47e-2)	unprognostic (1.64e-2)	unprognostic (6.42e-2)	prognostic favorable (1.75e-7)	unprognostic (7.63e-2)	unprognostic (6.15e-2)	unprognostic (7.66e-2)	unprognostic (2.50e-1)	0.5	2	0.4	0.6	0.4	0	0.4	0.9	0.4	0.6	5.6	0.4	0.4	1	4.3	0.8	4.3	2.7	0.7	3	0.4	0	64.2	0.9	0.4	0.4	0.4	0.4	0.6	0.4	0	0.4	2.6	0.4	1.8	0	0.4	0.4	0.4	0.7	0.2	16	0.9	0.4	0.4	1.7	0.6	0.4	0.4	0.4	0.4	0.5	6	0.6	0	0.1	7.6	0.2	0	0	0	0	0	0	0	0	0	0.1	0.1	0	0	0	0	0	0	1.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0.2	0	0	3.4	0	1.9	0	6.5	0	0	0	0	3.7	0	0	0	0	0	0	0.1	0.2	0	0	0	0	0	0	0	0	0.1	0.9	0	0.1	0	0	0	0	0.1	0	0	0	7.6	0	0.2	0	0	0	0.4	0.4	0.9	0.4	0.4	0	0.4	0.4	0.4	0.4	0	0	0	0	0	0	0.6	0	0	0	0	0	0	1.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.1	0	0	0	0	0	0	0	0	0	0	Proximal tubular cells
ODF3L2	C19orf19, FLJ40059	ENSG00000181781	Outer dense fiber of sperm tails 3 like 2	Q3SX64	19	463346-474983	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	26	skeletal muscle: 12.5;testis: 16.7	Cell type enriched	Detected in some	5	Late spermatids: 894.9	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		AN3-CA: 1.5;BEWO: 2.2;EFO-21: 3.1;HMC-1: 2.3	Low region specificity	Detected in many			Not detected	Not detected			HPA067065, HPA067973	Uncertain		Approved	Nucleoplasm,Nucleoli,Golgi apparatus						Nucleoli	Nucleoplasm, Golgi apparatus	HPA067065: , HPA067973: AB_2685937	unprognostic (3.75e-4)	unprognostic (1.79e-2)	unprognostic (1.83e-3)	unprognostic (9.69e-3)	unprognostic (5.88e-2)	unprognostic (5.65e-2)	unprognostic (9.32e-2)	unprognostic (1.35e-1)	unprognostic (2.34e-2)	unprognostic (1.77e-2)	unprognostic (2.13e-2)	unprognostic (4.06e-2)	unprognostic (2.02e-5)	unprognostic (3.13e-3)	unprognostic (8.99e-2)	unprognostic (3.05e-1)	unprognostic (1.99e-1)	0.4	0.1	0.1	0	0.2	0	0	0	0	0	0			0	0	0	0	0.1	0.1	0	0.1	0.1	0	0.2	0	0	0.2		0	0	0	0	0.3		0.1	0		0	0	12.5	0	0	0	0.3	0.5	0	16.7			0.1		0	0	0	0	0	0	0	0	0	0.3	0	0	0	1.5	0	0	2.2	0	0.1	0.1	0.1	0	0	0.1	3.1	0	0.5	0.1	0	0	0.2	0	0.8	0	0	0	0	0.3	2.3	0	0.3	0	0.2	1.1	0	0	0.6	0.1	0.6	1	0.1	0	0.8	0	0.6	0.1	0	0	0	0	0.1	0.2	0	0.1	0.1	0	0	0.9	0	0.5	0.1	0	0	0.6	0	0	0.1	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3											0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	187	0.1	0	0	0	0	0	0	0	0	0	0	0	7.4	0	894.9	7.8	0	0	0	0	0.1	0	0	4.6	0	0.7	0	0.1	6.4	5.2	0	0	0	0	0	Late spermatids
ADGRB1	BAI1	ENSG00000181790	Adhesion G protein-coupled receptor B1	O14514	8	142449430-142545009	Cancer-related genes, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins	Immunity, Innate immunity, Myogenesis, Neurogenesis, Phagocytosis	G-protein coupled receptor, Receptor, Transducer	Cancer-related genes	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	7	brain: 27.4	Cell type enriched	Detected in some	9	Horizontal cells: 119.2	Cancer enhanced	Detected in many		glioma: 11.3	Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		AN3-CA: 11.8;MCF7: 4.3;NB-4: 5.8;RPMI-8226: 16.3;U-2 OS: 11.2	Low region specificity	Detected in all			Low region specificity	Detected in all								Secreted in brain								unprognostic (9.57e-4)	unprognostic (1.28e-1)	unprognostic (3.87e-3)	unprognostic (8.50e-3)	unprognostic (9.98e-2)	unprognostic (5.87e-2)	unprognostic (3.39e-1)	unprognostic (2.14e-2)	unprognostic (2.76e-1)	unprognostic (2.55e-1)	unprognostic (6.48e-2)	unprognostic (3.43e-1)	unprognostic (7.30e-11)	unprognostic (6.27e-2)	unprognostic (7.42e-2)	unprognostic (4.52e-3)	unprognostic (3.29e-2)	1	3.4	13.6	1.4	18.1	0.9	1.1	5.4	27.4	2	1	3.1	0.1	1.4	1.8	2.3	0.9	1.4	0.9	0.9	11	11.9	1.1	0.8	1.2	1.6	8.7	9.2	1.6	1.1	0.9	2.7	2.5	9.1	1.3	0.9	0.9	2.6	1.9	0.7	3.1	1.4	1	2.3	3.7	1.5	2.1	3.2	0	0.9	0	1	0.9	0.4	0.2	0	0	0.1	0	0.6	0	0	0.1	0.1	11.8	0	0	0	0	0	0	0	0	0.1	0	1	0	0.1	0	0.9	0	0	0.8	0.4	0	0	0	0	0	0.8	0	0	0	0	0	0	0	0	0	0	4.3	0	5.8	1.8	0.2	0	0.1	0	16.3	0	0	3.1	3.1	0	0	0.2	0.2	0.1	0.3	0	0.1	11.2	0	0	0	0	0	0	0.2	0.8	0	0.1	0	0	0	0	0.1	0.6	0	0	0.2	0	0	0	0	0	0	0	0	13.6	18.1	5.4	19.5	11	11.9	8.7	9.2	9.1	3.2	0	0	0	0.2	0	13.1	5.3	2.5	0	0	0	0	0	1.7	0.4	0.2	0	0	0	0	0	0	0.2	0	0	0.1	119.2	0	0	0	0.6	0.3	0	0	1	0	3.8	0.1	0	12.7	0	0.6	6.5	0	0	0.9	0	0	0	0	0.1	Horizontal cells
FTMT	MtF	ENSG00000181867	Ferritin mitochondrial	Q8N4E7	5	121851955-121852833	Enzymes, Predicted intracellular proteins	Iron storage	Oxidoreductase		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	59	testis: 68.0	Cell type enriched	Detected in some	9	Early spermatids: 604.2	Not detected	Not detected			Not detected	Not detected			Cell type enhanced	Detected in single		neutrophil: 1.1	Low lineage specificity	Detected in single			Cell line enriched	Detected in single	4	HDLM-2: 3.2	Not detected	Not detected			Not detected	Not detected																														unprognostic (4.39e-2)			0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	68	0	0	0	0	0	0	0	0	0.2	1.1	0.6	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0.4	0.7	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0.3	0.6	0.3	0	0.2	0	0	0	0	0.2	0	0	0	1.1	0	0.2	0.1	0.1	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	604.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	65.4	5.2	0	0	0	0	0	0	0	3.2	0	0	0	0	4.6	2.4	0	0	0	0	0	Early spermatids
RTKN2	bA531F24.1, Em:AC024597.2, FLJ39352, PLEKHK1	ENSG00000182010	Rhotekin 2	Q8IZC4	10	62183035-62268707	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	4	lung: 67.6	Cell type enriched	Detected in many	4	Alveolar cells type 1: 1628.8	Low cancer specificity	Detected in many			Low region specificity	Detected in single			Cell type enriched	Detected in some	7	T-reg: 15.4	Lineage enriched	Detected in single	47	T-cells: 15.4	Cell line enhanced	Detected in many		A-431: 25.5;HaCaT: 20.5	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA037946, HPA038446	Enhanced		Approved	Nucleoplasm,Mitochondria						Nucleoplasm	Mitochondria	HPA037946: AB_10795398, HPA038446: AB_10796218	unprognostic (2.33e-1)	unprognostic (2.59e-1)	unprognostic (2.52e-2)	unprognostic (1.52e-2)	unprognostic (1.26e-1)	unprognostic (8.92e-3)	unprognostic (6.66e-5)	unprognostic (7.81e-3)	unprognostic (2.33e-2)	unprognostic (3.24e-1)	unprognostic (3.72e-2)	unprognostic (9.48e-4)	unprognostic (3.70e-11)	unprognostic (3.95e-2)	unprognostic (9.34e-3)	unprognostic (4.68e-3)	unprognostic (1.55e-1)	0.3	0.1	0.7	1.8	0.8	0.5	0.7	0.1	1.6	1.5	1.1	0	0.1	0.7	0.6	0.1	7.1	0.2	0.4	0.2	0.5	0.2	0.5	0.2	67.6	2.3	0.2	0.5	0.3	0.2	0.2	0.8	0.7	0.1	0.7	1.2	0.1	1.6	0.1	0.1	0.7	1.1	0.3	0.2	0.8	0.7	5.3	0.1	6.9	0.8	1.3	4.1	0.7	3	0.3	0.2	0.3	0.1	0.2	15.4	0.2	25.5	1.4	13.7	6.3	0	0.1	3.3	3.7	4.3	4.2	6.7	10.6	5.1	0.1	1.6	1.4	4.3	20.5	7.6	0.6	4.4	3.6	5.2	4.2	3.1	4.4	0	5.7	3.3	0.2	0.3	5.2	0.5	2.3	0.6	6.8	0.2	0.2	5.6	3.2	11	7.3	5.8	3.8	5.2	9.5	14.6	0	2.7	11.1	7.5	8.6	2.4	8.6	3.5	4.2	7.8	3.1	0	1.9	12.5	0.1	9.3	0.1	0	9.8	2.5	0	3	0.1	0.1	0.1	1.3	0	0.1	0.1	2.1	0.4	0	0.3	0.8	0.3	0.3	0.2	0.1	0.2	15.4	0.2	0.7	0.8	0.1	1.6	0.5	0.2	0.2	0.5	0.1	0.1	1628.8	44.5	0.9	8.3	4.1	0.6	0.4	0	4	15.9	0	0	3	0	1.4	376.8	0.1	0.4	0	1.4	4.9	2.5	7	3.5	0	2.1	0	1.7	1.8	0.6	65.6	2	2.2	1.7	0	5.9	0.4	9.1	0	1.8	1.4	0.5	0	1.9	21.3	23.6	1.6	1.7	12.7	3.3	87.2	Alveolar cells type 1
KCNIP1	KCHIP1	ENSG00000182132	Potassium voltage-gated channel interacting protein 1	Q9NZI2	5	170353487-170736632	Predicted intracellular proteins, Transporters	Ion transport, Potassium transport, Transport	Ion channel, Potassium channel, Voltage-gated channel		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 31.2;epididymis: 27.8	Cell type enriched	Detected in some	4	Horizontal cells: 47.7	Cancer enriched	Detected in some	18	glioma: 22.8	Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	23	RPTEC TERT1: 36.8	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA022864, HPA066717	Uncertain		Approved	Vesicles						Vesicles		HPA022864: AB_1858712, HPA066717: 	unprognostic (7.75e-5)	unprognostic (2.66e-2)	unprognostic (6.78e-2)	unprognostic (3.22e-4)	unprognostic (4.51e-2)	unprognostic (3.49e-1)	unprognostic (1.25e-2)	unprognostic (2.69e-1)	unprognostic (5.46e-2)	unprognostic (6.62e-3)	unprognostic (4.74e-2)	unprognostic (7.52e-2)	unprognostic (2.55e-1)	unprognostic (2.58e-2)	unprognostic (1.63e-1)	unprognostic (2.39e-1)	unprognostic (6.05e-2)	1.1	5.9	20.6	1.2	27.9	0.6	1.9	6.4	31.2	4	1	6	5.2	0.9	2.7	27.8	1	2.8	2.9	1.2	11.7	20.5	4.9	0.8	1.9	1.2	12.9	7.3	0.9	2.4	5.1	0.7	2.1	11.1	2.3	1.3	0.8	1.3	7.9	0.8	0.7	1.1	2.1	6.9	2.2	1.1	5.2	5.3	0	1.2	0	1.2	1.2	0.6	0	0	0	0	0	0	0	0	0	0.6	0.1	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0.6	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	36.8	0	0.4	0	0	0	0	0.2	0	0	0	0	1.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	20.6	27.9	6.4	14.6	11.7	20.5	12.9	7.3	11.1	5.3	0	0	0	0.1	0.3	0.2	0.3	0	0	0	0	0	0	0	0.2	0.7	0.3	0	0	0	0	0.2	0	0	0	0.1	47.7	0	0	0	0	4.6	0	0	0	0	0.2	0	0	11	0	0.2	0	0	0	0	0	0	0	0	0	Horizontal cells
ASB18		ENSG00000182177	Ankyrin repeat and SOCS box containing 18	Q6ZVZ8	2	236194872-236264409	Predicted intracellular proteins, Predicted membrane proteins	Ubl conjugation pathway			Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Group enriched	Detected in some	8	heart muscle: 9.8;skeletal muscle: 14.3	Cell type enriched	Detected in single	21	Cardiomyocytes: 5.0	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		BEWO: 1.9;CACO-2: 1.7;HEK 293: 2.4;K-562: 2.8;MCF7: 3.1;PC-3: 1.4;RH-30: 2.5;SiHa: 1.8	Low region specificity	Detected in many			Low region specificity	Detected in many																				unprognostic (1.12e-1)	unprognostic (7.33e-3)				unprognostic (3.07e-1)			unprognostic (1.78e-6)	unprognostic (4.75e-2)	unprognostic (3.22e-1)			0	0	0	0	1.5	0	0	0	0.3	0	0			0	0	0	0	0	0	9.8	0.1	0.1	0	0	0	0	0		0	0	0	0	0		0	0		0	0	14.3	0	0	0	0	0	0	0.7			0		0	0	0	0	0	0	0	0	0	0	0.7	0.3	0	0.3	0	0	1.9	0.1	0	0	0	1.7	0	0	0.2	0	0.5	0	0	0	0	0	2.4	0	0.9	0	0	0	0	0	0	0	0.2	0	0	0	2.8	0	0	3.1	0	0	0	0	1.4	0	2.5	0	0	0	0.1	0	1.8	0	0	0.1	0.1	0	1.4	0.6	0	0.1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0	0	5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	Cardiomyocytes
TMIGD1	TMIGD, UNQ9372	ENSG00000182271	Transmembrane and immunoglobulin domain containing 1	Q6UXZ0	17	30316333-30334059	Predicted intracellular proteins, Predicted membrane proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in some	33	intestine: 47.3	Cell type enriched	Detected in some	14	Enterocytes: 341.7	Cancer enhanced	Detected in single		colorectal cancer: 1.6	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		BEWO: 1.4;NB-4: 1.3;U-2197: 1.8;U-698: 2.0	Not detected	Not detected			Not detected	Not detected			HPA021946			Approved	Mitochondria						Mitochondria		HPA021946: AB_1858140			unprognostic (1.28e-1)										unprognostic (1.30e-1)	unprognostic (1.61e-1)				0.2	0	0.2	1.1	0.2	0	0.2	0.2	0.2	0.2	26.8	0.2	0.2	0	0.2	0.2	0.2	0	0.2	0.2	0.2	0	1.4	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0	0.2	0.2	0.2	0.2	33.9	0.2	0.2	0.2	0.2	0	47.3	0.2	0.2	0.2	0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0	0	0	0	0	0.2	0.2	0	0	0	0	0	0	1.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	1.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	1.8	0.1	0	0	2	0	0	0.5	0	0	0	0.2	0	0	0	0.2	0	0	0	0.2	0	0	0	0	0	0	0.2	0.2	0.2	0.2	0.2	0.2	0	0.2	0.2	0.2	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	341.7	0	0	0	0	0	0	0	0	0	4.1	0	0	0	0	0	0	0	3.6	0	0	24.6	0	1.7	0	0	0	0	0	0	0	0	3.2	0	Enterocytes
KCNJ14	IRK4, Kir2.4	ENSG00000182324	Potassium voltage-gated channel subfamily J member 14	Q9UNX9	19	48455509-48466980	Predicted membrane proteins, Voltage-gated ion channels	Ion transport, Potassium transport, Transport	Ion channel, Voltage-gated channel		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		retina: 22.9	Cell type enriched	Detected in many	8	Rod photoreceptor cells: 311.1	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		NB-4: 12.4	Not detected	Not detected			Low region specificity	Detected in many			HPA071765			Approved	Nucleoli						Nucleoli		HPA071765: AB_2686444	unprognostic (1.38e-1)	unprognostic (1.23e-2)	unprognostic (1.33e-5)	unprognostic (5.77e-2)	unprognostic (9.41e-2)	unprognostic (5.26e-2)	unprognostic (7.05e-4)	unprognostic (7.83e-4)	unprognostic (1.26e-1)	unprognostic (6.48e-2)	unprognostic (4.43e-3)	unprognostic (4.92e-2)	unprognostic (5.02e-6)	unprognostic (1.47e-1)	unprognostic (4.98e-2)	unprognostic (6.82e-3)	unprognostic (4.41e-2)	1	0.4	1.1	0.9	6.1	4.9	1.8	2.3	2.2	0.9	0.9	0.9	0.9	0.6	0.9	1.8	1.5	1.1	1	0.9	1.4	1.3	0.9	0.9	0.9	1.2	1.2	0.9	1.3	1.4	1	1	1.4	1.4	1.5	0.7	22.9	0.9	0.9	3.3	4.9	0.9	0.9	0.9	0.9	0.6	2.8	0.9	0.9	1.6	0.9	0.9	0.9	1.1	1.5	0.8	3.5	0.8	0.6	1	0.2	1.6	3.8	0.8	2.5	1.7	1.7	2.6	0.6	0.3	0.8	1.3	3.9	2.2	1.8	0.8	0.6	2	5.5	1.2	0.6	2.1	1.3	2	1.1	2.2	1	1	1.6	3.2	1.6	2.8	2	2.3	1.1	0.5	1.7	1.8	2	0.5	2.4	0.6	12.4	1.4	2	2.2	2.6	1.5	0.4	0.6	4.6	1.4	1.7	1.8	2.6	1.4	1.5	1.8	1.3	1.1	2.7	3.6	2.7	3	2.1	3.1	1.3	0.7	4	2.8	3.5	0.8	0.6	0.6	0.6	0.5	1.2	0.7	1	0.4	1.5	0.8	1	2.9	0.6	0.3	0.8	0.6	0.2	1.1	6.1	2.3	2	1.4	1.3	1.2	0.9	1.4	0.9	0	4.3	0	3.7	3.9	15	0.4	2.5	1.4	0	1.8	39.3	1.3	0	0.8	4.1	1	0.4	0	0.9	2.1	0.8	2.5	0	0.5	0.5	14.3	0	0.6	0	0	1.1	0.2	0	0	1.2	17.5	2.1	0	0.4	0	311.1	0	0.9	3.4	2.7	4.6	0.8	0	1.7	2.1	Rod photoreceptor cells
CDY2A	CDY2	ENSG00000182415	Chromodomain Y-linked 2A	Q9Y6F7	Y	18025787-18028597	Enzymes, Predicted intracellular proteins		Acyltransferase, Transferase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Group enriched	Detected in some	50	epididymis: 3.8;testis: 6.0	Cell type enriched	Detected in single	18	Collecting duct cells: 1.8	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	12	U-266/84: 1.2									HPA066682	Supported											HPA066682: 																		0	0	0	0	0	0	0	0	0	0	0			0	0	3.8	0	0	0	0	0	0	0	0	0	0	0		0	0	0	0	0		0	0		0	0	0	0	0	0	0	0	0	6			0		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0	0	0	0	0	0	1.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Collecting duct cells
CLEC4G	LSECtin, UNQ431	ENSG00000182566	C-type lectin domain family 4 member G	Q6UXB4	19	7728957-7733906	Predicted membrane proteins	Host-virus interaction	Host cell receptor for virus entry, Receptor		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	4	liver: 63.1;lymphoid tissue: 53.5	Cell type enriched	Detected in some	13	Ito cells: 979.0	Low cancer specificity	Detected in some			Region enriched	Detected in many	5	cerebellum: 11.8	Cell type enhanced	Detected in some		classical monocyte: 13.9;myeloid DC: 11.9	Group enriched	Detected in many	19	B-cells: 4.1;dendritic cells: 11.9;monocytes: 13.9	Cell line enhanced	Detected in some		ASC TERT1: 1.3;hTEC/SVTERT24-B: 1.0;RPMI-8226: 1.3;RT4: 1.2;TIME: 2.7;U-937: 2.2	Not detected	Not detected			Low region specificity	Detected in all			CAB003789, HPA014044	Enhanced											CAB003789: , HPA014044: AB_1846916	unprognostic (7.20e-2)	unprognostic (1.20e-1)	unprognostic (1.12e-1)	unprognostic (3.64e-1)	unprognostic (4.47e-2)	unprognostic (1.35e-1)	unprognostic (7.98e-2)	unprognostic (1.64e-1)	unprognostic (2.23e-1)	unprognostic (3.29e-2)	unprognostic (7.45e-2)	unprognostic (3.04e-1)	unprognostic (2.13e-8)	unprognostic (5.21e-2)	unprognostic (1.27e-1)	unprognostic (1.77e-1)	unprognostic (6.65e-2)	11.2	0.1	0.9	1.5	1.2	0.9	2.6	11.8	1.6	0.2	1.5	0.2	0.2	0.4	0.2	1.3	5.2	2.7	1	7.3	2.6	1	0.3	63.1	0.5	53.5	0.8	0.2	0.5	0.8	0	0.2	0.8	0.2	0.8	0.7	0.3	4.9	0.5	0.2	0.4	0.7	0.7	0.2	1.3	0.3	0.7	0.2	0.3	0.5	0.6	0.2	2	0.6	4.1	11.9	0.5	13.9	0.4	0.1	2.8	0	0	0	0	0	1.3	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0.3	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0.1	0	0.4	0	0	0	0	0	0	0.7	1.3	0	1.2	0.1	0	0.2	0	0	0	0.6	0.7	2.7	0	0.1	0.7	0	0.1	0	0.3	0	2.2	0.1	0	13.9	0	0	3.3	0	0.3	0	0	11.9	4.1	0.1	0	0.5	0.4	0.4	0.6	0	2.8	0.9	1.2	11.8	1.6	2.6	1	0.8	0.2	0.2	0.2	0	0	9.3	0	0.1	0	0.4	7.6	0	1.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.4	0.7	0	0	979	76.3	0	0.3	2	0	0	0	0	0	0	0	0	0	0	0	0.5	0.7	0.3	0.2	0	0	0	Ito cells
HS3ST4	3OST4	ENSG00000182601	Heparan sulfate-glucosamine 3-sulfotransferase 4	Q9Y661	16	25692026-26137688	Enzymes, Predicted membrane proteins		Transferase		Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enriched	Detected in some	5	brain: 23.9	Cell type enriched	Detected in single	8	Bipolar cells: 5.8	Low cancer specificity	Detected in some			Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		NTERA-2: 5.5;SCLC-21H: 2.3;SuSa: 1.5	Low region specificity	Detected in many			Low region specificity	Detected in many																unprognostic (1.09e-2)	unprognostic (1.87e-1)	unprognostic (2.95e-1)		unprognostic (2.24e-1)	unprognostic (1.43e-3)		unprognostic (1.27e-1)		unprognostic (3.84e-1)	unprognostic (8.81e-3)	unprognostic (6.71e-2)		unprognostic (2.39e-1)	unprognostic (1.92e-1)	unprognostic (2.51e-2)	unprognostic (3.67e-2)	0.7	0.8	6.9	0.6	9.3	0.6	5.1	6.8	23.9	1.1	0.6	2.6	0	0.6	0.7	1.3	0.9	0.7	0.6	0.6	11.5	10	0.7	0.6	0.6	0.6	5.9	10.8	0.7	0.6	0.6	0.1	0.6	14.3	2	0.6	0.3	0.8	0.6	0.6	0.7	0.6	0.6	2.2	3.7	1.1	1.3	1.5	0	0.6	0	0.8	1	0.2	0.1	0	0.1	0	0.1	0	0	0	0	0.3	0	0	0	0	0.2	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0.5	0	5.5	0	0	0	0	0	0	0	2.3	0	0	0	0.1	1.5	0	0	0.1	0	0.8	0	0	0.4	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0.1	0	0	0	0.1	0	0	0	0	6.9	9.3	6.8	13.4	11.5	10	5.9	10.8	14.3	1.5	0	0	0	0.4	0	5.8	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0.1	Bipolar cells
CCDC172	C10orf96, MGC35062	ENSG00000182645	Coiled-coil domain containing 172	P0C7W6	10	116324428-116380029	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in some	17	testis: 23.4	Cell type enriched	Detected in some	5	Spermatocytes: 116.5	Cancer enriched	Detected in single	14	testis cancer: 1.1	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	20	NTERA-2: 26.7	Not detected	Not detected			Not detected	Not detected																														unprognostic (9.85e-2)			0	0.1	0	0	0.3	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0.2	1.3	0	0	0	0	0	0	0	0	0	0	0.1	23.4	0	0	0	0	0	0	0	0.2	0.2	0.1	0	0.1	0.5	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	26.7	0	0	0	0	0	0	0	0	0	0	0	0	1.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0.3	0	0.2	0.1	0.5	0.1	0.1	0	0.2	0.1	0	0	0.3	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	6.2	0.9	0	0	0	0	0.5	0	0	0	0	1.3	0	0	116.5	24.9	0	0	0	0	0	Spermatocytes
KCNB2	Kv2.2	ENSG00000182674	Potassium voltage-gated channel subfamily B member 2	Q92953	8	72537391-72938349	FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels	Ion transport, Potassium transport, Transport	Ion channel, Potassium channel, Voltage-gated channel	FDA approved drug targets	Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		brain: 9.7;lymphoid tissue: 8.6;pituitary gland: 9.2	Cell type enriched	Detected in some	15	Cone photoreceptor cells: 249.4	Not detected	Not detected			Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	5	HaCaT: 3.2;HDLM-2: 3.1;HEK 293: 7.6;SCLC-21H: 6.3	Low region specificity	Detected in many			Low region specificity	Detected in many			HPA065970			Approved	Nucleoli,Plasma membrane,Midbody		Yes				Plasma membrane	Nucleoli, Midbody	HPA065970: AB_2685591	unprognostic (9.87e-3)	unprognostic (1.71e-1)	unprognostic (7.57e-2)	unprognostic (1.10e-3)	unprognostic (1.22e-1)	unprognostic (1.34e-1)		unprognostic (1.44e-2)		unprognostic (2.72e-1)	unprognostic (6.93e-5)	unprognostic (5.53e-3)	unprognostic (3.30e-2)	unprognostic (1.62e-1)	unprognostic (3.35e-2)	unprognostic (3.26e-1)		0.8	1.9	3.8	0.6	5.3	0.4	0.7	0.3	9.7	0.5	0.7	0	0	1.2	0.4	0.4	1.1	2.1	0.5	0.4	7.1	3.1	0.5	0.4	0.6	0.5	0.9	7.8	0.4	2.4	0.4	9.2	0.5	3.2	0.7	0.7	4.2	0.5	0.5	0.4	0.4	1.6	0.5	1.6	8.6	2.4	1.7	0.4	0.9	0.4	0	0.9	0.6	0.4	0	0	0	0	0	0	0	0.7	0	0.1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	3.2	0	0	0	3.1	7.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.8	0	0	0	0	0	0	0	6.3	0	0	0	0	0.1	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.8	5.3	0.3	9.7	7.1	3.1	0.9	7.8	3.2	0.4	0	0	0	0	0	12.9	0.2	0	0	0	1.8	249.4	0	0	0	4	0	0	0	0	0	0	0	0	0	0	1.6	17.1	0	0	5	1.1	0	0	0	0	0.7	0.2	0	0.4	0	2.4	0	0	0.4	0.7	0	0	0	0	0	Cone photoreceptor cells
PPP1R27	DYSFIP1, toonin	ENSG00000182676	Protein phosphatase 1 regulatory subunit 27	Q86WC6	17	81833492-81835050	Predicted intracellular proteins		Protein phosphatase inhibitor		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	22	skeletal muscle: 211.0	Cell type enriched	Detected in some	10	Early spermatids: 22.1	Cancer enriched	Detected in single	10	head and neck cancer: 3.0	Not detected	Not detected			Cell type enhanced	Detected in some		neutrophil: 3.2	Low lineage specificity	Detected in single			Group enriched	Detected in some	23	HL-60: 63.9;THP-1: 123.9	Not detected	Not detected			Not detected	Not detected			HPA042227, HPA048632	Uncertain		Approved	Plasma membrane,Cytosol						Plasma membrane, Cytosol		HPA042227: , HPA048632: AB_2680469	unprognostic (3.35e-2)	unprognostic (1.12e-4)	unprognostic (1.48e-1)	unprognostic (1.08e-1)	unprognostic (1.29e-1)	unprognostic (1.85e-2)	unprognostic (1.37e-1)	unprognostic (2.21e-2)	unprognostic (7.07e-2)	unprognostic (1.32e-1)	unprognostic (5.38e-2)	unprognostic (8.70e-2)	unprognostic (4.98e-6)	unprognostic (7.97e-2)	unprognostic (1.21e-1)	unprognostic (2.19e-3)	unprognostic (1.30e-1)	1.8	0.1	0	0	0	0.6	0	0	0	0	0	0	0	0	0	4.3	1.8	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	1.6	0	0	0.7	0	0	1.7	0	211	0.3	0	0	0	0	0	0.1	0	0	1.9	9.6	1.2	0	0	0.8	0.4	3.2	0.4	0.7	0.4	0.2	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	63.9	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	4	0	0	0	0	0	0	0	0	0	0	0	0.4	0.1	0	0	123.9	0	0	0	0	0	0	0	0	0	0.6	0	1.6	0.4	0.3	0.3	0.2	0.3	0.4	0.2	0.2	0.3	0.8	0.3	0.4	3.2	0.7	0.3	0.4	0.2	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	1.7	0.6	0	0	0	0	0	1.6	0	0	22.1	0	2	0	0.4	2.1	0.2	0.1	0	1	0.5	0	1.2	0	0	0.5	0.9	0.2	0	0	0.7	0.1	0	0	0.4	0.2	0	0	0	0.7	0.7	0.1	1.1	0	0.9	0.1	Early spermatids
TSKU	E2IG4, LRRC54, TSK	ENSG00000182704	Tsukushi, small leucine rich proteoglycan	Q8WUA8	11	76782251-76798154	Predicted secreted proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		liver: 86.8	Cell type enriched	Detected in many	7	Hepatocytes: 427.8	Low cancer specificity	Detected in all			Low region specificity	Detected in many			Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		A549: 41.4;ASC diff: 70.9;OE19: 44.7	Low region specificity	Detected in many			Low region specificity	Detected in some			HPA008164	Approved		Approved	Nucleoplasm,Nuclear bodies	Secreted - unknown location				2100000	Nucleoplasm	Nuclear bodies	HPA008164: AB_1853327	unprognostic (1.07e-2)	unprognostic (2.29e-3)	unprognostic (6.15e-2)	prognostic favorable (3.66e-4)	unprognostic (7.05e-2)	unprognostic (2.39e-1)	unprognostic (3.08e-1)	unprognostic (2.17e-3)	unprognostic (4.81e-2)	unprognostic (4.62e-2)	prognostic unfavorable (2.87e-4)	prognostic favorable (1.66e-4)	prognostic unfavorable (2.80e-8)	unprognostic (1.47e-1)	unprognostic (4.93e-2)	unprognostic (6.71e-2)	unprognostic (3.88e-2)	33.1	2.8	1	3.6	1.4	0.6	26.9	1.5	2	38.8	16.1	1.8	6.4	11.5	13.2	25.5	17.8	15.3	8.6	9.3	1.2	0.3	31.8	86.8	5.1	3.7	1.7	1.3	27.8	12.2	2.6	4.3	43	3.4	15.7	4.5	48.5	9.3	10.8	7	15	21.4	13	0.8	3	8.7	9	0.8	1.5	12.2	16	12.4	18.2	27.9	1.8	0.7	2.1	0.4	0.7	1.3	0.2	0.8	41.4	4.6	4.5	70.9	9.1	8.5	1.4	7.8	3.1	3	5.3	11.4	0.1	8.1	5.1	13.2	16.6	2.6	10.2	0.9	8.5	1.4	2	10.7	14.8	13.4	0.7	3.1	9.3	11.2	5.5	4.5	5.9	3.8	1.5	4.5	0.3	2.8	19.1	0.1	1.5	6.1	44.7	1.8	1.3	4.4	6.5	7.3	7.2	4.2	6.9	7.9	6.2	3.8	4.1	8.3	0.6	1.1	8.7	6.9	21.1	3.3	0.3	0.1	0.3	4.1	2.1	1.5	1.8	0.4	0.5	0.9	0.2	0.4	1.8	0.8	0.7	0.4	1.8	0.9	1.3	2.1	0.7	0.4	0.7	0.8	0.2	1	1.4	1.5	2	1.2	0.3	1.7	1.3	3.4	0.8	0	0.3	0	13	15.3	3.2	3.9	15.3	2.7	5.7	1.8	0	42.8	0	5.8	0.2	3.6	20.6	23.3	19.6	58.8	39.7	6.5	1.1	427.8	8.4	0	7.5	8.6	9.5	1.2	34.5	1.6	5	2.8	14.2	10.4	17.7	20.1	42.5	21.9	0.5	0	13.4	0.4	2.3	19.7	36.6	4.4	11.3	17	Hepatocytes
MAFA	hMafA, RIPE3b1	ENSG00000182759	MAF bZIP transcription factor A	Q8NHW3	8	143419182-143430406	Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	Activator, DNA-binding	Diabetes mellitus, Disease mutation	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	5	skeletal muscle: 25.6	Cell type enriched	Detected in some	8	Intestinal endocrine cells: 41.2	Low cancer specificity	Detected in some			Region enhanced	Detected in single		amygdala: 2.5	Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HaCaT: 2.8;MCF7: 4.5;RH-30: 2.7;SCLC-21H: 6.5;T-47d: 6.2;U-2 OS: 4.3	Low region specificity	Detected in many			Not detected	Not detected																unprognostic (5.92e-3)	unprognostic (9.89e-3)	unprognostic (2.81e-3)	unprognostic (1.42e-8)	unprognostic (1.75e-2)	unprognostic (8.67e-2)	unprognostic (6.08e-2)	unprognostic (5.67e-2)	unprognostic (4.41e-1)	unprognostic (3.71e-1)	unprognostic (1.37e-1)	unprognostic (1.21e-1)	unprognostic (1.68e-5)	unprognostic (2.11e-2)	unprognostic (1.00e-1)	unprognostic (3.36e-1)	unprognostic (3.38e-2)	0.2	0.1	2.5	0.1	0.2	0.2	0.1	0	0.6	0.2	0.2	0	0	0.1	0.1	0.3	0.6	0.1	0.1	2.1	0.4	0.2	0.3	0.1	0.7	0.1	0.1	0.2	0.1	2.2	0.2	0.5	1.8	0.9	0.3	0.1	0.7	0.4	0.1	25.6	0.1	0.1	0.1	0.7	0.1	0.1	3.4	0	0.4	2.5	5.5	0.4	0.1	0.1	0	0	0.8	0.4	0	0	0	0	0.1	0	0.4	0	0	1	0.1	0	0	0	0	0	0	1	0	0.2	2.8	0.9	0	0	0.1	1.9	1	0.1	0	0	0	0.3	0.1	0	0	0	0	0	0	1.5	0.1	0	4.5	0.1	0.6	0.6	0	0.4	0.6	2.7	0.4	0	0	6.5	0.2	1.6	0	0	1.2	6.2	0.1	0	0.2	4.3	0.1	0	0.2	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.8	0	0.4	0	0	0	2.5	0.2	0	0.6	0.4	0.2	0.1	0.2	0.9	0	0	0	0	0.4	0.5	1.2	4.9	0	0	0	3.5	2	0.2	0	0	0.2	0	1.3	0	0	0.1	0.3	0.4	0	0	0.1	0	41.2	0	0	0	0	0	0	0	0.8	0.8	0.2	0.6	0	0	2.2	0	0.9	0.6	2.3	1	0.2	0	0.4	0.1	Intestinal endocrine cells
GSTA5		ENSG00000182793	Glutathione S-transferase alpha 5	Q7RTV2	6	52831655-52846095	Enzymes, Predicted intracellular proteins		Transferase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in single		testis: 1.3	Cell type enriched	Detected in single	5	Distal tubular cells: 1.7	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Not detected	Not detected											HPA004342, HPA048934, HPA053817	Uncertain		Approved	Cytosol						Cytosol		HPA004342: AB_1078987, HPA048934: AB_2680563, HPA053817: AB_2630367							unprognostic (1.97e-2)			unprognostic (2.83e-1)								0	0	0	0	0	0	0.3	0	0	0.9	0			0	0	0	0	0	0	0	0	0	0.3	0.1	0	0	0		0	0	0	0	0		0	0		0.1	0	0	0	0	0	0	0	0	1.3			0		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0	0	0	0	0	0	0	0	0	1.7	0	0.4	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0.2	0	0	0	0	0	Distal tubular cells
OTOP3		ENSG00000182938	Otopetrin 3	Q7RTS5	17	74935719-74949992	Predicted membrane proteins, Transporters	Hydrogen ion transport, Ion transport, Transport	Ion channel		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Group enriched	Detected in some	11	esophagus: 17.5;intestine: 42.9	Cell type enriched	Detected in some	11	Paneth cells: 71.9	Cancer enhanced	Detected in some		head and neck cancer: 3.0	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HaCaT: 1.3;HDLM-2: 2.4;RPMI-8226: 2.3;SH-SY5Y: 1.0	Not detected	Not detected			Not detected	Not detected																	unprognostic (9.28e-3)				prognostic favorable (3.86e-4)			unprognostic (2.77e-1)		unprognostic (8.60e-2)	unprognostic (3.42e-1)		unprognostic (1.03e-1)	unprognostic (8.36e-2)			0	0	0	0	0	0	0	0	0	0.7	34.1	0	0	42.9	0	0	17.5	0	1	0	0	0	0	0	0	0	0	0	0	1.7	0	0	0	0	0	0	0.3	1.8	0	0	2.5	29.2	0	0	0	0.1	0	0	0	0	2.7	1.6	0	1.2	0	0	0	0	0	0	0	0.2	0	0	0.2	0	0	0.7	0	0	0	0	0	0	0	0	0	0	1.3	0.3	0	0	2.4	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0.1	0	0	0	0.2	0	0.1	0	0	0	2.3	0	0	0.1	1	0	0.1	0	0	0	0	0	0	0	0	0	0.6	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0.1	0	0	2.1	0	0	0	0	0	0	0	0	6.4	0	0	0	0	0	0	0	0	0.3	0	0.1	71.9	0	0	0	0	0	0	0	0	0	0	0.2	0	Paneth cells
ODF3L1	MGC48986	ENSG00000182950	Outer dense fiber of sperm tails 3 like 1	Q8IXM7	15	75723977-75727688	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	17	testis: 53.2	Cell type enriched	Detected in some	10	Early spermatids: 64.7	Low cancer specificity	Detected in many			Not detected	Not detected			Cell type enriched	Detected in single	25	myeloid DC: 2.4	Lineage enriched	Detected in single	25	dendritic cells: 2.4	Cell line enhanced	Detected in some		A549: 3.0;CAPAN-2: 2.7;HaCaT: 2.7;HeLa: 3.6;U-87 MG: 3.8	Not detected	Not detected			Not detected	Not detected																unprognostic (6.24e-2)	unprognostic (1.97e-2)	unprognostic (4.58e-2)	unprognostic (8.42e-2)	unprognostic (2.08e-2)	unprognostic (1.41e-1)	unprognostic (2.77e-1)	unprognostic (1.56e-1)	unprognostic (1.99e-1)	unprognostic (2.74e-1)	unprognostic (7.55e-4)	unprognostic (9.65e-2)	unprognostic (9.96e-3)	unprognostic (6.40e-2)	unprognostic (4.14e-2)	unprognostic (8.94e-3)	unprognostic (1.45e-2)	1.5	0.1	0.5	0.8	0.7	0.1	1.3	0.3	0.5	0.6	1.2	0.3	0.5	0.4	1.3	1.5	1.8	1.1	3.1	1.2	0.6	0.6	0.3	1.2	1.8	0.1	0.3	0.4	0.8	0.3	0	1.2	1.3	0.8	0.8	0.3	0.8	0.5	0.5	0.1	1.7	1.5	3	0.2	0.4	2	53.2	0.2	0.5	1.6	1.2	0.6	0.6	0.3	0	2.4	0	0	0	0	0	0.2	3	0.8	0	0.2	0.6	0.2	0.4	1.5	0.1	0.2	0.6	2.7	0	0.1	0.4	0	2.7	0.1	1.7	0	2.1	1.2	0	3.6	0.5	0.8	0	0	2	0.1	0.6	1.1	1	0	0	0	0.3	0.1	0	0	0	0	0.1	0	0	0.2	0.9	0	0	0.3	0.3	0	0	0.2	1.4	0.1	1.6	0	0.7	0.1	0	0.1	0.6	0.2	0	3.8	0.3	1.1	0	0	0	0	0	0	0	0	0	2.4	0	0	0	0	0	0	0	0	0	0.5	0.7	0.3	0.5	0.6	0.6	0.3	0.4	0.8	0.2	0	0.6	0	3.6	5.5	0	0	0	0	4.5	0	0	0.6	0	0.2	64.7	0.2	0.7	0	0	0.6	2	1	0	0	0.4	0	0	1.8	0	4.2	0	0	3.3	0	0	0	0.2	0	0.7	0.6	0	6.5	0.2	0.9	0.2	5.6	1.6	0	0	2.2	Early spermatids
C12orf60	MGC47869	ENSG00000182993	Chromosome 12 open reading frame 60	Q5U649	12	14803572-14906586	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		testis: 22.5	Cell type enriched	Detected in many	7	Early spermatids: 342.1	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low cell line specificity	Detected in many			Low region specificity	Detected in many							HPA043911			Approved	Nucleoplasm,Cytosol						Nucleoplasm, Cytosol		HPA043911: AB_10963941	unprognostic (3.71e-2)	unprognostic (7.02e-2)	unprognostic (1.72e-1)	unprognostic (6.39e-2)	unprognostic (4.01e-1)	unprognostic (1.21e-1)	unprognostic (1.72e-1)	unprognostic (3.09e-2)	unprognostic (8.56e-2)	unprognostic (1.18e-1)	unprognostic (8.25e-3)	unprognostic (9.42e-2)	unprognostic (2.17e-1)	unprognostic (7.09e-2)	unprognostic (1.85e-1)	unprognostic (1.97e-2)	unprognostic (2.75e-2)	1.7	8.9	2.6	2.3	9.9	1.7	1.8	1.9	4.7	1.5	1.3	4.8	1.6	0.7	1.1	2.9	1.3	2.9	1.8	5.4	3.7	2	4.8	8.7	2	3.2	6.3	4.7	1.5	2.1	1.7	3.8	1.6	7.2	2.1	1.2	5.1	1.9	1.4	2.5	1.3	1.4	0.8	9.2	5.5	1.9	22.5	4.9	1.7	3.3	1	2	1.5	1.7	3.9	1.1	3.6	1.4	3.3	4.5	1.2	2.5	2.8	2.8	8.1	3.1	2.2	2.5	1.9	1	2	2.4	1.2	2.8	2.2	2.3	0.6	3	2.9	3.1	6.2	2.7	5	3.1	1.7	0.8	1.9	2.5	2.6	0.9	1.1	3.8	2	4.2	2.7	3.8	3.6	2.8	0.5	2.7	0.8	1	1.5	9.6	3.8	1.6	3.1	4.8	3.3	3.6	0.8	2	2.5	4.1	1	3.6	8.6	3.2	1.2	2.9	1.8	2	1.4	2.1	1.4	0.9	7.3	2.2	2.4	2.5	0.3	1.3	3.6	2.3	1.4	3.7	3.9	1.9	3.3	1.1	2.6	4.5	3.8	0.3	3.3	0.8	1	3.6	1.2	2.6	9.9	1.9	4.7	3.7	2	6.3	4.7	7.2	4.9	0	0	7.5	0.4	0.2	3.3	3.3	0	5.3	2.3	5.2	19.6	1.4	6.6	1.3	342.1	2.3	0	0	1	1.7	1.2	0.4	0	0.8	1	1.6	0	0	1.2	51.4	2.8	1.1	0	3.6	0.1	2.5	0.6	0	2.5	2.9	16.1	19.4	1	10.5	7.9	0.9	0.2	2.5	0.3	0.3	Early spermatids
SLC8A1	NCX1	ENSG00000183023	Solute carrier family 8 member A1	P32418	2	40097270-40611053	FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters	Antiport, Calcium transport, Ion transport, Sodium transport, Transport	Calmodulin-binding	FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		heart muscle: 67.7	Cell type enriched	Detected in many	11	Cardiomyocytes: 601.5	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Cell type enriched	Detected in some	4	neutrophil: 25.2	Lineage enriched	Detected in many	4	granulocytes: 25.2	Cell line enhanced	Detected in many		BJ: 15.4;fHDF/TERT166: 37.3;hTERT-HME1: 10.9	Low region specificity	Detected in all			Low region specificity	Detected in all			CAB022694, HPA070007	Uncertain		Supported	Nucleoplasm,Plasma membrane	Intracellular and membrane					Nucleoplasm, Plasma membrane		CAB022694: , HPA070007: AB_2686227	unprognostic (2.46e-1)	unprognostic (1.33e-2)	unprognostic (1.42e-2)	unprognostic (7.57e-6)	unprognostic (1.56e-1)	unprognostic (3.94e-1)	unprognostic (2.28e-2)	unprognostic (4.60e-2)	unprognostic (1.31e-1)	unprognostic (7.71e-2)	unprognostic (1.21e-2)	unprognostic (1.07e-1)	unprognostic (3.66e-2)	unprognostic (7.04e-3)	unprognostic (3.93e-2)	unprognostic (5.46e-2)	unprognostic (6.77e-2)	3.9	2.9	7.7	4.4	14.3	1.4	2	3.5	15.3	5.5	7.3	1.8	7.1	3.3	12.2	3.9	4	3.9	5.3	67.7	7.7	6.6	11	2.2	3.7	2.5	5.2	8.2	2.1	1.5	1.1	1.9	6.8	7.6	12.2	3.4	1	1.5	17.2	1.5	2.1	3.6	20.5	2.8	4.4	2.5	1.4	2.5	0.1	1.6	0	1.3	9.8	2.8	0	2.4	25.2	6	0	0	0.5	1.5	1.2	1.1	0.1	1.7	3.6	0	15.4	6	5.1	3.3	0	2.5	0	1.2	37.3	5.5	0.6	0.3	2.5	5.3	0	2.1	0	0	0	0	0	0.2	2	0	5.9	10.9	2.3	0.4	0	0	0.2	6.5	0	0.4	0	0.8	0.1	2.1	4.1	8.1	0	1.8	0.2	1.7	0.3	0	0	0	5.6	0	0.3	5.2	4.8	0.1	0	1.6	0.8	0	0	0.8	0.9	0.7	0	4.9	0	0	5.1	0	0	0	0	2.4	0	0	0	25.2	0	6	0.1	0	0.5	7.7	14.3	3.5	15.3	7.7	6.6	5.2	8.2	7.6	2.5	3	3.2	2.9	0	1.1	50.8	601.5	2.5	0	1.2	33.2	3.9	0.4	0	0	0.8	3.3	0	0	0	1.4	4.8	0.1	0	0	28.3	0	0	20.3	56.6	0.7	0	46.7	1.7	1	0.6	35.9	0.1	0	7.8	0.1	6.9	12.9	19.6	0.2	0.4	2.8	0.9	0	0	0	Cardiomyocytes
SLC25A21	ODC, ODC1	ENSG00000183032	Solute carrier family 25 member 21	Q9BQT8	14	36678431-37172866	Predicted intracellular proteins, Transporters	Transport			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		testis: 25.6	Cell type enriched	Detected in many	11	Erythroid cells: 93.5	Not detected	Not detected			Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	4	K-562: 15.5;Karpas-707: 34.0	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA000662	Uncertain											HPA000662: AB_1080000	unprognostic (6.81e-3)	unprognostic (6.98e-2)	unprognostic (7.21e-2)	unprognostic (2.45e-1)	unprognostic (2.78e-2)	unprognostic (2.20e-1)	unprognostic (2.44e-2)	unprognostic (1.09e-1)	unprognostic (7.32e-2)	unprognostic (6.86e-2)	unprognostic (9.16e-2)	unprognostic (1.66e-1)	unprognostic (6.70e-4)	unprognostic (9.09e-3)	unprognostic (1.95e-2)	unprognostic (3.52e-1)	unprognostic (1.07e-1)	1.3	2.1	1.1	1	2	8.8	1.4	0.4	2.5	3	1.9	0.7	0.1	1.1	4	1.4	2.9	1.8	1.2	2.2	1.1	1.4	2.8	1.1	1.9	0.1	1.4	0.7	4.6	5.2	0.9	1.8	0.4	1.7	3.1	0.4	3.6	2.9	0.9	9.6	0.9	2.4	3	1.2	0.9	2.6	25.6	1	0.2	3.3	2.2	1.3	1.3	1.4	0	0	0	0	0	0.3	0.1	0.8	0.7	0.2	2	0	0.6	0	0.3	0.5	1	0.4	0.1	0.7	0	0.9	0.2	0	0.7	0	0.4	0.4	0.5	5.9	0.6	0.6	0.6	0.6	0	0	0.5	0.8	0	0.3	0.6	2.4	0	15.5	34	0.5	1.8	0	0	1.3	0	2.5	0	0	0	0.5	2.4	1.5	0	1.6	0.1	0.8	0.3	2.2	0	1.1	0	1	0	0	0.1	0	0	0	0	1.6	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0.1	1.1	2	0.4	2.5	1.1	1.4	1.4	0.7	1.7	1	0	0	0	1.7	0.9	0	1	0	0	0	0	0	0	1.7	0.7	1	0.4	0	93.5	8.3	0	0.8	2.3	0	0	0.2	1.6	1.7	1.3	0	0	1.4	0	0	0	0.2	3.4	5.4	0	0.7	3.1	1.5	0	1	3	2.1	0.6	0	0	0.8	0.6	Erythroid cells
OTOP2		ENSG00000183034	Otopetrin 2	Q7RTS6	17	74924275-74933912	Predicted membrane proteins, Transporters	Hydrogen ion transport, Ion transport, Transport	Ion channel		Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	4	intestine: 20.4;testis: 5.1	Cell type enriched	Detected in some	48	Paneth cells: 508.5	Not detected	Not detected			Not detected	Not detected			Cell type enhanced	Detected in single		myeloid DC: 1.4	Lineage enhanced	Detected in single		dendritic cells: 1.4	Cell line enriched	Detected in single	47	HDLM-2: 15.2	Region enriched	Detected in single	13	olfactory region: 15.6	Low region specificity	Detected in all			HPA024524, HPA053090	Uncertain		Approved	Plasma membrane						Plasma membrane		HPA024524: AB_2671592, HPA053090: AB_2682041		unprognostic (1.62e-2)	unprognostic (1.45e-1)			unprognostic (7.25e-2)		unprognostic (3.21e-2)	unprognostic (3.62e-1)	unprognostic (1.30e-1)			unprognostic (2.85e-2)	unprognostic (3.81e-1)	unprognostic (9.04e-2)		unprognostic (2.04e-2)	0.1	0	0.1	2.9	0.1	0	0.1	0.1	0.1	0.1	20.4	0.1	0.1	0.2	0.5	0.1	1	0	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	10.9	0.1	0.1	0.1	0.1	0.2	11.3	0.2	0.1	0.1	0	5.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	1.4	0	0.6	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	15.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0.3	0	0	0	0	1.4	0	0	0	0	0	0	0	0	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	8.4	0	5.5	0	0	0	0	0	0	0	0	0	1.2	0	0	10.6	0	0	0	0	2.7	0	0	508.5	0	0	0	0	0	0	0.3	0	0	0	2.5	0	Paneth cells
IGSF5	JAM4	ENSG00000183067	Immunoglobulin superfamily member 5	Q9NSI5	21	39745407-39802096	Predicted membrane proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in many		heart muscle: 5.8	Cell type enriched	Detected in some	9	Syncytiotrophoblasts: 95.4	Cancer enhanced	Detected in some		testis cancer: 2.3					Cell type enriched	Detected in single	5	neutrophil: 2.2	Lineage enriched	Detected in single	5	granulocytes: 2.2	Cell line enhanced	Detected in many		T-47d: 10.8					Low region specificity	Detected in all			HPA057282	Uncertain		Approved	Focal adhesion sites						Focal adhesion sites		HPA057282: AB_2683395	unprognostic (1.06e-1)	unprognostic (2.53e-1)	unprognostic (7.06e-2)	unprognostic (9.73e-5)	unprognostic (1.56e-2)	unprognostic (3.15e-1)		unprognostic (1.41e-1)	unprognostic (2.18e-2)	unprognostic (2.09e-1)	unprognostic (8.35e-2)	unprognostic (9.61e-2)	unprognostic (4.01e-1)	unprognostic (4.18e-1)	unprognostic (3.75e-2)	unprognostic (6.89e-2)	unprognostic (1.07e-2)	0	2	0.9	0	3.4	0.1	1.3	0.1	0.7	1.1	0.3			0.2	0.9	3.4	0	0.9	0.3	5.8	1.2	2.3	0.3	0.3	0.1	0.2	1.3		1.5	2.5	0.3	1.5	4.3		2.4	0.9		0.9	0.4	0	0.6	0.1	0.4	0.7	0.3	0.6	1.5			0.8		0.2	0.5	0.2	0.4	0.3	2.2	0.4	0	0.4	0	1.3	0.7	4.5	1.1	4.4	3.6	1.2	0.8	1.2	1.3	2	0.7	1.3	1.4	1.2	1.7	1.7	1.2	1.5	3	2.5	2.3	2.1	1.4	3.3	0.5	2.8	1.9	0.6	3.2	5.5	2.9	3.2	2.2	0.6	0.7	2.6	0.9	1.7	1.6	0.3	0.6	2.5	1.1	0.8	0.7	2	0.8	1.9	1.9	2	0.5	1.2	3	1.8	2.1	10.8	1.1	0.4	2	2.3	1	1.8	1	0.8	0.9	1.1	1.4	2	0.1	0.4	0.4	0.4	0	0.2	0.1	0.3	0.1	0.1	0.4	0.1	0.2	2.2	0	0.1	0.3	0	0											0	0	0	0.2	0	1.3	8.7	0	0	0	1.8	0	0.9	5	0.3	11.1	0	0	0	0.2	0.9	0	0.9	0	0	0.4	0	0	0	0	4.5	0.3	0	0	0	0	0.9	0.1	0	0.4	2.7	0.1	0	0.2	0.5	0.1	0	95.4	0	0	0.9	Syncytiotrophoblasts
NKX2-5	CSX, CSX1, NKX2.5, NKX2E, NKX4-1	ENSG00000183072	NK2 homeobox 5	P52952	5	173232109-173235357	Disease related genes, Predicted intracellular proteins, Transcription factors		Developmental protein, DNA-binding	Atrial septal defect, Congenital hypothyroidism, Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	7	heart muscle: 95.6	Cell type enriched	Detected in some	32	Cardiomyocytes: 56.0	Low cancer specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HEK 293: 21.0;NTERA-2: 7.6;SK-MEL-30: 9.3;U-2 OS: 17.3;U-251 MG: 12.9	Not detected	Not detected			Not detected	Not detected			HPA065034			Approved	Nucleoplasm,Cytosol						Nucleoplasm	Cytosol	HPA065034: AB_2685409	unprognostic (3.81e-1)	unprognostic (8.53e-2)		unprognostic (2.62e-2)	unprognostic (9.57e-3)	unprognostic (3.22e-3)		unprognostic (6.63e-2)	unprognostic (1.57e-1)	unprognostic (2.72e-1)	unprognostic (2.31e-1)			unprognostic (5.80e-2)	unprognostic (2.19e-1)		unprognostic (1.77e-2)	0.1	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0.1	0.1	0	0	95.6	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0.1	0	0	0	0	0	0	13.8	0	0.1	0	0	0.2	4.2	0.4	0	0	0	0	0	0	0	0.8	0	0	3	1.1	0.1	0	0	1.8	0	0	0	0	0	0	0	0	0	2.7	0	0	0	0	4.9	21	0	0.1	1.7	0	0	0	0	0.1	0.1	0	1.8	0	0.1	0	0	0	0	0	0	7.6	0	0	0	5.8	0	0	0	0.1	0.3	4.2	0	9.3	2.9	0	0	0	4	17.3	5.3	12.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	56	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	1.7	0.1	0.1	0	0	0	Cardiomyocytes
BEGAIN	KIAA1446	ENSG00000183092	Brain enriched guanylate kinase associated	Q9BUH8	14	100537147-100587413	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 24.9	Cell type enriched	Detected in many	15	Horizontal cells: 135.1	Low cancer specificity	Detected in some			Low region specificity	Detected in all			Cell type enriched	Detected in some	5	eosinophil: 6.8	Lineage enriched	Detected in many	5	granulocytes: 6.8	Group enriched	Detected in some	7	HeLa: 21.8;SH-SY5Y: 53.1	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA002899			Approved	Nucleoplasm,Golgi apparatus,Cytosol						Nucleoplasm	Golgi apparatus, Cytosol	HPA002899: AB_1078277	unprognostic (2.98e-4)	unprognostic (2.75e-3)	unprognostic (2.66e-2)	unprognostic (2.66e-4)	unprognostic (2.77e-3)	unprognostic (1.93e-2)	unprognostic (5.16e-2)	unprognostic (6.35e-2)	unprognostic (3.83e-1)	unprognostic (4.33e-2)	unprognostic (4.15e-2)	unprognostic (5.47e-2)	unprognostic (1.59e-1)	unprognostic (9.01e-2)	unprognostic (3.11e-1)	unprognostic (2.75e-1)	unprognostic (2.60e-1)	1.8	5.5	16.4	1.1	10.8	6.4	1.5	24.9	21.6	1.3	1.3	0.9	0	4.6	2	1.8	1.4	3	2.5	1.5	15.3	7.1	0.9	0.8	1	1.3	4.4	6	3.5	13	2.3	8.2	3.1	3.6	2.6	0.9	2.1	2.8	2.7	0.9	1.3	3	1.7	2	3.3	1	2.6	1.4	5.4	1	0.4	1.3	0.8	0.6	0.6	1	6.8	1.5	0	0.4	0.1	0.3	1.3	0.7	4.5	0	0	0.1	0.1	0	0.2	0	0	0.4	0.1	0.2	0.2	1	0.1	0.2	0	0	0	0.4	2	21.8	0	0	0	0.1	0.1	0.1	0.3	0.5	0	0	0.3	0.2	0	0	1.7	0.1	0.6	0.5	0.1	0.7	0	0.1	2.7	0	0	1.2	53.1	1.2	0	1.2	0	0.3	5.4	0	0.1	1.6	0	0	0	0	0	3.8	1	0.1	1.3	0.1	6.8	0	1.5	0	0.6	0.4	0	0	0.2	0.1	0	0.6	0	1.4	1	0	0.1	16.4	10.8	24.9	17.3	15.3	7.1	4.4	6	3.6	1.4	0	1.1	0	1.4	2.2	1.5	1.4	0	0	1.2	0	0	0.1	0	1	0.3	0.6	0.7	0	6.9	0.2	1.4	0.5	9.2	0	0.2	135.1	0	0	0	0.6	1.7	0.7	1.7	1.8	0	0.7	4.1	0	6.3	0	2.4	0	0.3	0.9	0.4	1.8	0.1	0	0.2	0.3	Horizontal cells
RABIF	mss4, RASGRF3	ENSG00000183155	RAB interacting factor	P47224	1	202878957-202889135	Predicted intracellular proteins	Protein transport, Transport	Guanine-nucleotide releasing factor		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	5	Late spermatids: 2502.1	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low cell line specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA027715, HPA054936	Approved		Approved	Microtubules,Cytokinetic bridge						Microtubules, Cytokinetic bridge		HPA027715: AB_10602151, HPA054936: AB_2732590	unprognostic (4.87e-2)	unprognostic (3.70e-2)	unprognostic (2.09e-1)	unprognostic (1.37e-1)	unprognostic (3.51e-1)	unprognostic (1.36e-2)	prognostic unfavorable (1.55e-4)	unprognostic (1.70e-1)	unprognostic (5.62e-3)	prognostic favorable (5.64e-5)	unprognostic (4.40e-2)	unprognostic (2.94e-1)	prognostic unfavorable (2.61e-5)	unprognostic (1.23e-1)	unprognostic (5.21e-2)	unprognostic (8.54e-2)	unprognostic (2.47e-1)	7.1	7	13.4	10.3	13.8	14	7.9	11.5	17.9	8.9	10.4	10.9	3.1	9.9	6.3	8.2	13.8	6.2	8.4	6.7	12.7	15.4	11.2	10.9	8.9	11.7	13.4	10.4	4	5.7	6	9.2	11.2	14.5	8.6	11.7	6.6	7.9	6.8	7.4	10.6	12	9.3	18.2	10.2	7	30.2	10.6	8.9	6.3	8.8	15.8	9.4	7.5	15.7	17.7	31.1	21	14.9	18.7	15.6	12.4	13.5	9.6	11	15.2	11.7	10.6	13.9	7.7	14.4	13.5	9.3	10.9	10.3	6.9	11	9.9	11.8	7.6	8.8	10.9	12.2	14.1	8.5	11.1	9.7	12.3	11.6	14.8	9.7	12.7	18.1	4.7	7.2	18.9	13.4	13.4	11.4	14	20.8	12.9	12.6	7.8	9.8	16.7	9.3	13	14.1	14.7	13	13.7	12	12	21.2	10.7	12.5	13.7	8.5	14.5	10.1	9.3	4.6	12.2	6	13.2	11	9.9	10.8	9.3	24.1	20	27.6	18.3	21	13.3	15.7	17.4	17.2	17.7	15.5	15.9	16.7	31.1	14.9	18.8	16.9	18.7	15.6	13.4	13.8	11.5	17.9	12.7	15.4	13.4	10.4	14.5	10.6	0	15.7	22.8	29	48.2	4.6	9.3	7.6	9.4	7.9	12.2	2	43.7	13.3	34	555	24.8	30.4	0	46.5	41.5	19.7	25.2	12.7	28.9	36.9	1.6	22.4	16	37.6	2502.1	26.2	34.4	50.6	48.7	12.4	10.8	58.5	31.6	28.3	47.7	5.7	12.9	27.6	68.8	55.8	45.4	66	26.1	13.4	37.3	Late spermatids
POTEC	A26B2, CT104.6, DKFZp686J0529, POTE-18, POTE18	ENSG00000183206	POTE ankyrin domain family member C	B2RU33	18	14507339-14543585	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enriched	Detected in single	16	testis: 5.9	Cell type enriched	Detected in some	9	Spermatocytes: 34.5	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	14	U-266/70: 1.4																						unprognostic (1.63e-1)									unprognostic (9.88e-2)				unprognostic (8.05e-2)	unprognostic (1.64e-1)			0	0	0	0	0	0	0	0	0	0	0			0	0	0	0	0	0	0	0	0	0	0	0	0	0		0	0	0	0	0		0.3	0		0	0	0	0	0	0	0	0	0	5.9			0		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	1	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	1	0.3	0	0	0	0	0	0	0	0	0	0	0	0	34.5	3.8	0	0.2	0	0	0	Spermatocytes
PLGLB1	PLGL, PRP-B	ENSG00000183281	Plasminogen-like B1	Q02325	2	87002559-87021852	Predicted secreted proteins				Evidence at transcript level	Evidence at transcript level	No human protein/transcript evidence	No human protein/transcript evidence		Tissue enriched	Detected in many	5	liver: 66.8	Cell type enriched	Detected in many	5	Hepatocytes: 67.6	Cancer enriched	Detected in single	7	liver cancer: 0.7					Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Low cell line specificity	Detected in many																Secreted to blood								unprognostic (7.25e-2)	unprognostic (7.25e-2)	unprognostic (2.35e-1)	unprognostic (1.15e-1)	unprognostic (1.75e-2)	unprognostic (1.39e-5)	unprognostic (7.04e-3)	unprognostic (1.15e-1)	unprognostic (8.53e-4)	unprognostic (1.60e-1)	unprognostic (4.56e-4)	unprognostic (9.90e-3)	unprognostic (2.96e-5)	unprognostic (1.02e-1)	unprognostic (1.16e-1)	unprognostic (4.32e-2)	unprognostic (3.98e-5)	0.3	1.3	2	0.7	3.4	1.7	0.7	14.3	2.1	0.4	0.5			0.7	1.3	2.1	0.3	0.8	1	0.6	1.9	2.1	1	66.8	0.6	1.5	1.4		1.5	0.4	0.7	1.6	0.3		1	0.3		1.1	0.5	1.9	3.4	0.8	0.2	1.1	1.3	0.7	0.8			1.1		0.5	0.7	0.5	2.7	1.6	5.1	0.8	0.9	2.7	0.4	2.9	4.2	4.8	2.6	4.5	5.4	5.1	3.4	2.5	2.1	2.8	3.3	7.6	7.6	3.4	1.2	1.5	2.5	1.3	0.6	2.1	9.1	3.5	6.6	6.4	3.5	3.1	4.1	1.6	5.6	4.6	5.6	5.7	8.3	0.9	8.7	3.1	6.6	2.6	4.4	13.3	11.3	6.9	2.4	2.7	2.2	2.1	4.5	4.6	3	3.8	4.2	2.9	2.6	3	5.1	1.2	7	5.5	3.8	2.5	2.2	2.1	6.9	5.3	3.4	2.1	5.5	2.6	5.1	0.4	0.9	1.9	0.2	1.2	2.7	2	1.4	0.2	2.2	2.7	1.6	1.9	0.9	0.8	1.6	2.6	0.4											0	4.3	0.8	0.2	1	10.8	1.8	2.5	2.7	2.3	0	5.9	0.2	0	0.7	0.5	1.5	0.1	0	0.2	0.2	0.9	0.4	0	67.6	0.2	4.8	1.2	1.8	1.8	0	1.1	0.9	3.3	1	2.3	2.4	0.2	0	1.8	0.6	14.1	0	0.9	0.3	0.2	1.1	0	0.8	0.7	0.3	Hepatocytes
OR5P2	JCG3	ENSG00000183303	Olfactory receptor family 5 subfamily P member 2	Q8WZ92	11	7795905-7796973	G-protein coupled receptors, Predicted membrane proteins	Olfaction, Sensory transduction	G-protein coupled receptor, Receptor, Transducer		Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Group enriched	Detected in some	4	skin 1: 1.7;urinary bladder: 1.3	Cell type enriched	Detected in some	5	Rod photoreceptor cells: 19.2	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in single		RT4: 1.0																																							0	0	0	0	0	0	0.3	0	0	0	0			0	0	0	0	0	0	0	0	0	0	0	0.2	0	0		0	0	0	0	0		0.3	0		0.3	0.1	0	1.7	0	0	0	0	0	0			0		0	1.3	0	0	0	0	0	0	0	0	0.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0	0	0	0	0	0	3.5	3.9	0.4	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.8	0	0	0	0	19.2	0	0	0	0	0	0	0	0	0	Rod photoreceptor cells
SPDYE4		ENSG00000183318	Speedy/RINGO cell cycle regulator family member E4	A6NLX3	17	8753106-8758559	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at transcript level		Tissue enriched	Detected in some	11	testis: 17.4	Cell type enriched	Detected in some	12	Early spermatids: 15.5	Not detected	Not detected			Not detected	Not detected			Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		A549: 4.6;HeLa: 4.7;NB-4: 2.9;RT4: 2.2									HPA025704, HPA051750	Enhanced											HPA025704: AB_1853093, HPA051750: AB_2681590										unprognostic (3.20e-1)	unprognostic (7.16e-4)		unprognostic (3.15e-3)			unprognostic (2.79e-1)		0.1	0	0.1	0.2	0.2	1.3	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.5	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.3	0.1	0.3	0.1	0.1	0.1	0.2	17.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.6	0.7	1.2	0.9	0	1.1	0.4	0.9	4.6	0	0.8	0	0	0	0	0	0	0	1.3	0	0	0.3	0	0.1	0	0	0	0	0	0	1.7	4.7	0	0	1.3	1.6	0	0	0.2	0	0	0	0.6	0	0.4	0	1.6	0	2.9	0	0	0	0.7	0	0	0	2.2	0.8	0.2	0.8	1	0	0	0.9	0	0	0.4	0.3	1.4	1	0.7	0.1	0.8	0	0.2	0.5	0.7	0.9	1.2	1	0.4	0.5	0.5	0.6	0.6	0	1.6	0.8	1.1	0.4	0	0.9	0.7	0.1	0.4	0.1	0.2	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	15.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	Early spermatids
CABCOCO1	bA63A2.1, C10orf107, Em:AC022398.2, MGC44593	ENSG00000183346	Ciliary associated calcium binding coiled-coil 1	Q8IVU9	10	61662961-61766766	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		fallopian tube: 33.1;testis: 18.6	Cell type enriched	Detected in some	12	Ciliated cells: 163.3	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	4	MOLT-4: 24.0	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA041398	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol						Centrosome	Nucleoplasm, Cytosol	HPA041398: AB_10794374	unprognostic (1.89e-3)	unprognostic (7.37e-2)	unprognostic (2.23e-1)	prognostic favorable (1.79e-4)	prognostic unfavorable (4.88e-4)	unprognostic (1.02e-1)	unprognostic (2.55e-1)	unprognostic (5.52e-2)	unprognostic (4.43e-2)	unprognostic (3.31e-1)	unprognostic (1.16e-1)	unprognostic (1.26e-2)	unprognostic (3.46e-1)	unprognostic (1.52e-3)	unprognostic (2.48e-1)	unprognostic (2.90e-2)	unprognostic (1.33e-2)	1.5	1.2	6.3	0.7	5.7	0.5	2.1	0.4	6.8	6.1	1.6	9.5	3	1	5.2	7.6	0.9	33.1	3.8	0.7	8.1	7.3	2.6	0.9	10.3	0.9	8.1	5.8	4.1	1.6	10	5.2	1.4	13.7	5.9	1.3	1.5	1.7	3.7	0.6	0.8	0.9	3	14.8	1.9	0.9	18.6	5.6	0	1.9	0	0.6	0.8	0.9	0	0	0	0	0	0.1	0	0	0.2	0.1	0	0	2.4	0	0.4	1.6	0.3	0.5	0	0	0	0	0.5	0.4	0	0	0	0	0	0.2	2.4	0	0	1.2	0	0	0.2	0	0.1	0.1	0.9	0.9	0.5	0.1	0	0.1	0	24	0	0	0	0	0	0	0	1.4	0	0	5.4	0.5	0	0	0.2	0	0	0	0.4	0.2	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	6.3	5.7	0.4	6.8	8.1	7.3	8.1	5.8	13.7	5.6	3	0.6	0	0	0	0	0	0	163.3	13.6	3.5	0	0.2	0	0.4	0	0	0	0	0.2	0.2	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0.3	0	0	0	Ciliated cells
ACSM5	FLJ20581	ENSG00000183549	Acyl-CoA synthetase medium chain family member 5	Q6NUN0	16	20409534-20441336	Enzymes, Predicted intracellular proteins	Fatty acid metabolism, Lipid metabolism	Ligase		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	9	liver: 94.6	Cell type enriched	Detected in some	6	Hepatocytes: 179.6	Group enriched	Detected in some	7	liver cancer: 20.5;renal cancer: 9.6	Low region specificity	Detected in all			Group enriched	Detected in some	6	classical monocyte: 2.8;intermediate monocyte: 1.9;myeloid DC: 3.2;non-classical monocyte: 1.3	Group enriched	Detected in many	8	dendritic cells: 3.2;monocytes: 2.8	Group enriched	Detected in some	5	ASC diff: 5.8;ASC TERT1: 12.6;HSkMC: 15.0;U-87 MG: 9.2	Low region specificity	Detected in some			Low region specificity	Detected in all			HPA041435	Uncertain		Uncertain	Vesicles						Vesicles		HPA041435: AB_10961121	unprognostic (1.01e-1)	unprognostic (1.61e-3)	unprognostic (3.73e-2)	unprognostic (1.98e-2)	unprognostic (1.03e-1)	unprognostic (1.59e-2)	unprognostic (1.84e-2)	unprognostic (4.64e-3)	unprognostic (1.64e-1)	unprognostic (2.01e-2)	unprognostic (2.15e-2)	unprognostic (2.33e-1)	unprognostic (5.11e-3)	unprognostic (2.09e-2)	unprognostic (3.85e-2)	unprognostic (2.78e-2)	unprognostic (1.57e-1)	11.1	1.1	1.9	0.7	2.1	0.4	3.2	1.3	1.6	1	1	2.9	0	0.5	0.3	2.8	0.5	0.6	1	0.9	3	1.9	8.9	94.6	0.9	1.6	2.9	2.1	0.4	1.4	0.4	0.1	0.7	2	0.4	0.6	0.5	0.5	0.5	4.4	0.6	0.6	0.5	2.9	1.7	0.9	1	3	0.1	1.7	0.6	0.4	0.5	0.7	0.3	3.2	0.3	2.8	0	0.3	0.5	0	0	0.1	0.1	5.8	12.6	0	0.1	1.2	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	1.2	0	0.2	0	15	0	0.8	0.1	0.3	0	0	0.1	0.6	1.7	0	0	0.3	0.2	0	0	0	0.1	2.2	0	0.1	0	0	0.3	0	0	0	0	0.4	0	0.3	0.1	0	0	0.1	0	0	9.2	0.1	0	0.3	2.8	0.1	0.1	1.9	0.1	0.1	0.3	0.2	3.2	0.3	0.2	0.3	0.1	0	1.3	0.1	0	0.5	1.9	2.1	1.3	1.6	3	1.9	2.9	2.1	2	3	0	0	0	0.1	0	0	1.6	0	0	0	0	0	0	6.6	0.3	0.4	0.6	0	0	0	0	0.7	0.3	0	179.6	3.3	0	0	6.7	8.8	0.2	8.6	1.2	0	1.8	0	1.1	0	0	5.6	31.5	0	0	0.1	0	0.2	0.5	0	0	0	0.1	Hepatocytes
C10orf120	bA318C4.1	ENSG00000183559	Chromosome 10 open reading frame 120	Q5SQS8	10	122697709-122699822	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	20	testis: 25.6	Cell type enriched	Detected in some	9	Early spermatids: 609.6	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected																																									0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	25.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	609.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	64.8	1.7	0	0	0	0	0	0	0	3.5	0	0	0	0	1.5	1	0	0	0	0	0	Early spermatids
FAM167B	C1orf90, MGC10820	ENSG00000183615	Family with sequence similarity 167 member B	Q9BTA0	1	32247233-32248856	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	4	vagina: 91.1	Cell type enriched	Detected in some	10	Ito cells: 188.4	Cancer enhanced	Detected in all		melanoma: 46.6	Low region specificity	Detected in many			Cell type enhanced	Detected in some		T-reg: 4.5	Lineage enriched	Detected in many	4	T-cells: 4.5	Cell line enhanced	Detected in some		BJ hTERT+: 7.0;EFO-21: 8.9;SK-MEL-30: 21.5;U-2197: 22.0	Not detected	Not detected			Not detected	Not detected			HPA029398, HPA062074	Uncertain		Approved	Actin filaments						Actin filaments		HPA029398: AB_10602807, HPA062074: AB_2684677	unprognostic (2.16e-1)	unprognostic (2.06e-1)	prognostic unfavorable (1.11e-4)	unprognostic (6.03e-2)	unprognostic (1.74e-2)	unprognostic (3.36e-3)	unprognostic (7.44e-3)	unprognostic (3.64e-1)	unprognostic (3.00e-3)	unprognostic (1.02e-2)	unprognostic (1.30e-2)	unprognostic (8.89e-2)	unprognostic (4.80e-2)	unprognostic (2.69e-2)	unprognostic (1.60e-1)	unprognostic (8.04e-2)	unprognostic (5.08e-2)	17.2	10.5	1.4	5	1.7	0.1	20.1	1.7	1.9	6.1	3.1	1.1	7.4	3.6	7.8	2.2	4.5	3.4	5.5	11.3	1.8	1.7	20.3	18.4	22.4	6.2	3.2	0.6	3.8	6.6	5.2	8.5	5.8	3.3	9.2	2.7	5.2	2.6	8.2	3.3	1.1	4.1	7.5	2.6	1.4	4	1.8	2.7	1.2	11.8	1.5	1.9	7.2	91.1	1	0	0.8	0	0.3	4.5	0.7	0.6	1.3	0.4	0	0.9	0.8	0	3.1	7	1.4	1.9	0	0.6	0.1	8.9	5.2	1.6	1	0.2	0	0.4	0.1	0	0	2.8	0.4	0.3	0	0.1	0.8	0.5	1	0.3	1.8	2.6	0.4	0	0	0.1	0.4	0.1	0	0.2	0.1	3	0.6	0	0.8	0.9	0.3	1.3	0.3	2	0.1	21.5	0.5	0.3	0	2.3	0.6	0.7	22	0	0.1	0.2	0.5	0.2	0.1	0.3	0	0	0.8	2.6	0	0.7	0.5	0.8	0.8	0	1	0.5	1.6	0	0.3	0	0	4.5	0.7	1.4	1.7	1.7	1.9	1.8	1.7	3.2	0.6	3.3	2.7	0	1.4	3.9	0.4	0.2	0.2	0.4	0	0	0	5.2	0	0.1	0	0.4	0	19.1	0	0	0.7	0.3	0.9	0.6	0	1	0.5	0	0	188.4	11.9	0	2.6	0.4	1.7	0	1	0	0.2	0.2	1.1	0	0.6	0	1.2	0	0.2	0.9	0.2	3.3	0.4	0.3	Ito cells
GOLGA8G	DKFZp434K052	ENSG00000183629	Golgin A8 family member G		15	28519611-28533014	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level				Tissue enriched	Detected in single	126	testis: 12.6	Cell type enriched	Detected in some	6	Spermatocytes: 18.1	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Not detected	Not detected																																					unprognostic (7.17e-2)				0	0	0	0	0	0	0	0	0	0	0			0	0	0	0	0	0	0	0	0	0	0	0	0	0		0	0	0	0	0		0	0		0	0	0	0	0	0	0	0	0	12.6			0		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	3.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0.4	0	0	0	0	18.1	0.2	0	0	0	0	0	Spermatocytes
C11orf88	FLJ46266	ENSG00000183644	Chromosome 11 open reading frame 88	Q6PI97	11	111514785-111537031	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		brain: 48.8;fallopian tube: 53.7	Cell type enriched	Detected in some	10	Ciliated cells: 1019.8	Cancer enhanced	Detected in some		endometrial cancer: 1.7	Region enriched	Detected in many	4	pons and medulla: 48.8	Low cell type specificity	Detected in some			Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		CACO-2: 4.6;Karpas-707: 4.9;SuSa: 3.7;U-266/70: 2.8	Low region specificity	Detected in many			Low region specificity	Detected in many																unprognostic (2.25e-1)	unprognostic (3.07e-5)	unprognostic (3.85e-4)	unprognostic (4.16e-2)	unprognostic (4.44e-5)	unprognostic (2.56e-3)	unprognostic (6.91e-2)	unprognostic (5.49e-3)	unprognostic (2.86e-1)	unprognostic (9.96e-3)	unprognostic (2.70e-1)	unprognostic (4.40e-2)	unprognostic (6.80e-3)	unprognostic (7.57e-2)	unprognostic (6.22e-2)	unprognostic (8.45e-2)	unprognostic (1.11e-1)	0.2	0.2	5.7	0.3	10.9	0.3	0.2	0.2	1	5.8	0.2	5.7	0	0.4	2.2	13.1	0.2	53.7	0.4	0.2	7.3	7.6	0.2	0.2	13.9	0.3	0.6	0.2	8.3	0.2	0.2	0.5	0.4	48.8	0.3	0.2	0	0.3	0.3	0.2	0.3	0.3	0.2	1.1	0.3	0.3	13.5	1.5	0.1	0.7	0	0.2	0.2	0	0.7	0.6	2.6	0.5	0.6	0.4	0	0.3	1	0.1	0.1	0	0	0.6	1.6	0	0.1	0	4.6	2.1	0.3	0.2	0.3	0.2	0.1	0	0	0	0.1	0.3	0	0.8	0	0	0.2	0.4	0.4	0	0.5	0	0.4	0	0.7	0.1	4.9	0	0.5	0.3	0.2	0.2	0	0.5	0	0.8	0	0.1	0.2	0.2	0.5	0.3	0.1	0	3.7	0.9	0	0	0.7	0.6	0.7	0.9	2.8	0.4	0.2	0.4	0.3	0.9	1.7	0.5	1.2	0.3	0.2	0.4	0.5	0.2	0.1	0.4	0.7	0.3	0.3	2.6	0.6	0.5	0.6	0.4	0	5.7	10.9	0.2	1	7.3	7.6	0.6	0.2	48.8	1.5	3	6.9	0	0.2	0	0	4.4	0	1019.8	70.5	0	0	0.1	0	0	106.5	0	0	0	0	0	0	0.1	2.3	0	0.1	0	0	0	0	31.2	1.4	0	0	0	0	0	0	0	1.8	0	0	0	0	12.1	7.1	0	0	0	0	0.5	Ciliated cells
FAM19A1	TAFA-1, TAFA1	ENSG00000183662	Family with sequence similarity 19 member A1, C-C motif chemokine like	Q7Z5A9	3	68004216-68545625	Predicted intracellular proteins, Predicted secreted proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		blood: 13.9;brain: 28.0	Cell type enriched	Detected in some	12	Early spermatids: 14.9	Cancer enhanced	Detected in single		glioma: 0.5	Low region specificity	Detected in many			Group enriched	Detected in many	5	gdT-cell: 13.9;MAIT T-cell: 10.7;memory CD4 T-cell: 11.5;memory CD8 T-cell: 7.5;naive CD4 T-cell: 8.2;naive CD8 T-cell: 11.5;T-reg: 5.0	Lineage enriched	Detected in many	6	T-cells: 13.9	Cell line enriched	Detected in single	9	REH: 6.1	Low region specificity	Detected in many							HPA013407	Approved				Secreted in brain							HPA013407: AB_1848386	unprognostic (5.19e-2)	unprognostic (4.64e-3)	unprognostic (1.97e-2)	unprognostic (1.86e-2)	unprognostic (7.95e-2)	unprognostic (6.40e-2)	unprognostic (3.42e-3)	unprognostic (1.79e-1)	unprognostic (1.20e-1)	unprognostic (2.41e-1)	unprognostic (1.41e-2)	unprognostic (7.87e-2)	unprognostic (1.35e-3)	unprognostic (2.11e-1)	unprognostic (1.99e-1)	unprognostic (3.50e-4)	unprognostic (5.77e-2)	0.7	2	10.6	0.8	9	0.4	0.5	0.4	28	0.5	0.7	0.1	0.3	2.3	0.8	2	0.5	0.5	1.4	0.5	18.4	4.8	0.8	0.8	0.5	1.2	4.4	10.4	0.4	0.4	0.4	0.6	0.4	25.2	2.6	0.6	0	0.6	6.2	0.6	0.4	0.5	0.9	1.3	0.9	0.5	0.7	0.2	0	0.6	0	0.7	0.7	0.3	0	0	0.2	0.1	2.1	13.9	2.6	0	0.2	0	0	0.1	0.1	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0	0	0	0.6	0	0	6.1	0	0.1	0	0	0	0.1	0	0	0	0	0	0	0	0.1	0	0	0	0	0.2	0	0	0	0	0	0.1	0	13.9	0	10.7	0	11.5	7.5	0	0	8.2	11.5	0.2	2.1	0	0	5	2.6	10.6	9	0.4	24.4	18.4	4.8	4.4	10.4	25.2	0.2	0	0	0	0	0.1	0	0.3	0	0	1.2	0	0	0	0	0	14.9	0	0	0	0	0	0	0	0	0	0	0	0	1.3	0	0.4	0.6	0	0	0	0	0.3	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	Early spermatids
PSG9	PSG11, PSGII	ENSG00000183668	Pregnancy specific beta-1-glycoprotein 9	Q00887	19	43211791-43269530	Plasma proteins, Predicted membrane proteins, Predicted secreted proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	205	placenta: 299.0	Cell type enriched	Detected in some	109	Syncytiotrophoblasts: 231.8	Not detected	Not detected			Not detected	Not detected			Cell type enhanced	Detected in single		eosinophil: 1.4	Lineage enriched	Detected in single	15	granulocytes: 1.4	Cell line enhanced	Detected in some		BJ: 5.0;GAMG: 16.0;HBF TERT88: 9.2;SuSa: 11.0;U-2197: 9.5									HPA046327	Supported				Secreted in female reproductive system							HPA046327: AB_2679624	unprognostic (9.32e-2)	unprognostic (3.28e-1)				unprognostic (2.15e-1)												0.1	0	0.1	0	0.1	0	0.1	0.6	0.1	0.2	0.1	0	0	0	0.2	0	0.1	0	0	0	0.1	0.2	0.6	0	0	0	0.1	0	0	1.3	0	0.2	299	0	0.2	0	0	0.5	0.1	0	0.1	0	0.4	0.2	0.1	0.1	0.8	0	0	0	0	0	0.1	0.3	0	0	1.4	0	0	0	0	0.1	0	0	0	0	0	0.1	5	2.8	4.4	2.3	0.1	0.1	0	0.2	1.3	16	0.3	0	0	9.2	0	0	0	0	0	0.3	0	0	0	0	0	0.3	1.1	0	0	0	0	0	2.8	0	0	0	0	0	0	0.1	0	0.3	0.5	0	0	0	0	0.5	11	4.2	0	0.2	0.1	2.1	9.5	0.2	0	0	0	0.3	0	0	0.5	0	1.4	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0	0.1	0.1	0.6	0.1	0.1	0.2	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	1.5	0.5	0	0	0	0	2.1	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0.5	0	231.8	0	0	0	Syncytiotrophoblasts
NOG	SYM1, SYNS1	ENSG00000183691	Noggin	Q13253	17	56593699-56595590	Disease related genes, Predicted secreted proteins	Chondrogenesis, Differentiation	Developmental protein	Deafness, Disease mutation	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		blood: 32.8;placenta: 37.1;retina: 18.6	Cell type enriched	Detected in single	11	Extravillous trophoblasts: 8.9	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Group enriched	Detected in some	12	naive CD4 T-cell: 32.8;naive CD8 T-cell: 15.1	Lineage enriched	Detected in single	81	T-cells: 32.8	Cell line enhanced	Detected in some		EFO-21: 51.0;LHCN-M2: 15.5;NB-4: 11.3;PC-3: 15.4;U-2 OS: 15.8	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA061318	Approved				Secreted to blood							HPA061318: AB_2684478	unprognostic (1.49e-1)	unprognostic (1.17e-2)	unprognostic (1.49e-5)	prognostic favorable (6.66e-4)	unprognostic (4.69e-2)	unprognostic (5.23e-3)		unprognostic (1.26e-2)	unprognostic (3.06e-1)	unprognostic (3.02e-1)	prognostic unfavorable (6.86e-5)	unprognostic (2.88e-1)	unprognostic (1.14e-6)	unprognostic (8.39e-2)	unprognostic (1.40e-1)	unprognostic (5.00e-1)	unprognostic (1.65e-1)	0.9	0.3	4.9	2	7.2	0.7	0.5	0.9	8.3	5.5	0.6	1.8	0.4	0.5	0.8	6.3	0.4	0.4	0.3	0.4	3.8	3.1	0.8	0.4	1	3.3	1.9	2.7	0.3	0.5	0.3	0.8	37.1	1.1	1.4	0.4	18.6	0.4	2.9	3.6	0.4	0.7	0.5	0.8	1.5	0.8	1.6	1.8	1.7	0.3	0	1.1	0.9	3.1	0	0.1	0.4	0.1	0.2	32.8	1.7	2.4	0	0.1	0	0.1	0	0	1.3	1.4	0.5	0.5	0.1	0.4	0	51	0.6	2	0.2	0.8	0.1	1.4	0	0.9	0	1.9	0	0	0.3	0	0.2	0.2	0	0.2	0.1	0	0	0	0	15.5	0	0.4	11.3	1	0	15.4	6.7	4.7	0	1.2	0	0.1	0	2.6	0	0	4.3	0	0.2	0.3	0.9	15.8	0.1	1.1	0	0	0.1	0	1.2	0	0.3	0	0.1	0.2	0.1	0.1	0	1.9	0.2	0	0	32.8	15.1	0.4	0.2	0.1	0.1	1.3	1.7	4.9	7.2	0.9	2.5	3.8	3.1	1.9	2.7	1.1	1.8	0	0	0	0.2	0	0	0.8	0	0	0	0	0	0.1	0	0.2	0.1	0	0	0	0	8.9	0.6	0.2	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0.2	0	0	0.4	0	0	0.1	0.7	0	0	0	Extravillous trophoblasts
MRGPRX2	MRGX2	ENSG00000183695	MAS related GPR family member X2	Q96LB1	11	19054455-19060681	G-protein coupled receptors, Predicted membrane proteins		G-protein coupled receptor, Receptor, Transducer		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in many		smooth muscle: 9.2	Cell type enriched	Detected in single	9	Melanocytes: 1.7	Not detected	Not detected			Not detected	Not detected			Cell type enhanced	Detected in single		gdT-cell: 2.0	Lineage enriched	Detected in single	21	T-cells: 2.0	Cell line enriched	Detected in single	4	U-266/84: 1.9									HPA055220	Approved											HPA055220: AB_2682743						unprognostic (1.56e-2)											unprognostic (1.79e-1)	5.2	0	0	0.1	0	0	4.1	0	0	2.8	0.5	0	0	0	2	1	0.7	0.1	2.9	0.1	0	0	0	0	2.3	0.3	0	0	0.5	0	0.1	0	0	0	0.7	1.1	0	1.3	0	0.3	4.3	0.5	9.2	0	0.3	0.4	0.8	0	0	0	1.6	0.4	2.8	2.2	0	0	0	0	0	2	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.2	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0.3	0.4	0	0	0	0	0	0	0	0.2	0	0	0	0	0.4	0	0	0	1.9	0	0	0	0	0	0	0	2	0	0.4	0	0.1	0.7	0	0	0	0.1	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0.1	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Melanocytes
OR4N4		ENSG00000183706	Olfactory receptor family 4 subfamily N member 4	Q8N0Y3	15	22094522-22095472	G-protein coupled receptors, Predicted membrane proteins	Olfaction, Sensory transduction	G-protein coupled receptor, Receptor, Transducer		Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enriched	Detected in single	22	testis: 13.5	Cell type enriched	Detected in some	5	Early spermatids: 20.7	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		Karpas-707: 1.7;THP-1: 2.9									HPA057442	Uncertain		Uncertain	Centrosome						Centrosome		HPA057442: AB_2683442																		0	0	0	0	0	0	0	0	0.2	0.6	0			0	0	0	0	0	0	0.3	0	0	0	0	0	0	0		0	0	0	0	0		0	0		0	0	0	0	0	0	0	0	0	13.5			0		0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	1.7	0	0	0	0	0.5	0	0	0	0	0.6	0	0	0	0	0	0.3	0.5	0	0	2.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	20.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0.1	0	0	0	0	0	Early spermatids
LHFPL6	LHFP, MGC22429	ENSG00000183722	LHFPL tetraspan subfamily member 6	Q9Y693	13	39342892-39603528	Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in many			Cell type enriched	Detected in some	8	Extravillous trophoblasts: 146.6	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Group enriched	Detected in some	9	myeloid DC: 9.4;plasmacytoid DC: 3.2	Lineage enriched	Detected in single	14	dendritic cells: 9.4	Cell line enhanced	Detected in many		ASC diff: 66.1;HSkMC: 48.3	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA058975	Approved		Approved	Nucleoli						Nucleoli		HPA058975: AB_2683866	unprognostic (6.98e-2)	unprognostic (2.71e-1)	unprognostic (2.00e-2)	unprognostic (1.53e-1)	unprognostic (1.13e-2)	unprognostic (4.10e-2)	unprognostic (5.84e-2)	unprognostic (1.08e-1)	unprognostic (2.76e-1)	unprognostic (5.45e-2)	unprognostic (8.68e-2)	unprognostic (1.90e-2)	prognostic unfavorable (1.20e-7)	unprognostic (4.41e-3)	unprognostic (5.25e-2)	unprognostic (7.75e-2)	prognostic unfavorable (2.30e-4)	57.2	26.8	12.5	14.8	17.7	0.9	45.7	40.8	19	20.3	16.4	12.3	8.5	5.3	28.6	23.7	17.9	27	34.9	49.4	12.7	12.9	12.8	6.9	27	27.4	19.3	12.6	25.7	8.3	7.1	14.3	62	16.8	21.4	8.4	19.8	11.4	18.8	13.6	13.1	9.6	33.1	18.5	18.5	10.2	16.2	11.9	1.3	22.7	22.1	8.3	20.1	25.8	0.2	9.4	0.1	0.6	0	0	0.4	2.7	1	30	1.3	66.1	30	13.1	15.3	22.1	7.8	5.9	0.1	2.9	4.2	0.3	21.3	10.2	4.3	3.7	8.9	6.5	4.1	4.4	11.5	0.9	0	6.9	0.2	0.3	48.3	1.2	7	11.7	7	7.2	0.2	0	0	15	2.4	0	3.5	2.2	0	4	1.8	13	0	5.2	3.7	0.1	0.9	1.4	1.8	4.1	17.9	1.7	0	13.5	19.9	2.9	6.1	8.3	0.2	0	12	8.3	0	14.3	0	0.5	0	0	0.6	0	0	0	0	9.4	0.2	0	0	0.1	0	0.1	3.2	0	0.4	12.5	17.7	40.8	19	12.7	12.9	19.3	12.6	16.8	11.9	3	9.8	0	0	0	0	0	0	4	18.2	0	0	3.1	1.7	0.6	0	0	0	0	0.6	146.6	0	0	2.3	0	4.6	0	0	0	0	0	0	0.7	0	0	0	0	0.7	0	0	2.4	0	0	0	0	0	0	5.1	0	0	0	Extravillous trophoblasts
ASCL2	ASH2, bHLHa45, HASH2	ENSG00000183734	Achaete-scute family bHLH transcription factor 2	Q99929	11	2268495-2270952	Predicted intracellular proteins, Transcription factors	Differentiation, Neurogenesis	Developmental protein, DNA-binding		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		ductus deferens: 21.8;placenta: 16.0	Cell type enriched	Detected in many	12	Extravillous trophoblasts: 947.6	Group enriched	Detected in many	5	colorectal cancer: 76.1;stomach cancer: 23.1	Low region specificity	Detected in many			Cell type enhanced	Detected in many		eosinophil: 8.6	Low lineage specificity	Detected in many			Group enriched	Detected in some	5	BEWO: 18.5;NB-4: 5.4;OE19: 10.0;SCLC-21H: 15.1	Not detected	Not detected			Low region specificity	Detected in some																unprognostic (2.71e-3)	prognostic favorable (5.11e-4)	unprognostic (2.03e-1)	unprognostic (2.33e-2)	unprognostic (1.72e-1)	unprognostic (2.69e-2)	unprognostic (2.93e-2)	unprognostic (7.88e-2)	unprognostic (3.79e-2)	unprognostic (1.22e-2)	prognostic favorable (4.73e-4)	unprognostic (5.85e-2)	unprognostic (1.45e-6)	unprognostic (8.86e-3)	unprognostic (5.48e-2)	unprognostic (6.12e-4)	unprognostic (1.07e-3)	0.5	0.3	0.7	2.2	1.3	0.9	1.1	0	1.2	2.7	7.3	1.4	21.8	9.2	3.6	1.2	2.5	0.7	0.4	0.8	0.6	0.4	2.5	1.1	0.9	0.9	1.5	0.6	0.4	1.5	0	0.1	16	1.1	3.3	3.4	0.1	9.7	9.5	0.6	10	7.3	0.2	3.7	3	2.8	1.6	1.1	1.1	0.7	0.8	2.7	3.6	3.3	0.1	1	8.6	2	0	3	0.3	0	0	0.2	0	0	0	18.5	0	0	0	0	2.5	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0.1	0	2	0	0	0	0	0	1.7	0	0	1.9	0	5.4	0.4	10	0	0	0	0	0	0.4	15.1	0	0	0.3	0	0	1.9	1.2	0	0	0	0	0	0	0	0	0	0.8	0	4.5	1.4	8.6	3	2	0.2	0.1	0.7	1.7	1	0	0.2	1.7	1.2	0	1.7	0	0	0.3	0.7	1.3	0	1.2	0.6	0.4	1.5	0.6	1.1	1.1	0	0	1.9	12.4	12	0	0.8	0	1.4	0	19.2	0	15.5	6.6	0.1	0	0.7	6.8	0	0	947.6	0.8	3.8	0	0.2	28.4	0	75.2	20.3	18.4	0	1.7	8.5	1.7	1	19.5	0	0	3.4	1.4	0.3	0	0	0.3	0.3	11.3	4.1	19.5	8.5	77.9	4.6	Extravillous trophoblasts
ZNF703	FLJ14299, NLZ1, ZEPPO1, ZNF503L, Zpo1	ENSG00000183779	Zinc finger protein 703	Q9H7S9	8	37695751-37700021	Disease related genes, Predicted intracellular proteins	Transcription, Transcription regulation	Repressor		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		skeletal muscle: 64.6	Cell type enriched	Detected in many	4	Syncytiotrophoblasts: 363.1	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Group enriched	Detected in some	8	intermediate monocyte: 5.5;non-classical monocyte: 6.7	Lineage enriched	Detected in single	12	monocytes: 6.7	Cell line enhanced	Detected in many		HEK 293: 55.7;OE19: 21.1;SK-MEL-30: 20.1;T-47d: 18.7	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA023930, CAB068249	Supported											CAB068249: AB_2665667, HPA023930: AB_1859425	unprognostic (4.64e-2)	unprognostic (3.15e-2)	unprognostic (7.01e-3)	unprognostic (1.71e-3)	unprognostic (2.54e-1)	unprognostic (1.42e-1)	unprognostic (6.93e-2)	unprognostic (4.23e-2)	unprognostic (1.35e-1)	unprognostic (1.84e-1)	unprognostic (4.09e-1)	unprognostic (9.63e-2)	prognostic unfavorable (2.70e-7)	unprognostic (5.63e-2)	unprognostic (1.52e-1)	unprognostic (1.01e-1)	unprognostic (2.23e-1)	12.7	6.7	9.3	8.2	8.4	2.4	15.4	7.2	10.1	25.1	20	4.6	31.3	14	13.8	19.5	15.3	18.4	12.1	8	8.5	3.6	3.5	2.1	4.9	4	5.4	4.7	15	4.3	2	3.1	54.9	7.8	15.1	12.3	12	13.7	17.7	64.6	24.6	15.4	14.9	3.4	13.4	12.6	4.9	5.5	1.9	5.3	24	7.2	20.4	13.8	0	0.5	0.1	6.7	0	0.1	0.2	1.1	2.3	0.3	1.8	5.5	2.9	1.8	10.2	4.8	3.1	2.7	9.4	12.7	0	2.6	6.4	1.4	6	1	1.5	2.4	0.3	55.7	0	3.3	6	5.5	0	1.1	9.8	2.9	3.3	1.3	6.8	2.7	0.1	0.1	0	5	9.4	0	0.3	0.9	21.1	4.1	0.9	1.7	1.2	0.9	4.9	1	0.1	1.9	1.6	20.1	2.3	18.7	1	8.1	3.7	8.7	5.7	4.2	0.7	0	0	3.3	1.1	2.4	0	0.7	0.1	0	5.5	0	0	0	0	0.5	0	0	0.1	0	0	6.7	0	0	0.2	9.3	8.4	7.2	10.1	8.5	3.6	5.4	4.7	7.8	5.5	6	0	6.2	10.8	42.7	3.5	7.6	2.5	2.7	2.3	5.2	0	33	3.3	7.7	0.3	5	32.1	0	2.2	34.7	27.2	9.5	0	1.7	29.3	0	76.4	3.7	9.1	0	29.1	11.7	32.1	0	83.3	8.3	2.6	52.6	14.9	2.1	0.8	51.8	81.2	0	0.6	65.2	363.1	0.7	82.3	9.5	Syncytiotrophoblasts
C9orf66	FLJ31158	ENSG00000183784	Chromosome 9 open reading frame 66	Q5T8R8	9	212824-215741	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	6	blood: 20.9;kidney: 17.8	Cell type enriched	Detected in many	4	Proximal tubular cells: 60.2	Cancer enhanced	Detected in some		renal cancer: 2.7	Not detected	Not detected			Cell type enhanced	Detected in many		neutrophil: 20.9	Group enriched	Detected in many	4	granulocytes: 20.9;monocytes: 6.0	Cell line enhanced	Detected in some		BEWO: 3.6;MCF7: 3.7;RT4: 3.6;THP-1: 7.8									HPA035652	Uncertain											HPA035652: AB_10601151	unprognostic (1.24e-1)	unprognostic (7.20e-2)	unprognostic (7.64e-2)	unprognostic (1.89e-1)	unprognostic (3.32e-1)	unprognostic (1.37e-1)	unprognostic (2.55e-1)	unprognostic (2.94e-2)	unprognostic (9.48e-2)	unprognostic (6.65e-3)	unprognostic (9.92e-2)	unprognostic (5.66e-2)	prognostic favorable (1.32e-5)	unprognostic (2.04e-2)	unprognostic (1.63e-1)	unprognostic (2.73e-2)	unprognostic (3.10e-3)	0.5	3.1	0.3	0.3	0.9	1.7	0.7	0.3	0.3	0.3	0.3	0.3	0.3	0	0.3	0.3	0.5	0.1	0.3	0.3	0.3	0.1	17.8	0.5	0.3	0.3	0.3	0.3	0.5	1.3	1.9	0.3	0.3	0.3	0.7	0	0.3	0.3	0.3	0.3	0.2	0.3	0.3	0.3	1.4	0.2	0.7	0.8	0.3	1.3	0.3	0.3	0.4	0.3	2	3	20.9	6	1.6	0.6	0.6	0.1	0.4	0.3	0.4	0.1	0.1	3.6	0.1	0	0.2	0.1	0.7	2.1	0.4	1	0.3	0.4	0.6	0.1	0	0	0.3	1.1	0.3	0.5	0.3	0.1	0.9	1.2	0.2	0.1	0.1	0	0.1	0	0.2	1.9	0.8	0	3.7	0.2	2.4	0.4	0.1	0.8	0.4	0.3	2.1	0.1	3.6	0.6	0.4	0	0.2	0.5	0.3	1.6	7.8	1.1	0.3	0.8	0.5	0.2	0.9	0.4	0.1	0.2	1.3	0.7	7	4.9	8	0.3	3.3	0.1	1.8	0.6	0.4	3	2	0.1	0.2	20.9	1.6	6	0.7	0.1	0.6	0.3	0.9	0.3	0.3	0.3	0.1	0.3	0.3	0.3	0.8	0	0.3	2	1.5	1	0.6	1.1	2.5	1.4	0	10.4	13.7	8.5	10	1.1	0	0.3	0	0	4.7	1.7	0.7	1.5	0	0.4	4.9	0	3.4	0	3.1	0	0.9	3.8	0	6.4	2.6	0.8	1.1	0	0.4	60.2	3.2	6.5	1	2.2	5.5	0.1	3.9	2.1	0.2	1.4	Proximal tubular cells
SCN5A	CDCD2, CMD1E, CMPD2, HB1, HB2, HBBD, HH1, ICCD, IVF, LQT3, Nav1.5, PFHB1, SSS1	ENSG00000183873	Sodium voltage-gated channel alpha subunit 5	Q14524	3	38548057-38649673	Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels	Ion transport, Sodium transport, Transport	Calmodulin-binding, Ion channel, Sodium channel, Voltage-gated channel	Atrial fibrillation, Brugada syndrome, Cardiomyopathy, Disease mutation, FDA approved drug targets, Long QT syndrome	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	12	heart muscle: 67.3	Cell type enriched	Detected in some	5	Cardiomyocytes: 66.1	Low cancer specificity	Detected in some			Low region specificity	Detected in some			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	4	LHCN-M2: 22.0;RH-30: 18.3	Group enriched	Detected in some	5	amygdala: 3.2;basal ganglia: 10.5;hypothalamus: 7.0	Low region specificity	Detected in many			HPA063346			Supported	Nucleoplasm,Nucleoli,Plasma membrane						Plasma membrane	Nucleoplasm, Nucleoli	HPA063346: 	unprognostic (9.29e-4)	unprognostic (4.05e-2)	unprognostic (9.95e-2)	unprognostic (1.74e-1)	unprognostic (9.21e-2)	unprognostic (1.24e-2)	unprognostic (1.15e-1)	unprognostic (1.48e-1)	unprognostic (7.36e-2)	unprognostic (8.48e-2)	unprognostic (7.12e-3)	unprognostic (5.28e-2)	unprognostic (1.16e-4)	unprognostic (4.85e-3)	unprognostic (1.09e-1)	unprognostic (5.35e-2)	unprognostic (4.95e-3)	0.3	0.2	1.3	0.2	0.3	0.4	0.6	0.1	2.3	2	0.4	0	0.4	0.3	0.9	0.8	0.2	0.4	0.3	67.3	0.5	0.7	0.1	0.1	0.2	0.1	0.1	0.3	0.6	0.2	0.1	0.8	0.3	0	1.3	0.2	1.2	0.3	1.6	5.5	0.2	0.3	0.4	0.1	0.2	0.2	0.5	0	0	0.3	0.1	0.1	0.8	1.1	0	0	0	0	0	0.4	0	0	0.1	0	0.5	0.1	0	0.1	0.8	0.4	0	0.1	0.3	2.7	0	0	0	0.9	0.9	2.7	0	0.4	0	1.2	0.7	0	0.1	0.1	0	0.1	0.5	0	0.5	0	1.7	3.6	0.4	0	0	22	1.1	0	0	2	0	0	0	18.3	0	0	2.4	0.3	2.4	0	0	0	0.7	0	0	4.4	0	4.5	0	0	0.1	0	0	0	0	0.1	0	0	0	0.2	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	1.3	0.3	0.1	2.3	0.5	0.7	0.1	0.3	0	0	0	0	0	1.1	0.2	3.1	66.1	0	0	0	0	13.7	0.1	0	0.1	1	0.4	0	0	0	0.2	0.3	0.3	0	0	0	0	0	0	0	0	0.6	0	0	0	0	0.8	0.1	0	0	0	0.7	0	0.4	0.3	0.9	0	0	0	0	1	Cardiomyocytes
SRARP	C1orf64, ERRF, MGC24047	ENSG00000183888	Steroid receptor associated and regulated protein	Q8NEQ6	1	16004236-16008807	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in many		brain: 22.0;breast: 14.7	Cell type enriched	Detected in single	763	Distal tubular cells: 76.3	Cancer enhanced	Detected in some		breast cancer: 7.7;prostate cancer: 6.5	Low region specificity	Detected in all			Cell type enhanced	Detected in some		neutrophil: 5.3	Lineage enriched	Detected in many	5	granulocytes: 5.3	Group enriched	Detected in some	12	Hep G2: 9.2;SK-BR-3: 16.5;T-47d: 5.3					Low region specificity	Detected in all			HPA026676	Uncertain		Approved	Nucleoplasm						Nucleoplasm		HPA026676: AB_1853866	unprognostic (8.55e-2)	unprognostic (1.01e-1)		prognostic favorable (1.68e-6)	unprognostic (3.32e-2)	unprognostic (1.09e-2)	unprognostic (1.45e-2)	unprognostic (1.41e-2)		unprognostic (3.49e-1)		unprognostic (8.25e-2)	unprognostic (1.40e-2)	unprognostic (1.81e-1)	unprognostic (2.53e-1)	unprognostic (1.65e-3)	unprognostic (6.32e-2)	0.9	1.1	12.8	1.2	19.9	2.2	14.7	7.5	19.3	6.6	0.8	3.5	0	1.3	3.8	1.2	1.1	0.8	1.1	1.5	14.1	6.4	2.7	0.9	0.9	1.3	12.8	7.2	1.1	1.1	0.6	0.3	1	22	2.5	0.8	0	8.6	0.8	2.2	2.2	0.9	0.6	7.8	1.1	1.4	1.1	16.6	0	3.8	0	0.7	1.2	0.3	0.8	0.5	5.3	0.4	1	0.6	0.1	0.4	0.1	0.4	0.5	0	0.1	0.2	0.4	0	0	0	0.1	0.4	0.5	0.2	0	0.4	0.3	0	0	0	0.2	0.1	0.5	0.7	9.2	0	0.4	0.3	0	0	0.1	0	0.3	0	0.5	0.7	0.7	0	0.5	0.3	0.4	0.1	0.2	0.2	0.2	0.3	0.2	0	0.1	0.5	0.8	0.3	16.5	0.3	0.6	5.3	0.5	0.2	0.6	0.4	0.5	0.1	0.3	0.6	0.3	0.2	0.3	0.7	2	0.4	0.5	0.5	0.3	0.4	0.4	0.4	0.5	0.1	0.8	0.6	0.6	5.3	1	0.3	0.5	0.2	0.1	12.8	19.9	7.5	19.3	14.1	6.4	12.8	7.2	22	16.6	0	0	0	0	0	0	0	0	0	0	0	0	0	76.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Distal tubular cells
NPW	PPL8	ENSG00000183971	Neuropeptide W	Q8N729	16	2009926-2020755	Predicted intracellular proteins, Predicted secreted proteins		Neuropeptide		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	6	liver: 49.0;placenta: 17.7	Cell type enriched	Detected in many	5	Intestinal endocrine cells: 152.5	Low cancer specificity	Detected in many			Low region specificity	Detected in some			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Cell line enhanced	Detected in some		NB-4: 17.1;PC-3: 9.5;RPMI-8226: 29.9;SCLC-21H: 52.0	Low region specificity	Detected in single							HPA064874	Approved				Secreted to blood							HPA064874: AB_2685378	unprognostic (7.54e-2)	unprognostic (4.45e-3)	unprognostic (3.20e-1)	unprognostic (4.31e-3)	unprognostic (8.85e-2)	unprognostic (1.54e-1)	unprognostic (1.56e-1)	unprognostic (1.27e-1)	unprognostic (3.06e-1)	unprognostic (2.20e-2)	unprognostic (6.26e-3)	unprognostic (2.37e-1)	unprognostic (1.81e-5)	unprognostic (6.53e-3)	unprognostic (1.26e-1)	unprognostic (4.41e-1)	unprognostic (3.43e-2)	0.9	0.6	0.6	1.3	0.8	2.3	0.4	0.6	1.6	1.6	1.3	0	3.1	1.4	5.9	3	0.9	1.1	0.7	0.3	0.5	0.9	1	49	0.4	1.3	0.4	0.7	1	2	0.3	5.9	17.7	1.2	1.5	0.7	1.1	0.5	3.4	0.3	2.3	0.7	0.6	0.5	2.8	6	4.3	0.4	3.7	0.8	0.9	1	0.6	1.3	1.6	2	4.7	2.1	1.6	1.8	0.6	0.1	0.8	0.1	1.1	0.1	0	0.2	0.3	0.1	0.2	0.4	1.9	0.6	0.2	0	0.3	0.2	0.3	0.5	0.2	0.2	0.7	1	0	1.2	0.6	0.8	0.1	0	0.5	0.5	0.3	0.8	0	0	0.9	2.9	0.6	0	0.5	0.1	17.1	0.7	0.6	9.5	3.3	0	29.9	0.1	0	52	4.2	0.4	0.9	0.1	0.2	2.2	1.4	0.6	0.1	0.2	0.1	0	1.4	0.4	0.4	0.2	0.4	0.1	3.6	2.1	1.9	0.6	1.3	1.8	1.4	0.3	0.2	2	1.6	0.9	0.3	4.7	1.6	0.6	1.1	1.1	0.6	0.6	0.8	0.6	1.6	0.5	0.9	0.4	0.7	1.2	0.4	0	0	1.9	2.8	1.8	0.8	0.2	0	0	0	0	0	0.8	0	0.7	0.6	0.1	2.6	0	0.2	0.6	0.8	6.4	9.2	30	2.1	0	152.5	0.6	0.3	1.7	2	0.1	3.3	0	23.4	0	2.2	3.6	2.1	0.5	0.3	0	1	3.8	26.6	1.9	1.4	0.8	3	3.2	Intestinal endocrine cells
OR2T10		ENSG00000184022	Olfactory receptor family 2 subfamily T member 10	Q8NGZ9	1	248590487-248597700	G-protein coupled receptors, Predicted membrane proteins	Olfaction, Sensory transduction	G-protein coupled receptor, Receptor, Transducer		Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enriched	Detected in some	8	kidney: 11.2	Cell type enriched	Detected in single	59	Proximal tubular cells: 5.9	Cancer enhanced	Detected in single		renal cancer: 0.7					Cell type enhanced	Detected in single		naive B-cell: 1.4	Lineage enriched	Detected in single	15	B-cells: 1.4	Group enriched	Detected in some	7	BJ hTERT+: 3.1;Karpas-707: 2.4									HPA052019	Uncertain											HPA052019: AB_2681696													unprognostic (8.58e-2)					0	0	0	0	0	0	0	0	0	0	0			0	0	0	0	0.1	0	0	0	0	11.2	0	0	0	0		0	0.3	0	0	0		0.4	0		0.1	0	0	0.2	0	0	0	0.1	0	0.1			0		0	0	0	1.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.1	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	2.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0.3	0	0	0	1.4	0	0	0	0	0	0	0	0											0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5.9	0	0	0	0	0	0	0	0	0	0	Proximal tubular cells
TRIML1	FLJ36180, RNF209	ENSG00000184108	Tripartite motif family like 1	Q8N9V2	4	188139419-188147743	Enzymes, Predicted intracellular proteins	Ubl conjugation pathway	Developmental protein, Transferase		Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	21	testis: 14.1	Cell type enriched	Detected in some	4	Early spermatids: 94.5	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	5	BEWO: 5.9	Not detected	Not detected			Not detected	Not detected																					unprognostic (6.99e-2)									unprognostic (5.21e-1)			0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.1	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0.4	0	0	0	0	0	5.9	0	0	0	0	0	0	0	0	0	1.2	0	0	0	0	0	0.1	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0.1	0	0	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	1.1	0	0	94.5	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	23.2	0.6	0	0	0	0	0	0	0	1.1	0	0	0	0	0.9	0.2	0	0.9	0	0	0	Early spermatids
KCNJ12	hIRK1, IRK2, KCNJN1, Kir2.2, Kir2.2v	ENSG00000184185	Potassium voltage-gated channel subfamily J member 12	Q14500	17	21376197-21419872	FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels	Ion transport, Potassium transport, Transport	Ion channel, Voltage-gated channel	FDA approved drug targets	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Group enriched	Detected in many	4	brain: 39.4;skeletal muscle: 47.8	Cell type enriched	Detected in some	7	Horizontal cells: 84.2	Low cancer specificity	Detected in many			Region enriched	Detected in many	7	cerebellum: 39.4	Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		EFO-21: 3.6;HeLa: 5.9;PC-3: 6.3;SCLC-21H: 7.3;SiHa: 3.7;SuSa: 8.0;U-2197: 6.3	Low region specificity	Detected in all							HPA027021	Approved		Uncertain	Nucleoplasm,Golgi apparatus,Cytosol						Golgi apparatus	Nucleoplasm, Cytosol	HPA027021: AB_10602912	unprognostic (3.81e-3)	unprognostic (2.69e-2)	unprognostic (8.60e-2)	prognostic unfavorable (7.84e-5)	unprognostic (2.29e-1)	unprognostic (1.73e-2)	unprognostic (3.80e-2)	unprognostic (1.54e-2)	unprognostic (4.39e-2)	unprognostic (4.91e-2)	unprognostic (8.12e-2)	unprognostic (1.16e-1)	unprognostic (4.22e-2)	unprognostic (2.23e-1)	unprognostic (1.51e-1)	unprognostic (5.90e-2)	unprognostic (9.70e-3)	1.2	1.3	1.9	0.9	2.9	0.7	0.9	39.4	5.8	1.2	0.8	1.1	0.5	0.5	0.8	1.4	1.5	2.1	0.7	5.1	0.9	1.4	1.2	0.5	1.3	0.4	1.3	3.4	0.7	0.5	10.6	0.7	0.7	4	0.9	0.6	1.7	0.6	0.9	47.8	6	0.6	1	0.9	1.3	0.9	1.3	0.9	0	1	7.5	1.1	0.8	1.5	0	0.9	0	0.5	0	0.1	0	0	1.1	0.4	2.2	0	0	0	0.2	0	0.1	0	0.2	0	0	3.6	0.1	0.2	0	0	0.1	0	0	0.1	0.2	5.9	0	0	0	0	0.1	0	0.6	0	0	0.2	0	0	0	0.4	0.1	0.1	0	1.5	0	6.3	0	1	1.6	0	0	7.3	0.4	3.7	0	1.5	8	0	0	2.8	0	0.5	6.3	0.3	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0.9	0.1	0	1.9	2.9	39.4	5.8	0.9	1.4	1.3	3.4	4	0.9	0	0	0	0	1.3	0.8	12.5	0	0	0	1.8	0	0	1.7	0	0.4	1.4	0	0	0	0	2.1	0.2	0	0	0.2	84.2	1.2	5.5	0	0.2	6.9	0	0	0	0.4	11.2	0	0	3.9	0.6	1.4	0	0.5	0.5	1.3	1.9	0.1	0	0.6	0	Horizontal cells
GOLGA6L4		ENSG00000184206	Golgin A6 family-like 4	A6NEF3	15	84235773-84245368	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level	No human protein/transcript evidence	No human protein/transcript evidence		Low tissue specificity	Detected in all			Cell type enriched	Detected in many	6	Early spermatids: 78.4	Not detected	Not detected							Group enriched	Detected in some	7	basophil: 1.9;NK-cell: 6.0	Group enriched	Detected in many	7	granulocytes: 1.9;NK-cells: 6.0	Cell line enhanced	Detected in many		HEK 293: 7.4;U-266/70: 9.8																						unprognostic (7.35e-3)	unprognostic (6.23e-2)	unprognostic (3.66e-1)	unprognostic (3.74e-1)	unprognostic (3.53e-1)	unprognostic (6.83e-2)	unprognostic (4.49e-2)	unprognostic (1.41e-1)	unprognostic (2.10e-2)	unprognostic (1.75e-1)	unprognostic (7.23e-2)	unprognostic (6.23e-2)	unprognostic (1.72e-3)	unprognostic (4.70e-2)	unprognostic (1.48e-1)	unprognostic (3.55e-2)	unprognostic (1.44e-1)	3.6	4.2	0.7	1.4	0.8	2.2	3.7	0.6	1.3	3.1	2.5			0.7	5.2	5	1.8	2.4	2.1	2	0.6	1	2.1	2	2.3	1.2	0.5		9.9	3	2.3	2.3	1.4		2.7	2.3		2.2	1.6	3.1	4.2	1.6	2.4	0.5	1.2	1.9	6.1			3.4		0.6	2.7	4	0.5	0.5	1.9	0.1	6	0.5	0	0.4	0.2	2.5	2.8	3.1	2.9	0.3	2.2	0.8	0.1	0.8	0	0.6	1.8	2.3	1.9	0.9	0.6	2	0.7	0.6	1.1	7.4	1.1	2	1.8	0.7	2.4	3.6	1.1	1.2	0.5	0.8	3.7	3.7	2.9	4.3	3.1	1.3	1.6	0.2	2.1	1	0	0.8	0.6	0.5	1.8	2.2	2.3	1	2	1.5	1.1	1.4	5.3	1	1.7	2.7	0.8	1.7	2.1	2.1	9.8	2.9	0.8	1	1.2	0	1.9	0.1	0	0.2	0	0.5	0	0.3	0.5	0	0.5	0	0.4	0.2	6	0	0.5	0	0											0	1.3	0	1.8	3.2	6.8	0.6	2.5	1.4	4.5	1.8	11.8	0.8	0	3.4	78.4	3.3	0.4	0	3.8	0.1	3.6	2.3	4.7	3.4	1.5	0	1.2	3.7	1.2	7.3	6.4	3.5	6.8	1	0.4	4	7.9	2.9	5.3	0.3	7.3	12.9	4.7	14	4.3	4	0.7	1.3	1	0.6	Early spermatids
OLIG1	BHLHB6, bHLHe21	ENSG00000184221	Oligodendrocyte transcription factor 1	Q8TAK6	21	33070144-33072420	Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	Developmental protein, DNA-binding		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	4	brain: 95.6	Cell type enriched	Detected in some	11	Distal tubular cells: 54.7	Cancer enriched	Detected in some	18	glioma: 116.5	Low region specificity	Detected in all			Group enriched	Detected in some	9	basophil: 6.3;eosinophil: 22.0	Lineage enriched	Detected in many	14	granulocytes: 22.0	Group enriched	Detected in some	6	NB-4: 24.3;RPMI-8226: 12.7;THP-1: 16.0;U-937: 18.3	Low region specificity	Detected in all			Low region specificity	Detected in all																unprognostic (4.13e-2)	unprognostic (6.46e-2)	unprognostic (4.06e-1)	unprognostic (3.58e-1)	unprognostic (9.01e-3)	unprognostic (2.40e-1)		unprognostic (7.93e-2)	unprognostic (1.50e-1)	unprognostic (3.82e-3)	unprognostic (5.19e-2)	unprognostic (8.17e-2)	unprognostic (2.51e-1)	unprognostic (4.05e-2)	unprognostic (5.96e-3)	unprognostic (3.20e-2)	unprognostic (1.17e-1)	1.8	1.8	44.6	1.9	51.6	2.5	1.9	7.3	95.6	1.8	1.8	58.3	0	1.9	1.8	1.8	1.8	1.8	1.8	1.8	42.7	30.4	3.1	1.8	1.9	1.8	40.7	22.7	1.8	1.9	1.8	0.1	1.8	35.5	1.8	1.8	0	1.9	1.8	3	1.8	2	1.8	41.4	2.3	2	2.2	35.7	0	1.8	0	1.8	1.9	0	0	0.2	22	1.6	0	0	0.3	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0.4	0	0	1.6	0.4	0	0	0	0	1.1	3.1	0	0	0	0	0	0	0	0	0.1	0	0	0	24.3	0.1	0	0	0	0.1	12.7	0	0	0.9	0	0	0	2.9	0	0.1	16	0	0	0.4	0	0	0	0	0	0.4	18.3	1	6.3	1.6	22	0	0.5	0	0	0	0	0.2	0	0	0	0.3	0	1.4	0.1	0	0.3	44.6	51.6	7.3	35.2	42.7	30.4	40.7	22.7	35.5	35.7	0	0	0	0	0	0	0.8	0	0	0	0	0	0	54.7	0	0.2	0	0	0	0	0	0	0	0	0	0.7	0	0	0.6	3.5	0	0	0.5	5	0	0	0	0.1	0	0	0.3	0	0	0	1.2	0.2	0.1	0.1	0	0	0	Distal tubular cells
ACOT1	ACH2, CTE-1, LACH2	ENSG00000184227	Acyl-CoA thioesterase 1	Q86TX2	14	73537114-73543794	Enzymes, Predicted intracellular proteins	Fatty acid metabolism, Lipid metabolism	Hydrolase, Serine esterase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		liver: 27.6	Cell type enriched	Detected in some	6	Cardiomyocytes: 44.7	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Cell line enhanced	Detected in many		Hep G2: 18.2;T-47d: 25.1									HPA043705	Approved		Approved	Mitochondria						Mitochondria		HPA043705: AB_2678626	unprognostic (4.74e-3)	unprognostic (3.81e-3)	unprognostic (7.65e-2)	unprognostic (8.66e-2)	unprognostic (1.22e-1)	unprognostic (1.29e-1)	unprognostic (4.54e-2)	unprognostic (1.29e-2)	unprognostic (1.53e-1)	unprognostic (1.73e-2)	unprognostic (1.84e-1)	unprognostic (4.16e-1)	prognostic favorable (5.09e-8)	unprognostic (1.35e-3)	unprognostic (4.60e-2)	unprognostic (1.75e-1)	unprognostic (1.43e-1)	8.5	7.2	5.1	3.7	3.9	1	13.7	2	7.7	3	5.8	4.1	0.9	5.3	6.8	8.8	2.7	3.4	1.8	11.3	4.3	3.6	16.4	27.6	9	0.9	3.2	6	4.5	1.4	2.9	0.9	4.1	5.6	5.5	3.4	2.4	2.7	6.1	10.7	3.8	12.9	13	1.9	1	3.4	2.7	2.4	0.9	1.8	5	1.9	5.6	1.7	3.8	5.7	1	1.7	4.2	6.3	3.1	4.2	5	1.9	0.1	9.9	6.1	0.1	1.3	5.4	4.5	8.2	1.9	2.1	0	0	3.6	0	2.5	0	0.9	2.2	2.3	1.6	2.7	1.2	18.2	9.6	0.1	3	7.9	0.4	3.6	0	0.1	2	0	0	0	3.5	1.6	0.3	0.5	1.9	0.6	1.9	5.1	3.9	0.1	4.4	4.7	2.3	3.8	4.2	12.4	6.8	0.4	25.1	6.2	2.2	2.5	3.2	2.3	0	0	0	1.3	3.6	0	4	0.1	1.3	1	6	1.7	4.9	3.8	5.5	4.7	5.7	2.6	4.8	5.3	0.2	4.2	1.5	3.2	6.3	3.1	5.1	3.9	2	7.7	4.3	3.6	3.2	6	5.6	2.4	0	2.7	0	0	0	0	44.7	0	0	0	0	0	0.6	0	0.5	0.4	0	0	0	7.2	0.2	0.3	0	0	0.6	0.8	0	0	0	0	0	0	0	1.7	0	0	0	1.7	0	0.4	0.8	0	0	0.5	0	0.2	0	0.7	0	0	0	Cardiomyocytes
DEFB108B		ENSG00000184276	Defensin beta 108B	Q8NET1	11	71833200-71837710	Predicted secreted proteins		Antibiotic, Antimicrobial, Defensin		Evidence at transcript level	No human protein/transcript evidence	Evidence at transcript level	Evidence at transcript level		Not detected	Not detected			Cell type enriched	Detected in single	18	Collecting duct cells: 1.8	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	28	HaCaT: 2.8									HPA042588	Uncertain				Secreted - unknown location							HPA042588: AB_10959523																		0	0.2	0.2	0	0	0	0	0.2	0.2	0	0.2			0	0	0	0.1	0	0	0	0	0	0	0	0.2	0	0		0	0.3	0	0	0		0	0		0.1	0	0	0.1	0.2	0	0	0	0	0			0.2		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0	0	0	0	0	0	1.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Collecting duct cells
COLEC10	CL-L1	ENSG00000184374	Collectin subfamily member 10	Q9Y6Z7	8	118995452-119106582	Disease related genes, Plasma proteins, Predicted secreted proteins			Disease mutation	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	6	liver: 47.4	Cell type enriched	Detected in single	42	Ito cells: 16.5	Low cancer specificity	Detected in some			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		BJ hTERT+: 8.4;HHSteC: 3.5;SK-BR-3: 15.0	Not detected	Not detected			Low region specificity	Detected in all								Secreted to blood				5700000				unprognostic (1.28e-1)	unprognostic (1.29e-2)	unprognostic (3.79e-4)	unprognostic (6.25e-3)	unprognostic (1.80e-3)	unprognostic (7.73e-2)	prognostic favorable (5.79e-4)	unprognostic (1.05e-1)		unprognostic (1.61e-1)	unprognostic (1.13e-1)	unprognostic (9.25e-2)	unprognostic (9.02e-5)	unprognostic (2.47e-1)	unprognostic (1.82e-1)	unprognostic (5.85e-5)	unprognostic (7.12e-2)	0	0.5	0.1	0	0.1	0	0	0.1	0.1	0	0.1	0	0	0	0	0	0	0	1.3	0.4	0.1	0.1	0.3	47.4	0.7	0.6	0.1	0	0	0	0	0.1	8.5	0.1	2.4	0	0.2	0	0	0	0	0.5	0	0.1	0	0	0	0	0	1.3	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0.1	0	0.2	0	0	0.7	8.4	0.1	0.1	0.1	0.3	0	0.7	0.1	0	0	0	0	0.4	0	0	0	0	0	3.5	0.1	0	0	0	1.2	0	0.2	0	0.1	0	0.3	0.4	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	15	0	0.1	0	0	0	0	0.1	1.2	0	1	0.4	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0.1	0	0.3	0	0	0.3	0	0	16.5	0	0	0	0	0	0	0	0	0.1	0	0	0.4	0	0	0	0	0	0.4	0	0	0	0.2	Ito cells
ACTRT3	ARPM1	ENSG00000184378	Actin related protein T3	Q9BYD9	3	169766921-169769895	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	17	testis: 57.4	Cell type enriched	Detected in many	9	Early spermatids: 728.6	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Cell type enhanced	Detected in some		MAIT T-cell: 3.4	Group enriched	Detected in many	4	B-cells: 1.2;T-cells: 3.4	Cell line enhanced	Detected in many		ASC diff: 16.0;HSkMC: 10.3	Low region specificity	Detected in many			Not detected	Not detected			HPA035817, HPA035818	Approved		Approved	Nucleoplasm						Nucleoplasm		HPA035817: AB_10671938, HPA035818: AB_2674801	unprognostic (2.35e-1)	unprognostic (9.39e-2)	unprognostic (2.10e-2)	prognostic unfavorable (4.11e-4)	unprognostic (1.89e-2)	unprognostic (1.75e-1)	unprognostic (3.29e-1)	unprognostic (1.24e-1)	unprognostic (7.31e-4)	unprognostic (2.64e-1)	unprognostic (9.16e-2)	unprognostic (4.41e-2)	unprognostic (8.03e-2)	unprognostic (8.49e-2)	unprognostic (1.63e-1)	unprognostic (8.25e-3)	unprognostic (2.22e-1)	1	0.7	0.9	0.4	1.1	0.5	1.5	2.4	1.3	1	0.5	0.5	1.3	0.7	0.7	1.4	0.6	1.4	0.5	0.7	0.7	0.9	1.8	1.7	0.7	0.6	1	0.4	1.1	0.3	0.8	1	0.7	1.1	1	0.4	0.6	0.5	1.3	0.7	0.3	0.5	1	0.6	0.1	0.8	57.4	0.7	0.2	1	0.1	0.5	1.5	3.1	1.2	0.5	0	0	0	3.4	0.4	3.6	2.2	0.2	1.1	16	5.2	0	4.4	2.6	2.7	2.3	0	4.6	0	6.1	4.9	1.8	2.3	1.2	2.1	2.8	2.7	1.6	8.4	1.9	0.4	2.6	0.9	0.7	10.3	0.5	3.3	0.6	1.8	4.9	1	0	0	4.8	1.8	0.3	0.1	3.9	3.1	4.6	0.7	0	0.1	2.9	0.9	2.9	2	5.2	1.3	0.1	0.5	2.2	3.6	2.2	0	0	2.2	0	0.5	0.2	0.2	1.1	0	0.5	0	0	0	0.7	0	3.4	1.2	0	1.1	0.5	1.1	0.4	0.4	0	0	0	0.5	0	0.4	0.9	1.1	2.4	1.3	0.7	0.9	1	0.4	1.1	0.7	0	1	0	0.7	0.3	1	0.6	0	2.7	2.3	0	2	1.4	1.7	2	728.6	0.7	0	0	1.8	1.1	1.4	0.4	1.1	1.7	1.4	3.2	0	1.8	0.6	82.5	8.9	0.6	1.7	0	0.1	1.4	1.3	0	5.3	2.5	1.1	12.9	1.9	5.5	4	0	0.7	0	0.4	0.3	Early spermatids
POU3F2	BRN2, OCT7, OTF7, POUF3	ENSG00000184486	POU class 3 homeobox 2	P20265	6	98834592-98839470	Predicted intracellular proteins, Transcription factors	Differentiation, Neurogenesis, Transcription, Transcription regulation	Activator, DNA-binding		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	23	brain: 28.0	Cell type enriched	Detected in some	8	Muller glia cells: 12.3	Cancer enriched	Detected in some	11	glioma: 16.9	Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		AF22: 52.2;SK-MEL-30: 7.1;U-251 MG: 15.9;WM-115: 13.9	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA047081, HPA056261		Approved	Supported	Nucleoplasm						Nucleoplasm		HPA047081: , HPA056261: AB_2683081	unprognostic (5.94e-4)	unprognostic (7.80e-2)	unprognostic (3.07e-3)	unprognostic (1.83e-1)	unprognostic (3.57e-1)	unprognostic (1.38e-1)	unprognostic (1.17e-3)	unprognostic (1.84e-1)	unprognostic (1.16e-1)	unprognostic (1.60e-1)	unprognostic (1.63e-3)	unprognostic (4.77e-1)	unprognostic (9.38e-11)	unprognostic (4.77e-2)	unprognostic (2.84e-2)	unprognostic (8.47e-3)	unprognostic (4.04e-1)	0.9	1	9	0.9	10.8	0.9	0.9	3.4	28	0.9	0.9	10.3	0	0.9	0.9	0.9	0.9	0.9	0.9	0.9	9.8	7.1	0.9	0.9	0.9	0.9	10.7	6.8	0.9	0.9	0.9	0	0.9	9.7	0.9	0.9	0	0.9	0.9	0.9	1	0.9	0.9	8.4	0.9	0.9	1.2	9	0	0.9	0	0.9	0.9	0	0	0	0	0	0.6	0	0	0	0	52.2	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	2.3	0	0	0	3.1	0	0	0	0	0	0.7	0	0	0	0	0	0	0.6	1.9	0	0	0	0.4	0	0.2	0	2.2	1.7	0.4	0	0	0	2.9	1.5	0	0	7.1	0	0.4	0	0	0.3	0	0.1	15.9	0	0	0	0	0	13.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0	9	10.8	3.4	12.5	9.8	7.1	10.7	6.8	9.7	9	0	0	0	0.2	0.1	0.1	1.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0.1	0	0	0	0	0	0	0	0	0	0	12.3	0	0	0	0	0	0	0.1	0.2	1.4	0.1	0	0	0	0.2	Muller glia cells
GAST	GAS	ENSG00000184502	Gastrin	P01350	17	41712326-41715969	Cancer-related genes, Predicted secreted proteins		Hormone	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	61	stomach 1: 529.2	Cell type enriched	Detected in some	5	Syncytiotrophoblasts: 7.3	Group enriched	Detected in many	6	pancreatic cancer: 38.8;stomach cancer: 23.5	Region enhanced	Detected in single		cerebral cortex: 1.2	Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	6	OE19: 27.5	Low region specificity	Detected in some			Not detected	Not detected			CAB000038	Enhanced				Secreted to digestive system				43000			CAB000038: 		unprognostic (1.27e-1)	unprognostic (4.27e-3)		unprognostic (1.12e-1)	unprognostic (1.07e-2)		unprognostic (2.75e-2)		unprognostic (5.68e-2)	unprognostic (2.11e-1)			unprognostic (2.85e-1)	unprognostic (3.17e-1)		unprognostic (9.07e-2)	0	0	0.1	0	0.4	0	0	0	1.2	0.1	1.7	6.9	0	2.4	7.3	0	0	0	2.6	0	0.1	0.3	0.2	0.1	0	0	0.1	0	0	0.1	0	0.1	5.1	0	0	0	0	0	0	0	0.1	0	0	0.1	0.3	529.2	0.1	0	8.6	0	0	0.2	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	2.2	0.1	0	0	0	0.2	0	0	0.3	0	0	4.3	0	0.2	0	0	0	0	0	0	0	0	0	0	2.7	0	0	0	0	0	0	0	0	0	0	0	0	27.5	0	0.5	0	0.3	0	0	0	0	0	0.1	0	0.8	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.4	0	1.2	0.1	0.3	0.1	0	0	0	0	0	0	0	0.3	0	0.2	0	0	0	0	0	0.4	0	0	1.3	0	0	0	0	0	0	0.1	0	0	1.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	7.3	0	0	0.1	Syncytiotrophoblasts
C6orf58	LEG1	ENSG00000184530	Chromosome 6 open reading frame 58	Q6P5S2	6	127519455-127591817	Predicted secreted proteins		Developmental protein		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	48	intestine: 98.4;salivary gland: 189.6;stomach 1: 54.2;tongue: 122.6	Cell type enriched	Detected in single	14	Early spermatids: 8.7	Group enriched	Detected in some	6	pancreatic cancer: 17.1;stomach cancer: 14.0	Not detected	Not detected			Cell type enhanced	Detected in single		naive B-cell: 1.0	Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		GAMG: 5.1;RPMI-8226: 6.4;WM-115: 4.6	Not detected	Not detected			Low region specificity	Detected in many			HPA036263, HPA041449	Enhanced				Secreted to digestive system				41000			HPA036263: AB_10673349, HPA041449: AB_2677486	unprognostic (1.49e-1)	unprognostic (8.55e-2)	unprognostic (2.71e-1)	unprognostic (5.69e-2)	unprognostic (3.86e-2)	unprognostic (2.54e-1)	unprognostic (1.37e-1)	unprognostic (2.09e-1)	unprognostic (1.02e-1)	unprognostic (3.26e-2)	unprognostic (7.72e-3)	unprognostic (1.69e-1)	unprognostic (6.62e-4)	unprognostic (2.10e-2)	unprognostic (2.31e-1)	unprognostic (1.53e-2)	unprognostic (8.99e-3)	0.1	0.1	0.1	0	0.1	0	0.1	0.1	0.1	0.1	0.1	0.4	0	98.4	0.1	0	2.4	0.1	0.4	0.1	0.1	0.1	0.1	0.1	2.3	0	0.1	0	0.1	1.8	0	0.1	0	0	0.1	0	0	189.6	0.1	0.1	0.1	0.1	0	0.1	0.1	54.2	0.2	0	0	0.1	122.6	1.7	0.1	0.1	1	0.3	0	0	0	0.1	0	0	0	0.2	0.2	0.2	0.5	0.2	0.1	0.3	0.3	0.2	0	0.9	0.2	0.4	0.5	5.1	0.1	0	0	0.8	0.8	0.1	0.1	0	0.1	0.3	0	0	0	0	1.4	0.1	0.2	0	0.5	0	0.1	0.5	0.2	0.4	0.9	0.3	0.2	0.2	0.2	0	6.4	0.6	0.1	0.2	1	0.3	0	0	0.2	0	0	0.3	1.4	0	0	1.7	0.1	0	0.1	0	0	4.6	0	0	0	0.1	0	0	0	0	0	0	1	0	0	0	0	0	0.3	0	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0.2	0	0	8.7	0	0	0	0.4	0	0	0	0	0	0.1	0	0	0	0	0.5	0.6	0	0	0	0	0.1	0.3	0	0	0	0	0	0	0.6	0.6	0.1	0.2	0	0	0.2	Early spermatids
DHRS7C	SDR32C2	ENSG00000184544	Dehydrogenase/reductase 7C	A6NNS2	17	9771434-9791297	Predicted intracellular proteins, Predicted secreted proteins		Oxidoreductase		Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	21	heart muscle: 44.0;skeletal muscle: 87.4;tongue: 40.1	Cell type enriched	Detected in some	5	Cardiomyocytes: 62.1	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	28	BJ hTERT+: 4.5;HeLa: 1.1	Not detected	Not detected			Not detected	Not detected								Secreted in other tissues												unprognostic (6.83e-2)													0.1	0	0	0	0	0	0	0	0.2	0	0.1	0	0	0	0	0.2	1.5	0	0	44	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.3	0	2.7	0	87.4	0	0.1	0	0	0	0	0.1	0	0	0.2	40.1	1.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0.1	0	0	0	0	0	0	0	62.1	0	0	0	0	0	0	0	0	3.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	12.8	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	Cardiomyocytes
PIWIL3	HIWI3	ENSG00000184571	Piwi like RNA-mediated gene silencing 3	Q7Z3Z3	22	24719034-24774720	Predicted intracellular proteins	Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis, Translation regulation	Developmental protein, RNA-binding		Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	7	testis: 4.7	Cell type enriched	Detected in some	13	Early spermatids: 21.0	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		BEWO: 2.8;HeLa: 1.6;RPMI-8226: 1.1									HPA061955	Uncertain											HPA061955: AB_2684647					unprognostic (9.05e-2)				unprognostic (2.20e-1)				unprognostic (3.12e-4)	unprognostic (2.73e-1)	unprognostic (7.33e-2)		unprognostic (1.72e-1)	0	0	0	0	0.1	0.2	0	0	0	0	0			0	0	0	0	0	0	0	0	0	0	0	0	0	0		0.4	0	0	0	0		0	0		0	0	0	0.5	0	0	0	0	0	4.7			0		0	0	0	0.1	0	0.6	0.2	0	0.1	0	0	0	0	0	0	0	2.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0.2	0.4	1.6	0	0	0	0.6	0	0	0	0	0	0	0	0.6	0.1	0	0	0	0	0.8	0	0	0	0	1.1	0	0	0.5	0	0.1	0.2	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0.6	0.2	0.2	0	0	0	0.1	0.1	0	0	0	0	0	0.1	0	0	0	0	0											0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	21	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.4	0.3	0	0	0	0	0	0	0	0.4	0	0	0	0	0.5	1.6	0	0	0	0	0	Early spermatids
PRSS55	CT153, T-SP1, UNQ9391	ENSG00000184647	Serine protease 55	Q6UWB4	8	10525546-10554166	Enzymes, Predicted intracellular proteins		Hydrolase, Protease, Serine protease		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	67	testis: 25.5	Cell type enriched	Detected in some	5	Early spermatids: 179.9	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Low region specificity	Detected in all								Intracellular and membrane											unprognostic (3.64e-1)	unprognostic (8.44e-3)					unprognostic (6.10e-2)	unprognostic (7.40e-2)		unprognostic (6.23e-5)	unprognostic (6.62e-2)				0	0	0.1	0	0.1	0	0	0.3	0	0	0	0	0	0	0	0.3	0	0	0	0	0.1	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	25.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.3	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	179.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	37.4	1.4	0	0	0	0	0	0.1	0	1.1	0	0	0	0	1.5	1.2	0	0	0	0	0	Early spermatids
LRRC26	bA350O14.10	ENSG00000184709	Leucine rich repeat containing 26	Q2I0M4	9	137168758-137170051	Predicted membrane proteins	Ion transport, Transport	Ion channel		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	4	salivary gland: 173.1	Cell type enriched	Detected in some	9	Mucus-secreting cells: 513.0	Cancer enriched	Detected in many	5	prostate cancer: 47.6	Not detected	Not detected			Cell type enriched	Detected in single	408	plasmacytoid DC: 40.8	Lineage enriched	Detected in single	408	dendritic cells: 40.8	Cell line enriched	Detected in some	6	RPMI-8226: 52.8	Not detected	Not detected			Not detected	Not detected			HPA056312	Approved		Supported	Nucleoli fibrillar center,Plasma membrane						Plasma membrane	Nucleoli fibrillar center	HPA056312: AB_2683098	unprognostic (1.75e-1)	unprognostic (2.28e-2)	unprognostic (1.04e-2)	prognostic favorable (4.82e-6)	unprognostic (3.39e-1)	unprognostic (1.67e-2)	unprognostic (1.82e-1)	unprognostic (2.13e-2)		unprognostic (1.98e-1)	unprognostic (1.06e-1)	unprognostic (1.75e-1)		prognostic favorable (3.48e-4)	unprognostic (3.27e-1)		unprognostic (2.29e-1)	0.1	0	0	1.3	0	0	2.1	0.7	0.1	0.3	6.8	0	11.2	1.2	0.3	0.1	0.7	0.3	0.4	0	0	0.1	0.1	0	0.3	0.1	0	0	0	0.8	0	0	0	0	15.4	0.4	0	173.1	20	0	1.3	4	0	0	0.1	1	0	0	0.7	0	10.3	4.6	0	0.1	0	40.8	0	0	0	0	0.1	0	0	0	0	0	0	1.1	0	0	0	0	0	0	0	0.3	0	0	0.2	0	0	0	2.2	0.3	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0.3	0	0.1	0.3	8.7	0	52.8	0	0	0.4	0.1	0.2	2.6	0	0	1.1	0.2	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	40.8	0	0.1	0	0	0.7	0	0	0.1	0	0	0	0	0	0	0.8	1.2	0.9	0	0.4	0	0	0	0	0	0	1.7	0	0.2	0	13.9	0	0.4	0	0.1	45.8	0	0	0.1	0	8.6	0	0	0.6	0	0	54	1	513	0	0.2	12.5	0	0	0	0	0	0.2	2.6	0.3	0	0	16.2	3.3	Mucus-secreting cells
DDX53	CAGE, CT26	ENSG00000184735	DEAD-box helicase 53	Q86TM3	X	22999961-23003589	Enzymes, Predicted intracellular proteins		Helicase, Hydrolase, RNA-binding		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	33	testis: 11.5	Cell type enriched	Detected in some	5	Early spermatids: 47.4	Cancer enhanced	Detected in single		testis cancer: 0.7	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		GAMG: 4.6;K-562: 6.3;RPMI-8226: 3.3;U-2197: 2.1;U-266/84: 14.1					Low region specificity	Detected in many			HPA003186			Supported	Nucleoplasm,Nucleoli,Cytosol						Nucleoplasm	Nucleoli, Cytosol	HPA003186: AB_1078637														unprognostic (5.76e-1)	unprognostic (1.12e-1)			0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	11.5	0	0	0	0	0	0	0	0.3	0	0.3	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	4.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	6.3	0.1	0	0	0	0	0	0	0	0	0	3.3	0	0	0	0	0	0	0	0	0	0.2	0	0	0	2.1	0	0.4	14.1	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0.3	0	0.2	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	47.4	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	6.2	0	0	0	0	0	0	0	0	0.4	0	0	0	0	10	8.8	0	0	0	0	0	Early spermatids
TCTE3	TCTEX1D3	ENSG00000184786	T-complex-associated-testis-expressed 3	Q8IZS6	6	169740114-169751587	Predicted intracellular proteins	Transport	Motor protein		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	4	testis: 23.6	Cell type enriched	Detected in many	5	Early spermatids: 126.4	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HL-60: 1.5;MCF7: 1.7					Low region specificity	Detected in many																unprognostic (1.29e-1)	unprognostic (1.70e-1)	unprognostic (1.69e-1)	unprognostic (2.22e-2)	unprognostic (1.05e-2)	unprognostic (6.15e-2)	unprognostic (1.70e-2)	unprognostic (2.63e-2)	unprognostic (5.11e-2)	unprognostic (1.87e-1)	unprognostic (6.11e-5)	unprognostic (1.58e-1)	unprognostic (2.04e-10)	unprognostic (1.16e-2)	unprognostic (1.89e-1)	unprognostic (1.35e-1)	unprognostic (3.56e-5)	0.9	1	1.3	3	3.8	1.2	1	3.8	3.8	0.9	1.3	0.4	1.2	0.9	1.1	0.9	0.9	0.9	0.9	0.9	3	0.8	1	0.9	0.9	0.9	4.2	0.8	1.6	0.9	0.9	4.9	0.9	2.8	1	0.9	0.7	1	0.9	0.9	1	1.1	1	2.7	1.1	0.9	23.6	2.9	1.8	1.1	0.4	1.1	1	5.3	0.7	0	0.2	0.2	0	0.4	0	0.1	0	0	0.6	0	0	0	0.8	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	1.5	0	0	0	0	0	0	0	0.2	0.1	0	0	1.7	0.3	0	0	0.2	0	0	0	0	0	0	0.1	0.4	0	0	0	0	0	0.3	0	0.2	0	0	0.2	0.7	0.5	0.4	0	0.3	0	0	0.2	0	0	0	0	0.4	0.4	0	0	0.7	0	0.1	0.2	0	0	0	0	0	1.3	3.8	3.8	3.8	3	0.8	4.2	0.8	2.8	2.9	0	1	5.4	5.7	0	5.8	1	2.5	1.4	3.4	8.7	19.6	1.2	0	0.8	126.4	2.2	0.8	0	0.7	1	1.7	2.4	3.5	0.9	1	11.1	1.2	2.5	7.5	17.6	6.4	0.8	0	0	1.1	4.8	0.4	0	4.2	0.9	9.8	6.5	0.8	24.1	7.5	0	1.4	3.8	1.8	3.5	Early spermatids
SLC22A10	hOAT5, OAT5	ENSG00000184999	Solute carrier family 22 member 10	Q63ZE4	11	63137867-63369718	Predicted membrane proteins, Transporters	Transport			Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enriched	Detected in some	32	liver: 41.7	Cell type enriched	Detected in some	13	Hepatocytes: 15.5	Cancer enriched	Detected in single	14	liver cancer: 6.0	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected																								unprognostic (1.17e-2)				unprognostic (9.77e-2)		unprognostic (7.07e-3)	unprognostic (7.46e-4)			unprognostic (7.62e-3)	unprognostic (2.87e-1)	unprognostic (1.56e-1)	unprognostic (6.52e-2)	unprognostic (4.25e-1)			0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	41.7	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0.5	0	0	0	0.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	15.5	0	0	0	0	1.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Hepatocytes
RFX6	dJ955L16.1, MGC33442, RFXDC1	ENSG00000185002	Regulatory factor X6	Q8HWS3	6	116877212-116932163	Disease related genes, Predicted intracellular proteins, Transcription factors	Differentiation, Transcription, Transcription regulation	Developmental protein, DNA-binding	Diabetes mellitus, Disease mutation	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in some		adrenal gland: 7.4;intestine: 9.2;pancreas: 8.3;stomach 1: 11.8	Cell type enriched	Detected in some	15	Intestinal endocrine cells: 65.8	Cancer enhanced	Detected in some		pancreatic cancer: 1.7	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	7	HEK 293: 5.4;U-266/70: 2.6	Not detected	Not detected			Not detected	Not detected			HPA037696	Approved											HPA037696: AB_2675616	unprognostic (2.92e-1)		unprognostic (4.66e-2)				unprognostic (2.49e-2)	unprognostic (1.55e-1)			prognostic favorable (3.59e-4)	unprognostic (2.59e-2)		unprognostic (1.63e-1)	unprognostic (1.25e-1)			0.1	7.4	0.1	0.8	0.1	0	4.5	0.1	0.4	0.2	6.9	0.2	0	3.4	0.1	0	0.3	0.1	1.3	0.1	0.1	0.1	0.1	0.1	1	0	0.1	0	0.1	8.3	0	2.1	1.5	0	0.5	2	0	1.2	4	0.1	0.1	9.2	0	0.1	0.1	11.8	0.9	0	0	0.1	0	0	0.4	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0.2	0	0	0	0	0	0	0	5.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0.5	0	0	2.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.1	0.4	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	4.5	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	65.8	0	0	0	0	0	0	0	0.5	0	1.1	0	0	0	0	0	0	0	0	0	1.9	0	0.2	0	Intestinal endocrine cells
F8	DXS1253E, F8C, FVIII, HEMA	ENSG00000185010	Coagulation factor VIII	P00451	X	154835788-155026940	Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Acute phase, Blood coagulation, Hemostasis		Disease mutation, FDA approved drug targets, Hemophilia	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	11	Ito cells: 376.3	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Cell line enhanced	Detected in many		U-2197: 15.0	Low region specificity	Detected in many			Low region specificity	Detected in many			CAB018777	Enhanced				Secreted to blood				6400000			CAB018777: AB_640320	unprognostic (2.09e-1)	unprognostic (5.66e-4)	unprognostic (4.94e-2)	unprognostic (8.32e-5)	unprognostic (1.26e-1)	unprognostic (5.05e-2)	unprognostic (6.05e-2)	unprognostic (8.27e-2)	unprognostic (6.58e-2)	unprognostic (1.68e-1)	unprognostic (1.67e-2)	unprognostic (5.58e-2)	unprognostic (1.24e-2)	unprognostic (2.16e-3)	unprognostic (1.69e-1)	unprognostic (1.17e-2)	unprognostic (4.44e-2)	48.9	9.4	6.8	3.1	7.2	1.5	32.2	1.5	8.6	11.9	10.3	2.2	6.1	2.3	11.1	8.5	18.4	5.4	4.4	38	4.9	4.4	17.1	31.3	24.4	25.6	5.6	1.2	18.8	7.2	6	14	2.8	5.1	20.5	3.5	8.8	4	7.1	30.3	2	4.3	12.8	3.3	39	3.2	17.2	1.8	1.1	15.8	15	3	17.5	20.2	2.3	3	5.2	3.3	4	12.9	2.7	4.8	3.9	0.8	1.8	6.1	9.6	0.2	2.6	1.7	1.9	3.1	0.1	5.8	10.4	7.3	2.7	4.2	0.5	0.9	0.9	1.7	4.2	1.5	2.2	2	0	2.9	1.7	5	6.8	0.5	1.6	2.2	3.3	1.1	5.1	0.8	8	9.1	2.3	1.4	1.6	1.2	1.5	4	1.2	1.3	1.4	1.7	1.1	3.2	2.4	6.3	0.6	3.3	1	1.4	4.3	1.1	9.5	4.8	15	2.8	4.7	3.9	5	8.7	10.8	5	3.7	3.3	0.5	6.5	2.8	12.9	2.3	3.9	6.8	3	1.6	2	5.1	5.2	4	2.6	0.4	5.2	2.7	6.8	7.2	1.5	8.6	4.9	4.4	5.6	1.2	5.1	1.8	0	4.6	2.2	1.5	1.5	7.9	14.6	12.7	2.7	2.3	3.5	2	0.9	6.6	2.3	0.9	33.2	0.5	0	0.6	0.7	2.8	1.7	1.1	9.2	2.9	6.4	0	376.3	25.4	1.9	10.6	3.2	0	1.8	0.7	6.5	6.9	0	4.9	8.4	3.3	6.5	3.3	1.6	2.5	1	0.1	4.9	0.4	0.9	Ito cells
C5orf47	LOC133491	ENSG00000185056	Chromosome 5 open reading frame 47	Q569G3	5	173973779-174006140	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	241	testis: 70.1	Cell type enriched	Detected in some	7	Spermatocytes: 567.4	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	7	U-266/84: 4.5					Low region specificity	Detected in many																unprognostic (7.54e-2)			unprognostic (4.81e-3)	unprognostic (3.81e-1)	unprognostic (1.64e-2)	unprognostic (1.31e-2)	unprognostic (3.94e-1)	unprognostic (8.72e-3)	unprognostic (2.00e-2)	unprognostic (2.82e-1)	unprognostic (4.09e-2)	unprognostic (3.03e-3)	unprognostic (2.59e-1)	unprognostic (2.63e-1)	unprognostic (2.99e-2)		0	0	0.1	0	0.2	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	70.1	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0.1	0	0.2	0	0	0	0	0.6	0	0	0	0	0.3	0	0	0	0	0.1	0	0	0.1	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0.1	0.1	0.1	0.2	0	0	0.1	0	0	0.5	0.2	0	0.1	0.5	0.2	0	0	0	0	0	0.1	0	0.5	4.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0.1	0.1	0.2	0	0.2	0	0	0.1	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	81.2	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	15.2	6.4	0	0	1	0	1	0	0	1.4	0.2	0	0	0	567.4	86.7	0	0	0	0	0	Spermatocytes
NPY2R		ENSG00000185149	Neuropeptide Y receptor Y2	P49146	4	155208629-155217078	G-protein coupled receptors, Predicted membrane proteins		G-protein coupled receptor, Receptor, Transducer		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		brain: 10.2;breast: 4.1	Cell type enriched	Detected in some	11	Leydig cells: 19.5	Cancer enhanced	Detected in single		glioma: 1.0	Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		A549: 2.6;ASC diff: 3.6;HSkMC: 1.7;SH-SY5Y: 12.9	Group enriched	Detected in many	5	amygdala: 13.5;basal ganglia: 13.1;hippocampal formation: 51.2;hypothalamus: 27.7	Region enriched	Detected in all	5	hippocampal formation: 19.7														unprognostic (7.14e-2)				unprognostic (4.36e-3)					unprognostic (7.08e-2)		unprognostic (5.50e-2)			unprognostic (9.35e-2)			0.8	1.1	3.4	1.3	6.9	0.1	4.1	0.1	8.6	0.4	2.7	1.8	0	1.1	0.2	0.4	0.2	0.5	0.2	0.7	7.3	5.5	0.3	0.1	0.2	0.2	0.8	0	0.4	0.1	0.1	0.2	0.2	7.8	0.5	2.8	0.2	2	0.2	0.1	0.5	1.5	0.6	10.2	0.6	0.3	2.5	0	0	0.1	0	0.3	0.2	0.1	0	0	0	0	0	0	0	0	2.6	0.2	0	3.6	0.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.7	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0.1	0	0	0	0	0	0	12.9	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.4	6.9	0.1	8.6	7.3	5.5	0.8	0	7.8	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.7	0	0	0	19.5	0	0	0	0	0	0	0	0.4	0	0	0	0	0.1	0.4	0	0	0	0	0	Leydig cells
NOMO2	NOMO, PM5	ENSG00000185164	NODAL modulator 2	Q5JPE7	16	18417325-18562211	Predicted intracellular proteins, Predicted membrane proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in some	14	Cardiomyocytes: 88.9	Low cancer specificity	Detected in all							Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low cell line specificity	Detected in all											HPA046697, HPA061174	Approved											HPA046697: AB_2679758, HPA061174: AB_2684444	unprognostic (2.58e-3)	unprognostic (4.11e-3)	unprognostic (2.58e-2)	unprognostic (9.10e-2)	unprognostic (1.74e-1)	unprognostic (2.85e-2)	unprognostic (4.80e-2)	unprognostic (9.37e-2)	unprognostic (1.34e-1)	unprognostic (3.47e-2)	unprognostic (1.09e-2)	unprognostic (1.78e-1)	unprognostic (1.78e-3)	unprognostic (2.22e-1)	unprognostic (3.42e-2)	unprognostic (8.39e-2)	unprognostic (1.54e-2)	5.6	6	5	3.6	6.7	3.6	4.4	11	13.2	5.4	6.3			5	6	10.1	4.4	4.5	3.2	16	5.5	8.4	4.6	8.2	6.9	2.7	6		4.5	21.4	19.6	6.7	8.4		6.7	6.1		5.8	5.6	12.8	5.6	4.4	7	4.4	4.3	7.2	3.2			6.6		4.4	5.6	3.7	10.6	20.9	13.2	13	7.3	20.1	15.5	14	20	7.7	21.4	29.9	18.2	23.2	24.6	29.5	20.9	26.1	17.5	21.6	16.7	89.2	42.9	14.7	16.3	16.3	17.1	18.4	13	12.9	7.2	21.5	62.6	41.6	17.2	51.9	19.1	22.6	24.4	22.2	22.4	22.9	13.8	10	37.5	24.7	42.2	6.4	38.2	14.8	21.2	8.3	13.5	10.4	45	31.2	11.9	10.6	8.7	19.1	26	15.8	16.4	20.6	36.9	21.2	12.5	9.8	25.3	16.8	19.2	21.6	8.9	28.5	18	17.3	13.2	11.1	10.1	13.5	11.1	10.9	10.6	13.7	13.9	13	7.7	9.2	11.8	12.8	7.3	13	20.9	20.1	15.5											6	3.2	0	0.1	0.3	0.8	88.9	0	2.7	2.3	0	3.9	0.3	1.7	0	0.1	0.1	0	0	0.6	0.2	0.5	0.3	0	0.8	0.1	0	0	1.3	1.5	0	0	0	0	0	0	0.2	0.4	0	0.4	0	0.5	6.5	1	0.5	1.3	0.5	0.3	0	0.2	0.1	Cardiomyocytes
TEX33	C22orf33, EAN57, MGC35206	ENSG00000185264	Testis expressed 33	O43247	22	36991120-37007841	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	465	testis: 49.1	Cell type enriched	Detected in some	5	Early spermatids: 731.7	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in single		CACO-2: 1.6	Not detected	Not detected			Not detected	Not detected			HPA005998	Enhanced											HPA005998: AB_1078352																		0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	49.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	1.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	731.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	161.1	4.4	0	0	0	0	0	0	0	2.5	0	0	12.9	0	3.1	2.1	0	0	0	0	0	Early spermatids
NOTUM		ENSG00000185269	Notum, palmitoleoyl-protein carboxylesterase	Q6P988	17	81952507-81961840	Enzymes, Predicted intracellular proteins, Predicted secreted proteins	Wnt signaling pathway	Hydrolase, Serine esterase		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	12	placenta: 127.4	Cell type enriched	Detected in some	47	Extravillous trophoblasts: 865.2	Low cancer specificity	Detected in many			Low region specificity	Detected in some			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	6	Hep G2: 96.3	Low region specificity	Detected in many			Low region specificity	Detected in many			HPA022851			Approved	Endoplasmic reticulum	Secreted in female reproductive system				59000	Endoplasmic reticulum		HPA022851: 	unprognostic (1.49e-1)	unprognostic (1.55e-1)	unprognostic (1.23e-2)	unprognostic (4.80e-3)	unprognostic (1.97e-1)	unprognostic (9.02e-3)	unprognostic (3.01e-2)	unprognostic (1.01e-2)	unprognostic (6.49e-2)	unprognostic (8.72e-2)	unprognostic (1.40e-1)	unprognostic (2.01e-2)	unprognostic (4.48e-6)	unprognostic (1.76e-1)	unprognostic (9.88e-2)	unprognostic (1.22e-3)	unprognostic (1.00e-1)	0.2	0.1	1.1	0.2	1.2	0.1	0.2	0.3	1	0.2	0.2	0.2	0.5	0.6	1	1.3	0.3	0.2	0.3	0.3	0.5	0.9	0.8	10.4	1.8	0.2	0.7	0.4	0.2	0.2	0	0.2	127.4	0.6	0.4	0	0.2	0.3	0.2	4.9	2.4	0.2	0.2	0.3	0.3	0.9	3	0.5	0.2	0.2	0.3	0.2	1.3	1.3	0.7	0	0	0	0	0.4	0.5	0	0.2	0	0	0	0	0.3	0	0	0	0	2.2	0.1	0	0.4	0	0	0.1	0.5	0	0	0	0.2	0.5	0.6	96.3	0	0.1	0	0	0	0	0	0.1	0	0	2.5	0	0	0.1	0	0	0	15.6	0.1	0	0	0	0	0	3.7	0.3	0.9	0.4	1.4	0.5	0	1.1	0	0.1	1.5	0	0	0	0	0.3	0	0	0	0	0	0	0.2	0	0	0	0.4	0	0	0.7	0.1	0	0	0	0	0	0	0.5	1.1	1.2	0.3	1	0.5	0.9	0.7	0.4	0.6	0.5	0	3	0	0.1	0.1	0	1.1	0	0	0	0	0	8.8	0	0	0.1	0	0	0	0	865.2	2.3	0	0	0.9	17.2	0	0	0	0	0	0.3	0	0	0	0	0	0.1	0	0	0	0	0	0	0.2	9.8	0	18.4	0	0	0	Extravillous trophoblasts
KLHL33		ENSG00000185271	Kelch like family member 33	A6NCF5	14	20425852-20436158	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	No human protein/transcript evidence	Evidence at transcript level		Tissue enriched	Detected in some	4	skeletal muscle: 39.2	Cell type enriched	Detected in single	215	Cardiomyocytes: 21.5	Not detected	Not detected			Not detected	Not detected			Cell type enriched	Detected in single	24	plasmacytoid DC: 9.3	Lineage enriched	Detected in single	24	dendritic cells: 9.3	Cell line enriched	Detected in some	9	REH: 9.5	Low region specificity	Detected in many							HPA049985, HPA056560	Enhanced											HPA049985: , HPA056560: AB_2683174	unprognostic (6.92e-2)	unprognostic (6.39e-2)	unprognostic (2.07e-1)	unprognostic (4.81e-1)	unprognostic (2.43e-1)	unprognostic (2.26e-1)	unprognostic (2.38e-3)	unprognostic (1.60e-1)	unprognostic (9.77e-2)	unprognostic (1.25e-1)	unprognostic (7.39e-2)	unprognostic (4.15e-2)	unprognostic (4.60e-2)	unprognostic (7.43e-3)	unprognostic (4.88e-3)	unprognostic (3.32e-5)	unprognostic (2.32e-1)	1.2	0.1	0.1	0.1	0.1	0	0.3	0.6	0.6	0.6	0.4	0.3	0.1	0	0.8	0.7	0.4	0.4	0.3	0.5	0.1	0.1	0.3	0.1	0.1	0.2	0.1	0.1	0.6	0.1	0.7	0.1	0.1	0.4	0.5	0	0.1	0.8	0.5	39.2	0	0.3	0.2	0.1	0.2	0.1	0.2	0.1	0.1	0.2	8.5	0.6	0.3	0.8	0.3	9.3	0.3	0.1	0.1	0.3	0.2	0.2	0	0.1	0	0	0.2	0.2	0.1	0	0.1	0.1	0.3	0.3	0.1	0.2	0.2	0.1	0.2	0	0	0.1	0.2	0	0.4	0.3	0.3	0.1	0.2	0.4	0.7	0	0	0	0	0.1	0.2	0.2	0.5	0	0	0.2	0.3	0.4	0.1	0	9.5	0.1	0.2	0	0.2	0.2	0.3	0	0.1	0.1	0.1	0.2	0.4	0.2	1	0.5	0.1	0.1	0.3	0.3	0.2	0.1	0.7	0.2	0.3	0.1	0	0.1	0.1	0.1	0.1	0.1	0.2	0	0.3	0.1	0.3	0.2	0.1	0	9.3	0	0.2	0.1	0.1	0.6	0.6	0.1	0.1	0.1	0.1	0.4	0.1	0	0	0	0	0	0	21.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Cardiomyocytes
SFTPA2	COLEC5, SP-A2	ENSG00000185303	Surfactant protein A2	Q8IWL1	10	79555852-79560402	Disease related genes, Predicted secreted proteins	Gaseous exchange		Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in some	225	lung: 501.0	Cell type enriched	Detected in some	10	Alveolar cells type 2: 14379.1	Cancer enriched	Detected in many	21	lung cancer: 863.5	Not detected	Not detected			Cell type enriched	Detected in single	11	plasmacytoid DC: 2.2	Lineage enriched	Detected in single	11	dendritic cells: 2.2	Group enriched	Detected in some	21	BEWO: 6.5;NB-4: 6.8;RPMI-8226: 21.7;U-2197: 13.1									CAB002439, HPA042638, HPA045752, HPA049368	Enhanced				Secreted in other tissues							CAB002439: AB_564143, HPA042638: AB_2678095, HPA045752: AB_2679442, HPA049368: AB_2680731	unprognostic (2.51e-1)	unprognostic (4.87e-2)	unprognostic (4.99e-2)	unprognostic (4.38e-2)	unprognostic (4.29e-2)	unprognostic (1.05e-1)		unprognostic (5.78e-2)	unprognostic (5.08e-1)	unprognostic (4.94e-2)	unprognostic (1.68e-3)	unprognostic (3.10e-1)	unprognostic (3.56e-2)	unprognostic (1.20e-1)		unprognostic (1.33e-1)	unprognostic (4.69e-3)	0.1	0.4	0.1	0.1	0.1	0	0.1	0.3	0.1	0.1	0.2	0.1	0.1	0	0.1	0.1	0.1	0	0.2	0.1	0.1	0	0.1	0.1	501	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	1.2	0	0.1	0.4	0.3	0.1	0	0.2	0.1	0.1	0.2	0.4	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0	2.2	0	0	0	0.2	0	0	0	0	0	0	0	6.5	0	0	0	0	0	0.5	0.3	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0.2	6.8	0.4	0	0	0.2	0	21.7	0	0.3	0.2	0.3	0	0.2	0	0	0.5	0	0	0	0.2	13.1	0.1	0.5	0	0.3	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	2.2	0	0	0.1	0.1	0.3	0.1	0.1	0	0.1	0.1	0.1	0.1	1479.9	14379.1	0	0	0	0	0	0	248.9	606.2	0	0	0	0	0.1	0.1	0	0	0	2.7	0	0	1	397.6	0	0	0	1.7	0	0	0	0	0	0	0	0.4	0	1.7	2.5	0	0	0	0	0	0	0	0	0	0	2.3	0	Alveolar cells type 2
FAM47A	MGC27003	ENSG00000185448	Family with sequence similarity 47 member A	Q5JRC9	X	34129756-34132314	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	127	testis: 12.7	Cell type enriched	Detected in some	5	Early spermatids: 9.5	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	6	REH: 1.5;U-266/84: 1.1									HPA000610	Uncertain											HPA000610: AB_1078805															unprognostic (1.68e-1)			0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	12.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	1.5	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0.1	1.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	9.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0	0	0	0	0	Early spermatids
PDE6G	PDEG, RP57	ENSG00000185527	Phosphodiesterase 6G	P18545	17	81650459-81663112	Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins	Sensory transduction, Vision	Hydrolase	Retinitis pigmentosa	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	5	retina: 260.3	Cell type enriched	Detected in many	6	Rod photoreceptor cells: 2889.5	Cancer enhanced	Detected in many		testis cancer: 10.6	Not detected	Not detected			Group enriched	Detected in many	5	basophil: 29.7;NK-cell: 57.8	Group enriched	Detected in all	5	granulocytes: 29.7;NK-cells: 57.8	Cell line enhanced	Detected in some		Hep G2: 6.3;NB-4: 6.7;NTERA-2: 11.6;REH: 13.5;SuSa: 8.6	Not detected	Not detected			Not detected	Not detected			HPA045118	Supported		Uncertain	Vesicles						Vesicles		HPA045118: AB_2732517	unprognostic (6.16e-2)	unprognostic (1.95e-2)	unprognostic (2.83e-2)	unprognostic (3.51e-3)	unprognostic (1.68e-1)	unprognostic (1.46e-2)	unprognostic (6.33e-2)	unprognostic (3.80e-2)	unprognostic (1.10e-2)	unprognostic (1.02e-1)	unprognostic (4.85e-2)	unprognostic (5.01e-2)	unprognostic (1.94e-2)	unprognostic (5.71e-2)	unprognostic (5.44e-2)	unprognostic (2.73e-1)	unprognostic (1.14e-1)	0.9	1.3	0.4	2.9	0.5	4.7	0.7	0.5	0.6	0.4	0.8	0.5	0.4	0	0.4	0.5	0.6	0.3	1.6	0.5	0.5	0.7	3.8	2.6	2	13.8	0.6	0.5	0.5	0.4	0	0.5	8.6	0.5	0.5	0.5	260.3	0.5	0.4	0.6	0.8	2.8	0.4	0.8	17.9	0.7	2.2	0.5	2.5	0.6	0.4	4.6	2.1	0.4	1.3	8.6	29.7	7.7	57.8	2.4	3.7	0.2	0.3	0.5	0	0.3	0	0	0.3	1.1	1.2	1.3	0.1	0.8	0.6	0.2	0.7	0.6	0.1	0.2	0.2	2.8	0.2	0	0.9	0.1	6.3	0.9	0.1	0.2	0	0.2	1.2	0	2.4	3.3	0.4	0.1	0.3	1.3	0.8	0.1	6.7	11.6	0	0.4	13.5	0.1	2	0	0	0.1	0.3	0	0.3	0.5	8.6	0.1	0.8	1.3	0.4	0.1	0.2	0.3	0.1	0.6	1	1.6	2.7	0.2	29.7	5.1	8.6	1.2	7.7	0.4	0.8	0.3	0.6	8.6	1.3	0.7	2.4	0.7	57.8	4.2	0.8	0	3.7	0.4	0.5	0.5	0.6	0.5	0.7	0.6	0.5	0.5	0.5	0	1.1	1.4	0	0.8	338	0	0	0	0	5.2	486.9	0.2	1.7	0.4	0.6	0	0	0	0.2	0.3	0.2	0.1	24.1	0	18.8	247.9	0	3.1	3.8	1.6	0	3.2	3.3	19.8	0	402.2	0.3	0	0	0.3	2889.5	0	0	0.7	0.2	1.3	0.2	2.1	0	0	Rod photoreceptor cells
SPATA8	MGC44294	ENSG00000185594	Spermatogenesis associated 8	Q6RVD6	15	96783389-96785615	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in single	292	testis: 172.8	Cell type enriched	Detected in some	8	Spermatocytes: 1040.7	Cancer enriched	Detected in single	11	testis cancer: 0.5	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		NTERA-2: 1.5;U-2 OS: 1.5;U-2197: 1.1;U-87 MG: 1.6																													unprognostic (7.61e-3)					unprognostic (8.45e-2)		unprognostic (1.94e-1)			0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	172.8	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0.2	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.5	0	0	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0	1.5	1.1	0	0	0	0	1.6	0	0.8	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	2.5	0	0	0	2	0.4	0	0	97.1	0	0	0	0	0.2	0	0	0	0	0.2	0	0	0	1.6	137.4	7.8	0	0	0	0	0.1	0	0	7.4	0	0.1	12.9	0	1040.7	4.1	0	0.1	0	0	0	Spermatocytes
PDIA2	PDA2, PDI, PDIP, PDIR	ENSG00000185615	Protein disulfide isomerase family A member 2	Q13087	16	283152-287215	Enzymes, Predicted intracellular proteins		Chaperone, Isomerase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	19	pancreas: 286.5	Cell type enriched	Detected in some	6	Exocrine glandular cells: 253.2	Cancer enriched	Detected in many	5	pancreatic cancer: 28.6	Region enhanced	Detected in many		cerebellum: 15.3	Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HAP1: 5.2;HEK 293: 11.6;Hep G2: 8.6;Karpas-707: 4.0;MCF7: 6.1;SH-SY5Y: 5.0	Not detected	Not detected			Low region specificity	Detected in some			HPA051692, HPA053492	Enhanced				Intracellular and membrane							HPA051692: AB_2681575, HPA053492: AB_2682169	unprognostic (3.46e-2)	unprognostic (7.98e-3)	unprognostic (3.01e-2)	unprognostic (1.30e-1)	unprognostic (2.21e-1)	unprognostic (2.17e-2)	unprognostic (6.27e-3)	unprognostic (1.11e-2)	unprognostic (3.98e-1)	unprognostic (1.76e-1)	unprognostic (4.42e-2)	unprognostic (2.90e-2)	unprognostic (1.58e-14)	unprognostic (3.06e-2)	unprognostic (1.66e-1)	unprognostic (8.75e-2)	unprognostic (2.87e-2)	0.3	0.3	2.1	0.2	1.5	0.3	0.2	15.3	3	0.2	0.7	4.3	0.2	2.9	0.2	0.3	0.2	0.2	0.8	0.4	2.8	3	0.2	0.2	0.2	0.2	4	0.5	0.4	286.5	0.2	0.2	0.5	2.2	0.2	0.2	0.2	0.3	0.2	0.2	0.2	1	0.2	5.4	0.2	10.2	0.3	2.8	0.1	0.2	0.2	0.3	0.2	0.1	0	0	0	0	0.2	0	0	0	1.3	0	1	0	0	0.2	0	0	0	0	0.7	0.1	0	0.1	0.1	0.1	0.1	5.2	0.2	0.7	0.1	11.6	0	0.3	8.6	1	0	0	0	0.4	0	0	1	0.2	0	0.4	4	0.2	6.1	0.2	0.6	0.4	2.1	0	0.1	0	1.1	0	0	2.2	5	0	0.1	0	0.7	1.5	0	0	0	0.5	0.2	0	0	0.1	0.2	0.4	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	2.1	1.5	15.3	3	2.8	3	4	0.5	2.2	2.8	0	0.3	0	0	0.5	1.8	0.6	0	0	0	0	0	0	0	0.4	0	0	0.9	0	253.2	0.6	1.2	0	0	0	0.3	0	0	0	0	0	0	0	0	2.8	1	0.2	39.2	0.3	0.4	0	0.5	0	0	0	0.2	0	0.5	0	0.9	0	Exocrine glandular cells
SMIM23	C5orf50, LOC644994	ENSG00000185662	Small integral membrane protein 23	A6NLE4	5	171782432-171796126	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enriched	Detected in single	166	testis: 21.6	Cell type enriched	Detected in some	5	Early spermatids: 170.3	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		U-2197: 1.5;U-266/70: 1.0																						unprognostic (6.47e-3)			unprognostic (1.71e-1)						unprognostic (7.80e-2)	unprognostic (1.15e-2)	unprognostic (3.79e-2)		unprognostic (2.72e-1)			unprognostic (5.36e-4)	0	0	0	0	0	0	0	0	0	0	0			0	0	0	0	0	0	0	0	0	0	0	0	0	0		0	0	0	0	0		0	0		0	0	0	0	0	0	0	0.1	0	21.6			0		0	0	0	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.5	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	170.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	36.1	0.9	0	0	0	0	0	0	0	0.4	0	0	0	0	1.4	0.7	0	0	0	0	0	Early spermatids
PMEL	D12S53E, gp100, Pmel17, SI, SIL, SILV	ENSG00000185664	Premelanosome protein	P40967	12	55954105-55973317	Predicted intracellular proteins, Predicted membrane proteins	Melanin biosynthesis			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	5	retina: 230.1	Cell type enriched	Detected in many	34	Melanocytes: 1396.9	Cancer enriched	Detected in many	500	melanoma: 2481.9	Not detected	Not detected			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enriched	Detected in some	66	SK-MEL-30: 442.3	Low region specificity	Detected in many			Low region specificity	Detected in many			HPA031649	Enhanced		Supported	Endoplasmic reticulum,Golgi apparatus	Intracellular and membrane				14000000	Endoplasmic reticulum	Golgi apparatus	HPA031649: AB_2673976	unprognostic (4.63e-1)	unprognostic (8.93e-2)	unprognostic (1.53e-1)	unprognostic (1.60e-1)	unprognostic (5.90e-2)	unprognostic (6.46e-2)	unprognostic (1.94e-1)	unprognostic (1.46e-3)	unprognostic (6.44e-2)	unprognostic (1.21e-1)	unprognostic (5.12e-2)	unprognostic (3.98e-1)	prognostic favorable (3.70e-4)	unprognostic (2.86e-2)	unprognostic (1.54e-1)	unprognostic (7.60e-2)	unprognostic (1.04e-1)	0.9	0.1	0.4	0.4	0.5	0.4	3.4	0.4	0.5	38.2	1	0.4	0.5	0.4	11.8	0.4	0.4	0.2	0.6	0.5	0.4	0	0.6	1.8	0.7	1.9	0.4	0.4	1.6	0.6	0.9	0.4	0.9	0.4	0.5	0.2	230.1	1.1	0.4	0.6	46.8	0.6	1.3	0.8	0.4	0.2	1.5	0.4	0.4	0.4	0.6	0.6	0.5	0.8	1.3	2.3	2.1	1.4	0.2	1.9	0.6	0.7	0	0.2	0	4.5	0	6.6	0	0	0.1	0.1	0.6	0.3	0.1	0.3	0	0	0.1	0	0	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0.9	0.1	0	0	0.1	0	0	0.1	0	0.1	0	0.1	442.3	0.2	0.2	0.4	0	0	0.3	0	0.4	0.1	0.5	0.1	0	0.1	0	0	1.4	0.7	0.3	0	1.9	1.3	0.5	0.4	0	0.9	1.1	0.1	2.1	0.2	0.4	2.3	0.4	0.6	0.4	0.5	0.4	0.5	0.4	0	0.4	0.4	0.4	0.4	0	0.3	0	0.6	40.8	0	0.2	2.5	0	2.3	0	0	8	0	1.3	6.7	0.6	1.3	0	2	12	2.4	0.7	0	2.4	1.5	0	0	0	0.3	4.1	11.2	0.3	1396.9	1	1.5	0.3	0.9	0	0.7	2.1	0	0	0.5	3	2.7	8.9	20.8	0	1.5	0.3	Melanocytes
PRAME	CT130, MAPE	ENSG00000185686	Preferentially expressed antigen in melanoma	P78395	22	22547701-22559361	Plasma proteins, Predicted intracellular proteins	Apoptosis, Differentiation, Growth regulation, Transcription, Transcription regulation	Repressor		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	5	testis: 54.3	Cell type enriched	Detected in some	8	Spermatogonia: 241.6	Group enriched	Detected in many	5	endometrial cancer: 73.4;melanoma: 139.6;ovarian cancer: 29.4;testis cancer: 51.7	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	5	K-562: 143.2					Not detected	Not detected			HPA045153, HPA068562	Enhanced		Approved	Nucleoplasm,Plasma membrane						Nucleoplasm	Plasma membrane	HPA045153: AB_10797259, HPA068562: 	unprognostic (9.36e-3)	unprognostic (9.74e-2)	unprognostic (1.02e-1)	unprognostic (3.87e-2)	unprognostic (5.20e-2)	prognostic unfavorable (3.41e-4)	unprognostic (3.43e-2)	unprognostic (4.00e-2)	unprognostic (1.33e-1)	unprognostic (6.52e-3)	unprognostic (9.68e-3)	unprognostic (2.06e-1)	prognostic unfavorable (7.48e-9)	unprognostic (1.95e-1)	unprognostic (2.21e-1)	unprognostic (8.87e-2)	unprognostic (1.26e-1)	0.1	1.7	0.1	0.3	0.3	0	0.1	0.3	0.1	0.2	0.3	0.1	0.5	0	2.8	10.9	0.1	0.2	0.1	0.3	0.2	0	0.7	0.1	0.1	0.1	0.1	0.1	2.2	0.1	0	0.1	0.4	0.4	0.1	0	0.2	0.1	0.1	0.1	0	0.1	0.1	0.8	0.2	0	54.3	0.1	0.3	0.1	0.1	0.4	0.2	0.1	0	0	0	0.1	0	0.5	0	0.1	9.4	0	19.8	0	0	5.1	0	0	0	0	0	0.1	0.5	14.2	0	0	0	0.6	0	0	8.6	2.1	5	3.7	0.1	0	0.4	27.3	0	0	0	0	0	0	2.2	143.2	2.3	0	1.2	0	0	0	4.2	0.6	0.8	0	0	0	0	0.1	29.4	0	0	0	0	4.3	3.5	0.7	0	25.8	0	0	0.4	2	0.1	0	0.1	3.7	0	0.1	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0.1	0.3	0.3	0.1	0.2	0	0.1	0.1	0.4	0.1	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	23.5	0	0	0	0	0.8	0	0	0	0	0.1	9.5	0	0	0	30.6	5.2	0	0	5.4	0	0.2	0.1	0	3.2	0.8	0.3	6.5	0	29.8	241.6	0	0	0	0	0	Spermatogonia
SRL		ENSG00000185739	Sarcalumenin	Q86TD4	16	4189374-4242080	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	17	heart muscle: 70.9;skeletal muscle: 104.1;tongue: 48.3	Cell type enriched	Detected in some	7	Cardiomyocytes: 216.0	Group enriched	Detected in some	5	head and neck cancer: 1.5;thyroid cancer: 5.9	Low region specificity	Detected in single			Cell type enhanced	Detected in some		basophil: 2.4	Low lineage specificity	Detected in single			Cell line enriched	Detected in single	13	HSkMC: 9.8					Low region specificity	Detected in some			HPA041535, HPA045520	Enhanced				Intracellular and membrane				26000			HPA041535: AB_2677538, HPA045520: AB_2679358	unprognostic (1.24e-2)	unprognostic (1.36e-2)	unprognostic (1.29e-1)	unprognostic (1.16e-2)	unprognostic (2.21e-1)	unprognostic (8.11e-2)	unprognostic (2.04e-7)	unprognostic (1.41e-1)	unprognostic (8.28e-2)	unprognostic (7.40e-4)	unprognostic (4.91e-2)	unprognostic (8.70e-2)	unprognostic (7.78e-4)	unprognostic (3.33e-2)	unprognostic (2.15e-1)	unprognostic (1.51e-3)	unprognostic (1.68e-4)	3.1	0.1	0.2	0.2	0.2	0	0.4	0.1	1	0.8	0.3	0	1.2	0.1	0.9	4.2	2.9	0.8	0.4	70.9	0.2	0.2	0.5	0.1	0.3	0.1	0.3	0.2	0.4	0.1	0.1	0.1	0.3	0.4	1.3	0.2	0.1	2.1	0.6	104.1	0.2	0.4	0.8	0.2	0.4	0.3	0.5	0.1	0.2	0.9	48.3	3.4	0.9	0.7	0.6	0.3	2.4	0.5	0.8	0.5	0.9	0	0.1	0	0	0	0	0	0	0.1	0	0.1	0.1	0.2	0.3	0	0	0	0	0	0	0	0	0.1	0.3	0.3	0.1	0	0.2	0.2	9.8	0	0	0	0	0.6	0.1	0.1	0.1	0	0.7	0	0.3	0	0	0	0.1	0.4	0	0.3	0	0.1	0	0	0.1	0	0.1	0.2	0.3	0	0	0	0.1	0	0.1	0.2	0.1	0	0.4	0	2.4	0.2	0.8	0.5	0.5	0.2	0.3	0.3	0.3	0.1	0.6	0.4	0.4	1.3	0.8	0.3	0.3	0.3	0.9	0.2	0.2	0.1	1	0.2	0.2	0.3	0.2	0.4	0.1	0	0	0	0	0.2	0.6	216	0	0	0	1.8	7.9	0	0	0	0	1.5	0	0	0	0	0.4	0.3	0	0	0	0	0	3.1	0.3	0	1.7	0	0	0	0	0.8	0.1	0	3.5	0	11.6	6.5	32	0	0.1	0.4	0	0	0	0	Cardiomyocytes
C11orf87	LOC399947, LOH11CR1A, NEURIM1	ENSG00000185742	Chromosome 11 open reading frame 87	Q6NUJ2	11	109422120-109429114	Predicted membrane proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	14	brain: 32.3	Cell type enriched	Detected in some	17	Horizontal cells: 19.1	Cancer enhanced	Detected in single		glioma: 0.7	Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	4	BJ hTERT+ SV40 Large T+: 4.0;fHDF/TERT166: 15.8;SCLC-21H: 4.1	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA034656	Approved											HPA034656: AB_10600788	unprognostic (5.42e-2)	unprognostic (2.09e-1)	unprognostic (2.28e-1)	unprognostic (8.55e-2)	unprognostic (3.87e-2)	unprognostic (1.85e-1)		unprognostic (1.63e-1)	unprognostic (1.55e-2)	unprognostic (1.62e-1)	unprognostic (2.44e-2)	unprognostic (2.45e-1)	unprognostic (5.28e-5)	unprognostic (8.38e-2)	unprognostic (9.65e-2)		unprognostic (2.72e-6)	0.7	1	5.8	0.7	18.1	0.7	0.8	2.7	32.3	2.3	0.8	1.5	0	0.8	2.2	1.2	0.8	1.1	0.7	0.7	8.3	3.8	0.8	0.7	0.7	0.7	2.5	12	0.7	0.7	0.7	0.3	0.8	11.1	0.9	0.7	0	0.8	0.8	0.7	0.8	0.7	0.8	1.2	2.2	0.8	0.8	0.1	0	0.7	0	0.7	0.7	0.2	0	0	0	0	0	0	0	0	0	0.7	0	0.3	0.6	0	0.1	0.2	4	1.9	0	0	0	0	15.8	0	0	0	0	1	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	1	0	0	0	0	0	0	0	4.1	0	0	0	0	0	0	0	0	0.1	0	1.3	0.2	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5.8	18.1	2.7	27.7	8.3	3.8	2.5	12	11.1	0.1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	19.1	0	0	0	0	0	0	0	0	0	0	0.1	0	1.1	0	0.3	0	0	0	0	0	0	0	0	0	Horizontal cells
NLRP9	CLR19.1, NALP9, NOD6, PAN12	ENSG00000185792	NLR family pyrin domain containing 9	Q7RTR0	19	55708432-55738402	Predicted intracellular proteins	Immunity, Inflammatory response, Innate immunity			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		prostate: 5.3	Cell type enriched	Detected in some	17	Extravillous trophoblasts: 21.1	Cancer enriched	Detected in single	59	testis cancer: 14.4					Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		BEWO: 3.3;HEK 293: 1.0;Karpas-707: 1.2;U-266/84: 1.3					Not detected	Not detected			HPA042623	Uncertain											HPA042623: AB_10965692	unprognostic (2.50e-1)	unprognostic (3.03e-1)	unprognostic (1.74e-1)	unprognostic (2.85e-1)	unprognostic (8.82e-2)	unprognostic (6.53e-2)	unprognostic (9.92e-3)	unprognostic (1.63e-1)	unprognostic (9.55e-2)	unprognostic (3.68e-1)	unprognostic (1.17e-1)	unprognostic (1.40e-1)	unprognostic (4.56e-3)	unprognostic (2.73e-1)	unprognostic (3.46e-1)	unprognostic (9.56e-2)	unprognostic (8.09e-3)	0.1	0.2	0	0.2	0.5	0.7	0.1	0.5	0.1	0.1	0.3			0.2	0.4	0.7	0.1	0.4	0.2	0.1	0	0	1	0.9	0.4	0.2	0		0.7	0.8	0.1	0.6	0.1		5.3	0.1		0.1	0.2	0.1	0.4	1.2	0.1	0	0.9	2	1.9			0.2		0.1	0.1	0	0	0.2	0.7	0.2	0	0	0	0	0	0	0.1	0	0	3.3	0	0	0	0	0.1	0.1	0.2	0	0	0	0.2	0	0	0	0	1	0	0	0	0	0	0.2	0	0	0	0	0	0	0.6	0.2	1.2	0	0	0	0.1	0.2	0.2	0	0.1	0.9	0.6	0	0	0	0.1	0	0	0.1	0	0	0	0	0	0.1	0.1	0	0.4	1.3	0.3	0	0.2	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0.2	0	0											0	0	0	0	0	0	0.4	0	0	0	0	0	0.3	0	0	0	0	0	0	0	21.1	0	0.2	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	1.3	0	0	0	Extravillous trophoblasts
CCDC190	C1orf110, MGC48998	ENSG00000185860	Coiled-coil domain containing 190	Q86UF4	1	162824458-162868815	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in some		esophagus: 8.3;lung: 7.2;tongue: 7.5	Cell type enriched	Detected in some	27	Ciliated cells: 48.2	Low cancer specificity	Detected in some			Low region specificity	Detected in some			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		hTEC/SVTERT24-B: 4.1;hTERT-RPE1: 5.1;HUVEC TERT2: 5.0;LHCN-M2: 7.6;TIME: 17.3;U-2197: 9.3	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA028579, HPA028584, HPA028592	Uncertain		Approved	Vesicles						Vesicles		HPA028579: AB_10610978, HPA028584: AB_10599423, HPA028592: AB_10601001	unprognostic (4.29e-1)	unprognostic (8.37e-2)		unprognostic (1.75e-1)	unprognostic (5.47e-2)	unprognostic (1.68e-2)		unprognostic (8.33e-3)		unprognostic (3.04e-2)	unprognostic (3.09e-2)	unprognostic (6.41e-2)	unprognostic (7.41e-5)	unprognostic (2.64e-1)	unprognostic (1.52e-1)	unprognostic (5.26e-1)	unprognostic (1.70e-1)	0.2	0.1	1.1	0.2	1.7	0	0.2	0.2	0.9	0.3	0.2	0.2	0.2	0	0.2	0.8	8.3	1.1	1.3	1	1.2	0.7	0.2	0.2	7.2	0.2	0.4	0.2	0.2	0.2	0	0.2	0.2	0.2	0.2	0	0.2	0.2	0.3	0.5	0	0.2	0.2	0.3	0.2	0.1	0.7	0.2	0.6	0.2	7.5	2.4	0.3	0.2	0.1	0.2	0.5	0	0	0	0	0.1	0	0	0	0.1	1.9	0	0.2	0.2	0.4	0.2	0	0	0	0.3	0.2	0.1	0.1	0	0	1.8	0	0	0	0	0	0	0	0	2.1	0	4.1	2.6	5.1	5	0	0	0	7.6	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	17.3	0.4	0	9.3	0.2	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0.2	0.1	0	0	0.5	0	0	0	0	0	1.1	1.7	0.2	0.6	1.2	0.7	0.4	0.2	0.2	0.2	0	0.3	0	0.4	0	0	0	0	48.2	0	1.8	0	0	0	0	1.8	0	0	0	0	0	0	0.5	0	0	0.1	0	0	0.6	0	0.2	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0.2	0	0	0	0	0.3	Ciliated cells
NPIPB4		ENSG00000185864	Nuclear pore complex interacting protein family member B4	C9JG80	16	21834569-21880827	Predicted intracellular proteins, Predicted membrane proteins				Evidence at protein level	Evidence at protein level	No human protein/transcript evidence	Evidence at transcript level		Tissue enhanced	Detected in all		skin 1: 31.2	Cell type enriched	Detected in many	7	Early spermatids: 92.2	Low cancer specificity	Detected in some							Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low cell line specificity	Detected in all											HPA053611	Approved		Approved	Nucleoplasm						Nucleoplasm		HPA053611: AB_2682206	unprognostic (3.09e-3)	unprognostic (3.51e-3)	unprognostic (4.01e-2)	unprognostic (1.35e-1)	unprognostic (1.02e-1)	unprognostic (1.18e-3)	unprognostic (2.03e-1)	unprognostic (1.35e-1)	unprognostic (6.82e-2)	unprognostic (3.66e-1)	unprognostic (1.76e-1)	unprognostic (4.05e-3)	unprognostic (6.04e-8)	unprognostic (3.37e-1)	unprognostic (7.78e-2)	unprognostic (2.32e-1)	unprognostic (5.46e-3)	5.5	3.7	4.4	7	4.6	23.5	6.1	10.4	5.4	5.1	6.5			4.5	5.4	22.4	4.5	5.7	4.9	4.2	5	4	5.4	6.6	6	10.7	3.8		5.9	5.3	3.3	5.4	3.8		6.6	8.2		5.5	3.2	7.1	31.2	8.6	3.5	4.4	10.1	7.3	4.3			7.9		7.5	4.1	5.4	6.3	3.7	4.7	2.5	5.2	2.3	0.3	7.1	9.7	9.3	7.3	6.7	9.7	15.7	8.8	2.7	3	4.9	20.6	10.2	13.8	6.8	7.6	2.8	8.2	5.2	7.4	6	5.6	4.7	5.5	24.8	27.2	4.5	22.6	14.6	7.2	9.2	8	13.3	6.1	6.5	11.3	11.8	12.2	4.5	20.9	8.5	14.2	11.3	2.3	5.4	13	5.6	8	3.4	7.1	9.4	5.7	5.9	6.8	4.8	9.3	9	6.8	14.2	16	8	7.6	7.6	6.3	5.8	14.7	5	10.8	7.4	4.7	2.5	0.7	1.8	1	1.3	2.2	2.3	1.1	0.4	6.3	1.8	1.9	3	5.2	1.2	3.7	0.6	0.3											3	12.6	2	1	6.8	4.7	1.5	0	6.7	10.3	0	3.9	0.4	0	0.9	92.2	4.2	1.1	0	0.5	0.2	5.9	0.4	10.4	1	0.6	1.6	1.2	1.8	0.8	13.6	0.3	3	0	2.8	1.1	1.9	1.2	2.3	0.4	0	7.1	0	2.9	1.6	0.5	7.3	0.7	2.2	1.7	0.5	Early spermatids
ZNF829	DKFZp779O175	ENSG00000185869	Zinc finger protein 829	Q3KNS6	19	36888124-36916291	Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	DNA-binding		Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		testis: 20.1	Cell type enriched	Detected in many	8	Early spermatids: 241.5	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		U-266/84: 15.0									HPA073073			Approved	Nucleoplasm,Nuclear bodies		No	No			Nucleoplasm	Nuclear bodies	HPA073073: AB_2686567	unprognostic (4.55e-2)	unprognostic (2.34e-1)	unprognostic (5.63e-2)	unprognostic (3.44e-4)	unprognostic (1.32e-1)	unprognostic (6.46e-2)	unprognostic (8.20e-2)	unprognostic (1.33e-2)	unprognostic (9.35e-4)	unprognostic (1.20e-2)	unprognostic (3.57e-2)	unprognostic (3.39e-2)	unprognostic (3.48e-4)	unprognostic (5.47e-3)	unprognostic (1.64e-1)	unprognostic (1.73e-1)	unprognostic (8.92e-4)	2.6	2.8	4.9	2.4	5.9	1.9	4.3	8	4.8	2.9	2.6	2.3	5	1.7	3.6	2	2.2	3.1	1.8	2.4	3.3	2.5	2.6	1.8	2.2	2.8	6.4	2.9	5.3	2.1	3.8	3.4	3.6	3.3	3.6	1.6	1.6	2.6	3	1.9	3.5	2.1	4.8	4.4	2.8	2.3	20.1	5.1	3.4	5.2	1	2.9	3.1	4.7	3.3	1.4	4.2	0.8	2.1	4.9	1	0	1.2	3.3	0.1	1.8	2.8	1.4	3.7	2.2	4.6	7.1	0.1	0.6	0.1	4.4	2.3	4.3	0.7	0	2.7	5.4	0	5.3	1.9	0.1	0.1	1.8	0	5.2	2.8	2.6	5.1	0	1.5	0.5	1.4	0	0.1	5	0.8	0.7	0.8	5.5	0	0	0	4.5	1.7	1.3	5.5	3.8	5.6	0.1	0	3.1	4.9	3.5	0.3	1.4	3	3.9	3.8	4	9.8	15	6.3	0	0.1	6.9	4.2	0.6	2.9	3.2	0.7	4.2	2.2	3.2	4.9	1	3.3	4.1	4.2	1.3	2.1	0.8	1.4	3.2	1	4.9	5.9	8	4.8	3.3	2.5	6.4	2.9	3.3	5.1	0	4.3	1.3	1.8	1.3	5.8	4.6	5.1	1.4	5.7	3.5	3.9	3.2	0	2.3	241.5	3.9	0	0	0.9	2.1	2.8	1.6	1.1	0	1.4	11.1	0	1.3	0.3	29.7	5.5	2.5	3.3	1.8	0.9	2.4	0.8	0	6.7	1.1	11.3	0	2.3	9.5	10	2.4	3.5	2.9	0.4	0.7	Early spermatids
FAM186A	LOC121006	ENSG00000185958	Family with sequence similarity 186 member A	A6NE01	12	50326230-50396622	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	6	testis: 19.3	Cell type enriched	Detected in some	16	Early spermatids: 388.2	Not detected	Not detected			Not detected	Not detected			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Low cell line specificity	Detected in some											HPA047128	Uncertain											HPA047128: AB_10967726	unprognostic (1.01e-1)	unprognostic (1.29e-1)	unprognostic (1.25e-1)	unprognostic (2.31e-1)	unprognostic (1.88e-1)	unprognostic (3.69e-2)	unprognostic (3.48e-3)	unprognostic (1.43e-2)	unprognostic (1.30e-2)	unprognostic (6.96e-2)	unprognostic (4.65e-5)	unprognostic (1.93e-1)	unprognostic (2.42e-5)	unprognostic (1.65e-1)	unprognostic (1.32e-1)	unprognostic (7.51e-2)	unprognostic (3.22e-3)	0.2	0.2	0.4	0.3	0.8	0.9	0.2	0.9	0.8	0.2	0.2	0.2	0.2	0.1	0.2	1.2	0.2	0.1	0.2	0.3	0.4	0.4	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0	1	0.2	0.2	0.2	0.2	0.2	0.4	0.2	2	0.8	0.3	0.2	0.2	0.3	0	19.3	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.8	0.9	3.1	1.5	1.8	1.4	0.3	0.6	0.3	0.2	2.1	0	0	1	0.3	0	0.1	0	0.2	1	0.8	0.7	0.6	0.7	0.3	0.1	0.2	0	1.2	0.8	0.4	1	1	0.4	0.6	0.9	1	0.3	0	0.2	0.5	0	0.7	0.9	1.6	1	1.7	0.2	0.8	0.9	0.3	0.2	0.7	0.5	0.2	0.1	1.3	0.4	0.2	0.4	0.4	0.2	0.2	1.1	0.3	0	0.6	0.9	0.5	0.5	1.2	0.5	0.8	0.9	0.1	0.2	2.4	1.5	1.2	1.4	0.7	0.8	0.5	0.8	0.5	0.2	0.8	0.9	1.2	3.1	1.8	0.6	0.9	0.4	0.3	0.4	0.8	0.9	0.8	0.4	0.4	0.2	0.2	0.2	0.2	0	0	0	0	0	0.5	0.8	0	0	0	0	0	0	0	0	388.2	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	24.3	0.6	0	0	0	0	0.3	0	0	0.7	0	0.6	0	0	1.5	0.5	0	0	0	0	0	Early spermatids
SHOX	GCFX, PHOG, SHOXY, SS	ENSG00000185960	Short stature homeobox	O15266	X	624344-659411	Disease related genes, Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	Activator, Developmental protein, DNA-binding	Disease mutation, Dwarfism	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		brain: 6.3;breast: 13.9	Cell type enriched	Detected in single	6	Cardiomyocytes: 1.4	Not detected	Not detected			Region enhanced	Detected in some		pons and medulla: 6.3	Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Group enriched	Detected in some	4	BJ: 19.5;BJ hTERT+: 9.0									HPA035141, HPA060931			Enhanced	Nucleoplasm,Vesicles						Nucleoplasm	Vesicles	HPA035141: AB_2674489, HPA060931: AB_2684388	unprognostic (7.51e-3)	unprognostic (1.99e-1)	unprognostic (3.08e-2)	unprognostic (2.23e-1)	unprognostic (4.00e-1)	unprognostic (6.82e-2)			unprognostic (2.45e-2)	unprognostic (2.34e-1)	unprognostic (9.24e-2)	unprognostic (9.95e-2)	unprognostic (5.67e-6)	unprognostic (1.99e-1)	unprognostic (1.71e-1)	unprognostic (9.14e-2)	unprognostic (1.38e-1)	3.8	1	0.3	0.7	0.3	3	13.9	1.8	0.8	0.3	0.4	0.2	0.2	1.4	0.3	0.6	0.3	0.4	0.4	0.4	0.7	0.3	0.3	0.3	0.3	0.6	0.3	1.4	0.3	0.9	0	0.3	4.8	6.3	0.8	0.3	0.2	1.4	0.2	2.8	1.4	1	0.2	0.4	1.6	0.4	0.4	0.2	0.2	0.5	0.2	0.2	0.3	0.3	2.2	1.9	5.5	1.8	2.5	1.5	0.8	0.1	0.2	0.1	0.2	0.2	0.1	3.2	19.5	9	2.9	3.2	0.3	0.3	0.3	0.1	0.4	0.8	0.3	0.2	0	1	0.2	0.1	0.1	1.3	0.1	0.1	0.1	0.4	0.6	0	0	0	0.1	0	0.2	0.2	0.8	0.1	0.2	0.1	0.2	0.1	0	0.4	0.1	0.3	0.2	0	0.2	0.2	0	0.1	0.1	0.1	0.2	0.6	0	0.1	0.3	0.2	0.1	0.1	0.9	0.1	0.3	0.1	0.2	0.1	5.5	1.8	1.8	1.4	1.1	1.5	1.6	1.1	1.2	0.5	2.2	1.5	1.5	5.2	2.5	1.5	1.9	1	0.8	0.3	0.3	1.8	0.4	0.7	0.3	0.3	1.4	6.3	0.2	0	0	0	0	0.1	0	1.4	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0.2	0.1	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0.1	Cardiomyocytes
CCIN	BTBD20, KBTBD14	ENSG00000185972	Calicin	Q13939	9	36169394-36171334	Predicted intracellular proteins	Differentiation, Spermatogenesis	Developmental protein		Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	39	testis: 72.9	Cell type enriched	Detected in some	5	Early spermatids: 864.3	Not detected	Not detected			Not detected	Not detected			Cell type enriched	Detected in single	6	myeloid DC: 1.8	Lineage enriched	Detected in single	6	dendritic cells: 1.8	Cell line enhanced	Detected in some		BEWO: 3.6;BJ: 5.5;fHDF/TERT166: 6.6;hTEC/SVTERT24-B: 8.2;TIME: 11.0	Not detected	Not detected			Not detected	Not detected																unprognostic (5.10e-2)	unprognostic (9.26e-3)	unprognostic (6.27e-2)	unprognostic (8.26e-6)	unprognostic (1.78e-2)	unprognostic (5.38e-2)	unprognostic (1.57e-2)	unprognostic (7.74e-3)	unprognostic (5.43e-3)	unprognostic (4.49e-2)	unprognostic (1.77e-1)	unprognostic (1.36e-1)	unprognostic (5.98e-5)	unprognostic (3.27e-3)	unprognostic (7.86e-2)	unprognostic (1.07e-1)	unprognostic (2.43e-3)	0.2	0.2	0.1	0.1	0.1	0.6	0.1	0.1	0.1	0.4	0.1	0.1	0.1	0	0.7	0.5	0.1	0.1	0.2	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.2	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.1	1.1	0.1	0.1	0	72.9	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	1.8	0	0.3	0	0.1	0	0	0	0	0	0.2	1.4	3.6	5.5	0.5	0.1	0.2	0	0	0	1.5	6.6	0	0	0	0	0.1	0	0	0	0.1	0	0	0	0	0	0	8.2	0	0	2.2	0	0	0	2.8	0.1	0	0	0	0	0.6	0	0	0	0	0	0.6	0	0	0	0	1.1	0	0	11	0.1	1.8	0.3	2	0	0	0	0.3	0	0	0	0.1	0	0	0	0	0	0.1	0	1.8	0	0	0	0	0	0.3	0	0	0	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	864.3	0	0	0	0	0	0	0	0	0	0.3	0	0	0.6	1.6	184	2.8	0	0	0	0	0	0	0	3.5	0	0	6.5	0.1	4.2	2.6	0	0.1	0	0	0	Early spermatids
SLITRK2	CXorf1, CXorf2, KIAA1854, SLITL1, TMEM257	ENSG00000185985	SLIT and NTRK like family member 2	Q9H156, O96002	X	145817832-145829856	Predicted membrane proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 25.1	Cell type enriched	Detected in some	9	Muller glia cells: 226.8	Cancer enhanced	Detected in some		glioma: 5.4	Low region specificity	Detected in all			Cell type enhanced	Detected in single		basophil: 1.5	Low lineage specificity	Detected in single			Cell line enriched	Detected in single	35	HAP1: 21.7	Low region specificity	Detected in all			Low region specificity	Detected in all												26000				unprognostic (2.13e-1)	unprognostic (1.12e-1)	unprognostic (2.73e-3)	unprognostic (6.79e-6)	unprognostic (3.39e-1)	unprognostic (1.68e-1)	unprognostic (2.89e-4)	unprognostic (6.23e-2)	unprognostic (3.60e-1)	unprognostic (1.29e-1)	unprognostic (1.50e-2)	unprognostic (3.53e-2)	unprognostic (4.13e-8)	unprognostic (3.12e-3)	unprognostic (2.18e-2)	unprognostic (1.14e-1)	unprognostic (1.14e-2)	1.6	1.5	12.8	1.2	16.4	0.9	1.2	4.3	25.1	1.7	1.2	13.3	0	1.1	1.1	1.1	1.1	4.9	1.1	1.6	12.1	3.5	1.4	1	2.2	1.6	11.3	9.2	1.1	1.8	0.9	1.1	0.9	10.4	1.4	1.4	5.6	1.3	8.5	1.2	3.9	1.3	1.5	12.6	7.4	1	1.2	11.5	0	1.1	0	0.9	1.3	1.1	0.3	0.3	1.5	0.3	0.4	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	21.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0.1	0	0	0	0.1	0	0.2	0	0.1	0	0	0	0.5	0.1	0	0	0	0.1	0.6	0	0.5	0	0	0	0	0	0	1.5	0.1	0.4	0.2	0.2	0.3	0.1	0.2	0.2	0	0.3	0.3	0.2	0.6	0.4	0.3	0.3	0.2	0	12.8	16.4	4.3	14.6	12.1	3.5	11.3	9.2	10.4	11.5	0	0	0	0	1	4.7	0.8	0	0	0	0	0	0	1.7	0	0	0	0	0	0	0	0.4	0.1	0	0	0	6.4	1.7	1.8	0	0	0	0	25.3	0	0	226.8	0	0	0	0	9.5	0	0.5	0	0	1.3	0	0	0	0	Muller glia cells
ATP4B	ATP6B	ENSG00000186009	ATPase H+/K+ transporting beta subunit	P51164	13	113648804-113658186	FDA approved drug targets, Predicted membrane proteins, Transporters	Cell adhesion, Hydrogen ion transport, Ion transport, Potassium transport, Transport		FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	24	stomach 1: 156.3	Cell type enriched	Detected in single	6	Distal tubular cells: 1.7	Cancer enriched	Detected in some	12	stomach cancer: 8.9	Region enriched	Detected in single	9	cerebral cortex: 1.0	Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		REH: 3.9;RPMI-8226: 1.6;SCLC-21H: 2.6	Not detected	Not detected			Not detected	Not detected			HPA045400, HPA052649	Enhanced											HPA045400: AB_2679314, HPA052649: AB_2681900	unprognostic (9.92e-2)	unprognostic (2.19e-1)		unprognostic (2.66e-1)	unprognostic (4.86e-1)			unprognostic (6.43e-3)	unprognostic (7.81e-3)	unprognostic (1.95e-1)	unprognostic (3.22e-1)	unprognostic (6.50e-2)	unprognostic (6.65e-4)	unprognostic (2.25e-1)	unprognostic (2.78e-1)	unprognostic (3.78e-2)		0.1	0	0.1	0.1	0.1	0	0.1	0.1	1	0.1	0.1	2	0.1	0	0.1	0.1	1.5	1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	6.5	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	156.3	0.1	0.1	0.6	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0	0.8	0	0.2	0	0.2	0.1	0	0	0.2	0.2	0	0	0	0	0	0.3	0.3	0	0	0	0	0	0	0	0	0.2	0.1	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0.1	0	0	3.9	0	1.6	0	0	2.6	0.9	0.2	0.7	0	0	0.1	0.8	0	0	0.2	0.1	0	0	0	0	0	0	0.3	0	0	0	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.1	1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0.1	0	0	0.3	0	0	0	0	0	0	1.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	Distal tubular cells
HTR3E		ENSG00000186038	5-hydroxytryptamine receptor 3E	A5X5Y0	3	184097064-184106995	FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins	Ion transport, Transport	Ion channel, Ligand-gated ion channel, Receptor	FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in some	6	intestine: 7.0	Cell type enriched	Detected in single	24	Intestinal endocrine cells: 3.4	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	6	RH-30: 5.5									HPA049764	Enhanced											HPA049764: AB_2680869		unprognostic (4.12e-2)	unprognostic (5.86e-2)	unprognostic (2.15e-1)		unprognostic (4.57e-4)		unprognostic (3.61e-3)		unprognostic (1.15e-1)	unprognostic (3.16e-1)	unprognostic (4.47e-1)		unprognostic (3.32e-1)	unprognostic (2.67e-1)		unprognostic (4.16e-2)	0	0	0.1	0	0	0	0	0	0.1	0	5.7	0	0	4	0	0	0	0	0	0	0	0	0	0	0.1	0.2	0	0	0	0.1	0	0	1.1	0	0.1	0.4	0	0	0	0	0	7	0	0	0	0.2	0.3	0	0	0	0	0	0.1	0	0	0	0.3	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0.4	0.1	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0.1	0	0	0	5.5	0	0	0	0	0	0	0.1	0	0	0.9	0	0	0	0	0	0	0.4	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0.3	0	0	0	0	0	0.1	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	3.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0.1	Intestinal endocrine cells
CYP4F2		ENSG00000186115	Cytochrome P450 family 4 subfamily F member 2	P78329	19	15878023-15898120	Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins	Fatty acid metabolism, Lipid metabolism	Monooxygenase, Oxidoreductase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	7	intestine: 69.1;liver: 102.9	Cell type enriched	Detected in some	8	Hepatocytes: 132.0	Cancer enriched	Detected in some	9	liver cancer: 29.6	Not detected	Not detected			Cell type enriched	Detected in single	12	basophil: 8.5	Lineage enriched	Detected in single	86	granulocytes: 8.5	Cell line enriched	Detected in some	4	Hep G2: 9.0									HPA014048, HPA017265, HPA058960	Supported				Intracellular and membrane							HPA014048: AB_1847452, HPA017265: AB_1847451, HPA058960: AB_2683862	unprognostic (7.46e-3)	unprognostic (3.58e-1)	unprognostic (3.01e-1)	unprognostic (9.39e-2)	unprognostic (1.74e-1)	unprognostic (2.87e-2)	unprognostic (4.55e-3)	unprognostic (6.52e-2)	unprognostic (2.05e-1)	unprognostic (4.64e-2)	unprognostic (9.82e-2)	unprognostic (2.92e-1)	unprognostic (8.69e-4)	unprognostic (3.24e-1)	unprognostic (1.89e-1)		unprognostic (7.79e-3)	0.1	0.1	0.2	0.5	0.1	0	0.2	0.1	0.2	0.2	10.1	0.2	0.1	24.5	0.1	8.8	0.2	0.1	1.8	0.1	0.2	0.1	11.9	102.9	0.1	0.1	0.1	0.1	0.1	0.2	0	0.1	0.1	0.2	1.9	0	0.1	0.1	0.2	0.1	0.5	69.1	0.1	0.2	0.2	0.2	0.3	0.1	0.1	0.1	0.1	0.1	0.4	0.3	0	0	8.5	0	0	0	0	0.1	0	0.2	0	0	0	2.2	0	0	0	0.3	0.7	0.1	0.3	0.1	0	0	0.6	0	0.3	0	0	0.1	0	0.2	9	0	1	0.5	0	0.2	0.1	0	0	0	0	0.1	0.1	0	0	0.5	1.6	0.1	0	0.1	0.3	0.6	0.8	0.1	0.4	0.4	0.9	0.1	0	0	0.2	0	0	0	0	0.4	0.2	0	0.4	0	0	0	0.1	0	8.5	0	0	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0	0.2	0.1	0.1	0.2	0.2	0.1	0.1	0.1	0.2	0.1	0	0	0	0.1	0.3	0	0.5	5.1	0	0	0	0	0	1.7	0	6.2	0	16.2	0	0.3	0	0	0.6	0	132	0	0	1.7	0.6	3.9	11	0	0	0	0	3.6	0	0	5.8	0	14.7	0	0	0	0	0.2	0.1	0	0	3	0.1	Hepatocytes
UBL4B	FLJ25690	ENSG00000186150	Ubiquitin like 4B	Q8N7F7	1	110112468-110113945	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	79	testis: 65.3	Cell type enriched	Detected in some	4	Late spermatids: 5150.4	Cancer enhanced	Detected in single		glioma: 0.5	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	5	BJ hTERT+: 21.5	Not detected	Not detected			Not detected	Not detected			HPA031364	Enhanced											HPA031364: AB_10604000	unprognostic (2.92e-1)	unprognostic (3.48e-2)		unprognostic (3.53e-1)	unprognostic (9.81e-2)	unprognostic (1.65e-2)		unprognostic (5.24e-2)	unprognostic (1.29e-2)	unprognostic (3.43e-2)	unprognostic (6.87e-3)	unprognostic (4.46e-1)	unprognostic (2.20e-9)	unprognostic (3.29e-2)	unprognostic (7.39e-2)	unprognostic (1.59e-4)	unprognostic (3.90e-2)	0.2	0	0	0	0.1	0	0.2	0	0.2	0	0	0	0.3	0	0.2	0.8	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0.1	0	0	0	0	0.1	0	0	0	65.3	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.9	21.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	2.7	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1273.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5150.4	27	0	0	0	0	0	0.1	0	20.8	0	0	12.9	0	37.9	15.1	0	0	0	0	0	Late spermatids
CYP4Z1	CYP4A20	ENSG00000186160	Cytochrome P450 family 4 subfamily Z member 1	Q86W10	1	47067488-47118319	Enzymes, Predicted membrane proteins		Monooxygenase, Oxidoreductase		Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	9	breast: 23.1	Cell type enriched	Detected in some	4	Alveolar cells type 1: 8.9	Cancer enriched	Detected in some	50	breast cancer: 42.3	Low region specificity	Detected in some			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	39	HDLM-2: 13.7;SK-BR-3: 5.9																						unprognostic (4.11e-2)	unprognostic (2.57e-2)	unprognostic (2.46e-1)	unprognostic (5.12e-2)	unprognostic (1.37e-1)	unprognostic (4.33e-4)	unprognostic (1.10e-1)	unprognostic (3.53e-3)		unprognostic (7.76e-3)	unprognostic (1.21e-1)	unprognostic (3.53e-1)	unprognostic (6.82e-3)	unprognostic (5.09e-3)	unprognostic (3.88e-2)	unprognostic (6.46e-2)	unprognostic (3.49e-3)	2.5	0.2	0.4	0.4	0.9	0	23.1	0.4	2	1	0.4	0.4	0.4	0	0.4	0.8	0.8	0.7	0.4	0.4	0.4	1.8	0.4	1.5	2.1	0.4	0.4	0.4	0.4	0.4	0.3	0.4	0.4	0.7	1.3	0	0.4	1.5	0.8	0.5	2.2	0.4	0.4	0.4	0.4	0.2	1	0.4	0.6	0.4	0.4	0.5	0.6	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0.2	0	0	0	5.9	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0.9	0.4	2	0.4	1.8	0.4	0.4	0.7	0.4	8.9	0.6	0	0.4	0.1	0	0.2	0	1.4	1.2	0	0	0	0	0	2.2	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	Alveolar cells type 1
SLC51B	OSTbeta	ENSG00000186198	Solute carrier family 51 beta subunit	Q86UW2	15	65045370-65053396	Predicted membrane proteins, Transporters	Transport			Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	6	intestine: 85.0	Cell type enriched	Detected in many	6	Enterocytes: 518.3	Cancer enhanced	Detected in many		liver cancer: 9.8	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	6	CACO-2: 16.9;EFO-21: 11.3;Hep G2: 14.1	Not detected	Not detected			Low region specificity	Detected in all			HPA008398, HPA008533	Enhanced		Approved	Vesicles,Mitochondria		No				Mitochondria	Vesicles	HPA008398: , HPA008533: AB_1854824	unprognostic (6.18e-2)	unprognostic (6.75e-3)	unprognostic (1.66e-1)	unprognostic (1.31e-2)	unprognostic (5.88e-2)	unprognostic (9.49e-2)	unprognostic (9.77e-3)	unprognostic (1.81e-2)	unprognostic (3.35e-2)	unprognostic (2.76e-1)	unprognostic (2.24e-1)	unprognostic (4.34e-2)	prognostic favorable (8.46e-5)	unprognostic (5.87e-2)	unprognostic (2.64e-2)	unprognostic (1.05e-2)	unprognostic (1.17e-2)	0.4	0.5	0.4	3.8	0.6	0	0.4	0.4	0.8	14	34.9	0.4	0.4	28.1	0.9	3.3	0.4	1	0.5	0.4	0.5	0.6	7.5	2.4	1.6	0.4	0.6	0.4	0.4	0.4	0	0.4	0.4	0.4	0.8	9.5	0.4	0.4	0.8	0.4	0.1	85	0.4	0.4	0.4	0.2	4.1	0.4	0.4	0.4	0.4	0.4	0.4	0.5	0	0	0.7	0.1	0	0.5	0.3	0	1.4	0.2	0.8	0	0.1	0.4	0	0	0.2	0	16.9	0	0.1	11.3	0	0	0	0	0	0	0.1	0.2	0	0.1	14.1	0.1	0.2	0	0	0	0.1	0	0	0	0.3	0.2	0.2	0	0.4	0	0.3	0.4	0	0.4	0	0	0.8	0.4	0	0.6	0.5	0	0	0	2.2	0.4	0	0	0.3	0	0.1	0.1	0.2	0.3	0.2	0	0.1	0.1	0.1	0	0	0.4	0	0.5	0	0.3	0.2	0	0	0.1	0.3	0.7	0	0.1	0	0	0.3	0.4	0.6	0.4	0.4	0.5	0.6	0.6	0.4	0.4	0.4	0	0.6	1.5	0.1	0	0	0	2.5	10.7	0	0	0	0	11.6	0	48.8	0	518.3	0	0	0	0	0	4.6	1.5	0.1	0	1.7	0.6	0	9.7	0.3	0	0	0	7.7	0	0	84.2	0	54	0	6.5	0	1.5	0.4	0	0.1	0	19.7	0	Enterocytes
LCE1E	LEP5	ENSG00000186226	Late cornified envelope 1E	Q5T753	1	152786214-152788426	Predicted intracellular proteins	Keratinization			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in some	8	skin 1: 39.5	Cell type enriched	Detected in some	9	Suprabasal keratinocytes: 15.9	Cancer enhanced	Detected in single		melanoma: 0.7	Region enriched	Detected in single	15	cerebellum: 1.4	Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	4	HaCaT: 14.9																							unprognostic (9.92e-2)				unprognostic (9.50e-2)			unprognostic (2.30e-2)								unprognostic (2.56e-1)	0	0	0	0	0	0	0.2	1.4	0	0	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.6	0.1	0	0	0	0.3	39.5	0	0	0	0	0	0	0	0	0	0	0	5.1	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0.3	0	0.2	0.2	0	0	0	2.7	0	0	0	14.9	0	1.4	0.2	0	0	0	0	0.5	0	0	0	0	0.9	0.4	0.2	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	3.3	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.4	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.7	0	0	0	0	0	1.7	0	0	0	0	0	0	0	0	0	0	0	0	15.9	0	0	0	0	Suprabasal keratinocytes
PRELID2	FLJ38376, MGC21644	ENSG00000186314	PRELI domain containing 2	Q8N945	5	145471799-145835369	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		intestine: 31.2	Cell type enriched	Detected in many	4	Cone photoreceptor cells: 377.0	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Group enriched	Detected in many	5	basophil: 15.8;myeloid DC: 5.2	Group enriched	Detected in all	5	dendritic cells: 5.2;granulocytes: 15.8	Low cell line specificity	Detected in many			Low region specificity	Detected in some			Low region specificity	Detected in all			HPA042486	Uncertain		Approved	Nucleoplasm						Nucleoplasm		HPA042486: AB_10797498	unprognostic (9.45e-3)	unprognostic (1.95e-1)	unprognostic (7.58e-3)	unprognostic (2.71e-5)	unprognostic (1.96e-3)	unprognostic (6.53e-4)	unprognostic (6.62e-5)	unprognostic (2.27e-1)	unprognostic (4.21e-1)	unprognostic (1.04e-1)	prognostic unfavorable (3.78e-4)	unprognostic (3.83e-1)	prognostic unfavorable (9.65e-6)	unprognostic (2.65e-1)	unprognostic (1.29e-1)	unprognostic (7.83e-4)	unprognostic (6.42e-3)	6.6	2.4	1.6	5.3	2	3.9	4.4	0.7	2.9	4.9	16.4	2.3	2.8	10.6	5.2	2.9	2.4	3	14.5	6.4	1.4	1.4	2.6	2.7	2.4	2.7	2.3	1.1	5.2	15.9	1.3	2.8	0.9	2	4.2	16.2	9.2	4.3	2.7	1.3	3	31.2	6.2	2.5	2.1	7.8	2.5	1.5	0.8	4.1	2.4	1.9	4.3	11.6	1.8	5.2	15.8	1.9	1.8	2	0.9	10.8	3.6	3.4	5.4	0.8	1.9	0	3.6	6.3	6.8	9.6	11.6	17.9	0	6.2	4.3	15.6	3.3	2.6	8.2	10.1	3.1	4.2	12.5	4	6	2.1	1.6	13.3	1.1	3.5	7.8	6.9	9.5	7.6	0	6.8	5	3.3	1.8	0	1.9	1.7	12.6	2.4	0	0	1.7	3.2	1.7	1.5	3	4.6	0.6	7.2	1.6	5.5	2.4	7	5.9	3.2	10.4	8.1	0.2	0	0	10.6	0	2.4	15.8	1.3	0.4	0.8	1.9	0.4	1.7	1.6	1.2	5.2	1.8	0.2	1.2	0.5	1.8	1.3	0.6	2	0.9	1.6	2	0.7	2.9	1.4	1.4	2.3	1.1	2	1.5	0	2.4	1.9	11.1	3.7	19.4	7.7	5.1	2.7	6.8	0	377	0.1	0	11.6	3.4	5.8	91.5	0	11.4	2.4	5.3	2.7	17.3	2.1	2.4	4.8	9.2	3.1	2.1	1	3.1	4.3	0	3.6	27.5	7.5	15	48	4.2	2.4	47.8	0	4.7	0.9	1	2.9	0.2	3.2	32.3	8	Cone photoreceptor cells
SLC36A2	PAT2, TRAMD1, tramdorin	ENSG00000186335	Solute carrier family 36 member 2	Q495M3	5	151314978-151347590	Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters	Amino-acid transport, Transport		Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	9	kidney: 60.3;skeletal muscle: 36.8;tongue: 16.1	Cell type enriched	Detected in some	9	Proximal tubular cells: 44.0	Cancer enriched	Detected in single	9	renal cancer: 0.5	Region enhanced	Detected in single		midbrain: 1.2	Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		HL-60: 1.9;NB-4: 2.0	Low region specificity	Detected in some			Low region specificity	Detected in single			HPA044002, HPA062229	Enhanced											HPA044002: AB_10964214, HPA062229: AB_2684717	unprognostic (3.47e-1)	unprognostic (3.40e-1)		unprognostic (2.26e-2)	unprognostic (6.23e-2)	unprognostic (8.38e-3)	unprognostic (4.66e-3)	unprognostic (3.03e-1)	unprognostic (7.73e-2)	unprognostic (1.92e-2)	unprognostic (2.11e-1)	unprognostic (1.92e-1)	unprognostic (1.20e-3)	unprognostic (1.43e-1)	unprognostic (1.05e-1)	unprognostic (2.18e-1)	unprognostic (3.89e-2)	0.6	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0	0.1	2.6	0.5	0.1	0	0.2	0.1	0.1	60.3	0.1	0.1	0	1.2	0	0.1	0.1	0	0.1	0	0.4	0.1	0	1.1	2	0	36.8	0.1	0.1	0	0.2	0.1	0.1	0.7	0	0	0.1	16.1	1.4	0.1	0.1	2.1	1.5	4.3	0.8	1.5	0.9	0.3	0.1	0.3	0.4	0.7	0.3	0.1	1	0.4	0	0.1	0	0.6	0.3	0.8	0.3	0.2	0.3	0.4	0	0.7	0	1.5	1.5	0.3	0.8	0.3	0	1.9	0.5	0.1	0.1	0	0	0	0.5	0.5	0.1	1.4	0.2	0.3	0.4	2	1.2	0	0.2	0.5	0.4	0.2	0.2	0.1	0.4	0.4	0.1	1.2	0	0.2	0.3	0.3	0.5	0.2	0.2	1.2	0.2	0.5	0.2	0.4	0.3	0.3	0.1	3.2	0.8	0.9	0.7	0.6	0.6	1.1	0.6	0.6	0.2	2.1	0.7	0.9	4.3	1.5	0.6	1.5	0.5	0.3	0.1	0.1	0.1	0.1	0.1	0.1	1.2	0	0.4	0	0	0	0	0	0	0	0.6	0	0	0	1.8	0	0	5	0	4.4	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	4.5	0	0	0	0	0	0	0	0	0	44	0	0	0.3	0	0	0	0	0	0	0	Proximal tubular cells
C9orf47	bA791O21.3, C9orf108, FLJ37523	ENSG00000186354	Chromosome 9 open reading frame 47	Q6ZRZ4	9	88990863-88996140	Predicted secreted proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Low tissue specificity	Detected in many			Cell type enriched	Detected in some	4	Sertoli cells: 12.9	Not detected	Not detected							Cell type enriched	Detected in single	5	classical monocyte: 2.2	Lineage enriched	Detected in single	6	monocytes: 2.2	Cell line enhanced	Detected in some		AF22: 6.6;ASC diff: 3.2;HeLa: 5.6;JURKAT: 3.5									CAB009902	Approved				Secreted - unknown location							CAB009902: AB_2184764	unprognostic (6.51e-3)	unprognostic (2.50e-1)	unprognostic (2.94e-4)	unprognostic (2.24e-3)	unprognostic (1.75e-1)	unprognostic (1.46e-1)	unprognostic (2.47e-2)	unprognostic (9.39e-2)	unprognostic (2.10e-2)	unprognostic (2.98e-1)	unprognostic (7.39e-2)	unprognostic (1.98e-1)	unprognostic (4.19e-6)	unprognostic (5.61e-2)	unprognostic (3.72e-2)	unprognostic (6.91e-2)	unprognostic (1.77e-2)	1.7	5.3	0.6	1	0.7	0.8	2.3	0	0.7	1.8	1			0.3	1.1	0.6	2.1	2.1	0.9	1.8	0.8	0.5	3.9	0.8	1	1.7	0.4		0.4	1.7	0	3.3	1.2		1.9	0.2		0.3	0.8	0	0	0.8	1.4	0.5	1.7	1	0			0.7		0.5	0.9	1.9	0	0.2	0.3	2.2	0	0	0.4	0	0.4	6.6	0.2	3.2	1.9	0.1	1.1	0.3	0.4	0.5	0	0	0	0	0.5	0.5	0	0	0.4	0.5	0	0.1	0	5.6	0	0	0.4	0	0.2	0.1	0.7	0	0.2	0.7	3.5	0.3	0	0	0.5	1.6	1.4	0.4	0	0.3	0.7	0	0	0	0.6	0.2	0.5	0.3	0.1	0	0.7	0.1	1.8	1.8	0.6	1.4	1.1	0	0	0	0	0.7	0.5	0.1	0	2.2	0	0	0.4	0	0	0	0	0.2	0	0	0	0.3	0	0.1	0	0	0.4											0	0	0	2	2.6	0	1.2	0	0	0	0	0	1	0	0	0	0.6	0	0	0.2	0.1	1.2	1	0	0	0.2	3.2	0	0.6	0	0	0.3	0	1.7	0	0	2.6	0	0	0.4	0	0	12.9	1.4	0	0.2	0.3	0.2	0	0	0.6	Sertoli cells
CYP4X1	MGC40051	ENSG00000186377	Cytochrome P450 family 4 subfamily X member 1	Q8N118	1	47023568-47050751	Enzymes, Predicted membrane proteins		Monooxygenase, Oxidoreductase		Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		cervix, uterine: 38.1	Cell type enriched	Detected in many	6	Ciliated cells: 156.6	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		ASC diff: 3.7;CACO-2: 6.2;NTERA-2: 2.9;SCLC-21H: 3.8;T-47d: 13.5	Low region specificity	Detected in all							HPA017661	Approved											HPA017661: AB_2669633	unprognostic (1.19e-1)	unprognostic (2.28e-2)	unprognostic (1.53e-1)	unprognostic (1.78e-2)	unprognostic (9.88e-2)	unprognostic (1.56e-3)	unprognostic (2.30e-1)	unprognostic (2.34e-2)	unprognostic (1.10e-2)	unprognostic (2.35e-2)	unprognostic (1.46e-1)	unprognostic (2.76e-2)	unprognostic (3.03e-2)	unprognostic (1.79e-3)	unprognostic (3.65e-2)	unprognostic (8.56e-2)	unprognostic (5.03e-2)	7.9	3.6	9	1.1	14.9	0.5	16	7.1	16.9	38.1	2	1.6	2.5	2.1	3.6	3.2	12	9.7	2	6.7	4.8	10.6	6.3	10	8.9	2	3.3	13.5	1.7	2	2	4.1	1.5	7.8	8	2.3	17.6	23.7	3.4	4.5	5	1.8	2.4	2	1	14.3	4.2	0.9	0	4	6.9	8.8	3.9	5.4	0	0	0	0	0	0.1	0	0	0	0	0	3.7	0.2	0.1	0	0.1	0	0	6.2	0	0	0.7	0	1.7	0	0	0	0	0.5	2.5	0	0	0	0	0	0	0.3	2.2	0	0	0.9	0.1	0	0.1	0.3	0	0	0	0	2.9	1	0	0	0.5	0	0.6	0.2	3.8	0	0	0.3	0	0.2	13.5	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	9	14.9	7.1	16.9	4.8	10.6	3.3	13.5	7.8	0.9	20.8	10.5	0	23.5	2.3	0.9	1	0	156.6	27.3	0	0	0	0	0.3	6	2.3	0	0	0.6	0	1.9	10.7	0	2.5	2.9	0	0	0.6	0.3	5.6	9.8	0.6	5	0	0	0	0.2	0	19.4	1.3	0.7	0	14.5	0	1.5	1.3	0.1	0	0.6	26.2	Ciliated cells
KRT10	CK10, K10, KPP	ENSG00000186395	Keratin 10	P13645	17	40818117-40822595	Disease related genes, Plasma proteins, Predicted intracellular proteins			Disease mutation, Ichthyosis	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in all	20	skin 1: 1236.8	Cell type enriched	Detected in all	5	Suprabasal keratinocytes: 10939.8	Cancer enhanced	Detected in all		melanoma: 562.4	Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Cell line enhanced	Detected in many		hTCEpi: 131.9	Low region specificity	Detected in all			Low region specificity	Detected in some			CAB000132, HPA012014	Enhanced				Intracellular and membrane				34000000000			CAB000132: , HPA012014: AB_1852195	unprognostic (3.07e-1)	unprognostic (5.19e-2)	unprognostic (1.71e-1)	unprognostic (1.37e-2)	unprognostic (2.00e-2)	unprognostic (2.60e-1)	unprognostic (3.02e-2)	unprognostic (1.29e-2)	unprognostic (1.09e-1)	unprognostic (1.56e-1)	unprognostic (1.00e-2)	unprognostic (2.14e-1)	prognostic unfavorable (9.32e-5)	unprognostic (1.64e-1)	unprognostic (1.85e-1)	unprognostic (1.66e-2)	unprognostic (8.10e-2)	4.1	4.4	5.3	3.7	6	3.9	41.4	7.2	6.4	37.3	3.7	1.4	8.2	4	14.9	5.4	7.4	3	3.7	9.3	6.4	2.9	5.9	7.6	3	5.3	5.2	3.2	3.3	9.2	2.6	8.1	5.7	4.9	5.6	2.9	2.4	17.4	8.3	12.2	1236.8	4.9	3	4	3.7	4.3	9.6	6.1	11.6	5.5	21.7	5.8	3.3	62.7	17.5	15.4	21.7	5.7	13.2	13.4	3.4	17.9	22.9	6.7	7.2	8.3	7.4	6.2	16.2	10	6.7	6.1	8.7	6.8	5	24.4	7.1	8.8	36.3	2.8	6.1	8.6	11.9	18	4.7	29.9	15.9	9.6	10	13.9	5.8	131.9	4.4	9.6	8.7	4.6	5.9	25.3	9.6	7.7	13.5	13	9.7	8.6	12.4	14.6	9.7	9.8	10.6	6.8	19.5	5.9	6.9	11.5	27.7	21.1	10	21.5	13.6	5.2	11.3	16.7	13.9	20	0.2	12.1	14.1	15.3	6.5	14.1	21.7	4.7	19.1	9.8	4.2	11.1	17.5	10.8	13.4	7.7	10.1	12.1	11.8	1.6	13.2	5.7	15.4	10.3	3.4	5.3	6	7.2	6.4	6.4	2.9	5.2	3.2	4.9	6.1	32.8	40.2	140.7	245.9	1989.5	42.2	180.5	168.2	18.7	37.5	106.4	19.6	108	258.6	178.2	67.5	155.9	127.9	70	325.5	259.5	164.5	278.2	74.8	191.4	95	20.6	173.9	148	93.7	31.5	200.5	149.2	372.8	55.1	172.8	131.5	192.1	133.3	164.4	188.8	57	103.5	208.9	225.9	128.5	10939.8	133.9	135.5	151.3	432.6	Suprabasal keratinocytes
DEFB132	DEFB32, RP5-1103G7.6	ENSG00000186458	Defensin beta 132	Q7Z7B7	20	257736-261096	Predicted secreted proteins		Antibiotic, Antimicrobial, Defensin		Evidence at protein level	Evidence at transcript level	No human protein/transcript evidence	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	5	ductus deferens: 37.1;epididymis: 119.7	Cell type enriched	Detected in some	10	Collecting duct cells: 10.4	Cancer enhanced	Detected in some		liver cancer: 0.8;prostate cancer: 1.4	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	7	BEWO: 1.1;NB-4: 3.3;RPMI-8226: 1.8;SH-SY5Y: 1.7									HPA046399	Approved				Secreted in male reproductive system							HPA046399: AB_10960992	unprognostic (9.27e-3)						unprognostic (1.61e-2)					unprognostic (2.54e-2)						17.2	0.1	0.1	0	0.1	0	4.4	0.1	0.1	0.1	0.1	0	37.1	0	0.1	119.7	0.1	0.1	0	0.1	0.1	0.1	0.2	0.9	0.1	0	0.1	0	0.1	0.1	0	0.1	0	0	2.6	0	0	0.1	6.4	0.1	0.1	0.2	0	0.1	0.1	0.1	1.3	0	0	0.1	0	0	1.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	1.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.3	0	0	0	0	0	1.8	0	0	0	1.7	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	10.4	0	0	0	0	0	0	0	0	0	0	0	1	0	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	Collecting duct cells
CLCNKA	hClC-Ka	ENSG00000186510	Chloride voltage-gated channel Ka	P51800	1	16018875-16034050	Disease related genes, Predicted membrane proteins	Ion transport, Transport	Chloride channel, Ion channel, Voltage-gated channel	Bartter syndrome, Deafness, Disease mutation	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	5	kidney: 46.9;parathyroid gland: 15.4	Cell type enriched	Detected in some	4	Late spermatids: 171.7	Group enriched	Detected in some	7	renal cancer: 4.4;thyroid cancer: 1.6	Region enriched	Detected in single	7	cerebellum: 2.1	Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	4	U-266/70: 13.0									HPA057717	Approved											HPA057717: AB_2683509	unprognostic (2.35e-2)	unprognostic (1.24e-1)	unprognostic (1.37e-2)	unprognostic (4.02e-1)	unprognostic (2.76e-3)	unprognostic (8.20e-2)	unprognostic (6.16e-2)	unprognostic (1.18e-2)	unprognostic (6.92e-3)	unprognostic (3.49e-2)	unprognostic (1.76e-2)	unprognostic (1.41e-1)	unprognostic (8.13e-3)	unprognostic (1.36e-1)	unprognostic (9.13e-2)	unprognostic (4.37e-3)	unprognostic (1.28e-1)	0.2	0.7	0.2	0.2	0.2	0	0.2	2.1	0.2	0.2	0.2	0.2	0.2	0	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0	46.9	0.2	0.2	0.2	0.2	0.2	0.2	1.2	15.4	5.8	0.2	0.2	0.2	0	0.2	4.4	0.2	0.2	0	0.2	0.2	0.2	0.2	1.6	1.1	0.2	0.2	6	0.2	0.2	0.2	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0.1	0	0.1	0.1	0	0	0	0	0	0	0.1	0	0.1	0	0	0	0.2	0	0	0	0	0.2	0	0	0.1	0	0	0	0	0.1	0	0.5	0	0.1	0.4	3.1	0	0	0	0	0	3.2	0.1	0.3	0.2	0.5	0	0	0.1	0	0	13	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0.2	2.1	0.2	0.2	0	0.2	0.2	0.2	0.2	3	0.3	0	0	0.1	0.6	3.5	0	0	1.2	24.4	0	0.4	21.6	0.1	38.8	0	0	0	0.2	0	0.5	0.2	0	0	0.1	12.7	1.2	0	0	171.7	0.3	0	1.7	0	0	1.7	0	0	0.4	0	0.4	0	0	1.7	0.7	0	0.6	0	0	0.1	Late spermatids
CYP4F3	CYP4F, LTB4H	ENSG00000186529	Cytochrome P450 family 4 subfamily F member 3	Q08477	19	15640897-15662825	Enzymes, Predicted intracellular proteins	Fatty acid metabolism, Lipid metabolism	Monooxygenase, Oxidoreductase		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	5	liver: 159.2	Cell type enriched	Detected in many	6	Hepatocytes: 506.3	Cancer enhanced	Detected in many		liver cancer: 30.6	Low region specificity	Detected in many			Cell type enriched	Detected in single	68	neutrophil: 33.1	Lineage enriched	Detected in single	166	granulocytes: 33.1	Cell line enhanced	Detected in some		CAPAN-2: 20.0;HaCaT: 9.1;Hep G2: 10.9;OE19: 29.3									HPA058960	Approved											HPA058960: AB_2683862	unprognostic (1.73e-2)	unprognostic (9.70e-3)	unprognostic (1.21e-1)	unprognostic (1.16e-3)	unprognostic (5.40e-1)	unprognostic (1.57e-1)	unprognostic (7.15e-3)	unprognostic (5.19e-2)	unprognostic (2.12e-1)	unprognostic (3.61e-2)	unprognostic (1.26e-2)	unprognostic (2.32e-1)	unprognostic (1.59e-3)	unprognostic (2.36e-1)	unprognostic (1.12e-1)	unprognostic (1.07e-2)	unprognostic (2.07e-1)	0.4	0.1	0.3	0.3	1.5	24.8	0.1	0.1	2.2	2.1	3.4	6.5	0	3.1	0.1	0.4	8.6	0.3	19.8	0.2	0.8	0.2	23.7	159.2	0.7	0	0.4	1.9	0.1	0.2	0	0.2	0	1.6	0.3	0.5	0	1.3	0.1	0.1	1.2	13.4	0.1	1	2.6	1.7	0.2	1.8	0	0.1	1.1	0.8	1.8	2.7	0	0	33.1	0.1	0	0	0	0.2	4.4	0	0	0	0	0	0	0	0.2	0	0	20	0	0.1	0	0	9.1	0	0.1	0	0.3	0	0.1	1.9	10.9	0	0.1	0.1	0	0.9	0	0	0	0	0	0	0.2	0	0	0	0.1	0	29.3	0	0	0	0	0	0.5	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0.6	0	0	0.1	0.4	0	0	0	0	0	0	0	0	0	0	33.1	0	0	0	0	0	0.3	1.5	0.1	2.2	0.8	0.2	0.4	1.9	1.6	1.8	8.9	5.9	5.1	2.3	0.9	0	0.8	91.7	0	0	0	0	0	0	1.2	0	0.1	13.5	23.3	0.2	0.1	0.3	1.7	1.1	506.3	0	0	50.9	6.2	10.2	0.4	0	0.4	0	0	5.6	0	2.5	7	0	31.2	0	0	0.2	0	0.1	5.6	0	0.8	8.3	10.8	Hepatocytes
FSD2	RP11-127F21, SPRYD1	ENSG00000186628	Fibronectin type III and SPRY domain containing 2	A1L4K1	15	82755362-82806070	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	13	heart muscle: 20.8;skeletal muscle: 54.0;tongue: 18.1	Cell type enriched	Detected in some	6	Cardiomyocytes: 70.6	Not detected	Not detected			Not detected	Not detected			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		U-266/70: 8.5	Low region specificity	Detected in some			Low region specificity	Detected in many			HPA046263			Approved	Cytosol						Cytosol		HPA046263: AB_2679604	unprognostic (2.80e-1)	unprognostic (3.54e-1)	unprognostic (6.63e-2)	unprognostic (6.30e-2)	unprognostic (7.71e-2)	unprognostic (1.83e-1)	unprognostic (5.97e-2)	unprognostic (7.66e-2)	unprognostic (1.07e-1)	unprognostic (9.37e-2)	unprognostic (3.05e-2)	unprognostic (2.21e-1)	unprognostic (1.07e-2)	unprognostic (1.27e-1)	unprognostic (8.03e-2)	unprognostic (1.68e-2)	unprognostic (1.59e-2)	1.7	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0	0	0.2	0.1	0.6	0.7	0.1	0	20.8	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0	0.1	0.1	0.2	0.2	0	0	0.3	0	0.4	1	0	54	0.4	0.1	0	0.1	0.1	0.1	0.1	0	0	0.2	18.1	1.4	0	0.1	1.4	0.8	2.3	0.9	0.8	2.2	0.5	1.3	1.3	2	2.4	0	0	1.2	1.3	0	0	0	1.1	2.1	4.1	0.9	0	1.1	5	0	0	0.4	0.7	5.4	2.3	5.7	1.8	0	1.4	0.9	0.1	0.2	0	0.6	1.4	0	1.7	2	3.7	0	1.2	0.7	2.4	1.9	0.8	1.1	1.3	1.5	1	0.2	2.3	1.9	1.7	1	1	1.5	1	1.7	1.8	0.8	3	1.6	1.1	1.8	8.5	3.6	1.4	1.8	4.9	0.7	2.3	0.8	0.8	1	0.7	0.8	1.4	1.1	0.9	0.8	1.1	2.2	1.1	1.1	0.8	0.9	0.8	1	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	2.1	0	1	0.3	2.6	70.6	2.5	0	1.2	0	5.9	0	0	0	1.6	0.6	0	0	0.3	0.1	0.2	0.3	1.1	0	0.2	11.1	1.2	0	0.8	1.8	0.3	0	0	0	0	0.3	0.1	0	0	0	3.6	0	0.3	0.7	0.2	0.5	0.2	0	0	0.3	Cardiomyocytes
CARMIL3	BC008134, C14orf121, crml-1, LRRC16B	ENSG00000186648	Capping protein regulator and myosin 1 linker 3	Q8ND23	14	24052000-24069728	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	5	brain: 30.6;pituitary gland: 7.8;skin 1: 9.4	Cell type enriched	Detected in single	8	Collecting duct cells: 1.8	Low cancer specificity	Detected in some			Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		Daudi: 8.4;HMC-1: 5.9;Karpas-707: 5.3;SCLC-21H: 8.7;SH-SY5Y: 4.2	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA030596	Uncertain											HPA030596: AB_10603012	unprognostic (2.67e-2)	unprognostic (2.07e-3)	unprognostic (1.50e-1)	unprognostic (3.09e-2)	unprognostic (6.17e-2)	unprognostic (1.29e-4)	unprognostic (6.13e-2)	unprognostic (8.92e-4)	unprognostic (4.02e-1)	unprognostic (7.08e-2)	unprognostic (1.39e-4)	unprognostic (4.49e-2)	unprognostic (1.17e-1)	unprognostic (7.01e-2)	unprognostic (1.25e-2)	unprognostic (4.19e-1)	unprognostic (2.16e-1)	0.6	1.6	6.5	1.4	5.2	1	0.8	30.6	7.9	0.6	0.9	3.3	0	2.3	0.6	0.5	1	0.6	1.6	0.4	7.4	5.2	1	0.8	0.9	1.4	2.8	2.4	0.6	1.3	0.5	7.8	0.5	7.2	0.8	1	1.7	1.6	0.7	0.5	9.4	1.6	0.7	2.9	1	1.2	3.1	2.8	0	1	0	2	0.8	0.5	0	0	0	0	0	0.7	0	0	0.3	0.1	1.6	0.1	0	0	0	0	0	0	0	0	8.4	0	0	0.1	0.1	0.3	0	0	1.4	0	0.1	0.1	0.1	0	0	5.9	0	0	0	0	0	0	0.2	0	5.3	0	0.3	1.3	0	0.5	0.1	0.1	0.6	0	0	0	0.1	8.7	4.2	0	0.4	0.6	0	0.1	0	0	0	0.1	0.1	0	1.3	0.7	0.1	0	0	0	0	0	0	0.7	0	0	0	0.1	0	0	0	0	0.1	0	0	0	0	0	0	6.5	5.2	30.6	7.7	7.4	5.2	2.8	2.4	7.2	2.8	0	0	0	0	0	0	0	0	0	0	1.8	0	0	0	0.2	0	0	0	0	0.2	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0.1	0	0	0	0	0	0	0	0	0	0	Collecting duct cells
ZNF732	FLJ59067	ENSG00000186777	Zinc finger protein 732	B4DXR9	4	270675-305321	Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	DNA-binding		Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in many		testis: 19.5	Cell type enriched	Detected in some	4	Spermatogonia: 8.3	Cancer enhanced	Detected in some		testis cancer: 2.1	Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	4	NTERA-2: 12.3																						unprognostic (7.83e-3)	unprognostic (1.30e-1)	unprognostic (1.09e-1)	unprognostic (3.54e-2)	unprognostic (8.99e-4)	unprognostic (7.60e-3)	unprognostic (8.13e-2)	unprognostic (3.83e-2)	unprognostic (4.89e-3)	unprognostic (1.44e-3)	unprognostic (3.60e-3)	unprognostic (5.45e-3)	unprognostic (8.40e-4)	unprognostic (3.85e-1)	unprognostic (1.27e-1)	unprognostic (1.51e-1)	unprognostic (2.53e-1)	0.7	0.6	1.1	3.8	5.9	0.6	1.9	4.6	1.8	1.3	1	0.1	0.8	0.4	1.6	0.2	2.3	1.1	0.6	0.9	1.1	1.1	0.5	0.3	0.6	2.3	0.8	0.3	2.3	0.7	0.7	2.2	2.3	1.5	1.3	0.3	0.2	0.8	0.3	0.2	3.3	0.4	1	0.9	1	0.4	19.5	0.4	0.3	1.6	2.4	2.8	2	1.2	0.5	0.1	0.1	0	0.9	0.2	0	0	0	1.7	0	0	0.1	0	1	0	0	0	0	0.1	0	0	0.8	0	0	0	1.7	0	0	0	0	0	0	0.2	0	0	0.2	1.1	2.1	1.2	0	0	0	0	0	0	0	0	0.4	12.3	0	2.4	0	0	0	1	1.5	0	2.8	0	0	0	3	2.7	0	0	0	0.1	2.7	0.1	0	0	0	0	0	0.7	0	0	0.1	0.1	0	0	0.2	0	0.1	0	0.5	0.2	0.1	0	0.9	0	0.1	0.1	0	1.1	5.9	4.6	1.8	1.1	1.1	0.8	0.3	1.5	0.4	0	0	0	0.1	0.3	0	0.5	0	0	0	0	0	0.2	0	0	0.8	0	0	0	0	0.6	0.1	0	0	0	0	0	0	0	0	0.4	0.3	0	0	0	0	0	0	0	0	0	0	0	0	1.9	8.3	0.3	0	0	0	0	Spermatogonia
SPATA31D3	FAM75D3, FLJ44082	ENSG00000186788	SPATA31 subfamily D member 3	P0C874	9	81943586-81950038	Predicted membrane proteins	Differentiation, Spermatogenesis			Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enriched	Detected in single	99	testis: 9.9	Cell type enriched	Detected in some	13	Early spermatids: 16.6	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Not detected	Not detected																																									0	0		0		0	0		0	0	0			0	0	0	0	0	0	0			0	0	0	0			0	0	0		0		0	0		0	0	0	0	0	0		0	0	9.9			0		0	0		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	Early spermatids
LCE1A	LEP1	ENSG00000186844	Late cornified envelope 1A	Q5T7P2	1	152827473-152827894	Predicted intracellular proteins	Keratinization			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	10	skin 1: 97.7	Cell type enriched	Detected in some	26	Suprabasal keratinocytes: 35.3	Cancer enriched	Detected in some	6	melanoma: 14.4					Not detected	Not detected			Not detected	Not detected			Not detected	Not detected																													unprognostic (3.82e-2)			unprognostic (1.70e-1)									0	0	0	0	0	0	9.5	0	0	0	0			0	0	0	0	0	0	0	0	0	0	0	0	0	0		0	0	0	0	0		0	0		0	0	0.4	97.7	0	0	0.1	0	0	0			0		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	1.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	35.3	0	0	0	0	Suprabasal keratinocytes
SERPINA11		ENSG00000186910	Serpin family A member 11	Q86U17	14	94442464-94452790	Plasma proteins, Predicted secreted proteins		Protease inhibitor, Serine protease inhibitor		Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	140	liver: 189.6	Cell type enriched	Detected in some	50	Hepatocytes: 255.3	Cancer enriched	Detected in some	9	liver cancer: 94.3	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	8	Hep G2: 19.6	Not detected	Not detected			Not detected	Not detected								Secreted to blood				460000000				unprognostic (2.50e-2)	unprognostic (3.26e-1)	unprognostic (9.00e-2)	prognostic favorable (6.30e-4)		unprognostic (7.44e-2)	unprognostic (2.02e-2)	unprognostic (1.70e-1)	unprognostic (3.44e-1)		unprognostic (5.14e-2)	unprognostic (1.53e-1)		unprognostic (1.64e-1)				0	0	0	0.1	0	0	0.9	0	0	1.3	0	0	0	0	0.1	0	0.1	0	0	0	0	0	0	189.6	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0.9	0	0	0.1	0	0	0	0	0	0	0	0	0	0.2	0.7	0	0	0	0	0	0.9	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.4	0	0	0	0	0	0	0	0	0	0	0	19.6	0	0.6	0	0	0	0	0	0	0	0	0.1	0	0	0.5	0	0	1.2	0	0	0	0.6	0	0	0	0	0	0.1	0	0	0	0.1	0	0	0	0	0	0	0	0	0.2	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	5.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	255.3	0	0	0	3.7	5.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	Hepatocytes
FAM183A	hCG23177, LOC440585	ENSG00000186973	Family with sequence similarity 183 member A	A6NL82	1	43145153-43156396	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	No human protein/transcript evidence	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		brain: 25.5;fallopian tube: 55.8	Cell type enriched	Detected in many	7	Ciliated cells: 1011.8	Cancer enhanced	Detected in many		endometrial cancer: 19.3	Region enhanced	Detected in many		pons and medulla: 25.5	Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		CAPAN-2: 5.9;hTCEpi: 4.4;NTERA-2: 5.4;SCLC-21H: 4.6;SuSa: 9.1	Low region specificity	Detected in many							HPA043382, HPA049120	Approved											HPA043382: AB_2678456, HPA049120: AB_2680640	unprognostic (6.66e-2)	unprognostic (2.39e-1)	unprognostic (9.56e-2)	unprognostic (1.42e-3)	unprognostic (6.79e-2)	unprognostic (3.79e-2)	unprognostic (1.44e-2)	unprognostic (1.47e-1)	unprognostic (3.94e-2)	unprognostic (1.27e-1)	unprognostic (5.04e-3)	unprognostic (1.04e-1)	unprognostic (4.30e-2)	unprognostic (1.27e-2)	unprognostic (7.88e-2)	unprognostic (1.18e-3)	unprognostic (1.73e-2)	0.1	0.1	3.6	0.1	9.8	0.1	0.8	0	0.5	2.6	0.3	6.5	0	0.2	1.3	16.5	0.5	55.8	0.2	0.1	4.6	4.7	0.3	0.2	14.5	0.2	0.1	0.2	10.1	0.3	1	5.5	0.5	25.5	1.4	0.3	0	0.9	0.3	0.1	5.5	0.1	0.3	0.6	0.2	0.2	6.7	1.7	0	0.2	0	0.3	0.3	0.5	0	0	0	0	0	0	0	0.4	0	1.4	0	0	0	0.4	0	0.6	0.6	0.6	1	5.9	0	0.8	0.4	0.6	0.7	0	0.4	0.3	0	1.3	0	0	0	0	0	0	0	4.4	0	0.4	0	0	0	0.1	0	0	2.9	0	0	5.4	0.2	0	0	0	0	2.3	1.1	4.6	0	0	0.3	0	9.1	1.3	0	0.9	0	0.7	0.2	0.1	2	0.1	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.6	9.8	0	0.5	4.6	4.7	0.1	0.2	25.5	1.7	0	6.1	0	12.9	1.6	0	0.1	0	1011.8	135.4	3.5	0	1.5	3.3	0	89.9	0.1	0	0	0	0.2	0.4	3.8	3.5	0	0.1	0	4.1	0	0	153.7	1.7	0	3.3	0	0.1	0.4	0.2	0	0.7	1.3	0	0	0	1.9	2.8	2.3	1.7	0	0.4	10.2	Ciliated cells
KRTAP19-5	KAP19.5	ENSG00000186977	Keratin associated protein 19-5	Q3LI72	21	30501657-30502117	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	27	skin 1: 23.5	Cell type enriched	Detected in single	18	Syncytiotrophoblasts: 1.8	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	6	HEK 293: 10.3																		2100000																					0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	23.5	0	0	0	0	0	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.9	0	0	0	0	0	0	0	0	0	0	10.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.8	0	0	0	Syncytiotrophoblasts
RHD	CD240D, DIIIc, RH, Rh30a, Rh4, RhII, RhPI	ENSG00000187010	Rh blood group D antigen	Q02161	1	25272393-25330445	Blood group antigen proteins, CD markers, Predicted membrane proteins, Transporters		Blood group antigen		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		blood: 10.0;bone marrow: 16.5;salivary gland: 7.1	Cell type enriched	Detected in some	20	Erythroid cells: 23.3	Not detected	Not detected			Low region specificity	Detected in some			Cell type enhanced	Detected in many		neutrophil: 10.0	Lineage enriched	Detected in many	5	granulocytes: 10.0	Group enriched	Detected in some	6	HEL: 28.2;K-562: 8.7									HPA060951, HPA077385	Supported		Uncertain	Nucleoplasm,Plasma membrane						Nucleoplasm, Plasma membrane		HPA060951: , HPA077385: 	unprognostic (4.75e-3)	unprognostic (7.70e-2)	unprognostic (1.34e-1)	unprognostic (1.38e-1)	unprognostic (1.09e-2)	unprognostic (4.84e-2)	unprognostic (1.11e-2)	unprognostic (5.25e-2)	unprognostic (1.11e-2)	unprognostic (1.91e-1)	unprognostic (1.27e-2)	unprognostic (1.89e-1)	unprognostic (4.96e-3)	unprognostic (1.93e-1)	unprognostic (8.09e-2)	unprognostic (5.53e-2)	unprognostic (4.92e-3)	0.3	0.3	0.3	0.5	0.5	16.5	0.3	1.5	1.4	0.6	0.3	0.3	0.3	0.3	0.4	0.3	0.3	0.3	0.4	0.9	0.3	0.2	0.3	0.3	2.5	0.8	0.3	0.3	0.9	0.3	0.1	0.4	0.3	1.1	0.5	0	0.3	7.1	0.3	4.1	2.5	0.4	0.3	0.4	1.8	0.3	0.5	0.3	0.3	0.4	2.3	0.3	0.3	0.3	2	0.6	10	1.4	1.4	1.4	1.2	0.1	0	0.2	0.2	0.1	0	0.4	0.1	0.1	0.1	0	0.1	0.3	0.4	0.1	0	0.1	0.2	0	0	0	0.5	0.1	28.2	0.7	0.2	0	0.3	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	8.7	0.7	0	0.1	0.2	0.2	3.1	0	0.1	0.2	0.1	0.1	0	0.1	0.5	0.3	0.1	0.2	0.1	0.1	0.2	0.5	0.4	0.5	0.2	0.4	0.1	0.3	0.1	0.1	0.5	0.2	0.1	4.9	1.4	2.8	1	0.6	1.1	1.3	1.3	0.8	0.2	2	1.4	1.3	10	1.4	0.8	0.6	0.9	1.2	0.3	0.5	1.5	1.4	0.3	0.2	0.3	0.3	1.1	0.3	0	0.3	0	0.1	0.1	0.2	0.8	0	0	1.2	0	0	0	0	0	0.2	0.3	0	23.3	0.2	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0.2	0	0	0	0.5	0	0	0	0	0	Erythroid cells
PNLIPRP1	PLRP1	ENSG00000187021	Pancreatic lipase related protein 1	P54315	10	116590385-116609175	Predicted secreted proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	2629	pancreas: 516.5	Cell type enriched	Detected in some	5	Exocrine glandular cells: 576.9	Cancer enriched	Detected in single	475	pancreatic cancer: 32.5	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	7	EFO-21: 1.1;U-2 OS: 1.8;U-266/84: 4.5	Not detected	Not detected			Not detected	Not detected								Secreted to digestive system				210000						unprognostic (1.21e-1)	unprognostic (4.08e-3)						unprognostic (1.40e-1)	unprognostic (1.80e-1)		unprognostic (2.76e-2)	unprognostic (1.41e-1)	unprognostic (1.46e-1)	unprognostic (1.49e-1)		0.1	0	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	516.5	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.1	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.8	0	0.3	0	4.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	0	0.2	0.1	0	0.2	0	0	0	0	0	0	0	1.3	0.4	0	0	0	576.9	0	0.1	0.2	0	0	0	0	0	0	0	1.9	0	0	0	3.6	0.1	0	108.1	0	0	0	0	0	0.3	0	0	0.3	0	0	0	0.2	Exocrine glandular cells
KRTAP21-2	KAP21.2	ENSG00000187026	Keratin associated protein 21-2	Q3LI59	21	30746794-30747233	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level	No human protein/transcript evidence	No human protein/transcript evidence		Group enriched	Detected in some	45	skin 1: 3.4;testis: 5.7	Cell type enriched	Detected in single	21	Early spermatids: 4.3	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	10	HEK 293: 6.6																																							0.1	0	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	3.4	0.1	0.1	0.1	0.1	0	5.7	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	6.6	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0.4	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	Early spermatids
TMEM262		ENSG00000187066	Transmembrane protein 262	E9PQX1	11	65084979-65089375	Predicted membrane proteins				Evidence at transcript level	Evidence at transcript level	No human protein/transcript evidence	Evidence at transcript level		Tissue enriched	Detected in some	12	testis: 18.1	Cell type enriched	Detected in some	16	Early spermatids: 137.1	Not detected	Not detected							Group enriched	Detected in some	5	memory B-cell: 1.5;neutrophil: 1.1	Group enriched	Detected in many	5	B-cells: 1.5;granulocytes: 1.1	Cell line enhanced	Detected in some		JURKAT: 1.1;Karpas-707: 1.9;T-47d: 1.1	Low region specificity	Detected in single																				unprognostic (4.36e-2)	unprognostic (2.77e-1)	unprognostic (1.78e-3)	unprognostic (1.62e-1)	unprognostic (1.61e-1)	unprognostic (1.71e-4)	unprognostic (1.85e-5)	unprognostic (3.28e-1)	unprognostic (2.87e-1)	unprognostic (1.12e-1)	unprognostic (3.19e-3)	unprognostic (7.18e-3)	unprognostic (7.13e-9)	unprognostic (9.53e-2)	unprognostic (1.66e-1)	unprognostic (1.08e-1)	unprognostic (1.84e-3)	0	0	0	0	0	0	0	0	0	0.2	0			0	0	0	0	0	0	0	0	0	0	0	0	0	0		0	0	0	0	0		0	0		0	0	0	0.1	0	0	0	0	0	18.1			0		0	0	0	1.5	0.1	1.1	0.2	0	0.2	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.1	0	1.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	1.5	0.1	0	0	0	0.2	0	1.1	0	0	0.1	0	0											0	0	0	0	0.2	0.1	1.1	0	0	0	0	0	0.2	0	0	137.1	0	0	0	0	0.2	0.3	0	0	0	0.3	0	0	0	0	8.5	0.9	0	0	0	0	0	0	0	1.1	0	0.2	0	0.3	0.9	0.5	0.3	0.3	0	0	0	Early spermatids
MITF	bHLHe32, MI, WS2, WS2A	ENSG00000187098	Melanogenesis associated transcription factor	O75030	3	69739435-69968337	Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	Activator, Developmental protein, DNA-binding	Albinism, Cancer-related genes, Deafness, Disease mutation, Microphthalmia, Osteopetrosis, Waardenburg syndrome	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in many			Cell type enriched	Detected in many	5	Melanocytes: 555.0	Group enriched	Detected in all	8	melanoma: 39.2;renal cancer: 9.1	Low region specificity	Detected in all			Group enriched	Detected in many	4	basophil: 4.5;classical monocyte: 10.9;intermediate monocyte: 3.6;myeloid DC: 6.8;non-classical monocyte: 5.7	Group enriched	Detected in many	5	dendritic cells: 6.8;granulocytes: 4.5;monocytes: 10.9	Cell line enhanced	Detected in many		HMC-1: 27.1;SK-MEL-30: 72.8	Low region specificity	Detected in all			Low region specificity	Detected in all			CAB002578, HPA003259	Enhanced											CAB002578: AB_564111, HPA003259: AB_1079381	unprognostic (3.29e-1)	unprognostic (4.26e-2)	unprognostic (2.98e-2)	unprognostic (6.04e-2)	unprognostic (1.03e-1)	unprognostic (3.25e-1)	unprognostic (1.04e-2)	unprognostic (1.09e-1)	unprognostic (2.75e-1)	unprognostic (5.31e-3)	unprognostic (3.87e-3)	unprognostic (1.94e-1)	prognostic favorable (8.35e-10)	unprognostic (6.37e-2)	unprognostic (1.08e-1)	unprognostic (2.04e-1)	unprognostic (1.73e-1)	12.8	3.8	2.6	2.6	3.9	0.8	17.8	1.7	3	30.6	10.1	5.9	6.4	1.5	37.9	6.2	8.3	6.4	9.9	23.4	3.1	2.4	12.8	1.8	7.1	1.7	4.2	1.1	11.1	2.4	9.7	6.2	1.8	4	9	2.5	40.1	4	8.2	39.1	5.8	4.1	26.2	5	1.8	5.1	4.7	5.1	0.1	4.4	8.1	1	12.1	10.3	0	6.8	4.5	10.9	1.4	0.1	3.4	4.9	3.4	0.4	1.5	5.7	0.1	0.6	5	2.9	2.3	1.4	1.8	0.2	0	1.2	0	6.4	2.7	1	2.7	2.6	0	0.6	10.9	7.3	0.1	1.4	0.2	27.1	4.7	1.1	0.6	2.6	8.7	0.7	0	3.6	1.5	1.6	0.2	0.2	0.3	0.2	0.2	2.4	0	0.5	2.3	13.7	2.5	0.2	0.6	2.6	0.9	72.8	0.6	0.2	0.6	0	1.1	4.1	1.6	1	0.1	0.3	0	2.3	0.8	2.9	4.5	10.9	0	0	3.6	0	0	0	0.1	6.8	0	0	0	0.7	1.4	5.7	0.5	0	3.4	2.6	3.9	1.7	3	3.1	2.4	4.2	1.1	4	5.1	26.8	5	0	3.1	38	0.2	101.2	5.1	12	9.1	14	0	1.2	43.1	11.4	1.1	6.8	0	0	7.7	1	21	4.4	100.8	2.4	40.1	6.4	1.2	4.3	23.9	0.6	41.1	24	555	10.8	0	0.8	7.4	0	47.4	18.3	0.2	12.9	20.3	3.3	7.3	16.6	0.9	2.5	0.6	4.7	Melanocytes
HEATR4	MGC48595	ENSG00000187105	HEAT repeat containing 4	Q86WZ0	14	73478484-73558947	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		testis: 14.0	Cell type enriched	Detected in some	6	Early spermatids: 54.9	Not detected	Not detected							Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		MCF7: 5.8;SCLC-21H: 5.8	Not detected	Not detected							HPA003642, HPA079348	Enhanced											HPA003642: AB_1079376, HPA079348: 	unprognostic (5.25e-2)	unprognostic (2.45e-3)	unprognostic (2.85e-2)	unprognostic (1.36e-2)	unprognostic (2.53e-2)	unprognostic (2.60e-2)	unprognostic (3.50e-1)	unprognostic (8.09e-2)	unprognostic (3.13e-1)	unprognostic (1.51e-1)	unprognostic (4.49e-2)	unprognostic (1.39e-1)	unprognostic (1.02e-1)	unprognostic (3.28e-1)	unprognostic (5.50e-2)	unprognostic (1.96e-1)	unprognostic (4.82e-3)	0.3	0.3	0.7	0.7	1.1	0.8	0.4	3.4	1.1	0.7	0.3			2	1	0.1	0.5	0.7	0.7	0.7	0.9	0.8	0.3	0.9	0.4	1.6	0.5		1	0.8	0.5	0.5	0.1		0.5	0		0.8	0	2	4.4	0.7	0	0.8	0.9	0.7	14			1		0	0.2	0.7	3	1	1.7	0.7	1.4	2.3	0.4	1.6	1.8	0.9	1.3	0.1	0	0.7	0.8	0	0.1	0.3	0.5	0.4	1.8	0.1	0	0.3	3.6	0	0	0.2	0.5	0.4	1.3	0.3	0.1	0.3	1.2	2.4	0	0	0.2	0	1.3	0	1.9	0.6	0.7	0	5.8	0.5	2.1	0.8	0.4	1.8	1	0.9	0.8	0	2.5	5.8	0.7	2	2.6	2.9	1.3	3	0.2	1.1	0.2	2.2	1.8	0.2	1.5	0.5	0.4	1.2	0.5	0.2	1	0.7	0.3	1.8	0.5	1	2.1	2.2	1.2	0.3	3	2.3	2.3	1.7	1.4	0.1	1	1.1	0.4											0	1	0	0.3	0.2	0.8	0.8	0	1.4	0	0	0	0.2	0	0	54.9	0.1	0	0	0	0.1	0.2	0.2	0	0.4	0.1	0	0	0	0	8.7	0.6	0.2	0	0	0	0.5	0.1	0	0	0	0	0	0.4	0.7	1.5	0.6	0.1	0	0	0.1	Early spermatids
FOXD3	Genesis, HFH2	ENSG00000187140	Forkhead box D3	Q9UJU5	1	63323041-63325126	Disease related genes, Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	Activator, Developmental protein, DNA-binding, Repressor		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in many			Cell type enriched	Detected in single	7	Melanocytes: 5.0	Group enriched	Detected in some	6	melanoma: 9.9;testis cancer: 3.5	Group enriched	Detected in some	11	midbrain: 1.9;pons and medulla: 1.9	Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	5	NTERA-2: 13.8;SK-MEL-30: 11.2;WM-115: 17.2	Region enriched	Detected in single	13	olfactory region: 2.1	Region enriched	Detected in single	22	olfactory region: 18.3	CAB022455	Uncertain											CAB022455: 	unprognostic (1.39e-1)	unprognostic (3.23e-3)	unprognostic (2.33e-3)		unprognostic (4.63e-2)	unprognostic (7.79e-2)		unprognostic (8.22e-2)	unprognostic (3.83e-2)	unprognostic (1.29e-1)	unprognostic (9.92e-2)	unprognostic (3.28e-1)		unprognostic (3.00e-2)	unprognostic (8.56e-2)		unprognostic (5.83e-2)	1.1	2	0	2.9	0	0.2	1.6	0	0.1	4.2	9.3	0	1.8	1.3	0.7	3.1	8.7	0.8	7.3	3.3	0.1	0	0.3	0.2	0.1	0.1	1.9	0	1.1	0.3	0	0.2	0	1.9	4.6	1.2	7.7	2.2	3.9	5.9	2	2.7	1.7	0.5	0.1	2.3	2.7	0	0	0.4	2	0.4	5.8	4.4	0	0	0	0	0	0	0	0.1	0.2	0.1	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0.8	0	1.4	0	0	0.3	3	0	0	0	0	0	0.2	0	0	0	0	0	0	2.3	2.2	0	0	0.3	0	0	13.8	0	0.1	0	0	0	0	0	0.2	0	3	0	11.2	1.8	0.1	0	0	0	0	0	0	0	0	0	0	0	17.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0	1.9	0	1.9	0	0	0	0	0	0.5	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	5	0	0	0	0	0	0	0	0	0	0	0.7	0	0.3	0	0	0	0	Melanocytes
LCE2A	LEP9	ENSG00000187173	Late cornified envelope 2A	Q5TA79	1	152698364-152699442	Predicted intracellular proteins	Keratinization			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Group enriched	Detected in some	8	skin 1: 54.2;tongue: 14.1	Cell type enriched	Detected in single	7	Melanocytes: 1.7	Cancer enriched	Detected in some	5	melanoma: 10.9	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		BJ hTERT+: 11.0;SK-MEL-30: 3.9;U-138 MG: 2.0;U-2197: 2.8;U-87 MG: 1.4																											unprognostic (3.45e-2)			unprognostic (6.77e-2)									0	0	0	0	0	0	4.1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0	0.5	54.2	1.4	0	0	0	0	0	0	0.6	0	14.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.1	11	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.9	0	0	0	0	2	0	2.8	0	0	0	0	1.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.7	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	Melanocytes
LCE2C	LEP11	ENSG00000187180	Late cornified envelope 2C	Q5TA81	1	152675295-152676574	Predicted intracellular proteins	Keratinization			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in some	10	skin 1: 75.3	Cell type enriched	Detected in single	54	Suprabasal keratinocytes: 12.4	Group enriched	Detected in some	30	head and neck cancer: 2.0;melanoma: 9.3					Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		BJ: 1.0;CACO-2: 2.0																											unprognostic (1.47e-2)			unprognostic (7.00e-2)									0	0	0	0	0	0	7.4	0	0	0	0			0	0	0	0	0	0	0	0	0	0	0	0	0	0		0	0	0	0	0		0	0		0	0	0.9	75.3	0	0	0	0	0	0			0		0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	12.4	0	0	0	0	Suprabasal keratinocytes
KRT12	K12	ENSG00000187242	Keratin 12	Q99456	17	40861303-40867210	Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins			Corneal dystrophy, Disease mutation, FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		intestine: 3.3;retina: 3.6;skin 1: 1.9	Cell type enriched	Detected in some	5	Paneth cells: 7.0	Low cancer specificity	Detected in single			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	6	HeLa: 3.8	Low region specificity	Detected in many			Not detected	Not detected			HPA055217, HPA055835	Enhanced											HPA055217: AB_2682742, HPA055835: AB_2682935	unprognostic (1.89e-1)	unprognostic (2.40e-2)	unprognostic (1.01e-1)	unprognostic (4.82e-1)	unprognostic (2.19e-1)	unprognostic (2.04e-1)	unprognostic (1.74e-2)	unprognostic (5.52e-2)	unprognostic (9.41e-3)	unprognostic (3.49e-1)	unprognostic (1.73e-1)		unprognostic (3.94e-3)	unprognostic (2.01e-2)	unprognostic (1.27e-1)	unprognostic (2.60e-4)	unprognostic (6.31e-3)	0.1	0	0.1	0.2	0.1	0	0.1	0.1	0.9	0.1	3.3	0.1	0.1	1.3	0.1	0.1	0.1	0	0.2	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	1	3.6	0.1	0.1	0.1	1.9	3.3	0.1	0.1	0.1	0.4	0.7	0.1	1.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0	0.3	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0.2	0.1	0.1	3.8	0.6	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0.3	0	0.3	0.2	0.3	0	0.1	0	0	0	0	0.2	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0.1	0.1	0.1	0.9	0.1	0	0.1	0.1	0.1	0.1	0	0	0	0	0.2	0	0.2	0	0	0	0	0	0	0	0	1.3	0	1.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0	7	0	0	0	0	0	0	0.4	0	0	0	0	0	Paneth cells
NPSR1	GPR154, GPRA, PGR14	ENSG00000187258	Neuropeptide S receptor 1	Q6W5P4	7	34658239-34878332	Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins		G-protein coupled receptor, Receptor, Transducer	Asthma	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in some		brain: 3.5;retina: 9.1;stomach 1: 3.7	Cell type enriched	Detected in single	6	Early spermatids: 3.7	Cancer enhanced	Detected in some		stomach cancer: 2.9	Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	5	HAP1: 4.7;SCLC-21H: 2.6	Low region specificity	Detected in many			Region enhanced	Detected in many		midbrain: 9.6															unprognostic (3.56e-1)	unprognostic (9.34e-2)	unprognostic (7.55e-2)	unprognostic (1.80e-1)	unprognostic (2.00e-2)		unprognostic (9.35e-2)			unprognostic (6.34e-3)			unprognostic (2.85e-1)	unprognostic (1.36e-2)		unprognostic (2.08e-2)	0	0.2	0.5	1	0.1	0	0	3.5	1	0.1	0.9	1.1	0	0	0	0	0.2	0.1	0	0	0.6	3.2	0	0	0	0	0.6	0	0	0	0	0.1	0.2	1.1	0	0.6	9.1	0	0	0	0.2	0	0.1	0.5	0	3.7	1.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0.5	4.7	0	0	0	0	0	0.1	0.5	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0	0	0.1	2.6	0	0.4	0	0	0.2	0	0	0	0	0.4	0	0	0.1	0.5	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0.1	3.5	1	0.6	3.2	0.6	0	1.1	0	0	0	0	0	0	0	0.6	0	0	0	0	0	0.3	0	0	3.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0.3	0	0	0	Early spermatids
CIDEC	CIDE-3, FLJ20871, Fsp27	ENSG00000187288	Cell death inducing DFFA like effector c	Q96AQ7	3	9866711-9880254	Disease related genes, Predicted intracellular proteins	Apoptosis, Transcription, Transcription regulation	Activator		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Group enriched	Detected in many	16	adipose tissue: 129.9;breast: 63.7;intestine: 60.5	Cell type enriched	Detected in some	6	Enterocytes: 107.8	Low cancer specificity	Detected in many			Not detected	Not detected			Cell type enhanced	Detected in some		memory B-cell: 2.2;plasmacytoid DC: 1.8	Low lineage specificity	Detected in many			Cell line enriched	Detected in some	4	ASC diff: 197.1	Not detected	Not detected			Low region specificity	Detected in all			HPA018837, HPA020553	Approved											HPA018837: AB_1846767, HPA020553: AB_1846769	unprognostic (1.83e-2)	unprognostic (3.08e-2)	unprognostic (2.32e-1)	unprognostic (1.83e-1)	unprognostic (1.19e-1)	unprognostic (7.80e-2)	unprognostic (1.66e-3)	unprognostic (1.26e-5)	unprognostic (9.03e-2)	unprognostic (1.81e-1)	unprognostic (5.48e-3)	unprognostic (8.14e-2)	unprognostic (5.37e-5)	unprognostic (9.47e-3)	unprognostic (2.02e-1)	unprognostic (7.46e-3)	unprognostic (2.94e-2)	129.9	1.1	0.1	5.3	0.1	0	63.7	0.1	0.1	0.4	44.3	0.1	0.9	13.5	0.5	0.6	0.1	0.2	5.3	2.3	0.1	0	0.6	2.6	0.1	2.7	0.1	0.1	0.1	1.4	0	0.1	0.1	0.1	0.4	0.8	0.1	2.9	0.8	1.7	2.4	60.5	0.8	0.1	0.1	0.8	0.4	0.1	0.1	0.4	1.9	0.2	2.4	1.1	2.2	1.8	0.1	0.5	0.2	0.2	0.2	0	0	0	0	197.1	44.5	0.1	0	0	0	0	0.8	1	0	0	0	0	0	0	0	0	0	0	0	0	2.1	0.3	0	0	26.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.4	0.1	0	0.5	0	2.2	0.1	0	0.5	0.6	0	0.2	0	0.2	0.4	1.8	0	0.2	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	0	0.3	0	0	0.2	0	0	0	0	0	0	1.7	0	0.4	0	107.8	0	0	0	0	0.3	0	0.8	0	0	3.4	0	0	0.8	2.3	0	1.7	0	1.7	0	0.6	17.3	0.4	0.3	0	0	0.1	0.5	0	0	0	0	0.3	0.1	Enterocytes
CDHR4	CDH29, VLLR9392	ENSG00000187492	Cadherin related family member 4	A6H8M9	3	49790732-49799835	Predicted intracellular proteins, Predicted membrane proteins	Cell adhesion			Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		epididymis: 37.8;fallopian tube: 42.7	Cell type enriched	Detected in some	7	Ciliated cells: 132.5	Cancer enriched	Detected in some	6	endometrial cancer: 6.8	Region enhanced	Detected in some		pons and medulla: 5.7	Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		ASC TERT1: 4.7;HeLa: 4.5	Region enhanced	Detected in many		basal ganglia: 17.7	Low region specificity	Detected in single			HPA076277	Enhanced				Intracellular and membrane							HPA076277: AB_2732306	unprognostic (1.50e-4)	unprognostic (4.87e-2)	unprognostic (6.00e-2)	unprognostic (2.00e-3)	unprognostic (2.37e-2)	unprognostic (2.45e-3)	unprognostic (6.35e-7)	unprognostic (1.17e-1)	unprognostic (1.13e-2)	unprognostic (1.12e-1)	unprognostic (9.61e-2)	unprognostic (2.35e-1)	unprognostic (9.07e-11)	unprognostic (2.65e-1)	unprognostic (3.70e-2)	unprognostic (1.13e-2)	unprognostic (2.37e-1)	0.2	0.1	0.4	0.1	1.6	0.3	0.1	0	0	4.9	0.2	1.9	0	0.1	1.3	37.8	0.1	42.7	0.1	0.1	0.7	0.9	0.1	0.1	11.4	0.1	0	0	8	0	0	0.8	0.6	5.7	0.1	0.1	0	0.1	0.2	0.1	0.9	0.1	0.3	0.2	0	0.1	3.9	0	0	0	0.5	0.2	0.2	0.1	1.1	1.5	3	4.1	1.3	0.4	5.8	0.5	1.8	0.5	0.3	0.5	4.7	0.3	0.4	0.1	1	1	0	2.7	0	0.2	1.1	0.6	0.5	0.1	0	0.3	0.3	0.3	0.8	4.5	1	0	0.3	0.5	0.7	1.5	0.8	0.3	1.2	0	0.3	0.2	0.7	0	0	0	0.8	0.3	0.6	0.2	0.8	0.2	0	0	0.3	0.1	0.1	1.6	1.1	0	0.1	0.2	0.1	0	0.6	0.2	0.7	0.1	0.7	2.4	0.1	2.2	1.3	0	3	4.1	0.4	0.4	1.6	0.3	0.4	0.3	0.3	1.5	1.1	0.3	0.4	2.5	1.3	0.2	0.5	0.2	5.8	0.4	1.6	0	0	0.7	0.9	0	0	5.7	0	0	4.3	0	0.1	0.1	0	0.4	0	132.5	18.2	0	0	0	0	0	0.6	0	0	0	0.2	0	0.2	0.1	0	0	0.1	0	0	0	0	2.2	0	0	0	0	0	0	0	0	0.4	0	0	0	0	4.4	0.5	0	0	0	0	0.1	Ciliated cells
PLEKHG7	FLJ46688	ENSG00000187510	Pleckstrin homology and RhoGEF domain containing G7	Q6ZR37	12	92721462-92772455	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in some		epididymis: 5.6;fallopian tube: 7.9	Cell type enriched	Detected in some	5	Ciliated cells: 56.2	Low cancer specificity	Detected in single							Group enriched	Detected in some	31	memory B-cell: 4.5;naive B-cell: 1.6	Lineage enriched	Detected in single	45	B-cells: 4.5	Cell line enhanced	Detected in some		Daudi: 1.8;HBF TERT88: 1.3;RPMI-8226: 5.1;RT4: 1.2;SK-BR-3: 4.2									HPA060632	Uncertain											HPA060632: AB_2684333	unprognostic (4.47e-3)	unprognostic (3.95e-2)	unprognostic (1.16e-1)	unprognostic (1.05e-3)	unprognostic (1.80e-2)	unprognostic (9.91e-5)	unprognostic (1.38e-1)	unprognostic (9.44e-2)	unprognostic (1.61e-1)	unprognostic (6.20e-2)	unprognostic (1.27e-1)	unprognostic (1.37e-1)	unprognostic (2.56e-1)	unprognostic (2.13e-1)	unprognostic (2.75e-1)		unprognostic (3.27e-5)	0	0	0	1.3	0	0	0	0	0	3.3	0.6			0.1	0.4	5.6	0.1	7.9	0.3	0	0	0	0.7	0.5	2.2	2	0		0	1.4	0	0	0		0.8	0.4		0.1	0.6	0	0	2.6	0	0	1.6	2.7	0.1			0		2.9	2.9	0	4.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0.5	0	0.2	1.8	0	0.4	0	0	0	0	1.3	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0.2	0.1	0.1	0	0	0.1	0	5.1	0.1	1.2	0	0	0	4.2	0	0.5	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4.5	0	0	0	1.6	0	0	0	0	0	0	0	0											0	0.3	6.9	0.1	0.1	0.3	0.6	0	56.2	11.4	1.8	0	0	0	0.4	0.9	0	0	0	0.2	0	0	0.4	1.1	0	0	0	1.2	0	0	0.5	0	0	1.7	0	0.2	0	0.3	0	0	0	0.4	0	0	0	0	0	0	0	0.2	0.8	Ciliated cells
AGMO	FLJ16237, TMEM195	ENSG00000187546	Alkylglycerol monooxygenase	Q6ZNB7	7	15200318-15562015	Enzymes, Predicted intracellular proteins, Predicted membrane proteins		Oxidoreductase		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	7	intestine: 41.9;liver: 57.9	Cell type enriched	Detected in some	5	Hepatocytes: 79.7	Cancer enriched	Detected in many	5	liver cancer: 15.7	Low region specificity	Detected in some			Group enriched	Detected in some	5	basophil: 3.6;neutrophil: 3.1	Lineage enriched	Detected in single	5	granulocytes: 3.6	Cell line enhanced	Detected in some		HSkMC: 4.1;Karpas-707: 8.7;NTERA-2: 3.9;SCLC-21H: 3.7;TIME: 4.4;WM-115: 17.2	Low region specificity	Detected in all			Low region specificity	Detected in many			HPA057900			Uncertain	Vesicles						Vesicles		HPA057900: 	unprognostic (2.82e-1)	unprognostic (9.28e-2)	unprognostic (5.60e-3)	unprognostic (1.44e-4)	unprognostic (7.52e-2)	unprognostic (1.07e-2)	unprognostic (3.61e-2)	unprognostic (6.56e-2)	unprognostic (3.31e-1)	unprognostic (3.35e-1)	unprognostic (4.18e-3)	unprognostic (3.24e-1)	unprognostic (1.64e-1)	unprognostic (2.04e-2)	unprognostic (3.45e-1)	unprognostic (1.00e-1)	unprognostic (1.93e-1)	6.8	0.2	0.8	1	1.2	0.1	3.7	0.3	0.5	0.3	16.5	1.1	0.1	4.6	0.3	7.3	0.3	0.3	4.7	0.9	0.7	0.6	5.3	57.9	0.4	0.5	1.1	0.8	0.3	0.3	0	0.7	0.4	0.7	0.4	0.3	0	0.4	0.1	0.5	0.5	41.9	0.1	1.1	0.3	0.3	1.8	2	0	0.7	0.1	0.1	1	0.4	0.2	0.1	3.6	0.1	0.6	0.1	0	0	2.5	0.1	2.2	0.2	3.2	0.1	0	0.1	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0.2	0	0.1	0	0.3	0	0	4.1	0	0	0	0	0	0	0	8.7	0	0	0	0.1	3.9	0	0	0	0	1.3	0	0.7	3.7	0	0	0	0	2.9	0	0	4.4	1.5	0.3	0.2	0	0.7	0	0	0	0	17.2	3.6	0.1	0.1	0.1	0	0.1	0.1	0.1	0	0	0.2	0.1	0.1	3.1	0.6	0	0.1	0	0	0.8	1.2	0.3	0.4	0.7	0.6	1.1	0.8	0.7	2	0	0	0	0.1	0.1	0	0	15.3	0	0	3.5	0	0.1	0	0	0.7	0.1	2.6	0	0	0.1	0.7	0	0	79.7	0.1	0	1.7	1.3	1.3	0.9	0	0.1	3.3	0	0.1	0	0.6	0	0	15.2	0	6.5	0.2	0.4	2.5	0	0.1	0	0.6	0	Hepatocytes
ZNF385C		ENSG00000187595	Zinc finger protein 385C		17	42025576-42098479	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level				Group enriched	Detected in many	6	brain: 19.0;testis: 21.9	Cell type enriched	Detected in some	9	Early spermatids: 27.8	Low cancer specificity	Detected in many			Region enriched	Detected in some	9	cerebellum: 19.0	Cell type enriched	Detected in single	7	plasmacytoid DC: 3.2	Lineage enriched	Detected in single	7	dendritic cells: 3.2	Cell line enhanced	Detected in some		HDLM-2: 3.9;JURKAT: 3.7;MOLT-4: 6.7;SCLC-21H: 5.5	Region enriched	Detected in single	12	cerebellum: 31.8	Region enriched	Detected in all	7	cerebellum: 44.2														unprognostic (1.58e-3)	unprognostic (3.38e-2)	unprognostic (2.02e-3)	unprognostic (3.95e-2)	unprognostic (3.95e-2)	unprognostic (2.61e-1)	unprognostic (3.07e-1)	unprognostic (2.64e-1)	unprognostic (2.48e-1)	unprognostic (8.67e-3)	unprognostic (1.10e-1)	unprognostic (8.90e-2)	unprognostic (2.59e-1)	unprognostic (8.71e-2)	unprognostic (1.50e-1)	unprognostic (6.22e-2)	unprognostic (6.05e-2)	0.4	0	0.7	1.6	0.7	0.5	1.6	19	0.8	0.5	0.4	0.4	0.4	0.1	1	0.5	0.4	2	0.4	0.4	0.5	0.4	0.6	0.4	0.8	0.4	2	0.4	3.4	3.1	0.6	2.1	0.4	1.4	1.4	0.2	0.4	2.3	0.5	2.9	0.7	0.4	0.4	0.9	0.6	0.5	21.9	0.4	0.9	0.4	0.9	1.5	0.4	0.5	0.4	3.2	0	0	0	0.2	0	0.3	0.3	0.5	0	0	0	0.4	0.1	0.1	0.1	0.1	0.5	2.4	0	1.2	0	0.1	0.8	0.3	0	0	3.9	2.4	0	0	0.8	0.1	0	1	0	2.9	0	1.4	0.1	0	3.7	0.2	0	0	0.5	6.7	0.1	0.5	1.2	0	0.5	0	1.1	0.1	0.4	5.5	0.6	0.2	0.5	0.3	0.7	3.1	1.2	0	0	0.4	0	0	2.6	0.5	0.4	0	0.7	0.4	0	0	0	0	0	0	0.4	0	0	0	0	0	0.2	0	0	0	3.2	0	0	0.7	0.7	19	0.8	0.5	0.4	2	0.4	1.4	0.4	0	0.3	0	1.6	0.3	2	0.4	0	0	0	1.8	0	0.1	1.7	0.4	27.8	0	0.4	0	0.4	0.1	0.6	2.3	0	0	0.6	1.6	0	0	0	3.1	1.4	0	0	0	0.5	2.9	0.2	0	0	0	1.8	0	0	0.9	1.9	0.5	0	0	0.4	0.8	Early spermatids
SAMD11	MGC45873	ENSG00000187634	Sterile alpha motif domain containing 11	Q96NU1	1	923928-944581	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in many			Cell type enriched	Detected in many	7	Rod photoreceptor cells: 235.2	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enriched	Detected in single	10	NK-cell: 4.7	Lineage enriched	Detected in single	10	NK-cells: 4.7	Group enriched	Detected in many	4	HEK 293: 38.7;HeLa: 42.9;SCLC-21H: 28.0	Not detected	Not detected			Low region specificity	Detected in many			HPA030110			Approved	Nucleoplasm,Vesicles						Nucleoplasm, Vesicles		HPA030110: 	unprognostic (9.96e-2)	unprognostic (1.75e-1)	unprognostic (4.11e-2)	unprognostic (1.11e-2)	unprognostic (1.20e-2)	unprognostic (2.42e-1)	unprognostic (9.28e-2)	unprognostic (6.90e-2)	unprognostic (3.11e-2)	unprognostic (1.45e-1)	unprognostic (1.62e-2)	unprognostic (1.56e-1)	prognostic unfavorable (3.35e-5)	unprognostic (3.01e-2)	unprognostic (1.05e-2)	unprognostic (3.26e-2)	unprognostic (1.18e-1)	2.1	10	2.4	5	3	1	1.6	1.6	4.7	4.4	3	7.2	2.5	5.1	9.5	7.4	4.2	13.6	4.5	8.5	5.7	4	10	2.9	2.4	2.1	6.9	2	5.9	1.8	0.6	21.9	0.6	5.9	12.4	1.4	16.9	2.4	22.1	1.4	0.3	5.6	6	8.8	11.7	5.5	2.7	5.1	0.3	4.6	0.6	0.5	7.2	22.8	0.3	0	0	0.2	4.7	0.4	0	0.1	2.7	0	2.5	0.1	0	0.9	4.2	0.2	0.2	0.1	0.1	0.8	0	8.1	8.7	2.2	5.5	2.7	0	0	0.3	38.7	0	42.9	0.1	0.7	0	0.3	1.6	0	0	0	4.3	0	0.1	1.4	0	0	2.9	0	0	1.6	0.1	0.3	0.2	0.6	2.2	0.4	0	28	8.6	8.8	4.2	0	2.6	4.9	0.2	0.5	1.4	6.4	0.1	0.9	0.5	0	0.1	1.8	0.6	0	0	0.1	0	0.3	0.2	0.4	0.3	0.2	0.2	0	0.1	0.1	0.4	0	4.7	0.1	0	0	0	2.4	3	1.6	4.7	5.7	4	6.9	2	5.9	5.1	0	2.6	0	0.1	0.3	16.4	0.8	0	0	3.4	3.5	27.5	0.2	0	0.5	2.2	0.8	0	0	0.3	0.6	2.3	2.5	0	0	0.2	33.4	25.4	6.7	0.3	7.9	0.9	0	0	0	0	15	2.6	0.2	3.9	0.2	235.2	0	1.4	0.9	16.6	0.5	0.1	0	0	0.3	Rod photoreceptor cells
HAPLN4	BRAL2, KIAA1926	ENSG00000187664	Hyaluronan and proteoglycan link protein 4	Q86UW8	19	19255641-19262796	Predicted secreted proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	4	brain: 38.5;intestine: 24.3	Cell type enriched	Detected in single	6	Hepatocytes: 4.9	Not detected	Not detected			Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		NB-4: 5.7;NTERA-2: 14.9;SCLC-21H: 3.2	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA055856	Enhanced				Secreted in brain							HPA055856: AB_2682946					unprognostic (3.36e-4)													0.5	1.9	3	0.4	7.5	0.4	0.7	8.9	38.5	2.4	0.6	1.6	0	19.6	1.6	0.5	0.4	0.7	0.6	0.5	8.9	9.4	0.5	7.5	0.6	0.4	7.8	2.7	1.4	1.3	0.4	0.2	0.7	26.4	1.1	0.6	0.4	0.5	0.8	0.4	0.4	24.3	0.6	3.8	0.4	0.8	0.5	0	0	0.4	0	0.4	0.5	0.3	0	0.6	0	0	0	0	0	0	0	0.5	0	0	0	0.1	0	0	0	0.1	0	0	0	1.7	0	0.2	0	1.7	0	0	0	0.1	0	0	0	0.6	0.6	0	0.1	0	0.1	0	0	0	0	0.2	0	0.3	0	0	5.7	14.9	0	0	0	0	0	0	0	3.2	1.5	0	0	0	0.6	0	1.1	0	0	0.4	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0	3	7.5	8.9	38.5	8.9	9.4	7.8	2.7	26.4	0	0	0	0	0	0.1	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4.9	0.1	0	0	0.6	0	0	0.3	0	0	0	0	0	0	0	0	0	0.9	0	0	0	0.1	0	0	0	0	0	Hepatocytes
ADH1A	ADH1	ENSG00000187758	Alcohol dehydrogenase 1A (class I), alpha polypeptide	P07327	4	99276367-99291028	Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins		Oxidoreductase	FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	322	liver: 250.3	Cell type enriched	Detected in some	10	Hepatocytes: 212.0	Cancer enriched	Detected in some	251	liver cancer: 165.9	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	5	ASC diff: 11.2									CAB009562, HPA047814, HPA060902	Enhanced		Approved	Plasma membrane,Cytosol					12000000	Plasma membrane, Cytosol		CAB009562: AB_2257984, HPA047814: AB_2680163, HPA060902: AB_2684384	unprognostic (5.89e-2)	unprognostic (6.16e-2)		unprognostic (1.20e-1)	unprognostic (2.07e-1)	unprognostic (4.40e-1)	prognostic favorable (2.38e-4)	unprognostic (2.78e-3)		unprognostic (4.25e-1)	unprognostic (4.79e-3)	unprognostic (6.21e-2)	unprognostic (9.36e-2)	unprognostic (3.25e-2)	unprognostic (1.40e-1)		unprognostic (2.86e-2)	0.4	0	0	0	0	0	0.1	0	0	0	0.7	0	0	0.7	0	0	0	0	0.6	0	0	0	0	250.3	0	0	0	0	0.1	0	0	0	0	0.1	0	0	0	0	0	0	0	0.4	0	0	0	0	0.3	0	0.1	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0.5	0	11.2	0	0	0.4	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0.9	0	0.1	0	2.2	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0.1	0	0	0	1.7	0	0	0	0.1	0	1.3	0	0	0.2	0	0	0	0	0.1	0	0	0.1	0	1	0	0.6	0.1	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0.5	0	0	0	0.2	20.4	0	0	0	0	0	0	0	0.9	0	0	0	0	0	0.2	0	0	212	0	0	0	7.4	6.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0.2	0	0	0	0	0	Hepatocytes
FAM69C	C18orf51	ENSG00000187773	Family with sequence similarity 69 member C	Q0P6D2	18	74434099-74457944	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 29.1;heart muscle: 10.8	Cell type enriched	Detected in some	5	Muller glia cells: 197.8	Group enriched	Detected in some	18	glioma: 11.1;melanoma: 6.8	Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	9	SK-MEL-30: 11.0	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA048928	Enhanced											HPA048928: AB_2680560	unprognostic (6.35e-2)	unprognostic (1.13e-2)	unprognostic (8.09e-2)	unprognostic (3.32e-2)	unprognostic (4.08e-2)	unprognostic (3.19e-1)	unprognostic (1.43e-2)	unprognostic (1.10e-1)	unprognostic (3.31e-1)	unprognostic (8.97e-2)	unprognostic (2.43e-1)	unprognostic (4.10e-2)	unprognostic (1.91e-4)	unprognostic (2.16e-1)	unprognostic (6.73e-2)	unprognostic (3.23e-2)	unprognostic (4.40e-3)	1.1	0.9	13.8	0.7	20.5	0.6	1.1	3.5	29.1	3.4	1	9.5	0	0.7	0.9	0.8	0.8	1	1.3	10.8	11	9	0.8	1.1	0.6	0.7	15.5	5.2	0.7	0.9	0.8	0.1	0.9	9.9	1.1	0.9	3.7	0.9	1.7	2.3	7	0.9	0.9	5.3	0.8	3	7.3	18.8	0	0.8	0	0.7	0.7	0.2	0.5	0	0	0	0	0	0	0	0	0	0	0	0	1.2	0	0	0.1	0	0.1	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	1.2	0	0	0	0	0	0	0	0	11	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	13.8	20.5	3.5	10.3	11	9	15.5	5.2	9.9	18.8	0	0	0	0	1.1	1	18.7	0	0	0	0	0	0	0	0.1	3.5	0.1	0	0	1.2	0	0.2	0.1	0	0	0.4	38.1	0	2.5	0.8	2	0	0	30.4	0	0	197.8	0.8	0	0	0	3.7	12.9	1.4	0.6	0	0.1	0	0	0	0	Muller glia cells
HELT	bHLHb44, HCM1228, HESL, MEGANE, Mgn	ENSG00000187821	Helt bHLH transcription factor	A6NFD8	4	185018841-185020804	Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	DNA-binding, Repressor		Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in some		kidney: 2.9;lung: 2.2;skin 1: 2.0	Cell type enriched	Detected in single	9	Distal tubular cells: 3.3	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	8	HAP1: 5.2;HEK 293: 3.3	Not detected	Not detected			Not detected	Not detected			HPA036188, HPA036189	Uncertain											HPA036188: AB_10672237, HPA036189: AB_2674997																		0	0	0	0	0	0	0	0	0.1	0	0			0	0	0	0	0	0	0	0	0	2.9	0	2.2	0	0		0	0	0	0	0		0	0		0	0	0	2	0	0	0	1	0.5	0.5			0		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	5.2	0	0	0	3.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0	0	0.3	0	0	0	0	0	0	3.3	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Distal tubular cells
C2orf78	COG5373, FLJ43987, hCG1989538	ENSG00000187833	Chromosome 2 open reading frame 78	A6NCI8	2	73784189-73817147	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enriched	Detected in single	141	testis: 14.0	Cell type enriched	Detected in some	13	Early spermatids: 42.1	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	5	GAMG: 4.1;U-266/70: 1.7;U-266/84: 1.2					Not detected	Not detected																			unprognostic (5.25e-2)			unprognostic (6.56e-3)							unprognostic (2.42e-1)				0	0	0	0	0	0	0	0	0	0	0			0	0	0	0	0	0	0	0	0	0	0	0	0	0		0	0	0	0	0		0	0		0	0	0	0	0	0	0	0	0	14			0		0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0.1	0	0	0	0.1	0	0	0.1	0.1	0	0	0.1	4.1	0	0	0	0.3	0	0	0	0	0	0	0	0.1	0	0	0	0.2	0	0	0	0	0.1	0	0	0	0.1	0	0	0.1	0	0.4	0	0	0	0	0	0	0	0	0.2	0.3	0	0	0	0	0	0.2	1.7	1.2	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	42.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0.1	0	0	0	0	0	Early spermatids
P2RX2	DFNA41, P2X2	ENSG00000187848	Purinergic receptor P2X 2	Q9UBL9	12	132618776-132622386	Disease related genes, Predicted membrane proteins	Hearing, Ion transport, Transport	Ion channel, Ligand-gated ion channel, Receptor	Deafness, Disease mutation, Non-syndromic deafness	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		epididymis: 23.1;prostate: 11.1;seminal vesicle: 16.1	Cell type enriched	Detected in single	5	Peritubular cells: 2.8	Low cancer specificity	Detected in some			Group enriched	Detected in some	4	amygdala: 6.1;hippocampal formation: 8.6	Cell type enriched	Detected in single	13	plasmacytoid DC: 1.2	Lineage enriched	Detected in single	13	dendritic cells: 1.2	Group enriched	Detected in some	4	MCF7: 6.7;T-47d: 15.4	Not detected	Not detected			Low region specificity	Detected in many																unprognostic (1.12e-1)	unprognostic (1.49e-2)	unprognostic (5.92e-2)	unprognostic (5.94e-2)	unprognostic (2.79e-1)	unprognostic (1.07e-1)	unprognostic (3.12e-1)	unprognostic (5.79e-3)	unprognostic (6.75e-2)	unprognostic (2.92e-1)	unprognostic (1.11e-2)	unprognostic (3.66e-2)	unprognostic (1.88e-2)	unprognostic (6.21e-2)	unprognostic (3.05e-1)		unprognostic (9.12e-2)	0.4	0.1	6.1	0.5	0.6	0	0.3	0.3	1.6	0.7	1.5	0.3	3	1.1	0.3	23.1	5.3	2.5	0.3	0.3	8.6	0.9	1.1	0.3	3.6	1.8	0.3	0.3	0.3	0.3	0	0.9	0.7	0.3	11.1	0.3	0.6	0.3	16.1	0.3	0	3.4	0.3	0.3	2.4	1.3	1.3	0.3	0.3	0.3	0.3	0.8	0.7	1.7	0	1.2	0	0	0	0	0	0.2	0	0	0.1	0	0	1.2	0	0	0	0	0.7	0	0.2	0	0	0	0.2	0	0	0	0	1.1	0	0.1	0.1	0	0	0.2	0	0	0	0	0	0	0.3	0.2	0.1	0	6.7	0.1	0.4	0.7	0	0.1	0.1	0.2	0.1	0	0.4	0.1	0	0	2.7	0	1	15.4	0	0	0	0	0.1	0.1	0.2	1.3	0.8	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.2	0	0	6.1	0.6	0.3	1.6	8.6	0.9	0.3	0.3	0.3	0.3	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0	0	0.1	0	2.8	0	0	0	0	0	0.1	0	0	0	0	0	Peritubular cells
LRRC74B		ENSG00000187905	Leucine rich repeat containing 74B	Q6ZQY2	22	21045960-21064168	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in some		brain: 17.1;epididymis: 5.6;fallopian tube: 11.4	Cell type enriched	Detected in some	6	Ciliated cells: 132.5	Not detected	Not detected			Region enriched	Detected in many	7	pons and medulla: 17.1	Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		U-138 MG: 1.7;U-87 MG: 3.4	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA049947	Uncertain											HPA049947: AB_2680966	unprognostic (3.43e-2)	unprognostic (1.76e-1)		unprognostic (3.28e-4)	unprognostic (1.06e-1)	unprognostic (6.44e-3)		unprognostic (2.23e-2)	unprognostic (1.93e-1)	unprognostic (1.66e-1)	unprognostic (1.64e-2)	unprognostic (1.18e-1)	unprognostic (7.57e-9)	unprognostic (4.20e-1)	unprognostic (1.23e-1)	unprognostic (2.10e-2)	unprognostic (4.92e-2)	0.2	0.2	2.1	0.2	2.3	0.2	0.2	0.4	1.6	1.5	0.2	3.7	0	0.4	0.3	5.6	0.2	11.4	0.2	0.2	1.5	1.2	0.2	0.2	1.9	0.2	0.1	0.7	1.9	0.2	0.2	0.9	0.2	17.1	0.2	0.3	0.3	0.2	0.3	0.2	0.2	0.2	0.2	0.5	0.2	0.2	3.6	0.3	0	0.2	0	0.2	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0.5	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0.1	0	0.1	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.8	0.4	0	0	0.1	0	0	0	0	0	0	0	0	1.7	0	0	0	0	0	0	3.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.1	2.3	0.4	1.6	1.5	1.2	0.1	0.7	17.1	0.3	0	2.6	0	0.6	0	1	0.4	0	132.5	22.7	0	3.9	0.1	0	0	2.8	0	0	0	0	0.1	0	0.4	0	0.2	0.1	1.6	0	0.6	0	0.4	0.3	1.1	0	0	0	0.4	0	0	0	0	1.4	0	0	2.7	2.1	0	0.2	0	0	0	Ciliated cells
C2orf66	UNQ6411	ENSG00000187944	Chromosome 2 open reading frame 66	Q6UXQ4	2	196805002-196810276	Predicted secreted proteins				Evidence at transcript level	Evidence at transcript level	No human protein/transcript evidence	No human protein/transcript evidence		Tissue enhanced	Detected in some		adipose tissue: 7.0;pituitary gland: 6.4	Cell type enriched	Detected in some	12	Early spermatids: 27.1	Low cancer specificity	Detected in single							Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	4	HEL: 9.4;RT4: 3.5;TIME: 3.9									HPA020869	Uncertain		Uncertain	Nucleoplasm,Cytosol	Secreted - unknown location					Nucleoplasm	Cytosol	HPA020869: AB_1851545	unprognostic (1.19e-1)	unprognostic (4.85e-2)	unprognostic (6.95e-2)	unprognostic (1.19e-1)	unprognostic (3.48e-2)	unprognostic (1.61e-2)	unprognostic (6.80e-3)	unprognostic (3.05e-2)	unprognostic (1.95e-1)	unprognostic (4.10e-3)	unprognostic (4.54e-4)	unprognostic (1.98e-1)	unprognostic (1.75e-5)	unprognostic (1.84e-1)	unprognostic (2.30e-1)	unprognostic (1.38e-2)	unprognostic (1.86e-2)	7	4	0.4	0.2	0.7	0.2	1	0.1	0.4	0	0.2			0	0.1	1.2	0.1	1.1	0.4	0.7	0.4	2.8	0.3	0	0.2	0	0.7		0.3	0.6	0	6.4	0.1		0.3	0.4		0	0.2	0	2.8	0.3	0.1	0	0.2	0	2.6			0.1		0.2	0.8	0	0	0.6	0	0	0	0.5	0.4	0.1	0.1	0.4	1.1	0.5	0.3	0	0.5	0.2	0.2	0.3	0.1	0.2	0.1	0	0.1	0.1	0	0	1.1	0.2	0.3	0.6	9.4	1	0.1	0	0.1	0.8	0.7	1.4	0.2	0.2	0.2	0.8	0	0	0.1	0.5	0	0	0	0	0.2	0.8	0	0	0	0.2	3.5	0.4	0.2	0	0.1	0.1	0.4	0	0	3.9	0.3	0.3	0	0.9	0	0	0	0.1	0	0.9	0	0	0	0.1	0	0	0	0.3	0	0	0	0	0	0	0	0	0.6	0.5	0.4											0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	27.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.2	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0.1	0	0	0	Early spermatids
C17orf99	GLPG464, UNQ464	ENSG00000187997	Chromosome 17 open reading frame 99	Q6UX52	17	78146353-78166177	Predicted intracellular proteins, Predicted secreted proteins	Adaptive immunity, Immunity	Cytokine		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in some	7	bone marrow: 13.5	Cell type enriched	Detected in some	53	Erythroid cells: 93.5	Not detected	Not detected			Not detected	Not detected			Cell type enhanced	Detected in some		naive B-cell: 1.2;non-classical monocyte: 1.1	Low lineage specificity	Detected in many			Group enriched	Detected in some	11	HaCaT: 5.6;HMC-1: 11.6;K-562: 6.5									HPA029655	Uncertain				Secreted to blood							HPA029655: AB_10601691	unprognostic (3.55e-5)	unprognostic (1.87e-2)	unprognostic (2.06e-1)	unprognostic (1.22e-1)	unprognostic (1.88e-1)	unprognostic (1.45e-3)	unprognostic (1.47e-3)	unprognostic (2.39e-1)	unprognostic (3.86e-1)	unprognostic (9.77e-2)	unprognostic (2.05e-2)	unprognostic (5.13e-2)	unprognostic (1.38e-4)	unprognostic (6.58e-2)	unprognostic (4.72e-2)	unprognostic (2.66e-1)	unprognostic (5.78e-3)	0.2	0	0.1	0.1	0.1	13.5	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.7	0.9	0.1	0.1	0.1	0	0.1	0.1	1.6	1.2	0.1	0.1	0.6	0.1	0	0.1	1.9	0.1	0.2	0	0.1	0.4	0.1	0.1	2	0.6	0.1	0.1	1.3	0	0.1	0.1	0.1	0.1	0.1	1.1	1.9	0.9	1.2	0	0	1.1	0	0.3	0.1	0	0.5	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	5.6	0	0.7	0	0	0	0.2	0.3	0.5	0	0	11.6	0	0.1	0	0	0	0	0	6.5	0	0	0	0.4	0	0	0.1	0	0	0	0.3	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0.6	0	0	0	0	0	0	0	0.5	0	0	0	1.2	0	0.3	0	0	1.1	0	0	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	0	1.2	0.1	0.7	0	0	0	1.2	1.8	0	0.1	0	0	0	0	0	93.5	0.4	0.4	0.4	0.5	0	0	0.5	0	0	0.6	0	0	0.6	0	0	0	0.1	0	0	0	0	0	0	0	0.9	0.1	0.1	0.6	0.2	0	0.1	0.6	Erythroid cells
OR7D2	FLJ38149, HTPCRH03, OR19-4	ENSG00000188000	Olfactory receptor family 7 subfamily D member 2	Q96RA2	19	9178979-9188817	G-protein coupled receptors, Predicted membrane proteins	Olfaction, Sensory transduction	G-protein coupled receptor, Receptor, Transducer		Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in some		testis: 4.4	Cell type enriched	Detected in single	9	Early spermatids: 4.6	Not detected	Not detected							Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		HEL: 6.0																						unprognostic (5.00e-4)	unprognostic (2.03e-1)	unprognostic (3.40e-2)	unprognostic (1.66e-1)	unprognostic (3.84e-1)	unprognostic (2.86e-2)	unprognostic (2.56e-2)	unprognostic (3.40e-2)	unprognostic (6.34e-2)	unprognostic (1.54e-1)	unprognostic (7.09e-2)	unprognostic (3.07e-1)	unprognostic (5.16e-2)	unprognostic (1.35e-2)	unprognostic (2.63e-1)	unprognostic (4.08e-2)	unprognostic (4.92e-4)	0.6	0.8	0.6	0.9	0.8	2.3	0.5	0.7	1.5	0.6	0.5			0.1	0.7	0.8	0.4	0.5	0.2	0.4	0.6	0.8	0.6	0.5	0.3	1.9	0.4		0.3	0.6	0.1	0.8	0.1		0.6	0.4		0.5	1.2	0.9	1.9	0.8	0.6	0.6	1.5	1.2	4.4			0.6		0.9	0.9	0.3	1	1.2	3.1	0.7	1.3	1	0.1	0.6	0.5	0.8	2.8	0.9	0.8	0.6	0.6	0.1	0.3	0.2	0.5	0.7	1.2	1.4	0.2	0.8	1.3	0.5	0.4	0.5	0.9	0.7	6	1.2	1	0.2	0.8	1.4	0.2	0.8	0.2	0.3	0.7	0.2	1.4	1.8	2.9	0.1	0.3	1.4	1.6	0.8	0.3	0.8	1.3	1.3	0	0.1	1.8	1.1	0.8	0.6	1.1	0.4	1.2	1	0.3	0	1	1.1	0.6	0.7	1.6	0.9	1	0.8	0.7	0.5	2.8	0.7	0.5	0.9	0.4	0.7	0.6	0.6	0.5	0.3	1	0.7	1	3.1	1.3	0.6	1.2	0.4	0.1											0	0	0	0.2	0	0	0.3	0	0	0	0	0	0	0	0	4.6	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0.2	0	0.2	0	0	0.3	Early spermatids
RTP5	C2orf85, CXXC11, FLJ33590, Z3CXXC5	ENSG00000188011	Receptor transporter protein 5 (putative)	Q14D33	2	241869600-241873823	Predicted membrane proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in some	18	brain: 44.8	Cell type enriched	Detected in some	7	Early spermatids: 7.7	Cancer enriched	Detected in single	10	glioma: 1.7	Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	23	MOLT-4: 3.7;SCLC-21H: 7.4									HPA050902	Enhanced											HPA050902: AB_2681268	unprognostic (3.26e-2)	unprognostic (5.38e-4)	unprognostic (2.43e-2)	unprognostic (1.15e-1)	unprognostic (3.01e-1)	unprognostic (9.40e-4)	unprognostic (8.68e-3)	unprognostic (2.04e-1)	unprognostic (6.34e-4)	unprognostic (3.30e-1)	unprognostic (9.01e-3)	unprognostic (3.91e-1)	unprognostic (9.08e-8)	unprognostic (1.81e-1)	unprognostic (1.77e-1)	unprognostic (2.68e-2)	unprognostic (3.72e-2)	0.8	0.8	27.9	1.1	44.8	1.9	0.7	0.2	13.5	0.7	0.7	2.1	0	0.9	0.7	0.7	0.7	0.7	0.8	0.8	32.9	24.9	0.7	0.7	0.8	2.4	3.1	4.8	0.7	0.9	0.7	0	0.7	7.3	0.7	0.7	0	0.9	0.7	0.7	0.7	0.7	0.7	2.1	1.1	0.8	0.7	1.5	0	0.7	0	1.1	0.8	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	3.7	0	0	0	0	0.1	0	0	0	0	7.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	27.9	44.8	0.2	12.7	32.9	24.9	3.1	4.8	7.3	1.5	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	7.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Early spermatids
NWD1		ENSG00000188039	NACHT and WD repeat domain containing 1	Q149M9	19	16719976-16817963	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 27.8;fallopian tube: 14.1	Cell type enriched	Detected in some	8	Ciliated cells: 101.7	Cancer enriched	Detected in many	6	prostate cancer: 9.5	Low region specificity	Detected in many			Cell type enhanced	Detected in single		neutrophil: 1.3	Low lineage specificity	Detected in single			Group enriched	Detected in some	12	MCF7: 3.4;U-937: 7.9	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA075476			Approved	Nucleoli,Cytosol						Nucleoli, Cytosol		HPA075476: 	unprognostic (5.29e-3)	unprognostic (3.08e-2)	unprognostic (3.05e-2)	prognostic favorable (2.55e-4)	unprognostic (2.49e-1)	unprognostic (4.20e-4)	unprognostic (6.54e-2)	unprognostic (5.15e-2)	unprognostic (2.95e-1)	unprognostic (1.60e-1)	unprognostic (7.94e-2)	unprognostic (1.76e-1)	unprognostic (9.20e-2)	unprognostic (1.31e-1)	unprognostic (5.09e-2)	unprognostic (3.53e-2)	unprognostic (3.25e-1)	0.6	0.7	6.9	0.6	8.1	0.8	1	0.9	5.9	1.7	0.9	11.3	0.5	0.7	1.1	6.5	0.6	14.1	0.8	0.7	10.9	4.2	1	0.7	1.8	0.7	3.9	7.8	0.7	4.3	0.6	1.3	0.7	27.8	10.6	0.9	10.3	2.7	3.9	0.8	0.6	0.7	0.8	2.2	0.6	1	1.4	4.6	0	1.6	0	0.6	0.8	0.5	0.5	0.1	1.3	0.1	0.5	0.2	0.1	0	0	0	0	0	0	0.1	0	0	0	0	0	0.1	0.1	0.3	0	0.1	0	0	0.1	0	0	0.1	0	0	0	0	0	0	0	0.2	0	0.1	0	0	0	0	0	0	3.4	0.1	0	0	0	0.4	0	0	0.1	0	0	0.2	0	0	0	0	0	0	0	0.1	0	0.1	0	0	0	0	0	0	7.9	0	0.5	0.1	0.2	0.2	0.1	0.1	0	0	0	0	0.5	0	0.2	1.3	0.5	0	0.1	0	0.1	6.9	8.1	0.9	5.9	10.9	4.2	3.9	7.8	27.8	4.6	0	1	0	1.6	0.2	0.1	0.6	0	101.7	5.7	0	0	0.1	0	0	12	0	0	0	0	0.1	0	6.7	0	0	0.1	0	1.2	0	0	2.7	0.6	0.2	0	0	0.6	9.3	0.2	0	0	0	0	0	0	0	0.2	0.1	0.9	0	0.4	1.4	Ciliated cells
RAB42	MGC45806	ENSG00000188060	RAB42, member RAS oncogene family	Q8N4Z0	1	28592200-28595443	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		lymphoid tissue: 14.3	Cell type enriched	Detected in some	7	Hofbauer cells: 74.2	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		ASC TERT1: 10.6;Hep G2: 15.5;HSkMC: 11.0;REH: 8.5									HPA050290			Approved	Endoplasmic reticulum						Endoplasmic reticulum		HPA050290: AB_2681075	unprognostic (1.10e-1)	unprognostic (2.56e-1)	unprognostic (1.72e-1)	unprognostic (1.00e-1)	unprognostic (8.25e-2)	unprognostic (7.59e-2)	unprognostic (2.00e-4)	unprognostic (8.81e-2)	unprognostic (2.39e-1)	unprognostic (4.09e-2)	unprognostic (1.34e-2)	unprognostic (2.82e-2)	unprognostic (1.52e-2)	unprognostic (8.77e-2)	unprognostic (3.02e-2)	unprognostic (8.83e-2)	unprognostic (2.07e-3)	4.3	1.2	0.8	1.8	1.6	0.4	3.2	0.8	1.6	3.7	2.3	0.8	0.8	1.8	3.1	4.1	1.5	1.4	2.4	1.3	1.6	0.5	1.5	3.2	3.4	14.3	1.2	0.8	1.4	0.8	5	0.8	6.2	1.2	3.3	2.5	1.7	4.2	0.8	1.5	0.9	2.3	1.8	5.5	5.9	1.6	3	0.8	3.4	1	0.8	4.4	4.1	1.8	0.7	0.7	1.2	0.9	2.4	0.5	0.1	0.1	1.2	1	0	4.6	10.6	0	0.7	4.4	4.6	6.1	2.2	1.5	0.2	2.9	5	0.4	0.1	4.5	0	3	0.1	0.1	0.4	7.1	15.5	1.8	1.2	0	11	0.2	2.8	0	0.4	1.4	0.1	0.2	0.1	0.9	0	0.2	2.4	5.4	0.1	0	8.5	0	1.8	1.8	0	0.3	2.1	4.2	0.1	0	0.7	0.1	2	0.7	0	1.4	4.6	0.1	0.4	2.8	0.2	0.2	4.5	0.1	1.2	0.9	0.2	0.3	0.4	0.3	0.6	0.2	0.2	0.7	0.7	0.5	0.4	0.9	2.4	0.8	0.4	0.1	0.1	0.8	1.6	0.8	1.6	1.6	0.5	1.2	0.8	1.2	0.8	0	0	0	0.2	0.1	0.3	0.3	0	0	1.2	0	0	0.5	0	6.9	4	0.1	0	0	0	0.6	2.3	0.2	0	0	74.2	0	0	2.5	2.9	10	1.4	4.4	0	1.8	0	0.9	1.9	0.3	0	0.3	0.9	0	0.9	1.5	1.9	0.4	0.3	0	0	0.1	Hofbauer cells
SBK1	Sbk	ENSG00000188322	SH3 domain binding kinase 1	Q52WX2	16	28292519-28323849	Enzymes, Predicted membrane proteins		Kinase, Serine/threonine-protein kinase, Transferase		Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	7	brain: 31.1;lymphoid tissue: 22.1;skeletal muscle: 39.6	Cell type enriched	Detected in many	8	Cone photoreceptor cells: 76.6	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Group enriched	Detected in many	8	gdT-cell: 4.3;MAIT T-cell: 1.4;memory CD4 T-cell: 1.2;memory CD8 T-cell: 2.4;naive CD4 T-cell: 1.4;naive CD8 T-cell: 3.0;NK-cell: 1.4;T-reg: 1.4	Group enriched	Detected in many	10	NK-cells: 1.4;T-cells: 4.3	Cell line enhanced	Detected in some		AF22: 15.3;AN3-CA: 11.0;NTERA-2: 15.8;REH: 16.7;SCLC-21H: 24.3;SH-SY5Y: 22.9	Region enriched	Detected in all	5	cerebellum: 306.7																		unprognostic (5.15e-2)	prognostic favorable (6.88e-4)	unprognostic (2.08e-1)	unprognostic (6.22e-2)	unprognostic (1.81e-1)	unprognostic (1.71e-2)	unprognostic (5.71e-3)	unprognostic (3.66e-3)	unprognostic (1.17e-1)	unprognostic (1.62e-2)	unprognostic (2.87e-2)	unprognostic (6.38e-2)	unprognostic (1.19e-3)	unprognostic (3.99e-2)	unprognostic (3.50e-2)	unprognostic (7.91e-2)	unprognostic (5.03e-3)	0.9	2	8	1.8	7.3	2	1.7	31.1	17.5	1.7	1.2	1.5	0	1.1	1.9	1.3	1.5	1.6	1	1.8	9.9	5.6	1.6	0.9	1.8	2.7	6	4	1.1	2.7	4.2	4.1	0.8	8.3	2.6	1.2	1.4	3.8	1	39.6	1.4	1.1	0.9	3.1	2.8	1.6	2.3	3.1	22.1	2.6	0	1.7	1.2	0.3	0.2	0.2	0.2	0.1	1.4	4.3	0.4	0.1	0.2	15.3	11	0	0	2.4	0	0	0	0	0.1	0.7	0.3	0.1	0	0.3	0.3	4.6	0.1	0	1.5	0.5	0	0.1	0.4	0	0.1	0.3	0	0.1	0	0	0.1	0.1	5.8	0	1	0	1.8	7	0.1	15.8	1	0.1	16.7	0.8	0.1	0.1	0.9	24.3	22.9	0.4	1.4	0.2	1.9	1.7	0	0.4	0	2.4	0.2	0.1	0.2	0	0.2	0.1	0.2	0.9	0.2	0.1	0.1	4.3	0	1.4	0	1.2	2.4	0	0.2	1.4	3	0.1	1.4	0.1	0.2	1.4	0.4	8	7.3	31.1	17.5	9.9	5.6	6	4	8.3	3.1	3	0.3	0	0.8	0.6	9.4	3.1	2.5	2.7	3.4	0	76.6	0	1.7	6.1	1	0	0	0	4.8	0	0.4	1.5	0	0.2	0.1	0	5.8	0	0	3.1	0.6	0	0	0	0.3	4.2	4.7	0	0	0.5	2.7	0	0.3	1.4	2.3	0.1	0.1	2.5	0.8	0.3	Cone photoreceptor cells
IFNA2	IFN-alphaA, IFNA	ENSG00000188379	Interferon alpha 2	P01563	9	21384254-21385388	Predicted secreted proteins	Antiviral defense	Cytokine		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		blood: 1.6;brain: 1.3;lymphoid tissue: 1.1	Cell type enriched	Detected in single	20	Cardiomyocytes: 2.0	Not detected	Not detected			Low region specificity	Detected in some			Cell type enriched	Detected in single	17	eosinophil: 1.6	Lineage enriched	Detected in single	17	granulocytes: 1.6	Cell line enhanced	Detected in single		SuSa: 1.3									HPA047557	Uncertain				Secreted to blood			253000				HPA047557: AB_2680087																		0.1	0	0.8	0.1	1.3	0.8	0.1	0.3	0.4	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0	0.1	0.1	1	0.4	0.1	0.1	0.1	0.1	0.6	0.1	0.1	0.1	0	0.1	0.2	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.4	1.1	0	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	1.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.8	1.3	0.3	0.4	1	0.4	0.6	0.1	0.1	0.1	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Cardiomyocytes
TCTEX1D4		ENSG00000188396	Tctex1 domain containing 4	Q5JR98	1	44805913-44806675	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	4	blood: 7.9;epididymis: 3.1;fallopian tube: 12.4	Cell type enriched	Detected in some	8	Ciliated cells: 45.5	Low cancer specificity	Detected in some							Cell type enriched	Detected in single	12	neutrophil: 7.9	Lineage enriched	Detected in single	12	granulocytes: 7.9	Cell line enhanced	Detected in some		BEWO: 3.4;EFO-21: 2.4;HDLM-2: 2.7;SK-MEL-30: 2.2;TIME: 3.4	Low region specificity	Detected in many			Low region specificity	Detected in single			HPA062652	Enhanced											HPA062652: AB_2684818	unprognostic (3.12e-1)	unprognostic (3.13e-1)	unprognostic (1.81e-1)	prognostic favorable (1.58e-4)	unprognostic (5.28e-2)	unprognostic (3.59e-2)	unprognostic (2.85e-2)	unprognostic (2.26e-1)	unprognostic (3.85e-1)	unprognostic (1.69e-2)	unprognostic (1.26e-2)	unprognostic (4.92e-2)	unprognostic (4.70e-3)	unprognostic (2.86e-1)	unprognostic (2.20e-1)	unprognostic (1.59e-1)	unprognostic (7.83e-3)	0	1.1	0.2	0.4	0.2	0.8	0.2	0	0.1	1	0.2			0.5	0.8	3.1	0.2	12.4	0.7	0.2	0.3	0.4	0.3	0.5	1.8	0	0		0	0.7	0	0.3	0		0.1	0		0.6	0.3	0.1	0.2	0.5	0	0.1	0	1.2	0.1			0.5		0	0.2	0	0	0	7.9	0.6	0	0.2	0.3	1.4	1.2	0.3	0	0	0	3.4	1.5	0	0	0.2	0	1.2	0	2.4	0	0.5	1.9	0	0	0	2.7	0	0.3	0.5	0	0	0	0.6	0	0	0	0	0.7	0.6	0.5	0.4	0	0	0	0.1	0	0.1	0	1	0.6	0	1.5	0	0	0	0.1	0	0.2	2.2	0.2	0	0	3.4	0.2	1.9	0.2	0.7	1.4	1.2	0	0.2	0.4	0.6	0	0.6	0	0	0.3	0	0	0.2	0	0	0	0	0	7.9	0	0	0	0	0.3											0	0.3	0	0.5	0.2	0	0.2	2.5	45.5	5.7	1.8	0	0.1	0	0.9	0	0	1.4	0	3.5	0.2	0.2	0.2	0	0.9	0.7	0	0	0	0	0	0.3	0.9	0	1	1.2	0	1.3	2.9	0	1	0	0	0	0	0.2	0	0.2	0	0.6	0.5	Ciliated cells
SLC24A5	JSX, OCA6	ENSG00000188467	Solute carrier family 24 member 5	Q71RS6	15	48120972-48142672	Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters	Antiport, Calcium transport, Ion transport, Potassium transport, Sensory transduction, Sodium transport, Symport, Transport		Albinism	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	5	retina: 71.9	Cell type enriched	Detected in some	4	Melanocytes: 72.6	Cancer enriched	Detected in single	162	melanoma: 8.0	Low region specificity	Detected in some			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	751	SK-MEL-30: 75.0	Group enriched	Detected in some	5	hippocampal formation: 3.3;pons and medulla: 4.4;thalamus: 1.7	Low region specificity	Detected in all																				unprognostic (3.47e-2)				unprognostic (1.80e-1)	unprognostic (1.35e-1)			unprognostic (1.92e-3)					0.1	0.1	0.5	0.1	0.6	0.1	0.6	1.5	0.5	0.1	0.1	0.2	0.1	0.2	0.1	0.1	0.2	0.1	0.4	0.1	0.5	1	0.3	0.1	0.2	0.1	1.7	0.1	0.1	0.1	0.1	1.5	0.1	0.4	0.1	0.1	71.9	0.2	0.1	0.1	15.4	0.7	0.1	0.6	0.1	0.1	3	0.4	0.1	0.1	0.2	0.1	0.1	0.1	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	75	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0.5	0	0.5	0.6	1.5	0.5	0.5	1	1.7	0.1	0.4	0.4	0	0.3	0	0	2.2	6.1	0.3	0	1.4	0	0	2	0	0	0	16.5	0	0	0	0	0	0.2	0	0	0	0.1	4.8	0	0	0	3.8	0	0	72.6	0	0	0.8	0	0	0	0	4	0	0	0	0.1	0.9	0	0	0	0	Melanocytes
KRTDAP	KDAP, UNQ467	ENSG00000188508	Keratinocyte differentiation associated protein	P60985	19	35487324-35495558	Plasma proteins, Predicted secreted proteins	Differentiation			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		cervix, uterine: 110.5;skin 1: 326.3;tongue: 234.9	Cell type enriched	Detected in some	15	Suprabasal keratinocytes: 4612.7	Group enriched	Detected in many	7	head and neck cancer: 486.4;melanoma: 207.9	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	55	hTCEpi: 42.5	Not detected	Not detected			Not detected	Not detected			HPA063474	Enhanced				Secreted in other tissues				62000000			HPA063474: AB_2685019	unprognostic (4.55e-2)	unprognostic (2.46e-1)		unprognostic (1.64e-1)		unprognostic (6.11e-2)		unprognostic (1.59e-1)	unprognostic (8.80e-2)	unprognostic (7.13e-2)	unprognostic (3.05e-1)	unprognostic (3.80e-2)	unprognostic (1.50e-1)	unprognostic (2.76e-1)	unprognostic (1.57e-1)	unprognostic (1.05e-1)	unprognostic (1.16e-2)	0.2	0	0.2	0.2	0.2	0.1	29.4	0.2	0.2	110.5	0.2	0.2	0.2	0	8.2	0.2	5.7	0.1	0.3	0.2	0.2	0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.6	0.2	0.2	0	0.2	11.3	0.2	1.4	326.3	0.2	0.2	0.2	0.2	0	0.2	0.2	3.5	0.2	234.9	5.5	0.2	77.8	0	0	0	0	0	0.8	0	0	0	0	0	0	0	0.2	0	0	0	0	0.7	0	0.1	0	0	0	0.2	0	0	0	0	0.1	0	0	0.7	0.1	0	0	0	42.5	0	0	0	0	0	0	0	0	0.3	0	0	0.2	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0.2	0.2	0.2	0.2	0	0.2	0.2	0.2	0.2	0	0	0	0.2	309.6	0	0.3	0	0	0	0	0	0	0	0.3	15.3	0	0	0	0.2	0	0.8	0.4	0	0	0	0	0	0	0	40.6	0.9	0	40.5	0	0	0	0.7	0	0	0	0	0	0.3	38.6	16.1	4612.7	0	0	0	0.3	Suprabasal keratinocytes
HBA2	HBA-T2	ENSG00000188536	Hemoglobin subunit alpha 2	P69905	16	172876-173710	Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Transporters	Oxygen transport, Transport		Disease mutation, FDA approved drug targets, Hereditary hemolytic anemia	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	6	blood: 427.1;bone marrow: 1094.2	Cell type enriched	Detected in many	20	Erythroid cells: 168432.0	Cancer enhanced	Detected in all		glioma: 59.7	Low region specificity	Detected in all			Group enriched	Detected in many	6	eosinophil: 9.8;neutrophil: 33.6;plasmacytoid DC: 15.7	Group enriched	Detected in many	8	dendritic cells: 15.7;granulocytes: 33.6	Group enriched	Detected in some	18	HEL: 161.2;K-562: 43.2									CAB038417, HPA043780	Enhanced								17000000000			CAB038417: , HPA043780: AB_2678667	unprognostic (1.57e-1)	unprognostic (7.02e-2)	unprognostic (2.59e-2)	unprognostic (2.13e-1)	unprognostic (3.59e-1)	unprognostic (3.18e-1)	unprognostic (3.39e-2)	unprognostic (2.12e-1)	unprognostic (4.99e-2)	unprognostic (4.43e-1)	unprognostic (1.09e-2)	unprognostic (1.19e-2)	unprognostic (1.72e-3)	unprognostic (1.36e-1)	unprognostic (2.11e-1)	unprognostic (4.73e-2)	unprognostic (8.92e-2)	15.4	11.8	7.2	6.9	7.3	1094.2	7.6	4.1	4.1	4.1	4.1	4.1	4.1	1.1	4.1	4.1	4.1	7.7	5.8	19.5	5.8	6.2	24.3	17.7	38.4	4.1	11.2	4.1	4.1	4.1	0.5	8.9	128.7	4.1	4.1	1.3	4.1	9.2	5.6	17.7	0.9	4.1	4.1	9.3	98.3	1.9	4.1	4.1	4.1	12.5	4.1	4.1	4.1	20.1	1.4	15.7	33.6	0.9	1.5	3	427.1	0	0	0	0	0	0.1	0	0	0	0	0	0.4	0	0.2	0.6	0	0	0	0	0	0	0	0	161.2	0	0	0	0	0.2	0	0	0	0	0	0	0	43.2	0	0	0	0	0	0	0	0	0	0	5.7	0	0.1	1.6	1.3	0.1	0	0	0	0.2	0	0.7	0	0	0	0	0	0	0	0	0	0	3.5	0.9	9.8	3	0	0.1	1.4	0.3	0.2	1.4	0.8	0.8	2.6	33.6	1.5	0	15.7	0	427.1	7.2	7.3	4.1	4.1	5.8	6.2	11.2	4.1	4.1	4.1	3	1	72.9	0.1	39.4	1.2	4	12.7	4	1.2	0	0	0	46.4	0	2.6	9	1	168432	0	0	2.1	0.2	1.1	54.4	0	0	2.9	39.9	114.1	9.4	0	1.1	8337.5	0	1.3	1.3	0	3.7	0	12.3	41	0	364.9	0.2	6.6	39	0	20.8	0.7	0	Erythroid cells
CC2D2B	bA248J23.4, bA690P14.3, C10orf130, C10orf131	ENSG00000188649	Coiled-coil and C2 domain containing 2B	Q6DHV5	10	95907603-96032684	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		testis: 10.6	Cell type enriched	Detected in some	6	Early spermatids: 8.2	Not detected	Not detected							Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Low cell line specificity	Detected in many											HPA044091, HPA072122	Enhanced		Approved	Nucleoli,Nucleoli rim						Nucleoli, Nucleoli rim		HPA044091: AB_2732514, HPA072122: AB_2686489	unprognostic (6.38e-2)	unprognostic (5.95e-2)	unprognostic (1.47e-1)	unprognostic (5.00e-2)	unprognostic (1.36e-1)	unprognostic (1.19e-2)	unprognostic (1.04e-1)	unprognostic (2.39e-3)	unprognostic (1.21e-1)	unprognostic (3.63e-1)	unprognostic (8.18e-3)	unprognostic (2.11e-3)	unprognostic (9.11e-4)	unprognostic (1.93e-2)	unprognostic (4.34e-1)	unprognostic (5.45e-3)	unprognostic (1.41e-1)	0.5	1.7	1	1.7	1	1.7	0.6	0.3	3.1	0.8	0.8			0.6	2.3	0.2	0.8	1.3	2	0.8	0.6	0.6	0.6	0.3	0.9	1.1	0.9		0.8	0.2	0	0.4	0.7		0.9	0		0.5	0.1	1.6	2.6	0.9	1.2	0.7	1.4	0.6	10.6			4		0	1	1.1	4.1	1	1.8	1	0.8	2.9	0.5	1.2	4	3.9	7.2	0.2	0.4	4.1	3.9	0.4	0.6	0.1	4.2	0.8	5.1	3.1	0	4	2.8	0.3	0.2	0	4.9	8.8	9.2	3.4	3.2	0	9.8	0.6	0.7	0	0.4	0.1	1.7	0.3	1.3	7.9	3	0.9	2.5	4.5	3.3	8.5	3	6.6	11.6	3.5	4.3	0.7	1.3	7.1	3.8	4.3	1.1	2.7	5.1	7	4.4	3.4	4.5	4.5	3.1	5.6	2.6	11	0.1	3.4	10	2.9	0	1	0.2	1.9	0.3	2.9	3.4	1.4	1.1	0.9	4.1	1.3	0.4	1.8	0.8	0.8	1	0.8	0.5											0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	8.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.3	0	0	0	0	0	0	0	0	0	1	0	0	0	0.2	0	0	0	0	0	0	Early spermatids
RHCE	CD240CE, RH	ENSG00000188672	Rh blood group CcEe antigens	P18577	1	25362249-25430192	Blood group antigen proteins, CD markers, Predicted intracellular proteins, Predicted membrane proteins, Transporters		Blood group antigen		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in many	4	bone marrow: 40.5	Cell type enriched	Detected in some	33	Erythroid cells: 210.2	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Cell type enhanced	Detected in some		basophil: 2.4	Lineage enriched	Detected in single	7	granulocytes: 2.4	Cell line enriched	Detected in some	5	HEL: 44.7									HPA060951, HPA077385	Supported		Uncertain	Nucleoplasm,Plasma membrane						Nucleoplasm, Plasma membrane		HPA060951: , HPA077385: 	unprognostic (1.37e-1)	unprognostic (3.53e-1)	unprognostic (2.38e-1)	unprognostic (6.75e-2)	unprognostic (1.41e-2)	unprognostic (4.91e-2)	unprognostic (7.01e-2)	unprognostic (3.12e-2)	unprognostic (3.81e-2)	unprognostic (1.35e-1)	unprognostic (6.08e-2)	unprognostic (4.61e-2)	unprognostic (5.77e-5)	unprognostic (1.38e-1)	unprognostic (3.94e-2)	unprognostic (7.15e-3)	unprognostic (1.63e-1)	0.6	0.8	2	0.6	5.1	40.5	0.9	3.3	4.7	0.8	0.7	3.5	1	0.7	0.7	5.2	1.4	1.6	0.8	2.1	2.6	1.5	0.8	2.2	0.7	1	2.1	2.5	0.9	9.6	0.5	4	1.6	5.9	1.6	0.8	2.2	8.4	0.8	1.9	1.1	0.6	0.5	2.9	2.1	0.8	2.6	1.4	1.2	1.1	1.2	0.8	0.5	0.6	0.1	0.2	2.4	0.2	0.1	0.3	0.9	0.1	0	0.1	0.2	0.4	0.3	0	0.1	0.1	0.2	0	0	0.7	0.3	0.5	0.5	0	0.1	0	0.1	0.1	0.2	0	44.7	0	0	0.6	0	0.3	1	0.7	0.3	0.2	0	0	0.3	8.7	0.2	0.2	0.4	0	0.3	0.9	0.3	0.2	0.1	0.1	1.2	0	0	0.3	0.4	0.1	0.1	0.5	0.4	0.2	0	0	0.1	0	0.4	0	2.6	0.6	0.5	1.5	0.4	0.2	2.4	0.2	0.6	0.3	0	0.3	0.1	0	0.1	0.2	0	0.2	0	1	0.1	0	0.1	0.3	0.9	2	5.1	3.3	4.7	2.6	1.5	2.1	2.5	5.9	1.4	0	0	0	0.5	0.5	3.3	0.4	2.5	0	0	0	0	0.7	0	0.3	0.8	0	0	210.2	0.2	0.4	0.2	0.4	4.6	0.4	0.2	6.4	0	0	0	0	0.6	0	0	0	0	4.1	0.4	0	0.7	0	2.5	6.5	0	2.8	5.1	1.3	0.7	0	0.1	0.7	Erythroid cells
OPTC		ENSG00000188770	Opticin	Q9UBM4	1	203494143-203508864	Predicted secreted proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	92	retina: 245.8	Cell type enriched	Detected in single	6	Spermatocytes: 1.4	Cancer enriched	Detected in single	6	testis cancer: 1.1	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		BJ: 1.0;HeLa: 1.4;hTERT-RPE1: 1.3;NTERA-2: 2.4;RT4: 1.5;SCLC-21H: 1.2;SuSa: 1.5	Low region specificity	Detected in many			Low region specificity	Detected in single			HPA034951, HPA034952	Enhanced				Secreted in other tissues							HPA034951: AB_10669852, HPA034952: AB_2674379				unprognostic (3.29e-1)	unprognostic (1.56e-1)					unprognostic (7.69e-2)	unprognostic (3.19e-2)	unprognostic (1.70e-3)		unprognostic (8.24e-2)	unprognostic (3.65e-2)			0.3	0	0.2	0.1	0.2	0	0.2	0.4	1	0.4	1.3	0.1	0.1	0.4	1.3	2.2	0.8	0.8	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.2	0.1	1.1	0.3	0	0.1	0.4	0.1	0.7	0.3	245.8	0.1	0.6	0.1	1.1	0.2	1.1	0.1	0.1	0.1	2.6	0.1	0.1	0.2	0.1	0.1	0.5	0.6	0	0	0	0	0	0	0	0.6	0	0.2	0	0	0	0.1	1	0.3	0	0	0	0.1	0.4	0.3	0	0.1	0.1	0	0	0	0	0	0	1.4	0	0.3	0	0	0	0	0	0	1.3	0	0	0	0	0	0	0	0	2.4	0.1	0.7	0	0.1	0	0	1.5	1.2	0	0	0	0	1.5	0	0	0	0.5	0.9	0.1	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0.2	0.4	0.1	0.1	0.2	0.2	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.4	0.2	0	0	0	0	0	Spermatocytes
CATSPER4		ENSG00000188782	Cation channel sperm associated 4	Q7RTX7	1	26190561-26202968	Predicted membrane proteins, Transporters, Voltage-gated ion channels	Calcium transport, Differentiation, Ion transport, Spermatogenesis, Transport	Calcium channel, Developmental protein, Ion channel, Voltage-gated channel		Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	34	testis: 13.5	Cell type enriched	Detected in some	5	Early spermatids: 36.9	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		CAPAN-2: 1.1;hTCEpi: 1.3	Not detected	Not detected			Not detected	Not detected			HPA045257	Enhanced											HPA045257: AB_10968995	unprognostic (7.20e-2)	unprognostic (2.06e-2)		unprognostic (4.56e-2)		unprognostic (2.69e-2)		unprognostic (3.49e-1)		unprognostic (3.86e-2)	unprognostic (1.52e-2)	unprognostic (2.16e-1)		unprognostic (3.06e-1)	unprognostic (6.78e-2)	unprognostic (6.98e-2)	unprognostic (6.67e-5)	0	0	0	0	0	0	0	0	0	0	0			0	0	0	0	0	0	0	0	0	0	0	0	0	0		0	0	0	0	0		0	0		0	0	0.3	0.1	0	0	0	0	0	13.5			0		0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.1	0	0	0	0.1	0.3	0	0	0	0	0	0	0	0	0	0	0	0	1.3	0	0.5	0	0	0.4	0.1	0.3	0	0	0	0	0.6	0	0	0	0	0	0	0	0.3	0	0	0	0	0.5	0.5	0	0	0	0.3	0	0	0.3	0	0.1	0	0	0.2	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0											0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	36.9	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	7.2	0.3	0	0	0	0	0	0.1	0	1.1	0	0	0	0	0.4	0.8	0	0	0	0	0	Early spermatids
SNTN	FLJ44379, S100AL	ENSG00000188817	Sentan, cilia apical structure protein	A6NMZ2	3	63652668-63679020	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	6	epididymis: 26.6;fallopian tube: 73.9;lung: 29.5;ovary: 18.5	Cell type enriched	Detected in some	13	Ciliated cells: 823.1	Group enriched	Detected in some	6	endometrial cancer: 1.9;lung cancer: 0.8;ovarian cancer: 0.5	Not detected	Not detected			Low cell type specificity	Detected in some			Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		OE19: 3.1;RH-30: 2.4;SH-SY5Y: 3.4	Low region specificity	Detected in many			Not detected	Not detected			HPA043322, HPA058399	Enhanced											HPA043322: AB_10793945, HPA058399: AB_2683705	unprognostic (9.70e-3)	unprognostic (3.67e-1)	unprognostic (4.64e-2)	unprognostic (1.20e-3)				unprognostic (4.34e-3)		unprognostic (1.93e-1)	unprognostic (4.52e-2)	unprognostic (1.73e-1)		unprognostic (2.07e-2)	unprognostic (1.66e-1)		unprognostic (8.43e-3)	0	0	0.1	0	0.2	0	0	0	0	4.3	0	0.5	0	0	1.1	26.6	0	73.9	0	0	0.6	0.3	0	0	29.5	0	0	0	18.5	0.1	0	1.4	0.1	0.6	0	0	0	0	0	0	0	0	0	0	0	0.1	2	0	0.1	5.8	0	0.1	0	0	0.9	0.4	1.6	0.2	0.4	0.5	0.1	0.3	0.2	0.6	0.8	0.1	1.4	0.5	0	0	0	0.3	0.2	0.8	0.3	0	0	0.4	0.3	0	0	0	0.1	0.3	0.1	0.4	0.1	0	0.1	0.1	0	0	0	0.1	0.1	0	0.3	0.1	0.5	0	0	0.2	0.4	0.2	3.1	0	0.3	2.4	0.2	0.1	0.3	0.3	3.4	0.1	0.3	0	0.6	0.1	0.3	0	0.6	0.6	0.1	0.1	0.2	0.3	0.1	0.1	0.1	0.6	1.6	0.2	0.2	0.3	0.2	0.3	0.1	0.2	0.3	0	0.9	0.5	0.4	1.1	0.4	0.2	0.4	0.2	0.1	0.1	0.2	0	0	0.6	0.3	0	0	0.6	0	3	3.4	0	0	0	0	0.2	0	823.1	64.8	0	0	0.2	0	0	2.9	0	0	0	0.3	0	0	0.1	1.1	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0.3	0	0.4	0.1	Ciliated cells
CALHM6	C6orf187, dJ93H18.5, FAM26F, INAM, OTTHUMP00000017061, OTTHUMP00000017062, RP1-93H18.5	ENSG00000188820	Calcium homeostasis modulator family member 6	Q5R3K3	6	116461370-116463779	Predicted intracellular proteins, Predicted membrane proteins, Transporters	Ion transport, Transport	Ion channel		Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	6	blood: 95.3;lymphoid tissue: 58.7	Cell type enriched	Detected in some	7	Hofbauer cells: 118.3	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enhanced	Detected in many		intermediate monocyte: 83.9;non-classical monocyte: 95.3	Low lineage specificity	Detected in all			Cell line enhanced	Detected in some		HEL: 10.0;Karpas-707: 16.7;RPMI-8226: 56.6;U-937: 21.5	Low region specificity	Detected in single			Low region specificity	Detected in all																unprognostic (1.14e-2)	unprognostic (2.31e-2)	unprognostic (6.46e-3)	unprognostic (7.15e-3)	unprognostic (9.53e-3)	unprognostic (4.10e-2)	unprognostic (2.69e-1)	unprognostic (1.68e-1)	unprognostic (8.19e-2)	unprognostic (1.24e-1)	unprognostic (4.19e-1)	unprognostic (1.20e-1)	prognostic unfavorable (9.31e-10)	unprognostic (1.69e-1)	unprognostic (2.12e-2)	unprognostic (3.85e-3)	unprognostic (9.25e-3)	3	2.7	2.8	19.6	5.2	12.9	3.1	1.1	2.1	1.5	3.4	1.5	1.7	3.9	1.1	1.3	2	1.5	3.9	4.3	3.1	3.2	2.9	8.1	4.2	30.6	2.6	1.8	2.8	1	0.4	2.5	4.6	3.4	3.1	2.2	2.7	4.2	0.7	1	0.9	8.1	3.7	5.1	58.7	2.2	3.3	1.7	7.3	2.1	1.9	7.5	3.5	1.4	39.6	23.3	13.8	95.3	3.1	3.8	17.8	2.3	0	0.2	0.1	0.2	0.7	4.3	0	0.4	0.7	0.5	0	0.3	0	1.3	0.5	0	0	0.1	0	1.6	0.2	0.1	10	0	0	1	0	0	0.8	0	0	0	0.1	0.2	0	0	16.7	2	0	0.9	1.7	1.3	0	0	0.8	0	56.6	0.8	0.1	1	0	5.4	0	4	0.6	0.1	2.6	0	0	0	0	0.3	4.3	0	0	0.1	21.5	1.4	1.8	24.7	5.5	2.1	83.9	2.1	27	2.9	1.9	23.3	39.6	3.8	1.9	13.8	3.1	95.3	10.2	0.3	17.8	2.8	5.2	1.1	2.1	3.1	3.2	2.6	1.8	3.4	1.7	0	1.7	0	0	0	0	0	0	0	0	0	0	1.2	0	0.5	0	0	0	0	9.1	4.9	0	0	0	0	118.3	0	0	0	0	0	0	2.1	0	18	0	0	2.2	0	0	0.6	0	0	0	0	0	0	1.8	0	0	0	Hofbauer cells
GLRA4		ENSG00000188828	Glycine receptor alpha 4	Q5JXX5	X	103707224-103728655	Predicted membrane proteins	Ion transport, Transport	Chloride channel, Ion channel, Ligand-gated ion channel, Receptor		Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in some		brain: 3.5;endometrium 1: 5.1;smooth muscle: 6.7	Cell type enriched	Detected in single	21	Enterocytes: 2.9	Not detected	Not detected			Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	10	SCLC-21H: 7.5	Low region specificity	Detected in some			Low region specificity	Detected in all			HPA044759	Uncertain											HPA044759: AB_10795885	unprognostic (4.96e-2)		unprognostic (2.09e-2)		unprognostic (3.95e-1)	unprognostic (2.24e-1)			unprognostic (1.28e-1)		unprognostic (1.08e-1)	unprognostic (1.32e-1)	unprognostic (4.94e-7)	unprognostic (4.49e-1)	unprognostic (1.94e-1)		unprognostic (1.87e-1)	0	0	0.9	0.1	1.5	0	0.3	2.8	3.5	1.9	1.4	0.9	0	2.2	5.1	0.1	0.2	0.6	0.1	0.1	1.5	1.8	0	0	0	0	0.5	1	1.2	0	2.4	0.2	0	1.2	0.5	1.8	0	0	0.4	0.1	0.3	2.3	6.7	1.5	0	0.1	1.4	0	2.5	0	0	0	0.2	0.1	0	0	0	0	0	0	0.2	0	0	0.1	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0	0	0.1	0	0	0.1	0	0	0.1	0	0	0.1	0	0	0.1	0	0	0	0	0	0	0.4	0	0	0	0	0.1	0	0.5	7.5	0	0	0	0	0.7	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0.9	1.5	2.8	3.5	1.5	1.8	0.5	1	1.2	0	0	0	0	0.1	0	0	0.1	0	0	0	0	0	0	0	0	0	0	2.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Enterocytes
ZNF563	FLJ34797	ENSG00000188868	Zinc finger protein 563	Q8TA94	19	12317477-12333720	Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	DNA-binding		Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	8	Early spermatids: 144.2	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Group enriched	Detected in all	5	B-cells: 5.5;T-cells: 11.6	Cell line enhanced	Detected in many		Hep G2: 12.0									HPA042136	Uncertain		Approved	Vesicles						Vesicles		HPA042136: AB_10795395	unprognostic (1.40e-1)	unprognostic (3.61e-1)	unprognostic (1.02e-1)	unprognostic (8.81e-2)	unprognostic (9.88e-2)	unprognostic (2.49e-1)	unprognostic (1.20e-1)	unprognostic (9.16e-4)	unprognostic (1.02e-2)	unprognostic (5.38e-2)	unprognostic (3.36e-2)	unprognostic (1.51e-1)	unprognostic (2.29e-3)	unprognostic (9.90e-2)	unprognostic (2.12e-1)	unprognostic (1.27e-3)	unprognostic (1.18e-2)	4.6	5.4	5.6	7.7	7.9	2.1	6.9	7.5	6	5.5	3.7	3.6	6.2	2.5	4.5	6.2	4.7	5.7	4.1	7.3	6.4	2.2	8.7	17.2	3.6	4.6	4.8	4.8	6.4	4	4.9	9.3	2.2	5.4	8.5	4	3.8	4.9	7.1	3.5	6.8	4	4.3	4.6	4.4	3.2	22.6	7.2	6.1	9.1	2	5.1	5.8	6.4	5.5	1.7	1.1	1.4	1.6	11.6	2.6	2.4	0.3	0.9	3.5	3.5	2.3	0.3	2.9	5.5	3.5	5.5	3	0.9	5.6	3	3.6	4.1	2	2.8	6.8	3.3	0.1	0.5	0.8	0.5	12	3.1	0.5	3.7	3.9	5	3.6	2.4	2.7	0.1	3.1	1.1	1.3	3.2	1.6	3.2	1.2	1.5	1.3	2.3	0.2	2.6	0.2	4	3.5	0.9	1.6	0.3	0.7	0.4	4.2	2.3	0.3	0.4	5.5	1.1	6.5	1.8	5.7	4.4	0.4	1.1	0.5	2	0.7	1.3	0.8	3.4	1.3	2	3.8	5.8	3.1	1.6	5.5	11.6	6.5	1.1	1.6	1.4	1.7	4.5	2.6	5.6	7.9	7.5	6	6.4	2.2	4.8	4.8	5.4	7.2	3	1.7	2	1.6	1.1	7.6	5.2	5.1	5.3	2.3	1.8	0	0.4	1.7	4.1	144.2	3.4	1.3	0	4.4	0.1	1.3	2.1	0	6.7	1.9	4.8	0	4.3	2.1	17.6	7.2	1.5	5	1.8	2.6	14.3	2.5	3.5	5.3	6.3	3.3	12.9	3.1	12.8	4.3	1.8	0.1	2.1	2.6	0.6	Early spermatids
LRRK2	DKFZp434H2111, FLJ45829, PARK8, RIPK7, ROCO2	ENSG00000188906	Leucine rich repeat kinase 2	Q5S007	12	40196744-40369285	Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins	Autophagy, Differentiation	GTPase activation, Hydrolase, Kinase, Serine/threonine-protein kinase, Transferase	Cancer-related genes, Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in all	4	blood: 40.4;lung: 50.4	Cell type enriched	Detected in many	5	Alveolar cells type 2: 391.0	Group enriched	Detected in many	7	lung cancer: 5.3;renal cancer: 17.1;thyroid cancer: 22.7	Low region specificity	Detected in all			Cell type enriched	Detected in many	7	neutrophil: 40.4	Lineage enriched	Detected in many	7	granulocytes: 40.4	Cell line enhanced	Detected in some		A549: 9.9;ASC TERT1: 10.2;BJ hTERT+: 5.7;RPTEC TERT1: 10.9	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA014293, CAB037160	Approved		Supported	Vesicles						Vesicles		CAB037160: AB_1840989, HPA014293: AB_1853353	unprognostic (2.67e-1)	unprognostic (1.75e-1)	unprognostic (6.45e-3)	unprognostic (1.06e-1)	unprognostic (3.00e-2)	unprognostic (6.10e-3)	unprognostic (2.71e-1)	unprognostic (3.14e-1)	unprognostic (2.25e-1)	unprognostic (9.07e-2)	unprognostic (2.76e-1)	unprognostic (1.23e-1)	prognostic favorable (3.02e-6)	unprognostic (2.55e-2)	unprognostic (3.43e-2)	unprognostic (2.01e-3)	unprognostic (5.21e-3)	3.7	3.4	2.3	7	3.9	8.6	3	1.7	5	5.1	4.5	1.7	2.6	0.7	5.3	2.9	5.3	3.8	4.5	4	1.8	1.4	10.6	4.5	50.4	6.8	2.2	3.6	5.8	3.3	10.9	2.5	1	1.9	3.6	1.6	3.3	4.2	2	5.6	2.6	3.4	6.7	4.9	8.6	2.7	1.2	2.4	0.5	3.9	2.7	4.9	4.6	6.8	0.9	1.5	40.4	5.8	0	0	0.8	0	9.9	0.1	0	3.9	10.2	0.1	2.1	5.7	0.4	0.3	0	0	0	0	1.9	0.3	0	0.3	0	0.4	0	0.8	0.3	0.2	0	0.7	0.5	0.1	2.5	0.7	0	0.2	3.8	0.6	0	0	0	0.7	0	0	1.2	0.2	0	0.1	0	0	0	10.9	0	0.1	0.6	0	0.2	2.8	0.3	2.8	2.2	1.4	1.2	1.1	1.2	0.7	0	0	0	2.4	0	0.5	0	5.8	1.2	0	3.1	0	0.9	0	0	1.5	0.9	0	0	40.4	0	3	0.2	0	0.8	2.3	3.9	1.7	5	1.8	1.4	2.2	3.6	1.9	2.4	29.8	391	17.5	1.5	2.2	7.5	6.9	5.1	5.3	30.7	26.2	0	0	1.7	0.8	0.4	4.5	0	0	2.3	0.1	9.4	0.6	12.8	7.8	4.6	44.5	0	9.2	74.8	0	17.5	19.9	11.8	10.8	0	11	1.1	0	11.3	15.2	0.9	0	3.9	0.2	0.4	2.8	0.3	0.8	0	0.5	Alveolar cells type 2
CFAP126	C1orf192, Flattop, Fltp	ENSG00000188931	Cilia and flagella associated protein 126	Q5VTH2	1	161364731-161367874	Predicted intracellular proteins	Cilium biogenesis/degradation			Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	5	brain: 53.4;fallopian tube: 85.7	Cell type enriched	Detected in some	7	Ciliated cells: 370.7	Not detected	Not detected			Region enriched	Detected in all	7	pons and medulla: 53.4	Cell type enhanced	Detected in single		memory CD8 T-cell: 1.2	Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		CAPAN-2: 7.4;RPTEC TERT1: 2.5;SCLC-21H: 2.5;T-47d: 1.3	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA045904	Enhanced											HPA045904: AB_10960411																		0.7	0.7	5.8	0.7	7.5	0.7	1.1	1.2	2.7	3	0.7	23.3	0	0.7	2.7	14.8	0.7	85.7	0.8	0.7	7	8	1.8	0.8	8.1	0.7	4.1	3.9	11.2	0.8	0.7	3.3	0.7	53.4	0.8	0.7	0	0.7	1.2	2.8	0.7	0.7	0.7	3.3	0.7	0.7	15.3	4.3	0	2.7	0.1	0.8	0.7	0	0	0.1	0.6	0.5	0	1.2	0.1	0.1	0	0	0.2	0	0	0	0	0	0	0	0	7.4	0	0.2	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.5	0	2.5	0	0	0	0	0	1.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0.5	0	0	0.8	1.2	0	0	0	0	0	0	0	0.1	0	0.1	5.8	7.5	1.2	2.7	7	8	4.1	3.9	53.4	4.3	6	2.6	0	0.5	0	0.4	0	0	370.7	35.2	0	0	0	0	0.3	53.4	0	0	0	0	0.1	0	0.2	2.3	0	0	0	0	0	0	18.8	0.3	0.3	0	0	0	0.8	0	0	1.1	1	0.1	0	0	1.5	0.7	0	0	0	0	0.1	Ciliated cells
NYX	CLRP, CSNB1, CSNB1A, CSNB4	ENSG00000188937	Nyctalopin	Q9GZU5	X	41447434-41475710	Disease related genes, Predicted intracellular proteins	Sensory transduction, Vision		Congenital stationary night blindness, Disease mutation	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in some	5	retina: 13.9	Cell type enriched	Detected in some	8	Bipolar cells: 13.9	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	7	HDLM-2: 7.4;NTERA-2: 1.9	Not detected	Not detected			Low region specificity	Detected in single								Intracellular and membrane											unprognostic (3.27e-2)	unprognostic (6.72e-2)				unprognostic (4.21e-2)	unprognostic (4.10e-4)			unprognostic (1.83e-1)	unprognostic (3.96e-2)	unprognostic (1.80e-1)			0	0	0.1	0	0.4	0	0	0	0.7	0	0	0.4	0	0	0	0	0	0	0	0	0	0	2.7	0	0	0	0.1	0	0	0	0.4	0	0.1	0.3	0	0	13.9	0	0.2	0	0	0	0	0	0.3	0	1.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	7.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.9	0	0	0	0	0.4	0	0	0	0	0	0.3	0	0.4	0	0	0	0	0.1	0	0	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.4	0	0.7	0	0	0.1	0	0.3	0	0	0	0	0	0	13.9	0.4	0	0	0	1.8	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.1	0.5	0	0	0.5	1.1	0	0.2	0	0	0	Bipolar cells
LIPI	CT17, LPDL, mPA-PLA1beta, PLA1C, PRED5	ENSG00000188992	Lipase I	Q6XZB0	21	14108813-14210891	Disease related genes, Predicted intracellular proteins, Predicted secreted proteins	Lipid degradation, Lipid metabolism	Heparin-binding, Hydrolase	Disease mutation	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	24	epididymis: 113.2	Cell type enriched	Detected in single	7	Early spermatids: 1.1	Cancer enriched	Detected in single	6	thyroid cancer: 0.5	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		NB-4: 3.1;REH: 2.0;SH-SY5Y: 1.9	Not detected	Not detected			Low region specificity	Detected in all								Secreted in male reproductive system								unprognostic (2.60e-2)	unprognostic (3.49e-1)		unprognostic (1.12e-3)	unprognostic (1.14e-1)	unprognostic (1.08e-2)		unprognostic (1.19e-1)	unprognostic (2.05e-2)	unprognostic (1.68e-1)	unprognostic (4.53e-2)	unprognostic (2.90e-1)	unprognostic (3.64e-13)	unprognostic (2.82e-1)	unprognostic (4.14e-2)	unprognostic (2.90e-1)	unprognostic (7.87e-3)	0	0	0	0	0	0	0	0.5	0	0.5	1	0	0.6	0	1.2	113.2	0.5	0.1	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0.3	0.1	0	0	0	0.1	0	0.2	0	0.1	1.4	0	0	4.7	0	0	0.2	0.4	0	0	0	0	0	0	0.2	0	0	1.1	0.9	0	0	1.5	0.9	0	0	0	0.7	0	1.2	0	0	0.2	0	0	0	0	0.1	0.9	1.4	0.7	0.2	0	0.7	0.4	0	0	0	0	0	0	1.6	1.1	0	0	0	0.5	3.1	1.4	0	0.4	2	0.5	1	0	0	0.3	1.9	0.7	0.1	0.1	1.8	0.1	0.1	0	0.5	0.3	0.8	0.2	0.3	0	0.3	0.3	1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	Early spermatids
SBSN	HLAR698, UNQ698	ENSG00000189001	Suprabasin	Q6UWP8	19	35523367-35528351	Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		esophagus: 105.1;skin 1: 241.3;tongue: 338.1	Cell type enriched	Detected in some	11	Suprabasal keratinocytes: 889.6	Group enriched	Detected in many	9	cervical cancer: 76.5;head and neck cancer: 355.2;melanoma: 153.1	Region enriched	Detected in single	7	basal ganglia: 1.6	Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		ASC diff: 20.2;ASC TERT1: 35.2;HSkMC: 47.6;U-2197: 16.3;U-87 MG: 38.5					Low region specificity	Detected in some			HPA062568, HPA067734	Enhanced		Approved	Vesicles	Secreted - unknown location				62000000	Vesicles		HPA062568: AB_2684794, HPA067734: AB_2685894	unprognostic (1.10e-1)	unprognostic (1.01e-1)	unprognostic (2.02e-2)	unprognostic (1.21e-1)	unprognostic (1.73e-1)	unprognostic (1.83e-2)	unprognostic (1.23e-3)	unprognostic (3.45e-3)	unprognostic (2.56e-1)	unprognostic (4.83e-4)	unprognostic (4.31e-4)	unprognostic (6.97e-2)	unprognostic (9.08e-14)	unprognostic (6.37e-2)	unprognostic (6.51e-3)	unprognostic (2.09e-1)	unprognostic (1.36e-3)	0.3	0	0.2	0.2	1.6	0.1	11.2	0.2	0.2	65.1	0.2	0.2	0.2	0	3.5	0.2	105.1	0	0.2	0.2	0.2	0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0	0.2	0.7	0.2	0.2	0	0.2	26.8	0.2	1.3	241.3	0.2	0.2	0.2	0.2	0	0.2	0.2	1.8	0.2	338.1	51.7	0.4	51.4	0.4	0	0	0	0	0.2	0	0	0	0	0	20.2	35.2	0	1.6	2.2	0.7	0.2	0	0	0	0.3	1.4	0.5	0.1	0	0.5	0.3	0	0	0	0	0	0.2	0	0	47.6	2.6	9.5	2.3	0.6	0	0	0	0.1	0	0.1	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0.4	0.1	0	0	0.1	5.9	1.2	16.3	0.4	0.1	0	0	38.5	0	0	0	0	0	0	0	0	0	0.2	0	0	0.4	0	0	0	0	0	0	0	0	0.2	1.6	0.2	0.2	0.2	0	0.2	0.2	0.2	0.2	0	0	0	0	79.3	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0.5	0	3.1	0.9	0	0	0.1	0	0	0	0	2.4	0	0	13.5	0	0	0	1.5	0	0	0	0	0	0.2	0.2	0.1	889.6	0.2	0	0	0.1	Suprabasal keratinocytes
CGB5	HCG	ENSG00000189052	Chorionic gonadotropin beta subunit 5	P0DN86	19	49043884-49045311	Predicted secreted proteins		Hormone		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in some	8	placenta: 105.2	Cell type enriched	Detected in some	7	Syncytiotrophoblasts: 16.5	Cancer enhanced	Detected in some		pancreatic cancer: 10.0	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	24	BEWO: 46.9;U-251 MG: 21.3									HPA038925, HPA038934	Supported		Approved	Cytosol	Secreted to blood					Cytosol		HPA038925: AB_2676272, HPA038934: AB_2676277		unprognostic (1.38e-1)				unprognostic (1.68e-1)					unprognostic (1.51e-3)			prognostic unfavorable (1.18e-5)	unprognostic (1.07e-1)		prognostic unfavorable (9.47e-4)	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0.2	0	0	0.4	0.1	0	0	0	0	0	0	0.1	0	0	0	0	2.1	0.1	12.7	105.2	0	0.6	0	0	0.1	0	0.2	0.6	0	0	0	0	0.2	0.7	0	0	0	0	0	0	0.3	0	0	0	0	0	0.5	0	1.4	0.2	0	0	0	0	46.9	0	0	0	0	0	0.1	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	1.3	0	0	0	0	1.1	0	21.3	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0.2	2.2	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	16.5	0	0	0	Syncytiotrophoblasts
RELN	PRO1598, RL	ENSG00000189056	Reelin	P78509	7	103471784-103989516	Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Cell adhesion	Developmental protein, Hydrolase, Protease, Serine protease	Disease mutation, Epilepsy, Lissencephaly	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	5	brain: 73.4;liver: 35.8	Cell type enriched	Detected in some	15	Ito cells: 182.3	Cancer enhanced	Detected in many		liver cancer: 5.7	Region enriched	Detected in many	11	cerebellum: 73.4	Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		Hep G2: 34.4;PC-3: 7.0;SCLC-21H: 8.4;SH-SY5Y: 9.1;TIME: 20.0	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA077891			Approved	Golgi apparatus,Vesicles	Secreted to extracellular matrix				59000000	Golgi apparatus	Vesicles	HPA077891: 	unprognostic (1.42e-1)	unprognostic (2.93e-3)	unprognostic (4.31e-2)	unprognostic (1.29e-4)	unprognostic (1.30e-1)	unprognostic (6.95e-2)	unprognostic (1.85e-1)	unprognostic (8.35e-2)	unprognostic (1.54e-1)	unprognostic (1.48e-2)	unprognostic (3.31e-3)	unprognostic (3.86e-1)	unprognostic (2.02e-2)	unprognostic (1.43e-2)	unprognostic (3.03e-1)	unprognostic (1.35e-1)	unprognostic (3.06e-2)	2.7	5.9	5.7	1.2	5.3	0.5	6.3	73.4	6.7	2.9	2.1	0.8	0	1.1	1	3	1.7	4.4	1.9	3.2	5.7	5.3	1.2	35.8	1.6	7.9	1.8	2.5	1.3	1	0.3	0.8	0.4	5.1	1.2	2.1	10.6	1.1	2.1	0.4	1.1	1.9	2.4	3.2	1.1	0.8	1.5	0	0	2.6	1.7	0.9	1.7	2.5	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0.8	0	0.2	0	0	0	0	0	3.7	0	0	1.3	0	0.1	0	0	2.4	0	34.4	0	0	0	0	0	0.3	0	2.2	0.4	0	0	0	0.1	0	0	0	0	0	7	0	1.4	0	0	0	8.4	9.1	0	0	0	0	0	0	20	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	5.7	5.3	73.4	6.7	5.7	5.3	1.8	2.5	5.1	0	0	0	0	0	0.6	11.3	3.1	5.1	0	0	0	0	0	0	0.2	12.3	2.6	0	0	1	0.1	2.4	0.3	0	2.4	0.2	0	0	182.3	9.4	4.8	0	0	0	0	0	0.2	0.2	0	0	0	1.2	0	0.4	0	0.1	0.5	0.2	0	0	0	Ito cells
GAGE2A	CT4.2, GAGE2	ENSG00000189064	G antigen 2A	Q6NT46	X	49589529-49596827	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in some	34	testis: 46.7	Cell type enriched	Detected in some	13	Spermatogonia: 363.5	Low cancer specificity	Detected in many							Low cell type specificity	Detected in single			Low lineage specificity	Detected in single			Group enriched	Detected in some	5	Karpas-707: 19.6;T-47d: 67.6;WM-115: 74.4									HPA043232	Supported		Approved	Golgi apparatus,Plasma membrane,Cytosol						Plasma membrane	Golgi apparatus, Cytosol	HPA043232: AB_2678376															unprognostic (1.29e-1)			0	0	0	0	0	0	0	0	0	0	0			0	0	0	0	0	0	0	0	0	0	0	0	0	0		0	0	0	0	0		0	0		0	0	0	0	0	0	0	0	0	46.7			0		0	0	0	1	0.7	0.4	0.7	0.5	0.6	1.3	0	0	0	0.3	0	0	1.3	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4.9	0	0	0	0	0	0	0.1	0.1	19.6	0	0	0.1	0	0	0	0	0	0	0.1	0	0	0	0	0	0.8	0	0	67.6	0	0	11	2.4	0	0	0.2	2.9	0	0.6	0	74.4	0.4	0.6	0.1	0.1	0.7	0	1	0.5	0.6	0	0.4	0.5	0.2	0	0.5	0.6	0.7	0.6	1.3											0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.6	2.3	0	0	0	0	0	0	0	0.7	0	0	12.9	0	27.8	363.5	0	0	0	0	0	Spermatogonia
VSTM1	UNQ3033	ENSG00000189068	V-set and transmembrane domain containing 1	Q6UX27	19	54040825-54063953	Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins	Immunity	Cytokine		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	5	blood: 53.5;bone marrow: 39.4	Cell type enriched	Detected in some	5	Late spermatids: 15.9	Low cancer specificity	Detected in some			Not detected	Not detected			Cell type enriched	Detected in many	15	eosinophil: 53.5	Lineage enriched	Detected in many	15	granulocytes: 53.5	Group enriched	Detected in some	7	EFO-21: 1.0;HMC-1: 2.5;hTERT-HME1: 4.0;U-2 OS: 3.6									HPA059365			Approved	Vesicles	Secreted to blood					Vesicles		HPA059365: 	unprognostic (5.13e-2)	unprognostic (5.31e-2)	unprognostic (1.05e-1)	unprognostic (1.42e-1)	unprognostic (1.36e-3)	unprognostic (1.30e-1)		unprognostic (1.09e-1)	unprognostic (3.80e-1)	unprognostic (1.09e-1)	unprognostic (1.59e-1)	unprognostic (9.47e-2)	unprognostic (1.31e-5)	unprognostic (3.73e-1)	unprognostic (1.14e-1)	unprognostic (9.74e-2)	unprognostic (4.67e-2)	0.9	0.2	0.7	0.1	0.2	39.4	0.1	0	0.5	0.2	0.1	1.3	0	0.1	0.3	0.1	0.1	0.6	0.1	4.2	0.7	0.2	0.5	1.2	4	7.2	0.6	0	0.2	1.1	0.1	8.7	2	0.2	0.1	0.1	0.2	0.1	0.1	2.1	0.1	0.8	0.3	0.1	7.9	0.1	0.5	0.3	3	0.4	0	0.1	0.8	0	0	0	53.5	3.6	0	0	2.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	2.5	0	0	0	4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	3.6	0	0	0	0	0	0	0	0	1.5	3	53.5	0	2.8	0	0	0	0	0	0	0	0	1.1	0	3.6	0	0	2.1	0.7	0.2	0	0.5	0.7	0.2	0.6	0	0.2	0.3	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	0	0	0	2.2	0	0	0	2.2	15.9	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0.1	0	0	0	Late spermatids
ARID2	BAF200, DKFZp686G052, FLJ30619, KIAA1557	ENSG00000189079	AT-rich interaction domain 2	Q68CP9	12	45729665-45908040	Cancer-related genes, Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	Chromatin regulator, DNA-binding	Cancer-related genes, Disease mutation, Mental retardation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	4	Early spermatids: 522.0	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low cell line specificity	Detected in many			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA063044			Supported	Nucleoplasm,Plasma membrane						Nucleoplasm	Plasma membrane	HPA063044: AB_2684929	unprognostic (8.41e-2)	unprognostic (1.03e-1)	unprognostic (4.02e-2)	unprognostic (3.94e-2)	unprognostic (4.15e-2)	prognostic favorable (5.75e-4)	unprognostic (1.26e-2)	unprognostic (9.71e-2)	unprognostic (9.04e-2)	unprognostic (5.57e-2)	unprognostic (1.34e-1)	unprognostic (2.47e-1)	unprognostic (1.12e-2)	unprognostic (9.21e-2)	unprognostic (3.02e-1)	unprognostic (2.00e-1)	unprognostic (6.53e-2)	9	7.9	7.1	14.6	7.2	14	11.8	15.7	8.8	10.2	11.4	8.2	17.9	6.4	12.2	10.7	11.5	8.8	10.6	8.2	7.4	5.8	8.7	6.9	10.2	13	9.6	3.8	12.2	10.7	18.4	15.1	10.3	7.5	9.9	8.1	10.1	9.7	20.6	8.6	13.5	12.6	12.5	7.3	10.2	9	30.9	11	33.3	11.5	8.2	11.2	10	10	2.1	5.3	10.5	4.9	3.1	4.4	1.3	5.4	7.8	14	6.1	6	4.2	7.6	3.8	5.4	5.3	5	11.1	5.6	10.5	7.1	5.2	3.9	6.6	11.3	6.5	7.7	4.6	5.4	13.9	8.6	5.4	4.1	10.9	6.4	3.4	4.9	6.7	10.8	7.5	5.4	15.9	11.7	10.9	4.7	7.1	15.6	7.8	8.4	0	4.2	12.1	10	10.1	5.1	9.1	7.6	9.7	6.2	7.2	6	8.4	11	21.9	6.4	5.7	6.9	3.8	4.9	7.3	6.1	29.4	4.4	28.8	4	10.5	1.7	4.2	4.1	2.2	4.3	1.7	3.7	4.4	2.4	2.1	3.6	3.3	2.4	3.1	4.9	5.3	3.1	1.3	7.1	7.2	15.7	8.8	7.4	5.8	9.6	3.8	7.5	11	26.8	27.9	10.2	11.5	30	49	12.6	5.1	9.4	12.5	27.9	64.8	11.9	6.6	11.2	522	21.5	15	0	8.7	8.9	17.5	17.9	20.9	13.1	9.9	30.2	20.2	16.5	27.5	122.6	23	20	13.5	12.6	19.9	19.7	15.6	24.6	21.2	6.9	67.9	25.8	22.7	61.7	16.5	36.1	19.6	24.5	16	16.5	Early spermatids
FAM25G	bA301J7.4	ENSG00000189090	Family with sequence similarity 25 member G	B3EWG6	10	47487219-47491693	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	No human protein/transcript evidence	Evidence at protein level		Tissue enriched	Detected in some	7	skin 1: 42.4	Cell type enriched	Detected in some	8	Pancreatic endocrine cells: 33.4	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	28	SK-BR-3: 22.5									HPA044808	Uncertain											HPA044808: AB_2679096						unprognostic (1.97e-2)												0	0	0	0	0	0	2.7	0	0	3.8	0			0	0	0	5.7	0	0	0	0	0	0	0	0	0	0		0	0	0	0	0		0	0		1.7	0	0	42.4	0.7	0	0	0	0	0			0		1.7	0	3.5	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	22.5	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0	0	0	0	0	0	0	0	0	0	4.4	0.2	0	0	0	2.8	0	0	0	0	0	0.1	0	0	0	0	0.9	0.3	0	0	0	0.3	0	33.4	0	0	0	0	0	0	0	0.9	0	0.3	0	0	0	Pancreatic endocrine cells
PRSS48	ESSPL	ENSG00000189099	Serine protease 48	Q7RTY5	4	151277171-151291453	Enzymes, Predicted membrane proteins, Predicted secreted proteins		Hydrolase, Protease, Serine protease		Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Group enriched	Detected in some	5	brain: 1.0;skin 1: 1.9;testis: 4.1	Cell type enriched	Detected in some	6	Sertoli cells: 6.5	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HHSteC: 1.4;LHCN-M2: 1.4;PC-3: 1.5;RT4: 1.0	Not detected	Not detected			Low region specificity	Detected in all			HPA053801	Uncertain				Secreted in male reproductive system							HPA053801: AB_2682267			unprognostic (9.68e-2)		unprognostic (1.35e-2)			unprognostic (2.15e-1)		unprognostic (2.18e-2)				unprognostic (3.76e-2)	unprognostic (4.10e-2)			0	0	0.5	0	1	0	0	0	0.9	0	0.1			0	0	0	0	0.1	0	0	0.7	0.1	0	0	0.1	0	0.2		0	0	0	0	0.1		0	0		0	0.3	0	1.9	0	0	0.5	0	0	4.1			0		0	0	0	0	0.4	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	1.4	0	0.6	0	0	0	0	0	0	0	0	0	1.4	0	0	0	0.6	0	1.5	0	0	0	0	1	0	0	0	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0											0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0.3	6.5	0	1.1	1.1	0	0	0	0	0	Sertoli cells
OR14I1	OR5BU1, OR5BU1P	ENSG00000189181	Olfactory receptor family 14 subfamily I member 1	A6ND48	1	248681369-248682304	G-protein coupled receptors, Predicted membrane proteins	Olfaction, Sensory transduction	G-protein coupled receptor, Receptor, Transducer		Evidence at transcript level	Evidence at transcript level	No human protein/transcript evidence	Evidence at transcript level		Tissue enriched	Detected in some	5	brain: 7.4	Cell type enriched	Detected in single	7	Early spermatids: 1.2	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in single		RPMI-8226: 2.1																																	unprognostic (3.68e-1)	unprognostic (1.63e-1)					0	0	1.2	0	1.9	0	0	0	7.4	0	0			0	0	0	0	0	0	0	0.8	0.1	0.4	0	0	0	0		0	0	0	0	0		1.4	0.1		0	0	0	0	0	0	0	0	0	0.7			0		0	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0.8	0	0	0	0	0	2.1	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0.4	0	0.3	0	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	1.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Early spermatids
KRT77	KRT1B	ENSG00000189182	Keratin 77	Q7Z794	12	52689626-52703463	Plasma proteins, Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	12	skin 1: 77.7	Cell type enriched	Detected in some	9	Suprabasal keratinocytes: 17.7	Low cancer specificity	Detected in some			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	36	HaCaT: 9.1	Group enriched	Detected in many	5	amygdala: 9.3;basal ganglia: 6.7;cerebral cortex: 4.7;hippocampal formation: 8.3;hypothalamus: 6.3	Not detected	Not detected			HPA045934	Enhanced		Approved	Nuclear membrane,Plasma membrane					2100000000	Nuclear membrane, Plasma membrane		HPA045934: AB_10960065	unprognostic (3.52e-2)	unprognostic (1.54e-1)				unprognostic (1.41e-1)		unprognostic (3.79e-1)	unprognostic (2.61e-1)						unprognostic (2.11e-1)		unprognostic (2.06e-1)	0.1	0	0.1	0.1	0.1	0	6.4	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	1.2	0	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	77.7	0.1	0.1	0.1	0.1	0	0.1	0.1	4.6	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	9.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	0	0	2.1	0	0.2	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	17.7	0	0	0	0	Suprabasal keratinocytes
SPANXN4	CT11.9, SPANX-N4	ENSG00000189326	SPANX family member N4	Q5MJ08	X	143025918-143034702	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	No human protein/transcript evidence	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	15	testis: 23.7	Cell type enriched	Detected in some	4	Late spermatids: 233.5	Not detected	Not detected			Not detected	Not detected			Cell type enriched	Detected in single	16	neutrophil: 1.5	Lineage enriched	Detected in single	16	granulocytes: 1.5	Cell line enhanced	Detected in some		HEL: 2.4;HeLa: 4.2;hTERT-HME1: 1.0									HPA045730, HPA059094	Uncertain		Approved	Nuclear membrane,Vesicles,Plasma membrane						Vesicles, Plasma membrane	Nuclear membrane	HPA045730: AB_10961036, HPA059094: 																		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	23.7	0	0	0	0	0	0	0	0	0	1.5	0	0	0	1.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.4	4.2	0	0	0	0.4	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0.3	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.5	0	0	0	0	1.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	58.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	233.5	1.1	0	0	0	0	0	0	0	0	0	0	0	0	0.7	0.3	0	0	0	0	0	Late spermatids
TOGARAM2	Crescerin-2, FAM179A, FLJ43249, LOC165186	ENSG00000189350	TOG array regulator of axonemal microtubules 2	Q6ZUX3	2	28956611-29061373	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 15.3;epididymis: 14.4;fallopian tube: 15.7;lung: 14.2	Cell type enriched	Detected in some	5	Ciliated cells: 56.2	Not detected	Not detected			Low region specificity	Detected in all			Cell type enhanced	Detected in some		gdT-cell: 3.7	Lineage enriched	Detected in single	5	T-cells: 3.7	Cell line enhanced	Detected in some		HMC-1: 3.8;NB-4: 3.6	Low region specificity	Detected in many			Not detected	Not detected			HPA037561, HPA037562, HPA075216	Uncertain		Approved	Nucleoplasm,Plasma membrane						Nucleoplasm, Plasma membrane		HPA037561: AB_10670384, HPA037562: AB_2675545, HPA075216: 	unprognostic (8.35e-5)	unprognostic (2.85e-3)	unprognostic (1.41e-1)	unprognostic (7.01e-3)	unprognostic (6.41e-2)	unprognostic (1.23e-2)	unprognostic (1.11e-1)	unprognostic (2.53e-3)	unprognostic (3.93e-1)	unprognostic (6.83e-2)	unprognostic (2.32e-3)	unprognostic (5.92e-2)	unprognostic (3.94e-11)	unprognostic (3.75e-2)	unprognostic (4.46e-1)	unprognostic (2.01e-2)	unprognostic (2.81e-3)	0.3	2.3	3	1.7	8.4	2.6	0.4	3.4	1.7	0.6	0.6	7.1	0	0.8	1.1	14.4	0.7	15.7	0.5	2.6	3.3	3.9	0.3	0.5	14.2	1.1	2.1	2	4.5	0.8	0.1	6.1	0.6	15.3	0.5	0.4	0.1	0.5	0.1	1.7	0.6	0.7	0.8	2.5	2.2	1.5	3.2	6.1	0	0.3	0.3	1.3	0.4	0.3	0.3	0.3	0.6	0.3	0.6	3.7	1	0.2	0.2	0.3	0.2	0.3	0	0.7	0.1	2.3	0.7	2.2	0.4	0.3	0.3	0.3	0	0.3	0.9	0.4	0	0.7	0.4	1.4	0.2	2	0.5	0.9	2	3.8	0.2	0.3	0	0	0.8	0.3	2.7	0.3	1	0.8	0.2	0.8	3.6	2.7	1.2	0.7	0.1	0.7	1.5	1.1	0.3	2.6	1.8	0.1	0.1	0.1	0.4	0.4	0.2	0.2	0.2	0.5	0.2	0.3	0.5	0.5	0.2	1.7	1.3	0.1	0.5	0.3	0.3	3.7	0.1	2	0.2	0.6	2.9	0.1	0.3	0.4	1	0.6	0.6	0.2	0.3	1.5	1	3	8.4	3.4	1.2	3.3	3.9	2.1	2	15.3	6.1	0	5.1	0	0	0	0	0	0	56.2	10.3	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0.2	0	0	0	Ciliated cells
SPATA31D4	FAM75D4, FLJ43859	ENSG00000189357	SPATA31 subfamily D member 4		9	81928514-81934948	Predicted membrane proteins				Evidence at transcript level	Evidence at transcript level				Tissue enriched	Detected in single	78	testis: 7.8	Cell type enriched	Detected in some	15	Early spermatids: 29.5	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Not detected	Not detected																																									0	0		0		0	0		0	0	0			0	0	0	0	0	0	0			0	0	0	0			0	0	0		0		0	0		0	0	0	0	0	0		0	0	7.8			0		0	0		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	29.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Early spermatids
ALG1L	ALG1L1	ENSG00000189366	ALG1, chitobiosyldiphosphodolichol beta-mannosyltransferase like	Q6GMV1	3	125929275-125937039	Predicted intracellular proteins		Glycosyltransferase, Transferase		Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in many		epididymis: 11.4;urinary bladder: 12.5	Cell type enriched	Detected in many	5	Ciliated cells: 30.8	Low cancer specificity	Detected in all							Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		CACO-2: 11.0;CAPAN-2: 10.0;HaCaT: 10.7;MCF7: 20.7;OE19: 13.1;T-47d: 13.9									HPA036108	Uncertain											HPA036108: AB_10673344	unprognostic (7.06e-3)	unprognostic (1.50e-3)	unprognostic (1.47e-1)	unprognostic (4.14e-2)	prognostic favorable (3.00e-4)	unprognostic (2.40e-2)	unprognostic (1.86e-1)	unprognostic (1.15e-1)	unprognostic (2.10e-1)	unprognostic (1.47e-1)	unprognostic (4.37e-2)	unprognostic (5.79e-2)	unprognostic (4.50e-6)	unprognostic (1.35e-1)	unprognostic (3.30e-1)	unprognostic (1.57e-2)	prognostic favorable (6.24e-4)	0	0.5	2.3	0.8	1.6	0	1.1	0.3	1.8	0.8	0.9			0	0.9	11.4	1.3	2	0.4	0.1	1.6	2	1	1	0.7	0	2.2		1.7	0.7	0	1.2	1.2		1.2	0.6		1.6	0.6	5.9	5.5	0.1	0.2	1	0	1.1	0.5			1		2.3	12.5	0.9	3.1	2.4	4.8	0.2	5.3	5	2.1	0.7	0.6	0.3	0	0	0.2	1.3	0	0	0.1	0.3	11	10	3	4.9	0	0.2	10.7	0.3	0	0.6	0.4	2.5	0.5	1.7	0	0.1	0.1	0.1	0.1	0	0	0.1	0	0	2.9	0.8	1	0	20.7	0.6	0.2	4.5	13.1	2.6	0.1	0	5	0	0.6	1.7	0.7	0.4	0.1	0.5	2.4	13.9	0.2	0.2	0.1	1.7	0.1	0	7.8	1.1	4	0.1	0	0.7	4.8	0.1	0.2	3.9	0.2	2.1	3.1	2.1	4.2	0	1.9	2.3	1.6	0.8	5.3	0	2.4	5	2.1											0	0.3	0.8	1.6	3	0.2	0	0	30.8	3.4	1.8	0	2.8	1.7	0.3	1.5	0	0	0	0.3	1.8	1.5	0.6	1.1	0	0.2	0	1.7	0	0	1.5	1.7	0	1.7	0	0	0.6	0.4	0.8	2.8	0.7	0	0	1.2	1.7	1.6	4.4	1.1	0	0.2	6.4	Ciliated cells
KIAA0408		ENSG00000189367	KIAA0408	Q6ZU52	6	127440343-127459391	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		skeletal muscle: 38.6;smooth muscle: 37.2	Cell type enriched	Detected in some	5	Alveolar cells type 1: 86.4	Not detected	Not detected			Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in many		AF22: 12.5;GAMG: 10.9;SCLC-21H: 31.5;SH-SY5Y: 15.6;U-138 MG: 8.6	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA044035, HPA053341	Uncertain		Approved	Nucleoplasm,Cytosol						Nucleoplasm	Cytosol	HPA044035: AB_10964274, HPA053341: AB_2732578	unprognostic (1.06e-1)				unprognostic (4.36e-2)	unprognostic (3.06e-1)		unprognostic (1.09e-1)			unprognostic (8.56e-4)	unprognostic (1.00e-1)	unprognostic (4.95e-2)	unprognostic (6.05e-3)	unprognostic (2.29e-1)	unprognostic (5.94e-2)	unprognostic (3.20e-2)	22.9	3.1	9.1	3.4	6.9	0	2.8	12.4	21	7.4	12	0.6	1.9	1.1	2.6	4.7	16.7	1.1	2.9	2.6	10.2	9.7	0.6	0.7	15.3	0.5	11.5	0.7	3.3	0.5	0	6.8	1.1	0.9	20.4	5	0.7	1.9	1.7	38.6	0.4	6.7	37.2	13.1	2	3.7	3.4	1.2	0.7	1.5	15.4	0.8	25.2	11.3	0	0	0	0.2	0	0.9	0.1	0	2.9	12.5	0	1.1	3	0	0.3	2.2	1.9	4.5	0	0	0	0	0.4	10.9	0	1.2	0	2.9	0.6	0	0	0	0	0.2	0	0	4.7	0	8.1	0	1.4	0	1.2	0	0.3	2.3	0	4.3	0	4.2	0	0.1	0	2.1	0	0.7	0	31.5	15.6	0	0	0.3	0	0	0.9	0	8.6	1.4	0	2	0	0	0	5	0.2	6.7	0	0.2	0	0	0	0	0	0.9	0.3	0	0	0	0	0	0	0	0	0	0.1	9.1	6.9	12.4	11.8	10.2	9.7	11.5	0.7	0.9	1.2	86.4	19	0	0.1	0	3.3	0	0	6.7	5.7	0	0	0	0	0	1.9	0	0	0	0	0	1.5	0.1	0	0	0.2	7.9	0	1.3	0.8	0	0.9	0	1.7	0	0	0	0	0	0.4	0	1	0	0.2	0.9	0.1	0	0.1	0	0	0	Alveolar cells type 1
ZFP92	ZNF897	ENSG00000189420	ZFP92 zinc finger protein	A6NM28	X	153418322-153426481	Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	DNA-binding		Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		ovary: 6.7	Cell type enriched	Detected in some	6	Sertoli cells: 19.4	Cancer enhanced	Detected in some		ovarian cancer: 3.2					Cell type enhanced	Detected in single		intermediate monocyte: 1.8	Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		HDLM-2: 6.1;HMC-1: 5.9;THP-1: 3.9;U-937: 10.1	Region enhanced	Detected in many		hypothalamus: 10.3	Low region specificity	Detected in all			HPA003030	Uncertain											HPA003030: AB_2666758	unprognostic (6.94e-2)	unprognostic (2.54e-2)	unprognostic (7.85e-2)	unprognostic (2.57e-4)	unprognostic (1.01e-2)	unprognostic (3.84e-2)	unprognostic (1.21e-1)	unprognostic (1.54e-1)	unprognostic (1.65e-2)	unprognostic (1.62e-2)	unprognostic (6.51e-3)	unprognostic (6.71e-2)	unprognostic (1.84e-1)	unprognostic (8.49e-4)	unprognostic (1.81e-1)	unprognostic (2.71e-2)	unprognostic (6.66e-3)	2	2.8	1.1	0.4	1.5	4	0.8	3.6	2.5	1.1	0.5			0.1	1.8	4.3	0	5.4	0.4	0.7	0.9	1.9	0.8	0.2	2.3	0.3	0.9		6.7	0.8	1.3	1.8	0.8		0.5	0		0	2.5	0	0	0.6	1.5	0.2	0.6	0.4	0.7			0.4		0.4	0	0	0.4	0	0.1	1.8	0	0.9	0.3	0	0.9	0	0	0	0	0	0.8	1.5	1.4	1.3	0.7	0.1	0	0.8	0.9	0.4	0.7	0.6	0.7	1.1	6.1	0	2.3	0	0	2.5	0.7	5.9	0.4	0.9	0	0.1	0	2.4	1.5	1.8	0	0	0	1.5	0.5	0.3	0.8	0	0	0	0.4	0	0	0.6	1.5	0	0	1.6	0	0.1	3.9	0	0	3	0	0	1.4	0	1.6	0	10.1	0.6	0	0.7	0	0.9	1.8	0.2	0.4	0.1	0	0	0	0.1	0.1	0.1	0	0.3	0	0	0.3											0	0	0	0	0	0.2	0.8	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0.3	0	0	0	0.8	0	0	0.6	0.8	0	2.3	0.5	0	0	0	0.2	0.3	0	3.2	0.2	0.2	19.4	0.8	0.1	0.6	0	0	0	0	0	Sertoli cells
GJB4	CX30.3	ENSG00000189433	Gap junction protein beta 4	Q9NTQ9	1	34759741-34763724	Disease related genes, Predicted membrane proteins			Disease mutation, Palmoplantar keratoderma	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in many		epididymis: 11.1;skin 1: 26.2	Cell type enriched	Detected in some	4	Urothelial cells: 91.2	Low cancer specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		A-431: 6.7;HaCaT: 9.9;HBEC3-KT: 6.4;hTCEpi: 4.2;OE19: 3.7;RPTEC TERT1: 3.9;RT4: 4.5	Not detected	Not detected			Not detected	Not detected			HPA055112, HPA073904	Enhanced		Supported	Cell Junctions						Cell Junctions		HPA055112: AB_2682699, HPA073904: 	unprognostic (3.30e-2)	prognostic favorable (5.48e-4)	unprognostic (1.57e-1)	unprognostic (2.70e-2)	unprognostic (4.21e-2)	unprognostic (2.22e-1)	unprognostic (2.16e-2)	unprognostic (2.18e-2)	unprognostic (5.40e-2)	unprognostic (3.65e-1)	prognostic unfavorable (3.24e-5)	unprognostic (3.73e-2)	unprognostic (5.81e-3)	unprognostic (1.26e-1)	unprognostic (1.67e-1)	unprognostic (3.52e-4)	unprognostic (5.42e-2)	0.1	0.1	0.1	1.2	0.1	0	1.5	0.1	0.1	1.7	0.3	0	2.9	0	0.1	11.1	2.9	0.1	8.3	0.1	0.1	0.1	0.5	0.1	0.1	0	0.1	0	0.1	0.1	0	0.1	3.4	0	2	0.2	0	0.8	2	0.1	26.2	0.3	1.2	0.1	0.1	0.2	0.7	0	0.1	0.1	1.6	2.4	3.2	6.3	0	0	0	0	0	0.3	0.2	6.7	0.6	0	0	0	0	0	0	0	0	0	0.1	1.2	0	1	0	0.1	9.9	0	6.4	0	0	0	1.4	0	0	0	0	0	0	4.2	0	0	0	0	0	0	0	0	0	0	0	0	3.7	0	0	0	0	3.9	4.5	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0.1	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0	0	22.7	4.2	0	0	0	0	0	0	0	0	0	4	0	0	0	0	0.5	0	0	6.5	0	0	0	0	1.7	0	0	0	0	0	1.7	0	0	0	21.6	0.6	0	0	0	0	0	0	0	5.3	0.2	0	0	91.2	Urothelial cells
SYCP2	SCP2	ENSG00000196074	Synaptonemal complex protein 2	Q9BX26	20	59863563-59933655	Predicted intracellular proteins	Cell cycle, Cell division, Meiosis	DNA-binding		Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	5	breast: 11.1;testis: 41.7	Cell type enriched	Detected in many	6	Spermatocytes: 330.2	Group enriched	Detected in many	6	breast cancer: 6.7;cervical cancer: 11.3	Low region specificity	Detected in many			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		JURKAT: 19.1;MOLT-4: 21.1;SiHa: 37.2;T-47d: 33.6	Not detected	Not detected			Low region specificity	Detected in many			HPA062401, HPA065613			Supported	Nucleoplasm,Plasma membrane,Cytosol						Nucleoplasm	Plasma membrane, Cytosol	HPA062401: AB_2684752, HPA065613: AB_2685519	unprognostic (8.10e-3)	unprognostic (8.28e-3)	unprognostic (1.62e-1)	unprognostic (2.48e-2)	unprognostic (1.57e-1)	unprognostic (1.19e-3)	unprognostic (2.50e-2)	unprognostic (2.18e-1)	unprognostic (4.11e-2)	unprognostic (1.44e-1)	unprognostic (3.74e-1)	unprognostic (7.02e-3)	unprognostic (4.84e-3)	unprognostic (8.48e-2)	unprognostic (2.46e-1)	unprognostic (7.87e-3)	unprognostic (1.21e-1)	2.2	0.5	1.3	0.9	2.3	1.4	11.1	2.5	5.7	1.3	1.2	1	0.8	1.1	1.1	0.9	0.8	0.8	2	2.1	1.2	1.2	3.3	0.8	1.6	3.1	1.8	2.7	0.4	4.9	1.3	3	2.9	3.9	2.9	0.8	0.6	3	0.7	0.8	2	1.7	0.6	1.6	2.3	4.5	41.7	0.8	3	1.9	0.2	1.5	1.3	1	0.9	0.1	2.6	0.3	0	2.7	0.5	0.1	0.5	0.1	0.5	0.2	0.3	0.6	1.6	0.4	0.7	0.1	10.2	1	0	1.6	0.7	0.3	0.2	0.2	0	0.4	3.2	0.2	0.1	2	0.1	0	0.1	7.6	0.1	0.1	0.1	0	0.4	0	19.1	0.1	0	0.3	4.9	21.1	1.1	0.2	0.6	0.1	0	0	0.1	0.9	2.4	0.1	1.8	37.2	5.4	1.1	0.7	33.6	1.9	0.2	0	1.1	4.5	0	0	0	0	0	0.7	2.1	2.5	0.3	2.3	2.6	0	2.7	0.7	1.5	1.7	0.1	0.9	0.9	1.5	2.6	0	0.1	0.1	1	0.5	1.3	2.3	2.5	5.7	1.2	1.2	1.8	2.7	3.9	0.8	0	0.6	0.5	1	0.9	1.3	3.6	2.5	14.7	10.3	1.8	2	0.5	1.7	0.6	36.7	2.3	0	0	3.1	0.2	1.2	2	2.3	0	0.5	0	0	3.1	0.6	13.5	4.4	1.1	5	0	0	2.2	1.6	0.2	1.8	2.6	1	51.8	1.9	330.2	31.3	0	0.3	1.3	0.2	1.1	Spermatocytes
ACADSB	ACAD7, SBCAD	ENSG00000196177	Acyl-CoA dehydrogenase short/branched chain	P45954	10	123008979-123058311	Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins	Fatty acid metabolism, Lipid metabolism	Oxidoreductase	Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in all	4	kidney: 28.9;liver: 114.2	Cell type enriched	Detected in many	4	Hepatocytes: 481.6	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Cell line enhanced	Detected in all		Hep G2: 35.3	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA041458, HPA063555	Enhanced		Supported	Mitochondria					63000	Mitochondria		HPA041458: AB_2677491, HPA063555: 	unprognostic (1.53e-2)	unprognostic (1.31e-1)	unprognostic (3.91e-3)	unprognostic (2.02e-1)	unprognostic (1.25e-1)	unprognostic (4.87e-2)	unprognostic (4.15e-2)	unprognostic (1.32e-3)	unprognostic (1.30e-1)	unprognostic (3.67e-1)	prognostic favorable (3.40e-4)	unprognostic (9.37e-3)	prognostic favorable (6.37e-12)	unprognostic (2.69e-1)	unprognostic (7.20e-2)	unprognostic (1.60e-3)	unprognostic (7.14e-2)	4.6	9.4	6.7	2.4	9	1.4	8.3	10.3	8.3	3.9	5.3	5.5	6.4	16.8	4.1	3.3	4.4	4.1	3.1	13.7	8.5	4.8	28.9	114.2	4.3	2.7	5.1	8.2	5	5.3	8	4.9	1.9	7.5	7.9	5.8	4.9	5.6	6	12.7	4.7	5.5	5.2	4.8	2.7	4.8	2.9	5.4	3.6	4.3	7.9	3.9	5	4.1	6.3	6.8	13.5	5	9	11.7	6	9.7	7	5.2	9.5	7.1	8.9	4.6	6	12.2	6.1	6.1	6.1	3.2	10.2	4.2	5.1	3.7	4.1	8.1	4.2	10.1	6.6	8.4	5.3	2.1	35.3	5	7.5	5.1	6.5	4.3	3.8	3.5	9	5.8	8.6	5.1	7.5	7.5	4.5	7.1	6.2	3.2	5.4	4.4	8.5	10.9	3.2	8.6	10.8	1	6	9.2	2.8	9.5	5.2	8.4	3.7	6.1	3.3	3	7.5	7.3	8.5	9.6	5.4	5.1	7.1	2.5	13.5	5	12.3	10	5	11.7	5.9	9.4	8.6	6.8	6.3	8.9	9.9	3.2	9	3	4.1	7.6	6	6.7	9	10.3	8.3	8.5	4.8	5.1	8.2	7.5	5.4	26.8	40.3	7.3	7.2	8.2	17.2	64.9	43.3	17.4	29.6	10.4	9.8	17.9	39.7	6.4	6	7.4	6.8	0	4.2	2.5	7.5	26.5	3.5	481.6	6.3	20.6	11.6	15.4	11.8	7.8	12.4	7.6	6.8	8.2	13.3	12.2	4.3	5.8	10.3	116.2	7.3	19.4	11.3	9.7	2.5	12	25.2	13.8	15.7	10.7	Hepatocytes
RYR1	CCO, MHS, MHS1, PPP1R137, RYR	ENSG00000196218	Ryanodine receptor 1	P21817	19	38433699-38587564	Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters	Calcium transport, Ion transport, Transport	Calcium channel, Calmodulin-binding, Developmental protein, Ion channel, Ligand-gated ion channel, Receptor	Disease mutation, FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	4	skeletal muscle: 231.0	Cell type enriched	Detected in many	5	Muller glia cells: 46.0	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Group enriched	Detected in some	6	intermediate monocyte: 3.2;myeloid DC: 5.3;non-classical monocyte: 6.3	Group enriched	Detected in many	7	dendritic cells: 5.3;monocytes: 6.3	Cell line enhanced	Detected in some		A549: 5.7;HaCaT: 14.0;hTCEpi: 5.7;RH-30: 11.5;SiHa: 22.8;U-2 OS: 9.6	Low region specificity	Detected in some							HPA056416	Enhanced		Approved	Golgi apparatus,Vesicles,Cytosol						Golgi apparatus, Vesicles	Cytosol	HPA056416: AB_2683121	unprognostic (2.22e-3)	unprognostic (1.91e-3)	unprognostic (9.59e-2)	unprognostic (5.34e-4)	unprognostic (2.50e-1)	unprognostic (6.00e-2)	unprognostic (2.11e-1)	unprognostic (1.06e-1)	unprognostic (1.18e-1)	unprognostic (3.20e-3)	unprognostic (3.52e-1)	unprognostic (2.35e-1)	unprognostic (1.07e-5)	unprognostic (1.13e-2)	unprognostic (8.10e-2)	unprognostic (6.62e-3)	unprognostic (1.34e-1)	5.3	0.7	3	0.6	1.9	0.4	0.6	2.7	1.7	0.6	0.4	2.7	0	0.4	0.4	6.7	3	0.6	0.5	0.4	1.8	4	0.5	0.4	0.7	0.6	1.5	1.3	0.4	0.4	0.3	0.3	0.6	1.9	0.9	0.4	0.4	2.2	0.6	231	2.4	0.5	0.4	1.1	0.6	0.5	1.6	1.9	0	1.6	55.1	3.2	0.6	0.5	0.7	5.3	0.1	6.3	0	0.6	0.6	0	5.7	0	0	0	0	1.4	0	0	0	0	2	0.3	0.3	4.8	0	0	14	0.2	0	0	0	0.3	1	0	0	0	0	0.4	1.3	5.7	0	0	0	0	0	0.8	0	0	0.1	0	0	0.4	0.7	0	0	11.5	1.1	0.6	0	0	1.1	22.8	0	0	0.4	0.5	4.3	0	0	9.6	0.2	0	0.3	1	0.3	0.1	0	0	0	0.6	0	0.4	3.2	0.5	0.4	0.3	0.6	5.3	0.7	0	0	0.1	0	6.3	0	0.6	0.6	3	1.9	2.7	1.7	1.8	4	1.5	1.3	1.9	1.9	0	0.6	0	3.4	10.1	4.1	3.4	0	0	0	0	2	0.1	5	0.1	5.2	0	0	0	0	0.2	0.3	0.6	0	0	7.1	1.6	0	0.6	1.9	4.7	2.8	4.5	0	0	0	46	0	0	1.8	0	1.5	0	0.3	5.5	6.9	4.1	0.2	0	0	0.1	Muller glia cells
OR2T2	OR2T2P	ENSG00000196240	Olfactory receptor family 2 subfamily T member 2	Q6IF00	1	248445512-248455725	G-protein coupled receptors, Predicted membrane proteins	Olfaction, Sensory transduction	G-protein coupled receptor, Receptor, Transducer		Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enriched	Detected in some	7	kidney: 14.1	Cell type enriched	Detected in single	14	Proximal tubular cells: 1.4	Not detected	Not detected			Not detected	Not detected			Cell type enhanced	Detected in single		naive B-cell: 1.9	Lineage enriched	Detected in single	20	B-cells: 1.9	Cell line enriched	Detected in single	22	Karpas-707: 3.2																																							0	0	0	0.2	0	0	0	0	0.1	0.3	0.1	0	0	0	0	2	0	0	0	0	0	0	14.1	0	0	1.5	0	0	0.2	0.1	0	0	0.2	0	0.4	0	0	0.1	0	0	0.1	0	0	0	0.1	0	0.1	0	0	0.3	0	0.4	0.2	0	1.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.2	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.8	0	0	0	1.9	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.4	0	0	0	0	0	0	0	0	0	0	Proximal tubular cells
STK31	SgK396, TDRD8	ENSG00000196335	Serine/threonine kinase 31	Q9BXU1	7	23710167-23832513	Enzymes, Predicted intracellular proteins		Kinase, Serine/threonine-protein kinase, Transferase		Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	63	testis: 56.0	Cell type enriched	Detected in some	5	Spermatocytes: 163.1	Low cancer specificity	Detected in some			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	8	CACO-2: 20.1	Not detected	Not detected			Low region specificity	Detected in many			HPA023194	Enhanced											HPA023194: AB_1857590	unprognostic (4.25e-2)	unprognostic (1.04e-1)	unprognostic (3.98e-2)	unprognostic (5.41e-2)	unprognostic (1.62e-1)	unprognostic (1.50e-2)	unprognostic (1.09e-2)	unprognostic (1.26e-1)	unprognostic (1.34e-1)	unprognostic (1.73e-1)	unprognostic (2.42e-3)	unprognostic (2.92e-1)	unprognostic (1.29e-6)	unprognostic (7.83e-2)	unprognostic (9.21e-3)	unprognostic (1.46e-1)	unprognostic (3.65e-1)	0.1	0	0.1	0.1	0.7	0	0.1	0.8	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.2	0.1	0	0.1	0.1	0.2	0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.2	0.1	0.1	56	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0	0.2	0.5	0	0	0	0	0.5	0	0	0	0	20.1	2.5	0	2.5	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0	0	0	0.1	0	0	0.1	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.7	0.8	0.1	0.2	0	0.1	0.1	0.1	0.1	3	1.4	0	0.2	0.1	1.7	0.4	2.5	6.7	4.5	0	0	0.5	0	0.2	16.5	0	0.3	0	0.6	0.1	0	0.3	0	0.8	0.2	0	1.2	0	0	12.3	3.1	0	0	0	0.2	1.3	0.4	0.8	2.8	0	1.2	0	0	163.1	32.6	0.1	0.5	0	0.4	0.4	Spermatocytes
CGB7	CG-beta-a	ENSG00000196337	Chorionic gonadotropin beta subunit 7	P0DN87	19	49054275-49058860	Predicted secreted proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in many		skin 1: 8.1	Cell type enriched	Detected in some	5	Syncytiotrophoblasts: 49.1	Not detected	Not detected			Low region specificity	Detected in some			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		BEWO: 7.1;HaCaT: 5.7;HBEC3-KT: 4.8;hTCEpi: 6.9;U-251 MG: 10.4									HPA038925, HPA038934	Supported		Approved	Cytosol	Secreted in other tissues					Cytosol		HPA038925: AB_2676272, HPA038934: AB_2676277	unprognostic (9.53e-2)	unprognostic (1.99e-1)	unprognostic (1.87e-1)	unprognostic (3.53e-1)	unprognostic (4.60e-5)	unprognostic (2.64e-1)	unprognostic (2.46e-1)	unprognostic (8.37e-2)	unprognostic (2.88e-2)	unprognostic (4.80e-2)	unprognostic (8.83e-4)	unprognostic (1.54e-1)	unprognostic (3.89e-8)	unprognostic (1.63e-2)	unprognostic (1.94e-1)	unprognostic (2.05e-1)	unprognostic (9.28e-2)	0.3	0.2	0.3	0.3	0.3	0	0.8	0.3	1.5	1.7	0.3	0.3	3.7	0.3	1.2	0.5	4	1	2	2	0.4	0.2	1	0.3	0.8	0.3	0.3	0.3	0.9	2.5	0	2.7	3.7	1.3	4.6	0	0.8	1.3	3.9	6.4	8.1	0.3	0.3	0.3	0.3	0	1.5	0.3	0.3	0.9	2.2	0.3	2.4	2.7	0.2	0	0	0	0	0.3	0	3.2	0.8	0.2	1.5	0	0.2	7.1	0.6	0	1.4	1.2	1.2	2.6	0	0.1	1.3	2.1	5.7	0.2	4.8	0.5	0.1	0.3	0	0	0	0.3	0	0.3	0.4	6.9	0.4	0.7	1.6	0	0	0	0.2	1.3	0.3	0	0	0	0	0	0.1	0.1	0	0	4	0.1	0.1	1.4	0.1	0.1	1.7	1	0.2	0.2	2.3	2.3	0	10.4	0.3	0.4	0	1.1	0.1	0	0	0	0	0	0	0	0.2	0.2	0	0	0	0	0	0	0	0	0	0.3	0	0.3	0.3	0.3	1.5	0.4	0.2	0.3	0.3	1.3	0.3	0	0.3	0	0	0.6	0	0.3	0	0	0	0	0	0.4	0	0	0	0	0	0	0	2.7	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	9.6	0	0	0	0	0	0	0.6	0.3	0	49.1	0	0	0	Syncytiotrophoblasts
NLGN3	ASPGX1, AUTSX1, HNL3, KIAA1480	ENSG00000196338	Neuroligin 3	Q9NZ94	X	71144831-71171201	Disease related genes, Predicted intracellular proteins, Predicted membrane proteins	Cell adhesion		Asperger syndrome, Autism, Autism spectrum disorder, Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 45.9	Cell type enriched	Detected in some	6	Peritubular cells: 16.3	Cancer enriched	Detected in many	19	glioma: 37.4	Low region specificity	Detected in all			Cell type enriched	Detected in single	6	neutrophil: 3.3	Lineage enriched	Detected in single	6	granulocytes: 3.3	Cell line enhanced	Detected in some		AF22: 11.1;NTERA-2: 8.1;SH-SY5Y: 4.4	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA003183, HPA004066	Enhanced		Supported	Golgi apparatus,Cell Junctions	Intracellular and membrane					Golgi apparatus, Cell Junctions		HPA003183: AB_1079469, HPA004066: AB_2732397	unprognostic (4.06e-2)	unprognostic (1.77e-1)	unprognostic (1.59e-2)	unprognostic (2.38e-2)	unprognostic (2.42e-1)	unprognostic (3.87e-1)	unprognostic (6.52e-2)	unprognostic (1.63e-1)	unprognostic (7.10e-2)	unprognostic (1.17e-1)	unprognostic (1.94e-1)	unprognostic (6.18e-2)	unprognostic (4.27e-9)	unprognostic (4.28e-2)	unprognostic (1.90e-1)	unprognostic (2.22e-5)	unprognostic (9.01e-2)	1.4	8.9	16.3	1.6	19.4	2.2	1.3	11.5	45.9	3.2	1.6	30	0.1	1.1	4.2	8.1	1.5	6	2.4	2.1	15.7	9.7	1.2	0.9	1.3	1.2	12.7	13.1	6.1	1.2	1.4	1.1	1.5	15.2	7.9	1.4	1.6	1.6	16	0.8	1.6	1.6	2.9	12.9	1.4	1.5	3.8	12.3	0	1	0	1.1	1.5	1.3	0.2	0.1	3.3	0.3	0.3	0.5	0	0.1	0.8	11.1	0.3	2.6	1.1	1.9	0.3	0.1	0	0.2	0.1	0.5	0.8	0.8	0.1	0	0.2	0.4	0	0.2	0.7	1.3	0.5	0.5	0.1	0	0.2	0.9	0.6	0.1	0.3	0	0.5	0.1	3.1	0.7	2.1	0.1	0.6	0.7	1.7	8.1	0.1	0	0.9	0.4	0.5	0	1.2	2.7	4.4	0.3	0	1	1.4	0	0.5	0.3	0.2	1.3	0.5	0.1	1.7	1.5	0.6	0.3	0.5	0.6	0.3	0.3	0	0.1	0	0.1	0.2	0.1	0	0.1	0.2	0.5	0.1	3.3	0.3	0	0.1	0.1	0	16.3	19.4	11.5	23.1	15.7	9.7	12.7	13.1	15.2	12.3	0	0	0	0.4	0.6	2.1	0.4	0	0	0	0	0	0.8	0	0	1.2	0.3	0	0	0	0.1	0.8	0	0	0	0.1	0	0	0.6	0	2.5	2	0	0	0	0	2.4	0.1	0	16.3	0	0.5	0	0.1	0.2	0	0.4	0.2	0	0	0.3	Peritubular cells
THEM5	FLJ37964	ENSG00000196407	Thioesterase superfamily member 5	Q8N1Q8	1	151847263-151853697	Enzymes, Predicted intracellular proteins	Fatty acid metabolism, Lipid metabolism	Hydrolase		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	7	skin 1: 59.8;tongue: 24.7	Cell type enriched	Detected in some	18	Suprabasal keratinocytes: 30.4	Low cancer specificity	Detected in all			Low region specificity	Detected in single			Cell type enhanced	Detected in some		MAIT T-cell: 4.2	Lineage enriched	Detected in single	7	T-cells: 4.2	Cell line enriched	Detected in some	6	HDLM-2: 39.1	Not detected	Not detected			Region enriched	Detected in single	15	basal ganglia: 20.0														unprognostic (2.28e-2)	unprognostic (1.21e-1)	unprognostic (1.07e-1)	unprognostic (3.41e-2)	unprognostic (2.58e-3)	unprognostic (9.55e-3)	unprognostic (1.27e-1)	unprognostic (1.93e-1)	unprognostic (1.83e-1)	unprognostic (7.86e-3)	unprognostic (3.07e-3)	unprognostic (9.37e-2)	unprognostic (1.20e-1)	unprognostic (1.97e-2)	unprognostic (2.49e-1)	unprognostic (5.34e-2)	unprognostic (1.62e-2)	0.1	0.6	0.3	0.5	0.2	0	1.8	0.2	1.6	3.6	0.1	0.2	0.1	0.3	0.8	0.1	4.4	0.1	1	1.1	0.3	0.2	0.3	0.2	0.3	1.9	0.2	0.8	0.1	0.3	0	0.2	5.8	0.1	0.1	0	0.1	1.5	0.1	0.2	59.8	0.1	0.1	0.3	0.1	0.5	0.3	0.1	0.4	0.1	24.7	1.7	0.6	1.1	0	0.5	0.5	0.2	0	4.2	5.6	4.4	0	0	0.1	0	0	0.8	0.2	0	0	0	0	0.4	0	0.1	0	0	1.6	0	0	0	39.1	0	0	1.2	0	0	0	0	0	0	0	0	0	0	0.6	0	1.6	0	1.2	0.1	0	4.7	0.7	0.3	0	0.2	0.5	0	0	0.3	0.1	6	1.4	0.8	1	1	1.4	0	0	0	1	0.1	0.1	0	0	0	0	0.2	0	0.2	0	1.8	0.2	4.2	0	1.6	1	0	0	0	0.6	0.5	0	0	0.5	1.9	5.6	0.3	0.2	0.2	1.3	0.3	0.2	0.2	0.8	0.1	0.1	0	0	0	0	1.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	1.7	0	0	0	0	0	0	0	0	0	0	0	0	30.4	0.9	0	0	0	Suprabasal keratinocytes
FGF16	MF4	ENSG00000196468	Fibroblast growth factor 16	O43320	X	77447405-77457278	Disease related genes, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins		Growth factor	Disease mutation	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in some		adipose tissue: 3.2;seminal vesicle: 4.2	Cell type enriched	Detected in single	4	Melanocytes: 1.7	Not detected	Not detected			Group enriched	Detected in some	6	cerebral cortex: 1.5;hypothalamus: 1.1;pons and medulla: 1.8	Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	5	U-2197: 22.7	Group enriched	Detected in some	6	basal ganglia: 3.7;hippocampal formation: 2.2;olfactory region: 8.3	Not detected	Not detected								Secreted in other tissues								unprognostic (4.01e-2)					unprognostic (5.30e-2)		unprognostic (1.12e-1)		unprognostic (1.10e-1)	unprognostic (1.28e-1)			unprognostic (2.31e-1)	unprognostic (6.57e-2)	unprognostic (1.49e-2)		3.2	0	0.2	0.1	0.2	0	2.3	0.1	1.5	0.1	0.5	0.7	0.1	0	1.2	0.6	0.5	0.4	0.7	1	0.1	1.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.7	0.1	0.1	1.8	0.1	0.2	0.1	0.5	4.2	1.3	0.4	0.4	0.7	0.1	0.1	0.1	0.1	0.1	0.1	0.5	0.1	0.1	2	0.2	0.3	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.4	0	0	4.9	0	0	0	0	0	0	0	1	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	22.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0.2	0.2	0.1	1.5	0.1	1.1	0.1	0.1	1.8	0.1	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.7	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0.1	Melanocytes
OR5AC2	HSA1	ENSG00000196578	Olfactory receptor family 5 subfamily AC member 2	Q9NZP5	3	98087173-98088102	G-protein coupled receptors, Predicted membrane proteins	Olfaction, Sensory transduction	G-protein coupled receptor, Receptor, Transducer		Evidence at transcript level	Evidence at transcript level	No human protein/transcript evidence	No human protein/transcript evidence		Tissue enhanced	Detected in single		testis: 2.3	Cell type enriched	Detected in single	9	Early spermatids: 1.7	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Not detected	Not detected																																									0	0	0	0	0	0	0	0	0	0.3	0			0	0	0	0	0.2	0	0	0	0	0	0	0	0	0		0	0	0	0	0		0	0		0	0	0	0	0	0	0	0	0	2.3			0		0	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0	0											0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.7	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Early spermatids
SLC22A25	HIMTP, MGC120420, UST6	ENSG00000196600	Solute carrier family 22 member 25	Q6T423	11	63163776-63229652	Predicted membrane proteins, Transporters	Transport			Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enriched	Detected in single	165	liver: 16.5	Cell type enriched	Detected in single	9	Hepatocytes: 5.8	Cancer enriched	Detected in single	66	liver cancer: 3.2					Not detected	Not detected			Not detected	Not detected			Not detected	Not detected											HPA039390	Uncertain											HPA039390: AB_10671996	unprognostic (3.19e-2)				unprognostic (2.38e-1)	unprognostic (4.51e-1)	prognostic favorable (7.04e-4)							unprognostic (1.01e-1)				0	0	0	0	0	0	0	0	0	0	0			0	0	0	0	0	0	0	0	0	0	16.5	0	0	0		0	0	0	0	0		0	0		0	0	0	0	0	0	0	0	0	0			0		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5.8	0	0	0	0.6	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Hepatocytes
MMP1	CLG	ENSG00000196611	Matrix metallopeptidase 1	P03956	11	102789920-102798160	Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins	Collagen degradation, Host-virus interaction	Hydrolase, Metalloprotease, Protease	Cancer-related genes, FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		gallbladder: 62.4;stomach 1: 27.2	Cell type enriched	Detected in some	7	Pancreatic endocrine cells: 1303.6	Cancer enhanced	Detected in many		head and neck cancer: 344.2	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		BJ hTERT+: 90.2;HBF TERT88: 89.3;HUVEC TERT2: 234.8;WM-115: 115.7									HPA004920			Approved	Vesicles	Secreted to extracellular matrix			7730000	430000	Vesicles		HPA004920: AB_2667293	unprognostic (4.11e-3)	prognostic unfavorable (4.66e-4)	unprognostic (4.20e-3)	unprognostic (1.19e-3)	unprognostic (6.46e-2)	unprognostic (6.50e-2)	prognostic unfavorable (4.22e-6)	unprognostic (7.83e-3)	unprognostic (2.94e-2)	unprognostic (5.44e-2)	unprognostic (1.11e-3)	unprognostic (1.75e-1)	prognostic unfavorable (9.86e-10)	unprognostic (1.67e-2)	unprognostic (1.49e-1)	unprognostic (1.26e-2)	unprognostic (5.11e-2)	0.2	0.1	0.3	12.3	0.3	0	0.9	0.3	0.3	0.3	2.7	0.3	0.2	3.2	4.8	0.2	3.3	0.1	62.4	0.4	0.2	0.1	0.7	1.3	4.7	0.2	0.2	0.2	0.2	1.6	0	0.2	8.6	0.5	0.7	3	0.3	2	0.2	0.2	0.3	8.8	0.2	0.4	1.8	27.2	2.2	0.2	0.4	0.3	1.3	0.9	11	0.2	0	0	0.6	0	0	0	1.9	0	0	0	0	0	0	0	40.8	90.2	36.9	9.6	0.7	0	0	0.4	21.6	14.2	0.3	0	12.6	89.3	0	0	0	0	0	0.2	0	0	0	0	37.9	3.2	0	234.8	0	0.1	0	0	0	0	0	0	14.7	1.6	0	0	0	0	0.1	0	0	0.3	0	0.1	0	0	0	12.1	30.6	0	1.3	0.1	0	0	0	0.7	0	115.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0	1.9	0.3	0.3	0.3	0.3	0.2	0.1	0.2	0.2	0.5	0.2	3	1.6	0	14.4	2.1	0	0	35.7	0	23.9	3.5	0	0	0	3.5	0	0.1	0	0	184	0	0.2	5.4	0	0	0.3	0	0	0	1.9	0	0	0.2	0	7.2	0	0	1303.6	0	0	0	0	0	0.4	0	0	0.3	0.1	0	0	25	Pancreatic endocrine cells
ADH1B	ADH2	ENSG00000196616	Alcohol dehydrogenase 1B (class I), beta polypeptide	P00325	4	99304964-99352760	Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins		Oxidoreductase	FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	5	adipose tissue: 253.5;liver: 466.3	Cell type enriched	Detected in many	38	Hepatocytes: 3603.2	Cancer enriched	Detected in many	31	liver cancer: 223.1	Group enriched	Detected in some	5	midbrain: 2.3;pons and medulla: 1.6	Low cell type specificity	Detected in single			Low lineage specificity	Detected in single			Cell line enriched	Detected in some	7	ASC diff: 394.3									HPA047814, HPA060902	Supported		Approved	Plasma membrane,Cytosol					16000000	Plasma membrane, Cytosol		HPA047814: AB_2680163, HPA060902: AB_2684384	unprognostic (5.13e-2)	unprognostic (9.80e-3)	unprognostic (6.59e-2)	unprognostic (5.56e-2)	unprognostic (9.49e-2)	unprognostic (5.53e-2)	unprognostic (1.54e-3)	unprognostic (1.04e-2)	unprognostic (6.51e-2)	unprognostic (2.73e-2)	unprognostic (7.47e-3)	unprognostic (7.79e-2)	prognostic unfavorable (7.87e-4)	unprognostic (4.60e-3)	unprognostic (2.33e-1)	unprognostic (2.58e-1)	unprognostic (1.60e-2)	253.5	12.3	0.2	21.8	0	0.4	78.7	0.2	0.4	18.3	60	0.4	5.7	3.5	12.8	14.4	33.5	22.3	31.9	24.2	0.3	0	9.2	466.3	43.8	17.5	2.3	0.1	18	8.7	0.8	5.3	0.9	1.6	30.7	10.1	2.3	11.2	3.9	20.5	11.9	25.4	30.8	2.4	5.9	10.9	18	0.2	0.2	16.1	9.7	2	42.3	76	0.6	0.2	1.2	0.3	0.8	0.4	0	0	0	0	0	394.3	57.8	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.6	0.1	0	12.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0.3	0.3	0.2	0.1	0.1	0.2	0.4	0.1	0	0.6	0.3	0.4	1.2	0.8	0.1	0.2	0.1	0	0.2	0	0.2	0	0.3	0	2.3	0.1	1.6	0.2	0	4.3	14	0.4	19.8	0	8.9	66.2	0	3.4	0	0	0	0	0	0.4	9.2	0	46.7	0	0	81	0.3	1.1	3603.2	0.1	0	0	93.9	77.5	0	51.2	1	27	0	0	0	0	0	0.4	0	0	6.5	43.7	0	0	11.4	0.1	12.5	0	0.1	Hepatocytes
LCE1B	LEP2, SPRL2A	ENSG00000196734	Late cornified envelope 1B	Q5T7P3	1	152811971-152813109	Predicted intracellular proteins	Keratinization			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in some	9	skin 1: 59.7	Cell type enriched	Detected in single	18	Suprabasal keratinocytes: 16.6	Cancer enriched	Detected in some	10	melanoma: 6.0					Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	8	HBEC3-KT: 1.7;hTCEpi: 6.7																							unprognostic (1.79e-1)				unprognostic (1.24e-2)			unprognostic (6.43e-2)									0	0	0	0	0	0	6.3	0	0	0	0			0	0	0	0	0	0	0	0	0	0	0	0	0	0		0	0	0	0	0		0	0		0	0	0.4	59.7	0	0	0	0	0	0			0		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0.3	0	0	0	0	0	1.7	0	0	0	0	0	0	0	0	0	0	6.7	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0.2	0	0	0	0	0	0	0	0.1	0	0	0.1	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.6	0	0	0	0	Suprabasal keratinocytes
POU3F4	BRN4, DFN3, DFNX2, OTF9	ENSG00000196767	POU class 3 homeobox 4	P49335	X	83508261-83512127	Disease related genes, Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	DNA-binding	Deafness, Disease mutation, Non-syndromic deafness	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in some	15	brain: 39.0	Cell type enriched	Detected in some	6	Collecting duct cells: 10.4	Cancer enriched	Detected in single	21	glioma: 5.6	Region enriched	Detected in all	6	basal ganglia: 39.0	Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	145	AF22: 15.1	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA062295			Supported	Nucleoplasm						Nucleoplasm		HPA062295: AB_2732681					unprognostic (5.73e-2)										unprognostic (2.00e-1)			0.5	0.5	3.3	0.5	39	0.6	0.5	5	15.2	0.5	0.7	2.4	0	0.5	0.5	0.5	0.5	0.5	1.3	0.5	2.8	1.6	2.5	0.5	0.5	0.5	2.4	3.7	1.1	0.5	0.5	0.1	0.5	2.4	0.5	0.6	0	0.5	0.5	0.5	0.5	0.5	0.6	1.7	0.5	0.5	0.5	6.6	0	0.5	0	0.5	0.6	0.1	0	0	0	0	0	0	0	0	0	15.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.3	39	5	4.2	2.8	1.6	2.4	3.7	2.4	6.6	0	0	0	0	0	0	0.3	0	0	0	10.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Collecting duct cells
SPRR2B		ENSG00000196805	Small proline rich protein 2B	P35325	1	153070224-153070840	Predicted intracellular proteins	Keratinization			Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Group enriched	Detected in some	5	esophagus: 22.3;lymphoid tissue: 11.7;skin 1: 11.2	Cell type enriched	Detected in single	58	Leydig cells: 5.8	Cancer enriched	Detected in many	5	head and neck cancer: 77.2					Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HL-60: 1.7;SiHa: 1.3;U-2197: 1.2																							unprognostic (1.52e-1)				unprognostic (1.44e-2)			unprognostic (3.62e-1)									0	0	0	0	0	0	0	0	0	1.2	0			0	0	0	22.3	0	0	0	0	0	0	0	0	0	0		0.4	0	0	0	0		0	0		3	0	0	11.2	0	0	0	0	0	3.2			0		11.7	0	2.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.7	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.3	0	0	0	0	0	0	0	0	1.2	0	0	0	0	0	0.4	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Leydig cells
TOMM20L	UNQ9438	ENSG00000196860	Translocase of outer mitochondrial membrane 20 like	Q6UXN7	14	58395916-58408701	Predicted membrane proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	13	testis: 28.3	Cell type enriched	Detected in some	8	Early spermatids: 116.6	Low cancer specificity	Detected in single			Not detected	Not detected			Cell type enhanced	Detected in some		naive CD8 T-cell: 1.9	Group enriched	Detected in many	10	B-cells: 1.0;T-cells: 1.9	Cell line enhanced	Detected in some		SCLC-21H: 3.4	Not detected	Not detected			Low region specificity	Detected in many			HPA076397	Enhanced											HPA076397: 	unprognostic (1.72e-1)	unprognostic (2.34e-4)	unprognostic (8.13e-2)	unprognostic (7.80e-3)	unprognostic (5.08e-2)	unprognostic (2.15e-1)	unprognostic (1.35e-1)	unprognostic (4.28e-2)	unprognostic (4.93e-1)	unprognostic (1.37e-3)	unprognostic (3.06e-2)	unprognostic (5.66e-3)	unprognostic (4.57e-6)	unprognostic (8.75e-2)	unprognostic (1.50e-1)	unprognostic (1.32e-1)	unprognostic (7.66e-3)	0.5	0.4	0.2	0.2	0.6	0.1	0.5	0.6	0.8	0.5	0.5	0.8	0	0	0.9	1.8	0.2	0.4	0.5	0.3	0.2	0.2	0.7	0.3	0.4	2.2	0.3	0	0.7	1.2	1.1	0.5	0.3	0.6	0.8	0.5	1.7	0.5	0.5	0.2	0.3	0.4	1.4	0.3	0.3	0.6	28.3	0	0	0.9	0	0.6	0.3	0.2	1	0.1	0	0.1	0	1.9	0.4	1.8	0	0.5	1.9	0	0	2.1	0.3	0	0.3	0	0	0.5	1.6	0.2	1	0	0.3	0	0	0	2.8	0.6	0.5	0	0.5	0	1.9	1.3	0	0	0	0	0.2	0.9	0.7	0.3	0.2	0	0.9	1.2	0.5	0.8	0.3	2	2.2	0.8	0.3	0.3	0.5	3.4	2.3	0.5	0.4	0.5	1.2	1.4	2.8	0	0.2	0.4	0	0.5	0	0.4	0.2	1.5	1.5	0.5	0	0	0	0.4	0.1	0	1	0.1	0.5	0	0.2	0.1	1.9	0	0	0.1	0.1	0	0.4	0.2	0.6	0.6	0.8	0.2	0.2	0.3	0	0.6	0	0	0	0	0.1	0	0	0.4	0	0	0	0	0	0.1	0	0	116.6	0	0	0	0.2	0	0	0.2	0	0	0.1	0	0	0	0	15.5	0.9	0	0	0	0	0.6	0.1	0	0.7	0.4	0	0	0	6.7	0.9	0.4	0	0	0.2	0.1	Early spermatids
TEX43	C5orf48, FLJ27505, MGC163367, MGC163369, Tseg7	ENSG00000196900	Testis expressed 43	Q6ZNM6	5	126631722-126636287	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	24	testis: 23.8	Cell type enriched	Detected in some	5	Early spermatids: 386.4	Cancer enriched	Detected in single	7	colorectal cancer: 1.0	Not detected	Not detected			Cell type enhanced	Detected in single		memory B-cell: 1.0	Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		BJ hTERT+ SV40 Large T+: 2.2;BJ hTERT+ SV40 Large T+ RasG12V: 2.1;HeLa: 1.1;SK-BR-3: 1.9	Region enhanced	Detected in single		pons and medulla: 0.4	Not detected	Not detected																		unprognostic (1.73e-1)		unprognostic (3.85e-2)		unprognostic (4.06e-2)							unprognostic (2.76e-1)	unprognostic (1.85e-2)			0	0	0	0	0	0	0	0.1	0	0	0.6	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	23.8	0	0	0	0	0	0	0	1	0.5	0	0.1	0	0.9	0	0	0	0	0.6	0	0	0.9	0	0	2.2	2.1	0	0	0	0.1	0	0	0	0	0	0	0	0	0	1.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.9	0	0.5	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0.1	1	0.9	0	0	0	0	0.1	0	0	0	0.5	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	386.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	83.9	1.1	0	0	0	0	0	0	0	0.7	0	0	0	0	1.4	0.9	0	0	0	0	0	Early spermatids
FAM163B	C9orf166	ENSG00000196990	Family with sequence similarity 163 member B	P0C2L3	9	133578415-133586197	Predicted membrane proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	5	brain: 41.7	Cell type enriched	Detected in some	4	Late spermatids: 15.1	Cancer enriched	Detected in some	6	glioma: 3.2					Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	21	SH-SY5Y: 40.0	Low region specificity	Detected in many			Low region specificity	Detected in many			HPA067336	Enhanced		Approved	Nuclear bodies,Plasma membrane,Cytosol						Nuclear bodies, Plasma membrane, Cytosol		HPA067336: AB_2685825	unprognostic (2.94e-2)	unprognostic (6.87e-3)	unprognostic (2.65e-2)	unprognostic (2.70e-1)	unprognostic (1.23e-2)	unprognostic (9.05e-2)	unprognostic (1.02e-2)	unprognostic (3.48e-2)	unprognostic (1.43e-1)	unprognostic (1.16e-1)	unprognostic (3.31e-3)	unprognostic (7.61e-2)	unprognostic (5.75e-4)	unprognostic (1.07e-1)	unprognostic (9.54e-2)	unprognostic (1.65e-1)	unprognostic (4.73e-4)	0.1	8.2	10	0	2.7	0	0	3.2	41.7	0	0.4			0	0	0.3	0	0	0.4	1.2	6.1	3.9	0.1	2.7	0	1.3	3.3		0	0.1	0	0	0.6		0	0.4		0.4	0.7	0	0	0	0	0.9	0	0.1	0.8			0		0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	1.3	0	0	0.5	0.1	0	0	0	1.8	40	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	3.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Late spermatids
NPIPB9		ENSG00000196993	Nuclear pore complex interacting protein family member B9	F8W1W9	16	28751787-28772807	Predicted intracellular proteins, Predicted membrane proteins				Evidence at protein level	Evidence at protein level	No human protein/transcript evidence	Evidence at transcript level		Tissue enriched	Detected in many	4	testis: 13.6	Cell type enriched	Detected in some	5	Ciliated cells: 5.3	Not detected	Not detected							Cell type enhanced	Detected in some		memory B-cell: 3.1	Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		hTCEpi: 8.0;U-266/70: 6.7									HPA011188, HPA053611	Approved		Approved	Nucleoplasm						Nucleoplasm		HPA011188: AB_2668455, HPA053611: AB_2682206	unprognostic (7.38e-2)	unprognostic (6.63e-4)		unprognostic (6.63e-2)	unprognostic (5.05e-2)			unprognostic (5.53e-2)		unprognostic (4.44e-2)	unprognostic (1.53e-1)	unprognostic (9.36e-2)	unprognostic (7.52e-2)	unprognostic (2.84e-1)	unprognostic (2.86e-1)	unprognostic (2.31e-1)	unprognostic (4.71e-2)	0.6	0.3	1.7	0.9	1.8	1.6	0.4	2.7	1.4	0.4	1			0	1.1	2.4	0.4	1.5	0.6	0.2	2.2	1.3	0.4	0.4	0.4	1.5	1.7		1.4	0.2	0.5	1.4	0.4		1.2	0.8		0.9	0.9	1.1	2.8	0.8	0.8	2.2	1.1	0.5	13.6			1.7		1	0.3	0.7	3.1	0.1	0.5	0.2	1.8	0.7	0.3	0.4	4	1.1	0.6	0.5	1.3	3.3	0	0.1	0	0	0.4	2.1	1.6	1.1	0	0.5	0.4	0.7	0.2	0.1	0.4	1.9	0.7	0	0.8	0.1	2.5	2.7	0.2	8	0.6	1.5	0.8	0	2.9	0.4	2.5	0.2	3	0.9	3.3	1.6	0.2	0.9	3.3	0	1.6	0	0.4	0.1	0	0.2	0.4	0.2	2.2	2.2	1.1	0	0	2.8	1.9	0.6	6.7	2.9	2	0.1	0.9	0.5	0	0.2	0	0.7	0	0.2	3.1	0.4	0.1	0.1	1.2	0.3	0.1	0.5	1.8	0.2	0	0.3	0.3											0	0.3	0	0	0.3	0	0.1	0	5.3	1.2	0	0	0	0	0	0.9	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0.4	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0.1	0.1	0.1	0	0	0	Ciliated cells
DTHD1	FLJ16686	ENSG00000197057	Death domain containing 1	Q6ZMT9	4	36281622-36345756	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in many		brain: 16.6;fallopian tube: 20.6;lung: 18.5	Cell type enriched	Detected in some	6	Ciliated cells: 286.4	Low cancer specificity	Detected in single			Low region specificity	Detected in many			Cell type enhanced	Detected in some		gdT-cell: 6.8	Lineage enriched	Detected in many	6	T-cells: 6.8	Not detected	Not detected			Low region specificity	Detected in some			Low region specificity	Detected in many																unprognostic (9.79e-6)	unprognostic (4.04e-2)	unprognostic (1.15e-2)	unprognostic (5.54e-3)	unprognostic (2.85e-1)	unprognostic (5.45e-5)	unprognostic (5.12e-3)	unprognostic (9.11e-2)	unprognostic (1.82e-2)	unprognostic (7.59e-2)	unprognostic (1.03e-2)	unprognostic (1.32e-1)	unprognostic (5.05e-5)	unprognostic (1.19e-1)	unprognostic (2.16e-1)	unprognostic (5.65e-2)	unprognostic (7.12e-3)	0.7	0.5	1.9	5.8	14.8	0.9	0.4	0.3	0.3	2.1	1.1	2.8	1.4	0.7	1.1	11.9	0.7	20.6	3.5	0.4	3.1	2.9	0.4	0.7	18.5	5.4	0.4	0	8.1	0.3	0.2	0.8	0.2	16.6	0.5	0.7	0.1	0.6	0.3	0.2	0.2	1.3	0.4	0.7	8	0.8	2.2	4.5	0	0.6	1.2	4	3.1	0.5	0	0	0.1	0	1.1	6.8	0.7	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0.2	0	0.5	0.3	0	0	0.1	6.8	0	1.2	0	0.6	2.1	0	0	0	2.6	0	1.1	0	0	0	0.7	1.9	14.8	0.3	0.2	3.1	2.9	0.4	0	16.6	4.5	3	2.6	0	0	0	0	0.4	0	286.4	40.9	0	0	0	0	0	45.5	0	0	0	0	0	0	0	1.1	0	0.1	0	0	0	0.6	16.3	0.3	0	0	0	0	0	0.1	0	0	0	0	0	0	0.5	0.2	0.1	0	20.1	0	0	Ciliated cells
LCE1C	LEP3	ENSG00000197084	Late cornified envelope 1C	Q5T751	1	152804835-152806628	Predicted intracellular proteins	Keratinization			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at transcript level		Tissue enriched	Detected in some	11	skin 1: 100.1	Cell type enriched	Detected in some	4	Suprabasal keratinocytes: 72.5	Cancer enriched	Detected in some	6	melanoma: 17.9	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	5	BJ hTERT+: 2.5;HBEC3-KT: 5.3;hTEC/SVTERT24-B: 2.8;hTERT-HME1: 7.1																							unprognostic (3.35e-2)			unprognostic (5.95e-2)	unprognostic (3.46e-2)			unprognostic (3.35e-2)									0.1	0	0.1	0.1	0.1	0	8.6	0.1	0.1	0.5	0.1	0.1	0.1	0	0.1	0.1	0.1	0	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.9	0	0.1	0.1	0.1	0.7	100.1	0.1	0.1	0.1	0.1	0	0.1	0.1	3.1	0.1	8.8	0.5	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.5	0	0	0	0	0.9	0	0	0	0.9	0	5.3	0	0	0	0	0	0	0	0	0	0	0.3	2.8	7.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	0	0	16.4	0	0	0	0	0	0	0	0	3.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.3	0	0	0	0	0	0	5	0	0	0.1	0	0	72.5	0	0	0	0	Suprabasal keratinocytes
GAL3ST4	FLJ12116	ENSG00000197093	Galactose-3-O-sulfotransferase 4	Q96RP7	7	100159244-100168750	Predicted membrane proteins		Transferase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		lymphoid tissue: 37.8	Cell type enriched	Detected in some	6	Hofbauer cells: 38.9	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Group enriched	Detected in some	6	memory CD4 T-cell: 4.4;naive CD4 T-cell: 15.0;naive CD8 T-cell: 4.5;plasmacytoid DC: 4.3	Group enriched	Detected in many	26	dendritic cells: 4.3;T-cells: 15.0	Cell line enhanced	Detected in many		WM-115: 29.6	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA038137, HPA038138	Uncertain		Approved	Nucleoplasm,Cytosol						Nucleoplasm	Cytosol	HPA038137: AB_10697239, HPA038138: AB_2675854	unprognostic (4.22e-2)	unprognostic (2.97e-2)	prognostic unfavorable (5.44e-4)	unprognostic (8.64e-2)	unprognostic (3.01e-2)	unprognostic (1.40e-1)	unprognostic (3.10e-2)	unprognostic (1.81e-1)	unprognostic (1.31e-1)	prognostic unfavorable (2.57e-4)	unprognostic (2.80e-1)	unprognostic (2.25e-1)	prognostic unfavorable (4.14e-4)	unprognostic (3.98e-2)	unprognostic (9.67e-2)	unprognostic (1.89e-2)	unprognostic (5.36e-2)	3.9	5.4	8.4	4.2	9.4	1	4.1	1.5	10.9	7.8	6.5	18.6	0.4	4.1	9	3.7	8.4	6.3	5.9	4.9	8	3.8	1.8	1	5.3	2.9	11.9	4.7	7.6	1.5	1.6	4.6	9.8	8.1	6.5	7	4.2	24.9	4.3	1.9	27.8	8.9	10.6	14.9	2.7	2.8	4.4	10.2	37.8	2	2.4	3.9	7.3	10.6	0.1	4.3	0.3	0.1	0.2	15	2.2	0	0.6	4	1.8	3.6	7.1	7.6	2.2	2.2	1.3	1.8	0.4	0.2	0.7	0.5	7.4	2.3	8.6	0.2	1.3	0.4	0	0.4	0.2	0.1	0.2	2.4	0.4	2.4	8.7	3.4	3.9	0.4	2.8	2.5	3.1	1.1	0.1	2.4	0.3	2.7	0.1	1.3	8.2	0.9	2.2	1.8	0.1	0	0.3	0.2	1.7	0.6	0	4.6	0.7	0	0.2	2.2	0.2	1.2	0.3	0.1	0.1	0.1	1.7	1.4	0.4	29.6	0	0.1	0	0.5	0	0	0	4.4	0.3	0	0.1	15	4.5	0.3	0.2	0.1	4.3	1.1	2.2	8.4	9.4	1.5	10.9	8	3.8	11.9	4.7	8.1	10.2	0	0.3	0	2	3.8	0	0.8	2.5	0	1.2	0	0	0.3	0	0.5	0.1	0.5	0	0	0	0.2	6	0.3	0	0	38.9	0	0	1.8	0.3	0	4.4	0.7	5	1	0.6	0.5	0.5	2.9	4.9	0	0	0	2.2	0.4	0.2	7	0.7	0	6	0.9	Hofbauer cells
SULT1A2	HAST4, STP2	ENSG00000197165	Sulfotransferase family 1A member 2	P50226	16	28591943-28597109	Enzymes, Predicted intracellular proteins	Catecholamine metabolism, Lipid metabolism, Steroid metabolism	Transferase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		intestine: 37.5;liver: 26.2;seminal vesicle: 24.2	Cell type enriched	Detected in many	5	Enterocytes: 311.3	Cancer enhanced	Detected in many		liver cancer: 6.8	Low region specificity	Detected in some			Group enriched	Detected in many	7	classical monocyte: 10.2;intermediate monocyte: 7.0;myeloid DC: 3.5;neutrophil: 12.6;non-classical monocyte: 3.6	Group enriched	Detected in many	16	dendritic cells: 3.5;granulocytes: 12.6;monocytes: 10.2	Cell line enhanced	Detected in many		BEWO: 6.9;EFO-21: 8.8;Hep G2: 32.6									HPA049500, HPA051051	Supported											HPA049500: AB_2680796, HPA051051: AB_2681327	unprognostic (4.15e-2)	unprognostic (9.88e-2)	unprognostic (1.53e-1)	unprognostic (6.13e-2)	unprognostic (5.35e-2)	unprognostic (1.43e-1)	unprognostic (1.05e-1)	unprognostic (2.41e-2)	unprognostic (1.05e-1)	unprognostic (2.49e-4)	unprognostic (5.83e-2)	unprognostic (2.81e-1)	unprognostic (1.02e-1)	unprognostic (2.74e-1)	unprognostic (2.98e-1)	unprognostic (1.44e-1)	unprognostic (8.52e-3)	1	1.9	0.6	2.5	1	0.5	1.2	1.6	0.7	0.3	9.8	0.6	5.9	25.7	0.5	1.1	0.9	0.6	1.6	2.1	0.8	0.5	2.3	26.2	11.9	0.3	0.6	0.6	0.9	1.4	1	1.2	2.7	0.7	0.3	6.8	4.6	0.9	24.2	0.2	0.2	37.5	0.2	0.6	2.7	0.7	0.3	0.2	0.5	4.5	0.5	0.2	1.9	1.1	0.2	3.5	12.6	10.2	0.4	0.5	3.9	1.3	0.7	0.6	0.5	0.1	0.3	6.9	0.7	0	0.1	0	1.3	3	0.2	8.8	0.2	0.1	1.2	0.3	0.5	0.2	0.4	0.4	1.3	1.7	32.6	0.5	1.1	1.3	0.2	0.6	0.5	0.1	0.4	0.2	0.6	0.7	1.5	0.1	1.6	0.2	2.1	1	0.3	0.3	1.3	0.2	0.6	0.1	1.3	0.4	0.9	0.2	4.6	0	1.1	3.2	0.6	0.4	1.7	1	1.3	0.5	2.4	1.3	0.3	0.4	0.5	0.5	1.1	10.2	0.1	0.3	7	0.5	0.1	0.2	0.2	3.5	0.2	0.3	0.3	12.6	0.4	3.6	0.8	0.4	3.9	0.6	1	1.6	0.7	0.8	0.5	0.6	0.6	0.7	0.2	26.8	10.8	0.5	0.5	0.2	0.2	2	0	2.7	9.1	3.5	0	0.1	13.3	5.9	0.1	0.8	311.3	0	4.1	0.2	2.6	0.2	11.5	43.6	1.3	0	2.9	10.4	7.9	0.8	1.4	0.2	0	0	6.8	3.7	5	59.6	1.4	5.6	0.5	0	0.4	0.7	0.1	0.1	0.2	0	9.8	0.9	Enterocytes
NEK5		ENSG00000197168	NIMA related kinase 5	Q6P3R8	13	52033611-52129078	Enzymes, Predicted intracellular proteins		Kinase, Serine/threonine-protein kinase, Transferase		Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in some		brain: 11.8;fallopian tube: 12.7;testis: 15.7	Cell type enriched	Detected in many	4	Ciliated cells: 172.6	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Cell type enhanced	Detected in some		basophil: 2.5	Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		JURKAT: 3.5;OE19: 6.4;T-47d: 3.3	Low region specificity	Detected in many			Low region specificity	Detected in many			HPA035565, HPA041399	Enhanced											HPA035565: AB_10672095, HPA041399: AB_2677453	unprognostic (4.14e-2)	unprognostic (1.49e-1)	unprognostic (1.89e-1)	unprognostic (5.80e-3)	unprognostic (2.80e-2)	unprognostic (2.47e-1)	unprognostic (3.57e-2)	unprognostic (6.50e-2)	unprognostic (8.82e-2)	unprognostic (1.32e-1)	unprognostic (1.37e-2)	unprognostic (2.94e-1)	unprognostic (2.06e-3)	unprognostic (1.83e-3)	unprognostic (1.10e-1)	unprognostic (1.19e-3)	unprognostic (9.44e-3)	0.6	0.3	3.2	1.4	3.2	0.7	0.9	0.4	2.6	0.9	0.4	5.4	0.3	0.5	2.5	3	0.4	12.7	0.5	1.3	3.2	1.6	0.9	0.3	4.9	0.5	0.7	1.3	2.8	0.5	0.9	5.3	0.8	11.8	1.5	0.4	0.3	0.5	0.3	0.6	0.5	0.4	0.5	0.9	0.4	0.3	15.7	2.1	0	0.7	0	0.3	0.4	0.4	0.9	1.1	2.5	0.5	0.6	0.4	0	0.4	0.5	0.3	1.7	0.2	1.1	2.2	0	0	0	0.2	0.1	1.1	0.5	0.2	0	0.1	0.4	0.2	0.4	0	0.1	0.3	0.6	0.6	0.4	0.3	1.1	1.3	0.3	0.8	0.1	0.6	0.4	0.2	3.5	1.2	0.8	0	1.3	0.6	0.8	0.5	6.4	0.6	0.2	0.1	0	1.9	0.5	0.6	0.8	0.4	0	1	1	3.3	1.3	0.4	0.2	0.2	0.2	0.2	0.3	0.2	0.3	0.1	0.2	0.3	2.5	0.5	0.1	0.3	0.3	0.4	0.5	0.2	0.2	0.1	0.9	0.3	0.3	0.9	0.6	0.1	1.1	0.2	0	3.2	3.2	0.4	2.6	3.2	1.6	0.7	1.3	11.8	2.1	0	1.3	2.2	1.7	0	8	1.6	2.5	172.6	21.6	7	13.7	2.2	1.7	1.1	43	1.7	0.8	0	2.6	1.5	1.1	3.2	2.3	0.9	1	12.7	1.7	0.6	0	24.4	2	0.8	0	1	0.3	2.4	0.7	0	2.1	1	11.4	6.5	0.3	21.1	12	0.1	1.6	0	1	0.8	Ciliated cells
MAGEA6	CT1.6, MAGE-3b, MAGE3B, MAGE6	ENSG00000197172	MAGE family member A6	P43360	X	152766136-152769747	Cancer-related genes, Predicted intracellular proteins	Ubl conjugation pathway	Tumor antigen	Cancer-related genes	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	20	testis: 11.7	Cell type enriched	Detected in some	6	Spermatogonia: 45.4	Low cancer specificity	Detected in many							Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		GAMG: 46.4;HMC-1: 35.0;K-562: 28.4;OE19: 58.2;PC-3: 32.3;SK-BR-3: 30.6;U-266/70: 39.1;U-266/84: 24.3																							unprognostic (3.09e-1)			unprognostic (5.94e-2)	unprognostic (3.77e-2)	prognostic unfavorable (1.93e-4)	unprognostic (3.50e-2)	unprognostic (1.74e-1)					unprognostic (5.33e-2)	unprognostic (8.33e-2)		unprognostic (6.00e-2)	0.3	0	0	0	0	0	0	0	0.2	0	0			0	0.5	0	0	0	0	0	0	0	0	0	0	0	0		0	0	0	0	0.1		0	0		0	0	0	0	0	0	0	0.1	0	11.7			0		0	0	0	0	0	0	0	0	0	0	0.2	3.8	0	0	0	0	8.3	0	0	0	0	0	0	0	0	0	46.4	0	0	0	0	0	0	0.2	11.7	0.2	0	0	35	0	0	0	0	0	0	0	28.4	16.5	0	0	0	0	0	58.2	32.3	0	0	1.8	0	0	1.7	12.8	0	30.6	4.2	0	0.4	2.1	0.1	14.3	22.5	0.8	4.2	39.1	24.3	0	0.2	0	16.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0	0	1.2	0	0	0	0	0	0	0	0	1.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0.6	0	0	0	0	0	0	0	0.4	0	0	6.5	0	7	45.4	0	0.1	0	0	0	Spermatogonia
CYSRT1	C9orf169, MGC59937	ENSG00000197191	Cysteine rich tail 1		9	137224635-137226311	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level				Tissue enriched	Detected in many	4	esophagus: 33.4	Cell type enriched	Detected in some	6	Pancreatic endocrine cells: 33.8	Cancer enhanced	Detected in all		head and neck cancer: 23.0	Low region specificity	Detected in many			Cell type enhanced	Detected in some		non-classical monocyte: 3.0	Low lineage specificity	Detected in single			Cell line enhanced	Detected in many		A-431: 10.0;CAPAN-2: 12.7;HaCaT: 14.1;HeLa: 12.5;MCF7: 19.6	Not detected	Not detected			Low region specificity	Detected in all			HPA021883, HPA021886	Approved		Approved	Nuclear speckles,Vesicles,Midbody		Yes	No			Nuclear speckles	Vesicles, Midbody	HPA021883: AB_1853190, HPA021886: AB_1853192	unprognostic (1.35e-1)	unprognostic (2.53e-2)	unprognostic (8.31e-3)	unprognostic (6.87e-3)	unprognostic (2.14e-1)	unprognostic (2.66e-2)	unprognostic (8.11e-2)	unprognostic (5.86e-2)	unprognostic (3.45e-1)	unprognostic (2.73e-1)	unprognostic (1.24e-2)	unprognostic (1.05e-1)	unprognostic (6.24e-3)	unprognostic (7.92e-3)	unprognostic (1.99e-1)	unprognostic (1.03e-1)	unprognostic (2.29e-1)	0.7	0.4	1	0.7	0.9	0.2	0.8	0.7	1.7	1.4	0.7	0.7	0.7	0.3	0.7	0.7	33.4	1	0.7	0.7	1.4	1.3	1.4	0.7	0.7	0.7	0.8	0.7	0.7	0.7	0.3	3.5	0.7	0.7	1.1	0	0.7	2.2	0.7	0.7	8.1	0.7	0.7	0.7	0.7	0.8	2.2	0.7	0.7	1.3	0.7	5.3	0.7	2.1	0.9	0.6	0.9	3	0.9	0.3	0.1	10	1.2	1	2.1	0	0.1	2.8	0.3	0.3	0.4	0.2	0.7	12.7	0.7	0.8	0.2	0.4	14.1	0.3	3.2	0	1.3	1	0.2	12.5	6.6	0.7	0.1	0.6	0.3	1.5	0.4	0.1	0.7	0.1	1	0.4	2.2	0.8	19.6	0.4	0.7	0.5	2	1.5	1.5	1.3	1.7	0.5	0.7	0.3	1	2.1	1.8	0.5	0.7	4	0.2	0.5	0.8	0.5	1.8	0.3	1.2	0.9	0.7	0.8	0.6	0.8	0.9	0.2	0.2	0.3	1.7	0.1	0.9	0.3	0.2	0.6	0.8	0.2	0.3	0.7	0.9	3	0.4	0.2	0.1	1	0.9	0.7	1.7	1.4	1.3	0.8	0.7	0.7	0.7	0	0.6	0	0.2	0	0.1	0.2	0	0	4.5	5.2	0	0.4	0	1.1	0.5	0	0.4	0	5.1	0.2	0	0.2	0	0	0.2	0	0	0.6	0.3	0	0	0	0	0	0	0.5	33.8	0	0.4	0.5	0.5	0	0.2	1.9	0.3	0	0	0	0.2	1.1	Pancreatic endocrine cells
ZSCAN5B	ZNF371, ZNF495B	ENSG00000197213	Zinc finger and SCAN domain containing 5B	A6NJL1	19	56189570-56197920	Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	DNA-binding		Evidence at protein level	Evidence at protein level	No human protein/transcript evidence	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		blood: 1.5;testis: 6.1	Cell type enriched	Detected in single	11	Spermatogonia: 5.7	Not detected	Not detected							Cell type enhanced	Detected in some		myeloid DC: 1.5;plasmacytoid DC: 1.0	Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		HEK 293: 1.7;hTCEpi: 1.3									HPA043123, HPA046836, HPA059494, HPA060667	Uncertain		Uncertain	Nuclear speckles						Nuclear speckles		HPA043123: AB_2678328, HPA046836: AB_2679832, HPA059494: AB_2684038, HPA060667: 	unprognostic (4.73e-2)	unprognostic (9.73e-2)	unprognostic (3.43e-1)	unprognostic (1.18e-1)	unprognostic (1.06e-2)	unprognostic (5.79e-2)	unprognostic (2.88e-2)	unprognostic (2.44e-1)	unprognostic (5.15e-1)	unprognostic (1.98e-1)	unprognostic (7.01e-2)	unprognostic (2.90e-1)	unprognostic (2.55e-1)	unprognostic (3.52e-2)	unprognostic (2.24e-2)	unprognostic (1.02e-1)	unprognostic (2.83e-2)	0	0	0.7	0	1.2	0.2	0	0	0.3	0	0			0.1	0	0	0.1	0.3	0	0	0.1	0	0.1	0.1	0	0	0.1		0	0	0.1	0	0.1		0.1	0		0	0.1	0	0.2	0.1	0	0	0	0	6.1			0		0	0	0	0	1.5	0.1	0.4	0	0.2	0.1	0	0	0.8	0.3	0.4	0.3	0.2	0.5	0.5	0	0.6	0	0	1	0.1	0.9	0.1	0.1	0.2	0	0	0	1.7	0.9	0	0.3	0	0.6	0.3	0.4	1.3	0	0	0.1	0.2	0.5	0	0.4	0	0	0	0.1	0.1	0.1	0	0.2	0.1	0	0.1	0.2	0	0.9	0	0.3	0	0.4	0	1	0	0.4	0	0.3	0	0.6	0.8	0.3	0	0.6	0	0.1	0.3	0	0	0.4	0.2	0	0	0	1.5	0	0.1	0	0	0	0.1	1	0	0.1											0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	5.7	0	0	0	0	0	Spermatogonia
SERPINA1	A1A, A1AT, AAT, alpha-1-antitrypsin, alpha1AT, PI, PI1	ENSG00000197249	Serpin family A member 1	P01009	14	94376747-94390693	Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Acute phase, Blood coagulation, Hemostasis	Protease inhibitor, Serine protease inhibitor	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	16	liver: 3314.2	Cell type enriched	Detected in many	7	Hepatocytes: 29973.4	Cancer enriched	Detected in all	10	liver cancer: 3850.6	Low region specificity	Detected in some			Group enriched	Detected in many	5	classical monocyte: 110.2;intermediate monocyte: 165.9;neutrophil: 139.3;non-classical monocyte: 203.0	Group enriched	Detected in many	5	granulocytes: 139.3;monocytes: 203.0	Cell line enriched	Detected in some	8	Hep G2: 326.1					Region enriched	Detected in many	6	cerebellum: 334.2	HPA000927, HPA001292, CAB013211, CAB016648, CAB073396	Enhanced		Enhanced	Vesicles	Secreted to blood			2070000000000	210000000000	Vesicles		CAB013211: , CAB016648: AB_1611888, CAB073396: , HPA000927: AB_1844761, HPA001292: AB_1844762	prognostic favorable (1.61e-5)	unprognostic (3.37e-1)	prognostic favorable (5.86e-4)	unprognostic (1.38e-2)	unprognostic (1.98e-2)	unprognostic (5.50e-3)	unprognostic (3.81e-2)	unprognostic (6.78e-2)	unprognostic (2.54e-2)	unprognostic (7.96e-2)	unprognostic (1.08e-1)	unprognostic (4.54e-1)	unprognostic (1.23e-2)	unprognostic (1.89e-1)	unprognostic (1.30e-2)	unprognostic (1.17e-2)	unprognostic (1.96e-1)	0.9	0.4	0.7	4.9	1.4	3	2.4	0.2	0.7	2.6	7.5	0.5	3.1	6.3	0.8	8.6	0.4	0.7	14.2	1	0.4	0.5	74.1	3314.2	13.6	5.3	1	0.2	0.6	7.4	0	0.4	0.8	0.8	0.6	4.1	0.6	0.9	3.6	0.2	0.3	36.2	1.4	1.3	8.9	7	0.8	0.8	0.5	0.8	0.2	0.9	0.5	0.6	0.3	33.5	139.3	203	0.2	0.3	100	2.3	0	0	0	0	0	0.1	0	0.1	0	0	12.9	41	0.1	1.1	0	0.1	0.1	0	0.8	0	5	0	0.2	0.1	326.1	0	1.1	0.1	0.3	0.4	0	1.4	0.1	0	0	0.2	0	0	0	0	0.8	0.1	0.3	0.5	0.1	1.1	0.1	22.1	0.2	0	0.1	0.4	0.1	0.1	0	19.4	0.2	0.1	0.1	5.1	0.1	0.6	0.2	0.1	0.5	0.3	2.8	0	0.4	110.2	29.1	0.2	165.9	0.3	0.3	0.1	0.2	33.5	0.1	0.2	0.1	139.3	0.2	203	0.7	0.2	100	0.7	1.4	0.2	0.7	0.4	0.5	1	0.2	0.8	0.8	32.8	233.5	435.3	1.1	2.1	0	2.8	4603.8	45.5	60.3	143.1	0	1.4	58	1848.5	0.1	6.6	53.3	817.7	189.3	1.7	1.6	5	1.1	29973.4	171.4	0	11.6	922.6	1276.8	0	0	188.6	1.7	107.4	659.1	0.3	1376.2	37.4	0	447	0.2	0	5.1	0	0.1	1.5	5.4	46.5	24.7	7.1	Hepatocytes
FITM2	C20orf142, dJ881L22.2, FIT2	ENSG00000197296	Fat storage inducing transmembrane protein 2	Q8N6M3	20	44302838-44311169	Predicted membrane proteins			Deafness, Disease mutation, Dystonia, Mental retardation	Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in all	4	heart muscle: 56.7	Cell type enriched	Detected in many	9	Cardiomyocytes: 134.0	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low cell line specificity	Detected in many			Low region specificity	Detected in all			Low region specificity	Detected in all																unprognostic (2.92e-2)	unprognostic (7.61e-2)	unprognostic (2.27e-2)	unprognostic (2.10e-3)	unprognostic (1.02e-1)	unprognostic (3.57e-3)	unprognostic (1.63e-2)	unprognostic (3.90e-2)	unprognostic (8.43e-2)	unprognostic (5.19e-2)	unprognostic (6.56e-3)	unprognostic (1.19e-1)	prognostic favorable (8.98e-12)	unprognostic (2.07e-1)	unprognostic (2.54e-1)	unprognostic (3.38e-3)	unprognostic (2.49e-3)	8.8	9.9	5	2.6	5.7	1.2	9.5	7.1	8.2	4	4.5	4.3	3.8	3.8	3.7	7.7	3.1	3.5	3.3	56.7	4.9	5.1	7.7	8	3.6	2	4.7	5.5	4.3	7.8	13	4.5	1.9	6.6	5.8	5.3	4.7	5.3	4.2	6.9	4.5	3.7	4.6	4.7	2.5	3.8	3.6	5.1	0.2	5.5	4.4	2.4	3.9	3.8	2	2.7	1.7	3	3.8	6.2	2.5	4.5	7	3	4.3	21.2	8.7	3	7.4	5.4	5.9	3.2	8.6	3.3	3.1	4.3	8.3	9.3	10.2	3.7	5	6.4	0.9	1.7	1	4.4	14.4	4.4	2	2.6	6.6	11.3	4.1	3.1	3.2	4.2	2	1.7	9.3	5.9	14.1	0.7	2.1	0.7	6.8	9.1	1.2	5.5	3.1	3.3	4.3	1.8	2.1	15.7	8.9	6.5	1.4	10.8	1.5	5.1	18.8	8.4	10.8	4.3	3.4	8.8	0.8	8.3	3.1	9.3	1.4	3	1.7	3.4	2.7	3.5	1.8	3.6	2.8	2.7	2	6.2	4.8	1.4	3.8	2.1	1.7	3.2	2.5	5	5.7	7.1	8.2	4.9	5.1	4.7	5.5	6.6	5.1	6	8.9	7.3	3.1	6.2	5.8	134	15.3	4	3.4	5.2	5.9	1.9	1.7	4.5	3.6	3.6	4.3	0	7.4	2.7	4.7	2.9	0	12.1	3	6.4	8.7	9.8	4	0.4	7.2	1.7	6.8	1.8	5.6	5.3	5.4	5.3	7.1	5.1	5.7	0	4.7	7.5	5.2	7	1.3	3.8	8	2	Cardiomyocytes
LYPD2	LYPDC2, RGTR430, UNQ430	ENSG00000197353	LY6/PLAUR domain containing 2	Q6UXB3	8	142750150-142752534	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Group enriched	Detected in some	6	blood: 76.5;esophagus: 77.5;lymphoid tissue: 69.2;tongue: 37.9	Cell type enriched	Detected in single	13	Ito cells: 4.9	Low cancer specificity	Detected in many			Not detected	Not detected			Cell type enriched	Detected in some	13	non-classical monocyte: 76.5	Lineage enriched	Detected in many	20	monocytes: 76.5	Cell line enhanced	Detected in some		EFO-21: 15.1;HaCaT: 4.1;OE19: 2.8	Low region specificity	Detected in many			Not detected	Not detected			HPA028599	Uncertain				Intracellular and membrane							HPA028599: AB_10603777		prognostic favorable (2.00e-4)		unprognostic (3.10e-2)		prognostic favorable (2.63e-4)	unprognostic (3.85e-3)	unprognostic (3.75e-2)	unprognostic (2.49e-1)	unprognostic (1.57e-2)	unprognostic (3.11e-3)		unprognostic (1.53e-1)	unprognostic (2.41e-1)	unprognostic (1.85e-1)	unprognostic (1.12e-1)	unprognostic (2.04e-1)	0	0	0	0.1	0	0.1	0.4	0	0	6.7	0	0	0.1	0	0.3	0	77.5	0.2	0.1	1.2	0	0	0	3.6	0.4	0	0	0	0.3	0	0	0	0.5	0.1	0	0	0.4	7.7	0	0.5	6.5	0	0	0	0.1	11.6	0	0	5.7	0	37.9	69.2	0	10.1	0.2	3.7	0	76.5	0	0	1.5	0	0	0.1	0	0	0	0.3	0	0	0	0	0	0.1	0.1	15.1	0	0	4.1	0	0	0	0	0	0	0	0.2	0	0	0.1	0	0.4	0	0	0	0	0.1	0	0.1	0	0	0	0	0.1	2.8	0	0.1	0	0	0	0	0	0.1	0	0	0	0	0	0	0.5	0	0.1	0	0	0	0	0.1	0	0	0	0	0	0	0	5.8	0	0.2	0	0	3.7	0	0	0	0	0	76.5	0.3	0	1.5	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0.3	0	0	4.9	0.3	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0.4	0.1	0	0	0	Ito cells
OR6N1		ENSG00000197403	Olfactory receptor family 6 subfamily N member 1	Q8NGY5	1	158747814-158772195	G-protein coupled receptors, Predicted membrane proteins	Olfaction, Sensory transduction	G-protein coupled receptor, Receptor, Transducer		Evidence at transcript level	Evidence at transcript level	No human protein/transcript evidence	Evidence at transcript level		Group enriched	Detected in some	7	blood: 7.5;bone marrow: 4.4	Cell type enriched	Detected in single	33	Distal tubular cells: 3.3	Not detected	Not detected							Cell type enriched	Detected in single	18	basophil: 7.5	Lineage enriched	Detected in single	75	granulocytes: 7.5	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected																																	0	0	0	0	0	4.4	0	0	0	0.2	0			0	0.1	0	0	0	0	0	0	0	0	0	0.8	0	0		0	0	0	0	0		0	0		0	0	0	0	0	0	0	0.6	0	0.1			0		0	0	0	0	0	7.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	7.5	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0											0	0	0	0	0	0	0	0	0	0	0	0	0	3.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Distal tubular cells
CYP2B6	CPB6, CYP2B, CYPIIB6	ENSG00000197408	Cytochrome P450 family 2 subfamily B member 6	P20813	19	40991250-41018398	Plasma proteins, Predicted intracellular proteins		Monooxygenase, Oxidoreductase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	44	liver: 137.3	Cell type enriched	Detected in some	7	Hepatocytes: 326.3	Cancer enhanced	Detected in many		liver cancer: 28.8	Not detected	Not detected			Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		HaCaT: 7.0;OE19: 4.9					Not detected	Not detected			CAB033866, HPA048124, HPA062973	Enhanced		Approved	Nucleoplasm,Nuclear membrane,Cytosol	Intracellular and membrane					Nuclear membrane	Nucleoplasm, Cytosol	CAB033866: AB_2292644, HPA048124: AB_2680274, HPA062973: AB_2684914	unprognostic (1.86e-1)	unprognostic (1.23e-2)	unprognostic (1.13e-2)	unprognostic (6.13e-2)		unprognostic (4.59e-2)	unprognostic (4.63e-2)	unprognostic (4.41e-2)	unprognostic (1.73e-1)		unprognostic (5.78e-2)		unprognostic (1.04e-3)	unprognostic (2.19e-1)	unprognostic (9.43e-2)		unprognostic (5.44e-1)	0.1	0	0.1	0.5	0.1	0	0.1	0.1	0.1	0.1	0.8	0.1	0.1	0.9	0.1	0.1	0.1	0	0.5	0.1	0.1	0	3	137.3	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0	1.6	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.9	1.8	3.1	0.8	0.7	0.9	0.1	0.4	0.4	0.5	0.4	0.1	0	0.4	0.2	0.3	0	0.1	1.5	0	0.3	0.3	0.2	0.1	7	0.4	0.1	0.1	0.3	0.6	0.4	0.7	0.4	0.4	0.4	0.4	0	0.4	0.3	0.1	0.3	0.5	0.7	0.4	0.1	0.2	0.1	0.8	1.8	0.6	4.9	0.4	0.2	0.5	0.4	1.7	0.1	0.9	0.2	0.3	0.1	0.5	0.3	0.7	1.1	0.8	0.6	0.3	0.7	0.5	0.3	0.7	0.9	0.2	1.1	0.3	3.1	0.8	0.4	0.4	0.5	0.4	0.6	0.6	0.4	0.1	1.9	0.5	0.8	2.7	0.7	0.3	1.8	0.9	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.6	0	0.3	0	0	0.2	2.5	1.4	1.2	1.8	0	0	0	0	0	0	9.9	46.7	0.2	0	0	0.1	0	326.3	0	0	0	10.4	11	0	0	0	0	0	1.4	0	0	7	0	9.7	0	0	0	0	0	0	0	1.3	3.2	0.6	Hepatocytes
GYPE	GPE, MNS	ENSG00000197465	Glycophorin E (MNS blood group)	P15421	4	143870867-143905563	Predicted membrane proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in some		bone marrow: 14.5;lymphoid tissue: 6.9	Cell type enriched	Detected in some	5	Erythroid cells: 70.0	Not detected	Not detected			Low region specificity	Detected in many			Cell type enhanced	Detected in some		memory B-cell: 3.5	Group enriched	Detected in many	12	B-cells: 3.5;NK-cells: 2.1;T-cells: 1.3	Group enriched	Detected in some	11	HEL: 50.9;K-562: 16.4																						unprognostic (2.17e-1)	unprognostic (6.03e-2)	unprognostic (2.66e-1)	unprognostic (1.00e-2)	unprognostic (4.71e-2)	unprognostic (1.09e-4)	unprognostic (2.05e-2)	unprognostic (1.29e-1)	unprognostic (6.77e-2)	unprognostic (1.10e-1)	unprognostic (1.53e-2)	unprognostic (2.81e-3)	unprognostic (1.10e-4)	unprognostic (7.81e-3)	unprognostic (1.76e-1)	unprognostic (2.97e-1)	unprognostic (3.49e-2)	2.7	0.2	1.2	1.5	0.5	14.5	1.2	0.5	1.2	0.9	0.5	0.5	0.5	0	0.5	0.8	0.5	0.1	0.7	2.6	1.1	0.3	0.7	0.5	3.7	1	0.5	0.5	1.5	0.5	0	0.5	5.7	1.1	0.5	0.4	0.5	0.5	0.6	0.5	0.5	1.7	0.5	0.7	6.9	0.4	0.8	0.5	1.5	1.4	0.5	3.1	0.9	0.5	3.5	0.1	0	0	2.1	1.3	0	0	0	0	0	3	3	0	1.2	2.7	0.6	0.8	0	0	0	0	1.5	0	0	0	0	0.7	0	0	50.9	0	0	0.6	0	0	0.3	0	0	0	0.7	0	0	16.4	0	0	0	0	0	0	0	0	0.3	0.4	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0.5	0	0	1.5	0	0	0	0	0	0	0	0	0	0	1.3	3.5	0	0	0	1.1	0.8	0.6	0	2.1	0	0.1	0	0	1.2	0.5	0.5	1.2	1.1	0.3	0.5	0.5	1.1	0.5	14.9	1	1.7	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	70	0	0.1	0.3	0	0	0	0.2	0	0	0	0.6	0	0	0.1	3.3	0	0	0	0	0	0.7	0	0	0	0.1	0.7	0.2	0	0.1	0	0	0	Erythroid cells
MFAP5	MAGP2, MP25	ENSG00000197614	Microfibril associated protein 5	Q13361	12	8637346-8662888	Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins			Aortic aneurysm, Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		placenta: 128.1	Cell type enriched	Detected in many	4	Extravillous trophoblasts: 937.0	Low cancer specificity	Detected in many			Not detected	Not detected			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		BEWO: 50.0;BJ: 18.1;EFO-21: 43.9;HeLa: 16.6;SuSa: 42.1	Low region specificity	Detected in some			Low region specificity	Detected in all			HPA010553	Enhanced				Secreted to extracellular matrix				3800000			HPA010553: AB_1853843	unprognostic (1.80e-1)	unprognostic (1.11e-2)	unprognostic (4.25e-2)	unprognostic (4.84e-2)	unprognostic (1.44e-1)	unprognostic (6.05e-2)	unprognostic (2.15e-3)	unprognostic (1.10e-1)	unprognostic (1.64e-1)	unprognostic (8.79e-2)	unprognostic (8.63e-3)	unprognostic (3.05e-1)	unprognostic (4.41e-7)	prognostic unfavorable (6.87e-4)	unprognostic (8.81e-2)	unprognostic (2.05e-2)	prognostic unfavorable (5.81e-4)	44.3	3.2	0.6	3.3	0.7	0.3	21.8	0.5	0.5	71.5	11.2	0.5	18.2	1.4	78.4	34	31.3	9	6.8	16.5	0.7	0.6	1.9	3	3.3	3.3	0.6	0.4	4.7	1.4	0.2	1.7	128.1	0.7	7.6	11	0.9	6	13.5	19.6	13	9	37	3.4	1	7.9	12.3	0.3	1	13.1	35	4.5	46.3	21.1	1.1	1.2	5.3	2.4	0.6	1.2	0.8	0.4	1.6	0.4	0.7	8.7	3.7	50	18.1	0.3	0.2	0.3	0.6	0.3	0.1	43.9	5.6	0.4	2.5	0.1	3.7	0	0.1	0.1	0.4	16.6	0.5	0.1	0.3	0.2	2.5	1.3	2.1	0	0.9	0	0.5	0.7	1	15.1	0.2	0.5	0.2	0.9	0.2	0.8	0.3	0.4	1.8	1.8	0.7	0.2	0.2	0.5	0.2	0.3	42.1	6.9	0.2	0.6	3.2	6.3	13.2	0.8	0.6	0.5	0.5	1.7	0.2	0	5.3	2.4	2	0.7	1.9	1.2	0.4	0.4	0.4	1.2	1.1	1.2	0.5	3.1	0.6	1.4	1	0.1	0.8	0.6	0.7	0.5	0.5	0.7	0.6	0.6	0.4	0.7	0.3	11.9	4.3	0	0.4	20.5	0.2	5.2	0	2.7	3.4	0	0	70.9	0	0	0.3	4.4	0	0	0	937	96.1	0	0	0	24.9	0	0	7.4	1.9	0.2	56.7	3.6	11.8	0	0	0.1	1.1	0	0	0	0.6	0	20.2	0	0	15.7	210.9	0	0	0.1	Extravillous trophoblasts
MYH6		ENSG00000197616	Myosin heavy chain 6	P13533	14	23381990-23408277	Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins		Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin	Atrial septal defect, Cardiomyopathy, Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	36	heart muscle: 313.7	Cell type enriched	Detected in some	1060	Cardiomyocytes: 5369.5	Cancer enriched	Detected in single	5	testis cancer: 1.4	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	23	NTERA-2: 10.4	Not detected	Not detected			Not detected	Not detected			HPA001239, HPA001349, CAB075723, CAB075724, CAB075725	Enhanced								20000000			CAB075723: AB_2665728, CAB075724: AB_2665729, CAB075725: AB_2665730, HPA001239: AB_1079438, HPA001349: AB_1079437	unprognostic (2.09e-2)	unprognostic (8.53e-4)		unprognostic (1.80e-2)	unprognostic (2.99e-1)	unprognostic (1.66e-1)		unprognostic (2.09e-1)	unprognostic (1.66e-1)	unprognostic (5.73e-2)	unprognostic (1.44e-2)	unprognostic (5.34e-3)		unprognostic (6.90e-2)	unprognostic (1.42e-1)	unprognostic (1.85e-1)	unprognostic (1.22e-2)	0.1	0	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.5	0	0.1	0.2	0.2	0	0.1	313.7	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.5	0	0.1	0.1	0.1	0.1	0	0.1	0.2	0.2	8.6	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.5	0.7	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	10.4	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	0	0	0	0	5369.5	0	0	0	0	0	0	0	0	2.1	0	0	0	0	0	0	0	0	0	0	0	0	1.3	0	5.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0.2	0	0	0	Cardiomyocytes
MPEG1	MPG1	ENSG00000197629	Macrophage expressed 1	Q2M385	11	59208510-59212951	Predicted membrane proteins, Transporters	Immunity, Innate immunity	Antibiotic, Antimicrobial		Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		blood: 47.3;lymphoid tissue: 108.6	Cell type enriched	Detected in many	5	Kupffer cells: 355.6	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Group enriched	Detected in many	5	classical monocyte: 47.3;intermediate monocyte: 38.9;myeloid DC: 26.6;non-classical monocyte: 41.6;plasmacytoid DC: 38.3	Group enriched	Detected in many	6	dendritic cells: 38.3;monocytes: 47.3	Cell line enhanced	Detected in some		Daudi: 2.8;HMC-1: 1.3;THP-1: 3.8									HPA046801	Approved											HPA046801: AB_2679814	unprognostic (1.24e-1)	unprognostic (2.17e-3)	unprognostic (1.05e-2)	unprognostic (2.00e-2)	unprognostic (3.38e-2)	unprognostic (2.79e-3)	unprognostic (7.82e-2)	unprognostic (1.41e-2)	unprognostic (6.23e-2)	unprognostic (2.76e-1)	unprognostic (5.48e-2)	unprognostic (3.51e-1)	unprognostic (1.48e-1)	unprognostic (9.38e-2)	unprognostic (2.48e-2)	unprognostic (1.76e-1)	unprognostic (5.86e-2)	17.6	6.4	2.2	27.7	2.1	3.6	5.9	1.3	1.8	3.3	9.5	4.9	0.9	9	3.2	13.2	3.7	4.9	8.2	7.7	2.2	2.3	7	17.3	13.1	51.3	2.6	1	4.2	2.7	0.8	2.3	13.4	2.5	5.6	10	8.9	7.5	2.4	2.9	2.6	20.6	6	3.9	108.6	4	3.2	1.7	18.5	3.7	5.5	23	11	2.7	2.9	38.3	7	47.3	0.2	0.1	29.1	0	0	0.2	0	0.2	0	1	0	0	0	0	0.1	0	2.8	0	0	0.1	0.9	0	0	0	0	0	0.2	0.3	0.1	0	0.6	1.3	0	0	0	0	0	0	0.1	0.3	0.1	0	0	0.3	0.5	0.5	0.1	0	0.5	0.4	0.7	0	0.5	0.3	0.5	0.2	0	0	0	0	3.8	0.5	0	0.2	0.4	0	0.9	0.1	0.5	0	0.2	0.1	0	47.3	1.4	0.1	38.9	0.1	2.4	0	0	26.6	2.9	0	0	7	0.2	41.6	38.3	0.1	29.1	2.2	2.1	1.3	1.8	2.2	2.3	2.6	1	2.5	1.7	0	12.2	29.3	0	1	0	1.2	2.5	1.4	1.2	0	0	0.3	0	0	0.1	0.6	0	0	0	0.4	0.9	0	2.3	1.7	41.8	0	0	6.2	355.6	0	0	71.1	1.7	0	0	0.4	0	0	0	0.5	0	6.5	0.3	0	0	1.4	0.2	0	0	0	Kupffer cells
CCER1	C12orf12, MGC26598	ENSG00000197651	Coiled-coil glutamate rich protein 1	Q8TC90	12	90905622-90955176	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	67	testis: 51.2	Cell type enriched	Detected in some	5	Early spermatids: 348.4	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected																														unprognostic (1.35e-1)			0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	51.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	348.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	66.9	2.8	0	0	0	0	0	0	0	3.5	0	0	0	0	5.9	1.3	0	0	0	0	0	Early spermatids
SLC22A24	MGC34821, NET46	ENSG00000197658	Solute carrier family 22 member 24	Q8N4F4	11	63079940-63144221	Predicted membrane proteins, Transporters	Ion transport, Lipid metabolism, Steroid metabolism, Transport			Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enriched	Detected in some	5	kidney: 10.5	Cell type enriched	Detected in single	30	Proximal tubular cells: 8.4	Cancer enriched	Detected in single	11	renal cancer: 0.5					Not detected	Not detected			Not detected	Not detected			Not detected	Not detected											HPA045015	Uncertain											HPA045015: AB_2679183							unprognostic (5.72e-3)						unprognostic (1.80e-7)					0	0	0	0	0.2	0	0	0	0	0	0			0	0	0	0	0	0	0	0	0	10.5	2.1	0	0	0		0	0.1	0	0	0		0	0		0	0	0	0	0	0	0	0	0	0			0		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	8.4	0	0	0	0	0	0	0	0	0	0	Proximal tubular cells
CR1L		ENSG00000197721	Complement C3b/C4b receptor 1 like	Q2VPA4	1	207645113-207738416	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		bone marrow: 6.1;brain: 4.3	Cell type enriched	Detected in some	19	Erythroid cells: 93.5	Cancer enhanced	Detected in some		testis cancer: 1.6	Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	5	HEL: 3.1;HMC-1: 7.8;K-562: 3.8									HPA049348	Approved				Intracellular and membrane							HPA049348: AB_2680723	unprognostic (2.35e-2)	unprognostic (8.27e-2)	unprognostic (1.99e-1)	unprognostic (8.89e-2)	unprognostic (1.31e-2)	unprognostic (5.50e-2)	unprognostic (2.01e-1)	unprognostic (7.45e-2)	unprognostic (5.27e-2)	unprognostic (8.21e-3)	unprognostic (7.94e-2)	unprognostic (3.02e-1)	unprognostic (6.33e-2)	unprognostic (2.02e-1)	unprognostic (8.90e-2)	unprognostic (1.31e-2)	unprognostic (9.68e-2)	0.4	0.3	0.2	1.3	2.5	6.1	0.2	0.2	4	0.7	0.3	0.9	0.9	0.1	0.2	0.1	0.2	1.3	0.1	0.2	0.8	0.2	3.2	0.8	2.8	1.3	1	1.7	0.9	0.2	0.1	0.2	2.6	1.1	0.3	0.2	0	0.9	1	0.2	0.2	0.6	0.1	4.3	1	0.2	0.2	3.3	0	0.3	0	0.8	0.2	0.2	0.4	0	0.5	0.2	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.1	0	0	0	0	7.8	0	0	0	0	0	0	0	3.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0.9	0	0	0	0	0	0	0	0.6	0	0	0	0	0	0	0.1	0	0	0.2	0	0.4	0	0	0	0.2	0	0	0.5	0	0	0	0	0	0.2	2.5	0.2	4	0.8	0.2	1	1.7	1.1	3.3	0	0	0	0.1	0	0	0.4	0	0	0	1.8	0	0.1	5	0.4	0	0.1	0	93.5	0	0.2	0	0.3	0	0	1	0	0	1.8	0	0	0	0	0	1	0	0	0.1	0	0	0	0	0	0	0	0	0.3	0.2	0	0	0.1	Erythroid cells
CFAP43	bA373N18.2, C10orf79, FLJ22944, FLJ36006, WDR96	ENSG00000197748	Cilia and flagella associated protein 43	Q8NDM7	10	104129888-104232362	Predicted intracellular proteins	Cilium biogenesis/degradation		Disease mutation	Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 25.5;epididymis: 21.6;fallopian tube: 37.7;testis: 40.3	Cell type enriched	Detected in many	6	Ciliated cells: 424.3	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Cell type enhanced	Detected in single		T-reg: 1.1	Low lineage specificity	Detected in single			Cell line enhanced	Detected in many		CAPAN-2: 8.2;U-266/70: 6.5;U-266/84: 5.3	Low region specificity	Detected in many																				unprognostic (1.20e-2)	unprognostic (3.05e-2)	unprognostic (3.61e-2)	unprognostic (6.46e-3)	unprognostic (2.03e-1)	unprognostic (3.35e-2)	unprognostic (1.07e-1)	unprognostic (1.78e-1)	unprognostic (1.56e-1)	unprognostic (2.80e-1)	unprognostic (6.88e-3)	unprognostic (2.18e-1)	unprognostic (1.76e-1)	unprognostic (3.41e-1)	unprognostic (3.35e-2)	unprognostic (9.11e-4)	unprognostic (6.67e-2)	0.5	0.9	5.3	0.6	15.3	0.5	2.4	0.9	4.4	4.6	0.6	7.1	3.2	0.7	2.7	21.6	0.5	37.7	1.1	0.5	6	7.5	2.5	0.8	9.1	0.6	1.1	1.9	5.2	1.3	4.3	10.9	0.7	25.5	1.3	0.6	1.8	1.2	1.5	0.5	1.1	0.8	0.6	1.7	0.6	0.9	40.3	2.9	0	4.1	0.1	0.6	0.7	0.3	0	0	0.5	0.4	0	1.1	0	3.2	1.2	1.1	2.1	0	0.7	0.2	0	0.9	0.7	0.5	0.2	8.2	0	0.1	0	3	1.1	0.2	1.2	1.5	0.4	1.4	0	0.5	0.5	0.2	0	0.3	0.8	1.1	0.9	0.6	1.8	0.3	0.6	2.3	0.2	0	2	0.2	0.4	0.3	0.8	0.5	0.2	0	0	2.9	0	1.8	1.8	0.8	0.1	1.6	1.1	1.1	0	0.1	0.3	0.7	1	0.4	6.5	5.3	0.7	0.5	0.2	0.2	0	0.4	0	0	0	0.3	0	0.1	0	0	0	0.1	0.2	0.5	0	0	0	1.1	0	5.3	15.3	0.9	4.4	6	7.5	1.1	1.9	25.5	2.9	3	5.9	0	0.7	0	1.1	0.8	0	424.3	70.5	1.8	9.8	0.1	0	0.7	71.7	0.3	0	0	0	0.1	0	0.9	5.8	0	0.1	0	3.5	0.6	0	43.4	1.4	0	0	1	0	1.2	0.2	0	2.1	1	8.9	0	0	53.3	3.8	0	0	0	0	0.3	Ciliated cells
LHFPL5	DFNB67, dJ510O8.8, MGC33835, Tmhs	ENSG00000197753	LHFPL tetraspan subfamily member 5	Q8TAF8	6	35805293-35833874	Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters	Ion transport, Transport		Deafness, Disease mutation, Non-syndromic deafness	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Group enriched	Detected in some	4	bone marrow: 7.4;brain: 6.7;epididymis: 12.0;pancreas: 12.3	Cell type enriched	Detected in single	16	Cardiomyocytes: 13.0	Not detected	Not detected			Low region specificity	Detected in many			Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Low cell line specificity	Detected in many			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA055110	Uncertain											HPA055110: AB_2682697	unprognostic (2.35e-1)	unprognostic (6.45e-2)	unprognostic (2.41e-2)	unprognostic (1.22e-3)	unprognostic (1.96e-1)	unprognostic (1.78e-1)		unprognostic (4.89e-3)		unprognostic (2.96e-3)	unprognostic (2.46e-2)		unprognostic (1.47e-8)	unprognostic (5.53e-2)	unprognostic (1.70e-1)	unprognostic (2.15e-1)	unprognostic (1.41e-1)	0.5	0.5	3.9	1.2	4.1	7.4	0.5	0.4	5.8	0.4	0.4	0.2	0	0.9	0.9	12	0.3	0.3	0.7	0.3	3.5	2.8	0.4	0.4	0.3	1.5	1.2	6.7	0.6	12.3	0	2.2	0.6	2	0.6	0.3	0.2	1.1	0.1	0.6	2.3	0.8	0.1	0.6	1	0.5	0.8	0	0	0.8	0	0.4	0.3	0.4	1	0.3	1	0.8	0.5	0.9	0	1.5	1.9	3.6	2.2	0.6	1.7	3.2	2.5	0.9	0.4	1.1	2.1	2.2	3.6	1.9	1.3	2.3	2	0.6	1.4	0.9	1.8	2.9	3.8	5.6	1.9	0.1	1.7	2.6	1.4	0.7	0.7	1	3.1	0.5	3.4	2	7.2	2	1.2	2.3	1.8	2.4	0.9	1.5	2	1.6	1	1.2	3.3	3.3	2.2	1.6	1.9	1.1	2.5	3	1.3	3.6	2.4	2.1	3.3	1	4.1	3.4	2.8	1.1	2.4	1.5	1	0.3	0.2	0.9	0.6	0.5	0.5	0.5	0.3	0	1	0.6	0.8	0.9	0.5	0.8	0.3	0.4	0	3.9	4.1	0.4	5.8	3.5	2.8	1.2	6.7	2	0	0	0	0	0	0	0	13	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0.8	0	0	0	0.1	0	0.1	0	0	0	Cardiomyocytes
CYP2A13	CPAD, CYP2A	ENSG00000197838	Cytochrome P450 family 2 subfamily A member 13	Q16696	19	41088472-41096195	Enzymes, Predicted intracellular proteins		Monooxygenase, Oxidoreductase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	20	liver: 30.7	Cell type enriched	Detected in single	7	Early spermatids: 3.0	Cancer enriched	Detected in single	5	liver cancer: 2.3	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HaCaT: 2.1;NTERA-2: 1.6									HPA046713, HPA047262	Supported				Intracellular and membrane							HPA046713: AB_2679767, HPA047262: AB_2680005	unprognostic (9.79e-2)						unprognostic (1.00e-1)	unprognostic (4.51e-3)		unprognostic (4.92e-2)				unprognostic (1.99e-1)	unprognostic (1.49e-1)			0	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0.4	1.5	0	0	0.1	0	0.1	0.1	0	30.7	1	0	0.1	0	0	0	0	0	0.1	0	0	0	0	0.2	0	0	0.1	0	0	0.1	0	0	1.1	0	0	0	0	0	0	0.5	0	0	0	0.1	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	2.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0.4	0	0	0	0	0	Early spermatids
FAM212B	C1orf183, FLJ31105, INKA2	ENSG00000197852	Family with sequence similarity 212 member B	Q9NTI7	1	111680630-111739424	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Low tissue specificity	Detected in many			Cell type enriched	Detected in single	10	Hofbauer cells: 3.6	Cancer enhanced	Detected in many		glioma: 6.4	Low region specificity	Detected in all			Cell type enriched	Detected in some	13	neutrophil: 19.2	Lineage enriched	Detected in many	13	granulocytes: 19.2	Cell line enhanced	Detected in many		hTEC/SVTERT24-B: 18.2;U-87 MG: 37.5;WM-115: 14.2									HPA027809, HPA027810, HPA027811	Approved		Supported	Nucleoplasm,Nucleoli,Vesicles						Nucleoplasm	Nucleoli, Vesicles	HPA027809: AB_10599616, HPA027810: , HPA027811: AB_10600872	unprognostic (1.92e-1)	unprognostic (9.70e-3)	unprognostic (1.84e-1)	unprognostic (1.85e-2)	unprognostic (2.81e-2)	prognostic favorable (4.51e-5)	unprognostic (9.96e-4)	unprognostic (1.15e-1)	unprognostic (1.36e-2)	unprognostic (9.50e-3)	unprognostic (9.92e-5)	unprognostic (8.66e-2)	unprognostic (1.31e-3)	unprognostic (2.84e-1)	unprognostic (1.42e-1)	unprognostic (3.03e-3)	unprognostic (5.07e-2)	12.1	1.4	14.9	4.6	11.5	4	8.6	5.5	22.4	2.6	3.7	2.9	1.5	1.8	4.9	1.8	11.1	7.9	4.7	12.9	13.1	3.5	3.9	1.4	6.9	2.4	4.8	13.4	3.2	1.7	4.5	0.9	9.4	3.9	4.6	3.3	1.8	2.7	6.3	8.3	8.8	2.9	8.1	3.9	6.3	4.9	4.3	3.7	0.5	3.8	3.5	2.9	3.1	3.9	0.4	0.8	19.2	1.4	0	0	0.4	1.2	1.1	2.1	1.6	10.7	3.8	0.9	0.9	2	1.7	4	2.1	0	0.9	0.4	0.8	0.8	1.1	1.1	2.4	1.5	2.3	1.1	7.4	0.7	1.9	3.6	0.3	1.2	2.6	10.7	18.2	0.8	0.4	4.5	1.1	0	1.7	2	1.1	0.4	0.3	0.3	0.9	1	1.1	9.9	0.3	0.5	1.7	5.6	1.6	0.5	0	4.9	2.3	1.4	1.2	1.7	3.8	6	2	0.7	10.8	1.9	0.9	37.5	1.8	14.2	0	1.3	1	0	1.1	0	0.2	0	0	0.8	0.4	0	0	19.2	0	1.4	0.3	0	0.4	14.9	11.5	5.5	22.4	13.1	3.5	4.8	13.4	3.9	3.7	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0.1	0	0	0	0	3.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	Hofbauer cells
SLC22A12	OAT4L, RST, URAT1	ENSG00000197891	Solute carrier family 22 member 12	Q96S37	11	64590641-64602353	Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters	Ion transport, Transport		Disease mutation, FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	349	kidney: 70.1	Cell type enriched	Detected in some	18	Proximal tubular cells: 149.1	Group enriched	Detected in some	207	liver cancer: 4.0;renal cancer: 16.5	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Low region specificity	Detected in single			Not detected	Not detected			HPA024575	Enhanced											HPA024575: AB_1858650					unprognostic (5.88e-2)		unprognostic (2.33e-1)						prognostic favorable (2.63e-4)	unprognostic (6.19e-2)	unprognostic (3.91e-2)			0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	70.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	1.8	0	0	8.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	149.1	0	0	0	0	0	0	0	0	0	0	Proximal tubular cells
NRAP		ENSG00000197893	Nebulin related anchoring protein	Q86VF7	10	113588716-113664127	Plasma proteins, Predicted intracellular proteins		Actin-binding		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	15	heart muscle: 74.1;skeletal muscle: 268.1;tongue: 82.3	Cell type enriched	Detected in some	147	Cardiomyocytes: 530.6	Group enriched	Detected in some	7	head and neck cancer: 8.2;prostate cancer: 3.1	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	4	OE19: 3.1	Low region specificity	Detected in some			Not detected	Not detected			HPA037953, HPA037954	Enhanced											HPA037953: AB_2675755, HPA037954: AB_10672394	unprognostic (1.13e-1)	unprognostic (2.95e-1)	unprognostic (3.61e-2)	unprognostic (2.05e-2)	unprognostic (5.75e-2)	unprognostic (1.97e-2)	unprognostic (1.25e-2)	unprognostic (3.03e-3)	unprognostic (3.72e-2)	unprognostic (4.20e-2)	unprognostic (6.40e-2)	unprognostic (2.88e-1)	unprognostic (5.39e-4)	unprognostic (8.21e-2)	unprognostic (1.16e-1)	unprognostic (3.16e-1)		5.1	0	0.1	0	0.1	0	0.1	0	0.3	0	0.1	0	0	0	0	9.4	5.8	0	0	74.1	0.1	0.1	0	0.1	0.1	0	0.1	0	0	0.1	0	0.1	0	0	2.3	0.1	0	4.2	0	268.1	0.1	0	0	0.1	0	0.1	0.1	0	0	1.8	82.3	7.8	0	0	0	0	0	0	0	0	0	0	0.4	0.3	0	0	0	0.1	0	0.1	0.1	0	0.2	0	0	0	0	0	0	0	0	0.1	0	0	0.5	0	0.1	0	0.1	0	0.2	0	0	0	0	0	0.1	0	0	0	0	0	0	0.7	3.1	0	0	0.4	0	0	0	0	0	0	0.1	0	0	0.5	0	0.1	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0	0.5	0	530.6	0	0	0	0	0	0	0	0	1.3	0	0	0	0	0	0	0.1	0	0	0.2	0	0	0	0	1	0	0	0	0	3.6	0	0	0	0	0	0	0	0	0.3	2.5	0.1	0	0	0.2	0	Cardiomyocytes
SLC22A6	OAT1, PAHT, ROAT1	ENSG00000197901	Solute carrier family 22 member 6	Q4U2R8	11	62936385-62984983	FDA approved drug targets, Predicted membrane proteins, Transporters			FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	10	kidney: 94.2	Cell type enriched	Detected in some	14	Proximal tubular cells: 213.4	Cancer enriched	Detected in single	102	renal cancer: 18.8	Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Low region specificity	Detected in many			Low region specificity	Detected in all			HPA074559, CAB075704	Enhanced											CAB075704: , HPA074559: AB_2732260					unprognostic (2.42e-2)								unprognostic (2.25e-3)	unprognostic (4.43e-1)				0.2	0.2	0.8	0.2	1.3	0.2	0.2	0.4	1.4	0.2	0.2	0.7	0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.8	1.8	94.2	0.2	0.2	0.2	2.4	0.6	0.2	0.2	0.2	0.1	0.2	4.1	0.2	0.2	9.4	0.2	0.2	0.2	0.2	0.2	0.2	2.4	0.2	0.2	0.2	0.5	0	0.2	0	0.2	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.8	1.3	0.4	1.4	0.8	1.8	2.4	0.6	4.1	0.5	0	0	0	0	0	0.4	0	0	0	0	7	0	0	14.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	213.4	0	0	0	0	0	0	0	0	0	0	Proximal tubular cells
HES5	bHLHb38	ENSG00000197921	Hes family bHLH transcription factor 5	Q5TA89	1	2528745-2530245	Predicted intracellular proteins, Transcription factors	Differentiation, Neurogenesis, Transcription, Transcription regulation	Developmental protein, DNA-binding, Repressor		Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in many		brain: 16.7	Cell type enriched	Detected in some	22	Muller glia cells: 105.2	Cancer enhanced	Detected in some		glioma: 3.8	Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		AF22: 2.7;HaCaT: 5.1;HAP1: 1.1;SCLC-21H: 1.0	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA065458, HPA076164	Enhanced		Approved	Nucleoplasm,Nuclear speckles,Cytosol		No				Nucleoplasm	Nuclear speckles, Cytosol	HPA065458: AB_2685492, HPA076164: AB_2732303	unprognostic (2.04e-3)	unprognostic (2.83e-2)	unprognostic (4.26e-2)	unprognostic (2.75e-3)	unprognostic (5.26e-3)	unprognostic (1.60e-4)	unprognostic (1.76e-4)	unprognostic (1.60e-1)	unprognostic (5.30e-2)	unprognostic (9.51e-2)	unprognostic (1.16e-1)	unprognostic (4.67e-1)	unprognostic (9.95e-4)	unprognostic (1.14e-3)	unprognostic (1.45e-1)	unprognostic (3.89e-2)	unprognostic (1.72e-1)	1.1	0.9	11.1	1.1	12.7	1.4	2.8	3.5	16.7	1	1.9	1.2	0.4	1.2	1.9	2.7	1.6	1.1	1.2	2.3	9.7	11.2	1	1	1.4	1.1	4.1	15.8	1	0.9	1	2.4	2.2	1.6	1.3	1.4	6.3	1.2	1.1	1.6	6.2	1.2	0.9	0.9	1	1.2	2	1.9	0	1.1	1.9	1.4	1.7	0.6	0	0	0	0	0	0	0	0	0	2.7	0	0	0	0.1	0.1	0	0.1	0	0	0.1	0	0.2	0	0	5.1	1.1	0	0	0	0	0.1	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0.9	0.1	0	0	0	0	0	1	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	11.1	12.7	3.5	16.7	9.7	11.2	4.1	15.8	1.6	1.9	0	0	0	0.2	0.1	2	1.1	0	0	0	0	0	0	0	0	0	0.5	0.4	0	0	0	0	0.6	0	0	0	3.2	0	0	0	0	0	0	0	0	3	105.2	0	3.5	0	0	4.8	0	0.7	0	0	1.3	0	0	1.1	0.1	Muller glia cells
FCHSD1	FLJ00007	ENSG00000197948	FCH and double SH3 domains 1	Q86WN1	5	141639302-141651419	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	4	Horizontal cells: 50.9	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low cell line specificity	Detected in many			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA043795	Approved		Approved	Nucleoplasm,Cytosol						Nucleoplasm	Cytosol	HPA043795: AB_10963435	prognostic favorable (8.62e-4)	unprognostic (4.08e-2)	unprognostic (6.17e-2)	unprognostic (5.28e-2)	unprognostic (3.50e-3)	unprognostic (8.56e-3)	unprognostic (5.34e-2)	unprognostic (9.61e-3)	unprognostic (2.17e-2)	unprognostic (2.66e-2)	unprognostic (1.88e-3)	unprognostic (1.50e-2)	prognostic unfavorable (6.19e-6)	unprognostic (2.26e-1)	prognostic unfavorable (4.77e-4)	unprognostic (4.12e-3)	prognostic favorable (1.21e-4)	7.5	6.6	9.2	16.1	14.1	15.2	8.6	3	12.5	11.7	9.9	11.1	4.9	9.7	12.5	8.6	8.6	8.5	13.7	5.4	8.8	6.6	6.8	2.9	9.6	18.6	18.8	4.3	17.7	7.5	23.8	12.6	7.9	14.5	10	4.8	5.6	10.3	6.1	2.6	18.5	15.3	8.8	14.5	18.4	10.5	7.4	15.4	7.4	10.6	8.8	23.2	12.1	13.8	5.3	1.9	9.8	3	2.3	7.2	2.9	7.3	4.6	6.3	13.1	5.3	6.8	11	16	8.2	14.4	22.7	8.7	15.8	3.1	8	12.3	2.3	4.2	2	8.8	6.5	13	3.4	6.4	6.2	3.1	4.1	2	21.9	8.3	7.1	11.3	3.7	12.2	8.2	0.2	4	5.8	1.6	6.5	1.6	3.9	1.8	2.6	4.3	0	0	2.9	4.9	11	0.7	7.1	0.3	6	9.1	5	7.3	6.1	16.6	0.2	4	5.8	6.6	7	2.3	1.6	12.6	7.3	6.9	6.3	1.7	5.6	7	2	5.2	5.3	3.8	7.2	1.9	3	3.6	4.9	9.8	2.3	3	1.7	5	2.9	9.2	14.1	3	12.5	8.8	6.6	18.8	4.3	14.5	15.4	0	2.1	9	3.2	2.4	4.3	0.4	5.1	1.4	2.3	3.5	11.8	0.8	0	4	6.4	2.9	4.1	0	5.7	3.8	3.5	3	9.2	0.8	4.7	50.9	4.1	2.5	2.2	4.3	3.7	3.3	3.3	1.8	4.4	1.9	5.6	3.4	3.5	0.3	1.1	6.5	3.1	1.8	3.9	2.5	1.1	10.5	2.4	2	Horizontal cells
AADACL2	MGC72001	ENSG00000197953	Arylacetamide deacetylase like 2	Q6P093	3	151733916-151761339	Predicted secreted proteins		Hydrolase		Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Group enriched	Detected in some	10	placenta: 8.6;skin 1: 26.1;tongue: 22.2	Cell type enriched	Detected in some	8	Suprabasal keratinocytes: 26.8	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	5	hTCEpi: 1.7	Not detected	Not detected			Not detected	Not detected								Secreted in other tissues									unprognostic (2.20e-2)				unprognostic (3.10e-3)		unprognostic (2.63e-2)	unprognostic (1.37e-1)	unprognostic (1.22e-1)				unprognostic (3.00e-1)			unprognostic (2.91e-4)	1.3	0	0	0	0	0	1.9	0	0	0.4	0.8	0	0.7	0	0	0.6	0.3	0.1	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	8.6	0	0.4	0	0	0.4	0	0.2	26.1	0.3	0	0	0	0.1	0.3	0	0.4	0	22.2	1	0.7	1.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0.1	0	0	0	0	0	0	0	0.3	0	0	0	0	0	1.7	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3	0	0	0	3.5	0	0.1	0	1.4	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	3.3	0	0	0	0	0	0	0	0	0	0	0	0	26.8	0.1	0	0	0	Suprabasal keratinocytes
KEL	CD238, ECE3	ENSG00000197993	Kell blood group, metallo-endopeptidase	P23276	7	142941114-142962681	Blood group antigen proteins, Cancer-related genes, CD markers, Enzymes, Predicted intracellular proteins, Predicted membrane proteins		Blood group antigen, Hydrolase, Metalloprotease, Protease	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	6	bone marrow: 21.1;testis: 36.4	Cell type enriched	Detected in some	14	Erythroid cells: 46.7	Low cancer specificity	Detected in some			Low region specificity	Detected in some			Cell type enriched	Detected in single	7	intermediate monocyte: 1.4	Lineage enriched	Detected in single	14	monocytes: 1.4	Group enriched	Detected in some	12	HEL: 15.3;K-562: 12.4	Not detected	Not detected			Not detected	Not detected			HPA064442			Supported	Nucleoplasm,Plasma membrane						Plasma membrane	Nucleoplasm	HPA064442: 	unprognostic (5.78e-3)	unprognostic (1.08e-5)	unprognostic (5.29e-3)	unprognostic (4.85e-3)	unprognostic (9.68e-2)	unprognostic (1.96e-2)	unprognostic (1.03e-1)	unprognostic (1.54e-2)	unprognostic (5.18e-2)	unprognostic (1.08e-2)	unprognostic (3.71e-2)	unprognostic (3.57e-2)	unprognostic (2.29e-3)	unprognostic (9.24e-2)	unprognostic (7.05e-2)	unprognostic (3.32e-2)	unprognostic (3.25e-3)	0.2	0	0.9	2.5	1.1	21.1	0.2	0.2	0.4	0.4	0.2	0.3	0.2	0	0.2	0.2	0.6	0.1	0.2	0.2	1.4	0.7	0.4	0.2	1.4	5	2	0.2	0.2	0.2	0	0.2	1.1	0.3	0.2	0	0.3	2.5	0.2	0.2	0	0.5	0.2	4.4	3.8	0	36.4	0.3	0.4	0.2	0.2	3.7	0.2	0.2	0	0	0	1.4	0	0	0.1	0	0	0.1	0	0	0	0	0.2	0.1	0	0	0.1	0.1	0	0	0	0	0	0	0	0	0	0	15.3	0	0	0	0	0.1	0	0	0	0	0	0	0.2	12.4	0.1	0	0	0.5	0.3	0.3	0	0	0.1	0	0.1	0	1.2	0	0.1	0.2	0	0.5	0.4	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.4	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0.1	0.9	1.1	0.2	0.4	1.4	0.7	2	0.2	0.3	0.3	0	0	0	0.8	0	0	0.3	0	0	2.3	3.5	0	0	1.7	0.2	1.9	0	0	46.7	0	0.2	0	0.2	0	0	1	0	0	0	0	0.4	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0.9	0	0	0.1	0	0	1	Erythroid cells
ZNF560	FLJ31986	ENSG00000198028	Zinc finger protein 560	Q96MR9	19	9466507-9498607	Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	DNA-binding		Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at transcript level		Tissue enriched	Detected in some	8	testis: 21.1	Cell type enriched	Detected in some	4	Early spermatids: 48.7	Cancer enriched	Detected in some	7	testis cancer: 7.4	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	4	HEL: 17.9;HMC-1: 4.4;NTERA-2: 17.8;SuSa: 8.8									HPA045439, HPA074438			Enhanced	Nucleoplasm,Nuclear speckles						Nucleoplasm	Nuclear speckles	HPA045439: AB_2732520, HPA074438: 	unprognostic (4.43e-3)			unprognostic (8.91e-2)	unprognostic (9.85e-3)	unprognostic (2.43e-2)		unprognostic (1.17e-1)	unprognostic (3.29e-1)	unprognostic (1.04e-1)	unprognostic (1.39e-1)	unprognostic (6.57e-3)	unprognostic (6.33e-5)	unprognostic (5.60e-2)	unprognostic (2.32e-1)	unprognostic (9.15e-3)	unprognostic (1.65e-1)	0	0	0	0	0.1	0	0	0	0.2	0.2	0	0	0	0	0.2	0	0.4	0	0	0	0.1	0	0.1	0	0	1	0.1	0	0.1	0	0	0.4	2.6	0	0.3	0	1.3	0	0	0	0	0	0	0.1	0.1	0	21.1	0	0.1	0.1	0	0	0	0	0	0.6	0	0	0	0.1	0	0	0	1.9	0	0.8	2.4	0	1.4	0	0.1	0.2	0	0	0	0.1	0.3	0.2	0	0	0	0.1	0	1	17.9	0	0	1.3	0	4.4	2	0	2.8	0	0	0	0	0	0	0	0	0	0	17.8	0	0	0	0	0.1	0	0	0	1	0	0	0	8.8	0	0	0	0	0.2	0	0	0	0	0	0	0	0.7	0	0	0	0.1	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0	0	0.1	0	0.2	0.1	0	0.1	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	48.7	0	0	0	0	0.1	0	0.1	4.6	0	0.1	0	0	0	0	11.3	0.3	0	0	0	0	0.2	0	0	0	0	0.8	0	0	6	8.3	0	0	0	0	0	Early spermatids
ZNF273	HZF9	ENSG00000198039	Zinc finger protein 273	Q14593	7	64870172-64930966	Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	DNA-binding		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in many			Cell type enriched	Detected in many	4	Ciliated cells: 95.0	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Low cell line specificity	Detected in many											HPA077549			Approved	Nucleoplasm						Nucleoplasm		HPA077549: AB_2732352	unprognostic (7.01e-2)	unprognostic (3.10e-1)	unprognostic (1.80e-2)	unprognostic (5.87e-4)	unprognostic (1.83e-1)	unprognostic (2.31e-1)	unprognostic (1.97e-2)	unprognostic (1.65e-2)	unprognostic (2.02e-5)	unprognostic (2.54e-1)	unprognostic (5.76e-2)	unprognostic (1.33e-1)	unprognostic (3.43e-2)	unprognostic (1.04e-2)	unprognostic (3.14e-1)	unprognostic (9.48e-2)	unprognostic (1.85e-2)	2.8	1.5	1.9	1.7	4.1	5.5	4.8	8.6	3.7	3.5	1.5	2.1	1	1.4	2.6	0.7	2.9	3.4	0.9	1.7	2.7	1.6	1.7	1.8	1.8	5	4.4	2.6	3.7	1.7	0.9	2.8	2.1	5.2	1.9	1.9	0	1.8	1.7	1.9	12.1	1.6	1.4	2.6	3.8	1.7	9.2	5.1	11.5	5.8	4.2	3.5	2.2	1.8	3.2	1.8	5	0.7	0.7	2.5	1	2.2	1.6	3.6	5.2	0.5	1.2	3	1	0.7	1.5	2.8	2.5	2	5.9	3.2	0.4	2.8	0.7	7.2	1.4	1.2	2.9	2.6	3.1	0.9	0.8	0.2	3.1	2.1	0.8	0.9	2.5	2.4	1.1	1.4	8.8	8.3	2.2	1.8	2	6.5	3.1	7.1	1.2	2.5	6.9	5.6	3.5	0.8	1.3	3.3	3.4	2.8	1.4	1.6	7.3	2.6	4.2	0.7	1.8	1.9	1.3	2.1	2.2	2.9	8.7	0.5	3	1.3	5	0.6	3.1	1	0.7	1.9	3.2	2.1	1.4	1.7	2.4	1.7	2.5	1	0.7	0.5	1.8	2.2	1	1.9	4.1	8.6	3.7	2.7	1.6	4.4	2.6	5.2	5.1	3	2.9	8.7	5.1	22.1	5.3	3.7	2.5	95	13.6	1.8	0	5.2	6.6	2.6	20.2	8	0.3	23.3	2.5	10.4	7.5	3.1	3.5	0.8	3.1	4.8	0	6.7	4.3	8.2	5.8	3.7	5	3.6	1.7	2.9	2.6	5.8	3.2	1.1	2.6	0	3.3	16.7	7.9	16.6	2.4	7.2	3.3	2.5	Ciliated cells
ADH4	ADH-2	ENSG00000198099	Alcohol dehydrogenase 4 (class II), pi polypeptide	P08319	4	99123657-99157792	Enzymes, Plasma proteins, Predicted intracellular proteins		Oxidoreductase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	31	liver: 345.2	Cell type enriched	Detected in some	34	Hepatocytes: 802.6	Cancer enriched	Detected in some	60	liver cancer: 230.7	Not detected	Not detected			Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Cell line enriched	Detected in some	11	Hep G2: 22.4	Not detected	Not detected			Not detected	Not detected			HPA020525	Enhanced		Uncertain	Nucleoplasm,Cytosol					5300000	Nucleoplasm, Cytosol		HPA020525: AB_1844609	unprognostic (2.75e-1)	unprognostic (1.69e-2)	unprognostic (1.85e-2)	unprognostic (5.54e-3)	unprognostic (2.14e-2)	unprognostic (1.33e-2)	prognostic favorable (7.08e-6)	unprognostic (1.49e-1)		unprognostic (1.39e-2)	unprognostic (6.91e-2)	unprognostic (1.88e-1)	unprognostic (2.34e-2)	unprognostic (7.16e-3)	unprognostic (2.20e-1)		unprognostic (5.89e-3)	0.3	0.1	0	0.1	0	0	0.6	0	0.1	0.2	3.6	0	0.1	11	0	0.1	0.7	0	0	0.1	0	0	0.2	345.2	0.1	0	0.1	0	0.1	0	0	0	0	0.1	0.1	0	0	0.4	0.1	0.4	0.1	4.5	0	0	0.1	0.1	0.1	0	0	0.2	0.8	0.1	0.1	0.5	1.2	0.7	2.8	0.5	0.4	0.9	0.1	0.3	0.3	0.2	0.3	0.5	0.1	0.2	0.2	0	0	0	0.2	0.2	0.5	0.3	0	0.2	0.3	0	0.2	0.4	0.3	0.1	0.6	0.8	22.4	0.1	1.8	0.5	0.3	0	0.2	0.2	0.2	0.1	0.2	0.4	1	0.1	0.3	0.3	0.6	0.4	0	0.2	0.2	1.8	0.5	0.2	0.4	0.2	0.3	2	0.3	0	0.3	0.5	0	0.4	0.5	0.2	0.5	0.1	0.6	0.4	0.7	0.1	0.7	0.1	2.8	0.4	0.5	0.9	0.5	0.8	0.4	0.5	0.5	0.1	1.2	0.8	0.8	1	0.4	0.5	0.7	0.3	0.1	0	0	0	0.1	0	0	0.1	0	0.1	0	0	0	2.2	0	0	0	0.2	15.3	0	0	1.8	0	0	0	0	21.9	0	0	23.3	0.5	0	0	0	0	802.6	0	0	0	13.5	20.9	2.6	0.3	0	0	0	0	0	0.1	0	0	0.8	0	0	0	0	0.1	0	0	0	0.6	0	Hepatocytes
MB	PVALB	ENSG00000198125	Myoglobin	P02144	22	35606764-35637951	Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Transporters	Oxygen transport, Transport	Muscle protein		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	26	heart muscle: 366.6;skeletal muscle: 871.2;tongue: 310.7	Cell type enriched	Detected in many	38	Cardiomyocytes: 4117.3	Group enriched	Detected in many	7	breast cancer: 13.6;head and neck cancer: 31.1;prostate cancer: 30.4	Not detected	Not detected			Cell type enriched	Detected in single	6	NK-cell: 4.4	Lineage enriched	Detected in single	6	NK-cells: 4.4	Cell line enriched	Detected in some	4	SK-BR-3: 62.9	Not detected	Not detected							CAB000060, HPA003123	Enhanced							13500000	190000000			CAB000060: , HPA003123: AB_1079442	unprognostic (7.51e-2)	unprognostic (3.92e-3)	unprognostic (1.07e-1)	unprognostic (7.71e-2)	unprognostic (2.35e-1)	unprognostic (4.66e-3)	unprognostic (5.78e-3)	unprognostic (1.18e-1)	unprognostic (2.74e-1)	unprognostic (1.72e-1)	unprognostic (2.74e-3)	unprognostic (1.17e-2)	unprognostic (8.34e-2)	unprognostic (1.51e-2)	unprognostic (2.35e-1)	unprognostic (3.44e-3)	unprognostic (1.19e-2)	3.6	0.1	0.2	0.1	0.2	0	1.1	0.1	0.1	0	0.3	0	0	0	0	13	19.6	0.4	0	366.6	0.2	0.1	0.1	0.2	0.1	0	0.2	0	0.1	0.7	0	0.3	0.1	0	5	0.3	0	13	0	871.2	0.3	0.3	0	0.2	0.1	0.1	0.1	0	0	4.6	310.7	14.4	0.3	0.1	0.1	0.4	0.1	0	4.4	0.7	0	0.6	2.6	0	0	0	0	0	0	0	0.1	0	0	1.6	0.2	0	0.1	0.3	0.3	0	0	0	1.8	0.1	0	0.1	0	0	0	0.1	0	0	0.1	0	0	0	0	0.2	0.1	0	6.4	0	0.2	0	0.6	0.9	0.3	0.2	2.7	0	2.2	0.5	0	6.7	62.9	0	0.1	14	0	0.1	0.2	0.4	0.8	0	0	0	0	0.1	0.2	0	0	0	0	0	0	0	0.1	0	0.7	0.4	0	0	0	0.1	4.4	0	0	0	0	0.2	0.2	0.1	0.1	0.2	0.1	0.2	0	0	0	0	0	0	3.7	0.2	0	4117.3	0	20.1	3.4	0	0	0	0	3.6	20.4	0	1.6	0	0.2	0	0	28.6	0	0	0	0	11.1	0	0	52.6	0	0	11.8	0	109.2	0	0.4	2.9	0.7	0	0	0	1.9	0.4	0.6	0.1	0.2	0	2.6	8.4	Cardiomyocytes
FAM47C		ENSG00000198173	Family with sequence similarity 47 member C	Q5HY64	X	37008397-37011666	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enriched	Detected in single	22	testis: 7.9	Cell type enriched	Detected in some	4	Early spermatids: 7.2	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Not detected	Not detected																																						unprognostic (8.69e-2)			0	0	0	0	0	0	0	0	0	0	0			0	0	0	0	0	0	0	0	0.1	0	0	0	0	0		0	0	0.3	0.3	0		0	0		0	0	0	0	0	0	0	0.1	0	7.9			0.1		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0.2	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0.4	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0.8	0.3	0	0	0	0	0	0	0.2	0	0	0	0	0.3	0	0	0	0.3	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	7.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.6	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0.7	0	0	0	0	0	0	Early spermatids
CLEC4C	BDCA2, CD303, CLECSF11, CLECSF7, DLEC, HECL	ENSG00000198178	C-type lectin domain family 4 member C	Q8WTT0	12	7729415-7751605	CD markers, Predicted intracellular proteins, Predicted membrane proteins	Adaptive immunity, Immunity, Innate immunity			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	8	blood: 80.0	Cell type enriched	Detected in some	5	Spermatogonia: 5.3	Not detected	Not detected			Not detected	Not detected			Cell type enriched	Detected in some	16	plasmacytoid DC: 80.0	Lineage enriched	Detected in many	16	dendritic cells: 80.0	Cell line enriched	Detected in some	4	HDLM-2: 6.6									HPA029432	Approved											HPA029432: AB_10601259	unprognostic (3.55e-3)	unprognostic (3.01e-2)		unprognostic (1.03e-1)	unprognostic (3.70e-2)	unprognostic (7.37e-5)		unprognostic (2.36e-2)	unprognostic (2.06e-1)	unprognostic (2.55e-2)	unprognostic (6.98e-2)	unprognostic (1.39e-1)	unprognostic (1.88e-3)	unprognostic (2.82e-2)	unprognostic (3.18e-3)	unprognostic (2.36e-2)	unprognostic (1.25e-1)	0.3	0.2	0.2	1.6	0.2	1.8	2	0.2	0.6	0.2	0.2	0.1	0.1	0	0.2	0.1	0.3	0.5	1.2	0.3	0.2	0.2	0.5	0.3	1.5	7	0.2	0.1	0.4	0.2	0	0.2	0.1	0.1	0.2	0	0.4	0.3	2	0.2	0.3	0.3	0.1	0.2	4.6	0.3	9.9	0.1	6.7	0.3	0.1	7.1	1.9	0.3	0.5	80	4.9	0.1	0.5	0	0.5	0.2	0	0.3	0.3	0.5	0	0.4	0	0	0.1	0	0.5	0.6	0.3	0	0	0	0.3	0	0	0.2	6.6	0.2	0.3	0.7	0.2	0	0.6	1.3	0.4	0.3	0	0	0.1	0.1	0	0.2	1	0	0.1	0.1	0.8	1.5	0	0.2	0.1	0	0.1	0.1	0.4	0.2	0.2	0.1	0.2	0	0.4	0.9	0.1	0.4	0.4	0.2	0.1	0.1	0.6	0.2	1.4	0.1	0.3	0.3	0.9	0.1	4.9	0	0	0	0.1	0	0	0.7	0.5	0	0	2.6	0.5	0	80	0	0.5	0.2	0.2	0.2	0.6	0.2	0.2	0.2	0.1	0.1	0.1	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	5.3	0.3	0	0	0	0	Spermatogonia
BPIFA1	bA49G10.5, LUNX, PLUNC, SPLUNC1	ENSG00000198183	BPI fold containing family A member 1	Q9NP55	20	33235995-33243311	Plasma proteins, Predicted secreted proteins	Immunity, Innate immunity	Antibiotic, Antimicrobial		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	4	cervix, uterine: 8.0;lung: 20.2;lymphoid tissue: 25.2;pituitary gland: 16.9;tongue: 11.9	Cell type enriched	Detected in some	26	Ciliated cells: 116.4	Cancer enriched	Detected in many	27	lung cancer: 262.1	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		MOLT-4: 1.3;NTERA-2: 2.2;REH: 1.2;U-266/70: 1.6					Not detected	Not detected			CAB025669	Supported				Secreted in other tissues				1200000			CAB025669: 						unprognostic (1.06e-1)		unprognostic (1.53e-1)						unprognostic (3.65e-1)		unprognostic (1.80e-1)		0	0	0	0	0	0	0	0	0	8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	20.2	0	0	0	0	0	0	16.9	0	0	0	0	0	3.9	0	0	0	0	0	0	0	0	0.8	0	0.1	0	11.9	25.2	2.1	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	1.3	0	2.2	0	0	1.2	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0.3	0	0	1.6	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3	0.6	0	0	0	0	0	0	116.4	4.5	0	0	0	0	0	1.3	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	2.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Ciliated cells
TMEM239		ENSG00000198326	Transmembrane protein 239	Q8WW34	20	2816302-2820284	Predicted membrane proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in some	24	testis: 42.1	Cell type enriched	Detected in some	5	Late spermatids: 109.9	Not detected	Not detected			Not detected	Not detected			Cell type enhanced	Detected in single		neutrophil: 1.7	Low lineage specificity	Detected in single			Cell line enriched	Detected in some	7	HDLM-2: 13.6	Not detected	Not detected			Not detected	Not detected																					unprognostic (5.12e-3)								unprognostic (2.95e-1)				0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	42.1	0	0	0	0	0	0	0	0.3	0.3	1.7	0.5	0.3	0.3	0	0	0	0	0.1	0	0.1	0.3	0	0.1	0	0	0	0	0	0	0	0.2	0	0	0	0	13.6	0	0	0	0.1	0	0	0	0.4	0	0.3	0	0	0	0	0	0.1	0	0.1	0	0.1	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	1.8	0	0	0	0	0.1	0	0	0.7	0.5	0.2	0.3	0.2	0	0.1	0.2	0.1	0.1	0.3	0.2	0.2	1.7	0.3	0.1	0.3	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	20.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	109.9	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0.1	0	0	0	0	0	Late spermatids
MYL4	ALC1, AMLC, GT1, PRO1957	ENSG00000198336	Myosin light chain 4	P12829	17	47200446-47223679	Disease related genes, Plasma proteins, Predicted intracellular proteins		Motor protein, Muscle protein, Myosin	Atrial fibrillation, Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	68	heart muscle: 712.3	Cell type enriched	Detected in many	5	Cardiomyocytes: 2384.1	Group enriched	Detected in some	7	testis cancer: 2.4;thyroid cancer: 11.7	Not detected	Not detected			Cell type enriched	Detected in single	11	plasmacytoid DC: 5.2	Lineage enriched	Detected in single	11	dendritic cells: 5.2	Cell line enriched	Detected in some	4	HEL: 109.9	Group enriched	Detected in many	6	amygdala: 25.9;cerebral cortex: 83.3;hippocampal formation: 27.8	Not detected	Not detected			HPA046859, HPA051884, HPA063034	Enhanced		Approved	Plasma membrane					140000	Plasma membrane		HPA046859: AB_2679842, HPA051884: AB_2681651, HPA063034: AB_2684927	unprognostic (2.43e-2)	unprognostic (9.57e-2)	unprognostic (2.25e-1)	unprognostic (5.51e-2)	unprognostic (2.33e-1)	unprognostic (4.12e-3)	unprognostic (5.06e-3)	unprognostic (1.34e-1)	unprognostic (1.13e-1)	unprognostic (6.52e-2)	unprognostic (2.10e-2)	unprognostic (7.37e-2)	unprognostic (1.00e-6)	unprognostic (1.92e-4)	unprognostic (2.54e-1)	unprognostic (6.51e-3)	unprognostic (1.50e-1)	0.1	0	0	0.1	0	10.4	0.1	0	0.1	0	0	0.1	0	0	0.1	0.1	0.1	0	0	712.3	0	0	0	0	0.1	0.1	0	0.1	0.1	0.7	0	0	0.7	0.1	0	0	0.8	3.3	0	0.5	0	0	0.1	0	0.1	0.2	0.7	0	0.1	0.6	4.6	0.1	0.1	0.2	0.2	5.2	0	0.4	0	0	0.7	0	0	0	0	0	0	0.1	0	0	0	0	0.1	0	0.3	0.1	0	0	0	0	0	0	0.5	0	109.9	0	0	0	0	0	4.5	0	0	0	0	0.2	0.3	26	0	0	0	1.9	0	0	0	0	0	2.6	0	0	0	0	0	0	0	0	5.2	0	0	0.9	0	0	0	0	0	0	2.6	0	0	0	0	0	0	0	0.4	0	0	0	0	0.4	0.2	0	0	0	0	0.1	5.2	0	0.7	0	0	0	0.1	0	0	0	0.1	0.1	0	3	0	0	0	0.7	4.5	2384.1	0	0	0	0	60.9	0.4	0	0	16.3	3	0.3	443.9	0	2.6	2.1	0	0	0	1.8	1.6	0	1.3	0	42.1	3.1	0	11.8	0	0	4.9	0.1	0	1.4	0	17	0	2	1.5	0.4	0.6	1.1	0	0	0	Cardiomyocytes
TMEM207		ENSG00000198398	Transmembrane protein 207	Q6UWW9	3	190428655-190449876	Predicted membrane proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in single	75	kidney: 21.1	Cell type enriched	Detected in some	17	Distal tubular cells: 58.0	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	6	U-266/70: 4.5	Not detected	Not detected			Not detected	Not detected			HPA014332	Uncertain											HPA014332: AB_2204907															unprognostic (4.81e-2)			0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	21.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0.2	0	0.1	0	0	0	0	0	0	4.5	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.5	0	0	58	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0.1	0.9	0	0	0	0	0	Distal tubular cells
MT1F	MT1	ENSG00000198417	Metallothionein 1F	P04733	16	56657694-56660698	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		kidney: 84.1;liver: 98.0;thyroid gland: 152.5	Cell type enriched	Detected in many	4	Proximal tubular cells: 4487.9	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Group enriched	Detected in many	5	basophil: 14.7;classical monocyte: 10.2;gdT-cell: 14.0;MAIT T-cell: 12.7;memory B-cell: 7.4;memory CD4 T-cell: 15.3;memory CD8 T-cell: 23.9;naive CD4 T-cell: 15.2;naive CD8 T-cell: 25.4;T-reg: 23.9	Low lineage specificity	Detected in all			Cell line enhanced	Detected in many		HDLM-2: 18.4;NB-4: 29.8;NTERA-2: 19.1;RPTEC TERT1: 82.7;THP-1: 17.9;U-937: 16.0																						unprognostic (4.15e-2)	unprognostic (3.60e-2)	unprognostic (6.78e-2)	unprognostic (2.78e-2)	unprognostic (1.95e-3)	unprognostic (1.88e-3)	unprognostic (2.70e-1)	unprognostic (4.08e-2)	unprognostic (3.67e-1)	unprognostic (1.15e-1)	unprognostic (1.14e-1)	unprognostic (3.53e-1)	prognostic unfavorable (2.02e-7)	unprognostic (2.78e-1)	unprognostic (3.50e-2)	unprognostic (2.65e-2)	unprognostic (2.85e-1)	6.4	12.1	14.8	5.8	22.9	2.4	3.1	5.9	18.6	2.2	24.6	9.7	4.9	15.9	2.3	13.5	2.2	3.7	10.6	1.9	16	13.7	84.1	98	2.5	6.5	27.5	15.7	1.3	55.7	1.4	4.5	1.5	37	11.6	17.6	8.3	3.9	4.3	1.1	2	37.9	3.3	23.8	3.9	15.1	1.6	9.2	0	152.5	0	2.8	3.3	1.1	7.4	2.5	14.7	10.2	2.3	25.4	14.4	1.3	0.8	0	0	0	0	1.6	0.9	1.9	0.6	1.1	0.3	5	0	3.2	0.1	1.3	4.6	5.8	0.9	0.7	18.4	0.8	1.3	0.2	0.6	0.4	0	15.3	0.1	0.2	0.7	0.2	0.4	0	0.4	0	0	0	2.5	0	29.8	19.1	0.3	1.8	0	0	0.7	82.7	0.8	9.6	1.2	1.2	0.4	0.5	2.8	0.6	17.9	0	0	0.2	0.1	0	0	0	0	13.9	16	0.1	14.7	10.2	2.8	14	0.9	12.7	7.4	15.3	23.9	2.5	3	15.2	25.4	1.5	2.3	0.4	0.8	23.9	14.4	14.8	22.9	5.9	18.6	16	13.7	27.5	15.7	37	9.2	0	9.4	25.5	29.5	7.6	0	6.1	137.6	38.8	21.6	310.6	0	3.4	948.3	194.8	0.4	5.4	802.3	23.3	105.7	281.1	9.2	83.9	11.5	847	26.2	0	164.4	28.3	35.5	0	29.1	28.8	87.7	79.4	549.3	0	152.7	997.7	4.9	4487.9	0	6.5	36.6	0.2	1.7	6.9	16.2	34.8	560.8	18.8	Proximal tubular cells
KRTAP4-1	KAP4.1, KAP4.10, KRTAP4-10	ENSG00000198443	Keratin associated protein 4-1	Q9BYQ7	17	41184102-41185342	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	6	skin 1: 14.8	Cell type enriched	Detected in single	6	Intestinal endocrine cells: 1.7	Low cancer specificity	Detected in some			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		A-431: 2.2;A549: 3.5;CAPAN-2: 2.6;HDLM-2: 9.8;SCLC-21H: 2.4;SK-BR-3: 2.0	Not detected	Not detected																					unprognostic (1.21e-1)	unprognostic (3.57e-1)			unprognostic (1.64e-2)		unprognostic (2.78e-2)		unprognostic (1.04e-1)	unprognostic (2.49e-2)			unprognostic (2.42e-2)			unprognostic (1.06e-1)	0.1	0	0.1	0.5	0.1	0	0.1	0.1	0.1	0.1	2.4	0.1	0.1	0	0.1	0.1	0.1	0	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	1.2	0.1	0.1	1.3	0.1	0.1	0.2	0.1	14.8	1.7	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0.3	2.2	3.5	0	0	0	0	0	0.1	0	0	0	0.8	2.6	0	0.2	0	0.2	0	0	0	0	9.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0.5	1.6	0	0	0	1.4	0	0	2.4	0	0	2	0	0.1	1.1	0	0	0	0	0.1	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0.1	0	0.1	0	0	0.1	0	1.7	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	Intestinal endocrine cells
B3GNT6	B3Gn-T6	ENSG00000198488	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6	Q6ZMB0	11	77034398-77041973	Enzymes, Predicted intracellular proteins		Glycosyltransferase, Transferase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	5	intestine: 15.8;lymphoid tissue: 17.5;stomach 1: 17.9	Cell type enriched	Detected in some	38	Mucus-secreting cells: 60.5	Group enriched	Detected in some	14	colorectal cancer: 6.3;lung cancer: 3.9;pancreatic cancer: 5.1;prostate cancer: 5.0;stomach cancer: 4.7	Not detected	Not detected			Cell type enhanced	Detected in some		basophil: 2.3;neutrophil: 2.2	Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		MCF7: 2.0;RPMI-8226: 1.5	Not detected	Not detected			Not detected	Not detected			HPA039805	Enhanced				Intracellular and membrane							HPA039805: AB_2676690		unprognostic (1.71e-1)	prognostic favorable (2.31e-4)	unprognostic (4.79e-2)	unprognostic (5.42e-2)	unprognostic (7.64e-2)		unprognostic (1.95e-1)		unprognostic (2.72e-1)	unprognostic (1.23e-2)	unprognostic (7.77e-2)		unprognostic (2.19e-1)		unprognostic (9.30e-2)	unprognostic (1.71e-1)	0.2	0.2	0.3	6.6	0.4	0	0.2	0.3	0.4	0.5	15.8	0	0	3.7	0.2	0	2.5	0.2	0.9	0.2	0.3	0.3	0.2	0.2	1.4	0	0.3	0	0.2	0.2	0	0.2	0	0	0.3	12.4	0	1.6	0	0.2	0.2	9.4	0	0.2	0.2	17.9	0.6	0	0	0.2	3.4	17.5	0.2	0.3	0.4	0.3	2.3	0.2	0.8	0.5	0.2	0.1	0	0.5	0.5	0	0.2	0.2	0.1	0.2	0.5	0.1	1.2	0.2	0.7	0.3	0	0.5	0	0.1	0.6	0.1	0.4	0.2	0.2	0.1	0.2	0	0.6	0.2	0.5	0.5	0	0	0	0	0	0.2	0.7	0	2	0.2	0.5	0.7	0	0	0	0.1	1.5	0	0.3	0.3	0.4	0	0	0	0	0.7	0	0	0.1	0.2	0.1	0.3	0.4	0.5	0.3	0.1	0.2	0.2	2.3	0.2	0.3	0.4	0.2	0.5	0.2	0.2	0.2	0	0.4	0.3	0.3	2.2	0.8	0	0.3	0.1	0.2	0.3	0.4	0.3	0.4	0.3	0.3	0.3	0	0	0	0	0.3	0	0.5	0	0	0.4	0	0	1.2	0	0	0	0	0	0	0	1.6	0	0	0	0.1	0.3	0	0	0.1	0	0	0	0	0	0	0	0	0	60.5	0	0.9	0.3	0	0	0	0	0.1	0	0.2	0	0	0	0.8	0.1	Mucus-secreting cells
CNGA1	CNCG, CNCG1, CNG1, RCNC1, RCNCa, RP49	ENSG00000198515	Cyclic nucleotide gated channel alpha 1	P29973	4	47935977-48016672	Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels	Ion transport, Sensory transduction, Transport, Vision	Ion channel, Ligand-gated ion channel	Disease mutation, Retinitis pigmentosa	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		liver: 23.7	Cell type enriched	Detected in many	9	Rod photoreceptor cells: 880.8	Low cancer specificity	Detected in many			Low region specificity	Detected in some			Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		CAPAN-2: 13.4;RT4: 10.7;U-2 OS: 4.2	Not detected	Not detected			Not detected	Not detected			HPA076168			Approved	Nucleoplasm,Vesicles,Plasma membrane						Vesicles, Plasma membrane	Nucleoplasm	HPA076168: AB_2686781	unprognostic (2.68e-2)	unprognostic (4.90e-2)	unprognostic (1.33e-1)	unprognostic (8.59e-2)	unprognostic (2.07e-1)	unprognostic (1.11e-2)	unprognostic (1.76e-2)	unprognostic (3.85e-2)	unprognostic (1.12e-1)	unprognostic (1.98e-2)	unprognostic (3.18e-1)	unprognostic (2.91e-1)	unprognostic (5.48e-6)	unprognostic (1.86e-1)	unprognostic (1.04e-1)	unprognostic (4.66e-2)	unprognostic (8.23e-2)	4.9	1.1	0.6	2.7	1	0.1	2.9	0.3	0.5	5.7	6.1	0.2	1.6	2.1	0.6	12.1	13.7	3.9	1.5	1	0.6	0.6	4.9	23.7	0.5	0	1.3	0	1.6	2.1	5.2	4.2	21.3	0.4	6.2	2.3	14.7	4.9	1.7	4.2	5.3	12.7	0.5	0.9	8.2	2.5	1.4	0.2	0.1	2.2	3.6	2.7	8.2	8.8	0.7	2.7	1.2	0.4	1.9	1.6	0.1	3.2	1.2	0	0.1	0	0	0.3	0	0.2	0	0.2	2.9	13.4	0.1	0.7	0	3.6	2.1	0.3	0.4	0.1	0	0.9	0	0.3	1	0	0.1	0.3	0.1	0.6	0	0.1	1.6	0	1.1	0.9	0.7	0.2	1.3	0.1	0.2	0.6	2	3.1	0.1	0	0.1	0.6	10.7	0.3	0.1	0.2	0.6	0.2	0.3	1.2	0	0.6	0.3	4.2	0.1	0.1	0.9	1	0.1	0.1	0.1	2.4	0.2	0.4	0	0.5	0.4	0.1	0.3	0.2	1.6	0.3	0.7	0.3	0.6	1.2	1.9	0.2	2.7	0.1	0.1	0.6	1	0.3	0.5	0.6	0.6	1.3	0	0.4	0.2	0	0	0	1.4	0.1	78.5	0.4	2.5	0	0	59.3	86.4	0	0	7.8	0.4	0.1	8.4	0	5.9	0	0.2	4	0	30	1.3	42.9	0	0	1.5	0	0.3	0	0	0	3.2	100.9	1.6	10.5	0	0.3	880.8	0	3.1	0.3	1.3	2.4	0.2	0	2.9	15.6	Rod photoreceptor cells
PLN	CMD1P, PLB	ENSG00000198523	Phospholamban	P26678	6	118548298-118560730	Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters			Cardiomyopathy, Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	5	heart muscle: 337.5	Cell type enriched	Detected in some	8	Cardiomyocytes: 2230.5	Low cancer specificity	Detected in many			Low region specificity	Detected in some			Cell type enhanced	Detected in some		eosinophil: 1.3;naive CD4 T-cell: 1.4	Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		fHDF/TERT166: 1.3;Karpas-707: 1.6;NB-4: 1.8;SuSa: 1.7;U-2197: 1.3	Low region specificity	Detected in many			Low region specificity	Detected in all			CAB005597, HPA026900	Enhanced											CAB005597: AB_2252716, HPA026900: AB_1855314	unprognostic (2.49e-1)	unprognostic (5.67e-2)	unprognostic (1.96e-3)	unprognostic (4.81e-2)	unprognostic (1.20e-1)	unprognostic (5.54e-2)	unprognostic (2.35e-3)	unprognostic (4.66e-2)	unprognostic (3.97e-1)	unprognostic (8.98e-2)	unprognostic (8.98e-2)	unprognostic (3.28e-1)	prognostic unfavorable (4.11e-4)	unprognostic (2.98e-3)	unprognostic (1.80e-1)	unprognostic (2.11e-1)	prognostic unfavorable (5.59e-4)	9	1.8	0.4	2.7	0.5	0	5.4	0.4	0.6	22.3	22.2	0	9.8	2	21.1	22.3	27.3	11.6	29.8	337.5	0.4	0.5	6.4	0.4	5.3	0.8	0.7	1.4	18.6	0.5	0.1	0.4	0.1	1.4	14.4	3.9	0	1.6	6	68.4	1.5	14	30.8	1.2	0.6	6.5	12.3	0	0	2.8	23.7	0.8	32.2	6.6	0.3	0	1.3	0.4	0	1.4	0	0	0	0.3	0	0	0	0.9	0.2	0.1	0	0	0	0.2	0	0.1	1.3	0	0.2	0	0	0.3	0.6	0	0	0.5	0	0	0.1	0.2	0	0.3	0.5	0.2	0.1	0	0.2	0.2	1.6	0.1	0	0	1.8	0.1	0	0	0	0.1	1	0	0.7	0.2	0.8	0.4	0.1	0	1.7	0.4	0	0.5	0.3	0.2	1.3	0.3	0.2	0.3	0.4	0	1	0.1	0	0.4	1.3	0.1	0	0.3	0.1	0.4	0	0	0.3	1.4	0.4	0.3	0	0	0	0	0	0.4	0.5	0.4	0.6	0.4	0.5	0.7	1.4	1.4	0	0	0	0	0	3.8	1.6	2230.5	0	0	0	0	2	0	0	0	71.2	0.4	0	0	0	0	1.7	0.4	0	0	0.1	0	0	0	0	13.7	0.9	0.3	3.3	0	0	0	0.1	0	11	0	0.2	271.7	280.1	1.1	0.4	1.4	0	0	0	0.4	Cardiomyocytes
C20orf203	FLJ33706	ENSG00000198547	Chromosome 20 open reading frame 203	Q8NBC4	20	32631652-32673941	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in some		blood: 4.2;ovary: 2.1	Cell type enriched	Detected in some	4	Horizontal cells: 14.3	Not detected	Not detected							Cell type enriched	Detected in single	13	basophil: 4.2	Lineage enriched	Detected in single	13	granulocytes: 4.2	Cell line enhanced	Detected in some		HEL: 7.7;HMC-1: 5.4;NB-4: 2.3;U-266/70: 1.6																						unprognostic (6.24e-2)	unprognostic (3.39e-3)	unprognostic (8.39e-3)	unprognostic (2.06e-1)	unprognostic (1.19e-2)	unprognostic (6.70e-3)	unprognostic (7.53e-2)	unprognostic (2.52e-1)	unprognostic (5.39e-2)	unprognostic (6.22e-2)	unprognostic (1.00e-2)	unprognostic (1.39e-3)	unprognostic (1.25e-10)	unprognostic (3.37e-1)	unprognostic (2.04e-1)	unprognostic (1.23e-1)	unprognostic (7.46e-5)	0.1	0		0		0.3	0.3		1.1	0.2	0			0	1	1.1	0.4	1.1	0	0.5			0	0	0	0.4			2.1	0	0		0		0	0		1	0.5	0	0.8	0	0		0.3	0	0.3			0		0	0		0	0	4.2	0	0.1	0.3	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	7.7	0	0	0	0.4	5.4	0	0	0	0	0.1	0	0.3	0.3	0.1	0	0.1	0.3	2.3	0	0	0.1	0.3	0.1	0	0	0	0.1	0	0	0.1	0	0	0	0	0	0	0	0	0	1.6	0.2	0.4	0	1.1	0	4.2	0	0	0	0	0.3	0	0	0	0	0	0	0	0.1	0.1	0	0	0	0											0	0	0	0.1	0.2	3.5	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0.1	14.3	0	0	0	0	0.9	0	0	0	0	1.2	0	0	1.1	0	2.7	0	0.3	0	0.1	0.1	0	0	0	0	Horizontal cells
KCNRG		ENSG00000198553	Potassium channel regulator	Q8N5I3	13	50015254-50020922	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in some		fallopian tube: 27.7;ovary: 17.1	Cell type enriched	Detected in some	8	Ciliated cells: 92.3	Low cancer specificity	Detected in single			Not detected	Not detected			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low cell line specificity	Detected in many			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA001027			Uncertain	Vesicles						Vesicles		HPA001027: 	unprognostic (1.85e-3)	unprognostic (1.66e-2)	unprognostic (1.08e-2)	prognostic favorable (2.61e-5)	unprognostic (3.15e-1)	unprognostic (1.47e-1)	unprognostic (1.27e-1)	unprognostic (5.39e-3)	unprognostic (1.26e-1)	unprognostic (1.09e-1)	unprognostic (1.71e-1)	unprognostic (5.91e-1)	unprognostic (1.65e-2)	unprognostic (4.98e-2)	unprognostic (4.69e-2)	unprognostic (1.52e-1)	unprognostic (9.16e-2)	0.4	0.2	0.3	0.3	0.3	1.1	0.6	0.9	0.3	1.8	0.3	0.5	0.3	0.3	1	4.8	0.6	27.7	0.3	1	0.3	0.5	0.6	0.3	9.1	0.3	0.3	0.3	17.1	0.3	0.4	0.4	0.3	0.5	0.5	0.8	0.3	0.3	1.7	0.4	0.8	0.4	0.4	0.3	0.4	0.3	1.7	0.3	0.3	0.4	0.3	0.6	0.3	0.3	2.7	1.2	4.4	1.1	1.3	1.4	0.4	0.9	0.9	2.9	0.9	0.9	1.4	0.4	0.1	2.3	1.9	0.1	3.4	0.9	1.8	0.6	2.8	1.2	1.2	2.2	0.8	1.4	1.3	1.4	3.8	1.4	1.6	2.7	3.1	1.1	1.9	2.1	1.4	3.5	1.6	3.7	6.8	1.5	0.4	2.3	1.1	3.4	3.1	2	2.3	1.3	2.5	0	0	1.7	2.4	2.5	5.3	1	1.8	1.7	1.5	1.4	1	1.2	1.7	0.7	1.1	0.7	0.2	0.4	2	0.6	1.3	0.4	3.2	1.1	0.7	0.5	1.1	0.7	1.5	0.7	1	0.9	2.7	0.8	0.9	4.4	1.3	0.8	1.2	1.4	0.4	0.3	0.3	0.9	0.3	0.3	0.5	0.3	0.3	0.5	0.3	0	2.4	0	0.7	0.1	0.6	0.5	0	92.3	6.8	0	2	0.6	0	0.5	11.5	0.1	0.5	0	1.2	0.4	0.8	0.6	0	0.2	0.5	3.2	4.1	0	0	8.9	0.6	0	0	1	1.1	0.8	0.4	0	0.7	1.5	1	0	0.3	3.4	1.5	0.1	0.6	0	0.6	1	Ciliated cells
SLC34A3	FLJ38680, NPTIIc	ENSG00000198569	Solute carrier family 34 member 3	Q8N130	9	137230757-137236554	Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters	Ion transport, Sodium transport, Symport, Transport		Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		intestine: 10.4;kidney: 14.8	Cell type enriched	Detected in some	12	Proximal tubular cells: 20.3	Low cancer specificity	Detected in single			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		CAPAN-2: 6.0;HDLM-2: 3.7;HeLa: 4.0;MCF7: 9.7	Low region specificity	Detected in single			Low region specificity	Detected in some			HPA023776	Enhanced											HPA023776: AB_1857102	unprognostic (2.69e-1)	unprognostic (4.16e-1)	unprognostic (9.08e-3)	unprognostic (1.83e-2)	unprognostic (2.41e-1)	unprognostic (1.29e-3)	unprognostic (4.02e-3)	unprognostic (1.75e-2)	unprognostic (1.05e-2)	unprognostic (9.84e-3)	unprognostic (2.05e-2)	unprognostic (2.20e-2)	unprognostic (5.94e-2)	unprognostic (1.94e-2)	unprognostic (9.12e-2)	unprognostic (5.80e-2)	unprognostic (2.20e-1)	0.2	0	0.2	0.2	0.2	0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.5	0.2	0.2	3.6	0.5	0.2	0.2	0.2	0	14.8	0.2	0.2	0.2	0.2	0.2	0.2	0.6	0	1.6	0.2	0.2	0.2	0	0.2	1.2	0.2	0.2	0.3	10.4	0.2	0.2	0.2	0.4	0.3	0.2	0.2	0.3	0.2	0.2	0.2	0.5	0	0	0	0	0	0	0	0.8	1.7	0.7	2	0	0	0.5	0.1	0	0	0	0.5	6	0.4	0.2	0	0.1	3	0	0	0	3.7	0.2	0	4	2.6	0	0	0.5	0	0	0	0	0.4	0	0.3	0.4	0.7	0	9.7	0.1	0.1	0.6	1.1	1.2	1.3	0.5	0	0	0.5	0	1.5	0.6	1.4	0.3	0.7	3.4	0.1	0.4	0.5	0.4	1.9	0.1	1.1	0.5	0.4	0.8	0.2	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0.2	0.2	0.2	0.2	0	0.2	0.2	0.2	0.2	0	0	0	0	0	0	0.3	0	0	0	0	0	0	1.7	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	20.3	0	0	0	0	0	0	0	0	0	0	Proximal tubular cells
ARC	Arg3.1, KIAA0278	ENSG00000198576	Activity regulated cytoskeleton associated protein	Q7LC44	8	142611044-142614472	Predicted intracellular proteins	Endocytosis, Transport	Developmental protein, RNA-binding		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		pituitary gland: 25.8;seminal vesicle: 67.7	Cell type enriched	Detected in many	11	Intestinal endocrine cells: 157.5	Cancer enriched	Detected in many	12	glioma: 36.1	Low region specificity	Detected in many			Cell type enhanced	Detected in single		gdT-cell: 1.6	Lineage enhanced	Detected in single		T-cells: 1.6	Cell line enhanced	Detected in some		AN3-CA: 6.9;HEK 293: 8.5;SCLC-21H: 20.4;U-2 OS: 9.9;U-87 MG: 11.2	Group enriched	Detected in many	5	amygdala: 48.9;basal ganglia: 51.6;cerebral cortex: 144.6;hippocampal formation: 99.8;olfactory region: 50.5	Group enriched	Detected in many	7	basal ganglia: 25.3;cerebral cortex: 87.7;hippocampal formation: 55.8;olfactory region: 47.5	HPA056430, CAB079013		Supported	Approved	Vesicles,Microtubules						Vesicles, Microtubules		CAB079013: , HPA056430: AB_2683130	unprognostic (1.40e-3)	unprognostic (2.95e-2)	unprognostic (4.35e-3)	unprognostic (4.87e-4)	unprognostic (6.83e-2)	unprognostic (8.12e-2)	unprognostic (5.13e-2)	unprognostic (1.77e-1)	unprognostic (5.07e-2)	unprognostic (9.43e-2)	unprognostic (4.15e-3)	unprognostic (1.40e-1)	unprognostic (2.14e-2)	unprognostic (1.01e-2)	unprognostic (7.42e-2)	unprognostic (1.54e-1)	unprognostic (3.35e-2)	18.1	15.9	6.1	1	6.5	0.7	1	0.8	17	1.5	0.9	4.2	11.8	0.8	1.4	1.8	0.9	1.2	3.5	0.5	13.9	7.1	1.5	0.7	2.7	0.4	2.4	2.1	0.5	6.2	0.4	25.8	1.8	4	1	0.6	0	0.5	67.7	0.5	3.5	0.7	0.9	1.2	0.7	2.1	0.6	1.1	0	1.5	0.8	1.9	0.6	1.5	0	0	0	0.5	0	1.6	0	0	0.1	0.3	6.9	0.1	0.8	0	1.5	0	0.3	0.1	0.1	0	0	0.9	0.2	0.2	0.1	0.5	0	0	0	8.5	0	0.1	0	0	0	0	0	0	1.2	0	0	0.3	0.1	0	0	0	2.9	0	0	3.2	1.2	1.5	0	0.7	0	0	0	20.4	4.8	0.5	0	0.2	0	0	0.1	0	1.1	9.9	0.7	0.2	1.9	0	0	11.2	0	2.9	0	0	0	1.6	0.5	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	6.1	6.5	0.8	17	13.9	7.1	2.4	2.1	4	1.1	0	4	0	11.1	4.5	7.7	3.1	0	0	0	0	0	0.1	0	0.9	0	2.8	0.4	0	0	0.3	7.4	13.8	0	0	1.5	3.2	157.5	1.8	0.8	0	0.3	1	6.8	0	1.7	7.8	0.1	0	1.8	0	2.7	0	10.3	0.2	0.7	5.6	0.1	0.7	1.2	2.2	Intestinal endocrine cells
MMP17	MT4-MMP	ENSG00000198598	Matrix metallopeptidase 17	Q9ULZ9	12	131828393-131851783	Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins		Hydrolase, Metalloprotease, Protease	FDA approved drug targets	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 23.3	Cell type enriched	Detected in some	7	Melanocytes: 27.0	Cancer enriched	Detected in many	10	melanoma: 29.9	Low region specificity	Detected in all			Group enriched	Detected in many	9	classical monocyte: 2.2;intermediate monocyte: 2.1;memory B-cell: 1.4;myeloid DC: 1.2;naive B-cell: 1.7;non-classical monocyte: 2.7	Group enriched	Detected in many	9	B-cells: 1.7;dendritic cells: 1.2;monocytes: 2.7	Group enriched	Detected in many	4	REH: 17.3;SK-MEL-30: 42.1;WM-115: 62.3	Group enriched	Detected in many	5	amygdala: 51.6;basal ganglia: 52.2;cerebral cortex: 70.8;hippocampal formation: 73.1;hypothalamus: 21.6	Low region specificity	Detected in all								Secreted to extracellular matrix								unprognostic (9.11e-2)	unprognostic (1.27e-2)	unprognostic (1.69e-2)	unprognostic (3.71e-3)	unprognostic (5.62e-2)	unprognostic (1.85e-2)	unprognostic (8.90e-3)	unprognostic (2.14e-2)	unprognostic (2.60e-1)	unprognostic (2.66e-4)	unprognostic (7.68e-2)	unprognostic (5.88e-2)	unprognostic (9.26e-10)	unprognostic (1.15e-2)	unprognostic (2.65e-1)	unprognostic (1.21e-3)	unprognostic (2.81e-2)	4.6	2	12.6	3	23.3	6.2	2.5	1.4	21.5	5.6	3	3.1	0	1.4	4.2	0.9	2.1	2.1	7	1.1	22.5	10.1	0.5	0.5	1.8	5.5	3.7	7.6	9	5	3.1	0.7	1.1	2.2	1.6	0.8	1.6	8.5	2.5	1.6	9.7	1.9	1.7	1.6	4.8	1.4	2.9	3.5	0	0.8	1.5	1.6	2.8	2.8	1.7	1.2	0.2	2.7	0.1	0	1.1	0.1	5.3	0.2	0.5	4.3	1.7	0.1	2.7	6.7	2.6	2.7	0	1.5	0	2.2	4.2	1.6	2.3	2.2	2.5	0.5	0	0.3	0.9	1.9	0	5.3	0	3.8	2.6	0.7	3.7	0.9	1	3.5	0	1	0.1	3.3	4.7	0.1	4	2.4	1.6	3.2	17.3	0	2	0	0	2.3	0.7	0.3	0.9	42.1	0.7	4.9	10	2.7	0.7	0.7	3.8	0.3	0	0	0	1.4	0.5	62.3	0.1	2.2	0	0	2.1	0	1.4	0	0	1.2	1.7	0	0	0.2	0.1	2.7	0	0	1.1	12.6	23.3	1.4	17.9	22.5	10.1	3.7	7.6	2.2	3.5	0	0	0	0.1	2.3	0.5	1	0	0	0	0	0	0	0	0	0	0.3	0	0	0.2	0.1	1	0.2	0	0	0.6	3.2	0	1.3	4	0	0.9	0.4	27	0	0	0.2	0	0	1.8	0.3	0	0	1	0.5	0.4	1	0	0	0	0.1	Melanocytes
AKR1C4	3-alpha-HSD, C11, CDR, CHDR, DD4, HAKRA, MGC22581	ENSG00000198610	Aldo-keto reductase family 1 member C4	P17516	10	5195462-5218949	Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins		Oxidoreductase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	17	liver: 127.0	Cell type enriched	Detected in some	10	Hepatocytes: 437.4	Cancer enriched	Detected in some	86	liver cancer: 108.4	Not detected	Not detected			Group enriched	Detected in some	4	basophil: 1.2;gdT-cell: 1.1	Group enriched	Detected in many	6	granulocytes: 1.2;T-cells: 1.1	Group enriched	Detected in some	4	HDLM-2: 11.6;OE19: 5.1									HPA044720, HPA068265	Uncertain		Approved	Nucleoplasm,Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol					1800000	Nucleoplasm, Cytosol	Nucleoli fibrillar center, Endoplasmic reticulum	HPA044720: AB_2679058, HPA068265: AB_2685966	unprognostic (2.21e-1)	unprognostic (3.04e-1)	unprognostic (5.15e-2)	unprognostic (1.25e-1)		unprognostic (5.99e-2)	unprognostic (9.40e-2)	unprognostic (2.32e-1)		unprognostic (1.26e-1)	unprognostic (1.52e-2)		unprognostic (1.29e-1)	unprognostic (3.31e-1)	unprognostic (7.34e-2)		unprognostic (1.45e-2)	0	0	0	0	0	0	0	0	0.1	0	0.1	0.1	0	0.3	0	0	0	0	7.4	0	0	0	0	127	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0.2	0	0	0	0.1	0.1	0	0	0	0	0	0	0	0	0.2	1.2	0	0	1.1	0.1	0	1.5	0.1	1	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	11.6	0	0.5	0.3	1.9	0	0.6	0	0	0	0	0	0	0	0	0.1	0	0	0	0.2	0	0	5.1	0	0	0.7	0	0	0.2	0	0	0.2	0	0	0	0	0	0.8	0	0.1	0.4	0	0	0	0.1	0.1	0.1	0	1.2	0	0	1.1	0	0	0	0.1	0.1	0	0	0	0.1	0.2	0	0	0.2	0.1	0.1	0	0	0	0.1	0	0	0	0	0.1	0	0	0	3.9	0	0	0	0.2	45.9	2.7	1.2	0	0	0	0	0	5.8	0	0	23.3	0.6	0	0	0	0	437.4	0	0	0	14.1	11.8	0	0	0	0	0	0	0	0.2	0	0.4	0.6	0	0	0	0.5	0.2	0	0	0	0	0.1	Hepatocytes
RYR2	ARVC2, ARVD2, VTSIP	ENSG00000198626	Ryanodine receptor 2	Q92736	1	237042205-237833988	Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters	Calcium transport, Ion transport, Transport	Calcium channel, Calmodulin-binding, Developmental protein, Ion channel, Ligand-gated ion channel, Receptor	Cardiomyopathy, Disease mutation, FDA approved drug targets	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	6	heart muscle: 106.6	Cell type enriched	Detected in many	30	Cardiomyocytes: 1960.0	Low cancer specificity	Detected in some			Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HDLM-2: 7.8;HEK 293: 10.7;K-562: 3.3;NB-4: 2.7;NTERA-2: 4.0;U-937: 4.9	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA020028	Approved		Uncertain	Nucleoplasm,Plasma membrane,Cytosol						Nucleoplasm, Plasma membrane, Cytosol		HPA020028: AB_1856528	unprognostic (5.23e-3)	unprognostic (2.15e-2)	unprognostic (5.02e-4)	unprognostic (6.26e-2)	unprognostic (8.74e-2)	unprognostic (2.99e-3)	unprognostic (5.28e-2)	unprognostic (1.45e-3)	unprognostic (2.69e-2)	unprognostic (1.04e-1)	unprognostic (1.10e-1)	unprognostic (4.04e-2)	unprognostic (0.00e+0)	unprognostic (2.36e-2)	unprognostic (1.42e-1)	unprognostic (3.13e-2)	unprognostic (1.06e-2)	1.1	0.9	6.2	0.9	18.7	0.5	1.1	14.8	10.5	1.3	1.2	0	1.2	0.7	1.1	0.7	1.8	1	1.8	106.6	5.7	1.1	0.9	0.9	1.4	0.6	1	7.3	2.2	4.2	0.5	2	1.1	1.6	2	0.8	0.2	0.9	1.4	0.9	1	1	4.6	1	1	1.2	1.1	3	0	2.7	0	0.6	1.2	1	0	0	0	0	0	0.6	0	0	0	0	0.2	0	0	0	0	0	0	0	0.2	0	0.7	0.3	0	0	0.3	0.6	0	0	7.8	10.7	2.1	0.1	0	0	0	0	0	0.4	0	0	0	0	0	3.3	0.2	0	0	0	2.7	4	0.1	0.4	0	0.1	0.1	0	0	0.1	0.2	0	0	0.1	0.6	0	0	0	0	0.1	0	0	0	0	0	0.2	4.9	0	0	0	0	0.1	0	0.6	0	0.1	0	0	0	0	0	0	0	0	0	0.1	0	6.2	18.7	14.8	10.5	5.7	1.1	1	7.3	1.6	3	0	0.3	0	0	0.3	65.2	1960	0	1.4	2.3	1.8	9.8	0	0	0	15.8	1.5	0	0	2.5	0	2.1	0	0	0	0.1	1.6	3.4	1.3	0	10.2	1.1	0	8.5	0	0	1.5	0.3	0	0	0	4.7	0	18.6	3.2	0.9	0	0	0	0	0	Cardiomyocytes
TAT		ENSG00000198650	Tyrosine aminotransferase	P17735	16	71565660-71577130	Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins	Phenylalanine catabolism, Tyrosine catabolism	Aminotransferase, Transferase	Disease mutation, Mental retardation, Palmoplantar keratoderma	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	44	liver: 387.0	Cell type enriched	Detected in some	42	Hepatocytes: 3069.2	Cancer enriched	Detected in some	10	liver cancer: 152.8	Not detected	Not detected			Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Group enriched	Detected in some	5	Daudi: 2.4;Hep G2: 7.3	Not detected	Not detected			Not detected	Not detected																unprognostic (3.66e-3)	unprognostic (1.29e-1)	unprognostic (8.17e-2)	unprognostic (2.21e-1)	unprognostic (1.67e-1)	unprognostic (1.01e-2)	prognostic favorable (6.51e-4)	unprognostic (1.69e-1)	unprognostic (9.32e-2)	unprognostic (2.27e-1)	unprognostic (3.73e-3)	unprognostic (1.88e-1)	unprognostic (1.27e-4)	unprognostic (1.19e-1)	unprognostic (1.28e-1)	unprognostic (1.09e-1)	unprognostic (1.05e-2)	0	0	0	0	0	0	8.8	0	0.1	0	0	0	0	0	0	0.1	0	0	0.1	0	0	0	0	387	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0.1	0	0	0	0	0.1	0	0.2	0	0	0.1	0	0.1	0	0	1.9	2.6	1.5	0.4	0.2	0.5	0.2	0.1	0.2	0.2	0.4	0.1	0	0	0	0	0	0	0	0	2.4	0.1	0	0.2	0	0	0	0	0.2	0.4	0.5	0.2	7.3	0	0.9	0.1	0	0	0	0	0	0	0.6	0.2	0	0	0.9	0	0.2	0.4	0	0.1	0	0.7	0.9	0	0.1	0.3	0.1	0.6	0	0.2	0	0.1	0	0	0.1	0.4	0	0	0.5	0.2	0.5	0	0.3	0.2	1.5	0.4	0.2	0.3	0.1	0.4	1.2	0.5	0.4	0.2	1.9	0.5	0.5	1.5	0.2	0.1	2.6	0.1	0.2	0	0	0	0.1	0	0	0	0	0.1	0	0	0	14	0	0	0.2	0.3	73.9	0	0	0	0	0	0	0.2	0.9	0	1	23.3	0.6	0	0	0	0	3069.2	0	0	0	53.4	61.8	0.6	0.6	0	0	0	0	0	0.2	0	0	0	0.9	0	0	0.9	1.5	0	0	0	0	0	Hepatocytes
LPA	LP, Lp(a)	ENSG00000198670	Lipoprotein(a)	P08519	6	160531483-160664259	Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Lipid transport, Transport	Hydrolase, Protease, Serine protease	Atherosclerosis	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	71	liver: 43.4	Cell type enriched	Detected in some	32	Hepatocytes: 79.7	Cancer enriched	Detected in single	38	liver cancer: 3.6	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	6	RT4: 4.7									CAB016072, HPA060604	Supported				Secreted to blood			78800000000	2900000000			CAB016072: AB_2135240, HPA060604: AB_2684330		unprognostic (2.16e-1)	unprognostic (5.10e-1)	unprognostic (7.75e-3)	unprognostic (6.70e-2)	unprognostic (1.60e-1)	unprognostic (4.17e-3)	unprognostic (1.59e-1)		unprognostic (6.38e-3)	unprognostic (3.63e-2)	unprognostic (3.18e-1)	unprognostic (7.45e-3)	unprognostic (2.56e-1)	unprognostic (1.80e-1)	unprognostic (1.34e-1)	unprognostic (3.72e-2)	0.1	0	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.2	0.2	43.4	0.1	0.1	0.1	0.1	0.1	0.2	0	0.1	0.1	0.1	0.2	0	0.1	0.1	0.6	0.1	0	0.1	0.1	0.1	0.1	0	0.2	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0.1	0	0	0	0	0	0	0	0	0.1	0	0.1	0.4	0	0	0.5	0.7	0	0	0.1	0	0	4.7	0	0	0.1	0	0	0.2	0	0	0	0.1	0	0	0	0.7	0.1	0	0	0.1	0.1	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0	0	0	0.2	0	0	0.4	2.5	0	0	0	0	0	0	0	0.8	0	0	0	0	0	0	0	0	79.7	0	0	0	1.3	2.1	1.5	0	0	0	0	0	0	0	0	0	1	0	0	0	0.6	0.8	0	0	0	0	0.2	Hepatocytes
OR10G6	OR10G6P, OR10G6Q	ENSG00000198674	Olfactory receptor family 10 subfamily G member 6	Q8NH81	11	123994163-123995161	G-protein coupled receptors, Predicted membrane proteins	Olfaction, Sensory transduction	G-protein coupled receptor, Receptor, Transducer		Evidence at transcript level	Evidence at transcript level	No human protein/transcript evidence	No human protein/transcript evidence		Tissue enhanced	Detected in single		pancreas: 1.7	Cell type enriched	Detected in single	17	Distal tubular cells: 1.7	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Low region specificity	Detected in some																																	0	0	0	0	0	0	0	0	0	0	0			0	0	0	0	0	0	0	0	0	0	0	0	0	0		0	1.7	0	0	0		0	0		0	0	0	0	0	0	0	0	0	0.3			0		0	0	0	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0	0	0	0	0	0	0	0	0	1.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Distal tubular cells
MAGEA1	CT1.1, MAGE1, MGC9326	ENSG00000198681	MAGE family member A1	P43355	X	153179285-153183880	Predicted intracellular proteins	Transcription, Transcription regulation	Tumor antigen		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	18	testis: 13.5	Cell type enriched	Detected in some	4	Spermatogonia: 29.0	Low cancer specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HEL: 17.8;HMC-1: 31.0;RPMI-8226: 15.3;U-2 OS: 29.6;U-266/70: 44.3;U-266/84: 70.5									CAB002620	Enhanced		Supported	Cytosol						Cytosol		CAB002620: 						unprognostic (8.65e-2)	unprognostic (1.33e-1)	unprognostic (6.40e-3)	unprognostic (1.39e-1)	unprognostic (1.23e-1)				unprognostic (1.15e-1)	unprognostic (1.18e-1)		unprognostic (2.35e-2)	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.7	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0.1	13.5	0	0	0	0	0	0.1	0	0	0	0	0	0	0.2	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0.3	0	0	0	0	0	0	17.8	3.2	0	0	0	31	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0.4	0	0	15.3	0	0	0	0	0	0.1	0	0	1.9	0.1	0	0	29.6	0.1	0.1	44.3	70.5	0	2	0	0.8	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0.5	0.3	0	0	0	0	0	0	0	0	0	0	0	0	6.6	29	0	0	0	0	0	Spermatogonia
MT-ND6	MTND6, NAD6, ND6	ENSG00000198695	Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6	P03923	MT	14149-14673	Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins	Electron transport, Respiratory chain, Transport	Translocase	Disease mutation, Dystonia, Leber hereditary optic neuropathy, Leigh syndrome, MELAS syndrome, Primary mitochondrial disease	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		heart muscle: 395.3;skeletal muscle: 593.2	Cell type enriched	Detected in many	16	Cardiomyocytes: 10763.4	Low cancer specificity	Detected in all							Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Cell line enhanced	Detected in many		HeLa: 524.8	Low region specificity	Detected in all			Low region specificity	Detected in all																unprognostic (1.96e-1)	unprognostic (3.27e-1)	unprognostic (2.28e-1)	unprognostic (1.13e-1)	unprognostic (2.21e-1)	unprognostic (1.22e-2)	unprognostic (1.03e-3)	unprognostic (6.02e-3)	unprognostic (1.68e-2)	unprognostic (1.48e-1)	unprognostic (6.06e-3)	unprognostic (2.91e-1)	prognostic favorable (8.91e-6)	unprognostic (3.64e-2)	unprognostic (1.42e-2)	unprognostic (1.15e-2)	unprognostic (2.92e-2)	79.2	43.1	55.5	34.4	78.5	30.7	9.6	14.7	76.1	5.9	30.2			90.3	19.2	0	69.5	23.2	40.2	395.3	50.7	41.2	65.5	42.8	28.5	25.9	41.9		23.2	48	0	3.5	10.3		28	0.3		48.1	0	593.2	176.3	63.8	0	24.8	19.9	53.2	22.7			17.5		0	32.3	5.7	127.3	91.2	164.8	108.2	88.8	104.3	29.7	99.5	80.8	71.5	90.8	12	1.1	51.3	134.7	0.2	0.4	0.4	109.8	101.1	214.8	91.6	3.6	13.5	149	0.7	2.4	0.7	126.9	62	128.7	524.8	313.8	0.9	81.4	121.6	2	3.3	3.3	2.7	68.1	0.7	45	55.3	84.4	2.9	212.8	25	112.4	15.5	57.2	39.8	60.9	45.7	92.3	1.9	293.8	29.5	47.4	70.1	123.5	55.6	118.8	95.7	158.8	273.9	79.6	67.2	112.6	53.9	28.9	77.1	51.5	54	83.1	46.2	164.8	108.2	68.3	89.1	103.5	104.3	118.4	94.5	96.1	66.2	127.3	94.7	102.4	53.7	88.8	103.7	91.2	71.8	29.7											77.4	48.1	340.3	38	14.9	0	10763.4	298.1	156.6	138.8	122.1	0	0	14.9	22.5	5.1	82.2	98.6	584	30.5	0	11.3	44.8	92.7	656.7	0	0	29	406.4	492.6	24.4	57.8	31.8	32.1	42.3	60.4	0	23.3	63.7	42.5	111.6	0	58.2	27.7	25.6	53	17.9	0	156.7	77	76.6	Cardiomyocytes
MT-CO2	CO2, COX2, MTCO2	ENSG00000198712	Mitochondrially encoded cytochrome c oxidase II	P00403	MT	7586-8269	Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters	Electron transport, Respiratory chain, Transport	Translocase	Disease mutation, Primary mitochondrial disease	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		blood: 489.9;skeletal muscle: 343.4	Cell type enriched	Detected in many	10	Cardiomyocytes: 412590.4	Low cancer specificity	Detected in all							Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Cell line enhanced	Detected in all		HeLa: 1073.7	Low region specificity	Detected in all			Low region specificity	Detected in all			CAB016243, HPA051505, HPA054758	Enhanced								1300000			CAB016243: AB_2066366, HPA051505: AB_2681511, HPA054758: AB_2682595	unprognostic (2.67e-1)	unprognostic (5.72e-2)	unprognostic (4.57e-2)	unprognostic (5.31e-2)	unprognostic (2.77e-2)	unprognostic (1.96e-2)	prognostic favorable (2.89e-4)	unprognostic (1.06e-1)	unprognostic (3.39e-1)	unprognostic (2.72e-3)	prognostic favorable (7.10e-4)	unprognostic (1.25e-1)	unprognostic (9.30e-2)	unprognostic (3.05e-1)	unprognostic (1.70e-1)	unprognostic (9.50e-2)	unprognostic (3.72e-3)	54.6	64.8	149.7	21.7	194.8	30.2	45.5	48.9	99.5	27	106.9			73.6	23.8	46.3	35.8	25.1	23.7	252.1	151.9	112.4	158.4	173.8	22.7	22.8	154.6		21.2	46.4	50.4	22.5	41.4		38.2	106.4		61.7	56	343.4	56.4	51.1	40	77.8	25.9	68.5	28.2			23.3		29.5	29.9	16.2	379.8	278.1	489.9	409.1	220.4	273.9	181.4	111.2	179.1	238.3	230.3	487.6	188	175.6	145.1	117.7	82.5	124.6	192.6	251.5	232.6	121.5	213.4	84.9	422.7	31.5	298.5	111.8	180.1	161.5	166.8	1073.7	370.2	106.1	140.2	187.4	275.7	441.7	42.5	152.4	270.3	91.3	232.4	155.7	226.9	226	240.8	102.5	404.1	62.3	220.6	114	107.2	72.6	194.8	336.5	310.9	89.2	147.6	119.5	294.8	209.6	367.9	205.2	568.6	225.1	200	173.5	188.5	102	115.3	114.6	131.1	106.4	283.3	131.3	489.9	409.1	476	194.9	292.9	236.6	379.8	217.1	218.8	205.5	378.1	227.9	273.9	180.3	220.4	308.7	278.1	170.3	181.4											1343	1746.9	18282	6995.6	5999.6	0	412590.4	19500.5	2813.3	2462.5	17642.7	0	0	3143.4	3272.8	866	2789.7	27604.7	22029.3	4281.1	0	1817.5	4991	2029.2	43011.4	0	0	6162.7	12438.4	17929.8	4401	7095.7	4687.5	4875.7	4595.3	21499.4	0	3881.8	14501.3	4815.7	15512.8	0	6946.2	3920.2	6682.3	8100.4	5859.1	0	11198.1	21247.6	11593.6	Cardiomyocytes
MT-CYB	COB, CYTB, MTCYB, UQCR3	ENSG00000198727	Mitochondrially encoded cytochrome b	P00156	MT	14747-15887	Disease related genes, Predicted membrane proteins	Electron transport, Respiratory chain, Transport		Cardiomyopathy, Cataract, Deafness, Disease mutation, Leber hereditary optic neuropathy, Primary mitochondrial disease	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		blood: 324.2;skeletal muscle: 302.1	Cell type enriched	Detected in many	4	Cardiomyocytes: 61379.6	Low cancer specificity	Detected in all							Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Cell line enhanced	Detected in all		ASC diff: 490.3;HeLa: 493.3	Low region specificity	Detected in all			Low region specificity	Detected in all			CAB032215, HPA068400, HPA074796	Approved		Supported	Mitochondria						Mitochondria		CAB032215: AB_2261378, HPA068400: AB_2685982, HPA074796: 	unprognostic (4.50e-1)	unprognostic (2.56e-1)	unprognostic (9.12e-2)	unprognostic (3.88e-2)	unprognostic (9.22e-2)	unprognostic (3.50e-1)	prognostic favorable (5.96e-4)	unprognostic (1.63e-2)	unprognostic (8.53e-2)	unprognostic (1.49e-2)	unprognostic (1.01e-3)	unprognostic (6.09e-2)	unprognostic (1.40e-1)	unprognostic (7.90e-3)	unprognostic (3.07e-1)	unprognostic (4.09e-2)	unprognostic (1.54e-2)	78	52.4	98.5	14.7	143.5	14.4	32.3	38.4	59.6	30.9	54			55.6	25	43.6	28	25	21.2	222.5	93.9	68	128.7	144.7	19.6	13.7	83.6		25.3	51.4	33.6	23.7	32.6		32.9	57.7		59.2	49.5	302.1	63.5	37.2	37.4	44.3	15.7	55.2	20.2			20.9		20.6	23.6	14.7	183.7	78.7	324.2	155.7	90	146.7	57.6	73.4	99.2	123	131.3	490.3	78.9	99.1	84.7	35.1	22.2	38.5	97.6	162.5	188.2	41.5	100.3	26.6	231.5	18.2	104.1	54.5	91.9	81.5	105.1	493.3	174	92.4	59	128.5	170.3	155.3	42	90.5	150.2	56.2	76.8	53.7	118.5	113.1	202.8	54.8	121.7	27.3	71.8	67.4	64.8	48.4	117.8	176.2	171.6	43.9	77.6	59	111.5	83.4	192.8	162.6	203.7	176.1	77.9	101.9	141.8	65	32.5	43.6	80.6	46.8	92	48.9	324.2	155.7	235.1	102.8	94.4	135.3	150.5	118.7	132	78	183.7	128.3	146.7	148	90	96.8	78.7	79.8	57.6											1101.8	1182.9	10535.1	6605.8	2949	0	61379.6	10280.2	2941.7	2205.5	7087.1	0	0	1833.6	2297.4	679	1928.7	15168.1	14904.3	3076	0	1463.9	4337.7	1777.7	14746	0	0	2756	7288.5	8580.4	3048.7	7355	2431.1	2478.3	3811.6	11241	0	2672.3	10113.2	5078	11513.5	0	5704.4	3210.7	4468.4	3767.8	2992.1	0	6827.7	9828	8723.5	Cardiomyocytes
SYCP1	CT8, HOM-TES-14, SCP1	ENSG00000198765	Synaptonemal complex protein 1	Q15431	1	114854803-114995370	Plasma proteins, Predicted intracellular proteins	Cell cycle, Cell division, Meiosis	DNA-binding		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	51	testis: 30.6	Cell type enriched	Detected in some	14	Spermatocytes: 1077.5	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	93	THP-1: 19.5	Region enriched	Detected in single	51	cerebellum: 16.5	Not detected	Not detected			HPA021083	Enhanced		Approved	Nuclear bodies,Cytosol						Nuclear bodies, Cytosol		HPA021083: AB_1857685	unprognostic (2.91e-1)									unprognostic (6.89e-3)				unprognostic (4.87e-1)	unprognostic (8.74e-3)			0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	30.6	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	19.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	79.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	40.7	4.9	0	0	0	0	0	0	0	0.7	0	0	6.5	0	1077.5	21.3	0	0	0	0	0	Spermatocytes
BRINP2	DBCCR1L2, FAM5B	ENSG00000198797	BMP/retinoic acid inducible neural specific 2	Q9C0B6	1	177171497-177282422	Predicted secreted proteins, Transporters	Cell cycle, Growth arrest			Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	10	adrenal gland: 11.5;brain: 27.9	Cell type enriched	Detected in some	9	Horizontal cells: 14.3	Cancer enriched	Detected in some	5	glioma: 11.4	Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HDLM-2: 10.7;PC-3: 2.6;REH: 3.0;SCLC-21H: 9.7;SH-SY5Y: 2.2	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA050681	Uncertain				Secreted in other tissues							HPA050681: 	unprognostic (7.78e-2)	unprognostic (4.49e-1)	unprognostic (2.53e-1)	unprognostic (1.57e-1)	unprognostic (2.57e-1)	unprognostic (2.43e-2)	unprognostic (1.77e-1)	unprognostic (5.77e-2)	unprognostic (1.23e-2)	unprognostic (1.95e-2)	unprognostic (2.20e-4)	unprognostic (8.95e-2)	unprognostic (1.78e-2)	unprognostic (2.60e-3)	unprognostic (1.17e-1)	unprognostic (2.60e-2)	unprognostic (4.82e-3)	0.4	11.5	12.2	0.3	8.2	0.3	1.9	0.4	27.9	0.3	0.4	0.6	0	0.3	0.5	0.9	0.3	0.6	0.4	0.4	7	6	0.3	0.4	0.3	0.3	4.5	3.6	0.3	0.3	0.3	2	1	0.8	0.4	0.3	0	0.3	0.4	0.3	0.3	0.3	0.4	1.5	0.5	0.3	1.8	0.3	0	0.3	0	0.3	0.3	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	10.7	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.4	0	0	0.1	0	2.6	3	0	0	0	0	9.7	2.2	0	0	0	0.1	0	0	0	0	0.1	0	0	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	12.2	8.2	0.4	15.9	7	6	4.5	3.6	0.8	0.3	0	0	0	0	0	0.3	0.4	0	0	0	0	0	0	1.7	0	1.5	0	0	0	0	0	0	0	0	0	0.1	14.3	0	0	0	0.8	0.9	0	0	0	0	0.5	0.1	0	0	0	0.8	0	0	1.5	0.5	0	0	0	0	0	Horizontal cells
LRRC10	HRLRRP, LRRC10A	ENSG00000198812	Leucine rich repeat containing 10	Q5BKY1	12	69608564-69611162	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	31	heart muscle: 42.5	Cell type enriched	Detected in single	323	Cardiomyocytes: 32.3	Not detected	Not detected			Not detected	Not detected			Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		HDLM-2: 2.5	Not detected	Not detected			Not detected	Not detected																				unprognostic (3.76e-4)										unprognostic (4.59e-1)			0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	42.5	0	0	0	0	0.1	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0.1	0	0.3	0	0	0	0	0	0	0	1.3	1.1	1	0.5	0.4	0.8	0.1	0.1	0.5	0.6	0.6	0	0	0.5	0.2	0	1	0.4	0.3	0.3	1	0.3	0.1	0.2	0.7	0	0.1	0	2.5	0.7	0.5	0.7	0.6	0.1	0	0.8	0.2	0.7	0.6	0	0.9	0.4	0.5	0.6	0.1	0.1	0	0.8	0.4	0.2	0	0.4	0.9	0.1	0.1	0.8	1.3	0.8	0.9	0	0.1	0	0.7	0.3	0.1	0.4	0.2	0.8	0.5	0.4	0.6	0.4	0.8	1	1.3	0.1	0.4	0.5	0.4	0.6	0.2	0.5	0.7	0.5	0.6	0.1	1.3	0.8	0.7	1	0.4	0.3	1.1	0.4	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	32.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Cardiomyocytes
DUSP27		ENSG00000198842	Dual specificity phosphatase 27, atypical	Q5VZP5	1	167094045-167129165	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	20	heart muscle: 46.8;skeletal muscle: 64.8;tongue: 18.2	Cell type enriched	Detected in some	10	Cardiomyocytes: 131.1	Group enriched	Detected in many	6	colorectal cancer: 12.8;stomach cancer: 3.5	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	6	RH-30: 18.0	Low region specificity	Detected in single			Not detected	Not detected			HPA012912			Approved	Nucleoplasm						Nucleoplasm		HPA012912: AB_2668767	unprognostic (1.26e-2)		unprognostic (1.74e-1)	unprognostic (1.44e-3)	unprognostic (1.22e-1)	unprognostic (2.10e-3)	unprognostic (4.65e-2)	unprognostic (1.53e-1)	unprognostic (8.19e-2)	unprognostic (1.07e-2)	unprognostic (1.48e-1)	unprognostic (2.44e-2)	unprognostic (1.15e-1)	unprognostic (2.72e-1)	unprognostic (7.65e-2)	unprognostic (8.23e-2)	unprognostic (3.39e-1)	2.1	0.1	0.1	0	0.1	0	0	0	0.3	0	0	0	0	0	0	1.5	1.1	0	0.1	46.8	0.2	0.1	0	0	0.1	0	0.1	0	0	0	0	0	0.9	0.1	0.8	0	0	0.9	0	64.8	0	0	0.1	0	0	0	0.2	0.1	0	0.5	18.2	0.8	0	0	0	0.3	0	0.1	0	0	0	0	0	0	0	0	0	1.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0	1.8	0	0	0	0.2	0	0	0	18	0	0	0	0	0	0	0.2	0	3.2	0	0.3	0	0	0.1	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0.1	0.1	0	0.2	0.2	0.1	0.1	0	0.1	0.1	0	0	0	0	0	0	131.1	0	0	1.2	0	0	0	0	0	0	0	0	0	0	0.4	1	0	0	0	13.8	0	0	0	0	0	0	0	0	0	0	8.6	0	0	0	0	0.1	0	0	0	0	0	0.2	0	0	0	Cardiomyocytes
C1orf68	LEP7, XP32	ENSG00000198854	Chromosome 1 open reading frame 68	Q5T750	1	152719522-152720470	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	14	skin 1: 123.1	Cell type enriched	Detected in some	14	Suprabasal keratinocytes: 68.4	Group enriched	Detected in some	13	head and neck cancer: 2.4;melanoma: 6.3					Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	5	HaCaT: 6.4	Not detected	Not detected			Not detected	Not detected			HPA057942			Approved	Plasma membrane,Cytosol					61000	Plasma membrane	Cytosol	HPA057942: 		unprognostic (1.73e-1)				unprognostic (7.46e-2)			unprognostic (9.34e-2)									0	0	0	0	0	0	8.5	0	0	0	0			0	0	0	0.1	0	0	0	0	0	0	0	0	0	0		0	0	0	0	0		0	0		0	0	0.4	123.1	0	0	0	0	0	0			0		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	6.4	0	1.3	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	2.4	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	5	0	0	0	0	0	0	0	0	0	0.1	0	0	68.4	0	0	0	0	Suprabasal keratinocytes
LTN1	C21orf10, C21orf98, FLJ11053, KIAA0714, LISTERIN, RNF160, ZNF294	ENSG00000198862	Listerin E3 ubiquitin protein ligase 1	O94822	21	28928144-28992956	Enzymes, Predicted intracellular proteins, Predicted membrane proteins	Ubl conjugation pathway	Transferase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	5	Early spermatids: 218.4	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low cell line specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA029143, CAB034164, HPA055604	Uncertain		Enhanced	Cytosol						Cytosol		CAB034164: AB_2180094, HPA029143: AB_10671360, HPA055604: AB_2682859	unprognostic (3.67e-2)	unprognostic (7.07e-2)	unprognostic (7.78e-2)	unprognostic (3.99e-1)	unprognostic (1.42e-2)	unprognostic (3.66e-3)	unprognostic (5.38e-2)	unprognostic (5.40e-2)	unprognostic (9.98e-2)	unprognostic (4.45e-2)	unprognostic (2.85e-2)	unprognostic (1.13e-1)	unprognostic (9.87e-2)	unprognostic (1.72e-1)	unprognostic (8.22e-2)	unprognostic (4.57e-2)	unprognostic (1.52e-1)	17.9	15.1	10.3	12.4	19.8	21.2	17.9	19.9	23.2	16.6	14.7	17.8	12.1	12.4	16.5	15.4	15.2	14.5	10.8	13.1	12	10.6	14.1	19.3	12	15.7	19.6	14.2	16.4	23.7	18.4	22.6	29	28.7	19	15.6	9.7	16.1	12.6	22.5	14.8	17.1	13.4	17.4	16.7	15.4	20.7	15.8	23	17.6	14.6	14.9	16.6	14.7	7.8	6.2	12.2	11.9	8.6	8.4	3.3	12.8	5.5	11.5	5.2	9.9	13.6	11.7	10.9	8.9	9.4	13	7.7	10.7	8.5	5.3	9.7	8.1	6.6	12.2	8.9	17.1	9.9	8.5	25.3	7.6	6.1	7.4	8.4	9.9	9.4	8.1	13.3	11.1	9.3	9.9	6.2	20.6	20.4	10.7	4	5.3	8.1	16.5	10.7	6.6	7.2	23.1	17.7	10.6	11.1	6.3	13.1	12.5	9.6	10.9	11.3	9.7	11.8	13	8.3	15.4	11.1	9.1	16.6	15.6	12	12.9	18.2	9.8	12.2	6.4	9.5	8.4	9.8	7	7.8	5.8	5.6	6.2	7.1	6.2	4.7	11.3	8.6	11.9	3.9	6.1	3.3	10.3	19.8	19.9	23.2	12	10.6	19.6	14.2	28.7	15.8	14.9	19.9	19	22.3	26.9	24.3	23.8	7.6	21.4	19.4	10.4	31.4	15.4	1.7	12.5	218.4	21.5	16.6	0	12.2	16.4	19.2	28	26.6	18.4	11.3	39.7	21.8	15.4	24.1	45.8	24.7	18.9	11.8	19	17.8	44.4	16.5	17.3	19.8	15.7	29.4	12.9	19.5	36.9	19	28	24.9	27.3	17.8	29.8	Early spermatids
ASB12	FLJ39577	ENSG00000198881	Ankyrin repeat and SOCS box containing 12	Q8WXK4	X	64224196-64230631	Predicted intracellular proteins	Ubl conjugation pathway			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Group enriched	Detected in some	5	skeletal muscle: 43.4;tongue: 11.5	Cell type enriched	Detected in some	4	Late spermatids: 14.2	Low cancer specificity	Detected in single			Not detected	Not detected			Group enriched	Detected in some	5	basophil: 4.0;naive B-cell: 1.1;T-reg: 1.0	Group enriched	Detected in many	6	B-cells: 1.1;granulocytes: 4.0;T-cells: 1.0	Cell line enhanced	Detected in some		AF22: 3.8;HEK 293: 2.1;HL-60: 2.2;HMC-1: 2.7;JURKAT: 2.2;NB-4: 2.2;NTERA-2: 2.3;REH: 2.1;THP-1: 3.5	Not detected	Not detected			Not detected	Not detected			HPA049542	Uncertain											HPA049542: AB_2680810	unprognostic (6.52e-2)	unprognostic (2.31e-1)	unprognostic (1.48e-2)	unprognostic (1.06e-3)	unprognostic (6.76e-2)	unprognostic (4.23e-2)	unprognostic (6.50e-2)	unprognostic (8.25e-2)	unprognostic (6.75e-2)	unprognostic (9.69e-3)	unprognostic (6.75e-3)	unprognostic (5.18e-2)	unprognostic (5.12e-2)	unprognostic (5.15e-2)	unprognostic (1.35e-1)	unprognostic (4.32e-2)	unprognostic (4.63e-2)	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0.1	2	1	0.7	0	5.9	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0.1	0.2	0	0.6	0.2	43.4	0	0	0.1	0	0	0	0.4	0	0	0.6	11.5	0.7	0	0	1.1	0	4	0.3	0.1	1	0.3	0	0.2	3.8	0	0	0	0	0	0	0	0	0.2	0.6	0.5	0.6	0	0	0	0.9	0	0.4	0	2.1	1.8	0	0	0	2.2	2.7	0	0.5	0	0	0	0	2.2	0.3	1.2	0	0.1	0.5	2.2	2.3	0.5	0.4	2.1	0	0	0.1	0	0	0.6	0	0	0	0.8	0	3.5	0	0	0.1	0.6	0	0	0.1	0.6	0	0	0	4	0	0	0.3	0.3	0.4	0	0.4	0.2	0	1.1	0.3	0.2	0	0.1	0	0	1	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.2	0	0	0	0	0	0.1	0	0.2	3.5	0	0	0	0.3	0	0	0	0	0	0.1	0	0	0	0	14.2	0.3	0	0	0	0	0	0.2	0	0.4	0	0	0	0	0.1	0	0	0.1	0	0	0	Late spermatids
PNMA5	KIAA1934	ENSG00000198883	PNMA family member 5	Q96PV4	X	152988824-152994127	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	15	brain: 21.6;testis: 16.8	Cell type enriched	Detected in some	8	Spermatogonia: 94.9	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Low cell type specificity	Detected in some			Low lineage specificity	Detected in single			Group enriched	Detected in some	573	HMC-1: 63.5;U-266/70: 100.0;U-266/84: 59.3									HPA044690, HPA073946	Enhanced											HPA044690: AB_2679049, HPA073946: 	unprognostic (5.25e-2)	unprognostic (1.03e-2)	prognostic unfavorable (2.25e-4)	unprognostic (1.66e-1)	unprognostic (2.93e-3)	unprognostic (9.98e-3)	unprognostic (3.55e-2)	prognostic favorable (3.16e-4)	unprognostic (1.15e-1)	unprognostic (1.16e-3)	unprognostic (2.66e-2)	unprognostic (1.11e-1)	unprognostic (4.76e-9)	unprognostic (1.00e-1)	unprognostic (1.47e-1)	unprognostic (1.08e-1)	unprognostic (1.41e-2)	0.4	0.3	8.2	0.5	21.6	0.4	0.3	0	11.6	0.3	0.4	0.3	0	0.5	0.4	0.5	0.4	0.4	0.4	0.4	3.9	19.1	0.4	0.4	0.4	0.6	1	6.6	0.3	0.3	0.3	0.6	0.7	2.4	0.3	0.4	0	0.4	0.4	0.3	1.2	0.4	0.4	0.5	1.1	0.7	16.8	0	0	0.4	0	0.5	0.5	0	0.8	0.7	0.1	1.2	0	0.6	0.2	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	63.5	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	100	59.3	0	0	0	0	0	1	0	0.1	0.8	0	0.8	0.6	0	0.7	0	0.2	0	0.1	0	1.2	0.4	0.6	0.2	8.2	21.6	0	11.6	3.9	19.1	1	6.6	2.4	0	0	0	0	0	0.1	0	0.8	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0.8	0	0	0	0	0.7	0	0	0	1.3	0.9	0.3	0.2	0	0	0	0	0	0	0	0	0	0	0	12.2	94.9	0	0.2	0	0	0	Spermatogonia
MT-ND4	LHON, MTND4, NAD4, ND4	ENSG00000198886	Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4	P03905	MT	10760-12137	Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins	Electron transport, Respiratory chain, Transport	Translocase	Disease mutation, Dystonia, Leber hereditary optic neuropathy, MELAS syndrome, Primary mitochondrial disease	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		blood: 392.9	Cell type enriched	Detected in many	4	Cardiomyocytes: 130137.0	Low cancer specificity	Detected in all							Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Cell line enhanced	Detected in all		HeLa: 821.0	Low region specificity	Detected in all							HPA053928	Approved		Supported	Mitochondria						Mitochondria		HPA053928: AB_2682313	unprognostic (8.39e-2)	unprognostic (1.83e-1)	unprognostic (7.29e-2)	unprognostic (9.54e-2)	unprognostic (5.41e-2)	unprognostic (3.78e-2)	unprognostic (2.50e-3)	unprognostic (8.16e-2)	unprognostic (1.45e-1)	prognostic favorable (1.76e-4)	unprognostic (1.01e-2)	unprognostic (7.23e-2)	unprognostic (2.79e-2)	unprognostic (1.53e-1)	unprognostic (1.43e-1)	unprognostic (3.14e-2)	unprognostic (4.24e-2)	82.5	72.4	124.2	19.8	138.2	14.9	34.5	43.8	78.5	34.1	68.7			56.5	27.8	37.1	32.9	25.2	23.7	292.7	122.4	90.3	129.8	178.5	20.8	17.4	101.6		25.5	58.3	37.8	19.7	39.1		37.3	82.1		61.7	65.6	288.4	61.1	41	37.8	63.6	21.7	67.7	29.6			24.3		23.4	26	15.3	164.7	87.6	392.9	119.5	87.1	129.7	53	102.6	106.9	138.9	205.1	326.5	82.3	97.3	104.6	40	24.3	47.5	162.1	117.7	182.9	92.3	89.1	35.8	192.5	12.4	169.4	43.6	105.5	67.2	112.6	821	271.8	49.3	113.1	134	139.2	179.5	35.8	128.4	229.8	58.7	92.3	93.8	226.5	87.5	231.7	44.5	257	39.3	89.7	72.7	60.6	43.6	110.2	177.8	222.1	51.2	69.3	60.8	202.4	104.6	257.3	141.7	267.4	162.8	99.5	96.8	133.1	81	135.9	55.1	81.4	64.9	196.6	52.9	392.9	119.5	268.8	82.9	91.3	115.5	148	93	98.9	65.9	164.7	109.6	129.7	105.7	87.1	89	87.6	67.6	53											1179.2	1324.7	15760.8	7514.4	3912.5	0	130137	15452.1	2295.3	2103.1	12148.5	0	0	2064.1	2636.7	917	2449.9	17720.8	23127.3	3538.6	0	2017.3	5309	2067.8	31565.1	0	0	4902.7	11944.3	15339	4282.8	8180.5	3605.2	3603.6	4879.3	17860.7	0	3353.9	12846	5441.2	13683.6	0	6208.8	3859.5	7259.5	5529.7	4316.1	0	9799.9	18174.2	10097.1	Cardiomyocytes
MT-ND1	MTND1, NAD1, ND1	ENSG00000198888	Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1	P03886	MT	3307-4262	Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins	Electron transport, Respiratory chain, Transport	Translocase	Alzheimer disease, Amyloidosis, Diabetes mellitus, Disease mutation, Epilepsy, Leber hereditary optic neuropathy, MELAS syndrome, Neurodegeneration, Primary mitochondrial disease	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		blood: 314.4;skeletal muscle: 398.2	Cell type enriched	Detected in many	5	Cardiomyocytes: 72531.4	Low cancer specificity	Detected in all							Cell type enhanced	Detected in all		basophil: 314.4	Lineage enriched	Detected in all	5	granulocytes: 314.4	Cell line enhanced	Detected in all		HeLa: 673.1	Low region specificity	Detected in all							CAB033779, HPA066847	Approved											CAB033779: AB_2149736, HPA066847: 	prognostic favorable (3.63e-4)	unprognostic (3.55e-1)	unprognostic (3.77e-2)	unprognostic (3.65e-1)	unprognostic (3.50e-1)	unprognostic (1.28e-1)	unprognostic (1.95e-3)	unprognostic (5.84e-2)	unprognostic (1.06e-1)	unprognostic (5.05e-2)	prognostic favorable (3.26e-4)	unprognostic (8.67e-2)	unprognostic (8.66e-2)	unprognostic (3.24e-2)	unprognostic (1.42e-2)	unprognostic (3.99e-2)	unprognostic (2.85e-2)	83.5	48	118	15.2	136.1	17.7	31.8	45	85.9	19.6	58.3			40.2	16.3	43.4	30.7	16.7	17.6	223.1	106.1	74.3	96	104.7	20.5	12.1	101.8		14.2	48.2	35.1	14.3	32.2		26.6	58.6		71.2	48.4	398.2	75.4	33.3	24.6	55.2	16.7	45	29.8			13.8		17.1	19.9	9.4	60.8	32.2	314.4	54.4	35.8	46.4	19.5	101.9	104.3	85.6	77.9	325	59.2	110.1	88	26	24.4	25.8	181.3	111.3	125.2	56	66.3	24.8	68.2	9.4	53	49	89.2	73.5	139.3	673.1	257	69.8	65.9	137.7	140.2	144.8	37.8	54.6	99.7	26.2	36.7	64	78.3	72.4	140.2	53	273.1	22.9	64.3	78.6	55.9	38.9	67.2	135.5	165.5	35.6	56.7	48.8	78.1	85.3	108.9	69.7	228.7	137.9	81.8	73.9	104.2	73.1	86.9	53.5	58	55	116.9	22.3	314.4	54.4	103	25.7	31.4	37.3	54.3	30.8	34	20.6	60.8	41.1	46.4	157.8	35.8	32	32.2	22	19.5											1256.6	1138.7	6703.3	2831.5	2012.7	0	72531.4	10000	1801.4	2082.6	4374	0	0	875.4	1190.4	925.4	1519.1	10706.5	9881.7	3135.3	0	1058.8	2565.3	1330	13675.3	0	0	3018.7	7368.9	9328.1	4287.1	6527.3	2029.2	1420.6	1887.4	12938.3	0	1718	6638.7	3334.2	5210	0	6305.8	2437.5	5090.3	4626.8	1812.2	0	3284.5	11055	4223	Cardiomyocytes
MT-ATP6	ATP6, ATPase-6, MTATP6, RP, Su6m	ENSG00000198899	Mitochondrially encoded ATP synthase membrane subunit 6	P00846	MT	8527-9207	Disease related genes, Predicted membrane proteins	ATP synthesis, Hydrogen ion transport, Ion transport, Transport		Cardiomyopathy, Disease mutation, Leber hereditary optic neuropathy, Leigh syndrome, Neuropathy, Primary mitochondrial disease, Retinitis pigmentosa	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		blood: 419.0;skeletal muscle: 475.3	Cell type enriched	Detected in many	5	Cardiomyocytes: 108059.0	Low cancer specificity	Detected in all							Cell type enhanced	Detected in all		basophil: 419.0	Low lineage specificity	Detected in all			Cell line enhanced	Detected in all		HeLa: 1186.6	Low region specificity	Detected in all																				unprognostic (2.97e-1)	unprognostic (4.16e-1)	unprognostic (1.86e-2)	unprognostic (4.55e-2)	unprognostic (8.45e-3)	unprognostic (1.66e-1)	prognostic favorable (3.79e-4)	unprognostic (6.47e-2)	unprognostic (2.39e-1)	unprognostic (1.44e-2)	prognostic favorable (7.64e-4)	unprognostic (6.01e-2)	unprognostic (4.64e-2)	unprognostic (1.46e-1)	unprognostic (1.37e-1)	unprognostic (3.56e-1)	unprognostic (2.52e-3)	85.2	89.2	126	25.1	159.3	20.1	29.6	45.2	81.2	20.1	60.3			75.6	23.5	30.9	42.8	19.8	24.6	309.5	122.3	90.2	154.4	166.8	18	19.3	102.8		26.5	54.7	36.2	22	34.1		37.6	59.4		66.8	35.6	475.3	62.5	52.6	27.9	61.3	20.7	58.4	27.7			22.4		18.6	23	15.7	110.2	58.9	419	88.2	72.3	90.5	35.3	100.8	166.4	116.2	182.2	221.8	50.9	75.9	148.7	27.1	20.1	34	195.6	110.9	179.7	63.2	80.2	31.2	219.8	12.1	116	37.3	128.3	105.3	157.3	1186.6	338.6	37.7	93.1	203.9	83	102.9	36.1	34.9	141.5	35.7	100.8	103.4	131.1	78.3	284	57.3	247.9	30.5	77.4	68.9	72.2	49.5	110.7	208.9	256	66.4	85.2	53.3	113.7	107.5	199.3	121.6	319.6	188.2	82	121.2	135.4	106.1	58	76.5	124.6	71.6	198.7	45.8	419	88.2	156.1	56.6	66.3	71.6	106	64.7	71.1	47.5	110.2	76.5	90.5	100.1	72.3	67.8	58.9	47.6	35.3											1381.7	1526	11633.9	5315.5	2578.7	0	108059	10741.3	2731.6	2651.3	6092.6	0	0	1593.2	1756.2	808.5	1505.8	13591.3	14997.7	2949.2	0	1371.6	3985.7	1952.8	21340.2	0	0	3847.9	7623.7	10387.2	3622.6	7103.8	2816.3	2404.1	3082.2	11928.5	0	2519.5	9780.9	4668.2	10316.3	0	6202.4	2943.8	6022.8	4841.7	2653	0	6498.2	11027.9	6485.3	Cardiomyocytes
CSAG1	CSAGE, CT24.1	ENSG00000198930	Chondrosarcoma associated gene 1	Q6PB30	X	152727484-152733735	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Group enriched	Detected in some	5	brain: 4.2;lymphoid tissue: 3.3;testis: 6.3	Cell type enriched	Detected in some	6	Spermatogonia: 10.7	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		GAMG: 38.2;HMC-1: 21.2;K-562: 13.5;OE19: 44.1;PC-3: 19.1;U-266/70: 33.6																						unprognostic (2.37e-1)	unprognostic (4.66e-2)		unprognostic (8.96e-3)	unprognostic (4.48e-2)	unprognostic (2.70e-1)	unprognostic (2.83e-3)	unprognostic (5.96e-2)	unprognostic (4.21e-1)	unprognostic (6.68e-3)	unprognostic (3.15e-2)	unprognostic (1.13e-1)	unprognostic (4.07e-6)	unprognostic (5.68e-2)	unprognostic (1.03e-1)	unprognostic (2.32e-3)	unprognostic (8.70e-3)	0.2	0.2	3.3	1.1	4.2	0.2	0.2	1.6	4.1	0.2	0.3	1.5	0	0.2	0.8	0.2	0.2	0.4	0.2	0.2	3.2	1.8	0.3	0.4	0.3	3.3	3	0.9	0.2	0.2	0.2	0	0.3	2	0.4	0.3	0	0.5	0.5	0.2	0.5	0.6	0.7	1.3	0.5	0.4	6.3	2.7	0.1	0.9	0	2.1	0.4	0	0	0	0	0	0	0	0	0	0.5	0	2.7	0	0	0.8	0	0	0	0	0	0	0	0	0	38.2	0	0	0	0	0.1	0	0.7	1	0	0	0	21.2	0	0.1	0	0	0	0	0	13.5	0.1	0	0	0	0	0	44.1	19.1	0	0	0.1	0	0	2.1	11.9	0	7.1	5.6	0	0.3	0	0.1	1.3	0.3	6.9	2.2	33.6	0.5	0	0.2	0	2.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.3	4.2	1.6	4.1	3.2	1.8	3	0.9	2	2.7	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	1.9	10.7	0	0.1	0	0	0.6	Spermatogonia
STUM	C1orf95, DKFZp761P211	ENSG00000203685	Stum, mechanosensory transduction mediator homolog	Q69YW2	1	226548800-226609214	Predicted membrane proteins				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 32.2	Cell type enriched	Detected in some	6	Distal tubular cells: 8.3	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	6	HEL: 25.6	Group enriched	Detected in many	5	amygdala: 137.0;basal ganglia: 92.5;cerebral cortex: 117.9;hippocampal formation: 203.1;thalamus: 84.4	Low region specificity	Detected in many			HPA074381			Approved	Cytosol						Cytosol		HPA074381: AB_2732253	unprognostic (3.23e-3)	unprognostic (1.42e-1)	unprognostic (1.58e-1)	unprognostic (1.94e-1)	unprognostic (4.09e-2)	unprognostic (2.68e-2)	unprognostic (2.64e-2)	unprognostic (1.41e-3)	unprognostic (3.07e-1)	unprognostic (5.15e-2)	unprognostic (7.62e-2)	unprognostic (3.28e-2)	prognostic favorable (6.40e-4)	unprognostic (1.14e-2)	unprognostic (9.04e-2)	unprognostic (5.89e-2)	unprognostic (1.79e-3)	2.8	2.2	30.4	2.1	16.2	0.6	3.5	2.4	32.2	3.7	8.1	6.3	0	2.8	3.7	3	8.9	3.1	1.6	2.5	21.8	7	5.8	0.7	1.2	0.9	6.8	15.9	2.7	1	1.9	4.2	1.2	18.2	6.2	3.7	1.4	2	2.4	5	3.7	3.5	8.7	3	1.8	1.8	2	7.4	0	0.8	0.4	1	5.5	2.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0.2	0.3	0	0	4.2	0.3	25.6	0	0	0	0	0.3	0.7	0	0	0	0	0	0.2	0	0	0	0	0	0	0.1	0	0	0.8	0	0.3	0.2	0	3.9	0	0	0	0.6	0.1	0	0.1	0	0	0.1	0	0	0.4	0	0.1	4.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	30.4	16.2	2.4	30	21.8	7	6.8	15.9	18.2	7.4	0	0	0	0	0	0	0	0	0	0	0	0	0	8.3	0	0	0	0	0	0.2	0.2	0	0	0	0	1.4	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0.4	0	0	0	0	0	0	0.1	0	0	0	Distal tubular cells
TCP10		ENSG00000203690	T-complex 10	Q12799	6	167357031-167384510	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level		Tissue enriched	Detected in some	11	testis: 16.8	Cell type enriched	Detected in some	4	Spermatocytes: 50.1	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	7	NTERA-2: 2.5;SCLC-21H: 1.9									HPA044709, HPA078219	Enhanced											HPA044709: AB_10961410, HPA078219: 			unprognostic (8.33e-2)				unprognostic (1.52e-1)			unprognostic (2.27e-1)				unprognostic (7.79e-2)				0	0	0	0	0	0	0	0	0	0	0.2			0.5	0	0	0	0	0	0	0	0	0	0	0	0	0		0	0	0	0	0		0	0.1		0	0	0	0	1.5	0	0	0	0.1	16.8			0		0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.5	0.3	0	0	0	0	0	0	1.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0	0	0.8	0	0	0	0	0	0	0	0	12	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	11.3	0.6	0	0	0	0.2	0	0	0	0	0	0	6.5	0	50.1	0.4	0	0	0	0.2	0	Spermatocytes
ECT2L	ARHGEF32, C6orf91, FBXO49, LFDH	ENSG00000203734	Epithelial cell transforming 2 like	Q008S8	6	138795926-138904070	Predicted intracellular proteins		Guanine-nucleotide releasing factor		Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Group enriched	Detected in many	4	brain: 8.1;epididymis: 7.7;fallopian tube: 18.5;lung: 12.2;ovary: 9.4	Cell type enriched	Detected in some	6	Ciliated cells: 133.8	Not detected	Not detected			Region enriched	Detected in many	7	pons and medulla: 8.1	Low cell type specificity	Detected in single			Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		HEL: 2.8;SCLC-21H: 2.9	Low region specificity	Detected in single			Low region specificity	Detected in many			HPA035488	Uncertain											HPA035488: AB_10672865	unprognostic (2.88e-2)	unprognostic (7.88e-2)	unprognostic (2.52e-2)	unprognostic (5.53e-3)	unprognostic (3.48e-2)	unprognostic (8.45e-3)	unprognostic (9.42e-2)	unprognostic (2.44e-2)	unprognostic (1.18e-1)	unprognostic (7.03e-2)	unprognostic (5.90e-4)	unprognostic (2.32e-1)	unprognostic (5.21e-2)	unprognostic (1.38e-2)	unprognostic (7.27e-2)	unprognostic (7.07e-3)	unprognostic (2.65e-3)	0.5	0.3	0.7	0.2	1.1	0.5	0.4	0.8	0.7	1.1	0.3	4.2	0	0.2	0.6	7.7	1	18.5	1.7	2.7	1.1	1.1	0.1	0.2	12.2	0.2	0.3	0	9.4	0.1	0.3	1.8	0.2	8.1	0.3	0.1	0.8	0.6	0.2	0.5	0.7	0.6	1.6	0.3	0.3	0.3	1.2	0.8	0	0.4	0	0.1	0.8	0.3	0.6	0.3	1.7	0.6	0.7	0.8	0	0.2	0.1	0.2	0.8	0	0.5	1.2	0	0	0.1	0.1	0.8	0.8	0.8	0.3	0	0.3	0.3	0	0	0.9	0.2	0.5	2.8	0.2	0	0.1	0.9	0.4	1.3	1	0	0	0.6	0	0.2	0.2	0.9	0	0.3	0.6	1	0.6	0.2	0.6	0.5	0.3	0.2	0	0.7	2.9	0.7	0.2	0.8	0.4	0.5	0.3	1.2	0	0.6	0.3	0.8	0.3	0.4	0.2	0.3	0.4	0.8	0.2	1.7	0.3	0.6	0.3	0.3	0.4	0.3	0.2	0.7	0.1	0.6	0.7	0.8	0.6	0.7	0.6	0.3	0.2	0	0.7	1.1	0.8	0.7	1.1	1.1	0.3	0	8.1	0.8	0	0.6	0	0.5	0.5	2.2	1.2	0	133.8	21.6	0	2	0.1	0	0	4.1	0	0	0	0	0	0	0.2	0	0	0.1	0	0	0	0	3.6	0	0	0	0	0	2.2	0	0	0	0	3.1	0	0	0.5	0.1	0	0.2	0	0	0.3	Ciliated cells
LOR		ENSG00000203782	Loricrin	P23490	1	153259700-153262122	Disease related genes, Predicted intracellular proteins	Keratinization		Ichthyosis, Palmoplantar keratoderma	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	6	skin 1: 181.8	Cell type enriched	Detected in some	7	Suprabasal keratinocytes: 164.2	Cancer enriched	Detected in some	11	melanoma: 45.5	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	89	HDLM-2: 28.2									HPA076123, HPA077266	Enhanced											HPA076123: AB_2732302, HPA077266: AB_2732338	unprognostic (1.97e-2)	unprognostic (1.93e-2)			unprognostic (4.16e-2)	prognostic favorable (8.53e-4)		unprognostic (1.65e-1)	unprognostic (2.69e-1)	unprognostic (1.61e-1)	unprognostic (3.41e-1)			unprognostic (1.47e-1)	unprognostic (3.03e-1)		unprognostic (1.02e-2)	0.1	0	0.1	0.1	0.1	0	6.4	0.1	0.1	0.7	0.1	0.1	0.1	0	0.9	0.1	0.3	0	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	2.3	181.8	0.1	0.1	0.1	0.1	0	0.1	0.1	15.7	0.1	31.2	2	0.1	2.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	28.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	0	0	5	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0.1	0	0	0	0.1	0	0	0	0	0	0	0	8.5	22.6	0	0	0	0	0	0	0	0	0.7	0	0.1	164.2	0	0	0	0	Suprabasal keratinocytes
LELP1		ENSG00000203784	Late cornified envelope like proline rich 1	Q5T871	1	153203443-153205120	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	No human protein/transcript evidence	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	65	testis: 147.4	Cell type enriched	Detected in some	5	Late spermatids: 16141.9	Cancer enriched	Detected in single	10	testis cancer: 0.9	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in single		BEWO: 1.6									HPA070231	Enhanced											HPA070231: AB_2686237															unprognostic (1.77e-1)			0	0	0	0	0	0	0	0	0.1	0	0	0	0.4	0	0	2.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	147.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3232.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16141.9	82.3	0	0	0	0	0	0	0	83.8	0	0	45.3	0	103.7	46.9	0	0	0	0	0	Late spermatids
SPRR2E		ENSG00000203785	Small proline rich protein 2E	P22531	1	153093135-153106184	Predicted intracellular proteins	Keratinization			Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in some		esophagus: 210.2;skin 1: 94.0;tongue: 291.9	Cell type enriched	Detected in some	22	Suprabasal keratinocytes: 38.1	Cancer enhanced	Detected in many		head and neck cancer: 612.7	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	11	hTCEpi: 19.7																							unprognostic (2.27e-1)				unprognostic (3.86e-2)		unprognostic (5.04e-2)	unprognostic (3.40e-1)								prognostic unfavorable (9.47e-4)	0.3	0	0.3	0.3	0.3	0	5.7	0.3	0.3	25.9	0.3	0.3	0.3	0	0.6	0.3	210.2	0	0.3	0.3	0.3	0	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0	0.3	0.3	0.3	0.3	0	0.3	26.8	0.3	0.3	94	0.3	0.3	0.3	0.3	0	0.3	0.3	0.4	0.3	291.9	54.7	0.3	38.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0	1.7	0	0	0	0	0	0.1	0	0	0	0.4	0	0	19.7	0	0.3	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0.1	0	0	0	0	0	1	0	0	0	0	0	0	0.1	0	0.3	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0.3	0.3	0.3	0.3	0	0.3	0.3	0.3	0.3	0	0	0	0	1.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	1.7	0	0	0	0	0	0	0	0	0	0	0	0	38.1	0	0	0	0	Suprabasal keratinocytes
KPRP	C1orf45	ENSG00000203786	Keratinocyte proline rich protein	Q5T749	1	152759561-152762052	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	15	skin 1: 72.4	Cell type enriched	Detected in some	10	Suprabasal keratinocytes: 17.6	Group enriched	Detected in some	22	head and neck cancer: 6.9;melanoma: 13.6					Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		BJ hTERT+: 2.0;hTEC/SVTERT24-B: 5.8;LHCN-M2: 1.9;U-2197: 3.5;U-87 MG: 2.5	Not detected	Not detected			Not detected	Not detected			HPA031988, HPA031990	Enhanced								2700000			HPA031988: AB_10671582, HPA031990: AB_2674102		unprognostic (1.03e-1)				unprognostic (2.67e-2)			unprognostic (1.22e-1)								unprognostic (1.03e-1)	0	0	0	0	0	0	3.6	0	0	3.2	0			0	0	0	4.7	0	0	0	0	0	0	0	0	0	0		0	0	0	0	0		0	0		0.9	0	0.3	72.4	0	0	0	0	0	0			0		1.1	0	1.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0.7	0	0	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0.6	5.8	0.9	0	0	0	0	0.1	1.9	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	3.5	0	0	0	0	2.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.7	0	0	0	0	0	0	0	0	0	0	0	0	17.6	0	0	0	0	Suprabasal keratinocytes
FAM24A	AC073585.4	ENSG00000203795	Family with sequence similarity 24 member A	A6NFZ4	10	122910701-122913111	Predicted intracellular proteins, Predicted secreted proteins				Evidence at protein level	Evidence at protein level	No human protein/transcript evidence	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	95	testis: 20.9	Cell type enriched	Detected in some	17	Early spermatids: 125.3	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HMC-1: 1.9;LHCN-M2: 1.2									HPA052490	Supported				Secreted in male reproductive system							HPA052490: AB_2681851																		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	20.9	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0.8	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.9	0	0	0	0	0	0	0	0.7	0.7	1.2	0	0	0.5	0.6	0.6	0	0.5	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0.3	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	125.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	7.3	0.6	0	0	0	0	0	0	0	1.4	0	0	0	0	1.4	0.9	0	0	0	0	0	Early spermatids
RBM20		ENSG00000203867	RNA binding motif protein 20	Q5T481	10	110644397-110839469	Disease related genes, Predicted intracellular proteins	mRNA processing, mRNA splicing	RNA-binding	Cardiomyopathy, Disease mutation	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		heart muscle: 45.9;skeletal muscle: 20.9	Cell type enriched	Detected in some	8	Cardiomyocytes: 137.1	Low cancer specificity	Detected in some			Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HEK 293: 5.7;HEL: 4.8;K-562: 4.6;RH-30: 15.7;SH-SY5Y: 14.6;SuSa: 5.0;T-47d: 8.8	Region enhanced	Detected in some		olfactory region: 4.6	Not detected	Not detected			HPA035806, HPA070358	Approved		Approved	Nucleoplasm,Nucleoli,Golgi apparatus		Yes	No			Nucleoplasm, Nucleoli, Golgi apparatus		HPA035806: AB_10672097, HPA070358: 	unprognostic (2.43e-1)	unprognostic (8.24e-3)	unprognostic (5.81e-2)	unprognostic (1.27e-2)	unprognostic (1.03e-1)	unprognostic (2.03e-2)	unprognostic (2.75e-2)	unprognostic (5.47e-3)	unprognostic (1.33e-1)	unprognostic (2.78e-2)	unprognostic (4.14e-3)	unprognostic (1.44e-1)	unprognostic (2.39e-3)	unprognostic (3.34e-1)	unprognostic (3.35e-2)	unprognostic (1.20e-1)	unprognostic (6.46e-2)	1.7	0.1	0.4	0.6	1.9	0.1	2.2	0.5	1.5	0.9	2.6	1.3	0	0.2	2.5	7.5	3.6	1.9	2.3	45.9	0.6	0.2	1.1	0.1	0.5	0.1	0.3	1.3	2.4	13.7	0.9	1.2	1.4	1.4	1	0.5	4.3	6.3	0.7	20.9	0.7	1	2.1	0.6	0.1	0.6	0.9	1.4	0	0.7	3.4	0.5	1.8	3.2	0.1	0.2	0	0	0	0.5	0	0	1.5	0.5	0.4	0	0	0	0	0	0	0	0.1	0	0	0	0	2.1	0.1	0.1	0	0	2.3	5.7	4.8	0	0	0	0	0.6	0.1	0	0	0	0	0	0	4.6	0	0.2	0	0	0	0.4	0	1.4	0	15.7	0	0	0	0.1	14.6	0.1	0	0.6	5	8.8	0	0	0.3	0.5	0	0	0.4	0.1	0.1	0	0	1	0	0	0	0	0	0.3	0	0	0	0	0.1	0.5	0.2	0	0	0	0.2	0	0	0.4	1.9	0.5	1.5	0.6	0.2	0.3	1.3	1.4	1.4	0	0	0	0.2	0.1	1.3	137.1	0	17.4	0	0	2	1	1.7	0	0.7	0.6	0.4	0	0.2	0.1	0.2	0	0	0	0.1	0	0	1.8	0	0.4	4	0	0	0	0.4	0	0	0	12.7	1.4	2.3	6.5	1.9	0	0.5	0	2.6	0	0	0.1	Cardiomyocytes
LIME1	dJ583P15.4, FLJ20406, LIME	ENSG00000203896	Lck interacting transmembrane adaptor 1	Q9H400	20	63736283-63739103	Predicted intracellular proteins	Adaptive immunity, Immunity			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	4	blood: 87.5;liver: 43.7;lymphoid tissue: 80.4	Cell type enriched	Detected in single	11	Hepatocytes: 2.6	Low cancer specificity	Detected in all			Low region specificity	Detected in many			Group enriched	Detected in many	6	gdT-cell: 39.4;MAIT T-cell: 35.4;memory CD4 T-cell: 54.9;memory CD8 T-cell: 51.2;naive CD4 T-cell: 37.5;naive CD8 T-cell: 40.6;plasmacytoid DC: 87.5;T-reg: 77.8	Group enriched	Detected in many	9	dendritic cells: 87.5;T-cells: 77.8	Cell line enhanced	Detected in some		Karpas-707: 13.4;MOLT-4: 14.0;RPMI-8226: 51.4;U-266/70: 27.8									CAB015363	Approved				Intracellular and membrane							CAB015363: AB_629890	unprognostic (1.16e-1)	unprognostic (2.35e-1)	unprognostic (5.95e-3)	unprognostic (3.01e-1)	unprognostic (1.34e-1)	unprognostic (3.85e-3)	unprognostic (3.06e-2)	unprognostic (1.46e-1)	unprognostic (1.36e-1)	unprognostic (1.94e-1)	unprognostic (1.05e-3)	unprognostic (1.51e-3)	prognostic unfavorable (5.04e-5)	unprognostic (2.39e-2)	unprognostic (4.25e-2)	unprognostic (1.67e-1)	prognostic favorable (6.92e-6)	1.9	0.6	2.1	17.9	4.9	4	0.7	4.4	2.1	2	5.2	0.4	0.5	2.2	0.9	0.3	4.2	0.7	8.4	0.8	2	1.8	13.6	43.7	5	20.3	1.4	1.1	1.2	0.5	0.4	1.8	0.6	0.4	2.3	0.6	1.1	9.9	0.7	0.9	4.9	3.7	0.7	1.7	10	16.9	0.7	0.5	80.4	1.6	2.4	22.8	2.5	1.1	9.6	87.5	1.3	0.1	9.2	77.8	22.3	0.7	0.2	0	0.1	0	0	1.8	0.9	0	0.1	0	0.4	0.8	2.2	1.4	0	0	1.9	0	0.1	0.1	0.9	1.7	0.4	0.7	8.6	0	0.6	0.8	0.1	0.2	0	0	0	0	6.4	0.8	13.4	0	0.4	14	3.8	0.7	0.6	2.4	9.7	0.3	51.4	0.2	0.1	0.7	1.1	0.5	0.5	1	0	0.4	0.3	0.2	0.7	1	0.7	0.5	27.8	1	4.4	0.6	0.4	0.2	0.1	0.1	0.2	39.4	0.1	35.4	9.6	54.9	51.2	0.2	3.7	37.5	40.6	1.3	9.2	0.1	87.5	77.8	22.3	2.1	4.9	4.4	2.1	2	1.8	1.4	1.1	0.4	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0.1	0	0	0.1	0	Hepatocytes
C1orf146		ENSG00000203910	Chromosome 1 open reading frame 146	Q5VVC0	1	92217940-92245813	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enriched	Detected in some	5	testis: 12.7	Cell type enriched	Detected in some	8	Spermatocytes: 58.0	Not detected	Not detected			Not detected	Not detected			Cell type enhanced	Detected in single		neutrophil: 2.6	Low lineage specificity	Detected in single			Low cell line specificity	Detected in some			Not detected	Not detected																				unprognostic (2.89e-2)	unprognostic (4.26e-3)	unprognostic (1.81e-1)	unprognostic (5.37e-3)	unprognostic (8.77e-2)	unprognostic (1.50e-2)	unprognostic (1.38e-1)	unprognostic (1.02e-1)	unprognostic (1.89e-3)	unprognostic (1.90e-1)	unprognostic (7.13e-2)	unprognostic (4.17e-2)	unprognostic (2.78e-7)	unprognostic (3.36e-2)	unprognostic (6.76e-2)	unprognostic (3.17e-1)	unprognostic (5.19e-3)	0.1	0	0.1	0.4	0.2	0.1	0.1	0.5	0.4	0.1	0.1	0.1	0.1	0	0.1	0.3	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.4	0.1	0.1	0.3	1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.2	0.1	0.1	1.2	0.1	0.1	0.1	0.1	0.1	12.7	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.5	0.5	2.6	0.1	0.7	0.5	0	0.4	0	0.9	2.3	0	0.5	1.1	0.3	0	0.6	0.7	0	1.2	2.1	0.3	0	0.1	0.8	0.3	0	0	0.5	1	0.9	0.7	0	0	0.7	1.9	0.5	0.3	0.9	0	0.6	0.3	1.7	0	0.8	0	1.3	1.1	1.7	0.7	0.1	0	0.6	0.2	0.3	0	1.6	0.7	0.1	0.4	1.2	0	1.4	0.2	1.2	1	1.2	0.9	1	0.9	1.9	0.4	0.9	0.5	1	0.5	0.2	0.1	0.1	0.5	0	0.1	0.1	0.2	0.4	0.1	0.5	0.3	0.2	2.6	0.7	0.1	0.5	0	0	0.1	0.2	0.5	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	1.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	1.4	0	0	0	0	0	0	0	0	0	0	0	0	58	7.5	0	0	0	0	0	Spermatocytes
CXorf66	RP11-35F15.2, SGPX	ENSG00000203933	Chromosome X open reading frame 66	Q5JRM2	X	139955725-139965520	Predicted membrane proteins				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	21	testis: 17.8	Cell type enriched	Detected in some	12	Early spermatids: 95.0	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected																														unprognostic (3.87e-2)											0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	95	0	0	0	0	0	0	0	0	0	0	0	0	0	0	7.8	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0.7	0.2	0	0	0	0	0	Early spermatids
C10orf62	bA548K23.1	ENSG00000203942	Chromosome 10 open reading frame 62	Q5T681	10	97589727-97590934	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	60	testis: 81.1	Cell type enriched	Detected in some	5	Late spermatids: 7737.3	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		AN3-CA: 2.3;Hep G2: 2.9;T-47d: 2.1									HPA072947	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol						Cytosol	Nucleoplasm, Vesicles	HPA072947: AB_2686562		unprognostic (3.66e-2)		unprognostic (3.97e-2)	unprognostic (2.81e-1)		unprognostic (5.36e-2)		unprognostic (3.62e-1)	unprognostic (1.20e-1)	unprognostic (3.63e-2)		unprognostic (2.53e-2)	unprognostic (2.04e-2)				0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	1.3	0	0	0	0.1	0	0	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	81.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	2.3	0	0	0.6	0	0.2	0	0	0.4	0.1	0	0.8	0	0.4	0.1	0	0.3	0	0	0.3	0	0.5	2.9	0	0	0	0.4	0	0.2	0	0	0.2	0	0	0	0	0	0	0.5	0	0	0	0	0.2	0	0.2	0.2	0	0.2	0	0	0	0.1	2.1	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	1574.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	7737.3	36.5	0	0	0	0	0	0	0	35	0.3	0	6.5	0	33.1	18.8	0	0	0	0	0	Late spermatids
LDLRAD1		ENSG00000203985	Low density lipoprotein receptor class A domain containing 1	Q5T700	1	54007299-54018186	Predicted intracellular proteins, Predicted membrane proteins		Receptor		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	7	fallopian tube: 64.2;lung: 16.1;ovary: 20.5	Cell type enriched	Detected in some	15	Ciliated cells: 499.2	Cancer enhanced	Detected in many		endometrial cancer: 5.7	Not detected	Not detected			Low cell type specificity	Detected in some			Low lineage specificity	Detected in single			Group enriched	Detected in some	5	CAPAN-2: 3.7;Hep G2: 15.0	Not detected	Not detected			Not detected	Not detected			HPA052489	Enhanced		Uncertain	Nucleoplasm,Golgi apparatus						Nucleoplasm	Golgi apparatus	HPA052489: AB_2681850	unprognostic (6.53e-3)	unprognostic (2.05e-2)	unprognostic (2.51e-1)	prognostic favorable (9.21e-4)		unprognostic (1.59e-2)	unprognostic (1.67e-1)	unprognostic (1.97e-1)		unprognostic (1.32e-1)	unprognostic (8.07e-3)	unprognostic (2.43e-1)		unprognostic (2.86e-1)	unprognostic (5.23e-1)		unprognostic (4.27e-2)	0	1.1	0	0	0	0	0.2	0	0	2.6	0.1	0.1	0	0	0.6	2.1	0.4	64.2	1.1	0	0	0	0	0	16.1	0	0	0	20.5	0.1	0	1.5	0.1	0.2	0.5	0	0	2.7	0	0	0.1	0.1	0	0	0	0.8	1.1	0	0	0	0.8	4.8	0	0	0.7	0.5	2.1	0.4	0.4	0.5	0	0.2	0	0	0	0	0	0.2	0.1	0	0	0.2	0.1	3.7	0	1.9	0	0.1	0.6	0	0.1	0	0	0.1	0.3	0.8	15	0	0.1	0.1	0	0	0	0	0.1	0	0.1	0.1	1	0	0.3	0.1	0.1	0	0.1	0	0.1	0	0.2	0.1	0.6	0.3	0	0.1	1	0	0.1	0.8	0.1	0	0.3	0.2	0.1	0.1	0.4	0	0.1	0.3	0	0.2	2.1	0.4	0.3	0.4	0.2	0.3	0.5	0.3	0.4	0.1	0.7	0.4	0.5	2.1	0.4	0.2	0.5	0.2	0	0	0	0	0	0	0	0	0	0.2	0	6	7.4	0	0.2	0	0	0	0	499.2	34.2	0	0	0	0	0.2	0	0	0	0	0.2	0	0	3.6	4.7	0	0.1	0	20.1	0	0	0	0	0	0	0	0.2	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0.3	Ciliated cells
RHOXF2B		ENSG00000203989	Rhox homeobox family member 2B	P0C7M4	X	120070672-120077705	Predicted intracellular proteins, Transcription factors		DNA-binding		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Group enriched	Detected in some	6	blood: 2.6;testis: 9.4	Cell type enriched	Detected in single	20	Spermatogonia: 2.0	Not detected	Not detected							Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Group enriched	Detected in some	348	HL-60: 47.1;K-562: 47.2;NB-4: 76.4									HPA003314	Supported		Approved	Nucleoplasm,Plasma membrane						Plasma membrane	Nucleoplasm	HPA003314: AB_1855193																		0	0	0	0	0	0.1	0	0	0	0	0			0	0	0	0	0.1	0	0	0	0	0	0.2	0	0	0		0.3	0	0	0	0		0	0		0	0	0.9	0.3	0	0	0	0.2	0	9.4			0		0	0	0	1	1.6	2.6	1.3	1.7	1	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	47.1	0	0	0	0	0	0	0	0	47.2	0	0	0	0	76.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0	0	0	0	0	0.1	0	0	0	0	2.6	0.7	0.8	0.5	0.9	1	0.7	0.5	0.7	0.7	1	0.7	0.7	1.4	1.7	1.3	1.6	0.5	0.2											0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2	0	0	0	0	0	Spermatogonia
C1orf185	FLJ27485	ENSG00000204006	Chromosome 1 open reading frame 185	Q5T7R7	1	51102234-51148086	Predicted intracellular proteins, Predicted membrane proteins				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	63	testis: 23.8	Cell type enriched	Detected in some	14	Early spermatids: 474.9	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		LHCN-M2: 1.1;THP-1: 1.2					Not detected	Not detected																																	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	23.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0	1.1	0	0.6	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	474.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	33.4	4.4	0	0	0	0	0	0	0	3.2	0	0	0	0	3	1.8	0	0	0	0	0	Early spermatids
IFIT1B	bA149I23.6, IFIT1L	ENSG00000204010	Interferon induced protein with tetratricopeptide repeats 1B	Q5T764	10	89378056-89385205	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Group enriched	Detected in some	4	bone marrow: 23.2;placenta: 14.6	Cell type enriched	Detected in single	1635	Erythroid cells: 163.5	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		BJ hTERT+ SV40 Large T+: 2.1;BJ hTERT+ SV40 Large T+ RasG12V: 1.7									HPA062924	Approved											HPA062924: AB_2684906	unprognostic (2.59e-1)	unprognostic (3.13e-1)			unprognostic (6.62e-3)	unprognostic (4.55e-2)			unprognostic (4.11e-2)	unprognostic (9.34e-2)			unprognostic (1.76e-1)	unprognostic (6.86e-2)				0.4	0	0.2	0	0.2	23.2	0	0	0.1	0.2	0	0.2	0	0	0	0.5	0	0.1	0	0.2	0.3	0.1	0.2	0.5	4	0	0.2	0	0	0	0	0.2	14.6	0.2	0	0	0.2	0	0	0	0	0	0	0.7	4.6	0	0.1	0	0.7	0.2	0	0	0.6	0	0.2	0	0.9	0.2	0	0.1	2.4	0	0	0.1	0.2	0	0	0	0	0	2.1	1.7	0	0.1	0	0.2	0	0.3	0.2	0	0	0.2	0	0	0.2	0	0	0	0	0	0.3	0	0.4	0.3	0	0	0	0	0	0.2	0	0	0.4	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0.1	0	0	0.1	0.5	0	0	0.1	0.1	0	0.1	0	0	0	0	0	0.2	0.1	0	0.9	0	0.2	0	0	2.4	0.2	0.2	0	0.1	0.3	0.1	0.2	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	163.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Erythroid cells
LIPJ	bA425M17.2, LIPL1	ENSG00000204022	Lipase family member J	Q5W064	10	88586753-88606976	Predicted intracellular proteins	Lipid degradation, Lipid metabolism	Hydrolase		Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enriched	Detected in some	7	testis: 11.5	Cell type enriched	Detected in some	6	Early spermatids: 32.3	Not detected	Not detected							Cell type enhanced	Detected in single		eosinophil: 1.0	Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		Karpas-707: 2.7;NB-4: 1.0;SK-MEL-30: 2.4;U-2197: 1.0									HPA048594	Uncertain		Approved	Plasma membrane						Plasma membrane		HPA048594: AB_2680456	unprognostic (4.79e-3)	unprognostic (6.77e-2)	unprognostic (4.80e-2)	unprognostic (2.36e-1)	unprognostic (2.70e-2)	unprognostic (9.33e-2)	unprognostic (2.90e-3)	unprognostic (7.50e-2)	unprognostic (1.65e-1)	unprognostic (1.09e-1)	unprognostic (4.73e-2)	unprognostic (1.73e-2)	unprognostic (6.21e-4)	unprognostic (9.87e-2)	unprognostic (9.57e-2)	unprognostic (1.85e-1)	unprognostic (1.88e-1)	0.2	0	0.3	0	0.3	0	0.2	1	0.3	0.1	0			0.4	0.2	1.6	0	1.1	0.1	0.1	0.4	0.5	0.2	0.7	0	0.3	0		0.1	0.6	0	0.1	0		0.3	0.2		0.6	0	0.4	0.1	0.1	0.3	0.1	0.1	0.3	11.5			0.9		0.4	0.5	0.1	0.7	0	1	0.1	0.5	0.2	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0.4	0.8	0	0	0.5	0	0	0	0	0	0	0	0	0	0.2	0	0	2.7	0	0	0	1	0	0	0	0	0	0	0	0	0.6	0	0	0	2.4	0	0	0.8	0	0.1	0.7	1	0.1	0.1	0	0	0	0.3	0	0	0.1	1	0.2	0	0	0.1	0	0	0	0.7	0.1	0	0	0.5	0	0	0	0											0	0	0	0.1	0	0	0.5	0	0	0	0	0	0	1.7	0	32.3	0	0	0	0	0	0	0	0	0	0.1	0	0	0	1.2	5.8	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0.7	0.2	0	0	0	0	0	Early spermatids
LRRC73	C6orf154, dJ337H4.2	ENSG00000204052	Leucine rich repeat containing 73	Q5JTD7	6	43506969-43510686	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 23.5;testis: 31.6	Cell type enriched	Detected in many	7	Early spermatids: 299.6	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Cell type enriched	Detected in single	12	naive B-cell: 1.2	Lineage enriched	Detected in single	12	B-cells: 1.2	Cell line enhanced	Detected in some		AN3-CA: 5.7;MCF7: 5.7;OE19: 8.0;T-47d: 5.8	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA046698	Enhanced		Approved	Cytosol						Cytosol		HPA046698: AB_10959526	unprognostic (3.23e-2)	unprognostic (1.03e-1)	unprognostic (2.13e-1)	unprognostic (4.42e-3)	unprognostic (1.04e-2)	unprognostic (3.52e-1)	unprognostic (6.08e-3)	unprognostic (1.19e-1)	unprognostic (2.25e-1)	unprognostic (1.01e-1)	unprognostic (2.24e-2)	unprognostic (1.93e-1)	unprognostic (1.81e-1)	unprognostic (2.72e-1)	unprognostic (1.46e-1)	unprognostic (1.76e-3)	unprognostic (1.89e-2)	1.2	6.1	10.4	0.9	19.4	0.8	1.1	2.3	23.5	1.4	1.3	2.3	0.9	2.1	1.4	1.5	1	11.3	1.8	1.8	8.9	5.2	3	1.2	1.6	0.9	3.1	12.1	2	2.8	7.5	4.1	1.2	6.2	1.9	1.1	0.6	1.4	2.1	1	1.1	1.2	1.5	1.1	1.2	1.8	31.6	1.8	0	1.6	0	0.9	1.4	0.5	1.2	0	0	0	0	0	0	0.5	1.3	0.8	5.7	0.9	2.9	0.2	0.2	1.6	0.5	0.3	0	0.3	0.2	0.1	1	0.8	2.2	0.7	0.7	0	0.1	0.9	0	0.4	0.2	0.9	0	0.1	0.5	1.1	1.8	0.3	2.8	0.1	0.3	0.3	0.5	1	5.7	0	0	0.1	8	0.7	0	0	0.1	1.5	0	2.1	2.5	0.5	0.4	0.2	0	5.8	0	0.2	0.4	0.6	2.1	0.2	0.5	0.3	0.2	0.8	0.2	0	0	0	0	0	0	0	0	0	0	0	1.2	0	0	0	0	0	0	0	0	10.4	19.4	2.3	23.5	8.9	5.2	3.1	12.1	6.2	1.8	0	0	0	2.4	0.3	4.9	0.8	0	8.1	2.3	3.5	0	0.1	6.6	0.6	299.6	0.1	1.3	0	0.7	0.1	0.6	2.3	0	0.4	0.1	27	5.2	0	0	27.3	4	0	1.7	0	2	8.3	0.2	0	3.9	5.1	6.6	6.5	1.1	41.7	9.7	0	0.2	0	0.6	0.6	Early spermatids
AGAP9	bA301J7.2, CTGLF6, FLJ00312	ENSG00000204172	ArfGAP with GTPase domain, ankyrin repeat and PH domain 9	Q5VTM2	10	47501854-47523638	Predicted intracellular proteins		GTPase activation		Evidence at transcript level	Evidence at transcript level	No human protein/transcript evidence	Evidence at transcript level		Low tissue specificity	Detected in all			Cell type enriched	Detected in many	5	Early spermatids: 82.5	Low cancer specificity	Detected in all							Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Low cell line specificity	Detected in many											HPA042490	Uncertain											HPA042490: AB_2678022	unprognostic (6.26e-2)	unprognostic (5.74e-2)	prognostic unfavorable (9.98e-5)	unprognostic (1.85e-1)	unprognostic (6.80e-2)	unprognostic (9.89e-4)	unprognostic (1.13e-2)	unprognostic (3.71e-2)	unprognostic (1.13e-1)	unprognostic (5.85e-2)	unprognostic (4.51e-2)	unprognostic (2.14e-2)	prognostic unfavorable (3.02e-5)	unprognostic (9.44e-2)	unprognostic (3.42e-2)	unprognostic (2.70e-3)	prognostic favorable (7.04e-4)	2.5	2.5	2.2	2.9	2.8	5	4.6	5.2	2.5	2.8	2.5			10.7	2.6	5.1	2.7	2.5	3.6	2.2	2.9	2.9	4.9	9.7	3.2	3.1	2.9		5	7.8	2.5	6.1	1		3.9	2.3		5.2	3.3	5.8	14.4	8.7	2.1	3.2	3.2	5.7	6.3			4.3		1.7	2.6	3	0.3	1.2	0.7	1.2	1	1.3	0.4	4.1	6.4	5.7	5.8	5.2	4.6	6.7	4.1	1.8	2	1.5	7.6	6.9	0.9	5.1	2.9	1.2	12.6	2.2	3.1	1.5	8.1	12.1	2.4	2.3	8.9	4.5	9	7.5	3.2	6	5.4	14.1	2.2	1	0.5	3.8	3.5	1.4	7.1	1.5	11.4	3	2.9	1.2	3.1	3.1	2.6	4.3	4.7	0.8	4.1	3.4	6.9	0.8	5.7	9.1	4.6	5.4	4.3	6.9	5.2	7.4	4.5	3.2	4	4.2	9.5	1.7	0.7	1.2	0	1.3	0.2	0.3	0	1	0.2	0.2	0.3	0.5	0.2	0	1	0.5	1.2	0	0.4											3	6.9	0	1.5	0	6.3	1.8	10.2	12	5.7	10.4	17.7	2.2	1.7	1.1	82.5	1.8	0	0	1.8	0.6	1	2.1	7	6.7	1.8	11.1	1.2	2.5	0.6	15.9	3.1	1.2	0	1	1.5	5.5	3.8	0	5.6	0.6	9.2	0	0.3	7.1	4.1	0	0.8	0	1.6	1.7	Early spermatids
C6orf10	TSBP	ENSG00000204296	Chromosome 6 open reading frame 10	Q5SRN2	6	32288526-32371912	Predicted intracellular proteins, Predicted membrane proteins				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	40	testis: 28.6	Cell type enriched	Detected in some	12	Early spermatids: 313.8	Cancer enhanced	Detected in single		testis cancer: 0.6	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		SuSa: 1.1;U-2197: 1.3									HPA047479			Approved	Cytosol						Cytosol		HPA047479: 	unprognostic (1.00e-1)	unprognostic (2.24e-1)				unprognostic (1.05e-1)		unprognostic (5.63e-2)	unprognostic (2.86e-2)	unprognostic (2.14e-1)		unprognostic (1.55e-1)	unprognostic (4.32e-4)	unprognostic (2.42e-1)	unprognostic (8.19e-2)	unprognostic (6.56e-2)		0	0.2	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.5	0	0.1	0	0	0	0	0	0	0	0.2	0	0	0.1	0	0	0	0	0	0	0	0	0.7	0	0	0.1	0	0	0	0	0	28.6	0	0	0	0	0	0	0	0.4	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.1	0	0	0	0	0.4	1.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0.1	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	313.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	26.8	2.6	0	0	0	0	0	0	0	0	0	0	0	0	1.9	1.1	0	0	0	0	0	Early spermatids
TMEM225	PMP22CD, PPP1R154, SPATA47	ENSG00000204300	Transmembrane protein 225	Q6GV28	11	123882926-123885642	Predicted membrane proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enriched	Detected in single	79	testis: 35.8	Cell type enriched	Detected in some	4	Early spermatids: 78.2	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected																																					unprognostic (3.38e-1)				0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	35.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	78.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.7	2	0	0	0	0	0	0	0	0.4	0	0	0	0	6.9	0.8	0	0	0	0	0	Early spermatids
AGER	RAGE, SCARJ1	ENSG00000204305	Advanced glycosylation end-product specific receptor	Q15109	6	32180968-32184324	Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins	Inflammatory response		Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	8	lung: 178.6	Cell type enriched	Detected in many	18	Alveolar cells type 1: 2224.3	Cancer enhanced	Detected in all		lung cancer: 27.2	Not detected	Not detected			Low cell type specificity	Detected in single			Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		HEK 293: 4.9;JURKAT: 8.1;MCF7: 4.2;RPTEC TERT1: 5.1;U-266/70: 6.1	Low region specificity	Detected in single			Not detected	Not detected			CAB011682, HPA064436, HPA069474	Enhanced		Approved	Nucleoli fibrillar center,Plasma membrane,Cell Junctions	Secreted in other tissues			5360000	140000	Plasma membrane, Cell Junctions	Nucleoli fibrillar center	CAB011682: AB_2258049, HPA064436: AB_2685264, HPA069474: 	unprognostic (9.37e-2)	unprognostic (3.70e-1)	unprognostic (2.37e-2)	unprognostic (1.14e-1)	unprognostic (4.55e-2)	unprognostic (1.59e-3)	unprognostic (4.36e-2)	unprognostic (1.00e-1)	unprognostic (4.38e-2)	unprognostic (1.27e-1)	prognostic favorable (3.41e-4)	unprognostic (1.24e-1)	prognostic unfavorable (9.01e-7)	unprognostic (3.57e-1)	unprognostic (3.70e-2)	unprognostic (4.44e-2)	prognostic favorable (2.74e-6)	0.2	0.3	0.2	0.3	0.2	0.2	0.2	0.9	0.2	0.3	0.3	0.2	0.2	0.2	0.3	0.6	0.4	0.4	0.2	0.2	0.2	0	0.5	0.2	178.6	0.2	0.2	0.2	0.5	0.3	0.1	0.7	0.4	0.4	0.5	0.3	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.2	1	0.2	0.2	0.2	0.2	22.6	0.2	0.2	0.2	0.3	0.7	0.7	1	0.3	0.1	0.5	0.1	0.2	0.2	0	0.6	0.2	1.9	2.7	0.1	0.2	0.1	0.2	0.1	0.4	0.2	2.1	0.5	0	2.2	0.2	1.1	0.3	0.4	4.9	1.3	0.1	0	0	0.6	2.2	0.3	0.3	0.1	0.2	0.3	0.3	8.1	0	0.8	0.2	4.2	0.3	1.5	0	0.2	0	0.1	0.2	0.3	5.1	0.1	0.1	0.5	0.1	0	1.9	0.1	1.2	0.1	0.2	0	1.5	1.5	0.1	6.1	3.2	2.2	2.2	0.5	0.5	0	0.3	0	0.5	0	0.1	0	0.3	0.2	0	0.7	0.4	0.3	1	0.1	0.2	0.7	0	0.1	0.2	0.2	0.9	0.2	0.2	0	0.2	0.2	0.4	0.2	2224.3	120.3	1.7	1.1	0.8	4.8	3.4	5.1	8.1	37.5	1.8	0	0.9	0	1.5	0	2.6	0.5	0	0.8	0.8	1.6	2.3	16.3	1.8	1.2	6.4	0	2.5	9	0.2	1.7	4.9	1.7	2.8	1.4	7.4	0.8	2.9	1.1	0.2	4.1	6.5	1.7	0	0.7	1.6	1.8	5	0.9	0.8	Alveolar cells type 1
ERICH2		ENSG00000204334	Glutamate rich 2	A1L162	2	170783786-170798971	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	9	testis: 61.2	Cell type enriched	Detected in many	8	Early spermatids: 1704.8	Low cancer specificity	Detected in all			Low region specificity	Detected in many			Cell type enhanced	Detected in single		gdT-cell: 2.7	Lineage enriched	Detected in single	28	T-cells: 2.7	Cell line enriched	Detected in many	4	hTCEpi: 36.9					Low region specificity	Detected in all			HPA061010			Approved	Nucleoli fibrillar center,Vesicles						Nucleoli fibrillar center	Vesicles	HPA061010: 	unprognostic (1.02e-1)	unprognostic (1.19e-2)	unprognostic (2.26e-1)	prognostic favorable (9.49e-4)	unprognostic (7.57e-3)	unprognostic (6.61e-2)	unprognostic (9.62e-3)	unprognostic (6.96e-2)	unprognostic (1.05e-1)	unprognostic (2.27e-2)	unprognostic (1.12e-2)	unprognostic (2.83e-1)	prognostic unfavorable (8.98e-7)	unprognostic (1.03e-1)	unprognostic (5.28e-3)	unprognostic (7.35e-2)	unprognostic (2.76e-1)	0.6	0.3	1.4	0.6	1.1	0	1.3	0.6	0.8	2.1	0.6	0.6	0.6	0	1.5	1	0.6	3.3	0.6	0.9	1	1.5	0.9	1.6	4.2	0.6	1.1	0.6	0.6	0.7	0.8	0.6	0.6	0.6	0.6	0	0.6	0.6	0.6	0.6	0.1	0.6	0.6	0.6	0.6	1	61.2	0.6	0.6	6.7	0.6	0.6	0.6	0.6	0	0	0	0	0	2.7	0	5.4	0	0	4.6	0	0	0.2	0	0	0.9	1.9	4.6	1.1	0	0.2	0	2	0.1	1.1	0.4	0	0.7	1.2	2.3	0	0.1	4.8	0.2	0.3	0.7	36.9	0	8.5	0.1	0	0.9	5.1	0	0	1.9	0	0.4	5.7	6.5	0.9	0	0.9	0	2.6	0.1	0.6	1.2	3.3	0	1.3	1.1	0.8	0.7	0	1.2	1	0	0.5	0	0	0	4.6	2.2	3.5	0	0	0	2.7	0	0.9	0	0.5	0.4	0	0	0	0.5	0	0	0	0	0	0	1.4	1.1	0.6	0.8	1	1.5	1.1	0.6	0.6	0.6	6	19.5	0	0.6	0.2	1.3	1.7	5.1	20.1	2.3	1.8	0	0	11.6	0.7	1704.8	0	0	0	1.5	0.2	1	0.2	0	2.1	0	0	7.5	0	0	202.2	8.9	0	0	0	0.6	1.1	1.9	0	7.1	0.3	0.2	6.5	0.3	12.1	9.1	0.1	0	0	0.1	0	Early spermatids
BTBD17	BTBD17A, LGALS3BPL, TANGO10A	ENSG00000204347	BTB domain containing 17	A6NE02	17	74356416-74361946	Predicted secreted proteins				Evidence at protein level	Evidence at transcript level	No human protein/transcript evidence	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	12	brain: 18.2	Cell type enriched	Detected in some	7	Horizontal cells: 27.0	Group enriched	Detected in some	11	glioma: 9.5;testis cancer: 1.9	Low region specificity	Detected in all			Cell type enhanced	Detected in single		naive CD4 T-cell: 1.4	Lineage enriched	Detected in single	14	T-cells: 1.4	Group enriched	Detected in some	20	AF22: 3.9;NTERA-2: 5.1;SCLC-21H: 15.4	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA025022	Approved				Secreted in brain							HPA025022: AB_2067352					unprognostic (2.63e-1)					unprognostic (2.77e-1)	unprognostic (4.82e-5)			unprognostic (3.89e-2)	unprognostic (2.55e-1)	unprognostic (9.89e-3)		0.4	1.5	5.4	0.4	5.1	0.4	0.4	5.6	18.2	0.4	0.4	2.7	0	1.2	0.4	0.4	0.4	0.4	0.4	0.4	3.7	5.7	0.4	0.4	0.4	0.4	3.8	1.8	0.4	0.4	0.4	0.2	0.4	6.1	0.4	0.4	0	0.4	0.4	0.4	0.4	0.5	0.4	3.7	0.6	1.4	0.5	2.2	0	0.6	0	0.4	0.4	0	0	0	0	0	0	1.4	0	0	0	3.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5.1	0	0.1	0.4	0	0	0	0	15.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	1.4	0.5	0	0	0	0	0	0	5.4	5.1	5.6	8.2	3.7	5.7	3.8	1.8	6.1	2.2	0	0	0	0	0	0.8	2.8	0	0	0	0	3.9	0	0	0	0.8	0	0	0	0	0	0	0	0	0	0	27	4.1	0	0	1.7	0	0	0	0	0	1.2	0	0	0	0	0.1	0	0	0.2	0.2	0	0	0	0	0	Horizontal cells
CSHL1	CS-5, CSHP1, CSL, hCS-L, MGC149868	ENSG00000204414	Chorionic somatomammotropin hormone like 1	Q14406	17	63909597-63918838	Predicted intracellular proteins, Predicted secreted proteins		Hormone		Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at transcript level		Group enriched	Detected in some	864	pituitary gland: 334.1;placenta: 293.7	Cell type enriched	Detected in some	16	Syncytiotrophoblasts: 18.1	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		MCF7: 1.2;SCLC-21H: 1.3;SuSa: 1.7									CAB025646, HPA043715	Enhanced				Secreted to blood							CAB025646: , HPA043715: AB_2678632																		0.1	0.1	0.1	0	0.1	0	0.1	0.1	0.1	0.1	0.1	0	0	0	0.1	0	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0	0.1	0.2	0	334.1	293.7	0	0.1	0	0	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0	0	0.1	0	0	0.1	0.1	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.2	0	0	0	0	0	0	0	0	0	0	1.3	0.4	0	0	0	1.7	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	1.1	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	18.1	0	0	0	Syncytiotrophoblasts
AL662899.1		ENSG00000204422			6	31686962-31714072	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level				Tissue enhanced	Detected in some		bone marrow: 3.8;brain: 5.3	Cell type enriched	Detected in single	7	Club cells: 2.3	Not detected	Not detected			Group enriched	Detected in some	5	amygdala: 2.9;cerebral cortex: 5.3;hippocampal formation: 1.8	Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enriched	Detected in single	25	HEL: 10.9																								unprognostic (1.83e-1)							unprognostic (2.84e-1)						unprognostic (3.49e-1)		0.1	0	2.9	0.1	0.5	3.8	0.1	0.1	5.3	0.4	0.7	0.1	0.1	0	0.5	0.7	0.9	0.2	0.4	0.1	1.8	0.2	0.1	0.1	1.1	0.1	0.1	0.1	0.6	0.1	0.3	0.2	0.1	0.7	0.1	0.5	0.1	0.2	0.1	0.1	2.7	0.1	0.1	0.1	1.7	0	0.9	0.1	0.6	2.3	0.1	0.1	0.1	0.8	0.8	1.3	2.9	1.5	0.7	0.9	1.5	0	0	0.1	0.1	0	0	0	0.4	0.1	0.3	0.1	0	0	0.1	0	0	0	0	0	0	0	0.3	0	10.9	0.1	0	0	0.1	0.3	0	0.1	0	0.1	0	0	0.1	0.2	0.4	0	0	0.1	0.2	0	0.1	0	0	0	0.3	0	0.1	0	0.2	0	0	0	0.1	0.1	0.3	0	0	0.2	0	0	0	0	0.2	0	0.4	0	0.8	1.3	1.7	0.9	1.5	0.6	0.5	0.6	0.6	1.3	0.8	0.4	0.4	2.9	0.7	1.4	1.1	0.6	1.5	2.9	0.5	0.1	5.3	1.8	0.2	0.1	0.1	0.7	0.1	0	0.3	0	0	0	0	0	0	0	2.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Club cells
LRCOL1		ENSG00000204583	Leucine rich colipase like 1	A6NCL2	12	132603150-132610543	Predicted secreted proteins				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	12	epididymis: 54.8	Cell type enriched	Detected in some	13	Hepatocytes: 39.8	Cancer enhanced	Detected in some		liver cancer: 3.0					Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		BEWO: 1.7;BJ hTERT+ SV40 Large T+: 1.2;RPMI-8226: 1.0														Secreted in male reproductive system								unprognostic (5.09e-3)	unprognostic (7.83e-3)	unprognostic (3.26e-1)	unprognostic (6.94e-2)	unprognostic (3.15e-2)	unprognostic (2.38e-2)	prognostic favorable (7.04e-4)	unprognostic (4.54e-2)	unprognostic (6.08e-2)	unprognostic (5.29e-2)	unprognostic (4.66e-3)	unprognostic (1.52e-1)	unprognostic (6.50e-6)	unprognostic (1.46e-3)	unprognostic (9.63e-2)	unprognostic (3.31e-1)	unprognostic (4.00e-3)	0	0	0	0	0.1	0	0	0	0	0.1	0.1	0	4.4	0.1	0	54.8	0	0.2	0.4	0	0.2		0.1	0	0.5	0.6	0	0	0	0	0	0.1	0.1	0	0.1	0	0.1	0	1.9	0.1	0	0.1	0	0	0.1	0	0.6	0	0	0	0	0.1	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	1.7	0.7	0.5	1.2	0	0	0	0.4	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	1	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0											0	0	0	0	0.1	0	0.3	0	0	0	0	0	0	0	0	0	1.8	0	0	0	0	0	0	0	39.8	0	0	0	3.1	1.3	0	1.4	0	0	0	0	0	0	0	0.7	0	0	0	0.8	0	0.2	0.1	0	0	0	0	Hepatocytes
DPRX		ENSG00000204595	Divergent-paired related homeobox	A6NFQ7	19	53632056-53637009	Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	DNA-binding		Evidence at transcript level	Evidence at transcript level	No human protein/transcript evidence	No human protein/transcript evidence		Tissue enhanced	Detected in some		placenta: 4.9;skeletal muscle: 4.2	Cell type enriched	Detected in some	4	Syncytiotrophoblasts: 4.7	Cancer enriched	Detected in single	20	thyroid cancer: 2.6					Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		BEWO: 2.5;SuSa: 3.3									HPA043682	Uncertain											HPA043682: AB_10963073												unprognostic (2.47e-1)			unprognostic (1.89e-1)			2	0	0.1	0	0.1	0	1.3	0.1	0	0.2	0.1			0	0.1	1.8	0	0.1	0	1.2	0.2	0	0	0.1	1.6	0	0.1		0	0	0	0	4.9		0.7	0		0	0.1	4.2	0.5	0	0.1	0.1	0.1	0	1.6			0		0	0	0	0	0	0.6	0.2	0	0	0	0	0	0	0	0	0	2.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.8	0	0	0.9	0	0	0	0	0	0	0	0	0	0.1	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.3	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0.2	0	0	0.2	0	0	0	0	0	0	0	0	0.6	0	0.1	0	0	0											0	0	0	0	0	0	0	0	0	0	0	0	1.1	0	0	0.7	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0.8	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0.2	0	4.7	0	0	0	Syncytiotrophoblasts
TRIM10	HERF1, RFB30, RNF9	ENSG00000204613	Tripartite motif containing 10	Q9UDY6	6	30151945-30160934	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		intestine: 3.0;kidney: 3.1;liver: 5.9;placenta: 5.8	Cell type enriched	Detected in some	12	Erythroid cells: 70.0	Low cancer specificity	Detected in some			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	11	EFO-21: 1.9	Not detected	Not detected			Region enriched	Detected in single	18	hippocampal formation: 4.0	HPA043325	Uncertain											HPA043325: AB_2678428		unprognostic (2.98e-1)	unprognostic (3.13e-2)	unprognostic (2.99e-2)		unprognostic (2.13e-1)	unprognostic (2.98e-1)	unprognostic (9.53e-3)	unprognostic (6.32e-2)	unprognostic (2.71e-1)	unprognostic (2.64e-2)		unprognostic (1.74e-3)	unprognostic (1.46e-2)	unprognostic (4.37e-2)		unprognostic (1.22e-2)	0	0	0	0.3	0	0	0	0	0.5	0.6	2.6	0	0	0	0	0	0	0	0	0	0	0	3.1	5.9	0.7	0	0	0	0.7	0	0	0	5.8	0	0	0	0.6	0	0	0.9	1	3	0	0	1.4	0.1	0.5	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.9	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0.3	2.5	0	0	0	0	0	0	0	0	0	3.3	70	0	0	0	0	0	1.5	0.1	0	1.2	0	0.3	0	0	0	0	0	1.7	0	0.3	5.8	0	3	0	0	0	0	0	0	0.1	0	1.1	0	Erythroid cells
HLA-G		ENSG00000204632	Major histocompatibility complex, class I, G	P17693	6	29826967-29831125	Cancer-related genes, Predicted membrane proteins, Predicted secreted proteins	Immunity		Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	4	placenta: 66.0	Cell type enriched	Detected in many	15	Extravillous trophoblasts: 586.1	Low cancer specificity	Detected in all			Not detected	Not detected			Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Group enriched	Detected in some	4	CAPAN-2: 1.2;SuSa: 3.9									CAB016158	Enhanced				Secreted to blood			32800000				CAB016158: AB_627938	unprognostic (1.13e-2)	unprognostic (9.95e-2)	unprognostic (1.30e-1)	unprognostic (3.40e-2)	unprognostic (8.35e-2)	unprognostic (1.35e-1)	unprognostic (1.18e-3)	unprognostic (2.51e-1)	prognostic favorable (3.91e-5)	unprognostic (6.34e-2)	unprognostic (8.31e-2)	unprognostic (1.78e-1)	unprognostic (1.03e-2)	unprognostic (6.56e-3)	unprognostic (1.40e-1)	unprognostic (1.52e-2)	unprognostic (3.19e-3)	0.2	0.1	0	0.5	0.1	0.2	0.3	0.1	0.1	0.2	0.5	0.1	0	1.2	0.2	0.6	0.1	0.1	0.2	0.3	0.2	0	0.5	0.2	2.8	0.7	0.1	0.1	0.3	1.9	0.1	15.2	66	0.1	0.2	0.2	0.3	0.4	0.6	0.2	0.2	0.8	0.1	0.2	1.2	0.9	2.2	0.2	1.3	0.4	0.2	0.2	0.2	0.3	0.3	0.3	2.2	0.9	0.2	1.2	5.7	0.2	0	0	0	0.1	0	0	0	0.1	0	0.1	0	1.2	0.1	0	0	0.5	0	0	0.1	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0.1	0.2	0	0	0	0	0	0.2	0.2	3.9	0	0	0	0	0	0	0	0.1	0	0	0.1	0	0.1	0.6	0.9	1.2	0.7	0.5	1.2	0.3	0.1	0.5	0.3	0.3	0.6	1.2	2.2	0.2	0.6	0.1	0.5	5.7	0	0.1	0.1	0.1	0.2	0	0.1	0.1	0.1	0.2	0	1.1	1.4	6.4	20.3	0	0.8	5.1	0	0	0	0	7.8	0	2.8	16.1	5.2	2.6	0	4.7	586.1	11.7	5.5	0	1.1	21.9	0	16.8	8	11	5.3	2.3	3.3	11.8	0	39.2	0	15.5	20.1	2.5	0.2	0	0	3.3	4.7	3	30.7	33.9	6.9	9.7	6.7	Extravillous trophoblasts
OR2H2	hs6M1-12	ENSG00000204657	Olfactory receptor family 2 subfamily H member 2	O95918	6	29585121-29590500	G-protein coupled receptors, Predicted membrane proteins	Olfaction, Sensory transduction	G-protein coupled receptor, Receptor, Transducer		Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Group enriched	Detected in some	4	brain: 3.3;epididymis: 11.7;testis: 4.8	Cell type enriched	Detected in some	7	Early spermatids: 15.6	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		AF22: 2.3;NTERA-2: 3.5;TIME: 1.9																						unprognostic (2.95e-1)	unprognostic (3.76e-1)			unprognostic (2.33e-2)			unprognostic (2.42e-1)	unprognostic (2.34e-1)	unprognostic (3.11e-1)	unprognostic (2.76e-1)	unprognostic (3.20e-1)		unprognostic (1.34e-1)	unprognostic (2.04e-1)			0.2	0.1	1.5	0.3	3.3	1.5	0.1	2.2	0.9	0.1	0.1			0	0.2	11.7	0.1	0.1	0.1	0.3	1.2	0.9	0.1	0.1	0.2	0.4	0.6		0.2	0	0	0.7	0.1		0.2	0.1		0.1	0.9	0.1	0.4	0.1	0.1	0.2	0.4	0.2	4.8			0.2		0.2	0.1	0.1	0.4	0.2	0.8	0.1	0.1	0.3	0	0.4	0	2.3	0.3	0	0	0.5	0.2	0.1	0	0.2	0	0.2	0.5	0.1	0.4	0.2	0.3	0.2	0	0	0.2	0.7	0.9	0.7	0.6	0.1	0.6	1	0.1	0.1	0	0.2	0.3	0.3	0.7	0.4	0.7	0.2	0.1	0	0.2	3.5	0.1	0.2	0.4	0.3	0	0	0.2	0.7	0.2	0.3	0.2	0	1.1	0.2	0.2	1.9	0.4	0.9	0.3	0.2	1	0.2	0.5	0.2	0.4	0.1	0	0	0	0	0.1	0.3	0.2	0.1	0	0	0.4	0.1	0.1	0.8	0.1	0.1	0.2	0.1	0											0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.2	0	0	0	0	0	0	0.1	0	0.4	0	0	0	0	0	0	0	0	0	0	0	Early spermatids
C9orf57		ENSG00000204669	Chromosome 9 open reading frame 57	Q5W0N0	9	72051376-72072721	Predicted intracellular proteins, Predicted membrane proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enriched	Detected in single	114	testis: 31.4	Cell type enriched	Detected in some	16	Spermatocytes: 17.7	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in single		Daudi: 3.2																								unprognostic (3.26e-2)				unprognostic (1.15e-1)							unprognostic (5.05e-2)				0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	31.4	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.2	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.8	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	17.7	0	0	0	0	0	0	Spermatocytes
OR2H1	OR2H6, OR2H8, OR6-2	ENSG00000204688	Olfactory receptor family 2 subfamily H member 1	Q9GZK4	6	29457181-29464328	G-protein coupled receptors, Predicted membrane proteins	Olfaction, Sensory transduction	G-protein coupled receptor, Receptor, Transducer		Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enriched	Detected in single	124	testis: 12.3	Cell type enriched	Detected in some	5	Early spermatids: 52.8	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Not detected	Not detected																																									0	0	0	0	0	0	0	0	0	0	0			0	0	0	0	0	0	0	0	0	0	0	0	0	0		0	0	0	0	0		0	0		0	0	0	0	0	0	0	0	0	12.3			0		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	52.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	10.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0.2	0	0	0	0	0	Early spermatids
SPATA31A1	C9orf36, C9orf36A, DKFZP434B204, FAM75A1, FAM75A2, SPATA31A2	ENSG00000204849	SPATA31 subfamily A member 1		9	39355669-39361959	Predicted membrane proteins				Evidence at transcript level	Evidence at transcript level				Tissue enriched	Detected in single	103	testis: 10.2	Cell type enriched	Detected in some	8	Early spermatids: 13.7	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	33	U-2197: 3.3																																				unprognostic (1.40e-1)			0	0	0	0	0	0	0	0	0	0	0			0	0	0	0	0	0	0	0	0	0	0	0	0	0		0	0	0	0	0		0	0		0	0	0	0	0	0	0	0	0	10.2			0		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0	0	0	0	0	Early spermatids
FAM216A	C12orf24, HSU79274	ENSG00000204856	Family with sequence similarity 216 member A	Q8WUB2	12	110468364-110490385	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		testis: 43.9	Cell type enriched	Detected in many	6	Spermatocytes: 244.4	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low cell line specificity	Detected in many			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA038286	Enhanced		Approved	Actin filaments						Actin filaments		HPA038286: AB_2675931	unprognostic (7.91e-2)	unprognostic (3.73e-2)	unprognostic (1.56e-1)	unprognostic (6.02e-3)	unprognostic (3.04e-1)	unprognostic (2.76e-1)	prognostic unfavorable (4.49e-5)	unprognostic (8.49e-2)	unprognostic (1.31e-1)	unprognostic (1.70e-1)	unprognostic (2.04e-3)	unprognostic (3.25e-2)	prognostic unfavorable (4.18e-10)	unprognostic (7.60e-2)	unprognostic (4.35e-2)	unprognostic (6.66e-2)	unprognostic (1.05e-1)	3.3	6.6	8.6	6.1	11.7	3.7	3.9	15.8	19.7	4.6	2.5	3.8	0.7	1.8	4.9	1.5	2.6	3.9	4.2	7	11.6	13	3	3.2	2.1	6.3	8.3	11.9	6.5	2.3	4.4	4	3.7	12.5	4.1	2.5	1.2	2.2	5.1	6	1.9	2.3	5.6	6.6	4.3	2.2	43.9	6.2	5	3	1.4	4.4	3.8	2.5	9.9	5.5	3.2	4.9	2.5	12.3	5.4	8	7	5.1	6.6	3.8	7	1.3	14.3	3.9	16.5	7.6	6.9	2.3	29.2	3.8	6.6	4.3	5.9	9.5	8.6	18.8	9.3	23	15	4.4	5	5.6	17.8	11.8	6.4	2.2	8.4	18.5	9.9	5.5	12.6	16	7.6	10.9	2.7	14.3	22.9	17.6	3.2	13	7.2	7.7	20.5	5.8	0.1	25.3	8.3	7	4.4	3.5	1.6	11.6	10.4	4.8	5.5	2.4	4.8	13.8	14.1	10.2	22.8	9	16.6	10.1	1.4	4.9	1.9	3.1	3.3	4.4	9.2	4.8	5	5.5	9.9	12.3	7.3	3.2	2.5	3.1	2.9	3.3	5.4	8.6	11.7	15.8	19.7	11.6	13	8.3	11.9	12.5	6.2	0	1	8.5	4.7	1.4	10.2	15.3	0	5.3	4.5	3.5	2	0.6	0	3.2	29.5	5.8	0	0	0.8	1.9	5.1	1.6	10.3	3.9	6.7	12.7	1.2	4.9	4.5	44.3	8.9	2.1	3.3	1.8	0	4.6	2.5	0	5.3	2.9	4.1	12.9	5.1	244.4	20	1.8	0.5	3.2	0.2	1.3	Spermatocytes
GPR20		ENSG00000204882	G protein-coupled receptor 20	Q99678	8	141356500-141367267	G-protein coupled receptors, Predicted membrane proteins		G-protein coupled receptor, Receptor, Transducer		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Low tissue specificity	Detected in many			Cell type enriched	Detected in some	4	Sertoli cells: 71.1	Low cancer specificity	Detected in some			Low region specificity	Detected in many			Group enriched	Detected in some	12	intermediate monocyte: 3.7;non-classical monocyte: 5.4	Lineage enriched	Detected in single	14	monocytes: 5.4	Cell line enriched	Detected in some	4	EFO-21: 7.0	Not detected	Not detected			Region enhanced	Detected in single		midbrain: 1.3	HPA071337			Supported	Plasma membrane,Cytosol						Plasma membrane	Cytosol	HPA071337: 	unprognostic (4.47e-2)	unprognostic (2.64e-3)	unprognostic (5.18e-2)	unprognostic (2.00e-2)	unprognostic (7.47e-2)	unprognostic (2.28e-1)	unprognostic (4.43e-2)	unprognostic (5.01e-2)	unprognostic (3.54e-1)	unprognostic (2.13e-2)	unprognostic (1.57e-1)	unprognostic (1.13e-1)	unprognostic (1.07e-2)	unprognostic (7.41e-2)	unprognostic (5.50e-2)	unprognostic (6.23e-2)	unprognostic (4.07e-1)	2.8	0.5	0.7	2.7	1.4	0.1	2.5	0.2	2	10.6	9.1	1	4.3	2.2	6.7	1.9	3.4	3.9	6.1	2.1	0.8	0.4	1.1	0.4	3.5	0.3	1.4	0.9	3.7	0.5	0.5	0.5	3.2	2.1	2.2	1	1.1	0.5	3	2.1	1	10.5	4.5	0.5	0.8	4.3	1.6	0.7	0	1.4	1.5	0.5	1.7	3.4	0	0.3	0.3	5.4	0	0	0.1	0	0.8	0	0	0	0.1	0	0.3	0	0	0	0.5	0.1	0	7	0	0.1	0.1	0	0	0	0	0.3	0	1.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.2	0	0	0.5	0.2	0.5	0	0	0.5	0	0	0.3	0	0	0	0	1.1	0	0.1	0	0	1.6	0	0	0	0.1	0	0	0.8	0	0	0	0	0	3.7	0	0	0	0	0.3	0	0	0	0.3	0	5.4	0	0	0.1	0.7	1.4	0.2	2	0.8	0.4	1.4	0.9	2.1	0.7	0	0	0	0.1	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0.1	0	0	0.1	0	0	0	0	0.9	0	0	1.7	0	0	0	0	0	0.4	0	0	71.1	16.5	0	0	0.1	0	0	0	0	Sertoli cells
PSG5	FL-NCA-3, PSG	ENSG00000204941	Pregnancy specific beta-1-glycoprotein 5	Q15238	19	43166256-43186536	Predicted secreted proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in some	73	placenta: 171.3	Cell type enriched	Detected in some	41	Syncytiotrophoblasts: 605.9	Low cancer specificity	Detected in single			Not detected	Not detected			Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Group enriched	Detected in some	8	BJ: 52.4;fHDF/TERT166: 180.6									HPA046327	Supported				Secreted in female reproductive system							HPA046327: AB_2679624	unprognostic (1.59e-1)	unprognostic (3.38e-2)				unprognostic (4.69e-2)		unprognostic (1.62e-2)	unprognostic (2.18e-1)	unprognostic (2.04e-1)	unprognostic (1.75e-2)		unprognostic (1.12e-2)	unprognostic (2.62e-2)		unprognostic (1.03e-1)	unprognostic (7.92e-2)	0.3	0	0	0	0.1	0	0.2	0.9	0.1	0.1	0	0	0	0	0	0	0.1	0	0	0	0.1	0	2.3	0	0	0	0	0	0	1.1	0.2	0.1	171.3	0	0	0	0	0.9	0	0	1.2	0	0.4	0	0.1	0.1	0.1	0	0	0	0	0	0	0	1	0.5	2	0.5	0.6	0.7	0	0.1	0	0	0	0	0	0	52.4	15.1	0.8	7.3	0	0	0	0	180.6	0.2	2	0	0	8.3	0	0	0	0	0	0	0	0	0.1	0	0.1	0.9	0.3	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.3	0	0	0	0	0.2	6.8	0	0	0	0	0	0	0	1.7	0.5	0.4	0.7	0.4	0.5	0.6	0.5	0.5	0.2	1	0.7	0.5	2	0.6	0.4	0.5	0.4	0	0	0.1	0.9	0.1	0.1	0	0	0	0	0	0	0	0	0.1	0	0.4	0.1	0	0	0	1.8	0	5.3	0	4.3	0.8	0	0	0	0	14.9	0	0	0	0	2.3	0	0	0	0	0	0	0	0	1	0	0	0.1	0	0	0	0.1	0	0	0	0	0	605.9	0	0	0	Syncytiotrophoblasts
TRIM13	DLEU5, Leu5, RFP2, RNF77	ENSG00000204977	Tripartite motif containing 13	O60858	13	49995888-50020481	Enzymes, Predicted intracellular proteins, Predicted membrane proteins	Immunity, Innate immunity, Ubl conjugation pathway	Transferase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in all	8	Early spermatids: 422.5	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low cell line specificity	Detected in many			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA000367	Enhanced											HPA000367: AB_1856196	unprognostic (1.14e-1)	unprognostic (8.22e-2)	unprognostic (6.14e-2)	unprognostic (2.23e-3)	unprognostic (4.75e-3)	unprognostic (5.01e-2)	unprognostic (4.60e-2)	unprognostic (2.83e-2)	unprognostic (2.59e-2)	unprognostic (2.38e-2)	unprognostic (2.44e-1)	unprognostic (5.07e-1)	unprognostic (7.28e-3)	unprognostic (4.66e-2)	unprognostic (9.01e-2)	unprognostic (2.37e-2)	unprognostic (1.55e-2)	13.2	9.8	9.9	11.9	11.4	37.5	19.6	18.5	13.5	13.1	11.7	12.3	15.2	8.6	13.9	10.7	18.8	12.2	8.7	12.4	10.1	9.2	16.6	9.9	14.7	12.4	12.2	8	13.8	14	10.8	14.4	10	11.5	14.5	14	9.6	16.2	15.6	16.3	18.2	13	10.4	10.8	15.3	10.6	49	12.1	25.1	17.3	13.9	15.5	13	12.9	28.4	20.6	21.6	13	15.4	17.2	8.4	5.1	6.1	21.1	16.3	11.9	18.6	9.6	8.5	12.4	6.9	4.9	8.4	11.9	19.3	2.7	9.2	6.3	8.1	9.2	11.2	8.6	7.3	8.2	19.1	4.6	9.2	13.3	18.2	11.2	13.6	16.6	6.3	10.6	17.5	15.3	16.5	10.1	6.1	13.6	4.7	15.1	28.6	19.1	12	4.5	18.5	0.9	5.7	14.8	8.5	8.5	13.9	7.8	8.1	11.9	15.6	9.1	23.1	14.2	7.2	6.7	5.8	4.8	4.4	3.7	14.1	3.2	8.4	9.7	12.1	10.8	16.1	12.2	9.3	15.3	28.2	16.5	15.9	13.5	28.4	14.6	13.6	21.6	15.4	13	20.6	17.2	8.4	9.9	11.4	18.5	13.5	10.1	9.2	12.2	8	11.5	12.1	23.8	23.2	36.1	36.2	24.5	23.5	16.2	17.8	36.1	21.6	26.2	19.6	29.2	16.6	21	422.5	29.4	20.1	23.3	17.5	13.3	23.7	28.6	38.1	13.7	16.3	11.1	43.1	22.1	17.3	42.4	23.9	27.2	16.9	23.4	24.2	13.2	17.6	31.1	28	24.9	52.1	19.4	29.7	55.2	19.6	29.2	26.9	36.3	22.4	26.3	Early spermatids
ERICH4	C19orf69, LOC100170765	ENSG00000204978	Glutamate rich 4	A6NGS2	19	41443158-41444765	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	No human protein/transcript evidence	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	8	intestine: 78.1	Cell type enriched	Detected in some	6	Proximal tubular cells: 73.4	Low cancer specificity	Detected in single			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	12	CACO-2: 4.8;Hep G2: 11.1;THP-1: 3.1	Not detected	Not detected			Low region specificity	Detected in many			HPA042632, HPA048484	Uncertain		Approved	Nucleoplasm,Cytosol						Nucleoplasm	Cytosol	HPA042632: AB_2678090, HPA048484: AB_2680415	unprognostic (1.41e-1)	unprognostic (3.05e-1)	unprognostic (9.52e-2)	unprognostic (1.24e-1)	unprognostic (2.76e-1)		unprognostic (4.03e-5)	unprognostic (8.53e-2)		unprognostic (7.54e-2)	unprognostic (1.97e-1)	unprognostic (3.09e-2)	unprognostic (1.04e-1)	unprognostic (2.79e-1)	unprognostic (2.35e-1)	unprognostic (1.16e-1)		0.6	0	0.2	0.2	0.3	0	0.6	0.2	0.3	0.4	21	0.2	0.2	27.1	0.4	0.4	0.2	0.4	0.5	1.3	0.2	0	10	0.2	1.2	0.2	0.3	0.2	0.2	0.2	0	0.2	0.2	0.2	0.2	0	0.2	0.2	0.2	0.9	0	78.1	0.2	0.3	0.2	0.1	0.8	0.2	0.2	0.3	0.2	0.2	0.3	0.4	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	4.8	0	0.1	0	0	0.1	0	0	0	0	0	0	0	0.1	11.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0.1	0	0.2	0.1	0	0	0	0	0	0	3.1	0.3	0	0	0	0	0.1	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0.2	0.3	0.2	0.3	0.2	0	0.3	0.2	0.2	0.2	0	0	0	0	0	0	0	0	0	0	1.8	0	0	11.6	0	3.1	0	0.3	0	0	0	0	0	0	0	0.1	0	0	0	0	0.9	0	0	0	0	0.3	0	0.1	0	0	73.4	0	0	0	0.4	0.6	0	0	0	0	0	Proximal tubular cells
PRSS1	TRY1	ENSG00000204983	Serine protease 1	P07477	7	142749468-142753076	Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins	Digestion	Hydrolase, Protease, Serine protease	Cancer-related genes, Disease mutation, FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	1708	pancreas: 3057.4	Cell type enriched	Detected in some	17	Exocrine glandular cells: 49265.4	Cancer enriched	Detected in many	224	pancreatic cancer: 1920.3	Not detected	Not detected			Cell type enhanced	Detected in some		basophil: 1.7	Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		EFO-21: 2.7;OE19: 10.1;RPMI-8226: 5.4;U-2 OS: 3.2;U-266/84: 1.9									CAB025487, CAB025538, HPA062452, HPA063471	Enhanced		Approved	Endoplasmic reticulum,Vesicles	Secreted to digestive system				26000000000	Vesicles	Endoplasmic reticulum	CAB025487: , CAB025538: , HPA062452: AB_2684768, HPA063471: AB_2685017	unprognostic (6.55e-5)	unprognostic (5.28e-1)	unprognostic (7.58e-2)	prognostic unfavorable (6.41e-6)				unprognostic (8.26e-2)		prognostic favorable (7.05e-4)	unprognostic (1.35e-1)			unprognostic (3.93e-2)	unprognostic (1.96e-1)	prognostic favorable (4.91e-4)	unprognostic (3.12e-1)	0.4	0	0.1	0.1	0.1	0	0.1	0.1	0.2	0.1	0.1	0.2	0.2	0.2	0.2	0.1	0.1	0	0.1	0.4	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	1.6	3057.4	0	0.1	0.1	0.1	0.2	0	0.1	0.4	0.2	0.1	0	0.4	0.1	0.1	0.1	0.5	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1	0	1.7	0	0	0.9	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0.2	0	0	2.7	0	0	0	0	0	0	1.4	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0.1	0	0	0	0.1	0	10.1	0	0	0	5.4	0	0.1	0	0	0	0	0	0	0	0	0	0	3.2	0	1.1	0	1.9	0.4	0	0	0	1.7	0	0	0	0	0	1	0.9	0	0	0.8	0.3	0	0	0	0	0	0.6	0.1	0.1	0.1	0.1	0.2	0.1	0	0.1	0.1	0.1	0.1	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	58.1	0	0	0	0	49265.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	208.2	0	0.5	2827.2	0	0	0	0	0	0	0	0	0.5	0	0	0	0.1	Exocrine glandular cells
FRG2	FRG2A	ENSG00000205097	FSHD region gene 2	Q64ET8	4	190024351-190027257	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Group enriched	Detected in some	5	blood: 2.0;brain: 2.8;skin 1: 3.8	Cell type enriched	Detected in single	8	Distal tubular cells: 1.7	Not detected	Not detected							Cell type enriched	Detected in single	5	basophil: 2.0	Lineage enriched	Detected in single	5	granulocytes: 2.0	Cell line enhanced	Detected in some		GAMG: 1.1;HMC-1: 2.1;Karpas-707: 1.1									HPA039264, HPA047769	Uncertain											HPA039264: AB_2676420, HPA047769: AB_2680149																		0	0	0	0	0	0.5	0	2.8	0.1	0	0			0	0	0	0	0	0	0	0	0	0	0	0	0.3	0		0	0	0	0.1	0		0	0		0	0	0	3.8	0	0	0	0	0	0.4			0.2		0	0.1	0	0.2	0.1	2	0	0.4	0.1	0	0.1	0.1	0	0.2	0	0	0.4	0.4	0	0.3	0	0	0.6	0	0.2	0	1.1	0.3	0.1	0	0	1.1	0.4	0.8	0.4	0.3	0	0.7	2.1	0	0	0	0	0.6	0	0.4	0.2	1.1	0	0	0	0	0	0.3	0	0.2	0.3	0	0.1	0.1	0.3	0.3	0	0.3	0.3	0.2	0	0	0	0.7	0.2	0.3	0.2	0.2	0	0.2	0.3	0.2	0.3	2	0	0	0	0	0	0	0.1	0	0	0.2	0	0.1	0.1	0.4	0	0.1	0.1	0											0	0	0	0	0	0	0.2	0	0	0	0	0	0	1.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Distal tubular cells
FAM205A	C9orf144B	ENSG00000205108	Family with sequence similarity 205 member A	Q6ZU69	9	34723055-34729467	Predicted membrane proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	243	testis: 24.3	Cell type enriched	Detected in some	6	Early spermatids: 99.0	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		AN3-CA: 1.0;THP-1: 2.3									HPA071267	Enhanced		Uncertain	Nucleoli fibrillar center,Plasma membrane						Plasma membrane	Nucleoli fibrillar center	HPA071267: AB_2686376	unprognostic (2.25e-1)					unprognostic (3.66e-3)		unprognostic (6.29e-3)	unprognostic (1.90e-1)	unprognostic (2.73e-3)	unprognostic (7.82e-2)	unprognostic (9.61e-2)	unprognostic (6.41e-2)	unprognostic (4.78e-1)		unprognostic (7.34e-2)		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	24.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	1	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0.1	0	0.7	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.2	0	0	0	0.1	0	2.3	0	0	0.2	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	99	0	0	0	0	0	0	0	0	0	0	0	0	0	0	16.8	0.6	0	0	0	0	0	0	0	1.4	0	0	0	0	0.2	0.4	0	0	0	0	0	Early spermatids
VIT		ENSG00000205221	Vitrin	Q6UXI7	2	36696690-36814792	Predicted intracellular proteins, Predicted secreted proteins	Neurogenesis			Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in many			Cell type enriched	Detected in some	5	Leydig cells: 106.7	Low cancer specificity	Detected in some			Low region specificity	Detected in some			Group enriched	Detected in some	8	gdT-cell: 5.3;memory CD8 T-cell: 2.3;naive CD8 T-cell: 3.4	Lineage enriched	Detected in single	11	T-cells: 5.3	Cell line enhanced	Detected in some		ASC diff: 13.5;ASC TERT1: 26.5;BJ: 12.7;fHDF/TERT166: 43.0;SuSa: 25.7;THP-1: 13.5	Low region specificity	Detected in many			Low region specificity	Detected in many								Secreted to extracellular matrix				120000				unprognostic (5.34e-4)	unprognostic (4.49e-2)	unprognostic (1.49e-2)	unprognostic (1.20e-1)	unprognostic (7.78e-3)	unprognostic (8.32e-2)		unprognostic (1.81e-1)	unprognostic (3.08e-1)	unprognostic (3.35e-1)	unprognostic (1.64e-1)	unprognostic (2.63e-2)	unprognostic (3.66e-6)	unprognostic (2.09e-1)	unprognostic (2.01e-1)	unprognostic (3.62e-3)	unprognostic (1.41e-2)	25.5	1.2	0.2	0.6	0.4	0.9	10.3	2.5	1	7.4	2.1	0.3	6.3	0.6	1.9	11.4	17.1	5	2.7	14.2	0.2	0.1	0.5	0.2	1.2	2.3	3.4	0.7	30	2.2	1	2	6.8	1	15.3	1.7	18.1	7.8	2.9	11.6	8.3	1.5	20.5	5.1	0.3	3.4	10.5	0	0	7.9	22	3.9	21.4	10.9	0	0	0	0.1	0.4	5.3	1.1	0	0	0	0	13.5	26.5	0	12.7	3	4.1	1.7	0	0	0	0	43	0	0	2.4	0	2.7	0	0	0	0.9	0	0	0	0	0.4	0	0	0	1.3	0.6	0	0	0	1	0	0	0.5	0	0	0	0	0	0	0.1	0	0	0	0.1	0.3	0	25.7	0	13.5	0	0	0	0	0	0	0	0	0.1	0.9	0.9	0	0	0	5.3	0	0	0	0.2	2.3	0	0	0	3.4	0	0.4	0.1	0	0	1.1	0.2	0.4	2.5	0.6	0.2	0.1	3.4	0.7	1	0	0	0	0	1	3.8	0	3.6	0	0	0	0	0	8.7	0	0	1.1	0.3	0	0	0	6.9	7.4	0.1	0	0	1	0	0	0.6	0	0.2	106.7	0	6.8	0	0.3	0	0	0	21.9	0	0	6.5	2.1	1.1	0.2	3	3.5	0	0	0.1	Leydig cells
CTXN3		ENSG00000205279	Cortexin 3	Q4LDR2	5	127649044-127658630	Predicted membrane proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at transcript level		Group enriched	Detected in some	4	brain: 21.9;kidney: 58.1	Cell type enriched	Detected in some	6	Proximal tubular cells: 121.0	Cancer enriched	Detected in single	8	renal cancer: 1.0	Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	4	AF22: 4.5;NTERA-2: 1.5	Low region specificity	Detected in many			Region enriched	Detected in many	4	olfactory region: 50.2																		unprognostic (7.32e-2)	unprognostic (9.88e-2)		unprognostic (1.19e-1)				unprognostic (1.29e-1)	unprognostic (6.20e-3)					0.6	0.6	2.2	0.5	9.4	0.5	0.6	0.2	19.1	0.6	0.6	0.7	0	0.5	0.6	0.5	0.6	0.6	0.6	0.6	7.9	4.8	58.1	0.6	0.6	0.6	12.6	4.6	0.5	0.5	0.5	5.9	0.5	21.9	0.9	0.6	0	0.7	0.6	9.1	0.5	0.5	0.5	0.5	0.5	0.6	0.6	1	0	0.5	0.3	0.5	0.6	0.1	0	0	0	0	0	0	0	0	0	4.5	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0.5	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	1.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.2	9.4	0.2	19.1	7.9	4.8	12.6	4.6	21.9	1	0	0	0	0	0	0	0	0	0	0	3.5	0	0	19.9	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0.6	0	0	0	0	0	0	0	0	121	0	0	0	0	0.1	0	0	0	0	0	Proximal tubular cells
MUC19	FLJ35746	ENSG00000205592	Mucin 19, oligomeric		12	40393395-40570832	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level				Tissue enriched	Detected in some	4	salivary gland: 22.6	Cell type enriched	Detected in single	6	Cardiomyocytes: 1.4	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	4	U-937: 8.9														Intracellular and membrane								unprognostic (7.80e-3)	unprognostic (2.84e-1)		unprognostic (1.69e-1)	unprognostic (2.53e-1)	unprognostic (4.25e-3)		unprognostic (8.16e-2)	unprognostic (1.27e-1)	unprognostic (5.45e-2)	unprognostic (8.63e-2)	unprognostic (6.99e-2)	unprognostic (8.64e-3)	unprognostic (2.57e-2)	unprognostic (1.60e-1)	unprognostic (2.12e-1)	unprognostic (7.35e-3)	0	0	0	0	0	0.9	0	0	0	0	0			0	0	0.2	0	0	0.1	0	0	0	0	0	0	0	0		0	0	0	0	0		0	0		22.6	0	0	0	0	0	0	0	0	5.3			0		0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0.6	0	0.1	0	0	0	0	0.3	0	0	0	0	0	0.3	0	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0.9	0	0	0	0.1	0.8	0	0.2	0	0	0	0	0	0	0	0	0	8.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0.2	0	1.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Cardiomyocytes
TECRL	DKFZp313B2333, DKFZp313D0829, GPSN2L, SRD5A2L2, TERL	ENSG00000205678	Trans-2,3-enoyl-CoA reductase like	Q5HYJ1	4	64275257-64409468	Disease related genes, Predicted intracellular proteins, Predicted membrane proteins		Oxidoreductase	Disease mutation	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	7	heart muscle: 131.5	Cell type enriched	Detected in single	16229	Cardiomyocytes: 1622.9	Not detected	Not detected			Not detected	Not detected			Cell type enhanced	Detected in single		neutrophil: 1.3	Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		OE19: 2.8	Low region specificity	Detected in single			Low region specificity	Detected in many																																	0.2	0.1	0	0	0	0.2	0	0	0.1	0	0	0	0	0	0	3.3	0.2	0	0	131.5	0	0.1	0	0	0	0	0	0.1	0	0	0	0	0	0	0.2	0	0	0	0	19.8	0.1	0	0	0	0	0	0.1	0	0	0.2	1	0.1	0	0	0.2	0.2	1.3	0	0	0.3	0	0.9	0.9	0.6	1.1	0.5	0.2	0.3	1.1	0	0.1	0.2	1.1	0.7	0.5	0.3	0.3	0.6	0.5	0.3	0.1	0.4	0.5	0	0.7	1.4	1.4	0.2	1.2	0.6	0.1	0.5	0.2	0.3	1	0.2	0.3	0.7	1.1	0.2	0.2	0.5	0.8	0.7	2.8	0.2	0.5	0.8	0.4	2.5	0.5	0.2	0.6	0.5	0.1	0.1	1.4	0.4	0.5	0.7	1.1	0.8	0.7	0.8	1	0.2	0.7	0.5	0.8	0.6	0.6	0	0.2	0.3	0	0.2	0.1	0.1	0.1	0	0.2	0.2	0.2	1.3	0	0	0.2	0.1	0	0	0	0	0.1	0	0.1	0	0.1	0	0	0	0	0	0	0	0	1622.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Cardiomyocytes
GAGE1	CT4.1	ENSG00000205777	G antigen 1	Q13068	X	49589496-49608536	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in some	37	testis: 36.8	Cell type enriched	Detected in some	11	Spermatogonia: 107.0	Not detected	Not detected							Low cell type specificity	Detected in single			Low lineage specificity	Detected in single			Cell line enriched	Detected in some	4	AN3-CA: 249.2									HPA043232	Supported		Approved	Golgi apparatus,Plasma membrane,Cytosol						Plasma membrane	Golgi apparatus, Cytosol	HPA043232: AB_2678376																		0	0	0	0	0	0	0	0	0	0	0			0	0	0	0	0	0	0	0	0	0	0	0	0	0		0	0	0	0	0		0	0		0	0	0	0	0	0	0	0	0	36.8			0		0	0	0	0.6	1	0.7	0.8	0.1	0.7	0	0	0	0	249.2	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.8	0	0	0	0	0	0	0	57.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	22.9	0	0.1	0	0	0	0	0	0.2	0	0	0	6.8	0.1	0.3	0.3	0.7	0	0.2	0.3	0.3	0	0	0.6	0.1	0.3	0.7	0.1	0.8	1	0.1	0											0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.3	1.4	0	0	0	0	0	0	0	0.4	0	0	6.5	0	9.7	107	0	0	0	0	0	Spermatogonia
ARRDC5		ENSG00000205784	Arrestin domain containing 5	A6NEK1	19	4890437-4902867	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	No human protein/transcript evidence	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	7	testis: 29.1	Cell type enriched	Detected in some	6	Early spermatids: 233.3	Low cancer specificity	Detected in single			Not detected	Not detected			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Cell line enriched	Detected in single	16	REH: 6.8	Not detected	Not detected			Low region specificity	Detected in many																unprognostic (2.85e-2)	unprognostic (3.83e-5)	unprognostic (2.53e-1)	unprognostic (7.22e-5)	unprognostic (1.70e-1)	unprognostic (7.16e-5)	unprognostic (1.65e-2)	unprognostic (1.18e-2)	unprognostic (8.00e-2)	unprognostic (9.03e-2)	unprognostic (8.76e-2)	unprognostic (6.45e-2)	unprognostic (7.18e-8)	unprognostic (1.76e-1)	unprognostic (3.07e-1)	unprognostic (1.95e-1)	unprognostic (3.79e-2)	0.2	0	0.2	0.7	0.2	2.2	0.2	0.2	0.6	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.1	0.3	0.2	0.2	0.1	0.2	0.2	0.5	2.2	0.2	0.2	0.2	0.2	0	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0	1	0.2	0.3	2.3	0.2	29.1	0.2	0.2	0.2	0.2	0.8	0.2	0.2	2.6	3.9	3.3	1.2	1.7	3.5	0.9	0	0	0.1	0	0	0	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0.1	0	0.1	0	0	0	0	0	0.1	0	0.1	0	0	0	0	0.3	0	0	6.8	0	0.1	0	0.2	0	0	0.2	0.4	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0.7	1.2	3.3	3.5	0.9	1.9	2.6	0.7	2.3	1.4	2.5	3.2	3.4	0.2	1.7	0.4	3.9	1.5	0.9	0.2	0.2	0.2	0.6	0.2	0.1	0.2	0.2	0.2	0.2	0	0	0.9	0.1	0.1	0	0.3	0	0	0	0	0	0	0	0	233.3	0	0	0	0.2	0	0	0	0	0	1	0	0	0	2.1	38.2	1.1	1.5	0	1	0	0	0.1	0	0.7	0	0	0	0	1.5	0.9	0.1	0	4.4	0	0.5	Early spermatids
LRRC72		ENSG00000205858	Leucine rich repeat containing 72	A6NJI9	7	16526880-16581568	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	15	testis: 15.6	Cell type enriched	Detected in some	5	Early spermatids: 117.7	Not detected	Not detected			Region enhanced	Detected in single		pons and medulla: 1.0	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected							Low region specificity	Detected in many			HPA020554	Uncertain											HPA020554: AB_1859508															unprognostic (1.58e-2)			0	0	0	0	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	15.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0.1	0	0	0.3	0	0	0	1	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	117.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	22	0.9	0	0	0	0	0	0	0	0	0	0	0	0	0.7	0.4	0	0	0	0	0	Early spermatids
DEFB135		ENSG00000205883	Defensin beta 135	Q30KP9	8	11982321-11984590	Predicted secreted proteins		Antibiotic, Antimicrobial, Defensin		Evidence at transcript level	Evidence at transcript level	No human protein/transcript evidence	Evidence at transcript level		Tissue enriched	Detected in some	23	epididymis: 30.8	Cell type enriched	Detected in single	6	Early spermatids: 2.2	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	4	HEK 293: 1.8;MCF7: 7.0					Not detected	Not detected								Secreted in male reproductive system																									0	0	0.2	0	0.3	0	0	0.1	0.5	0	0.1	0	0	0	0	30.8	0	0	0	0.6	0.3	0.3	0	0	0	0	0.1	0	0	0.1	0	0.7	0	0	0.3	0	0	0	0	0.1	0	0	0	0.2	0	0	1.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	7	0	0.9	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0.3	0.1	0.5	0.3	0.3	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Early spermatids
ONECUT3		ENSG00000205922	One cut homeobox 3	O60422	19	1752373-1780988	Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	Activator, DNA-binding		Evidence at protein level	Evidence at protein level	No human protein/transcript evidence	No human protein/transcript evidence		Tissue enhanced	Detected in some		stomach 1: 9.4;testis: 3.8	Cell type enriched	Detected in some	4	Horizontal cells: 295.6	Group enriched	Detected in some	7	pancreatic cancer: 3.5;stomach cancer: 3.9					Low cell type specificity	Detected in some			Low lineage specificity	Detected in single			Group enriched	Detected in some	8	HaCaT: 7.6;OE19: 10.1;PC-3: 17.1	Low region specificity	Detected in single			Region enhanced	Detected in some		hypothalamus: 1.3	HPA059936			Supported	Nucleoplasm						Nucleoplasm		HPA059936: AB_2684172	unprognostic (9.43e-2)	unprognostic (1.36e-1)	unprognostic (6.28e-2)	unprognostic (1.36e-3)	unprognostic (2.27e-1)	unprognostic (1.09e-2)	unprognostic (2.21e-1)	unprognostic (3.61e-3)	unprognostic (2.02e-1)	unprognostic (1.84e-1)	unprognostic (3.87e-2)	unprognostic (3.64e-1)	unprognostic (3.08e-10)	unprognostic (1.18e-1)	unprognostic (9.86e-2)	unprognostic (4.62e-1)	unprognostic (1.21e-2)	0	0	0	0	0.1	0.4	0	0	0	0	0			1.2	0	0.1	0.1	0	1.3	0.1	0	1.8	0	0	0	0	0		0	0.1	0	0	0		0	0		0	0	0	0.2	0.3	0	0.1	0.1	9.4	3.8			0.1		0	0	0	0.6	0.4	1.6	0.4	0.4	0.3	0	0	0	0.1	0.1	0	0	0	0	0	0	0	0	1.4	0.1	0.2	0	0	7.6	0	0	0	0	0	0.1	0.2	0	0	0	0.1	0	0	0	0	0	0	0.2	0	0.2	0	0.1	0	0.2	0	10.1	17.1	0	0	0	0	0	0.1	0	0	0	0	0.1	0	0	0.1	0	0.5	0.1	0	0.1	0	0.1	0	0	0	1.5	0.3	0.2	0.3	0.1	0.2	0.3	0.2	0.2	0.1	0.6	0.3	0.3	1.6	0.4	0.4	0.4	0.1	0											0	0	0	0.3	0.2	0.7	73.6	0	0	0	0	0	0	0	0	1.9	0	0	0	0.2	0	0.2	0.3	0	0	0.1	295.6	0	0	0	0.9	0	0	0	0	0	0.2	3.7	0	0.4	0	2.3	0	0	1.8	0.6	0.3	0	0	0	0.4	Horizontal cells
C18orf63	DKFZP781G0119	ENSG00000206043	Chromosome 18 open reading frame 63	Q68DL7	18	74315813-74359187	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	48	testis: 17.4	Cell type enriched	Detected in some	14	Spermatocytes: 47.2	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in single		CACO-2: 1.1					Not detected	Not detected			HPA042233			Approved	Mitochondria						Mitochondria		HPA042233: AB_10960843								unprognostic (1.40e-1)					unprognostic (1.43e-4)					0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	17.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0.1	1.1	0	0	0	0	0	0	0	0.2	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0.1	0.9	0.2	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.8	0	0	0	0	0	0	0	0	0.4	0	0	0	0	47.2	3.4	0	0	0	0	0	Spermatocytes
DOK6	DOK5L, HsT3226, MGC20785	ENSG00000206052	Docking protein 6	Q6PKX4	18	69401055-69849087	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 22.1	Cell type enriched	Detected in some	7	Bipolar cells: 239.6	Low cancer specificity	Detected in some			Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		fHDF/TERT166: 10.4;Hep G2: 10.9;RPMI-8226: 10.5;SCLC-21H: 4.8;SH-SY5Y: 10.9;SuSa: 8.1	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA041099, HPA063534	Approved		Approved	Focal adhesion sites,Cytosol						Focal adhesion sites, Cytosol		HPA041099: AB_2677299, HPA063534: AB_2685032	unprognostic (5.83e-2)	unprognostic (1.39e-1)	unprognostic (2.06e-1)	unprognostic (1.21e-1)	unprognostic (2.77e-2)	unprognostic (2.59e-1)	unprognostic (1.55e-1)	unprognostic (1.90e-2)	unprognostic (8.62e-2)	unprognostic (5.99e-2)	unprognostic (1.04e-2)	unprognostic (4.60e-3)	unprognostic (2.13e-4)	unprognostic (2.30e-3)	unprognostic (2.88e-2)	unprognostic (4.49e-3)	unprognostic (1.09e-3)	2.1	1.6	21.3	1.6	11.3	0.6	1.3	6.8	22.1	3.8	1.5	0.9	0.3	1	3	1.4	1.7	1.7	5.8	10.2	19.2	9.2	8.7	4.4	4.2	1.2	13.7	13.1	4.2	0.7	3.4	1.1	9.9	14	3.5	1.3	5.5	1.7	4.2	0.6	1.2	1.3	6.6	2.7	1.8	1.3	2.8	2.7	0	4.1	0	1.2	5.2	6.6	0	0	0	0	0.9	0.9	0.4	0	0	2.7	0	0	0	0	0.1	0.4	0	0	0	0	0.2	0	10.4	0	0	0	0	0	0	1.2	1	0	10.9	0.3	0	0.2	0.8	0	0	0	0.1	0	0	0	0	0	0	0	0	1.7	0	0	0	0	10.5	0	0	4.8	10.9	0	0	0	8.1	0	0	0	4.1	0.6	0	1.5	0.3	0	0	3.1	0	3.2	0	0	0	0.9	0	0.6	0	0.2	0.4	0	0	0.1	0.5	0	0.9	0	0	0.3	0.4	21.3	11.3	6.8	17.1	19.2	9.2	13.7	13.1	14	2.7	0	0	0	0.1	0.2	239.6	6.5	0	0	2.3	0	13.7	0	1.7	0	32.5	0.7	0	0	0	0	5.3	0.1	0	1	0	9.5	0	0	0.3	23	1.4	0.3	0	0	0	4.1	0	0	6.3	7.8	12.7	0	2.7	0.7	0.1	0.5	0	0	0	0.1	Bipolar cells
KRTAP20-4	KAP20.4	ENSG00000206105	Keratin associated protein 20-4	Q3LI62	21	30620627-30620850	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level	No human protein/transcript evidence	No human protein/transcript evidence		Tissue enriched	Detected in single	41	testis: 6.8	Cell type enriched	Detected in single	6	Spermatogonia: 1.4	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	9	U-2 OS: 11.1																																	unprognostic (1.31e-1)			unprognostic (2.73e-1)			0	0	0	0	0	0	0	0	0	0	0			0	0	0	0	0	0	0	0	0	0	0	0	0	0		0	0	0	0	0.1		0	0		0	0	0	0	0	0	0	0	0	6.8			0		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	11.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	1.4	0	0	0	0	0	Spermatogonia
HBA1	HBA-T3	ENSG00000206172	Hemoglobin subunit alpha 1	P69905	16	176680-177522	Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Transporters	Oxygen transport, Transport		Disease mutation, FDA approved drug targets, Hereditary hemolytic anemia	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	5	bone marrow: 1020.7	Cell type enriched	Detected in many	24	Erythroid cells: 99681.0	Cancer enhanced	Detected in many		glioma: 6.3	Low region specificity	Detected in all			Cell type enhanced	Detected in some		neutrophil: 11.7;plasmacytoid DC: 7.4	Group enriched	Detected in many	4	dendritic cells: 7.4;granulocytes: 11.7	Group enriched	Detected in some	37	HEL: 248.9;K-562: 175.4									CAB032534, HPA043780	Enhanced								17000000000			CAB032534: AB_2294993, HPA043780: AB_2678667	unprognostic (1.16e-1)	unprognostic (1.45e-2)	unprognostic (8.87e-2)	unprognostic (9.78e-3)	unprognostic (3.02e-1)	unprognostic (1.44e-1)	unprognostic (1.67e-1)	unprognostic (1.35e-1)	unprognostic (6.21e-3)	unprognostic (1.92e-2)	unprognostic (1.64e-1)	unprognostic (1.02e-2)	unprognostic (3.59e-2)	unprognostic (3.79e-1)	unprognostic (6.61e-2)	unprognostic (2.67e-2)	unprognostic (9.56e-2)	12.6	8.8	7.1	5	6.6	1020.7	5	7.9	10	2.2	3.2	3	2.2	1.3	2.2	4.1	2.8	4.8	4	16.9	5.2	5.1	20.6	15.7	30.3	8.1	10.1	5.8	4.9	2.2	0.9	7.5	104.1	3.3	4.8	1.4	4.5	6.7	3.3	9.4	1.9	2.2	5.1	7.9	101.4	1.6	6.7	2.2	2.2	9.3	2.2	2.2	3.4	9.4	0.6	7.4	11.7	0.5	0.9	2.1	186.1	0	0	0	0	0	0	0	0	0	0	0	4.3	0	0.4	0.1	0	0	0	0.2	0	0	0	0	248.9	0	2.7	0	0.1	0	0	0	0	0	0	0	0.1	175.4	0	0	1	0	0	0	0	0	0	0.1	5.8	0	0	0.5	0.4	0.2	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0	0	0.5	0.5	3.3	1.9	0	0	0.6	0.2	0.7	0.7	0.4	0.7	2.1	11.7	0.9	0	7.4	0	186.1	7.1	6.6	7.9	10	5.2	5.1	10.1	5.8	3.3	2.2	0	0	18.2	0	9.4	0.2	0.8	2.5	0	0	0	0	0	6.6	0	4.6	0.5	0.7	99681	0	0	0	0.1	0	30.9	0	0	1.2	17.2	53	11.2	0	0	4114.8	0	0.9	0.3	0.1	1.7	0.4	3.7	14.8	0	179.2	0.1	5.1	11.5	0	21.3	1.4	0	Erythroid cells
HBM	HBAP2, HBK	ENSG00000206177	Hemoglobin subunit mu	Q6B0K9	16	153892-166768	Predicted intracellular proteins	Oxygen transport, Transport			Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	5	bone marrow: 109.8;placenta: 50.2	Cell type enriched	Detected in some	740	Erythroid cells: 12474.7	Not detected	Not detected			Low region specificity	Detected in single			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in single		SCLC-21H: 2.3					Low region specificity	Detected in some												400000								unprognostic (1.30e-1)										unprognostic (7.59e-2)			0.9	0.2	0.4	0.2	0.5	109.8	0.3	0.1	0.2	0.2	0.2	0.5	0	0.2	0.2	0.2	0.6	0.2	0.2	4.4	0.3	0.4	1.7	2.6	16.5	0.2	0.7	0	1.6	0.2	0.2	1.1	50.2	1.2	0.5	0.2	1.2	0.2	0.2	0.4	0.2	0.2	0.2	0.4	17.5	0.2	0.2	0	1	2	0.1	0.3	2.1	4.9	0.1	0.5	0.5	0	0.9	0.4	10.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.3	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0.4	0	0	0	0	0	0	0.1	0	0	0	0.9	0	0.5	0	10.5	0.4	0.5	0.1	0.2	0.3	0.4	0.7	0	1.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	12474.7	0	0	0	0	0	0	0	0	0	0.6	1	0	0	0	16.9	0	0	0	0	0	0	0	0	0	1.9	0	2.3	0.1	0	0	0	0	Erythroid cells
ANKUB1	C3orf16	ENSG00000206199	Ankyrin repeat and ubiquitin domain containing 1	A6NFN9	3	149761100-149968385	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in some		fallopian tube: 12.2;lung: 11.9;ovary: 10.4	Cell type enriched	Detected in some	5	Ciliated cells: 100.4	Not detected	Not detected			Region enhanced	Detected in many		pons and medulla: 5.2	Cell type enriched	Detected in single	8	neutrophil: 4.8	Lineage enriched	Detected in single	10	granulocytes: 4.8	Cell line enhanced	Detected in some		OE19: 4.6					Low region specificity	Detected in all			HPA053749	Uncertain											HPA053749: AB_2682248	unprognostic (1.71e-2)	unprognostic (1.89e-4)	unprognostic (1.01e-1)	unprognostic (4.20e-2)	unprognostic (1.98e-1)	unprognostic (1.18e-1)	unprognostic (2.42e-1)	unprognostic (1.61e-2)	unprognostic (1.48e-1)	unprognostic (9.61e-2)	unprognostic (1.52e-2)	unprognostic (2.35e-1)	unprognostic (2.18e-9)	unprognostic (3.06e-1)	unprognostic (2.96e-1)	unprognostic (3.17e-1)	unprognostic (7.07e-4)	0	0	0.8	0.2	1.2	0.6	0	0	0.3	2.1	0	1.8	0	0.2	0.9	0.1	0	12.2	0.1	0	1.5	1.7	0	0	11.9	0.1	0	0	10.4	0.1	0	1.1	0.1	5.2	0.1	0	0	0.5	0	0.1	0.6	0.1	0	0.3	0.2	0.3	2.2	0.8	0	0	0.6	0.1	0.1	0	0.4	0.3	4.8	0.4	0.2	0.3	0	0.4	0.6	0.6	0.2	0	0.1	0.5	0.2	0	0	0	0.9	0.9	0.8	0.2	0	0.2	1.4	0.4	0.4	0.2	0.5	0.3	0.8	1.9	0.4	0	0.4	0.7	0.1	0	0	0.1	0.1	0	0.4	0.4	0.8	0	0.3	0.5	0.8	0.4	4.6	0.5	0.9	0.6	0.5	0	0.8	0.5	0.1	0.4	0.4	0	0.3	0.7	0.2	0	0.6	0.5	0.2	0.3	0.5	0.4	0.8	0.4	0.7	0.2	0.5	0.4	0.5	0.2	0.1	0.1	0.3	0.1	0.2	0	0.4	0.1	0.3	4.8	0.2	0.1	0.3	0.1	0	0.8	1.2	0	0.3	1.5	1.7	0	0	5.2	0.8	0	1.7	0	0.6	0.5	0	0.3	0	100.4	20.5	0	0	0	0	0	9.8	0	0	0	0	0	0.2	0.3	0	0	0.1	0	0	0	0.6	3.3	0.3	0.6	0	0	0	0	0	0	0	0	0	0	0	0.1	0	1.1	0	0	0	0.5	Ciliated cells
PRR23A		ENSG00000206260	Proline rich 23A	A6NEV1	3	139005468-139006268	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level	No human protein/transcript evidence	No human protein/transcript evidence		Tissue enriched	Detected in single	8	testis: 6.1	Cell type enriched	Detected in single	6	Spermatocytes: 1.1	Cancer enriched	Detected in single	17	testis cancer: 0.8					Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in single		MCF7: 2.8									HPA047473	Uncertain		Approved	Nucleoplasm,Nuclear bodies,Microtubules,Cytokinetic bridge,Mitotic spindle,Cytosol						Nucleoplasm, Microtubules	Nuclear bodies, Cytokinetic bridge, Mitotic spindle, Cytosol	HPA047473: AB_2680062															unprognostic (1.48e-1)			0	0	0	0	0	0	0	0	0	0	0			0	0.1	0	0	0	0	0	0	0	0	0	0	0	0		0.7	0	0	0	0		0	0		0	0	0	0	0	0	0	0	0	6.1			0		0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.1	0.2	0	0	0	0	0	Spermatocytes
COL6A6		ENSG00000206384	Collagen type VI alpha 6 chain	A6NMZ7	3	130560334-130678155	Predicted intracellular proteins, Predicted secreted proteins	Cell adhesion			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in some		heart muscle: 5.6;lung: 11.1;pituitary gland: 5.7	Cell type enriched	Detected in some	4	Fibroblasts: 7.1	Cancer enhanced	Detected in some		testis cancer: 1.0					Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	6	SuSa: 5.5	Not detected	Not detected			Not detected	Not detected			HPA045239	Uncertain				Secreted to extracellular matrix				490000			HPA045239: AB_2679268	unprognostic (4.86e-3)	unprognostic (2.16e-2)	unprognostic (9.91e-2)	unprognostic (2.08e-4)	unprognostic (2.79e-1)	unprognostic (1.11e-5)	unprognostic (3.74e-3)	unprognostic (5.59e-2)	unprognostic (1.42e-1)	unprognostic (3.50e-2)	unprognostic (8.90e-2)	unprognostic (2.70e-1)	unprognostic (2.96e-4)	unprognostic (5.82e-2)	unprognostic (1.61e-1)	unprognostic (1.45e-2)	unprognostic (1.07e-1)	2.3	0	0	0	0.1	0	3.4	0	0	0	0			0	0.7	0.3	1.2	0.3	0	5.6	0	0	0	0.9	11.1	0	0		0.2	0	0	5.7	0.8		0	0		2.2	0	0	0.4	0	0.5	0	1.5	0	0.3			0		0	0	0	0	0	0.1	0.1	0	0.4	0	0	0	0	0	0	0	0.1	0.3	0.4	0	0	0.1	0.3	0.1	0	0	0	0	0	0	0	0	0	0.5	0.1	0	0	0.1	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0.3	0	0	0	0.1	0	0	0	0.1	0.9	0	0	0	5.5	0	0.1	0.1	0	0.3	0.1	0	0	0	0	0	0.3	0	0	0	0	0.4	0	0	0	0.2	0.2	0	0	0.2	0.3	0.1	0	0.1	0	0.2	0											0	1.4	0	0	0.8	1.2	1.3	0	0	1.2	0	0	0	0	0	0.4	0	0	0	0	0	7.1	0	0	0	0.2	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	1.7	0	0.2	0	0.4	0.6	0.1	0	0	0	Fibroblasts
RAB12		ENSG00000206418	RAB12, member RAS oncogene family	Q6IQ22	18	8609445-8639381	Predicted intracellular proteins	Autophagy, Protein transport, Transport			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		skeletal muscle: 96.4	Cell type enriched	Detected in many	4	Cardiomyocytes: 87.9	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low cell line specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA040727	Approved		Approved	Vesicles						Vesicles		HPA040727: AB_10794858	unprognostic (7.92e-2)	unprognostic (4.11e-2)	unprognostic (1.05e-1)	unprognostic (1.72e-2)	unprognostic (1.53e-2)	unprognostic (1.47e-2)	unprognostic (1.25e-2)	unprognostic (2.77e-2)	unprognostic (1.11e-1)	unprognostic (1.29e-3)	unprognostic (2.67e-1)	unprognostic (5.72e-2)	unprognostic (2.02e-1)	unprognostic (1.63e-1)	unprognostic (1.46e-1)	unprognostic (1.61e-1)	unprognostic (9.11e-2)	20	16	18	10.2	18.3	7.2	15.6	23.5	22.1	17.2	16.8	13.8	9.2	7.3	18.5	12.3	17.3	13.4	11.2	45.6	16.2	16.2	18.4	20.7	15.8	12.5	13.7	17.8	19	7.5	10.4	12.7	17.6	15.3	15.3	10.5	13.7	10.1	18.6	96.4	18.1	10.3	25.4	12.2	16.3	10.8	8.3	10.6	7.7	12.1	21.2	11.9	19.4	20.2	3.2	4.1	7.7	5.1	3.9	3.1	1.3	11.6	6.9	8.1	8.5	24.2	20.6	4.5	15.9	21.9	18.2	21.4	9.4	10.8	4	15.5	19	13.6	7.4	9.4	17	22.1	1.6	7.6	3.4	7.4	9.8	22.5	4.5	3.6	20.3	24.1	13.3	17.1	18.8	21.9	3.6	5.2	5.8	17.6	12.6	5.1	4.5	5.2	40.4	6.6	3.6	19.7	3.8	17.7	15.7	13.5	9.6	12.1	16.5	19.9	12	4.8	6.9	18.3	21.1	12.3	21	24.1	3.9	2.2	3.4	15.8	4.2	13.4	7.7	2.2	2.4	2.1	3.6	3	3.2	2.3	2.5	1.8	3	3.1	3	4.1	3.9	5.1	4.1	2.5	1.3	18	18.3	23.5	22.1	16.2	16.2	13.7	17.8	15.3	10.6	11.9	17.1	3.4	1.7	5.8	14.8	87.9	2.5	10.7	13.6	3.5	5.9	1.4	3.3	2	0	7.4	1.6	0	1.2	1.1	5	3.2	5.8	15.3	1.5	11.1	5.2	19.6	13.9	0	3.1	6.9	3.3	2.8	2.8	14.3	2.5	0	4.2	4.9	6.7	0	5.2	1	1.5	7.3	0.9	2.5	2.3	3.5	Cardiomyocytes
CFAP44	FLJ11142, WDR52	ENSG00000206530	Cilia and flagella associated protein 44	Q96MT7	3	113286947-113441610	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 38.2;epididymis: 20.2;testis: 20.3	Cell type enriched	Detected in many	4	Ciliated cells: 192.7	Low cancer specificity	Detected in many			Region enhanced	Detected in all		pons and medulla: 38.2	Low cell type specificity	Detected in single			Low lineage specificity	Detected in single			Low cell line specificity	Detected in many			Low region specificity	Detected in many							HPA067258	Uncertain											HPA067258: AB_2685814	unprognostic (2.83e-1)	unprognostic (7.07e-2)	unprognostic (1.65e-1)	unprognostic (1.06e-1)	unprognostic (2.35e-1)	unprognostic (3.39e-3)	unprognostic (7.51e-4)	unprognostic (6.73e-2)	unprognostic (1.10e-1)	unprognostic (2.89e-1)	unprognostic (1.62e-2)	unprognostic (2.18e-3)	unprognostic (2.13e-6)	unprognostic (8.77e-2)	unprognostic (1.04e-1)	unprognostic (1.77e-2)	prognostic favorable (7.09e-6)	1.5	1.2	2.8	1.5	10.1	1.4	3.6	3.9	2.3	2.8	2.3	15.4	0.7	1.1	3.2	20.2	1.6	11.1	1.6	1.7	6.1	1.3	2.6	1.9	7	2.1	1.2	1	8.8	4	6	5.8	1.1	38.2	3.9	3.9	0.8	5.7	1.9	1.3	3.7	2.9	1.2	2	1.8	3.5	20.3	5.9	0.9	3.4	0.7	1.9	2.6	2.6	1.3	0.3	0.8	0.2	0.1	0.7	0	3.9	2.6	4.2	4.5	2.8	4	5.6	1.8	0.9	1.2	2.3	1.3	2.3	4.4	0.6	1.1	1.5	4.8	2.8	1.4	2.4	1.9	3	3	7.9	1.5	0.1	4.9	3	0.9	3.3	1	1.1	4.5	0.9	4.3	1.2	2.8	1.5	2.5	2.7	4.9	2.7	5.3	6.1	3.3	1.1	0.7	2.1	6.3	4.3	4.7	2.7	0.6	2.6	2.5	3.3	3.5	2.8	3.4	3.7	1.3	1.7	3.9	2.2	0.4	2.1	3	2.7	0	0.2	0.8	0.4	0.1	0.4	0.4	0.5	0	0	1.3	0.7	0.4	0.6	0.1	0	0.3	0.2	0	2.8	10.1	3.9	2.3	6.1	1.3	1.2	1	38.2	5.9	8.9	10.7	0	1.8	0	7	5.3	0	192.7	34.2	3.5	19.6	0.8	0	1.9	46.7	2.2	1	0	2.6	0.8	0.7	3.3	10.5	3	0.5	7.9	0	0.6	1.2	38.2	5.8	0	0	0	5.2	5.3	2	0	6.3	1.1	20.3	0	0.9	25	4.8	0	0.7	0	3.7	1.7	Ciliated cells
CTAGE1	CT21.1, CT21.2, CTAGE, cTAGE-1, cTAGE-2	ENSG00000212710	Cutaneous T cell lymphoma-associated antigen 1	Q96RT6, Q9HC47	18	22413601-22417915	Predicted membrane proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	49	testis: 12.9	Cell type enriched	Detected in some	11	Early spermatids: 62.0	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HBF TERT88: 2.3;U-2 OS: 1.8									HPA000387, HPA000922, CAB016204	Uncertain											CAB016204: AB_673617, HPA000387: AB_1078582, HPA000922: AB_1078581					unprognostic (1.41e-1)		unprognostic (5.65e-2)	unprognostic (2.34e-1)		unprognostic (1.81e-2)	unprognostic (1.52e-1)		unprognostic (1.70e-2)	unprognostic (3.15e-1)	unprognostic (1.63e-1)	unprognostic (3.62e-1)		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	12.9	0	0	0	0	0	0	0	0	0.2	0.2	0.2	0.1	0.1	0	0	0	0	0	0	0	0	0.5	0	0.6	0.1	0	0	0	0	0.4	0.1	0.1	0	0	2.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0.2	0	0.1	0	0	1.8	0	0	0.1	0	0	0	0	0	0.2	0	0	0	0.2	0.1	0	0	0.1	0.2	0	0.1	0.1	0	0.1	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0.1	0	1.3	0	0	0	0	0	0	0	0	62	0	0	0	0.3	0.1	0	0.4	0	0	0.1	0	0	0	0	5.6	0.3	0	0	0	0	0	0	0	0.4	0	0	0	0.1	4.9	0.5	0.3	0.1	0	0	0.3	Early spermatids
KRTAP2-3	KAP2.3	ENSG00000212724	Keratin associated protein 2-3	P0C7H8	17	41059240-41060114	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in some	6	skin 1: 19.5	Cell type enriched	Detected in some	4	Ductal cells: 25.6	Low cancer specificity	Detected in some			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		BJ: 21.3;fHDF/TERT166: 12.7;HBF TERT88: 19.0;LHCN-M2: 23.9;U-2 OS: 9.2									HPA059203	Supported											HPA059203: AB_2683947	unprognostic (2.22e-1)	unprognostic (2.58e-2)		unprognostic (3.79e-3)		unprognostic (3.25e-3)		unprognostic (2.78e-2)	unprognostic (6.91e-2)	unprognostic (1.38e-1)	unprognostic (6.41e-4)		unprognostic (7.83e-6)			unprognostic (1.71e-1)	unprognostic (9.36e-2)	0.1	0	0	0.3	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	1.4	0	0	0	0	0.1	0	0	19.5	0.2	0.4	0	0	0	0	0	0	0	3.1	0.1	0	0	0	0	0	0	0	0.1	0	4.7	0	0	0	0	0	0	21.3	0.7	5.3	4.5	0.2	0.2	0	0	12.7	1.3	0	0	0.3	19	0	0	0	0	0.1	0	0	0	0	0	1.3	0.3	0.4	0	0	0	0	23.9	0	0	0	0	0	1.6	0	0.1	0	3.1	0	0.6	0	0	0	0	0	0	0	0	0.9	9.2	0.6	0.6	0	0	0	0.1	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0.3	0	25.6	0	0	0	0	0.5	0.3	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	6.4	0	0	0	0	0	0	0	0	0	0	0	0	0	Ductal cells
KRTAP3-3	KAP3.3	ENSG00000212899	Keratin associated protein 3-3	Q9BYR6	17	40993430-40994133	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Group enriched	Detected in some	25	skin 1: 50.5;tongue: 29.5	Cell type enriched	Detected in single	17	Intestinal endocrine cells: 1.7	Cancer enhanced	Detected in single		urothelial cancer: 0.9	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HeLa: 1.1;SCLC-21H: 2.3									HPA042992	Supported											HPA042992: AB_2678258																		0.2	0	0	0	0	0	1.5	0	0	0	0.2	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0.1	0.6	0.4	0	0.3	0	0	50.5	0	0	0	0	0	0.3	0	0.5	0	29.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.3	0	0	0	0	0	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	1.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Intestinal endocrine cells
CGB8		ENSG00000213030	Chorionic gonadotropin beta subunit 8	P0DN86	19	49047638-49049106	Predicted secreted proteins		Hormone		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Group enriched	Detected in some	85	pituitary gland: 7.0;placenta: 22.2	Cell type enriched	Detected in some	15	Syncytiotrophoblasts: 37.1	Cancer enhanced	Detected in some		testis cancer: 5.9					Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	7	BEWO: 61.9;U-251 MG: 21.5									HPA038925, HPA038934	Supported		Approved	Cytosol	Secreted to blood					Cytosol		HPA038925: AB_2676272, HPA038934: AB_2676277		unprognostic (3.35e-2)				unprognostic (1.72e-1)					unprognostic (7.44e-3)				unprognostic (4.70e-1)		unprognostic (1.67e-2)	0	0	0	0	0	0	0	0	0	0	0			0	0	0	0.1	0	0	0	0	0	0	0	0	0	0		0	0	0.1	7	22.2		0	0		0	0	0	0.1	0	0	0	0	0	0.1			0		0	0	0	0	0	0	0	0	0	0	5.6	0.3	0	0	0	0	61.9	0	0	0.2	0	0	1.9	0	0	0.3	1.4	0.4	0	0	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0.8	0	0	3.9	0	0.2	0	1.2	2.6	0.2	21.5	0	0.1	0	2.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0	0	0	0	2.5	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	37.1	0	0	0	Syncytiotrophoblasts
FAM24B	AC073585.2, MGC45962	ENSG00000213185	Family with sequence similarity 24 member B	Q8N5W8	10	122849078-122879641	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	No human protein/transcript evidence	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		kidney: 24.5	Cell type enriched	Detected in many	4	Distal tubular cells: 43.1	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Group enriched	Detected in many	6	hTERT-HME1: 43.9;LHCN-M2: 55.2;TIME: 17.8									HPA052490	Supported				Intracellular and membrane							HPA052490: AB_2681851	unprognostic (4.03e-2)	unprognostic (4.27e-2)	unprognostic (3.13e-3)	unprognostic (8.40e-5)	unprognostic (2.55e-2)	unprognostic (3.31e-2)	unprognostic (6.42e-7)	unprognostic (2.99e-1)	unprognostic (7.06e-3)	unprognostic (3.00e-1)	unprognostic (5.89e-2)	unprognostic (3.59e-2)	unprognostic (1.78e-1)	unprognostic (2.58e-1)	unprognostic (9.23e-2)	unprognostic (1.25e-1)	unprognostic (8.81e-3)	2.2	2.4	6.9	13.5	6.4	3.9	4	6.7	7.4	2.3	4.1	5.1	2.2	2.8	3.4	3.8	3.1	3.8	3.7	1.5	5.8	5.9	24.5	1.7	3.7	6.5	6.9	3.4	5	12.5	2.6	11.4	1.1	6.6	3.2	5.9	1.9	2.7	2.6	1.7	4.5	4.1	3	6.8	4.7	4.4	11.4	5.6	9.8	2.9	2	6.3	2.4	2.5	5.9	11.3	3	2.2	2.7	5.3	1.9	2.2	3.8	0.7	0	0.4	1.1	1	3.3	3.3	1.5	1.1	3.8	4.2	0.8	1.1	1.8	0.4	1.1	0	1.7	3.9	4.1	1.5	6.3	3.6	2	3.4	0	3.7	1.3	0.2	3.1	43.9	0.2	3.4	4.7	2.7	1.5	55.2	2.1	3.9	3.6	1.3	2.3	3.9	0	5.6	0.8	2.5	1.7	2.5	1	1.5	0.7	4.5	2.2	1.2	3.8	17.8	0.3	1.7	1.4	0.3	1.8	2	5.2	2.9	6.1	0	3	2.2	1.4	2.6	1.9	0.9	5.9	5	3.4	3	3.7	5.3	3.4	1.4	2.7	1.8	11.3	4.9	1.9	6.9	6.4	6.7	7.4	5.8	5.9	6.9	3.4	6.6	5.6	0	0.3	6.9	1.3	6	3.6	0.2	2.5	0	0	8.7	0	0.1	43.1	3.7	1.6	0.7	1.5	0	6.2	0.1	0.8	1.8	9.2	0.5	1.1	1.6	4.6	1.3	3.2	1.6	3.4	1.9	1.7	2.8	2.8	2.3	7.6	3.5	3.9	1.4	4.5	0	2.1	9.8	4.9	4.6	0	8.6	2.8	1	Distal tubular cells
CSH2	CS-2, CSB, hCS-B	ENSG00000213218	Chorionic somatomammotropin hormone 2	P0DML3	17	63872012-63873766	Predicted intracellular proteins, Predicted secreted proteins		Hormone		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in some	36	placenta: 246.2	Cell type enriched	Detected in some	25	Syncytiotrophoblasts: 230.4	Cancer enhanced	Detected in single		testis cancer: 0.6	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	25	BEWO: 10.2;SuSa: 15.3									HPA043715	Supported				Secreted to blood							HPA043715: AB_2678632		unprognostic (1.68e-1)								unprognostic (1.85e-1)					unprognostic (1.86e-1)			0.3	0	0	0	0	0	0	0.1	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	6.7	246.2	0	0	0	0	0	0	0	0.1	0	1.1	0	0.4	0.3	0.6	0	0	0	0	0	0.1	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	10.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0.2	0.1	0	0	0	15.3	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.1	0	0	0	0	0	0	0	7.4	0	0	0	0	9.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	230.4	0	0	0	Syncytiotrophoblasts
TCL1B	TML1	ENSG00000213231	T cell leukemia/lymphoma 1B	O95988	14	95686417-95692643	Predicted intracellular proteins			Proto-oncogene	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		blood: 13.0;lymphoid tissue: 5.4;placenta: 12.7;testis: 7.3	Cell type enriched	Detected in some	13	Syncytiotrophoblasts: 60.8	Cancer enriched	Detected in single	72	testis cancer: 8.3	Not detected	Not detected			Group enriched	Detected in some	23	naive B-cell: 13.0;plasmacytoid DC: 5.9	Group enriched	Detected in many	23	B-cells: 13.0;dendritic cells: 5.9	Cell line enriched	Detected in some	7	U-698: 104.8					Not detected	Not detected			HPA053163	Uncertain		Approved	Cytosol						Cytosol		HPA053163: AB_2682064															unprognostic (1.55e-1)			0.1	0.2	0.1	0.9	0.1	2.5	0.1	0.1	0.1	0.1	0.1	0	0	0	0.4	1.4	0.4	0.1	0	0.1	0.1	0.1	1.1	0.1	0.1	5.3	0.1	0	0.2	0.1	0	0.1	12.7	0	0.3	0	0	0.1	0	0.1	0.1	0.6	0	0.1	1.8	0.1	7.3	0	0	0.1	0	5.4	0.1	0.1	13	5.9	0.3	0	0.4	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.1	0	0	0	0	0	0	0	0.1	0	0.5	0.1	0	0	0	0.2	0	0	0	0.1	104.8	0	0	0	0	0	0	0	0	0	0	0	0	0	13	0	0	0.3	0.4	0	5.9	0	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	1.1	0	0	0.2	0	0	0	0	2	0	0	0	0	0.3	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0.3	0	0	0	0	4.7	0	60.8	0	0	0	Syncytiotrophoblasts
MXD3	bHLHc13, MAD3	ENSG00000213347	MAX dimerization protein 3	Q9BW11	5	177301461-177312757	Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	DNA-binding, Repressor		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		bone marrow: 32.1;lymphoid tissue: 59.4	Cell type enriched	Detected in many	7	Erythroid cells: 116.8	Low cancer specificity	Detected in all			Low region specificity	Detected in many			Cell type enhanced	Detected in many		neutrophil: 14.1	Group enriched	Detected in many	6	granulocytes: 14.1;monocytes: 8.7	Cell line enhanced	Detected in many		HDLM-2: 59.2	Low region specificity	Detected in some			Low region specificity	Detected in all			HPA070111			Approved	Nucleoplasm,Nucleoli			Yes			Nucleoplasm, Nucleoli		HPA070111: AB_2686228	unprognostic (2.78e-1)	unprognostic (1.32e-2)	unprognostic (2.11e-1)	unprognostic (3.63e-1)	unprognostic (8.26e-2)	unprognostic (6.18e-3)	prognostic unfavorable (3.60e-4)	unprognostic (3.32e-1)	unprognostic (6.84e-2)	unprognostic (3.12e-2)	unprognostic (4.97e-2)	unprognostic (2.84e-2)	unprognostic (3.33e-16)	unprognostic (8.55e-3)	unprognostic (2.22e-1)	unprognostic (1.61e-1)	unprognostic (3.22e-3)	2.5	1.8	1.3	28.2	1.9	32.1	5.4	1.2	3.4	2.4	6.8	1.2	2.8	6.9	2.7	6.2	6.6	3.6	2.8	2.4	1.6	0.8	2.7	6.6	5.4	7.3	2.2	1.2	2.6	5.8	0.7	4.3	4.5	2.1	5	0.9	1.1	4.7	2.1	3.6	10.3	5.6	1.4	1.3	10.3	3.8	3.1	2.9	59.4	3.5	3.7	13.5	2.7	3.6	2	1.6	14.1	8.7	0.7	0.8	1.1	8.1	5.6	3.5	9.5	0.2	0.5	5.8	10.6	3.5	4.8	4.6	3.7	8.5	4.3	4.4	1.4	2.6	4	0.4	1.2	0.2	59.2	7.2	2.4	8.1	5.4	0.5	2.3	7.5	0.3	0.6	0.3	0.2	0.4	4.4	19.2	1.5	13.6	0.9	10.4	21.6	6.5	1.2	2.5	9.8	10.6	10.8	6.2	1	1.1	8.6	7.1	6.8	6.9	3.7	0.5	10.9	6.2	3.2	5.8	15	4.6	5.6	18	5.9	4.7	4.5	8.1	3.3	3.5	2.6	7.7	0.7	7.2	0	1.6	0.1	0.1	1.6	2	0	0.3	14.1	0.7	8.7	1	0.8	1.1	1.3	1.9	1.2	3.4	1.6	0.8	2.2	1.2	2.1	2.9	3	2.2	0	1.5	4.9	2.8	1.2	5.1	5.3	4.5	5.2	0	4.5	0	1.3	16.3	2.3	4	116.8	3.5	7.2	3.4	2.4	9.2	3.9	8.8	3.2	1.7	4.3	4.9	1.9	1.7	5.1	3.3	1	5	1	1.9	3.1	1.4	0.3	2.2	0	3.1	0.7	5.9	5	11	5.1	6.9	1.8	Erythroid cells
LCAT		ENSG00000213398	Lecithin-cholesterol acyltransferase	P04180	16	67939750-67944131	Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins	Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism	Acyltransferase, Hydrolase, Transferase	Corneal dystrophy, Disease mutation	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	11	brain: 64.4;liver: 154.2	Cell type enriched	Detected in many	16	Hepatocytes: 204.0	Low cancer specificity	Detected in all			Region enriched	Detected in all	7	cerebellum: 64.4	Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		BEWO: 35.6;Hep G2: 27.7	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA044767			Approved	Nucleoplasm	Secreted to blood			6470000000	9500000000	Nucleoplasm		HPA044767: AB_2756312	unprognostic (3.34e-2)	unprognostic (3.56e-2)	prognostic unfavorable (8.50e-4)	unprognostic (5.43e-3)	unprognostic (1.25e-2)	unprognostic (2.16e-1)	prognostic favorable (4.21e-8)	unprognostic (6.42e-2)	unprognostic (4.26e-1)	unprognostic (4.12e-1)	unprognostic (1.50e-2)	unprognostic (7.21e-2)	prognostic unfavorable (1.71e-4)	unprognostic (9.93e-2)	unprognostic (1.83e-1)	unprognostic (2.85e-1)	unprognostic (1.90e-3)	4.4	3.6	6.3	2.2	3.7	0.9	4.3	64.4	9.6	4.5	4.4	7.3	1.4	1.3	5.3	3	1.8	3.5	3.5	4.5	8.4	1.8	3.9	154.2	5.6	1.9	5.5	6.3	4.7	2.5	5.9	2.7	5.5	9.2	6.4	1.3	1.8	2.4	6.2	3.4	9.9	2.4	3.8	7.5	3.9	2.3	2.2	6.1	1.4	7.6	1.6	1.4	2.6	4.5	1.8	0.8	5	1.1	1.3	1.4	0.1	2.5	4	6	6.8	5.2	7.4	35.6	9.9	4.3	6.7	4.7	13.3	3.1	1.3	1.9	14.3	2.4	8.8	1.4	13.6	4.2	0.6	3.6	1.7	8.9	27.7	7.2	0.3	4.7	12.8	12.9	13.9	4.8	9.1	4.9	4	3.8	0.6	4.7	4.1	1.6	4.2	3.9	0.4	2.2	1.7	6.5	1.4	1.9	4.3	0.2	3.1	15	0.7	1.7	12.9	8.5	2.7	9.3	8.7	13.6	9.5	3.5	8.2	2.2	3.7	4.1	1.1	7.5	2.4	1.1	5	0.9	0.1	1.3	1.2	0.7	0.8	0.2	1.8	1.4	0.4	2.8	1.3	0.5	0.8	0	0.1	6.3	3.7	64.4	9.6	8.4	1.8	5.5	6.3	9.2	6.1	8.9	4.5	0	4.1	8.4	0.2	4.2	7.6	2.7	3.4	3.5	2	6	0	1.6	0	4.3	0	0	0.9	2.7	7.1	2.9	1.1	204	2.1	0	1.2	12.3	3.2	0.5	8.1	1.6	6.8	2.8	0	7.5	1.4	0	8.1	0	0.5	12.9	7.1	1	1.5	2.3	10.2	0	0	1.4	Hepatocytes
MAGEA12	CT1.12, MAGE12	ENSG00000213401	MAGE family member A12	P43365	X	152733779-152737669	Predicted intracellular proteins		Tumor antigen		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	21	brain: 4.1;testis: 8.3	Cell type enriched	Detected in some	6	Spermatogonia: 19.4	Cancer enhanced	Detected in many		melanoma: 10.8	Region enhanced	Detected in some		cerebral cortex: 4.1	Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		GAMG: 45.5;HMC-1: 18.4;K-562: 26.7;OE19: 34.5;SH-SY5Y: 15.3;U-2 OS: 27.9;U-266/70: 22.0																										unprognostic (3.47e-2)	unprognostic (4.54e-1)	prognostic unfavorable (3.22e-4)	unprognostic (1.82e-1)	unprognostic (3.25e-1)		unprognostic (1.60e-3)		unprognostic (8.57e-4)	unprognostic (4.61e-2)	unprognostic (1.78e-1)		unprognostic (4.06e-2)	0.2	0	0.7	0	1.1	0	0	0.1	4.1	0	0	0	0	0.2	0.2	0	0	0	0	0	0.5	0.4	0	0	0	0.1	1.1	0	0	0	0	0	0.1	0	0	0	0	0.1	0	0	0	0.1	0.1	0.1	0.1	0.1	8.3	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0.1	0	1.6	0	0	0.7	0	0	0	0	0	0	0	0	0	45.5	0	0	0	0	0	0	0.2	0.4	0	0	0	18.4	0	0	0	0	0	0	0	26.7	0	0	0	0	0	0	34.5	13.1	0	0	0.3	0	0	1	15.3	0	7.6	3.9	0	0.2	0	0.1	0	27.9	4	1.9	22	0	0	0	0	0.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.7	1.1	0.1	4.1	0.5	0.4	1.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.7	0.6	0	0	0	0	0	0	0	0.4	0	0	0	0	3.4	19.4	0	0	0	0	0	Spermatogonia
CPLX3	CPX-III	ENSG00000213578	Complexin 3	Q8WVH0	15	74826547-74831802	Predicted intracellular proteins	Exocytosis, Neurotransmitter transport, Sensory transduction, Transport, Vision			Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		brain: 20.8;lymphoid tissue: 31.8;prostate: 56.4;retina: 32.8	Cell type enriched	Detected in some	7	Bipolar cells: 506.7	Not detected	Not detected			Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		Daudi: 5.6;Karpas-707: 4.9;SCLC-21H: 2.2;SK-BR-3: 2.8;U-266/84: 3.2;U-698: 2.3	Low region specificity	Detected in some			Low region specificity	Detected in many			CAB079003		Supported										CAB079003: 																		0.4	2.5	6.4	0.5	7.4	0.4	0.4	20.8	19.6	0.5	0.5	3.3	0	0.4	0.4	0.5	0.5	0.4	0.4	13.4	6.4	0.8	0.4	0.4	0.4	0.5	0.6	7.9	0.4	0.4	0.4	1.7	0.4	8.2	56.4	0.4	32.8	9.8	0.4	0.4	0.5	0.6	0.4	1	31.8	4.6	2.2	1.2	0	0.4	0	0.5	0.4	0	0	0	0	0	0	0	0	0	0	0.1	0.3	0	0	1.5	0	0	0.1	0.2	0.1	0	5.6	0.1	0	0	0.2	0.1	0	0	1.9	0.1	0	0.1	0	0	0	1.2	0	0.2	0.2	0	0	0	0.3	0	4.9	0	0.1	0	0.9	0.1	0	0.3	0.2	0	0.4	0	0.1	2.2	0.1	0	2.8	1.2	0.3	1.7	0	0	0.1	0.1	0.5	0	1.4	3.2	2.3	0.1	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	6.4	7.4	20.8	19.6	6.4	0.8	0.6	7.9	8.2	1.2	0	0	0	0.2	0	506.7	0	0	0	0	0	72.6	0	0	0	2.2	0	0	0	0	0	0	11.9	0	0	0	14.3	0	0	0	2.7	0	0	0	0	0	10.5	0	0	0	0	54.1	0	0	8.1	1.7	0	0	0	0	0.1	Bipolar cells
FAM209B	C20orf107, dJ1153D9.4	ENSG00000213714	Family with sequence similarity 209 member B	Q5JX69	20	56533246-56536520	Predicted membrane proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	10	testis: 40.8	Cell type enriched	Detected in some	10	Early spermatids: 1427.6	Low cancer specificity	Detected in single							Cell type enhanced	Detected in many		eosinophil: 3.4	Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		U-266/70: 5.0									HPA042144	Enhanced											HPA042144: AB_10794414	unprognostic (2.93e-1)	unprognostic (6.90e-2)	unprognostic (9.49e-3)	unprognostic (4.96e-3)	unprognostic (1.72e-1)	unprognostic (3.77e-1)	unprognostic (1.72e-1)	unprognostic (7.77e-2)	unprognostic (3.63e-2)	unprognostic (1.43e-1)	unprognostic (4.59e-4)	unprognostic (3.47e-1)	unprognostic (2.02e-3)	unprognostic (1.48e-1)	unprognostic (1.55e-1)	unprognostic (7.13e-2)	unprognostic (1.48e-4)	0.2	0	0	0.2	0.1	4.1	0.3	0.1	0	0	0			0	0	0	0	0.1	0	0	0	0	0	0.1	0.2	0.5	0		0	0.3	0	0.2	0		0.1	0.1		0.2	0	0.3	0.3	0.2	0	0	0.9	0.1	40.8			0		0.3	0	0	1	0.8	3.4	1.1	0	2.1	0.4	0	2.7	0.7	0	0	0.3	0.4	1.1	1.9	2.4	0.9	1.7	0.1	0.3	1.8	1.2	0.6	1.4	1.2	0.7	2.1	0.4	1.1	1.2	0	1.1	0	2.2	4.2	1.3	2	0.2	1.5	0	0	1.9	0.2	1.9	0	2.6	0.8	2	0.5	0.2	1.5	0.7	0.8	0.2	1.5	0.9	1.7	0.4	0.9	3.4	0.6	0.8	1.5	0.6	0	0.3	0.7	1.7	0.1	5	4.5	0.9	0.4	1	0.3	0	1.1	3.4	2.1	0.4	0.3	0	0.1	1.3	0.8	1	0.7	0	1.8	0	0.7	0	0	0.4											0	3.4	0	0.4	0.1	0	0.3	0	0	0	0	0	0.2	0	0.8	1427.6	0	0	0	1.4	0.4	0	0.3	1.1	0	0.5	0	1.2	0	0.3	148.4	10.6	0.7	0	1	0	0	0.6	0	7.8	0.5	0	0	0.5	6.9	6.8	0	0	0	0	0.6	Early spermatids
UGT2B11		ENSG00000213759	UDP glucuronosyltransferase family 2 member B11	O75310	4	69199951-69214731	Enzymes, Predicted membrane proteins		Glycosyltransferase, Transferase		Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level		Tissue enriched	Detected in some	10	breast: 77.4	Cell type enriched	Detected in some	7	Cholangiocytes: 12.7	Group enriched	Detected in some	17	breast cancer: 17.4;liver cancer: 13.1	Not detected	Not detected			Group enriched	Detected in some	62	basophil: 6.8;eosinophil: 5.6	Lineage enriched	Detected in single	68	granulocytes: 6.8	Cell line enhanced	Detected in some		Hep G2: 1.5;HL-60: 3.1;NB-4: 2.5;RPTEC TERT1: 3.7;U-2197: 1.5									HPA045108	Uncertain											HPA045108: AB_2679218	unprognostic (1.12e-1)						unprognostic (1.18e-3)			unprognostic (1.49e-1)	unprognostic (6.53e-2)	unprognostic (2.26e-2)	unprognostic (1.65e-1)	unprognostic (7.84e-3)	unprognostic (5.47e-1)	unprognostic (1.32e-1)	unprognostic (1.51e-3)	0.1	0	0.1	0.1	0.1	0	77.4	0.1	0.1	0.1	0.6	0.1	0.1	0	0.1	0.1	0.1	0	3.3	0.1	0.1	0	1.2	7.3	0.1	0.1	0.1	0.1	0.1	0.5	0	0.1	0.1	0.1	0.1	0	0.1	7	0.1	0.1	1.2	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.9	0.1	0.1	0.1	0.1	0	0	6.8	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0.2	0	0.5	0.9	0	0	0	0	0	0	0	0	0	0	1.5	0	3.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	2.5	0	0.5	0	0	0.1	0	3.7	0.2	0	0	0.1	0.3	0	0.1	0	0	0	0	0	1.5	0	0	0	0.1	0.6	0	0	6.8	0	5.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0	12.7	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	1.9	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0	0	Cholangiocytes
HBE1	HBE	ENSG00000213931	Hemoglobin subunit epsilon 1	P02100	11	5268345-5505652	Plasma proteins, Predicted intracellular proteins	Oxygen transport, Transport			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 7.7;liver: 6.7	Cell type enriched	Detected in some	6	Hofbauer cells: 131.4	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Cell type enriched	Detected in single	6	neutrophil: 2.1	Lineage enriched	Detected in single	6	granulocytes: 2.1	Cell line enriched	Detected in some	15	K-562: 472.7	Low region specificity	Detected in many			Not detected	Not detected			HPA043234	Approved											HPA043234: AB_2678378	unprognostic (7.59e-2)			unprognostic (6.70e-2)	unprognostic (3.76e-2)	unprognostic (4.25e-1)		unprognostic (1.64e-1)	unprognostic (9.03e-2)	unprognostic (2.28e-1)	unprognostic (1.26e-1)	unprognostic (7.32e-2)	unprognostic (1.02e-3)		unprognostic (2.14e-1)	unprognostic (5.80e-2)	unprognostic (7.34e-2)	1.8	1.1	1.1	0.4	1	1.3	0.9	1	1.9	0.7	0.4	0.4	0.4	0.1	0.6	2	0.4	1	0.6	0.4	1.4	0.8	0.9	6.7	0.6	0.4	7.7	5.1	1.9	0.5	0.1	0.6	3.6	3.2	1.1	0.3	0.4	0.7	0.6	1.5	0.6	0.4	1.2	0.5	1	0.4	2.2	0.4	1.6	0.6	0.4	0.4	0.4	0.7	0	0	2.1	0	0	0.3	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0	31.1	0	0.2	0	0	0	0	0	0	0	0	0	0	472.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.5	0	0	0.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	2.1	0	0	0	0	0.7	1.1	1	1	1.9	1.4	0.8	7.7	5.1	3.2	0.4	0	0	0	0	0.1	0	0	0	0	0	0	0	4.2	0	0	0.5	0	0	23.3	0	16.6	0.2	0	0	0	131.4	0	0	0	0	1.4	0.3	0	5	0	0	0	0	0	0	0	0	0	0.1	0.2	0.1	0	12.4	0	0	0	Hofbauer cells
MEF2B	RSRFR2	ENSG00000213999	Myocyte enhancer factor 2B	Q02080	19	19145568-19170289	Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	Activator, DNA-binding		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	22	lymphoid tissue: 81.2	Cell type enriched	Detected in single	16	Sertoli cells: 6.5	Not detected	Not detected			Low region specificity	Detected in many			Cell type enhanced	Detected in single		neutrophil: 1.1	Low lineage specificity	Detected in single			Group enriched	Detected in some	12	Daudi: 50.9;U-266/70: 51.2;U-698: 67.3	Not detected	Not detected			Low region specificity	Detected in all			HPA004734	Supported		Approved	Nucleoplasm,Cell Junctions,Cytosol						Nucleoplasm, Cytosol	Cell Junctions	HPA004734: AB_10963939	unprognostic (7.31e-3)	unprognostic (4.06e-2)	unprognostic (9.44e-5)	unprognostic (5.07e-2)	unprognostic (2.01e-1)	unprognostic (7.19e-3)	unprognostic (1.64e-1)	unprognostic (1.78e-1)	unprognostic (2.76e-1)	unprognostic (1.98e-2)	unprognostic (8.66e-3)	unprognostic (1.92e-2)	unprognostic (1.56e-11)	unprognostic (2.40e-1)	unprognostic (1.92e-1)	unprognostic (3.68e-1)	unprognostic (8.98e-3)	2	1	0.8	81.2	1.2	1.4	1.9	0.6	1.4	2.7	3	0.9	0.6	1.5	2.2	1.1	1.5	2.3	2.2	1.9	1	0.6	1.8	2.9	2	32.3	1.1	0.9	3.7	0.8	0.8	2.1	0.8	1	3.7	1	1.8	3.5	1.1	1.4	2.3	3.1	1.1	1.2	6.7	1.7	1.7	0.8	1.6	3	3.5	58.7	1.9	2.9	0.1	0.2	1.1	0.9	0	0.2	0	0.2	0.1	0.1	0.2	0.2	0.1	0.1	0	0	0.1	0	0	0.3	50.9	0.1	0.2	0.1	0.4	0	0	0	0.1	0.3	0.1	0.1	0.1	0.2	0.2	0.4	0.1	0.2	0.1	0.1	0.1	0	0.4	0.1	0.5	0	0.2	0.3	0.3	0	0	0.9	0.4	0	1	0	0	0	0.1	0.1	0	0.1	0	0	0.5	0.1	0	0.4	0.5	0.1	51.2	4.7	67.3	0.1	0.3	0	0	0.9	0	0.2	0.1	0.2	0.1	0.1	0.1	0.2	0	0.1	0.2	1.1	0	0	0	0	0	0.8	1.2	0.6	1.4	1	0.6	1.1	0.9	1	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	6.5	0	0	0	0	0	0	0	0	Sertoli cells
SMCO1	C3orf43, DKFZp313B0440, FLJ41923	ENSG00000214097	Single-pass membrane protein with coiled-coil domains 1	Q147U7	3	196506877-196515366	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Group enriched	Detected in some	22	heart muscle: 48.6;skeletal muscle: 57.8;tongue: 66.9	Cell type enriched	Detected in single	76	Cardiomyocytes: 71.8	Not detected	Not detected			Not detected	Not detected			Cell type enriched	Detected in single	5	NK-cell: 2.1	Lineage enriched	Detected in single	5	NK-cells: 2.1	Cell line enhanced	Detected in some		MCF7: 1.5;NTERA-2: 1.4;U-251 MG: 1.3	Not detected	Not detected			Low region specificity	Detected in all																unprognostic (4.86e-2)	unprognostic (1.62e-1)		unprognostic (1.51e-2)	unprognostic (6.08e-2)	unprognostic (1.72e-2)		unprognostic (1.73e-1)		unprognostic (3.25e-1)	unprognostic (1.64e-1)	unprognostic (1.94e-2)		unprognostic (2.95e-1)	unprognostic (2.72e-1)	unprognostic (3.07e-2)	unprognostic (2.88e-3)	0	0	0.1	0	0.1	0	0	0.1	0.1	0	0	0	0	0	0	1	1	0	0	48.6	0.1	0.1	0	0	0	0	0.1	0	0	0	0	0	0	0	0.3	0	0.6	2.1	0	57.8	0	0	0	0	0	0	0.4	0	0	0.6	66.9	2.5	0	0	0	0	0.4	0	2.1	0	0	0.3	0	0.7	0	0	0	0.3	0	0.2	0	0.1	0.3	0.1	0	0.4	0.6	0.9	0.3	0.4	0	0	0.5	0	0	0	0.3	0	0.7	0.1	0	0.2	0.2	0	0.7	0.2	0.4	0.2	0.8	0.2	1.5	0.7	0.1	1.4	0	0	0	0.2	0	0.2	0	0.3	0.3	0.3	0.4	0	0.4	0.1	0	0	0.5	0	0	1.3	0.5	0.5	0.4	0	0.7	0.1	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	2.1	0	0	0	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0.1	0	0	71.8	0	0	0	0	0	0	0	0	0.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.7	0.3	0	0	0	0	0	Cardiomyocytes
ANG	RAA1, RNASE5	ENSG00000214274	Angiogenin	P03950	14	20684177-20698971	Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins	Angiogenesis, Differentiation, Stress response	Developmental protein, DNA-binding, Endonuclease, Hydrolase, Nuclease, Protein synthesis inhibitor	Amyotrophic lateral sclerosis, Cancer-related genes, Disease mutation, Neurodegeneration	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	18	liver: 371.4	Cell type enriched	Detected in many	21	Hepatocytes: 4646.2	Cancer enriched	Detected in all	17	liver cancer: 279.2	Low region specificity	Detected in single			Cell type enhanced	Detected in many		classical monocyte: 18.1;myeloid DC: 10.4	Low lineage specificity	Detected in many			Group enriched	Detected in many	4	Hep G2: 52.5;OE19: 40.2					Low region specificity	Detected in many			HPA055896			Approved	Nucleoli,Nucleoli rim,Mitotic chromosome,Actin filaments	Secreted to blood	Yes	No	308000000	230000000	Nucleoli, Nucleoli rim, Mitotic chromosome	Actin filaments	HPA055896: 	unprognostic (2.50e-2)	unprognostic (1.82e-1)	unprognostic (9.77e-2)	prognostic favorable (6.85e-4)	unprognostic (5.71e-3)	unprognostic (6.99e-2)	prognostic favorable (7.83e-5)	unprognostic (1.16e-1)	unprognostic (3.20e-3)	unprognostic (9.19e-3)	unprognostic (1.31e-1)	unprognostic (3.69e-1)	unprognostic (6.65e-2)	unprognostic (1.03e-1)	unprognostic (3.39e-1)	unprognostic (2.00e-1)	unprognostic (3.09e-1)	17	0.9	0.7	2.6	0.7	0.7	16.4	0.5	0.7	14.4	9	0.7	6.6	3.5	10.7	10.3	8	3.8	13.3	3.8	0.8	0.7	10.6	371.4	6.9	2.3	1	0.1	17.7	9	1.3	1.1	1.9	0.8	17.5	6.5	5.5	20.2	7.7	3.5	4	7.4	9.7	1.5	1.5	7.9	7.1	0.4	0	4.2	5.5	3.6	14.3	15	4.5	10.4	0.3	18.1	0	0.9	4.8	1.3	3.4	0.8	0	8.6	10.3	0.1	1.4	3	0.4	1.4	2	1.8	0.1	0.4	4.2	2.9	1.3	0.9	1	0.4	5.8	1.3	0.3	1.9	52.5	1.8	1.3	0.1	8.3	0.8	0.5	1.8	4.3	2	1.5	0	9.6	1.2	0.2	0.2	0.4	0.2	40.2	3.8	0.2	1.3	3.9	0.8	1	0	0.1	1.5	0.6	2.3	1.9	1.4	0.2	1.7	0.5	1	0.5	0.2	2	1.6	0.2	1.1	0.6	1.6	0	18.1	0	0.3	2.1	0.2	4.5	0.9	0.8	10.4	2.4	0.2	0.2	0.3	0	0.1	1.6	0.4	4.8	0.7	0.7	0.5	0.6	0.8	0.7	1	0.1	0.8	0.4	26.8	12.4	18	36	24.2	0	0.6	219.1	60.2	18.2	10.4	0	1.5	10	27.6	0.7	12.2	37.1	23.3	27.7	3.3	31	52.1	0	4646.2	15.9	0	68.2	70	110.5	1.1	65.9	16	21.9	1	138.3	9.1	26.8	17.3	22.6	45.5	0.6	12.9	18.6	0.7	1	45.8	7.8	12.1	44.2	29.8	Hepatocytes
SCART1	CD163c-alpha	ENSG00000214279	Scavenger receptor family member expressed on T cells 1	Q4G0T1	10	133453928-133523558	Predicted membrane proteins	Immunity			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		brain: 5.6	Cell type enriched	Detected in single	6	Cardiomyocytes: 5.6	Not detected	Not detected							Low cell type specificity	Detected in single			Low lineage specificity	Detected in single			Group enriched	Detected in some	5	HMC-1: 7.2;NB-4: 6.7;THP-1: 2.2;U-266/84: 7.3					Not detected	Not detected			HPA043101	Supported											HPA043101: AB_10797026	unprognostic (4.32e-2)	unprognostic (2.15e-2)	unprognostic (1.13e-2)	unprognostic (2.40e-2)	unprognostic (7.42e-2)	unprognostic (8.20e-4)	unprognostic (1.29e-3)	unprognostic (4.28e-3)	unprognostic (2.63e-2)	unprognostic (1.68e-1)	unprognostic (2.91e-1)	unprognostic (2.24e-2)	unprognostic (6.24e-5)	unprognostic (8.53e-2)	unprognostic (1.25e-1)	unprognostic (5.03e-2)	unprognostic (1.94e-1)	0.3	0.2	0	0.3	0.5	1.6	0	0.4	4.8	0.1	0.3	0.2	0	1.3	0.9	0	0.4	0	0.9	0	5.6		0.7	0.2	0.3	0	0	0	0	1.2	0	0	0.1	0.3	0.3	0	0.2	0.8	0.4	0.2	0.2	0.7	1.2	0	0.2	0	0.1	0	0	0	1.1	0.2	0.2	0	0.4	0.3	0.8	0.4	0.2	1.2	0	0.4	0.1	0	0	0	0.1	0.2	0.7	0.2	0	0	0	0	0.7	0.1	0.1	0.3	0.1	0.1	0.2	0	0.3	0.4	0.8	0.1	0	0	0.2	7.2	0	0.2	0.3	0	0	0.1	0	0.1	0	0.1	0.3	0.3	6.7	0.2	0.1	0	0.7	0.2	0	0	0	0	0.1	0.1	0	0	0.1	0	2.2	0	0.1	0.4	0	0.4	0.5	7.3	1.1	0	0	0.3	0.8	0.2	0.3	0.3	0.1	1.2	0.3	0.4	0.6	0.1	0.4	0.3	0.4	0.2	0.2	0.4	0.3	0.1	0											0	1	0	0	0	0	5.6	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	Cardiomyocytes
SPDYE3		ENSG00000214300	Speedy/RINGO cell cycle regulator family member E3	A6NKU9	7	100307702-100322196	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at transcript level		Group enriched	Detected in some	5	blood: 1.3;testis: 5.2	Cell type enriched	Detected in some	5	Early spermatids: 174.4	Low cancer specificity	Detected in all							Cell type enhanced	Detected in single		memory B-cell: 1.3	Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		Karpas-707: 2.4									HPA051750	Supported											HPA051750: AB_2681590	prognostic favorable (8.73e-4)	unprognostic (6.27e-2)	unprognostic (1.21e-2)	prognostic unfavorable (2.00e-6)	unprognostic (1.06e-2)	unprognostic (1.54e-1)	unprognostic (5.04e-2)	unprognostic (2.96e-2)	unprognostic (2.90e-1)	unprognostic (6.91e-2)	unprognostic (3.99e-2)	unprognostic (7.32e-2)	unprognostic (5.25e-2)	unprognostic (9.08e-2)	unprognostic (5.06e-2)	unprognostic (9.17e-2)	unprognostic (3.58e-1)	0	0	0	0.2	0	0.3	0	0.1	0.1	0	0			0	0	0	0	0	0	0	0	0	0.1	0.1	0	0.5	0		0	0.2	0	0.2	0		0.1	0		0.1	0	0.2	0.6	0	0	0	0.1	0.1	5.2			0.1		0	0	0	1.3	0.7	0	0.1	0	0.2	0	0.3	0	0.2	1.2	0	0	0.2	0.2	0	0	0	0.2	0.4	0.5	0.4	0	0.1	0.1	0	0	0	0.6	0.3	0	1.2	0.1	0	0.4	0.2	0	0	0	0	0	0	0.7	0.4	2.4	0	0.1	0.2	0.8	0.5	0.1	0.1	0.3	0.3	0.1	0	0.4	0	0.4	0.5	0.1	0	0.5	0.4	0	0	0.5	0.5	0.5	0.3	0.6	0.6	1.1	0.1	0.6	0.3	0	0.1	0	0.2	0.1	0.2	1.3	0.2	0.1	0	0.8	0.2	0.2	0	0	0	0.7	0	0											0	0.3	0	0.6	1.4	5.3	1.8	0	1.4	1.2	0	9.8	0.1	0	0	174.4	0.6	0	0	0	0.1	0.7	0.3	0	0	0.2	0	0	0	0.3	36.7	2	0.6	0	0	0	0.7	0	0	1.8	0	3.5	0	1.9	3.3	0.9	1.5	0.1	1.3	0	0.7	Early spermatids
GNAT3	GDCA, gustducin	ENSG00000214415	G protein subunit alpha transducin 3	A8MTJ3	7	80458671-80512020	Predicted intracellular proteins		Transducer		Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	10	intestine: 14.5	Cell type enriched	Detected in single	22	Early spermatids: 2.2	Group enriched	Detected in some	6	breast cancer: 0.8;urothelial cancer: 1.7	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	6	SCLC-21H: 8.8	Not detected	Not detected			Region enriched	Detected in single	17	olfactory region: 1.8																								unprognostic (2.01e-1)							1.4	0	0	0	0	0	0.3	0	0.1	0	6.8	0	0	6.4	0	0	0	0	0	0.1	0	0	0	0	0	0	0.1	0	0	0	0	0	0.1	0.7	0.1	0	0	0	0	0	0	14.5	0	0	0	0.1	1.1	0	0.4	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0.1	0.1	0	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0.4	0	0	0	0	0	0	0	0	0	0	8.8	0	0.1	0.1	0	0	1.4	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Early spermatids
FAM187A		ENSG00000214447	Family with sequence similarity 187 member A	A6NFU0	17	44899712-44905390	Predicted intracellular proteins, Predicted membrane proteins				Evidence at protein level	Evidence at transcript level	No human protein/transcript evidence	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		fallopian tube: 21.2;testis: 37.0	Cell type enriched	Detected in single	67	Ciliated cells: 6.7	Not detected	Not detected			Low region specificity	Detected in all			Cell type enhanced	Detected in some		classical monocyte: 2.9	Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		RPTEC TERT1: 12.4;U-87 MG: 14.1									HPA043131			Approved	Cytosol						Cytosol		HPA043131: AB_10796686																		0.7	1.3	5.8	0.6	8.9	0.7	1.4	1	5	2.5	0.9	3.1	1.7	0.3	1.9	2.7	0.5	21.2	3	0.6	5.4	6.7	3.7	0.5	2	0.7	5.3	4.1	3.7	1.6	2.2	2.2	0.3	4.5	1.1	1	1.7	1.3	1.9	0.4	0.6	0.6	1.1	4.2	0.4	0.6	37	1.1	0.3	4.5	0.2	0.6	0.9	0.3	0.8	1.8	1.9	2.9	0.2	0.8	2	1.7	8.8	2.2	1.8	2.7	3.1	1.4	0.5	4.3	2.5	3.1	2.6	4.7	0.2	1.4	1.6	5.9	5.2	0.5	2.3	1.1	5.2	2.1	0.7	3.7	0.7	1.1	1	0.7	0.4	3	4.7	1	4.2	1.1	1.1	1.6	0.1	0.9	1.2	0.1	1.3	0.7	3	1.2	0.8	0.3	0.4	12.4	0.8	5.9	1.4	0.5	0.1	0.7	1.7	6.3	1	0.6	1	2.2	1.2	1	0.2	0.2	0.4	14.1	0.8	1.1	0	2.9	1.9	0.2	0.8	0	0	0	0.8	1.8	0.8	0	0.1	0	0.2	0.3	0	0.6	2	5.8	8.9	1	5	5.4	6.7	5.3	4.1	4.5	1.1	0	0	0	0	0	0	0	0	6.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Ciliated cells
HIGD1C	Gm921	ENSG00000214511	HIG1 hypoxia inducible domain family member 1C	A8MV81	12	50953922-50970506	Predicted membrane proteins				Evidence at transcript level	Evidence at transcript level	No human protein/transcript evidence	No human protein/transcript evidence		Low tissue specificity	Detected in many			Cell type enriched	Detected in single	19	Early spermatids: 7.3	Not detected	Not detected							Cell type enhanced	Detected in some		memory B-cell: 2.0	Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		BEWO: 3.9;CACO-2: 2.2;Karpas-707: 4.9;TIME: 2.3					Low region specificity	Detected in all																				unprognostic (2.81e-1)		unprognostic (3.10e-1)			unprognostic (1.01e-1)			unprognostic (4.21e-1)	unprognostic (2.70e-1)	unprognostic (5.49e-1)	unprognostic (2.99e-1)		0.8	0.4	0.2	0	0.4	0	0.6	0.9	0.3	1.4	0.6			0	0.8	0	0.1	1.1	0.9	0.3	0.5	0.3	0.1	2.7	1.3	1.3	0.3		0.8	2.3	3.3	0.8	0		0.4	0.5		0.9	0.2	0.4	1.1	0.6	0.6	0.3	0.5	1.1	3.6			2.4		0.3	1.2	0.5	2	1.2	0	0.6	0	1	0	0	0	0.4	1.6	0	1.6	3.9	0	0	0	0	2.2	0	0.7	0.7	0	0	0	0	0	0	0.5	0	0	0	0	1.2	0	0.5	0	0	0	0	0.5	0	0.2	0	4.9	1.2	0	0.5	0	0	0	0	0.4	0	0.8	0	0	0.3	1.4	0	0.6	0	0.3	0	0	2.3	0	0.1	0	0.2	0.5	0.1	0	0	0	0	0	0.6	0	0.5	0.5	0	2	0.1	0	1.2	0.4	0	0.5	0	0	0.4	0	1	0											0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	7.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Early spermatids
C12orf71	LOC728858	ENSG00000214700	Chromosome 12 open reading frame 71	A8MTZ7	12	27081058-27082514	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	No human protein/transcript evidence	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	5	blood: 4.1;bone marrow: 3.8;skin 1: 2.5;testis: 7.4	Cell type enriched	Detected in some	8	Early spermatids: 9.5	Not detected	Not detected							Cell type enriched	Detected in single	23	NK-cell: 4.1	Lineage enriched	Detected in single	23	NK-cells: 4.1	Cell line enhanced	Detected in some		HDLM-2: 5.7;JURKAT: 2.1									HPA038359, HPA058728	Uncertain		Approved	Cytosol						Cytosol		HPA038359: , HPA058728: AB_2683800	unprognostic (1.14e-1)	unprognostic (9.86e-2)	unprognostic (1.61e-1)	unprognostic (1.92e-1)	unprognostic (2.36e-1)	unprognostic (6.78e-3)	unprognostic (9.90e-2)	unprognostic (3.13e-1)	unprognostic (7.12e-3)	unprognostic (1.02e-1)	unprognostic (6.73e-3)	unprognostic (1.96e-1)	unprognostic (4.15e-8)	unprognostic (4.85e-2)	unprognostic (9.71e-2)	unprognostic (1.10e-1)	unprognostic (1.01e-2)	0.1	0	0.1	0.4	0.1	3.8	0.2	0.8	0.3	0.4	0.1			0.2	0.1	0	0.3	0.2	0.1	0.1	0.1	0	0	0.2	0.3	0.3	0		0.1	0.3	0	0.1	0		0.2	0		0.3	0	0.5	2.5	0.4	0	0	0.5	0.1	7.4			0.1		0	0.2	0.2	0.1	0	0	0	4.1	0	0	0.3	0.5	0.2	0.8	0	0	0.2	0.2	0	0	0	0.4	0.3	0.3	0	0	0.1	0.1	0	0	0	5.7	0	1.2	0	0.3	0	0.2	0.1	0	0	0	0	0.1	0	2.1	0.4	0.1	0	0	0.5	0.3	0.9	0.4	0	0	0	0.2	0	1.1	0	0	0.3	0	0.4	0.2	0.1	0.9	0	0.6	0.3	0.1	0	0.1	0	0.6	0.1	0.6	0.1	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	4.1	0	0	0	0											0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	9.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.2	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0.2	0	0	0	0	0.1	Early spermatids
CAPN14		ENSG00000214711	Calpain 14	A8MX76	2	31173056-31233858	Enzymes, Predicted intracellular proteins		Hydrolase, Protease, Thiol protease		Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	18	esophagus: 92.6;lymphoid tissue: 25.0	Cell type enriched	Detected in some	4	Urothelial cells: 8.0	Group enriched	Detected in some	7	cervical cancer: 2.9;head and neck cancer: 2.3;lung cancer: 0.8;stomach cancer: 1.4;urothelial cancer: 0.6	Not detected	Not detected			Cell type enhanced	Detected in single		memory B-cell: 1.3	Lineage enhanced	Detected in single		B-cells: 1.3	Cell line enriched	Detected in some	6	U-266/70: 7.9					Not detected	Not detected																unprognostic (5.81e-3)	unprognostic (1.20e-1)	unprognostic (4.57e-2)	unprognostic (1.88e-2)	unprognostic (3.85e-2)	unprognostic (3.30e-1)	unprognostic (3.61e-2)	unprognostic (4.67e-2)	unprognostic (1.71e-1)	unprognostic (3.14e-1)	unprognostic (3.77e-1)	unprognostic (1.60e-1)	unprognostic (3.71e-4)	unprognostic (8.42e-2)	unprognostic (6.84e-2)	unprognostic (1.91e-1)	unprognostic (4.47e-4)	0.1	0.1	0.2	0	0.3	0	0.2	0.5	0.3	1.1	0.1	0	0	0	0.4	0	92.6	0.1	0	0.2	0.2	0.3	0.1	0.4	0.2	0	0.2	0	0.2	0.3	0	0.2	0.1	0	0.2	0	0	0.3	0	0.2	0.1	0.1	0	0.1	0	0.2	0.1	0	0	0.2	3.2	25	0.2	0.4	1.3	0	0	0.1	0	0.5	0.2	0	0.1	0	0	0	0	0	0	0.3	0	0	0.1	0	0.1	0	0.1	0.1	0.1	0	0.5	0.1	0.4	0.2	1.4	0	0	0	0	0	0	0	0	0	0	0	1	0	0.1	0	0.1	0.3	0	0.2	0	0	0.2	0	0.9	0	0.1	0	0.2	0	0	0	0	0	0	0	0	0	0	0	7.9	0.4	0.1	0.1	0	1.1	0	0	0	0.5	0	0	1.3	0	0	0	0.4	0	0	0	0	0.1	0	0	0.2	0.2	0.3	0.5	0.3	0.2	0.3	0.2	0	0	0	0	0	0	0.5	0	0.6	1.9	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0.3	0	0	0.1	1.6	0	0	0.3	0.5	0	0	0	0	0	0	0	0	0	0	1.3	0	0	0	0	0	1.1	0	0	8	Urothelial cells
CDRT15L2		ENSG00000214819	CMT1A duplicated region transcript 15 like 2	A8MXV6	17	20579724-20580911	Predicted membrane proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enriched	Detected in some	6	testis: 15.3	Cell type enriched	Detected in some	7	Early spermatids: 54.0	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		A549: 1.4;AN3-CA: 1.7;Hep G2: 1.3;HMC-1: 1.4;U-138 MG: 2.3																																							0	0	0	0	0.1	0	0	0	0	0	0			0	0	1.9	0	0	0	0	2.7	0	0	0	0	0.2	0		0	0	0	0	0		0	0		0.1	0.2	0	0	0	0	0	0	0	15.3			0		0	0	0	0.2	0	0	0	0	0	0.8	0	1.4	0.1	1.7	0	0	1	0.3	0	0.2	0	1	0	0.7	0.2	0	0	0.7	0	0	0	0.5	0	0.8	0	1.3	0	0	1.4	0	0	0	0	0.4	0	0	0	0	0	0	0.2	0.1	0.2	0.9	0	0	0	0	0	0	0	0.3	0	0.2	0	0.1	0.2	0.7	0	2.3	0	0	0.3	0.9	0.2	0.5	0.2	0.1	0.4	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0.8											0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	54	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5.9	0.6	0	0	0	0	0	0	0	0.4	0	0	0	0	7.5	0.7	0	0	0	0	0	Early spermatids
RAD51AP2	FLJ17540	ENSG00000214842	RAD51 associated protein 2	Q09MP3	2	17510584-17518439	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in some	14	testis: 19.1	Cell type enriched	Detected in some	9	Spermatocytes: 222.9	Not detected	Not detected			Region enhanced	Detected in single		cerebellum: 1.3	Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	4	AN3-CA: 2.6;CAPAN-2: 3.8;HaCaT: 2.9					Not detected	Not detected																unprognostic (3.87e-2)	unprognostic (3.31e-2)	unprognostic (9.98e-2)	unprognostic (3.12e-2)	unprognostic (4.61e-1)	unprognostic (3.51e-1)	unprognostic (9.80e-2)	unprognostic (4.84e-3)		unprognostic (2.64e-1)	unprognostic (1.92e-1)	unprognostic (1.71e-1)		unprognostic (6.26e-3)	unprognostic (3.82e-2)	unprognostic (1.62e-3)	unprognostic (1.15e-1)	0	0.1	0.1	0	0	0	0.2	1.3	0.5	0	0	0	0	0	0	0	0.4	0.1	0	1.2	0.1	0.2	0	0.3	0	0	0	0	0.2	0.4	0	0	0.1	0.2	0.1	0.1	0	0.1	0	0	0.3	0	0	0	0	0	19.1	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0.2	0	0	2.6	0.5	0.4	0	0	0	0	0	0	3.8	0	0	0	0	2.9	0.1	0	0	0	0	0	0	0.2	0	0	0	0	0.6	0	0.5	0	0	0	0	0	0.2	0	0	0	0.6	0.3	0	0	0	0	0	0	0.2	0.7	0	0	0	0.1	0	0	0	0.1	0	0	0	0	0	0.7	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	1.3	0.5	0.1	0.2	0	0	0.2	0	0	0	0	1	0.5	0	0.8	0	0	0	0	2	0	0	0	7.6	0	0	0	0	0	0.2	0.2	0	1.7	0.1	0	0	0	0	4.2	0.9	0	0	0	0.2	0.8	0.1	0	0.4	0	0.1	25.8	0.1	222.9	2.3	0.5	0	0	0.2	0.3	Spermatocytes
DCDC2C		ENSG00000214866	Doublecortin domain containing 2C	A8MYV0	2	3703592-3847411	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	13	testis: 9.0	Cell type enriched	Detected in some	5	Early spermatids: 180.0	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected											HPA045848	Uncertain											HPA045848: AB_10961120											unprognostic (2.63e-2)	unprognostic (1.81e-1)		unprognostic (3.81e-3)	unprognostic (6.98e-2)			0.2	0.2	0.1	0.1	0.2	0	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.4	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0	0.6	0.1	0.1	0.5	0	0.5	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.2	9	0.1	0.1	0.6	0.1	0.1	0.1	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.2	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	180	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	36.1	5.2	0	0	0	0	0	0.2	0	10.6	0	0	0	0.3	0.7	0.7	0	0	0	0	0	Early spermatids
SPATA31D1	FAM75D1, FLJ46321	ENSG00000214929	SPATA31 subfamily D member 1	Q6ZQQ2	9	81988772-81995256	Predicted membrane proteins	Differentiation, Spermatogenesis			Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	134	testis: 13.3	Cell type enriched	Detected in some	6	Early spermatids: 8.8	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	5	HDLM-2: 3.7									HPA047897	Uncertain											HPA047897: AB_2680204															unprognostic (1.25e-1)			0	0	0	0	0	0	0	0	0	0	0			0	0	0	0	0	0	0	0	0	0	0	0	0	0		0	0	0	0	0		0	0		0	0	0	0	0	0	0	0	0	13.3			0		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	8.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.6	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	Early spermatids
CXorf49		ENSG00000215115	Chromosome X open reading frame 49	A8MYA2	X	71714371-71718151	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	58	testis: 5.8	Cell type enriched	Detected in single	12	Alveolar cells type 1: 3.0	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	6	A-431: 14.2																																							0	0		0		0	0		0	0	0			0	0	0	0	0	0	0			0	0	0	0			0	0	0		0		0	0		0	0	0	0	0	0		0	0	5.8			0		0	0		0	0	0	0	0	0	0	14.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	2.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0.1	0	0	0	0	0	Alveolar cells type 1
GOLGA6B		ENSG00000215186	Golgin A6 family member B	A6NDN3	15	72654738-72666394	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	No human protein/transcript evidence	No human protein/transcript evidence		Group enriched	Detected in some	34	liver: 8.4;testis: 10.5	Cell type enriched	Detected in single	60	Early spermatids: 6.0	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		Karpas-707: 1.0;SuSa: 1.3;U-266/70: 2.5;U-266/84: 1.1									HPA044978, HPA050087, HPA072134	Supported		Approved	Nucleoplasm,Vesicles,Centrosome						Vesicles	Nucleoplasm, Centrosome	HPA044978: AB_2679165, HPA050087: AB_2681010, HPA072134: 					unprognostic (5.47e-3)		unprognostic (1.88e-2)			unprognostic (2.07e-1)				unprognostic (2.01e-1)	unprognostic (2.03e-1)			0	0	0	0	0	0	0	0.1	0.2	0	0			0	0.1	0	0	0.1	0	0	0	0	0	8.4	0	0	0		0.1	0	0	0	0		0	0		0	0	0	0.2	0	0	0.1	0	0	10.5			0		0	0	0	0	0	0	0	0	0	0	0	0	0.3	0.4	0	0	0.2	0	0.1	0.1	0	0	0.4	0	0.1	0	0	0	0	0	0.1	0	0.2	0	0.3	0	0	0	0.6	0	0.5	0	0	0.1	0	0.1	0.1	1	0	0.6	0	0.3	0.8	0	0	0.3	0	0.2	0.1	0	0	0	0	0.1	0.1	1.3	0	0	0	0	0.3	0	0	2.5	1.1	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Early spermatids
GRXCR1	DFNB25, PPP1R88	ENSG00000215203	Glutaredoxin and cysteine rich domain containing 1	A8MXD5	4	42893267-43030658	Disease related genes, Predicted intracellular proteins	Hearing		Deafness, Disease mutation, Non-syndromic deafness	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in some	6	seminal vesicle: 11.0	Cell type enriched	Detected in single	9	Early spermatids: 1.3	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Low region specificity	Detected in many			HPA040824	Uncertain											HPA040824: AB_10794863																		0	0	0	0	0.5	0	0	0	0.1	0.1	0			0	0	0	0	0	0	0	0	0	0	0	0	0	0		0	0	0	0	0		0.6	0		0	11	0	0	0	0	0	0	0	1.9			0		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0.8	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0	0	0	0	0	Early spermatids
HOMEZ	KIAA1443	ENSG00000215271	Homeobox and leucine zipper encoding	Q8IX15	14	23272422-23299447	Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	DNA-binding		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	4	Early spermatids: 220.5	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low cell line specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA036316, HPA036317	Approved		Supported	Nucleoplasm,Nucleoli						Nucleoplasm, Nucleoli		HPA036316: AB_2675056, HPA036317: AB_10669787	unprognostic (3.70e-2)	unprognostic (7.58e-2)	unprognostic (6.36e-2)	unprognostic (3.93e-2)	unprognostic (9.11e-2)	unprognostic (5.23e-2)	unprognostic (1.20e-2)	unprognostic (1.59e-2)	unprognostic (1.37e-1)	prognostic favorable (2.41e-5)	unprognostic (2.23e-1)	unprognostic (1.77e-1)	prognostic favorable (1.17e-11)	unprognostic (2.62e-1)	unprognostic (2.00e-1)	prognostic favorable (1.75e-4)	unprognostic (3.23e-1)	7.6	8.3	6.6	7.2	6.8	1.7	9.2	4.6	6.6	9.3	8.5	12.1	18.5	8.1	8.4	11.2	14.4	9.1	12.7	8.9	6.4	5.1	11.6	8.8	7.2	6.4	6.5	5.4	12.5	11	8	7	6.6	7.2	11.1	7.6	12.2	13.6	22	12	9.1	8.4	8.6	7.6	8.1	9.9	39.9	7.4	16	14.7	6.3	11.3	12.9	8.3	4.3	7.4	10.8	7.2	3.6	6.3	3.9	4.3	4.4	8.5	8.2	13.4	5.9	9.5	4.8	6.2	4.5	5.6	1.8	9.5	9.5	3.9	4.4	10.7	14.6	11.4	11.6	5.6	5.1	3.9	3.3	3.6	8.8	16.8	4.8	2.8	9.2	11.9	3.4	7.7	10.2	8.6	11	9.2	4	7.9	9.8	3.7	3.4	3.4	13.8	2.6	5.8	6.4	4.1	8.6	18.3	2.7	3.5	4.5	12.9	5.1	13.9	7.8	5.9	9.1	3.2	1.4	3.9	2.1	16	6.8	3.3	1.7	3.5	4.6	4.1	7.2	10.8	5.7	7.1	4.6	4.3	4.9	4.8	7.4	3.9	5.4	6.3	1.4	3.6	4.9	4.7	6.2	3.9	6.6	6.8	4.6	6.6	6.4	5.1	6.5	5.4	7.2	7.4	6	6.5	6.9	14.8	2.5	4.7	6.5	10.2	6.7	9.1	22.7	5.9	6	11.6	9.6	220.5	3.5	6.3	0	9.5	5.4	4.6	9.3	3.5	4.4	7.6	9.5	3.5	5.5	2.9	54.5	6.4	5.5	3.3	20.8	9.8	6.8	8.8	3.5	7.1	15.1	3.4	6.5	3.8	5.7	4.5	4.4	7.8	2.9	9.3	27.4	Early spermatids
SCRT2	ZNF898B	ENSG00000215397	Scratch family transcriptional repressor 2	Q9NQ03	20	661596-676179	Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	DNA-binding		Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Group enriched	Detected in some	5	brain: 17.9;retina: 6.1	Cell type enriched	Detected in some	51	Horizontal cells: 57.2	Cancer enriched	Detected in single	5	glioma: 1.0	Group enriched	Detected in many	4	cerebellum: 8.8;cerebral cortex: 17.9	Cell type enriched	Detected in single	25	neutrophil: 2.4	Lineage enriched	Detected in single	25	granulocytes: 2.4	Group enriched	Detected in some	5	Karpas-707: 4.0;NTERA-2: 3.7;RPMI-8226: 8.1;SCLC-21H: 3.9;SH-SY5Y: 4.3	Low region specificity	Detected in all			Low region specificity	Detected in many			HPA067697			Approved	Nucleoplasm						Nucleoplasm		HPA067697: AB_2685890					unprognostic (9.71e-2)					unprognostic (2.03e-1)	unprognostic (6.97e-2)			unprognostic (9.70e-2)	unprognostic (1.70e-1)			0.3	0.3	0.7	0.3	0.7	0.3	0.3	8.8	17.9	0.3	0.3	0.6	0	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.7	0.6	0.3	0.3	0.3	0.3	1.9	0	0.3	1.3	0.3	0	0.4	3.2	0.3	0.3	6.1	0.3	0.3	0.3	0.3	0.3	0.3	1.1	0.6	0.3	0.7	0	0	0.3	0	0.3	0.3	0	0	0	2.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.9	0	0	0	0	0.3	0	0	0	0	0	0	0	0	4	0	0	0	0	3.7	0	0	0	0	8.1	0	0	3.9	4.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.4	0	0	0	0	0	0.7	0.7	8.8	17.9	0.7	0.6	1.9	0	3.2	0	0	0	0	0	0	0.8	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	57.2	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	1.1	0	0	0	0	0	0	0	0	0	Horizontal cells
GCGR	GGR	ENSG00000215644	Glucagon receptor	P47871	17	81804132-81814013	FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins		G-protein coupled receptor, Receptor, Transducer	Diabetes mellitus, FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	6	liver: 68.8	Cell type enriched	Detected in some	7	Hepatocytes: 60.2	Cancer enhanced	Detected in many		liver cancer: 10.3	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HeLa: 3.9;MCF7: 6.1;SK-BR-3: 5.3;U-87 MG: 6.1	Region enriched	Detected in single	5	cerebellum: 0.9	Not detected	Not detected			HPA071228			Uncertain	Golgi apparatus						Golgi apparatus		HPA071228: AB_2686368	unprognostic (3.28e-4)	unprognostic (9.30e-2)	unprognostic (2.20e-1)	unprognostic (1.53e-4)	unprognostic (1.11e-1)	unprognostic (2.30e-3)	unprognostic (4.38e-2)	unprognostic (1.79e-3)	unprognostic (2.18e-1)	unprognostic (2.77e-1)	unprognostic (3.09e-1)	unprognostic (2.61e-1)	unprognostic (6.42e-2)	unprognostic (5.99e-3)	unprognostic (1.71e-1)	unprognostic (1.17e-3)	unprognostic (8.36e-3)	0.2	3.9	0.1	0.6	0.3	0	0.1	0.1	0.3	0.2	0.2	0.1	0.1	0.2	0.1	0.2	0.2	0	0.1	0.1	0.1	0	11.4	68.8	0.1	0.1	0.1	0.1	0.1	0.5	3.9	0.1	0.1	0.5	0.2	0	1.4	0.3	0.1	0.1	0.9	0.2	0.1	0.1	0.1	0	0.2	0.1	0.2	0.2	0.6	0.1	0.1	0.5	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0.1	0	0	0	0	0.1	0	0	0	0	0	0.5	0	3.9	0.2	0	0.4	0	0	0	0	0	0	0	0	0	0	0	6.1	0	0.3	0	0	0	0	0	0.2	0	0	0.3	1.6	0	5.3	0	0	0	0.6	0	0	1.3	0	0	0	0	0	6.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.3	0.1	0.3	0.1	0	0.1	0.1	0.5	0.1	0	0	0	0	0.8	0.2	0.6	0	0	0	3.5	2	0	3.3	0	0	0	0	0	0	0	0	0	0	60.2	0.1	0	0	1.3	3.7	0	0	0	0	0	0	8.3	0.1	0	0	0	0.2	0	0	0.1	0.2	0.4	0	0	0	0	Hepatocytes
CELA2B	ELA2B, RP11-265F14.2	ENSG00000215704	Chymotrypsin like elastase family member 2B	P08218	1	15465909-15491400	Enzymes, Predicted intracellular proteins, Predicted secreted proteins		Hydrolase, Protease, Serine protease		Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	188	pancreas: 697.9	Cell type enriched	Detected in some	42	Exocrine glandular cells: 1081.3	Cancer enriched	Detected in single	574	pancreatic cancer: 69.9	Not detected	Not detected			Group enriched	Detected in some	5	basophil: 3.7;neutrophil: 1.2	Lineage enriched	Detected in single	7	granulocytes: 3.7	Cell line enriched	Detected in some	5	U-138 MG: 9.3														Secreted to digestive system								unprognostic (4.36e-3)	unprognostic (5.45e-2)	unprognostic (6.66e-2)	unprognostic (5.31e-3)	unprognostic (4.47e-3)	unprognostic (1.37e-3)	unprognostic (4.66e-2)	unprognostic (6.32e-2)	unprognostic (2.73e-1)	unprognostic (2.44e-1)	unprognostic (2.94e-1)	unprognostic (3.85e-2)	unprognostic (1.22e-6)	unprognostic (2.47e-1)	unprognostic (6.67e-2)	unprognostic (1.88e-1)	unprognostic (7.80e-2)	0	0.2	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0.4	697.9	0	0	0	0.1	0	0	0	0.1	0	0	0	0	0	0	0	0	0.2	0	0	0	0.1	0	0	0	0.1	0	3.7	0.2	0	0.5	0	0.1	1.5	1	0.6	0	0	0	0	0	0	0	0	1	0.5	0.1	0	0.2	0.3	0	0	0	0.7	1	1.8	0.7	0.3	0	0	1.2	0	0	0	0	0.8	0	1.4	0.2	1.1	0	0	0	0	0.4	0.1	1.2	0	0	0	0	0	0	0	0.7	0	0.2	0.5	0.4	0	0	9.3	0	0	0	0.9	0.1	0.3	0.4	0	0	3.7	0.2	0	0.5	0	0	0	0	0	0	0.1	0	0	1.2	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0.1	0	0	0	0	0	0.1	0	0.1	0	0	0	0	0	0	0	0.1	0	0	0	0	1081.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	25.6	0	0	0	0	0	0.3	0	0	0.1	0	0	0	0	Exocrine glandular cells
LACTBL1		ENSG00000215906	Lactamase beta like 1	A8MY62	1	22953043-22965338	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	17	testis: 2.2	Cell type enriched	Detected in single	7	Bipolar cells: 2.6	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	10	Hep G2: 3.1	Not detected	Not detected			Not detected	Not detected			HPA066810			Approved	Nuclear bodies						Nuclear bodies		HPA066810: 																		0	0	0	0.1	0	0	0	0	0	0	0			0	0	0	0	0	0	0	0	0	0	0	0	0	0		0	0	0	0	0		0	0		0	0	0	0	0	0	0	0	0	2.2			0		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	3.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0.1	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0	2.6	0.3	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	Bipolar cells
GAGE12E		ENSG00000216649	G antigen 12E	A1L429	X	49551333-49558649	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in single	18	testis: 9.6	Cell type enriched	Detected in some	12	Spermatogonia: 11.5	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		AN3-CA: 7.4;HeLa: 4.1;Karpas-707: 2.0;T-47d: 1.7;U-266/84: 4.4;WM-115: 2.0									HPA043232	Supported		Uncertain	Golgi apparatus,Plasma membrane,Cytosol						Plasma membrane	Golgi apparatus, Cytosol	HPA043232: AB_2678376																		0.3	0	0	0	0	0	0	0	0	0	0			0	0	0	0	0	0	0	0	0	0	0	0	0	0		0	0	0	0	0		0	0		0	0	0	0	0.3	0	0	0	0	9.6			0		0	0	0	0	0	0	0.3	0.5	0.1	0	0	0	0	7.4	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	4.1	0	0	0.6	0.9	0	0.4	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.8	0	0	1.7	0	0	0.5	0.3	0	0	0.7	4.4	0	0	0	2	0	0	0	0	0	0	0	0.1	0.1	0	0	0	0	0	0.5	0.3	0	0	0											0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	11.5	0	0	0	0	0	Spermatogonia
AC131097.2		ENSG00000216921			2	241893985-241902551	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level				Group enriched	Detected in many	7	pancreas: 27.6;tongue: 59.2	Cell type enriched	Detected in some	4	Exocrine glandular cells: 7.2	Cancer enhanced	Detected in many		thyroid cancer: 3.1	Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		JURKAT: 4.1;MCF7: 1.8;REH: 6.3;SCLC-21H: 4.1									HPA073342			Approved	Nucleoplasm						Nucleoplasm		HPA073342: 	unprognostic (9.31e-2)	unprognostic (4.59e-2)	unprognostic (1.61e-2)	unprognostic (1.10e-1)	unprognostic (7.48e-2)	unprognostic (3.12e-1)	unprognostic (2.93e-2)	unprognostic (4.75e-2)		unprognostic (1.76e-1)	unprognostic (1.50e-1)	unprognostic (2.04e-2)	unprognostic (5.12e-2)	unprognostic (5.44e-2)	unprognostic (8.45e-2)	unprognostic (2.44e-1)	unprognostic (3.29e-1)	2.7	0.3	4.9	0.6	4.4	0.2	1.6	1.7	2.4	0.8	0.6	0.6	0.6	0.1	0.6	0.6	3.8	0.5	0.9	0.6	2.1	2.3	0.6	0.6	0.6	0.6	3.9	0.6	1.4	27.6	0	0.6	0.6	0.6	2.6	0	0.6	4.4	4	3.7	2.6	0.6	0.6	0.6	0.6	0.1	0.8	0.6	1.1	6.4	59.2	2.6	0.6	0.6	0	0	0	0	0	0.7	0	0	0	0	0.4	0	0	0.3	0	0	0	0	0	0	0	0.1	0	0	0	0	0.5	0	0.3	0	0	0.5	0	0	1.1	0.2	0	0	0	0	0	0	4.1	0.5	0.6	0	1.8	1.4	0.2	0.5	0	0	6.3	0	0.6	0	0	4.1	0.1	0	0.6	0	0.9	0	0.9	1.2	0	0.2	0	0	0	0.2	0.5	0	0.1	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4.9	4.4	1.7	2.4	2.1	2.3	3.9	0.6	0.6	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	7.2	0.2	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	1.6	0	0	0	0	0	0	0	0	0	0.1	0	0	0	Exocrine glandular cells
CELA3B	CBPP, ELA3B	ENSG00000219073	Chymotrypsin like elastase family member 3B	P08861	1	21977021-21998642	Enzymes, Predicted intracellular proteins, Predicted secreted proteins		Hydrolase, Protease, Serine protease		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	196	pancreas: 1614.4	Cell type enriched	Detected in some	24	Exocrine glandular cells: 12399.8	Cancer enriched	Detected in single	1218	pancreatic cancer: 408.8	Not detected	Not detected			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low cell line specificity	Detected in many											HPA028086, HPA045650	Supported		Approved	Cytosol	Secreted to digestive system					Cytosol		HPA028086: AB_2672482, HPA045650: AB_2679407			unprognostic (2.89e-1)	unprognostic (4.01e-3)						unprognostic (6.53e-3)	unprognostic (1.30e-1)	unprognostic (1.29e-1)		unprognostic (6.40e-2)				0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.6	1614.4	0	0.1	0.1	0.1	0.1	0	0.1	0.2	0.1	0.1	0	0.1	0.1	0.1	0.1	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	5.9	5.3	8.2	3	2.3	3.2	0.9	0.6	5	1.7	1.3	2.5	1.5	2.2	1.2	1.8	1.8	1.7	5.4	2.7	5.5	2.7	1.5	2.2	1.6	1	0.5	0	2.5	4.1	2.4	4.9	4	1.3	1.9	3.2	2.3	2.4	1.5	0	2.7	2.5	3.6	2.5	5.6	0.4	2.6	2.2	1.5	1.4	0.9	3.5	3.6	0.9	4.3	0	3.6	3.2	1.8	3.5	0.8	0.3	3.7	2.6	2.8	3.7	2.9	1.6	2.3	1	4.9	4.8	2.5	1.9	4.8	0.6	5.1	2.5	1.8	3.1	3	2	3.7	2.2	2.8	1.4	5.9	3.2	3	8.2	2.3	1.7	5.3	2.9	0.9	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	3.6	65.6	0	4.9	0	12399.8	0	0	0	0	0	0	0	0	0	0	149	0.9	0	0	105.6	0	0	510.5	7	0.7	0	0	0	0	0.3	0.2	0	0	0	0.2	0	Exocrine glandular cells
CATSPERZ	C11orf20, DKFZP566E164, TEX40	ENSG00000219435	Catsper channel auxiliary subunit zeta	Q9NTU4	11	64300391-64304770	Predicted intracellular proteins	Differentiation, Spermatogenesis			Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	105	testis: 139.5	Cell type enriched	Detected in some	4	Extravillous trophoblasts: 29.2	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		BEWO: 5.7;CACO-2: 15.6;PC-3: 9.3;T-47d: 7.6									HPA052822			Approved	Nucleoplasm						Nucleoplasm		HPA052822: AB_2797245	unprognostic (1.89e-1)	unprognostic (7.81e-2)			unprognostic (1.88e-1)				unprognostic (8.23e-2)	unprognostic (2.18e-1)		unprognostic (1.11e-1)	unprognostic (5.66e-4)	unprognostic (5.96e-2)	unprognostic (3.07e-2)		unprognostic (1.43e-1)	0.1	0	0.5	0	0.4	0	0.8	0.1	0.9	0.2	0.1	0.1	0.2	0	0.1	0.7	0.1	0	0.2	0	0.5	0.2	0.1	0	0.2	0	0.1	0.2	0	0.1	0	0	1.3	0.1	0.3	0.1	0.3	0	0	0	0.2	0.1	0	0	0	0	139.5	0.1	0	0.4	0	0.1	0.1	0.2	0.5	0.4	0.6	0.6	0	0.3	0	0	4.1	0.3	0	0.5	1	5.7	0	0.3	0	0	15.6	3.2	0.1	0.2	0.2	0.2	3.4	3.2	0.5	0.1	0	0	1.5	0.1	1	0.1	0	0	0.1	0.3	1	0	0	0.2	0	1.6	0.7	0.2	0.7	0	0.7	1.1	4.5	9.3	1.7	0	2	4.5	1.5	0.1	0.9	1.7	0.5	0.2	0.3	7.6	0.4	0.3	0.2	0.1	2.1	0	0.4	0.1	0.5	0.3	0	0.1	0	0.3	0	0.3	0.2	0.1	0.5	0	0.2	0	0.1	0.1	0	0.6	0	0.6	0.4	0	0	0.5	0.4	0.1	0.3	0.5	0.2	0.1	0.2	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	3.3	0	0	0	0	0	0	0.4	29.2	0	0	0	0	1.5	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0.3	0	0	0	0	0	0	7	0	0	0	Extravillous trophoblasts
PPP1R3G		ENSG00000219607	Protein phosphatase 1 regulatory subunit 3G	B7ZBB8	6	5084581-5089487	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		heart muscle: 8.3	Cell type enriched	Detected in some	5	Cardiomyocytes: 16.7	Cancer enhanced	Detected in many		liver cancer: 5.7					Group enriched	Detected in some	4	classical monocyte: 1.7;intermediate monocyte: 1.2;myeloid DC: 2.4;non-classical monocyte: 2.9	Group enriched	Detected in many	6	dendritic cells: 2.4;monocytes: 2.9	Cell line enhanced	Detected in some		EFO-21: 4.9;PC-3: 4.7;THP-1: 16.4;U-266/70: 2.9	Low region specificity	Detected in many			Not detected	Not detected			HPA056393	Uncertain											HPA056393: AB_2683115	unprognostic (1.99e-2)	unprognostic (5.50e-3)	unprognostic (2.10e-1)	unprognostic (5.29e-2)	unprognostic (1.70e-2)	unprognostic (1.38e-1)	unprognostic (6.56e-3)	unprognostic (8.64e-3)	unprognostic (1.81e-2)	unprognostic (2.98e-1)	unprognostic (1.04e-2)	unprognostic (3.71e-1)	unprognostic (7.60e-2)	unprognostic (1.33e-2)	unprognostic (5.56e-2)	unprognostic (3.17e-3)	unprognostic (1.27e-1)	1.9	3.5	3.3	0.6	4	0.1	1	0.1	2.3	2.1	1.7			0.4	1.2	1.9	2	1.1	0.6	8.3	1.8	1.4	0.8	6.4	0.4	0.7	2.4		1.7	0	0	0	1.3		2	0.8		0.4	3	0.9	0.9	0.5	0.9	0.1	5.3	0.5	0.3			0.1		0.5	3.2	2.2	0.3	2.4	0.4	2.9	0.3	0.2	0.5	0	0.3	0.1	0	1.9	1.2	0.1	0.3	0.5	0.3	0.4	0.1	0.3	0	4.9	0.7	0	0	0.1	0	0.7	0	0.1	0.1	0.5	0.5	0.2	0.2	0.1	0.1	0.1	0	0	0.8	0.1	0.1	0.1	0	0	0.2	0	0.9	0.1	0	4.7	0.1	0	0	0.4	0.5	0	0.1	0.6	0	0	0.4	0.1	16.4	0	0	0	1	0.6	2.9	2.3	0.1	0.9	0	0.1	0.4	1.7	0	0	1.2	0	0.3	0.2	0	2.4	0.2	0	0.1	0.3	0.3	2.9	0.1	0	0.5											0	0	0	0.4	0.5	0.7	16.7	0	0	0	3.5	0	0.7	0	0.2	0	1.7	0	0	0	0.3	3.7	0.3	0	0	3.5	0	1.2	0.6	1.9	0	0.9	1.9	0	1.8	0.3	0	0.4	1.9	2.8	1.2	0.1	0	1.4	0	0.2	0.3	0.7	0	0	0.8	Cardiomyocytes
LINGO3	LERN2, LRRN6B	ENSG00000220008	Leucine rich repeat and Ig domain containing 3	P0C6S8	19	2289784-2292024	Predicted membrane proteins				Evidence at protein level	Evidence at protein level	No human protein/transcript evidence	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		blood: 6.9;brain: 15.7;lymphoid tissue: 7.1	Cell type enriched	Detected in some	7	Bipolar cells: 32.9	Cancer enhanced	Detected in some		glioma: 1.4					Cell type enhanced	Detected in some		eosinophil: 6.9	Lineage enriched	Detected in many	7	granulocytes: 6.9	Cell line enriched	Detected in some	4	HMC-1: 19.7	Low region specificity	Detected in many			Group enriched	Detected in all	7	basal ganglia: 34.0;cerebellum: 34.4;hippocampal formation: 11.5	HPA043781, HPA059558	Enhanced		Approved	Mitochondria						Mitochondria		HPA043781: AB_2678668, HPA059558: AB_2684062	unprognostic (1.24e-1)	unprognostic (1.00e-1)	unprognostic (7.16e-3)	unprognostic (3.10e-1)	unprognostic (1.59e-1)	unprognostic (3.61e-3)	unprognostic (3.53e-1)	unprognostic (7.45e-3)	unprognostic (1.11e-2)	unprognostic (3.19e-2)	unprognostic (4.03e-4)	unprognostic (2.35e-2)	unprognostic (1.36e-2)	unprognostic (1.79e-1)	unprognostic (5.74e-2)	unprognostic (1.05e-1)	unprognostic (4.14e-2)	0.1	0.2	2.2	3.1	15.7	2.8	0	4.6	2.9	0	0.4			0.5	0	0	0	0	0	0	1.9	1.2	0	0	0.2	2.7	1.2		0	0	0	0	0		0	0		0.1	0	0.3	0.1	1.2	0	0.4	7.1	1.2	0.1			0		0	0	0	1	0.1	6.9	0.1	0.3	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.7	0	0	0	0	0	0	0	0.8	0	0.8	0	0	0	2.1	19.7	0	0	0	0	0	0	0	0.2	0.6	0	0	0	2.6	0.2	0	0.1	1.9	0	4.8	0	0	0.7	0.2	0	0	0	0	0	2.2	0	0	0	0	0	0	0	0.1	0	1.9	0	1.9	0.1	6.9	0.4	0	0.4	0.5	0	0.2	0.1	1	0.1	0	2.9	0.3	0.1	0	0.6	0											0	0	0	0	0.1	32.9	0.6	0	0	0	0	3.9	0	0	0	0.4	0	0	0	0	0.1	0	0	4.6	0	0.2	3.2	0	0	2.1	0	0	0.2	0	1.8	0	0.1	0	0	0	0	1.8	0	0	0.3	0.9	0	0	0	0	0	Bipolar cells
EBF2	COE2, FLJ11500	ENSG00000221818	Early B cell factor 2	Q9HAK2	8	25841730-26045397	Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	Activator, Developmental protein, DNA-binding		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		adipose tissue: 25.8	Cell type enriched	Detected in some	4	Sertoli cells: 38.8	Low cancer specificity	Detected in many			Region enhanced	Detected in single		pons and medulla: 2.8	Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		ASC diff: 12.5;ASC TERT1: 25.5;HSkMC: 25.9;hTEC/SVTERT24-B: 14.4;U-138 MG: 9.3;U-2197: 12.2;U-87 MG: 10.4	Group enriched	Detected in many	4	basal ganglia: 5.9;cerebellum: 3.4;hypothalamus: 2.4;midbrain: 5.3;pons and medulla: 2.9	Low region specificity	Detected in some			HPA003954, HPA055101			Approved	Nucleoplasm,Nuclear bodies						Nucleoplasm	Nuclear bodies	HPA003954: , HPA055101: 	unprognostic (3.70e-1)	unprognostic (3.88e-3)	unprognostic (2.69e-2)	unprognostic (2.47e-3)	unprognostic (1.03e-1)	unprognostic (6.10e-2)	unprognostic (5.92e-2)	unprognostic (6.75e-2)	unprognostic (1.11e-2)	unprognostic (6.13e-3)	unprognostic (1.58e-1)	unprognostic (1.30e-1)	prognostic unfavorable (2.51e-6)	unprognostic (7.41e-4)	unprognostic (2.28e-1)	unprognostic (3.80e-2)	unprognostic (1.82e-2)	25.8	1.1	0.2	3.2	0.9	0.1	14.5	0.2	0.2	3	4.2	0	2.9	0.2	3	14.1	5.2	5.1	3.8	16.4	0.2	0.5	0.9	0.2	1.3	4.4	0.9	0	3.9	4	3.1	0.6	0.8	2.8	3.7	0.7	0.1	1.7	0.8	11.1	1.8	1	5.4	10.1	0.2	1.2	4.2	0	0.4	7.4	11.6	0.5	6.2	5.4	0	0	0	0	0	0	0	0	0	0.4	0	12.5	25.5	0.2	0.1	0	0	0	0	0	0	0	0	0.8	0	0	0	0.1	0	0.8	0	0	0	0	0	0	25.9	0	14.4	0	0	0	1.2	0	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	9.3	0.1	12.2	0	0	0	0	10.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0.9	0.2	0.2	0.2	0.5	0.9	0	2.8	0	0	0.3	0	0.1	0.1	0	4.5	0	0	1.2	0	0	0	0	0	5.2	1.9	0	0	0	0	0.7	0	0	0	0.1	0	0	0	0	1.9	5.5	0	0	0	0	0	0.1	0	0.4	0	0.3	38.8	9.5	0.2	0.2	0.3	0	0	0	0	Sertoli cells
PSG3		ENSG00000221826	Pregnancy specific beta-1-glycoprotein 3	Q16557	19	42721638-42740569	Predicted secreted proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	146	placenta: 495.8	Cell type enriched	Detected in some	171	Syncytiotrophoblasts: 1321.0	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	4	hTERT-RPE1: 1.7;SuSa: 3.5;U-2197: 5.0									HPA046327	Supported				Secreted in female reproductive system							HPA046327: AB_2679624																		0.1	0.1	0.1	0	0	0	0.1	0.1	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0.1	495.8	0	0	0	0	0.1	0	0	0	0	0.2	0.1	0	0	3.4	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0.1	0.8	0.7	0.4	0.1	0	0	0	0.5	0.6	0.6	0.1	0	0.2	0.5	0	0	0	0	0	0	0	0	0	0	0	0	1.7	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0.1	0	3.5	0	0	0	0	0.1	5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.3	0	3.5	6.3	0	0	0	0	7.7	0	0	0	0	3.6	0	0	0	0	1.4	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0.1	0.1	0	1321	0	0	0	Syncytiotrophoblasts
C2orf16	DKFZp434G118	ENSG00000221843	Chromosome 2 open reading frame 16	Q68DN1	2	27537386-27582721	Predicted intracellular proteins, Predicted membrane proteins				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	21	testis: 22.3	Cell type enriched	Detected in some	10	Early spermatids: 68.8	Low cancer specificity	Detected in single			Not detected	Not detected			Cell type enhanced	Detected in single		classical monocyte: 1.0	Low lineage specificity	Detected in single			Cell line enhanced	Detected in many		SCLC-21H: 6.3;SiHa: 4.5					Not detected	Not detected			HPA052136, HPA056962	Uncertain		Approved	Nucleoplasm,Nuclear bodies		No	No			Nuclear bodies	Nucleoplasm	HPA052136: AB_2681742, HPA056962: AB_2683290	unprognostic (4.32e-2)	unprognostic (1.08e-2)	unprognostic (8.36e-2)	unprognostic (3.40e-3)	unprognostic (6.36e-2)	unprognostic (6.17e-2)	unprognostic (6.15e-2)	unprognostic (3.07e-1)	unprognostic (9.35e-2)	unprognostic (3.79e-3)	unprognostic (4.59e-1)	unprognostic (2.19e-2)	unprognostic (8.82e-2)	unprognostic (8.00e-2)	unprognostic (1.44e-1)	unprognostic (1.46e-2)	unprognostic (8.53e-3)	0.2	0.5	0.2	0.2	0.2	0	0.2	0.2	0.7	0.2	0.2	0.2	0.2	0.2	0.2	1	0.5	0.1	0.4	0.5	0.2	0.2	0.2	0.9	0.2	0.2	0.2	0.2	0.4	0.4	0	0.3	0.2	0.2	0.2	0	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.6	22.3	0.2	0.2	0.7	0.2	0.2	0.4	0.2	0	0.3	0.3	1	0	0.6	0.1	1.6	1.6	2.3	1.1	0	0	0	1.3	0	0	0	1.2	2.1	0.8	2	0	1.5	0.5	0	0	0	1.4	0.4	3	1.2	1.6	0	1.7	1.3	0	0	0.2	0	1.1	0.2	0.9	1.2	2.2	0.1	0.4	0	0.8	0.4	0.8	0	1.2	1.3	0.6	0	1.5	6.3	1.1	4.5	1.2	0.6	0.4	1	1.1	2.7	1.5	2.1	1	1	0.4	0	1.9	0.5	0.3	2.1	0	1	0	0.6	0.3	0	0	0	0	0.3	0	0.4	0.1	0.3	0	0.8	0.2	0	0.1	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0	0	0	0	0	1.5	0.6	0	0	0	1.8	0	0	0	0.1	68.8	0	0	0	0.4	0	0	0	0	0	0	3.2	0	0	0	6.8	0.6	0	0	0	0	0.5	0.2	0	0.4	0	1.7	0	0	0.7	0.3	0	0	0	0	0	Early spermatids
MAGEA3	CT1.3, HIP8, HYPD, MAGE3, MGC14613	ENSG00000221867	MAGE family member A3	P43357	X	152698752-152702347	Cancer-related genes, Predicted intracellular proteins	Ubl conjugation pathway	Tumor antigen	Cancer-related genes	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	22	testis: 12.8	Cell type enriched	Detected in some	5	Spermatogonia: 46.4	Low cancer specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		GAMG: 53.9;K-562: 31.5;OE19: 70.3;PC-3: 29.4;SH-SY5Y: 29.2;SK-BR-3: 33.3;U-266/70: 46.6;U-266/84: 51.9																										unprognostic (1.29e-1)	unprognostic (9.34e-2)	prognostic unfavorable (3.58e-4)	unprognostic (4.20e-2)	unprognostic (2.48e-1)					unprognostic (2.53e-3)	unprognostic (3.95e-2)		unprognostic (2.92e-1)	0.3	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	12.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	1	0	0	0	0	13.3	0	0	0	0	0	0	0	0	0	53.9	0	0	0	0	0	0	0	9.9	0.2	0	0	20.7	0	0	0	0	0	0	0	31.5	3.2	0	0	0	0	0	70.3	29.4	0	0	0.5	0	0	6.3	29.2	0	33.3	1.6	0	0.3	1.9	0.1	2	3.9	1.9	2.7	46.6	51.9	0	0.2	0	19.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	2	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	1.1	0.3	0	0	0	0	0	0	0	0.4	0	0	0	0	8.6	46.4	0	0.1	0	0	0	Spermatogonia
PSG7		ENSG00000221878	Pregnancy specific beta-1-glycoprotein 7 (gene/pseudogene)		19	42924132-42937178	Predicted intracellular proteins, Predicted secreted proteins				Evidence at protein level	Evidence at protein level				Tissue enriched	Detected in some	8	placenta: 23.1	Cell type enriched	Detected in some	105	Syncytiotrophoblasts: 135.5	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		BJ: 4.0;fHDF/TERT166: 2.8;HBF TERT88: 5.9;U-2197: 4.8									HPA046327	Supported				Secreted in female reproductive system							HPA046327: AB_2679624																		0	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0		0	0	0	0	0	0	0	0	0.3	0	23.1	0	0	0	0	0	0	0	2.8	0	1.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0	4	0.9	0.2	1.3	0	0	0	0	2.8	0.9	0.1	0	0.1	5.9	0	0	0	0	0	0	0	0	0	0	1.2	1.3	0.1	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0.9	0	0	0	0.1	0	4.8	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0	1.3	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0.3	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	135.5	0	0	0	Syncytiotrophoblasts
OR3A2	OLFRA04, OR17-228, OR228	ENSG00000221882	Olfactory receptor family 3 subfamily A member 2	P47893	17	3276942-3386317	G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins	Olfaction, Sensory transduction	G-protein coupled receptor, Receptor, Transducer		Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Group enriched	Detected in some	5	blood: 3.6;brain: 8.6;lymphoid tissue: 6.5;pituitary gland: 5.5;testis: 10.9	Cell type enriched	Detected in some	4	Alveolar cells type 2: 4.6	Cancer enhanced	Detected in single		testis cancer: 0.5	Low region specificity	Detected in many			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Group enriched	Detected in some	6	HDLM-2: 13.1;JURKAT: 14.2																						unprognostic (7.58e-2)				unprognostic (5.10e-2)						unprognostic (6.89e-2)		unprognostic (1.12e-1)		unprognostic (1.32e-1)			0.5	0.5	2.2	0.5	8.6	0.5	0.6	0.4	2.8	0.6	0.4	1.2	0	0.4	0.5	1.5	0.4	0.3	0.2	0.4	2.5	1.2	0.5	0.3	0.8	6.5	1.4	0.6	1	0.4	0.2	5.5	1	2.7	0.7	0.4	1.3	0.3	0.5	0.8	0.6	0.5	0.4	1.9	0.9	0.4	10.9	2.1	2.3	0.3	0	0.7	0.6	0.4	3	3.4	3.6	0.6	0.7	1.8	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.1	0	0	0	0	0	0	0	0	0	0	0	0	0	14.2	0	0.2	0	0	0	0	0.2	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	2.2	0	0	0	0	0	0	0	0	3.6	0.6	0.7	0.9	0.3	1.6	3	1.2	0.3	0.8	0.8	1.2	1.8	1.6	0.7	0.4	3.4	0.5	0.8	2.2	8.6	0.4	2.8	2.5	1.2	1.4	0.6	2.7	2.1	0	4.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	1.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Alveolar cells type 2
POM121L12	DKFZp564N2472	ENSG00000221900	POM121 transmembrane nucleoporin like 12	Q8N7R1	7	53035642-53036924	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	175	testis: 36.1	Cell type enriched	Detected in single	7	Spermatocytes: 5.4	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected											HPA027836	Enhanced											HPA027836: AB_10669592																		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	36.1	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.8	0	0	0	0	0	0	0	0	0.7	0	0	0	0	5.4	0	0	0	0	0	0	Spermatocytes
HEPN1		ENSG00000221932	Hepatocellular carcinoma, down-regulated 1	Q6WQI6	11	124919244-124920677	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level				Tissue enriched	Detected in some	5	brain: 43.3	Cell type enriched	Detected in some	10	Muller glia cells: 23.5	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	240	Hep G2: 34.3									HPA043768, HPA063054	Uncertain		Approved	Golgi apparatus		Yes				Golgi apparatus		HPA043768: AB_2678662, HPA063054: AB_2684932																		8.4	0.5	22	0.4	20.4	0.3	0.3	4.2	43.3	0.3	0.4			0.3	0.4	0.3	0.4	0.3	0.3	0.5	17.9	11	0.4	4.5	0.3	0.5	19.3		0.4	0.3	0.3	0	0.3		0.3	0.3		0.5	0.3	0.5	0.3	0.5	0.3	19.4	0.3	0.4	0.4			0.3		0.3	0.3	0	0	0	0	0	0	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	34.3	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0.1	0	2.4	0	0	0	0.6	0	0.4	0.6	0	0	0	0	23.5	0	0	1.1	0	1.4	0	0	1.9	0.4	0	0	0	0	0	Muller glia cells
XKR9		ENSG00000221947	XK related 9	Q5GH70	8	70669365-70790371	Predicted membrane proteins, Transporters				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		testis: 17.1	Cell type enriched	Detected in many	11	Spermatocytes: 89.2	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		CACO-2: 5.4;hTCEpi: 11.1	Not detected	Not detected			Not detected	Not detected			HPA044430	Enhanced		Approved	Mitochondria						Mitochondria		HPA044430: AB_10961283	unprognostic (1.79e-2)	unprognostic (7.31e-2)	unprognostic (1.42e-1)	unprognostic (1.40e-3)	unprognostic (1.85e-1)	unprognostic (1.22e-1)	unprognostic (2.23e-2)	unprognostic (9.33e-2)	unprognostic (1.63e-1)	unprognostic (2.63e-2)	prognostic unfavorable (7.20e-4)	unprognostic (2.29e-1)	unprognostic (6.96e-6)	unprognostic (3.65e-1)	unprognostic (3.26e-1)	unprognostic (4.04e-3)	unprognostic (3.71e-2)	0.9	3.4	1.9	0.8	4.3	0.9	1.1	0.6	6.4	0.9	1.7	1.9	0	4.9	0.7	2.5	1.1	0.7	4.1	1	2.3	1.5	1	7.5	2.1	1	1.3	7.3	1	1.3	0.3	2.1	0.8	7.4	1.4	1	2.6	2	0.2	0.9	1.7	9.6	3.5	1.7	1	3.6	17.1	0.7	0	1	0	1	2.5	1.2	1.2	0.3	0.9	0.2	0.6	3.1	0.2	3.9	0.3	0.8	0.4	0	1	0.6	1.6	0.8	0.5	1.7	5.4	0.4	0.5	2.7	0.1	1.9	0.1	0.1	0.9	2	0.8	0.5	0.4	0.3	0.6	0.1	1.2	2.2	1.1	11.1	0.3	0	0.5	0	2.6	0.2	3.9	0.3	0.5	0.7	0.6	2.2	0.1	0.5	0.5	1.1	0.2	0.3	2.9	2.4	0.4	0.9	1.6	0.5	0.3	0.5	0.2	0.4	0.5	1.1	0.8	0.6	3.4	0.9	2.5	0.2	0.5	0.3	0.9	0.1	0.3	0.9	0.1	1.7	0.9	1.7	0.8	0.1	1.2	2.6	1.7	0.6	0.6	0.2	0.3	3.1	0.2	1.9	4.3	0.6	6.4	2.3	1.5	1.3	7.3	7.4	0.7	6	2.1	0	3.1	2.4	2.3	0.4	2.5	4	4.5	0	7.9	0.8	0	1	4	0.1	1.2	0	3.9	0.3	0.7	1.1	0	0.5	0.3	1.6	0	0	0	2.9	0.9	0.2	0	0	1	1.5	5.3	0.2	0.4	0.3	5.4	0	0.3	89.2	5.1	0.6	0.8	0	0.1	1.8	Spermatocytes
MYBPHL		ENSG00000221986	Myosin binding protein H like	A2RUH7	1	109292365-109307041	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	46	heart muscle: 64.6	Cell type enriched	Detected in some	14	Cardiomyocytes: 139.3	Low cancer specificity	Detected in some			Low region specificity	Detected in single			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		BEWO: 2.4;Daudi: 1.5;Hep G2: 6.7;K-562: 1.7;RH-30: 3.9;THP-1: 1.5	Not detected	Not detected			Low region specificity	Detected in all			HPA077633			Approved	Vesicles						Vesicles		HPA077633: 	unprognostic (6.07e-3)	unprognostic (1.43e-1)	unprognostic (2.78e-1)	unprognostic (1.17e-2)	unprognostic (1.47e-1)	unprognostic (1.37e-1)	unprognostic (1.80e-2)	unprognostic (1.24e-2)	unprognostic (5.53e-2)	unprognostic (5.89e-1)	unprognostic (5.22e-3)	unprognostic (4.10e-1)	unprognostic (7.05e-9)	unprognostic (6.01e-2)	unprognostic (1.53e-1)	unprognostic (5.81e-2)	unprognostic (2.64e-1)	0	0	0.1	0	0.5	0	0	0.1	0.6	0	0	0.6	0	0	0	0.4	0.3	1.3	0	64.6	0.4	0.1	0	0	0.7	0	1.4	0.1	0	0	0	1.2	0	0.4	0	0	0.3	0	0	0.2	0	0	0	0.2	0	0.3	0.4	0.9	0	0	0	0	0.1	0	0	0.2	0	0.8	0	0	0.4	0.1	0	0.3	0	0	0	2.4	0	0	0	0	0.4	0	1.5	0.1	0	0	0	0	0.1	0	0	0.1	0	0	6.7	0	0	0	0.3	0.5	0	0	0	0	0	1.7	0	0.3	0	0	0	0	0	0	0	3.9	0	0	0.1	0.4	0.1	0.2	0.1	0.8	0.5	0	1.5	0	0	0.1	0	0	0	0	0	0	0	0.2	0	0	0	0	0.8	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0.4	0.1	0.5	0.1	0.6	0.4	0.1	1.4	0.1	0.4	0.9	0	3.2	0	0.1	0	1.1	139.3	0	0	1.2	0	5.9	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0.1	0	0	0	0	0.2	0	0	0	0	0	1	0.2	0	0.7	0	9.8	0	0.3	0.3	0.3	0.1	0	0	0	0.5	Cardiomyocytes
RAB6C	WTH3	ENSG00000222014	RAB6C, member RAS oncogene family	Q9H0N0	2	129979664-129982738	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in many		parathyroid gland: 17.2	Cell type enriched	Detected in some	9	Cardiomyocytes: 8.7	Cancer enhanced	Detected in some		prostate cancer: 1.1	Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	5	BEWO: 4.5;HMC-1: 4.0;REH: 9.3;T-47d: 5.8;U-266/70: 3.9									HPA059131	Uncertain		Uncertain	Golgi apparatus						Golgi apparatus		HPA059131: AB_2683916	unprognostic (3.84e-2)	unprognostic (5.77e-2)	unprognostic (1.02e-1)	unprognostic (1.07e-1)	unprognostic (2.54e-1)	unprognostic (8.62e-2)	unprognostic (1.83e-1)	unprognostic (1.98e-1)	unprognostic (1.38e-2)	unprognostic (1.50e-2)	unprognostic (1.28e-1)	unprognostic (2.44e-1)	unprognostic (1.33e-1)	unprognostic (4.48e-2)	unprognostic (6.04e-2)	unprognostic (1.24e-1)	unprognostic (4.78e-1)	1.7	3.3	5.1	1.4	6.2	1.1	9.9	1.3	10.3	7.6	2	4	1.3	1.1	3.3	1.4	2.2	1.6	1.5	1.5	7.6	5.3	1.4	3.8	1.2	1.2	5.2	4.9	1.5	4.2	17.2	1.6	2.8	8.6	7	1.3	2.1	2	2.8	1.7	1.2	4.4	1.3	5.3	2.7	1.3	4	1.5	0.8	1.5	0.9	1.3	1.2	1.5	0.2	0.3	0.8	0.5	0.6	0.9	0.3	0	0	0	0	0	0	4.5	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	4	0.1	0	0	0	0	0	0	0	0.1	0	0.7	0	0.1	0	0	0	9.3	0	0.9	0	0	0.1	0.8	0	0.8	0.2	1.1	5.8	0	0	0	0.7	0	0	3.9	0	0	0	0	0	0.8	0	0.4	0.9	0.4	0.3	0.2	0.2	0.4	0.3	0.1	0.1	0.2	0.2	0.6	0.5	0.2	0.4	0.3	5.1	6.2	1.3	10.3	7.6	5.3	5.2	4.9	8.6	1.5	0	0	0	0.2	0.7	0	8.7	0	0	0	0	0	0.5	0	0	0	0.4	0	0	0	0.9	0.4	0.7	0	0	0.2	0	0	0	0	0	0.3	0	0	0	0.2	0	0	0	0.7	0	0	0	0	0.5	0.8	1	0.5	0	0	0.3	Cardiomyocytes
C21orf140		ENSG00000222018	Chromosome 21 open reading frame 140	B9A014	21	34400317-34401072	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Low tissue specificity	Detected in many			Cell type enriched	Detected in some	6	Early spermatids: 26.9	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		hTERT-RPE1: 4.3									HPA045123	Uncertain											HPA045123: AB_10961912																		0.9	2.2	1	1	1.9	0.4	1.1	2.8	6.1	1.3	1.6			0.9	2.2	0.2	3.9	1.1	1.9	1.4	1.3	0.9	0.9	0.4	2	2.4	1		2.4	2.4	0.2	1.5	0.8		1.4	0.2		1.3	0.2	3.2	1.5	0.7	0.2	0.8	0.8	5	7.4			2.2		0.2	2.6	1.3	0	0	0	0.1	0	0.6	0	0.2	0.1	1.6	0.8	0	0	0.6	1.6	0	0	0	2.8	0	0	0.9	0	0.3	0	0	0	0	2.1	0.9	0.2	2.3	2.4	0	1.3	1.4	0	0	0	0	4.3	0	1.1	0	1.3	0	0.2	0.6	0.4	0.9	0.4	0	0.1	0.2	1.3	0	0	0.1	1.4	1.2	0.2	0.3	0.6	2.9	2.2	0	1.2	0.7	0.6	0.9	1.2	0.7	0.1	1	2.8	0.4	0	0.1	0	0	0	0.1	0	0	0	0	0	0.3	0.6	0	0	0	0	0	0											0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	26.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Early spermatids
DCDC2B		ENSG00000222046	Doublecortin domain containing 2B	A2VCK2	1	32209094-32216196	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		epididymis: 11.1;fallopian tube: 26.6;lung: 10.1	Cell type enriched	Detected in some	13	Ciliated cells: 115.1	Low cancer specificity	Detected in some			Not detected	Not detected			Cell type enhanced	Detected in single		myeloid DC: 1.0	Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		AF22: 1.6;hTERT-RPE1: 2.9;TIME: 3.6	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA045832	Uncertain											HPA045832: AB_10962048	unprognostic (6.45e-3)	unprognostic (3.71e-2)	unprognostic (1.32e-2)	unprognostic (3.89e-3)	unprognostic (2.18e-1)	unprognostic (1.87e-3)	unprognostic (7.66e-3)	unprognostic (6.35e-2)	unprognostic (4.84e-2)	unprognostic (3.33e-1)	unprognostic (2.71e-3)	unprognostic (8.73e-2)	unprognostic (6.18e-4)	unprognostic (8.53e-2)	unprognostic (2.00e-1)	unprognostic (4.76e-2)	unprognostic (4.39e-3)	0	0.1	0	0.1	0.1	0	0	0	0	1.2	0	0.2	0	0	0.3	11.1	0	26.6	0.2	0	0	0	0	0	10.1	0	0	0	5.5	0	0	0.6	0	0.5	0	0	0	0	0	0	0	0.1	0	0	0	0.1	3.3	0	0	0.1	0	0.2	0	0	0.2	1	0.6	0.1	0.2	0.3	0	0.1	0.8	1.6	0.3	0	0	0.2	0.4	0	0	0	0	1	0.3	0.1	0	0.1	0.1	0.1	0	0	0	0.2	0.4	0.8	0	0	0	0.5	0	0.1	0	0.2	2.9	0	0.9	0.1	0.5	0	0	0.2	0.2	0	0	0	0	0.6	0.1	0	1.2	0.4	0	0	0.6	0.2	0.5	0.8	0.1	3.6	0.1	0.7	1	0.7	1.4	0.1	0	0	0.2	0	0	0.1	0	0.3	0	0	0.2	0.1	0	1	0.1	0	0	0.6	0.2	0	0.4	0	0	0	0.1	0	0	0	0	0	0	0.5	0	0	0.3	0	0	0	2.7	0	0	115.1	9.1	1.8	3.9	0	0	0	4.7	0	0	0	0	0	0	0.1	1.1	0	0	3.2	0	0	0	7.5	0	0	0	0	0	0	0	0	0	0	4.4	0	0	2.7	0.2	0	0	0	0	0	Ciliated cells
HBD		ENSG00000223609	Hemoglobin subunit delta	P02042	11	5232678-5243657	Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins	Oxygen transport, Transport			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	7	bone marrow: 233.7	Cell type enriched	Detected in some	231	Erythroid cells: 15231.4	Not detected	Not detected			Low region specificity	Detected in some			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	5	HEL: 31.3;U-266/70: 42.6									CAB037087, HPA043234	Supported								11000000000			CAB037087: AB_260051, HPA043234: AB_2678378	unprognostic (1.32e-2)		unprognostic (4.87e-2)		unprognostic (4.14e-2)	unprognostic (2.26e-3)		unprognostic (1.52e-1)		unprognostic (3.56e-2)	unprognostic (1.04e-1)		unprognostic (8.67e-2)	unprognostic (2.83e-2)	unprognostic (3.17e-1)	unprognostic (6.24e-2)	unprognostic (3.17e-1)	1.6	0.2	0.4	0.3	0.6	233.7	0.8	0.1	0.5	0.2	0.2	1.5	0	0.2	0.4	0.2	0.9	0.5	0.2	4.3	1.3	0.4	1.4	3.9	22.5	0.2	1	0	1.1	0.2	0.2	1.3	12	0.8	0.5	0.2	1	0.9	0.2	1	0.2	0.2	0.2	0.4	29.6	0.2	0.2	0	1.2	4.4	0	0.4	1.7	11.9	0	0.5	0.8	0	0	0	31.6	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	31.3	0	0	0	0.1	7.3	0	0	0	0	0	0	0	3.1	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	42.6	7.5	0	0	0	0	0.1	0	0.7	0	0	0	0	0	0	0	0	0	0	0.8	0	0	0.5	0	31.6	0.4	0.6	0.1	0.5	1.3	0.4	1	0	0.8	0	0	0	0	0	0.2	0	0	0	0	0	1.8	0	0	0	0	0	0	0	15231.4	0	0	0.5	0	0	1.6	0.1	0	0	0.6	9.3	0	0	0	65.8	0	0	0	0	0	0	0.2	0	0	0.9	0	0	0.1	0	0	0	0	Erythroid cells
CERS1	LAG1, LASS1, UOG1	ENSG00000223802	Ceramide synthase 1	P27544	19	18868545-18896727	Disease related genes, Predicted intracellular proteins, Predicted membrane proteins	Lipid biosynthesis, Lipid metabolism	Transferase	Disease mutation, Epilepsy	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	5	brain: 86.3	Cell type enriched	Detected in some	5	Late spermatids: 85.2	Cancer enhanced	Detected in many		glioma: 13.5	Low region specificity	Detected in all			Cell type enriched	Detected in single	9	neutrophil: 1.7	Lineage enriched	Detected in single	9	granulocytes: 1.7	Cell line enhanced	Detected in many		AN3-CA: 17.7;EFO-21: 13.0;HEK 293: 18.1;NB-4: 19.4;NTERA-2: 13.3									HPA045724	Enhanced		Approved	Endoplasmic reticulum	Intracellular and membrane					Endoplasmic reticulum		HPA045724: AB_10969762	unprognostic (8.25e-2)	unprognostic (8.91e-2)	unprognostic (2.12e-2)	unprognostic (2.14e-1)	unprognostic (3.59e-2)	unprognostic (6.47e-2)	unprognostic (1.15e-2)	unprognostic (1.13e-1)	unprognostic (4.02e-1)	unprognostic (7.04e-3)	unprognostic (3.52e-3)	unprognostic (1.92e-1)	unprognostic (4.59e-2)	unprognostic (2.99e-2)	unprognostic (3.15e-2)	unprognostic (9.15e-2)	unprognostic (3.49e-1)	2.4	4.7	28.9	2.3	32.9	1.7	1.7	12.5	86.3	2.2	2.1	40.5	0	1.6	2	2.1	2.5	2.1	3.9	3.4	29.5	23.2	1.6	1.6	1.9	1.6	31.9	20.5	4.3	2.4	1.7	3.2	1.9	33.8	2	1.8	1.8	2.3	2.1	17.8	2	1.9	3	37.8	1.7	1.8	15.7	22.2	0	2.4	0	1.6	2.6	0.4	0	0	1.7	0.1	0	0.1	0	0.1	1.8	10.9	17.7	0.6	0.2	0.3	1.2	0.1	3.1	2.2	8.7	0.6	0	13	0.8	2.5	0.1	8	0.3	1.2	0	18.1	0.1	0.4	6.5	1.4	1.8	0.2	0.6	0.1	1	0.3	3.5	0.7	0.1	1.1	0.1	2.1	4.5	0.1	19.4	13.3	0	0.3	0	0.3	0.3	2.4	0	9.3	9.3	0.4	0	7.9	3.7	3	10.8	0.3	0	2.5	1.7	2.5	0.3	0.2	0	0	0.6	6.6	0	0	0	0	0.1	0	0	0	0.1	0	0	0.1	0	1.7	0	0	0	0	0	28.9	32.9	12.5	35.7	29.5	23.2	31.9	20.5	33.8	22.2	0	0	0	0.1	0.5	2	0.5	0	0	0	0	2	0	0	0	18.9	0.4	0	0	0.2	0	0.6	0.1	0	0	0.5	0	0	0	0	85.2	1.1	0	1.7	0	0	9.2	0	0	1.1	0	1.2	0	0.3	0.9	2.7	0.4	0.2	0	0	0	Late spermatids
C1QTNF5	CTRP5, DKFZp586B0621, LORD	ENSG00000223953	C1q and TNF related 5	Q9BXJ0	11	119338939-119340940	Disease related genes, Predicted secreted proteins			Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		retina: 30.5	Cell type enriched	Detected in single	4	Ductal cells: 4.1	Not detected	Not detected			Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		ASC diff: 9.4;HHSteC: 19.0;hTERT-RPE1: 14.9;HUVEC TERT2: 28.0;TIME: 25.6	Low region specificity	Detected in all							CAB025607, HPA038604	Uncertain				Secreted to blood			219000000	1600000			CAB025607: , HPA038604: AB_2676110																		13.6	3.2	3.7	4.3	4	0	6.4	3.1	7.1	6.4	6.1	7.9	1.5	5.5	7.1	8.3	3.7	3.8	19	10.2	3.9	3.6	7.3	3.2	8.9	3.6	8.1	2.3	6.2	3.1	1.2	4.2	5	9.6	4.3	2.7	30.5	3.2	3.2	4.2	3.1	5.8	10.9	5.4	5.7	4.3	3.1	5.2	0	4.1	4.6	1.1	8.1	3.3	0	0	0	0	0	0.2	0	0	0	1.7	0	9.4	2.6	0.1	2.3	0.1	0.3	1.4	0	0	0	1	7.4	0	0	0	0	0.2	0	0	0	0	0.3	19	0	0	4.5	0	0.1	0	14.9	28	0	0	0	1.4	0	0	0	0.4	0	0	0	2.1	0	0	0	0	3.4	0	0	0.5	0.5	0	0	25.6	0	0.1	0.1	0	0	0	0	0.1	0	1.7	0	0	0	0	0	0	0	0.1	0	0	0	0	0.2	0	0	0	0	0	0	3.7	4	3.1	3.2	3.9	3.6	8.1	2.3	9.6	5.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4.1	0	0	0	0	1	0	0	0	0	0	0.2	0	0	0.6	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	Ductal cells
PRR29	C17orf72, DKFZp761M2312, FLJ11724	ENSG00000224383	Proline rich 29	P0C7W0	17	63998351-64004304	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in many		epididymis: 17.9;fallopian tube: 48.7;testis: 23.5	Cell type enriched	Detected in some	8	Ciliated cells: 164.6	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		CAPAN-2: 6.8;REH: 7.0;TIME: 5.6									HPA051264			Uncertain	Nucleoli						Nucleoli		HPA051264: 	unprognostic (2.05e-2)	unprognostic (6.46e-2)	unprognostic (2.87e-2)	unprognostic (2.92e-3)	unprognostic (4.71e-3)	unprognostic (3.22e-2)	unprognostic (3.84e-1)	unprognostic (3.95e-2)	unprognostic (1.04e-2)	unprognostic (1.44e-1)	unprognostic (2.63e-3)	unprognostic (5.76e-2)	unprognostic (1.30e-3)	unprognostic (6.48e-2)	unprognostic (1.80e-1)	unprognostic (1.32e-1)	unprognostic (9.98e-3)	0.9	0.5	3.3	0.8	7.6	0.6	0.9	0.1	2.1	4	0.5	8.3	0.4	0.6	1	17.9	0.6	48.7	1	0.7	5.6	5.5	0.6	0.6	7.3	0.7	1.6	0.8	8.1	0.5	0.9	5.8	0.7	15.2	0.6	0.4	0.2	0.9	0.9	0.6	0.5	0.5	0.6	1.1	2.5	0.5	23.5	1	0	2.5	0	0.7	1	0	1	0.7	3.1	1.8	1	3	1.6	0	0	0	0	0	1.3	0.5	0.2	0	0	0.4	0	6.8	0	0.7	0	1.5	0	0.1	0.5	0.2	0	0	2.3	0	0.3	0	0	0.1	0	0	0.3	0	0.8	0.2	1.9	1	0	0	0	2.4	0	0.2	1.4	0.2	7	0.1	2.9	0.5	0	0.4	2.1	0	0.3	0.4	1.1	1.1	0	5.6	0.2	2.4	0.7	0.2	0.7	0.2	0.5	0.9	0.3	0	3.1	0.9	0	2	1.8	0.4	0.7	1.7	1	0.7	1	3	1.7	0.8	1	1.7	0.1	1.1	1.6	3.3	7.6	0.1	2.1	5.6	5.5	1.6	0.8	15.2	1	0	3.2	0.5	0	0	0	0.1	0	164.6	18.2	3.5	0	0	0	0	7.5	0.1	0	0	0	0.1	0.4	0	0	0	0.3	0	0	2.5	0	4.5	0	0	0	0	0	0	0	0	0.7	0	0	0	0	21.8	1.4	0	0.2	0	0	0	Ciliated cells
ATXN1L	BOAT1	ENSG00000224470	Ataxin 1 like	P0C7T5	16	71845991-71885268	Predicted intracellular proteins	Transcription, Transcription regulation	DNA-binding, Repressor		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	5	Late spermatids: 197.6	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low cell line specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA062596, HPA062789			Enhanced	Nucleoplasm						Nucleoplasm		HPA062596: AB_2684802, HPA062789: AB_2684868	unprognostic (1.51e-1)	unprognostic (1.73e-2)	unprognostic (1.39e-1)	unprognostic (1.67e-1)	unprognostic (3.01e-2)	unprognostic (1.01e-1)	unprognostic (1.68e-1)	unprognostic (1.14e-1)	unprognostic (1.00e-1)	unprognostic (1.04e-1)	unprognostic (8.13e-2)	unprognostic (1.99e-1)	prognostic favorable (5.33e-8)	unprognostic (1.61e-1)	unprognostic (1.42e-1)	unprognostic (5.30e-2)	prognostic unfavorable (8.42e-4)	19.2	12	17.1	14.2	15.9	41.3	16.2	11.9	20.9	15	15.4	22.7	9.1	10.2	19.4	9.8	14.7	14.2	14.5	11.9	13.5	10.9	23.4	10	14.9	11.4	14.7	13.1	16.7	16.3	29.3	10.3	14.6	14.7	14.4	11.9	14.2	14.4	14	15.9	18.6	14.9	16.3	14.5	13.8	16	25.3	16.9	10.9	15.1	8.2	12.9	16.2	18.5	1.8	1.3	3.2	2.1	2	3	1.4	8.5	11.6	11.8	8.6	13.9	6.9	13.9	7.2	8.1	13.2	10.1	16.5	9.6	9.6	11.4	11.3	6	15.1	10	11	14.4	2.6	8.8	7	12.1	11.5	10.4	8.5	14.4	9.9	14.1	14.9	10.8	8.7	11.9	12.7	7.9	7.7	7.7	24.3	14.3	8.4	10.8	6.7	5.5	15.4	12	11.4	9.1	12	6.3	10.8	14.4	7.7	8.8	13	11.9	9.1	14.3	14.5	15.3	9.1	9.7	17.4	14.6	22.9	9	5.8	12.2	3.2	1.5	1.7	2.3	2.1	1.6	1.8	1.7	2	1.3	1.5	3	2.7	2.2	2	0.9	0.8	3	1.4	17.1	15.9	11.9	20.9	13.5	10.9	14.7	13.1	14.7	16.9	0	8.8	10.7	13.3	20.3	11.2	11	7.6	5.3	5.7	14	13.7	7.2	14.9	10.6	37.1	15.7	13.6	0	10.3	6.3	10.5	13	12.7	10.6	7.5	14.3	7.5	13.5	8.8	197.6	13.8	11.3	11.8	15.4	7.5	8	12.2	16.4	12	14	15.5	12.9	14.4	20.4	17.9	21.8	9.6	23.5	8.5	23.8	Late spermatids
GAGE12H		ENSG00000224902	G antigen 12H	A6NDE8	X	49579983-49587301	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	No human protein/transcript evidence	Evidence at transcript level		Tissue enriched	Detected in single	223	testis: 22.3	Cell type enriched	Detected in single	12	Spermatogonia: 4.7	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	52	A-431: 19.6;U-266/84: 58.0									HPA043232	Supported		Approved	Golgi apparatus,Plasma membrane,Cytosol						Plasma membrane	Golgi apparatus, Cytosol	HPA043232: AB_2678376																		0	0	0	0	0	0	0	0	0	0	0			0	0	0	0	0	0	0	0	0	0	0	0	0	0		0	0	0	0	0		0	0		0	0	0	0	0	0	0	0	0	22.3			0		0	0	0	0	0	0	0	0	0	0	19.6	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0.1	0	0	0.1	0.5	0	0	0	58	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	4.7	0	0	0	0	0	Spermatogonia
APOC4-APOC2		ENSG00000224916	APOC4-APOC2 readthrough (NMD candidate)		19	44942238-44949565	Predicted membrane proteins				Evidence at protein level	Evidence at protein level				Tissue enriched	Detected in single	267	liver: 178.9	Cell type enriched	Detected in some	6	Hepatocytes: 139.4	Cancer enriched	Detected in some	17	liver cancer: 9.6	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	5	THP-1: 11.6									HPA055877	Supported											HPA055877: AB_2682953	unprognostic (1.45e-1)	unprognostic (4.00e-2)	unprognostic (1.86e-1)	unprognostic (1.33e-1)	unprognostic (1.27e-1)	unprognostic (1.42e-1)	unprognostic (1.49e-2)	unprognostic (2.07e-2)	unprognostic (1.52e-1)	unprognostic (4.73e-2)	unprognostic (1.25e-1)	unprognostic (1.85e-1)	unprognostic (2.01e-4)	unprognostic (2.28e-1)	unprognostic (2.88e-1)	unprognostic (5.95e-2)	unprognostic (1.68e-2)	0.1	0.1	0.4	0.1	0.1	0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0	0.1	0.2	0.1	0	0.1	0.1	0.3	0.2	0.1	178.9	0.1	0.1	0.6	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.3	0.1	0	0.1	0.1	0.5	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0.6	0.5	0	0	0	0	0.1	0	0	0.6	0	0	0	0	0	0	0	0	0	0	0.2	1.7	0	1.5	2.2	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0.1	0	0	0	1.1	0	0	0	0	0	1.2	0	0.7	0	0	11.6	0	0	0	0	0	0	0	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0.1	0.1	0.1	0.3	0.2	0.6	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	23.3	0	0	0	0	2.3	139.4	2.2	0	0	1.3	4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Hepatocytes
PRRT4		ENSG00000224940	Proline rich transmembrane protein 4	C9JH25	7	128350325-128361685	Predicted intracellular proteins, Predicted membrane proteins				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	4	bone marrow: 49.0	Cell type enriched	Detected in some	8	Horizontal cells: 9.5	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Cell type enhanced	Detected in single		naive CD4 T-cell: 1.5	Low lineage specificity	Detected in single			Cell line enriched	Detected in some	5	SH-SY5Y: 72.0	Low region specificity	Detected in many			Not detected	Not detected			HPA046373, HPA052681	Uncertain		Approved	Nucleoplasm,Peroxisomes,Plasma membrane	Intracellular and membrane					Nucleoplasm	Peroxisomes, Plasma membrane	HPA046373: AB_2679642, HPA052681: AB_2681912	unprognostic (1.72e-1)	unprognostic (4.55e-2)	unprognostic (5.36e-3)	unprognostic (1.20e-4)	unprognostic (2.60e-1)	unprognostic (7.81e-2)	unprognostic (1.88e-1)	unprognostic (1.56e-1)	unprognostic (5.62e-3)	unprognostic (1.61e-1)	unprognostic (2.48e-4)	unprognostic (9.11e-2)	unprognostic (3.73e-4)	unprognostic (5.28e-3)	unprognostic (9.09e-2)	unprognostic (1.22e-2)	unprognostic (1.27e-2)	12.1	1.9	2	5.9	11.3	49	6.8	6.5	3.1	1.6	2.7	0.6	0	0.6	0.7	0.5	1.9	1	1.1	2.4	1.7	6.2	0.5	0.7	0.8	0.6	1.6	2.4	1	0.6	0.8	0	0.6	2.9	0.8	0.7	3.4	1.9	1.3	4.2	1.5	0.8	1	2.8	1.3	1.6	0.7	1.5	0.7	0.7	1.7	1	2	3.2	0	0.4	0.4	0.4	0	1.5	0.4	0	0	0.1	0.1	0.4	0	1.2	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0	0	0	1.4	0	0	0	0	2.8	0	0.4	0	0	0	0	0	4.3	0	0	0	0.3	0.7	14.1	0.3	0	0	3.9	0.2	0.3	0	0	0.1	72	0.1	0	0.1	0.5	0	1.9	0	0	0.3	0.1	0	0	0	0	0	8.1	0	0	0.4	0	0.3	0	0	0	0.2	0.5	0	0	1.5	0.7	0.4	0	0	0.4	0	0.4	2	11.3	6.5	3.1	1.7	6.2	1.6	2.4	2.9	1.5	0	0	0	0	0.6	1.2	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0.2	9.5	0	0	0	0	0.9	0	0	0	0	0.8	0	0	0	0	0.4	0	0.4	0	0.4	0.3	0.2	0	0	0	Horizontal cells
FRG2B		ENSG00000225899	FSHD region gene 2 family member B	Q96QU4	10	133623895-133626795	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in some		brain: 2.0;kidney: 1.9;pancreas: 1.2	Cell type enriched	Detected in single	33	Distal tubular cells: 3.3	Not detected	Not detected							Cell type enhanced	Detected in single		neutrophil: 1.1	Lineage enriched	Detected in single	5	granulocytes: 1.1	Cell line enriched	Detected in single	22	HDLM-2: 13.4									HPA039264, HPA047769	Uncertain											HPA039264: AB_2676420, HPA047769: AB_2680149																		0	0	0	0	0.1	0.1	0	2	0.8	0	0			0	0	0	0.4	0.1	0	0.5	0	0.1	1.9	0.1	0	0	0		0.4	1.2	0	0	0.5		0	0		0.3	0	0	0	0	0	0.1	0.3	0	0.8			0		0	0	0	0.2	0	1.1	0.1	0.1	0.1	0	0	0	0	0	0	0	0.3	0	0.1	0	0	0	0	0	0	0	0.4	0	0	0	0.1	13.4	0.5	0	0	0	0	0	0.2	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0.1	0.5	0	0	0	0	0.1	0	0	0.3	0	0	0	0	0	0.6	0	0.2	0.1	0	0.1	0	0	0	0	0.1	0.4	0	0	0.1	0.2	0	0	0	0.1	0	0	1.1	0.1	0	0	0	0											0	0	0	0	0	0	0	0	0	0	0	0	0	3.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Distal tubular cells
SRRM5		ENSG00000226763	Serine/arginine repetitive matrix 5	B3KS81	19	43596617-43614497	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in all	7	testis: 47.6	Cell type enriched	Detected in some	4	Early spermatids: 182.3	Low cancer specificity	Detected in some			Low region specificity	Detected in all			Cell type enhanced	Detected in single		gdT-cell: 1.2	Lineage enhanced	Detected in single		T-cells: 1.2	Low cell line specificity	Detected in many							Not detected	Not detected			HPA047399	Uncertain											HPA047399: AB_10963088	unprognostic (3.95e-3)	unprognostic (7.56e-3)	unprognostic (6.72e-2)	unprognostic (3.40e-2)	unprognostic (1.38e-1)	unprognostic (2.41e-2)	unprognostic (1.10e-3)	unprognostic (1.12e-1)	unprognostic (8.02e-2)	unprognostic (2.89e-2)	unprognostic (3.69e-2)	unprognostic (2.16e-2)	unprognostic (2.68e-5)	unprognostic (2.44e-1)	unprognostic (3.31e-1)	unprognostic (2.07e-1)	unprognostic (1.00e-3)	1.9	2.6	2.9	2.5	4.1	2.2	2	6.8	4.3	1.8	1.9	3.1	2	2.2	2	2.1	2.1	1.9	2.4	1.8	2.5	2.1	2.2	5.5	1.8	3.4	3.2	3.6	2.1	2.5	2	2.8	1.8	3.5	3	1.8	1.5	2.2	2	2.1	3	3.1	1.7	2.6	2.1	2.4	47.6	2.6	2.6	2.6	1.1	1.7	1.9	2	0	0	0	0.4	0	1.2	0.1	3.6	3.2	1.3	2.3	1.2	0.9	0.9	0.9	0.3	0.3	0.5	2	1.6	1.3	2	0.3	1.1	2.3	1.2	0.3	0.6	1.6	1.4	1.3	2.9	1.6	0.5	0.9	1.8	1.1	1.3	0.2	0.3	1.2	0.3	1.8	1	3.2	0.2	3.1	1.4	1.6	0.5	2.7	0.9	2.3	0.9	1	0.8	4.7	2.4	1	0.5	1.4	1.1	1.6	2.7	0.7	1.8	3.4	2	1.3	1.9	3.8	2.6	1.4	2	1.1	1.6	0	0.4	0	1.2	0	0	0	0.5	0	0	0	0.2	0	0	0	0.3	0	0	0.1	2.9	4.1	6.8	4.3	2.5	2.1	3.2	3.6	3.5	2.6	0	0	0	0.1	0.3	0.2	0.3	0	0	0	0	0	0	0	0	182.3	0	0	0	0	0	0	0.2	0	0	0.1	0	0	0	0	44.7	1.1	0	0	0	0	0.3	0	0	0	0	0.7	0	0	0.7	0.5	0.3	0.1	0	0	0.1	Early spermatids
C13orf42	LINC00371	ENSG00000226792	Chromosome 13 open reading frame 42		13	51082119-51200252	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level	No human protein/transcript evidence			Tissue enriched	Detected in single	5	testis: 3.2	Cell type enriched	Detected in single	5	Alveolar cells type 1: 3.0	Cancer enriched	Detected in single	46	testis cancer: 2.3					Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HAP1: 11.0;NTERA-2: 13.9;SuSa: 3.4	Not detected	Not detected																								unprognostic (9.77e-2)									unprognostic (5.61e-2)	unprognostic (1.73e-2)			0	0		0		0	0		0.2	0	0			0	0	0	0	0	0	0.2			0.5	0	0.1	0			0	0	0		0		0	0.1		0	0	0	0.4	0	0		0.7	0	3.2			0		0	0		0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	11	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	13.9	0	0	0	0	0	0	0	0	0	0	0	0	3.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0											3	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Alveolar cells type 1
ANHX		ENSG00000227059	Anomalous homeobox	E9PGG2	12	133218312-133236095	Predicted intracellular proteins		DNA-binding		Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	66	testis: 9.9	Cell type enriched	Detected in some	12	Spermatogonia: 22.4	Cancer enriched	Detected in single	55	testis cancer: 3.5					Not detected	Not detected			Not detected	Not detected			Not detected	Not detected																																						unprognostic (2.28e-1)			0	0	0	0	0.1	0	0	0	0	0	0			0	0	0	0	0	0	0	0	0	0	0	0	0	0		0	0	0	0	0		0	0		0	0	0	0	0	0	0	0	0	9.9			0		0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0.4	0	0.9	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	1.8	22.4	0	0	0	0	0	Spermatogonia
OR2M3	OR2M3P, OR2M6, OST003	ENSG00000228198	Olfactory receptor family 2 subfamily M member 3	Q8NG83	1	248197265-248212925	G-protein coupled receptors, Predicted membrane proteins	Olfaction, Sensory transduction	G-protein coupled receptor, Receptor, Transducer		Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Low tissue specificity	Detected in many			Cell type enriched	Detected in single	23	Club cells: 2.3	Not detected	Not detected							Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Low cell line specificity	Detected in many																																									0.5	0.5	0.9	0.5	0.9	3.6	0.5	0.6	1.2	1.5	1.2			0.7	0.6	2	0.5	0.5	0.6	0.5	1	1.1	1.6	1.6	0.5	0.8	1.1		1	0.7	0	0.7	0.3		0.5	1.4		1.4	0	0.8	2.4	0.6	0	0.7	0.8	0.8	1.6			0.9		0	0.7	0.5	1.7	1.4	3.3	1.9	0.9	1.4	0.5	2.8	1.6	2.5	2.6	1	1.1	2.4	2.2	0.3	0.3	0.6	6.2	3.7	3.3	2.4	0.5	3.6	2.6	1.1	0.8	0.9	3.2	2.2	1.7	5.2	2	0.4	2.2	2.1	0.9	1.1	0.6	0.8	1.7	0.5	2.3	3.7	6.6	0.7	2.4	1.8	2.5	3.9	2.4	1.4	2.1	2.8	3	1	2.2	2.7	2.3	2.9	1.5	1.7	3.1	2.9	2	3.1	2.9	3.6	2.9	1.9	4.2	2.6	2.5	2.4	2	2.6	3.3	1.6	0.8	1.4	1.9	1.2	1	1.1	0.9	0.6	1.7	1.2	1.2	3.2	0.9	1.3	1.4	0.9	0.5											0	0	0	0	0	0	0	0	0	2.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Club cells
MT-ATP8	A6L, ATP8, MTATP8	ENSG00000228253	Mitochondrially encoded ATP synthase membrane subunit 8	P03928	MT	8366-8572	Disease related genes, Predicted membrane proteins	ATP synthesis, Hydrogen ion transport, Ion transport, Transport		Cardiomyopathy, Disease mutation, Primary mitochondrial disease	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		skeletal muscle: 959.7	Cell type enriched	Detected in many	31	Cardiomyocytes: 20663.1	Low cancer specificity	Detected in all							Cell type enhanced	Detected in all		basophil: 352.9	Lineage enriched	Detected in all	4	granulocytes: 352.9	Cell line enhanced	Detected in all		HeLa: 805.0																						unprognostic (1.54e-1)	unprognostic (4.12e-2)	unprognostic (3.95e-2)	unprognostic (2.56e-1)	unprognostic (3.07e-2)	unprognostic (1.17e-1)	prognostic favorable (7.56e-5)	unprognostic (5.17e-2)	unprognostic (6.61e-2)	unprognostic (2.52e-3)	unprognostic (8.26e-2)	unprognostic (1.30e-2)	unprognostic (1.10e-1)	unprognostic (1.31e-1)	unprognostic (2.76e-1)	unprognostic (2.62e-1)	unprognostic (1.63e-2)	257.8	128.5	111.1	33.5	124.1	20.5	31.2	42.1	82.1	14.9	78.9			115.5	23.9	11.6	31.6	14.4	19.9	203.6	108.7	78.8	151.5	165.2	16.9	18.5	88.8		24.3	56.4	22.8	21.1	27.7		44.2	38.7		65.2	25.7	959.7	33.1	91.5	14.2	52	19.3	67.4	26.1			23.2		11.8	19.6	15.4	87.7	58	352.9	78.1	75.9	79.1	24.2	189.4	69.9	228.3	43.4	248.7	39.8	112.1	398.9	23.6	18.1	31.7	81.2	127.3	485.5	99.6	85.8	69.2	326	14	131.5	28.5	214.5	91.1	367.2	805	183.1	45.4	213.8	314.4	85.5	69.8	40.2	34.6	254.6	25.8	193.9	194.4	154	55.5	101.3	125.2	315.4	50.2	106.8	50.5	103.4	111	102.1	133.6	189.5	71.8	129.8	151.3	140.3	147.4	378.1	136.9	449.1	377.2	88.4	195.8	194.6	182.8	104.4	174.8	277.5	87.1	380.3	53.6	352.9	78.1	97.9	49.4	68.6	73.5	87.7	55.9	58.5	47.2	87.3	68.9	79.1	49	75.9	68	58	44	24.2											175.7	127.6	194.5	6.6	10.3	0	20663.1	265	662.5	619.9	12.2	0	0	3.3	11.5	6	7.1	98.6	420.4	26.4	0	6.7	3.9	274.2	625.8	0	0	28	241.2	345.1	31.7	37.7	12.6	11.8	11.8	48.6	0	16.1	47	23.7	20.3	0	38.8	11.3	24.7	22.2	8	0	192.9	46.4	6.2	Cardiomyocytes
ORM2	AGP-B, AGP-B', AGP2	ENSG00000228278	Orosomucoid 2	P19652	9	114329869-114333252	Plasma proteins, Predicted secreted proteins	Acute phase, Transport			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	31	liver: 404.1	Cell type enriched	Detected in some	43	Hepatocytes: 9578.7	Cancer enriched	Detected in many	34	liver cancer: 873.1					Cell type enriched	Detected in single	35	neutrophil: 13.2	Lineage enriched	Detected in single	35	granulocytes: 13.2	Cell line enriched	Detected in single	237	Hep G2: 136.6									HPA046438, HPA047725, HPA057726	Approved		Approved	Golgi apparatus,Vesicles	Secreted to blood			422000000	61000000000	Vesicles	Golgi apparatus	HPA046438: AB_2679666, HPA047725: AB_2680133, HPA057726: AB_2683512	unprognostic (6.77e-2)	unprognostic (8.00e-2)	unprognostic (1.19e-1)	unprognostic (4.44e-3)	unprognostic (1.18e-1)	unprognostic (5.61e-2)	unprognostic (5.66e-2)	unprognostic (9.70e-2)	unprognostic (3.05e-1)	unprognostic (1.48e-1)	unprognostic (1.99e-2)	unprognostic (5.76e-2)	prognostic unfavorable (1.23e-9)	unprognostic (3.23e-1)	unprognostic (6.80e-2)	unprognostic (7.62e-2)	unprognostic (9.15e-4)	0	0.1	0	0	0	1.2	0	0	0	0	0			0	0	0	0	0	0	0	0	0	0	404.1	0.1	0	0		0	0	0	0	0		1.2	0		0	0	0	0	0	0	0	0.3	1	0			0		0	0	0	0	0	13.2	0.3	0	0.1	0.1	0	0	0	0	0.3	0	0	0	0	0	0	0.5	0	0.1	0	0	0	0	0	0	0	0	0	0.1	0	136.6	0	0.5	0.1	0	0	0	0	0	0	0	0	0.3	0	0	0	0.2	0	0.4	0	0	0.3	0	0	0	0	0	0.4	0.3	0	0	0	0.2	0	0	0	0	0	0.1	0.1	0.4	0	0.1	0	0	0.3	0	0.1	0	0	0	0	0	0	0	0	0	13.2	0	0.1	0	0	0.1											0	8	42.8	0	0	0	0	224.2	0	0	0	0	0	0	1.2	6.5	0	0	70	5.4	0	0	2.1	0	9578.7	0	0	0	141.2	136	5	0	0	0	0	0	0	2.4	0	0	0	0	0	0	0	0	0	0	0	0	0	Hepatocytes
SAPCD1	C6orf26, NG23	ENSG00000228727	Suppressor APC domain containing 1	Q5SSQ6	6	31762799-31764851	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in many		retina: 8.8;skin 1: 14.7	Cell type enriched	Detected in single	27	Ciliated cells: 2.7	Low cancer specificity	Detected in some			Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HeLa: 7.3;JURKAT: 6.4	Not detected	Not detected			Low region specificity	Detected in many			HPA071699			Approved	Vesicles,Cell Junctions						Vesicles	Cell Junctions	HPA071699: AB_2686433	unprognostic (9.25e-4)	unprognostic (1.32e-1)	unprognostic (3.41e-2)	unprognostic (3.28e-1)	unprognostic (9.34e-2)	unprognostic (8.02e-4)	unprognostic (1.63e-2)	unprognostic (3.80e-2)	unprognostic (2.01e-1)	unprognostic (8.16e-3)	unprognostic (1.56e-2)	unprognostic (2.25e-1)	unprognostic (8.15e-10)	unprognostic (2.65e-2)	unprognostic (4.45e-1)	unprognostic (3.57e-1)	unprognostic (7.98e-5)	0.8	0.3	0.7	1.6	1	4.8	1.8	0.7	1.3	2	1	1.3	0.7	0.2	1.2	0.8	0.7	1.8	2.5	0.7	0.7	0.8	3.2	0.9	1.4	2.5	1.9	0.7	1.6	0.7	0.2	2.9	3.3	3.9	2.6	1.1	8.8	0.7	1.6	0.7	14.7	1.5	0.7	3.1	2.1	0.8	1.2	0.7	0.7	0.7	0.7	0.7	0.8	0.7	0	0.5	0.2	0.1	0	0.7	0	0.5	0	0	0.5	0.4	0.8	0.8	0.4	0.2	0.2	0	2.8	1	0.8	0.1	0.2	0	1.6	0	0.7	0.1	0	3.1	3.8	7.3	1	0.2	0.3	0.1	0.2	0	1.1	1.4	0.3	0.5	6.4	0.4	1.1	0	3.7	2.8	2.3	0	0.3	0.8	0.4	0.9	0	0.6	0.7	1.2	0.6	0.3	0.7	0.4	0.9	0.3	0	0.2	0.1	2.9	0	0.3	2.1	2	2	0.2	2.7	0.1	0	0	0	0.7	0	0	0	0	0.2	0	0	0	0	0.2	0	0.1	0.5	0	0	0.7	1	0.7	1.3	0.7	0.8	1.9	0.7	3.9	0.7	0	0	0	0	0	0	0	0	2.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Ciliated cells
TSPY3	CT78	ENSG00000228927	Testis specific protein, Y-linked 3	P0CV98	Y	9398421-9401223	Predicted intracellular proteins	Differentiation, Gonadal differentiation, Spermatogenesis	Developmental protein		Evidence at protein level	Evidence at protein level	Evidence at protein level	No human protein/transcript evidence		Tissue enriched	Detected in some	4	testis: 7.6	Cell type enriched	Detected in single	25	Spermatogonia: 6.1	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	75	U-266/70: 50.9;U-266/84: 46.1									HPA049384, HPA067289	Supported		Approved	Cytosol						Cytosol		HPA049384: AB_2680738, HPA067289: 															unprognostic (4.19e-1)			0	0	0	0	0	0	0	0	0	0	0			0.2	0	1.8	0.7	0	0.2	0	0	0	0	0	0	0	0		0	0	0	0	0		0	0		0	0	0	0	0.1	0	0	0	0	7.6			0		0	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0.1	50.9	46.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	6.1	0	0	0	0	0	Spermatogonia
PGA4		ENSG00000229183	Pepsinogen 4, group I (pepsinogen A)	P0DJD7	11	61222216-61231927	Enzymes, Predicted intracellular proteins, Predicted secreted proteins	Digestion	Aspartyl protease, Hydrolase, Protease		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in some	120	stomach 1: 924.0	Cell type enriched	Detected in single	128	Exocrine glandular cells: 100.1	Not detected	Not detected							Group enriched	Detected in some	16	classical monocyte: 7.6;intermediate monocyte: 5.9;non-classical monocyte: 2.1	Lineage enriched	Detected in single	23	monocytes: 7.6	Group enriched	Detected in some	8	BJ hTERT+: 17.6;THP-1: 8.9									HPA046875	Supported				Secreted to digestive system							HPA046875: AB_2679851										unprognostic (2.22e-1)								0	0	0	0	0	0	0	0	0	0	0			0	0	0	0	0.2	0	0	0	0	0.1	0	0.5	0	0		0	0	0	0	0		0	0		0	0	0	0	0	0	0	0	924	0			0		0	0	0	0	0.3	0.1	7.6	0	0.1	1.4	0	0	0	0	0	0	0	0	17.6	0	0	0	0	0	1.6	0	0	0.4	0	0	0	0	0	0	0	0.1	0	0	1	0	0	0.1	0	0	0	0	0	0	0.1	0.1	1.4	0	1.2	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	8.9	0	0	0	0.2	0	0.3	0	0	0	0	0	0	7.6	0	0	5.9	0	0	0	0	0.3	0	0	0.1	0.1	0	2.1	0	0	1.4											0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	100.1	0	0	0	0	0	0.3	0	0	0	0	0.8	0	0	0	0	0	0.5	0.1	0	0	0	0.1	0	0	0	0	0	0	0	0	0	Exocrine glandular cells
ORM1		ENSG00000229314	Orosomucoid 1	P02763	9	114323056-114326475	Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins	Acute phase, Transport		Cancer-related genes	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	16	liver: 834.6	Cell type enriched	Detected in some	35	Hepatocytes: 50531.7	Cancer enriched	Detected in many	16	liver cancer: 2506.9					Cell type enriched	Detected in some	45	neutrophil: 53.4	Lineage enriched	Detected in many	45	granulocytes: 53.4	Cell line enriched	Detected in some	11	Hep G2: 161.7									CAB006265, HPA046438, HPA047725, HPA057726	Approved		Approved	Golgi apparatus,Vesicles	Secreted to blood			945000000000	120000000000	Vesicles	Golgi apparatus	CAB006265: AB_425575, HPA046438: AB_2679666, HPA047725: AB_2680133, HPA057726: AB_2683512	unprognostic (3.85e-1)	unprognostic (2.12e-1)	unprognostic (1.09e-2)	unprognostic (2.16e-2)	unprognostic (3.22e-2)	unprognostic (1.47e-1)	unprognostic (2.29e-1)	unprognostic (2.26e-1)		unprognostic (1.16e-1)	unprognostic (4.85e-2)	unprognostic (1.74e-1)	prognostic unfavorable (2.35e-4)	unprognostic (2.10e-1)	unprognostic (4.38e-2)	unprognostic (9.32e-3)	unprognostic (4.51e-2)	0.1	0	0	0.2	0	6.7	0	0	0	0	0			0	0	0	0	0	0	0	0	0	0	834.6	0.3	0	0		0	0	0	0	0		0.6	0		0	0	0	0	0	0	0	1.3	0.4	0			0		0	0	0	0	0	53.4	1.1	0	0	0.3	0	0	0	0	0.1	0	0	0	0	0	0	0.5	0	0.2	0	0	0	0	0	0	0	0	0	0.4	0	161.7	0	0.7	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0.1	0	0	0.1	1	0	0	0	0	0	0.8	0.8	0	0	0	14.3	0.1	0	0	0	0	0.1	0	0.5	0	0.6	0	0	1.1	0	0	0.1	0	0	0	0	0	0	0	0	53.4	0	0.2	0	0	0.3											3	14.9	263	0	0	0	0	1452.2	0	1.2	0	0	0	0	6.6	0	0	0	794.3	4.5	0.1	0	31.6	0	50531.7	0.1	0	0	844.6	848.5	0	0	0	0	0	0	0	10.4	0	0	0	0	0	0	0	0	0	0	2.9	0	0.3	Hepatocytes
TSPY8		ENSG00000229549	Testis specific protein, Y-linked 8	P0CW00	Y	9357797-9360599	Predicted intracellular proteins	Differentiation, Gonadal differentiation, Spermatogenesis	Developmental protein		Evidence at protein level	Evidence at protein level	No human protein/transcript evidence	No human protein/transcript evidence		Tissue enriched	Detected in single	10	testis: 4.1	Cell type enriched	Detected in single	12	Spermatogonia: 5.9	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	230	U-266/84: 77.1									HPA049384, HPA067289	Supported		Approved	Cytosol						Cytosol		HPA049384: AB_2680738, HPA067289: 																		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0.1	0.3	77.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	5.9	0	0	0	0	0	Spermatogonia
GK3P	GKP3, GKTB	ENSG00000229894	Glycerol kinase 3 pseudogene	Q14409	4	165277812-165279679	Enzymes, Predicted membrane proteins	Glycerol metabolism	Kinase, Transferase		Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	6	testis: 17.0	Cell type enriched	Detected in single	17	Distal tubular cells: 1.7	Not detected	Not detected							Cell type enriched	Detected in single	12	neutrophil: 2.9	Lineage enriched	Detected in single	12	granulocytes: 2.9	Cell line enhanced	Detected in single		TIME: 1.1									HPA060687	Uncertain											HPA060687: AB_2684343	unprognostic (1.34e-1)	unprognostic (2.41e-1)	unprognostic (3.01e-2)		unprognostic (1.17e-2)	unprognostic (2.11e-2)	unprognostic (3.94e-1)	unprognostic (1.61e-1)	unprognostic (2.04e-1)	unprognostic (6.19e-2)			unprognostic (6.99e-2)	unprognostic (4.63e-2)	unprognostic (2.02e-1)	unprognostic (4.56e-1)	unprognostic (3.34e-4)	0	0		0		0.4	0		0	0	0			0	0	0	0	0	0	0			0	0	0	0			0	0	0		0		0	0		0	0	0	0	0	0		0	0	17			0		0	0		0	0.1	2.9	0.2	0	0.1	0	0.3	0	0	0.2	0	0	0.2	0.4	0	0	0	0.5	0	0.3	0	0	0.1	0.2	0	0	0	0	0	0.4	0	0.4	0	0	0	0	0	0	0	0	0	0.1	0	0.6	0	0	0	0	0.2	0	0	0	0.4	0	0	0	0.2	0	0	0.3	0.4	0	0	0.2	1.1	0	0.1	0	0.1	0	0.4	0.9	0	0	0.7	0	0.2	0.1	0	0.1	0	0	0	0	0.1	0	0	0.1	2.9	0	0.1	0	0.1	0											0	0	0	0	0	0	0	0	0	0	0	0	0	1.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Distal tubular cells
ANKRD66		ENSG00000230062	Ankyrin repeat domain 66	B4E2M5	6	46746917-46759506	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in some		brain: 15.0;epididymis: 12.1;fallopian tube: 36.0;ovary: 11.1	Cell type enriched	Detected in some	10	Ciliated cells: 210.1	Cancer enhanced	Detected in single		endometrial cancer: 1.0	Region enhanced	Detected in many		pons and medulla: 15.0	Cell type enriched	Detected in single	6	myeloid DC: 1.0	Lineage enriched	Detected in single	6	dendritic cells: 1.0	Not detected	Not detected			Low region specificity	Detected in many			Low region specificity	Detected in all																			unprognostic (1.67e-3)	unprognostic (2.52e-1)			unprognostic (2.44e-2)		unprognostic (2.03e-2)		unprognostic (9.36e-2)		unprognostic (4.30e-3)	unprognostic (2.19e-1)			0.1	0.2	2	0.2	4.3	0.1	0.2	0	0.6	1.7	0.1	5.9	0	0.1	0.9	12.1	0.1	36	0.1	0.1	3	3	0.1	0.1	7.1	0.2	0	0	11.1	0.1	0.1	0.5	0.2	15	0.2	0.1	0	0.1	0.1	0.1	0.2	0.2	0.1	0.3	0.2	0.2	0.9	1.9	0	0.2	0.1	0.2	0.2	0	0	1	0	0.1	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	2	4.3	0	0.6	3	3	0	0	15	1.9	0	0.3	0	0	0	0	0	0	210.1	20.5	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Ciliated cells
YY2	ZNF631	ENSG00000230797	YY2 transcription factor	O15391	X	21855987-21858727	Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	Activator, DNA-binding, Repressor		Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		testis: 9.5	Cell type enriched	Detected in many	8	Spermatogonia: 52.4	Low cancer specificity	Detected in some							Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Low cell line specificity	Detected in many			Low region specificity	Detected in many							HPA001119, HPA030335	Enhanced		Approved	Nuclear bodies						Nuclear bodies		HPA001119: AB_1858930, HPA030335: AB_2673434	unprognostic (1.90e-2)	unprognostic (3.34e-2)	unprognostic (2.75e-2)	unprognostic (8.39e-3)	unprognostic (3.48e-2)	unprognostic (2.38e-2)	unprognostic (4.62e-2)	unprognostic (1.99e-1)	unprognostic (1.20e-1)	unprognostic (1.30e-1)	unprognostic (2.21e-2)	unprognostic (2.03e-1)	unprognostic (8.78e-4)	unprognostic (4.04e-1)	unprognostic (9.38e-2)	unprognostic (1.44e-1)	unprognostic (2.05e-1)	1.6	1.8	0.7	1.4	0.9	0.3	1.4	1.8	0.8	1.6	1.2			0.3	2.8	1.9	1.3	1.6	1.2	1.2	0.5	0.6	1	2.5	1.4	0.7	0.8		3.3	1.4	1.5	2.5	2.2		1.8	0.9		1.3	1.6	1.2	1.8	0.8	2	1.1	0.9	0.9	9.5			1.6		0.6	1.1	1.5	1.5	1.2	0	0.6	1.4	2.7	0.5	3.6	3.3	2.3	7.3	2.9	1.2	0.3	4	2.3	4.7	5.3	2.7	6.1	4.2	2.4	5.2	6	2	5	5.5	8.2	3	4.8	1.1	8.9	2.2	5	4.5	2.2	2.4	4.1	3.5	5.8	3.6	2.9	1.6	4.2	5	8.2	2.5	2.4	4.6	4.3	1.8	4.4	2.3	3.9	6.4	2.5	1.6	1.3	3.3	2.3	2	6.6	6.3	3.5	1.5	3.1	8.6	1.7	14.9	4.7	3.4	3.9	2.6	5.6	2.2	6.8	0	0.6	0	0.8	0.1	0.6	1.5	1.3	0.8	0.6	1.1	2.7	0.6	0	1.4	0.4	1.2	1.2	0.5											0	1.6	0	0.7	0.8	2.3	0.8	0	0	0	1.8	3.9	2.5	0	0.8	0.4	1.8	0.4	0	0.6	1.1	1.9	1.2	1.1	2.1	1.9	6.4	1.2	1.8	2.2	1	5.8	1.8	0	3.6	0.3	1.3	1.3	0	3.5	0.3	3.4	0	0.5	6.9	52.4	1.3	1.7	0	0.6	1.1	Spermatogonia
SBK3	SgK110	ENSG00000231274	SH3 domain binding kinase family member 3	P0C264	19	55540656-55545543	Enzymes, Predicted intracellular proteins, Predicted membrane proteins		Kinase, Serine/threonine-protein kinase, Transferase		Evidence at protein level	Evidence at transcript level	No human protein/transcript evidence	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	12	heart muscle: 24.2	Cell type enriched	Detected in single	25	Cardiomyocytes: 2.5	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		A549: 9.4;CACO-2: 3.3;CAPAN-2: 5.6;NTERA-2: 2.5;RH-30: 4.1	Low region specificity	Detected in many			Not detected	Not detected			HPA078322			Approved	Mitochondria						Mitochondria		HPA078322: AB_2732379	unprognostic (2.15e-1)	unprognostic (1.99e-3)	unprognostic (2.71e-1)	unprognostic (1.39e-3)	unprognostic (7.52e-2)	unprognostic (2.83e-1)	unprognostic (5.47e-5)	unprognostic (4.64e-3)		unprognostic (7.24e-2)	unprognostic (1.65e-1)	unprognostic (3.38e-1)	unprognostic (3.08e-3)	unprognostic (1.21e-2)	unprognostic (4.92e-2)	unprognostic (2.41e-1)	unprognostic (1.79e-1)	2	0	0	0	0	0	0.2	0.1	0	0	0			0.2	0	0	1.7	0	0.1	24.2	0	0	0	0	0.1	0	0		0	0.2	0	0	0		0	0		0.1	0	1.9	0	0	0	0	0	0.2	0			0.1		0	0	0	0	0	0	0	0	0	0	0	9.4	0.8	0	0.1	0	0.2	0.2	0	0.1	0.3	3.3	5.6	0	0.2	0.2	0.2	0	0	0	0	0	0	0	0.9	1.8	0.4	0	0	0.1	0	0	0	0	0	0	2.2	0	0	1	0	0	2.5	0.1	0.6	0.2	4.1	0	0.1	0	0	0	0	0.2	0.1	0.1	0	0	0	0.2	1.3	0.4	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0	0	2.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Cardiomyocytes
TSPAN19		ENSG00000231738	Tetraspanin 19	P0C672	12	85014311-85036277	Predicted intracellular proteins, Predicted membrane proteins				Evidence at transcript level	Evidence at transcript level				Tissue enhanced	Detected in many		lung: 9.7;pituitary gland: 20.0	Cell type enriched	Detected in some	8	Ciliated cells: 360.0	Not detected	Not detected			Low region specificity	Detected in all			Cell type enhanced	Detected in many		neutrophil: 5.4	Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		SCLC-21H: 6.4;SK-BR-3: 4.3					Low region specificity	Detected in all			HPA057066	Uncertain											HPA057066: AB_2683325				unprognostic (1.94e-1)	unprognostic (9.81e-4)	unprognostic (8.57e-2)		unprognostic (8.37e-2)	unprognostic (2.33e-1)	unprognostic (6.57e-2)	unprognostic (2.26e-3)	unprognostic (9.52e-2)	unprognostic (5.09e-3)		unprognostic (2.22e-1)	unprognostic (3.78e-2)		0.4	0.8	1.5	0.5	1.9	2.3	0.2	1	2.6	0.5	0.4	1.4	0	1.1	0.5	2.5	0.8	1.8	0.8	0.4	3.2	4.4	0.7	0.1	9.7	0.5	2.3	4.4	0.4	1.6	0.4	20	0.5	4.9	1	0.2	2.4	0.8	0	1.6	4.5	0.6	0	1.6	0.5	0.5	8.4	1.4	0	4.1	1.3	0.2	0.5	0.2	1.8	0.9	5.4	1	0.8	1.1	0	0.9	0	1.6	0.5	0.9	1.4	1.8	0.9	0.1	0	0.5	0.8	0	1	0.1	0	1.1	0.3	0.2	0.3	0	0.8	1.6	0	0.5	0.7	2.1	1.5	1.7	1	1.1	0.9	0.6	3.2	0	0.8	0.1	0	0	0	0	0	1.3	0.8	0	1.4	0.2	0	0	0.3	6.4	2.7	0	4.3	0.9	0.7	1	0.3	1.2	3	0.9	1.3	0.8	3.8	0	0.5	3.3	0	1.4	1.1	1	1.1	1	0.7	0.7	0.9	0.8	0.5	0.1	1.8	1.1	1	5.4	0.8	0.4	0.9	0.3	0	1.5	1.9	1	2.6	3.2	4.4	2.3	4.4	4.9	1.4	3	1.3	0	0	0.1	2.4	0.8	0	360	34.2	0	7.9	0	0	0	46.9	0.1	0	0	0	0	0.2	0.8	0	0	0	0	0	0	0	2.5	0	0	0	0	0	4.7	0	0	0.4	0	7.9	6.5	0	0.9	0.5	0	0	0	0	0	Ciliated cells
CYP21A2	CA21H, CAH1, CPS1, CYP21, CYP21B, P450c21B	ENSG00000231852	Cytochrome P450 family 21 subfamily A member 2	P08686	6	32038265-32041670	Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins	Steroidogenesis	Monooxygenase, Oxidoreductase	Congenital adrenal hyperplasia, Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	23	adrenal gland: 170.9	Cell type enriched	Detected in some	6	Hepatocytes: 14.4	Cancer enhanced	Detected in some		liver cancer: 2.7	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HDLM-2: 11.8;Hep G2: 1.9;Karpas-707: 3.2					Not detected	Not detected			HPA048979, HPA053371	Enhanced				Intracellular and membrane							HPA048979: AB_2680584, HPA053371: AB_2682131	unprognostic (1.03e-2)	unprognostic (1.65e-1)	unprognostic (1.02e-4)	unprognostic (2.58e-1)	unprognostic (2.97e-1)	unprognostic (2.93e-2)	unprognostic (2.76e-2)	unprognostic (8.75e-2)	unprognostic (1.39e-1)	unprognostic (1.71e-1)	unprognostic (1.41e-1)	unprognostic (1.93e-1)	unprognostic (6.67e-7)	unprognostic (7.39e-2)	unprognostic (5.24e-2)	unprognostic (1.09e-1)	unprognostic (1.82e-1)	0.1	170.9	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	6.7	0.1	0	0.1	0.2	0.1	0	0.1	0.1	0.1	0	0.3	7.4	0.1	0.1	0.1	0.1	0.2	0.1	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	3.6	0	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	11.8	0.3	0	0	1.9	0	0	0	0	0	0	0	0	0	0	0	3.2	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0.4	1.1	0	0	0.1	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	0	0.1	0.1	0.3	0.3	2.5	1.4	1.2	0	0	0	0	0.2	0	0	0	0	0	0	0.5	0.3	1.1	14.4	0	0	1.7	0	0	0	0.6	0	1.7	0	0	0.2	0.5	0	0	1.7	0.4	0	0.2	0.5	0.4	0	0	0	0	0	Hepatocytes
PSG1	CD66f, PBG1, PSBG1, PSGGA	ENSG00000231924	Pregnancy specific beta-1-glycoprotein 1	P11464	19	42866464-42879822	CD markers, Predicted intracellular proteins, Predicted secreted proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	362	placenta: 497.6	Cell type enriched	Detected in some	130	Syncytiotrophoblasts: 173.1	Cancer enhanced	Detected in single		thyroid cancer: 0.5	Not detected	Not detected			Cell type enhanced	Detected in single		neutrophil: 1.0	Low lineage specificity	Detected in single			Cell line enriched	Detected in some	18	U-2197: 98.0									HPA046327	Supported				Secreted in female reproductive system							HPA046327: AB_2679624					unprognostic (2.02e-1)	unprognostic (3.54e-1)							unprognostic (2.44e-7)			unprognostic (2.28e-2)		1.3	0	0.1	0	0.1	0	0.6	0.5	0.2	0.3	0.1	0	0	0	0	0	0.1	0.1	0	0.2	0.1	0.1	0.2	0	0	0	0.1	0	0	0.2	0.1	0.1	497.6	0	0	0	0	0.2	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.2	0	0	0.5	0	0	0.2	0	0.2	0	1	0.3	0	0.1	0	0	0.1	0	0	0	0	0	4.2	1.4	0.3	0.5	0	0	0	0	4.8	1	0	0	0	4.1	0	0	0	0	0	0	0	0	0	0	0	0.5	0.5	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0	5.4	0	0	0.1	0	0	98	0	0	0	0	0	0	0	0.4	0	0.1	0	0	0.1	0.1	0	0	0	0.2	0	0.1	1	0	0.3	0	0.1	0	0.1	0.1	0.5	0.2	0.1	0.1	0.1	0	0	0	0	0	0	0	0.2	1.3	0	0	0	0	0	0	0.5	0	0.1	0.6	0	0	0	0	0.7	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0.1	0	0	0	0	0.1	173.1	0	0	0	Syncytiotrophoblasts
TMEM253	C14orf176, C14orf95, NCRNA00220	ENSG00000232070	Transmembrane protein 253	P0C7T8	14	21098937-21103724	Predicted membrane proteins				Evidence at protein level	Evidence at protein level	No human protein/transcript evidence	Evidence at transcript level		Tissue enriched	Detected in some	31	intestine: 110.5	Cell type enriched	Detected in some	7	Enterocytes: 67.8	Low cancer specificity	Detected in some			Not detected	Not detected			Cell type enriched	Detected in single	7	neutrophil: 1.6	Lineage enriched	Detected in single	7	granulocytes: 1.6	Low cell line specificity	Detected in many			Low region specificity	Detected in some			Low region specificity	Detected in all			HPA052329, HPA065092	Enhanced											HPA052329: AB_2681791, HPA065092: AB_2685420	unprognostic (7.48e-3)	unprognostic (1.33e-2)	unprognostic (7.19e-2)	unprognostic (3.84e-2)	unprognostic (1.41e-2)	unprognostic (1.50e-2)	unprognostic (2.07e-1)	unprognostic (2.90e-2)	unprognostic (2.04e-1)	unprognostic (1.40e-1)	unprognostic (1.28e-2)	unprognostic (5.46e-2)	unprognostic (9.93e-2)	unprognostic (3.59e-1)	unprognostic (1.80e-1)	unprognostic (2.20e-2)	unprognostic (1.04e-1)	0.4	1.5	0.4	2.2	0.4	0	0.3	0.5	0.5	0.5	32.6	0.4	2	41.8	0.4	0.8	0.9	0.2	3.1	0.9	0.3	0.4	0.4	0.5	0.4	0.2	0.5	0.4	0.4	0.7	0.4	0.3	0.5	0.4	0.5	5.7	0.4	2.8	0.7	0.3	0.6	110.5	0.6	0.3	0.4	0.2	0.4	0.2	0.2	3.6	0.8	0.7	0.3	0.5	0	0.2	1.6	0	0	0	0	0.4	0.9	2.7	2.6	4	1	4.4	1	2	0.5	0.9	2.3	2.1	3.2	0.6	0.2	0.2	4.1	0.9	5	0.6	1.9	0.2	1.6	3	2.7	0.6	0	0.1	1.9	4.3	2.1	3.3	1.8	0.3	1.3	1.1	0.2	1.3	0.8	0.1	0.3	3.5	4.6	0.1	0.7	1.3	1.7	2.3	2	0.7	1.4	1.1	0.8	2.4	2.6	0.8	0	0	0	1.4	0.5	0.3	0.8	0.4	0	0.2	1.3	1.6	0	0	0	0	0	0	0	0	0	0	0	0	0	1.6	0	0	0.2	0	0	0.4	0.4	0.5	0.5	0.3	0.4	0.5	0.4	0.4	0.2	0	0	0	0.7	0.7	0.4	0	2.5	0	0	0	0	1	0	0.4	0	0.1	67.8	0	0	0.1	0.3	0.1	0	0	0.2	0	3.5	0	0.3	0	0	0	0	0	4.6	0.2	0.1	5.8	0	0	0.4	0	0.2	0	0.3	0.5	0.8	0	10	0.7	Enterocytes
MTRNR2L4		ENSG00000232196	MT-RNR2-like 4	P0CJ71	16	3370979-3372740	Predicted intracellular proteins, Predicted secreted proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Group enriched	Detected in many	4	blood: 49.5;skeletal muscle: 52.2	Cell type enriched	Detected in some	24	Cardiomyocytes: 125.1	Not detected	Not detected			Low region specificity	Detected in all			Cell type enhanced	Detected in all		neutrophil: 49.5	Lineage enriched	Detected in all	8	granulocytes: 49.5	Cell line enhanced	Detected in many		AN3-CA: 22.3;HaCaT: 23.3;HeLa: 31.2														Secreted to blood								unprognostic (8.53e-2)	unprognostic (1.10e-1)	unprognostic (1.44e-1)	unprognostic (1.80e-1)	unprognostic (1.05e-1)	unprognostic (3.66e-3)	unprognostic (1.58e-1)	unprognostic (1.37e-2)	unprognostic (2.26e-1)	unprognostic (1.71e-1)	unprognostic (6.81e-3)	unprognostic (1.65e-1)	unprognostic (2.79e-1)	unprognostic (1.19e-1)	unprognostic (9.27e-2)	unprognostic (1.90e-1)	unprognostic (1.65e-1)	2.5	10.3	3.5	1.3	4.4	0.9	1.2	2.7	6.6	1.5	2.2	0.5	0.3	3.4	1.6	0.9	1.5	2	1.7	11.7	2.3	1.2	5.8	2.5	1	0.3	6.3	4.8	5.8	9.7	0	3.1	1	2.5	1.7	1.1	1.2	2.7	3.3	52.2	1.2	3.6	2.1	1.5	1.1	3.1	2.3	3.1	0.3	2.6	1.1	0.8	1.5	1.3	5.4	3.8	49.5	6.4	2.5	2.5	5	6	4	1.2	22.3	0.5	0.7	6.9	3.3	0.1	0.4	0.3	1.8	13.1	4.5	6.7	0.2	0.1	23.3	0	0.2	0.2	3.4	2.2	4	31.2	16.2	0.1	1.3	10.9	0.4	0.3	0.1	0.2	0.5	0	0.5	3	6.3	0.7	1.3	2.8	10.5	1.8	0.2	0.8	5.2	3.2	4.1	0.9	4.6	2.7	6	2.1	5.3	8	0.4	7.4	10.1	2.9	7.2	6.4	8.3	2.3	3.3	1.1	4.2	4.9	10.3	1.6	12.1	6.4	19.1	1.4	3.7	1.7	4.2	1.9	1.9	3.1	5.4	2.1	2.5	49.5	2.5	3.6	3.8	2.1	5	3.5	4.4	2.7	5.5	2.3	1.2	6.3	4.8	2.5	3.1	0	0	0	2.4	0.1	0	125.1	5.1	0	0	1.8	0	0.1	3.3	0	0	0	0	0	0.2	0	0.2	1.6	0	0	0.1	0	0	0	0.3	0	0	0	1.7	0	0	0	0	0	0.4	0.3	0	0	1.7	0.5	0.2	0.3	0.1	0	0	1.4	Cardiomyocytes
RAB6D	RAB6CL, WTH3DI	ENSG00000233087	RAB6D, member RAS oncogene family		2	131361111-131364142	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level			Tissue enriched	Detected in some	7	parathyroid gland: 13.4	Cell type enriched	Detected in single	27	Ciliated cells: 2.7	Cancer enhanced	Detected in some		prostate cancer: 1.3					Low cell type specificity	Detected in single			Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		MOLT-4: 6.4;OE19: 2.6;REH: 2.5;U-2 OS: 2.5									HPA059131	Uncertain		Approved	Golgi apparatus						Golgi apparatus		HPA059131: AB_2683916	unprognostic (4.19e-2)	unprognostic (8.54e-2)	unprognostic (1.16e-1)	unprognostic (3.03e-2)	unprognostic (4.08e-1)	unprognostic (4.79e-2)		unprognostic (4.41e-2)	unprognostic (1.01e-1)	unprognostic (1.87e-2)	unprognostic (2.42e-1)	unprognostic (3.21e-1)	unprognostic (2.55e-2)	unprognostic (2.61e-2)	unprognostic (2.50e-1)	unprognostic (1.82e-1)	unprognostic (2.12e-1)	0	0		0		0	0		1.1	0	1.1			0	0	0.2	0	0	0	0			0	0	0	0			0	0	13.4		0		1.9	1		0	0	0	0	0.8	0		0	0	1			0		0	0		0.2	0.3	1.4	0.4	0.5	0.5	0.5	0	0.1	0	0.1	0	0	0.4	0	0	0	0	0.2	0.1	0	0	0	0	0	0.4	0	0	0	0.4	0	0	0	0	0	0.1	0	0	0	0	0	0	0.1	0	0	0	0.6	6.4	0.1	0.9	2.6	0	2.5	0	0	0.1	0.1	0	0.1	0	0	0.1	0.4	0.1	0.1	0	0	2.5	0.2	0	0	0.7	0	0	0	0.1	1.4	0.3	0.5	0.4	0.4	0.4	0.1	0.5	0.3	0.3	0.2	0.5	0.4	0.2	0.5	0.4	0.1	0.5	0.5											0	0	0	0	0	0	0	0	2.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Ciliated cells
NPIPB7	LOC440350, NPIPL1	ENSG00000233232	Nuclear pore complex interacting protein family member B7	O75200	16	28456372-28471175	Predicted membrane proteins				Evidence at protein level	Evidence at protein level	No human protein/transcript evidence	Evidence at transcript level		Tissue enriched	Detected in some	7	testis: 14.9	Cell type enriched	Detected in some	6	Early spermatids: 117.4	Not detected	Not detected							Cell type enhanced	Detected in single		memory B-cell: 1.2	Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		BEWO: 6.2;hTCEpi: 2.5;U-266/70: 1.6									HPA011188, HPA053611	Approved		Approved	Nucleoplasm	Intracellular and membrane					Nucleoplasm		HPA011188: AB_2668455, HPA053611: AB_2682206	unprognostic (1.18e-1)	unprognostic (1.35e-1)	unprognostic (8.35e-2)	unprognostic (1.94e-1)	unprognostic (1.94e-1)		unprognostic (7.43e-2)	unprognostic (3.07e-3)	unprognostic (3.35e-2)	unprognostic (3.44e-1)	unprognostic (2.78e-2)	unprognostic (3.62e-2)	unprognostic (3.04e-2)	unprognostic (4.40e-1)	unprognostic (2.22e-1)	unprognostic (7.73e-2)	unprognostic (2.03e-2)	0	0	0.5	0.2	0.9	0.1	0.1	2.3	0.5	0.1	0.3			0.3	0.3	0.3	0	0.2	0.1	0.1	0.5	0.8	0	0	0.2	0.4	0.3		0.5	0.4	0	0	0		0.1	0.5		0	0.1	0	0.8	0.2	0.1	0.2	0.1	0.1	14.9			0.4		0.1	0.1	0	1.2	0	0.7	0	0	0	0	0	0	0.7	0.2	0	0	6.2	0	0.2	0	0.1	0.4	0.2	0	0.1	0.2	0	0.1	0	0	0	0.3	0.4	0	0	0	0	0	0.8	0	2.5	0.4	0.2	0.1	0	1.2	0	0.1	0	0.9	0.1	1	0.6	0	0	0.1	0.8	0	0	0	0	0.3	0	0	0	0	0.4	0.4	0	0	0.4	0.1	0	1.6	0.5	0.4	0	0	0	0	0	0	0	0	0	1.2	0	0	0	0	0	0	0.7	0	0	0	0	0											0	0	0	0	0.1	0	0.4	0	0	0	1.8	0	0.2	0	0	117.4	0	0	0	0	0	0	0	0	0.2	0.1	0	0	0	0	19.9	0	0	0	0	0	0	0	0	1.1	0	0	0	0	0	0.2	0	0.2	0	0	0	Early spermatids
UQCRHL		ENSG00000233954	Ubiquinol-cytochrome c reductase hinge protein like	A0A096LP55	1	15807169-15809348	Predicted intracellular proteins	Electron transport, Respiratory chain, Transport			Evidence at protein level	Evidence at protein level	No human protein/transcript evidence	No human protein/transcript evidence		Group enriched	Detected in some	5	blood: 5.5;bone marrow: 2.2;epididymis: 1.6;skeletal muscle: 4.4;skin 1: 2.1	Cell type enriched	Detected in many	7	Cardiomyocytes: 418.0	Low cancer specificity	Detected in all							Cell type enhanced	Detected in many		neutrophil: 5.5	Low lineage specificity	Detected in all			Low cell line specificity	Detected in many											HPA042574	Approved											HPA042574: AB_10960998	unprognostic (8.91e-2)	unprognostic (1.05e-1)	unprognostic (1.81e-1)	unprognostic (3.70e-2)	unprognostic (3.19e-2)	unprognostic (7.10e-2)	unprognostic (4.01e-3)	unprognostic (4.83e-1)	unprognostic (6.76e-2)	unprognostic (6.46e-2)	unprognostic (4.60e-1)	unprognostic (9.67e-3)	unprognostic (9.76e-3)	unprognostic (2.71e-3)	unprognostic (1.16e-1)	unprognostic (9.70e-3)	unprognostic (1.02e-1)	0	0.1		0.2		2.2	0.4		0.4	0	0			0.2	0.4	1.6	0.1	0.4	0.4	0.1			0	0.4	0.2	0.2			0.5	0	0		0		0.1	0.1		0.5	0	4.4	2.1	0.4	0.1		0.6	0	0.5			0.2		0	0		1.5	1.2	5.5	1	1.3	1	0.5	0.7	0.5	3.2	3.3	0.8	0.9	1.2	0.6	0.3	0.1	0.3	0.7	2.5	1.2	0.9	0.5	0.9	1.3	0.6	0.5	0.7	2.2	0.4	1.1	1.9	0.5	0.7	0.9	1.5	0.6	1	0.4	0.3	1.2	0	1.6	1.1	2.4	0.2	1.9	0.4	1.5	1.6	0.4	1.3	1.1	0.7	1.1	0	1.7	2.7	1.8	1	2.1	0.8	0.7	0.9	2.7	0.5	2	1.1	1.2	0.8	2.3	0.9	1.3	1	2.1	0.9	3.6	1	0.9	0.8	0.7	0.6	1.1	0.6	0.8	0.6	1.5	1	1	5.5	1.3	0.7	1.2	0.5	0.5											0	0.6	37.2	21.8	0	3.8	418	28.1	0	1.2	8.7	5.9	20.5	19.9	1	2.4	12.3	7.7	0	0.6	18	10.8	25.1	2.3	21.7	18.5	1.6	7	17.8	58.5	2.7	10.3	0.8	0	0	14.1	3	0.7	0	11.7	6.1	7.3	6.5	1	3.2	14.6	0	19.7	4.5	17.7	24.4	Cardiomyocytes
H2BFS		ENSG00000234289	H2B histone family member S	P57053	21	43565189-43565648	Predicted intracellular proteins		Antibiotic, Antimicrobial, DNA-binding		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in many	4	lymphoid tissue: 65.0	Cell type enriched	Detected in single	5	Syncytiotrophoblasts: 3.3	Not detected	Not detected							Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Cell line enhanced	Detected in many		K-562: 23.7;U-2 OS: 23.4;U-266/84: 23.8									HPA042205, HPA043013, HPA048671	Supported		Approved	Nucleoplasm,Cytosol						Nucleoplasm	Cytosol	HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488					unprognostic (1.29e-1)					unprognostic (4.33e-3)				unprognostic (2.06e-2)				1.1	0.9	0.2	7.4	0.3	1.8	2.6	0.3	0.8	1.8	1.7	0.4	1.1	2.3	2.4	4.3	4.9	4.2	4.2	4.9	0.5		0.5	4	3.3	12.2	0.1	0.5	2.2	4.2	0	0	4.5	0.4	5.3	1.8	0.8	3	2.1	1	0.4	3	1.8	0.7	5.7	2	7.9	0	65	2.6	7.1	6.1	2.1	1.3	7.7	6.2	16	4.9	1.6	3.6	3.2	2.1	3.3	0.6	0.9	2.2	0.9	2.4	2.6	1.3	3.2	2	4.6	1.1	0.6	8.8	0.8	2.5	2.5	0.2	0.7	0.9	2.2	3.6	0.6	5	0.2	0.3	0.9	4.5	2.5	0.4	0.6	0	1.2	0.3	0.4	23.7	2.8	0.9	6.1	1	2.2	0.3	4.1	2.6	0.8	0.5	8.7	0.7	0.7	3.5	2.5	10.5	3.2	2.1	0.5	11.1	1.4	0.9	1.7	23.4	1.1	0.6	7.6	23.8	5	1.1	11.8	1	10	2.1	15	1.2	2.2	1	5.7	1.2	1.3	2.8	7.7	1.6	1.1	16	1.6	4.9	6.2	3.6	3.2											0	0	0	0	0	0	0.3	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0.7	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.3	0	0	0	Syncytiotrophoblasts
APOC2		ENSG00000234906	Apolipoprotein C2	P02655	19	44945982-44949565	Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins	Lipid degradation, Lipid metabolism, Lipid transport, Transport		Disease mutation, Hyperlipidemia	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	78	liver: 506.5	Cell type enriched	Detected in some	26	Hepatocytes: 936.4	Cancer enriched	Detected in some	17	liver cancer: 49.7	Low region specificity	Detected in many			Cell type enriched	Detected in single	21	NK-cell: 6.5	Lineage enriched	Detected in single	21	NK-cells: 6.5	Group enriched	Detected in some	4	Hep G2: 84.9;THP-1: 156.9					Not detected	Not detected			HPA055877	Supported				Secreted to blood			43000000000	110000000000			HPA055877: AB_2682953	unprognostic (4.28e-2)	unprognostic (7.73e-3)	unprognostic (1.33e-1)	unprognostic (3.66e-2)	unprognostic (8.91e-2)	unprognostic (1.90e-1)	unprognostic (2.07e-1)	unprognostic (5.41e-2)	unprognostic (2.56e-1)	unprognostic (1.96e-2)	unprognostic (2.86e-1)	unprognostic (1.15e-2)	unprognostic (5.14e-8)	unprognostic (1.32e-1)	unprognostic (1.45e-1)	unprognostic (1.77e-2)	unprognostic (9.80e-3)	0.2	0.4	2.8	0.3	3.7	0.2	0.5	0.4	1.6	0.4	2.1	3.7	0	2.8	0.2	0.5	0.3	0.4	0.4	0.2	2.3	2.2	1.2	506.5	2.2	0.8	4.7	0.5	0.2	0.2	0.3	0.2	0.3	2.2	0.2	0.4	0	0.3	0.3	0.3	0.4	6.3	0.2	4.7	0.3	0.3	0.2	2.1	0	0.2	0	0.7	0.3	0	0.1	0.3	0	0	6.5	0	0	0.3	0	0	0	0	0	0.1	0	0	0	0	0.3	0.3	0.1	0	0	0	0.3	0	0	0	0	0	14.7	0.2	84.9	0	1.8	29	0	0	0	0	0	0	0	0.2	0.3	0	0.1	0.1	14.1	0	0.4	0	0.1	0.6	0.1	0	0.1	0	0	0.2	0	0.9	0	0	156.9	0	0	0	0.1	0	0.3	0.1	0.2	0	0.4	0	0	0	0	0	0	0	0.1	0	0	0.3	0	0	0	0	6.5	0	0	0	0	2.8	3.7	0.4	1.6	2.3	2.2	4.7	0.5	2.2	2.1	0	2.9	1.5	0	0.6	0	0.1	12.7	0	0	3.5	0	0	3.3	0	0	0	0	0	0	0	0	0.1	25.4	936.4	35.6	0	0	18.4	13.7	0	0	11.1	6.8	3.6	0	0	0	0	0.7	11.2	0	0	0	0.1	0	0.4	0.2	1.3	0	0	Hepatocytes
SHISA8	C22orf17, Orf26	ENSG00000234965	Shisa family member 8	B8ZZ34	22	41909554-41914667	Predicted membrane proteins, Transporters				Evidence at protein level	Evidence at transcript level	No human protein/transcript evidence	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	4	brain: 42.2	Cell type enriched	Detected in some	114	Horizontal cells: 451.3	Low cancer specificity	Detected in some			Region enriched	Detected in many	15	cerebellum: 42.2	Cell type enhanced	Detected in single		memory B-cell: 1.7	Lineage enriched	Detected in single	17	B-cells: 1.7	Cell line enriched	Detected in some	7	HEK 293: 20.9	Group enriched	Detected in some	5	cerebellum: 8.7;olfactory region: 19.4	Group enriched	Detected in all	4	cerebellum: 61.4;olfactory region: 45.2	HPA059173	Uncertain											HPA059173: AB_2683938	unprognostic (8.76e-2)	unprognostic (2.98e-4)	unprognostic (1.03e-1)	prognostic favorable (2.76e-4)	unprognostic (4.42e-2)	unprognostic (1.45e-3)	unprognostic (4.40e-1)	unprognostic (1.16e-2)	unprognostic (2.13e-1)	unprognostic (2.57e-1)	unprognostic (1.45e-3)	unprognostic (2.16e-1)	unprognostic (1.12e-1)	unprognostic (8.59e-2)	unprognostic (2.60e-2)	unprognostic (6.22e-4)	unprognostic (7.84e-2)	0.1	9.4	0.5	1.6	0.5	0.2	0.1	42.2	2.7	0.2	0.2	0.2	0	0	0.1	0	0.4	0.2	0.3	0.3	0.5	0.2	0.2	0.1	0.1	3	0.3	1.7	0.1	0.1	0.1	0.8	0	2.2	0.2	0	1.5	1.8	0.2	0.8	0.5	0.8	0	0.3	2.7	0.7	0.2	0	0	0.1	0	3.8	0.4	0.1	1.7	0	0	0	0	0	0	0	0	0	0.4	0	0	1.4	0	0	0	0	0	0	0	0.9	0	0	0	0.2	0	0	0	20.9	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0.2	0	0	1.1	0	0	0	0	0	2.9	0	0.3	0.2	0	0.2	0	0	0	0	0	0.5	2.2	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	1.7	0	0	0	0.8	0	0	0	0	0	0	0	0	0.5	0.5	42.2	2.7	0.5	0.2	0.3	1.7	2.2	0	0	0	2.7	0	0	4	3.6	0	0	0	0	3.9	0	1.7	0	0.7	0	0	0	0	0	0	0.2	0	0	0	451.3	0	0	0	0.4	0	0	0	0	0	0.7	0	0	0.4	0	3.2	0	0	0.9	1.9	0	0	0	0	0	Horizontal cells
RNF148	MGC35222	ENSG00000235631	Ring finger protein 148	Q8N7C7	7	122701664-122702967	Predicted intracellular proteins, Predicted membrane proteins				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	54	testis: 31.0	Cell type enriched	Detected in some	9	Early spermatids: 297.0	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		Karpas-707: 7.4;MCF7: 2.8;OE19: 1.6;RPMI-8226: 1.8;SK-BR-3: 1.6	Not detected	Not detected																				unprognostic (1.75e-1)	unprognostic (2.15e-1)	unprognostic (3.19e-1)	unprognostic (1.21e-2)	unprognostic (2.85e-1)	unprognostic (3.23e-2)	unprognostic (1.04e-2)	unprognostic (9.81e-2)	unprognostic (8.48e-2)	unprognostic (2.14e-2)	unprognostic (2.18e-1)	unprognostic (2.37e-1)	unprognostic (3.33e-2)	unprognostic (2.24e-2)	unprognostic (1.24e-1)	unprognostic (6.63e-2)	unprognostic (1.09e-1)	0.1	0	0.1	0.1	0.1	0	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0	0.3	0.5	0.1	0	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0	0.1	0.1	0.1	0.1	0	0.1	0.2	0.1	0.1	0	0.1	0.1	0.1	0.1	0	31	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0.3	0	0	0	0.4	0	0	0.1	0	0	0	0	0.1	0	0	0.1	0	0.3	0.3	0	0	0	0	0.5	0.3	0	0.3	0	0	7.4	0	2.8	0	0	1	1.6	0.8	0	0	1.8	0	0.6	0.7	0	0	1.6	0	0	0	0	0	0.2	0	0	0.5	1.3	0.1	0	0.7	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.3	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	297	0	0	0	0.9	0.1	0	0.2	0	0	0.1	0	0	1.8	0	34.3	2	0	0	0	0	0	0.3	0	1.8	0	0	6.5	0	1.6	1.6	0	0	0	0	0.1	Early spermatids
MFRP	C1QTNF5, FLJ30570, NNO2, rd6	ENSG00000235718	Membrane frizzled-related protein	Q9BY79	11	119338942-119346673	Disease related genes, Predicted intracellular proteins, Predicted membrane proteins			Disease mutation, Microphthalmia, Retinitis pigmentosa	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	40	brain: 54.9;retina: 112.9	Cell type enriched	Detected in single	27	Ciliated cells: 2.7	Not detected	Not detected			Region enriched	Detected in some	10	pons and medulla: 54.9	Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		hTERT-RPE1: 1.5;JURKAT: 1.0;NB-4: 1.8	Group enriched	Detected in many	4	basal ganglia: 3.5;hippocampal formation: 13.2;pons and medulla: 10.8;thalamus: 8.9	Low region specificity	Detected in some																																	0.9	0.3	0.6	0	0.4	0.1	0.1	0.2	2.8	0.2	0.1	14.6	0	0.2	0.3	0	0.1	0.2	0.1	0.2	5.5	0.5	0.2	0.1	0.3	0.2	0.8	0	0.1	0.1	2	0.5	0.6	54.9	0.1	0	112.9	0.1	0.1	0.5	0.1	0.2	0.4	0.4	0.3	0.2	0.5	0	0	0.1	0	0.1	0.1	0.1	0	0	0	0.5	0	0	0	0	0	0	0.3	0.5	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	1.5	0.3	1	0	0	0	0	0	1.8	0	0	0	0	0.3	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0.6	0.4	0.2	2.8	5.5	0.5	0.8	0	54.9	0	0	0	0	0	0	0	0	0	2.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Ciliated cells
KIAA0040		ENSG00000235750	KIAA0040	Q15053	1	175156987-175192999	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in many	5	Syncytiotrophoblasts: 315.3	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Cell line enhanced	Detected in many		Daudi: 32.8;RPMI-8226: 23.3;U-698: 42.2	Low region specificity	Detected in many			Low region specificity	Detected in some			HPA016895, HPA068812	Approved		Approved	Nucleoplasm						Nucleoplasm		HPA016895: AB_2669476, HPA068812: AB_2686041	unprognostic (5.98e-2)	unprognostic (1.43e-1)	unprognostic (1.77e-1)	unprognostic (2.99e-2)	unprognostic (1.01e-2)	unprognostic (8.54e-3)	unprognostic (2.91e-1)	unprognostic (2.87e-2)	unprognostic (3.83e-1)	unprognostic (1.21e-1)	unprognostic (2.66e-2)	unprognostic (1.63e-1)	unprognostic (2.53e-2)	unprognostic (1.49e-1)	unprognostic (2.57e-1)	unprognostic (2.28e-2)	unprognostic (3.05e-1)	25.7	4	2.7	18.4	7.4	5.1	16	2	3.9	8	7.7	1.8	3.5	5.2	8.6	7.9	7	9.2	11	16.3	3.2	2.9	17.8	12.1	25.3	16.1	6.9	1	5	17.9	4.6	13.6	45.6	7.6	7.9	5.6	12.2	15.2	4.1	11.1	5.1	10.2	6	5.4	27.6	9.8	3.4	3.5	14.8	9.6	7.2	18.6	6.6	10.7	16.5	5.4	26.4	6.1	3.3	9.6	5.4	3.1	0.1	0.1	0	0	0	0	1.4	3.8	0	0	1.6	4.6	32.8	7.8	0	0.1	13.2	2.3	15.4	0	11.1	1.9	3.5	7.2	0.2	0.4	0.2	0.4	0	4.2	0	5.9	0	5.1	4.8	2.8	5.5	0	0.7	4.1	0	1	2.7	2.8	3.5	1.7	23.3	5	7.9	0.2	1.2	2.4	12.9	0.3	8.4	8.2	0.7	2	0	1.5	0	0.3	13.6	16.5	42.2	0.6	0	3.5	12.8	6.1	1	5.9	3.3	5.3	16.2	6.5	4.9	5.4	16.5	6.9	5.9	26.4	3.3	1.2	1.2	9.6	5.4	2.7	7.4	2	3.9	3.2	2.9	6.9	1	7.6	3.5	35.7	5.6	53.8	61.7	23.7	0	3.1	12.7	20.1	15.9	12.2	0	57.4	11.6	11.3	0.5	20.2	11.2	0	20.8	5.6	39.4	46.5	10.5	6	10.4	0	4.1	13.5	10.6	1.2	15.5	16.9	6.8	10	5.5	4.3	17.8	14.2	9.9	4.7	0	25.8	65.9	0.3	3.3	9.7	315.3	25.4	10.3	30.7	Syncytiotrophoblasts
LCE6A	C1orf44	ENSG00000235942	Late cornified envelope 6A	A0A183	1	152842868-152843983	Predicted intracellular proteins	Keratinization			Evidence at protein level	Evidence at protein level	No human protein/transcript evidence	Evidence at transcript level		Tissue enriched	Detected in some	12	skin 1: 77.1	Cell type enriched	Detected in single	11	Suprabasal keratinocytes: 2.3	Cancer enriched	Detected in some	5	melanoma: 5.2	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	16	RPMI-8226: 1.5									HPA046376	Enhanced											HPA046376: AB_10965998						unprognostic (4.25e-2)			unprognostic (8.73e-2)									0.1	0	0.1	0.1	0.1	0	6.6	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	2.2	0	0.1	0.1	0.1	0.2	77.1	0.1	0.1	0.1	0.1	0	0.1	0.1	1.8	0.1	6.5	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.3	0	0	0	0	Suprabasal keratinocytes
GAGE12F		ENSG00000236362	G antigen 12F	P0CL80, O76087, P0CL82	X	49551278-49568218	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Group enriched	Detected in some	8	blood: 16.2;testis: 58.6	Cell type enriched	Detected in single	5	Spermatogonia: 1.3	Not detected	Not detected							Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Group enriched	Detected in some	4	AN3-CA: 136.7;K-562: 133.6									HPA043232	Supported		Approved	Golgi apparatus,Plasma membrane,Cytosol						Plasma membrane	Golgi apparatus, Cytosol	HPA043232: AB_2678376																		0	0	0	0	0.3	0	0	0.1	0	0	0			0	0.1	0	0	0	0	0.1	0	0	0	0.1	0	0	0		0.2	0	0	0.1	0		0	0		0.1	0	0	0	0	0	0	0.1	4.9	58.6			0		0	0	0	7	8.5	3.1	9.1	9.6	14.7	16.2	1.1	0	0	136.7	0	0	0.5	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0.3	0	0	0	1.1	0	0	0	0	0	0	0	133.6	3.6	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	32.8	0	0.5	6.9	0.9	0	0.1	0	7.9	0	0	0	17	0.9	9.1	3.1	3.9	7.5	2.5	7	10.3	7.2	0	6.2	8.5	7.5	0.9	9.6	6.3	8.5	14.7	16.2											0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	1.3	0	0	0	0	0	Spermatogonia
TSPY10		ENSG00000236424	Testis specific protein, Y-linked 10		Y	9527880-9530682	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level				Tissue enriched	Detected in single	11	testis: 6.3	Cell type enriched	Detected in single	14	Spermatogonia: 8.6	Cancer enriched	Detected in single	13	testis cancer: 1.1					Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	5	U-266/84: 36.6									HPA049384, HPA067289	Supported		Approved	Cytosol						Cytosol		HPA049384: AB_2680738, HPA067289: 															unprognostic (5.36e-1)			0.5	0	0	0	0	0	0	0	0	0	0			0	0	0	0	0	0	0	0	0	0	0	0	0	0		0	0	0	0	0		0	0		0	0	0	0	0	0	0	0	0	6.3			0		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	7.3	36.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	8.6	0	0	0	0	0	Spermatogonia
UBE2L5	UBE2L5P	ENSG00000236444	Ubiquitin conjugating enzyme E2 L5		13	30422488-30428616	Enzymes, Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level			Tissue enriched	Detected in some	9	testis: 31.5	Cell type enriched	Detected in single	4	Ciliated cells: 1.4	Low cancer specificity	Detected in single							Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low cell line specificity	Detected in many							Low region specificity	Detected in single			HPA045609, HPA062415	Approved		Uncertain	Nucleoplasm,Cytosol						Nucleoplasm, Cytosol		HPA045609: AB_10961322, HPA062415: AB_2684756	unprognostic (2.09e-1)	unprognostic (1.18e-2)	unprognostic (8.01e-3)	unprognostic (6.41e-4)	unprognostic (1.78e-1)	unprognostic (7.13e-2)	unprognostic (2.20e-1)	unprognostic (1.65e-1)	unprognostic (1.19e-1)	unprognostic (6.49e-3)	unprognostic (1.78e-1)	unprognostic (8.00e-2)	unprognostic (3.50e-2)	unprognostic (9.37e-2)	unprognostic (2.60e-1)	unprognostic (2.44e-2)	unprognostic (8.75e-2)	0.2	0	0	0	0.7	0.1	0	0.3	0.3	0	0.1	0.4	0	0	0.3	0	0	0	0	0.7	0.7		0.3	0.2	0.2	0.1	0.2	0.5	0.3	0	0	0	0.1	0.5	0.1	0	0	0	0	0.1	0.3	0	0.1	0	0	0	31.5	0.1	0	0	0	0	0.1	0	3.2	1.9	2.7	3.6	1.9	2	2.8	0.7	0.3	1.3	1.6	0.6	0.7	0.7	1.2	0.6	0.4	0.2	0	3.1	1.4	0.6	1.3	1.3	0.6	0.8	0.4	1.1	2.5	0.6	0.4	0.8	0.2	0.2	0.7	1.5	0.2	0.3	0.6	0.2	1.4	0.9	0.9	0.8	1.3	0.3	0	1.6	2.6	1.4	0.2	0.2	0.4	0.6	0.4	0.9	1.5	1.2	0.3	0.4	0.1	1.8	0.9	0.6	2.4	0	0.7	0.5	0.7	1.1	1.5	0.3	1.6	1	0.9	0.4	1.8	1.1	1.9	1.4	3.6	1.2	3.2	1.5	1.6	1.5	1.7	1.4	2	2.7	1.9	1.6	1.9	2	2.8											0	0.3	0	0	0	0	0	0	1.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Ciliated cells
C4orf51		ENSG00000237136	Chromosome 4 open reading frame 51	C9J302	4	145680115-145771032	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level	No human protein/transcript evidence	No human protein/transcript evidence		Tissue enriched	Detected in single	12	testis: 10.8	Cell type enriched	Detected in some	14	Early spermatids: 60.4	Cancer enriched	Detected in single	8	testis cancer: 1.8					Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		BJ: 1.0;CAPAN-2: 1.3	Not detected	Not detected																				unprognostic (1.37e-2)	unprognostic (1.44e-1)		unprognostic (1.03e-1)	unprognostic (1.93e-2)	unprognostic (4.37e-1)		unprognostic (1.32e-1)		unprognostic (2.19e-3)	unprognostic (8.13e-2)	unprognostic (2.16e-1)	unprognostic (3.97e-2)	unprognostic (1.39e-1)	unprognostic (1.48e-1)	unprognostic (1.98e-1)	unprognostic (6.07e-2)	0	0	0	0	0	0	0	0	0	0	0			0	0	0.8	0	0.1	0	0	0	0	0	0	0	0	0		0	0	0	0	0		0	0		0	0	0	0	0	0	0	0	0	10.8			0		0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	1	0	0	0	0	1.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0.7	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	60.4	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	3.4	1.4	0	0	0	0	0	0	0	0.4	0.3	0	0	0	4.4	1.2	0	0	0	0	0	Early spermatids
AMY1A	AMY1	ENSG00000237763	Amylase, alpha 1A (salivary)	P04745	1	103655290-103664554	Enzymes, Predicted secreted proteins	Carbohydrate metabolism	Glycosidase, Hydrolase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	100	salivary gland: 654.0	Cell type enriched	Detected in some	11	Ciliated cells: 38.8	Not detected	Not detected							Low cell type specificity	Detected in single			Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		NTERA-2: 1.4;SH-SY5Y: 2.4									CAB004310, HPA045394, HPA045399, HPA046980	Enhanced				Secreted to digestive system				68000000			CAB004310: AB_626668, HPA045394: AB_2679311, HPA045399: AB_2679313, HPA046980: AB_2679889																		0	0	0	0	0	0	0	0	0	6.5	0			0	0	0	0.1	1.5	0	0	0	0	0	0	0.5	0	0		0	3.7	0	0	0		0	0		654	0	0.1	0	0	0	0	0	0	0			0.2		0	0	0.1	0.1	0.3	0.3	0.6	0	1.1	0.7	0.1	0.3	0	0.1	0	0	0	0	0	0.1	0.1	0	0	0	0	0	0	0.8	0	0	0	0.2	0	0	0.5	0	0	0.1	0	0	0	0	0	0	0	0	0.1	0	0	0	0.3	0	1.4	0	0	0	0.1	0	0	0	0	2.4	0	0	0	0	0	0	0	0.2	0.1	0.2	0	0.4	0	0	0	0	0.1	0	0.3	0.3	0.1	0.6	0	0.1	1.1	0.1	0.3	0.1	0	0.7	0.2	0	0.5	0	0.1	0.7											3	2.1	0	0.8	0.6	0	2.4	0	38.8	3.4	0	0	0	0	0	1	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0.3	Ciliated cells
KLHL41	KBTBD10, Krp1, SARCOSIN	ENSG00000239474	Kelch like family member 41	O60662	2	169509702-169526262	Disease related genes, Plasma proteins, Predicted intracellular proteins			Disease mutation, Nemaline myopathy	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	20	skeletal muscle: 564.4;tongue: 157.3	Cell type enriched	Detected in some	12	Cardiomyocytes: 97.4	Group enriched	Detected in some	9	head and neck cancer: 10.8;prostate cancer: 3.3	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	9	HSkMC: 12.8;LHCN-M2: 20.3;RH-30: 32.6	Not detected	Not detected			Low region specificity	Detected in single			HPA021165, HPA021753, HPA021760	Enhanced		Supported	Nucleoplasm,Plasma membrane,Cytosol						Cytosol	Nucleoplasm, Plasma membrane	HPA021165: AB_1852087, HPA021753: AB_1852089, HPA021760: AB_1852091	unprognostic (2.44e-2)	unprognostic (6.12e-2)	unprognostic (9.01e-2)	unprognostic (2.94e-2)	unprognostic (2.90e-1)	unprognostic (1.36e-3)	unprognostic (2.05e-1)	unprognostic (5.46e-3)	unprognostic (1.88e-1)	unprognostic (5.38e-2)	unprognostic (6.65e-4)	unprognostic (9.64e-2)	unprognostic (1.50e-1)	unprognostic (1.69e-3)	unprognostic (1.19e-1)	unprognostic (1.12e-2)	unprognostic (1.52e-1)	12	0.1	0.2	0.1	0.2	0.1	0.2	0.3	0.2	0.1	0.2	0	0	0.1	0.1	17.8	9.8	0.2	0.6	10.2	0.2	0.3	0.1	0.1	0.2	0.1	0.2	0	0.2	0.2	0.1	0.5	0.1	0	3.9	0.1	0	6.6	0.1	564.4	0.2	0.1	2.3	0.2	0.1	0.2	0.5	0	0	2	157.3	5	2.1	0.1	0.2	0.5	0	0.2	0	0.8	0	0	0.1	0	0.3	0.2	1.6	0	0	0	0.1	0	0	0	0	0	0	0.1	0	0	0	0	0	2.5	0	0	0	0.1	0.1	0	12.8	0.2	0.1	0	0.1	0	0.1	0	0	20.3	0	0	0	0	0	0.1	0	32.6	0	0.1	0	0.4	0	0	0	0.8	0	0	0	0	0.2	0.1	0.2	0	0	0.1	0	0	0	0	0	0	0	0.5	0.2	0	0.2	0.1	0	0	0	0.8	0.3	0	0	0	0.5	0	0	0.2	0.2	0.3	0.2	0.2	0.3	0.2	0	0	0	0	0.3	0	0.2	0.1	2.2	97.4	0	4	3.4	0	7.9	0	0	0.4	3.7	0	0	0	0.5	0	0.3	0.4	0	0	0.2	0	1.2	0.6	0	2.1	0.9	0	0	0	0	0.7	0.7	0	1.1	0.2	5.7	0	0.6	3.3	0.5	0	0	0	0	0	Cardiomyocytes
MEIKIN		ENSG00000239642	Meiotic kinetochore factor	A0A087WXM9	5	131806993-131945698	Predicted intracellular proteins	Chromosome partition, Meiosis			Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	5	testis: 16.3	Cell type enriched	Detected in some	4	Spermatocytes: 16.9	Not detected	Not detected							Cell type enhanced	Detected in some		intermediate monocyte: 2.7;non-classical monocyte: 3.2	Low lineage specificity	Detected in many			Group enriched	Detected in some	5	SuSa: 2.3;U-2 OS: 5.9					Low region specificity	Detected in all																unprognostic (3.21e-1)				unprognostic (2.30e-1)			unprognostic (2.64e-2)		unprognostic (5.27e-2)	unprognostic (4.31e-1)		unprognostic (4.64e-6)	unprognostic (2.38e-1)		unprognostic (3.81e-1)		0	0	0	0.3	0.3	0	0	0	0.3	0	0	0.1	0	0	0	0	0.2	0	0	0	0		0.1	0.1	0	1.3	0	0	0	0	0.7	0	0.5	0.3	0	0	0	0	1.1	0	0.1	0.3	0	0	0.2	0	16.3	0	0	0	0	0	0.2	0	0.5	1.5	0	3.2	0	1	0.2	0	0	0	0	0	0	0	0	0.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.3	0	0	0	0	5.9	0	0	0	0	0	0	0	0	0	0.6	0	0.4	2.7	0.4	0.5	0.1	0.1	1.5	0.5	1	0	0	0	3.2	0	0	0.2											0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.7	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1.7	0	3.6	0	0	0	0	0	0	0	0	0	16.9	4.1	0	0	0	0	0	Spermatocytes
DWORF		ENSG00000240045	DWARF open reading frame		3	155290229-155293775	Predicted membrane proteins				Evidence at transcript level	Evidence at transcript level				Tissue enriched	Detected in some	7	skeletal muscle: 173.0	Cell type enriched	Detected in some	4	Proximal tubular cells: 7.9	Low cancer specificity	Detected in some							Cell type enhanced	Detected in single		basophil: 2.9	Lineage enriched	Detected in single	6	granulocytes: 2.9	Low cell line specificity	Detected in some			Region enriched	Detected in some	8	basal ganglia: 19.5																					unprognostic (6.77e-4)		unprognostic (1.60e-2)					unprognostic (6.62e-2)	unprognostic (1.58e-1)	unprognostic (7.82e-3)	unprognostic (1.33e-2)				0.4	0	0	0	1.4	0	0	0	0	0	0	0	0	0.7	0	5.2	2.9	0	0	0.6	0		0.7	0	0	0	0	0	0	0	0	0	0	0	1.4	0	0	1.6	0	173	0	0.3	0	0	0	0	0	1.6	0	0.7	23.7	0.9	0	0	0.5	0.4	2.9	0.2	0.4	0.2	0	0.2	0	0.6	0	0	2.3	0.7	0.3	0	0	0.6	0	1.3	0	0.4	0	0.4	0.5	0.3	0.5	0	0.3	0.6	0.4	0.5	0.5	0	1.8	0.4	2.1	0	0	0.5	0.4	0.8	0	0.6	1.3	1.2	0.4	0.2	1.7	1.2	0.7	0.6	0.3	0.2	0.3	0	0	1	0.9	0	0.7	0.1	1	0.9	1.1	1.9	1.8	1.3	0.8	0.2	0.2	0.3	0.8	0.8	0.3	0	2.9	0.2	0.2	0.1	0.1	0.1	0.2	0.1	0.2	0.2	0.5	0.2	0.2	0.8	0.4	0.1	0.4	0.1	0											0	0	0	0	0	0	0	0	0	0	1.8	0	0	1.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	7.9	0	0	0	0	0	0	0	0	0	0	Proximal tubular cells
LCE1F	LEP6	ENSG00000240386	Late cornified envelope 1F	Q5T754	1	152776372-152776728	Predicted intracellular proteins	Keratinization			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in some	21	skin 1: 69.5	Cell type enriched	Detected in some	11	Suprabasal keratinocytes: 15.9	Group enriched	Detected in some	13	head and neck cancer: 5.5;melanoma: 14.3	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	4	BJ hTERT+: 11.7;hTERT-HME1: 5.4																											unprognostic (2.21e-1)			unprognostic (8.43e-2)									0.1	0	0.1	0.1	0.1	0	3.2	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	69.5	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	11.7	0	0.5	0	0	0	0	0	0	1.7	0	1.7	0	0	0	0	0	0	0	0	0	0	0	2	5.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	1.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	0	0	1.5	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.9	0	0	0	0	Suprabasal keratinocytes
KRBOX1		ENSG00000240747	KRAB box domain containing 1	C9JBD0	3	42809483-42942792	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Group enriched	Detected in many	8	placenta: 78.4;testis: 68.5	Cell type enriched	Detected in many	7	Spermatocytes: 1048.9	Low cancer specificity	Detected in some			Low region specificity	Detected in many			Cell type enriched	Detected in some	5	NK-cell: 9.0	Lineage enriched	Detected in many	5	NK-cells: 9.0	Cell line enhanced	Detected in some		BJ hTERT+: 10.6;CAPAN-2: 22.9;EFO-21: 11.2;GAMG: 17.6;hTEC/SVTERT24-B: 16.1;hTERT-HME1: 10.8;U-2197: 31.8									HPA046901			Approved	Nucleoplasm,Golgi apparatus						Nucleoplasm	Golgi apparatus	HPA046901: AB_2797232	unprognostic (2.62e-1)	unprognostic (1.19e-1)	unprognostic (1.82e-1)	unprognostic (1.53e-3)	unprognostic (7.63e-3)	unprognostic (1.24e-2)	unprognostic (1.05e-1)	unprognostic (1.11e-1)	unprognostic (3.46e-2)	unprognostic (2.27e-1)	unprognostic (5.64e-2)	unprognostic (2.95e-2)	unprognostic (9.66e-2)	unprognostic (2.27e-2)	unprognostic (1.04e-1)	unprognostic (1.31e-1)	unprognostic (2.28e-1)	1.1	1.8	1.6	0.3	2.1	0.3	1.4	2.1	2.3	1.9	1.6	1.8	1.2	0.8	2.6	5.4	2.1	1.9	1.2	2.3	1.4	1.2	1.4	0.3	0.7	0.7	1.4	1.2	3.2	2.3	0.3	1.9	78.4	1.6	1.6	1	2.3	2.1	2.7	0.5	2.5	1	2.3	1.8	0.7	1.1	68.5	0.6	0.2	2.5	1.1	0.8	1.2	1.1	0.8	1.7	1.2	1.2	9	0.9	0.2	0	0	0	0	0	0	0.9	4.1	10.6	0	0	0	22.9	0	11.2	0.8	17.6	0	0	0	0	0	0	0	0	0	2.4	0	0	4.5	0	16.1	10.8	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.8	0	0	0	0	0	8.2	0	31.8	0	3.4	1.1	0	1.7	0	0.6	0	0.6	1.2	0	0.5	0	0	0	0	0.1	0.8	0.3	0.9	0	9	1.2	1.7	0.5	0.2	1.6	2.1	2.1	2.3	1.4	1.2	1.4	1.2	1.6	0.6	0	1.6	0	2.5	0	6.5	4.8	5.1	1.4	3.4	5.2	2	9.4	16.6	4.1	134.8	0.4	0.7	0	10.5	8.6	1.6	1.5	0	0.5	2	1.6	0	1.3	0	72.9	18.7	0	0	0	0.8	12.4	6.2	1.9	12.7	1.7	7.4	12.9	3.3	1048.9	159.2	0	7.6	0	1.7	0.8	Spermatocytes
OR14A2	OR5AX1, OR5AX1P	ENSG00000241128	Olfactory receptor family 14 subfamily A member 2	Q96R54	1	247722957-247724043	G-protein coupled receptors, Predicted membrane proteins	Olfaction, Sensory transduction	G-protein coupled receptor, Receptor, Transducer		Evidence at transcript level	Evidence at transcript level	No human protein/transcript evidence	No human protein/transcript evidence		Tissue enriched	Detected in single	12	testis: 7.4	Cell type enriched	Detected in some	7	Early spermatids: 11.2	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	109	GAMG: 10.9									HPA052685	Uncertain											HPA052685: AB_2681914																		0	0	0	0	0	0	0	0	0	0	0			0	0	0	0	0	0	0	0	0	0	0	0	0	0		0	0	0	0	0		0	0		0	0	0	0	0	0	0	0	0	7.4			0		0	0	0	0	0.6	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	10.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0											0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	11.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	Early spermatids
TDGF1	CR, CRIPTO, Cripto-1	ENSG00000241186	Teratocarcinoma-derived growth factor 1	P13385	3	46574534-46582463	Predicted intracellular proteins, Predicted secreted proteins		Growth factor		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in some		kidney: 9.9;lymphoid tissue: 16.7;ovary: 9.7	Cell type enriched	Detected in some	18	Distal tubular cells: 102.8	Group enriched	Detected in many	9	colorectal cancer: 6.4;testis cancer: 27.1	Low region specificity	Detected in single			Cell type enhanced	Detected in some		neutrophil: 3.7	Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		HEL: 9.5;NTERA-2: 43.2;SuSa: 27.0	Group enriched	Detected in many	5	cerebellum: 12.5;pons and medulla: 9.1	Low region specificity	Detected in single			HPA051928			Uncertain	Vesicles,Cytosol	Secreted in other tissues					Vesicles	Cytosol	HPA051928: 	unprognostic (7.84e-3)	unprognostic (2.00e-2)	unprognostic (1.30e-2)	unprognostic (1.17e-2)	unprognostic (2.80e-2)	unprognostic (1.14e-1)	unprognostic (4.01e-2)	unprognostic (1.93e-1)	unprognostic (3.61e-1)	unprognostic (1.72e-2)	unprognostic (6.77e-2)	unprognostic (1.74e-1)	unprognostic (8.76e-3)	unprognostic (2.01e-1)	unprognostic (2.10e-2)	unprognostic (1.75e-2)	unprognostic (1.05e-1)	0.6	3.9	0.6	0.6	0.8	0	0.6	0.6	0.6	0.6	2.1	0.6	0.6	0.2	0.7	1.3	0.6	0	0.6	0.6	1	0.6	9.9	0.8	0.6	0.6	0.9	0.6	9.7	0.6	0	0.6	0.6	0.6	0.6	4.3	1.1	0.6	0.6	1	0	0.6	0.8	1	16.7	2.4	0.6	0.6	5.2	2.1	0.6	0.6	0.6	0.6	1	0.7	3.7	0.6	1.5	0.6	0.1	0	0	0	0.2	0	0	0.1	0	0	0	0	0	0.2	0.1	0	0	0	0	0.8	0	0.1	0	0	9.5	0	0.6	0	0	0.1	0	0	0	0	0	0	0	0.1	0	0	0	0	0	43.2	1.7	0	0.1	0.1	0	0	0.1	0	0	0	0	0	27	0	0	0.8	0.1	0	0.1	0	0.1	0	0	0	0	0	2.1	0.6	0.5	0.5	0.3	0.3	0.6	0.4	0.3	0.1	1	0.6	0.4	3.7	1.5	0.4	0.7	0.2	0.1	0.6	0.8	0.6	0.6	1	0.6	0.9	0.6	0.6	0.6	0	0	0	0.1	0	0	0.3	0	0	0	5.2	0	0	102.8	0.1	4.3	0.8	0.4	0	0	0	0	0	0	1	0.1	0	2.4	0	0	0.7	0.3	0	0	0	4	0	0	0	0	0.3	0	0	0	0	0.1	0	0	0	5.7	0	Distal tubular cells
C3orf85	FLJ22763	ENSG00000241224	Chromosome 3 open reading frame 85		3	109118252-109150514	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level	No human protein/transcript evidence			Tissue enriched	Detected in some	5	intestine: 50.1	Cell type enriched	Detected in some	7	Proximal tubular cells: 108.1	Cancer enhanced	Detected in some		colorectal cancer: 1.3					Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		BEWO: 1.2;CACO-2: 5.0;RPMI-8226: 1.5;SH-SY5Y: 1.5	Not detected	Not detected			Not detected	Not detected																		unprognostic (9.10e-2)				unprognostic (9.48e-3)						unprognostic (3.80e-4)	unprognostic (1.15e-1)	unprognostic (6.70e-2)			0	0	0	2.5	0	0	0	0	0	0	14.6	0	0	36.2	0	0.6	0	0	0	0.4	0		6.8	9.8	0	0	0	0	0	0	0	0	0	0	0	2.5	0	0	0	0	0	50.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.2	0	0	0	0	5	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0.4	0	0	0	1.5	0	0	0.2	1.5	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0	0	0	0	0	0	5.2	0	0	14.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	108.1	0	0	0	0	0	0	0	0	0	0	Proximal tubular cells
KRTAP5-8	KRTAP5-2, KRTAP5.8, UHSKerB	ENSG00000241233	Keratin associated protein 5-8	O75690	11	71538025-71539207	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at transcript level		Group enriched	Detected in some	8	epididymis: 3.4;kidney: 7.1;skin 1: 8.7;testis: 2.7	Cell type enriched	Detected in single	8	Distal tubular cells: 1.7	Cancer enhanced	Detected in single		renal cancer: 1.4					Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HDLM-2: 1.2;RT4: 4.2																						unprognostic (9.72e-2)	unprognostic (8.49e-2)	unprognostic (9.79e-2)	unprognostic (1.52e-1)	unprognostic (1.66e-1)	unprognostic (2.58e-2)	unprognostic (1.99e-1)	unprognostic (6.92e-2)		unprognostic (2.89e-2)	unprognostic (2.42e-2)	unprognostic (2.08e-1)	unprognostic (3.02e-2)	unprognostic (1.14e-1)		unprognostic (3.62e-2)	unprognostic (2.21e-3)	0	0.1	0.2	0.1	0.6	0	0.3	0.3	0.4	0	0.2			0.3	0	3.4	0	0.1	0.2	0	0.2	0.3	7.1	0.1	0.2	0.1	0.2		0	0	0.1	0	0		0	0.2		0.1	0.2	0.4	8.7	0.4	0	0.1	0.1	0	2.7			0.1		0.1	0.6	0	0.1	0	0	0	0	0.3	0	0	0	0.1	0	0	0.3	0	0.3	0	0	0	0	0.1	0	0.2	0	0.1	0	0	0	0	1.2	0.3	0	0	0	0	0.7	0.5	0.4	0	0	0	0	0.2	0.1	0	0	0.2	0.8	0	0.2	0	0.2	0	0	0	0	0	4.2	0	0.1	0	0	0	0	0	0.6	0	0.1	0	0	0	0	0	0.3	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0.3	0	0	0	0	0	0											0	0	0	0.2	0	0	0	0	0	0	0	0	0	1.7	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	Distal tubular cells
SSX2	CT5.2a, HD21, HOM-MEL-40, MGC119055, MGC15364, MGC3884, SSX	ENSG00000241476	SSX family member 2	Q16385	X	52696896-52707189	Cancer-related genes, Disease related genes, Predicted intracellular proteins	Transcription, Transcription regulation		Cancer-related genes, Proto-oncogene	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	57	testis: 24.1	Cell type enriched	Detected in single	28	Spermatogonia: 2.8	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		PC-3: 3.2;U-2197: 1.9									HPA045683, CAB046020	Enhanced		Approved	Nucleoplasm,Nucleoli						Nucleoplasm, Nucleoli		CAB046020: AB_2194010, HPA045683: AB_2679418																		0	0	0	0	0	0	0	0	0	0	0			0	0	0	0	0	0	0	0	0	0	0	0	0	0		0	0	0	0	0		0	0		0	0	0	0	0	0	0	0	0	24.1			0.4		0	0	0	0	0	0	0.2	0	0	0	0.1	0.5	0	0.1	0	0	0.2	0	0	0	0	0	0.1	0	0	0.3	0.9	0.1	0	0	0	0	0	0.1	0.4	0	0	0	0	0	0	0	0	0	0	0	0.4	0.3	0.3	0	0	0	0.2	0	3.2	0	0	0	0	0	0	0	0	0.2	0	0.1	0.9	0	0.6	0.1	0.6	1.9	0	0	0.3	0	0.1	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0											0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.8	0	0	0	0	0	Spermatogonia
UGT1A1	GNT1, UGT1, UGT1A	ENSG00000241635	UDP glucuronosyltransferase family 1 member A1	P22309	2	233760248-233773299	Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins		Glycosyltransferase, Transferase	Cancer-related genes, Disease mutation	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	16	intestine: 48.6;liver: 120.3	Cell type enriched	Detected in some	12	Hepatocytes: 83.9	Cancer enriched	Detected in some	19	liver cancer: 16.4	Not detected	Not detected			Cell type enhanced	Detected in some		neutrophil: 4.7	Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		HaCaT: 8.1;OE19: 35.4;RT4: 19.3	Not detected	Not detected																						unprognostic (7.28e-2)			unprognostic (2.49e-2)	unprognostic (3.60e-1)	unprognostic (5.69e-2)			unprognostic (4.17e-3)	unprognostic (6.31e-3)	unprognostic (1.94e-5)	unprognostic (2.78e-3)			unprognostic (2.99e-4)	0.1	0	0.1	0.1	0.1	0	0.1	0.1	0.2	0.2	35.6	0.1	0.1	48.6	0.1	0.1	4.3	0	0.3	0.1	0.1	0	4.5	120.3	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.3	0.4	0.1	0.7	0.1	0.1	0.9	48.2	0.5	0.1	0.1	1.3	0.2	0.1	0.1	0.2	0.1	0.1	5.2	0.8	1	0.4	4.7	0.4	1.1	0.5	0.2	0.2	0.6	0.1	0.1	0	0.1	0.4	0	0	0	0	3.1	0.2	0.1	1.4	0	0	8.1	0	0.1	0	0.1	0.1	0	0.3	0.8	0	0.3	0.1	0.1	0.3	0	0	0	0	0.1	0.1	0.3	0	0.4	0	0.2	0.3	35.4	3.6	0	0.1	0.3	0	19.3	0.1	0.2	1.4	0.2	0	0.1	0.1	0	0	0.1	0	0.2	0	0.1	0.1	0.1	0.4	0.2	0.1	2.1	0.4	0.4	0.4	0.3	0.3	0.4	0.4	0.3	0.1	1	0.4	0.5	4.7	1.1	0.4	0.4	0.3	0.2	0.1	0.1	0.1	0.2	0.1	0	0.1	0.1	0.1	0.1	0	0	0	1	0	0	0	0	2.7	6.8	1.8	0	0	0	0.2	2.8	0	3.5	0	0	0	0	0.9	0	83.9	0	0	0	1.3	3.3	0.8	0	0	0	0	0.6	0	0.5	1.4	0	1.4	0	0	0	0	0.1	0	0	0	0.6	6.2	Hepatocytes
PSG2	CEA, PSBG2, PSG1, PSGGB	ENSG00000242221	Pregnancy specific beta-1-glycoprotein 2	P11465	19	43064211-43083045	Predicted intracellular proteins, Predicted secreted proteins				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	102	placenta: 75.3	Cell type enriched	Detected in some	35	Syncytiotrophoblasts: 671.0	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		BJ: 6.5;fHDF/TERT166: 14.0;HBF TERT88: 21.8;SuSa: 6.1;U-2197: 28.0														Secreted in female reproductive system																					unprognostic (1.02e-2)				0.4	0	0.2	0	0.1	0.1	0.1	0.3	0.2	0.1	0.1	0	0	0	0	0	0	0	0	0.1	0.1	0.1	0.1	0.1	0	0	0.1	0	0	0.2	0	0	75.3	0	0.1	0	0	0.2	0	0.1	0.7	0	0.2	0	0.1	0.1	0.2	0	0	0.1	0	0	0.1	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	6.5	1.1	0.6	2.9	0	0	0	0	14	0.8	0.3	0	0	21.8	0	0	0	0	0	0	0	0	0	0	0.6	0.8	0	0	0	0	0	0.1	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	6.1	0	0	0	0	0	28	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0.2	0.1	0.3	0.2	0.1	0.1	0.1	0	0	0	0	0	0	0.3	0.3	0.4	0	0	0	0	0	0	3.6	0	0.8	0.2	0	0	0	0	19.2	0.3	0.5	0	0	1.6	0	0	0	0	0	0	0	1.7	0	0	0	0.1	0	0	0	0.2	0	0	0	0	0	671	0	0	0.6	Syncytiotrophoblasts
CNTF	HCNTF	ENSG00000242689	Ciliary neurotrophic factor	P26441	11	58622673-58625733	Cancer-related genes, Plasma proteins, Predicted intracellular proteins	Differentiation, Neurogenesis	Developmental protein, Growth factor	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in many	5	brain: 47.5	Cell type enriched	Detected in single	5	Melanocytes: 1.7	Low cancer specificity	Detected in some			Region enriched	Detected in many	5	midbrain: 47.5	Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in many		U-2197: 12.9	Low region specificity	Detected in many							HPA019654	Approved		Approved	Vesicles				69200		Vesicles		HPA019654: AB_1859050	unprognostic (1.88e-1)	unprognostic (2.64e-3)	unprognostic (1.01e-2)	unprognostic (4.37e-2)	unprognostic (1.52e-1)	unprognostic (5.91e-2)	unprognostic (1.63e-1)	unprognostic (9.24e-2)	unprognostic (5.87e-2)	unprognostic (1.63e-1)	unprognostic (8.25e-4)	unprognostic (5.42e-2)	unprognostic (8.50e-2)	unprognostic (1.02e-1)	unprognostic (1.91e-1)	unprognostic (9.50e-2)	unprognostic (9.67e-2)	2	0.7	1.4	0.9	4.8	10	0.8	1.2	1.6	0.3	0.9	2.5	1.1	1.4	0.3	1.4	0.9	8.3	0.8	2.5	1.8	1.6	0.9	0.9	0.8	0.6	47.5	0.9	0.3	0.5	1.2	0.5	0.6	9.3	0.6	1.3	3.1	1.3	0.4	3.7	0.9	0.9	0.6	22.8	0.6	0.5	0.7	1.2	0.2	1	3.7	0.6	0.6	0.3	0.4	0	0	0.3	0	0.7	0.2	2.1	0.8	3.4	3.6	1.1	0.3	1.7	1.6	2.2	1.6	1.2	3	3	4.4	1.2	2.2	1.8	3.9	3.7	3.9	3.3	3.1	2.1	2.3	4.4	1.6	0.4	3.4	4.3	1	1.4	5.3	1.7	0.7	1.7	3.1	3.4	1	2	0.9	3.3	3.2	2.1	1.5	1.6	2.2	2.4	3	1.9	2.5	1.6	4.3	2.3	2.4	5.9	2.6	3	2.5	1.2	2.5	2	12.9	4	2.4	5	3.8	6.7	1.7	2.9	0	0.3	0	0.3	0	0	0.4	0	0	0	0	0	0.7	0	0	0	0	0	0.2	1.4	4.8	1.2	1.4	1.8	1.6	47.5	0.9	9.3	1.2	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0.1	0	0	0	0	0.1	0	0	0	0	0	0	0	1.7	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0.2	0	0	0	Melanocytes
PSG11	MGC22484, PSG13, PSG14	ENSG00000243130	Pregnancy specific beta-1-glycoprotein 11	Q9UQ72	19	43007656-43026512	Predicted intracellular proteins, Predicted secreted proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	220	placenta: 151.1	Cell type enriched	Detected in single	172	Syncytiotrophoblasts: 135.4	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	8	U-2197: 19.7									HPA042240, HPA046327	Enhanced				Secreted in female reproductive system							HPA042240: AB_10797384, HPA046327: AB_2679624					unprognostic (2.58e-1)													0.2	0	0	0	0.1	0	0.1	0.2	0.1	0.2	0.1	0	0	0	0.1	0	0.1	0	0	0.1	0.1	0.2	0.1	0.1	0	0	0	0	0	0.1	0	0.1	151.1	0	0	0	0	0	0	0.1	0.1	0	0.4	0.1	0.1	0.1	0.2	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0.5	0.2	0	0.1	0	0	0	0	0.7	0.3	0	0	0	0.6	0	0	0	0	0	0	0	0	0.1	0	0.4	0.1	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.5	0	0	0	0	0	19.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.2	0.1	0.1	0.2	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0.8	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	135.4	0	0	0	Syncytiotrophoblasts
PSG4		ENSG00000243137	Pregnancy specific beta-1-glycoprotein 4	Q00888	19	43192702-43207299	Predicted intracellular proteins, Predicted secreted proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	7	placenta: 348.5	Cell type enriched	Detected in some	54	Syncytiotrophoblasts: 463.1	Low cancer specificity	Detected in some			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	6	fHDF/TERT166: 107.6;U-2197: 29.2									HPA046327	Supported				Secreted in female reproductive system							HPA046327: AB_2679624	unprognostic (4.29e-2)	unprognostic (5.18e-2)		unprognostic (9.49e-2)		unprognostic (2.52e-2)		unprognostic (3.63e-2)	unprognostic (1.94e-1)	unprognostic (2.07e-2)	unprognostic (1.70e-1)	unprognostic (7.75e-2)	unprognostic (8.82e-3)	unprognostic (1.03e-3)	unprognostic (1.68e-2)	unprognostic (2.85e-1)	unprognostic (2.57e-1)	0.6	0.4	0.2	0.5	0.2	0	1.4	0.2	0.2	0.2	8.2	0.2	0.2	0	0.2	0.2	1.2	0	0.2	0.2	0.2	0	2	0.2	0.2	0.2	0.2	0.2	0.2	2	49.1	0.6	348.5	0.2	0.6	5.8	0.2	4.4	0.2	0.2	6.3	0.2	0.2	0.2	0.2	1.1	0.2	0.2	0.2	0.2	0.3	0.3	0.2	1	0	0	0.6	0.4	0	0	0	0	0	0	0	0	0.1	0	0.3	0	0.1	0	0	0.5	0	0.3	107.6	0.8	0.1	0	0	1	0	0	0	0	0	0	0	0	0.1	0	1.6	11	0.7	0	0	0	0	0.8	0	0	0	0	0.3	0	0	0	0	0.4	0	0	0	0	1.4	0.1	3	0	0	0.8	0.4	1.1	29.2	0	0	0	0	0.3	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0	0	0.2	0.2	0.2	0.2	0.2	0	0.2	0.2	0.2	0.2	0	0	0	3	0	0.7	0.3	0	0	0	0	0	1.3	0	4.9	0	0	0	0	0	8.5	0.2	0.2	0	0	1.9	0	0	0	0	0	0	0	0	1	0	0	1.1	0	0	0	0	0	0	0	0.1	0	463.1	0	0	0.3	Syncytiotrophoblasts
AMY2A	AMY2	ENSG00000243480	Amylase, alpha 2A (pancreatic)	P04746	1	103616811-103625780	Enzymes, FDA approved drug targets, Predicted secreted proteins	Carbohydrate metabolism	Glycosidase, Hydrolase	FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	31	pancreas: 1849.4	Cell type enriched	Detected in some	68	Exocrine glandular cells: 849.6	Cancer enriched	Detected in single	2010	pancreatic cancer: 200.3	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		THP-1: 1.0;U-2 OS: 1.3									HPA045394, HPA045399, CAB045960, HPA046980	Enhanced				Secreted to digestive system				77000000			CAB045960: AB_2226891, HPA045394: AB_2679311, HPA045399: AB_2679313, HPA046980: AB_2679889					unprognostic (3.27e-1)					unprognostic (1.78e-3)	unprognostic (3.24e-2)			unprognostic (1.29e-1)		unprognostic (2.13e-2)		0.2	0	0.2	0.2	0.2	0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0	0.2	0.2	0.2	0	0.2	0.2	0.2	0.2	0.2	0.2	0.9	1849.4	0	0.2	0.2	0.2	0.2	0	0.2	59.9	0.2	0.2	0	0.2	0.2	0.2	0.2	0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0	0.2	0.2	0.3	0	0.1	0.2	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0.4	0	0.1	0	0	0	0	0	0	1	0	0	1.3	0	0	0	0	0	0	0.9	0	0.2	0.3	0	0.1	0	0.1	0	0	0	0.1	0	0	0.1	0.2	0	0	0.2	0	0.2	0.2	0.2	0.2	0.2	0.2	0	0.2	0.2	0.2	0.2	0	0	0	0.7	0	0	0.8	0	1.4	0	0	0	0	0	0.9	1.5	0	0	0	849.6	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	8.2	0	0	12.4	0	0	0	0	0	0	0.2	0.1	0	0	0	0	0.4	Exocrine glandular cells
WFDC6	C20orf171, dJ461P17.11, WAP6	ENSG00000243543	WAP four-disulfide core domain 6	Q9BQY6	20	45534196-45539495	Predicted secreted proteins		Protease inhibitor, Serine protease inhibitor		Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Group enriched	Detected in some	7	epididymis: 79.9;testis: 25.5	Cell type enriched	Detected in some	16	Ciliated cells: 56.2	Cancer enhanced	Detected in some		endometrial cancer: 0.9	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	4	U-87 MG: 7.8														Secreted in male reproductive system								unprognostic (3.68e-3)			unprognostic (2.21e-3)				unprognostic (1.26e-2)		unprognostic (8.74e-2)					unprognostic (2.91e-2)			0.1	0	0.1	0.1	0.1	0	0.1	0.1	0.1	1.1	0.1	0.1	7.6	0	0.2	79.9	0.1	2.8	0.1	0.1	0.1	0	0.1	0.1	0.8	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.4	0.1	0.3	0.1	0.1	0.1	0.1	0	25.5	0.1	0.1	0.3	0.1	0.3	0.4	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0.1	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	1.7	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	7.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0	0	56.2	3.4	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.8	0.6	0	0	0	0	0	0	0	0.4	0	0	0	0	0.9	0.2	0	0	0	0	0.1	Ciliated cells
UPK3B	FLJ32198, MGC10902, p35, UPIIIb	ENSG00000243566	Uroplakin 3B	Q9BT76	7	76510428-76516521	Predicted intracellular proteins, Predicted membrane proteins, Transporters				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		adipose tissue: 28.5;esophagus: 40.2;lung: 34.1;lymphoid tissue: 25.0	Cell type enriched	Detected in some	10	Alveolar cells type 1: 113.2	Group enriched	Detected in many	12	ovarian cancer: 64.6;urothelial cancer: 78.4	Region enriched	Detected in single	58	pons and medulla: 5.8	Cell type enriched	Detected in single	6	neutrophil: 1.2	Lineage enriched	Detected in single	6	granulocytes: 1.2	Cell line enhanced	Detected in some		A549: 7.8;CAPAN-2: 28.5;HaCaT: 5.8;RT4: 19.5;T-47d: 16.2									HPA010506	Approved											HPA010506: AB_1080479	unprognostic (8.33e-2)	unprognostic (1.30e-1)	unprognostic (3.62e-3)	unprognostic (2.26e-3)	unprognostic (7.87e-2)	unprognostic (8.60e-2)	unprognostic (1.12e-1)	unprognostic (2.63e-1)	unprognostic (4.03e-1)	unprognostic (5.92e-2)	unprognostic (1.37e-2)	unprognostic (4.06e-2)	unprognostic (8.37e-9)	unprognostic (3.56e-2)	unprognostic (2.01e-1)	unprognostic (1.66e-1)	unprognostic (6.34e-2)	28.5	0.3	0	7.1	0	0.4	0.3	0	0.3	1.5	6.9	0.1	0	0.3	0.8	7.9	40.2	2.8	3	9.4	0	0	0.3	0.4	34.1	0.4	0	0	13.2	0.3	0.3	0.1	0.3	5.8	1.4	0.3	0.8	1.4	0.3	0.4	1.1	0.5	1.5	0.2	0.4	0.6	6.1	0	0.2	0.3	6.1	25	20.5	2.1	0	0	1.2	0	0	0.2	0	0.6	7.8	0	0	0	0	0	0	0	0	0	0.1	28.5	0	0.2	0	0	5.8	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.9	0	0	0	1.6	0	0	0	0	0	19.5	0	0	0.2	2.3	0	0	16.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	1.2	0	0	0	0	0	0	0	0	0	0	0	0	0	5.8	0	113.2	3.5	0	0.2	1.4	0	0.3	2.5	4	9.1	3.5	3.9	0.1	0	0	0	0.4	0	0	0	0	0.4	0.2	1.1	0	0.1	1.6	0	0.6	0	0	11.2	0.9	3.3	0	0	0.5	0.1	0	0	0	0.1	0	0.1	0	0.1	2.5	0.1	0	0.1	2.5	Alveolar cells type 1
LEFTY1	LEFTB, LEFTYB	ENSG00000243709	Left-right determination factor 1	O75610	1	225886282-225911382	Predicted intracellular proteins, Predicted secreted proteins		Cytokine, Developmental protein, Growth factor		Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	6	blood: 12.1;epididymis: 19.0;intestine: 26.6;pancreas: 46.5	Cell type enriched	Detected in many	4	Undifferentiated cells: 330.1	Cancer enhanced	Detected in many		colorectal cancer: 44.8	Low region specificity	Detected in some			Cell type enriched	Detected in single	35	basophil: 12.1	Lineage enriched	Detected in single	35	granulocytes: 12.1	Cell line enriched	Detected in some	6	NTERA-2: 34.0									HPA047883, HPA056210	Approved				Secreted in other tissues							HPA047883: AB_2680200, HPA056210: AB_2683067	unprognostic (2.81e-1)	unprognostic (2.31e-1)	unprognostic (7.26e-2)	unprognostic (1.18e-2)	unprognostic (1.83e-2)	unprognostic (3.50e-2)	unprognostic (1.52e-2)	unprognostic (4.60e-2)	unprognostic (2.19e-1)	unprognostic (1.28e-1)	unprognostic (7.76e-2)	unprognostic (6.13e-2)	prognostic unfavorable (2.48e-6)	unprognostic (2.78e-2)	unprognostic (1.12e-1)	unprognostic (2.01e-1)	unprognostic (2.61e-2)	0.2	0	0.6	4.5	1.1	0	0.2	1.2	0.9	0.6	26.6	0.2	1.5	0	0.7	19	0.4	0.1	0.2	0.2	0.6	0.7	3.6	0.2	0.3	0.2	0.2	0.2	2	46.5	0	0.3	0.3	0.2	0.6	15.1	0.3	0.5	1.6	0.2	0	0.8	0.4	0.2	0.2	0.4	2.1	0.2	0.3	0.2	0.2	0.2	0.9	0.2	0	0	12.1	0	0.3	0.2	1.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5.4	0	0	0.2	0	0	0	2.9	0	0.2	0	0.1	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	34	0	0	0	3.6	0.4	0.8	0	0	0	0	0.1	0	0.5	0	0.1	0	0	0.4	0.1	0	0.1	0.1	0	0	0	0	12.1	0	0	0	0	0	0	0	0.2	0	0	0	0.2	0	0.3	0	0	0	1.7	0.6	1.1	1.2	0.9	0.6	0.7	0.2	0.2	0.2	0.2	0	0	0	0.5	0.3	1.7	0	0	0	0	0	0	0	1.7	14.5	1.5	0	6.7	0	27	0	0.2	1	0	0	0	0	30.3	0	0	2.1	1.4	0	0	0	45.3	0.8	0.5	73.7	1.8	4.8	1.3	0	0.3	1.6	1.5	0	0	0	330.1	1.3	Undifferentiated cells
CFAP57	FLJ32000, WDR65	ENSG00000243710	Cilia and flagella associated protein 57	Q96MR6	1	43172149-43254358	Predicted intracellular proteins, Predicted membrane proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		fallopian tube: 25.6;testis: 29.2	Cell type enriched	Detected in some	7	Ciliated cells: 156.6	Low cancer specificity	Detected in some			Region enhanced	Detected in many		pons and medulla: 12.7	Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		HaCaT: 6.9;HDLM-2: 4.5	Low region specificity	Detected in many			Low region specificity	Detected in many			HPA002736, HPA028623	Enhanced		Approved	Cytosol						Cytosol		HPA002736: AB_2272982, HPA028623: AB_10603234	unprognostic (1.15e-2)	unprognostic (2.29e-3)	unprognostic (2.16e-1)	prognostic favorable (6.02e-4)	unprognostic (2.50e-2)	unprognostic (3.71e-1)	unprognostic (2.42e-2)	unprognostic (1.02e-1)	unprognostic (1.39e-1)	unprognostic (4.11e-1)	unprognostic (2.05e-2)	unprognostic (1.38e-1)	unprognostic (3.46e-2)	unprognostic (1.43e-1)	unprognostic (1.80e-1)	unprognostic (1.34e-2)	unprognostic (7.78e-2)	0.4	0.4	1.6	0.3	6.7	0.2	0.6	0.1	1.8	1.6	0.3	4.2	0	0.3	1	9.1	0.4	25.6	0.5	0.4	3.6	2.7	1.5	2.7	4.7	0.2	0.3	1.4	7.1	0.9	0.4	5.9	0.5	12.7	0.7	0.3	0.3	0.5	0.5	0.4	0.9	0.3	0.3	0.4	0.2	0.4	29.2	0.4	0	1.9	0	0.3	0.5	0.2	3.2	2.4	0.7	4.8	1.2	1.5	1.4	2.9	1	0.8	0.6	0.2	0.2	0.9	1.1	1.8	1.4	1.4	0.9	1.2	0.3	1.3	2.4	0.8	6.9	0.4	0.9	2.6	4.5	0.2	0.4	0.6	0.6	0.5	0	0.3	0.2	1.2	1.1	0.4	1.9	2	0.4	0.2	0.1	0.2	0.1	0.3	0.3	1.4	0.2	0.1	0.4	1	0.2	3	0.5	1.2	0.5	1.4	0.2	1.1	0.8	1.7	0.5	3.9	0.2	1.5	0.7	0.8	0.4	0.6	0.3	0.3	0.8	0.9	0.5	1.1	0.7	1.4	2	1.4	2.2	1.4	1.2	2.4	3.2	1.3	1.3	0	1.2	4.8	1.9	1.5	1.4	1.6	6.7	0.1	1.8	3.6	2.7	0.3	1.4	12.7	0.4	6	0.3	0	0.1	0	0.4	0.4	0	156.6	10.3	0	5.9	0.8	0	0.3	22.1	0	0.2	0	0.2	0.1	0.2	0.1	0	0.2	0.1	1.6	0	0.6	0	21.6	0.9	0	0	3.6	0	0.5	0.2	0	0.7	1.4	0.8	0	0	18.7	3.3	0	0	0	0	0.1	Ciliated cells
TUBA4B	FLJ13940, TUBA4	ENSG00000243910	Tubulin alpha 4b	Q9H853	2	219253243-219272188	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level				Tissue enriched	Detected in some	7	fallopian tube: 29.7	Cell type enriched	Detected in some	8	Ciliated cells: 152.6	Cancer enriched	Detected in some	6	endometrial cancer: 8.4					Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		Hep G2: 3.1;SCLC-21H: 3.6																						unprognostic (3.20e-5)	unprognostic (1.47e-4)	unprognostic (1.85e-1)	unprognostic (3.70e-3)	unprognostic (9.63e-2)	unprognostic (8.97e-2)	unprognostic (2.18e-3)	unprognostic (7.32e-2)	unprognostic (9.50e-2)	unprognostic (6.56e-2)	unprognostic (2.50e-1)	unprognostic (2.12e-1)	unprognostic (2.41e-3)	unprognostic (3.78e-2)	unprognostic (9.57e-2)	unprognostic (3.91e-2)	unprognostic (4.08e-1)	0	0		0		0	0		0	0	0			0	0.2	0.4	0	29.7	0	0			0.4	0	2	0			0	0	0		0		0	0		0	0	0.1	0	0	0		0	0	0			0		0	0		1	0.2	2.4	0.6	0.6	1.5	4	0.3	0	0	0	0	0	0	0	0	0	0	0.3	0.4	0.5	0.7	0	0.3	0.7	0	0.7	0	0.4	0.2	0.2	0.6	3.1	0	0	0.2	0	0	0	0	0	0	0	0	0.6	0	0	0	0.6	0.1	0	0	0	0.2	0.1	0	0.1	3.6	0.1	0.9	0.3	0	0	0.2	0.4	0	0	0.5	0.3	0.1	0.4	0	0.6	0.8	0.5	0	0.7	0.4	1.4	0.7	0.4	0.8	1	1.5	1.2	0.2	0.8	1.2	1.4	2.4	0.6	0.6	0.1	1.3	4											0	2.7	0	0.3	0	0	0.8	0	152.6	7.9	1.8	0	0	1.7	0	1.3	0	0	0	0.2	0	0	0.2	0	0.2	0	0	1.7	0	0	0.6	0	0	0	0	0	0	0.1	0	0	18.8	0	0	0	0	0	0	0	0	0	0.1	Ciliated cells
UGT1A7	UGT1G	ENSG00000244122	UDP glucuronosyltransferase family 1 member A7	Q9HAW7	2	233681938-233773299	Enzymes, Predicted intracellular proteins, Predicted membrane proteins		Glycosyltransferase, Transferase		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	12	esophagus: 54.4;lymphoid tissue: 40.2;tongue: 23.6	Cell type enriched	Detected in some	5	Urothelial cells: 8.4	Group enriched	Detected in some	10	cervical cancer: 1.2;head and neck cancer: 2.3;lung cancer: 3.0	Not detected	Not detected			Cell type enhanced	Detected in single		basophil: 1.6	Low lineage specificity	Detected in single			Cell line enriched	Detected in some	14	SiHa: 50.6																							unprognostic (6.27e-2)	unprognostic (1.02e-1)			unprognostic (7.76e-2)	unprognostic (1.03e-2)	unprognostic (1.09e-1)			unprognostic (7.92e-2)		unprognostic (1.71e-7)	unprognostic (2.14e-1)			unprognostic (4.57e-2)	0.1	0.7	0	0	0	0	0.3	0	0.1	0.7	0.1	0	0	0.1	0	0	54.4	0	0	0	0	0	0.3	0.5	0	0	0	0	0	0	0	0	0	0	0	0.1	0	3.2	0	0	2.3	0.1	0	0	0	0	0	0	0	0	23.6	40.2	0.2	2.8	0.2	0.1	1.6	0.2	0.6	0.1	0	0	0.8	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0.1	0	0.5	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	50.6	3.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.6	0	0	0.1	0.1	0	0.2	0.1	0.1	0	0.2	0.1	0	0.2	0.6	0.2	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.7	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	1.5	0	0	0.2	8.4	Urothelial cells
ERVFRD-1	envFRD, ERVFRDE1, HERV-FRD, HERV-W/FRD, syncytin-2	ENSG00000244476	Endogenous retrovirus group FRD member 1, envelope	P60508	6	11102489-11111732	Predicted membrane proteins, Transporters				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	4	placenta: 66.9	Cell type enriched	Detected in some	52	Syncytiotrophoblasts: 481.3	Not detected	Not detected			Not detected	Not detected			Cell type enhanced	Detected in single		NK-cell: 2.1	Low lineage specificity	Detected in single			Cell line enriched	Detected in some	4	SuSa: 30.4																						unprognostic (1.99e-1)	unprognostic (3.29e-4)	unprognostic (4.75e-2)	unprognostic (1.80e-1)	unprognostic (1.34e-1)	unprognostic (2.19e-3)	unprognostic (3.35e-1)	unprognostic (6.44e-2)	unprognostic (1.24e-1)	unprognostic (1.99e-1)	unprognostic (1.30e-2)	unprognostic (2.78e-3)	unprognostic (5.80e-4)	unprognostic (3.40e-2)	unprognostic (1.82e-1)	unprognostic (1.95e-2)	unprognostic (1.37e-2)	1.4	2	0.1	0.1	0.1	0.1	0.8	0.2	0.2	0.5	0.8	0.1	0.1	0.3	1.3	0.8	0.7	0.2	0.5	0.5	0.1	0	1.5	0.7	1.5	1	0.1	0.1	0.1	0.1	15.8	0.1	66.9	0.1	1.2	0.2	0.7	0.9	0.5	0.1	0.9	1.9	0.8	0.1	0.1	1	0.3	0.1	0.6	0.2	0.9	0.3	1.5	2.2	0.5	0	0.3	0.1	2.1	0.7	0.1	0	0	0	0	0	0	6.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	30.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0.1	0	0.1	0	0	0.5	0.7	0.4	0.3	2.1	0	0	0	0.1	0.1	0.1	0.2	0.2	0.1	0	0.1	0.1	0.1	0.1	0	2.6	0	0	0	0.9	0.4	0	0	1.2	0	0	3.7	0	0	0	0	0	0	0	1.6	0	0	9.3	0	2.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	481.3	0	0	0	Syncytiotrophoblasts
HBB	beta-globin, CD113t-C	ENSG00000244734	Hemoglobin subunit beta	P68871	11	5225464-5229395	Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Transporters	Oxygen transport, Transport	Hypotensive agent, Vasoactive	Congenital dyserythropoietic anemia, Disease mutation, FDA approved drug targets, Hereditary hemolytic anemia	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in all	7	bone marrow: 3646.7	Cell type enriched	Detected in many	16	Erythroid cells: 407904.6	Cancer enhanced	Detected in all		glioma: 244.6	Low region specificity	Detected in all			Group enriched	Detected in many	7	neutrophil: 19.3;plasmacytoid DC: 9.9	Group enriched	Detected in many	12	dendritic cells: 9.9;granulocytes: 19.3	Cell line enhanced	Detected in some		HEL: 5.5;SCLC-21H: 4.8;SH-SY5Y: 6.1;U-266/70: 22.3;U-266/84: 3.7									CAB009526, HPA043234	Enhanced								15000000000			CAB009526: AB_2143058, HPA043234: AB_2678378	unprognostic (2.41e-1)	unprognostic (8.55e-2)	unprognostic (2.40e-1)	unprognostic (4.40e-2)	unprognostic (1.14e-1)	unprognostic (3.22e-1)	unprognostic (4.88e-2)	unprognostic (7.46e-2)	unprognostic (2.91e-2)	unprognostic (1.76e-1)	unprognostic (1.91e-1)	unprognostic (8.11e-3)	unprognostic (2.40e-2)	unprognostic (5.81e-2)	unprognostic (1.42e-1)	unprognostic (8.87e-3)	unprognostic (6.41e-2)	32.7	20	20.9	10.1	21	3646.7	43.4	6.5	10.7	9.2	11.3	7.2	3.4	3.2	7.3	11.1	36.6	28.4	30.4	38.9	17.9	17.4	45	37.6	305.8	7	31.6	10.8	82.6	28.4	2.9	18.6	236.8	23.7	23.1	7.5	32	17.4	12.8	29.5	3.8	3.9	12	26.5	216.8	4	9.3	3.8	5.6	46.4	20.2	7.6	124.5	256.7	0.6	9.9	19.3	0.6	1.2	1.1	523.2	0	0	0	0	0	0	0.3	0	0	0.1	0	0	0	0	0	0	0	0.1	0	0	0	0	0	5.5	0	0	0	0.1	0	0	0	0	0	0	0	0	1.3	2.1	0	0	0	0.8	0.2	0.4	0	0	0.4	0.3	0	0	4.8	6.1	0.2	0	0	0	0	0	0	0	0	0.6	0	22.3	3.7	0	0	0	0	2.2	0.6	1.9	0.9	0	0.1	0.6	0.2	0	0.9	0.4	0.4	1.1	19.3	1.2	0.1	9.9	0	523.2	20.9	21	6.5	10.7	17.9	17.4	31.6	10.8	23.7	3.8	3	5.9	120	0	139.4	3.4	2	28.1	49.5	2.3	7	3.9	1.1	43.1	0	0	20.2	1	407904.6	0	2.3	16.4	0	0	226.1	6.6	3.2	3.5	92.1	289.2	0	0	2.3	25972.5	0	3.8	6.2	0.1	2.9	0	79.6	86.7	0	737.5	0	0	220.7	1.8	46.8	0.6	0	Erythroid cells
CCDC153	LOC283152	ENSG00000248712	Coiled-coil domain containing 153	Q494R4	11	119189638-119196769	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in many		blood: 15.1;fallopian tube: 15.8;pituitary gland: 20.0	Cell type enriched	Detected in many	7	Ciliated cells: 151.3	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Cell type enhanced	Detected in many		neutrophil: 15.1	Lineage enriched	Detected in many	6	granulocytes: 15.1	Cell line enhanced	Detected in many		T-47d: 13.1	Low region specificity	Detected in many			Low region specificity	Detected in many			HPA041497	Uncertain		Uncertain	Cytosol						Cytosol		HPA041497: AB_10794378	unprognostic (4.66e-2)	unprognostic (1.86e-2)	unprognostic (3.88e-2)	unprognostic (1.45e-2)	unprognostic (1.53e-1)	unprognostic (3.22e-2)	unprognostic (6.87e-2)	unprognostic (2.23e-3)	unprognostic (5.19e-2)	unprognostic (9.43e-3)	unprognostic (1.36e-1)	unprognostic (2.36e-1)	unprognostic (2.92e-3)	unprognostic (1.15e-1)	unprognostic (3.80e-1)	unprognostic (1.52e-3)	unprognostic (1.98e-3)	1.4	1.1	2.2	0.6	4.8	3.8	0.8	0.5	0.9	1.4	0.6	2	0.5	0.5	1.1	5.3	1.5	15.8	3.1	2	2.6	3.9	1.5	0.6	5.2	0.5	0.5	0.5	1.7	0.5	3.3	20	1.3	9.8	0.5	0.6	0.5	0.7	1.6	0.5	1.4	0.8	0.7	1.2	0.8	1.6	2.8	2.4	0.5	1.1	0.5	0.9	0.7	0.5	0.4	1.6	15.1	2.4	0.3	0.6	0.7	2.2	3	1.8	1.8	0.3	0.3	4.4	1.3	1.5	0.6	0.7	4.9	7.7	1.5	6.4	0.3	2.2	1.6	0.4	1.5	0.1	3	2.5	7.2	2.2	3.3	1.1	2.3	0.9	0.7	1	1.6	0.4	2.4	1.5	1.6	2.1	2.9	0.1	8.9	1.5	2.2	0.9	3.2	5.2	2	2.5	1.4	0.5	2.2	2.4	1.2	3	1.5	1.7	1.2	13.1	2.7	3	3.3	2.6	2	2.7	1.2	1.8	1.2	1.5	1.3	4	0.4	2.4	3.8	0.3	1.5	0.2	0.4	0.2	0.4	1.6	0.4	0.6	0.5	15.1	0.3	1.5	1.6	0.4	0.7	2.2	4.8	0.5	0.9	2.6	3.9	0.5	0.5	9.8	2.4	0	6.7	0	1.3	2.5	0	0.2	0	151.3	20.5	7	0	3.5	0	0.8	2.5	1.5	3.3	0	1.8	2.9	1.3	0.9	0	1.3	3.1	0	1.7	3.1	3.5	4.8	0.3	3.4	3.3	5.4	2.7	0.9	1	7	2.5	2.9	1.9	6.5	6.2	6.6	3.4	1.9	2.7	0	1.8	2	Ciliated cells
ATP5MF-PTCD1	ATP5J2-PTCD1	ENSG00000248919	ATP5MF-PTCD1 readthrough		7	99419749-99466197	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level				Low tissue specificity	Detected in all			Cell type enriched	Detected in single	8	Ciliated cells: 1.4	Not detected	Not detected			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low cell line specificity	Detected in all											HPA020106, HPA047679	Uncertain		Approved	Mitochondria						Mitochondria		HPA020106: AB_2176551, HPA047679: AB_2680119	unprognostic (1.15e-3)	unprognostic (3.63e-2)	unprognostic (1.73e-1)	unprognostic (2.83e-1)	unprognostic (3.29e-2)	unprognostic (3.51e-1)	unprognostic (1.18e-3)	unprognostic (2.84e-2)	unprognostic (6.44e-2)	unprognostic (2.18e-1)	unprognostic (3.50e-2)	unprognostic (1.28e-1)	unprognostic (1.70e-1)	unprognostic (2.04e-1)	unprognostic (7.45e-2)	unprognostic (2.00e-2)	unprognostic (7.50e-2)	9.3	10.3	7.5	8.6	9.2	1.2	8.1	8.2	13	9.6	12.4	3.6	9.2	8.7	10.4	8.1	14.8	11	8.3	18.6	8.3	6.7	14.5	23.6	7	7.8	6.2	10.2	9	15.6	11.5	7.1	8.3	8.3	12.3	7.2	6.8	13.9	12.1	35.7	8.7	15	8.4	6.7	8.3	8.9	14.2	5.4	12.7	8.7	24.8	8.6	14.1	10.4	4.2	8.7	1.8	8.3	6.2	6.1	6.8	5.5	6.1	5.1	14.4	6.3	3.7	10.9	3.8	4.6	9.7	8.8	23.3	9.2	7.3	9.5	3.6	9	5.5	8.7	7.9	4.1	8.1	8.2	4.2	4.1	4.8	6.7	5.7	4.5	6.3	7.1	8.7	7.1	3.6	4	8.6	13.9	11.1	6.2	11.6	13.1	7.5	9	9.6	7.9	7.1	4.8	19.3	5.2	1.9	6.7	6.7	8.2	14	8.3	3.6	6.9	9.1	2.4	6.8	6.1	14.2	10	8.9	7.6	11.5	5	6.5	12.1	1.8	6.3	1.7	5.5	8.3	5.8	3.6	4.6	4.6	8.7	4.2	4.9	6.1	0.5	6.2	4.8	4.3	3.5	6.8	7.5	9.2	8.2	13	8.3	6.7	6.2	10.2	8.3	5.4	0	0	0	0	0	0	0	0	1.4	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	Ciliated cells
EPPIN-WFDC6	SPINLW1-WFDC6	ENSG00000249139	EPPIN-WFDC6 readthrough	O95925	20	45536986-45547426	Predicted secreted proteins		Antimicrobial, Protease inhibitor, Serine protease inhibitor		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	48	epididymis: 25.8;testis: 68.0	Cell type enriched	Detected in some	6	Ciliated cells: 6.7	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in single		U-87 MG: 2.7									HPA067335	Supported				Secreted in male reproductive system							HPA067335: 										unprognostic (1.46e-3)					unprognostic (6.38e-2)			0.1	0.1	0.1	0	0.1	0	0.1	0.1	0.1	0.1	0.1	0	0.2	0	0.9	25.8	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0	0.2	0.1	0	0.1	0	0	0.1	0	0	0.1	0	0.1	0.1	0.1	0	0.1	0.1	0.1	68	0	0	0.2	0	0	0.1	0.1	0	0.1	0.2	0.1	0.1	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.7	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.1	0	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	6.7	1.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	Ciliated cells
ECSCR	ARIA, ECSM2	ENSG00000249751	Endothelial cell surface expressed chemotaxis and apoptosis regulator	Q19T08	5	139448556-139462743	Predicted membrane proteins	Angiogenesis, Apoptosis, Chemotaxis, Differentiation	Developmental protein		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Low tissue specificity	Detected in many			Cell type enriched	Detected in some	20	Endothelial cells: 271.3	Low cancer specificity	Detected in all							Cell type enhanced	Detected in some		gdT-cell: 2.7	Lineage enhanced	Detected in single		T-cells: 2.7	Group enriched	Detected in some	121	EFO-21: 49.7;HUVEC TERT2: 125.6;TIME: 92.7									HPA063337			Supported	Nucleoplasm,Vesicles,Plasma membrane						Vesicles, Plasma membrane	Nucleoplasm	HPA063337: AB_2732701	unprognostic (5.91e-2)	unprognostic (2.37e-2)	unprognostic (1.95e-2)	unprognostic (2.83e-2)	unprognostic (3.69e-2)	unprognostic (2.15e-3)	unprognostic (3.95e-2)	unprognostic (1.12e-1)	unprognostic (2.29e-2)	unprognostic (1.78e-1)	unprognostic (2.78e-2)	unprognostic (1.91e-1)	unprognostic (1.83e-3)	unprognostic (2.41e-3)	unprognostic (1.36e-1)	unprognostic (9.90e-2)	unprognostic (2.91e-1)	14.8	1.9	0.8	5.7	1.6	0	17.5	0.4	0.7	13.7	6.1	1	5.1	1.9	14.3	14.4	11	7.9	8.6	26.9	0.8		5.6	4.3	23.4	26.9	1.4	0.7	7.9	1	1.3	0.4	19.6	2.9	9.3	4.3	6.8	3.6	5.5	13.4	2.9	3.4	14.3	4.3	12.1	1.1	6.8	1.1	0.1	11.5	14.5	4.6	13.2	13.1	0.6	0	0	0	0.1	2.7	0	0	0	0.2	0	0	0	0	0	0	0	0.1	0	0	0	49.7	0.1	0	0	0	0	0.1	0.2	0	0	0	0	0	0	0	0.1	0	0	0	0	125.6	0	0	0	0.4	0	0	0.2	0.7	0	0	0	0.1	0	0	0	0	0	0	0	0	0.5	0	0.1	92.7	0.1	0.1	0	0.4	0	0	0	0	0.4	0	0	0	0	2.7	0	0	0.6	1.1	1	0	0	0.1	0.9	0	0.1	0	0	0.6	0											0	4.6	0	0.2	13.3	0	0	0	1.4	1.2	0	0	0.1	0	0.5	0	271.3	0	0	1	0.1	2.6	0.8	0	0	0.6	0	0	0	0	0	0	5.8	10.1	0	0	0	0.7	0	0	0	0.2	0	1.2	0	0	12.2	0.2	0	0	0.7	Endothelial cells
MTRNR2L5		ENSG00000249860	MT-RNR2-like 5	P0CJ72	10	55599303-55600041	Predicted intracellular proteins, Predicted secreted proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in some		seminal vesicle: 7.0;skeletal muscle: 16.4;tongue: 6.6	Cell type enriched	Detected in single	42	Cardiomyocytes: 23.8	Not detected	Not detected			Low region specificity	Detected in many			Cell type enhanced	Detected in some		neutrophil: 1.8	Lineage enriched	Detected in single	4	granulocytes: 1.8	Cell line enhanced	Detected in some		HeLa: 1.7;Hep G2: 2.5;HL-60: 1.0														Secreted - unknown location																	unprognostic (2.11e-2)				unprognostic (1.20e-1)				0.4	1.8	1.5	1.2	2.5	0.2	0.4	0.4	2.3	0.4	0.6	0.4	0	0.5	0.4	1.3	0.4	0.4	0.6	0.5	1	0.5	0.9	0.4	0.4	0.3	1.4	0.6	0.4	0.7	0.1	0.8	0.1	0.6	0.4	0.3	0	4.7	7	16.4	0.4	0.8	0.5	0.4	0.4	0.5	0.5	0.9	0	0.4	6.6	0.3	1	0.4	0.2	0.1	1.8	0.4	0.1	0.1	0.1	0.3	0	0.3	0.3	0	0	0.5	0.6	0	0	0	0	0	0.3	0.4	0	0	0.8	0	0	0	0	0	0.7	1.7	2.5	0	1	0.4	0	0	0	0.8	0	0	0	0.7	0	0	0	0	0.7	0	0	0	0.2	0.3	0	0	0.5	0	0	0	0	0.2	0	0	0	0	0.8	0.4	0.4	0	0	0	0.2	0	0.5	0	1	0.4	0.2	0.1	0.1	0	0.1	0	0	0.1	0.2	0.1	0.1	1.8	0.1	0.1	0.1	0	0.1	1.5	2.5	0.4	2.3	1	0.5	1.4	0.6	0.6	0.9	0	0	0	0.1	0.6	0	23.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0.1	0	0	0	0	Cardiomyocytes
LGALS16		ENSG00000249861	Galectin 16	A8MUM7	19	39655894-39660647	Predicted intracellular proteins	Apoptosis			Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enriched	Detected in some	5	placenta: 14.2	Cell type enriched	Detected in some	76	Syncytiotrophoblasts: 852.8	Cancer enriched	Detected in single	11	testis cancer: 0.5	Region enhanced	Detected in some		cerebellum: 2.6	Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	105	BEWO: 5.5;SuSa: 16.1																																							0	0	0.1	0	0.1	0	0	2.6	0.5	0	0	0	0	0	0	0	0	0	0	0	0.1	1.3	0	0	0	0	1.2	0	0	0	0	0	14.2	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0.4	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	5.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	16.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0.1	0.1	2.6	0.5	0.1	1.3	1.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	7.4	0	0	0.7	0	0	0	0	4.4	0	0	0	0	11.2	0	0	0	0	1.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	852.8	0	0	0	Syncytiotrophoblasts
GOLGA8K		ENSG00000249931	Golgin A8 family member K	D6RF30	15	32392782-32403292	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level	No human protein/transcript evidence	No human protein/transcript evidence		Tissue enriched	Detected in some	5	testis: 9.2	Cell type enriched	Detected in single	14	Early spermatids: 9.3	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		AF22: 2.1;HEL: 2.0;HMC-1: 2.3;JURKAT: 3.0;THP-1: 4.2;U-937: 4.1																						unprognostic (2.47e-1)	unprognostic (3.27e-1)			unprognostic (4.01e-2)	unprognostic (1.09e-2)	unprognostic (6.62e-2)	unprognostic (7.35e-2)	unprognostic (2.86e-1)	unprognostic (5.75e-2)	unprognostic (1.37e-1)	unprognostic (1.21e-1)	unprognostic (1.97e-1)	unprognostic (7.00e-3)	unprognostic (4.81e-2)	unprognostic (1.18e-2)	unprognostic (9.81e-2)	0.7	0.2	0	0.2	0.1	1.3	0.3	0	0.2	0.6	0.3			0	0.2	0	0.2	0.2	0	0.2	0	0	0	0	0.4	0.1	0		0.5	1.7	0.5	0.5	0		0.2	0.1		0.2	0.2	0.1	0.2	0.4	0.3	0.2	0.3	0.2	9.2			1.8		0.4	0.9	0.3	0.1	0	0	0	0.7	0.6	0	0	0	2.1	0	0	0.2	0.1	0	0	0	0.1	0	0	0	0	0	0.8	0	0	0.1	0.2	0	1.5	2	0	0	0	0.7	2.3	0	0	0.5	0	0.8	0.4	3	0	0	0.1	0	0	0.1	0.1	0	0.6	0	1.3	0	0.1	0	0	0	0	0	0	0.1	0	4.2	1	0	0	0	0	0	0	0	0	4.1	0.1	0	0	0	0.1	0	0.6	0.1	0	0.2	0	0	0	0	0	0.7	0	0	0	0											0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	9.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0	0	Early spermatids
GYPB	CD235b, GPB, MNS, SS	ENSG00000250361	Glycophorin B (MNS blood group)	P06028	4	143996104-144019345	Blood group antigen proteins, CD markers, Predicted intracellular proteins, Predicted membrane proteins		Blood group antigen		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in some	5	bone marrow: 37.1	Cell type enriched	Detected in some	591	Erythroid cells: 981.2	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	4	HEL: 61.4														Intracellular and membrane																									0.2	0	0.2	0.1	0.1	37.1	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.6	0.8	0.6	0.1	0.1	0.1	0.1	0.1	0	0.2	3.3	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	6.8	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.4	0	0	0	0	3.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	61.4	0	0	0	0	0	0	0	0	0	0	0	0	15	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0.4	0	3.2	0.2	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	1.7	0	0	0	0	981.2	0	0.4	0	0	0	0	1.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	Erythroid cells
REELD1		ENSG00000250673	Reeler domain containing 1		4	146214515-146230878	Predicted membrane proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level			Tissue enhanced	Detected in some		breast: 1.3;epididymis: 1.5;skin 1: 1.7	Cell type enriched	Detected in single	17	Ciliated cells: 2.7	Low cancer specificity	Detected in some							Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	87	HDLM-2: 14.6																						unprognostic (6.26e-3)	unprognostic (1.40e-1)		unprognostic (3.81e-2)	unprognostic (8.94e-2)	unprognostic (3.77e-2)	unprognostic (7.75e-2)	unprognostic (7.88e-2)	unprognostic (1.36e-1)	unprognostic (2.88e-1)	unprognostic (1.04e-2)	unprognostic (1.40e-1)	unprognostic (3.55e-6)	unprognostic (2.19e-2)	unprognostic (3.14e-1)	unprognostic (3.90e-1)	unprognostic (3.13e-2)	0.1	0		0.9		0.4	1.3		0.2	0.4	0			0	0	1.5	0	0.2	0	0			0.1	0.7	0.2	0.2			0	0.4	0		0		0.3	0		0	0	0.5	1.7	0	0		1	0	0.1			0		0.7	0		0	0	0	0	0	0.5	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.6	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0.3	0.5	0	0	0	0	0	0.2											0	0	0	0	0	0	0	0	2.7	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	Ciliated cells
AC010255.3		ENSG00000250803	Uncharacterized protein LOC100505841 		5	122129622-122183949	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level				Tissue enriched	Detected in some	14	testis: 59.7	Cell type enriched	Detected in single	63	Ciliated cells: 10.7	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		CACO-2: 3.0;GAMG: 1.3;HUVEC TERT2: 1.7;U-2197: 1.7;U-266/84: 1.3;U-87 MG: 1.8	Not detected	Not detected																					unprognostic (8.24e-2)		unprognostic (3.81e-3)	unprognostic (3.43e-2)	unprognostic (1.42e-1)		unprognostic (8.28e-2)		unprognostic (1.76e-1)				unprognostic (4.18e-1)		unprognostic (5.54e-2)		0	0	0	0	0.4	0	0	0	0	0.6	0	2.3	0	0	0.1	2.2	0	1.7	0	0	0.3		0	0	2.8	0	0	0	2.6	0	0	0.1	0	4.2	0	0	0	0	0	0	0	0	0	0	0	0	59.7	0.2	0	0.1	0	0	0.1	0	0	0	0	0	0	0.4	0	0.4	0	0	0	0	0	0	0.5	0.1	0.1	0.1	3	0	0	0.1	0.9	1.3	0	0	0	0	0	0.2	0	0.3	0	0	0	0.1	0	0	0	0	0	1.7	0.2	0	0.1	0.3	0	0	0.5	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0.8	0.1	1.7	0.1	0	1.3	0	1.8	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0	0	0	0	10.7	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	Ciliated cells
RFPL4B	RNF211	ENSG00000251258	Ret finger protein like 4B	Q6ZWI9	6	112347330-112351296	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enriched	Detected in some	5	testis: 8.0	Cell type enriched	Detected in some	8	Extravillous trophoblasts: 13.9	Group enriched	Detected in some	7	liver cancer: 0.6;testis cancer: 1.0	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		BJ hTERT+: 1.5;K-562: 3.1;RPTEC TERT1: 4.1;U-266/70: 1.7;U-266/84: 12.7									HPA059324, HPA066464	Uncertain											HPA059324: , HPA066464: 	unprognostic (4.26e-1)				unprognostic (1.45e-1)						unprognostic (6.66e-2)	unprognostic (3.78e-1)	unprognostic (2.80e-3)		unprognostic (3.73e-2)			0.2	0	0	0	0.3	0	0	0	0.4	0	0.1	0	0	0	0	0	0	0	0.2	0	0	0	0.5	0	0	0	0	0.9	0	0	0	0	1.5	0	0	0	0	0	0	0	0	0	0.1	0	0	0	8	0	0.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0.3	0	0	0.1	1.5	0	0	0	0.2	0	0.2	0.8	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	3.1	0	0	0	0	0	0	0	0	0	0	0	4.1	0	0.1	0	0.1	0	0	0	0	0	0	0.2	0.1	0.1	0	1.7	12.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0.4	0	0	0	0.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0.2	0	0	0	0	13.9	0.2	0	0	0	0.2	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0.4	0	0	0	0	1.7	1.4	0	0.3	0	0	0	Extravillous trophoblasts
SHANK3	KIAA1650, prosap2, PSAP2, SPANK-2	ENSG00000251322	SH3 and multiple ankyrin repeat domains 3		22	50674415-50733298	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level				Tissue enhanced	Detected in many		brain: 32.4	Cell type enriched	Detected in some	5	Ito cells: 90.2	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HEL: 6.4;TIME: 10.2	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA003446	Enhanced		Approved	Nucleoplasm,Plasma membrane						Nucleoplasm, Plasma membrane		HPA003446: AB_1079958	unprognostic (3.62e-1)	unprognostic (1.08e-2)	prognostic unfavorable (7.40e-4)	unprognostic (6.02e-2)	unprognostic (4.17e-1)	unprognostic (1.72e-3)	unprognostic (3.41e-2)	unprognostic (3.13e-1)	unprognostic (9.67e-2)	unprognostic (5.62e-2)	unprognostic (2.09e-2)	unprognostic (7.52e-2)	unprognostic (2.47e-2)	unprognostic (7.81e-2)	unprognostic (1.19e-1)	unprognostic (4.89e-2)	unprognostic (1.41e-1)	9.5	5.4	23.5	1.3	26.1	2.6	8.7	13	32.4	3.5	2	2.4	0.1	5.2	3.8	3.4	2.5	2.8	1.1	4.4	21.6	2.4	2.9	5.1	5.3	2.9	2.5	18.1	1.6	7.6	7.9	1	1.7	2.6	1.9	1.9	0.6	8.5	3.4	3.6	3.1	6.6	1.5	2	12.3	1.3	3.4	6.4	0.2	4.1	1.4	2.6	5.3	2.7	0	0	0	0	0	0	0	3.5	0.9	0.6	2.9	0.5	0.5	0	0.6	0	0.2	0	0.6	1.7	0	1.2	0.2	1.7	0.6	0.9	0.4	0	0	0	6.4	0.4	1.7	1.5	0.8	0.3	1.6	1.1	0.1	0.3	0.1	2	0.7	0.1	0.1	0.1	0.9	0.5	0.2	1.3	0.7	1.8	1.7	0	0.7	0.3	0.5	1.3	1.9	1.7	0	0.8	0.4	0.3	0.4	10.2	0.2	1.7	0.7	0.4	0.1	0.1	0	0.1	0.5	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	23.5	26.1	13	32.4	21.6	2.4	2.5	18.1	2.6	6.4	0	1.4	0	0	0.2	0.5	19.6	0	1.4	1.2	0	0	0	0	0	1.8	16.8	0	0	0	0	0.2	0.1	0	5.6	0.3	0	2.4	90.2	5.6	0	0	0	0	0	0	1.4	0.1	0	0.4	0.7	0	0	0.9	0.2	0.4	0.3	0	0	0	0.3	Ito cells
AC093899.2		ENSG00000251569			2	169479480-169525922	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level				Tissue enhanced	Detected in many		testis: 19.1	Cell type enriched	Detected in single	14	Ciliated cells: 1.4	Not detected	Not detected			Low region specificity	Detected in all			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in many		ASC TERT1: 9.0;HSkMC: 6.4;LHCN-M2: 9.1									HPA046125	Uncertain											HPA046125: AB_2679549																		2.4	2.4	3.7	0.9	7.8	0.5	4.8	3.1	8.6	3	2.5	4.1	2.9	0.9	5.5	5	2.3	5.8	5.1	5.5	7.8	2.7	3.6	2.1	3.2	1.1	2.4	5.8	4	2.5	5	8.5	1.6	7.7	5.7	2.5	10.5	3.1	4.5	6.7	2.3	2.2	3.5	2.5	2	2.4	19.1	2.6	0	5.5	2	2	2.4	2.4	0	0.2	0	0	0	0.6	0	0	0	2.1	1	2.9	9	0	1.9	1	1	1	0	0	0	0.3	1.9	2.2	0.1	1.4	0.1	2.4	0.3	0	0.1	0.1	0.3	0.7	1.1	0	6.4	2	2.7	0.8	2.4	3.2	1.5	0.3	0	9.1	0	0.3	0.5	0.2	0	0	0	0.3	0	1.8	0	1.3	0.4	0.3	0	2.4	0.3	0.5	0	0	1.9	0.5	0.2	0.5	0	1	0	0.2	0.3	0.2	0	0	0	0.6	0	0	0	0.3	0	0	0	0.6	0.2	0	0	0	0.2	0	0	3.7	7.8	3.1	8.6	7.8	2.7	2.4	5.8	7.7	2.6	0	0	0	0	0	0	0	0	1.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Ciliated cells
RGS21		ENSG00000253148	Regulator of G protein signaling 21	Q2M5E4	1	192316992-192367285	Predicted intracellular proteins		Signal transduction inhibitor		Evidence at transcript level	No human protein/transcript evidence	Evidence at transcript level	Evidence at transcript level		Not detected	Not detected			Cell type enriched	Detected in single	13	Early spermatids: 1.3	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in single		U-266/70: 1.1	Not detected	Not detected			Low region specificity	Detected in all			HPA052843	Uncertain											HPA052843: AB_2681971																		0	0	0.1	0	0.1	0	0	0	0.5	0.1	0			0	0	0	0	0	0	0	0.1	0	0	0	0	0	0		0	0	0	0	0		0.1	0		0	0.5	0	0	0	0	0	0	0	0.5			0		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0	0.1	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0.5	0	0	0	0	0	0	0.3	0	0	0	1.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Early spermatids
TRNP1	C1orf225, LOC388610	ENSG00000253368	TMF1-regulated nuclear protein 1	Q6NT89	1	26993707-27000898	Predicted intracellular proteins	Cell cycle, Neurogenesis, Transcription, Transcription regulation	Developmental protein, DNA-binding		Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in many		stomach 1: 81.1	Cell type enriched	Detected in many	12	Bipolar cells: 375.7	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Group enriched	Detected in some	9	intermediate monocyte: 2.8;non-classical monocyte: 1.7	Lineage enriched	Detected in single	12	monocytes: 2.8	Cell line enhanced	Detected in many		ASC TERT1: 46.9;BJ hTERT+: 44.5;EFO-21: 37.6;RPTEC TERT1: 37.5	Low region specificity	Detected in all			Low region specificity	Detected in all																unprognostic (1.41e-1)	unprognostic (7.15e-2)	unprognostic (7.70e-2)	unprognostic (1.15e-1)	unprognostic (2.88e-3)	unprognostic (6.23e-2)	prognostic unfavorable (1.90e-6)	unprognostic (3.53e-1)	unprognostic (8.39e-3)	unprognostic (1.64e-1)	unprognostic (1.90e-1)	unprognostic (9.71e-3)	prognostic unfavorable (7.72e-4)	unprognostic (1.55e-1)	unprognostic (5.56e-2)	unprognostic (1.88e-1)	unprognostic (2.55e-2)	4.1	4.3	11.3	2	11.7	0.9	8.5	12.3	22	6.3	5.3	1.8	0.5	3.7	6.8	3.7	32	7.9	20.9	11.6	9.7	10.2	9.3	2.6	5.1	2.3	10.1	9.2	3.6	13.2	12.9	5.3	5.8	18.4	5.9	2.6	9.6	6	8.1	1.6	4.2	3.7	7.8	2.8	3	81.1	2.1	1.7	0.1	2.8	2.4	16.2	9.1	9.3	0	0.2	0	2.8	0	0	0	6.3	18.7	4.6	2.9	36.2	46.9	0	32.7	44.5	3	1.4	2.5	3.1	0	37.6	30.4	1.2	6.6	2.4	13.2	3.7	0.1	1.9	0	0.4	13	26.2	0	0	26.8	28.1	1.5	28.9	2.9	2.9	0.2	0.4	0	7.2	0.9	0	0.4	6	28.7	31	1.8	0	0.5	37.5	1.9	7.7	0.5	6.3	1.3	14.9	3	0.6	0.1	15.3	1	7.5	16	1.4	0	0.1	0.1	1	0.1	1.8	0	0.1	0	0	2.8	0	0	0	0	0.2	0	0	0	0	0	1.7	0	0	0	11.3	11.7	12.3	22	9.7	10.2	10.1	9.2	18.4	1.7	17.9	1.1	0	10.1	6.5	375.7	21.9	30.6	2.7	3.4	8.7	7.9	0.1	26.6	6.9	0.4	1	0	0	27.2	0.1	1.4	4	0	0.2	0.2	7.9	11.5	1.8	1.9	0	8.9	0.8	3.3	1.8	0.5	27.5	20.3	0	2.8	0	31.8	25.8	13.3	1.4	0.5	7.8	0	0	0.2	9.5	Bipolar cells
INS	IDDM1, IDDM2	ENSG00000254647	Insulin	P01308	11	2159779-2161341	Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins, RAS pathway related proteins	Carbohydrate metabolism, Glucose metabolism	Hormone	Cancer-related genes, Diabetes mellitus, Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	193	pancreas: 514.0	Cell type enriched	Detected in some	21	Pancreatic endocrine cells: 2404.6	Cancer enriched	Detected in single	7166	pancreatic cancer: 1751.3	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	9	EFO-21: 53.7;U-2 OS: 70.4;U-698: 22.2					Region enriched	Detected in single	13	midbrain: 1.7	CAB000048, HPA004932, CAB012098, CAB053843	Enhanced				Secreted to blood			437000				CAB000048: , CAB012098: AB_300968, CAB053843: AB_620123, HPA004932: AB_1851816											unprognostic (7.61e-2)							0.4	0.1	0.1	0.1	0.1	1.1	0.1	0.1	0.7	0.1	0.3	0.1	0.1	0	0.1	0.1	0.1	0	0.1	0.1	0.1	0	1.4	0.1	0.1	0.1	0.1	0.1	0.1	514	0	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	2.6	0.1	0.1	0.1	0.1	1.1	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	53.7	0	0	0	0	0	0	1.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0	1.8	0	0	0	0	0	0	0	0	0	70.4	0	5.4	0	2.4	22.2	0	1.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.8	0	0	0	0	23.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	117.2	0	0	2404.6	0	0	0	0	0	0	0	0	0	0	0	0	0	Pancreatic endocrine cells
IGLL5		ENSG00000254709	Immunoglobulin lambda like polypeptide 5	B9A064	22	22887780-22896107	Predicted intracellular proteins, Predicted secreted proteins				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		blood: 87.9;lymphoid tissue: 102.9	Cell type enriched	Detected in some	923	Melanocytes: 89092.5	Low cancer specificity	Detected in all			Low region specificity	Detected in many			Group enriched	Detected in some	230	memory B-cell: 87.9;naive B-cell: 72.8	Lineage enriched	Detected in single	252	B-cells: 87.9	Group enriched	Detected in some	7	Daudi: 103.5;U-266/70: 74.1;U-698: 70.4														Secreted to blood				120000000000				prognostic favorable (6.10e-4)	unprognostic (7.64e-3)	unprognostic (4.33e-2)	unprognostic (1.51e-3)	unprognostic (2.82e-2)	prognostic favorable (3.41e-5)	unprognostic (1.76e-2)	unprognostic (2.18e-1)	unprognostic (7.28e-2)	unprognostic (1.87e-2)	unprognostic (1.01e-1)	unprognostic (3.73e-1)	prognostic unfavorable (5.94e-8)	unprognostic (1.85e-1)	unprognostic (4.63e-1)	unprognostic (8.52e-2)	unprognostic (6.50e-2)	3.5	1.8	1.3	82.6	1.5	6.5	12.3	1.3	1.5	3.3	37.7	1.4	1.3	39	1.5	1.7	7.5	4.3	5.8	1.3	1.3	0.3	4.6	3.6	10.8	22.8	1.5	1.3	2.1	1.3	0	1.3	1.5	1.7	2.1	23.3	3.3	42.9	2.8	1.5	0.6	25.2	1.3	1.3	102.9	27.7	3.1	1.3	5.8	5.8	2.9	69.8	38.2	2.6	87.9	0.3	0.1	0	0	0	10.7	0.1	0	0	0	0	0	0.1	0	0	0	0	0	0	103.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0.7	0.1	0	0	0.1	0.2	0	0	0	0	0	0.1	0.2	0	0.3	0	0	74.1	12	70.4	0	0	0	0	0	0	0	0	0	87.9	0	0	0.1	72.8	0	0	0.1	0	0	0.3	0	10.7	1.3	1.5	1.3	1.5	1.3	0.3	1.5	1.3	1.7	1.3	3	54.3	41.7	0	96.5	0	0	2.5	0	0	0	0	0	0	0	0.6	0	0	23.3	0	0	1	0	10.5	0	0	0	1.2	1.3	0.3	2.7	0	1.6	89092.5	0	0	0	0	0	0	0	0	0	0	0	0	81.8	0	0.9	0	0	Melanocytes
KRTAP5-9	KRN1, KRTAP5-1, KRTAP5.9	ENSG00000254997	Keratin associated protein 5-9	P26371	11	71548418-71549553	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in some		epididymis: 5.1;testis: 4.6;urinary bladder: 4.6	Cell type enriched	Detected in single	5	Late spermatids: 4.9	Cancer enhanced	Detected in some		urothelial cancer: 2.0					Cell type enriched	Detected in single	11	myeloid DC: 1.0	Lineage enriched	Detected in single	11	dendritic cells: 1.0	Cell line enriched	Detected in single	20	RT4: 14.4																						unprognostic (1.72e-3)	unprognostic (2.20e-1)	unprognostic (2.22e-2)	unprognostic (2.16e-1)	unprognostic (4.13e-1)	unprognostic (6.53e-2)	unprognostic (8.10e-2)	unprognostic (2.09e-1)	unprognostic (1.06e-1)	unprognostic (7.76e-2)	unprognostic (7.23e-2)	unprognostic (2.56e-1)	unprognostic (3.29e-1)	unprognostic (2.05e-2)	unprognostic (2.01e-1)	unprognostic (4.82e-4)	prognostic favorable (9.25e-4)	0.4	0.4	1.1	0.1	2.8	0.5	0.5	1.3	1.3	0.1	0.9			0.3	0.1	5.1	0.5	0.8	0.9	0.1	1	2	0.4	0.8	0.3	0.3	0.8		0.2	0	1.5	1.1	0.2		0.9	0.7		0.8	1.4	0.4	1.4	0.7	0.1	1	0.7	0.4	4.6			0.4		0.4	4.6	0.1	0	1	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0.3	0	0.1	0.4	0.1	0.1	0	0	0	0	0.3	0	0	0	0.1	0.1	0.2	0.2	0.7	0	0	0.1	0	0	0.3	0	0.2	0.1	0.6	0	0.4	0.1	0.5	0	0.1	0	0	0	14.4	0	0.1	0.2	0	0	0	0	0.4	0	0.1	0.1	0.1	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0											0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4.9	0	0	0	0	0	0.2	0	0	0	0.1	0.3	0	0	0	0	0	0	0	0	0	Late spermatids
UBTFL1	C11orf27	ENSG00000255009	Upstream binding transcription factor, RNA polymerase I-like 1	P0CB47	11	90085950-90087131	Predicted intracellular proteins, Transcription factors		Developmental protein, DNA-binding		Evidence at transcript level	Evidence at transcript level	No human protein/transcript evidence	No human protein/transcript evidence		Tissue enhanced	Detected in single		blood: 2.5	Cell type enriched	Detected in single	17	Distal tubular cells: 1.7	Not detected	Not detected							Cell type enriched	Detected in single	25	plasmacytoid DC: 2.5	Lineage enriched	Detected in single	25	dendritic cells: 2.5	Not detected	Not detected																																									0	0		0		0	0		0.4	0	0			0	0	0	0	0	0	0.2			0	0	0	0.5			0	0	0		0		0	0.1		0	0	0	0	0	0		0	0	0.2			0.1		0.6	0.7		0	2.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.5	0	0											0	0	0	0	0	0	0	0	0	0	0	0	0	1.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Distal tubular cells
EID3	FLJ25832, NSE4B, NSMCE4B	ENSG00000255150	EP300 interacting inhibitor of differentiation 3	Q8N140	12	104303739-104305205	Predicted intracellular proteins	DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation	Repressor		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	7	testis: 69.1	Cell type enriched	Detected in many	6	Spermatocytes: 291.8	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Group enriched	Detected in many	4	B-cells: 2.9;NK-cells: 6.6;T-cells: 9.5	Cell line enhanced	Detected in many		A549: 10.2;BJ: 9.5;BJ hTERT+: 7.8;BJ hTERT+ SV40 Large T+ RasG12V: 7.8;HeLa: 8.6	Low region specificity	Detected in single							HPA059367	Uncertain		Supported	Nucleoplasm,Nucleoli						Nucleoplasm, Nucleoli		HPA059367: AB_2683992	unprognostic (1.25e-1)	unprognostic (5.41e-3)	unprognostic (5.82e-2)	unprognostic (8.21e-2)	prognostic unfavorable (1.14e-4)	unprognostic (8.02e-2)	unprognostic (5.88e-5)	unprognostic (1.06e-1)	unprognostic (1.31e-1)	unprognostic (1.66e-2)	unprognostic (5.38e-3)	unprognostic (1.18e-1)	prognostic unfavorable (5.96e-5)	unprognostic (8.70e-2)	unprognostic (3.54e-1)	unprognostic (2.04e-3)	unprognostic (2.87e-2)	1.7	1.7	2	2.9	2.7	3	1.7	4	2.6	1.6	1.8	1.5	0.2	0.6	2.1	1.9	1.3	1.8	1.8	1.2	1.9	1.9	1.2	0.9	1.8	3.7	1.2	2.3	3.4	1.7	0.9	5.3	1.1	2.2	2.7	0.6	1.7	1.3	4.1	1.5	1.6	1.6	1.6	1.2	1.9	1.4	69.1	1.6	2.3	1	0.4	2.5	1.5	1.3	2.9	0.5	0.7	1.5	6.6	9.5	2.6	0.3	10.2	0.3	1	2.3	2.4	2	9.5	7.8	4.6	7.8	0.2	0.5	0.1	0.1	2.1	2.1	0.2	0.3	0.8	6.8	0.6	0.1	1.9	8.6	1.5	3.4	0.2	0.5	3.2	0	2.9	0.6	0.4	0.7	0.4	0.1	0.6	2.8	0.1	3.4	1.4	0.5	0.2	2	0.3	0	0.1	2.5	0.3	0.1	0	6.3	0.4	0.2	0.2	0	0	1.4	0.1	0.3	2.3	0.4	0.5	0.2	0.1	0.2	0	1	0	0.3	0.5	5.2	1.5	5.5	2.7	6.6	6.2	0.3	2.9	9.5	5.7	0.7	6.6	0.9	0.5	7.6	2.6	2	2.7	4	2.6	1.9	1.9	1.2	2.3	2.2	1.6	0	5.9	2.9	50.8	11.8	3.4	1.1	0	4	1.2	1.8	25.5	2	0	2.4	44.2	5.2	1.3	0	1.2	1.1	8	25.2	1.1	1.7	1.7	11.1	0	6.2	4	12.9	8.1	6.1	1.7	5.4	0	7.6	5	0.2	4.2	1	17.5	6.5	8.2	291.8	33.6	6.8	2.1	10.2	0.7	39.4	Spermatocytes
CCDC166		ENSG00000255181	Coiled-coil domain containing 166	P0CW27	8	143706694-143708109	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	No human protein/transcript evidence	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	33	testis: 7.8	Cell type enriched	Detected in some	4	Early spermatids: 18.4	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Low region specificity	Detected in all							HPA025058	Uncertain											HPA025058: AB_2671717	unprognostic (2.65e-1)	unprognostic (3.64e-1)								unprognostic (6.18e-2)				unprognostic (4.97e-1)	unprognostic (1.67e-1)			0	0	0.1	0	0	0	0	0	0.2	0.1	0			0	0	0	0	0	0	0	0	0	0	0	0	0	0		0	0	0	0	0		0	0		0	0	0	0.2	0	0	0	0	0	7.8			0		0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0.4	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0.8	0	0.4	0	0.4	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0.4	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	18.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0.7	1.2	0	0	0	0	0	Early spermatids
FXYD6-FXYD2		ENSG00000255245	FXYD6-FXYD2 readthrough		11	117820163-117876667	Predicted membrane proteins				Evidence at transcript level	Evidence at transcript level				Low tissue specificity	Detected in many			Cell type enriched	Detected in some	8	Distal tubular cells: 82.9	Not detected	Not detected			Low region specificity	Detected in all			Cell type enhanced	Detected in some		memory CD8 T-cell: 1.3	Low lineage specificity	Detected in many			Group enriched	Detected in some	6	MOLT-4: 9.8;RPTEC TERT1: 11.2									HPA068838, HPA075209	Approved		Approved	Nuclear membrane,Vesicles						Nuclear membrane, Vesicles		HPA068838: AB_2686047, HPA075209: AB_2732285																		2.8	2.7	7.4	1.8	12.4	1.8	2.7	4.2	22.2	6	4.5	7.9	1.4	1.8	11.4	5.2	2.5	3.9	6.6	3	4.8	2.9	23	2.8	3.1	2.1	2.5	16.5	10.2	9.6	2.4	4.2	2.5	4.6	9.4	2	2.2	19.5	2.2	2.9	2.5	3	13.7	2.5	4.2	2.9	3.6	4.3	0	2.9	0.5	2.3	10.1	2.8	0	0.5	0	1.1	0.8	1.3	0.7	0	0.4	0.6	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	1.6	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0	9.8	0	0.7	0	0	0	0.5	0	11.2	0	0.6	1.2	0	0	0.1	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0	1.1	0	0	0	0	0	0.1	1.3	0.3	0	0.4	0.3	0	0.8	0	0.5	0	0.7	7.4	12.4	4.2	22.2	4.8	2.9	2.5	16.5	4.6	4.3	0	0	0	0	0	0	0	10.2	0	0	10.4	0	0	82.9	0.5	0.1	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	1.8	0.9	0	0	0	0	0	0.3	0	0.7	9	0	6.5	0	0	0	0.1	0	0	0	0	Distal tubular cells
SMIM35	TMPRSS4-AS1	ENSG00000255274	Small integral membrane protein 35		11	118003634-118088299	Predicted membrane proteins				Evidence at transcript level	Evidence at transcript level	No human protein/transcript evidence			Group enriched	Detected in some	7	blood: 4.6;bone marrow: 3.1;kidney: 3.4;lymphoid tissue: 1.7	Cell type enriched	Detected in single	18	Collecting duct cells: 1.8	Not detected	Not detected							Cell type enhanced	Detected in some		T-reg: 4.6	Low lineage specificity	Detected in many			Group enriched	Detected in some	5	Karpas-707: 14.6;RPMI-8226: 9.1	Group enriched	Detected in some	5	basal ganglia: 1.1;olfactory region: 4.3																			unprognostic (8.83e-2)	unprognostic (3.42e-2)	unprognostic (2.64e-1)		unprognostic (1.58e-1)		unprognostic (3.04e-4)		unprognostic (2.92e-1)	unprognostic (1.09e-1)			unprognostic (1.64e-1)			unprognostic (1.88e-1)	0	0		1.2		3.1	0.4		0.4	0	0			0	0	0	0	0	0.4	0			3.4	0.1	0	1.7			0	0	0		0.2		0	0		0	0	0	0	0	0		1.4	0	0			0		1.5	0		1.7	0.8	0.1	0.5	1.2	4.6	0.4	0	0	0	0	0	0.1	0	0	0	0	0	0.1	0.1	2.4	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.6	0	0	0	1	0	0.2	0	0	0	9.1	0	0.4	2	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0.5	0	0.4	0	0	0.1	0	0.9	0	0	1.7	0.7	1.1	0.7	0.4	0	0.6	0.1	1.2	0.5	0.8	4.6	0.4											0	0	0	0	0	0	0	0	0	0	1.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	Collecting duct cells
AP001458.2		ENSG00000255432			11	62649694-62665178	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level				Low tissue specificity	Detected in all			Cell type enriched	Detected in single	4	Ciliated cells: 1.4	Not detected	Not detected			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Cell line enhanced	Detected in some		JURKAT: 2.1;K-562: 2.0;REH: 2.6;U-266/84: 2.7;WM-115: 3.4																																							6.8	4.4	4.9	3.4	5.1	3.6	3.1	4.1	6.8	2.7	4.7	3	2.6	2.7	3.2	2.7	4	2.7	3.1	6.4	4.2	4.4	6.3	11.5	3.4	3.9	3.8	2.8	4.4	3.5	2.7	3.1	4.2	3.8	3.8	2.7	1.6	3.5	3.2	13.9	3	7	4	3.5	6.3	2.9	3.4	2.6	7.7	4.7	3.7	5.2	3.3	2.7	2.9	2.3	3.3	2.4	2.4	3.4	1	0.6	0	0	0	0	0	0	0	0	0	1	0	0	0	1.5	0	0.4	0	1.4	1.4	0.7	0	0	0	0	0	0	0	0	1.2	0	0	0	0.5	0	2.1	2	0	0	0	0	0	0	0	0	2.6	0	0	0	0	0.6	0.5	0	0	0	0	0.9	0	0	0	0.5	0	1	0	2.7	0.7	0	0	3.4	3.3	1.4	2.6	1.1	2.4	1.8	2.7	1.8	2.1	2.3	2.9	1.5	2.4	0.6	2.4	1.3	1.6	3.4	1	4.9	5.1	4.1	5.5	4.2	4.4	3.8	2.8	3.8	2.6	0	0.3	0	0	0	0	0	0	1.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Ciliated cells
MTRNR2L8		ENSG00000255823	MT-RNR2-like 8	P0CJ75	11	10507887-10509189	Predicted intracellular proteins, Predicted secreted proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in all		blood: 329.5;skeletal muscle: 107.4	Cell type enriched	Detected in many	28	Cardiomyocytes: 28256.5	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Group enriched	Detected in all	4	basophil: 89.7;eosinophil: 97.5;neutrophil: 329.5	Lineage enriched	Detected in all	8	granulocytes: 329.5	Cell line enhanced	Detected in many		HeLa: 192.6;Hep G2: 140.8														Secreted to blood								unprognostic (6.19e-2)	unprognostic (1.43e-1)	unprognostic (6.66e-2)	unprognostic (3.26e-2)	unprognostic (3.71e-2)	unprognostic (3.52e-2)	unprognostic (2.81e-2)	unprognostic (3.45e-2)	unprognostic (5.28e-2)	unprognostic (1.41e-1)	unprognostic (4.87e-2)	unprognostic (1.90e-1)	unprognostic (4.59e-2)	unprognostic (4.59e-2)	unprognostic (3.45e-2)	unprognostic (1.12e-1)	unprognostic (1.96e-2)	35.7	33.4	22.5	4.2	22.8	6.6	4.3	7.3	17.5	6.5	15.6	3.6	19.3	10.2	3.8	6.1	12.7	4.6	14.1	73.2	20.1	14.7	30.7	21.7	6.3	4	22	7.3	7	10.9	1.9	6.9	7	9	7.7	15.5	3.3	12.3	14.8	107.4	12	12.9	8.8	16.1	9.7	10.2	28.4	6.5	2.2	4.4	32.3	4.3	10	5.8	35.3	24.5	329.5	42.7	16.6	19	36.2	30.8	55.6	21.8	97.9	21.9	12	30.1	29.2	4.3	4.1	5.2	33.8	47.5	43.4	34.3	6.3	3.2	87.4	0.6	6.6	4.4	18.4	48.1	40.4	192.6	140.8	8.5	7.4	39	21.3	10.4	3.3	10	43.4	4	24.4	34.1	22.6	12.6	19.7	11.3	55.8	7.2	14.6	15.5	19.5	18.7	20.8	24.9	31.3	12.3	28	14.6	21.4	44.5	21.4	25.1	56.1	26.1	28.8	25.6	30.4	11.4	12.7	6	23	18.9	66.2	6.9	89.7	42.7	97.5	11.6	21	14.3	33.7	14.8	13	16.3	35.3	19	17.5	329.5	16.6	20.1	24.5	14.9	36.2	22.5	22.8	7.3	16.7	20.1	14.7	22	7.3	9	6.5	771.2	760.8	62	993.3	419	0	28256.5	137.6	867.3	881.5	54.1	0	5.8	61.3	0	12.2	397.4	0	140.2	0	5	628.6	627.3	501.1	277.9	11	0	0	103.2	108.7	41.9	60.7	803.5	686.7	0	0.3	0	0.1	0	42.1	73.2	0	64.7	701.4	22.4	27.9	427.3	9.4	68.2	0.6	948	Cardiomyocytes
AC073610.2		ENSG00000255863			12	48921963-48939663	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level				Tissue enhanced	Detected in some		blood: 1.0;skeletal muscle: 1.5	Cell type enriched	Detected in single	14	Alveolar cells type 2: 1.4	Not detected	Not detected							Low cell type specificity	Detected in single			Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		BJ hTERT+: 2.5;MOLT-4: 1.8;NB-4: 1.1																																							0	0	0	0	0.6	0	0	0	0.1	0	0			0	0	0	0	0	0	0	0.4	0	0	0	0	0	0		0	0	0	0	0		0	0		0	0	1.5	0	0	0	0	0	0	0			0.8		0	0	0	0	0.4	0.7	0.8	0.3	1	0.8	0	0	0	0	0	0	0	0	2.5	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.8	1.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.3	0	0	0.8	0	0	0	0.3	0.4	0	0.6	0.5	0.7	0.3	0.7	0	1	0.8											0	1.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Alveolar cells type 2
CYP2A6	CPA6, CYP2A, CYP2A3	ENSG00000255974	Cytochrome P450 family 2 subfamily A member 6	P11509	19	40843538-40850447	Plasma proteins, Predicted intracellular proteins		Monooxygenase, Oxidoreductase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	165	liver: 199.5	Cell type enriched	Detected in some	13	Hepatocytes: 161.7	Cancer enriched	Detected in some	12	liver cancer: 281.2	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		Daudi: 1.3;HL-60: 2.9;K-562: 1.4;RH-30: 4.4;SiHa: 2.2;TIME: 1.0;U-698: 1.0;U-937: 1.0									HPA046713, HPA047262	Supported				Intracellular and membrane							HPA046713: AB_2679767, HPA047262: AB_2680005	unprognostic (5.40e-2)	unprognostic (2.36e-2)	unprognostic (1.21e-1)	unprognostic (4.10e-1)	unprognostic (5.05e-2)	unprognostic (2.64e-2)	prognostic favorable (5.38e-5)	unprognostic (4.98e-3)	unprognostic (4.86e-2)	unprognostic (6.23e-2)	unprognostic (5.20e-2)	unprognostic (1.95e-1)	unprognostic (2.25e-2)	unprognostic (8.83e-3)	unprognostic (2.46e-1)	unprognostic (3.07e-2)	unprognostic (2.55e-1)	0	0	0	0	0	0	1.2	0	0.1	0	0	0	0	0	0.1	0	0	0	0.1	0	0	0	0	199.5	0.2	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0.1	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.3	0	0	0	0.1	0	0	0	0	0	0.2	0	0	0	2.9	0	0	0	0	0	0	0	0	1.4	0	0	0.8	0	0	0	0	0	0	4.4	0	0	0	0	0	2.2	0	0	0	0	0	1	0	0	0	0	0	0	1	0	1	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0.1	0	0	0	0	0.2	0	0	0	5.1	5.3	1.2	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	161.7	0	0	0	12.9	7.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	Hepatocytes
MTRNR2L10		ENSG00000256045	MT-RNR2-like 10	P0CJ77	X	55181391-55182920	Predicted intracellular proteins, Predicted secreted proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in many		blood: 60.2	Cell type enriched	Detected in many	21	Cardiomyocytes: 8067.8	Low cancer specificity	Detected in single			Low region specificity	Detected in many			Group enriched	Detected in all	5	basophil: 16.9;eosinophil: 19.1;neutrophil: 60.2	Lineage enriched	Detected in all	9	granulocytes: 60.2	Group enriched	Detected in many	4	A549: 22.8;HeLa: 83.8;Hep G2: 71.6														Secreted to blood								unprognostic (4.42e-1)	unprognostic (3.04e-2)	unprognostic (1.15e-1)	unprognostic (5.10e-4)	unprognostic (1.59e-1)	unprognostic (1.27e-1)	unprognostic (1.71e-2)	unprognostic (8.42e-2)	unprognostic (1.58e-2)	unprognostic (9.01e-2)	unprognostic (5.26e-2)	unprognostic (1.22e-1)	unprognostic (3.01e-1)	unprognostic (6.28e-2)	unprognostic (2.97e-2)	unprognostic (4.99e-2)	unprognostic (3.97e-4)	4.2	3.8	3.2	0.6	4.6	0	1	1.3	4.4	1.2	4.5	1.2	0.6	0.6	1	4.7	2.2	1.5	1.5	19.8	4.1	2.2	14.3	8.5	2	5.1	2.6	0.6	1.2	2.4	0	2.5	1	2.7	1.1	8.4	0.6	3	0.6	16.9	1.1	1	2.6	2.1	1	1.1	3.7	1	0.6	1	1.6	1.7	1	1	6.1	3.9	60.2	6.9	3.5	3.4	7.4	1.3	22.8	0.3	6.5	0.5	0.3	1.6	2	0.1	0.1	0	1.4	3.3	3.1	0.4	0.1	0.2	4.8	0	0.1	0	0.9	4.7	1.5	83.8	71.6	0.1	0.5	0.8	0.8	0.3	0	0.2	5.6	0	2.4	2.7	1.8	0.2	8.4	0.4	3.6	0.1	0.1	1.8	1.2	1.3	1.4	0.5	13.9	0.3	1.3	0.6	0.5	2.2	3.2	1.9	2.7	3.3	2.4	0.5	0.8	0.2	0.6	0.3	0.2	1.5	0.6	0.5	16.9	6.9	19.1	1.5	3.8	1.8	5.8	2.4	2	3.2	6.1	3.1	3.4	60.2	3.5	3.5	3.9	2.4	7.4	3.2	4.6	1.3	4.4	4.1	2.2	2.6	0.6	2.7	1	0	0	8	376.7	7.2	0	8067.8	0	0	0	40.1	0	0.2	71.3	0	0.2	2.2	0	0	0	0.2	13.1	232.2	0	4.9	0.5	0	0	1.8	3.2	0.4	0.6	10.6	15.1	0	0	0	0	0	1.1	4.3	0	0	22.6	0.5	0.7	8	0.2	0	0	338.2	Cardiomyocytes
DNAAF4	CILD25, DYX1C1, EKN1, FLJ37882	ENSG00000256061	Dynein axonemal assembly factor 4	Q8WXU2	15	55410525-55508234	Disease related genes, Predicted intracellular proteins	Neurogenesis		Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		pituitary gland: 26.6	Cell type enriched	Detected in some	7	Ciliated cells: 187.4	Low cancer specificity	Detected in many			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		RPTEC TERT1: 17.1					Low region specificity	Detected in all			HPA051048	Uncertain		Supported	Plasma membrane,Cytosol						Plasma membrane, Cytosol		HPA051048: AB_2681325	unprognostic (5.97e-4)	unprognostic (3.60e-2)	unprognostic (1.69e-1)	unprognostic (7.45e-4)	unprognostic (1.74e-1)	unprognostic (5.30e-3)	unprognostic (4.05e-2)	unprognostic (3.08e-2)	unprognostic (8.24e-2)	unprognostic (2.91e-1)	unprognostic (9.47e-2)	unprognostic (1.75e-1)	unprognostic (5.29e-2)	unprognostic (3.85e-2)	unprognostic (3.06e-2)	unprognostic (1.34e-1)	unprognostic (1.84e-1)	1.8	3	11.4	1.8	14.7	1.6	4.9	1.8	8	4.3	2.1	3.2	5.9	1.1	7	15.3	1.8	15.7	3.4	1.6	9.2	7.8	7.2	1	6.2	1.5	4.2	8.9	4.8	3.5	13.6	26.6	1.2	9.1	3.2	1.5	6.9	2.4	3.2	1.3	2.4	1.3	3.1	3.7	2	1.7	14.6	4.5	0.1	14.3	0.9	1.3	2.8	2	2.9	4.2	4.3	1.8	0.7	1.1	0.4	6.5	4.4	4.7	10.1	1.9	3.3	1.5	0.9	2.4	3.1	3.6	0.9	2.6	0.5	4.2	2	5	1.8	1.8	2.6	3.7	2	2.1	2.3	2.8	1.5	1.8	5	4.1	2	5.5	7.5	2.8	4.9	7	2.1	0.7	0.3	4.6	2.3	0.9	4.3	2.6	10.1	3.6	0.8	2.3	0.8	17.1	2.3	4.8	10.5	4.3	1.1	5.8	4.4	6	1.2	2.3	5	2.5	4.1	4.8	1.8	4.8	1.4	8.2	1	1.1	0	1.8	1.3	0.6	1.2	0.4	2.9	0.9	0.7	1.2	2.6	1.1	0.8	4.3	0.7	1.2	4.2	0.9	0.4	11.4	14.7	1.8	8	9.2	7.8	4.2	8.9	9.1	4.5	11.9	15.9	0	0	0	0	0	0	187.4	28.4	12.2	0	1.6	5	11.3	0	0	0	0	4.4	1.1	0	0	2.3	0	18.2	0	0	0	0	0	0	0.6	0	0	0	0	3.9	0	0	19.5	0	0	0	0	0	0	0.5	0	0	0	Ciliated cells
SMLR1		ENSG00000256162	Small leucine rich protein 1	H3BR10	6	130827406-130837135	Predicted membrane proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	21	intestine: 33.8;liver: 67.3	Cell type enriched	Detected in some	13	Hepatocytes: 193.4	Cancer enriched	Detected in some	20	liver cancer: 16.1	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	12	Hep G2: 42.5					Low region specificity	Detected in all			HPA066060	Uncertain											HPA066060: AB_2685607	unprognostic (1.73e-1)		unprognostic (7.37e-3)	unprognostic (1.43e-1)	unprognostic (1.32e-2)		unprognostic (2.35e-1)			unprognostic (1.31e-1)	unprognostic (1.50e-1)		unprognostic (6.43e-3)	unprognostic (2.68e-3)	unprognostic (3.29e-1)			0.1	0.3	0.1	0	0.1	0	0	0	0.1	0.1	14	0	0	7.8	0	0.2	0	0.1	0.1	0.1	0.1	0.1	2.3	67.3	0.1	0	0.1	0	0.2	1	0	0	0	0	0	0	0	0	0	0	0	33.8	0	0.1	0.1	0.1	0.8	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.4	0	0	0	0	0	0	0	0	0	0	0	0	0	42.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0.1	0	0.1	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0	0	10.2	0	0	1.8	0	0	0	0	0	0	0	0	0	0	0	0	0	193.4	0.1	0	0	1.8	3.2	0	0	0	0	0	0	0.3	0.5	0	0	15.3	1.3	0	0	0	0	0	0.1	0	0	0	Hepatocytes
MTRNR2L3		ENSG00000256222	MT-RNR2-like 3	P0CJ70	20	57358442-57359980	Predicted intracellular proteins, Predicted secreted proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in many		skeletal muscle: 13.3	Cell type enriched	Detected in many	94	Cardiomyocytes: 2712.0	Not detected	Not detected			Low region specificity	Detected in many			Cell type enhanced	Detected in some		neutrophil: 3.7	Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		HeLa: 5.0;Hep G2: 1.6														Secreted - unknown location								unprognostic (1.55e-4)	unprognostic (2.65e-1)	unprognostic (2.59e-1)	unprognostic (8.34e-2)	unprognostic (2.64e-1)	unprognostic (1.80e-2)	unprognostic (9.44e-6)	unprognostic (2.56e-1)	unprognostic (6.68e-2)	unprognostic (5.35e-3)	unprognostic (1.52e-3)	unprognostic (7.52e-2)	unprognostic (5.36e-2)	unprognostic (4.37e-2)	unprognostic (2.44e-1)	unprognostic (1.18e-1)	unprognostic (2.94e-3)	0.8	1	2.9	0.3	2.4	2.4	0.5	1	3.6	0.7	0.9	0	2.5	0.6	0.5	1.4	0.7	0.5	1	1.3	2.5	0.7	1.2	1.1	0.4	0.5	2.1	2.7	0.8	1.2	0.2	0.5	0.3	2.4	0.5	0.9	0	2.4	1.1	13.3	1.1	0.5	0.5	1.7	0.4	0.9	1.2	2.7	0	0.6	0	0.3	0.3	0.6	1	0.8	3.7	0.7	0.1	1.3	0.4	0.3	0	0.2	0.9	0	0	0.1	0.3	0.1	0	0	0.2	0.3	0	0.1	0.2	0.2	0.4	0	0	0	0	0	0.2	5	1.6	0	0	0.3	0	0.3	0	0	0.5	0	0.6	0.1	0.2	0.1	0.5	0.3	0.6	0.2	0	0.2	0.4	0.1	0.2	0	0.1	0.4	0.1	0.2	0.2	0.6	0.2	0.3	0.5	0	0.4	0.1	0.1	0.1	0	0.1	0	0.1	0.3	0.1	0.7	0.7	1.1	0.8	0.2	0.6	0.4	0.5	0.5	0.8	1	1.3	0.5	3.7	0.1	0.6	0.2	0.7	0.4	2.9	2.4	1	3.6	2.5	0.7	2.1	2.7	2.4	2.7	0	0	0.9	28.7	2.9	0	2712	2.5	0	0	0	0	0.4	1.7	0	0	1.3	0	0	0	0.3	5.1	15	0	2.4	0.6	0	0	1.8	1.6	0.4	1.4	0.4	6.8	0	0	0	0	0	0.4	1.4	0	0	8.5	0.2	0.8	2.8	0.5	0	0	16.2	Cardiomyocytes
HMBS	PBGD, PORC, UPS	ENSG00000256269	Hydroxymethylbilane synthase	P08397	11	119084866-119093549	Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins	Heme biosynthesis, Porphyrin biosynthesis	Transferase	Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in all		bone marrow: 75.2	Cell type enriched	Detected in many	16	Erythroid cells: 794.3	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low cell line specificity	Detected in all			Low region specificity	Detected in all			Low region specificity	Detected in all			HPA006114, HPA050659	Supported		Approved	Lipid droplets					28000000	Lipid droplets		HPA006114: AB_1079067, HPA050659: AB_2681206	unprognostic (6.24e-2)	unprognostic (9.10e-3)	unprognostic (1.42e-2)	unprognostic (4.98e-2)	unprognostic (1.04e-1)	unprognostic (1.30e-1)	unprognostic (2.29e-3)	unprognostic (2.81e-1)	unprognostic (2.18e-1)	unprognostic (1.13e-2)	unprognostic (6.83e-2)	unprognostic (5.06e-2)	unprognostic (2.90e-3)	unprognostic (3.91e-3)	unprognostic (9.53e-2)	unprognostic (1.32e-1)	unprognostic (6.11e-2)	5.5	11	5.3	6.2	9.3	75.2	8.6	5.2	8	5.5	8.3	6	6	7.9	6.9	7.9	9.4	5.5	6.4	11.5	5.9	5.5	9.9	22.2	5.8	14.5	8.8	4.5	3.7	21.2	7.9	5.9	9.7	8.4	5.5	9.2	4.1	10.1	7.2	17.4	6	7.9	6.8	9.7	10.4	7.1	7.4	7.5	6	8.4	13	9.3	5.7	4.8	7.7	19.1	12	14	3.8	7.4	9.4	9.2	14.1	6.8	12	5.4	6.8	10.2	7.4	8.3	10.9	9.4	17.5	14.7	14.3	16.6	9.4	10.3	13.2	10.1	14.4	7	9.8	10.4	23.6	5.7	12.8	10.1	8.8	7.7	7.4	9.2	17.2	13.2	4.8	5	13.5	34.9	6.4	8.6	37.2	8.5	17	7.6	17.1	9	9.9	6.7	14	11	8.5	7.5	10.2	5.9	9.3	6.5	5.1	15.9	12.2	4.7	8.3	6.3	8.1	8.6	3.5	4.1	8.5	5.5	11.6	9.8	12	14	1.4	5.1	12.2	6.7	7.7	4.8	5.7	19.1	7.2	7.4	5.6	0.4	3.8	7.3	12.3	4.9	9.4	5.3	9.3	5.2	8	5.9	5.5	8.8	4.5	8.4	7.5	8.9	7	9.3	7.6	7	4.7	12.6	7.6	10.7	4.5	10.4	25.5	50.1	16.6	18.3	1.2	4.9	8.5	794.3	27	50.5	8.4	10.8	2.3	20.2	25.6	9.5	12.7	6.7	10.8	1.8	5.5	10.1	13.5	15.4	15.5	5.7	19.8	8.6	8.1	18.1	24.3	0	8.2	1.1	24.4	7	19.5	4.1	27.6	5.9	Erythroid cells
AP002748.4		ENSG00000256349			11	66509079-66533613	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level				Tissue enhanced	Detected in some		pancreas: 3.4	Cell type enriched	Detected in single	14	Ciliated cells: 1.4	Not detected	Not detected							Low cell type specificity	Detected in single			Low lineage specificity	Detected in single			Group enriched	Detected in some	6	NTERA-2: 16.3;THP-1: 4.1									HPA058283	Uncertain		Uncertain	Midbody						Midbody		HPA058283: AB_2683667																		0.2	0.9	0	0	0.6	0	0.3	0.7	0.2	0.5	0.3			0	1	0	0.1	0.3	0.5	0	0.7	0.3	0.7	1	0.3	1.4	0.2		0.3	3.4	0	0.2	0.1		0.3	0.1		0.4	0.2	0.9	0	0.3	0.7	0.3	0.5	0.4	0			0.5		0.4	0.7	0.1	0	0.7	0	1.2	0.6	0.8	1	0.9	0	0.6	0	0	0	0.5	0.5	0.5	0	0	0	0.2	0.3	0.6	0	0.3	0	0	0	0	0.7	0.3	0	0	0.7	0	0.3	1.2	0	0	0.3	1.7	0.2	0	1.8	0.2	0.8	0	0.6	0.2	0.5	16.3	0.9	0	0.9	0	0	0.3	0.8	0.3	0	0.3	0.4	0.6	0.2	1.4	4.1	0	0.7	0.1	0	0.1	0	0.2	0.7	0	0.2	0.4	0	0.2	0	0.2	1.2	0.7	0	0.3	0.5	0.7	0	0.3	0	0	0.6	0.3	0.5	0.8	1											0	0	0	0	0	0	0	0	1.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Ciliated cells
TAS2R31	T2R31, T2R53, TAS2R44	ENSG00000256436	Taste 2 receptor member 31	P59538	12	11030387-11031407	G-protein coupled receptors, Predicted membrane proteins	Sensory transduction, Taste	G-protein coupled receptor, Receptor, Transducer		Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Low tissue specificity	Detected in some			Cell type enriched	Detected in single	5	Cone photoreceptor cells: 3.9	Low cancer specificity	Detected in single							Cell type enhanced	Detected in single		plasmacytoid DC: 1.5	Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		hTERT-HME1: 3.9;SuSa: 1.7																						unprognostic (2.23e-2)	unprognostic (3.80e-1)	unprognostic (2.85e-2)	unprognostic (4.70e-3)	unprognostic (2.16e-1)	unprognostic (9.07e-2)	unprognostic (3.33e-1)	unprognostic (2.77e-1)	unprognostic (2.77e-1)	unprognostic (1.60e-2)	unprognostic (2.72e-2)	unprognostic (4.32e-2)	unprognostic (7.54e-4)	unprognostic (2.99e-2)	unprognostic (1.87e-1)	unprognostic (6.53e-3)	unprognostic (1.83e-1)	0.7	0.8	0.2	0.1	0.3	0.5	1	1.4	1.1	0.8	0.3			0	1.6	2.2	0.7	0.9	0.4	0.5	0.3	0.3	0.2	0.3	0.7	0.5	0.2		2.8	0.7	1.8	1.6	0.7		0.6	0.1		0.5	0.2	0.2	0.4	0.5	0.5	0.5	0.6	0.3	1.6			1.1		0.1	0.3	0.7	0.1	1.5	0	0.2	0	0.5	0	0.1	0	0.2	0.6	0.1	0	0	0.4	0.3	0	1.1	0.1	0.2	0.9	0	0	0.9	0.3	0	0	0.2	0.6	0.3	0.1	0	0.1	0.3	0	0	0	0	0.2	3.9	0.1	0.1	0.6	0.3	0.5	0.5	0	0	0.1	0.2	0	0.6	0	0	0	0.1	0.6	0.3	0.1	0	0	0.1	1.7	0.8	0	1.1	1.3	0.2	0.6	0.3	0	0	0.6	0.2	0	0.7	0	0	0	0	0.2	0	0	0	0.2	0.4	0.1	0.5	0	0	0	0	1.5	0	0											0	0	0	0	0	0.8	0	0	0	0	0	3.9	0	0	0.1	0	0	0	0	0	0	0	0.1	0	0.5	0.1	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0.8	0	0	0	0	0	0	0	0	0	Cone photoreceptor cells
MTRNR2L1		ENSG00000256618	MT-RNR2-like 1	P0CJ68	17	22523111-22524663	Predicted intracellular proteins, Predicted secreted proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enriched	Detected in all	4	blood: 249.5	Cell type enriched	Detected in many	13	Cardiomyocytes: 14115.0	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enhanced	Detected in all		neutrophil: 249.5	Lineage enriched	Detected in all	7	granulocytes: 249.5	Cell line enhanced	Detected in all		HeLa: 188.9;Hep G2: 129.8														Secreted to blood								unprognostic (2.31e-2)	unprognostic (1.50e-1)	unprognostic (1.08e-1)	unprognostic (4.41e-3)	unprognostic (2.99e-2)	unprognostic (9.82e-3)	prognostic favorable (8.99e-4)	unprognostic (2.14e-1)	unprognostic (2.59e-2)	unprognostic (1.48e-2)	unprognostic (2.42e-2)	unprognostic (1.63e-2)	unprognostic (2.56e-2)	unprognostic (3.35e-2)	unprognostic (1.64e-1)	unprognostic (1.49e-2)	unprognostic (5.21e-3)	9.4	16.2	7.9	3.7	10	2.3	3	4	8.4	2.5	8.9	3.3	4.8	4.5	2.6	6.8	4.8	2.6	3.3	34.3	8.1	6.1	17.8	12.8	4.2	5.6	8.9	3	4.1	15	1.5	3.4	2.5	4.6	3.5	7.7	3.3	5.9	5	55.5	5.3	5.2	7.5	5.9	3.3	5.6	4.4	4	1.8	2.7	6.8	1.8	3.3	2.6	29.4	21.6	249.5	34.3	15	18.3	28.7	20.6	48.2	18.6	62.5	29.5	12.2	23.6	19.5	4.6	4.5	5.3	29.6	33.5	28.1	21.3	10	3.2	55	1.4	7	5.6	16.5	34.6	25.7	188.9	129.8	9.6	6	31	27.3	15.1	5	12.2	32.8	4.8	18.4	20.8	17.2	13.4	16.7	9.3	41.3	5.3	16.1	10.8	15.3	11.8	14.6	25.7	29.5	9.9	17.6	9.4	17.9	28.7	18.7	16.8	43	9.3	24.9	21	29.6	12	16	5.1	13.3	14.2	38	5.4	74.4	34.3	62.1	10.9	16.7	13.5	28.7	13.9	11.8	12.1	29.4	18.3	15.9	249.5	15	16.1	21.6	12.1	28.7	7.9	10	4	6.8	8.1	6.1	8.9	3	4.6	4	122.1	126.9	16.9	1081.8	75	0	14115	2.5	184.7	263.9	73.3	0	0.7	94.5	0.5	4.6	52.2	1.1	0	0.6	0.6	57.9	106.8	153.5	10.2	0.7	0	1.7	4.9	6.9	6.9	14.4	92.3	59.1	0	1.3	0	0.2	1.4	3.9	12.2	0	0	31.1	6.6	18.6	149.7	0.8	7.5	1.2	234.3	Cardiomyocytes
CLEC12B		ENSG00000256660	C-type lectin domain family 12 member B	Q2HXU8	12	10010627-10018619	Predicted membrane proteins		Receptor		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in some	5	testis: 30.9	Cell type enriched	Detected in some	6	Melanocytes: 75.9	Not detected	Not detected			Not detected	Not detected			Cell type enhanced	Detected in single		neutrophil: 1.3	Low lineage specificity	Detected in single			Group enriched	Detected in some	10	GAMG: 5.7;U-937: 12.0	Region enhanced	Detected in single		pons and medulla: 0.8	Not detected	Not detected																unprognostic (2.08e-2)	unprognostic (4.81e-2)	unprognostic (3.60e-1)		unprognostic (1.81e-1)	unprognostic (3.76e-1)	unprognostic (3.36e-3)	unprognostic (4.14e-4)	unprognostic (7.69e-2)	unprognostic (1.59e-1)	unprognostic (1.04e-2)	unprognostic (1.29e-1)	unprognostic (2.02e-5)	unprognostic (1.41e-2)	unprognostic (1.99e-1)	unprognostic (5.48e-1)	unprognostic (8.95e-4)	0.4	0	0.2	0.5	0.2	5.6	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0	0.2	0.2	1.3	0.2	0.4	0.2	0.2	0.2	0	0.2	0.2	0.3	0.2	0.1	0.2	0.2	0.2	0.2	5.4	0.2	0.2	0.2	2.7	0.1	30.9	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0	0.5	1.3	0.8	0	0	0.5	0	0	0	0	0	0	0	0	0.2	0.1	0	0	0	0	0	0.2	5.7	0	0	0	0.1	0	0	0	0	0	0	0.8	0	0	0	0	0	0	0.3	0	0	0	0.1	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0.1	0	0	0.3	0	0.3	12	0.4	0	0.8	0	0	0.7	0	0	0	0	0.5	0	0	0	1.3	0	0.3	0	0	0.5	0.2	0.2	0.2	0.2	0.2	0	0.4	0.2	0.3	0.2	0	0	0	0	2.4	0	0	0	0	0	0	0	0	0	0	11.9	0	0	0	0	0	0	0	1.1	0	0.1	0	0	0	2.6	7.2	0.3	0.4	75.9	0	0	0	0	0	0	0	0	0	0	0.9	0.4	0.6	0	0	0	0	Melanocytes
PGA5		ENSG00000256713	Pepsinogen 5, group I (pepsinogen A)	P0DJD9	11	61241042-61251448	Enzymes, Predicted intracellular proteins, Predicted secreted proteins	Digestion	Aspartyl protease, Hydrolase, Protease		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in some	38	stomach 1: 296.9	Cell type enriched	Detected in some	278	Exocrine glandular cells: 4020.2	Cancer enriched	Detected in some	12	stomach cancer: 15.0					Group enriched	Detected in some	50	classical monocyte: 3.4;intermediate monocyte: 7.7;non-classical monocyte: 3.7	Lineage enriched	Detected in single	77	monocytes: 7.7	Cell line enriched	Detected in some	14	BJ hTERT+: 25.7									HPA046875	Supported				Secreted to digestive system							HPA046875: AB_2679851				unprognostic (1.36e-3)	unprognostic (2.98e-2)		unprognostic (5.83e-3)			unprognostic (2.11e-1)	unprognostic (4.22e-1)		unprognostic (4.36e-2)	unprognostic (2.16e-2)	unprognostic (1.05e-1)	unprognostic (7.10e-2)		0	0	0	0	0	0	0	0	0.1	0	0			0	0	0	0	0.1	0	0	0	0	0.1	0	0	0	0		0	0	0	0	0		0	0		0	0	0	0	0	0	0	0	296.9	0			0		0	0	0	0	0	0	7.7	0	0	0.6	0	0	0.1	0	0	0	0	0	25.7	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0.2	0	0	0	0	1.8	0	0	0.3	0	0	0	0.1	0	0	0.4	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	1.2	0	0	0	0.3	0	0	0.1	0	0	0	0	0	3.4	0	0	7.7	0	0	0	0	0	0	0	0	0	0	3.7	0	0	0.6											0	0	0	0	0	0	0.8	0	0	0	0	0	0	0	0	0.4	0	0	0	4020.2	0	0.2	0	0	0	5	0	0	0	6.3	1.3	0.9	0.3	0	1	0	14.5	5.9	0	0	0.7	0.3	0	0	0	0	0	0	0	0	0	Exocrine glandular cells
MTRNR2L7		ENSG00000256892	MT-RNR2-like 7	P0CJ74	10	37601440-37602974	Predicted intracellular proteins, Predicted secreted proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in some		blood: 2.1;heart muscle: 1.6;skeletal muscle: 1.9	Cell type enriched	Detected in single	277	Cardiomyocytes: 171.5	Not detected	Not detected							Cell type enhanced	Detected in some		neutrophil: 2.1	Lineage enriched	Detected in single	7	granulocytes: 2.1	Cell line enhanced	Detected in some		HeLa: 3.2;Hep G2: 1.6														Secreted - unknown location																	unprognostic (2.28e-1)				unprognostic (5.87e-2)				0.3	0.6	0.1	0	0.1	0.2	0.1	0.1	0.4	0.1	0.3			0	0.1	0.2	0.1	0.1	0	1.6	0.1	0.1	0.9	0.4	0.1	0	0.1		0.1	0.1	0	0.3	0		0.1	0.5		0.1	0	1.9	0.1	0.1	0	0.1	0.1	0.2	0.2			0.1		0	0.1	0.1	0.3	0.2	2.1	0.2	0.2	0.2	0.2	0.2	0	0.2	0.4	0.3	0	0.3	0.2	0	0.1	0	0.7	0	0.6	0.1	0.2	0	0.5	0	0	0	0	0	0.9	3.2	1.6	0	0	0.3	0.3	0	0	0	0.1	0	0	0.2	0.2	0	0.2	0.1	0.7	0	0.5	0	0.1	0.3	0.5	0.4	0.3	0	0.2	0.8	0.1	0.1	0	0.1	0.3	0	0.1	0.1	0.1	0	0	0.2	0.2	0.1	0.8	0	1.2	0.2	0.6	0	0.1	0.1	0.3	0.1	0.1	0	0.3	0.2	0.2	2.1	0.2	0.1	0.2	0.1	0.2											0	0	0	0.6	0.1	0	171.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0.6	Cardiomyocytes
HP		ENSG00000257017	Haptoglobin	P00738	16	72054592-72061055	Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins	Acute phase, Immunity	Antibiotic, Antimicrobial, Antioxidant, Serine protease homolog	Cancer-related genes, Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	37	liver: 1156.9	Cell type enriched	Detected in many	51	Hepatocytes: 52541.7	Cancer enriched	Detected in many	81	liver cancer: 1297.4	Not detected	Not detected			Group enriched	Detected in some	4	classical monocyte: 20.0;eosinophil: 30.9	Group enriched	Detected in many	7	granulocytes: 30.9;monocytes: 20.0	Group enriched	Detected in some	5	Hep G2: 66.2;HSkMC: 37.9									CAB003787, HPA047750	Enhanced		Approved	Vesicles	Secreted to blood			998000000000	140000000000	Vesicles		CAB003787: , HPA047750: AB_2680146	unprognostic (6.38e-3)	unprognostic (7.73e-3)	unprognostic (1.23e-1)	unprognostic (2.41e-2)	unprognostic (2.34e-3)	unprognostic (2.07e-1)	unprognostic (7.79e-3)	unprognostic (1.37e-1)	unprognostic (2.31e-1)	unprognostic (1.84e-1)	unprognostic (6.30e-2)	unprognostic (8.18e-2)	prognostic unfavorable (6.94e-13)	unprognostic (4.34e-4)	unprognostic (1.80e-1)	unprognostic (6.61e-2)	unprognostic (2.49e-2)	9.8	0	0.3	0.4	0.3	4.4	0.3	0.3	0.3	1.5	0.4	0.3	0.3	0	0.3	0.5	0.3	1.1	0.3	3	0.3	0	0.4	1156.9	1.4	0.4	0.3	0.3	0.3	0.5	0	0.5	0.3	0.3	0.3	0	0.3	0.3	0.3	0.3	0	0.3	0.3	0.3	1.4	0	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.5	0	3.5	30.9	20	0	0	5	0	0	0	0	2.1	0	0.1	0	0	0	0	0	0.1	2.5	0.1	0	0	0.7	0	0	0	0	0	3.4	0	66.2	0.1	9.5	1.8	37.9	0	0	0	0	0	0	2.5	0	0	0	0.6	0.1	0.8	0	0	0.3	7.1	0	0	0	0	0	4.8	0	0	0	0	2.1	1.4	0	0.2	0	0	1.2	0	4.5	0	3.7	0	2.6	20	30.9	0	0.8	0	0	0	0	3.5	0	0	0	5.8	0	0.9	0	0	5	0.3	0.3	0.3	0.3	0.3	0	0.3	0.3	0.3	0.3	17.9	220.1	295.8	0.8	0.1	0.2	72.5	853.5	10.7	10.3	0	0	0	0	0	0.1	6.8	0	864.3	9.6	0	0.2	0.2	3.5	52541.7	2.4	0	0	971	1021.7	0	9.5	0	1.7	0	0	1.2	0	0	0	0.5	0.1	0	0.9	0	0	0.3	0.1	23	0	0	Hepatocytes
AC133555.3		ENSG00000258150			16	29464967-29467833	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level				Tissue enhanced	Detected in many		testis: 9.8	Cell type enriched	Detected in some	7	Alveolar cells type 1: 11.9	Not detected	Not detected							Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		A549: 4.9;CAPAN-2: 22.0;SK-BR-3: 17.2									HPA053608	Uncertain											HPA053608: AB_2682205										unprognostic (9.92e-2)								1.5	0.2	1.1	0.2	0.3	1.5	1.3	0.1	1.6	0.7	0.8			4.2	1.1	0	0.7	3	4.1	0.8	0.4	1	1.3	0	0.8	3.1	0.5		0.5	0.2	0.2	1.6	0		0.5	0.3		5.1	0.3	0.9	0.6	0.7	0.2	0.3	0.5	0.3	9.8			0.5		0.3	0.3	0.6	0.6	2.5	0.9	2.5	0.2	1.7	0.8	1.4	4.9	0.2	0.1	0.8	0.5	0.6	0.1	0.4	0.4	0.6	0	22	0.7	2.2	0.4	0	1.4	0	0.5	0	0.2	0	0	0	0	0	0	0	1.5	0	1.8	0	0.4	0	0.2	0	0.1	0.8	0.5	0.1	0	0	0.5	0	0.4	0	0.4	2.5	0.2	0	0.3	0	17.2	0	0	0.3	0	0.5	0.6	0.1	0	0	0	0.5	0	1.7	0	0.4	0.6	1.8	0.1	1.7	1.5	0.4	0.6	1.2	0.4	2.5	0.2	0.5	1	0.9	0.2	2.5	0.2	0.8	0.8											11.9	0.6	0	0	0	0	0	0	1.4	1.2	1.8	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0.3	0	0	0	0	0	0	0.1	0	0	0	Alveolar cells type 1
TRIM6-TRIM34		ENSG00000258588	TRIM6-TRIM34 readthrough		11	5596725-5644398	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level				Group enriched	Detected in many	6	kidney: 30.3;salivary gland: 9.5;testis: 8.0	Cell type enriched	Detected in single	9	Ciliated cells: 2.7	Not detected	Not detected			Not detected	Not detected			Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Cell line enriched	Detected in some	6	A549: 10.1									HPA077996			Uncertain	Nucleoli,Centrosome						Centrosome	Nucleoli	HPA077996: AB_2686873																		0.9	0.7	0.4	0.6	0.4	0.1	0.9	0.4	0.4	1.4	0.4	0	0.7	0.8	1.5	1.6	1.9	0.7	0.2	1.4	0.4	0.3	30.3	0.4	0.7	0.1	0.3	0	1.7	2.7	1.1	0.4	1.4	0.3	1.5	0.2	2.2	9.5	1.9	0.4	0.4	0.6	1.9	0.4	1.1	0.4	8	0	0	1.7	0	1.5	1.1	0.5	0.5	1.5	1.3	0.8	0.9	0.2	0.2	0	10.1	0	0	0.2	0.8	1	1.4	0	0	0	0	0.1	0	0.2	0.3	1.1	0	0	0.7	0.6	0.6	0	0.5	0.4	0	0	0	0	0	0	0	1.1	0	0.4	0	0	0	0	0.4	0	0	0	1.6	0.2	0.6	0	0	0	0.8	0	0	0	0	0	0.6	0.1	0	0	0	0.2	0	0.2	0	0	0	0	0	0	0.3	0.8	0.1	0.2	0.2	0.1	0.4	0	0.1	1.5	0.5	0.1	0.1	1.3	0.9	0.4	0.3	0	0.2	0.4	0.4	0.4	0.4	0.4	0.3	0.3	0	0.3	0	0	0.3	0	0	0	0	0	0	2.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Ciliated cells
AC105001.2		ENSG00000258724			8	10725399-10839847	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level				Low tissue specificity	Detected in many			Cell type enriched	Detected in single	12	Club cells: 1.2	Not detected	Not detected			Low region specificity	Detected in all			Cell type enriched	Detected in single	13	NK-cell: 1.5	Lineage enriched	Detected in single	13	NK-cells: 1.5	Cell line enhanced	Detected in some		HaCaT: 6.1;HBEC3-KT: 2.5;SiHa: 2.2					Not detected	Not detected			HPA009065	Uncertain		Approved	Nuclear speckles,Golgi apparatus						Nuclear speckles	Golgi apparatus	HPA009065: AB_1857390									unprognostic (2.57e-1)					unprognostic (6.34e-2)				6.7	2.7	1.9	3.7	3.1	1.7	2.7	2.9	3.9	9.8	3.1	2.6	0.9	3.3	3.6	1.7	4	2.1	3.1	3.2	2	1.9	2.2	4.8	4.7	2.2	2.8	2.1	3.8	4.1	1.7	2.3	3.3	4.2	2.7	1.8	3.6	3.4	2	8.7	4.6	3	2.1	2.5	3.3	3.2	6.3	1.7	4.6	2.6	4.3	3.8	2.2	15.2	0.1	0	0	0	1.5	0	0	0	0	0	0.3	0	0	0.6	0.2	0.3	0	0.1	0.2	0.4	0	0.1	0	0.3	6.1	0.4	2.5	0	0.1	0.2	0	0	0.2	0.4	0	0.4	0	0.2	0	0	0	0.2	0	0.3	0.3	0.2	1.2	0	0	0.3	0	0	1	0.2	0	0	0	0	0	2.2	0	0.2	0	0.3	0.2	0	0.1	1	0.1	0.1	0.3	0.7	0.4	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	1.5	0	0	0	0	1.9	3.1	2.9	3.9	2	1.9	2.8	2.1	4.2	1.7	0	0	0	0	0	0	0	0	0	1.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Club cells
AL132780.3		ENSG00000259132			14	22946270-22982258	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level				Low tissue specificity	Detected in many			Cell type enriched	Detected in single	30	Alveolar cells type 1: 3.0	Not detected	Not detected			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Cell line enhanced	Detected in many		Hep G2: 28.1									HPA029803	Approved		Approved	Plasma membrane,Focal adhesion sites						Plasma membrane, Focal adhesion sites		HPA029803: AB_10601428																		4.8	6.2	4.5	4.7	5.5	6.6	5.3	3.5	2.4	16.1	7.1	2.3	7.1	5.5	12.4	9.2	16.2	6.6	11.2	6	4.6	3.8	20.4	24.5	10.5	7.9	5.3	1.9	11.8	13.8	0	3.5	18.1	3.8	13.1	6.1	10.4	5.7	16	6.2	8.8	4.5	3.5	4.5	11.3	4.5	6	1.9	10.3	22.1	7.7	9.6	5	7.9	3.3	5.7	10.2	5.9	1.1	4.1	2.8	4.1	8.9	6.2	2	6.1	7.2	4	0.7	5.8	3.7	3.8	3	3.1	0	2.4	6.8	2.1	1.6	2.9	3.1	2.6	0	0.7	1.3	6.8	28.1	4	3.2	2.6	3.2	8.2	2.9	7	8.1	5.1	7.4	0	6.1	4	16.8	7	12	3	6.9	1.9	3.4	4.4	3.8	10.3	8.4	3.5	2	2.8	3.6	1.7	4.5	5.5	7.1	1	4.7	3.4	1.9	3.5	6	7.3	6.3	1.6	3.2	2.9	0.5	5.9	2.1	2.5	4.2	1.2	2.7	1.8	2.1	5.7	3.3	3.4	1.7	10.2	1.1	2.9	2.6	4.1	2.8	4.5	5.5	3.5	2.4	4.6	3.8	5.3	1.9	3.8	1.9	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Alveolar cells type 1
SLC35G6	AMAC1L3, TMEM21B	ENSG00000259224	Solute carrier family 35 member G6	P0C7Q6	17	7481332-7483496	Predicted membrane proteins, Transporters				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enriched	Detected in some	7	testis: 8.5	Cell type enriched	Detected in some	6	Early spermatids: 26.9	Not detected	Not detected							Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		CACO-2: 1.1;HeLa: 3.7;U-138 MG: 1.2																						unprognostic (3.81e-2)	unprognostic (5.10e-2)	unprognostic (2.05e-2)	unprognostic (1.79e-1)	unprognostic (1.65e-1)	unprognostic (3.11e-3)		unprognostic (1.37e-2)	unprognostic (1.65e-3)	unprognostic (3.29e-1)	unprognostic (9.19e-3)	unprognostic (1.69e-1)	unprognostic (1.61e-1)	unprognostic (3.13e-1)	unprognostic (5.21e-2)	unprognostic (3.79e-2)	unprognostic (2.01e-2)	0	0.1	0	0	0	0.3	0	0.4	0	0	0			0.1	0	0	0	0	0	0	0	0	0	0	0	0	0		0	0	0	0	0		0	0		0.2	0	1.3	0.1	0	0	0	0	0	8.5			0.2		0	0	0	1.1	0.9	1.1	0.3	0	0.3	0	0	0.7	0.1	0.6	0.1	0	0	0	0	0	0	1.1	0	0	0.1	0	0	0.1	0	0	0	0.2	0.5	0.1	3.7	0.2	0	0	0.4	0	0	0	0	0	0	0.4	0	0.4	0	0.2	0.1	0.3	0	0	0.2	0.1	0.7	0	0	0	0.1	0	0.2	0	0.1	0.1	0.1	0	0.2	1.2	0.1	0.6	0.4	0.1	0.2	0.1	0.4	0.2	0.1	0	0.3	0	0.1	0.2	0.1	0	0.3	0	0.1	1.1	0.3	0.1	1.1	0	0	0.9	0	0											0	0	0	0	0.1	0.4	0	0	0	0	0	0	0	0	0	26.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4.6	0	0	0	0	0	0.2	0	0	0.4	0	0.8	0	0	1	0.3	0.1	0	0	0	0	Early spermatids
TGIF2-C20orf24		ENSG00000259399	TGIF2-C20orf24 readthrough		20	36574553-36612384	Predicted membrane proteins				Evidence at transcript level	Evidence at transcript level				Tissue enhanced	Detected in many		pancreas: 22.1	Cell type enriched	Detected in single	11	Alveolar cells type 2: 1.1	Not detected	Not detected			Low region specificity	Detected in many			Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Cell line enhanced	Detected in many		AF22: 20.9	Low region specificity	Detected in all			Low region specificity	Detected in all																unprognostic (7.38e-2)	unprognostic (1.79e-1)	unprognostic (3.92e-2)	unprognostic (5.58e-2)	unprognostic (2.62e-2)	unprognostic (1.94e-1)	unprognostic (7.39e-2)	unprognostic (2.22e-2)	unprognostic (6.57e-3)	unprognostic (3.97e-2)	unprognostic (2.86e-3)	unprognostic (1.72e-1)	unprognostic (1.46e-2)	unprognostic (2.69e-1)	unprognostic (2.93e-1)	unprognostic (3.70e-2)	unprognostic (1.07e-1)	2.1	1.4	1.9	8.5	1.9	4.9	2.3	0.9	3.1	3.1	2.1	1.7	0.6	2.1	4.1	2.6	1.4	4.2	1.7	2.2	1.4	1.1	2	5.3	2.2	1.8	2.5	1.7	3.8	22.1	3.1	1.3	2.7	1.9	1.9	1.5	2	3.2	2.2	2.7	1.5	1.6	4.7	1.6	3	1.4	6.1	1.3	4.1	4	1.4	5.7	1.3	2.8	3.4	3.6	2.8	2.2	1.9	3.3	0.9	3.7	1.6	20.9	10.5	3.1	1.6	1.5	0.7	4.8	7.3	5.6	8.9	7.8	1.7	2.1	4.3	3.1	1.6	17.7	2.6	11.1	4.8	2.1	4.6	5.4	10.1	1.5	5.4	1.1	1.2	2.9	3.9	7.3	9.3	4.9	9.8	1.3	10.7	1.9	9.4	12.4	2.9	4.4	4.1	0.4	9.3	2.1	7.6	2.9	4.5	2.6	7	1.2	9.3	5.3	3.7	8.3	14.9	1.3	2.7	0.9	0.2	2.8	2.4	1.2	6.9	0.2	6.2	4.4	0	1.9	0	2.6	2.2	2.4	3.4	0.6	0.5	3.6	3.4	3.2	3.3	2.8	1.9	0.4	2.6	0.5	0.9	1.9	1.9	0.9	3.1	1.4	1.1	2.5	1.7	1.9	1.3	0	1.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Alveolar cells type 2
SLC22A31		ENSG00000259803	Solute carrier family 22 member 31		16	89195761-89201664	Predicted membrane proteins				Evidence at transcript level	Evidence at transcript level				Group enriched	Detected in some	21	brain: 39.3;lung: 50.7;pancreas: 69.7	Cell type enriched	Detected in some	6	Alveolar cells type 2: 129.3	Group enriched	Detected in many	9	liver cancer: 6.1;lung cancer: 26.2;thyroid cancer: 20.4	Region enriched	Detected in some	23	cerebellum: 39.3	Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	5	BEWO: 23.7;Hep G2: 19.0;NB-4: 9.7;RPMI-8226: 11.4;THP-1: 6.2																						unprognostic (2.71e-3)	unprognostic (2.53e-1)	unprognostic (5.02e-3)	unprognostic (6.82e-2)	unprognostic (8.20e-2)	unprognostic (1.95e-1)	unprognostic (3.00e-2)	unprognostic (1.93e-2)	unprognostic (2.12e-1)	unprognostic (2.67e-1)	unprognostic (8.98e-2)	unprognostic (1.09e-1)	unprognostic (8.26e-4)	unprognostic (2.74e-1)	unprognostic (2.05e-1)	unprognostic (2.72e-3)	unprognostic (1.89e-1)	0.1	0.3	0	0.3	0.4	1.1	0.1	39.3	0.1	0.3	0.5	0	0	0.6	0.2	0.5	0.1	0.2	0.2	0.1	0.1	0	0.1	0.3	50.7	2.5	0	0	0.7	69.7	0.1	0	0.1	1.7	0.2	0.1	0.4	0.7	0.2	0.1	0.3	0.3	0.1	0.3	1	0.5	1.1	0	0	0.3	0	0.1	0.2	0	0.5	0	0	0.1	0	0.6	0.7	0	0	0	1.1	0	0	23.7	0.1	0	0	0	0.8	0	0	2.7	0	0	0	0	0	0	0	0.6	0	0	19	2.5	0	0.2	0	0	0	0	0	0	0.3	0.3	0	0	0.3	0	9.7	0.6	0.2	2.4	0	2.6	11.4	0	0	1	0.7	0	0	0	0.1	0.2	6.2	0	0	0	0	0	0	0.9	0	0	0.1	0.1	0	0.1	0	0	0	0	0.5	0	0	0	0	0.6	0	0	0	0	0	0	0.7	0	0.4	39.3	0.1	0.1	0	0	0	1.7	0	6	129.3	0	0	0	0	0.4	0	4	14.8	0	0	0	0	0.1	20.8	0	0	0	4.2	0.1	0	0.2	8.1	0.2	0.6	0	0	0.6	0.3	23.1	0.6	0	0	0	0	0	0.1	0	0	0	0	0	0.3	0.7	2.8	0.1	0	0	0	0	Alveolar cells type 2
LYPD8		ENSG00000259823	LY6/PLAUR domain containing 8	Q6UX82	1	248718649-248755739	Predicted secreted proteins				Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	16	intestine: 60.0;lymphoid tissue: 40.9	Cell type enriched	Detected in some	7	Paneth cells: 701.4	Cancer enriched	Detected in some	7	colorectal cancer: 15.2					Group enriched	Detected in some	6	classical monocyte: 1.0;intermediate monocyte: 1.1;MAIT T-cell: 1.7;neutrophil: 2.3;plasmacytoid DC: 3.1	Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		NB-4: 1.2;THP-1: 2.5					Not detected	Not detected								Secreted to digestive system								unprognostic (6.69e-3)		unprognostic (3.53e-2)	unprognostic (1.08e-5)	unprognostic (1.42e-2)	unprognostic (1.35e-1)	unprognostic (2.16e-4)	unprognostic (8.62e-2)	unprognostic (7.28e-2)	unprognostic (3.22e-1)	unprognostic (9.73e-2)	unprognostic (1.87e-1)	unprognostic (1.19e-4)	unprognostic (2.57e-1)	unprognostic (2.89e-1)		unprognostic (1.07e-1)	0	0	0	40.9	0	0	0	0	0.1	0	60	0	0	0	0	0	0	0	0	0	0		0	0	0	0	0	0	0	0	0	0	0	0	0.1	36.8	0	0	0	0	0	8.1	0.8	0	0.3	0	0	0	0	0	0	0.1	0	0	0.3	3.1	2.3	1.1	0	1.7	0.2	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0.1	0	0.1	0	0	0	0	0.6	0	0	0	0	0	0.6	0.3	0	0	0	0	0	0	0.2	0	0.3	0	0	0.2	1.2	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0.8	2.5	0	0	0.4	0	0.1	0.5	0	0.1	0	0	0	0	1	0	0.1	1.1	1.7	0	0	0	0	0.3	0	0	2.3	0	0	3.1	0	0.2											0	0	0	0	0	0	0.2	0	0	0	0	0	0.2	1.7	0	3.4	0	57.5	0	0	0	0	0.1	0	0	0.1	0	30.2	0	0	7.5	0	0	0	0	104.6	0	0	701.4	0	1.7	0	0	0	0.2	0.7	0	0.2	0	16.3	0	Paneth cells
AL845331.2		ENSG00000259916			2	94588522-94604573	Predicted membrane proteins				Evidence at transcript level	Evidence at transcript level				Tissue enriched	Detected in single	13	adipose tissue: 12.1	Cell type enriched	Detected in single	10	Proximal tubular cells: 1.0	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	11	ASC diff: 6.8																						unprognostic (1.97e-1)				unprognostic (1.24e-1)		unprognostic (8.07e-3)	unprognostic (1.39e-1)		unprognostic (1.85e-1)	unprognostic (1.45e-1)	unprognostic (1.15e-1)	unprognostic (9.15e-3)	unprognostic (6.22e-2)		unprognostic (4.66e-2)		12.1	0.1		0		0	0.2		0	0	0			0	0	0	0	0	0	0.1			0.9	0.2	0	0			0	0	0		0		0	0		0.1	0	0	0	0	0		0	0	0			0		0	0		0	0	0	0	0	0	0	0	0	0	0.5	6.8	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0.1	0	0	0.3	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	Proximal tubular cells
AC012184.2		ENSG00000260537			16	70299194-70372582	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level				Low tissue specificity	Detected in many			Cell type enriched	Detected in single	27	Ciliated cells: 2.7	Not detected	Not detected			Low region specificity	Detected in all			Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Cell line enhanced	Detected in many		REH: 22.6;U-698: 22.3									HPA046380, HPA066668	Approved		Uncertain	Nucleoplasm						Nucleoplasm		HPA046380: AB_2679645, HPA066668: 																		12.9	11.6	2.6	10.2	4.7	10.4	7.2	12.9	6.3	4.8	7.4	5.6	5.2	9.8	5.7	5.2	9.8	4.2	7.1	10.8	2.9	2.7	7.2	14.6	6.6	8.8	3.6	3.7	4.5	13.7	0.8	7.1	4.3	4.9	4.7	7.5	7.7	8.7	5.8	23.5	15.9	7	6	3.2	7	7.3	2.6	4.5	6.8	8	6.6	13.3	13.4	5.2	8.8	14.7	12.3	16	12	17.9	11.1	1.4	4.9	4.2	9.8	0	4.7	8.2	4.6	5.5	7.9	8.4	9	12.6	8.3	5.8	4.7	1.5	5	0	3.4	6.2	2.5	6.2	5.4	4.1	0.6	5.1	8.2	4.4	3	0.8	8.2	0	2	5.6	2.3	3.1	2.2	3.3	3.7	0.1	0	5.1	0.7	1.1	22.6	1.7	15.2	2.5	6.3	5.3	5.1	11.7	2.1	2.3	1.3	4.3	2	5.2	5.4	5.6	2.2	2.9	7.7	5.1	22.3	0.7	5.2	9.7	12.3	13	9.2	13.5	16	11.2	8.8	11.9	13.2	14.7	8.3	10.2	9.9	1.8	12	11.5	3	17.9	11.1	2.6	4.7	12.9	6.3	2.9	2.7	3.6	3.7	4.9	4.5	0	0	0	0	0	0	0	0	2.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Ciliated cells
AC002310.4		ENSG00000260869			16	30534227-30558279	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level				Low tissue specificity	Detected in all			Cell type enriched	Detected in single	12	Club cells: 1.2	Not detected	Not detected			Low region specificity	Detected in all			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		A549: 5.0;BEWO: 1.6;CAPAN-2: 1.0;NB-4: 1.8;NTERA-2: 1.6																																							5.6	2.4	3.8	1.6	3	1.5	1.9	6.9	3.5	1.8	6.5	3	2.9	5.9	3.2	1.5	2.5	1.5	3.3	2.6	3.2	1.9	2.6	2.7	2.5	2.3	3.2	1.9	2.6	4.5	1.5	4	1.5	2.9	1.6	1.5	2.3	2.4	1.5	4.3	2.3	5.7	1.5	2.5	5	3.1	3.5	3.2	5	2.3	1.4	2.2	2.7	2.2	0.5	2.6	2	1.6	0.2	1.6	1	0	5	0	0	0	0	1.6	0.9	0	0	0.4	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0	0	0	1.8	1.6	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0.9	0.8	0	0.8	0	0	1.6	1.1	1.6	0.3	1.5	0.5	0	0.2	0.7	0.5	0.5	0.6	2	0.2	0	2.6	0	1	3.8	3	6.9	3.5	3.2	1.9	3.2	1.9	2.9	3.2	0	0	0	0	0	0	0	0	0	1.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Club cells
AC026464.4		ENSG00000260914			16	69299682-69322700	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level				Tissue enhanced	Detected in many		blood: 28.3	Cell type enriched	Detected in single	11	Alveolar cells type 2: 1.1	Not detected	Not detected							Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low cell line specificity	Detected in all											HPA060092			Approved	Midbody						Midbody		HPA060092: AB_2684203	unprognostic (2.95e-1)	unprognostic (4.21e-1)			unprognostic (7.34e-2)	unprognostic (8.50e-2)		unprognostic (1.02e-1)	unprognostic (2.74e-1)		unprognostic (3.50e-1)	unprognostic (4.08e-2)	unprognostic (6.51e-4)	unprognostic (1.69e-1)		unprognostic (2.76e-1)	unprognostic (5.11e-2)	5.6	3.4	1	2.7	2.2	2.3	4.8	15.1	6.8	5.5	4.5			3.1	9.1	0.6	5	7.5	2	5	1	1.3	3.3	1.4	7.3	2.4	1		6.4	5.7	7.1	3.9	3		3	2.7		3.7	3	19.4	6.4	4.6	3.5	1.2	4.4	3.1	1.3			5.3		3	4.5	5.1	17.5	19.5	24.9	19.1	15.9	28.3	21.1	22.5	20	23.6	22.2	18.2	19.3	13.3	28.6	19.4	30.6	20.2	25.4	12.5	21.5	30	22.9	15.6	17.6	22.4	19.5	19.6	13.2	10.7	17	11	12.6	23	21.3	18.1	16.3	26.9	25.3	28	17.4	25.2	18.6	21.5	10.7	24.8	29.5	21.2	10.4	19.1	14.8	9.7	32.6	13.5	28.6	14.3	14.6	24.6	13.7	38.4	12.8	16.4	15.1	18.1	15.1	26.4	28.6	20.5	24.5	21.5	37.1	26.6	50.6	28.9	8	34	11.1	17.7	24.9	23.6	14.1	22	17.5	21.2	28.3	19.5	15.7	21.8	21.3	12.4	15.9	19.1	13.4	19.9	21.1											0	1.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Alveolar cells type 2
GOLGA8T		ENSG00000261247	Golgin A8 family member T		15	30135149-30145567	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level				Tissue enriched	Detected in some	6	testis: 8.4	Cell type enriched	Detected in single	6	Early spermatids: 1.9	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Not detected	Not detected																								unprognostic (1.01e-1)				unprognostic (1.38e-1)			unprognostic (2.05e-1)	unprognostic (2.41e-1)		unprognostic (1.22e-1)	unprognostic (1.38e-1)	unprognostic (5.20e-2)		unprognostic (5.37e-2)	unprognostic (2.10e-2)		0.2	0.2	0	0.2	0.1	0.2	0.2	0	0.2	0.3	0.2			0.2	0.2	0.2	0.2	0.2	0.2	0.7	0	0	0.2	0.2	0.2	0.2	0		0.7	0.8	0.2	0.6	0.2		0.2	0.2		0.2	0.2	0.2	0.2	0.2	0.2	0	0.2	0.2	8.4			1.4		0.2	0.2	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	1.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Early spermatids
FIGNL2		ENSG00000261308	Fidgetin like 2	A6NMB9	12	51817840-51848766	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level				Tissue enhanced	Detected in many		kidney: 16.7	Cell type enriched	Detected in single	13	Proximal tubular cells: 7.6	Low cancer specificity	Detected in some							Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		AF22: 16.7;BEWO: 10.8;NTERA-2: 6.6;SuSa: 12.9	Low region specificity	Detected in some			Low region specificity	Detected in many																unprognostic (1.83e-1)	unprognostic (3.77e-2)	unprognostic (2.26e-2)	unprognostic (7.36e-4)	unprognostic (1.99e-1)	unprognostic (2.45e-1)	unprognostic (1.57e-3)	unprognostic (2.71e-2)	unprognostic (4.75e-2)	unprognostic (6.40e-2)	unprognostic (9.78e-6)	unprognostic (7.95e-3)	unprognostic (9.65e-2)	unprognostic (1.15e-2)	unprognostic (1.31e-1)	unprognostic (1.01e-1)	unprognostic (1.48e-2)	1.1	0	0.6	0.6	0.7	0	1	0	2.2	1.4	0.1	0	0.4	0	2.6	0.9	0	0.2	0.3	1.5	0.1		16.7	1.4	2	0.7	0.2	1.7	0	0	4.3	0.1	1.9	1.3	0.9	0	1	1.8	0.5	2	0.2	0.4	0.2	0.2	1	0.9	1.3	0	0	0.2	0.5	0.3	0.2	0.8	0.4	0.8	0.2	0.2	0	0.5	0	0	0.1	16.7	0	0.2	0.1	10.8	0	0	0	0	3.3	0	0	1.6	0.1	0.1	0	0.6	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0.4	0.3	0	0	0	0	0.3	0	6.6	0	0.2	0	0	0	0.4	0	0.5	1.9	0	0	0	12.9	0	0	0	0.1	0.2	0	0	0	0	0	0	0.1	0	0.2	0.2	0	0.5	0	0.1	0	0.3	0.3	0.1	0.4	0.1	0.1	0	0	0.1	0.8	0	0											0	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	7.6	0	0	0	0	0	0	0	0	0	0	Proximal tubular cells
HPR		ENSG00000261701	Haptoglobin-related protein	P00739	16	72063224-72077246	Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins		Serine protease homolog		Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	10	liver: 151.4	Cell type enriched	Detected in some	18	Hepatocytes: 430.8	Cancer enriched	Detected in some	53	liver cancer: 185.1					Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enriched	Detected in some	14	Hep G2: 33.6									HPA047750	Supported		Approved	Vesicles	Secreted to blood			49000000000	77000000000	Vesicles		HPA047750: AB_2680146	unprognostic (2.43e-1)		unprognostic (4.69e-2)	unprognostic (5.97e-3)	unprognostic (2.42e-1)		unprognostic (2.32e-3)	unprognostic (2.36e-1)		unprognostic (1.66e-1)	unprognostic (8.21e-2)	unprognostic (2.30e-1)	unprognostic (3.44e-6)	unprognostic (2.09e-2)	unprognostic (1.45e-1)	unprognostic (1.29e-1)		0.2	0	1.3	0	1.6	0	0	0	0.6	0.1	0			0.1	0	0.1	0	0	0.1	15.2	0.7	0.8	0.1	151.4	0	0.1	2.1		0.4	0	0	0	0		0	0		0	0.1	0	0	0.1	0	0.3	0	0	0.2			0		0	0	0	1.1	2.9	1.1	1	0.4	2.3	0.3	0	0	0	0	0	0	0.6	0	0	0	0	0.1	0	0.2	0	0	0	0	0	0	0	0	0	0	0	33.6	1.6	0	0	2.4	0	0	0	0	0	0	0.2	0	0	0.1	0	0	0	0	0	0	0.1	0	0	0	0	0	0.1	0	0	0	0	0	0.4	0	0	0	0	0	0	0.1	0	0	0	0	0.8	1.1	1.3	1	0.1	0.5	0.4	0.4	0.3	1.1	2	1.1	0.3	0.4	0.3	2.9	2.3	0.3											0	9.8	0	0	0.1	0	14.9	17.8	0	0	0	0	0	0	0	2.4	0	0	23.3	0.2	0	0.2	0	0	430.8	0	0	0	9.8	7.3	2.1	9.2	0	0	0	0	5.2	0	0	4.9	4.8	0	0	0.1	0	0	0	0	0	0	0	Hepatocytes
MMP12	HME	ENSG00000262406	Matrix metallopeptidase 12	P39900	11	102862736-102875034	Cancer-related genes, Enzymes, FDA approved drug targets, Predicted secreted proteins		Hydrolase, Metalloprotease, Protease	Cancer-related genes, FDA approved drug targets	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		lymphoid tissue: 42.4;urinary bladder: 13.2	Cell type enriched	Detected in some	5	Extravillous trophoblasts: 80.4	Low cancer specificity	Detected in all							Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	12	BJ: 4.2;fHDF/TERT166: 14.6;hTEC/SVTERT24-B: 8.4	Not detected	Not detected			Not detected	Not detected								Secreted to extracellular matrix								unprognostic (7.33e-2)	unprognostic (3.20e-2)	unprognostic (1.00e-2)	unprognostic (1.03e-1)	unprognostic (2.74e-1)	unprognostic (1.67e-1)	prognostic unfavorable (1.42e-4)	unprognostic (1.69e-2)	unprognostic (7.31e-2)	unprognostic (1.52e-2)	unprognostic (1.52e-3)	unprognostic (5.45e-2)	unprognostic (3.05e-6)	unprognostic (1.08e-2)	unprognostic (4.66e-2)	unprognostic (1.73e-1)	unprognostic (6.92e-2)	2.7	0	0	21.2	0	0	0	0	0	0.3	6.9	0	0	3.3	0	5.9	0	0	1	0	0		0	0.4	0.6	18.9	0	0	0.1	0	0	0	9.7	0	0.3	8.4	0	0.9	0	0	0	3.8	4.6	0	42.4	1.3	0.1	0	5.5	0	1.5	9.9	13.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4.2	0.4	0.2	0	0.1	0	0	0	14.6	0.1	0.5	0	0	0.4	0.4	0.3	0	0	0	0	0	0	0	0	8.4	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0.1	0	0.4	0	0	0	0.5	0	0.1	0	0	0	0.5	0.6	0.2	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0.8	0	0	0	0	0	0	0	0	1.1	0	1	0	0	0	0	17	80.4	0	0	0	0	15	0	0	0	0	0	0	0	0	0	0	0	4.2	0	0	0	0	0	0	0	0	0	3.8	0	0	1.4	Extravillous trophoblasts
CCER2		ENSG00000262484	Coiled-coil glutamate rich protein 2	I3L3R5	19	38908980-38912158	Predicted intracellular proteins, Predicted secreted proteins				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 9.5;skin 1: 9.9	Cell type enriched	Detected in some	9	Melanocytes: 585.4	Low cancer specificity	Detected in many			Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		A549: 4.0;THP-1: 4.0	Low region specificity	Detected in many							HPA069716	Uncertain				Secreted - unknown location							HPA069716: AB_2686183	unprognostic (6.58e-2)	unprognostic (2.24e-2)	unprognostic (5.03e-3)	unprognostic (2.49e-2)	unprognostic (1.05e-1)	unprognostic (2.76e-3)	unprognostic (3.88e-2)	unprognostic (2.16e-1)	unprognostic (5.97e-2)	unprognostic (1.45e-1)	unprognostic (4.08e-3)	unprognostic (3.82e-2)	unprognostic (1.01e-9)	unprognostic (1.75e-2)	unprognostic (3.87e-2)	unprognostic (3.61e-1)	prognostic favorable (2.32e-4)	0.9	1	2.7	1.1	5.1	2.4	1.6	4.7	4.6	1.2	0.9	2.7	0.4	1.3	1.5	1.6	3.9	1	0.6	0.6	3.1	2.4	0.9	2.1	0.9	1.5	2.5	0.4	1	0.6	1.4	2.6	0.7	9.5	1.1	0.9	1.4	1.1	1.2	4.4	9.9	1.4	0.8	3.5	1.2	1.1	4	1.4	0.4	0.8	0.4	0.8	0.4	0.4	0	0	0	0	0.5	0.7	0	0.3	4	1	0.4	0.7	0.2	0.8	0	0	0.1	0.2	0.3	1.5	2.8	0.3	0.2	0.2	0.4	0.6	0.1	0	1.1	1.3	0.2	0.8	0	0	1.6	1.6	0.4	0.7	0.3	0	0.1	0	2.8	0.7	2.7	0	2.7	0.6	1.2	0.9	0.2	0.5	2	0.4	0.7	0.3	1.9	1.2	0.8	0.5	0.5	0	0.3	3	4	0	0.2	2	0.1	0.1	1.8	1.3	0.7	0.3	2	0.3	0	0	0	0.6	0	0	0	0.3	0	0	0	0	0.7	0	0.5	0	0	0	0	2.7	5.1	4.7	4.6	3.1	2.4	2.5	0.4	9.5	1.4	3	0	0	0	68.3	3	0.1	2.5	0	0	1.8	3.9	0.2	0	0	1	0	0	0	0	0.1	0.8	0	0	0.5	0.2	0	1.2	0	0	3.7	0.3	0.5	585.4	0	0.2	1.8	0.1	0	0	0.1	3.8	0	0.1	0.9	1.6	2.6	0.2	0	0.6	0	Melanocytes
SPON1	f-spondin, KIAA0762	ENSG00000262655	Spondin 1	Q9HCB6	11	13962689-14267884	Plasma proteins, Predicted secreted proteins	Cell adhesion			Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		gallbladder: 40.2	Cell type enriched	Detected in many	5	Muller glia cells: 163.5	Cancer enhanced	Detected in all		ovarian cancer: 199.1					Cell type enriched	Detected in some	5	MAIT T-cell: 7.3	Lineage enriched	Detected in single	74	T-cells: 7.3	Group enriched	Detected in some	35	EFO-21: 42.0;RPTEC TERT1: 118.0	Low region specificity	Detected in all			Low region specificity	Detected in all			HPA038584, HPA077546	Uncertain		Approved	Nucleoplasm,Nucleoli,Actin filaments,Microtubule ends,Cytokinetic bridge	Secreted to blood	Yes	No	11500000	27000000	Nucleoli, Microtubule ends	Nucleoplasm, Actin filaments, Cytokinetic bridge	HPA038584: AB_10697394, HPA077546: AB_2732351	unprognostic (1.66e-1)	unprognostic (1.03e-2)	unprognostic (8.36e-2)	unprognostic (8.72e-2)	unprognostic (1.52e-1)	unprognostic (3.76e-2)	unprognostic (1.82e-1)	unprognostic (8.20e-2)	unprognostic (1.05e-1)	unprognostic (5.93e-2)	unprognostic (6.45e-2)	unprognostic (1.07e-1)	prognostic favorable (3.12e-4)	unprognostic (7.22e-3)	unprognostic (7.89e-2)	unprognostic (4.65e-2)	prognostic unfavorable (1.88e-4)	16.8	5.1	8.3	5.2	12.5	0	3.3	4.8	10.7	15.7	9.7	7.6	0	9.6	12	4.6	5.3	20.3	40.2	4.9	7.2		5.4	0.1	8.1	0.7	5.1	8.8	12	0.8	0	2	12.3	7.5	7.2	15	8.5	0.9	2.5	0	1.6	12.4	15.7	3.2	1.8	3.9	0.8	5.7	0	0.8	0.6	0	15.6	9.9	0	0	0	0	0	7.3	0.3	0	0	0	0	0	0	0	0.2	0	0	0	1.8	0	0	42	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	2.2	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0.3	0	0	118	0	0	0	0	0	0	0.8	0	0	0.4	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0.4	0	7.3	0	1.3	0.7	0	0	0.9	0.1	0	0	0	0	0	0.3											0	2.9	10.4	12.6	0	8.9	1.2	2.5	1.4	0	0	2	2.6	3.3	3.3	1.3	1	19.8	0	1.8	3.1	18.3	5	2.3	0	1.6	1.6	16	3.7	0.3	1.2	4	0	0	0	18.6	163.5	4.5	10.5	28.3	0.8	29.7	6.5	5.4	0.2	0.6	0	4.1	5	35.1	8	Muller glia cells
AC139530.2		ENSG00000262660			17	81703371-81720539	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level				Low tissue specificity	Detected in many			Cell type enriched	Detected in single	12	Club cells: 1.2	Not detected	Not detected			Low region specificity	Detected in many			Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		Karpas-707: 6.6;MOLT-4: 18.5;SK-BR-3: 7.0									HPA022853, HPA023043, HPA023048	Approved		Supported	Mitochondria						Mitochondria		HPA022853: AB_1854099, HPA023043: AB_1854100, HPA023048: AB_2301950		unprognostic (2.36e-3)					unprognostic (1.17e-1)		unprognostic (2.87e-1)								unprognostic (3.83e-1)	2.4	3.6	2.3	2.3	3	1.5	6.3	2.7	5.7	2.3	4.6	0.8	2.7	13.8	3.4	1.5	4.6	2.3	2.7	16.3	2.4	2.3	4.9	16.6	3	4.2	2.5	1.5	2.3	9.9	3.6	2.3	3.4	2.2	2.4	1.5	1.1	3.1	2.4	15.5	2.4	5.9	1.6	2.3	3.3	2.6	2.6	0.6	3	2.4	12.6	3	2.3	2.3	0	0.4	0	0.1	0.8	0.6	0.1	1.3	0.6	1.8	4.7	0	0	0.9	0	0	0	0.6	0.3	0.3	0.9	0.3	0	1.7	2.7	0	0	0	0.4	0	0	0	0	0	0	0.5	0.7	0.2	0	0.6	0.7	0.3	0.1	0	6.6	0	0.8	18.5	0.8	1	0.7	0	3.3	0.3	1.2	0	0	3.2	1.6	0	7	1.8	0.4	3	1.6	0	0.5	1.1	1	1.7	0.6	0	0.7	1.2	0.5	2.5	0	0.1	0	0	0	0.3	0	0.6	0	0.4	0	0	0	0	0.8	0.1	0	0	0.1	2.3	3	2.7	3.7	2.4	2.3	2.5	1.5	2.2	0.6	0	0	0	0	0	0	0	0	0	1.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Club cells
MYZAP	GCOM1, Gup, Gup1, MYOZAP	ENSG00000263155	Myocardial zonula adherens protein	P0CAP1	15	57591941-57685364	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		heart muscle: 132.6;smooth muscle: 52.2	Cell type enriched	Detected in many	16	Cardiomyocytes: 451.1	Low cancer specificity	Detected in many			Group enriched	Detected in many	5	cerebellum: 6.9;pons and medulla: 6.1	Cell type enhanced	Detected in some		naive B-cell: 6.7;naive CD4 T-cell: 3.6	Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		HEL: 52.3;hTERT-HME1: 9.6;HUVEC TERT2: 11.5;OE19: 18.4;RT4: 10.1;TIME: 12.3					Not detected	Not detected			HPA039827	Approved											HPA039827: AB_10673364	unprognostic (1.30e-2)	unprognostic (1.25e-1)	unprognostic (2.44e-1)	unprognostic (1.66e-1)	unprognostic (9.26e-3)	unprognostic (1.49e-1)	unprognostic (6.10e-3)	unprognostic (5.19e-2)	unprognostic (8.92e-2)	unprognostic (2.30e-2)	unprognostic (1.26e-1)	unprognostic (9.67e-2)	unprognostic (1.44e-1)	unprognostic (1.12e-1)	unprognostic (1.07e-1)	unprognostic (3.86e-2)	unprognostic (1.77e-2)	11.8	12.3	0.6	1.4	1.2	0.5	13	6.9	1	5.5	5.6	0.6	3.3	3.3	6.1	1.9	12.6	1.1	3.2	132.6	0.6	0.9	1.4	0.4	9.8	2.1	0.9	0.5	1.5	7.4	0	1	11.7	6.1	13	2.4	0	6.1	8.4	3.3	2.2	9.1	52.2	0.5	2.4	4.9	1.6	0.2	0.4	1	6.6	6.4	31.4	12.1	6.7	0.1	1	1.3	0	3.6	5	2.3	0.7	0	4.2	1	0	1.2	0.3	3.5	0.5	0.7	2.9	1.6	0	0.2	0	3.5	0.9	0	1.6	0.7	0	0.1	52.3	0.6	0	0.1	0	0	0	1.3	0.1	9.6	0	11.5	0	0.7	0	0.3	0.8	0	0	0	18.4	1	0	4.4	0.1	0	10.1	0	1.5	0.2	2.4	0	0.5	3.1	0	12.3	0	1	0.1	0	0	0	0	0.7	0	0	0	0.2	0	0	1	0	0.7	0.6	0	0.1	6.7	3.6	0	1	0	1.3	0	0.3	5	0.6	1.2	6.9	1	0.6	0.9	0.9	0.5	6.1	0.2	8.9	1.1	0	8.9	0	0.1	451.1	7.6	1.4	1.2	24.4	0	3.6	6.6	28.1	0.1	3.6	13.7	0	16.8	2.3	0	6	0	0	1.3	0	1.7	4.9	5.9	0.4	4.4	0	0	5.4	6.1	0.1	17.9	21	15.9	0	0	0	0.9	0	0.9	0	1	0	6	4.9	Cardiomyocytes
DPEP2NB		ENSG00000263201	DPEP2 neighbor		16	68013436-68015911	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level				Tissue enhanced	Detected in some		blood: 3.6;placenta: 2.8;testis: 5.7	Cell type enriched	Detected in some	46	Syncytiotrophoblasts: 54.9	Not detected	Not detected							Group enriched	Detected in some	29	eosinophil: 3.6;neutrophil: 2.1	Lineage enriched	Detected in single	37	granulocytes: 3.6	Cell line enhanced	Detected in some		JURKAT: 1.7;SuSa: 1.4;U-2197: 1.5	Not detected	Not detected																									unprognostic (1.91e-1)											unprognostic (3.22e-2)	0	0		0		1.2	0		0	0	0			0	0	0	0	0	0	0			0	0	0	0			0	0	0		2.8		0	0		0	0	0	0	0	0		0	0	5.7			0		0	0		0	0	3.6	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0.5	0	0	0	0.1	0	0	0.5	0	0	0	0	0.3	0	0	0	0.2	0	0	0.8	0	0	0	1.7	0.1	0	0	0	0	0.5	0	0	0	0	0	0.3	0	0	0	0	0	0	0	1.4	0	0.3	0	0	0	1.5	0.1	0	0	0.1	0.3	0.4	0	0	0	3.6	0	0	0	0	0	0	0	0	0	0	2.1	0	0	0	0	0											0	0	0	0	0	0	0	0	0	0	0	0	1.2	0	0	0	0	0	0	0	0.1	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	54.9	0	0	0	Syncytiotrophoblasts
PPIAL4A	COAS2, PPIAL4, PPIAL4B	ENSG00000263353	Peptidylprolyl isomerase A like 4A	Q9Y536	1	120889746-120890405	Enzymes, Predicted intracellular proteins		Isomerase, Rotamase		Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in some		blood: 3.5;intestine: 1.6	Cell type enriched	Detected in single	10	Distal tubular cells: 1.7	Not detected	Not detected							Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		Karpas-707: 3.8;NB-4: 4.6;SK-BR-3: 4.7									HPA058345	Uncertain											HPA058345: AB_2683685	unprognostic (3.49e-3)	unprognostic (2.78e-2)	unprognostic (1.45e-1)	unprognostic (1.42e-1)	unprognostic (4.17e-1)	unprognostic (1.77e-1)	unprognostic (2.09e-1)	unprognostic (1.42e-2)	unprognostic (7.94e-3)	unprognostic (1.72e-2)	unprognostic (1.91e-1)	unprognostic (7.11e-2)	unprognostic (5.32e-2)	unprognostic (3.66e-2)	unprognostic (1.55e-1)	unprognostic (1.83e-2)	unprognostic (1.74e-1)	0.3	0.8		1		1.4	0.2		1.2	0	0			1.6	0	0	0	0	0	0.1			0.2	1.2	0	0.5			0.1	0	0		0.4		0	0		0	0	0	0.2	1	0		0.4	0.4	0			0		0	0		3	3.2	0.6	1.6	2.2	2.4	3.5	0.9	0	0.1	1.4	0	0	0.7	0	0	0.2	0	0	1	0.7	0.2	0	0.3	1.8	0.2	0	0	0.8	0	0	0	0	0	0.8	1	0	0.8	0	0	0	0.3	0	0.2	3.8	0.3	0.6	1.7	4.6	2.5	0	0	0.8	1.5	1.9	0	0	1	0.3	0.3	4.7	0.4	0.1	3.1	2.5	0.7	3	1.2	2.9	1.7	1.4	0.9	2.5	2.6	1.6	3.2	0.2	1.6	0.6	1.4	1.2	1.4	3	2.3	2.4	3.1	2.2	1.5	2.4	0	2.2	1.2	3.2	2.4	3.5											0	0	0	0.1	0	0	0	0	0	0	0	0	0	1.7	0	0	0	0	0	0	0.1	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Distal tubular cells
TMEM238L	LINC00675	ENSG00000263429	Transmembrane protein 238 like		17	10794913-10804099	Predicted membrane proteins				Evidence at transcript level	Evidence at transcript level				Tissue enhanced	Detected in many		ductus deferens: 19.9;intestine: 19.0;seminal vesicle: 14.6;stomach 1: 23.0	Cell type enriched	Detected in some	15	Collecting duct cells: 15.7	Cancer enhanced	Detected in many		colorectal cancer: 13.0					Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	10	OE19: 11.0;RT4: 7.1	Not detected	Not detected																				unprognostic (7.23e-3)	unprognostic (1.55e-1)	unprognostic (3.49e-2)	unprognostic (2.38e-1)	unprognostic (2.43e-1)	unprognostic (2.59e-2)	unprognostic (2.99e-2)	unprognostic (2.71e-1)	unprognostic (1.20e-1)	unprognostic (9.30e-3)	unprognostic (6.09e-2)	unprognostic (1.74e-1)	unprognostic (1.27e-1)	unprognostic (3.13e-1)	unprognostic (3.11e-1)	unprognostic (7.56e-2)	unprognostic (1.19e-2)	0	0	0.2	7.5	0.6	0	0.6	0	1	0	18.3	0	19.9	8.8	0	1.1	3.2	0	9.5	0	0.4		0.8	0	0	0	0	0	0	0	0	0	0	0.6	2.5	19	0	0	14.6	0	0.2	14	1.2	0	0	23	0	0	0	0	2.8	3.1	6	1.2	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	11	0.1	0	0	0.2	0	7.1	0	0	0	0.9	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0	0	0	0	0	0	15.7	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.1	0	0	0	0	0	0	0	0	0	0	0	0	0	Collecting duct cells
PPIAL4C		ENSG00000263464	Peptidylprolyl isomerase A like 4C	A0A0B4J2A2	1	149583865-149584464	Enzymes, Predicted intracellular proteins		Isomerase, Rotamase		Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in some		blood: 10.9;intestine: 5.5	Cell type enriched	Detected in single	16	Cardiomyocytes: 1.6	Not detected	Not detected							Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Cell line enhanced	Detected in many		NB-4: 14.4;THP-1: 16.9									HPA058345	Uncertain											HPA058345: AB_2683685	unprognostic (3.16e-1)	unprognostic (2.83e-2)			unprognostic (1.50e-2)	unprognostic (7.93e-2)		unprognostic (5.98e-2)	unprognostic (1.37e-1)	unprognostic (1.79e-1)				unprognostic (6.61e-2)			unprognostic (2.25e-1)	0	3.3		2.7		0.1	0		1.5	0	0.8			5.5	0.8	0	0	0	0	0			1	0	1	2.9			0.2	0	0.9		0.7		0.3	0		0	0	0.2	0.5	2.9	0		1.4	0.9	0			0		0.3	0		9.1	9.7	1.9	6	4.6	7.8	10.9	3.6	0.3	0.4	3.1	0.1	0.3	2	0.6	0.4	1	0.7	0	4.8	1.3	2.1	0	2.5	3.9	0	0.2	0.6	3.5	0	0.5	0	0	0.1	2	1.9	0.1	0.5	0.6	0.3	0	0	0.5	0.9	5.4	0.7	0.4	5.3	14.4	6.2	1	0.1	5.3	0	9	0.2	0	4	5.5	1.1	11.3	6.2	0.3	5.3	16.9	1.3	3.6	5.6	3.3	8.2	4.2	5.6	9.2	3.9	4.6	7.8	0.9	4.3	1.9	5.4	6	6	9.1	6.1	5.7	9.4	7.2	5	5.9	0	4.6	5.3	9.7	7.8	10.9											0	0	0	0	0	0	1.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Cardiomyocytes
MSMB	IGBF, MSP, MSPB, PN44, PRPS, PSP, PSP-94, PSP57, PSP94	ENSG00000263639	Microseminoprotein beta	P08118	10	46033307-46046269	Cancer-related genes, Disease related genes, Predicted secreted proteins			Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	15	prostate: 437.8	Cell type enriched	Detected in some	25	Glandular cells: 8376.6	Cancer enriched	Detected in many	42	prostate cancer: 3435.3					Cell type enriched	Detected in single	5	eosinophil: 1.9	Lineage enriched	Detected in single	5	granulocytes: 1.9	Cell line enhanced	Detected in some		BEWO: 20.5;NB-4: 16.5;RPMI-8226: 8.6;SH-SY5Y: 4.7;SK-BR-3: 4.8;U-2197: 9.7									CAB026357, HPA051257	Enhanced				Secreted in male reproductive system				3700000			CAB026357: , HPA051257: AB_2681410	unprognostic (6.47e-2)	unprognostic (7.21e-3)		unprognostic (1.37e-2)		unprognostic (8.18e-3)	unprognostic (4.28e-3)	unprognostic (9.24e-3)	unprognostic (1.66e-1)	unprognostic (8.66e-2)	unprognostic (2.01e-1)	unprognostic (4.55e-2)		unprognostic (2.01e-1)	unprognostic (7.04e-2)	unprognostic (1.39e-1)	prognostic favorable (7.19e-4)	0	0	0	0	0	0	0.7	0	0.4	1	0.8	0	0.1	0.1	0	1.8	0.1	0	7.2	0	0		0	0	29.8	0	0	0	0	0	0	0	0	0	437.8	0	0	14.8	0.1	0	0	0	0.2	0	0	26.8	0.6	0	0	0	0.1	0.7	0.7	0	0	0	1.9	0	0	0.4	0	0	0.2	0	0	0	0	20.5	0.1	0	0	0	0.5	0	0	0.5	0	0	0.2	0	0	0	0	0	0	0.3	0.7	0	0	0.2	0	1.2	0	0	0.1	0	0	0	0.1	0	1.2	0.3	16.5	0.2	0.1	0	0	0	8.6	0	1.2	0.9	4.7	0	4.8	0	0.2	0.4	0	0	0	0	9.7	0	0.1	0	0	0.1	0	0	0	0	1.9	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0											0	3.2	0	273.5	0	0	0	7.6	333.3	236.6	0	0	1.9	0	0	43.1	0	0	0	0.2	0.2	0	8376.6	1.1	1	0.2	0	0	0	0	49.8	0.3	0	3.3	0	0	0	2.7	2.3	0	0	0	0	0	0.2	0.5	0.4	1.3	0	0	190.4	Glandular cells
MYH4	MYH2B, MyHC-2B, MyHC-IIb	ENSG00000264424	Myosin heavy chain 4	Q9Y623	17	10443290-10469559	Plasma proteins, Predicted intracellular proteins		Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin		Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	29	skeletal muscle: 15.1	Cell type enriched	Detected in single	25	Cardiomyocytes: 2.5	Cancer enriched	Detected in single	115	liver cancer: 9.4	Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	25	OE19: 14.2	Not detected	Not detected			Not detected	Not detected			HPA001349	Supported								34000000			HPA001349: AB_1079437	unprognostic (3.27e-2)		unprognostic (2.94e-2)			unprognostic (4.94e-2)	unprognostic (1.69e-2)	unprognostic (4.72e-1)			unprognostic (1.37e-1)		unprognostic (3.32e-2)	unprognostic (1.21e-3)	unprognostic (3.52e-4)		unprognostic (9.97e-2)	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	15.1	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0.1	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	2.5	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Cardiomyocytes
AC099850.2		ENSG00000265303			17	59197566-59215226	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level				Low tissue specificity	Detected in many			Cell type enriched	Detected in single	12	Club cells: 1.2	Not detected	Not detected							Group enriched	Detected in some	5	naive B-cell: 1.4;NK-cell: 5.1	Group enriched	Detected in many	5	B-cells: 1.4;NK-cells: 5.1	Group enriched	Detected in some	5	NB-4: 14.8;THP-1: 7.9																																							0.4	1.8	2.4	0.2	2.6	3.7	1.1	0.3	2.1	0.2	2.6			0.2	2.2	0.5	1.2	0.6	0.2	1.1	2.9	3.2	0.9	4.1	0.6	2.7	2.7		2.1	2.1	0.2	1.6	0.8		0.8	1.4		0.9	1	1.9	2.2	1.6	0.6	1.2	2.9	1.3	1.5			0.2		3.4	0.2	0.2	1.4	0.6	0.3	0.1	5.1	0.4	0	0	0.6	0.5	0.4	0	0	0	0.7	0.2	0	0.5	0	0	0	0.6	0	0	1.1	0.5	0	0.9	0	2.1	1	0	1.8	0	0	0.4	0	0	0	1.1	0.5	0.5	1.4	0	0	1.1	0	0.8	14.8	0	0	0	0	0	0	1.9	0	0	0.5	0.4	0	2.4	0.4	0.4	7.9	0	0	0.8	0.2	0.2	0.3	0.5	0	0.5	0.7	0	0.3	0.1	0	0	0	0	0	0	0	0	1.4	0	0	0	5.1	0	0.6	0.4	0											0	0	0	0	0	0	0	0	0	1.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Club cells
ZNF488	FLJ32104	ENSG00000265763	Zinc finger protein 488	Q96MN9	10	47365496-47384273	Predicted intracellular proteins	Neurogenesis, Transcription, Transcription regulation	DNA-binding, Repressor		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Group enriched	Detected in some	7	brain: 29.7;intestine: 25.8	Cell type enriched	Detected in some	5	Syncytiotrophoblasts: 30.2	Low cancer specificity	Detected in many							Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HaCaT: 23.7;HDLM-2: 34.3;RT4: 19.1	Low region specificity	Detected in many			Low region specificity	Detected in all			HPA035957, HPA035958			Supported	Nucleoplasm,Cytosol	Intracellular and membrane					Nucleoplasm, Cytosol		HPA035957: AB_10672234, HPA035958: AB_2674887	unprognostic (3.29e-2)	unprognostic (1.05e-2)	unprognostic (7.87e-2)	unprognostic (1.49e-4)	unprognostic (1.16e-1)	unprognostic (8.85e-2)	unprognostic (1.60e-3)	unprognostic (2.13e-2)	unprognostic (3.11e-1)	unprognostic (2.45e-1)	prognostic unfavorable (4.02e-7)	unprognostic (3.60e-1)	unprognostic (6.62e-5)	unprognostic (2.76e-1)	unprognostic (4.47e-1)	unprognostic (8.10e-2)	unprognostic (3.18e-2)	0.4	0.4	5.7	0.4	18.5	0.3	1.2	2.9	14.2	0.5	3.2	17	0	25.8	0.5	2.3	0.9	0.5	0.6	0.4	15.1		1.1	0.3	0.5	0.3	19.8	6	0.7	0.3	0.3	0	4.1	21.4	0.6	1.1	0	0.6	0.4	0.3	2.2	12.5	0.4	29.7	0.3	0.6	1.2	12.8	0	0.3	0	0.9	0.7	0	0	0	0	0.2	0	0	0	2.4	6.8	1.2	0.3	0	0	0.1	0.2	0.3	0.4	0.4	2.7	6.4	0.1	0.4	0	2.7	23.7	0.6	2.6	0.3	34.3	0.7	0.1	0.7	0.2	0	0	0.3	0	6.2	0.2	0.6	0.1	0	1.3	0	0	0	0.1	0.2	0.1	1.8	5.1	0.6	0	3	0	0.1	19.1	5.7	1	1.6	0.2	0	2.7	0.5	0	0	0	1.8	0	0.3	0	0	0	0	0	0.7	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0.8	0.6	0.8	0.3	0	0	0	0	0	5.6	5	0.3	0	0	1	0	0.2	0.3	0.2	0.1	0	0	0.3	0	0	0	0	0	0	0	0	0	1.4	0.1	0.3	0	0	0	0	0	0.1	0	1.3	0.1	30.2	0	0.8	0.3	Syncytiotrophoblasts
PTGES3L		ENSG00000267060	Prostaglandin E synthase 3 like		17	42968088-42980433	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level				Tissue enhanced	Detected in many		heart muscle: 18.3;skeletal muscle: 61.3	Cell type enriched	Detected in some	5	Cardiomyocytes: 41.4	Low cancer specificity	Detected in some			Region enhanced	Detected in some		basal ganglia: 4.2	Cell type enriched	Detected in some	7	plasmacytoid DC: 8.9	Lineage enriched	Detected in many	7	dendritic cells: 8.9	Cell line enhanced	Detected in many		HMC-1: 8.9;RH-30: 8.7;THP-1: 22.7	Low region specificity	Detected in many			Low region specificity	Detected in all																unprognostic (1.83e-1)	unprognostic (1.64e-1)	unprognostic (9.77e-2)	unprognostic (6.61e-2)	unprognostic (7.45e-2)	unprognostic (4.66e-2)	unprognostic (2.36e-2)	unprognostic (1.31e-2)	unprognostic (1.24e-1)	unprognostic (6.23e-2)	unprognostic (2.80e-4)	unprognostic (9.24e-2)	unprognostic (3.03e-2)	unprognostic (1.40e-1)	unprognostic (3.10e-1)	unprognostic (6.25e-2)	unprognostic (4.08e-2)	0.5	0.2	0.7	0.8	4.2	1.1	0.5	0.3	1.2	1.3	5.1	0.2	0	0.6	3.5	2.2	2.2	1.1	3.3	18.3	0.5	0.7	0.2	0.1	0.4	0.5	0.6	0.7	0.6	0.2	0.2	0.4	0.2	0.3	1.8	1.5	1.5	1	2.2	61.3	0.5	1.2	10	0.2	0.3	1.7	0.6	0.1	0.4	0.4	13.6	0.6	4.7	1.3	0.7	8.9	1.3	0.3	0.6	0.3	0.8	0.7	0.6	1.9	3.6	0.1	0.3	1.6	1.3	0.8	1.1	0.6	1.5	0.7	0.6	0.5	0.5	1.1	1.4	1.5	1.4	1.7	0.5	0.6	5.2	3	3.1	0.1	0.8	8.9	0.7	1	2.4	1.7	0.7	0.3	3.3	1.8	1.6	3.4	1	3.2	2	2.1	2.8	0.5	1.3	8.7	0.7	2.1	1.4	1.7	5.9	1.6	3.2	2.6	2.1	1.7	22.7	0.7	1.9	1.8	0.6	1.2	3.9	2.5	0.9	0.3	0.9	0.7	1.3	0.3	0.4	0.3	0.2	0.3	0.3	0.3	0.3	0.3	0.7	0.3	0.3	1.2	0.6	0.2	8.9	0.2	0.8	0.7	4.2	0.3	1.2	0.5	0.7	0.6	0.7	0.3	0.1	0	0	0.5	0.6	0	0.9	41.4	0	1.4	0	0	7.9	0.1	0	1.4	8.6	0.1	0.9	0	0.2	0.5	0.2	0.6	0	0	1	0	1.7	1.3	0	3.3	0.6	0.2	0	2.8	0.6	0.7	0.7	2.9	0.4	0.3	2.5	0	4.2	5.2	4.1	0	0.1	0	1	0.3	Cardiomyocytes
AC099811.2		ENSG00000267261			17	42119674-42154916	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level				Low tissue specificity	Detected in all			Cell type enriched	Detected in single	30	Alveolar cells type 1: 3.0	Not detected	Not detected			Low region specificity	Detected in all			Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		MOLT-4: 6.9;REH: 5.0;SK-BR-3: 5.0;U-87 MG: 4.7																																							5.1	4.4	4.5	9.1	5.9	3.4	4.5	6.6	9.5	4.6	4.4	7	2.5	10.4	4	2.9	4	3	3.7	4.1	4.5	5.2	9.7	8.6	7	5.5	5.8	3.6	4	14	2.9	3.2	5.1	5	4	3.5	4.4	3.4	4.7	4.8	4.4	6.2	4.4	3.7	6.4	4.3	4.3	5.2	3.2	7	1.7	4.3	6.2	4.3	0.5	0.7	1.3	1.4	0.2	0.5	0.3	2.6	0	0.9	1.1	0	0	0	0	0	0.7	0.6	0	0	0.3	1	0	2.1	2.6	0	0.7	0	2	1.1	1.3	1.3	1.4	0	0	0	2	0.5	1.3	0	0	0	0.8	0.2	0.9	0	0	6.9	0.1	1.1	2.4	0	5	1.1	0	0	1.3	0.4	2.2	0	5	0.2	1.2	0	0	0	0.9	1.3	0	1.9	2.5	0.7	0	4.7	0	0	0	1.4	0.3	0.3	0.3	0.1	0.2	0.2	0.3	0.6	0.5	0.2	0.3	1.3	0.2	0.2	0.7	0.5	0.3	4.5	5.9	6.6	9.5	4.5	5.2	5.8	3.6	5	5.2	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Alveolar cells type 1
APOC4		ENSG00000267467	Apolipoprotein C4	P55056	19	44942238-44945496	Plasma proteins, Predicted secreted proteins	Lipid transport, Transport			Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	29	liver: 126.0	Cell type enriched	Detected in single	34	Hepatocytes: 3.4	Cancer enriched	Detected in single	15	liver cancer: 0.7	Not detected	Not detected			Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		HEL: 4.2;SK-MEL-30: 6.5;TIME: 3.1									HPA062671	Approved				Secreted to blood			1000000000	1500000000			HPA062671: AB_2684828							unprognostic (1.82e-3)											0	0.2	0.1	0	0.2	0.1	0	0.1	0.1	0	0	0	0	0	0	0.2	0	0	0	0	0.2	0.2	0	126	0.1	0	0.2	0	0.1	0	0	0	0	0	0	0	0	0	0.2	0	0	0.1	0	0.2	0.2	0	0.1	0	0	0.1	0	0	0	0	1.4	3.1	4.3	1.7	0.8	1.2	0.1	0.8	0	0	0.8	0	0.9	1.6	0	0	1.1	0.2	0	0.2	1.1	0.1	0	0.2	0.1	0.6	0.4	0.3	0.2	0.4	4.2	0	2.6	0	0.3	1.2	2.5	0.3	0	0.4	0.1	0	1.3	1.2	1.9	0.8	1	0.4	0	0	0.1	0.5	0	0.6	0.8	0	1.5	0.5	0.2	0.7	0.8	6.5	0.2	1.4	0	3.1	0.6	0.3	0.4	0	0.8	0.9	2	0.2	1.3	0	2.1	0.8	1.9	0.9	1.7	0.4	0.6	0.9	1.2	0.4	1.4	0.6	0.6	4.3	0.8	0.8	3.1	0.5	0.1	0.1	0.2	0.1	0.1	0.2	0.2	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Hepatocytes
CGB1		ENSG00000267631	Chorionic gonadotropin beta subunit 1	A6NKQ9	19	49035610-49036895	Predicted intracellular proteins, Predicted secreted proteins		Hormone		Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enriched	Detected in some	5	pancreas: 8.4	Cell type enriched	Detected in single	125	Syncytiotrophoblasts: 58.5	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	5	HMC-1: 20.5									HPA038925, HPA038934	Uncertain		Approved	Cytosol	Secreted to blood					Cytosol		HPA038925: AB_2676272, HPA038934: AB_2676277																		0	0.1	0	0	0	0	0	0	0	0	0			0.6	0	0	0	0	0	0	0	0	0	0	0	0	0		0	8.4	0	1.4	0.1		0	0		0	0	0	0.1	0.1	0	0	0	0.1	1.8			0		0	0	0	0	0	0	0	0	0	0	0	0.5	0	0.1	0	0	1.4	0	0	0.1	0	0.6	0.3	0	0	0	0	0	0.2	0	0	0.1	0.6	0	0.2	0	0	0	20.5	0	0	0	0	0	0	0.1	0	0.1	0	0.1	0	0	0	0.2	0.3	0.1	0	0	0	0	0.1	0.3	0.2	0.1	0.9	0	0.1	0.1	0	0	0.5	0.3	4.1	0	3.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0.2	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	58.5	0	0	0	Syncytiotrophoblasts
OPN1MW	CBBM, CBD, COD5, GCP, OPN1MW1	ENSG00000268221	Opsin 1, medium wave sensitive	P04001	X	154182596-154196135	Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins	Sensory transduction, Vision	G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer	Disease mutation	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in single		lymphoid tissue: 1.5	Cell type enriched	Detected in single	97	Cone photoreceptor cells: 31.4	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in single		HEK 293: 1.9																																							0	0.6		1.5		0	0.7		0	0	0			0	0	0	0	0.2	0	0			0	0	0	0			0	0	0		0		0	0		0	0	0	0	0.4	0.3		0.1	0	0.1			0		0	0		0	0.2	0	0	0	0.1	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	1.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0.9	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0.2	0	0	0.1	0	0	0	0	0	0											0	0	0	0	0	0.3	0	0	0	0	0	31.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Cone photoreceptor cells
SSX2B	CT5.2b	ENSG00000268447	SSX family member 2B	Q16385	X	52751132-52790305	Cancer-related genes, Disease related genes, Predicted intracellular proteins	Transcription, Transcription regulation		Cancer-related genes, Proto-oncogene	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	24	testis: 13.5	Cell type enriched	Detected in single	10	Spermatogonia: 4.4	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		CAPAN-2: 1.8;HMC-1: 5.4;PC-3: 5.2;T-47d: 2.3;U-2197: 3.3									HPA045683	Supported		Approved	Nucleoplasm,Nucleoli						Nucleoplasm, Nucleoli		HPA045683: AB_2679418																		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	13.5	0	0	0.5	0	0	0	0	0	0.1	0	0.3	0	0.1	0	0	0.9	0	0.9	0	0	1	0	0	0	0	0	1.8	0	0	0.4	1.1	0	0	0	0	0	0.1	0	0.7	0	0	0	5.4	0	0	0	0	0.1	0	0.1	0.7	0.6	0.5	0.1	0	0	0.2	0	5.2	0	0.1	0	0.1	0	0	0.1	0	0.7	0	0	2.3	0	1	0	0.5	3.3	0	0.1	0.6	0	0	0	0.1	0	0	0	0	0	0.1	0	0	0	0	0	0.1	0	0	0	0.3	0.1	0	0											0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	4.4	0	0	0	0	0	Spermatogonia
AC008687.4		ENSG00000268655			19	49017496-49020523	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level				Tissue enriched	Detected in some	14	pancreas: 13.7	Cell type enriched	Detected in single	10	Pancreatic endocrine cells: 2.3	Low cancer specificity	Detected in some							Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HDLM-2: 2.7;HEK 293: 4.0;SiHa: 2.7;U-2 OS: 3.1;U-251 MG: 2.7																						unprognostic (2.06e-1)	unprognostic (7.61e-3)	unprognostic (7.17e-3)	unprognostic (1.12e-2)	unprognostic (2.93e-1)	unprognostic (1.23e-1)		unprognostic (5.63e-2)	unprognostic (4.91e-2)	unprognostic (3.85e-1)	unprognostic (7.96e-4)	unprognostic (9.37e-3)	unprognostic (4.19e-2)	unprognostic (2.72e-2)	unprognostic (1.33e-1)	unprognostic (6.96e-2)	unprognostic (1.46e-1)	0	0		0		0	0		0	0	0			0.2	0	0	0	0	0	0			0	0	0	0			0	13.7	0		0		0	0		0	0	0	0	0	0		0	0.4	1			0		0	0		0	0	0	0.2	0	0.8	0	0.6	0.2	0	0.6	0.2	0	0.7	0.3	0.1	0	0	0.6	1.3	0.8	0.1	0.3	0	0.3	0.1	0	0.1	2.7	4	0	0.4	0.1	0.1	0.7	0.6	0	0.1	0.1	0	0	0	0.4	0.7	1.5	0	0.2	0	0.2	0.2	0.2	0.1	1.5	0.4	1.2	0	0.1	0.4	0.2	2.7	0.2	0.2	0.1	0.3	0.3	0	0.7	3.1	0	2.7	1.2	2.2	1.2	0.6	1.1	0	0	0.2	0	0.3	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0.8	0											0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.3	0	0	0	0	0	0	0	0	0	0	0	0	0	Pancreatic endocrine cells
HSFX2		ENSG00000268738	Heat shock transcription factor family, X-linked 2	Q9UBD0	X	149592515-149594716	Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	DNA-binding		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in some	5	testis: 9.3	Cell type enriched	Detected in single	11	Cardiomyocytes: 1.1	Not detected	Not detected							Cell type enhanced	Detected in some		basophil: 1.7;naive CD4 T-cell: 1.8	Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		HaCaT: 2.7;hTCEpi: 3.4									HPA063040	Supported											HPA063040: AB_2732695					unprognostic (7.64e-2)					unprognostic (6.92e-3)				unprognostic (2.00e-1)				0	0		0		0	0.3		0.1	0	0			0	0	0	0	0.7	0	0			0	0.1	0.3	0.1			0.2	0	0.5		0.1		0.1	0.3		0.6	1.3	0.1	0.5	0	0.1		0	0	9.3			0		0	0.1		0.2	0.5	1.7	0.2	0.2	1.8	0.3	0.6	0	1.9	0.3	0	1.1	0.2	1	0.9	1.2	0.1	1.6	0	0.4	0	0	0	2.7	0	0.9	0.8	0	0.9	0.8	0	0.2	0.2	0.2	0.8	1.6	3.4	1.2	0	0.4	0	1	0	0	0	1	0.2	2.5	0.9	0.5	1.3	0.1	0	0.4	1.4	0.8	0	0.4	0	0.5	1.1	0.9	0.3	0.9	1.4	2.4	0	0.1	0	0.2	0	0.3	0.6	0.5	0.5	1.7	0.2	0	0.5	0	0	0	0.2	0	0.2	0.2	1.8	0.1	1.1	0.2	0.2	0.5	0	0.3											0	0	0	0	0	0	1.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Cardiomyocytes
CT45A1	CT45-1, CT45.1	ENSG00000268940	Cancer/testis antigen family 45 member A1	Q5HYN5	X	135713453-135723539	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at transcript level		Tissue enriched	Detected in single	17	testis: 12.5	Cell type enriched	Detected in some	5	Spermatogonia: 5.5	Low cancer specificity	Detected in some							Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	7	HMC-1: 70.1;Karpas-707: 32.4									HPA044735, HPA044757, HPA046872, HPA046987	Supported		Approved	Nucleoplasm,Nucleoli						Nucleoplasm, Nucleoli		HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893										unprognostic (6.58e-3)					unprognostic (2.14e-1)			0	0	0	0	0	0	0	0	0.3	0	0	0.4	0	0	0	0	0	0	0	0	0		0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	12.5	0	0	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	1.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	70.1	0	0	0	0	0	0	0	0.5	32.4	0	0.2	0	0	0	0	0	0	0	1.9	0	0	0	0	0	0	0	0	0.6	0	0	0	6.6	0	0	0.5	6.8	0	0.1	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.1	5.5	0	0	0	0	0	Spermatogonia
ERVV-2	ENVV2	ENSG00000268964	Endogenous retrovirus group V member 2, envelope	B6SEH9	19	53044738-53051076	Predicted membrane proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enriched	Detected in single	105	placenta: 85.9	Cell type enriched	Detected in single	5	Syncytiotrophoblasts: 3.2	Low cancer specificity	Detected in single			Not detected	Not detected			Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	4	BEWO: 19.1;SuSa: 12.9;T-47d: 5.4									HPA076115			Approved	Centrosome,Cytosol						Cytosol	Centrosome	HPA076115: 				unprognostic (3.14e-3)		unprognostic (2.06e-1)				unprognostic (1.31e-1)			unprognostic (4.33e-9)	unprognostic (3.01e-2)	unprognostic (1.68e-1)	unprognostic (1.05e-1)	unprognostic (2.60e-4)	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0.7	0	0	0	0.8	0	0	0	0	0	85.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0.7	0	0	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	19.1	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0.2	0	0	0	0	12.9	5.4	0	0	0	0	0	0	0	3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0.2	0.8	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0.3	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.2	0	0	0	Syncytiotrophoblasts
MTRNR2L12		ENSG00000269028	MT-RNR2-like 12	P0DMP1	3	96617188-96618236	Predicted intracellular proteins, Predicted secreted proteins				Evidence at transcript level	Evidence at transcript level	No human protein/transcript evidence	Evidence at transcript level		Tissue enriched	Detected in all	5	blood: 603.3	Cell type enriched	Detected in many	12	Cardiomyocytes: 31937.7	Low cancer specificity	Detected in all			Low region specificity	Detected in all			Cell type enhanced	Detected in all		neutrophil: 603.3	Lineage enriched	Detected in all	7	granulocytes: 603.3	Cell line enhanced	Detected in all		HeLa: 496.6														Secreted to blood								unprognostic (3.79e-2)	unprognostic (1.05e-1)	unprognostic (1.88e-2)	unprognostic (1.37e-1)	unprognostic (1.09e-1)	unprognostic (9.76e-3)	unprognostic (1.69e-3)	unprognostic (1.81e-2)	unprognostic (7.77e-2)	unprognostic (3.55e-2)	unprognostic (2.08e-2)	unprognostic (4.90e-2)	unprognostic (9.59e-3)	unprognostic (1.81e-2)	unprognostic (2.61e-1)	unprognostic (2.08e-1)	unprognostic (1.85e-2)	18	29.1	32.5	5.2	31	4.5	7.5	8.8	19.2	5.1	20.2	6.4	5.7	8.1	5.1	75.3	10.9	3.8	40.2	114.2	26.3	19.8	32.9	29.8	5.4	7.8	26.2	7.5	4.9	9.7	4.3	6.6	5	10.4	6.9	16.5	6.8	10.8	9.3	101.3	10.6	9.3	6.9	15.3	5.3	13.3	9.7	8.7	72.1	5.1	11	5.3	6	8.5	69.1	53.1	603.3	81.8	37.9	45.5	57.6	99.3	122.4	91.7	329	142.5	76.9	84.3	129.6	26.5	25	32.3	67.2	160.7	219.2	105.6	48.9	14.5	274.9	6.4	54.7	34.2	64.2	118.4	232.2	496.6	283	54.2	46	128.5	139.1	65.6	26.3	72.2	153.1	27.8	99.1	164.5	75.6	84.7	52	39.7	145.5	26.7	60.3	36.9	63.6	88.2	67.6	149.9	74	41.8	81.5	84.4	85.9	111.3	85.1	88.3	134.4	122.9	103.5	86	115.6	36.6	40.2	25.1	108.9	64.2	290.2	27.9	183.7	81.8	153.2	28.1	44	37	65.7	35.7	29.9	31.2	69.1	45.5	40.8	603.3	37.9	42.3	53.1	31.4	57.6	32.5	31	8.8	19	26.3	19.8	26.2	7.5	10.4	8.7	2513.2	2660	61.6	386.4	99.9	0	31937.7	112.1	2625.9	2640	80.3	0	6.1	53	0.7	11.2	82.6	5.6	163.5	1.6	7.5	167.2	335.7	1581.1	147.2	10.6	0	4.7	79.2	93.4	36.3	39.7	230.1	183.9	1	7.8	0	1.3	7	21.5	70	0	45.3	270.2	25.4	36.6	70.6	8.8	96.9	2.4	333.1	Cardiomyocytes
CALR3	CRT2, CT93, FLJ25355, MGC26577	ENSG00000269058	Calreticulin 3	Q96L12	19	16479057-16496192	Disease related genes, Plasma proteins, Predicted intracellular proteins	Differentiation, Spermatogenesis	Chaperone	Cardiomyopathy, Disease mutation	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	19	testis: 43.6	Cell type enriched	Detected in some	4	Early spermatids: 46.5	Not detected	Not detected			Not detected	Not detected			Cell type enhanced	Detected in some		neutrophil: 2.2	Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		hTCEpi: 3.9	Low region specificity	Detected in many			Low region specificity	Detected in many			CAB025749, HPA043355, HPA048460	Enhanced				Intracellular and membrane							CAB025749: , HPA043355: AB_2678442, HPA048460: AB_2680403	unprognostic (1.19e-1)	unprognostic (3.84e-1)		unprognostic (7.17e-2)	unprognostic (4.34e-1)	unprognostic (2.32e-1)	unprognostic (2.95e-1)	unprognostic (1.30e-2)	unprognostic (1.44e-1)	unprognostic (4.28e-2)		unprognostic (1.18e-2)	unprognostic (6.69e-7)	unprognostic (1.60e-1)	unprognostic (2.78e-1)	unprognostic (6.28e-3)	unprognostic (6.34e-3)	0	0	0.5	0.3	0.4	0	0	0.8	0.8	0	0	0	0.2	0	0	1	0	0.1	0	0	0.4	0	0	0.1	0	0	0.4	0	0	0	0	0.5	0	0.3	0	0	0.2	0.2	0	0	0	0.1	0	0.5	0	0	43.6	0.3	0.8	0.1	0	0	0	0	1.3	0.8	2.2	0.1	0	0.6	0.1	0.2	0	0.1	0.5	0	0	0.7	0.2	0	1.1	0	1	0.9	0.6	0.1	0	0.1	0.2	1.1	0.2	0	1.3	1.4	0.9	0	0	0.5	0	1.1	0	3.9	0	0	0.1	0	0.8	1	0	0	0	0.5	0.4	1.3	1.1	0	0	0	0	0.9	1.1	1	0.1	0.7	0.7	0.5	0.4	0.1	0.1	0	0	0.1	0	0.1	1.4	1.8	1.1	0.3	0.1	0.3	0	0.1	0	0	0	0.2	1.2	0.2	0	0.2	1.3	0.6	0.1	2.2	0	0	0.8	0	0.1	0.5	0.4	0.8	0.8	0.4	0	0.4	0	0.3	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	46.5	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	11.2	0.6	0	0	0	0	0	0.1	0	1.1	0	0	0	0	2.6	1.1	0	0	0	0	0	Early spermatids
SPIB	SPI-B	ENSG00000269404	Spi-B transcription factor	Q01892	19	50418938-50431313	Predicted intracellular proteins, Transcription factors	Transcription, Transcription regulation	Activator, DNA-binding		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in many	8	blood: 83.3;intestine: 22.3;lymphoid tissue: 73.2	Cell type enriched	Detected in many	4	Paneth cells: 708.4	Low cancer specificity	Detected in many			Not detected	Not detected			Group enriched	Detected in some	57	memory B-cell: 47.4;naive B-cell: 39.9;plasmacytoid DC: 83.3	Group enriched	Detected in many	105	B-cells: 47.4;dendritic cells: 83.3	Cell line enhanced	Detected in some		Daudi: 45.4;HDLM-2: 28.9;Karpas-707: 14.5;U-698: 63.1									HPA018523	Uncertain											HPA018523: AB_1857443	prognostic favorable (4.76e-5)	unprognostic (1.06e-5)	unprognostic (9.15e-3)	unprognostic (3.70e-2)	unprognostic (9.72e-3)	prognostic favorable (2.14e-5)	unprognostic (2.33e-1)	unprognostic (4.79e-3)	unprognostic (1.18e-2)	unprognostic (7.85e-2)	unprognostic (1.12e-1)	unprognostic (1.50e-1)	unprognostic (3.96e-8)	unprognostic (1.43e-1)	unprognostic (2.65e-2)	unprognostic (1.75e-1)	unprognostic (7.33e-2)	0.6	0.4	0.4	73.2	0.4	1.9	0.5	0.4	0.4	0.4	18.9	0.1	0.1	4.6	0.4	0	2.3	0.5	0.7	0.6	0.4	0.4	1.1	0.5	3.7	33	0.4	0	0.4	1.5	0	0.5	0.2	0.3	1.1	6.7	0.4	7.7	0	0.6	0.4	22.3	0	1.2	26.9	2.4	0.6	0	9.3	1	1.5	53.7	2.2	0.6	47.4	83.3	0.4	0	0.6	0	2	0.1	0.3	0	0	0	0	0.2	0	0	0	0	0.8	0	45.4	0	0	0	0	0.3	0	0	28.9	0.1	0.1	0	0	0	0.1	0.1	0	0	0	0	0	0	0.2	1.2	14.5	0	0.1	0	0.1	0.4	0	0	3.1	0.2	0.5	0	0	0	0	0	0	0	0	0.1	1.4	0.2	0	0.8	0	0	1.3	0.9	63.1	0	0.7	0	0.4	0	0.1	0	0	0	47.4	0	0	1	39.9	0	0	0.4	0.6	0	83.3	0	2	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0	0.3	0	0	2.6	160	2.1	1.5	1	0.3	0	1.4	0	0	0	0.2	0	0.4	0	0.3	15.4	0	1	0.1	1.3	0.7	4.6	0.8	1.3	0	19	0	0.8	0	0	6.4	6.8	0	6.9	0.8	0	708.4	0.4	0.3	0.9	0	1	0.1	1.1	1.1	0.2	1.3	17.2	1.4	Paneth cells
OPN1MW3		ENSG00000269433	Opsin 1, medium wave sensitive 3	P0DN78	X	154257538-154271805	Predicted membrane proteins	Sensory transduction, Vision	G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer		Evidence at transcript level	Evidence at transcript level	No human protein/transcript evidence	No human protein/transcript evidence		Group enriched	Detected in some	4	blood: 2.2;skin 1: 1.8	Cell type enriched	Detected in some	12	Cone photoreceptor cells: 17.7	Not detected	Not detected							Cell type enhanced	Detected in single		gdT-cell: 2.2	Lineage enriched	Detected in single	23	T-cells: 2.2	Not detected	Not detected																																									0	0		0		0.2	0		0	0	0			0	0	0	0	0	0	0			0	0	0	0			0	0	0		0		0	0		0	0	0	1.8	0	0		0	0	0.4			0		0	0		0	0	0	0	0	2.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	2.2	0	0	0	0.2	0	0	0	0	0.8	0	0	0	0	0	0											0	0	0	0	0	0.2	0	0	0	0	0	17.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	1.5	0	0	0	0	0	0	0	0	0	Cone photoreceptor cells
ERVV-1	ENVV1, FLJ32214, HERV-V1	ENSG00000269526	Endogenous retrovirus group V member 1, envelope	B6SEH8	19	53013921-53016122	Predicted membrane proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enriched	Detected in some	5	placenta: 19.7	Cell type enriched	Detected in some	31	Syncytiotrophoblasts: 218.2	Low cancer specificity	Detected in some							Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	7	BEWO: 11.7;SuSa: 9.8									HPA076115			Approved	Centrosome,Cytosol						Cytosol	Centrosome	HPA076115: 	unprognostic (1.04e-3)			unprognostic (7.32e-3)	unprognostic (2.97e-1)	unprognostic (2.70e-2)		unprognostic (1.67e-2)		unprognostic (9.92e-2)		unprognostic (6.75e-2)	unprognostic (4.34e-5)	unprognostic (3.48e-2)	unprognostic (5.80e-2)	unprognostic (3.18e-1)	unprognostic (1.35e-1)	0	0	0	0	0	0	0	4.1	0	0.9	0			0	0	0	0	0	0	0.2	0	0	0.2	0	0	0	0		0	0	0	0	19.7		0.8	0		0	0	0.2	0	0	0	0	0	0	0			0		0	1.3	1.2	0	0	0	0	0	0	0	0	0	0	0	0	0	11.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0.4	0	0	0	0	0	9.8	0.1	0	0	0	0	0	0	0.2	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0	0	0	0	0	0	0	0	7.1	0	0	0	0	0	0	0	1.5	0	0.1	0	0	1.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	218.2	0	0	0	Syncytiotrophoblasts
CT45A10		ENSG00000269586	Cancer/testis antigen family 45 member A10	P0DMU9	X	135881063-135889086	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	21	testis: 14.1	Cell type enriched	Detected in some	16	Spermatogonia: 57.9	Low cancer specificity	Detected in some							Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		AN3-CA: 33.3;K-562: 9.9;Karpas-707: 36.9;U-266/84: 31.0									HPA044735, HPA044757, HPA046872, HPA046987	Supported		Approved	Nucleoplasm,Nucleoli						Nucleoplasm, Nucleoli		HPA044735: AB_2679065, HPA044757: AB_2679075, HPA046872: AB_2679849, HPA046987: AB_2679893					unprognostic (3.55e-1)					unprognostic (7.08e-3)					unprognostic (2.08e-1)			0	0		0		0	0		0.6	0	0			0	0	0	0	0	0	0			0	0	0	0			0	0	0		0		0	0		0	0	0	0	0	0		0	0	14.1			0		0	0		0	0	0	0	0	0.3	0	0	0	0	33.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	3.3	0	0	0	0	0	0	0	9.9	36.9	0	0	0	0	0	0	0	0	0	2.5	0	0	0	0	0	0	0	0	0	0	0	0	7.3	0	0	7.3	31	0	4.2	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	2.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	3.7	57.9	0	0	0	0	0	Spermatogonia
AC004233.2		ENSG00000270168			16	2988256-3002016	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level				Tissue enriched	Detected in some	8	skin 1: 8.9	Cell type enriched	Detected in single	30	Alveolar cells type 2: 5.0	Low cancer specificity	Detected in many							Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		CAPAN-2: 3.4;HaCaT: 7.3;hTCEpi: 5.5;MCF7: 3.8;OE19: 6.0;SCLC-21H: 5.6																						unprognostic (7.38e-2)	unprognostic (2.28e-1)	unprognostic (1.04e-1)	unprognostic (6.21e-2)	unprognostic (7.98e-3)	unprognostic (1.50e-1)	unprognostic (2.72e-1)	unprognostic (9.48e-2)	unprognostic (2.06e-2)	unprognostic (1.42e-1)	unprognostic (2.30e-1)	unprognostic (3.61e-1)		unprognostic (1.97e-3)	unprognostic (1.28e-1)	unprognostic (6.73e-2)	unprognostic (4.21e-1)	0.1	0	0.1	0.1	0.1	0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.4	0.1	0.1	0.2	0	0.1	0.1	0.1		0.1	0.1	0.8	0.1	0.1	0.1	0.1	0.4	0	0.1	0.2	0.1	0.6	0.1	0.1	1.1	0.1	0.1	8.9	0.1	0.1	0.1	0.1	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0	0.8	0	0	0	0	2.9	0	0	0.8	0	0	0.6	0.4	0.1	0.1	0.5	0.2	3.4	0	0.2	0	0.1	7.3	0	0.2	0.1	0.7	0	0	0.1	0.2	0	0.1	0.4	0.1	5.5	0.2	0	0.1	0	0	0.6	0.3	0	3.8	0	0.4	0	6	0	0	1	0.1	0	0.2	5.6	0.2	0.5	2.3	0.1	0.1	2.9	0.1	0	0	0.2	0.2	0.4	0.2	0	0	0	0.5	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0.8	0	0	0	0	0											0	5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Alveolar cells type 2
MTRNR2L11		ENSG00000270188	MT-RNR2-like 11	S4R3Y5	1	237943724-237945275	Predicted secreted proteins				Evidence at transcript level	Evidence at transcript level	No human protein/transcript evidence	Evidence at transcript level		Group enriched	Detected in many	4	blood: 64.8;skeletal muscle: 46.5	Cell type enriched	Detected in many	26	Cardiomyocytes: 1023.1	Not detected	Not detected			Low region specificity	Detected in all			Cell type enriched	Detected in all	4	neutrophil: 64.8	Lineage enriched	Detected in all	9	granulocytes: 64.8	Cell line enhanced	Detected in many		HeLa: 66.8;Hep G2: 42.8														Secreted to blood												unprognostic (1.07e-1)					unprognostic (9.70e-2)			unprognostic (4.49e-2)	unprognostic (5.26e-2)				9.9	11.8	3.7	0.9	3.8	1.4	5.5	2.1	8.5	2	7	1.4	3.7	2.9	2	3.1	2	2	0.2	12.4	4.2	2.3	11.1	7.2	3	2.8	2.2	2.6	2	3.3	0	2	1.3	4.6	2.1	3.1	0.9	4.4	6.5	46.5	2	3.5	0.7	3.3	2	4.3	4	3	0.8	2	7.4	0.3	2	2	5.9	3.4	64.8	7	2.9	3.1	8.2	7.1	16.9	7.9	22.1	6.8	1.7	6.3	12	0.9	0.7	0.9	7.1	10.4	12.3	7.7	2.3	1.3	21.8	0.2	1.6	0.6	5.3	11.8	12.3	66.8	42.8	2.2	3.4	9.9	6.8	2.3	0.8	3	15.5	1	8	8.6	7.4	2	6.1	3.4	11.7	2.1	8.9	3.1	6.5	6.4	5	4.6	9.9	3	5.3	4.7	5.5	8.7	8.1	6.7	10.8	19.3	8.9	6.3	7.2	3.4	5.6	1.8	5	4.9	12.1	2.1	14.8	7	16.1	1.4	3.2	1.7	5.5	2.2	1.9	2.7	5.9	3.1	3.1	64.8	2.9	3.1	3.4	2	8.2	3.7	3.8	2.1	5.1	4.2	2.3	2.2	2.6	4.6	3	0	0	0	22.2	3.5	0	1023.1	0	0	0	12.2	0	0.1	39.7	0	0	2.2	0	0	0	0.1	2.4	23	0	1.3	0.1	0	0	1.3	0.3	0	0	2.4	8.5	0	0	0	0	0	0	1.7	0	0	3.1	0.3	0.2	3.4	0	0	0	20.9	Cardiomyocytes
AC093668.1		ENSG00000270249			7	102541501-102592444	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level				Tissue enhanced	Detected in many		parathyroid gland: 6.9	Cell type enriched	Detected in single	12	Club cells: 1.2	Not detected	Not detected							Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		ASC TERT1: 3.7;hTERT-RPE1: 3.4;Karpas-707: 4.0									HPA046970			Uncertain	Nucleoplasm						Nucleoplasm		HPA046970: AB_2679882																		0.4	0.7	0.6	0.8	0.6	0.7	0.4	3.1	1.1	1	1			2.5	0.9	2.5	0.4	0.6	0	0.3	0.6	0.5	1.4	0.1	0.7	0.5	0.3		0.7	1.2	6.9	2.9	0.4		0.5	0.6		1.1	0.2	5.4	1.7	1.4	0	0.3	1.3	1.1	0.2			0.3		0.1	0.4	0.7	4	3.5	1.3	1	0.7	5.3	1.2	0.1	0	1	0.2	0.2	3.7	0.5	1.1	0.7	0.6	0	0	2.1	2.3	0.7	1.6	0.4	0.8	0	0	0	0.7	0	1.3	0	0.7	0	0.8	0	0	0	0	0	3.4	0	1.2	0	4	0	0.4	2.6	1.3	0.5	2.3	1	1.4	0	0.5	0.3	0.8	1.5	1.2	0	0	0.2	1.7	0.5	0	0	0	0.1	0.3	0	1.8	1.5	0.4	0.4	1	0	0	0.7	0.4	2.9	0.9	4.1	4	3.8	2.9	1.7	3.1	5.3	3	1.3	0.7	1	3.5	5.1	1.2											0	0	0	0	0	0	0	0	0	1.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Club cells
MTRNR2L13		ENSG00000270394	MT-RNR2-like 13	S4R3P1	4	116298876-116300320	Predicted intracellular proteins, Predicted secreted proteins				Evidence at transcript level	Evidence at transcript level	No human protein/transcript evidence	No human protein/transcript evidence		Tissue enhanced	Detected in many		skeletal muscle: 11.5	Cell type enriched	Detected in some	39	Cardiomyocytes: 161.5	Not detected	Not detected			Low region specificity	Detected in many			Cell type enriched	Detected in some	5	neutrophil: 4.9	Lineage enriched	Detected in single	10	granulocytes: 4.9	Group enriched	Detected in some	5	HeLa: 8.3;Hep G2: 4.4														Secreted - unknown location												unprognostic (6.40e-2)					unprognostic (2.88e-1)			unprognostic (2.49e-1)	unprognostic (1.99e-1)				1.7	2.5	0.6	0.2	1.1	0.4	0.6	0.6	1.8	0.6	1.2	0	2.9	0.5	0.6	1	0.6	0.6	0.4	3.3	0.6	0.6	2.3	1.4	0.9	1.7	0.6	0.5	0.6	0.6	0	0.6	0.4	2.7	0.6	1.1	0.2	1.2	0.4	11.5	0.6	1	1.1	2.6	0.6	0.6	2	1.2	0	0.6	1.4	0.2	1	0.6	0.4	0.2	4.9	0.4	0.3	0.2	0.3	0.3	1.1	0.1	1.1	0.1	0.1	0.4	0.9	0	0	0	0.1	0.5	0.4	0.2	0	0	0.2	0	0	0	0.5	0.2	0.1	8.3	4.4	0.1	0.1	0.4	0.4	0	0.2	0	0.3	0	0.1	0	0	0	0.5	0.1	0.4	0	0.2	0.1	0.2	0.1	0.4	0.3	1.2	0.1	0.4	0.2	0.1	0.5	0.2	0.2	0.3	0	0.2	0	0.3	0	0	0	0.1	0.1	0.1	0	1	0.4	1	0.1	0.3	0.1	0.3	0.2	0.1	0.2	0.4	0.2	0.2	4.9	0.3	0.2	0.2	0	0.3	0.6	1.1	0.6	1.8	0.6	0.6	0.6	0.5	2.7	1.2	0	0	0	4.2	0.1	0	161.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0.4	0	0	0	0	0	0	3.5	Cardiomyocytes
MTRNR2L6		ENSG00000270672	MT-RNR2-like 6	P0CJ73	7	142666272-142667718	Predicted intracellular proteins, Predicted secreted proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in many		blood: 81.7;skeletal muscle: 39.1	Cell type enriched	Detected in many	7	Cardiomyocytes: 849.8	Low cancer specificity	Detected in single			Low region specificity	Detected in all			Cell type enhanced	Detected in all		neutrophil: 81.7	Lineage enriched	Detected in all	10	granulocytes: 81.7	Cell line enhanced	Detected in many		HeLa: 50.0;Hep G2: 44.1														Secreted to blood								unprognostic (5.34e-2)	unprognostic (1.34e-3)	unprognostic (3.80e-1)	unprognostic (4.45e-3)	unprognostic (1.33e-1)	unprognostic (2.89e-1)	unprognostic (1.40e-2)	unprognostic (3.49e-2)	unprognostic (1.30e-1)	unprognostic (1.10e-2)	unprognostic (6.02e-2)	unprognostic (1.04e-1)	unprognostic (3.69e-1)	unprognostic (3.03e-2)		unprognostic (2.66e-2)	unprognostic (8.07e-3)	3.4	8.2	1.4	0.8	2.3	0.1	1.1	1.2	5.5	1.1	3.9	1.5	0.8	1.1	1.1	0.8	1.7	1.1	0.8	17.9	6.1	1.4	7.3	4.7	1.1	5.9	2.2	3.9	1.1	2.2	0	1.1	0.8	4.5	1.1	2.3	0.8	2.5	0.8	39.1	1.5	2.6	0.8	3.5	1.1	2.2	1.7	1.8	0.8	1.5	0.8	0.8	1.8	1.1	8.4	4.2	81.7	8.2	4.7	3.9	9.5	5.6	9.6	3.3	22.6	3.8	2	5.5	6	0.5	0.6	1	3.1	10.3	4.9	8.2	1.1	0.5	19.9	0.1	1.1	0.5	3.1	3.7	6.8	50	44.1	1.2	1.4	7.3	3.4	1.4	0.5	1.6	12.7	0.5	6.1	5.8	7.3	1.8	3.1	2.8	15.2	1.2	3.1	1.1	4.5	2.8	3.7	3.9	8.3	2.2	8.2	1.6	3.8	11.5	4.9	5.3	9.6	6.9	6.5	6.6	7.8	2	2.9	1.3	3.1	3.9	8.7	1.6	20	8.2	21.6	2.4	4.9	2.4	8.4	2.9	2.9	4.1	7.7	3.2	3.9	81.7	4.7	4.4	4.2	3.1	9.5	1.4	2.3	1.2	2.9	6.1	1.4	2.2	3.9	4.5	1.8	35.7	50.8	1.4	7.4	5.7	0	849.8	0	75	127.4	31.4	0	0.5	38.1	0	0.3	1.5	0	23.3	0	0.6	7.1	3.3	51.1	1.9	0.5	0	0	0.6	0.6	0.6	2.3	14.5	3.3	0	0	0	0	0	0.4	4.9	0	0	4.7	0.3	2	3.9	0.2	1	0	3.7	Cardiomyocytes
SMIM32		ENSG00000271824	Small integral membrane protein 32		5	136191468-136193134	Predicted membrane proteins				Evidence at transcript level	Evidence at transcript level	No human protein/transcript evidence			Group enriched	Detected in some	9	brain: 7.8;gallbladder: 9.8;intestine: 12.3;kidney: 26.2	Cell type enriched	Detected in some	8	Proximal tubular cells: 233.2	Cancer enhanced	Detected in many		renal cancer: 12.4					Not detected	Not detected			Not detected	Not detected			Group enriched	Detected in some	7	HaCaT: 2.3;SCLC-21H: 6.1	Low region specificity	Detected in many			Low region specificity	Detected in many																unprognostic (2.35e-5)	unprognostic (3.08e-1)	unprognostic (7.74e-2)	unprognostic (7.79e-2)	unprognostic (2.11e-2)	unprognostic (9.13e-2)	prognostic favorable (1.63e-4)	unprognostic (1.86e-2)		unprognostic (1.75e-2)	prognostic favorable (6.13e-4)	unprognostic (1.51e-1)	unprognostic (1.19e-2)	unprognostic (2.78e-1)	unprognostic (1.14e-1)	unprognostic (4.85e-3)	unprognostic (8.05e-2)	0	0	0	1.2	2.2	0	0	0	7.8	0	5.1	0	0	12.3	0	0	0	0	9.8	0	0.6		26.2	0	0	0	0	0.4	0	0	0	0	0	0.2	0.2	1.4	0.1	0	0	0.2	0	8.3	0	0	0	1.5	0	1.4	0	1.1	0	0	0	0.3	0	0	0	0	0	0.3	0	0	0.2	0.1	0	0	0	0.4	0.1	0	0	0	0.2	0	0	0.3	0	0	2.3	0.2	0	0	0	0.1	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0.2	0	0.1	0.2	0	0.2	0	0	0.3	0	0	6.1	0.6	0	0	0	0.4	0	0.1	0	0	0.1	0.1	0.1	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0											0	0	0	0	0	0	0	0	0	0	17.4	0	0	28.2	0	0	0	0	0	0.5	0.2	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0.9	0	0	233.2	0	0	0	0	0	0	0.1	0	0	0	Proximal tubular cells
MUSTN1	Mustang	ENSG00000272573	Musculoskeletal, embryonic nuclear protein 1	Q8IVN3	3	52833114-52835219	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	No human protein/transcript evidence	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	9	skeletal muscle: 252.5	Cell type enriched	Detected in single	7	Alveolar cells type 2: 2.2	Not detected	Not detected			Low region specificity	Detected in many			Cell type enhanced	Detected in single		neutrophil: 2.1	Lineage enhanced	Detected in single		granulocytes: 2.1	Cell line enhanced	Detected in some		Hep G2: 9.5;HSkMC: 6.0;RH-30: 8.5																						unprognostic (2.79e-2)	unprognostic (3.73e-2)			unprognostic (4.11e-1)	unprognostic (2.60e-2)	unprognostic (2.34e-2)	unprognostic (6.21e-3)	unprognostic (2.78e-1)	unprognostic (1.13e-2)	unprognostic (1.66e-2)	unprognostic (1.04e-1)	unprognostic (1.65e-3)	unprognostic (6.00e-2)	unprognostic (1.79e-1)	unprognostic (8.11e-2)	unprognostic (1.88e-2)	12.1	1.8	2.5	1.8	5.2	1.3	6.1	1.5	5.7	16	4.6	2.6	2.4	1.7	11.1	18.9	7.9	6.4	10.6	15.5	2.6	2.2	1.8	0.8	3.2	1.4	4.3	3.9	5.1	1.6	0.8	1.1	1.3	5.2	11.6	3.4	3.8	5.9	8.9	252.5	2.7	2.6	6.1	2.2	0.9	2.3	6.4	0.2	0	5.4	26.9	3.6	8.1	7.9	0	0	2.1	0.6	0	0.3	0.2	0.1	0.2	3	0	0.8	2.1	3.5	0.2	0.9	0.4	0.3	0.4	0.5	0	0	1.4	0.1	1.3	0.7	0.6	0.5	0.1	0.9	0	1.6	9.5	1.4	1.9	0.6	6	1	0.9	0	1.4	1.2	0.4	0.2	0	0.1	0.6	0.7	2.8	0.4	0.4	2.2	1	8.5	0	0.6	0	0.3	0.3	0.6	0.7	1.5	3.2	0	0.7	0	0.4	0.7	1.2	0.6	0	0.1	0	0.3	2.4	0.3	0	0.4	0	0.3	0	0.2	0	0.3	0	0	0	0	0	2.1	0	0.6	0	0	0.2	2.5	5.2	1.5	5.7	2.6	2.2	4.3	3.9	5.2	0.2	0	2.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0.3	0	0	0	0	0	0	0	Alveolar cells type 2
AC011841.1		ENSG00000273496			Unmapped	99351-104855	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level				Tissue enhanced	Detected in some		ovary: 1.2;skin 1: 1.8	Cell type enriched	Detected in single	7	Melanocytes: 1.7									Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in many		A-431: 6.4;NB-4: 5.5																																							0	0.1		0		0	0		0.5	0	0.1			0	0	0	0	0	0	0.5			0	0	0	0			1.2	1	0		0.1		1.1	0.3		0.9	0.2	0.1	1.8	0.3	0		0	0	0.4			0		0	0		0.2	0.1	0	0	0.5	0.7	0	6.4	0.4	1.8	2.5	0.5	0.1	1.7	0.9	0.6	0.7	1.4	2.7	0.6	0.1	0.4	0.2	1.8	2	1.7	0.5	1.9	1.4	2	1.2	1.7	2.5	0.1	2.5	2.8	0	0.9	0.6	1.2	0.9	0.3	1.8	0.5	2.1	0.9	0.4	0.6	5.5	1.2	0.5	0.1	0.1	0.4	0	0.3	0.3	0.6	0.3	0.3	0.2	1.2	1.2	0.2	1.2	0.1	1.2	0.5	0.5	1.3	0.6	0.5	0.1	0.6	1.8	1	0	0	0	0.4	0	0.2	0	0.4	0	0.1	0.2	0	0	0	0.5	0	0	0.7	0											0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Melanocytes
LHX1	LIM-1, LIM1	ENSG00000273706	LIM homeobox 1	P48742	17	36936785-36944612	Cancer-related genes, Predicted intracellular proteins, Transcription factors	Differentiation, Neurogenesis, Transcription, Transcription regulation	Developmental protein, DNA-binding	Cancer-related genes	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Group enriched	Detected in some	5	brain: 15.0;kidney: 5.7;seminal vesicle: 7.1	Cell type enriched	Detected in some	9	Horizontal cells: 341.7	Cancer enhanced	Detected in some		ovarian cancer: 8.1					Cell type enhanced	Detected in single		memory CD8 T-cell: 1.1	Lineage enhanced	Detected in single		T-cells: 1.1	Cell line enhanced	Detected in some		HAP1: 6.3;HMC-1: 2.7;WM-115: 11.7	Region enhanced	Detected in many		cerebellum: 21.5	Region enriched	Detected in many	4	cerebellum: 20.4	HPA044307, HPA073521, HPA074382	Enhanced		Supported	Nucleoplasm,Nuclear membrane,Golgi apparatus						Nucleoplasm	Nuclear membrane, Golgi apparatus	HPA044307: , HPA073521: AB_2732226, HPA074382: 	unprognostic (3.86e-5)	unprognostic (1.64e-1)		prognostic unfavorable (3.63e-5)	unprognostic (3.85e-2)	unprognostic (1.06e-4)		unprognostic (2.67e-2)	unprognostic (2.72e-1)	unprognostic (1.52e-1)	unprognostic (4.20e-3)		unprognostic (1.74e-5)	unprognostic (1.33e-1)	unprognostic (8.62e-2)		unprognostic (3.05e-2)	0.1	0	0	0.1	0	0	0	15	0	0.2	0	0	1.8	0	0	0	0	0.5	0	0	0.1		5.7	0	0	0	0	0	0	0	0	0	0	1.2	0	0	0	0	7.1	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0.3	0	0.1	0	0	1.1	0.1	1.3	0	0	0	0	0	0.1	0	0	0	0	0	0.4	0	0.7	0	0.2	0	6.3	0	0	0	0.2	0	0	0.2	0	0	2.7	0	0.1	0	2	0.7	0	0	0	0	0	1.6	0	0.1	0.2	0	1.4	0	0	0	0	0	0.3	0	0	0	0	0.2	0.1	0.4	0	0	1.9	0	1.5	0	0	0	0.1	0	11.7	0	0	0	0	0	0	0.3	0	1.1	0	0	0	0	0.1	0	0	0	0.4	0.1											0	0	0	0	0	0.5	1.1	0	0	0	40.1	0	0	0	0	0.2	0	0	0	0	0.5	0	0	0	0	0.1	341.7	0	0	0	0	0	0	0	0	0	0.2	0	0	0	9.2	1.7	0	0	0.9	1.2	0	0.3	0	0	0	Horizontal cells
GOLGA6L1		ENSG00000273976	Golgin A6 family-like 1		15	23128268-23136822	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level				Tissue enriched	Detected in some	4	testis: 7.4	Cell type enriched	Detected in some	6	Early spermatids: 44.4	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Not detected	Not detected											HPA047733	Uncertain											HPA047733: 																		0	0		0		1.6	0		0	0	0			0	0	0	0	0	0	0			0	0	0	0			0	0	0		0		0	0		0	0	0	0	0	0		0	0	7.4			0		0	0		0.3	0.1	0.2	0.4	0	0.3	0	0	0	0	0	0	0.1	0	0	0	0	0	0.5	0	0	0	0.1	0.3	0	0	0.5	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0.9	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0.3	0.2	0.1	0.2	0	0	0	0.3	0	0.3	0.2	0.2	0	0	0.4	0.1	0.1	0											0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	44.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	8	0.6	0	0	0	0	0	0	0	0.4	0	0	0	0	0.1	0.2	0	0	0	0	0	Early spermatids
OR4M2		ENSG00000274102	Olfactory receptor family 4 subfamily M member 2	Q8NGB6	15	22070241-22083221	G-protein coupled receptors, Predicted membrane proteins	Olfaction, Sensory transduction	G-protein coupled receptor, Receptor, Transducer		Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in single		testis: 1.1	Cell type enriched	Detected in single	9	Sertoli cells: 6.5	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	10	U-2 OS: 1.0									HPA058889	Uncertain											HPA058889: AB_2683845																		0	0		0		0.2	0.1		0.9	0	0			0	0	0	0	0	0	0			0	0	0	0			0	0	0		0		0	0		0	0	0	0	0	0		0	0	1.1			0		0	0		0	0.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.9	0	0	0	0	0	0	0.3	0	0											0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	6.5	0	0	0	0	0	0	0	0	Sertoli cells
HIST1H3B	H3/l, H3FL	ENSG00000274267	Histone cluster 1 H3 family member b	P68431	6	26031650-26032060	Cancer-related genes, Disease related genes, Predicted intracellular proteins		DNA-binding	Cancer-related genes, Disease mutation	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in many	13	lymphoid tissue: 343.5	Cell type enriched	Detected in some	5	Spermatogonia: 5.1	Low cancer specificity	Detected in many							Cell type enhanced	Detected in some		T-reg: 1.4	Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		U-266/84: 12.0									HPA042570	Approved											HPA042570: AB_2678056	unprognostic (2.82e-1)	unprognostic (2.64e-2)	unprognostic (1.09e-1)	unprognostic (5.59e-2)	unprognostic (1.37e-1)	unprognostic (2.34e-2)	unprognostic (2.31e-2)	unprognostic (1.17e-1)	unprognostic (1.13e-1)	unprognostic (2.03e-2)	unprognostic (1.08e-2)	unprognostic (5.34e-2)	unprognostic (2.31e-7)	unprognostic (8.52e-2)	unprognostic (2.78e-1)		unprognostic (1.90e-3)	1.7	0.7	0	36.1	0	18.1	3.6	0	0.3	0.8	6.9	0	0	0.3	0.8	2.5	11.8	0.5	1.9	2.4	0		0.6	0.3	3.4	10.4	0	0	0.3	0.3	0.3	0	7.8	0	0.3	0.8	0	1	0.3	0.3	0.3	6.3	0.8	0	14.7	0.5	26.9	0	343.5	0.8	18.2	27.7	0.3	0	0.8	0.1	1.2	0	0	1.4	3.1	1.8	4.6	1.3	4	0	0.4	0	0.2	0.8	0.8	0.7	1.1	1	3	2	0.3	1.2	0.7	1.6	1.2	1.7	2	4.4	3.2	6	1.3	0	2.4	2.1	2.9	0	0.6	0	0.1	1	0.9	6.5	5.9	1.1	1	7.4	7.4	3.1	0.7	3.2	4.3	2.9	8.5	0.5	0	2.1	1.7	5.1	1.6	0.5	0.1	2.8	1.5	1.4	1.4	4.1	0.7	1.7	9.6	12	3.9	3.4	4.6	2.7	0	0	0	0	0	0	0.8	0.8	0.8	0.1	0.5	0	0.2	1.2	0	0	0	1.4	3.1											0	0	0	0.1	0.1	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	1.1	0	0.1	0	0	0.6	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	5.1	0.1	0.2	0	0.6	0.1	Spermatogonia
GAGE13	GAGE12A	ENSG00000274274	G antigen 13		X	49331616-49338952	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level				Tissue enriched	Detected in some	17	testis: 26.8	Cell type enriched	Detected in some	10	Spermatogonia: 13.9	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	6	AN3-CA: 129.9									HPA043232	Supported		Approved	Golgi apparatus,Plasma membrane,Cytosol						Plasma membrane	Golgi apparatus, Cytosol	HPA043232: AB_2678376																		0	0		0		0	0		0	0	0			0	0	0	0	0	0	0			0	0	0	0			0	0	0		0		0	0		0	0	0	0	0	0		0	0	26.8			0		0	0		0	0	0	0	0	0	1.6	0	0	0	129.9	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.5	0	0	0	0	0	0	0	4.7	0.6	0	0.3	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	21.8	0	0.1	0.5	0.1	0	0	0	0	0	0	0	11.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.6											0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.4	13.9	0	0	0	0	0	Spermatogonia
ADRA2B	ADRA2L1, ADRA2RL1, ADRARL1	ENSG00000274286	Adrenoceptor alpha 2B	P18089	2	96112875-96116245	Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins		G-protein coupled receptor, Receptor, Transducer	Epilepsy, FDA approved drug targets	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Low tissue specificity	Detected in many			Cell type enriched	Detected in some	4	Sertoli cells: 32.3	Low cancer specificity	Detected in many							Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		BEWO: 5.1;EFO-21: 3.3;HAP1: 1.8;NTERA-2: 1.8;SuSa: 3.1	Low region specificity	Detected in some			Low region specificity	Detected in many			HPA066029, HPA074948	Approved		Supported	Vesicles,Cytosol						Vesicles	Cytosol	HPA066029: AB_2685599, HPA074948: 	unprognostic (6.16e-2)	unprognostic (1.31e-2)	unprognostic (1.76e-2)	unprognostic (4.93e-4)	unprognostic (1.84e-2)	unprognostic (5.24e-2)	unprognostic (6.80e-5)	unprognostic (4.85e-2)	unprognostic (1.69e-1)	unprognostic (3.16e-2)	unprognostic (8.34e-2)	unprognostic (2.54e-1)	unprognostic (2.21e-1)	unprognostic (4.43e-2)	unprognostic (3.39e-1)	unprognostic (1.36e-1)	unprognostic (6.55e-2)	4.9	2.2	0.3	0.4	2.2	1.2	8.1	0.1	0.7	4.5	4	1.9	0.2	0.5	1.3	7.5	4.3	0.8	3.2	6.1	0.5		2.9	7.5	0.3	0.2	4.4	0	5	2.3	1	0	1.3	3.3	3.3	0.4	0.9	1.8	2.9	8	0.3	1.2	2.1	0.6	4.8	0.7	2.6	1.9	0	2.1	1.8	0	3.8	4.9	0	0	0	0	0	0	0	0	0	1	0	0	0	5.1	0	0	0	0	0.1	0.2	0	3.3	0	0.3	0.2	1.8	0	0	0	0.8	0	0.2	0	0	0	0	0	0	0.1	0	0	0	1.1	0	0.2	0	0.7	0	0.1	1.8	0.1	0.3	0	0	0.4	0	0.3	1.4	0	0	1.2	0	3.1	0.3	0.1	0	0	0.4	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0.2	1	0	2	0	1.4	1.2	1.8	0	0.4	0	0.2	0	0.7	0	0	0.5	0.1	0.4	0.9	0	0	0.3	0	2.4	3.1	0.3	0	1.7	0.9	1.7	0	0.1	0	0.1	0	0.4	0	0	32.3	8	0	0.2	1.3	0.3	0	0	0.3	Sertoli cells
CCL23	Ckb-8, CKb8, MIP-3, MPIF-1, SCYA23	ENSG00000274736	C-C motif chemokine ligand 23	P55773	17	36013056-36017968	Cancer-related genes, Plasma proteins, Predicted secreted proteins	Chemotaxis, Inflammatory response	Cytokine, Heparin-binding	Cancer-related genes	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		blood: 50.3	Cell type enriched	Detected in some	13	Ito cells: 276.2	Low cancer specificity	Detected in some							Cell type enriched	Detected in single	173	eosinophil: 50.3	Lineage enriched	Detected in single	173	granulocytes: 50.3	Group enriched	Detected in some	4	HEL: 12.9;THP-1: 27.6									HPA042015	Uncertain				Secreted to blood			937000	57000			HPA042015: AB_10794039	unprognostic (1.65e-3)	unprognostic (1.43e-2)	unprognostic (1.04e-1)	unprognostic (9.50e-2)	unprognostic (3.59e-2)	unprognostic (2.39e-1)	unprognostic (1.20e-4)	unprognostic (2.17e-1)	unprognostic (6.49e-2)	unprognostic (1.08e-2)	unprognostic (7.05e-2)	unprognostic (6.93e-2)	unprognostic (1.35e-3)	unprognostic (2.18e-1)	unprognostic (2.76e-1)	unprognostic (1.20e-2)	unprognostic (1.95e-1)	5.8	0.5	0	13.1	0	2.1	3.7	0	0.5	2.1	2	0	1	0	1.8	3	1.3	1.5	2.2	4.6	0		3	5.9	7.9	8	0.3	0	1.2	0	0	0.5	1.5	0.2	1.7	7.2	0.7	0	1.1	0.5	0.4	1	8.4	0	2	0	0.1	0	0.4	1.1	0.6	0.5	3	0	0.2	0.1	50.3	0.2	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	12.9	0	0	0	1.7	0.9	0	0	0	0	0	0	0	0	0	0	0	0	3.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	27.6	0	0	0	0	0	0	0	0	0	4.7	0	0.2	0.2	50.3	0	0.2	0	0.2	0	0.1	0.1	0	0	0.1	0.2	0	0.2	0	0	0											3	2.9	0	0.2	1.4	0	0.3	0	2.7	1.2	0	0	0	0	0	0.9	9	0.4	0	0	0	0.2	0.1	9.3	1.5	6.8	0	0	276.2	21.2	0	0	1.7	1.7	0	0	0	0	17.8	0	0	0	0	0.3	0	0	2.4	0.2	0.8	0.4	0.1	Ito cells
F8A2		ENSG00000274791	Coagulation factor VIII associated 2	P23610	X	155382115-155383230	Predicted intracellular proteins				Evidence at protein level	No human protein/transcript evidence	Evidence at protein level	Evidence at protein level	Evidence at protein level	Not detected	Not detected			Cell type enriched	Detected in single	4	Melanocytes: 1.7	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	25	BEWO: 2.4																										unprognostic (2.04e-2)					unprognostic (5.07e-1)				unprognostic (8.70e-2)				0	0		0		0	0		0	0	0			0	0	0	0	0	0	0			0	0	0	0			0	0	0		0		0	0		0	0	0	0	0	0		0	0	0			0		0	0		0	0	0.2	0	0	0	0	0	0	0	0	0	0	2.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0.1	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Melanocytes
TBC1D3B	PRC17, TBC1D3I	ENSG00000274808	TBC1 domain family member 3B	A6NDS4	17	36165681-36176636	Predicted intracellular proteins, Predicted membrane proteins		GTPase activation		Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in some		skin 1: 6.6;testis: 3.5	Cell type enriched	Detected in some	11	Early spermatids: 11.6	Not detected	Not detected							Cell type enhanced	Detected in single		NK-cell: 1.0	Low lineage specificity	Detected in single			Cell line enhanced	Detected in many		CAPAN-2: 11.5;HeLa: 9.8;T-47d: 8.0									HPA046969, HPA047745, HPA052553	Approved		Uncertain	Vesicles						Vesicles		HPA046969: , HPA047745: AB_2680144, HPA052553: AB_2681869	unprognostic (1.05e-1)	unprognostic (3.63e-1)	unprognostic (1.94e-2)	unprognostic (1.49e-1)	unprognostic (1.67e-1)	unprognostic (4.13e-2)	unprognostic (1.11e-1)	unprognostic (2.83e-1)	unprognostic (2.51e-1)	unprognostic (1.17e-1)	unprognostic (7.15e-2)	unprognostic (9.96e-3)	unprognostic (1.05e-3)	unprognostic (1.46e-1)	unprognostic (1.32e-1)	unprognostic (3.56e-1)	unprognostic (1.34e-1)	0	0.1		1		0.4	0.4		0.1	0	0.1			1.2	0	0	1	0.4	0.2	0			0	0	0.2	0.6			0.1	1.3	0		0		0.2	0		0.8	0.8	1.2	6.6	0.5	0		2	1.9	3.5			0		0.1	0.4		0	0	0.7	0	1	0.4	0.1	1.5	2.5	1.5	1.8	1.5	1.8	4.9	1.2	0.7	1.3	2.1	0.5	11.5	0.2	1	0.7	0.6	5	0.7	1.1	0.5	2	3.9	0.8	9.8	0.7	0.9	0.3	1.4	1.5	2.3	1.6	0.2	3.3	1	1.2	0.7	1.1	0.5	0.1	1	4.4	0.5	0.4	0.5	1.5	0.4	0.2	1.6	1.5	1	1.3	1.1	0.7	0.9	2	8	1	2.7	0.5	0.4	4	0.5	1.6	1.2	0.5	1.5	0.5	0.3	0	0	0.2	0	0	0	0	0	0.4	0	0	0	0	0.7	1	0	0	0	0.1											0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	11.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	Early spermatids
TBC1D3I		ENSG00000274933	TBC1 domain family member 3I	A0A087WXS9	17	36253456-36264553	Predicted intracellular proteins, Predicted membrane proteins		GTPase activation		Evidence at protein level	Evidence at protein level	No human protein/transcript evidence	No human protein/transcript evidence		Tissue enhanced	Detected in some		skin 1: 1.3;testis: 3.0	Cell type enriched	Detected in some	23	Early spermatids: 30.1	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	6	CAPAN-2: 11.1									HPA046969, HPA047745, HPA052553	Approved		Uncertain	Vesicles						Vesicles		HPA046969: , HPA047745: AB_2680144, HPA052553: AB_2681869																		0	0		0		0.1	0		0	0	0			0	0	0	0	0	0	0			0	0	0	0.7			0	0	0.4		0		0.2	0		0.9	0.5	0	1.3	0.9	0		0.3	0.1	3			0		0.1	0.2		0.1	0.2	0.7	0.2	0	0.7	0	0.1	0	0.1	0.2	0.2	0	0.6	0	0.1	0.1	0.2	0.1	11.1	0.1	0.6	0	0	1.7	0	0.1	0	0.1	0.7	0.7	0.3	0.4	0	0	0	0.2	0	0	0.2	0	0	0.3	0.1	0	0	0.1	0	0.1	0.1	0	0.1	0.1	0.1	0.2	0.1	0.4	0.2	0.1	0.9	0	0	0.2	0.2	0.1	0	0.1	0.1	0.2	0	0.2	0.2	0	0.1	0	0	0.7	0.1	0.2	0.2	0.2	0	0	0.1	0.1	0	0.1	0	0.2	0.3	0	0	0.2	0.7	0											0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	30.1	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	1.3	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	Early spermatids
AL139260.3		ENSG00000274944			1	38864501-38881617	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level				Tissue enhanced	Detected in some		blood: 7.3;testis: 15.5	Cell type enriched	Detected in some	5	Ciliated cells: 8.1	Not detected	Not detected							Cell type enhanced	Detected in many		plasmacytoid DC: 7.3	Low lineage specificity	Detected in many			Low cell line specificity	Detected in many											HPA041188, HPA078331	Uncertain		Approved	Nucleoplasm,Mitochondria						Nucleoplasm	Mitochondria	HPA041188: AB_10794405, HPA078331: AB_2686882	unprognostic (8.00e-2)	unprognostic (3.86e-2)	unprognostic (2.54e-1)	unprognostic (2.00e-1)	unprognostic (9.72e-3)	unprognostic (4.27e-4)	unprognostic (4.64e-7)	unprognostic (2.59e-2)	unprognostic (4.01e-2)	unprognostic (1.22e-1)	unprognostic (6.52e-2)	unprognostic (9.54e-3)	unprognostic (6.09e-6)	unprognostic (1.30e-2)	unprognostic (3.69e-1)	unprognostic (1.27e-1)	unprognostic (2.32e-3)	1.2	0	0.4	1.3	0.9	0	0.4	0.4	1	0.4	3.3	0.6	0.4	2	0.4	0.4	3	0	0.4	0.4	0.4		0.5	1.5	0.4	2.7	0.4	0.4	0.4	0.4	0	0.4	0.8	0.6	0.4	2.3	1.8	2.3	0.4	0.4	1.5	2.1	0.4	0.4	0.4	2.4	15.5	0.4	0.4	0.4	0.4	0.4	0.4	0.4	3	7.3	2.8	4	0	1.7	0	12.4	1.3	3.3	0	0.6	0	3.6	0.4	0	0	0.5	6.7	13.3	2.4	11.3	0.2	0.5	9.2	0	0.9	0	7.9	2.1	2.8	2.5	2.2	0	17	5	0	0	1.6	1.1	1.5	2	0.5	6.4	4.6	1.7	3.3	6.8	16.1	6.5	9.8	7.7	7.9	8	12.6	0	7	6.3	3.4	7.7	7.3	1.5	3.6	4.2	5.2	5.8	2.3	6.5	6.3	11.5	1.5	11.7	9.4	5.7	7.4	2.6	0	1.3	0.2	0.5	1.9	1.1	3	0.2	0.5	4.2	2	0.4	0.4	2.8	0	4	7.3	1.7	0											0	1.7	0	0	0	0	0	0	8.1	1.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0.1	0	0	0	Ciliated cells
HIST1H2AH	dJ86C11.1, H2A/S, H2AFALii	ENSG00000274997	Histone cluster 1 H2A family member h	Q96KK5	6	27147129-27147515	Predicted intracellular proteins		DNA-binding		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in many	13	lymphoid tissue: 301.1	Cell type enriched	Detected in some	5	Erythroid cells: 23.3	Low cancer specificity	Detected in some							Cell type enhanced	Detected in many		naive B-cell: 16.2	Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		HEK 293: 9.0;MOLT-4: 9.3;NB-4: 10.2									CAB004030, HPA041189	Supported		Approved	Nucleoplasm			Yes			Nucleoplasm		CAB004030: AB_2118804, HPA041189: AB_2677357	unprognostic (4.07e-1)	unprognostic (2.73e-3)	unprognostic (4.04e-2)	unprognostic (4.01e-1)	unprognostic (2.02e-1)	unprognostic (5.35e-3)	unprognostic (3.90e-2)	unprognostic (3.20e-1)	unprognostic (2.36e-1)	unprognostic (2.38e-3)	unprognostic (2.91e-1)	unprognostic (2.32e-1)		unprognostic (9.74e-3)	unprognostic (1.87e-1)		unprognostic (1.26e-4)	0.8	0.7	0	26	0	20.2	1.5	0	0.4	3.1	6.6	0	0.6	1	1.8	2.6	6.4	1	2.7	1.3	0		0.5	0.4	4.1	5.4	0	0	2.4	0.5	0.4	0	9	0	0.6	0.9	0.1	1.7	0.6	0.4	0.6	6.5	0.9	0	13.9	0.7	23.5	0	301.1	0.6	9	27.3	1.9	0	16.2	2.2	0	2.4	5.1	4.7	2.3	2.6	3.5	1.1	4.9	0	0	0.7	0.3	0.6	0.6	0	2.6	1	3.8	0.9	0	0.6	0.3	1	0	0	2.1	9	4.7	3	0	0	3.2	1.8	0	0	1.2	0	0	0.9	1.8	4.8	2.4	0.9	0.4	9.3	10.2	3.2	0.9	1.2	3.4	3.1	5	0	0.3	2.5	0.6	1.4	0.5	0.2	0.1	1	1.5	0	0.8	2.8	0.2	2.7	2.9	2.9	6.1	1.3	4.6	0.8	0	0.9	0	2.6	2.4	1.2	3.8	4.7	4.2	2.2	16.2	2.4	1.6	0	5.1	1.5	1.5	0.8	2.3											0	0	0	1	0.2	0	0	0	0	3.4	0	0	0.7	0	0.3	1.7	0.1	1.6	23.3	0.3	1.9	0.3	0.8	1.1	0	0.7	0	1.7	1.8	1.2	4.3	0.6	0.6	0	0	0.3	0.2	0.1	0.9	0	0	0	0	0	0	4.5	0.5	0.2	2.5	1	0.6	Erythroid cells
CCL16	CKb12, HCC-4, LCC-1, LEC, LMC, Mtn-1, NCC-4, SCYA16, SCYL4	ENSG00000275152	C-C motif chemokine ligand 16	O15467	17	35976493-35981496	Cancer-related genes, Plasma proteins, Predicted secreted proteins	Chemotaxis, Inflammatory response	Cytokine	Cancer-related genes	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	127	liver: 79.1	Cell type enriched	Detected in some	14	Hepatocytes: 244.8	Cancer enriched	Detected in single	154	liver cancer: 49.0					Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	23	Hep G2: 15.0					Low region specificity	Detected in many								Secreted to blood			2780000	20000000				unprognostic (3.85e-1)	unprognostic (4.71e-1)	unprognostic (1.49e-1)	unprognostic (3.75e-2)		unprognostic (2.72e-1)	unprognostic (4.58e-2)	unprognostic (2.80e-1)	unprognostic (1.09e-1)	unprognostic (1.54e-1)	unprognostic (1.91e-2)	unprognostic (3.57e-1)	unprognostic (1.40e-3)	unprognostic (1.66e-2)	unprognostic (2.32e-1)	unprognostic (1.09e-1)	unprognostic (4.08e-2)	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0		0	79.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.6	0.4	0.2	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	15	0	0	0	0	0	0	0	0	0.6	0.1	0	0	0	0.1	0	0	0.1	0	0.2	0.2	0.1	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0.1	0	0.1	0	0	0.1	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0.2											0	0	0	0	0	0	0.3	5.1	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	244.8	0	0	0	17.8	4.1	0	0	0	0	0	0.1	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0.1	Hepatocytes
CCL18	AMAC-1, CKb7, DC-CK1, DCCK1, MIP-4, PARC, SCYA18	ENSG00000275385	C-C motif chemokine ligand 18	P55774	17	36064280-36072032	Cancer-related genes, Plasma proteins, Predicted secreted proteins	Chemotaxis, Inflammatory response	Cytokine	Cancer-related genes	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		heart muscle: 41.4;lung: 77.9;lymphoid tissue: 61.9	Cell type enriched	Detected in some	5	Hofbauer cells: 197.4	Low cancer specificity	Detected in all							Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in single		SK-MEL-30: 1.5														Secreted to blood			55500000	940000				unprognostic (8.91e-2)	unprognostic (2.96e-2)	unprognostic (5.71e-2)	unprognostic (9.64e-2)	unprognostic (1.60e-2)	unprognostic (3.28e-2)	unprognostic (1.04e-1)	unprognostic (2.96e-1)	unprognostic (2.50e-1)	unprognostic (3.11e-2)	unprognostic (1.21e-2)	unprognostic (4.06e-2)	unprognostic (2.95e-3)	unprognostic (2.49e-1)	unprognostic (1.68e-1)	unprognostic (3.63e-1)	unprognostic (4.87e-2)	18.2	0	0	1.3	0	0	0.3	0	0.2	0	3.1	0	0	1.6	0	5.8	3.2	0	0.4	41.4	0		0	1.3	77.9	61.9	0	0	3.7	0.3	0	0	5.9	0	0.2	2.5	0	0.2	0	0	0.3	3.4	4.1	0	3.7	0.3	1.6	0	43.8	2.2	4.3	16.7	6.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0.9	0	0	0	0	0	0	0	0.2	0.5	0	0	0	0.6	0	0	0	0	0	0	0	0	0.3	0.2	0	0	1.5	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	23.1	0	0	8.5	0	0.2	0	9.4	25	0	0	0.4	0	0	24.7	0.3	0	0	0	0.3	2.1	0	4.7	0	197.4	0	0	0	2.2	3.6	0	40.3	1.7	0	0	0	0	0	0.4	0	0	0	0	0	0.1	3	1.4	0	0	0	Hofbauer cells
FCGBP	FC(GAMMA)BP	ENSG00000275395	Fc fragment of IgG binding protein		19	39863323-39934626	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level				Group enriched	Detected in many	5	cervix, uterine: 13.9;gallbladder: 46.6;intestine: 43.3;stomach 1: 17.0;thyroid gland: 20.9	Cell type enriched	Detected in many	10	Mucus-secreting cells: 4433.7	Low cancer specificity	Detected in all							Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Cell line enhanced	Detected in some		A549: 9.8;JURKAT: 3.3;RH-30: 11.0;RPMI-8226: 3.8;U-266/70: 3.6					Not detected	Not detected			HPA003517, HPA003564	Enhanced		Approved	Golgi apparatus,Plasma membrane,Cytokinetic bridge						Plasma membrane	Golgi apparatus, Cytokinetic bridge	HPA003517: AB_1078838, HPA003564: AB_2231648	unprognostic (1.65e-2)	unprognostic (1.92e-2)	unprognostic (1.62e-3)	unprognostic (1.77e-2)	unprognostic (2.04e-2)	prognostic favorable (1.28e-5)	prognostic unfavorable (4.74e-5)	unprognostic (1.36e-2)	unprognostic (1.83e-1)	prognostic unfavorable (9.70e-6)	unprognostic (9.44e-2)	unprognostic (3.03e-2)	unprognostic (5.92e-3)	unprognostic (8.60e-2)	unprognostic (1.82e-1)	prognostic unfavorable (4.27e-4)	unprognostic (2.08e-1)	1.7	0.6	1.7	5.9	1.8	0	2.7	0.2	1.6	13.9	43.3	0.8	0.7	15.2	0.2	0.4	0.2	0	46.6	0.7	0.6		0.6	0.2	0.6	0.2	0.9	0.6	0.6	0.2	0	1.2	1.5	1.1	0.4	16.7	0.3	1.3	1.2	0.2	2.8	16.9	0.2	2.1	0.2	17	0.4	0.9	0.5	20.9	0.2	0.5	0.2	0.2	0.6	2.3	0	0.9	1.3	3.2	0.6	0	9.8	0	0.2	0.4	0	0.1	0	0	0	0	0	0.1	3.1	0.2	0	0.1	0.2	0	0	0	0	0.1	0	0	2.9	0.3	0.1	0.3	1	0.2	0	0	0	0	3.3	0.1	0.4	0	0.4	2.8	1.2	0.3	3.2	0.7	0.2	11	3.8	0.2	1.3	0.2	0.3	0	0	0.1	0	0	0	0	0	0.3	0.1	0	3.6	0.4	0.2	0	0	0	0	0.2	0	1.6	0.9	0.3	0	0.7	1.4	2.3	0.6	0.9	3.2	0	1.3	0.5	0	0.2	0.6											3	3.2	2.7	0.7	3.3	1.2	3.1	114.7	5.3	21.6	24.4	0	0.6	0	3.5	6.2	0.7	445.8	0	0.8	0.2	1.1	18.9	16.1	0.8	33.7	0	77.9	0.6	21.7	7.1	0.9	10	8.5	0	4433.7	0	2.4	241.9	0	1.3	1	58.2	0.4	0.7	2.4	5.9	0.3	2.9	169.3	4.7	Mucus-secreting cells
C17orf98	LOC388381	ENSG00000275489	Chromosome 17 open reading frame 98	A8MV24	17	38835088-38841455	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	No human protein/transcript evidence	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	8	testis: 10.7	Cell type enriched	Detected in some	14	Early spermatids: 184.7	Not detected	Not detected							Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Cell line enriched	Detected in some	6	hTCEpi: 7.9	Low region specificity	Detected in many			Low region specificity	Detected in many			HPA051696	Uncertain		Approved	Nucleoli,Intermediate filaments						Intermediate filaments	Nucleoli	HPA051696: AB_2681576	unprognostic (2.30e-1)			unprognostic (3.25e-4)	unprognostic (1.46e-1)					unprognostic (3.01e-1)	unprognostic (2.82e-3)	unprognostic (1.14e-2)	unprognostic (8.69e-3)	unprognostic (2.56e-1)	unprognostic (7.58e-2)	unprognostic (9.02e-2)		0.1	0		0		0	0		0	0	0			0	0	0	0	0	0	0			0	0	0	0			0	0	0		0		0	0		0	0	0	0.2	0	0		0	0	10.7			0		0	0		1.3	0.5	0.4	0.4	0.2	1.1	0	0	0	0	0.2	0	0	0.2	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0.3	0	0.2	0.2	0	0.2	0.2	0.3	0	0	7.9	0.1	0	0.1	0.1	0	0.1	0	0	0.5	0	1.2	0.1	0	0.3	0	0.1	0.1	0.1	0	0	0	0	0.1	0	0	0.5	1	0	0	0.1	0	0	0	0.1	0	0	0	0	0	0.4	0.4	0	0	1.1	0	1	0.5	0	1.3	0.3	0.5	0	0.2	0.2	0.5	0.7	0											0	0	0	0.1	0.1	0	0	0	0	0	0	0	0	3.3	0	184.7	0	0	0	0.2	0.1	0	0.3	0	0	0.4	0	0	0	0	13.1	1.1	0	0	1	0	0	0	0	0	0.2	0	0	0.1	2.2	1.3	0	0	0	0	0	Early spermatids
LYZL6	LYC1, PRO1485, TKAL754	ENSG00000275722	Lysozyme like 6	O75951	17	35934518-35943699	Enzymes, Predicted intracellular proteins, Predicted secreted proteins	Fertilization	Antimicrobial, Bacteriolytic enzyme, Glycosidase, Hydrolase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in single	51	testis: 33.2	Cell type enriched	Detected in some	10	Early spermatids: 287.4	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	5	NB-4: 1.8	Not detected	Not detected			Not detected	Not detected			HPA025734, HPA053073	Enhanced				Secreted in male reproductive system							HPA025734: AB_1853444, HPA053073: AB_2682034																		0	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0		0	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	33.2	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0.1											0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	287.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	30.2	1.7	0	0	0	0	0	0	0	1.1	0	0	0	0	2.1	2.5	0	0	0	0	0	Early spermatids
PRSS2	TRY2	ENSG00000275896	Serine protease 2	P07478	7	142760398-142774564	Enzymes, Plasma proteins, Predicted secreted proteins	Digestion	Hydrolase, Protease, Serine protease		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	708	pancreas: 6267.9	Cell type enriched	Detected in some	6	Exocrine glandular cells: 92348.3	Cancer enriched	Detected in many	72	pancreatic cancer: 3463.4					Group enriched	Detected in some	6	basophil: 5.6;T-reg: 5.1	Group enriched	Detected in many	6	granulocytes: 5.6;T-cells: 5.1	Cell line enhanced	Detected in some		OE19: 11.6;RPMI-8226: 37.4;U-2 OS: 8.1									HPA062452, HPA063471	Supported		Approved	Endoplasmic reticulum,Vesicles	Secreted to digestive system				27000000000	Vesicles	Endoplasmic reticulum	HPA062452: AB_2684768, HPA063471: AB_2685017	prognostic favorable (2.32e-4)	unprognostic (3.80e-1)	unprognostic (2.46e-1)	unprognostic (3.30e-3)		unprognostic (1.99e-2)	unprognostic (3.06e-2)	unprognostic (1.36e-1)		unprognostic (4.62e-3)	unprognostic (1.48e-1)	unprognostic (4.65e-2)	unprognostic (1.55e-3)	unprognostic (1.58e-2)	unprognostic (3.50e-1)	unprognostic (5.36e-3)	unprognostic (1.18e-1)	0	0	0	0	0	0	0	0	0.1	0	4.1	0	0	3.7	0	0	0	0	0	0	0		0	0	0	0	0	0	0.6	6267.9	0	0	0	0	0	0	0	0	0	0	0	8.8	0	0	0	0.1	0.1	0	0	0	0	0	0	0	0.9	0	5.6	0	0.7	5.1	0.3	0	0	0	0	0	0	0.8	0	0	0	0	0	0	0	3.2	0	0	0	0	0	0	1.4	0	0	0	0	0	0	0	0	0	0	0	0	0.3	1.4	2.4	0.2	0	0	0	1.1	0	11.6	0	0	0	37.4	0	0	0	0.5	0	0	0	0	0	0	0	0	8.1	0.5	2.1	0	1.6	0.2	0	0	0	5.6	0	0	0	0	0	0.9	0	0	0	0	0	0	0	0.7	0	0	5.1	0.3											0	0	0	0	0	0	0	0	0	0	0	0	0	0	307	0	0	0	0	92348.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	608.7	0	0	14696.4	0.3	0	0	0	0	0	0	0	0	0	0	0	0	Exocrine glandular cells
AC007325.1		ENSG00000276017			Unmapped	72411-74814	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level				Tissue enriched	Detected in single	17	testis: 14.0	Cell type enriched	Detected in single	25	Spermatocytes: 2.5									Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		ASC diff: 1.0;ASC TERT1: 2.8;HSkMC: 4.4																																							0.1	0		0		0	0		0	0	0			0	0	0	0	0	0	0			0	0	0	0			0	0	0		0		0	0		0	0	0	0	0	0		0	0	14			0		0	0		0.5	0.3	0.6	0.8	0.5	0.3	0	0	0	0	0	1	2.8	0	0.1	0.1	0	0	0	0	0	0	0	0	0.1	0	0.4	0	0	0	0	0	0	0	0.2	0	4.4	0	0.1	0	0.1	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0.2	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0.6	0.8	0.1	0	0.2	0.2	0.1	0.1	0	0.1	0.5	0.2	0.3	0.2	0.5	0	0.3	0	0											0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.5	0	0	0	0	0	0	Spermatocytes
CCL4L2		ENSG00000276070	C-C motif chemokine ligand 4 like 2	Q8NHW4	17	36210924-36212878	Predicted secreted proteins	Chemotaxis, Inflammatory response	Cytokine		Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in many		blood: 41.8;bone marrow: 18.7;lung: 15.2	Cell type enriched	Detected in many	4	Hofbauer cells: 323.5	Low cancer specificity	Detected in all							Cell type enriched	Detected in many	7	eosinophil: 41.8	Lineage enriched	Detected in many	7	granulocytes: 41.8	Group enriched	Detected in some	4	Daudi: 5.7;HMC-1: 8.2;U-266/70: 12.7														Secreted to blood								unprognostic (1.79e-1)	unprognostic (1.17e-1)	unprognostic (2.46e-2)	unprognostic (1.44e-2)	unprognostic (1.16e-1)	unprognostic (6.07e-2)	unprognostic (3.82e-1)	unprognostic (3.19e-1)	unprognostic (1.53e-2)	unprognostic (1.14e-1)	unprognostic (3.62e-2)	unprognostic (1.93e-1)	unprognostic (1.27e-2)	unprognostic (2.27e-1)	unprognostic (2.08e-1)	unprognostic (8.51e-2)	unprognostic (1.99e-3)	0.8	2.4	0	4.5	0.6	18.7	8	0.3	4.6	0.9	0.4	2.3	0	0.6	0.3	0.3	0.1	0	4.5	2.1	0		0.7	5	15.2	8.1	0.6	0.3	0.1	0.1	1	0	1	0.5	0.7	0.8	1	1.6	0	0	0	0.5	0.5	0	2.6	0	0.4	0.4	0.3	0	0.9	1.8	1.9	0	0	0	41.8	0.1	0.3	5.6	1.5	0	0	0	0	0	0	0	0	0	0	0	0	0	5.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	8.2	0	0	0	0	0	0	0	0	1.5	0	0	0	2.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	12.7	1.9	1	0	0.1	0	0.2	0.1	41.8	5.6	0	1.3	0	0.2	3.2	0	0	0	3.3	6.3	0.3	0	0	0	1.5											0	10.6	0	0.2	0.3	0.4	6.1	0	0	0	0	0	3.4	0	0	0.1	0.6	0	0	0	5.4	3.1	0.5	4.7	0.2	323.5	1.6	0	4.3	51.8	0.4	0	52.5	1.7	0	0	0.7	0.1	0	0	0	2.3	12.9	0.4	0	0.1	0.4	8	78.4	0	1.5	Hofbauer cells
KCNE1B		ENSG00000276289	Potassium voltage-gated channel subfamily E regulatory subunit 1B	A0A087WTH5	21	7816675-7829926	Predicted membrane proteins				Evidence at transcript level	Evidence at transcript level	No human protein/transcript evidence	No human protein/transcript evidence		Group enriched	Detected in some	5	blood: 4.0;fallopian tube: 8.2;heart muscle: 8.3;kidney: 3.8	Cell type enriched	Detected in single	5	Ciliated cells: 2.7	Not detected	Not detected							Cell type enhanced	Detected in some		basophil: 3.0;eosinophil: 4.0	Group enriched	Detected in many	17	granulocytes: 4.0;monocytes: 1.6	Cell line enhanced	Detected in some		CACO-2: 5.6;SK-MEL-30: 2.4;SuSa: 3.9																						unprognostic (5.41e-4)	unprognostic (8.78e-2)		unprognostic (7.14e-3)	unprognostic (1.35e-1)	unprognostic (3.34e-2)		unprognostic (1.78e-2)	unprognostic (3.08e-1)	unprognostic (7.47e-2)	unprognostic (3.24e-1)		unprognostic (1.73e-3)	unprognostic (6.59e-2)	unprognostic (1.49e-1)			0	0		0		0	1		0	0	0			0	0	0	0	8.2	0	8.3			3.8	0.4	1.2	0			0	0	0.8		0		0	0		0	0	0	0	0	0.9		0	0	1.2			0		0	0		0	0	4	1.6	0	0.1	0.2	0	0	0	0	0	0	0	0.4	0.9	0.7	0.5	5.6	0.2	0	0	0	0	0	0	0.6	0.1	0	0	0	0	0	0.2	0.2	0	0	0	0	0.6	0	0	0	0	0.1	0.2	0	0	0.3	0	0	0.1	0	0	0	0	0	0	0	0	0	2.4	3.9	0	0	0	0	0	0	0	1	0	0	0	0.1	0	3	1.6	4	0	0.4	0	0	0	0	0	0	0	0	0.8	0	0.6	0	0.1	0.2											0	0	0	0	0	0	0	0	2.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0.3	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	Ciliated cells
HIST1H2AJ	H2A/E, H2AFE	ENSG00000276368	Histone cluster 1 H2A family member j	Q99878	6	27814354-27814740	Predicted intracellular proteins		DNA-binding		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level		Tissue enriched	Detected in some	22	lymphoid tissue: 357.7	Cell type enriched	Detected in some	29	Erythroid cells: 46.7	Low cancer specificity	Detected in many							Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		Hep G2: 10.0;Karpas-707: 12.1;MCF7: 16.8					Low region specificity	Detected in some			HPA041189	Supported		Approved	Nucleoplasm			Yes			Nucleoplasm		HPA041189: AB_2677357	unprognostic (8.95e-3)	unprognostic (4.08e-3)	unprognostic (3.28e-2)	unprognostic (5.72e-3)	unprognostic (2.29e-2)	unprognostic (2.69e-2)	unprognostic (6.06e-2)	unprognostic (1.97e-2)	unprognostic (1.05e-1)	unprognostic (2.18e-1)	unprognostic (9.39e-3)	unprognostic (3.43e-1)		unprognostic (9.35e-2)	unprognostic (1.51e-1)		unprognostic (1.88e-2)	0.6	0.1	0	7.2	0	16.5	0.2	0	0.2	1	5.2	0	0	0.3	0.3	0.6	6.6	0.3	0.8	0.2	0		0.3	0.4	2.2	3.1	0	0	0.1	0.1	0.1	0	3.6	0	0.2	0.4	0	0.1	0.1	0.1	0.4	3.9	0.1	0	10.5	0.8	5.2	0	357.7	0.1	7.9	23.1	1.5	0	4.2	2.7	2.5	0.5	0.4	5.9	5	4	0	1.2	0	0	0	1	1.2	1.2	1.1	2.6	2.1	0.2	3.9	0.4	0.7	0.1	1.1	0	1.1	0.6	1.9	0.6	5.6	0.5	10	0.3	0	2.1	0	0.3	0.5	0.3	0	1.5	2.1	0	12.1	0.3	16.8	6.7	6.1	2	1.7	3.5	6	0	2.3	0.2	2.4	0.5	0.8	1.1	1.2	0.5	0.3	0.4	4.1	0	0	2.4	0.4	0.2	6.2	3.9	3.8	1.3	4.5	2.8	0	0.1	0	0.7	0.5	0.9	0.7	3.4	3.1	2.7	4.2	1.1	0.4	2.5	0.4	0.2	0.3	5.9	5											0	0	0	0.6	0	0	0	0	0	1.2	0	0	0.4	0	0	0	0	0	46.7	0	1.6	0	0.4	0	0	0.4	0	0	0	0.3	0	0	0.7	0	0	0.1	0	0	0	0	0	0	0	0.3	0	0.5	0	0.6	0	0.4	0.3	Erythroid cells
CCL14	CKb1, HCC-1, HCC-3, MCIF, NCC-2, SCYA14, SCYL2	ENSG00000276409	C-C motif chemokine ligand 14	Q16627	17	35983291-35987004	Cancer-related genes, Plasma proteins, Predicted secreted proteins		Cytokine	Cancer-related genes	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		breast: 80.7;lymphoid tissue: 98.4	Cell type enriched	Detected in many	16	Ito cells: 1401.9	Low cancer specificity	Detected in some							Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	52	HUVEC TERT2: 35.9									CAB004423, HPA030268	Uncertain				Secreted to blood			5200000	19000000			CAB004423: AB_627716, HPA030268: AB_10603782	unprognostic (4.13e-2)	unprognostic (5.85e-2)	unprognostic (4.86e-2)	unprognostic (3.55e-3)	unprognostic (2.50e-1)	unprognostic (1.99e-2)	unprognostic (8.79e-5)	unprognostic (1.44e-1)	unprognostic (1.53e-1)	unprognostic (8.10e-2)	unprognostic (6.33e-3)	unprognostic (3.00e-2)	unprognostic (7.27e-3)	unprognostic (1.36e-2)	unprognostic (3.95e-1)	unprognostic (3.52e-1)	unprognostic (1.14e-1)	56.3	5.1	0	5.9	0	0	80.7	0	0	37.6	8.4	0	16.6	0	37.6	11.1	20.9	9.1	17.3	27.5	0		8.7	34.2	26.4	39.1	0	0	12.4	0.8	2	6.5	0	0	23.5	0.7	4.1	6.5	11.4	21.9	7.5	3.9	19.1	0	98.4	0.2	15	0	1.3	17.6	16.7	6.2	25.3	45.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	35.9	0	0	0	0	0	0	0.1	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0.6	0.2	0	0	0	0.2	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	14.6	7	0.1	1.6	0	0.1	28.1	4	1.2	0	0	0	0	0	22.9	57.6	1.7	0	0	0	0.2	0.2	1.1	5.9	0.2	0	0	1401.9	89.1	43.1	1.4	0	0	0	1	0	0	3.5	0	1	0	0	0.3	0	0	1.3	0	1.3	0.6	0.1	Ito cells
GOLGA6L6	FLJ36131	ENSG00000277322	Golgin A6 family-like 6	A8MZA4	15	20531856-20541800	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level	No human protein/transcript evidence	No human protein/transcript evidence		Tissue enriched	Detected in single	21	testis: 7.2	Cell type enriched	Detected in some	7	Early spermatids: 20.6	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		Karpas-707: 1.0;SCLC-21H: 1.3									HPA047733	Uncertain											HPA047733: 						unprognostic (1.10e-1)								unprognostic (1.67e-1)				0	0		0		0	0		0	0	0			0	0	0	0	0	0	0			0	0	0	0			0	0	0		0		0	0		0	0	0	0	0	0		0	0	7.2			0		0	0		0	0.3	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0.7	0	0	0	0	0	0	0	1.3	0	0	0	0	0	0	0.8	0	0.5	0.1	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0.3	0	0											0	1.1	0	0	0	0	0.2	0	0	1.2	0	0	0	0	0	20.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.1	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	Early spermatids
GPR179	CSNB1E, GPR158L1	ENSG00000277399	G protein-coupled receptor 179		17	38325530-38343847	Predicted membrane proteins				Evidence at transcript level	Evidence at transcript level				Tissue enhanced	Detected in some		brain: 3.0;retina: 7.5	Cell type enriched	Detected in some	13	Bipolar cells: 24.9	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		AN3-CA: 1.0;U-266/84: 1.1	Not detected	Not detected			Low region specificity	Detected in many			HPA017885	Uncertain											HPA017885: AB_2279357	unprognostic (1.65e-1)	unprognostic (2.27e-1)	unprognostic (1.24e-4)	unprognostic (8.89e-3)	unprognostic (1.34e-1)	unprognostic (1.09e-1)	unprognostic (2.10e-1)	unprognostic (3.04e-2)	unprognostic (4.76e-2)	unprognostic (2.34e-2)	unprognostic (6.57e-3)	unprognostic (5.31e-2)	unprognostic (5.09e-10)	unprognostic (6.18e-2)	unprognostic (2.31e-1)	unprognostic (1.62e-2)	unprognostic (3.41e-4)	0.2	0.6	1.6	0	3	0	0.2	0.8	1.9	0.1	0.1	0.2	0	0.3	0.2	1	0	0.2	0	0	0.5		0	0.1	0.2	0	0	0.3	0	0	0	0	0.1	1.4	0.3	0	7.5	0.6	0.3	1.5	0	0.3	0.1	0.6	0	0.5	0.4	0.1	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0.2	0	1	0.3	0	0.1	0	0	0	0	0.1	0	0.1	0	0.1	0	0	0	0	0	0.7	0.2	0	0	0	0	0	0.2	0.4	0.5	0.1	0	0	0	0.5	0	0.7	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0.3	0	0.2	0.1	0.1	0.1	0	0	0.4	0	0	0	1.1	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0	0	0	0	0	0											0	0	0	0	0	24.9	0.6	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	1.5	0	0	0	0	0	0	0	0	0	Bipolar cells
AC007906.2		ENSG00000277639			16	53035690-53052873	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level				Tissue enriched	Detected in some	7	fallopian tube: 29.9	Cell type enriched	Detected in some	7	Ciliated cells: 385.4	Cancer enhanced	Detected in many		ovarian cancer: 31.6					Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in many		ASC diff: 9.3;ASC TERT1: 7.9;BEWO: 12.7;HSkMC: 7.9;RPTEC TERT1: 8.1	Low region specificity	Detected in all																				unprognostic (1.97e-2)	unprognostic (8.34e-3)	unprognostic (1.63e-1)	unprognostic (5.38e-3)	unprognostic (1.70e-1)	unprognostic (5.75e-2)	unprognostic (2.54e-1)	unprognostic (1.06e-1)	unprognostic (3.34e-1)	unprognostic (2.25e-2)	unprognostic (1.54e-2)	unprognostic (5.02e-2)	unprognostic (6.07e-2)	unprognostic (5.68e-2)	unprognostic (1.32e-1)	unprognostic (1.02e-2)	unprognostic (4.46e-3)	0	0		0		0	1.7		0	4.3	1			0	0.4	0	2.8	29.9	3.4	0			3.8	0	3	0			0	3.7	0		0		3.1	1.4		0.8	0.5	0	0	0	0		0	0	0			0		0	0.1		0	0	0	0.9	0	0	0	0.1	2.7	4.5	2.3	9.3	7.9	12.7	1.3	1	0.1	0	0.3	1.8	0.2	2.3	1.8	0.8	0.7	0	1.7	0.5	0.2	0.1	0	0.1	0.6	1.8	0	2	7.9	6.8	2.5	0.8	2.6	1.8	0.1	0.1	0.1	4.1	0.1	0.1	0	4.9	0.4	0.6	1.1	0	0	8.1	1.7	0.2	0	0.3	0	0.1	4	0.9	0.1	2.1	3	3	0.1	0	0	0	0	3.6	0.4	1.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.9	0	0	0											0	4.3	0	0	0	0	0	0	385.4	55.7	24.4	0	0.1	5	3	0	0	0	0	0	0.2	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	2.9	0	0	0	0	0	0	0	0	0	0	Ciliated cells
GOLGA6L22		ENSG00000277865	Golgin A6 family-like 22		15	22458903-22469230	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level				Tissue enriched	Detected in some	5	testis: 7.7	Cell type enriched	Detected in some	9	Early spermatids: 49.8	Not detected	Not detected							Cell type enriched	Detected in single	5	neutrophil: 1.4	Lineage enriched	Detected in single	5	granulocytes: 1.4	Cell line enhanced	Detected in some		AN3-CA: 1.3;HeLa: 1.0;Karpas-707: 1.1;U-266/70: 1.7									HPA047733	Uncertain											HPA047733: 						unprognostic (2.71e-2)								unprognostic (1.08e-1)				0.1	0		0.2		0	0		0.3	0	0			0.1	0	0	0	0	0	0			0	0	0	0			0	0.1	0		0		0	0		0	0	0	0.5	0	0		0.2	0	7.7			0		0	0		0.2	0.3	1.4	0	0	0.1	0	0	0	0	1.3	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0.3	0	0	0	0	0.4	0	1	0	0	0	0.7	0	0	0	0	0	0	0	0.3	1.1	0	0	0	0.3	0	0	0	0.9	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0.5	0	1.7	0	0.6	0	0.5	0	0.2	0	0	0.1	0	0.1	0.2	0	0	0.1	0.1	0	0	1.4	0	0	0.3	0	0											0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	49.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0.2	0	0	0	0	0	Early spermatids
FAM230A	DGCR15	ENSG00000277870	Family with sequence similarity 230 member A		22	18422244-18500594	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level				Tissue enriched	Detected in some	12	testis: 16.4	Cell type enriched	Detected in some	5	Early spermatids: 29.8	Not detected	Not detected							Group enriched	Detected in some	7	classical monocyte: 1.1;myeloid DC: 1.3	Group enriched	Detected in many	12	dendritic cells: 1.3;monocytes: 1.1	Cell line enhanced	Detected in some		A549: 16.4;HeLa: 6.3;Karpas-707: 7.7;RH-30: 6.9;U-266/84: 13.5																																							0	0		0		0.4	0		0.2	0	0			0	0	0	0	0	0	0			0	0	0	0			0.1	0	0		0		0	0		0	0	0	0.1	0	0		0	1.1	16.4			0.2		0	0.2		0.1	1.3	0	1.1	0	0	0.1	1.9	16.4	1.2	0	0	0	2.4	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0.1	0	5.8	6.3	1.8	0	0	0	0	0	0	0	0	0	0.2	4.5	7.7	0	4.1	0.3	0.6	3.2	0	1.2	1.1	6.9	4.6	0	0.8	5.7	0	0.3	4.5	0.9	0.1	0	2.1	0	1.4	0.3	0	0.2	0.6	13.5	0	0	3.3	0.1	0	1.1	0	0	0	0	0	0	0	1.3	0.1	0	0	0	0	0	0.1	0	0.1											0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0.1	29.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5.9	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0.2	0	0.5	0	0	0	0	Early spermatids
SSTR3		ENSG00000278195	Somatostatin receptor 3	P32745	22	37204238-37212322	FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins		G-protein coupled receptor, Receptor, Transducer	FDA approved drug targets	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level		Tissue enhanced	Detected in some		brain: 11.1;lymphoid tissue: 29.6;testis: 11.3	Cell type enriched	Detected in single	5	Late spermatids: 1.9	Cancer enhanced	Detected in some		pancreatic cancer: 1.9					Cell type enhanced	Detected in some		naive CD4 T-cell: 3.9;naive CD8 T-cell: 3.0	Lineage enriched	Detected in single	10	T-cells: 3.9	Group enriched	Detected in some	11	RPMI-8226: 22.3;SCLC-21H: 8.4	Low region specificity	Detected in all			Low region specificity	Detected in all			CAB022647	Approved											CAB022647: 	unprognostic (1.63e-2)	unprognostic (5.58e-3)	unprognostic (1.32e-2)	unprognostic (3.18e-2)	unprognostic (7.03e-2)	unprognostic (6.26e-5)	unprognostic (1.11e-1)	unprognostic (1.72e-2)	unprognostic (1.90e-2)	unprognostic (8.95e-2)	unprognostic (3.88e-3)	unprognostic (2.93e-1)	unprognostic (1.51e-7)	unprognostic (1.55e-1)	unprognostic (1.24e-2)	unprognostic (5.61e-3)	unprognostic (1.06e-2)	0.1	0.8	2.8	1.9	1.9	0.9	0.1	2.7	11.1	0	0.5	0.2	0	2.6	1.9	0.2	0.1	0.1	0.1	0	5.6		0.1	0	0.1	3.5	0	7.9	5.8	3.9	0	6.4	0	7.9	0.2	0.6	0	0.6	0.1	0	0	1	2.2	4.3	1.2	0.5	11.3	0.1	29.6	0	0	2	0.3	0	0.3	0.1	0.1	0	0	3.9	0.8	0	0	0	0	0	0	0	0	0	0	0	0.2	0	1	0	0	0	0	0	0	0	0	0	0	0	0.8	0	0	0	0	0	0	0	0	0	0.2	0	0.3	0	0	0	0	0	0	0	0	0	22.3	0	0	8.4	0.6	0	0	0	0	0	0	0	0	0	0	0	1.4	0.3	0	0	0	0	0	0	0	0	0	0	0.3	0.9	0	0	0.3	3.9	3	0.1	0	0	0.1	0.3	0.8											0	0	0	0	0	0.3	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0.1	0	0	0	0	0	Late spermatids
TBC1D3C	MGC44903	ENSG00000278299	TBC1 domain family member 3C	Q6IPX1	17	38057693-38068592	Predicted membrane proteins		GTPase activation		Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in some		bone marrow: 3.3;skin 1: 3.5;testis: 3.4	Cell type enriched	Detected in single	8	Early spermatids: 1.4	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in some	5	CAPAN-2: 27.5									HPA046969, HPA047745, HPA052553	Approved		Uncertain	Vesicles						Vesicles		HPA046969: , HPA047745: AB_2680144, HPA052553: AB_2681869																		0	0		0.6		3.3	0		0	0	0			0.9	0.2	0	0	0.5	1.2	0.5			0.1	0	1.8	1			0.7	0	0		0		0	0		0.8	0	1.3	3.5	0	0.1		0	1.5	3.4			0		0.9	0		0	0	0.8	0.3	0	0.6	0	0	0	0.3	0	0	0	0	0	0	0	0	0	27.5	0	0	0	0.3	0	0	0	0	0	0	1.6	5.3	0.1	1	0.4	0	0	0	0	0	0	0	0.2	0	0	0.6	0	0.8	0.1	0.1	0	0	0	0	1	0	0.5	0.2	0	1	0	0	2.8	5.6	2.6	0	0	0	0.1	0	0	0	0	0	0	0	0	0.3	0	0.6	0	0.1	0	0	0	0	0	0	0.5	0.8	0	0	0	0	0											0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	1.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	Early spermatids
POTEB3		ENSG00000278522	POTE ankyrin domain family member B3	A0JP26, Q6S5H4	15	21408243-21440451	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level	Evidence at transcript level	Evidence at transcript level		Tissue enriched	Detected in single	53	testis: 5.2	Cell type enriched	Detected in single	10	Spermatocytes: 1.9	Not detected	Not detected							Not detected	Not detected			Not detected	Not detected			Not detected	Not detected																																									0	0		0		0	0		0	0	0			0	0	0	0	0	0	0			0	0	0	0			0	0	0		0		0	0		0	0	0	0	0	0		0	0	5.2			0		0	0		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.9	0	0	0	0	0	0	Spermatocytes
NR2E3	PNR, rd7, RP37	ENSG00000278570	Nuclear receptor subfamily 2 group E member 3	Q9Y5X4	15	71792638-71818259	Disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors	Sensory transduction, Transcription, Transcription regulation, Vision	DNA-binding, Receptor, Repressor	Disease mutation, Retinitis pigmentosa	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	26	retina: 50.2	Cell type enriched	Detected in some	35	Rod photoreceptor cells: 1391.6	Low cancer specificity	Detected in single							Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		AN3-CA: 3.0;GAMG: 2.5;MCF7: 3.2;T-47d: 2.9	Not detected	Not detected			Not detected	Not detected																unprognostic (9.90e-2)	unprognostic (2.50e-1)	unprognostic (8.25e-3)	unprognostic (2.63e-3)	unprognostic (2.04e-1)	unprognostic (1.01e-1)	unprognostic (9.85e-3)	unprognostic (3.60e-2)	unprognostic (2.59e-1)	unprognostic (2.89e-1)	unprognostic (3.51e-1)	unprognostic (3.65e-1)	unprognostic (4.75e-2)	unprognostic (2.11e-2)	unprognostic (2.75e-1)	unprognostic (2.55e-1)	unprognostic (1.82e-1)	0.1	0.4	0.1	0.1	0.1	0.2	1.5	0.1	0.1	1.9	0.2	0.1	0.1	0	0.2	1.3	0.1	0.7	0.3	0.1	0.1		0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0	0.1	0.1	0.2	1.8	0.2	50.2	0.9	0.1	0.1	0.7	0.5	0.1	0.1	0.1	0.9	1.3	0.1	0.1	0.4	0.1	0.1	0.1	0.1	0.2	0.1	0	0	0.2	0.7	0	0.3	1.8	0	3	0.1	0.9	0	0.7	0.4	0.1	0.1	0.3	0.3	1.3	1.2	0	2.5	2.2	1	0.7	0.2	0	0.9	0	0.5	0.1	0.1	0.1	0	0	0.2	0.2	0.5	1.5	0.3	0	0	0	0.1	3.2	0	0.8	0.2	0.3	1.4	0.1	1	0	1.6	0.2	0.3	0.2	0.3	0.4	0.5	0.6	2.9	0.3	1.6	0.4	0.2	1.1	0.2	0.3	0.5	0.2	0.5	0.2	0.2	0	0	0	0	0	0.1	0	0	0.6	0	0.2	0.1	0	0	0.2	0	0.1	0.7	0											0	0	0	1.7	0	29.1	0.6	0	0	0	0	39.3	0	0	0.3	0.3	0	0	0	0.2	0.2	0	3.6	0	0	0.1	28.6	0	0	0.3	0	0.6	0	0	0	0	38.7	0.3	0	1.8	0	1391.6	0	0	0.4	0.4	0	0	0	0.5	0.6	Rod photoreceptor cells
AC023491.2		ENSG00000278633			Unmapped	10598-13001	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level				Tissue enriched	Detected in single	36	testis: 28.4	Cell type enriched	Detected in single	40	Spermatocytes: 20.9									Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		AN3-CA: 1.3;HEK 293: 1.1																																							0	0		0		0	0		0	0	0			0	0	0	0	0	0	0			0	0	0	0			0	0	0		0		0	0		0	0	0	0	0	0		0	0	28.4			0		0	0		0.1	0.1	0.7	0.1	0.2	0.3	0	0	0.1	0	1.3	0	0	0	0.1	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	1.1	0.1	0	0	0	0.1	0.2	0	0	0	0	0	0	0	0	0.3	0	0.1	0	0.6	0.3	0	0	0	0	0.3	0.1	0	0.3	0.7	0	0	0.1	0	0.4	0.1	0	0	0.6	0.4	0	0.1	0.1	0	0.1	0	0	0.6	0	0	0.2	0.1	0	0	0	0	0.1	0.1	0.1	0.2	0.7	0.2	0	0	0.3	0											0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.4	0.3	0	0	0	0	0	0	0	0	0	0	0	0	20.9	0.2	0	0	0	0	0	Spermatocytes
GOLGA6L10	GOLGA6L18	ENSG00000278662	Golgin A6 family-like 10	A6NI86	15	82339998-82349475	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level	No human protein/transcript evidence	No human protein/transcript evidence		Tissue enhanced	Detected in some		blood: 3.4;testis: 8.2	Cell type enriched	Detected in many	7	Early spermatids: 126.0	Not detected	Not detected							Cell type enhanced	Detected in single		NK-cell: 3.4	Lineage enhanced	Detected in single		NK-cells: 3.4	Cell line enhanced	Detected in some		HaCaT: 2.9;HEK 293: 7.7;SK-MEL-30: 3.9;SuSa: 3.6																						unprognostic (8.06e-2)	unprognostic (2.56e-1)	unprognostic (2.51e-1)	unprognostic (8.31e-2)	unprognostic (2.97e-1)	unprognostic (1.43e-1)	unprognostic (7.37e-2)	unprognostic (6.12e-2)	unprognostic (7.01e-2)	unprognostic (4.10e-1)	unprognostic (2.36e-4)	unprognostic (8.30e-2)	unprognostic (6.06e-6)	unprognostic (4.13e-2)	unprognostic (3.08e-1)	unprognostic (2.16e-1)	unprognostic (5.34e-2)	0	0.3		0.1		0.5	0.5		0	0	0			0	0.8	0	0.2	0.1	0.1	0			0	0	0.1	0			1.5	0.1	0.8		0		0.2	0		0	0	0.9	1.6	0	0		0.1	0.2	8.2			0.2		0	0		0.1	0	0.9	0	3.4	0.2	0	0.1	0.1	0.4	0.3	0.1	0.4	0	0.5	0.3	1.2	0.1	0	0	0.8	0.4	0.4	1.3	2.9	0.2	0.1	0	0.1	7.7	0	1.9	0.9	0.4	0	0.1	0	0.3	0.1	0.3	0.8	0.1	1.2	2.7	0	0	1.3	0	0	0.5	0.1	0	1	0.1	0	0.2	0.8	1.7	0.3	0.6	0	3.9	3.6	0.5	0.2	0	0.9	0.3	0.7	0	2.3	0.4	0.2	0.6	0	0.1	0.9	0	0	0	0	0	0	0.1	0.1	0	0.1	0.1	0.2	0	3.4	0	0	0	0											6	5.6	0	3.7	0	4.5	2	2.5	4	5.7	5.2	3.9	2.2	0	1.9	126	0.6	1	0	2.5	0.4	0.7	4.2	1.1	1.8	0.7	3.2	4.7	2.5	0.8	19.1	3.4	0.6	0	0	2.2	5.1	3.5	2.3	1.4	0	5.9	0	0.5	17.2	11	0	0.2	0	4.1	2.4	Early spermatids
AC104662.2		ENSG00000281028			4	25160663-25277306	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level				Low tissue specificity	Detected in many			Cell type enriched	Detected in single	14	Ciliated cells: 1.4	Not detected	Not detected							Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Low cell line specificity	Detected in many											HPA004099	Uncertain		Uncertain	Cytosol						Cytosol		HPA004099: AB_1855353					unprognostic (3.59e-2)													1.7	2.3	6.7	5.5	11.1	6.7	3.7	9.7	9.3	2	4.1	4.3	5	7.8	1.7	2.5	5.4	3.5	1.6	1.5	7.3		2.8	10.1	4	4.4	10	2.4	1.5	1.8	2.9	14.9	2.8	7.1	1.1	5.4	2.1	4.5	2.5	1.8	0	6	2.6	11.3	2.5	3.6	9.2	10.6	6.1	5.3	1.6	5.3	3.1	4.8	2.1	2	7.5	1.9	1.4	4.3	0.9	5.3	3.7	4.4	2.4	3.2	6.1	4.1	8.9	9.1	11.4	12.2	4	7.5	13.5	2.1	11.4	10.7	2.9	9.3	3.8	6.9	5.8	2.6	6.3	9.1	3.8	0.6	12.4	3.6	3.1	0.7	4.5	4.6	2.2	3.9	6	4.2	15.7	3.5	6.1	10.8	0.9	3.6	6.7	2.4	6.3	12	5.9	2.7	9.8	5	1	3.6	1.3	2.6	4.4	2.9	1.7	7.4	6.3	1.8	2.9	5.2	10.6	12	19.1	5.4	6.5	4.6	7.5	1.9	6.2	2.4	1.8	1.6	2.1	2.4	2.3	1.4	1.9	1.8	2.1	3.2	1.4	1.3	2	4.3	0.9											0	0	0	0	0	0	0	0	1.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Ciliated cells
CYP3A7-CYP3A51P		ENSG00000282301	CYP3A7-CYP3A51P readthrough	P24462	7	99685226-99735093	Enzymes, Predicted membrane proteins	Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis	Monooxygenase, Oxidoreductase		Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enriched	Detected in some	21	liver: 73.9	Cell type enriched	Detected in some	7	Cholangiocytes: 7.6									Cell type enhanced	Detected in single		eosinophil: 1.1	Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		ASC TERT1: 4.3;U-87 MG: 2.6									HPA072245, HPA075539			Approved	Vesicles,Cytosol						Cytosol	Vesicles	HPA072245: , HPA075539: 																		0	0.1	0	0	0	0	2.3	0	0.1	0	0.6	0	0	0.4	0	0	0.1	0	3.5	0	0		1.1	73.9	0.5	0.2	0	0	0.1	0	0	0	0.1	0	0.3	0	0	0.1	0	0	0	1.3	0	0	0.2	0	0	0	0	0.2	0	0	0	0.2	0	0.2	1.1	0	0	0.5	0	0.3	0.5	1.6	0.5	0.2	4.3	0	0.6	0.2	0	0	0	1.3	0.1	0.4	0	0.1	0.3	0	0	0	0.4	0.9	1.4	1.9	0	0	0.5	0.3	0.4	0.4	0	0.4	0.5	0	0.8	0.5	1.1	0.1	0.2	1.2	0.5	0.2	0.5	0.2	0.1	0.4	1.5	0	0	0.4	0.2	0	0.5	0.6	0.6	0	0.1	0.4	0.3	0.5	0.5	0.6	0.9	0.7	0.1	2.6	0.7	0.1	0	0	1.1	0.1	0	0	0	0.1	0.1	0	0	0.5	0	0	0	0	0.2	0.1	0											0	0	0	0.1	0	0	0	7.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Cholangiocytes
FAM237B		ENSG00000283267	Family with sequence similarity 237 member B		7	90316503-90321308	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level				Tissue enhanced	Detected in some		prostate: 1.1;testis: 1.7	Cell type enriched	Detected in single	20	Ciliated cells: 2.7									Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		HSkMC: 1.0;U-266/70: 1.0	Group enriched	Detected in some	6	hypothalamus: 1.9;thalamus: 5.4	Low region specificity	Detected in all																																	0	0.2		0.3		0.1	0		0.1	0	0			0.2	0.2	0	0	0.1	0.1	0			0.5	0	0.8	0			0	0	0		0		1.1	0		0.2	0	0	0.2	0	0		0.1	0	1.7			0.3		0	0		0	0	0	0	0	0	0	0.2	0	0	0.2	0	0.2	0.1	0	0	0	0	0.2	0.2	0	0	0	0	0.1	0	0	0	0	0.2	0	0	0	0	0.2	0	1	0	0	0	0.2	0	0	0	0	0	0	0	0.2	0.6	0	0.2	0	0.1	0	0	0	0	0.2	0	0	0	0	0	0	0.4	0.2	0.1	0.7	0	1	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0	0	0	0	2.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	Ciliated cells
CFAP97D2		ENSG00000283361	CFAP97 domain containing 2		13	114154691-114223084	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level				Tissue enhanced	Detected in some		blood: 7.7;brain: 8.4;fallopian tube: 22.4;pancreas: 7.8	Cell type enriched	Detected in some	8	Ciliated cells: 34.8									Cell type enriched	Detected in single	12	naive CD8 T-cell: 7.7	Lineage enriched	Detected in single	78	T-cells: 7.7	Cell line enhanced	Detected in some		HL-60: 1.8;NTERA-2: 1.0																																							0	0	0.5	0	7	0.8	0	0	1.4	0.3	0	8.4	0	0	0	2.1	0	22.4	0	0	1.9		0	0	2.6	0.3	0	2	3.6	7.8	0	0.1	0	8.3	0	0	0	0	0	0	0	0	0	0	0.2	0	2.1	2.4	1	0	0	0.1	0	0	0	0	0	0	0	7.7	0.7	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.8	0	0	0	1.8	0	0	0	0	0	0	0	0.2	0	0	0	0	0.3	0	1	0.1	0	0	0.4	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0.1	0	0.1	0	0	0	0.3	0	0	0	0	0	0.6	0	0	0	0.1	0.1	0	0	0.6	7.7	0	0	0	0	0	0.7											0	0	0	0	0	0	0	0	34.8	4.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Ciliated cells
SPEM3		ENSG00000283439	SPEM family member 3		17	7428863-7432762	Predicted membrane proteins				Evidence at transcript level	Evidence at transcript level	No human protein/transcript evidence			Tissue enriched	Detected in single	73	testis: 43.2	Cell type enriched	Detected in single	17	Distal tubular cells: 1.7									Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in single		U-2 OS: 1.1					Not detected	Not detected																																	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	43.2	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0.1	0	0	0.2	0.3	0.2	0	0.2	0	0	0	0.1	0.2	0	0.1	0	0.1	0	0	0	0	0	0	0.2	0	0.2	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0.2	0	0	0.1	0	0	0	0	0	0.2	0	0	0	0	1.1	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0	0	0	0	0	0	0	0	0	1.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Distal tubular cells
ZNF511-PRAP1		ENSG00000283496	ZNF511-PRAP1 readthrough		10	133309410-133352529	Predicted membrane proteins				Evidence at protein level	Evidence at protein level				Tissue enhanced	Detected in many		intestine: 31.6;liver: 23.8	Cell type enriched	Detected in single	12	Club cells: 1.2									Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in many		Hep G2: 16.1;OE19: 11.5									HPA035360, HPA038713, HPA052451	Supported		Uncertain	Nucleoplasm,Nuclear bodies,Vesicles						Nuclear bodies	Nucleoplasm, Vesicles	HPA035360: AB_10601931, HPA038713: AB_10673117, HPA052451: AB_2681839																		2.1	1.6	1.1	5	1.7	1.2	6.2	3	2.7	3.1	11.9	1.9	4.9	31.6	3.9	3.5	3.5	1.3	3	4.8	1.8		13.7	23.8	2.1	4.7	2.2	1.9	4.9	9.7	0.9	2.1	1.5	1.7	5.1	7.6	2.9	5	3	5.8	1.3	28.1	4.4	0.8	3	3.4	6.5	2.7	3.2	4.6	7.1	3	2	4.8	0	0	0	0	0	0.8	0	0.2	0.2	3.1	5	0	0	6.7	0	1.4	0	0	6.7	2.1	0	3.2	1.7	0.2	0.1	0.8	0	2.1	0.3	0	0.9	0	16.1	0	1.2	1.8	0	0	1.5	4.8	0	0	0.6	0.3	6.1	0	0	3.2	5.2	0.3	11.5	0	0.9	1.2	2.9	0.2	0.3	0.5	5.4	0.3	2.7	2.3	3.3	0	0.5	0	0	3	2.5	0.1	1.5	0	0.8	0.3	1.1	0.7	0	0	0	0.8	0	0	0	0	0	0	0	0.4	0.5	0	0	0	0	0	0											0	0	0	0	0	0	0	0	0	1.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Club cells
EXOC3L2	FLJ36147, XTP7	ENSG00000283632	Exocyst complex component 3 like 2	Q2M3D2	19	45212621-45245431	Predicted intracellular proteins				Evidence at protein level	Evidence at transcript level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in many			Cell type enriched	Detected in some	10	Ito cells: 57.1									Group enriched	Detected in some	4	basophil: 1.6;neutrophil: 2.5	Lineage enriched	Detected in single	5	granulocytes: 2.5	Group enriched	Detected in some	7	HEL: 18.2;K-562: 16.8									HPA041595, HPA061110	Approved		Approved	Nucleoplasm,Golgi apparatus,Vesicles,Cytosol						Vesicles	Nucleoplasm, Golgi apparatus, Cytosol	HPA041595: AB_10794521, HPA061110: AB_2684431																		3.2	4.3	0	2	0	0.9	3	0	0.3	3.6	2.1	0.1	2.4	2.3	14.5	1.2	2.3	0.6	6.9	1.9	0		12.7	9.4	3.4	6.3	0	0	3.4	2.8	2.4	3.5	0.4	0	3.7	0.2	13.7	3.3	3.6	1	2.4	3.9	1.6	0	12.6	2.4	2.1	0	0	4.6	1.5	3.2	1.6	3.3	0.5	0.3	2.5	0.4	0.2	0.4	0.2	0.1	0.3	2.3	0.2	0	0	0.2	0.1	0	0	0	0.1	0.3	0.1	2.2	0	0.2	1.2	0	0.1	0	0.1	0	18.2	0.5	0.1	0	0	0.1	0	0	0	0	0.2	0.1	0	16.8	0.3	0	0.2	0	0	0.2	0.1	0.5	1.3	0	0.1	0	0.1	0.3	0	0.1	0.1	0.1	0.7	0.1	0.3	0.4	0.8	1.6	0.3	0.1	0.2	0.1	0	0.1	0.2	0.1	1.6	0.4	0.2	0.4	0.2	0.2	0.2	0.2	0.2	0.2	0.5	0.2	0.3	2.5	0.2	0.3	0.3	0.1	0.2											0	2.2	0	0.3	0.3	0.6	0.3	0	0	0	0	0	0	0	0	0.1	6	0	0	0	0	0	0.2	0	0	0	0	0	57.1	1.5	0	1.7	0	0	0	0	0.2	0	0	1.8	0	0.1	0	0.1	0.2	3.4	0.6	0	0	0	0.1	Ito cells
AC051649.2		ENSG00000283787			11	1888577-1891895	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level				Tissue enhanced	Detected in some		blood: 7.0;skeletal muscle: 18.5	Cell type enriched	Detected in single	22	Cardiomyocytes: 2.2									Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Cell line enhanced	Detected in some		Daudi: 4.3;HDLM-2: 11.9;JURKAT: 2.7;Karpas-707: 8.1;NB-4: 3.3;U-937: 6.0					Low region specificity	Detected in many																																	0	4.9		3		4.5	0		0	0	0			0.3	0	0	0.1	0	0.3	0.2			0	0	0	3			0	0	0		0.3		0	0		0.7	0	18.5	6	0.6	0		4.5	0.8	0			0		0	0.2		1.6	2.8	7	3.1	1	1.9	4	0	0	0	0	0	0	0	0	0	0	0	0	0	4.3	0	0	0	0	0	0	0	11.9	0	0.1	0	0	0	0	0	0	0	0	0	0	0	2.7	0	8.1	0	0	0.7	3.3	0	0	0	0	0.2	1.2	0	0	0	0.1	0	0	0	0	0	0	0	0.2	0.3	0	0	0	0	0.4	0	6	0	1.1	2.8	2.8	1.5	2.9	0.7	1.6	1.2	1.3	2.8	1.2	0.8	1.1	7	1	3.1	2.7	1.9	4											0	0	0	0	0	0	2.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Cardiomyocytes
AP001273.2		ENSG00000284057			11	93741664-93812378	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level				Low tissue specificity	Detected in many			Cell type enriched	Detected in some	7	Ciliated cells: 8.1									Low cell type specificity	Detected in all			Low lineage specificity	Detected in all			Cell line enhanced	Detected in many		OE19: 6.5									HPA040511, HPA046619	Approved		Approved	Nuclear speckles,Cytosol						Nuclear speckles	Cytosol	HPA040511: AB_10795369, HPA046619: 																		2.4	3	1.8	4.2	3.4	0.6	2.7	2.8	2.4	3.6	6.1	3.5	3.6	8.2	2.6	3	2.9	2.5	3.3	4	2		16.9	17.6	3.6	1.7	3.9	1.9	4.8	5.4	5.3	5.9	2.8	3.2	4.5	2.7	4.2	3.8	2.8	4.2	3.7	11.1	2.9	4.5	1.9	3.7	2.6	3.6	4.2	5.7	2	1.8	3	1	2.7	2.9	4.4	2.9	3	3.8	2	0.2	0	4.5	0.8	3.3	0	0.6	0	1.4	0.9	1.9	1.5	1.1	0.3	4	2.4	0	1.7	5	0.7	0	1.3	0	0	1.5	0	0.8	0	0.9	0	0.7	0	0.5	3.4	0	2.6	0.9	0.5	5.2	0	2.1	3.5	1.9	6.5	0	1	2.6	1.7	4.8	0	0.3	0.4	0	1.3	3.5	3.8	2	0.9	2.2	0	0.8	0.7	1.8	0.9	0.9	3.7	0.3	1.1	1.6	2.9	2.9	4.4	3.2	2.1	3	2.7	2.6	2.6	2.9	1	2.9	3.6	4.4	3	2.3	1.5	3.8	2											0	1.1	0	0	0	0	0	0	8.1	1.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0.2	0	0	0	0	0	0	0	0	0	0	Ciliated cells
AL451007.3		ENSG00000284188			1	244729898-244730962	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level				Tissue enriched	Detected in some	5	testis: 12.4	Cell type enriched	Detected in single	33	Distal tubular cells: 3.3									Cell type enhanced	Detected in single		naive B-cell: 1.1	Low lineage specificity	Detected in single			Cell line enhanced	Detected in some		CACO-2: 1.6;NTERA-2: 1.2;SCLC-21H: 1.6																																							0.4	0	0	0	0	0.2	0	0	0.4	0.6	0	0.1	0	0	0	0	0	0.1	0.6	0	0.3		0.6	0	0	0	0.8	0.4	0	0	1	0	0	0.5	0.1	0	0	0	0.2	2.3	0	0.2	1.6	1.5	0.2	0.2	12.4	0.2	0	0.2	0	0	0	0	1.1	0.5	0	0	0.4	0.2	0.1	0	0	0	0	0	0	0	0	0	0	0.3	1.6	0	0	0.5	0	0	0	0	0	0.9	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0.4	0	0	0	0	0	0	0	1.2	0	0.6	0	0	0	0	0	1.6	0	0	0	0	0.2	0	0	0	0	0.8	0	0.3	0.3	0	0.1	0	0.4	0.2	0	0	0	0	0	0.2	0	0	0	0	1.1	0	0	0	0.4	0	0.5	0	0.1											0	0	0	0	0	0	0	0	0	0	0	0	0	3.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Distal tubular cells
THSD8		ENSG00000284491	Thrombospondin type 1 domain containing 8		19	12802031-12813581	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level				Group enriched	Detected in some	5	pancreas: 2.5;testis: 8.9	Cell type enriched	Detected in single	14	Ciliated cells: 1.4									Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	5	BEWO: 3.4	Not detected	Not detected																																					0	0	0	0	0	0.7	0	0	0.3	0	0	0	0	0	0	0	0	0.1	0	0	0		0	0	0	0	0	0	0	2.5	0	0	0	0	0	0	0	0	0	0.9	1.1	0	0	0	0	0	8.9	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.7	0	0.4	0.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0	0	0	0	1.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Ciliated cells
LYNX1-SLURP2		ENSG00000284505	LYNX1-SLURP2 readthrough		8	142764334-142778224	Predicted intracellular proteins				Evidence at transcript level	Evidence at transcript level				Tissue enhanced	Detected in many		brain: 13.1;esophagus: 13.6	Cell type enriched	Detected in single	9	Pancreatic endocrine cells: 5.9									Group enriched	Detected in some	5	intermediate monocyte: 2.7;non-classical monocyte: 4.1	Lineage enriched	Detected in single	6	monocytes: 4.1	Cell line enhanced	Detected in some		A549: 2.3;BJ: 3.6;EFO-21: 3.0;HaCaT: 2.6;SH-SY5Y: 1.7;TIME: 1.7														Intracellular and membrane																									3.8	2.4	3.7	0.8	4.1	0.3	1.1	1.2	13.1	1.1	1.4	2.1	0	1.1	1.9	1.4	13.6	2.1	1.2	7	3		1.6	6.5	1.1	0.6	2.3	4.2	1.6	1	1.2	0	0.7	6.7	3.6	0.9	1.9	2	5	2	8.6	1.5	3.5	1.2	1.5	1.2	0.8	1.4	0	0.5	0.5	1.1	4.2	0.8	0	0.2	0	4.1	0	0.6	0.1	0	2.3	0	0	0	0	0	3.6	0	0.1	0.4	0.3	0	0	3	0	1	2.6	0	0	0	0	0	0	0	0.7	0.3	0	1.3	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0.5	0.9	0.1	0	0	0	0	0	0.4	1.7	0.4	0.2	0	0.1	1.1	0	1.7	0	0.1	0	0	0	0	0	0	0	0	0	0.1	0	0.3	2.7	0.1	0	0	0.1	0.2	0	0.6	0.2	0	0	4.1	0	0	0.1											0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5.9	0	0	0	0	0	0	0	0	0	0	0	0	0	Pancreatic endocrine cells
AC092718.8		ENSG00000284512			16	81022316-81096284	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level				Tissue enhanced	Detected in many		testis: 20.6	Cell type enriched	Detected in single	11	Alveolar cells type 2: 1.1									Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low cell line specificity	Detected in many											HPA041368	Uncertain		Approved	Vesicles						Vesicles		HPA041368: AB_10804001																		1.4	1.9	3.2	2.1	4.7	4	1.7	1.8	6.9	1.4	1.3	4.4	4	1.4	2	4.2	1.3	1.7	1.6	2.4	3.7		2.5	4.2	1.4	1.9	5.1	4.7	2.2	2.5	3.6	1.4	1.7	5.7	4	1.3	2.6	2.3	1.7	3.2	1.9	1.6	1.3	3.9	1.5	1.7	20.6	5.4	1.2	4.5	0.9	1.2	1.7	0	1.9	2.8	2.3	1	1.7	2.1	0.9	1.3	0.7	1.9	1.6	0.3	0	1.6	2.4	0.2	0.5	0.1	1.2	1.9	1.8	1	0.6	0.9	2.8	0.1	0.1	0.5	0.3	1.1	1.1	2.5	1.8	0.2	1.8	3.4	0.6	0.2	0.4	0	1	0	2.2	1	3.3	0	3.7	1.6	4	1.9	0.7	1.1	1.6	1.3	0.5	0.2	0.8	2.8	0.8	1.8	1.2	0.4	1	1.2	0.5	0.3	1.7	2	1.3	1.1	1.6	0.8	3.4	0.6	0.8	0.8	1.9	1	0.6	1.2	0.6	1	1.1	0.9	2.1	0.6	1.9	1.2	1.5	2.3	1.7	0.9	2.8	1.8	0.9											0	1.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Alveolar cells type 2
OR8S1		ENSG00000284723	Olfactory receptor family 8 subfamily S member 1	Q8NH09	12	48525632-48528103	G-protein coupled receptors, Predicted membrane proteins	Olfaction, Sensory transduction	G-protein coupled receptor, Receptor, Transducer		Evidence at protein level	Evidence at protein level	No human protein/transcript evidence	No human protein/transcript evidence		Tissue enhanced	Detected in some		intestine: 1.2;ovary: 1.0	Cell type enriched	Detected in single	7	Spermatocytes: 4.1									Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		BEWO: 1.1;CAPAN-2: 1.6					Not detected	Not detected			HPA045595	Uncertain		Supported	Plasma membrane						Plasma membrane		HPA045595: AB_10964447																		0	0		0		0	0		0	0	0			1.2	0.1	0	0	0	0.5	0			0	0	0	0			1	0	0		0		0	0		0	0	0	0	0	0		0	0	0.7			0		0	0		0	0	0	0	0	0	0	0	0	0	0	0	0	1.1	0	0	0	0	0	1.6	0	0	0	0.3	0	0	0	0	0	0	0	0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.3	0	0	0	0	0	0	0	0	0	0	0	0	4.1	0.4	0	0	0	0	0	Spermatocytes
TBCE	HRD, KCS, KCS1, pac2	ENSG00000284770	Tubulin folding cofactor E	Q15813	1	235367360-235452443	Disease related genes, Predicted intracellular proteins		Chaperone	Disease mutation, Dwarfism, Mental retardation, Neurodegeneration	Evidence at protein level	Evidence at transcript level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Low tissue specificity	Detected in all			Cell type enriched	Detected in single	141	Cardiomyocytes: 14.1									Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low cell line specificity	Detected in all											HPA026552, HPA026557	Approved											HPA026552: AB_1857797, HPA026557: AB_1857798																		5.2	6.6	4	4.3	5.9	3.4	3.1	9.4	6.9	3.8	5.6	5.6	3.6	6.2	7.3	3.4	8.5	2.5	5.8	9.2	4.3		6.7	7.2	3.5	4	3	4.5	4.1	10.5	2.6	8.7	4.9	11	4.5	3.7	6.2	7.8	2.7	15.5	6.5	4.6	3.6	4.4	3.1	5.6	5	3.8	3.6	10.7	5.7	5	6	3	1.8	5.3	1.5	6	2	2.4	1.8	12	14.6	11.3	7.5	7.8	8.8	12.7	13.7	5.2	11.7	14.7	12.9	10.3	9.3	25.9	4.5	10.1	8.1	9.9	6.7	9.9	15.8	19	9.1	9.3	11.5	11.4	15.2	7.1	9.4	6.1	9.3	9.7	7.3	5.8	15.8	33.5	6.1	11.5	5.9	9	7.4	19.6	25.9	3.3	8.9	15.9	19.1	11.4	8.7	9.4	8.9	9.9	10	12.9	7.9	17.6	15.9	9.5	10.8	8.3	14.3	13.6	10	18.4	10.7	10	10.8	16	0.6	3.7	1.5	2	6	2.3	0.8	1.8	2.4	5.3	1.8	1.2	2	0.3	2	3.2	1.9	1.2	1.8											0	0	0	0	0	0	14.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Cardiomyocytes
IGF2		ENSG00000284779	Insulin like growth factor 2		11	2129112-2158658	Predicted intracellular proteins, RAS pathway related proteins				Evidence at transcript level	Evidence at transcript level				Tissue enriched	Detected in some	8	liver: 24.1	Cell type enriched	Detected in many	5	Leydig cells: 2784.7									Not detected	Not detected			Not detected	Not detected			Cell line enhanced	Detected in some		CACO-2: 1.2;RH-30: 3.3														Intracellular and membrane																									1.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0		0	24.1	0	0	0	0	0	0	0	2.8	1.2	0	0	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	1.4	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.5	0	0	0	1.2	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0.3	0	0	0	0.3	0	0	0	0	0	0	0	0	0.5	0	0	0	0	0	0	0	3.3	0	0	0	0	0.8	0.3	0	0	0.1	0.1	0	0	0	0	0	0	0	0	0	0	0.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0											3	1.9	0	0.6	4.7	0	0	2.5	1.4	1.2	3.5	0	0	0	0	9.1	11.3	0	0	0	0	3.9	0.3	0	350.3	0	0	0	38.1	8.5	19.9	2784.7	1.7	3.3	0	0	0.1	0	0	605.3	0	0.3	64.7	7.3	3.2	4.3	3.6	0	0	0	0.1	Leydig cells
AC008397.1		ENSG00000284797			19	18249950-18255419	Predicted membrane proteins				Evidence at transcript level	Evidence at transcript level				Group enriched	Detected in some	4	gallbladder: 19.9;intestine: 13.8;pancreas: 12.5	Cell type enriched	Detected in some	5	Collecting duct cells: 34.9									Not detected	Not detected			Not detected	Not detected			Cell line enriched	Detected in single	528	OE19: 67.7																																							0	0	0	3.1	0	0	0	0	0	1.5	13.8	0	0	0	0	0	3.4	0.2	19.9	0	0		0.3	0	0.4	0	0	0	0	12.5	0	0	0.2	0	0	0.7	0	1.7	0	0	0	9.4	0.2	0	0	1.7	1.1	0	0	0.1	0.5	3.5	0.4	1.2	0.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	67.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.9	0	0	0	0	0	0	0	0											0	1	0	0	0	0	0	0	0	0	34.9	0	0	0	1.1	0	0	0	0	2.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	7.3	0	0	0	0	0	0	0	0	0	0	0	0	0	Collecting duct cells
UPK3BL2		ENSG00000284981	Uroplakin 3B like 2	E5RIL1	7	102538417-102543849	Predicted membrane proteins				Evidence at protein level	Evidence at transcript level	No human protein/transcript evidence	Evidence at protein level		Tissue enhanced	Detected in many		esophagus: 12.2;lymphoid tissue: 12.8	Cell type enriched	Detected in single	14	Ciliated cells: 1.4									Low cell type specificity	Detected in many			Low lineage specificity	Detected in all			Low cell line specificity	Detected in many											HPA011403	Approved											HPA011403: AB_2668503																		0.8	0		1.5		6.5	1		0.3	0	0.6			1	0.7	0.4	12.2	0.9	0.6	0			0	0.1	0.8	3.4			0.4	0.7	0.2		0.3		1.2	0.8		1.5	3.6	2.7	2.8	0.9	0.1		3.2	0.4	0			4.5		12.8	2.5		5	8.4	6.1	3.7	1	7.9	1.3	5.8	9	3.9	6.8	1.9	0.6	13.4	10.7	13.4	13.5	16.7	3.1	9.8	6.6	5.3	4	1.4	18.9	0.4	5	3.7	7.3	11	2.3	14.8	5.3	7.8	5.7	7.3	6.5	7.4	3.9	3.6	3.1	6.1	8.6	6.1	15.3	4.9	23.9	6.4	9.6	1.5	2.8	1.8	5	2.1	9.6	7.6	22.9	5	5.5	6	2.9	5.4	7	3.1	5.4	2.7	7.2	3.2	4.6	4.3	15.3	4.8	4.1	2	10.3	5.2	0.2	3.7	2.6	7.9	1.9	2.9	4.7	3.1	2.5	1.5	5	5.6	2.8	6.1	1	2	8.4	3	1.3											0	0	0	0	0	0	0	0	1.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Ciliated cells
ARHGAP11B		ENSG00000285077	Rho GTPase activating protein 11B	Q3KRB8	15	30624494-30638805	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at transcript level	Evidence at transcript level		Tissue enhanced	Detected in some		esophagus: 2.6;intestine: 2.7;stomach 1: 1.9	Cell type enriched	Detected in many	5	Erythroid cells: 93.5									Low cell type specificity	Detected in some			Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		HeLa: 17.9									HPA064479	Uncertain		Uncertain	Vesicles						Vesicles		HPA064479: AB_2685272																		0.2	0		0		0.3	0		0	0	1.1			1.1	0	0	2.6	0.1	0	0			0	0.1	0.1	1.6			0	0	0		1		0	2.7		0	0	0	0.3	0.1	0		0.3	1.9	0.4			0		0.9	0.3		1	0.8	0	0	0	1.3	0	2.9	0.4	0	1.8	0.6	0.6	1.6	0.2	1	1.3	0.5	4.6	3.1	0	1.4	1	1.8	5.3	4.2	0.1	2.5	4.1	0.4	0	17.9	1.4	0.4	0.9	0.2	0.4	0.1	0.5	1.1	0.9	1.5	0	1.3	7.8	3.9	0.2	2.4	0.6	0.9	1.4	0.3	0.9	1.8	1.2	1.3	4.6	2.7	1	1.1	1.3	0.6	0.7	1.5	3.3	1.3	4.8	2.7	0.1	3	3	2.1	1.4	1.1	3.7	5	0	0	0	0.1	0	0	0.3	1.3	0.9	0.8	1	0.3	0.6	0	0	0	0.3	0.2	0											0	1	11.2	1	1.8	3.4	0.7	0	1.4	0	1.8	5.9	0	0	0.4	20.2	0.5	1.7	93.5	0.5	0	0.9	0.9	1.1	0.8	0	3.2	0	4.3	5.7	12.8	2	2.9	0	3.6	4	13.2	0.4	3.4	1.1	0.3	2.4	0	1	13.6	10	1.3	0	5.3	2.9	0.9	Erythroid cells
AC026316.5		ENSG00000285218			3	170418868-170860380	Predicted membrane proteins				Evidence at transcript level	Evidence at transcript level				Group enriched	Detected in many	5	brain: 64.6;testis: 27.4	Cell type enriched	Detected in single	18	Collecting duct cells: 1.8									Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Low cell line specificity	Detected in many																																									2.4	3.9	6.2	3.5	30.3	9	3.1	2.1	18.4	1.2	1.4	64.6	0	2.7	3.4	4.2	2.8	1.9	4.9	2.4	9		2.4	1.8	2.1	3	44.6	12.4	7.2	1.7	2.6	0	2.2	27.8	4.4	1.2	0	3.8	2.2	3.1	6.2	2.7	2.1	27.1	2.1	1.9	27.4	35.8	0	2.5	0.2	1.6	1.8	1.6	1	0.6	2.4	0.9	0.4	1.3	0.3	1.5	2.4	2.9	2.4	0.7	0.6	2.4	1.6	1	0.5	0.1	0.5	2.2	2.4	3.6	1.2	1	3	0.1	0	0.5	2.4	2	3.2	3.6	2.1	0	2	3.3	0.7	0.6	0.7	0.3	0.9	0.6	2.1	1.5	2.7	0.7	0.7	0.8	3.4	4	2.5	3.1	1.5	0.8	1	1.4	2	5.6	1.7	1.9	1.6	0.8	2.5	1.8	0.5	2	1.5	2.2	5.8	0.6	1.6	2	1	1	2.4	1.2	0.6	0.6	0.5	0.8	0.9	1.3	0.8	1.1	1.1	0.6	1	1.3	1.2	2.4	0.4	0.9	0.5	0.9	0.3											0	0	0	0	0	0	0	0	0	0	1.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Collecting duct cells
AL035078.4		ENSG00000285283	Reticulocalbin-1 	Q15293	11	31812391-32104665	Predicted intracellular proteins				Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Evidence at protein level	Tissue enhanced	Detected in many		brain: 16.2	Cell type enriched	Detected in single	4	Ciliated cells: 1.4									Low cell type specificity	Detected in many			Low lineage specificity	Detected in many			Cell line enhanced	Detected in many		BJ: 63.7;RH-30: 39.5;RT4: 43.1									HPA038474	Uncertain		Supported	Endoplasmic reticulum					2300000	Endoplasmic reticulum		HPA038474: AB_10672595																		4.7	0.9	1.6	7.5	2.4	0	0.3	16.2	3.2	0.3	5.9	1.7	0.3	0.9	3.8	0.3	1.7	4.3	0.3	0.3	3.1		0.4	2.8	1.4	0.3	2.2	1.9	6.1	0.3	0	1.8	1.6	3	0.3	0.8	6.9	0.3	0.3	3.3	0	2.4	4.6	3.6	0.5	2.2	0.3	1	0.3	0.5	0.3	0.7	1.9	0.3	0.6	5.3	0.4	3.5	3.2	2.1	1.7	7.4	12.4	12	11.5	3.4	2.1	6.7	63.7	21.2	11.2	10.4	6	9.6	0	21	24	16.2	6.5	9	7.2	12.3	5	1.5	3.6	9	0.7	0	3.1	1.5	10.6	1.4	12.3	8.1	3.9	15.8	2	1.2	3.9	0.1	2.6	4.9	0	5.1	0	0.1	2.7	39.5	1.6	0	43.1	5	1.9	12.4	0.8	7.6	3.1	9.1	0.1	37.7	28.7	12.1	17.3	24.3	0	0	0.1	30.4	1.2	13.1	0	3.5	0	2.1	3.4	1.9	0.6	0.2	1.8	5.3	0.1	0.3	0.9	0.4	3.2	2	0.6	0	1.7											0	0.3	0	0	0	0	0	0	1.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Ciliated cells
